PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Wei, T; Weiler, SME; Toth, M; Sticht, C; Lutz, T; Thomann, S; De La Torre, C; Straub, B; Merker, S; Ruppert, T; Marquardt, J; Singer, S; Gretz, N; Schirmacher, P; Breuhahn, K				Wei, Teng; Weiler, Sofia Maria Elisabeth; Toth, Marcell; Sticht, Carsten; Lutz, Teresa; Thomann, Stefan; De La Torre, Carolina; Straub, Beate; Merker, Sabine; Ruppert, Thomas; Marquardt, Jens; Singer, Stephan; Gretz, Norbert; Schirmacher, Peter; Breuhahn, Kai			YAP-dependent induction of UHMK1 supports nuclear enrichment of the oncogene MYBL2 and proliferation in liver cancer cells	ONCOGENE			English	Article							YES-ASSOCIATED PROTEIN; ORGAN SIZE CONTROL; HIPPO PATHWAY; EXPRESSION; KINASE; GENE; KIS; HOMEOSTASIS; INSTABILITY; ACTIVATION	The oncogene yes-associated protein (YAP) is a key modifier of liver homeostasis and regulates mitosis in hepatocytes as well as in malignantly transformed cells. However, the question of how YAP supports cell proliferation in hepatocellular carcinoma (HCC) is not well understood. Here we identified U2AF momology motif kinase 1 (UHMK1) as a direct transcriptional target of YAP and the transcription factor forkhead box M1 (FOXM1), which supports HCC cell proliferation but not migration. Indeed, UHMK1 stimulates the expression of genes that are specific for cell cycle regulation and which are known downstream effectors of YAP. By using BioID labeling and mass spectrometry, the dimerization partner, RB-like, E2F and multi-vulval class B (DREAM) complex constituent MYB proto-oncogene like 2 (MYBL2, B-MYB) was identified as a direct UHMK1 interaction partner. Like YAP, UHMK1 stimulates nuclear enrichment of MYBL2, which is associated HCC cell proliferation and the expression of the cell cycle regulators CCNB1, CCNB2, KIF20A, and MAD2L1. The association between YAP, UHMK1, MYBL2, and proliferation was confirmed in YAP(s127A)-transgenic mice and human HCC tissues. In summary, we provide a model by which YAP supports cell proliferation through the induction of important cell cycle regulators in a UHMK1- and MYBL2-dependent manner.	[Wei, Teng; Weiler, Sofia Maria Elisabeth; Toth, Marcell; Lutz, Teresa; Thomann, Stefan; Schirmacher, Peter; Breuhahn, Kai] Univ Hosp Heidelberg, Inst Pathol, Heidelberg, Germany; [Sticht, Carsten; De La Torre, Carolina; Gretz, Norbert] Heidelberg Univ, Med Fac Mannheim, Med Res Ctr, Mannheim, Germany; [Straub, Beate] Johannes Gutenberg Univ Mainz, Inst Pathol, Mainz, Germany; [Merker, Sabine; Ruppert, Thomas] Univ Heidelberg ZMBH, DKFZ ZMBH Alliance, Zentrum Mol Biol, Heidelberg, Germany; [Marquardt, Jens] Johannes Gutenberg Univ Mainz, Dept Med 1, Mainz, Germany; [Singer, Stephan] Univ Med Greifswald, Inst Pathol, Greifswald, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Johannes Gutenberg University of Mainz; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Johannes Gutenberg University of Mainz; Greifswald Medical School	Breuhahn, K (corresponding author), Univ Hosp Heidelberg, Inst Pathol, Heidelberg, Germany.	kai.breuhahn@med.uni-heidelberg.de	Ruppert, Thomas/AAC-2467-2021	Ruppert, Thomas/0000-0001-9152-2266; Thomann, Stefan/0000-0002-3500-0014; wei, teng/0000-0001-7560-2848	German Cancer Aid (Deutsche Krebshilfe) [DKH 111524]; China Scholarship Council/CSC; German Research Foundation [MA 4443/2-2]; Volkswagen Foundation (Lichtenberg program);  [SFB/TR 209];  [SPP1782/2]	German Cancer Aid (Deutsche Krebshilfe)(Deutsche Krebshilfe); China Scholarship Council/CSC(China Scholarship Council); German Research Foundation(German Research Foundation (DFG)); Volkswagen Foundation (Lichtenberg program); ; 	We thank M. Bissinger and J. Schmitt for excellent technical assistance, Dr. A. Ori for providing us with the BirA vector, as well as T. R. Brummelkamp and F. D. Camargo for providing Col1A1-YAPS127A transgenic mice. Tissue samples were provided by the tissue bank of the National Center of Tumor Diseases (Heidelberg, Germany) in accordance with the regulations of the tissue bank and the approval of the Ethics Committee of Heidelberg University. We also thank the Center of Model System and Comparative Pathology (CMCP; Dr. F. Lasitschka, Dr. T. Poth) and H. Conrad for their support. This study was supported by a grant from the German Cancer Aid (Deutsche Krebshilfe/Dr. Mildred Scheel Stiftung, to K.B., DKH 111524), the SFB/TR 209 "Liver Cancer" (to K.B., S.S., and P.S.), the priority program SPP1782/2 (to K. B.), and the China Scholarship Council/CSC (to T.W.). J.U.M. is supported by grants from the German Research Foundation (MA 4443/2-2) and the Volkswagen Foundation (Lichtenberg program).	Ally A, 2017, CELL, V169, P1327, DOI 10.1016/j.cell.2017.05.046; Benhamouche S, 2010, GENE DEV, V24, P1718, DOI 10.1101/gad.1938710; Bieche I, 2003, MOL BRAIN RES, V114, P55, DOI 10.1016/S0169-328X(03)00132-3; Boehm M, 2002, EMBO J, V21, P3390, DOI 10.1093/emboj/cdf343; Calvisi DF, 2011, HEPATOLOGY, V53, P1226, DOI 10.1002/hep.24174; Carter SL, 2006, NAT GENET, V38, P1043, DOI 10.1038/ng1861; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Eisinger-Mathason TSK, 2015, P NATL ACAD SCI USA, V112, pE3402, DOI 10.1073/pnas.1420005112; Guan Z, 2018, CURR RES TRANSL MED, V66, P27, DOI 10.1016/j.retram.2017.11.002; Guiley KZ, 2015, GENE DEV, V29, P961, DOI 10.1101/gad.257568.114; Johnson R, 2014, NAT REV DRUG DISCOV, V13, P63, DOI 10.1038/nrd4161; Langenickel TH, 2008, J CLIN INVEST, V118, P3848, DOI 10.1172/JCI33206; Manceau V, 2006, FEBS J, V273, P577, DOI 10.1111/j.1742-4658.2005.05091.x; Manceau V, 2008, J MOL BIOL, V381, P748, DOI 10.1016/j.jmb.2008.06.026; Manceau V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043946; MAUCUER A, 1995, P NATL ACAD SCI USA, V92, P3100, DOI 10.1073/pnas.92.8.3100; Panciera T, 2017, NAT REV MOL CELL BIO, V18, P758, DOI 10.1038/nrm.2017.87; Petrovic V, 2008, J BIOL CHEM, V283, P453, DOI 10.1074/jbc.M705792200; Qiao YT, 2017, CELL REP, V19, P1495, DOI 10.1016/j.celrep.2017.04.075; Roux KJ, 2012, J CELL BIOL, V196, P801, DOI 10.1083/jcb.201112098; Sadasivam S, 2013, NAT REV CANCER, V13, P585, DOI 10.1038/nrc3556; Schopp IM, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15690; Song H, 2010, P NATL ACAD SCI USA, V107, P1431, DOI 10.1073/pnas.0911409107; Tschaharganeh DF, 2013, GASTROENTEROLOGY, V144, P1530, DOI 10.1053/j.gastro.2013.02.009; Weiler SME, 2017, GASTROENTEROLOGY, V152, P2037, DOI 10.1053/j.gastro.2017.02.018; Xu MZ, 2011, ONCOGENE, V30, P1229, DOI 10.1038/onc.2010.504; Yu FX, 2015, CELL, V163, P811, DOI 10.1016/j.cell.2015.10.044; Zanconato F, 2015, NAT CELL BIOL, V17, P1218, DOI 10.1038/ncb3216; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408	29	33	35	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 4	2019	38	27					5541	5550		10.1038/s41388-019-0801-y	http://dx.doi.org/10.1038/s41388-019-0801-y			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	IG5KR	30936457				2022-12-26	WOS:000473842500015
J	Nagy, N; Gurevich, I; Kuipers, HF; Ruppert, SM; Marshall, PL; Xie, BJ; Sun, WC; Malkovskiy, AV; Rajadas, J; Grandoch, M; Fischer, JW; Frymoyer, AR; Kaber, G; Bollyky, PL				Nagy, Nadine; Gurevich, Irina; Kuipers, Hedwich F.; Ruppert, Shannon M.; Marshall, Payton L.; Xie, Bryan J.; Sun, Wenchao; Malkovskiy, Andrey V.; Rajadas, Jayakumar; Grandoch, Maria; Fischer, Jens W.; Frymoyer, Adam R.; Kaber, Gernot; Bollyky, Paul L.			4-Methylumbelliferyl glucuronide contributes to hyaluronan synthesis inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						hyaluronan; diabetes; extracellular matrix; autoimmune disease; immunology; 2-photon imaging; 4-methylumbelliferone; 4-methylumbelliferyl glucuronide; glycosaminoglycan; N-acetylglucosamine (GlcNAc)	EXTRACELLULAR-MATRIX; IMMUNE TOLERANCE; PROMOTES; PHARMACOKINETICS; ACCUMULATION; AUTOIMMUNITY; RECOGNITION; MAINTENANCE; PERSISTENCE; EXPRESSION	4-Methylumbelliferone (4-MU) inhibits hyaluronan (HA) synthesis and is an approved drug used for managing biliary spasm. However, rapid and efficient glucuronidation is thought to limit its utility for systemically inhibiting HA synthesis. In particular, 4-MU in mice has a short half-life, causing most of the drug to be present as the metabolite 4-methylumbelliferyl glucuronide (4-MUG), which makes it remarkable that 4-MU is effective at all. We report here that 4-MUG contributes to HA synthesis inhibition. We observed that oral administration of 4-MUG to mice inhibits HA synthesis, promotes FoxP3(+) regulatory T-cell expansion, and prevents autoimmune diabetes. Mice fed either 4-MUG or 4-MU had equivalent 4-MU:4-MUG ratios in serum, liver, and pancreas, indicating that 4-MU and 4-MUG reach an equilibrium in these tissues. LC-tandem MS experiments revealed that 4-MUG is hydrolyzed to 4-MU in serum, thereby greatly increasing the effective bioavailability of 4-MU. Moreover, using intravital 2-photon microscopy, we found that 4-MUG (a nonfluorescent molecule) undergoes conversion into 4-MU (a fluorescent molecule) and that 4-MU is extensively tissue bound in the liver, fat, muscle, and pancreas of treated mice. 4-MUG also suppressed HA synthesis independently of its conversion into 4-MU and without depletion of the HA precursor UDP-glucuronic acid (GlcUA). Together, these results indicate that 4-MUG both directly and indirectly inhibits HA synthesis and that the effective bioavailability of 4-MU is higher than previously thought. These findings greatly alter the experimental and therapeutic possibilities for HA synthesis inhibition.	[Nagy, Nadine; Kuipers, Hedwich F.; Ruppert, Shannon M.; Marshall, Payton L.; Xie, Bryan J.; Kaber, Gernot; Bollyky, Paul L.] Stanford Univ, Sch Med, Dept Med, Div Infect Dis & Geog Med, Stanford, CA 94305 USA; [Gurevich, Irina] Stanford Univ, Sch Med, Dept Dermatol, Stanford, CA 94305 USA; [Sun, Wenchao; Malkovskiy, Andrey V.; Rajadas, Jayakumar] Stanford Univ, Sch Med, Biomat & Adv Drug Delivery BioADD Lab, Palo Alto, CA 94304 USA; [Grandoch, Maria; Fischer, Jens W.] Univ Clin Dusseldorf, Pharmacol & Clin Pharmacol, Univ Str 1, D-40225 Dusseldorf, Germany; [Frymoyer, Adam R.] Stanford Univ, Sch Med, Dept Pediat, Palo Alto, CA 94304 USA	Stanford University; Stanford University; Stanford University; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Stanford University	Nagy, N (corresponding author), Beckman Ctr, 279 Campus Dr,Rm B237, Stanford, CA 94305 USA.	nnagy@stanford.edu	Rajadas, Jayakumar/AHC-0630-2022; Sun, Wenchao/H-7738-2017; Kuipers, Hedwich F./AAF-1925-2021	Sun, Wenchao/0000-0003-4306-2896; Kuipers, Hedwich F./0000-0002-7275-5889; gurevich, irina/0000-0001-9576-0456; Nagy, Nadine/0000-0002-2638-2436; Rajadas, Jayakumar/0000-0001-6520-3923; Xie, Bryan/0000-0002-8625-5981	National Institutes of Health [NS069375]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113294] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007290, U01AI101984] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK114174, P30DK116074, R01DK096087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS069375] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We appreciate the use of the Stanford Neuroscience Microscopy Service Center, supported by National Institutes of Health Grant NS069375, and we thank Dr. Andrew Olson for helpful discussions and advice regarding 2-photon measurements.	Berninsone P, 2001, P NATL ACAD SCI USA, V98, P3738, DOI 10.1073/pnas.061593098; Bollyky PL, 2007, J IMMUNOL, V179, P744, DOI 10.4049/jimmunol.179.2.744; Bollyky PL, 2012, CURR DIABETES REP, V12, P471, DOI 10.1007/s11892-012-0297-0; Bollyky PL, 2011, P NATL ACAD SCI USA, V108, P7938, DOI 10.1073/pnas.1017360108; Bollyky PL, 2010, CELL MOL IMMUNOL, V7, P211, DOI 10.1038/cmi.2010.9; Bollyky PL, 2009, J LEUKOCYTE BIOL, V86, P567, DOI 10.1189/jlb.0109001; Bollyky PL, 2009, J IMMUNOL, V183, P2232, DOI 10.4049/jimmunol.0900191; Cheng G, 2011, MATRIX BIOL, V30, P126, DOI 10.1016/j.matbio.2010.12.003; Coulson-Thomas V., 2016, BIO-PROTOCOL, V4, DOI [10.21769/bioprotoc.1236, DOI 10.21769/BIOPROTOC.1236, 10.21769/BioProtoc.1236]; Fraser JRE, 1997, J INTERN MED, V242, P27, DOI 10.1046/j.1365-2796.1997.00170.x; Garantziotis S, 2010, AM J RESP CRIT CARE, V181, P666, DOI 10.1164/rccm.200903-0381OC; GARRETT ER, 1993, BIOPHARM DRUG DISPOS, V14, P13, DOI 10.1002/bdd.2510140103; Hull RL, 2015, J HISTOCHEM CYTOCHEM, V63, P592, DOI 10.1369/0022155415576542; Hull RL, 2012, J HISTOCHEM CYTOCHEM, V60, P749, DOI 10.1369/0022155412457048; Itano N, 2002, P NATL ACAD SCI USA, V99, P3609, DOI 10.1073/pnas.052026799; Jackson DG, 2009, IMMUNOL REV, V230, P216, DOI 10.1111/j.1600-065X.2009.00803.x; Jiang DH, 2011, PHYSIOL REV, V91, P221, DOI 10.1152/physrev.00052.2009; Kakizaki I, 2004, J BIOL CHEM, V279, P33281, DOI 10.1074/jbc.M405918200; Kang L, 2013, DIABETES, V62, P1888, DOI 10.2337/db12-1502; Kuipers HF, 2016, CLIN EXP IMMUNOL, V185, P372, DOI 10.1111/cei.12815; Kuipers HF, 2016, P NATL ACAD SCI USA, V113, P1339, DOI 10.1073/pnas.1525086113; Kultti A, 2009, EXP CELL RES, V315, P1914, DOI 10.1016/j.yexcr.2009.03.002; Lee-Sayer SSM, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00150; Mahaffey CL, 2007, J IMMUNOL, V179, P8191, DOI 10.4049/jimmunol.179.12.8191; McKee CM, 1996, J CLIN INVEST, V98, P2403, DOI 10.1172/JCI119054; Medina CO, 2018, CURR OPIN IMMUNOL, V55, P22, DOI 10.1016/j.coi.2018.09.006; Mine S, 2006, ENDOCR J, V53, P761, DOI 10.1507/endocrj.K05-119; Mueller AM, 2014, J BIOL CHEM, V289, P22888, DOI 10.1074/jbc.M114.559583; MULDER GJ, 1985, BIOCHEM PHARMACOL, V34, P1325, DOI 10.1016/0006-2952(85)90513-1; Nagy N, 2015, J CLIN INVEST, V125, P3928, DOI 10.1172/JCI79271; Nagy N, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00123; Nagy N, 2010, CIRCULATION, V122, P2313, DOI 10.1161/CIRCULATIONAHA.110.972653; Petrey AC, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00101; Ruppert Shannon M, 2015, Int J Cell Biol, V2015, P614297, DOI 10.1155/2015/614297; TAKEDA S, 1981, J PHARMACOBIO-DYNAM, V4, P724, DOI 10.1248/bpb1978.4.724; Taylor KR, 2004, J BIOL CHEM, V279, P17079, DOI 10.1074/jbc.M310859200; Taylor KR, 2007, J BIOL CHEM, V282, P18265, DOI 10.1074/jbc.M606352200; Termeer C, 2003, TRENDS IMMUNOL, V24, P112, DOI 10.1016/S1471-4906(03)00029-2; Termeer C, 2002, J EXP MED, V195, P99, DOI 10.1084/jem.20001858; Vigetti D, 2006, J BIOL CHEM, V281, P8254, DOI 10.1074/jbc.M508516200; Vigetti D, 2014, MATRIX BIOL, V35, P8, DOI 10.1016/j.matbio.2013.10.002; Vigetti D, 2009, GLYCOBIOLOGY, V19, P537, DOI 10.1093/glycob/cwp022; Weigel PH, 2007, J BIOL CHEM, V282, P36777, DOI 10.1074/jbc.R700036200; Yoshioka Y, 2013, ARTHRITIS RHEUM-US, V65, P1160, DOI 10.1002/art.37861; Yung SS, 2012, AUTOIMMUN DIS, V2012, DOI 10.1155/2012/207190	45	18	19	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2019	294	19					7864	7877		10.1074/jbc.RA118.006166	http://dx.doi.org/10.1074/jbc.RA118.006166			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IB3FL	30914479	Green Published, hybrid			2022-12-26	WOS:000470153300027
J	Parsons, LM; Bouwman, KM; Azurmendi, H; de Vries, RP; Cipollo, JF; Verheije, MH				Parsons, Lisa M.; Bouwman, Kim M.; Azurmendi, Hugo; de Vries, Robert P.; Cipollo, John F.; Verheije, Monique H.			Glycosylation of the viral attachment protein of avian coronavirus is essential for host cell and receptor binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycobiology; cell-surface receptor; glycomics; computational biology; glycoprotein; sialic acid; glycosylation; avian infectious bronchitis virus; coronavirus; receptor-binding; spike protein; viral envelope	SPIKE PROTEIN; SECONDARY STRUCTURE; MOLECULAR-GRAPHICS; SIALIC-ACID; VIRUS; DOMAIN; IBV	Avian coronaviruses, including infectious bronchitis virus (IBV), are important respiratory pathogens of poultry. The heavily glycosylated IBV spike protein is responsible for binding to host tissues. Glycosylation sites in the spike protein are highly conserved across viral genotypes, suggesting an important role for this modification in the virus life cycle. Here, we analyzed the N-glycosylation of the receptor-binding domain (RBD) of IBV strain M41 spike protein and assessed the role of this modification in host receptor binding. Ten single Asn-to-Ala substitutions at the predicted N-glycosylation sites of the M41-RBD were evaluated along with two control Val-to-Ala substitutions. CD analysis revealed that the secondary structure of all variants was retained compared with the unmodified M41-RBD construct. Six of the 10 glycosylation variants lost binding to chicken trachea tissue and an ELISA-presented 2,3-linked sialic acid oligosaccharide ligand. LC/MSE glycomics analysis revealed that glycosylation sites have specific proportions of N-glycan subtypes. Overall, the glycosylation patterns of most variant RBDs were highly similar to those of the unmodified M41-RBD construct. In silico docking experiments with the recently published cryo-EM structure of the M41 IBV spike protein and our glycosylation results revealed a potential ligand receptor site that is ringed by four glycosylation sites that dramatically impact ligand binding. Combined with the results of previous array studies, the glycosylation and mutational analyses presented here suggest a unique glycosylation-dependent binding modality for the M41 spike protein.	[Parsons, Lisa M.; Azurmendi, Hugo; Cipollo, John F.] US FDA, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA; [Bouwman, Kim M.; Verheije, Monique H.] Univ Utrecht, Fac Vet Med, Dept Pathobiol, Div Pathol, NL-3584 CL Utrecht, Netherlands; [de Vries, Robert P.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Dept Chem Biol & Drug Discovery, NL-3512 JE Utrecht, Netherlands	US Food & Drug Administration (FDA); Utrecht University; Utrecht University	Cipollo, JF (corresponding author), US FDA, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA.	john.cipollo@fda.hhs.gov		, Hugo/0000-0003-3540-4585; Bouwman, Kim/0000-0003-1794-6735; de Vries, Robert/0000-0002-1586-4464; Azurmendi, Hugo/0000-0002-5773-9127	Netherlands Organisation for Scientific Research (NWO); National Institutes of Health, Health and Human Services, Food and Drug Administration [Z01 BJ 02044-04 LBP]	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); National Institutes of Health, Health and Human Services, Food and Drug Administration	This work was supported by The Netherlands Organisation for Scientific Research (NWO) with VENI Grants (to R. P. dV.) and MEERVOUD (to M. H. V.) and National Institutes of Health, Health and Human Services, Food and Drug Administration Grant Z01 BJ 02044-04 LBP (to L. M. P. and J. F. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	An YM, 2015, J PROTEOME RES, V14, P3957, DOI 10.1021/acs.jproteome.5b00416; An YM, 2011, ANAL BIOCHEM, V415, P67, DOI 10.1016/j.ab.2011.04.018; BINNS MM, 1985, J GEN VIROL, V66, P719, DOI 10.1099/0022-1317-66-4-719; Bosch BJ, 2003, J VIROL, V77, P8801, DOI 10.1128/JVI.77.16.8801-8811.2003; Bucior I, 2004, GLYCOCONJUGATE J, V21, P111, DOI 10.1023/B:GLYC.0000044843.72595.7d; CAVANAGH D, 1983, J GEN VIROL, V64, P2577, DOI 10.1099/0022-1317-64-12-2577; CAVANAGH D, 1983, J GEN VIROL, V64, P1187, DOI 10.1099/0022-1317-64-5-1187; Cheng K, 2017, GLYCOBIOLOGY, V27, P200, DOI 10.1093/glycob/cww115; Ciucanu I, 2003, J AM CHEM SOC, V125, P16213, DOI 10.1021/ja035660t; CIUCANU I, 1984, CARBOHYD RES, V131, P209, DOI 10.1016/0008-6215(84)85242-8; Cook JKA, 2012, AVIAN PATHOL, V41, P239, DOI 10.1080/03079457.2012.680432; DELMAS B, 1990, J VIROL, V64, P5367, DOI 10.1128/JVI.64.11.5367-5375.1990; Dormitzer PR, 2002, EMBO J, V21, P885, DOI 10.1093/emboj/21.5.885; Ferrara C, 2011, P NATL ACAD SCI USA, V108, P12669, DOI 10.1073/pnas.1108455108; GEILHAUSEN HE, 1973, ARCH GES VIRUSFORSCH, V40, P285, DOI 10.1007/BF01242547; Kirschner KN, 2008, J COMPUT CHEM, V29, P622, DOI 10.1002/jcc.20820; Krieger E, 2014, BIOINFORMATICS, V30, P2981, DOI 10.1093/bioinformatics/btu426; Lewicki DN, 2002, J BIOL CHEM, V277, P19727, DOI 10.1074/jbc.M201837200; Lorenz B, 2012, J AM CHEM SOC, V134, P3326, DOI 10.1021/ja210304j; MANAVALAN P, 1987, ANAL BIOCHEM, V167, P76, DOI 10.1016/0003-2697(87)90135-7; Masters PS, 2013, FIELDS VIROLOGY, V6, P825; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Parsons LM, 2017, J PROTEOME RES, V16, P398, DOI 10.1021/acs.jproteome.6b00175; Peng GQ, 2012, J BIOL CHEM, V287, P41931, DOI 10.1074/jbc.M112.418210; Promkuntod N, 2014, VIROLOGY, V448, P26, DOI 10.1016/j.virol.2013.09.018; Radziejewska I, 2013, ADV CLIN EXP MED, V22, P347; Raman R, 2016, CURR OPIN STRUC BIOL, V40, P153, DOI 10.1016/j.sbi.2016.10.003; Shang J, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007009; Sletmoen M, 2018, GLYCOBIOLOGY, V28, P437, DOI 10.1093/glycob/cwy032; SREERAMA N, 1993, ANAL BIOCHEM, V209, P32, DOI 10.1006/abio.1993.1079; Truhlar DG, 2007, J COMPUT CHEM, V28, P73, DOI 10.1002/jcc.20529; VANSTOKKUM IHM, 1990, ANAL BIOCHEM, V191, P110, DOI 10.1016/0003-2697(90)90396-Q; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Wickramasinghe INA, 2015, J VIROL, V89, P8783, DOI 10.1128/JVI.00745-15; Wickramasinghe INA, 2014, VIRUS RES, V194, P37, DOI 10.1016/j.virusres.2014.10.009; Wickramasinghe INA, 2011, J VIROL, V85, P8903, DOI 10.1128/JVI.05112-11; Winter C, 2006, J GEN VIROL, V87, P1209, DOI 10.1099/vir.0.81651-0; Woods Group, 2005, GLYCAM WEB; Zheng J, 2018, VIROLOGY, V513, P65, DOI 10.1016/j.virol.2017.10.003	39	42	44	3	29	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2019	294	19					7797	7809		10.1074/jbc.RA119.007532	http://dx.doi.org/10.1074/jbc.RA119.007532			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IB3FL	30902814	hybrid, Green Published			2022-12-26	WOS:000470153300022
J	Kovalenko, AA; Brenn, T; Odland, JO; Nieboer, E; Krettek, A; Anda, EE				Kovalenko, Anton A.; Brenn, Tormod; Odland, Jon Oyvind; Nieboer, Evert; Krettek, Alexandra; Anda, Erik Eik			Risk Factors for hypospadias in Northwest Russia: A Murmansk County Birth Registry Study	PLOS ONE			English	Article							MALFORMATIONS; PREGNANCY; EXPOSURE; INFANTS; SWEDEN; AGE	Background Hypospadias is the most common congenital anomaly of the penis, but its causes are mainly unknown. Of the risk factors identified, the most plausible are hormonal and genetic. The aim of this study was to identify risk factors for hypospadias in Northwest Russia based on registry data. Methods The study population included male infants registered in the Murmansk County Birth Registry between 1 January 2006 and 31 December 2011 (n = 25 475). These infants were followed-up for 2 years using the Murmansk Regional Congenital Defects Registry to identify cases of hypospadias not diagnosed at birth. We used logistic regression analysis to examine the contributions of hypospadias risk factors. Results Out of 25 475 male infants born during the study period, 148 had isolated hypospadias. The overall prevalence rate was 54.2 (95% CI 53.6-54.8) per 10 000 male infants. Those born to mothers with preeclampsia (OR = 1.65; 95% CI 1.03-2.66) or infant birthweight < 2500 g (OR = 2.06; 95% CI 1.18-3.60) exhibited increased risk for hypospadias. Maternal age, smoking during pregnancy, folic acid intake during pregnancy or hepatitis B surface antigen positivity did not associate with increased risk of hypospadias. Conclusions Combining data from a birth registry with those from a congenital defects registry provided optimal information about the prevalence of hypospadias and its association with low infant birthweight and preeclampsia. These factors have in common changes in hormone levels during pregnancy, which in turn may have contributed to hypospadias development.	[Kovalenko, Anton A.; Brenn, Tormod; Odland, Jon Oyvind; Krettek, Alexandra; Anda, Erik Eik] UiT Arctic Univ Norway, Dept Community Med, Tromso, Norway; [Kovalenko, Anton A.] Northern State Med Univ, Int Sch Publ Hlth, Arkhangelsk, Russia; [Nieboer, Evert] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada; [Krettek, Alexandra] Univ Skovde, Sch Hlth & Educ, Dept Biomed & Publ Hlth, Skovde, Sweden; [Krettek, Alexandra] Univ Gothenburg, Sahlgrenska Acad, Dept Internal Med & Clin Nutr, Gothenburg, Sweden	UiT The Arctic University of Tromso; Northern State Medical University; McMaster University; University of Skovde; University of Gothenburg	Kovalenko, AA (corresponding author), UiT Arctic Univ Norway, Dept Community Med, Tromso, Norway.; Kovalenko, AA (corresponding author), Northern State Med Univ, Int Sch Publ Hlth, Arkhangelsk, Russia.	drkovalenko@rambler.ru	Brenn, Tormod/AAY-5357-2021	Brenn, Tormod/0000-0003-3717-8323	Publication Fund of UiT The Arctic University of Norway	Publication Fund of UiT The Arctic University of Norway	The publication charges for this article were provided by a grant from the Publication Fund of UiT The Arctic University of Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agopian AJ, 2015, HYPOSPADIAS RISK FAC, P1; Akre O, 2008, ENVIRON HEALTH PERSP, V116, P1071, DOI 10.1289/ehp.10791; Anda EE, 2008, INT J CIRCUMPOL HEAL, V67, P318, DOI 10.3402/ijch.v67i4.18339; Aschim EL, 2004, INT J ANDROL, V27, P213, DOI 10.1111/j.1365-2605.2004.00473.x; Baskin L, 2017, CLIN PEDIATR, V56, P409, DOI 10.1177/0009922816684613; Bergman JEH, 2015, WORLD J UROL, V33, P2159, DOI 10.1007/s00345-015-1507-6; Brouwers MM, 2007, EUR J PEDIATR, V166, P671, DOI 10.1007/s00431-006-0304-z; Brouwers MM, 2010, BJU INT, V105, P254, DOI 10.1111/j.1464-410X.2009.08772.x; CALZOLARI E, 1986, J MED GENET, V23, P333, DOI 10.1136/jmg.23.4.333; CANNING DA, 2014, J UROLOGY, V191, P465, DOI DOI 10.1016/J.JUR0.2013.10.106; Carlson WH, 2009, J PEDIATR UROL, V5, P283, DOI 10.1016/j.jpurol.2008.12.005; Carmichael SL, 2005, PAEDIATR PERINAT EP, V19, P406, DOI 10.1111/j.1365-3016.2005.00680.x; Carmichael SL, 2013, AM J EPIDEMIOL, V178, P434, DOI 10.1093/aje/kws591; Carmichael SL, 2012, BIRTH DEFECTS RES A, V94, P499, DOI 10.1002/bdra.23021; Carter TC, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.08.044; Caton AR, 2008, BIRTH DEFECTS RES A, V82, P34, DOI 10.1002/bdra.20415; Chen MJ, 2014, INT J PEDIATR ENDOCR, DOI 10.1186/1687-9856-2014-20; Cunha GR, 2015, NAT REV UROL, V12, P271, DOI 10.1038/nrurol.2015.57; Czeizel AE, 1997, TERATOLOGY, V56, P335, DOI 10.1002/(SICI)1096-9926(199711)56:5<335::AID-TERA7>3.0.CO;2-W; Djakovic N, 2008, ADV UROL, V2008, DOI 10.1155/2008/650135; Gatti JM, 2001, BJU INT, V87, P548, DOI 10.1046/j.1464-410X.2001.00088.x; Hussain N, 2002, PEDIATRICS, V109, P473, DOI 10.1542/peds.109.3.473; Kallen Bengt, 2007, Congenital Anomalies, V47, P119, DOI 10.1111/j.1741-4520.2007.00159.x; Kallen K, 2002, TERATOLOGY, V66, P185, DOI 10.1002/tera.10092; Keays MA, 2017, CUAJ-CAN UROL ASSOC, V11, P48, DOI 10.5489/cuaj.4386; Kim KS, 2004, ENVIRON RES, V94, P267, DOI 10.1016/S0013-9351(03)00085-9; Konstantinidou A E, 2007, J Infect, V54, pe41, DOI 10.1016/j.jinf.2006.03.030; Kovalenko AA, 2017, INT J CIRCUMPOL HEAL, V76, DOI 10.1080/22423982.2017.1366785; MCINTOSH GC, 1995, EPIDEMIOLOGY, V6, P282, DOI 10.1097/00001648-199505000-00016; Morera A M, 2006, J Pediatr Urol, V2, P169, DOI 10.1016/j.jpurol.2005.09.008; Nassar N, 2010, OCCUP ENVIRON MED, V67, P585, DOI 10.1136/oem.2009.048272; Nordenvall AS, 2014, J UROLOGY, V191, P783, DOI 10.1016/j.juro.2013.09.058; Porter Michael P, 2005, Pediatrics, V115, pe495, DOI 10.1542/peds.2004-1552; Sorensen HT, 2005, EPIDEMIOLOGY, V16, P806; STOLL C, 1990, J MED GENET, V27, P559, DOI 10.1136/jmg.27.9.559; Sun G, 2009, UROLOGY, V73, P1241, DOI 10.1016/j.urology.2008.12.081; Thorup J, 2014, CURR OPIN ENDOCRINOL, V21, P227, DOI 10.1097/MED.0000000000000063; Vaktskjold A, 2006, SCAND J WORK ENV HEA, V32, P41, DOI 10.5271/sjweh.975; Weidner IS, 1999, J UROLOGY, V161, P1606, DOI 10.1016/S0022-5347(05)68992-6; Xu LF, 2014, ASIAN J ANDROL, V16, P778, DOI 10.4103/1008-682X.131704	40	2	3	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0214213	10.1371/journal.pone.0214213	http://dx.doi.org/10.1371/journal.pone.0214213			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR7EH	30946760	Green Published, gold, Green Submitted			2022-12-26	WOS:000463314500020
J	Cai, Y; Zheng, WG; Zhang, X; Zhangzhong, LL; Xue, XZ				Cai, Yu; Zheng, Wengang; Zhang, Xin; Zhangzhong, Lili; Xue, Xuzhang			Research on soil moisture prediction model based on deep learning	PLOS ONE			English	Article								Soil moisture is one of the main factors in agricultural production and hydrological cycles, and its precise prediction is important for the rational use and management of water resources. However, soil moisture involves complex structural characteristics and meteorological factors, and it is difficult to establish an ideal mathematical model for soil moisture prediction. Existing prediction models have problems such as prediction accuracy, generalization, and multi-feature processing capability, and prediction performance must improve. Based on this, taking the Beijing area as the research object, the deep learning regression network (DNNR) with big data fitting capability was proposed to construct a soil moisture prediction model. By integrating the dataset, analyzing the time series of the predictive variables, and clarifying the relationship between features and predictive variables through the Taylor diagram, selected meteorological parameters can provide effective weights for moisture prediction. Test results prove that the deep learning model is feasible and effective for soil moisture prediction. It's good data fitting and generalization capability can enrich the input characteristics while ensuring high accuracy in predicting the trends and values of soil moisture data and provides an effective theoretical basis for water-saving irrigation and drought control.	[Cai, Yu; Zheng, Wengang; Zhang, Xin; Zhangzhong, Lili; Xue, Xuzhang] Natl Res Ctr Intelligent Equipment Agr, Beijing, Peoples R China; [Cai, Yu; Zheng, Wengang; Zhang, Xin; Zhangzhong, Lili; Xue, Xuzhang] Minist Agr, Key Lab Qual Testing Hardware & Software Prod Agr, Beijing, Peoples R China; [Cai, Yu] Hebei Univ Technol, Coll Elect Informat Engn, Tianjin, Peoples R China	Ministry of Agriculture & Rural Affairs; Hebei University of Technology	Zheng, WG (corresponding author), Natl Res Ctr Intelligent Equipment Agr, Beijing, Peoples R China.; Zheng, WG (corresponding author), Minist Agr, Key Lab Qual Testing Hardware & Software Prod Agr, Beijing, Peoples R China.	zhengwg@nercita.org.cn		zheng, wengang/0000-0001-8901-6284	National Key Research and Development Program of China [2016YFC0403102]; Innovation ability construction project of Beijing academy of agriculture and forestry sciences [KJCX20170204, KJCX20180704]	National Key Research and Development Program of China; Innovation ability construction project of Beijing academy of agriculture and forestry sciences	The research was supported by the National Key Research and Development Program of China (2016YFC0403102); the Innovation ability construction project of Beijing academy of agriculture and forestry sciences (KJCX20170204) (KJCX20180704).	Akita R., 2016, COMPUTER SCI, V15, P1, DOI [10.1109/ICIS.2016.7550882, DOI 10.1109/ICIS.2016.7550882]; Andrew Zisserman, 2015, Arxiv, DOI arXiv:1409.1556; Caraballo MA, 2016, SCI TOTAL ENVIRON, V539, P427, DOI 10.1016/j.scitotenv.2015.08.156; Chang, 2016, WATER SAVING IRRIG, V7, P70; Chen SuYing, 2015, Zhongguo Shengtai Nongye Xuebao / Chinese Journal of Eco-Agriculture, V23, P535; Chukalla AD, 2015, HYDROL EARTH SYST SC, V19, P4877, DOI 10.5194/hess-19-4877-2015; Collobert R., 2008, P 25 INT C MACH LEAR, P160, DOI DOI 10.1145/1390156.1390177; Dehghani M, 2010, J APPL REMOTE SENS, V4, P402; Feki M, 2018, WATER-SUI, V10, DOI 10.3390/w10070850; Gill MK, 2006, J AM WATER RESOUR AS, V42, P1033, DOI 10.1111/j.1752-1688.2006.tb04512.x; He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90; Hinton GE, 2006, NEURAL COMPUT, V18, P1527, DOI 10.1162/neco.2006.18.7.1527; Hummel JW, 2001, COMPUT ELECTRON AGR, V32, P149, DOI 10.1016/S0168-1699(01)00163-6; Jackson SH, 2003, AGR WATER MANAGE, V58, P209, DOI 10.1016/S0378-3774(02)00078-1; Leng G, 2016, AGU FALL M ABSTR, pGC31B; Li, 2014, CHINA RURAL WATER HY, V5, P165; [李宁 Li Ning], 2018, [计算机工程与应用, Computer Engineering and Application], V54, P54; Liao RK, 2018, SOIL SCI SOC AM J, V82, P436, DOI 10.2136/sssaj2017.05.0164; Liao RK, 2018, ENVIRON SCI TECHNOL, V52, P1695, DOI 10.1021/acs.est.7b02928; Liao RK, 2018, LAND DEGRAD DEV, P1; Martinez-Fernandez J, 2016, REMOTE SENS ENVIRON, V177, P277, DOI 10.1016/j.rse.2016.02.064; Ronghua JI., 2017, T CHINESE SOC AGR EN, V33, P126, DOI DOI 10.11975/J.ISSN.1002-6819.2017.Z1; Schlesinger WH, 2014, AGR FOREST METEOROL, V189, P115, DOI 10.1016/j.agrformet.2014.01.011; Shandany SMH, 2018, AGR WATER MANAGE, V204, P234, DOI 10.1016/j.agwat.2018.04.014; [舒素芳 SHU Su-fang], 2009, [中国农业气象, Chinese Journal of Agrometeorology], V30, P180; Veres M, 2015, 2015 12TH CONFERENCE ON COMPUTER AND ROBOT VISION CRV 2015, P8, DOI 10.1109/CRV.2015.15; [王儒敬 Wang Rujing], 2017, [发光学报, Chinese Journal of Luminescence], V38, P109; Williams A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160974; Zhang XiaoYue, 2016, Transactions of the Chinese Society of Agricultural Engineering, V32, P140	30	43	46	18	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0214508	10.1371/journal.pone.0214508	http://dx.doi.org/10.1371/journal.pone.0214508			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR5NS	30943228	Green Submitted, Green Published, gold			2022-12-26	WOS:000463194300044
J	Hernandez-Hernandez, R; Kluge, J; Ah-Peng, C; Gonzalez-Mancebo, JM				Hernandez-Hernandez, Raquel; Kluge, Jurgen; Ah-Peng, Claudine; Maria Gonzalez-Mancebo, Juana			Natural and human-impacted diversity of bryophytes along an elevational gradient on an oceanic island (La Palma, Canarias)	PLOS ONE			English	Article							SPECIES RICHNESS; DISTRIBUTION PATTERNS; EPIPHYTIC BRYOPHYTES; COMMUNITIES; FORESTS; BIODIVERSITY; DISTURBANCE; SPECIFICITY; STRATEGIES; TENERIFE	Bryophytes have been proposed as ideal indicators of ecosystem change, because they are important components of forest integrity, and considerable research indicates that some groups are sensitive to the changes associated with specific human disturbances. Bryophyte richness and abundance have been found to vary predictably along elevational gradients, but the role of human impacts on these distribution patterns remains unclear. The aim of this study is to explore the impact of human disturbance on the elevational patterns of bryophyte diversity, along an elevational gradient. Along the gradient we collected three datasets in the following sites: preserved (P), forest track roadsides (R) and disturbed by agriculture/silviculture practices (D). Two survey plots of 100 m(2) were established at every 200 m elevational step for each sites P, R, D, and in each plot bryophytes were sampled in a stratified manner. At each plot we recorded all species on available substrates and estimated their percentage cover. Our results showed that species number did not differ among studied sites, but that species diversity pattern differs among the three gradient types and species life strategy composition along the elevational gradient showed a clear response to the disturbance of mature communities. We conclude that human impact has strongly changed the elevational pattern of diversity, and that these changes vary depending on the ecological and taxonomical group considered.	[Hernandez-Hernandez, Raquel; Kluge, Jurgen; Maria Gonzalez-Mancebo, Juana] Univ La Laguna, Dept Bot Ecol & Fisiol Vegetal, Plant Conservat & Biogeog Grp, C Astrofis Francisco Sanchez S-N, San Cristobal la Laguna, Islas Canarias, Spain; [Kluge, Jurgen] Philipps Univ Marburg, Dept Geog, Marburg, Germany; [Ah-Peng, Claudine] Univ La Reunion, UMR PVBMT, San Cristobal la Laguna, Spain	Universidad de la Laguna; Philipps University Marburg	Hernandez-Hernandez, R (corresponding author), Univ La Laguna, Dept Bot Ecol & Fisiol Vegetal, Plant Conservat & Biogeog Grp, C Astrofis Francisco Sanchez S-N, San Cristobal la Laguna, Islas Canarias, Spain.	rhernand@ull.es		Gonzalez-Mancebo, Juana Maria/0000-0002-3840-9501	Agence Nationale de la recherche; Conseil Regional de La Reunion; Conseil Regional de Guadeloupe; Government of Azores; Government of Canarias	Agence Nationale de la recherche(French National Research Agency (ANR)); Conseil Regional de La Reunion; Conseil Regional de Guadeloupe; Government of Azores; Government of Canarias	This research benefited from the support of the Agence Nationale de la recherche, Conseil Regional de La Reunion, Conseil Regional de Guadeloupe, Government of Azores, Government of Canarias, under the framework of the Net-Biome transnational first call (Moveclim project).	Ah-Peng C, 2014, ARCT ANTARCT ALP RES, V46, P841, DOI 10.1657/1938-4246-46.4.841; Ah-Peng C, 2012, ACTA OECOL, V42, P58, DOI 10.1016/j.actao.2012.04.010; Andrew NR, 2003, J BIOGEOGR, V30, P731, DOI 10.1046/j.1365-2699.2003.00849.x; [Anonymous], 2001, AM J BOT; Berges L, 2017, APPL VEG SCI, V20, P468, DOI 10.1111/avsc.12296; Carracedo J. C., 2002, GEOLOGY SPAIN, P439, DOI DOI 10.1144/GOSPP; Del Arco-Aguilar MJ, 2006, MAPA VEGETACION CANA; Delgado JD, 2007, LANDSCAPE URBAN PLAN, V81, P328, DOI 10.1016/j.landurbplan.2007.01.005; Didham RK, 2007, TRENDS ECOL EVOL, V22, P489, DOI 10.1016/j.tree.2007.07.001; Donohue I, 2016, ECOL LETT, V19, P1172, DOI 10.1111/ele.12648; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; During Heinjo J., 1992, P1; DURING HJ, 1979, LINDBERGIA, V5, P2; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Gabriel R, 2005, PLANT ECOL, V177, P125, DOI 10.1007/s11258-005-2243-6; Gabriel R., 2014, ARQUIPEL LIFE MAR SC, V31, P45; Glenn-Lewin David C., 1992, V11, P11; Gonzalez-Mancebo JM, 2003, BRYOLOGIST, V106, P383, DOI 10.1639/04; GONZALEZMANCEBO JM, 2013, P INT C ISL BIOD 201, P1; Gradstein S.R., 1989, TROPICAL RAIN FOREST, P311; Grau O, 2007, J BIOGEOGR, V34, P1907, DOI 10.1111/j.1365-2699.2007.01745.x; Henriques DSG, 2016, J BRYOL, V38, P183, DOI 10.1080/03736687.2016.1156360; Hernandez-Hernandez R, 2017, J VEG SCI, V28, P1209, DOI 10.1111/jvs.12573; Kaufmann S, 2017, FOREST ECOL MANAG, V400, P58, DOI 10.1016/j.foreco.2017.05.043; Lehosmaa K, 2017, BIOL CONSERV, V215, P169, DOI 10.1016/j.biocon.2017.09.010; Lloret F, 2011, FLORA, V206, P769, DOI 10.1016/j.flora.2011.04.007; Lomolino MV, 2001, GLOBAL ECOL BIOGEOGR, V10, P3, DOI 10.1046/j.1466-822x.2001.00229.x; LONGTON RE, 1988, BOT J LINN SOC, V98, P253, DOI 10.1111/j.1095-8339.1988.tb02429.x; LOSADA-LIMA A., 2010, LISTA ESPECIES SILVE, P106; Marini L, 2011, J BIOGEOGR, V38, P78, DOI 10.1111/j.1365-2699.2010.02376.x; McCain CM, 2004, J BIOGEOGR, V31, P19, DOI 10.1046/j.0305-0270.2003.00992.x; McCain CM, 2010, ENCY LIFE SCI, P1, DOI [10.1002/9780470015902.a0022548, DOI 10.1002/9780470015902.A0022548]; Medail F, 1997, ANN MO BOT GARD, V84, P112, DOI 10.2307/2399957; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nogues-Bravo D, 2008, NATURE, V453, P216, DOI 10.1038/nature06812; Patino J, 2011, PLANT ECOL, V212, P433, DOI 10.1007/s11258-010-9835-5; Patino J, 2010, ECOL APPL, V20, P1648, DOI 10.1890/09-1086.1; Patino J, 2009, ANN FOREST SCI, V66, DOI 10.1051/forest/2009042; Patino J, 2009, CAN J FOREST RES, V39, P48, DOI 10.1139/X08-155; RAHBEK C, 1995, ECOGRAPHY, V18, P200, DOI 10.1111/j.1600-0587.1995.tb00341.x; RCore Team, 2020, R LANG ENV STAT COMP; Roberts D.W., 2016, LABDSV ORDINATION MU; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Sauvajot Raymond M., 1999, Urban Ecosystems, V2, P279, DOI 10.1023/A:1009588723665; SOUSA WP, 1984, ANNU REV ECOL SYST, V15, P353, DOI 10.1146/annurev.es.15.110184.002033; Steinbauer MJ, 2017, ECOL EVOL, V7, P771, DOI 10.1002/ece3.2640; Strayer DL, 2006, J N AM BENTHOL SOC, V25, P271, DOI 10.1899/0887-3593(2006)25[271:CFFIC]2.0.CO;2; van Gemerden BS, 2003, J BIOGEOGR, V30, P1381, DOI 10.1046/j.1365-2699.2003.00937.x; Vanderpoorten A, 2009, INTRODUCTION TO BRYOPHYTES, P1, DOI 10.1017/CBO9780511626838; Vanderpoorten A, 2003, BIODIVERS CONSERV, V12, P545, DOI 10.1023/A:1022476902547; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Whitworth A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150520; WOLF JHD, 1993, ANN MO BOT GARD, V80, P928, DOI 10.2307/2399938; Zechmeister HG, 2001, BIODIVERS CONSERV, V10, P1609, DOI 10.1023/A:1012008828522	54	2	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0213823	10.1371/journal.pone.0213823	http://dx.doi.org/10.1371/journal.pone.0213823			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR5NS	30943204	Green Submitted, Green Published, gold			2022-12-26	WOS:000463194300019
J	Lerman, SB; D'Amico, V				Lerman, Susannah B.; D'Amico, Vincent			Lawn mowing frequency in suburban areas has no detectable effect on Borrelia spp. vector Ixodes scapularis (Acari: Ixodidae)	PLOS ONE			English	Article							LYME-DISEASE; HABITAT ASSOCIATIONS; DAMMINI ACARI; DEER TICK; ABUNDANCE; ECOLOGY; LANDSCAPE; BIODIVERSITY; URBANIZATION; DIVERSITY	Forests have become increasingly fragmented throughout the US, with residential development serving as the primary driver of these changes. These altered landscapes have provided suitable conditions for a broad range of wildlife, including blacklegged ticks and their hosts. Lawns dominate residential landscapes, and thus their management has the potential to reduce the likelihood of contact with ticks in residential yards. We tested the hypothesis that lawn mowing frequency influences tick occurrence in 16 suburban yards in Springfield, MA. We conducted 144 tick drags in lawns of various lawn mowing frequencies (mowed every week, every 2-weeks and every 3-weeks) and did not collect any ticks of any species. Promoting frequent mowing (i.e., shorter lawns) and the removal of grass clippings could have minimal impacts on tick microhabitats, but is consequential for beneficial wildlife and other ecosystem services associated with urban biodiversity.	[Lerman, Susannah B.] US Forest Serv, Northern Res Stn, USDA, Amherst, MA 01002 USA; [Lerman, Susannah B.] Univ Massachusetts, Dept Environm Conservat, Amherst, MA 01003 USA; [D'Amico, Vincent] US Forest Serv, Northern Res Stn, USDA, Newark, DC USA	United States Department of Agriculture (USDA); United States Forest Service; University of Massachusetts System; University of Massachusetts Amherst; United States Department of Agriculture (USDA); United States Forest Service	Lerman, SB (corresponding author), US Forest Serv, Northern Res Stn, USDA, Amherst, MA 01002 USA.; Lerman, SB (corresponding author), Univ Massachusetts, Dept Environm Conservat, Amherst, MA 01003 USA.	sblerman@fs.fed.us		Lerman, Susannah/0000-0002-2331-8439	SEES Fellowship Program, National Science Foundation [DEB-1215859]	SEES Fellowship Program, National Science Foundation	This work was supported by DEB-1215859, SEES Fellowship Program, National Science Foundation, https://www.nsf.gov, to SBL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adalsteinsson SA, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2623-0; Adalsteinsson SA, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1317; Alig RJ, 2004, LANDSCAPE URBAN PLAN, V69, P219, DOI 10.1016/j.landurbplan.2003.07.004; Allan BF, 2003, CONSERV BIOL, V17, P267, DOI 10.1046/j.1523-1739.2003.01260.x; Aronson MFJ, 2017, FRONT ECOL ENVIRON, V15, P189, DOI 10.1002/fee.1480; Bradley CA, 2007, TRENDS ECOL EVOL, V22, P95, DOI 10.1016/j.tree.2006.11.001; CARROLL MC, 1992, J MED ENTOMOL, V29, P1052, DOI 10.1093/jmedent/29.6.1052; CDC C for DC and P, 2017, LYM DIS DAT TABL INT; Daniels TJ, 2000, J MED ENTOMOL, V37, P357, DOI 10.1603/0022-2585(2000)037[0357:EPSADS]2.0.CO;2; Del Fabbro S, 2015, J VECTOR ECOL, V40, P107, DOI 10.1111/jvec.12138; DUFFY DC, 1994, J MED ENTOMOL, V31, P875, DOI 10.1093/jmedent/31.6.875; FALCO RC, 1992, EXP APPL ACAROL, V14, P165, DOI 10.1007/BF01219108; Feldman KA, 2015, J VECTOR ECOL, V40, P198, DOI 10.1111/jvec.12153; Frank DH, 1998, LANDSCAPE ECOL, V13, P27, DOI 10.1023/A:1007965600166; Goddard MA, 2010, TRENDS ECOL EVOL, V25, P90, DOI 10.1016/j.tree.2009.07.016; Hope P., 2018, CONSUMER REPORTS; Kremen C, 2005, FRONT ECOL ENVIRON, V3, P540, DOI 10.1890/1540-9295(2005)003[0540:ACTEMA]2.0.CO;2; Lerman SB, 2019, LANDSCAPE URBAN PLAN, V182, P114, DOI 10.1016/j.landurbplan.2018.10.016; Lerman SB, 2018, BIOL CONSERV, V221, P160, DOI 10.1016/j.biocon.2018.01.025; LoGiudice K, 2003, P NATL ACAD SCI USA, V100, P567, DOI 10.1073/pnas.0233733100; Lubelczyk CB, 2004, ENVIRON ENTOMOL, V33, P900, DOI 10.1603/0046-225X-33.4.900; Mackenstedt U, 2015, INT J PARASITOL-PAR, V4, P71, DOI 10.1016/j.ijppaw.2015.01.006; MAUPIN GO, 1991, AM J EPIDEMIOL, V133, P1105, DOI 10.1093/oxfordjournals.aje.a115823; Milesi C, 2005, ENVIRON MANAGE, V36, P426, DOI 10.1007/s00267-004-0316-2; NEEDHAM GR, 1991, ANNU REV ENTOMOL, V36, P659, DOI 10.1146/annurev.en.36.010191.003303; OSTFELD RS, 1995, ECOL APPL, V5, P353, DOI 10.2307/1942027; Petry WK, 2010, EXP APPL ACAROL, V52, P427, DOI 10.1007/s10493-010-9373-9; Rizzoli A, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00251; Robbins P., 2007, LAWN PEOPLE GRASSES; Shochat E, 2010, BIOSCIENCE, V60, P199, DOI 10.1525/bio.2010.60.3.6; STAFFORD KC, 1993, J MED ENTOMOL, V30, P762, DOI 10.1093/jmedent/30.4.762; WILSON ML, 1985, ANN ENTOMOL SOC AM, V78, P172, DOI 10.1093/aesa/78.2.172	32	5	5	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0214615	10.1371/journal.pone.0214615	http://dx.doi.org/10.1371/journal.pone.0214615			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR5NS	30943238	gold, Green Published, Green Submitted			2022-12-26	WOS:000463194300048
J	Haltmayer, E; Ribitsch, I; Gabner, S; Rosser, J; Gueltekin, S; Peham, J; Giese, U; Dolezal, M; Egerbacher, M; Jenner, F				Haltmayer, Eva; Ribitsch, Iris; Gabner, Simone; Rosser, Julie; Gueltekin, Sinan; Peham, Johannes; Giese, Ulrich; Dolezal, Marlies; Egerbacher, Monika; Jenner, Florien			Co-culture of osteochondral explants and synovial membrane as in vitro model for osteoarthritis	PLOS ONE			English	Article							ARTICULAR CHONDROCYTES; CARTILAGE; MACROPHAGES; CELLS; INFLAMMATION; EXPRESSION; VIVO; METALLOPROTEINASES; OSTEOBLASTS; REPAIR	The purpose of the current study was to establish an in vitro model for osteoarthritis (OA) by co-culture of osteochondral and synovial membrane explants. Osteochondral explants were cultured alone (control-1) or in co-culture with synovial membrane explants (control-2) in standard culture medium or with interleukin-1 beta (IL1 beta) and tumor necrosis factor (TNF alpha) added to the culture medium (OA-model-1 = osteochondral explant; OA-model-2 = osteo-chondroal-synovial explant). In addition, in OA-model groups a 2-mm partial-thickness defect was created in the centre of the cartilage explant. Changes in the expression of extra cellular matrix (ECM) genes (collagen type-1 (Col1), Col2, Col10 and aggrecan) as well as presence and quantity of inflammatory marker genes (IL6, matrix metalloproteinase-1 (MMP1), MMP3, MMP13, a disintegrin and metalloproteinase with-thrombospondin-motif-5 (ADAMTS5) were analysed by immunohistochemistry, qPCR and ELISA. To monitor the activity of classically-activated pro-inflammatory (M1) versus alternatively-activated anti-inflammatory/repair (M2) synovial macrophages, the nitric oxide/urea ratio in the supernatant of osteochondral-synovial explant co-cultures was determined. In both OA-model groups immunohistochemistry and qPCR showed a significantly increased expression of MMPs and IL6 compared to their respective control group. ELISA results confirmed a statistically significant increase in MMP1 and MMP3 production over the culturing period. In the osteochondral-synovial explant co-culture OA-model the nitric oxide/urea ratio was increased compared to the control group, indicating a shift toward M1 synovial macrophages. In summary, chemical damage (TNF alpha, IL1 beta) in combination with a partial-thickness cartilage defect elicits an inflammatory response similar to naturally occurring OA in osteochondral explants with and without osteochondral-synovial explant co-cultures and OA model -2 showing a closer approximation of OA due to the additional shift of synovial macrophages toward the pro-inflammatory M1 phenotype.	[Haltmayer, Eva; Ribitsch, Iris; Gueltekin, Sinan; Jenner, Florien] Univ Vet Med, Univ Equine Hosp, Equine Surg, Dept Compan Anim & Horses, Vienna, Austria; [Gabner, Simone; Egerbacher, Monika] Univ Vet Med, Dept Pathobiol Histol & Embryol, Vienna, Austria; [Rosser, Julie] Tech Univ, Inst Appl Synthet Chem, Vienna, Austria; [Peham, Johannes; Giese, Ulrich] AIT, Ctr Hlth & Bioresources, Mol Diagnost, Vienna, Austria; [Dolezal, Marlies] Univ Vet Med, Dept Biomed Sci Bioinformat & Biostat Platform, Vienna, Austria	University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna; Technische Universitat Wien; Austrian Institute of Technology (AIT); University of Veterinary Medicine Vienna	Haltmayer, E (corresponding author), Univ Vet Med, Univ Equine Hosp, Equine Surg, Dept Compan Anim & Horses, Vienna, Austria.	Eva.Haltmayer@vetmeduni.ac.at	Jenner, Florien/H-2679-2013	Jenner, Florien/0000-0002-6977-1984; Peham, Johannes/0000-0003-1381-2545	Bright Sparks program of the University of Veterinary Medicine Vienna, Austria	Bright Sparks program of the University of Veterinary Medicine Vienna, Austria	The current research was funded by the Bright Sparks program of the University of Veterinary Medicine Vienna, Austria to EH. The funding source was not involved in any part of the study, neither the study design, execution of the in vitro experiments, sample analysis, data analysis nor writing of the manuscript or publication.	Aigner T, 2002, CELL MOL LIFE SCI, V59, P5, DOI 10.1007/s00018-002-8400-3; Arden NK, 2013, OSTEOARTHR CARTILAGE, V21, P1409, DOI 10.1016/j.joca.2013.06.021; Bau B, 2002, ARTHRITIS RHEUM, V46, P2648, DOI 10.1002/art.10531; Benito MJ, 2005, ANN RHEUM DIS, V64, P1263, DOI 10.1136/ard.2004.025270; Berenbaum F, 2013, OSTEOARTHR CARTILAGE, V21, P16, DOI 10.1016/j.joca.2012.11.012; Blom AB, 2004, OSTEOARTHR CARTILAGE, V12, P627, DOI 10.1016/j.joca.2004.03.003; Bondeson J, 2010, ARTHRITIS RHEUM-US, V62, P647, DOI 10.1002/art.27290; D'Andrea P, 1998, BIOCHEM J, V329, P681, DOI 10.1042/bj3290681; de Lange-Brokaar BJE, 2012, OSTEOARTHR CARTILAGE, V20, P1484, DOI 10.1016/j.joca.2012.08.027; Dimitrijevic M, 2014, AGE, V36, DOI 10.1007/s11357-014-9696-2; DINGLE JT, 1979, BIOCHEM J, V184, P177, DOI 10.1042/bj1840177; Fahy N, 2014, OSTEOARTHR CARTILAGE, V22, P1167, DOI 10.1016/j.joca.2014.05.021; Fuentes-Boquete I, 2004, WOUND REPAIR REGEN, V12, P444, DOI 10.1111/j.1067-1927.2004.012412.x; Goldring MB, 2007, J CELL PHYSIOL, V213, P626, DOI 10.1002/jcp.21258; Haq I, 2003, POSTGRAD MED J, V79, P377, DOI 10.1136/pmj.79.933.377; Hiligsmann M, 2014, SEMIN ARTHRITIS RHEU, V44, P271, DOI 10.1016/j.semarthrit.2014.06.005; Huser CAM, 2006, J ORTHOP RES, V24, P725, DOI 10.1002/jor.20111; Johnson CI, 2016, VET J, V209, P40, DOI 10.1016/j.tvjl.2015.07.011; Kevorkian L, 2004, ARTHRITIS RHEUM-US, V50, P131, DOI 10.1002/art.11433; Kraus VB, 2007, OSTEOARTHR CARTILAGE, V15, P1217, DOI 10.1016/j.joca.2007.03.017; Kraus VB, 2016, OSTEOARTHR CARTILAGE, V24, P1613, DOI 10.1016/j.joca.2016.04.010; Laria A, 2016, J INFLAMM RES, V9, P1, DOI 10.2147/JIR.S82320; Lee CM, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-54; Lee CM, 2013, AM J VET RES, V74, P40, DOI 10.2460/ajvr.74.1.40; Lee JH, 2009, ARCH BIOCHEM BIOPHYS, V489, P118, DOI 10.1016/j.abb.2009.07.006; Lenth RV, 2016, J STAT SOFTW, V69, P1, DOI 10.18637/jss.v069.i01; Li GY, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4405; LINDBLAD S, 1985, ARTHRITIS RHEUM, V28, P977, DOI 10.1002/art.1780280904; Manferdini C, 2017, OSTEOARTHR CARTILAGE, V25, P1161, DOI 10.1016/j.joca.2017.01.011; Manferdini C, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-0983-4; Mills CD, 2001, CRIT REV IMMUNOL, V21, P399, DOI 10.1615/critrevimmunol.v21.i5.10; Ogawa K, 2007, J BONE MINER METAB, V25, P354, DOI 10.1007/s00774-007-0761-0; Patwari P, 2009, SCAND J MED SCI SPOR, V19, P528, DOI 10.1111/j.1600-0838.2009.00911.x; Rath M, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00532; Romeis B., 1989, MIKROSKOPISCHE TECHN; Sanchez C, 2005, OSTEOARTHR CARTILAGE, V13, P988, DOI 10.1016/j.joca.2005.07.012; Sanchez C, 2005, OSTEOARTHR CARTILAGE, V13, P979, DOI 10.1016/j.joca.2005.03.008; Sandell LJ, 2001, ARTHRITIS RES, V3, P107, DOI 10.1186/ar148; Schmutzer M, 2017, J BIOSCI BIOENG, V123, P512, DOI 10.1016/j.jbiosc.2016.11.002; Sellam J, 2010, NAT REV RHEUMATOL, V6, P625, DOI 10.1038/nrrheum.2010.159; Seol D, 2014, TISSUE ENG PT A, V20, P1807, DOI [10.1089/ten.tea.2013.0444, 10.1089/ten.TEA.2013.0444]; Sokolove J, 2013, THER ADV MUSCULOSKEL, V5, P77, DOI 10.1177/1759720X12467868; Spiller KL, 2011, TISSUE ENG PART B-RE, V17, P281, DOI [10.1089/ten.TEB.2011.0077, 10.1089/ten.teb.2011.0077]; Stewart HL, 2018, FRONT VET SCI, V5, DOI 10.3389/fvets.2018.00178; Thysen S, 2015, DIS MODEL MECH, V8, P17, DOI 10.1242/dmm.016881; Uitterlinden EJ, 2006, OSTEOARTHR CARTILAGE, V14, P250, DOI 10.1016/j.joca.2005.10.001; Utomo L, 2016, OSTEOARTHR CARTILAGE, V24, P1629, DOI 10.1016/j.joca.2016.04.013; Williams A, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4424; Wynn Thomas A, 2011, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1422s93	49	35	37	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2019	14	4							e0214709	10.1371/journal.pone.0214709	http://dx.doi.org/10.1371/journal.pone.0214709			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR2UW	30939166	Green Submitted, Green Published, gold			2022-12-26	WOS:000462993900037
J	Gonzalez-Escalona, N; Kase, JA				Gonzalez-Escalona, Narjol; Kase, Julie Ann			Virulence gene profiles and phylogeny of Shiga toxin-positive Escherichia coli strains isolated from FDA regulated foods during 2010-2017	PLOS ONE			English	Article							HEMOLYTIC-UREMIC-SYNDROME; SEQUENCE TYPING SCHEME; UNITED-STATES; ANTIMICROBIAL RESISTANCE; MULTISTATE OUTBREAK; INFECTION; NON-O157; GERMANY; EPIDEMIOLOGY; PREVALENCE	Illnesses caused by Shiga toxin-producing Escherichia coli (STECs) can be life threatening, such as hemolytic uremic syndrome (HUS). The STECs most frequently identified by USDA's Microbiological Data Program (MDP) carried toxin gene subtypes stx1a and/or stx2a. Here we described the genome sequences of 331 STECs isolated from foods regulated by the FDA 2010-2017, and determined their genomic identity, serotype, sequence type, virulence potential, and prevalence of antimicrobial resistance. Isolates were selected from the MDP archive, routine food testing by FDA field labs (ORA), and food testing by a contract company. Only 276 (83%) strains were confirmed as STECs by in silico analysis. Foods from which STECs were recovered included cilantro (6%), spinach (25%), lettuce (11%), and flour (9%). Phylogenetic analysis using core genome MLST revealed these STEC genomes were highly variable, with some clustering associated with ST types and serotypes. We detected 95 different sequence types (ST); several ST were previously associated with HUS: ST21 and ST29 (O26:H11), ST11 (O157:H7), ST33 (O91:H14), ST17 (O103:H2), and ST16 (O111:H-). in silico virulome analyses showed similar to 51% of these strains were potentially pathogenic [besides stx gene they also carried eae (25%) or 26% saa (26%)]. Virulence gene prevalence was also determined: stx1 only (19%); stx2 only (66%); and stx1/sxt2 (15%). Our data form a new WGS dataset that can be used to support food safety investigations and monitor the recurrence/emergence of E. coli in foods.	[Gonzalez-Escalona, Narjol; Kase, Julie Ann] US FDA, Div Microbiol, Ctr Food Safety & Appl Nutr, College Pk, MD 20740 USA	US Food & Drug Administration (FDA)	Gonzalez-Escalona, N (corresponding author), US FDA, Div Microbiol, Ctr Food Safety & Appl Nutr, College Pk, MD 20740 USA.	narjol.gonzalez-escalona@fda.hhs.gov	Gonzalez-Escalona, Narjol/H-6161-2019; Gonzalez-Escalona, Narjol/A-7598-2009	Gonzalez-Escalona, Narjol/0000-0003-4568-0022; Kase, Julie/0000-0002-5094-7492	FDA Foods Science and Research Intramural Program	FDA Foods Science and Research Intramural Program	This work was supported by the FDA Foods Science and Research Intramural Program.	Allard MW, 2018, CURR OPIN BIOTECH, V49, P224, DOI 10.1016/j.copbio.2017.11.002; Allard MW, 2016, J CLIN MICROBIOL, V54, P1975, DOI 10.1128/JCM.00081-16; BELL BP, 1994, JAMA-J AM MED ASSOC, V272, P1349, DOI 10.1001/jama.272.17.1349; Bergholz TM, 2014, TRENDS MICROBIOL, V22, P275, DOI 10.1016/j.tim.2014.01.006; Beutin L, 2004, J CLIN MICROBIOL, V42, P1099, DOI 10.1128/JCM.42.3.1099-1108.2004; BEUTIN L, 1988, ZBL BAKT-INT J MED M, V267, P576; Beutin L, 2014, EMERG INFECT DIS, V20, P1567, DOI 10.3201/eid2009.131373; Beutin L, 2012, J FOOD PROTECT, V75, P408, DOI 10.4315/0362-028X.JFP-11-452; Bielaszewska M, 2007, APPL ENVIRON MICROB, V73, P3144, DOI 10.1128/AEM.02937-06; Bielaszewska M, 2006, CLIN INFECT DIS, V43, P1160, DOI 10.1086/508195; Bielaszewska M, 2013, CLIN INFECT DIS, V56, P1373, DOI 10.1093/cid/cit055; Boerlin P, 1999, J CLIN MICROBIOL, V37, P497, DOI 10.1128/JCM.37.3.497-503.1999; Brooks JT, 2005, J INFECT DIS, V192, P1422, DOI 10.1086/466536; Bugarel M, 2011, APPL ENVIRON MICROB, V77, P2275, DOI 10.1128/AEM.02832-10; Byrne L, 2015, EPIDEMIOL INFECT, V143, P3475, DOI 10.1017/S0950268815000746; Chen Y, 2016, APPL ENVIRON MICROB, V82, P6258, DOI 10.1128/AEM.01532-16; Cooper KK, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-17; Crowe SJ, 2017, NEW ENGL J MED, V377, P2036, DOI [10.1056/NEJMoa1615910, 10.1056/nejmoa1615910]; Dallman TJ, 2015, EPIDEMIOL INFECT, V143, P1672, DOI 10.1017/S0950268814002696; Elliott SJ, 2000, INFECT IMMUN, V68, P6115, DOI 10.1128/IAI.68.11.6115-6126.2000; Erickson MC, 2007, J FOOD PROTECT, V70, P2426, DOI 10.4315/0362-028X-70.10.2426; Ethelberg S, 2009, CLIN INFECT DIS, V48, pE78, DOI 10.1086/597502; Feng PCH, 2014, APPL ENVIRON MICROB, V80, P4757, DOI 10.1128/AEM.01182-14; Feng PCH, 2014, J FOOD PROTECT, V77, P820, DOI 10.4315/0362-028X.JFP-13-412; Feng PCH, 2013, APPL ENVIRON MICROB, V79, P6917, DOI 10.1128/AEM.02455-13; Fey PD, 2000, EMERG INFECT DIS, V6, P530, DOI 10.3201/eid0605.000513; Galia W., 2015, GENOME ANNOUNC, V3, P1568; Garmendia J, 2005, J CLIN MICROBIOL, V43, P5715, DOI 10.1128/JCM.43.11.5715-5720.2005; Garmendia J, 2005, INFECT IMMUN, V73, P2573, DOI 10.1128/IAI.73.5.2573-2585.2005; Ghanem M, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.01145-17; Gonzalez-Escaloa N, 2017, J CLIN MICROBIOL, V55, P1682, DOI 10.1128/JCM.00227-17; Gonzalez-Escalona N, 2016, APPL ENVIRON MICROB, V82, P3900, DOI 10.1128/AEM.00498-16; Gonzalez-Escalona N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117485; Hoffmann M, 2016, J INFECT DIS, V213, P502, DOI 10.1093/infdis/jiv297; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Joensen KG, 2015, J CLIN MICROBIOL, V53, P2410, DOI 10.1128/JCM.00008-15; Joensen KG, 2014, J CLIN MICROBIOL, V52, P1501, DOI 10.1128/JCM.03617-13; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Karami N, 2007, J ANTIMICROB CHEMOTH, V60, P1142, DOI 10.1093/jac/dkm327; KARCH H, 1992, INFECT IMMUN, V60, P3464, DOI 10.1128/IAI.60.8.3464-3467.1992; Karmali MA, 2003, J CLIN MICROBIOL, V41, P4930, DOI 10.1128/JCM.41.11.4930-4940.2003; Khaitan A, 2007, J CLIN MICROBIOL, V45, P1374, DOI 10.1128/JCM.00076-07; Kuehne A, 2016, EPIDEMIOL INFECT, V144, P3305, DOI 10.1017/S0950268816001436; Li Z, 2017, BMC MICROBIOL, V17, P1, DOI 10.1186/s12866-017-1043-1; Liu YY, 2016, LANCET INFECT DIS, V16, P161, DOI 10.1016/S1473-3099(15)00424-7; Lorenz SC, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.00846-16; Maiden MCJ, 2016, J CLIN MICROBIOL, V54, P1949, DOI 10.1128/JCM.00301-16; Martinez-Urtaza J, 2017, MBIO, V8, DOI 10.1128/mBio.01425-17; McAllister LJ, 2016, INFECT IMMUN, V84, P775, DOI 10.1128/IAI.01229-15; Mcwilliams BD, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.EHEC-0003-2013; Mellmann A, 2008, EMERG INFECT DIS, V14, P1287, DOI 10.3201/eid1408.071082; Melton-Chelsa A.R., 1998, ESCHERICHIA COLI O15, P121; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; NEI M, 1983, J MOL EVOL, V19, P153, DOI 10.1007/BF02300753; Ochoa TJ, 2011, CURR OPIN INFECT DIS, V24, P478, DOI 10.1097/QCO.0b013e32834a8b8b; Ogura Y, 2009, P NATL ACAD SCI USA, V106, P17939, DOI 10.1073/pnas.0903585106; Okello E, 2015, TROP ANIM HEALTH PRO, V47, P117, DOI 10.1007/s11250-014-0694-2; Paton AW, 2001, INFECT IMMUN, V69, P6999, DOI 10.1128/IAI.69.11.6999-7009.2001; Pennington H, 2011, LANCET INFECT DIS, V11, P652, DOI 10.1016/S1473-3099(11)70166-9; Rangel JM, 2005, EMERG INFECT DIS, V11, P603, DOI 10.3201/eid1104.040739; Rasko DA, 2011, NEW ENGL J MED, V365, P709, DOI 10.1056/NEJMoa1106920; Rohde H, 2011, NEW ENGL J MED, V365, P718, DOI 10.1056/NEJMoa1107643; Ruppitsch W, 2015, J CLIN MICROBIOL, V53, P2869, DOI 10.1128/JCM.01193-15; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Scheutz F, 2012, J CLIN MICROBIOL, V50, P2951, DOI 10.1128/JCM.00860-12; SCHMIDT H, 1995, INFECT IMMUN, V63, P1055, DOI 10.1128/IAI.63.3.1055-1061.1995; Schmidt H, 1996, MICROBIOL-UK, V142, P907, DOI 10.1099/00221287-142-4-907; Shin SW, 2015, APPL ENVIRON MICROB, V81, P5560, DOI 10.1128/AEM.01511-15; Strauss L, 2017, P NATL ACAD SCI USA, V114, pE10596, DOI 10.1073/pnas.1702472114; Taylor EV, 2013, J FOOD PROTECT, V76, P939, DOI 10.4315/0362-028X.JFP-12-503; Thi KNO, 2012, INFECT IMMUN, V80, P469, DOI 10.1128/IAI.05539-11; Trabulsi LR, 2002, EMERG INFECT DIS, V8, P508, DOI 10.3201/eid0805.010385; U.S. Department of Agriculture Food Safety and Inspection Service (USDA-FSIS), 2012, FED REGISTER, V77, P31975; Watanabe H, 1996, LANCET, V348, P831, DOI 10.1016/S0140-6736(05)65257-9; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261	76	30	31	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2019	14	4							e0214620	10.1371/journal.pone.0214620	http://dx.doi.org/10.1371/journal.pone.0214620			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR1CY	30934002	gold, Green Published, Green Submitted			2022-12-26	WOS:000462867000027
J	Pham, TT; Park, B				Thu-Thi Pham; Park, Boyoung			Alcohol use disorder and health-related quality of life in Korean night-shift workers: A cross-sectional study using the KNHANES 2007-2015 data	PLOS ONE			English	Article							NATIONAL-HEALTH; GENDER; FAMILY; DRINKING; SLEEP	This study aimed to evaluate the prevalence of night-shift work, and the association of night-shift work with alcohol use disorders(AUDs), as well as with health-related quality of life (HRQL), in Korean adult workers. A total of 26,895 adult workers aged 20-59 years were included in the analysis. AUDs were assessed using the Alcohol Use Disorders Identification Test(AUDIT), and HRQL was measured by the EuroQol-5D questionnaire with five main dimensions. We found an interaction effect between gender and working status on AUDs (p = 0.0065), suggesting that women are more fragile than men in terms of the effects of night work but not regarding HRQL (p = 0.1729). Female night workers had higher risk of AUDs than female day workers (odds ratio(OR): 2.23, 95% confidence interval (CI): 1.48-3.38) but this effect was not noted in male night workers (OR: 0.97, 95% CI: 0.69-1.37). Lower HRQL was found in depression dimension for night workers compared to day workers (OR: 1.37, 95% CI: 1.00-1.89), whereas day-night regular shift workers were protected from depression. Risk of AUDs and lower HRQL were identified in female night workers but not in male night workers. This association suggests that women are more fragile than men in terms of the effects of night work.	[Thu-Thi Pham] Natl Canc Ctr, Grad Sch Canc Sci & Policy, Goyang, South Korea; [Park, Boyoung] Hanyang Univ, Coll Med, Dept Med, Seoul, South Korea	National Cancer Center - Korea (NCC); Hanyang University	Park, B (corresponding author), Hanyang Univ, Coll Med, Dept Med, Seoul, South Korea.	hayejine@hanmail.net		Pham, Thu Thi/0000-0002-2129-0911	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning [NRF-2016R1C1B1013621]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning (NRF-2016R1C1B1013621 to BP). The funders had no role in study design, data collection and analysis, decision to present, or preparation of the manuscript.	Allen JP, 1997, ALCOHOL CLIN EXP RES, V21, P613, DOI 10.1111/j.1530-0277.1997.tb03811.x; Ames GM, 1996, SOC SCI MED, V43, P1649, DOI 10.1016/S0277-9536(96)00081-0; Babor TF., 2001, AUDIT ALCOHOL USE DI; Bildt C, 2002, INT ARCH OCC ENV HEA, V75, P252, DOI 10.1007/s00420-001-0299-8; Boivin DB, 2014, PATHOL BIOL, V62, P292, DOI 10.1016/j.patbio.2014.08.001; Boschloo L, 2010, J AFFECT DISORDERS, V126, P441, DOI 10.1016/j.jad.2010.04.019; Buchvold HV, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2470-2; Costa G, 1997, CHRONOBIOL INT, V14, P89, DOI 10.3109/07420529709001147; Costa G, 2010, SAF HEALTH WORK, V1, P112, DOI 10.5491/SHAW.2010.1.2.112; De Sio S, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/7340781; Driesen K, 2011, SCAND J WORK ENV HEA, V37, P402, DOI 10.5271/sjweh.3158; Fenwick R, 2001, AM BEHAV SCI, V44, P1179, DOI 10.1177/00027640121956719; Flo E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033981; Frick KD, 2008, WOMEN HEALTH ISS, V18, P4, DOI 10.1016/j.whi.2007.11.003; Fryback DG, 2007, MED CARE, V45, P1162, DOI 10.1097/MLR.0b013e31814848f1; Harper A, 1998, PSYCHOL MED, V28, P551, DOI 10.1017/S0033291798006667; Heikkila K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040101; Hermansson U, 2003, OCCUPATIONAL MED, V53; Higgins-Biddle JC, 2018, AM J DRUG ALCOHOL AB, V44, P578, DOI 10.1080/00952990.2018.1456545; Hong JW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175299; Hong S, 2015, FACTORS ASS HLTH REL; ILO, 1990, C171 NIGHT WORK CONV; Isahak M, 2017, ASIA PACIFIC J PUBLI; Kang MY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188019; Kim H-JS-Y, 2011, MANAGEMENT EMPLOYEES; Kim W, 2016, HEALTH QUAL LIFE OUT, V14, DOI 10.1186/s12955-016-0564-x; Konig HH, 2009, MED CARE, V47, P255, DOI 10.1097/MLR.0b013e318184759e; Kweon S, 2014, INT J EPIDEMIOL, V43, P69, DOI 10.1093/ije/dyt228; Lee EK, 2015, ASIAN NURS RES, V9, P132, DOI 10.1016/j.anr.2015.04.002; Lee YK, 2009, VALUE HEALTH, V12, P1187, DOI 10.1111/j.1524-4733.2009.00579.x; Magnavita N, 2013, EUR J RADIOL, V82, pE502, DOI 10.1016/j.ejrad.2013.04.007; Maume DJ, 2010, GENDER SOC, V24, P746, DOI 10.1177/0891243210386949; Meyers JL, 2017, PSYCHOL MED, V47, P103, DOI 10.1017/S0033291716001975; Michalak L, 2007, DRUG ALCOHOL DEPEN, V87, P268, DOI 10.1016/j.drugalcdep.2006.07.013; Morikawa Y, 2013, ALCOHOL ALCOHOLISM, V48, P202, DOI 10.1093/alcalc/ags128; Rajaratnam SM, 2001, LANCET, V358, P999, DOI 10.1016/S0140-6736(01)06108-6; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Schuckit MA, 2009, LANCET, V373, P492, DOI 10.1016/S0140-6736(09)60009-X; Soric M, 2013, COLLEGIUM ANTROPOL, V37, P379; Stein Michael D, 2005, Subst Abus, V26, P1, DOI 10.1300/J465v26n01_01; Venturelli F, 2017, MED LAV, V108, P52, DOI 10.23749/mdl.v108i1.5581; Yoshioka E, 2012, SOC PSYCH PSYCH EPID, V47, P651, DOI 10.1007/s00127-011-0370-z	42	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2019	14	4							e0214593	10.1371/journal.pone.0214593	http://dx.doi.org/10.1371/journal.pone.0214593			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HR1CY	30933996	Green Submitted, gold, Green Published			2022-12-26	WOS:000462867000025
J	Ellaway, A; Dundas, R; Robertson, T; Shiels, PG				Ellaway, Anne; Dundas, Ruth; Robertson, Tony; Shiels, Paul G.			More miles on the clock: Neighbourhood stressors are associated with telomere length in a longitudinal study	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; HEALTH; DEPRESSION; WEST; ENVIRONMENT; GENDER	Background There is a substantial gap in health and longevity between more affluent and more deprived areas, and more knowledge of the determinants of this health divide is required. Experience of the local residential environment is important for health although few studies have examined this in relation to biological markers of age such as telomere length. We sought to examine if residents' perceptions of neighbourhood stressors over time were associated with telomere length in a community study. Methodology/Principal finding In a prospective cohort study of 2186 adults in the West of Scotland, we measured neighbourhood stressors at three time points over a 12-year period and telomere length at the end of the study. Using linear regression models, we found that a higher accumulation of neighbourhood stressors over time was associated with shorter telomere length, even after taking cohort, social class, health behaviours (smoking status, diet, physical activity), BMI and depression into account among females only (Beta = 0.007; 95%Cl [0.001, 0.012]; P<0.014). Conclusions/Significance Neighborhood environments are potentially modifiable, and future efforts directed towards improving deleterious local environments may be useful to lessen telomere attrition.	[Ellaway, Anne; Dundas, Ruth] Univ Glasgow, MRC CSO Social & Publ Hlth Sci Unit, Glasgow, Lanark, Scotland; [Robertson, Tony] Univ Stirling, Fac Hlth Sci & Sport, Ctr Publ Hlth & Populat Hlth Res, Stirling, Scotland; [Shiels, Paul G.] Univ Glasgow, Inst Canc Sci, Glasgow, Lanark, Scotland	MRC/CSO SOCIAL AND PUBLIC HEALTH SCIENCES UNIT; University of Glasgow; University of Stirling; University of Glasgow	Ellaway, A (corresponding author), Univ Glasgow, MRC CSO Social & Publ Hlth Sci Unit, Glasgow, Lanark, Scotland.	anne.ellaway@glasgow.ac.uk	Robertson, Tony/L-5062-2015	Robertson, Tony/0000-0002-1962-5874; Ellaway, Anne/0000-0002-2117-4451	UK Medical Research Council (MRC) [MC_A540_53462]; Medical Research Council [MC_UU_12017/10, MC_UU_12017/13]; Chief Scientist's Office [SPHSU10, SPHSU13]; MRC [MC_UU_12017/10, MC_UU_12017/13] Funding Source: UKRI	UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Chief Scientist's Office; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The West of Scotland: Twenty-07 Study is funded by the UK Medical Research Council (MRC; MC_A540_53462). A.E. and R.D. are funded by the Medical Research Council (MC_UU_12017/10; MC_UU_12017/13) and the Chief Scientist's Office (SPHSU10; SPHSU13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aneshensel CS, 2010, ADVANCES IN THE CONCEPTUALIZATION OF THE STRESS PROCESS: ESSAYS IN HONOR OF LEONARD I. PEARLIN, P35, DOI 10.1007/978-1-4419-1021-9_3; Arsenis NC, 2017, ONCOTARGET, V8, P45008, DOI 10.18632/oncotarget.16726; Astuti Y, 2017, ENVIRON RES, V158, P480, DOI 10.1016/j.envres.2017.06.038; Benzeval M, 2009, INT J EPIDEMIOL, V38, P1215, DOI 10.1093/ije/dyn213; Carrero JJ, 2008, J INTERN MED, V263, P302, DOI 10.1111/j.1365-2796.2007.01890.x; Cawthon R.M., 2009, NUCLEIC ACIDS RES, V37, P3, DOI [10.1093/nar/gkn1027, DOI 10.1093/NAR/GKN1027]; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Cherkas LF, 2006, AGING CELL, V5, P361, DOI 10.1111/j.1474-9726.2006.00222.x; Clarke P, 2014, RES AGING, V36, P115, DOI 10.1177/0164027512470702; Connelly R., 2016, METHODOLOGICAL INNOV, V9, P1, DOI [10.1177/2059799116642885, DOI 10.1177/2059799116638003, 10.1177/2059799116638001]; Crous-Bou M, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6674; Der G., 1998, COMP W SCOTLAND 20 0; Der G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045166; Ellaway A, 2009, J EPIDEMIOL COMMUN H, V63, P78, DOI 10.1136/jech.2007.068767; Ellaway A, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012268; Ellaway A, 2009, PUBLIC HEALTH, V123, P708, DOI 10.1016/j.puhe.2009.09.019; Ellaway A, 2013, NEIGHBOURHOOD STRUCT; Ellaway A, 2001, GEOGRAPHIES WOMENS H; Ellaway A, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15091854; Ellaway A, 2012, HEALTH PLACE, V18, P132, DOI 10.1016/j.healthplace.2011.08.005; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Evans G, 2012, OXFORD HDB POVERTY C; Gale CR, 2011, HEALTH PLACE, V17, P867, DOI 10.1016/j.healthplace.2011.05.003; Galobardes B, 2006, J EPIDEMIOL COMMUN H, V60, P95, DOI 10.1136/jech.2004.028092; Gardner M, 2014, EXP GERONTOL, V51, P15, DOI 10.1016/j.exger.2013.12.004; Gebreab SY, 2016, PSYCHONEUROENDOCRINO, V69, P90, DOI 10.1016/j.psyneuen.2016.03.018; Goldberg D.P., 1988, USERS GUIDE GEN HLTH; Jones R, 2014, HEALTH PLACE, V28, P187, DOI 10.1016/j.healthplace.2014.04.006; Kim D, 2008, EPIDEMIOL REV, V30, P101, DOI 10.1093/epirev/mxn009; Kooman JP, 2014, NAT REV NEPHROL, V10, P732, DOI 10.1038/nrneph.2014.185; Koppelstaetter C, 2008, AGING CELL, V7, P491, DOI 10.1111/j.1474-9726.2008.00398.x; Lopez-Isac E, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4432; Lynch SM, 2017, CANCER EPIDEM BIOMAR, V26, P553, DOI 10.1158/1055-9965.EPI-16-0554; Macintyre S, 2003, HEALTH PLACE, V9, P207, DOI 10.1016/S1353-8292(02)00040-0; McGuinness D, 2012, INT J EPIDEMIOL, V41, P151, DOI 10.1093/ije/dyr215; Mishra G, 2009, INT J EPIDEMIOL, V38, P528, DOI 10.1093/ije/dyn229; Needham BL, 2014, HEALTH PLACE, V28, P167, DOI 10.1016/j.healthplace.2014.04.009; Nettleton JA, 2008, AM J CLIN NUTR, V88, P1405, DOI 10.3945/ajcn.2008.26429; Office of Population Censuses and Surveys, 1991, OPCS STAND OCC CLASS; OLOVNIKOV AM, 1973, J THEOR BIOL, V41, P181, DOI 10.1016/0022-5193(73)90198-7; Olsen JR, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14121473; Ornish D, 2013, LANCET ONCOL, V14, P1112, DOI 10.1016/S1470-2045(13)70366-8; Park M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128460; Pasquali R, 2012, ANN NY ACAD SCI, V1264, P20, DOI 10.1111/j.1749-6632.2012.06569.x; Phillips AC, 2013, PSYCHOSOM MED, V75, P288, DOI 10.1097/PSY.0b013e318289e6b5; Ridout KK, 2016, J AFFECT DISORDERS, V191, P237, DOI 10.1016/j.jad.2015.11.052; Robertson T, 2013, EPIDEMIOL REV, V35, P98, DOI 10.1093/epirev/mxs001; Robertson T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041805; Roux AVD, 2010, ANN NY ACAD SCI, V1186, P125, DOI 10.1111/j.1749-6632.2009.05333.x; Shareck M, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-930; Shiels PG, 2017, PRACT LAB MED, V7, P49, DOI 10.1016/j.plabm.2016.04.002; Shiels PG, 2017, NAT REV NEPHROL, V13, P471, DOI 10.1038/nrneph.2017.78; Shiels PG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022521; Shiels PG, 2003, MOL BIOL NEURONE, P435; Smith SJ, 2012, HOUS THEORY SOC, V29, P40, DOI 10.1080/14036096.2012.624884; Sooman A, 1995, HEALTH PLACE, V1, P15, DOI 10.1016/1353-8292(95)00003-5; Stafford M, 2005, SOC SCI MED, V60, P1681, DOI 10.1016/j.socscimed.2004.08.028; Stansfeld S, 1993, J PSYCHOSOMATIC RES, P37; Timmermans EJ, 2016, CLIN RHEUMATOL, V35, P2797, DOI 10.1007/s10067-016-3388-5; Watson J., 1972, NAT NEW BIOL, P239; Wulaningsih W, 2018, J GERONTOL A-BIOL, V73, P966, DOI 10.1093/gerona/glx151; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	62	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214380	10.1371/journal.pone.0214380	http://dx.doi.org/10.1371/journal.pone.0214380			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HQ7IR	30921393	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000462594000062
J	Gutierrez, C; Lopez-Abente, J; Perez-Fernandez, V; Prieto-Sanchez, A; Correa-Rocha, R; Moreno-Guillen, S; Munoz-Fernandez, MA; Pion, M				Gutierrez, Carolina; Lopez-Abente, Jacobo; Perez-Fernandez, Veronica; Prieto-Sanchez, Adrian; Correa-Rocha, Rafael; Moreno-Guillen, Santiago; Munoz-Fernandez, Maria-Angeles; Pion, Marjorie			Analysis of the dysregulation between regulatory B and T cells (Breg and Treg) in human immunodeficiency virus (HIV)-infected patients	PLOS ONE			English	Article							DISEASE PROGRESSION; HIV-INFECTION; ANTIRETROVIRAL THERAPY; ACTIVATING FACTOR; FOXP3 EXPRESSION; IL-10 PRODUCTION; MAINTENANCE; MECHANISMS; INDUCTION; CORRELATE	This study examines the relationship between regulatory B (Breg) and T (Treg) compartments, which play crucial roles in the maintenance of immune homeostasis in the context of HIV. Using flow cytometry, the phenotypes of different Breg and Treg subsets from HIV-infected and healthy individuals were analyzed, along with the suppressive capacity of Breg. Peripheral blood samples of thirteen HIV+ treatment-naive individuals, fourteen treated-HIV+ individuals with undetectable viral load and twelve healthy individuals were analyzed. The absolute counts of Breg and Treg subsets were decreased in HIV+ treatment-naive individuals in comparison to treated-HIV+ and healthy individuals. Interestingly, correlations between Breg subsets (CD24(hi)CD27(+) and PD-L1(+) B cells) and IL-10-producing Breg observed in healthy individuals were lost in HIV+ treatment-naive individuals. However, a correlation between frequencies of CD24(hi)CD38(hi) or TIM-1(+)-Breg subsets and Treg was observed in HIV+ treatment-naive individuals and not in healthy individuals. Therefore, we hypothesized that various Breg subsets might have different functions during B and T-cell homeostasis during HIV-1 infection. In parallel, stimulated Breg from HIV-infected treatment-naive individuals presented a decreased ability to suppress CD4(+) T-cell proliferation in comparison to the stimulated Breg from treated-HIV+ or healthy individuals. We demonstrate a dysregulation between Breg and Treg subsets in HIV-infected individuals, which might participate in the hyper-activation and exhaustion of the immune system that occurs in such patients.	[Gutierrez, Carolina; Moreno-Guillen, Santiago] Ramon y Cajal Univ Hosp, Ramon y Cajal Hlth Res Inst IRYCIS, Mol Immunovirol Lab, Dept Infect Dis, Madrid, Spain; [Lopez-Abente, Jacobo; Perez-Fernandez, Veronica; Prieto-Sanchez, Adrian; Correa-Rocha, Rafael; Pion, Marjorie] Univ Gen Hosp Gregorio Maranon, Hlth Res Inst Gregorio Maranon IiSGM, Immunoregulat Lab, Med & Expt Surg Bldg, Madrid, Spain; [Munoz-Fernandez, Maria-Angeles] Univ Gen Hosp Gregorio Maranon, Mol ImmunoBiol Lab, Hlth Res Inst Gregorio Maranon IiSGM, Spanish HIV HGM BioBank, Madrid, Spain; [Munoz-Fernandez, Maria-Angeles] Networking Res Ctr Bioengn Biomat & Nanomed CIBER, Madrid, Spain; [Lopez-Abente, Jacobo] Univ Complutense Madrid, Sch Chem, Dept Biochem & Mol Biol, Vaccines & Dendrit Cells Lab, Madrid, Spain	Hospital Universitario Ramon y Cajal; General University Gregorio Maranon Hospital; General University Gregorio Maranon Hospital; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; Complutense University of Madrid	Pion, M (corresponding author), Univ Gen Hosp Gregorio Maranon, Hlth Res Inst Gregorio Maranon IiSGM, Immunoregulat Lab, Med & Expt Surg Bldg, Madrid, Spain.	marjorie.pon@iisgm.com	Pion, Marjorie/AAB-5812-2022; Correa-Rocha, Rafael/C-8213-2011; Pion, Marjorie/D-8139-2012; Pion, Marjorie/D-8139-2012	Correa-Rocha, Rafael/0000-0003-3456-9986; Pion, Marjorie/0000-0003-1828-4745; Pion, Marjorie/0000-0002-6406-747X; Munoz-Fernandez/0000-0002-0813-4500; Lopez-Abente, Jacobo/0000-0003-3640-4077	Ministry of Economy and Competitiveness ISCIII-FIS [PI12/01763, PI12/00934, PI15/00923]; ERDF (FEDER) Funds from the European Commission; Research Health Institute Gregorio Maranon (IiSGM) [II-PI-MP-2018]; IiSGM; Youth Employment Program - Madrid community; FEDER Founds [PEJ15-BIO-TL-0094, PEJ15-BIO-TL0373]; Spanish AIDS Research Network; "Miguel Servet" program [CPII13/00033]; Spanish MICINN through the Ramon y Cajal [RYC-2009-05486]	Ministry of Economy and Competitiveness ISCIII-FIS; ERDF (FEDER) Funds from the European Commission; Research Health Institute Gregorio Maranon (IiSGM); IiSGM; Youth Employment Program - Madrid community; FEDER Founds(European Commission); Spanish AIDS Research Network; "Miguel Servet" program; Spanish MICINN through the Ramon y Cajal	This work was partially supported by the Ministry of Economy and Competitiveness ISCIII-FIS grants PI12/01763, PI12/00934 and PI15/00923, co-financed by ERDF (FEDER) Funds from the European Commission, "A way of making Europe". This work was also supported by the internal grant from the Research Health Institute Gregorio Maranon (IiSGM; grant II-PI-MP-2018). J.L-A. was supported by a Grant from IiSGM. A.P-S and V. P-F were supported by the Youth Employment Program co-financed by the Madrid community and FEDER Founds (PEJ15-BIO-TL-0094, PEJ15-BIO-TL0373, respectively). C.G. was supported by the Spanish AIDS Research Network. R.C-R was supported by "Miguel Servet" program (CPII13/00033), and M.P by the Spanish MICINN through the Ramon y Cajal (RYC-2009-05486). All this work was performed in the Laboratorio de Inmuno-Biologia Molecular (HGUG and IiSGM) lead by M-A.M-F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravena O, 2017, ARTHRITIS RES THER, V19, DOI 10.1186/s13075-016-1213-9; Barsotti NS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151761; Berthelot JM, 2013, JOINT BONE SPINE, V80, P18, DOI 10.1016/j.jbspin.2012.04.010; Blair PA, 2010, IMMUNITY, V32, P129, DOI 10.1016/j.immuni.2009.11.009; Buisker TR, 2015, AIDS BEHAV, V19, P2108, DOI 10.1007/s10461-015-1018-x; Cagigi A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005427; Carter NA, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3736; Chagnon-Choquet J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101949; CHIRMULE N, 1992, BLOOD, V79, P1245; Correa-Rocha R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203419; den Hartog G, 2018, EUR J IMMUNOL, V48, P283, DOI 10.1002/eji.201646861; Eggena MP, 2005, J IMMUNOL, V174, P4407, DOI 10.4049/jimmunol.174.7.4407; Figueiro F, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1082703; Flores-Borja F, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005407; Floudas A, 2016, J CLIN IMMUNOL, V36, pS25, DOI 10.1007/s10875-016-0263-8; Fontaine J, 2011, BLOOD, V117, P145, DOI 10.1182/blood-2010-08-301887; Gheybi MK, 2017, BREAST CANCER-TOKYO, V24, P756, DOI 10.1007/s12282-017-0775-y; Gu XL, 2017, APMIS, V125, P872, DOI 10.1111/apm.12729; Hua C, 2016, J AUTOIMMUN, V73, P64, DOI 10.1016/j.jaut.2016.06.002; Iwata Y, 2011, BLOOD, V117, P530, DOI 10.1182/blood-2010-07-294249; Jiao YM, 2014, MICROBIOL IMMUNOL, V58, P449, DOI 10.1111/1348-0421.12171; Perise-Barrios AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039472; Khan AR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6997; Lal G, 2016, IMMUNOL LETT, V170, P52, DOI 10.1016/j.imlet.2016.01.002; Li GM, 2017, J INFECT DIS, V216, P1579, DOI 10.1093/infdis/jix547; Liu J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089236; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Lopez-Abente J, 2017, CELL MOL IMMUNOL; Lopez-Abente J, 2016, FRONT IMMUNOL, V7, DOI [10.3389/fimmu.2016.00192, 10.3389/fimmu.2016.00197]; Ma N, 2017, MOL IMMUNOL, V85, P18, DOI 10.1016/j.molimm.2017.02.002; Mauri C, 2017, J CLIN INVEST, V127, P772, DOI 10.1172/JCI85113; McBride JA, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006624; Miller V, 1999, ANN INTERN MED, V130, P570, DOI 10.7326/0003-4819-130-7-199904060-00005; Moir S, 2008, J EXP MED, V205, P1797, DOI 10.1084/jem.20072683; Nikolova M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005995; Ohkura N, 2013, IMMUNITY, V38, P414, DOI 10.1016/j.immuni.2013.03.002; Pion M, 2013, AIDS, V27, P2019, DOI 10.1097/QAD.0b013e32836253fd; Ray A, 2015, INT IMMUNOL, V27, P531, DOI 10.1093/intimm/dxv033; Rodriguez B, 2003, AIDS, V17, P1983, DOI 10.1097/00002030-200309050-00018; Sainz T, 2013, AIDS, V27, P1513, DOI 10.1097/QAD.0b013e32835faa72; Saison J, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv063; Sambleben C, 2018, APMIS, V126, P143, DOI 10.1111/apm.12795; Sauce D, 2013, CURR OPIN HIV AIDS, V8, P125, DOI 10.1097/COH.0b013e32835d08a9; Siewe B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092934; Siewe B, 2013, J LEUKOCYTE BIOL, V93, P811, DOI 10.1189/jlb.0912436; Thibult ML, 2013, INT IMMUNOL, V25, P129, DOI 10.1093/intimm/dxs098; van de Veen W, 2013, J ALLERGY CLIN IMMUN, V131, P1204, DOI 10.1016/j.jaci.2013.01.014; Walters S, 2009, J IMMUNOL, V182, P793, DOI 10.4049/jimmunol.182.2.793; Wang WW, 2015, ONCOTARGET, V6, P33486, DOI 10.18632/oncotarget.5588; Xiao S, 2015, J IMMUNOL, V194, P1602, DOI 10.4049/jimmunol.1402632; Yang M, 2010, J IMMUNOL, V184, P3321, DOI 10.4049/jimmunol.0902551; Zhang MX, 2012, CELL IMMUNOL, V274, P89, DOI 10.1016/j.cellimm.2012.01.007; Zhu GF, 2018, IMMUNOL RES, V66, P281, DOI 10.1007/s12026-017-8983-2	53	8	11	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2019	14	3							e0213744	10.1371/journal.pone.0213744	http://dx.doi.org/10.1371/journal.pone.0213744			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ5PT	30917149	Green Published, gold, Green Submitted			2022-12-26	WOS:000462465800039
J	Starko, S; Bailey, LA; Creviston, E; James, KA; Warren, A; Brophy, MK; Danasel, A; Fass, MP; Townsend, JA; Neufeld, CJ				Starko, Samuel; Bailey, Lauren A.; Creviston, Elandra; James, Katelyn A.; Warren, Alison; Brophy, Megan K.; Danasel, Andreea; Fass, Megan P.; Townsend, James A.; Neufeld, Christopher J.			Environmental heterogeneity mediates scale-dependent declines in kelp diversity on intertidal rocky shores	PLOS ONE			English	Article							TEMPERATURE TOLERANCE; CLIMATE-CHANGE; WAVE EXPOSURE; LOCAL-SCALE; BIODIVERSITY CHANGE; SARGASSUM MUTICUM; EL-NINO; PATTERNS; ECOSYSTEM; ECOLOGY	Biodiversity loss is driven by interacting factors operating at different spatial scales. Yet, there remains uncertainty as to how fine-scale environmental conditions mediate biological responses to broad-scale stressors. We surveyed intertidal rocky shore kelp beds situated across a local gradient of wave action and evaluated changes in kelp diversity and abundance after more than two decades of broad scale stressors, most notably the 2013-2016 heat wave. Across all sites, species were less abundant on average in 2017 and 2018 than during 1993-1995 but changes in kelp diversity were dependent on wave exposure, with wave exposed habitats remaining stable and wave sheltered habitats experiencing near complete losses of kelp diversity. In this way, wave exposed sites have acted as refugia, maintaining regional kelp diversity despite widespread local declines. Fucoids, seagrasses and two stress-tolerant kelp species (Saccharine sessilis, Egregia menziesii) did not decline as observed in other kelps, and the invasive species Sargassum muticum increased significantly at wave sheltered sites. Long-term monitoring data from a centrally-located moderate site suggest that kelp communities were negatively impacted by the recent heatwave which may have driven observed losses throughout the region. Wave-sheltered shores, which saw the largest declines, are a very common habitat type in the Northeast Pacific and may be especially sensitive to losses in kelp diversity and abundance, with potential consequences for coastal productivity. Our findings highlight the importance of fine-scale environmental heterogeneity in mediating biological responses and demonstrate how incorporating differences between habitat patches can be essential to capturing scale-dependent biodiversity loss across the landscape.	[Starko, Samuel; Fass, Megan P.] Univ British Columbia, Dept Bot, Vancouver, BC, Canada; [Starko, Samuel; Bailey, Lauren A.; Creviston, Elandra; James, Katelyn A.; Warren, Alison; Brophy, Megan K.; Danasel, Andreea; Townsend, James A.; Neufeld, Christopher J.] Bamfield Marine Sci Ctr, Bamfield, BC, Canada; [Bailey, Lauren A.; Creviston, Elandra] Univ Victoria, Dept Biol, Victoria, BC, Canada; [Warren, Alison] Univ British Columbia Okanagan, Dept Biol, Kelowna, BC, Canada; [Danasel, Andreea; Townsend, James A.] Univ Calgary, Dept Biol Sci, Calgary, AB, Canada; [Fass, Megan P.] Univ British Columbia, Dept Biol, Vancouver, BC, Canada	University of British Columbia; Simon Fraser University; University of Victoria; University of British Columbia; University of British Columbia Okanagan; University of Calgary; University of British Columbia	Starko, S (corresponding author), Univ British Columbia, Dept Bot, Vancouver, BC, Canada.; Starko, S (corresponding author), Bamfield Marine Sci Ctr, Bamfield, BC, Canada.	samuel.starko@gmail.com		Brophy, Megan/0000-0001-5968-2147; Neufeld, Christopher/0000-0002-6326-7998; Fass, Megan/0000-0001-7739-8182; Starko, Samuel/0000-0002-9604-9188	Parks Canada	Parks Canada	This work would not have been possible without the initial surveys which were conducted by Druehl and Elliot and funded by Parks Canada. We thank the Huu-ay-aht First Nations, S. Rogers, B. Anholt, S. Gray, B. Rogers, T. Eastham, N. Wiewel and other Bamfield Marine Sciences Centre (BMSC) staff for making this work logistically feasible. Students in the 2017 Coastal Community Ecology class and the 2018 Marine Ecology class at BMSC and L. Campbell contributed to field logistics and planning. We thank the many instructors, researchers, and students who contributed to the collection of long-term monitoring data on Wizard Islet. We thank C. Harley, P. Thompson and M. Whalen for their many insightful comments on an earlier version of this paper, and thank J. Sunday for helpful feedback on data interpretation. SS and CJN designed the study, collected and analyzed the data, and wrote the paper with input from all authors. LB, EC, KJ, AW, MB, AD, MF and JT assisted with data collection, data curation and sampling logistics. The authors declare no competing interests.	Alexander MA, 1999, J CLIMATE, V12, P2419, DOI 10.1175/1520-0442(1999)012<2419:TROSAI>2.0.CO;2; Amos CL, 2015, J COASTAL RES, V31, P434, DOI 10.2112/JCOASTRES-D-14-00114.1; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Arsenault DJ, 2001, P ROY SOC B-BIOL SCI, V268, P2149, DOI 10.1098/rspb.2001.1776; Assis J, 2017, SCI REP-UK, V7, DOI 10.1038/srep44348; BARBER RT, 1983, SCIENCE, V222, P1203, DOI 10.1126/science.222.4629.1203; Bates AE, 2009, DIS AQUAT ORGAN, V86, P245, DOI 10.3354/dao02125; Bennett S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10280; Bolton JJ, 2010, HELGOLAND MAR RES, V64, P263, DOI 10.1007/s10152-010-0211-6; Bond NA, 2015, GEOPHYS RES LETT, V42, P3414, DOI 10.1002/2015GL063306; Britton-Simmons KH, 2011, HYDROBIOLOGIA, V661, P187, DOI 10.1007/s10750-010-0523-1; Bruno JF, 2003, TRENDS ECOL EVOL, V18, P119, DOI 10.1016/S0169-5347(02)00045-9; Burns KC, 2009, OIKOS, V118, P191, DOI 10.1111/j.1600-0706.2008.16816.x; Burt JM, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.0553; Cardinale BJ, 2018, BIOL CONSERV, V219, P175, DOI 10.1016/j.biocon.2017.12.021; Cinner JE, 2016, NATURE, V535, P416, DOI 10.1038/nature18607; Cosson J, 1999, CRYPTOGAMIE ALGOL, V20, P35, DOI 10.1016/S0181-1568(99)80005-1; DANTONIO CM, 1986, MAR ECOL PROG SER, V27, P263, DOI 10.3354/meps027263; DEAN TA, 1986, MAR BIOL, V90, P597, DOI 10.1007/BF00409280; Denny MW, 2006, AQUAT ECOL, V40, P439, DOI 10.1007/s10452-004-5409-8; DETHIER MN, 1988, MAR ECOL PROG SER, V50, P97, DOI 10.3354/meps050097; Di Lorenzo E, 2016, NAT CLIM CHANGE, V6, P1042, DOI [10.1038/NCLIMATE3082, 10.1038/nclimate3082]; DIECK IT, 1993, MAR ECOL PROG SER, V100, P253; Dornelas M, 2014, SCIENCE, V344, P296, DOI 10.1126/science.1248484; Druehl L. D., 1996, K348930006 PARKS CAN; Druehl L. D, 2016, PACIFIC SEAWEEDS; DUGGINS DO, 1989, SCIENCE, V245, P170, DOI 10.1126/science.245.4914.170; Elahi R, 2015, CURR BIOL, V25, P1938, DOI 10.1016/j.cub.2015.05.030; Fanin N, 2018, NAT ECOL EVOL, V2, P269, DOI 10.1038/s41559-017-0415-0; Filbee-Dexter K, 2018, BIOSCIENCE, V68, P64, DOI 10.1093/biosci/bix147; Filbee-Dexter K, 2016, MAR ECOL PROG SER, V543, P141, DOI 10.3354/meps11554; Fitzhenry T, 2004, MAR BIOL, V145, P339, DOI 10.1007/s00227-004-1318-6; Frolicher TL, 2018, NATURE, V560, P360, DOI 10.1038/s41586-018-0383-9; Gentemann CL, 2017, GEOPHYS RES LETT, V44, P312, DOI 10.1002/2016GL071039; Gerard VA, 1997, J PHYCOL, V33, P800, DOI 10.1111/j.0022-3646.1997.00800.x; Gonzalez A, 2016, ECOLOGY, V97, P1949, DOI 10.1890/15-1759.1; Graham MH, 2004, ECOSYSTEMS, V7, P341, DOI 10.1007/s10021-003-0245-6; HAFFER J, 1969, SCIENCE, V165, P131, DOI 10.1126/science.165.3889.131; Harley CDG, 2003, LIMNOL OCEANOGR, V48, P1498, DOI 10.4319/lo.2003.48.4.1498; Harley CDG, 2011, SCIENCE, V334, P1124, DOI 10.1126/science.1210199; Harvell CD, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau7042; Helmuth B, 2002, SCIENCE, V298, P1015, DOI 10.1126/science.1076814; Helmuth B, 2003, LIMNOL OCEANOGR, V48, P1338, DOI 10.4319/lo.2003.48.3.1338; Helmuth B, 2014, CLIMATE CHANGE RESPO, V1, P6, DOI [10.1186/s40665-014-0006-0, DOI 10.1186/S40665-014-0006-0]; Helmuth B, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.87; Henley WJ, 1997, LIMNOL OCEANOGR, V42, P209, DOI 10.4319/lo.1997.42.2.0209; Howes D., 2001, P 2001 PUG SOUND RES; Hurd C.L., 2017, PERSPECT PHYCOLOGY, V4, P73, DOI [10.1127/pip/2017/0072, DOI 10.1127/PIP/2017/0072]; Iacarella JC, 2018, GLOBAL CHANGE BIOL, V24, P1904, DOI 10.1111/gcb.14090; Isbell F, 2017, NATURE, V546, P65, DOI 10.1038/nature22899; Jacox MG, 2016, GEOPHYS RES LETT, V43, P7072, DOI 10.1002/2016GL069716; Krumhansl KA, 2016, P NATL ACAD SCI USA, V113, P13785, DOI 10.1073/pnas.1606102113; LEIGH EG, 1987, P NATL ACAD SCI USA, V84, P1314, DOI 10.1073/pnas.84.5.1314; Levine AFZ, 2016, GEOPHYS RES LETT, V43, P6503, DOI 10.1002/2016GL069204; Light SF, 1954, INTERTIDAL INVERTEBR; LINSENMEYER T A, 1975, Veliger, V18, P83; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; LUNING K, 1988, J PHYCOL, V24, P310, DOI 10.1111/j.1529-8817.1988.tb00178.x; MacMillan C., 1902, POSTELSIA, V1, P193; Neufeld CJ, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.1957; Oliver ECJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03732-9; Paine RT, 2002, SCIENCE, V296, P736, DOI 10.1126/science.1069811; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Pfister CA, 2018, J ECOL, V106, P1520, DOI 10.1111/1365-2745.12908; Puchalski SS, 2010, TAPHONOMIC APPROACHE; Raybaud V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066044; Reed D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13757; Riosmena-Rodriguez R, 2012, BOT MAR, V55, P547, DOI 10.1515/bot-2012-0120; Russell BD, 2012, MAR BIOL, V159, P2633, DOI 10.1007/s00227-011-1863-8; Schultz JA, 2016, PEERJ, V4, DOI 10.7717/peerj.1980; Sigwart JD, 2015, MAR BIOL, V162, P2257, DOI 10.1007/s00227-015-2761-2; Smale DA, 2019, NAT CLIM CHANGE, V9, P306, DOI 10.1038/s41558-019-0412-1; Staehr PA, 2000, MAR ECOL PROG SER, V207, P79, DOI 10.3354/meps207079; Starko S, 2016, NEW PHYTOL, V212, P719, DOI 10.1111/nph.14120; Steneck RS, 2002, ENVIRON CONSERV, V29, P436, DOI 10.1017/S0376892902000322; Teagle H, 2017, J EXP MAR BIOL ECOL, V492, P81, DOI 10.1016/j.jembe.2017.01.017; Tewksbury JJ, 2008, SCIENCE, V320, P1296, DOI 10.1126/science.1159328; Thomas CD, 2013, P NATL ACAD SCI USA, V110, P19187, DOI 10.1073/pnas.1319304110; Thomas MK, 2017, GLOBAL CHANGE BIOL, V23, P3269, DOI 10.1111/gcb.13641; Thomsen MS, 2019, FRONT MAR SCI, V6, DOI 10.3389/fmars.2019.00084; TOPINKA J, 1981, BOT MAR, V24, P311, DOI 10.1515/botm.1981.24.6.311; Underwood AJ, 1996, OECOLOGIA, V107, P212, DOI 10.1007/BF00327905; Vellend M, 2013, P NATL ACAD SCI USA, V110, P19456, DOI 10.1073/pnas.1312779110; Viejo RM, 1997, J MAR BIOL ASSOC UK, V77, P325, DOI 10.1017/S0025315400071708; Wernberg T, 2019, WORLD SEAS: AN ENVIRONMENTAL EVALUATION, VOL III: ECOLOGICAL ISSUES AND ENVIRONMENTAL IMPACTS, 2ND EDITION, P57, DOI 10.1016/B978-0-12-805052-1.00003-6; Wernberg T, 2013, NAT CLIM CHANGE, V3, P78, DOI [10.1038/NCLIMATE1627, 10.1038/nclimate1627]; Wernberg T, 2016, SCIENCE, V353, P169, DOI 10.1126/science.aad8745; Wernberg T, 2011, J EXP MAR BIOL ECOL, V400, P7, DOI 10.1016/j.jembe.2011.02.021; Widdowson TB, 1959, SOME ASPECTS INTERTI, DOI [10.14288/1.0106061, DOI 10.14288/1.0106061]; Willis KJ, 2000, SCIENCE, V287, P1406, DOI 10.1126/science.287.5457.1406; Witman JD, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0189388; Yee T.W, 2015, VECTOR GEN LINEAR AD; ZIMMERMAN RC, 1984, J MAR RES, V42, P591, DOI 10.1357/002224084788506031	94	20	19	4	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2019	14	3							e0213191	10.1371/journal.pone.0213191	http://dx.doi.org/10.1371/journal.pone.0213191			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ3IW	30913219	Green Submitted, gold, Green Published			2022-12-26	WOS:000462305600009
J	Gumucio, JP; Qasawa, AH; Ferrara, PJ; Malik, AN; Funai, K; McDonagh, B; Mendias, CL				Gumucio, Jonathan P.; Qasawa, Austin H.; Ferrara, Patrick J.; Malik, Afshan N.; Funai, Katsuhiko; McDonagh, Brian; Mendias, Christopher L.			Reduced mitochondrial lipid oxidation leads to fat accumulation in myosteatosis	FASEB JOURNAL			English	Article						muscle injury; rotator cuff; fatty degeneration; muscle atrophy	SKELETAL-MUSCLE; ROTATOR-CUFF; FORCE PRODUCTION; TGF-BETA; EXERCISE; FIBROSIS; ATROPHY; GENERATION; EXPRESSION; CAPACITY	Myosteatosis is the pathologic accumulation of lipid that can occur in conjunction with atrophy and fibrosis following skeletal muscle injury. Little is known about the mechanisms by which lipid accumulates in myosteatosis, but many clinical studies have demonstrated that the degree of lipid infiltration negatively correlates with muscle function and regeneration. Our objective was to determine the pathologic changes that result in lipid accumulation in injured muscle fibers. We used a rat model of rotator cuff injury in this study because the rotator cuff muscle group is particularly prone to the development of myosteatosis after injury. Muscles were collected from uninjured controls or 10, 30, or 60 d after injury and analyzed using a combination of muscle fiber contractility assessments, RNA sequencing, and undirected metabolomics, lipidomics, and proteomics, along with bioinformatics techniques to identify potential pathways and cellular processes that are dysregulated after rotator cuff tear. Bioinformatics analyses indicated that mitochondrial function was likely disrupted after injury. Based on these findings and given the role that mitochondria play in lipid metabolism, we then performed targeted biochemical and imaging studies and determined that mitochondrial dysfunction and reduced fatty acid oxidation likely leads to the accumulation of lipid in myosteatosis.-Gumucio, J. P., Qasawa, A. H., Ferrara, P. J., Malik, A. N., Funai, K., McDonagh, B., Mendias, C. L. Reduced mitochondrial lipid oxidation leads to fat accumulation in myosteatosis.	[Gumucio, Jonathan P.; Qasawa, Austin H.; Mendias, Christopher L.] Univ Michigan, Dept Orthoped Surg, Ann Arbor, MI 48109 USA; [Gumucio, Jonathan P.; Mendias, Christopher L.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Ferrara, Patrick J.; Funai, Katsuhiko] Univ Utah, Diabet & Metab Res Ctr, Salt Lake City, UT USA; [Malik, Afshan N.] Kings Coll London, Fac Life Sci & Med, Sch Life Course Sci, Dept Diabet, London, England; [McDonagh, Brian] Natl Univ Ireland, Sch Med, Dept Physiol, Galway, Ireland; [Mendias, Christopher L.] Hosp Special Surg, 535 E 70th St, New York, NY 10021 USA; [Mendias, Christopher L.] Weill Cornell Med Coll, Dept Physiol & Biophys, New York, NY USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Utah System of Higher Education; University of Utah; University of London; King's College London; Ollscoil na Gaillimhe-University of Galway; Cornell University	Mendias, CL (corresponding author), Hosp Special Surg, Res Inst, 535 E 70th St,S-602, New York, NY 10021 USA.	mendiasc@hss.edu	Mendias, Christopher/C-5557-2018	Mendias, Christopher/0000-0002-2384-0171; Malik, Afshan/0000-0001-7207-1666	U.S. National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and skin Diseases [F31-AR065931, R01-AR063649]; NIH National Institute of Diabetes and Digestive and Kidney Diseases [R01-DK107397, R03-DK109888, U24-DK097153]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR063649] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK107397, R03DK109888, U24DK097153] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors acknowledge technical contributions from Dr. Richard McEachin, Dr. James Markworth (both from the University of Michigan, Ann Arbor, MI), and Jacob Swanson (Hospital for Special Surgery, New York, NY). This work was supported by Grants from the U.S. National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and skin Diseases (F31-AR065931, R01-AR063649), and from the NIH National Institute of Diabetes and Digestive and Kidney Diseases (R01-DK107397, R03-DK109888, and U24-DK097153). The authors declare no conflicts of interest.	Afshinnia F, 2018, J AM SOC NEPHROL, V29, P295, DOI 10.1681/ASN.2017030350; Ajaz Saima, 2015, Methods Mol Biol, V1264, P117, DOI 10.1007/978-1-4939-2257-4_12; Aon MA, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00282; Baumer TG, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967116666506; Bedi A, 2010, J BONE JOINT SURG AM, V92A, P1894, DOI 10.2106/JBJS.I.01531; Bhattacharya A, 2011, FREE RADICAL BIO MED, V50, P592, DOI 10.1016/j.freeradbiomed.2010.12.014; Bhattacharya A, 2009, J BIOL CHEM, V284, P46, DOI 10.1074/jbc.M806311200; Biever A, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00075; Boucher J, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a009191; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; Carda S, 2013, EUR J PHYS REHAB MED, V49, P119; Carter HN, 2015, PHYSIOLOGY, V30, P208, DOI 10.1152/physiol.00039.2014; Chong J, 2018, NUCLEIC ACIDS RES, V46, pW486, DOI 10.1093/nar/gky310; Claflin DR, 2011, J APPL PHYSIOL, V111, P1021, DOI 10.1152/japplphysiol.01119.2010; COGSWELL AM, 1993, AM J PHYSIOL, V264, pC383, DOI 10.1152/ajpcell.1993.264.2.C383; Colvin AC, 2012, J BONE JOINT SURG AM, V94A, P227, DOI [10.2106/JBJS.J.00739, 10.2106/JBJS.J.01886]; Davis ME, 2015, J SHOULDER ELB SURG, V24, P280, DOI 10.1016/j.jse.2014.06.048; Davis ME, 2015, CLIN ORTHOP RELAT R, V473, P226, DOI 10.1007/s11999-014-3860-y; Demine S, 2014, METABOLITES, V4, P831, DOI 10.3390/metabo4030831; DOHM GL, 1972, AM J PHYSIOL, V223, P783, DOI 10.1152/ajplegacy.1972.223.4.783; Drake JC, 2017, J PHYSIOL-LONDON, V595, P6391, DOI 10.1113/JP274337; Elenich LA, 1999, IMMUNOGENETICS, V49, P835, DOI 10.1007/s002510050562; Ferreira R, 2010, PROTEOMICS, V10, P3142, DOI 10.1002/pmic.201000173; Flores DV, 2018, RADIOGRAPHICS, V38, P124, DOI 10.1148/rg.2018170072; Fry CS, 2017, J ORTHOP RES, V35, P1876, DOI 10.1002/jor.23502; Gerber C, 2007, J SHOULDER ELB SURG, V16, P691, DOI 10.1016/j.jse.2007.02.122; Gibbons MC, 2017, J BONE JOINT SURG AM, V99, DOI 10.2106/JBJS.16.00335; Gibbons MC, 2016, J ORTHOP RES, V34, P2089, DOI 10.1002/jor.23256; Gigliotti D, 2015, AM J PHYSIOL-CELL PH, V309, pC383, DOI 10.1152/ajpcell.00143.2015; Gladstone JN, 2007, AM J SPORT MED, V35, P719, DOI 10.1177/0363546506297539; Glancy B, 2015, NATURE, V523, P617, DOI 10.1038/nature14614; Gram M, 2015, J PHYSIOL-LONDON, V593, P4011, DOI 10.1113/JP270211; Gumucio JP, 2015, EXERC SPORT SCI REV, V43, P93, DOI 10.1249/JES.0000000000000041; Gumucio JP, 2012, J ORTHOP RES, V30, P1963, DOI 10.1002/jor.22168; Iijima Y, 2002, J BIOL CHEM, V277, P23065, DOI 10.1074/jbc.M200328200; Jia Z, 2004, PROTEIN EXPRES PURIF, V38, P153, DOI 10.1016/j.pep.2004.08.013; Kienesberger PC, 2009, J LIPID RES, V50, pS63, DOI 10.1194/jlr.R800082-JLR200; Killian ML, 2013, J ORTHOP RES, V31, P1240, DOI 10.1002/jor.22345; Kim JK, 2002, METABOLISM, V51, P460, DOI 10.1053/meta.2002.31326; Kind T, 2013, NAT METHODS, V10, P755, DOI 10.1038/nmeth.2551; Koves TR, 2005, AM J PHYSIOL-CELL PH, V288, pC1074, DOI 10.1152/ajpcell.00391.2004; Larsen S, 2012, J PHYSIOL-LONDON, V590, P3349, DOI 10.1113/jphysiol.2012.230185; Liu XH, 2011, J ORTHOP RES, V29, P588, DOI 10.1002/jor.21266; Lorenz MA, 2011, ANAL CHEM, V83, P3406, DOI 10.1021/ac103313x; Ma SP, 2016, ANTIOXID REDOX SIGN, V24, P486, DOI 10.1089/ars.2015.6336; MacPherson REK, 2015, APPL PHYSIOL NUTR ME, V40, P641, DOI 10.1139/apnm-2014-0485; Marabita M, 2016, CELL REP, V17, P501, DOI 10.1016/j.celrep.2016.09.020; Mathewson MA, 2014, J EXP BIOL, V217, P261, DOI 10.1242/jeb.083923; McDonagh B, 2014, J PROTEOME RES, V13, P5008, DOI 10.1021/pr5006394; Mears JA, 2011, NAT STRUCT MOL BIOL, V18, P20, DOI 10.1038/nsmb.1949; Mendias CL, 2017, J APPL PHYSIOL, V122, P571, DOI 10.1152/japplphysiol.00719.2016; Mendias CL, 2015, J SHOULDER ELB SURG, V24, P111, DOI 10.1016/j.jse.2014.06.037; Mendias CL, 2012, MUSCLE NERVE, V45, P55, DOI 10.1002/mus.22232; Menshikova EV, 2006, J GERONTOL A-BIOL, V61, P534, DOI 10.1093/gerona/61.6.534; Meyer GA, 2015, J ORTHOP RES, V33, P421, DOI 10.1002/jor.22786; Morag Y, 2006, RADIOGRAPHICS, V26, P1045, DOI 10.1148/rg.264055087; Overmyer KA, 2015, CELL METAB, V21, P468, DOI 10.1016/j.cmet.2015.02.007; Patel KD, 2016, BBA-BIOENERGETICS, V1857, P1284, DOI 10.1016/j.bbabio.2016.02.014; Pollock N, 2017, FREE RADICAL BIO MED, V112, P84, DOI 10.1016/j.freeradbiomed.2017.07.017; Powers SK, 2016, FREE RADICAL BIO MED, V98, P208, DOI 10.1016/j.freeradbiomed.2016.02.021; Richter K, 2016, CELL TISSUE RES, V365, P591, DOI 10.1007/s00441-016-2445-3; Roche SM, 2015, JOVE-J VIS EXP, DOI 10.3791/52695; Sartori R, 2014, TRENDS ENDOCRIN MET, V25, P464, DOI 10.1016/j.tem.2014.06.002; Sarver DC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02754-5; Soslowsky L J, 1996, J Shoulder Elbow Surg, V5, P383; Sugg KB, 2017, FEBS LETT, V591, P801, DOI 10.1002/1873-3468.12571; Tavares MR, 2015, LIFE SCI, V131, P1, DOI 10.1016/j.lfs.2015.03.001; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Tryon LD, 2014, INTEGR MED RES, V3, P161, DOI 10.1016/j.imr.2014.09.001; Valencia AP, 2018, AM J SPORT MED, V46, P2161, DOI 10.1177/0363546518769267; Ward SR, 2010, J ORTHOP SPORT PHYS, V40, P729, DOI 10.2519/jospt.2010.3279; Watabe S, 1997, EUR J BIOCHEM, V249, P52, DOI 10.1111/j.1432-1033.1997.t01-1-00052.x; Watt MJ, 2012, AM J PHYSIOL-ENDOC M, V302, pE1315, DOI 10.1152/ajpendo.00561.2011; West DWD, 2016, J PHYSIOL-LONDON, V594, P453, DOI 10.1113/JP271365; Wicks SE, 2015, P NATL ACAD SCI USA, V112, pE3300, DOI 10.1073/pnas.1418560112; Wilde JM, 2016, J SHOULDER ELB SURG, V25, P1501, DOI 10.1016/j.jse.2016.01.035; Yamaguchi K, 2006, J BONE JOINT SURG AM, V88A, P1699, DOI 10.2106/JBJS.E.00835; Yamaki T, 2012, AM J PHYSIOL-CELL PH, V303, pC135, DOI 10.1152/ajpcell.00111.2012; Zhang C, 2014, J BIOMECH, V47, P944, DOI 10.1016/j.jbiomech.2014.01.026; Zoico E, 2013, ARCH GERONTOL GERIAT, V57, P411, DOI 10.1016/j.archger.2013.06.001	80	35	36	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2019	33	7					7863	7881		10.1096/fj.201802457RR	http://dx.doi.org/10.1096/fj.201802457RR			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ9SM	30939247	Green Submitted, Green Published, Bronze			2022-12-26	WOS:000476234700007
J	Hashimoto, M; Kusudo, T; Takeuchi, T; Kataoka, N; Mukai, T; Yamashita, H				Hashimoto, Michihiro; Kusudo, Tatsuya; Takeuchi, Tamaki; Kataoka, Naoya; Mukai, Takako; Yamashita, Hitoshi			CREG1 stimulates brown adipocyte formation and ameliorates diet-induced obesity in mice	FASEB JOURNAL			English	Article						brown adipose tissue; transgenic mouse; uncoupling protein 1; browning	MITOCHONDRIAL UNCOUPLING PROTEIN; ADIPOSE-TISSUE; E1A-STIMULATED GENES; CELLULAR REPRESSOR; BEIGE FAT; GROWTH; ENERGY; FGF21; CONTRIBUTES; RESISTANCE	Increased formation of brown and beige adipocytes is critical for adaptive thermogenesis to maintain homeothermy in cold or to circumvent diet-induced obesity (DIO). Cellular repressor of adenovirus early region 1A-stimulated genes 1 (CREG1) exhibits the ability to stimulate brown adipogenesis, including the induction of uncoupling protein 1 (UCP1), in vitro. Thus, we aimed to clarify whether CREG1 promotes brown adipocyte formation and inhibits DIO at the whole-animal level. In mouse brown adipose tissue (BAT), CREG1 expression was markedly increased in cold but was decreased under thermoneutrality, suggesting CREG1 involvement in BAT thermogenesis. Moreover, in BAT and white adipose tissue, expression of UCP1 and fibroblast growth factor-21 and browning were both significantly higher in adipocyte P2-Creg1-transgenic (Tg) mice than in wild-type (WT) littermates. Following stimulation with a beta 3-adrenergic agonist, energy consumption was elevated in the Tg mice, which showed increased resistance to DIO and improvement of obesity-associated complications including fatty liver relative to WT mice. The CREG1 stimulatory effect on brown adipogenesis was confirmed in Tg-BAT primary cultures. It was also found that CREG1 binds to retinoid X receptor alpha, which interacts with thyroid hormone receptor for brown adipogenesis. Our findings demonstrate that CREG1 stimulates brown adipocyte formation and browning, ameliorating obesity and its related pathology in vivo.-Hashimoto, M., Kusudo, T., Takeuchi, T., Kataoka, N., Mukai, T., Yamashita, H. CREG1 stimulates brown adipocyte formation and ameliorates diet-induced obesity in mice.	[Hashimoto, Michihiro; Kusudo, Tatsuya; Takeuchi, Tamaki; Kataoka, Naoya; Yamashita, Hitoshi] Chubu Univ, Coll Life & Hlth Sci, Dept Biomed Sci, 1200 Matsumoto Cho, Kasugai, Aichi 4878501, Japan; [Kusudo, Tatsuya; Mukai, Takako] Tezukayama Gakuin Univ, Fac Human Sci, Dept Nutr & Food Sci, Sakai, Osaka, Japan; [Kataoka, Naoya] Nagoya Univ, Dept Integrat Physiol, Sch Med, Nagoya, Aichi, Japan	Chubu University; Nagoya University	Yamashita, H (corresponding author), Chubu Univ, Coll Life & Hlth Sci, Dept Biomed Sci, 1200 Matsumoto Cho, Kasugai, Aichi 4878501, Japan.	hyamashi@isc.chubu.ac.jp	Kataoka, Naoya/AGY-5263-2022	Kataoka, Naoya/0000-0002-2339-5522; Yamashita, Hitoshi/0000-0002-5785-5208	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) [S1201007]; Japan Society for the Promotion of Science [24580499, 15K07846, 15K07446, 16K21453]; Chubu University	Ministry of Education, Culture, Sports, Science, and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Chubu University	The authors thank Y. Yamashita, Y. Ohmi, A. Nozaki, and Y. Endo (all from Chubu University) for technical support and Dr. Y. Kamei (Kyoto Prefectural University) for adipocyte protein 2 promoter. This work was supported by a grant from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT)-supported program for the Strategic Research Foundation at Private Universities (S1201007), Grant-in-Aid for Scientific Research (Kakenhi) from the Japan Society for the Promotion of Science (Grants 24580499 and 15K07846 to H.Y., 15K07446 to T.K., and 16K21453 to M.H.), and Chubu University Grant A (to H.Y.). The authors declare no conflicts of interest.	Bergman D, 2013, GERONTOLOGY, V59, P240, DOI 10.1159/000343995; Bordicchia M, 2012, J CLIN INVEST, V122, P1022, DOI 10.1172/JCI59701; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cannon B, 2012, J CLIN INVEST, V122, P486, DOI 10.1172/JCI60941; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Di Bacco A, 2003, ONCOGENE, V22, P5436, DOI 10.1038/sj.onc.1206670; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Evans RM, 2014, CELL, V157, P255, DOI 10.1016/j.cell.2014.03.012; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Fisher FM, 2016, ANNU REV PHYSIOL, V78, P223, DOI 10.1146/annurev-physiol-021115-105339; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; Gordon PV, 2005, J ENDOCRINOL, V185, P265, DOI 10.1677/joe.1.06093; Han YL, 2008, CARDIOVASC RES, V78, P597, DOI 10.1093/cvr/cvn036; Ikushima H, 2000, P NATL ACAD SCI USA, V97, P8439, DOI 10.1073/pnas.97.15.8439; Inokuma K, 2006, AM J PHYSIOL-ENDOC M, V290, pE1014, DOI 10.1152/ajpendo.00105.2005; Kajimura S, 2015, CELL METAB, V22, P546, DOI 10.1016/j.cmet.2015.09.007; Kontani Y, 2005, AGING CELL, V4, P147, DOI 10.1111/j.1474-9726.2005.00157.x; Kopecky J, 1995, J CLIN INVEST, V96, P2914, DOI 10.1172/JCI118363; Kozak LP, 2000, ANNU REV NUTR, V20, P339, DOI 10.1146/annurev.nutr.20.1.339; Kusudo T, 2019, J BIOCHEM, V165, P47, DOI 10.1093/jb/mvy083; Kusudo T, 2012, J APPL PHYSIOL, V112, P1223, DOI 10.1152/japplphysiol.01070.2011; Li LY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122024; Liu J, 2016, STEM CELLS, V34, P2648, DOI 10.1002/stem.2434; Liu XT, 2003, J CLIN INVEST, V111, P399, DOI 10.1172/JCI200315737; Mullur R, 2014, PHYSIOL REV, V94, P355, DOI 10.1152/physrev.00030.2013; Ni B, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00148; Nishio M, 2012, CELL METAB, V16, P394, DOI 10.1016/j.cmet.2012.08.001; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Samms RJ, 2015, CELL REP, V11, P991, DOI 10.1016/j.celrep.2015.04.046; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; Sidossis L, 2015, J CLIN INVEST, V125, P478, DOI 10.1172/JCI78362; Tian XX, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176873; Tseng YH, 2008, NATURE, V454, P1000, DOI 10.1038/nature07221; Veal E, 1998, MOL CELL BIOL, V18, P5032, DOI 10.1128/MCB.18.9.5032; Veal E, 2000, ONCOGENE, V19, P2120, DOI 10.1038/sj.onc.1203529; Veniant MM, 2015, CELL METAB, V21, P731, DOI 10.1016/j.cmet.2015.04.019; Villarroya F, 2013, CELL METAB, V17, P638, DOI 10.1016/j.cmet.2013.02.020; Wang T, 2008, ENDOCRINOLOGY, V149, P358, DOI 10.1210/en.2007-0467; WANG ZQ, 1994, NATURE, V372, P464, DOI 10.1038/372464a0; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Yamada K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062304; YAMASHITA H, 1994, PFLUG ARCH EUR J PHY, V428, P352, DOI 10.1007/BF00724518	44	11	11	1	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2019	33	7					8069	8082		10.1096/fj.201802147RR	http://dx.doi.org/10.1096/fj.201802147RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ9SM	30917000	Bronze			2022-12-26	WOS:000476234700022
J	Boone, DR; Weisz, HA; Willey, HE; Torres, KEO; Falduto, MT; Sinha, M; Spratt, H; Bolding, IJ; Johnson, KM; Parsley, MA; DeWitt, DS; Prough, DS; Hellmich, HL				Boone, Deborah R.; Weisz, Harris A.; Willey, Hannah E.; Torres, Karen E. O.; Falduto, Michael T.; Sinha, Mala; Spratt, Heidi; Bolding, Ian J.; Johnson, Kathea M.; Parsley, Margaret A.; DeWitt, Douglas S.; Prough, Donald S.; Hellmich, Helen L.			Traumatic brain injury induces long-lasting changes in immune and regenerative signaling	PLOS ONE			English	Article							NEURODEGENERATIVE DISEASES; COMPLEMENT-SYSTEM; TERM POTENTIATION; INFLAMMATION; EXPRESSION; NEUROINFLAMMATION; BIOLOGY; VALIDATION; INDUCTION; BEHAVIOR	There are no existing treatments for the long-term degenerative effects of traumatic brain injury (TBI). This is due, in part, to our limited understanding of chronic TBI and uncertainty about which proposed mechanisms for long-term neurodegeneration are amenable to treatment with existing or novel drugs. Here, we used microarray and pathway analyses to interrogate TBI-induced gene expression in the rat hippocampus and cortex at several acute, subchronic and chronic intervals (24 hours, 2 weeks, 1, 2, 3, 6 and 12 months) after parasagittal fluid percussion injury. We used Ingenuity pathway analysis (IPA) and Gene Ontology enrichment analysis to identify significantly expressed genes and prominent cell signaling pathways that are dysregulated weeks to months after TBI and potentially amenable to therapeutic modulation. We noted long-term, coordinated changes in expression of genes belonging to canonical pathways associated with the innate immune response (i.e., NF-kappa B signaling, NFAT signaling, Complement System, Acute Phase Response, Toll-like receptor signaling, and Neuroinflammatory signaling). Bioinformatic analysis suggested that dysregulation of these immune mediators-many are key hub genes-would compromise multiple cell signaling pathways essential for homeostatic brain function, particularly those involved in cell survival and neuroplasticity. Importantly, the temporal profile of beneficial and maladaptive immunoregulatory genes in the weeks to months after the initial TBI suggests wider therapeutic windows than previously indicated.	[Boone, Deborah R.; Weisz, Harris A.; Willey, Hannah E.; Sinha, Mala; Spratt, Heidi; Bolding, Ian J.; Johnson, Kathea M.; Parsley, Margaret A.; DeWitt, Douglas S.; Prough, Donald S.; Hellmich, Helen L.] Univ Texas Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA; [Torres, Karen E. O.; Falduto, Michael T.] GenUs Biosyst, Northbrook, IL USA; [Falduto, Michael T.] Paradise Genom Inc, Northbrook, IL USA	University of Texas System; University of Texas Medical Branch Galveston	Hellmich, HL (corresponding author), Univ Texas Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA.	hhellmic@utmb.edu		DeWitt, Douglas/0000-0001-9810-8156; Spratt, Heidi/0000-0002-9420-5028	Moody Project for Translational Traumatic Brain Injury Research	Moody Project for Translational Traumatic Brain Injury Research	This work was funded through a private grant from the Moody Project for Translational Traumatic Brain Injury Research. Recipients are DRB, HAW, HEW, MS, HS, IJB, KMJ, MAP, DSD, DSP, HLH. The funder did not play any role in the study design, data collection and analysis, or in the preparation or decision to publish manuscript. GenUs Biosystems provided support in the form of salaries for authors [MTF, KEOT], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Paradise genomics provided support in the form of salaries for [MTF], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of MTF is articulated in the 'author contributions' section.	Addington CP, 2015, BIOMARK INSIGHTS, V10, P43, DOI [10.4137/BMIMI.S20062, 10.4137/BMI.S20062]; Adzic M, 2018, CURR NEUROPHARMACOL, V16, P176, DOI 10.2174/1570159X15666170828163048; Alawieh A, 2018, J NEUROSCI, V38, P2519, DOI 10.1523/JNEUROSCI.2197-17.2018; Armstrong RJE, 2001, LANCET, V358, P1174, DOI 10.1016/S0140-6736(01)06260-2; Ashabi G, 2015, METAB BRAIN DIS, V30, P747, DOI 10.1007/s11011-014-9632-2; Bayram FEO, 2018, CURR TOP MED CHEM, V18, P1416, DOI 10.2174/1568026618666180821144704; Belarbi K, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-23; Bhandari R, 2018, DRUG TODAY, V54, P349, DOI 10.1358/dot.2018.54.6.2828189; Bodnar CN, 2018, NEURAL REGEN RES, V13, P1693, DOI 10.4103/1673-5374.238604; Bondi CO, 2015, NEUROSCI BIOBEHAV R, V58, P123, DOI 10.1016/j.neubiorev.2014.12.004; Boone DK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06341-6; Boone DR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127287; Broussard JI, 2016, CELL REP, V14, P1930, DOI 10.1016/j.celrep.2016.01.070; Caesar R, 2015, CELL METAB, V22, P658, DOI 10.1016/j.cmet.2015.07.026; Caeyenberghs K, 2014, BRAIN STRUCT FUNCT, V219, P193, DOI 10.1007/s00429-012-0494-2; Chauhan NB, 2014, RESTOR NEUROL NEUROS, V32, P337, DOI 10.3233/RNN-130354; Chin LM, 2015, ARCH PHYS MED REHAB, V96, P754, DOI 10.1016/j.apmr.2014.11.009; Chiu CC, 2016, J NEUROSCI METH, V272, P38, DOI 10.1016/j.jneumeth.2016.06.018; Chu H, 2008, J IMMUNOL, V181, P3373, DOI 10.4049/jimmunol.181.5.3373; Dai HW, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000012018; Dai JX, 2018, ONCOL LETT, V15, P8245, DOI 10.3892/ol.2018.8376; Dolgin E, 2017, NATURE, V551, P427, DOI 10.1038/d41586-017-07291-9; Faden AI, 2016, BRIT J PHARMACOL, V173, P681, DOI 10.1111/bph.13179; Faden AI, 2015, NEUROTHERAPEUTICS, V12, P143, DOI 10.1007/s13311-014-0319-5; Fang B, 2014, INT J MOL SCI, V15, P6378, DOI 10.3390/ijms15046378; Feigin VL, 2017, LANCET NEUROL, V16, P877, DOI 10.1016/S1474-4422(17)30299-5; Fluiter K, 2014, J IMMUNOL, V192, P2339, DOI 10.4049/jimmunol.1302793; Forstner P, 2018, J NEUROTRAUM, V35, P2317, DOI 10.1089/neu.2017.5593; Franceschi C, 2014, J GERONTOL A-BIOL, V69, pS4, DOI 10.1093/gerona/glu057; Gao HM, 2008, TRENDS IMMUNOL, V29, P357, DOI 10.1016/j.it.2008.05.002; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Hai T, 2010, GENE EXPRESSION, V15, P1, DOI 10.3727/105221610X12819686555015; Heimberg G, 2016, CELL SYST, V2, P239, DOI 10.1016/j.cels.2016.04.001; Hellmich HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053230; Jalles A., 2016, MOL SCI, V2, P259; Jarosik J, 2007, EXP NEUROL, V204, P20, DOI 10.1016/j.expneurol.2006.09.008; Kabadi SV, 2014, INT J MOL SCI, V15, P1216, DOI 10.3390/ijms15011216; Kang S, 2018, BMB REP, V51, P92, DOI 10.5483/BMBRep.2018.51.2.219; Kinch MS, 2015, DRUG DISCOV TODAY, V20, P920, DOI 10.1016/j.drudis.2015.02.006; Kobeissy FH, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00198; Kobeissy FH, 2010, METHODS MOL BIOL, V662, P303, DOI 10.1007/978-1-60761-800-3_15; Lai WF, 2018, INFLAMMATION, V41, P449, DOI 10.1007/s10753-017-0701-7; Lakshmikanthan S, 2018, J CELL SCI, V131, DOI 10.1242/jcs.207605; Li JR, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0959-6; Lipponen A, 2016, SCI REP-UK, V6, DOI 10.1038/srep31570; Liu XY, 2017, BMC NEUROSCI, V18, DOI 10.1186/s12868-017-0348-1; Lynch MA, 2004, PHYSIOL REV, V84, P87, DOI 10.1152/physrev.00014.2003; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Maqbool A, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-40; Mendez MF, 2017, J ALZHEIMERS DIS, V57, P667, DOI 10.3233/JAD-161002; Morey JS, 2006, BIOL PROCED ONLINE, V8, P175, DOI 10.1251/bpo126; Mota BC, 2012, NEUROTOX RES, V21, P175, DOI 10.1007/s12640-011-9257-8; Muller WA, 2013, VET PATHOL, V50, P7, DOI 10.1177/0300985812469883; Natale JE, 2003, J NEUROTRAUM, V20, P907, DOI 10.1089/089771503770195777; Nordstrom A, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002496; Pandey AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088889; Pettit LK, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-16; Piao CS, 2013, NEUROBIOL DIS, V54, P252, DOI 10.1016/j.nbd.2012.12.017; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Rapoport MJ, 2012, CNS DRUGS, V26, P111, DOI 10.2165/11599560-000000000-00000; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Rojo DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023111; Rubin RD, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7070082; Ruzafa N, 2018, PROTEOMICS, V18, DOI 10.1002/pmic.201700321; Sarnico I, 2009, INT REV NEUROBIOL, V85, P351, DOI 10.1016/S0074-7742(09)85024-1; Savin C, 2009, J R SOC INTERFACE, V6, P655, DOI 10.1098/rsif.2008.0387; Schouten JW, 2007, CURR OPIN CRIT CARE, V13, P134, DOI 10.1097/MCC.0b013e3280895d5c; Sell SL, 2017, J NEUROTRAUM, V34, P1086, DOI 10.1089/neu.2016.4616; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Shi LM, 2010, NAT BIOTECHNOL, V28, P827, DOI 10.1038/nbt.1665; Shih RH, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00077; Shimamura M, 2004, MOL BRAIN RES, V122, P47, DOI 10.1016/j.molbrainres.2003.11.015; Shojo H, 2010, NEUROSCIENCE, V171, P1273, DOI 10.1016/j.neuroscience.2010.10.018; Sigurdsson T, 2016, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00190; Sin O, 2015, CELL MOL LIFE SCI, V72, P4027, DOI 10.1007/s00018-015-1985-0; Soares HD, 1995, J NEUROSCI, V15, P8223; Stephan AH, 2012, ANNU REV NEUROSCI, V35, P369, DOI 10.1146/annurev-neuro-061010-113810; Stylli SS, 2000, J CLIN NEUROSCI, V7, P137, DOI 10.1054/jocn.1999.0187; Thomas TC, 2018, BEHAV BRAIN RES, V340, P137, DOI 10.1016/j.bbr.2016.12.038; Turner RC, 2013, FRONT NEUROL, V3, DOI 10.3389/fneur.2012.00186; Vezzani A, 2011, NAT REV NEUROL, V7, P31, DOI 10.1038/nrneurol.2010.178; Villarino AV, 2004, J IMMUNOL, V173, P715, DOI 10.4049/jimmunol.173.2.715; Vizuete AFK, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1109-5; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Webster KM, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-016-0786-1; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Zhang JH, 2011, CHIN OPT LETT, V9, DOI 10.3788/COL201109.090606; Zheng S, 2017, FUTURE ONCOL, V13, P2053, DOI 10.2217/fon-2017-0199	90	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0214741	10.1371/journal.pone.0214741	http://dx.doi.org/10.1371/journal.pone.0214741			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR5NS	30943276	gold, Green Published, Green Submitted			2022-12-26	WOS:000463194300058
J	Baatjes, KJ; Kotze, MJ; McCaul, M; Conradie, M				Baatjes, Karin J.; Kotze, Maritha J.; McCaul, Micheal; Conradie, Magda			Baseline bone health status in multi-ethnic South African postmenopausal breast cancer patients at initiation of aromatase inhibitor therapy: A descriptive study	PLOS ONE			English	Article							MINERAL DENSITY; BIG 1-98; FAT DISTRIBUTION; RISK-FACTOR; WOMEN; FRACTURES; TAMOXIFEN; MANAGEMENT; HIP; LETROZOLE	Introduction Osteoporosis (OP) risk factor assessment and bone mineral density (BMD) testing are frequently omitted at baseline in aromatase inhibitor (Al) studies, which may lead to misinterpretation of Al associated bone loss. The present study describes bone health of South African postmenopausal women of predominantly Mixed Ancestry, prior to Al treatment. Methods This descriptive baseline study, nested in a prospective Al cohort study, included postmenopausal women with endocrine sensitive breast cancer, aged 50 to 80 years. A baseline questionnaire documented demographic-, medical-, lifestyle- and fracture history. Body weight was assessed clinically, and body composition and BMD measured via dual energy absorptiometry (DXA). Data was analysed in STATA 14 using descriptive and inferential statistics. Results 101 participants were recruited, with a mean age of 61 +/- 7 years. Nearly a third (n = 32) of women at baseline fulfilled global criteria for bone protection (BMD T-score >=-2SD (n = 18); BMD T-score-1.5SD to < -2SD with risk factors (n = 14). Lower body weight, body mass index (BMI), fat mass index and lean mass index were significantly associated with the participants with a BMD measurement in keeping with a diagnosis of OP (p < 0.001). Low vitamin D was present in 93% of the cohort tested (n = 95), whilst deficient vitamin D status (<20ng/ml) was documented in 52 women (55%). Conclusions In this study, a third of postmenopausal women considered for Al therapy fulfilled international criteria for bone protective pharmacological intervention. This emphasizes the need for clinical risk and BMD assessment in postmenopausal breast cancer patients at baseline. Body composition and bone health associations highlight bone fragility associated with lower body weight.	[Baatjes, Karin J.] Stellenbosch Univ, Dept Surg Sci, Fac Med & Hlth Sci, Tygerberg, South Africa; [Kotze, Maritha J.] Stellenbosch Univ, Div Chem Pathol, Dept Pathol, Fac Med & Hlth Sci, Tygerberg, South Africa; [Kotze, Maritha J.] Tygerberg Hosp, Natl Hlth Lab Serv, Tygerberg, South Africa; [McCaul, Micheal] Stellenbosch Univ, Biostat Unit, Div Epidemiol & Biostat, Dept Global Hlth, Tygerberg, South Africa; [Conradie, Magda] Stellenbosch Univ, Div Endocrinol, Dept Med, Fac Med & Hlth Sci, Tygerberg, South Africa	Stellenbosch University; Stellenbosch University; Tygerberg Hospital; Stellenbosch University; Stellenbosch University	Baatjes, KJ (corresponding author), Stellenbosch Univ, Dept Surg Sci, Fac Med & Hlth Sci, Tygerberg, South Africa.	kbaatjes@sun.ac.za	Kotze, Maritha J/GMX-0989-2022	McCaul, Michael/0000-0002-2730-6478; Kotze, Martha/0000-0002-6050-2876; Baatjes, Karin/0000-0001-8432-8844	Cancer Association of South Africa (CANSA); Strategic Health Innovation Partnerships (SHIP) Unit of the South African Medical Research Council (MRC); South African Department of Science and Technology [S003665]	Cancer Association of South Africa (CANSA); Strategic Health Innovation Partnerships (SHIP) Unit of the South African Medical Research Council (MRC); South African Department of Science and Technology	The research was supported by the Cancer Association of South Africa (CANSA) and the Strategic Health Innovation Partnerships (SHIP) Unit of the South African Medical Research Council (MRC), with funds received from the South African Department of Science and Technology (Research grant number S003665).	Andreopoulou P, 2015, ANNU REV MED, V66, P329, DOI 10.1146/annurev-med-070313-022841; Blaauw R, 1996, S AFR MED J, V86, P1081; Body Jean-Jacques, 2012, Bonekey Rep, V1, P201, DOI 10.1038/bonekey.2012.201; Bouvard B, 2012, ANN ONCOL, V23, P1151, DOI 10.1093/annonc/mdr356; California I, 2016, CAISO FLEX RES FAST, P1; Cauley JA, 2011, CLIN ORTHOP RELAT R, V469, P1891, DOI 10.1007/s11999-011-1863-5; Christodoulou S, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/396541; Conradie M, 2014, ARCH OSTEOPOROS, V9, DOI 10.1007/s11657-014-0193-0; Da Shao H, 2015, J BONE MINER METAB, V33, P507, DOI 10.1007/s00774-014-0613-7; Edwards BJ, 2011, CLIN CANCER RES, V17, P560, DOI 10.1158/1078-0432.CCR-10-1595; Hadji P, 2011, ANN ONCOL, V22, P2546, DOI 10.1093/annonc/mdr017; Hadji P, 2017, J BONE ONCOL, V7, P1, DOI 10.1016/j.jbo.2017.03.001; Ho-Pham LT, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-59; Howell A, 2005, LANCET, V365, P60, DOI 10.1016/s0140-6736(04)17666-6; Johnell O, 2005, J BONE MINER RES, V20, P1185, DOI 10.1359/JBMR.050304; Kalder M, 2014, J CLIN DENSITOM, V17, P66, DOI 10.1016/j.jocd.2013.03.003; KALLA AA, 1994, S AFR MED J, V84, P398; KANIS JA, 1994, J BONE MINER RES, V9, P1137, DOI 10.1002/jbmr.5650090802; Kimble RB, 1996, J BIOL CHEM, V271, P28890, DOI 10.1074/jbc.271.46.28890; Lupsa BC, 2015, ENDOCRIN METAB CLIN, V44, P517, DOI 10.1016/j.ecl.2015.05.002; Mo D, 2016, ETHN HLTH, P1; Nanes MS, 2014, SEMIN NUCL MED, V44, P439, DOI 10.1053/j.semnuclmed.2014.06.006; Oliveros E, 2014, PROG CARDIOVASC DIS, V56, P426, DOI 10.1016/j.pcad.2013.10.003; Pettifor JM, 1996, S AFR MED J, V86, P1270; Pisani P, 2016, WORLD J ORTHOP, V7, P171, DOI 10.5312/wjo.v7.i3.171; Prieto-Alhambra D, 2012, BREAST CANCER RES TR, V133, P1159, DOI 10.1007/s10549-012-2013-9; Rabaglio M, 2009, ANN ONCOL, V20, P1489, DOI 10.1093/annonc/mdp033; Romero-Corral A, 2008, INT J OBESITY, V32, P959, DOI 10.1038/ijo.2008.11; Roux C, 2003, BONE, V33, P847, DOI 10.1016/j.bone.2003.07.008; Servitja S, 2015, THER ADV MED ONCOL, V7, P291, DOI 10.1177/1758834015598536; Servitja S, 2012, BREAST, V21, P95, DOI 10.1016/j.breast.2011.09.001; Wardley AM, 2008, ADV THER, V25, P1257, DOI 10.1007/s12325-008-0128-5; Yang PLS, 2013, J CLIN ENDOCR METAB, V98, P4516, DOI 10.1210/jc.2013-2454; Zaman K, 2012, ANN ONCOL, V23, P1474, DOI 10.1093/annonc/mdr448	34	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2019	14	4							e0214153	10.1371/journal.pone.0214153	http://dx.doi.org/10.1371/journal.pone.0214153			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR2UW	30939140	Green Published, Green Submitted, gold			2022-12-26	WOS:000462993900014
J	Shimeles, E; Enquselassie, F; Aseffa, A; Tilahun, M; Mekonen, A; Wondimagegn, G; Hailu, T				Shimeles, Ezra; Enquselassie, Fikre; Aseffa, Abraham; Tilahun, Melaku; Mekonen, Alemayehu; Wondimagegn, Getachew; Hailu, Tsegaye			Risk factors for tuberculosis: A case-control study in Addis Ababa, Ethiopia	PLOS ONE			English	Article							RESISTANT TUBERCULOSIS; CONTACT; PREVALENCE; REGION	Background Tuberculosis remains a major public-health problem in the world, despite several efforts to improve case identification and treatment compliance. It is well known cause of ill-health among millions of people each year and ranks as the second leading cause of death from infectious disease worldwide. Despite implementation of the World health organization recommended strategy, the reductions in the incidence of TB have been minimal in high burden countries. Objectives and methods A case control study was carried out to assess the risk factors of TB, where cases were newly registered bacteriologically confirmed pulmonary TB patients with age greater than 15 years who present at twenty health centres in Addis Ababa. Controls were age and sex matched attendees who presented in the same health centers for non-TB health problems. Results A total of 260 cases and 260 controls were enrolled in the study and 45.8% of cases and 46.2% of controls were in the 26-45 years age bracket. According to the multivariable logistic regression analysis, seven variables were found to be independent predictors for the occurrence of TB after controlling possible confounders. Patients who live in house with no window or one window were almost two times more likely to develop tuberculosis compared to people whose house has multiple windows (AOR = 1.81; 95% CI: 1.06, 3.07). Previous history of hospital admission was found to pose risk almost more than three times (AOR = 3.39; 95% CI: 1.64-7.03). Having a household member who had TB was shown to increase risk of developing TB by three fold (AOR = 3.00; 95% CI: 1.60, 5.62). The study showed that illiterate TB patients were found to be more than twice more likely to develop TB compared to subjects who can atleast read and write (AOR, 95% CI = 2.15, 1.05, 4.40). Patients with household income of less than 1000 birrs per month were more than two times more likely to develop TB compared to those who had higher income (AOR = 2.2; 95% CI: 1.28, 3.78). Smoking has also been identified as important risk factor for developing TB by four times (AOR = 4.43; 95% CI: 2.10, 9.3). BCG was found to be protective against TB reducing the risk by one-third (AOR = 0.34; 95% CI: 0.22, 0.54). Conclusion This study showed that TB is more common among the most agile and economically active age group, and number of windows, history of hospital admission, a household member who had TB, illiteracy, low household income and smoking and lack of BCG scar were identified as independent risk factors. Therefore it is imperative that the TB control effort need a strategy to address socio economic issues such as poverty, overcrowding, smoking, and infection control at health care facilities level is an important intervention to prevent transmission of TB within the facilities.	[Shimeles, Ezra; Aseffa, Abraham; Tilahun, Melaku; Hailu, Tsegaye] ALERT Compound, Armauer Hanson Res Inst, Addis Ababa, Ethiopia; [Shimeles, Ezra; Enquselassie, Fikre] Addis Ababa Univ, Sch Publ Hlth, Coll Hlth Sci, Black Lion Hosp, Addis Ababa, Ethiopia; [Mekonen, Alemayehu] Ethiopian Publ Hlth Assoc, Addis Ababa, Ethiopia; [Wondimagegn, Getachew] KNCV TB Fdn, Addis Ababa, Ethiopia	Addis Ababa University; KNCV Tuberculosis Foundation	Shimeles, E (corresponding author), ALERT Compound, Armauer Hanson Res Inst, Addis Ababa, Ethiopia.; Shimeles, E (corresponding author), Addis Ababa Univ, Sch Publ Hlth, Coll Hlth Sci, Black Lion Hosp, Addis Ababa, Ethiopia.	ezraashi@yahoo.com	Aseffa, Abraham/J-3248-2016	Aseffa, Abraham/0000-0002-8028-1150	Armauer Hanson research Institute in Addis Ababa, Ethiopia	Armauer Hanson research Institute in Addis Ababa, Ethiopia	This research was fully funded ed by Armauer Hanson research Institute in Addis Ababa, Ethiopia.	Adesokan H K, 2014, Afr J Med Med Sci, V43, P45; Ali S, 2018, ANTIMICROB RESIST IN, V7, DOI 10.1186/s13756-017-0298-5; Bam TS, 2015, BMJ-BRIT MED J, V15, P604; Berhe Gebretsadik, 2013, Ethiop Med J, V51, P227; Bhat J, 2017, INDIAN J MED RES, V146, P96, DOI 10.4103/ijmr.IJMR_1029_16; Bigwan Ei, 2014, Afr J Infect Dis, V8, P22; Central Statistical Agency (CSA) [Ethiopia] ICF, 2016, ETHIOPIA DEMOGRAPHIC; Coker R, 2006, BRIT MED J, V332, P85, DOI 10.1136/bmj.38684.687940.80; Crampin AC, 2006, EMERG INFECT DIS, V12, P729; Fox GJ, 2013, EUR RESPIR J, V41, P140, DOI 10.1183/09031936.00070812; Gambhir HS, 2010, INT HEALTH, V2, P216, DOI 10.1016/j.inhe.2010.07.001; Hirpa S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-782; Kehinde A O, 2010, Afr J Med Med Sci, V39, P105; Kirenga BJ, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1376-3; Kurniawati Fivy, 2012, INT J PHARM PHARM SC, V4; Lienhardt C, 2005, INT J EPIDEMIOL, V34, P914, DOI 10.1093/ije/dyi100; Lienhardt C, 2003, AM J RESP CRIT CARE, V168, P448, DOI 10.1164/rccm.200212-1483OC; Lienhardt C, 2001, EPIDEMIOL REV, V23, P288, DOI 10.1093/oxfordjournals.epirev.a000807; Louwagie GMC, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1031; Mahbubul Hoque AK, 2017, INT J MED RES REV, V5; MANGTANI P, 1995, BRIT MED J, V310, P963, DOI 10.1136/bmj.310.6985.963; Middelkoop K, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-156; Ministry of Health, 2012, NAT GUID CLIN PROGR; Mumpe-Mwanja D, 2015, AFR HEALTH SCI, V15, P851, DOI 10.4314/ahs.v15i3.20; Narasimhan P, 2013, PULM MED, V2013, DOI 10.1155/2013/828939; Ndishimye Pacifique, 2017, Clujul Med, V90, P54, DOI 10.15386/cjmed-652; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Ryan H, 2012, J ENV PUBLIC HLTH, V91, P83; Sethi S, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-137; Son M, 2018, POSTGRAD MED, V130, P637, DOI 10.1080/00325481.2018.1510709; Tulu Begna, 2014, BMC Res Notes, V7, P285, DOI 10.1186/1756-0500-7-285; Wang J, 2009, BMC PUBLIC HEALTH, V9, P1471; Webb RM, 2003, INT J TUBERC LUNG D, V7, pS353; WHO, 2016, GLOB TUB REP; Wondemagegn Mulu, 2015, AFRICAN HLTH SCI, V15; Workicho A, 2017, INFECT DRUG RESIST, V10, P91, DOI 10.2147/IDR.S126274; World Health Organization, 2020, GLOBAL TUBERCULOSIS; World Health Organization, 2017, GLOB TB TUB REP; Xu Chen, 2008, Zhonghua Liu Xing Bing Xue Za Zhi, V29, P693; Yallew WW, 2016, DRUG HEALTHC PATIENT, V8, P71, DOI 10.2147/DHPS.S107344; Zignol M, 2013, DRUG RESIST UPDATE, V16, P108, DOI 10.1016/j.drup.2014.02.003	41	27	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2019	14	4							e0214235	10.1371/journal.pone.0214235	http://dx.doi.org/10.1371/journal.pone.0214235			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR2UW	30939169	Green Submitted, Green Published, gold			2022-12-26	WOS:000462993900016
J	Stanislawska-Sachadyn, A; Borzyszkowska, J; Krzeminski, M; Janowicz, A; Dziadziuszko, R; Jassem, J; Rzyman, W; Limon, J				Stanislawska-Sachadyn, Anna; Borzyszkowska, Joanna; Krzeminski, Michal; Janowicz, Alicja; Dziadziuszko, Rafal; Jassem, Jacek; Rzyman, Witold; Limon, Janusz			Folate/homocysteine metabolism and lung cancer risk among smokers	PLOS ONE			English	Article							FOLIC-ACID; HOMOCYSTEINE CONCENTRATIONS; THYMIDYLATE SYNTHASE; METHYLENETETRAHYDROFOLATE REDUCTASE; SERINE HYDROXYMETHYLTRANSFERASE; ESTROGEN-RECEPTORS; B-VITAMINS; POLYMORPHISMS; FOLATE; GENES	Background Folate and homocysteine are involved in DNA synthesis and methylation processes, which are deregulated during carcinogenesis. Objectives The aim of this study was to assess the relationship between folate/homocysteine concentrations, the functional polymorphisms of folate/homocysteine genes and lung cancer risk among cigarette smokers. Study design The study included 132 lung cancer patients and 396 controls from northern Poland, matched by sex, age and smoking status. The median cigarette pack-years of smoking among both cases and controls was 30.0. Serum, red blood cell (RBC) folates and serum homocysteine concentrations were measured. The genotypes in selected polymorphic sites of the MTHFR, CBS, SHMT1, MTHFD1, MTRR, MTR, TYMS DHFR, TCN2, and SLC19A1 genes were determined. All study participants underwent scanning with low-dose computed tomography. Results Serum folate concentrations above the median (> 17.5 nmol/l among the healthy controls) were associated with an increased lung cancer risk (odds ratio [OR], 1.54, 95% confidence intervals [CI], 1.04-2.29, P = 0.031). An analogous trend was observed when the population was analysed after subdivision according to RBC folate concentrations, that is, above a value of 506.5 nmol/l(OR, 1.53; 95% CI, 0.95-2.47; P = 0.084). Additionally, in a subset of women, an increased risk of lung cancer development was associated with the SLC19A1 c.80AA genotype (c.80AA versus GG OR, 3.14; 95% CI, 1.32-7.46; P = P = 0.010). Conclusion These results suggest that, in the population consisting of heavy smokers, high folate levels add to the cancerogenic effect of smoking.	[Stanislawska-Sachadyn, Anna; Borzyszkowska, Joanna; Limon, Janusz] Med Univ Gdansk, Dept Biol & Genet, Gdansk, Poland; [Stanislawska-Sachadyn, Anna] Gdansk Univ Technol, Dept Mol Biotechnol & Microbiol, Gdansk, Poland; [Krzeminski, Michal] Gdansk Univ Technol, Dept Probabil & Biomath, Gdansk, Poland; [Janowicz, Alicja; Rzyman, Witold] Med Univ Gdansk, Dept Thorac Surg, Gdansk, Poland; [Dziadziuszko, Rafal; Jassem, Jacek] Med Univ Gdansk, Dept Oncol & Radiotherapy, Gdansk, Poland; [Limon, Janusz] Polish Acad Sci, Gdansk Branch, Gdansk, Poland	Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Gdansk University of Technology; Fahrenheit Universities; Gdansk University of Technology; Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Medical University Gdansk; Polish Academy of Sciences	Stanislawska-Sachadyn, A (corresponding author), Med Univ Gdansk, Dept Biol & Genet, Gdansk, Poland.; Stanislawska-Sachadyn, A (corresponding author), Gdansk Univ Technol, Dept Mol Biotechnol & Microbiol, Gdansk, Poland.	astanisl@gumed.edu.pl	Krzemiński, Michał/K-6536-2018; Krzemiński, Michał/Z-3520-2019; Dziadziuszko, Rafal/U-7036-2018	Krzemiński, Michał/0000-0002-5596-366X; Krzemiński, Michał/0000-0002-5596-366X; Jassem, Jacek/0000-0002-8875-6747; Rzyman, Witold/0000-0002-9044-7791; Stanislawska-Sachadyn, Anna/0000-0002-9490-4582; Dziadziuszko, Rafal/0000-0001-8080-9843	National Centre for Research and Development, Poland [POIG.01.01.02-22-080/09]	National Centre for Research and Development, Poland(National Centre for Research & Development, Poland)	This work was supported by the National Centre for Research and Development, Poland [grant number: POIG.01.01.02-22-080/09]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Arslan S, 2011, MOL BIOL REP, V38, P991, DOI 10.1007/s11033-010-0194-z; Barbaux S, 2000, CLIN CHEM, V46, P907; Brown KS, 2004, HUM GENET, V114, P182, DOI 10.1007/s00439-003-1039-9; Crider KS, 2011, NUTRIENTS, V3, P370, DOI 10.3390/nu3030370; CZEIZEL AE, 1992, NEW ENGL J MED, V327, P1832, DOI 10.1056/NEJM199212243272602; Dougherty SM, 2006, ENDOCR-RELAT CANCER, V13, P113, DOI 10.1677/erc.1.01118; Ebbing M, 2009, JAMA-J AM MED ASSOC, V302, P2119, DOI 10.1001/jama.2009.1622; Hartman TJ, 2001, AM J EPIDEMIOL, V153, P688, DOI 10.1093/aje/153.7.688; Hung RJ, 2007, CARCINOGENESIS, V28, P1334, DOI 10.1093/carcin/bgm067; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jeng YL, 2003, ANTICANCER RES, V23, P5149; Johansson M, 2010, JAMA-J AM MED ASSOC, V303, P2377, DOI 10.1001/jama.2010.808; Johnson WG, 2004, AM J MED GENET A, V124A, P339, DOI 10.1002/ajmg.a.20505; Kim YI, 2006, NUTR REV, V64, P468, DOI 10.1301/nr.2006.oct.468-475; Kinnaird A, 2016, NAT REV CANCER, V16, P694, DOI 10.1038/nrc.2016.82; Kiyohara C, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-459; Liu HL, 2008, LUNG CANCER, V61, P21, DOI 10.1016/j.lungcan.2007.12.001; Lonn E, 2006, NEW ENGL J MED, V354, P1567, DOI 10.1056/NEJMoa060900; McNulty H, 2012, P NUTR SOC, V71, P213, DOI 10.1017/S0029665111003387; Niikawa H, 2008, CLIN CANCER RES, V14, P4417, DOI 10.1158/1078-0432.CCR-07-1950; Ozkan Y, 2007, ANTICANCER RES, V27, P1185; Piskac-Collier AL, 2011, GENE CHROMOSOME CANC, V50, P1, DOI 10.1002/gcc.20826; Sasco AJ, 2004, LUNG CANCER, V45, pS3, DOI 10.1016/j.lungcan.2004.07.998; Shen HB, 2001, CANCER EPIDEM BIOMAR, V10, P397; Shen M, 2005, LUNG CANCER-J IASLC, V49, P299, DOI 10.1016/j.lungcan.2005.04.002; Shi QL, 2005, PHARMACOGENET GENOM, V15, P547, DOI 10.1097/01.fpc.0000170916.96650.70; Shi QL, 2005, CARCINOGENESIS, V26, P649, DOI 10.1093/carcin/bgh351; Siemianowicz K, 2003, ONCOL REP, V10, P1341; Skibola CF, 2002, BLOOD, V99, P3786, DOI 10.1182/blood.V99.10.3786; Skibola CF, 2004, BLOOD, V104, P2155, DOI 10.1182/blood-2004-02-0557; Stanislawska-Sachadyn A, 2008, MOL GENET METAB, V93, P355, DOI 10.1016/j.ymgme.2007.11.004; Stanislawska-Sachadyn A, 2009, ANN HUM GENET, V73, P484, DOI 10.1111/j.1469-1809.2009.00529.x; Summers CM, 2008, J RHEUMATOL, V35, P2179, DOI 10.3899/jrheum.080071; Summers CM, 2010, BIRTH DEFECTS RES A, V88, P679, DOI 10.1002/bdra.20683; Suzuki T, 2007, CARCINOGENESIS, V28, P1718, DOI 10.1093/carcin/bgm104; Swartz MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053475; Truong T, 2010, CARCINOGENESIS, V31, P625, DOI 10.1093/carcin/bgq001; Vineis P, 2007, ANN ONCOL, V18, P1230, DOI 10.1093/annonc/mdm109; Wang L, 2007, LUNG CANCER, V57, P143, DOI 10.1016/j.lungcan.2007.03.002; Zhang SMM, 2008, JAMA-J AM MED ASSOC, V300, P2012, DOI 10.1001/jama.2008.555	40	7	7	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2019	14	4							e0214462	10.1371/journal.pone.0214462	http://dx.doi.org/10.1371/journal.pone.0214462			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR2UW	30939165	gold, Green Submitted, Green Published			2022-12-26	WOS:000462993900025
J	Isberg, HK; Hedin, K; Melander, E; Molstad, S; Beckman, A				Isberg, Helena Kornfalt; Hedin, Katarina; Melander, Eva; Molstad, Sigvard; Beckman, Anders			Increased adherence to treatment guidelines in patients with urinary tract infection in primary care: A retrospective study	PLOS ONE			English	Article							RECOMMENDATIONS	Background Urinary tract infection (UTI) is common in primary care and leads to a high number of antibiotic prescriptions. Antimicrobial resistance is a global health problem; better antimicrobial prescribing is one way to limit antimicrobial resistance. We aimed to describe the number of consultations for patients diagnosed with lower urinary tract infection (LUTI) and pyelonephritis and changes in prescribing of antibiotics to men and women with LUTI and pyelonephritis in Swedish PHC between the years 2008 and 2013. Methods We performed a descriptive study of changes in UTI diagnosis and antibiotic prescribing in UTI for the years 2008, 2010 and 2013. The Primary Care Record of Infections in Sweden, a database regarding diagnosis linked antibiotic prescribing in primary care, was analyzed concerning data for men and women of all ages regarding UTI visits and antibiotic prescribing. The results were analyzed in relation to current national guidelines. Results There was a variability in consultation incidence for LUTI with an increase between 2008 and 2010 and a decrease between 2010 and 2013, resulting in a slight rise in consultation incidence between 2008 and 2013. The use of recommended nitrofurantoin or pivmecillinam in LUTI in women increased from 54% in 2008 to 69% in 2013. Fluoroquinolones or trimethoprim were prescribed in 24% of LUTI cases in women in 2008 and in 7% of cases in 2013. Prescriptions of pivmecillinam or nitrofurantoin in male LUTI cases increased from 13% in 2008 to 31% in 2013. Fluoroquinolones or trimethoprim were prescribed in 54% of male LUTI cases in 2008 and 32% in 2013. Conclusions Swedish GPs seem to follow national guidelines in the treatment of LUTI in women. In male LUTI cases, the prescriptions of fluoroquinolones remain high and further research is needed to follow prescription patterns and enhance more prudent prescribing to this group of patients.	[Isberg, Helena Kornfalt; Hedin, Katarina; Molstad, Sigvard; Beckman, Anders] Lund Univ, Dept Clin Sci, Family Med, Malmo, Sweden; [Hedin, Katarina] Futurum, Reg Jonkoping County, Jonkoping, Sweden; [Hedin, Katarina] Linkoping Univ, Dept Med & Hlth Sci, Linkoping, Sweden; [Melander, Eva] Reg Ctr Communicable Dis Control, Malmo, Sweden; [Melander, Eva] Lund Univ, Dept Translat Med, Malmo, Sweden	Lund University; Futurum; Linkoping University; Lund University	Isberg, HK (corresponding author), Lund Univ, Dept Clin Sci, Family Med, Malmo, Sweden.	Helena.Isberg@med.lu.se		Beckman, Anders/0000-0002-1676-8183				Andre M, 2004, SCAND J INFECT DIS, V36, P134, DOI 10.1080/00365540410019075; Andre Malin, 2008, Lakartidningen, V105, P1107; [Anonymous], 2010, SWEDR 2010 REP SWED; Batalden PB, 2007, QUAL SAF HEALTH CARE, V16, P2, DOI 10.1136/qshc.2006.022046; Czaja CA, 2007, CLIN INFECT DIS, V45, P273, DOI 10.1086/519268; Dolk FCK, 2018, J ANTIMICROB CHEMOTH, V73, P2, DOI 10.1093/jac/dkx504; Grol R, 2003, LANCET, V362, P1225, DOI 10.1016/S0140-6736(03)14546-1; Haslund JM, 2013, SCAND J PRIM HEALTH, V31, P235, DOI 10.3109/02813432.2013.844410; Hawker JI, 2014, J ANTIMICROB CHEMOTH, V69, P3423, DOI 10.1093/jac/dku291; Hummers-Pradier E, 2004, INT J CLIN PHARM TH, V42, P360; Levi Ragnar, 2010, Lakartidningen, V107, P3134; Medical Products Agency-Sweden, 2007, LOW UR TRACT INF UTI; Molstad S, 2008, EUROSURVEILLANCE, P13; Molstad S, 2017, B WORLD HEALTH ORGAN, V95, P764, DOI 10.2471/BLT.16.184374; Nord Maria, 2013, Lakartidningen, V110, P1282; Osterlund A, 2008, LAKARTIDNINGEN, P210; Public Health Agency of Sweden and National Veterinary Institute, 2013, US ANT OCC ANT RES S; Public Health Agency of Sweden National Veterinary Institute, 2015, CONS ANT OCC ANT RES; Public Health Agency of Sweden PRIS, PRIM REG INF SVER; Strama, STRAMAS GOALS US ANT; Tyrstrup M, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-2018-9; van den Broek d'Obrenan J, 2014, J ANTIMICROB CHEMOTH, V69, P1701, DOI 10.1093/jac/dku005	22	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214572	10.1371/journal.pone.0214572	http://dx.doi.org/10.1371/journal.pone.0214572			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921411	Green Published, gold, Green Submitted			2022-12-26	WOS:000462594000088
J	Jo, S; Jeong, T; Lee, JB; Jin, Y; Yoon, J; Park, B				Jo, Sion; Jeong, Taeoh; Lee, Jae Baek; Jin, Youngho; Yoon, Jaechol; Park, Boyoung			Incidence of acute cerebral infarction or space occupying lesion among patients with isolated dizziness and the role of D-dimer	PLOS ONE			English	Article							TRANSIENT ISCHEMIC ATTACK; EMERGENCY-DEPARTMENT; DIAGNOSTIC-ACCURACY; PULMONARY-EMBOLISM; ISOLATED VERTIGO; STROKE; MANAGEMENT; RULE	Background To determine the incidence of acute cerebral infarction or space occupying lesion (SOL) among patients with isolated vertigo or dizziness (IVD) and to evaluate the role of cerebellar function test (CFT) and D-dimer to discriminate ACI/SOL and non-ACI/SOL. Methods A retrospective study of consecutive emergency department (ED) patients with IVD during one year was conducted. ACI was based on the diffusion-weighted magnetic resonance imaging (DW-MRI), and SOL was based on the concurrent MRI sequences. A sensitivity analysis of CFT and D-dimer was also performed. Results Among the 468 patients enrolled, 13 patients (2.8%) had ACI, 11 at cerebellum, 1 at occipital lobe, and 1 at centrum semiovale. Twenty-five patients (5.3%) had SOL. Aneurysm is most frequent (n = 7), followed by meningioma (n = 4) and venous anomaly (n = 4). In total, ACI/ SOL was found in 8.1% (n = 38). Abnormal findings in finger-to-nose (FN), heel-to-shin (HTS), and rapid alternative movement (RAM) tests were significantly higher in ACI or ACl/ SOL group, while gait disturbance, tandem gait abnormality, and Romberg's test were not. CFT sensitivities were low for ACI as well as for ACI/SOL, but specificities were high for ACI and ACI/SOL. D-dimer level showed a sensitivity of 100% at >0.18 mg/L for ACI and >0.15 mg/L for ACI/SOL. However, specificity was low at corresponding D-dimer level. Among the subgroup (n = 411) who did not show any abnormality in CFT, 9 patients (2.2%) had ACI, and 33 patients (8.0%) had ACI/SOL. Conclusion The present study reports a clinically significant incidence of ACI/SOL among ED patients with IVD. D-dimer showed high sensitive and low specificity, while CFT showed low sensitivity and high specificity.	[Jo, Sion; Jeong, Taeoh; Lee, Jae Baek; Jin, Youngho; Yoon, Jaechol] Chonbuk Natl Univ, Res Inst Clin Med, Dept Emergency Med, Jeonju Si, South Korea; [Jo, Sion; Jeong, Taeoh; Lee, Jae Baek; Jin, Youngho; Yoon, Jaechol] Chonbuk Natl Univ Hosp, Biomed Res Inst, Jeonju Si, South Korea; [Park, Boyoung] Hanyang Univ, Dept Med, Coll Med, Seoul, South Korea	Jeonbuk National University; Jeonbuk National University; Jeonbuk National University Hospital; Hanyang University	Jeong, T (corresponding author), Chonbuk Natl Univ, Res Inst Clin Med, Dept Emergency Med, Jeonju Si, South Korea.; Jeong, T (corresponding author), Chonbuk Natl Univ Hosp, Biomed Res Inst, Jeonju Si, South Korea.	emmd@jbnu.ac.kr			Biomecial Research Institute, Chonbuk National University Hospital [CUH 2018-08-022]	Biomecial Research Institute, Chonbuk National University Hospital	This research was funded by the Biomecial Research Institute, Chonbuk National University Hospital (CUH 2018-08-022 to TJ). The funder play no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This paper was supported by Fund of Biomedical Research Institute, Chonbuk National University Hospital.	[Anonymous], 2015, HEALTH TECHNOL ASSES, V19, P1, DOI 10.3310/hta19440; Bossuyt PM, 2003, BRIT MED J, V326, P41, DOI 10.1136/bmj.326.7379.41; Doijiri R, 2016, J STROKE CEREBROVASC, V25, P2549, DOI 10.1016/j.jstrokecerebrovasdis.2016.06.038; Valls MJF, 2015, THROMB HAEMOSTASIS, V113, P406, DOI 10.1160/TH14-06-0488; Fischer U, 2010, STROKE, V41, P661, DOI 10.1161/STROKEAHA.109.572883; Gilbert EH, 1996, ANN EMERG MED, V27, P305, DOI 10.1016/S0196-0644(96)70264-0; Hoo GWS, 2018, J AM COLL RADIOL, V15, P1673, DOI 10.1016/j.jacr.2018.04.031; Kerber KA, 2006, STROKE, V37, P2484, DOI 10.1161/01.STR.0000240329.48263.0d; Khatri P, 2010, STROKE, V41, P2581, DOI 10.1161/STROKEAHA.110.593632; Lavallee P, 2014, FRONT NEUROL NEUROSC, V33, P30, DOI 10.1159/000351890; Lee H, 2006, NEUROLOGY, V67, P1178, DOI 10.1212/01.wnl.0000238500.02302.b4; Lee H, 2014, J STROKE, V16, P124, DOI 10.5853/jos.2014.16.3.124; Luengo-Fernandez R, 2009, LANCET NEUROL, V8, P235, DOI 10.1016/S1474-4422(09)70019-5; Perloff MD, 2017, AM J EMERG MED, V35, P1724, DOI 10.1016/j.ajem.2017.06.034; Righini M, 2014, JAMA-J AM MED ASSOC, V311, P1117, DOI 10.1001/jama.2014.2135; Ross MA, 2007, ANN EMERG MED, V50, P109, DOI 10.1016/j.annemergmed.2007.03.008; Sanchis J, 2014, HEART, V100, P1591, DOI 10.1136/heartjnl-2013-305440; Savitz SI, 2007, ACAD EMERG MED, V14, P63, DOI 10.1197/j.aem.2006.06.060; Schappert Susan M, 2006, Vital Health Stat 13, P1; Simel DL, 2008, J GEN INTERN MED, V23, P768, DOI 10.1007/s11606-008-0583-3; Stead LG, 2009, NEUROCRIT CARE, V10, P204, DOI 10.1007/s12028-008-9146-z	21	4	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214661	10.1371/journal.pone.0214661	http://dx.doi.org/10.1371/journal.pone.0214661			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921431	Green Published, gold, Green Submitted			2022-12-26	WOS:000462594000105
J	Restrepo, C; Gutierrez-Rivas, M; Pacheco, YM; Garcia, M; Blanco, J; Medrano, LM; Navarrete-Munoz, MA; Gutierrez, F; Miralles, P; Dalmau, D; Gomez, JL; Gorgolas, M; Cabello, A; Resino, S; Benito, JM; Rallon, N; Munoz-Fernandez, MA				Restrepo, Clara; Gutierrez-Rivas, Monica; Pacheco, Yolanda M.; Garcia, Marcial; Blanco, Julia; Medrano, Luz M.; Navarrete-Munoz, Maria A.; Gutierrez, Felix; Miralles, Pilar; Dalmau, David; Luis Gomez, Juan; Gorgolas, Miguel; Cabello, Alfonso; Resino, Salvador; Benito, Jose M.; Rallon, Norma; Munoz-Fernandez, M. A.		Spanish AIDS Res Network Project	Genetic variation in CCR2 and CXCL12 genes impacts on CD4 restoration in patients initiating cART with advanced immunesupression	PLOS ONE			English	Article							HIV-INFECTED PATIENTS; ACTIVE ANTIRETROVIRAL THERAPY; T-CELL RECOVERY; DISEASE PROGRESSION; COUNT RECOVERY; POLYMORPHISMS; VIRUS; GENOTYPE; HAART; EXPRESSION	Objective We investigated the association of genetic polymorphisms in chemokine and chemokine receptor genes with poor immunological recovery in HIV patients starting combined antiretroviral therapy (cART) with low CD4 T-cell counts. Methods A case-control study was conducted in 412 HIV-infected patients starting cART with CD4 T-cell count <200 cells/mu L and successful viral control for two years. CD4 count increase below 200 cells/mu L after two years on cART was used to define INR (immunological nonresponder) patients. Polymorphisms in CXCL12, CCL5 and CCR2 genes were genotyped using sequenom's MassARRAY platform. Results Thirty two percent (134/412) of patients were classified as INR. After adjusting by age, route of HIV infection, length of infection before cART and viral hepatitis coinfection, CCR2 rs1799864-AG genotype was significantly associated with INR status (OR [95% CI]: 1.80 [1.04-3.11]; p = 0.04), and CXCL1 2 rs1801157-TT genotype showed a trend (OR [95% CI]: 2.47 [0.96-6.35]; p = 0.06). Conclusions CCR2 rs1799864-AG or CXCL12 rs1801157-TT genotypes influence on the probability of poor CD4 recovery in the population of HIV patients starting cART with low CD4 counts. Genotyping of these polymorphisms could be used to estimate the risk of poor CD4 restoration, mainly in patients who are diagnosed late in the course of infection.	[Restrepo, Clara; Garcia, Marcial; Navarrete-Munoz, Maria A.; Benito, Jose M.; Rallon, Norma] UAM, FJD, IIS, HIV & Viral Hepatitis Res Lab, Madrid, Spain; [Restrepo, Clara; Garcia, Marcial; Navarrete-Munoz, Maria A.; Benito, Jose M.; Rallon, Norma] Hosp Univ Rey Juan Carlos, Mostoles, Madrid, Spain; [Gutierrez-Rivas, Monica; Medrano, Luz M.; Resino, Salvador] Inst Salud Carlos III, Madrid, Spain; [Pacheco, Yolanda M.] Hosp Univ Virgen del Rocio, UGC Clin Labs, Inst Biomed Sevilla IBiS, Immunol Lab, Seville, Spain; [Blanco, Julia] IrsiCaixa AIDS Res Inst, Badalona, Spain; [Gutierrez, Felix] Hosp Gen Univ Elche, Alicante, Spain; [Gutierrez, Felix] Univ Miguel Hernandez, Alicante, Spain; [Miralles, Pilar] Hosp Gen Univ Gregorio Maranon, Madrid, Spain; [Dalmau, David] Hosp Univ Mutua Terrasa, Terrassa, Spain; [Luis Gomez, Juan] Hosp Univ Canarias, Santa Cruz De Tenerife, Spain; [Gorgolas, Miguel; Cabello, Alfonso] Fdn Jimenez Diaz, Univ Hosp, Madrid, Spain; [Munoz-Fernandez, M. A.] Hosp Gen Univ Gregorio Maranon, Lab Mol Immunobiol, Inst Invest Sanitaria Gregorio Maranon, Madrid, Spain	Autonomous University of Madrid; Fundacion Jimenez Diaz; Instituto de Salud Carlos III; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; Institut de Recerca de la Sida - IrsiCaixa; Universidad Miguel Hernandez de Elche; General University Gregorio Maranon Hospital; Hospital Universitario Mutua Terrassa; Universidad de la Laguna; Fundacion Jimenez Diaz; General University Gregorio Maranon Hospital	Benito, JM (corresponding author), UAM, FJD, IIS, HIV & Viral Hepatitis Res Lab, Madrid, Spain.; Benito, JM (corresponding author), Hosp Univ Rey Juan Carlos, Mostoles, Madrid, Spain.; Resino, S (corresponding author), Inst Salud Carlos III, Madrid, Spain.	mmunoz.hgugm@gmail.com; Sresino@isciii.es; jbenito1@hotmail.com	Rivas, Mónica Gutiérrez/G-9713-2016; Pacheco, Yolanda M/C-8457-2015; Fernández-González, Marta/U-7492-2017; Resino, Salvador/B-2430-2008; Cabello, Alfonso/ABH-3203-2021; Benito, Jose/AAC-4554-2020; Blanco, Julià/A-5347-2008; Rodero, Félix Gutiérrez/Q-7880-2018; de dios, luz maria medrano/K-1946-2016	Rivas, Mónica Gutiérrez/0000-0001-9752-7498; Pacheco, Yolanda M/0000-0002-9451-8083; Fernández-González, Marta/0000-0001-9949-8504; Resino, Salvador/0000-0001-8783-0450; Blanco, Julià/0000-0002-2225-0217; Rodero, Félix Gutiérrez/0000-0002-9485-6867; de dios, luz maria medrano/0000-0003-3717-5384; Garcia, Marcial/0000-0001-7462-1836; Benito, Jose/0000-0002-7172-049X; GARCIA GOMEZ, JOSE ALBERTO/0000-0002-1203-7260; Cabello-Ubeda, Alfonso/0000-0001-8429-8358; Rallon, Norma/0000-0002-4643-247X	Spanish AIDS Research Network as part of the Health Research and Development Strategy, State Plan for Scientific and Technical Research and Innovation [RD12/0017/0031, RD16/0025/0013, RD16CIII/0002/0002, PI14CIII/00011]; Institute of Health Carlos III, ISCIII-Sub-Directorate General for Research Assessment and Promotion; European Regional Development Fund (ERDF); IISCIII [CD14/00002, PI08/893, PI13/02256, PI16/01740]; FISABIO [UGP-14-197, UGP-15232, RD16/0025/0038]; ISCIII, Madrid, Spain [CP14/00198]; IIS-FJD	Spanish AIDS Research Network as part of the Health Research and Development Strategy, State Plan for Scientific and Technical Research and Innovation; Institute of Health Carlos III, ISCIII-Sub-Directorate General for Research Assessment and Promotion; European Regional Development Fund (ERDF)(European Commission); IISCIII; FISABIO; ISCIII, Madrid, Spain(Instituto de Salud Carlos III); IIS-FJD	This work has been (partially) funded by the Spanish AIDS Research Network RD12/0017/0031, RD16/0025/0013, RD16CIII/0002/0002, and PI14CIII/00011 projects as part of the Health Research and Development Strategy, State Plan for Scientific and Technical Research and Innovation (2008-2011, 2013-2016) and co-financed by Institute of Health Carlos III, ISCIII-Sub-Directorate General for Research Assessment and Promotion and European Regional Development Fund (ERDF). M Gutierrez-Rivas is funded by project RD16CIII/0002/0002. LM Medrano is supported by IISCIII, grant CD14/00002. F. Gutierrez is supported by ISCIII, grants PI08/893, PI13/02256 and PI16/01740; FISABIO, grants UGP-14-197 and UGP-15232, and RD16/0025/0038. N Rallon is a Miguel Servet investigator from the ISCIII (grant CP14/00198), Madrid, Spain. MA Navarrete-Munoz is co-funded by RD16/0025/0013 project and Intramural Research Scholarship from IIS-FJD. M Garcia is co-funded by CP14/00198 project and Intramural Research Scholarship from IIS-FJD. C Restrepo was funded by project RD12/0017/0031 and currently is funded by project RD16/0025/0013.	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; An P, 2002, P NATL ACAD SCI USA, V99, P10002, DOI 10.1073/pnas.142313799; Appay V, 2011, AIDS, V25, P1813, DOI 10.1097/QAD.0b013e32834640e6; Arenzana-Seisdedos F, 2006, SEMIN IMMUNOL, V18, P387, DOI 10.1016/j.smim.2006.07.007; Brambilla A, 2000, J INFECT DIS, V182, P311, DOI 10.1086/315650; Caro-Murillo AM, 2007, ENFERM INFEC MICR CL, V25, P23, DOI 10.1157/13096749; Chan DPC, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010998; Daar ES, 2005, J INFECT DIS, V192, P1597, DOI 10.1086/496893; de Oliveira KB, 2013, CLIN EXP MED, V13, P211, DOI 10.1007/s10238-012-0194-5; Fernandez S, 2006, JAIDS-J ACQ IMM DEF, V41, P1, DOI 10.1097/01.qai.0000188990.57760.e3; Gaardbo JC, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/670957; Garcia-Merino I, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-27; Gazzola L, 2009, CLIN INFECT DIS, V48, P328, DOI 10.1086/595851; Guzman-Fulgencio M, 2015, EUR J CLIN INVEST, V45, P1192, DOI 10.1111/eci.12539; Haas DW, 2006, J INFECT DIS, V194, P1098, DOI 10.1086/507313; Ioannidis JPA, 2001, ANN INTERN MED, V135, P782, DOI 10.7326/0003-4819-135-9-200111060-00008; Kelley CF, 2009, CLIN INFECT DIS, V48, P787, DOI 10.1086/597093; Kostrikis LG, 1998, NAT MED, V4, P350, DOI 10.1038/nm0398-350; Lee B, 1998, J VIROL, V72, P7450, DOI 10.1128/JVI.72.9.7450-7458.1998; Li TS, 2011, CLIN INFECT DIS, V53, P944, DOI 10.1093/cid/cir552; Mahajan SD, 2010, BIOCHEM BIOPH RES CO, V396, P348, DOI 10.1016/j.bbrc.2010.04.095; Massanella M, 2010, AIDS, V24, P959, DOI 10.1097/QAD.0b013e328337b957; Miller MF, 2005, CLIN INFECT DIS, V41, P713, DOI 10.1086/432618; Mocroft A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001510; Moore RD, 2007, CLIN INFECT DIS, V44, P441, DOI 10.1086/510746; Nakanjako D, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-43; Negredo E, 2010, CLIN INFECT DIS, V50, P1300, DOI 10.1086/651689; O'Brien TR, 2000, AIDS, V14, P821, DOI 10.1097/00002030-200005050-00008; Oberlin E, 1996, NATURE, V382, P833, DOI 10.1038/382833a0; Passam AM, 2005, J CLIN VIROL, V34, P302, DOI 10.1016/j.jcv.2004.05.021; Philpott S, 2004, CLIN INFECT DIS, V39, P861, DOI 10.1086/423386; Puissant B, 2006, AIDS RES HUM RETROV, V22, P153, DOI 10.1089/aid.2006.22.153; Rigato PO, 2008, CURR HIV RES, V6, P466, DOI 10.2174/157016208785861131; Smith MW, 1997, SCIENCE, V277, P959, DOI 10.1126/science.277.5328.959; Sobrino-Vegas P, 2011, ENFERM INFEC MICR CL, V29, P645, DOI 10.1016/j.eimc.2011.06.002; Sole X, 2006, BIOINFORMATICS, V22, P1928, DOI 10.1093/bioinformatics/btl268; Soria A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027349; Soriano A, 2002, J INFECT DIS, V186, P922, DOI 10.1086/343741; Winkler C, 1998, SCIENCE, V279, P389, DOI 10.1126/science.279.5349.389; Zoufaly A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087160	40	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214421	10.1371/journal.pone.0214421	http://dx.doi.org/10.1371/journal.pone.0214421			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921390	Green Published, gold, Green Submitted			2022-12-26	WOS:000462594000067
J	Thilakarathne, DS; Coppo, MJC; Hartley, CA; Diaz-Mendez, A; Quinteros, JA; Fakhri, O; Vaz, PK; Devlin, JM				Thilakarathne, Dulari S.; Coppo, Mauricio J. C.; Hartley, Carol A.; Diaz-Mendez, Andres; Quinteros, Jose A.; Fakhri, Omid; Vaz, Paola K.; Devlin, Joanne M.			Attenuated infectious laryngotracheitis virus vaccines differ in their capacity to establish latency in the trigeminal ganglia of specific pathogen free chickens following eye drop inoculation	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; IN-VIVO; GLYCOPROTEIN-G; VIRAL REPLICATION; TYPE-1 MUTANT; STRAINS; VIRULENCE; EFFICACY; DELETION; VITRO	Infectious laryngotracheitis (ILT) is a respiratory disease that affects chickens. It is caused by the alphaherpesvirus, infectious laryngotracheitis virus (ILTV). This virus undergoes lytic replication in the epithelial cells of the trachea and upper respiratory tract (URT) and establishes latent infection in the trigeminal ganglia (TG) and trachea. Live attenuated vaccines are widely used to control ILT. At least one of these vaccines can establish latent infections in chickens, but this has not been demonstrated for all vaccines. The aim of the current study was to determine the capacity of three commercially available vaccines (SA2, A20 and Serva) and a glycoprotein G deletion mutant vaccine candidate (Delta gG ILTV) to establish latent infection in the TG of specific pathogen free (SPF) chickens. Five groups of 7-day-old SPF chickens were eye-drop vaccinated with either one of the vaccine strains or mock-vaccinated with sterile media and followed until 20 or 21 days post-vaccination (dpv). ILTV DNA was detected at 20-21 dpv in the TG of 23/40 (57.5%) vaccinated SPF chickens (SA2 = 10/10; A20 = 6/10; Serva = 3/10; Delta gG = 4/10) by PCR, but virus could not be reactivated from TG co-cultivated with primary chicken embryo kidney cells. In the birds from which ILTV DNA was detected in the TG, ILTV DNA could not be detected in the URT or trachea of 3 birds in each of the SA2, A20 and Serva vaccinated groups, and in 4 birds in the Delta gG vaccinated group, indicating that these birds were latently infected in the absence of active lytic replication and virus shedding. Results from this study demonstrate the capacity of commercial ILTV vaccines to establish latent infections and underline their importance in the epidemiology of this disease.	[Thilakarathne, Dulari S.; Coppo, Mauricio J. C.; Hartley, Carol A.; Diaz-Mendez, Andres; Quinteros, Jose A.; Fakhri, Omid; Vaz, Paola K.; Devlin, Joanne M.] Univ Melbourne, Melbourne Vet Sch, Asia Pacific Ctr Anim Hlth, Parkville, Vic, Australia	University of Melbourne	Thilakarathne, DS (corresponding author), Univ Melbourne, Melbourne Vet Sch, Asia Pacific Ctr Anim Hlth, Parkville, Vic, Australia.	dthilakarath@student.unimelb.edu.au	Fakhri, Omid/Z-4995-2019; Vaz, Paola K./D-8713-2015; Quinteros, Jose Antonio/Q-2482-2016	Fakhri, Omid/0000-0002-2448-8501; Vaz, Paola K./0000-0001-6877-7383; Coppo, Mauricio/0000-0002-4344-9532; Hartley, Carol/0000-0001-6174-7341; Diaz-Mendez, Andres/0000-0003-3004-8518; Quinteros, Jose Antonio/0000-0002-3194-9783; Devlin, Joanne/0000-0003-0400-9670	Australian Research Council [DP140100480, FT140101287]	Australian Research Council(Australian Research Council)	The work was funded by the Australian Research Council through grant DP140100480 awarded to CAH and JMD and through grant FT140101287 awarded to JMD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnew-Crumpton R, 2016, INFECT GENET EVOL, V43, P67, DOI 10.1016/j.meegid.2016.05.023; ALLS AA, 1969, AVIAN DIS, V13, P36, DOI 10.2307/1588412; ANDREASEN JR, 1989, AVIAN DIS, V33, P524, DOI 10.2307/1591116; BAGUST TJ, 1995, AVIAN PATHOL, V24, P373, DOI 10.1080/03079459508419079; BAGUST TJ, 1986, AVIAN PATHOL, V15, P581, DOI 10.1080/03079458608436317; Chacon JLV, 2007, BRAZ J POULTRY SCI, V9, P61, DOI 10.1590/S1516-635X2007000100009; Chacon JL, 2008, J VIROL METHODS, V151, P188, DOI 10.1016/j.jviromet.2008.05.012; Chacon JL, 2015, TROP ANIM HEALTH PRO, V47, P1101, DOI 10.1007/s11250-015-0834-3; Chin RP, 2009, AVIAN DIS, V53, P574, DOI 10.1637/8873-041309-Reg.1; CLEMENTS GB, 1989, J GEN VIROL, V70, P2501, DOI 10.1099/0022-1317-70-9-2501; COEN DM, 1989, P NATL ACAD SCI USA, V86, P4736, DOI 10.1073/pnas.86.12.4736; Coppo MJC, 2012, AVIAN PATHOL, V41, P99, DOI 10.1080/03079457.2011.643222; Coppo MJC, 2011, AVIAN PATHOL, V40, P411, DOI 10.1080/03079457.2011.588686; Davison S, 2006, AVIAN DIS, V50, P50, DOI 10.1637/7398-062105R.1; Devlin JM, 2008, AVIAN PATHOL, V37, P83, DOI 10.1080/03079450701802214; Devlin JM, 2006, J GEN VIROL, V87, P2839, DOI 10.1099/vir.0.82194-0; Devlin JM, 2007, VACCINE, V25, P3561, DOI 10.1016/j.vaccine.2007.01.080; DOBSON AT, 1990, NEURON, V5, P353, DOI 10.1016/0896-6273(90)90171-B; Fuchs W, 2005, J VIROL, V79, P705, DOI 10.1128/JVI.79.2.705-716.2005; Garcia M, 2013, VIROLOGY, V440, P64, DOI 10.1016/j.virol.2013.02.007; GELENCZEI EF, 1965, AVIAN DIS, V9, P44, DOI 10.2307/1587792; GELENCZEI EF, 1964, AVIAN DIS, V8, P105, DOI 10.2307/1587827; GUY JS, 1991, AVIAN DIS, V35, P348, DOI 10.2307/1591188; Han MG, 2003, AVIAN DIS, V47, P261, DOI 10.1637/0005-2086(2003)047[0261:EOLVVA]2.0.CO;2; Helferich D, 2007, J GEN VIROL, V88, P732, DOI 10.1099/vir.0.82533-0; HUGHES CS, 1991, ARCH VIROL, V121, P213, DOI 10.1007/BF01316755; Johnson DI, 2010, AVIAN DIS, V54, P1251, DOI 10.1637/9401-052310-Reg.1; KATZ JP, 1990, J VIROL, V64, P4288, DOI 10.1128/JVI.64.9.4288-4295.1990; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kirkpatrick NC, 2006, AVIAN PATHOL, V35, P449, DOI 10.1080/03079450601028803; KOSZVNENCHAK M, 1990, J VIROL, V64, P5396, DOI 10.1128/JVI.64.11.5396-5402.1990; KRAMER MF, 1995, J VIROL, V69, P1389, DOI 10.1128/JVI.69.3.1389-1399.1995; Lee SW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120282; Lee SW, 2012, SCIENCE, V337, P188, DOI 10.1126/science.1217134; Lee SKW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021249; LEIB DA, 1989, J VIROL, V63, P2893, DOI 10.1128/JVI.63.7.2893-2900.1989; LEIST TP, 1989, J VIROL, V63, P4976, DOI 10.1128/JVI.63.11.4976-4978.1989; LUKERT PD, 1965, AVIAN DIS, V9, P308, DOI 10.2307/1588016; Mahmoudian A, 2011, AVIAN PATHOL, V40, P237, DOI 10.1080/03079457.2011.553582; MEHTA A, 1995, VIROLOGY, V206, P633, DOI 10.1016/S0042-6822(95)80080-8; MEIGNIER B, 1988, VIROLOGY, V162, P251, DOI 10.1016/0042-6822(88)90417-5; Mostafa HH, 2011, J VIROL, V85, P12631, DOI 10.1128/JVI.05661-11; Nicoll MP, 2012, FEMS MICROBIOL REV, V36, P684, DOI 10.1111/j.1574-6976.2011.00320.x; Oldoni I, 2009, AVIAN PATHOL, V38, P47, DOI 10.1080/03079450802632031; Parra SHS, 2015, BRAZ J POULTRY SCI, V17, P117, DOI 10.1590/1516-635x1701117-120; Pavlova SP, 2010, J GEN VIROL, V91, P847, DOI 10.1099/vir.0.016634-0; RAGGI LG, 1961, POULTRY SCI, V40, P134, DOI 10.3382/ps.0400134; Rodriguez-Avila A, 2007, AVIAN DIS, V51, P905, DOI 10.1637/8011-041907-REGR.1; SAWTELL NM, 1992, J VIROL, V66, P2150, DOI 10.1128/JVI.66.4.2150-2156.1992; SCHNITZLEIN WM, 1995, VIROLOGY, V209, P304, DOI 10.1006/viro.1995.1262; SPECK PG, 1991, J VIROL, V65, P4001, DOI 10.1128/JVI.65.8.4001-4005.1991; STEINER I, 1990, J VIROL, V64, P1630, DOI 10.1128/JVI.64.4.1630-1638.1990; TENSER RB, 1989, J VIROL, V63, P2861, DOI 10.1128/JVI.63.6.2861-2865.1989; Thellman NM, 2017, PATHOGENS, V6, DOI 10.3390/pathogens6030028; Vagnozzi A, 2015, AVIAN DIS, V59, P394, DOI 10.1637/11075-033115-Reg.1; VanDevanter DR, 1996, J CLIN MICROBIOL, V34, P1666, DOI 10.1128/JCM.34.7.1666-1671.1996; Veits J, 2003, J GEN VIROL, V84, P3343, DOI 10.1099/vir.0.19570-0; Waidner LA, 2011, VIROLOGY, V411, P25, DOI 10.1016/j.virol.2010.12.023; Waidner LA, 2009, VIROLOGY, V388, P128, DOI 10.1016/j.virol.2009.02.043; WILLIAMS RA, 1992, J GEN VIROL, V73, P2415, DOI 10.1099/0022-1317-73-9-2415	60	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0213866	10.1371/journal.pone.0213866	http://dx.doi.org/10.1371/journal.pone.0213866			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921344	Green Published, gold			2022-12-26	WOS:000462594000026
J	Waye, KP; Fredriksson, S; Hussain-Alkhateeb, L; Gustafsson, J; van Kamp, I				Waye, Kerstin Persson; Fredriksson, Sofie; Hussain-Alkhateeb, Laith; Gustafsson, Johanna; van Kamp, Irene			Preschool teachers' perspective on how high noise levels at preschool affect children's behavior	PLOS ONE			English	Article								Early-age exposure to noise may have long-term health implications of which we have little knowledge of today. Age-specific hearing, learning inadequate coping strategies, and alterations in biological stress regulatory responses could play a role in the long-term health impacts. In Sweden about half a million children in the age between 1-5 years attend preschool. The noise exposure at preschools is intermittent and unpredictable and levels reach up to 84 dB LAeq (time indoors) with maximum levels of 118 dB LA(F), mostly due to child activity. To increase the overall understanding of the possible implications of preschool noise environments for children, this paper describes children's behavioral and emotional reactions to and coping with their everyday sound environment from a teachers perspective. A postal questionnaire study performed in 2013-2014 with answers from 3,986 preschool teachers provided the data. Content analysis was combined with quantitative analysis. Eighty-two percent of the personnel considered that children's behavior was affected rather or very much by preschool noise. The most prevalent behaviors were categorized into: be heard, be distracted, show negative internal emotions, crowd, avoid, withdraw, be exhausted, and learning. The quantitative analyses confirmed an association between the perceived loudness and noise annoyance at preschool and affirmative reporting on noise affecting the children's behavior. Age of the personnel, with the youngest age group reporting noise related behavior less often, and age distribution of the class, with 1-5 years old seeming less affected by noise, were also indicated, while pedagogic orientation was not a significant factor. Future studies should address the long-term health effects of these behaviors.	[Waye, Kerstin Persson; Fredriksson, Sofie; Hussain-Alkhateeb, Laith] Univ Gothenburg, Sahlgrenska Acad, Occupat & Environm Med, Publ Hlth & Community Med, Gothenburg, Sweden; [Waye, Kerstin Persson; Gustafsson, Johanna] Orebro Univ, Sch Hlth Sci, SIDR, Orebro, Sweden; [van Kamp, Irene] Natl Inst Publ Hlth & Environm RIVM, Ctr Sustainabil Environm & Hlth, Bilthoven, Netherlands	University of Gothenburg; Orebro University; Netherlands National Institute for Public Health & the Environment	Waye, KP (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Occupat & Environm Med, Publ Hlth & Community Med, Gothenburg, Sweden.; Waye, KP (corresponding author), Orebro Univ, Sch Hlth Sci, SIDR, Orebro, Sweden.	kerstin.persson.waye@amm.gu.se	Gustafsson, Johanna/X-7241-2019; Hussain-Alkhateeb, Laith/K-3485-2013	Gustafsson, Johanna/0000-0003-3023-3422; Fredriksson, Sofie/0000-0003-0698-527X; Hussain-Alkhateeb, Laith/0000-0001-9607-110X	Swedish Research Council for Health, Working Life and Welfare [2016-07193]; Swedish Hearing Research Foundation [2016-528]	Swedish Research Council for Health, Working Life and Welfare(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Swedish Hearing Research Foundation	This work was supported by the Swedish Research Council for Health, Working Life and Welfare https://forte.se/en/[Grant nr 2016-07193]; and the Swedish Hearing Research Foundation https://hrf.se/[2016-528]. The grants were received by Kerstin Persson Waye. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bistrup M L, 2003, Noise Health, V5, P59; Bistrup ML, 2006, ACTA PAEDIATR, V95, P31, DOI 10.1080/08035250600885951; Creed K, 2014, THESIS; Dellve L, 2013, QUAL RES PSYCHOL, V10, P1, DOI 10.1080/14780887.2011.586099; Evans G.W., 2007, NOISE ITS EFFECTS; Evans GW, 2006, ANNU REV PSYCHOL, V57, P423, DOI 10.1146/annurev.psych.57.102904.190057; Fels J., 2008, THESIS; Fredriksson S, 2017, 12 ICBEN C NOIS PUBL; Fredriksson S, 2018, THESIS; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Job R.F. Soames, 1999, Noise Health, V1, P57; Kihlbom M, 2009, PRESCHOOL YOUNGEST G; Kondracki NL, 2002, J NUTR EDUC BEHAV, V34, P224, DOI 10.1016/S1499-4046(06)60097-3; Krippendorff K. H., 2013, CONTENT ANAL INTRO I; Kristiansen J, 2014, INT ARCH OCC ENV HEA, V87, P851, DOI 10.1007/s00420-014-0927-8; Official Report of the Swedish Government, 1972, 197226 SOU OFF RE 1; Official Report of the Swedish Government, 1972, 197227 SOU OFF REP 2; Persson Waye K., 2011, 20113 GOTH U SAHLGR, P3; Stansfeld SA, 2009, J ENVIRON PSYCHOL, V29, P203, DOI 10.1016/j.jenvp.2009.01.002; Swedish National Agency for Education, 2014, 201400036 DNR SWED N; Swedish Work Environment Authority, 200516 AFS SWED WORK; Wadsworth ME, 2015, CHILD DEV PERSPECT, V9, P96, DOI 10.1111/cdep.12112; Waye KP, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002408; Williams P, 2019, SCAND J EDUC RES, V63, P696, DOI 10.1080/00313831.2018.1434823	24	7	8	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214464	10.1371/journal.pone.0214464	http://dx.doi.org/10.1371/journal.pone.0214464			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HQ7IR	30921409	gold, Green Published, Green Submitted			2022-12-26	WOS:000462594000072
J	Imboden, S; Nastic, D; Ghaderi, M; Rydberg, F; Rau, TT; Mueller, MD; Epstein, E; Carlson, JW				Imboden, Sara; Nastic, Denis; Ghaderi, Mehran; Rydberg, Filippa; Rau, Tilman T.; Mueller, Michael D.; Epstein, Elisabeth; Carlson, Joseph W.			Phenotype of POLE-mutated endometrial cancer	PLOS ONE			English	Article							EXONUCLEASE DOMAIN MUTATIONS; DNA-POLYMERASE; CARCINOMAS; CLASSIFICATION; PROGRESSION; LANDSCAPE; SURVIVAL; REVEAL; RISK; PD-1	Background and purpose Individualized therapy in endometrial cancer, the most common gynaecologic cancer in the developed world, focuses on identifying specific molecular subtypes. Mutations in the exonuclease domain of the DNA polymerase epsilon (POLE) gene define one such subtype, which causes an ultra-mutated tumour phenotype. These tumours may have an improved progression-free survival and may be receptive to specific therapies. However, the clinical phenotype of these tumours is unknown. The objective of this study was to evaluate the clinical and genetic features of POLE-mutated tumours from a large cohort of women whose cases are characterized by: (1) the availability of detailed clinical and lifestyle data; (2) mutation analysis; and (3) long-term follow-up. Methods A total of 604 patients with endometrial cancer were included in the study. Data from a detailed questionnaire, including lifestyle and family history information, provided extensive pertinent information on the patients. Sequencing of exons 9-14 of the POLE gene was performed. Follow-up data were gathered and analysed. Results Hotspot pathogenic POLE mutations were identified in N = 38/599 patients (6.3%). Patients with a POLE-mutated tumour were significantly younger, were more often nulliparous, and had a history of smoking. POLE-mutated tumours were more frequently aneuploid. Prognosis for patients with hotspot POLE-mutated tumours was significantly better in comparison with patients with non-mutated tumours; however careful selection of pathogenic mutations is essential to the definition of this prognostically favourable group. Conclusions This study demonstrates that POLE-mutated endometrial cancer is significantly associated with previously unknown clinicopathologic characteristics. Outcome in POLE-mutated tumours was excellent in cases with hotspot mutations. Our results suggest that prediction of excellent outcome in cases of POLE-mutated EMCA should be restricted to cases of EMCA with hotspot mutations until further data are available on the rising number of mutations with unknown significance.	[Imboden, Sara; Mueller, Michael D.] Univ Hosp Bern, Dept Obstet & Gynaecol, Bern, Switzerland; [Imboden, Sara; Mueller, Michael D.] Univ Bern, Bern, Switzerland; [Nastic, Denis; Ghaderi, Mehran; Rydberg, Filippa; Carlson, Joseph W.] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden; [Nastic, Denis; Ghaderi, Mehran; Rydberg, Filippa; Carlson, Joseph W.] Karolinska Univ Hosp, Dept Pathol & Cytol, Stockholm, Sweden; [Rau, Tilman T.] Univ Bern, Inst Pathol, Bern, Switzerland; [Epstein, Elisabeth] Karolinska Inst, Dept Clin Sci & Educ, Stockholm, Sweden; [Epstein, Elisabeth] Soder Sjukhuset, Dept Obstet & Gynaecol, Stockholm, Sweden	University of Bern; University Hospital of Bern; University of Bern; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; University of Bern; Karolinska Institutet; Sodersjukhuset Hospital	Carlson, JW (corresponding author), Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden.; Carlson, JW (corresponding author), Karolinska Univ Hosp, Dept Pathol & Cytol, Stockholm, Sweden.	joseph.carlson@ki.se	epstein, elisabeth/F-4586-2014; Epstein, Elisabeth/GRO-7235-2022; Ghaderi, Mehran/AAB-7416-2021	epstein, elisabeth/0000-0003-2298-7785; Carlson, Joseph/0000-0002-3006-4107	Bernese cancer league; Swiss national science foundation [IZSE70_177073]; Swedish governmental grants; Avtal om Lakarutbildning och Forskning (ALF); ALF-Stockholm County [550411]; 'Radiumhemmet' Stockholm Sweden [154112]; Magnus Bergvalls Stiftelse [2016-01472]; Stockholms Lans Landsting [20150892]	Bernese cancer league; Swiss national science foundation(Swiss National Science Foundation (SNSF)European Commission); Swedish governmental grants; Avtal om Lakarutbildning och Forskning (ALF); ALF-Stockholm County; 'Radiumhemmet' Stockholm Sweden; Magnus Bergvalls Stiftelse; Stockholms Lans Landsting	Bernese cancer league (https://bern.krebsliga.ch/), Swiss national science foundation (IZSE70_177073)http://www of chi, Swedish governmental grants; Avtal om Lakarutbildning och Forskning (ALF), ALF-Stockholm County (grant no 550411)https://ki.se, Cancer research funding from 'Radiumhemmet' Stockholm Sweden (grant no 154112)https://www.rahfo.se; Magnus Bergvalls Stiftelse (2016-01472); and Stockholms Lans Landsting (20150892). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barroso-Sousa R, 2017, ONCOTARGET, V8, P106169, DOI 10.18632/oncotarget.22583; Bellone S, 2017, GYNECOL ONCOL, V144, P146, DOI 10.1016/j.ygyno.2016.11.023; Billingsley CC, 2016, INT J GYNECOL CANCER, V26, P933, DOI 10.1097/IGC.0000000000000681; Billingsley CC, 2015, CANCER-AM CANCER SOC, V121, P386, DOI 10.1002/cncr.29046; Cancer Genome Atlas Research Network T, 2013, INT GEN CHAR END CAR, DOI [10.1038/NATURE12113, DOI 10.1038/NATURE12113]; Chalmers ZR, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0424-2; Church DN, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/dju402; Church DN, 2013, HUM MOL GENET, V22, P2820, DOI 10.1093/hmg/ddt131; Colombo N, 2016, ANN ONCOL, V27, P16, DOI 10.1093/annonc/mdv484; Cosgrove CM, 2018, GYNECOL ONCOL, V148, P174, DOI 10.1016/j.ygyno.2017.10.037; Epstein E, 2018, ULTRASOUND OBST GYN, V51, P818, DOI 10.1002/uog.18909; Gibson WJ, 2016, NAT GENET, V48, P848, DOI 10.1038/ng.3602; Goodman AM, 2017, MOL CANCER THER, V16, P2598, DOI 10.1158/1535-7163.MCT-17-0386; Howitt BE, 2015, JAMA ONCOL, V1, P1319, DOI 10.1001/jamaoncol.2015.2151; Hussein YR, 2015, MODERN PATHOL, V28, P505, DOI 10.1038/modpathol.2014.143; Hussein YR, 2018, MOL INSIGHTS CLASSIF, DOI [10.1016/J.PATHOL.2017.09.010, DOI 10.1016/J.PATHOL.2017.09.010]; Jacob Louis, 2018, Oncotarget, V9, P17420, DOI 10.18632/oncotarget.24724; Lindemann K, 2008, BRIT J CANCER, V98, P1582, DOI 10.1038/sj.bjc.6604313; Mauland KK, 2014, CYTOM PART B-CLIN CY, V86, P154, DOI 10.1002/cyto.b.21164; McAlpine J, 2018, J PATHOL, V244, P538, DOI 10.1002/path.5034; McConechy MK, 2016, CLIN CANCER RES, V22, P2865, DOI 10.1158/1078-0432.CCR-15-2233; McShane LM, 2006, BREAST CANCER RES TR, V100, P229, DOI 10.1007/s10549-006-9242-8; Meng B, 2014, GYNECOL ONCOL, V134, P15, DOI 10.1016/j.ygyno.2014.05.006; Motz GT, 2013, IMMUNITY, V39, P61, DOI 10.1016/j.immuni.2013.07.005; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nelson BH, 2015, GYNECOL ONCOL, V138, P1, DOI 10.1016/j.ygyno.2015.06.004; Pradhan M, 2012, ANN ONCOL, V23, P1178, DOI 10.1093/annonc/mdr368; Proctor L, 2017, ASSESSMENT DNA PLOID, DOI [10.1016/J.YGYNO.2017.06.020, DOI 10.1016/J.YGYNO.2017.06.020]; Pursell ZF, 2007, SCIENCE, V317, P127, DOI 10.1126/science.1144067; Rayner E, 2016, NAT REV CANCER, V16, P71, DOI 10.1038/nrc.2015.12; Reed SD, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2009.02.032; Rizvi NA, MUTATIONAL LANDSCAPE; Sauerbrei W, 2018, JNCI-J NATL CANCER I, V110, P803, DOI 10.1093/jnci/djy088; Shinbrot E, 2014, GENOME RES, V24, P1740, DOI 10.1101/gr.174789.114; Stelloo E, 2016, CLIN CANCER RES, V22, P4215, DOI 10.1158/1078-0432.CCR-15-2878; Supek F, 2017, CELL, V170, P534, DOI 10.1016/j.cell.2017.07.003; Talhouk A, 2015, BRIT J CANCER, V113, P299, DOI 10.1038/bjc.2015.190; Talhouk A, 2016, GYNECOL ONCOL, V143, P46, DOI 10.1016/j.ygyno.2016.07.090; van Gool IC, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1072675; van Gool IC, 2015, CLIN CANCER RES, V21, P3347, DOI 10.1158/1078-0432.CCR-15-0057; Wise MR, 2016, AM J OBSTET GYNECOL, V214, DOI 10.1016/j.ajog.2016.01.175; Wong A, 2016, MUTATION SPECTRUM PO, DOI [10.1016/J.YGYNO.2015.12.031, DOI 10.1016/J.YGYNO.2015.12.031]; Zhou B, 2008, AM J MED, V121, P501, DOI 10.1016/j.amjmed.2008.01.044	43	34	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2019	14	3							e0214318	10.1371/journal.pone.0214318	http://dx.doi.org/10.1371/journal.pone.0214318			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ5PT	30917185	Green Published, gold, Green Submitted			2022-12-26	WOS:000462465800060
J	Gutierrez, BL; Zambrano, AMA; Zambrano, SLA; Gil, CAQ; Bohlman, S; Arias, EA; Mulder, G; Ols, C; Dirzo, R; DeLuycker, AM; Lewis, K; Broadbent, EN				Gutierrez, Beatriz Lopez; Zambrano, Angelica M. Almeyda; Zambrano, Sandra L. Almeyda; Gil, Carlos A. Quispe; Bohlman, Stephanie; Avellan Arias, Eduardo; Mulder, Guillermo; Ols, Clare; Dirzo, Rodolfo; DeLuycker, Anneke M.; Lewis, Karen; Broadbent, Eben N.			An island of wildlife in a human-dominated landscape: The last fragment of primary forest on the Osa Peninsula's Golfo Dulce coastline, Costa Rica	PLOS ONE			English	Article							HABITAT FRAGMENTATION; TERRESTRIAL MAMMALS; CONSERVATION VALUE; RIPARIAN FOREST; EXTINCTION RISK; NATIONAL-PARKS; CAMERA-TRAP; RAIN-FOREST; LAND-USE; DYNAMICS	Habitat loss and fragmentation, together with related edge effects, are the primary cause of global biodiversity decline. Despite a large amount of research quantifying and demonstrating the degree of these effects, particularly in top predators and their prey, most fragmented patches are lost before their conservation value is recognized. This study evaluates terrestrial vertebrates in Playa Sandalo, in the Osa Peninsula of Costa Rica, which represents the last patch of "primary" forest in the most developed part of this region. Our study indicates that the diversity of ground species detected within Playa Sandalo rival other areas under active conservation like Lapa Rios Ecolodge. Historical fragmentation, together with the maintenance of forest cover in isolated conditions, are potentially responsible for the species composition observed within Playa Sandalo; facilitating the development of a prey-predator system including ocelots, medium-size mammals, and birds at the top of the trophic chain. The high diversity of both habitat and vertebrates, its prime location and cultural value, as well as its unique marine importance represent the ideal conditions for conservation. Conservation of Playa Sandalo, and other small tropical forest remnants, might represent the only management option for wildlife conservation within ever growing human-dominated landscapes.	[Gutierrez, Beatriz Lopez; Zambrano, Sandra L. Almeyda; Gil, Carlos A. Quispe; Bohlman, Stephanie; Ols, Clare; Broadbent, Eben N.] Univ Florida, Sch Forest Resources & Conservat, Spatial Ecol & Conservat Lab, Gainesville, FL 32611 USA; [Zambrano, Angelica M. Almeyda] Univ Florida, Dept Tourism Recreat & Sport Management, Spatial Ecol & Conservat Lab, Gainesville, FL USA; [Avellan Arias, Eduardo] Casa Rodden, Osa Peninsula, Costa Rica; [Mulder, Guillermo; Lewis, Karen] Lapa Rios Ecolodge, Osa Peninsula, Costa Rica; [Dirzo, Rodolfo] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [DeLuycker, Anneke M.] George Mason Univ, Smithsonian Mason Sch Conservat, Washington, DC USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Stanford University; George Mason University; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute	Gutierrez, BL (corresponding author), Univ Florida, Sch Forest Resources & Conservat, Spatial Ecol & Conservat Lab, Gainesville, FL 32611 USA.	blopezgutierrez@ufl.edu	Almeyda Zambrano, Angelica/Q-4758-2017	Almeyda Zambrano, Angelica/0000-0001-5081-9936				Aguilera M., HIST PUERTO JIMENEZ; Algeet-Abarquero N, 2015, REG ENVIRON CHANGE, V15, P1461, DOI 10.1007/s10113-014-0714-9; Andren H., 1994, EFFECTS HABITAT FRAG, V1, P355; Barrantes G., 1999, EVALUACION PLANES MA; Blake John G., 2017, Neotropical Biodiversity, V3, P57, DOI 10.1080/23766808.2017.1292756; Blake JG, 2012, ECOTROPICA, V18, P137; Brandon K., 2004, GETTING BIODIVERSITY, P154; Brinck K, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14855; Broadbent EN, 2008, BIOL CONSERV, V141, P1745, DOI 10.1016/j.biocon.2008.04.024; BROKAW NVL, 1982, BIOTROPICA, V14, P158, DOI 10.2307/2387750; Canale GR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041671; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; Cortes J., 1990, CORAL REEF DECLINE G; Cortes Nunez J., 1990, CORAL REEFS GOLFO DU; Cove MV, 2012, REV LATINOAMERICANA, V3; Crooks KR, 2017, P NATL ACAD SCI USA, V114, P7635, DOI 10.1073/pnas.1705769114; Cusack JJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126373; Emmons, 2016, IUCN RED LIST THREAT, V2016, DOI DOI 10.2305/IUCN.UK.2016-2.RLTS.T89497686A78319610.EN; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Fahrig L, 2017, ANNU REV ECOL EVOL S, V48, P1, DOI 10.1146/annurev-ecolsys-110316-022612; Tapia-Armijos MF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133701; Fletcher R, 2012, DEV CHANGE, V43, P295, DOI 10.1111/j.1467-7660.2011.01751.x; Foster CN, 2014, J APPL ECOL, V51, P929, DOI 10.1111/1365-2664.12268; Galetti M, 2015, GLOB ECOL CONSERV, V3, P824, DOI 10.1016/j.gecco.2015.04.008; Galetti M, 2013, BIOL CONSERV, V163, P1, DOI 10.1016/j.biocon.2013.04.020; Haddad NM, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500052; Harmsen BJ, 2010, BIOTROPICA, V42, P126, DOI 10.1111/j.1744-7429.2009.00544.x; Hunt CA, 2015, HUM ORGAN, V74, P217, DOI 10.17730/0018-7259-74.3.217; Hunt CA, 2015, J SUSTAIN TOUR, V23, P339, DOI 10.1080/09669582.2014.965176; (INBio) Instituto Nacional de Biodiversidad, 1999, SANT DOM HER; Keenan RJ, 2015, FOREST ECOL MANAG, V352, P9, DOI 10.1016/j.foreco.2015.06.014; Lamb D, 2005, SCIENCE, V310, P1628, DOI 10.1126/science.1111773; Lees AC, 2008, CONSERV BIOL, V22, P439, DOI 10.1111/j.1523-1739.2007.00870.x; Lopez Gutierrez B, 2019, EVALUATING EFFECTS E; Lyra-Jorge MC, 2008, BIODIVERS CONSERV, V17, P1573, DOI 10.1007/s10531-008-9366-8; Matsuda I, 2015, ECOL RES, V30, P191, DOI 10.1007/s11284-014-1219-1; McCauley DJ, 2012, SCI REP-UK, V2, DOI 10.1038/srep00409; Meyer NFV, 2015, J NAT CONSERV, V26, P28, DOI 10.1016/j.jnc.2015.04.003; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Newbold T, 2015, NATURE, V520, P45, DOI 10.1038/nature14324; Oksanen J, 2015, PACKAGE VEGAN COMMUN, V2; Pereira HM, 2010, SCIENCE, V330, P1496, DOI 10.1126/science.1196624; Peres CA, 2001, CONSERV BIOL, V15, P1490, DOI 10.1046/j.1523-1739.2001.01089.x; Phillips HRP, 2017, BIODIVERS CONSERV, V26, P2251, DOI 10.1007/s10531-017-1356-2; R Core Team, 2021, R LANGUAGE ENV STAT; REDFORD KH, 1992, BIOSCIENCE, V42, P412, DOI 10.2307/1311860; Rugani T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052641; Sanchez-Azofeifa GA, 2002, MT RES DEV, V22, P352, DOI 10.1659/0276-4741(2002)022[0352:DOTDAN]2.0.CO;2; Sanchez-Azofeifa GA, 2003, BIOL CONSERV, V109, P123, DOI 10.1016/S0006-3207(02)00145-3; Sanchez-Azofeifa GA, 1999, CONSERV BIOL, V13, P407, DOI 10.1046/j.1523-1739.1999.013002407.x; Schulenberg T. S., NEOTROPICAL BIRDS ON; Schwartz GJ, 2015, THESIS; Si XF, 2014, PEERJ, V2, DOI 10.7717/peerj.374; Solano J, 2001, REGIONES SUBREGIONES; Sollmann R, 2013, BIOL CONSERV, V159, P405, DOI 10.1016/j.biocon.2012.12.025; STEWART GH, 1991, J VEG SCI, V2, P679, DOI 10.2307/3236178; Taylor P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126748; TERBORGH J, 1992, BIOTROPICA, V24, P283, DOI 10.2307/2388523; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thornton DH, 2012, ORYX, V46, P567, DOI 10.1017/S0030605311001451; Tobler MW, 2008, ANIM CONSERV, V11, P169, DOI 10.1111/j.1469-1795.2008.00169.x; Turner IM, 1996, TRENDS ECOL EVOL, V11, P330, DOI 10.1016/0169-5347(96)10046-X; Wilkie DS, 2011, ANN NY ACAD SCI, V1223, P120, DOI 10.1111/j.1749-6632.2010.05908.x; Zambrano A. M. A., 2010, Journal of Ecotourism, V9, P62, DOI 10.1080/14724040902953076	64	5	5	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2019	14	3							e0214390	10.1371/journal.pone.0214390	http://dx.doi.org/10.1371/journal.pone.0214390			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ3IW	30913255	Green Submitted, Green Published, gold			2022-12-26	WOS:000462305600054
J	Gao, PY; Li, N; Ji, KH; Wang, Y; Xu, C; Liu, Y; Wang, Q; Wang, JH; He, NN; Sun, ZJ; Du, LQ; Liu, Q				Gao, Piaoyang; Li, Na; Ji, Kaihua; Wang, Yan; Xu, Chang; Liu, Yang; Wang, Qin; Wang, Jihan; He, Ningning; Sun, Zhijuan; Du, Liqing; Liu, Qiang			Resveratrol targets TyrRS acetylation to protect against radiation-induced damage	FASEB JOURNAL			English	Article						irradiation; DNA damage; SIRT1	TRANSFER-RNA SYNTHETASES; PREVENTION; APOPTOSIS	Resveratrol (RSV) has broad prospective applications as a radiation protection drug, but its mechanism of action is not yet clear. Here, we found that 5 mu M RSV can effectively reduce the cell death caused by irradiation. Irradiation leads to G(2)/M phase arrest in the cell cycle, whereas RSV treatment increases S-phase cell cycle arrest, which is associated with sirtuin 1 (SIRT1) regulation. Meanwhile, RSV promotes DNA damage repair, mainly by accelerating the efficiency of homologous recombination repair. Under oxidative stress, tyrosyl-tRNA synthetase (TyrRS) is transported to the nucleus to protect against DNA damage. RSV can promote TyrRS acetylation, thus promoting TyrRS to enter the nucleus, where it regulates the relevant signaling proteins and reduces apoptosis and DNA damage. SIRT1 is a deacetylase, and SIRT1 knockdown or inhibition can increase TyrRS acetylation levels, further reducing radiation-induced apoptosis after RSV treatment. Our study revealed a new radiation protection mechanism for RSV, in which the acetylation of TyrRS and its translocation into the nucleus is promoted, and this mechanism may also represent a novel protective target against irradiation.-Gao, P., Li, N., Ji, K., Wang, Y., Xu, C., Liu, Y., Wang, Q., Wang, J., He, N., Sun, Z., Du, L., Liu, Q. Resveratrol targets TyrRS acetylation to protect against radiation-induced damage.	[Gao, Piaoyang; Li, Na; Ji, Kaihua; Wang, Yan; Xu, Chang; Liu, Yang; Wang, Qin; Wang, Jihan; He, Ningning; Sun, Zhijuan; Du, Liqing; Liu, Qiang] Chinese Acad Med Sci, Inst Radiat Med, Tianjin Key Lab Radiat Med & Mol Nucl Med, Peking Union Med Coll, Tianjin, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Radiation Medicine - CAMS; Peking Union Medical College	Du, LQ; Liu, Q (corresponding author), Chinese Acad Med Sci, Inst Radiat Med, 238 Baidi Rd, Tianjin 300192, Peoples R China.	duliqing2004@126.com; liuqiang@irm-cams.ac.cn	Liu, Qiang/HHZ-3181-2022; Liu, Qiang/AFK-6590-2022; liu, liu yang/Y-8494-2019	Liu, Qiang/0000-0002-7668-6868; 	National Natural Science Foundation of China [31670859, 81302803]; Concord Youth Fund; Central University Basic Scientific Research Business [3332016100]; Concord Small-Scale Characteristics of School Funding [100232016016 02]; Chinese Academy of Medical Sciences, Medical and Health Science and Technology Innovation Project [2017-I2M-1-02]; Fundamental Research Funds for the Central Universities [3332018158]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Concord Youth Fund; Central University Basic Scientific Research Business; Concord Small-Scale Characteristics of School Funding; Chinese Academy of Medical Sciences, Medical and Health Science and Technology Innovation Project; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by grants from the National Natural Science Foundation of China (31670859 and 81302803), the Concord Youth Fund, special funds from the Central University Basic Scientific Research Business (3332016100), the Concord Small-Scale Characteristics of School Funding (100232016016 02), the Chinese Academy of Medical Sciences, Medical and Health Science and Technology Innovation Project (2017-I2M-1-02), and The Fundamental Research Funds for the Central Universities (3332018158). The authors declare no conflicts of interest.	Afaq F, 2003, TOXICOL APPL PHARM, V186, P28, DOI 10.1016/S0041-008X(02)00014-5; Ahmed KM, 2018, MOL CELL BIOL, V38, DOI 10.1128/MCB.00672-17; Becatti M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061572; Boczonadi V, 2018, FEBS LETT, V592, P703, DOI 10.1002/1873-3468.12962; Bonnefond L, 2005, BIOCHIMIE, V87, P873, DOI 10.1016/j.biochi.2005.03.008; Bradamante S, 2004, CARDIOVASC DRUG REV, V22, P169; Cao DF, 2015, GENE DEV, V29, P1316, DOI 10.1101/gad.265462.115; Cao XY, 2017, P NATL ACAD SCI USA, V114, P687, DOI 10.1073/pnas.1608488114; Carsten RE, 2008, RADIAT RES, V169, P633, DOI 10.1667/RR1190.1; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Das Samarjit, 2007, Inflammation & Allergy Drug Targets, V6, P168, DOI 10.2174/187152807781696464; de la Lastra CA, 2005, MOL NUTR FOOD RES, V49, P405; Deng HY, 2016, NEUROCHEM RES, V41, P2367, DOI 10.1007/s11064-016-1950-9; Fabre KM, 2011, CANCER BIOL THER, V12, P915, DOI 10.4161/cbt.12.10.17714; Giege R, 2006, J BIOSCIENCES, V31, P477, DOI 10.1007/BF02705187; Guo M, 2013, NAT CHEM BIOL, V9, P145, DOI [10.1038/nchembio.1158, 10.1038/NCHEMBIO.1158]; Han CF, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01654-6; Howitz KT, 2008, CELL, V133, P387, DOI 10.1016/j.cell.2008.04.019; Hu YD, 2014, CANCER DISCOV, V4, P1430, DOI 10.1158/2159-8290.CD-13-0891; Jordanova A, 2006, NAT GENET, V38, P197, DOI 10.1038/ng1727; Kanaji T, 2018, P NATL ACAD SCI USA, V115, pEB228, DOI 10.1073/pnas.1807000115; Kim S, 2011, NAT REV CANCER, V11, P708, DOI 10.1038/nrc3124; Kumari A, 2015, CELL DEATH DIFFER, V22, P311, DOI 10.1038/cdd.2014.146; Lahusen TJ, 2018, ONCOGENE, V37, P2343, DOI 10.1038/s41388-018-0127-1; Lee IC, 2018, CELL DEATH DIFFER, V25, P255, DOI 10.1038/cdd.2017.152; Li CQ, 2017, MOL CELL ONCOL, V4, DOI 10.1080/23723556.2017.1293597; Li YB, 2006, PHARMACOL RES, V53, P6, DOI 10.1016/j.phrs.2005.08.002; Losa GA, 2003, EUR J CLIN INVEST, V33, P818, DOI 10.1046/j.1365-2362.2003.01219.x; Luna Augustin, 2013, Genome Integr, V4, P6, DOI 10.1186/2041-9414-4-6; Markus MA, 2008, CLIN INTERV AGING, V3, P331; Mirando AC, 2014, INT J MOL SCI, V15, P23725, DOI 10.3390/ijms151223725; Mueck K, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112473; Mukhopadhyay R, 2009, TRENDS BIOCHEM SCI, V34, P324, DOI 10.1016/j.tibs.2009.03.004; Park SG, 2005, TRENDS BIOCHEM SCI, V30, P569, DOI 10.1016/j.tibs.2005.08.004; Pervaiz S, 2009, ANTIOXID REDOX SIGN, V11, P2851, DOI [10.1089/ars.2008.2412, 10.1089/ARS.2008.2412]; Sa L. I., 2011, KEXUE JISHU YU GONGC, V11, P8271; Sajish M, 2015, NATURE, V519, P370, DOI 10.1038/nature14028; Sanders TH, 2000, J AGR FOOD CHEM, V48, P1243, DOI 10.1021/jf990737b; Walle T, 2004, DRUG METAB DISPOS, V32, P1377, DOI 10.1124/dmd.104.000885; Wei N, 2014, MOL CELL, V56, P323, DOI 10.1016/j.molcel.2014.09.006; Yao P, 2013, EMBO MOL MED, V5, P332, DOI 10.1002/emmm.201100626; Zhang H, 2018, INT J RADIAT BIOL, V94, P28, DOI 10.1080/09553002.2018.1408976; Zhang H, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-017-1915-9; Zhang JL, 2017, INT IMMUNOPHARMACOL, V43, P33, DOI 10.1016/j.intimp.2016.12.002; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	45	6	7	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2019	33	7					8083	8093		10.1096/fj.201802474RR	http://dx.doi.org/10.1096/fj.201802474RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ9SM	30939244	Bronze			2022-12-26	WOS:000476234700023
J	Thada, V; Cortez, D				Thada, Vaughn; Cortez, David			Common motifs in ETAA1 and TOPBP1 required for ATR kinase activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA damage response; cell cycle; serine; threonine protein kinase; DNA replication; signaling; cancer; ATR; ATR activation domain (AAD); DNA topoisomerase II binding protein 1 (TOPBP1); ETAA1 activator of ATR kinase (ETAA1); PI3K-related protein kinase (PIKK)	DNA-DAMAGE RESPONSE; C-TERMINAL TAIL; COILED COILS; CHECKPOINT; PROTEIN; REPLICATION; MEC1/ATR; COMPLEX; RHINO; CLAMP	DNA damage response Ser/Thr kinases, including ataxia telangiectasia-mutated (ATM) and Rad3-related (ATR), control cell cycle progression, DNA repair, and apoptosis. ATR is activated by ETAA1 activator of ATR kinase (ETAA1) or DNA topoisomerase II binding protein 1 (TOPBP1). Both ETAA1 and TOPBP1 contain experimentally defined ATR activation domains (AADs) that are mostly unstructured and have minimal sequence similarity. A tryptophan residue in both AADs is required for ATR activation, but the other features of these domains and the mechanism by which they activate ATR are unknown. In this study, using bioinformatic analyses, kinase assays, co-immunoprecipitation, and immunofluorescence measures of signaling, we more specifically defined the TOPBP1 and ETAA1 AADs and identified additional features of the AADs needed for ATR activation. We found that both ETAA1 and TOPBP1 contain a predicted coiled-coil motif that is required for ATR activation in vitro and in cells. Mutation of the predicted coiled coils does not alter AAD oligomerization but does impair binding of the AADs to ATR. These results suggest that TOPBP1 and ETAA1 activate ATR using similar motifs and mechanisms.	[Thada, Vaughn; Cortez, David] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA	Vanderbilt University	Cortez, D (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA.	david.cortez@vanderbilt.edu			National Institutes of Health [CA102729, CA239161]; NIEHS, National Institutes of Health [5T32ES007028]; NIGMS, National Institutes of Health [1F31GM128334-01]; NATIONAL CANCER INSTITUTE [R01CA239161, R01CA102729] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007028] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM128334] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided by National Institutes of Health grants CA102729 and CA239161 (to D.C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by NIEHS, National Institutes of Health training grant 5T32ES007028 and NIGMS, National Institutes of Health grant 1F31GM128334-01.	Ball HL, 2007, MOL CELL BIOL, V27, P3367, DOI 10.1128/MCB.02238-06; Bass TE, 2019, J CELL BIOL, V218, P1235, DOI 10.1083/jcb.201810058; Bass TE, 2016, NAT CELL BIOL, V18, P1185, DOI 10.1038/ncb3415; Blackford AN, 2017, MOL CELL, V66, P801, DOI 10.1016/j.molcel.2017.05.015; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cortez D, 2001, SCIENCE, V294, P1713, DOI 10.1126/science.1065521; Cortez D, 2004, P NATL ACAD SCI USA, V101, P10078, DOI 10.1073/pnas.0403410101; Cotta-Ramusino C, 2011, SCIENCE, V332, P1313, DOI 10.1126/science.1203430; Delacroix S, 2007, GENE DEV, V21, P1472, DOI 10.1101/gad.1547007; Duursma AM, 2013, MOL CELL, V50, P116, DOI 10.1016/j.molcel.2013.03.006; Forment JV, 2018, PHARMACOL THERAPEUT, V188, P155, DOI 10.1016/j.pharmthera.2018.03.005; Haahr P, 2016, NAT CELL BIOL, V18, P1196, DOI 10.1038/ncb3422; Kobayashi M, 2013, GENES CELLS, V18, P238, DOI 10.1111/gtc.12031; Kumagai A, 2006, CELL, V124, P943, DOI 10.1016/j.cell.2005.12.041; Kumar S, 2013, GENE DEV, V27, P313, DOI 10.1101/gad.204750.112; Lee YC, 2016, CURR BIOL, V26, P3257, DOI 10.1016/j.cub.2016.10.030; Lindsey-Boltz LA, 2015, CELL CYCLE, V14, P99, DOI 10.4161/15384101.2014.967076; McDonnell AV, 2006, BIOINFORMATICS, V22, P356, DOI 10.1093/bioinformatics/bti797; Meszaros B, 2018, NUCLEIC ACIDS RES, V46, pW329, DOI 10.1093/nar/gky384; Mordes DA, 2008, GENE DEV, V22, P1478, DOI 10.1101/gad.1666208; Mordes DA, 2008, P NATL ACAD SCI USA, V105, P18730, DOI 10.1073/pnas.0806621105; Navadgi-Patil VM, 2011, J BIOL CHEM, V286, P40999, DOI 10.1074/jbc.M111.283994; Navadgi-Patil VM, 2009, MOL CELL, V36, P743, DOI 10.1016/j.molcel.2009.10.014; Navadgi-Patil VM, 2008, J BIOL CHEM, V283, P35853, DOI 10.1074/jbc.M807435200; Rappas M, 2011, NUCLEIC ACIDS RES, V39, P313, DOI 10.1093/nar/gkq743; Saldivar JC, 2018, SCIENCE, V361, P806, DOI 10.1126/science.aap9346; Saldivar JC, 2017, NAT REV MOL CELL BIO, V18, P622, DOI 10.1038/nrm.2017.67; Wanrooij PH, 2016, J BIOL CHEM, V291, P393, DOI 10.1074/jbc.M115.687145; Zeman MK, 2014, NAT CELL BIOL, V16, P2, DOI 10.1038/ncb2897; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	31	21	23	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2019	294	21					8395	8402		10.1074/jbc.RA119.008154	http://dx.doi.org/10.1074/jbc.RA119.008154			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC6UQ	30940728	Green Published, hybrid			2022-12-26	WOS:000471108200010
J	Caballero, A; Mahn, SA; Ali, MS; Rogers, MR; Marchese, A				Caballero, Adriana; Mahn, Sarah A.; Ali, Mudassir S.; Rogers, M. Rose; Marchese, Adriano			Heterologous regulation of CXCR4 lysosomal trafficking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G protein-coupled receptor (GPCR); CXC chemokine receptor type 4 (CXCR4); receptor desensitization; receptor internalization; receptor protein serine; threonine kinase; phorbol ester; receptor modification; chemokine; lysosomal trafficking; receptor down-regulation; heterotrimeric G protein; receptor endocytosis; receptor degradation; signal transduction; protein kinase C (PKC); cyclic AMP (cAMP)	CHEMOKINE RECEPTOR CXCR4; C-TERMINAL TAIL; ARRESTIN-2 INTERACTS; MOLECULAR-CLONING; WHIM-SYNDROME; GENE CXCR4; CHEMOTAXIS; INTERNALIZATION; UBIQUITINATION; PHOSPHORYLATION	G protein-coupled receptor (GPCR) signaling is regulated by members of the protein kinase C (PKC) and GPCR kinase (GRK) families, although the relative contribution of each to GPCR function varies among specific GPCRs. The CXC motif receptor 4 (CXCR4) is a member of the GPCR superfamily that binds the CXC motif chemokine ligand 12 (CXCL12), initiating signaling that is subsequently terminated in part by internalization and lysosomal degradation of CXCR4. The purpose of this study is to define the relative contribution of PKC and GRK to CXCR4 signaling attenuation by studying their effects on CXCR4 lysosomal trafficking and degradation. Our results demonstrate that direct activation of PKC via the phorbol ester phorbol 12-myristate 13-acetate (PMA) mimics CXCL12-mediated desensitization, internalization, ubiquitination, and lysosomal trafficking of CXCR4. In agreement, heterologous activation of PKC by stimulating the chemokine receptor CXCR5 with its ligand, CXCL13, also mimics CXCL12-mediated desensitization, internalization, ubiquitination, and lysosomal degradation of CXCR4. Similar to CXCL12, PMA promotes PKC-dependent phosphorylation of serine residues within CXCR4 C-tail that are required for binding and ubiquitination by the E3 ubiquitin ligase AIP4 (atrophin-interacting protein 4). However, inhibition of PKC activity does not alter CXCL12-mediated ubiquitination and degradation of CXCR4, suggesting that other kinases are also required. Accordingly, siRNA-mediated depletion of GRK6 results in decreased degradation and ubiquitination of CXCR4. Overall, these results suggest that PKC and GRK6 contribute to unique aspects of CXCR4 phosphorylation and lysosomal degradation to ensure proper signal propagation and termination.	[Caballero, Adriana; Marchese, Adriano] Loyola Univ Chicago, Dept Pharmacol, Maywood, IL 60153 USA; [Mahn, Sarah A.; Ali, Mudassir S.; Rogers, M. Rose; Marchese, Adriano] Med Coll Wisconsin, Dept Biochem, TBRC C3850,8701 Watertown Plank Rd, Milwaukee, WI 53226 USA; [Caballero, Adriana] Univ Illinois, Coll Med, Dept Anat & Cell Biol, Chicago, IL 60612 USA	Loyola University Chicago; Medical College of Wisconsin; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Marchese, A (corresponding author), Med Coll Wisconsin, Dept Biochem, TBRC C3850,8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	amarchese@mcw.edu		Wedemeyer, Sarah/0000-0003-4787-4672; Caballero, Adriana/0000-0001-7052-7594	National Institutes of Health [GM122889]; Loyola University Chicago; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM122889] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Loyola University Chicago; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM122889 (to A. M.). This work was also supported in part by institutional funds at Loyola University Chicago. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Al Ustwani O, 2014, BRIT J HAEMATOL, V164, P15, DOI 10.1111/bjh.12574; Alekhina O, 2016, J BIOL CHEM, V291, P26083, DOI 10.1074/jbc.M116.757138; Ali H, 1999, J BIOL CHEM, V274, P6027, DOI 10.1074/jbc.274.10.6027; Amara A, 1997, J EXP MED, V186, P139, DOI 10.1084/jem.186.1.139; Balabanian K, 2005, BLOOD, V105, P2449, DOI 10.1182/blood-2004-06-2289; Balabanian K, 2008, J CLIN INVEST, V118, P1074, DOI 10.1172/JCI33187; Balkwill F, 2004, SEMIN CANCER BIOL, V14, P171, DOI 10.1016/j.semcancer.2003.10.003; Bhandari D, 2007, J BIOL CHEM, V282, P36971, DOI 10.1074/jbc.M705085200; Bhandari D, 2009, MOL BIOL CELL, V20, P1324, DOI 10.1091/mbc.E08-03-0308; Binkowski BF, 2011, METHODS MOL BIOL, V756, P263, DOI 10.1007/978-1-61779-160-4_14; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Busillo JM, 2007, BBA-BIOMEMBRANES, V1768, P952, DOI 10.1016/j.bbamem.2006.11.002; Busillo JM, 2010, J BIOL CHEM, V285, P7805, DOI 10.1074/jbc.M109.091173; Caballero A, 2011, METHODS MOL BIOL, V746, P251, DOI 10.1007/978-1-61779-126-0_13; Chatterjee S, 2014, ADV CANCER RES, V124, P31, DOI 10.1016/B978-0-12-411638-2.00002-1; El-Haibi CP, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-64; English EJ, 2018, J BIOL CHEM, V293, P11470, DOI 10.1074/jbc.RA118.001872; Fong AM, 2002, P NATL ACAD SCI USA, V99, P7478, DOI 10.1073/pnas.112198299; Goldsmith ZG, 2007, ONCOGENE, V26, P3122, DOI 10.1038/sj.onc.1210407; Grimsey N, 2014, METHOD ENZYMOL, V535, P389, DOI 10.1016/B978-0-12-397925-4.00022-5; Guinamard R, 1999, J EXP MED, V189, P1461, DOI 10.1084/jem.189.9.1461; Gutkind JS, 1998, J BIOL CHEM, V273, P1839, DOI 10.1074/jbc.273.4.1839; Haribabu B, 1997, J BIOL CHEM, V272, P28726, DOI 10.1074/jbc.272.45.28726; Hernandez PA, 2003, NAT GENET, V34, P70, DOI 10.1038/ng1149; Hezareh Marjan, 2004, Antiviral Chemistry & Chemotherapy, V15, P207; Holm NT, 2007, J SURG RES, V141, P53, DOI 10.1016/j.jss.2007.03.015; Horuk R, 1997, METHOD ENZYMOL, V288, P326; Li YM, 2004, CANCER CELL, V6, P459, DOI 10.1016/j.ccr.2004.09.027; Luo JS, 2017, MOL PHARMACOL, V91, P554, DOI 10.1124/mol.116.106468; Luttrell LM, 2002, J CELL SCI, V115, P455; Malik R, 2010, MOL BIOL CELL, V21, P2529, DOI 10.1091/mbc.E10-02-0169; Marchese A, 2001, J BIOL CHEM, V276, P45509, DOI 10.1074/jbc.C100527200; Marchese A, 2003, DEV CELL, V5, P709, DOI 10.1016/S1534-5807(03)00321-6; Marchese A, 2016, METHOD ENZYMOL, V570, P281, DOI 10.1016/bs.mie.2015.10.004; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; McCudden CR, 2005, CELL MOL LIFE SCI, V62, P551, DOI 10.1007/s00018-004-4462-3; Mueller W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064975; NAGASAWA T, 1994, P NATL ACAD SCI USA, V91, P2305, DOI 10.1073/pnas.91.6.2305; Nagasawa T, 1996, P NATL ACAD SCI USA, V93, P14726, DOI 10.1073/pnas.93.25.14726; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Newton AC, 2018, CRIT REV BIOCHEM MOL, V53, P208, DOI 10.1080/10409238.2018.1442408; Obara B, 2013, HISTOCHEM CELL BIOL, V139, P391, DOI 10.1007/s00418-012-1068-3; Orsini MJ, 1999, J BIOL CHEM, V274, P31076, DOI 10.1074/jbc.274.43.31076; Rajagopal S, 2017, CELL SIGNAL, V41, P9, DOI 10.1016/j.cellsig.2017.01.024; Richardson RM, 2003, J BIOL CHEM, V278, P15867, DOI 10.1074/jbc.M211745200; Schuller U, 2005, INT J CANCER, V117, P82, DOI 10.1002/ijc.21116; Signoret N, 1997, J CELL BIOL, V139, P651, DOI 10.1083/jcb.139.3.651; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; Verma R, 2015, J BIOL CHEM, V290, P6810, DOI 10.1074/jbc.M114.606699; Vroon A, 2004, J LEUKOCYTE BIOL, V75, P698, DOI 10.1189/jlb.0703320; Woerner BM, 2005, CANCER RES, V65, P11392, DOI 10.1158/0008-5472.CAN-05-0847; Worz S, 2010, IEEE T MED IMAGING, V29, P1474, DOI 10.1109/TMI.2010.2049857	53	8	8	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2019	294	20					8023	8036		10.1074/jbc.RA118.005991	http://dx.doi.org/10.1074/jbc.RA118.005991			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC0NH	30936203	Green Published, hybrid			2022-12-26	WOS:000470656500006
J	Meier, J; Nolte, G; Schneider, TR; Engel, AK; Leicht, G; Mulert, C				Meier, Jan; Nolte, Guido; Schneider, Till R.; Engel, Andreas K.; Leicht, Gregor; Mulert, Christoph			Intrinsic 40Hz-phase asymmetries predict tACS effects during conscious auditory perception	PLOS ONE			English	Article							ALTERNATING-CURRENT STIMULATION; EVENT-RELATED POTENTIALS; SPECTRAL FINGERPRINTS; BRAIN; EEG; PHASE; COMMUNICATION; OSCILLATIONS; DYNAMICS; CORTEX	Synchronized oscillatory gamma-band activity (30-100Hz) has been suggested to constitute a key mechanism to dynamically orchestrate sensory information integration across multiple spatio-temporal scales. We here tested whether interhemispheric functional connectivity and ensuing auditory perception can selectively be modulated by high-density transcranial alternating current stimulation (HD-tACS). For this purpose, we applied multi-site HD-tACS at 40Hz bilaterally with a phase lag of 180 degrees and recorded a 64-channel EEG to study the oscillatory phase dynamics at the source-space level during a dichotic listening (DL) task in twenty-six healthy participants. In this study, we revealed an oscillatory phase signature at 40Hz which reflects different temporal profiles of the phase asymmetries during left and right ear percept. Here we report that 180 degrees-tACS did not affect the right ear advantage during DL at group level. However, a follow-up analysis revealed that the intrinsic phase asymmetries during sham-tACS determined the directionality of the behavioral modulations: While a shift to left ear percept was associated with augmented interhemispheric asymmetry (closer to 180 degrees), a shift to right ear processing was elicited in subjects with lower asymmetry (closer to 0 degrees). Crucially, the modulation of the interhemispheric network dynamics depended on the deviation of the tACS-induced phase-lag from the intrinsic phase asymmetry. Our characterization of the oscillatory network trends is giving rise to the importance of phase-specific gamma-band coupling during ambiguous auditory perception, and emphasizes the necessity to address the inter-individual variability of phase asymmetries in future studies by tailored stimulation protocols.	[Meier, Jan; Leicht, Gregor; Mulert, Christoph] Univ Med Ctr Hamburg Eppendorf, Dept Psychiat & Psychotherapy, Hamburg, Germany; [Nolte, Guido; Schneider, Till R.; Engel, Andreas K.] Univ Med Ctr Hamburg Eppendorf, Dept Neurophysiol & Pathophysiol, Hamburg, Germany; [Mulert, Christoph] Justus Liebig Univ Giessen, Ctr Psychiat & Psychotherapy, Giessen, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Justus Liebig University Giessen	Meier, J (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Psychiat & Psychotherapy, Hamburg, Germany.	j.meier@uke.de	Mulert, Christoph/AAB-3210-2020; Leicht, Gregor/AAF-7364-2020; Schneider, Till/B-3751-2010; Leicht, Gregor/ABE-2404-2020; Engel, Andreas K./AAH-6384-2019	Leicht, Gregor/0000-0002-5104-9336; Schneider, Till/0000-0002-8889-6248; Leicht, Gregor/0000-0002-5104-9336; Engel, Andreas K./0000-0003-4899-8466	German Research Foundation [SFB936/C6, SFB936/A3/Z1, SPP1665 EN 533/13-1, SFB936/Z3, SPP1665/2 SCHN 1511/1-2]; Werner Otto Foundation	German Research Foundation(German Research Foundation (DFG)); Werner Otto Foundation	This work was supported by grants from the German Research Foundation (SFB936/C6 to G.L., C.M.; SFB936/A3/Z1 to A.K.E.; SPP1665 EN 533/13-1 to A.K.E.; SFB936/Z3 to G.N.; SPP1665/2 SCHN 1511/1-2 to T.R.S.) and the Werner Otto Foundation (J.M.). German Research Foundation: www.dfg.de.Werner Otto Foundation: http://www.werner-otto-stiftung.de/de/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alagapan S, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002424; Ali MM, 2013, J NEUROSCI, V33, P11262, DOI 10.1523/JNEUROSCI.5867-12.2013; Andreou C, 2015, SCHIZOPHRENIA BULL, V41, P930, DOI 10.1093/schbul/sbu121; Bachinger M, 2017, J NEUROSCI, V37, P4766, DOI 10.1523/JNEUROSCI.1756-16.2017; Baldwin SA, 2015, PSYCHOPHYSIOLOGY, V52, P790, DOI 10.1111/psyp.12401; Bastos AM, 2015, CURR OPIN NEUROBIOL, V31, P173, DOI 10.1016/j.conb.2014.11.001; Berens P, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i10; BLAIR RC, 1993, PSYCHOPHYSIOLOGY, V30, P518, DOI 10.1111/j.1469-8986.1993.tb02075.x; Bosman CA, 2012, NEURON, V75, P875, DOI 10.1016/j.neuron.2012.06.037; Brittain JS, 2013, CURR BIOL, V23, P436, DOI 10.1016/j.cub.2013.01.068; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Carl C, 2012, NEUROIMAGE, V59, P1657, DOI 10.1016/j.neuroimage.2011.09.020; Clayson PE, 2017, INT J PSYCHOPHYSIOL, V111, P57, DOI 10.1016/j.ijpsycho.2016.09.005; Curcic-Blake B, 2017, PROG NEUROBIOL, V148, P1, DOI 10.1016/j.pneurobio.2016.11.002; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Delorme A, 2015, J NEUROSCI METH, V250, P3, DOI 10.1016/j.jneumeth.2014.10.003; Dowsett J, 2016, FRONT HUM NEUROSCI, V10, P309, DOI [10.3389/fnhum.2016.00309, DOI 10.3389/FNHUM.2016.00309]; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; ENGEL AK, 1991, SCIENCE, V252, P1177, DOI 10.1126/science.252.5009.1177; Feher KD, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00471; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Fries P, 2015, NEURON, V88, P220, DOI 10.1016/j.neuron.2015.09.034; Frohlich F, 2015, EXPERT REV NEUROTHER, V15, P145, DOI 10.1586/14737175.2015.992782; GREEN MF, 1994, AM J PSYCHIAT, V151, P357; Gregoriou GG, 2009, SCIENCE, V324, P1207, DOI 10.1126/science.1171402; Griffiths TD, 2002, TRENDS NEUROSCI, V25, P348, DOI 10.1016/S0166-2236(02)02191-4; Grothe I, 2012, J NEUROSCI, V32, P16172, DOI 10.1523/JNEUROSCI.0890-12.2012; Gundlach C, 2016, BRAIN STIMUL, V9, P712, DOI 10.1016/j.brs.2016.04.014; Heimrath K, 2016, FRONT CELL NEUROSCI, V10, P261, DOI [10.3389/fncel.2016.00261, DOI 10.3389/FNCEL.2016.00261]; Helfrich RF, 2016, HUM BRAIN MAPP, V37, P4099, DOI 10.1002/hbm.23298; Helfrich RF, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1002031; Helfrich RF, 2014, CURR BIOL, V24, P333, DOI 10.1016/j.cub.2013.12.041; Herrmann CS, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00279; Herrmann CS, 2005, CLIN NEUROPHYSIOL, V116, P2719, DOI 10.1016/j.clinph.2005.07.007; Hipp JF, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00338; Huffmeijer R, 2014, PHYSIOL BEHAV, V130, P13, DOI 10.1016/j.physbeh.2014.03.008; Hugdahl K, 2003, COGNITIVE BRAIN RES, V16, P58, DOI 10.1016/S0926-6410(02)00210-0; Hugdahl K, 2016, NEUROPSYCHOLOGIA, V93, P466, DOI 10.1016/j.neuropsychologia.2015.12.011; Hugdahl K, 2011, BRAIN COGNITION, V76, P211, DOI 10.1016/j.bandc.2011.03.006; Hugdahl Kenneth, 2008, Cogn Neuropsychiatry, V13, P166, DOI 10.1080/13546800801906808; Kar K, 2017, J NEUROSCI, V37, P2325, DOI 10.1523/JNEUROSCI.2266-16.2016; Kilian-Hutten N, 2011, J NEUROSCI, V31, P1715, DOI 10.1523/JNEUROSCI.4572-10.2011; Kimura D., 1967, CORTEX, V3, P163, DOI DOI 10.1016/S0010-9452(67)80010-8; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Menon V, 2005, INT REV NEUROBIOL, V66, P291, DOI 10.1016/S0074-7742(05)66010-2; Moliadze V, 2012, BRAIN STIMUL, V5, P505, DOI 10.1016/j.brs.2011.11.004; Moseley Peter, 2015, Front Neurosci, V9, P515, DOI 10.3389/fnins.2015.00515; Neuling T, 2012, NEUROIMAGE, V63, P771, DOI 10.1016/j.neuroimage.2012.07.024; Neuling T, 2013, FRONT HUM NEUROSCI, V7, DOI [10.3389/fnhum.2013.00007, DOI 10.3389/FNHUM.2013.00007]; Neuling T, 2017, NEUROIMAGE, V147, P960, DOI 10.1016/j.neuroimage.2016.11.022; Neuling T, 2015, NEUROIMAGE, V118, P406, DOI 10.1016/j.neuroimage.2015.06.026; Nolte G, 2004, CLIN NEUROPHYSIOL, V115, P2292, DOI 10.1016/j.clinph.2004.04.029; Noury N, 2018, NEUROIMAGE, V167, P53, DOI 10.1016/j.neuroimage.2017.11.023; Noury N, 2017, NEUROIMAGE, V158, P406, DOI 10.1016/j.neuroimage.2017.07.010; Noury N, 2016, NEUROIMAGE, V140, P99, DOI 10.1016/j.neuroimage.2016.03.065; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Ozen S, 2010, J NEUROSCI, V30, P11476, DOI 10.1523/JNEUROSCI.5252-09.2010; PANTEV C, 1995, ELECTROEN CLIN NEURO, V94, P26, DOI 10.1016/0013-4694(94)00209-4; Pascual-Marqui R. D, 2007, ARXIV07111455; Pascual-Marqui RD, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00448; Pascual-Marqui RD, 2011, PHILOS T R SOC A, V369, P3768, DOI 10.1098/rsta.2011.0081; Philip NS, 2017, AM J PSYCHIAT, V174, P628, DOI 10.1176/appi.ajp.2017.16090996; Picton TW, 2000, PSYCHOPHYSIOLOGY, V37, P127, DOI 10.1111/1469-8986.3720127; Polania R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9090; Polania R, 2012, CURR BIOL, V22, P1314, DOI 10.1016/j.cub.2012.05.021; Riecke L, 2015, BRAIN STIMUL, V8, P777, DOI 10.1016/j.brs.2015.04.004; Rose M, 2005, J NEUROSCI, V25, P10101, DOI 10.1523/JNEUROSCI.2998-05.2005; Rufener KS, 2016, INT J PSYCHOPHYSIOL, V101, P18, DOI 10.1016/j.ijpsycho.2016.01.002; Ruhnau P, 2016, SCI REP-UK, V6, DOI 10.1038/srep27138; Saenz M, 2014, HEARING RES, V307, P42, DOI 10.1016/j.heares.2013.07.016; Schilberg L, 2018, CORTEX, V103, P142, DOI 10.1016/j.cortex.2018.03.001; Shahin AJ, 2007, BRAIN TOPOGR, V20, P55, DOI 10.1007/s10548-007-0031-4; Siegel M, 2012, NAT REV NEUROSCI, V13, P121, DOI 10.1038/nrn3137; Steinmann S, 2017, SCI REP, V7, P193, DOI [10.1038/s41598-017-00306-5, DOI 10.1038/S41598-017-00306-5]; Steinmann S, 2018, BRAIN TOPOGR, V31, P218, DOI 10.1007/s10548-017-0583-x; Steinmann S, 2014, NEUROIMAGE, V100, P435, DOI 10.1016/j.neuroimage.2014.06.012; Steinmann S, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00055; Stonkus R, 2016, PROBING CAUSAL ROLE, DOI [10.1101/044636, DOI 10.1101/044636]; Struber D, 2014, BRAIN TOPOGR, V27, P158, DOI 10.1007/s10548-013-0294-x; ten Oever S, 2015, P NATL ACAD SCI USA, V112, P15833, DOI 10.1073/pnas.1517519112; Thut G, 2017, CLIN NEUROPHYSIOL, V128, P843, DOI 10.1016/j.clinph.2017.01.003; Thut G, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00170; Tseng P, 2016, SCI REP-UK, V6, DOI 10.1038/srep32138; Uhlhaas PJ, 2012, NEURON, V75, P963, DOI 10.1016/j.neuron.2012.09.004; Vossen A, 2015, BRAIN STIMUL, V8, P499, DOI 10.1016/j.brs.2014.12.004; Voytek B, 2015, BIOL PSYCHIAT, V77, P1089, DOI 10.1016/j.biopsych.2015.04.016; Westerhausen R, 2008, NEUROSCI BIOBEHAV R, V32, P1044, DOI 10.1016/j.neubiorev.2008.04.005; Westerhausen R, 2009, CEREB CORTEX, V19, P1322, DOI 10.1093/cercor/bhn173; Wilsch A, 2018, NEUROIMAGE, V172, P766, DOI 10.1016/j.neuroimage.2018.01.038; Witkowski M, 2016, NEUROIMAGE, V140, P89, DOI 10.1016/j.neuroimage.2015.10.024; Wostmann M, 2018, BRAIN STIMUL, V11, P752, DOI 10.1016/j.brs.2018.04.006; Zaehle T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013766	92	8	9	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0213996	10.1371/journal.pone.0213996	http://dx.doi.org/10.1371/journal.pone.0213996			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HR5NS	30943251	Green Published, Green Submitted, gold			2022-12-26	WOS:000463194300028
J	Lundervold, AJ; Vik, A; Lundervold, A				Lundervold, Astri J.; Vik, Alexandra; Lundervold, Arvid			Lateral ventricle volume trajectories predict response inhibition in older age-A longitudinal brain imaging and machine learning approach	PLOS ONE			English	Article							EXECUTIVE FUNCTIONS; COGNITIVE DECLINE; GRAY-MATTER; MEMORY; SEGMENTATION; PROGRESSION; ATROPHY; GENDER; ADULTS	Objective In a three-wave 6 yrs longitudinal study we investigated if the expansion of lateral ventricle (LV) volumes (regarded as a proxy for brain tissue loss) predicts third wave performance on a test of response inhibition (RI). Participants and methods Trajectories of left and right lateral ventricle volumes across the three waves were quantified using the longitudinal stream in Freesurfer. All participants (N= 74;48 females;mean age 66.0 yrs at the third wave) performed the Color-Word Interference Test (CWIT). Response time on the third condition of CWIT, divided into fast, medium and slow, was used as outcome measure in a machine learning framework. Initially, we performed a linear mixed effect (LME) analysis to describe subject-specific trajectories of the left and right LV volumes (LVV). These features were input to a multinomial logistic regression classification procedure, predicting individual belongings to one of the three RI classes. To obtain results that might generalize, we evaluated the significance of a k-fold cross-validated f1-score with a permutation test, providing a p-value that approximates the probability that the score would be obtained by chance. We also calculated a corresponding confusion matrix. Results The LME-model showed an annual similar to 3.0% LVV increase. Evaluation of a cross-validated score using 500 permutations gave an f1-score of 0.462 that was above chance level (p = 0.014). 56% of the fast performers were successfully classified. All these were females, and typically older than 65 yrs at inclusion. For the true slow performers, those being correctly classified had higher LVVs than those being misclassified, and their ages at inclusion were also higher. Conclusion Major contributions were: (i) a longitudinal design, (ii) advanced brain imaging and segmentation procedures with longitudinal data analysis, and (iii) a data driven machine learning approach including cross-validation and permutation testing to predict behaviour, solely from the individual's brain "signatures" (LVV trajectories).	[Lundervold, Astri J.; Vik, Alexandra] Univ Bergen, Dept Biol & Med Psychol, Bergen, Norway; [Lundervold, Arvid] Univ Bergen, Mohn Med Imaging & Visualizat Ctr, Dept Biomed, Bergen, Norway	University of Bergen; University of Bergen	Lundervold, A (corresponding author), Univ Bergen, Mohn Med Imaging & Visualizat Ctr, Dept Biomed, Bergen, Norway.	arvid.lundervold@uib.no	Lundervold, Astri/AAH-9796-2021	Lundervold, Astri/0000-0002-6819-6164	Research Council of Norway [154313/V50]; Western Norway Regional Health Authority [911397, 911687, 911995]	Research Council of Norway(Research Council of Norway); Western Norway Regional Health Authority	This work was supported by Research Council of Norway (grant 154313/V50), the second and third study-wave from the Western Norway Regional Health Authority (grants 911397 and 911687, AJL). We also acknowledge the Western Norway Regional Health Authority for funding the Freesurfer Longitudinal Stream (grant 911995, AL).	Adolfsdottir S, 2017, J INT NEUROPSYCH SOC, V23, P90, DOI 10.1017/S1355617716000898; Adolfsdottir S, 2014, NEUROPSYCHOLOGY, V28, P859, DOI 10.1037/neu0000082; Aljondi R, 2019, BRAIN IMAGING BEHAV, V13, P554, DOI 10.1007/s11682-018-9887-z; Arbabshirani MR, 2017, NEUROIMAGE, V145, P137, DOI 10.1016/j.neuroimage.2016.02.079; Beck A.T., 1987, BECK DEPRESSION INVE; Borelli WV, 2018, INT PSYCHOGERIATR, V30, P1813, DOI 10.1017/S1041610218000431; Buckner RL, 2004, NEURON, V44, P195, DOI 10.1016/j.neuron.2004.09.006; Cabeza R, 2018, NAT REV NEUROSCI, V19, P701, DOI 10.1038/s41583-018-0068-2; Calhoun Vince D, 2016, Biol Psychiatry Cogn Neurosci Neuroimaging, V1, P230; Cardenas VA, 2011, NEUROBIOL AGING, V32, P572, DOI 10.1016/j.neurobiolaging.2009.04.011; Carmichael OT, 2007, ALZ DIS ASSOC DIS, V21, P14, DOI 10.1097/WAD.0b013e318032d2b1; Carmichael OT, 2007, NEUROBIOL AGING, V28, P389, DOI 10.1016/j.neurobiolaging.2006.01.006; Chung SC, 2006, NEUROSCI LETT, V395, P155, DOI 10.1016/j.neulet.2005.10.066; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Delis DC, 2001, DELIS KAPLAN EXECUTI; Espeseth T, 2012, TWIN RES HUM GENET, V15, P442, DOI 10.1017/thg.2012.8; Fjell AM, 2013, NEUROBIOL AGING, V34, P2239, DOI 10.1016/j.neurobiolaging.2013.04.006; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Friedman NP, 2017, CORTEX, V86, P186, DOI 10.1016/j.cortex.2016.04.023; Gale SA, 2018, AM J MED, V131, P1161, DOI 10.1016/j.amjmed.2018.01.022; Gauthier S, 2006, LANCET, V367, P1262, DOI 10.1016/S0140-6736(06)68542-5; Goh JO, 2012, PSYCHOL AGING, V27, P707, DOI 10.1037/a0026715; Gorbach T, 2017, NEUROBIOL AGING, V51, P167, DOI 10.1016/j.neurobiolaging.2016.12.002; Gunning-Dixon FM, 2003, NEUROPSYCHOLOGIA, V41, P1929, DOI 10.1016/S0028-3932(03)00129-5; Hasan KM, 2014, MAGN RESON IMAGING, V32, P405, DOI 10.1016/j.mri.2014.01.014; Jack CR, 2004, NEUROLOGY, V62, P591, DOI 10.1212/01.WNL.0000110315.26026.EF; Leong RLF, 2017, NEUROIMAGE, V147, P852, DOI 10.1016/j.neuroimage.2016.10.016; Lundervold AJ, 2014, SCAND J PSYCHOL, V55, P225, DOI 10.1111/sjop.12114; Madsen SK, 2015, NEUROBIOL AGING, V36, pS32, DOI 10.1016/j.neurobiolaging.2014.03.044; McDonald CR, 2012, NEUROBIOL AGING, V33, P242, DOI 10.1016/j.neurobiolaging.2010.03.015; Nevalainen N, 2015, BRAIN RES, V1612, P83, DOI 10.1016/j.brainres.2014.09.010; Nyberg L, 2019, ANNU REV PSYCHOL, V70, P219, DOI 10.1146/annurev-psych-010418-103052; Nyberg Lars, 2017, F1000Res, V6, P1215, DOI 10.12688/f1000research.11419.1; Nyberg L, 2016, P NATL ACAD SCI USA, V113, P7918, DOI 10.1073/pnas.1606309113; Nyberg L, 2012, TRENDS COGN SCI, V16, P292, DOI 10.1016/j.tics.2012.04.005; Preul C, 2006, J MAGN RESON IMAGING, V24, P513, DOI 10.1002/jmri.20665; Pudas S, 2018, CEREB CORTEX, V28, P936, DOI 10.1093/cercor/bhw418; Reuter M, 2012, NEUROIMAGE, V61, P1402, DOI 10.1016/j.neuroimage.2012.02.084; Reuter M, 2010, NEUROIMAGE, V53, P1181, DOI 10.1016/j.neuroimage.2010.07.020; Reuter-Lorenz PA, 2014, NEUROPSYCHOL REV, V24, P355, DOI 10.1007/s11065-014-9270-9; Rogalski EJ, 2013, J COGNITIVE NEUROSCI, V25, P29, DOI 10.1162/jocn_a_00300; Salthouse TA, 2003, J EXP PSYCHOL GEN, V132, P566, DOI 10.1037/0096-3445.132.4.566; Scahill RI, 2003, ARCH NEUROL-CHICAGO, V60, P989, DOI 10.1001/archneur.60.7.989; Stern Y, 2018, NEUROIMAGE, V178, P36, DOI 10.1016/j.neuroimage.2018.05.033; Stuss DT, 2000, PSYCHOL RES-PSYCH FO, V63, P289, DOI 10.1007/s004269900007; Tampubolon G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144907; Todd KL, 2018, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00445; Trimarchi F, 2013, ANAT SCI INT, V88, P61, DOI 10.1007/s12565-012-0162-x; Turner GR, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.06.005; Vidal-Pineiro D, 2019, CEREB CORTEX, V29, P3111, DOI 10.1093/cercor/bhy177; Walhovd KB, 2014, SCAND J PSYCHOL, V55, P244, DOI 10.1111/sjop.12120; Wechsler D., 2011, WASI 2 WECHSLER ABBR; Yuan P, 2018, NEUROIMAGE, V172, P21, DOI 10.1016/j.neuroimage.2018.01.032	53	7	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2019	14	4							e0207967	10.1371/journal.pone.0207967	http://dx.doi.org/10.1371/journal.pone.0207967			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HR2UW	30939173	Green Published, gold, Green Submitted			2022-12-26	WOS:000462993900003
J	Zhou, D; Eliasy, A; Abass, A; Markov, P; Whitford, C; Boote, C; Movchan, A; Movchan, N; Elsheikh, A				Zhou, Dong; Eliasy, Ashkan; Abass, Ahmed; Markov, Petar; Whitford, Charles; Boote, Craig; Movchan, Alexander; Movchan, Natalia; Elsheikh, Ahmed			Analysis of X-ray scattering microstructure data for implementation in numerical simulations of ocular biomechanical behaviour	PLOS ONE			English	Article							HUMAN CORNEAL STROMA; COLLAGEN ORIENTATION; MODEL; ORGANIZATION; DIFFRACTION; ANISOTROPY; FIBRILS	This study aimed to analyse microstructure data on the density and orientation of collagen fibrils in whole eye globes and to propose an effective method for the preparation of data for use in numerical simulations of the eye's biomechanical performance. Wide-angle X-ray scattering was applied to seven healthy ex-vivo human eyes. Each eye was dissected into an anterior and a posterior cup, and radial incisions were used to flatten the tissue before microstructure characterisation. A method was developed to use the microstructure data obtained for the dissected tissue to build realistic 3D maps of fibril density and orientation covering the whole eye globe. At the central cornea, 61.5 +/- 2.3% of fibrils were aligned within 45 degrees sectors surrounding the two orthogonal directions. In contrast, more than one-third of the total fibril content was concentrated along the circumferential direction at the limbus (37.0 +/- 2.4%) and around the optic nerve head (34.8 +/- 2.1%). The insertion locations of the four recti muscles exhibited a preference in the meridional direction near the equator (38.6 +/- 3.9%). There was also a significant difference in fibril density between the limbus and other regions (ratio = 1.91 +/- 0.45, p < 0.01 at the central cornea and ratio = 0.80 +/- 0.21, p < 0.01 at the posterior pole). Characterisation of collagen fibril density and orientation across the whole ocular surface has been possible but required the use of a technique that involved tissue dissection and hence caused tissue damage. The method presented in this paper aimed to minimise the effect of dissection on the quality of obtained data and was successful in identifying fibril distribution trends that were compatible with earlier studies, which concentrated on localised areas of the ocular globe.	[Zhou, Dong; Eliasy, Ashkan; Abass, Ahmed; Elsheikh, Ahmed] Univ Liverpool, Sch Engn, Liverpool, Merseyside, England; [Markov, Petar; Boote, Craig] Cardiff Univ, Sch Optometry & Vis Sci, Cardiff, S Glam, Wales; [Whitford, Charles] Mfg Technol Ctr, Liverpool, Merseyside, England; [Movchan, Alexander; Movchan, Natalia] Univ Liverpool, Dept Math Sci, Liverpool, Merseyside, England; [Elsheikh, Ahmed] Moorfields Eye Hosp Natl Hlth Serv Fdn Trust, Biomed Res Ctr Ophthalmol, Natl Inst Hlth Res, London, England; [Elsheikh, Ahmed] UCL, Inst Ophthalmol, London, England; [Elsheikh, Ahmed] Beihang Univ, Sch Biol Sci & Biomed Engn, Beijing, Peoples R China	University of Liverpool; Cardiff University; University of Liverpool; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London; Beihang University	Zhou, D (corresponding author), Univ Liverpool, Sch Engn, Liverpool, Merseyside, England.	sgdzhou3@student.liverpool.ac.uk	Abass, Ahmed/S-3107-2019; Elsheikh, Ahmed/AAT-1476-2020; Eliasy, Ashkan/AAF-4941-2019	Abass, Ahmed/0000-0002-8622-4632; Elsheikh, Ahmed/0000-0001-7456-1749; Eliasy, Ashkan/0000-0002-4473-1900; Markov, Petar/0000-0002-0306-5868	Engineering and Physical Sciences Research Council (EPSRC); EPSRC [EP/N014499/1, 1805086] Funding Source: UKRI	Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This research was partly supported by the UK's Science and Technology Facilities Council (STFC) who provided beam times at the Diamond Research Centre and the Engineering and Physical Sciences Research Council (EPSRC) which provided a PhD studentship for Petar Markov at Cardiff University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abahussin M, 2009, INVEST OPHTH VIS SCI, V50, P5159, DOI 10.1167/iovs.09-3669; Abass A, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.0717; Aghamohammadzadeh H, 2004, STRUCTURE, V12, P249, DOI 10.1016/j.str.2004.01.002; [Anonymous], 2006, J BIOMECHANICAL ENG, V128, P150; Benoit A, 2016, J MECH BEHAV BIOMED, V60, P93, DOI 10.1016/j.jmbbm.2015.12.031; Bjorck A., 1996, NUMERICAL METHODS LE; Boote C, 2006, INVEST OPHTH VIS SCI, V47, P901, DOI 10.1167/iovs.05-0893; Boote C, 2005, J STRUCT BIOL, V149, P1, DOI 10.1016/j.jsb.2004.08.009; Boote C, 2003, INVEST OPHTH VIS SCI, V44, P2941, DOI 10.1167/iovs.03-0131; Boote C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068166; Bryant MR, 1996, J BIOMECH ENG-T ASME, V118, P473, DOI 10.1115/1.2796033; Daxer A, 1997, INVEST OPHTH VIS SCI, V38, P121; Elsheikh A, 2010, EYE VIS RES DEV, P1; Elsheikh A, 2008, J REFRACT SURG, V24, P178, DOI 10.3928/1081597X-20080201-09; Elsheikh Ahmed, 2007, Computer Methods in Biomechanics and Biomedical Engineering, V10, P85, DOI 10.1080/10255840600976013; Everitt B. S., 2006, CAMBRIDGE DICT STAT; Girard MJA, 2009, INVEST OPHTH VIS SCI, V50, P5226, DOI 10.1167/iovs.08-3363; Girard MJA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3113682; Grytz R, 2014, J MECH BEHAV BIOMED, V29, P602, DOI 10.1016/j.jmbbm.2013.03.027; Grytz R, 2011, BIOMECH MODEL MECHAN, V10, P371, DOI 10.1007/s10237-010-0240-8; Grytz R, 2010, BIOMECH MODEL MECHAN, V9, P225, DOI 10.1007/s10237-009-0173-2; Jogi R., 2016, BASIC OPHTHALMOLOGY; Mashige KP, 2013, AFR VIS EYE HEALTH J, V72, P185; Meek K. M., 2008, P359, DOI 10.1007/978-0-387-73906-9_13; Meek KM, 2015, PROG RETIN EYE RES, V49, P1, DOI 10.1016/j.preteyeres.2015.07.001; Meek KM, 2009, PROG RETIN EYE RES, V28, P369, DOI 10.1016/j.preteyeres.2009.06.005; Meek KM, 2001, MICRON, V32, P261, DOI 10.1016/S0968-4328(00)00041-X; Meek KM, 2005, INVEST OPHTH VIS SCI, V46, P1948, DOI 10.1167/iovs.04-1253; MEEK KM, 1987, CURR EYE RES, V6, P841, DOI 10.3109/02713688709034853; Nejad TM, 2014, ARQ BRAS OFTALMOL, V77, P60, DOI 10.5935/0004-2749.20140016; Pandolfi A, 2006, BIOMECH MODEL MECHAN, V5, P237, DOI 10.1007/s10237-005-0014-x; Pandolfi A, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2982251; Pijanka JK, 2012, INVEST OPHTH VIS SCI, V53, P5258, DOI 10.1167/iovs.12-9705; Pijanka JK, 2013, J APPL CRYSTALLOGR, V46, P1481, DOI 10.1107/S0021889813022358; Pinsky PM, 2005, J CATARACT REFR SURG, V31, P136, DOI 10.1016/j.jcrs.2004.10.048; Pinsky PM, 1991, J BIOMECH, V24; Shen J, 1997, INTELLIGENT SYSTEMS; SHENG YL, 1994, J OPT SOC AM A, V11, P1748, DOI 10.1364/JOSAA.11.001748; Smith G., 1997, EYE VISUAL OPTICAL I; Smith M., 2020, ABAQUSSTANDARD USERS; Studer H, 2010, J BIOMECH, V43, P836, DOI 10.1016/j.jbiomech.2009.11.021; Whitford C, 2014, CHINESE J OPTOMETRY, V16, P257; Whitford C, 2015, J MECH BEHAV BIOMED, V42, P76, DOI 10.1016/j.jmbbm.2014.11.006; Zernike F, 1934, PHYSICA, V1, P689	45	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2019	14	4							e0214770	10.1371/journal.pone.0214770	http://dx.doi.org/10.1371/journal.pone.0214770			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR1CY	30934028	Green Accepted, Green Submitted, Green Published, gold			2022-12-26	WOS:000462867000040
J	Kaltsonoudis, E; Pelechas, E; Papoudou-Bai, A; Markatseli, TE; Elisaf, M; Voulgari, PV; Drosos, AA				Kaltsonoudis, Evripidis; Pelechas, Eleftherios; Papoudou-Bai, Alexandra; Markatseli, Theodora E.; Elisaf, Moses; Voulgari, Paraskevi V.; Drosos, Alexandros A.			The impact of temporal artery biopsy for the diagnosis of giant cell arteritis in clinical practice in a tertiary university hospital	PLOS ONE			English	Article							ULTRASOUND; SPECTRUM; ULTRASONOGRAPHY	Background Temporal artery biopsy (TAB) is useful in assisting with giant cell arteritis (GCA) diagnosis but lacks sensitivity. The aim of our study was to assess the diagnostic impact of TAB histology in patients with suspected GCA on hospital admission. Methods A prospectively maintained database was queried for all TABs performed between 1-1-2000 until 31-12-2017 at the University Hospital of Ioannina. Thus, inclusion criteria were made on the grounds of every patient that underwent a TAB during the above-mentioned period, regardless of demographic, clinical and laboratory data. Results Two hundred forty-five TABs were included (149 females and 96 males), with a mean age of 64.5 (+/- 3.5) years. The mean symptoms duration until admission to the hospital was 8.6 (+/- 1.3) weeks and all had elevated acute phase reactants on admission. The reasons of admission were fever of unknown origin (FUO) in 114 (46.5%) patients, symptoms of polymyalgia rheumatica (PMR) in 84 (34.3%), new headache in 33 (13.5%), anemia of chronic disease (ACD) in 8 (3.32%) and eye disturbances in 6 (2.5%) patients. Positive results were found in 49 (20%) TABs. More specifically, in 14% of patients with FUO, 21% in those with PMR, while in patients with a new headache the percentage was 27%. Finally, 5 out of 6 (83.3%) of patients with ocular symptoms and only one (12.5%) of those suffering from ACD. Visual manifestations and FUO are correlated with a positive TAB. Conclusion It seems that TAB is useful in assisting with GCA diagnosis, but lacks sensitivity.	[Kaltsonoudis, Evripidis; Pelechas, Eleftherios; Markatseli, Theodora E.; Voulgari, Paraskevi V.; Drosos, Alexandros A.] Univ Ioannina, Sch Med, Dept Internal Med, Rheumatol Clin, Ioannina, Greece; [Papoudou-Bai, Alexandra] Univ Ioannina, Sch Med, Dept Pathol, Ioannina, Greece; [Elisaf, Moses] Univ Ioannina, Sch Med, Dept Internal Med, Ioannina, Greece	University of Ioannina; University of Ioannina; University of Ioannina	Drosos, AA (corresponding author), Univ Ioannina, Sch Med, Dept Internal Med, Rheumatol Clin, Ioannina, Greece.	adrosos@cc.uoi.gr	Drosos, Alexandros A./AAK-1115-2020; Pelechas, Eleftherios/O-6851-2019	Pelechas, Eleftherios/0000-0002-9383-5722				Aranda-Valera IC, 2017, CLIN EXP RHEUMATOL, V35, pS123; Arida A, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-44; Bajko Z, 2015, NEUROL NEUROCHIR POL, V49, P139, DOI 10.1016/j.pjnns.2015.03.003; Berthod PE, 2018, EUR RADIOL; Bowling K, 2017, ANN MED SURG, V20, P1, DOI 10.1016/j.amsu.2017.06.020; Brack A, 1999, ARTHRITIS RHEUM, V42, P311, DOI 10.1002/1529-0131(199902)42:2<311::AID-ANR14>3.0.CO;2-F; Dejaco C, 2018, ANN RHEUM DIS, V77, P636, DOI 10.1136/annrheumdis-2017-212649; Dejaco C, 2017, RHEUMATOLOGY, V56, P506, DOI 10.1093/rheumatology/kew273; Diamantopoulos AP, 2016, RHEUMATOLOGY, V55, P66, DOI 10.1093/rheumatology/kev289; Duhaut P, 1999, ANN RHEUM DIS, V58, P335, DOI 10.1136/ard.58.6.335; Gonzalez-Gay MA, 2005, MEDICINE, V84, P269, DOI 10.1097/01.md.0000180042.42156.d1; Gonzalez-Gay MA, 2001, SEMIN ARTHRITIS RHEU, V30, P249, DOI 10.1053/sarh.2001.16650; Hellmann DB, 2017, NEW ENGL J MED, V377, P385, DOI 10.1056/NEJMe1706439; HUNDER GG, 1990, ARTHRITIS RHEUM, V33, P1122; Jennette JC, 2013, ARTHRITIS RHEUM-US, V65, P1, DOI 10.1002/art.37715; Jese R, 2017, EUR J RADIOL, V95, P9, DOI 10.1016/j.ejrad.2017.07.007; Karassa FB, 2005, ANN INTERN MED, V142, P359, DOI 10.7326/0003-4819-142-5-200503010-00011; Luqmani R, 2016, HEALTH TECHNOL ASSES, V20, P1, DOI 10.3310/hta20900; Mari B, 2009, EUR J INTERN MED, V20, P533, DOI 10.1016/j.ejim.2009.05.002; Moiseev S, 2018, ANN RHEUM DIS, V77, P1164, DOI 10.1136/annrheumdis-2018-eular.2757; Pipitone NAM, 2018, CURR OPIN RHEUMATOL, V30, P24, DOI 10.1097/BOR.0000000000000459; Ponte C, 2015, WORLD J CLIN CASES, V3, P484, DOI 10.12998/wjcc.v3.i6.484; Rana AQ, 2014, J NEUROSCI RURAL PRA, V5, P409, DOI 10.4103/0976-3147.140005; Samson M, 2015, J NEUROL NEUROSUR PS, V86, P216, DOI 10.1136/jnnp-2014-307614; Schmidt WA, 2014, THER ADV MUSCULOSKEL, V6, P39, DOI 10.1177/1759720X13512256; Shu XM, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000007651; Soriano A, 2017, NAT REV RHEUMATOL, V13, P476, DOI 10.1038/nrrheum.2017.98; Soussan M, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000622; Stone JH, 2017, NEW ENGL J MED, V377, P317, DOI 10.1056/NEJMoa1613849; Unger M, 2016, WIEN KLIN WOCHENSCHR, V128, P796, DOI 10.1007/s00508-016-1083-9	30	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2019	14	3							e0210845	10.1371/journal.pone.0210845	http://dx.doi.org/10.1371/journal.pone.0210845			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ9FO	30925156	Green Submitted, gold, Green Published			2022-12-26	WOS:000462732300002
J	Munk, R; Martindale, JL; Yang, XL; Yang, JH; Grammatikakis, I; Di Germanio, C; Mitchell, SJ; de Cabo, R; Lehrmann, E; Zhang, YQ; Becker, KG; Raz, V; Gorospe, M; Abdelmohsen, K; Panda, AC				Munk, Rachel; Martindale, Jennifer L.; Yang, Xiaoling; Yang, Jen-Hao; Grammatikakis, Ioannis; Di Germanio, Clara; Mitchell, Sarah J.; de Cabo, Rafael; Lehrmann, Elin; Zhang, Yongqing; Becker, Kevin G.; Raz, Vered; Gorospe, Myriam; Abdelmohsen, Kotb; Panda, Amaresh C.			Loss of miR-451a enhances SPARC production during myogenesis	PLOS ONE			English	Article							SKELETAL-MUSCLE; EXTRACELLULAR-MATRIX; IN-VITRO; PROLIFERATION; BINDING; GROWTH; DIFFERENTIATION; REGENERATION; BIOGENESIS; EXPRESSION	MicroRNAs (miRNAs) are small noncoding RNAs that critically regulate gene expression. Their abundance and function have been linked to a range of physiologic and pathologic processes. In aged monkey muscle, miR-451a and miR-144-3p were far more abundant than in young monkey muscle. This observation led us to hypothesize that miR-451a and miR-144-3p may influence muscle homeostasis. To test if these conserved microRNAs were implicated in myogenesis, we investigated their function in the mouse myoblast line C2C12. The levels of both microRNAs declined with myogenesis; however, only overexpression of miR-451a, but not miR-144-3p, robustly impeded C2C12 differentiation, suggesting an inhibitory role for miR-451a in myogenesis. Further investigation of the regulatory influence of miR-451a identified as one of the major targets Sparc mRNA, which encodes a secreted protein acidic and rich in cysteine (SPARC) that functions in wound healing and cellular differentiation. In mouse myoblasts, miR-451a suppressed Sparc mRNA translation. Together, our findings indicate that miR-451a is downregulated in differentiated myoblasts and suggest that it decreases C2C12 differentiation at least in part by suppressing SPARC biosynthesis.	[Munk, Rachel; Martindale, Jennifer L.; Yang, Xiaoling; Yang, Jen-Hao; Grammatikakis, Ioannis; Lehrmann, Elin; Zhang, Yongqing; Becker, Kevin G.; Gorospe, Myriam; Abdelmohsen, Kotb; Panda, Amaresh C.] NIA, Lab Genet & Genom, NIH, Baltimore, MD 21224 USA; [Di Germanio, Clara; Mitchell, Sarah J.; de Cabo, Rafael] NIA, Translat Gerontol Branch, NIH, Baltimore, MD 21224 USA; [Raz, Vered] Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands; [Panda, Amaresh C.] Inst Life Sci, Bhubaneswar, Odisha, India	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Department of Biotechnology (DBT) India; Institute of Life Sciences India (ILS)	Gorospe, M; Panda, AC (corresponding author), NIA, Lab Genet & Genom, NIH, Baltimore, MD 21224 USA.; Panda, AC (corresponding author), Inst Life Sci, Bhubaneswar, Odisha, India.	gorospem@mail.nih.gov; amaresh.panda@ils.res.in	Panda, Amaresh C./H-5459-2019; Gorospe, Myriam/Y-3613-2019; Martindale, Jennifer Luethy/AAD-1963-2022; Abdelmohsen, Kotb/AAX-4191-2020; de Cabo, Rafael Carlos/J-5230-2016	Panda, Amaresh C./0000-0003-3189-8995; Martindale, Jennifer Luethy/0000-0002-3234-6861; Abdelmohsen, Kotb/0000-0001-6240-5810; de Cabo, Rafael Carlos/0000-0003-2830-5693	National Institute on Aging Intramural Research Program, National Institutes of Health; Science & Engineering Research Board, Department of Science & Technology (DST), Government of India; NATIONAL INSTITUTE ON AGING [ZIAAG000363, ZICAG000616, ZIAAG000394] Funding Source: NIH RePORTER	National Institute on Aging Intramural Research Program, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Science & Engineering Research Board, Department of Science & Technology (DST), Government of India; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by the National Institute on Aging Intramural Research Program, National Institutes of Health. ACP was further supported by the Science & Engineering Research Board, Department of Science & Technology (DST), Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altuvia Y, 2005, NUCLEIC ACIDS RES, V33, P2697, DOI 10.1093/nar/gki567; Bandres E, 2009, CLIN CANCER RES, V15, P2281, DOI 10.1158/1078-0432.CCR-08-1818; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Carvajal JJ, 2010, EXP CELL RES, V316, P3014, DOI 10.1016/j.yexcr.2010.07.005; Chaillou T, 2016, FASEB J, V30, P3929, DOI 10.1096/fj.201600757R; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Cheloufi S, 2010, NATURE, V465, P584, DOI 10.1038/nature09092; Cho WJ, 2000, BIOCHEM BIOPH RES CO, V271, P630, DOI 10.1006/bbrc.2000.2682; Davidsen PK, 2011, J APPL PHYSIOL, V110, P309, DOI 10.1152/japplphysiol.00901.2010; Dmitriev P, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-265; Dumont NA, 2017, METHODS MOL BIOL, V1560, P179, DOI 10.1007/978-1-4939-6788-9_12; Fu YF, 2009, BLOOD, V113, P1340, DOI 10.1182/blood-2008-08-174854; Gal H, 2008, BIOCHEM BIOPH RES CO, V376, P86, DOI 10.1016/j.bbrc.2008.08.107; Guweidhi A, 2005, ANN SURG, V242, P224, DOI 10.1097/01.sla.0000171866.45848.68; Helwak A, 2013, CELL, V153, P654, DOI 10.1016/j.cell.2013.03.043; Johnson AN, 2013, DEVELOPMENT, V140, P3645, DOI 10.1242/dev.095596; Kim M, 2015, BRIT J HAEMATOL, V168, P583, DOI 10.1111/bjh.13164; Lee KP, 2015, GENE DEV, V29, P1605, DOI 10.1101/gad.263574.115; Li JH, 2014, NUCLEIC ACIDS RES, V42, pD92, DOI 10.1093/nar/gkt1248; Liu ZR, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/207684; MALEY MAL, 1995, EXP CELL RES, V219, P169, DOI 10.1006/excr.1995.1217; Mercken EM, 2013, AGING-US, V5, P692, DOI 10.18632/aging.100598; Nakamura K, 2013, MUSCLE NERVE, V48, P791, DOI 10.1002/mus.23822; Nakamura K, 2012, AGING-US, V4, P40; Pan X, 2013, MOL CANCER THER, V12, P1153, DOI 10.1158/1535-7163.MCT-12-0802; Panda AC, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkx297; Panda AC, 2017, BIO-PROTOCOL, V7, DOI 10.21769/BioProtoc.2126; Panda AC, 2016, NUCLEIC ACIDS RES, V44, P2393, DOI 10.1093/nar/gkw023; Panda AC, 2014, MOL CELL BIOL, V34, P3106, DOI 10.1128/MCB.00423-14; Pase L, 2009, BLOOD, V113, P1794, DOI 10.1182/blood-2008-05-155812; SAGE H, 1989, J CELL BIOL, V109, P341, DOI 10.1083/jcb.109.1.341; Thorsteinsdottir S, 2011, DEV BIOL, V354, P191, DOI 10.1016/j.ydbio.2011.03.015; Ullah S, 2014, MOL BIOL REP, V41, P225, DOI 10.1007/s11033-013-2855-1; Yang JS, 2010, P NATL ACAD SCI USA, V107, P15163, DOI 10.1073/pnas.1006432107	34	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2019	14	3							e0214301	10.1371/journal.pone.0214301	http://dx.doi.org/10.1371/journal.pone.0214301			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ9FO	30925184	Green Submitted, Green Published, gold			2022-12-26	WOS:000462732300012
J	Szczepankiewicz, F; Sjolund, J; Stahlberg, F; Latt, J; Nilsson, M				Szczepankiewicz, Filip; Sjolund, Jens; Stahlberg, Freddy; Latt, Jimmy; Nilsson, Markus			Tensor-valued diffusion encoding for diffusional variance decomposition (DIVIDE): Technical feasibility in clinical MRI systems	PLOS ONE			English	Article							PULSED-FIELD-GRADIENT; BRAIN WHITE-MATTER; IN-VIVO; RESTRICTED DIFFUSION; WATER DIFFUSION; ECHO-PLANAR; ANISOTROPY; TIME; MODEL; QUANTIFICATION	Microstructure imaging techniques based on tensor-valued diffusion encoding have gained popularity within the MRI research community. Unlike conventional diffusion encoding-applied along a single direction in each shot-tensor-valued encoding employs diffusion encoding along multiple directions within a single preparation of the signal. The benefit is that such encoding may probe tissue features that are not accessible by conventional encoding. For example, diffusional variance decomposition (DIVIDE) takes advantage of tensor-valued encoding to probe microscopic diffusion anisotropy independent of orientation coherence. The drawback is that tensor-valued encoding generally requires gradient waveforms that are more demanding on hardware; it has therefore been used primarily in MRI systems with relatively high performance. The purpose of this work was to explore tensorvalued diffusion encoding on clinical MRI systems with varying performance to test its technical feasibility within the context of DIVIDE. We performed whole-brain imaging with linear and spherical b-tensor encoding at field strengths between 1.5 and 7 T, and at maximal gradient amplitudes between 45 and 80 mT/m. Asymmetric gradient waveforms were optimized numerically to yield b-values up to 2 ms/mu m(2). Technical feasibility was assessed in terms of the repeatability, SNR, and quality of DIVIDE parameter maps. Variable system performance resulted in echo times between 83 to 115 ms and total acquisition times of 6 to 9 minutes when using 80 signal samples and resolution 2x2x4 mm(3). As expected, the repeatability, signal-to-noise ratio and parameter map quality depended on hardware performance. We conclude that tensor-valued encoding is feasible for a wide range of MRI systems-even at 1.5 T with maximal gradient waveform amplitudes of 33 mT/m-and baseline experimental design and quality parameters for all included configurations. This demonstrates that tissue features, beyond those accessible by conventional diffusion encoding, can be explored on a wide range of MRI systems.	[Szczepankiewicz, Filip; Stahlberg, Freddy] Lund Univ, Dept Clin Sci Lund, Med Radiat Phys, Lund, Sweden; [Sjolund, Jens] Elekta Instrument AB, Kungstensgatan 18, Stockholm, Sweden; [Sjolund, Jens] Linkoping Univ, Dept Biomed Engn, Linkoping, Sweden; [Sjolund, Jens] Linkoping Univ, Ctr Med Image Sci & Visualizat CMIV, Linkoping, Sweden; [Stahlberg, Freddy; Nilsson, Markus] Lund Univ, Dept Clin Sci Lund, Diagnost Radiol, Lund, Sweden; [Latt, Jimmy] Skane Univ Hosp, Dept Imaging & Funct, Lund, Sweden; [Nilsson, Markus] Lund Univ, Bioimaging Ctr, Lund, Sweden	Lund University; Elekta; Linkoping University; Linkoping University; Lund University; Lund University; Skane University Hospital; Lund University	Szczepankiewicz, F (corresponding author), Lund Univ, Dept Clin Sci Lund, Med Radiat Phys, Lund, Sweden.	filip.szczepankiewicz@med.lu.se	Szczepankiewicz, Filip/AAV-9958-2021; Nilsson, Markus/C-6920-2012	Szczepankiewicz, Filip/0000-0002-5251-587X; Sjolund, Jens/0000-0002-9099-3522; Nilsson, Markus/0000-0002-3140-8223	Swedish Research Council [2016-03443]; Swedish Foundation for Strategic Research [AM13-0090]; Random Walk Imaging AB [MN15]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Random Walk Imaging AB	This work was supported by: MN: Swedish Research Council. Grant no. 2016-03443, https://www.vr.se/; MN: Swedish Foundation for Strategic Research. Grant no. AM13-0090, https://strategiska.se/en/; and MN: Random Walk Imaging AB. Grant no MN15, www.rwi.se.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliotta E, 2018, MAGN RESON MED, V79, P663, DOI 10.1002/mrm.26709; Andersson P, 1997, J ENG DESIGN, V8, P277, DOI 10.1080/09544829708907966; Assaf Y, 2000, MAGNET RESON MED, V44, P713, DOI 10.1002/1522-2594(200011)44:5<713::AID-MRM9>3.0.CO;2-6; Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Avram AV, 2013, NEUROIMAGE, V64, P229, DOI 10.1016/j.neuroimage.2012.08.048; Baron CA, 2012, MAGN RESON MED, V68, P1190, DOI 10.1002/mrm.24120; Bartlett JW, 2008, ULTRASOUND OBST GYN, V31, P466, DOI 10.1002/uog.5256; Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Bernstein MA, 1998, MAGN RESON MED, V39, P300, DOI 10.1002/mrm.1910390218; Butts K, 1997, MAGNET RESON MED, V38, P741, DOI 10.1002/mrm.1910380510; Choi S, 2011, MAGN RESON IMAGING, V29, P739, DOI 10.1016/j.mri.2011.02.009; Clark CA, 2001, MAGNET RESON MED, V45, P1126, DOI 10.1002/mrm.1149; CORY DG, 1990, ABSTR PAP AM CHEM S, V199, P105; Cox EF, 2010, MAGN RESON MED, V64, P1441, DOI 10.1002/mrm.22522; Dietrich O, 2008, MAGN RESON IMAGING, V26, P754, DOI 10.1016/j.mri.2008.02.001; Does MD, 2003, MAGN RESON MED, V49, P206, DOI 10.1002/mrm.10385; Eriksson S, 2013, J MAGN RESON, V226, P13, DOI 10.1016/j.jmr.2012.10.015; Fieremans E, 2016, NEUROIMAGE, V129, P414, DOI 10.1016/j.neuroimage.2016.01.018; Gelman N, 1999, RADIOLOGY, V210, P759, DOI 10.1148/radiology.210.3.r99fe41759; Grussu F, 2019, MAGN RESON MED, V81, P1247, DOI 10.1002/mrm.27463; GUDBJARTSSON H, 1995, MAGNET RESON MED, V34, P910, DOI 10.1002/mrm.1910340618; Ham CLG, 1997, JMRI-J MAGN RESON IM, V7, P933, DOI 10.1002/jmri.1880070524; Hebrank FX, 2000, P INT SOC MAG RES ME; Henriques RN, 2019, MAGN RESON MED, V81, P3245, DOI 10.1002/mrm.27606; Hutter J, 2018, HIGHLY EFFICIENT DIF; Ianus A, 2018, MAGN RESON MED, V79, P2198, DOI 10.1002/mrm.26894; Ianus A, 2016, NMR BIOMED, V29, P672, DOI 10.1002/nbm.3496; Jensen JH, 2014, NMR BIOMED, V27, P363, DOI [10.1002/nbm.3030, 10.1002/nbm.3094]; Jensen JH, 2010, NMR BIOMED, V23, P698, DOI 10.1002/nbm.1518; Jensen JH, 2005, MAGNET RESON MED, V53, P1432, DOI 10.1002/mrm.20508; Jespersen SN, 2019, J MAGN RESON, V300, P84, DOI 10.1016/j.jmr.2019.01.007; Jespersen SN, 2013, NMR BIOMED, V26, P1647, DOI 10.1002/nbm.2999; Jespersen SN, 2012, NMR BIOMED, V25, P813, DOI 10.1002/nbm.1808; Jeurissen B, 2018, P INT SOC MAG RESON, V26; Jones DK, 2004, MAGN RESON MED, V52, P979, DOI 10.1002/mrm.20283; Klein S, 2010, IEEE T MED IMAGING, V29, P196, DOI 10.1109/TMI.2009.2035616; Lampinen B, 2018, P INT SOC MAG RESON, V26; Lampinen B, 2017, NEUROIMAGE, V147, P517, DOI 10.1016/j.neuroimage.2016.11.053; Lasic S, 2014, FRONT PHYS-LAUSANNE, V2, DOI 10.3389/fphy.2014.00011; Latt J, 2009, NMR BIOMED, V22, P619, DOI 10.1002/nbm.1376; Lawrenz M, 2015, NEUROIMAGE, V109, P283, DOI 10.1016/j.neuroimage.2015.01.025; Lawrenz M, 2013, MAGN RESON MED, V69, P1072, DOI 10.1002/mrm.24347; Lawrenz M, 2010, J MAGN RESON, V202, P43, DOI 10.1016/j.jmr.2009.09.015; Lundell H., 2017, P INT SOC MAG RESON, V25; Lundell H, 2018, P INT SOC MAG RESON, V26; MITRA PP, 1995, PHYS REV B, V51, P15074, DOI 10.1103/PhysRevB.51.15074; MORI S, 1995, MAGNET RESON MED, V33, P41, DOI 10.1002/mrm.1910330107; Moser E, 2012, NMR BIOMED, V25, P695, DOI 10.1002/nbm.1794; Nery F, 2018, P INT SOC MAG RESON, V26; Nilsson M, 2018, P INT SOC MAG RESON, V26; Nilsson M, 2017, P INT SOC MAG RESON, V25; Nilsson M, 2018, NEUROIMAGE, V182, P232, DOI 10.1016/j.neuroimage.2018.04.075; Nilsson M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141825; Nilsson M, 2009, MAGN RESON IMAGING, V27, P176, DOI 10.1016/j.mri.2008.06.003; Ning LP, 2017, MAGN RESON MED, V78, P763, DOI 10.1002/mrm.26403; Novikov DS, 2018, MAGN RESON MED, V79, P3172, DOI 10.1002/mrm.27101; Ozarslan E, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2905765; Oouchi H, 2007, AM J NEURORADIOL, V28, P1102, DOI 10.3174/ajnr.A0488; Polders DL, 2011, J MAGN RESON IMAGING, V33, P1456, DOI 10.1002/jmri.22554; Qin W, 2009, MAGN RESON MED, V61, P755, DOI 10.1002/mrm.21920; Qiuyun F, 2017, P INT SOC MAG RESON, V25; Raab P, 2010, RADIOLOGY, V254, P876, DOI 10.1148/radiol.09090819; Roding M, 2012, J MAGN RESON, V222, P105, DOI 10.1016/j.jmr.2012.07.005; Ronen I, 2006, MAGN RESON IMAGING, V24, P61, DOI 10.1016/j.mri.2005.10.023; Setsompop K, 2012, NEUROIMAGE, V63, P569, DOI 10.1016/j.neuroimage.2012.06.033; Shemesh N, 2010, NMR BIOMED, V23, P757, DOI 10.1002/nbm.1550; Shemesh N, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3454131; Siemonsen S, 2008, AM J NEURORADIOL, V29, P950, DOI 10.3174/ajnr.A0951; Sigmund EE, 2011, MAGN RESON IMAGING, V29, P752, DOI 10.1016/j.mri.2011.02.016; Sjolund J, 2018, NEUROIMAGE, V175, P272, DOI 10.1016/j.neuroimage.2018.03.059; Sjolund J, 2015, J MAGN RESON, V261, P157, DOI 10.1016/j.jmr.2015.10.012; Stanisz GJ, 1997, MAGNET RESON MED, V37, P103, DOI 10.1002/mrm.1910370115; STEJSKAL EO, 1965, J CHEM PHYS, V43, P3597, DOI 10.1063/1.1696526; Szczepankiewicz F, 2018, P INT SOC MAG RESON, V26; Szczepankiewicz F, 2016, ARXIV161206741; Szczepankiewicz F, 2016, NEUROIMAGE, V142, P522, DOI 10.1016/j.neuroimage.2016.07.038; Szczepankiewicz F, 2015, NEUROIMAGE, V104, P241, DOI 10.1016/j.neuroimage.2014.09.057; Szczepankiewicz F, 2013, NEUROIMAGE, V76, P145, DOI 10.1016/j.neuroimage.2013.02.078; Szezepankiewicz F, 2016, P INT SOC MAG RESON, V24; Tax CM, 2017, P INT SOC MAG RESON, V25; Topgaard D., 2016, DIFFUSION NMR CONFIN; Topgaard D, 2017, J MAGN RESON, V275, P98, DOI 10.1016/j.jmr.2016.12.007; Van Cauter S, 2012, RADIOLOGY, V263, P492, DOI 10.1148/radiol.12110927; Veraart J, 2017, P INT SOC MAG RESON, V25; Vos SB, 2017, MAGN RESON MED, V77, P285, DOI 10.1002/mrm.26124; Westin CF, 2016, NEUROIMAGE, V135, P345, DOI 10.1016/j.neuroimage.2016.02.039; Winther Andersen K, 2018, P INT SOC MAG RESON, V26; WONG EC, 1995, MAGNET RESON MED, V34, P139, DOI 10.1002/mrm.1910340202; Yablonskiy DA, 2010, NMR BIOMED, V23, P661, DOI 10.1002/nbm.1520; Yang G, 2019, MAGN RESON MED, V81, P1818, DOI 10.1002/mrm.27539; Yang G, 2018, MAGN RESON MED, V80, P507, DOI 10.1002/mrm.27043	92	49	50	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214238	10.1371/journal.pone.0214238	http://dx.doi.org/10.1371/journal.pone.0214238			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921381	Green Published, Green Submitted, gold			2022-12-26	WOS:000462594000045
J	Bernstein, DI; Cardin, RD; Pullum, DA; Bravo, FJ; Kousoulas, KG; Dixon, DA				Bernstein, David I.; Cardin, Rhonda D.; Pullum, Derek A.; Bravo, Fernando J.; Kousoulas, Konstantin G.; Dixon, David A.			Duration of protection from live attenuated vs. sub unit HSV-2 vaccines in the guinea pig model of genital herpes: Reassessing efficacy using endpoints from clinical trials	PLOS ONE			English	Article							SIMPLEX-VIRUS TYPE-1; GLYCOPROTEIN K GK; AMINO-TERMINUS; INFECTION; VACCINATION; EXPRESSION; RESPONSES; PROTEIN	Background Although herpes simplex viruses (HSV) are a major target for vaccine development no vaccine is currently licensed. Methods A live attenuated HSV virus vaccine, VC2 was compared to a subunit HSV vaccine, glycoprotein D (gD2) administered with the adjuvant, MPL/Alum using the guinea pig model of genital herpes. Three doses of intramuscular (IM) vaccine were provided followed by intravaginal challenge with HSV-2 at either 3 weeks or six months after the last vaccination. Results Both VC2 and gD2 vaccines reduced acute genital disease. VC2 was somewhat more effective in reducing acute vaginal replication, the amount of virus in neural tissue, subsequent recurrent disease and recurrent virus shedding following challenge at 3 weeks post vaccination. Both vaccines continued to provide protection at 6 months after vaccination but the differences between the vaccines became more pronounced in favor of the live attenuated vaccine, VC2. Significant differences in acute disease, acute vaginal virus replication, recurrent disease and recurrent virus shedding (P<0.05 for each) was observed comparing the vaccines. Re-examination of protection for this study using criteria similar to those used in recent clinical trials (inclusion of recurrent disease) showed that efficacy may not be as high in this model as previously thought prompting a need to assess the best predictive outcomes for protection in humans. Conclusion While both the live attenuated vaccine, VC2, and the gD2 subunit vaccine provided protection, the duration of protection appeared to be greater for VC2. Using the same evaluation criteria as used in human trials provided unique insights into the utility of the guinea pig model.	[Bernstein, David I.; Pullum, Derek A.; Bravo, Fernando J.; Dixon, David A.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH 45221 USA; [Bernstein, David I.; Pullum, Derek A.; Bravo, Fernando J.; Dixon, David A.] Cincinnati Childrens Hosp Med Ctr, Div Infect Dis, Cincinnati, OH 45229 USA; [Cardin, Rhonda D.; Kousoulas, Konstantin G.] Louisiana State Univ, Sch Vet Med, Baton Rouge, LA 70803 USA	University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Louisiana State University School of Veterinary Medicine; Louisiana State University System; Louisiana State University	Bernstein, DI (corresponding author), Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH 45221 USA.; Bernstein, DI (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Infect Dis, Cincinnati, OH 45229 USA.	david.bernstein@cchmc.org		KOUSOULAS, KONSTANTIN/0000-0001-7077-9003	National Institute of Allergy and Infectious Diseases [HHSN272201000008I]	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institute of Allergy and Infectious Diseases Contract No. HHSN272201000008I to CCHMC. Kousoulas has intellectual property rights to the VC2 vaccine and is a founder of IOSBiomedical Group, INC, which owns these rights and intends to commercialize the vaccine. No other authors have a financial interest or other conflicts.	Awasthi S, 2015, J VIROL, V89, P8497, DOI 10.1128/JVI.01089-15; Awasthi S, 2014, CURR OPIN VIROL, V6, P6, DOI 10.1016/j.coviro.2014.02.006; Belshe RB, 2012, NEW ENGL J MED, V366, P34, DOI 10.1056/NEJMoa1103151; Bernstein David I., 2015, Antiviral Chemistry & Chemotherapy, V24, P19, DOI 10.1177/2040206614566581; Bernstein David I, 2014, Antivir Chem Chemother, V23, P189, DOI 10.3851/IMP2499; Bernstein DI, 2013, CLIN INFECT DIS, V56, P344, DOI 10.1093/cid/cis891; Bernstein DI, 2011, VACCINE, V29, P2071, DOI 10.1016/j.vaccine.2011.01.005; Bernstein DI, 2010, VACCINE, V28, P3748, DOI 10.1016/j.vaccine.2009.10.025; BERNSTEIN DI, 1990, J CLIN MICROBIOL, V28, P11, DOI 10.1128/JCM.28.1.11-15.1990; BERNSTEIN DI, 1993, J INFECT DIS, V167, P731, DOI 10.1093/infdis/167.3.731; Bernstein DI, EVALUATION VC2 LIVE; Bourne N, 2003, J INFECT DIS, V187, P542, DOI 10.1086/374002; Chouljenko VN, 2010, J VIROL, V84, P8596, DOI 10.1128/JVI.00298-10; Chouljenko VN, 2009, J VIROL, V83, P12301, DOI 10.1128/JVI.01329-09; David AT, 2008, CURR EYE RES, V33, P455, DOI 10.1080/02713680802130362; David AT, 2012, MBIO, V3, DOI 10.1128/mBio.00144-12; Diaz F, 2018, VIROLOGY, V513, P129, DOI 10.1016/j.virol.2017.10.011; Dropulic LK, 2012, EXPERT REV VACCINES, V11, P1429, DOI [10.1586/ERV.12.129, 10.1586/erv.12.129]; Harris SA, 2015, J ALZHEIMERS DIS, V48, P319, DOI 10.3233/JAD-142853; Hoshino Y, 2005, J VIROL, V79, P410, DOI 10.1128/JVI.79.1.410-418.2005; Hoshino Y, 2009, J INFECT DIS, V200, P1088, DOI 10.1086/605645; Itzhaki RF, 2018, J ALZHEIMERS DIS, V64, P363, DOI 10.3233/JAD-180266; Johnston C, 2016, VACCINE, V34, P2948, DOI 10.1016/j.vaccine.2015.12.076; Kim IJ, 2013, J VIROL, V87, P8029, DOI 10.1128/JVI.01181-13; Lee HC, 2009, J VIROL, V83, P6115, DOI 10.1128/JVI.00128-09; McNicholl JM, 2017, INT J STD AIDS, V28, P372, DOI 10.1177/0956462416650123; Musarrat F, 2018, J VIROL, V92, DOI 10.1128/JVI.01842-17; Phipps W, 2016, J INFECT DIS, V213, P439, DOI 10.1093/infdis/jiv451; Roberts CM, 2003, SEX TRANSM DIS, V30, P797, DOI 10.1097/01.OLQ.0000092387.58746.C7; Saied AA, 2014, CURR EYE RES, V39, P596, DOI 10.3109/02713683.2013.855238; SISK WP, 1994, J VIROL, V68, P766, DOI 10.1128/JVI.68.2.766-775.1994; STANBERRY LR, 1987, J INFECT DIS, V155, P914, DOI 10.1093/infdis/155.5.914; Stanfield BA, 2017, VACCINE, V35, P536, DOI 10.1016/j.vaccine.2016.12.018; Stanfield BA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109890; Tanaka M, 2003, J VIROL, V77, P1382, DOI 10.1128/JVI.77.2.1382-1391.2003	35	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2019	14	3							e0213401	10.1371/journal.pone.0213401	http://dx.doi.org/10.1371/journal.pone.0213401			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ5PT	30917165	Green Submitted, gold, Green Published			2022-12-26	WOS:000462465800031
J	Folt, B; Bauder, J; Spear, S; Stevenson, D; Hoffman, M; Oaks, JR; Wood, PL; Jenkins, C; Steen, DA; Guyer, C				Folt, Brian; Bauder, Javan; Spear, Stephen; Stevenson, Dirk; Hoffman, Michelle; Oaks, Jamie R.; Wood, Perry L., Jr.; Jenkins, Christopher; Steen, David A.; Guyer, Craig			Taxonomic and conservation implications of population genetic admixture, mito-nuclear discordance, and male-biased dispersal of a large endangered snake, Drymarchon couperi	PLOS ONE			English	Article							EASTERN INDIGO SNAKE; SPECIES-DELIMITATION; MOLECULAR SYSTEMATICS; MARK-RECAPTURE; UNITED-STATES; HOME RANGES; BODY-SIZE; SEX; PHYLOGEOGRAPHY; PATTERNS	Accurate species delimitation and description are necessary to guide effective conservation of imperiled species, and this synergy is maximized when multiple data sources are used to delimit species. We illustrate this point by examining Drymarchon couperi (Eastern Indigo Snake), a large, federally-protected species in North America that was recently divided into two species based on gene sequence data from three loci and heuristic morphological assessment. Here, we re-evaluate the two-species hypothesis for D. couperi by evaluating both population genetic and gene sequence data. Our analyses of 14 microsatellite markers revealed 6-8 genetic population clusters with significant admixture, particularly across the contact zone between the two hypothesized species. Phylogenetic analyses of gene sequence data with maximum-likelihood methods suggested discordance between mitochondrial and nuclear markers and provided phylogenetic support for one species rather than two. For these reasons, we place Drymarchon kolpobasileus into synonymy with D. couperi. We suggest inconsistent patterns between mitochondrial and nuclear DNA are driven by high dispersal of males relative to females. We advocate for species delimitation exercises that evaluate admixture and gene flow in addition to phylogenetic analyses, particularly when the latter reveal monophyletic lineages. This is particularly important for taxa, such as squamates, that exhibit strong sex-biased dispersal. Problems associated with over-delimitation of species richness can become particularly acute for threatened and endangered species, because of high costs to conservation when taxonomy demands protection of more individual species than are supported by accumulating data.	[Folt, Brian; Oaks, Jamie R.; Wood, Perry L., Jr.; Guyer, Craig] Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA; [Folt, Brian; Oaks, Jamie R.; Wood, Perry L., Jr.; Guyer, Craig] Auburn Univ, Museum Nat Hist, Auburn, AL 36849 USA; [Bauder, Javan; Spear, Stephen; Stevenson, Dirk; Jenkins, Christopher] Orianne Soc, 11 Fruitstand Lane, Tiger, GA USA; [Bauder, Javan] Univ Massachusetts, Dept Environm Conservat, Amherst, MA 01003 USA; [Bauder, Javan] Univ Illinois, Illinois Nat Hist Survey, Champaign, IL 61820 USA; [Spear, Stephen] The Wilds, Cumberland, OH USA; [Stevenson, Dirk] Altamaha Environm Consulting, Hinesville, GA USA; [Hoffman, Michelle] Cent Florida Zoo & Bot Gardens, Orianne Ctr Indigo Conservat, Sanford, FL USA; [Steen, David A.] Jekyll Isl Author, Georgia Sea Turtle Ctr, Jekyll Isl, GA USA	Auburn University System; Auburn University; Auburn University System; Auburn University; University of Massachusetts System; University of Massachusetts Amherst; Illinois Natural History Survey; University of Illinois System; University of Illinois Urbana-Champaign	Folt, B (corresponding author), Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA.; Folt, B (corresponding author), Auburn Univ, Museum Nat Hist, Auburn, AL 36849 USA.	brian.folt@gmail.com	Wood, Perry/ABA-3954-2020	Wood, Perry/0000-0003-3767-5274; Oaks, Jamie/0000-0002-3757-3836	Alabama Department of Conservation and Natural Resources; Auburn University College of Science and Mathematics; Orianne Society; U.S. Fish and Wildlife Service	Alabama Department of Conservation and Natural Resources; Auburn University College of Science and Mathematics; Orianne Society; U.S. Fish and Wildlife Service(US Fish & Wildlife Service)	We thank the Alabama Department of Conservation and Natural Resources, Auburn University College of Science and Mathematics, Orianne Society, and U.S. Fish and Wildlife Service for funding that made this study possible. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Alabama Department of Conservation and Natural Resources, Auburn University College of Science and Mathematics, Orianne Society, and U.S. Fish and Wildlife Service for funding that made this study possible. We thank the Orianne Center for Indigo Conservation for allowing us access to the captive breeding collection of D. couperi, and we thank the Florida Museum of Natural History, M. Aldecoa, P. Barnhart, D. Ceilley, Z. Forsburg, G. Graziani, C. Lechowicz, J. Macey, S. Mortellaro, L. Paden, D. Parker, K. Ravenscroft, M. Ravenscroft, B. Rothermel, A. Safer, J. Sage, F. Snow, K. Stohlgren, M. Wallace, Sr., and J. Wasilewski for providing samples. Our manuscript benefitted greatly from comments made by five peer reviewers. This paper is contribution no. 886 of the Auburn University Museum of Natural History.	Agapow PM, 2004, Q REV BIOL, V79, P161, DOI 10.1086/383542; AVISE JC, 1989, TRENDS ECOL EVOL, V4, P279, DOI 10.1016/0169-5347(89)90203-6; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Bauder JM, 2016, HERPETOLOGICA, V72, P214, DOI 10.1655/Herpetologica-D-15-00039.1; Bauder JM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160033; Bauder Javan M., 2014, Herpetological Review, V45, P590; Bauder JM, 2018, LANDSCAPE ECOL, DOI [10.1007/s10980-017-0605-9, DOI 10.1007/S10980-017-0605-9]; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Bouckaert RR, 2017, BMC EVOL BIOL, V17, DOI 10.1186/s12862-017-0890-6; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; Bowen BW, 2005, MOL ECOL, V14, P2389, DOI 10.1111/j.1365-294X.2005.02598.x; Breininger DR, 2004, ECOSYSTEMS; Breinnger DR, 2011, J HERPETOL, V45, P484; Burbrink FT, 2015, ZOOL J LINN SOC-LOND, V173, P505, DOI 10.1111/zoj.12211; Calsbeek R, 2009, J ANIM ECOL, V78, P617, DOI 10.1111/j.1365-2656.2009.01527.x; Carstens BC, 2013, MOL ECOL, V22, P4369, DOI 10.1111/mec.12413; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Chernomor O, 2016, SYST BIOL, V65, P997, DOI 10.1093/sysbio/syw037; DAUGHERTY CH, 1990, NATURE, V347, P177, DOI 10.1038/347177a0; Dayrat B, 2005, BIOL J LINN SOC, V85, P407, DOI 10.1111/j.1095-8312.2005.00503.x; de Fraga R, 2017, J HERED, V108, P524, DOI 10.1093/jhered/esx051; de Queiroz K, 2005, P NATL ACAD SCI USA, V102, P6600, DOI 10.1073/pnas.0502030102; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; Hoang DT, 2018, MOL BIOL EVOL, V35, P518, DOI 10.1093/molbev/msx281; Doan TM, 2016, ZOOTAXA, V4138, P271, DOI 10.11646/zootaxa.4138.2.3; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Dubey S, 2008, MOL ECOL, V17, P3506, DOI 10.1111/j.1365-294X.2008.03859.x; Dupuis JR, 2012, MOL ECOL, V21, P4422, DOI 10.1111/j.1365-294X.2012.05642.x; Echelle AA, 2010, CONSERV GENET, V11, P1375, DOI 10.1007/s10592-009-9966-1; Enge KM, 2013, HERPETOL CONSERV BIO, V8, P288; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Folt B, 2016, MOL PHYLOGENET EVOL, V98, P97, DOI 10.1016/j.ympev.2016.01.016; Folt B, 2015, ZOOTAXA, V3947, P447, DOI 10.11646/zootaxa.3947.3.11; Forrest MJ, 2017, WEST N AM NATURALIST, V77, P162, DOI 10.3398/064.077.0204; Frankham R, 2012, BIOL CONSERV, V153, P25, DOI 10.1016/j.biocon.2012.04.034; Frankham R, 2011, CONSERV BIOL, V25, P465, DOI 10.1111/j.1523-1739.2011.01662.x; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Funk DJ, 1999, MOL BIOL EVOL, V16, P67, DOI 10.1093/oxfordjournals.molbev.a026039; Gamble T, 2008, MOL PHYLOGENET EVOL, V48, P112, DOI 10.1016/j.ympev.2008.03.015; Ghiselin M, 1987, METAPHYSICS ORIGIN S; Gordon MR, 2017, ZOOTAXA, V4290, P123, DOI 10.11646/zootaxa.4290.1.7; Grismer JL, 2014, BIOL J LINN SOC, V113, P1080, DOI 10.1111/bij.12367; Grismer LL, 2018, ZOOL J LINN SOC-LOND, V182, P862; Guillot G, 2005, MOL ECOL NOTES, V5, P712, DOI 10.1111/j.1471-8286.2005.01031.x; Hillis DM, 2019, J HERPETOL, V53, P3, DOI 10.1670/18-123; Hyslop NL, 2014, J WILDLIFE MANAGE, V78, P101, DOI 10.1002/jwmg.645; Hyslop NL, 2012, POPUL ECOL, V54, P145, DOI 10.1007/s10144-011-0292-3; Hyslop NL, 2009, COPEIA, P458, DOI 10.1643/CH-07-171; Irwin DE, 2002, EVOLUTION, V56, P2383; JACKSON C G JR, 1971, Journal of Herpetology, V5, P188, DOI 10.2307/1562744; Janes JK, 2017, MOL ECOL, V26, P3594, DOI 10.1111/mec.14187; Johansson H, 2008, MOL ECOL, V17, P4425, DOI 10.1111/j.1365-294X.2008.03923.x; Johnson PCD, 2014, METHODS ECOL EVOL, V5, P944, DOI 10.1111/2041-210X.12225; Jombart T, 2008, HEREDITY, V101, P92, DOI 10.1038/hdy.2008.34; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jones KS, 2018, EVOLUTION, V72, P2378, DOI 10.1111/evo.13606; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Keogh JS, 2007, BIOL LETTERS, V3, P33, DOI 10.1098/rsbl.2006.0570; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Krysko KL, 2017, J HERED, V108, P226, DOI 10.1093/jhered/esw086; Krysko KL, 2016, ZOOTAXA, V4138, P549, DOI 10.11646/zootaxa.4138.3.9; Krysko KL, 2016, MOL PHYLOGENET EVOL, V98, P111, DOI 10.1016/j.ympev.2015.12.022; Leache AD, 2017, ANNU REV ECOL EVOL S, V48, P69, DOI 10.1146/annurev-ecolsys-110316-022645; Leturque H, 2004, EVOLUTION, V58, P2398; Li YL, 2018, MOL ECOL RESOUR, V18, P176, DOI 10.1111/1755-0998.12719; MACARTNEY JM, 1988, J HERPETOL, V22, P61, DOI 10.2307/1564357; Mace GM, 2004, PHILOS T R SOC B, V359, P711, DOI 10.1098/rstb.2003.1454; McKelvy AD, 2017, MOL PHYLOGENET EVOL, V106, P61, DOI 10.1016/j.ympev.2016.09.006; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Newman CE, 2016, MOL ECOL, V25, P6162, DOI 10.1111/mec.13909; Nguyen Lam-Tung, 2015, Mol Biol Evol, V32, P268, DOI 10.1093/molbev/msu300; Noss R.F., 2013, FORGOTTEN GRASSLANDS; Noss RF, 2015, DIVERS DISTRIB, V21, P236, DOI 10.1111/ddi.12278; O'Bryan Christopher J., 2017, Herpetology Notes, V10, P317; Pauly GB, 2007, MOL ECOL, V16, P415, DOI 10.1111/j.1365-294X.2006.03149.x; Perry G, 2002, ECOLOGY, V83, P1870, DOI 10.2307/3071771; Peterman WE, 2018, METHODS ECOL EVOL, V9, P1638, DOI 10.1111/2041-210X.12984; Peters JL, 2012, MOL ECOL, V21, P3562, DOI 10.1111/j.1365-294X.2012.05612.x; Pritchard JK, 2000, GENETICS, V155, P945; Puechmaille SJ, 2016, MOL ECOL RESOUR, V16, P608, DOI 10.1111/1755-0998.12512; Pyron RA, 2016, ZOOL J LINN SOC-LOND, V177, P937, DOI 10.1111/zoj.12392; Roth ED, 2005, COPEIA, P399, DOI 10.1643/CH-04-243R1; Scott PA, 2018, MOL PHYLOGENET EVOL, V120, P1, DOI 10.1016/j.ympev.2017.11.008; Scribner KT, 2001, EVOLUTION, V55, P2105; Shamblin BM, 2011, CONSERV GENET RESOUR, V3, P303, DOI 10.1007/s12686-010-9348-5; Soltis DE, 2006, MOL ECOL, V15, P4261, DOI 10.1111/j.1365-294X.2006.03061.x; Soltis PS, 1999, CONSERV BIOL, V13, P471, DOI 10.1046/j.1523-1739.1999.97286.x; Sovic MG, 2016, HEREDITY, V117, P358, DOI 10.1038/hdy.2016.56; Stevenson DJ, 2009, HERPETOL CONSERV BIO, V4, P30; Stevenson Dirk J., 2010, Herpetological Review, V41, P91; Stevenson DJ, 2003, SOUTHEAST NAT, V2, P393, DOI 10.1656/1528-7092(2003)002[0393:SAMOTE]2.0.CO;2; Stiles JA, 2013, EVALUATING USE ENCLO; Stiles S, 2013, GLOBAL REINTRODUCTIO, P37, DOI [10.1016/S0262-1762(06)71090-2, DOI 10.1016/S0262-1762(06)71090-2]; Strickland JL, 2014, COPEIA, P639, DOI 10.1643/CG-13-123; Thomas TM, 2014, ZOOTAXA, V3786, P141, DOI 10.11646/zootaxa.3786.2.4; Thorpe RS, 2008, PHILOS T R SOC B, V363, P3071, DOI 10.1098/rstb.2008.0077; US Fish and Wildlife Service, 2008, E IND SNAK DRYM COUP; US Fish and Wildlife Service, 1978, FED REGISTER, V43, P4026, DOI [10.1111/j.1365-294X.2006.03149.x, DOI 10.1111/J.1365-294X.2006.03149.X]; US Fish and Wildlife Service, 1982, E IND SNAK REC PLAN; Van Strien MJ, 2012, MOL ECOL, V21, P4010, DOI 10.1111/j.1365-294X.2012.05687.x; Warwick AR, 2015, MOL ECOL, V24, P3281, DOI 10.1111/mec.13242; Will KW, 2005, SYST BIOL, V54, P844, DOI 10.1080/10635150500354878; Winter D., 2012, MOL ECOL RESOUR, P12, DOI [10.1016/j.ympev.2008.03.015, DOI 10.1016/J.YMPEV.2008.03.015]	103	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2019	14	3							e0214439	10.1371/journal.pone.0214439	http://dx.doi.org/10.1371/journal.pone.0214439			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ3IW	30913266	Green Published, Green Submitted, gold			2022-12-26	WOS:000462305600061
J	Uno, Y; Nishida, C; Hata, A; Ishishita, S; Matsuda, Y				Uno, Yoshinobu; Nishida, Chizuko; Hata, Ayano; Ishishita, Satoshi; Matsuda, Yoichi			Molecular cytogenetic characterization of repetitive sequences comprising centromeric heterochromatin in three Anseriformes species	PLOS ONE			English	Article							QUAIL COTURNIX-CHINENSIS; SATELLITE DNA-SEQUENCES; DUCK ANAS-PLATYRHYNCHOS; CHROMOSOMAL DISTRIBUTION; CAIRINA-MOSCHATA; TANDEM REPEATS; CHICKEN; EVOLUTION; GENOME; REVEALS	The highly repetitive DNA sequence of centromeric heterochromatin is an effective molecular cytogenetic marker for investigating genomic compartmentalization between macrochromosomes and microchromosomes in birds. We isolated four repetitive sequence families of centromeric heterochromatin from three Anseriformes species, viz., domestic duck (Anas platyrhynchos, APL), bean goose (Anser fabalis, AFA), and whooper swan (Cygnus Cygnus, CCY), and characterized the sequences by molecular cytogenetic approach. The 190-bp APL-HaeIII and 101-bp AFA-Hinfl-S sequences were localized in almost all chromosomes of A. platyrhynchos and A. fabalis, respectively. However, the 192-bp AFA-Hinfl-L and 290bp CCY-Apal sequences were distributed in almost all microchromosomes of A. fabalis and in approximately 10 microchromosomes of C. cygnus, respectively. APL-HaeIII, AFA-HinflL, and CCY-Apal showed partial sequence homology with the chicken nuclear-membraneassociated (CNM) repeat families, which were localized primarily to the centromeric regions of microchromosomes in Galliformes, suggesting that ancestral sequences of the CNM repeat families are observed in the common ancestors of Anseriformes and Galliformes. These results collectively provide the possibility that homogenization of centromeric heterochromatin occurred between microchromosomes in Anseriformes and Galliformes; however, homogenization between macrochromosomes and microchromosomes also occurred in some centromeric repetitive sequences.	[Uno, Yoshinobu; Hata, Ayano; Matsuda, Yoichi] Nagoya Univ, Grad Sch Bioagr Sci, Dept Anim Sci, Lab Avian Biosci, Nagoya, Aichi, Japan; [Nishida, Chizuko] Hokkaido Univ, Dept Nat Hist Sci, Fac Sci, Sapporo, Hokkaido, Japan; [Ishishita, Satoshi; Matsuda, Yoichi] Nagoya Univ, Grad Sch Bioagr Sci, Avian Biosci Res Ctr, Nagoya, Aichi, Japan; [Uno, Yoshinobu] RIKEN, Ctr Biosyst Dynam Res BDR, Lab Phyloinformat, Kobe, Hyogo, Japan	Nagoya University; Hokkaido University; Nagoya University; RIKEN	Uno, Y; Matsuda, Y (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Dept Anim Sci, Lab Avian Biosci, Nagoya, Aichi, Japan.; Matsuda, Y (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Avian Biosci Res Ctr, Nagoya, Aichi, Japan.; Uno, Y (corresponding author), RIKEN, Ctr Biosyst Dynam Res BDR, Lab Phyloinformat, Kobe, Hyogo, Japan.	yoshinobu.uno@riken.jp; yoimatsu@agr.nagoya-u.ac.jp		Uno, Yoshinobu/0000-0001-9609-1186	Ministry of Education, Culture, Sports, Science and Technology, Japan [22370081]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for Scientific Research (B) (no. 22370081) from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Axelsson E, 2005, GENOME RES, V15, P120, DOI 10.1101/gr.3021305; BELTERMAN RHR, 1984, GENETICA, V65, P39, DOI 10.1007/BF00056765; Berchtold D, 2011, CHROMOSOME RES, V19, P165, DOI 10.1007/s10577-010-9182-3; Burrack LS, 2012, TRENDS GENET, V28, P204, DOI 10.1016/j.tig.2012.02.003; Christidis L., 1990, ANIMAL CYTOGENETICS; Damas J, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1544-8; de Oliveira TD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169987; Denjean B, 1997, REV MED VET-TOULOUSE, V148, P695; Eichler EE, 1999, HUM MOL GENET, V8, P151, DOI 10.1093/hmg/8.2.151; Figuet E, 2015, GENOME BIOL EVOL, V7, P240, DOI 10.1093/gbe/evu277; Griffin DK, 1999, CYTOGENET CELL GENET, V87, P278, DOI 10.1159/000015449; Guttenbach M, 2003, CYTOGENET GENOME RES, V103, P173, DOI 10.1159/000076309; Habermann FA, 2001, CHROMOSOME RES, V9, P569, DOI 10.1023/A:1012447318535; Henikoff S, 2001, SCIENCE, V293, P1098, DOI 10.1126/science.1062939; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Ishishita S, 2014, CHROMOSOME RES, V22, P15, DOI 10.1007/s10577-014-9402-3; Islam FB, 2014, J POULT SCI, V51, P1, DOI 10.2141/jpsa.0130090; Kumar S, 2017, MOL BIOL EVOL, V34, P1812, DOI 10.1093/molbev/msx116; Kuraku S, 2006, CHROMOSOME RES, V14, P187, DOI 10.1007/s10577-006-1035-8; MADSEN CS, 1992, GENOME, V35, P1037, DOI 10.1139/g92-159; Maslova A, 2015, CHROMOSOME RES, V23, P625, DOI 10.1007/s10577-015-9485-5; Matsubara K, 2016, CHROMOSOMA, V125, P111, DOI 10.1007/s00412-015-0531-z; Matsubara K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-604; MATSUDA Y, 1995, ELECTROPHORESIS, V16, P261, DOI 10.1002/elps.1150160142; MATZKE AJM, 1992, CHROMOSOMA, V102, P9, DOI 10.1007/BF00352284; MATZKE MA, 1990, CHROMOSOMA, V99, P131, DOI 10.1007/BF01735329; MCHUGH KP, 1990, GENE, V87, P193, DOI 10.1016/0378-1119(90)90301-7; Nakatani Y, 2007, GENOME RES, V17, P1254, DOI 10.1101/gr.6316407; Nishida C, 2013, CYTOGENET GENOME RES, V141, P284, DOI 10.1159/000352067; Nishida-Umehara C, 2007, CHROMOSOME RES, V15, P721, DOI 10.1007/s10577-007-1157-7; O'Connor RE, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04267-9; OHNO S, 1964, CHROMOSOMA, V15, P280, DOI 10.1007/BF00321513; Plohl M, 2008, GENE, V409, P72, DOI 10.1016/j.gene.2007.11.013; Rodrigues BS, 2014, BIOL J LINN SOC, V111, P274, DOI 10.1111/bij.12202; Romanov MN, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1060; Saifitdinova AF, 2001, GENOME, V44, P96, DOI 10.1139/gen-44-1-96; Schmid M, 2017, CYTOGENET GENOME RES, V151, P216, DOI 10.1159/000464268; Sessions SK, 2008, CHROMOSOME RES, V16, P183, DOI 10.1007/s10577-007-1205-3; Shetty S, 1999, CHROMOSOME RES, V7, P289, DOI 10.1023/A:1009278914829; Shibusawa M, 2004, CYTOGENET GENOME RES, V106, P82, DOI 10.1159/000078569; Shibusawa M, 2004, CYTOGENET GENOME RES, V106, P111, DOI 10.1159/000078570; Signorino G., 2005, CHROMOREP REPTILE CH; SINGER MF, 1982, INT REV CYTOL, V76, P67, DOI 10.1016/S0074-7696(08)61789-1; Skinner BM, 2009, CYTOGENET GENOME RES, V126, P156, DOI 10.1159/000245915; Skinner BM, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-357; SUMNER AT, 1972, EXP CELL RES, V75, P304, DOI 10.1016/0014-4827(72)90558-7; Suzuki T, 1999, CYTOGENET CELL GENET, V87, P32, DOI 10.1159/000015388; TAKAGI N, 1966, CARYOLOGIA, V19, P443, DOI 10.1080/00087114.1966.10796235; TAKAGI N, 1974, CHROMOSOMA, V46, P91, DOI 10.1007/BF00332341; Tanaka K, 2000, J HERED, V91, P412, DOI 10.1093/jhered/91.5.412; Uno Y, 2013, CYTOGENET GENOME RES, V141, P212, DOI 10.1159/000354668; Uno Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053027; Voss SR, 2011, GENOME RES, V21, P1306, DOI 10.1101/gr.116491.110; Wojcik E, 2007, FOLIA BIOL-KRAKOW, V55, P115, DOI 10.3409/173491607781492588; Yamada K, 2005, CHROMOSOME RES, V13, P33, DOI 10.1007/s10577-005-2351-0; Yamada K, 2004, CHROMOSOMA, V112, P277, DOI 10.1007/s00412-003-0267-z; Yamada K, 2002, CYTOGENET GENOME RES, V98, P255, DOI 10.1159/000071044; Yamada K, 2002, CHROMOSOME RES, V10, P513, DOI 10.1023/A:1020996431588; Young MJ, 2013, CHROMOSOME RES, V21, P361, DOI 10.1007/s10577-013-9362-z; Zhang GJ, 2014, SCIENCE, V346, P1311, DOI 10.1126/science.1251385; Zlotina A, 2019, CHROMOSOME RES, V27, P253, DOI 10.1007/s10577-018-9597-9; [No title captured]	62	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2019	14	3							e0214028	10.1371/journal.pone.0214028	http://dx.doi.org/10.1371/journal.pone.0214028			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ3IW	30913221	Green Published, Green Submitted, gold			2022-12-26	WOS:000462305600023
J	Garma, LD; Matino, L; Melle, G; Moia, F; De Angelis, F; Santoro, F; Dipalo, M				Garma, Leonardo D.; Matino, Laura; Melle, Giovanni; Moia, Fabio; De Angelis, Francesco; Santoro, Francesca; Dipalo, Michele			Cost-effective and multifunctional acquisition system for in vitro electrophysiological investigations with multi-electrode arrays	PLOS ONE			English	Article							CARDIOMYOCYTES; CELLS	In vitro multi-electrode array (MEA) technology is nowadays involved in a wide range of applications beyond neuroscience, such as cardiac electrophysiology and bio-interface studies. However, the cost of commercially available acquisition systems severely limits its adoption outside specialized laboratories with high budget capabilities. Thus, the availability of low-cost methods to acquire signals from MEAs is important to allow research labs worldwide to exploit this technology for an ever-expanding pool of experiments independently from their economic possibilities. Here, we provide a comprehensive toolset to assemble a multifunctional in vitro MEA acquisition system with a total cost 80% lower than standard commercial solutions. We demonstrate the capabilities of this acquisition system by employing it to i) characterize commercial MEA devices by means of electrical impedance measurements ii) record activity from cultures of HL-1 cells extracellularly, and iii) electroporate HL-1 cells through nanostructured MEAs and record intracellular signals.	[Garma, Leonardo D.; Matino, Laura; Santoro, Francesca] Ist Italiano Tecnol, Ctr Adv Biomat Healthcare, Naples, Italy; [Matino, Laura] Univ Naples Federico II, Dipartimento Ingn Chim Mat & Prod Ind DICMAPI, Naples, Italy; [Melle, Giovanni; Moia, Fabio; De Angelis, Francesco; Dipalo, Michele] Ist Italiano Tecnol, Genoa, Italy; [Melle, Giovanni] Univ Genoa, DIBRIS, Genoa, Italy	Istituto Italiano di Tecnologia - IIT; University of Naples Federico II; Istituto Italiano di Tecnologia - IIT; University of Genoa	Santoro, F (corresponding author), Ist Italiano Tecnol, Ctr Adv Biomat Healthcare, Naples, Italy.; Dipalo, M (corresponding author), Ist Italiano Tecnol, Genoa, Italy.	francesca.santoro@iit.it; michele.dipalo@iit.it	Dipalo, Michele/D-6708-2014	Dipalo, Michele/0000-0002-1823-8231; Garma, Leonardo Daniel/0000-0003-1220-8397; Santoro, Francesca/0000-0001-7323-9504				Abbott J, 2017, NAT NANOTECHNOL, V12, P460, DOI [10.1038/NNANO.2017.3, 10.1038/nnano.2017.3]; Angotzi GN, 2018, IEEE T BIOMED CIRC S, V12, P532, DOI 10.1109/TBCAS.2018.2792046; Blau A, 2011, BIOMATERIALS, V32, P1778, DOI 10.1016/j.biomaterials.2010.11.014; Blinova K, 2018, CELL REP, V24, P3582, DOI 10.1016/j.celrep.2018.08.079; Cohen-Karni T, 2009, P NATL ACAD SCI USA, V106, P7309, DOI 10.1073/pnas.0902752106; Colatsky T, 2016, J PHARMACOL TOX MET, V81, P15, DOI 10.1016/j.vascn.2016.06.002; Dipalo M, 2018, NAT NANOTECHNOL, V13, P965, DOI 10.1038/s41565-018-0222-z; Dipalo M, 2018, NANO LETT, V18, P6100, DOI 10.1021/acs.nanolett.8b03163; Dipalo M, 2017, NANO LETT, V17, P3932, DOI 10.1021/acs.nanolett.7b01523; Dipalo M, 2015, NANOSCALE, V7, P3703, DOI 10.1039/c4nr05578k; Feinerman O, 2008, NAT PHYS; Ingebrandt S, 2001, BIOSENS BIOELECTRON, V16, P565, DOI 10.1016/S0956-5663(01)00170-1; Kim R, 2014, BIOMEDICAL ENG LETT; Law JKY, 2009, PHYSL MEAS; Liu YX, 2018, P NATL ACAD SCI USA, V115, P11718, DOI 10.1073/pnas.1810827115; Marzullo TC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030837; Mcguire AF, 2018, ANN REV ANAL CHEM AN; Obien MEJ, 2015, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00423; Rastogi SK, 2018, J MATER CHEM B, V6, P7159, DOI 10.1039/c8tb01600c; Rastogi SK, 2018, CELL MOL BIOENG, V11, P407, DOI 10.1007/s12195-018-0525-z; Rolston JD, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00031; Rolston John D, 2009, Front Neuroeng, V2, P12, DOI 10.3389/neuro.16.012.2009; Santoro F, 2014, ACS NANO, V8, P6713, DOI 10.1021/nn500393p; Santoro F, 2013, NANO LETT, V13, P5379, DOI 10.1021/nl402901y; Sessolo M, 2013, ADV MATER, V25, P2135, DOI 10.1002/adma.201204322; Sprossler C, 1999, PHYS REV E, V60, P2171, DOI 10.1103/PhysRevE.60.2171; Xie C, 2012, NAT NANOTECHNOL, V7, P185, DOI [10.1038/nnano.2012.8, 10.1038/NNANO.2012.8]	27	11	11	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2019	14	3							e0214017	10.1371/journal.pone.0214017	http://dx.doi.org/10.1371/journal.pone.0214017			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ1KV	30908502	Green Published, gold, Green Submitted			2022-12-26	WOS:000462157600029
J	Chen, H; Ji, X; Lee, WC; Shi, Y; Li, BE; Abel, ED; Jiang, DM; Huang, W; Long, FX				Chen, Hong; Ji, Xing; Lee, Wen-Chih; Shi, Yu; Li, Boer; Abel, E. Dale; Jiang, Dianming; Huang, Wei; Long, Fanxin			Increased glycolysis mediates Wnt7b-induced bone formation	FASEB JOURNAL			English	Article						Glut1; Slc2a1; glucose; osteoblast; mouse	AEROBIC GLYCOLYSIS; WNT1 MUTATIONS; BETA-CATENIN; SOST GENE; OSTEOBLAST; DIFFERENTIATION; ACTIVATION; METABOLISM; ANABOLISM; DELETION	Wingless/integrated (Wnt) signaling has emerged as a major mechanism for promoting bone formation and a target pathway for developing bone anabolic agents against osteoporosis. However, the downstream events mediating the potential therapeutic effect of Wnt proteins are not fully understood. Previous studies have indicated that increased glycolysis is associated with osteoblast differentiation in response to Wnt signaling, but direct genetic evidence for the importance of glucose metabolism in Wnt-induced bone formation is lacking. Here, we have generated compound transgenic mice to overexpress Wnt family member 7B (Wnt7b) transiently in the osteoblast lineage of postnatal mice, with or without concurrent deletion of the glucose transporter 1 (Glut1), also known as solute carrier family 2, facilitated glucose transporter member 1. Overexpression of Wnt7b in 1-mo-old mice for 1 wk markedly stimulated bone formation, but the effect was essentially abolished without Glut1, even though transient deletion of Glut1 itself did not affect normal bone accrual. Consistent with the in vivo results, Wnt7b increased Glut1 expression and glucose consumption in the primary culture of osteoblast lineage cells, and deletion of Glut1 diminished osteoblast differentiation in vitro. Thus, Wnt7b promotes bone formation in part through stimulating glucose metabolism in osteoblast lineage cells.-Chen, H., Ji, X., Lee, W.-C., Shi, Y., Li, B., Abel, E. D., Jiang, D., Huang, W., Long, F. Increased glycolysis mediates Wnt7b-induced bone formation.	[Chen, Hong; Huang, Wei] Chongqing Med Univ, Dept Orthoped, Affiliated Hosp 1, Chongqing, Peoples R China; [Chen, Hong; Ji, Xing; Lee, Wen-Chih; Shi, Yu; Li, Boer; Long, Fanxin] Washington Univ, Sch Med, Dept Orthoped Surg, St Louis, MO USA; [Abel, E. Dale] Univ Iowa, Div Endocrinol & Metab, Fraternal Order Eagles Diabet Res Ctr, Carver Coll Med, Iowa City, IA USA; [Jiang, Dianming] Chongqing Med Univ, Affiliated Hosp 3, Dept Orthoped, Chongqing, Peoples R China; [Ji, Xing; Lee, Wen-Chih; Shi, Yu; Long, Fanxin] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA	Chongqing Medical University; Washington University (WUSTL); University of Iowa; Chongqing Medical University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Long, FX (corresponding author), Univ Penn, Dept Orthopaed Surg, Perelman Sch Med, 3615 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	longf1@email.chop.edu	CHEN, Hong/AAC-7879-2019	CHEN, Hong/0000-0002-4152-624X; Abel, E. Dale/0000-0001-5290-0738	U.S. National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases [AR060456]; NIH National Institute of Diabetes and Digestive and Kidney Diseases Grant [DK111212]; Washington University Musculoskeletal Research Center [NIH P30 AR057235]; China Scholarship Council [201608500093]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR057235, R01AR060456] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056341, R01DK111212] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH National Institute of Diabetes and Digestive and Kidney Diseases Grant; Washington University Musculoskeletal Research Center; China Scholarship Council(China Scholarship Council); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	T This work was supported by U.S. National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases Grant AR060456 (to F.L.), NIH National Institute of Diabetes and Digestive and Kidney Diseases Grant DK111212 (to F.L.), and the Washington University Musculoskeletal Research Center (NIH P30 AR057235). H.C. is a visiting scholar supported by the China Scholarship Council (201608500093). The authors declare no conflicts of interest.	Bakker AD, 2012, METHODS MOL BIOL, V816, P19, DOI 10.1007/978-1-61779-415-5_2; Balemans W, 2002, J MED GENET, V39, P91, DOI 10.1136/jmg.39.2.91; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; Brunkow ME, 2001, AM J HUM GENET, V68, P577, DOI 10.1086/318811; Chen Jia-Shing, 2014, BMC Res Notes, V7, P15, DOI 10.1186/1756-0500-7-15; Chen JQ, 2013, J BONE MINER RES, V28, P1160, DOI 10.1002/jbmr.1834; Cui YJ, 2011, NAT MED, V17, P684, DOI 10.1038/nm.2388; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Esen E, 2015, J BONE MINER RES, V30, P1959, DOI 10.1002/jbmr.2556; Esen E, 2014, CURR OSTEOPOROS REP, V12, P433, DOI 10.1007/s11914-014-0235-y; Esen E, 2013, CELL METAB, V17, P745, DOI 10.1016/j.cmet.2013.03.017; Fahiminiya S, 2013, J MED GENET, V50, P345, DOI 10.1136/jmedgenet-2013-101567; Frey JL, 2015, MOL CELL BIOL, V35, P1979, DOI 10.1128/MCB.01343-14; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013; Hu HL, 2005, DEVELOPMENT, V132, P49, DOI 10.1242/dev.01564; Joeng KS, 2017, J CLIN INVEST, V127, P2678, DOI 10.1172/JCI92617; Joeng KS, 2014, BONE RES, V2, DOI 10.1038/boneres.2014.4; Karner CM, 2017, MOL CELL BIOL, V37; Karner CM, 2017, CELL MOL LIFE SCI, V74, P1649, DOI 10.1007/s00018-016-2425-5; Karner CM, 2015, J CLIN INVEST, V125, P551, DOI 10.1172/JCI78470; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Keupp K, 2013, AM J HUM GENET, V92, P565, DOI 10.1016/j.ajhg.2013.02.010; Laine CM, 2013, NEW ENGL J MED, V368, P1809, DOI 10.1056/NEJMoa1215458; Lee SY, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07316-5; Lee SY, 2018, J CLIN INVEST, V128, P5573, DOI 10.1172/JCI96221; Li XD, 2008, J BONE MINER RES, V23, P860, DOI 10.1359/JBMR.080216; Little RD, 2002, AM J HUM GENET, V70, P11, DOI 10.1086/338450; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Maes C, 2010, DEV CELL, V19, P329, DOI 10.1016/j.devcel.2010.07.010; Mai V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020647; Medina-Gomez C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002718; Moverare-Skrtic S, 2014, NAT MED, V20, P1279, DOI 10.1038/nm.3654; Pyott SM, 2013, AM J HUM GENET, V92, P590, DOI 10.1016/j.ajhg.2013.02.009; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Song LG, 2012, J BONE MINER RES, V27, P2344, DOI 10.1002/jbmr.1694; Sun WW, 2016, BONE, V85, P1, DOI 10.1016/j.bone.2016.01.013; Tu XL, 2007, DEV CELL, V12, P113, DOI 10.1016/j.devcel.2006.11.003; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; Wei JW, 2015, CELL, V161, P1576, DOI 10.1016/j.cell.2015.05.029; Wu XM, 2008, CELL, V133, P340, DOI 10.1016/j.cell.2008.01.052; Zheng HF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002745; Zhong ZD, 2014, WIRES DEV BIOL, V3, P489, DOI 10.1002/wdev.159	43	22	22	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2019	33	7					7810	7821		10.1096/fj.201900201RR	http://dx.doi.org/10.1096/fj.201900201RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ9SM	30913395	Bronze, Green Published			2022-12-26	WOS:000476234700003
J	Ghoshal, A; Rodrigues, LC; Gowda, CP; Elcheva, IA; Liu, ZQ; Abraham, T; Spiegelman, VS				Ghoshal, Archita; Rodrigues, Lucas C.; Gowda, Chethana P.; Elcheva, Irina A.; Liu, Zhenqiu; Abraham, Thomas; Spiegelman, Vladimir S.			Extracellular vesicle-dependent effect of RNA-binding protein IGF2BP1 on melanoma metastasis	ONCOGENE			English	Article							MYC MESSENGER-RNA; CRD-BP; CODING REGION; C-MYC; NICHE FORMATION; EXPRESSION; CELLS; TRANSCRIPTION; BETA-TRCP1; PHENOTYPE	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) is a multifunctional RNA-binding protein with an oncofetal pattern of expression shown to be implicated in the development of a variety of malignancies. In this study, we explored the role and mechanisms of IGF2BP1 in melanoma development and progression. In two different in vivo models, we showed that although genetic deletion or shRNA-mediated suppression of IGF2BP1 did not affect primary tumor formation, it drastically suppressed lung metastasis. Here we demonstrated that extracellular vesicles (EVs) secreted by melanoma cells mediate the effects of IGF2BP1 on metastasis: EVs from the IGF2BP1 knockdown melanoma cells failed to promote metastasis, whereas EVs isolated from IGF2BP1-overexpressed melanoma cells further accelerated EV-induced metastasis. Moreover, the EVs from IGF2BP1 knockdown melanoma cells inhibited fibronectin deposition and accumulation of CD45(+) cells in the lungs compared with control EVs, thus blocking the pre-metastatic niche formation potential of EVs. IGF2BP1 knockdown did not affect size, number, or protein/RNA concentration of secreted EVs or their uptake by recipient cells in vitro or in vivo. However, RNA-sequencing and proteomics analysis of the EVs revealed differential expression in a number of mRNA, proteins, and miRNAs. This suggested that IGF2BP1 is intimately involved in the regulation of the cargo of EVs, thereby affecting the pro-metastatic function of melanoma-derived EVs. To the best of our knowledge, this is the first study that demonstrates the role of RNA-binding protein IGF2BP1 in EV-mediated promotion of melanoma metastasis and may provide novel avenues for the development of metastatic inhibitors.	[Ghoshal, Archita; Rodrigues, Lucas C.; Gowda, Chethana P.; Elcheva, Irina A.; Liu, Zhenqiu; Spiegelman, Vladimir S.] Penn State Univ, Coll Med, Dept Pediat, Div Pediat Hematol Oncol, Hershey, PA 17033 USA; [Abraham, Thomas] Penn State Univ, Coll Med, Dept Neural & Behav Sci, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Spiegelman, VS (corresponding author), Penn State Univ, Coll Med, Dept Pediat, Div Pediat Hematol Oncol, Hershey, PA 17033 USA.	vspiegelman@pennstatehealth.psu.edu	Abraham, Thomas/AAJ-7950-2020; Abraham, Thomas/J-7080-2014	Spiegelman, Vladimir S/0000-0003-4847-155X; Abraham, Thomas/0000-0003-0750-8774; Ghoshal, Archita/0000-0002-9210-3140	NIH [R01 AR063361]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR063361] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was supported in part by the NIH grant R01 AR063361 (VSS). We thank Dr Ze'ev Ronai for the generous gift of reagents and Dr JM Sundstrom for the help with Nanosight (TM) analysis of EVs. We thank Penn State Cancer Institute Genomics Sciences, Penn State College of Medicine Imaging Core, Flow Cytometry Core, and Molecular and Histopathology Core Facilities for help with respective data acquisition and analysis.	Azmi AS, 2013, CANCER METAST REV, V32, P623, DOI 10.1007/s10555-013-9441-9; Bell JL, 2015, J CLIN ONCOL, V33, P1285, DOI 10.1200/JCO.2014.55.9880; Bosenberg M, 2006, GENESIS, V44, P262, DOI 10.1002/dvg.20205; Chen Y, 2017, ONCOGENE, V36, P4692, DOI 10.1038/onc.2017.100; Costa-Silva B, 2015, NAT CELL BIOL, V17, P816, DOI 10.1038/ncb3169; Craig EA, 2012, PIGM CELL MELANOMA R, V25, P83, DOI 10.1111/j.1755-148X.2011.00921.x; Dankort D, 2009, NAT GENET, V41, P544, DOI 10.1038/ng.356; Dimitriadis E, 2007, INT J CANCER, V121, P486, DOI 10.1002/ijc.22716; Dorayappan KDP, 2018, ONCOGENE, V37, P3806, DOI 10.1038/s41388-018-0189-0; Elcheva I, 2008, ONCOGENE, V27, P5069, DOI 10.1038/onc.2008.141; Elcheva I, 2009, MOL CELL, V35, P240, DOI 10.1016/j.molcel.2009.06.007; Ghoshal A, 2016, MOL CELL BIOCHEM, V418, P119, DOI 10.1007/s11010-016-2738-6; Goswami S, 2015, J BIOL CHEM, V290, P384, DOI 10.1074/jbc.M114.590158; Gupta S, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-0923-0; Hamilton KE, 2013, CARCINOGENESIS, V34, P2647, DOI 10.1093/carcin/bgt217; Hood JL, 2011, CANCER RES, V71, P3792, DOI 10.1158/0008-5472.CAN-10-4455; Hoshino A, 2015, NATURE, V527, P329, DOI 10.1038/nature15756; Iyer SC, 2015, MOL CELL BIOCHEM, V407, P223, DOI 10.1007/s11010-015-2471-6; Jao CY, 2008, P NATL ACAD SCI USA, V105, P15779, DOI 10.1073/pnas.0808480105; Kim T, 2018, MOL CARCINOGEN, V57, P678, DOI 10.1002/mc.22786; Leeds P, 1997, ONCOGENE, V14, P1279, DOI 10.1038/sj.onc.1201093; Li WH, 2014, APMIS, V122, P1080, DOI 10.1111/apm.12261; Liu YF, 2016, CANCER CELL, V30, P243, DOI 10.1016/j.ccell.2016.06.021; Lobb RJ, 2017, SEMIN CELL DEV BIOL, V67, P3, DOI 10.1016/j.semcdb.2017.01.004; Meerbrey KL, 2011, P NATL ACAD SCI USA, V108, P3665, DOI 10.1073/pnas.1019736108; Noubissi FK, 2006, NATURE, V441, P898, DOI 10.1038/nature04839; Noubissi FK, 2009, CANCER RES, V69, P8572, DOI 10.1158/0008-5472.CAN-09-1500; Oberman F, 2007, RNA, V13, P1558, DOI 10.1261/rna.559507; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Peinado H, 2011, SEMIN CANCER BIOL, V21, P139, DOI 10.1016/j.semcancer.2011.01.002; Psaila B, 2009, NAT REV CANCER, V9, P285, DOI 10.1038/nrc2621; Sparanese D, 2007, NUCLEIC ACIDS RES, V35, P1209, DOI 10.1093/nar/gkl1148; Stohr N, 2012, CELL ADHES MIGR, V6, P312, DOI 10.4161/cam.20628; Su YL, 2016, ONCOTARGET, V7, P68397, DOI 10.18632/oncotarget.11722; Vikesaa J, 2006, EMBO J, V25, P1456, DOI 10.1038/sj.emboj.7601039; Wang RJ, 2015, J BIOL CHEM, V290, P8938, DOI 10.1074/jbc.M114.624700; Weidle UH, 2017, CANCER GENOM PROTEOM, V14, P1, DOI 10.21873/cgp.20015; Wen SW, 2016, CANCER RES, V76, P6816, DOI 10.1158/0008-5472.CAN-16-0868	38	22	22	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 23	2019	38	21					4182	4196		10.1038/s41388-019-0797-3	http://dx.doi.org/10.1038/s41388-019-0797-3			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HZ3HX	30936459	Green Accepted			2022-12-26	WOS:000468740200015
J	Jones, JL; Hofmann, KB; Cowan, AT; Temiakov, D; Cramer, P; Anikin, M				Jones, Julia L.; Hofmann, Katharina B.; Cowan, Andrew T.; Temiakov, Dmitry; Cramer, Patrick; Anikin, Michael			Yeast mitochondrial protein Pet111p binds directly to two distinct targets in COX2 mRNA, suggesting a mechanism of translational activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mitochondria; cytochrome c oxidase (Complex IV); gene expression; RNA-protein interaction; translation regulation; PAR-CLIP; pentatricopeptide repeat (PPR) protein; respiratory complex; translational activator	5-UNTRANSLATED LEADER; NUCLEOTIDE-SEQUENCE; INNER MEMBRANE; ORGANIZATION; EXPRESSION	The genes in mitochondrial DNA code for essential subunits of the respiratory chain complexes. In yeast, expression of mitochondrial genes is controlled by a group of gene-specific translational activators encoded in the nucleus. These factors appear to be part of a regulatory system that enables concerted expression of the necessary genes from both nuclear and mitochondrial genomes to produce functional respiratory complexes. Many of the translational activators are believed to act on the 5-untranslated regions of target mRNAs, but the molecular mechanisms involved in this regulation remain obscure. In this study, we used a combination of in vivo and in vitro analyses to characterize the interactions of one of these translational activators, the pentatricopeptide repeat protein Pet111p, with its presumed target, COX2 mRNA, which encodes subunit II of cytochrome c oxidase. Using photoactivatable ribonucleoside-enhanced cross-linking and immunoprecipitation analysis, we found that Pet111p binds directly and specifically to a 5-end proximal region of the COX2 transcript. Further, we applied in vitro RNase footprinting and mapped two binding targets of the protein, of which one is located in the 5-untranslated leader and the other is within the coding sequence. Combined with the available genetic data, these results suggest a plausible mechanism of translational activation, in which binding of Pet111p may prevent inhibitory secondary structures from forming in the translation initiation region, thus rendering the mRNA available for interaction with the ribosome.	[Jones, Julia L.] Rowan Univ, Sch Osteopath Med, Grad Sch Biomed Sci, Grad Program Cell & Mol Biol, Stratford, NJ 08084 USA; [Jones, Julia L.; Cowan, Andrew T.; Anikin, Michael] Rowan Univ, Sch Osteopath Med, Dept Cell Biol & Neurosci, 42 East Laurel Rd,UDP 2200, Stratford, NJ 08084 USA; [Hofmann, Katharina B.; Cramer, Patrick] Max Planck Inst Biophys Chem, Dept Mol Biol, D-37077 Gottingen, Germany; [Temiakov, Dmitry] Thomas Jefferson Univ, Sidney Kimmel Canc Ctr, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA; [Cowan, Andrew T.] Thomas Jefferson Univ Hosp, Dept Pharm, 111 South 11th St,Suite 2260, Philadelphia, PA 19107 USA	Rowan University; Rowan University School of Osteopathic Medicine; Rowan University; Rowan University School of Osteopathic Medicine; Max Planck Society; Jefferson University; Jefferson University	Anikin, M (corresponding author), Rowan Univ, Sch Osteopath Med, Dept Cell Biol & Neurosci, 42 East Laurel Rd,UDP 2200, Stratford, NJ 08084 USA.	anikinmi@rowan.edu		Hofmann, Katharina/0000-0002-0683-6277	New Jersey Health Foundation [PC127-13]; Rowan University Graduate School of Biomedical Sciences	New Jersey Health Foundation; Rowan University Graduate School of Biomedical Sciences	This work was supported by New Jersey Health Foundation Grant PC127-13 (to M.A.) and by the Rowan University Graduate School of Biomedical Sciences (to J.L.J.). The authors declare that they have no conflicts of interest with the contents of this article.	Baejen C, 2014, MOL CELL, V55, P745, DOI 10.1016/j.molcel.2014.08.005; Barkan A, 2014, ANNU REV PLANT BIOL, V65, P415, DOI 10.1146/annurev-arplant-050213-040159; Barkan A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002910; Bonnefoy N, 2001, MOL CELL BIOL, V21, P2359, DOI 10.1128/MCB.21.7.2359-2372.2001; CORUZZI G, 1981, J BIOL CHEM, V256, P2780; Costanzo MC, 2000, GENETICS, V154, P999; Couvillion MT, 2016, NATURE, V533, P499, DOI 10.1038/nature18015; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dunstan HM, 1997, GENETICS, V147, P87; Fox TD, 2012, GENETICS, V192, P1203, DOI 10.1534/genetics.112.141267; Fukasawa Y, 2015, MOL CELL PROTEOMICS, V14, P1113, DOI 10.1074/mcp.M114.043083; Gelperin DM, 2005, GENE DEV, V19, P2816, DOI 10.1101/gad.1362105; Green-Willms NS, 2001, J BIOL CHEM, V276, P6392, DOI 10.1074/jbc.M009856200; Henzel WJ, 2003, J AM SOC MASS SPECTR, V14, P931, DOI 10.1016/S1044-0305(03)00214-9; Herbert CJ, 2013, RNA BIOL, V10, P1477, DOI 10.4161/rna.25392; Herrmann JM, 2013, BBA-MOL CELL RES, V1833, P286, DOI 10.1016/j.bbamcr.2012.03.007; Kehrein K, 2015, CELL REP, V10, P843, DOI 10.1016/j.celrep.2015.01.012; Krause K, 2004, MOL BIOL CELL, V15, P2674, DOI 10.1091/mbc.E04-02-0126; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Lipinski KA, 2011, MOL BIOL EVOL, V28, P2935, DOI 10.1093/molbev/msr120; MEADOR J, 1990, EUR J BIOCHEM, V187, P549, DOI 10.1111/j.1432-1033.1990.tb15336.x; MULERO JJ, 1993, MOL BIOL CELL, V4, P1327, DOI 10.1091/mbc.4.12.1327; MULERO JJ, 1993, GENETICS, V133, P509; Naithani S, 2003, MOL BIOL CELL, V14, P324, DOI 10.1091/mbc.E02-08-0490; Nilsen Timothy W, 2014, Cold Spring Harb Protoc, V2014, P677, DOI 10.1101/pdb.prot080788; OSINGA KA, 1984, EMBO J, V3, P829, DOI 10.1002/j.1460-2075.1984.tb01892.x; Ott M, 2016, ANNU REV BIOCHEM, V85, P77, DOI 10.1146/annurev-biochem-060815-014334; PAPADOPOULOU B, 1990, EMBO J, V9, P4135, DOI 10.1002/j.1460-2075.1990.tb07636.x; POUTRE CG, 1987, GENETICS, V115, P637; Prikryl J, 2011, P NATL ACAD SCI USA, V108, P415, DOI 10.1073/pnas.1012076108; Richman TR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11884; Sanchirico ME, 1998, EMBO J, V17, P5796, DOI 10.1093/emboj/17.19.5796; Schmitz-Linneweber C, 2008, TRENDS PLANT SCI, V13, P663, DOI 10.1016/j.tplants.2008.10.001; Small ID, 2000, TRENDS BIOCHEM SCI, V25, P46, DOI 10.1016/S0968-0004(99)01520-0; Strecker V, 2016, BBA-MOL CELL RES, V1863, P1643, DOI 10.1016/j.bbamcr.2016.04.012; STRICK CA, 1987, MOL CELL BIOL, V7, P2728, DOI 10.1128/MCB.7.8.2728; Wiesenberger G, 1997, MOL CELL BIOL, V17, P2816, DOI 10.1128/MCB.17.5.2816; Williams EH, 2003, RNA, V9, P419, DOI 10.1261/rna.2182903	38	9	9	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2019	294	18					7528	7536		10.1074/jbc.RA118.005355	http://dx.doi.org/10.1074/jbc.RA118.005355			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PT	30910813	Green Published, hybrid			2022-12-26	WOS:000468402900035
J	Anderson, AM; Friis, C; Gratto-Trevor, CL; Morrison, RIG; Smith, PA; Nol, E				Anderson, Alexandra M.; Friis, Christian; Gratto-Trevor, Cheri L.; Morrison, R. I. Guy; Smith, Paul A.; Nol, Erica			Consistent declines in wing lengths of Calidridine sandpipers suggest a rapid morphometric response to environmental change	PLOS ONE			English	Article							WHITE-RUMPED SANDPIPER; SEXUAL SIZE DIMORPHISM; WESTERN SANDPIPERS; CLIMATE-CHANGE; MORPHOLOGICAL ADAPTATIONS; BODY-SIZE; POPULATION DECLINES; POTENTIAL IMPACTS; PREDATOR EVASION; STOPOVER SITE	A recent study demonstrated that semipalmated sandpiper (Calidris pusffla) wing lengths have shortened from the 1980s to the present-day. We examined alternative and untested hypotheses for this change at an important stopover site, James Bay, Ontario, Canada. We evaluated morphometric patterns in wing length and bill length by age and sex, when possible, and assessed if wing shape has also changed during this time-period. We investigated patterns of morphological change in two additional Calidridine sandpipers, white-rumped sandpipers (Calidris fuscicollis) and least sandpipers (Calidris minutilla), to determine if shorter wing lengths are a widespread pattern in small sandpipers. We also examined allometric changes in wing and bill lengths to clarify if wing length declines were consistent with historical scaling relationships and indicative of a change in body size instead of only wing length change. We found that including sex and wing shape in analyses revealed important patterns in morphometric change for semipalmated sandpipers. Wing lengths declined for both sexes, but the magnitude of decline was smaller and not significant for males. Additionally, semipalmated sandpiper wings have become more convex, a shape that increases maneuverability in flight. Wing lengths, but not bill lengths, declined for most species and age classes, a pattern that was inconsistent with historical allometric scaling relationships. For juvenile semipalmated sandpipers, however, both bill and wing lengths declined according to historical scaling relationships, which could be a consequence of nutritional stress during development or a shift in the proportion of birds from smaller-sized, western breeding populations. Except for juvenile semipalmated sandpipers, we did not find evidence for an increase in the proportion of birds from different breeding populations at the stopover site. Given the wide, hemispheric distribution of these sandpipers throughout their annual cycles, our results, paired with those from a previous study, provide evidence for wide-spread reduction in wing lengths of Calidridine sandpipers since the 1980s. The shorter wing lengths and more convex wing shapes found in this study support the hypothesis that selection has favored more maneuverable wing morphology in small sandpipers.	[Anderson, Alexandra M.] Trent Univ, Environm & Life Sci, Peterborough, ON, Canada; [Friis, Christian] Environm & Climate Change Canada, Canadian Wildlife Serv, Toronto, ON, Canada; [Gratto-Trevor, Cheri L.] Environm & Climate Change Canada, Prairie & Northern Wildlife Res Ctr, Saskatoon, SK, Canada; [Morrison, R. I. Guy; Smith, Paul A.] Environm & Climate Change Canada, Natl Wildlife Res Ctr, Ottawa, ON, Canada; [Nol, Erica] Trent Univ, Biol Dept, Peterborough, ON, Canada	Trent University; Environment & Climate Change Canada; Canadian Wildlife Service; Environment & Climate Change Canada; Environment & Climate Change Canada; Canadian Wildlife Service; National Wildlife Research Centre - Canada; Trent University	Anderson, AM (corresponding author), Trent Univ, Environm & Life Sci, Peterborough, ON, Canada.	aande763@gmail.com		Anderson, Alexandra/0000-0001-6751-1751; Friis, Christian/0000-0002-4739-580X	Environment and Climate Change Canada; Ontario Trillium Scholarship; W. Garfield Weston Fellowship for Northern Research; Ontario Ministry of Natural Resources and Forestry Species at Risk Stewardship Fund [16-19-Nol]; Neotropical Migratory Bird Conservation Act Grant [F14AP00405, F17AP00668]	Environment and Climate Change Canada; Ontario Trillium Scholarship; W. Garfield Weston Fellowship for Northern Research; Ontario Ministry of Natural Resources and Forestry Species at Risk Stewardship Fund; Neotropical Migratory Bird Conservation Act Grant	This study was funded by Environment and Climate Change Canada, the Ontario Trillium Scholarship (AMA), The W. Garfield Weston Fellowship for Northern Research (AMA), the Ontario Ministry of Natural Resources and Forestry Species at Risk Stewardship Fund (16-19-Nol, EN), and the Neotropical Migratory Bird Conservation Act Grant (Award #F14AP00405, CF, and #F17AP00668, EN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alerstam T, 2003, OIKOS, V103, P247, DOI 10.1034/j.1600-0706.2003.12559.x; Apple ME, 2000, INT J PLANT SCI, V161, P127, DOI 10.1086/314237; Austin GE, 2005, GLOBAL CHANGE BIOL, V11, P31, DOI 10.1111/j.1529-8817.2003.00876.x; Baker AJ, 1999, CONDOR, V101, P887, DOI 10.2307/1370083; Bart J, 2007, J AVIAN BIOL, V38, P73, DOI 10.1111/j.2007.0908-8857.03698.x; Bartlett JW, 2008, ULTRASOUND OBST GYN, V31, P466, DOI 10.1002/uog.5256; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Blankers T, 2012, J EVOLUTION BIOL, V25, P634, DOI 10.1111/j.1420-9101.2012.02458.x; Blomqvist D, 1997, ANIM BEHAV, V54, P1291, DOI 10.1006/anbe.1997.0532; BOAG PT, 1981, SCIENCE, V214, P82, DOI 10.1126/science.214.4516.82; Both C, 2006, NATURE, V441, P81, DOI 10.1038/nature04539; Bowlin MS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002154; BRADSHAW A. D., 1965, ADVANCE GENET, V13, P115, DOI 10.1016/S0065-2660(08)60048-6; BRADSTREET MSW, 1977, CAN FIELD NAT, V91, P225; BRONMARK C, 1992, SCIENCE, V258, P1348, DOI 10.1126/science.258.5086.1348; Brown CR, 2013, CURR BIOL, V23, pR233, DOI 10.1016/j.cub.2013.02.023; Burns JG, 2003, AUK, V120, P827, DOI 10.1642/0004-8038(2003)120[0827:ROCSWS]2.0.CO;2; Burns JG, 2002, BEHAV ECOL SOCIOBIOL, V52, P128, DOI 10.1007/s00265-002-0494-y; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; de la Hera I, 2014, IBIS, V156, P209, DOI 10.1111/ibi.12112; Dos Remedios Natalie, 2010, Wader Study Group Bulletin, V117, P109; Doswald N, 2009, J BIOGEOGR, V36, P1194, DOI 10.1111/j.1365-2699.2009.02086.x; Dunn JC, 2017, IBIS, V159, P152, DOI 10.1111/ibi.12435; ENGELMOER M, 1983, Ringing and Migration, V4, P245; Evans KL, 2009, OIKOS, V118, P251, DOI 10.1111/j.1600-0706.2008.17092.x; Fernandez G, 2007, AUK, V124, P1037, DOI 10.1642/0004-8038(2007)124[1037:VITWMO]2.0.CO;2; Flinks H, 2012, J ORNITHOL, V153, P1053, DOI 10.1007/s10336-012-0834-2; Forstmeier W, 2011, BEHAV ECOL SOCIOBIOL, V65, P47, DOI 10.1007/s00265-010-1038-5; Gardner JL, 2011, TRENDS ECOL EVOL, V26, P285, DOI 10.1016/j.tree.2011.03.005; GIBBS HL, 1987, NATURE, V327, P511, DOI 10.1038/327511a0; Gienapp P, 2008, MOL ECOL, V17, P167, DOI 10.1111/j.1365-294X.2007.03413.x; Grant PR, 2002, SCIENCE, V296, P707, DOI 10.1126/science.1070315; Gratto C.L., 1981, Wader Study Group Bulletin, P33; Gratto CL., 1983, MIGRATORY REPROD STR; Gratto-Trevor, 2004, N AM BANDERS MANUAL; Gratto-Trevor C, 2012, WATERBIRDS, V35, P83, DOI 10.1675/063.035.0109; Guerin GR, 2012, BIOL LETTERS, V8, P882, DOI 10.1098/rsbl.2012.0458; Harrington B.A., 1979, Studies in Avian Biology, V2, P83; HEDENSTROM A, 1992, P ROY SOC B-BIOL SCI, V247, P183, DOI 10.1098/rspb.1992.0026; Hicklin P., 2010, BIRDS N AM, DOI [10. 2173/bna. 6, DOI 10.2173/BNA.6]; Huntley B, 2006, IBIS, V148, P8, DOI 10.1111/j.1474-919X.2006.00523.x; Jehl J.R. Jr, 1986, Current Ornithology, V3, P1; Krapu GL, 2006, AUK, V123, P323, DOI 10.1642/0004-8038(2006)123[323:FDOASD]2.0.CO;2; Kullberg C, 2000, AUK, V117, P1034, DOI 10.1642/0004-8038(2000)117[1034:HMFLIP]2.0.CO;2; Kullberg C, 1996, P ROY SOC B-BIOL SCI, V263, P1671, DOI 10.1098/rspb.1996.0244; La Sorte FA, 2010, J EXP BIOL, V213, P862, DOI 10.1242/jeb.038356; Lank DB, 2017, ECOL EVOL, V7, P3243, DOI 10.1002/ece3.2898; Lenth RV, 2016, J STAT SOFTW, V69, P1, DOI 10.18637/jss.v069.i01; Lockwood R, 1998, J AVIAN BIOL, V29, P273, DOI 10.2307/3677110; Ludecke D., 2017, SJPLOT DATA VISUALIZ; Telleria JL, 2013, IBIS, V155, P750, DOI 10.1111/ibi.12078; Maclean IMD, 2008, GLOBAL CHANGE BIOL, V14, P2489, DOI 10.1111/j.1365-2486.2008.01666.x; McCollum SA, 1997, OECOLOGIA, V109, P615, DOI 10.1007/s004420050124; McKinnon L, 2010, SCIENCE, V327, P326, DOI 10.1126/science.1183010; McNeil R., 1972, Naturalist can, V99, P589; Minias P, 2015, IBIS, V157, P528, DOI 10.1111/ibi.12262; Moller AP, 2017, J EVOLUTION BIOL, V30, P1177, DOI 10.1111/jeb.13086; Nebel S., 2008, BIRDS N AM, DOI [10. 2173/bna. 115, DOI 10.2173/BNA.115]; O'Hara PD, 2006, CONDOR, V108, P225, DOI 10.1650/0010-5422(2006)108[0225:DMIWSW]2.0.CO;2; Outomuro D, 2015, J EVOLUTION BIOL, V28, P791, DOI 10.1111/jeb.12605; Ozgul A, 2010, NATURE, V466, P482, DOI 10.1038/nature09210; PAGE G, 1975, CONDOR, V77, P73, DOI 10.2307/1366760; PARMELEE DF, 1968, WILSON BULL, V80, P5; Parmelee DF., 1992, BIRDS N AM, DOI [10.2173/bna.29, DOI 10.2173/BNA.29]; Parmesan C, 2007, GLOBAL CHANGE BIOL, V13, P1860, DOI 10.1111/j.1365-2486.2007.01404.x; Pergams ORW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006452; Piersma T, 2005, ANN NY ACAD SCI, V1046, P282, DOI 10.1196/annals.1343.026; Piersma T., 2010, FLEXIBLE PHENOTYPE B; Pomeroy AC, 2006, OIKOS, V112, P629, DOI 10.1111/j.0030-1299.2006.14403.x; Pomeroy AC, 2006, BEHAV ECOL, V17, P1041, DOI 10.1093/beheco/arl043; Pulido F, 2005, ANN NY ACAD SCI, V1046, P228, DOI 10.1196/annals.1343.020; Quinn G, 2002, RES DESIGN DATA ANAL; R Core Team, 2021, R LANGUAGE ENV STAT; Rayner J.M.V., 1988, Current Ornithology, V5, P1; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Serra L, 2001, J AVIAN BIOL, V32, P377, DOI 10.1111/j.0908-8857.2001.320415.x; Sheridan JA, 2011, NAT CLIM CHANGE, V1, P401, DOI 10.1038/NCLIMATE1259; Stoffel MA, 2017, METHODS ECOL EVOL, V8, P1639, DOI 10.1111/2041-210X.12797; Swaddle JP, 1998, J AVIAN BIOL, V29, P172, DOI 10.2307/3677195; Szekely T, 2000, EVOLUTION, V54, P1404, DOI 10.1111/j.0014-3820.2000.tb00572.x; Tomassini A, 2014, J BIOGEOGR, V41, P944, DOI 10.1111/jbi.12248; Tseng M, 2018, J ANIM ECOL, V87, P647, DOI 10.1111/1365-2656.12789; Vagasi CI, 2016, EVOL BIOL, V43, P48, DOI 10.1007/s11692-015-9349-0; Van Buskirk J, 2010, OIKOS, V119, P1047, DOI 10.1111/j.1600-0706.2009.18349.x; Van Den Hout PJ, 2008, IBIS, V150, P219, DOI 10.1111/j.1474-919X.2008.00785.x; van der Velde Marco, 2017, Wader Study, V124, P147, DOI 10.18194/ws.00069; van Gils JA, 2016, SCIENCE, V352, P819, DOI 10.1126/science.aad6351; Vaz S, 2013, PLOS ONE, V8, P7; Wennerberg L, 2002, OECOLOGIA, V131, P380, DOI 10.1007/s00442-002-0890-z; Whitfield DP, 2003, IBIS, V145, P432, DOI 10.1046/j.1474-919X.2003.00183.x; Whittingham MJ, 2006, J ANIM ECOL, V75, P1182, DOI 10.1111/j.1365-2656.2006.01141.x; Wickham H., 2016, GGPLOT2 ELEGANT GRAP, DOI 10.1007/978-3-319-24277-4	92	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0213930	10.1371/journal.pone.0213930	http://dx.doi.org/10.1371/journal.pone.0213930			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR5NS	30943247	Green Submitted, Green Published, gold			2022-12-26	WOS:000463194300024
J	Buglak, AA; Zherdev, AV; Lei, HT; Dzantiev, BB				Buglak, Andrey A.; Zherdev, Anatoly V.; Lei, Hong-Tao; Dzantiev, Boris B.			QSAR analysis of immune recognition for triazine herbicides based on immunoassay data for polyclonal and monoclonal antibodies	PLOS ONE			English	Article							BROAD-SPECIFICITY; PREDICTIVE ABILITY; ATRAZINE; DEALKYLATION; ENANTIOMERS; REGRESSION; MOLECULES; OFLOXACIN; RESIDUES; IMPROVE	A common task in the immunodetection of structurally close compounds is to analyze the selectivity of immune recognition; it is required to understand the regularities of immune recognition and to elucidate the basic structural elements which provide it. Triazines are compounds of particular interest for such research due to their high variability and the necessity of their monitoring to provide safety for agricultural products and foodstuffs. We evaluated the binding of 20 triazines with polyclonal (pAb) and monoclonal (mAb) antibodies obtained using atrazine as the immunogenic hapten. A total of over 3000 descriptors were used in the quantitative structure-activity relationship (QSAR) analysis of binding activities (pIC(50)). A comparison of the two enzyme immunoassay systems showed that the system with pAb is much easier to describe using 2D QSAR methodology, while the system with mAb can be described using the 3D QSAR CoMFA. Thus, for the 3D QSAR model of the polyclonal antibodies, the main statistical parameter q(2) ('leave-many-out') is equal to 0.498, and for monoclonal antibodies, q(2) is equal to 0.566. Obviously, in the case of pAb, we deal with several targets, while in the case of mAb the target is one, and therefore it is easier to describe it using specific fields of molecular interactions distributed in space.	[Buglak, Andrey A.; Zherdev, Anatoly V.; Dzantiev, Boris B.] Russian Acad Sci, AN Bach Inst Biochem, Res Ctr Biotechnol, Moscow, Russia; [Buglak, Andrey A.] St Petersburg State Univ, St Petersburg, Russia; [Lei, Hong-Tao] South China Agr Univ, Guangdong Prov Key Lab Food Qual & Safety, Guangzhou, Guangdong, Peoples R China	Research Center of Biotechnology RAS; Russian Academy of Sciences; Saint Petersburg State University; South China Agricultural University	Buglak, AA (corresponding author), Russian Acad Sci, AN Bach Inst Biochem, Res Ctr Biotechnol, Moscow, Russia.; Buglak, AA (corresponding author), St Petersburg State Univ, St Petersburg, Russia.	andreybuglak@gmail.com	Buglak, Andrey A/J-8242-2016; Buglak, Andrey/X-7871-2019; Zherdev, Anatoly/G-2916-2013	Buglak, Andrey A/0000-0002-6405-6594; Buglak, Andrey/0000-0002-6405-6594; Zherdev, Anatoly/0000-0003-3008-2839	Russian Science Foundation [14-16-00149]	Russian Science Foundation(Russian Science Foundation (RSF))	The work was financially supported by the Russian Science Foundation (Project No. 14-16-00149).	Agopian AJ, 2013, MATERN CHILD HLTH J, V17, P1768, DOI 10.1007/s10995-012-1196-3; Alexander DLJ, 2015, J CHEM INF MODEL, V55, P1316, DOI 10.1021/acs.jcim.5b00206; BARONI M, 1992, J CHEMOMETR, V6, P347, DOI 10.1002/cem.1180060605; BARONI M, 1993, QUANT STRUCT-ACT REL, V12, P9, DOI 10.1002/qsar.19930120103; Bitencourt M, 2008, PEST MANAG SCI, V64, P800, DOI 10.1002/ps.1565; Bottoni P, 2013, MICROCHEM J, V107, P136, DOI 10.1016/j.microc.2012.06.011; Chen JH, 2017, ANAL CHEM, V89, P6740, DOI 10.1021/acs.analchem.7b00997; Chen JH, 2016, J AGR FOOD CHEM, V64, P2772, DOI 10.1021/acs.jafc.6b00039; Cheney MA, 1998, COLLOID SURFACE A, V137, P267, DOI 10.1016/S0927-7757(97)00368-3; Dankwardt A, 1996, ENVIRON SCI TECHNOL, V30, P3493, DOI 10.1021/es9601604; DEWAR MJS, 1985, J AM CHEM SOC, V107, P3902, DOI 10.1021/ja00299a024; Funar-Timofei S, 2017, MOL DIVERS, V21, P437, DOI 10.1007/s11030-017-9735-x; Golbraikh A, 2002, J MOL GRAPH MODEL, V20, P269, DOI 10.1016/S1093-3263(01)00123-1; Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI [10.1002/(SICI)1096-987X(199604)17:5/6<490::AID-JCC1>3.0.CO;2-P, 10.1002/(SICI)1096-987X(199604)17:5/6<616::AID-JCC5>3.0.CO;2-X]; HALL LH, 1991, J CHEM INF COMP SCI, V31, P76, DOI 10.1021/ci00001a012; Li YF, 2017, TRAC-TREND ANAL CHEM, V88, P25, DOI 10.1016/j.trac.2016.12.010; Liu CM, 2018, ANAL CHIM ACTA, V1012, P90, DOI 10.1016/j.aca.2018.01.042; Mu HT, 2018, SPECTROCHIM ACTA A, V194, P83, DOI 10.1016/j.saa.2018.01.008; Mu HT, 2015, ANALYST, V140, P1037, DOI 10.1039/c4an02155j; Pastor M, 1997, J MED CHEM, V40, P1455, DOI 10.1021/jm9608016; Rowe AM, 2008, BASIC CLIN PHARMACOL, V102, P139, DOI 10.1111/j.1742-7843.2007.00175.x; Shin JY, 2005, ENVIRON TOXICOL CHEM, V24, P1353, DOI 10.1897/04-248R.1; Sliwoski G, 2014, PHARMACOL REV, V66, P334, DOI 10.1124/pr.112.007336; STAHLE L, 1987, Journal of Chemometrics, V1, P185, DOI 10.1002/cem.1180010306; Tian Y, 2017, CHEM ENG J, V330, P1075, DOI 10.1016/j.cej.2017.08.048; Tosco P, 2011, J COMPUT AID MOL DES, V25, P777, DOI 10.1007/s10822-011-9462-9; Tosco P, 2011, J MOL MODEL, V17, P201, DOI 10.1007/s00894-010-0684-x; Tropsha A, 2010, MOL INFORM, V29, P476, DOI 10.1002/minf.201000061; Wang ZH, 2007, ANAL CHEM, V79, P4471, DOI 10.1021/ac070064t; Wang ZH, 2012, INT J MOL SCI, V13, P6334, DOI 10.3390/ijms13056334; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1; Xie Y, 2018, PEST MANAG SCI, V74, P189, DOI 10.1002/ps.4693; Xu ZL, 2010, ANAL CHEM, V82, P9314, DOI 10.1021/ac1018414; Xu ZL, 2009, ANAL CHIM ACTA, V647, P90, DOI 10.1016/j.aca.2009.05.025; Yuan M, 2012, J AGR FOOD CHEM, V60, P10486, DOI 10.1021/jf303256r; Yuan M, 2011, ANAL CHEM, V83, P4767, DOI 10.1021/ac200227v; Zuo Y, 2016, J AGR FOOD CHEM, V64, P552, DOI 10.1021/acs.jafc.5b05378	37	2	2	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0214879	10.1371/journal.pone.0214879	http://dx.doi.org/10.1371/journal.pone.0214879			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR5NS	30943259	Green Submitted, Green Published, gold			2022-12-26	WOS:000463194300067
J	Di Giorgio, JAP; Lepage, E; Tremblay-Belzile, S; Truche, S; Loubert-Hudon, A; Brisson, N				Di Giorgio, Juliana Andrea Perez; Lepage, Etienne; Tremblay-Belzile, Samuel; Truche, Sebastien; Loubert-Hudon, Audrey; Brisson, Normand			Transcription is a major driving force for plastid genome instability in Arabidopsis	PLOS ONE			English	Article							DOUBLE-STRAND BREAK; EARLY CHLOROPLAST DEVELOPMENT; LIGHT-INDUCED TRANSCRIPTION; SIGMA-FACTOR; R-LOOPS; GENE-EXPRESSION; RNA-POLYMERASE; DNA-REPAIR; PROTEIN; REPLICATION	Though it is an essential process, transcription can be a source of genomic instability. For instance, it may generate RNA:DNA hybrids as the nascent transcript hybridizes with the complementary DNA template. These hybrids, called R-loops, act as a major cause of replication fork stalling and DNA breaks. In this study, we show that lowering transcription and R-loop levels in plastids of Arabidopsis thaliana reduces DNA rearrangements and mitigates plastid genome instability phenotypes. This effect can be observed on a genome-wide scale, as the loss of the plastid sigma transcription factor SIG6 prevents DNA rearrangements by favoring conservative repair in the presence of ciprofloxacin-induced DNA damage or in the absence of plastid genome maintenance actors such as WHY1/WHY3, RECA1 and POLIB. Additionally, resolving R-loops by the expression of a plastid-targeted exogenous RNAse H1 produces similar results. We also show that highly-transcribed genes are more susceptible to DNA rearrangements, as increased transcription of the psbD operon by SIG5 correlates with more locus-specific rearrangements. The effect of transcription is not specific to Sigma factors, as decreased global transcription levels by mutation of heat-stress-induced factor HSP21, mutation of nuclear-encoded polymerase RPOTp, or treatment with transcription-inhibitor rifampicin all prevent the formation of plastid genome rearrangements, especially under induced DNA damage conditions.	[Di Giorgio, Juliana Andrea Perez; Lepage, Etienne; Tremblay-Belzile, Samuel; Truche, Sebastien; Loubert-Hudon, Audrey; Brisson, Normand] Univ Montreal, Dept Biochem & Mol Med, Montreal, PQ, Canada	Universite de Montreal	Di Giorgio, JAP (corresponding author), Univ Montreal, Dept Biochem & Mol Med, Montreal, PQ, Canada.	juliana.perez@umontreal.ca		Perez Di Giorgio, Juliana/0000-0002-8959-5500	Natural Sciences and Engineering Research Council of Canada (NSERC); NSERC	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by scholarships from the Natural Sciences and Engineering Research Council of Canada (NSERC) to E.L. and S.T.B., and grants from NSERC to N.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera A, 2017, NAT STRUCT MOL BIOL, V24, P439, DOI 10.1038/nsmb.3395; Aguilera A, 2012, MOL CELL, V46, P115, DOI 10.1016/j.molcel.2012.04.009; Amon JD, 2016, ELIFE, V5, DOI 10.7554/eLife.20533; Asara JM, 2006, NAT PROTOC, V1, P46, DOI 10.1038/nprot.2006.7; Barkan A, 2014, ANNU REV PLANT BIOL, V65, P415, DOI 10.1146/annurev-arplant-050213-040159; BAUMGARTNER BJ, 1993, PLANT PHYSIOL, V101, P781, DOI 10.1104/pp.101.3.781; Bock S, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00667; Borner T, 2015, BBA-BIOENERGETICS, V1847, P761, DOI 10.1016/j.bbabio.2015.02.004; Bouwman BAM, 2018, GENES-BASEL, V9, DOI 10.3390/genes9120632; Callegari AJ, 2016, DNA REPAIR, V41, P1, DOI 10.1016/j.dnarep.2016.03.001; Cappadocia L, 2010, PLANT CELL, V22, P1849, DOI 10.1105/tpc.109.071399; Castandet B, 2016, G3-GENES GENOM GENET, V6, P2817, DOI 10.1534/g3.116.030783; Chakraborty A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13049; Chang EYC, 2017, GENES-BASEL, V8, DOI 10.3390/genes8010033; Chi W, 2008, PLANT PHYSIOL, V147, P573, DOI 10.1104/pp.108.116194; Chi W, 2015, BBA-BIOENERGETICS, V1847, P770, DOI 10.1016/j.bbabio.2015.01.001; Chi W, 2010, PLANT J, V64, P14, DOI 10.1111/j.1365-313X.2010.04304.x; Costes Audrey, 2012, Biomolecules, V3, P39, DOI 10.3390/biom3010039; De Septenville AL, 2012, PLOS GENET, V8, P116, DOI 10.1371/journal.pgen.1002622; Deng SK, 2014, NAT STRUCT MOL BIOL, V21, P405, DOI 10.1038/nsmb.2786; Drouin G, 2008, MOL PHYLOGENET EVOL, V49, P827, DOI 10.1016/j.ympev.2008.09.009; Dutta D, 2011, CELL, V146, P533, DOI 10.1016/j.cell.2011.07.034; Evans-Roberts KM, 2016, J BIOL CHEM, V291, P3136, DOI 10.1074/jbc.M115.689554; Ferrarini M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-670; Gadaleta MC, 2017, GENES-BASEL, V8, DOI 10.3390/genes8030098; Gaillard H, 2016, ANNU REV BIOCHEM, V85, P291, DOI 10.1146/annurev-biochem-060815-014908; Garcia-Muse T, 2016, NAT REV MOL CELL BIO, V17, P553, DOI 10.1038/nrm.2016.88; Ghulam MM, 2012, PLANT MOL BIOL, V79, P259, DOI 10.1007/s11103-012-9910-5; Goldberg S, 2015, METHODS MOL BIOL, V1295, P1, DOI 10.1007/978-1-4939-2550-6_1; Gowrishankar J, 2013, TRANSCR-AUSTIN, V4, P153, DOI 10.4161/trns.25101; Hamperl S, 2016, CELL, V167, P1455, DOI 10.1016/j.cell.2016.09.053; Hartono SR, 2018, J MOL BIOL, V430, P272, DOI 10.1016/j.jmb.2017.12.016; Hricova A, 2006, PLANT PHYSIOL, V141, P942, DOI 10.1104/pp.106.080069; Huang C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073092; Ishizaki Y, 2005, PLANT J, V42, P133, DOI 10.1111/j.1365-313X.2005.02362.x; Kamarthapu V, 2015, CURR OPIN MICROBIOL, V24, P15, DOI 10.1016/j.mib.2014.12.005; Kanamaru K, 2001, PLANT CELL PHYSIOL, V42, P1034, DOI 10.1093/pcp/pce155; Kantidze OL, 2016, ACTA NATURAE, V8, P75, DOI 10.32607/20758251-2016-8-2-75-78; Kim N, 2012, NAT REV GENET, V13, P204, DOI 10.1038/nrg3152; KLEIN RR, 1990, J BIOL CHEM, V265, P1895; Konig F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178875; Kwon T, 2010, P NATL ACAD SCI USA, V107, P13954, DOI 10.1073/pnas.1004326107; Lai ZB, 2011, PLANT CELL, V23, P3824, DOI 10.1105/tpc.111.090571; Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090; Lee DW, 2006, PLANT PHYSIOL, V140, P466, DOI 10.1104/pp.105.074575; Lepage E, 2013, PLANT PHYSIOL, V163, P867, DOI 10.1104/pp.113.223560; Lerbs-Mache S, 2011, PLANT MOL BIOL, V76, P235, DOI 10.1007/s11103-010-9714-4; Little SE, 1997, LARGE OR SMALL SCALE, P1; Loschelder H, 2006, PLANT PHYSIOL, V142, P642, DOI 10.1104/pp.106.085878; Lysenko EA, 2007, PLANT CELL REP, V26, P845, DOI 10.1007/s00299-007-0318-7; Majeran W, 2012, PLANT PHYSIOL, V158, P156, DOI 10.1104/pp.111.188474; Marechal A, 2009, P NATL ACAD SCI USA, V106, P14693, DOI 10.1073/pnas.0901710106; McDevitt S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03483-7; McVey M, 2008, TRENDS GENET, V24, P529, DOI 10.1016/j.tig.2008.08.007; Meers C, 2016, DNA REPAIR, V44, P17, DOI 10.1016/j.dnarep.2016.05.002; Merrikh H, 2012, NAT REV MICROBIOL, V10, P449, DOI 10.1038/nrmicro2800; Merrikh H, 2011, NATURE, V470, P554, DOI 10.1038/nature09758; Nagashima A, 2004, PLANT CELL PHYSIOL, V45, P357, DOI 10.1093/pcp/pch050; Nguyen HD, 2017, MOL CELL, V65, P832, DOI 10.1016/j.molcel.2017.01.029; Nukarinen E, 2016, SCI REP-UK, V6, DOI 10.1038/srep31697; Oh S, 2013, J EXP BOT, V64, P5457, DOI 10.1093/jxb/ert308; Ohle C, 2016, CELL, V167, P1001, DOI 10.1016/j.cell.2016.10.001; Olejniczak SA, 2016, PLANTA, V244, P517, DOI 10.1007/s00425-016-2551-1; Ortelt J, 2014, METHODS MOL BIOL, V1132, P47, DOI 10.1007/978-1-62703-995-6_3; Parent JS, 2011, PLANT PHYSIOL, V156, P254, DOI 10.1104/pp.111.173849; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Prikryl J, 2008, NUCLEIC ACIDS RES, V36, P5152, DOI 10.1093/nar/gkn492; Schlucking K, 2013, MOL PLANT, V6, P1814, DOI 10.1093/mp/sst065; Schweer J, 2006, FEBS LETT, V580, P6617, DOI 10.1016/j.febslet.2006.11.010; Shikanai T, 2013, FUNCTION PPR PROTEIN, P6286, DOI [10.4161/rna.25207, DOI 10.4161/RNA.25207]; Singh SK, 2011, PLANT SIGNAL BEHAV, V6, P120, DOI 10.4161/psb.6.1.14215; Skourti-Stathaki K, 2014, GENE DEV, V28, P1384, DOI 10.1101/gad.242990.114; Slager J, 2014, CELL, V157, P395, DOI 10.1016/j.cell.2014.01.068; Sollier J, 2015, TRENDS CELL BIOL, V25, P514, DOI 10.1016/j.tcb.2015.05.003; Srivatsan A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000810; Stern DB, 2010, ANNU REV PLANT BIOL, V61, P125, DOI 10.1146/annurev-arplant-042809-112242; Stoppel R, 2012, J EXP BOT, V63, P1663, DOI 10.1093/jxb/err401; Tadi SK, 2016, MOL BIOL CELL, V27, P223, DOI 10.1091/mbc.E15-05-0260; Tsunoyama Y, 2004, P NATL ACAD SCI USA, V101, P3304, DOI 10.1073/pnas.0308362101; Tsunoyama Y, 2002, FEBS LETT, V516, P225, DOI 10.1016/S0014-5793(02)02538-3; Villarreal DD, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003026; Wahba L, 2011, MOL CELL, V44, P978, DOI 10.1016/j.molcel.2011.10.017; Wei LZ, 2016, DNA REPAIR, V44, P76, DOI 10.1016/j.dnarep.2016.05.009; Weigel D., 2002, ARABIDOPSIS LAB MANU; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Woodson Jesse D, 2013, Plant J, V73, P1, DOI 10.1111/tpj.12011; Wu J, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00243; Xia J, 2019, CELL, V176, P127, DOI 10.1016/j.cell.2018.12.008; Yagi Y, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00061; Zampini E, 2015, GENOME RES, V25, P645, DOI 10.1101/gr.188573.114; Zeman MK, 2014, NAT CELL BIOL, V16, P2, DOI 10.1038/ncb2897; Zghidi W, 2007, NUCLEIC ACIDS RES, V35, P455, DOI 10.1093/nar/gkl1067; ZHANG Y, 2017, PLANT CELL, P1, DOI DOI 10.1105/TPC.17.00065; Zhelyazkova P, 2012, PLANT CELL, V24, P123, DOI 10.1105/tpc.111.089441; Zhong LL, 2013, PLANT CELL, V25, P2925, DOI 10.1105/tpc.113.111229; Zhou WB, 2009, PLANT J, V58, P82, DOI 10.1111/j.1365-313X.2008.03766.x; Zubo YO, 2011, METHODS MOL BIOL, V774, P171, DOI 10.1007/978-1-61779-234-2_11	97	5	5	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0214552	10.1371/journal.pone.0214552	http://dx.doi.org/10.1371/journal.pone.0214552			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR5NS	30943245	gold, Green Submitted, Green Published			2022-12-26	WOS:000463194300046
J	Paris, AJ; Guo, L; Dai, N; Katzen, JB; Patel, PN; Worthen, S; Brenner, JS				Paris, Andrew J.; Guo, Lei; Dai, Ning; Katzen, Jeremy B.; Patel, Priyal N.; Worthen, Scott; Brenner, Jacob S.			Using selective lung injury to improve murine models of spatially heterogeneous lung diseases	PLOS ONE			English	Article							ACUTE RESPIRATORY-DISTRESS; INFLUENZA-VIRUS; STEM-CELLS; REGENERATION; RESOLUTION	Many lung diseases, such as the acute respiratory distress syndrome (ARDS), display significant regional heterogeneity with patches of severely injured tissue adjacent to apparently healthy tissue. Current mouse models that aim to mimic ARDS generally produce diffuse injuries that cannot reproducibly generate ARDS's regional heterogeneity. This deficiency prevents the evaluation of how well therapeutic agents reach the most injured regions and precludes many regenerative medicine studies since it is not possible to know which apparently healing regions suffered severe injury initially. Finally, these diffuse injury models must be relatively mild to allow for survival, as their diffuse nature does not allow for residual healthy lung to keep an animal alive long enough for many drug and regenerative medicine studies. To solve all of these deficiencies in current animal models, we have created a simple and reproducible technique to selectively induce lung injury in specific areas of the lung. Our technique, catheter-in-catheter selective lung injury (CICSLI), involves guiding an inner catheter to a particular area of the lung and delivering an injurious agent mixed with nanoparticles (fluorescently and/or radioactively labeled) that can be used days later to track the location and extent of where the initial injury occurred. Furthermore, we demonstrate that CICSLI can produce a more severe injury than diffuse models, yet has much higher survival since CICSLI intentionally leaves lung regions undamaged. Collectively, these attributes of CICSLI will allow investigators to better study how drugs act within heterogeneous lung pathologies and how regeneration occurs in severely damaged lung tissue, thereby aiding the development of new therapies for ARDS and other heterogenous lung diseases.	[Paris, Andrew J.; Katzen, Jeremy B.; Patel, Priyal N.; Brenner, Jacob S.] Univ Penn, Dept Med, Div Pulm Allergy & Crit Care Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Guo, Lei] Chinese Acad Med Sci, Kunming Natl High Level Biosafety Res Ctr, Inst Med Biol, Kunming, Yunnan, Peoples R China; [Dai, Ning; Worthen, Scott] Univ Penn, Dept Pediat, Div Neonatol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Patel, Priyal N.; Brenner, Jacob S.] Univ Penn, Perelman Sch Med, Dept Syst Pharmacol & Translat Therapeut, Philadelphia, PA 19104 USA; [Patel, Priyal N.; Brenner, Jacob S.] Univ Penn, Perelman Sch Med, Ctr Translat Targeted Therapeut & Nanomed, Philadelphia, PA 19104 USA; [Worthen, Scott] Univ Penn, Penn Ctr Pulm Biol, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medical Biology - CAMS; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Brenner, JS (corresponding author), Univ Penn, Dept Med, Div Pulm Allergy & Crit Care Med, Perelman Sch Med, Philadelphia, PA 19104 USA.; Brenner, JS (corresponding author), Univ Penn, Perelman Sch Med, Dept Syst Pharmacol & Translat Therapeut, Philadelphia, PA 19104 USA.; Brenner, JS (corresponding author), Univ Penn, Perelman Sch Med, Ctr Translat Targeted Therapeut & Nanomed, Philadelphia, PA 19104 USA.	Jacob.Brenner@uphs.upenn.edu	Guo, Lei/AEU-0178-2022	Paris, Andrew/0000-0002-9808-071X; Guo, Lei/0000-0003-1733-1802; Patel, Priyal/0000-0003-0569-0699	Univesrty of Pennsylvania Measey Physician Scientist Fellowship Alward; Parker B. Francis Fellowship Program;  [NIH - K08 HL136698];  [K08 HL138269];  [R01 AI099479];  [UG3 TR002198]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UG3TR002198] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL136698, K08HL138269] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI099479] Funding Source: NIH RePORTER	Univesrty of Pennsylvania Measey Physician Scientist Fellowship Alward; Parker B. Francis Fellowship Program; ; ; ; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded through the generous support of the Univesrty of Pennsylvania Measey Physician Scientist Fellowship Alward (AJP), the Parker B. Francis Fellowship Program (AJP), and multiple grants form the NIH - K08 HL136698 (AJP), K08 HL138269 (JSB), R01 AI099479 (GSW) and UG3 TR002198 (GSW).	Amigoni M, 2008, ANESTHESIOLOGY, V108, P1037, DOI 10.1097/ALN.0b013e318173f64f; ASHBAUGH DG, 1967, LANCET, V2, P319; Barkauskas CE, 2013, J CLIN INVEST, V123, P3025, DOI 10.1172/JCI68782; Bellani G, 2016, JAMA-J AM MED ASSOC, V315, P788, DOI 10.1001/jama.2016.0291; Bernard G, 2017, NEW ENGL J MED, V377, P507, DOI 10.1056/NEJMp1706595; Brenner Jacob S, 2017, Nanomedicine, V13, P1495, DOI 10.1016/j.nano.2016.12.019; Chapman HA, 2011, NEW ENGL J MED, V364, P1867, DOI 10.1056/NEJMe1101800; Cross LJM, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-51; Dames C, 2014, AM J RESP CELL MOL, V51, P730, DOI 10.1165/rcmb.2014-0052MA; Das S, 2013, JOVE-J VIS EXP, DOI 10.3791/50318; Fukunaga K, 2005, J IMMUNOL, V174, P5033, DOI 10.4049/jimmunol.174.8.5033; Guerin C, 2013, NEW ENGL J MED, V368, P2159, DOI 10.1056/NEJMoa1214103; Jaramillo-Rocha V, 2017, NEW ENGL J MED, V377, P1903, DOI 10.1056/NEJMc1711824; Kips JC, 2003, EUR RESPIR J, V22, P374, DOI 10.1183/09031936.03.00026403; Kretzschmar K, 2012, CELL, V148, P33, DOI 10.1016/j.cell.2012.01.002; Lederer DJ, 2018, NEW ENGL J MED, V378, P1811, DOI 10.1056/NEJMra1705751; MATTHAY MA, 1990, AM REV RESPIR DIS, V142, P1250, DOI 10.1164/ajrccm/142.6_Pt_1.1250; Matthay MA, 2016, JAMA-J AM MED ASSOC, V315, P747, DOI 10.1001/jama.2016.0661; Matute-Bello G, 2008, AM J PHYSIOL-LUNG C, V295, pL379, DOI 10.1152/ajplung.00010.2008; Matute-Bello G, 2011, AM J RESP CELL MOL, V44, P725, DOI 10.1165/rcmb.2009-0210ST; Morales-Nebreda L, 2014, J VIROL METHODS, V209, P116, DOI 10.1016/j.jviromet.2014.09.004; Mouratis MA, 2011, CURR OPIN PULM MED, V17, P355, DOI 10.1097/MCP.0b013e328349ac2b; Musher DM, 2014, NEW ENGL J MED, V371, P1619, DOI 10.1056/NEJMra1312885; Nuermberger E, 2005, PHARMACOTHERAPY, V25, p134S, DOI 10.1592/phco.2005.25.12part2.134S; Paris AJ, 2016, AM J PHYSIOL-LUNG C, V311, pL1062, DOI 10.1152/ajplung.00327.2016; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Ray S, 2016, STEM CELL REP, V7, P817, DOI 10.1016/j.stemcr.2016.09.010; Standiford TJ, 2016, TRANSL RES, V167, P183, DOI 10.1016/j.trsl.2015.04.015; Vaughan AE, 2015, NATURE, V517, P621, DOI 10.1038/nature14112; Vlahos R, 2014, CLIN SCI, V126, P253, DOI 10.1042/CS20130182; Zacharias WJ, 2018, NATURE, V555, P251, DOI 10.1038/nature25786; Zuo W, 2015, NATURE, V517, P616, DOI 10.1038/nature13903	32	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0202456	10.1371/journal.pone.0202456	http://dx.doi.org/10.1371/journal.pone.0202456			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR5NS	30943189	gold, Green Published, Green Submitted			2022-12-26	WOS:000463194300001
J	Burns, NM; Bailey, DM; Wright, PJ				Burns, Neil M.; Bailey, David M.; Wright, Peter J.			A method to improve fishing selectivity through age targeted fishing using life stage distribution modelling	PLOS ONE			English	Article							WHITING MERLANGIUS-MERLANGUS; COD GADUS-MORHUA; HADDOCK MELANOGRAMMUS-AEGLEFINUS; FISHERIES-INDUCED EVOLUTION; NORTH-SEA; SPAWNING GROUNDS; ATLANTIC COD; MATURATION SCHEDULES; SPECIES DISTRIBUTION; HABITAT SELECTION	Understanding spatial distributions of fish species is important to those seeking to manage fisheries and advise on marine developments. Distribution patterns, habitat use, and aggregative behaviour often vary throughout the life cycle and can increase the vulnerability of certain life stages to anthropogenic impacts. Here we investigate distribution changes during the life cycle of whiting (Merlangius merlangus) to the west of the UK. Density distributions for age-0, age-1 and mature fish were modelled as functions of environmental variables using generalised additive mixed effects models. The greatest densities of age-0 whiting occurred over finer sediments where temperatures were between 12 to 13 degrees C. Age-0 whiting densities decreased with increasing depth. Higher densities of age-1 whiting were also associated with fine sediments and peaked at 60 m, but this influence was also dependent on proximity to shore. Mature fish, while showing no association with any particular sediment type, were strongly associated with depths >60 m. Geostatistical aggregation curves were used to classify space use and showed persistent aggregations of age-0 whiting occupying inshore waters while age-1 and mature fish were more dispersed and differed among years. The differences in distributions among life stages suggested a general coastal to offshore shift as cohorts developed with mature whiting mainly occupying deep offshore waters. The spatial dynamics and areas of persistent life stage aggregation identified here could enable informed targeting and avoidance of specific age-class whiting to aid bycatch reduction. Given that landing obligation legislation is counterproductive unless it encourages greater fishing selectivity, the ability to avoid this species and undersized individuals would aid conservation measures and fishermen alike.	[Burns, Neil M.; Bailey, David M.] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Glasgow, Lanark, Scotland; [Burns, Neil M.; Wright, Peter J.] Marine Lab, Marine Scotland Sci, Aberdeen, Scotland	University of Glasgow; Marine Scotland Science (MSS)	Burns, NM (corresponding author), Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Glasgow, Lanark, Scotland.; Burns, NM (corresponding author), Marine Lab, Marine Scotland Sci, Aberdeen, Scotland.	neil.burns@glasgow.ac.uk	WRIGHT, PETER J/C-8536-2011; Bailey, David/A-6240-2008	Bailey, David/0000-0002-0824-8823; Burns, Neil/0000-0002-6453-0161	Scottish Government Clyde 2020 project [ST02i]	Scottish Government Clyde 2020 project	This work was funded by the Scottish Government Clyde 2020 project (ST02i). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander KA, 2015, ICES J MAR SCI, V72, P436, DOI 10.1093/icesjms/fsu149; Andre Carl, 2016, BMC Research Notes, V9, P63, DOI 10.1186/s13104-016-1878-9; [Anonymous], 2016, ICES DAT PORT OC; Apostolaki P, 2002, CAN J FISH AQUAT SCI, V59, P405, DOI 10.1139/F02-018; Asjes A, 2016, MAR ECOL PROG SER, V553, P203, DOI 10.3354/meps11754; ATKINSON RJA, 1987, J FISH BIOL, V31, P639, DOI 10.1111/j.1095-8649.1987.tb05268.x; Babcock EA, 2005, ICES J MAR SCI, V62, P469, DOI 10.1016/j.icesjms.2005.01.010; Bailey N, 2011, W SCOTLAND MARINE EC; Baskett ML, 2005, ECOL APPL, V15, P882, DOI 10.1890/04-0723; Baudron AR, 2019, FISH RES, V211, P217, DOI 10.1016/j.fishres.2018.10.024; Baudron AR, 2019, P NATL ACAD SCI USA, V116, P2390, DOI 10.1073/pnas.1817295116; Beck MW, 2001, BIOSCIENCE, V51, P633, DOI 10.1641/0006-3568(2001)051[0633:TICAMO]2.0.CO;2; BGS, 2007, EDINA GEOL DIG SERV; Bivand, 2016, RGEOS INTERFACE GEOM; Bivand R., 2013, APPL SPATIAL DATA AN, V2nd; BOWERS AB, 1954, J MAR BIOL ASSOC UK, V33, P97, DOI 10.1017/S0025315400003507; Charrier G, 2007, MAR ECOL PROG SER, V330, P201, DOI 10.3354/meps330201; Ciannelli L, 2013, MAR ECOL PROG SER, V480, P227, DOI 10.3354/meps10067; Colloca F, 2009, MAR ECOL PROG SER, V381, P287, DOI 10.3354/meps07942; Conover DO, 2009, P ROY SOC B-BIOL SCI, V276, P2015, DOI 10.1098/rspb.2009.0003; Conover DO, 2000, MAR ECOL PROG SER, V208, P303; COOPER A, 1983, J FISH BIOL, V22, P317, DOI 10.1111/j.1095-8649.1983.tb04755.x; Coull K, 1998, FISHERIES SENSITIVIT; DAAN N, 1990, NETH J SEA RES, V26, P343, DOI 10.1016/0077-7579(90)90096-Y; Demain DK, 2011, J FISH BIOL, V79, P89, DOI 10.1111/j.1095-8649.2011.02997.x; Dickey-Collas M, 2010, ICES J MAR SCI, V67, P1875, DOI 10.1093/icesjms/fsq033; Dormann CF, 2007, BASIC APPL ECOL, V8, P387, DOI 10.1016/j.baae.2006.11.001; Douvere F, 2008, MAR POLICY, V32, P762, DOI 10.1016/j.marpol.2008.03.021; Dunlop ES, 2009, ECOL APPL, V19, P1815, DOI 10.1890/08-1404.1; Eigaard OR, 2017, ICES J MAR SCI, V74, P847, DOI 10.1093/icesjms/fsw194; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Enberg K, 2009, EVOL APPL, V2, P394, DOI 10.1111/j.1752-4571.2009.00077.x; Fernandes PG, 2011, ICES J MAR SCI, V68, P1734, DOI 10.1093/icesjms/fsr131; Frank KT, 2018, P NATL ACAD SCI USA, V115, P6422, DOI 10.1073/pnas.1802096115; Frisk MG, 2014, FISH FISH, V15, P242, DOI 10.1111/faf.12014; Garrod D, 1965, FISH INVEST-LONDON, P24, DOI 10.1371/journal.pgen.1000643; Gonzalez-Irusta JM, 2017, FISH RES, V195, P141, DOI 10.1016/j.fishres.2017.07.005; Gonzalez-Irusta JM, 2016, FISH RES, V183, P180, DOI 10.1016/j.fishres.2016.05.028; Gonzalez-Irusta JM, 2016, ICES J MAR SCI, V73, P304, DOI 10.1093/icesjms/fsv180; GORDON JDM, 1977, J FISH BIOL, V10, P587, DOI 10.1111/j.1095-8649.1977.tb04091.x; Greenstreet SPR, 1997, ICES J MAR SCI, V54, P243, DOI 10.1006/jmsc.1996.0183; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; HALLIDAY RG, 1988, NAFO SCI COUN STUDIE, V12, P27; HAWKINS AD, 1978, J MAR BIOL ASSOC UK, V58, P891, DOI 10.1017/S0025315400056848; Heath MR, 2012, P ROY SOC B-BIOL SCI, V279, P543, DOI 10.1098/rspb.2011.1015; Heino M, 1998, CAN J FISH AQUAT SCI, V55, P1971, DOI 10.1139/cjfas-55-8-1971; Heino M, 2002, B MAR SCI, V70, P639; Heino M, 2015, ANNU REV ECOL EVOL S, V46, P461, DOI 10.1146/annurev-ecolsys-112414-054339; Hijmans RJ, 2014, RASTER GEOGRAPHIC DA, DOI [10.1016/j.indcrop.2009.04.001, DOI 10.1016/J.INDCROP.2009.04.001]; Hislop J. R. G., 1975, ICES J MAR SCI, V36, P119, DOI [10.1093/icesjms/36.2.119, DOI 10.1093/ICESJMS/36.2.119]; HISLOP JRG, 1976, J CONSEIL, V37, P98; HISLOP JRG, 1974, J CONSEIL, V36, P42; HISLOP JRG, 1991, ICES J MAR SCI, V48, P139, DOI 10.1093/icesjms/48.2.139; Hunter A, 2015, FISH RES, V170, P14, DOI 10.1016/j.fishres.2015.05.004; ICES, 2017, ICES CM DOC; ICES, 2010, MAN INT BOTT TRAWL S; ICES, 2016, ADV JUN 2016 CELT SE, P1; International Hydrographic Organization, 2014, INT HYDR ORG PUBL B, P331, DOI [10.1016/0198-0149(86)90015-4, DOI 10.1016/0198-0149(86)90015-4]; Keitt TH., 2010, RGDAL BINDINGS GEOSP; Kelleher K., 2005, FAO FISHERIES TECHNI; Kuparinen A, 2009, EVOL APPL, V2, P234, DOI 10.1111/j.1752-4571.2009.00070.x; Law R, 2007, MAR ECOL PROG SER, V335, P271, DOI 10.3354/meps335271; Le Pape O, 2003, J SEA RES, V50, P139, DOI 10.1016/S1385-1101(03)00059-5; Le Quesne WJF, 2007, FISH FISH, V8, P181, DOI 10.1111/j.1467-2679.2007.00246.x; Lelievre S, 2014, J SEA RES, V91, P1, DOI 10.1016/j.seares.2014.03.008; Lloret J, 2002, ICES J MAR SCI, V59, P1215, DOI 10.1006/jmsc.2002.1294; Long D., 2006, FOLK; Loots C, 2011, FISH OCEANOGR, V20, P18, DOI 10.1111/j.1365-2419.2010.00564.x; MacCall AD, 1988, DYNAMIC GEOGRAPHY MA; Marteinsdottir G, 2000, ICES J MAR SCI, V57, P824, DOI 10.1006/jmsc.2000.0568; Matthiopoulos J, 2015, ECOL MONOGR, V85, P413, DOI 10.1890/14-2244.1; Mengual B, 2016, OCEAN DYNAM, V66, P1181, DOI 10.1007/s10236-016-0974-7; Metz J, 2000, CAMBRIDGE STUDIES AD, DOI [10.1017/CBO9780511525537, DOI 10.1017/CBO9780511525537]; Millar RB, 1999, REV FISH BIOL FISHER, V9, P89, DOI 10.1023/A:1008838220001; Miller J, 2007, ECOL MODEL, V202, P225, DOI 10.1016/j.ecolmodel.2006.12.012; Myers RA, 1996, MAR ECOL PROG SER, V138, P293, DOI 10.3354/meps138293; Nychka D., 2017, FIELDS TOOLS SPATIAL, DOI [10.5065/D6W957CT, DOI 10.5065/D6W957CT.R]; Oberle FKJ, 2016, J MARINE SYST, V159, P120, DOI 10.1016/j.jmarsys.2015.12.008; Petitgas P, 1998, ICES J MAR SCI, V55, P443, DOI 10.1006/jmsc.1997.0345; Povoa I, 2011, AQUAC RES, V42, P386, DOI 10.1111/j.1365-2109.2010.02632.x; R Core Team, 2018, R LANG ENV STAT COMP; Riley K., 2007, MARINE LIFE INFORM N; ROBB AP, 1981, J FISH BIOL, V18, P183, DOI 10.1111/j.1095-8649.1981.tb02813.x; Rose GA, 1999, CAN J FISH AQUAT SCI, V56, P118, DOI 10.1139/cjfas-56-S1-118; Schrope M, 2010, NATURE, V465, P540, DOI 10.1038/465540a; Sharpe DMT, 2009, EVOL APPL, V2, P260, DOI 10.1111/j.1752-4571.2009.00080.x; Shepherd TD, 2004, FISH FISH, V5, P141, DOI 10.1111/j.1467-2979.2004.00143.x; Sheridan A.K., 1995, Reviews in Fisheries Science, V3, P91; Simmonds EJ, 2007, ICES J MAR SCI, V64, P686, DOI 10.1093/icesjms/fsm045; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Stefansson G, 1996, ICES J MAR SCI, V53, P577, DOI 10.1006/jmsc.1996.0079; Tobin D, 2010, MAR BIOL, V157, P1063, DOI 10.1007/s00227-009-1387-7; Trenkel VM, 2005, MAR ECOL PROG SER, V299, P257, DOI 10.3354/meps299257; TRIPPEL EA, 1995, BIOSCIENCE, V45, P759, DOI 10.2307/1312628; Ummenhofer CC, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0135; USDC (U. S. Department of Commerce), 2007, MAGN STEV FISH CONS, P178; van Overzee HMJ, 2015, REV FISH BIOL FISHER, V25, P65, DOI 10.1007/s11160-014-9370-x; Watling L, 1998, CONSERV BIOL, V12, P1180, DOI 10.1046/j.1523-1739.1998.0120061180.x; Whitehead PJP, 1989, FISHES NE ATLANTIC M, VI; WINTERS GH, 1985, CAN J FISH AQUAT SCI, V42, P989, DOI 10.1139/f85-124; Wood S., 2014, GAMM4 GEN ADDITIVE M; Wright PJ, 2014, ICES J MAR SCI, V71, P1393, DOI 10.1093/icesjms/fsu100; Wright PJ, 2011, ICES J MAR SCI, V68, P1918, DOI 10.1093/icesjms/fsr111; Zuur Alain F., 2009, P1	104	2	2	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2019	14	4							e0214459	10.1371/journal.pone.0214459	http://dx.doi.org/10.1371/journal.pone.0214459			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR2UW	30939152	Green Submitted, Green Accepted, Green Published, gold			2022-12-26	WOS:000462993900022
J	Sanada, TJ; Sakao, S; Naito, A; Ishibashi-Ueda, H; Suga, M; Shoji, H; Miwa, H; Suda, R; Iwasawa, S; Tada, Y; Ishida, K; Tanabe, N; Tatsumi, K				Sanada, Takayuki Jujo; Sakao, Seiichiro; Naito, Akira; Ishibashi-Ueda, Hatsue; Suga, Masaki; Shoji, Hiroki; Miwa, Hideki; Suda, Rika; Iwasawa, Shunichiro; Tada, Yuji; Ishida, Keiichi; Tanabe, Nobuhiro; Tatsumi, Koichiro			Characterization of pulmonary intimal sarcoma cells isolated from a surgical specimen: In vitro and in vivo study	PLOS ONE			English	Article							KINASE INHIBITOR; ARTERY SARCOMA; PAZOPANIB; RECEPTOR; GROWTH; TARGETS; CANCER	Pulmonary intimal sarcoma (PIS) constitutes a rare sarcoma originating from the intimal cells of pulmonary arteries. The pathogenesis of PIS remains to be elucidated and specific treatments have not been established; therefore, prognosis is generally poor. The purpose of our study was to isolate and characterize PIS cells from a specimen resected from a patient with PIS. The surgical specimen was minced and incubated, and spindle-shaped and small cells were successfully isolated and designated as PIS-1. PIS-1 cells at passages 8-9 were used for all in vitro and in vivo experiments. Immunocytochemistry showed that PIS-1 cells were positive for vimentin, murine double minute 2, and CD44 and negative for a-smooth muscle actin, CD31, von Willebrand factor, and desmin. PIS-1 cells exhibited the hallmarks of malignant cells including the potential for autonomous proliferation, anchorage-independent growth, invasion, genetic instability, and tumorigenicity in severe combined immunodeficiency mice. The PIS-1 cells highly expressed tyrosine kinase receptors such as platelet-derived growth factor receptor, and vascular endothelial growth factor receptor 2. Pazopanib, a multi-targeted tyrosine kinase inhibitor, suppressed the proliferation of PIS-1 cells in vitro and the growth of tumors formed from xenografted PIS-1 cells. A PIS cell line was thus successfully established. The PIS-1 cells highly expressed tyrosine kinase receptors, which may be a target for treatment of PIS.	[Sanada, Takayuki Jujo; Sakao, Seiichiro; Naito, Akira; Suga, Masaki; Shoji, Hiroki; Miwa, Hideki; Suda, Rika; Iwasawa, Shunichiro; Tada, Yuji; Tanabe, Nobuhiro; Tatsumi, Koichiro] Chiba Univ, Dept Respirol B2, Grad Sch Med, Chiba, Japan; [Sanada, Takayuki Jujo; Tanabe, Nobuhiro] Chiba Univ, Dept Adv Med Pulm Hypertens, Grad Sch Med, Chiba, Japan; [Naito, Akira; Iwasawa, Shunichiro] Chiba Univ, Dept Adv Res Treatment Strategies Resp Dis, Grad Sch Med, Chiba, Japan; [Ishibashi-Ueda, Hatsue] Natl Cerebral & Cardiovasc Ctr, Dept Pathol, Osaka, Japan; [Ishida, Keiichi] Chiba Univ, Grad Sch Med, Dept Cardiovasc Surg, Chiba, Japan	Chiba University; Chiba University; Chiba University; National Cerebral & Cardiovascular Center - Japan; Chiba University	Sanada, TJ (corresponding author), Chiba Univ, Dept Respirol B2, Grad Sch Med, Chiba, Japan.; Sanada, TJ (corresponding author), Chiba Univ, Dept Adv Med Pulm Hypertens, Grad Sch Med, Chiba, Japan.	naikamo_resp19184@chiba-u.jp	Jujo, Takayuki/Q-7627-2018	Jujo, Takayuki/0000-0001-5725-1810	Japan Society for the Promotion of Science from the Ministry of Culture, Sports, Science, and Technology of Japan [16K19444]; Ministry of Health, Labor, and Welfare, Japan; Japan Agency for Medical Research and Development (AMED) [27280401]; Japan Society for the Promotion of Science KAKENHI from the Ministry of Culture, Sports, Science, and Technology of Japan [15K09210]; Ministry of Education, Culture, Sports, Science, and Technology of Japan [25461148]; Japan Society for the Promotion of Science KAKENHI [17H04181]; AMED [16ek0109127h0002]	Japan Society for the Promotion of Science from the Ministry of Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labor, and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Japan Society for the Promotion of Science KAKENHI from the Ministry of Culture, Sports, Science, and Technology of Japan; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); AMED	T.J.S was supported by a Grant-in-Aid for Young Scientists (Japan Society for the Promotion of Science KAKENHI Grant Number 16K19444) from the Ministry of Culture, Sports, Science, and Technology of Japan; S.S. was supported by research grants to the Intractable Respiratory Diseases and Pulmonary Hypertension Research Group of the Ministry of Health, Labor, and Welfare, Japan, a grant to the Pulmonary Hypertension Research Group (27280401) from the Japan Agency for Medical Research and Development (AMED) and a Grant-in-Aid for Scientific Research (Japan Society for the Promotion of Science KAKENHI Grant Number 15K09210) from the Ministry of Culture, Sports, Science, and Technology of Japan; N.T. was supported by a research grant from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (25461148), and a grant to The Intractable Respiratory Diseases and Pulmonary Hypertension Research Group of the Ministry of Health, Labor, and Welfare, Japan (27280401); and K.T. was supported by a Grant-in-Aid for Scientific Research (Japan Society for the Promotion of Science KAKENHI Grant Number 17H04181) and grants to the Intractable Respiratory Diseases and Pulmonary Hypertension Research Group from the Ministry of Health, Labor, and Welfare, Japan and to the Pulmonary Hypertension Research Group from AMED (No. 16ek0109127h0002). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN NH, 1973, JOHNS HOPKINS MED J, V133, P214; Bacha EA, 1999, EUR J CARDIO-THORAC, V15, P456, DOI 10.1016/S1010-7940(99)00045-7; Blackmon SH, 2009, ANN THORAC SURG, V87, P977, DOI 10.1016/j.athoracsur.2008.08.018; Bode-Lesniewska B, 2013, WHO CLASSIFICATION T, P232; Bode-Lesniewska B, 2002, PATHOLOGY GENETICS T, P223; Dewaele B, 2010, CANCER RES, V70, P7304, DOI 10.1158/0008-5472.CAN-10-1543; Funatsu Y, 2016, INTERNAL MED, V55, P2197, DOI 10.2169/internalmedicine.55.6199; Gan HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083200; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hosaka S, 2012, J ORTHOP RES, V30, P1493, DOI 10.1002/jor.22091; Jujo T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087489; Jujo T, 2012, INT J ONCOL, V41, P701, DOI 10.3892/ijo.2012.1493; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kerr KM, 2005, NAT CLIN PRACT CARD, V2, P108, DOI 10.1038/ncpcardio0118; Kim ST, 2014, MOL CANCER THER, V13, P2527, DOI 10.1158/1535-7163.MCT-14-0255; Kollar A, 2017, ACTA ONCOL, V56, P88, DOI 10.1080/0284186X.2016.1234068; Li HF, 2014, TRANSL ONCOL, V7, P665, DOI 10.1016/j.tranon.2014.09.007; Mandelstamm M, 1923, VIRCHOWS ARCH A, V245, P43, DOI 10.1007/BF01992097; Maruoka M, 2012, INT J CARDIOL, V159, P119, DOI 10.1016/j.ijcard.2011.02.037; Miura S, 2005, PATHOL RES PRACT, V201, P469, DOI 10.1016/j.prp.2005.06.001; NONOMURA A, 1988, ACTA PATHOL JAPON, V38, P883; Outani H, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-455; Ozbek C, 2007, TEX HEART I J, V34, P119; Quesada Jorge, 2012, Sarcoma, V2012, P849456, DOI 10.1155/2012/849456; Sakao S, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-109; Tamborini E, 2007, J PATHOL, V212, P227, DOI 10.1002/path.2177; Vasuri F, 2012, HISTOPATHOLOGY, V61, P737, DOI 10.1111/j.1365-2559.2012.04241.x; Wong HH, 2015, CLIN SARCOMA RES, V5, DOI 10.1186/s13569-014-0019-2	28	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2019	14	3							e0214654	10.1371/journal.pone.0214654	http://dx.doi.org/10.1371/journal.pone.0214654			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ9FO	30925179	Green Published, gold, Green Submitted			2022-12-26	WOS:000462732300025
J	Boehm, M; Bukosza, EN; Huttary, N; Herzog, R; Aufricht, C; Kratochwill, K; Gebeshuber, CA				Boehm, Michael; Bukosza, Eva Nora; Huttary, Nicole; Herzog, Rebecca; Aufricht, Christoph; Kratochwill, Klaus; Gebeshuber, Christoph A.			A systems pharmacology workflow with experimental validation to assess the potential of anakinra for treatment of focal and segmental glomerulosclerosis	PLOS ONE			English	Article							MMP-9 CONTRIBUTE; RECEPTOR; EXPRESSION; INDUCTION; PODOCYTES; DISEASE; DRUGS; MODEL; GENE	Focal and Segmental Glomerulosclerosis (FSGS) is a severe glomerulopathy that frequently leads to end stage renal disease. Only a subset of patients responds to current therapies, making it important to identify alternative therapeutic options. The interleukin (IL)-1 receptor antagonist anakinra is beneficial in several diseases with renal involvement. Here, we evaluated the potential of anakinra for FSGS treatment. Molecular process models obtained from scientific literature data were used to build FSGS pathology and anakinra mechanism of action models by exploiting information on protein interactions. These molecular models were compared by statistical interference analysis and expert based molecular signature matching. Experimental validation was performed in Adriamycin- and lipopolysaccharide (LPS)-induced nephropathy mouse models. Interference analysis (containing 225 protein coding genes and 8 molecular process segments) of the FSGS molecular pathophysiology model with the drug mechanism of action of anakinra identified a statistically significant overlap with 43 shared molecular features that were enriched in pathways relevant in FSGS, such as plasminogen activating cascade, inflammation and apoptosis. Expert adjudication of molecular signature matching, focusing on molecular process segments did not suggest a high therapeutic potential of anakinra in FSGS. In line with this, experimental validation did not result in altered proteinuria or significant changes in expression of the FSGS-relevant genes COL1A1 and NPHS1. In summary, an integrated bioinformatic and experimental workflow showed that FSGS relevant molecular processes can be significantly affected by anakinra beyond the direct drug target IL-1 receptor type 1 (IL1R1) context but might not counteract central pathophysiology processes in FSGS. Anakinra is therefore not suggested for extended preclinical trials.	[Boehm, Michael; Herzog, Rebecca; Aufricht, Christoph; Kratochwill, Klaus] Med Univ Vienna, Div Pediat Nephrol & Gastroenterol, Dept Pediat & Adolescent Med, Vienna, Austria; [Bukosza, Eva Nora] Semmelweis Univ Budapest, Inst Pathophysiol, Budapest, Hungary; [Huttary, Nicole] Med Univ Vienna, Clin Inst Pathol, Vienna, Austria; [Herzog, Rebecca; Kratochwill, Klaus] Med Univ Vienna, Dept Pediat & Adolescent Med, Christian Doppler Lab Mol Stress Res Peritoneal D, Vienna, Austria; [Gebeshuber, Christoph A.] Epsilon 3 Gmbh, Vienna, Austria	Medical University of Vienna; Semmelweis University; Medical University of Vienna; Medical University of Vienna	Kratochwill, K (corresponding author), Med Univ Vienna, Div Pediat Nephrol & Gastroenterol, Dept Pediat & Adolescent Med, Vienna, Austria.; Kratochwill, K (corresponding author), Med Univ Vienna, Dept Pediat & Adolescent Med, Christian Doppler Lab Mol Stress Res Peritoneal D, Vienna, Austria.; Gebeshuber, CA (corresponding author), Epsilon 3 Gmbh, Vienna, Austria.	klaus.kratochwill@meduniwien.ac.at; c.gebeshuber@epsilon3.at		Herzog, Rebecca/0000-0003-1946-7770; Gebeshuber, Christoph A/0000-0003-3293-4572; Kratochwill, Klaus/0000-0003-0803-614X	Austrian Federal Ministry of Science, Research and Economy; National Foundation for Research, Technology and Development; Austrian Science Fund [FWF -P26967-B20]	Austrian Federal Ministry of Science, Research and Economy; National Foundation for Research, Technology and Development; Austrian Science Fund(Austrian Science Fund (FWF))	The financial support by the Austrian Federal Ministry of Science, Research and Economy and the National Foundation for Research, Technology and Development is gratefully acknowledged (CDL-MSRPD; RH, KK). CAG was partially funded by the Austrian Science Fund (FWF -P26967-B20). The funder (Epsilon 3 Gmbh) provided support in the form of salary for CAG and research materials, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afsar B, 2018, DRUGS, V78, P1073, DOI 10.1007/s40265-018-0942-2; Akar S, 2018, ARTHRIT CARE RES, V70, P1090, DOI 10.1002/acr.23446; [Anonymous], 2016, KINERET HIGHLIGHTS P; Aschauer C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169518; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Boerries M, 2013, KIDNEY INT, V83, P1052, DOI 10.1038/ki.2012.487; Cheng FX, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05116-5; Chu SC, 2006, J RHEUMATOL, V33, P311; Czech KA, 2011, PEDIATR NEPHROL, V26, P2179, DOI 10.1007/s00467-011-1897-7; D'Agati V, 2003, SEMIN NEPHROL, V23, P117, DOI 10.1053/snep.2003.50012; Dalgic B, 2007, PEDIATR NEPHROL, V22, P1391, DOI 10.1007/s00467-007-0500-8; Heerspink HJL, 2015, NEPHROL DIAL TRANSPL, V30, P105, DOI 10.1093/ndt/gfv210; Heinzel A, 2014, FRONT CELL DEV BIOL, V2, DOI 10.3389/fcell.2014.00037; Heinzel A, 2014, METHODS MOL BIOL, V1159, P109, DOI 10.1007/978-1-4939-0709-0_7; Hodgin JB, 2010, AM J PATHOL, V177, P1674, DOI 10.2353/ajpath.2010.090746; Kemper MJ, 2018, PEDIATR NEPHROL, V33, P1641, DOI 10.1007/s00467-017-3780-7; Kratochwill K, 2012, NEPHROL DIAL TRANSPL, V27, P937, DOI 10.1093/ndt/gfr459; Kusano K, 1998, ENDOCRINOLOGY, V139, P1338, DOI 10.1210/en.139.3.1338; Lee VWS, 2011, NEPHROLOGY, V16, P30, DOI 10.1111/j.1440-1797.2010.01383.x; Liu SY, 2006, MOL CELL BIOCHEM, V284, P9, DOI 10.1007/s11010-005-9005-6; Maas RJH, 2013, PEDIATR NEPHROL, V28, P1041, DOI 10.1007/s00467-013-2452-5; Mayer B, 2016, DIABETOLOGIA, V59, P2503, DOI 10.1007/s00125-016-4032-2; Mayer P, 2012, NEPHROL DIAL TRANSPL, V27, P3995, DOI 10.1093/ndt/gfs489; Mia MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091559; Niemir ZI, 1997, KIDNEY INT, V52, P393, DOI 10.1038/ki.1997.346; Panchapakesan U, 2018, KIDNEY INT, V94, P40, DOI 10.1016/j.kint.2017.12.026; Petrasek J, 2012, J CLIN INVEST, V122, P3476, DOI 10.1172/JCI60777; Pippin JW, 2009, AM J PHYSIOL-RENAL, V296, pF213, DOI 10.1152/ajprenal.90421.2008; Pullen N, 2016, KIDNEY INT, V89, P1211, DOI 10.1016/j.kint.2015.12.058; Reiser J, 2004, J CLIN INVEST, V113, P1390, DOI 10.1172/JCI200420402; Rosenberg AZ, 2017, CLIN J AM SOC NEPHRO, V12, P502, DOI 10.2215/CJN.05960616; Saha TC, 2006, SOUTH MED J, V99, P1264, DOI 10.1097/01.smj.0000243183.87381.c2; Saleem M. A., 2016, F1000RES, V5; Topaloglu R, 2016, PEDIATR NEPHROL, V31, P633, DOI 10.1007/s00467-015-3249-5; Trachtman H, 2017, EXPERT OPIN INV DRUG, V26, P945, DOI 10.1080/13543784.2017.1351544; Trautmann A, 2017, J AM SOC NEPHROL, V28, P3055, DOI 10.1681/ASN.2016101121; Wang CS, 2018, AM J KIDNEY DIS, V71, P392, DOI 10.1053/j.ajkd.2017.09.025; Wang XY, 2005, INT J MOL MED, V16, P1117; Wei CL, 2011, NAT MED, V17, P952, DOI 10.1038/nm.2411	39	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214332	10.1371/journal.pone.0214332	http://dx.doi.org/10.1371/journal.pone.0214332			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921378	Green Published, gold, Green Submitted			2022-12-26	WOS:000462594000056
J	Latour, K; Huang, TD; Jans, B; Berhin, C; Bogaerts, P; Noel, A; Nonhoff, C; Dodemont, M; Denis, O; Ieven, M; Loens, K; Schoevaerdts, D; Catry, B; Glupczynski, Y				Latour, Katrien; Huang, Te-Din; Jans, Beatrice; Berhin, Catherine; Bogaerts, Pierre; Noel, Audrey; Nonhoff, Claire; Dodemont, Magali; Denis, Olivier; Ieven, Margareta; Loens, Katherine; Schoevaerdts, Didier; Catry, Boudewijn; Glupczynski, Youri			Prevalence of multidrug-resistant organisms in nursing homes in Belgium in 2015	PLOS ONE			English	Article							TERM-CARE FACILITIES; LACTAMASE-PRODUCING ENTEROBACTERIACEAE; CARBAPENEMASE-PRODUCING ENTEROBACTERIACEAE; STAPHYLOCOCCUS-AUREUS; RISK-FACTORS; COLONIZATION; RESIDENTS; CARRIAGE; BACTERIA; EPIDEMIOLOGY	Objectives Following two studies conducted in 2005 and 2011, a third prevalence survey of multidrug-resistant microorganisms (MDRO) was organised in Belgian nursing homes (NHs) using a similar methodology. The aim was to measure the prevalence of carriage of methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci (VRE), extended-spectrum beta-lactamase producing Enterobacteriaceae (ESBLE) and carbapenemase-producing Enterobacteriaceae (CPE) in NH residents. Risk factors for MDRO carriage were also explored. Methods Up to 51 randomly selected residents per NH were screened for MDRO carriage by trained local nurses between June and October 2015. Rectal swabs were cultured for ESBLE, CPE and VRE, while pooled samples of nose, throat and perineum and chronic wound swabs were obtained for culture of MRSA. Antimicrobial susceptibility testing, molecular detection of resistance genes and strain genotyping were performed. Significant risk factors for MDRO colonization MDRO was determined by univariate and multivariable analysis. Results Overall, 1447 residents from 29 NHs were enrolled. The mean weighted prevalence of ESBLE and MRSA colonization was 11.3% and 9.0%, respectively. Co-colonization occurred in 1.8% of the residents. VRE and CPE carriage were identified in only one resident each. Impaired mobility and recent treatment with fluoroquinolones or with combinations of sulphonamides and trimethoprim were identified as risk factors for ESBLE carriage, while for MRSA these were previous MRSA carriage/infection, a stay in several different hospital wards during the past year, and a recent treatment with nitrofuran derivatives. Current antacid use was a predictor for both ESBL and MRSA carriage. Conclusions In line with the evolution of MRSA and ESBL colonization/infection in hospitals, a decline in MRSA carriage and an increase in ESBLE prevalence was seen in Belgian NHs between 2005 and 2015. These results show that a systemic approach, including surveillance and enhancement of infection control and antimicrobial stewardship programs is needed in both acute and chronic care facilities.	[Latour, Katrien; Jans, Beatrice; Catry, Boudewijn] Sciensano, Operat Directorate Epidemiol & Publ Hlth, Brussels, Belgium; [Latour, Katrien] Univ Leuven, Dept Publ Hlth & Primary Care, Leuven, Belgium; [Huang, Te-Din; Berhin, Catherine; Bogaerts, Pierre; Noel, Audrey; Glupczynski, Youri] Catholic Univ Louvain, Natl Reference Ctr Antibiot Resistant Gram Negat, Ctr Hosp Univ Namur, Lab Clin Microbiol, Yvoir, Belgium; [Nonhoff, Claire; Dodemont, Magali] Univ Libre Bruxelles, Dept Clin Microbiol, Natl Reference Ctr Methicillin Resistant Staphylo, Hop Erasme, Brussels, Belgium; [Denis, Olivier; Catry, Boudewijn] Univ Libre Bruxelles, Ecole Sante Publ, Brussels, Belgium; [Ieven, Margareta; Loens, Katherine] Univ Hosp Antwerp, Dept Clin Microbiol, Natl Reference Ctr Vancomycin Resistant Enterococ, Edegem, Belgium; [Schoevaerdts, Didier] Catholic Univ Louvain, Ctr Hosp Univ Namur, Dept Geriatr Med, Mont Godinne, Belgium; [Schoevaerdts, Didier] Catholic Univ Louvain, Inst Hlth & Soc, Ecole Sante Publ, Brussels, Belgium	Sciensano; KU Leuven; Universite Catholique Louvain; Universite Libre de Bruxelles; Universite Libre de Bruxelles; University of Antwerp; Universite Catholique Louvain; Universite Catholique Louvain	Latour, K (corresponding author), Sciensano, Operat Directorate Epidemiol & Publ Hlth, Brussels, Belgium.; Latour, K (corresponding author), Univ Leuven, Dept Publ Hlth & Primary Care, Leuven, Belgium.	katrien.latour@sciensano.be		Noel, Audrey/0000-0003-4600-8529; Latour, Katrien/0000-0001-9113-7712	Belgian Antibiotic Policy Coordination Committee	Belgian Antibiotic Policy Coordination Committee	This study was organized with the support of the Belgian Antibiotic Policy Coordination Committee. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argudin MA, 2017, J ANTIMICROB CHEMOTH, V72, P56, DOI 10.1093/jac/dkw380; Aschbacher R, 2016, ANTIMICROB RESIST IN, V5, DOI 10.1186/s13756-016-0136-1; Belgian Antibiotic Policy Coordination Committee, 2017, GUID BELG TRAIT ANT; Belgian Antibiotic Policy Coordination Committee, 2017, REC TRAIT ANT MIL HO; Belgian Infection Control Society, 2008, BICS, P1; Ben-Ami R, 2006, CLIN INFECT DIS, V42, P925, DOI 10.1086/500936; Ben-Ami R, 2009, CLIN INFECT DIS, V49, P682, DOI 10.1086/604713; BenAbdelhafidh L, 2016, 2017015 IPHEPI; Benenson S, 2009, INFECT CONT HOSP EP, V30, P786, DOI 10.1086/598345; Blay N, 2017, J CLIN NURS, V26, P4822, DOI 10.1111/jocn.13838; Bogaerts P, 2013, J ANTIMICROB CHEMOTH, V68, P2414, DOI 10.1093/jac/dkt201; Bonomo RA, 2000, CLIN INFECT DIS, V31, P1414, DOI 10.1086/317489; Bradley SF, 1999, INFECT CONT HOSP EP, V20, P362, DOI 10.1086/501637; Cassone M, 2015, CURR GERIATR REP, V4, P87, DOI 10.1007/s13670-015-0120-2; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cohen ML, 2000, NATURE, V406, P762, DOI 10.1038/35021206; Conseil superieur de la Sante, 2017, REC PREV MAITR PRIS; Conseil superieur Sante, 2012, MES EM ENT PROD CARB; Cunha CB, 2016, AM J INFECT CONTROL, V44, P126, DOI 10.1016/j.ajic.2015.09.019; Denis O, 2009, J ANTIMICROB CHEMOTH, V64, P1299, DOI 10.1093/jac/dkp345; Dinkelacker AG, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/JCM.00843-18, 10.1128/jcm.00843-18]; El Emam K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093285; Elizaga ML, 2002, CLIN INFECT DIS, V34, P441, DOI 10.1086/338461; EUCAST,, 2019, BREAKPOINT TABLES IN; European Centre for Disease Prevention and Control, 2013, POINT PREV SURV HEAL; Flokas ME, 2017, INT J ANTIMICROB AG, V50, P649, DOI 10.1016/j.ijantimicag.2017.08.003; Fonguh S, 2015, 201554 IPHEPI, V2015-54; Fonguh S, 2016, ARCH PUBLIC HEALTH, V74, DOI 10.1186/s13690-016-0159-3; Garazi M, 2009, J AM MED DIR ASSOC, V10, P414, DOI 10.1016/j.jamda.2009.02.014; GDEPIH-GOSPIZ, 2003, BICS, P1; GDEPIH-GOSPIZ, 2005, MES PREV TRANSM STAP; Giufre M, 2017, CLIN MICROBIOL INFEC, V23, P961, DOI 10.1016/j.cmi.2017.04.006; Gruber I, 2013, INT J MED MICROBIOL, V303, P405, DOI 10.1016/j.ijmm.2013.05.002; Harrison EM, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0353-5; Hayakawa K, 2013, ANTIMICROB AGENTS CH, V57, P4010, DOI 10.1128/AAC.02516-12; Huizinga P, 2017, CLIN INFECT DIS, V64, P361, DOI 10.1093/cid/ciw743; Imhann F, 2016, GUT, V65, P740, DOI 10.1136/gutjnl-2015-310376; Jackson MA, 2016, GUT, V65, P749, DOI 10.1136/gutjnl-2015-310861; Jans B, 2016, 2016020 IPHEPI; Jans B, 2013, 2013037 IPHEPI; Jans B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064908; Latour K., 2012, BRUSS BELG INF CONTR; Lin MY, 2013, CLIN INFECT DIS, V57, P1246, DOI 10.1093/cid/cit500; Livermore DM, 2007, J ANTIMICROB CHEMOTH, V59, P165, DOI 10.1093/jac/dkl483; Ludden C, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0880-5; March A, 2010, CLIN MICROBIOL INFEC, V16, P934, DOI 10.1111/j.1469-0691.2009.03024.x; McKinnell JA, 2016, INFECT CONT HOSP EP, V37, P1485, DOI 10.1017/ice.2016.215; Moro ML, 2010, INFECT CONT HOSP EP, V31, pS59, DOI 10.1086/655989; Nicolle LE, 2000, CLIN INFECT DIS, V31, P752, DOI 10.1086/314010; Nordmann P, 2012, EMERG INFECT DIS, V18, P1503, DOI 10.3201/eid1809.120355; O'Fallon E, 2009, INFECT CONT HOSP EP, V30, P1172, DOI 10.1086/648453; Patel J.B., 2015, PERFORMANCE STANDARD; Prabaker K, 2012, INFECT CONT HOSP EP, V33, P1193, DOI 10.1086/668435; Reuland EA, 2016, J ANTIMICROB CHEMOTH, V71, P1076, DOI 10.1093/jac/dkv441; Rodriguez-Villalobos H, 2011, J ANTIMICROB CHEMOTH, V66, P37, DOI 10.1093/jac/dkq388; Rooney PJ, 2009, J ANTIMICROB CHEMOTH, V64, P635, DOI 10.1093/jac/dkp220; Ruiz-Garbajosa P, 2016, J ANTIMICROB CHEMOTH, V71, P348, DOI 10.1093/jac/dkv355; Saegeman VSM, 2014, ACTA CLIN BELG, V69, P30, DOI 10.1179/0001551213Z.00000000013; Stuart RL, 2011, MED J AUSTRALIA, V195, P530, DOI 10.5694/mja11.10724; van den Dool C, 2016, INFECT CONT HOSP EP, V37, P761, DOI 10.1017/ice.2016.59; Vovko P, 2005, INFECT CONT HOSP EP, V26, P191, DOI 10.1086/502525; Zhao SY, 2016, EPIDEMIOL INFECT, V144, P695, DOI 10.1017/S0950268815001879	62	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214327	10.1371/journal.pone.0214327	http://dx.doi.org/10.1371/journal.pone.0214327			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921364	Green Submitted, Green Published, gold			2022-12-26	WOS:000462594000055
J	Shin, JH; Choi, Y; Park, B; Shin, NY; Jang, J; Choi, HS; Jung, SL; Ahn, K; Kim, BS				Shin, Jae Ho; Choi, Yangsean; Park, Borim; Shin, Na-Young; Jang, Jinhee; Choi, Hyun Seok; Jung, So Lyung; Ahn, Kookjin; Kim, Bum-soo			Diagnostic accuracy and efficiency of combined acquisition of low-dose time- resolved and single-phase high-resolution contrast-enhanced magnetic resonance angiography in a single session for pre- angiographic evaluation of spinal vascular disease	PLOS ONE			English	Article							DURAL ARTERIOVENOUS-FISTULAS; MR-ANGIOGRAPHY; CORD ARTERIOGRAPHY; LOCALIZATION; CLASSIFICATION; MALFORMATIONS; ARTERIES	Background/Purpose The purpose of this study was to evaluate the utility and efficacy of combined low-dose, time-resolved (TR) and single-phase high-resolution (HR) contrast-enhanced MRA (CE-MRA) as a pre-angiographic study for spinal vascular disease. Materials and methods Seventeen consecutive patients with suspected spinal vascular disease were retrospectively reviewed. All patients underwent combined low-dose TR CE-MRA and three-dimensional single-phase HR CE-MRA at 3 Tesla, followed by conventional spinal digital subtraction angiography (DSA) within 90 days. Six patients underwent additional spinal MRA and DSA for treatment follow-up. Spinal lesions were analyzed in terms of presence, disease type, laterality, spinal level, and number of arterial feeders. Results Low-dose TR CE-MRA helped proper localization of subsequent HR CE-MRA in two patients with high or low level of the lesion. For initial detection of spinal vascular disease, sensitivity, specificity and accuracy of CE-MRA were 93.3% (n = 14/15), 100% (n = 3/3), and 94.4% (n = 17/18), respectively. In characterization of dural arteriovenous fistula (AVF), perimedullary AVF, spinal cord arteriovenous malformation (AVM), and extraspinal AVM, CE-MRA correctly characterized in 86.7% (n = 13/15) among the positive findings, and in 88.9% (n = 16/18) among the several patients including negative results. CE-MRA showed matched per-case localization of arterial feeders within 1 vertebral level in 80% (n = 12/15), and matched per-lesion localization in 78.3% (n = 18/23). Conclusion Combined low-dose TR CE-MRA and single-phase HR CE-MRA at 3 Tesla was an effective and accurate non-invasive tool for the pre-angiographic evaluation of spinal vascular diseases in a single session.	[Shin, Jae Ho; Choi, Yangsean; Park, Borim; Shin, Na-Young; Jang, Jinhee; Choi, Hyun Seok; Jung, So Lyung; Ahn, Kookjin; Kim, Bum-soo] Catholic Univ Korea, Seoul St Marys Hosp, Dept Radiol, Seoul, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital	Kim, BS (corresponding author), Catholic Univ Korea, Seoul St Marys Hosp, Dept Radiol, Seoul, South Korea.	bumrad@catholic.ac.kr	Choi, Yangsean/AAR-5274-2020; KIM, Bum-soo/F-3086-2018	KIM, Bum-soo/0000-0002-3870-6813				Ali S, 2007, AM J NEURORADIOL, V28, P1806, DOI 10.3174/ajnr.A0639; Amarouche M, 2015, AM J NEURORADIOL, V36, P417, DOI 10.3174/ajnr.A4164; Backes WH, 2008, AM J NEURORADIOL, V29, P619, DOI 10.3174/ajnr.A0910; Bao YH, 1997, NEUROSURGERY, V40, P75, DOI 10.1097/00006123-199701000-00017; Binkert CA, 1999, AM J NEURORADIOL, V20, P1785; CHOI IS, 1988, RADIOL CLIN N AM, V26, P1131; Farb RI, 2002, RADIOLOGY, V222, P843, DOI 10.1148/radiol.2223010826; FORBES G, 1988, RADIOLOGY, V169, P479, DOI 10.1148/radiology.169.2.3174997; Jaspers K, 2007, J MAGN RESON IMAGING, V26, P31, DOI 10.1002/jmri.20940; Kieffer E, 2002, J VASC SURG, V35, P262, DOI 10.1067/mva.2002.120378; Kiyosue H, 2017, STROKE, V48, P3215, DOI 10.1161/STROKEAHA.117.019131; Kralik SF, 2017, NEURORADIOLOGY, V59, P997, DOI 10.1007/s00234-017-1893-0; Krings T, 2005, EUR RADIOL, V15, P267, DOI 10.1007/s00330-004-2510-2; Lee YJ, 2015, ACTA RADIOL, V56, P673, DOI 10.1177/0284185114538426; Lee YJ, 2011, J MAGN RESON IMAGING, V33, P71, DOI 10.1002/jmri.22396; Lindenholz A, 2014, EUR RADIOL, V24, P2885, DOI 10.1007/s00330-014-3307-6; Luetmer PH, 2005, AM J NEURORADIOL, V26, P711; Mull M, 2007, AM J NEURORADIOL, V28, P1249, DOI 10.3174/ajnr.A0612; Nijenhuis RJ, 2007, J VASC SURG, V45, P71, DOI 10.1016/j.jvs.2006.08.085; Nijenhuis RJ, 2007, J VASC SURG, V45, P677, DOI 10.1016/j.jvs.2006.11.046; Saraf-Lavi E, 2002, AM J NEURORADIOL, V23, P858; SAVADER SJ, 1993, RADIOLOGY, V189, P165, DOI 10.1148/radiology.189.1.8372189; Spetzler RF, 2002, J NEUROSURG, V96, P145, DOI 10.3171/spi.2002.96.2.0145; Vargas MI, 2010, EUR RADIOL, V20, P2491, DOI 10.1007/s00330-010-1815-6; Zozulya Yuri P, 2006, Neurosurg Focus, V20, pE7	25	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214289	10.1371/journal.pone.0214289	http://dx.doi.org/10.1371/journal.pone.0214289			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921365	gold, Green Published, Green Submitted			2022-12-26	WOS:000462594000050
J	Chatterjee, S; Biswas, N; Datta, A; Maiti, PK				Chatterjee, Susmita; Biswas, Nupur; Datta, Alokmay; Maiti, Prasanta Kumar			Periodicities in the roughness and biofilm growth on glass substrate with etching time: Hydrofluoric acid etchant	PLOS ONE			English	Article							BACTERIAL ADHESION; PSEUDOMONAS-AERUGINOSA; SURFACES; ATTACHMENT	Adherence of the microorganism to submerged solid surfaces leads to biofilm formation. Biofilm formation modifies the surfaces in favor of bacteria facilitating the survival of the bacteria under different stressed conditions. On the other hand, the formation of biofilm has a direct adverse economic impact in various industries and more importantly in medical practices. This adherence is the reason for the failure of many indwelling medical devices. Surface biofilm adhesion is the key to biofilm growth and stability. Hence this adhesion needs to be substantially lowered to inhibit biofilm stability. Both chemical and physical properties of the surface influence biofilm formation and modulating these properties can control this formation. In this study, we have investigated the effect of Hydrofluoric acid (HF), at a specific concentration as an etchant, on the surface morphology of substrates and the growth of biofilms of Pseudomonas aeruginosa. and Staphylococcus aureus. We find that the bacterial counts on the etched surfaces undergo a periodic increase and decrease. This, on one hand, shows the close correlation between the biofilm growth and the particular roughness scale, and on the other hand, explains the existing contradictory results regarding the effects of etching on substrate roughness and biofilm growth. We propose a simple model of a sequence of hole formation, hole expansion and etching away of the hole walls to form a new, comparatively smooth surface, coupled with the preferential accumulation of bacteria at the hole edges, to explain these periodicities.	[Chatterjee, Susmita; Maiti, Prasanta Kumar] Inst Postgrad Med Educ & Res, Kolkata, India; [Biswas, Nupur; Datta, Alokmay] Saha Inst Nucl Phys, Surface Phys & Mat Sci Div, 1-AF Bidhannagar, Kolkata, India; [Biswas, Nupur] Indian Inst Chem Biol, CSIR, Canc Biol & Inflammatory Disorder Div, IICB TRUE Campus, Kolkata, India; [Datta, Alokmay] Cent Glass & Ceram Res Inst, CSIR, Adv Mech & Mat Characterizat Div, Kolkata, India	Institute of Post Graduate Medical Education & Research (IPGMER), Kolkata; Saha Institute of Nuclear Physics; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Glass & Ceramic Research Institute (CGCRI)	Chatterjee, S (corresponding author), Inst Postgrad Med Educ & Res, Kolkata, India.	drsusmita.chatterjee@gmail.com	Datta, Alokmay/C-1252-2008	Datta, Alokmay/0000-0002-2542-1042; Biswas, Nupur/0000-0002-8468-5208; Chatterjee, Susmita/0000-0002-4296-4380	Department of Science & Technology, Govt of India; Department of Science and Technology, India; Council of Scientific and Industrial Research through Saha Institute of Nuclear Physics; Department of Atomic Energy through Saha Institute of Nuclear Physics	Department of Science & Technology, Govt of India(Department of Science & Technology (India)); Department of Science and Technology, India(Department of Science & Technology (India)); Council of Scientific and Industrial Research through Saha Institute of Nuclear Physics; Department of Atomic Energy through Saha Institute of Nuclear Physics	This research was carried out jointly at Institute of Post Graduate Medical Education and Research and at Saha Institute of Nuclear Physics, with the logistics and funding Department of Science & Technology, Govt of India. The fellowship of S.C. was funded by Department of Science and Technology, India, and that of N.B. was funded Council of Scientific and Industrial Research and Department of Atomic Energy through Saha Institute of Nuclear Physics.	Broderick AH, 2013, ADV HEALTHC MATER, V2, P993, DOI 10.1002/adhm.201200334; BROWN CA, 1991, WEAR, V141, P211, DOI 10.1016/0043-1648(91)90269-Z; Burmolle M, 2006, APPL ENVIRON MICROB, V72, P3916, DOI 10.1128/AEM.03022-05; BUSSCHER HJ, 1987, FEMS MICROBIOL LETT, V46, P165, DOI 10.1111/j.1574-6968.1987.tb02457.x; Chatterjee S, 2014, MICROSCOPY-JPN, V63, P269, DOI 10.1093/jmicro/dfu013; Cross SE, 2009, DENT MATER, V25, P1517, DOI 10.1016/j.dental.2009.07.012; Díaz Carolina, 2007, Mat. Res., V10, P11, DOI 10.1590/S1516-14392007000100004; Feng GP, 2015, NPJ BIOFILMS MICROBI, V1, DOI 10.1038/npjbiofilms.2015.22; Garrett TR, 2008, PROG NAT SCI-MATER, V18, P1049, DOI 10.1016/j.pnsc.2008.04.001; Gharechahi M., 2012, J BIOMATER NANOBIOTE, V03, P541, DOI DOI 10.4236/JBNB.2012.324056; Guo K, 2013, ENVIRON SCI TECHNOL, V47, P7563, DOI 10.1021/es400901u; Ista LK, 2010, BIOFOULING, V26, P111, DOI 10.1080/08927010903383455; Ista LK, 1999, APPL ENVIRON MICROB, V65, P1603; Kolewe KW, 2018, ACS APPL MATER INTER, V10, P2275, DOI 10.1021/acsami.7b12145; Li BK, 2004, COLLOID SURFACE B, V36, P81, DOI 10.1016/j.colsurfb.2004.05.006; Lorenzetti M, 2015, ACS APPL MATER INTER, V7, P1644, DOI 10.1021/am507148n; Miles AA, 1938, J HYG-CAMBRIDGE, V38, P732, DOI 10.1017/S002217240001158X; Mitik-Dineva N, 2009, CURR MICROBIOL, V58, P268, DOI 10.1007/s00284-008-9320-8; Nosonovsky M, 2012, SPRINGER SER MATER S, V152, P25, DOI 10.1007/978-1-4614-0926-7_2; PALIK ED, 1991, J APPL PHYS, V70, P3291, DOI 10.1063/1.349263; Qiu Y, 2007, INT J ARTIF ORGANS, V30, P828, DOI 10.1177/039139880703000913; Renner LD, 2011, MRS BULL, V36, P347, DOI 10.1557/mrs.2011.65; Singh AV, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0026803, 10.1371/journal.pone.0025029]; Sinha SD, 2017, PROG BIOMATER, V6, P27, DOI 10.1007/s40204-017-0061-2; SPIERINGS GACM, 1993, J MATER SCI, V28, P6261, DOI 10.1007/BF01352182; Teughels W, 2006, CLIN ORAL IMPLAN RES, V17, P68, DOI 10.1111/j.1600-0501.2006.01353.x; Tran PA, 2013, INT J NANOMED, V8, P2001, DOI 10.2147/IJN.S42970; Yu P, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/8901253; Zogheib Lucas Villaça, 2011, Braz. Dent. J., V22, P45, DOI 10.1590/S0103-64402011000100008	29	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2019	14	3							e0214192	10.1371/journal.pone.0214192	http://dx.doi.org/10.1371/journal.pone.0214192			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ5PT	30917172	gold, Green Published, Green Submitted			2022-12-26	WOS:000462465800054
J	Lee, SU; Li, CF; Mortales, CL; Pawling, J; Dennis, JW; Grigorian, A; Demetriou, M				Lee, Sung-Uk; Li, Carey F.; Mortales, Christie-Lynn; Pawling, Judy; Dennis, James W.; Grigorian, Ani; Demetriou, Michael			Increasing cell permeability of N-acetylglucosamine via 6-acetylation enhances capacity to suppress T-helper 1 (T(H)1)/T(H)17 responses and autoimmunity	PLOS ONE			English	Article							SURFACE ORGANIZATION; AEROBIC GLYCOLYSIS; METABOLISM; GLYCOSYLATION; ACTIVATION; SUBSTRATE; FLUX	N-acetylglucosamine (GIcNAc) branching of Asn (N)-linked glycans inhibits pro-inflammatory T cell responses and models of autoimmune diseases such as Multiple Sclerosis (MS). Metabolism controls N-glycan branching in T cells by regulating de novo hexosamine pathway biosynthesis of UDP-GIcNAc, the donor substrate for the Golgi branching enzymes. Activated T cells switch metabolism from oxidative phosphorylation to aerobic glycolysis and glutaminolysis. This reduces flux of glucose and glutamine into the hexosamine pathway, thereby inhibiting de novo UDP-GIcNAc synthesis and N-glycan branching. Salvage of GIcNAc into the hexosamine pathway overcomes this metabolic suppression to restore UDP-GIcNAc synthesis and N-glycan branching, thereby promoting anti-inflammatory T regulatory (Treg) over pro-inflammatory T helper (T-H) 17 and T(H)1 differentiation to suppress autoimmunity. However, GIcNAc activity is limited by the lack of a cell surface transporter and requires high doses to enter cells via macropinocytosis. Here we report that GIcNAc-6-acetate is a superior pro-drug form of GIcNAc. Acetylation of amino-sugars improves cell membrane permeability, with subsequent de-acetylation by cytoplasmic esterases allowing salvage into the hexosamine pathway. Per- and bi-acetylation of GIcNAc led to toxicity in T cells, whereas mono-acetylation at only the 6 > 3 position raised N-glycan branching greater than GIcNAc without inducing significant toxicity. GIcNAc-6-acetate inhibited T cell activation/proliferation, T(H)1/T(H)17 responses and disease progression in Experimental Autoimmune Encephalomyelitis (EAE), a mouse model of MS. Thus, GIcNAc-6-Acetate may provide an improved therapeutic approach to raise N-glycan branching, inhibit pro-inflammatory T cell responses and treat autoimmune diseases such as MS.	[Lee, Sung-Uk; Li, Carey F.; Demetriou, Michael] Univ Calif Irvine, Dept Neurol, Irvine, CA 92717 USA; [Lee, Sung-Uk; Grigorian, Ani] Glixis Therapeut LLC, Santa Rosa, CA USA; [Mortales, Christie-Lynn; Demetriou, Michael] Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92717 USA; [Pawling, Judy; Dennis, James W.] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada; [Dennis, James W.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Dennis, James W.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Demetriou, Michael] Univ Calif Irvine, Inst Immunol, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University of California System; University of California Irvine	Demetriou, M (corresponding author), Univ Calif Irvine, Dept Neurol, Irvine, CA 92717 USA.; Demetriou, M (corresponding author), Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92717 USA.; Demetriou, M (corresponding author), Univ Calif Irvine, Inst Immunol, Irvine, CA 92697 USA.	mdemetri@uci.edu		Demetriou, Michael/0000-0002-2224-7798	Small Business Innovation Research (SBIR) [R43AI106168]; National Institute of Allergy and Infectious Disease (NIAID); National Center for Complementary and Integrative Health (NCCIH) [R01AT007452]; National Center for Advancing Translational Sciences (NCATS) [UL1 TR001414]; University of California; SBIR award [R43AI106168]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001414] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [R01AT007452] Funding Source: NIH RePORTER	Small Business Innovation Research (SBIR)(United States Department of Agriculture (USDA)); National Institute of Allergy and Infectious Disease (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Center for Complementary and Integrative Health (NCCIH); National Center for Advancing Translational Sciences (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); University of California(University of California System); SBIR award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by a Small Business Innovation Research (SBIR) grant (R43AI106168) to A.G. (Glixis Therapeutics), from the National Institute of Allergy and Infectious Disease (NIAID, www.niaid.nih.gov), which included a subcontract to M.D. (University of California, Irvine), as well as by R01AT007452 from the National Center for Complementary and Integrative Health (NCCIH, www.nccih.nih.gov), UL1 TR001414 from the National Center for Advancing Translational Sciences (NCATS, www.ncats.nih.gov) and the University of California 'Proof of Concept' grant to M.D. (University of California, Irvine). The NIH and the University of California had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Glixis Therapeutics was co-founded by A.G., M.D. and J.W.D. and provided support in the form of salaries to A.G. and S.U.L., research funding and a subcontract to UC Irvine all via an SBIR award (R43AI106168), but did not have any additional financial role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. This does not alter our adherence to PLOS ONE policies on sharing data and materials.	Aich U, 2008, ACS CHEM BIOL, V3, P230, DOI 10.1021/cb7002708; Araujo L, 2017, ELIFE, V6, DOI 10.7554/eLife.21330; BERNACKI RJ, 1977, J SUPRAMOL STR CELL, V7, P235, DOI 10.1002/jss.400070208; Brynedal B, 2010, J NEUROIMMUNOL, V220, P120, DOI 10.1016/j.jneuroim.2010.01.003; Chen IJ, 2007, J BIOL CHEM, V282, P35361, DOI 10.1074/jbc.M706923200; CUMMINGS RD, 1982, J BIOL CHEM, V257, P1230; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; Dennis JW, 2009, CELL, V139, P1229, DOI 10.1016/j.cell.2009.12.008; Dennis JW, 2001, CURR OPIN STRUC BIOL, V11, P601, DOI 10.1016/S0959-440X(00)00254-2; Dias AM, 2018, P NATL ACAD SCI US; Grigorian A, 2007, J BIOL CHEM, V282, P20027, DOI 10.1074/jbc.M701890200; Grigorian A, 2012, SEMIN IMMUNOPATHOL, V34, P415, DOI 10.1007/s00281-012-0307-y; Grigorian A, 2009, IMMUNOL REV, V230, P232, DOI 10.1111/j.1600-065X.2009.00796.x; HUME DA, 1978, BIOCHEM J, V174, P703, DOI 10.1042/bj1740703; Jacobs CL, 2000, METHOD ENZYMOL, V327, P260, DOI 10.1016/S0076-6879(00)27282-0; Jacobs CL, 2001, BIOCHEMISTRY-US, V40, P12864, DOI 10.1021/bi010862s; Jones MB, 2004, BIOTECHNOL BIOENG, V85, P394, DOI 10.1002/bit.10901; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; Lavis LD, 2008, ACS CHEM BIOL, V3, P203, DOI 10.1021/cb800065s; Lee SU, 2007, J BIOL CHEM, V282, P33725, DOI 10.1074/jbc.M704839200; Li CF, 2013, J NEUROIMMUNOL; Mkhikian H, 2016, ELIFE, V5, DOI 10.7554/eLife.14814; Mkhikian H, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1333; Morgan R, 2004, J IMMUNOL, V173, P7200, DOI 10.4049/jimmunol.173.12.7200; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; Puleston DJ, 2017, CELL METAB, V26, P131, DOI 10.1016/j.cmet.2017.06.019; Rahman AMA, 2014, ANAL CHIM ACTA, V845, P53, DOI 10.1016/j.aca.2014.06.012; Rahman AMA, 2013, ACS CHEM BIOL, V8, P2053, DOI 10.1021/cb4004173; Salvatore S, 2000, ALIMENT PHARM THER, V14, P1567, DOI 10.1046/j.1365-2036.2000.00883.x; Yu Z, 2014, GENES IMMUN, V15, P218, DOI 10.1038/gene.2014.7; Zhou RW, 2014, NAT IMMUNOL, V15, P1038, DOI 10.1038/ni.3007	32	8	8	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2019	14	3							e0214253	10.1371/journal.pone.0214253	http://dx.doi.org/10.1371/journal.pone.0214253			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ3IW	30913278	Green Published, gold, Green Submitted			2022-12-26	WOS:000462305600034
J	Zhang, H; Yu, H; Zhou, CT; Zhao, HT; Qian, XQ				Zhang, Hui; Yu, Hua; Zhou, Chaoting; Zhao, Haitao; Qian, Xiaoqing			Aboveground net primary productivity not CO2 exchange remain stable under three timing of extreme drought in a semi-arid steppe	PLOS ONE			English	Article							LEYMUS CHINENSIS STEPPE; CLIMATE EXTREMES; CHLOROPHYLL FLUORESCENCE; INNER-MONGOLIA; PRECIPITATION PULSE; ECOSYSTEM CARBON; WEATHER EVENTS; GROWING-SEASON; RESPIRATION; GRASSLAND	Precipitation patterns are expected to change in the semi-arid region within the next decades, with projected increasing in extreme drought events. Meanwhile, the timing of extreme drought also shows great uncertainty, suggesting that the timing of drought, especially during growing season, may subsequently impose stronger stress on ecosystem functions than drought itself. However, how the timing of extreme drought will impact on community productivity and carbon cycle is still not clear. In this study, three timing of extreme drought (a consecutive 30-day period without precipitation event) experiments were set up separately in early-, mid- and late-growing season in a temperate steppe in Inner Mongolia since 2013. The data, including soil water content (SWC), soil temperature (ST) chlorophyll fluorescence parameter (F-t/F-m), ecosystem respiration (Re), gross primary productivity (GPP), net ecosystem carbon absorption (NEE) and aboveground net primary productivity (ANPP) were collected in growing season (from May to September) of 2016. In this study, extreme drought significantly decreased SWC during the drought treatment but not for the whole growing season. Extreme drought decreased maximum quantum efficiency of plant photosystem II (F-t/F-m) under "optimum" value (0.75-0.85) of two dominant species (Leymus chinensis and Stipa grandis). While ANPP kept stable under extreme drought treatments due to the different responses of two dominant species, which brought a compensating effect in relative abundance and biomass. In addition, only early-growing season drought significantly decreased the average Re (P < 0.01) and GPP (P < 0.01) and depressed net CO2 uptake (P < 0.01) than mid- and late-growing season drought. ST and SWC influenced the changes of GPP directly and indirectly through photosynthetic ability of the dominant species by path analysis. Our results indicated that the timing of drought should be considered in carbon cycle models to accurately estimate carbon exchange and productivity of semi-arid grasslands in the context of changing climate.	[Zhang, Hui; Qian, Xiaoqing] Yangzhou Univ, Coll Biosci & Biotechnol, Yangzhou, Jiangsu, Peoples R China; [Zhang, Hui; Zhou, Chaoting] Univ Chinese Acad Sci, Coll Life Sci, Beijing, Peoples R China; [Yu, Hua] Univ Chinese Acad Sci, Dept Foreign Languages, Beijing, Peoples R China; [Zhao, Haitao; Qian, Xiaoqing] Yangzhou Univ, Coll Environm Sci & Engn, Yangzhou, Jiangsu, Peoples R China	Yangzhou University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Yangzhou University	Qian, XQ (corresponding author), Yangzhou Univ, Coll Biosci & Biotechnol, Yangzhou, Jiangsu, Peoples R China.; Qian, XQ (corresponding author), Yangzhou Univ, Coll Environm Sci & Engn, Yangzhou, Jiangsu, Peoples R China.	gianxq@yzu.edu.cn			CAS Strategic Priority Research Program [XDA19030202, XDA20050103]; National Natural Science Foundation of China [31761123001, 31761143018]	CAS Strategic Priority Research Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was funded by the CAS Strategic Priority Research Program (A) (XDA19030202, XDA20050103) and the funds for International Cooperation and Exchange of National Natural Science Foundation of China (31761123001, 31761143018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aires LMI, 2008, GLOBAL CHANGE BIOL, V14, P539, DOI 10.1111/j.1365-2486.2007.01507.x; Bai YF, 2004, NATURE, V431, P181, DOI 10.1038/nature02850; Baker NR, 2004, J EXP BOT, V55, P1607, DOI 10.1093/jxb/erh196; Baker NR, ANN REV PLANT BIOL A, P89; Bates JD, 2006, J ARID ENVIRON, V64, P670, DOI 10.1016/j.jaridenv.2005.06.026; Darenova E, 2017, J PLANT ECOL, V10, P476, DOI 10.1093/jpe/rtw058; De Boeck HJ, 2011, NEW PHYTOL, V189, P806, DOI 10.1111/j.1469-8137.2010.03515.x; Deleglise C, 2015, AGR ECOSYST ENVIRON, V213, P94, DOI 10.1016/j.agee.2015.07.020; Denton EM, 2017, PLANT ECOL, V218, P317, DOI 10.1007/s11258-016-0690-x; Dietrich JD, 2016, OECOLOGIA, V181, P391, DOI 10.1007/s00442-016-3579-4; Digrado A, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00067; Dong G, 2011, ECOHYDROLOGY, V4, P211, DOI 10.1002/eco.200; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Fernandez ME, 2014, TREES-STRUCT FUNCT, V28, P745, DOI 10.1007/s00468-014-0986-1; [范德芹 Fan Deqin], 2016, [北京师范大学学报. 自然科学版, Journal of Beijing Normal University. Natural Science], V52, P639; Gong DY, 2004, J ARID ENVIRON, V59, P771, DOI 10.1016/j.jaridenv.2004.02.006; Gu DX, 2017, SCI TOTAL ENVIRON, V609, P1200, DOI 10.1016/j.scitotenv.2017.07.254; Hao YB, 2017, AGR FOREST METEOROL, V240, P1, DOI 10.1016/j.agrformet.2017.03.006; Hao YB, 2012, ECOL INFORM, V12, P23, DOI 10.1016/j.ecoinf.2012.07.006; Hao Yan-Bin, 2010, Chinese Journal of Plant Ecology, V34, P898, DOI 10.3773/j.issn.1005-264x.2010.08.002; Hao YB, 2008, ACTA OECOL, V33, P133, DOI 10.1016/j.actao.2007.07.002; Hao YB, 2018, AGR ECOSYST ENVIRON, V266, P153, DOI 10.1016/j.agee.2018.06.010; Hasibeder R, 2015, NEW PHYTOL, V205, P1117, DOI 10.1111/nph.13146; Hoover DL, 2016, GLOBAL CHANGE BIOL, V22, P1809, DOI 10.1111/gcb.13161; Huang JP, 2017, NAT CLIM CHANGE, V7, P417, DOI [10.1038/nclimate3275, 10.1038/NCLIMATE3275]; Hueso S, 2012, SOIL BIOL BIOCHEM, V50, P167, DOI 10.1016/j.soilbio.2012.03.026; Isbell F, 2015, NATURE, V526, P574, DOI 10.1038/nature15374; Jentsch A, 2007, FRONT ECOL ENVIRON, V5, P365, DOI 10.1890/1540-9295(2007)5[365:ANGOCE]2.0.CO;2; Jentsch A, 2011, J ECOL, V99, P689, DOI 10.1111/j.1365-2745.2011.01817.x; JINALI, 2010, J INNER MONG NORM U, V39, P269; Jongen M, 2011, AGR FOREST METEOROL, V151, P595, DOI 10.1016/j.agrformet.2011.01.008; Kreyling J, 2008, ECOSYSTEMS, V11, P752, DOI 10.1007/s10021-008-9157-9; Li LF, 2016, ATMOS ENVIRON, V142, P32, DOI 10.1016/j.atmosenv.2016.07.039; Liu M, RESPONSE DOMINANT GR; Liu WJ, 2017, AGR FOREST METEOROL, V247, P356, DOI 10.1016/j.agrformet.2017.08.029; Liu YS, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01767; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; Moore LM, 2017, ECOSPHERE, V8, DOI [10.1002/ecs2.1806, DOI 10.1002/ECS2.1806]; Murchie EH, 2013, J EXP BOT, V64, P3983, DOI 10.1093/jxb/ert208; Pereira JS, 2007, BIOGEOSCIENCES, V4, P791, DOI 10.5194/bg-4-791-2007; Pfisterer AB, 2002, NATURE, V416, P84, DOI 10.1038/416084a; Resco V, 2008, FUNCT ECOL, V22, P479, DOI 10.1111/j.1365-2435.2008.01396.x; Schwalm CR, 2012, NAT GEOSCI, V5, P551, DOI [10.1038/NGEO1529, 10.1038/ngeo1529]; Shao CL, 2017, ENVIRON RES, V159, P124, DOI 10.1016/j.envres.2017.08.001; Shi Z, 2014, BIOGEOSCIENCES, V11, P621, DOI 10.5194/bg-11-621-2014; Sippel S, 2016, P NATL ACAD SCI USA, V113, P5768, DOI 10.1073/pnas.1605667113; Strack M, 2009, ECOHYDROLOGY, V2, P454, DOI 10.1002/eco.68; Sun Y, 2010, SCI CHINA EARTH SCI, V53, P871, DOI 10.1007/s11430-010-0056-5; Tong SQ, 2017, MATH PROBL ENG, V2017, DOI 10.1155/2017/5209173; Walter J, 2016, PLANT BIOLOGY, V18, P262, DOI 10.1111/plb.12379; Walter J, 2011, ENVIRON EXP BOT, V71, P34, DOI 10.1016/j.envexpbot.2010.10.020; Wang RZ, 2008, J PLANT GROWTH REGUL, V27, P39, DOI 10.1007/s00344-007-9029-0; Wolf S, 2016, P NATL ACAD SCI USA, V113, P5880, DOI 10.1073/pnas.1519620113; Wolf S, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/3/035007; Xu X, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.1704; Yang FL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055418; Yiruhan, 2011, GRASSL SCI, V57, P168, DOI 10.1111/j.1744-697X.2011.00224.x; Yue K, 2017, ECOL LETT, V20, P663, DOI 10.1111/ele.12767; De Arruda PHZ, 2016, J GEOPHYS RES-BIOGEO, V121, P2110, DOI 10.1002/2016JG003404; Zeiter M, 2016, J VEG SCI, V27, P238, DOI 10.1111/jvs.12362; Zhang BW, 2017, FUNCT ECOL, V31, P1301, DOI 10.1111/1365-2435.12836; Zhang Feng, 2008, Zhiwu Shengtai Xuebao, V32, P1312, DOI 10.3773/j.issn.1005-264x.2008.06.012	62	4	5	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2019	14	3							e0214418	10.1371/journal.pone.0214418	http://dx.doi.org/10.1371/journal.pone.0214418			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ3IW	30913282	Green Published, Green Submitted, gold			2022-12-26	WOS:000462305600058
J	Nahirnak, V; Rivarola, M; Almasia, NI; Baron, MPB; Hopp, HE; Vile, D; Paniego, N; Rovere, CV				Nahirnak, Vanesa; Rivarola, Maximo; Ines Almasia, Natalia; Barrios Baron, Maria Pilar; Esteban Hopp, Horacio; Vile, Denis; Paniego, Norma; Vazquez Rovere, Cecilia			Snakin-1 affects reactive oxygen species and ascorbic acid levels and hormone balance in potato	PLOS ONE			English	Article							PLANT-GROWTH; HYDROGEN-PEROXIDE; GENE-EXPRESSION; SALICYLIC-ACID; ABIOTIC STRESS; ARABIDOPSIS; ROS; BIOSYNTHESIS; GIBBERELLINS; METABOLISM	Snakin-1 is a member of the Solanum tuberosum Snakin/GASA family. We previously demonstrated that Snakin-1 is involved in plant defense to pathogens as well as in plant growth and development, but its mechanism of action has not been completely elucidated yet. Here, we showed that leaves of Snakin-1 silenced potato transgenic plants exhibited increased levels of reactive oxygen species and significantly reduced content of ascorbic acid. Furthermore, Snakin-1 silencing enhanced salicylic acid content in accordance with an increased expression of SA-inducible PRs genes. Interestingly, gibberellic acid levels were also enhanced and transcriptome analysis revealed that a large number of genes related to sterol biosynthesis were downregulated in these silenced lines. Moreover, we demonstrated that Snakin-1 directly interacts with StDIM/DWF1, an enzyme involved in plant sterols biosynthesis. Additionally, the analysis of the expression pattern of PStSN1::GUS in potato showed that Snakin-1 is present mainly in young tissues associated with active growth and cell division zones. Our comprehensive analysis of Snakin-1 silenced lines demonstrated for the first time in potato that Snakin-1 plays a role in redox balance and participates in a complex crosstalk among different hormones.	[Nahirnak, Vanesa; Rivarola, Maximo; Ines Almasia, Natalia; Esteban Hopp, Horacio; Paniego, Norma; Vazquez Rovere, Cecilia] INTA, CNIA, CICVyA, Inst Biotecnol, Buenos Aires, DF, Argentina; [Rivarola, Maximo; Barrios Baron, Maria Pilar; Paniego, Norma; Vazquez Rovere, Cecilia] Consejo Nacl Invest Cient & Tecn CONICET, Buenos Aires, DF, Argentina; [Vile, Denis] Univ Montpellier, INRA, LEPSE, SupAgro, Montpellier, France; [Vazquez Rovere, Cecilia] INTA LABINTEX Agropolis Int, Montpellier, France	Instituto Nacional de Tecnologia Agropecuaria (INTA); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); INRAE; Institut Agro; Montpellier SupAgro; Universite de Montpellier	Rovere, CV (corresponding author), INTA, CNIA, CICVyA, Inst Biotecnol, Buenos Aires, DF, Argentina.; Rovere, CV (corresponding author), Consejo Nacl Invest Cient & Tecn CONICET, Buenos Aires, DF, Argentina.; Rovere, CV (corresponding author), INTA LABINTEX Agropolis Int, Montpellier, France.	vazquezrovere@hotmail.com	Vile, Denis/A-5637-2008; Paniego, Norma/AAK-6140-2021	Vile, Denis/0000-0002-7948-1462; Nahirnak, Vanesa/0000-0002-8210-9266; Rivarola, Maximo/0000-0003-2818-1037; Vazquez Rovere, Cecilia/0000-0002-5804-6197; Almasia, Natalia Ines/0000-0002-2961-6488; Paniego, Norma/0000-0003-3906-5330; Hopp, H. Esteban/0000-0002-2230-641X	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) [PICT 2011-1377, PICT 2012-0639]; Instituto Nacional de Tecnologia Agropecuaria (INTA) [PNBIO 1131022/3]; mobility grant Montpellier Universited'Excellence (MUSE) EXPLORE [24001146]	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT); Instituto Nacional de Tecnologia Agropecuaria (INTA); mobility grant Montpellier Universited'Excellence (MUSE) EXPLORE	This work was supported by PICT 2011-1377 (to CVR) and PICT 2012-0639 (to NIA) from Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) and by projects PNBIO 1131022/3 from Instituto Nacional de Tecnologia Agropecuaria (INTA). DV was supported by a mobility grant Montpellier Universited'Excellence (MUSE) EXPLORE #24001146. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Teresa Cabrera, Valeria Beracochea, Valeria Peralta, Florencia Olivari, Matias Rodriguez, Ignacio Tevez and Agustin Montenegro for their excellent technical assistance in the production and maintenance of transgenic potato plants. We also thank Julia Sabio for her invaluable help as English editor. Microscopic analyses were performed at Laboratorio Integral de Microscopia, CICVyA, INTA. This work was supported by PICT 2011-1377 and PICT 2012-0639 from Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) and by projects PNBIO 1131022/3 from Instituto Nacional de Tecnologia Agropecuaria (INTA). DV was supported by a mobility grant Montpellier Universited'Excellence (MUSE) EXPLORE #24001146. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No conflicts of interest declared.	Almasia NI, 2008, MOL PLANT PATHOL, V9, P329, DOI 10.1111/J.1364-3703.2008.00469.X; Alonso-Ramirez A, 2009, PLANT PHYSIOL, V150, P1335, DOI 10.1104/pp.109.139352; Torres MA, 2010, PHYSIOL PLANTARUM, V138, P414, DOI 10.1111/j.1399-3054.2009.01326.x; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Aubert D, 1998, PLANT MOL BIOL, V36, P871, DOI 10.1023/A:1005938624418; Benveniste P, 2004, ANNU REV PLANT BIOL, V55, P429, DOI 10.1146/annurev.arplant.55.031903.141616; CHINOY NJ, 1969, HISTOCHEMISTRY, V20, P105, DOI 10.1007/BF00268703; Choe S, 1999, PLANT PHYSIOL, V119, P897, DOI 10.1104/pp.119.3.897; Choe SW, 1999, PLANT CELL, V11, P207, DOI 10.1105/tpc.11.2.207; Clouse SD, 2002, PLANT CELL, V14, P1995, DOI 10.1105/tpc.140930; Conti G, 2012, MOL PLANT MICROBE IN, V25, P1370, DOI 10.1094/MPMI-03-12-0075-R; Daviere JM, 2016, MOL PLANT, V9, P10, DOI 10.1016/j.molp.2015.09.011; del Vas M., 1992, THESIS; Depuydt S, 2011, CURR BIOL, V21, pR365, DOI 10.1016/j.cub.2011.03.013; Ezaki B, 2000, PLANT PHYSIOL, V122, P657, DOI 10.1104/pp.122.3.657; Fenech M, 2019, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.02006; Franceschi VR, 2002, PLANT PHYSIOL, V130, P649, DOI 10.1104/pp.007062; Gallie DR, 2013, SCIENTIFICA, V2013, DOI 10.1155/2013/795964; Gehl C, 2009, MOL PLANT, V2, P1051, DOI 10.1093/mp/ssp040; Gray WM, 2004, PLOS BIOL, V2, P1270, DOI 10.1371/journal.pbio.0020311; JEFFERSON RA, 1987, BIOCHEM SOC T, V15, P17, DOI 10.1042/bst0150017; Klahre U, 1998, PLANT CELL, V10, P1677, DOI 10.1105/tpc.10.10.1677; Kocsy G, 2013, PLANT SCI, V211, P77, DOI 10.1016/j.plantsci.2013.07.004; Lee SC, 2015, J PLANT BIOL, V58, P96, DOI 10.1007/s12374-014-0497-z; Mi HY, 2017, NUCLEIC ACIDS RES, V45, pD183, DOI 10.1093/nar/gkw1138; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Mittler R, 2011, TRENDS PLANT SCI, V16, P300, DOI 10.1016/j.tplants.2011.03.007; Mizrachi E, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-681; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mukherjee M, 2010, MOL PLANT MICROBE IN, V23, P340, DOI 10.1094/MPMI-23-3-0340; MUNSHI CB, 1989, J FOOD SCI, V54, P220, DOI 10.1111/j.1365-2621.1989.tb08607.x; Nahirnak V, 2016, AM J POTATO RES, V93, P172, DOI 10.1007/s12230-016-9494-8; Nahirnak V, 2012, PLANT SIGNAL BEHAV, V7, P1004, DOI 10.4161/psb.20813; Nahirnak V, 2012, PLANT PHYSIOL, V158, P252, DOI 10.1104/pp.111.186544; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Olmos E, 2006, J EXP BOT, V57, P1645, DOI 10.1093/jxb/erl010; Paulsen CE, 2013, CHEM REV, V113, P4633, DOI 10.1021/cr300163e; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Rhee SG, 2010, MOL CELLS, V29, P539, DOI 10.1007/s10059-010-0082-3; Ricardi MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041008; Rosello PL, 2016, PLANT PHYSIOL BIOCH, V102, P133, DOI 10.1016/j.plaphy.2016.02.021; Rubinovich L, 2014, MOL PLANT, V7, P244, DOI 10.1093/mp/sst141; Rubinovich L, 2010, PLANT J, V64, P1018, DOI 10.1111/j.1365-313X.2010.04390.x; Schaller H, 2004, PLANT PHYSIOL BIOCH, V42, P465, DOI 10.1016/j.plaphy.2004.05.012; Schaller H, 2003, PROG LIPID RES, V42, P163, DOI 10.1016/S0163-7827(02)00047-4; Schippers JHM, 2016, CURR OPIN PLANT BIOL, V29, P121, DOI 10.1016/j.pbi.2015.11.009; Schmidt R, 2015, BBA-GEN SUBJECTS, V1850, P1497, DOI 10.1016/j.bbagen.2014.12.020; Segura A, 1999, MOL PLANT MICROBE IN, V12, P16, DOI 10.1094/MPMI.1999.12.1.16; Singh R, 2017, REDOX BIOL, V11, P213, DOI 10.1016/j.redox.2016.11.006; Singh R, 2016, FRONT PLANT SCI, V7, P1, DOI 10.3389/fpls.2016.01299; Smirnoff N, 2000, CURR OPIN PLANT BIOL, V3, P229, DOI 10.1016/S1369-5266(00)00069-8; Smirnoff N, 2000, CRIT REV BIOCHEM MOL, V35, P291, DOI 10.1080/10409230008984166; Souza PVL, 2019, CRIT REV PLANT SCI, V38, P1, DOI 10.1080/07352689.2018.1528409; Sun SL, 2013, J EXP BOT, V64, P1637, DOI 10.1093/jxb/ert021; Swanson S, 2010, PHYSIOL PLANTARUM, V138, P384, DOI 10.1111/j.1399-3054.2009.01313.x; ThordalChristensen H, 1997, PLANT J, V11, P1187, DOI 10.1046/j.1365-313X.1997.11061187.x; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Vanstraelen M, 2012, ANNU REV CELL DEV BI, V28, P463, DOI 10.1146/annurev-cellbio-101011-155741; Wang L, 2009, PLANT J, V57, P498, DOI 10.1111/j.1365-313X.2008.03707.x; Wigoda N, 2006, PLANT J, V48, P796, DOI 10.1111/j.1365-313X.2006.02917.x; Wohlgemuth H, 2002, PLANT CELL ENVIRON, V25, P717, DOI 10.1046/j.1365-3040.2002.00859.x; Xia XJ, 2015, J EXP BOT, V66, P2839, DOI 10.1093/jxb/erv089; Zhang CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061987; Zhang SC, 2011, J PLANT PHYSIOL, V168, P2093, DOI 10.1016/j.jplph.2011.06.010	65	17	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2019	14	3							e0214165	10.1371/journal.pone.0214165	http://dx.doi.org/10.1371/journal.pone.0214165			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ1KV	30909287	Green Published, gold, Green Submitted			2022-12-26	WOS:000462157600042
J	Casado-Medrano, V; Barrio-Real, L; Wang, A; Cooke, M; Lopez-Haber, C; Kazanietz, MG				Casado-Medrano, Victoria; Barrio-Real, Laura; Wang, Anita; Cooke, Mariana; Lopez-Haber, Cynthia; Kazanietz, Marcelo G.			Distinctive requirement of PKC epsilon in the control of Rho GTPases in epithelial and mesenchymally transformed lung cancer cells	ONCOGENE			English	Article							PROTEIN-KINASE-C; DOWN-REGULATION; PROSTATE-CANCER; BREAST-CANCER; CONSTITUTIVE ACTIVATION; ESSENTIAL MEDIATOR; EXPRESSION; GEF; PHOSPHORYLATION; DIFFERENTIATION	Diacylglycerol (DAG)/phorbol ester-regulated protein kinase C (PKC) isozymes have been widely linked to tumor promotion and the development of a metastatic phenotype. PKC epsilon, an oncogenic member of the PKC family, is abnormally overexpressed in lung cancer and other cancer types. This kinase plays significant roles in proliferation, survival, and migration; however, its role in epithelial-to-mesenchymal transition (EMT) has been scarcely studied. Silencing experiments in non-small lung cancer (NSCLC) cells revealed that PKC epsilon or other DAG-regulated PKCs (PKC alpha and PKC delta) were dispensable for the acquisition of a mesenchymal phenotype induced by transforming growth factor beta (TGF-beta. Unexpectedly, we found a nearly complete down-regulation of PKC epsilon expression in TGF-beta-mesenchymally transformed NSCLC cells. PMA and AJH-836 (a DAG-mimetic that preferentially activates PKC epsilon) promote ruffle formation in NSCLC cells via Racl, however they fail to induce these morphological changes in TGF-beta-mesenchymally transformed cells despite their elevated Racl activity. Several Rac guanine nucleotide exchange-factors (Rac-GEFs) were also up-regulated in TGF-beta-treated NSCLC cells, including Trio and Tiam2, which were required for cell motility. Lastly, we found that silencing or inhibiting PKC epsilon enhances RhoA activity and stress fiber formation, a phenotype also observed in TGF-beta-transformed cells. Our studies established a distinctive involvement of PKC in epithelial and mesenchymal NSCLC cells, and identified a complex interplay between PKC epsilon and small GTPases that contributes to regulation of NSCLC cell morphology and motile activity.	[Casado-Medrano, Victoria; Barrio-Real, Laura; Wang, Anita; Cooke, Mariana; Lopez-Haber, Cynthia; Kazanietz, Marcelo G.] Univ Penn, Perelman Sch Med, Dept Syst Pharmacol & Translat Therapeut, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Kazanietz, MG (corresponding author), Univ Penn, Perelman Sch Med, Dept Syst Pharmacol & Translat Therapeut, Philadelphia, PA 19104 USA.	marcelog@upenn.edu	Cooke, Mariana/ABD-5051-2021; Casado-Medrano, Victoria/ABE-6429-2021	Casado-Medrano, Victoria/0000-0002-6929-4559; Cooke, Mariana/0000-0001-9300-8447; Lopez Haber, Cynthia/0000-0001-9106-543X	National Institutes of Health [R01-ES026023, R01-ES026023-S1]; NATIONAL CANCER INSTITUTE [R01CA196232] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES026023] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by grant R01-ES026023 and R01-ES026023-S1 from the National Institutes of Health to M.G.K.	Aziz MH, 2007, CANCER RES, V67, P8828, DOI 10.1158/0008-5472.CAN-07-1604; Bae KM, 2007, CANCER RES, V67, P6053, DOI 10.1158/0008-5472.CAN-06-4037; Barrio-Real Laura, 2018, Oncotarget, V9, P28612, DOI 10.18632/oncotarget.25584; Bassini A, 1999, BLOOD, V93, P1178, DOI 10.1182/blood.V93.4.1178.404k28_1178_1188; Basu A, 2007, CELL SIGNAL, V19, P1633, DOI 10.1016/j.cellsig.2007.04.008; Benavides F, 2011, CELL CYCLE, V10, P268, DOI 10.4161/cc.10.2.14469; Bhowmick NA, 2001, MOL BIOL CELL, V12, P27, DOI 10.1091/mbc.12.1.27; Bin Hafeez B, 2011, CANCER RES, V71, P2318, DOI 10.1158/0008-5472.CAN-10-4170; Brown KA, 2004, BREAST CANCER RES, V6, pR215, DOI 10.1186/bcr778; Burgos M, 2007, GLIA, V55, P1437, DOI 10.1002/glia.20555; Bustelo XR, 2018, BIOCHEM SOC T, V46, P741, DOI 10.1042/BST20170531; Caino MC, 2012, ONCOGENE, V31, P2593, DOI 10.1038/onc.2011.428; Caino MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031714; Chang MT, 2016, NAT BIOTECHNOL, V34, P155, DOI 10.1038/nbt.3391; Cook Danielle R, 2011, Genes Cancer, V2, P932, DOI 10.1177/1947601912437035; Cooke M, 2018, J BIOL CHEM, V293, P8330, DOI 10.1074/jbc.RA117.000235; David CJ, 2016, CELL, V164, P1015, DOI 10.1016/j.cell.2016.01.009; Di Marcantonio D, 2015, EXP CELL RES, V339, P10, DOI 10.1016/j.yexcr.2015.09.017; Fleming IN, 1997, J BIOL CHEM, V272, P33105, DOI 10.1074/jbc.272.52.33105; Gaboardi GC, 2010, CELL SIGNAL, V22, P629, DOI 10.1016/j.cellsig.2009.11.017; Galli D, 2015, EXP CELL RES, V330, P277, DOI 10.1016/j.yexcr.2014.11.011; Gandellini P, 2009, CANCER RES, V69, P2287, DOI 10.1158/0008-5472.CAN-08-2894; Gao S, 2009, MOL CELL, V36, P457, DOI 10.1016/j.molcel.2009.09.043; Garcia-Mata R, 2007, TRENDS CELL BIOL, V17, P36, DOI 10.1016/j.tcb.2006.11.004; Garg R, 2014, ONCOGENE, V33, P5225, DOI 10.1038/onc.2013.524; Garg R, 2018, ONCOGENE, V37, P4735, DOI 10.1038/s41388-018-0318-9; Garg R, 2017, CELL REP, V19, P375, DOI 10.1016/j.celrep.2017.03.042; Garg R, 2012, J BIOL CHEM, V287, P37570, DOI 10.1074/jbc.M112.398925; Garofalo M, 2011, ANNU REV PHARMACOL, V51, P25, DOI 10.1146/annurev-pharmtox-010510-100517; Gobbi G, 2007, STEM CELLS, V25, P2322, DOI 10.1634/stemcells.2006-0839; Gobbi G, 2013, BLOOD, V122, P1305, DOI 10.1182/blood-2013-04-490599; Gobbi G, 2012, J CELL PHYSIOL, V227, P630, DOI 10.1002/jcp.22765; Gobbi G, 2010, INT J ONCOL, V37, P719, DOI 10.3892/ijo_00000721; Gonzalez DM, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005189; Gorin MA, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-9; Gorshkova I, 2008, J BIOL CHEM, V283, P11794, DOI 10.1074/jbc.M800250200; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Griner EM, 2010, J BIOL CHEM, V285, P16931, DOI 10.1074/jbc.M109.099036; Guilluy C, 2011, NAT PROTOC, V6, P2050, DOI 10.1038/nprot.2011.411; Gutierrez-Uzquiza A, 2015, MOL CANCER RES, V13, P1336, DOI 10.1158/1541-7786.MCR-15-0111; Hafeez Bilal Bin, 2015, Cancer Prev Res (Phila), V8, P375, DOI 10.1158/1940-6207.CAPR-14-0231; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; Hill KS, 2014, ONCOGENE, V33, P2134, DOI 10.1038/onc.2013.147; Isakov N, 2018, SEMIN CANCER BIOL, V48, P36, DOI 10.1016/j.semcancer.2017.04.012; Iyengar PV, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040877; Jain K, 2014, CANCERS, V6, P860, DOI 10.3390/cancers6020860; Jain K, 2014, BREAST CANCER-BASIC, V8, P61, DOI 10.4137/BCBCR.S13640; Kang YB, 2004, CELL, V118, P277, DOI 10.1016/j.cell.2004.07.011; Leask A, 2008, J CELL SCI, V121, P3459, DOI 10.1242/jcs.029215; Leontieva OV, 2004, J BIOL CHEM, V279, P5788, DOI 10.1074/jbc.M308375200; Levay M, 2009, BIOCHEMISTRY-US, V48, P8615, DOI 10.1021/bi900667y; Lopez-Haber C, 2016, MOL CELL BIOL, V36, P2011, DOI 10.1128/MCB.00180-16; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; Meshki J, 2010, J BIOL CHEM, V285, P26033, DOI 10.1074/jbc.M110.128371; Mochly-Rosen D, 2012, NAT REV DRUG DISCOV, V11, P937, DOI 10.1038/nrd3871; Montero JC, 2016, ONCOTARGET, V7, P77937, DOI 10.18632/oncotarget.12846; Newton AC, 2017, TRENDS PHARMACOL SCI, V38, P438, DOI 10.1016/j.tips.2017.02.002; Ong ST, 2014, J BIOL CHEM, V289, P19420, DOI 10.1074/jbc.M113.545863; Pan Q, 2005, CANCER RES, V65, P8366, DOI 10.1158/0008-5472.CAN-05-0553; Pan Q, 2006, CANCER RES, V66, P9379, DOI 10.1158/0008-5472.CAN-06-2646; Pang MF, 2016, ONCOGENE, V35, P748, DOI 10.1038/onc.2015.133; Pardo OE, 2006, EMBO J, V25, P3078, DOI 10.1038/sj.emboj.7601198; Prekeris R, 1996, J CELL BIOL, V132, P77, DOI 10.1083/jcb.132.1.77; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Shankar E, 2008, ONCOGENE, V27, P3957, DOI 10.1038/onc.2008.39; Slupsky JR, 2007, AM J PATHOL, V170, P745, DOI 10.2353/ajpath.2007.060557; Sosa MS, 2010, MOL CELL, V40, P877, DOI 10.1016/j.molcel.2010.11.029; Sun XW, 2018, J CELL PHYSIOL, V233, P596, DOI 10.1002/jcp.25920; Symonds JM, 2011, CANCER RES, V71, P2087, DOI 10.1158/0008-5472.CAN-10-1511; Ungefroren H, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061568; Ungefroren H, 2018, DEV DYNAM, V247, P451, DOI 10.1002/dvdy.24505; Wang HB, 2014, J BIOL CHEM, V289, P19823, DOI 10.1074/jbc.M114.548446; Wang LY, 2017, PEPTIDES, V96, P44, DOI 10.1016/j.peptides.2017.08.006; Wang YY, 2015, CELL PHYSIOL BIOCHEM, V36, P179, DOI 10.1159/000374062; Wu-Zhang AX, 2013, BIOCHEM J, V452, P195, DOI 10.1042/BJ20130220; Yu JR, 2015, GENE DEV, V29, P250, DOI 10.1101/gad.248963.114; Zeidman R, 2002, MOL BIOL CELL, V13, P12, DOI 10.1091/mbc.01-04-0210; Zhang HT, 2009, BIOL REPROD, V80, P440, DOI 10.1095/biolreprod.108.072983; Zhang XP, 2014, INT J CANCER, V134, P257, DOI 10.1002/ijc.28141; Zhao W, 2015, MOL BIOL CELL, V26, P1786, DOI 10.1091/mbc.E14-10-1474	81	8	11	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 4	2019	38	27					5396	5412		10.1038/s41388-019-0796-4	http://dx.doi.org/10.1038/s41388-019-0796-4			17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	IG5KR	30923343	Green Accepted			2022-12-26	WOS:000473842500005
J	Wu, MQ; Sheng, L; Cheng, MS; Zhang, HJ; Jiang, YZ; Lin, SB; Liang, Y; Zhu, FY; Liu, ZQ; Zhang, YY; Zhang, XH; Gao, Q; Chen, DM; Li, J; Li, Y				Wu, Mingqing; Sheng, Lu; Cheng, Maosheng; Zhang, Haojie; Jiang, Yizhou; Lin, Shuibin; Liang, Yu; Zhu, Fengyu; Liu, Zhenqing; Zhang, Yingyin; Zhang, Xiuhong; Gao, Qian; Chen, Demeng; Li, Jiong; Li, Yang			Low doses of decitabine improve the chemotherapy efficacy against basal-like bladder cancer by targeting cancer stem cells	ONCOGENE			English	Article							ACUTE MYELOID-LEUKEMIA; DNA METHYLATION; UROTHELIAL CARCINOMA; MOLECULAR CHARACTERIZATION; AGENT DECITABINE; INITIATING CELLS; PROGRESSION; DIFFERENTIATION; IDENTIFICATION; COMBINATION	Low dose treatment with the DNA methylation inhibitor decitabine has been shown to be applicable for the management of certain types of cancer. However, its antitumor effect and mechanisms are context dependent and its activity has never been systematically studied in bladder cancer treatment. We used mouse models, cultured cell lines and patient-derived xenografts to demonstrate that low dose decitabine treatment remarkably enhanced the effects of cisplatin and gemcitabine on basal-like bladder cancer both in vivo and in vitro. Genetic lineage tracing revealed that the stemness of a bladder cancer stem cell population was inhibited by decitabine treatment in mice. These effects were accompanied by decreases in genome-wide DNA methylation, gene re-expression, and changes in key cellular regulatory pathways such as STAT3 signaling. These results indicate that this DNA-demethylating reagent is a promising therapeutic approach for basal-like bladder cancer treatment.	[Wu, Mingqing; Cheng, Maosheng; Liang, Yu; Zhu, Fengyu; Zhang, Yingyin; Zhang, Xiuhong; Gao, Qian; Li, Yang] Anhui Med Univ, Sch Life Sci, Dept Genet, Hefei 230031, Anhui, Peoples R China; [Sheng, Lu; Zhang, Haojie] Fudan Univ, Huadong Hosp, Dept Urol, Shanghai 200040, Peoples R China; [Jiang, Yizhou] Shenzhen Univ, Inst Adv Study, Shenzhen 518060, Guangdong, Peoples R China; [Lin, Shuibin; Chen, Demeng] Sun Yat Sen Univ, Affiliated Hosp 1, Ctr Translat Med, Guangzhou 510080, Guangdong, Peoples R China; [Liu, Zhenqing; Li, Jiong] Univ Calif Los Angeles, Lab Mol Signaling, Div Oral Biol & Med, Sch Dent, Los Angeles, CA 90095 USA; [Liu, Zhenqing; Li, Jiong] Univ Calif Los Angeles, Broad Stem Cell Res Ctr, Los Angeles, CA 90095 USA; [Li, Jiong] Virginia Commonwealth Univ, Inst Struct Biol Drug Discovery & Dev, Dept Med Chem, Sch Pharm, 800 E Leigh St, Richmond, VA 23284 USA	Anhui Medical University; Fudan University; Shenzhen University; Sun Yat Sen University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Virginia Commonwealth University	Li, Y (corresponding author), Anhui Med Univ, Sch Life Sci, Dept Genet, Hefei 230031, Anhui, Peoples R China.; Chen, DM (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Ctr Translat Med, Guangzhou 510080, Guangdong, Peoples R China.; Li, J (corresponding author), Univ Calif Los Angeles, Lab Mol Signaling, Div Oral Biol & Med, Sch Dent, Los Angeles, CA 90095 USA.; Li, J (corresponding author), Univ Calif Los Angeles, Broad Stem Cell Res Ctr, Los Angeles, CA 90095 USA.; Li, J (corresponding author), Virginia Commonwealth Univ, Inst Struct Biol Drug Discovery & Dev, Dept Med Chem, Sch Pharm, 800 E Leigh St, Richmond, VA 23284 USA.	chendm29@mail.sysu.edu.cn; jli29@vcu.edu; liyang@ahmu.edu.cn			National Natural Science Foundation of China [81872313, 81672776, 31501838]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (81872313 and 81672776 to YL, 31501838 to XHZ).	Alcazar O, 2012, INT J CANCER, V131, P18, DOI 10.1002/ijc.26320; Anastasiadis A, 2012, THER ADV UROL, V4, P13, DOI 10.1177/1756287211431976; Babjuk M, 2013, EUR UROL, V64, P639, DOI 10.1016/j.eururo.2013.06.003; BECCI PJ, 1978, CANCER RES, V38, P4463; Beck B, 2013, NAT REV CANCER, V13, P727, DOI 10.1038/nrc3597; Blum W, 2007, J CLIN ONCOL, V25, P3884, DOI 10.1200/JCO.2006.09.4169; Cashen AF, 2010, J CLIN ONCOL, V28, P556, DOI 10.1200/JCO.2009.23.9178; Chan KS, 2009, P NATL ACAD SCI USA, V106, P14016, DOI 10.1073/pnas.0906549106; Chen MX, 2018, INT J CANCER, V143, P1530, DOI 10.1002/ijc.31531; Choi W, 2014, CANCER CELL, V25, P152, DOI 10.1016/j.ccr.2014.01.009; Deng WK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111988; Felsenstein KM, 2018, NAT REV UROL, V15, P92, DOI 10.1038/nrurol.2017.179; Ferguson AT, 1997, J BIOL CHEM, V272, P32260, DOI 10.1074/jbc.272.51.32260; Flotho C, 2009, LEUKEMIA, V23, P1019, DOI 10.1038/leu.2008.397; Fu XY, 2015, CURR PROTEIN PEPT SC, V16, P329, DOI 10.2174/138920371604150429155740; Ghoshal K, 2005, MOL CELL BIOL, V25, P4727, DOI 10.1128/MCB.25.11.4727-4741.2005; Hagemann S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017388; Ho PL, 2012, NAT REV UROL, V9, P583, DOI 10.1038/nrurol.2012.142; Ho PL, 2012, CANCER RES, V72, P3135, DOI 10.1158/0008-5472.CAN-11-3195; Huang HY, 2007, HUM PATHOL, V38, P1703, DOI 10.1016/j.humpath.2007.04.003; Issa JPJ, 2004, BLOOD, V103, P1635, DOI 10.1182/blood-2003-03-0687; Juergens RA, 2011, CANCER DISCOV, V1, P598, DOI 10.1158/2159-8290.CD-11-0214; Kahn SL, 2008, CANCER CYTOPATHOL, V114, P57, DOI 10.1002/cncr.23258; Kandimalla R, 2013, NAT REV UROL, V10, P327, DOI 10.1038/nrurol.2013.89; Khandelwal M, 2018, MOL CELL BIOCHEM, V446, P105, DOI 10.1007/s11010-018-3278-z; Kurtova AV, 2015, NATURE, V517, P209, DOI 10.1038/nature14034; Li LM, 2018, ONCOTARGETS THER, V11, P6863, DOI 10.2147/OTT.S161919; Li X, 2017, CLIN CANCER RES, V23, P6031, DOI 10.1158/1078-0432.CCR-17-1201; Li Y, 2015, ONCOTARGET, V6, P10195, DOI 10.18632/oncotarget.3555; Li Y, 2011, CANCER SCI, V102, P2043, DOI 10.1111/j.1349-7006.2011.02061.x; Liang Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep29479; Licht JD, 2015, CELL, V162, P938, DOI 10.1016/j.cell.2015.08.005; Lv L, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.367; Malik P, 2014, CANCER MANAG RES, V6, P53, DOI 10.2147/CMAR.S40600; Momparler RL, 2005, SEMIN HEMATOL, V42, pS9, DOI 10.1053/j.seminhematol.2005.05.002; O'Flaherty JD, 2012, J THORAC ONCOL, V7, P1880, DOI 10.1097/JTO.0b013e31826bfbc6; Oz S, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku775; Oing C, 2016, J UROLOGY, V195, P254, DOI 10.1016/j.juro.2015.06.115; Paner GP, 2014, HUM PATHOL, V45, P1473, DOI 10.1016/j.humpath.2014.02.024; Papafotiou G, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11914; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pei M, 2009, DIFFERENTIATION, V78, P260, DOI 10.1016/j.diff.2009.08.001; Peng D, 2018, EPIGENOMICS-UK, V10, P1189, DOI 10.2217/epi-2018-0017; Rebouissou S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008970; Ribas A, 2014, CLIN CANCER RES, V20, P4982, DOI 10.1158/1078-0432.CCR-14-0933; Saito R, 2018, CANCER RES, V78, P3954, DOI 10.1158/0008-5472.CAN-18-0173; Schulz WA, 2016, EPIGENOMICS-UK, V8, P1415, DOI 10.2217/epi-2016-0064; Shah JB, 2011, CLIN CANCER RES, V17, P2608, DOI 10.1158/1078-0432.CCR-10-2770; Shang DH, 2008, UROLOGY, V71, P1220, DOI 10.1016/j.urology.2007.11.029; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Sonpavde G, 2016, J CLIN ONCOL, V34, P780, DOI 10.1200/JCO.2015.65.4442; Su Y, 2010, CANCER EPIDEM BIOMAR, V19, P327, DOI 10.1158/1055-9965.EPI-09-0865; Timp W, 2013, NAT REV CANCER, V13, P497, DOI 10.1038/nrc3486; Triozzi PL, 2012, CANCER IMMUNOL IMMUN, V61, P1441, DOI 10.1007/s00262-012-1204-x; Tsai HC, 2012, CANCER CELL, V21, P430, DOI 10.1016/j.ccr.2011.12.029; Van Batavia J, 2014, NAT CELL BIOL, V16, P982, DOI 10.1038/ncb3038; Volkmer JP, 2012, P NATL ACAD SCI USA, V109, P2078, DOI 10.1073/pnas.1120605109; von der Maase H, 2005, J CLIN ONCOL, V23, P4602, DOI 10.1200/JCO.2005.07.757; Weinstein JN, 2014, NATURE, V507, P315, DOI 10.1038/nature12965; Williams PD, 2008, NEOPLASIA, V10, P838, DOI 10.1593/neo.08432; Xylinas E, 2016, BIOMOLECULES, V6, DOI 10.3390/biom6030037; Yan P, 2012, BLOOD, V120, P2466, DOI 10.1182/blood-2012-05-429175; Yang YM, 2008, CANCER INVEST, V26, P725, DOI 10.1080/07357900801941845; Yu GJ, 2019, CELL MOL IMMUNOL, V16, P401, DOI 10.1038/s41423-018-0026-y; Zhao D, 2015, ONCOGENE, V34, P3107, DOI 10.1038/onc.2014.257; Zhu FY, 2017, STEM CELL REP, V9, P429, DOI 10.1016/j.stemcr.2017.07.004	66	15	16	3	26	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 4	2019	38	27					5425	5439		10.1038/s41388-019-0799-1	http://dx.doi.org/10.1038/s41388-019-0799-1			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	IG5KR	30918330				2022-12-26	WOS:000473842500007
J	Peters, F; Scharfenberg, F; Colmorgen, C; Armbrust, F; Wichert, R; Arnold, P; Potempa, B; Potempa, J; Pietrzik, CU; Hasler, R; Rosenstiel, P; Becker-Pauly, C				Peters, Florian; Scharfenberg, Franka; Colmorgen, Cynthia; Armbrust, Fred; Wichert, Rielana; Arnold, Philipp; Potempa, Barbara; Potempa, Jan; Pietrzik, Claus U.; Hasler, Robert; Rosenstiel, Philip; Becker-Pauly, Christoph			Tethering soluble meprin alpha in an enzyme complex to the cell surface affects IBD-associated genes	FASEB JOURNAL			English	Article						protease; quaternary structure; chronic intestinal inflammation; meprin beta	PABA-PEPTIDE; BETA; METALLOPROTEASE; EXPRESSION; MEMBRANE; SUBUNIT; RAT; MECHANISM; RELEASE; DIMERS	Biologic activity of proteases is mainly characterized by the substrate specificity, tissue distribution, and cellular localization. The human metalloproteases meprin alpha and meprin beta share 41% sequence identity and exhibit a similar cleavage specificity with a preference for negatively charged amino acids. However, shedding of meprin alpha by furin on the secretory pathway makes it a secreted enzyme in comparison with the membrane-bound meprin beta. In this study, we identified human meprin alpha and meprin beta as forming covalently linked membrane-tethered heterodimers in the early endoplasmic reticulum, thereby preventing furin-mediated secretion of meprin alpha. Within this newly formed enzyme complex, meprin alpha was able to be activated on the cell surface and detected by cleavage of a novel specific fluorogenic peptide substrate. However, the known meprin beta substrates amyloid precursor protein and CD99 were not shed by membrane-tethered meprin alpha. On the other hand, being linked to meprin alpha, activation of or substrate cleavage by meprin beta on the cell surface was not altered. Interestingly, proteolytic activity of both proteases was increased in the heteromeric complex, indicating an increased proteolytic potential at the plasma membrane. Because meprins are susceptibility genes for inflammatory bowel disease (IBD), and to investigate the physiologic impact of the enzyme complex, we performed transcriptome analyses of intestinal mucosa from meprin-knockout mice. Comparison of the transcriptional gene analysis data with gene analyses of IBD patients revealed that different gene subsets were dysregulated if meprin alpha was expressed alone or in the enzyme complex, demonstrating the physiologic and pathophysiological relevance of the meprin heterodimer formation.-Peters, F., Scharfenberg, F., Colmorgen, C., Armbrust, F., Wichert, R., Arnold, P., Potempa, B., Potempa, J., Pietrzik, C. U., Hasler, R., Rosenstiel, P., Becker-Pauly, C. Tethering soluble meprin alpha in an enzyme complex to the cell surface affects IBD-associated genes.	[Peters, Florian; Scharfenberg, Franka; Colmorgen, Cynthia; Armbrust, Fred; Wichert, Rielana; Becker-Pauly, Christoph] Univ Kiel, Biochem Inst, Unit Degrad Protease Web, Otto Hahn Pl 9, D-24098 Kiel, Germany; [Arnold, Philipp] Univ Kiel, Anat Inst, Kiel, Germany; [Hasler, Robert; Rosenstiel, Philip] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Potempa, Barbara; Potempa, Jan] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Microbiol, Krakow, Poland; [Pietrzik, Claus U.] Univ Med Ctr Mainz, Inst Pathobiochem, Mainz, Germany	University of Kiel; University of Kiel; University of Kiel; Jagiellonian University; Johannes Gutenberg University of Mainz	Becker-Pauly, C (corresponding author), Univ Kiel, Biochem Inst, Unit Degrad Protease Web, Otto Hahn Pl 9, D-24098 Kiel, Germany.	cbeckerpauly@biochem.uni-kiel.de	Potempa, Jan/AAA-6850-2021; Scharfenberg, Franka/AAS-9798-2021; Rosenstiel, Philip/A-5137-2009; Häsler, Robert/A-4908-2009; Becker-Pauly, Christoph/B-7569-2011	Rosenstiel, Philip/0000-0002-9692-8828; Häsler, Robert/0000-0003-4174-8229; Peters, Florian/0000-0002-8529-2326	Deutsche Forschungsgemeinschaft (DFG) [SFB 877, EXC 22167-390884018, BE 4086/2-2, BE 4086/5-1]; U.S. National Institutes of Health (NIH), National Institute of Dental and Craniofacial Research (NIDCR) [DE 022597]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022597] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); U.S. National Institutes of Health (NIH), National Institute of Dental and Craniofacial Research (NIDCR); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The authors thank Judith Bond (Pennsylvania State University, State College, PA, USA) for intense discussions on biochemical properties of meprin oligomerization. The authors also thank Lennard Arp (University of Kiel) for excellent technical assistance. This work was supported by the Deutsche Forschungsgemeinschaft (DFG) SFB 877 (Proteolysis as a Regulatory Event in Pathophysiology, Projects A9, A13, and A15) under Germany's Excellence Strategy, EXC 22167-390884018, and BE 4086/2-2 and BE 4086/5-1 (both to C.B.P.). J.P. is supported by the U.S. National Institutes of Health (NIH), National Institute of Dental and Craniofacial Research (NIDCR) (Grant DE 022597). The authors declare no conflicts of interest.	Agg B, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30163-9; Agg B, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27740-3; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Arolas JL, 2012, P NATL ACAD SCI USA, V109, P16131, DOI 10.1073/pnas.1211076109; Banerjee S, 2009, MUCOSAL IMMUNOL, V2, P220, DOI 10.1038/mi.2009.3; Banerjee S, 2011, AM J PHYSIOL-GASTR L, V300, pG273, DOI 10.1152/ajpgi.00504.2009; BARNES K, 1989, BIOCHEM J, V264, P335, DOI 10.1042/bj2640335; Becker-Pauly C, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009233; Bedau T, 2017, FASEB J, V31, P1226, DOI 10.1096/fj.201601113R; Bertenshaw GP, 2003, J BIOL CHEM, V278, P2522, DOI 10.1074/jbc.M208808200; BEYNON RJ, 1981, BIOCHEM J, V199, P591, DOI 10.1042/bj1990591; Biasin V, 2018, THROMB HAEMOSTASIS, V118, P1790, DOI 10.1055/s-0038-1670657; Bien J, 2012, J BIOL CHEM, V287, P33304, DOI 10.1074/jbc.M112.395608; Broder C, 2013, BIOCHEM J, V450, P253, DOI 10.1042/BJ20121751; Chevallier S, 1996, BIOCHEM J, V317, P731, DOI 10.1042/bj3170731; GRUNBERG J, 1993, FEBS LETT, V335, P376, DOI 10.1016/0014-5793(93)80422-Q; Hasler R, 2017, GUT, V66, P2087, DOI 10.1136/gutjnl-2016-311651; Hahn D, 2000, BIOCHEM J, V346, P83, DOI 10.1042/0264-6021:3460083; Hata S, 2016, J BIOL CHEM, V291, P27313, DOI 10.1074/jbc.M116.763912; Herzog C, 2014, J BIOL CHEM, V289, P13308, DOI 10.1074/jbc.M114.559088; Ishmael SS, 2006, J BIOL CHEM, V281, P37404, DOI 10.1074/jbc.M602769200; Jackle F, 2015, BIOCHEM J, V470, P91, DOI 10.1042/BJ20141417; Jefferson T, 2011, J BIOL CHEM, V286, P27741, DOI 10.1074/jbc.M111.252718; JOHNSON GD, 1994, J BIOL CHEM, V269, P7682; Johnson GD, 1997, J BIOL CHEM, V272, P28126, DOI 10.1074/jbc.272.44.28126; JOHNSON GD, 1992, J BIOL CHEM, V267, P13505; Laskowski RA, 2018, PROTEIN SCI, V27, P129, DOI 10.1002/pro.3289; Lottaz D, 1999, EUR J BIOCHEM, V259, P496, DOI 10.1046/j.1432-1327.1999.00071.x; Lottaz D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026450; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; MARCHAND P, 1995, J BIOL CHEM, V270, P5449, DOI 10.1074/jbc.270.10.5449; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Norman LP, 2003, MOL CELL BIOL, V23, P1221, DOI 10.1128/MCB.23.4.1221-1230.2003; Ohler A, 2010, BIOL CHEM, V391, P455, DOI 10.1515/BC.2010.023; Schonherr C, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0084-5; Schutte A, 2014, P NATL ACAD SCI USA, V111, P12396, DOI 10.1073/pnas.1407597111; STERCHI EE, 1982, CLIN SCI, V62, P557, DOI 10.1042/cs0620557; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; TRACHTMAN H, 1995, BIOCHEM BIOPH RES CO, V208, P498, DOI 10.1006/bbrc.1995.1366; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Wichert R, 2017, CELL REP, V21, P2090, DOI 10.1016/j.celrep.2017.10.087	42	12	12	1	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					7490	7504		10.1096/fj.201802391R	http://dx.doi.org/10.1096/fj.201802391R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30916990	Bronze, Green Published			2022-12-26	WOS:000476114200066
J	Tapia, VS; Daniels, MJD; Palazon-Riquelme, P; Dewhurst, M; Luheshi, NM; Rivers-Auty, J; Green, J; Redondo-Castro, E; Kaldis, P; Lopez-Castejon, G; Brough, D				Tapia, Victor S.; Daniels, Michael J. D.; Palazon-Riquelme, Pablo; Dewhurst, Matthew; Luheshi, Nadia M.; Rivers-Auty, Jack; Green, Jack; Redondo-Castro, Elena; Kaldis, Philipp; Lopez-Castejon, Gloria; Brough, David			The three cytokines IL-1, IL-18, and IL-1 share related but distinct secretory routes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						inflammasome; inflammation; interleukin 1 (IL-1); NLRP3; caspase 1 (CASP1); calpain; cytokine; immunology; immune cell; neutrophil	NLRP3 INFLAMMASOME; GASDERMIN-D; IL-1-BETA SECRETION; RELEASE; INTERLEUKIN-1-ALPHA; SENESCENCE; MECHANISM; MEMBRANE; ACTIVATION; EFFECTORS	Interleukin (IL)-1 family cytokines potently regulate inflammation, with the majority of the IL-1 family proteins being secreted from immune cells via unconventional pathways. In many cases, secretion of IL-1 cytokines appears to be closely coupled to cell death, yet the secretory mechanisms involved remain poorly understood. Here, we studied the secretion of the three best-characterized members of the IL-1 superfamily, IL-1, IL-1, and IL-18, in a range of conditions and cell types, including murine bone marrow-derived and peritoneal macrophages, human monocyte-derived macrophages, HeLa cells, and mouse embryonic fibroblasts. We discovered that IL-1 and IL-18 share a common secretory pathway that depends upon membrane permeability and can operate in the absence of complete cell lysis and cell death. We also found that the pathway regulating the trafficking of IL-1 is distinct from the pathway regulating IL-1 and IL-18. Although the release of IL-1 could also be dissociated from cell death, it was independent of the effects of the membrane-stabilizing agent punicalagin, which inhibited both IL-1 and IL-18 release. These results reveal that in addition to their role as danger signals released from dead cells, IL-1 family cytokines can be secreted in the absence of cell death. We propose that models used in the study of IL-1 release should be considered context-dependently.	[Tapia, Victor S.; Rivers-Auty, Jack; Green, Jack; Lopez-Castejon, Gloria; Brough, David] Univ Manchester, Lydia Becker Inst Immunol & Inflammat, Manchester M13 9PT, Lancs, England; [Tapia, Victor S.; Daniels, Michael J. D.; Dewhurst, Matthew; Luheshi, Nadia M.; Rivers-Auty, Jack; Green, Jack; Redondo-Castro, Elena; Brough, David] Univ Manchester, Manchester Acad Hlth Sci Ctr, Div Neurosci & Expt Psychol, Sch Biol Sci,Fac Biol Med & Hlth, AV Hill Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England; [Daniels, Michael J. D.] Univ Edinburgh, UK Dementia Res Inst, Coll Med & Vet Med, 49 Little France Crescent, Edinburgh EH16 4SB, Midlothian, Scotland; [Palazon-Riquelme, Pablo; Lopez-Castejon, Gloria] Univ Manchester, Manchester Acad Hlth Sci Ctr, Core Technol Facil,Div Infect Immun & Resp Med, Sch Biol Sci,Fac Biol Med & Hlth,Manchester Colla, Manchester M13 9PT, Lancs, England; [Palazon-Riquelme, Pablo] Claude Bernard Lyon 1 Univ, Ecole Normale Super Lyon, CNRS, UMR5308,INSERM,U1111,Int Ctr Infectiol Res, F-69100 Lyon, France; [Luheshi, Nadia M.] MedImmune Ltd, Aaron Klug Bldg,Granta Pk, Cambridge CB21 6GH, England; [Dewhurst, Matthew; Kaldis, Philipp] NUS, A STAR, IMCB, Dept Biochem, Singapore 119007, Singapore	University of Manchester; University of Manchester; University of Edinburgh; University of Manchester; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; AstraZeneca; Medimmune; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore	Lopez-Castejon, G; Brough, D (corresponding author), Univ Manchester, Lydia Becker Inst Immunol & Inflammat, Manchester M13 9PT, Lancs, England.; Brough, D (corresponding author), Univ Manchester, Manchester Acad Hlth Sci Ctr, Div Neurosci & Expt Psychol, Sch Biol Sci,Fac Biol Med & Hlth, AV Hill Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	Gloria.lopez-castejon@manchester.ac.uk; david.brough@manchester.ac.uk	Green, Jack/AAV-7447-2021; Lopez-Castejon, Gloria/F-6985-2015; Kaldis, Philipp/G-2714-2010; Palazon-Riquelme, Pablo/G-5449-2019	Lopez-Castejon, Gloria/0000-0002-8585-3381; Kaldis, Philipp/0000-0002-7247-7591; Dewhurst, Matthew/0000-0003-4667-4070; Tapia, Victor/0000-0001-5009-4779; Green, Jack/0000-0003-1108-3422; Palazon-Riquelme, Pablo/0000-0001-6799-2698; Daniels, Michael/0000-0001-7489-5626; Rivers-Auty, Jack/0000-0001-5321-2347; Brough, David/0000-0002-2250-2381	Medical Research Council [MR/N029992/1]; Wellcome Trust [104192/Z/14/Z]; Royal Society [104192/Z/14/Z]; CONICYT (Becas Chile) [721704488]; MRC DTP Studentship [MR/K501311/1]; Manchester Collaborative Centre for Inflammation Research, an initiative of the University of Manchester; Manchester Collaborative Centre for Inflammation Research, an initiative of AstraZeneca; Manchester Collaborative Centre for Inflammation Research, an initiative of GlaxoSmithKline; BBSRC [BB/P01061X/1]; MRC [MR/N029992/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London); CONICYT (Becas Chile)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); MRC DTP Studentship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Manchester Collaborative Centre for Inflammation Research, an initiative of the University of Manchester; Manchester Collaborative Centre for Inflammation Research, an initiative of AstraZeneca; Manchester Collaborative Centre for Inflammation Research, an initiative of GlaxoSmithKline; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Medical Research Council Grant MR/N029992/1 (to D. B.) and a Sir Henry Dale Fellowship jointly funded by the Wellcome Trust and the Royal Society (Grant 104192/Z/14/Z (to G. L.-C)).; Supported by CONICYT (Becas Chile 721704488).; Supported by MRC DTP Studentship MR/K501311/1.; Supported by the Manchester Collaborative Centre for Inflammation Research, as a joint initiative of the University of Manchester, AstraZeneca, and GlaxoSmithKline.; Supported by BBSRC Grant BB/P01061X/1.	Acosta JC, 2013, NAT CELL BIOL, V15, P978, DOI 10.1038/ncb2784; Afonina IS, 2011, MOL CELL, V44, P265, DOI 10.1016/j.molcel.2011.07.037; Baldwin AG, 2017, CELL CHEM BIOL, V24, P1321, DOI 10.1016/j.chembiol.2017.08.011; Baroja-Mazo A, 2014, NAT IMMUNOL, V15, P738, DOI 10.1038/ni.2919; Brough D, 2007, J CELL SCI, V120, P772, DOI 10.1242/jcs.03377; Brough D, 2017, J CELL SCI, V130, P3197, DOI 10.1242/jcs.204206; Chen KWW, 2014, CELL REP, V8, P569, DOI 10.1016/j.celrep.2014.06.028; Childs BG, 2014, EMBO REP, V15, P1139, DOI 10.15252/embr.201439245; Clancy DM, 2018, CELL REP, V22, P2937, DOI 10.1016/j.celrep.2018.02.062; Coll RC, 2015, NAT MED, V21, P248, DOI 10.1038/nm.3806; Cullen SP, 2015, CELL REP, V11, P1535, DOI 10.1016/j.celrep.2015.05.003; Daniels MJD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12504; Dinarello CA, 2012, NAT REV DRUG DISCOV, V11, P633, DOI 10.1038/nrd3800; Diril MK, 2012, P NATL ACAD SCI USA, V109, P3826, DOI 10.1073/pnas.1115201109; England H, 2014, J BIOL CHEM, V289, P15942, DOI 10.1074/jbc.M114.557561; Evavold CL, 2018, IMMUNITY, V48, P35, DOI 10.1016/j.immuni.2017.11.013; Franklin BS, 2014, NAT IMMUNOL, V15, P727, DOI 10.1038/ni.2913; Gaidt MM, 2016, IMMUNITY, V44, P833, DOI 10.1016/j.immuni.2016.01.012; Gardner SE, 2015, ARTERIOSCL THROM VAS, V35, P1963, DOI 10.1161/ATVBAHA.115.305896; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Green JP, 2018, P NATL ACAD SCI USA, V115, pE9371, DOI 10.1073/pnas.1812744115; Gross Olaf, 2012, Immunity, V36, P388, DOI 10.1016/j.immuni.2012.01.018; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Kovacs SB, 2017, TRENDS CELL BIOL, V27, P673, DOI 10.1016/j.tcb.2017.05.005; Laberge RM, 2015, NAT CELL BIOL, V17, P1049, DOI 10.1038/ncb3195; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Lopez-Castejon G, 2011, CYTOKINE GROWTH F R, V22, P189, DOI 10.1016/j.cytogfr.2011.10.001; Martin SJ, 2016, FEBS J, V283, P2599, DOI 10.1111/febs.13775; Martin-Sanchez F, 2016, CELL DEATH DIFFER, V23, P1219, DOI 10.1038/cdd.2015.176; Monteleone M, 2018, CELL REP, V24, P1425, DOI 10.1016/j.celrep.2018.07.027; Pelegrin P, 2008, J IMMUNOL, V180, P7147, DOI 10.4049/jimmunol.180.11.7147; Perregaux DG, 1998, J IMMUNOL, V160, P2469; Redondo-Castro E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24029-3; Rivers-Auty J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03362-1; RUBARTELLI A, 1990, EMBO J, V9, P1503, DOI 10.1002/j.1460-2075.1990.tb08268.x; Semino C, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1121-9; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Shirasaki Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep04736; Stoffels M, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00054; Swanton T, 2018, SLAS DISCOV, V23, P991, DOI 10.1177/2472555218786210; Venegas C, 2017, NATURE, V552, P355, DOI 10.1038/nature25158; Verhoef PA, 2005, J IMMUNOL, V175, P7623, DOI 10.4049/jimmunol.175.11.7623; Xu X, 2015, MEDIAT INFLAMM, V2015, DOI [10.1155/2015/810798, 10.1155/2015/380218]; Zheng Y, 2013, IMMUNITY, V38, P285, DOI 10.1016/j.immuni.2013.01.008	44	34	35	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2019	294	21					8325	8335		10.1074/jbc.RA119.008009	http://dx.doi.org/10.1074/jbc.RA119.008009			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC6UQ	30940725	Green Published, hybrid			2022-12-26	WOS:000471108200001
J	Kochert, BA; Fleischhacker, AS; Wales, TE; Becker, DF; Engen, JR; Ragsdale, SW				Kochert, Brent A.; Fleischhacker, Angela S.; Wales, Thomas E.; Becker, Donald F.; Engen, John R.; Ragsdale, Stephen W.			Dynamic and structural differences between heme oxygenase-1 and-2 are due to differences in their C-terminal regions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						heme oxygenase; enzyme catalysis; enzyme mechanism; protein dynamics; membrane protein; hydrogen exchange mass spectrometry; enzyme kinetics; conformational change; heme homeostasis; membrane anchor	THIOL/DISULFIDE REDOX SWITCH; SIGNAL PEPTIDE PEPTIDASE; BOUND CRYSTAL-STRUCTURES; REV-ERB-BETA; REGULATORY MOTIFS; BINDING; PROTEIN; DEGRADATION; AFFINITY; COMPLEX	Heme oxygenase (HO) catalyzes heme degradation, a process crucial for regulating cellular levels of this vital, but cytotoxic, cofactor. Two HO isoforms, HO1 and HO2, exhibit similar catalytic mechanisms and efficiencies. They also share catalytic core structures, including the heme-binding site. Outside their catalytic cores are two regions unique to HO2: a 20-amino acid-long N-terminal extension and a C-terminal domain containing two heme regulatory motifs (HRMs) that bind heme independently of the core. Both HO isoforms contain a C-terminal hydrophobic membrane anchor; however, their sequences diverge. Here, using hydrogen-deuterium exchange MS, size-exclusion chromatography, and sedimentation velocity, we investigated how these divergent regions impact the dynamics and structure of the apo and heme-bound forms of HO1 and HO2. Our results reveal that heme binding to the catalytic cores of HO1 and HO2 causes similar dynamic and structural changes in regions (proximal, distal, and A6 helices) within and linked to the heme pocket. We observed that full-length HO2 is more dynamic than truncated forms lacking the membrane-anchoring region, despite sharing the same steady-state activity and heme-binding properties. In contrast, the membrane anchor of HO1 did not influence its dynamics. Furthermore, although residues within the HRM domain facilitated HO2 dimerization, neither the HRM region nor the N-terminal extension appeared to affect HO2 dynamics. In summary, our results highlight significant dynamic and structural differences between HO2 and HO1 and indicate that their dissimilar C-terminal regions play a major role in controlling the structural dynamics of these two proteins.	[Kochert, Brent A.; Wales, Thomas E.; Engen, John R.] Northeastern Univ, Dept Chem & Chem Biol, Boston, MA 02115 USA; [Fleischhacker, Angela S.; Ragsdale, Stephen W.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Becker, Donald F.] Univ Nebraska, Dept Biochem, Redox Biol Ctr, Lincoln, NE 68588 USA; [Kochert, Brent A.] Merck & Co Inc, Prot Mass Spectrometry, Analyt R&D, Proc R&D, 2000 Galloping Hill Rd, Kenilworth, NJ 07033 USA	Northeastern University; University of Michigan System; University of Michigan; University of Nebraska System; University of Nebraska Lincoln; Merck & Company	Ragsdale, SW (corresponding author), Univ Michigan, Dept Biol Chem, Sch Med, 1150 W Med Ctr Dr,5301 MSRB 3, Ann Arbor, MI 48109 USA.	sragsdal@umich.edu	Fleischhacker, Angela/AAN-3275-2021	Engen, John R./0000-0002-6918-9476; Wales, Thomas E./0000-0001-6133-5689	National Institutes of Health [R01-GM123513, P30GM103335, GM061068]; Waters Corp.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103335, R01GM123513] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Waters Corp.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01-GM123513 (to S. W. R.) and P30GM103335 and GM061068 (to D. F. B.) and a research collaboration with Waters Corp. (to J. R. E.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; Bagai I, 2015, BIOCHEMISTRY-US, V54, P2693, DOI 10.1021/bi501489r; Bianchetti CM, 2007, J BIOL CHEM, V282, P37624, DOI 10.1074/jbc.M707396200; Boname JM, 2014, J CELL BIOL, V205, P847, DOI 10.1083/jcb.201312009; Carter EL, 2017, J BIOL CHEM, V292, P11280, DOI 10.1074/jbc.M117.783118; Carter EL, 2016, J BIOL CHEM, V291, P2196, DOI 10.1074/jbc.M115.670281; Dam J, 2005, BIOPHYS J, V89, P619, DOI 10.1529/biophysj.105.059568; Dawson R.M., 1969, DATA BIOCH RES, P316; DWYER BE, 1992, GLIA, V5, P300, DOI 10.1002/glia.440050407; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Eschenfeldt William H., 2009, V498, P105, DOI 10.1007/978-1-59745-196-3_7; Fleischhacker AS, 2018, ANTIOXID REDOX SIGN, V29, P1841, DOI 10.1089/ars.2017.7368; Fleischhacker AS, 2015, BIOCHEMISTRY-US, V54, P2709, DOI 10.1021/acs.biochem.5b00266; HARGROVE MS, 1994, J BIOL CHEM, V269, P4207; Hargrove MS, 1996, BIOCHEMISTRY-US, V35, P11293, DOI 10.1021/bi960371l; Houde D, 2011, J PHARM SCI-US, V100, P2071, DOI 10.1002/jps.22432; Hsu FF, 2015, ONCOGENE, V34, P2360, DOI 10.1038/onc.2014.166; Huber WJ, 2007, BIOCHEMISTRY-US, V46, P12212, DOI 10.1021/bi701496z; Huber WJ, 2009, BIOCHEMISTRY-US, V48, P190, DOI 10.1021/bi801912z; Hwang HW, 2009, J BIOL CHEM, V284, P22672, DOI 10.1074/jbc.M109.028001; Lad L, 2003, J BIOL CHEM, V278, P7834, DOI 10.1074/jbc.M211450200; Linnenbaum M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035483; Lou XW, 2004, J CHROMATOGR A, V1029, P67, DOI 10.1016/j.chroma.2003.12.023; MAINES MD, 1986, J BIOL CHEM, V261, P411; Owens CP, 2012, BIOCHEMISTRY-US, V51, P1518, DOI 10.1021/bi2018305; Reddi AR, 2016, ACCOUNTS CHEM RES, V49, P1104, DOI 10.1021/acs.accounts.5b00553; Schaefer B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188344; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schuller DJ, 1999, NAT STRUCT BIOL, V6, P860; Spencer ALM, 2014, J BIOL CHEM, V289, P29836, DOI 10.1074/jbc.M114.582783; Wales TE, 2006, MASS SPECTROM REV, V25, P158, DOI 10.1002/mas.20064; Wales TE, 2008, ANAL CHEM, V80, P6815, DOI 10.1021/ac8008862; Yi L, 2007, J BIOL CHEM, V282, P21056, DOI 10.1074/jbc.M700664200; Yi L, 2009, J BIOL CHEM, V284, P20556, DOI 10.1074/jbc.M109.015651; Yu CM, 2006, J CHROMATOGR A, V1132, P99, DOI 10.1016/j.chroma.2006.07.017	35	12	12	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2019	294	20					8259	8272		10.1074/jbc.RA119.008592	http://dx.doi.org/10.1074/jbc.RA119.008592			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC0NH	30944174	hybrid, Green Published			2022-12-26	WOS:000470656500022
J	Zhang, ZM; Huang, Q; Tao, X; Song, GB; Zheng, P; Li, HY; Sun, HZ; Xia, W				Zhang, Zhemin; Huang, Qi; Tao, Xuan; Song, Guobing; Zheng, Peng; Li, Hongyan; Sun, Hongzhe; Xia, Wei			The unique trimeric assembly of the virulence factor HtrA from Helicobacter pylori occurs via N-terminal domain swapping	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Helicobacter pylori; secretion; serine protease; virulence factor; protein structure; PDZ domain; high-temperature requirement A (HtrA)	PROTEIN-QUALITY-CONTROL; ESCHERICHIA-COLI; IV SECRETION; SERINE-PROTEASE; E-CADHERIN; CRYSTAL-STRUCTURE; STRESS SENSOR; CHAPERONE; FAMILY; DEGS	Knowledge of the molecular mechanisms of specific bacterial virulence factors can significantly contribute to antibacterial drug discovery. Helicobacter pylori is a Gram-negative microaerophilic bacterium that infects almost half of the world's population, leading to gastric disorders and even gastric cancer. H. pylori expresses a series of virulence factors in the host, among which high-temperature requirement A (HpHtrA) is a newly identified serine protease secreted by H. pylori. HpHtrA cleaves the extracellular domain of the epithelial cell surface adhesion protein E-cadherin and disrupts gastric epithelial cell junctions, allowing H. pylori to access the intercellular space. Here we report the first crystal structure of HpHtrA at 3.0 resolution. The structure revealed a new type of HtrA protease trimer stabilized by unique N-terminal domain swapping distinct from other known HtrA homologs. We further observed that truncation of the N terminus completely abrogates HpHtrA trimer formation as well as protease activity. In the presence of unfolded substrate, HpHtrA assembled into cage-like 12-mers or 24-mers. Combining crystallographic, biochemical, and mutagenic data, we propose a mechanistic model of how HpHtrA recognizes and cleaves the well-folded E-cadherin substrate. Our study provides a fundamental basis for the development of anti-H. pylori agents by using a previously uncharacterized HtrA protease as a target.	[Zhang, Zhemin; Huang, Qi; Tao, Xuan; Xia, Wei] Sun Yat Sen Univ, MOE Key Lab Bioinorgan & Synthet Chem, Sch Chem, Guangzhou 510275, Guangdong, Peoples R China; [Song, Guobing; Zheng, Peng] Univ Hong Kong, Dept Chem, Pokfulam Rd, Hong Kong, Peoples R China; [Li, Hongyan; Sun, Hongzhe] Nanjing Univ, Sch Chem & Chem Engn, State Key Lab Coordinat Chem, Nanjing 210023, Jiangsu, Peoples R China	Sun Yat Sen University; University of Hong Kong; Nanjing University	Xia, W (corresponding author), Sun Yat Sen Univ, MOE Key Lab Bioinorgan & Synthet Chem, Sch Chem, Guangzhou 510275, Guangdong, Peoples R China.	xiawei5@mail.sysu.edu.cn	xia, wei/C-2628-2015; /D-3123-2009	xia, wei/0000-0001-6480-3265; /0000-0001-6697-6899	National Natural Science Foundation of China [21671203, 21771103, 21877131]; Science and Technology Program of Guangzhou, China [201707010038]; RGC of Hong Kong [17305415, 17333616, 17307017]; Ministry of Education of China [IRT-17R111]; Fundamental Research Funds for the Central Universities; Natural Science Foundation of Jiangsu Province [BK20160639]; Shuangchuang Program of Jiangsu Province; Sun Yat-sen University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Program of Guangzhou, China; RGC of Hong Kong(Hong Kong Research Grants Council); Ministry of Education of China(Ministry of Education, China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Shuangchuang Program of Jiangsu Province; Sun Yat-sen University	This work was supported by grants from the National Natural Science Foundation of China (21671203, 21771103, and 21877131); the Science and Technology Program of Guangzhou, China (201707010038); RGC of Hong Kong (17305415, 17333616, and 17307017); the Ministry of Education of China (IRT-17R111); Fundamental Research Funds for the Central Universities, Natural Science Foundation of Jiangsu Province (BK20160639); the Shuangchuang Program of Jiangsu Province; and startup funding from Sun Yat-sen University. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alba BM, 2001, MOL MICROBIOL, V40, P1323, DOI 10.1046/j.1365-2958.2001.02475.x; Albrecht N, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00642; Ausiello G, 1997, PROTEINS, V28, P556, DOI 10.1002/(SICI)1097-0134(199708)28:4<556::AID-PROT9>3.3.CO;2-C; Backert S, 2008, CELL MICROBIOL, V10, P1573, DOI 10.1111/j.1462-5822.2008.01156.x; Bai XC, 2011, STRUCTURE, V19, P1328, DOI 10.1016/j.str.2011.06.013; Boehm M, 2012, GUT PATHOG, V4, DOI 10.1186/1757-4749-4-3; Bonsor DA, 2015, J BIOL CHEM, V290, P12929, DOI 10.1074/jbc.M115.641829; Clausen T, 2002, MOL CELL, V10, P443, DOI 10.1016/S1097-2765(02)00658-5; Clausen T, 2011, NAT REV MOL CELL BIO, V12, P152, DOI 10.1038/nrm3065; Dickey SW, 2017, NAT REV DRUG DISCOV, V16, P457, DOI 10.1038/nrd.2017.23; DOIG P, 1994, INFECT IMMUN, V62, P4526, DOI 10.1128/IAI.62.10.4526-4533.1994; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Foegeding NJ, 2016, TOXINS, V8, DOI 10.3390/toxins8060173; Frees Dorte, 2013, Subcell Biochem, V66, P161, DOI 10.1007/978-94-007-5940-4_7; Gloeckl S, 2013, MOL MICROBIOL, V89, P676, DOI 10.1111/mmi.12306; Gottesman S, 1997, GENE DEV, V11, P815, DOI 10.1101/gad.11.7.815; Grohmann E, 2018, MOL MICROBIOL, V107, P455, DOI 10.1111/mmi.13896; Hatakeyama M, 2004, NAT REV CANCER, V4, P688, DOI 10.1038/nrc1433; Hoy B, 2013, J BASIC MICROB, V53, P402, DOI 10.1002/jobm.201200074; Hoy B, 2012, J BIOL CHEM, V287, P10115, DOI 10.1074/jbc.C111.333419; Hoy B, 2010, EMBO REP, V11, P798, DOI 10.1038/embor.2010.114; Ingmer H, 2009, RES MICROBIOL, V160, P704, DOI 10.1016/j.resmic.2009.08.017; Iwanczyk J, 2007, J BACTERIOL, V189, P3176, DOI 10.1128/JB.01788-06; Iwig JS, 2008, J AM CHEM SOC, V130, P7592, DOI 10.1021/ja710067d; Jiang JS, 2008, P NATL ACAD SCI USA, V105, P11939, DOI 10.1073/pnas.0805464105; Jomaa A, 2007, J BACTERIOL, V189, P706, DOI 10.1128/JB.01334-06; Kaplan-Turkoz B, 2012, P NATL ACAD SCI USA, V109, P14640, DOI 10.1073/pnas.1206098109; KENNEDY MB, 1995, TRENDS BIOCHEM SCI, V20, P350, DOI 10.1016/S0968-0004(00)89074-X; Kim DY, 2005, J BIOCHEM MOL BIOL, V38, P266; Kim S, 2012, P NATL ACAD SCI USA, V109, P7263, DOI 10.1073/pnas.1204791109; Kim S, 2011, CELL, V145, P67, DOI 10.1016/j.cell.2011.02.024; Krojer T, 2002, NATURE, V416, P455, DOI 10.1038/416455a; Krojer T, 2008, NATURE, V453, P885, DOI 10.1038/nature07004; Krojer T, 2010, NAT STRUCT MOL BIOL, V17, P844, DOI 10.1038/nsmb.1840; Kwok T, 2007, NATURE, V449, P862, DOI 10.1038/nature06187; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Lower M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003510; Maurizi MR, 2002, NAT STRUCT BIOL, V9, P410, DOI 10.1038/nsb0602-410; MEGRAUD F, 1992, INFECT IMMUN, V60, P1858; Niessen CM, 2007, J INVEST DERMATOL, V127, P2525, DOI 10.1038/sj.jid.5700865; Niessen CM, 2011, PHYSIOL REV, V91, P691, DOI 10.1152/physrev.00004.2010; Olofsson A, 2010, MOL MICROBIOL, V77, P1539, DOI 10.1111/j.1365-2958.2010.07307.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perna AM, 2015, ANGEW CHEM INT EDIT, V54, P10244, DOI 10.1002/anie.201504035; Perna AM, 2014, CHEM SCI, V5, P3583, DOI 10.1039/c4sc01443j; Polk DB, 2010, NAT REV CANCER, V10, P403, DOI 10.1038/nrc2857; Raju RM, 2012, NAT REV DRUG DISCOV, V11, P777, DOI 10.1038/nrd3846; Rasko DA, 2010, NAT REV DRUG DISCOV, V9, P117, DOI 10.1038/nrd3013; Rieder G, 2005, CURR OPIN MICROBIOL, V8, P67, DOI 10.1016/j.mib.2004.12.004; Salama NR, 2004, J BACTERIOL, V186, P7926, DOI 10.1128/JB.186.23.7926-7935.2004; Sawa J, 2011, J BIOL CHEM, V286, P30680, DOI 10.1074/jbc.M111.243832; Schmidt TP, 2016, GUT PATHOG, V8, DOI 10.1186/s13099-016-0112-6; Schmidt TP, 2016, SCI REP-UK, V6, DOI 10.1038/srep23264; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shen QT, 2009, P NATL ACAD SCI USA, V106, P4858, DOI 10.1073/pnas.0811780106; Skorko-Glonek J, 2003, BBA-PROTEINS PROTEOM, V1649, P171, DOI 10.1016/S1570-9639(03)00170-5; Skorko-Glonek J, 2013, CURR PHARM DESIGN, V19, P977, DOI 10.2174/1381612811319060003; Sohn J, 2007, CELL, V131, P572, DOI 10.1016/j.cell.2007.08.044; STRAUCH KL, 1988, P NATL ACAD SCI USA, V85, P1576, DOI 10.1073/pnas.85.5.1576; Suzuki Y, 2001, MOL CELL, V8, P613, DOI 10.1016/S1097-2765(01)00341-0; SWAISGOOD HE, 1993, J DAIRY SCI, V76, P3054, DOI 10.3168/jds.S0022-0302(93)77645-6; Tarsia C, 2018, BBA-GEN SUBJECTS, V1862, P2245, DOI 10.1016/j.bbagen.2018.07.020; Tegtmeyer N, 2017, CELL HOST MICROBE, V22, P552, DOI 10.1016/j.chom.2017.09.005; Tegtmeyer N, 2016, MOL MICROBIOL, V99, P925, DOI 10.1111/mmi.13276; Walsh NP, 2003, CELL, V113, P61, DOI 10.1016/S0092-8674(03)00203-4; Wilken C, 2004, CELL, V117, P483, DOI 10.1016/S0092-8674(04)00454-4; Yang XM, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2003887; Zhang L, 2017, CELL RES, V27, P582, DOI 10.1038/cr.2017.5	69	9	9	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2019	294	20					7990	8000		10.1074/jbc.RA119.007387	http://dx.doi.org/10.1074/jbc.RA119.007387			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC0NH	30936204	Green Published, hybrid			2022-12-26	WOS:000470656500003
J	Kuckelkorn, U; Stubler, S; Textoris-Taube, K; Kilian, C; Niewienda, A; Henklein, P; Janek, K; Stumpf, MPH; Mishto, M; Liepe, J				Kuckelkorn, Ulrike; Stuebler, Sabine; Textoris-Taube, Kathrin; Kilian, Christiane; Niewienda, Agathe; Henklein, Petra; Janek, Katharina; Stumpf, Michael P. H.; Mishto, Michele; Liepe, Juliane			Proteolytic dynamics of human 20S thymoproteasome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						proteasome; protein degradation; antigen processing; computational biology; bioinformatics; thymoproteasome; thymus; proteolysis	MYELIN BASIC-PROTEIN; T-CELL RESPONSES; APPROXIMATE BAYESIAN COMPUTATION; MODEL SELECTION; PARAMETER-ESTIMATION; EXPRESSION; PROTEASOMES; CLEAVAGE; SYSTEMS; SUBUNIT	An efficient immunosurveillance of CD8(+) T cells in the periphery depends on positive/negative selection of thymocytes and thus on the dynamics of antigen degradation and epitope production by thymoproteasome and immunoproteasome in the thymus. Although studies in mouse systems have shown how thymoproteasome activity differs from that of immunoproteasome and strongly impacts the T cell repertoire, the proteolytic dynamics and the regulation of human thymoproteasome are unknown. By combining biochemical and computational modeling approaches, we show here that human 20S thymoproteasome and immunoproteasome differ not only in the proteolytic activity of the catalytic sites but also in the peptide transport. These differences impinge upon the quantity of peptide products rather than where the substrates are cleaved. The comparison of the two human 20S proteasome isoforms depicts different processing of antigens that are associated to tumors and autoimmune diseases.	[Kuckelkorn, Ulrike; Textoris-Taube, Kathrin; Kilian, Christiane; Niewienda, Agathe; Henklein, Petra; Janek, Katharina; Mishto, Michele] Charite Univ Med Berlin, D-10117 Berlin, Germany; [Kuckelkorn, Ulrike; Textoris-Taube, Kathrin; Kilian, Christiane; Niewienda, Agathe; Henklein, Petra; Janek, Katharina; Mishto, Michele] Free Univ Berlin, D-10117 Berlin, Germany; [Kuckelkorn, Ulrike; Kilian, Christiane; Henklein, Petra] Humboldt Univ, Inst Biochem, D-10117 Berlin, Germany; [Stuebler, Sabine; Stumpf, Michael P. H.; Liepe, Juliane] Imperial Coll London, Dept Life Sci, Ctr Integrat Syst Biol & Bioinformat, London SW7 2AZ, England; [Stuebler, Sabine] Univ Potsdam, Inst Math, Math Modelling & Syst Biol, D-14469 Potsdam, Germany; [Textoris-Taube, Kathrin; Niewienda, Agathe; Janek, Katharina; Mishto, Michele] Humboldt Univ, D-10117 Berlin, Germany; [Textoris-Taube, Kathrin; Niewienda, Agathe; Janek, Katharina; Mishto, Michele] Berlin Inst Hlth, Inst Biochem, D-10117 Berlin, Germany; [Textoris-Taube, Kathrin; Niewienda, Agathe; Janek, Katharina] Berlin Inst Hlth, Shared Facil Mass Spectrometry, D-10117 Berlin, Germany; [Mishto, Michele] Kings Coll London, Sch Immunol & Microbial Sci, CIBCI, London SE1 1UL, England; [Mishto, Michele] Kings Coll London, Sch Immunol & Microbial Sci, Peter Gorer Dept Immunobiol, London SE1 1UL, England; [Liepe, Juliane] Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany; [Stumpf, Michael P. H.] Univ Melbourne, Sch BioSci, Melbourne Integrat Genom, Parkville, Vic 3010, Australia; [Stumpf, Michael P. H.] Univ Melbourne, Sch BioSci, Sch Math & Stat, Parkville, Vic 3010, Australia	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Imperial College London; University of Potsdam; Humboldt University of Berlin; Berlin Institute of Health; Berlin Institute of Health; University of London; King's College London; University of London; King's College London; Max Planck Society; University of Melbourne; University of Melbourne	Mishto, M (corresponding author), Charite Univ Med Berlin, D-10117 Berlin, Germany.; Mishto, M (corresponding author), Free Univ Berlin, D-10117 Berlin, Germany.; Liepe, J (corresponding author), Imperial Coll London, Dept Life Sci, Ctr Integrat Syst Biol & Bioinformat, London SW7 2AZ, England.; Mishto, M (corresponding author), Humboldt Univ, D-10117 Berlin, Germany.; Mishto, M (corresponding author), Berlin Inst Hlth, Inst Biochem, D-10117 Berlin, Germany.; Mishto, M (corresponding author), Kings Coll London, Sch Immunol & Microbial Sci, CIBCI, London SE1 1UL, England.; Mishto, M (corresponding author), Kings Coll London, Sch Immunol & Microbial Sci, Peter Gorer Dept Immunobiol, London SE1 1UL, England.; Liepe, J (corresponding author), Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany.	michele.mishto@kcl.ac.uk; juliane.liepe@mpibpc.mpg.de	mishto, michele/A-5592-2010	mishto, michele/0000-0003-3042-2792; Kuckelkorn, Ulrike/0000-0002-3085-9161; Liepe, Juliane/0000-0003-2515-9707; Henklein, Petra/0000-0001-7468-8926	Cancer Research UK King's Health Partners Centre at King's College London; Berlin Institute of Health [CRG1-TP1]	Cancer Research UK King's Health Partners Centre at King's College London; Berlin Institute of Health	This work was supported in part by Cancer Research UK King's Health Partners Centre at King's College London (Development Fund 2018) (to M. M.), Berlin Institute of Health Grant CRG1-TP1 (to P. M. Kloetzel). The authors declare that they have no conflicts of interest with the contents of this article.	Adamopoulou E, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3039; [Anonymous], 2014, R LANG ENV STAT COMP; Berthelot L, 2008, EUR J IMMUNOL, V38, P1889, DOI 10.1002/eji.200838023; Deol P, 2007, J IMMUNOL, V178, P7557, DOI 10.4049/jimmunol.178.12.7557; Ebner F, 2014, ALLERGY, V69, P1489, DOI 10.1111/all.12496; Ebstein F, 2016, SCI REP-UK, V6, DOI 10.1038/srep24032; Erguler K, 2011, MOL BIOSYST, V7, P1593, DOI 10.1039/c0mb00107d; Faridi P, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aar3947; Friese MA, 2008, NAT MED, V14, P1227, DOI 10.1038/nm.1881; GACZYNSKA M, 1994, P NATL ACAD SCI USA, V91, P9213, DOI 10.1073/pnas.91.20.9213; GACZYNSKA M, 1993, NATURE, V365, P264, DOI 10.1038/365264a0; Gubin MM, 2014, NATURE, V515, P577, DOI 10.1038/nature13988; Gutenkunst RN, 2007, PLOS COMPUT BIOL, V3, P1871, DOI 10.1371/journal.pcbi.0030189; Jaravine V, 2017, BIOINFORMATICS, V33, P104, DOI 10.1093/bioinformatics/btw567; Jurewicz A, 1998, J IMMUNOL, V160, P3056; Keller M, 2015, EUR J IMMUNOL, V45, P3257, DOI 10.1002/eji.201445243; Kincaid EZ, 2016, NAT IMMUNOL, V17, P938, DOI 10.1038/ni.3480; Kincaid EZ, 2012, NAT IMMUNOL, V13, P129, DOI 10.1038/ni.2203; Klein L, 2014, NAT REV IMMUNOL, V14, P377, DOI 10.1038/nri3667; Liepe J, 2019, CANCER IMMUNOL RES, V7, P62, DOI 10.1158/2326-6066.CIR-18-0424; Liepe J, 2018, CURR OPIN IMMUNOL, V52, P81, DOI 10.1016/j.coi.2018.04.016; Liepe J, 2016, SCIENCE, V354, P354, DOI 10.1126/science.aaf4384; Liepe J, 2015, ELIFE, V4, DOI 10.7554/eLife.07545; Liepe J, 2014, NAT PROTOC, V9, P439, DOI 10.1038/nprot.2014.025; Liepe J, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002888; Liepe J, 2010, BIOINFORMATICS, V26, P1797, DOI 10.1093/bioinformatics/btq278; Liepe J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000830; Mishto M, 2006, BIOL CHEM, V387, P417, DOI 10.1515/BC.2006.056; Mishto M, 2017, TRENDS IMMUNOL, V38, P904, DOI 10.1016/j.it.2017.07.011; Mishto M, 2015, BRAIN BEHAV IMMUN, V49, P188, DOI 10.1016/j.bbi.2015.05.007; Mishto M, 2014, EUR J IMMUNOL, V44, P3508, DOI 10.1002/eji.201444902; Mishto M, 2012, MOL CELL PROTEOMICS, V11, P1008, DOI 10.1074/mcp.M112.020164; Mishto M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009287; Murata S, 2007, SCIENCE, V316, P1349, DOI 10.1126/science.1141915; Nil A, 2004, EUR J IMMUNOL, V34, P2681, DOI 10.1002/eji.200425032; Nitta T, 2010, IMMUNITY, V32, P29, DOI 10.1016/j.immuni.2009.10.009; Nurse P, 2011, CELL, V144, P850, DOI 10.1016/j.cell.2011.02.045; Olshina MA, 2018, CELL CYCLE, V17, P393, DOI 10.1080/15384101.2017.1414682; Pearson H, 2016, J CLIN INVEST, V126, P4690, DOI 10.1172/JCI88590; Perchellet A, 2004, NAT IMMUNOL, V5, P606, DOI 10.1038/ni1073; Perchellet A, 2008, P NATL ACAD SCI USA, V105, P14040, DOI 10.1073/pnas.0804970105; Peters B, 2002, J MOL BIOL, V318, P847, DOI 10.1016/S0022-2836(02)00167-5; Princiotta MF, 2003, IMMUNITY, V18, P343, DOI 10.1016/S1074-7613(03)00051-7; Putter H, 2002, STAT MED, V21, P2199, DOI 10.1002/sim.1211; Sasaki K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8484; Schrader J, 2016, SCIENCE, V353, P594, DOI 10.1126/science.aaf8993; Solomon H, 2017, CELL DEATH DIFFER, V24, P2187, DOI 10.1038/cdd.2017.139; Takada K, 2015, NAT IMMUNOL, V16, P1069, DOI 10.1038/ni.3237; Takase H, 2005, INT IMMUNOL, V17, P1131, DOI 10.1093/intimm/dxh275; Textoris-Taube K, 2015, J BIOL CHEM, V290, P30417, DOI 10.1074/jbc.M115.695189; Toes REM, 2001, J EXP MED, V194, P1, DOI 10.1084/jem.194.1.1; Toni T, 2010, BIOINFORMATICS, V26, P104, DOI 10.1093/bioinformatics/btp619; Toni T, 2009, J R SOC INTERFACE, V6, P187, DOI 10.1098/rsif.2008.0172; TSUCHIDA T, 1994, P NATL ACAD SCI USA, V91, P10859, DOI 10.1073/pnas.91.23.10859; Vyshemirsky V, 2008, BIOINFORMATICS, V24, P833, DOI 10.1093/bioinformatics/btm607; Weissman AM, 2011, NAT REV MOL CELL BIO, V12, P605, DOI 10.1038/nrm3173; Yamada Y, 2014, J CLIN PATHOL, V67, DOI 10.1136/jclinpath-2013-201930; Yamada Y, 2011, AM J SURG PATHOL, V35, P1296, DOI 10.1097/PAS.0b013e3182237f5d; Zang YCQ, 2004, J IMMUNOL, V172, P5120, DOI 10.4049/jimmunol.172.8.5120; Zanker D, 2013, J IMMUNOL, V191, P52, DOI 10.4049/jimmunol.1300802; Zhou YX, 2011, BIOINFORMATICS, V27, P874, DOI 10.1093/bioinformatics/btr015	61	19	19	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2019	294	19					7740	7754		10.1074/jbc.RA118.007347	http://dx.doi.org/10.1074/jbc.RA118.007347			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IB3FL	30914481	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000470153300018
J	Zhang, YS; Zhou, NN; Knoll, BM; Samra, S; Ward, MR; Weintraub, S; Fawzi, AA				Zhang, Yi Stephanie; Zhou, Nina; Knoll, Brianna Marie; Samra, Sahej; Ward, Mallory R.; Weintraub, Sandra; Fawzi, Amani A.			Parafoveal vessel loss and correlation between peripapillary vessel density and cognitive performance in amnestic mild cognitive impairment and early Alzheimer's Disease on optical coherence tomography angiography	PLOS ONE			English	Article							ASSOCIATION WORKGROUPS; DIAGNOSTIC GUIDELINES; NATIONAL INSTITUTE; AXIAL LENGTH; RECOMMENDATIONS; DEMENTIA; AGE; THICKNESS; BATTERY; VERSION	Purpose Patients with Alzheimer's Disease (AD) exhibit decreased retinal blood flow and vessel density (VD). However, it is not known whether these changes are also present in individuals with early AD (eAD) or amnestic type mild cognitive impairment (aMCI), an enriched pre-AD population with a higher risk for progressing to dementia. We performed a prospective case control clinical study to investigate whether optical coherence tomography angiography (OCTA) parameters in the macula and disc are altered in those with aMCI and eAD. Methods This is a single center study of 32 participants. Individuals with aMCl/eAD (n = 16) were 1:1 matched to cognitively normal controls (n = 16). We evaluated OCTA images of the parafoveal superficial capillary plexus (SCP) and two vascular layers in the peripapillary region, the radial peripapillary capillary (RPC) and superficial vascular complex (SVC). Outcome vascular and structural parameters included VD, vessel length density (VLD), adjusted flow index (AFI) and structural retinal nerve fiber layer (RNFL) thickness. We compared these parameters between the two groups and examined the correlation between OCTA parameters and cognitive performance on the Montreal Cognitive Assessment (MoCA). Results Cognitively impaired participants demonstrated statistically significant decrease in parafoveal SCP VD and AFI as compared to controls, but no statistically significant difference in peripapillary parameters. Furthermore, we found a significant positive correlation between MoCA scores for the entire study cohort and both the parafoveal SCP VD and peripapillary RPC VLD. Conclusion OCTA shows significant decline in parafoveal flow and VD in individuals with early cognitive impairment related to AD, suggesting that these parameters could have potential utility as early disease biomarkers. In contrast, the presence of larger vascular channels in the peripapillary region may have obscured subtle capillary changes in that region. Overall, the correlation between vascular OCTA parameters and cognitive performance supports further OCTA studies in this population.	[Zhang, Yi Stephanie; Zhou, Nina; Knoll, Brianna Marie; Samra, Sahej; Fawzi, Amani A.] Northwestern Univ, Dept Ophthalmol, Feinberg Sch Med, Chicago, IL 60611 USA; [Ward, Mallory R.; Weintraub, Sandra] Northwestern Univ, Feinberg Sch Med, Mesulam Ctr Cognit Neurol, Chicago, IL 60611 USA; [Ward, Mallory R.; Weintraub, Sandra] Northwestern Univ, Feinberg Sch Med, Alzheimers Dis Ctr, Chicago, IL 60611 USA; [Weintraub, Sandra] Northwestern Univ, Feinberg Sch Med, Dept Psychiat & Behav Sci, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Fawzi, AA (corresponding author), Northwestern Univ, Dept Ophthalmol, Feinberg Sch Med, Chicago, IL 60611 USA.	afawzimd@gmail.com	fawzi, amani/AAA-9199-2021	fawzi, amani/0000-0002-9568-3558; Samra, Sahej/0000-0002-6037-3795; Knoll, Brianna/0000-0002-7569-1518	Illinois Society for the Prevention of Blindness; National Institutes of Health [DP3DK108248, NIA-AG13584]	Illinois Society for the Prevention of Blindness; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by the Illinois Society for the Prevention of Blindness (BMK) and National Institutes of Health [grant numbers DP3DK108248 (AAF), NIA-AG13584 (CNADC)]. Optovue Inc provided research instrument support with no involvement in research design, recruitment, or manuscript production.	Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; BELL MA, 1990, NEUROBIOL AGING, V11, P359, DOI 10.1016/0197-4580(90)90001-G; Blanks JC, 1996, NEUROBIOL AGING, V17, P377, DOI 10.1016/0197-4580(96)00010-3; Bulut M, 2018, BRIT J OPHTHALMOL, V102, P233, DOI 10.1136/bjophthalmol-2017-310476; Campbell JP, 2017, SCI REP-UK, V7, DOI 10.1038/srep42201; Cheung CYL, 2015, J ALZHEIMERS DIS, V45, P45, DOI 10.3233/JAD-141659; Cheung CYL, 2014, ALZHEIMERS DEMENT, V10, P135, DOI 10.1016/j.jalz.2013.06.009; Chu ZD, 2016, J BIOMED OPT, V21, DOI 10.1117/1.JBO.21.6.066008; Coppola G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134750; Curcio CA, 2018, JAMA OPHTHALMOL, V136, P1249, DOI 10.1001/jamaophthalmol.2018.3569; Feke Gilbert T, 2015, Alzheimers Dement (Amst), V1, P144, DOI 10.1016/j.dadm.2015.01.004; Fischer P, 2007, NEUROLOGY, V68, P288, DOI 10.1212/01.wnl.0000252358.03285.9d; Frost S, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2012.150; Gold DA, 2012, J CLIN EXP NEUROPSYC, V34, P11, DOI 10.1080/13803395.2011.614598; Handels RLH, 2017, J ALZHEIMERS DIS, V60, P1477, DOI 10.3233/JAD-170324; HINTON DR, 1986, NEW ENGL J MED, V315, P485, DOI 10.1056/NEJM198608213150804; Hughes S, 2000, INVEST OPHTH VIS SCI, V41, P1217; Jeste DV, 2007, ARCH GEN PSYCHIAT, V64, P966, DOI 10.1001/archpsyc.64.8.966; Jia YL, 2012, BIOMED OPT EXPRESS, V3, DOI 10.1364/BOE.3.003127; Jia YL, 2017, INVEST OPHTH VIS SCI, V58, P5188, DOI 10.1167/iovs.17-22593; Jia YL, 2014, OPHTHALMOLOGY, V121, P1322, DOI 10.1016/j.ophtha.2014.01.021; Jia YL, 2012, OPT EXPRESS, V20, P4710, DOI 10.1364/OE.20.004710; Jiang H, 2018, J NEURO-OPHTHALMOL, V38, P292, DOI 10.1097/WNO.0000000000000580; Jiang H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192154; Johnson KA, 1998, NEUROLOGY, V50, P1563, DOI 10.1212/WNL.50.6.1563; Johnson N, 2004, ALZ DIS ASSOC DIS, V18, P223; Kashani AH, 2017, PROG RETIN EYE RES, V60, P66, DOI 10.1016/j.preteyeres.2017.07.002; Kim SYH, 2002, AM J GERIAT PSYCHIAT, V10, P151, DOI 10.1176/appi.ajgp.10.2.151; Knight OJ, 2012, ARCH OPHTHALMOL-CHIC, V130, P312, DOI 10.1001/archopthalmol.2011.1576; Knoll Brianna, 2016, Alzheimers Dement (Amst), V4, P85; Koronyo Y, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93621; Lad EM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192646; Leung H, 2003, INVEST OPHTH VIS SCI, V44, P2900, DOI 10.1167/iovs.02-1114; Lim JS, 2017, J NEUROL SCI, V373, P285, DOI 10.1016/j.jns.2017.01.001; Linderman RE, 2018, TRANSL VIS SCI TECHN, V7, DOI 10.1167/tvst.7.5.20; London A, 2013, NAT REV NEUROL, V9, P44, DOI 10.1038/nrneurol.2012.227; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Monsell SE, 2016, ALZ DIS ASSOC DIS, V30, P134, DOI 10.1097/WAD.0000000000000111; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Nelis P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26475-5; Nesper PL, 2018, INVEST OPHTH VIS SCI, V59, P3858, DOI 10.1167/iovs.18-24710; O'Bryhim BE, 2018, JAMA OPHTHALMOL, V136, P1242, DOI 10.1001/jamaophthalmol.2018.3556; Paris Daniel, 2004, Angiogenesis, V7, P75, DOI 10.1023/B:AGEN.0000037335.17717.bf; Park JJ, 2016, RETINA-J RET VIT DIS, V36, P2039, DOI 10.1097/IAE.0000000000001077; Phansalkar N., 2011, P INT C COMMUN SIGNA, P218, DOI DOI 10.1109/ICCSP.2011.5739305; Prince M, 2011, WORLD ALZHEIMER REPO; Roberts PK, 2017, INVEST OPHTH VIS SCI, V58; Ruitenberg A, 2005, ANN NEUROL, V57, P789, DOI 10.1002/ana.20493; Sampson DM, 2017, INVEST OPHTH VIS SCI, V58, P3065, DOI 10.1167/iovs.17-21551; Scripsema Nicole K, 2016, Invest Ophthalmol Vis Sci, V57, pOCT611, DOI 10.1167/iovs.15-18945; Sharma N, 2016, J CLIN DIAGN RES, V10, pKE1, DOI 10.7860/JCDR/2016/18828.8166; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Tan CS, 2016, INVEST OPHTH VIS SCI, V57, pOCT224, DOI 10.1167/iovs.15-18869; Tang FY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02767-0; Thomson Kelsey L, 2015, Alzheimers Dement (Amst), V1, P136, DOI 10.1016/j.dadm.2015.03.001; Vos SJB, 2013, LANCET NEUROL, V12, P957, DOI 10.1016/S1474-4422(13)70194-7; Wagner-Schuman M, 2011, INVEST OPHTH VIS SCI, V52, P625, DOI 10.1167/iovs.10-5886; Wei YT, 2017, INVEST OPHTH VIS SCI, V58, P3804, DOI 10.1167/iovs.17-21460; Weintraub S, 2018, ALZ DIS ASSOC DIS, V32, P10, DOI 10.1097/WAD.0000000000000223; Weintraub S, 2009, ALZ DIS ASSOC DIS, V23, P91, DOI 10.1097/WAD.0b013e318191c7dd; Zhu L, 2018, J GLAUCOMA, V27, P322, DOI 10.1097/IJG.0000000000000900; Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114	63	65	67	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2019	14	4							e0214685	10.1371/journal.pone.0214685	http://dx.doi.org/10.1371/journal.pone.0214685			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR2UW	30939178	Green Published, gold, Green Submitted			2022-12-26	WOS:000462993900036
J	Dormann, D				Dormann, Dirk			IntensityCheck - The light measuring app for microscope performance checks and consistent fluorescence imaging	PLOS ONE			English	Article							SLIDE-BASED SYSTEMS; CONFOCAL MICROSCOPY; QUALITY ASSESSMENT	Quantitative fluorescence imaging is an essential tool in biomedical research. It requires consistent and repeatable conditions such as constant sample illumination. Even on a confocal microscope this can usually only be achieved by using an external laser power meter. By combining low-cost wireless Arduino based light sensors with an easy to use Android smartphone app we provide microscope users with a simple but powerful tool to maintain sample illumination for quantitative imaging, for tracking the intensity, stability and alignment of the light sources and for comparing microscope performance.	[Dormann, Dirk] Imperial Coll London, MRC London Inst Med Sci, Microscopy Facil, Fac Med, London, England	Imperial College London	Dormann, D (corresponding author), Imperial Coll London, MRC London Inst Med Sci, Microscopy Facil, Fac Med, London, England.	dirk.dormann@lms.mrc.ac.uk						Amos WB, 2003, BIOL CELL, V95, P335, DOI 10.1016/S0248-4900(03)00078-9; Cho EH, 2006, J MICROSC-OXFORD, V223, P15, DOI 10.1111/j.1365-2818.2006.01598.x; Deagle RC, 2017, INT J BIOCHEM CELL B, V89, P120, DOI 10.1016/j.biocel.2017.06.008; Garsha K, 2008, QUANTITATIVE FLUORES; Hng KI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079879; Jonkman J, 2014, METHOD CELL BIOL, V123, P113, DOI 10.1016/B978-0-12-420138-5.00007-0; Russ J.C., 1994, IMAGE PROCESSING HDB; Swedlow JR, 2013, METHOD CELL BIOL, V114, P407, DOI 10.1016/B978-0-12-407761-4.00017-8; van de Linde S, 2011, NAT PROTOC, V6, P991, DOI 10.1038/nprot.2011.336; Zucker RM, 2010, EVALUATION PURCHASE; Zucker RM, 2006, CYTOM PART A, V69A, P659, DOI 10.1002/cyto.a.20314; Zucker RM, 2006, CYTOM PART A, V69A, P677, DOI 10.1002/cyto.a.20313; Zucker RM, 2014, METHODS MOL BIOL, V1075, P321, DOI 10.1007/978-1-60761-847-8_17	13	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214659	10.1371/journal.pone.0214659	http://dx.doi.org/10.1371/journal.pone.0214659			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921439	Green Published, Green Submitted, gold			2022-12-26	WOS:000462594000104
J	Malinowska, M; Miroslaw, B; Sikora, E; Ogonowski, J; Wojtkiewicz, AM; Szaleniec, M; Pasikowska-Piwko, M; Eris, I				Malinowska, Magdalena; Miroslaw, Barbara; Sikora, Elzbieta; Ogonowski, Jan; Wojtkiewicz, Agnieszka M.; Szaleniec, Maciej; Pasikowska-Piwko, Monika; Eris, Irena			New lupeol esters as active substances in the treatment of skin damage	PLOS ONE			English	Article							PREDICTION; DELIVERY; FILMS	The purpose of the research was to obtain new derivatives of natural triterpene lupeol and to evaluate their potential as active substances in the treatment of skin damage. Four new lupeol esters (propionate, succinate, isonicotinate and acetylsalicylate) and lupeol acetate were obtained using an eco-friendly synthesis method. In the esterification process, the commonly used hazardous reagents in this type of synthesis were replaced by safe ones. This unconventional, eco-friendly, method is particularly important because the compounds obtained are potentially active substances in skin care formulations. Even trace amounts of hazardous reagents can have a toxic effect on damaged or irritated tissues. The molecular structure of the esters were confirmed by H-1 NMR, C-13 NMR and IR spectroscopy methods. Their crystal structures were determined using XRD method. To complete the analysis of their characteristics, physicochemical properties (melting point, lipophilicity, water solubility) and biological activity of the lupeol derivatives were studied. Results of an irritant potential test, carried out on Reconstructed Human Epidermis (RHE), confirmed that the synthesized lupeol derivatives are not cytotoxic and they stimulate a process of human cell proliferation. The safety of use for tested compounds was determined in a cell viability test (cytotoxicity detection kit based on the measurement of lactate dehydrogenase activity) for keratinocytes and fibroblasts. The results obtained showed that the modification of lupeol structure improve its bioavailability and activity. All of the esters penetrate the stratum corneum and the upper layers of the dermis better than the maternal lupeol. Lupeol isonicotinate, acetate and propionate were the most effective compounds in a stimulation of the human skin cell proliferation process. This combination resulted in an increase in the concentration of cells of more than 30% in comparison to control samples. The results indicate that the chemical modification of lupeol allows to obtain promising active substances for treatment of skin damage, including thermal, chemical and radiation burns.	[Malinowska, Magdalena; Sikora, Elzbieta; Ogonowski, Jan] Cracow Univ Technol, Inst Organ Chem & Technol, Krakow, Poland; [Miroslaw, Barbara] Marie Curie Sklodowska Univ, Dept Crystallog, Fac Chem, Lublin, Poland; [Wojtkiewicz, Agnieszka M.; Szaleniec, Maciej] Polish Acad Sci, Jerzy Haber Inst Catalysis & Surface Chem, Krakow, Poland; [Pasikowska-Piwko, Monika; Eris, Irena] Dr Irena Eris Ctr Sci & Res, Piaseczno, Poland	Cracow University of Technology; Maria Curie-Sklodowska University; Polish Academy of Sciences; Jerzy Haber Institute of Catalysis & Surface Chemistry	Malinowska, M (corresponding author), Cracow Univ Technol, Inst Organ Chem & Technol, Krakow, Poland.	mmalinowska@chemia.pk.edu.pl	Wojtkiewicz, Agnieszka M./AAC-2246-2020; Miroslaw, Barbara/AAB-2775-2022; Miroslaw, Barbara/R-3859-2018; Szaleniec, Maciej/A-1198-2013	Miroslaw, Barbara/0000-0002-5765-4641; Szaleniec, Maciej/0000-0002-7650-9263; Malinowska, Magdalena Anna/0000-0001-9172-7341; Wojtkiewicz, Agnieszka Maria/0000-0001-7521-2233	European Regional Development Fund [POPW.01.03.00-06-009/11-00]	European Regional Development Fund(European Commission)	The research was carried out with the equipment purchased thanks to the financial support of the European Regional Development Fund in the framework of the Operational Program Development of Eastern Poland 2007-2013 (Contract No. POPW.01.03.00-06-009/11-00, Equipping the laboratories of the Faculties of Biology and Biotechnology, Mathematics, Physics and Informatics, and Chemistry for studies of biologically active substances and environmental samples). The calculations in Discovery Studio (BIOVIA) were supported by PL-Grid Infrastructure (AGH CYFRONET). Calculator Plugins of Chemicalize was used for structure property prediction and calculation 01.2019 https://chemicalize.com/developed by ChemAxon (http://www.chemaxon.com) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achrem-Achremowicz J, 2007, THESIS; Agilent Technologies, 2014, CRYSALISPRO; [Anonymous], 2016, DISC STUD VERS 4 1; Bhandari P, 2014, BIOORG MED CHEM LETT, V24, P3596, DOI 10.1016/j.bmcl.2014.05.032; BLESSING RH, 1995, ACTA CRYSTALLOGR A, V51, P33, DOI 10.1107/S0108767394005726; Bouwstra JA, 2010, OPEN DERMATOL J, V4, P10, DOI [10.2174/1874372201004010010, DOI 10.2174/1874372201004010010]; Chemsketch, 2015, CHEMSK; Chen QH, 2009, ULTRASON SONOCHEM, V16, P599, DOI 10.1016/j.ultsonch.2008.11.009; Cheng AL, 2003, J MED CHEM, V46, P3572, DOI 10.1021/jm020266b; Choy YB, 2011, PHARM RES-DORDR, V28, P943, DOI 10.1007/s11095-010-0292-6; Copp BR, 2007, NAT PROD REP, V24, P278, DOI 10.1039/b513520f; Correa RS, 2009, ACTA CRYSTALLOGR C, V65, pO97, DOI 10.1107/S0108270109004910; Csizmadia F, 1997, J PHARM SCI-US, V86, P865, DOI 10.1021/js960177k; Martins DCD, 2016, CATAL COMMUN, V86, P104, DOI 10.1016/j.catcom.2016.08.014; Dolomanov OV, 2009, J APPL CRYSTALLOGR, V42, P339, DOI 10.1107/S0021889808042726; Valencia-Gomez LE, 2016, INT J BIOL MACROMOL, V93, P1217, DOI 10.1016/j.ijbiomac.2016.09.083; Fontanay S, 2008, J ETHNOPHARMACOL, V120, P272, DOI 10.1016/j.jep.2008.09.001; Fotie J, 2006, J NAT PROD, V69, P62, DOI 10.1021/np050315y; Gong YH, 2004, ANTIVIR RES, V64, P127, DOI 10.1016/j.antiviral.2004.05.006; Hernandez-Vazquez L, 2010, IND CROP PROD, V31, P476, DOI 10.1016/j.indcrop.2010.01.009; Hooft RWW, 2008, J APPL CRYSTALLOGR, V41, P96, DOI 10.1107/S0021889807059870; Jain P. S., 2010, Asian Journal of Plant Sciences, V9, P163; Kandarova Helena, 2009, J Vis Exp, DOI 10.3791/1366; Khan MF, 2014, MED CHEM RES, V23, P4156, DOI 10.1007/s00044-014-0984-2; Khan PM, 2019, CHEMOSPHERE, V224, P470, DOI 10.1016/j.chemosphere.2019.02.147; Laszczyk MN, 2009, PLANTA MED, V75, P1549, DOI 10.1055/s-0029-1186102; Msika P, 2014, U.S. Patent, Patent No. [US8747815 B2, 8747815, 8,747,815]; Mukhtar H, 2013, Patent No. [US 8618082 B2, 8618082]; Nanimi D, 2008, J AM ACAD DERMATOL, V58, pAB62; Parsons S, 2013, ACTA CRYSTALLOGR B, V69, P249, DOI 10.1107/S2052519213010014; Patel S, 2018, INT J BIOL MACROMOL, V107, P1888, DOI 10.1016/j.ijbiomac.2017.10.056; PreADME, 2004, BIOASSAY SCI VERS 1; Pyka A, 2005, CHROMATOGRAPHIA, V61, P37, DOI 10.1365/s10337-004-0468-5; Saleem M, 2009, CANCER LETT, V285, P109, DOI 10.1016/j.canlet.2009.04.033; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Siddique HR, 2011, LIFE SCI, V88, P285, DOI 10.1016/j.lfs.2010.11.020; VASNEV VV, 1987, MAKROMOL CHEM, V188, P683; Wang WH, 2016, BIOMED PHARMACOTHER, V79, P231, DOI 10.1016/j.biopha.2016.02.010; Wang X, 2010, CHEM-BIOL INTERACT, V184, P328, DOI 10.1016/j.cbi.2010.01.034; WERTZ PW, 1985, J INVEST DERMATOL, V84, P410, DOI 10.1111/1523-1747.ep12265510; WILLIAMS AC, 1991, PHARM RES-DORDR, V8, P17, DOI 10.1023/A:1015813803205; World Health Organization (WHO), BURNS; Xu F, 2018, BIOMED PHARMACOTHER, V103, P198, DOI 10.1016/j.biopha.2018.04.019	43	13	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214216	10.1371/journal.pone.0214216	http://dx.doi.org/10.1371/journal.pone.0214216			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921370	Green Published, Green Submitted, gold			2022-12-26	WOS:000462594000043
J	Shaffer, JG; Schieffelin, JS; Gbakie, M; Alhasan, F; Roberts, NB; Goba, A; Randazzo, J; Momoh, M; Moon, TD; Kanneh, L; Levy, DC; Podgorski, RM; Hartnett, JN; Boisen, ML; Branco, LM; Samuels, R; Grant, DS; Garry, RF				Shaffer, Jeffrey G.; Schieffelin, John S.; Gbakie, Michael; Alhasan, Foday; Roberts, Nicole B.; Goba, Augustine; Randazzo, Jessica; Momoh, Mambu; Moon, Troy D.; Kanneh, Lansana; Levy, Danielle C.; Podgorski, Rachel M.; Hartnett, Jessica N.; Boisen, Matt L.; Branco, Luis M.; Samuels, Robert; Grant, Donald S.; Garry, Robert F.		Viral Hemorrhagic Fever Consortium	A medical records and data capture and management system for Lassa fever in Sierra Leone: Approach, implementation, and challenges	PLOS ONE			English	Article							VIRUS-DISEASE; WEST-AFRICA; EBOLA; EPIDEMIOLOGY	Situated in southeastern Sierra Leone, Kenema Government Hospital (KGH) maintains one of the world's only Lassa fever isolation wards and was a strategic Ebola virus disease (EVD) treatment facility during the 2014 EVD outbreak. Since 2006, the Viral Hemorrhagic Fever Consortium (VHFC) has carried out research activities at KGH, capturing clinical and laboratory data for suspected cases of Lassa fever. Here we describe the approach, progress, and challenges in designing and maintaining a data capture and management system (DCMS) at KGH to assist infectious disease researchers in building and sustaining DCMS in low-resource environments. Results on screening patterns and case-fatality rates are provided to illustrate the context and scope of the DCMS covered in this study. A medical records system and DCMS was designed and implemented between 2010 and 2016 linking historical and prospective Lassa fever data sources across KGH Lassa fever units and its peripheral health units. Data were captured using a case report form (CRF) system, enzyme-linked immunosorbent assay (ELISA) plate readers, polymerase chain reaction (PCR) machines, blood chemistry analyzers, and data auditing procedures. Between 2008 and 2016, blood samples for 4,229 suspected Lassa fever cases were screened at KGH, ranging from 219 samples in 2008 to a peak of 760 samples in 2011. Lassa fever case-fatality rates before and following the Ebola outbreak were 65.5% (148/226) and 89.5% (17/19), respectively, suggesting that fewer, but more seriously ill subjects with Lassa fever presented to KGH following the 2014 EVD outbreak (p = .040). DCMS challenges included weak specificity of the Lassa fever suspected case definition, limited capture of patient survival outcome data, Internet costs, lapses in Internet connectivity, low bandwidth, equipment and software maintenance, lack of computer teaching laboratories, and workload fluctuations due to variable screening activity. DCMS are the backbone of international research efforts and additional literature is needed on the topic for establishing benchmarks and driving goal-based approaches for its advancement in developing countries.	[Shaffer, Jeffrey G.; Randazzo, Jessica] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Global Biostat & Data, New Orleans, LA 70118 USA; [Schieffelin, John S.] Tulane Univ, Sch Med, Sect Pediat, Dept Pediat, 1430 Tulane Ave, New Orleans, LA 70112 USA; [Schieffelin, John S.] Tulane Univ, Sch Med, Sect Pediat, Dept Internal Med, 1430 Tulane Ave, New Orleans, LA 70112 USA; [Schieffelin, John S.] Tulane Univ, Sch Med, Sect Adult Infect Dis, Dept Pediat, 1430 Tulane Ave, New Orleans, LA 70112 USA; [Schieffelin, John S.] Tulane Univ, Sch Med, Sect Adult Infect Dis, Dept Internal Med, 1430 Tulane Ave, New Orleans, LA 70112 USA; [Gbakie, Michael; Alhasan, Foday; Goba, Augustine; Momoh, Mambu; Kanneh, Lansana; Samuels, Robert; Grant, Donald S.] Kenema Govt Hosp, Viral Hemorrhag Fever Program, Kenema, Sierra Leone; [Gbakie, Michael; Alhasan, Foday; Goba, Augustine; Momoh, Mambu; Kanneh, Lansana; Samuels, Robert; Grant, Donald S.] Minist Hlth & Sanitat, Freetown, Sierra Leone; [Roberts, Nicole B.; Levy, Danielle C.; Podgorski, Rachel M.; Hartnett, Jessica N.; Garry, Robert F.] Tulane Univ, Dept Microbiol & Immunol, New Orleans, LA 70118 USA; [Moon, Troy D.] Vanderbilt Univ, Inst Global Hlth, 221 Kirkland Hall, Nashville, TN 37235 USA; [Boisen, Matt L.; Branco, Luis M.; Garry, Robert F.] Zalgen Labs LLC, Germantown, MD USA	Tulane University; Tulane University; Tulane University; Tulane University; Tulane University; Kenema Government Hospital; Ministry of Health & Sanitation Sierra Leone; Tulane University; Vanderbilt University	Shaffer, JG (corresponding author), Tulane Univ, Sch Publ Hlth & Trop Med, Dept Global Biostat & Data, New Orleans, LA 70118 USA.	jshaffer@tulane.edu		Moon, Troy/0000-0002-1637-829X; Garry, Robert/0000-0002-5683-3250	National Institute of Allergy and Infectious Diseases [1U19AI115589, AI067188, AI082119, AI2008031, AI2009061, AI104216, AI104621, P20GM103501, HHSN272200900018C, HHSN272200900049C, HHSN272201000022C, 5U19AI115589-02]; FOGARTY INTERNATIONAL CENTER [D43TW009340] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI135995, U19AI115589] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institute of Allergy and Infectious Diseases grants/contracts 1U19AI115589, AI067188, AI082119, AI2008031, AI2009061, AI104216, AI104621, P20GM103501, HHSN272200900018C, HHSN272200900049C, HHSN272201000022C, and 5U19AI115589-02. The funder provided support in the form of salaries for authors [JGS, JSS, MG, FA, NBR, AG, JR, MM, TDM, LK, DCL, RMP, JNH, MLB, LMB, RS, DSG, RFG], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are provided in the 'author contributions' section. The authors MLB, LMB, and RFG are current employees or affiliates of Zalgen Labs, LLC.	[Anonymous], 2018, AWOKO NEWSPAPER; Boerma JT, 2007, LANCET, V369, P779, DOI 10.1016/S0140-6736(07)60364-X; BUCKLEY SM, 1970, AM J TROP MED HYG, V19, P680, DOI 10.4269/ajtmh.1970.19.680; Centers for Disease Control and Prevention, 2018, VIR HERM FEV VHFS AR; Central Intelligence Agency, 2018, WORLD FACTBOOK; Dawson J, 2011, STUD HEALTH TECHNOL, V164, P174, DOI 10.3233/978-1-60750-709-3-174; Enria DA, 2006, TROPICAL INFECT DIS, P734; Frieden TR, 2015, EMERG INFECT DIS, V21, P1897, DOI 10.3201/eid2111.150949; Goba A, 2016, J INFECT DIS, V214, pS110, DOI 10.1093/infdis/jiw239; Guthrie S, 2017, MICROSOFT DELIVER MI; Hayden EC, 2014, NATURE, V513, P474; Jazayeri D, 2015, STUD HEALTH TECHNOL, V216, P916, DOI 10.3233/978-1-61499-564-7-916; Kahn M, 2014, AUST ACAD RES LIBR, V45, P296, DOI 10.1080/00048623.2014.951910; Khan SH, 2008, ANTIVIR RES, V78, P103, DOI 10.1016/j.antiviral.2007.11.003; Kirigia JM, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-135; Magbity E, 2006, REPORT ASSESSMENT SI; Mamlin Burke W, 2006, AMIA Annu Symp Proc, P529; MCCORMICK JB, 1987, J INFECT DIS, V155, P437, DOI 10.1093/infdis/155.3.437; MCCORMICK JB, 1987, J INFECT DIS, V155, P445, DOI 10.1093/infdis/155.3.445; MONATH TP, 1974, AM J TROP MED HYG, V23, P1140, DOI 10.4269/ajtmh.1974.23.1140; MONATH TP, 1975, B WORLD HEALTH ORGAN, V52, P577; Network HM, 2006, COUNTR HLTH INF SYST; Nwagwu W, 2010, S AFR J LIBR INF, V76, P168, DOI 10.7553/76-2-79; Omollo R, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003134; Owada K, 2016, FRONT PUBLIC HEALTH, V4, DOI 10.3389/fpubh.2016.00163; Oza S, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.7881; Prokscha S., 2012, PRACTICAL GUIDE CLIN; REDCap, 2018, MOB APP; Ridley M, 2015, IT NEWS AFRICA; Schieffelin JS, 2014, NEW ENGL J MED, V371, P2092, DOI 10.1056/NEJMoa1411680; Shaffer JG, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002748; Vital Wave Consulting HIS, 2009, HLTH INFORM SYSTEMS; Washburn F, 2015, EBOLA VIRUS DIS OUTB; World Health Organization, 2018, STAT END EB OUTBR SI; World Health Organization, SIERR LEON LONG REC	35	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214284	10.1371/journal.pone.0214284	http://dx.doi.org/10.1371/journal.pone.0214284			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921383	Green Published, Green Submitted, gold			2022-12-26	WOS:000462594000049
J	Zeiberg, D; Prahlad, T; Nallamothu, BK; Iwashyna, TJ; Wiens, J; Sjoding, MW				Zeiberg, Daniel; Prahlad, Tejas; Nallamothu, Brahmajee K.; Iwashyna, Theodore J.; Wiens, Jenna; Sjoding, Michael W.			Machine learning for patient risk stratification for acute respiratory distress syndrome	PLOS ONE			English	Article							INJURY PREDICTION SCORE	Background Existing prediction models for acute respiratory distress syndrome (ARDS) require manual chart abstraction and have only fair performance-limiting their suitability for driving clinical interventions. We sought to develop a machine learning approach for the prediction of ARDS that (a) leverages electronic health record (EHR) data, (b) is fully automated, and (c) can be applied at clinically relevant time points throughout a patient's stay. Methods and Findings We trained a risk stratification model for ARDS using a cohort of 1,621 patients with moderate hypoxia from a single center in 2016, of which 51 patients developed ARDS. We tested the model in a temporally distinct cohort of 1,122 patients from 2017, of which 27 patients developed ARDS. Gold standard diagnosis of ARDS was made by intensive care trained physicians during retrospective chart review. We considered both linear and non-linear approaches to learning the model. The best model used L2-logistic regression with 984 features extracted from the EHR. For patients observed in the hospital at least six hours who then developed moderate hypoxia, the model achieved an area under the receiver operating characteristics curve (AUROC) of 0.81 (95% CI: 0.73-0.88). Selecting a threshold based on the 85th percentile of risk, the model had a sensitivity of 56% (95% CI: 35%, 74%), specificity of 86% (95% CI: 85%, 87%) and positive predictive value of 9% (95% CI: 5%, 14%), identifying a population at four times higher risk for ARDS than other patients with moderate hypoxia and 17 times the risk of hospitalized adults. Conclusions We developed an ARDS prediction model based on EHR data with good discriminative performance. Our results demonstrate the feasibility of a machine learning approach to risk stratifying patients for ARDS solely from data extracted automatically from the EHR.	[Zeiberg, Daniel; Prahlad, Tejas; Wiens, Jenna] Univ Michigan, Comp Sci & Engn, Ann Arbor, MI 48109 USA; [Nallamothu, Brahmajee K.; Iwashyna, Theodore J.; Sjoding, Michael W.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Nallamothu, Brahmajee K.; Iwashyna, Theodore J.; Sjoding, Michael W.] Univ Michigan, Inst Healthcare Policy & Innovat, Ann Arbor, MI 48109 USA; [Nallamothu, Brahmajee K.; Iwashyna, Theodore J.] US Dept Vet Affairs, VA Ctr Clin Management Res, Ann Arbor, MI USA; [Nallamothu, Brahmajee K.; Iwashyna, Theodore J.; Wiens, Jenna; Sjoding, Michael W.] Univ Michigan, Michigan Integrated Ctr Hlth Analyt & Med Predict, Ann Arbor, MI 48109 USA; [Iwashyna, Theodore J.] Univ Michigan, Inst Social Res, Ann Arbor, MI USA; [Sjoding, Michael W.] Univ Michigan, Ctr Computat Med & Bioinformat, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; US Department of Veterans Affairs; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Sjoding, MW (corresponding author), Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA.; Sjoding, MW (corresponding author), Univ Michigan, Inst Healthcare Policy & Innovat, Ann Arbor, MI 48109 USA.; Sjoding, MW (corresponding author), Univ Michigan, Michigan Integrated Ctr Hlth Analyt & Med Predict, Ann Arbor, MI 48109 USA.; Sjoding, MW (corresponding author), Univ Michigan, Ctr Computat Med & Bioinformat, Ann Arbor, MI 48109 USA.	msjoding@umich.edu		Zeiberg, Daniel/0000-0002-6919-7572	NHLBI [K01HL136687]; VA HSRD IIR [17-045]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K01HL136687] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); VA HSRD IIR; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants to Dr. Sjoding from the NHLBI K01HL136687 and Dr. Nallamothu from the Michigan Institute for Data Science (http://midas.umich.edu/).Additional funding from VA HSR&D IIR 17-045 to Brahmajee K. Nallamothu and Theodore J. Iwashyna. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellani G, 2016, JAMA-J AM MED ASSOC, V315, P788, DOI 10.1001/jama.2016.0291; Brown SM, 2017, CRIT CARE MED, V45, P1317, DOI 10.1097/CCM.0000000000002514; COCHRAN WG, 1968, BIOMETRICS, V24, P295, DOI 10.2307/2528036; de Haro C, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-11; Gajic O, 2011, AM J RESP CRIT CARE, V183, P462, DOI 10.1164/rccm.201004-0549OC; Guestrin, 2016, P 22 ACM SIGKDD INT; Headley AS, 1997, CHEST, V111, P1306, DOI 10.1378/chest.111.5.1306; Herasevich V, 2009, INTENS CARE MED, V35, P1018, DOI 10.1007/s00134-009-1460-1; Janz DR, 2015, J INTENSIVE CARE, V3, DOI 10.1186/s40560-015-0086-3; Kor DJ, 2016, JAMA-J AM MED ASSOC, V315, P2406, DOI 10.1001/jama.2016.6330; Levitt JE, 2013, CRIT CARE MED, V41, P1929, DOI 10.1097/CCM.0b013e31828a3d99; Oh J, 2018, INFECT CONT HOSP EP, V39, P425, DOI 10.1017/ice.2018.16; Rajkomar A, 2018, NPJ DIGIT MED, V1, DOI 10.1038/s41746-018-0029-1; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Sjoding MW, 2018, CHEST, V153, P361, DOI 10.1016/j.chest.2017.11.037; Sjoding MW, 2016, CRIT CARE MED, V44, P1611, DOI 10.1097/CCM.0000000000001771; Soto GJ, 2016, CRIT CARE MED, V44, P2182, DOI 10.1097/CCM.0000000000002001; Summers C, 2016, THORAX, V71, P1050, DOI 10.1136/thoraxjnl-2016-208402; Toll DB, 2008, J CLIN EPIDEMIOL, V61, P1085, DOI 10.1016/j.jclinepi.2008.04.008; Wang JX, 2018, KDD'18: PROCEEDINGS OF THE 24TH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY & DATA MINING, P2417, DOI 10.1145/3219819.3220070; Weiss CH, 2016, CRIT CARE MED, V44, P1515, DOI 10.1097/CCM.0000000000001710; Wetzel R., 2017, LEARNING DIAGNOSE LS; Yadav H, 2017, AM J RESP CRIT CARE, V195, P725, DOI 10.1164/rccm.201609-1767CI; Yadav H, 2015, AM J PHYSIOL-LUNG C, V309, pL915, DOI 10.1152/ajplung.00266.2015	24	32	32	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214465	10.1371/journal.pone.0214465	http://dx.doi.org/10.1371/journal.pone.0214465			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921400	Green Published, Green Submitted, gold			2022-12-26	WOS:000462594000073
J	Ravnsborg, T; Svaneklink, S; Andersen, LLT; Larsen, MR; Jensen, DM; Overgaard, M				Ravnsborg, Tina; Svaneklink, Sarah; Andersen, Lise Lotte T.; Larsen, Martin R.; Jensen, Dorte M.; Overgaard, Martin			First-trimester proteomic profiling identifies novel predictors of gestational diabetes mellitus	PLOS ONE			English	Article							HORMONE-BINDING GLOBULIN; 1ST TRIMESTER; RISK; PREGNANCY; ADIPONECTIN; BIOMARKERS; WOMEN; PHOSPHOPROTEOME; PREECLAMPSIA; MASS	Background Gestational diabetes mellitus (GDM) is a common pregnancy complication associated with adverse outcomes including preeclampsia, caesarean section, macrosomia, neonatal morbidity and future development of type 2 diabetes in both mother and child. Current selective screening strategies rely on clinical risk factors such as age, family history of diabetes, macrosomia or GDM in a previous pregnancy, and they possess a relatively low specificity. Here we hypothesize that novel first trimester protein predictors of GDM can contribute to the current selective screening strategies for early and accurate prediction of GDM, thus allowing for timely interventions. Methods A proteomics discovery approach was applied to first trimester sera from obese (BMI >= 27 kg/m(2)) women (n = 60) in a nested case-control study design, utilizing tandem mass tag labelling and tandem mass spectrometry. A subset of the identified protein markers was further validated in a second set of serum samples (n = 210) and evaluated for their contribution as predictors of GDM in relation to the maternal risk factors, by use of logistic regression and receiver operating characteristic analysis. Results Serum proteomic profiling identified 25 proteins with significantly different levels between cases and controls. Three proteins; afamin, serum amyloid P-component and vitronectin could be further confirmed as predictors of GDM in a validation set. Vitronectin was shown to contribute significantly to the predictive power of the maternal risk factors, indicating it as a novel independent predictor of GDM. Conclusions Current selective screening strategies can potentially be improved by addition of protein predictors.	[Ravnsborg, Tina; Svaneklink, Sarah; Overgaard, Martin] Odense Univ Hosp, Dept Clin Biochem & Pharmacol, Odense, Denmark; [Ravnsborg, Tina; Jensen, Dorte M.] Odense Univ Hosp, Danish Diabet Acad, Odense, Denmark; [Andersen, Lise Lotte T.; Jensen, Dorte M.] Odense Univ Hosp, Dept Obstet & Gynaecol, Odense, Denmark; [Larsen, Martin R.] Univ Southern Denmark, Dept Biochem & Mol Biol, Odense, Denmark; [Jensen, Dorte M.; Overgaard, Martin] Univ Southern Denmark, Inst Clin Res, Odense, Denmark; [Jensen, Dorte M.] Odense Univ Hosp, Dept Endocrinol, Odense, Denmark; [Jensen, Dorte M.] Odense Univ Hosp, Steno Diabet Ctr Odense, Odense, Denmark	University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; University of Southern Denmark; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital	Overgaard, M (corresponding author), Odense Univ Hosp, Dept Clin Biochem & Pharmacol, Odense, Denmark.; Overgaard, M (corresponding author), Univ Southern Denmark, Inst Clin Res, Odense, Denmark.	Martin.Overgaard@rsyd.dk	Jensen, Dorte Møller/T-6656-2019; Sánchez-Margalet, Victor/AAB-9986-2021	Jensen, Dorte Møller/0000-0002-3298-9824; Sánchez-Margalet, Victor/0000-0001-8638-8680; Ravnsborg, Tina/0000-0002-6376-621X; Overgaard, Martin/0000-0003-2277-590X	Danish Diabetes Academy - Novo Nordisk Foundation [PO0113]; Odense University Hospital Research Foundation [7-A212]	Danish Diabetes Academy - Novo Nordisk Foundation; Odense University Hospital Research Foundation	This work was supported by a post doc grant (PO0113) from the Danish Diabetes Academy (https://www.danishdiabetesacademy.dk/) supported by the Novo Nordisk Foundation to TR and DMJ and by a research grant (7-A212) from Odense University Hospital Research Foundation (http://www.ouh.dk/wm379761) to MO. The Villum Center for Bioanalytical Sciences at University of Southern Denmark is acknowledged for access to advanced LC-MS/MS instrumentation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benhalima K, 2016, EUR J OBSTET GYN R B, V201, P192, DOI 10.1016/j.ejogrb.2016.04.002; Caglar GS, 2012, J OBSTET GYNAECOL RE, V38, P1286, DOI 10.1111/j.1447-0756.2012.01870.x; Chu SY, 2007, DIABETES CARE, V30, P2070, DOI 10.2337/dc06-2559a; Coustan DR, 2013, CLIN CHEM, V59, P1310, DOI 10.1373/clinchem.2013.203331; Ekmekci OB, 2015, ARCH GYNECOL OBSTET, V292, P53, DOI 10.1007/s00404-014-3601-1; Georgiou HM, 2008, ACTA DIABETOL, V45, P157, DOI 10.1007/s00592-008-0037-8; Iliodromiti S, 2016, DIABETOLOGIA, V59, P692, DOI 10.1007/s00125-015-3855-6; Jensen DM, 2003, AM J OBSTET GYNECOL, V189, P1383, DOI 10.1067/S0002-9378(03)00601-X; Jensen DM, 2003, DIABETIC MED, V20, P51, DOI 10.1046/j.1464-5491.2003.00857.x; Kim C, 2002, DIABETES CARE, V25, P1862, DOI 10.2337/diacare.25.10.1862; Kolialexi A, 2017, EXPERT REV PROTEOMIC, V14, P269, DOI 10.1080/14789450.2017.1291345; Lacroix M, 2013, DIABETES CARE, V36, P1577, DOI 10.2337/dc12-1731; Lamain-de Ruiter M, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4338; Liao Y, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000012232; LIND T, 1991, DIABETES, V40, P8, DOI 10.2337/diab.40.2.S8; Lindsay RS, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0925-2; Maged AM, 2014, J MATERN-FETAL NEO M, V27, P1108, DOI 10.3109/14767058.2013.850489; McIntyre HD, 2018, DIABETES CARE, V41, P1339, DOI 10.2337/dc17-2393; McNulty DE, 2008, MOL CELL PROTEOMICS, V7, P971, DOI 10.1074/mcp.M700543-MCP200; Melo-Braga MN, 2014, MOL CELL PROTEOMICS, V13, P311, DOI 10.1074/mcp.M112.026898; Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943; Metzger BE, 2010, DIABETES CARE, V33, P676, DOI 10.2337/dc09-1848; Nanda S, 2011, PRENATAL DIAG, V31, P135, DOI 10.1002/pd.2636; Overgaard M, 2015, PROTEOM CLIN APPL, V9, P767, DOI 10.1002/prca.201400070; Ovesen PG, 2015, J MATERN-FETAL NEO M, V28, P1720, DOI 10.3109/14767058.2014.966677; Powe CE, 2017, CURR DIABETES REP, V17, DOI 10.1007/s11892-017-0834-y; Qiu CF, 2004, PAEDIATR PERINAT EP, V18, P377, DOI 10.1111/j.1365-3016.2004.00578.x; Ravnsborg T, 2016, DIABETOLOGIA, V59, P970, DOI 10.1007/s00125-016-3869-8; Savvidou M, 2010, DIABETES, V59, P3017, DOI 10.2337/db10-0688; Smirnakis KV, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2006.12.011; Thadhani R, 2003, AM J OBSTET GYNECOL, V189, P171, DOI 10.1067/mob.2003.343; Theriault S, 2016, CLIN CHEM LAB MED, V54, P509, DOI 10.1515/cclm-2015-0537; Tramontana A, 2018, PLACENTA, V62, P9, DOI 10.1016/j.placenta.2017.12.014; Tramontana A, 2018, CLIN CHIM ACTA, V476, P160, DOI 10.1016/j.cca.2017.11.031; WHO, 2013, DIAGN CRIT CLASS HYP; Worda C, 2004, AM J OBSTET GYNECOL, V191, P2120, DOI 10.1016/j.ajog.2004.04.038; Zhao DQ, 2017, PROTEOM CLIN APPL, V11, DOI 10.1002/prca.201600152	37	20	20	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2019	14	3							e0214457	10.1371/journal.pone.0214457	http://dx.doi.org/10.1371/journal.pone.0214457			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ5PT	30917176	Green Published, Green Submitted, gold			2022-12-26	WOS:000462465800067
J	Rock, S; Li, X; Song, J; Townsend, CM; Weiss, HL; Rychahou, P; Gao, TY; Li, J; Evers, BM				Rock, Stephanie; Li, Xian; Song, Jun; Townsend, Courtney M., Jr.; Weiss, Heidi L.; Rychahou, Piotr; Gao, Tianyan; Li, Jing; Evers, B. Mark			Kinase suppressor of Ras 1 and Exo70 promote fatty acid-stimulated neurotensin secretion through ERK1/2 signaling	PLOS ONE			English	Article							RAF/MEK/ERK PATHWAY; SCAFFOLD PROTEINS; EXOCYST COMPLEX; GENE-EXPRESSION; ACTIVATION; CANCER; MECHANISMS; KSR; ENDOCRINE; BREAST	Neurotensin is a peptide hormone released from enteroendocrine cells in the small intestine in response to fat ingestion. Although the mechanisms regulating neurotensin secretion are still incompletely understood, our recent findings implicate a role for extracellular signal-regulated kinase 1 and 2 as positive regulators of free fatty acid-stimulated neurotensin secretion. Previous studies have shown that kinase suppressor of Ras 1 acts as a molecular scaffold of the Raf/MEK/extracellular signal-regulated kinase 1 and 2 kinase cascade and regulates intensity and duration of extracellular signal-regulated kinase 1 and 2 signaling. Here, we demonstrate that inhibition of kinase suppressor of Ras 1 attenuates neurotensin secretion and extracellular signal-regulated kinase 1 and 2 signaling in human endocrine cells. Conversely, we show that overexpression of kinase suppressor of Ras 1 enhances neurotensin secretion and extracellular signal-regulated kinase 1 and 2 signaling. We also show that inhibition of extracellular signal-regulated kinase 2 and exocyst complex component 70, a substrate of extracellular signal-regulated kinase 2 and mediator of secretory vesicle exocytosis, potently inhibits basal and docosahexaenoic acid-stimulated neurotensin secretion, whereas overexpression of exocyst complex component 70 enhances basal and docosahexaenoic acid-stimulated neurotensin secretion. Together, our findings demonstrate a role for kinase suppressor of Ras 1 as a positive regulator of neurotensin secretion from human endocrine cells and indicate that this effect is mediated by the extracellular signal- regulated kinase 1 and 2 signaling pathway. Moreover, we reveal a novel role for exocyst complex component 70 in regulation of neurotensin vesicle exocytosis through its interaction with the extracellular signal-regulated kinase 1 and 2 signaling pathway.	[Rock, Stephanie] Univ Kentucky, Dept Toxicol & Canc Biol, Lexington, KY USA; [Rock, Stephanie; Li, Xian; Song, Jun; Weiss, Heidi L.; Rychahou, Piotr; Gao, Tianyan; Li, Jing; Evers, B. Mark] Univ Kentucky, Lucille P Markey Canc Ctr, Lexington, KY 40506 USA; [Song, Jun] Univ Kentucky, Dept Surg, Lexington, KY USA; [Townsend, Courtney M., Jr.; Rychahou, Piotr; Li, Jing; Evers, B. Mark] Univ Texas Med Branch, Dept Surg, Galveston, TX 77555 USA; [Weiss, Heidi L.] Univ Kentucky, Dept Biostat, Lexington, KY USA; [Gao, Tianyan] Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY USA	University of Kentucky; University of Kentucky; University of Kentucky; University of Texas System; University of Texas Medical Branch Galveston; University of Kentucky; University of Kentucky	Evers, BM (corresponding author), Univ Kentucky, Lucille P Markey Canc Ctr, Lexington, KY 40506 USA.; Evers, BM (corresponding author), Univ Texas Med Branch, Dept Surg, Galveston, TX 77555 USA.	mark.evers@uky.edu			National Institutes of Health [R01 DK112034, R01 DK048498]; NCI [P30 CA177558]; NIH [T32 DK007778]; NATIONAL CANCER INSTITUTE [P30CA177558] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK112034, T32DK007778, R01DK048498] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health Grants R01 DK112034 (to B.M.E.), R01 DK048498 (to B.M.E.) and NCI P30 CA177558. S.R. is supported by NIH Training Grant T32 DK007778.	Azrad M, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00224; Barchetta I, 2018, NUTRIENTS, V10, DOI 10.3390/nu10040526; Barchetta I, 2018, J CLIN ENDOCR METAB, V103, P2253, DOI 10.1210/jc.2017-02751; Bartsch H, 1999, CARCINOGENESIS, V20, P2209, DOI 10.1093/carcin/20.12.2209; Bhathena SJ, 2006, NUTR NEUROSCI, V9, P1, DOI 10.1080/10284150600627128; Blucher C, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00293; Boden G, 2008, ENDOCRIN METAB CLIN, V37, P635, DOI 10.1016/j.ecl.2008.06.007; Boden G, 2011, CURR OPIN ENDOCRINOL, V18, P139, DOI 10.1097/MED.0b013e3283444b09; Burack WR, 2000, CURR OPIN CELL BIOL, V12, P211, DOI 10.1016/S0955-0674(99)00078-2; Carraway RE, 2006, PEPTIDES, V27, P2445, DOI 10.1016/j.peptides.2006.04.030; Doihara H, 2009, MOL CELL BIOCHEM, V331, P239, DOI 10.1007/s11010-009-0165-7; Drewe J, 2008, J CLIN ENDOCR METAB, V93, P1964, DOI 10.1210/jc.2007-2238; EVERS BM, 1995, J CLIN INVEST, V95, P2822, DOI 10.1172/JCI117987; EVERS BM, 1991, GASTROENTEROLOGY, V101, P303, DOI 10.1016/0016-5085(91)90004-5; EVERS BM, 1994, AM J PHYSIOL-GASTR L, V267, pG875, DOI 10.1152/ajpgi.1994.267.5.G875; EVERS BM, 1992, ANN SURG, V216, P423, DOI 10.1097/00000658-199210000-00005; Frodyma Danielle, 2017, F1000Res, V6, P1621, DOI 10.12688/f1000research.11895.1; Goettel JA, 2011, GASTROENTEROLOGY, V140, P265, DOI 10.1053/j.gastro.2010.09.041; Good MC, 2011, SCIENCE, V332, P680, DOI 10.1126/science.1198701; Harnack K, 2009, NUTR METAB, V6, DOI 10.1186/1743-7075-6-8; Henderson BE, 2000, CARCINOGENESIS, V21, P427, DOI 10.1093/carcin/21.3.427; Inoue M, 2003, NATURE, V422, P629, DOI 10.1038/nature01533; Jaiswal BS, 2018, CLIN CANCER RES, V24, P4044, DOI 10.1158/1078-0432.CCR-17-3674; Jing Li JS, 2018, ENDOCRINOLOGY; Joneson T, 1998, J BIOL CHEM, V273, P7743, DOI 10.1074/jbc.273.13.7743; Kirsammer G, 2014, SEMIN CANCER BIOL, V29, P40, DOI 10.1016/j.semcancer.2014.07.007; Klutho PJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029304; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Kortum RL, 2004, MOL CELL BIOL, V24, P4407, DOI 10.1128/MCB.24.10.4407-4416.2004; Lavoie H, 2018, NATURE, V554, P549, DOI 10.1038/nature25478; Li J, 2002, AM J PHYSIOL-GASTR L, V283, pG1197, DOI 10.1152/ajpgi.00177.2002; Li J, 2008, J BIOL CHEM, V283, P2614, DOI 10.1074/jbc.M707513200; Li J, 2007, MOL ENDOCRINOL, V21, P159, DOI 10.1210/me.2006-0340; Li J, 2016, NATURE, V533, P411, DOI 10.1038/nature17662; Li J, 2011, AM J PHYSIOL-CELL PH, V301, pC213, DOI 10.1152/ajpcell.00067.2011; Lopez JP, 2010, AM J PHYSIOL-ENDOC M, V299, pE772, DOI 10.1152/ajpendo.00199.2010; Lozano J, 2003, CANCER RES, V63, P4232; Lu HZ, 2013, DEV CELL, V27, P560, DOI 10.1016/j.devcel.2013.10.020; Ma YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053916; Mazella Jean, 2012, Front Endocrinol (Lausanne), V3, P143, DOI 10.3389/fendo.2012.00143; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; McKay MM, 2009, P NATL ACAD SCI USA, V106, P11022, DOI 10.1073/pnas.0901590106; Melander O, 2012, JAMA-J AM MED ASSOC, V308, P1469, DOI 10.1001/jama.2012.12998; Meloche S, 2007, ONCOGENE, V26, P3227, DOI 10.1038/sj.onc.1210414; Michael DJ, 2006, TRENDS ENDOCRIN MET, V17, P408, DOI 10.1016/j.tem.2006.10.011; Mustain WC, 2011, CURR OPIN ENDOCRINOL, V18, P75, DOI 10.1097/MED.0b013e3283419052; Neilsen BK, 2017, EXPERT OPIN THER TAR, V21, P499, DOI 10.1080/14728222.2017.1311325; Nguyen A, 2002, MOL CELL BIOL, V22, P3035, DOI 10.1128/MCB.22.9.3035-3045.2002; PAREKH D, 1994, PANCREAS, V9, P83, DOI 10.1097/00006676-199401000-00013; Park JJ, 2008, MOL ENDOCRINOL, V22, P2583, DOI 10.1210/me.2008-0209; Qiu S, 2017, GASTROENT RES PRACT, V2017, DOI 10.1155/2017/6456257; Razidlo GL, 2004, J BIOL CHEM, V279, P47808, DOI 10.1074/jbc.M406395200; Ren JQ, 2012, DEV CELL, V22, P967, DOI 10.1016/j.devcel.2012.03.005; Roy F, 2002, GENE DEV, V16, P427, DOI 10.1101/gad.962902; Shaw AS, 2009, NAT REV IMMUNOL, V9, P47, DOI 10.1038/nri2473; Steele CB, 2017, MMWR-MORBID MORTAL W, V66, P1052, DOI 10.15585/mmwr.mm6639e1; Thiebaut ACM, 2009, JNCI-J NATL CANCER I, V101, P1001, DOI 10.1093/jnci/djp168; Thompson N, 2005, CURR OPIN PHARMACOL, V5, P350, DOI 10.1016/j.coph.2005.04.007; Vincent JP, 1999, TRENDS PHARMACOL SCI, V20, P302, DOI 10.1016/S0165-6147(99)01357-7; Wang S, 2006, BIOCHEM SOC T, V34, P687, DOI 10.1042/BST0340687; Wortzel Inbal, 2011, Genes Cancer, V2, P195, DOI 10.1177/1947601911407328; Wu B, 2015, J CELL SCI, V128, P2957, DOI 10.1242/jcs.156398; Wu Zherui, 2012, Front Endocrinol (Lausanne), V3, P184, DOI 10.3389/fendo.2012.00184; Xiao L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05308-x; Yan F, 2004, J CLIN INVEST, V114, P1272, DOI 10.1172/JCI200421022; Yan F, 2001, CANCER RES, V61, P8668; Yehuda-Shnaidman E, 2012, OBES REV, V13, P1083, DOI 10.1111/j.1467-789X.2012.01024.x; Yoshinaga K, 1992, Surg Oncol, V1, P127, DOI 10.1016/0960-7404(92)90025-G; Zhao DZ, 2001, J BIOL CHEM, V276, P44464, DOI 10.1074/jbc.M104942200	69	5	5	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2019	14	3							e0211134	10.1371/journal.pone.0211134	http://dx.doi.org/10.1371/journal.pone.0211134			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ5PT	30917119	gold, Green Published, Green Submitted			2022-12-26	WOS:000462465800007
J	Athey, KJ; Ruberson, JR; Olson, DM; Harwood, JD				Athey, Kacie J.; Ruberson, John R.; Olson, Dawn M.; Harwood, James D.			Predation on stink bugs (Hemiptera: Pentatomidae) in cotton and soybean agroecosystems	PLOS ONE			English	Article							DETECTABILITY HALF-LIFE; NEZARA-VIRIDULA; NATURAL ENEMIES; BIOLOGICAL-CONTROL; EGGS; HETEROPTERA; PREY; BIODIVERSITY; LANDSCAPE; GREEN	Stink bugs (Hemiptera: Pentatomidae) are significant pests of cotton and soybeans in the southeastern United States with annual control costs exceeding $14 million in these crops. Three of the most prominent stink bug pests are the southern green (Nezara viridula), brown (Euschistus servus) and green (Chinavia hilaris) stink bugs. To determine trophic linkages between generalist arthropod predators and these pests, species-specific 16S molecular markers were designed and used to detect the presence of prey DNA in predator gut-contents. Over 2700 predators were collected over two growing seasons in cotton and soybean in southern Georgia in 2011 and 2012 and screened for stink bug DNA. Trophic linkages were analyzed relative to prey availability, crop type and field location. The frequency of stink bug DNA in predator guts was negligible on E. servus (0.23%) and C. hilaris (0.09%). Overall gut content detection of N. viridula was 3.3% and Geocoris sp. (Hemiptera: Geocoridae), Orius sp. (Hemiptera: Anthocoridae) and Notoxus monodon (Coleoptera: Anthicidae) were the primary predators. This contrasts with previous studies that reported a much more diverse suite of predators consuming stink bugs with much higher frequency of gut-content positives. The discrepancy between studies highlights the need for replicating studies in space and time, especially if the goal is to implement effective and durable conservation biological control in integrated pest management.	[Athey, Kacie J.] Univ Kentucky, Dept Entomol, Lexington, KY 40508 USA; [Ruberson, John R.] Univ Nebraska, Dept Entomol, Lincoln, NE 68583 USA; [Olson, Dawn M.] USDA ARS, Crop Protect & Management Res Unit, Tifton, GA 31793 USA; [Harwood, James D.] Qingdao Agr Univ, Coll Plant Hlth & Med, Qingdao, Shandong, Peoples R China; [Athey, Kacie J.] Washington State Univ, Ctr Tree Fruit Res & Extens, Wenatchee, WA 98801 USA	University of Kentucky; University of Nebraska System; University of Nebraska Lincoln; United States Department of Agriculture (USDA); Qingdao Agricultural University; Washington State University	Athey, KJ (corresponding author), Univ Kentucky, Dept Entomol, Lexington, KY 40508 USA.; Athey, KJ (corresponding author), Washington State Univ, Ctr Tree Fruit Res & Extens, Wenatchee, WA 98801 USA.	kacie.athey@gmail.com		Harwood, James/0000-0002-0018-7288; Ruberson, John/0000-0002-4475-8177	Cotton Incorporated State Support Program Project [07-942GA11]	Cotton Incorporated State Support Program Project	This work was supported by the Cotton Incorporated State Support Program Project 07-942GA11 Awarded to J. R. Ruberson and J. D. Harwood. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen CT, 2008, AREAWIDE PEST MANAGEMENT: THEORY AND IMPLEMENTATION, P467, DOI 10.1079/9781845933722.0467; Batary P, 2011, P ROY SOC B-BIOL SCI, V278, P1894, DOI 10.1098/rspb.2010.1923; Biles S., 2018, STINK BUGS COTTON SO; Bundy CS, 2000, J ECON ENTOMOL, V93, P697, DOI 10.1603/0022-0493-93.3.697; Chapman EG, 2013, BIOL CONTROL, V65, P72, DOI 10.1016/j.biocontrol.2012.08.005; COHEN AC, 1995, ANNU REV ENTOMOL, V40, P85, DOI 10.1146/annurev.en.40.010195.000505; Cook D., 2017, COTTON INSECT LOSSES; Correa-Ferreira BS, 2002, AGR FOREST ENTOMOL, V4, P145, DOI 10.1046/j.1461-9563.2002.00136.x; Davis DL, 1981, POPULATION DYNAMICS; DELIMA JOG, 1984, J ECON ENTOMOL, V77, P898, DOI 10.1093/jee/77.4.898; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ehler LE, 2002, BIOCONTROL, V47, P309, DOI 10.1023/A:1014895028451; Fenoglio MS, 2007, ENVIRON ENTOMOL, V36, P1159, DOI 10.1603/0046-225X(2007)36[1159:IOWCAD]2.0.CO;2; Furlong MJ, 2015, INSECT SCI, V22, P6, DOI 10.1111/1744-7917.12157; Greene JK, 1999, J ECON ENTOMOL, V92, P941, DOI 10.1093/jee/92.4.941; Greene JK, 2001, J ECON ENTOMOL, V94, P403, DOI 10.1603/0022-0493-94.2.403; Greenstone MH, 2014, J ECON ENTOMOL, V107, P947, DOI 10.1603/EC13356; Greenstone MH, 2014, MOL ECOL, V23, P3799, DOI 10.1111/mec.12552; Greenstone MH, 2010, ENTOMOL EXP APPL, V136, P97, DOI 10.1111/j.1570-7458.2010.01006.x; Grey TL, 2006, AGRON J, V98, P141, DOI 10.2134/agronj2005-0145; Hagler JR, 2015, METHODS ECOL EVOL, V6, P1426, DOI 10.1111/2041-210X.12436; Hagler JR, 2013, ECOL ENTOMOL, V38, P258, DOI 10.1111/een.12014; Harwood JD, 2007, MOL ECOL, V16, P4390, DOI 10.1111/j.1365-294X.2007.03482.x; Harwood JD, 2009, BIOL INVASIONS, V11, P895, DOI 10.1007/s10530-008-9302-6; Hollifield S., 2014, COTTON INSECT THRESH; JONES WA, 1982, ENVIRON ENTOMOL, V11, P867, DOI 10.1093/ee/11.4.867; Juen A, 2007, MOL ECOL, V16, P1545, DOI 10.1111/j.1365-294X.2007.03238.x; King RA, 2008, MOL ECOL, V17, P947, DOI 10.1111/j.1365-294X.2007.03613.x; Kleijn D, 2011, TRENDS ECOL EVOL, V26, P474, DOI 10.1016/j.tree.2011.05.009; Losey JE, 2006, BIOSCIENCE, V56, P311, DOI 10.1641/0006-3568(2006)56[311:TEVOES]2.0.CO;2; Lucas Eric, 2015, Acta Societatis Zoologicae Bohemicae, V79, P83; McPherson J.E., 2000, STINK BUGS EC IMPORT; MCPHERSON RM, 1979, J ECON ENTOMOL, V72, P188, DOI 10.1093/jee/72.2.188; Naranjo SE, 2011, J AGR FOOD CHEM, V59, P5842, DOI 10.1021/jf102939c; Olson DM, 2012, BIOCONTROL SCI TECHN, V22, P1417, DOI 10.1080/09583157.2012.731495; Palumi SR, 1991, SIMPLE FOOLS GUIDE P; Panizzi A. R., 2000, HETEROPTERA EC IMPOR; Panizzi AR, 2012, INSECT BIOECOLOGY AND NUTRITION FOR INTEGRATED PEST MANAGEMENT, P687; Panizzi Antonio R., 2000, Anais da Sociedade Entomologica do Brasil, V29, P1, DOI 10.1590/S0301-80592000000100001; PANIZZI AR, 1985, FLA ENTOMOL, V68, P184, DOI 10.2307/3494344; Penn HJ, 2017, ECOL LETT, V20, P609, DOI 10.1111/ele.12759; Pfannenstiel RS, 2008, ANN ENTOMOL SOC AM, V101, P763, DOI 10.1603/0013-8746(2008)101[763:BADBAN]2.0.CO;2; Power AG, 2010, PHILOS T R SOC B, V365, P2959, DOI 10.1098/rstb.2010.0143; RAGSDALE DW, 1981, ENVIRON ENTOMOL, V10, P402, DOI 10.1093/ee/10.3.402; Reed JT, 2010, J ENTOMOL SCI, V45, P111, DOI 10.18474/0749-8004-45.2.111; Rozen S, 2000, Methods Mol Biol, V132, P365; Ruberson JR, 2012, P 2012 BELTW COTT C, P1153; Schmidt JM, 2014, MOL ECOL, V23, P3777, DOI 10.1111/mec.12734; Snodgrass GL, 2005, J ECON ENTOMOL, V98, P177, DOI 10.1603/0022-0493-98.1.177; STAM PA, 1987, ENVIRON ENTOMOL, V16, P1211, DOI 10.1093/ee/16.6.1211; Tillman G, 2008, J ENTOMOL SCI, V43, P191, DOI 10.18474/0749-8004-43.2.191; Tillman PG, 2011, ENVIRON ENTOMOL, V40, P303, DOI 10.1603/EN10154; Tillman PG, 2015, FLA ENTOMOL, V98, P1114, DOI 10.1653/024.098.0416; TODD JW, 1989, ANNU REV ENTOMOL, V34, P273, DOI 10.1146/annurev.en.34.010189.001421; Tscharntke T, 2005, ECOL LETT, V8, P857, DOI 10.1111/j.1461-0248.2005.00782.x; Tscharntke T, 2012, BIOL REV, V87, P661, DOI 10.1111/j.1469-185X.2011.00216.x; Turnipseed S. G., 1995, 1995 Proceedings Beltwide Cotton Conferences, San Antonio, TX, USA, January 4-7, 1995: Volume 2., P768; TURNIPSEED SG, 1976, ANNU REV ENTOMOL, V21, P247, DOI 10.1146/annurev.en.21.010176.001335; Ubick D, 2005, SPIDERS N AM IDENTIF; VANDENBERG H, 1995, INT J PEST MANAGE, V41, P134, DOI 10.1080/09670879509371938; von Berg K, 2012, PEDOBIOLOGIA, V55, P1, DOI 10.1016/j.pedobi.2011.07.001; Vyavhare SS, 2014, ENVIRON ENTOMOL, V43, P1621, DOI 10.1603/EN14059; Williams MR, COTTON INSECT LOSSES; Willrich M. M., 2003, Journal of Cotton Science, V7, P156; YEARGAN KV, 1979, ENVIRON ENTOMOL, V8, P715, DOI 10.1093/ee/8.4.715; Zeilinger AR, 2016, ECOL APPL, V26, P1047, DOI 10.1890/15-1314; Zeilinger AR, 2015, ANN ENTOMOL SOC AM, V108, P109, DOI 10.1093/aesa/sau011	67	8	8	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2019	14	3							e0214325	10.1371/journal.pone.0214325	http://dx.doi.org/10.1371/journal.pone.0214325			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ3IW	30913247	Green Published, gold			2022-12-26	WOS:000462305600046
J	Maresova, J; Habel, JC; Neve, G; Sielezniew, M; Bartonova, A; Kostro-Ambroziak, A; Fric, ZF				Maresova, Jana; Habel, Jan Christian; Neve, Gabriel; Sielezniew, Marcin; Bartonova, Alena; Kostro-Ambroziak, Agata; Fric, Zdenek Faltynek			Cross-continental phylogeography of two Holarctic Nymphalid butterflies, Boloria eunomia and Boloria selene	PLOS ONE			English	Article							VOLE MICROTUS-OECONOMUS; EVOLUTIONARY HISTORY; PLEISTOCENE GLACIATIONS; LEPIDOPTERA NYMPHALIDAE; GENETIC DIVERSITY; L. RANUNCULACEAE; NORTHERN REFUGIA; MITOCHONDRIAL; COLONIZATION; DISPERSAL	Pleistocene glaciations had significant effects on the distribution and evolution of species inhabiting the Holarctic region. Phylogeographic studies concerning the entire region are still rare. Here, we compared global phylogeographic patterns of one boreo-montane and one boreo-temperate butterflies with largely overlapping distribution ranges across the Northern Hemisphere, but with different levels of range fragmentation and food specialization. We reconstructed the global phylogeographic history of the boreo-montane specialist Boloria eunomia (n = 223) and of the boreo-temperate generalist Boloria selene (n = 106) based on mitochondrial and nuclear DNA markers, and with species distribution modelling (SDM). According to the genetic structures obtained, both species show a Siberian origin and considerable split among populations from Nearctic and Palaearctic regions. According to SDMs and molecular data, both butterflies could inhabit vast areas during the moderate glacials. In the case of B. selene, high haplotype diversity and low geographic structure suggest long-lasting interconnected gene flow among populations. A stronger geographic structuring between populations was identified in the specialist B. eunomia, presumably due to the less widespread, heterogeneously distributed food resources, associated with cooler and more humid climatic conditions. Populations of both species show opposite patterns across major parts of North America and in the case of B. eunomia also across Asia. Our data underline the relevance to cover entire distribution ranges to reconstruct the correct phylogeographic history of species.	[Maresova, Jana; Bartonova, Alena; Fric, Zdenek Faltynek] Czech Acad Sci, Inst Entomol, Ctr Biol, Ceske Budejovice, Czech Republic; [Maresova, Jana; Bartonova, Alena] Univ South Bohemia, Fac Sci, Ceske Budejovice, Czech Republic; [Habel, Jan Christian] Tech Univ Munich, Sch Life Sci Weihenstephan, Dept Ecol & Ecosyst Management, Terr Ecol Res Grp, Freising Weihenstephan, Germany; [Neve, Gabriel] Avignon Univ, Aix Marseille Univ, CNRS, IMBE,IRD, Marseille, France; [Sielezniew, Marcin; Kostro-Ambroziak, Agata] Univ Bialystok, Inst Biol, Lab Insect Evolutionary Biol & Ecol, Bialystok, Poland	Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; Technical University of Munich; Avignon Universite; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; University of Bialystok	Maresova, J (corresponding author), Czech Acad Sci, Inst Entomol, Ctr Biol, Ceske Budejovice, Czech Republic.; Maresova, J (corresponding author), Univ South Bohemia, Fac Sci, Ceske Budejovice, Czech Republic.	maresovajana2@gmail.com	Kostro-Ambroziak, Agata/AAE-9227-2020; Bartonova, Alena Suchackova/ABH-7498-2020; FALTYNEK, FRIC ZDENEK/H-1468-2014; Habel, Jan Christian/H-2112-2019	Kostro-Ambroziak, Agata/0000-0001-8172-2985; Bartonova, Alena Suchackova/0000-0001-6298-2466; FALTYNEK, FRIC ZDENEK/0000-0002-3611-8022; Maresova, Jana/0000-0001-5068-9975; Habel, Jan Christian/0000-0003-1378-9381; Neve, Gabriel/0000-0002-0304-8937	University of South Bohemia [168/2013/P, 152/2016/P, 038/2019/P]; Fulbright Association (ZFF)	University of South Bohemia; Fulbright Association (ZFF)	The study was granted by the University of South Bohemia (168/2013/P) (ZFF) and (152/2016/P, 038/2019/P) (JM) and the Fulbright Association (ZFF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott RJ, 2003, MOL ECOL, V12, P299, DOI 10.1046/j.1365-294X.2003.01731.x; Alsos IG, 2005, MOL ECOL, V14, P2739, DOI 10.1111/j.1365-294X.2005.02621.x; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Bartonova A, 2018, BIOL J LINN SOC, V125, P867, DOI 10.1093/biolinnean/bly136; Beatty GE, 2010, MOL ECOL, V19, P5009, DOI 10.1111/j.1365-294X.2010.04859.x; BENES J., 2002, BUTTERFLIES CZECH RE; Binney HA, 2009, QUATERNARY SCI REV, V28, P2445, DOI 10.1016/j.quascirev.2009.04.016; Brunhoff C, 2006, J BIOGEOGR, V33, P2136, DOI 10.1111/j.1365-2699.2006.01573.x; Chernov T.I., 2006, ENTOMOL REV, V86, P760, DOI DOI 10.1134/S0013873806070037; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; de Lattin G., 1967, GRUNDRISS ZOOGEOGRAP; Dellicour S, 2014, MOL ECOL RESOUR, V14, P647, DOI 10.1111/1755-0998.12200; Despres L, 2002, MOL ECOL, V11, P2337, DOI 10.1046/j.1365-294X.2002.01618.x; Dinca V, 2013, BIOL J LINN SOC, V109, P817, DOI 10.1111/bij.12096; Drees C, 2016, J BIOGEOGR, V43, P2223, DOI 10.1111/jbi.12828; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dyke AS, 2004, DEV QUA SCI, V2, P373, DOI 10.1016/S1571-0866(04)80209-4; Ehlers J, 2011, DEV QUATER SCI, V15, P1; Ehlers J, 2013, ENCY QUATERNARY SCI; Ehlers J, 2007, QUATERN INT, V164-65, P6, DOI 10.1016/j.quaint.2006.10.008; Eidesen PB, 2007, MOL ECOL, V16, P3902, DOI 10.1111/j.1365-294X.2007.03425.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Forister ML, 2004, MOL ECOL, V13, P3489, DOI 10.1111/j.1365-294X.2004.02349.x; Fourcade Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097122; Fu YX, 1997, GENETICS, V147, P915; Galbreath KE, 2004, MOL ECOL, V13, P135, DOI 10.1046/j.1365-294X.2004.02026.x; Godbout J, 2005, MOL ECOL, V14, P3497, DOI 10.1111/j.1365-294X.2005.02674.x; Goetcheus VG, 2001, QUATERNARY SCI REV, V20, P135, DOI 10.1016/S0277-3791(00)00127-X; Gratton P, 2008, MOL ECOL, V17, P4248, DOI 10.1111/j.1365-294X.2008.03901.x; Habel JC, 2012, BIOL CONSERV, V147, P270, DOI 10.1016/j.biocon.2011.11.028; Habel JC, 2010, BIOL J LINN SOC, V101, P155, DOI 10.1111/j.1095-8312.2010.01471.x; Hegna RH, 2015, J BIOGEOGR, V42, P1469, DOI 10.1111/jbi.12513; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Hewitt Godfrey M, 2004, Front Zool, V1, P4; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hope AG, 2013, J BIOGEOGR, V40, P415, DOI 10.1111/jbi.12056; Horreo JL, 2018, J BIOGEOGR, V45, P1616, DOI 10.1111/jbi.13349; Jackson ST, 2000, QUATERNARY SCI REV, V19, P489, DOI 10.1016/S0277-3791(99)00093-1; Jaksic Predrag, 2007, Nota Lepidopterologica, V30, P65; Jaramillo-Correa JP, 2004, MOL ECOL, V13, P2735, DOI 10.1111/j.1365-294X.2004.02258.x; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kleckova I, 2015, MOL PHYLOGENET EVOL, V92, P255, DOI 10.1016/j.ympev.2015.06.012; Klimczuk Przemyslaw, 2017, Polish Journal of Entomology, V86, P251, DOI 10.1515/pjen-2017-0015; Kodandaramaiah U, 2007, J EVOLUTION BIOL, V20, P2181, DOI 10.1111/j.1420-9101.2007.01425.x; Kodandaramaiah U, 2011, J EVOLUTION BIOL, V24, P2173, DOI 10.1111/j.1420-9101.2011.02352.x; Kodandaramaiah U, 2018, SYST ENTOMOL, V43, P798, DOI 10.1111/syen.12303; Kodandaramaiah U, 2012, J INSECT CONSERV, V16, P305, DOI 10.1007/s10841-012-9465-4; Kodandaramaiah U, 2009, SYST ENTOMOL, V34, P315, DOI 10.1111/j.1365-3113.2008.00453.x; Kohli BA, 2015, J BIOGEOGR, V42, P377, DOI 10.1111/jbi.12433; Konvicka M, 2012, POPUL ECOL, V54, P91, DOI 10.1007/s10144-011-0277-2; Kramp K, 2009, PLANT BIOLOGY, V11, P392, DOI 10.1111/j.1438-8677.2008.00130.x; Kramp K, 2016, BIOL J LINN SOC, V119, P1068, DOI 10.1111/bij.12840; KRZYWICKI M, 1967, Annales Zoologici (Warsaw), V25, P1; Kudrna O., 2015, DISTRIBUTION ATLAS E; Lafontaine J.D., 1988, MEMOIRS ENTOMOLOGICA, V144, P109, DOI DOI 10.4039/ENTM120144109-1; Lait LA, 2018, PEERJ, V6, DOI 10.7717/peerj.4479; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Latutrie M, 2016, BMC EVOL BIOL, V16, DOI 10.1186/s12862-016-0810-1; LAYBERRY R., 1998, BUTTERFLIES CANADA; Lee-Yaw JA, 2008, MOL ECOL, V17, P867, DOI 10.1111/j.1365-294X.2007.03611.x; Leigh JW, 2015, METHODS ECOL EVOL, V6, P1110, DOI 10.1111/2041-210X.12410; Li P, 2013, AM J BOT, V100, P801, DOI 10.3732/ajb.1200250; Magdefrau K., 1953, PALAOBIOLOGIE PFLANZ; Mardulyn P, 2009, EVOLUTION, V63, P2717, DOI 10.1111/j.1558-5646.2009.00755.x; Mennechez G, 2003, LANDSCAPE ECOL, V18, P279, DOI 10.1023/A:1024448829417; MIKKOLA K, 1991, ENTOMOL FENNICA, V2, P157, DOI 10.33338/ef.83545; Miller M.A., 2010, P GAT COMP ENV WORKS; Monteiro A, 2001, MOL PHYLOGENET EVOL, V18, P264, DOI 10.1006/mpev.2000.0872; Mullen SP, 2006, MOL PHYLOGENET EVOL, V39, P747, DOI 10.1016/j.ympev.2006.01.021; Muscarella R, 2014, METHODS ECOL EVOL, V5, P1198, DOI 10.1111/2041-210X.12261; Neve G, 1996, J APPL ECOL, V33, P14, DOI 10.2307/2405011; Neve G, 1994, NOTA LEPID S5, P3; Neve G, 2009, EUR J ENTOMOL, V106, P11, DOI 10.14411/eje.2009.002; Neve G, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-84; Pena C, 2015, BIOL J LINN SOC, V116, P449, DOI 10.1111/bij.12597; Pena C, 2011, ZOOL J LINN SOC-LOND, V161, P64, DOI 10.1111/j.1096-3642.2009.00627.x; Pena C, 2010, ZOOL SCR, V39, P243, DOI 10.1111/j.1463-6409.2010.00421.x; Petersen B., 1956, ZOOLOGISKA BIDRAG FR, V30, P233; Phillips S.J., MAXENT SOFTWARE MODE; QGIS Development Team, QGIS GEOGR INF SYST; Quinzin MC, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2016.2799; Ratkiewicz M, 2006, ANN ZOOL FENN, V43, P285; Ronikier M, 2012, MOL ECOL, V21, P5561, DOI 10.1111/mec.12030; Rowe KC, 2004, P NATL ACAD SCI USA, V101, P10355, DOI 10.1073/pnas.0401338101; Sanmartin I, 2001, BIOL J LINN SOC, V73, P345, DOI 10.1006/bijl.2001.0542; Schmitt T, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-11; Schmitt T, 2012, FRONT ZOOL, V9, DOI 10.1186/1742-9994-9-22; Schmitt T, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-9; Schtickzelle N, 2007, BIOL CONSERV, V136, P651, DOI 10.1016/j.biocon.2007.01.012; Seddon JM, 2001, MOL ECOL, V10, P2187, DOI 10.1046/j.0962-1083.2001.01357.x; Sielezniew M, 2019, J ZOOL, V307, P93, DOI 10.1111/jzo.12625; Sielezniew M, 2011, EUR J ENTOMOL, V108, P537, DOI 10.14411/eje.2011.069; Simonsen TJ, 2010, SYST BIODIVERS, V8, P513, DOI 10.1080/14772000.2010.532833; Svendsen JI, 2004, QUATERNARY SCI REV, V23, P1229, DOI 10.1016/j.quascirev.2003.12.008; TAJIMA F, 1989, GENETICS, V123, P585; Tarasov PE, 2000, J BIOGEOGR, V27, P609, DOI 10.1046/j.1365-2699.2000.00429.x; Todisco V, 2012, J BIOGEOGR, V39, P1058, DOI 10.1111/j.1365-2699.2011.02675.x; Todisco V, 2010, BIOL J LINN SOC, V101, P169, DOI 10.1111/j.1095-8312.2010.01476.x; Tolman T., 2008, COLLINS BUTTERFLY GU; Trettin J, 2016, BMC EVOL BIOL, V16, DOI 10.1186/s12862-016-0711-3; Tshikolovets V. V., 2011, Butterflies of Europe & the Mediterranean area; TSHIKOLOVETS V. V., 2012, BUTTERFLIES CAUCASUS; Tshikolovets VV, 2009, BUTTERFLIES ALTAI SA; Tshikolovets VV, 2009, BUTTERFLIES MONGOLIA; Tshikolovets VV, 2002, BUTTERFLIES TRANSBAI; Tshikolovets VV, 2016, BUTTERFLIES KAZAKHST; Tuzov VK, 2006, NYMPHALIDAE 2; Vandewoestijne S, 2004, MOL PHYLOGENET EVOL, V31, P630, DOI 10.1016/j.ympev.2003.09.007; VARGA Z, 1977, Acta Biologica Debrecina, V14, P223; Varga ZS, 2008, BIOL J LINN SOC, V93, P415, DOI 10.1111/j.1095-8312.2007.00934.x; Vences M, 2013, MOL PHYLOGENET EVOL, V68, P657, DOI 10.1016/j.ympev.2013.04.014; Wahlberg N, 2008, SYST BIOL, V57, P231, DOI 10.1080/10635150802033006; Wahlberg N, 2007, EUR J ENTOMOL, V104, P675, DOI 10.14411/eje.2007.085; Wahlberg N, 2006, SYST BIOL, V55, P703, DOI 10.1080/10635150600913235; Wahlberg N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080875; Yakovlev RV, 2018, UKR J ECOL, V8, P222, DOI 10.15421/2018_206	118	16	16	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2019	14	3							e0214483	10.1371/journal.pone.0214483	http://dx.doi.org/10.1371/journal.pone.0214483			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ3IW	30913279	gold, Green Published, Green Submitted			2022-12-26	WOS:000462305600067
J	Rose, L; McKim, D; Leasa, D; Nonoyama, M; Tandon, A; Bai, YQ; Amin, R; Katz, S; Goldstein, R; Gershon, A				Rose, Louise; McKim, Douglas; Leasa, David; Nonoyama, Mika; Tandon, Anu; Bai, Yu Qing; Amin, Reshma; Katz, Sherri; Goldstein, Roger; Gershon, Andrea			Trends in incidence, prevalence, and mortality of neuromuscular disease in Ontario, Canada: A population-based retrospective cohort study (2003-2014)	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; AMYOTROPHIC-LATERAL-SCLEROSIS; GUILLAIN-BARRE-SYNDROME; PALLIATIVE CARE; UNITED-STATES; EPIDEMIOLOGY; METAANALYSIS; BURDEN	Background Population trends of disease prevalence and incidence over time measure burden of disease and inform healthcare planning. Neuromuscular disorders (NMD) affect muscle and nerve function with varying degrees of severity and disease progression. Objective Using health administrative databases we described trends in incidence, prevalence, and mortality of adults and children with NMD. We also explored place of death and use of palliative care. Methods Population-based (Ontario, Canada) cohort study (2003 to 2014) of adults and children with NMD identified using International Classification of Disease and health insurance billing codes within administrative health databases. Results Adult disease prevalence increased on average per year by 8% (95% confidence interval (CI) 6% to 10%, P <.001), with the largest increase in adults 18-39 years. Childhood disease prevalence increased by 10% (95% CI 8% to 11%, P <.0001) per year, with the largest increase in children 0 to 5 years. Prevalence increased across all diagnoses except amyotrophic lateral sclerosis and spinal muscular atrophy for adults and all diagnoses for children. Adult incidence decreased by 3% (95% CI -4% to -2%, P <.0001) but incidence remained stable in children. Death occurred in 34,336 (18.5%) adults; 21,236 (61.8%) of whom received palliative care. Death occurred in 1,009 (5.6%) children; 507 (50.2%) of whom received palliative care. Mortality decreased over time in adults (odds ratio (OR) 0.86, 95% CI 0.86-0.87, P <.0001) and children (OR 0.79, 95% CI 0.76-0.82, P <.0001). Use of palliative care over time increased for adults (OR 1.18, 95% CI 1.09 to 1.28, P <.0001) and children (OR 1.22, 95% CI 1.20 to 1.23, P <.0001). Conclusions In both adults and children, NMD prevalence is rising and mortality rates are declining. In adults incidence is decreasing while in children it remains stable. This confirms on a population-based level the increased survival of children and adults with NMD.	[Rose, Louise] Sunnybrook Hlth Sci Ctr, Dept Crit Care, Toronto, ON, Canada; [Rose, Louise; Tandon, Anu; Gershon, Andrea] Sunnybrook Res Inst, Toronto, ON, Canada; [Rose, Louise] Kings Coll London, Florence Nightingale Fac Nursing Midwifery & Pall, London, England; [Rose, Louise] Univ Toronto, Lawrence S Bloomberg Fac Nursing, Toronto, ON, Canada; [Rose, Louise; Gershon, Andrea] Inst Clin Evaluat Sci, Toronto, ON, Canada; [McKim, Douglas] Ottawa Hosp Resp Rehabil, Ottawa, ON, Canada; [McKim, Douglas] Ottawa Hosp, Sleep Ctr, Ottawa, ON, Canada; [McKim, Douglas] Ottawa Hosp, Res Inst, Ottawa, ON, Canada; [McKim, Douglas; Katz, Sherri] Univ Ottawa, Fac Med, Ottawa, ON, Canada; [Leasa, David] London Hlth Sci Ctr, Dept Med, Div Crit Care, London, England; [Leasa, David] London Hlth Sci Ctr, Dept Med, Div Respirol, London, England; [Leasa, David] Western Univ, Fac Med, London, ON, Canada; [Nonoyama, Mika] Univ Ontario Inst Technol, Fac Hlth Sci, Oshawa, ON, Canada; [Nonoyama, Mika; Amin, Reshma] Hosp Sick Children, SickKids Res Inst, Toronto, ON, Canada; [Nonoyama, Mika] Univ Toronto, Rehabil Sci Inst, Toronto, ON, Canada; [Tandon, Anu; Gershon, Andrea] Sunnybrook Hlth Sci Ctr, Dept Respirol & Clin Immunol, Toronto, ON, Canada; [Tandon, Anu; Amin, Reshma; Goldstein, Roger; Gershon, Andrea] Univ Toronto, Fac Med, Toronto, ON, Canada; [Bai, Yu Qing] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Katz, Sherri] Childrens Hosp Eastern Ontario, Ottawa, ON, Canada; [Katz, Sherri] Childrens Hosp Eastern Ontario, Res Inst, Ottawa, ON, Canada; [Goldstein, Roger] West Pk Healthcare Ctr, Toronto, ON, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of London; King's College London; University of Toronto; University of Toronto; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Western University (University of Western Ontario); Ontario Tech University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Toronto; University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; Children's Hospital of Eastern Ontario	Rose, L (corresponding author), Sunnybrook Hlth Sci Ctr, Dept Crit Care, Toronto, ON, Canada.; Rose, L (corresponding author), Sunnybrook Res Inst, Toronto, ON, Canada.; Rose, L (corresponding author), Kings Coll London, Florence Nightingale Fac Nursing Midwifery & Pall, London, England.; Rose, L (corresponding author), Univ Toronto, Lawrence S Bloomberg Fac Nursing, Toronto, ON, Canada.; Rose, L (corresponding author), Inst Clin Evaluat Sci, Toronto, ON, Canada.	louise.rose@utotonto.ca	Nonoyama, Mika Laura/M-1011-2019	Nonoyama, Mika Laura/0000-0001-5323-9638; Rose, Louise/0000-0003-1700-3972	Muscular Dystrophy Canada; Canadian Institutes of Health Research (CIHR) New Investigators Award; Physicians Services Incorporated Fellowship; Ontario Ministry of Health and Long-Term Care (MOHLTC); CIHR Foundation Award	Muscular Dystrophy Canada(Muscular Dystrophy Association); Canadian Institutes of Health Research (CIHR) New Investigators Award; Physicians Services Incorporated Fellowship; Ontario Ministry of Health and Long-Term Care (MOHLTC)(Ministry of Health and Long-Term Care, Ontario); CIHR Foundation Award(Canadian Institutes of Health Research (CIHR))	The study was funded by a Respiratory Care grant from Muscular Dystrophy Canada to Louise Rose as the principal investigator. Louise Rose holds a Canadian Institutes of Health Research (CIHR) New Investigators Award. Andrea Gershon holds a CIHR Foundation Award and received funding from a Physicians Services Incorporated Fellowship for Translational Research while working on this study.; Disclaimer: The Institute for Clinical Evaluative Sciences (ICES) is the custodian for the data used in this study. ICES is funded by an annual grant from the Ontario Ministry of Health and Long-Term Care (MOHLTC). The opinions, results and conclusions reported in this paper are those of the authors. No endorsement by ICES or the Ontario MOHLTC is intended or should be inferred. Parts of this material are based on data and information compiled and provided by CIHI. However, the analyses, conclusions, opinions and statements expressed herein are those of the authors, and not necessarily those of CIHI.	Arias R, 2011, MUSCLE NERVE, V44, P93, DOI 10.1002/mus.22005; Bray GM., 2014, MAPPING CONNECTIONS; Breiner A, 2016, NEUROMUSCULAR DISORD, V26, P41, DOI 10.1016/j.nmd.2015.10.009; Connor SR, 2014, GLOBAL ATLAS PALLIAT; Eagle M, 2007, NEUROMUSCULAR DISORD, V17, P470, DOI 10.1016/j.nmd.2007.03.002; Hardiman O, 2017, J NEUROL NEUROSURG P; Herring AA, 2013, CRIT CARE MED, V41, P1197, DOI 10.1097/CCM.0b013e31827c086f; Howard RS, 2016, CURR OPIN NEUROL, V29, P592, DOI 10.1097/WCO.0000000000000363; Hsu Amy T, 2017, Healthc Q, V20, P6; Juurlink D, 2006, CANADIAN I HLTH INFO; Kieny P., 2013, Annals of Physical and Rehabilitation Medicine, V56, P443, DOI 10.1016/j.rehab.2013.06.002; Korngut L, 2013, CAN J NEUROL SCI, V40, P698, DOI 10.1017/S0317167100014943; Kwong JC, 2013, LANCET INFECT DIS, V13, P769, DOI 10.1016/S1473-3099(13)70104-X; Mah JK, 2016, CAN J NEUROL SCI, V43, P163, DOI 10.1017/cjn.2015.311; Mah JK, 2014, NEUROMUSCULAR DISORD, V24, P482, DOI 10.1016/j.nmd.2014.03.008; Mehal JM, 2013, AMYOTROPH LAT SCL FR, V14, P346, DOI 10.3109/21678421.2013.787629; Mehta P, 2016, MMWR SURVEILL SUMM, V65, P1, DOI 10.15585/mmwr.ss6508a1; Parker D, 1999, J PAEDIATR CHILD H, V35, P245, DOI 10.1046/j.1440-1754.1999.00351.x; Ray JG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102275; Ruiz E, 2016, INT J NEUROSCI, V126, P985, DOI 10.3109/00207454.2015.1090437; Ryder S, 2017, ORPHANET J RARE DIS, V12, DOI 10.1186/s13023-017-0631-3; Tanuseputro P, 2017, PALLIATIVE MED, V31, P247, DOI 10.1177/0269216316653524; Theadom A, 2014, NEUROEPIDEMIOLOGY, V43, P259, DOI 10.1159/000369343; Traynor BJ, 2003, J NEUROL NEUROSUR PS, V74, P1258, DOI 10.1136/jnnp.74.9.1258; UCLA: Statistical Consulting Group, 2018, SAS COD FRAGM AN CHA; Widdifield J, 2015, MULT SCLER J, V21, P1045, DOI 10.1177/1352458514556303	26	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2019	14	3							e0210574	10.1371/journal.pone.0210574	http://dx.doi.org/10.1371/journal.pone.0210574			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ3IW	30913206	gold, Green Published, Green Submitted			2022-12-26	WOS:000462305600005
J	Filimao, DBC; Moon, TD; Senise, JF; Diaz, RS; Sidat, M; Castelo, A				Filimao, Dercio B. C.; Moon, Troy D.; Senise, Jorge F.; Diaz, Ricardo S.; Sidat, Mohsin; Castelo, Adauto			Individual factors associated with time to non-adherence to ART pick-up within HIV care and treatment services in three health facilities of Zambezia Province, Mozambique	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY INITIATION; SUB-SAHARAN AFRICA; ADHERENCE; DETERMINANTS; CHILDREN; PREDICTORS; RETENTION	Introduction Mozambique has made significant gains in addressing its HIV epidemic, yet adherence to visit schedules remains a challenge. HIV programmatic gains to date could be impaired if adherence and retention to ART remains low. We investigate individual factors associated with non-adherence to ART pick-up in Mozambique. Methods This was a retrospective cohort of patients initiating ART between January 2013 and June 2014. Non-adherence to ART pick-up was defined as a delay in pick-up. 15 days. Descriptive statistics were used to calculate socio-demographic and clinical characteristics. Adherence to ART pick-up was assessed using Kaplan Meier estimates. Cox proportional hazards model was used to determine factors associated with non-adherence. Results 1,413 participants were included (77% female). Median age was 30.4 years. 19% of patients remained adherent to ART pick-up during the evaluation period, while 81% of patients were non-adherent to ART pick-up. Probability of being non-adherent to ART pick-up by 166 days following initiation was 50%. In univariate analysis, being widowed was associated with higher adherence to ART pick-up than other marital status groups (p = 0.01). After adjusting, being >= 35 years (aHR: 0.843, 95% CI: 0.738-0.964, p = 0.012); receiving efavirenz (aHR: 0.932, 95% CI: 0.875-0.992, p = 0.026); and being urban (aHR: 0.754, 95% CI: 0.661-0.861, p < 0.0001) were associated with improved adherence. Non-participation in a Community ART Support Group (CASG) was associated with a 43% increased hazard of non-adherence to ART pick-up (aHR 1.431, 1.192-1.717, p < 0.0001) Conclusions Interventions should focus on the first 6 months following ARV initiation for improvements. Younger persons and widows are two target groups for better understanding facilitators and barriers to visit schedule adherence. Future strategies should explore the benefits of joining CASGs earlier in ones treatment course. Finally, greater efforts should be made to accelerate the scale-up of viral load capacity and HIV resistance monitoring.	[Filimao, Dercio B. C.] Prov Directorate Hlth, Quelimane, Zambezia Provin, Mozambique; [Filimao, Dercio B. C.; Moon, Troy D.] Vanderbilt Univ, Med Ctr, Vanderbilt Inst Global Hlth, Nashville, TN 37232 USA; [Filimao, Dercio B. C.; Senise, Jorge F.; Castelo, Adauto] Univ Fed Sao Paulo, Dept Med, Sao Paulo, Brazil; [Filimao, Dercio B. C.; Diaz, Ricardo S.] Univ Fed Sao Paulo, Retrovirol Lab, Sao Paulo, Brazil; [Sidat, Mohsin] Univ Eduardo Mondlane, Fac Med, Maputo, Mozambique	Vanderbilt University; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Eduardo Mondlane University	Filimao, DBC (corresponding author), Prov Directorate Hlth, Quelimane, Zambezia Provin, Mozambique.; Filimao, DBC (corresponding author), Vanderbilt Univ, Med Ctr, Vanderbilt Inst Global Hlth, Nashville, TN 37232 USA.; Filimao, DBC (corresponding author), Univ Fed Sao Paulo, Dept Med, Sao Paulo, Brazil.; Filimao, DBC (corresponding author), Univ Fed Sao Paulo, Retrovirol Lab, Sao Paulo, Brazil.	derciobelo18@gmail.com	Sidat, Mohsin/AAS-1894-2021	Moon, Troy/0000-0002-1637-829X; Sidat, Mohsin/0000-0002-8378-2014	Fogarty International Center of the National Institutes for Health [D43 TW009745]; President's Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Centers for Disease Control and Prevention (CDC) [NU2GGH002071]; FOGARTY INTERNATIONAL CENTER [D43TW009745] Funding Source: NIH RePORTER	Fogarty International Center of the National Institutes for Health; President's Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Centers for Disease Control and Prevention (CDC); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This project has been supported by the Fogarty International Center of the National Institutes for Health under Award Number D43 TW009745 to TDM and by the President's Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Centers for Disease Control and Prevention (CDC) under the terms of grant number NU2GGH002071. The findings and conclusions in this report are solely the responsibility of the author (s) and do not necessarily represent the office position of the National Institutes for Health or the U.S. Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alakija Kazeem Salami, 2010, J Int Assoc Physicians AIDS Care (Chic), V9, P191, DOI 10.1177/1545109710368722; Ammon N, 2018, PUBLIC HEALTH, V157, P20, DOI 10.1016/j.puhe.2017.12.010; [Anonymous], MOZ STEPP FAST TRACK; Audet CM, 2017, IMPLEMENT SCI, V12, DOI 10.1186/s13012-017-0582-z; Audet CM, 2012, SAHARA J-J SOC ASP H, V9, P41, DOI 10.1080/17290376.2012.665257; Audet CM, 2010, BMC INT HEALTH HUM R, V10, DOI 10.1186/1472-698X-10-15; Bayham M, 2017, AM J TROP MED HYG, V96, P493, DOI 10.4269/ajtmh.16-0233; Beyene KA, 2009, PHARMACOEPIDEM DR S, V18, P1007, DOI 10.1002/pds.1814; Bezabhe WM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097353; Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; Carlucci JG, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1741-z; Charurat M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010584; Ciampa PJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039391; Cook RE, 2011, JAIDS-J ACQ IMM DEF, V56, pE104, DOI 10.1097/QAI.0b013e318207a535; da Silva M, 2015, AIDS BEHAV, V19, P666, DOI 10.1007/s10461-014-0874-0; Edwards LJ, 2015, INT J HEALTH POLICY, V4, P353, DOI 10.15171/ijhpm.2015.58; Enane LA, 2018, CURR OPIN HIV AIDS, V13, P212, DOI [10.1097/COH.0000000000000459, 10.1097/coh.0000000000000459]; Fonsah JY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170893; Gill CJ, 2005, AIDS, V19, P1243, DOI 10.1097/01.aids.0000180094.04652.3b; Gokarn Anant, 2012, J Assoc Physicians India, V60, P16; Groh K, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-650; Jamieson D, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20917; Jobarteh K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166444; Mannheimer S, 2002, CLIN INFECT DIS, V34, P1115, DOI 10.1086/339074; Mocumbi S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173243; Moon TD, 2011, INT J STD AIDS, V22, P621, DOI 10.1258/ijsa.2011.010442; Moon TD, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1250-5; Moon TD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109653; Moon TD, 2014, B WORLD HEALTH ORGAN, V92, P680, DOI 10.2471/BLT.13.129478; Moon Troy D, 2010, Retrovirology (Auckl), V3, P1; Mukui IN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167465; Nosyk B, 2015, AIDS, V29, P1681, DOI 10.1097/QAD.0000000000000746; Reliquet V, 2001, HIV Med, V2, P92, DOI 10.1046/j.1468-1293.2001.00066.x; Rose Elizabeth S, 2015, BMC Nutr, V1; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Shemwell SA, 2017, INT HEALTH, V9, P234, DOI 10.1093/inthealth/ihx020; Shepherd BE, 2013, AM J EPIDEMIOL, V178, P819, DOI 10.1093/aje/kwt030; Skovdal M, 2011, INT J HEALTH PLAN M, V26, P296, DOI 10.1002/hpm.1082; UNAIDS, 90 90 90 AMB TREATM; Uzochukwu BSC, 2009, HEALTH POLICY PLANN, V24, P189, DOI 10.1093/heapol/czp006; Vermund SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110116; Victor B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108654; Wakibi SN, 2011, AIDS RES THER, V8, DOI 10.1186/1742-6405-8-43	43	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2019	14	3							e0213804	10.1371/journal.pone.0213804	http://dx.doi.org/10.1371/journal.pone.0213804			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ1KV	30908522	Green Published, gold, Green Submitted			2022-12-26	WOS:000462157600020
J	Engelhart, EA; Hoppins, S				Engelhart, Emily A.; Hoppins, Suzanne			A catalytic domain variant of mitofusin requiring a wildtype paralog for function uncouples mitochondrial outer-membrane tethering and fusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Charcot-Marie-Tooth disease (CMT); fusion protein; membrane fusion; GTPase; mitochondria; organelle; structure-function; dynamin related protein (DRP); mitochondrial network; tethering	STRUCTURAL BASIS; ENDOPLASMIC-RETICULUM; PROVIDE INSIGHT; MFN1; OPA1; DYNAMICS; FISSION; DIMERIZATION; MORPHOLOGY; FORM	Mitofusins (Mfns) are dynamin-related GTPases that mediate mitochondrial outer-membrane fusion, a process that is required for mitochondrial and cellular health. In Mfn1 and Mfn2 paralogs, a conserved phenylalanine (Phe-202 (Mfn1) and Phe-223 (Mfn2)) located in the GTPase domain on a conserved strand is part of an aromatic network in the core of this domain. To gain insight into the poorly understood mechanism of Mfn-mediated membrane fusion, here we characterize a Mitofusin mutant variant etiologically linked to Charcot-Marie-Tooth syndrome. From analysis of mitochondrial structure in cells and mitochondrial fusion in vitro, we found that conversion of Phe-202 to leucine in either Mfn1 or Mfn2 diminishes the fusion activity of heterotypic complexes with both Mfn1 and Mfn2 and abolishes fusion activity of homotypic complexes. Using coimmunoprecipitation and native gel analysis, we further dissect the steps of mitochondrial fusion and demonstrate that the mutant variant has normal tethering activity but impaired higher-order nucleotide-dependent assembly. The defective coupling of tethering to membrane fusion observed here suggests that nucleotide-dependent self-assembly of Mitofusin is required after tethering to promote membrane fusion.	[Engelhart, Emily A.; Hoppins, Suzanne] Univ Washington, Sch Med, Dept Biochem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Hoppins, S (corresponding author), Univ Washington, Dept Biochem, 1959 NE Pacific St,Hlth Sci Bldg,J383, Seattle, WA 98195 USA.	shoppins@uw.edu		Hoppins, Suzanne/0000-0002-8070-3560	University of Washington Department of Biochemistry; NIGMS, National Institutes of Health [R01 GM118509, T32GM008268]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM118509, T32GM008268] Funding Source: NIH RePORTER	University of Washington Department of Biochemistry; NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the University of Washington Department of Biochemistry and NIGMS, National Institutes of Health Grants R01 GM118509 (to S. H.) and T32GM008268 (to E. A. E.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Antonny B, 2016, EMBO J, V35, P2270, DOI 10.15252/embj.201694613; Ban T, 2017, NAT CELL BIOL, V19, P856, DOI 10.1038/ncb3560; Bian X, 2011, P NATL ACAD SCI USA, V108, P3976, DOI 10.1073/pnas.1101643108; Brandt T, 2016, ELIFE, V5, DOI 10.7554/eLife.14618; Byrnes LJ, 2011, P NATL ACAD SCI USA, V108, P2216, DOI 10.1073/pnas.1012792108; Cao YL, 2017, NATURE, V542, P372, DOI 10.1038/nature21077; Chan DC, 2012, ANNU REV GENET, V46, P265, DOI 10.1146/annurev-genet-110410-132529; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Cipolat S, 2004, P NATL ACAD SCI USA, V101, P15927, DOI 10.1073/pnas.0407043101; Daumke O, 2017, CURR BIOL, V27, pR353, DOI 10.1016/j.cub.2017.03.024; Detmer SA, 2007, J CELL BIOL, V176, P405, DOI 10.1083/jcb.200611080; DeVay RM, 2009, J CELL BIOL, V186, P793, DOI 10.1083/jcb.200906098; Dorn GW, 2019, ANNU REV PHYSIOL, V81, P1, DOI 10.1146/annurev-physiol-020518-114358; Friedman JR, 2014, NATURE, V505, P335, DOI 10.1038/nature12985; Hoppins S, 2011, MOL CELL, V41, P150, DOI 10.1016/j.molcel.2010.11.030; Hu JJ, 2016, SEMIN CELL DEV BIOL, V60, P105, DOI 10.1016/j.semcdb.2016.06.001; Ishihara N, 2004, J CELL SCI, V117, P6535, DOI 10.1242/jcs.01565; Itoh K, 2013, TRENDS CELL BIOL, V23, P64, DOI 10.1016/j.tcb.2012.10.006; Karbowski M, 2006, NATURE, V443, P658, DOI 10.1038/nature05111; Kijima K, 2005, HUM GENET, V116, P23, DOI 10.1007/s00439-004-1199-2; Koshiba T, 2004, SCIENCE, V305, P858, DOI 10.1126/science.1099793; Labbe K, 2014, ANNU REV CELL DEV BI, V30, P357, DOI 10.1146/annurev-cellbio-101011-155756; Meeusen S, 2004, SCIENCE, V305, P1747, DOI 10.1126/science.1100612; Mishra P, 2014, CELL METAB, V19, P630, DOI 10.1016/j.cmet.2014.03.011; Nasrallah CM, 2014, NAT REV ENDOCRINOL, V10, P650, DOI 10.1038/nrendo.2014.160; Pareyson D, 2015, NEUROSCI LETT, V596, P66, DOI 10.1016/j.neulet.2015.04.001; Pernas L, 2016, ANNU REV PHYSIOL, V78, P505, DOI 10.1146/annurev-physiol-021115-105011; Qi YB, 2016, J CELL BIOL, V215, P621, DOI 10.1083/jcb.201609019; Santel A, 2001, J CELL SCI, V114, P867; Smirnova E, 1998, J CELL BIOL, V143, P351, DOI 10.1083/jcb.143.2.351; Song ZY, 2009, MOL BIOL CELL, V20, P3525, DOI 10.1091/mbc.E09-03-0252; Steffen J, 2017, MOL BIOL CELL, V28, P600, DOI 10.1091/mbc.E16-07-0545; Stuppia G, 2015, J NEUROL SCI, V356, P7, DOI 10.1016/j.jns.2015.05.033; Valente AJ, 2017, ACTA HISTOCHEM, V119, P315, DOI 10.1016/j.acthis.2017.03.001; Yan LM, 2018, NAT STRUCT MOL BIOL, V25, P233, DOI 10.1038/s41594-018-0034-8; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341	37	9	9	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2019	294	20					8001	8014		10.1074/jbc.RA118.006347	http://dx.doi.org/10.1074/jbc.RA118.006347			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC0NH	30936207	Green Published, hybrid			2022-12-26	WOS:000470656500004
J	Mazumder, S; De, R; Debsharma, S; Bindu, S; Maity, P; Sarkar, S; Saha, SJ; Siddiqui, AA; Banerjee, C; Nag, S; Saha, D; Pramanik, S; Mitra, K; Bandyopadhyay, U				Mazumder, Somnath; De, Rudranil; Debsharma, Subhashis; Bindu, Samik; Maity, Pallab; Sarkar, Souvik; Saha, Shubhra Jyoti; Siddiqui, Asim Azhar; Banerjee, Chinmoy; Nag, Shiladitya; Saha, Debanjan; Pramanik, Saikat; Mitra, Kalyan; Bandyopadhyay, Uday			Indomethacin impairs mitochondrial dynamics by activating the PKC-p38-DRP1 pathway and inducing apoptosis in gastric cancer and normal mucosal cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						inflammation; apoptosis; oxidative stress; mitochondrial membrane potential; mitochondrial respiratory chain complex; dynamin-related protein 1 (DRP1); kinase signaling	NONSTEROIDAL ANTIINFLAMMATORY DRUGS; NF-KAPPA-B; OXIDATIVE STRESS; MOLECULAR-MECHANISMS; SIGNALING PATHWAY; FISSION; DEATH; DRP1; NSAIDS; INJURY	The subcellular mechanism by which nonsteroidal anti-inflammatory drugs (NSAIDs) induce apoptosis in gastric cancer and normal mucosal cells is elusive because of the diverse cyclooxygenase-independent effects of these drugs. Using human gastric carcinoma cells (AGSs) and a rat gastric injury model, here we report that the NSAID indomethacin activates the protein kinase C (PKC)-p38 MAPK (p38)-dynamin-related protein 1 (DRP1) pathway and thereby disrupts the physiological balance of mitochondrial dynamics by promoting mitochondrial hyper-fission and dysfunction leading to apoptosis. Notably, DRP1 knockdown or SB203580-induced p38 inhibition reduced indomethacin-induced damage to AGSs. Indomethacin impaired mitochondrial dynamics by promoting fissogenic activation and mitochondrial recruitment of DRP1 and down-regulating fusogenic optic atrophy 1 (OPA1) and mitofusins in rat gastric mucosa. Consistent with OPA1 maintaining cristae architecture, its down-regulation resulted in EM-detectable cristae deformity. Deregulated mitochondrial dynamics resulting in defective mitochondria were evident from enhanced Parkin expression and mitochondrial proteome ubiquitination. Indomethacin ultimately induced mitochondrial metabolic and bioenergetic crises in the rat stomach, indicated by compromised fatty acid oxidation, reduced complex I- associated electron transport chain activity, and ATP depletion. Interestingly, Mdivi-1, a fission-preventing mito-protective drug, reversed indomethacin-induced DRP1 phosphorylation on Ser-616, mitochondrial proteome ubiquitination, and mitochondrial metabolic crisis. Mdivi-1 also prevented indomethacin-induced mitochondrial macromolecular damage, caspase activation, mucosal inflammation, and gastric mucosal injury. Our results identify mitochondrial hyper-fission as a critical and common subcellular event triggered by indomethacin that promotes apoptosis in both gastric cancer and normal mucosal cells, thereby contributing to mucosal injury.	[Mazumder, Somnath; De, Rudranil; Debsharma, Subhashis; Maity, Pallab; Sarkar, Souvik; Saha, Shubhra Jyoti; Siddiqui, Asim Azhar; Banerjee, Chinmoy; Nag, Shiladitya; Saha, Debanjan; Pramanik, Saikat; Bandyopadhyay, Uday] CSIR Indian Inst Chem Biol, Div Infect Dis & Immunol, 4 Raja SC Mullick Rd, Kolkata 700032, W Bengal, India; [Bindu, Samik] Cooch Behar Panchanan Barma Univ, Dept Zool, Cooch Behar 736101, W Bengal, India; [Mitra, Kalyan] CSIR Cent Drug Res Inst, Sophisticated Analyt Instrument Facil, Sect 10,Sitapur Rd, Lucknow 226031, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI)	Bandyopadhyay, U (corresponding author), CSIR Indian Inst Chem Biol, Div Infect Dis & Immunol, 4 Raja SC Mullick Rd, Kolkata 700032, W Bengal, India.	ubandyo_1964@yahoo.com	Maity, Pallab/L-3896-2017	Maity, Pallab/0000-0001-9769-3533; Mazumder, Somnath/0000-0003-3588-4283; De, Rudranil/0000-0001-5846-3479; Bindu, Samik/0000-0003-1416-2003	Council of Scientific and Industrial Research, New Delhi, India [BSC 0206]; DST (J. C. Bose Fellowship) [SB/S2/JCB-54/2014]	Council of Scientific and Industrial Research, New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India); DST (J. C. Bose Fellowship)(Department of Science & Technology (India))	This work was supported by a Council of Scientific and Industrial Research, New Delhi, India, fellowship (to S. M. and R. D.), Research Grants BEnD, BSC 0206, and DST (J. C. Bose Fellowship) Grant SB/S2/JCB-54/2014. The authors declare that they have no conflicts of interest with the contents of this article.	Akita M, 2014, INT J ONCOL, V45, P1901, DOI 10.3892/ijo.2014.2608; Alavi MV, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-32; Anderson EJ, 2012, CLIN EXP PHARMACOL P, V39, P179, DOI 10.1111/j.1440-1681.2011.05641.x; Archer SL, 2013, NEW ENGL J MED, V369, P2236, DOI 10.1056/NEJMra1215233; Ashrafi G, 2013, CELL DEATH DIFFER, V20, P31, DOI 10.1038/cdd.2012.81; Atchison JW, 2013, J MANAGE CARE PHARM, V19, pS3; Barbato F, 1997, J PHARM SCI, V86, P225, DOI 10.1021/js960233h; Bhala N, 2013, LANCET, V382, P769, DOI 10.1016/S0140-6736(13)60900-9; Biswas D, 2016, FASEB J, V30, P3822, DOI 10.1096/fj.201600571RR; Blair IA, 2008, J BIOL CHEM, V283, P15545, DOI 10.1074/jbc.R700051200; Bordt EA, 2017, DEV CELL, V40, P583, DOI 10.1016/j.devcel.2017.02.020; Boring MA, 2017, MMWR-MORBID MORTAL W, V66, pS27; Brook Robert D., 2000, J Clin Hypertens (Greenwich), V2, P319; Brooks C, 2009, J CLIN INVEST, V119, P1275, DOI 10.1172/JCI37829; Burian M, 2005, PHARMACOL THERAPEUT, V107, P139, DOI 10.1016/j.pharmthera.2005.02.004; Burke SJ, 2014, AM J PHYSIOL-ENDOC M, V306, pE131, DOI 10.1152/ajpendo.00347.2013; Campello S, 2010, EMBO REP, V11, P678, DOI 10.1038/embor.2010.115; Carrasco-Pozo C, 2011, J AGR FOOD CHEM, V59, P11501, DOI 10.1021/jf202621d; Chowdhury SR, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.77; Chuang YC, 2016, J BIOMED SCI, V23, DOI 10.1186/s12929-016-0262-3; Cosentino-Gomes D, 2012, INT J MOL SCI, V13, P10697, DOI 10.3390/ijms130910697; Crofford LJ, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4174; Cryer B, 2001, CURR OPIN GASTROEN, V17, P503, DOI 10.1097/00001574-200111000-00005; da Costa BR, 2017, LANCET, V390, pE21, DOI 10.1016/S0140-6736(17)31744-0; de Groot DJA, 2007, CRIT REV ONCOL HEMAT, V61, P52, DOI 10.1016/j.critrevonc.2006.07.001; Dey S, 2009, FREE RADICAL BIO MED, V46, P271, DOI 10.1016/j.freeradbiomed.2008.10.032; Dey S, 2014, INFECT IMMUN, V82, P3113, DOI 10.1128/IAI.01598-14; Dey S, 2012, J BIOL CHEM, V287, P26630, DOI 10.1074/jbc.M112.341255; Dong YH, 2018, BRIT J CLIN PHARMACO, V84, P1045, DOI 10.1111/bcp.13537; Fernandez-Checa JC, 2010, SIGNALING PATHWAYS IN LIVER DISEASES, SECOND EDITION, P439, DOI 10.1007/978-3-642-00150-5_29; Ferreira-da-Silva A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122308; Fischer TD, 2016, FRONT SYST NEUROSCI, V10, DOI [10.3389/fnsys.2016.00029, 10.3389/fnsys.2010.00020]; FROMM D, 1987, CLIN INVEST MED, V10, P251; Gargaun Serghei, 2014, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, V13, P121, DOI 10.2174/1871523012666131229132519; Gharanei M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077713; Guo CY, 2013, NEURAL REGEN RES, V8, P2003, DOI 10.3969/j.issn.1673-5374.2013.21.009; Gurpinar E, 2014, CLIN CANCER RES, V20, P1104, DOI 10.1158/1078-0432.CCR-13-1573; Gurpinar E, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00181; Handa O, 2014, J CLIN BIOCHEM NUTR, V54, P2, DOI 10.3164/jcbn.13-84; Horl WH, 2010, PHARMACEUTICALS, V3, P2291, DOI 10.3390/ph3072291; Huang QC, 2016, AUTOPHAGY, V12, P999, DOI 10.1080/15548627.2016.1166318; Huang SB, 2015, DIABETES, V64, P1728, DOI 10.2337/db14-0758; Hung CHL, 2018, REDOX BIOL, V14, P7, DOI 10.1016/j.redox.2017.08.010; Hunter TS, 2015, AM J MANAG CARE, V21, pS139; Isaya G, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00029; IVEY K J, 1988, American Journal of Medicine, V84, P41, DOI 10.1016/0002-9343(88)90253-7; Jezek J, 2018, ANTIOXIDANTS-BASEL, V7, DOI 10.3390/antiox7010013; Kagan VE, 2005, NAT CHEM BIOL, V1, P223, DOI 10.1038/nchembio727; Kashatus DF, 2011, NAT CELL BIOL, V13, P1108, DOI 10.1038/ncb2310; Kashatus JA, 2015, MOL CELL, V57, P537, DOI 10.1016/j.molcel.2015.01.002; Ki YW, 2013, TOXICOL LETT, V218, P235, DOI 10.1016/j.toxlet.2013.02.003; Kim TI, 2002, ANN NY ACAD SCI, V973, P241, DOI 10.1111/j.1749-6632.2002.tb04641.x; Ko AR, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00124; Ko SH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12692-x; Kubli DA, 2012, CIRC RES, V111, P1208, DOI 10.1161/CIRCRESAHA.112.265819; Lee S, 2014, TOX RESEARCH, V30, P243, DOI 10.5487/TR.2014.30.4.243; Lethaby A, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000400.pub2; Li XY, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-19; Li YF, 2012, HUM REPROD, V27, P2096, DOI 10.1093/humrep/des110; Liesa M, 2009, PHYSIOL REV, V89, P799, DOI 10.1152/physrev.00030.2008; Lim S, 2016, CELL BIOSCI, V6, DOI 10.1186/s13578-016-0089-3; Liu R, 2015, MOL BIOL CELL, V26, P4466, DOI 10.1091/mbc.E15-08-0591; Loson OC, 2013, MOL BIOL CELL, V24, P659, DOI 10.1091/mbc.E12-10-0721; Luczaj W, 2003, CELL MOL BIOL LETT, V8, P391; LUNDHOLM K, 1994, CANCER RES, V54, P5602; Luo C, 2013, J CELL BIOCHEM, V114, P212, DOI 10.1002/jcb.24356; Manczak M, 2019, HUM MOL GENET, V28, P177, DOI 10.1093/hmg/ddy335; Mansouri A, 2003, J BIOL CHEM, V278, P19245, DOI 10.1074/jbc.M208134200; Mao K, 2013, CELL CYCLE, V12, P3131, DOI 10.4161/cc.26352; Marcum Zachary A, 2010, Ann Longterm Care, V18, P24; Marin-Garcia J, 2016, HEART FAIL REV, V21, P123, DOI 10.1007/s10741-016-9530-2; Matsui H, 2011, J CLIN BIOCHEM NUTR, V48, P107, DOI 10.3164/jcbn.10-79; Mazumder S, 2016, BIOCHEM PHARMACOL, V121, P33, DOI 10.1016/j.bcp.2016.09.027; Mebratu Y, 2009, CELL CYCLE, V8, P1168, DOI 10.4161/cc.8.8.8147; Mercadante S, 2001, CANCER TREAT REV, V27, P51, DOI 10.1053/ctrv.2000.0192; Mishra P, 2014, NAT REV MOL CELL BIO, V15, P634, DOI 10.1038/nrm3877; Mohanty K, 2016, ASIA-PAC J OPHTHALMO, V5, P293, DOI 10.1097/APO.0000000000000203; Monnier Yan, 2005, Current Drug Targets - Inflammation and Allergy, V4, P31, DOI 10.2174/1568010053622975; Moris D, 2016, BREAST CARE, V11, P339, DOI 10.1159/000452315; Munoz E, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.198952; Musumba C, 2009, ALIMENT PHARM THER, V30, P517, DOI 10.1111/j.1365-2036.2009.04086.x; Ong CKS, 2007, CLIN MED RES, V5, P17, DOI 10.3121/cmr.2007.698; Otera H, 2013, BBA-MOL CELL RES, V1833, P1256, DOI 10.1016/j.bbamcr.2013.02.002; Ott M, 2007, APOPTOSIS, V12, P913, DOI 10.1007/s10495-007-0756-2; Pantziarka P, 2016, ECANCERMEDICALSCIENC, V10, DOI 10.3332/ecancer.2016.610; Parameyong A, 2015, MITOCHONDRION, V24, P1, DOI 10.1016/j.mito.2015.07.004; Pletjushkina OY, 2006, BBA-BIOENERGETICS, V1757, P518, DOI 10.1016/j.bbabio.2006.03.018; Pradere JP, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aab2820; Renault TT, 2014, CHEM BIOL, V21, P114, DOI 10.1016/j.chembiol.2013.10.009; Rosdah AA, 2016, PHARMACOL RES PERSPE, V4, DOI 10.1002/prp2.235; Sanchis-Gomar F, 2016, TRENDS MOL MED, V22, P267, DOI 10.1016/j.molmed.2016.02.007; SCHAFER AI, 1995, J CLIN PHARMACOL, V35, P209, DOI 10.1002/j.1552-4604.1995.tb04050.x; Scholz CC, 2013, P NATL ACAD SCI USA, V110, P18490, DOI 10.1073/pnas.1309718110; Shimura T, 2016, CELL CYCLE, V15, P1099, DOI 10.1080/15384101.2016.1156276; Shorrock C J, 1989, Scand J Rheumatol Suppl, V78, P5; Skulachev VP, 2001, TRENDS BIOCHEM SCI, V26, P23, DOI 10.1016/S0968-0004(00)01735-7; Smith G, 2017, DEV NEUROBIOL, V77, P1260, DOI 10.1002/dneu.22519; SMOLINSKE SC, 1990, DRUG SAFETY, V5, P252, DOI 10.2165/00002018-199005040-00003; Soh JW, 2003, PROG EXP TUMOR RES, V37, P261; Solt LA, 2008, IMMUNOL RES, V42, P3, DOI 10.1007/s12026-008-8025-1; Song ZY, 2007, J CELL BIOL, V178, P749, DOI 10.1083/jcb.200704110; Spinazzi M, 2012, NAT PROTOC, V7, P1235, DOI 10.1038/nprot.2012.058; Sui XB, 2014, CANCER LETT, V344, P174, DOI 10.1016/j.canlet.2013.11.019; Taguchi N, 2007, J BIOL CHEM, V282, P11521, DOI 10.1074/jbc.M607279200; Tang WX, 2013, J NEPHROL, V26, P1073, DOI 10.5301/jn.5000268; Tao HL, 2014, NAT MED, V20, P1263, DOI 10.1038/nm.3699; Tarnawski AS, 2003, J MOL MED, V81, P627, DOI 10.1007/s00109-003-0479-y; Thakre-Nighot M, 2016, TISSUE BARRIERS, V4, DOI 10.1080/21688370.2016.1187325; Thun MJ, 2002, JNCI-J NATL CANCER I, V94, P252, DOI 10.1093/jnci/94.4.252; Traverso N, 2004, J GERONTOL A-BIOL, V59, P890, DOI 10.1093/gerona/59.9.B890; Vallecillo-Hernandez J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21455-1; van der Bliek AM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011072; van Laar Mart, 2012, Open Rheumatol J, V6, P320, DOI 10.2174/1874312901206010320; Vincenti MP, 2002, ARTHRITIS RES, V4, P157, DOI 10.1186/ar401; Wakabayashi Keiji, 2000, Asian Pac J Cancer Prev, V1, P97; Waldron RT, 2004, J BIOL CHEM, V279, P27482, DOI 10.1074/jbc.M402875200; Wallace JL, 2008, PHYSIOL REV, V88, P1547, DOI 10.1152/physrev.00004.2008; Wang JN, 2015, BIOCHEM BIOPH RES CO, V456, P7, DOI 10.1016/j.bbrc.2014.11.010; Wang LG, 2017, BIOSCIENCE REP, V37, DOI 10.1042/BSR20170942; Wang ZG, 2012, CELL, V148, P228, DOI 10.1016/j.cell.2011.11.030; Westermann B, 2012, BBA-BIOENERGETICS, V1817, P1833, DOI 10.1016/j.bbabio.2012.02.033; Wieckowski MR, 2009, NAT PROTOC, V4, P1582, DOI 10.1038/nprot.2009.151; Wigdal SS, 2002, J NEUROCHEM, V82, P1029, DOI 10.1046/j.1471-4159.2002.01049.x; Wu SN, 2011, FEBS J, V278, P941, DOI 10.1111/j.1742-4658.2011.08010.x; Xie Q, 2015, NAT NEUROSCI, V18, P501, DOI 10.1038/nn.3960; Xie ST, 2010, J IMMUNOL, V184, P2289, DOI 10.4049/jimmunol.0903133; Xu S, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.7; Xu SC, 2016, J PINEAL RES, V60, P291, DOI 10.1111/jpi.12310; Yu TZ, 2008, CARDIOVASC RES, V79, P341, DOI 10.1093/cvr/cvn104; Yu TZ, 2014, J BIOL CHEM, V289, P34074, DOI 10.1074/jbc.M114.588616; Zhan M, 2013, KIDNEY INT, V83, P568, DOI 10.1038/ki.2012.441; Zhang H, 2013, SCAND J IMMUNOL, V77, P230, DOI 10.1111/sji.12030; Zhang JM, 2007, INT ANESTHESIOL CLIN, V45, P27, DOI 10.1097/AIA.0b013e318034194e; Zhang N, 2013, NEUROSCI LETT, V535, P104, DOI 10.1016/j.neulet.2012.12.049; Zhao XP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01644-0; Zhou X, 2017, ONCOTARGET, V8, P44682, DOI 10.18632/oncotarget.17967	137	34	36	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2019	294	20					8238	8258		10.1074/jbc.RA118.004415	http://dx.doi.org/10.1074/jbc.RA118.004415			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC0NH	30940726	Green Published, hybrid			2022-12-26	WOS:000470656500021
J	McGregor, NE; Murat, M; Elango, J; Poulton, IJ; Walker, EC; Crimeen-Irwin, B; Ho, PWM; Gooi, JH; Martin, TJ; Sims, NA				McGregor, Narelle E.; Murat, Melissa; Elango, Jeevithan; Poulton, Ingrid J.; Walker, Emma C.; Crimeen-Irwin, Blessing; Ho, Patricia W. M.; Gooi, Jonathan H.; Martin, T. John; Sims, Natalie A.			IL-6 exhibits both cis- and trans-signaling in osteocytes and osteoblasts, but only trans-signaling promotes bone formation and osteoclastogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						osteoblast; osteocyte; osteoclast; interleukin 6 (IL-6); STAT3; cell signaling; bone; cytokine; inflammation; bone growth; osteopenia	SOLUBLE INTERLEUKIN-6 RECEPTOR; LEUKEMIA INHIBITORY FACTOR; ONCOSTATIN M; DESIGNER CYTOKINE; IN-VIVO; DIFFERENTIATION; EXPRESSION; ACTIVATOR; CELLS; BLOCKADE	Interleukin 6 (IL-6) supports development of bone-resorbing osteoclasts by acting early in the osteoblast lineage via membrane-bound (cis) or soluble (trans) receptors. Here, we investigated how IL-6 signals and modifies gene expression in differentiated osteoblasts and osteocytes and determined whether these activities can promote bone formation or support osteoclastogenesis. Moreover, we used a genetically altered mouse with circulating levels of the pharmacological IL-6 trans-signaling inhibitor sgp130-Fc to determine whether IL-6 trans-signaling is required for normal bone growth and remodeling. We found that IL-6 increases suppressor of cytokine signaling 3 (Socs3) and CCAAT enhancer-binding protein (Cebpd) mRNA levels and promotes signal transducer and activator of transcription 3 (STAT3) phosphorylation by both cis- and trans-signaling in cultured osteocytes. In contrast, RANKL (Tnfsf11) mRNA levels were elevated only by trans-signaling. Furthermore, we observed soluble IL-6 receptor release and ADAM metallopeptidase domain 17 (ADAM17) sheddase expression by osteocytes. Despite the observation that IL-6 cis-signaling occurs, IL-6 stimulated bone formation in vivo only via trans-signaling. Although IL-6 stimulated RANKL (Tnfsf11) mRNA in osteocytes, these cells did not support osteoclast formation in response to IL-6 alone; binucleated TRAP+ cells formed, and only in response to trans-signaling. Finally, pharmacological, sgp130-Fc-mediated inhibition of IL-6 trans-signaling did not impair bone growth or remodeling unless mice had circulating sgp130-Fc levels > 10 g/ml. At those levels, osteopenia and impaired bone growth occurred, reducing bone strength. We conclude that high sgp130-Fc levels may have detrimental off-target effects on the skeleton.	[McGregor, Narelle E.; Murat, Melissa; Elango, Jeevithan; Poulton, Ingrid J.; Walker, Emma C.; Crimeen-Irwin, Blessing; Ho, Patricia W. M.; Martin, T. John; Sims, Natalie A.] St Vincents Inst Med Res, Bone Cell Biol & Dis Unit, Melbourne, Vic 3065, Australia; [Elango, Jeevithan] Shanghai Ocean Univ, Coll Food Sci & Technol, Dept Marine Biopharmacol, Shanghai 201306, Peoples R China; [Murat, Melissa] La Trobe Univ, Dept Physiol Anat & Microbiol, Bundoora, Vic 3086, Australia; [Gooi, Jonathan H.; Martin, T. John; Sims, Natalie A.] Univ Melbourne, St Vincents Hosp, Dept Med, Melbourne, Vic 3065, Australia; [Gooi, Jonathan H.] St Vincents Inst Med Res, Struct Biol Unit, Melbourne, Vic 3065, Australia	St. Vincent's Institute of Medical Research; Shanghai Ocean University; La Trobe University; St Vincent's Hospital Melbourne; University of Melbourne; St. Vincent's Institute of Medical Research	Sims, NA (corresponding author), St Vincents Inst Med Res, Bone Biol & Dis Unit, 9 Princes St, Fitzroy, Vic 3065, Australia.	nsims@svi.edu.au	Gooi, Jonathan/AAS-7982-2020; Elango, Jeevithan/Y-8106-2019; Sims, Natalie Ann/A-7192-2012	Gooi, Jonathan/0000-0002-8839-1602; Elango, Jeevithan/0000-0003-4115-9918; Sims, Natalie Ann/0000-0003-1421-8468	National Health and Medical Research Council (Australia); Victorian State Government Operational Infrastructure Support scheme	National Health and Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia); Victorian State Government Operational Infrastructure Support scheme	This work was supported by the National Health and Medical Research Council (Australia) through project grant funding (to N. A. S. and T. J. M.). St. Vincent's Institute is supported by the Victorian State Government Operational Infrastructure Support scheme. The authors declare that they have no conflicts of interest with the contents of this article.	Allan EH, 2003, J CELL BIOCHEM, V90, P158, DOI 10.1002/jcb.10614; Atreya R, 2000, NAT MED, V6, P583, DOI 10.1038/75068; Bakker AD, 2014, J DENT RES, V93, P394, DOI 10.1177/0022034514522485; Bellido T, 1996, J CLIN INVEST, V97, P431, DOI 10.1172/JCI118432; Bellido T, 1997, ENDOCRINOLOGY, V138, P3666, DOI 10.1210/en.138.9.3666; Chia LY, 2015, BONE, V72, P34, DOI 10.1016/j.bone.2014.11.005; Cho DC, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00920-x; CORNISH J, 1993, ENDOCRINOLOGY, V132, P1359, DOI 10.1210/en.132.3.1359; Dallas DJ, 1999, BONE, V25, P9, DOI 10.1016/S8756-3282(99)00099-X; Dame JB, 2000, EARLY HUM DEV, V58, P25, DOI 10.1016/S0378-3782(00)00064-5; Dreymueller D, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/9621724; Fischer M, 1997, NAT BIOTECHNOL, V15, P142, DOI 10.1038/nbt0297-142; Gao Y, 1998, BONE, V22, P487, DOI 10.1016/S8756-3282(98)00040-4; Garbers C, 2011, J BIOL CHEM, V286, P42959, DOI 10.1074/jbc.M111.295758; Garbers C, 2011, J BIOL CHEM, V286, P14804, DOI 10.1074/jbc.M111.229393; Girasole G, 1999, CLIN ENDOCRINOL, V51, P801, DOI 10.1046/j.1365-2265.1999.00896.x; Hall KC, 2013, MOL CELL BIOL, V33, P3077, DOI 10.1128/MCB.00291-13; Hikita A, 2006, J BIOL CHEM, V281, P36846, DOI 10.1074/jbc.M606656200; HONDA M, 1992, J IMMUNOL, V148, P2175; Horwood NJ, 1998, ENDOCRINOLOGY, V139, P4743, DOI 10.1210/en.139.11.4743; Jepsen KJ, 2015, J BONE MINER RES, V30, P951, DOI 10.1002/jbmr.2539; JILKA RL, 1992, SCIENCE, V257, P88, DOI 10.1126/science.1621100; Johnson RW, 2015, BONE, V81, P343, DOI 10.1016/j.bone.2015.08.005; Johnson RW, 2014, J BONE MINER RES, V29, P1492, DOI 10.1002/jbmr.2159; Jostock T, 2001, EUR J BIOCHEM, V268, P160, DOI 10.1046/j.1432-1327.2001.01867.x; Kartsogiannis V, 1999, BONE, V25, P525, DOI 10.1016/S8756-3282(99)00214-8; Kartsogiannis V, 2008, J BIOL CHEM, V283, P30850, DOI 10.1074/jbc.M801761200; Kotake S, 1996, J BONE MINER RES, V11, P88; Kyrtsonis MC, 1996, BRIT J HAEMATOL, V93, P398, DOI 10.1046/j.1365-2141.1996.4721018.x; Lazzaro L, 2018, BONE, V112, P120, DOI 10.1016/j.bone.2018.04.015; Li Y, 2008, CYTOKINE, V43, P165, DOI 10.1016/j.cyto.2008.05.007; LITTLEWOOD AJ, 1991, ENDOCRINOLOGY, V129, P1513, DOI 10.1210/endo-129-3-1513; MARTIN TJ, 1987, METHOD ENZYMOL, V145, P324; Matthews V, 2003, J BIOL CHEM, V278, P38829, DOI 10.1074/jbc.M210584200; MITSUYAMA K, 1995, GUT, V36, P45, DOI 10.1136/gut.36.1.45; MULLBERG J, 1993, EUR J IMMUNOL, V23, P473, DOI 10.1002/eji.1830230226; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; Nishimura R, 1998, J BONE MINER RES, V13, P777, DOI 10.1359/jbmr.1998.13.5.777; POLI V, 1994, EMBO J, V13, P1189, DOI 10.1002/j.1460-2075.1994.tb06368.x; Poulton IJ, 2012, J BONE MINER RES, V27, P586, DOI 10.1002/jbmr.1485; Quinn JMW, 2008, J IMMUNOL, V181, P5720, DOI 10.4049/jimmunol.181.8.5720; Rabe B, 2008, BLOOD, V111, P1021, DOI 10.1182/blood-2007-07-102137; Rakemann T, 1999, J BIOL CHEM, V274, P1257, DOI 10.1074/jbc.274.3.1257; Richards CD, 2000, CYTOKINE, V12, P613, DOI 10.1006/cyto.1999.0635; ROODMAN GD, 1992, J CLIN INVEST, V89, P46, DOI 10.1172/JCI115584; Rose-John S, 2017, CLIN PHARMACOL THER, V102, P591, DOI 10.1002/cpt.782; Schaffler MB, 2014, CALCIFIED TISSUE INT, V94, P5, DOI 10.1007/s00223-013-9790-y; Scheller J, 2014, SEMIN IMMUNOL, V26, P2, DOI 10.1016/j.smim.2013.11.002; Schlondorff J, 2001, J BIOL CHEM, V276, P14665, DOI 10.1074/jbc.M010741200; Sims NA, 2005, J BONE MINER RES, V20, P1093, DOI 10.1359/JBMR.050209; Spatz JM, 2015, J BIOL CHEM, V290, P16744, DOI 10.1074/jbc.M114.628313; SUDA T, 1995, BONE, V17, pS87, DOI 10.1016/8756-3282(95)00185-G; TAMURA T, 1993, P NATL ACAD SCI USA, V90, P11924, DOI 10.1073/pnas.90.24.11924; TURNER CH, 1993, BONE, V14, P595, DOI 10.1016/8756-3282(93)90081-K; UDAGAWA N, 1995, J EXP MED, V182, P1461, DOI 10.1084/jem.182.5.1461; Walker EC, 2016, J BIOL CHEM, V291, P21703, DOI 10.1074/jbc.M116.748483; Walker EC, 2010, J CLIN INVEST, V120, P582, DOI 10.1172/JCI40568; Walker EC, 2008, J BONE MINER RES, V23, P2025, DOI 10.1359/JBMR.080706; Wong PKK, 2006, ARTHRITIS RHEUM-US, V54, P158, DOI 10.1002/art.21537; Wu Andy C, 2014, Bonekey Rep, V3, P571, DOI 10.1038/bonekey.2014.66; Xiong JH, 2011, NAT MED, V17, P1235, DOI 10.1038/nm.2448	61	38	40	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2019	294	19					7850	7863		10.1074/jbc.RA119.008074	http://dx.doi.org/10.1074/jbc.RA119.008074			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IB3FL	30923130	Green Published, hybrid			2022-12-26	WOS:000470153300026
J	Yahav, D; Abbas, M; Nassar, L; Ghrayeb, A; Kurnik, D; Shepshelovich, D; Leibovici, L; Paul, M				Yahav, Dafna; Abbas, Maria; Nassar, Laila; Ghrayeb, Alia; Kurnik, Daniel; Shepshelovich, Daniel; Leibovici, Leonard; Paul, Mical			The association of vancomycin trough levels with outcomes among patients with methicillin-resistant Staphylococcus aureus (MRSA) infections: Retrospective cohort study	PLOS ONE			English	Article							EFFICACY	Introduction Current guidelines recommend maintaining vancomycin trough concentrations between 15-20 mg/L for serious methicillin resistant staphylococcus aureus (MRSA) infections. This recommendation is based on limited evidence. Methods A retrospective study including patients with vancomycin susceptible MRSA infections (MIC< = 2 mg/L), treated with vancomycin. We compared outcomes among patients attaining high (> = 15mg/L) vs low (<15mg/L) trough vancomycin levels. We used a propensity score to matching patients achieving low and high levels and conducted an adjusted analysis in the propensity score (PS)-matched cohort using regression analysis. Primary outcome was 30-day all-cause mortality. Results Among 285 patients included, there were no significant differences between patients achieving high and low vancomycin levels in mortality (46/131, 35.1% vs 41/154, 26.6%), clinical success, microbiological success, or nephrotoxicity. Similarly, in the PS-matched cohort (n = 162), there was no significant difference in mortality between patients with high and low vancomycin levels (2 4 / 5 3, 45.3% vs 57/109, 52.3%, respectively), adjusted odds ratio for mortality with high levels 0.63 (95% confidence interval 0.28-1.43). In both cohorts, patients with pneumonia achieving high levels had significantly higher clinical and microbiological success (PS-matched cohort: clinical success: 16/32, 50.0% vs 5/27, 18.5%, p = PLOS 0.012; microbiological success: 19/32, 59.4% vs 7/27, 25.9%, p = 0.010), without significant differences in mortality. Conclusions We found no association between vancomycin levels > =15 mg/L and clinical outcomes in patients with MRSA infections. In patients with MRSA pneumonia, vancomycin levels > = 15 mg/L were associated with higher clinical success rates. Further larger cohort studies are needed to define optimal vancomycin levels according to the site of infection.	[Yahav, Dafna] Beilinson Med Ctr, Rabin Med Ctr, Infect Dis Unit, Petah Tiqwa, Israel; [Yahav, Dafna; Abbas, Maria; Shepshelovich, Daniel; Leibovici, Leonard] Tel Aviv Univ, Sackler Sch Med, Ramat Aviv, Israel; [Nassar, Laila; Ghrayeb, Alia; Kurnik, Daniel; Paul, Mical] Technion Israel Inst Technol, Rappaport Fac Med, Haifa, Israel; [Nassar, Laila; Kurnik, Daniel] Rambam Hlth Care Campus, Clin Pharmacol Unit, Haifa, Israel; [Shepshelovich, Daniel] Beilinson Med Ctr, Rabin Med Ctr, Med A, Petah Tiqwa, Israel; [Leibovici, Leonard] Beilinson Med Ctr, Rabin Med Ctr, Med E, Petah Tiqwa, Israel; [Paul, Mical] Rambam Hlth Care Campus, Inst Infect Dis, Haifa, Israel	Rabin Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Rambam Health Care Campus; Rabin Medical Center; Rabin Medical Center; Rambam Health Care Campus	Yahav, D (corresponding author), Beilinson Med Ctr, Rabin Med Ctr, Infect Dis Unit, Petah Tiqwa, Israel.; Yahav, D (corresponding author), Tel Aviv Univ, Sackler Sch Med, Ramat Aviv, Israel.	dafna.yahav@gmail.com	Yahav, Dafna/AAX-9961-2020; Shepshelovich, Daniel/AAB-1142-2019	Yahav, Dafna/0000-0003-3181-9791; Kurnik, Daniel/0000-0002-8462-7673	State of Israel Ministry of Science, Technology Space [3-12075]	State of Israel Ministry of Science, Technology Space	This study was funded in part by the State of Israel Ministry of Science, Technology & Space, "Optimizing diagnosis, treatment and outcome definitions in elderly patients with bacterial infections", Grant number 3-12075, author who received the grant: MP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Al-Hasan MN, 2013, CLIN MICROBIOL INFEC, V19, P948, DOI 10.1111/1469-0691.12085; Bakke V, 2017, ACTA ANAESTH SCAND, V61, P627, DOI 10.1111/aas.12897; Holmes NE, 2013, ANTIMICROB AGENTS CH, V57, P1654, DOI 10.1128/AAC.01485-12; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Liu C, 2011, CLIN INFECT DIS, V53, P319, DOI [10.1093/cid/cir353, 10.1093/cid/ciq146]; Quan HD, 2011, AM J EPIDEMIOL, V173, P676, DOI 10.1093/aje/kwq433; Stein GE, 2010, CURR MED RES OPIN, V26, P571, DOI 10.1185/03007990903512057; Steinmetz T, 2015, CLIN MICROBIOL INFEC, V21, P665, DOI 10.1016/j.cmi.2015.04.003; Stulik L, 2017, CLIN INFECT DIS, V64, P1081, DOI 10.1093/cid/cix055; Tongsai Sasima, 2016, BMC Res Notes, V9, P455	10	3	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0214309	10.1371/journal.pone.0214309	http://dx.doi.org/10.1371/journal.pone.0214309			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR7EH	30946754	Green Published, gold, Green Submitted			2022-12-26	WOS:000463314500025
J	Kang, SH; Cho, KH; Do, JY				Kang, Seok Hui; Cho, Kyu Hyang; Do, Jun Young			Association between periodontitis and cardiometabolic risk: Results from the Korean National Health and Nutrition Examination Survey 2008-2014	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; METABOLIC SYNDROME; SUBCLINICAL ATHEROSCLEROSIS; STROKE; HYPERTENSION; INFLAMMATION; MANAGEMENT; MORTALITY; PROFILE	Background Periodontitis and cardiovascular disease (CVD) share inflammation as common pathogenesis. Evaluating the association between periodontitis and CVD would be helpful to better understand the pathophysiology and various complications of periodontitis. We aimed to determine whether there is an independent relationship between periodontitis and various CVD risk indicators or prevalence. Patients and methods Our study used representative data from the Korea National Health and Nutrition Examination Survey. Finally, data from 26,097 participants were used for analysis. Periodontitis was defined as a community periodontal index (CPI) >= 3. Participants were classified into 3 groups according to CPI score: Non-PO (participants without periodontitis, CPI score <3), NS-PO (participants with non-severe periodontitis, CPI score = 3), and Severe PO (participants with severe periodontitis, CPI score = 4). Cardiometabolic risk was evaluated based on metabolic syndrome, future CVD risk, and prevalent CVD. Prevalent CVD was defined as participants with cerebrovascular accidents and/or coronary artery disease. Framingham risk score (FRS) was calculated in participants without prevalent CVD. Results The numbers of participants in Non-PO, NS-PO, and Severe PO groups were 17,237, 6,738, and 2,122, respectively. The proportions of participants with high FRS and/or prevalent CVD increased as the severity of periodontitis increased. In participants without prevalent CVD, the FRS according to severity of periodontitis increased in both univariate and multivariate analyses as the severity of periodontitis increased. Logistic regression showed that the odds ratio for metabolic syndrome increased as the severity of periodontitis increased on univariate analysis and that the presence of periodontitis was associated with a higher odds ratio for metabolic syndrome on multivariate analysis. Trends for prevalent CVD were similar to those of metabolic syndrome. For participants without prevalent CVD, the odds ratio for high FRS increased as the severity of periodontitis increased in both uni-variate and multivariate analyses. Subgroup analyses according to sex and age showed similar trends. Conclusion Periodontitis was associated with CVD in the Korean population. Therefore, those with periodontitis, especially young adults with severe periodontitis, may be closely monitored for CVD.	[Kang, Seok Hui; Cho, Kyu Hyang; Do, Jun Young] Yeungnam Univ Hosp, Dept Internal Med, Div Nephrol, Daegu, South Korea	Yeungnam University; Yeungnam University Hospital	Do, JY (corresponding author), Yeungnam Univ Hosp, Dept Internal Med, Div Nephrol, Daegu, South Korea.	jydo@med.yu.ac.kr			2016 Yeungnam University Research Grant	2016 Yeungnam University Research Grant	This work was supported by the 2016 Yeungnam University Research Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn YB, 2016, ATHEROSCLEROSIS, V251, P311, DOI 10.1016/j.atherosclerosis.2016.07.898; Ahn YB, 2015, J CLIN PERIODONTOL, V42, P998, DOI 10.1111/jcpe.12471; American Diabetes Association, 2018, Diabetes Care, V41, pS13, DOI 10.2337/dc18-S002; Grundy Scott M, 2005, Crit Pathw Cardiol, V4, P198; Avina-Zubieta JA, 2008, ARTHRIT RHEUM-ARTHR, V59, P1690, DOI 10.1002/art.24092; Cardoso EM, 2018, POSTGRAD MED, V130, P98, DOI 10.1080/00325481.2018.1396876; Chistiakov DA, 2016, EXP MOL PATHOL, V100, P220, DOI 10.1016/j.yexmp.2016.01.006; Choi HM, 2015, J PERIODONTOL, V86, P866, DOI 10.1902/jop.2015.150025; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Dietrich T, 2013, J CLIN PERIODONTOL, DOI [10.1016/j.amjcard.2016.05.036, DOI 10.1016/J.AMJCARD.2016.05.036]; Golia E, 2014, CURR ATHEROSCLER REP, V16, DOI 10.1007/s11883-014-0435-z; Han DH, 2012, J PERIODONTOL, V83, P612, DOI 10.1902/jop.2011.110304; Han DH, 2012, J CLIN PERIODONTOL, V39, P30, DOI 10.1111/j.1600-051X.2011.01806.x; Han DH, 2010, J CLIN PERIODONTOL, V37, P609, DOI 10.1111/j.1600-051X.2010.01580.x; Hansen GM, 2016, AM J CARDIOL, V118, P489, DOI 10.1016/j.amjcard.2016.05.036; Hay SI, 2017, LANCET, V390, P1260, DOI 10.1016/S0140-6736(17)32130-X; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Inker LA, 2014, AM J KIDNEY DIS, V63, P713, DOI 10.1053/j.ajkd.2014.01.416; Jung YS, 2014, J CLIN PERIODONTOL, V41, P262, DOI 10.1111/jcpe.12204; Katz J, 2002, J PERIODONTOL, V73, P494, DOI 10.1902/jop.2002.73.5.494; Kelly JT, 2013, J AM DENT ASSOC, V144, P371, DOI 10.14219/jada.archive.2013.0130; Kim HD, 2010, J PERIODONTOL, V81, P658, DOI 10.1902/jop.2010.090614; Kim OS, 2018, J PERIODONTAL RES, V53, P362, DOI 10.1111/jre.12521; Kweon S, 2014, INT J EPIDEMIOL, V43, P69, DOI 10.1093/ije/dyt228; Kwon YE, 2011, J CLIN PERIODONTOL, V38, P781, DOI 10.1111/j.1600-051X.2011.01756.x; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Libby P, 2009, J AM COLL CARDIOL, V54, P2129, DOI 10.1016/j.jacc.2009.09.009; MATTILA KJ, 1989, BRIT MED J, V298, P779, DOI 10.1136/bmj.298.6676.779; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Nibali L, 2013, J CLIN ENDOCR METAB, V98, P913, DOI 10.1210/jc.2012-3552; Petersen PE, 2005, J PERIODONTOL, V76, P2187, DOI 10.1902/jop.2005.76.12.2187; Saito T, 2004, J DENT RES, V83, P485, DOI 10.1177/154405910408300610; Schoenfeld SR, 2013, SEMIN ARTHRITIS RHEU, V43, P77, DOI 10.1016/j.semarthrit.2012.12.002; Sim SJ, 2008, J PERIODONTOL, V79, P1652, DOI [10.1902/jop.2008.080015, 10.1902/jop.2008.080015 ]; The Korea Centers for Disease Control and Prevention, 2018, ALC DRINK; Tonetti MS, 2007, NEW ENGL J MED, V356, P911, DOI 10.1056/NEJMoa063186; Tonetti MS, 2013, J CLIN PERIODONTOL, V40, pS24, DOI 10.1111/jcpe.12089; WHO, 2016, GLOB REC PHYS ACT HL; WHO, 2016, TOP 10 CAUS DEATH; Williams B, 2018, EUR HEART J, V39, P3021, DOI 10.1093/eurheartj/ehy339; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837	41	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0214731	10.1371/journal.pone.0214731	http://dx.doi.org/10.1371/journal.pone.0214731			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR5NS	30943271	Green Published, gold, Green Submitted			2022-12-26	WOS:000463194300057
J	Singh, A; Banerjee, T; Kumar, R; Shukla, SK				Singh, Aradhana; Banerjee, Tuhina; Kumar, Raju; Shukla, Sunit Kumar			Prevalence of cases of amebic liver abscess in a tertiary care centre in India: A study on risk factors, associated microflora and strain variation of Entamoeba histolytica	PLOS ONE			English	Article							PCR AMPLIFICATION; BACTERIA; DIVERSITY; IDENTIFICATION; INFECTION; DISEASE; ASSAY	Background Amebiasis, caused by Entamoeba histolytica (E. histolytica), is a significant cause of morbidity and mortality in developing countries. Mortality due to amebiasis is mostly by extra intestinal infections, amebic liver abscess being the most common one. This study was conducted to determine the current epidemiological status, risk factors, associated microflora and strain variation of E. histolytica causing liver abscesses. Methods/Findings A total of 115 liver abscess cases comprising of 107 (93%) males and 8 (6.9%) females were included in the study. Microscopic examination of pus samples from the abscesses and species discrimination using nested multiplex PCR showed the presence of E. histolytica in 101 (87.5%) cases. Data collected by face to face interviews using a pre tested questionnaire suggested intake of untreated drinking water (ORs: 6.4, p = 0.002), habit of alcohol consumption (ORs: 4.0, p = 0.019) and lack of urban services (ORs: 0.08, p = 0.017) to be major risk factors associated with E. histolytica infections. The study of associated bacterial flora through aerobic culture of liver aspirates and conventional PCR for detection of anaerobes revealed the presence of Fusobacterium (19, 25.5%), Peptococcus (19, 25.5%), Prevotella (18, 24.3%), Bacteroides (8, 10.8%), Staphylococcus aureus (3, 4%), Escherichia coli (2, 2.7%), Peptostreptococcus (2, 2.7%), Clostridium (2, 2.7%) and Klebsiella pneumoniae (1, 1.3%). Further to study the clonality, genotyping of E. histolytica targeting six tRNA-linked polymorphic STR loci (A-L, D-A, N-K, R-R, S-TGA -D and S-Q) was carried out which showed the presence of 89 different genotypes in the liver aspirate samples. Conclusion The findings highlight the high prevalence of genetically diverse E. histolytica from the liver abscess cases in this geographical region. Low socio-economic status and habit of alcohol consumption were important predictors of amebic liver abscess.	[Singh, Aradhana; Banerjee, Tuhina] Banaras Hindu Univ, Inst Med Sci, Dept Microbiol, Varanasi, UP, India; [Kumar, Raju; Shukla, Sunit Kumar] Banaras Hindu Univ, Inst Med Sci, Dept Gastroenterol, Varanasi, UP, India	Banaras Hindu University (BHU); Banaras Hindu University (BHU)	Banerjee, T (corresponding author), Banaras Hindu Univ, Inst Med Sci, Dept Microbiol, Varanasi, UP, India.	drtuhina@yahoo.com	Banerjee, Tuhina/AAP-7084-2021	Banerjee, Tuhina/0000-0003-0035-2842				Ali IKM, 2007, J CLIN MICROBIOL, V45, P285, DOI 10.1128/JCM.01335-06; Ali IKM, 2005, J CLIN MICROBIOL, V43, P5842, DOI 10.1128/JCM.43.12.5842-5847.2005; Ayeh-Kumi PF, 2001, EXP PARASITOL, V99, P80, DOI 10.1006/expr.2001.4652; Benetton MLFN, 2005, T ROY SOC TROP MED H, V99, P532, DOI 10.1016/j.trstmh.2004.11.015; Brook I, 1998, J MED MICROBIOL, V47, P1075, DOI 10.1099/00222615-47-12-1075; Bs Sri-Hidajati, 2018, Afr J Infect Dis, V12, P120, DOI 10.2101/Ajid.12v1S.18; Das SK, 2013, AM J TROP MED HYG, V89, P339, DOI 10.4269/ajtmh.12-0570; Farhana F, 2009, TROP BIOMED, V26, P262; Fotedar R, 2007, CLIN MICROBIOL REV, V20, P511, DOI 10.1128/CMR.00004-07; Haghighi A, 2003, J CLIN MICROBIOL, V41, P3748, DOI 10.1128/JCM.41.8.3748-3756.2003; Haque R, 2003, NEW ENGL J MED, V348, P1565, DOI 10.1056/NEJMra022710; Jaiswal Virendra, 2012, BMC Res Notes, V5, P416, DOI 10.1186/1756-0500-5-416; Khairnar K, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-47; Koneman E., 2006, KONEMANS COLOR ATLAS, V6; Lodhi S, 2004, TROP MED INT HEALTH, V9, P718, DOI 10.1111/j.1365-3156.2004.01246.x; Matsuki T, 2002, APPL ENVIRON MICROB, V68, P5445, DOI 10.1128/AEM.68.11.5445-5451.2002; MIRELMAN D, 1987, MICROBIOL REV, V51, P272, DOI 10.1128/MMBR.51.2.272-284.1987; Mirelman D, 1997, J CLIN MICROBIOL, V35, P2405, DOI 10.1128/JCM.35.9.2405-2407.1997; Nagano Y, 2007, BRIT J BIOMED SCI, V64, P74, DOI 10.1080/09674845.2007.11732760; Parija SC, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-41; Pimenta PEP, 2002, J EUKARYOT MICROBIOL, V49, P209, DOI 10.1111/j.1550-7408.2002.tb00525.x; Rani R, 2006, AM J TROP MED HYG, V75, P880, DOI 10.4269/ajtmh.2006.75.880; Rekha R, 2006, ELECT J BIOTECHNOL, V9; Reyna-Fabian ME, 2016, AM J TROP MED HYG, V94, P147, DOI 10.4269/ajtmh.15-0458; Shirley DAT, 2018, OPEN FORUM INFECT DI, V5, DOI 10.1093/ofid/ofy161; Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1; WITTNER M, 1970, AM J TROP MED HYG, V19, P755, DOI 10.4269/ajtmh.1970.19.755	27	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0214880	10.1371/journal.pone.0214880	http://dx.doi.org/10.1371/journal.pone.0214880			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR5NS	30943253	Green Published, gold			2022-12-26	WOS:000463194300068
J	Wang, ZS; Gu, XJ; Thrift, AP				Wang, Zhensheng; Gu, Xiangjun; Thrift, Aaron P.			Factors associated with favorable survival outcomes for Asians with hepatocellular carcinoma: A sequential matching cohort study	PLOS ONE			English	Article							FATTY LIVER-DISEASE; UNITED-STATES; RACIAL/ETHNIC DISPARITIES; SOCIOECONOMIC-STATUS; RACIAL DISPARITIES; MARITAL-STATUS; IMPACT; STAGE; RACE; SORAFENIB	Background Overall 5-year survival rates for patients diagnosed with hepatocellular carcinoma (HCC) are poor, but vary by race/ethnicity. We undertook a comprehensive assessment of underlying contributing factors to the favorable survival outcomes of HCC among Asians compared with non-Hispanic whites (NHW). Methods We identified 1,284 Asian and 7,072 NHW patients newly diagnosed with HCC between 1994 and 2011 in the Surveillance, Epidemiology and End Results (SEER)-Medicare linked database. We used a novel three-step sequential matching approach to identify demographic, presentation and treatment factors that may explain survival differences between Asians and NHWs. Hazard ratios (HRs) and corresponding 95% confidence intervals (Cis) for the association between Asian race and risk of HCC-related mortality were estimated using Cox proportional hazards models. Results The absolute difference in 5-year survival rates between Asians and NHWs was 8.4% (95% CI: 4.6%-12.0%) in the demographics match analysis. The disparity remained unchanged after additionally matching on stage, grade and comorbidities in the presentation match analysis. However, in the treatment match analysis, which accounts for differences in demographic, presentation and treatment factors, the absolute difference in 5-year survival rates was reduced to 5.8% (95% CI: 2.6%-9.3%). Treatment differences explained more of survival disparity in Asian and NHW patients with localized disease than for those with regional or distant stage HCC. Conclusions Asian patients with HCC continue to have more favorable survival outcomes than NHWs with HCC. This persistent disparity seems to be more related to treatment differences than to differences in presentation characteristics including stage.	[Wang, Zhensheng; Gu, Xiangjun; Thrift, Aaron P.] Baylor Coll Med, Dept Med, Sect Epidemiol & Populat Sci, Houston, TX 77030 USA; [Thrift, Aaron P.] Baylor Coll Med, Dan L Duncan Comprehens Canc Ctr, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Thrift, AP (corresponding author), Baylor Coll Med, Dept Med, Sect Epidemiol & Populat Sci, Houston, TX 77030 USA.; Thrift, AP (corresponding author), Baylor Coll Med, Dan L Duncan Comprehens Canc Ctr, Houston, TX 77030 USA.	aaron.thrift@bcm.edu		Wang, Zhensheng/0000-0003-2383-588X; Thrift, Aaron/0000-0002-0084-5308	Research Training Grant from the Cancer Prevention and Research Institute of Texas (CPRIT) [RP160097]	Research Training Grant from the Cancer Prevention and Research Institute of Texas (CPRIT)	ZW was supported by a Research Training Grant from the Cancer Prevention and Research Institute of Texas (CPRIT; RP160097), http://www.cprit.state.tx.us/funding-opportunities/. The funding bodies played no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.	Aizer AA, 2013, J CLIN ONCOL, V31, P3869, DOI 10.1200/JCO.2013.49.6489; Alavi M, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3110-0; American Cancer Society, CANC FACTS FIG 2018; [Anonymous], 2014, J AM STAT ASSOC, V109, P991, DOI [10.1080/01621459.2013.823775, DOI 10.1080/01621459.2013.823775]; Artinyan A, 2010, CANCER-AM CANCER SOC, V116, P1367, DOI 10.1002/cncr.24817; Bureau UC, POV THRESH; Davila JA, 2006, CLIN GASTROENTEROL H, V4, P104, DOI 10.1016/S1542-3565(05)00745-7; Eskander MF, 2016, AM J SURG, V212, P691, DOI 10.1016/j.amjsurg.2016.07.004; Ha J, 2016, J CLIN GASTROENTEROL, V50, P423, DOI 10.1097/MCG.0000000000000448; Hoehn RS, 2015, SURGERY, V158, P1244, DOI 10.1016/j.surg.2015.03.026; Jones PD, 2018, DIGEST DIS SCI, V63, P515, DOI 10.1007/s10620-017-4869-3; Keating GM, 2009, DRUGS, V69, P223, DOI 10.2165/00003495-200969020-00006; Klabunde CN, 2000, J CLIN EPIDEMIOL, V53, P1258, DOI 10.1016/S0895-4356(00)00256-0; Kwak M, 2017, J KOREAN MED SCI, V32, P1974, DOI 10.3346/jkms.2017.32.12.1974; Li J, 2017, ONCOTARGET, V8, P15193, DOI 10.18632/oncotarget.14771; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Mathur AK, 2010, ARCH SURG-CHICAGO, V145, P1158, DOI 10.1001/archsurg.2010.272; Mathur AK, 2010, LIVER TRANSPLANT, V16, P1033, DOI 10.1002/lt.22108; Piscaglia F, 2016, HEPATOLOGY, V63, P827, DOI 10.1002/hep.28368; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Silber JH, 2014, ANN INTERN MED, V161, P845, DOI 10.7326/M14-0900; Silber JH, 2013, JAMA-J AM MED ASSOC, V310, P389, DOI 10.1001/jama.2013.8272; Stewart SL, 2016, WORLD J GASTROENTERO, V22, P8584, DOI 10.3748/wjg.v22.i38.8584; White DL, 2017, GASTROENTEROLOGY, V152, P812, DOI 10.1053/j.gastro.2016.11.020; Wong LL, 2012, AM J SURG, V203, P726, DOI 10.1016/j.amjsurg.2011.06.055; Xu L, 2016, HEPATOBIL SURG NUTR, V5, P43, DOI 10.3978/j.issn.2304-3881.2015.08.05; Yau T, 2014, GASTROENTEROLOGY, V146, P1691, DOI 10.1053/j.gastro.2014.02.032; Younossi ZM, 2015, HEPATOLOGY, V62, P1723, DOI 10.1002/hep.28123	28	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0214721	10.1371/journal.pone.0214721	http://dx.doi.org/10.1371/journal.pone.0214721			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR5NS	30943273	gold, Green Submitted, Green Published			2022-12-26	WOS:000463194300053
J	Elliott, RL; Jiang, XP				Elliott, Robert L.; Jiang, Xian-Peng			The adverse effect of gentamicin on cell metabolism in three cultured mammary cell lines: "Are cell culture data skewed?"	PLOS ONE			English	Article							EPITHELIAL MITOCHONDRIA; CANCER; ANTIBIOTICS	Many cells are cultured in media that contains an antibiotic to prevent bacterial contamination. Mycoplasma and other bacterial contamination is a serious problem for those involved in cell culture. Antibiotics in the media helps prevent this contamination and make life easier for the investigators; as performing cell culture experiments in antibiotic free media is difficult and requires vigorous sterile technique. There are many reports of antibiotics causing mitochondrial damage. In this study, we tested the effect of gentamicin in culture media on human mammary epithelial MCF-12A and breast cancer MCF-7 and MDA-MB-231 cell lines by real time PCR, immunofluorescent microscopy, lactate assay, DNA damage assay. We found that the addition of gentamicin in media upregulated the gene expression of hypoxia inducer factor 1 alpha (HIF1a), glycolytic enzymes and glucose transporters, compared to the cells cultured in gentamicin free media. Gentamicin also increased the lactate production and inhibited mitochondrial membrane potential of the cell lines. Furthermore, the antibiotics in media induced mitochondrial reactive oxygen species causing DNA damage. We found an increase of 8-hydroxy-2'-deoxyguanosine a product of DNA oxidative damage in the media of MCF-12A, MCF-7 and MDA-MB-231 cell lines. These results showed that normal epithelial and breast cancer cells cultured in the media with gentamicin had increased HIF1a, aerobic glycolysis and DNA oxidative damage. If we use these unhealthy cells in the experiment, all data will be different, compared to cells grown in gentamicin free media. We have studied the detrimental effects of three antibiotics on mitochondrial function in the untransformed MCF-12A human mammary cell line and two human mammary cancer cell lines, MCF-7 and MB-MDA-231. The metabolic changes in all cell lines were dramatically different between those in antibiotic free media versus antibiotic containing media. There was a marked difference in gene expression of glycolytic enzymes, reactive oxygen species production and effects on membrane potential. Ironically, our first studies were done in media containing gentamicin, and repeated studies were done in gentamicin free media. The results were very different. The purpose of this report is to emphasize that metabolic cell culture data may be inaccurate because experiments were performed in cell culture media containing antibiotics. We will present evidence to support this theory.	[Elliott, Robert L.; Jiang, Xian-Peng] Sallie A Burdine Breast Fdn, Baton Rouge, LA 70816 USA		Elliott, RL (corresponding author), Sallie A Burdine Breast Fdn, Baton Rouge, LA 70816 USA.	drrobertelliott@cox.net			Sallie A Burdine Breast Foundation; Delta State University Foundation	Sallie A Burdine Breast Foundation; Delta State University Foundation	This work was funded by the Sallie A Burdine Breast Foundation and the Delta State University Foundation. The funders had no role in the study design, data collection and analysis, decision to publish, or any preparation of the manuscript.	Ahler E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064561; Coecke S, 2005, ATLA-ALTERN LAB ANIM, V33, P261, DOI 10.1177/026119290503300313; CURGY JJ, 1985, BIOL CELL, V54, P1; Drexler HG, 2002, CYTOTECHNOLOGY, V39, P75, DOI 10.1023/A:1022913015916; Duewelhenke N, 2007, ANTIMICROB AGENTS CH, V51, P54, DOI 10.1128/AAC.00729-05; Duivenvoorden WCM, 2002, CANCER RES, V62, P1588; Elliott R., 2011, MICROSC MICROANAL, V17, P194; Elliott RL, 2012, BREAST CANCER RES TR, V136, P347, DOI 10.1007/s10549-012-2283-2; Elliott RL, 2017, J CANC TREATMENT RES, V5, P62, DOI DOI 10.11648/j.jctr.20170504.11; Elliott RL, 2018, INT J CLIN MED, V9, P182; Geraghty RJ, 2014, BRIT J CANCER, V111, P1021, DOI 10.1038/bjc.2014.166; Gray MW, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011403; Jiang XP, 2015, BREAST CANCER RES TR, V153, P519, DOI 10.1007/s10549-015-3583-0; Kalghatgi S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006055; KROON AM, 1983, PHARM WEEKBLAD, V5, P81, DOI 10.1007/BF01960982; Lamb R, 2015, ONCOTARGET, V6, P4569, DOI 10.18632/oncotarget.3174; Margulis L, 1970, ORIGIN EUKARYOTIC CE; McKee EE, 2006, ANTIMICROB AGENTS CH, V50, P2042, DOI 10.1128/AAC.01411-05; RIESBECK K, 1990, ANTIMICROB AGENTS CH, V34, P167, DOI 10.1128/AAC.34.1.167; Son K, 2009, ANTICANCER RES, V29, P3995; Tan Q, 2017, MED SCI MONITOR, V23, DOI 10.12659/MSM.903245; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Warburg O., 1930, METABOLISM TUMORS, P254	23	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2019	14	4							e0214586	10.1371/journal.pone.0214586	http://dx.doi.org/10.1371/journal.pone.0214586			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR1CY	30934018	gold, Green Published, Green Submitted			2022-12-26	WOS:000462867000024
J	Song, YJ; Gyarmati, P				Song, Yajing; Gyarmati, Peter			Bacterial translocation in acute lymphocytic leukemia	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; GENE-THERAPY; CONTAMINATION; SENSITIVITY; PROGRESSION; EXPRESSION; IMMUNITY	Bloodstream infection (BSI) is the major cause of mortality in acute lymphocytic leukemia (ALL). Causative pathogens in BSI originate from the gut microbiota due to an increase in intestinal permeability, a process known as bacterial translocation (BT). The gut microbiota in physiological conditions is controlled by a large number of immune cells as part of the gut-associated lymphoid tissue (GALT). The aim of the current study was to investigate the mechanism of bacterial translocation in leukemia by identifying and characterizing alterations in the GALT in leukemic mouse model. Our studies revealed a severe impairment of the GALT characterized by a loss of lymphatic cells in ALL, which eventually led to BSI. We identified differentially expressed genes in the intraepithelium and the lamina propria, which may contribute to BT and to the impairment of lymphocyte migration.	[Song, Yajing; Gyarmati, Peter] Univ Illinois, Coll Med, Peoria, IL 61656 USA	University of Illinois System; University of Illinois Peoria	Gyarmati, P (corresponding author), Univ Illinois, Coll Med, Peoria, IL 61656 USA.	gyarmati@uic.edu	Gyarmati, Peter/F-4887-2013	Gyarmati, Peter/0000-0001-7362-316X	University of Illinois College of Medicine at Peoria	University of Illinois College of Medicine at Peoria	This work was supported by the University of Illinois College of Medicine at Peoria start up grant to PG. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadzadeh Ahmad, 2015, Int J Hematol Oncol Stem Cell Res, V9, P203; Aslanzadeh J, 2004, ANN CLIN LAB SCI, V34, P389; Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011; Bischoff SC, 2012, ALLERGY, P287; Bustin SA, 2004, A Z QUANTITATIVE PCR; Chandran P, 2003, SURG-J R COLL SURG E, V1, P63, DOI 10.1016/S1479-666X(03)80118-X; Chopra A, 2014, EUR J HAEMATOL, V92, P211, DOI 10.1111/ejh.12238; Corless CE, 2000, J CLIN MICROBIOL, V38, P1747, DOI 10.1128/JCM.38.5.1747-1752.2000; Costa-Lima Carolina, 2014, Rev. Bras. Hematol. Hemoter., V36, P390, DOI 10.1016/j.bjhh.2014.09.007; de Naurois J, 2010, ANN ONCOL, V21, pv252, DOI 10.1093/annonc/mdq196; Fahlgren A, 2003, CLIN EXP IMMUNOL, V131, P90, DOI 10.1046/j.1365-2249.2003.02035.x; Gawad C, 2014, P NATL ACAD SCI USA, V111, P17947, DOI 10.1073/pnas.1420822111; Ghantoji SS, 2011, LEUKEMIA; Gyarmati P, 2016, SCI REP-UK, V6, DOI 10.1038/srep23532; Ha YJ, 2015, INT J RADIAT ONCOL, V91, P650, DOI 10.1016/j.ijrobp.2014.11.013; Hoang P, 1997, MEDIAT INFLAMM, V6, P105, DOI 10.1080/09629359791794; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang GTJ, 2002, HUM GENE THER, V13, P2017, DOI 10.1089/10430340260395875; Hutter JJ, 2010, PEDIATR REV, V31, P234, DOI 10.1542/pir.31-6-234; Kong LB, 2000, RNA, V6, P890, DOI 10.1017/S1355838200000157; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Leite JB, 2014, REV BRAS HEMATOL HEM, V36, P409, DOI [10.1016/j.bjhh.2014.07.007, DOI 10.1016/J.BJHH.2014.07.007]; Lian QS, 2017, CELL RES, V27, P784, DOI 10.1038/cr.2017.54; Lohse M, 2012, NUCLEIC ACIDS RES, V40, pW622, DOI 10.1093/nar/gks540; Mowat AM, 2003, NAT REV IMMUNOL, V3, P331, DOI 10.1038/nri1057; Mukherjee S, 2015, IMMUNITY, V42, P28, DOI 10.1016/j.immuni.2014.12.028; Nganga VK, 2013, BLOOD, V121, P3855, DOI 10.1182/blood-2012-08-446732; Nijmeijer BA, 2001, EXP HEMATOL, V29, P322, DOI 10.1016/S0301-472X(00)00669-X; Pals ST, 2007, BLOOD, V110, P3102, DOI 10.1182/blood-2007-05-075176; Piovan E, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00633; Prattes J, 2016, J CLIN MICROBIOL, V54, P798, DOI 10.1128/JCM.02972-15; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schirmer M, 2016, CELL, V167, P1897, DOI 10.1016/j.cell.2016.11.046; Sequeira IR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099256; Singh RK, 2010, CELL CYCLE, V9, P4236, DOI 10.4161/cc.9.20.13636; Smith CL, 2018, NUCLEIC ACIDS RES, V46, pD836, DOI 10.1093/nar/gkx1006; Son JS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127985; Sundstrom GM, 1998, EUR J HAEMATOL, V61, P250; Tian Tian, 2014, Stem Cell Investig, V1, P12, DOI 10.3978/j.issn.2306-9759.2014.04.02; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Wiest R, 2003, BEST PRACT RES CL GA, V17, P397, DOI 10.1016/S1521-6918(03)00024-6; Xu B, 2007, GENE THER, V14, P1181, DOI 10.1038/sj.gt.3302966; Yu T, 2011, DIGEST DIS SCI, V56, P1354, DOI 10.1007/s10620-010-1441-9; Zgheib NB, 2012, INT J ONCOL, V41, P179, DOI 10.3892/ijo.2012.1451	44	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2019	14	4							e0214526	10.1371/journal.pone.0214526	http://dx.doi.org/10.1371/journal.pone.0214526			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR1CY	30934014	gold, Green Submitted, Green Published			2022-12-26	WOS:000462867000020
J	Cantu, I; van de Werken, HJG; Gillemans, N; Stadhouders, R; Heshusius, S; Maas, A; Esteghamat, F; Ozgur, Z; van IJcken, WFJ; Grosveld, F; von Lindern, M; Philipsen, S; van Dijk, TB				Cantu, Ileana; van de Werken, Harmen J. G.; Gillemans, Nynke; Stadhouders, Ralph; Heshusius, Steven; Maas, Alex; Esteghamat, Fatemehsadat; Ozgur, Zeliha; van IJcken, Wilfred F. J.; Grosveld, Frank; von Lindern, Marieke; Philipsen, Sjaak; van Dijk, Thamar B.			The mouse KLF1 Nan variant impairs nuclear condensation and erythroid maturation	PLOS ONE			English	Article							KRUPPEL-LIKE FACTOR; RED-BLOOD-CELLS; CHROMATIN CONDENSATION; GLOBAL ROLE; CHIP-SEQ; EKLF; EXPRESSION; EKLF/KLF1; ANEMIA; MUTATIONS	Kruppel-like factor 1 (KLF1) is an essential transcription factor for erythroid development, as demonstrated by Klf1 knockout mice which die around E14 due to severe anemia. In humans, >140 KLF1 variants, causing different erythroid phenotypes, have been described. The KLF1 Nan variant, a single amino acid substitution (p.E339D) in the DNA binding domain, causes hemolytic anemia and is dominant over wildtype KLF1. Here we describe the effects of the KLF1 Nan variant during fetal development. We show that Nan embryos have defects in erythroid maturation. RNA-sequencing of the KLF1 Nan fetal liver cells revealed that Exportin 7 (Xpo7) was among the 782 deregulated genes. This nuclear exportin is implicated in terminal erythroid differentiation; in particular it is involved in nuclear condensation. Indeed, KLF1 Nan fetal liver cells had larger nuclei and reduced chromatin condensation. Knockdown of XPO7 in wildtype erythroid cells caused a similar phenotype. We propose that reduced expression of XPO7 is partially responsible for the erythroid defects observed in KLF1 Nan erythroid cells.	[Cantu, Ileana; van de Werken, Harmen J. G.; Gillemans, Nynke; Stadhouders, Ralph; Heshusius, Steven; Maas, Alex; Esteghamat, Fatemehsadat; Grosveld, Frank; Philipsen, Sjaak; van Dijk, Thamar B.] Erasmus MC, Dept Cell Biol, Rotterdam, Netherlands; [Heshusius, Steven; von Lindern, Marieke] Sanquin Res, Dept Hematopoiesis, Amsterdam, Netherlands; [Ozgur, Zeliha; van IJcken, Wilfred F. J.] Erasmus MC, Ctr Biom, Rotterdam, Netherlands; [van de Werken, Harmen J. G.] Erasmus MC, Dept Urol, Rotterdam, Netherlands; [van de Werken, Harmen J. G.] Erasmus MC, Canc Computat Biol Ctr, Rotterdam, Netherlands; [Stadhouders, Ralph] Erasmus MC, Dept Pulm Med, Rotterdam, Netherlands; [Esteghamat, Fatemehsadat] Yale Sch Med, Yale Cardiovasc Res Ctr, New Haven, CT USA	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Erasmus University Rotterdam; Erasmus MC; Yale University	Philipsen, S (corresponding author), Erasmus MC, Dept Cell Biol, Rotterdam, Netherlands.	j.philipsen@erasmusmc.nl	von Lindern, Marieke/AAH-2350-2020; Werken, Harmen van de/G-8979-2013; van ijcken, willem/N-9805-2018; Stadhouders, Ralph/J-8663-2015	Werken, Harmen van de/0000-0002-9794-1477; van ijcken, willem/0000-0002-0421-8301; Stadhouders, Ralph/0000-0002-1060-5607; Esteghamat Hanzaei, Fatemehsadat/0000-0002-1243-8013	Netherlands Genomics Initiative [NGI Zenith 93511036]; Landsteiner Foundation for Blood Transfusion Research [LSBR 1040]; Netherlands Organization for Health Research and Development [ZonMw TOP 40-00812-98-12128]; EU fp7 Specific Cooperation Research Project THALAMOSS [306201]	Netherlands Genomics Initiative; Landsteiner Foundation for Blood Transfusion Research; Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); EU fp7 Specific Cooperation Research Project THALAMOSS	TvD and HvdW were supported by the Netherlands Genomics Initiative (NGI Zenith 93511036); IC, TvD, FG and SP by the Landsteiner Foundation for Blood Transfusion Research (LSBR 1040); SH, MvL and SP by the Netherlands Organization for Health Research and Development (ZonMw TOP 40-00812-98-12128); IC, TvD, FG and SP by the EU fp7 Specific Cooperation Research Project THALAMOSS (306201). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnaud L, 2010, AM J HUM GENET, V87, P721, DOI 10.1016/j.ajhg.2010.10.010; Borg J, 2011, HAEMATOL-HEMATOL J, V96, P635, DOI 10.3324/haematol.2011.043265; Borg J, 2010, NAT GENET, V42, P801, DOI 10.1038/ng.630; de Krom M, 2002, MOL CELL, V9, P1319, DOI 10.1016/S1097-2765(02)00558-0; de-la-Iglesia-Inigo S, 2017, CLIN CASE REP, V5, P248, DOI 10.1002/ccr3.825; Dolznig H, 2001, FASEB J, V15, P1442, DOI 10.1096/fj.00-0705fje; DONZE D, 1995, J BIOL CHEM, V270, P1955, DOI 10.1074/jbc.270.4.1955; Drissen R, 2005, MOL CELL BIOL, V25, P5205, DOI 10.1128/MCB.25.12.5205-5214.2005; Drissen R, 2004, GENE DEV, V18, P2485, DOI 10.1101/gad.317004; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Ghamari A, 2013, GENE DEV, V27, P767, DOI 10.1101/gad.216200.113; Giarratana MC, 2005, NAT BIOTECHNOL, V23, P69, DOI 10.1038/nbt1047; Gillinder KR, 2017, NUCLEIC ACIDS RES, V45, P1130, DOI 10.1093/nar/gkw1014; Hattangadi SM, 2014, BLOOD, V124, P1931, DOI 10.1182/blood-2013-11-537761; Heruth DP, 2010, GENOMICS, V96, P303, DOI 10.1016/j.ygeno.2010.07.009; Hodge D, 2006, BLOOD, V107, P3359, DOI 10.1182/blood-2005-07-2888; Jaffray JA, 2013, BLOOD CELL MOL DIS, V51, P71, DOI 10.1016/j.bcmd.2013.02.006; Ji P, 2010, HAEMATOL-HEMATOL J, V95, P2013, DOI 10.3324/haematol.2010.029827; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kingsley PD, 2013, BLOOD, V121, pE5, DOI 10.1182/blood-2012-04-422394; Kurita R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059890; Lu SJ, 2008, BLOOD, V112, P4475, DOI 10.1182/blood-2008-05-157198; Lyon M, 1986, MOUSE NEWS LETT, V74, P95; Lyon M. F., 1983, MOUSE NEWS LETT, V68, P68; Meinders M, 2015, BLOOD, V125, P1957, DOI 10.1182/blood-2014-08-593343; Nebor D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30839-2; Nilson DG, 2006, EXP HEMATOL, V34, P705, DOI 10.1016/j.exphem.2006.02.018; Norton LJ, 2017, BLOOD ADV, V1, P685, DOI 10.1182/bloodadvances.2016002303; NUEZ B, 1995, NATURE, V375, P316, DOI 10.1038/375316a0; Ortolano R, 2018, J PEDIAT HEMATOL ONC, V40, pE389, DOI 10.1097/MPH.0000000000001042; Palis J, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00003; PERKINS AC, 1995, NATURE, V375, P318; Perkins AC, 1996, P NATL ACAD SCI USA, V93, P12267, DOI 10.1073/pnas.93.22.12267; Perseu L, 2011, BLOOD, V118, P4454, DOI 10.1182/blood-2011-04-345736; Pilon AM, 2011, BLOOD, V118, pE139, DOI 10.1182/blood-2011-05-355107; Pilon AM, 2008, MOL CELL BIOL, V28, P7394, DOI 10.1128/MCB.01087-08; Planutis A, 2017, DEVELOPMENT, V144, P430, DOI 10.1242/dev.145656; Popova EY, 2009, CHROMOSOME RES, V17, P47, DOI 10.1007/s10577-008-9005-y; Ravindranath Y, 2018, J PEDIAT HEMATOL ONC, V40, pE405, DOI 10.1097/MPH.0000000000001056; Sankaran VG, 2009, NATURE, V460, P1093, DOI 10.1038/nature08243; Satta S, 2011, HAEMATOL-HEMATOL J, V96, P767, DOI 10.3324/haematol.2010.037333; Schoenfelder S, 2010, NAT GENET, V42, P53, DOI 10.1038/ng.496; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Siatecka M, 2011, BLOOD, V118, P2044, DOI 10.1182/blood-2011-03-331371; Siatecka M, 2010, P NATL ACAD SCI USA, V107, P15151, DOI 10.1073/pnas.1004996107; Singleton B.K., 2009, BLOOD, V114, P162, DOI [10.1182/blood.V114.22.162.162, DOI 10.1182/BLOOD.V114.22.162.162, DOI 10.1182/BL00D.V114.22.162.162]; Singleton BK, 2008, BLOOD, V112, P2081, DOI 10.1182/blood-2008-03-145672; Southwood CM, 1996, DEV DYNAM, V206, P248, DOI 10.1002/(SICI)1097-0177(199607)206:3<248::AID-AJA3>3.0.CO;2-I; Stadhouders R, 2013, NAT PROTOC, V8, P509, DOI 10.1038/nprot.2013.018; Su MY, 2013, J BIOL CHEM, V288, P8433, DOI 10.1074/jbc.M112.413260; Tallack MR, 2010, GENOME RES, V20, P1052, DOI 10.1101/gr.106575.110; Tallack MR, 2009, J BIOL CHEM, V284, P20966, DOI 10.1074/jbc.M109.006346; van de Werken HJG, 2012, METHOD ENZYMOL, V513, P89, DOI 10.1016/B978-0-12-391938-0.00004-5; von Lindern M, 2001, ONCOGENE, V20, P3651, DOI 10.1038/sj.onc.1204494; White RA, 2009, BLOOD CELL MOL DIS, V43, P141, DOI 10.1016/j.bcmd.2009.03.009; Wijgerde M, 1996, GENE DEV, V10, P2894, DOI 10.1101/gad.10.22.2894; Zhang LB, 2011, GENE DEV, V25, P119, DOI 10.1101/gad.1998711; Zhou DW, 2010, NAT GENET, V42, P742, DOI 10.1038/ng.637	58	6	7	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0208659	10.1371/journal.pone.0208659	http://dx.doi.org/10.1371/journal.pone.0208659			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921348	Green Published, Green Submitted, gold			2022-12-26	WOS:000462594000005
J	Choi, SY; Shin, E; Choe, EK; Park, B; Lee, H; Park, HE; Lee, JE; Choi, SH				Choi, Su-Yeon; Shin, Eunsoon; Choe, Eun Kyung; Park, Boram; Lee, Heesun; Park, Hyo Eun; Lee, Jong-Eun; Choi, Seung Ho			Genome-wide association study of coronary artery calcification in asymptomatic Korean populations	PLOS ONE			English	Article							AFRICAN-AMERICANS; RISK-FACTORS; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; CHROMOSOME 9P21; CALCIUM; PREVALENCE; BURDEN; LOCUS	Epidemiologic evidence indicates that the prevalence and severity of coronary artery disease vary depending on ethnicity. In this study, a genome-wide association study for coronary artery calcification (CAC) was performed in a Korean population-based sample of 400 subjects without prior coronary artery disease and replicated in another of 1,288 subjects. CAC score, as assessed by multi-detector computed tomography, was evaluated in volunteers for screening purposes as part of a routine health examination. CAC score greater than the 90th percentile across the age in each sex group was considered severe CAC. Single nucleotide polymorphisms (SNPs) associated with severe CAC after adjusting for age, sex, hypertension, and diabetes were investigated using the additive model of logistic regression. One SNP (rs10757272 in the intronic region of the CDKN2B-AS1 gene in chromosome 9p21.3) met Bonferroni correction in the discovery set (p = 7.55E-08) and was also significant in the validation set by TaqMan assay (p = 0.036). Subjects with rs10757272 were found to have an increased odds ratio (OR) of having severe CAC in multivariate logistic regression analysis after adjusting for age, sex, hypertension, and diabetes (adjusted OR 3.24 and 95% CI 2.11-4.97). In conclusion, SNP rs10757272 in chromosome 9p21.3 was associated with severe CAC based on age and sex in an asymptomatic community-based Korean population. Therefore, it was associated with promotion of coronary artery calcification in subclinical state.	[Choi, Su-Yeon; Lee, Heesun; Park, Hyo Eun; Choi, Seung Ho] Seoul Natl Univ Hosp, Dept Internal Med, Healthcare Syst Gangnam Ctr, Seoul, South Korea; [Choi, Su-Yeon; Lee, Heesun; Park, Hyo Eun; Choi, Seung Ho] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Shin, Eunsoon; Lee, Jong-Eun] DNA Link Inc, Seoul, South Korea; [Choe, Eun Kyung] Seoul Natl Univ Hosp, Healthcare Syst Gangnam Ctr, Dept Surg, Seoul, South Korea; [Park, Boram] Seoul Natl Univ, Dept Publ Hlth Sci, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); DNA Link, Inc.; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU)	Choi, SY; Choi, SH (corresponding author), Seoul Natl Univ Hosp, Dept Internal Med, Healthcare Syst Gangnam Ctr, Seoul, South Korea.; Choi, SY; Choi, SH (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea.	sychoi9@gmail.com; cshmed@snuh.org	Choi, Su-Yeon/C-4312-2013	Choi, Su-Yeon/0000-0001-9977-4740	Technology Innovation Program (Business Model Development for Personalized Medicine Based on Integrated Genome and Clinical Information) - Ministry of Trade, Industry & Energy (MOTIE, Korea) [10050154]	Technology Innovation Program (Business Model Development for Personalized Medicine Based on Integrated Genome and Clinical Information) - Ministry of Trade, Industry & Energy (MOTIE, Korea)	This work was supported by the Technology Innovation Program (10050154, Business Model Development for Personalized Medicine Based on Integrated Genome and Clinical Information) funded By the Ministry of Trade, Industry & Energy (MOTIE, Korea). Eunsoon Shin and Jong-Eun Lee are employed by DNA Link, Inc. DNA Link, Inc. provided support in the form of salaries for authors ES and J-EL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Chan K, 2013, J AM COLL CARDIOL, V61, P957, DOI 10.1016/j.jacc.2012.10.051; Cho I, 2018, EUR HEART J, V39, P934, DOI 10.1093/eurheartj/ehx774; Cho I, 2017, ATHEROSCLEROSIS, V262, P185, DOI 10.1016/j.atherosclerosis.2016.12.006; Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480; Detrano R, 2008, NEW ENGL J MED, V358, P1336, DOI 10.1056/NEJMoa072100; Divers J, 2013, CIRC-CARDIOVASC GENE, V6, P97, DOI 10.1161/CIRCGENETICS.112.964114; Gong L, 2014, PLOS ONE, V9, pe9482; Gonzalez-Navarro H, 2010, J AM COLL CARDIOL, V55, P2258, DOI 10.1016/j.jacc.2010.01.026; Greenland P, 2003, JAMA-J AM MED ASSOC, V290, P891, DOI 10.1001/jama.290.7.891; Han D, 2016, CIRC J, V80, P2349, DOI 10.1253/circj.CJ-16-0762; Helgadottir A, 2008, NAT GENET, V40, P217, DOI 10.1038/ng.72; Jarinova O, 2009, ARTERIOSCL THROM VAS, V29, P1671, DOI 10.1161/ATVBAHA.109.189522; Kim DS, 2014, BMC MED GENET, V15, DOI 10.1186/s12881-014-0089-2; Lee Ji Hyun, 2015, J Cardiovasc Ultrasound, V23, P195, DOI 10.4250/jcu.2015.23.4.195; Lee TC, 2003, J AM COLL CARDIOL, V41, P39, DOI 10.1016/S0735-1097(02)02618-9; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Musunuru K, 2010, CIRC-CARDIOVASC GENE, V3, P445, DOI 10.1161/CIRCGENETICS.109.923508; O'Donnell CJ, 2011, CIRCULATION, V124, P2855, DOI 10.1161/CIRCULATIONAHA.110.974899; Park HE, 2012, INT J CARDIOVAS IMAG, V28, P1227, DOI 10.1007/s10554-011-9922-2; Peden JF, 2011, HUM MOL GENET, V20, pR198, DOI 10.1093/hmg/ddr384; Peden JF, 2011, NAT GENET, V43, P339, DOI 10.1038/ng.782; Saab KR, 2015, J AM SOC NEPHROL, V26, P247, DOI 10.1681/ASN.2014040393; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Shen GQ, 2008, ARTERIOSCL THROM VAS, V28, P360, DOI 10.1161/ATVBAHA.107.157248; Visel A, 2010, NATURE, V464, P409, DOI 10.1038/nature08801; Wassel CL, 2009, CIRC-CARDIOVASC GENE, V2, P629, DOI 10.1161/CIRCGENETICS.109.876243; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	31	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214370	10.1371/journal.pone.0214370	http://dx.doi.org/10.1371/journal.pone.0214370			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921371	Green Submitted, Green Published, gold			2022-12-26	WOS:000462594000060
J	Torres, DA; Freitas, MB; da Matta, SLP; Novaes, RD; Goncalves, RV				Torres, Diego A.; Freitas, Mariella B.; da Matta, Sergio L. P.; Novaes, Romulo D.; Goncalves, Reggiani Vilela			Is bone loss a physiological cost of reproduction in the Great fruit-eating bat Artibeus lituratus?	PLOS ONE			English	Article							CALCIUM HOMEOSTASIS; MINERAL DENSITY; DIETARY CALCIUM; CORTICAL BONE; LACTATION; PREGNANCY; METABOLISM; STRENGTH; HISTOMORPHOMETRY; CHIROPTERA	During mammalian pregnancy and lactation, the maternal demand for calcium is increased to satisfy fetus and newborn skeletal growth. In addition to the dietary intake, females use the calcium contained in their bones to supply this increased demand, leading to a decrease in maternal bone mineral content. In reproductive insectivorous female bats, bone loss has been described as a physiological cost of reproduction, due to the reported increased risk of bone fracture. This physiological cost may be the mechanism underlying the conflict between increasing litter size and maintaining wing skeletal integrity, which would help to explain the small litter size of most bat species. If bone loss is a linking cost between reproduction and survival in bats, and most bat species have small litter sizes, one would expect to find a loss of bone and an increasing probability of bone fracture during pregnancy and lactation in other non-insectivorous bats. In this study, we tested for the existence of this cost in the Great-fruit eating bat, Artibeus lituratus. We analyzed trabecular structure, bone strength and bone mineral content for the humerus bone, hypothesizing that bone loss during reproduction in females would increase the risk of fracture. Our results showed a decrease of 22-31% in bone trabecular area in lactating females, rapidly compensated following weaning. Bone strength did not differ among reproductive and non-reproductive groups and seems to be more influenced by bone organic components rather than mineral contents. Since we observed bone loss during reproduction yet the humerus strength seems to be unaffected, we suggest that bone loss may not represent a physiological cost during reproduction for this frugivorous bat.	[Torres, Diego A.; Freitas, Mariella B.; da Matta, Sergio L. P.; Goncalves, Reggiani Vilela] Univ Fed Vicosa, Dept Anim Biol, Vicosa, MG, Brazil; [da Matta, Sergio L. P.] Univ Fed Vicosa, Dept Gen Biol, Vicosa, MG, Brazil; [Novaes, Romulo D.] Univ Fed Alfenas, Dept Biol Struct, Alfenas, Brazil	Universidade Federal de Vicosa; Universidade Federal de Vicosa; Universidade Federal de Alfenas	Goncalves, RV (corresponding author), Univ Fed Vicosa, Dept Anim Biol, Vicosa, MG, Brazil.	reggysvilela@yahoo.com.br	Novaes, Romulo D/F-1210-2015; Gonçalves, Reggiani V/J-1550-2016; Torres, Diego Alejandro/Y-7411-2019; Freitas, Mariella B/H-9512-2015	Novaes, Romulo D/0000-0002-3186-5328; Gonçalves, Reggiani V/0000-0002-5831-3590; Torres, Diego Alejandro/0000-0001-8115-2070; Freitas, Mariella/0000-0001-5132-242X	Minas Gerais State Agency for Research and Development [FAPEMIG-PPM 00687-17]; National Counsel of Technological and Scientific Development (CNPq-PQ) [305093/2017-7, MCTIC 408503/2018-1]; Coordination of Improvement of Higher Level Personnel (Capes)	Minas Gerais State Agency for Research and Development; National Counsel of Technological and Scientific Development (CNPq-PQ)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordination of Improvement of Higher Level Personnel (Capes)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The authors acknowledge the financial support of the Minas Gerais State Agency for Research and Development (FAPEMIG-PPM 00687-17), and the National Counsel of Technological and Scientific Development (CNPq-PQ 305093/2017-7 and MCTIC 408503/2018-1) and Coordination of Improvement of Higher Level Personnel (Capes). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade TY, 2013, J MAMMAL, V94, P1094, DOI 10.1644/12-MAMM-A-244.1; Ardeshirpour L, 2007, ENDOCRINOLOGY, V148, P3875, DOI 10.1210/en.2006-1467; Augat P, 2006, AGE AGEING, V35, P27, DOI 10.1093/ageing/afl081; Barclay RMR, 2003, BAT ECOLOGY, P209; BARCLAY RMR, 1994, AM NAT, V144, P1021, DOI 10.1086/285723; BELL G, 1980, AM NAT, V116, P45, DOI 10.1086/283611; Bernard RTF, 1996, S AFR J ZOOL, V31, P218; Booher CM, 2010, J MAMMAL, V91, P952, DOI 10.1644/09-MAMM-A-186.1; Bowman B. M., 2001, Journal of Musculoskeletal & Neuronal Interactions, V1, P347; Brunet-Rossinni Anja K., 2009, P315; Charoenphandhu N, 2010, TRENDS ENDOCRIN MET, V21, P395, DOI 10.1016/j.tem.2010.02.002; CROSS NA, 1995, AM J CLIN NUTR, V61, P514, DOI 10.1093/ajcn/61.3.514; Cupertino MC, 2013, INT J EXP PATHOL, V94, P343, DOI 10.1111/iep.12046; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Doube M, 2010, BONE, V47, P1076, DOI 10.1016/j.bone.2010.08.023; Egan KP, 2012, HISTOPATHOLOGY, V61, P1168, DOI 10.1111/j.1365-2559.2012.04333.x; Erben RG, 2012, METHODS MOL BIOL, V816, P279, DOI 10.1007/978-1-61779-415-5_19; Fox J, 2005, J BEHAV EDUC, V14, P1, DOI 10.1007/s10864-005-0957-0; Hildebrand T, 1997, J MICROSC-OXFORD, V185, P67, DOI 10.1046/j.1365-2818.1997.1340694.x; Hood WR, 2011, J COMP PHYSIOL B, V181, P423, DOI 10.1007/s00360-010-0521-7; Kalkwarf HJ, 1999, J CLIN ENDOCR METAB, V84, P464, DOI 10.1210/jc.84.2.464; Kalkwarf HJ, 2002, ENDOCRINE, V17, P49, DOI 10.1385/ENDO:17:1:49; Kovacs CS, 2011, ENDOCRIN METAB CLIN, V40, P795, DOI 10.1016/j.ecl.2011.08.002; KWIECINSKI GG, 1987, AM J ANAT, V178, P410, DOI 10.1002/aja.1001780410; Liu XS, 2012, J BONE MINER RES, V27, P865, DOI 10.1002/jbmr.1503; MORSE A, 1945, J DENT RES, V24, P143, DOI 10.1177/00220345450240030501; Nelson SL, 2005, J CHEM ECOL, V31, P1683, DOI 10.1007/s10886-005-5920-y; Papadimitriou HM, 1996, J ZOOL, V240, P411, DOI 10.1111/j.1469-7998.1996.tb05295.x; Reeder Deeann M., 2009, P554; Sanz-Salvador L, 2015, EUR J ENDOCRINOL, V172, DOI 10.1530/EJE-14-0424; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sequetto PL, 2017, MICROSC MICROANAL, V23, P989, DOI 10.1017/S1431927617012363; Siu WS, 2003, J BONE MINER METAB, V21, P316, DOI 10.1007/s00774-003-0427-5; Soares EA, 2015, INT J EXP PATHOL, V96, P261, DOI 10.1111/iep.12134; Speakman JR, 2008, PHILOS T R SOC B, V363, P375, DOI 10.1098/rstb.2007.2145; STEARNS SC, 1989, FUNCT ECOL, V3, P259, DOI 10.2307/2389364; Stearns SC, 2000, NATURWISSENSCHAFTEN, V87, P476, DOI 10.1007/s001140050763; Swartz SM, 2008, CELLS TISSUES ORGANS, V187, P59, DOI 10.1159/000109964; Taylor MS, 2009, J DAIRY SCI, V92, P223, DOI 10.3168/jds.2008-1345; Torres DA, 2018, REPROD FERT DEVELOP, V30, P681, DOI 10.1071/RD17163; Turner CH, 2006, ANN NY ACAD SCI, V1068, P429, DOI 10.1196/annals.1346.039; Wachter NJ, 2002, BONE, V31, P90, DOI 10.1016/S8756-3282(02)00779-2; Walker RS, 2008, P ROY SOC B-BIOL SCI, V275, P827, DOI 10.1098/rspb.2007.1511; Wendeln MC, 2000, BIOTROPICA, V32, P489, DOI 10.1111/j.1744-7429.2000.tb00495.x; Wysolmerski JJ, 2012, J CLIN ENDOCR METAB, V97, P2947, DOI 10.1210/jc.2012-2142; Zeni S, 2003, CALCIFIED TISSUE INT, V73, P594, DOI 10.1007/s00223-002-1093-7; ZORTEA M, 1993, J TROP ECOL, V9, P117, DOI 10.1017/S0266467400007057	47	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0213781	10.1371/journal.pone.0213781	http://dx.doi.org/10.1371/journal.pone.0213781			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921346	gold, Green Published, Green Submitted			2022-12-26	WOS:000462594000024
J	Gordon, DG; Zelaya, A; Arganda-Carreras, I; Arganda, S; Traniello, JFA				Gordon, Darcy Greer; Zelaya, Alejandra; Arganda-Carreras, Ignacio; Arganda, Sara; Traniello, James F. A.			Division of labor and brain evolution in insect societies: Neurobiology of extreme specialization in the turtle ant Cephalotes varians	PLOS ONE			English	Article							MUSHROOM BODY CALYX; SYNAPTIC ORGANIZATION; ZACRYPTOCERUS-VARIANS; VISUAL EXPERIENCE; CASTE DIFFERENCES; PLASTICITY; BODIES; HONEYBEE; PERFORMANCE; MORPHOLOGY	Strongly polyphenic social insects provide excellent models to examine the neurobiological basis of division of labor. Turtle ants, Cephalotes varians, have distinct minor worker, soldier, and reproductive (gyne/queen) morphologies associated with their behavioral profiles: small-bodied task-generalist minors lack the phragmotic shield-shaped heads of soldiers, which are specialized to block and guard the nest entrance. Gynes found new colonies and during early stages of colony growth overlap behaviorally with soldiers. Here we describe patterns of brain structure and synaptic organization associated with division of labor in C. varians minor workers, soldiers, and gynes. We quantified brain volumes, determined scaling relationships among brain regions, and quantified the density and size of microglomeruli, synaptic complexes in the mushroom body calyxes important to higher-order processing abilities that may underpin behavioral performance. We found that brain volume was significantly larger in gynes; minor workers and soldiers had similar brain sizes. Consistent with their larger behavioral repertoire, minors had disproportionately larger mushroom bodies than soldiers and gynes. Soldiers and gynes had larger optic lobes, which may be important for flight and navigation in gynes, but serve different functions in soldiers. Microglomeruli were larger and less dense in minor workers; soldiers and gynes did not differ. Correspondence in brain structure despite differences in soldiers and gyne behavior may reflect developmental integration, suggesting that neurobiological metrics not only advance our understanding of brain evolution in social insects, but may also help resolve questions of the origin of novel castes.	[Gordon, Darcy Greer; Zelaya, Alejandra; Arganda, Sara; Traniello, James F. A.] Boston Univ, Dept Biol, 5 Cummington St, Boston, MA 02215 USA; [Arganda-Carreras, Ignacio] Basque Fdn Sci, Ikerbasque, Bilbao, Spain; [Arganda-Carreras, Ignacio] Univ Basque Country, Dept Comp Sci & Artificial Intelligence, San Sebastian, Spain; [Arganda-Carreras, Ignacio] DIPC, San Sebastian, Spain; [Arganda, Sara] Univ Rey Juan Carlos, Dept Biol & Geologia Fis & Quim Inorgan, Area Biodiversidad & Conservac, Madrid, Spain; [Traniello, James F. A.] Boston Univ, Grad Program Neurosci, Boston, MA 02215 USA	Boston University; Basque Foundation for Science; University of Basque Country; Universidad Rey Juan Carlos; Boston University	Gordon, DG (corresponding author), Boston Univ, Dept Biol, 5 Cummington St, Boston, MA 02215 USA.	dggordon@bu.edu	Carreras, Sara Arganda/B-2200-2017; Arganda-Carreras, Ignacio/L-4605-2014	Carreras, Sara Arganda/0000-0002-9875-2379; Arganda-Carreras, Ignacio/0000-0003-0229-5722	National Science Foundation [IOS 1354291]; Marie Sklodowska-Curie Individual Fellowship; European Union [660976]	National Science Foundation(National Science Foundation (NSF)); Marie Sklodowska-Curie Individual Fellowship; European Union(European Commission)	This research was supported by grant IOS 1354291 from the National Science Foundation to JFAT, a Marie Sklodowska-Curie Individual Fellowship to SA (funded by the European Union's Horizon 2020 research and innovation program under grant agreement No BrainiAnts-Project 660976), and participation of AZ in the Undergraduate Research Opportunities Program at Boston University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arganda-Carreras I, 2017, I S BIOMED IMAGING, P429, DOI 10.1109/ISBI.2017.7950553; Arganda-Carreras I, 2018, FRONT NEUROINFORM, V12, DOI 10.3389/fninf.2018.00013; Avants B, 2004, INSIGHT IN IMAGES: PRINCIPLES AND PRACTICE FOR SEGMENTATION REGISTRATION AND IMAGE ANALYSIS, P307; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Chessel D., 2004, R NEWS, V4, P5; COLE BJ, 1980, INSECT SOC, V27, P265, DOI 10.1007/BF02223668; Fahrbach SE, 2016, CURR OPIN INSECT SCI, V18, P27, DOI 10.1016/j.cois.2016.08.009; Falibene A, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00073; Falibene A, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00084; Frambach I, 2004, J COMP NEUROL, V475, P303, DOI 10.1002/cne.20165; Giraldo YM, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.2603; Gordon DG, 2018, INSECT SOC, V65, P431, DOI 10.1007/s00040-018-0629-4; Gordon DG, 2018, NEUROSCI LETT, V676, P46, DOI 10.1016/j.neulet.2018.04.001; Gordon DG, 2018, NEUROSCI LETT, V662, P110, DOI 10.1016/j.neulet.2017.10.009; Gordon DG, 2017, BEHAV ECOL SOCIOBIOL, V71, DOI 10.1007/s00265-017-2396-z; Groh C, 2004, P NATL ACAD SCI USA, V101, P4268, DOI 10.1073/pnas.0400773101; Groh C, 2008, ARTHROPOD STRUCT DEV, V37, P459, DOI 10.1016/j.asd.2008.04.001; Groh C, 2006, BRAIN BEHAV EVOLUT, V68, P1, DOI 10.1159/000092309; Groh C, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0432; Groh C, 2012, J COMP NEUROL, V520, P3509, DOI 10.1002/cne.23102; Groh C, 2011, ARTHROPOD STRUCT DEV, V40, P358, DOI 10.1016/j.asd.2010.12.002; HASEGAWA E, 1993, INSECT SOC, V40, P261, DOI 10.1007/BF01242362; Holekamp KE, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0350; Holldobler B., 1990, pi; Hourcade B, 2010, J NEUROSCI, V30, P6461, DOI 10.1523/JNEUROSCI.0841-10.2010; Huang MH, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.0101; Ilies I, 2015, BRAIN BEHAV EVOLUT, V85, P63, DOI 10.1159/000370100; Julian GE, 2002, BRAIN BEHAV EVOLUT, V60, P152, DOI 10.1159/000065936; Kamhi JF, 2017, DEV NEUROBIOL, V77, P1072, DOI 10.1002/dneu.22496; Kamhi JF, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.1949; Klein A, 2009, NEUROIMAGE, V46, P786, DOI 10.1016/j.neuroimage.2008.12.037; Krofczik S, 2008, DEV NEUROBIOL, V68, P1007, DOI 10.1002/dneu.20640; Liao WB, 2015, J EVOLUTION BIOL, V28, P1986, DOI 10.1111/jeb.12714; Lillico-Ouachour A, 2017, CURR OPIN INSECT SCI, V19, P43, DOI 10.1016/j.cois.2016.11.003; Londe S, 2015, EVODEVO, V6, DOI 10.1186/s13227-015-0031-5; Mares S, 2005, BRAIN BEHAV EVOLUT, V66, P50, DOI 10.1159/000085047; Molet M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084929; Molet M, 2012, AM NAT, V180, P328, DOI 10.1086/667368; Muenz TS, 2015, DEV NEUROBIOL, V75, P1368, DOI 10.1002/dneu.22290; Muscedere ML, 2016, BEHAV ECOL, V27, P271, DOI 10.1093/beheco/arv152; Muscedere ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031618; Muscedere ML, 2009, ANIM BEHAV, V77, P911, DOI 10.1016/j.anbehav.2008.12.018; O'Donnell S, 2018, BMC ZOOL, V3, DOI 10.1186/s40850-018-0028-3; O'Donnell S, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0791; O'Donnell S, 2014, BEHAV ECOL SOCIOBIOL, V68, P529, DOI 10.1007/s00265-013-1667-6; O'Donnell S, 2011, P NATL ACAD SCI USA, V108, P7107, DOI 10.1073/pnas.1017566108; Ott SR, 2008, J NEUROSCI METH, V172, P220, DOI 10.1016/j.jneumeth.2008.04.031; Peeters C, 2001, ANNU REV ENTOMOL, V46, P601, DOI 10.1146/annurev.ento.46.1.601; Peeters C, 2013, ARTHROPOD STRUCT DEV, V42, P257, DOI 10.1016/j.asd.2013.02.003; Powell BJ, 2012, BRAIN BEHAV EVOLUT, V80, P170, DOI 10.1159/000341161; Powell S, 2009, J EVOLUTION BIOL, V22, P1004, DOI 10.1111/j.1420-9101.2009.01710.x; Powell S, 2006, FUNCT ECOL, V20, P1105, DOI 10.1111/j.1365-2435.2006.01184.x; Powell S, 2016, BEHAV ECOL SOCIOBIOL, V70, P1075, DOI 10.1007/s00265-016-2080-8; Rajakumar R, 2018, NATURE, V562, P574, DOI 10.1038/s41586-018-0613-1; Rajakumar R, 2012, SCIENCE, V335, P79, DOI 10.1126/science.1211451; Riccomagno MM, 2015, ANNU REV CELL DEV BI, V31, P779, DOI 10.1146/annurev-cellbio-100913-013038; Scholl C, 2014, DEV NEUROBIOL, V74, P1141, DOI 10.1002/dneu.22195; Schurmann FW, 2016, ARTHROPOD STRUCT DEV, V45, P399, DOI 10.1016/j.asd.2016.08.005; Seid MA, 2005, J COMP NEUROL, V488, P269, DOI 10.1002/cne.20545; Seid MA, 2006, BEHAV ECOL SOCIOBIOL, V60, P631, DOI 10.1007/s00265-006-0207-z; Smith CR, 2008, NAT REV GENET, V9, P735, DOI 10.1038/nrg2429; Stieb SM, 2012, DEV NEUROBIOL, V72, P729, DOI 10.1002/dneu.20982; Stieb SM, 2010, DEV NEUROBIOL, V70, P408, DOI 10.1002/dneu.20785; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Trible W, 2017, J EXP BIOL, V220, P53, DOI 10.1242/jeb.145292; Tsuboi M, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-39; Urbani CB, 1998, INSECT SOC, V45, P315, DOI 10.1007/s000400050091; Warton DI, 2006, BIOL REV, V81, P259, DOI 10.1017/S1464793106007007; Waxman HK, 2017, BRAIN BEHAV EVOLUT, V89, P195, DOI 10.1159/000470899; WHEELER DE, 1991, AM NAT, V138, P1218, DOI 10.1086/285279; WILSON E O, 1974, Psyche (Cambridge), V81, P182, DOI 10.1155/1974/17428; WILSON EO, 1976, ANIM BEHAV, V24, P354, DOI 10.1016/S0003-3472(76)80043-7; WITHERS GS, 1993, NATURE, V364, P238, DOI 10.1038/364238a0; Yilmaz A, 2016, DEV NEUROBIOL, V76, P1041, DOI 10.1002/dneu.22374	74	14	14	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2019	14	3							e0213618	10.1371/journal.pone.0213618	http://dx.doi.org/10.1371/journal.pone.0213618			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ5PT	30917163	Green Published, Green Submitted, gold			2022-12-26	WOS:000462465800036
J	Hernandez-Izquierdo, C; Lopez-Valcarcel, BG; Morris, S; Melnychuk, M; Alesson, IA				Hernandez-Izquierdo, Cristina; Gonzalez Lopez-Valcarcel, Beatriz; Morris, Stephen; Melnychuk, Mariya; Abasolo Alesson, Ignacio			The effect of a change in co-payment on prescription drug demand in a National Health System: The case of 15 drug families by price elasticity of demand	PLOS ONE			English	Article							CARE UTILIZATION; FREE MEDICINES; IMPACT; EXPENDITURES; NUMBER	Objectives To test the heterogeneity of the effect of a change in pharmaceutical cost-sharing by therapeutic groups in a Spanish region. Methods Data: random sample (provided by the Canary Islands Health Service) of 40,471 people covered by the Spanish National Health System (SNHS) in the Canary Islands. The database includes individualised monthly-dispensed medications (prescribed by the SNHS) from one year before (August 2011) to one year after (June 2013) the Royal Decree Law 16/2012 (RDL 16/2012). Sample: two intervention groups (low-income pensioners and middle-income working population) and one control group (low-income working population). Empirical model: quasi-experimental difference-in-differences design to study the change in consumption (measured in number of monthly Defined Daily Dose (DDDs) per individual) among 13 therapeutic groups. The policy break indicator (three-level categorical variable) tested the existence of stockpiling between the reform's announcement and its implementation. We ran 16 linear regression models (general, by therapeutic groups and by comorbidities) that considered whether the exclusion of some drugs from public provision impacted on consumption more than the co-payment increase. Results General: Reduction (-13.04) in consumption after the reform's implementation, which was fully compensated by a previous increase (16.60 i.e., stockpiling) among low-income pensioners. The middle-income working population maintained its trend of increasing consumption. Therapeutic groups: Reductions in consumption after the reform's implementation among low-income pensioners in 7 of the 13 groups, which were fully compensated for by a previous increase (i.e., stockpiling) in 4 groups and partially compensated for in the remaining 3. The analysis without the excluded medicines provided fewer negative coefficients. Comorbidities: Reduction in consumption that was only slightly compensated for by a previous increase (i.e., stockpiling). Conclusions The negative impact of cost-sharing produced, among low-income pensioners, a risk of loss of adherence to treatments, which could deteriorate the health status of individuals, especially among pensioners within the most inelastic therapeutic groups (associated with chronic diseases) and patients with comorbidities (also, associated with chronic diseases). Notwithstanding the above, this risk was more related to the exclusion of some drugs from provision than to the cost-sharing increase.	[Hernandez-Izquierdo, Cristina; Abasolo Alesson, Ignacio] ULL, Fac Econ Empresa & Turismo, Dept Econ Aplicada & Metodos Cuantitat, San Cristobal De La Lagu, Spain; [Gonzalez Lopez-Valcarcel, Beatriz] ULPGC, Fac Econ Empresa & Turismo, Dept Metodos Cuantitat Econ & Gest, Las Palmas Gran Canaria, Spain; [Morris, Stephen; Melnychuk, Mariya] UCL, Dept Appl Hlth Res, London, England; [Melnychuk, Mariya] URJC, Dept Econ Empresa ADO Econ Aplicada & Fundamentos, Madrid, Spain; [Abasolo Alesson, Ignacio] ULL, Fac Econ Empresa & Turismo, Inst Univ Desarrollo Reg, San Cristobal De La Lagu, Spain	Universidad de Las Palmas de Gran Canaria; University of London; University College London; Universidad Rey Juan Carlos	Hernandez-Izquierdo, C (corresponding author), ULL, Fac Econ Empresa & Turismo, Dept Econ Aplicada & Metodos Cuantitat, San Cristobal De La Lagu, Spain.	chernani@ull.edu.es		Abasolo, Ignacio/0000-0002-9297-232X; Morris, Stephen/0000-0002-5828-3563; Hernandez-Izquierdo, Cristina/0000-0003-3188-1085	Ministry of Science, Innovation and Universities [ECO2016-79588-R]	Ministry of Science, Innovation and Universities	IAA received an award from the national grant ECO2016-79588-R aimed at Research, Development and Innovation oriented to the challenges of society (Ministry of Science, Innovation and Universities) and this study is part of the works developed in this national grant. http://www.ciencia.gob.es/portal/site/MICINN/menuitem.dbc68b34d11ccbd5d52ffeb801432ea0/? vgnextoid=	Villar FA, 2014, REV ESP SALUD PUBLIC, V88, P233, DOI 10.4321/S1135-57272014000200006; Baixauli Fernandez VJ, 2015, SOC ESPANOLA FARMACI, P22; Chen SY, 2014, J MANAGE CARE PHARM, V20, P34, DOI 10.18553/jmcp.2014.20.1.34; Contoyannis P, 2005, HEALTH ECON, V14, P909, DOI 10.1002/hec.1041; Damiani G, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-6; Fraeyman J, 2013, APPL HEALTH ECON HEA, V11, P543, DOI 10.1007/s40258-013-0054-9; Gallo P, 2013, HEALTH POLICY, V113, P1, DOI 10.1016/j.healthpol.2013.06.016; Garcia-Gomez P, 2018, APPL HEALTH ECON HEA, V16, P407, DOI 10.1007/s40258-018-0382-x; Gobierno de Espana, 2013, PROGR NAC REF; Gobierno de Espana, 2012, INF AN SIST NAC SAL; Gonzalez B, 2016, VALUE HEALTH, V19, pA659, DOI 10.1016/j.jval.2016.09.1800; Gonzalez Lopez-Valcarcel B, 2004, CUAD EC ICE, P161; Gonzalez Lopez-Valcarcel B, 2016, COPAGOS SANITARIOS R; Grootendorst P, 2002, DO DRUG PLANS MATTER; IMS, 2012, EV MERC FARM IMPL CO; Jimenez-Martin S, 2016, CONSUMO MEDICAMENTOS; Kiil A, 2014, EUR J HEALTH ECON, V15, P813, DOI 10.1007/s10198-013-0526-8; Lesen E, 2014, EUR J PUBLIC HEALTH, V24, P85, DOI 10.1093/eurpub/ckt062; Li X, 2013, APPL ECON LETT, V20, P23, DOI 10.1080/13504851.2012.669456; Li X, 2007, HEALTH POLICY, V82, P340, DOI 10.1016/j.healthpol.2006.11.002; Lopez Navarro AT, 2015, REV HOSP U GRAN CANA; Malani A, 2010, ACCOUNTING ANTICIPAT; Margolles Martins M, 2015, 3 ENCUESTA SALUD AST; Lesende IM, 2014, ATEN PRIM, V46, P55, DOI 10.1016/j.aprim.2013.11.001; Mas N., 2011, SISTEMAS COPAGO EURO; McManus P, 1996, Pharmacoepidemiol Drug Saf, V5, P385, DOI 10.1002/(SICI)1099-1557(199611)5:6<385::AID-PDS246>3.0.CO;2-8; Puig-Junoy J, 2016, REV ESPANOLA SALUD P, V90; Puig-Junoy J, 2011, FREE MED THANKS RETI, V07, DOI [10.2139/ssrn.1912438, DOI 10.2139/SSRN.1912438]; Puig-Junoy J, 2014, ESTIMATION PRICE ELA; Puig-Junoy J, 1999, CUADERNOS INFORM EC, V143, P77; Puig-Junoy J, 2001, HACIENDA PUBLICA ESP, V158, P105; Puig-Junoy J, 2016, HEALTH ECON, V25, P750, DOI 10.1002/hec.3182; Puig-Junoy J, 2014, APPL HEALTH ECON HEA, V12, P279, DOI 10.1007/s40258-014-0097-6; Robert BH, 2006, HLTH INSURANCE EXPT; Rodriguez M, 2012, GAC SANIT, V26, P78, DOI 10.1016/j.gaceta.2011.09.026; Sanchez DP, 2015, ATEN PRIM, V47, P411, DOI 10.1016/j.aprim.2014.10.005; Siles Gutierrez M, 2001, SISTEMA CODIFICACION; Minana JS, 2015, ATEN PRIM, V47, P669, DOI 10.1016/j.aprim.2015.06.010; Simonsen M, 2016, J APPL ECONOMET, V31, P320, DOI 10.1002/jae.2436; Skipper N, 2010, UTILIZATION STOCKPIL; Skipper N, 2013, HEALTH ECON, V22, P857, DOI 10.1002/hec.2864; Tamblyn R, 2001, JAMA-J AM MED ASSOC, V285, P421, DOI 10.1001/jama.285.4.421; WHO Collaborating Centre for Drug Statistics Methodology, 2018, ATC DDD IND 2018	43	10	10	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2019	14	3							e0213403	10.1371/journal.pone.0213403	http://dx.doi.org/10.1371/journal.pone.0213403			39	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HQ5PT	30917142	gold, Green Submitted, Green Published			2022-12-26	WOS:000462465800032
J	Zhou, J; Jenkins, TG; Jung, AM; Jeong, KS; Zhai, J; Jacobs, ET; Griffin, SC; Dearmon-Moore, D; Littau, SR; Peate, WF; Ellis, NA; Lance, P; Chen, Y; Burgess, JL				Zhou, Jin; Jenkins, Timothy G.; Jung, Alesia M.; Jeong, Kyoung Sook; Zhai, Jing; Jacobs, Elizabeth T.; Griffin, Stephanie C.; Dearmon-Moore, Devi; Littau, Sally R.; Peate, Wayne F.; Ellis, Nathan A.; Lance, Peter; Chen, Yin; Burgess, Jefferey L.			DNA methylation among firefighters	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; TUMOR-SUPPRESSOR GENE; LONG-TERM SHIFTWORK; PROSTATE-CANCER; ANDROGEN RECEPTOR; PROMOTER HYPERMETHYLATION; US FIREFIGHTERS; P21 EXPRESSION; SAN-FRANCISCO; P73 GENE	Firefighters are exposed to carcinogens and have elevated cancer rates. We hypothesized that occupational exposures in firefighters would lead to DNA methylation changes associated with activation of cancer pathways and increased cancer risk. To address this hypothesis, we collected peripheral blood samples from 45 incumbent and 41 new recruit nonsmoking male firefighters and analyzed the samples for DNA methylation using an Illumina Methylation EPIC 850k chip. Adjusting for age and ethnicity, we performed: 1) genome-wide differential methylation analysis; 2) genome-wide prediction for firefighter status (incumbent or new recruit) and years of service; and 3) Ingenuity Pathway Analysis (IPA). Four CpGs, including three in the YIPF6, MPST, and PCED1B genes, demonstrated above 1.5-fold statistically significant differential methylation after Bonferroni correction. Genome-wide methylation predicted with high accuracy incumbent and new recruit status as well as years of service among incumbent firefighters. Using IPA, the top pathways with more than 5 gene members annotated from differentially methylated probes included Sirtuin signaling pathway, p53 signaling, and 5' AMP-activated protein kinase (AMPK) signaling. These DNA methylation findings suggest potential cellular mechanisms associated with increased cancer risk in firefighters.	[Zhou, Jin; Jung, Alesia M.; Zhai, Jing; Jacobs, Elizabeth T.] Univ Arizona, Dept Epidemiol & Biostat, Mel & Enid Zuckerman Coll Publ Hlth, Tucson, AZ USA; [Jenkins, Timothy G.] Univ Utah, Sch Med, Dept Surg, Salt Lake City, UT USA; [Jeong, Kyoung Sook] Hallym Univ, Dept Occupat & Environm Med, Sacred Heart Hosp, Anyang, South Korea; [Jeong, Kyoung Sook; Ellis, Nathan A.; Lance, Peter] Univ Arizona, Ctr Canc, Tucson, AZ USA; [Griffin, Stephanie C.; Dearmon-Moore, Devi; Littau, Sally R.; Burgess, Jefferey L.] Univ Arizona, Dept Commun Environm & Policy, Mel & Enid Zuckerman Coll Publ Hlth, Tucson, AZ 85724 USA; [Peate, Wayne F.] WellAmerica, Tucson, AZ USA; [Chen, Yin] Univ Arizona, Coll Pharm, Dept Pharmacol & Toxicol, Tucson, AZ 85721 USA	University of Arizona; Utah System of Higher Education; University of Utah; Hallym University; University of Arizona; University of Arizona; University of Arizona	Burgess, JL (corresponding author), Univ Arizona, Dept Commun Environm & Policy, Mel & Enid Zuckerman Coll Publ Hlth, Tucson, AZ 85724 USA.	jburgess@email.arizona.edu	Zhai, Jing/AAQ-4318-2021; Jeong, Kyoung Sook/AAI-6244-2021; Jenkins, Tim/AAC-5072-2021; Jeong, Kyoung Sook/AAX-4539-2020	Jeong, Kyoung Sook/0000-0002-6897-8289; Jenkins, Tim/0000-0003-1171-4482	US Federal Emergency Management Agency Assistance to Firefighters Grant program [EMW-2014-FP-00200]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006694] Funding Source: NIH RePORTER	US Federal Emergency Management Agency Assistance to Firefighters Grant program; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by a grant from the US Federal Emergency Management Agency Assistance to Firefighters Grant program (https://www.fema.gov/assistance-firefighters-grant-awards), #EMW-2014-FP-00200. This grant was awarded to the corresponding author, JLB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by a grant from the US Federal Emergency Management Agency Assistance to Firefighters Grant program, EMW-2014-FP-00200.	Ahn YS, 2012, AM J IND MED, V55, P768, DOI 10.1002/ajim.22068; Aoki Y, 2003, BLOOD, V101, P1535, DOI 10.1182/blood-2002-07-2130; Aryee MJ, 2014, BIOINFORMATICS, V30, P1363, DOI 10.1093/bioinformatics/btu049; Balint E, 2001, BRIT J CANCER, V85, P1813, DOI 10.1054/bjoc.2001.2128; Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Belinsky SA, 2005, CARCINOGENESIS, V26, P1481, DOI 10.1093/carcin/bgi020; Biswas S, 2017, PHARMACOL THERAPEUT, V173, P118, DOI 10.1016/j.pharmthera.2017.02.011; Bollati V, 2010, CHRONOBIOL INT, V27, P1093, DOI 10.3109/07420528.2010.490065; Bolstad-Johnson DM, 2000, AIHAJ, V61, P636, DOI 10.1202/0002-8894(2000)061<0636:COFEDF>2.0.CO;2; Burgess JL, 2001, J OCCUP ENVIRON MED, V43, P467, DOI 10.1097/00043764-200105000-00007; Chalkiadaki A, 2015, NAT REV CANCER, V15, DOI 10.1038/nrc3985; Chang C, 2014, ONCOGENE, V33, P3225, DOI 10.1038/onc.2013.274; Chu ML, 2014, ONCOL REP, V31, P34, DOI 10.3892/or.2013.2810; Corn PG, 1999, CANCER RES, V59, P3352; CRAWHALL JC, 1969, AM J DIS CHILD, V117, P71, DOI 10.1001/archpedi.1969.02100030073008; D'Addario G, 2010, ANN ONCOL; Daniels RD, 2015, OCCUP ENVIRON MED, V72, P699, DOI 10.1136/oemed-2014-102671; Daniels RD, 2014, OCCUP ENVIRON MED, V71, P388, DOI 10.1136/oemed-2013-101662; Djusberg E, 2017, PROSTATE, V77, P625, DOI 10.1002/pros.23307; Dobraca D, 2015, J OCCUP ENVIRON MED, V57, P88, DOI 10.1097/JOM.0000000000000307; Dodeller F, 2008, J BIOL CHEM, V283, P21487, DOI 10.1074/jbc.M801908200; Dunning MJ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-85; Elbendary AA, 1996, CLIN CANCER RES, V2, P1571; Fagerberg L, 2014, MOL CELL PROTEOMICS, V13, P397, DOI 10.1074/mcp.M113.035600; Fent Kenneth W, 2015, J Occup Environ Hyg, V12, P404, DOI 10.1080/15459624.2015.1025135; Fent KW, 2014, ANN OCCUP HYG, V58, P830, DOI 10.1093/annhyg/meu036; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; FROINES JR, 1987, AM IND HYG ASSOC J, V48, P202, DOI 10.1202/0002-8894(1987)048<0202:EOFTDE>2.0.CO;2; Gal-Yam EN, 2008, P NATL ACAD SCI USA, V105, P12979, DOI 10.1073/pnas.0806437105; Glass DC, 2016, OCCUP ENVIRON MED, V73, P761, DOI 10.1136/oemed-2015-103467; Guo JF, 2017, CANCER LETT, V386, P161, DOI 10.1016/j.canlet.2016.08.018; Gyorffy B, 2016, INT J CANCER, V138, P87, DOI 10.1002/ijc.29684; Han CY, 2016, SCI REP-UK, V6, DOI 10.1038/srep31237; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Horvath S, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0649-6; Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115; Houseman EA, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-86; IARC, 2010, PAINT FIR SHIFTW; Ide CW, 2014, OCCUP MED-OXFORD, V64, P421, DOI 10.1093/occmed/kqu080; Jaffe AE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r31; Jeong KS, 2018, J OCCUP ENV MED; Jin CF, 2011, J OCCUP ENVIRON MED, V53, P324, DOI 10.1097/JOM.0b013e31820d1314; Jones PA, 1999, TRENDS GENET, V15, P34, DOI 10.1016/S0168-9525(98)01636-9; Karaca E, 2015, NEURON, V88, P499, DOI 10.1016/j.neuron.2015.09.048; Kassim S, 2008, IUBMB LIFE, V56, P417; Kawano S, 1999, BLOOD, V94, P1113; Keir JLA, 2017, ENVIRON SCI TECHNOL, V51, P12745, DOI 10.1021/acs.est.7b02850; Khamas A, 2012, INT J ONCOL, V41, P490, DOI 10.3892/ijo.2012.1500; Kijima T, 2002, CELL GROWTH DIFFER, V13, P355; Klutstein M, 2016, CANCER RES, V76, P3446, DOI 10.1158/0008-5472.CAN-15-3278; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Lagal V, 2014, J CELL SCI, V127, P328, DOI 10.1242/jcs.130161; Laitinen JA, 2014, TOXICOL LETT, V231, P227, DOI 10.1016/j.toxlet.2014.09.007; Lee H, 2012, P NATL ACAD SCI USA, V109, P7765, DOI 10.1073/pnas.1205132109; Lehner B, 2006, NAT GENET, V38, P896, DOI 10.1038/ng1844; LeMasters GK, 2006, J OCCUP ENVIRON MED, V48, P1189, DOI 10.1097/01.jom.0000246229.68697.90; Levine AJ, 2006, CELL DEATH DIFFER, V13, P1027, DOI 10.1038/sj.cdd.4401910; Li S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08595-6; Link A, 2010, BIOCHEM PHARMACOL, V80, P1771, DOI 10.1016/j.bcp.2010.06.036; Liu D, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14070679; Liu R, 2015, CANCER CAUSE CONTROL, V26, P171, DOI 10.1007/s10552-014-0494-z; Lou W, 2000, PROSTATE, V42, P239, DOI 10.1002/(SICI)1097-0045(20000215)42:3<239::AID-PROS10>3.0.CO;2-G; Maksimovic J, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r44; Massion PP, 2003, CANCER RES, V63, P7113; Mehta C R, 1994, Stat Methods Med Res, V3, P135, DOI 10.1177/096228029400300203; Mikeska T, 2014, GENES-BASEL, V5, P821, DOI 10.3390/genes5030821; Milani L, 2010, BLOOD, V115, P1214, DOI 10.1182/blood-2009-04-214668; Moore KJ, 2018, JAMA DERMATOL, V154, P219, DOI 10.1001/jamadermatol.2017.4254; Nakayama M, 1998, BLOOD, V92, P4296, DOI 10.1182/blood.V92.11.4296.423k25_4296_4307; Nesset KA, 2014, EPIGENETICS-US, V9, P851, DOI 10.4161/epi.28484; Oliveira M, 2017, SCI TOTAL ENVIRON, V592, P277, DOI 10.1016/j.scitotenv.2017.03.081; Ouyang B, 2012, J OCCUP ENVIRON MED, V54, P774, DOI 10.1097/JOM.0b013e31825296bc; Pavanello S, 2009, INT J CANCER, V125, P1692, DOI 10.1002/ijc.24492; Perera F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004488; Peters TJ, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/1756-8935-8-6; Price EM, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-4; Pukkala E, 2014, OCCUP ENVIRON MED, V71, P398, DOI 10.1136/oemed-2013-101803; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rivlin Noa, 2011, Genes Cancer, V2, P466, DOI 10.1177/1947601911408889; Sedgwick P, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6284; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Shenker N, 2012, BRIT J CANCER, V106, P248, DOI 10.1038/bjc.2011.550; Shi FQ, 2013, ENVIRON MOL MUTAGEN, V54, P406, DOI 10.1002/em.21790; Smith JF, 2007, EPIGENETICS-US, V2, P161, DOI 10.4161/epi.2.3.4805; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Stec AA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20616-6; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Tan MHE, 2015, ACTA PHARMACOL SIN, V36, P3, DOI 10.1038/aps.2014.18; Tian J, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.395574; Tokino T, 2000, CRIT REV ONCOL HEMAT, V33, P1, DOI 10.1016/S1040-8428(99)00051-7; TOOHEY JI, 1989, BIOCHEM J, V264, P625, DOI 10.1042/bj2640625; Tsai RJ, 2015, AM J IND MED, V58, P715, DOI 10.1002/ajim.22466; Vainio P, 2012, PROSTATE, V72, P789, DOI 10.1002/pros.21487; Wang KC, 2016, CLIN LAB, V62, P327, DOI 10.7754/Clin.Lab.2015.150602; Yang HY, 2003, CLIN CANCER RES, V9, P4034; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Zhang Y, 2016, ONCOL REP, V36, P299, DOI 10.3892/or.2016.4821; Zhang Z, 2008, EMBO J, V27, P852, DOI 10.1038/emboj.2008.25; Zhu Y, 2011, CHRONOBIOL INT, V28, P852, DOI 10.3109/07420528.2011.618896; ZYKADIA (ceritinib) [package insert], 2014, ZYKADIA CER; Zykadia (certinib) [package insert], 2015, ZYK CERT	101	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2019	14	3							e0214282	10.1371/journal.pone.0214282	http://dx.doi.org/10.1371/journal.pone.0214282			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ3IW	30913233	Green Published, Green Submitted, gold			2022-12-26	WOS:000462305600036
J	van Putten, M; Putker, K; Overzier, M; Adamzek, WA; Pasteuning-Vuhman, S; Plomp, JJ; Aartsma-Rus, A				van Putten, Maaike; Putker, Kayleigh; Overzier, Maurice; Adamzek, W. A.; Pasteuning-Vuhman, Svetlana; Plomp, Jaap J.; Aartsma-Rus, Annemieke			Natural disease history of the D2-mdx mouse model for Duchenne muscular dystrophy	FASEB JOURNAL			English	Article						pathology; fibrosis; calcification; muscle function; regeneration	MDX MOUSE; SATELLITE CELLS; MICE; REGENERATION; PHENOTYPE; GENE	The C57BL/10ScSn-Dmd(mdx)/J (BL10-mdx) mouse has been the most commonly used model for Duchenne muscular dystrophy (DMD) for decades. Their muscle dysfunction and pathology is, however, less severe than in patients with DMD, which complicates preclinical studies. Recent discoveries indicate that disease severity is exacerbated when muscular dystrophy mouse models are generated on a DBA2/J genetic background. Knowledge on the natural history of animal models is pivotal for high-quality preclinical testing. However, for BL10-mdx mice on a DBA2/J background (D2-mdx), limited data are available. We addressed this gap in the natural history knowledge. First, we compared histopathological aspects in skeletal muscles of young D2-mdx, BL10-mdx, and wild-type mice. Pathology was more pronounced in D2-mdx mice and differed in severity between muscles within individuals. Secondly, we subjected D2-mdx mice to a functional test regime for 34 weeks and identified that female D2-mdx mice outperform severely impaired males, making females less useful for functional preclinical studies. Direct comparisons between 10- and 34-wk-old D2-mdx mice revealed that disease pathology ameliorates with age. Heart pathology was progressive, with some features already evident at a young age. This natural history study of the D2-mdx mouse will be instrumental for experimental design of future preclinical studies.-Van Putten, M., Putker, K., Overzier, M., Adamzek, W. A., Pasteuning-Vuhman, S., Plomp, J. J., Aartsma-Rus, A. Natural disease history of the D2-mdx mouse model for Duchenne muscular dystrophy.	[van Putten, Maaike; Putker, Kayleigh; Overzier, Maurice; Adamzek, W. A.; Pasteuning-Vuhman, Svetlana; Aartsma-Rus, Annemieke] Leiden Univ, Med Ctr, Dept Human Genet, Einthovenweg 20,Postzone S4-P,Albinusdreef 2, NL-2333 ZA Leiden, Netherlands; [Plomp, Jaap J.] Leiden Univ, Med Ctr, Dept Neurol, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Aartsma-Rus, A (corresponding author), Leiden Univ, Med Ctr, Dept Human Genet, Einthovenweg 20,Postzone S4-P,Albinusdreef 2, NL-2333 ZA Leiden, Netherlands.	a.m.rus@lumc.nl		Overzier, Maurice/0000-0002-8143-4884	Duchenne Parent Project, French Muscular Dystrophy Association (AFM) Telethon [20251]; ZonMw [113302001]; Italpharmaco; Alpha Anomeric	Duchenne Parent Project, French Muscular Dystrophy Association (AFM) Telethon; ZonMw(Netherlands Organization for Health Research and Development); Italpharmaco; Alpha Anomeric	The authors are grateful for the experimental help of Davy van de Vijver, Mandy Kater, and Joris van der Hurk [Leiden University Medical Centre (LUMC)]. This work was supported by funding from Duchenne Parent Project, French Muscular Dystrophy Association (AFM) Telethon (Grant 20251) and ZonMw (Grant 113302001) for researchers' salaries. A.A.-R. is employed by Leiden University Medical Center (LUMC), which has patents on exon skipping technology, some of which has been licensed to BioMarin and subsequently sublicensed to Sarepta. As co-inventor of some of these patents, A.A.-R. is entitled to a share of royalties. A.A.-R. is also an ad hoc consultant for PTC Therapeutics, Summit PLC, Alpha Anomeric, BioMarin Pharmaceuticals, Eisai, Global Guidepoint and GLG consultancy, Grunenthal, Wave, and BioClinica. A.A.-R. was also a member of the Duchenne Network Steering Committee (BioMarin) and a member of the scientific advisory boards of ProQR, MirrX Therapeutics, and Philae Pharmaceuticals. Remuneration for these activities is paid to LUMC. LUMC also received speaker honoraria from PTC Therapeutics and BioMarin Pharmaceuticals and funding for contract research from Italpharmaco and Alpha Anomeric. The remaining authors declare no conflicts of interest.	Aartsma-Rus A, 2014, JOVE-J VIS EXP, DOI 10.3791/51303; Aherrahrou Z, 2007, PHYSIOL GENOMICS, V28, P203, DOI 10.1152/physiolgenomics.00133.2006; Bladen CL, 2015, HUM MUTAT, V36, P395, DOI 10.1002/humu.22758; Boldrin L, 2015, STEM CELL RES, V14, P20, DOI 10.1016/j.scr.2014.10.007; Coley WD, 2016, HUM MOL GENET, V25, P130, DOI 10.1093/hmg/ddv460; De Luca Annamaria, 2012, Acta Myol, V31, P40; DIMARIO JX, 1991, DEV BIOL, V148, P314, DOI 10.1016/0012-1606(91)90340-9; Emery AE, 2015, OXFORD MONOGRAPHS G, V67; Emery AEH, 2002, LANCET, V359, P687, DOI 10.1016/S0140-6736(02)07815-7; Flanigan KM, 2013, ANN NEUROL, V73, P481, DOI 10.1002/ana.23819; Fukada S, 2010, AM J PATHOL, V176, P2414, DOI 10.2353/ajpath.2010.090887; Gissel H, 2005, ANN NY ACAD SCI, V1066, P166, DOI 10.1196/annals.1363.013; Gordish-Dressman Heather, 2018, J Neuromuscul Dis, V5, P407, DOI 10.3233/JND-180324; Grounds MD, 2008, NEUROBIOL DIS, V31, P1, DOI 10.1016/j.nbd.2008.03.008; Hakim CH, 2017, MOL THER-METH CLIN D, V6, P216, DOI 10.1016/j.omtm.2017.06.006; Hakim CH, 2012, MUSCLE NERVE, V45, P250, DOI 10.1002/mus.22275; Heydemann A, 2009, J CLIN INVEST, V119, P3703, DOI 10.1172/JCI39845; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Hourde C, 2013, MUSCLE NERVE, V48, P68, DOI 10.1002/mus.23700; Kim S, 2015, J CHILD NEUROL, V30, P1275, DOI 10.1177/0883073814558120; Klingler Werner, 2012, Acta Myol, V31, P184; Mendell JR, 2013, ANN NEUROL, V74, P637, DOI 10.1002/ana.23982; Meng HJ, 2007, P NATL ACAD SCI USA, V104, P4530, DOI 10.1073/pnas.0607620104; Moat SJ, 2013, EUR J HUM GENET, V21, P1049, DOI 10.1038/ejhg.2012.301; Moxley RT, 2010, J CHILD NEUROL, V25, P1116, DOI 10.1177/0883073810371004; Pasteuning-Vuhman S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182704; Roberts NW, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/131436; Rodrigues M, 2016, SCI REP-UK, V6, DOI 10.1038/srep38371; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; SICINSKI P, 1989, SCIENCE, V244, P1578, DOI 10.1126/science.2662404; Straub V, 2016, LANCET NEUROL, V15, P882, DOI 10.1016/S1474-4422(16)30035-7; Swaggart KA, 2014, P NATL ACAD SCI USA, V111, P6004, DOI 10.1073/pnas.1324242111; van den Bergen JC, 2015, J NEUROL NEUROSUR PS, V86, P1060, DOI 10.1136/jnnp-2014-308409; van der Pijl EM, 2018, NEUROMUSCULAR DISORD, V28, P427, DOI 10.1016/j.nmd.2018.02.013; van der Pijl EM, 2016, EUR J NEUROSCI, V43, P1623, DOI 10.1111/ejn.13249; Vohra R, 2017, AM J PATHOL, V187, P2060, DOI 10.1016/j.ajpath.2017.05.010; Wallace GQ, 2009, ANNU REV PHYSIOL, V71, P37, DOI 10.1146/annurev.physiol.010908.163216; Weiss RB, 2018, ANN NEUROL, V84, P234, DOI 10.1002/ana.25283	38	51	51	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2019	33	7					8110	8124		10.1096/fj.201802488R	http://dx.doi.org/10.1096/fj.201802488R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ9SM	30933664	Green Published, hybrid			2022-12-26	WOS:000476234700025
J	Zhang, XF; Grosfeld, A; Williams, E; Vasiliauskas, D; Barretto, S; Smith, L; Mariadassou, M; Philippe, C; Devime, F; Melchior, C; Gourcerol, G; Dourmap, N; Lapaque, N; Larraufie, P; Blottiere, HM; Herberden, C; Gerard, P; Rehfeld, JF; Ferraris, RP; Fritton, JC; Ellero-Simatos, S; Douard, V				Zhang, Xufei; Grosfeld, Alexandra; Williams, Edek; Vasiliauskas, Daniel; Barretto, Sharon; Smith, Lorraine; Mariadassou, Mahendra; Philippe, Catherine; Devime, Fabienne; Melchior, Chloe; Gourcerol, Guillaume; Dourmap, Nathalie; Lapaque, Nicolas; Larraufie, Pierre; Blottiere, Herve M.; Herberden, Christine; Gerard, Philippe; Rehfeld, Jens F.; Ferraris, Ronaldo P.; Fritton, J. Christopher; Ellero-Simatos, Sandrine; Douard, Veronique			Fructose malabsorption induces cholecystokinin expression in the ileum and cecum by changing microbiota composition and metabolism	FASEB JOURNAL			English	Article						CCK; KHK; propionate	CHAIN FATTY-ACIDS; Y GASTRIC BYPASS; GLUCAGON-LIKE PEPTIDE-1; ENTEROENDOCRINE CELLS; DIETARY FRUCTOSE; HORMONE EXPRESSION; RECEPTOR; CCK; GLUCOSE; GLP-1	Current fructose consumption levels often overwhelm the intestinal capacity to absorb fructose. We investigated the impact of fructose malabsorption on intestinal endocrine function and addressed the role of the microbiota in this process. To answer this question, a mouse model of moderate fructose malabsorption [ketohexokinase mutant (KHK)(-/-)] and wild-type (WT) littermate mice were used and received a 20%-fructose (KHK-F and WT-F) or 20%-glucose diet. Cholecystokinin (Cck) mRNA and protein expression in the ileum and cecum, as well as preproglucagon (Gcg) and neurotensin (Nts) mRNA expression in the cecum, increased in KHK-F mice. In KHK-F mice, triple-label immunohistochemistry showed major up-regulation of CCK in enteroendocrine cells (EECs) that were glucagon-like peptide-1 (GLP-1)(+)/Peptide YY (PYY-) in the ileum and colon and GLP-1(-)/PYY- in the cecum. The cecal microbiota composition was drastically modified in the KHK-F in association with an increase in glucose, propionate, succinate, and lactate concentrations. Antibiotic treatment abolished fructose malabsorption-dependent induction of cecal Cck mRNA expression and, in mouse GLUTag and human NCI-H716 cells, Cck mRNA expression levels increased in response to propionate, both suggesting a microbiota-dependent process. Fructose reaching the lower intestine can modify the composition and metabolism of the microbiota, thereby stimulating the production of CCK from the EECs possibly in response to propionate.-Zhang, X., Grosfeld, A., Williams, E., Vasiliauskas, D., Barretto, S., Smith, L., Mariadassou, M., Philippe, C., Devime, F., Melchior, C., Gourcerol, G., Dourmap, N., Lapaque, N., Larraufie, P., Blottiere, H. M., Herberden, C., Gerard, P., Rehfeld, J. F., Ferraris, R. P., Fritton, J. C., Ellero-Simatos, S., Douard, V. Fructose malabsorption induces cholecystokinin expression in the ileum and cecum by changing microbiota composition and metabolism.	[Zhang, Xufei; Philippe, Catherine; Devime, Fabienne; Lapaque, Nicolas; Larraufie, Pierre; Blottiere, Herve M.; Herberden, Christine; Gerard, Philippe; Douard, Veronique] Univ Paris Saclay, AgroParisTech, INRA, Micalis Inst, Jouy En Josas, France; [Zhang, Xufei] Sorbonne Univ, Coll Doctoral, Paris, France; [Grosfeld, Alexandra] UPD, Sorbonne Univ, Sorbonne Cites,CNRS,IHU,ICAN, Ctr Rech Cordeliers,INSERM Unite Mixte Rech UMR S, Paris, France; [Williams, Edek; Fritton, J. Christopher] Rutgers State Univ, Dept Orthoped, Newark, NJ USA; [Ferraris, Ronaldo P.] Rutgers State Univ, Dept Pharmacol Physiol & Neurosci, Newark, NJ USA; [Vasiliauskas, Daniel] Univ Paris Saclay, CNRS, Univ Paris Sud, Paris Saclay Inst Neurosci, Gif Sur Yvette, France; [Barretto, Sharon; Smith, Lorraine; Ellero-Simatos, Sandrine] Univ Toulouse, INRA, Toxalim, Toulouse, France; [Mariadassou, Mahendra] INRA, Unite Rech UR 1404, Math & Informat Appl Genome Environm MaIAGE, Jouy En Josas, France; [Melchior, Chloe; Gourcerol, Guillaume] Normandie Univ, Univ Rouen UNIROUEN, INSERM, U1073, Rouen, France; [Dourmap, Nathalie] Normandy Univ, UNIROUEN, INSERM U1245, Rouen, France; [Dourmap, Nathalie] Normandy Univ, Rouen Univ Hosp, Normandy Ctr Genom & Personalized Med, Rouen, France; [Rehfeld, Jens F.] Univ Copenhagen, Rigshosp, Dept Clin Biochem, Copenhagen, Denmark	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Newark; Rutgers State University New Brunswick; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; INRAE; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Rouen; Rigshospitalet; University of Copenhagen	Douard, V (corresponding author), INRA, Micalis Inst, F-78352 Jouy En Josas, France.	veronique.douard@inra.fr	Larraufie, Pierre/P-7063-2015; Grosfeld, Alexandra/R-1404-2017; Gérard, Philippe/H-8138-2019; Lapaque, Nicolas/AAB-4530-2021; Larraufie, Pierre/ABH-2988-2021; BLOTTIERE, Hervé M/C-6120-2011; Melchior, Chloé/AAM-8148-2020; Vasiliauskas, Daniel/AAV-1981-2020; Douard, veronique/AAU-6271-2020; Grosfeld, Alexandra/AAH-3510-2020	Larraufie, Pierre/0000-0001-7718-6200; Grosfeld, Alexandra/0000-0002-9508-036X; Gérard, Philippe/0000-0001-9521-0067; Lapaque, Nicolas/0000-0003-0824-0108; BLOTTIERE, Hervé M/0000-0002-8390-0607; Vasiliauskas, Daniel/0000-0002-0570-2322; Melchior, Chloe/0000-0002-8146-1540; Fritton, James/0000-0002-6475-7622; Gourcerol, Guillaume/0000-0001-8220-9155; DOURMAP, nathalie/0000-0002-9453-5828	Institut Benjamin Delessert; INRA; China Scholarship Council (CSC); National Center for Complementary & Integrative Health [R01AT010243] Funding Source: NIH RePORTER	Institut Benjamin Delessert; INRA; China Scholarship Council (CSC)(China Scholarship Council); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank J.P. Furet (Micalis Institute, INRA, Jouyen-Josas, France), F. Rouyer (Paris-Saclay Institute of Neuroscience, Universite Paris Sud, CNRS, Universite Paris-Saclay, Gif-sur-Yvette, France), and S. P. Shirazi-Beechey (Institute of Integrative Biology, University of Liverpool, United Kingdom) for sharing reagents and equipment. The authors are grateful to the INRA Migale bioinformatics platform (http://migale.jouy.inra.fr/) for providing computational resources, the Genotoul high-throughput sequencing platform (http://bioinfo.genotoul.fr/), and the histology facility of UMR 1313 Genetique Animale et Biologie Integrative (GABI). This work was supported by grants from Institut Benjamin Delessert and by INRA. The China Scholarship Council (CSC) and INRA funded PhD fellowships to X.Z. The authors declare no conflicts of interest.	AIKEN KD, 1994, DEV DYNAM, V201, P63, DOI 10.1002/aja.1002010107; Akiba Y, 2015, J PHYSIOL-LONDON, V593, P585, DOI 10.1113/jphysiol.2014.280792; Arora T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18079-2; Barrett TD, 2008, BRIT J PHARMACOL, V153, P1650, DOI 10.1038/bjp.2008.44; Bokulich NA, 2013, NAT METHODS, V10, P57, DOI [10.1038/nmeth.2276, 10.1038/NMETH.2276]; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; Cani PD, 2007, BRIT J NUTR, V98, P32, DOI 10.1017/S0007114507691648; Cao B, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-19; Cavin JB, 2016, GASTROENTEROLOGY, V150, P454, DOI 10.1053/j.gastro.2015.10.009; Chua ASB, 2006, WORLD J GASTROENTERO, V12, P2688, DOI 10.3748/wjg.v12.i17.2688; Daly K, 2013, AM J PHYSIOL-GASTR L, V304, pG271, DOI 10.1152/ajpgi.00074.2012; DAVIDSON NO, 1992, AM J PHYSIOL, V262, pC795, DOI 10.1152/ajpcell.1992.262.3.C795; De Gregoris TB, 2011, J MICROBIOL METH, V86, P351, DOI 10.1016/j.mimet.2011.06.010; Delmee E, 2006, LIFE SCI, V79, P1007, DOI 10.1016/j.lfs.2006.05.013; Diehl J, 2016, CELL TISSUE RES, V364, P245, DOI 10.1007/s00441-015-2318-1; Diggle CP, 2010, PHYSIOL GENOMICS, V42A, P235, DOI 10.1152/physiolgenomics.00128.2010; Douard V, 2008, AM J PHYSIOL-ENDOC M, V295, pE227, DOI 10.1152/ajpendo.90245.2008; Douard V, 2013, J PHYSIOL-LONDON, V591, P401, DOI 10.1113/jphysiol.2011.215731; Egerod KL, 2012, ENDOCRINOLOGY, V153, P5782, DOI 10.1210/en.2012-1595; Escudie F, 2018, BIOINFORMATICS, V34, P1287, DOI 10.1093/bioinformatics/btx791; Fakhry J, 2017, CELL TISSUE RES, V369, P245, DOI 10.1007/s00441-017-2612-1; Furet JP, 2009, FEMS MICROBIOL ECOL, V68, P351, DOI 10.1111/j.1574-6941.2009.00671.x; Ganzle MG, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00340; Gill RK, 2005, AM J PHYSIOL-CELL PH, V289, pC846, DOI 10.1152/ajpcell.00112.2005; Gillard L, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00224; Gillard L, 2016, SCI REP-UK, V6, DOI 10.1038/srep28345; Gribble FM, 2016, ANNU REV PHYSIOL, V78, P277, DOI 10.1146/annurev-physiol-021115-105439; Grunddal KV, 2016, ENDOCRINOLOGY, V157, P176, DOI 10.1210/en.2015-1600; Habib AM, 2012, ENDOCRINOLOGY, V153, P3054, DOI 10.1210/en.2011-2170; HARVEY RF, 1973, LANCET, V1, P1; Hill ME, 1999, MOL ENDOCRINOL, V13, P1474, DOI 10.1210/me.13.9.1474; Ishimoto T, 2012, P NATL ACAD SCI USA, V109, P4320, DOI 10.1073/pnas.1119908109; Jang C, 2018, CELL METAB, V27, P351, DOI 10.1016/j.cmet.2017.12.016; Jenny M, 2002, EMBO J, V21, P6338, DOI 10.1093/emboj/cdf649; Jones HF, 2011, J PEDIATR GASTR NUTR, V52, P581, DOI 10.1097/MPG.0b013e3181fd1315; Jones HF, 2011, AM J PHYSIOL-GASTR L, V300, pG202, DOI 10.1152/ajpgi.00457.2010; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Lan A, 2008, BRIT J NUTR, V100, P1251, DOI 10.1017/S0007114508978284; Larraufie P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18259-0; Ledochowski M, 2001, CLIN CHIM ACTA, V311, P119, DOI 10.1016/S0009-8981(01)00580-0; LOPEZ MJ, 1995, J BIOL CHEM, V270, P885, DOI 10.1074/jbc.270.25.14989; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lukowicz C, 2018, ENVIRON HEALTH PERSP, V126, DOI [10.1289/EHP2877, 10.1289/ehp2877]; Manolescu AR, 2007, PHYSIOLOGY, V22, P234, DOI 10.1152/physiol.00011.2007; Marriott BP, 2009, J NUTR, V139, pS1228, DOI 10.3945/jn.108.098277; Mumphrey MB, 2013, NEUROGASTROENT MOTIL, V25, pE70, DOI 10.1111/nmo.12034; Nakanishi Y, 2006, APPL ENVIRON MICROB, V72, P6271, DOI 10.1128/AEM.00477-06; NAYA FJ, 1995, GENE DEV, V9, P1009, DOI 10.1101/gad.9.8.1009; Nergard BJ, 2015, SURG OBES RELAT DIS, V11, P1237, DOI 10.1016/j.soard.2015.03.021; Nohr MK, 2013, ENDOCRINOLOGY, V154, P3552, DOI 10.1210/en.2013-1142; Patel C, 2015, AM J PHYSIOL-GASTR L, V309, pG779, DOI 10.1152/ajpgi.00188.2015; Patel C, 2015, AM J PHYSIOL-REG I, V309, pR499, DOI 10.1152/ajpregu.00128.2015; Patel C, 2015, FASEB J, V29, P4046, DOI 10.1096/fj.15-272195; Plovier Hubert, 2017, Endocr Dev, V32, P139, DOI 10.1159/000475736; Pouteau E, 2003, P NUTR SOC, V62, P87, DOI 10.1079/PNS2003208; Psichas A, 2015, INT J OBESITY, V39, P424, DOI 10.1038/ijo.2014.153; Putkonen L, 2013, CURR OPIN CLIN NUTR, V16, P473, DOI 10.1097/MCO.0b013e328361c556; Ranganathan P, 2018, J IMMUNOL, V200, P1781, DOI 10.4049/jimmunol.1700604; Rehfeld JF, 1998, REGUL PEPTIDES, V78, P31, DOI 10.1016/S0167-0115(98)00133-5; Reichardt N, 2014, ISME J, V8, P1323, DOI 10.1038/ismej.2014.14; Rhee NA, 2015, DIABETOLOGIA, V58, P2254, DOI 10.1007/s00125-015-3696-3; Richards P, 2016, PEPTIDES, V77, P21, DOI 10.1016/j.peptides.2015.06.006; Schonhoff SE, 2004, ENDOCRINOLOGY, V145, P2639, DOI 10.1210/en.2004-0051; SEALY L, 1978, CELL, V14, P115, DOI 10.1016/0092-8674(78)90306-9; Sun SR, 2017, PHYSIOLOGY, V32, P453, DOI 10.1152/physiol.00016.2017; Tappy L, 2010, PHYSIOL REV, V90, P23, DOI 10.1152/physrev.00019.2009; Tolhurst G, 2012, DIABETES, V61, P364, DOI 10.2337/db11-1019; Wichmann A, 2013, CELL HOST MICROBE, V14, P582, DOI 10.1016/j.chom.2013.09.012; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1	69	23	23	4	26	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					7126	7142		10.1096/fj.201801526RR	http://dx.doi.org/10.1096/fj.201801526RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30939042	Green Published, Bronze			2022-12-26	WOS:000476114200038
J	Eloundou, SN; Lee, J; Wu, D; Lei, J; Feller, MC; Ozen, M; Zhu, Y; Hwang, M; Jia, B; Xie, H; Clemens, JL; McLane, MW; AlSaggaf, S; Nair, N; Wills-Karp, M; Wang, XB; Graham, EM; Baschat, A; Burd, I				Eloundou, Solange N.; Lee, JiYeon; Wu, Dan; Lei, Jun; Feller, Mia C.; Ozen, Maide; Zhu, Yan; Hwang, Misun; Jia, Bei; Xie, Han; Clemens, Julia L.; McLane, Michael W.; AlSaggaf, Samar; Nair, Nita; Wills-Karp, Marsha; Wang, Xiaobin; Graham, Ernest M.; Baschat, Ahmet; Burd, Irina			Placental malperfusion in response to intrauterine inflammation and its connection to fetal sequelae	PLOS ONE			English	Article							MYOCARDIAL PERFORMANCE INDEX; DEFINING NORMAL VALUES; CEREBRAL-PALSY; PRETERM BIRTH; THROMBOTIC VASCULOPATHY; DOPPLER CHANGES; BRAIN-INJURY; MOUSE MODEL; RISK; INSUFFICIENCY	Exposure to intrauterine inflammation (IUI) is associated with short- and long-term adverse perinatal outcomes. However, little data exist on utilizing placenta to prognosticate fetal injury in this scenario. Our study aimed to utilize imaging modalities to evaluate mechanisms contributing to placental injury following IUI exposure and correlated it to concomitant fetal brain injury. CD1 pregnant dams underwent laparotomies and received intrauterine injections of either lipopolysaccharide (LPS; a model of IUI) or phosphate-buffered saline (PBS). In utero ultrasound Doppler velocimetry of uterine and umbilical arteries and magnetic resonance imaging (MRI) of placental volumes with confirmatory immunohistochemical (vimentin) and histochemistry (fibrin) analyses were performed. ELISA for thrombosis markers, fibrinogen and fibrin was performed to analyze thrombi in placenta. Fetal brain immunohistochemistry was performed to detect microglial activation (ionized calcium-binding adaptor molecule 1, lba1). On ultrasound, LPS group demonstrated elevated resistance indices, pulsatility indices and a greater occurrence of absent end-diastolic flow in the umbilical and uterine arteries. In the fetus, there was an increased cardiac Tei indices in the LPS group. MRI revealed decreased volume of placenta in the LPS group associated with placental thinning and placental endothelial damage on immunohistochemistry. Decreased fibrinogen content and more thrombi staining in placenta exposed to maternal LPS indicated the hypercoagulability. Furthermore, the expression of lba1was significantly associated with placental thickness (r = -0.7890, Pearson correlation coefficient). Our data indicate that IUI can trigger events leading to maternal placental malperfusion and fetal vessel resistance, as well as predispose the developing fetus to cardiac dysfunction and brain damage. Furthermore, our data suggest that prenatal ultrasound can be a real-time clinical tool for assessing fetal risk for adverse neurologic outcomes following the potential IUI exposure.	[Eloundou, Solange N.; Lee, JiYeon; Lei, Jun; Feller, Mia C.; Ozen, Maide; Zhu, Yan; Jia, Bei; Xie, Han; Clemens, Julia L.; McLane, Michael W.; Nair, Nita; Graham, Ernest M.; Burd, Irina] Johns Hopkins Univ, Sch Med, Dept Gynecol & Obstet, Integrated Res Ctr Fetal Med,Div Maternal Fetal M, Baltimore, MD 21205 USA; [Wu, Dan; Hwang, Misun] Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD USA; [Ozen, Maide] Johns Hopkins Univ, Sch Med, Dept Pediat, Div Neonatol, Baltimore, MD 21205 USA; [AlSaggaf, Samar] King Abdulaziz Univ, Dept Pathol, Jeddah, Saudi Arabia; [Wills-Karp, Marsha] Johns Hopkins Univ, Sch Publ Hlth, Dept Environm Hlth & Engn, Baltimore, MD USA; [Wang, Xiaobin] Johns Hopkins Univ, Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Ctr Early Life Origins Dis, Baltimore, MD USA; [Baschat, Ahmet] Johns Hopkins Univ, Sch Med, Dept Gynecol & Obstet, Fetal Therapy, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; King Abdulaziz University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Burd, I (corresponding author), Johns Hopkins Univ, Sch Med, Dept Gynecol & Obstet, Integrated Res Ctr Fetal Med,Div Maternal Fetal M, Baltimore, MD 21205 USA.	iburd@jhmi.edu		Nair, Nita/0000-0002-9186-7026	Integrated Research Center for Fetal Medicine Fund [NICHDK08HD073315, R21NS098018]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K08HD073315] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS098018] Funding Source: NIH RePORTER	Integrated Research Center for Fetal Medicine Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Integrated Research Center for Fetal Medicine Fund, NICHDK08HD073315 (I.B.), and R21NS098018 (D.W.).	Andescavage N, 2017, J PERINATOL, V37, P1278, DOI 10.1038/jp.2017.129; Bahtiyar MO, 2008, SEMIN PERINATOL, V32, P190, DOI 10.1053/j.semperi.2008.02.010; Bashiri A, 2006, J PERINAT MED, V34, P5, DOI 10.1515/JPM.2006.001; Breen K, 2012, REPROD SCI, V19, P839, DOI 10.1177/1933719112438439; Brosens I, 2013, PLACENTA, V34, P100, DOI 10.1016/j.placenta.2012.11.017; Crispi F, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.06.056; Dada T, 2014, BRAIN BEHAV IMMUN, V38, P142, DOI 10.1016/j.bbi.2014.01.014; Dikshit S, 2011, J POSTGRAD MED, V57, P138, DOI 10.4103/0022-3859.81880; Friedman D, 2003, ULTRASOUND OBST GYN, V21, P33, DOI 10.1002/uog.11; Gaillard R, 2013, AM J EPIDEMIOL, V177, P743, DOI 10.1093/aje/kws296; Ghawi H, 2013, PEDIATR CARDIOL, V34, P1808, DOI 10.1007/s00246-013-0709-1; Giles W, 2003, BJOG-INT J OBSTET GY, V110, P593, DOI 10.1016/S1470-0328(03)02966-5; Girard S, 2010, J IMMUNOL, V184, P3997, DOI 10.4049/jimmunol.0903349; Girardi G, 2015, MOL PSYCHIATR, V20, P1017, DOI 10.1038/mp.2014.110; Goldenberg RL, 2000, NEW ENGL J MED, V342, P1500, DOI 10.1056/NEJM200005183422007; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Gotsch F, 2007, CLIN OBSTET GYNECOL, V50, P652, DOI 10.1097/GRF.0b013e31811ebef6; Grether JK, 1997, JAMA-J AM MED ASSOC, V278, P207, DOI 10.1001/jama.278.3.207; Kirik OV KD, 2016, NEUROSCI BEHAV PHYSL, V46, P7; Kraus FT, 1999, HUM PATHOL, V30, P759, DOI 10.1016/S0046-8177(99)90136-3; Kraus FT, 1997, HUM PATHOL, V28, P246, DOI 10.1016/S0046-8177(97)90114-3; Lax A, 2007, MAGN RESON IMAGING, V25, P87, DOI 10.1016/j.mri.2006.10.007; Lei J., 2015, AM J OBSTET GYNECOL, V212, pe631; Leitner K, 2014, AM J REPROD IMMUNOL, V71, P418, DOI 10.1111/aji.12216; Lepais L, 2014, PLACENTA, V35, P611, DOI 10.1016/j.placenta.2014.04.012; Lertkiatmongkol P, 2016, CURR OPIN HEMATOL, V23, P253, DOI 10.1097/MOH.0000000000000239; Muller ALL, 2010, ULTRASOUND OBST GYN, V36, P26, DOI 10.1002/uog.7584; LETTIERI L, 1993, AM J OBSTET GYNECOL, V168, P1480, DOI 10.1016/S0002-9378(11)90785-6; Levine D, 1997, RADIOLOGY, V204, P635, DOI 10.1148/radiology.204.3.9280237; Liu TG, 2010, AM J PHYSIOL-CELL PH, V299, pC363, DOI 10.1152/ajpcell.00057.2010; Lo JO, 2018, REPROD SCI, V25, P64, DOI 10.1177/1933719117699704; MCCORMICK MC, 1985, NEW ENGL J MED, V312, P82, DOI 10.1056/NEJM198501103120204; Mone F, 2014, J MATERN-FETAL NEO M, V27, P1633, DOI 10.3109/14767058.2013.871698; Muresan D, 2016, MED ULTRASON, V18, P103, DOI 10.11152/mu.2013.2066.181.dop; Nair A, 2016, ANN PEDIAT CARDIOL, V9, P132, DOI 10.4103/0974-2069.177516; RIZZO G, 1992, ULTRASOUND OBST GYN, V2, P434, DOI 10.1046/j.1469-0705.1992.02060434.x; Romero R, 2004, J Matern Fetal Neonatal Med, V16, P146; Spinillo A, 2012, PRENATAL DIAG, V32, P1263, DOI 10.1002/pd.3988; Stanifer JW, 2016, J MED BIOGR, V24, P89, DOI 10.1177/0967772013520101; Tei C, 1995, J Cardiol, V26, P357; Vermillion MS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14575; Viscardi RM, 2001, EARLY HUM DEV, V62, P1, DOI 10.1016/S0378-3782(01)00114-1; WHO, 2006, NEONATAL PERINATAL M; Wu D, 2018, J MAGN RESON IMAGING, V47, P1260, DOI 10.1002/jmri.25867; Wu D, 2015, J MAGN RESON IMAGING, V42, P717, DOI 10.1002/jmri.24828; Yoon BH, 2000, AM J OBSTET GYNECOL, V182, P675, DOI 10.1067/mob.2000.104207	46	22	21	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0214951	10.1371/journal.pone.0214951	http://dx.doi.org/10.1371/journal.pone.0214951			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR5NS	30943260	Green Submitted, Green Published, gold			2022-12-26	WOS:000463194300075
J	Lillie, TA; Persaud, NE; DiCarlo, MC; Gashobotse, D; Kamali, DR; Cheron, M; Nishimoto, L; Akolo, C; Mahler, HR; Au, MC; Wolf, RC				Lillie, Tiffany A.; Persaud, Navindra E.; DiCarlo, Meghan C.; Gashobotse, Dismas; Kamali, Didier R.; Cheron, Magda; Nishimoto, Lirica; Akolo, Christopher; Mahler, Hally R.; Au, Maria C.; Wolf, R. Cameron			Reaching the unreached: Performance of an enhanced peer outreach approach to identify new HIV cases among female sex workers and men who have sex with men in HIV programs in West and Central Africa	PLOS ONE			English	Article							SOCIAL NETWORKS; DRIVEN; INFECTION; BURDEN; MSM	Finding new HIV-positive cases remains a priority to achieve the UNAIDS goals. An enhanced peer outreach approach (EPOA) was implemented to expand the delivery of HIV services to female sex workers (FSWs) and men who have sex with men (MSM) in three countries in West and Central Africa. The aim of EPOA is to identify new HIV-positive cases. EPOA was implemented in Burundi among FSWs, and in Cote d'Ivoire and Democratic Republic of the Congo (DRC) among both FSWs and MSM. Implementation ranged from five to nine weeks and was nested within a three-month reporting period. Standard outreach was suspended for the duration of EPOA implementation but was resumed thereafter. Summary service statistics were used to compare HIV seropositivity during standard outreach and EPOA. Trends were analyzed during the quarter in which EPOA was implemented, and these were compared with the two preceding quarters. Differences in proportions of HIV seropositivity were tested using Pearson's chi-square test; p-values of less than 0.05 were considered statistically significant. Overall, EPOA resulted in a higher proportion of new HIV-positive cases being found, both within and between quarters. In Burundi, HIV seropositivity among FSWs was significantly higher during EPOA than during standard outreach (10.8% vs. 4.1%, p<0.001). In Cote d'Ivoire, HIV seropositivity was significantly higher during EPOA among both populations (FSWs: 5.6% vs. 1.81%, p<0.01; MSM: 15.4% vs. 5.9%; p<0.01). In DRC, HIV seropositivity was significantly higher during EPOA among MSM (6.9% vs. 1.6%; p<0.001), but not among FSWs (5.2% vs. 4.3%; p = 0.08). Trends in HIV seropositivity during routine outreach for both populations were constant during three successive quarters but increased with the introduction of EPOA. EPOA is a public health approach with great potential for reaching new populations and ensuring that they are aware of their HIV status.	[Lillie, Tiffany A.; Persaud, Navindra E.; DiCarlo, Meghan C.; Nishimoto, Lirica; Akolo, Christopher; Mahler, Hally R.] FHI 360 LINKAGES, Washington, DC 20009 USA; [Gashobotse, Dismas] FHI 360 LINKAGES, Bujumbura, Burundi; [Kamali, Didier R.] FHI 360 LINKAGES, Abidjan, Cote Ivoire; [Cheron, Magda] FHI 360 LINKAGES, Kinshasa, DEM REP CONGO; [Au, Maria C.; Wolf, R. Cameron] USAID, Washington, DC USA	United States Agency for International Development (USAID)	Lillie, TA (corresponding author), FHI 360 LINKAGES, Washington, DC 20009 USA.	tlillie@fhi360.org		Lillie, Tiffany/0000-0002-1960-503X	U.S. President's Emergency Plan for AIDS Relief (PEPFAR); USAID [AID-OAA-A-14-00045]	U.S. President's Emergency Plan for AIDS Relief (PEPFAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); USAID(United States Agency for International Development (USAID))	U.S. Agency for International Development (USAID), with support from U.S. President's Emergency Plan for AIDS Relief (PEPFAR), is the funder of the LINKAGES project. LINKAGES award number with USAID is: AID-OAA-A-14-00045, https://www.usaid.gov/, https://www.pepfar. gov/. Two authors of the manuscript are employed by USAID and provided support in preparation of the manuscript (MA, CW). The other authors are employed by the FHI360 project, LINKAGES (TL, NP, MD, DG, DK, MC, LN, CA, HM).	Amirkhanian YA, 2015, AIDS, V29, P583, DOI 10.1097/QAD.0000000000000558; Baral S, 2012, LANCET INFECT DIS, V12, P538, DOI 10.1016/S1473-3099(12)70066-X; Baral SD, 2013, LANCET INFECT DIS, V13, P214, DOI 10.1016/S1473-3099(12)70315-8; Beyrer C, 2013, AIDS, V27, P2665, DOI 10.1097/01.aids.0000432449.30239.fe; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; BROADHEAD RS, 1995, J DRUG ISSUES, V25, P531, DOI 10.1177/002204269502500303; Decker MR, 2013, AM J REPROD IMMUNOL, V69, P122, DOI 10.1111/aji.12063; Deering KN, 2013, SEX TRANSM DIS, V40, P168, DOI 10.1097/OLQ.0b013e31827df174; FHI 360/LINKAGES, 2016, LINKAGES SYST ASS RO; FHI 360/LINKAGES, LINK CONT HIV SERV K; FHI 360/LINKAGES, 2017, LINKAGES ENH PEER OU; Fuqua V, 2012, AIDS BEHAV, V16, P256, DOI 10.1007/s10461-011-9918-x; Girault P, 2015, AIDS BEHAV, V19, P1990, DOI 10.1007/s10461-015-1069-z; Global Commission on HIV and the Law, 2012, HIV LAW RISKS RIGHTS; Golden MR, 2006, AIDS, V20, P1961, DOI 10.1097/01.aids.0000247118.74208.6a; Johnston LG, 2008, AIDS BEHAV, V12, pS131, DOI 10.1007/s10461-008-9413-1; Johnston LG, 2006, J URBAN HEALTH, V83, pI16, DOI 10.1007/s11524-006-9099-5; Joint United Nations Programme on HIV/AIDS, 2018, MIL GO CLOS GAPS BRE; Kimbrough LW, 2009, AM J PUBLIC HEALTH, V99, P1093, DOI 10.2105/AJPH.2008.139329; Mehta SH, 2016, CROI C FEB 22 25 BOS; Mehta SH, 2015, CLIN INFECT DIS, V61, P1732, DOI 10.1093/cid/civ669; Pines HA, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010388; Rosenberg NE, 2014, JAIDS-J ACQ IMM DEF, V65, pE162, DOI 10.1097/QAI.0000000000000066; Smyrnov P, 2018, J INT AIDS SOC, V21, DOI 10.1002/jia2.25040; Ssali S, 2012, AIDS RES TREAT, V2012, DOI 10.1155/2012/815823; UNAIDS, 2014, UND FAST TRACK ACC A; UNAIDS, 2016, UNAIDS PREV GAP REP; Uuskula A, 2010, J URBAN HEALTH, V87, P304, DOI 10.1007/s11524-009-9427-7; Yeka W, 2006, J URBAN HEALTH, V83, pI60, DOI 10.1007/s11524-006-9103-0	29	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0213743	10.1371/journal.pone.0213743	http://dx.doi.org/10.1371/journal.pone.0213743			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HR5NS	30943205	Green Published, Green Submitted, gold			2022-12-26	WOS:000463194300017
J	Poole, JR; Bajer, PG				Poole, Joshua R.; Bajer, Przemyslaw G.			A small native predator reduces reproductive success of a large invasive fish as revealed by whole-lake experiments	PLOS ONE			English	Article							COMMON CARP; PARENTAL CARE; RECRUITMENT; ABUNDANCE; SIZE; EGG	The extent to which native fish communities might control the success of invasive fish has been of interest to ecologists, but it has been rarely addressed using experiments. We conducted an experiment in six small lakes in the Upper Mississippi Region to test the effects of a small native predator, bluegill sunfish (Lepomis macrochirus) on the recruitment of a large, invasive fish, the common carp (Cyprinus carpio). Bluegills are predominant throughout the region and were previously shown to consume carp eggs and larvae. We stocked both lakes at each of our 3 sites with adult carp (spawners) and one lake at each site with bluegills. We repeated the experiment at two of the three sites for two consecutive years. In each lake we assessed the abundance of post-larval carp one month after spawning (backpack electrofishing surveys) and at the end of the season (mark-recapture). For each site/year combination, catch rate of post-larval carp was typically an order of magnitude higher in control than bluegill lakes, but it often declined quickly over time. The abundance of end-of-seasonal juveniles was significantly higher (no 95% CI overlap) in control lakes than in bluegill lakes, except for one pair of lakes during one year when both the control and bluegill lake had similar, low abundance of end-of-season carp. Overall, our results support the hypothesis that common carp recruitment is substantially reduced in habitats dominated by bluegills. We also suggest our results may be applicable to other species, and that managers should explore how predation on early life stages may control other invasive species.	[Poole, Joshua R.; Bajer, Przemyslaw G.] Univ Minnesota, Minnesota Aquat Invas Species Res Ctr, St Paul, MN 55108 USA; [Poole, Joshua R.] Idaho Fish & Game, Mccall, ID 83638 USA	University of Minnesota System; University of Minnesota Twin Cities	Poole, JR (corresponding author), Univ Minnesota, Minnesota Aquat Invas Species Res Ctr, St Paul, MN 55108 USA.; Poole, JR (corresponding author), Idaho Fish & Game, Mccall, ID 83638 USA.	poole066@umn.edu			Legislative Citizen Commission on Minnesota Resources, Environment and Natural Resource Trust Fund	Legislative Citizen Commission on Minnesota Resources, Environment and Natural Resource Trust Fund	This work was supported by: PB, Grant #: M.L. 2013, Chp. 52, Sec. 2, Subd. 06a Aquatic Invasive Species Research Center Sub-Project #4: Common carp management using biocontrol and toxins: Phase II. Awarded to Przemyslaw Bajer, Funder: Legislative Citizen Commission on Minnesota Resources, Environment and Natural Resource Trust Fund, https://www.lccmr.leg.mn/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAILEY KM, 1989, ADV MAR BIOL, V25, P1; Bajer PG, 2015, DIVERS DISTRIB, V21, P500, DOI 10.1111/ddi.12315; Bajer PG, 2015, OIKOS, V124, P1520, DOI 10.1111/oik.01795; Bajer PG, 2012, BIOL INVASIONS, V14, P1919, DOI 10.1007/s10530-012-0203-3; Bajer PG, 2010, BIOL INVASIONS, V12, P1101, DOI 10.1007/s10530-009-9528-y; Balon EK, 2004, J FISH BIOL, V65, P1, DOI 10.1111/j.0022-1112.2004.00563.x; Bosch VD, 1982, INTRO BIOL CONTROL; BRANDT SB, 1987, T AM FISH SOC, V116, P641, DOI 10.1577/1548-8659(1987)116<641:PBAOLO>2.0.CO;2; Brett MT, 1996, P NATL ACAD SCI USA, V93, P7723, DOI 10.1073/pnas.93.15.7723; Brown P, 2004, ECOL MODEL, V176, P83, DOI 10.1016/j.ecolmodel.2003.11.009; CARLANDER KD, 1955, J FISH RES BOARD CAN, V12, P543, DOI 10.1139/f55-029; Chase JM, 2000, TRENDS ECOL EVOL, V15, P408, DOI 10.1016/S0169-5347(00)01942-X; Rojas DC, 2018, REV BIOL TROP, V66, P189, DOI 10.15517/rbt.v66i1.28197; Cornelius R, 2006, DESCRIPTION SUMMARY; Crawford Stephen S., 1996, Advances in the Study of Behavior, V25, P53; Dauphinais JD, 2018, BIOL INVASIONS, P1; Davies GD, 2015, J APPL ECOL, V52, P1264, DOI 10.1111/1365-2664.12488; GITTLEMAN JL, 1981, ANIM BEHAV, V29, P936, DOI 10.1016/S0003-3472(81)80031-0; Hackerott S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068259; Hansen GJA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077415; Hermoso V, 2011, ECOL APPL, V21, P175, DOI 10.1890/09-2011.1; Iguchi K, 2004, ECOL RES, V19, P469, DOI 10.1111/j.1440-1703.2004.00660.x; Lechelt JD, 2016, THESIS; Lechelt JD, 2016, AQUAT INVASIONS, V11, P469, DOI 10.3391/ai.2016.11.4.11; Lechelt JD, 2016, BIOL INVASIONS, V18, P831, DOI 10.1007/s10530-016-1054-0; Lohmeyer AM, 2009, BIOL INVASIONS, V11, P905, DOI 10.1007/s10530-008-9303-5; Munoz RC, 2017, B MAR SCI, V93, P789, DOI 10.5343/bms.2016.1135; OBRIEN WJ, 1976, ECOLOGY, V57, P1304, DOI 10.2307/1935055; Ogle D.H., 2021, R PACKAGE; R Core Team, 2021, R LANGUAGE ENV STAT; RAHEL FJ, 1984, ECOLOGY, V65, P1276, DOI 10.2307/1938333; RICKER W E, 1975, P382; Silbernagel JJ, 2013, T AM FISH SOC, V142, P1134, DOI 10.1080/00028487.2013.788889; Smejkal M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07339-w; SMITH C, 1995, REV FISH BIOL FISHER, V5, P7, DOI 10.1007/BF01103363; Thresher R, 2014, NAT BIOTECHNOL, V32, P424, DOI 10.1038/nbt.2903; TONN WM, 1992, ECOLOGY, V73, P951, DOI 10.2307/1940171; TURNER AM, 1990, ECOLOGY, V71, P2241, DOI 10.2307/1938636; Weber MJ, 2013, T AM FISH SOC, V142, P471, DOI 10.1080/00028487.2012.754791; Weber MJ, 2011, N AM J FISH MANAGE, V31, P269, DOI 10.1080/02755947.2011.574923; WERNER EE, 1974, J FISH RES BOARD CAN, V31, P1531, DOI 10.1139/f74-186	41	4	4	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0214009	10.1371/journal.pone.0214009	http://dx.doi.org/10.1371/journal.pone.0214009			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR5NS	30943222	Green Published, gold, Green Submitted			2022-12-26	WOS:000463194300029
J	Bhattacharyya, S; Sathe, AA; Bhakta, M; Xing, C; Munshi, NV				Bhattacharyya, Samadrita; Sathe, Adwait A.; Bhakta, Minoti; Xing, Chao; Munshi, Nikhil V.			PAN-INTACT enables direct isolation of lineage-specific nuclei from fibrous tissues	PLOS ONE			English	Article							TRANSLATIONAL PROFILING APPROACH; GENE-EXPRESSION; CELL-TYPES; CHROMATIN; IDENTIFICATION; PURIFICATION; DIVERSITY; ENHANCERS	Recent studies have highlighted the extraordinary cell type diversity that exists within mammalian organs, yet the molecular drivers of such heterogeneity remain elusive. To address this issue, much attention has been focused on profiling the transcriptome and epigenome of individual cell types. However, standard cell type isolation methods based on surface or fluorescent markers remain problematic for cells residing within organs with significant connective tissue. Since the nucleus contains both genomic and transcriptomic information, the isolation of nuclei tagged in specific cell types (INTACT) method provides an attractive solution. Although INTACT has been successfully applied to plants, flies, zebrafish, frogs, and mouse brain and adipose tissue, broad use across mammalian organs remains challenging. Here we describe the PAN-INTACT method, which can be used to isolate cell type specific nuclei from fibrous mouse organs, which are particularly problematic. As a proof-of-concept, we demonstrate successful isolation of cell type-specific nuclei from the mouse heart, which contains substantial connective tissue and harbors multiple cell types, including cardiomyo-cytes, fibroblasts, endothelial cells, and epicardial cells. Compared to established techniques, PAN-INTACT allows more rapid isolation of cardiac nuclei to facilitate downstream applications. We show cell type-specific isolation of nuclei from the hearts of Nkx2-5(cre/+); R26(sun1-2xsf-GFP-6xmyc/+) mice, which we confirm by expression of lineage markers. Furthermore, we perform Assay for Transposase Accessible Chromatin (ATAC)-Seq to provide high-fidelity chromatin accessibility maps of Nkx2-5(+) nuclei. To extend the applicability of PAN-INTACT, we also demonstrate successful isolation of Wt1(+) podocytes from adult kidney. Taken together, our data suggest that PAN-INTACT is broadly applicable for profiling the transcriptional and epigenetic landscape of specific cell types. Thus, we envision that our method can be used to systematically probe mechanistic details of cell type-specific functions within individual organs of intact mice.	[Bhattacharyya, Samadrita; Bhakta, Minoti; Munshi, Nikhil V.] UT Southwestern Med Ctr, Dept Internal Med, Div Cardiol, Dallas, TX 75390 USA; [Sathe, Adwait A.; Xing, Chao; Munshi, Nikhil V.] UT Southwestern Med Ctr, McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA; [Munshi, Nikhil V.] UT Southwestern Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA; [Munshi, Nikhil V.] Hamon Ctr Regenerat Sci & Med, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Munshi, NV (corresponding author), UT Southwestern Med Ctr, Dept Internal Med, Div Cardiol, Dallas, TX 75390 USA.; Munshi, NV (corresponding author), UT Southwestern Med Ctr, McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA.; Munshi, NV (corresponding author), UT Southwestern Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA.; Munshi, NV (corresponding author), Hamon Ctr Regenerat Sci & Med, Dallas, TX 75390 USA.	Nikhil.Munshi@UTSouthwestern.edu	Sathe, Adwait/P-8609-2019	Sathe, Adwait/0000-0001-7532-7305; Xing, Chao/0000-0002-1838-0502	AHA [17PRE33670730]; NIH [HL136604, HL133642, HL135217]; Burroughs Wellcome Fund [1009838]; March of Dimes Foundation [5-FY13-203]; Department of Defense [PR172060]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R03HL133642, R03HL135217, R01HL136604] Funding Source: NIH RePORTER	AHA(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); March of Dimes Foundation(March of Dimes); Department of Defense(United States Department of Defense); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the AHA (17PRE33670730 to S.B.), NIH (HL136604, HL133642, and HL135217 to N.V.M.), the Burroughs Wellcome Fund (1009838 to N.V.M.), the March of Dimes Foundation (#5-FY13-203 to N.V.M.), and the Department of Defense (PR172060 to N.V.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad Z, 2017, PEERJ, V5, DOI 10.7717/peerj.4040; Amin NM, 2014, DEVELOPMENT, V141, P962, DOI 10.1242/dev.098327; Andrews S., 2010, FASTQC QUALITY CONTR; Aronesty E., 2013, OPEN BIOINFORM J, V7, P1, DOI 10.2174/1875036201307010001; Bergmann O, 2012, JOVE-J VIS EXP, DOI 10.3791/4205; Bergmann O, 2011, EXP CELL RES, V317, P188, DOI 10.1016/j.yexcr.2010.08.017; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Brunskill EW, 2008, DEV CELL, V15, P781, DOI 10.1016/j.devcel.2008.09.007; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Corces MR, 2017, NAT METHODS, V14, P959, DOI [10.1038/NMETH.4396, 10.1038/nmeth.4396]; Deal RB, 2011, NAT PROTOC, V6, P56, DOI 10.1038/nprot.2010.175; Deal RB, 2010, DEV CELL, V18, P1030, DOI 10.1016/j.devcel.2010.05.013; DeLaughter DM, 2016, DEV CELL, V39, P480, DOI 10.1016/j.devcel.2016.10.001; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Doyle JP, 2008, CELL, V135, P749, DOI 10.1016/j.cell.2008.10.029; Gilsbach R, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02762-z; Gilsbach R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6288; Guo JK, 2002, HUM MOL GENET, V11, P651, DOI 10.1093/hmg/11.6.651; He AB, 2011, P NATL ACAD SCI USA, V108, P5632, DOI 10.1073/pnas.1016959108; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Henry GL, 2012, NUCLEIC ACIDS RES, V40, P9691, DOI 10.1093/nar/gks671; Horsthuis T, 2009, CIRC RES, V105, P61, DOI 10.1161/CIRCRESAHA.108.192443; Lake BB, 2016, SCIENCE, V352, P1586, DOI 10.1126/science.aaf1204; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li G, 2016, DEV CELL, V39, P491, DOI 10.1016/j.devcel.2016.10.014; Mo A, 2015, NEURON, V86, P1369, DOI 10.1016/j.neuron.2015.05.018; Moses Kelvin A., 2001, Genesis The Journal of Genetics and Development, V31, P176, DOI 10.1002/gene.10022; Nakano A, 2016, BBA-MOL CELL RES, V1863, P1937, DOI 10.1016/j.bbamcr.2016.01.022; Paige SL, 2012, CELL, V151, P221, DOI 10.1016/j.cell.2012.08.027; Pinto AR, 2016, CIRC RES, V118, P400, DOI 10.1161/CIRCRESAHA.115.307778; Preissl S, 2015, CIRC RES, V117, P413, DOI 10.1161/CIRCRESAHA.115.306337; Quillien A, 2017, CELL REP, V20, P709, DOI 10.1016/j.celrep.2017.06.070; Quinlan Aaron R, 2014, Curr Protoc Bioinformatics, V47, DOI 10.1002/0471250953.bi1112s47; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Serpooshan V, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12869-4; Sessions AO, 2016, CIRC RES, V118, P1553, DOI 10.1161/CIRCRESAHA.116.307472; Steiner FA, 2012, GENOME RES, V22, P766, DOI 10.1101/gr.131748.111; Tryon RC, 2013, GENESIS, V51, P187, DOI 10.1002/dvg.22363; Vedantham V, 2015, CIRC RES, V116, P797, DOI 10.1161/CIRCRESAHA.116.305913; Wagner A, 2016, NAT BIOTECHNOL, V34, P1145, DOI 10.1038/nbt.3711; Wamstad JA, 2012, CELL, V151, P206, DOI 10.1016/j.cell.2012.07.035; Watson N., ISOLATION USE MAMMAL; Wingett S, 2011, FASTQ SCREEN QUALITY; Wu SM, 2006, CELL, V127, P1137, DOI 10.1016/j.cell.2006.10.028; Yu GC, 2015, BIOINFORMATICS, V31, P2382, DOI 10.1093/bioinformatics/btv145; Yue F, 2014, NATURE, V515, P355, DOI 10.1038/nature13992; Zebrowski DC, 2015, ELIFE, V4, DOI 10.7554/eLife.05563; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou B, 2008, NATURE, V454, P109, DOI 10.1038/nature07060; Zhou P, 2017, ELIFE, V6, P777, DOI [10.1101/gr.131748.111, DOI 10.1101/GR.131748.111]; Zhou PZ, 2016, CIRC RES, V118, P368, DOI 10.1161/CIRCRESAHA.116.308139	52	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2019	14	4							e0214677	10.1371/journal.pone.0214677	http://dx.doi.org/10.1371/journal.pone.0214677			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR2UW	30939177	Green Published, gold, Green Submitted			2022-12-26	WOS:000462993900035
J	Qiao, X; Sai, LH; Chen, XW; Xue, LH; Lei, JJ				Qiao, Xu; Sai, Lihan; Chen, Xingwu; Xue, Lihua; Lei, Junjie			Impact of fruit-tree shade intensity on the growth, yield, and quality of intercropped wheat	PLOS ONE			English	Article							ALLEY CROPPING SYSTEM; AGROFORESTRY SYSTEMS; SOUTHERN ONTARIO; COMPETITION; NITROGEN; MAIZE; CHINA; PHOTOSYNTHESIS; GLIRICIDIA; DENSITY	Agroforestry is a common traditional practice in China-especially in the southern Xinjiang of Northwest China. However, the productivity of many agroforestry systems has been lower than expected in recent years, highlighting the need for an actionably deep mechanistic understanding of the competition between crops and trees. Here, three different fruit tree/wheat (jujube/wheat, apricot/wheat, and walnut/wheat) intercropping agroforestry systems were chosen to investigate influence of different fruit tree shade intensity on the growth, yield and quality of intercropping wheat. Compared to the monoculture wheat system, the mean daily shade intensity of the jujube-, apricot-, and walnut-based intercropping systems were, respectively, 23.2%, 57.5%, and 80.7% shade. The photosynthetic rate of wheat in the jujube-, apricot-, and walnut-based intercropping systems decreased by, respectively, 11.3%, 31.9%, and 36.2% compared to monoculture wheat, and the mean number of fertile florets per spike decreased by 26.4%, 37.4%, and 49.5%. Moreover, the apricot- and walnut-based intercropping systems deleteriously affected grain yield (constituent components spike number, grains per spike, and thousand grain weight) and decreased the total N, P, and K content of intercropping wheat. Tree shading intensity strongly enhanced the grain protein content, wet gluten content, dough development time, and dough stability time of wheat, but significantly decreased the softening degree. Strong negative linear correlations were observed between tree shade intensity and the number of fertile florets, grain yield related traits (including spike number, grains per spike, and thousand grain weight), nutrient content (N, P and K), and softening degree of wheat. In contrast, Daily shade intensity was positively linearly correlated with grain protein content, wet gluten content, dough development time, and dough stability time. We conclude that jujube-based intercropping systems can be practical in the region, as they do not decrease the yield and quality of intercropping wheat.	[Qiao, Xu] Chinese Acad Med Sci, Inst Med Plant Dev, Beijing, Peoples R China; [Qiao, Xu; Sai, Lihan; Chen, Xingwu; Xue, Lihua; Lei, Junjie] Xinjiang Acad Agr Sci, Inst Grain Grp, Urumqi, Xinjiang, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS	Lei, JJ (corresponding author), Xinjiang Acad Agr Sci, Inst Grain Grp, Urumqi, Xinjiang, Peoples R China.	leijunjie@sohu.com			National Natural Science Foundation of China [31560587, 31660370, 31760364]; Special Fund for Agro-scientific Research in the Public Interest [201503116]; Modern Agricultural Industry Technology System [CARS-03-49]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest; Modern Agricultural Industry Technology System	This work was funded by the National Natural Science Foundation of China (Grant Nos. 31560587, 31660370, 31760364), Special Fund for Agro-scientific Research in the Public Interest (201503116) and the Modern Agricultural Industry Technology System (CARS-03-49). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AACC-International, 2013, APPR METH AN; Alam M, 2014, AGROFOREST SYST, V88, P679, DOI 10.1007/s10457-014-9681-x; Awal MA, 2006, AGR FOREST METEOROL, V139, P74, DOI 10.1016/j.agrformet.2006.06.001; Bergeron M, 2011, AGROFOREST SYST, V83, P321, DOI 10.1007/s10457-011-9402-7; Bhatta M, 2017, J SCI FOOD AGR, V97, P5311, DOI 10.1002/jsfa.8417; Brandle J. R., 2000, North American agroforestry: an integrated science and practice., P79; Celette F, 2009, EUR J AGRON, V30, P41, DOI 10.1016/j.eja.2008.07.003; Chirko CP, 1996, FOREST ECOL MANAG, V83, P171, DOI 10.1016/0378-1127(96)03721-8; Cui Hai-yan, 2013, Yingyong Shengtai Xuebao, V24, P3099; Evers A. K., 2010, The Open Agriculture Journal, V4, P49, DOI 10.2174/1874331501004010049; Friday JB, 2002, AGROFOREST SYST, V55, P125, DOI 10.1023/A:1020598110484; Gao LB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070739; Garrett H. E., 2000, North American agroforestry: an integrated science and practice., P149; Ghosh PK, 2009, EUR J AGRON, V31, P43, DOI 10.1016/j.eja.2009.03.002; Grove JH., 1990, SOIL TESTING PLANT A; Jose S, 2000, AGROFOREST SYST, V48, P61, DOI 10.1023/A:1006241406462; Kittur BH, 2016, AGROFOREST SYST, V90, P237, DOI 10.1007/s10457-015-9849-z; Lu Q, 1997, ACTA ECOLOGICA SINIC, V17, P36; Peng XB, 2009, AGROFOREST SYST, V76, P569, DOI 10.1007/s10457-009-9227-9; Price GW, 1998, AGROFOREST SYST, V44, P141, DOI 10.1023/A:1006213603150; Reynolds PE, 2007, ECOL ENG, V29, P362, DOI 10.1016/j.ecoleng.2006.09.024; Rivest D, 2013, SCI TOTAL ENVIRON, V463, P51, DOI 10.1016/j.scitotenv.2013.05.071; Rivest D, 2009, J ENVIRON MANAGE, V91, P432, DOI 10.1016/j.jenvman.2009.09.013; Rowe EC, 2001, PLANT SOIL, V235, P167, DOI 10.1023/A:1011961409353; Smethurst PJ, 2017, AGR SYST, V155, P70, DOI 10.1016/j.agsy.2017.04.008; Toyota M, 2001, PLANT PROD SCI, V4, P283, DOI 10.1626/pps.4.283; Wang BJ, 2014, AGROFOREST SYST, V88, P835, DOI 10.1007/s10457-014-9729-y; [王晶晶 Wang Jingjing], 2015, [西北农业学报, Acat Agriculturae Boreali-Occidentalis Sinica], V24, P44; WILLEY RW, 1971, J AGR SCI, V77, P453, DOI 10.1017/S0021859600064522; Yang LL, 2016, EUR J AGRON, V75, P105, DOI 10.1016/j.eja.2016.01.008; Yang T, 2019, AGROFOREST SYST, V93, P1545, DOI 10.1007/s10457-018-0267-x; Zhang W, 2017, AGROFOREST SYST, V91, P881, DOI 10.1007/s10457-016-9962-7; ZOU XM, 1990, AGROFOREST SYST, V11, P85, DOI 10.1007/BF00122813	33	16	19	6	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2019	14	4							e0203238	10.1371/journal.pone.0203238	http://dx.doi.org/10.1371/journal.pone.0203238			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR2UW	30939172	Green Submitted, gold, Green Published			2022-12-26	WOS:000462993900001
J	Zietzer, A; Niepmann, ST; Camara, B; Lenart, MA; Jansen, F; Becher, MU; Andrie, R; Nickenig, G; Tiyerili, V				Zietzer, Andreas; Niepmann, Sven Thomas; Camara, Bakary; Lenart, Monika Anna; Jansen, Felix; Becher, Marc Ulrich; Andrie, Rene; Nickenig, Georg; Tiyerili, Vedat			Sodium thiocyanate treatment attenuates atherosclerotic plaque formation and improves endothelial regeneration in mice	PLOS ONE			English	Article							HYPOTHIOCYANOUS ACID HOSCN; HIGH-DENSITY-LIPOPROTEIN; C-REACTIVE PROTEIN; NEOINTIMA FORMATION; CLASS-B; MYELOPEROXIDASE; INFLAMMATION; OXIDATION; SMOKING; PLASMA	Introduction Atherosclerotic plaque formation is an inflammatory process that involves the recruitment of neutrophil granulocytes and the generation of reactive oxygen species (ROS). ROS formation by myeloperoxidase, a key enzyme in H2O2 degradation, can be modulated by addition of sodium thiocyanate (NaSCN). However, the therapeutic use of NaSCN to counteract atherogenesis has been controversial, because MPO oxidizes NaSCN to hypothiocyanous acid, which is a reactive oxygen species itself. Therefore, this study aimed to investigate the effect of NaSCN treatment on atherogenesis in vivo. Methods Apolipoprotein E knockout (ApoE(-/-)) mice on western-diet were treated with NaSCN for 8 weeks. Blood levels of total cholesterol, IL-10, and IL-6 were measured. Aortic roots from these mice were analyzed histologically to quantify plaque formation, monocyte, and neutrophil granulocyte infiltration. Oxidative damage was evaluated via an L-012 chemiluminescence assay and staining for chlorotyrosine in the aortic walls. Endothelial function was assessed by use of endothelium-dependent vasodilation in isolated aortic rings. Neointima formation was evaluated in wild-type mice following wire injury of the carotid artery. Results NaSCN treatment of ApoE(-/-) mice lead to a reduction of atherosclerotic plaque size in the aortic roots but had no effect on monocyte or granulocyte infiltration. Serum levels of the pro-inflammatory cytokine IL-6 decreased whereas anti-inflammatory IL-10 increased upon NaSCN treatment. In our experiments, we found oxidative damage to be reduced and the endothelial function to be improved in the NaSCN-treated group. Additionally, NaSCN inhibited neointima formation. Conclusion NaSCN has beneficial effects on various stages of atherosclerotic plaque development in mice.	[Zietzer, Andreas; Niepmann, Sven Thomas; Camara, Bakary; Lenart, Monika Anna; Jansen, Felix; Becher, Marc Ulrich; Andrie, Rene; Nickenig, Georg; Tiyerili, Vedat] Univ Hosp Bonn, Med Dept 2, Bonn, Germany	University of Bonn	Tiyerili, V (corresponding author), Univ Hosp Bonn, Med Dept 2, Bonn, Germany.	vedat.tiyerili@ukbonn.de	Tiyerili, Vedat/CAF-1914-2022		German Society of Cardiology [DGK16/2018]; Medical Faculty of the Rheinische Friedrich-Wilhelms-University Bonn (BONFOR Gerok-grant); Else-Kroner-Fresenius-Foundation through the Medical Faculty of the University of Bonn; German Heart Foundation (Kaltenbach Stipendium)	German Society of Cardiology; Medical Faculty of the Rheinische Friedrich-Wilhelms-University Bonn (BONFOR Gerok-grant); Else-Kroner-Fresenius-Foundation through the Medical Faculty of the University of Bonn; German Heart Foundation (Kaltenbach Stipendium)	AZ was supported by the German Society of Cardiology (DGK16/2018) and by the Medical Faculty of the Rheinische Friedrich-Wilhelms-University Bonn (BONFOR Gerok-grant). STN was supported by the Else-Kroner-Fresenius-Foundation through the Medical Faculty of the University of Bonn. MAL was supported by the German Heart Foundation (Kaltenbach Stipendium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdo AI, 2017, REDOX BIOL, V13, P623, DOI 10.1016/j.redox.2017.08.004; Chandler JD, 2013, J BIOL CHEM, V288, P18421, DOI 10.1074/jbc.M113.468090; Daiber A, 2017, REDOX BIOL, V12, P35, DOI 10.1016/j.redox.2017.02.001; DEGIAMPIETRO P, 1987, J CLIN CHEM CLIN BIO, V25, P711; Exner M, 2004, FREE RADICAL BIO MED, V37, P146, DOI 10.1016/j.freeradbiomed.2004.04.039; Hadfield KA, 2013, BIOCHEM J, V449, P531, DOI 10.1042/BJ20121210; Heslop CL, 2010, J AM COLL CARDIOL, V55, P1102, DOI 10.1016/j.jacc.2009.11.050; Ismael FO, 2015, ARCH BIOCHEM BIOPHYS, V573, P40, DOI 10.1016/j.abb.2015.03.008; Kettle AJ, 1997, BIOCHEM J, V321, P503, DOI 10.1042/bj3210503; Lau D, 2006, PHARMACOL THERAPEUT, V111, P16, DOI 10.1016/j.pharmthera.2005.06.023; Laufs U, 2004, CIRCULATION, V109, P220, DOI 10.1161/01.CIR.0000109141.48980.37; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Liu CQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050767; Love DT, 2016, FREE RADICAL BIO MED, V94, P88, DOI 10.1016/j.freeradbiomed.2016.02.016; Marsche G, 2004, ARTERIOSCL THROM VAS, V24, P2302, DOI 10.1161/01.ATV.0000148703.43429.25; Marsche G, 2003, J BIOL CHEM, V278, P47562, DOI 10.1074/jbc.M308428200; Marsche G, 2002, J BIOL CHEM, V277, P32172, DOI 10.1074/jbc.M200503200; Morgan PE, 2015, FREE RADICAL RES, V49, P743, DOI 10.3109/10715762.2015.1019347; Nedoboy PE, 2014, FREE RADICAL RES, V48, P1256, DOI 10.3109/10715762.2014.947286; Pasceri V, 2001, CIRCULATION, V103, P2531; Ronald JA, 2009, CIRCULATION, V120, P592, DOI 10.1161/CIRCULATIONAHA.108.813998; Sokolov AV, 2014, CHEM PHYS LIPIDS, V180, P72, DOI 10.1016/j.chemphyslip.2014.02.006; Teng N, 2017, REDOX REP, V22, P51, DOI 10.1080/13510002.2016.1256119; Tiyerili V, 2016, INT J CARDIOL, V204, P29, DOI 10.1016/j.ijcard.2015.11.128; vanDalen CJ, 1997, BIOCHEM J, V327, P487; Vita JA, 2004, CIRCULATION, V110, P1134, DOI 10.1161/01.CIR.0000140262.20831.8F; Wang Z, 2007, NAT MED, V13, P1176, DOI 10.1038/nm1637; WATKINSON G, 1947, BRIT MED J, V1, P595, DOI 10.1136/bmj.1.4504.595; WHO, 2018, GLOB HLTH EST 2019 D; Zielonka J, 2013, FREE RADICAL BIO MED, V65, P1310, DOI 10.1016/j.freeradbiomed.2013.09.017	30	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2019	14	4							e0214476	10.1371/journal.pone.0214476	http://dx.doi.org/10.1371/journal.pone.0214476			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR2UW	30939159	Green Published, Green Submitted, gold			2022-12-26	WOS:000462993900026
J	Dhamoon, MS; Cheung, YK; Moon, YP; Wright, CB; Sacco, RL; Elkind, MSV				Dhamoon, Mandip S.; Cheung, Ying-Kuen; Moon, Yeseon P.; Wright, Clinton B.; Sacco, Ralph L.; Elkind, Mitchell S. V.			Interleukin-6 and lipoprotein-associated phospholipase A2 are associated with functional trajectories	PLOS ONE			English	Article							C-REACTIVE PROTEIN; MOBILITY LIMITATION; VASCULAR EVENTS; ISCHEMIC-STROKE; DISABILITY; INFLAMMATION; SENSITIVITY; MORTALITY; MARKERS; TRIALS	Background/Objectives Inflammatory biomarkers have been associated with stroke and mortality, but inflammation may also have detrimental effects beyond acute events. We hypothesized that serum concentrations of interleukin-6 (IL6) and lipoprotein-associated phospholipase A2 (LpPLA2) were inversely associated with long-term functional decline independently of vascular risk factors, stroke and myocardial infarction (MI) occurring during follow-up. Design Prospective population based cohort study Setting The Northern Manhattan Study Participants (including the sample size) Race/ethnically diverse stroke-free individuals in northern Manhattan aged >= 40 years (n = 3298). Intervention None Measurements Annual functional assessments with the Barthel index (BI), for a median of 13 years. BI was analyzed as a continuous variable (range 0-100). Baseline demographics, risk factors, and laboratory studies were collected, including IL6 (n = 1679), LpPLA2 mass (n = 1912) and activity (n = 1937). Separate mixed models estimated standardized associations between each biomarker and baseline functional status and change over time, adjusting for demographics, vascular risk factors, social variables, cognition, and depression measured at baseline, and stroke and MI occurring during follow-up. Results Mean age was 69 (SD 10) years, 35% were male, 53% Hispanic, 74% hypertensive, and 16-24% diabetic. LogIL6 was associated with decline in BI over time (-0.13 points per year, 95% CI -0.24, -0.02) and marginally with baseline BI (-0.20, 95% CI -0.40, 0.01). LpPLA2 activity levels were associated with baseline BI (-0.36, 95% CI -0.68, -0.04) but not change over time, and LpPLA2 mass levels were not associated with either. Conclusion In this large population-based study, higher serum inflammatory biomarker levels were associated with disability, even when adjusting for baseline covariates and stroke and MI occurring during follow-up.	[Dhamoon, Mandip S.] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA; [Dhamoon, Mandip S.; Elkind, Mitchell S. V.] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10032 USA; [Cheung, Ying-Kuen] Columbia Univ, Mailman Sch Publ Hlth, Dept Biostat, New York, NY USA; [Moon, Yeseon P.; Elkind, Mitchell S. V.] Columbia Univ, Coll Phys & Surg, Dept Neurol, New York, NY USA; [Wright, Clinton B.] NIH, Bldg 10, Bethesda, MD 20892 USA; [Sacco, Ralph L.] Univ Miami, Miller Sch Med, McKnight Brain Inst, Miami, FL 33136 USA; [Sacco, Ralph L.] Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA; [Sacco, Ralph L.] Univ Miami, Miller Sch Med, Publ Hlth Sci, Miami, FL 33136 USA; [Sacco, Ralph L.] Univ Miami, Miller Sch Med, Human Genet, Miami, FL 33136 USA	Icahn School of Medicine at Mount Sinai; Columbia University; Columbia University; Columbia University; National Institutes of Health (NIH) - USA; University of Miami; University of Miami; University of Miami; University of Miami	Dhamoon, MS (corresponding author), Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA.; Dhamoon, MS (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10032 USA.	mandip.dhamoon@mssm.edu	Sacco, Ralph/Y-9278-2019	Wright, Clinton/0000-0002-9797-6215	National Institute of Neurological Disorders and Stroke [R01 NS48134, R37 29993, K23NS079422]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K23NS079422] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the National Institute of Neurological Disorders and Stroke (R01 NS48134, MSVE; R37 29993, RLS/MSVE; K23NS079422, MSD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bath PMW, 2007, STROKE, V38, P1911, DOI 10.1161/STROKEAHA.106.474080; Bustamante A, 2014, J NEUROIMMUNOL, V274, P215, DOI 10.1016/j.jneuroim.2014.07.015; Cesari M, 2012, J GERONTOL A-BIOL, V67, P671, DOI 10.1093/gerona/glr246; Cohen HJ, 1997, J GERONTOL A-BIOL, V52, pM201, DOI 10.1093/gerona/52A.4.M201; Colley KJ, 2011, EPMA J, V2, P27, DOI 10.1007/s13167-011-0063-4; Dallmeier D, 2014, BEST PRACT RES CL EN, V28, P281, DOI 10.1016/j.beem.2014.01.003; Dhamoon MS, 2017, AGE AGEING, V46, P77, DOI 10.1093/ageing/afw179; Dromerick AW, 2003, J REHABIL RES DEV, V40, P1, DOI 10.1682/JRRD.2003.01.0001; Economos A, 2013, NEUROEPIDEMIOLOGY, V40, P253, DOI 10.1159/000343276; Elkind MSV, 2006, ARCH INTERN MED, V166, P2073, DOI 10.1001/archinte.166.19.2073; Elkind MSV, 2006, STROKE, V37, P13, DOI 10.1161/01.STR.0000195048.86810.5b; Gentry E M, 1985, Am J Prev Med, V1, P9; GRANGER CV, 1979, ARCH PHYS MED REHAB, V60, P14; Heneka MT, 2015, LANCET NEUROL, V14, P388, DOI 10.1016/S1474-4422(15)70016-5; Heppner FL, 2015, NAT REV NEUROSCI, V16, P358, DOI 10.1038/nrn3880; Katan M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083393; Lin JX, 2015, NEUROLOGY, V85, P1585, DOI 10.1212/WNL.0000000000001938; MAHONEY F I, 1965, Md State Med J, V14, P61; Munoz-Canoves P, 2013, FEBS J, V280, P4131, DOI 10.1111/febs.12338; Nagai K, 2011, GERIATR GERONTOL INT, V11, P328, DOI 10.1111/j.1447-0594.2010.00686.x; Penninx BWJH, 2004, J AM GERIATR SOC, V52, P1105, DOI 10.1111/j.1532-5415.2004.52308.x; Perez-Baos S, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00409; Peterson MJ, 2015, J GERONTOL A; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Sacco RL, 2004, STROKE, V35, P2263, DOI 10.1161/01.STR.0000142374.33919.92; Saver JL, 2011, STROKE, V42, P2356, DOI 10.1161/STROKEAHA.111.619122; SHINAR D, 1987, ARCH PHYS MED REHAB, V68, P723; Singh T, 2011, AGEING RES REV, V10, P319, DOI 10.1016/j.arr.2010.11.002; Song FJ, 2006, CLIN REHABIL, V20, P347, DOI 10.1191/0269215506cr948oa; SPITZER WO, 1981, J CHRON DIS, V34, P585, DOI 10.1016/0021-9681(81)90058-8; Thompson A, 2010, LANCET, V375, P1536, DOI 10.1016/S0140-6736(10)60319-4; Trapero I, 2014, METAB BRAIN DIS, V29, P593, DOI 10.1007/s11011-014-9551-2; Wannamethee SG, 2014, J AM GERIATR SOC, V62, P2357, DOI 10.1111/jgs.13133; Willey JZ, 2010, J COMMUNITY HLTH; Wright CB, 2009, STROKE, V40, P3466, DOI 10.1161/STROKEAHA.109.559567; Zuliani G, 2007, INT J GERIATR PSYCH, V22, P305, DOI 10.1002/gps.1674	36	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2019	14	4							e0214784	10.1371/journal.pone.0214784	http://dx.doi.org/10.1371/journal.pone.0214784			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HR1CY	30934019	Green Published, gold, Green Submitted			2022-12-26	WOS:000462867000041
J	Cho, HW; Ouh, YT; Lee, KM; Han, SW; Lee, JK; Cho, GJ; Hong, JH				Cho, Hyun-Woong; Ouh, Yung-Taek; Lee, Kyu-Min; Han, Sung Won; Lee, Jae Kwan; Cho, Geum Jun; Hong, Jin Hwa			Long-term effect of pregnancy-related factors on the development of endometrial neoplasia: A nationwide retrospective cohort study	PLOS ONE			English	Article							REPRODUCTIVE FACTORS; GROWTH-FACTOR; BREAST-CANCER; VEGF RECEPTOR-1; FOLLOW-UP; RISK; PREECLAMPSIA; WOMEN; OBESITY; IMPACT	Objective By identifying pregnancy-related risk factors for endometrial neoplasia, women's risk of developing this disease after childbirth can be predicted and high-risk women can be screened for early detection. Methods Study data from women who gave birth in Korea in 2007 were collected from the Korea National Health Insurance (KNHI) claims database between 2007 and 2015. The adjusted hazard ratios (HRs) and 95% confidence intervals (Cis) for the development of endometrial neoplasia were estimated by multivariate Cox proportional hazards models. Results Data from 386,614 women were collected for this study. By 2015, 3,370 women from the initial cohort had been diagnosed with endometrial neoplasia secondary to delivery. Multivariate Cox proportional hazards regression revealed that preeclampsia (HR 1.55, 95% CI 1.29, 1.86), advanced maternal age (>= 35; HR 1.52, 95% CI 1.39, 1.66), multifetal pregnancy (HR 1.81, 95% CI 1.46, 2.23), multiparity (HR 1.16, 95% CI 1.08, 1.24), cesarean section (HR 1.15, 95% CI 1.07, 1.23) and delivery of a large-for-gestational-age infant (HR 1.19, 95% CI 1.02, 1.39) were independent risk factors for future endometrial neoplasia. The risk for endometrial neoplasia increased as the number of risk factors increased (risk factors >= 3: HR 2.11, 95% CI 1.86-2.40). Conclusion This study showed that six pregnancy-related factors-advanced maternal age, multiparity, multifetal pregnancy, cesarean section, delivery of a large-for-gestational-age infant, and preeclampsia-are positively correlated with future development of endometrial neoplasia, including endometrial hyperplasia or cancer. Close observation and surveillance are warranted to enable early diagnosis of endometrial diseases, including endometrial cancer after pregnancy in high-risk women. However, due to unavailability of clinical information, many clinical/epidemiological factors can become confounders. Further research is needed on factors associated with the risk of endometrial neoplasia.	[Cho, Hyun-Woong; Ouh, Yung-Taek; Lee, Jae Kwan; Cho, Geum Jun; Hong, Jin Hwa] Korea Univ, Dept Obstet & Gynecol, Guro Hosp, Coll Med, Seoul, South Korea; [Lee, Kyu-Min; Han, Sung Won] Korea Univ, Sch Ind Management Engn, Seoul, South Korea	Korea University; Korea University Medicine (KU Medicine); Korea University	Cho, GJ; Hong, JH (corresponding author), Korea Univ, Dept Obstet & Gynecol, Guro Hosp, Coll Med, Seoul, South Korea.	md_cho@hanmail.net; jhhong93@korea.ac.kr	Hong, Jinhwa/AAY-9037-2020	Hong, Jinhwa/0000-0002-6905-5363; LEE, Jae Kwan/0000-0003-3101-6403; Lee, Kyu-min/0000-0002-6290-1272; Ouh, Yung-Taek/0000-0001-5887-4497; CHO, HYUN-WOONG/0000-0002-0724-9971				Ali Aus Tariq, 2013, Ceska Gynekol, V78, P448; Allen N, 2015, LANCET ONCOL, V16, P1061, DOI 10.1016/S1470-2045(15)00212-0; Baba T, 2011, J OBSTET GYNAECOL RE, V37, P245, DOI 10.1111/j.1447-0756.2010.01381.x; Ferreira RAB, 2015, REV PANAM SALUD PUBL, V37, P337; BRINTON LA, 1992, AM J OBSTET GYNECOL, V167, P1317, DOI 10.1016/S0002-9378(11)91709-8; Britt K, 2012, LANCET ONCOL, V13, P1071, DOI 10.1016/S1470-2045(12)70456-4; Burton GJ, 2017, PLACENTA, V60, P134, DOI 10.1016/j.placenta.2017.06.007; Chatzaki E, 1996, CANCER RES, V56, P2059; Coenegrachts L, 2013, ONCOL REP, V29, P413, DOI 10.3892/or.2012.2178; Devor EJ, 2014, OBSTET GYNECOL INT, V2014, DOI 10.1155/2014/678984; Emons G, 2000, ENDOCR-RELAT CANCER, V7, P227, DOI 10.1677/erc.0.0070227; Emons G, 2015, GEBURTSH FRAUENHEILK, V75, P135, DOI 10.1055/s-0034-1396256; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Hajiahmadi M, 2015, MED PRIN PRACT, V24, P70, DOI 10.1159/000368358; Hallum S, 2016, BRIT J CANCER, V114, P809, DOI 10.1038/bjc.2016.55; Harry VN, 2007, OBSTET GYNECOL, V110, P469, DOI 10.1097/01.AOG.0000260393.46154.5f; Kaaks R, 2002, CANCER EPIDEM BIOMAR, V11, P1531; Kessous R, 2016, J CANCER RES CLIN, V142, P287, DOI 10.1007/s00432-015-2035-x; Kim JJ, 2005, BIOL REPROD, V73, P833, DOI 10.1095/biolreprod.105.043182; Kroener L, 2017, CURR OPIN OBSTET GYN, V29, P195, DOI 10.1097/GCO.0000000000000370; KURMAN RJ, 1985, CANCER, V56, P403, DOI 10.1002/1097-0142(19850715)56:2<403::AID-CNCR2820560233>3.0.CO;2-X; KVALE G, 1991, CANCER DETECT PREV, V15, P369; Lacey JV, 2008, BRIT J CANCER, V98, P45, DOI 10.1038/sj.bjc.6604102; Lacey JV, 2010, J CLIN ONCOL, V28, P788, DOI 10.1200/JCO.2009.24.1315; LESKO SM, 1991, AM J EPIDEMIOL, V133, P554, DOI 10.1093/oxfordjournals.aje.a115926; Lochen ML, 1997, ACTA OBSTET GYN SCAN, V76, P373, DOI 10.1111/j.1600-0412.1997.tb07996.x; Macdonald EM, 2014, PLACENTA, V35, P582, DOI 10.1016/j.placenta.2014.04.019; Markopoulos C., 1996, European Journal of Gynaecological Oncology, V17, P520; McPherson CP, 1996, AM J EPIDEMIOL, V143, P1195, DOI 10.1093/oxfordjournals.aje.a008707; Mogren I, 2001, ACTA ONCOL, V40, P849; Montoya-Williams D, 2017, J WOMENS HEALTH, V26, P1285, DOI 10.1089/jwh.2016.6188; Owings RA, 2014, ARCH PATHOL LAB MED, V138, P484, DOI 10.5858/arpa.2012-0709-RA; Pacheco NLP, 2015, BREAST, V24, P613, DOI 10.1016/j.breast.2015.06.006; Paltiel O, 2004, BMJ-BRIT MED J, V328, P919, DOI 10.1136/bmj.38032.820451.7C; Piccinino LJ, 1998, FAM PLANN PERSPECT, V30, P4, DOI 10.2307/2991517; Pinar H, 1996, PEDIATR PATHOL LAB M, V16, P901, DOI 10.1080/15513819609168713; Pocobelli G, 2011, EPIDEMIOLOGY, V22, P638, DOI 10.1097/EDE.0b013e3182263018; Pollio F, 2006, AM J OBSTET GYNECOL, V194, P527, DOI 10.1016/j.ajog.2005.07.048; Reigstad MM, 2017, CANCER EPIDEM BIOMAR, V26, P953, DOI 10.1158/1055-9965.EPI-16-0809; Richardson BS, 2017, EARLY HUM DEV, V112, P42, DOI 10.1016/j.earlhumdev.2017.06.009; Roberts JM, 2001, LANCET, V357, P53, DOI 10.1016/S0140-6736(00)03577-7; Shibuya M, 2011, P JPN ACAD B-PHYS, V87, P167, DOI 10.2183/pjab.87.167; Sonderegger S, 2010, PLACENTA, V31, P839, DOI 10.1016/j.placenta.2010.07.011; Sovino Hugo, 2002, Reprod Biomed Online, V4, P303; Sponholtz TR, 2017, CANCER CAUSE CONTROL, V28, P579, DOI 10.1007/s10552-017-0880-4; Taylor A, 2004, BRIT MED J, V328, P909, DOI 10.1136/bmj.328.7445.909; Taylor HS, 1998, J CLIN INVEST, V101, P1379, DOI 10.1172/JCI1057; Terry MB, 2007, AM J EPIDEMIOL, V165, P1007, DOI 10.1093/aje/kwk105; Toi M, 2002, INT J CANCER, V98, P14, DOI 10.1002/ijc.10121; Trimble CL, 2012, OBSTET GYNECOL, V120, P1160, DOI [10.1097/AOG.0b013e31826bb121, http://10.1097/AOG.0b013e31826bb121]; Wu QJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep14243; Yang F, 2011, EXPERT REV ANTICANC, V11, P541, DOI [10.1586/era.10.171, 10.1586/ERA.10.171]; Zhang L, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0052-2; Zyla MM, 2016, MENOPAUSE REV, V15, P176, DOI 10.5114/pm.2016.63500; Zyla MM, 2014, MENOPAUSE REV, V13, P122, DOI 10.5114/pm.2014.42714	55	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214600	10.1371/journal.pone.0214600	http://dx.doi.org/10.1371/journal.pone.0214600			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921436	Green Published, Green Submitted, gold			2022-12-26	WOS:000462594000095
J	Guezennec, C; Bourhis, D; Orlhac, F; Robin, P; Corre, JB; Delcroix, O; Gobel, Y; Schick, U; Salaun, PY; Abgral, R				Guezennec, Catherine; Bourhis, David; Orlhac, Fanny; Robin, Philippe; Corre, Jean-Baptiste; Delcroix, Olivier; Gobel, Yves; Schick, Ulrike; Salaun, Pierre-Yves; Abgral, Ronan			Inter-observer and segmentation method variability of textural analysis in pre- therapeutic FDG PET/CT in head and neck cancer	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; METABOLIC TUMOR VOLUME; PROGNOSTIC VALUE; F-18-FDG PET/CT; HETEROGENEITY; FEATURES; SURVIVAL; IMAGES; RADIOTHERAPY; PARAMETERS	Aim Characterizing tumor heterogeneity with textural indices extracted from 18F-fluorodeoxyglucose positron emission tomography (FDG PET/CT) is of growing interest in oncology. Several series showed promising results to predict survival in patients with head and neck squamous cell carcinoma (HNSCC), analyzing various tumor segmentation methods and textural indices. This preliminary study aimed at assessing the inter-observer and inter-segmentation method variability of textural indices in HNSCC pre-therapeutic FDG PET/CT. Materials and methods Consecutive patients with HNSCC referred in our department for a pre-therapeutic FDG PET/CT from January to March 2016 were retrospectively included. Two nuclear medicine physicians separately segmented all tumors using 3 different segmentation methods: a relative standardized uptake value (SUV) threshold (40%SUVmax), a signal-to-noise adaptive SUV threshold (DAISNE) and an image gradient-based method (PET-EDGE). SUV and metabolic tumor volume were recorded. Thirty-one textural indices were calculated using LIFEx software (www.lifexsoft.org). After correlation analysis, selected indices' inter-segmentation method and inter-observer variability were calculated. Results Forty-three patients (mean age 63.8 +/- 9.3y) were analyzed. Due to a too small segmented tumor volume of interest, textural analysis could not be performed in 6, 11 and 15 cases with respectively DAISNE, 40%SUVmax and PET-EDGE segmentation methods. Five independent textural indices were selected (Homogeneity, Correlation, Entropy, Busyness and LZLGE). There was a high inter-contouring method variability for Homogeneity, Correlation, Entropy and LZLGE (p<0.0001 for each index). The inter-observer reproducibility analysis revealed an excellent agreement for 3 indices (Homogeneity, Correlation and Entropy) with an intraclass correlation coefficient higher than 0.90 for the 3 methods. Conclusions This preliminary study showed a high variability of 4 out of 5 textural indices (Homogeneity, Correlation, Entropy and LZLGE) extracted from pre-therapeutic FDG PET/CT in HNSCC using 3 different contouring methods. However, for each method, there was an excellent agreement between observers for 3 of these textural indices (Homogeneity, Correlation and Entropy).	[Guezennec, Catherine; Bourhis, David; Robin, Philippe; Corre, Jean-Baptiste; Delcroix, Olivier; Salaun, Pierre-Yves; Abgral, Ronan] Brest Univ Hosp, Dept Nucl Med, Brest, France; [Orlhac, Fanny] Univ Paris Saclay, Univ Paris Sud, CNRS, Imagerie Mol Vivo,CEA SHJF,INSERM, Orsay, France; [Gobel, Yves] Brest Univ Hosp, Dept Head & Neck Surg, Brest, France; [Schick, Ulrike] Brest Univ Hosp, Dept Radiotherapy, Brest, France	CHU Brest; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; CHU Brest; CHU Brest	Abgral, R (corresponding author), Brest Univ Hosp, Dept Nucl Med, Brest, France.	ronan.abgral@chu-brest.fr	SALAUN, Pierre-Yves/X-6701-2019; Orlhac, Fanny/AAC-6428-2019; Robin, Philippe/X-6290-2019	SALAUN, Pierre-Yves/0000-0002-3899-2135; Orlhac, Fanny/0000-0002-5588-1867; Robin, Philippe/0000-0001-5521-9454; Gobel, Yves/0000-0003-3847-9937; abgral, ronan/0000-0002-5585-2564; Bourhis, David/0000-0001-8224-2027				Abgral R, 2016, HEAD NECK-J SCI SPEC, V38, pE600, DOI 10.1002/hed.24048; Abgral R, 2014, EUR J NUCL MED MOL I, V41, P659, DOI 10.1007/s00259-013-2618-1; AMADASUN M, 1989, IEEE T SYST MAN CYB, V19, P1264, DOI 10.1109/21.44046; Ang KK, 2001, INT J RADIAT ONCOL, V51, P571, DOI 10.1016/S0360-3016(01)01690-X; [Anonymous], [No title captured]; Brooks FJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116574; Brooks FJ, 2014, J NUCL MED, V55, P37, DOI 10.2967/jnumed.112.116715; Cheng NM, 2015, EUR J NUCL MED MOL I, V42, P419, DOI 10.1007/s00259-014-2933-1; Cheng NM, 2013, J NUCL MED, V54, P1703, DOI 10.2967/jnumed.112.119289; Daisne JF, 2004, RADIOLOGY, V233, P93, DOI 10.1148/radiol.2331030660; De Cecco L, 2015, ONCOTARGET, V6, P9627, DOI 10.18632/oncotarget.3301; Dibble EH, 2012, J NUCL MED, V53, P709, DOI 10.2967/jnumed.111.099531; Edge SB, 2010, AJCC CANC STAGING MA; Fakhry C, 2008, JNCI-J NATL CANCER I, V100, P261, DOI 10.1093/jnci/djn011; Fitzmaurice C, 2017, JAMA ONCOL, V3, P524, DOI 10.1001/jamaoncol.2016.5688; Geets X, 2007, EUR J NUCL MED MOL I, V34, P1427, DOI 10.1007/s00259-006-0363-4; Guezennec C, 2019, HEAD NECK-J SCI SPEC, V41, P495, DOI 10.1002/hed.25433; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Hasina R, 2008, LAB INVEST, V88, P342, DOI 10.1038/labinvest.2008.6; Hatt M, 2015, J NUCL MED, V56, P38, DOI 10.2967/jnumed.114.144055; Hatt M, 2013, EUR J NUCL MED MOL I, V40, P1662, DOI 10.1007/s00259-013-2486-8; Jou A, 2017, ONCOL RES TREAT, V40, P328, DOI 10.1159/000477127; Kao CH, 2012, EUR J NUCL MED MOL I, V39, P1297, DOI 10.1007/s00259-012-2127-7; Leijenaar RTH, 2015, SCI REP-UK, V5, DOI 10.1038/srep11075; National Comprehensive Cancer Network, 2021, NCCN CLIN PRACTICE G; Nestle U, 2005, J NUCL MED, V46, P1342; Nioche C, 2018, CANCER RES, V78, P4786, DOI 10.1158/0008-5472.CAN-18-0125; Oh JS, 2015, ANN SURG ONCOL, V22, P2746, DOI 10.1245/s10434-014-4284-3; Orlhac F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145063; Orlhac F, 2014, J NUCL MED, V55, P414, DOI 10.2967/jnumed.113.129858; Pak K, 2014, J NUCL MED, V55, P884, DOI 10.2967/jnumed.113.133801; Querellou S, 2012, HEAD NECK-J SCI SPEC, V34, P462, DOI 10.1002/hed.21765; Sittel C, 1999, ORAL ONCOL, V35, P583, DOI 10.1016/S1368-8375(99)00041-X; Sobin L, 2009, TNM CLASSIFICATION M; Vallieres M, 2018, J NUCL MED, V59, P189, DOI 10.2967/jnumed.117.200501; Worsham MJ, 2012, MOL DIAGN THER, V16, P209, DOI 10.2165/11635330-000000000-00000; Xie S, 2016, J CANCER, V7, P758, DOI 10.7150/jca.14214; Xu D-H, 2004, RESEARCHGATE	38	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214299	10.1371/journal.pone.0214299	http://dx.doi.org/10.1371/journal.pone.0214299			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921388	gold, Green Published, Green Submitted			2022-12-26	WOS:000462594000051
J	Kolb, JP; Draxinger, W; Klee, J; Pfeiffer, T; Eibl, M; Klein, T; Wieser, W; Huber, R				Kolb, Jan Philip; Draxinger, Wolfgang; Klee, Julian; Pfeiffer, Tom; Eibl, Matthias; Klein, Thomas; Wieser, Wolfgang; Huber, Robert			Live video rate volumetric OCT imaging of the retina with multi-MHz A-scan rates	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; DOMAIN MODE-LOCKING; SWEPT-SOURCE; VISUALIZATION; SPEED; FDML	Surgical microscopes are vital tools for ophthalmic surgeons. The recent development of an integrated OCT system for the first time allows to look at tissue features below the surface. Hence, these systems can drastically improve the quality and reduce the risk of surgical interventions. However, current commercial OCT-enhanced ophthalmic surgical microscopes provide only one additional cross sectional view to the standard microscope image and feature a low update rate. To present volumetric data at a high update rate, much faster OCT systems than the ones applied in today's surgical microscopes need to be developed. We demonstrate live volumetric retinal OCT imaging, which may provide a sufficiently large volume size (330x330x595 Voxel) and high update frequency (24.2 Hz) such that the surgeon may even purely rely on the OCT for certain surgical maneuvers. It represents a major technological step towards the possible application of OCT-only surgical microscopes in the future which would be much more compact thus enabling many additional minimal invasive applications. We show that multi-MHz A-scan rates are essential for such a device. Additionally, advanced phase-based OCT techniques require 3D OCT volumes to be detected with a stable optical phase. These techniques can provide additional functional information of the retina. Up to now, classical OCT was to slow for this, so our system can pave the way to holographic OCT with a traditional confocal flying spot approach. For the first time, we present point scanning volumetric OCT imaging of the posterior eye with up to 191.2 Hz volume rate. We show that this volume rate is high enough to enable a sufficiently stable optical phase to a level, where remaining phase errors can be corrected. Applying advanced post processing concepts for numerical refocusing or computational adaptive optics should be possible in future with such a system.	[Kolb, Jan Philip; Draxinger, Wolfgang; Klee, Julian; Pfeiffer, Tom; Eibl, Matthias; Huber, Robert] Univ Lubeck, Inst Biomed Opt, Lubeck, Germany; [Klein, Thomas; Wieser, Wolfgang] Optores GmbH, Munich, Germany	University of Lubeck	Huber, R (corresponding author), Univ Lubeck, Inst Biomed Opt, Lubeck, Germany.	Robert.Huber@bmo.uni-luebeck.de	Eibl, Matthias/AAN-5097-2020; Huber, Robert A/B-9419-2008	Eibl, Matthias/0000-0003-0351-5707; Huber, Robert A/0000-0001-9785-6574; Draxinger, Wolfgang/0000-0002-9413-3474; Pfeiffer, Tom/0000-0001-7791-1126	European Union (ERC CoG) [646669]; German Research Foundation [HU1006/6, EXC306/2]; European Union within Interreg Deutschland-Danmark from the European Regional Development Fund in the project CELLTOM; Bundesministerium fur Bildung und Forschung (BMBF) [13GW0227B]	European Union (ERC CoG); German Research Foundation(German Research Foundation (DFG)); European Union within Interreg Deutschland-Danmark from the European Regional Development Fund in the project CELLTOM; Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF))	Funded by European Union (ERC CoG no. 646669) https://erc.europa.eu/; German Research Foundation (HU1006/6) and (EXC306/2), http://www.dfg.de/; European Union within Interreg Deutschland-Danmark from the European Regional Development Fund in the project CELLTOM, http://www.interreg.de/INTERREG2014/DE/Home/home_ node. html; Bundesministerium fur Bildung und Forschung (BMBF) 13GW0227B project Neuro-OCT, https://www.bmbf.de/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2013, NAT PHOTONICS, V7, P445, DOI [10.1038/nphoton.2013.71, 10.1038/NPHOTON.2013.71]; Biedermann BR, 2008, OPT LETT, V33, P2556, DOI 10.1364/OL.33.002556; Buades A, 2011, IMAGE PROCESS ON LIN, V1, P208, DOI 10.5201/ipol.2011.bcm_nlm; Carrasco-Zevallos O, 2017, SPIE BIOS; Carrasco-Zevallos OM, 2016, SCI REP-UK, V6, DOI 10.1038/srep31689; Choma MA, 2003, OPT EXPRESS, V11, P2183, DOI 10.1364/OE.11.002183; De Benito-Llopis L, 2014, AM J OPHTHALMOL, V157, P334, DOI 10.1016/j.ajo.2013.10.001; Ehlers JP, 2013, RETINA-J RET VIT DIS, V33, P232, DOI 10.1097/IAE.0b013e31826e86f5; El-Haddad MT, 2015, BIOMED OPT EXPRESS, V6, P3014, DOI 10.1364/BOE.6.003014; Fechtig DJ, 2015, PROC SPIE, V9312, DOI 10.1117/12.2081924; Fechtig DJ, 2015, BIOMED OPT EXPRESS, V6, P716, DOI 10.1364/BOE.6.000716; FERCHER AF, 1993, AM J OPHTHALMOL, V116, P113, DOI 10.1016/S0002-9394(14)71762-3; Ginner L, 2014, PHOTONICS; GUAYLORD R, 2016, BIOMEDO, V21, DOI DOI 10.1117/1.JBO.21.11.116008; Hillmann D, 2016, P NATL ACAD SCI; Hillmann D, 2016, SCI REP-UK, V6, DOI 10.1038/srep35209; Hiro-Oka H., 2012, BIOMED OPT EXPRESS, V3, P3067, DOI DOI 10.1364/B0E.3.003067; Holcombe AO, 2009, TRENDS COGN SCI, V13, P216, DOI 10.1016/j.tics.2009.02.005; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Huber R, 2006, OPT EXPRESS, V14, P3225, DOI 10.1364/OE.14.003225; Huber R, 2006, OPT LETT, V31, P2975, DOI 10.1364/OL.31.002975; [Institute ANS Z136 Committee. ANSI], 2000, SAF US LAS SAF US OP; IZATT JA, 1994, OPT LETT, V19, P590, DOI 10.1364/OL.19.000590; Jian YF, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.2.026002; Junker B, 2016, OPHTHALMOLOGE, V113, P663, DOI 10.1007/s00347-016-0321-x; Kaschke M, 2014, OPTICAL DEVICES IN OPHTHALMOLOGY AND OPTOMETRY: TECHNOLOGY, DESIGN PRINCIPLES, AND CLINICAL APPLICATIONS, P1, DOI 10.1002/9783527648962; Klein T, 2013, BIOMED OPT EXPRESS, V4, P1890, DOI 10.1364/BOE.4.001890; Kocaoglu OP, 2014, BIOMED OPT EXPRESS, V5, P4186, DOI 10.1364/BOE.5.004186; Kolb JP, 2015, BIOMED OPT EXPRESS, V6, P1534, DOI 10.1364/BOE.6.001534; Laubscher M, 2002, OPT EXPRESS, V10, P429, DOI 10.1364/OE.10.000429; Lee LB, 2011, OPHTHALMIC SURG LASE; Martinez-Conde S, 2009, TRENDS NEUROSCI, V32, P463, DOI 10.1016/j.tins.2009.05.006; Miller R. B., 1968, P DEC 9 11 1968 FALL; Nemeth A., 2013, OPT COHER TOMOGRAPH, V6, P163, DOI [10.1111/j.1399-3054.1981.tb04512.x, DOI 10.1111/J.1399-3054.1981.TB04512.X]; PALMER KF, 1974, J OPT SOC AM, V64, P1107, DOI 10.1364/JOSA.64.001107; PCISIG, 2015, PCI EXPR BAS SPEC RE; Pfazffle C, 2017, BIOMED OPT EXPRESS, V8, P1499, DOI 10.1364/BOE.8.001499; Probst J, 2010, BIOMEDO, V15; PULIAFITO CA, 1995, OPHTHALMOLOGY, V102, P217; SCHMITT JM, 1995, DERMATOLOGY, V191, P93, DOI 10.1159/000246523; Shemonski ND, 2015, NAT PHOTONICS, V9, P440, DOI [10.1038/NPHOTON.2015.102, 10.1038/nphoton.2015.102]; Shemonski ND, 2015, COMPUTATIONAL APPROA; Shen LB, 2016, BIOMED OPT EXPRESS, V7, P1711, DOI 10.1364/BOE.7.001711; Spahr H, 2015, OPT LETT, V40, P4771, DOI 10.1364/OL.40.004771; Steven P, 2014, BRIT J OPHTHALMOL, V98, P900, DOI 10.1136/bjophthalmol-2013-304585; Steven P, 2013, JAMA OPHTHALMOL, V131, P1135, DOI 10.1001/jamaophthalmol.2013.4672; SWANSON EA, 1993, OPT LETT, V18, P1864, DOI 10.1364/OL.18.001864; Tao YKK, 2010, OPT LETT, V35, P3315, DOI 10.1364/OL.35.003315; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; Todorich B, 2016, INVEST OPHTH VIS SCI, V57; Tsai TH, 2013, BIOMED OPT EXPRESS, V4, P1119, DOI 10.1364/BOE.4.001119; US Food and Drug Administration, 2016, K161194510 K PREM NO; Viehland C, 2016, BIOMED OPT EXPRESS, V7, P1815, DOI 10.1364/BOE.7.001815; Wang RK, 2007, OPT EXPRESS, V15, P4083, DOI 10.1364/OE.15.004083; Wang S, 2015, OPT LETT, V40, P4791, DOI 10.1364/OL.40.004791; Wang TS, 2016, JACC-CARDIOVASC IMAG, V9, P622, DOI 10.1016/j.jcmg.2015.08.010; Wieser W, 2014, BIOMED OPT EXPRESS, V5, P2963, DOI 10.1364/BOE.5.002963; Wieser W, 2010, OPT EXPRESS, V18, P14685, DOI 10.1364/OE.18.014685; Willomitzer F, 2017, OPT EXPRESS, V25, P23451, DOI 10.1364/OE.25.023451; Yelin R, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2822904; Yun SH, 2004, OPT EXPRESS, V12, P2977, DOI 10.1364/OPEX.12.002977; Zhang K, 2010, OPT EXPRESS, V18, P11772, DOI 10.1364/OE.18.011772; Zhi ZW, 2015, OPT LETT, V40, P1779, DOI 10.1364/OL.40.001779	63	28	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0213144	10.1371/journal.pone.0213144	http://dx.doi.org/10.1371/journal.pone.0213144			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921342	Green Submitted, Green Published, gold			2022-12-26	WOS:000462594000014
J	Yu, Q; Liu, AL; Liu, TB; Mao, YW; Chen, W; Liu, HX				Yu, Qiong; Liu, Aili; Liu, Tiebing; Mao, Yuwei; Chen, Wei; Liu, Hongxing			ECG R-wave peaks marking with simultaneously recorded continuous blood pressure	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; ROBUST-DETECTION; BEATS	Background and objectives ECG signal is relatively weak and vulnerable to various noise interferences, such as electromyography. There will be robustness problems when detecting the instantaneous heart rate independently. In some cases, multiple human physiologic parameters are monitored to help in heart rate detection. Methods In this paper, an algorithm that marks the R-wave peaks with the help of simultaneously recorded continuous blood pressure is proposed and tested on two databases. One database, called the challenge database, is provided by the PhysioNet/Computing in Cardiology Challenge 2014, and the other is the MGH/MF waveform database. Results The final scores of the proposed algorithm are 97.3% for the challenge database and 96.6% for the MGH/MF waveform database. Conclusions The experimental results show that this algorithm has high detection accuracy and a relatively strong robustness.	[Yu, Qiong; Liu, Aili; Mao, Yuwei; Chen, Wei; Liu, Hongxing] Nanjing Univ, Sch Elect Sci & Engn, Xianlin Campus, Nanjing, Jiangsu, Peoples R China; [Liu, Tiebing] Nanjing Mil Command, Nanjing Gen Hosp, Nanjing, Jiangsu, Peoples R China	Nanjing University; Nanjing General Hospital	Liu, HX (corresponding author), Nanjing Univ, Sch Elect Sci & Engn, Xianlin Campus, Nanjing, Jiangsu, Peoples R China.	njhxliu@nju.edu.cn			National Natural Science Foundation of China [61271079]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The National Natural Science Foundation of China (No. 61271079) supported this paper. The URLs of the funders' website is http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chin FJ, 2010, IEEE ENG MED BIO, P1922, DOI 10.1109/IEMBS.2010.5628088; Chiu CC, 2005, BIOMED ENG-APP BAS C, V17, DOI 10.4015/S1016237205000238; Cui X., 2011, NEW REAL TIME ECG R, P1252; DEBOER RW, 1984, IEEE T BIO-MED ENG, V31, P384, DOI 10.1109/TBME.1984.325351; Dosinas A., 2006, Elektronika ir Elektrotechnika, P77; Johnson AEW, 2015, PHYSIOL MEAS, V36, P1665, DOI 10.1088/0967-3334/36/8/1665; PAN J, 1985, IEEE T BIO-MED ENG, V32, P230, DOI 10.1109/TBME.1985.325532; Pangerc U, 2015, PHYSIOL MEAS, V36, P1645, DOI 10.1088/0967-3334/36/8/1645; Sameni R, 2010, OPEN SOURCE ELECTROP; Sasikala P, 2011, INT J ADV COMPUTER S; She Lihuang, 2009, IM SIGN PROC 2 INT C, P1; Silva I, 2015, PHYSIOL MEAS, V36, P1629, DOI 10.1088/0967-3334/36/8/1629; Su L, 2005, J HARBIN ENG U, V26, P513; WELCH JP, 1991, J CLIN MONIT, V0007; Winchell RJ, 1996, J SURG RES, V63, P11, DOI 10.1006/jsre.1996.0214; WO CCJ, 1993, CRIT CARE MED, V21, P218, DOI 10.1097/00003246-199302000-00012	16	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214443	10.1371/journal.pone.0214443	http://dx.doi.org/10.1371/journal.pone.0214443			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921387	Green Submitted, Green Published, gold			2022-12-26	WOS:000462594000070
J	Becerikli, M; Jaurich, H; Wallner, C; Wagner, JM; Dadras, M; Jettkant, B; Pohl, F; Seifert, M; Jung, O; Mitevski, B; Karkar, A; Lehnhardt, M; Fischer, A; Kauther, MD; Behr, B				Becerikli, Mustafa; Jaurich, Henriette; Wallner, Christoph; Wagner, Johannes Maximilian; Dadras, Mehran; Jettkant, Birger; Poehl, Fabian; Seifert, Merlin; Jung, Ole; Mitevski, Bojan; Karkar, Ahmet; Lehnhardt, Marcus; Fischer, Alfons; Kauther, Max Daniel; Behr, Bjoern			P2000-A high-nitrogen austenitic steel for application in bone surgery	PLOS ONE			English	Article							STAINLESS-STEEL; ELASTIC-MODULUS; TITANIUM; NICKEL; OSTEOBLASTS; METALS; INDENTATION; ATTACHMENT; DIFFERENCE; FIXATION	Optimal treatment of bone fractures with minimal complications requires implant alloys that combine high strength with high ductility. Today, TiAl6V4 titanium and 316L steel are the most applied alloys in bone surgery, whereas both share advantages and disadvantages. The nickel-free, high-nitrogen austenitic steel X13CrMnMoN18-14-3 (1.4452, brand name: P2000) exhibits high strength in combination with superior ductility. In order to compare suitable alloys for bone implants, we investigated titanium, 316L steel, CoCrMo and P2000 for their biocompatibility and hemocompatibility (according to DIN ISO 10993-5 and 10993-4), cell metabolism, mineralization of osteoblasts, electrochemical and mechanical properties. P2000 exhibited good biocompatibility of fibroblasts and osteoblasts without impairment in vitality or changing of cell morphology. Furthermore, investigation of the osteoblasts function by ALP activity and protein levels of the key transcription factor RUNX2 revealed 2x increased ALP activity and more than 4x increased RUNX2 protein levels for P2000 compared to titanium or 316 steel, respectively. Additionally, analyses of osteoblast biomineralization by Alizarin Red S staining exhibited more than 6x increased significant mineralization of osteoblasts grown on P2000 as compared to titanium. Further, P2000 showed no hemolytic effect and no significant influence on hemocompatibility. Nanoindentation hardness tests of Titanium and 316L specimens exposed an indentation hardness (H-IT) of about 4 GPa, whereas CoCrMo and P2000 revealed HIT of 7.5 and 5.6 GPa, respectively. Moreover, an improved corrosion resistance of P2000 compared to 316L steel was observed. In summary, we could demonstrate that the nickel-free high-nitrogen steel P2000 appears to be a promising alternative candidate for applications in bone surgery. As to nearly all aspects like biocompatibility and hemocompatibility, cell metabolism, mineralization of osteoblasts and mechanical properties, P2000 was similar to or revealed advantages against titanium, 316L or CoCrMo.	[Becerikli, Mustafa; Jaurich, Henriette; Wallner, Christoph; Wagner, Johannes Maximilian; Dadras, Mehran; Jung, Ole; Lehnhardt, Marcus; Behr, Bjoern] Ruhr Univ Bochum, BG Univ Hosp Bergmannsheil, Dept Plast & Reconstruct Surg, Bochum, Germany; [Jettkant, Birger] Ruhr Univ Bochum, BG Univ Hosp Bergmannsheil, Dept Gen & Trauma Surg, Bochum, Germany; [Poehl, Fabian; Seifert, Merlin] Ruhr Univ Bochum, Chair Mat Technol, Bochum, Germany; [Mitevski, Bojan; Karkar, Ahmet; Fischer, Alfons] Univ Duisburg Essen, Dept Mat Sci & Engn, Duisburg, Germany; [Kauther, Max Daniel] Univ Duisburg Essen, Univ Hosp Essen, Dept Orthopaed & Trauma Surg, Essen, Germany	Ruhr University Bochum; Ruhr University Bochum; Ruhr University Bochum; University of Duisburg Essen; University of Duisburg Essen	Behr, B (corresponding author), Ruhr Univ Bochum, BG Univ Hosp Bergmannsheil, Dept Plast & Reconstruct Surg, Bochum, Germany.	bjorntehr@rub.cie	Dadras, Mehran/R-2089-2019; Jung, Ole/AAJ-4138-2021; Dadras, Mehran/ABB-8737-2020; Behr, Björn/AAS-1877-2021	Dadras, Mehran/0000-0003-1283-2982; Becerikli, Mustafa/0000-0002-2695-5273; Fischer, Alfons/0000-0003-0407-2813	Mercator Research Center Ruhr [MERCUR Pr-2015-0047]; DFG Open Access Publication Funds of the Ruhr-Universitat Bochum	Mercator Research Center Ruhr; DFG Open Access Publication Funds of the Ruhr-Universitat Bochum	This work was supported by a grant of the Mercator Research Center Ruhr [MERCUR Pr-2015-0047] to B.B, M.D.K and A.F. We acknowledge support by the DFG Open Access Publication Funds of the Ruhr-Universitat Bochum. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhami MD, 2015, J BONE MINER RES, V30, P71, DOI 10.1002/jbmr.2321; Andersen OZ, 2013, BIOMATERIALS, V34, P5883, DOI 10.1016/j.biomaterials.2013.04.031; [Anonymous], 2004, G5942004 ASTM INT; Axe Jeremie M, 2015, Del Med J, V87, P182; Banovetz JM, 1996, J ORTHOP TRAUMA, V10, P389, DOI 10.1097/00005131-199608000-00005; Becerikli M, 2017, J CELL MOL MED; Caicedo MS, 2009, J ORTHOP RES, V27, P847, DOI 10.1002/jor.20826; CARTANA J, 1989, ENZYME, V41, P1; DELMAS PD, 1991, BAILLIERE CLIN OB GY, V5, P817, DOI 10.1016/S0950-3552(05)80289-5; Diamanti MV, 2011, J APPL BIOMATER BIOM, V9, P55, DOI 10.5301/JABB.2011.7429; Disegi J A, 2000, Injury, V31 Suppl 4, P2; Fischer A, 2012, J MECH BEHAV BIOMED, V9, P50, DOI 10.1016/j.jmbbm.2012.01.007; Gosain AK, 1998, PLAST RECONSTR SURG, V101, P582, DOI 10.1097/00006534-199803000-00004; Hanninen H, 1999, MATER SCI FORUM, V318-3, P479, DOI 10.4028/www.scientific.net/MSF.318-320.479; Hayes JS, 2010, EXPERT REV MED DEVIC, V7, P843, DOI [10.1586/erd.10.53, 10.1586/ERD.10.53]; International A, 2012, F7507 ASTM INT A; Kanaji A, 2009, BONE, V45, P528, DOI 10.1016/j.bone.2009.05.020; Kanis JA, 2002, LANCET, V359, P1929, DOI 10.1016/S0140-6736(02)08761-5; Kawane T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31853-0; Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102; Khan W, 2007, ACTA BIOMATER, V3, P541, DOI 10.1016/j.actbio.2007.01.006; Koch S, 2002, MATERIALWISS WERKST, V33, P705, DOI 10.1002/mawe.200290000; Krischak GD, 2004, ARCH ORTHOP TRAUM SU, V124, P104, DOI 10.1007/s00402-003-0614-9; Lai M, 2017, COLLOID SURFACE B, V159, P743, DOI 10.1016/j.colsurfb.2017.08.043; Lai M, 2017, MAT SCI ENG C-MATER, V73, P490, DOI 10.1016/j.msec.2016.12.083; Li MH, 2017, MAT SCI ENG C-MATER, V73, P198, DOI 10.1016/j.msec.2016.12.070; LIEBERHERR M, 1987, KIDNEY INT, V31, P736, DOI 10.1038/ki.1987.60; McKay GC, 1996, BIOMATERIALS, V17, P1339, DOI 10.1016/0142-9612(96)88681-9; Oliver WC, 2004, J MATER RES, V19, P3, DOI 10.1557/jmr.2004.19.1.3; OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564; Philipp D, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-1039-2; Pohl F, 2016, AIMS MATER SCI, V3, P390, DOI 10.3934/matersci.2016.2.390; Raucci A, 2008, J CELL PHYSIOL, V215, P442, DOI 10.1002/jcp.21323; Ren L, 2015, J BIOMED MATER RES B, V103, P1433, DOI 10.1002/jbm.b.33318; Ren L, 2013, J MATER SCI TECHNOL, V29, P1005, DOI 10.1016/j.jmst.2013.09.008; Roberts TT, 2013, ORTHOPEDICS, V36, P12, DOI 10.3928/01477447-20121217-02; RODRIGUEZ RE, 1990, TOXICOLOGY, V63, P45, DOI 10.1016/0300-483X(90)90067-Q; Schram SE, 2010, INT J DERMATOL, V49, P115, DOI 10.1111/j.1365-4632.2009.04307.x; Schymura M, 2014, INT J FATIGUE, V61, P1, DOI 10.1016/j.ijfatigue.2013.11.018; Shah KM, 2015, J ORTHOP RES, V33, P1663, DOI 10.1002/jor.22932; Shen XK, 2014, ACS APPL MATER INTER, V6, P16426, DOI 10.1021/am5049338; SINHA RK, 1994, CLIN ORTHOP RELAT R, P258; Suzuki T, 2010, J ORTHOP TRAUMA, V24, P369, DOI 10.1097/BOT.0b013e3181c29bf5; Sykaras N, 2000, INT J ORAL MAX IMPL, V15, P675; Wiemann M, 1998, CALCIFIED TISSUE INT, V63, P154, DOI 10.1007/s002239900507; Williams D, 2001, Med Device Technol, V12, P8; Winters GL, 2003, STAINLESS STEELS MED; Yates LB, 2007, BONE, V41, P722, DOI 10.1016/j.bone.2007.06.001; Zhang DM, 2017, J BIOMED MATER RES A, V105, P148, DOI 10.1002/jbm.a.35895	49	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2019	14	3							e0214384	10.1371/journal.pone.0214384	http://dx.doi.org/10.1371/journal.pone.0214384			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ3IW	30913254	Green Published, gold			2022-12-26	WOS:000462305600052
J	Li, ZS; Liu, YM; Li, LY; Fang, ZY; Yang, LM; Zhuang, M; Zhang, YY; Lv, HH				Li, Zhansheng; Liu, Yumei; Li, Lingyun; Fang, Zhiyuan; Yang, Limei; Zhuang, Mu; Zhang, Yangyong; Lv, Honghao			Transcriptome reveals the gene expression patterns of sulforaphane metabolism in broccoli florets	PLOS ONE			English	Article							GLUCOSINOLATE BIOSYNTHESIS; MYROSINASE ACTIVITY; NATURAL VARIATION; OILSEED RAPE; PHASE-II; ARABIDOPSIS; GLUCORAPHANIN; HYDROLYSIS; CELLS; ISOTHIOCYANATES	Sulforaphane is a new and effective anti-cancer component that is abundant in broccoli. In the past few years, the patterns of variability in glucosinolate content and its regulation in A. thaliana have been described in detail. However, the diversity of glucosinolate and sulforaphane contents in different organs during vegetative and reproductive stages has not been clearly explained. In this paper, we firstly investigated the transcriptome profiles of the developing buds and leaves at bolting stage of broccoli (B52) to further assess the gene expression patterns involved in sulforaphane synthesis. The CYP79F1 gene, as well as nine other genes related to glucorahpanin biosynthesis, MAM1, MAM3, St5b-2, FMO GSOX1, MY, AOP2, AOP3, ESP and ESM1 were selected by digital gene expression analysis and were validated by quantitative real-time PCR (qRT-PCR). Meanwhile, the compositions of glucosinolates and sulforaphane were detected for correlation analysis with related genes. Finally the RNA sequencing libraries generated 147 957 344 clean reads, and 8 539 unigene assemblies were produced. In digital result, only CYP79F1, in the glucoraphanin pathway, was up-regulated in young buds but absent from the other organs, which was consistent with the highest level of sulforaphane content being in this organ compared to mature buds, buds one day before flowering, flowers and leaves. The sequencing results also presented that auxin and cytokinin might affect glucoraphanin accumulation. The study revealed that up-regulated expression of CYP79F1 plays a fundamental and direct role in sulforaphane production in inflorescences. Two genes of MAM1 and St5b-2 could up-regulated glucoraphanin generation. Synergistic expression of MAM1, MAM3, St5b-2, FMO GSOX1, MY, ESP and ESM1 was found in sulforaphane metabolism. This study will be beneficial for understanding the diversity of sulforaphane in broccoli organs.	[Li, Zhansheng; Liu, Yumei; Li, Lingyun; Fang, Zhiyuan; Yang, Limei; Zhuang, Mu; Zhang, Yangyong; Lv, Honghao] Chinese Acad Agr Sci, Inst Vegetables & Flowers, Beijing, Peoples R China; [Li, Zhansheng; Liu, Yumei; Li, Lingyun; Fang, Zhiyuan; Yang, Limei; Zhuang, Mu; Zhang, Yangyong; Lv, Honghao] Minist Agr, Key Lab Biol & Genet Improvement Hort Crops, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Vegetables & Flowers, CAAS; Ministry of Agriculture & Rural Affairs	Li, ZS (corresponding author), Chinese Acad Agr Sci, Inst Vegetables & Flowers, Beijing, Peoples R China.; Li, ZS (corresponding author), Minist Agr, Key Lab Biol & Genet Improvement Hort Crops, Beijing, Peoples R China.	lizhansheng@caas.cn	Lv, Honghao/AFS-6332-2022	Lv, Honghao/0000-0003-2635-3042; li, zhan sheng/0000-0003-0132-2741	National Nature Science Foundation [31501761, 31372067]; China Agriculture Research System [CARS-23-A8]; National Key Research and Development Program of China [2017YFD0101805]; Science and Technology Innovation Program of the Chinese Academy of Agricultural Sciences (CAAS-ASTIP-IVFCAAS)	National Nature Science Foundation(National Natural Science Foundation of China (NSFC)); China Agriculture Research System; National Key Research and Development Program of China; Science and Technology Innovation Program of the Chinese Academy of Agricultural Sciences (CAAS-ASTIP-IVFCAAS)	This work was founded by the National Nature Science Foundation (31501761, 31372067) to ZL, the China Agriculture Research System (CARS-23-A8) to ZL, the National Key Research and Development Program of China (2017YFD0101805) to ZL, as well as the Science and Technology Innovation Program of the Chinese Academy of Agricultural Sciences (CAAS-ASTIP-IVFCAAS) to ZL.	Abbaoui B, 2012, MOL NUTR FOOD RES, V56, P1675, DOI 10.1002/mnfr.201200276; Agerbirk N, 2010, J AGR FOOD CHEM, V58, P4693, DOI 10.1021/jf904362m; Agudo A, 2008, EUR J CLIN NUTR, V62, P324, DOI 10.1038/sj.ejcn.1602750; Alumkal JJ, 2015, INVEST NEW DRUG, V33, P480, DOI 10.1007/s10637-014-0189-z; Angelino D, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00831; Angelino D, 2014, J FUNCT FOODS, V7, P67, DOI 10.1016/j.jff.2013.09.029; Angeloni C, 2009, J AGR FOOD CHEM, V57, P5615, DOI 10.1021/jf900549c; Ares AM, 2015, FOOD RES INT, V76, P498, DOI 10.1016/j.foodres.2015.06.037; Asakage Masahiro, 2006, Angiogenesis, V9, P83, DOI 10.1007/s10456-006-9034-0; Azarenko O, 2008, CARCINOGENESIS, V29, P2360, DOI 10.1093/carcin/bgn241; Bak S, 2001, PLANT PHYSIOL, V127, P108, DOI 10.1104/pp.127.1.108; BENNETT RN, 1995, PLANT PHYSIOL, V109, P299, DOI 10.1104/pp.109.1.299; Brader G, 2006, PLANT J, V46, P758, DOI 10.1111/j.1365-313X.2006.02743.x; Brooks JD, 1999, PROSTATE CANCER P D, V2, pS8, DOI 10.1038/sj.pcan.4500334; Brown PD, 2003, PHYTOCHEMISTRY, V62, P471, DOI 10.1016/S0031-9422(02)00549-6; Brudenell AJP, 1999, J EXP BOT, V50, P745, DOI 10.1093/jexbot/50.335.745; Burow M, 2015, MOL PLANT, V8, P1201, DOI 10.1016/j.molp.2015.03.001; Cano-Gomez C, 2011, INFECT GENET EVOL, V11, P2144, DOI 10.1016/j.meegid.2011.09.014; Chen S, 2001, PLANT PHYSIOL BIOCH, V39, P743, DOI 10.1016/S0981-9428(01)01301-8; Chen SX, 2003, PLANT J, V33, P923, DOI 10.1046/j.1365-313X.2003.01679.x; Cheng F, 2013, PLANT CELL, V25, P1541, DOI 10.1105/tpc.113.110486; Chung YK, 2015, J BIOSCI BIOENG, V119, P35, DOI 10.1016/j.jbiosc.2014.06.009; Clark CG, 2007, CAN J MICROBIOL, V53, P27, DOI 10.1139/W06-099; Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; Cramer JM, 2009, FASEB J, P23; Du LC, 1998, PHYTOCHEMISTRY, V48, P1145, DOI 10.1016/S0031-9422(97)00877-7; Evans PC, 2011, EPMA J, V2, P9, DOI 10.1007/s13167-011-0064-3; Fahey JW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140963; Fahey JW, 2001, PHYTOCHEMISTRY, V56, P5, DOI 10.1016/S0031-9422(00)00316-2; de Oliveira JMPF, 2014, NUTR CANCER, V66, P325, DOI 10.1080/01635581.2014.864777; Field B, 2004, PLANT PHYSIOL, V135, P828, DOI 10.1104/pp.104.039347; Fu LL, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060892; Gao MQ, 2004, GENOME, V47, P666, DOI [10.1139/g04-021, 10.1139/G04-021]; Giamoustaris A, 1996, ENTOMOL EXP APPL, V80, P206, DOI 10.1007/BF00194758; Glade MJ, 2015, NUTRITION, V31, P1175, DOI 10.1016/j.nut.2015.03.003; Gorissen A, 2011, FOOD CHEM, V127, P192, DOI 10.1016/j.foodchem.2010.12.067; Grubb CD, 2006, TRENDS PLANT SCI, V11, P89, DOI 10.1016/j.tplants.2005.12.006; Guo LP, 2016, J SCI FOOD AGR, V96, P4329, DOI 10.1002/jsfa.7629; Guo LP, 2014, J FUNCT FOODS, V9, P70, DOI 10.1016/j.jff.2014.04.015; Halkier BA, 1997, TRENDS PLANT SCI, V2, P425, DOI 10.1016/S1360-1385(97)01128-X; Halkier BA, 2006, ANNU REV PLANT BIOL, V57, P303, DOI 10.1146/annurev.arplant.57.032905.105228; Hall C, 2001, THEOR APPL GENET, V102, P369, DOI 10.1007/s001220051655; Hansen BG, 2007, PLANT J, V50, P902, DOI 10.1111/j.1365-313X.2007.03101.x; Hansen BG, 2008, PLANT PHYSIOL, V148, P2096, DOI 10.1104/pp.108.129981; Hansen CH, 2001, J BIOL CHEM, V276, DOI [10.1038/ncomms4930, DOI 10.1038/NCOMMS4930]; Heidel AJ, 2006, GENETICS, V173, P1629, DOI 10.1534/genetics.106.056986; Heinl S, 2011, PLASMID, V66, P159, DOI 10.1016/j.plasmid.2011.08.002; Iori R, 1999, BIOORG MED CHEM LETT, V9, P1047, DOI 10.1016/S0960-894X(99)00136-5; Jin CY, 2007, CARCINOGENESIS, V28, P1058, DOI 10.1093/carcin/bgl251; Kallifatidis G, 2009, GUT, V58, P949, DOI 10.1136/gut.2008.149039; Kensler TW, 2012, CARCINOGENESIS, V33, P101, DOI 10.1093/carcin/bgr229; Kliebenstein DJ, 2001, PLANT CELL, V13, P681, DOI 10.1105/tpc.13.3.681; Kliebenstein DJ, 2001, PLANT PHYSIOL, V126, P811, DOI 10.1104/pp.126.2.811; Kong WW, 2016, FRONT PLANT SCI, V7, DOI [10.3389/fpls.2016.01202, 10.3389/fpls.2016.01292]; Kroymann J, 2001, PLANT PHYSIOL, V127, P1077, DOI 10.1104/pp.010416; Lambrix V, 2001, PLANT CELL, V13, P2793, DOI 10.1105/tpc.13.12.2793; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li G, 2003, THEOR APPL GENET, V106, P1116, DOI 10.1007/s00122-002-1161-4; Li J, 2008, PLANT PHYSIOL, V148, P1721, DOI 10.1104/pp.108.125757; Li J, 2011, J EXP BOT, V62, P1337, DOI 10.1093/jxb/erq369; Li YM, 2015, PR INT PLANT SULFUR, P195, DOI 10.1007/978-3-319-20137-5_20; Li ZS, 2014, J LIQ CHROMATOGR R T, V37, P1199, DOI 10.1080/10826076.2012.704608; Li ZS, 2016, J FOOD NUTR RES, V4, P490, DOI [10.1104/pp.106.091579, DOI 10.1104/PP.106.091579]; Liang H, 2006, J MOL CATAL B-ENZYM, V43, P19, DOI 10.1016/j.molcatb.2006.03.008; Liu C, 2016, IN VITRO CELL DEV-PL, V52, P130, DOI 10.1007/s11627-016-9754-9; Liu S, 2014, NAT PROD COMMUN, V9, P7, DOI 10.1038/ncomms4930; Matusheski NV, 2001, J AGR FOOD CHEM, V49, P5743, DOI 10.1021/jf010809a; Nolling J, 2001, J BACTERIOL, V183, P4823, DOI 10.1128/JB.183.16.4823-4838.2001; Pang QY, 2012, PLANT SOIL, V355, P363, DOI 10.1007/s11104-011-1108-0; Piotrowski M, 2004, J BIOL CHEM, V279, P50717, DOI 10.1074/jbc.M407681200; Sivakumar MR, 2007, CLIN EXP RHEUMATOL, V25, pS120; Sonderby IE, 2010, TRENDS PLANT SCI, V15, P283, DOI 10.1016/j.tplants.2010.02.005; Tantikanjana T, 2004, PLANT PHYSIOL, V135, P840, DOI 10.1104/pp.104.040113; Textor S, 2007, PLANT PHYSIOL, V144, P60, DOI 10.1104/pp.106.091579; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Wittstock U, 2002, TRENDS PLANT SCI, V7, P263, DOI 10.1016/S1360-1385(02)02273-2; Wittstock U, 2003, RECENT ADV PHYTOCHEM, V37, P101; Xing MM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148048; Yabar E, 2011, FOOD CHEM, V127, P1576, DOI 10.1016/j.foodchem.2011.02.021; Zhang R, 2015, AM J ALZHEIMERS DIS, V30, P183, DOI 10.1177/1533317514542645; Zhang XL, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01929	81	15	17	4	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2019	14	3							e0213902	10.1371/journal.pone.0213902	http://dx.doi.org/10.1371/journal.pone.0213902			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ1KV	30908527	Green Submitted, Green Published, gold			2022-12-26	WOS:000462157600024
J	Wang, LZ; Holland, L; Fong, R; Khokhar, S; Fox, AP; Xie, Z				Wang, Lingzhi; Holland, Lindsay; Fong, Robert; Khokhar, Suhail; Fox, Aaron P.; Xie, Zheng			A pilot study showing that repeated exposure to stress produces alterations in subsequent responses to anesthetics in rats	PLOS ONE			English	Article							MINIMUM ALVEOLAR CONCENTRATION; GENERAL-ANESTHESIA; PRENATAL STRESS; RECEPTOR EXPRESSION; ALTERS SENSITIVITY; RAPHE NUCLEI; MECHANISMS; ADAPTATION; MEMORY; SLEEP	The repeated use of a drug frequently leads to alterations in the response to that drug. We undertook this study to determine whether multiple exposures to the general anesthetic produced alterations in subsequent exposures to this anesthetic. For this study, adult male rats were anesthetized with 2.5% isoflurane for one hour. The rats were divided into 4 groups of 8 rats each. Groups 13 were transported between their homeroom and the anesthesia testing room and were handled in an identical manner weekly for a period of 12 weeks, but were anesthetized on different schedules. Group 1 was anesthetized weekly for 12 weeks, Group 2 on either a 3 or 4 week schedule and Group 3 was anesthetized a single time, at the end of the 12 week period. To receive anesthesia multiple times, animals were transported from their homeroom to the anesthesia location and handled repeatedly. We took into consideration of the frequency of anesthesia exposure and the stress involved. Rats in groups 2 and 3 were placed in the anesthesia chamber, with O-2 but with no anesthetic, every week when they were not scheduled to receive anesthesia. In Group 4, rats were not transported or handled in any way and stayed in the home room for a period of 12 weeks. Rats in this group were anesthetized once, at the very end of the study. Recovery of the rats righting reflex was used to assess the acceleration of recovery time from general anesthesia. Group 1 rats showed dramatically faster emergence from anesthesia after several rounds of anesthesia. Surprisingly, Groups 2 and 3 rats, treated in an identical manner as Group 1, but which were anesthetized on different schedules, also exhibited more rapid emergence from anesthesia, when compared to Group 4 rats, which were never handled or transported prior to a single anesthesia. These results suggest that the stress of transportation and handling altered responsiveness to anesthesia. Our results show that responsiveness to anesthetic agents can change over time outside of the normal developmental changes taking place in rats as they age.	[Wang, Lingzhi; Fong, Robert; Xie, Zheng] Univ Chicago, Dept Anesthesia & Crit Care, Box 428, Chicago, IL 60637 USA; [Wang, Lingzhi] Guangzhou Med Univ, Affiliated Hosp 2, Dept Anesthesia, Guangzhou, Guangdong, Peoples R China; [Holland, Lindsay] Univ Michigan, Coll Med, Ann Arbor, MI 48109 USA; [Khokhar, Suhail] Univ Illinois, Coll Med, Chicago, IL USA; [Fox, Aaron P.] Univ Chicago, Dept Neurobiol Pharmacol & Physiol, Chicago, IL 60637 USA	University of Chicago; Guangzhou Medical University; University of Michigan System; University of Michigan; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Chicago	Xie, Z (corresponding author), Univ Chicago, Dept Anesthesia & Crit Care, Box 428, Chicago, IL 60637 USA.	jxie@dacc.uchicago.edu		xie, zheng/0000-0001-8909-8339	NIH [RO-1GM-116119]; Medical Student Anesthesia Research Fellowship (MSARF); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM116119] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Student Anesthesia Research Fellowship (MSARF); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by a NIH grant (RO-1GM-116119) to Aaron Fox and Zheng Xie and by Medical Student Anesthesia Research Fellowship (MSARF) to Lindsay Holland and Suhail Khokhar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allouche S, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00280; Baum A, 1999, ANNU REV PSYCHOL, V50, P137, DOI 10.1146/annurev.psych.50.1.137; Brown EN, 2010, NEW ENGL J MED, V363, P2638, DOI 10.1056/NEJMra0808281; Chemali JJ, 2015, BRIT J ANAESTH, V115, P58, DOI 10.1093/bja/aev112; Chen YC, 2008, J NEUROSCI, V28, P2903, DOI 10.1523/JNEUROSCI.0225-08.2008; Chen YC, 2016, J NEUROSCI, V36, P11295, DOI 10.1523/JNEUROSCI.2542-16.2016; Chetty S, 2014, MOL PSYCHIATR, V19, P1275, DOI 10.1038/mp.2013.190; CLANCY JJ, 1978, PHYSIOL BEHAV, V21, P457, DOI 10.1016/0031-9384(78)90109-9; Dang VC, 2012, BRIT J PHARMACOL, V165, P1704, DOI 10.1111/j.1476-5381.2011.01482.x; Davidson AJ, 2018, ANESTHESIOLOGY, V128, P840, DOI 10.1097/ALN.0000000000001972; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; Eger EI, 2001, ANESTH ANALG, V93, P947, DOI 10.1097/00000539-200110000-00029; EGER EI, 1965, ANESTHESIOLOGY, V26, P756, DOI 10.1097/00000542-196511000-00010; GAUMANN DM, 1992, BRIT J ANAESTH, V68, P81, DOI 10.1093/bja/68.1.81; GEINISMAN Y, 1995, PROG NEUROBIOL, V45, P223, DOI 10.1016/0301-0082(94)00047-L; Grasshoff C, 2005, CURR OPIN ANESTHESIO, V18, P386, DOI 10.1097/01.aco.0000174961.90135.dc; HAEFELY W, 1984, NEUROSCI LETT, V47, P201, DOI 10.1016/0304-3940(84)90514-7; Ivy AS, 2010, J NEUROSCI, V30, P13005, DOI 10.1523/JNEUROSCI.1784-10.2010; Iwasaki Masae, 2015, Acta Anaesthesiol Taiwan, V53, P99, DOI 10.1016/j.aat.2015.07.002; Jevtovic-Todorovic V, 2018, ANESTHESIOLOGY, V128, P832, DOI 10.1097/ALN.0000000000002047; Lakehayli S, 2016, NEUROSCIENCE, V330, P50, DOI 10.1016/j.neuroscience.2016.05.035; Lakehayli S, 2015, NEUROSCI LETT, V591, P187, DOI 10.1016/j.neulet.2015.02.015; Licata SC, 2008, PHARMACOL BIOCHEM BE, V90, P74, DOI 10.1016/j.pbb.2008.01.001; LOSS GE, 1989, ANESTH ANALG, V68, P359; Mashour GA, 2005, BEST PRACT RES-CLIN, V19, P349, DOI 10.1016/j.bpa.2005.01.004; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; McEwen BS, 2015, J ENDOCRINOL, V226, pT67, DOI 10.1530/JOE-15-0121; McEwen Bruce S, 2011, Cerebrum, V2011, P14; Narciso SP, 2003, INHAL TOXICOL, V15, P1133, DOI 10.1080/08958370390228592; Orliaguet G, 2001, ANESTHESIOLOGY, V95, P734, DOI 10.1097/00000542-200109000-00028; Orser BA, 2018, ANESTH ANALG, V126, P1393, DOI 10.1213/ANE.0000000000002833; Raper J, 2015, ANESTHESIOLOGY, V123, P1084, DOI 10.1097/ALN.0000000000000851; Said N, 2015, NEUROSCIENCE, V304, P279, DOI 10.1016/j.neuroscience.2015.07.029; Said N, 2015, INT J DEV NEUROSCI, V43, P92, DOI 10.1016/j.ijdevneu.2015.04.008; SMITH RA, 1979, ANESTHESIOLOGY, V50, P505, DOI 10.1097/00000542-197906000-00006; Solt K, 2007, CURR OPIN ANESTHESIO, V20, P300, DOI 10.1097/ACO.0b013e32816678a5; Stephenson R, 2012, J BIOL RHYTHM, V27, P490, DOI 10.1177/0748730412461247; SUTANTO W, 1994, LAB ANIM-UK, V28, P293, DOI 10.1258/002367794780745092; Ueno S, 1999, BRIT J PHARMACOL, V127, P377, DOI 10.1038/sj.bjp.0702563; Varlinskaya EI, 2010, PHARMACOL BIOCHEM BE, V96, P228, DOI 10.1016/j.pbb.2010.05.011; Wang Q, 2014, J NEUROPHYSIOL, V111, P1331, DOI 10.1152/jn.00792.2013; Williams JT, 2013, PHARMACOL REV, V65, P223, DOI 10.1124/pr.112.005942; Yuen EY, 2012, NEURON, V73, P962, DOI 10.1016/j.neuron.2011.12.033	43	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2019	14	3							e0214093	10.1371/journal.pone.0214093	http://dx.doi.org/10.1371/journal.pone.0214093			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ1KV	30908509	Green Submitted, Green Published, gold			2022-12-26	WOS:000462157600033
J	Ippolito, L; Morandi, A; Taddei, ML; Parri, M; Comito, G; Iscaro, A; Raspollini, MR; Magherini, F; Rapizzi, E; Masquelier, J; Muccioli, GG; Sonveaux, P; Chiarugi, P; Giannoni, E				Ippolito, Luigi; Morandi, Andrea; Taddei, Maria Letizia; Parri, Matteo; Comito, Giuseppina; Iscaro, Alessandra; Raspollini, Maria Rosaria; Magherini, Francesca; Rapizzi, Elena; Masquelier, Julien; Muccioli, Giulio G.; Sonveaux, Pierre; Chiarugi, Paola; Giannoni, Elisa			Cancer-associated fibroblasts promote prostate cancer malignancy via metabolic rewiring and mitochondrial transfer	ONCOGENE			English	Article							TUMOR MICROENVIRONMENT; LACTATE METABOLISM; CELLS; PGC-1-ALPHA; MUSCLE; HOMEOSTASIS; SUPEROXIDE; ACTIVATION; SIRTUINS; KINASE	Cancer-associated fibroblasts (CAFs) are the major cellular stromal component of many solid tumors. In prostate cancer (PCa), CAFs establish a metabolic symbiosis with PCa cells, contributing to cancer aggressiveness through lactate shuttle. In this study, we report that lactate uptake alters the NAD(+)/NADH ratio in the cancer cells, which culminates with SIRT1-dependent PGC-1 alpha activation and subsequent enhancement of mitochondrial mass and activity. The high exploitation of mitochondria results in tricarboxylic acid cycle deregulation, accumulation of oncometabolites and in the altered expression of mitochondrial complexes, responsible for superoxide generation. Additionally, cancer cells hijack CAF-derived functional mitochondria through the formation of cellular bridges, a phenomenon that we observed in both in vitro and in vivo PCa models. Our work reveals a crucial function of tumor mitochondria as the energy sensors and transducers of CAF-dependent metabolic reprogramming and underscores the reliance of PCa cells on CAF catabolic activity and mitochondria trading.	[Ippolito, Luigi; Morandi, Andrea; Parri, Matteo; Comito, Giuseppina; Iscaro, Alessandra; Magherini, Francesca; Chiarugi, Paola; Giannoni, Elisa] Univ Florence, Dept Expt & Clin Biomed Sci, I-50134 Florence, Italy; [Taddei, Maria Letizia; Rapizzi, Elena] Univ Florence, Dept Expt & Clin Med, I-50134 Florence, Italy; [Raspollini, Maria Rosaria] Univ Hosp Careggi, Histopathol & Mol Diagnost, Largo Brambilla 3, I-50134 Florence, Italy; [Masquelier, Julien; Muccioli, Giulio G.] UCL, LDRI, Bioanal & Pharmacol Bioact Lipids Res Grp, B-1200 Brussels, Belgium; [Sonveaux, Pierre] UCL, IREC, Pole Pharmacol, B-1200 Brussels, Belgium; [Chiarugi, Paola] Tuscany Tumour Inst ITT, Florence, Italy; [Chiarugi, Paola] Excellence Ctr Res Transfer & High Educ DenoTHE, Florence, Italy	University of Florence; University of Florence; University of Florence; Azienda Ospedaliero Universitaria Careggi; Universite Catholique Louvain; Universite Catholique Louvain	Chiarugi, P; Giannoni, E (corresponding author), Univ Florence, Dept Expt & Clin Biomed Sci, I-50134 Florence, Italy.; Chiarugi, P (corresponding author), Tuscany Tumour Inst ITT, Florence, Italy.; Chiarugi, P (corresponding author), Excellence Ctr Res Transfer & High Educ DenoTHE, Florence, Italy.	paola.chiarugi@unifi.it; elisa.giannoni@unifi.it	Giannoni, Elisa/AAE-2092-2020; Morandi, Andrea/AAC-1901-2022; Chiarugi, Paola/CDD-7988-2022	Morandi, Andrea/0000-0002-9222-5332; Chiarugi, Paola/0000-0001-7655-2969; Muccioli, Giulio/0000-0002-1600-9259; Ippolito, Luigi/0000-0001-7927-8555	Fondazione Umberto Veronesi; Associazione Italiana Ricerca sul Cancro (AIRC) [8797]; AIRC; Fondazione Cassa di Risparmio di Firenze [19515]; Istituto Toscano Tumori [0203607]; Interuniversity Attraction Pole from Belspo [UP7-03]; Action de Recherche Concertee from the Communaute Francaise de Belgique [ARC 14/19-058]; Belgian Fonds National de la Recherche Scientifique (F.R.S. FNRS); Programma operativo regionale Obiettivo "Competitivita regionale e occupazione" della Regione Toscana cofinanziato dal Fondo europeo di sviluppo regionale 2007-2013 (POR CReO FESR 2007-2013)	Fondazione Umberto Veronesi(Fondazione Umberto Veronesi); Associazione Italiana Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); AIRC(Fondazione AIRC per la ricerca sul cancro); Fondazione Cassa di Risparmio di Firenze(Fondazione Cassa Risparmio Firenze); Istituto Toscano Tumori; Interuniversity Attraction Pole from Belspo; Action de Recherche Concertee from the Communaute Francaise de Belgique; Belgian Fonds National de la Recherche Scientifique (F.R.S. FNRS)(Fonds de la Recherche Scientifique - FNRS); Programma operativo regionale Obiettivo "Competitivita regionale e occupazione" della Regione Toscana cofinanziato dal Fondo europeo di sviluppo regionale 2007-2013 (POR CReO FESR 2007-2013)	The work was supported by Fondazione Umberto Veronesi to AM, Associazione Italiana Ricerca sul Cancro (AIRC) (grant 8797 to PC), AIRC and Fondazione Cassa di Risparmio di Firenze (grant 19515 to PC and AM), Istituto Toscano Tumori (grant 0203607 to PC), Programma operativo regionale Obiettivo "Competitivita regionale e occupazione" della Regione Toscana cofinanziato dal Fondo europeo di sviluppo regionale 2007-2013 (POR CReO FESR 2007-2013, grant to PC), Interuniversity Attraction Pole from Belspo (grant #UP7-03 to PS), an Action de Recherche Concertee from the Communaute Francaise de Belgique (ARC 14/19-058 to PS), and the Belgian Fonds National de la Recherche Scientifique (F.R.S. FNRS, to PS). The authors thank: Dr Paolo E. Porporato (University of Turin, Italy) for providing mitochondria-targeted plasmids mt-HA-eGFP, AT-F001-D and mtDsRed, AT-F002-D (Aequotech srl); Dr Andrea Rasola (University of Padua, Italy) for providing pLJM1-EGFP plasmid for lentiviral infection; Dr Barbara Stecca (Istituto Toscano Tumori, Florence, Italy) for providing pCMV-dR8.91 packaging plasmid and pMD2G envelope plasmid; Dr. Nicla Lorito and Dr. Lavinia Ferrone for technical support. PS is a F.R.S.-FNRS Senior Research Associate. The MASSMET platform (https://www.uclouvain.be/en-massmet.html) is acknowledged for the access to the HLPC-MS.	Andrzejewski S, 2017, CELL METAB, V26, P778, DOI 10.1016/j.cmet.2017.09.006; Aspuria PJP, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-21; Benton CR, 2008, PHYSIOL GENOMICS, V35, P45, DOI 10.1152/physiolgenomics.90217.2008; Brauer HA, 2013, CLIN CANCER RES, V19, P571, DOI 10.1158/1078-0432.CCR-12-2123; Caicedo A, 2015, SCI REP-UK, V5, DOI 10.1038/srep09073; Cannito S, 2010, ANTIOXID REDOX SIGN, V12, P1383, DOI 10.1089/ars.2009.2737; Chandel NS, 2015, CELL METAB, V22, P204, DOI 10.1016/j.cmet.2015.05.013; Chen EI, 2007, CANCER RES, V67, P1472, DOI 10.1158/0008-5472.CAN-06-3137; Chen YJ, 2016, NAT CHEM BIOL, V12, P937, DOI [10.1038/NCHEMBIO.2172, 10.1038/nchembio.2172]; Dikalova AE, 2010, CIRC RES, V107, P106, DOI 10.1161/CIRCRESAHA.109.214601; Dong LF, 2017, ELIFE, V6, DOI 10.7554/eLife.22187; Faubert B, 2017, CELL, V171, P358, DOI 10.1016/j.cell.2017.09.019; Fiaschi T, 2012, CANCER RES, V72, P5130, DOI 10.1158/0008-5472.CAN-12-1949; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Gambini J, 2011, ARCH BIOCHEM BIOPHYS, V512, P24, DOI 10.1016/j.abb.2011.04.020; Giannoni E, 2005, MOL CELL BIOL, V25, P6391, DOI 10.1128/MCB.25.15.6391-6403.2005; Giannoni E, 2009, ONCOGENE, V28, P2074, DOI 10.1038/onc.2009.77; Giannoni E, 2015, ONCOTARGET, V6, P24061, DOI 10.18632/oncotarget.4448; Giannoni E, 2011, ANTIOXID REDOX SIGN, V14, P2361, DOI 10.1089/ars.2010.3727; Giannoni E, 2010, CANCER RES, V70, P6945, DOI 10.1158/0008-5472.CAN-10-0785; Guarente L, 2013, GENE DEV, V27, P2072, DOI 10.1101/gad.227439.113; Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293; Ippolito L, 2016, ONCOTARGET, V7, P61890, DOI 10.18632/oncotarget.11301; Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906; Kong XX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011707; Le Gal K, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad3740; LeBleu VS, 2014, NAT CELL BIOL, V16, P992, DOI 10.1038/ncb3039; Lou E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033093; MacKenzie ED, 2007, MOL CELL BIOL, V27, P3282, DOI 10.1128/MCB.01927-06; Martinez-Outschoorn UE, 2010, CELL CYCLE, V9, P3515, DOI 10.4161/cc.9.17.12928; Morandi A, 2016, TRENDS CANCER, V2, P736, DOI 10.1016/j.trecan.2016.11.001; Nazarewicz RR, 2013, ANTIOXID REDOX SIGN, V19, P344, DOI 10.1089/ars.2013.5185; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; Pasquier J, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-94; Pavlides S, 2009, CELL CYCLE, V8, P3984, DOI 10.4161/cc.8.23.10238; Pittelli M, 2011, MOL PHARMACOL, V80, P1136, DOI 10.1124/mol.111.073916; Porporato PE, 2015, MOL CELL ONCOL, V2, DOI 10.4161/23723548.2014.968043; Porporato PE, 2014, CELL REP, V8, P754, DOI 10.1016/j.celrep.2014.06.043; Rabinovitch RC, 2017, CELL REP, V21, P1, DOI 10.1016/j.celrep.2017.09.026; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rogers RS, 2013, PHYSIOLOGY, V28, P414, DOI 10.1152/physiol.00032.2013; Rustom A, 2004, SCIENCE, V303, P1007, DOI 10.1126/science.1093133; Salem AF, 2012, CELL CYCLE, V11, P2545, DOI 10.4161/cc.20920; Santi A, 2015, BBA-MOL CELL RES, V1853, P3211, DOI 10.1016/j.bbamcr.2015.09.013; Sciacovelli M, 2016, NATURE, V537, P544, DOI 10.1038/nature19353; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Spees JL, 2006, P NATL ACAD SCI USA, V103, P1283, DOI 10.1073/pnas.0510511103; Summermatter S, 2013, P NATL ACAD SCI USA, V110, P8738, DOI 10.1073/pnas.1212976110; Tan AS, 2015, CELL METAB, V21, P81, DOI 10.1016/j.cmet.2014.12.003; Torrano V, 2016, NAT CELL BIOL, V18, P645, DOI 10.1038/ncb3357; Viale A, 2014, NATURE, V514, P628, DOI 10.1038/nature13611; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107; Weinberg F, 2009, ANN NY ACAD SCI, V1177, P66, DOI 10.1111/j.1749-6632.2009.05039.x	53	97	99	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 4	2019	38	27					5339	5355		10.1038/s41388-019-0805-7	http://dx.doi.org/10.1038/s41388-019-0805-7			17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	IG5KR	30936458	Green Submitted			2022-12-26	WOS:000473842500001
J	Azam, SH; Porrello, A; Harrison, EB; Leslie, PL; Liu, XA; Waugh, TA; Belanger, A; Mangala, LS; Lopez-Berestein, G; Wilson, HL; McCann, JV; Kim, WY; Sood, AK; Liu, JZ; Dudley, AC; Pecot, CV				Azam, Salma H.; Porrello, Alessandro; Harrison, Emily B.; Leslie, Patrick L.; Liu, Xinan; Waugh, Trent A.; Belanger, Adam; Mangala, Lingegowda S.; Lopez-Berestein, Gabriel; Wilson, Harper L.; McCann, James V.; Kim, William Y.; Sood, Anil K.; Liu, Jinze; Dudley, Andrew C.; Pecot, Chad V.			Quaking orchestrates a post-transcriptional regulatory network of endothelial cell cycle progression critical to angiogenesis and metastasis	ONCOGENE			English	Article							MIR-200 FAMILY; MESSENGER-RNA; ANTIANGIOGENIC THERAPY; TUMOR ANGIOGENESIS; CANCER-CELLS; GROWTH; DIFFERENTIATION; PROTEINS; PROMOTES; ZEB1	Angiogenesis is critical to cancer development and metastasis. However, anti-angiogenic agents have only had modest therapeutic success, partly due to an incomplete understanding of tumor endothelial cell (EC) biology. We previously reported that the microRNA (miR)-200 family inhibits metastasis through regulation of tumor angiogenesis, but the underlying molecular mechanisms are poorly characterized. Here, using integrated bioinformatics approaches, we identified the RNA-binding protein (RBP) quaking (QKI) as a leading miR-200b endothelial target with previously unappreciated roles in the tumor microenvironment in lung cancer. In lung cancer samples, both miR-200b suppression and QKI overexpression corresponded with tumor ECs relative to normal ECs, and QKI silencing phenocopied miR-200b-mediated inhibition of sprouting. Additionally, both cancer cell and endothelial QKI expression in patient samples significantly corresponded with poor survival and correlated with angiogenic indices. QKI supported EC function by stabilizing cyclin D1 (CCND1) mRNA to promote EC Gl/S cell cycle transition and proliferation. Both nanoparticle-mediated RNA interference of endothelial QKI expression and palbociclib blockade of CCND1 function potently inhibited metastasis in concert with significant effects on tumor vasculature. Altogether, this work demonstrates the clinical relevance and therapeutic potential of a novel, actionable miR/RBP axis in tumor angiogenesis and metastasis.	[Azam, Salma H.] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA; [Porrello, Alessandro; Leslie, Patrick L.; Waugh, Trent A.; Belanger, Adam; Wilson, Harper L.; Kim, William Y.; Pecot, Chad V.] Univ N Carolina, UNC Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Harrison, Emily B.] Univ N Carolina, Eshelman Sch Pharm, Ctr Nanotechnol Drug Delivery, Chapel Hill, NC 27599 USA; [Liu, Xinan; Liu, Jinze] Univ Kentucky, Dept Comp Sci, Lexington, KY 40506 USA; [Belanger, Adam] Univ N Carolina, Div Pulm & Crit Care, Chapel Hill, NC 27599 USA; [Mangala, Lingegowda S.; Sood, Anil K.] Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol & Reprod Med, Houston, TX 77030 USA; [Mangala, Lingegowda S.; Lopez-Berestein, Gabriel; Sood, Anil K.] Univ Texas MD Anderson Canc Ctr, Ctr RNA Interference & Noncoding RNA, Houston, TX 77030 USA; [Lopez-Berestein, Gabriel] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [McCann, James V.] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA; [Kim, William Y.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Kim, William Y.; Pecot, Chad V.] Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA; [Sood, Anil K.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Dudley, Andrew C.] Univ Virginia, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA 22908 USA; [Dudley, Andrew C.] Univ Virginia, Emily Couric Canc Ctr, Charlottesville, VA 22908 USA; [Pecot, Chad V.] Univ N Carolina, Div Hematol & Oncol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Kentucky; University of North Carolina; University of North Carolina Chapel Hill; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Texas System; UTMD Anderson Cancer Center; University of Virginia; University of Virginia; University of North Carolina; University of North Carolina Chapel Hill	Pecot, CV (corresponding author), Univ N Carolina, UNC Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.; Pecot, CV (corresponding author), Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA.; Pecot, CV (corresponding author), Univ N Carolina, Div Hematol & Oncol, Chapel Hill, NC 27599 USA.	pecot@email.unc.edu	, Pathology Services Core/CEZ-2246-2022; Harrison, Emily B./AAW-1826-2021; , UNC Flow Cytometry Core/AGU-9839-2022; , Animal Studies Core/AAF-4432-2022; , Animal Studies Core/ADK-4234-2022; Sood, Anoop Kumar/A-7344-2013	Harrison, Emily B./0000-0002-6934-3875; Sood, Anoop Kumar/0000-0001-5702-4108; Wilson, Harper/0000-0002-6093-4767	National Institutes of Health [R01-CA215075, R01-CA042978, U54-CA198999, MRSG-14-222-01-RMC]; American Cancer Society; Jimmy V Foundation Scholar award; UCRF Innovator Award; Stuart Scott V Foundation/Lung Cancer Initiative Award for Clinical Research; University Cancer Research Fund; Lung Cancer Research Foundation; Free to Breathe Metastasis Research Award; Susan G. Komen Career Catalyst Award; National Institute of General Medical Sciences [5T32 GM007092]; National Cancer Institute of the National Institutes of Health [T32CA196589]; American Cancer Society Research Professor Award; National Cancer Institute [P50 CA217685, R35 CA209904]; National Cancer Institute Center Core Support Grant [CA016086]; North Carolina Biotech Center Institutional Support Grant [2012-IDG-1006]; NATIONAL CANCER INSTITUTE [U54CA198999, P50CA217685, P30CA016086, T32CA196589, R35CA209904, R01CA042978, R01CA215075] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007092] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Jimmy V Foundation Scholar award; UCRF Innovator Award; Stuart Scott V Foundation/Lung Cancer Initiative Award for Clinical Research; University Cancer Research Fund; Lung Cancer Research Foundation; Free to Breathe Metastasis Research Award; Susan G. Komen Career Catalyst Award(Susan G. Komen Breast Cancer Foundation); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society Research Professor Award(American Cancer Society); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute Center Core Support Grant; North Carolina Biotech Center Institutional Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors would like to especially thank members of the Victoria Bautch laboratory for their advice on performing the endothelial sprouting assay, the UNC Animal Histopathology Core, the UNC Biomedical Research Imaging Center, Janet Dow from the UNC Flow Cytometry Core Facility, and the Tissue Pathology Lab Core. The authors would also like to thank Adolfo Alfonso for providing the ZsGreen fluorescent labeled 10T1/2 (pericyte) cells used in the pericyte-coated sprouting assay. C.V.P. was supported in part by the National Institutes of Health R01-CA215075, R01-CA042978 and U54-CA198999, a Mentored Research Scholar Grants in Applied and Clinical Research (MRSG-14-222-01-RMC) from the American Cancer Society, the Jimmy V Foundation Scholar award, the UCRF Innovator Award, the Stuart Scott V Foundation/Lung Cancer Initiative Award for Clinical Research, the University Cancer Research Fund, the Lung Cancer Research Foundation, the Free to Breathe Metastasis Research Award and the Susan G. Komen Career Catalyst Award. S.H.A. was supported in part by a grant from the National Institute of General Medical Sciences under award 5T32 GM007092. E.B.H. was supported in part by a grant from the National Cancer Institute of the National Institutes of Health under award number T32CA196589. AKS was supported in part by The American Cancer Society Research Professor Award and grants from the National Cancer Institute (P50 CA217685 and R35 CA209904). The UNC Flow Cytometry Core Facility and Lineberger Comprehensive Cancer Center Animal Histopathology and Animal Studies Cores are all supported in part by a National Cancer Institute Center Core Support Grant (CA016086) to the UNC Lineberger Comprehensive Cancer Center. The UNC Flow Cytometry Core Facility is also supported in part by the North Carolina Biotech Center Institutional Support Grant 2012-IDG-1006.	Akerman M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r30; Azam SH, 2018, JOVE-J VIS EXP, DOI 10.3791/57309; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Bohnsack BL, 2006, GENESIS, V44, P93, DOI 10.1002/gene.20189; Bottsford-Miller JN, 2012, J CLIN ONCOL, V30, P4026, DOI 10.1200/JCO.2012.41.9242; Carmeliet P, 2011, NAT REV DRUG DISCOV, V10, P417, DOI 10.1038/nrd3455; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Chan YC, 2012, ARTERIOSCL THROM VAS, V32, P1372, DOI 10.1161/ATVBAHA.112.248583; Chan YC, 2011, J BIOL CHEM, V286, P2047, DOI 10.1074/jbc.M110.158790; Chen AJ, 2012, GENE DEV, V26, P1459, DOI 10.1101/gad.189001.112; Cochrane A, 2017, STEM CELLS, V35, P952, DOI 10.1002/stem.2594; Conn SJ, 2015, CELL, V160, P1125, DOI 10.1016/j.cell.2015.02.014; de Bruin RG, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10846; de Bruin RG, 2016, SCI REP-UK, V6, DOI 10.1038/srep21643; Ding YZ, 2017, LIFE SCI, V191, P245, DOI 10.1016/j.lfs.2017.09.001; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Fry DW, 2004, MOL CANCER THER, V3, P1427; Gibbons DL, 2009, GENE DEV, V23, P2140, DOI 10.1101/gad.1820209; Gill JG, 2012, STEM CELLS DEV, V21, P167, DOI 10.1089/scd.2011.0194; Goel S, 2013, JNCI-J NATL CANCER I, V105, P1188, DOI 10.1093/jnci/djt164; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; GRIFFIN MJ, 1976, IN VITRO CELL DEV B, V12, P393, DOI 10.1007/BF02796317; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hardy RJ, 1996, J NEUROSCI, V16, P7941; Harrison EB, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00307; Hlatky L, 2002, JNCI-J NATL CANCER I, V94, P883; Jain RK, 2014, CANCER CELL, V26, P605, DOI 10.1016/j.ccell.2014.10.006; Ji HB, 2007, NATURE, V448, P807, DOI 10.1038/nature06030; Kondo T, 1999, MAMM GENOME, V10, P662; Lamprecht MR, 2007, BIOTECHNIQUES, V42, P71, DOI 10.2144/000112257; Landen CN, 2005, CANCER RES, V65, P6910, DOI 10.1158/0008-5472.CAN-05-0530; Larocque D, 2005, NAT NEUROSCI, V8, P27, DOI 10.1038/nn1359; Larocque D, 2002, NEURON, V36, P815, DOI 10.1016/S0896-6273(02)01055-3; Li ZH, 2003, DEV GROWTH DIFFER, V45, P449; Li ZZ, 2000, J NEUROSCI, V20, P4944; Lu CH, 2010, CANCER CELL, V18, P185, DOI 10.1016/j.ccr.2010.06.016; Magenta A, 2011, CELL DEATH DIFFER, V18, P1628, DOI 10.1038/cdd.2011.42; Nakatsu Martin N, 2007, J Vis Exp, P186, DOI 10.3791/186; Noguera-Troise I, 2006, NATURE, V444, P1032, DOI 10.1038/nature05355; Noveroske JK, 2002, GENESIS, V32, P218, DOI 10.1002/gene.10060; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Pecot CV, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3427; Pillman KA, 2018, EMBO J, V37, DOI 10.15252/embj.201899016; Saccomanno L, 1999, P NATL ACAD SCI USA, V96, P12605, DOI 10.1073/pnas.96.22.12605; Santo L, 2015, SEMIN ONCOL, V42, P788, DOI 10.1053/j.seminoncol.2015.09.024; Teplova M, 2013, GENE DEV, V27, P928, DOI 10.1101/gad.216531.113; van Mil A, 2012, CARDIOVASC RES, V93, P655, DOI 10.1093/cvr/cvs003; Vasudev NS, 2014, ANGIOGENESIS, V17, P471, DOI 10.1007/s10456-014-9420-y; Welch-Reardon KM, 2015, ARTERIOSCL THROM VAS, V35, P303, DOI 10.1161/ATVBAHA.114.303220; Winkler F, 2004, CANCER CELL, V6, P553, DOI 10.1016/S1535-6108(04)00305-8; Wong PP, 2016, CURR BIOL, V26, pR1161, DOI 10.1016/j.cub.2016.09.043; Wong PP, 2015, CANCER CELL, V27, P123, DOI 10.1016/j.ccell.2014.10.015; Wu J, 1999, J BIOL CHEM, V274, P29202, DOI 10.1074/jbc.274.41.29202; Wu JI, 2002, P NATL ACAD SCI USA, V99, P4233, DOI 10.1073/pnas.072090399; Zearfoss NR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001269; Zhang YY, 2003, EMBO J, V22, P1801, DOI 10.1093/emboj/cdg171; Zhou X, 2017, ONCOTARGET, V8, P82174, DOI 10.18632/oncotarget.19066; Zong FY, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004289	60	12	14	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 27	2019	38	26					5191	5210		10.1038/s41388-019-0786-6	http://dx.doi.org/10.1038/s41388-019-0786-6			20	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	IF4AX	30918328	Green Accepted			2022-12-26	WOS:000473025300006
J	Maric, G; Annis, MG; MacDonald, PA; Russo, C; Perkins, D; Siwak, DR; Mills, GB; Siegel, PM				Maric, Gordana; Annis, Matthew G.; MacDonald, Patricia A.; Russo, Caterina; Perkins, Dru; Siwak, Doris R.; Mills, Gordon B.; Siegel, Peter M.			GPNMB augments Wnt-1 mediated breast tumor initiation and growth by enhancing PI3K/AKT/mTOR pathway signaling and beta-catenin activity	ONCOGENE			English	Article							GLYCOPROTEIN NONMETASTATIC B; WNT/BETA-CATENIN; TRANSGENIC MICE; MAMMARY-TUMORS; BASAL-LIKE; GLEMBATUMUMAB VEDOTIN; THERAPEUTIC TARGET; CANCER; EXPRESSION; PROMOTES	Glycoprotein Nmb (GPNMB) is overexpressed in triple-negative and basal-like breast cancers and its expression is predictive of poor prognosis within this aggressive breast cancer subtype. GPNMB promotes breast cancer growth, invasion, and metastasis; however, its role in mammary tumor initiation remains unknown. To address this question, we overexpressed GPNMB in the mammary epithelium to generate MMTV/GPNMB transgenic mice and crossed these animals to the MMTV/Wnt-1 mouse model, which is known to recapitulate features of human basal breast cancers. We show that GPNMB alone does not display oncogenic properties; however, its expression dramatically accelerates tumor onset in MMTV/Wnt-1 mice. MMTV/Wnt-1 x MMTV/GPNMB bigenic mice also exhibit a significant increase in the growth rate of established primary tumors, which is attributable to increased proliferation and decreased apoptosis. To elucidate molecular mechanisms underpinning the tumor-promoting effects of GPNMB in this context, we interrogated activated pathways in tumors derived from the MMTV/Wnt-1 and MMTV/Wnt-1 x MMTV/GPNMB mice using RPPA analysis. These data revealed that MMTV/Wnt-1 x MMTV/GPNMB bigenic tumors exhibit a pro-growth signature characterized by elevated PI3K/AKT/mTOR signaling and increased beta-catenin activity. Furthermore, we extended these observations to an independent Wnt-1 expressing model of aggressive breast cancer, and confirmed that GPNMB enhances canonical Wnt pathway activation, as evidenced by increased beta-catenin transcriptional activity, in breast cancer cells and tumors co-expressing Wnt-1 and GPNMB. GPNMB-dependent engagement of beta-catenin occurred, in part, through AKT activation. Taken together, these data ascribe a novel, pro-growth role for GPNMB in Wnt-1 expressing basal breast cancers.	[Maric, Gordana; Annis, Matthew G.; MacDonald, Patricia A.; Russo, Caterina; Perkins, Dru; Siegel, Peter M.] McGill Univ, Goodman Canc Res Ctr, Montreal, PQ, Canada; [Maric, Gordana; Annis, Matthew G.; MacDonald, Patricia A.; Russo, Caterina; Siegel, Peter M.] McGill Univ, Dept Med, Montreal, PQ, Canada; [Siwak, Doris R.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Mills, Gordon B.] Oregon Hlth & Sci Univ, Knight Canc Inst, Dept Cell Dev & Canc Biol, Portland, OR 97201 USA; [Siegel, Peter M.] McGill Univ, Dept Biochem, Montreal, PQ, Canada	McGill University; McGill University; University of Texas System; UTMD Anderson Cancer Center; Oregon Health & Science University; McGill University	Siegel, PM (corresponding author), McGill Univ, Goodman Canc Res Ctr, Montreal, PQ, Canada.; Siegel, PM (corresponding author), McGill Univ, Dept Med, Montreal, PQ, Canada.; Siegel, PM (corresponding author), McGill Univ, Dept Biochem, Montreal, PQ, Canada.	peter.siegel@mcgill.ca		Annis, Matthew/0000-0002-8776-004X; Mills, Gordon/0000-0002-0144-9614	Canadian Institutes for Health Research (CIHR); CIHR [MOP-119401, PJT-153327]	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR))	We acknowledge the Goodman Cancer Research Centre (GCRC) transgenic facility (McGill University) for generation of the MMTV/GPNMB mice, the GCRC histology core facility (McGill University) for routine histological services and Zhifeng Dong for some Immunohistochemical staining. We thank members of the Siegel laboratory for thoughtful discussions and critical reading of the manuscript. GM acknowledges studentship support from the Canadian Institutes for Health Research (CIHR). PMS is currently a McGill University William Dawson Scholar. This research was supported solely by grants from the CIHR (MOP-119401; PJT-153327).	Bankfalvi A, 2004, MODERN PATHOL, V17, P1051, DOI 10.1038/modpathol.3800082; Bao G, 2016, EXP BIOL MED, V241, P1968, DOI 10.1177/1535370216654224; Bianchini G, 2016, NAT REV CLIN ONCOL, V13, P674, DOI 10.1038/nrclinonc.2016.66; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Bocker W, 2002, LAB INVEST, V82, P737, DOI 10.1097/01.LAB.0000017371.72714.C5; Cadigan KM, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007906; Chen C, 2018, CANCER RES, V78, P6424, DOI 10.1158/0008-5472.CAN-18-0599; Conacci-Sorrell M, 2003, J CELL BIOL, V163, P847, DOI 10.1083/jcb.200308162; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Davies BR, 2012, MOL CANCER THER, V11, P873, DOI 10.1158/1535-7163.MCT-11-0824-T; Ding VW, 2000, J BIOL CHEM, V275, P32475, DOI 10.1074/jbc.M005342200; DONEHOWER LA, 1995, GENE DEV, V9, P882, DOI 10.1101/gad.9.7.882; Failor KL, 2007, MOL ENDOCRINOL, V21, P2403, DOI 10.1210/me.2007-0143; Geyer FC, 2011, MODERN PATHOL, V24, P209, DOI 10.1038/modpathol.2010.205; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Howe LR, 2004, CANCER BIOL THER, V3, P36, DOI 10.4161/cbt.3.1.561; Hu TH, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-236; Huang S, 2005, GENOME BIOL, V6, P1; Huang SX, 2008, NEOPLASIA, V10, P118, DOI 10.1593/neo.07637; Iadevaia S, 2010, CANCER RES, V70, P6704, DOI 10.1158/0008-5472.CAN-10-0460; Jin R, 2018, ONCOL REP, V39, P3034, DOI 10.3892/or.2018.6346; Kanematsu M, 2015, CANCER MED-US, V4, P1344, DOI 10.1002/cam4.480; Kapoun AM, 1997, ONCOGENE, V14, P2985, DOI 10.1038/sj.onc.1201146; Khramtsov AI, 2010, AM J PATHOL, V176, P2911, DOI 10.2353/ajpath.2010.091125; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Korkaya H, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000121; KWAN H, 1992, MOL CELL BIOL, V12, P147, DOI 10.1128/MCB.12.1.147; Li SG, 2014, TUMOR BIOL, V35, P7693, DOI 10.1007/s13277-014-1975-0; Li Y, 2000, ONCOGENE, V19, P1002, DOI 10.1038/sj.onc.1203273; Li Y, 2003, P NATL ACAD SCI USA, V100, P15853, DOI 10.1073/pnas.2136825100; Li Y, 2001, BMC Mol Biol, V2, P2, DOI 10.1186/1471-2199-2-2; Lim E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2560; Lin AF, 2016, NAT CELL BIOL, V18, P213, DOI 10.1038/ncb3295; Lin J, 2013, CLIN CANCER RES, V19, P1760, DOI 10.1158/1078-0432.CCR-12-3072; Lopez-Knowles E, 2010, INT J CANCER, V126, P1121, DOI 10.1002/ijc.24831; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Maric G, 2015, ONCOGENE, V34, P5494, DOI 10.1038/onc.2015.8; Maric G, 2013, ONCOTARGETS THER, V6, P839, DOI 10.2147/OTT.S44906; Marusyk A, 2012, NAT REV CANCER, V12, P323, DOI 10.1038/nrc3261; Maubant S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122333; Mulholland DJ, 2006, ONCOGENE, V25, P329, DOI 10.1038/sj.onc.1209020; Musgrove EA, 2004, BREAST CANCER RES, V6, P65, DOI 10.1186/bcr737; Nagahara Y, 2017, J NEUROSCI RES, V95, P1647, DOI 10.1002/jnr.23999; Nieto AI, 2003, COMPARATIVE MED, V53, P433; Northey JJ, 2008, MOL CELL BIOL, V28, P3162, DOI 10.1128/MCB.01734-07; Nusse R, 2017, CELL, V169, P985, DOI 10.1016/j.cell.2017.05.016; Okita Y, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aak9397; Ono Y, 2016, BIOCHEM BIOPH RES CO, V481, P7, DOI 10.1016/j.bbrc.2016.11.034; Perry JM, 2011, GENE DEV, V25, P1928, DOI 10.1101/gad.17421911; Pfefferle AD, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-11-r125; Podsypanina K, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-24; Prat A, 2013, ONCOLOGIST, V18, P123, DOI 10.1634/theoncologist.2012-0397; Prat A, 2011, MOL ONCOL, V5, P5, DOI 10.1016/j.molonc.2010.11.003; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Robles AI, 2008, CHEM-BIOL INTERACT, V171, P159, DOI 10.1016/j.cbi.2007.01.014; Rose AAN, 2007, MOL CANCER RES, V5, P1001, DOI 10.1158/1541-7786.MCR-07-0119; Rose AAN, 2017, PHARMACOL THERAPEUT, V179, P127, DOI 10.1016/j.pharmthera.2017.05.010; Rose AAN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012093; Rose AAN, 2010, CLIN CANCER RES, V16, P2147, DOI 10.1158/1078-0432.CCR-09-1611; Schroeder JA, 2000, ONCOGENE, V19, P3193, DOI 10.1038/sj.onc.1203652; Schroeder JA, 2002, J BIOL CHEM, V277, P22692, DOI 10.1074/jbc.M201975200; SHACKLEFORD GM, 1993, P NATL ACAD SCI USA, V90, P740, DOI 10.1073/pnas.90.2.740; Sharma P, 2016, ONCOLOGIST, V21, P1050, DOI 10.1634/theoncologist.2016-0067; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Taelman VF, 2010, CELL, V143, P1136, DOI 10.1016/j.cell.2010.11.034; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Vargo-Gogola T, 2007, NAT REV CANCER, V7, P659, DOI 10.1038/nrc2193; Wakefield LM, 2003, COMPARATIVE MED, V53, P424; Watanabe K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092317; Xu JH, 2016, MOL CARCINOGEN, V55, P431, DOI 10.1002/mc.22292; Yardley DA, 2015, J CLIN ONCOL, V33, P1609, DOI 10.1200/JCO.2014.56.2959; Yu B, 2016, J CELL BIOCHEM, V117, P1511, DOI 10.1002/jcb.25394; Yuan HD, 1999, J BIOL CHEM, V274, P30419, DOI 10.1074/jbc.274.43.30419; Zhang YX, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317699119	75	16	16	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 27	2019	38	26					5294	5307		10.1038/s41388-019-0793-7	http://dx.doi.org/10.1038/s41388-019-0793-7			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	IF4AX	30914799				2022-12-26	WOS:000473025300013
J	Julian, MC; Rabia, LA; Desai, AA; Arsiwala, A; Gerson, JE; Paulson, HL; Kane, RS; Tessier, PM				Julian, Mark C.; Rabia, Lilia A.; Desai, Alec A.; Arsiwala, Ammar; Gerson, Julia E.; Paulson, Henry L.; Kane, Ravi S.; Tessier, Peter M.			Nature-inspired design and evolution of anti-amyloid antibodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antibody engineering; monoclonal antibody; amyloid; amyloid- (A); directed evolution; fibril; neurodegeneration; Alzheimer's disease; aggregate; conformation; gammabody; scFv; yeast surface display	ALPHA-SYNUCLEIN STRAINS; NONSPECIFIC-BINDING; BETA; AFFINITY; DOMAIN; SELECTION; SEQUENCE; AMYLOID-BETA(1-42); PHARMACOKINETICS; OPTIMIZATION	Antibodies that recognize amyloidogenic aggregates with high conformational and sequence specificity are important for detecting and potentially treating a wide range of neurodegenerative disorders, including Alzheimer's and Parkinson's diseases. However, these types of antibodies are challenging to generate because of the large size, hydrophobicity, and heterogeneity of protein aggregates. To address this challenge, we developed a method for generating antibodies specific for amyloid aggregates. First, we grafted amyloidogenic peptide segments from the target polypeptide [Alzheimer's amyloid- (A) peptide] into the complementarity-determining regions (CDRs) of a stable antibody scaffold. Next, we diversified the grafted and neighboring CDR sites using focused mutagenesis to sample each WT or grafted residue, as well as one to five of the most commonly occurring amino acids at each site in human antibodies. Finally, we displayed these antibody libraries on the surface of yeast cells and selected antibodies that strongly recognize A-amyloid fibrils and only weakly recognize soluble A. We found that this approach enables the generation of monovalent and bivalent antibodies with nanomolar affinity for A fibrils. These antibodies display high conformational and sequence specificity as well as low levels of nonspecific binding and recognize a conformational epitope at the extreme N terminus of human A. We expect that this systematic approach will be useful for generating antibodies with conformational and sequence specificity against a wide range of peptide and protein aggregates associated with neurodegenerative disorders.	[Julian, Mark C.; Rabia, Lilia A.; Tessier, Peter M.] Rensselaer Polytech Inst, Isermann Dept Chem & Biol Engn, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA; [Rabia, Lilia A.; Tessier, Peter M.] Univ Michigan, Dept Pharmaceut Sci, Ann Arbor, MI 48109 USA; [Rabia, Lilia A.; Desai, Alec A.; Tessier, Peter M.] Univ Michigan, Biointerfaces Inst, Ann Arbor, MI 48109 USA; [Rabia, Lilia A.; Desai, Alec A.; Tessier, Peter M.] Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA; [Tessier, Peter M.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA; [Gerson, Julia E.; Paulson, Henry L.] Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA; [Paulson, Henry L.; Tessier, Peter M.] Univ Michigan, Prot Folding Dis Initiat, Ann Arbor, MI 48109 USA; [Paulson, Henry L.] Univ Michigan, Michigan Alzheimers Dis Ctr, Ann Arbor, MI 48109 USA; [Arsiwala, Ammar; Kane, Ravi S.] Georgia Inst Technol, Sch Chem & Biomol Engn, Atlanta, GA 30332 USA	Rensselaer Polytechnic Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University System of Georgia; Georgia Institute of Technology	Tessier, PM (corresponding author), Univ Michigan, Dept Chem Engn, Biointerfaces Inst, Ann Arbor, MI 48109 USA.; Tessier, PM (corresponding author), Univ Michigan, Dept Pharmaceut Sci, Biointerfaces Inst, Ann Arbor, MI 48109 USA.; Tessier, PM (corresponding author), Univ Michigan, Dept Biomed Engn, Biointerfaces Inst, Ann Arbor, MI 48109 USA.	ptessier@umich.edu	Arsiwala, Ammar/J-4892-2015; Tessier, Peter/GPP-3396-2022		National Institutes of Health [R01GM104130, RF1AG059723]; National Science Foundation [CBET 1159943, 1605266, 1813963]; Albert M. Mattocks Chair; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104130] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG053760, RF1AG059723] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Albert M. Mattocks Chair; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grants R01GM104130 (to P. M. T.) and RF1AG059723 (to P. M. T. and R. S. K.,), National Science Foundation Grants CBET 1159943, 1605266, and 1813963 (to P. M. T.), Graduate Research Fellowships (to M. C. J. and L. A. R.), and the Albert M. Mattocks Chair (to P. M. T). P. M. T. has received consulting fees and/or honorariums for presentations of this and/or related research findings at Pfizer, Adimab, Roche Applied Science, Boehringer Ingelheim, Bayer, and Novo Nordisk. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ackerman M, 2009, BIOTECHNOL PROGR, V25, P774, DOI 10.1002/btpr.174; Alam ME, 2018, MOL PHARMACEUT, V15, P150, DOI 10.1021/acs.molpharmaceut.7b00779; Arndt JW, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24501-0; Benatuil L, 2010, PROTEIN ENG DES SEL, V23, P155, DOI 10.1093/protein/gzq002; Birtalan S, 2008, J MOL BIOL, V377, P1518, DOI 10.1016/j.jmb.2008.01.093; Birtalan S, 2010, MOL BIOSYST, V6, P1186, DOI 10.1039/b927393j; Bohrmann B, 2012, J ALZHEIMERS DIS, V28, P49, DOI 10.3233/JAD-2011-110977; Bousset L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3575; Brannstrom K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090857; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Datta-Mannan A, 2015, MABS-AUSTIN, V7, P1084, DOI 10.1080/19420862.2015.1075109; Datta-Mannan A, 2015, MABS-AUSTIN, V7, P483, DOI 10.1080/19420862.2015.1016696; Dobson CL, 2016, SCI REP-UK, V6, DOI 10.1038/srep38644; Falk R, 2012, METHODS, V58, P69, DOI 10.1016/j.ymeth.2012.07.008; Feinberg H, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt261; Glabe CG, 2004, TRENDS BIOCHEM SCI, V29, P542, DOI 10.1016/j.tibs.2004.08.009; Gremer L, 2017, SCIENCE, V358, P116, DOI 10.1126/science.aao2825; Guo JL, 2013, CELL, V154, P103, DOI 10.1016/j.cell.2013.05.057; Habicht G, 2007, P NATL ACAD SCI USA, V104, P19232, DOI 10.1073/pnas.0703793104; Jain T, 2017, P NATL ACAD SCI USA, V114, P944, DOI 10.1073/pnas.1616408114; Julian MC, 2017, SCI REP-UK, V7, DOI 10.1038/srep45259; Julian MC, 2015, PROTEIN ENG DES SEL, V28, P339, DOI 10.1093/protein/gzv050; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kayed R, 2006, METHOD ENZYMOL, V413, P326, DOI 10.1016/S0076-6879(06)13017-7; Kehoe JW, 2014, PROTEIN ENG DES SEL, V27, P199, DOI 10.1093/protein/gzu012; Kelly RL, 2018, J MOL BIOL, V430, P119, DOI 10.1016/j.jmb.2017.11.008; Kelly RL, 2017, MABS-AUSTIN, V9, P1029, DOI 10.1080/19420862.2017.1356528; Lafaye P, 2009, MOL IMMUNOL, V46, P695, DOI 10.1016/j.molimm.2008.09.008; Lee CC, 2016, J BIOL CHEM, V291, P2858, DOI 10.1074/jbc.M115.682336; Li B, 2014, MABS-AUSTIN, V6, P1255, DOI 10.4161/mabs.29809; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Melki R, 2015, J PARKINSON DIS, V5, P217, DOI 10.3233/JPD-150543; MIAN IS, 1991, J MOL BIOL, V217, P133, DOI 10.1016/0022-2836(91)90617-F; Mouquet H, 2010, NATURE, V467, P591, DOI 10.1038/nature09385; Narasimhan S, 2017, J NEUROSCI, V37, P11406, DOI 10.1523/JNEUROSCI.1230-17.2017; Paravastu AK, 2008, P NATL ACAD SCI USA, V105, P18349, DOI 10.1073/pnas.0806270105; Peelaerts W, 2015, NATURE, V522, P340, DOI 10.1038/nature14547; Peelaerts W, 2016, J NEUROCHEM, V139, P256, DOI 10.1111/jnc.13595; Perchiacca JM, 2012, PROTEIN ENG DES SEL, V25, P591, DOI 10.1093/protein/gzs042; Perchiacca JM, 2012, P NATL ACAD SCI USA, V109, P84, DOI 10.1073/pnas.1111232108; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Rabia LA, 2018, PROTEIN ENG DES SEL, V31, P409, DOI 10.1093/protein/gzz002; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Sanders DW, 2014, NEURON, V82, P1271, DOI 10.1016/j.neuron.2014.04.047; Sevigny J, 2016, NATURE, V537, P50, DOI 10.1038/nature19323; Soto C, 2003, NAT REV NEUROSCI, V4, P49, DOI 10.1038/nrn1007; Starr CG, 2019, CURR OPIN BIOTECH, V60, P119, DOI 10.1016/j.copbio.2019.01.008; Stern LA, 2016, BIOTECHNOL BIOENG, V113, P2328, DOI 10.1002/bit.26001; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Swindells MB, 2017, J MOL BIOL, V429, P356, DOI 10.1016/j.jmb.2016.08.019; Tiller KE, 2017, J BIOL CHEM, V292, P16638, DOI 10.1074/jbc.M117.783837; Tiller KE, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00986; Walti MA, 2016, P NATL ACAD SCI USA, V113, pE4976, DOI 10.1073/pnas.1600749113; Yadav DB, 2015, J BIOL CHEM, V290, P29732, DOI 10.1074/jbc.M115.692434; Zemlin M, 2003, J MOL BIOL, V334, P733, DOI 10.1016/j.jmb.2003.10.007	57	13	13	0	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2019	294	21					8438	8451		10.1074/jbc.RA118.004731	http://dx.doi.org/10.1074/jbc.RA118.004731			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC6UQ	30918024	hybrid, Green Published			2022-12-26	WOS:000471108200014
J	Kukurugya, MA; Mendonca, CM; Solhtalab, M; Wilkes, RA; Thannhauser, TW; Aristilde, L				Kukurugya, Matthew A.; Mendonca, Caroll M.; Solhtalab, Mina; Wilkes, Rebecca A.; Thannhauser, Theodore W.; Aristilde, Ludmilla			Multi-omics analysis unravels a segregated metabolic flux network that tunes co-utilization of sugar and aromatic carbons in Pseudomonas putida	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Pseudomonas; bacterial metabolism; metabolomics; proteomics; glucose; benzoate; fluxomics; metabolic flux; metabolic regulation; mixed carbon metabolism	ISOCITRATE DEHYDROGENASE; CATABOLITE REPRESSION; GLUCOSE; DEGRADATION; CRC; PATHWAYS; BENZOATE; SEQUENCE; TOLUENE; GENOME	Pseudomonas species thrive in different nutritional environments and can catabolize divergent carbon substrates. These capabilities have important implications for the role of these species in natural and engineered carbon processing. However, the metabolic phenotypes enabling Pseudomonas to utilize mixed substrates remain poorly understood. Here, we employed a multi-omics approach involving stable isotope tracers, metabolomics, fluxomics, and proteomics in Pseudomonas putida KT2440 to investigate the constitutive metabolic network that achieves co-utilization of glucose and benzoate, respectively a monomer of carbohydrate polymers and a derivative of lignin monomers. Despite nearly equal consumption of both substrates, metabolite isotopologues revealed nonuniform assimilation throughout the metabolic network. Gluconeogenic flux of benzoate-derived carbons from the tricarboxylic acid cycle did not reach the upper Embden-Meyerhof-Parnas pathway nor the pentose-phosphate pathway. These latter two pathways were populated exclusively by glucose-derived carbons through a cyclic connection with the Entner-Doudoroff pathway. We integrated the C-13-metabolomics data with physiological parameters for quantitative flux analysis, demonstrating that the metabolic segregation of the substrate carbons optimally sustained biosynthetic flux demands and redox balance. Changes in protein abundance partially predicted the metabolic flux changes in cells grown on the glucose:benzoate mixture versus on glucose alone. Notably, flux magnitude and directionality were also maintained by metabolite levels and regulation of phosphorylation of key metabolic enzymes. These findings provide new insights into the metabolic architecture that affords adaptability of P. putida to divergent carbon substrates and highlight regulatory points at different metabolic nodes that may underlie the high nutritional flexibility of Pseudomonas species.	[Kukurugya, Matthew A.; Mendonca, Caroll M.; Solhtalab, Mina; Wilkes, Rebecca A.; Aristilde, Ludmilla] Cornell Univ, Coll Agr & Life Sci, Dept Biol & Environm Engn, Ithaca, NY 14853 USA; [Thannhauser, Theodore W.] ARS, USDA, Ithaca, NY 14853 USA	Cornell University; United States Department of Agriculture (USDA)	Aristilde, L (corresponding author), Cornell Univ, 214 Riley Robb Hall, Ithaca, NY 14850 USA.	ludmilla@cornell.edu	Solhtalab, Mina/ABG-4811-2020; Aristilde, Ludmilla/V-7611-2019	Mendonca, Caroll/0000-0001-6692-2911; Wilkes, Rebecca/0000-0002-4628-0170; Aristilde, Ludmilla/0000-0002-8566-1486	Integrative Graduate Education and Research Traineeship Fellowship from the National Science Foundation; Cornell University	Integrative Graduate Education and Research Traineeship Fellowship from the National Science Foundation; Cornell University	This work was supported by an Integrative Graduate Education and Research Traineeship Fellowship from the National Science Foundation (to M. A. K.), graduate fellowships from Cornell University (to M. S. and R. A. W.), and a start-up package from Cornell University. The authors declare that they have no conflicts of interest with the contents of this article.	Akkaya O, 2018, MBIO, V9, DOI 10.1128/mBio.01512-18; [Anonymous], 1967, HDB METHODS APPL STA; Aristilde L, 2017, FRONT ENV SCI-SWITZ, V5, DOI 10.3389/fenvs.2017.00034; Aristilde L, 2015, APPL ENVIRON MICROB, V81, P1452, DOI 10.1128/AEM.03199-14; Basu A, 2006, APPL ENVIRON MICROB, V72, P2226, DOI 10.1128/AEM.72.3.2226-2230.2006; Belda E, 2016, ENVIRON MICROBIOL, V18, P3403, DOI 10.1111/1462-2920.13230; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Bugg TDH, 2011, CURR OPIN BIOTECH, V22, P394, DOI 10.1016/j.copbio.2010.10.009; BURLAGE RS, 1989, APPL ENVIRON MICROB, V55, P1323, DOI 10.1128/AEM.55.6.1323-1328.1989; Cao B, 2008, BIOTECHNOL BIOENG, V101, P1297, DOI 10.1002/bit.21997; Chen JW, 2013, J PROTEOME RES, V12, P1151, DOI 10.1021/pr3007528; del Castillo T, 2007, J BACTERIOL, V189, P6602, DOI 10.1128/JB.00679-07; Dvorak P, 2018, METAB ENG, V48, P94, DOI 10.1016/j.ymben.2018.05.019; Fang W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050312; George KW, 2012, MICROBIOL-SGM, V158, P2781, DOI 10.1099/mic.0.058230-0; Gorke B, 2008, NAT REV MICROBIOL, V6, P613, DOI 10.1038/nrmicro1932; Hackett SR, 2016, SCIENCE, V354, DOI 10.1126/science.aaf2786; Hester KL, 2000, J BACTERIOL, V182, P1144, DOI 10.1128/JB.182.4.1144-1149.2000; Johnson Christopher W, 2016, Metab Eng Commun, V3, P111, DOI 10.1016/j.meteno.2016.04.002; Johnson GR, 2003, APPL MICROBIOL BIOT, V62, P110, DOI 10.1007/s00253-003-1341-4; Kim J, 2016, ENVIRON MICROBIOL, V18, P3327, DOI 10.1111/1462-2920.13054; Kleiber C, 2008, ECON STUD INEQUAL SO, V5, P97, DOI 10.1007/978-0-387-72796-7_6; Kohlstedt M, 2019, METAB ENG, V54, P35, DOI 10.1016/j.ymben.2019.01.008; La Rosa R, 2015, ENVIRON MICROBIOL, V17, P3362, DOI 10.1111/1462-2920.12812; LAPORTE DC, 1993, J CELL BIOCHEM, V51, P14, DOI 10.1002/jcb.240510104; Lassek C, 2016, PROTEOMICS, V16, P1381, DOI 10.1002/pmic.201500228; Melamud E, 2010, ANAL CHEM, V82, P9818, DOI 10.1021/ac1021166; Moreno R, 2009, NUCLEIC ACIDS RES, V37, P7678, DOI 10.1093/nar/gkp825; Nelson KE, 2002, ENVIRON MICROBIOL, V4, P799, DOI 10.1046/j.1462-2920.2002.00366.x; Nikel PI, 2015, J BIOL CHEM, V290, P25920, DOI 10.1074/jbc.M115.687749; Nikel PI, 2014, ENVIRON MICROBIOL, V16, P239, DOI 10.1111/1462-2920.12224; Palazzolo MA, 2016, WORLD J MICROB BIOT, V32, DOI 10.1007/s11274-016-2128-y; Park JO, 2016, NAT CHEM BIOL, V12, P482, DOI [10.1038/NCHEMBIO.2077, 10.1038/nchembio.2077]; Poblete-Castro I, 2012, APPL MICROBIOL BIOT, V93, P2279, DOI 10.1007/s00253-012-3928-0; ROJO F, 1987, SCIENCE, V238, P1395, DOI 10.1126/science.3479842; Ruiz-Manzano A, 2005, J BACTERIOL, V187, P3678, DOI 10.1128/JB.187.11.3678-3686.2005; Sasnow SS, 2016, MICROBIOLOGYOPEN, V5, P3, DOI 10.1002/mbo3.287; Silva-Rocha R, 2013, ISME J, V7, P229, DOI 10.1038/ismej.2012.98; SMITH CM, 1974, J BIOL CHEM, V249, P1497; Snedecor G.W., 1989, AMES IOWA STATE U PR; STEPHENS MA, 1974, J AM STAT ASSOC, V69, P730, DOI 10.2307/2286009; Sudarsan Suresh, 2016, Metab Eng Commun, V3, P97, DOI 10.1016/j.meteno.2016.03.005; Sudarsan S, 2014, APPL ENVIRON MICROB, V80, P5292, DOI 10.1128/AEM.01643-14; Tepper N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075370; Thomas CJ, 2017, ANAL BIOCHEM, V525, P46, DOI 10.1016/j.ab.2017.02.011; Tretter L, 2005, PHILOS T R SOC B, V360, P2335, DOI 10.1098/rstb.2005.1764; van Duuren JBJH, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-93; van Duuren JBJH, 2012, BIOTECHNOL PROGR, V28, P85, DOI 10.1002/btpr.709; Vardon DR, 2015, ENERG ENVIRON SCI, V8, P617, DOI [10.1039/C4EE03230F, 10.1039/c4ee03230f]; WALSH K, 1985, J BIOL CHEM, V260, P8430; Weitzel M, 2013, BIOINFORMATICS, V29, P143, DOI 10.1093/bioinformatics/bts646; Wilkes RA, 2019, APPL ENVIRON MICROB, V85, DOI 10.1128/AEM.02084-18; WORSEY MJ, 1975, J BACTERIOL, V124, P7, DOI 10.1128/JB.124.1.7-13.1975; Yang Shuping, 2018, Oncotarget, V9, P11352, DOI 10.18632/oncotarget.24250; Yang Y, 2011, J PROTEOME RES, V10, P4647, DOI 10.1021/pr200455s; Zamboni N, 2009, NAT PROTOC, V4, P878, DOI 10.1038/nprot.2009.58	57	23	23	4	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2019	294	21					8464	8479		10.1074/jbc.RA119.007885	http://dx.doi.org/10.1074/jbc.RA119.007885			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC6UQ	30936206	Green Published, hybrid			2022-12-26	WOS:000471108200016
J	Putri, DDP; Kawasaki, T; Murase, M; Sueyoshi, T; Deguchi, T; Ori, D; Suetsugu, S; Kawai, T				Putri, Dyaningtyas Dewi Pamungkas; Kawasaki, Takumi; Murase, Motoya; Sueyoshi, Takuya; Deguchi, Tomoya; Ori, Daisuke; Suetsugu, Shiro; Kawai, Taro			PtdIns3P phosphatases MTMR3 and MTMR4 negatively regulate innate immune responses to DNA through modulating STING trafficking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						phosphatidylinositol; phosphatidylinositol phosphatase; innate immunity; DNA viruses; interferon regulatory factor; IRF; DNA sensor; MTM; MTMR; PtdIns3P; STING; type I IFNs	MYOTUBULARIN; PROTEIN; 2ND-MESSENGER; AUTOPHAGY; PATHWAY	The innate immune system plays an essential role in initial recognition of pathogen infection by producing inflammatory cytokines and type I interferons. cGAS is a cytoplasmic sensor for DNA derived from DNA viruses. cGAS binding with DNA induces the production of cGAMP, a second messenger that associates with STING in endoplasmic reticulum (ER). STING changes its cellular distribution from ER to perinuclear Golgi, where it activates the protein kinase TBK1 that catalyzes the phosphorylation of IRF3. Here we found that STING trafficking is regulated by myotubularin-related protein (MTMR) 3 and MTMR4, members of protein tyrosine phosphatases that dephosphorylate 3 position in phosphatidylinositol (PtdIns) and generate PtdIns5P from PtdIns3,5P(2) and PtdIns from PtdIns3P. We established MTMR3 and MTMR4 double knockout (DKO) RAW264.7 macrophage cells and found that they exhibited increased type I interferon production after interferon-stimulatory DNA (ISD) stimulation and herpes simplex virus 1 infection concomitant with enhanced IRF3 phosphorylation. In DKO cells, STING rapidly trafficked from ER to Golgi after ISD stimulation. Notably, DKO cells exhibited enlarged cytosolic puncta positive for PtdIns3P and STING was aberrantly accumulated in this puncta. Taken together, these results suggest that MTMR3 and MTMR4 regulate the production of PtdIns3P, which plays a critical role in suppressing DNA-mediated innate immune responses via modulating STING trafficking.	[Putri, Dyaningtyas Dewi Pamungkas; Kawasaki, Takumi; Murase, Motoya; Sueyoshi, Takuya; Deguchi, Tomoya; Ori, Daisuke; Kawai, Taro] Nara Inst Sci & Technol NAIST, Lab Mol Immunobiol, Grad Sch Sci & Technol, Nara 6300192, Japan; [Suetsugu, Shiro] Nara Inst Sci & Technol NAIST, Lab Mol Med & Cell Biol, Grad Sch Sci & Technol, Div Biol Sci, Nara 6300192, Japan	Nara Institute of Science & Technology; Nara Institute of Science & Technology	Kawasaki, T; Kawai, T (corresponding author), 8916-5 Takayama Cho, Nara 6300192, Japan.	kawast01@bs.naist.jp; tarokawai@bs.naist.jp	Suetsugu, Shiro/B-3300-2010; Suetsugu, Shiro/ABB-6033-2020; Suetsugu, Shiro/AAF-4427-2019; -, Dyaningtyas Dewi Pamungkas Putri/GLV-3044-2022	Suetsugu, Shiro/0000-0002-4612-0628; Suetsugu, Shiro/0000-0002-4612-0628; -, Dyaningtyas Dewi Pamungkas Putri/0000-0002-1235-4346; Kawai, Taro/0000-0001-7510-4662	MEXT KAKENHI [17H04066, 17K15598]; Takeda Science Foundation	MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF))	This study was supported by MEXT KAKENHI Grant-in-Aid for Scientific Research B 17H04066 and Young Scientist B 17K15598 and by Takeda Science Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Ahn J, 2014, CURR OPIN IMMUNOL, V31, P121, DOI 10.1016/j.coi.2014.10.009; Axe EL, 2008, J CELL BIOL, V182, P685, DOI 10.1083/jcb.200803137; Chen Q, 2016, NAT IMMUNOL, V17, P1142, DOI 10.1038/ni.3558; Guittard G, 2010, FEBS LETT, V584, P2455, DOI 10.1016/j.febslet.2010.04.051; Hamasaki M, 2013, NATURE, V495, P389, DOI 10.1038/nature11910; Hille B, 2015, BBA-MOL CELL BIOL L, V1851, P844, DOI 10.1016/j.bbalip.2014.09.010; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kawasaki T, 2013, CELL HOST MICROBE, V14, P148, DOI 10.1016/j.chom.2013.07.011; Lahiri A, 2015, P NATL ACAD SCI USA, V112, P10461, DOI 10.1073/pnas.1501752112; Liu Y, 2010, PROG LIPID RES, V49, P201, DOI 10.1016/j.plipres.2009.12.001; Ma Z, 2016, CELL HOST MICROBE, V19, P150, DOI 10.1016/j.chom.2016.01.010; Marat AL, 2016, EMBO J, V35, P561, DOI 10.15252/embj.201593564; Mashiko D, 2013, SCI REP-UK, V3, DOI 10.1038/srep03355; Murase M, 2018, J IMMUNOL, V200, P2798, DOI 10.4049/jimmunol.1701390; Nascimbeni AC, 2017, EMBO J, V36, P2018, DOI 10.15252/embj.201797006; Naughtin MJ, 2010, J CELL SCI, V123, P3071, DOI 10.1242/jcs.060103; Oppelt A, 2013, EMBO REP, V14, P57, DOI 10.1038/embor.2012.183; Robinson FL, 2006, TRENDS CELL BIOL, V16, P403, DOI 10.1016/j.tcb.2006.06.001; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Saitoh T, 2009, P NATL ACAD SCI USA, V106, P20842, DOI 10.1073/pnas.0911267106; Seo GJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02936-3; Sueyoshi T, 2018, J IMMUNOL, V200, P3814, DOI 10.4049/jimmunol.1701282; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Taguchi-Atarashi N, 2010, TRAFFIC, V11, P468, DOI 10.1111/j.1600-0854.2010.01034.x; Takahama M, 2017, CELL REP, V20, P2944, DOI 10.1016/j.celrep.2017.08.085; Taylor GS, 2000, P NATL ACAD SCI USA, V97, P8910, DOI 10.1073/pnas.160255697; Teo WX, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00091; Tsuchida T, 2010, IMMUNITY, V33, P765, DOI 10.1016/j.immuni.2010.10.013; Ueyama T, 2007, MOL BIOL CELL, V18, P441, DOI 10.1091/mbc.E06-08-0731; Walker DM, 2001, CURR BIOL, V11, P1600, DOI 10.1016/S0960-9822(01)00501-2; Wu JX, 2014, ANNU REV IMMUNOL, V32, P461, DOI 10.1146/annurev-immunol-032713-120156; Wymann MP, 2008, NAT REV MOL CELL BIO, V9, P162, DOI 10.1038/nrm2335; Zhang J, 2012, J BIOL CHEM, V287, P28646, DOI 10.1074/jbc.M112.362608	34	9	9	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2019	294	21					8412	8423		10.1074/jbc.RA118.005731	http://dx.doi.org/10.1074/jbc.RA118.005731			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC6UQ	30944173	hybrid, Green Published			2022-12-26	WOS:000471108200012
J	Chen, JL; Smaardijk, S; Mattelaer, CA; Pamula, F; Vandecaetsbeek, I; Vanoevelen, J; Wuytack, F; Lescrinier, E; Eggermont, J; Vangheluwe, P				Chen, Jialin; Smaardijk, Susanne; Mattelaer, Charles-Alexandre; Pamula, Filip; Vandecaetsbeek, Ilse; Vanoevelen, Jo; Wuytack, Frank; Lescrinier, Eveline; Eggermont, Jan; Vangheluwe, Peter			An N-terminal Ca2+-binding motif regulates the secretory pathway Ca2+/Mn2+-transport ATPase SPCA1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Golgi; calcium ATPase; protein purification; membrane transporter reconstitution; calcium transport; manganese; breast cancer; Hailey-Hailey disease; ion homeostasis; proteoliposomes	PLASMA-MEMBRANE; BREAST-CANCER; ION-TRANSPORT; CALCIUM-PUMP; STEADY-STATE; MOUSE-BRAIN; CA2+; YEAST; LOCALIZATION; MN2+-ATPASE	The Ca2+/Mn2+ transport ATPases 1a and 2 (SPCA1a/2) are closely related to the sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA) and are implicated in breast cancer and Hailey-Hailey skin disease. Here, we purified the human SPCA1a/2 isoforms from a yeast recombinant expression system and compared their biochemical properties after reconstitution. We observed that the purified SPCA1a displays a lower Ca2+ affinity and slightly lower Mn2+ affinity than SPCA2. Remarkably, the turnover rates of SPCA1a in the presence of Mn2+ and SPCA2 incubated with Ca2+ and Mn2+ were comparable, whereas the turnover rate of SPCA1a in Ca2+ was 2-fold higher. Moreover, we noted an unusual biphasic activation curve for the SPCA1a ATPase and autophosphorylation activity, not observed with SPCA2. We also found that the biphasic pattern and low apparent ion affinity of SPCA1a critically depends on ATP concentration. We further show that the specific properties of SPCA1a at least partially depend on an N-terminal EF-hand-like motif, which is present only in the SPCA1a isoform and absent in SPCA2. This motif binds Ca2+, and its mutation lowered the Ca2+ turnover rate relative to that of Mn2+, increased substrate affinity, and reduced the level of biphasic activation of SPCA1a. A biochemical analysis indicated that Ca2+ binding to the N-terminal EF-hand-like motif promotes the activity of SPCA1a by facilitating autophosphorylation. We propose that this regulation may be physiologically relevant in cells with a high Ca2+ load, such as mammary gland cells during lactation, or in cells with a low ATP content, such as keratinocytes.	[Chen, Jialin; Smaardijk, Susanne; Pamula, Filip; Vandecaetsbeek, Ilse; Vanoevelen, Jo; Wuytack, Frank; Eggermont, Jan; Vangheluwe, Peter] Katholieke Univ Leuven, Rega Inst, Dept Cellular & Mol Med, Lab Cellular Transport Syst, Leuven, Belgium; [Mattelaer, Charles-Alexandre; Lescrinier, Eveline] Katholieke Univ Leuven, Rega Inst, Dept Pharmaceut & Pharmacol Sci, Med Chem, Leuven, Belgium	KU Leuven; KU Leuven	Vangheluwe, P (corresponding author), Katholieke Univ Leuven, ON1 Campus Gasthuisberg,Herestr 49 Box 802, B-3000 Leuven, Belgium.	peter.vangheluwe@kuleuven.be	Lescrinier, Eveline/G-9339-2016; Vanoevelen, Jo M/F-2686-2013; Vangheluwe, Peter/P-5476-2017	Lescrinier, Eveline/0000-0001-7066-4329; Vanoevelen, Jo M/0000-0003-1830-8858; Mattelaer, Charles-Alexandre/0000-0002-8801-062X; Pamula, Filip/0000-0002-1765-8218; Eggermont, Jan/0000-0002-8497-1159; Vangheluwe, Peter/0000-0002-7822-2944	Flanders Research Foundation FWO [G044212N, G0B1115N]; Inter-University Attraction Poles program [P7/13]	Flanders Research Foundation FWO(FWO); Inter-University Attraction Poles program(Belgian Federal Science Policy Office)	This work was supported by Flanders Research Foundation FWO Grants G044212N and G0B1115N (to P. V.) and Inter-University Attraction Poles program P7/13. The authors declare that they have no conflicts of interest with the contents of this article.	Aronchik I, 2003, J INVEST DERMATOL, V121, P681, DOI 10.1046/j.1523-1747.2003.12472.x; BAGINSKI ES, 1967, CLIN CHEM, V13, P326; Baron S, 2009, BBA-MOL CELL RES, V1793, P1041, DOI 10.1016/j.bbamcr.2008.11.005; BECKMAN RA, 1985, BIOCHEMISTRY-US, V24, P5810, DOI 10.1021/bi00342a019; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bolton EC, 2002, MOL CELL, V9, P879, DOI 10.1016/S1097-2765(02)00495-1; Chen JL, 2017, J BIOL CHEM, V292, P6938, DOI 10.1074/jbc.M117.778431; Cross BM, 2014, AM J PHYSIOL-CELL PH, V306, pC515, DOI 10.1152/ajpcell.00330.2013; Cross BM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067348; Dang DN, 2017, MOL CARCINOGEN, V56, P2474, DOI 10.1002/mc.22695; DAVIS AL, 1992, J MAGN RESON, V98, P207, DOI 10.1016/0022-2364(92)90126-R; Dode L, 2006, J BIOL CHEM, V281, P3182, DOI 10.1074/jbc.M511547200; Dode L, 2005, J BIOL CHEM, V280, P39124, DOI 10.1074/jbc.M506181200; Elias PM, 2002, J INVEST DERMATOL, V119, P1269, DOI 10.1046/j.1523-1747.2002.19622.x; Faddy HM, 2008, BIOCHEM BIOPH RES CO, V369, P977, DOI 10.1016/j.bbrc.2008.03.003; Feng MY, 2010, CELL, V143, P84, DOI 10.1016/j.cell.2010.08.040; Gong DS, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06075-7; Grice DM, 2010, J BIOL CHEM, V285, P37458, DOI 10.1074/jbc.M110.163329; GRZESIEK S, 1993, J AM CHEM SOC, V115, P12593, DOI 10.1021/ja00079a052; Holemans T, 2015, P NATL ACAD SCI USA, V112, P9040, DOI 10.1073/pnas.1508220112; Hu ZL, 2000, NAT GENET, V24, P61, DOI 10.1038/71701; Kuhlbrandt W, 2004, NAT REV MOL CELL BIO, V5, P282, DOI 10.1038/nrm1354; Leitch S, 2011, BIOMETALS, V24, P159, DOI 10.1007/s10534-010-9384-3; LLINAS R, 1992, SCIENCE, V256, P677, DOI 10.1126/science.1350109; Lopreiato R, 2014, J BIOL CHEM, V289, P10261, DOI 10.1074/jbc.O114.555565; LYTTON J, 1992, J BIOL CHEM, V267, P14483; Mandal D, 2000, J BIOL CHEM, V275, P23933, DOI 10.1074/jbc.M002619200; Monteith GR, 2007, NAT REV CANCER, V7, P519, DOI 10.1038/nrc2171; Moody B. J., 1991, COMP INORGANIC CHEM, p[xiii, 562]; POST RL, 1973, J BIOL CHEM, V248, P6993; Prebil SD, 2016, SCI REP-UK, V6, DOI 10.1038/srep27383; Reinhardt TA, 2000, AM J PHYSIOL-CELL PH, V279, pC1595, DOI 10.1152/ajpcell.2000.279.5.C1595; Rule G. S., 2006, FOCUS STRUCTURAL BIO, P530; Sepulveda MR, 2012, CONTRAST MEDIA MOL I, V7, P426, DOI 10.1002/cmmi.1469; Sepulveda MR, 2008, MOL CELL NEUROSCI, V38, P461, DOI 10.1016/j.mcn.2008.02.012; Sitsel A, 2019, EMBO J, V38, DOI 10.15252/embj.2018100020; Smaardijk S, 2018, BBA-MOL CELL RES, V1865, P855, DOI 10.1016/j.bbamcr.2018.03.007; Smaardijk S, 2017, TISSUE CELL, V49, P141, DOI 10.1016/j.tice.2016.09.004; Ton VK, 2002, J BIOL CHEM, V277, P6422, DOI 10.1074/jbc.M110612200; Vandecaetsbeek Ilse, 2014, Cold Spring Harb Protoc, V2014, P865, DOI 10.1101/pdb.prot076885; Vangheluwe P, 2009, CHEM REV, V109, P4733, DOI 10.1021/cr900013m; Vanoevelen J, 2005, J BIOL CHEM, V280, P22800, DOI 10.1074/jbc.M501026200; Wei Y, 1999, BIOCHEMISTRY-US, V38, P14534, DOI 10.1021/bi9911233; Xiang MH, 2005, J BIOL CHEM, V280, P11608, DOI 10.1074/jbc.M413116200; Yamamoto S, 2016, BIOCHEM BIOPH RES CO, V477, P266, DOI 10.1016/j.bbrc.2016.06.055; Zhou YB, 2009, CELL CALCIUM, V46, P1, DOI 10.1016/j.ceca.2009.05.005	46	9	9	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2019	294	19					7878	7891		10.1074/jbc.RA118.006250	http://dx.doi.org/10.1074/jbc.RA118.006250			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IB3FL	30923126	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000470153300028
J	Podolnikova, NP; Hlavackova, M; Wu, YF; Yakubenko, VP; Faust, J; Balabiyev, A; Wang, X; Ugarova, TP				Podolnikova, Nataly P.; Hlavackova, Marketa; Wu, Yifei; Yakubenko, Valentin P.; Faust, James; Balabiyev, Arnat; Wang, Xu; Ugarova, Tatiana P.			Interaction between the integrin Mac-1 and signal regulatory protein (SIRP) mediates fusion in heterologous cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						integrin; cell adhesion; cell-cell interaction; structure-function; macrophage; cell-cell fusion; chronic inflammation; Mac-1 (M2; CD11b; CD18); multinucleated giant cell; SIRP	MULTINUCLEATED GIANT-CELLS; BINDING-SITE; ALPHA(M)BETA(2) MAC-1; INTERFERON-GAMMA; GROWTH-FACTOR; A-DOMAIN; I-DOMAIN; IDENTIFICATION; RECEPTOR; LIGAND	Macrophage fusion leading to the formation of multinucleated giant cells is a hallmark of chronic inflammation. Several membrane proteins have been implicated in mediating cell-cell attachment during fusion, but their binding partners remain unknown. Recently, we demonstrated that interleukin-4 (IL-4)-induced fusion of mouse macrophages depends on the integrin macrophage antigen 1 (Mac-1). Surprisingly, the genetic deficiency of intercellular adhesion molecule 1 (ICAM-1), an established ligand of Mac-1, did not impair macrophage fusion, suggesting the involvement of other counter-receptors. Here, using various approaches, including signal regulatory protein (SIRP) knockdown, recombinant proteins, adhesion and fusion assays, biolayer interferometry, and peptide libraries, we show that SIRP, which, similar to ICAM-1, belongs to the Ig superfamily and has previously been implicated in cell fusion, interacts with Mac-1. The following results support the conclusion that SIRP is a ligand of Mac-1: (a) recombinant ectodomain of SIRP supports adhesion of Mac-1-expressing cells; (b) Mac-1-SIRP interaction is mediated through the ligand-binding I-M-domain of Mac-1; (c) recognition of SIRP by the I-M-domain conforms to general principles governing binding of Mac-1 to many of its ligands; (d) SIRP reportedly binds CD47; however, anti-CD47 function-blocking mAb produced only a limited inhibition of macrophage adhesion to SIRP; and (e) co-culturing of SIRP- and Mac-1-expressing HEK293 cells resulted in the formation of multinucleated cells. Taken together, these results identify SIRP as a counter-receptor for Mac-1 and suggest that the Mac-1-SIRP interaction may be involved in macrophage fusion.	[Podolnikova, Nataly P.; Hlavackova, Marketa; Wu, Yifei; Faust, James; Balabiyev, Arnat; Ugarova, Tatiana P.] Arizona State Univ, Sch Life Sci, Ctr Metab & Vasc Biol, Tempe, AZ 85287 USA; [Wang, Xu] Arizona State Univ, Sch Mol Sci, Tempe, AZ 85287 USA; [Yakubenko, Valentin P.] East Tennessee State Univ, Coll Med, Johnson City, TN 37614 USA; [Hlavackova, Marketa] Czech Acad Sci, Inst Physiol, Dept Dev Cardiol, Videnska 1083, Prague 14220 4, Czech Republic; [Faust, James] Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Nashville, TN 37240 USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; East Tennessee State University; Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Vanderbilt University	Ugarova, TP (corresponding author), Arizona State Univ, 530 E Orange St,ISTB 1,Mail Code 4501, Tempe, AZ 85287 USA.	tatiana.ugarova@asu.edu	Hlavackova, Marketa/N-5632-2015	Hlavackova, Marketa/0000-0003-3842-6907; Balabiyev, Arnat/0000-0002-8904-598X	National Institutes of Health [HL63199, DK102020]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063199] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK102020] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants HL63199 (to T. P. U.) and DK102020 (to V. P. Y.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aguilar PS, 2013, TRENDS GENET, V29, P427, DOI 10.1016/j.tig.2013.01.011; Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004; Brown EJ, 2001, TRENDS CELL BIOL, V11, P130, DOI 10.1016/S0962-8924(00)01906-1; Chen EH, 2005, SCIENCE, V308, P369, DOI 10.1126/science.1104799; Chen EH, 2007, FEBS LETT, V581, P2181, DOI 10.1016/j.febslet.2007.03.033; Chiozzi P, 1997, J CELL BIOL, V138, P697, DOI 10.1083/jcb.138.3.697; Cui WG, 2007, P NATL ACAD SCI USA, V104, P14436, DOI 10.1073/pnas.0702811104; DIAMOND MS, 1990, J CELL BIOL, V111, P3129, DOI 10.1083/jcb.111.6.3129; DUFF JL, 1995, J BIOL CHEM, V270, P7161, DOI 10.1074/jbc.270.13.7161; FAIS S, 1994, LAB INVEST, V71, P737; Flick MJ, 2004, J CLIN INVEST, V113, P1596, DOI 10.1172/JCI200420741; FRANK R, 1992, TETRAHEDRON, V48, P9217, DOI 10.1016/S0040-4020(01)85612-X; Han X, 2000, J BIOL CHEM, V275, P37984, DOI 10.1074/jbc.M002334200; Hatherley D, 2008, MOL CELL, V31, P266, DOI 10.1016/j.molcel.2008.05.026; Helming L, 2007, EUR J IMMUNOL, V37, P33, DOI 10.1002/eji.200636788; Helming L, 2009, TRENDS CELL BIOL, V19, P514, DOI 10.1016/j.tcb.2009.07.005; Jiang PH, 1999, J BIOL CHEM, V274, P559, DOI 10.1074/jbc.274.2.559; Kramer A, 1998, METH MOL B, V87, P25; KURACHI T, 1993, BIOCHIM BIOPHYS ACTA, V1178, P259, DOI 10.1016/0167-4889(93)90202-Z; LEE JO, 1995, CELL, V80, P631, DOI 10.1016/0092-8674(95)90517-0; Lee JO, 1995, STRUCTURE, V3, P1333, DOI 10.1016/S0969-2126(01)00271-4; Lee WY, 2010, J BIOL CHEM, V285, P37953, DOI 10.1074/jbc.M110.180018; Lishko VK, 2016, RES REP BIOCHEM, V6, P39, DOI 10.2147/RRBC.S107070; Lishko VK, 2004, J BIOL CHEM, V279, P44897, DOI 10.1074/jbc.M408012200; Lishko VK, 2003, EXP CELL RES, V283, P116, DOI 10.1016/S0014-4827(02)00024-1; Lishko VK, 2002, BIOCHEMISTRY-US, V41, P12942, DOI 10.1021/bi026324c; Martens S, 2008, NAT REV MOL CELL BIO, V9, P543, DOI 10.1038/nrm2417; Matozaki T, 2009, TRENDS CELL BIOL, V19, P72, DOI 10.1016/j.tcb.2008.12.001; Milde R, 2015, CELL REP, V13, P1937, DOI 10.1016/j.celrep.2015.10.065; MOST J, 1990, EUR J IMMUNOL, V20, P1661, DOI 10.1002/eji.1830200807; Oldenborg Per-Arne, 2013, ISRN Hematol, V2013, P614619, DOI 10.1155/2013/614619; Oren-Suissa M, 2007, TRENDS CELL BIOL, V17, P537, DOI 10.1016/j.tcb.2007.09.004; Podbilewicz B, 2006, DEV CELL, V11, P471, DOI 10.1016/j.devcel.2006.09.004; Podolnikova NP, 2016, AM J PATHOL, V186, P2105, DOI 10.1016/j.ajpath.2016.04.001; Podolnikova NP, 2015, MOL PAIN, V11, DOI 10.1186/s12990-015-0027-0; Podolnikova NP, 2015, BIOCHEMISTRY-US, V54, P1408, DOI 10.1021/bi5013782; Quinn MT, 2009, J INNATE IMMUN, V1, P509, DOI 10.1159/000228158; Saginario C, 1995, P NATL ACAD SCI USA, V92, P12210, DOI 10.1073/pnas.92.26.12210; Saginario C, 1998, MOL CELL BIOL, V18, P6213, DOI 10.1128/MCB.18.11.6213; Santoso S, 2002, J EXP MED, V196, P679, DOI 10.1084/jem.20020267; Schober JM, 2003, J BIOL CHEM, V278, P25808, DOI 10.1074/jbc.M301534200; Schober JM, 2002, BLOOD, V99, P4457, DOI 10.1182/blood.V99.12.4457; Shen D, 2017, J BIOL CHEM, V292, P18848, DOI 10.1074/jbc.M116.773713; Shilagardi K, 2013, SCIENCE, V340, P359, DOI 10.1126/science.1234781; Simon DI, 2000, J EXP MED, V192, P193, DOI 10.1084/jem.192.2.193; Subramanian S, 2006, BLOOD, V107, P2548, DOI 10.1182/blood-2005-04-1463; Ugarova TP, 1998, J BIOL CHEM, V273, P22519, DOI 10.1074/jbc.273.35.22519; Vernon-Wilson EF, 2000, EUR J IMMUNOL, V30, P2130; Xiong JP, 2000, J BIOL CHEM, V275, P38762, DOI 10.1074/jbc.C000563200; Yakubenko VP, 2002, J BIOL CHEM, V277, P48635, DOI 10.1074/jbc.M208877200; Yakubenko VP, 2001, J BIOL CHEM, V276, P13995, DOI 10.1074/jbc.M010174200; Yalamanchili P, 2000, J BIOL CHEM, V275, P21877, DOI 10.1074/jbc.M908868199; Zhang L, 1997, J BIOL CHEM, V272, P17558, DOI 10.1074/jbc.272.28.17558	53	14	14	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2019	294	19					7833	7849		10.1074/jbc.RA118.006314	http://dx.doi.org/10.1074/jbc.RA118.006314			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IB3FL	30910815	hybrid, Green Published			2022-12-26	WOS:000470153300025
J	Yu, ZY; Chiara, DC; Savechenkov, PY; Bruzik, KS; Cohen, JB				Yu, Zhiyi; Chiara, David. C.; Savechenkov, Pavel Y.; Bruzik, Karol S.; Cohen, Jonathan B.			A photoreactive analog of allopregnanolone enables identification of steroid-binding sites in a nicotinic acetylcholine receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						nicotinic acetylcholine receptors (nAChR); GABA receptor; anesthetic; steroid; ion channel; lipid-protein interaction; ligand-gated ion channel; neurosteroid allopregnanolone; neurotransmitter receptor; perfluorophenyl azide; photolabeling	GAMMA-AMINOBUTYRIC-ACID; ION-CHANNEL; NONCOMPETITIVE ANTAGONISTS; STRUCTURAL BASIS; AMINO-ACIDS; NEUROSTEROIDS; MODULATION; ACTIVATION; CHOLESTEROL; ANESTHETICS	Many neuroactive steroids potently and allosterically modulate pentameric ligand-gated ion channels, including GABA(A) receptors (GABA(A)R) and nicotinic acetylcholine receptors (nAChRs). Allopregnanolone and its synthetic analog alphaxalone are GABA(A)R-positive allosteric modulators (PAMs), whereas alphaxalone and most neuroactive steroids are nAChR inhibitors. In this report, we used 11-(p-azidotetrafluorobenzoyloxy)allopregnanolone (F(4)N(3)Bzoxy-AP), a general anesthetic and photoreactive allopregnanolone analog that is a potent GABA(A)R PAM, to characterize steroid-binding sites in the Torpedo (2) nAChR in its native membrane environment. We found that F(4)N(3)Bzoxy-AP (IC50 = 31 m) is 7-fold more potent than alphaxalone in inhibiting binding of the channel blocker [H-3]tenocyclidine to nAChRs in the desensitized state. At 300 m, neither steroid inhibited binding of [H-3]tetracaine, a closed-state selective channel blocker, or of [H-3]acetylcholine. Photolabeling identified three distinct [H-3]F(4)N(3)Bzoxy-AP-binding sites in the nAChR transmembrane domain: 1) in the ion channel, identified by photolabeling in the M2 helices of Val-261 and Val-269 (position M2-13); 2) at the interface between the M1 and M4 helices, identified by photolabeling in M1 (Cys-222/Leu-223); and 3) at the lipid-protein interface involving Trp-453 (M4), a residue photolabeled by small lipophilic probes and promegestone, a steroid nAChR antagonist. Photolabeling in the ion channel and M1 was higher in the nAChR-desensitized state than in the resting state and inhibitable by promegestone. These results directly indicate a steroid-binding site in the nAChR ion channel and identify additional steroid-binding sites also occupied by other lipophilic nAChR antagonists.	[Yu, Zhiyi; Chiara, David. C.; Cohen, Jonathan B.] Harvard Med Sch, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA; [Savechenkov, Pavel Y.; Bruzik, Karol S.] Univ Illinois, Dept Med Chem & Pharmacognosy, Chicago, IL 60612 USA	Harvard University; Harvard Medical School; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Cohen, JB (corresponding author), Harvard Med Sch, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	jonathan_cohen@hms.harvard.edu			National Institutes of Health [GM-58448]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM058448] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM-58448. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akk G, 2007, PHARMACOL THERAPEUT, V116, P35, DOI 10.1016/j.pharmthera.2007.03.004; Arevalo E, 2005, J BIOL CHEM, V280, P13631, DOI 10.1074/jbc.M413911200; Arias HR, 2003, BIOCHEMISTRY-US, V42, P7358, DOI 10.1021/bi034052n; Arias HR, 2006, INT J BIOCHEM CELL B, V38, P1254, DOI 10.1016/j.biocel.2006.01.006; Baenziger JE, 2017, CURR TOP MEMBR, V80, P95, DOI 10.1016/bs.ctm.2017.05.002; Barrantes FJ, 2004, BRAIN RES REV, V47, P71, DOI 10.1016/j.brainresrev.2004.06.008; Belelli D, 2005, NAT REV NEUROSCI, V6, P565, DOI 10.1038/nrn1703; Blanco MJ, 2018, BIOORG MED CHEM LETT, V28, P61, DOI 10.1016/j.bmcl.2017.11.043; Blanton MP, 1998, J BIOL CHEM, V273, P8659, DOI 10.1074/jbc.273.15.8659; Blanton MP, 1999, MOL PHARMACOL, V55, P269, DOI 10.1124/mol.55.2.269; BLANTON MP, 1994, BIOCHEMISTRY-US, V33, P2859, DOI 10.1021/bi00176a016; Blanton MP, 2001, BBA-BIOMEMBRANES, V1512, P215, DOI 10.1016/S0005-2736(01)00321-2; Bouzat C, 1996, J BIOL CHEM, V271, P25835, DOI 10.1074/jbc.271.42.25835; BOYD ND, 1984, BIOCHEMISTRY-US, V23, P4023, DOI 10.1021/bi00313a003; BRAUER AW, 1984, ANAL BIOCHEM, V137, P134, DOI 10.1016/0003-2697(84)90359-2; Cheng WWL, 2018, J BIOL CHEM, V293, P3013, DOI 10.1074/jbc.RA117.000359; Chiara DC, 2009, BIOCHEMISTRY-US, V48, P10066, DOI 10.1021/bi901271w; Chiara DC, 2003, BIOCHEMISTRY-US, V42, P13457, DOI 10.1021/bi0351561; Cline MR, 2007, BIOCHEMISTRY-US, V46, P1981, DOI 10.1021/bi061269j; Cymes GD, 2005, NATURE, V438, P975, DOI 10.1038/nature04293; Forman SA, 2016, ANESTH ANALG, V123, P1263, DOI 10.1213/ANE.0000000000001368; Forman SA, 2015, NEUROPHARMACOLOGY, V96, P169, DOI 10.1016/j.neuropharm.2014.10.002; Gallagher MJ, 1999, MOL PHARMACOL, V56, P300, DOI 10.1124/mol.56.2.300; Garbus I, 2002, NEUROPHARMACOLOGY, V43, P65, DOI 10.1016/S0028-3908(02)00068-0; Garbus I, 2001, NEUROREPORT, V12, P227, DOI 10.1097/00001756-200102120-00010; Garcia G, 2007, BIOCHEMISTRY-US, V46, P10296, DOI 10.1021/bi7008163; Hamouda AK, 2014, J MOL NEUROSCI, V53, P480, DOI 10.1007/s12031-013-0150-1; Hamouda AK, 2014, MOL PHARMACOL, V85, P735, DOI 10.1124/mol.113.090985; Hamouda AK, 2013, J NEUROSCI, V33, P485, DOI 10.1523/JNEUROSCI.3483-12.2013; Hamouda AK, 2011, J BIOL CHEM, V286, P20466, DOI 10.1074/jbc.M111.219071; HARRISON NL, 1987, J PHARMACOL EXP THER, V241, P346; HAWKINSON JE, 1994, MOL PHARMACOL, V46, P977; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hosie AM, 2006, NATURE, V444, P486, DOI 10.1038/nature05324; Jayakar SS, 2013, J BIOL CHEM, V288, P6178, DOI 10.1074/jbc.M112.435909; Ke L, 1996, J NEUROCHEM, V67, P1100; KEANA JFW, 1990, J ORG CHEM, V55, P3640, DOI 10.1021/jo00298a048; Laverty D, 2017, NAT STRUCT MOL BIOL, V24, P977, DOI 10.1038/nsmb.3477; MIDDLETON RE, 1991, BIOCHEMISTRY-US, V30, P6987, DOI 10.1021/bi00242a026; Miller PS, 2017, NAT STRUCT MOL BIOL, V24, P986, DOI 10.1038/nsmb.3484; Mitra A, 2004, STRUCTURE, V12, P1909, DOI 10.1016/j.str.2004.08.004; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Mnatsakanyan N, 2013, J NEUROCHEM, V125, P843, DOI 10.1111/jnc.12260; MOORE MA, 1995, BBA-BIOMEMBRANES, V1235, P336, DOI 10.1016/0005-2736(95)80022-8; Morales-Perez CL, 2016, NATURE, V538, P411, DOI 10.1038/nature19785; Nirthanan S, 2005, BIOCHEMISTRY-US, V44, P13447, DOI 10.1021/bi051209y; Nirthanan S, 2008, J BIOL CHEM, V283, P22051, DOI 10.1074/jbc.M801332200; Olsen Richard W, 2015, Adv Pharmacol, V73, P167, DOI 10.1016/bs.apha.2014.11.005; Paradiso K, 2000, MOL PHARMACOL, V58, P341, DOI 10.1124/mol.58.2.341; Pratt MB, 2000, J BIOL CHEM, V275, P29441, DOI 10.1074/jbc.M004710200; Purohit P, 2015, J PHYSIOL-LONDON, V593, P2851, DOI 10.1113/JP270223; Purohit P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3984; Reddy DS, 2016, TRENDS PHARMACOL SCI, V37, P543, DOI 10.1016/j.tips.2016.04.003; Santiago J, 2001, J BIOL CHEM, V276, P46523, DOI 10.1074/jbc.M104563200; Savechenkov PY, 2017, EUR J MED CHEM, V136, P334, DOI 10.1016/j.ejmech.2017.04.043; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCOTT MG, 1988, BIOCHEM BIOPH RES CO, V155, P1353, DOI 10.1016/S0006-291X(88)81290-7; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Unwin N, 2017, IUCRJ, V4, P393, DOI 10.1107/S2052252517005243; WACHTEL RE, 1992, BRIT J PHARMACOL, V106, P623, DOI 10.1111/j.1476-5381.1992.tb14385.x; WHITE BH, 1988, BIOCHEMISTRY-US, V27, P8741, DOI 10.1021/bi00424a009; WHITE BH, 1992, J BIOL CHEM, V267, P15770; Yu ZY, 2017, J BIOL CHEM, V292, P17258, DOI 10.1074/jbc.M117.808592	63	1	1	3	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2019	294	19					7892	7903		10.1074/jbc.RA118.007172	http://dx.doi.org/10.1074/jbc.RA118.007172			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IB3FL	30923128	Green Published, hybrid			2022-12-26	WOS:000470153300029
J	Zhang, W; Li, WC; Zhang, JM; Wang, N				Zhang, Wei; Li, Wenchao; Zhang, Jianming; Wang, Ning			Optimal parameter identification of synthetic gene networks using harmony search algorithm	PLOS ONE			English	Article							OPTIMAL EXPERIMENTAL-DESIGN; CIRCUITS; MODELS; EXPRESSION; SELECTION	Computational modeling of engineered gene circuits is an important while challenged task in systems biology. In order to describe and predict the response behaviors of genetic circuits using reliable model parameters, this paper applies an optimal experimental design(OED) method to obtain input signals. In order to obtain informative observations, this study focuses on maximizing Fisher information matrix(FIM)-based optimal criteria and to provide optimal inputs. Furthermore, this paper designs a two-stage optimization with the modified E-optimal criteria and applies harmony search(HS)-based OED algorithm to minimize estimation errors. The proposed optimal identification methodology involves estimation errors and the sample size to pursue a trade-off between estimation accuracy and measurement cost in modeling gene networks. The designed cost function takes two major factors into account, in which experimental costs are proportional to the number of time points. Experiments select two types of synthetic genetic networks to validate the effectiveness of the proposed HS-OED approach. Identification outcomes and analysis indicate the proposed HS-OED method outperforms two candidate OED approaches, with reduced computational effort.	[Zhang, Wei; Li, Wenchao; Zhang, Jianming; Wang, Ning] Zhejiang Univ, Dept Control & Engn, Inst Cyber Syst & Control, Hangzhou, Zhejiang, Peoples R China	Zhejiang University	Zhang, JM (corresponding author), Zhejiang Univ, Dept Control & Engn, Inst Cyber Syst & Control, Hangzhou, Zhejiang, Peoples R China.	jmzhang@iipc.zju.edu.cn		Li, Wenchao/0000-0002-7956-0742	National Natural Science Foundation of China (CN) [61573311]	National Natural Science Foundation of China (CN)(National Natural Science Foundation of China (NSFC))	Author Wei Zhang is partly supported by National Natural Science Foundation of China (CN) 61573311.	Adoteye K, 2015, APPL MATH LETT, V40, P84, DOI 10.1016/j.aml.2014.09.013; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Bandara S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000558; Banga JR, 2008, ESSAYS BIOCHEM, V45, P195, DOI 10.1042/BSE0450195; Bouffier AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110234; Busetto AG, 2013, BIOINFORMATICS, V29, P2625, DOI 10.1093/bioinformatics/btt436; Carbonell-Ballestero M, 2016, NUCLEIC ACIDS RES, V44, P496, DOI 10.1093/nar/gkv1280; Dehghannasiri R, 2015, IEEE ACM T COMPUT BI, V12, P938, DOI 10.1109/TCBB.2014.2377733; Faller D, 2003, SIMUL-T SOC MOD SIM, V79, P717, DOI 10.1177/0037549703040937; Firman T, 2017, BIOPHYS J, V113, P2121, DOI 10.1016/j.bpj.2017.08.057; FUTCHER AB, 1984, J BACTERIOL, V157, P283, DOI 10.1128/JB.157.1.283-290.1984; Geem ZW, 2001, SIMULATION, V76, P60, DOI 10.1177/003754970107600201; Huang B, 2018, BMC SYST BIOL, V12, DOI 10.1186/s12918-018-0594-6; Huynh L, 2014, ACS SYNTH BIOL, V3, P556, DOI 10.1021/sb400139h; Le Novere N, 2015, NAT REV GENET, V16, P146, DOI 10.1038/nrg3885; Liao C, 2017, NAT MICROBIOL, V2, P1658, DOI 10.1038/s41564-017-0022-5; Lin CD, 2015, QUAL RELIAB ENG INT, V31, P155, DOI 10.1002/qre.1591; Liu Z, 2015, STRUCT MULTIDISCIP O, V52, P813, DOI 10.1007/s00158-015-1271-7; Llamosi A, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004706; Mangan N. M., 2016, IEEE T MOL BIO MULT, V2, P52, DOI [10.1109/TMBMC.2016.2633265, DOI 10.1109/TMBMC.2016.2633265]; Melykuti B, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-38; Meyer P, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-13; Mishra D, 2014, NAT BIOTECHNOL, V32, P1268, DOI 10.1038/nbt.3044; Mohammadi P, 2017, CELL SYST, V4, P207, DOI 10.1016/j.cels.2017.01.003; Nimmegeers P, 2016, BMC SYST BIOL, V10, DOI 10.1186/s12918-016-0328-6; O'Brien EL, 2012, MATH BIOSCI, V236, P1, DOI 10.1016/j.mbs.2012.01.001; Pirgazi J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200094; Raue A, 2009, BIOINFORMATICS, V25, P1923, DOI 10.1093/bioinformatics/btp358; Segall-Shapiro TH, 2018, NAT BIOTECHNOL, V36, P352, DOI 10.1038/nbt.4111; Srinivas N, 2017, SCIENCE, V358, DOI 10.1126/science.aal2052; Steinke F, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-51; Stigter Johannes D, 2012, BMC Res Notes, V5, P518, DOI 10.1186/1756-0500-5-518; Ud-Dean SMM, 2016, BIOINFORMATICS, V32, P875, DOI 10.1093/bioinformatics/btv672; Vanlier J, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-20; WALTER E, 1990, AUTOMATICA, V26, P195, DOI 10.1016/0005-1098(90)90116-Y; Wilson AD, 2014, P AMER CONTR CONF, P443, DOI 10.1109/ACC.2014.6858649; Xie MQ, 2018, NAT REV MOL CELL BIO, V19, P507, DOI 10.1038/s41580-018-0024-z; Yamazaki K, 2017, SYN BIOL, V2, DOI 10.1093/synbio/ysx003; Zhu F, 2015, BIOINFORMATICS, V31, P2537, DOI 10.1093/bioinformatics/btv186	40	1	1	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2019	14	3							e0213977	10.1371/journal.pone.0213977	http://dx.doi.org/10.1371/journal.pone.0213977			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ9FO	30925150	Green Published, gold, Green Submitted			2022-12-26	WOS:000462732300008
J	Ma, LY; Hu, K; Li, PD; Liu, JQ; Yuan, XQ				Ma, Luyao; Hu, Kai; Li, Pengde; Liu, Jiaqi; Yuan, Xiangqun			Ultrastructure of the proboscis sensilla of ten species of butterflies (Insecta: Lepidoptera)	PLOS ONE			English	Article							FRUIT-FEEDING BUTTERFLIES; ANTENNAL SENSILLA; COMPARATIVE MORPHOLOGY; SPRUCE BUDWORM; PAPILIONOIDEA; NYMPHALIDAE; OVIPOSITION; PREFERENCES; FLIES; MOTH	The ultrastructure of the sensilla on the proboscis of ten species of butterflies, Iphiclides podalirius, Parara guttata, Colias fieldii, Celastrina oreas, Sasakia charonda, Tirumala lim-niece, Acraea issoria, Stichophthalma neumogeni, Callerebia suroia, and Libythea celtis, among five families were investigated using scanning electron microscopy. They were compared to reveal the morphological differences in the proboscis sensilla among these butterflies. Four distinct types of sensilla were found on the proboscis among these species. The types of proboscis sensilla of I. podalirius and T. limniace were sensilla chaetica, sensilla coeloconica, and sensilla basiconica. The types in the other eight species were sensilla chaetica, sensilla styloconica, and sensilla basiconica. The number of sensilla styloconica on the proboscis of non-flower-visiting species was greater than that of flower-visiting species.	[Ma, Luyao; Hu, Kai; Li, Pengde; Liu, Jiaqi; Yuan, Xiangqun] Northwest A&F Univ, Coll Plant Protect, Key Lab Plant Protect Resources & Pest Management, Minist Educ, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China	Yuan, XQ (corresponding author), Northwest A&F Univ, Coll Plant Protect, Key Lab Plant Protect Resources & Pest Management, Minist Educ, Yangling, Shaanxi, Peoples R China.	Yuanxq@nwsuaf.edu.cn			National Key R & D Program of China [2017YFD0200900, 2017YFD0201800]; National Natural Science Foundation of China [31772503, 31272345, 31871971]	National Key R & D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Key R & D Program of China (2017YFD0200900, 2017YFD0201800) and the National Natural Science Foundation of China (No. 31772503, No. 31272345 and No. 31871971). Xiangqun Yuan received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER P H, 1982, Journal of the Lepidopterists' Society, V36, P161; ALTNER H, 1983, FORTS ZOOL, V28, P17; ALTNER H, 1986, ZOOL ANZ, V216, P129; ALTNER H, 1985, ANNU REV ENTOMOL, V30, P273, DOI 10.1146/annurev.en.30.010185.001421; Bauder J A-S, 2014, J Res Lepid, V47, P65; Bauder JAS, 2011, ARTHROPOD STRUCT DEV, V40, P122, DOI 10.1016/j.asd.2010.11.002; Bauder JAS, 2013, BIOL J LINN SOC, V110, P291, DOI 10.1111/bij.12134; Baur R, 1998, PHYSIOL ENTOMOL, V23, P7, DOI 10.1046/j.1365-3032.1998.2310007.x; Blaney WM, 2011, ENTOMOLOGIA EXPT APP, V49, P111; Castro-Gerardino DJ, 2019, ZOOTAXA, V4559, P445, DOI 10.11646/zootaxa.4559.3.2; Corbet SA, 2010, ENTOMOLOGIA EXPT APP, V96, P289; Espeland M, 2018, CURR BIOL, V28, P770, DOI 10.1016/j.cub.2018.01.061; Faucheux MJ, 2017, ZOOL ANZ, V266, P105, DOI 10.1016/j.jcz.2016.11.002; Faucheux MJ, 2013, ANN SOC ENTOMOL FR, V49, P73, DOI 10.1080/00379271.2013.767514; GILBERT LE, 1972, P NATL ACAD SCI USA, V69, P1403, DOI 10.1073/pnas.69.6.1403; Guo MB, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00970; HALLBERG E, 1994, TISSUE CELL, V26, P489, DOI 10.1016/0040-8166(94)90002-7; HARTENSTEIN V, 1989, DEVELOPMENT, V107, P389; Hu Xiao-Wen, 2010, Acta Zootaxonomica Sinica, V35, P790; Inoue T, 2009, NATURWISSENSCHAFTEN, V96, P355, DOI 10.1007/s00114-008-0483-8; Karolyi F, 2012, BIOL J LINN SOC, V107, P414, DOI 10.1111/j.1095-8312.2012.01945.x; Krenn HW, 2010, ANNU REV ENTOMOL, V55, P307, DOI 10.1146/annurev-ento-112408-085338; Krenn HW, 1998, ZOOMORPHOLOGY, V118, P23, DOI 10.1007/s004350050053; Krenn HW, 2002, ZOOL ANZ, V241, P369, DOI 10.1078/0044-5231-00078; Krenn HW, 2001, J ZOOL, V254, P17, DOI 10.1017/S0952836901000528; Kunte K, 2007, FUNCT ECOL, V21, P982, DOI 10.1111/j.1365-2435.2007.01299.x; Kvello P, 2006, ARTHROPOD STRUCT DEV, V35, P35, DOI 10.1016/j.asd.2005.10.003; Lehnert MS, 2016, J MORPHOL, V277, P167, DOI 10.1002/jmor.20487; Li YP, 2018, PLOS ONE, V13; Liu HX, 2014, ANN SOC ENTOMOL FR, V50, P350, DOI 10.1080/00379271.2014.981405; Molleman F, 2005, BIOTROPICA, V37, P657, DOI 10.1111/j.1744-7429.2005.00083.x; Molleman F, 2005, BIOL J LINN SOC, V86, P333, DOI 10.1111/j.1095-8312.2005.00533.x; Monaenkova D, 2012, J R SOC INTERFACE, V9, P720, DOI 10.1098/rsif.2011.0392; Nagnan-Le Meillour P, 2000, CHEM SENSES, V25, P541, DOI 10.1093/chemse/25.5.541; Omura H, 2009, CHEMOECOLOGY, V19, P227, DOI 10.1007/s00049-009-0024-8; Paulus HF, 1996, J ZOOL SYST EVOL RES, V34, P203; Pauw A, 2009, EVOLUTION, V63, P268, DOI 10.1111/j.1558-5646.2008.00547.x; Petr D, 2004, T AM ENTOMOL SOC, V130, P293; Pophof B, 1997, PHYSIOL ENTOMOL, V22, P239, DOI 10.1111/j.1365-3032.1997.tb01164.x; SCHNEIDER D, 1964, ANNU REV ENTOMOL, V9, P103, DOI 10.1146/annurev.en.09.010164.000535; SMEDLEY SR, 1995, SCIENCE, V270, P1816, DOI 10.1126/science.270.5243.1816; STADLER E, 1975, ENTOMOL EXP APPL, V18, P153, DOI 10.1007/BF00299983; STADLER E, 1995, PHYSIOL ENTOMOL, V20, P175, DOI 10.1111/j.1365-3032.1995.tb00814.x; Stefanescu C, 2009, OIKOS, V118, P1109, DOI 10.1111/j.1600-0706.2009.17274.x; Walters BD, 1998, CAN J ZOOL, V76, P466, DOI 10.1139/cjz-76-3-466; Wang Na, 2012, Acta Entomologica Sinica, V55, P877; Wang R, 2015, NEOTROP ENTOMOL, V44, P68, DOI 10.1007/s13744-014-0258-1; Xu ML, 2017, CAN J ZOOL, V95; Xue S, 2016, ZOOL ANZ, V263, P75, DOI 10.1016/j.jcz.2016.05.002; Xue S, 2014, J ASIA-PAC ENTOMOL, V17, P295, DOI 10.1016/j.aspen.2014.01.014; Yang ZX, 2009, ZOOTAXA, P48, DOI 10.11646/zootaxa.2204.1.4; Yuan XQ, 2014, ZOOKEYS, P17, DOI 10.3897/zookeys.399.7063; Yuvaraj JK, 2018, MICRON, V111, P9, DOI 10.1016/j.micron.2018.05.006; Zaspel JM, 2013, ZOOL ANZ, V253, P6, DOI 10.1016/j.jcz.2013.06.001	54	6	11	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214658	10.1371/journal.pone.0214658	http://dx.doi.org/10.1371/journal.pone.0214658			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921417	Green Published, gold, Green Submitted			2022-12-26	WOS:000462594000103
J	Rupji, M; Dwivedi, B; Kowalski, J				Rupji, Manali; Dwivedi, Bhakti; Kowalski, Jeanne			NOJAH: NOt Just Another Heatmap for genome-wide cluster analysis	PLOS ONE			English	Article							CLASS DISCOVERY; EXPRESSION; CLASSIFICATION; SIGNATURES; TOOL	Since their inception, several tools have been developed for cluster analysis and heatmap construction. The application of such tools to the number and types of genome-wide data available from next generation sequencing (NGS) technologies requires the adaptation of statistical concepts, such as in defining a most variable gene set, and more intricate cluster analyses method to address multiple omic data types. Additionally, the growing number of publicly available datasets has created the desire to estimate the statistical significance of a gene signature derived from one dataset to similarly group samples based on another dataset. The currently available number of tools and their combined use for generating heat-maps, along with the several adaptations of statistical concepts for addressing the higher dimensionality of genome-wide NGS-derived data, has created a further challenge in the ability to replicate heatmap results. We introduce NOJAH (NOt Just Another Heatmap), an interactive tool that defines and implements a workflow for genome-wide cluster analysis and heatmap construction by creating and combining several tools into a single user interface. NOJAH includes several newly developed scripts for techniques that though frequently applied are not sufficiently documented to allow for replicability of results. These techniques include: defining a most variable gene set (a.k.a., 'core genes'), estimating the statistical significance of a gene signature to separate samples into clusters, and performing a result merging integrated cluster analysis. With only a user uploaded dataset, NOJAH provides as output, among other things, the minimum documentation required for replicating heatmap results. Additionally, NOJAH contains five different existing R packages that are connected in the interface by their functionality as part of a defined workflow for genome-wide cluster analysis. The NOJAH application tool is available at http://bbisr.shinyapps.winship.emory.edu/NOJAH/ http://shinygispa.winship.emory.edu/shinyGISPA/ with corresponding source code available at https://github.com/bbisr-shinyapps/NOJAH/.	[Rupji, Manali; Dwivedi, Bhakti; Kowalski, Jeanne] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA; [Kowalski, Jeanne] Rollins Sch Publ Hlth, Dept Biostat & Bioinformat, Atlanta, GA 30322 USA; [Kowalski, Jeanne] Dell Med Sch, Dept Oncol, Austin, TX 78701 USA	Emory University; Emory University; Rollins School Public Health	Kowalski, J (corresponding author), Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA.; Kowalski, J (corresponding author), Rollins Sch Publ Hlth, Dept Biostat & Bioinformat, Atlanta, GA 30322 USA.; Kowalski, J (corresponding author), Dell Med Sch, Dept Oncol, Austin, TX 78701 USA.	jeanne.kowalski@emory.edu	Rupji, Manali/K-1977-2019	Rupji, Manali/0000-0002-0520-1624; Kowalski, Jeanne/0000-0003-3458-3024	Winship Glenn Family Breast Cancer award; Biostatistics and Bioinformatics Shared resource of Winship Cancer Institute of Emory University; National Institutes of Health /National Cancer Institute [P30CA138292]; NATIONAL CANCER INSTITUTE [P30CA138292] Funding Source: NIH RePORTER	Winship Glenn Family Breast Cancer award; Biostatistics and Bioinformatics Shared resource of Winship Cancer Institute of Emory University; National Institutes of Health /National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Research reported in this publication was supported in part by a Winship Glenn Family Breast Cancer award (Kowalski) and the Biostatistics and Bioinformatics Shared resource of Winship Cancer Institute of Emory University and National Institutes of Health /National Cancer Institute under award number P30CA138292.	Afgan E, 2016, NUCLEIC ACIDS RES, V44, pW3, DOI 10.1093/nar/gkw343; Akbani R, 2015, CELL, V161, P1681, DOI 10.1016/j.cell.2015.05.044; Brat DJ, 2015, NEW ENGL J MED, V372, P2481, DOI 10.1056/NEJMoa1402121; Chang W., 2017, SHINY WEB APPL FRAME; Chermak E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166460; Chibon F, 2013, EUR J CANCER, V49, P2000, DOI 10.1016/j.ejca.2013.02.021; Colaprico A, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1507; Galili T, 2015, BIOINFORMATICS, V31, P3718, DOI 10.1093/bioinformatics/btv428; Gendoo DMA, 2016, BIOINFORMATICS, V32, P1097, DOI 10.1093/bioinformatics/btv693; Grossman RL, 2016, NEW ENGL J MED, V375, P1109, DOI 10.1056/NEJMp1607591; Hoadley KA, 2014, CELL, V158, P929, DOI 10.1016/j.cell.2014.06.049; Joshi VK, 2011, SOURCE CODE BIOL MED, V6, DOI 10.1186/1751-0473-6-3; Khomtchouk BB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176334; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Metsalu T, 2015, NUCLEIC ACIDS RES, V43, pW566, DOI 10.1093/nar/gkv468; Monti S, 2003, MACH LEARN, V52, P91, DOI 10.1023/A:1023949509487; Rupji Manali, 2017, F1000Res, V6, P919, DOI 10.12688/f1000research.11830.1; Wang C, 2017, CLIN CANCER RES, V23, P4077, DOI 10.1158/1078-0432.CCR-17-0246; Wilkerson MD, 2010, BIOINFORMATICS, V26, P1572, DOI 10.1093/bioinformatics/btq170	19	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0204542	10.1371/journal.pone.0204542	http://dx.doi.org/10.1371/journal.pone.0204542			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921318	Green Published, gold, Green Submitted			2022-12-26	WOS:000462594000002
J	Yoshida, Y; Matsubara, H; Fang, X; Hayashi, K; Nomura, I; Ugaji, S; Hamada, T; Tsuchiya, H				Yoshida, Yasuhisa; Matsubara, Hidenori; Fang, Xiang; Hayashi, Katsuhiro; Nomura, Issei; Ugaji, Shuhei; Hamada, Tomo; Tsuchiya, Hiroyuki			Adipose-derived stem cell sheets accelerate bone healing in rat femoral defects	PLOS ONE			English	Article							SUPERIOR OSTEOGENIC CAPACITY; MARROW STROMAL CELLS; IN-VITRO; TISSUE; DIFFERENTIATION; REGENERATION; PHENOTYPE; PHOSPHATE; CARTILAGE	In the present study, we investigated whether both adipose-derived stem cell (ADSC) and osteogenic-induced ADSC sheets could promote bone healing in a rat distal femoral metaphysis bone defect model. A through-hole defect of 1 mm diameter was drilled into each distal femur of 12 week old rats. Forty-five rats were randomly assigned to three groups: (1) control group; (2) ADSC sheet group; or (3) osteogenic-induced ADSC sheet group. We evaluated each group by analysis of computerized tomography scans every week after the surgery, histological analysis, and Dil labeling (a method of membrane staining for post implant cell tracing). Radiological and histological evaluations showed that a part of the hole persisted in the control group at four weeks after surgery, whereas the hole was restored almost completely by new bone formation in both sheet groups. The mean value of bone density (in Houndsfield units) for the bone defect area was significantly higher in both sheet groups than that in the control group (p = 0.05) at four weeks postoperative. A large number of osteocalcin positive osteoblasts were observed at the area of bone defect, especially in the osteogenic-induced ADCS sheet group. Dil labeling in the newly formed bone showed that each sheet had differentiated into bone tissue at four weeks after surgery. The ADSC and the osteogenic-induced ADSC sheets promoted significantly quicker bone healing in the bone defect. Moreover, the osteogenic-induced ADSC sheet may be more advantageous for bone healing than the ADSC sheet because of the higher number of osteocalcin positive osteoblasts via the transplantation.	[Yoshida, Yasuhisa; Matsubara, Hidenori; Fang, Xiang; Hayashi, Katsuhiro; Nomura, Issei; Ugaji, Shuhei; Hamada, Tomo; Tsuchiya, Hiroyuki] Kanazawa Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Kanazawa, Ishikawa, Japan	Kanazawa University	Matsubara, H (corresponding author), Kanazawa Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Kanazawa, Ishikawa, Japan.	ortho331@yahoo.co.jp	Hayashi, K/C-4685-2015	Hayashi, K/0000-0001-8665-2154; Yoshida, Yasuhisa/0000-0002-4472-7127	Japan Society for the Promotion of Science;  [2689309]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); 	This study was supported by a Grant-in-Aid for Young Scientists to Y.Y. Grant number: 2689309; KAKENHI, Grants-in-Aid for Scientific Research, Japan Society for the Promotion of Science, https://www.jsps.go.jp/j-grantsinaid/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando W, 2007, BIOMATERIALS, V28, P5462, DOI 10.1016/j.biomaterials.2007.08.030; ASHTON BA, 1980, CLIN ORTHOP RELAT R, P294; Banas A, 2009, J GASTROEN HEPATOL, V24, P70, DOI 10.1111/j.1440-1746.2008.05496.x; Barba M, 2017, EXPERT OPIN BIOL TH, V17, P677, DOI 10.1080/14712598.2017.1315403; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Dawson JI, 2014, STEM CELLS, V32, P35, DOI 10.1002/stem.1559; de Girolamo L, 2011, J ORTHOP RES, V29, P100, DOI 10.1002/jor.21184; De Long WG, 2007, J BONE JOINT SURG AM, V89A, P649, DOI 10.2106/JBJS.F.00465; Dixit M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144541; Doorn J, 2011, BIOMATERIALS, V32, P6089, DOI 10.1016/j.biomaterials.2011.05.010; Fang X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088874; Feng W, 2015, MAT SCI ENG C-MATER, V54, P133, DOI 10.1016/j.msec.2015.05.037; Lambert APF, 2009, DIFFERENTIATION, V77, P221, DOI 10.1016/j.diff.2008.10.016; Frasca S, 2017, J MATER SCI-MATER M, V28, DOI 10.1007/s10856-016-5839-6; Gimble JM, 2007, CIRC RES, V100, P1249, DOI 10.1161/01.RES.0000265074.83288.09; GREEN H, 1974, CELL, V3, P127, DOI 10.1016/0092-8674(74)90116-0; Harada N, 2014, BIOMATERIALS, V35, P7800, DOI 10.1016/j.biomaterials.2014.05.052; Higuchi T, 2018, ANTICANCER RES, V38, P3031, DOI 10.21873/anticanres.12558; Houdek MT, 2017, BONE JOINT J, V99B, P134, DOI 10.1302/0301-620X.99B1.BJJ-2016-0160.R1; Katsuno T, 2013, CELL TRANSPLANT, V22, P287, DOI 10.3727/096368912X655019; Kikuchi M, 2001, BIOMATERIALS, V22, P1705, DOI 10.1016/S0142-9612(00)00305-7; Kim DH, 2009, SPINE J, V9, P886, DOI 10.1016/j.spinee.2009.05.006; Kim D, 2010, CELL TISSUE RES, V341, P359, DOI 10.1007/s00441-010-1015-3; Kingham PJ, 2007, EXP NEUROL, V207, P267, DOI 10.1016/j.expneurol.2007.06.029; Kundu AK, 2006, BIOCHEM BIOPH RES CO, V347, P347, DOI 10.1016/j.bbrc.2006.06.110; LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529; Lee JH, 2014, BIOMED MATER, V9, DOI 10.1088/1748-6041/9/5/055002; Liu S, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060982; Matthews Brya G, 2014, Bonekey Rep, V3, P560, DOI 10.1038/bonekey.2014.55; Myeroff C, 2011, J BONE JOINT SURG AM, V93A, P2227, DOI 10.2106/JBJS.J.01513; Nakanishi C, 2011, CIRC J, V75, P2260, DOI 10.1253/circj.CJ-11-0246; Ning L, 2015, J ORAL IMPLANTOL, V41, P45, DOI 10.1563/AAID-JOI-D-12-00298; Nomura I, 2014, CLIN ORTHOP RELAT R, V472, P3798, DOI 10.1007/s11999-014-3608-8; Omata K, 2014, J TISSUE ENG REGEN M, V8, P604, DOI 10.1002/term.1553; Paino F, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2016.308; Pereira AC, 2007, ARQ BRAS CARDIOL, V88, P104, DOI 10.1590/S0066-782X2007000100017; Qomi RT, 2017, WORLD J STEM CELLS, V9, P107, DOI 10.4252/wjsc.v9.i8.107; Spina A, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00354; Stellavato A, 2017, CELL PHYSIOL BIOCHEM, V44, P1078, DOI 10.1159/000485414; Suganuma S, 2013, J ORTHOP SCI, V18, P145, DOI 10.1007/s00776-012-0306-9; Terai S, 2003, J BIOCHEM, V134, P551, DOI 10.1093/jb/mvg173; Tsuchiya H, 2002, J BONE JOINT SURG BR, V84B, P1162, DOI 10.1302/0301-620X.84B8.13330; Uchihara Y, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/629168; Ueha T, 2015, WORLD J STEM CELLS, V7, P873, DOI 10.4252/wjsc.v7.i5.873; Ueyama T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065685; Wang YH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195337; Wang ZL, 2018, CURR MED SCI, V38, P277, DOI 10.1007/s11596-018-1876-3; Wei FL, 2012, J CELL PHYSIOL, V227, P3216, DOI 10.1002/jcp.24012; Wen Y, 2013, OR SURG OR MED OR PA, V116, pE324, DOI 10.1016/j.oooo.2012.02.024; Yamada T, 2013, BONE, V57, P343, DOI 10.1016/j.bone.2013.08.028; Yu JS, 2014, BIOMATERIALS, V35, P3516, DOI 10.1016/j.biomaterials.2014.01.015; Zhang DW, 2018, BIOACT MATER, V3, P129, DOI 10.1016/j.bioactmat.2017.08.004; Zhang ZY, 2009, STEM CELLS, V27, P126, DOI 10.1634/stemcells.2008-0456; Zhu YX, 2008, CELL BIOCHEM FUNCT, V26, P664, DOI 10.1002/cbf.1488; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	55	21	22	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214488	10.1371/journal.pone.0214488	http://dx.doi.org/10.1371/journal.pone.0214488			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921414	Green Submitted, gold, Green Published			2022-12-26	WOS:000462594000077
J	Zhang, CY; Xia, L; Rainey, JJ; Li, Y; Chen, C; Rao, ZY; Duan, JC; Sun, HY; Cao, J; Liu, P; Cheng, J; Zhang, H; Wu, JL; Wang, LX				Zhang, Canyou; Xia, Lan; Rainey, Jeanette J.; Li, Yuan; Chen, Chuang; Rao, Zhengyuan; Duan, Jinchao; Sun, Hongying; Cao, Jie; Liu, Ping; Cheng, Jun; Zhang, Hui; Wu, Jianlin; Wang, Lixia			Findings from a pilot project to assess the feasibility of active tuberculosis case finding among seniors in rural Sichuan Province, China, 2017	PLOS ONE			English	Article							NATIONAL-SURVEY; PREVALENCE; HOUSEHOLD	Background China has a substantial tuberculosis (TB) disease burden and an aging population. Seniors have a higher risk of developing TB disease compared to younger age groups. Active case finding (ACF) could help identify seniors with TB disease. Methods From March to June 2017, we included ACF during annual physical check-ups for persons aged >= 65 years in Bayi, Sichuan Province. Seniors with clinical TB symptoms (i.e., cough lasting >= 2 weeks and/or hemoptysis) or one or more risk factors (e.g., previous TB disease, diabetes, and heavy alcohol consumption) were offered chest x-rays. We used acid-Fast Bacilli smear and solid culture laboratory testing for TB confirmation. We calculated the yield (i.e., cases identified among seniors screened) and cost per new each TB case detected. Focus group-interviews were conducted with health care workers and seniors to evaluate project acceptability. Participation rates and acceptability were used to assess feasibility. Results Of the 2,393 seniors residing in Bayi, 2,049 (85.6%) were enrolled in the pilot project. Of these seniors, 794 (38.7%) presented with at least one TB risk factor and 74 (3.6%) had symptoms consistent with active TB disease. Three seniors (0.2%)-each presenting with at least one risk factor-were diagnosed with active TB. The project yielded 146 TB cases per 100,000 seniors screened; the cost per case detected was $4,897. Most workers supported ACF if additional resources and staff could be provided. Seniors appreciated the convenience of this integrated health service approach. Conclusions Although the yield was lower than expected, ACF appeared feasible in Bayi. Targeting seniors with at least one known TB risk factor could help detect previously unidentified TB cases. However, similar projects in communities with a higher TB prevalence are needed to further evaluate the yield and required resources prior to implementation on a larger scale. Findings from our pilot project should be combined with data from these future ACF projects to improve TB screening criteria.	[Zhang, Canyou; Cheng, Jun; Zhang, Hui; Wang, Lixia] Chinese Ctr Dis Control & Prevent, Natl Ctr TB Control & Prevent, Beijing, Peoples R China; [Xia, Lan; Chen, Chuang; Rao, Zhengyuan; Wu, Jianlin] Sichuan Ctr Dis Control & Prevent, Chengdu, Sichuan, Peoples R China; [Rainey, Jeanette J.; Li, Yuan] US Ctr Dis Control & Prevent, Div Global Hlth Protect, Beijing, Peoples R China; [Duan, Jinchao; Sun, Hongying] Mianyang Ctr Dis Control & Prevent, Mianyang, Sichuan, Peoples R China; [Cao, Jie; Liu, Ping] Jiangyou Ctr Dis Control & Prevent, Mianyang, Sichuan, Peoples R China	Chinese Center for Disease Control & Prevention	Cheng, J; Zhang, H (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Ctr TB Control & Prevent, Beijing, Peoples R China.; Wu, JL (corresponding author), Sichuan Ctr Dis Control & Prevent, Chengdu, Sichuan, Peoples R China.	chengjun@chinacdc.cn; zhanghui@chinacdc.cn; scwjl888@163.com		Zhang, Canyou/0000-0003-1819-5347	China-U.S. Collaborative Program on Tuberculosis Control and Prevention [5U2GGH000018]	China-U.S. Collaborative Program on Tuberculosis Control and Prevention	The study was funded through the China-U.S. Collaborative Program on Tuberculosis Control and Prevention, covered by U.S.-China Emerging Infectious Diseases Cooperative Agreement 5U2GGH000018. LXW, HZ, and JC are recipients of the fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adane K, 2019, LANCET GLOB HEALTH, V7, pE482, DOI 10.1016/S2214-109X(18)30477-7; Diel R, 2016, EUR RESPIR J, V47, P575, DOI 10.1183/13993003.01333-2015; Donald PR, 2010, LANCET, V375, P1852, DOI 10.1016/S0140-6736(10)60580-6; Dye C, 2010, SCIENCE, V328, P856, DOI 10.1126/science.1185449; Fox GJ, 2018, NEW ENGL J MED, V378, P221, DOI 10.1056/NEJMoa1700209; Golub JE, 2005, INT J TUBERC LUNG D, V9, P1183; Huynh GH, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0341-4; Jiangyou Bureau of Statistics, 2017, JIANG STAT YB 2016; Krueger RA, 2009, FOCUS GROUPS PRACTIC; Lonnroth K, 2013, INT J TUBERC LUNG D, V17, P289, DOI 10.5588/ijtld.12.0797; Lonnroth K, 2010, LANCET, V375, P1814, DOI 10.1016/S0140-6736(10)60483-7; National Bureau of Standards (U.S.A), 1957, HDB H, V28, P5; National Bureau of Statistics of the People's Republic of China, 2017, CHIN STAT YB 2017; National Center for Tuberculosis Control and Prevention China CDC, 2018, NAT TUB SURV D UNPUB; Nguyen BH, 2010, B WORLD HEALTH ORGAN, V88, P273, DOI 10.2471/BLT.09.067801; Owiti P, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-018-6334-4; Pande T, 2015, EUR RESPIR J, V46, P1816, DOI 10.1183/13993003.01064-2015; Pratt RH, 2011, J AM GERIATR SOC, V59, P851, DOI 10.1111/j.1532-5415.2011.03369.x; Rajagopalan S, 2016, CLIN GERIATR MED, V32, P479, DOI 10.1016/j.cger.2016.02.006; Sekandi JN, 2014, INT J TUBERC LUNG D, V18, P13, DOI 10.5588/ijtld.13.0129; Technical Guidance Group of the Fifth National TB Epidemiological Survey, 2012, CHINESE J ANTITUBERC, V34, P485; Wang LX, 2014, LANCET, V383, P2057, DOI 10.1016/S0140-6736(13)62639-2; WHO, 2021, B WORLD HEALTH ORGAN, DOI DOI 10.2471/BLT.21.286807; Xiao D, 2009, GUIDELINES IMPLEMENT; Yadav RP, 2014, AM J TROP MED HYG, V90, P866, DOI 10.4269/ajtmh.13-0419; Zenner D, 2013, INT J TUBERC LUNG D, V17, P573, DOI 10.5588/ijtld.12.0920; Zhang CY, 2019, INFECT DIS POVERTY, V8, DOI 10.1186/s40249-019-0515-y; Zhang CY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176581; Zhang H, 2017, HDB GLOBAL TUBERCULO, P471, DOI [10.1007/978-1-4939-6667-7_29, DOI 10.1007/978-1-4939-6667-7_29]	29	0	2	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214761	10.1371/journal.pone.0214761	http://dx.doi.org/10.1371/journal.pone.0214761			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921451	Green Submitted, gold, Green Published			2022-12-26	WOS:000462594000111
J	Polanco, C; de Miera, LES; Gonzalez, AI; Garcia, P; Fratini, R; Vaquero, F; Vences, FJ; de la Vega, MP				Polanco, Carlos; Enrique Saenz de Miera, Luis; Isabel Gonzalez, Ana; Garcia, Pedro; Fratini, Richard; Vaquero, Francisca; Javier Vences, Francisco; Perez de la Vega, Marcelino			Construction of a high-density interspecific (Lens culinaris x L. odemensis) genetic map based on functional markers for mapping morphological and agronomical traits, and QTLs affecting resistance to Ascochyta in lentil	PLOS ONE			English	Article							WILD RELATIVES; WIDE CROSSES; LINKAGE MAP; IDENTIFICATION; HYBRIDIZATION; DIVERSITY; BLIGHT; WHEAT; LOCI; INTROGRESSION	Usage of high-throughput sequencing approaches allow for the generation and characterization of reference transcriptome datasets that support gene-based marker discovery, which in turn can be used to build genetic maps among other purposes. We have obtained a transcriptome assembly including 49,453 genes for the lentil (Lens culinaris Medik.) cultivar Alpo using RNAseq methodology. This transcriptome was used as reference to obtain 6,306 quality polymorphic markers (SNPs and short indels) analyzing genotype data from a RIL population at F-7 generation derived from the interspecific cross between L. culinaris cv. Alpo and L. odemensis accession ILWL235. L. odemensis is a wild species included in the secondary gene pool and can be used as a source for gene introgression in lentil breeding programs. Marker data were used to construct the first genetic interspecific map between these two species. This linkage map has been used to precisely identify regions of the CDC-Redberry lentil draft genome in which the candidate genes for some qualitative traits (seed coat spotting pattern, flower color, and stem pigmentation) could be located. The genome regions corresponding to a significant single quantitative trait locus (QTL) controlling "time to flowering" located in chromosome 6 and three QTLs regulating seed size and positioned in chromosomes 1 and 5 (two QTLs) were also identified. Significant QTLs for Ascochyta blight resistance in lentil were mapped to chromosome 6 in the genome region or close to it where QTLs for Ascochyta blight resistance have previously been reported.	[Polanco, Carlos; Enrique Saenz de Miera, Luis; Isabel Gonzalez, Ana; Garcia, Pedro; Fratini, Richard; Vaquero, Francisca; Javier Vences, Francisco; Perez de la Vega, Marcelino] Univ Leon, Dept Biol Mol, Area Genet, Leon, Spain	Universidad de Leon	Polanco, C (corresponding author), Univ Leon, Dept Biol Mol, Area Genet, Leon, Spain.	carlos.polanco@unileon.es	Sáenz de Miera, Luis/ABA-4573-2021; de Miera, Luis E Sáenz/D-6864-2018; De La Vega, Marcelino Perez/B-7988-2008; Polanco, Carlos/K-7793-2017; Garcia Garcia, Pedro/D-7281-2018	Sáenz de Miera, Luis/0000-0003-1871-7379; de Miera, Luis E Sáenz/0000-0003-1871-7379; De La Vega, Marcelino Perez/0000-0002-1744-7437; Polanco, Carlos/0000-0003-1175-306X; Garcia Garcia, Pedro/0000-0002-3800-7326	Consejeria de Educacion, Junta de Castilla y Leon, Spain [LE005G18]; Spanish Ministerio de Economia y Competitividad - (FEDER funds) [AGL2013-44714-R]	Consejeria de Educacion, Junta de Castilla y Leon, Spain(Junta de Castilla y Leon); Spanish Ministerio de Economia y Competitividad - (FEDER funds)	This project was financed by the Consejeria de Educacion, Junta de Castilla y Leon, Spain (grant LE005G18) and the Spanish Ministerio de Economia y Competitividad (grant AGL2013-44714-R, co-financed with FEDER funds).	Abberton MT, 2007, PLANT BREEDING, V126, P337, DOI 10.1111/j.1439-0523.2007.01374.x; Alhakami H, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1213-3; Andrews S., 2010, FASTQC QUALITY CONTR; Ates D, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.e0149210, DOI 10.1371/JOURNAL.PONE.E0149210]; Ates D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191375; Balyan HS, 2002, CARYOLOGIA, V55, P121, DOI 10.1080/00087114.2002.10589267; Bett K, 2016, PLANT AN GEN 25 C SA; Bhadauria V, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03463-9; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brar DS, 1997, PLANT MOL BIOL, V35, P35, DOI 10.1023/A:1005825519998; Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; Dadu RHR, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01038; de la Puente R, 2013, SPAN J AGRIC RES, V11, P132, DOI 10.5424/sjar/2013111-3283; Dempewolf H, 2017, CROP SCI, V57, P1070, DOI 10.2135/cropsci2016.10.0885; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Duran Y, 2004, THEOR APPL GENET, V108, P1265, DOI 10.1007/s00122-003-1542-3; Emami MK, 1999, PLANT BREEDING, V118, P579, DOI 10.1046/j.1439-0523.1999.00416.x; ERSKINE W, 1994, THEOR APPL GENET, V88, P423, DOI 10.1007/BF00223655; Eujayl I, 1998, THEOR APPL GENET, V97, P83, DOI 10.1007/s001220050869; Fedoruk MJ, 2013, PLANT GENOME-US, V6, DOI 10.3835/plantgenome2013.05.0012; Fernandez M, 2005, GENOME, V48, P937, DOI 10.1139/g05-052; Fiala JV, 2009, CROP SCI, V49, P825, DOI 10.2135/cropsci2008.05.0260; Ford R, 1999, THEOR APPL GENET, V98, P93, DOI 10.1007/s001220051044; Fratini R, 2007, SPAN J AGRIC RES, V5, P348; Fratini R, 2011, GRAIN LEGUMES, V57, P18; Fratini R, 2006, EUPHYTICA, V150, P271, DOI 10.1007/s10681-006-9118-3; Fratini R, 2011, METHODS MOL BIOL, V710, P131, DOI 10.1007/978-1-61737-988-8_11; Galasso I, 2003, GENOME, V46, P1118, DOI [10.1139/g03-077, 10.1139/G03-077]; Gorim LY, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01129; Gujaria-Verma N, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00676; Gupta D, 2012, MOL BREEDING, V30, P429, DOI 10.1007/s11032-011-9634-2; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; HALEY CS, 1992, HEREDITY, V69, P315, DOI 10.1038/hdy.1992.131; HAVEY MJ, 1989, THEOR APPL GENET, V77, P395, DOI 10.1007/BF00305835; Hoque M. E., 2002, Indian Journal of Genetics and Plant Breeding, V62, P5; Kaur S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-265; Khazaei H, 2018, PLANT GENOME-US, V11, DOI 10.3835/plantgenome2017.06.0051; Khorramdelazad M, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4488-1; Kumar J, 2018, EUPHYTICA, V214, DOI 10.1007/s10681-018-2155-x; Kumar J, 2014, PHYSIOL MOL BIOL PLA, V20, P125, DOI 10.1007/s12298-013-0214-2; Kumar Y, 2005, J LENTIL RES, V2, P22; LADIZINSKY G, 1993, CRIT REV PLANT SCI, V12, P169, DOI 10.1080/713608047; LADIZINSKY G, 1979, J HERED, V70, P135, DOI 10.1093/oxfordjournals.jhered.a109209; Ladizinsky G, 2015, SPRINGERBR PLANT SCI, P1, DOI 10.1007/978-3-319-14505-1_1; LAL S, 1975, INDIAN J GENET PL BR, V35, P29; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Liu TY, 2012, PLANT CELL, V24, P2168, DOI 10.1105/tpc.112.096636; Manichaikul A, 2006, GENETICS, V174, P481, DOI 10.1534/genetics.106.061549; McCouch S, 2004, PLOS BIOL, V2, P1507, DOI 10.1371/journal.pbio.0020347; MUEHLBAUER FJ, 1994, EUPHYTICA, V73, P109, DOI 10.1007/BF00027187; Mujeeb-Kazi A, 2013, ADV AGRON, V122, P179, DOI 10.1016/B978-0-12-417187-9.00004-8; Nelson R, 2018, NAT REV GENET, V19, P21, DOI 10.1038/nrg.2017.82; Ocampo B, 2000, CURR PLANT SCI BIOT, V34, P411; Ogutcen E, 2018, APPL PLANT SCI, V6, DOI 10.1002/aps3.1165; Outchkourov NS, 2018, PLANT PHYSIOL, V176, P1862, DOI 10.1104/pp.17.01662; Perez de la Vega M., 2011, Genetics, genomics and breeding of cool season grain legumes, P98; Piaskowski J, 2017, EUPHYTICA, V213, DOI 10.1007/s10681-017-1961-x; Poirier Yves, 2002, Arabidopsis Book, V1, pe0024, DOI 10.1199/tab.0024; RCore Team, 2020, R LANG ENV STAT COMP; Rodda MS, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01136; Rubeena, 2006, PLANT BREEDING, V125, P506, DOI 10.1111/j.1439-0523.2006.01259.x; Sari E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204124; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sharma DR, 1996, EUPHYTICA, V89, P325; SHARMA HC, 1995, EUPHYTICA, V82, P43, DOI 10.1007/BF00028709; Sharma S, 2017, CROP SCI, V57, P1132, DOI 10.2135/cropsci2017.01.0033; Sharpe AG, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-192; Singh D, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3596-7; Singh M, 2018, PLANT BREEDING, V137, P470, DOI 10.1111/pbr.12615; Singh M, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01162; Singh M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107781; Singh M, 2013, PLANT BREEDING, V132, P667, DOI 10.1111/pbr.12089; Sudheesh S, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01604; Suvorova G. N., 2014, Russian Agricultural Sciences, V40, P22, DOI 10.3103/S1068367414010182; TADMOR Y, 1987, THEOR APPL GENET, V73, P883, DOI 10.1007/BF00289394; VANDENBERG A, 1990, J HERED, V81, P484, DOI 10.1093/oxfordjournals.jhered.a111030; Verma P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139666; Voss-Fels K, 2016, PLANT BIOTECHNOL J, V14, P1086, DOI 10.1111/pbi.12456; Warschefsky E, 2014, AM J BOT, V101, P1791, DOI 10.3732/ajb.1400116; Wong MML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122025; Wu YH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000212; Wulff BBH, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00692; Yu YM, 2018, BIOINFORMATICS, V34, P1229, DOI 10.1093/bioinformatics/btx763; Zaim M, 2017, FIELD CROP RES, V214, P219, DOI 10.1016/j.fcr.2017.09.007; Zeng HQ, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00877; Zhang HY, 2017, EVOL APPL, V10, P5, DOI 10.1111/eva.12434; Zhang LY, 2010, THEOR APPL GENET, V121, P1071, DOI 10.1007/s00122-010-1372-z	89	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2019	14	3							e0214409	10.1371/journal.pone.0214409	http://dx.doi.org/10.1371/journal.pone.0214409			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ5PT	30917174	Green Submitted, Green Published, gold			2022-12-26	WOS:000462465800064
J	von Streit, F; Bartels, C; Kuczius, T; Cassier, C; Gardemann, J; Schaumburg, F				von Streit, Friederike; Bartels, Christoph; Kuczius, Thorsten; Cassier, Christoph; Gardemann, Joachim; Schaumburg, Frieder			Prevalence of latent tuberculosis in homeless persons: A single-centre cross-sectional study, Germany	PLOS ONE			English	Article							INFECTION; DIAGNOSIS; TESTS	Purpose Homeless persons have a high risk for tuberculosis. The prevalence of latent tuberculosis infection and the risk for a progression to active tuberculosis is higher in the homeless than in the general population. The objective was to assess the prevalence and risk factors of tuberculosis/latent tuberculosis infection in a homeless population in Germany. Methods Homeless individuals (n = 150) were enrolled in a cross-sectional study at three shelters in Munster, Germany (October 2017-July 2018). All participants were screened using an ELI-SPOT interferon-y release assay (IGRA). Those participants tested positive/borderline by IGRA provided three sputa for microbiological analysis (line probe assay, microscopy, culture) and underwent a chest X-ray to screen for active pulmonary TB. Risk factors for tuberculosis/latent tuberculosis infection were analysed using a standardized questionnaire. Results Of the 142 evaluable IGRA, 21 (15%) were positive and two (1%) were borderline. No participant with a positive/borderline IGRA had an active tuberculosis as assessed by chest X-ray and microbiology. A negative IGRA was associated with a citizenship of a low-incidence country for tuberculosis (according to WHO, p = 0.01), low-incidence country of birth (p<0.001) or main residence in a low-incidence country in the past five years (p = 0.002). Conclusions The prevalence of latent tuberculosis infection (diagnosed by a positive/borderline IGRA) was 16%; no active tuberculosis was detected. The highest risk for latent tuberculosis infection was found in patients from high-incidence countries. This population at risk should be either treated for latent tuberculosis infection or need to be monitored to early detect a progression into active disease.	[von Streit, Friederike; Schaumburg, Frieder] Univ Hosp Munster, Inst Med Microbiol, Munster, Nordrhein Westf, Germany; [Bartels, Christoph] Klin Schlossgarten Dulmen, Dulmen, Nordrhein Westf, Germany; [Kuczius, Thorsten] Univ Hosp Munster, Inst Hyg, Munster, Nordrhein Westf, Germany; [Cassier, Christoph] Amt Gesundheit Vet & Lebensmitteluberwachung, Abt Arztliche Gutachten, Munster, Nordrhein Westf, Germany; [Cassier, Christoph] Amt Gesundheit Vet & Lebensmitteluberwachung, Abt Infekt Schutz & Umwelthyg, Munster, Nordrhein Westf, Germany; [Gardemann, Joachim] Fachhsch Munster, Kompetenzzentrum Humanitare Hilfe, Munster, Nordrhein Westf, Germany	University of Munster; University of Munster	Schaumburg, F (corresponding author), Univ Hosp Munster, Inst Med Microbiol, Munster, Nordrhein Westf, Germany.	frieder.schaumburg@ukmuenster.de		Schaumburg, Frieder/0000-0002-9168-9290				Adetifa IMO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012502; [Anonymous], 2017, FUBALL TALENTE DEUTS; Beijer U, 2009, SCAND J PUBLIC HEALT, V37, P93, DOI 10.1177/1403494808099972; Bundesarbeitsgemeinschaft Wohnungslosenhilfe e. V, 2017, AKTUELLE SCHATZUNG Z; Diel R, 2012, EUR RESPIR J, V40, P143, DOI 10.1183/09031936.00204611; European Centre for Disease Prevention and Control (ECDC) /WHO Regional Office for Europe, 2018, TUB SURV MON EUR 201; Getahun H, 2015, EUR RESPIR J, V46, P1563, DOI 10.1183/13993003.01245-2015; Getahun H, 2015, NEW ENGL J MED, V372, P2127, DOI 10.1056/NEJMra1405427; Goetsch U, 2012, INFECTION, V40, P389, DOI 10.1007/s15010-011-0238-x; Horton KC, 2016, PLOS MED, V13, DOI [10.1371/journal.pmed.1002119, 10.1371/journal.pmed.1002152]; Hwang SW, 2008, J HEALTH CARE POOR U, V19, P1163, DOI 10.1353/hpu.0.0070; Khan K, 2011, EMERG INFECT DIS, V17, P357, DOI 10.3201/eid1703.100833; Kong PM, 2002, EMERG INFECT DIS, V8, P1280; Kruczak K, 2014, SCAND J INFECT DIS, V46, P649, DOI 10.3109/00365548.2014.927955; Lee CH, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-720; Lee SW, 2011, EUR RESPIR J, V37, P1447, DOI 10.1183/09031936.00089510; Lu P, 2016, LUNG, V194, P447, DOI 10.1007/s00408-016-9872-5; Mack U, 2009, EUR RESPIR J, V33, P956, DOI 10.1183/09031936.00120908; Moss AR, 2000, AM J RESP CRIT CARE, V162, P460, DOI 10.1164/ajrccm.162.2.9910055; Rego K, 2018, TUBERCULOSIS, V108, P178, DOI 10.1016/j.tube.2017.12.005; Schaberg T, 2017, PNEUMOLOGIE, V71, P703, DOI 10.1055/s-0043-121677; Schaberg T, 2017, PNEUMOLOGIE, V71, P325, DOI 10.1055/s-0043-105954; Skoura E, 2015, INT J INFECT DIS, V32, P87, DOI 10.1016/j.ijid.2014.12.007; Stadt Munster, 2018, JAHR STAT 2017 STADT; Tabuchi T, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-22; Uplekar M, 2015, LANCET, V385, P1799, DOI 10.1016/S0140-6736(15)60570-0; WHO, 2017, GLOB TUB REP 2017; World Health Organization, 2015, IMPL TUB DIAGN POL F; World Health Organization, 2018, LAT TUB INF UPD CONS; ZOLOPA AR, 1994, JAMA-J AM MED ASSOC, V272, P455, DOI 10.1001/jama.272.6.455	30	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2019	14	3							e0214556	10.1371/journal.pone.0214556	http://dx.doi.org/10.1371/journal.pone.0214556			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ3IW	30913275	Green Published, Green Submitted, gold			2022-12-26	WOS:000462305600070
J	Rozanov, D; Cheltsov, A; Nilsen, A; Boniface, C; Forquer, I; Korkola, J; Gray, J; Tyner, J; Tognon, CE; Mills, GB; Spellman, P				Rozanov, Dmitri; Cheltsov, Anton; Nilsen, Aaron; Boniface, Christopher; Forquer, Isaac; Korkola, James; Gray, Joe; Tyner, Jeffrey; Tognon, Cristina E.; Mills, Gordon B.; Spellman, Paul			Targeting mitochondria in cancer therapy could provide a basis for the selective anticancer activity	PLOS ONE			English	Article							OXIDATIVE STRESS; THIOREDOXIN REDUCTASE; GLUTATHIONE-REDUCTASE; DRUG-RESISTANCE; CELL-GROWTH; IN-VITRO; APOPTOSIS; 1,4-NAPHTHOQUINONE; METABOLISM; PHENFORMIN	To determine the target of the recently identified lead compound NSC130362 that is responsible for its selective anti-cancer efficacy and safety in normal cells, structure-activity relationship (SAR) studies were conducted. First, NSC13062 was validated as a starting compound for the described SAR studies in a variety of cell-based viability assays. Then, a small library of 1,4-naphthoquinines (1,4-NQs) and quinoline-5,8-diones was tested in cell viability assays using pancreatic cancer MIA PaCa-2 cells and normal human hepatocytes. The obtained data allowed us to select a set of both non-toxic compounds that preferentially induced apoptosis in cancer cells and toxic compounds that induced apoptosis in both cancer and normal cells. Anti-cancer activity of the selected non-toxic compounds was confirmed in viability assays using breast cancer HCC1187 cells. Consequently, the two sets of compounds were tested in multiple cell-based and in vitro activity assays to identify key factors responsible for the observed activity. Inhibition of the mitochondrial electron transfer chain (ETC) is a key distinguishing activity between the non-toxic and toxic compounds. Finally, we developed a mathematical model that was able to distinguish these two sets of compounds. The development of this model supports our conclusion that appropriate quantitative SAR (QSAR) models have the potential to be employed to develop anti-cancer compounds with improved potency while maintaining non-toxicity to normal cells.	[Rozanov, Dmitri; Boniface, Christopher; Spellman, Paul] Oregon Hlth & Sci Univ, Knight Canc Inst, Dept Mol & Med Genet, Portland, OR 97201 USA; [Cheltsov, Anton] Q MOL LLC, San Diego, CA USA; [Nilsen, Aaron] Oregon Hlth & Sci Univ, Med Chem Core, Portland, OR 97201 USA; [Forquer, Isaac] Portland State Univ, Dept Chem, Portland, OR 97207 USA; [Korkola, James; Gray, Joe] Oregon Hlth & Sci Univ, Dept Biomed Engn, Portland, OR 97201 USA; [Tyner, Jeffrey; Tognon, Cristina E.; Mills, Gordon B.] Oregon Hlth & Sci Univ, Dept Cell Dev & Canc Biol, Portland, OR 97201 USA; [Tognon, Cristina E.] Howard Hughes Med Inst, Portland, OR USA; [Tognon, Cristina E.] Oregon Hlth & Sci Univ, Div Hematol & Med Oncol, Portland, OR 97201 USA	Oregon Health & Science University; Oregon Health & Science University; Portland State University; Oregon Health & Science University; Oregon Health & Science University; Howard Hughes Medical Institute; Oregon Health & Science University	Rozanov, D (corresponding author), Oregon Hlth & Sci Univ, Knight Canc Inst, Dept Mol & Med Genet, Portland, OR 97201 USA.	rozanov@ohsu.edu	Nilsen, Aaron/U-6094-2019; Gray, Joe/AAX-9549-2020	Mills, Gordon/0000-0002-0144-9614	Q-MOL LLC	Q-MOL LLC	The authors received no specific funding for this work. The funder Q-MOL LLC provided support in the form of salaries for authors [AC], and has an additional role in the study in data collection and analysis and preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Barbini L, 2007, MOL CELL BIOCHEM, V300, P19, DOI 10.1007/s11010-006-9341-1; Bender RP, 2007, BIOCHEMISTRY-US, V46, P2856, DOI 10.1021/bi062017l; Benites J, 2010, EUR J MED CHEM, V45, P6052, DOI 10.1016/j.ejmech.2010.10.006; Bhasin D, 2013, BIOORG MED CHEM LETT, V23, P6864, DOI 10.1016/j.bmcl.2013.09.098; Bin Hafeez B, 2013, MOL ONCOL, V7, P428, DOI 10.1016/j.molonc.2012.12.001; BUFFINTON GD, 1989, BIOCHEM J, V257, P561, DOI 10.1042/bj2570561; Chen F, 2015, PROTEIN CELL, V6, P654, DOI 10.1007/s13238-015-0178-9; Cheng G, 2012, CANCER RES, V72, P2634, DOI 10.1158/0008-5472.CAN-11-3928; Ciriaci N, 2015, FASEB J S, V29; Couto N, 2016, FREE RADICAL BIO MED, V95, P27, DOI 10.1016/j.freeradbiomed.2016.02.028; Couzin J, 2002, SCIENCE, V298, P522, DOI 10.1126/science.298.5593.522; Criddle DN, 2006, J BIOL CHEM, V281, P40485, DOI 10.1074/jbc.M607704200; Das SK, 2018, J MED CHEM, V61, P804, DOI 10.1021/acs.jmedchem.7b01297; Donadelli M, 2007, BBA-MOL CELL RES, V1773, P1095, DOI 10.1016/j.bbamcr.2007.05.002; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890; Fernando MR, 2006, FASEB J, V20, P2645, DOI 10.1096/fj.06-5919fje; Frantz S, 2005, NATURE, V437, P942, DOI 10.1038/437942a; Geisbrecht BV, 1999, J BIOL CHEM, V274, P30527, DOI 10.1074/jbc.274.43.30527; Han WD, 2007, MOL CANCER THER, V6, P1641, DOI 10.1158/1535-7163.MCT-06-0511; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Hughes JP, 2011, BRIT J PHARMACOL, V162, P1239, DOI 10.1111/j.1476-5381.2010.01127.x; Jackson AL, 2017, ONCOTARGET, V8, P100113, DOI 10.18632/oncotarget.22012; Janzer A, 2014, P NATL ACAD SCI USA, V111, P10574, DOI 10.1073/pnas.1409844111; Kalyanaraman B, 2018, REDOX BIOL, V14, P316, DOI 10.1016/j.redox.2017.09.020; Kamada K, 2004, FREE RADICAL BIO MED, V37, P1875, DOI 10.1016/j.freeradbiomed.2004.09.002; Kayashima T, 2009, CANCER LETT, V278, P34, DOI 10.1016/j.canlet.2008.12.020; Liu KKC, 2004, MINI-REV MED CHEM, V4, P1105; Lu J, 2012, ANTIOXID REDOX SIGN, V17, P1738, DOI 10.1089/ars.2012.4650; Maeda H, 2004, CELL DEATH DIFFER, V11, P737, DOI 10.1038/sj.cdd.4401389; Maiti AK, 2012, INT J CANCER, V130, P1, DOI 10.1002/ijc.26306; MCCORD JM, 1988, FREE RADICAL BIO MED, V5, P363, DOI 10.1016/0891-5849(88)90109-8; Miller WH, 2002, CANCER RES, V62, P3893; Morin C, 2008, ORG BIOMOL CHEM, V6, P2731, DOI 10.1039/b802649c; NICOTERA P, 1990, ARCH BIOCHEM BIOPHYS, V283, P200, DOI 10.1016/0003-9861(90)90631-8; NORDHOFF A, 1993, BIOCHEMISTRY-US, V32, P4060, DOI 10.1021/bi00066a029; OBRIEN PJ, 1991, CHEM-BIOL INTERACT, V80, P1, DOI 10.1016/0009-2797(91)90029-7; Pelicano H, 2004, DRUG RESIST UPDATE, V7, P97, DOI 10.1016/j.drup.2004.01.004; Pervaiz S, 2004, CURR PHARM DESIGN, V10, P1969, DOI 10.2174/1381612043384411; Prachayasittikul V, 2014, EUR J MED CHEM, V84, P247, DOI 10.1016/j.ejmech.2014.07.024; Prati F, 2015, J MED CHEM, V58, P6422, DOI 10.1021/acs.jmedchem.5b00748; Ramadori G, 2010, ANN HEPATOL, V9, P133, DOI 10.1016/S1665-2681(19)31651-5; Ramzan R, 2013, BIOCHEM SOC T, V41, P1294, DOI 10.1042/BST20130067; Reuter S, 2010, FREE RADICAL BIO MED, V49, P1603, DOI 10.1016/j.freeradbiomed.2010.09.006; Rozanov D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129566; RUMSEY WL, 1990, J BIOL CHEM, V265, P15392; Sandur SK, 2006, J BIOL CHEM, V281, P17023, DOI 10.1074/jbc.M601595200; Saso L, 2014, CURR DRUG TARGETS, V15, P1177, DOI 10.2174/1389450115666141024113925; Shahabuddin MS, 2007, TOXICOL MECH METHOD, V17, P135, DOI 10.1080/15376510600899605; SHAIKH IA, 1986, J MED CHEM, V29, P1329, DOI 10.1021/jm00158a002; Shiryaev SA, 2011, ASSAY DRUG DEV TECHN, V9, P69, DOI 10.1089/adt.2010.0309; Song Y, 2010, FREE RADICAL BIO MED, V49, P919, DOI 10.1016/j.freeradbiomed.2010.05.009; Sosa V, 2013, AGEING RES REV, V12, P376, DOI 10.1016/j.arr.2012.10.004; Sunassee SN, 2013, EUR J MED CHEM, V62, P98, DOI 10.1016/j.ejmech.2012.12.048; Trachootham D, 2006, CANCER CELL, V10, P241, DOI 10.1016/j.ccr.2006.08.009; Tyner JW, 2013, CANCER RES, V73, P285, DOI 10.1158/0008-5472.CAN-12-1906; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Weinberg SE, 2015, NAT CHEM BIOL, V11, P9, DOI 10.1038/nchembio.1712; Xu K, 2001, BIOCHEM PHARMACOL, V61, P165, DOI 10.1016/S0006-2952(00)00526-8; Yan C, 2012, MOL PHARMACOL, V81, P401, DOI 10.1124/mol.111.076091; Yang M, 2013, J CLIN INVEST, V123, P3652, DOI 10.1172/JCI67228; Yuan P, 2013, P NATL ACAD SCI USA, V110, P18226, DOI 10.1073/pnas.1317577110; Zhang R, 2008, APOPTOSIS, V13, P1465, DOI 10.1007/s10495-008-0278-6; Zheng ZD, 2018, ONCOL LETT, V15, P5952, DOI 10.3892/ol.2018.7999; Zhou SY, 2001, TOXICOL LETT, V121, P151, DOI 10.1016/S0378-4274(01)00329-0	65	18	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2019	14	3							e0205623	10.1371/journal.pone.0205623	http://dx.doi.org/10.1371/journal.pone.0205623			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ1KV	30908483	gold, Green Submitted, Green Published			2022-12-26	WOS:000462157600001
J	Slavov, SN; Ciliao-Alves, DC; Gonzaga, FAC; Moura, DR; de Moura, ACAM; de Noronha, LAG; Cassemiro, EM; Pimentel, BMS; Costa, FJQ; da Silva, GA; Ramos, DDR; de Araujo, WN; Kashima, S; Haddad, R				Slavov, Svetoslav Nanev; Ciliao-Alves, Daiani Cristina; Carvalho Gonzaga, Filipe Almeida; Moura, Drielly Rodrigues; Alves Melo de Moura, Ana Carolina; Goncalves de Noronha, Lorena Aparecida; Cassemiro, Evelin Mota; Sidou Pimentel, Barbara Maciel; Queiroz Costa, Fabiano Jose; da Silva, Grasiela Araujo; Rabello Ramos, Doralina do Amaral; de Araujo, Wildo Navegantes; Kashima, Simone; Haddad, Rodrigo			Dengue seroprevalence among asymptomatic blood donors during an epidemic outbreak in Central-West Brazil	PLOS ONE			English	Article							VIRUS; VIREMIA; INFECTION; DIAGNOSIS; REGION; RNA	Dengue virus (DENV) transmission by blood transfusion is an important route of viral acquisition during outbreaks. The prevalence of DENV markers (viral RNA, NS1, anti-DENV IgM, and IgG) among blood donors in Central-West Brazil has never been evaluated. Our aim was to evaluate the full set of serological and molecular markers for DENV among blood donors of the Federal District of Brazil during an extensive outbreak in 2016. We found an anti-DENV IgM prevalence of 6.74% (n = 32/475). Of 475, 20 samples (4.21%) were also anti-DENV IgG positive. All samples were non-reactive for NS1 and DENV RNA. Our results imply that a significant proportion of the tested donors had experienced asymptomatic infection. More studies are necessary to evaluate the real prevalence of DENV viremia in blood donors from the Federal District of Brazil and if specific measures are needed to routinely test the blood donors for DENV RNA during outbreaks.	[Slavov, Svetoslav Nanev; Kashima, Simone] Univ Sao Paulo, Fac Med Ribeirao Preto, Blood Ctr Ribeirao Preto, Ribeirao Preto, SP, Brazil; [Slavov, Svetoslav Nanev] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Internal Med, Ribeirao Preto, SP, Brazil; [Ciliao-Alves, Daiani Cristina] Euroamer Univ Ctr UNIEURO, Brasilia, DF, Brazil; [Carvalho Gonzaga, Filipe Almeida; Moura, Drielly Rodrigues; Alves Melo de Moura, Ana Carolina; Goncalves de Noronha, Lorena Aparecida; Cassemiro, Evelin Mota; de Araujo, Wildo Navegantes; Haddad, Rodrigo] Univ Brasilia, Fac Ceilandia, Brasilia, DF, Brazil; [Carvalho Gonzaga, Filipe Almeida; Cassemiro, Evelin Mota; de Araujo, Wildo Navegantes; Haddad, Rodrigo] Univ Brasilia, Ctr Trop Med, Brasilia, DF, Brazil; [Sidou Pimentel, Barbara Maciel] Blood Ctr Brasilia, Brasilia, DF, Brazil; [Queiroz Costa, Fabiano Jose; da Silva, Grasiela Araujo] Cent Publ Hlth Lab Fed Dist LACEN DF, Brasilia, DF, Brazil; [Rabello Ramos, Doralina do Amaral] Univ Brasilia, Fac Hlth Sci & Med, Lab Mol Pathol Canc, Brasilia, DF, Brazil; [Kashima, Simone] Univ Sao Paulo, Fac Pharmaceut Sci Ribeirao Preto, Dept Clin Toxicol & Bromatol Anal, Ribeirao Preto, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Brasilia; Universidade de Brasilia; Universidade de Brasilia; Universidade de Sao Paulo	Haddad, R (corresponding author), Univ Brasilia, Fac Ceilandia, Brasilia, DF, Brazil.; Haddad, R (corresponding author), Univ Brasilia, Ctr Trop Med, Brasilia, DF, Brazil.	haddad@unb.br	Haddad, Rodrigo/A-3460-2013; Rabello, Doralina/E-9900-2013; Kashima, Simone/G-4876-2012	Rabello, Doralina/0000-0002-6272-6558; Gonzaga, Filipe Almeida Carvalho/0000-0002-3680-4284; Haddad, Rodrigo/0000-0003-4699-164X; Kashima, Simone/0000-0002-1487-0141	Financiadora de Estudos e Projetos - FINEP, Brazil [245/2016]; Fundacao de Apoio a Pesquisa do Distrito Federal, Federal District, Brazil - FAPDF [0193000416/2016]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq, Brazil [453906/2014-01]; Coordenacao Geral de Laboratorios de Saude Publica (CGLAB/SVS/MS)	Financiadora de Estudos e Projetos - FINEP, Brazil(Financiadora de Inovacao e Pesquisa (Finep)); Fundacao de Apoio a Pesquisa do Distrito Federal, Federal District, Brazil - FAPDF(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao Geral de Laboratorios de Saude Publica (CGLAB/SVS/MS)	This project was supported financially by Financiadora de Estudos e Projetos - FINEP, Brazil (245/2016) (www.finep.gov.br), Fundacao de Apoio a Pesquisa do Distrito Federal, Federal District, Brazil - FAPDF (0193000416/2016) (www.fap.df.gov.br), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq, Brazil (453906/2014-01)(www.cnpq.br) and and Coordenacao Geral de Laboratorios de Saude Publica (CGLAB/SVS/MS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashshi AM, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0768-7; Busch MP, 2016, J INFECT DIS, V214, P49, DOI 10.1093/infdis/jiw122; Chen JinYan, 2015, Journal of Tropical Medicine (Guangzhou), V15, P1014; Chuang Vivien W. M., 2008, Hong Kong Medical Journal, V14, P170; da Costa AG, 2011, REV SOC BRAS MED TRO, V44, P471, DOI 10.1590/S0037-86822011000400014; deBlas I, WINEPI WORKING EPIDE; Dias LL, 2012, TRANSFUSION, V52, P1667, DOI 10.1111/j.1537-2995.2012.03729.x; Faddy HM, 2013, EMERG INFECT DIS, V19, P787, DOI 10.3201/eid1905.121664; Huhtamo E, 2010, J CLIN VIROL, V47, P49, DOI 10.1016/j.jcv.2009.11.001; Karim F, 2017, TRANSFUS APHER SCI, V56, P151, DOI 10.1016/j.transci.2016.10.013; KUNO G, 1987, AM J TROP MED HYG, V36, P153, DOI 10.4269/ajtmh.1987.36.153; Lavezzo LC, 2010, TRANSFUSION MED, V20, P278, DOI 10.1111/j.1365-3148.2010.00996.x; Levi JE, 2015, TRANSFUSION, V55, P961, DOI 10.1111/trf.12944; Linnen JM, 2008, TRANSFUSION, V48, P1355, DOI 10.1111/j.1537-2995.2008.01772.x; Low SL, 2015, AM J TROP MED HYG, V93, P40, DOI 10.4269/ajtmh.14-0671; Matos D, 2016, TRANSFUSION, V56, P215, DOI 10.1111/trf.13288; Mohammed H, 2008, TRANSFUSION, V48, P1348, DOI 10.1111/j.1537-2995.2008.01771.x; Muller DA, 2017, J INFECT DIS, V215, pS89, DOI 10.1093/infdis/jiw649; Ranjan P, 2016, J CLIN DIAGN RES, V10, pDC8, DOI 10.7860/JCDR/2016/21262.8711; Rothman AL, 2004, J CLIN INVEST, V113, P946, DOI [10.1172/JCI200421512, 10.1172/JCI21512]; Sabino EC, 2016, J INFECT DIS, V213, P694, DOI 10.1093/infdis/jiv326; Slavov SN, 2018, TRANSFUSION MED, V28, P465, DOI 10.1111/tme.12521; Stramer SL, 2012, TRANSFUSION, V52, P1657, DOI 10.1111/j.1537-2995.2012.03566.x; Tambyah PA, 2008, NEW ENGL J MED, V359, P1526, DOI 10.1056/NEJMc0708673; Teixeira MG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002520; WHO, 2015, DENG HAEM FEV DIAGN; Zeng P, 2018, TRANSFUSION MED, V28, P468, DOI 10.1111/tme.12551	27	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2019	14	3							e0213793	10.1371/journal.pone.0213793	http://dx.doi.org/10.1371/journal.pone.0213793			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ1KV	30908528	Green Published, Green Submitted, gold			2022-12-26	WOS:000462157600019
J	Hori, S; Hiramuki, Y; Nishimura, D; Sato, F; Sehara-Fujisawa, A				Hori, Shimpei; Hiramuki, Yosuke; Nishimura, Daigo; Sato, Fuminori; Sehara-Fujisawa, Atsuko			PDH-mediated metabolic flow is critical for skeletal muscle stem cell differentiation and myotube formation during regeneration in mice	FASEB JOURNAL			English	Article						satellite cell; tissue regeneration; cell division; metabolic control	PYRUVATE-DEHYDROGENASE KINASE; INHIBITS MYOGENIC DIFFERENTIATION; HYPOXIA-INDUCIBLE FACTORS; SELF-RENEWAL; E1-ALPHA SUBUNIT; SATELLITE CELLS; GENE; DEFICIENCY; GLYCOLYSIS; EXPRESSION	Skeletal muscle satellite cells (SMSCs), the major stem cells responsible for the regeneration of skeletal muscle, are normally cell cycle arrested but differentiate to generate myocytes upon muscle damage, forming new myofibers along with self-renewing stem cells in preparation for subsequent injury. In this study, we investigated which factors stimulate the proliferation and differentiation of SMSCs and found that pyruvate, the end product of glycolysis, stimulates their differentiation. Pyruvate antagonizes the effects of hypoxia on preferential self-renewal of SMSCs through dephosphorylation or activation of pyruvate dehydrogenase (PDH), which mediates opening of the gateway from glycolysis to the tricarboxylic acid (TCA) cycle by producing acetyl coenzyme A from pyruvate. PDH kinase 1, highly expressed under hypoxia, is down-regulated under normoxic conditions, leading to an increase in dephosphorylated PDH. Conditional deletion of PDH in SMSCs affects cell divisions generating myocytes and subsequent myotube formation, inefficient skeletal muscle regeneration upon injury, and aggravated pathogenesis of a dystrophin-deficient mouse model of Duchenne muscular dystrophy. Thus, the flow from glycolysis to the TCA cycle mediated by PDH plays a pivotal role in the differentiation of SMSCs, which is critical for the progression of skeletal muscle regeneration.-Hori, S., Hiramuki, Y., Nishimura, D., Sato, F., Sehara-Fujisawa, A. PDH-mediated metabolic flow is critical for skeletal muscle stem cell differentiation and myotube formation during regeneration in mice.	[Hori, Shimpei; Hiramuki, Yosuke; Nishimura, Daigo; Sato, Fuminori; Sehara-Fujisawa, Atsuko] Kyoto Univ, Dept Growth Regulat, Inst Frontier Life & Med Sci, Kyoto, Japan; [Hiramuki, Yosuke] Fred Hutchinson Canc Res Ctr, Human Biol Div, 1124 Columbia St, Seattle, WA 98104 USA	Kyoto University; Fred Hutchinson Cancer Center	Sehara-Fujisawa, A (corresponding author), Kyoto Univ, Dept Growth Regulat, Inst Frontier Life & Med Sci, Sakyo Ku, 53 Shogoin Kawara Cho, Kyoto, Kyoto 6068507, Japan.	sehara.atsuko.3m@kyoto-u.ac.jp			Japan Society for the Promotion of Science KAKENHI [16H04793, 15H05938, 15H05935, 15K21745]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors thank Dr. H. Harada (Kyoto University) for helpful discussion, and Drs. S. Fukada (Osaka University, Osaka, Japan) and K. Hanaoka (Kitasato University, Tokyo, Japan) for providing SM/C-2.6 mouse IgG biotin and dystrophin-knockout mice, respectively. This work was supported by the Japan Society for the Promotion of Science KAKENHI Grants 16H04793 [Grant-in-Aid for Scientific Research (B)], 15H05938, 15H05935, and 15K21745 (Grant-in-Aid for Scientific Research on Innovative Areas). The authors declare no conflicts of interest.	Bowker-Kinley MM, 1998, BIOCHEM J, V329, P191, DOI 10.1042/bj3290191; Buckingham M, 2015, SEMIN CELL DEV BIOL, V44, P115, DOI 10.1016/j.semcdb.2015.09.017; Carracedo A, 2013, NAT REV CANCER, V13, P227, DOI 10.1038/nrc3483; Chaillou T, 2016, FASEB J, V30, P3929, DOI 10.1096/fj.201600757R; Chang NC, 2018, CELL STEM CELL, V22, P755, DOI 10.1016/j.stem.2018.03.022; Charville GW, 2015, STEM CELL REP, V5, P621, DOI 10.1016/j.stemcr.2015.08.004; DAHL HHM, 1990, GENOMICS, V8, P225, DOI 10.1016/0888-7543(90)90275-Y; Di Carlo A, 2004, J BIOL CHEM, V279, P16332, DOI 10.1074/jbc.M313931200; Dumon NA, 2015, DEVELOPMENT, V142, P1572, DOI 10.1242/dev.114223; Fukada S, 2004, EXP CELL RES, V296, P245, DOI 10.1016/j.yexcr.2004.02.018; Garcia-Prat L, 2016, NATURE, V529, P37, DOI 10.1038/nature16187; GUDI R, 1995, J BIOL CHEM, V270, P28989, DOI 10.1074/jbc.270.48.28989; Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010; Harris RA, 2002, ADV ENZYME REGUL, V42, P249, DOI 10.1016/S0065-2571(01)00061-9; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Held NM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27875-3; Hou XJ, 2015, J CELL SCI, V128, P2319, DOI 10.1242/jcs.167049; Ito K, 2018, EXP HEMATOL, V64, P1, DOI 10.1016/j.exphem.2018.05.005; Jian BX, 2010, SHOCK, V34, P169, DOI 10.1097/SHK.0b013e3181cffe7d; Johnson MT, 2001, MOL GENET METAB, V74, P293, DOI 10.1006/mgme.2001.3249; Jones NC, 2005, J CELL BIOL, V169, P105, DOI 10.1083/jcb.200408066; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Kudoh H, 2005, BIOCHEM BIOPH RES CO, V328, P507, DOI 10.1016/j.bbrc.2004.12.191; L'honore A, 2018, ELIFE, V7, DOI 10.7554/eLife.32991; Liu WY, 2012, DEVELOPMENT, V139, P2857, DOI 10.1242/dev.079665; Majmundar AJ, 2015, DEVELOPMENT, V142, P2405, DOI 10.1242/dev.123026; Majmundar AJ, 2012, MOL CELL BIOL, V32, P36, DOI 10.1128/MCB.05857-11; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; MARAGOS C, 1989, J BIOL CHEM, V264, P12294; Mathieu J, 2017, DEVELOPMENT, V144, P541, DOI 10.1242/dev.128389; Mohyeldin A, 2010, CELL STEM CELL, V7, P150, DOI 10.1016/j.stem.2010.07.007; Mora A, 2003, EMBO J, V22, P4666, DOI 10.1093/emboj/cdg469; Moussaieff A, 2015, CELL METAB, V21, P392, DOI 10.1016/j.cmet.2015.02.002; Murphy MM, 2011, DEVELOPMENT, V138, P3625, DOI 10.1242/dev.064162; Nemeria NS, 2006, BIOORG CHEM, V34, P362, DOI 10.1016/j.bioorg.2006.09.001; Oginuma M, 2017, DEV CELL, V40, P342, DOI 10.1016/j.devcel.2017.02.001; Pala F, 2018, J CELL SCI, V131, DOI 10.1242/jcs.212977; Patel MS, 2014, J BIOL CHEM, V289, P16615, DOI 10.1074/jbc.R114.563148; Pliss L, 2004, J NEUROCHEM, V91, P1082, DOI 10.1111/j.1471-4159.2004.02790.x; PRATT ML, 1979, J BIOL CHEM, V254, P7191; Rajagopalan KN, 2015, CANCER METAB, V3, DOI 10.1186/s40170-015-0134-4; Rardin MJ, 2009, ANAL BIOCHEM, V389, P157, DOI 10.1016/j.ab.2009.03.040; Rocheteau P, 2012, CELL, V148, P112, DOI 10.1016/j.cell.2011.11.049; Scaduto RC, 1999, BIOPHYS J, V76, P469, DOI 10.1016/S0006-3495(99)77214-0; Semba H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11635; Sidhu S, 2008, AM J PHYSIOL-HEART C, V295, pH946, DOI 10.1152/ajpheart.00363.2008; Simsek T, 2010, CELL STEM CELL, V7, P380, DOI 10.1016/j.stem.2010.07.011; Srinivasan M, 2010, AM J PHYSIOL-ENDOC M, V299, pE910, DOI 10.1152/ajpendo.00339.2010; TAKAKUBO F, 1992, EXP CELL RES, V199, P39, DOI 10.1016/0014-4827(92)90459-L; Takubo K, 2013, CELL STEM CELL, V12, P49, DOI 10.1016/j.stem.2012.10.011; Tang AH, 2014, EMBO J, V33, P2782, DOI 10.15252/embj.201488278; Tormos KV, 2011, CELL METAB, V14, P537, DOI 10.1016/j.cmet.2011.08.007; Wang C, 2015, J BIOL CHEM, V290, P29707, DOI 10.1074/jbc.M115.688671; Willkomm L, 2014, STEM CELL RES, V12, P742, DOI 10.1016/j.scr.2014.03.004; Xie LW, 2018, J CLIN INVEST, V128, P2339, DOI 10.1172/JCI96208; Yang X, 2017, J BIOL CHEM, V292, P5981, DOI 10.1074/jbc.M116.756312; Yu WM, 2013, CELL STEM CELL, V12, P62, DOI 10.1016/j.stem.2012.11.022; Zhang HB, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.143420; Zheng X, 2016, ELIFE, V5, DOI [10.7554/eLife.18638, 10.7554/eLife.13374]	61	12	12	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2019	33	7					8094	8109		10.1096/fj.201802479R	http://dx.doi.org/10.1096/fj.201802479R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ9SM	30939245	Green Submitted, Bronze			2022-12-26	WOS:000476234700024
J	Tanaka, M; Sugimoto, K; Fujimoto, T; Xie, KY; Takahashi, T; Akasaka, H; Kurinami, H; Yasunobe, Y; Matsumoto, T; Fujino, H; Rakugi, H				Tanaka, Minoru; Sugimoto, Ken; Fujimoto, Taku; Xie, Keyu; Takahashi, Toshimasa; Akasaka, Hiroshi; Kurinami, Hitomi; Yasunobe, Yukiko; Matsumoto, Tomohiro; Fujino, Hidemi; Rakugi, Hiromi			Preventive effects of low-intensity exercise on cancer cachexia-induced muscle atrophy	FASEB JOURNAL			English	Article						protein degradation; protein synthesis; hypoxia; AMPK; mTOR	ACTIVATED PROTEIN-KINASE; SKELETAL-MUSCLE; ELECTRICAL-STIMULATION; SYSTEMIC INFLAMMATION; VEGF EXPRESSION; TNF-ALPHA; AMPK; BEARING; CELLS; MICE	We hypothesized that low-intensity endurance exercise might be more effective in preventing cancer cachexia-induced muscle atrophy through both an increase in protein synthesis and a decrease in protein degradation. The purpose of present study was to evaluate the effects and to clarify the mechanism of low-intensity endurance exercise on cancer cachexia-induced muscle atrophy. Twenty-four male Wistar rats were randomly divided into 4 groups: control (Cont), Cont plus exercise (Ex), AH130-induced cancer cachexia (AH130), and AH130 plus Ex. Cancer cachexia was induced by intraperitoneal injections with AH130 Yoshida ascites hepatoma cells; we analyzed the changes in muscle mass and the gene and protein expression levels of major regulators or indicators of skeletal muscle protein degradation and synthesis pathway in the soleus muscles. Low-intensity exercise inhibited the muscle mass loss through a suppression of the ubiquitin-proteasome pathway, increased hypoxia-inducible factor- 1 alpha and phosphorylated AMPK, and inhibited the deactivation of mammalian target of rapamycin pathway in the soleus muscle, which contributed to the prevention of cancer cachexia-induced muscle atrophy. These results suggest that low-intensity exercise has the potential to become an effective therapeutic intervention for the prevention of cancer cachexia-induced muscle atrophy.-Tanaka, M., Sugimoto, K., Fujimoto, T., Xie, K., Takahashi, T., Akasaka, H., Kurinami, H., Yasunobe, Y., Matsumoto, T., Fujino, H., Rakugi, H. Preventive effects of low-intensity exercise on cancer cachexia-induced muscle atrophy.	[Tanaka, Minoru; Sugimoto, Ken; Fujimoto, Taku; Xie, Keyu; Takahashi, Toshimasa; Akasaka, Hiroshi; Kurinami, Hitomi; Yasunobe, Yukiko; Rakugi, Hiromi] Osaka Univ, Grad Sch Med, Dept Geriatr & Gen Med, B6 2-2, Suita, Osaka 5650871, Japan; [Tanaka, Minoru; Matsumoto, Tomohiro; Fujino, Hidemi] Kobe Univ, Grad Sch Hlth Sci, Dept Rehabil Sci, Kobe, Hyogo, Japan; [Tanaka, Minoru; Sugimoto, Ken] Osaka Hlth Sci Univ, Dept Rehabil Sci, Osaka, Japan	Osaka University; Kobe University	Sugimoto, K (corresponding author), Osaka Univ, Grad Sch Med, Dept Geriatr & Gen Med, B6 2-2, Suita, Osaka 5650871, Japan.	sugimoto@geriat.med.osaka-u.ac.jp		Takahashi, Toshimasa/0000-0002-5203-155X	Japanese Ministry of Education, Culture, Sports, Science, and Technology	Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The authors are grateful to Koichi Yamamoto and Yoichi Takami (both from Osaka University) for their advice. The authors also thank Tomoko Sato (Osaka University) for her excellent technical assistance. This study was supported by grants-in-aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science, and Technology. The authors declare no conflicts of interest.	ARAKI CT, 1994, J VASC SURG, V20, P872, DOI 10.1016/0741-5214(94)90223-2; Argiles JM, 2012, J CACHEXIA SARCOPENI, V3, P73, DOI 10.1007/s13539-012-0067-5; Busquets S, 2012, J CACHEXIA SARCOPENI, V3, P37, DOI 10.1007/s13539-011-0049-z; Cannavino J, 2015, J PHYSIOL-LONDON, V593, P1981, DOI 10.1113/jphysiol.2014.286740; Carbo N, 2002, BRIT J CANCER, V86, P1012, DOI 10.1038/sj.bjc.6600167; Deans C, 2005, CURR OPIN CLIN NUTR, V8, P265, DOI 10.1097/01.mco.0000165004.93707.88; Devine RD, 2017, AM J PHYSIOL-HEART C, V312, pH1154, DOI 10.1152/ajpheart.00090.2016; Egan B, 2013, CELL METAB, V17, P162, DOI 10.1016/j.cmet.2012.12.012; Emerling BM, 2009, FREE RADICAL BIO MED, V46, P1386, DOI 10.1016/j.freeradbiomed.2009.02.019; Fearon K, 2011, LANCET ONCOL, V12, P489, DOI 10.1016/S1470-2045(10)70218-7; Fernandez-Celemin L, 2002, AM J PHYSIOL-ENDOC M, V283, pE1279, DOI 10.1152/ajpendo.00054.2002; Fillmore N, 2010, J APPL PHYSIOL, V109, P511, DOI 10.1152/japplphysiol.00126.2010; Frier BC, 2012, AM J PHYSIOL-CELL PH, V302, pC1772, DOI 10.1152/ajpcell.00410.2011; Fujita J, 1996, INT J CANCER, V68, P637, DOI 10.1002/(SICI)1097-0215(19961127)68:5<637::AID-IJC14>3.0.CO;2-Z; HANSENSMITH FM, 1992, J APPL PHYSIOL, V73, P776, DOI 10.1152/jappl.1992.73.2.776; Harber MP, 2009, AM J PHYSIOL-REG I, V296, pR708, DOI [10.1152/ajpregu.00354.2009, 10.1152/ajpregu.90906.2008]; Huttemann M, 2012, FASEB J, V26, P1413, DOI 10.1096/fj.11-196154; Jackman RW, 2004, AM J PHYSIOL-CELL PH, V287, pC834, DOI 10.1152/ajpcell.00579.2003; Jiang CM, 2016, INT J BIOCHEM CELL B, V72, P118, DOI 10.1016/j.biocel.2016.01.011; Jorgensen SB, 2006, J PHYSIOL-LONDON, V574, P17, DOI 10.1113/jphysiol.2006.109942; Keith B, 2007, CELL, V129, P465, DOI 10.1016/j.cell.2007.04.019; Kim Hye Jin, 2017, J Exerc Nutrition Biochem, V21, P19, DOI 10.20463/jenb.2017.0022; KJAER M, 1993, AM J PHYSIOL, V265, pE275, DOI 10.1152/ajpendo.1993.265.2.E275; Kondo H, 2015, MUSCLE NERVE, V51, P391, DOI 10.1002/mus.24316; Laderoute KR, 2006, MOL CELL BIOL, V26, P5336, DOI 10.1128/MCB.00166-06; Li WD, 2015, ONCOTARGET, V6, P7365, DOI 10.18632/oncotarget.3629; Lira FS, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00856; Llovera M, 1998, MOL CELL ENDOCRINOL, V142, P183, DOI 10.1016/S0303-7207(98)00105-1; Marabita M, 2016, CELL REP, V17, P501, DOI 10.1016/j.celrep.2016.09.020; Mijwel S, 2018, FASEB J, V32, P5495, DOI 10.1096/fj.201700968R; Milne KJ, 2002, J APPL PHYSIOL, V93, P561, DOI 10.1152/japplphysiol.00528.2001; Ouchi N, 2005, CIRC RES, V96, P838, DOI 10.1161/01.RES.0000163633.10240.3b; Perry BD, 2016, EXERC IMMUNOL REV, V22, P94; Phillips SM, 2009, APPL PHYSIOL NUTR ME, V34, P403, DOI 10.1139/H09-042; Qi Y, 2014, RESP RES, V15, DOI 10.1186/s12931-014-0156-4; Rattigan YL, 2012, EXP CELL RES, V318, P326, DOI 10.1016/j.yexcr.2011.11.014; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; Salminen A, 2011, J MOL MED, V89, P667, DOI 10.1007/s00109-011-0748-0; Sanchez AMJ, 2012, AM J PHYSIOL-CELL PH, V303, pC475, DOI 10.1152/ajpcell.00125.2012; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sriwijitkamol A, 2007, DIABETES, V56, P836, DOI 10.2337/db06-1119; Takeshita H, 2017, SCI REP-UK, V7, DOI 10.1038/srep42323; Tanaka M, 2016, J MUSCULOSKEL NEURON, V16, P152; Tanaka M, 2014, ACTA HISTOCHEM, V116, P1192, DOI 10.1016/j.acthis.2014.06.009; Tanaka M, 2013, J MOL HISTOL, V44, P203, DOI 10.1007/s10735-012-9473-4; TESSITORE L, 1987, BIOCHEM J, V241, P153, DOI 10.1042/bj2410153; Tisdale MJ, 2010, CURR OPIN GASTROEN, V26, P146, DOI 10.1097/MOG.0b013e3283347e77; Uchida K, 2016, GEN PHYSIOL BIOPHYS, V35, P425, DOI 10.4149/gpb_2016016; White JP, 2013, AM J PHYSIOL-ENDOC M, V304, pE1042, DOI 10.1152/ajpendo.00410.2012; White J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022339	50	19	19	1	22	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2019	33	7					7852	7862		10.1096/fj.201802430R	http://dx.doi.org/10.1096/fj.201802430R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ9SM	30916585	Bronze			2022-12-26	WOS:000476234700006
J	Seshacharyulu, P; Rachagani, S; Muniyan, S; Siddiqui, JA; Cruz, E; Sharma, S; Krishnan, R; Killips, BJ; Sheinin, Y; Lele, SM; Smith, LM; Talmon, GA; Ponnusamy, MP; Datta, K; Batra, SK				Seshacharyulu, Parthasarathy; Rachagani, Satyanarayana; Muniyan, Sakthivel; Siddiqui, Jawed A.; Cruz, Eric; Sharma, Sunandini; Krishnan, Ramakrishnan; Killips, Brigham J.; Sheinin, Yuri; Lele, Subodh M.; Smith, Lynette M.; Talmon, Geoffrey A.; Ponnusamy, Moorthy P.; Datta, Kaustubh; Batra, Surinder K.			FDPS cooperates with PTEN loss to promote prostate cancer progression through modulation of small GTPases/AKT axis	ONCOGENE			English	Article							FARNESYL PYROPHOSPHATE SYNTHASE; ZOLEDRONIC ACID; IN-VITRO; CELL-PROLIFERATION; ISOPRENOID PATHWAY; BINDING; INHIBITION; EXPRESSION; TARGET; BISPHOSPHONATE	Farnesyl diphosphate synthase (FDPS), a mevalonate pathway enzyme, is highly expressed in several cancers, including prostate cancer (PCa). To date, the mechanistic, functional, and clinical significance of FDPS in cancer remains unexplored. We evaluated the FDPS expression and its cancer-associated phenotypes using in vitro and in vivo methods in PTEN-deficient and sufficient human and mouse PCa cells and tumors. Interestingly, FDPS overexpression synergizes with PTEN deficiency in PTEN conditionally knockout mice (P < 0.05) and expressed significantly higher in human (P < 0.001) PCa tissues, cell lines, and murine tumoroids compared to respective controls. In silico analysis revealed that FDPS is associated with increasing Gleason score, PTEN functionally deficient status, and poor survival of PCa. Ectopic overexpression of FDPS promotes oncogenic phenotypes such as colony formation (P < 0.01) and proliferation (P < 0.01) through activation of AKT and ERK signaling by prenylating Rho A, Rho G, and CDC42 small GTPases. Of interest, knockdown of FDPS in PCa cells exhibits decreased colony growth and proliferation (P < 0.001) by modulating AKT and ERK pathways. Further, genetic and pharmacological inhibition of PI3K but not AKT reduced FDPS expression. Pharmacological targeting of FDPS by zoledronic acid (ZOL), which is already in clinics, exhibit reduced growth and clonogenicity of human and murine PCa cells (P < 0.01) and 3D tumoroids (P < 0.02) by disrupting AKT and ERK signaling through direct interference of small GTPases protein prenylation. Thus, FDPS plays an oncogenic role in PTEN-deficient PCa through GTPase/AKT axis. Identifying mevalonate pathway proteins could serve as a therapeutic target in PTEN dysregulated tumors.	[Seshacharyulu, Parthasarathy; Rachagani, Satyanarayana; Muniyan, Sakthivel; Siddiqui, Jawed A.; Cruz, Eric; Sharma, Sunandini; Krishnan, Ramakrishnan; Killips, Brigham J.; Ponnusamy, Moorthy P.; Datta, Kaustubh; Batra, Surinder K.] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA; [Sheinin, Yuri; Lele, Subodh M.; Talmon, Geoffrey A.; Batra, Surinder K.] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA; [Smith, Lynette M.] Univ Nebraska Med Ctr, Dept Stat, Omaha, NE USA; [Ponnusamy, Moorthy P.; Datta, Kaustubh; Batra, Surinder K.] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Fred & Pamela Buffett Canc Ctr, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Batra, SK (corresponding author), Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA.; Batra, SK (corresponding author), Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA.; Batra, SK (corresponding author), Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Fred & Pamela Buffett Canc Ctr, Omaha, NE 68198 USA.	sbatra@unmc.edu	Krishnan, Ramakrishnan/AAX-6627-2020; Siddiqui, Jawed/G-9258-2017; Muniyan, Sakthivel/L-3868-2019; Seshacharyulu, Parthasarathy/AGL-7648-2022	Siddiqui, Jawed/0000-0003-1287-3004; Muniyan, Sakthivel/0000-0001-9405-7857; Seshacharyulu, Parthasarathy/0000-0002-2348-3901	United States Department of Defense [PC170891]; National Institutes of Health [P01 CA217798, UO1 CA185148, 1R01CA182435-01A1, P30 GM106397]; NATIONAL CANCER INSTITUTE [P01CA217798, U01CA185148] Funding Source: NIH RePORTER	United States Department of Defense(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work/authors are supported, in parts, by the grants from the United States Department of Defense Grant PC170891, National Institutes of Health (P01 CA217798, UO1 CA185148 and 1R01CA182435-01A1) and P30 GM106397.	Abate M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14495-6; Algur E, 2005, INT J RADIAT ONCOL, V61, P535, DOI 10.1016/j.ijrobp.2004.09.065; Allott EH, 2014, CANCER EPIDEM BIOMAR, V23, P2349, DOI 10.1158/1055-9965.EPI-14-0458; Bastian PJ, 2012, EUR UROL, V61, P1096, DOI 10.1016/j.eururo.2012.02.031; Beier F, 2010, J CELL BIOCHEM, V110, P573, DOI 10.1002/jcb.22604; Bifulco M, 2005, LIFE SCI, V77, P1740, DOI 10.1016/j.lfs.2005.05.017; Castellano Esther, 2011, Genes Cancer, V2, P261, DOI 10.1177/1947601911408079; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen M, 2018, NAT GENET, V50, P206, DOI 10.1038/s41588-017-0027-2; COX A D, 1992, Critical Reviews in Oncogenesis, V3, P365; Dhar MK, 2013, NEW BIOTECHNOL, V30, P114, DOI 10.1016/j.nbt.2012.07.001; Dunford JE, 2001, J PHARMACOL EXP THER, V296, P235; Ellwood-Yen K, 2003, CANCER CELL, V4, P223, DOI 10.1016/S1535-6108(03)00197-1; Ettinger SL, 2004, CANCER RES, V64, P2212, DOI 10.1158/0008-5472.CAN-2148-2; Ferraldeschi R, 2015, EUR UROL, V67, P795, DOI 10.1016/j.eururo.2014.10.027; Fraser M, 2017, NATURE, V541, P359, DOI 10.1038/nature20788; Gao D, 2014, CELL, V159, P176, DOI 10.1016/j.cell.2014.08.016; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Gritzalis D, 2015, BIOORG MED CHEM LETT, V25, P1117, DOI 10.1016/j.bmcl.2014.12.089; Hatziieremia S, 2016, MOL CARCINOGEN, V55, P1667, DOI 10.1002/mc.22417; Heemers H, 2001, MOL ENDOCRINOL, V15, P1817, DOI 10.1210/me.15.10.1817; Hein AL, 2016, CANCER RES, V76, P2243, DOI 10.1158/0008-5472.CAN-15-2119; Hirschey MD, 2015, SEMIN CANCER BIOL, V35, pS129, DOI 10.1016/j.semcancer.2015.10.002; Ishimoto K, 2010, BIOCHEM J, V429, P347, DOI 10.1042/BJ20091511; Jagdev SP, 2001, BRIT J CANCER, V84, P1126, DOI 10.1054/bjoc.2001.1727; Karabulut B, 2009, CELL BIOL INT, V33, P239, DOI 10.1016/j.cellbi.2008.11.011; Kaushik G, 2018, STEM CELLS, V36, P1329, DOI 10.1002/stem.2852; Kijima T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064615; Kwak MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053476; Lakshmanan I, 2016, ONCOGENE, V35, P4112, DOI 10.1038/onc.2015.478; Leon CG, 2010, PROSTATE, V70, P390, DOI 10.1002/pros.21072; Li L, 2010, BIOCHEM PHARMACOL, V79, P399, DOI 10.1016/j.bcp.2009.08.033; Liao Chun-Peng, 2010, Hormones & Cancer, V1, P44, DOI 10.1007/s12672-009-0005-y; Long Q, 2014, CANCER RES, V74, P3228, DOI 10.1158/0008-5472.CAN-13-2699; MALTESE WA, 1990, FASEB J, V4, P3319, DOI 10.1096/fasebj.4.15.2123808; Muniyan S, 2015, CELL SIGNAL, V27, P2261, DOI 10.1016/j.cellsig.2015.08.002; Neville-Webbe HL, 2010, BRIT J CANCER, V102, P1010, DOI 10.1038/sj.bjc.6605579; Ottewell PD, 2008, JNCI-J NATL CANCER I, V100, P1167, DOI 10.1093/jnci/djn240; Ozturk OH, 2007, CELL BIOL INT, V31, P1069, DOI 10.1016/j.cellbi.2007.02.004; Reilly JE, 2017, CANCER BIOL THER, V18, P872, DOI 10.1080/15384047.2016.1219817; Sharon C, 2015, ONCOTARGET, V6, P15332, DOI 10.18632/oncotarget.3684; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Souchek JJ, 2014, BRIT J CANCER, V111, P1139, DOI 10.1038/bjc.2014.385; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Taylor LG, 2009, CANCER-AM CANCER SOC, V115, P2388, DOI 10.1002/cncr.24283; Todenhofer T, 2013, WORLD J UROL, V31, P345, DOI 10.1007/s00345-012-0844-y; Ullen A, 2005, ACTA ONCOL, V44, P644, DOI 10.1080/02841860510029617; Wang J, 2008, J PROTEOME RES, V7, P3879, DOI 10.1021/pr8001645; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Yue SH, 2014, CELL METAB, V19, P393, DOI 10.1016/j.cmet.2014.01.019	50	18	20	0	3	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 27	2019	38	26					5265	5280		10.1038/s41388-019-0791-9	http://dx.doi.org/10.1038/s41388-019-0791-9			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	IF4AX	30914801	Green Accepted			2022-12-26	WOS:000473025300011
J	Tanaka, N; Nakajima, M; Narukawa-Nara, M; Matsunaga, H; Kamisuki, S; Aramasa, H; Takahashi, Y; Sugimoto, N; Abe, K; Terada, T; Miyanaga, A; Yamashita, T; Sugawara, F; Kamakura, T; Komba, S; Nakai, H; Taguchi, H				Tanaka, Nobukiyo; Nakajima, Masahiro; Narukawa-Nara, Megumi; Matsunaga, Hiroki; Kamisuki, Shinji; Aramasa, Hiroki; Takahashi, Yuta; Sugimoto, Naohisa; Abe, Koichi; Terada, Tohru; Miyanaga, Akimasa; Yamashita, Tetsuro; Sugawara, Fumio; Kamakura, Takashi; Komba, Shiro; Nakai, Hiroyuki; Taguchi, Hayao			Identification, characterization, and structural analyses of a fungal endo-beta-1,2-glucanase reveal a new glycoside hydrolase family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fungi; oligosaccharide; enzyme catalysis; enzyme structure; glycoside hydrolase; -1; 2-glucan; -1; 2-gluco-oligosaccharide; endo--1; 2-glucanase; novel glycoside hydrolase family; Talaromyces funiculosus	ACTIVE-SITE; CRYSTAL-STRUCTURE; N-ACETYLGLUCOSAMINIDASES; SECONDARY-STRUCTURE; MOLECULAR-DYNAMICS; ENZYME; MECHANISM; AGROBACTERIUM; COMPLEX; POLYSACCHARIDE	endo--1,2-Glucanase (SGL) is an enzyme that hydrolyzes -1,2-glucans, which play important physiological roles in some bacteria as a cyclic form. To date, no eukaryotic SGL has been identified. We purified an SGL from Talaromyces funiculosus (TfSGL), a soil fungus, to homogeneity and then cloned the complementary DNA encoding the enzyme. TfSGL shows no significant sequence similarity to any known glycoside hydrolase (GH) families, but shows significant similarity to certain eukaryotic proteins with unknown functions. The recombinant TfSGL (TfSGLr) specifically hydrolyzed linear and cyclic -1,2-glucans to sophorose (Glc--1,2-Glc) as a main product. TfSGLr hydrolyzed reducing-end-modified -1,2-gluco-oligosaccharides to release a sophoroside with the modified moiety. These results indicate that TfSGL is an endo-type enzyme that preferably releases sophorose from the reducing end of substrates. Stereochemical analysis demonstrated that TfSGL is an inverting enzyme. The overall structure of TfSGLr includes an (/)(6) toroid fold. The substrate-binding mode was revealed by the structure of a Michaelis complex of an inactive TfSGLr mutant with a -1,2-glucoheptasaccharide. Mutational analysis and action pattern analysis of -1,2-gluco-oligosaccharide derivatives revealed an unprecedented catalytic mechanism for substrate hydrolysis. Glu-262 (general acid) indirectly protonates the anomeric oxygen at subsite -1 via the 3-hydroxy group of the Glc moiety at subsite +2, and Asp-446 (general base) activates the nucleophilic water via another water. TfSGLr is apparently different from a GH144 SGL in the reaction and substrate recognition mechanism based on structural comparison. Overall, we propose that TfSGL and closely-related enzymes can be classified into a new family, GH162.	[Tanaka, Nobukiyo; Nakajima, Masahiro; Narukawa-Nara, Megumi; Matsunaga, Hiroki; Kamisuki, Shinji; Abe, Koichi; Sugawara, Fumio; Kamakura, Takashi; Taguchi, Hayao] Tokyo Univ Sci, Fac Sci & Technol, Dept Appl Biol Sci, 2641 Yamazaki, Noda, Chiba 2788510, Japan; [Kamisuki, Shinji] Azabu Univ, Sch Vet Med, Chuo Ku, 1-17-71 Fuchinobe, Sagamihara, Kanagawa 2525201, Japan; [Aramasa, Hiroki; Takahashi, Yuta; Sugimoto, Naohisa; Nakai, Hiroyuki] Niigata Univ, Fac Agr, Niigata 9502181, Japan; [Abe, Koichi; Terada, Tohru] Univ Tokyo, Grad Sch Agr & Life Sci, Agr Bioinformat Res Unit, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan; [Miyanaga, Akimasa] Tokyo Inst Technol, Sch Sci, Dept Chem, Meguro Ku, 2-12-1 O Okayama, Tokyo 1528551, Japan; [Yamashita, Tetsuro] Iwate Univ, Fac Agr, Morioka, Iwate 0208550, Japan; [Komba, Shiro] Natl Agr & Food Res Org, Food Res Inst, Food Component Anal Unit, 2-1-12 Kannondai, Tsukuba, Ibaraki 3058642, Japan	Tokyo University of Science; Azabu University; Niigata University; University of Tokyo; Tokyo Institute of Technology; Iwate University; National Agriculture & Food Research Organization - Japan	Nakajima, M (corresponding author), Tokyo Univ Sci, Fac Sci & Technol, Dept Appl Biol Sci, 2641 Yamazaki, Noda, Chiba 2788510, Japan.	m-nakajima@rs.tus.ac.jp	Terada, Tohru/W-2956-2019; Miyanaga, Akimasa/C-1472-2015; komba, shiro/GPJ-9657-2022	Terada, Tohru/0000-0002-7091-0646; Miyanaga, Akimasa/0000-0003-2219-6051; komba, shiro/0000-0002-6716-7409; Taguchi, Hayao/0000-0001-5270-581X; Nakajima, Masahiro/0000-0002-3182-0859	Platform Project for Supporting Drug Discovery and Life Science Research (Basis for Supporting Innovative Drug Discovery and Life Science Research (BINDS)) from AMED [JP18am0101107]	Platform Project for Supporting Drug Discovery and Life Science Research (Basis for Supporting Innovative Drug Discovery and Life Science Research (BINDS)) from AMED	This work was supported in part by the Platform Project for Supporting Drug Discovery and Life Science Research (Basis for Supporting Innovative Drug Discovery and Life Science Research (BINDS)) from AMED under Grant JP18am0101107. The authors declare that they have no conflicts of interest with the contents of this article.	Abbott DW, 2009, J BIOL CHEM, V284, P11676, DOI 10.1074/jbc.M809663200; Abe K., 2015, J APPL GLYCOSCI, V62, P47, DOI [DOI 10.5458/JAG.JAG, 10.5458/jag.jag.JAG-2014_011, DOI 10.5458/JAG.JAG.JAG-2014_011]; Abe K, 2018, J BIOL CHEM, V293, P8812, DOI 10.1074/jbc.RA117.001536; Abe K, 2017, J BIOL CHEM, V292, P7487, DOI 10.1074/jbc.M116.762724; Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; ALTABE S, 1990, J BACTERIOL, V172, P2563, DOI 10.1128/jb.172.5.2563-2567.1990; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bianchetti CM, 2015, J BIOL CHEM, V290, P11819, DOI 10.1074/jbc.M114.623579; BREEDVELD MW, 1995, MICROBIOL-SGM, V141, P583, DOI 10.1099/13500872-141-3-583; BUNDLE DR, 1988, INFECT IMMUN, V56, P1101, DOI 10.1128/IAI.56.5.1101-1106.1988; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Case D. A., 2018, AMBER 2019; Castro LDS, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-41; Ciocchini AE, 2007, P NATL ACAD SCI USA, V104, P16492, DOI 10.1073/pnas.0708025104; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; CREMER D, 1975, J AM CHEM SOC, V97, P1354, DOI 10.1021/ja00839a011; Davies GJ, 1998, BIOCHEMISTRY-US, V37, P11707, DOI 10.1021/bi981315i; de Grotthuss CJT, 2006, BBA-BIOENERGETICS, V1757, P871, DOI 10.1016/j.bbabio.2006.07.004; DELL A, 1983, CARBOHYD RES, V117, P185, DOI 10.1016/0008-6215(83)88086-0; Dennis RJ, 2006, NAT STRUCT MOL BIOL, V13, P365, DOI 10.1038/nsmb1079; DYLAN T, 1990, J BACTERIOL, V172, P1400, DOI 10.1128/jb.172.3.1400-1408.1990; DYLAN T, 1990, J BACTERIOL, V172, P1409, DOI 10.1128/jb.172.3.1409-1417.1990; DYLAN T, 1986, P NATL ACAD SCI USA, V83, P4403, DOI 10.1073/pnas.83.12.4403; Eisenhaber B, 2004, J MOL BIOL, V337, P243, DOI 10.1016/j.jmb.2004.01.025; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Ficko-Blean E, 2011, PROTEINS, V79, P2771, DOI 10.1002/prot.23116; Furtado GP, 2013, PROTEIN ENG DES SEL, V26, P15, DOI 10.1093/protein/gzs057; Gregg KJ, 2015, J BIOL CHEM, V290, P25657, DOI 10.1074/jbc.M115.680470; Guidolin LS, 2009, J BACTERIOL, V191, P1230, DOI 10.1128/JB.01108-08; Hasegawa H, 2009, CURR OPIN STRUC BIOL, V19, P341, DOI 10.1016/j.sbi.2009.04.003; Hehemann JH, 2012, J BIOL CHEM, V287, P13985, DOI 10.1074/jbc.M112.345645; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; HISAMATSU M, 1992, CARBOHYD RES, V231, P137, DOI 10.1016/0008-6215(92)84014-J; Hisamatsu M., 1984, J JPN SOC STARCH SCI, V31, P117, DOI [10.5458/jag1972.31.117, DOI 10.5458/JAG1972.31.117]; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Ishiguro R, 2017, FEBS LETT, V591, P3926, DOI 10.1002/1873-3468.12911; Ito T, 2014, BIOCHEM BIOPH RES CO, V447, P32, DOI 10.1016/j.bbrc.2014.03.096; Javvadi S, 2018, EMBO REP, V19, P172, DOI 10.15252/embr.201744650; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karakashian M. W, 1975, Symposia Soc exp Biol, VNo. 29, P145; Kirschner KN, 2008, J COMPUT CHEM, V29, P622, DOI 10.1002/jcc.20820; KITAHATA S, 1987, AGR BIOL CHEM TOKYO, V51, P2701; Kobayashi K, 2018, ANAL BIOCHEM, V560, P1, DOI 10.1016/j.ab.2018.08.021; Koivula A, 2002, J AM CHEM SOC, V124, P10015, DOI 10.1021/ja012659q; KOIZUMI K, 1984, J CHROMATOGR, V299, P215, DOI 10.1016/S0021-9673(01)97833-1; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel EB, 2004, SOFTWARE PRACT EXPER, V34, P591, DOI 10.1002/spe.588; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEVER M, 1972, ANAL BIOCHEM, V47, P273, DOI 10.1016/0003-2697(72)90301-6; Macdonald SS, 2015, J BIOL CHEM, V290, P4887, DOI 10.1074/jbc.M114.621110; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Markovic-Housley Z, 2000, STRUCTURE, V8, P1025, DOI 10.1016/S0969-2126(00)00511-6; MCCARTER JD, 1994, CURR OPIN STRUC BIOL, V4, P885, DOI 10.1016/0959-440X(94)90271-2; Miao F, 2012, MOLECULES, V17, P14091, DOI 10.3390/molecules171214091; MILLER KJ, 1986, SCIENCE, V231, P48, DOI 10.1126/science.3941890; Miyatake H, 2006, ACTA CRYSTALLOGR D, V62, P280, DOI 10.1107/S0907444905041909; Miyazaki T, 2016, J STRUCT BIOL, V196, P479, DOI 10.1016/j.jsb.2016.09.015; Munoz-Munoz J, 2017, P NATL ACAD SCI USA, V114, P4936, DOI 10.1073/pnas.1701130114; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagae M, 2007, J BIOL CHEM, V282, P18497, DOI 10.1074/jbc.M702246200; Nakae S, 2013, J MOL BIOL, V425, P4468, DOI 10.1016/j.jmb.2013.08.002; Nakajima M, 2017, SCI REP-UK, V7, DOI 10.1038/srep42671; Nakajima M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148870; Nakajima M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092353; Nakamura A, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500263; Ndeh D, 2017, NATURE, V544, P65, DOI 10.1038/nature21725; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; REESE ET, 1961, CAN J MICROBIOL, V7, P309, DOI 10.1139/m61-038; Reid CW, 2007, FEBS LETT, V581, P4988, DOI 10.1016/j.febslet.2007.09.037; Rigano LA, 2007, PLANT CELL, V19, P2077, DOI 10.1105/tpc.106.047944; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Roset MS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101279; Shimizu H, 2018, BIOCHEMISTRY-US, V57, P3849, DOI 10.1021/acs.biochem.8b00385; Solovyev V, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s10; Suarez ER, 2008, CARBOHYD RES, V343, P2623, DOI 10.1016/j.carres.2008.07.009; Synstad B, 2004, EUR J BIOCHEM, V271, P253, DOI 10.1046/j.1432-1033.2003.03923.x; Tanaka N, 2018, CARBOHYD RES, V468, P13, DOI 10.1016/j.carres.2018.08.005; Terada T, 2012, J PHYS CHEM B, V116, P6810, DOI 10.1021/jp2125558; Tiels P, 2012, NAT BIOTECHNOL, V30, P1225, DOI 10.1038/nbt.2427; TUOHY MG, 1993, BIOCHEM J, V290, P515, DOI 10.1042/bj2900515; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vocadlo DJ, 2008, CURR OPIN CHEM BIOL, V12, P539, DOI 10.1016/j.cbpa.2008.05.010; Vocadlo DJ, 2005, BIOCHEMISTRY-US, V44, P12809, DOI 10.1021/bi051121k; Watts AG, 2006, J BIOL CHEM, V281, P4149, DOI 10.1074/jbc.M510677200; Yamada C, 2017, CELL CHEM BIOL, V24, P515, DOI 10.1016/j.chembiol.2017.03.012	92	5	5	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2019	294	19					7942	7965		10.1074/jbc.RA118.007087	http://dx.doi.org/10.1074/jbc.RA118.007087			24	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IB3FL	30926603	hybrid, Green Published			2022-12-26	WOS:000470153300033
J	Zhang, Y; Chen, JN; Wang, Y; Wang, DH; Cong, WH; Lai, BS; Zhao, Y				Zhang, Yang; Chen, Jiannan; Wang, Yu; Wang, Dehua; Cong, Weihui; Lai, Bo Shiun; Zhao, Yi			Multilayer network analysis of miRNA and protein expression profiles in breast cancer patients	PLOS ONE			English	Article							CELL-PROLIFERATION; INVASION; OVEREXPRESSION; PROGRESSION; INVASIVENESS; SIGNATURES; REGULATOR; MIGRATION; PATHWAYS; TARGETS	MiRNAs and proteins play important roles in different stages of breast tumor development and serve as biomarkers for the early diagnosis of breast cancer. A new algorithm that combines machine learning algorithms and multilayer complex network analysis is hereby proposed to explore the potential diagnostic values of miRNAs and proteins. XGBoost and random forest algorithms were employed to screen the most important miRNAs and proteins. Maximal information coefficient was applied to assess intralayer and interlayer connection. A multilayer complex network was constructed to identify miRNAs and proteins that could serve as biomarkers for breast cancer. Proteins and miRNAs that are nodes in the network were subsequently categorized into two network layers considering their distinct functions. The betweenness centrality was used as the first measurement of the importance of the nodes within each single layer. The degree of the nodes was chosen as the second measurement to map their signalling pathways. By combining these two measurements into one score and comparing the difference of the same candidate between normal tissue and cancer tissue, this novel multilayer network analysis could be applied to successfully identify molecules associated with breast cancer.	[Zhang, Yang; Chen, Jiannan; Wang, Yu; Wang, Dehua; Cong, Weihui; Zhao, Yi] Harbin Inst Technol Shenzhen, Shenzhen, Guangdong, Peoples R China; [Lai, Bo Shiun] Johns Hopkins Univ, Sch Med, Baltimore, MD USA	Harbin Institute of Technology; Johns Hopkins University	Zhao, Y (corresponding author), Harbin Inst Technol Shenzhen, Shenzhen, Guangdong, Peoples R China.	zhao.yi@hit.edu.cn	Zhao, Yi/AAX-3232-2020; Zhang, Yang/AAK-8021-2021	Zhang, Yang/0000-0002-3503-5161; chen, jiannan/0000-0002-6816-7056	National Natural Nature Science Foundation of China [61573119]; Fundamental Research Project of Shenzhen [JCYJ20170307150444573, JCYJ20180306172131515, JCYJ201703071513122153, JCYJ20150625142543468]	National Natural Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Project of Shenzhen	The project is supported by the National Natural Nature Science Foundation of China under Project No. 61573119 to Y Zhao and a Fundamental Research Project of Shenzhen under Project Nos. JCYJ20170307150444573 to Y Zhang, JCYJ20180306172131515 to Y Zhang, JCYJ201703071513122153 to Y Zhao, and JCYJ20150625142543468 to Y Zhao.	Azoulay-Alfaguter I, 2015, ONCOGENE, V34, P4613, DOI 10.1038/onc.2014.390; Biau G, 2016, TEST-SPAIN, V25, P197, DOI 10.1007/s11749-016-0481-7; Borgatti SP, 2005, SOC NETWORKS, V27, P55, DOI 10.1016/j.socnet.2004.11.008; Bosch A, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4442; Boulay PL, 2016, CANCER RES, V76, P2662, DOI 10.1158/0008-5472.CAN-15-2782; Cai J, 2013, J CLIN INVEST, V123, DOI [10.1007/s10549-011-1604-1, DOI 10.1007/S10549-011-1604-1]; Cantini L, 2015, SCI REP-UK, V5, DOI 10.1038/srep17386; Chang CH, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0257-3; Chao YL, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-179; Chen TQ, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P785, DOI 10.1145/2939672.2939785; Chen X, 2014, NATURE, V508, P103, DOI 10.1038/nature13119; Chu A, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv808; De Domenico M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7868; Escudero-Esparza A, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-43; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gasparini P, 2014, P NATL ACAD SCI USA, V111, P4536, DOI 10.1073/pnas.1402604111; Hardy SD, INVESTIGATING ROLE S; Hong YT, 2016, SCI REP-UK, V6, DOI 10.1038/srep37421; Hsieh TH, 2012, FASEB J, V26, P778, DOI 10.1096/fj.11-191742; Inza I, 2004, ARTIF INTELL MED, V31, P91, DOI 10.1016/j.artmed.2004.01.007; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Johnson N, 2011, NAT MED, V17, P875, DOI 10.1038/nm.2377; Joly MM, 2016, CANCER RES, V76, P4752, DOI 10.1158/0008-5472.CAN-15-3393; Karousou E, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/606458; Keklikoglou I, 2012, ONCOGENE, V31, P4150, DOI 10.1038/onc.2011.571; Kholoussi NM, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/249372; Kinoshita T, 2013, BRIT J CANCER, V109, P2636, DOI 10.1038/bjc.2013.607; Kivela M, 2014, J COMPLEX NETW, V2, P203, DOI 10.1093/comnet/cnu016; Knezevic J, 2015, ONCOGENE, V34, P5997, DOI 10.1038/onc.2015.48; Krishnan K, 2013, RNA, V19, P1767, DOI 10.1261/rna.042143.113; Lee JH, 2010, CANCER RES; Leung MKK, 2016, P IEEE, V104, P176, DOI 10.1109/JPROC.2015.2494198; Li M, 2015, INT J ONCOL, V47, P296, DOI 10.3892/ijo.2015.3015; Lin SB, 2015, NAT REV CANCER, V15, P321, DOI 10.1038/nrc3932; Lin WH, 2016, BIOMED PHARMACOTHER, V83, P177, DOI 10.1016/j.biopha.2016.06.011; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lu J, 2009, CANCER CELL, V16, P195, DOI 10.1016/j.ccr.2009.08.010; Macedo T, 2017, ONCOL LETT, V14, P1054, DOI 10.3892/ol.2017.6265; Paplomata E, 2014, THER ADV MED ONCOL, V6, P154, DOI 10.1177/1758834014530023; Rai A, 2017, SCI REP-UK, V7, DOI 10.1038/srep41676; Rao X, 2011, ONCOGENE, V30, P1082, DOI 10.1038/onc.2010.487; Reshef DN, 2011, SCIENCE, V334, P1518, DOI 10.1126/science.1205438; Ricketts CJ, 2018, CELL REP, V23, P313, DOI [10.1016/j.celrep.2018.03.075, 10.1016/j.celrep.2018.06.032]; Simpkins SA, 2012, J PATHOL, V227, P490, DOI 10.1002/path.4034; Sun LH, 2011, BRAIN RES, V1389, P9, DOI 10.1016/j.brainres.2011.03.013; Taipaleenmaki H, 2015, CANCER RES, V75, P1433, DOI 10.1158/0008-5472.CAN-14-1026; Taylor DD, 2008, GYNECOL ONCOL, V110, P13, DOI 10.1016/j.ygyno.2008.04.033; Uhlmann S, 2010, ONCOGENE, V29, P4297, DOI 10.1038/onc.2010.201; Viera AJ, 2005, FAM MED, V37, P360; Volinia S, 2012, P NATL ACAD SCI USA, V109, P3024, DOI 10.1073/pnas.1200010109; Wang J., 2016, SCI REP-UK, V6, P1, DOI [DOI 10.1038/SREP27327, 10.1038/s41598-016-0001-8]; Wisniewski JR, 2011, J PROTEOME RES, V10, P3040, DOI 10.1021/pr200019m; Wu BL, 2003, BIOINFORMATICS, V19, P1636, DOI 10.1093/bioinformatics/btg210; Xie FY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185565; Yan LX, 2008, RNA, V14, P2348, DOI 10.1261/rna.1034808; Yang MH, 2011, BREAST CANCER RES TR, V129, P983, DOI 10.1007/s10549-011-1604-1; Zhang JG, 2015, SCI REP-UK, V5, DOI 10.1038/srep08087	58	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0202311	10.1371/journal.pone.0202311	http://dx.doi.org/10.1371/journal.pone.0202311			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR7EH	30946749	Green Submitted, gold, Green Published			2022-12-26	WOS:000463314500001
J	Li, Y; Tang, XP; Zhao, ZQ; Wang, H; Wang, X; Shang, XY; Liu, P; Kou, ZH; Jiang, YQ; Li, Y				Li, Yan; Tang, Xueping; Zhao, Zunquan; Wang, Hui; Wang, Xin; Shang, Xueyi; Liu, Peng; Kou, Zhihua; Jiang, Yongqiang; Li, Yan			Intranasal immunization with recombinant outer membrane protein A induces protective immune response against Stenotrophomonas maltophilia infection	PLOS ONE			English	Article							MUCOSAL IMMUNIZATION; VACCINE; MICE; CELLS; OMPA	Stenotrophomonas maltophilia (S. maltophilia), a multi-drug resistant opportunistic pathogen, is associated with nosocomial and community-acquired infections. Preventive and therapeutic strategies for such infections are greatly needed. In this study, sequence alignment analysis revealed that Outer membrane protein A (OmpA) was highly conserved among S. maltophilia strains but shared no significant similarity with human and mouse proteomes. In mice, intranasal immunization with S. maltophilia recombinant OmpA (rOmpA) without additional adjuvant induced sustained mucosal and systemic rOmpA-specific antibody responses. Treatment with rOmpA stimulated significantly higher levels of secretion of IFN., IL-2, and IL-17A (All P<0.05) from the primary splenocytes isolated from rOmpA-immunized mice than from the primary splenocytes isolated from PBS-immunized mice. Furthermore, mice immunized with rOmpA showed significantly reduced bacterial burden in the lung and reduced levels of pro-inflammatory cytokines (TNF-alpha and IL-6) in bronchoalveolar lavage fluid (BALF) 24 hours after intranasal S. maltophilia infection, indicating that immunization with rOmpA may have protective effects against S. maltophilia challenge in mice. Our findings suggest that intranasal immunization with rOmpA may induce mucosal and systemic immune responses in mice, trigger Th1- and Th17-mediated cellular immune responses, and thus stimulate host immune defense against S. maltophilia infection. These results also demonstrate that intranasal vaccination may offer an alternative approach to current strategies since it induces a mucosal as well as a systemic immune response.	[Li, Yan; Li, Yan] Anhui Med Univ, Hosp PLA 307, Hefei, Anhui, Peoples R China; [Li, Yan; Tang, Xueping; Wang, Xin; Shang, Xueyi; Li, Yan] 307 Hosp PLA, Dept Crit Care Med, Beijing, Peoples R China; [Li, Yan] Fengyang First Peoples Hosp, Dept Resp & Digest, Fengyang, Anhui, Peoples R China; [Zhao, Zunquan; Wang, Hui; Liu, Peng; Kou, Zhihua; Jiang, Yongqiang] Acad Mil Med Sci, Inst Microbiol & Epidemiol, Beijing, Peoples R China	Anhui Medical University; Fifth Medical Center of Chinese PLA General Hospital; Academy of Military Medical Sciences - China	Li, Y (corresponding author), Anhui Med Univ, Hosp PLA 307, Hefei, Anhui, Peoples R China.; Li, Y (corresponding author), 307 Hosp PLA, Dept Crit Care Med, Beijing, Peoples R China.; Jiang, YQ (corresponding author), Acad Mil Med Sci, Inst Microbiol & Epidemiol, Beijing, Peoples R China.	liyanmdhuxi@163.com; jiangyq@nic.bmi.ac.cn	Shang, Xueyi/O-7478-2018; Zhao, Zunquan/AAA-2101-2020; Liu, Peng/V-9305-2019	Shang, XueYi/0000-0002-0818-2043	National Natural Science Foundation of China [81571959, 81071399]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (81571959, 81071399). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belzunegui J, 2000, CLIN EXP RHEUMATOL, V18, P265; Bertot GM, 2007, INFECT IMMUN, V75, P2740, DOI 10.1128/IAI.01668-06; Brooke JS, 2012, CLIN MICROBIOL REV, V25, P2, DOI 10.1128/CMR.00019-11; Cha MK, 2016, DIAGN MICR INFEC DIS, V85, P210, DOI 10.1016/j.diagmicrobio.2016.02.020; Chalifour A, 2004, BLOOD, V104, P1778, DOI 10.1182/blood-2003-08-2820; Chen YY, 2015, J MICROBIOL, V53, P535, DOI 10.1007/s12275-015-5202-5; Cho SY, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0801-7; Correia CR, 2014, PEDIATR INT, V56, pE21, DOI 10.1111/ped.12352; Crossman LC, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r74; Cui ZY, 2015, APPL MICROBIOL BIOT, V99, P667, DOI 10.1007/s00253-014-6147-z; Davis SS, 2001, ADV DRUG DELIVER REV, V51, P21, DOI 10.1016/S0169-409X(01)00162-4; Dutzan N, 2017, IMMUNITY, V46, P133, DOI 10.1016/j.immuni.2016.12.010; Fan HY, 2014, CLIN VACCINE IMMUNOL, V21, P126, DOI 10.1128/CVI.00434-13; Guan QF, 2015, APPL MICROBIOL BIOT, V99, P5451, DOI 10.1007/s00253-014-6339-6; Huntley JF, 2008, INFECT IMMUN, V76, P3664, DOI 10.1128/IAI.00374-08; Iliev ID, 2017, NAT REV IMMUNOL, V17, P635, DOI 10.1038/nri.2017.55; Jahangiri A, 2017, MICROB PATHOGENESIS, V105, P201, DOI 10.1016/j.micpath.2017.02.028; Jeannin P, 2002, VACCINE, V20, pA23, DOI 10.1016/S0264-410X(02)00383-3; Khassawneh M, 2010, PEDIATR NEPHROL, V25, P1377, DOI 10.1007/s00467-010-1473-6; Kim DK, 2000, VACCINE, V19, P1274, DOI 10.1016/S0264-410X(00)00235-8; Koebnik R, 2000, MOL MICROBIOL, V37, P239, DOI 10.1046/j.1365-2958.2000.01983.x; Liu YS, 2014, INFECT IMMUN, V82, P1666, DOI 10.1128/IAI.01391-13; Liu ZZ, 2016, BMC IMMUNOL, V17, DOI 10.1186/s12865-016-0173-9; Lopez-Cardenas S, 2012, MED CLIN-BARCELONA, V138, P411, DOI 10.1016/j.medcli.2011.07.002; Luo GPS, 2012, PLOS ONE, V7, P46, DOI 10.1371/journal.pone.0029446; McConnell MJ, 2011, INFECT IMMUN, V79, P518, DOI 10.1128/IAI.00741-10; McConnell MJ, 2010, VACCINE, V29, P1, DOI 10.1016/j.vaccine.2010.10.052; Nicodemo AC, 2007, EUR J CLIN MICROBIOL, V26, P229, DOI 10.1007/s10096-007-0279-3; O'Hagan DT, 2003, NAT REV DRUG DISCOV, V2, P727, DOI 10.1038/nrd1176; Pore D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022663; Rousseau A, 2004, LEUKEMIA LYMPHOMA, V45, P1293, DOI 10.1080/10428190310001638850; St Leger AJ, 2017, IMMUNITY, V47, P148, DOI 10.1016/j.immuni.2017.06.014; Subhani Shaik, 2016, Indian Heart J, V68 Suppl 2, pS267, DOI 10.1016/j.ihj.2015.07.048; Takahashi I, 2009, CURR OPIN IMMUNOL, V21, P352, DOI 10.1016/j.coi.2009.04.002; Wang XL, 2016, FISH SHELLFISH IMMUN, V57, P318, DOI 10.1016/j.fsi.2016.08.054; Xu GY, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3258-7; Yagnik B, 2017, J APPL MICROBIOL, V122, P493, DOI 10.1111/jam.13353; Zgair AK, 2011, J MED MICROBIOL, V60, P1032, DOI 10.1099/jmm.0.026377-0; Zhang XJ, 2016, MICROB PATHOGENESIS, V96, P20, DOI 10.1016/j.micpath.2016.04.019	39	6	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2019	14	4							e0214596	10.1371/journal.pone.0214596	http://dx.doi.org/10.1371/journal.pone.0214596			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR1CY	30934008	Green Submitted, Green Published, gold			2022-12-26	WOS:000462867000026
J	Tabor, A; Vollaard, N; Keogh, E; Eccleston, C				Tabor, Abby; Vollaard, Niels; Keogh, Edmund; Eccleston, Christopher			Predicting the consequences of physical activity: An investigation into the relationship between anxiety sensitivity, interoceptive accuracy and action	PLOS ONE			English	Article							FEAR-AVOIDANCE MODEL; HEART-RATE; PANIC-ATTACKS; PAIN; BELIEFS; BRAIN; PERCEPTION	The ability to predict the consequences of our actions is imperative for the everyday success of our interactions. From negotiating an uneven surface, to mounting an immune response, we continually infer the limits of our body. The current investigation considered the impact that the inferred consequences of action has on the placement of limits. We hypothesised that the performance of individuals in a novel, sprint task would reflect both their ability to accurately detect changes in bodily arousal (Interoceptive Accuracy) and the inferred consequences associated with heightened arousal signals (Anxiety Sensitivity). We found that individuals who demonstrated accuracy associated with physiological arousal changes, and who showed a heightened fear of the consequences of arousal symptoms, modified their actions by decreasing their power output (mean Watts.kg(-1)) in a sprint task (Delta R-2= 0.19; F (1,34) = 19.87); p<0.001). These findings provide a basis for understanding the varying actions taken as we encounter bodily perturbation.	[Tabor, Abby; Keogh, Edmund; Eccleston, Christopher] Univ Bath, Dept Hlth, Ctr Pain Res, Bath, Avon, England; [Vollaard, Niels] Univ Bath, Dept Hlth, Bath, Avon, England; [Eccleston, Christopher] Univ Ghent, Dept Clin & Hlth Psychol, Ghent, Belgium	University of Bath; University of Bath; Ghent University	Tabor, A (corresponding author), Univ Bath, Dept Hlth, Ctr Pain Res, Bath, Avon, England.	a.tabor@bath.ac.uk		Keogh, Edmund/0000-0002-1615-3699; Eccleston, Christopher/0000-0003-0698-1543	Reckitt Benckiser Healthcare (United Kingdom) Limited; EPSRC [EP/M023281/1] Funding Source: UKRI	Reckitt Benckiser Healthcare (United Kingdom) Limited; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by an unrestricted grant for research from Reckitt Benckiser Healthcare (United Kingdom) Limited awarded to Professor Christopher Eccleston. Co-author Prof Ed Keogh has provided unrelated consultancy services to Reckitt Benckiser UK Commercial Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], HDB BIOBEHAVIORAL AP; Boutelle Kerri N, 2004, Int J Behav Nutr Phys Act, V1, P13, DOI 10.1186/1479-5868-1-13; Brener J, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2016.0015; Cameron OG, 2001, PSYCHOSOM MED, V63, P697, DOI 10.1097/00006842-200109000-00001; Clark A, 2015, OPEN MIND, P1, DOI [10.15502/9783958570115, DOI 10.15502/9783958570115]; Clark A, 2013, BEHAV BRAIN SCI, V36, P181, DOI 10.1017/S0140525X12000477; Craig AD, 2004, TRENDS COGN SCI, V8, P239, DOI 10.1016/j.tics.2004.04.004; Critchley HD, 2013, NEURON, V77, P624, DOI 10.1016/j.neuron.2013.02.008; Crombez G, 2012, CLIN J PAIN, V28, P475, DOI 10.1097/AJP.0b013e3182385392; Dunn BD, 2010, BEHAV RES THER, V48, P1133, DOI 10.1016/j.brat.2010.07.006; Eccleston C., 2016, EMBODIED PSYCHOL PHY; Farb N, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00763; Feldman H, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00215; Friston KJ, 2010, NAT REV NEUROSCI, V11, P127, DOI 10.1038/nrn2787; Garfinkel SN, 2015, BIOL PSYCHOL, V104, P65, DOI 10.1016/j.biopsycho.2014.11.004; Giles D, 2016, EUR J APPL PHYSIOL, V116, P563, DOI 10.1007/s00421-015-3303-9; Hayes A. F., 2012, PROCESS VERSATILE CO; Herbert BM, 2007, PSYCHOPHYSIOLOGY, V44, P194, DOI 10.1111/j.1469-8986.2007.00493.x; Keogh E, 2004, PAIN, V111, P209, DOI 10.1016/j.pain.2004.06.017; Keogh E, 2002, J PAIN, V3, P320, DOI 10.1054/jpai.2002.125182; Knapp K, 1997, PSYCHOPHYSIOLOGY, V34, P467, DOI 10.1111/j.1469-8986.1997.tb02391.x; McCormick A, 2015, SPORTS MED, V45, P997, DOI 10.1007/s40279-015-0319-6; McNally RJ, 2002, BIOL PSYCHIAT, V52, P938, DOI 10.1016/S0006-3223(02)01475-0; Meacham F, 2016, EVOL MED PUBLIC HLTH, P270, DOI 10.1093/emph/eow024; Meulders A, 2011, PAIN, V152, P2460, DOI 10.1016/j.pain.2011.05.015; Morris JS, 2002, TRENDS COGN SCI, V6, P317, DOI 10.1016/S1364-6613(02)01946-0; Moshier SJ, 2016, BEHAV MODIF, V40, P178, DOI 10.1177/0145445515603704; Nam S, 2012, J CARDIOPULM REHABIL, V32, P370, DOI 10.1097/HCR.0b013e31826be485; Paulus MP, 2010, BRAIN STRUCT FUNCT, V214, P451, DOI 10.1007/s00429-010-0258-9; Paulus MP, 2009, NEUROSCI BIOBEHAV R, V33, P1080, DOI 10.1016/j.neubiorev.2009.05.003; Pezzulo G, 2014, COGN AFFECT BEHAV NE, V14, P902, DOI 10.3758/s13415-013-0227-x; Philippe RA, 2005, PERCEPT MOTOR SKILL, V101, P440, DOI 10.2466/PMS.101.6.440-444; Pollatos O, 2007, INT J PSYCHOPHYSIOL, V65, P167, DOI 10.1016/j.ijpsycho.2007.03.005; Pollatos O, 2012, PAIN, V153, P1680, DOI 10.1016/j.pain.2012.04.030; Porges, 1993, BODY PERCEPTION QUES; REISS S, 1991, CLIN PSYCHOL REV, V11, P141, DOI 10.1016/0272-7358(91)90092-9; Ring C, 1996, PSYCHOPHYSIOLOGY, V33, P541, DOI 10.1111/j.1469-8986.1996.tb02430.x; Ring C, 2018, PSYCHOPHYSIOLOGY, V6; Ring C, 2015, BIOL PSYCHOL, V104, P193, DOI 10.1016/j.biopsycho.2014.12.010; SALLIS JF, 1986, PREV MED, V15, P331, DOI 10.1016/0091-7435(86)90001-0; SCHANDRY R, 1981, PSYCHOPHYSIOLOGY, V18, P483, DOI 10.1111/j.1469-8986.1981.tb02486.x; Schmidt NB, 1997, J ABNORM PSYCHOL, V106, P355, DOI 10.1037/0021-843X.106.3.355; Schmidt NB, 2006, J PSYCHIATR RES, V40, P691, DOI 10.1016/j.jpsychires.2006.07.009; Seth AK, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2016.0007; Smits JAJ, 2008, DEPRESS ANXIETY, V25, P689, DOI 10.1002/da.20411; Smits Jasper A. J., 2010, Cognitive Behaviour Therapy, V39, P28, DOI 10.1080/16506070902915261; Taylor S, 2007, PSYCHOL ASSESSMENT, V19, P176, DOI 10.1037/1040-3590.19.2.176; Vilares I, 2011, ANN NY ACAD SCI, V1224, P22, DOI 10.1111/j.1749-6632.2011.05965.x; Vlaeyen JWS, 2012, PAIN, V153, P1144, DOI 10.1016/j.pain.2011.12.009; Wiese W, 2015, OPEN MIND, DOI [10.15502/9783958570108, DOI 10.15502/9783958570108]; Windmann S, 1999, PSYCHOPHYSIOLOGY, V36, P339, DOI 10.1017/S0048577299980381	51	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0210853	10.1371/journal.pone.0210853	http://dx.doi.org/10.1371/journal.pone.0210853			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HQ7IR	30921331	Green Submitted, Green Published, gold			2022-12-26	WOS:000462594000006
J	Abdel-Azeem, AM; Held, BW; Richards, JE; Davis, SL; Blanchette, RA				Abdel-Azeem, Ahmed M.; Held, Benjamin W.; Richards, Janet E.; Davis, Suzanne L.; Blanchette, Robert A.			Assessment of biodegradation in ancient archaeological wood from the Middle Cemetery at Abydos, Egypt	PLOS ONE			English	Article							SOFT-ROT FUNGI; DECAY; DEGRADATION; GORDION	Abydos is a large, complex archaeological site located approximately 500 km south of Cairo in Upper Egypt. The site has served as a cemetery for thousands of years and is where most of the Early Dynastic royal tombs are located. North Abydos includes the Middle Cemetery and the North Cemetery, which are separated from each other by a wadi. The Middle Cemetery was the burial ground for important Sixth Dynasty (2407-2260 BC) officials and over time for thousands of elite and non-elite individuals as well. Excavations at the core area of the Old Kingdom mortuary landscape have revealed many culturally important wooden objects but these are often found with extensive deterioration that can compromise their preservation. The objectives of this study were to characterize the biodegradation that has taken place in excavated wooden objects, elucidate the type of wood degradation present, obtain information on soil properties at the site and identify fungi currently associated with the wood and soils. Light and scanning electron microscopy studies were used to observe the micromorphological characteristics of the wood, and culturing on different media was done to isolate fungi. Identification of the fungi was done by examining morphological characteristics and extracting rDNA from pure cultures and sequencing the ITS region. Wooden objects, made from Cedrus, Juniperus and Acacia as well as several unidentified hardwoods, were found with extensive degradation and were exceedingly fragile. Termite damage was evident and frass from the subterranean termites along with sand particles were present in most woods. Evidence of soft rot attack was found in sections of wood that remained. Fungi isolated from wood and soils were identified as species of Aspergillus, Chaetomium, Cladosporium, Fusarium, Penicillium, Stemphylium Talaromyces and Trichoderma. Results provide important information on the current condition of the wood and gives insights to the identity of the fungi in wood and soils at the site. These results provide needed information to help develop conservation plans to preserve these degraded and fragile wooden objects.	[Abdel-Azeem, Ahmed M.] Suez Canal Univ, Fac Sci, Bot Dept, Ismailia, Egypt; [Held, Benjamin W.; Blanchette, Robert A.] Univ Minnesota, Dept Plant Pathol, St Paul, MN 55455 USA; [Richards, Janet E.] Univ Michigan, Dept Near Eastern Studies, Abydos Middle Cemetery Project, Ann Arbor, MI 48109 USA; [Davis, Suzanne L.] Univ Michigan, Kelsey Museum Archaeol, Abydos Middle Cemetery Project, Ann Arbor, MI 48109 USA	Egyptian Knowledge Bank (EKB); Suez Canal University; University of Minnesota System; University of Minnesota Twin Cities; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Blanchette, RA (corresponding author), Univ Minnesota, Dept Plant Pathol, St Paul, MN 55455 USA.	robertb@umn.edu	Abdel-Azeem, Ahmed Mohamed Ahmed/I-3637-2015	Abdel-Azeem, Ahmed Mohamed Ahmed/0000-0003-2897-3966; Davis, Suzanne/0000-0001-6667-2203; Blanchette, Robert A./0000-0003-2819-6511	AMA, Science and Development Technology Fund in Egypt (STF) [12295]; American Research Center in Egypt	AMA, Science and Development Technology Fund in Egypt (STF); American Research Center in Egypt	Funded by AMA, Science and Development Technology Fund in Egypt (STF project No. 12295). http://stdf.org.eg/old/.JR, Antiquities Endowment Fund grant from the American Research Center in Egypt. https://www.arce.org/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Azeem, 1991, BIOL DIV S INT CEL M, P241; Abdel-Azeem, 2009, ASSIUT U J BOT, V38, P29; Abdel-Azeem A. M., 2004, Egyptian Journal of Biology, V6, P21; Abdel-Azeem AM, 2003, THESIS; Allen S. E., 1976, Methods in plant ecology., P411; [Anonymous], 1976, MORE DEMATIACEOUS HY, DOI DOI 10.1079/9780851983653.0000; Balachandran S., 2010, BRIT ARCHAEOLOGICAL, V2116, P77; Blanchette R.A, 1994, J AM INST CONSERV, V33, P55, DOI DOI 10.1179/019713694806066428; Blanchette RA, 2004, APPL ENVIRON MICROB, V70, P1328, DOI 10.1128/AEM.70.3.1328-1335.2004; BLANCHETTE RA, 1992, IAWA BULL, V13, P201, DOI 10.1163/22941932-90001269; Blanchette RA, 2000, INT BIODETER BIODEGR, V46, P189, DOI 10.1016/S0964-8305(00)00077-9; BLANCHETTE RA, 1990, ADV CHEM SER, P141; BLANCHETTE RA, 2004, CONSERV MANAG ARCHEO, V6, P203, DOI DOI 10.1179/135050304793137775; Blanchette RA, 2016, FUNGAL ECOL, V23, P58, DOI 10.1016/j.funeco.2016.06.001; Blanchette RA, 2010, MICROB ECOL, V60, P29, DOI 10.1007/s00248-010-9664-z; Booth C., 1971, FUSARIUM LAB GUIDE I; Carter H., 1923, TOMB TUTANKHAMEN DIS, V3; Chemello Claudia., 2014, B AM RES CTR EGYPT, V204, P13; Darwish SS, 2013, INT J CONSERV SCI, V4, P271; Diab MS, 2002, ANN GEOL SURV EGYPT, VXXV, P487; Domsch KH, 2007, COMPENDIUM SOIL FUNG; El Hadidi NMN, 2017, STUD CONSERV, V62, P83, DOI 10.1179/2047058415Y.0000000028; El-Fouly MZ, 2011, ANN MICROBIOL, V61, P789, DOI 10.1007/s13213-011-0197-6; Ellis MB, 1971, DEMATIACEOUS HYPHOMY; Eriksson K.-E., 1990, MICROBIAL ENZYMATIC; Filley TR, 2001, P NATL ACAD SCI USA, V98, P13346, DOI 10.1073/pnas.221299598; Garrett SD, 1981, SOIL FUNGI SOIL FERT; Guarro J, 2012, CBS BIODIVERSITY SER, V10; Hamed SAM, 2013, INT BIODETER BIODEGR, V78, P98, DOI 10.1016/j.ibiod.2012.12.013; Held BW, 2017, FUNGAL BIOL-UK, V121, P145, DOI 10.1016/j.funbio.2016.11.009; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Klich M. A., 2002, IDENTIFICATION COMMO; Landvatter T., 2013, NEAR EAST ARCHAEOL, V76, P235; Loyd AL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199738; Mansour M, 2012, EGYPT J ARCHAEOL RES, V2, P91; Mansour M., 2007, THESIS; MOHARRAM AM, 1992, MYCOLOGIA, V84, P930, DOI 10.2307/3760295; NILSSON T, 1990, ADV CHEM SER, P67; Nilsson T., 1973, STUDIA FORESTALIA SU; OConnor David, 2009, ABYDOS EGYPTS 1 PHAR; Ortiz R, 2014, MICROB ECOL, V67, P568, DOI 10.1007/s00248-013-0358-1; Osman MES, 2014, INT J CONSERV SCI, V5, P295; Pitt J. I., 1980, GENUS PENICILLIUM IT; Raper KB, 1965, GENUS ASPERGILLUS GE; Richards J., 2007, ARCHAEOLOGY ART ANCI, VII, P313; RICHARDS J., 2002, JARCE, V39, P75; Richards J.E., 2005, SOC DEATH ANCIENT EG; Richards JE, 2005, FESTSCHRIFT MANFRED, P141; Rifai M.A., 1969, MYCOL PAP, V116, P1; Sefelnasr A, 2015, 8 INT C GEOL AFR; United States Department of Agriculture, 1996, SOIL SERV LAB MAN 42; Wilde S.A., 1972, SOIL PLANT ANAL TREE; Zaremski A., 2011, Pro Ligno, V7, P92	53	12	13	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2019	14	3							e0213753	10.1371/journal.pone.0213753	http://dx.doi.org/10.1371/journal.pone.0213753			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ5PT	30917134	gold, Green Published, Green Submitted			2022-12-26	WOS:000462465800040
J	Pankakoski, M; Anttila, A; Sarkeala, T; Heinavaara, S				Pankakoski, Maiju; Anttila, Ahti; Sarkeala, Tytti; Heinavaara, Sirpa			Effectiveness of cervical cancer screening at age 65-A register-based cohort study	PLOS ONE			English	Article							ELDERLY-WOMEN; RISK; MORTALITY; TRENDS	Most cervical cancer deaths in Finland occur after the termination of the national screening program, targeted at women aged 30 to 64 years. The purpose of this study was to examine the effectiveness of screening at age 65 in reducing cervical cancer mortality. A register-based cohort study was performed with a follow-up period between 1991 and 2014. Mortality risk ratios for incident cervical cancer cases diagnosed at age 65 or older were compared between women invited and not invited for screening. The background risk difference between the studied areas was accounted for by using a reference cohort. The relative risk of death for women invited for cervical cancer screening at the age of 65 was 0.52 (95% CI: 0.29-0.94). The relative risks for women not attending and attending to screening with respect to the uninvited were 1.28 (CI: 0.65-2.50) and 0.28 (CI: 0.13-0.59), respectively. Inviting 65-year-old women for screening has been effective in reducing cervical cancer mortality.	[Pankakoski, Maiju; Anttila, Ahti; Sarkeala, Tytti; Heinavaara, Sirpa] Finnish Canc Registry, Helsinki, Finland; [Pankakoski, Maiju; Heinavaara, Sirpa] Univ Helsinki, Fac Med, Helsinki, Finland	Finnish Cancer Registry; University of Helsinki	Pankakoski, M (corresponding author), Finnish Canc Registry, Helsinki, Finland.; Pankakoski, M (corresponding author), Univ Helsinki, Fac Med, Helsinki, Finland.	maiju.pankakoski@cancer.fi		Pankakoski, Maiju/0000-0002-2074-9559; Heinavaara, Sirpa/0000-0002-8308-9922	Cancer Society of Finland	Cancer Society of Finland	All authors are employees of the Cancer Society of Finland which provided funding for this work.	Anttila A, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-252; Arbyn M, 2010, ANN ONCOL, V21, P448, DOI 10.1093/annonc/mdp471; Beckman N, 2008, BMJ, P337; Blanks RG, 2009, BRIT J CANCER, V100, P1832, DOI 10.1038/sj.bjc.6605069; Castanon A, 2016, INT J CANCER, V139, P1040, DOI 10.1002/ijc.30152; Castanon A, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001585; Darlin L, 2014, ANTICANCER RES, V34, P5147; Finnish Cancer Registry, 2017, SCREEN STAT; Finnish Cancer Registry, 2017, CANC STAT; Hristova L, 1997, ACTA ONCOL, V36, P1; Kotaniemi-Talonen L, 2011, ACTA ONCOL, V50, P106, DOI 10.3109/0284186X.2010.496793; Lindau S.T., 2010, BMJ-BRIT MED J, V340, P810, DOI DOI 10.1136/BMJ.C810; Lonnberg S, 2013, INT J CANCER, V132, P2134, DOI 10.1002/ijc.27844; Lonnberg S, 2012, CANCER EPIDEM BIOMAR, V21, P1354, DOI 10.1158/1055-9965.EPI-12-0162; Luoto R, 2004, BRIT J CANCER, V90, P1756, DOI 10.1038/sj.bjc.6601763; Lynge E, 2017, EUR J CANCER, V74, P82, DOI 10.1016/j.ejca.2016.12.021; Nieminen P, 2011, 28 NAT I HLTH WELF; R Core Team, 2018, R LANG ENV STAT COMP; Rebolj M, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1354; Rustagi AS, 2014, AM J EPIDEMIOL, V179, P1107, DOI 10.1093/aje/kwu035; Salo H, 2014, INT J CANCER, V135, P204, DOI 10.1002/ijc.28646; Seppa K, 2016, BJOG-INT J OBSTET GY, V123, P772, DOI 10.1111/1471-0528.13754; Sharp L, 2014, J URBAN HEALTH, V91, P510, DOI 10.1007/s11524-013-9846-3; Siesling S, 2008, INT J CANCER, V122, P2106, DOI 10.1002/ijc.23358; Smith JS, 2008, J ADOLESCENT HEALTH, V43, pS5, DOI 10.1016/j.jadohealth.2008.07.009; Statistics Finland, 2018, POPULATION STRUCTURE; Statistics Finland, 2018, OFF STAT FINL OSF DE; Tarkkanen J, 2003, ACTA OBSTET GYN SCAN, V82, P82, DOI 10.1034/j.1600-0412.2003.820115.x; Vainikainen T., 2003, DUODECIM, V119, P1183; Vicus D, 2014, GYNECOL ONCOL, V133, P167, DOI 10.1016/j.ygyno.2014.02.037; Wang JR, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002414	31	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2019	14	3							e0214486	10.1371/journal.pone.0214486	http://dx.doi.org/10.1371/journal.pone.0214486			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ3IW	30913262	Green Published, Green Submitted, gold			2022-12-26	WOS:000462305600069
J	Yee, CN; Ooi, CHR; Tang, LP; Misran, M; Tang, NT				Yee, Chut-Ngeow; Ooi, C. H. Raymond; Tang, Luck-Pheng; Misran, Misni; Tang, Nyiak-Tao			Large-scale structure formation in ionic solution and its role in electrolysis and conductivity	PLOS ONE			English	Article								That water may not be an inert medium was indicated by the presence at water's interfaces a negatively charged solute free zone of several hundred microns in thickness called the exclusion zone (EZ). Further evidence was demonstrated by Ovchinnikova's experiments (2009) showing that water can store and release substantial amount of charge. We demonstrate that the charge storage capacity of water arises from highly stable large-scale ionic structures with measurable charge imbalances and discrete levels of charge density. We also show evidence that the charge zones formation requires ionic solutes, and their formation correlate to large change in conductivity, by as much as 250%. Our experiments indicate that large-scale structuring plays a pivotal role in electrolysis and conductivity in ionic solution. We propose that water is an electrochemically active medium and present a new model of electrolysis and conductivity in ionic solution.	[Yee, Chut-Ngeow; Ooi, C. H. Raymond] Univ Malaya, Dept Phys, Fac Sci, Kuala Lumpur, Malaysia; [Tang, Luck-Pheng] Prime Oleochem Ind Sdn Bhd, Petaling Jaya, Malaysia; [Misran, Misni; Tang, Nyiak-Tao] Univ Malaya, Dept Chem, Fac Sci, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya	Yee, CN (corresponding author), Univ Malaya, Dept Phys, Fac Sci, Kuala Lumpur, Malaysia.	yeechut@gmail.com	Ooi, C. H. Raymond/B-9461-2010	Ooi, C. H. Raymond/0000-0003-1084-5501; Yee, Chut-Ngeow/0000-0002-4455-8570	Universiti Malaya PPP [PG209-2016A]; Quat Research Sdn. Bhd.	Universiti Malaya PPP; Quat Research Sdn. Bhd.	The funder Prime Oleochemicals Industries Sdn. Bhd. provided support in the form of salaries for author Dr. Luck Pheng Tan, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author is articulated in the 'author contributions' section. Additional support was received from Universiti Malaya PPP (grant no. PG209-2016A) and Quat Research Sdn. Bhd.; This research is partially funded by:; Quat Research Sdn. Bhd.; University of Malaya PPP Grant no. PG209-2016A	[Anonymous], 2018, RAD AN; Bard A. J., 2001, ELECTROCHEMICAL METH; Chai B, 2012, Contemp Mater, V3, P1; Chai BH, 2009, J PHYS CHEM B, V113, P13953, DOI 10.1021/jp908163w; Chen CS, 2012, J BIOL PHYS, V38, P113, DOI 10.1007/s10867-011-9237-5; De Ninno A, 2017, CHEM PHYS LETT, V667, P322, DOI 10.1016/j.cplett.2016.11.015; Hwang SG, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195057; Ignatiev V, 2016, WATER J, P4; Ovchinnikova K, 2009, LANGMUIR, V25, P542, DOI 10.1021/la802430k; Pollack G.H., 2006, WATER CELL, P165, DOI DOI 10.1007/1-4020-4927-7_8; Yoo H, 2011, J PHYS CHEM LETT, V2, P532, DOI 10.1021/jz200057g; Zhao Q, 2010, P SOC PHOTO-OPT INS, P7376; Zheng JM, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.031408; Zheng JM, 2006, ADV COLLOID INTERFAC	14	0	0	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2019	14	3							e0213697	10.1371/journal.pone.0213697	http://dx.doi.org/10.1371/journal.pone.0213697			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ3IW	30913207	Green Published, gold, Green Submitted			2022-12-26	WOS:000462305600017
J	Brouillette, MJ; Fellows, LK; Finch, L; Thomas, R; Mayo, NE				Brouillette, Marie-Josee; Fellows, Lesley K.; Finch, Lois; Thomas, Rejean; Mayo, Nancy E.			Properties of a brief assessment tool for longitudinal measurement of cognition in people living with HIV	PLOS ONE			English	Article							BRIEF SCREENING TOOLS; NEUROCOGNITIVE DISORDERS; IMPAIRMENT; RELIABILITY; PREVALENCE; VALIDITY; HEALTH; LIFE	Background Mild cognitive impairment is common in chronic HIV infection and there is concern that it may worsen with age. Distinguishing static impairment from on-going decline is clinically important, but the field lacks well-validated cognitive measures sensitive to decline and feasible for routine clinical use. Measures capable of detecting improvement are also needed to assess interventions. The objective of this study is to estimate the extent of change on repeat administration of three different forms of a brief computerized cognitive assessment battery (B-CAM) developed for assessing cognitive ability in the mildly-impaired to normal range in people living with HIV. We hypothesized no change over a six-month period in people on effective antiretroviral therapy. Methods 102 HIV+ individuals completed a set of computerized cognitive tasks on three occasions over a six-month period. Rasch analysis was used to determine if change over time (i.e. improvement due to practice) was uniform across tasks and to refine scoring in order to produce three forms of the B-CAM of equivalent level of difficulty. Group-based trajectory analysis (GBTA) was then applied to determine if performance at baseline influenced the magnitude of practice-related improvement on the battery as a whole over the course of follow-up. Results Two cognitive tasks (fluency and word recall) had different levels of difficulty across test sessions, related to the different forms of the tasks. These two items were split by testing session. For all other items, the level of difficulty remained constant across all three time points. GBTA showed that the sample was composed of three distinct groups of people with unique trajectories, defined mainly by level of cognitive ability at baseline. Only the highest group showed an apparent improvement over time, but this change fell within measurement error. Conclusions Rasch analysis provides mathematical confirmation that these three forms of the B-CAM are of equivalent difficulty. GBTA demonstrates that no adjustment of the total score is required to correct for practice effects. Application of these modern statistical methods paves the way towards rapid and robust quantification of change in cognition.	[Brouillette, Marie-Josee] McGill Univ, Dept Psychiat, Fac Med, Montreal, PQ, Canada; [Brouillette, Marie-Josee] McGill Univ, Chron Viral Illness Serv, Ctr Hlth, Montreal, PQ, Canada; [Brouillette, Marie-Josee] McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ, Canada; [Fellows, Lesley K.] McGill Univ, Dept Neurol & Neurosurg, Fac Med, Montreal, PQ, Canada; [Fellows, Lesley K.] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada; [Finch, Lois; Mayo, Nancy E.] McGill Univ, Ctr Hlth, Div Clin Epidemiol, Montreal, PQ, Canada; [Thomas, Rejean] Clin Med Actuel, Montreal, PQ, Canada; [Mayo, Nancy E.] McGill Univ Montreal, Sch Phys & Occupat Therapy, Fac Med, Montreal, PQ, Canada	McGill University; McGill University; McGill University; McGill University; McGill University; McGill University	Brouillette, MJ (corresponding author), McGill Univ, Dept Psychiat, Fac Med, Montreal, PQ, Canada.; Brouillette, MJ (corresponding author), McGill Univ, Chron Viral Illness Serv, Ctr Hlth, Montreal, PQ, Canada.; Brouillette, MJ (corresponding author), McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ, Canada.	marie-josee.brouillette@mcgill.ca		Brouillette, Marie-Josee/0000-0003-3681-8798	Canadian Institutes of Health Research [TCO-125272]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes of Health Research (grant number TCO-125272 Dr. Lesley K Fellows), http://www.cihr-irsc.gc.ca/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basso MR, 2002, CLIN NEUROPSYCHOL, V16, P57, DOI 10.1076/clin.16.1.57.8329; Basso MR, 1999, CLIN NEUROPSYCHOL, V13, P283, DOI 10.1076/clin.13.3.283.1743; Bloch M, 2016, CLIN INFECT DIS, V63, P687, DOI 10.1093/cid/ciw399; Brouillette MJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155766; Brouillette MJ, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0483-1; Buckles VD, 2003, NEUROLOGY, V61, P1662, DOI 10.1212/01.WNL.0000098933.34804.FC; Cysique LA, 2011, J CLIN EXP NEUROPSYC, V33, P505, DOI 10.1080/13803395.2010.535504; Dikmen SS, 1999, J INT NEUROPSYCH SOC, V5, P346, DOI 10.1017/S1355617799544056; FILLENBAUM GG, 1981, J GERONTOL, V36, P428, DOI 10.1093/geronj/36.4.428; Gouse H, 2017, J NEUROVIROL, V23, P686, DOI 10.1007/s13365-017-0551-y; Heaton RK, 2010, NEUROLOGY, V75, P2087, DOI 10.1212/WNL.0b013e318200d727; Heaton RK, 2001, ARCH CLIN NEUROPSYCH, V16, P75, DOI 10.1016/S0887-6177(99)00062-1; Jones BL, 2001, SOCIOL METHOD RES, V29, P374, DOI 10.1177/0049124101029003005; Joska JA, 2016, AIDS BEHAV, V20, P1621, DOI 10.1007/s10461-016-1316-y; Joska JA, 2010, J NEUROVIROL, V16, P101, DOI 10.3109/13550281003682513; Kamminga J, 2013, CURR HIV-AIDS REP, V10, P342, DOI 10.1007/s11904-013-0176-6; Koski L, 2011, HIV MED, V12, P472, DOI 10.1111/j.1468-1293.2010.00910.x; Mayo NE, 2018, JAIDS-J ACQ IMM DEF, V78, pE7, DOI 10.1097/QAI.0000000000001668; Mayo NE, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0527-1; Modirrousta M, 2008, J NEUROSCI, V28, P14000, DOI 10.1523/JNEUROSCI.4450-08.2008; Munnoz-Moreno JA, 2013, JAIDS-J ACQ IMM DEF, V63, P585, DOI 10.1097/QAI.0b013e31829e1408; Nagin DS, 2001, PSYCHOL METHODS, V6, P18, DOI 10.1037/1082-989X.6.1.18; Nagin DS, 2003, DEV PSYCHOPATHOL, V15, P343, DOI 10.1017/S0954579403000191; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Norman GR, 2003, MED CARE, V41, P582, DOI 10.1097/00005650-200305000-00004; Robbins TW, 1998, J INT NEUROPSYCH SOC, V4, P474, DOI 10.1017/s1355617798455073; Robertson K, 2009, NEUROPSYCHOL REV, V19, P232, DOI 10.1007/s11065-009-9096-z; ROCCAFORTE WH, 1992, J AM GERIATR SOC, V40, P697, DOI 10.1111/j.1532-5415.1992.tb01962.x; Sacktor N, 2016, NEUROLOGY, V86, P334, DOI 10.1212/WNL.0000000000002277; Sullivan MJ, 1990, CAN J REHABIL, V4, P99; Temkin NR, 1999, J INT NEUROPSYCH SOC, V5, P357, DOI 10.1017/S1355617799544068; Valcour V, 2011, CLIN INFECT DIS, V53, P836, DOI 10.1093/cid/cir524; Woods SP, 2009, NEUROPSYCHOL REV, V19, P152, DOI 10.1007/s11065-009-9102-5; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zipursky AR, 2013, AIDS, V27, P2385, DOI 10.1097/QAD.0b013e328363bf56	35	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2019	14	3							e0213908	10.1371/journal.pone.0213908	http://dx.doi.org/10.1371/journal.pone.0213908			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HQ1KV	30908501	Green Published, gold, Green Submitted			2022-12-26	WOS:000462157600025
J	Esposito, M; Hermann-Le Denmat, S; Delahodde, A				Esposito, Michela; Hermann-Le Denmat, Sylvie; Delahodde, Agnes			Contribution of ERMES subunits to mature peroxisome abundance	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEIN; ENDOPLASMIC-RETICULUM; MITOCHONDRIAL MORPHOLOGY; SMP DOMAINS; YEAST; BIOGENESIS; ER; COMPLEX; DNA; INHERITANCE	Eukaryotic organelles share different components and establish physical contacts to communicate throughout the cell. One of the best-recognized examples of such interplay is the metabolic cooperation and crosstalk between mitochondria and peroxisomes, both organelles being functionally and physically connected and linked to the endoplasmic reticulum (ER). In Saccharomyces cerevisiae, mitochondria are linked to the ER by the ERMES complex that facilitates inter-organelle calcium and phospholipid exchanges. Recently, peroxi-some-mitochondria contact sites (PerMit) have been reported and among Permit tethers, one component of the ERMES complex (Mdm34) was shown to interact with the peroxin Pex11, suggesting that the ERMES complex or part of it may be involved in two membrane contact sites (ER-mitochondria and peroxisome-mitochondria). This opens the possibility of exchanges between these three membrane compartments. Here, we investigated in details the role of each ERMES subunit on peroxisome abundance. First, we confirmed previous studies from other groups showing that absence of Mdm10 or Mdm12 leads to an increased number of mature peroxisomes. Secondly, we showed that this is not simply due to respiratory function defect, mitochondrial DNA (mtDNA) loss or mitochondrial network alteration. Finally, we present evidence that the contribution of ERMES subunits Mdm10 and Mdm12 to peroxisome number involves two different mechanisms.	[Esposito, Michela; Hermann-Le Denmat, Sylvie; Delahodde, Agnes] Univ Paris Saclay, Univ Paris Sud, CNRS, I2BC,CEA, Gif Sur Yvette, France; [Hermann-Le Denmat, Sylvie] PSL Res Univ, Ecole Normale Super, Paris, France; [Esposito, Michela] Univ Paris Saclay, INSERM, U1170, Gustave Roussy Canc Campus, Villejuif, France	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy	Delahodde, A (corresponding author), Univ Paris Saclay, Univ Paris Sud, CNRS, I2BC,CEA, Gif Sur Yvette, France.	agnes.delahodde@i2bc.paris-saclay.fr		Delahodde, Agnes/0000-0001-8427-7047	Instituto Pasteur Fondazione Cenci Bolognetti	Instituto Pasteur Fondazione Cenci Bolognetti(Istituto Pasteur Italia Fondazione Cenci Bolognetti)	M.E. was supported by Instituto Pasteur Fondazione Cenci Bolognetti. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AhYoung AP, 2017, BIOCHEM BIOPH RES CO, V488, P129, DOI 10.1016/j.bbrc.2017.05.021; AhYoung AP, 2015, P NATL ACAD SCI USA, V112, pE3179, DOI 10.1073/pnas.1422363112; Baumgart E, 2001, AM J PATHOL, V159, P1477, DOI 10.1016/S0002-9440(10)62534-5; Belgareh-Touze N, 2017, AUTOPHAGY, V13, P114, DOI 10.1080/15548627.2016.1252889; Berger KH, 1997, J CELL BIOL, V136, P545, DOI 10.1083/jcb.136.3.545; Bockler S, 2014, AUTOPHAGY, V10, P1346, DOI 10.4161/auto.28981; Boldogh IR, 2003, MOL BIOL CELL, V14, P4618, DOI 10.1091/mbc.E03-04-0225; BURGESS SM, 1994, J CELL BIOL, V126, P1375, DOI 10.1083/jcb.126.6.1375; Butow RA, 2004, MOL CELL, V14, P1, DOI 10.1016/S1097-2765(04)00179-0; Camoes F, 2009, J INHERIT METAB DIS, V32, P163, DOI 10.1007/s10545-008-1018-3; Cohen Y, 2014, MOL BIOSYST, V10, P1742, DOI 10.1039/c4mb00001c; Delille HK, 2009, HISTOCHEM CELL BIOL, V131, P441, DOI 10.1007/s00418-009-0561-9; Dunn WA, 2005, AUTOPHAGY, V1, P75; Elbaz-Alon Y, 2014, DEV CELL, V30, P95, DOI 10.1016/j.devcel.2014.06.007; Epstein CB, 2001, MOL BIOL CELL, V12, P297, DOI 10.1091/mbc.12.2.297; Hobbs AEA, 2001, J CELL BIOL, V152, P401, DOI 10.1083/jcb.152.2.401; Hoepfner D, 2005, CELL, V122, P85, DOI 10.1016/j.cell.2005.04.025; Hoivik DJ, 2004, CARCINOGENESIS, V25, P1757, DOI 10.1093/carcin/bgh182; Kawano S, 2018, J CELL BIOL, V217, P959, DOI 10.1083/jcb.201704119; Kopec KO, 2010, BIOINFORMATICS, V26, P1927, DOI 10.1093/bioinformatics/btq326; Kornmann B, 2011, P NATL ACAD SCI USA, V108, P14151, DOI 10.1073/pnas.1111314108; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; Lang AB, 2015, J CELL BIOL, V210, P883, DOI 10.1083/jcb.201502105; Lockshon D, 2007, GENETICS, V175, P77, DOI 10.1534/genetics.106.064428; Lopez-Huertas E, 2000, EMBO J, V19, P6770, DOI 10.1093/emboj/19.24.6770; Meeusen S, 2003, J CELL BIOL, V163, P503, DOI 10.1083/jcb.200304040; Meisinger C, 2004, DEV CELL, V7, P61, DOI 10.1016/j.devcel.2004.06.003; Meisinger C, 2007, EMBO J, V26, P2229, DOI 10.1038/sj.emboj.7601673; Motley AM, 2008, J CELL SCI, V121, P1633, DOI 10.1242/jcs.026344; Motley AM, 2007, J CELL BIOL, V178, P399, DOI 10.1083/jcb.200702167; Motley AM, 2012, AUTOPHAGY, V8, P1680, DOI 10.4161/auto.21485; Motley AM, 2012, EMBO J, V31, P2852, DOI 10.1038/emboj.2012.151; Okamoto K, 2005, ANNU REV GENET, V39, P503, DOI 10.1146/annurev.genet.38.072902.093019; Opalinski L, 2011, INT J BIOCHEM CELL B, V43, P847, DOI 10.1016/j.biocel.2011.03.006; Park JS, 2016, MOL BIOL CELL, V27, P2435, DOI 10.1091/mbc.E16-02-0112; Peter ATJ, 2017, J CELL BIOL, V216, P3219, DOI 10.1083/jcb.201610055; Saleem RA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011953; Schrader M, 2012, BBA-MOL BASIS DIS, V1822, P1343, DOI 10.1016/j.bbadis.2011.12.014; Shai N, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03957-8; Shai N, 2016, BBA-MOL CELL RES, V1863, P1061, DOI 10.1016/j.bbamcr.2015.09.016; SOGO LF, 1994, J CELL BIOL, V126, P1361, DOI 10.1083/jcb.126.6.1361; Stroud DA, 2011, J MOL BIOL, V413, P743, DOI 10.1016/j.jmb.2011.09.012; Tamura Y, 2012, J BIOL CHEM, V287, P15205, DOI 10.1074/jbc.M111.338665; Tan T, 2013, J CELL SCI, V126, P3563, DOI 10.1242/jcs.121244; Usaj MM, 2015, J MOL BIOL, V427, P2072, DOI 10.1016/j.jmb.2015.03.004; van der Zand A, 2012, CELL, V149, P397, DOI 10.1016/j.cell.2012.01.054; Wach A, 1997, YEAST, V13, P1065, DOI 10.1002/(SICI)1097-0061(19970915)13:11<1065::AID-YEA159>3.3.CO;2-B; Walker CL, 2018, PHYSIOL REV, V98, P89, DOI 10.1152/physrev.00033.2016; Westermann B, 2000, YEAST, V16, P1421, DOI 10.1002/1097-0061(200011)16:15<1421::AID-YEA624>3.3.CO;2-L; Wiedemann N, 2009, SCIENCE, V325, P403, DOI 10.1126/science.1178016; Youngman MJ, 2004, J CELL BIOL, V164, P677, DOI 10.1083/jcb.200308012	51	3	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2019	14	3							e0214287	10.1371/journal.pone.0214287	http://dx.doi.org/10.1371/journal.pone.0214287			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ1KV	30908556	Green Published, Green Submitted, gold			2022-12-26	WOS:000462157600051
J	Pirisinu, M; Blasco, P; Tian, XL; Sen, Y; Bode, AM; Liu, KD; Dong, ZG				Pirisinu, Marco; Blasco, Pilar; Tian, Xueli; Sen, Yang; Bode, Ann M.; Liu, Kangdong; Dong, Zigang			Analysis of hydrophobic and hydrophilic moments of short penetrating peptides for enhancing mitochondrial localization: prediction and validation	FASEB JOURNAL			English	Article						cell-penetrating peptides; molecular dynamics; drug delivery; specificity	CELLULAR UPTAKE; MEMBRANE INTERACTION; SECONDARY STRUCTURE; DRUG-DELIVERY; ACID; ANALOGS; MODELS	Pharmaceutical interest in targeting mitochondria is increasing because of their contribution in incurable diseases. However, the inner mitochondrial layer represents a major hurdle to overcome for most drugs. Penetrating peptides are a promising strategy for drug delivery, but the absence of standard principles and reliable prediction tools limits the design and discovery of sequences with improved organelle specificity. In our hypothesis, peptide local flexibility represents a valuable source to predict peptide performance. Here, a pool of short nonnatural peptides was designed with the same amino acid content but different positioning. Molecular dynamics and membrane-transfer simulations were used to generate the low-energy conformers in extra, intracellular, and membrane-inserted environments. The contributions of the hydrophobic and hydrophilic side chain-exposed surfaces revealed that the amino acid's relative position significantly affected the simulated peptide's dynamics. Based on the structural versatility, we predicted the peptides' behavior and the sequence with the most efficient membrane penetration and mitochondrial localization. The prediction and the improved performance of our peptides were experimentally confirmed and compared with a reported mitochondrial-targeting sequence. We demonstrated that an accurate understanding of the structural versatility is a valid aid for future works in designing sequences with improved mitochondrial targeting.-Pirisinu, M., Blasco, P., Tian, X., Sen, Y., Bode, A. M., Liu, K., Dong, Z. Analysis of hydrophobic and hydrophilic moments of short penetrating peptides for enhancing mitochondrial localization: prediction and validation.	[Pirisinu, Marco; Blasco, Pilar; Tian, Xueli; Sen, Yang; Liu, Kangdong; Dong, Zigang] China US Henan Hormel Canc Inst, Zhengzhou, Henan, Peoples R China; [Pirisinu, Marco; Blasco, Pilar; Bode, Ann M.; Dong, Zigang] Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA; [Tian, Xueli; Liu, Kangdong; Dong, Zigang] Zhengzhou Univ, Pathophysiol Dept, Sch Basic Med Sci, Zhengzhou, Henan, Peoples R China; [Liu, Kangdong; Dong, Zigang] Zhengzhou Univ, Affiliated Canc Hosp, Zhengzhou, Henan, Peoples R China; [Liu, Kangdong; Dong, Zigang] Canc Chemoprevent Henan, Collaborat Innovat Ctr, Zhengzhou, Henan, Peoples R China	University of Minnesota System; Zhengzhou University; Zhengzhou University	Dong, ZG (corresponding author), Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA.; Liu, KD (corresponding author), Zhengzhou Univ, Affiliated Canc Hosp, Henan Canc Hosp, 127 Dongming Rd, Zhengzhou 450008, Henan, Peoples R China.	kdliu@zzu.edu.cn; zgdong@hi.umn.edu	Pirisinu, Marco/AAR-5399-2021	Pirisinu, Marco/0000-0002-7834-4386; Blasco Morales, Pilar/0000-0001-6703-5417	Key Program of Henan Province [161100510300]; National Natural Science Foundation of China [81572812, 81872335]	Key Program of Henan Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Key Program of Henan Province (Grant 161100510300) and the National Natural Science Foundation of China (Grants 81572812 and 81872335). The authors declare no conflicts of interest.	Agemy L, 2011, P NATL ACAD SCI USA, V108, P17450, DOI 10.1073/pnas.1114518108; Bayrhuber M, 2008, P NATL ACAD SCI USA, V105, P15370, DOI 10.1073/pnas.0808115105; Bolhassani A, 2011, BBA-REV CANCER, V1816, P232, DOI 10.1016/j.bbcan.2011.07.006; Cabra V, 2006, BBA-PROTEINS PROTEOM, V1764, P1110, DOI 10.1016/j.bbapap.2006.04.002; Cerrato CP, 2015, FASEB J, V29, P4589, DOI 10.1096/fj.14-269225; Dimauro Ivan, 2012, BMC Res Notes, V5, P513, DOI 10.1186/1756-0500-5-513; Eiriksdottir E, 2010, BBA-BIOMEMBRANES, V1798, P1119, DOI 10.1016/j.bbamem.2010.03.005; FAUCHERE JL, 1988, INT J PEPT PROT RES, V32, P269; Fonseca SB, 2011, CHEM BIOL, V18, P445, DOI 10.1016/j.chembiol.2011.02.010; Gautam A, 2012, DATABASE-OXFORD, DOI 10.1093/database/bas015; GOODFORD PJ, 1985, J MED CHEM, V28, P849, DOI 10.1021/jm00145a002; GREEN M, 1988, CELL, V55, P1179, DOI 10.1016/0092-8674(88)90262-0; Guidotti G, 2017, TRENDS PHARMACOL SCI, V38, P406, DOI 10.1016/j.tips.2017.01.003; Gupta A, 2011, EUR BIOPHYS J BIOPHY, V40, P727, DOI 10.1007/s00249-011-0685-4; Herst PM, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00296; Horton KL, 2008, CHEM BIOL, V15, P375, DOI 10.1016/j.chembiol.2008.03.015; Horton KL, 2012, CHEMBIOCHEM, V13, P476, DOI 10.1002/cbic.201100415; Horton KL, 2009, J MED CHEM, V52, P3293, DOI 10.1021/jm900178n; Huang Y, 2014, PROTEIN CELL, V5, P194, DOI 10.1007/s13238-014-0028-1; Jobin ML, 2015, BBA-BIOMEMBRANES, V1848, P593, DOI 10.1016/j.bbamem.2014.11.013; Kelley SO, 2011, PHARM RES-DORDR, V28, P2808, DOI 10.1007/s11095-011-0530-6; Kovacs JM, 2006, BIOPOLYMERS, V84, P283, DOI 10.1002/bip.20417; Kristensen M, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17020185; Kuhlbrandt W, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0201-x; Leopold P.L., 2016, LYSOSOMES BIOL DIS T, P383; Leung SSF, 2016, J CHEM INF MODEL, V56, P924, DOI 10.1021/acs.jcim.6b00005; Leung SSF, 2012, J CHEM INF MODEL, V52, P1621, DOI [10.1021/ci0120503t, 10.1021/ci200583t]; Mallick S, 2018, COLLOID SURFACE B, V161, P356, DOI 10.1016/j.colsurfb.2017.10.052; Marrache S, 2012, P NATL ACAD SCI USA, V109, P16288, DOI 10.1073/pnas.1210096109; Mellert K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052473; MOHAMADI F, 1990, J COMPUT CHEM, V11, P440, DOI 10.1002/jcc.540110405; Mueller J, 2008, BIOCONJUGATE CHEM, V19, P2363, DOI 10.1021/bc800194e; Nakase I, 2004, MOL THER, V10, P1011, DOI 10.1016/j.ymthe.2004.08.010; Oliver M, 2018, RSC ADV, V8, P14597, DOI 10.1039/c8ra02511h; Patterson MJ, 1996, MED MICROBIOLOGY; Pereira MP, 2011, J AM CHEM SOC, V133, P3260, DOI 10.1021/ja110246u; Rezgui R, 2016, BBA-BIOMEMBRANES, V1858, P1499, DOI 10.1016/j.bbamem.2016.03.023; Rink R, 2010, J PHARMACOL TOX MET, V61, P210, DOI 10.1016/j.vascn.2010.02.010; Rydberg HA, 2012, BIOCHEMISTRY-US, V51, P5531, DOI 10.1021/bi300454k; Sandberg M, 1998, J MED CHEM, V41, P2481, DOI 10.1021/jm9700575; Schmid S, 2017, BIOCONJUGATE CHEM, V28, P382, DOI 10.1021/acs.bioconjchem.6b00535; Schmidt N, 2010, FEBS LETT, V584, P1806, DOI 10.1016/j.febslet.2009.11.046; Smith LJ, 1996, FOLD DES, V1, pR95, DOI 10.1016/S1359-0278(96)00046-6; Soomets Ursel, 2005, V298, P241; Sun S, 2017, METHODS MOL BIOL, V1567, P1, DOI 10.1007/978-1-4939-6824-4_1; Verdurmen WPR, 2011, CHEM BIOL, V18, P1000, DOI 10.1016/j.chembiol.2011.06.006; Wang GS, 2009, NUCLEIC ACIDS RES, V37, pD933, DOI 10.1093/nar/gkn823; Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842; Woldetsadik AD, 2017, FASEB J, V31, P2168, DOI 10.1096/fj.201601173R; Yamashita H, 2016, SCI REP-UK, V6, DOI 10.1038/srep33003; Zhao KS, 2004, J BIOL CHEM, V279, P34682, DOI 10.1074/jbc.M402999200; Zheng N, 2017, ACTA BIOMATER, V58, P146, DOI 10.1016/j.actbio.2017.05.001	52	2	2	0	19	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2019	33	7					7970	7984		10.1096/fj.201802748RR	http://dx.doi.org/10.1096/fj.201802748RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ9SM	30917009	Bronze			2022-12-26	WOS:000476234700014
J	Zeng, H; Hu, MJ; Lu, YK; Zhang, ZH; Xu, Y; Wang, S; Chen, M; Shen, MQ; Wang, C; Chen, F; Du, CH; Tang, Y; Su, YP; Chen, SL; Wang, JP				Zeng, Hao; Hu, Mengjia; Lu, Yukai; Zhang, Zihao; Xu, Yang; Wang, Song; Chen, Mo; Shen, Mingqiang; Wang, Cheng; Chen, Fang; Du, Changhong; Tang, Yong; Su, Yongping; Chen, Shilei; Wang, Junping			MicroRNA 34a promotes ionizing radiation-induced DNA damage repair in murine hematopoietic stem cells	FASEB JOURNAL			English	Article						irradiation; apoptosis; hematopoiesis	MIR-34A; INFLAMMATION; ACTIVATION; MECHANISMS; APOPTOSIS; INJURY; P53	Hematopoietic stem cells (HSCs) establish the entire hematopoietic system and maintain lifelong hematopoiesis. Previous studies have reported the significance of microRNAs (miRNAs) in the regulation of self-renewal and differentiation of HSCs. In this study, we show that the expression of miRNA 34a (miR-34a) is markedly up-regulated in HSCs from mice subjected to ionizing radiation (IR). Reduced numbers and DNA damage repair, as well as increased apoptosis, are observed in HSCs from miR-34a-deficient mice induced by irradiation, although miR-34a is dispensable for steady-state hematopoiesis. Further investigations show that HSCs deficient in miR-34a exhibit decreased expressions of DNA repair-associated genes involved in homologous recombination and nonhomologous end joining. Competitive transplantation confirms that loss of miR-34a leads to more severe impairment of the long-term hematopoietic function of HSCs after irradiation exposure. Consistently, treating mice with an miR-34a agomir can significantly alleviate irradiation-induced DNA damage in HSCs. Our findings demonstrate that miR-34a contributes to promoting HSCs' survival after irradiation, which provides a promising approach for protecting HSCs from IR.-Zeng, H., Hu, M., Lu, Y., Zhang, Z., Xu, Y., Wang, S., Chen, M., Shen, M., Wang, C., Chen, F., Du, C., Tang, Y., Su,Y., Chen, S., Wang, J. MicroRNA 34a promotes ionizing radiation-induced DNA damage repair in murine hematopoietic stem cells.	[Zeng, Hao; Hu, Mengjia; Lu, Yukai; Zhang, Zihao; Xu, Yang; Wang, Song; Chen, Mo; Shen, Mingqiang; Wang, Cheng; Chen, Fang; Du, Changhong; Tang, Yong; Su, Yongping; Chen, Shilei; Wang, Junping] Third Mil Med Univ, Coll Prevent Med, Chongqing Engn Res Ctr Nanomed, State Key Lab Trauma Burns & Combined Injury,Inst, Gaotanyan St 30, Chongqing 400038, Peoples R China	Army Medical University	Chen, SL; Wang, JP (corresponding author), Third Mil Med Univ, Coll Prevent Med, Chongqing Engn Res Ctr Nanomed, State Key Lab Trauma Burns & Combined Injury,Inst, Gaotanyan St 30, Chongqing 400038, Peoples R China.	chen.shilei@foxmail.com; wangjunping@tmmu.edu.cn	Du, Changhong/GXH-2720-2022; Wang, Cheng/AAK-7457-2021	Du, Changhong/0000-0002-1537-0325; Wang, Cheng/0000-0002-6690-6433; Xu, Yang/0000-0002-8083-6750; Wang, Cheng/0000-0001-5850-4533	National Natural Science Fund of China [81725019, 81573084, 81500087]; Program for Scientific and Technological Innovation Leaders of Chongqing [CSTCKJCXLJRC06]; Scientific Research Project of the Chinese People's Liberation Army (PLA) [AWS16J014]	National Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); Program for Scientific and Technological Innovation Leaders of Chongqing; Scientific Research Project of the Chinese People's Liberation Army (PLA)	The authors thank Prof. Jun Peng (Qilu Hospital, Shandong University, Jinan, China) for providing miR-34a<SUP>-/-</SUP> mice, Prof. Jinyong Wang (Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Science, Guangzhou, China) for providing CD45.1 mice, Haiying Ran and Yang Liu (both from the Third Military Medical University) for technical support in flow cytometry, and Liting Wang (Third Military Medical University) for technical assistance in immunofluorescence microscopy. This work was supported by grants from the National Natural Science Fund of China (81725019, 81573084, and 81500087), the Program for Scientific and Technological Innovation Leaders of Chongqing (CSTCKJCXLJRC06), and the Scientific Research Project of the Chinese People's Liberation Army (PLA) (AWS16J014). The authors declare no conflicts of interest.	Acharya SS, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa6593; Asada N, 2017, NAT CELL BIOL, V19, P214, DOI 10.1038/ncb3475; Beerman I, 2014, CELL STEM CELL, V15, P37, DOI 10.1016/j.stem.2014.04.016; Beg MS, 2017, INVEST NEW DRUG, V35, P180, DOI 10.1007/s10637-016-0407-y; Ben Nasr M, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aam7543; Bianchi E, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010145; Bu PC, 2016, CELL STEM CELL, V18, P189, DOI 10.1016/j.stem.2016.01.006; Carrelha J, 2018, NATURE, V554, P106, DOI 10.1038/nature25455; Chen SL, 2018, BLOOD, V132, P210, DOI 10.1182/blood-2018-01-825927; Choi J, 2016, BLOOD, V128, P2117, DOI 10.1182/blood-2016-02-702464; Choi YJ, 2017, SCIENCE, V355, DOI 10.1126/science.aag1927; Cosco D, 2015, SCI REP-UK, V5, DOI 10.1038/srep17579; de Laval B, 2014, BLOOD, V123, P509, DOI 10.1182/blood-2013-07-515874; de Leeuw DC, 2016, LEUKEMIA, V30, P742, DOI 10.1038/leu.2015.160; Fang CY, 2017, CANCER LETT, V410, P50, DOI 10.1016/j.canlet.2017.09.012; Gougelet A, 2016, GUT, V65, P1024, DOI 10.1136/gutjnl-2014-308969; Guo F, 2013, LEUKEMIA, V27, P2040, DOI 10.1038/leu.2013.93; Haetscher N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9928; Halimi M, 2016, RADIAT ENVIRON BIOPH, V55, P423, DOI 10.1007/s00411-016-0661-6; Hong SH, 2015, STEM CELLS, V33, P1, DOI 10.1002/stem.1810; Hu MJ, 2018, BLOOD, V132, P911, DOI 10.1182/blood-2018-02-831669; Huang AF, 2014, EXP CELL RES, V326, P259, DOI 10.1016/j.yexcr.2014.04.010; Insinga A, 2013, P NATL ACAD SCI USA, V110, P3931, DOI 10.1073/pnas.1213394110; Itkin T, 2017, LEUKEMIA, V31, P1247, DOI 10.1038/leu.2017.50; Jiang LC, 2017, CANCER RES, V77, P2746, DOI 10.1158/0008-5472.CAN-16-2183; Kraft D, 2015, LEUKEMIA, V29, P1543, DOI 10.1038/leu.2015.28; Lacombe J, 2017, CRIT REV ONCOL HEMAT, V109, P69, DOI 10.1016/j.critrevonc.2016.11.017; Lechman ER, 2016, CANCER CELL, V29, P214, DOI 10.1016/j.ccell.2015.12.011; Li XJ, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.270; Liu L, 2017, CELL PHYSIOL BIOCHEM, V41, P1981, DOI 10.1159/000475277; Mendelson A, 2014, NAT MED, V20, P833, DOI 10.1038/nm.3647; Mohrin M, 2010, CELL STEM CELL, V7, P174, DOI 10.1016/j.stem.2010.06.014; Morgado AL, 2015, MOL NEUROBIOL, V51, P1168, DOI 10.1007/s12035-014-8794-6; O'Connell RM, 2010, P NATL ACAD SCI USA, V107, P14235, DOI 10.1073/pnas.1009798107; Pietras EM, 2017, BLOOD, V130, P1693, DOI 10.1182/blood-2017-06-780882; Rao DS, 2010, IMMUNITY, V33, P48, DOI 10.1016/j.immuni.2010.06.013; Salzman DW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10954; Shao LJ, 2014, BLOOD, V123, P3105, DOI 10.1182/blood-2013-07-515619; Shao LJ, 2014, ANTIOXID REDOX SIGN, V20, P1447, DOI 10.1089/ars.2013.5635; Slabakova E, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.495; Sotillo E, 2011, ONCOGENE, V30, P2587, DOI 10.1038/onc.2010.634; Sun YX, 2017, ONCOTARGET, V8, P6142, DOI 10.18632/oncotarget.14046; Takeda Y, 2015, CELL CYCLE, V14, P3830, DOI 10.1080/15384101.2015.1064202; Tan JL, 2012, J CELL BIOCHEM, V113, P2903, DOI 10.1002/jcb.24167; Yamashita M, 2015, CELL STEM CELL, V17, P23, DOI 10.1016/j.stem.2015.05.013; Zhang HJ, 2016, CELL STEM CELL, V18, P668, DOI 10.1016/j.stem.2016.03.002	46	9	10	1	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2019	33	7					8138	8147		10.1096/fj.201802639R	http://dx.doi.org/10.1096/fj.201802639R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ9SM	30922079	Bronze			2022-12-26	WOS:000476234700027
J	Clarke, PA; Roe, T; Swabey, K; Hobbs, SM; McAndrew, C; Tomlin, K; Westwood, I; Burke, R; van Montfort, R; Workman, P				Clarke, Paul A.; Roe, Toby; Swabey, Kate; Hobbs, Steve M.; McAndrew, Craig; Tomlin, Kathy; Westwood, Isaac; Burke, Rosemary; van Montfort, Robert; Workman, Paul			Dissecting mechanisms of resistance to targeted drug combination therapy in human colorectal cancer	ONCOGENE			English	Article							PHOSPHATIDYLINOSITOL 3-KINASE INHIBITION; MUTATIONS CONFER RESISTANCE; MEK INHIBITION; ACQUIRED-RESISTANCE; ERK1/2 INHIBITOR; COMBINED BRAF; CLINICAL DEVELOPMENT; APOPTOTIC RESPONSE; TUMOR-GROWTH; PI3 KINASE	Genomic alterations in cancer cells result in vulnerabilities that clinicians can exploit using molecularly targeted drugs, guided by knowledge of the tumour genotype. However, the selective activity of these drugs exerts an evolutionary pressure on cancers that can result in the outgrowth of resistant clones. Use of rational drug combinations can overcome resistance to targeted drugs, but resistance may eventually develop to combinatorial therapies. We selected MAPK- and PI3K-pathway inhibition in colorectal cancer as a model system to dissect out mechanisms of resistance. We focused on these signalling pathways because they are frequently activated in colorectal tumours, have well-characterised mutations and are clinically relevant. By treating a panel of 47 human colorectal cancer cell lines with a combination of MEK- and PI3K-inhibitors, we observe a synergistic inhibition of growth in almost all cell lines. Cells with KRAS mutations are less sensitive to PI3K inhibition, but are particularly sensitive to the combined treatment. Colorectal cancer cell lines with inherent or acquired resistance to monotherapy do not show a synergistic response to the combination treatment. Cells that acquire resistance to an MEK-PI3K inhibitor combination treatment still respond to an ERK-PI3K inhibitor regimen, but subsequently also acquire resistance to this combination treatment. Importantly, the mechanisms of resistance to MEK and PI3K inhibitors observed, MEK1/2 mutation or loss of PTEN, are similar to those detected in the clinic. ERK inhibitors may have clinical utility in overcoming resistance to MEK inhibitor regimes; however, we find a recurrent active site mutation of ERK2 that drives resistance to ERK inhibitors in mono- or combined regimens, suggesting that resistance will remain a hurdle. Importantly, we find that the addition of low concentrations of the BCL2-family inhibitor navitoclax to the MEK-PI3K inhibitor regimen improves the synergistic interaction and blocks the acquisition of resistance.	[Clarke, Paul A.; Roe, Toby; Swabey, Kate; Hobbs, Steve M.; McAndrew, Craig; Tomlin, Kathy; Westwood, Isaac; Burke, Rosemary; van Montfort, Robert; Workman, Paul] Inst Canc Res, Canc Res UK Canc Therapeut Unit, London SM2 5NG, England	Cancer Research UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Clarke, PA (corresponding author), Inst Canc Res, Canc Res UK Canc Therapeut Unit, London SM2 5NG, England.	paul.clarke@icr.ac.uk		Clarke, Paul/0000-0001-9342-1290	Cancer Research UK [C309/A11566, C368/A6743, A368/A7990]; Cancer Research UK; Kidani Memorial fund	Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK); Kidani Memorial fund	This work was supported by Cancer Research UK (grant numbers C309/A11566, C368/A6743, and A368/A7990). We acknowledge Cancer Research UK funding to the Cancer Research UK Unit at The Institute of Cancer Research. Paul Workman is a Cancer Research UK Life Fellow. We thank the Kidani Memorial fund for supporting KS. We thank Julian Blagg and Peter Sheldrake for synthesis of CCT245731, and Nicky Evans for editorial assistance.	Aronov AM, 2007, J MED CHEM, V50, P1280, DOI 10.1021/jm061381f; Bean GR, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003483; Blake JF, 2016, J MED CHEM, V59, P5650, DOI 10.1021/acs.jmedchem.6b00389; Chaikuad A, 2014, NAT CHEM BIOL, V10, P853, DOI [10.1038/NCHEMBIO.1629, 10.1038/nchembio.1629]; CHOU TC, 1983, TRENDS PHARMACOL SCI, V4, P450, DOI 10.1016/0165-6147(83)90490-X; Corcoran RB, 2015, J CLIN ONCOL, V33, P4023, DOI 10.1200/JCO.2015.63.2471; Corcoran RB, 2013, CANCER CELL, V23, P121, DOI 10.1016/j.ccr.2012.11.007; de Castro DG, 2013, CLIN PHARMACOL THER, V93, P252, DOI 10.1038/clpt.2012.237; Dreyling M, 2017, J CLIN ONCOL, V35, P3898, DOI 10.1200/JCO.2017.75.4648; Emery CM, 2009, P NATL ACAD SCI USA, V106, P20411, DOI 10.1073/pnas.0905833106; Faber AC, 2014, CANCER DISCOV, V4, P42, DOI 10.1158/2159-8290.CD-13-0315; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Folkes AJ, 2008, J MED CHEM, V51, P5522, DOI 10.1021/jm800295d; Garcia-Garcia C, 2015, CLIN CANCER RES, V21, P5499, DOI 10.1158/1078-0432.CCR-14-3091; Garraway LA, 2012, CANCER DISCOV, V2, P214, DOI 10.1158/2159-8290.CD-12-0012; Garrison Erik, 12073907 ARXIV; Germann UA, 2017, MOL CANCER THER, V16, P2351, DOI 10.1158/1535-7163.MCT-17-0456; Goetz EM, 2014, CANCER RES, V74, P7079, DOI 10.1158/0008-5472.CAN-14-2073; Guillard S, 2009, CELL CYCLE, V8, P443, DOI 10.4161/cc.8.3.7643; Haagensen EJ, 2012, BRIT J CANCER, V106, P1386, DOI 10.1038/bjc.2012.70; Hatzivassiliou G, 2012, MOL CANCER THER, V11, P1143, DOI 10.1158/1535-7163.MCT-11-1010; Hayakawa M, 2006, BIOORGAN MED CHEM, V14, P6847, DOI 10.1016/j.bmc.2006.06.046; Herrero A, 2015, CANCER CELL, V28, P170, DOI 10.1016/j.ccell.2015.07.001; Hobbs S, 1998, BIOCHEM BIOPH RES CO, V252, P368, DOI 10.1006/bbrc.1998.9646; Hoeflich KP, 2012, CANCER RES, V72, P210, DOI 10.1158/0008-5472.CAN-11-1515; Holford J, 1998, BRIT J CANCER, V77, P366, DOI 10.1038/bjc.1998.59; Jaiswal BS, 2018, CLIN CANCER RES, V24, P4044, DOI 10.1158/1078-0432.CCR-17-3674; Jha S, 2016, MOL CANCER THER, V15, P548, DOI 10.1158/1535-7163.MCT-15-0172; Johnson DB, 2014, J CLIN ONCOL, V32, P3697, DOI 10.1200/JCO.2014.57.3535; Jokinen E, 2015, THER ADV MED ONCOL, V7, P170, DOI 10.1177/1758834015571111; Juric D, 2015, NATURE, V518, P240, DOI 10.1038/nature13948; Kaserer T, 2018, CELL CHEM BIOL, V25, P1359, DOI 10.1016/j.chembiol.2018.07.013; Konieczkowski DJ, 2018, CANCER CELL, V33, P801, DOI 10.1016/j.ccell.2018.03.025; Kumar R, 2016, J PHARMACEUT BIOMED, V125, P140, DOI 10.1016/j.jpba.2016.03.036; Larkin J, 2014, NEW ENGL J MED, V371, P1867, DOI 10.1056/NEJMoa1408868; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Long GV, 2014, NEW ENGL J MED, V371, P1877, DOI 10.1056/NEJMoa1406037; Mancini M, 2016, SEMIN CELL DEV BIOL, V50, P164, DOI 10.1016/j.semcdb.2015.09.018; Martinelli E, 2013, INT J CANCER, V133, P2089, DOI 10.1002/ijc.28236; Migliardi G, 2012, CLIN CANCER RES, V18, P2515, DOI 10.1158/1078-0432.CCR-11-2683; Morris EJ, 2013, CANCER DISCOV, V3, P742, DOI 10.1158/2159-8290.CD-13-0070; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Oddo D, 2016, CANCER RES, V76, P4504, DOI 10.1158/0008-5472.CAN-16-0396; Petigny-Lechartier C, 2017, MOL CANCER THER, V16, P102, DOI 10.1158/1535-7163.MCT-16-0342; Raynaud FI, 2007, CANCER RES, V67, P5840, DOI 10.1158/0008-5472.CAN-06-4615; Raynaud FI, 2009, MOL CANCER THER, V8, P1725, DOI 10.1158/1535-7163.MCT-08-1200; Ren DC, 2010, SCIENCE, V330, P1390, DOI 10.1126/science.1190217; ROY S, 2010, J MOL SIGNAL, V5, DOI DOI 10.1186/1750-2187-5-10; Sale MJ, 2013, BIOCHEM J, V450, P285, DOI 10.1042/BJ20121212; Samatar AA, 2014, NAT REV DRUG DISCOV, V13, P928, DOI 10.1038/nrd4281; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Sullivan RJ, 2018, CANCER DISCOV, V8, P184, DOI 10.1158/2159-8290.CD-17-1119; Wagle N, 2014, CANCER DISCOV, V4, P61, DOI 10.1158/2159-8290.CD-13-0631; Workman P, 2013, CURR OPIN PHARMACOL, V13, P486, DOI 10.1016/j.coph.2013.06.004; Yang JY, 2008, NAT CELL BIOL, V10, P138, DOI 10.1038/ncb1676; Yang WS, 2008, NAT CELL BIOL, V10, P125, DOI 10.1038/ncb0208-125; Yap TA, 2012, ANNU REV PHARMACOL, V52, P549, DOI 10.1146/annurev-pharmtox-010611-134532; Yu J, 2003, P NATL ACAD SCI USA, V100, P1931, DOI 10.1073/pnas.2627984100; Zhang L, 2000, SCIENCE, V290, P989, DOI 10.1126/science.290.5493.989; Zhao YJ, 2014, NAT REV CLIN ONCOL, V11, P385, DOI 10.1038/nrclinonc.2014.83; Zunder ER, 2008, CANCER CELL, V14, P180, DOI 10.1016/j.ccr.2008.06.014	62	17	17	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 20	2019	38	25					5076	5090		10.1038/s41388-019-0780-z	http://dx.doi.org/10.1038/s41388-019-0780-z			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	IE1KY	30905967	Green Published, hybrid			2022-12-26	WOS:000472145900014
J	Saul, MJ; Baumann, I; Bruno, A; Emmerich, AC; Wellstein, J; Ottinger, SM; Contursi, A; Dovizio, M; Donnini, S; Tacconelli, S; Raouf, J; Idborg, H; Stein, S; Korotkova, M; Savai, R; Terzuoli, E; Sala, G; Seeger, W; Jakobsson, PJ; Patrignani, P; Suess, B; Steinhilber, D				Saul, Meike J.; Baumann, Isabell; Bruno, Annalisa; Emmerich, Anne C.; Wellstein, Julia; Ottinger, Sarah M.; Contursi, Annalisa; Dovizio, Melania; Donnini, Sandra; Tacconelli, Stefania; Raouf, Joan; Idborg, Helena; Stein, Stefan; Korotkova, Marina; Savai, Rajkumar; Terzuoli, Erika; Sala, Gianluca; Seeger, Werner; Jakobsson, Per-Johan; Patrignani, Paola; Suess, Beatrix; Steinhilber, Dieter			miR-574-5p as RNA decoy for CUGBP1 stimulates human lung tumor growth by mPGES-1 induction	FASEB JOURNAL			English	Article						PGE(2); lung cancer; A549 cells; alternative splicing; prostaglandins	PROSTAGLANDIN-E SYNTHASE-1; GU-RICH ELEMENTS; POSTTRANSCRIPTIONAL REGULATION; GENE-EXPRESSION; TETRANOR PGDM; UP-REGULATION; MICRORNAS; CANCER; CYCLOOXYGENASE-2; OVEREXPRESSION	MicroRNAs (miRs) are important posttranscriptional regulators of gene expression. Besides their well-characterized inhibitory effects on mRNA stability and translation, miRs can also activate gene expression. In this study, we identified a novel noncanonical function of miR-574-5p. We found that miR-574-5p acts as an RNA decoy to CUG RNA-binding protein 1 (CUGBP1) and antagonizes its function. MiR-574-5p induces microsomal prostaglandin E synthase-1 (mPGES-1) expression by preventing CUGBP1 binding to its 3 ' UTR, leading to an enhanced alternative splicing and generation of an mPGES-1 3 ' UTR isoform, increased mPGES-1 protein expression, PGE(2) formation, and tumor growth in vivo. miR-574-5p-induced tumor growth in mice could be completely inhibited with the mPGES-1 inhibitor CIII. Moreover, miR-574-5p is induced by IL-1 beta and is strongly overexpressed in human nonsmall cell lung cancer where high mPGES-1 expression correlates with a low survival rate. The discovered function of miR-574-5p as a CUGBP1 decoy opens up new therapeutic opportunities. It might serve as a stratification marker to select lung tumor patients who respond to the pharmacological inhibition of PGE(2) formation.-Saul, M. J., Baumann, I., Bruno, A., Emmerich, A. C., Wellstein, J., Ottinger, S. M., Contursi, A., Dovizio, M., Donnini, S., Tacconelli, S., Raouf, J., Idborg, H., Stein, S., Korotkova, M., Savai, R., Terzuoli, E., Sala, G., Seeger, W., Jakobsson, P.-J., Patrignani, P., Suess, B., Steinhilber, D. miR-574-5p as RNA decoy for CUGBP1 stimulates human lung tumor growth by mPGES-1 induction.	[Saul, Meike J.; Baumann, Isabell; Emmerich, Anne C.; Wellstein, Julia; Steinhilber, Dieter] Goethe Univ Frankfurt, Inst Pharmaceut Chem, Max von Laue Str 9, D-60438 Frankfurt, Germany; [Saul, Meike J.; Baumann, Isabell; Emmerich, Anne C.; Wellstein, Julia; Ottinger, Sarah M.; Suess, Beatrix] Tech Univ Darmstadt, Dept Biol, Schnittspahnstr 10, D-64287 Darmstadt, Germany; [Bruno, Annalisa; Contursi, Annalisa; Dovizio, Melania; Tacconelli, Stefania; Patrignani, Paola] Univ G dAnnunzio, Dept Neurosci Imaging & Clin Sci, Sect Cardiovasc & Pharmacol Sci, Sch Med, Chieti, Italy; [Bruno, Annalisa; Contursi, Annalisa; Dovizio, Melania; Tacconelli, Stefania; Sala, Gianluca; Patrignani, Paola] Univ G dAnnunzio, Ctr Sci Invecchiamento & Med Traslaz CeSI MeT, Chieti, Italy; [Sala, Gianluca] Univ G dAnnunzio, Dept Med & Oral Sci & Biotechnol, Chieti, Italy; [Donnini, Sandra; Terzuoli, Erika] Univ Siena, Dept Life Sci, Siena, Italy; [Raouf, Joan; Idborg, Helena; Korotkova, Marina; Jakobsson, Per-Johan] Karolinska Inst, Karolinska Univ Hosp, Dept Med, Rheumatol Unit, Stockholm, Sweden; [Stein, Stefan] Georg Speyer Haus, Frankfurt, Germany; [Savai, Rajkumar; Seeger, Werner] Max Planck Inst Heart & Lung Res, German Ctr Lung Res DZL, Dept Lung Dev & Remodeling, Bad Nauheim, Germany; [Seeger, Werner] Univ Giessen, Marburg Lung Ctr UGMLC, Dept Internal Med 2, Giessen, Germany	Goethe University Frankfurt; Technical University of Darmstadt; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; University of Siena; Karolinska Institutet; Karolinska University Hospital; Max Planck Society; Justus Liebig University Giessen	Steinhilber, D (corresponding author), Goethe Univ Frankfurt, Inst Pharmaceut Chem, Max von Laue Str 9, D-60438 Frankfurt, Germany.; Suess, B (corresponding author), Tech Univ Darmstadt, Dept Biol, Schnittspahnstr 10, D-64287 Darmstadt, Germany.	bsuess@bio-tu-darmstadt.de; steinhilber@em.uni-frankfurt.de	Sala, Gianluca/C-2056-2017; Patrignani, Paola/B-4844-2011; Jakobsson, Per-Johan/ABC-5594-2021; Terzuoli, Erika/M-7346-2016	Sala, Gianluca/0000-0002-4494-915X; Patrignani, Paola/0000-0003-1419-2691; Terzuoli, Erika/0000-0001-9248-4505; Donnini, Sandra/0000-0001-6617-1644; Donzelli, Julia/0000-0001-8790-9142; TACCONELLI, Stefania/0000-0003-4907-1822; Dovizio, Melania/0000-0003-0301-7767; Idborg, Helena/0000-0003-4041-4729; Stein, Stefan/0000-0003-1473-9706	Else Kroner-Fresenius Stiftung [2013_A265]; Else Kroner-Fresenius Stiftung (Else Kroner-Fresenius-Graduiertenkolleg); Deutsche Forschungsgemeinschaft (ECCPS); Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz (LOEWE) CompuGene; Associazione Italiana per la Ricerca sul Cancero [IG-12111]; Swedish Cancer Society; Swedish Rheumatism Association; Swedish Agency for Innovation Systems (Vinnova); Apotekare Hedbergs Foundation; Sigurd and Elsa Goljes Minnesfond; Stockholm County Council; King Gustaf V 80 Years Foundation	Else Kroner-Fresenius Stiftung; Else Kroner-Fresenius Stiftung (Else Kroner-Fresenius-Graduiertenkolleg); Deutsche Forschungsgemeinschaft (ECCPS)(German Research Foundation (DFG)); Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz (LOEWE) CompuGene; Associazione Italiana per la Ricerca sul Cancero(Fondazione AIRC per la ricerca sul cancro); Swedish Cancer Society(Swedish Cancer Society); Swedish Rheumatism Association; Swedish Agency for Innovation Systems (Vinnova)(Vinnova); Apotekare Hedbergs Foundation; Sigurd and Elsa Goljes Minnesfond; Stockholm County Council(Stockholm County Council); King Gustaf V 80 Years Foundation	The authors are grateful to Julia Weigand and Katrin Kemmerer [Technische Universitat (TU) Darmstadt] for generously providing pCUGBP1 and pCMV-MS plasmid. The authors give special thanks to Michaela Muller-McNicoll (Goethe University Frankfurt) for scientific discussion and technical support concerning the RIP assays. The authors also thank M. Cristina Cardoso for providing access to microscope facilities, and Theresa Greiner and Eva Wolf for technical support (all from TU Darmstadt). This project was supported by the Else Kroner-Fresenius Stiftung (2013_A265 and Else Kroner-Fresenius-Graduiertenkolleg), the Deutsche Forschungsgemeinschaft (ECCPS), the Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz (LOEWE) CompuGene, the Associazione Italiana per la Ricerca sul Cancero (Grant IG-12111) (to P.P.), and the Swedish Cancer Society, the Swedish Rheumatism Association, King Gustaf V 80 Years Foundation, Swedish Agency for Innovation Systems (Vinnova), the Apotekare Hedbergs Foundation, the Sigurd and Elsa Goljes Minnesfond, and the Stockholm County Council. M.J.S., I.B., P.-J.J., B.S., and D.S. have filed a patent application, "MiRNA-574-5p as a biomarker for stratification of prostaglandin E-dependent tumors" (FH59330EP). The remaining authors declare no conflicts of interests.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Audic Y, 2004, BIOL CELL, V96, P479, DOI 10.1016/j.biolcel.2004.05.002; Banat GA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139073; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Behm-Ansmant I, 2006, COLD SPRING HARB SYM, V71, P523, DOI 10.1101/sqb.2006.71.013; Burset M, 2000, NUCLEIC ACIDS RES, V28, P4364, DOI 10.1093/nar/28.21.4364; Chaudhury A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13362; Cifdaloz M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02353-y; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Daskalova E, 2006, EVOL BIOINFORM, V2, P103; Del Vescovo V, 2014, WORLD J CLIN ONCOL, V5, P604, DOI 10.5306/wjco.v5.i4.604; Diaz-Munoz MD, 2010, CELL SIGNAL, V22, P1427, DOI 10.1016/j.cellsig.2010.05.011; Dovizio M, 2013, MOL PHARMACOL, V84, P25, DOI 10.1124/mol.113.084988; Eiring AM, 2010, CELL, V140, P652, DOI 10.1016/j.cell.2010.01.007; Fitzpatrick T, 2012, NUCLEUS-PHILA, V3, P359, DOI 10.4161/nucl.20827; Foss KM, 2011, J THORAC ONCOL, V6, P482, DOI 10.1097/JTO.0b013e318208c785; Gao CH, 2015, TUMOR BIOL, V36, P4583, DOI 10.1007/s13277-015-3103-1; Gyorffy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082241; Idborg H, 2013, PROSTAG OTH LIPID M, V107, P18, DOI 10.1016/j.prostaglandins.2013.07.004; Jakobsson PJ, 1999, P NATL ACAD SCI USA, V96, P7220, DOI 10.1073/pnas.96.13.7220; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Leclerc P, 2013, SCAND J IMMUNOL, V77, P350, DOI 10.1111/sji.12041; Leclerc P, 2013, PROSTAG OTH LIPID M, V107, P26, DOI 10.1016/j.prostaglandins.2013.09.001; Li QC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048278; Masuda A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00209; Masuko-Hongo K, 2004, ARTHRITIS RHEUM-US, V50, P2829, DOI 10.1002/art.20437; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Ochs MJ, 2014, BASIC CLIN PHARMACOL, V114, P92, DOI 10.1111/bcpt.12116; Ochs MJ, 2013, J PROTEOME RES, V12, P2622, DOI 10.1021/pr301193f; Ochs MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031363; PATRIGNANI P, 1994, J PHARMACOL EXP THER, V271, P1705; Peng Y, 2016, SIGNAL TRANSDUCT TAR, V1, DOI 10.1038/sigtrans.2015.4; Pereira B, 2017, TRENDS CANCER, V3, P506, DOI 10.1016/j.trecan.2017.05.003; Sambandan S, 2017, SCIENCE, V355, P634, DOI 10.1126/science.aaf8995; Saul MJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep31995; Savai R, 2014, NAT MED, V20, P1289, DOI 10.1038/nm.3695; Savai R, 2012, AM J RESP CRIT CARE, V186, P897, DOI 10.1164/rccm.201202-0335OC; Shah MY, 2016, EBIOMEDICINE, V12, P34, DOI 10.1016/j.ebiom.2016.09.017; Smit A.F.A., 2015, REPEATMASKER OPEN 4; Song WL, 2008, J BIOL CHEM, V283, P1179, DOI 10.1074/jbc.M706839200; Song WL, 2007, METHOD ENZYMOL, V433, P51, DOI 10.1016/S0076-6879(07)33003-6; Vlasova IA, 2008, MOL CELL, V29, P263, DOI 10.1016/j.molcel.2007.11.024; Vlasova IA, 2008, RNA BIOL, V5, P201, DOI 10.4161/rna.7056; Vlasova-St Louis I, 2011, CURR OPIN GENET DEV, V21, P444, DOI 10.1016/j.gde.2011.03.002; Vockenhuber MP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120147; Walker SC, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng082; Wang D, 2006, GUT, V55, P115, DOI 10.1136/gut.2004.047100; Westman M, 2004, ARTHRITIS RHEUM-US, V50, P1774, DOI 10.1002/art.20286; Wu YC, 2010, J THORAC ONCOL, V5, P1167, DOI 10.1097/JTO.0b013e3181e2f4f5; Yao P, 2017, NUCLEIC ACIDS RES, V45, P7950, DOI 10.1093/nar/gkx440; Yoshimatsu K, 2001, CLIN CANCER RES, V7, P2669; Zhang YZ, 2011, J MASS SPECTROM, V46, P705, DOI 10.1002/jms.1941; Zhou R, 2016, SCI REP-UK, V6, DOI 10.1038/srep35714; Zhou R, 2015, ONCOTARGET, V6, P44609, DOI 10.18632/oncotarget.6338	54	14	17	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					6933	6947		10.1096/fj.201802547R	http://dx.doi.org/10.1096/fj.201802547R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30922080				2022-12-26	WOS:000476114200021
J	Pedchenko, V; Bauer, R; Pokidysheva, EN; Al-Shaer, A; Forde, NR; Fidler, AL; Hudson, BG; Boudko, SP				Pedchenko, Vadim; Bauer, Ryan; Pokidysheva, Elena N.; Al-Shaer, Alaa; Forde, Nancy R.; Fidler, Aaron L.; Hudson, Billy G.; Boudko, Sergei P.			A chloride ring is an ancient evolutionary innovation mediating the assembly of the collagen IV scaffold of basement membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						collagen; basement membrane; protein self-assembly; crystal structure; extracellular matrix; kinetics; connective tissue; animal evolution; chloride; collagen IV; ECM; NC1 domain	CRYSTAL-STRUCTURE; ANALYTICAL ULTRACENTRIFUGATION; NETWORK; DOMAINS; FIBRILLOGENESIS; STABILIZATION; RECOGNITION; STABILITY; CELLS	Collagen IV scaffold is a principal component of the basement membrane (BM), a specialized extracellular matrix that is essential for animal multicellularity and tissue evolution. Scaffold assembly begins with the trimerization of -chains into protomers inside the cell, which then are secreted and undergo oligomerization outside the cell. For the ubiquitous scaffold composed of 1- and 2-chains, both intracellular and extracellular stages are mediated by the noncollagenous domain (NC1). The association of protomers is chloride-dependent, whereby chloride ions induce interactions of the protomers' trimeric NC1 domains leading to NC1 hexamer formation. Here, we investigated the mechanisms, kinetics, and functionality of the chloride ion-mediated protomer assembly by using a single-chain technology to produce a stable NC1 trimer comprising 1, 2, and 1 NC1 monomers. We observed that in the presence of chloride, the single-chain NC1-trimer self-assembles into a hexamer, for which the crystal structure was determined. We discovered that a chloride ring, comprising 12 ions, induces the assembly of and stabilizes the NC1 hexamer. Furthermore, we found that the chloride ring is evolutionarily conserved across all animals, first appearing in cnidarians. These findings reveal a fundamental role for the chloride ring in the assembly of collagen IV scaffolds of BMs, a critical event enabling tissue evolution and development. Moreover, the single-chain technology is foundational for generating trimeric NC1 domains of other -chain compositions to investigate the 121, 345, and 565 collagen IV scaffolds and to develop therapies for managing Alport syndrome, Goodpasture's disease, and cancerous tumor growth.	[Pedchenko, Vadim; Bauer, Ryan; Pokidysheva, Elena N.; Fidler, Aaron L.; Hudson, Billy G.; Boudko, Sergei P.] Vanderbilt Univ, Med Ctr, Dept Med, Div Nephrol & Hypertens, Nashville, TN 37232 USA; [Pedchenko, Vadim; Bauer, Ryan; Pokidysheva, Elena N.; Fidler, Aaron L.; Hudson, Billy G.; Boudko, Sergei P.] Vanderbilt Univ, Med Ctr, Vanderbilt Ctr Matrix Biol, Nashville, TN 37232 USA; [Al-Shaer, Alaa; Forde, Nancy R.] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada; [Forde, Nancy R.] Simon Fraser Univ, Dept Phys, Burnaby, BC V5A 1S6, Canada; [Fidler, Aaron L.; Hudson, Billy G.] Vanderbilt Univ, Med Ctr, Aspirnaut Program, Nashville, TN 37232 USA; [Hudson, Billy G.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA; [Hudson, Billy G.] Vanderbilt Univ, Med Ctr, Dept Cell & Dev Biol, Nashville, TN 37232 USA; [Hudson, Billy G.] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA; [Hudson, Billy G.] Vanderbilt Univ, Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA; [Hudson, Billy G.] Vanderbilt Univ, Vanderbilt Inst Chem Biol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Simon Fraser University; Simon Fraser University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Boudko, SP (corresponding author), Vanderbilt Univ, Dept Med, Div Nephrol, Med Ctr, Nashville, TN 37232 USA.	sergey.budko@vanderbilt.edu	Fidler, Aaron L./C-4031-2014; Forde, Nancy R/D-8865-2015	Fidler, Aaron L./0000-0002-2519-8864; Forde, Nancy R/0000-0002-5479-7073; Boudko, Sergei/0000-0003-3856-4859	Vanderbilt Center for Matrix Biology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007569, R01DK018381, R25DK096999] Funding Source: NIH RePORTER	Vanderbilt Center for Matrix Biology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the Vanderbilt Center for Structural Biology for use of the Protein Characterization and Biomolecular Crystallography facilities and the Vanderbilt Center for Matrix Biology for support. Technical assistance from Neonila Danylevych and Mohamed Rafi is appreciated.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Boudko SP, 2018, METHOD CELL BIOL, V143, P171, DOI 10.1016/bs.mcb.2017.08.010; Boutaud A, 2000, J BIOL CHEM, V275, P30716, DOI 10.1074/jbc.M004569200; Brown KL, 2017, PROTEIN SCI, V26, P2151, DOI 10.1002/pro.3283; Casino P, 2018, IUCRJ, V5, P765, DOI 10.1107/S2052252518012459; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cole JL, 2008, METHOD CELL BIOL, V84, P143, DOI 10.1016/S0091-679X(07)84006-4; Cummings CF, 2016, J CELL BIOL, V213, P479, DOI 10.1083/jcb.201510065; Daley WP, 2013, CURR OPIN GENET DEV, V23, P408, DOI 10.1016/j.gde.2013.05.005; Delorenzi NJ, 1996, INT J BIOL MACROMOL, V19, P15, DOI 10.1016/0141-8130(96)01094-X; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fidler AL, 2018, J CELL SCI, V131, DOI 10.1242/jcs.203950; Fidler AL, 2017, ELIFE, V6, DOI 10.7554/eLife.24176; Fidler AL, 2014, P NATL ACAD SCI USA, V111, P331, DOI 10.1073/pnas.1318499111; Harris JR, 2013, MICRON, V49, P60, DOI 10.1016/j.micron.2013.03.004; Hjorleifsson JG, 2017, BIOCHEMISTRY-US, V56, P5075, DOI [10.1021/acs.blochem.7b00690, 10.1021/acs.biochem.7b00690]; Hong P, 2012, J LIQ CHROMATOGR R T, V35, P2923, DOI 10.1080/10826076.2012.743724; Hynes RO, 2012, J CELL BIOL, V196, P671, DOI 10.1083/jcb.201109041; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Inman JL, 2015, DEVELOPMENT, V142, P1028, DOI 10.1242/dev.087643; Khoshnoodi J, 2008, MICROSC RES TECHNIQ, V71, P357, DOI 10.1002/jemt.20564; Khoshnoodi J, 2006, J BIOL CHEM, V281, P38117, DOI 10.1074/jbc.R600025200; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Min XS, 2012, FEBS LETT, V586, P912, DOI 10.1016/j.febslet.2012.02.024; Moreau C, 2016, FRONT IMMUNOL, V7, DOI [10.3389/firmnu.2015.DDD79, 10.3389/fimmu.2016.00079]; Netzer KO, 1999, J BIOL CHEM, V274, P11267, DOI 10.1074/jbc.274.16.11267; OZCELIK U, 1994, EUR J PEDIATR, V153, P829; Padilla JE, 2003, ACTA CRYSTALLOGR D, V59, P1124, DOI 10.1107/S0907444903007947; Pastor-Pareja JC, 2011, DEV CELL, V21, P245, DOI 10.1016/j.devcel.2011.06.026; Pfortmueller CA, 2018, INTENS CARE MED EXP, V6, DOI 10.1186/s40635-018-0174-5; Piala AT, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005050; Poschl E, 2004, DEVELOPMENT, V131, P1619, DOI 10.1242/dev.01037; Rezaei N, 2018, BIOPHYS J, V115, P1457, DOI 10.1016/j.bpj.2018.09.003; Schrodinger LLC, 2016, PYMOL MOL GRAPH SYST; Sekiguchi R, 2018, CURR TOP DEV BIOL, V130, P143, DOI 10.1016/bs.ctdb.2018.02.005; Sherwood DR, 2015, J CELL BIOL, V210, P369, DOI 10.1083/jcb.201501083; Sundaramoorthy M, 2002, J BIOL CHEM, V277, P31142, DOI 10.1074/jbc.M201740200; Than ME, 2002, P NATL ACAD SCI USA, V99, P6607, DOI 10.1073/pnas.062183499; Vanacore RM, 2004, J BIOL CHEM, V279, P44723, DOI 10.1074/jbc.M406344200; Vistica J, 2004, ANAL BIOCHEM, V326, P234, DOI 10.1016/j.ab.2003.12.014; VRACKO R, 1974, AM J PATHOL, V77, P314; Wang XM, 2008, NATURE, V455, P72, DOI 10.1038/nature07214; Yurchenco PD, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004911	47	6	6	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2019	294	20					7968	7981		10.1074/jbc.RA119.007426	http://dx.doi.org/10.1074/jbc.RA119.007426			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC0NH	30923125	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000470656500001
J	Mehrpouya-Bahrami, P; Miranda, K; Singh, NP; Zumbrun, EE; Nagarkatti, M; Nagarkatti, PS				Mehrpouya-Bahrami, Pegah; Miranda, Kathryn; Singh, Narendra P.; Zumbrun, Elizabeth E.; Nagarkatti, Mitzi; Nagarkatti, Prakash S.			Role of microRNA in CB1 antagonist-mediated regulation of adipose tissue macrophage polarization and chemotaxis during diet-induced obesity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cannabinoid receptor type 1 (CB1); macrophage; microRNA (miRNA); obesity; adipose tissue; SR141716A; Netrin-1; Unc5b; AGAP-2; inflammation	INSULIN-RESISTANCE; ALTERNATIVE ACTIVATION; DEPENDENT INDUCTION; RISK-FACTORS; FOOD-INTAKE; IN-VIVO; INFLAMMATION; RIMONABANT; EXPRESSION; MONOCYTE	Although cannabinoid receptor 1 (CB1) antagonists have been shown to attenuate diet-induced obesity (DIO) and associated inflammation, the precise molecular mechanisms involved are not clear. In the current study, we investigated the role of microRNA (miR) in the regulation of adipose tissue macrophage (ATM) phenotype following treatment of DIO mice with the CB1 antagonist SR141716A. DIO mice were fed high-fat diet (HFD) for 12 weeks and then treated daily with SR141716A (10 mg/kg) for 4 weeks while continuing HFD. Treated mice experienced weight loss, persistent reduction in fat mass, improvements in metabolic profile, and decreased adipose inflammation. CB1 blockade resulted in down-regulation of several miRs in ATMs, including the miR-466 family and miR-762. Reduced expression of the miR-466 family led to induction of anti-inflammatory M2 transcription factors KLF4 and STAT6, whereas down-regulation of miR-762 promoted induction of AGAP-2, a negative regulator of the neuroimmune retention cues, Netrin-1 and its coreceptor UNC5B. Furthermore, treatment of primary macrophages with SR141716A up-regulated KLF4 and STAT6, reduced secretion of Netrin-1, and increased migration toward the lymph node chemoattractant CCL19. These studies demonstrate for the first time that CB1 receptor blockade attenuates DIO-associated inflammation through alterations in ATM miR expression that promote M2 ATM polarization and macrophage egress from adipose tissue. The current study also identifies additional novel therapeutic targets for diet-induced obesity and metabolic disorder.	[Mehrpouya-Bahrami, Pegah; Miranda, Kathryn; Singh, Narendra P.; Zumbrun, Elizabeth E.; Nagarkatti, Mitzi; Nagarkatti, Prakash S.] Univ South Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC 29208 USA	University of South Carolina System; University of South Carolina Columbia	Nagarkatti, PS (corresponding author), Univ South Carolina, 202 Osborne Adm Bldg, Columbia, SC 29208 USA.	prakash@mailbox.sc.edu		Nagarkatti, Prakash/0000-0003-2663-0759; Miranda, Kathryn/0000-0003-0922-7546	National Institutes of Health [P01AT003961, P20GM103641, R01AT006888, R01ES019313, R01MH094755]; National Center for Complementary & Integrative Health [P01AT003961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103641] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants P01AT003961, P20GM103641, R01AT006888, R01ES019313, and R01MH094755. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Becker W, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00688; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Cota D, 2009, OBESITY, V17, P1641, DOI 10.1038/oby.2009.84; Despres JP, 2005, NEW ENGL J MED, V353, P2121, DOI 10.1056/NEJMoa044537; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Eisenstein A, 2014, J BIOL CHEM, V289, P21071, DOI 10.1074/jbc.M114.566406; Enos RT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094897; Enos RT, 2013, J LIPID RES, V54, P152, DOI 10.1194/jlr.M030700; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Esser N, 2013, DIABETOLOGIA, V56, P2487, DOI 10.1007/s00125-013-3023-9; Feig JE, 2010, J CLIN INVEST, V120, P4415, DOI 10.1172/JCI38911; Gauthier BR, 2006, NAT MED, V12, P36, DOI 10.1038/nm0106-36; Ge Q, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/987285; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; He KY, 2011, MOL BIOL CELL, V22, P1943, DOI 10.1091/mbc.E10-11-0923; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Hwang LL, 2010, OBESITY, V18, P463, DOI 10.1038/oby.2009.273; Jbilo O, 2005, FASEB J, V19, P1567, DOI 10.1096/fj.04-3177fje; Khan JA, 2011, GENE THER, V18, P437, DOI 10.1038/gt.2010.155; Kloting N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004699; Li YS, 2013, IMMUNITY, V39, P885, DOI 10.1016/j.immuni.2013.10.011; Liao XD, 2011, J CLIN INVEST, V121, P2736, DOI 10.1172/JCI45444; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Ly NP, 2005, P NATL ACAD SCI USA, V102, P14729, DOI 10.1073/pnas.0506233102; Ma F, 2010, J IMMUNOL, V184, P6053, DOI 10.4049/jimmunol.0902308; Maianti JP, 2014, NATURE, V511, P94, DOI 10.1038/nature13297; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Medrikova D, 2012, INT J OBESITY, V36, P262, DOI 10.1038/ijo.2011.87; Mehrpouya-Bahrami P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15154-6; Miranda K, 2018, INT J OBESITY, V42, P1140, DOI 10.1038/s41366-018-0114-1; O'Rourke RW, 2011, DIABETOLOGIA, V54, P1480, DOI 10.1007/s00125-011-2103-y; Odegaard JI, 2008, CELL METAB, V7, P496, DOI 10.1016/j.cmet.2008.04.003; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Perkins JM, 2008, CURR DIABETES REP, V8, P12, DOI 10.1007/s11892-008-0004-3; Pi-Sunyer F, 2006, JAMA-J AM MED ASSOC, V295, P761, DOI 10.1001/jama.295.7.761; Ramkhelawon B, 2014, NAT MED, V20, P377, DOI 10.1038/nm.3467; RINALDICARMONA M, 1994, FEBS LETT, V350, P240, DOI 10.1016/0014-5793(94)00773-X; Rosenberger P, 2009, NAT IMMUNOL, V10, P195, DOI 10.1038/ni.1683; Sacerdote P, 2005, J NEUROIMMUNOL, V159, P97, DOI 10.1016/j.jneuroim.2004.10.003; Sam AH, 2011, J OBES, V2011, DOI 10.1155/2011/432607; Schafer A, 2008, BRIT J PHARMACOL, V154, P1047, DOI 10.1038/bjp.2008.158; Shimizu I, 2013, CELL METAB, V18, P491, DOI 10.1016/j.cmet.2013.09.001; SOFIA RD, 1974, PSYCHOPHARMACOLOGIA, V39, P213, DOI 10.1007/BF00421028; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Takamatsu H, 2012, TRENDS IMMUNOL, V33, P127, DOI 10.1016/j.it.2012.01.008; van Gils JM, 2012, NAT IMMUNOL, V13, P136, DOI 10.1038/ni.2205; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Vejnar CE, 2012, NUCLEIC ACIDS RES, V40, P11673, DOI 10.1093/nar/gks901; Wang Q, 2008, P NATL ACAD SCI USA, V105, P2889, DOI 10.1073/pnas.0800178105; Wang Q, 2011, OBESITY, V19, P505, DOI 10.1038/oby.2010.213; Wang WW, 2009, AM J PATHOL, V175, P1010, DOI 10.2353/ajpath.2009.090224; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wen HT, 2011, NAT IMMUNOL, V12, P408, DOI 10.1038/ni.2022; Yang WS, 2001, J CLIN ENDOCR METAB, V86, P3815, DOI 10.1210/jc.86.8.3815; Yang XS, 2014, MOL ENDOCRINOL, V28, P565, DOI 10.1210/me.2013-1293; Zhang YY, 2013, INT J MOL MED, V31, P797, DOI 10.3892/ijmm.2013.1260; Ziccardi P, 2002, CIRCULATION, V105, P804, DOI 10.1161/hc0702.104279	63	12	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2019	294	19					7669	7681		10.1074/jbc.RA118.005094	http://dx.doi.org/10.1074/jbc.RA118.005094			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IB3FL	30910812	Green Published, hybrid			2022-12-26	WOS:000470153300013
J	Corazza, O; Simonato, P; Demetrovics, Z; Mooney, R; van de Ven, K; Roman-Urrestarazu, A; Racmolnar, L; De Luca, I; Cinosi, E; Santacroce, R; Marini, M; Wellsted, D; Sullivan, K; Bersani, G; Martinotti, G				Corazza, Ornella; Simonato, Pierluigi; Demetrovics, Zsolt; Mooney, Roisin; van de Ven, Katinka; Roman-Urrestarazu, Andres; Racmolnar, Lili; De Luca, Ilaria; Cinosi, Eduardo; Santacroce, Rita; Marini, Massimo; Wellsted, David; Sullivan, Keith; Bersani, Giuseppe; Martinotti, Giovanni			The emergence of Exercise Addiction, Body Dysmorphic Disorder, and other image-related psychopathological correlates in fitness settings: A cross sectional study	PLOS ONE			English	Article							PERFORMANCE-ENHANCING DRUGS; ANDROGENIC STEROID USE; MEDITERRANEAN DIET; EXCESSIVE EXERCISE; MUSCLE DYSMORPHIA; PSYCHOACTIVE SUBSTANCES; APPEARANCE ANXIETY; EATING-DISORDER; CONSTRUCTION; PARTICIPANTS	Introduction In a society that perpetuates the strive for a perfect appearance, a fit body has become synonymous with success, but simultaneously hard to achieve. This represents a fertile ground for the development of Exercise Addiction (EA) alongside other disorders, such as Body Dysmorphic Disorder (BDD). This study aims to explore the diffusion of EA in fitness settings in the United Kingdom, Italy, Netherlands, Hungary and the previously unexplored association with appearance anxiety, BDD, self-esteem and the use of fitness supplements. Methods A large cross-sectional sample (N = 1711) was surveyed in fitness settings using the Exercise Addiction Inventory (EAI), Appearance Anxiety Inventory (AAI) and Rosenberg's Self Esteem Scale (RSE) in addition to questions surrounding the use of fitness supplements. Results Compulsive exercise, appearance anxiety and low self-esteem were present in this sample according to the psychometric measures used (EAI, AAI, RSE). 11.7% scored over the cut off for EA, with alarming peaks in the Netherlands (20.9%) and the United Kingdom (16.1%). 38.5% were found at risk of BDD, mainly female (47.2%). 39.8% used fitness enhancing supplements without medical consultation (95.5%). This cohort of supplement users scored higher in both EAI and AAI. The logistic regression model revealed a strong association between the consumption of sport products and the level of EA across the sample with an odds ratio (OR) of 3.03. Other co-variable factors among female were appearance anxiety (AAI; OR 1.59) and to a lesser extent self-esteem (RSE) (OR 1.08). Conclusions This study identified a high risk of EA, appearance anxiety and BDD amongst a cohort of gym users internationally. The previously-unexplored association between these disorders and the unsupervised use of a variety of fitness products, including illicit drugs, highlights the need for informed and integrated responses targeting such vulnerable individuals.	[Corazza, Ornella; Simonato, Pierluigi; Mooney, Roisin; De Luca, Ilaria; Cinosi, Eduardo; Santacroce, Rita; Wellsted, David; Sullivan, Keith; Martinotti, Giovanni] Univ Hertfordshire, Sch Life & Med Sci, Ctr Clin & Hlth Res Serv, Hatfield, Herts, England; [Corazza, Ornella; Bersani, Giuseppe] Sapienza Univ Rome, Dept Medicosurg Sci & Biotechnol, Rome, Italy; [Simonato, Pierluigi] Clin Parco Tigli, Dual Diag Unit, Padua, Italy; [Demetrovics, Zsolt; Racmolnar, Lili] Eotvos Lorand Univ, Inst Psychol, Dept Clin Psychol & Addict, Budapest, Hungary; [van de Ven, Katinka] Univ New South Wales, Social Policy Res Ctr, Sydney, NSW, Australia; [Roman-Urrestarazu, Andres] Univ Cambridge, Inst Publ Hlth, Cambridge, England; [Roman-Urrestarazu, Andres] Maastricht Univ, Dept Int Hlth, Maastricht, Netherlands; [Cinosi, Eduardo] Hertfordshire Partnership Univ NHS Fdn Trust, Hatfield, Herts, England; [Santacroce, Rita; Martinotti, Giovanni] Univ G dAnnunzio, Dept Neurosci Imaging & Clin Sci, Chieti, Italy; [Marini, Massimo] Univ Padua, Dept Psychiat, Padua, Italy	University of Hertfordshire; Sapienza University Rome; Eotvos Lorand University; University of New South Wales Sydney; University of Cambridge; Maastricht University; G d'Annunzio University of Chieti-Pescara; University of Padua	Corazza, O (corresponding author), Univ Hertfordshire, Sch Life & Med Sci, Ctr Clin & Hlth Res Serv, Hatfield, Herts, England.; Corazza, O (corresponding author), Sapienza Univ Rome, Dept Medicosurg Sci & Biotechnol, Rome, Italy.	o.corazza@herts.ac.uk	Corazza, Ornella/AAJ-9363-2021; Martinotti, Giovanni/AAC-7592-2022; Roman-Urrestarazu, Andres/U-9224-2018; Demetrovics, Zsolt/F-8613-2010; van de Ven, Katinka/S-8735-2018	Corazza, Ornella/0000-0001-7371-319X; Martinotti, Giovanni/0000-0002-7292-2341; Roman-Urrestarazu, Andres/0000-0002-2405-9432; Demetrovics, Zsolt/0000-0001-5604-7551; Wellsted, David/0000-0002-2895-7838; Mooney, Roisin/0000-0001-5792-3314; van de Ven, Katinka/0000-0003-3026-9978	Hungarian National Research, Development and Innovation Office [K111938, KKP126835]; Research Design Service (East of England)	Hungarian National Research, Development and Innovation Office(National Research, Development & Innovation Office (NRDIO) - Hungary); Research Design Service (East of England)	Zsolt Demetrovics was supported by the Hungarian National Research, Development and Innovation Office (Grant numbers: K111938, KKP126835). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to acknowledge the support of the Research Design Service (East of England), students from the Psychology BSc degree who assisted data collection, assessment of participants inside the gyms at the University of Hertfordshire and University of Chieti-Pescara, all the participants, and the gyms that helped to promote the study and hosted our teams. Zsolt Demetrovics' contribution was supported by the Hungarian National Research, Development and Innovation Office (Grant numbers: K111938, KKP126835).	Al-Sarraf A, 2018, RES ADV PSYCHIAT, V5, P38; Altabe M, 1996, COGNITIVE THER RES, V20, P171, DOI 10.1007/BF02228033; Altamura C, 2001, EUR ARCH PSY CLIN N, V251, P105, DOI 10.1007/s004060170042; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Asp K, 1999, AM FIT, P64; Barry CT, 2017, LET ME TAKE SELFIE A; Berczik K, 2012, SUBST USE MISUSE, V47, P403, DOI 10.3109/10826084.2011.639120; Bersani FS, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/120679; Beucke JC, 2016, EUR NEUROPSYCHOPHARM, V26, P1657, DOI 10.1016/j.euroneuro.2016.04.011; Bewley A, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j3208; Blaydon MJ, 2002, PSYCHOL SPORT EXERC, V3, P223, DOI 10.1016/S1469-0292(01)00021-8; Borchert J, 1996, J PSYCHOL, V130, P547, DOI 10.1080/00223980.1996.9915021; Brennan BP, 2013, AM J ADDICTION, V22, P158, DOI 10.1111/j.1521-0391.2013.00311.x; Buhlmann U, 2010, PSYCHIAT RES, V178, P171, DOI 10.1016/j.psychres.2009.05.002; Buhlmann U, 2009, J ANXIETY DISORD, V23, P694, DOI 10.1016/j.janxdis.2009.02.008; Button EJ, 1996, PROSPECTIVE STUDY SE, DOI [10.1111/j.2044-8260.1996.tb01176.x, DOI 10.1111/J.2044-8260.1996.TB01176.X]; Chandler M., 2014, STEROIDS IMAGE ENHAN; CHAPMAN CL, 1990, J SPORT MED PHYS FIT, V30, P283; Cockerill IM., 1996, COUNS PSYCHOL, V9, P119, DOI [10.1080/09515079608256358, DOI 10.1080/09515079608256358]; Corazza O, 2017, NOVEL PSYCHOACTIVE S; Corazza O, 2008, NEAR DEATH EXPERIENC; Corazza O, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/841798; Corazza O, 2013, HUM PSYCHOPHARM CLIN, V28, P317, DOI 10.1002/hup.2299; COUSINEAU D, 1977, J APPL PHYSIOL, V43, P801, DOI 10.1152/jappl.1977.43.5.801; De Vries H. A., 1981, PHYSICIAN SPORTSMED, V9, P47, DOI DOI 10.1080/00913847.1981.11711206; Evans-Brown M., 2012, HUMAN ENHANCEMENT DR; Fernandes HM, 2018, BODY DYSMORPHIC DISO, DOI [10.5772/intechopen.76446, DOI 10.5772/INTECHOPEN.76446]; Fineberg NA, 2018, INT J NEUROPSYCHOPH, V21, P42, DOI 10.1093/ijnp/pyx088; Furnham A, 2002, J PSYCHOL INTERD DEC; GAO, 2002, GAO02985T; Glasser W., 1976, POSITIVE ADDICTION; Godier LR, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00778; Graham MR, 2009, DRUG TEST ANAL, V1, P135, DOI 10.1002/dta.30; Griffiths M.D., 2005, J SUBST USE, V10, P191, DOI [DOI 10.1080/14659890500114359, 10.1080/14659890500114359]; Griffiths MD, 2015, SPORTS MED-OPEN, V1, DOI 10.1186/s40798-014-0005-5; Griffiths MD, 2005, BRIT J SPORT MED, V39, DOI 10.1136/bjsm.2004.017020; Grosso G, 2013, J CRITICAL REV FOOD; Hall M, 2016, J HEALTH PSYCHOL, V21, P1939, DOI 10.1177/1359105314568579; Huang CJ, 2012, EUR J PSYCHOL ASSESS, V28, P132, DOI 10.1027/1015-5759/a000101; Kamber M, 2010, ENDOCRIN METAB CLIN, V39, P1, DOI 10.1016/j.ecl.2009.10.009; Kostrzewa E, 2013, PSYCHIAT RES, V210, P1123, DOI 10.1016/j.psychres.2013.08.050; Kuss DJ, 2011, ED HLTH, V29, P63; Leone JE, 2005, J ATHL TRAINING, V40, P352; Lichtenstein MB., 2014, SCANDINAVIAN J MED S, V24; Lichtenstein Mia Beck, 2018, Addict Behav Rep, V8, P33, DOI 10.1016/j.abrep.2018.06.001; Lichtenstein Mia Beck, 2016, Addict Behav Rep, V3, P33, DOI 10.1016/j.abrep.2016.02.002; Mabe AG, 2014, INT J EAT DISORDER, V47, P516, DOI 10.1002/eat.22254; Marzano-Parisoli MM, 2001, QUEST, V53, P216; Mastro S, 2016, J OBSESS-COMPULS REL, V8, P50, DOI 10.1016/j.jocrd.2015.12.001; Mataix J, 2012, ACTAS DERMO-SIFILOGR, V103, P655, DOI 10.1016/j.adengl.2012.09.004; Maughan RJ, 2004, J SPORT SCI, V22, P95, DOI 10.1080/0264041031000140581; Meier EP, 2014, CYBERPSYCH BEH SOC N, V17, P199, DOI 10.1089/cyber.2013.0305; Meyer C, 2011, EUR EAT DISORD REV, V19, P174, DOI 10.1002/erv.1122; Molinero O, 2009, NUTR HOSP, V24, P128; Monok K, 2012, PSYCHOL SPORT EXERC, V13, P739, DOI 10.1016/j.psychsport.2012.06.003; Monteath SA, 1997, J SOC PSYCHOL, V137, P708, DOI 10.1080/00224549709595493; Mooney R, 2017, HUM PSYCHOPHARM CLIN, V32, DOI 10.1002/hup.2619; Muller Rudhard Klaus, 2010, Handb Exp Pharmacol, P1, DOI 10.1007/978-3-540-79088-4_1; Murray SB, 2012, BODY IMAGE, V9, P193, DOI 10.1016/j.bodyim.2012.01.008; Nogueira A, 2018, REV PSICOL DEPORTE, V27, P43; O'Dea J., 2016, CHEM MODIFIED BODIES, P51, DOI DOI 10.1057/978-1-137-53535-1_4; O'Hara SE, 2014, BODY IMAGE, V11, P109, DOI 10.1016/j.bodyim.2013.12.004; Pavan C, 2006, INT J PSYCHIAT CLIN, V10, DOI [10.1007/s10899-010-9206-0, DOI 10.1007/S10899-010-9206-0]; Penas-Lledo E, 2002, INT J EAT DISORDER, V31, P370, DOI 10.1002/eat.10042; Pope HG, 2014, AM J ADDICTION, V23, P371, DOI 10.1111/j.1521-0391.2013.12118.x; POPE HG, 1988, PHYSICIAN SPORTSMED, V16, P75, DOI 10.1080/00913847.1988.11709554; Prichard I, 2005, SEX ROLES, V53, P19, DOI 10.1007/s11199-005-4270-0; Qualtrics, 2008, QUALTR ACC COD; Reuter P, 2017, ADDICTION, V112, P25, DOI 10.1111/add.13439; Ricciardelli R, 2010, SEX ROLES, V63, P64, DOI 10.1007/s11199-010-9764-8; Rosenberg M., 1965, SOC ADOLESCENT SELF, DOI 10.1515/9781400876136; Sachs ML., 1992, THE EXERCISING ADULT; Sandgren SS, 2018, J LOSS TRAUMA, V23, P211, DOI 10.1080/15325024.2018.1428484; Serra-Majem L, 2006, NUTR REV, V64, pS27, DOI 10.1301/nr.2006.feb.S27-S47; Shai I, 2008, NEW ENGL J MED, V359, P229, DOI 10.1056/NEJMoa0708681; Shroff H, 2006, INT J EAT DISORDER, V39, P454, DOI 10.1002/eat.20247; Silver J, 2016, J HEALTH PSYCHOL, V21, P2647, DOI 10.1177/1359105315581516; Simon-Grima J, 2019, ADICCIONES, V31, P233, DOI 10.20882/adicciones.990; Simonato P, 2017, RES ADV PSYCHIAT, V4; Simpson CC, 2017, HEALTH COMMUN, V32, P560, DOI 10.1080/10410236.2016.1140273; Smith D, 2016, CHEM MODIFIED BODIES, P100; Snow J, 2013, QUALTRICS SURVEY SOF; Stoliaroff S, 2003, RUNNING FIT NEWS, V18, P4; Szabo, 2010, ADDICTION EXERCISE S; Szabo A, 1995, Aust J Sci Med Sport, V27, P68; Terry A, 2004, ADDICT RES THEORY, V12, P489, DOI 10.1080/16066350310001637363; Thevis M, 2008, J ANAL TOXICOL, V32, P232, DOI 10.1093/jat/32.3.232; Trichopoulou A, 2003, NEW ENGL J MED, V348, P2599, DOI 10.1056/NEJMoa025039; Underwood M, 2017, INT J DRUG POLICY, V39, P78, DOI 10.1016/j.drugpo.2016.08.012; Van de Ven K, 2018, DRUG ALCOHOL REV, V37, P837, DOI 10.1111/dar.12831; Van Hout M. C., 2014, PERFORMANCE ENHANCEM, V3, P3, DOI [10.1016/j.peh.2014.05.001, DOI 10.1016/J.PEH.2014.05.001]; Van Hout MC, 2014, INT J DRUG POLICY, V25, P444, DOI 10.1016/j.drugpo.2013.10.008; Veale D, 2001, BEHAV RES THER, V39, P1381, DOI 10.1016/S0005-7967(00)00102-9; Veale D, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2278; Veale D, 2014, PSYCHOTHER PSYCHOSOM, V83, P341, DOI 10.1159/000360740; Veale D, 2014, BEHAV COGN PSYCHOTH, V42, P605, DOI 10.1017/S1352465813000556; Veale DMW., 1995, EXERCISE ADDICTION M, P1, DOI DOI 10.12691/AJSSM-1-1-1; Villella C, 2011, J GAMBL STUD, V27, P203, DOI 10.1007/s10899-010-9206-0; WILLETT WC, 1995, AM J CLIN NUTR, V61, p1402S, DOI 10.1093/ajcn/61.6.1402S; Yuasa Yasuo, 1987, BODY E MINDBODY THEO; Zahnow R., 2017, CONTEMP DRUG PROBL, V44, P69, DOI DOI 10.1177/0091450917694268	101	44	45	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0213060	10.1371/journal.pone.0213060	http://dx.doi.org/10.1371/journal.pone.0213060			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HR5NS	30943200	Green Published, gold			2022-12-26	WOS:000463194300009
J	Wang, PY; Chen, KL; Yang, SY; Lin, PH				Wang, Po-Yu; Chen, Kai-Li; Yang, Shang-Yu; Lin, Pin-Hsuan			Relationship of sleep quality, smartphone dependence, and health-related behaviors in female junior college students	PLOS ONE			English	Article							BODY-MASS INDEX; UNIVERSITY-STUDENTS; PREVALENCE; LIFE; DEPRESSION; DURATION; INSOMNIA; GENDER; DISTURBANCES; ASSOCIATION	Introduction Smartphone usage has become commonplace and impact on sleep quality among adolescents. Adolescent girls have a greater tendency toward sleep quality problems. However, relationship of sleep quality, smartphone dependence, and health-related behaviors in female junior college students has not been studied. Objectives This study had the two goals: to investigate the relationship between female college students' sleep quality, smartphone dependence, and health-related behaviors, and to identify predictors of sleep quality. Methods This study employed a cross-sectional research approach to gather 409 subjects at a junior college in southern Taiwan, and used a structured questionnaire to collect data. The questionnaire consisted of four parts: basic demographic data, the Pittsburgh Sleep Quality Index, assessment of smartphone dependence, and the Health Promoting Lifestyle Profile (HPLP). Logistic regression analysis was employed to check for any association between sleep quality and smartphone dependence or HPLP. Results Sleep quality was significantly associated with degree of smartphone dependence, total HPLP score, and scores on the four HPLP subscales of nutritional behavior, self-actualization, interpersonal support, and stress management behavior. The lower the subjects' degree of smartphone dependence was, the better their sleep quality was. Furthermore, the degree of smartphone dependence and total HPLP score were significant predictors of sleep quality. Conclusions Smartphone dependence is associated with poor sleep quality among female college students. Improving health-related behaviors (nutritional behavior, self-actualization, interpersonal support, and stress management behavior) can also promote improvement in sleep quality.	[Wang, Po-Yu] Changhua Christian Children Hosp, Dept Pediat Emergency, Changhua, Taiwan; [Chen, Kai-Li] Tajen Univ, Coll Pharm & Hlth Care, Dept Nursing, Pingtung, Taiwan; [Yang, Shang-Yu] Asia Univ, Coll Med & Hlth Sci, Dept Occupat Therapy, Taichung, Taiwan; [Lin, Pin-Hsuan] Shu Zen Jr Coll Med & Management, Dept Hlth & Beauty, Kaohsiung, Taiwan	Asia University Taiwan	Yang, SY (corresponding author), Asia Univ, Coll Med & Hlth Sci, Dept Occupat Therapy, Taichung, Taiwan.	henry879019@yahoo.com.tw						Aceijas C, 2017, PERSPECT PUBLIC HEAL, V137, P227, DOI 10.1177/1757913916666875; Almutairi KM, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5999-z; Alosaimi FD, 2016, SAUDI MED J, V37, P675, DOI [10.15537/smj.2016.6.14430, 10.15537/Smj.2016.6.14430]; Baert S, 2015, SOC SCI MED, V130, P91, DOI 10.1016/j.socscimed.2015.02.011; Britton WB, 2013, MINDFULNESS RELATED, P92; Buysse D J, 1989, Psychiatry Res, V28, P193; Cajochen C, 2011, J APPL PHYSIOL, V110, P1432, DOI 10.1152/japplphysiol.00165.2011; Chahine R, 2018, E MEDITERR HEALTH J, V24, P722, DOI 10.26719/2018.24.8.722; Chang SP, 2015, J SPORT MED PHYS FIT, V55, P1234; Chen BF, 2017, BMC PSYCHIATRY, V17, DOI 10.1186/s12888-017-1503-z; Chen DR, 2013, J SCHOOL HEALTH, V83, P582, DOI 10.1111/josh.12068; Chen M.Y., 1997, CHANG GUNG NURS, V8, P14; Chen TY, 2015, NEUROPSYCH DIS TREAT, V11, P741, DOI 10.2147/NDT.S77179; Cheng GHL, 2018, QUAL LIFE RES, V27, P2517, DOI 10.1007/s11136-018-1895-3; Christensen MA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165331; Cohen J.E., 1988, STAT POWER ANAL BEHA; COREN S, 1994, INT J NEUROSCI, V79, P67, DOI 10.3109/00207459408986068; Lima TR, 2018, WORLD J PEDIATR, V14, P383, DOI 10.1007/s12519-018-0136-8; Demirci K, 2015, J BEHAV ADDICT, V4, P85, DOI 10.1556/2006.4.2015.010; Dewald JF, 2010, SLEEP MED REV, V14, P179, DOI 10.1016/j.smrv.2009.10.004; Heppner PP, 2004, COUNS PSYCHOL, V32, P344, DOI 10.1177/0011000003262793; Jaussent I, 2011, AM J GERIAT PSYCHIAT, V19, P88, DOI 10.1097/JGP.0b013e3181e049b6; Jenaro C, 2007, ADDICT RES THEORY, V15, P309, DOI 10.1080/16066350701350247; Johnson EO, 2006, PEDIATRICS, V117, pE247, DOI 10.1542/peds.2004-2629; Kazama M, 2015, TOHOKU J EXP MED, V236, P107, DOI 10.1620/tjem.236.107; Kenney SR, 2013, J STUD ALCOHOL DRUGS, V74, P841, DOI 10.15288/jsad.2013.74.841; Killgore WDS, 2008, SLEEP MED, V9, P517, DOI 10.1016/j.sleep.2007.07.003; Kim K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174619; Kim SY, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191713; Kuss DJ, 2011, INT J ENV RES PUB HE, V8, P3528, DOI 10.3390/ijerph8093528; Lai P P, 2013, Med J Malaysia, V68, P195; Lee SY, 2013, AM J HEALTH BEHAV, V37, P851, DOI 10.5993/AJHB.37.6.14; Lin L.-N., 2012, FORMOS J MED, V16, P72, DOI [10.6320/FJM.2012.16(1).08, DOI 10.6320/FJM.2012.16(1).08]; Lin P. H, 2018, SOC HLTH BEHAV, V1, P31, DOI [10.3389/fpsyg.2018.02316, DOI 10.3389/FPSYG.2018.02316]; Liu XC, 2017, EUR CHILD ADOLES PSY, V26, P271, DOI 10.1007/s00787-016-0885-7; Meijer AM, 2010, J CHILD PSYCHOL PSYC, V51, P1278, DOI 10.1111/j.1469-7610.2010.02261.x; Min CY, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-022848; Mirghani Hyder Osman, 2015, BMC Res Notes, V8, P706, DOI 10.1186/s13104-015-1712-9; Nakade Miyo, 2009, Journal of Physiological Anthropology, V28, P83, DOI 10.2114/jpa2.28.83; Nam GE, 2017, SLEEP MED, V35, P62, DOI 10.1016/j.sleep.2017.04.009; Perkinson-Gloor N, 2013, J ADOLESCENCE, V36, P311, DOI 10.1016/j.adolescence.2012.11.008; Peuhkuri K, 2012, NUTR RES, V32, P309, DOI 10.1016/j.nutres.2012.03.009; Lopez VAQ, 2018, NUTR HOSP, V35, P979, DOI 10.20960/nh.1680; REYNER A, 1995, SLEEP, V18, P127; ROSENTHAL DA, 1981, J YOUTH ADOLESCENCE, V10, P525, DOI 10.1007/BF02087944; St-Onge MP, 2016, ADV NUTR, V7, P938, DOI 10.3945/an.116.012336; Sumi K, 2012, PSYCHOL REP, V111, P929, DOI 10.2466/21.20.28.PR0.111.6.929-937; Swinkels CM, 2013, SLEEP, V36, P1019, DOI 10.5665/sleep.2800; Tanaka E, 2013, J EPIDEMIOL, V23, P132, DOI 10.2188/jea.JE20120101; Tang NKY, 2017, SLEEP, V40, DOI 10.1093/sleep/zsw079; Tsai LL, 2004, J PSYCHOSOM RES, V56, P231, DOI 10.1016/S0022-3999(03)00507-5; Tsai PS, 2005, QUAL LIFE RES, V14, P1943, DOI 10.1007/s11136-005-4346-x; Tsai S. C., 2012, FORUM ED RES, V4, P1; WALKER SN, 1987, NURS RES, V36, P76; Wallace DD, 2017, J AM COLL HEALTH, V65, P187, DOI 10.1080/07448481.2016.1269111; Wang H, 2018, NUTR METAB, V15, DOI 10.1186/s12986-018-0285-8; Wang L, 2016, PSYCHIAT RES, V244, P243, DOI 10.1016/j.psychres.2016.04.011; Xie XC, 2018, J BEHAV ADDICT, V7, P466, DOI 10.1556/2006.7.2018.40; Yang SY, 2018, J AM COLL HEALTH, V66, P693, DOI 10.1080/07448481.2018.1454930; Yang SY, 2017, J COMMUN HEALTH, V42, P423, DOI 10.1007/s10900-016-0271-x	60	32	32	5	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0214769	10.1371/journal.pone.0214769	http://dx.doi.org/10.1371/journal.pone.0214769			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HR5NS	30943270	Green Published, gold, Green Submitted			2022-12-26	WOS:000463194300060
J	Lee, PH; Chan, PC; Peng, YT; Chu, PW; Wu, MH; Jou, RW; Yu, MC; Lin, CJ; Huang, YW; Chien, ST; Lee, JJ; Chiang, CY				Lee, Pin-Hui; Chan, Pei-Chun; Peng, Yen-Ting; Chu, Po-Wei; Wu, Mei-Hua; Jou, Ruwen; Yu, Ming-Chih; Lin, Chou-Jui; Huang, Yi-Wen; Chien, Shun-Tien; Lee, Jen-Jyh; Chiang, Chen-Yuan			Impact of universal drug susceptibility testing and effective management of multidrug-resistant tuberculosis in Taiwan	PLOS ONE			English	Article							DIRECTLY OBSERVED THERAPY; MYCOBACTERIUM-TUBERCULOSIS; PROFICIENCY	Background The treatment outcomes of multidrug-resistant tuberculosis (MDR-TB) patients in the 1990s in Taiwan was not satisfactory. To strengthen programmatic management of drug-resistant tuberculosis (PMDT), Taiwan MDR-TB Consortium (TMTC) was established in 2007. We assess the performance and epidemiologic impact of TMTC. Methodology/Principle findings We analyzed the trends of proportion of TB cases with drug susceptibility testing, enrollment of MDR-TB patients into TMTC and outcomes of treatment of all MDR-TB patients in Taiwan from 2007-2016. We computed the trends of both incidence and prevalence of MDR-TB from 2007-2016. We assessed the trends of MDR-TB among both new and recurrent TB cases. The proportion of TB cases with drug susceptibility testing results increased from 24.2% in 2007 to 97.9% in 2016. Of the 1,452 MDR-TB patients who were eligible for TMTC care, 1,197 (82.4%) were enrolled in TMTC, in whom 82.9% had treatment success. MDR TB incidence was 9.0 cases per million in 2007, which declined to 4.6 cases per million in 2016 (p<0.0001). MDR-TB prevalence decreased from 19.4 cases per million in 2007 to 8.4 cases per million in 2016 (p<0.0001). The proportion of MDR-TB among new TB cases decreased from 1.4% in 2010 to 1.0% in 2016 (p = 0.039); and that among recurrent TB cases from 9.0% in 2010 to 1.8% in 2016 (p<0.0001). Conclusions We concluded that effective PMDT have had a significant impact on the epidemic of drug resistant TB in Taiwan.	[Lee, Pin-Hui; Chan, Pei-Chun; Peng, Yen-Ting; Chu, Po-Wei; Wu, Mei-Hua; Jou, Ruwen] Taiwan Ctr Dis Control, Taipei, Taiwan; [Chan, Pei-Chun] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei, Taiwan; [Yu, Ming-Chih; Chiang, Chen-Yuan] Taipei Med Univ, Wanfang Hosp, Dept Internal Med, Div Pulm Med, Taipei, Taiwan; [Yu, Ming-Chih] Taipei Med Univ, Coll Med, Sch Resp Therapy, Taipei, Taiwan; [Yu, Ming-Chih; Chiang, Chen-Yuan] Taipei Med Univ, Coll Med, Sch Med, Div Pulm Med,Dept Internal Med, Taipei, Taiwan; [Lin, Chou-Jui] Taoyuan Gen Hosp, Minist Hlth & Welf, Pulm & Crit Care Unit, Taoyuan, Taiwan; [Huang, Yi-Wen] Changhua Hosp, Minist Hlth & Welf, Pulm & Crit Care Unit, Changhua, Taiwan; [Chien, Shun-Tien] Chest Hosp, Minist Hlth & Welf, Pulm & Crit Care Unit, Tainan, Taiwan; [Lee, Jen-Jyh] Tzu Chi Univ, Buddhist Tzu Chi Gen Hosp, Dept Internal Med, Hualien, Taiwan; [Chiang, Chen-Yuan] Int Union TB & Lung Dis, Paris, France	National Taiwan University; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Taipei Medical University; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Tzu Chi University	Chiang, CY (corresponding author), Taipei Med Univ, Wanfang Hosp, Dept Internal Med, Div Pulm Med, Taipei, Taiwan.; Chiang, CY (corresponding author), Taipei Med Univ, Coll Med, Sch Med, Div Pulm Med,Dept Internal Med, Taipei, Taiwan.; Chiang, CY (corresponding author), Int Union TB & Lung Dis, Paris, France.	cychiang@theunion.org			Taiwan Centers for Disease Control [MOHW107-CDC-C-315-112117]	Taiwan Centers for Disease Control	The study was funded by Taiwan Centers for Disease Control (author: PHL, funder website: www.cdc.gov.tw, grant number: MOHW107-CDC-C-315-112117). The funder had no role in study design, data analysis, decision to publish, or preparation of the manuscript.	Agarwal MM, 2014, DIABETES RES CLIN PR, V103, P341, DOI 10.1016/j.diabres.2013.10.012; [Anonymous], 2018, GLOB TUB REP; Bloss E, 2012, INT J TUBERC LUNG D, V16, P462, DOI 10.5588/ijtld.11.0121; Chan PC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057719; Chen MY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170980; Chiang CY, 2006, EUR RESPIR J, V28, P980, DOI 10.1183/09031936.06.00125705; Chiang CY, 2010, INT J TUBERC LUNG D, V14, P878; Chiang CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044133; Chiang TY, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200755; Chien JY, 2013, J ANTIMICROB CHEMOTH, V68, P1910, DOI 10.1093/jac/dkt103; Huang SH, 2012, TAIWAN EPIDEMIOL B, V28, P269; Huang SH, 2014, TAIWAN EPIDEMIOL B, V30, P64; Jou R, 2009, INT J TUBERC LUNG D, V13, P1142; Lee CY, 2015, AM J MANAG CARE, V21, pE35; Lo HY, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-915; Taiwan Centers for Disease Control, TAIW TUB CONTR REP 2; World Health Organization, 2016, AMBIENT AIR POLLUTIO, DOI DOI 10.1017/CBO9781107415324.004; Wu MH, 2013, INT J TUBERC LUNG D, V17, P113, DOI 10.5588/ijtld.12.0521; Wu MH, 2009, INT J TUBERC LUNG D, V13, P606; Yu MC, 2018, CLIN INFECT DIS, V67, P202, DOI 10.1093/cid/ciy066	20	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2019	14	4							e0214792	10.1371/journal.pone.0214792	http://dx.doi.org/10.1371/journal.pone.0214792			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR2UW	30939150	Green Published, Green Submitted, gold			2022-12-26	WOS:000462993900040
J	Zhang, GY; Langan, EA; Meier, NT; Funk, W; Siemers, F; Paus, R				Zhang, Guo-You; Langan, Ewan A.; Meier, Natalia T.; Funk, Wolfgang; Siemers, Frank; Paus, Ralf			Thyroxine (T4) may promote re-epithelialisation and angiogenesis in wounded human skin ex vivo	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; HUMAN HAIR FOLLICLE; ORGAN-CULTURE MODEL; THYROID-HORMONE; MITOCHONDRIAL-FUNCTION; ANAGEN; ULCER; MANAGEMENT; BFGF; PROLIFERATION	There is a pressing need for improved preclinical model systems in which to study human skin wound healing. Here, we report the development and application of a serum-free full thickness human skin wound healing model. Not only can re-epithelialization (epidermal repair) and angiogenesis be studied in this simple and instructive model, but the model can also be used to identify clinically relevant wound-healing promoting agents, and to dissect underlying candidate mechanisms of action in the target tissue. We present preliminary ex vivo data to suggest that Thyroxine (T4), which reportedly promotes skin wound healing in rodents in vivo, may promote key features of human skin wound healing. Namely, T4 stimulates re-epithelialisation and angiogenesis, and modulates both wound healing-associated epidermal keratin expression and energy metabolism in experimentally wound human skin. Functionally, the wound healing-promoting effects of T4 are at least partially mediated via fibroblast growth factor/fibroblast growth factor receptor-mediated signalling, since they could be significantly antagonized by bFGF-neutralizing antibody. Thus, this pragmatic, easy-to-use full-thickness human skin wound healing model provides a useful preclinical research tool in the search for clinically relevant candidate wound healing-promoting agents. These ex vivo data encourage further pre-clinical testing of topical T4 as a cost-efficient, novel agent in the management of chronic human skin wounds.	[Zhang, Guo-You] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Dept Plast & Reconstruct Surg, Sch Med, Shanghai, Peoples R China; [Langan, Ewan A.] Univ Lubeck, Dept Dermatol, Lubeck, Germany; [Langan, Ewan A.] Univ Manchester, Ctr Dermatol Res, Manchester, Lancs, England; [Langan, Ewan A.] NIHR Manchester Biomed Res Ctr, Manchester, Lancs, England; [Meier, Natalia T.] Univ Lubeck, Dept Pathol, Lubeck, Germany; [Funk, Wolfgang] Klin Dr Funk, Munich, Germany; [Siemers, Frank] BG Klinikum Bergmannstrost, Dept Plast & Hand Surg, Halle, Germany; [Paus, Ralf] Univ Miami, Miller Sch Med, Dept Dermatol & Cutaneous Surg, Miami, FL 33136 USA; [Paus, Ralf] Univ Manchester, Ctr Dermatol Res, Manchester, Lancs, England; [Paus, Ralf] NIHR Manchester Biomed Res Ctr, Manchester, Lancs, England	Shanghai Jiao Tong University; University of Lubeck; University of Manchester; University of Lubeck; University of Miami; University of Manchester	Paus, R (corresponding author), Univ Miami, Miller Sch Med, Dept Dermatol & Cutaneous Surg, Miami, FL 33136 USA.; Paus, R (corresponding author), Univ Manchester, Ctr Dermatol Res, Manchester, Lancs, England.; Paus, R (corresponding author), NIHR Manchester Biomed Res Ctr, Manchester, Lancs, England.	rxp803@med.miami.edu			Federal Ministry of Economics, Germany (AiF/ZIM Programme); National Natural Science Foundation of China [81101430]; 2011 Chinese government award for outstanding self-financed students abroad (China Scholarship Council)	Federal Ministry of Economics, Germany (AiF/ZIM Programme); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 2011 Chinese government award for outstanding self-financed students abroad (China Scholarship Council)	This work was supported in part by a grant from the Federal Ministry of Economics, Germany (AiF/ZIM Programme) to R.P. G-Y Zhang was supported by 2011 Chinese government award for outstanding self-financed students abroad (China Scholarship Council) and National Natural Science Foundation of China (81101430).	Abramo F, 2017, VET DERMATOL, V28, P456, DOI 10.1111/vde.12456; Abramo F, 2016, ANN ANAT, V207, P109, DOI 10.1016/j.aanat.2016.03.009; Ansell DM, 2011, J INVEST DERMATOL, V131, P518, DOI 10.1038/jid.2010.291; Aoki S, 2017, WOUND REPAIR REGEN, V25, P1008, DOI 10.1111/wrr.12604; Arbiser JL, 2000, J AM ACAD DERMATOL, V42, P973, DOI 10.1016/S0190-9622(00)90288-3; Bekeschus S, 2017, EXP DERMATOL, V26, P145, DOI 10.1111/exd.13215; Bodo E, 2007, FASEB J, V21, P3346, DOI 10.1096/fj.07-8628com; Bodo E, 2007, AM J PATHOL, V171, P1153, DOI 10.2353/ajpath.2007.061164; Bodo E, 2010, ENDOCRINOLOGY, V151, P1633, DOI 10.1210/en.2009-0306; Bodo E, 2009, J INVEST DERMATOL, V129, P1126, DOI 10.1038/jid.2008.361; Cao YH, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003149; Cappellano G, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051404; Certan D, 2013, GIORN ITAL DERMAT V, V148, P287; Cheret J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05973-0; Choi EW, 2018, EXP DERMATOL, V27, P1170, DOI 10.1111/exd.13451; Choi SM, 2018, ACTA BIOMATER, V66, P325, DOI 10.1016/j.actbio.2017.11.045; Coleman S, 2018, J ADV NURS, V74, P407, DOI 10.1111/jan.13444; Davis FB, 2004, CIRC RES, V94, P1500, DOI 10.1161/01.RES.0000130784.90237.4a; Deshayes N, 2018, EXP DERMATOL, V27, P460, DOI 10.1111/exd.13390; Eming SA, 2017, EXP DERMATOL, V26, P97, DOI 10.1111/exd.13281; Erdogan M, 1999, ACTA CHIR BELG, V99, P72; FREINKEL RK, 1972, ARCH DERMATOL, V106, P349, DOI 10.1001/archderm.106.3.349; Garcin CL, 2017, EXP DERMATOL, V26, P101, DOI 10.1111/exd.13184; Guest JF, 2018, INT WOUND J, V15, P29, DOI 10.1111/iwj.12814; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Harn HIC, 2019, EXP DERMATOL, V28, P464, DOI 10.1111/exd.13460; Hawkshaw NJ, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2003705; HOLT PJA, 1978, J INVEST DERMATOL, V71, P202, DOI 10.1111/1523-1747.ep12547158; HOLT PJA, 1977, J INVEST DERMATOL, V68, P299, DOI 10.1111/1523-1747.ep12494564; Ilonzo Nicole, 2018, Surg Technol Int, V32, P49; Ito M, 2007, NATURE, V447, P316, DOI 10.1038/nature05766; Jeffcoate WJ, 2018, DIABETES CARE, V41, P645, DOI 10.2337/dc17-1836; Jimenez F, 2015, EXP DERMATOL, V24, P91, DOI 10.1111/exd.12521; KAPLAN MM, 1988, J CLIN ENDOCR METAB, V66, P815, DOI 10.1210/jcem-66-4-815; Kinoda J, 2018, J RADIAT RES, V59, P27, DOI 10.1093/jrr/rrx044; Knuever J, 2012, J CLIN ENDOCR METAB, V97, P978, DOI 10.1210/jc.2011-1096; Kress E, 2009, MOL CELL ENDOCRINOL, V313, P36, DOI 10.1016/j.mce.2009.08.028; Lebonvallet N, 2018, EXP DERMATOL, V27, P950, DOI 10.1111/exd.13681; Lu ZF, 2007, EXP DERMATOL, V16, P37, DOI 10.1111/j.1600-0625.2006.00510.x; Luidens MK, 2010, VASC PHARMACOL, V52, P142, DOI 10.1016/j.vph.2009.10.007; Markova A, 2012, DERMATOL CLIN, V30, P107, DOI 10.1016/j.det.2011.08.005; Martinez ML, 2016, J AM ACAD DERMATOL, V75, P1007, DOI 10.1016/j.jaad.2016.02.1161; Mecklenburg L, 2000, J INVEST DERMATOL, V114, P909, DOI 10.1046/j.1523-1747.2000.00954.x; Meier NT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073596; Messenger AG, 2000, BRIT J DERMATOL, V142, P633, DOI 10.1046/j.1365-2133.2000.03521.x; Mizukami Y, 2017, J DERMATOL SCI, V88, P308, DOI 10.1016/j.jdermsci.2017.08.005; Moll I, 1998, J INVEST DERMATOL, V111, P251, DOI 10.1046/j.1523-1747.1998.00265.x; Nygaard B, 2015, BASIC CLIN PHARMACOL, V117, P280, DOI 10.1111/bcpt.12401; Ogino S, 2018, J SURG RES, V221, P173, DOI 10.1016/j.jss.2017.08.051; Olah A, 2016, J INVEST DERMATOL, V136, P1711, DOI 10.1016/j.jid.2016.03.033; Olivera S, 2013, METHODS MOL BIOL, V1037, P255, DOI 10.1007/978-1-62703-505-7_14; Orlandi C, 2018, EXP DERMATOL, V27, P795, DOI 10.1111/exd.13552; Pastar I, 2018, EXP DERMATOL, V27, P551, DOI 10.1111/exd.13663; Paus R, 2017, ROOKS TXB DERMATOLOG; Paus R, 2010, J INVEST DERMATOL, V130, P7, DOI 10.1038/jid.2009.359; PHILPOTT MP, 1990, J CELL SCI, V97, P463; Poblet E, 2018, BRIT J DERMATOL, V178, P1163, DOI 10.1111/bjd.16436; Poeggeler B, 2010, FASEB J, V24, P1525, DOI 10.1096/fj.09-147728; POUMAY Y, 1994, J INVEST DERMATOL, V102, P111, DOI 10.1111/1523-1747.ep12371742; Raja, 2007, Front Biosci, V12, P2849; Rotty JD, 2012, J CELL BIOL, V197, P381, DOI 10.1083/jcb.201107078; Safer JD, 2005, ENDOCRINOLOGY, V146, P4425, DOI 10.1210/en.2005-0192; Safer JD, 2001, THYROID, V11, P717, DOI 10.1089/10507250152484547; Saijo H, 2017, WOUND REPAIR REGEN, V25, P972, DOI 10.1111/wrr.12609; Samuelov L, 2012, J INVEST DERMATOL, V132, P2332, DOI 10.1038/jid.2012.171; Shamloo A, 2018, INT J PHARMACEUT, V537, P278, DOI 10.1016/j.ijpharm.2017.12.045; Silva WN, 2018, EXP DERMATOL, V27, P630, DOI 10.1111/exd.13524; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; STENN KS, 1981, P NATL ACAD SCI-BIOL, V78, P6907, DOI 10.1073/pnas.78.11.6907; Sugawara K, 2012, J ALLERGY CLIN IMMUN, V129, P726, DOI 10.1016/j.jaci.2011.11.009; Takagi N, 2017, EXP DERMATOL, V26, P137, DOI 10.1111/exd.13115; Telek A, 2007, FASEB J, V21, P3534, DOI 10.1096/fj.06-7689com; van Beek N, 2008, J CLIN ENDOCR METAB, V93, P4381, DOI 10.1210/jc.2008-0283; Vidali S, 2016, J INVEST DERMATOL, V136, P2003, DOI 10.1016/j.jid.2016.05.118; Vidali S, 2014, J INVEST DERMATOL, V134, P33, DOI 10.1038/jid.2013.286; Wen J, 2017, EXP DERMATOL, V26, P433, DOI 10.1111/exd.13258; Wojcik SM, 2000, MOL CELL BIOL, V20, P5248, DOI 10.1128/MCB.20.14.5248-5255.2000; Wong P, 2003, J CELL BIOL, V163, P327, DOI 10.1083/jcb.200305032; Xie T, 2018, BURNS TRAUMA, V6, DOI 10.1186/s41038-018-0119-y	79	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2019	14	3							e0212659	10.1371/journal.pone.0212659	http://dx.doi.org/10.1371/journal.pone.0212659			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ9FO	30925152	Green Published, Green Submitted, gold			2022-12-26	WOS:000462732300003
J	Bar, L; Hase, P; Foller, M				Baer, Ludmilla; Hase, Philipp; Foeller, Michael			PKC regulates the production of fibroblast growth factor 23 (FGF23)	PLOS ONE			English	Article							PROTEIN-KINASE-C; NF-KAPPA-B; VASCULAR CALCIFICATION; BONE; EXPRESSION; PHOSPHATE; KLOTHO; OSTEOBLAST; DIFFERENTIATION; OSTEOCYTES	Serine/threonine protein kinase C (PKC) is activated by diacylglycerol that is released from membrane lipids by phospholipase C in response to activation of G protein-coupled receptors or receptor tyrosine kinases. PKC isoforms are particularly relevant for proliferation and differentiation of cells including osteoblasts. Osteoblasts/osteocytes produce fibroblast growth factor 23 (FGF23), a hormone regulating renal phosphate and vitamin D handling. PKC activates NF kappa B, a transcription factor complex controlling FGF23 expression. Here, we analyzed the impact of PKC on FGF23 synthesis. Fgf23 expression was analyzed by qRT-PCR in UMR106 osteoblast-like cells and in IDG-SW3 osteocytes, and FGF23 protein was measured by ELISA. Phorbol ester 12-O-tetradecanoylphorbol-13-acetate (PMA), a PKC activator, up-regulated FGF23 production. In contrast, PKC inhibitors calphostin C, Go6976, sotrastaurin and ruboxistaurin suppressed FGF23 formation. NF kappa B inhibitor withaferin A abolished the stimulatory effect of PMA on Fgf23. PKC is a powerful regulator of FGF23 synthesis, an effect which is at least partly mediated by NF kappa B.	[Baer, Ludmilla; Hase, Philipp] Martin Luther Univ Halle Wittenberg, Inst Agr & Nutr Sci, Halle, Saale, Germany; [Foeller, Michael] Univ Hohenheim, Inst Physiol, Stuttgart, Germany	Martin Luther University Halle Wittenberg; University Hohenheim	Foller, M (corresponding author), Univ Hohenheim, Inst Physiol, Stuttgart, Germany.	michael.foeller@uni-hohenheim.de			Deutsche Forschungsgemeinschaft [Fo 695/2-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The study was supported by the Deutsche Forschungsgemeinschaft [Fo 695/2-1].	Agoro R, 2018, FASEB J, V32, P3752, DOI 10.1096/fj.201700667R; Bar L, 2018, P NATL ACAD SCI USA, V115, P5804, DOI 10.1073/pnas.1800160115; Bar L, 2017, N-S ARCH PHARMACOL, V390, P1117, DOI 10.1007/s00210-017-1411-2; Christov M, 2014, CURR OPIN NEPHROL HY, V23, P340, DOI 10.1097/01.mnh.0000447021.51722.2f; Clinkenbeard EL, 2014, J BONE MINER RES, V29, P361, DOI 10.1002/jbmr.2049; David V, 2016, KIDNEY INT, V89, P135, DOI 10.1038/ki.2015.290; Durlacher-Betzer K, 2018, KIDNEY INT, V94, P315, DOI 10.1016/j.kint.2018.02.026; Egli-Spichtig Daniela, 2018, Frontiers in Physiology, V9, P1494, DOI 10.3389/fphys.2018.01494; Farrow EG, 2011, P NATL ACAD SCI USA, V108, pE1146, DOI 10.1073/pnas.1110905108; Faul C, 2017, BONE, V100, P69, DOI 10.1016/j.bone.2016.10.001; Faul C, 2011, J CLIN INVEST, V121, P4393, DOI 10.1172/JCI46122; Feger M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05226-y; Ferrari SL, 2005, J CLIN ENDOCR METAB, V90, P1519, DOI 10.1210/jc.2004-1039; Flamme I, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186979; Galea GL, 2014, J BIOL CHEM, V289, P25509, DOI 10.1074/jbc.M114.580365; Glosse P, 2018, KIDNEY INT, V94, P491, DOI 10.1016/j.kint.2018.03.006; Glosse P, 2018, NUTR DIABETES, V8, DOI 10.1038/s41387-018-0037-x; Graciolli FG, 2017, KIDNEY INT, V91, P1436, DOI 10.1016/j.kint.2016.12.029; Hanks LJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122885; Ichida F, 2004, J BIOL CHEM, V279, P34015, DOI 10.1074/jbc.M403621200; Isakov N, 2018, SEMIN CANCER BIOL, V48, P36, DOI 10.1016/j.semcancer.2017.04.012; Ito N, 2015, MOL CELL ENDOCRINOL, V399, P208, DOI 10.1016/j.mce.2014.10.007; Itoh N, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00247; Jeong HM, 2012, BBA-MOL CELL RES, V1823, P1225, DOI 10.1016/j.bbamcr.2012.05.018; Jimbo R, 2014, KIDNEY INT, V85, P1103, DOI 10.1038/ki.2013.332; Kim HJ, 2003, J BIOL CHEM, V278, P319, DOI 10.1074/jbc.M203750200; Kuro-o M, 2019, NEPHROL DIAL TRANSPL, V34, P15, DOI 10.1093/ndt/gfy126; Kuro-o M, 2017, BONE, V100, P4, DOI 10.1016/j.bone.2016.11.013; Kuro-o M, 2013, NAT REV NEPHROL, V9, P650, DOI 10.1038/nrneph.2013.111; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Lavi-Moshayoff V, 2010, AM J PHYSIOL-RENAL, V299, pF882, DOI 10.1152/ajprenal.00360.2010; Leifheit-Nestler M, 2017, NEPHROL DIAL TRANSPL, V32, P1493, DOI 10.1093/ndt/gfw454; Mackay HJ, 2007, NAT REV CANCER, V7, P554, DOI 10.1038/nrc2168; Martin A, 2011, FASEB J, V25, P2551, DOI 10.1096/fj.10-177816; Masuyama R, 2006, J CLIN INVEST, V116, P3150, DOI 10.1172/JCI29463; Matsui I, 2018, KIDNEY INT, V94, P60, DOI 10.1016/j.kint.2018.02.018; Mochly-Rosen D, 2012, NAT REV DRUG DISCOV, V11, P937, DOI 10.1038/nrd3871; Moscat J, 2003, EMBO REP, V4, P31, DOI 10.1038/sj.embor.embor704; Orfanidou T, 2009, J CELL MOL MED, V13, P3186, DOI 10.1111/j.1582-4934.2009.00678.x; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Pulskens WP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142510; Rodelo-Haad C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201537; Rossaint J, 2016, J CLIN INVEST, V126, P962, DOI 10.1172/JCI83470; Rowe PSN, 2012, CRIT REV EUKAR GENE, V22, P61, DOI 10.1615/CritRevEukarGeneExpr.v22.i1.50; Schnedl C, 2015, DIS MARKERS, V2015, DOI 10.1155/2015/358086; Shimada T, 2004, J CLIN INVEST, V113, P561, DOI 10.1172/JCI200419081; Singh S, 2016, KIDNEY INT, V90, P985, DOI 10.1016/j.kint.2016.05.019; Spichtig D, 2014, KIDNEY INT, V85, P1340, DOI 10.1038/ki.2013.526; Steinberg SF, 2008, PHYSIOL REV, V88, P1341, DOI 10.1152/physrev.00034.2007; Stubbs JR, 2007, J AM SOC NEPHROL, V18, P2116, DOI 10.1681/ASN.2006121385; Tsuprykov O, 2018, J STEROID BIOCHEM, V180, P87, DOI 10.1016/j.jsbmb.2017.11.014; Voelkl J, 2013, J CLIN INVEST, V123, P812, DOI 10.1172/JCI64093; Woo SM, 2011, J BONE MINER RES, V26, P2634, DOI 10.1002/jbmr.465; Yamazaki M, 2015, J BONE MINER METAB, V33, P342, DOI 10.1007/s00774-014-0598-2; Zhang BB, 2016, J MOL MED, V94, P557, DOI 10.1007/s00109-015-1370-3; Zhang Q, 2016, BONE RES, V4, DOI 10.1038/boneres.2016.11	56	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0211309	10.1371/journal.pone.0211309	http://dx.doi.org/10.1371/journal.pone.0211309			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921339	Green Published, Green Submitted, gold			2022-12-26	WOS:000462594000011
J	Kim, DK; Kim, EK; Jung, DW; Kim, J				Kim, Do Kyeong; Kim, Eun Kyoung; Jung, Da-Woon; Kim, Jin			Cytoskeletal alteration modulates cancer cell invasion through RhoA-YAP signaling in stromal fibroblasts	PLOS ONE			English	Article							CARCINOMA-ASSOCIATED FIBROBLASTS; ACTOMYOSIN CONTRACTILITY; GINGIVAL FIBROBLASTS; ACTIVATION PROTEIN; INDUCED SENESCENCE; TISSUE STIFFNESS; STRESS; PATHWAY; BREAST; TUMORS	Cancer-associated fibroblasts(CAFs) participate in carcinogenesis through interaction with cancer cells. This study aimed to investigate the mechanism of cytoskeletal alteration of CAFs and its role in invasion of oral squamous cell carcinoma(OSCC),Immortalized normal fibroblasts(hTERT-hNOFs) co-cultured with OSCC cells showed myofibroblastic and senescent phenotypes like CAFs. Thus, this study substituted hTERT-hNOFs for CAFs. Next, the cytoskeletal alteration and its molecular mechanism were investigated in hTERT-hNOFs co-cultured with OSCC. As results, we found that RhoA regulated cytoskeletal organization in fibroblasts surrounding OSCC cells. Furthermore, as a downstream transcriptional factor of RhoA, YAP was mainly localized in the nucleus of hTERT-hNOFs co-cultured with OSCC. Consequently, we examined whether nuclear YAP localization of fibroblasts could influence cancer progression. YAPS127A fibroblasts manifesting nuclear localization of YAP induced cytoskeletal alteration and increased gel contractility and matrix stiffness, and thereby enhances the invasiveness of OSCC cells. In conclusion, the modification of tumor microenvironment, such as cytoskeletal change and matrix remodeling via RhoA-YAP in CAFs, modulates OSCC invasion. These understandings will provide the development of novel approaches for CAFs-based cancer therapy.	[Kim, Do Kyeong; Kim, Eun Kyoung; Kim, Jin] Yonsei Univ, Oral Canc Res Inst, Dept Oral Pathol, BK21 PLUS Project,Coll Dent, Seoul, South Korea; [Kim, Do Kyeong] Jeonju Kijeon Coll, Dept Dent Hyg, Jeonju, South Korea; [Jung, Da-Woon] Gwangju Inst Sci & Technol, New Drug Targets Lab, Sch Life Sci, 1 Oryong Dong, Gwangju, South Korea	Yonsei University; Yonsei University Health System; Gwangju Institute of Science & Technology (GIST)	Kim, J (corresponding author), Yonsei Univ, Oral Canc Res Inst, Dept Oral Pathol, BK21 PLUS Project,Coll Dent, Seoul, South Korea.	jink@yuhs.ac			health fellowship foundation in Korea	health fellowship foundation in Korea	This work was supported by the health fellowship foundation in Korea (no grant number) (https://www.yuhanfoundation.or.kr) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhurst RJ, 2012, NAT REV DRUG DISCOV, V11, P790, DOI 10.1038/nrd3810; Bae JY, 2014, NEOPLASIA, V16, P928, DOI 10.1016/j.neo.2014.09.003; Calvo F, 2013, NAT CELL BIOL, V15, P637, DOI 10.1038/ncb2756; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Corver WE, 2011, CELL ONCOL, V34, P553, DOI 10.1007/s13402-011-0061-5; Crawford Y, 2009, CANCER CELL, V15, P21, DOI 10.1016/j.ccr.2008.12.004; Ferrari N, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-07987-0; Gorbunova V, 2002, J BIOL CHEM, V277, P38540, DOI 10.1074/jbc.M202671200; Haage A, 2014, FASEB J, V28, P3589, DOI 10.1096/fj.13-245613; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hassona Y, 2013, CARCINOGENESIS, V34, P1286, DOI 10.1093/carcin/bgt035; Illeperuma RP, 2015, INT J CANCER, V137, P2545, DOI 10.1002/ijc.29636; Illeperuma RP, 2012, J MATER SCI-MATER M, V23, P753, DOI 10.1007/s10856-011-4473-6; Jung DW, 2010, INT J CANCER, V127, P332, DOI 10.1002/ijc.25060; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kano MR, 2007, P NATL ACAD SCI USA, V104, P3460, DOI 10.1073/pnas.0611660104; Kim EK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0188847; Kumper S, 2011, CANCER CELL, V19, P695, DOI 10.1016/j.ccr.2011.05.021; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Lee EJ, 2005, EXP MOL MED, V37, P379, DOI 10.1038/emm.2005.48; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Loeffler M, 2006, J CLIN INVEST, V116, P1955, DOI 10.1172/JCI26532; Martinez-Outschoorn UE, 2010, CELL CYCLE, V9, P2423, DOI 10.4161/cc.9.12.12048; Naka K, 2004, J BIOL CHEM, V279, P2030, DOI 10.1074/jbc.M309457200; Narra K, 2007, CANCER BIOL THER, V6, P1691, DOI 10.4161/cbt.6.11.4874; Ohlund D, 2014, J EXP MED, V211, P1503, DOI 10.1084/jem.20140692; Prime SS, 2017, J ORAL PATHOL MED, V46, P82, DOI 10.1111/jop.12456; Procopio MG, 2015, NAT CELL BIOL, V17, P1193, DOI 10.1038/ncb3228; Qiu W, 2008, NAT GENET, V40, P650, DOI 10.1038/ng.117; Samuel MS, 2011, CANCER CELL, V19, P776, DOI 10.1016/j.ccr.2011.05.008; Sanz-Moreno V, 2011, CANCER CELL, V20, P229, DOI 10.1016/j.ccr.2011.06.018; Scott AM, 2003, CLIN CANCER RES, V9, P1639; Togo Shinsaku, 2013, Cancers (Basel), V5, P149, DOI 10.3390/cancers5010149; Tommelein J, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00063; Turner NC, 2012, LANCET ONCOL, V13, pE178, DOI 10.1016/S1470-2045(11)70335-7; Varelas X, 2014, DEVELOPMENT, V141, P1614, DOI 10.1242/dev.102376; Wada KI, 2011, DEVELOPMENT, V138, P3907, DOI 10.1242/dev.070987; Wang ZY, 2014, P NATL ACAD SCI USA, V111, pE89, DOI 10.1073/pnas.1319190110; Wheaton K, 2001, J CELL PHYSIOL, V187, P226, DOI 10.1002/jcp.1071; Zhang Y, 2018, J MOL NEUROSCI, V64, P262, DOI 10.1007/s12031-017-1018-6; Zhang YC, 2014, CELL SIGNAL, V26, P2504, DOI 10.1016/j.cellsig.2014.07.031; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408	42	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214553	10.1371/journal.pone.0214553	http://dx.doi.org/10.1371/journal.pone.0214553			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921404	Green Submitted, Green Published, gold			2022-12-26	WOS:000462594000086
J	Tramonte, AR; Christofferson, RC				Tramonte, A. Ryan; Christofferson, Rebecca C.			Investigating the probability of establishment of Zika virus and detection through mosquito surveillance under different temperature conditions	PLOS ONE			English	Article							EXTRINSIC INCUBATION-TEMPERATURE; AEDES-AEGYPTI COMPETENCE; WEST-NILE-VIRUS; CHIKUNGUNYA VIRUS; VECTOR COMPETENCE; DENGUE INFECTION; UNITED-STATES; TRANSMISSION; TRAVELERS; OUTBREAK	Because of the increasing threat that Zika virus (ZIKV) poses to more sub-tropical area due to increased global travel, there is a need for better understanding of the effect(s) of temperature on the establishment potential of ZIKV within these subtropical, temperate, and/or seasonal Ae. aegypti populations. The first step to determining risk establishment of ZIKV in these regions is to assess ZIKV's ability to infect mosquitoes at less tropical temperatures, and thus be detected through common surveillance programs. To that end, the effect of two rearing temperatures (RT) and extrinsic incubation temperatures (EIT) on infection and dissemination rates was evaluated, as well as the interactions of such. Total, there were four combinations (RT24-EIT24, RT24-EIT28, RT28-EIT24, RT28-EIT28). Further, a stochastic SEIR framework was adapted to determine whether observed data could lead to differential success of establishment of ZIKV in naive mosquito populations. There was no consistent pattern in significant differences found across treatments for either infection or dissemination rates (p>0.05), where only a significant difference was found in infection rates between RT24-EIT24 (44%) and RT28-EIT24 (82.6%). Across all temperature conditions, the model predicted between a 76.4% and 95.4% chance of successful establishment of ZIKV in naive mosquito populations under model assumptions. We further show that excluding the maximum observed infection and dissemination rates likely overestimates the probability of local establishment of ZIKV. These results indicate that 1) there is no straightforward relationship between RT, EIT, and infection/dissemination rates, 2) in more temperate climates, ZIKV may still have the ability to establish in populations of Aedes aegypti, 3) despite an overall lack of significant differences in infection/dissemination rates, temperature may still alter the kinetics of ZIKV within the mosquito enough to affect the likelihood of infection establishment and detection within the context of mosquito surveillance programs, and 4) both the temporal and magnitude qualities of vector competence are necessary for parameterization of within-mosquito virus kinetics.	[Tramonte, A. Ryan; Christofferson, Rebecca C.] Louisiana State Univ, Sch Vet Med, Dept Pathobiol Sci, Baton Rouge, LA 70803 USA; [Christofferson, Rebecca C.] Louisiana State Univ, Ctr Computat & Technol, Baton Rouge, LA 70803 USA	Louisiana State University School of Veterinary Medicine; Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University	Christofferson, RC (corresponding author), Louisiana State Univ, Sch Vet Med, Dept Pathobiol Sci, Baton Rouge, LA 70803 USA.; Christofferson, RC (corresponding author), Louisiana State Univ, Ctr Computat & Technol, Baton Rouge, LA 70803 USA.	rcarri1@lsu.edu			NIH/NIGMS [R01GM122077]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM122077] Funding Source: NIH RePORTER	NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH/NIGMS grant R01GM122077. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alto BW, 2018, J MED ENTOMOL, V55, P217, DOI 10.1093/jme/tjx182; Alto BW, 2013, AM J TROP MED HYG, V88, P497, DOI 10.4269/ajtmh.12-0421; Andreadis TG, 2001, EMERG INFECT DIS, V7, P670; Brady OJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-351; Buckner EA, 2016, J MED ENTOMOL, V53, P91, DOI 10.1093/jme/tjv145; Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167; Carrington LB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058824; Carrington LB, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002190; Carrington LB, 2013, AM J TROP MED HYG, V88, P689, DOI 10.4269/ajtmh.12-0488; Chisenhall DM, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-252; Christofferson RC, 2016, J INFECT DIS, V214, pS466, DOI 10.1093/infdis/jiw283; Christofferson RC, 2016, ENVIRON HEALTH INSIG, V10, P119, DOI [10.4137/EHI.S38345, 10.4137/ehi.s38345]; Christofferson RC, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-282; Christofferson RC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016298; Costa-da-Silva Andre Luis, 2017, PLoS One, V12, pe0171951, DOI 10.1371/journal.pone.0171951; Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297; Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311; Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332; Gillespie DT, 2001, J CHEM PHYS, V115, P1716, DOI 10.1063/1.1378322; Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400; Heitmann A, 2017, EUROSURVEILLANCE, V22, P4, DOI 10.2807/1560-7917.ES.2017.22.2.30437; Hennessey MJ, 2016, AM J TROP MED HYG, V95, P212, DOI 10.4269/ajtmh.16-0049; Kawiecki AB, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0749-x; Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347; Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065; Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1; Lindholm DA, 2017, AM J TROP MED HYG, V96, P903, DOI 10.4269/ajtmh.16-0635; Lindsey NP, 2015, AM J TROP MED HYG, V92, P82, DOI 10.4269/ajtmh.14-0442; Liu ZZ, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02337; San Martin JL, 2010, AM J TROP MED HYG, V82, P128, DOI 10.4269/ajtmh.2010.09-0346; Martin E, 2019, ACTA TROP, V192, P129, DOI 10.1016/j.actatropica.2019.02.006; Mbaika S, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0566-7; Moore CG, 1993, DIS DOV B DIS NCFL P; Mordecai EA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005568; Muturi EJ, 2012, J VECTOR ECOL, V37, P154, DOI 10.1111/j.1948-7134.2012.00212.x; Muturi EJ, 2011, VECTOR-BORNE ZOONOT, V11, P1157, DOI 10.1089/vbz.2010.0209; Pires AM, 2008, REVSTAT-STAT J, V6, P165; Prevention CfDCa, 2017, PREV DFDCA ADV PEOPL; Prevention CfDCa, 2017, PREV CFDCA ZIK VIR P; Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6; Rocklov J, 2016, EBIOMEDICINE, V9, P250, DOI 10.1016/j.ebiom.2016.06.009; Rohani A, 2009, SE ASIAN J TROP MED, V40, P942; Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929; SMITH GC, 1993, J MED ENTOMOL, V30, P257, DOI 10.1093/jmedent/30.1.257; Teets Frank D, 2014, Virol Rep, V1-2, P2; Tesla B, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.0795; Toro C, 2017, AM J TROP MED HYG, V96, P701, DOI 10.4269/ajtmh.16-0335; Villamil-Gomez WE, 2016, INT J INFECT DIS, V51, P135, DOI 10.1016/j.ijid.2016.07.017; Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101; White DJ, 2001, EMERG INFECT DIS, V7, P643	50	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214306	10.1371/journal.pone.0214306	http://dx.doi.org/10.1371/journal.pone.0214306			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921386	Green Published, gold, Green Submitted			2022-12-26	WOS:000462594000052
J	Krishnamurithy, G; Mohan, S; Yahya, NA; Mansor, A; Murali, MR; Raghavendran, HRB; Choudhary, R; Sasikumar, S; Kamarul, T				Krishnamurithy, Genasan; Mohan, Saktiswaren; Yahya, Noor Azlin; Mansor, Azura; Murali, Malliga Raman; Raghavendran, Hanumantha Rao Balaji; Choudhary, Rajan; Sasikumar, Swamiappan; Kamarul, Tunku			The physicochemical and biomechanical profile of forsterite and its osteogenic potential of mesenchymal stromal cells	PLOS ONE			English	Article							STEM-CELLS; BONE TISSUE; IN-VITRO; PROMOTES PROLIFERATION; DIFFERENTIATION; BIOCOMPATIBILITY; SURFACE; SCAFFOLDS; CALCIUM; SILICATES	It has been demonstrated that nanocrystalline forsterite powder synthesised using urea as a fuel in sol-gel combustion method had produced a pure forsterite (FU) and possessed superior bioactive characteristics such as bone apatite formation and antibacterial properties. In the present study, 3D-scaffold was fabricated using nanocrystalline forsterite powder in polymer sponge method. The FU scaffold was used in investigating the physicochemical, biomechanics, cell attachment, in vitro biocompatibility and osteogenic differentiation properties. For physicochemical characterisation, Fourier-transform infrared spectroscopy (FTIR), Energy dispersive X-ray (EDX), X-ray diffraction (XRD), Raman spectroscopy, Xray photoemission spectrometer (XPS) and Brunauer-Emmett-Teller (BET) were used. FTIR, EDX, XRD peaks and Raman spectroscopy demonstrated correlating to FU. The XPS confirmed the surface chemistry associating to FU. The BET revealed FU scaffold surface area of 12.67 m(2)/g and total pore size of 0.03 cm(3)/g. Compressive strength of the FU scaffold was found to be 27.18 +/- 13.4 MPa. The human bone marrow derived mesenchymal stromal cells (hBMSCs) characterisation prior to perform seeding on FU scaffold verified the stromal cell phenotypic and lineage commitments. SEM, confocal images and presto blue viability assay suggested good cell attachment and proliferation of hBMSCs on FU scaffold and comparable to a commercial bone substitutes (cBS). Osteogenic proteins and gene expression from day 7 onward indicated FU scaffold had a significant osteogenic potential (p < 0.05), when compared with day 1 as well as between FU and cBS. These findings suggest that FU scaffold has a greater potential for use in orthopaedic and/or orthodontic applications.	[Krishnamurithy, Genasan; Mohan, Saktiswaren; Mansor, Azura; Murali, Malliga Raman; Raghavendran, Hanumantha Rao Balaji; Kamarul, Tunku] Univ Malaya, Dept Orthopaed Surg NOCERAL, Fac Med, TEG, Kuala Lumpur, Malaysia; [Krishnamurithy, Genasan] Inst Translat Med, Dept Mol & Clin Canc Med, Musculoskeletal Res Grp, Liverpool, Merseyside, England; [Yahya, Noor Azlin] Univ Malaya, Fac Dent, Kuala Lumpur, Malaysia; [Choudhary, Rajan; Sasikumar, Swamiappan] Vellore Inst Technol, Sch Adv Sci, Dept Chem, Vellore, Tamil Nadu, India	Universiti Malaya; University of Liverpool; Universiti Malaya; Vellore Institute of Technology	Krishnamurithy, G; Kamarul, T (corresponding author), Univ Malaya, Dept Orthopaed Surg NOCERAL, Fac Med, TEG, Kuala Lumpur, Malaysia.; Krishnamurithy, G (corresponding author), Inst Translat Med, Dept Mol & Clin Canc Med, Musculoskeletal Res Grp, Liverpool, Merseyside, England.	veda_g82@hotmail.com; tkzrea@ummc.edu.my	Mansor, Azura/E-1250-2012; Swamiappan, Sasikumar/M-9921-2016; Tunku Zainol Abidin, Tunku Kamarul Zaman/B-9633-2011; Choudhary, Rajan/R-7998-2018; Genasan, Krishnamurithy/AAK-1277-2020; raghavendran, hanumantha rao balaji/B-8507-2012; YAHYA, NOOR AZLIN/B-9263-2010; genasan, krishnamurithy/M-4049-2018	Swamiappan, Sasikumar/0000-0003-2533-4923; Tunku Zainol Abidin, Tunku Kamarul Zaman/0000-0002-6028-1313; Choudhary, Rajan/0000-0001-6370-8071; YAHYA, NOOR AZLIN/0000-0002-5722-1280; 	University of Malaya Research Grant (UM RG) [RPOO5B-13HTM]; University of Malaya Postgraduate Research Grant [PPP-PG208-20146]; Fundamental Research Grant Scheme (FRGS) [FRGS-FP016]; Ministry of Higher Education [RPOO5B-13HTM, PG208-2014B]; Institute of post graduate dual PhD funding; Bright sparks scheme, University of Malaya	University of Malaya Research Grant (UM RG); University of Malaya Postgraduate Research Grant; Fundamental Research Grant Scheme (FRGS); Ministry of Higher Education(Science and Technology Development Fund (STDF)Ministry of Higher Education & Scientific Research (MHESR)); Institute of post graduate dual PhD funding; Bright sparks scheme, University of Malaya	This work was supported by: TK, RPOO5B-13HTM, University of Malaya Research Grant (UM RG) (https://www.um.edu.my); by TK, PPP-PG208-20146, University of Malaya Postgraduate Research Grant (https://www.um.edu.ma); and by AM, FRGS-FP016, Fundamental Research Grant Scheme (FRGS) (https://mastic.mosti.gov.my). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to express their highest gratitude to Ministry of Higher Education for fundamental research grant scheme (FRGS) FP016-2016, University of Malaya research grant-RPOO5B-13HTM and Postgraduate Research Fund-PG208-2014B. A special thanks to Institute of post graduate dual PhD funding and Bright sparks scheme, University of Malaya for supporting the student research at University of Liverpool.	Baino F, 2015, FRONT BIOENG BIOTECH, V3, DOI 10.3389/fbioe.2015.00202; Birmingham E, 2012, EUR CELLS MATER, V23, P13, DOI 10.22203/eCM.v023a02; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Choudhary R, 2017, MAT SCI ENG C-MATER, V77, P811, DOI 10.1016/j.msec.2017.03.308; Choudhary R, 2015, J ASIAN CERAM SOC, V3, P173, DOI 10.1016/j.jascer.2015.01.002; Coathup MJ, 2011, J BONE JOINT SURG AM, V93A, P2219, DOI [10.2106/JBJS.I.01623, 10.2106/JBJS.J.01623]; Cundy T., 2014, CLIN BIOCH METABOLIC, P604, DOI 10.1016/B978-0-7020-5140-1.00031-6; Diba M, 2012, COMPOS SCI TECHNOL, V72, P716, DOI 10.1016/j.compscitech.2012.01.023; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Garrido Carlos Antônio, 2010, Rev. bras. ortop., V45, P433, DOI [10.1590/S0102-36162010000400016, 10.1016/S2255-4971(15)30393-1]; Gattazzo F, 2014, BBA-GEN SUBJECTS, V1840, P2506, DOI 10.1016/j.bbagen.2014.01.010; Ghomi H, 2011, J ALLOY COMPD, V509, pL63, DOI 10.1016/j.jallcom.2010.10.106; Guan M, 2012, NAT MED, V18, P456, DOI 10.1038/nm.2665; He LY, 2016, BRAZ J MED BIOL RES, V49, DOI 10.1590/1414-431X20165257; Hosseini SN, 2015, MATER LETT, V143, P16, DOI 10.1016/j.matlet.2014.12.079; Jayaswal Gaurav P, 2010, J Indian Prosthodont Soc, V10, P8, DOI 10.1007/s13191-010-0002-4; Kalinkin AM, 2003, GLASS PHYS CHEM+, V29, P410, DOI 10.1023/A:1025185229274; Karsenty G, 2000, MATRIX BIOL, V19, P85, DOI 10.1016/S0945-053X(00)00053-6; Kharaziha M, 2010, J MECH BEHAV BIOMED, V3, P530, DOI 10.1016/j.jmbbm.2010.06.003; Kihara T, 2006, BIOCHEM BIOPH RES CO, V341, P1029, DOI 10.1016/j.bbrc.2006.01.059; Kim JA, 2018, BIOMATERIALS, V157, P51, DOI 10.1016/j.biomaterials.2017.11.032; Kim YJ, 2006, GENE, V366, P145, DOI 10.1016/j.gene.2005.08.021; Krishnamurithy G, 2016, CERAM INT, V42, P18247, DOI 10.1016/j.ceramint.2016.08.148; Krishnamurithy G, 2015, REGEN MED, V10, P579, DOI 10.2217/rme.15.27; Lavery K, 2008, J BIOL CHEM, V283, P20948, DOI 10.1074/jbc.M800850200; Li RW, 2014, J BIOMED MATER RES A, V102, P4346, DOI 10.1002/jbm.a.35111; Lin KL, 2016, RSC ADV, V6, P13867, DOI 10.1039/c5ra26916d; Liu C, 2014, J ORTHOP TRANSL, V2, P139, DOI 10.1016/j.jot.2014.06.002; Lund A W, 2009, Open Stem Cell J, V1, P40; Martinez LM, 2017, MESENCHYMAL STROMAL CELLS AS TUMOR STROMAL MODULATORS, P369, DOI 10.1016/B978-0-12-803102-5.00015-X; Mauney JR, 2005, TISSUE ENG, V11, P787, DOI 10.1089/ten.2005.11.787; Mohan S, 2017, ACS APPL MATER INTER, V9, P9291, DOI 10.1021/acsami.6b13422; Naddeo P, 2015, DENT MATER, V31, P235, DOI 10.1016/j.dental.2014.12.015; Naghieh S, 2017, MATER DESIGN, V133, P128, DOI 10.1016/j.matdes.2017.07.051; Nair MB, 2009, J BIOMED MATER RES A, V90A, P533, DOI 10.1002/jbm.a.32114; Nakamura A, 2009, TISSUE ENG PART C-ME, V15, P169, DOI 10.1089/ten.tec.2007.0334; Paino F, 2017, CLIN SCI, V131, P699, DOI 10.1042/CS20170047; Raghavendran HRB, 2016, COLLOID SURFACE B, V139, P68, DOI 10.1016/j.colsurfb.2015.11.053; Raghavendran HRB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104389; Ryoo HM, 2006, GENE, V366, P51, DOI 10.1016/j.gene.2005.10.011; Sase SP, 2012, OSTEOPONTIN NOVEL PR; Shie MY, 2017, MAT SCI ENG C-MATER, V73, P726, DOI 10.1016/j.msec.2016.12.071; Song SJ, 2007, J MICROBIOL BIOTECHN, V17, P1113; Stangarone C, 2017, J RAMAN SPECTROSC, V48, P1528, DOI 10.1002/jrs.5127; Tanabe N, 2010, OSTEOPONTIN ENHANCES; Tanabe N, 2011, J BIOL CHEM, V286, P39871, DOI 10.1074/jbc.M111.295048; Terajima M, 2014, J BIOL CHEM, V289, P22636, DOI 10.1074/jbc.M113.528513; Waked W, 2008, ORTHOPEDICS, V31, P591, DOI 10.3928/01477447-20080601-34; Wang GC., 2014, BONE SUBSTITUTE BIOM, V1st, P180, DOI [10.1533/9780857099037.2.180, DOI 10.1533/9780857099037.2.180]; Wang Liang, 2015, Chinese Medical Sciences Journal, V30, P108; Warnke PH, 2013, J CRANIO MAXILL SURG, V41, P153, DOI 10.1016/j.jcms.2012.07.003; Zanetti AS, 2015, J TISSUE ENG REGEN M, V9, P389, DOI 10.1002/term.1646; Zhao D-F, 2015, WORLD J TRADITIONAL, V1, P50	53	15	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2019	14	3							e0214212	10.1371/journal.pone.0214212	http://dx.doi.org/10.1371/journal.pone.0214212			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ5PT	30917166	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000462465800055
J	Lawman, HG; Bleich, SN; Yana, JL; LeVasseur, MT; Mitra, N; Roberto, CA				Lawman, Hannah G.; Bleich, Sara N.; Yana, Jiali; LeVasseur, Michael T.; Mitra, Nandita; Roberto, Christina A.			Unemployment claims in Philadelphia one year after implementation of the sweetened beverage tax	PLOS ONE			English	Article							SODA TAXES; EXCISE TAX; VIEWPOINT; HEALTH; IMPACT	Objectives Possible adverse economic impacts of sweetened drink taxes are a key concern for numerous stakeholders. This study examined changes in unemployment benefit claims filings in Philadelphia compared to its neighboring counties two years prior to and 14 months post implementation of a 1.5 cents per ounce excise tax on sugar- and artificially-sweetened beverages. Methods Data were obtained from the Pennsylvania Department of Labor. Interrupted time series analysis was used to determine if there was a change in new monthly unemployment claims filings post-tax implementation in Philadelphia compared to surrounding counties in supermarkets, select potentially affected industries, and in total claims filings across all industries combined. Results Results showed there were no statistically significant changes to unemployment claims in Philadelphia compared to neighboring counties for supermarkets (beta = -9.45, 95% CI = -98.11, 79.22), soft drink manufacturers (beta = -0.13, 95% CI = -9.13, 8.88), across other potentially affected industries (beta = 9.16, 95% CI = -488.29, 506.60), or across all industries (beta = -445.85, 95% CI = -4272.39, 3380.68) following implementation of the beverage tax. Unemployment declined similarly in Philadelphia compared to surrounding counties. Conclusions Public reports of increased unemployment within the first year following the implementation of the Philadelphia beverage tax are not supported by this analysis. Future work should examine employment outcomes and include longer follow-up periods.	[Lawman, Hannah G.] Philadelphia Dept Publ Hlth, Philadelphia, PA 19107 USA; [Bleich, Sara N.] Harvard TH Chan Sch Publ Hlth, Boston, MA USA; [Yana, Jiali; LeVasseur, Michael T.; Mitra, Nandita; Roberto, Christina A.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA	Harvard University; Harvard T.H. Chan School of Public Health; University of Pennsylvania; Pennsylvania Medicine	Lawman, HG (corresponding author), Philadelphia Dept Publ Hlth, Philadelphia, PA 19107 USA.	Hannah.Lawrnan@phila.gov			Bloomberg Philanthropies [47841]	Bloomberg Philanthropies	This study was supported by Bloomberg Philanthropies (#47841, CR, SB, HL, ML, NM). The funders had no role in analysis, interpretation, or manuscript preparation, review, or submission. https://www.bloomberg.org/.	[Anonymous], 2016, CHILDH OB INT COST E; Colchero MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144408; Brownell KD, 2009, NEW ENGL J MED, V361, P1599, DOI 10.1056/NEJMhpr0905723; Cawley J, 2018, JAMA-J AM MED ASSOC, V319, P305, DOI 10.1001/jama.2017.16903; Chodorow-Reich G, 2019, Q J ECON, V134, P227, DOI 10.1093/qje/qjy018; Colchero MA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163463; Cornelsen L, 2018, FOOD POLICY, V74, P138, DOI 10.1016/j.foodpol.2017.12.003; Falbe J, 2016, AM J PUBLIC HEALTH, V106, P1865, DOI 10.2105/AJPH.2016.303362; Guerrero-Lopez CM, 2017, PREV MED, V105, pS43, DOI 10.1016/j.ypmed.2017.09.001; Gunselman J., 2018, DID SHOPRITE OWNER S; Holmlund B, 1998, SCAND J ECON, V100, P113, DOI 10.1111/1467-9442.00093; JACOBS R, 2000, TOBACCO CONTROL DEV, P00311; Long MW, 2015, AM J PREV MED, V49, P112, DOI 10.1016/j.amepre.2015.03.004; Oxford Economics, 2017, EC IMP PHIL BEV TAX; Paarlberg R, 2017, FOOD POLICY, V71, P1, DOI 10.1016/j.foodpol.2017.05.007; Parker L, 2009, LOCAL GOVT ACTIONS P; Pennsylvania Department of Labor, AM I EL; Powell LM, 2014, AM J PUBLIC HEALTH, V104, P672, DOI 10.2105/AJPH.2013.301630; Robert Wood Johnson Foundation and University of Wisconsin Population Health Institute, 2018, COUNT HLTH RANK ROAD; Silver LD, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002283; Terruso J., 2017, PHILLY; Vartanian LR, 2007, AM J PUBLIC HEALTH, V97, P667, DOI 10.2105/AJPH.2005.083782; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x; Warner KE, 1996, JAMA-J AM MED ASSOC, V275, P1241, DOI 10.1001/jama.275.16.1241; World Health Organization, 2017, TAX SUG DRINKS WHY D; Zhong YC, 2018, AM J PREV MED, V55, P26, DOI 10.1016/j.amepre.2018.02.017	26	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2019	14	3							e0213218	10.1371/journal.pone.0213218	http://dx.doi.org/10.1371/journal.pone.0213218			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HQ5PT	30917140	Green Published, gold, Green Submitted			2022-12-26	WOS:000462465800022
J	Del Frari, G; Cabral, A; Nascimento, T; Ferreira, RB; Oliveira, H				Del Frari, Giovanni; Cabral, Ana; Nascimento, Teresa; Ferreira, Ricardo Boavida; Oliveira, Helena			Epicoccum layuense a potential biological control agent of esca-associated fungi in grapevine	PLOS ONE			English	Article							VITIS-VINIFERA L.; PHAEOMONIELLA-CHLAMYDOSPORA; TRUNK DISEASES; PATHOGENS; IDENTIFICATION; PURPURASCENS; INFECTION; NURSERIES; SYMPTOMS; BACTERIA	Epicoccum is a genus of ascomycetes often associated with the mycobiome of grapevines (Vitis vinifera). Epicoccum spp. are found in the soil, phyllosphere, as well as in the wood, where they interact both with the plant and with other endophytes and pathogens. Wood pathogens involved in the esca disease complex, a grapevine trunk disease, are particularly concerning in viticulture, as current control strategies have proven unsatisfactory. This study investigated the interaction among Epicoccum spp. and three esca-associated fungi, with the aim of establishing whether they are suitable candidates for biological control.A screening conducted in vitro, by means of dual culture, revealed that all tested Epicoccum spp. inhibited the growth of pathogens Phaeomoniella chlamydospora and Fomitiporia mediterranea, while only some of them inhibited Phaeoacremonium minimum. Epicoccum layuense E24, identified as the most efficient antagonist, was tested in rooted grapevine cuttings of cultivars Cabernet Sauvignon and Touriga Nacional, under greenhouse conditions, against P. chlamydospora and P. minimum. This study revealed that the inoculation of E. layuense E24 produced a successful colonization of the wood of grapevines; in addition it did not impair the growth of the plants or induce the appearance of symptoms in leaves or in wood. Moreover, grapevines colonized by E. layuense E24 showed a considerable decrease in the wood symptomatology caused by the inoculated pathogens (by 31-82%, depending on the pathogen/grapevine cultivar), as well as a reduction in their frequency of re-isolation (60-74%).Our findings suggest that E. layuense E24 is a promising candidate for its application in biological control, due to its antagonistic interaction with some esca-associated fungal pathogens.	[Del Frari, Giovanni; Cabral, Ana; Nascimento, Teresa; Ferreira, Ricardo Boavida; Oliveira, Helena] Univ Lisbon, Inst Super Agron, Linking Landscape Environm Agr & Food LEAF, Lisbon, Portugal	Universidade de Lisboa	Del Frari, G (corresponding author), Univ Lisbon, Inst Super Agron, Linking Landscape Environm Agr & Food LEAF, Lisbon, Portugal.	gdelfrari@isa.ulisboa.pt	Nascimento, Teresa/I-4151-2017; Cabral, Ana/J-9799-2013; Nascimento, Teresa/AFP-2103-2022	Nascimento, Teresa/0000-0002-3966-6788; Cabral, Ana/0000-0001-5007-7661; Nascimento, Teresa/0000-0002-3966-6788; Oliveira, Helena/0000-0002-8274-9757; Ferreira, Ricardo Boavida/0000-0002-5027-7564; Del Frari, Giovanni/0000-0002-4811-714X	Horizon 2020 Programme of the European Commission within the Marie Sklodowska-Curie Innovative Training Network "MicroWine" [643063]; Portuguese national funds through Fundacao para a Ciencia e a Tecnologia [SFRH/BPD/84508/2012]; FCT Unit fund [UID/AGR/04129/2013]	Horizon 2020 Programme of the European Commission within the Marie Sklodowska-Curie Innovative Training Network "MicroWine"; Portuguese national funds through Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and Technology); FCT Unit fund	This study was funded by the Horizon 2020 Programme of the European Commission within the Marie Sklodowska-Curie Innovative Training Network "MicroWine" (grant number 643063 to G. Del Frari) and by Portuguese national funds through Fundacao para a Ciencia e a Tecnologia, grant SFRH/BPD/84508/2012 for Ana Cabral and FCT Unit funding UID/AGR/04129/2013 (LEAF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfonzo A, 2012, ANN MICROBIOL, V62, P1593, DOI 10.1007/s13213-011-0415-2; Arenal F, 2002, J APPL MICROBIOL, V93, P36, DOI 10.1046/j.1365-2672.2002.01654.x; Aveskamp MM, 2010, STUD MYCOL, P1, DOI 10.3114/sim.2010.65.01; Bertsch C, 2013, PLANT PATHOL, V62, P243, DOI 10.1111/j.1365-3059.2012.02674.x; BROWN AE, 1987, SOIL BIOL BIOCHEM, V19, P657, DOI 10.1016/0038-0717(87)90044-7; Bruez E, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01137; Bruez E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095928; Bruez E, 2013, PHYTOPATHOL MEDITERR, V52, P262; Calzarano F, 2016, PHYTOPATHOL MEDITERR, V55, P410, DOI 10.14601/Phytopathol_Mediterr-18681; Chen Q, 2017, STUD MYCOL, P105, DOI 10.1016/j.simyco.2017.06.002; Chen Q, 2015, STUD MYCOL, P137, DOI 10.1016/j.simyco.2015.10.003; Choueiri E, 2014, J INT SCI VIGNE VIN, V48, P293; Christen D, 2005, J AGR FOOD CHEM, V53, P7043, DOI 10.1021/jf050863h; Compant S, 2016, BIOCONTROL MAJOR GRA; Cueva C, 2012, J APPL MICROBIOL, V112, P672, DOI 10.1111/j.1365-2672.2012.05243.x; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Favaro LCD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036826; Favaro LCD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014828; Di Marco S, 2007, PHYTOPATHOL MEDITERR, V46, P73; Di Marco S, 2004, PHYTOPATHOL MEDITERR, V43, P108; Diaz GA, 2014, PLANT DIS, V98, P351, DOI 10.1094/PDIS-12-12-1180-RE; Dzoyem JP, 2017, REV BRAS FARMACOGN, V27, P251, DOI 10.1016/j.bjp.2016.08.011; Edwards J., 2001, PHYTOPATHOL MEDITERR, V40, P303; El-Gremi SM, 2017, CROP PROT, V91, P13, DOI 10.1016/j.cropro.2016.08.034; Elmer PAG, 2006, PLANT PATHOL, V55, P155, DOI 10.1111/j.1365-3059.2006.01348.x; Fontaine F., 2016, GRAPEVINE TRUNK DIS; Fourie PH, 2004, AUSTRALAS PLANT PATH, V33, P313, DOI 10.1071/AP04005; Fourie PR, 2004, PLANT DIS, V88, P1241, DOI 10.1094/PDIS.2004.88.11.1241; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Gonzalez V, 2012, PHYTOPHATOL MEDITERR, V51, P448; Gramaje D, 2018, PLANT DIS, V102, P12, DOI 10.1094/PDIS-04-17-0512-FE; Haidar R, 2016, BIOL CONTROL, V92, P55, DOI 10.1016/j.biocontrol.2015.09.003; Haidar R, 2016, MICROBIOL RES, V192, P172, DOI 10.1016/j.micres.2016.07.003; Halleen F, 2003, AUSTRALAS PLANT PATH, V32, P47, DOI 10.1071/AP02062; Hofstetter V, 2012, FUNGAL DIVERS, V54, P51, DOI 10.1007/s13225-012-0171-z; Jayasiri SC, 2017, MYCOSPHERE, V8, P1080, DOI 10.5943/mycosphere/8/8/9; Katoh K, 2019, BRIEF BIOINFORM, V20, P1160, DOI 10.1093/bib/bbx108; Komarek M, 2010, ENVIRON INT, V36, P138, DOI 10.1016/j.envint.2009.10.005; Kosawang C, 2018, FUNGAL BIOL-UK, V122, P110, DOI 10.1016/j.funbio.2017.11.002; Koutb Mostafa, 2010, Mycobiology, V38, P286, DOI 10.4489/MYCO.2010.38.4.286; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Kuntzmann P, 2010, VITIS, V49, P71; Larena I, 2005, BIOL CONTROL, V32, P305, DOI 10.1016/j.biocontrol.2004.10.010; Li Y, 2013, BIOL CONTROL, V67, P462, DOI 10.1016/j.biocontrol.2013.09.007; Liu YJJ, 1999, MOL BIOL EVOL, V16, P1799, DOI 10.1093/oxfordjournals.molbev.a026092; MADRIGAL C, 1994, PLANT PATHOL, V43, P554, DOI 10.1111/j.1365-3059.1994.tb01590.x; Miller M.A., 2010, P GAT COMP ENV WORKS; Molla AH, 2001, WORLD J MICROB BIOT, V17, P849, DOI 10.1023/A:1013844306960; Mondello V, 2018, PLANT DIS, V102, P1189, DOI 10.1094/PDIS-08-17-1181-FE; Mugnai L, 1999, PLANT DIS, V83, P404, DOI 10.1094/PDIS.1999.83.5.404; Naidu Y, 2016, J PHYTOPATHOL, V164, P779, DOI 10.1111/jph.12498; NASCIMENTO T., 2001, PHYTOPATHOL MEDITERR, V40, P357; ODonnell K, 1997, MOL PHYLOGENET EVOL, V7, P103, DOI 10.1006/mpev.1996.0376; Pancher M, 2012, APPL ENVIRON MICROB, V78, P4308, DOI 10.1128/AEM.07655-11; Pertot I, 2016, BIOCONTROL, V61, P257, DOI 10.1007/s10526-016-9723-6; Pinto C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085622; Porter CL, 1924, AM J BOT, V11, P168, DOI 10.2307/2435538; Rego C., 2000, Phytopathologia Mediterranea, V39, P76; Rezgui A, 2016, BIOL CONTROL, V99, P28, DOI 10.1016/j.biocontrol.2016.04.005; Ridgway HJ, 2002, AUSTRALAS PLANT PATH, V31, P267, DOI 10.1071/AP02021; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Scheck HJ, 1998, PLANT DIS, V82, P590, DOI 10.1094/PDIS.1998.82.5.590C; Spagnolo A, 2012, PHYTOPATHOL MEDITERR, V51, P449; Sparapano L., 2000, Phytopathologia Mediterranea, V39, P46; Sung GH, 2007, MOL PHYLOGENET EVOL, V44, P1204, DOI 10.1016/j.ympev.2007.03.011; Surico Giuseppe, 2008, V3, P119, DOI 10.1007/978-1-4020-8571-0_6; Surico G, 2009, PHYTOPATHOL MEDITERR, V48, P5; Talontsi FM, 2013, EUR J ORG CHEM, V2013, P3174, DOI 10.1002/ejoc.201300146; Urbez-Torres JR, 2011, PLANT PATHOL, V60, P261, DOI 10.1111/j.1365-3059.2010.02381.x; Vaidya G, 2011, CLADISTICS, V27, P171, DOI 10.1111/j.1096-0031.2010.00329.x; Valenzuela-Lopez N, 2018, STUD MYCOL, P1, DOI 10.1016/j.simyco.2017.11.003; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Woudenberg JHC, 2013, STUD MYCOL, P171, DOI 10.3114/sim0015; Yacoub A, 2016, BIOL CONTROL, V92, P7, DOI 10.1016/j.biocontrol.2015.08.005	74	31	31	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2019	14	3							e0213273	10.1371/journal.pone.0213273	http://dx.doi.org/10.1371/journal.pone.0213273			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ3IW	30913218	Green Submitted, gold, Green Published			2022-12-26	WOS:000462305600010
J	Rios-Morales, RY; Chan, SH; Bell, SP				Rios-Morales, Ramon Y.; Chan, Sze Ham; Bell, Stephen P.			Initiation-specific alleles of the Cdc45 helicase-activating protein	PLOS ONE			English	Article							EUKARYOTIC DNA-REPLICATION; CRYO-EM STRUCTURE; MCM2-7 HELICASE; CMG HELICASE; STRUCTURAL BASIS; MCM10 PLAYS; POL EPSILON; ORIGIN DNA; S-PHASE; PHOSPHORYLATION	The committed step in DNA replication initiation is the activation of the Mcm2-7 replicative DNA helicase. Two activators, Cdc45 and GINS, associate with Mcm2-7 at origins of replication to form the CMG complex, which is the active eukaryotic replicative helicase. These activators function during both replication initiation and elongation, however, it remains unclear whether Cdc45 performs the same function(s) during both events. Here, we describe the genetic and biochemical characterization of seven Cdc45 mutations. Three of these mutations are temperature-sensitive lethal mutations in CDC45. Intriguingly, these mutants are defective for DNA replication initiation but not elongation. Consistent with an initiation defect, all three temperature-sensitive mutants are defective for CMG formation. Two of the lethal mutants are located within the RecJ-like domain of Cdc45 confirming the importance of this region for Cdc45 function. The remaining two lethal mutations localize to an intrinsically disordered region (IDR) of Cdc45 that is found in all eukaryotes. Despite the lethality of these IDR substitution mutants, Cdc45 lacking the IDR retains full function. Together, our data provide insights into the functional importance of Cdc45 domains and suggest that the requirements for Cdc45 function during DNA replication initiation are distinct from those involved in replication elongation.	[Rios-Morales, Ramon Y.; Chan, Sze Ham; Bell, Stephen P.] MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02138 USA; [Rios-Morales, Ramon Y.] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA; [Chan, Sze Ham] MIT, Whitehead Inst Biomed Res, Dept Biol, Cambridge, MA USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Vanderbilt University; Massachusetts Institute of Technology (MIT); Whitehead Institute	Bell, SP (corresponding author), MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02138 USA.	spbell@mit.edu		Bell, Stephen/0000-0002-2876-610X	National Institute of General Medical Sciences [GM007287]; Howard Hughes Medical Institute	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This work was supported by the National Institute of General Medical Sciences, predoctoral training grant, GM007287 to RYR-M and the Howard Hughes Medical Institute, Investigator Award to SPB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali FA, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02389-0; Ali FA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10708; Aparicio OM, 1999, P NATL ACAD SCI USA, V96, P9130, DOI 10.1073/pnas.96.16.9130; Bell SP, 2016, GENETICS, V203, P1027, DOI 10.1534/genetics.115.186452; Bochman ML, 2008, MOL CELL BIOL, V28, P5865, DOI 10.1128/MCB.00161-08; Can G., 2019, MOL CEL, V73, P1; Costa A, 2011, NAT STRUCT MOL BIOL, V18, P471, DOI 10.1038/nsmb.2004; Coster G, 2017, SCIENCE, V357, P314, DOI 10.1126/science.aan0063; Deegan TD, 2016, EMBO J, V35, P961, DOI 10.15252/embj.201593552; Douglas ME, 2018, NATURE, V555, P265, DOI 10.1038/nature25787; Evrin C, 2009, P NATL ACAD SCI USA, V106, P20240, DOI 10.1073/pnas.0911500106; Fu YV, 2011, CELL, V146, P930, DOI 10.1016/j.cell.2011.07.045; Georgescu R, 2017, P NATL ACAD SCI USA, V114, pE697, DOI 10.1073/pnas.1620500114; Heller RC, 2011, CELL, V146, P80, DOI 10.1016/j.cell.2011.06.012; Ilves I, 2010, MOL CELL, V37, P247, DOI 10.1016/j.molcel.2009.12.030; Kang S, 2014, MOL CELL, V55, P655, DOI 10.1016/j.molcel.2014.06.033; Kanke M, 2012, EMBO J, V31, P2182, DOI 10.1038/emboj.2012.68; Krastanova I, 2012, J BIOL CHEM, V287, P4121, DOI 10.1074/jbc.M111.285395; Li, 1999, Genome Inform Ser Workshop Genome Inform, V10, P30; Li NN, 2015, NATURE, V524, P186, DOI 10.1038/nature14685; Looke M, 2017, GENE DEV, V31, P291, DOI 10.1101/gad.291336.116; Mimura S, 1998, EMBO J, V17, P5699, DOI 10.1093/emboj/17.19.5699; Muramatsu S, 2010, GENE DEV, V24, P602, DOI 10.1101/gad.1883410; Noguchi Y, 2017, P NATL ACAD SCI USA, V114, pE9529, DOI 10.1073/pnas.1712537114; Owens JC, 1997, P NATL ACAD SCI USA, V94, P12521, DOI 10.1073/pnas.94.23.12521; PIATTI S, 1995, EMBO J, V14, P3788, DOI 10.1002/j.1460-2075.1995.tb00048.x; Randell JCW, 2010, MOL CELL, V40, P353, DOI 10.1016/j.molcel.2010.10.017; Remus D, 2009, CELL, V139, P719, DOI 10.1016/j.cell.2009.10.015; Romero P, 1998, Pac Symp Biocomput, P437; Samel SA, 2014, GENE DEV, V28, P1653, DOI 10.1101/gad.242404.114; Sanchez-Pulido L, 2011, BIOINFORMATICS, V27, P1885, DOI 10.1093/bioinformatics/btr332; Sengupta S, 2013, CURR BIOL, V23, P543, DOI 10.1016/j.cub.2013.02.011; Simon AC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11638; Sun JC, 2015, NAT STRUCT MOL BIOL, V22, P976, DOI 10.1038/nsmb.3113; Sun JC, 2013, NAT STRUCT MOL BIOL, V20, P944, DOI 10.1038/nsmb.2629; Tanaka S, 2007, NATURE, V445, P328, DOI 10.1038/nature05465; Tanaka S, 2011, CURR BIOL, V21, P2055, DOI 10.1016/j.cub.2011.11.038; Tercero JA, 2000, EMBO J, V19, P2082, DOI 10.1093/emboj/19.9.2082; Ticau S, 2017, NAT STRUCT MOL BIOL, V24, P309, DOI 10.1038/nsmb.3375; Ticau S, 2015, CELL, V161, P513, DOI 10.1016/j.cell.2015.03.012; van Deursen F, 2012, EMBO J, V31, P2195, DOI 10.1038/emboj.2012.69; Walter J, 2000, MOL CELL, V5, P617, DOI 10.1016/S1097-2765(00)80241-5; Warner MD, 2017, J BIOL CHEM, V292, P21417, DOI 10.1074/jbc.M117.815639; Watase G, 2012, CURR BIOL, V22, P343, DOI 10.1016/j.cub.2012.01.023; WERTMAN KF, 1992, GENETICS, V132, P337; Yardimci H, 2010, MOL CELL, V40, P834, DOI 10.1016/j.molcel.2010.11.027; Yeeles JTP, 2015, NATURE, V519, P431, DOI 10.1038/nature14285; Yuan ZN, 2017, NAT STRUCT MOL BIOL, V24, P316, DOI 10.1038/nsmb.3372; Yuan ZN, 2016, NAT STRUCT MOL BIOL, V23, P217, DOI 10.1038/nsmb.3170; Zegerman P, 2007, NATURE, V445, P281, DOI 10.1038/nature05432; Zhou JC, 2017, P NATL ACAD SCI USA, V114, P4141, DOI 10.1073/pnas.1700530114	51	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2019	14	3							e0214426	10.1371/journal.pone.0214426	http://dx.doi.org/10.1371/journal.pone.0214426			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ3IW	30913274	Green Submitted, gold, Green Published			2022-12-26	WOS:000462305600059
J	Kwena, ZA; Njuguna, SW; Ssetala, A; Seeley, J; Nielsen, L; De Bont, J; Bukusi, EA; Ochieng, P; Dago, B; Ondigo, F; Kamali, A; Grosskurth, H; Kapiga, S; Kiwanuka, N; Nielson, L; Bukusi, E; De Bont, J; Ssetala, A				Kwena, Zachary A.; Njuguna, Stella W.; Ssetala, Ali; Seeley, Janet; Nielsen, Leslie; De Bont, Jan; Bukusi, Elizabeth A.; Ochieng, Paul; Dago, Bernard; Ondigo, Fred; Kamali, Anatoli; Grosskurth, Heiner; Kapiga, Said; Kiwanuka, Noah; Nielson, Leslie; Bukusi, Elizabeth; De Bont, Jan; Ssetala, Ali		Lake Victoria Consortium Hlth Res	HIV prevalence, spatial distribution and risk factors for HIV infection in the Kenyan fishing communities of Lake Victoria	PLOS ONE			English	Article							MIDDLE-INCOME COUNTRIES; ANTIRETROVIRAL THERAPY; REDUCTION; PREVENTION; FISHERFOLK; COUPLES; WOMEN; SEX; PROPHYLAXIS; MARRIAGE	Introduction Global efforts to end HIV by 2030 focus on reducing and eventually eliminating new infections in priority populations. Identifying these populations and characterizing their vulnerability factors helps in guiding investment of scarce HIV prevention resources to achieve maximum impact. We sought to establish HIV prevalence, spatial distribution and risk factors for HIV infection in the Kenyan fishing communities of Lake Victoria. Methods We conducted a cross-sectional survey of 2637 people from all the 308 fish-landing beaches on the Kenyan shore of Lake Victoria. The number of participants enrolled at each beach were weighted based on the size of the beach, determined by the number of functional registered boats. We used simple random sampling to select those to be approached for study participation. Consenting participants were privately interviewed about their socioeconomic and demographic characteristics and sexual behavior, and were invited for HIV test using the Kenya rapid HIV testing protocol. We used descriptive statistics and multivariate logistic and linear regression for analysis. Results We found high HIV prevalence of 32% with significant differences between men (29%) and women (38%). Among men, having an HIV negative sexual partner, being circumcised, increasing number of condom protected sex acts in the preceding month, being younger and being a resident of Homa Bay, Kisumu, Siaya and Busia counties compared to Migori County reduced the risk of HIV infection. For women, being married, having more children with the current spouse, having an HIV negative sexual partner and being a resident of Busia compared to Migori County reduced the risk of HIV infection. We also found that longer distance from the beaches to the nearest public health facilities was associated with increasing cumulative HIV prevalence at the beaches. Conclusion Fishing communities have high HIV prevalence and may greatly benefit from interventions such as wider ART coverage, couple HIV risk reduction counseling, PrEP use for HIV negative partner at substantial continuous risk, alongside other HIV prevention services that the Kenyan government is currently rolling out. This will additionally require adequate plans to synchronize the provision of these services with the population's routine schedules for all these options to be reasonably accessible to them.	[Kwena, Zachary A.; Njuguna, Stella W.; Bukusi, Elizabeth A.; Bukusi, Elizabeth] Kenya Govt Med Res Ctr, Nairobi, Kenya; [Ssetala, Ali] UVRI IAVI HIV Vaccine Program, Entebbe, Uganda; [Seeley, Janet] MRC UVRI Uganda Res Unit, Entebbe, Uganda; [Nielsen, Leslie; De Bont, Jan] Int AIDS Vaccine Initiat, New York, NY USA; [Ochieng, Paul; Dago, Bernard; Ondigo, Fred] Couples Intervent Study & Family AIDS Care & Educ, Kisumu, Kenya; [Kamali, Anatoli; Nielson, Leslie; De Bont, Jan] IAVI, New York, NY USA; [Grosskurth, Heiner] LSHTM, London, England; [Kapiga, Said] MITU, London, England; [Kiwanuka, Noah; Ssetala, Ali] UVRI IAVI, Entebbe, Uganda	Kenya Medical Research Institute; International AIDS Vaccine Initiative; International AIDS Vaccine Initiative; International AIDS Vaccine Initiative; University of London; London School of Hygiene & Tropical Medicine; International AIDS Vaccine Initiative	Kwena, ZA (corresponding author), Kenya Govt Med Res Ctr, Nairobi, Kenya.	zkwena@kemri-ucsf.org	Fazli, Ghazal/AAE-8320-2022	Kwena, Zachary/0000-0002-5117-5084; Seeley, Janet/0000-0002-0583-5272	IAVI; USAID; Research, Training and Care Program (RCTP) Co-Directors' Discretionary Fund; International AIDS Vaccine Initiative; Training Program Co-Directors Discretionary Fund; Kenya Medical Research (Nairobi); Centre for Microbiology Research (Nairobi); FOGARTY INTERNATIONAL CENTER [D43TW009343] Funding Source: NIH RePORTER	IAVI; USAID(United States Agency for International Development (USAID)); Research, Training and Care Program (RCTP) Co-Directors' Discretionary Fund; International AIDS Vaccine Initiative; Training Program Co-Directors Discretionary Fund; Kenya Medical Research (Nairobi); Centre for Microbiology Research (Nairobi); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was partially funded by IAVI with the generous support of USAID and other donors; a full list of IAVI donors is available at www.iavi.org.The rest of the funding was support from Research, Training and Care Program (RCTP) Co-Directors' Discretionary Fund. There was no additional external funding received for this study. The contents of this manuscript are the responsibility of the authors and do not necessarily reflect the views of RCTP, USAID or the US Government. Funding information is International AIDS Vaccine Initiative and Research Care and Training Program Co-Directors Discretionary Fund to Zachary A Kwena, Elizabeth A Bukusi, StellaW Njuguna; We wish to acknowledge the following for their support and leadership that enabled the study to be conducted (a) Director, Kenya Medical Research (Nairobi) and; (b) Director, Centre for Microbiology Research (Nairobi). We thank Pat Fast, Anatoli Kamali, Heiner Grosskurth and Said Kapiga for their insightful review of this manuscript. Additionally, we thank the officials of LVCHR and all Beach Management Units that we worked with for their support. We would also like to acknowledge the hard work by Fisherfolk Study staff under the team leadership of Paul Ochieng, Bernard Dago and, Fred Ondigo as well as our sister projects the Couple's Intervention Study and the Family AIDS Care and Education Services in Kisumu, Kenya. In a special way, we thank fisherfolk who volunteered to participate in the study. LVCHR which consists of Pat Fast from International AIDS Vaccine Initiative (IAVI) as the group's lead author, Anatoli Kamali from IAVI (formerly of MRC/ UVRI), Heiner Grosskurth from London School of Health & Tropical Medicine (LSHTM) and Said Kapiga from Mwanza Intervention Trials Unit (MITU), Noah Kiwanuka formerly of UVRI- IAVI, Leslie Nielson formerly of IAVI, Elizabeth Bukusi from Kenya Medical Research Institute (KEMRI), Jan De Bont from IAVI, Ali Ssetala from UVRI- IAVI.	Agot KE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014028; Akullian A, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000005885; Allison EH, 2004, FISH FISH, V5, P215, DOI 10.1111/j.1467-2679.2004.00153.x; Anderson SJ, 2014, LANCET, V384, P249, DOI 10.1016/S0140-6736(14)61053-9; Asiki G, 2011, SEX TRANSM INFECT, V87, P511, DOI 10.1136/sti.2010.046805; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Baral S, 2012, LANCET INFECT DIS, V12, P538, DOI 10.1016/S1473-3099(12)70066-X; Bogart LM, 2016, AIDS BEHAV, V20, P2464, DOI 10.1007/s10461-016-1331-z; Borgdorff MW, 2018, LANCET HIV, V5, pE241, DOI 10.1016/S2352-3018(18)30025-0; Bulsara SM, 2018, AIDS BEHAV, V22, P752, DOI 10.1007/s10461-016-1644-y; Celum C, 2013, J INFECT DIS, V208, P189, DOI 10.1093/infdis/jit154; Chang LW, 2016, LANCET HIV, V3, pE388, DOI 10.1016/S2352-3018(16)30034-0; Cuadros DF, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-28; de Walque D, 2012, STUD FAMILY PLANN, V43, P1, DOI 10.1111/j.1728-4465.2012.00297.x; Ettarh RR, 2016, HEALTH CARE WOMEN IN, V37, P237, DOI 10.1080/07399332.2014.908194; Fiorillo SP, 2012, AIDS CARE, V24, P1264, DOI 10.1080/09540121.2012.658751; Galbraith JS, 2014, JAIDS-J ACQ IMM DEF, V66, pS37, DOI 10.1097/QAI.0000000000000121; Geng EH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021797; Government of Kenya, 2006, FISH ANN STAT B; Izudi J, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/1524016; Jackson DJ, 1997, AIDS, V11, P903, DOI 10.1097/00002030-199707000-00010; Jones D, 2014, AIDS PATIENT CARE ST, V28, P433, DOI 10.1089/apc.2014.0039; Kharsany Ayesha B M, 2016, Open AIDS J, V10, P34, DOI 10.2174/1874613601610010034; Kissling E, 2005, AIDS, V19, P1939, DOI 10.1097/01.aids.0000191925.54679.94; Kiwanuka N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094932; Kiwanuka N, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18621; Kripke K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158767; Kurth AE, 2015, J INT AIDS SOC, V18, P23, DOI 10.7448/IAS.18.2.19433; Kwena Z, 2017, C RETR OPP INF CROI; Kwena Z, 2014, 7 SEM E AFR COLL SCI; Kwena ZA, 2010, INT J STD AIDS, V21, P708, DOI 10.1258/ijsa.2010.010160; Kwena ZA, 2016, HIV PREVALENCE INCID; Kwena ZA, 2016, CROI; Kwena ZA, 2013, SEX TRANSM INFECT; Kwena ZA, 2015, U NAIR ANN COLL M; Kwena ZA, 2010, AIDS RES TREAT, V2010, DOI 10.1155/2010/865903; Kwena ZA, 2012, AJAR-AFR J AIDS RES, V11, P9, DOI 10.2989/16085906.2012.671267; Lakew Y, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008669; Lubega M, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2371-4; Lubega M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132740; Lungu A., 2010, ASSESSMENT ACCESS HL; Matovu JKB, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.19160; McCormack S, 2016, LANCET, V387, P53, DOI 10.1016/S0140-6736(15)00056-2; McMahon JH, 2013, B WORLD HEALTH ORGAN, V91, P377, DOI 10.2471/BLT.12.112946; Morton JF, 2017, JAIDS-J ACQ IMM DEF, V74, pS15, DOI 10.1097/qai.0000000000001210; NACC NASCOP, 2016, KEN HIV COUNT PROF; Nagoli J, 2010, AJAR-AFR J AIDS RES, V9, P71, DOI 10.2989/16085906.2010.484575; Namey E, 2016, CULT HEALTH SEX, V18, P1081, DOI 10.1080/13691058.2016.1164899; Nanvubya A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141531; NASCOP, 2015, NAT PLAN ACC HIV CAR; Odoyo-June E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185872; Okoboi S, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.5.20841; Ondondo RO, 2014, WORLD J AIDS, V4, P219; Opio A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070770; Perry B, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.19010; Rodger A., 2018, AIDS 2018 C; Rosenberg NE, 2017, JAIDS-J ACQ IMM DEF, V75, P417, DOI 10.1097/QAI.0000000000001398; Rousseau P., 2016, HIV HOTSPOT MAPPING; Sanders EJ, 2013, AIDS, V27, P437, DOI 10.1097/QAD.0b013e32835b0f81; Seeley JA, 2005, AIDS CARE, V17, P688, DOI 10.1080/09540120412331336698; Seeley J, 2012, SEX TRANSM DIS, V39, P433, DOI 10.1097/OLQ.0b013e318251555d; Smith DJ, 2007, AM J PUBLIC HEALTH, V97, P997, DOI 10.2105/AJPH.2006.088583; Tenkorang EY, 2014, INT HEALTH, V6, P46, DOI 10.1093/inthealth/ihu003; Tumwesigye NM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1069; UNAIDS, 2014, LOC EP ISS BRIEF; UNAIDS, 2014, 90 90 90 AMB TREATM; Wall KM, 2017, SEX TRANSM INFECT, V93, P259, DOI 10.1136/sextrans-2016-052743; Yang RR, 2015, INT J INFECT DIS, V33, P179, DOI 10.1016/j.ijid.2015.02.007; Ying R, 2015, J INT AIDS SOC, V18, P21, DOI 10.7448/IAS.18.4.20013; Zaidi J, 2013, AIDS, V27, P2301, DOI 10.1097/QAD.0b013e328362e832	70	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2019	14	3							e0214360	10.1371/journal.pone.0214360	http://dx.doi.org/10.1371/journal.pone.0214360			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HQ1KV	30908555	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000462157600057
J	Lu, D; Yamawaki, T; Zhou, H; Chou, WY; Chhoa, M; Lamas, E; Escobar, SS; Arnett, HA; Ge, HY; Juan, T; Wang, SL; Li, CM				Lu, Daniel; Yamawaki, Tracy; Zhou, Hong; Chou, Wen-Yu; Chhoa, Mark; Lamas, Edwin; Escobar, Sabine S.; Arnett, Heather A.; Ge, Huanying; Juan, Todd; Wang, Songli; Li, Chi-Ming			Limited differential expression of miRNAs and other small RNAs in LPS-stimulated human monocytes	PLOS ONE			English	Article							MICRORNA; MIR-146A; HETEROGENEITY; BIOGENESIS; INDUCTION; DATABASE; CELLS	Monocytes are a distinct subset of myeloid cells with diverse functions in early inflammatory immune modulation. While previous studies have surveyed the role of miRNA regulation on different myeloid cell lines and primary cultures, the time-dependent kinetics of inflammatory stimulation on miRNA expression and the relationship between miRNA-to-target RNA expression have not been comprehensively profiled in monocytes. In this study, we use next-generation sequencing and RT-PCR assays to analyze the non-coding small RNA transcriptome of unstimulated and lipopolysaccharide (LPS)-stimulated monocytes at 6 and 24 hours. We identified a miRNA signature consisting of five mature miRNAs (hsa-mir146a, hsa-mir-155, hsa-mir-9, hsa-mir-147b, and hsa-mir-193a) upregulated by LPS-stimulated monocytes after 6 hours and found that most miRNAs were also upregulated after 24 hours of stimulation. Only one miRNA gene was down-regulated and no other small RNAs were found dysregulated in monocytes after LPS treatment. In addition, novel tRNA-derived fragments were also discovered in monocytes although none showed significant changes upon LPS stimulation. Interrogation of validated miRNA targets by transcriptomic analysis revealed that absolute expression of most miRNA targets implicating in innate immune response decreased over time in LPS-stimulated monocytes although their expression patterns along the treatment were heterogeneous. Our findings reveal a potential role by which selective miRNA upregulation and stable expression of other small RNAs enable monocytes to develop finely tuned cellular responses during acute inflammation.	[Lu, Daniel; Yamawaki, Tracy; Zhou, Hong; Chou, Wen-Yu; Chhoa, Mark; Lamas, Edwin; Ge, Huanying; Juan, Todd; Wang, Songli; Li, Chi-Ming] Amgen Res, Genome Anal Unit, San Francisco, CA 94080 USA; [Escobar, Sabine S.; Arnett, Heather A.] Amgen Res, Inflammat Oncol TA, San Francisco, CA USA		Li, CM (corresponding author), Amgen Res, Genome Anal Unit, San Francisco, CA 94080 USA.	CHIMINGL@amgen.com	Zhou, Z Hong/HDN-0747-2022; Li, Chi-Ming/ABA-6457-2020		Amgen Inc.	Amgen Inc.(Amgen)	This study was funded and supported by Amgen Inc., which played a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bazzoni F, 2009, P NATL ACAD SCI USA, V106, P5282, DOI 10.1073/pnas.0810909106; Boldin MP, 2012, IMMUNOL REV, V246, P16; Ceppi M, 2009, P NATL ACAD SCI USA, V106, P2735, DOI 10.1073/pnas.0811073106; Chan PP, 2009, NUCLEIC ACIDS RES, V37, pD93, DOI 10.1093/nar/gkn787; Dhahbi JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020509; Etzrodt M, 2012, CELL REPORTS, V1, P317, DOI 10.1016/j.celrep.2012.02.009; Faraoni I, 2009, BBA-MOL BASIS DIS, V1792, P497, DOI 10.1016/j.bbadis.2009.02.013; Fehniger TA, 2010, GENOME RES, V20, P1590, DOI 10.1101/gr.107995.110; Gironella M, 2007, P NATL ACAD SCI USA, V104, P16170, DOI 10.1073/pnas.0703942104; Graff JW, 2012, J BIOL CHEM, V287, P21816, DOI 10.1074/jbc.M111.327031; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Haussecker D, 2010, RNA, V16, P673, DOI 10.1261/rna.2000810; Hu J, 2012, BIOINFORMATICS, V28, P1933, DOI 10.1093/bioinformatics/bts294; Jima DD, 2010, BLOOD, V116, pE118, DOI 10.1182/blood-2010-05-285403; Jimenez VC, 2014, PHYSIOL GENOMICS, V46, P91, DOI 10.1152/physiolgenomics.00140.2013; Kamali K, 2016, BRATISL MED J, V117, P376, DOI 10.4149/BLL_2016_074; Karwaciak I, 2017, ONCOTARGET, V8, P54243, DOI 10.18632/oncotarget.17342; Khoo CP, 2017, SCI REP-UK, V7, DOI 10.1038/srep44137; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Kosik KS, 2010, CELL, V143, P21, DOI 10.1016/j.cell.2010.09.008; Lee YS, 2009, GENE DEV, V23, P2639, DOI 10.1101/gad.1837609; Lestrade L, 2006, NUCLEIC ACIDS RES, V34, pD158, DOI 10.1093/nar/gkj002; Liang HW, 2015, J BIOL CHEM, V290, P926, DOI 10.1074/jbc.M114.621409; Liao JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010563; Lin Q, 2011, ARTERIOSCL THROM VAS, V31, P1024, DOI 10.1161/ATVBAHA.111.224048; Liu G, 2009, P NATL ACAD SCI USA, V106, P15819, DOI 10.1073/pnas.0901216106; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mathonnet G, 2007, SCIENCE, V317, P1764, DOI 10.1126/science.1146067; Meylan E, 2008, NAT IMMUNOL, V9, P581, DOI 10.1038/ni0608-581; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Naqvi Afsar Raza, 2016, J Microb Biochem Technol, V8, P136; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; Pederson T, 2010, RNA, V16, P1865, DOI 10.1261/rna.2266510; Rusca Nicole, 2011, Mol Biol Int, V2011, P437301, DOI 10.4061/2011/437301; Rusca N, 2012, MOL CELL BIOL, V32, P4432, DOI 10.1128/MCB.00824-12; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Sobala A, 2011, WIRES RNA, V2, P853, DOI 10.1002/wrna.96; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; Tili E, 2011, P NATL ACAD SCI USA, V108, P4908, DOI 10.1073/pnas.1101795108; Turner ML, 2011, J IMMUNOL, V187, P3911, DOI 10.4049/jimmunol.1101137	45	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2019	14	3							e0214296	10.1371/journal.pone.0214296	http://dx.doi.org/10.1371/journal.pone.0214296			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ1KV	30908559	gold, Green Published, Green Submitted			2022-12-26	WOS:000462157600052
J	Sawasato, K; Suzuki, S; Nishiyama, K				Sawasato, Katsuhiro; Suzuki, Sonomi; Nishiyama, Ken-ichi			Increased expression of the bacterial glycolipid MPIase is required for efficient protein translocation across membranes in cold conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein export; protein translocation; membrane protein; membrane lipid; glycolipid; lipochaperone; low temperature; membrane fluidity; MPIase (membrane protein integrase); protein integration; low temperature; cold sensitivity; cell stress	CDP-DIGLYCERIDE SYNTHETASE; ESCHERICHIA-COLI; CYTOPLASMIC MEMBRANE; TOPOLOGY INVERSION; SECG; YIDC; RECONSTITUTION; INTEGRATION; INSERTION; CLEAVAGE	Protein integration into and translocation across biological membranes are vital events for organismal survival and are fundamentally conserved among many organisms. Membrane protein integrase (MPIase) is a glycolipid that drives membrane protein integration into the cytoplasmic membrane in Escherichia coli. MPIase also stimulates protein translocation across the membrane, but how its expression is regulated is incompletely understood. In this study, we found that the expression level of MPIase significantly increases in the cold (<25 degrees C), whereas that of the SecYEG translocon does not. Using previously created gene-knockout E. coli strains, we also found that either the cdsA or ynbB gene, both encoding rate-limiting enzymes for MPIase biosynthesis, is responsible for the increase in the MPIase expression. Furthermore, using pulse-chase experiments and protein integration assays, we demonstrated that the increase in MPIase levels is important for efficient protein translocation, but not for protein integration. We conclude that MPIase expression is required to stimulate protein translocation in cold conditions and is controlled by cdsA and ynbB gene expression.	[Sawasato, Katsuhiro; Nishiyama, Ken-ichi] Iwate Univ, United Grad Sch Agr Sci, Morioka, Iwate 0208550, Japan; [Suzuki, Sonomi; Nishiyama, Ken-ichi] Iwate Univ, Dept Biol Chem & Food Sci, Fac Agr, Morioka, Iwate 0208550, Japan	Iwate University; Iwate University	Nishiyama, K (corresponding author), Iwate Univ, Dept Biol Chem & Food Sci, Fac Agr, Morioka, Iwate 0208550, Japan.	nishiyam@iwate-u.ac.jp		Nishiyama, Ken-ichi/0000-0003-0478-4482	Japan Society for the Promotion of Science [15KT0073, 16H01374, 16K15083, 17H02209, 18KK0197]; SUNBOR scholarship (Suntory Foundation for Life Sciences)	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); SUNBOR scholarship (Suntory Foundation for Life Sciences)	This work was supported by Grants-in-Aid from the Japan Society for the Promotion of Science (Grants 15KT0073, 16H01374, 16K15083, 17H02209, and 18KK0197 (to K. N.)). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a SUNBOR scholarship (Suntory Foundation for Life Sciences).	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Beckwith J, 2013, RES MICROBIOL, V164, P497, DOI 10.1016/j.resmic.2013.03.007; Breyton C, 2002, NATURE, V418, P662, DOI 10.1038/nature00827; Chen MY, 2003, J BIOL CHEM, V278, P23295, DOI 10.1074/jbc.M301008200; Du Plessis DJF, 2011, BBA-BIOMEMBRANES, V1808, P851, DOI 10.1016/j.bbamem.2010.08.016; Facey SJ, 2004, BBA-MOL CELL RES, V1694, P55, DOI 10.1016/j.bbamcr.2004.03.012; HUSSAIN M, 1980, J BIOL CHEM, V255, P3707; ICHO T, 1985, J BIOL CHEM, V260, P2078; Kaufmann A, 1999, BIOCHEMISTRY-US, V38, P9115, DOI 10.1021/bi990539d; Kiefer D, 2018, FEMS MICROBIOL LETT, V365, DOI 10.1093/femsle/fny106; KUHN A, 1985, J BIOL CHEM, V260, P5914; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MARR AG, 1962, J BACTERIOL, V84, P1260, DOI 10.1128/JB.84.6.1260-1267.1962; MATSUYAMA S, 1993, EMBO J, V12, P265, DOI 10.1002/j.1460-2075.1993.tb05652.x; Moser M, 2013, P NATL ACAD SCI USA, V110, P9734, DOI 10.1073/pnas.1303160110; Murakami A, 2004, P NATL ACAD SCI USA, V101, P12330, DOI 10.1073/pnas.0404907101; Nishikawa H, 2017, BIOCHEM BIOPH RES CO, V487, P477, DOI 10.1016/j.bbrc.2017.04.095; NISHIYAMA K, 1992, J BIOL CHEM, V267, P7170; NISHIYAMA K, 1991, BIOCHIM BIOPHYS ACTA, V1065, P89, DOI 10.1016/0005-2736(91)90015-Z; NISHIYAMA K, 1994, EMBO J, V13, P3272, DOI 10.1002/j.1460-2075.1994.tb06628.x; Nishiyama KI, 2006, J BIOL CHEM, V281, P35667, DOI 10.1074/jbc.M608228200; Nishiyama Ken-ichi, 2014, Biomol Concepts, V5, P429, DOI 10.1515/bmc-2014-0030; Nishiyama K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2267; Nishiyama K, 2010, BIOCHEM BIOPH RES CO, V394, P733, DOI 10.1016/j.bbrc.2010.03.061; Nishiyama KI, 1996, CELL, V85, P71, DOI 10.1016/S0092-8674(00)81083-1; POGLIANO KJ, 1993, GENETICS, V133, P763; Samuelson JC, 2000, NATURE, V406, P637, DOI 10.1038/35020586; Sato R, 2019, BIOCHEM BIOPH RES CO, V510, P636, DOI 10.1016/j.bbrc.2019.01.145; Sawasato K, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37809-8; Shimizu H, 1997, MOL MICROBIOL, V26, P1013, DOI 10.1046/j.1365-2958.1997.6392003.x; Shimizu Y, 2001, NAT BIOTECHNOL, V19, P751, DOI 10.1038/90802; SPARROW CP, 1985, J BIOL CHEM, V260, P2084; Sugai R, 2007, J BIOL CHEM, V282, P29540, DOI 10.1074/jbc.M704716200; Suzuki H, 1998, MOL MICROBIOL, V29, P331, DOI 10.1046/j.1365-2958.1998.00937.x; Suzuki H, 1999, J BIOL CHEM, V274, P31020, DOI 10.1074/jbc.274.43.31020; Tamura Y, 2013, CELL METAB, V17, P709, DOI 10.1016/j.cmet.2013.03.018; TANI K, 1990, J BIOL CHEM, V265, P17341; WICKNER W, 1991, ANNU REV BIOCHEM, V60, P101, DOI 10.1146/annurev.bi.60.070191.000533; Xie K, 2008, NAT REV MICROBIOL, V6, P234, DOI 10.1038/nrmicro3595	40	8	8	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2019	294	21					8403	8411		10.1074/jbc.RA119.008457	http://dx.doi.org/10.1074/jbc.RA119.008457			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC6UQ	30936205	Green Published, hybrid			2022-12-26	WOS:000471108200011
J	Yu, ZC; Zhang, W; Li, B; Luo, XP; Wang, R; Yang, XY				Yu, Zhi-Chao; Zhang, Wei; Li, Bin; Luo, Xiao-Ping; Wang, Rui; Yang, Xiao-Ye			A survey of Onchocerca fasciata infection in camels (Camelus bactrianus) with notes on morphology	PLOS ONE			English	Article							DEER CERVUS-ELAPHUS; DROMEDARIUS; NEMATODA; GUTTUROSA; RAILLIET; CATTLE; HENRY; FILARIOIDEA; PREVALENCE; ARMILLATA	The goal of this study was to provide insight into the pathogenicity of Onchocerca fasciata in Camelus bactrianus to help control onchocerciasis. From November 2015 to January 2016, the prevalence and severity of onchocerciasis were recorded in 152 camels. Nodules containing Onchocerca were collected and observed. Adult parasites were extracted from the nodules and identified via light microscopy as well as by partial sequencing of the cytochrome oxidase subunit I (C01) gene. The sequences were examined and compared to similar sequences from other Onchocerca species. In total, 80.3% of camels were parasitized. The severity of infection varied, as camels harboured between one and fifteen nodules. The morphology and the cuticle differed in both sexes and displayed considerable variation in the thickness and structure of different body parts. Identification was further confirmed using molecular biology methods. This study provides a comprehensive morphological description of Onchocerca fasciata isolated from camels. The prevalence and intensity of infection (assessed via nodules) varied in the Bactrian camels. The structure of the cuticle was an important morphological feature for species differentiation in Onchocerca. Based on our data, the morphological assessment of O. fasciata represents a reliable method to characterize other Onchocerca species.	[Yu, Zhi-Chao; Luo, Xiao-Ping; Wang, Rui; Yang, Xiao-Ye] Inner Mongolia Agr Univ, Coll Vet Med, Hohhot, Inner Mongolia, Peoples R China; [Zhang, Wei; Li, Bin] Xinjiang Agr Univ, Coll Vet Med, Urumqi, Sinkiang, Peoples R China; [Yu, Zhi-Chao] Technol Ctr, Hohhot, Inner Mongolia, Peoples R China	Inner Mongolia Agricultural University; Xinjiang Agricultural University	Wang, R; Yang, XY (corresponding author), Inner Mongolia Agr Univ, Coll Vet Med, Hohhot, Inner Mongolia, Peoples R China.	wr2006@163.com; xiaoyeyang122@sohu.com		Rui, Wang/0000-0002-2761-9466	National Natural Science Foundation of China [31360606]; Special Fund for Agro-scientific Research in the Public Interest, China [201303037]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest, China	This work was supported by the National Natural Science Foundation of China (grant no. 31360606) and the Special Fund for Agro-scientific Research in the Public Interest, China (grant no. 201303037). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bosch F, 2016, INT J PARASITOL-PAR, V5, P192, DOI 10.1016/j.ijppaw.2016.06.001; CHAUHAN PPS, 1978, J HELMINTHOL, V52, P343, DOI 10.1017/S0022149X00005605; CHEEMA AH, 1984, J HELMINTHOL, V58, P279, DOI 10.1017/S0022149X0002513X; Colella V, 2018, TRANSBOUND EMERG DIS, V65, P1107, DOI 10.1111/tbed.12842; Crosskey R.W., 1982, Fauna of Saudi Arabia, V4, P398; Determann A, 1997, PARASITOL RES, V83, P591, DOI 10.1007/s004360050303; EBERHARD ML, 1979, J PARASITOL, V65, P379, DOI 10.2307/3280279; El-Massry AA, 2000, VET PARASITOL, V88, P305, DOI 10.1016/S0304-4017(99)00203-4; GHANDOUR AM, 1991, VET PARASITOL, V39, P67, DOI 10.1016/0304-4017(91)90063-2; Henry A., 1933, Bulletin Acad Veter France, V6, P208; Hidalgo MR, 2015, J HELMINTHOL, V89, P326, DOI 10.1017/S0022149X1400011X; HOLDSWORTH PA, 1985, AUST VET J, V62, P26, DOI 10.1111/j.1751-0813.1985.tb06038.x; HOLDSWORTH PA, 1987, INT J PARASITOL, V17, P957, DOI 10.1016/0020-7519(87)90015-4; HUSSEIN HS, 1988, VET RES COMMUN, V12, P475, DOI 10.1007/BF01075477; Ishizawa H, 2015, PATHOL INT, V65, P271, DOI 10.1111/pin.12256; Khodakaram-Tafti A, 2010, J CAMEL PRACT RES, V17, P37; Krueger A, 2007, ACTA TROP, V101, P1, DOI 10.1016/j.actatropica.2006.11.004; Li GD, 2008, J CAMEL PRACT RES, V15, P211; Makepeace BL, 2016, TRENDS PARASITOL, V32, P966, DOI 10.1016/j.pt.2016.08.013; Marques SMT, 2004, TROP ANIM HEALTH PRO, V36, P633, DOI 10.1023/B:TROP.0000042863.83233.78; Mather Cheryl, 2012, Cardiovasc Pathol, V21, pe35, DOI 10.1016/j.carpath.2011.07.004; Moghaddar N, 2006, J CAMEL PRACT RES, V13, P31; Moya L, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004829; Muller R., 1979, SYMPOSIA OF THE BRITISH SOCIETY FOR PARASITOLOGY, V17, P175; Mutafchiev Y, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-309; NASHER AK, 1986, ANN PARASIT HUM COMP, V61, P77, DOI 10.1051/parasite/198661177; Upasna Sharma, 2012, International Journal of Animal and Veterinary Advances, V4, P284; Railliet A, 1910, CR SOC BIOL, V68, P248; Slama D, 2014, PARASITOL RES, V113, P2435, DOI 10.1007/s00436-014-3873-1; Takaoka H, 2012, MED VET ENTOMOL, V26, P372, DOI 10.1111/j.1365-2915.2012.01023.x; Townson Simon, 2006, Filaria J, V5, P4, DOI 10.1186/1475-2883-5-4; Uni S, 2010, PARASITOL INT, V59, P477, DOI 10.1016/j.parint.2010.05.006; Verocai GG, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-242; Zubairova M. M., 2010, Parazitologiya (St. Petersburg), V44, P525	34	3	3	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0214477	10.1371/journal.pone.0214477	http://dx.doi.org/10.1371/journal.pone.0214477			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR7EH	30946756	Green Published, gold, Green Submitted			2022-12-26	WOS:000463314500034
J	Frolov, AO; Malysheva, MN; Ganyukova, AI; Spodareva, VV; Yurchenko, V; Kostygov, AY				Frolov, Alexander O.; Malysheva, Marina N.; Ganyukova, Anna I.; Spodareva, Viktoria V.; Yurchenko, Vyacheslav; Kostygov, Alexei Y.			Development of Phytomonas lipae sp. n. (Kinetoplastea: Trypanosomatidae) in the true bug Coreus marginatus (Heteroptera: Coreidae) and insights into the evolution of life cycles in the genus Phytomonas	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; SALIVARY-GLANDS; PARASITES; DIVERSITY; HISTORY; PLANTS; PHYLOGENY; HEMIPTERA; INSECTS; SERPENS	Here we described a new trypanosomatid species, Phytomonas lipae, parasitizing the dock bug Coreus marginatus based on axenic culture and in vivo material. Using light and electron microscopy we characterized the development of this flagellate in the intestine, hemolymph and salivary glands of its insect host. The intestinal promastigotes of Phytomonas lipae do not divide and occur only in the anterior part of the midgut. From there they pass into hemolymph, increasing in size, and then to salivary glands, where they actively proliferate without attachment to the host's epithelium and form infective endomastigotes. We conducted molecular phylogenetic analyses based on 18s rRNA, gGAPDH and HSP83 gene sequences, of which the third marker performed the best in terms of resolving phylogenetic relationships within the genus Phytomonas. Our inference demonstrated rather early origin of the lineage comprising the new species, right after that of P. oxycareni, which represents the earliest known branch within the Phytomonas Glade. This allowed us to compare the development of P. lipae and three other Phytomonas spp. in their insect hosts and reconstruct the vectorial part of the life cycle of their common ancestor.	[Frolov, Alexander O.; Malysheva, Marina N.; Ganyukova, Anna I.; Spodareva, Viktoria V.; Kostygov, Alexei Y.] Russian Acad Sci, Zool Inst, St Petersburg, Russia; [Spodareva, Viktoria V.; Yurchenko, Vyacheslav; Kostygov, Alexei Y.] Univ Ostrava, Fac Sci, Life Sci Res Ctr, Ostrava, Czech Republic; [Yurchenko, Vyacheslav] Sechenov Univ, Martsinovsky Inst Med Parasitol Trop & Vector Bor, Moscow, Russia; [Yurchenko, Vyacheslav] Univ Ostrava, Fac Sci, Inst Environm Technol, Ostrava, Czech Republic	Russian Academy of Sciences; Zoological Institute of the Russian Academy of Sciences; University of Ostrava; Sechenov First Moscow State Medical University; University of Ostrava	Kostygov, AY (corresponding author), Russian Acad Sci, Zool Inst, St Petersburg, Russia.; Kostygov, AY (corresponding author), Univ Ostrava, Fac Sci, Life Sci Res Ctr, Ostrava, Czech Republic.	kostygov@gmail.com	Kostygov, Alexei Y/D-3931-2015; Frolov, Alexander/AAP-9475-2020; Yurchenko, Vyacheslav/E-4532-2013; Frolov, Alexander O./P-3414-2015	Kostygov, Alexei Y/0000-0002-1516-437X; Frolov, Alexander/0000-0003-1444-3104; Yurchenko, Vyacheslav/0000-0003-4765-3263; 	Russian Science Foundation [18-14-00134]; European Regional Funds [16_019/0000759]; project "Pristroje IET" [CZ.1.05/2.1.00/19.0388]; University of Ostrava	Russian Science Foundation(Russian Science Foundation (RSF)); European Regional Funds; project "Pristroje IET"; University of Ostrava	This work was supported by the Russian Science Foundation (http://rscf.ru/en/) grant 18-14-00134 to AOF, MNM, AIG, and AYK; European Regional Funds (https://ec.europa.eu/regional_policy/en/funding/erdf/) grant 16_019/0000759 to VY; the project "Pristroje IET" (http://www.ietech.eu/index.php/iet-1) grant CZ.1.05/2.1.00/19.0388 to VY; and a grant from the University of Ostrava (http://www.osu.cz) to VVS and VY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhoundi M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004349; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Butler CE, 2017, GENOME ANNOUNCEMENTS, V5, DOI [10.1128/genomeA.01266-16, 10.1128/genomea.01266-16]; Camargo EP, 1999, ADV PARASIT, V42, P29, DOI 10.1016/S0065-308X(08)60148-7; CAMARGO EP, 1990, PARASITOL TODAY, V6, P22, DOI 10.1016/0169-4758(90)90388-K; Camargo EP, 1994, ADV DISEASE VECTOR R, P333; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chistyakova LV, 2014, PARASITOL RES, V113, P4207, DOI 10.1007/s00436-014-4096-1; Dollet M, 2000, J EUKARYOT MICROBIOL, V47, P569, DOI 10.1111/j.1550-7408.2000.tb00091.x; DOLLET M, 1984, ANNU REV PHYTOPATHOL, V22, P115, DOI 10.1146/annurev.py.22.090184.000555; Dollet M, 2012, INFECT GENET EVOL, V12, P299, DOI 10.1016/j.meegid.2011.11.010; Donovan C, 1909, LANCET, V2, P1495; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FREYMULLER E, 1990, J PROTOZOOL, V37, P225, DOI 10.1111/j.1550-7408.1990.tb01132.x; Frolov A. O., 2015, Parazitologiya (St. Petersburg), V49, P233; Frolov A.O., 1995, Tsitologiya, V37, P539; Frolov A. O., 1993, Parazitologiya (St. Petersburg), V27, P227; Frolov AO, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204467; Frolov AO, 2017, EUR J PROTISTOL, V57, P85, DOI 10.1016/j.ejop.2016.10.007; Frolov AO, 2016, EUR J PROTISTOL, V52, P1, DOI 10.1016/j.ejop.2015.08.002; Gerasimov ES, 2012, EUR J PROTISTOL, V48, P185, DOI 10.1016/j.ejop.2011.09.002; HECKER H, 1990, PARASITOL RES, V76, P311, DOI 10.1007/BF00928185; Hoare C.A., 1972, P1; Hollar L, 1997, MOL BIOCHEM PARASIT, V89, P295, DOI 10.1016/S0166-6851(97)00117-5; Hruskova M, 2005, ACTA OECOL, V28, P281, DOI 10.1016/j.actao.2005.05.004; JANKEVICIUS JV, 1989, J PROTOZOOL, V36, P265, DOI 10.1111/j.1550-7408.1989.tb05361.x; Jaskowska E, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004484; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kment Petr, 2006, Klapalekiana, V42, P97; Koreny L, 2012, P NATL ACAD SCI USA, V109, P3808, DOI 10.1073/pnas.1201089109; Kostygov AY, 2016, MBIO, V7, DOI 10.1128/mBio.01985-15; Kostygov AY, 2014, PROTIST, V165, P594, DOI 10.1016/j.protis.2014.07.001; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lafont A., 1909, Compte Rendu de la Societe de Biologie Paris, V66; Lafont A, 1911, CR SOC BIOL, V70, P58; LIPA JERZY J., 1966, ACTA PROTOZOOL, V4, P19; Lukes J, 2018, TRENDS PARASITOL, V34, P466, DOI 10.1016/j.pt.2018.03.002; Maslov DA, 1996, MOL BIOCHEM PARASIT, V75, P197, DOI 10.1016/0166-6851(95)02526-X; Maslov DA, 2019, PARASITOLOGY; Maslov DA, 2013, TRENDS PARASITOL, V29, P43, DOI 10.1016/j.pt.2012.11.001; Maslov DA, 2010, J EUKARYOT MICROBIOL, V57, P177, DOI 10.1111/j.1550-7408.2009.00464.x; Nedved O, 2014, ACTA ZOOL BULGAR, V66, P203; Nguyen Lam-Tung, 2015, Mol Biol Evol, V32, P268, DOI 10.1093/molbev/msu300; PODLIPAEV SA, 1987, PARAZITOLOGIYA+, V21, P545; Podlipaev SA, 1990, CATALOGUE WORLD FAUN; Porcel BM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004007; SCHAUB GA, 1994, PARASITOL TODAY, V10, P463, DOI 10.1016/0169-4758(94)90155-4; Serrano MG, 1999, EXP PARASITOL, V91, P268, DOI 10.1006/expr.1998.4379; Seward EA, 2017, PROTIST, V168, P71, DOI 10.1016/j.protis.2016.11.002; Simpson AGB, 2002, MOL BIOL EVOL, V19, P2071, DOI 10.1093/oxfordjournals.molbev.a004032; Spodareva VV, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-3023-1; Stevens J R, 1999, Cad Saude Publica, V15, P673, DOI 10.1590/S0102-311X1999000400002; STURM NR, 1995, FEMS MICROBIOL LETT, V130, P177, DOI 10.1111/j.1574-6968.1995.tb07716.x; Tyc J, 2013, MOL PHYLOGENET EVOL, V69, P255, DOI 10.1016/j.ympev.2013.05.024; Votypka J, 2015, TRENDS PARASITOL, V31, P460, DOI 10.1016/j.pt.2015.06.015; Votypka J, 2014, PROTIST, V165, P825, DOI 10.1016/j.protis.2014.09.002; WALLACE FG, 1966, EXP PARASITOL, V18, P124, DOI 10.1016/0014-4894(66)90015-4; Yurchenko V, 2016, J EUKARYOT MICROBIOL, V63, P198, DOI 10.1111/jeu.12268; Zanetti A, 2016, EUR J PROTISTOL, V56, P232, DOI 10.1016/j.ejop.2016.09.004	60	11	13	4	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0214484	10.1371/journal.pone.0214484	http://dx.doi.org/10.1371/journal.pone.0214484			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR5NS	30943229	Green Published, gold, Green Submitted			2022-12-26	WOS:000463194300041
J	Willson, NL; Van, TTH; Bhattarai, SP; Courtice, JM; McIntyre, JR; Prasai, TP; Moore, RJ; Walsh, K; Stanley, D				Willson, Nicky-Lee; Van, Thi T. H.; Bhattarai, Surya P.; Courtice, Jodi M.; McIntyre, Joshua R.; Prasai, Tanka P.; Moore, Robert J.; Walsh, Kerry; Stanley, Dragana			Feed supplementation with biochar may reduce poultry pathogens, including Campylobacter hepaticus, the causative agent of Spotty Liver Disease	PLOS ONE			English	Article							GASTROINTESTINAL-TRACT; GROWTH PROMOTERS; CHARCOAL; CHICKENS; DATABASE; SEARCH; UPDATE	Increased global regulation and restrictions on the non-therapeutic use of antibiotics in the poultry industry means that there is a need to identify alternatives that prevent infection while still conveying the growth and performance benefits afforded by their use. Biochars are produced by the incomplete pyrolysis of organic materials, with reports of use as a feed supplement and activity against pathogenic bacteria. In the current study the dose-dependent effects of biochar dietary inclusion in layer diets at 1%, 2% and 4% w/w were investigated to determine a) the efficacy of biochar as an anti-pathogenic additive on the intestinal microbiota and b) the optimal inclusion level. Biochar inclusion for anti-pathogenic effects was found to be most beneficial at 2% w/w. Poultry pathogens such as Gallibacterium anatis and campylobacters, including Campylobacter hepaticus, were found to be significantly lower in biochar fed birds. A shift in microbiota was also associated with the incorporation of 2% w/w biochar in the feed in two large scale trials on two commercial layer farms. Biochar inclusion for anti-pathogenic effects was found to be most beneficial at 2% w/w. Differential effects of the timing of biochar administration (supplementation beginning at hatch or at point of lay) were also evident, with greater impact on community microbial structure at 48 weeks of age when birds were fed from hatch rather than supplemented at point of lay.	[Willson, Nicky-Lee; Bhattarai, Surya P.; McIntyre, Joshua R.; Prasai, Tanka P.; Walsh, Kerry; Stanley, Dragana] Cent Queensland Univ, Inst Future Farming Syst, Rockhampton, Qld, Australia; [Willson, Nicky-Lee] Univ Adelaide, Sch Anim & Vet Sci, Roseworthy, SA, Australia; [Van, Thi T. H.; Moore, Robert J.] RMIT Univ, Sch Sci, Bundoora, Vic, Australia; [Courtice, Jodi M.] Univ Southern Queensland, Toowoomba, Qld, Australia; [Prasai, Tanka P.] Govt Nepal, Minist Agr Land Management & Cooperat, Dept Livestock Serv, Hariharbhawan, Lalitpur, Nepal	Central Queensland University; University of Adelaide; Royal Melbourne Institute of Technology (RMIT); University of Southern Queensland	Stanley, D (corresponding author), Cent Queensland Univ, Inst Future Farming Syst, Rockhampton, Qld, Australia.	D.Stanley@cqu.edu.au	Willson, Nicky-Lee/ABF-4475-2021; Stanley, Dragana/AAC-2596-2020; Moore, Robert J/D-8352-2011	Stanley, Dragana/0000-0001-7019-4726; Moore, Robert J/0000-0002-0776-5861; Willson, Nicky-Lee/0000-0002-3851-8548; McIntyre, Joshua/0000-0002-6443-5367; walsh, kerry/0000-0002-3033-8622; Van, Thi Thu Hao/0000-0002-1559-568X				Allos BM, 2001, CLIN INFECT DIS, V32, P1201, DOI 10.1086/319760; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ashelford KE, 2005, APPL ENVIRON MICROB, V71, P7724, DOI 10.1128/AEM.71.12.7724-7736.2005; Bar-Shira E, 2006, DEV COMP IMMUNOL, V30, P930, DOI 10.1016/j.dci.2005.12.002; Blake JP, 2014, J APPL POULTRY RES, V23, P101, DOI 10.3382/japr.2013-00838; Bottone EJ, 2010, CLIN MICROBIOL REV, V23, P382, DOI 10.1128/CMR.00073-09; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Castanon JIR, 2007, POULTRY SCI, V86, P2466, DOI 10.3382/ps.2007-00249; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fadrosh DW, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-6; Flint S, 2017, INT DAIRY J, V65, P38, DOI 10.1016/j.idairyj.2016.10.002; Food and Agriculture Organization (FAO), 2016, FAO ACT PLAN ANT RES; Foster JA, 2017, NEUROBIOL STRESS, V7, P124, DOI 10.1016/j.ynstr.2017.03.001; Gerlach H., 2012, ITHAKA J, V2012, P262; Hagemann N, 2018, WATER-SUI, V10, DOI 10.3390/w10020182; Huyghebaert G, 2011, VET J, V187, P182, DOI 10.1016/j.tvjl.2010.03.003; Jiya E. Z., 2013, British Journal of Applied Science & Technology, V3, P268; Kana JR, 2011, TROP ANIM HEALTH PRO, V43, P51, DOI 10.1007/s11250-010-9653-8; Kutlu HR, 2001, ANIM FEED SCI TECH, V90, P213, DOI 10.1016/S0377-8401(01)00205-X; Lehman J., 2015, BIOCHAR ENV MANAGEME; Lehmann J., 2009, SCI TECHNOL HUM VAL, DOI 10.4324/9781849770552; Oakley BB, 2014, FEMS MICROBIOL LETT, V360, P100, DOI 10.1111/1574-6968.12608; Prasai TP, 2018, ANIM PROD SCI, V58, P1632, DOI [10.1071/AN16290, 10.1071/an16290]; Prasai TP, 2017, MICROBIOL RES, V195, P24, DOI 10.1016/j.micres.2016.11.006; Prasai TP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154061; Schokker D, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1646-6; Shin NR, 2015, TRENDS BIOTECHNOL, V33, P496, DOI 10.1016/j.tibtech.2015.06.011; Singh S. V., 2016, Journal of Veterinary Science and Technology, V7, P324; Stanley D, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0388-6; Stanley D, 2014, APPL MICROBIOL BIOT, V98, P4301, DOI 10.1007/s00253-014-5646-2; Van TTH, 2017, VET MICROBIOL, V207, P226, DOI 10.1016/j.vetmic.2017.06.022; Van TTH, 2016, INT J SYST EVOL MICR, V66, P4518, DOI 10.1099/ijsem.0.001383; Toth JD, 2016, SSSA SPEC PUBL, V63, P199, DOI 10.2136/sssaspecpub63.2014.0043.5; Van Boeckel TP, 2015, P NATL ACAD SCI USA, V112, P5649, DOI 10.1073/pnas.1503141112; Vartoukian SR, 2007, ANAEROBE, V13, P99, DOI 10.1016/j.anaerobe.2007.05.004; Watarai S, 2005, POULTRY SCI, V84, P515, DOI 10.1093/ps/84.4.515; WHO, 2015, GLOB ACT PLAN ANT RE, DOI DOI 10.1128/MICROBE.10.354.1; Woolf D, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1053; Zakrzewski M, 2017, BIOINFORMATICS, V33, P782, DOI 10.1093/bioinformatics/btw725	40	9	9	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0214471	10.1371/journal.pone.0214471	http://dx.doi.org/10.1371/journal.pone.0214471			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR5NS	30943226	Green Submitted, Green Published, gold			2022-12-26	WOS:000463194300040
J	Zandi, S; Pfister, IB; Traine, PG; Tappeiner, C; Despont, A; Rieben, R; Skowronska, M; Garweg, JG				Zandi, Souska; Pfister, Isabel B.; Traine, Peter G.; Tappeiner, Christoph; Despont, Alain; Rieben, Robert; Skowronska, Magdalena; Garweg, Justus G.			Biomarkers for PVR in rhegmatogenous retinal detachment	PLOS ONE			English	Article							PROLIFERATIVE VITREORETINOPATHY; EPIRETINAL MEMBRANES; SUBRETINAL FLUID; VITREOUS-HUMOR; TGF-BETA; CYTOKINES; CHEMOKINES; INTERLEUKIN-6; ASSOCIATION; EXPRESSION	Purpose Various profibrotic and proinflammatory cytokines have been found upregulated in uncomplicated primary retinal detachment (pRD), but without providing a uniform picture. Here, we compare the cyto- and chemokine profiles in pRD with and without proliferative vitreoretinopathy (PVR) in an attempt to unravel relevant differences not in single cytokines, but in the cytokine profiles at diagnosis. Methods Undiluted vitreous fluid (VF) was obtained at the beginning of surgery from 174 eyes with pRD without relevant PVR (maximally grade B; group 1; n = 81) and with moderate or advanced PVR requiring a gas tamponade (group 2; n = 49) or silicon oil filling (group 3; n = 44). VF of eyes undergoing macular hole (MH) surgery served as controls (group 4; n = 26). Forty-three cytokines were quantified in parallel using a multiplex cytokine analysis system (Bioplex). For all comparisons we applied Holm's correction to control for multiple comparisons. Results 44.9% of group 2 eyes presented grade C1 and 55.1% C2-C3, whereas 86.4% of group 3 eyes exhibited a PVR grade of C2-D. CCL19 was the only cytokine that displayed higher concentrations in the vitreous of eyes with PVR C1 compared to lower PVR grades. Eyes with PVR C2-D showed higher levels of CCL27, CXCL6, IL4, IL16, CXCL10, CCL8, CCL22, MIG/CXCL9, CCL15, CCL19, CCL 23 and CXCL12 compared to controls. Interestingly, no difference of cytokine levels was detected between C1 and C2-D PVR. Conclusions CCL19 may represent a potential biomarker for early PVR progression that holds promise for future diagnostic and therapeutic applications.	[Zandi, Souska; Pfister, Isabel B.; Traine, Peter G.; Skowronska, Magdalena; Garweg, Justus G.] Berner Augenklin Lindenhof Spital, Swiss Eye Inst, Bern, Switzerland; [Zandi, Souska; Pfister, Isabel B.; Traine, Peter G.; Skowronska, Magdalena; Garweg, Justus G.] Berner Augenklin Lindenhof Spital, Clin Vitreoretinal Dis, Bern, Switzerland; [Tappeiner, Christoph] Univ Bern, Bern Univ Hosp, Inselspital, Dept Ophthalmol, Bern, Switzerland; [Despont, Alain; Rieben, Robert] Univ Bern, Dept Biomed Res, Bern, Switzerland; [Garweg, Justus G.] Univ Bern, Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University of Bern	Garweg, JG (corresponding author), Berner Augenklin Lindenhof Spital, Swiss Eye Inst, Bern, Switzerland.; Garweg, JG (corresponding author), Berner Augenklin Lindenhof Spital, Clin Vitreoretinal Dis, Bern, Switzerland.; Garweg, JG (corresponding author), Univ Bern, Bern, Switzerland.	garweg@swiss-eye-institute.com	; Rieben, Robert/D-7044-2017	Zandi, Souska/0000-0001-9351-4278; Skowronska, Magdalena/0000-0002-5902-5486; Rieben, Robert/0000-0003-4179-8891	Lindenhof foundation	Lindenhof foundation	Independent unconditional funding was received from the research funds of the Lindenhof foundation for the project covering 30% of the laboratory kits, but these were not personal donations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Abe R, 2001, J IMMUNOL, V166, P7556, DOI 10.4049/jimmunol.166.12.7556; AHMED SA, 1985, AM J PATHOL, V121, P531; Asaria Riaz H Y, 2006, Compr Ophthalmol Update, V7, P179; Banerjee S, 2007, INVEST OPHTH VIS SCI, V48, P2203, DOI 10.1167/iovs.06-1358; Bu SC, 2015, INVEST OPHTH VIS SCI, V56, P6506, DOI 10.1167/iovs.14-15971; Candore G, 2010, REJUV RES, V13, P292, DOI 10.1089/rej.2009.0942; Pastor JC, 2016, PROG RETIN EYE RES, V51, P125, DOI 10.1016/j.preteyeres.2015.07.005; Ciprian Danielescu, 2015, Rom J Ophthalmol, V59, P88; Danielescu C, 2016, MED-SURG J, V120, P124; El-Ghrably IA, 2001, BRIT J OPHTHALMOL, V85, P461, DOI 10.1136/bjo.85.4.461; Gagliano C, 2015, CURR PHARM DESIGN, V21, P4698, DOI 10.2174/1381612821666150909100212; Garweg JG, 2019, ACTA OPHTHALMOL, V97, pE580, DOI 10.1111/aos.13998; Garweg JG, 2017, GRAEF ARCH CLIN EXP, V255, P1763, DOI 10.1007/s00417-017-3724-8; Garweg JG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182571; Garweg JG, 2013, SURV OPHTHALMOL, V58, P321, DOI 10.1016/j.survophthal.2012.12.004; HILTON G, 1983, OPHTHALMOLOGY, V90, P121, DOI 10.1016/s0161-6420(83)34588-7; Hollborn M, 2008, INVEST OPHTH VIS SCI, V49, P1262, DOI 10.1167/iovs.07-0879; Holm S., 1979, SCANDINAVIAN J STAT; KAUFFMANN DJH, 1994, INVEST OPHTH VIS SCI, V35, P900; Kiang L, 2018, INVEST OPHTH VIS SCI, V59, P3767, DOI 10.1167/iovs.18-24489; Kunikata H, 2013, AM J OPHTHALMOL, V155, P1028, DOI 10.1016/j.ajo.2013.01.013; Kwon OW, 2016, DEV OPHTHALMOL, V55, P154, DOI 10.1159/000438972; Lehmann EL, 2005, ANN STAT, V33, P1138, DOI 10.1214/009053605000000084; Lei HT, 2010, EXP EYE RES, V90, P376, DOI 10.1016/j.exer.2009.11.003; Marsland BJ, 2005, IMMUNITY, V22, P493, DOI 10.1016/j.immuni.2005.02.010; McGrory K, 2004, BIOCHEM BIOPH RES CO, V324, P317, DOI 10.1016/j.bbrc.2004.09.056; Nakazawa T, 2007, P NATL ACAD SCI USA, V104, P2425, DOI 10.1073/pnas.0608167104; Pastor JC, 2002, PROG RETIN EYE RES, V21, P127, DOI 10.1016/S1350-9462(01)00023-4; Patel VP, 1997, J EXP MED, V185, P1163, DOI 10.1084/jem.185.7.1163; Pennock S, 2011, AM J PATHOL, V179, P2931, DOI 10.1016/j.ajpath.2011.08.043; Rasier R, 2010, CURR EYE RES, V35, P505, DOI 10.3109/02713681003597248; Rea IM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00586; Ricker LJAG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019141; Ricker LJAG, 2010, INVEST OPHTH VIS SCI, V51, P4143, DOI 10.1167/iovs.09-5057; Roldan-Pallares M, 2008, J FR OPHTALMOL, V31, P36, DOI 10.1016/S0181-5512(08)70328-0; Roubenoff R, 1998, J GERONTOL A-BIOL, V53, pM20, DOI 10.1093/gerona/53A.1.M20; Sadaka A, 2012, CLIN OPHTHALMOL, V6, P1325, DOI 10.2147/OPTH.S27896; Symeonidis C, 2012, CYTOKINE, V59, P184, DOI 10.1016/j.cyto.2012.04.019; Takahashi S, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/4256183; Takeuchi M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137358; van Beek AA, 2019, TRENDS IMMUNOL, V40, P113, DOI 10.1016/j.it.2018.12.007; Ventura Maria Teresa, 2017, Clin Mol Allergy, V15, P21, DOI 10.1186/s12948-017-0077-0; Yoshida S, 2017, CLIN OPHTHALMOL, V11, P1697, DOI 10.2147/OPTH.S141821; Yoshimura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008158; Zaja-Milatovic S, 2008, HISTOL HISTOPATHOL, V23, P1399, DOI 10.14670/HH-23.1399; Zandi S, 2016, INVEST OPHTH VIS SCI, V57, P6320, DOI 10.1167/iovs.16-20657; Zhao QQ, 2018, MOL MED REP, V17, P7301, DOI 10.3892/mmr.2018.8787; Zhuang H, 2014, GRAEF ARCH CLIN EXP, V252, P1763, DOI 10.1007/s00417-014-2768-2	48	18	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0214674	10.1371/journal.pone.0214674	http://dx.doi.org/10.1371/journal.pone.0214674			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR5NS	30943234	Green Published, Green Submitted, gold			2022-12-26	WOS:000463194300050
J	Sabino-Pinto, J; Martel, A; Pasmans, F; Steinfartz, S; Vences, M				Sabino-Pinto, Joana; Martel, An; Pasmans, Frank; Steinfartz, Sebastian; Vences, Miguel			Pooling skin swabs does not inhibit qPCR detection of amphibian chytrid infection	PLOS ONE			English	Article							BATRACHOCHYTRIUM-SALAMANDRIVORANS; SP-NOV; DENDROBATIDIS; FUNGUS	Immediate and reliable pathogen detection in large numbers of samples is essential in wildlife disease monitoring and is often realized by DNA-based techniques. Pooling samples increases processing efficiency and reduces processing costs, and has been suggested as a viable technique for quantitative PCR detection of fungal amphibian pathogens of the genus Batrachochytrium. For these fungi, this diagnostic method has been validated by in vitro set ups that provided controlled test conditions but did not take into account potential effects from amphibian skin compounds (e.g. skin secretions and Microbiota) on the approach. Some of these skin compounds are known to cause PCR inhibition in single sample applications and could lead to false negative reactions and thereby hamper pathogen detection. In this study we examined the effect of skin compounds on the pooled extraction method by swabbing individuals of seven amphibian species (one Anura and six Caudata) prior to the inoculation of the swabs with chytrid zoospores. For each species, swabs were extracted in pools of different sizes (from one to four swabs) with only one swab per pool being inoculated with zoospores. There were no significant differences regarding the ability to detect zoospores when comparing pool sizes for any species, with a tendency for more false negatives when the inoculated swab had been inoculated with a single zoospore. This study provides further in vivo evidence for the viability of the pooled extraction method for DNA-based detection of pathogens.	[Sabino-Pinto, Joana; Steinfartz, Sebastian; Vences, Miguel] Braunschweig Univ Technol, Inst Zool, Braunschweig, Germany; [Martel, An; Pasmans, Frank] Univ Ghent, Dept Pathol Bacteriol & Avian Dis, Fac Vet Med, Merelbeke, Belgium; [Steinfartz, Sebastian] Univ Leipzig, Inst Biol Mol Evolut & Systemat Anim, Leipzig, Germany	Braunschweig University of Technology; Ghent University; Leipzig University	Sabino-Pinto, J (corresponding author), Braunschweig Univ Technol, Inst Zool, Braunschweig, Germany.	joanasabinopinto@gmail.com	Pasmans, Frank/D-3667-2014	Steinfartz, Sebastian/0000-0001-5347-3969; Sabino Pinto, Joana/0000-0002-4737-5665; Vences, Miguel/0000-0003-0747-0817	Deutsche Bundesstiftung Umwelt [Aktenzeichen 32635/01-33/2]; Ghent University [BOF16/GOA/024]	Deutsche Bundesstiftung Umwelt; Ghent University(Ghent University)	This study has been partially funded through a grant of the Deutsche Bundesstiftung Umwelt to MV, DBU (Aktenzeichen 32635/01-33/2) and partially through Ghent University to FP (BOF16/GOA/024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Belden LK, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01171; Bessetti J., 2007, PROFILES DNA, V10, P9, DOI [DOI 10.1161/STROKEAHA.109.559013, DOI 10.1161/STR0KEAHA.109.559013]; Blooi M, 2013, J CLIN MICROBIOL, V51, P4173, DOI 10.1128/JCM.02313-13; Dalbeck L, 2018, Z FELDHERPETOL, V25, P1; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Engering A, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.5; Farrer RA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003703; Fox J., 2019, R COMPANION APPL REG, V.; Gordon MA, 2010, CLIN INFECT DIS, V50, P953, DOI 10.1086/651080; Hyatt AD, 2007, DIS AQUAT ORGAN, V73, P175, DOI 10.3354/dao073175; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Lederberg J, 2001, EM INF DIS GLOB LOC, DOI [10.3354/DAO073175, DOI 10.3354/DAO073175]; Longcore JE, 1999, MYCOLOGIA, V91, P219, DOI 10.2307/3761366; Longo AV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059499; Martel A, 2014, SCIENCE, V346, P630, DOI 10.1126/science.1258268; Martel A, 2013, P NATL ACAD SCI USA, V110, P15325, DOI 10.1073/pnas.1307356110; Refsnider JM, 2015, G3-GENES GENOM GENET, V5, P2291, DOI 10.1534/g3.115.021808; Sabino-Pinto J, 2019, AMPHIBIA-REPTILIA, V40, P29, DOI 10.1163/15685381-20181011; Spitzen-van der Sluijs A, 2016, EMERG INFECT DIS, V22, P1286, DOI 10.3201/eid2207.160109; Stegen G, 2017, NATURE, V544, P353, DOI 10.1038/nature22059; Wake DB, 2008, P NATL ACAD SCI USA, V105, P11466, DOI 10.1073/pnas.0801921105; Webster RG, 1998, EMERG INFECT DIS, V4, P436, DOI 10.3201/eid0403.980325; Woolhouse MEJ, 2002, TRENDS MICROBIOL, V10, pS3, DOI 10.1016/S0966-842X(02)02428-9	24	1	1	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2019	14	4							e0214405	10.1371/journal.pone.0214405	http://dx.doi.org/10.1371/journal.pone.0214405			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR2UW	30939146	Green Published, Green Submitted, gold			2022-12-26	WOS:000462993900020
J	Yang, SK; Yusoff, K; Ajat, M; Thomas, W; Abushelaibi, A; Akseer, R; Lim, SHE; Lai, KS				Yang, Shun-Kai; Yusoff, Khatijah; Ajat, Mokrish; Thomas, Warren; Abushelaibi, Aisha; Akseer, Riaz; Lim, Swee-Hua Erin; Lai, Kok-Song			Disruption of KPC-producing Klebsiella pneumoniae membrane via induction of oxidative stress by cinnamon bark (Cinnamomum verum J. Presl) essential oil	PLOS ONE			English	Article							L. ESSENTIAL OIL; ESCHERICHIA-COLI; MECHANOSENSITIVE CHANNEL; ACID SYNTHESIS; MECHANISM; LIPOPOLYSACCHARIDE; ANTIOXIDANT; RESISTANCE; INHIBITION; INSIGHTS	Klebsiella pneumoniae (KP) remains the most prevalent nosocomial pathogen and carries the carbapenemase (KPC) gene which confers resistance towards carbapenem. Thus, it is necessary to discover novel antimicrobials to address the issue of antimicrobial resistance in such pathogens. Natural products such as essential oils are a promising source due to their complex composition. Essential oils have been shown to be effective against pathogens, but the overall mechanisms have yet to be fully explained. Understanding the molecular mechanisms of essential oil towards KPC-KP cells would provide a deeper understanding of their potential use in clinical settings. Therefore, we aimed to investigate the mode of action of essential oil against KPC-KP cells from a proteomic perspective by comparing the overall proteome profile of KPC-KP cells treated with cinnamon bark (Cinnamomum verum J. Presl) essential oil (CBO) at their sub-inhibitory concentration of 0.08% (v/v). A total of 384 proteins were successfully identified from the non-treated cells, whereas only 242 proteins were identified from the CBO-treated cells. Proteins were then categorized based on their biological processes, cellular components and molecular function prior to pathway analysis. Pathway analysis showed that CBO induced oxidative stress in the KPC-KP cells as indicated by the abundance of oxidative stress regulator proteins such as glycyl radical cofactor, catalase peroxidase and DNA mismatch repair protein. Oxidative stress is likely to oxidize and disrupt the bacterial membrane as shown by the loss of major membrane proteins. Several genes selected for qRT-PCR analysis validated the proteomic profile and were congruent with the proteomic abundance profiles. In conclusion, KPC-KP cells exposed to CBO undergo oxidative stress that eventually disrupts the bacterial membrane possibly via interaction with the phospholipid bilayer. Interestingly, several pathways involved in the bacterial membrane repair system were also affected by oxidative stress, contributing to the loss of cells viability.	[Yang, Shun-Kai; Lai, Kok-Song] Univ Putra Malaysia, Dept Cell & Mol Biol, Fac Biotechnol & Biomol Sci, Serdang, Selangor, Malaysia; [Yusoff, Khatijah] Univ Putra Malaysia, Dept Microbiol, Fac Biotechnol & Biomol Sci, Serdang, Selangor, Malaysia; [Ajat, Mokrish] Univ Putra Malaysia, Dept Vet Preclin Sci, Fac Vet Med, Serdang, Selangor, Malaysia; [Thomas, Warren; Lim, Swee-Hua Erin] Perdana Univ, Perdana Univ Royal Coll Surg Ireland, Sch Med, Serdang, Selangor, Malaysia; [Abushelaibi, Aisha; Akseer, Riaz; Lim, Swee-Hua Erin] Higher Coll Technol, Div Hlth Sci, Abu Dhabi Womens Coll, Abu Dhabi, U Arab Emirates	Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia; Perdana University; Royal College of Surgeons - Ireland; Higher Colleges of Technology - United Arab Emirates	Lai, KS (corresponding author), Univ Putra Malaysia, Dept Cell & Mol Biol, Fac Biotechnol & Biomol Sci, Serdang, Selangor, Malaysia.	laikoksong@upm.edu.my	Thomas, Warren/A-5477-2010; Song, Lai Kok/ABA-2585-2020; Ajat, Mokrish/AAD-4086-2021; Lim, Erin/AAR-9060-2020; Abushelaibi, Aisha/ABA-9950-2021; Lai, Kok Song/AAR-8772-2020	Lim, Erin/0000-0001-5177-0257; Thomas, Warren/0000-0003-2706-1770; Ajat, Mokrish/0000-0002-2905-4630	UPM Internal Grant [GP-IPS/2016/9505800]; Malaysian Medical Association (MMA); Fundamental Research Grant Scheme [FRGS/1/2018/SKK11/PERDANA/02/1]	UPM Internal Grant; Malaysian Medical Association (MMA); Fundamental Research Grant Scheme	The research received funding UPM Internal Grant (GP-IPS/2016/9505800), Malaysian Medical Association (MMA), and Fundamental Research Grant Scheme (FRGS/1/2018/SKK11/PERDANA/02/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barb AW, 2008, CURR PHARM BIOTECHNO, V9, P9; Bezerra DP, 2017, NUTRIENTS, V9, DOI 10.3390/nu9121367; Birkner JP, 2012, P NATL ACAD SCI USA, V109, P12944, DOI 10.1073/pnas.1205270109; Blount P, 2007, CURR TOP MEMBR, V58, P201, DOI 10.1016/S1063-5823(06)58008-1; Breazeale SD, 2003, J BIOL CHEM, V278, P24731, DOI 10.1074/jbc.M304043200; Broussard TC, 2013, BIOCHEMISTRY-US, V52, P3346, DOI 10.1021/bi4000707; Bubols GB, 2013, MINI-REV MED CHEM, V13, P318; Bunner AE, 2010, J MOL BIOL, V398, P1, DOI 10.1016/j.jmb.2010.02.036; Carvalho RL, 2016, POSTHARVEST BIOL TEC, V113, P29, DOI 10.1016/j.postharvbio.2015.11.004; Ciftci O, 2011, TOXICOL IND HEALTH, V27, P447, DOI 10.1177/0748233710388452; Cosentino M, 2014, PHYTOTHER RES, V28, P1232, DOI 10.1002/ptr.5121; Cronan JE, 2009, METHOD ENZYMOL, V459, P395, DOI 10.1016/S0076-6879(09)04617-5; Dahham SS, 2015, MOLECULES, V20, P11808, DOI 10.3390/molecules200711808; de Souza EL, 2010, INT J FOOD MICROBIOL, V137, P308, DOI 10.1016/j.ijfoodmicro.2009.11.025; Durdu B, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-3580-8; Egan AJF, 2014, P NATL ACAD SCI USA, V111, P8197, DOI 10.1073/pnas.1400376111; Emiola A, 2016, P NATL ACAD SCI USA, V113, P3108, DOI 10.1073/pnas.1521168113; Gerding MA, 2007, MOL MICROBIOL, V63, P1008, DOI 10.1111/j.1365-2958.2006.05571.x; Itri Rosangela, 2014, Biophys Rev, V6, P47, DOI 10.1007/s12551-013-0128-9; Kaskatepe B, 2016, INDIAN J PHARM SCI, V78, P541, DOI 10.4172/pharmaceutical-sciences.1000150; Kawatani M, 2016, SCI REP-UK, V6, DOI 10.1038/srep38385; Kitchel B, 2009, ANTIMICROB AGENTS CH, V53, P3365, DOI 10.1128/AAC.00126-09; Lee CJ, 2014, ACS CHEM BIOL, V9, P237, DOI 10.1021/cb400067g; Lorenzi V, 2009, ANTIMICROB AGENTS CH, V53, P2209, DOI 10.1128/AAC.00919-08; Lovering AL, 2012, ANNU REV BIOCHEM, V81, P451, DOI 10.1146/annurev-biochem-061809-112742; Mimica-Dukic N, 2016, ACS SYM SER, V1218, P187; Moynie L, 2013, J MOL BIOL, V425, P365, DOI 10.1016/j.jmb.2012.11.017; Nord S, 2009, J MOL BIOL, V386, P742, DOI 10.1016/j.jmb.2008.12.076; Paterson DL, 2005, CLIN MICROBIOL REV, V18, P657, DOI 10.1128/CMR.18.4.657-686.2005; Pavan B, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00018; Rahal A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/761264; Rahman SU, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/9519718; Rhomberg PR, 2009, DIAGN MICR INFEC DIS, V65, P414, DOI 10.1016/j.diagmicrobio.2009.08.020; Rosenfeld Y, 2006, BBA-BIOMEMBRANES, V1758, P1513, DOI 10.1016/j.bbamem.2006.05.017; Shisler KA, 2014, ARCH BIOCHEM BIOPHYS, V546, P64, DOI 10.1016/j.abb.2014.01.020; Silhavy TJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000414; Silva F, 2011, J MED MICROBIOL, V60, P1479, DOI 10.1099/jmm.0.034157-0; Turgis M, 2009, FOOD CONTROL, V20, P1073, DOI 10.1016/j.foodcont.2009.02.001; Ukuku DO, 2008, J FOOD PROTECT, V71, P684, DOI 10.4315/0362-028X-71.4.684; Vogel C, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009217; Wagner AFV, 2001, BIOCHEM BIOPH RES CO, V285, P456, DOI 10.1006/bbrc.2001.5186; Wendel AA, 2009, BBA-MOL CELL BIOL L, V1791, P501, DOI 10.1016/j.bbalip.2008.10.010; Willi J, 2018, NUCLEIC ACIDS RES, V46, P1945, DOI 10.1093/nar/gkx1308; Wu YP, 2016, MOLECULES, V21, DOI 10.3390/molecules21081084; Xu H, 2015, J PROTEOME RES, V14, P2480, DOI 10.1021/acs.jproteome.5b00004; Yang SK, 2018, REC NAT PROD, V12, P295, DOI 10.25135/rnp.41.17.09.058; Yang SK, 2017, MOLECULES, V22, DOI 10.3390/molecules22111733; Yang SK, 2018, REC NAT PROD, V12, P13; Yao JW, 2013, BBA-MOL CELL BIOL L, V1831, P495, DOI 10.1016/j.bbalip.2012.08.018; Yap P.S.X., 2017, RECENT ADV PHYSL PAT; Yap PSX, 2015, J MICROBIOL BIOTECHN, V25, P1299, DOI 10.4014/jmb.1407.07054; Yap Polly Soo Xi, 2014, Open Microbiol J, V8, P6, DOI 10.2174/1874285801408010006; Yap PSX, 2013, PHYTOMEDICINE, V20, P710, DOI 10.1016/j.phymed.2013.02.013; Yigit H, 2001, ANTIMICROB AGENTS CH, V45, P1151, DOI 10.1128/AAC.45.4.1151-1161.2001; Yoo CB, 2005, CANCER LETT, V225, P41, DOI 10.1016/j.canlet.2004.11.018; Zainal-Abidin Z, 2013, OPEN C P J, V4, P5; Zhang G, 2013, CURR OPIN MICROBIOL, V16, P779, DOI 10.1016/j.mib.2013.09.007	57	34	35	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2019	14	4							e0214326	10.1371/journal.pone.0214326	http://dx.doi.org/10.1371/journal.pone.0214326			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR2UW	30939149	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000462993900018
J	Tsuiki, S; Sasaki, R; Miyaguchi, S; Kojima, S; Saito, K; Inukai, Y; Masaki, M; Otsuru, N; Onishi, H				Tsuiki, Shota; Sasaki, Ryoki; Miyaguchi, Shota; Kojima, Sho; Saito, Kei; Inukai, Yasuto; Masaki, Mitsuhiro; Otsuru, Naofumi; Onishi, Hideaki			The effect of combined transcranial direct current stimulation and peripheral nerve electrical stimulation on corticospinal excitability	PLOS ONE			English	Article							HUMAN MOTOR CORTEX; MAGNETIC STIMULATION; CORTICOMOTOR EXCITABILITY; MODULATION; PLASTICITY; DC; VARIABILITY; MECHANISMS; PARAMETERS; TASK	Transcranial direct current stimulation (tDCS) and peripheral nerve electrical stimulation (PES) can change corticospinal excitability. tDCS can be used to non-invasively modulate the cerebral cortex's excitability by applying weak current to an electrode attached to the head, and the effect varies with the electrode's polarity. Previous studies have reported the effect of combined tDCS and PES on corticospinal excitability; when compared to single stimulation, combined stimulation increases cortical excitability. In contrast, another study reported that the effect of tDCS is attenuated by PES; hence, there is no consensus opinion on the effect on combined stimulation. Therefore, this study aimed to clarify the effect of combined tDCS and PES on corticospinal excitability. In Experiment 1, the combined stimulation of anodal tDCS and PES (anodal tDCS + PES) was performed, and in Experiment 2, a combined stimulation with PES, after cathodal tDCS (PES after cathodal tDCS), was performed using a homeostatic metaplasticity theoretical model. In Experiment 1, anodal tDCS produced a significant increase from baseline in motor-evoked potential (MEP) amplitude 10 min after stimulation, but no significant changes in MEP amplitude were observed with PES or the anodal tDCS + PES condition. Experiment 2 showed a significant decrease in MEP amplitude immediately after cathodal tDCS, and a significant increase in MEP amplitude 15 min after PES, but no significant change in MEP amplitude was observed with sequential PES following cathodal tDCS. In conclusion, our data indicate that PES with anodal tDCS suppressed the effect of tDCS. Also, PES after cathodal tDCS did not induce homeostatic metaplasticity and increase corticospinal excitability.	[Tsuiki, Shota; Sasaki, Ryoki] Niigata Univ Hlth & Welf, Grad Sch, Niigata, Japan; [Tsuiki, Shota; Sasaki, Ryoki; Miyaguchi, Shota; Kojima, Sho; Saito, Kei; Inukai, Yasuto; Masaki, Mitsuhiro; Otsuru, Naofumi; Onishi, Hideaki] Niigata Univ Hlth & Welf, Inst Human Movement & Med Sci, Niigata, Japan; [Tsuiki, Shota] Tochigi Med Assoc, Rehabil Ctr, Shiobara Hot Spring Hosp, Nasushiobara, Tochigi, Japan	Niigata University; Niigata University	Tsuiki, S (corresponding author), Niigata Univ Hlth & Welf, Grad Sch, Niigata, Japan.; Tsuiki, S (corresponding author), Niigata Univ Hlth & Welf, Inst Human Movement & Med Sci, Niigata, Japan.; Tsuiki, S (corresponding author), Tochigi Med Assoc, Rehabil Ctr, Shiobara Hot Spring Hosp, Nasushiobara, Tochigi, Japan.	hpm16007@nuhw.ac.jp		Sasaki, Ryoki/0000-0003-2758-0722	Japan Society for the Promotion of Science [16H03207]; Niigata University of Health and Welfare [H29F02]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Niigata University of Health and Welfare	This work was supported by a Grant-in-Aid for Scientific Research (B) 16H03207 from the Japan Society for the Promotion of Science and a Grant-in-Aid for Scientific Research of Graduate Students of Niigata University of Health and Welfare (H29F02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews RK, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-51; Antal A, 2007, EUR J NEUROSCI, V26, P2687, DOI 10.1111/j.1460-9568.2007.05896.x; BARKER AT, 1985, LANCET, V1, P1106; Bastani A, 2013, BRAIN STIMUL, V6, P932, DOI 10.1016/j.brs.2013.04.005; BINDMAN LJ, 1964, J PHYSIOL-LONDON, V172, P369, DOI 10.1113/jphysiol.1964.sp007425; Celnik P, 2009, STROKE, V40, P1764, DOI 10.1161/STROKEAHA.108.540500; Chipchase LS, 2011, ARCH PHYS MED REHAB, V92, P1423, DOI 10.1016/j.apmr.2011.01.011; Gandiga PC, 2006, CLIN NEUROPHYSIOL, V117, P845, DOI 10.1016/j.clinph.2005.12.003; Hamdy S, 1998, NAT NEUROSCI, V1, P64, DOI 10.1038/264; Jeffery DT, 2007, EXP BRAIN RES, V182, P281, DOI 10.1007/s00221-007-1093-y; Kaelin-Lang A, 2002, J PHYSIOL-LONDON, V540, P623, DOI 10.1113/jphysiol.2001.012801; Kirimoto H, 2014, BRAIN STIMUL, V7, P836, DOI 10.1016/j.brs.2014.09.016; Kirimoto H, 2011, CLIN NEUROPHYSIOL, V122, P777, DOI 10.1016/j.clinph.2010.09.025; Lang N, 2004, BIOL PSYCHIAT, V56, P634, DOI 10.1016/j.biopsych.2004.07.017; Lefaucheur JP, 2009, NEUROPHYSIOL CLIN, V39, P1, DOI 10.1016/j.neucli.2008.11.001; Liebetanz D, 2002, BRAIN, V125, P2238, DOI 10.1093/brain/awf238; Lopez-Alonso V, 2014, BRAIN STIMUL, V7, P372, DOI 10.1016/j.brs.2014.02.004; Luft AR, 2002, EXP BRAIN RES, V142, P562, DOI 10.1007/s00221-001-0952-1; Miyaguchi S, 2013, BRAIN RES, V1529, P83, DOI 10.1016/j.brainres.2013.07.026; Monai H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11100; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Nitsche MA, 2003, J PHYSIOL-LONDON, V553, P293, DOI 10.1113/jphysiol.2003.049916; Nitsche MA, 2005, J PHYSIOL-LONDON, V568, P291, DOI 10.1113/jphysiol.2005.092429; Nitsche MA, 2007, J NEUROSCI, V27, P3807, DOI 10.1523/JNEUROSCI.5348-06.2007; Rizzo V, 2014, BRAIN STIMUL, V7, P113, DOI 10.1016/j.brs.2013.10.002; Rothwell JC, 1997, J NEUROSCI METH, V74, P113, DOI 10.1016/S0165-0270(97)02242-5; ROTHWELL JC, 1991, EXP PHYSIOL, V76, P159, DOI 10.1113/expphysiol.1991.sp003485; Sasaki R, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00146; Sasaki R, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00030; Schabrun SM, 2018, PAIN MED, V19, P608, DOI 10.1093/pm/pnx099; Schabrun SM, 2014, BRAIN STIMUL, V7, P451, DOI 10.1016/j.brs.2014.01.058; Schabrun SM, 2013, BRAIN STIMUL, V6, P624, DOI 10.1016/j.brs.2012.09.009; Schabrun SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051298; Siebner HR, 2010, CLIN NEUROPHYSIOL, V121, P461, DOI 10.1016/j.clinph.2009.12.009; Siebner HR, 2004, J NEUROSCI, V24, P3379, DOI 10.1523/JNEUROSCI.5316-03.2004; Stefan K, 2000, BRAIN, V123, P572, DOI 10.1093/brain/123.3.572; Uy J, 2003, J NEUROSCI METH, V127, P193, DOI 10.1016/S0165-0270(03)00142-0; Wiethoff S, 2014, BRAIN STIMUL, V7, P468, DOI 10.1016/j.brs.2014.02.003; Ziemann U, 2008, BRAIN STIMUL, V1, P60, DOI 10.1016/j.brs.2007.08.003	39	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2019	14	3							e0214592	10.1371/journal.pone.0214592	http://dx.doi.org/10.1371/journal.pone.0214592			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ9FO	30925178	Green Published, gold, Green Submitted			2022-12-26	WOS:000462732300023
J	Northcott, D; Sevadjian, J; Sancho-Gallegos, DA; Wahl, C; Friederich, J; Chavez, FP				Northcott, Devon; Sevadjian, Jeff; Sancho-Gallegos, Diego A.; Wahl, Chris; Friederich, Jules; Chavez, Francisco P.			Impacts of urban carbon dioxide emissions on sea-air flux and ocean acidification in nearshore waters	PLOS ONE			English	Article							BREEZE; EXCHANGE; PACIFIC; WIND	Greatly enhanced atmospheric carbon dioxide (CO2) levels relative to well-mixed marine air are observed during periods of offshore winds at coastal sensor platforms in Monterey Bay, California, USA. The highest concentrations originate from urban and agricultural areas, are driven by diurnal winds, and peak in the early morning. These enhanced atmospheric levels can be detected across a similar to 100km wide nearshore area and represent a significant addition to total oceanic CO2 uptake. A global estimate puts the added sea-air flux of CO2 from these greatly enhanced atmospheric CO2 levels at 25 million tonnes, roughly 1% of the ocean's annual CO2 uptake. The increased uptake over the 100 km coastal swath is of order 20%, indicating a potentially large impact on ocean acidification in productive coastal waters.	[Northcott, Devon; Sevadjian, Jeff; Sancho-Gallegos, Diego A.; Wahl, Chris; Friederich, Jules; Chavez, Francisco P.] Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA; [Sevadjian, Jeff] Scripps Inst Oceanog, La Jolla, CA USA; [Sancho-Gallegos, Diego A.] Stanford Univ, Stanford, CA 94305 USA	Monterey Bay Aquarium Research Institute; University of California System; University of California San Diego; Scripps Institution of Oceanography; Stanford University	Northcott, D; Chavez, FP (corresponding author), Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA.	dnorthcott@mbari.org; chfr@mbari.org		Wahl, Christopher/0000-0001-9675-068X; Sancho Gallegos, Diego/0000-0001-9446-1964	David and Lucile Packard Foundation; National Science Foundation [OCE-1041075, PLR-1602946]; National Science Foundation	David and Lucile Packard Foundation(The David & Lucile Packard Foundation); National Science Foundation(National Science Foundation (NSF)); National Science Foundation(National Science Foundation (NSF))	This research was supported by the David and Lucile Packard Foundation and the National Science Foundation (OCE-1041075, PLR-1602946). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; CarbonTracker CT2016 results provided by NOAA ESRL, Boulder, Colorado, USA from the website at http://carbontracker.noaa.gov. Elevation data is from the GTOPO30 dataset. This Data is available from the U.S. Geological Survey. Coastline data used is from the freely available Global Self-consistent, Hierarchical, High-resolution Geography Database (GSHHG). This research was supported by the David and Lucile Packard Foundation and the National Science Foundation.	Andrews A. E., 2009, CARBON DIOXIDE CARBO; BANTA RM, 1993, J ATMOS SCI, V50, P3959, DOI 10.1175/1520-0469(1993)050<3959:EOTMBS>2.0.CO;2; Bourgeois T, 2016, BIOGEOSCIENCES, V13, P4167, DOI 10.5194/bg-13-4167-2016; Chavez FP, 2018, DEEP-SEA RES PT II, V151, P137, DOI 10.1016/j.dsr2.2017.01.001; Chavez FP, 2017, OCEANOGRAPHY, V30, P128, DOI 10.5670/oceanog.2017.429; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Friederich GE, 2002, PROG OCEANOGR, V54, P185, DOI 10.1016/S0079-6611(02)00049-6; Friederich GE, 1995, DEEP SEA RES 1, V42; Gille ST, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL022139; Idso CD, 2001, ATMOS ENVIRON, V35, P995, DOI 10.1016/S1352-2310(00)00412-X; Ishii M, 2014, BIOGEOSCIENCES, V11, P709, DOI 10.5194/bg-11-709-2014; Jacobson MZ, 2010, ENVIRON SCI TECHNOL, V44, P2497, DOI 10.1021/es903018m; Keeling CD, 1998, ANNU REV ENERG ENV, V23, P25, DOI 10.1146/annurev.energy.23.1.25; Kindle JC, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015566; Kort EA, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052738; Nakadai T, 2002, APPL SOIL ECOL, V19, P161, DOI 10.1016/S0929-1393(01)00180-9; Newman S, 2013, ATMOS CHEM PHYS, V13, P4359, DOI 10.5194/acp-13-4359-2013; Perlin N, 2004, MON WEATHER REV, V132, P2110, DOI 10.1175/1520-0493(2004)132<2110:SAMWAW>2.0.CO;2; Peters W, 2007, P NATL ACAD SCI USA, V104, P18925, DOI 10.1073/pnas.0708986104; Takahashi T, 2009, DEEP-SEA RES PT II, V56, P554, DOI 10.1016/j.dsr2.2008.12.009; VERMA SB, 1976, J GEOPHYS RES-OC ATM, V81, P399, DOI 10.1029/JC081i003p00399; Wanninkhof R, 2014, LIMNOL OCEANOGR-METH, V12, P351, DOI 10.4319/lom.2014.12.351; Weiss R.F., 1974, MAR CHEM, V2, P203, DOI DOI 10.1016/0304-4203(74)90015-2	23	11	11	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2019	14	3							e0214403	10.1371/journal.pone.0214403	http://dx.doi.org/10.1371/journal.pone.0214403			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ5PT	30917190	Green Published, gold, Green Submitted			2022-12-26	WOS:000462465800063
J	Parker, L; Bourgoin, C; Martinez-Valle, A; Laderach, P				Parker, Louis; Bourgoin, Clement; Martinez-Valle, Armando; Laderach, Peter			Vulnerability of the agricultural sector to climate change: The development of a pan-tropical Climate Risk Vulnerability Assessment to inform sub-national decision making	PLOS ONE			English	Article							ADAPTIVE CAPACITY; SOCIAL VULNERABILITY; NATURAL HAZARDS; SMALLHOLDER; ADAPTATION; INDICATORS; IMPACT; POLICY	As climate change continues to exert increasing pressure upon the livelihoods and agricultural sector of many developing and developed nations, a need exists to understand and prioritise at the sub national scale which areas and communities are most vulnerable. The purpose of this study is to develop a robust, rigorous and replicable methodology that is flexible to data limitations and spatially prioritizes the vulnerability of agriculture and rural livelihoods to climate change. We have applied the methodology in Vietnam, Uganda and Nicaragua, three contrasting developing countries that are particularly threatened by climate change. We conceptualize vulnerability to climate change following the widely adopted combination of sensitivity, exposure and adaptive capacity. We used Ecocrop and Maxent ecological models under a high emission climate scenario to assess the sensitivity of the main food security and cash crops to climate change. Using a participatory approach, we identified exposure to natural hazards and the main indicators of adaptive capacity, which were modelled and analysed using geographic information systems. We finally combined the components of vulnerability using equal-weighting to produce a crop specific vulnerability index and a final accumulative score. We have mapped the hotspots of climate change vulnerability and identified the underlying driving indicators. For example, in Vietnam we found the Mekong delta to be one of the vulnerable regions due to a decline in the climatic suitability of rice and maize, combined with high exposure to flooding, sea level rise and drought. However, the region is marked by a relatively high adaptive capacity due to developed infrastructure and comparatively high levels of education. The approach and information derived from the study informs public climate change policies and actions, as vulnerability assessments are the bases of any National Adaptation Plans (NAP), National Determined Contributions (NDC) and for accessing climate finance.	[Parker, Louis; Bourgoin, Clement; Laderach, Peter] Int Ctr Trop Agr CIAT, CGIAR Res Program Climate Change Agr & Food Secur, Hanoi, Vietnam; [Bourgoin, Clement] Ctr Cooperat Int Rech Agron Dev CIRAD UPR Forets, F-34398 Montpellier, France; [Martinez-Valle, Armando] Int Ctr Trop Agr CIAT, CGIAR Res Program Climate Change Agr & Food Secur, Managua, Nicaragua	Alliance; International Center for Tropical Agriculture - CIAT; CGIAR; Alliance; International Center for Tropical Agriculture - CIAT; CGIAR	Parker, L (corresponding author), Int Ctr Trop Agr CIAT, CGIAR Res Program Climate Change Agr & Food Secur, Hanoi, Vietnam.	louisartparker@gmail.com		Laderach, Peter/0000-0001-8708-6318	CGIAR	CGIAR(CGIAR)	This work was implemented as part of the CGIAR Research Program on Climate Change, Agriculture and Food Security (CCAFS), which is carried out with support from CGIAR Fund Donors and through bilateral funding agreements. For details please visit https://ccafs.cgiar.org/donors.The views expressed in this document cannot be taken to reflect the official opinions of these organizations. The authors of this paper would like to thank CIAT colleagues: Dr Julian Ramirez, Dr Godefroy Grosjean and Dr Pablo Imbach for their insightful comments and suggestions. Louis Parker would like to thank Ms Than Thi Nguyen (CIAT) for her assistance collecting, translating and analysing data for Vietnam. The authors would like to thank the government partner organisations in Vietnam, notably the Institute for Agricultural Environment (IAE) and the National Institute of Agricultural Planning and Projection (NIAPP) for their support and collaboration.; This work was implemented as part of the CGIAR Research Program on Climate Change, Agriculture and Food Security (CCAFS), which is carried out with support from CGIAR Fund Donors and through bilateral funding agreements. For details please visit https://ccafs.cgiar.org/donors.We specifically thank the International Fund for Agricultural Development for supporting this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abracosa R, 2015, CLIMATE CHANGE VULNE; Adger W.N., 2004, NEW INDICATORS VULNE; Adger WN, 2006, GLOBAL ENVIRON CHANG, V16, P268, DOI 10.1016/j.gloenvcha.2006.02.006; Allison EH, 2009, FISH FISH, V10, P173, DOI 10.1111/j.1467-2979.2008.00310.x; Aminga J, 2012, TREND ANAL FOOD NUTR; [Anonymous], 2007, UG VIS 2040; [Anonymous], 2016, NIC CIFR NIC; ASAP, 2014, STRENGTH COFF CAC VA; ASAP, 2014, IFAD OP UG PROJ REST; Auffhammer M, 2012, CLIMATIC CHANGE, V111, P411, DOI 10.1007/s10584-011-0208-4; Ayanlade A, 2017, WEATHER CLIM EXTREME, V15, P24, DOI 10.1016/j.wace.2016.12.001; Baca M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088463; Berry PM, 2006, ENVIRON SCI POLICY, V9, P189, DOI 10.1016/j.envsci.2005.11.004; Bourgoin C, 2016, SPATIALLY EXPLICIT A; Bouroncle C, 2017, CLIMATIC CHANGE, V141, P123, DOI 10.1007/s10584-016-1792-0; Bronson K, 2016, BIG DATA SOC, V3, P1, DOI 10.1177/2053951716648174; Broxton PD, 2014, J APPL METEOROL CLIM, V53, P1593, DOI 10.1175/JAMC-D-13-0270.1; Buchner B., 2017, GLOBAL LANDSCAPE CLI; Bunn C, 2015, CLIMATIC CHANGE, V129, P89, DOI 10.1007/s10584-014-1306-x; Central Intelligence Agency, 2016, WORLD FACTBOOK; Chau VN, 2014, 2014 C 58 FEBR 4 7 2; Chen J, 2015, ISPRS J PHOTOGRAMM, V103, P7, DOI 10.1016/j.isprsjprs.2014.09.002; Christoff P, 2016, ENVIRON POLIT, V25, P765, DOI 10.1080/09644016.2016.1191818; Cinner JE, 2018, NAT CLIM CHANGE, V8, P117, DOI 10.1038/s41558-017-0065-x; Climate Change and Food Security (CCAFS), 2015, GCM DOWNSC DAT PORT; Coumou D, 2012, NATURE CLIMATE CHANG, DOI [10.1038/nclimate1491, DOI 10.1038/NCLIMATE1491]; Cutter SL, 2003, SOC SCI QUART, V84, P242, DOI 10.1111/1540-6237.8402002; Dang TH, 2004, MAIZE VIETNAM PRODUC; de Sherbinin A, 2014, AFRICAN LATIN AM RES; Easterling W, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P273; Eriksen S.H., 2007, MITIG ADAPT STRATEG, V12, P495, DOI [10.1007/s11027-006-3460-6, DOI 10.1007/S11027-006-3460-6]; Fekete A, 2009, NAT HAZARD EARTH SYS, V9, P393, DOI 10.5194/nhess-9-393-2009; Fick SE, 2017, INT J CLIMATOL, V37, P4302, DOI 10.1002/joc.5086; Food and Agriculture Organization of the United Nations, 2008, INTR BAS CONC FOOD S; Fritzsche K., 2014, VULNERABILITY SOURCE; Fussel H-M, 2009, REV QUANTITATIVE ANA; Fussel HM, 2006, CLIMATIC CHANGE, V75, P301, DOI 10.1007/s10584-006-0329-3; General Statistics Office of Vietnam, 2011, PERC STUD GRAD HIGH; General Statistics Office of Vietnam, 2005, NUMB FARMS PROV; General Statistics Office of Vietnam, 2005, NUMB COOP 2005 KIND; General Statistics Office of Vietnam, 2018, AGR FOR FISH; Girvetz E., 2017, CSA COUNTRY PROFILES; Giuliani G, 2011, NAT HAZARD EARTH SYS, V11, P53, DOI 10.5194/nhess-11-53-2011; Gourdji S, 2015, AGR FOREST METEOROL, V200, P270, DOI 10.1016/j.agrformet.2014.10.002; Guha-Sapir D, 2017, ANN DISASTER STAT RE; Guzzetti F, 2016, TOXICOL ENVIRON CHEM, V98, P1043, DOI 10.1080/02772248.2015.1030664; Harvey CA, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0089; Hepworth N, 2008, CLIMATE CHANGE UGAND; Herrera B, 2010, NICARAGUA USO POTENC; HIJMANS RJ, 2004, DIVA GIS VSN 5 0 GEO; Hinkel J, 2011, GLOBAL ENVIRON CHANG, V21, P198, DOI 10.1016/j.gloenvcha.2010.08.002; HUTCHINSON MF, 1995, INT J GEOGR INF SYST, V9, P385, DOI 10.1080/02693799508902045; Jarvis A, 2008, HOLE FILLED SRTM GLO; Jarvis A., 2008, HOLE FILLED SRTM GLO; Jurgilevich A, 2017, ENVIRON RES LETT, V12, DOI 10.1088/1748-9326/aa5508; Keil A, 2009, C INT RES FOOD SEC N, P1; Knox J, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/3/034032; Kreft S., 2016, GLOBAL CLIMATE RISK; Kreft S, 2014, GLOBAL CLIMATE RISK; Laderach P, 2017, CLIMATIC CHANGE, V141, P47, DOI 10.1007/s10584-016-1788-9; Lanjouw P, 2013, VIETNAMS EVOLVING PO; Li YC, 2015, CLIMATIC CHANGE, V128, P355, DOI 10.1007/s10584-014-1165-5; Lung T, 2013, GLOBAL ENVIRON CHANG, V23, P522, DOI 10.1016/j.gloenvcha.2012.11.009; Marshall N, FRAMEWORK SOCIAL ADA, P44; Masson-Delmotte V., 2018, GLOBAL WARMING 15 C; MESA, 2015, MONITORING ENV SECUR; Morton JF, 2007, P NATL ACAD SCI USA, V104, P19680, DOI 10.1073/pnas.0701855104; Nachtergaele F.O., 2008, HARMONIZED WORLD SOI; National Institute of Nutrition Ministry of Health, 2010, AV UND STUNT WAST TO; Nelson A., 2008, ACCESSIBILITY; Oppenheimer M, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P1039; Osbahr H, 2011, EXP AGR, V47, P293, DOI 10.1017/S0014479710000785; Peduzzi P, 2009, NAT HAZARD EARTH SYS, V9, P1149, DOI 10.5194/nhess-9-1149-2009; Peduzzi P., 2015, TROPICAL CYCLONES BE; Peduzzi P., 2009, FLOOD EVENTS; Ramirez Villejas J., 2010, 1 INT CTR TROP AGR C; Redfern S. K., 2012, Building resilience for adaptation to climate change in the agriculture sector. Proceedings of a Joint FAO/OECD Workshop, Rome, Italy, 23-24 April 2012, P295; Renard KG., 1997, AGR HDB, DOI DOI 10.1201/9780203739358-5; Riahi K, 2007, TECHNOL FORECAST SOC, V74, P887, DOI 10.1016/j.techfore.2006.05.026; Rippke U, 2016, NATURE CLIMATE CHANG; Roy DP, 2008, MODIS ACTIVE FIRE BU; Schmidt-Thome P., 2006, THESIS; Schroter D., 2005, Mitigation and Adaptation Strategies for Global Change, V10, P573, DOI 10.1007/s11027-005-6135-9; Schroth G, 2017, MITIG ADAPT STRAT GL, V22, P903, DOI 10.1007/s11027-016-9707-y; Sehgal VK., 2013, VULNERABILITY AGR CL; Smit B, 2006, GLOBAL ENVIRON CHANG, V16, P282, DOI 10.1016/j.gloenvcha.2006.03.008; Statistics UBO, 2015, STAT ABSTR; Stevanovic M, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501452; Takeuchi W., 2013, SATELLITE BASED DROU; The Central Agency, 2016, WORLD FACTBOOK; The Word Bank, 2017, DAT UG; Thiault L, 2018, CONSERV BIOL, V32, P447, DOI 10.1111/cobi.12989; Torresan S, 2012, NAT HAZARD EARTH SYS, V12, P2347, DOI 10.5194/nhess-12-2347-2012; Trigg MA, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/9/094014; Tucker J, 2015, REG ENVIRON CHANGE, V15, P783, DOI 10.1007/s10113-014-0741-6; Turner BL, 2003, P NATL ACAD SCI USA, V100, P8074, DOI 10.1073/pnas.1231335100; *UN FAO, 2017, FAOSTAT DAT; United Nations Environment Programme (UNEP), 2013, DROUGHTS EV 1980 200; United Nations Environment Programme (UNEP), 2013, GLOB DAT RISK PLATF; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P5, DOI [10.1007/s10584-011-0148-z, 10.1007/s10584-011-0157-y]; Vos R, 2016, STATE FOOD AGR CLIMA; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1; Watson RT, 2001, CLIMATE CHANGE 2001: IMPACTS, ADAPTATION, AND VULNERABILITY, pIX; Webster PJ, 2005, SCIENCE, V309, P1844, DOI 10.1126/science.1116448; Weis SWM, 2016, CLIMATIC CHANGE, V136, P615, DOI 10.1007/s10584-016-1642-0; Yusuf A.A., 2009, CLIMATE CHANGE VULNE; Zorner RJ, 2008, AGR ECOSYST ENVIRON, V126, P67, DOI 10.1016/j.agee.2008.01.014	107	56	58	4	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2019	14	3							e0213641	10.1371/journal.pone.0213641	http://dx.doi.org/10.1371/journal.pone.0213641			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HQ5PT	30917146	gold, Green Published, Green Submitted			2022-12-26	WOS:000462465800037
J	Schuster, KD; Mohammadi, M; Cahill, KB; Matte, SL; Maillet, AD; Vashisth, H; Cote, RH				Schuster, Kevin D.; Mohammadi, Mohammadjavad; Cahill, Karyn B.; Matte, Suzanne L.; Maillet, Alexis D.; Vashisth, Harish; Cote, Rick H.			Pharmacological and molecular dynamics analyses of differences in inhibitor binding to human and nematode PDE4: Implications for management of parasitic nematodes	PLOS ONE			English	Article							CRYSTAL-STRUCTURES; PROTEIN; PHOSPHODIESTERASES; SPECIFICITY; GENERATION; MECHANICS; INSIGHTS; DOCKING; PATHWAY; DESIGN	Novel chemical controls are needed that selectively target human, animal, and plant parasitic nematodes with reduced adverse effects on the host or the environment. We hypothesize that the phosphodiesterase (PDE) enzyme family represents a potential target for development of novel nematicides and anthelmintics. To test this, we identified six PDE families present in the nematode phylum that are orthologous to six of the eleven human PDE families. We characterized the binding interactions of family-selective PDE inhibitors with human and C. elegans PDE4 in conjunction with molecular dynamics (MD) simulations to evaluate differences in binding interactions of these inhibitors within the PDE4 catalytic domain. We observed that roflumilast (human PDE4-selective inhibitor) and zardaverine (selective for human PDE3 and PDE4) were 159- and 77-fold less potent, respectively, in inhibiting C. elegans PDE4. The pan-specific PDE inhibitor isobutyl methyl xanthine (IBMX) had similar affinity for nematode and human PDE4. Of 32 residues within 5 A of the ligand binding site, five revealed significant differences in non-bonded interaction energies (van der Waals and electrostatic interaction energies) that could account for the differential binding affinities of roflumilast and zardaverine. One site (Phe506 in the human PDE4D3 amino acid sequence corresponding to Tyr253 in C. elegans PDE4) is predicted to alter the binding conformation of roflumilast and zardaverine (but not IBMX) into a less energetically favorable state for the nematode enzyme. The pharmacological differences in sensitivity to PDE4 inhibitors in conjunction with differences in the amino acids comprising the inhibitor binding sites of human and C. elegans PDE4 catalytic domains together support the feasibility of designing the next generation of anthelmintics/nematicides that could selectively bind to nematode PDEs.	[Schuster, Kevin D.; Cahill, Karyn B.; Matte, Suzanne L.; Maillet, Alexis D.; Cote, Rick H.] Univ New Hampshire, Dept Mol Cellular & Biomed Sci, Durham, NH 03824 USA; [Mohammadi, Mohammadjavad; Vashisth, Harish] Univ New Hampshire, Dept Chem Engn, Durham, NH 03824 USA; [Cahill, Karyn B.] Envirol Inc, Portland, ME USA	University System Of New Hampshire; University of New Hampshire; University System Of New Hampshire; University of New Hampshire	Cote, RH (corresponding author), Univ New Hampshire, Dept Mol Cellular & Biomed Sci, Durham, NH 03824 USA.; Vashisth, H (corresponding author), Univ New Hampshire, Dept Chem Engn, Durham, NH 03824 USA.	harish.vashisth@unh.edu; rick.cote@unh.edu	Mohammadi, Mohammadjavad/H-1276-2019; Cote, Rick/G-3363-2013	Mohammadi, Mohammadjavad/0000-0001-7344-0857; Cote, Rick/0000-0002-1573-6526	United State Department of Agriculture-National Institute of Food and Agriculture [2016-67013-24763]; NH Agricultural Experiment Station Hatch grant [NH-00631]; National Science Foundation (NSF) Major Research Instrumentation program [PHY-1229408]; NSF [ACI-1548562, TG-MCB160183]	United State Department of Agriculture-National Institute of Food and Agriculture; NH Agricultural Experiment Station Hatch grant; National Science Foundation (NSF) Major Research Instrumentation program; NSF(National Science Foundation (NSF))	This work was supported in part by United State Department of Agriculture-National Institute of Food and Agriculture under award number 2016-67013-24763 (to R.H.C.) and the NH Agricultural Experiment Station Hatch grant NH-00631 (to R.H.C.); this is Scientific Contribution Number 2812. Computations were performed in part on Trillian, a Cray XE6m-200 supercomputer supported by the National Science Foundation (NSF) Major Research Instrumentation program under grant PHY-1229408 (H.V.) and also using the NSF-supported (ACI-1548562) Extreme Science and Engineering Discovery Environment (XSEDE) Comet resource at San Diego Supercomputer Center (SDSC) under grant TG-MCB160183 (to H.V.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen M. P., 1989, COMPUTER SIMULATION, DOI DOI 10.1093/OSO/9780198803195.001.0001; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BARKER KR, 1994, J NEMATOL, V26, P127; Blaxter ML, 1998, NATURE, V392, P71, DOI 10.1038/32160; Bolger GB, 1997, BIOCHEM J, V328, P539; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown DK, 2017, BIOINFORMATICS, V33, P2768, DOI 10.1093/bioinformatics/btx349; Burgin AB, 2010, NAT BIOTECHNOL, V28, P63, DOI 10.1038/nbt.1598; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Ceron J, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-30; Charlie NK, 2006, GENETICS, V173, P111, DOI 10.1534/genetics.105.054007; Chen Y, 2009, NAT CHEM BIOL, V5, P358, DOI 10.1038/nchembio.155; Cho SW, 2004, BIOCHEM BIOPH RES CO, V325, P525, DOI 10.1016/j.bbrc.2004.10.060; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; Cote RH, 2000, METHOD ENZYMOL, V315, P646; D'Ursi P, 2016, MOL INFORM, V35, P369, DOI 10.1002/minf.201501033; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Francis SH, 2011, PHYSIOL REV, V91, P651, DOI 10.1152/physrev.00030.2010; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Fujisaki H, 2015, FRONT BIOENG BIOTECH, V3, DOI 10.3389/fbioe.2015.00125; Gross I, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00576; Haning H, 2003, PROGR MED CHEM, V41, P249, DOI 10.1016/S0079-6468(02)41007-7; Hatzelmann A, 2001, J PHARMACOL EXP THER, V297, P267; Holden-Dye Lindy, 2014, WormBook, P1, DOI 10.1895/wormbook.1.143.2; Huai Q, 2004, J BIOL CHEM, V279, P13095, DOI 10.1074/jbc.M311556200; Huai Q, 2003, BIOCHEMISTRY-US, V42, P13220, DOI 10.1021/bi034653e; Huang J, 2013, J COMPUT CHEM, V34, P2135, DOI 10.1002/jcc.23354; Huang YY, 2013, J CHEM INF MODEL, V53, P3044, DOI 10.1021/ci400458z; Hukema RK, 2006, EMBO J, V25, P312, DOI 10.1038/sj.emboj.7600940; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Johnson KR, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-247; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kaplan RM, 2004, TRENDS PARASITOL, V20, P477, DOI 10.1016/j.pt.2004.08.001; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Ke HM, 2007, CURR TOP MED CHEM, V7, P391, DOI 10.2174/156802607779941242; Kim S, 2012, GENETICS, V192, P905, DOI 10.1534/genetics.112.143271; Kiontke K, 2013, CURR BIOL, V23, pR862, DOI 10.1016/j.cub.2013.08.009; L'Etoile ND, 2000, NEURON, V25, P575, DOI 10.1016/S0896-6273(00)81061-2; Lee ME, 2002, FEBS LETT, V530, P53, DOI 10.1016/S0014-5793(02)03396-3; Liu J, 2010, NAT NEUROSCI, V13, P715, DOI 10.1038/nn.2540; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Maurice DH, 2014, NAT REV DRUG DISCOV, V13, P290, DOI 10.1038/nrd4228; Mohammadi M, 2019, PROTEINS, V87, P146, DOI 10.1002/prot.25642; Nicol JM, 2011, GENOMICS AND MOLECULAR GENETICS OF PLANT-NEMATODE INTERACTIONS, P21, DOI 10.1007/978-94-007-0434-3_2; Ortiz CO, 2006, GENETICS, V173, P131, DOI 10.1534/genetics.106.055749; Papaioannou Sylvana, 2008, Invertebrate Neuroscience, V8, P91, DOI 10.1007/s10158-008-0072-8; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Prichard RK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001549; Raizen DM, 2008, NATURE, V451, P569, DOI 10.1038/nature06535; Schade MA, 2005, GENETICS, V169, P631, DOI 10.1534/genetics.104.032334; Schmitz C, 2007, P NATL ACAD SCI USA, V104, P834, DOI 10.1073/pnas.0510527104; SCHUDT C, 1991, BIOCHEM PHARMACOL, V42, P153, DOI 10.1016/0006-2952(91)90694-Z; Seebeck T, 2011, FUTURE MED CHEM, V3, P1289, DOI [10.4155/fmc.11.77, 10.4155/FMC.11.77]; SEKHAR KR, 1996, PHOSPHODIESTERASE IN, P135; Shoemaker BA, 2012, NUCLEIC ACIDS RES, V40, pD834, DOI 10.1093/nar/gkr997; Shoemaker BA, 2010, NUCLEIC ACIDS RES, V38, pD518, DOI 10.1093/nar/gkp842; Spurr H. W. Jr., 1985, An advanced treatise on Meloidogyne. Volume 1: Biology and control., P269; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Usuyama M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042907; Wang C, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00787; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Xu RX, 2000, SCIENCE, V288, P1822, DOI 10.1126/science.288.5472.1822; Yesselman JD, 2012, J COMPUT CHEM, V33, P189, DOI 10.1002/jcc.21963	65	3	3	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2019	14	3							e0214554	10.1371/journal.pone.0214554	http://dx.doi.org/10.1371/journal.pone.0214554			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ5PT	30917179	Green Submitted, Green Published, gold			2022-12-26	WOS:000462465800071
J	Naumova, OY; Rychkov, SY; Kornilov, SA; Odintsova, VV; Anikina, VO; Solodunova, MY; Arintcina, IA; Zhukova, MA; Ovchinnikova, IV; Burenkova, OV; Zhukova, OV; Muhamedrahimov, RJ; Grigorenko, EL				Naumova, Oxana Yu.; Rychkov, Sergey Yu.; Kornilov, Sergey A.; Odintsova, Veronika V.; Anikina, Varvara O.; Solodunova, Maria Yu.; Arintcina, Irina A.; Zhukova, Marina A.; Ovchinnikova, Irina V.; Burenkova, Olga V.; Zhukova, Olga V.; Muhamedrahimov, Rifkat J.; Grigorenko, Elena L.			Effects of early social deprivation on epigenetic statuses and adaptive behavior of young children: A study based on a cohort of institutionalized infants and toddlers	PLOS ONE			English	Article							NEONATAL MATERNAL SEPARATION; EARLY-LIFE ADVERSITY; DNA METHYLATION; GLUCOCORTICOID-RECEPTOR; DEVELOPMENTAL DYNAMICS; CHILDHOOD ADVERSITY; SENSITIVE PERIODS; MOTOR DEVELOPMENT; WHOLE-GENOME; STRESS	Early social deprivation (i.e., an insufficiency or lack of parental care) has been identified as a significant adverse early experience that may affect multiple facets of child development and cause long-term outcomes in physical and mental health, cognition and behavior. Current research provides growing evidence that epigenetic reprogramming may be a mechanism modulating these effects of early adversities. This work aimed to investigate the impact of early institutionalization-the immersion in an extreme socially depriving environment in humans-on the epigenome and adaptive behavior of young children up to 4 years of age. We conducted a cross-sectional study involving two comparison groups: 29 children raised in orphanages and 29 children raised in biological families. Genome-wide DNA methylation profiles of blood cells were obtained using the Illumina MethylationEPIC array; the level of child adaptive functioning was assessed using the Vineland Adaptive Behavior Scales-II. In comparison to children raised in families, children residing in orphanages had both statistically significant deficits in multiple adaptive behavior domains and statistically significant differences in DNA methylation states. Moreover, some of these methylation states may directly modulate the behavioral deficits; according to preliminary estimates, about 7-14% of the deviation of adaptive behavior between groups of children may be determined by their difference in DNA methylation profiles. The duration of institutionalization had a significant impact on both the adaptive level and DNA methylation status of institutionalized children.	[Naumova, Oxana Yu.; Rychkov, Sergey Yu.; Zhukova, Olga V.] RAS, Vavilov Inst Gen Genet, Human Genet Lab, Moscow, Russia; [Naumova, Oxana Yu.; Kornilov, Sergey A.; Anikina, Varvara O.; Solodunova, Maria Yu.; Arintcina, Irina A.; Zhukova, Marina A.; Ovchinnikova, Irina V.; Burenkova, Olga V.; Muhamedrahimov, Rifkat J.; Grigorenko, Elena L.] St Petersburg State Univ, Dept Psychol, St Petersburg, Russia; [Naumova, Oxana Yu.; Kornilov, Sergey A.; Burenkova, Olga V.; Grigorenko, Elena L.] Univ Houston, Dept Psychol, Houston, TX 77204 USA; [Odintsova, Veronika V.] Vrije Univ Amsterdam, Dept Biol Psychol, Amsterdam, Netherlands; [Odintsova, Veronika V.] Natl Med Res Ctr Obstet Gynecol & Perinatol, Moscow, Russia; [Odintsova, Veronika V.] Fed Res Inst Hlth Org & Informat, Moscow, Russia; [Grigorenko, Elena L.] Baylor Coll Med, Houston, TX 77030 USA	Russian Academy of Sciences; Vavilov Institute of General Genetics; Saint Petersburg State University; University of Houston System; University of Houston; Vrije Universiteit Amsterdam; Russian Academy of Medical Sciences; Research Center for Obstetrics, Gynecology & Perinatology; Baylor College of Medicine	Naumova, OY (corresponding author), RAS, Vavilov Inst Gen Genet, Human Genet Lab, Moscow, Russia.; Naumova, OY; Grigorenko, EL (corresponding author), St Petersburg State Univ, Dept Psychol, St Petersburg, Russia.; Naumova, OY; Grigorenko, EL (corresponding author), Univ Houston, Dept Psychol, Houston, TX 77204 USA.; Grigorenko, EL (corresponding author), Baylor Coll Med, Houston, TX 77030 USA.	oksana.yu.naumova@gmail.com; Elena.Grigorenko@times.uh.edu	Аринцина, Ирина/AAI-3756-2021; Naumova, Oksana/N-4142-2016; Grigorenko, Elena/V-2418-2019; Burenkova, Olga/AAM-3088-2020; Kornilov, Sergey/F-1234-2010; Ovchinnikova, Irina V/K-2212-2017; Zhukova, Marina A./AAM-9550-2020; Odintsova, Veronika/H-5831-2013	Аринцина, Ирина/0000-0001-5746-1287; Naumova, Oksana/0000-0003-0889-526X; Burenkova, Olga/0000-0002-9440-6276; Kornilov, Sergey/0000-0002-8378-110X; Ovchinnikova, Irina V/0000-0001-5950-5765; Zhukova, Marina A./0000-0002-3069-570X; Odintsova, Veronika/0000-0002-9868-6981	Government of the Russian Federation [14, Z50.31.0027]	Government of the Russian Federation	Financial support of the study was provided by the Government of the Russian Federation; grant number 14.Z50.31.0027; PI: ELG. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aryee MJ, 2014, BIOINFORMATICS, V30, P1363, DOI 10.1093/bioinformatics/btu049; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Bibikova M, 2011, GENOMICS, V98, P288, DOI 10.1016/j.ygeno.2011.07.007; Bick J, 2016, NEUROPSYCHOPHARMACOL, V41, P177, DOI 10.1038/npp.2015.252; Bick J, 2012, DEV PSYCHOPATHOL, V24, P1417, DOI 10.1017/S0954579412000806; Borghol N, 2012, INT J EPIDEMIOL, V41, P62, DOI 10.1093/ije/dyr147; Bos KJ, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.016.2009; Caldji C, 1998, P NATL ACAD SCI USA, V95, P5335, DOI 10.1073/pnas.95.9.5335; Champagne FA, 2003, PHYSIOL BEHAV, V79, P359, DOI 10.1016/S0031-9384(03)00149-5; Champagne FA, 2010, DEV PSYCHOBIOL, V52, P299, DOI 10.1002/dev.20436; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Chen J, 2012, J NEUROENDOCRINOL, V24, P1055, DOI 10.1111/j.1365-2826.2012.02306.x; Cole SW, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004601; Coll CG, 1998, AM J PUBLIC HEALTH, V88, P1371, DOI 10.2105/AJPH.88.9.1371; Danese A, 2012, PHYSIOL BEHAV, V106, P29, DOI 10.1016/j.physbeh.2011.08.019; Dobrova-Krol NA, 2008, INFANT BEHAV DEV, V31, P539, DOI 10.1016/j.infbeh.2008.04.001; Elwenspoek MMC, 2015, PSYCHONEUROENDOCRINO, V61, P64, DOI 10.1016/j.psyneuen.2015.07.564; Elwenspoek MMC, 2017, PSYCHONEUROENDOCRINO, V82, P140, DOI 10.1016/j.psyneuen.2017.05.012; Esposito EA, 2016, DEV PSYCHOPATHOL, V28, P1385, DOI 10.1017/S0954579416000055; Essex MJ, 2013, CHILD DEV, V84, P58, DOI 10.1111/j.1467-8624.2011.01641.x; Fenton G, 2003, AUTISM, V7, P269, DOI 10.1177/1362361303007003004; Fox Nathan A, 2017, Psychodyn Psychiatry, V45, P441, DOI 10.1521/pdps.2017.45.4.441; Fox SE, 2010, CHILD DEV, V81, P28, DOI 10.1111/j.1467-8624.2009.01380.x; Francis DD, 2002, J NEUROSCI, V22, P7840; Gonzalez A, 2001, DEV PSYCHOBIOL, V38, P11, DOI 10.1002/1098-2302(2001)38:1<11::AID-DEV2>3.0.CO;2-B; Gunnar MR, 2007, DEV PSYCHOPATHOL, V19, P129, DOI 10.1017/S0954579407070071; Harrison EL, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.31; Hartwell KJ, 2013, J PSYCHIATR RES, V47, P604, DOI 10.1016/j.jpsychires.2013.01.008; Hawk B, 2010, CLIN CHILD FAM PSYCH, V13, P199, DOI 10.1007/s10567-010-0068-x; Heim C, 2001, BIOL PSYCHIAT, V49, P1023, DOI 10.1016/S0006-3223(01)01157-X; HERBERT TB, 1993, PSYCHOSOM MED, V55, P364, DOI 10.1097/00006842-199307000-00004; Houseman EA, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-86; Humphreys KL, 2015, LANCET PSYCHIAT, V2, P625, DOI 10.1016/S2215-0366(15)00095-4; Huot RL, 2001, PSYCHOPHARMACOLOGY, V158, P366, DOI 10.1007/s002130100701; Jaffe AE, 2013, GENOME BIOL, V15, pR31, DOI [10.1186/gb2014152r31, DOI 10.1186/GB2014152R31]; Johnson SB, 2013, PEDIATRICS, V131, P319, DOI 10.1542/peds.2012-0469; Julian MM, 2016, ADOPT Q, V19, P44, DOI 10.1080/10926755.2015.1088106; Kalinichev M, 2002, PHARMACOL BIOCHEM BE, V73, P131, DOI 10.1016/S0091-3057(02)00781-5; Knudsen EI, 2004, J COGNITIVE NEUROSCI, V16, P1412, DOI 10.1162/0898929042304796; Kumsta R, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.95; Labonte B, 2012, ARCH GEN PSYCHIAT, V69, P722, DOI 10.1001/archgenpsychiatry.2011.2287; Lindeyer CM, 2013, DEV PSYCHOBIOL, V55, P168, DOI 10.1002/dev.21009; Massart R, 2016, DEV PSYCHOPATHOL, V28, P1259, DOI 10.1017/S0954579416000833; McCrory E, 2010, J CHILD PSYCHOL PSYC, V51, P1079, DOI 10.1111/j.1469-7610.2010.02271.x; McGowan PO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014739; McGowan PO, 2009, NAT NEUROSCI, V12, P342, DOI 10.1038/nn.2270; Mehta D, 2013, P NATL ACAD SCI USA, V110, P8302, DOI 10.1073/pnas.1217750110; Moffett MC, 2016, J PHARM EXPT THERAPE, V317, P1210, DOI [10.1124/jpet.106, DOI 10.1124/JPET.106]; Muhamedrahimov RJ, 2005, J APPL DEV PSYCHOL, V26, P477, DOI 10.1016/j.appdev.2005.06.002; Murgatroyd C, 2009, NAT NEUROSCI, V12, P1559, DOI 10.1038/nn.2436; Nagy C, 2012, EPIGENOMICS-UK, V4, P445, DOI [10.2217/EPI.12.37, 10.2217/epi.12.37]; Naumova OY, 2016, CHILD DEV, V87, P98, DOI 10.1111/cdev.12485; Naumova OY, 2012, DEV PSYCHOPATHOL, V24, P143, DOI 10.1017/S0954579411000605; Non AL, 2016, AM J PHYS ANTHROPOL, V161, P84, DOI 10.1002/ajpa.23010; O'Connor TG, 2000, J AM ACAD CHILD PSY, V39, P703, DOI 10.1097/00004583-200006000-00008; Palma-Gudiel H, 2015, NEUROSCI BIOBEHAV R, V55, P520, DOI 10.1016/j.neubiorev.2015.05.016; Palmer FB, 2013, J PEDIATR-US, V163, P1733, DOI 10.1016/j.jpeds.2013.08.030; Pomerleau A, 2005, INT J BEHAV DEV, V29, P445, DOI 10.1177/01650250500206257; Provencal N, 2012, J NEUROSCI, V32, P15626, DOI 10.1523/JNEUROSCI.1470-12.2012; Qin LN, 2011, BEHAV BRAIN RES, V217, P142, DOI 10.1016/j.bbr.2010.10.018; Rebhan M, 1997, TRENDS GENET, V13, P163, DOI 10.1016/S0168-9525(97)01103-7; Reimand J, 2016, NUCLEIC ACIDS RES, V44, pW83, DOI 10.1093/nar/gkw199; Reinius LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041361; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Roeber BJ, 2012, DEV MED CHILD NEUROL, V54, P527, DOI 10.1111/j.1469-8749.2012.04257.x; Schwaiger M, 2016, NEUROPSYCHOPHARMACOL, V41, P2530, DOI 10.1038/npp.2016.57; Sheridan MA, 2016, CURR OPIN BEHAV SCI, V10, P108, DOI 10.1016/j.cobeha.2016.05.013; Shirtcliff EA, 2009, P NATL ACAD SCI USA, V106, P2963, DOI 10.1073/pnas.0806660106; Simon AK, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.3085; Sparrow S. S., 2005, VINELAND ADAPTIVE BE, V2nd, DOI [10.1037/t15164-000, DOI 10.1037/T15164-000]; Speir ML, 2016, NUCLEIC ACIDS RES, V44, pD717, DOI 10.1093/nar/gkv1275; Suderman M, 2014, BMC MED GENOMICS, V7, DOI 10.1186/1755-8794-7-13; Surtees P, 2003, INT J BEHAV MED, V10, P251, DOI 10.1207/S15327558IJBM1003_05; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Szyf M, 2013, J GENET GENOMICS, V40, P331, DOI 10.1016/j.jgg.2013.06.004; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Turecki G, 2016, BIOL PSYCHIAT, V79, P87, DOI 10.1016/j.biopsych.2014.11.022; Tyson P., 1990, PSYCHOANALYTIC THEOR; UNICEF, 2009, PROGR CHILDR REP CAR; Vaglio Stefano, 2009, Commun Integr Biol, V2, P279; van Ijzendoorn MH, 2008, MERRILL PALMER QUART, V54, P341; van IJzendoorn MH, 2011, MONOGR SOC RES CHILD, V76, P8, DOI 10.1111/j.1540-5834.2011.00626.x; VanTieghem MR, 2018, CURR TOP BEHAV NEURO, V38, P117, DOI 10.1007/7854_2016_42; Ventola P, 2014, J AUTISM DEV DISORD, V44, P283, DOI 10.1007/s10803-011-1278-x; Vinkers CH, 2015, EPIGENOMICS-UK, V7, P593, DOI [10.2217/EPI.15.11, 10.2217/epi.15.11]; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Wright ML, 2017, J CLIN TRANSL SCI, V1, P328, DOI 10.1017/cts.2018.3; Wright RJ, 2004, J ALLERGY CLIN IMMUN, V113, P1051, DOI 10.1016/j.jaci.2004.03.032; Yasuda H, 2016, EXP ANIM TOKYO, V65, P267, DOI 10.1538/expanim.15-0115; Zeanah CH, 2011, MONOGR SOC RES CHILD, V76, P147, DOI 10.1111/j.1540-5834.2011.00631.x; Zou LQ, 2016, SCI REP-UK, V6, DOI 10.1038/srep25026	91	13	13	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2019	14	3							e0214285	10.1371/journal.pone.0214285	http://dx.doi.org/10.1371/journal.pone.0214285			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HQ3IW	30913238	gold, Green Published, Green Submitted			2022-12-26	WOS:000462305600037
J	Clark, C; Berry, C; Demczuk, W				Clark, Clifford; Berry, Chrystal; Demczuk, Walter			Diversity of transducer-like proteins (Tlps) in Campylobacter	PLOS ONE			English	Article							ASPARTATE CHEMOSENSORY RECEPTOR; COMPARATIVE GENOMICS; JEJUNI CHEMOTAXIS; SEQUENCE; MECHANISMS; VIRULENCE; ALIGNMENT; STRAINS; BURDEN; DOMAIN	Campylobacter transducer-like proteins (Tlps), also known as methyl-accepting chemotaxis proteins (MCPs), are associated with virulence as well as niche and host adaptation. While functional attributes of these proteins are being elucidated, little has been published regarding their sequence diversity or chromosomal locations and context, although they appear to define invertible regions within Campylobacter jejuni genomes. Genome assemblies for several species of Campylobacter were obtained from the publicly available NCBI repositories. Genomes from all isolates were obtained from GenBank and assessed for Tlp content, while data from isolates with complete, finished genomes were used to determine the identity of Tlps as well as the gene content of putative invertible elements (IEs) in C. jejuni (Cj) and C. coli (Cc). Tlps from several Campylobacter species were organized into a nomenclature system and novel Tlps were defined and named for Cj and Cc. The content of Tlps appears to be species-specific, though diverse within species. Cj and Cc carried overlapping, related Tlp content, as did the three C. fetus subspecies. Tlp1 was detected in 88% of Cj isolates and approximately 43% of Cc, and was found in a different conserved chromosomal location and genetic context in each species. Tlp1 and Tlp 3 predominated in genomes from Cj whereas other Tlps were detected less frequently. Tlp13 and Tlp20 predominated in genomes from Cc while some Cj/Cc Tlps were not detected at all. Tlps 2-4 and 11-20 were less frequently detected and many showed sequence heterogeneity that could affect substrate binding, signal transduction, or both. Tlps other than Tlp1, 7, and 10 had substantial sequence identity in the C-terminal half of the protein, creating chromosomal repeats potentially capable of mediating the inversion of large chromosomal DNA. Cj and Cc Tlps were both found in association with only 14 different genes, indicating a limited genomic context. In Cj these Tlps defined IEs that were for the most part found at a single chromosomal location and comprised of a conserved set of genes. Cc IEs were situated at very different chromosomal locations, had different structures than Cj IEs, and were occasionally incomplete, therefore not capable of inversion. Tlps may have a role in Campylobacter genome structure and dynamics as well as acting as chemoreceptors mediating chemotactic responses.	[Clark, Clifford; Berry, Chrystal] Publ Hlth Agcy Canada, Natl Microbiol Lab, Div Enter Dis, Winnipeg, MB, Canada; [Demczuk, Walter] Publ Hlth Agcy Canada, Natl Microbiol Lab, Streptococci & STI Unit, Winnipeg, MB, Canada	Public Health Agency of Canada; Public Health Agency of Canada	Clark, C (corresponding author), Publ Hlth Agcy Canada, Natl Microbiol Lab, Div Enter Dis, Winnipeg, MB, Canada.	clifford.clark@canada.ca	; Demczuk, Walter/K-5994-2016	Clark, Clifford/0000-0003-0566-1468; Demczuk, Walter/0000-0003-3723-9843				Vu A, 2012, J MOL BIOL, V415, P759, DOI 10.1016/j.jmb.2011.11.043; Bolton DJ, 2015, FOOD MICROBIOL, V48, P99, DOI 10.1016/j.fm.2014.11.017; Casey E, 2017, BRIT J BIOMED SCI, V74, P53, DOI 10.1080/09674845.2017.1291205; Chandrashekhar K, 2017, GUT MICROBES, V8, P323, DOI 10.1080/19490976.2017.1279380; Clark CG, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3340; Coker AO, 2002, EMERG INFECT DIS, V8, P237, DOI 10.3201/eid0803.010233; Day CJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13206; Day CJ, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-128; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fahmy D, 2012, ARCH MICROBIOL, V194, P57, DOI 10.1007/s00203-011-0754-1; Fouts DE, 2005, PLOS BIOL, V3, P72, DOI 10.1371/journal.pbio.0030015; Gilbert MJ, 2016, GENOME BIOL EVOL, V8, P2006, DOI 10.1093/gbe/evw146; Gupta RS, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-167; Hartley-Tassell LE, 2010, MOL MICROBIOL, V75, P710, DOI 10.1111/j.1365-2958.2009.07010.x; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Kaakoush NO, 2015, CLIN MICROBIOL REV, V28, P687, DOI 10.1128/CMR.00006-15; Kaakoush NO, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00004; Kirk KF, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20135-4; Korolik V, 2010, VIRULENCE, V1, P414, DOI 10.4161/viru.1.5.12735; Korolik V, 2008, CAMPYLOBACTER, 3RD EDITION, P351; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Larsson A, 2014, BIOINFORMATICS, V30, P3276, DOI 10.1093/bioinformatics/btu531; Lee S, 2016, J MICROBIOL, V54, P459, DOI 10.1007/s12275-016-6254-x; Li ZF, 2014, J MED MICROBIOL, V63, P343, DOI 10.1099/jmm.0.068023-0; Liu YC, 2015, ACTA CRYSTALLOGR D, V71, P2127, DOI 10.1107/S139900471501384X; Lubke AL, 2018, BMC MICROBIOL, V18, DOI 10.1186/s12866-018-1254-0; Machuca MA, 2016, J STRUCT BIOL, V194, P205, DOI 10.1016/j.jsb.2016.02.019; Man SM, 2011, NAT REV GASTRO HEPAT, V8, P669, DOI 10.1038/nrgastro.2011.191; Manna D, 2005, J BACTERIOL, V187, P3586, DOI 10.1128/JB.187.10.3586-3588.2005; Manna D, 2004, P NATL ACAD SCI USA, V101, P9780, DOI 10.1073/pnas.0400745101; Marchant J, 2002, TRENDS MICROBIOL, V10, P155, DOI 10.1016/S0966-842X(02)02323-5; Marchler-Bauer A, 2017, NUCLEIC ACIDS RES, V45, pD200, DOI 10.1093/nar/gkw1129; Miller WG, 2014, GENOME BIOL EVOL, V6, P3252, DOI 10.1093/gbe/evu249; Mund NLA, 2016, EUR J MICROBIOL IMMU, V6, P162, DOI 10.1556/1886.2015.00041; O'Brien SJ, 2017, CURR OPIN GASTROEN, V33, P14, DOI 10.1097/MOG.0000000000000329; Ortega A, 2017, MICROBIOL MOL BIOL R, V81, DOI 10.1128/MMBR.00033-17; Parker CT, 2006, J CLIN MICROBIOL, V44, P4125, DOI 10.1128/JCM.01231-06; Parsons BN, 2012, VET MICROBIOL, V157, P391, DOI 10.1016/j.vetmic.2011.12.035; Platts-Mills JA, 2014, CURR OPIN INFECT DIS, V27, P444, DOI 10.1097/QCO.0000000000000091; Rahman H, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003822; Scott AE, 2007, PLOS PATHOG, V3, P1142, DOI 10.1371/journal.ppat.0030119; Shen W, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163962; Sheppard SK, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a018119; Sheppard SK, 2013, MOL ECOL, V22, P1051, DOI 10.1111/mec.12162; Silva J, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00200; Sneath P.H.A., 1973, NUMERICAL TAXONOMY P; Thomas MK, 2013, FOODBORNE PATHOG DIS, V10, P639, DOI 10.1089/fpd.2012.1389; Upadhyay AA, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004862; van der Graaf-van Bloois L, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3058-7; Zhang MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015060; Zuckerkandl E, 1965, EVOLVING GENES PROTE, P97, DOI DOI 10.1016/B978-1-4832-2734-4.50017-6	51	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2019	14	3							e0214228	10.1371/journal.pone.0214228	http://dx.doi.org/10.1371/journal.pone.0214228			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ1KV	30908544	Green Published, Green Submitted, gold			2022-12-26	WOS:000462157600045
J	Guan, YY; Li, G; Chu, ZL; Ru, ZG; Jiang, XL; Wen, ZP; Zhang, G; Wang, YQ; Zhang, Y; Wei, WH				Guan, Yuanyuan; Li, Gan; Chu, Zongli; Ru, Zhengang; Jiang, Xiaoling; Wen, Zhaopu; Zhang, Guang; Wang, Yuquan; Zhang, Yang; Wei, Wenhui			Transcriptome analysis reveals important candidate genes involved in grain-size formation at the stage of grain enlargement in common wheat cultivar "Bainong 4199"	PLOS ONE			English	Article							DIFFERENTIALLY EXPRESSED GENES; SEED SIZE; REGULATES SEED; ORGAN SIZE; IDENTIFICATION; PROTEIN; WEIGHT; QTL; EMBRYO; STARCH	Grain-size is one of the yield components, and the first 14 days after pollination (DAP) is a crucial stage for wheat grain-size formation. To understand the mechanism of grain-size formation at the whole gene expression level and to identify the candidate genes related to grain pattern formation, cDNA libraries from immature grains of 5 DAP and 14 DAP were constructed. According to transcriptome analysis, a total of 12,555 new genes and 9,358 differentially expressed genes (DEGs) were obtained. In DEGs, 2,876, 3,357 and 3,125 genes were located on A, B and D subgenome respectively. 9,937 (79.15%) new genes and 9,059 (96.80%) DEGs were successfully annotated. For DEGs, 4,453 were up-regulated and 4,905 were down-regulated at 14 DAP. The Gene Ontology (GO) database indicated that most of the grain-size-related genes were in the same cluster. The Kyoto Encyclopedia of Genes and Genomes (KEGG) database analysis showed that 130, 129 and 20 DEGs were respectively involved in starch and sucrose metabolism, plant hormone signal transduction and ubiquitin-mediated proteolysis. Expression levels of 8 randomly selected genes were confirmed by qRT-PCR, which was consistent with the transcriptome data. The present database will help us understand the molecular mechanisms underlying early grain development and provide the foundation for increasing grain-size and yield in wheat breeding programs.	[Guan, Yuanyuan; Li, Gan; Ru, Zhengang; Jiang, Xiaoling; Wen, Zhaopu; Zhang, Guang; Wang, Yuquan; Zhang, Yang; Wei, Wenhui] Henan Inst Sci & Technol, Coll Life Sci & Technol, Collaborat Innovat Ctr Modern Biol Breeding, Xinxiang, Henan, Peoples R China; [Chu, Zongli] Xinyang Agr & Forestry Univ, Xinyang, Peoples R China	Henan Institute of Science & Technology; Xinyang Agriculture & Forestry University	Ru, ZG; Wei, WH (corresponding author), Henan Inst Sci & Technol, Coll Life Sci & Technol, Collaborat Innovat Ctr Modern Biol Breeding, Xinxiang, Henan, Peoples R China.	rzgh58@163.com; whwei88@hotmail.com			National Natural Science Foundation of China [31371664]; National Key Research and Development Program of China [2017YFD0100705]; Key Project of Henan Natural Science Foundation [182300410002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; Key Project of Henan Natural Science Foundation	This work was funded by the National Natural Science Foundation of China (grant no. 31371664 to WW), the National Key Research and Development Program of China (grant no. 2017YFD0100705 to ZR) and the Key Project of Henan Natural Science Foundation (grant no. 182300410002 to WW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammiraju JSS, 2001, THEOR APPL GENET, V102, P726, DOI 10.1007/s001220051703; Bednarek J, 2012, J EXP BOT, V63, P5945, DOI 10.1093/jxb/ers249; Chen J, 2014, PLANT PHYSIOL, V166, P252, DOI 10.1104/pp.114.240689; Dai XY, 2016, J EXP BOT, V67, P947, DOI 10.1093/jxb/erv515; Du L, 2014, PLANT CELL, V26, P665, DOI 10.1105/tpc.114.122663; Eversole K, 2014, SCIENCE, V345, P285, DOI 10.1126/science.1257983; Fromm S, 2016, NEW PHYTOL, V211, P194, DOI 10.1111/nph.13886; Garcia D, 2003, PLANT PHYSIOL, V131, P1661, DOI 10.1104/pp.102.018762; Geng XX, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191297; Hauvermale AL, 2012, PLANT PHYSIOL, V160, P83, DOI 10.1104/pp.112.200956; Huang JY, 2011, MOL BIOL REP, V38, P1055, DOI 10.1007/s11033-010-0202-3; Jones SI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059270; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kato N, 2007, PLANT CELL PHYSIOL, V48, P8, DOI 10.1093/pcp/pcl041; Le Roy J, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00735; Liu XW, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4654-5; Lu J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144765; Ma M, 2016, J EXP BOT, V67, P1397, DOI 10.1093/jxb/erv542; Mechin V, 2007, PLANT PHYSIOL, V143, P1203, DOI 10.1104/pp.106.092148; Qi P, 2012, CELL RES, V22, P1666, DOI 10.1038/cr.2012.151; Qin R, 2018, GENES-BASEL, V9, DOI 10.3390/genes9060292; Robert HS, 2015, DEVELOPMENT, V142, P702, DOI 10.1242/dev.115832; Schruff MC, 2006, DEVELOPMENT, V133, P251, DOI 10.1242/dev.02194; Scofield GN, 2002, FUNCT PLANT BIOL, V29, P815, DOI 10.1071/PP01204; Sha AH, 2012, MOL BIOL REP, V39, P2867, DOI 10.1007/s11033-011-1046-1; Shewry PR, 2012, J CEREAL SCI, V56, P21, DOI 10.1016/j.jcs.2011.11.007; Shi JQ, 2009, GENETICS, V182, P851, DOI 10.1534/genetics.109.101642; Song XJ, 2007, NAT GENET, V39, P623, DOI 10.1038/ng2014; Su ZQ, 2011, THEOR APPL GENET, V122, P211, DOI 10.1007/s00122-010-1437-z; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wan YF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-121; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang SJ, 2014, J AGR FOOD CHEM, V62, P3636, DOI 10.1021/jf500249w; Wei WH, 2008, PLANT SCI, V175, P663, DOI 10.1016/j.plantsci.2008.06.018; Weichert N, 2010, PLANT PHYSIOL, V152, P698, DOI 10.1104/pp.109.150854; Weng JF, 2008, CELL RES, V18, P1199, DOI 10.1038/cr.2008.307; Weschke W, 2000, PLANT J, V21, P455, DOI 10.1046/j.1365-313x.2000.00695.x; Williams K, 2014, CROP SCI, V54, P98, DOI 10.2135/cropsci2012.10.0609; Xia T, 2013, PLANT CELL, V25, P3347, DOI 10.1105/tpc.113.115063; Xiang DQ, 2011, PLANT PHYSIOL, V156, P346, DOI 10.1104/pp.110.171702; Xu H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030646; Xu Z, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195913; Yang MM, 2016, J PROTEOMICS, V136, P157, DOI 10.1016/j.jprot.2016.01.002; Zhang YJ, 2014, MOL BREEDING, V34, P1097, DOI 10.1007/s11032-014-0102-7	46	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2019	14	3							e0214149	10.1371/journal.pone.0214149	http://dx.doi.org/10.1371/journal.pone.0214149			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ1KV	30908531	Green Published, gold, Green Submitted			2022-12-26	WOS:000462157600041
J	Romley, J; Trish, E; Goldman, D; Buntin, MB; He, YL; Ginsburg, P				Romley, John; Trish, Erin; Goldman, Dana; Buntin, Melinda Beeuwkes; He, Yulei; Ginsburg, Paul			Geographic variation in the delivery of high-value inpatient care	PLOS ONE			English	Article							HOSPITAL COSTS; REGIONAL-VARIATIONS; HEALTH-CARE; PRODUCTIVITY GROWTH; MORTALITY; QUALITY; RATES; RISK	Objectives To measure value in the delivery of inpatient care and to quantify its variation across U.S. regions. Data sources / Study setting A random (20%) sample of 33,713 elderly fee-for-service Medicare beneficiaries treated in 2,232 hospitals for a heart attack in 2013. Study design We estimate a production function for inpatient care, defining output as stays with favorable patient outcomes in terms of survival and readmission. The regression model includes hospital inputs measured by treatment costs, as well as patient characteristics. Region-level effects in the production function are used to estimate the productivity and value of the care delivered by hospitals within regions. Data collection / Extraction methods Medicare claims and enrollment files, linked to the Dartmouth Atlas of Health Care and Inpatient Prospective Payment System Impact Files. Principal findings Hospitals in the hospital referral region at the 90th percentile of the value distribution delivered 54% more high-quality stays than hospitals at the 10th percentile could have delivered, after adjusting for treatment costs and patient severity. Conclusions Variation in the delivery of high-value inpatient care points to opportunities for better quality and lower costs.	[Romley, John; Goldman, Dana; Ginsburg, Paul] Univ Southern Calif, Price Sch Publ Policy, Los Angeles, CA 90089 USA; [Romley, John; Trish, Erin; Goldman, Dana] Univ Southern Calif, Sch Pharm, Los Angeles, CA 90089 USA; [Buntin, Melinda Beeuwkes] Vanderbilt Univ, 221 Kirkland Hall, Nashville, TN 37235 USA; [He, Yulei] Univ Maryland, Univ Coll, Adelphi, MD USA; [Ginsburg, Paul] Brookings Inst, Washington, DC 20036 USA	University of Southern California; University of Southern California; Vanderbilt University; University System of Maryland; University of Maryland University College; Brookings Institution	Romley, J (corresponding author), Univ Southern Calif, Price Sch Publ Policy, Los Angeles, CA 90089 USA.; Romley, J (corresponding author), Univ Southern Calif, Sch Pharm, Los Angeles, CA 90089 USA.	romley@healthpolicy.usc.edu	Goldman, Dana P/E-7667-2013	Goldman, Dana P/0000-0001-8498-6396; He, Yulei/0000-0002-8451-5452	Commonwealth Fund; National Institute on Aging	Commonwealth Fund; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the Commonwealth Fund and the National Institute on Aging. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agency for Healthcare Quality and Research, 2008, GUID INP QUAL IND; [Anonymous], 2008, MODE PATIENT MIX ADJ; [Anonymous], HOSP VAL BAS PURCH; Bradley EH, 2005, MED CARE, V43, P282, DOI 10.1097/00005650-200503000-00011; Carey K, 1997, REV ECON STAT, V79, P443, DOI 10.1162/003465300556850; Centers for Medicare & Medicaid Services, WHAT AR VAL BAS PROG; Chandra A, 2007, J POLIT ECON, V115, P103, DOI 10.1086/512249; CMS, MEAS METH; CMS.gov, FY 16 IMP FIL; CONRAD RF, 1983, APPL ECON, V15, P341, DOI 10.1080/00036848300000005; COWING TG, 1983, SOUTHERN ECON J, V49, P637, DOI 10.2307/1058706; Curry LA, 2011, ANN INTERN MED, V154, P384, DOI 10.7326/0003-4819-154-6-201103150-00003; Dor A, 1996, J HEALTH ECON, V15, P1, DOI 10.1016/0167-6296(95)00029-1; Doyle JJ, 2011, AM ECON J-APPL ECON, V3, P221, DOI 10.1257/app.3.3.221; Dranove D, 1998, J HEALTH ECON, V17, P69, DOI 10.1016/S0167-6296(97)00013-1; Farsi M, 2008, HEALTH ECON, V17, P335, DOI 10.1002/hec.1268; Fisher ES, 2003, ANN INTERN MED, V138, P288, DOI 10.7326/0003-4819-138-4-200302180-00007; Fisher ES, 2003, ANN INTERN MED, V138, P273, DOI 10.7326/0003-4819-138-4-200302180-00006; FOURNIER GM, 1992, REV ECON STAT, V74, P627, DOI 10.2307/2109376; GAYNOR M, 1995, J HEALTH ECON, V14, P291, DOI 10.1016/0167-6296(95)00004-2; Gaynor MS, 2015, J APPL ECONOMET, V30, P398, DOI 10.1002/jae.2371; GRANNEMANN TW, 1986, J HEALTH ECON, V5, P107, DOI 10.1016/0167-6296(86)90001-9; Institute of Medicine, 2013, VARIATION HLTH CARE, DOI [10.17226/18393, DOI 10.17226/18393]; Jena AB, 2013, CIRCULATION, V128, P2754, DOI 10.1161/CIRCULATIONAHA.113.004074; MaCurdy T, 2009, REVISION MEDICARE WA; Markovitz AA, 2017, MED CARE RES REV, V74, P3, DOI 10.1177/1077558715619282; McKellar MR, 2017, HEALTH SERV RES, V52, P849, DOI 10.1111/1475-6773.12501; Medicare Payment Advisory Commission, 2012, REP C MED PAYM POL; Murphy S., 2013, DEATHS FINAL DATA 20; National Center for Health Statistics, NAT HOSP DISCH SURV; Olley GS, 1996, ECONOMETRICA, V64, P1263, DOI 10.2307/2171831; Porter ME, 2009, NEW ENGL J MED, V361, P109, DOI 10.1056/NEJMp0904131; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Romley JA, 2015, HEALTH AFFAIR, V34, P511, DOI 10.1377/hlthaff.2014.0587; Romley JA, 2011, ANN INTERN MED, V154, P160, DOI 10.7326/0003-4819-154-3-201102010-00005; Skinner J, 2016, JAMA-J AM MED ASSOC, V316, P497, DOI 10.1001/jama.2016.10158; Skinner J, 2015, REV ECON STAT, V97, P951, DOI 10.1162/REST_a_00535; Song YJ, 2010, NEW ENGL J MED, V363, P45, DOI 10.1056/NEJMsa0910881; StataCorp, STAT MULT MIX EFF RE; Tsai TC, 2013, NEW ENGL J MED, V369, P1134, DOI 10.1056/NEJMsa1303118; United States Census Bureau, AM COMMUNITY SURVEY; VITA MG, 1990, J HEALTH ECON, V9, P1, DOI 10.1016/0167-6296(90)90038-5; Volpp KG, 2007, JAMA-J AM MED ASSOC, V298, P984, DOI 10.1001/jama.298.9.984; Volpp KG, 2007, JAMA-J AM MED ASSOC, V298, P975, DOI 10.1001/jama.298.9.975; Welch HG, 2011, JAMA-J AM MED ASSOC, V305, P1113, DOI 10.1001/jama.2011.307; Wennberg JE., 1996, DARTMOUTH ATLAS HLTH, P15; Wooldridge J., 2002, ECONOMETRIC ANAL CRO; ZUCKERMAN S, 1994, J HEALTH ECON, V13, P255, DOI 10.1016/0167-6296(94)90027-2; Zuckerman S, 2010, NEW ENGLAND J MED	49	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2019	14	3							e0213647	10.1371/journal.pone.0213647	http://dx.doi.org/10.1371/journal.pone.0213647			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HQ1KV	30908492	Green Submitted, gold, Green Published			2022-12-26	WOS:000462157600013
J	Lofthouse, EM; Torrens, C; Manousopoulou, A; Nahar, M; Cleal, JK; O'Kelly, IM; Sengers, BG; Garbis, SD; Lewis, RM				Lofthouse, Emma M.; Torrens, Christopher; Manousopoulou, Antigoni; Nahar, Monica; Cleal, Jane K.; O'Kelly, Ita M.; Sengers, Bram G.; Garbis, Spiros D.; Lewis, Rohan M.			Ursodeoxycholic acid inhibits uptake and vasoconstrictor effects of taurocholate in human placenta	FASEB JOURNAL			English	Article						OATP4A1; membrane transport; vasoconstriction	INTRAHEPATIC-CHOLESTASIS; BILE-ACIDS; PREGNANCY; MODEL	Intrahepatic cholestasis of pregnancy (ICP) causes increased transfer of maternal bile acids to the fetus and an increased incidence of sudden fetal death. Treatment includes ursodeoxycholic acid (UDCA), but it is not clear if UDCA protects the fetus. This study explores the placental transport of the bile acid taurocholate (TC) by the organic anion-transporting polypeptide, (OATP)4A1, its effects on the placental proteome and vascular function, and how these are modified by UDCA. Various methodological approaches including placental villous fragments and Xenopus laevis oocytes were used to investigate UDCA transport. Placental perfusions and myography investigated the effect of TC on vasculature. The effects of acute TC exposure on placental tissue were investigated using quantitative proteomics. UDCA inhibited OATP4A1 activity in placental villous fragments and oocytes. TC induced vasoconstriction in placental and rat vasculature, which was attenuated by UDCA. Quantitative proteomic analysis of villous fragments showed direct effects of TC on multiple placental pathways, including oxidative stress and autophagy. The effects of TC on the placental proteome and vasculature demonstrate how bile acids may cause fetal distress in ICP. UDCA inhibition of OATP4A1 suggests it will protect the mother and fetus against the vascular effects of TC by inhibiting its cellular uptake. UDCA may protect the fetus in ICP by inhibiting OATP4A1-mediated bile acid transfer and TC-induced placental vasoconstriction. Understanding the physiologic mechanisms of UDCA may allow better therapeutic interventions to be designed specifically for the fetus in the future.-Lofthouse, E. M., Torrens, C., Manousopoulou, A., Nahar, M., Cleal, J. K., O'Kelly, I. M., Sengers, B. G., Garbis, S. D., Lewis, R. M. Ursodeoxycholic acid inhibits uptake and vasoconstrictor effects of taurocholate in human placenta.	[Lofthouse, Emma M.; Torrens, Christopher; Manousopoulou, Antigoni; Nahar, Monica; Cleal, Jane K.; O'Kelly, Ita M.; Garbis, Spiros D.; Lewis, Rohan M.] Univ Southampton, Fac Med, Southampton, Hants, England; [Lofthouse, Emma M.; Torrens, Christopher; Sengers, Bram G.; Garbis, Spiros D.; Lewis, Rohan M.] Univ Southampton, Inst Life Sci, Southampton, Hants, England; [Cleal, Jane K.; Sengers, Bram G.] Univ Southampton, Fac Engn, Southampton, Hants, England; [Garbis, Spiros D.] CALTECH, Beckman Inst, Div Biol & Biol Engn, Proteome Explorat Lab, Pasadena, CA 91125 USA	University of Southampton; University of Southampton; University of Southampton; California Institute of Technology	Lofthouse, EM (corresponding author), Univ Southampton, Southampton Gen Hosp, Fac Med, MP 887 IDS Bldg,Tremona Rd, Southampton SO16 6YD, Hants, England.	e.m.lofthouse@soton.ac.uk	Cleal, Jane/AAC-9070-2019; Cleal, Jane/AAC-5062-2019; Lewis, Rohan/C-9350-2011; Garbis, Spiros/L-3099-2013	Cleal, Jane/0000-0001-7978-4327; Lewis, Rohan/0000-0003-4044-9104; Lofthouse, Emma/0000-0002-0175-5590; Garbis, Spiros/0000-0002-1050-0805	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/L020823/1, BB/R002762/1]; BBSRC [BB/R002762/1, BB/L020823/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors thank the midwives at the Princess Anne Hospital (Southampton, United Kingdom) for their assistance in collecting placentas. This work was funded by project grants from the Biotechnology and Biological Sciences Research Council (BBSRC) (BB/L020823/1 and BB/R002762/1). The authors declare no conflicts of interest.	Ajouz H, 2014, WORLD J SURG ONCOL, V12, DOI 10.1186/1477-7819-12-164; Chappell LC, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.k104; Cleal JK, 2011, J PHYSIOL-LONDON, V589, P987, DOI 10.1113/jphysiol.2010.198549; Desai MS, 2013, HEART, V99, P1629, DOI 10.1136/heartjnl-2013-304546; Dolinsky BM, 2014, J REPROD MED, V59, P367; Estiu MC, 2015, BRIT J CLIN PHARMACO, V79, P316, DOI 10.1111/bcp.12480; Fujiwara K, 2001, ENDOCRINOLOGY, V142, P2005, DOI 10.1210/en.142.5.2005; Geenes VL, 2011, PLACENTA, V32, P1026, DOI 10.1016/j.placenta.2011.09.006; Geenes V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083828; Geenes V, 2014, HEPATOLOGY, V59, P1482, DOI 10.1002/hep.26617; Ghosh Sangita, 2013, Indian J Dermatol, V58, P327, DOI 10.4103/0019-5154.113971; Gorelik J, 2002, CLIN SCI, V103, P191, DOI 10.1042/cs1030191; Gu H., 2017, HAINAN YIXUEYUAN XUE, V23, P70; Imai Y, 2003, MOL PHARMACOL, V64, P610, DOI 10.1124/mol.64.3.610; Joutsiniemi T, 2015, BMC GASTROENTEROL, V15, DOI 10.1186/s12876-015-0324-0; Lee P, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-1; Lofthouse EM, 2018, BIOCHEM BIOPH RES CO, V506, P237, DOI 10.1016/j.bbrc.2018.10.074; MANDRUZZATO GP, 1991, ULTRASOUND OBST GYN, V1, P192, DOI 10.1046/j.1469-0705.1991.01030192.x; Manousopoulou A, 2017, NEUROPATH APPL NEURO, V43, P492, DOI 10.1111/nan.12342; Manousopoulou A, 2016, NUTR DIABETES, V6, DOI 10.1038/nutd.2016.10; Miragoli M, 2011, HEPATOLOGY, V54, P1282, DOI 10.1002/hep.24492; Papacleovoulou G, 2013, J CLIN INVEST, V123, P3172, DOI 10.1172/JCI68927; Patel P, 2003, PLACENTA, V24, P39, DOI 10.1053/plac.2002.0879; Patel S, 2014, FETAL PEDIATR PATHOL, V33, P210, DOI 10.3109/15513815.2014.899413; Roma MG, 2011, CLIN SCI, V121, P523, DOI 10.1042/CS20110184; SCHNEIDE.H, 1972, AM J OBSTET GYNECOL, V114, P822, DOI 10.1016/0002-9378(72)90909-X; SEPULVEDA WH, 1991, EUR J OBSTET GYN R B, V42, P211, DOI 10.1016/0028-2243(91)90222-7; Shemer EW, 2013, BJOG-INT J OBSTET GY, V120, P717, DOI 10.1111/1471-0528.12174; SHNEIDER BL, 1993, J BIOL CHEM, V268, P6985; Wang H., 2014, J INT OBSTET GYNECOL, V41, P692; Williamson C, 2001, CLIN SCI, V100, P363, DOI 10.1042/CS20000164; Xia YM, 2018, BIOPHARM DRUG DISPOS, V39, P335, DOI 10.1002/bdd.2150; Zhang T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083281; Zhang YH, 2016, J MOL CELL BIOL, V8, P530, DOI 10.1093/jmcb/mjw025	34	18	19	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2019	33	7					8211	8220		10.1096/fj.201900015RR	http://dx.doi.org/10.1096/fj.201900015RR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ9SM	30922127	hybrid, Green Published, Green Accepted			2022-12-26	WOS:000476234700033
J	Yamada, M; Iwata, M; Warabi, E; Oish, H; Lira, VA; Okutsu, M				Yamada, Mami; Iwata, Masahiro; Warabi, Eiji; Oish, Hisashi; Lira, Vitor A.; Okutsu, Mitsuharu			p62/SQSTM1 and Nrf2 are essential for exercise-mediated enhancement of antioxidant protein expression in oxidative muscle	FASEB JOURNAL			English	Article						glycolytic skeletal muscle; voluntary running; CuZnSOD; EcSOD; NQO1	CUL3-BASED E3 LIGASE; NRF2-KEAP1 PATHWAY; AUTOPHAGY; P62; ADAPTER; ADAPTATION; DEFICIENCY; MECHANISMS; MICE	Increased muscle contractile activity, as observed with regular exercise, prevents oxidative stress-induced muscle wasting, at least partially, by improving the antioxidant defense system. Phosphorylated p62/sequestosome1 competitively binds to the Kelch-like ECH-associated protein 1, activating nuclear factor erythroid 2-related factor 2 (Nrf2), which stimulates transcription of antioxidant/electrophile responsive elements. However, it remains to be determined if this process is activated by regular exercise in skeletal muscle. Here, we demonstrate that muscle contractile activity increases antioxidants, Nrf2 translocation into nuclei, and Nrf2 DNA-binding activity in association with increased p62 phosphorylation (Ser351) in mouse oxidative skeletal muscle. Skeletal muscle-specific loss of Nrf2 [i.e., Nrf2 muscle-specific knockout (mKO) mice] abolished the expression of the Nrf2 target antioxidant gene NAD(P)H-quinone oxidoreductase 1 (NQO1) in both glycolytic and oxidative muscles but reduced exercise-mediated increases of antioxidants (i.e., copper/zinc superoxide dismutase (SOD) and extracellular SOD only in oxidative muscle. Interestingly, skeletal muscle-specific loss of p62 (i.e., p62 mKO mice) also abolished the expression of NQO1 and reduced exercise-mediated increases of the same antioxidants in soleus muscle. Collectively, these findings indicate that p62 and Nrf2 cooperatively regulate the exercise-mediated increase of antioxidants in oxidative muscle.-Yamada, M., Iwata, M., Warabi, E., Oishi, H., Lira, V. A., Okutsu, M. p62/SQSTM1 and Nrf2 are essential for exercise-mediated enhancement of antioxidant protein expression in oxidative muscle.	[Yamada, Mami; Okutsu, Mitsuharu] Nagoya City Univ, Grad Sch Nat Sci, Nagoya, Aichi, Japan; [Oish, Hisashi] Nagoya City Univ, Dept Comparat & Expt Med, Grad Sch Med Sci, Nagoya, Aichi, Japan; [Iwata, Masahiro] Nihon Fukushi Univ, Dept Rehabil, Fac Hlth Sci, Handa, Japan; [Warabi, Eiji] Univ Tsukuba, Fac Med, Tsukuba, Ibaraki, Japan; [Lira, Vitor A.] Univ Iowa, Dept Hlth & Human Physiol, Pappajohn Biomed Inst,Obes Res & Educ Initiat, Diabet Res Ctr,Abboud Cardiovasc Res Ctr,FOE, Iowa City, IA USA	Nagoya City University; Nagoya City University; University of Tsukuba; University of Iowa	Okutsu, M (corresponding author), Nagoya City Univ, Grad Sch Nat Sci, Mizuho Ku, Yamanohata 1,Mizuho Cho, Nagoya, Aichi 4678501, Japan.	okutsu@nsc.nagoya-cu.ac.jp	Lira, Vitor/AAN-3403-2021	Lira, Vitor/0000-0002-3162-3804	Suzuken Memorial Foundation; Toyoaki Scholarship Foundation; The Nakatomi Foundation; The Uehara Memorial Foundation;  [25882036];  [15H03080];  [18H03153]	Suzuken Memorial Foundation; Toyoaki Scholarship Foundation(Toyoaki Scholarship Foundation); The Nakatomi Foundation; The Uehara Memorial Foundation(Uehara Memorial Foundation); ; ; 	The authors thank Dr. Steven J. Burden (New York University, New York, New York, USA), Dr. Toru Yanagawa (University of Tsukuba), and Dr. Jingbo Pi (China Medical University, Shenyang, China) for their generosity in providing mlc1-cre mice, p62 flox mice, and Nrf2 flox, respectively. The authors also thank Dr. Ichiro Miyoshi, Dr. Masayuki Yamamoto, Dr. Takahumi Suzuki (all from Tohuku University, Sendai, Japan) and Yasuo Kitajima (Kumamoto University, Kumamoto, Japan) for the transfer arrangements for the mice. The authors thank Yasuhiko Hayakawa (Nepa Gene, Ichikawa, Japan) for his excellent technical support in plasmid transfection. This study was supported by Grant-in-Aid for Research Activity Start-Up (25882036), Grant-in-Aid for Scientific Research (B) (15H03080), Grant-in-Aid for Scientific Research (B) (18H03153), the Suzuken Memorial Foundation, Toyoaki Scholarship Foundation, The Nakatomi Foundation, and The Uehara Memorial Foundation (to M.O.). The authors declare no conflicts of interest.	Akimoto T, 2004, AM J PHYSIOL-CELL PH, V287, pC1311, DOI 10.1152/ajpcell.00248.2004; Bothe GWM, 2000, GENESIS, V26, P165, DOI 10.1002/(SICI)1526-968X(200002)26:2<165::AID-GENE22>3.0.CO;2-F; Cullinan SB, 2004, MOL CELL BIOL, V24, P8477, DOI 10.1128/MCB.24.19.8477-8486.2004; Done AJ, 2016, FREE RADICAL BIO MED, V96, P130, DOI 10.1016/j.freeradbiomed.2016.04.024; Harada H, 2013, J NEUROSCI, V33, P14767, DOI 10.1523/JNEUROSCI.2954-12.2013; Horie M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144835; Ichimura Y, 2013, MOL CELL, V51, P618, DOI 10.1016/j.molcel.2013.08.003; Iwata M, 2007, PATHOBIOLOGY, V74, P159, DOI 10.1159/000103375; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Katsuragi Y, 2015, FEBS J, V282, P4672, DOI 10.1111/febs.13540; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Kobayashi A, 2004, METHOD ENZYMOL, V378, P273; Kobayashi M, 2005, ANTIOXID REDOX SIGN, V7, P385, DOI 10.1089/ars.2005.7.385; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Komatsu M, 2012, PHARMACOL RES, V66, P457, DOI 10.1016/j.phrs.2012.07.004; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Lira VA, 2013, FASEB J, V27, P4184, DOI 10.1096/fj.13-228486; Masiero E, 2009, CELL METAB, V10, P507, DOI 10.1016/j.cmet.2009.10.008; Muthusamy VR, 2012, FREE RADICAL BIO MED, V52, P366, DOI 10.1016/j.freeradbiomed.2011.10.440; Nezis IP, 2012, ANTIOXID REDOX SIGN, V17, P786, DOI 10.1089/ars.2011.4394; Ohishi S, 1997, CLIN EXP PHARMACOL P, V24, P326, DOI 10.1111/j.1440-1681.1997.tb01196.x; Okutsu M, 2014, CIRC-HEART FAIL, V7, P519, DOI 10.1161/CIRCHEARTFAILURE.113.000841; Powers SK, 2016, MED SCI SPORT EXER, V48, P2307, DOI 10.1249/MSS.0000000000000975; Powers SK, 2016, FREE RADICAL BIO MED, V98, P208, DOI 10.1016/j.freeradbiomed.2016.02.021; Raben N, 2008, HUM MOL GENET, V17, P3897, DOI 10.1093/hmg/ddn292; Ramos-Gomez M, 2001, P NATL ACAD SCI USA, V98, P3410, DOI 10.1073/pnas.051618798; Suzuki T, 2015, FREE RADICAL BIO MED, V88, P93, DOI 10.1016/j.freeradbiomed.2015.06.006; Wang P, 2016, EXP PHYSIOL, V101, P410, DOI 10.1113/EP085493; Xue P, 2013, DIABETES, V62, P845, DOI 10.2337/db12-0584; Yamada M, 2018, BIOCHEM BIOPHYS REP, V15, DOI 10.1016/j.bbrep.2018.06.001	30	26	26	1	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2019	33	7					8022	8032		10.1096/fj.201900133R	http://dx.doi.org/10.1096/fj.201900133R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ9SM	30913396	Bronze			2022-12-26	WOS:000476234700018
J	Pimenta, RJG; Brandao-Dias, PFP; Leal, HG; do Carmo, AO; de Oliveira-Mendes, BBR; Chavez-Olortegui, C; Kalapothakis, E				Gonzaga Pimenta, Ricardo Jose; Pinto Brandao-Dias, Pedro Ferreira; Leal, Hortensia Gomes; do Carmo, Anderson Oliveira; Ribeiro de Oliveira-Mendes, Barbara Bruna; Chavez-Olortegui, Carlos; Kalapothakis, Evanguedes			Selected to survive and kill: Tityus serrulatus, the Brazilian yellow scorpion	PLOS ONE			English	Article							VENOM; DICTYOPTERA; STARVATION; RESISTANCE	Annually, more than 1.2 million scorpion stings and more than 3,000 deaths occur world-wide. Tityus serrulatus Lutz and Mello, 1922 (Scorpiones, Buthidae) is the most medically relevant species in Brazil where it is spreading rapidly and causing over 90,000 cases of envenomation yearly. We monitored T. serrulatus longevity and ability to reproduce under conditions of food and/or water deprivation. We found that T. serrulatus is highly tolerant to food deprivation, with individuals enduring up to 400 days without food. On the other hand, access to water played a pivotal role in T. serrulatus survival. Food and water deprived scorpions showed weight reduction. Reproduction occurred throughout the year for food-deprived scorpions and controls, but not in the water-deprived groups. Remarkably, food-deprived animals were able to give birth after 209 days of starvation. Tityus serrulatus resistance to food and water deprivation is likely to be an additional factor underlying this species' geographic expansion and the difficulties encountered in controlling it.	[Gonzaga Pimenta, Ricardo Jose; Pinto Brandao-Dias, Pedro Ferreira; Leal, Hortensia Gomes; do Carmo, Anderson Oliveira; Ribeiro de Oliveira-Mendes, Barbara Bruna; Kalapothakis, Evanguedes] Univ Fed Minas Gerais, Dept Biol Geral, Inst Ciencias Biol, Belo Horizonte, MG, Brazil; [Chavez-Olortegui, Carlos] Univ Fed Minas Gerais, Dept Bioquim Imunol, Inst Ciencias Biol, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Kalapothakis, E (corresponding author), Univ Fed Minas Gerais, Dept Biol Geral, Inst Ciencias Biol, Belo Horizonte, MG, Brazil.	kalapothakis@gmail.com	Pinto, Pedro B. D. F./D-5628-2015; Pimenta, Ricardo José Gonzaga/AAK-7830-2020; Chavez Olortegui, Carlos Delfin/F-9227-2019	Pimenta, Ricardo José Gonzaga/0000-0003-0413-7138; Kalapothakis, Evanguedes/0000-0002-8326-249X; Chavez Olortegui, Carlos Delfin/0000-0001-9390-7207; Ferreira Pinto Brandao-Dias, Pedro/0000-0001-8583-0617; Oliveira Mendes, Barbara Bruna Ribeiro/0000-0002-2269-5750; Gomes Leal, Hortensia/0000-0003-0767-8781	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES (Edital Toxinologia 63/2010); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais - FAPEMIG [APQ-02826-15]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq [456505/2014-8, 14/2014]; CAPES; CNPq; FAPEMIG	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES (Edital Toxinologia 63/2010); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais - FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This study was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES (Edital Toxinologia 63/2010), by Fundacao de Amparo a Pesquisa do Estado de Minas Gerais - FAPEMIG, Processo APQ-02826-15 (Obtained by EK) and by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq, Processo 456505/2014-8 (Edital Universal MCTI/CNPq No. 14/2014) (Obtained by CCO); CAPES: capes.gov.br, CNPq: cnpq.br, FAPEMIG: fapemig.br/pt/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarenga E.R., 2012, OJGEN, V02, P210, DOI [10.4236/ojgen.2012.24027, DOI 10.4236/OJGEN.2012.24027]; ANDERSON JF, 1974, ECOLOGY, V55, P576, DOI 10.2307/1935148; BABIN DR, 1974, ARCH BIOCHEM BIOPHYS, V164, P694, DOI 10.1016/0003-9861(74)90082-4; Bortoluzzi LR, 2007, BIOTA NEOTROP, V7, P357; Brasil J, 2013, REV BRAS GEOGR MED S, V9, P158; Chippaux JP, 2008, ACTA TROP, V107, P71, DOI 10.1016/j.actatropica.2008.05.021; Colombo Wesley Dondoni, 2015, Revista Iberica de Aracnologia, V27, P105; Cruz Elieth Floret Spirandeli, 1995, Revista da Sociedade Brasileira de Medicina Tropical, V28, P123, DOI 10.1590/S0037-86821995000200007; Cupo P, 2015, REV SOC BRAS MED TRO, V48, P642, DOI 10.1590/0037-8682-0237-2015; D'Suze G, 1999, TOXICON, V37, P173, DOI 10.1016/S0041-0101(98)00180-9; de la Vega RCR, 2005, TOXICON, V46, P831, DOI 10.1016/j.toxicon.2005.09.006; de Roodt Adolfo Rafael, 2014, Acta toxicol. argent., V22, P5; FREIREMAIA L, 1994, TOXICON, V32, P1009, DOI 10.1016/0041-0101(94)90382-4; Gefen E, 2005, J EXP BIOL, V208, P1887, DOI 10.1242/jeb.01568; Gefen E, 2004, J EXP BIOL, V207, P1017, DOI 10.1242/jeb.00860; GOYFFON M, 1983, CELL TISSUE RES, V228, P661, DOI 10.1007/BF00211482; Holbrook GL, 2003, J ECON ENTOMOL, V96, P1548, DOI 10.1603/0022-0493-96.5.1548; Hoshino K, 2006, J VENOM ANIM TOXINS, V12, P59, DOI 10.1590/S1678-91992006000100005; Jorge Duprat Figueiredo de Seguranca e Medicina do Trabalho, 2001, PREV AC COM AN PEC; Kalra B, 2012, COMP BIOCHEM PHYS A, V162, P372, DOI 10.1016/j.cbpa.2012.04.013; Ko AE, 2016, PEST MANAG SCI, V72, P1778, DOI 10.1002/ps.4211; Lima ALM, 2011, CON SCI SAUDE, V10, P627; Lourenco W.R., 1996, Journal of Venomous Animals and Toxins, V2, P121; Lourenco W.R., 1995, Journal of Venomous Animals and Toxins, V1, P51; Lourenco WR, 2015, J VENOM ANIM TOXINS, V21, DOI 10.1186/s40409-015-0016-9; Lourenco WR, 2002, EUROPEAN ARACHNOLOGY 2000, P71; Lourenco WR, 2003, ANIMAIS PECONHENTOS, V1st, P182; MATTHIESEN FA, 1962, EVOLUTION, V16, P255, DOI 10.1111/j.1558-5646.1962.tb03217.x; McCormick SJ, 1990, BIOL SCORPIONS, P224; Millot J., 1949, TRAITE ZOOLOGIE, V6, P387; Ministerio da Saude, 2001, MAN DIAGN TRAT AC AN; Ministerio da Saude (BR), 2009, MAN CONTR ESC; Olivares B., 2018, SCI REP-UK, V8, P1, DOI DOI 10.1038/S41598-017-17765-5; Outeda-Jorge S, 2009, ZOOLOGIA-CURITIBA, V26, P43, DOI 10.1590/S1984-46702009000100008; Pucca MB, 2015, TOXICON, V108, P272, DOI 10.1016/j.toxicon.2015.10.015; Ramires EN, 2011, PESTICIDES IN THE MODERN WORLD - PESTS CONTROL AND PESTICIDES EXPOSURE AND TOXICITY ASSESSMENT, P553; SINHA RC, 1967, PHYSIOL ZOOL, V40, P386, DOI 10.1086/physzool.40.4.30158456; Skutelsky O, 1996, ANIM BEHAV, V52, P49, DOI 10.1006/anbe.1996.0151; Southcott R. V., 1955, Transactions of the Royal Society of South Australia, V78, P145; Szilagyi-Zecchin Vivian Jaskiw, 2012, Indian Journal of Arachnology, V1, P15; TANAKA K, 1982, RES POPUL ECOL, V24, P360, DOI 10.1007/BF02515582; Waterman J. A., 1939, Transactions of the Royal Society of Tropical Medicine and Hygiene London, V33, P113, DOI 10.1016/S0035-9203(39)90168-9; WHARTON D. R. A., 1965, J INSECT PHYSIOL, V11, P391, DOI 10.1016/0022-1910(65)90046-6	43	7	9	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0214075	10.1371/journal.pone.0214075	http://dx.doi.org/10.1371/journal.pone.0214075			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR5NS	30943232	Green Submitted, Green Published, gold			2022-12-26	WOS:000463194300031
J	Han, KS; Kim, SJ; Lee, EJ; Park, KY; Lee, JY; Lee, SW				Han, Kap Su; Kim, Su Jin; Lee, Eui Jung; Park, Kyoung Yae; Lee, Ji Young; Lee, Sung Woo			Impact of rapid lactate clearance as an indicator of hemodynamic optimization on outcome in out-of-hospital cardiac arrest: A retrospective analysis	PLOS ONE			English	Article							MEAN ARTERIAL-PRESSURE; AMERICAN-HEART-ASSOCIATION; INTERNATIONAL LIAISON COMMITTEE; CARDIOVASCULAR CARE COMMITTEE; NEW-ZEALAND COUNCIL; CARDIOPULMONARY-RESUSCITATION; EUROPEAN RESUSCITATION; COMATOSE SURVIVORS; STROKE FOUNDATION; SOUTHERN AFRICA	Objective We analyzed the impact of rapid lactate clearance as an indicator of hemodynamic optimization on the outcome of out-of-hospital cardiac arrest (OHCA) during early post-cardiac arrest care (PCAC). Methods This retrospective analysis was based on a prospective cohort. We selected adult patients with OHCA who achieved a survival event between May 2006 and December 2017. Serum lactate levels were measured at 0 and 6 h after a survival event. The lactate clearance rate was calculated as (lactate at 0 h-lactate at 6 h)/lactate at 0 h. The threshold lactate clearance value for predicting survival to discharge was determined by receiver operating characteristic (ROC) curve analysis. Rapid lactate clearance was defined as the lactate clearance above the threshold value or normalization of serum lactate level (<2.0 mmol/L) at 6 h after a survival event. The primary outcome was survival to discharge. Multivariate logistic regression was used to predict survival to discharge. Results We enrolled 335 patients. 145 patients (43.3%) survived at discharge. The threshold value of lactate clearance was >= 34% to predict survival to discharge. After adjustment for confounders, the adjusted odds ratios for no hypotension at both 0 and 6 hours and for the presence of rapid lactate clearance for survival to discharge were 8.018 (95% confidence interval [CI] 2.802-22.947) and 2.193 (95% CI 1.263-3.808), respectively. Among patients with early recovery from initial hypotension or with no hypotension events at both 0 and 6 hours, the survival rates were significantly higher in the rapid lactate clearance group than in the non-rapid lactate clearance group. Conclusions During the early PCAC period, a rapid decrease in serum lactate level was an indicator of good outcome. Hemodynamic optimization including not only prevention and immediate correction of hypotension but also rapid lactate clearance should be considered in OHCA patients.	[Han, Kap Su; Kim, Su Jin; Lee, Eui Jung; Park, Kyoung Yae; Lee, Ji Young; Lee, Sung Woo] Korea Univ, Coll Med, Dept Emergency Med, Inchon Ro 73, Seoul, South Korea	Korea University; Korea University Medicine (KU Medicine)	Lee, SW (corresponding author), Korea Univ, Coll Med, Dept Emergency Med, Inchon Ro 73, Seoul, South Korea.	kuedlee@korea.ac.kr						Beylin ME, 2013, INTENS CARE MED, V39, P1981, DOI 10.1007/s00134-013-3075-9; Bray JE, 2014, RESUSCITATION, V85, P509, DOI 10.1016/j.resuscitation.2013.12.005; Callaway CW, 2015, CIRCULATION, V132, pS465, DOI 10.1161/CIR.0000000000000262; Donnino MW, 2007, RESUSCITATION, V75, P229, DOI 10.1016/j.resuscitation.2007.03.021; Donnino MW, 2014, CRIT CARE MED, V42, P1804, DOI 10.1097/CCM.0000000000000332; Hayashida K, 2017, CRIT CARE MED, V45, pE559, DOI 10.1097/CCM.0000000000002307; Kilgannon JH, 2014, CRIT CARE MED, V42, P2083, DOI 10.1097/CCM.0000000000000406; Kiyatkin ME, 2017, CURR OPIN CRIT CARE, V23, P348, DOI 10.1097/MCC.0000000000000423; Kliegel A, 2004, MEDICINE, V83, P274, DOI 10.1097/01.md.0000141098.46118.4c; Laurikkala J, 2016, RESUSCITATION, V105, P116, DOI 10.1016/j.resuscitation.2016.05.026; Masyuk M, 2019, INTENS CARE MED, V45, P55, DOI 10.1007/s00134-018-5475-3; Riveiro DFM, 2016, J INTENSIVE CARE MED, V31, P544, DOI 10.1177/0885066615592865; Mullner M, 1997, INTENS CARE MED, V23, P1138, DOI 10.1007/s001340050470; Neumar RW, 2008, CIRCULATION, V118, P2452, DOI 10.1161/CIRCULATIONAHA.108.190652; Perkins GD, 2015, CIRCULATION, V132, P1286, DOI 10.1161/CIR.0000000000000144; Russo JJ, 2017, RESUSCITATION, V113, P27, DOI 10.1016/j.resuscitation.2017.01.007; Vincent JL, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1403-5; Young MN, 2015, RESUSCITATION, V88, P158, DOI 10.1016/j.resuscitation.2014.12.008	18	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2019	14	4							e0214547	10.1371/journal.pone.0214547	http://dx.doi.org/10.1371/journal.pone.0214547			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR1CY	30934011	Green Published, gold, Green Submitted			2022-12-26	WOS:000462867000021
J	Ignatov, KB; Blagodatskikh, KA; Shcherbo, DS; Kramarova, TV; Monakhova, YA; Kramarov, VM				Ignatov, Konstantin B.; Blagodatskikh, Konstantin A.; Shcherbo, Dmitry S.; Kramarova, Tatiana V.; Monakhova, Yulia A.; Kramarov, Vladimir M.			Fragmentation Through Polymerization (FTP): A new method to fragment DNA for next-generation sequencing	PLOS ONE			English	Article								Fragmentation of DNA is the very important first step in preparing nucleic acids for next-generation sequencing. Here we report a novel Fragmentation Through Polymerization (FTP) technique, which is a simple, robust, and low-cost enzymatic method of fragmentation. This method generates double-stranded DNA fragments that are suitable for direct use in NGS library construction and allows the elimination of the additional step of reparation of DNA ends.	[Ignatov, Konstantin B.; Monakhova, Yulia A.; Kramarov, Vladimir M.] Russian Acad Sci, All Russia Inst Agr Biotechnol, Moscow, Russia; [Ignatov, Konstantin B.; Kramarov, Vladimir M.] Russian Acad Sci, Vavilov Inst Gen Genet, Moscow, Russia; [Blagodatskikh, Konstantin A.] Evrogen JSC, Moscow, Russia; [Blagodatskikh, Konstantin A.; Shcherbo, Dmitry S.] Pirogov Russian Natl Res Med Univ, Moscow, Russia; [Kramarova, Tatiana V.] Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, Stockholm, Sweden; [Monakhova, Yulia A.] Syntol JSC, Moscow, Russia	All-Russia Research Institute of Agricultural Biotechnology; Russian Academy of Sciences; Russian Academy of Sciences; Vavilov Institute of General Genetics; Pirogov Russian National Research Medical University; Stockholm University	Ignatov, KB (corresponding author), Russian Acad Sci, All Russia Inst Agr Biotechnol, Moscow, Russia.; Ignatov, KB (corresponding author), Russian Acad Sci, Vavilov Inst Gen Genet, Moscow, Russia.	ignatovkb@bk.ru	Shcherbo, Dmitry S/B-3549-2019; Blagodatskikh, Konstantin A/A-4521-2011; Ignatov, Konstantin/D-9593-2018	Ignatov, Konstantin/0000-0001-8900-5278	Ministry of Education and Science of Russian Federation [14.579.21.0012, RFMEFI57914X0012, 0112-2016-0006]; Russian State Budget	Ministry of Education and Science of Russian Federation(Ministry of Education and Science, Russian Federation); Russian State Budget	The work was supported by the Ministry of Education and Science of Russian Federation, grant 14.579.21.0012 (ID #RFMEFI57914X0012) and by the grant 0112-2016-0006 from the Russian State Budget. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Syntol JSC provided support in the form of salary for Y.A. M. and reagents for NGS-analysis, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section. Evrogen JSC provided equipment for NGS-analysis and provided support in the form of salary for author K.A.B., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Bioron GmbH provided enzymes and reagents (including SD DNA polymerase), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRUKNER I, 1995, EMBO J, V14, P1812, DOI 10.1002/j.1460-2075.1995.tb07169.x; BRUKNER I, 1990, NUCLEIC ACIDS RES, V18, P891, DOI 10.1093/nar/18.4.891; Costello M, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1443; Dodt Matthias, 2012, Biology (Basel), V1, P895, DOI 10.3390/biology1030895; Earl D, 2011, GENOME RES, V21, P2224, DOI 10.1101/gr.126599.111; Grokhovsky SL, 2011, BIOPHYS J, V100, P117, DOI 10.1016/j.bpj.2010.10.052; Gurevich A, 2013, BIOINFORMATICS, V29, P1072, DOI 10.1093/bioinformatics/btt086; Head SR, 2014, BIOTECHNIQUES, V56, P61, DOI 10.2144/000114133; Ignatov KB, 2014, BIOTECHNIQUES, V57, P81, DOI 10.2144/000114198; Kasoji SK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133014; Knierim E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028240; Lan JH, 2015, HUM IMMUNOL, V76, P166, DOI 10.1016/j.humimm.2014.12.016; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Marine R, 2011, APPL ENVIRON MICROB, V77, P8071, DOI 10.1128/AEM.05610-11; Mikheenko A, 2018, BIOINFORMATICS, V34, P142, DOI 10.1093/bioinformatics/bty266; Miller JR, 2010, GENOMICS, V95, P315, DOI 10.1016/j.ygeno.2010.03.001; Poptsova MS, 2014, SCI REP-UK, V4, DOI 10.1038/srep04532; Richterich P, 1998, GENOME RES, V8, P251, DOI 10.1101/gr.8.3.251	18	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2019	14	4							e0210374	10.1371/journal.pone.0210374	http://dx.doi.org/10.1371/journal.pone.0210374			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR1CY	30933980	Green Published, Green Submitted, gold			2022-12-26	WOS:000462867000002
J	Merlo, M; Ammirati, E; Gentile, P; Artico, J; Cannata, A; Finocchiaro, G; Barbati, G; Sormani, P; Varrenti, M; Perkan, A; Fabris, E; Aleksova, A; Bussani, R; Petrella, D; Cipriani, M; Raineri, C; Frigerio, M; Sinagra, G				Merlo, Marco; Ammirati, Enrico; Gentile, Piero; Artico, Jessica; Cannata, Antonio; Finocchiaro, Gherardo; Barbati, Giulia; Sormani, Paola; Varrenti, Marisa; Perkan, Andrea; Fabris, Enrico; Aleksova, Aneta; Bussani, Rossana; Petrella, Duccio; Cipriani, Manlio; Raineri, Claudia; Frigerio, Maria; Sinagra, Gianfranco			Persistent left ventricular dysfunction after acute lymphocytic myocarditis: Frequency and predictors	PLOS ONE			English	Article							ENDOMYOCARDIAL BIOPSY; SOCIETY; ASSOCIATION; STATEMENT; DIAGNOSIS; FULMINANT	Background Persistent left ventricular (LV) systolic dysfunction in patients with acute lymphocytic myocarditis (LM) is widely unexplored. Objectives To assess the frequency and predictors of persistent LV dysfunction in patients with LM and reduced LVEF at admission. Methods and results We retrospectively evaluated 89 consecutive patients with histologically-proven acute myocarditis enrolled at three Italian referral hospitals. A subgroup of 48 patients with LM, baseline systolic impairment and an available echocardiographic assessment at 12 months (618) from discharge constituted the study population. The primary study end-point was persistent LV dysfunction, defined as LVEF <50% at 1-year, and was observed in 27/48 patients (56.3%). Higher LV end-diastolic diameter at admission (odds ratio [OR] 1.22, 95% confidence interval [CI] 1.04-1.43, p = 0.002), non-fulminant presentation (OR 8.46, 95% CI 1.28-55.75, p = 0.013) and presence of a poor lymphocytic infiltrate (OR 12.40, 95% CI 1.23-124.97, p = 0.010) emerged as independent predictors of persistent LV dysfunction at multivariate analysis (area under the curve 0.91, 95% CI 0.82-0.99). Pre-discharge LVEF was lower in patients with persistent LV dysfunction compared to the others (32%+/- 8 vs. 53%+/- 8, p <0.001), and this single variable showed the best accuracy in predicting the study end-point (area under the curve 0.95, 95% CI 0.89-1.00). Conclusions More than half of patients presenting with acute LM and LVEF <50% who survive the acute phase show persistent LV dysfunction after 1-year from hospital discharge. Features of subacute inflammatory process and of established myocardial damage at initial hospitalization emerged as predictors of this end-point.	[Merlo, Marco; Gentile, Piero; Artico, Jessica; Cannata, Antonio; Perkan, Andrea; Fabris, Enrico; Aleksova, Aneta; Sinagra, Gianfranco] Azienda Sanit Univ Integrata ASUITS, Cardiovasc Dept, Trieste, Italy; [Merlo, Marco; Gentile, Piero; Artico, Jessica; Cannata, Antonio; Perkan, Andrea; Fabris, Enrico; Aleksova, Aneta; Bussani, Rossana; Sinagra, Gianfranco] Univ Trieste, Trieste, Italy; [Ammirati, Enrico; Sormani, Paola; Varrenti, Marisa; Cipriani, Manlio; Frigerio, Maria] Osped Niguarda Ca Granda, De Gasperis Cardio Ctr, Milan, Italy; [Finocchiaro, Gherardo] St Georges Univ London, Cardiol Clin & Acad Grp, London, England; [Barbati, Giulia] Univ Trieste, Dept Med Sci, Biostat Unit, Trieste, Italy; [Bussani, Rossana] Azienda Sanit Univ Integrata ASUITS, Dept Pathol, Trieste, Italy; [Petrella, Duccio] Osped Niguarda Ca Granda, Pathol Labs, Milan, Italy; [Raineri, Claudia] Fdn IRCCS Policlin S Matteo, Dept Cardiol, Pavia, Italy	University of Trieste; IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda; St Georges University London; University of Trieste; IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda; IRCCS Fondazione San Matteo	Merlo, M (corresponding author), Azienda Sanit Univ Integrata ASUITS, Cardiovasc Dept, Trieste, Italy.; Merlo, M (corresponding author), Univ Trieste, Trieste, Italy.	marco.merlo79@gmail.com	Gentile, Piero/AHE-3297-2022; Ammirati, Enrico/AAA-9961-2020; Varrenti, Marisa/AAA-9837-2019; Fabris, Enrico/AAS-8429-2020; Barbati, Giulia/N-8418-2014; Sinagra, Gianfranco/AAE-3943-2020; VARRENTI, MARISA/GZG-1954-2022; Cannata, Antonio/O-6344-2015	Ammirati, Enrico/0000-0002-1676-5257; Fabris, Enrico/0000-0001-9458-0736; Barbati, Giulia/0000-0001-8942-5686; VARRENTI, MARISA/0000-0003-4375-5991; Cannata, Antonio/0000-0001-7609-6297; Artico, Jessica/0000-0001-7112-4607; Gentile, Piero/0000-0003-3360-3548; Raineri, Claudia/0000-0001-9653-1516; Bussani, Rossana/0000-0001-8241-9726; Cipriani, Manlio/0000-0002-0632-0561; Aleksova, Aneta/0000-0001-7711-9905				Ammirati E, 2017, CIRCULATION, V136, P529, DOI 10.1161/CIRCULATIONAHA.117.026386; Anzini M, 2013, CIRCULATION, V128, P2384, DOI 10.1161/CIRCULATIONAHA.113.003092; Aretz H T, 1987, Am J Cardiovasc Pathol, V1, P3; Caforio ALP, 2007, EUR HEART J, V28, P1326, DOI 10.1093/eurheartj/ehm076; Caforio ALP, 2013, EUR HEART J, V34, P2636, DOI 10.1093/eurheartj/eht210; Cooper LT, 2009, NEW ENGL J MED, V360, P1526, DOI 10.1056/NEJMra0800028; Dennert R, 2008, EUR HEART J, V29, P2073, DOI 10.1093/eurheartj/ehn296; Escher F, 2014, INT J CARDIOL, V177, P76, DOI 10.1016/j.ijcard.2014.09.071; Ginsberg F, 2013, CRIT CARE CLIN, V29, P465, DOI 10.1016/j.ccc.2013.03.004; Gruen S, 2012, J AM COLL CARDIOL, V59, P1604, DOI 10.1016/j.jacc.2012.01.007; Harrell F, 2007, REGRESSION MODELING; Japp AG, 2016, J AM COLL CARDIOL, V67, P2996, DOI 10.1016/j.jacc.2016.03.590; Lang RM, 2015, EUR HEART J-CARD IMG, V16, P233, DOI 10.1093/ehjci/jev014; Leone O, 2012, CARDIOVASC PATHOL, V21, P245, DOI 10.1016/j.carpath.2011.10.001; Merken J, 2018, CIRC-HEART FAIL, V11, DOI 10.1161/CIRCHEARTFAILURE.117.004228; Merlo M, 2016, AM J CARDIOL, V118, P895, DOI 10.1016/j.amjcard.2016.05.063; Sinagra G, 2016, MAYO CLIN PROC, V91, P1256, DOI 10.1016/j.mayocp.2016.05.013; Yilmaz A, 2010, CIRCULATION, V122, P900, DOI 10.1161/CIRCULATIONAHA.109.924167; Yuan Zuyi, 2003, Exp Clin Cardiol, V8, P13	19	13	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214616	10.1371/journal.pone.0214616	http://dx.doi.org/10.1371/journal.pone.0214616			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921422	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000462594000099
J	Mwagona, PC; Yao, YL; Shan, YQ; Yu, HX				Mwagona, Patteson Chula; Yao, Yunlong; Shan Yuanqi; Yu, Hongxian			Laboratory study on nitrate removal and nitrous oxide emission in intact soil columns collected from nitrogenous loaded riparian wetland, Northeast China	PLOS ONE			English	Article							DENITRIFICATION RATES; SPATIAL VARIATION; DRINKING-WATER; N2O; GROUNDWATER; REDUCTION; DYNAMICS; FOREST; PH; DECOMPOSITION	Nitrate (NO3-) pollution of surface and groundwater systems is a major problem globally. For some time now wetlands have been considered potential systems for improving water quality. Nitrate dissolved in water moving through wetlands can be removed through different processes, such as the denitrification process, where heterotrophic facultative anaerobic bacteria use NO3- for respiration, leading to the production of nitrogen (N-2) and nitrous oxide (N2O) gases. Nitrate removal and emission of N2O in wetlands can vary spatially, depending on factors such as vegetation, hydrology and soil structure. This study intended to provide a better understanding of the spatial variability and processes involved in NO3- removal and emission of N2O in riparian wetland soils. We designed a laboratory experiment simulating surface water flow through soil columns collected from different sites dominated by different plant species within a wetland. Water and gas samples for NO3-, NH4+ and N2O analyses were collected every 5 days for a period of 30 days. The results revealed significant removal of NO3- in all the soil columns, supporting the role of riparian wetland soils in removing nitrogen from surface runoff. Nitrate removal at 0 and 10cm depths in sites dominated by Phragmites australis and Carex schnimdtii was significantly higher than in the site dominated by Calamagrostis epigeio. Nitrous oxide emissions varied spatially and temporally with negative flux observed in sites dominated by P. australis and C. schnimdtii. These results reveal that in addition to the ability of wetlands to remove NO3-, some sites within wetlands are also capable of consuming N2O, hence mitigating not only agricultural nitrate pollution but also climate change.	[Mwagona, Patteson Chula; Yao, Yunlong; Shan Yuanqi; Yu, Hongxian] Northeast Forestry Univ, Coll Wildlife Resource, Harbin, Heilongjiang, Peoples R China	Northeast Forestry University - China	Yao, YL; Yu, HX (corresponding author), Northeast Forestry Univ, Coll Wildlife Resource, Harbin, Heilongjiang, Peoples R China.	yaoyunlong@nefu.edu.cn; china.yhx@163.com			Fundamental Research Funds for the Central Universities [2572017CA15]; Natural Science Foundation of Heilongjiang Province [QC201604]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Natural Science Foundation of Heilongjiang Province(Natural Science Foundation of Heilongjiang Province)	This study was supported by The Fundamental Research Funds for the Central Universities (2572017CA15) and Natural Science Foundation of Heilongjiang Province (QC201604). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audet J, 2014, SOIL BIOL BIOCHEM, V68, P291, DOI 10.1016/j.soilbio.2013.10.011; Berg B, 2000, FOREST ECOL MANAG, V133, P13, DOI 10.1016/S0378-1127(99)00294-7; BLACKMER AM, 1978, SOIL BIOL BIOCHEM, V10, P187, DOI 10.1016/0038-0717(78)90095-0; Brauer N, 2015, ECOL ENG, V81, P207, DOI 10.1016/j.ecoleng.2015.04.003; Burgin AJ, 2013, SSSA BOOK S, V10, P519, DOI 10.2136/sssabookser10.c28; Buss S, 2005, SC0301552 ENV AG SCI; Butterbach-Bahl K, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0122; Carrey R, 2013, APPL GEOCHEM, V32, P142, DOI 10.1016/j.apgeochem.2012.10.009; Chapuis-Lardy L, 2007, GLOBAL CHANGE BIOL, V13, P1, DOI 10.1111/j.1365-2486.2006.01280.x; Dong LF, 2011, LIMNOL OCEANOGR, V56, P279, DOI 10.4319/lo.2011.56.1.0279; Esperschutz J, 2013, BIOGEOSCIENCES, V10, P5115, DOI 10.5194/bg-10-5115-2013; Fan AM, 1996, REGUL TOXICOL PHARM, V23, P35, DOI 10.1006/rtph.1996.0006; Federation W.E., 2005, STANDARD METHODS EXA; Gardner WS, 2009, BIOGEOCHEMISTRY, V95, P185, DOI 10.1007/s10533-009-9329-5; Giles M, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00407; Hayakawa A, 2012, ECOL ENG, V47, P92, DOI 10.1016/j.ecoleng.2012.06.034; Hefting MM, 2006, ECOSYSTEMS, V9, P550, DOI 10.1007/s10021-006-0160-8; Hefting MM, 2003, J ENVIRON QUAL, V32, P1194, DOI 10.2134/jeq2003.1194; Hendzel LL, 2005, ENVIRON SCI TECHNOL, V39, P4353, DOI 10.1021/es049443j; Hoffmann CC, 2011, HYDROBIOLOGIA, V674, P5, DOI 10.1007/s10750-011-0734-0; Hoffmann CC, 2000, J ENVIRON QUAL, V29, P2020, DOI 10.2134/jeq2000.00472425002900060040x; Jacinthe PA, 2012, J ENVIRON QUAL, V41, P95, DOI 10.2134/jeq2011.0308; Jain AK, 2000, J GEOPHYS RES-ATMOS, V105, P20773, DOI 10.1029/2000JD900241; Ji GD, 2002, ECOL ENG, V18, P459, DOI 10.1016/S0925-8574(01)00106-9; KOSKINEN WC, 1982, SOIL SCI SOC AM J, V46, P1165, DOI 10.2136/sssaj1982.03615995004600060009x; Lin YF, 2007, J ENVIRON SCI HEAL A, V42, P471, DOI 10.1080/10934520601187690; Lind LPD, 2013, SOIL BIOL BIOCHEM, V60, P156, DOI 10.1016/j.soilbio.2013.01.021; MAGEE PN, 1956, BRIT J CANCER, V10, P114, DOI 10.1038/bjc.1956.15; Mayer PM, 2007, J ENVIRON QUAL, V36, P1172, DOI 10.2134/jeq2006.0462; Morse JL, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2011JG001923; Munoz-Leoz B, 2011, SCI TOTAL ENVIRON, V409, P763, DOI 10.1016/j.scitotenv.2010.10.008; Gonzalez-Alcaraz MN, 2013, J ENVIRON MANAGE, V128, P964, DOI 10.1016/j.jenvman.2013.07.002; Puckett LJ, 2008, J ENVIRON QUAL, V37, P1034, DOI 10.2134/jeq2006.0550; RCore Team, 2020, R LANG ENV STAT COMP; Rivett MO, 2008, WATER RES, V42, P4215, DOI 10.1016/j.watres.2008.07.020; Rocca C. della, 2005, Water SA, V31, P229; Saunders DL, 2001, HYDROBIOLOGIA, V443, P205, DOI 10.1023/A:1017506914063; Simek M, 2002, EUR J SOIL SCI, V53, P345, DOI 10.1046/j.1365-2389.2002.00461.x; SKIBA U, 1993, SOIL BIOL BIOCHEM, V25, P1527, DOI 10.1016/0038-0717(93)90007-X; Smolders AJP, 2010, BIOGEOCHEMISTRY, V98, P1, DOI 10.1007/s10533-009-9387-8; Song CC, 2008, J ENVIRON MANAGE, V88, P428, DOI 10.1016/j.jenvman.2007.03.030; STANFORD G, 1975, SOIL SCI SOC AM J, V39, P284, DOI 10.2136/sssaj1975.03615995003900020019x; Van den Heuvel RN, 2011, GEOBIOLOGY, V9, P294, DOI 10.1111/j.1472-4669.2011.00276.x; Ward MH, 2005, ENVIRON HEALTH PERSP, V113, P1607, DOI 10.1289/ehp.8043; WEATHERBURN MW, 1967, ANAL CHEM, V39, P971, DOI 10.1021/ac60252a045; Weslien P, 2009, EUR J SOIL SCI, V60, P311, DOI 10.1111/j.1365-2389.2009.01123.x; WIJLER J, 1954, PLANT SOIL, V5, P155, DOI 10.1007/BF01343848; Willems HPL, 1997, WATER RES, V31, P841, DOI 10.1016/S0043-1354(96)00315-6; Wu DM, 2013, SOIL BIOL BIOCHEM, V60, P165, DOI 10.1016/j.soilbio.2013.01.028; Zaman M, 2008, AUST J SOIL RES, V46, P526, DOI 10.1071/SR07218; Zhang LH, 2013, ECOL ENG, V61, P82, DOI 10.1016/j.ecoleng.2013.09.065; Zhang WL, 1996, AGR ECOSYST ENVIRON, V59, P223, DOI 10.1016/0167-8809(96)01052-3; Zhao TQ, 2009, J ENVIRON SCI-CHINA, V21, P933, DOI 10.1016/S1001-0742(08)62364-5; Zou YC, 2018, J ENVIRON MANAGE, V224, P140, DOI 10.1016/j.jenvman.2018.07.052	54	5	5	9	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214456	10.1371/journal.pone.0214456	http://dx.doi.org/10.1371/journal.pone.0214456			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921385	Green Published, Green Submitted, gold			2022-12-26	WOS:000462594000071
J	Sapkota, A; Murtugudde, R; Curriero, FC; Upperman, CR; Ziska, L; Jiang, CS				Sapkota, Amir; Murtugudde, Raghu; Curriero, Frank C.; Upperman, Crystal R.; Ziska, Lewis; Jiang, Chengsheng			Associations between alteration in plant phenology and hay fever prevalence among US adults: Implication for changing climate	PLOS ONE			English	Article							ALLERGIC RHINITIS; POLLEN SEASONS; RESPONSES; MANAGEMENT; EXPOSURE; BUDBURST; RAGWEED; HEALTH	Plant phenology (e.g. timing of spring green-up, flowering) is among the most sensitive indicator of ecological response to ongoing climate variability and change. While previous studies have documented changes in the timing of spring green-up and flowering across different parts of the world, empirical evidence regarding how such ongoing ecological changes impact allergic disease burden at population level is lacking. Because earlier spring green-up may increase season length for tree pollen, we hypothesized that early onset of spring (negative anomaly in start of season (SOS)) will be associated with increased hay fever burden. To test this, we first calculated a median cardinal date for SOS for each county within the contiguous US for the years 2001-2013 using phenology data from the National Aeronautics and Space Administration's Moderate Resolution Imaging Spectroradiometer (MODIS). We categorized yearly deviations in SOS for each county from their respective long-term averages as: very early (>3 wks early), early (1-3 wks early), average (within 1 wk), late (1-3 wks late) and very late (> 3 wks late). We linked these data to 2002-2013 National Health Interview Survey data, and investigated the association between changes in SOS and hay fever prevalence using logistic regression. We observed that adults living in counties with a very early onset of SOS had a 14% higher odds of hay fever compared to the reference group, i.e. those living in counties where onset of spring was within the normal range (Odds Ratios (OR): 1.14. 95% Confidence Interval (CI): 1.03-1.27). Likewise, adults living in counties with very late onset of SOS had a 18% higher odds hay fever compared to the reference group (OR: 1.18, CI: 1.05-1.32). Our data provides the first-ever national scale assessment of the impact of changing plant phenology-linked to ongoing climate variability and change-on hay fever prevalence. Our findings are likely tied to changes in pollen dynamics, i.e early onset of spring increases the duration of exposure to tree pollen, while very late onset of spring increases the propensity of exposure because of simultaneous blooming.	[Sapkota, Amir; Upperman, Crystal R.; Jiang, Chengsheng] Univ Maryland, Sch Publ Hlth, Maryland Inst Appl Environm Hlth, College Pk, MD 20742 USA; [Murtugudde, Raghu] Univ Maryland, Dept Atmospher & Ocean Sci, College Pk, MD 20742 USA; [Curriero, Frank C.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Ziska, Lewis] ARS, Crop Syst & Global Change Lab, USDA, Beltsville, MD USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; United States Department of Agriculture (USDA)	Sapkota, A (corresponding author), Univ Maryland, Sch Publ Hlth, Maryland Inst Appl Environm Hlth, College Pk, MD 20742 USA.	amirsap@umd.edu			National Institute of Environmental Health Sciences [NIEHS 1R21ES021422-01A1]	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Institute of Environmental Health Sciences (NIEHS 1R21ES021422-01A1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahas R, 2006, INT J BIOMETEOROL, V51, P17, DOI 10.1007/s00484-006-0041-z; [Anonymous], 2012, MANAGING RISKS EXTRE; [Anonymous], 2014, CLIMATE CHANGE 2014; Bernstein JA, 2010, ALLERGY ASTHMA PROC, V31, P365, DOI 10.2500/aap.2010.31.3380; Bernstein L. B. P., 2007, INTERGOVERNMENTAL PA; Blaiss MS, 2010, ALLERGY ASTHMA PROC, V31, P375, DOI 10.2500/aap.2010.31.3329; Bock A, 2014, GLOBAL CHANGE BIOL, V20, P3508, DOI 10.1111/gcb.12579; Bousquet J, 2008, ALLERGY, V63, P8, DOI 10.1111/j.1398-9995.2007.01620.x; CANNELL MGR, 1986, J APPL ECOL, V23, P177, DOI 10.2307/2403090; Centers for Disease Control and Prevention, 2016, ALL HAY FEV; Cook BI, 2012, P NATL ACAD SCI USA, V109, P9000, DOI 10.1073/pnas.1118364109; Donnelly A, 2017, INT J BIOMETEOROL, V61, pS29, DOI 10.1007/s00484-017-1371-8; Emberlin J, 2002, INT J BIOMETEOROL, V46, P159, DOI 10.1007/s00484-002-0139-x; Emberlin J, 2007, INT J BIOMETEOROL, V51, P181, DOI 10.1007/s00484-006-0059-2; Fitter AH, 2002, SCIENCE, V296, P1689, DOI 10.1126/science.1071617; Fu Y. H, GLOBAL ECOL BIOGEOGR, V23, P1255; Fu YSH, 2015, NATURE, V526, P104, DOI 10.1038/nature15402; Galan C, 2005, INT J BIOMETEOROL, V49, P184, DOI 10.1007/s00484-004-0223-5; Garcia-Mozo H, 2010, AGR FOREST METEOROL, V150, P575, DOI 10.1016/j.agrformet.2010.01.023; Garcia-Mozo H, 2015, ANN AGR ENV MED, V22, P421, DOI 10.5604/12321966.1167706; Ingram Deborah D, 2012, Vital Health Stat 2, P1; Jackson K, 2013, BFI FILM CLASSICS, P1, DOI 10.1007/978-1-84457-702-6; Jenkerson CB, 2010, 20101055 USGS, P2010; Li XC, 2017, SCI TOTAL ENVIRON, V605, P721, DOI 10.1016/j.scitotenv.2017.06.245; Lind T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166887; Luber G., 2014, HUMAN HLTH, P220, DOI DOI 10.7930/J0PN93H5; Menzel A, 2000, INT J BIOMETEOROL, V44, P76, DOI 10.1007/s004840000054; Menzel A, 2006, GLOBAL CHANGE BIOL, V12, P1969, DOI 10.1111/j.1365-2486.2006.01193.x; MURRAY MB, 1989, J APPL ECOL, V26, P693, DOI 10.2307/2404093; Penuelas J, 2009, SCIENCE, V324, P887, DOI 10.1126/science.1173004; Portier Christopher J., 2010, HUMAN HLTH PERSPECTI; Salo PM, 2014, J ALLERGY CLIN IMMUN, V134, P350, DOI 10.1016/j.jaci.2013.12.1071; Seidman MD, 2015, OTOLARYNG HEAD NECK, V152, pS1, DOI 10.1177/0194599814561600; Soneja S, 2016, ENVIRON HEALTH-GLOB, V15, DOI 10.1186/s12940-016-0142-z; Swets D.L., 1999, IMAGE INFORM 1999 AS; Tran NP, 2011, ALLERGY ASTHMA IMMUN, V3, P148, DOI 10.4168/aair.2011.3.3.148; Ugolotti M, 2015, AEROBIOLOGIA, V31, P341, DOI 10.1007/s10453-015-9368-4; Upperman CR, 2016, J ALLERGY CLIN IMMUN; Upperman CR, 2017, J ALLER CL IMM-PRACT, V5, P435, DOI 10.1016/j.jaip.2016.09.016; van Cauwenberge P, 2000, ALLERGY, V55, P116, DOI 10.1034/j.1398-9995.2000.00526.x; Wallace DV, 2008, J ALLERGY CLIN IMMUN, V122, pS1, DOI 10.1016/j.jaci.2008.06.003; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Ziska L, 2016, IMPACTS CLIMATE CHAN, P74; Ziska L, 2011, P NATL ACAD SCI USA, V108, P4248, DOI 10.1073/pnas.1014107108; Ziska LH, 2012, J ALLERGY CLIN IMMUN, V129, P27, DOI 10.1016/j.jaci.2011.10.032; Ziska LH, 2003, J ALLERGY CLIN IMMUN, V111, P290, DOI 10.1067/mai.2003.53	46	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0212010	10.1371/journal.pone.0212010	http://dx.doi.org/10.1371/journal.pone.0212010			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921361	Green Submitted, gold, Green Published			2022-12-26	WOS:000462594000012
J	Vlasblom, E; Boere-Boonekamp, MM; Hafkamp-de Groen, E; Dusseldorp, E; van Dommelen, P; Verkerk, PH				Vlasblom, Eline; Boere-Boonekamp, Magda M.; Hafkamp-de Groen, Esther; Dusseldorp, Elise; van Dommelen, Paula; Verkerk, Paul H.			Predictive validity of developmental milestones for detecting limited intellectual functioning	PLOS ONE			English	Article							EARLY INTERVENTION; MOTOR-PERFORMANCE; CHILDREN; INFANT; DISABILITIES; ATTAINMENT; DIAGNOSIS; DELAY; BIRTH; AGE	Developmental milestones are commonly used in child health care, although from many milestones the predictive validity has not been adequately assessed. We aimed to determine the predictive validity of 75 developmental milestones for detecting limited intellectual functioning that can be obtained before the age of 4 years. We performed a case-control study with 148 children aged 5-10 years with limited intellectual functioning (IQ 50-69), who were in special education (cases) and a random sample of 300 children aged 5-10 years who were in regular elementary education (controls). Developmental milestones scores were retrieved from Child Healthcare files. We calculated sensitivity, specificity, positive likelihood ratios (LR+) and diagnostic odds ratios (DOR) for limited intellectual functioning. The LR+ determines whether a test result changes the probability that a condition exists. Given the prevalence of intellectual disability (1-3%), we considered that an LR+ > 10 would be clinically useful, as it increases the a priori probability of limited intellectual functioning from 2% to a posteriori probability of at least 17%. Out of 75 assessed milestones, 50 were included in the analysis. We found nine milestones to have a significant adjusted (for socioeconomic status and prematurity) DOR > 1 and a significant LR+ > 10 (assessment age in months between brackets): 'says "dada-baba''' (9), 'balances head well while sitting' (9), 'sits on buttocks while legs stretched' (9), 'babbles while playing' (12), 'sits in stable position without support' (12), 'walks well alone' (24), 'says "sentences" of 3 or more words' (36), 'places 3 forms in form-box' (36) and 'copies circle' (48). Sensitivities of these 9 milestones varied from 8-54%, specificities of these 9 milestones varied from 95-100%. Combining these milestones at 9,12, and 36 months respectively resulted in sensitivities of 27-60% and specificities of 94-99%. These nine developmental milestones have substantial predictive validity for limited intellectual functioning.	[Vlasblom, Eline; van Dommelen, Paula; Verkerk, Paul H.] TNO, Dept Child Hlth, Leiden, Netherlands; [Boere-Boonekamp, Magda M.] Univ Twente, Dept Hlth Technol & Serv Res, Tech Med Ctr, Enschede, Netherlands; [Hafkamp-de Groen, Esther] Rivas Zorggrp, Gorinchem, Netherlands; [Dusseldorp, Elise] Leiden Univ, Inst Psychol, Leiden, Netherlands	Netherlands Organization Applied Science Research; University of Twente; Leiden University; Leiden University - Excl LUMC	Vlasblom, E (corresponding author), TNO, Dept Child Hlth, Leiden, Netherlands.	eline.vlasblom@tno.nl						Allely CS, 2014, J ED CHILD PSYCHOL, V31, P28; Aylward GP, 2009, J DEV BEHAV PEDIATR, V30, P169, DOI 10.1097/DBP.0b013e31819f1c3e; Bilder DA, 2013, AJIDD-AM J INTELLECT, V118, P156, DOI 10.1352/1944-7558-118.2.156; Bleichrodt N, 1987, RAKIT HANDLEIDING RE; BRESLOW N, 1982, J OCCUP ENVIRON MED, V24, P255; Calonge N, 2006, PEDIATRICS, V117, P497, DOI 10.1542/peds.2005-2766; CAPUTE AJ, 1985, CLIN PEDIATR, V24, P671, DOI 10.1177/000992288502401201; Colombo J., 1993, INDIVIDUAL DIFFERENC; CRONBACH LJ, 1955, PSYCHOL BULL, V52, P281, DOI 10.1037/h0040957; Duby JC, 2006, PEDIATRICS, V118, P405, DOI 10.1542/peds.2006-1231; FIRST LR, 1994, NEW ENGL J MED, V330, P478, DOI 10.1056/NEJM199402173300708; Flensborg-Madsen T, 2018, DEV PSYCHOL, V54, P1434, DOI 10.1037/dev0000545; Flensborg-Madsen T, 2015, EARLY HUM DEV, V91, P393, DOI 10.1016/j.earlhumdev.2015.04.006; FUNK JB, 1982, J DEV BEHAV PEDIATR, V3, P143, DOI 10.1097/00004703-198209000-00004; Glas AS, 2003, J CLIN EPIDEMIOL, V56, P1129, DOI 10.1016/S0895-4356(03)00177-X; Grimes DA, 2005, LANCET, V365, P1500, DOI 10.1016/S0140-6736(05)66422-7; Guralnick MJ, 2017, J APPL RES INTELLECT, V30, P211, DOI 10.1111/jar.12233; Guralnick MJ, 2005, J APPL RES INTELLECT, V18, P313, DOI 10.1111/j.1468-3148.2005.00270.x; Hamadani JD, 2013, MATERN CHILD NUTR, V9, P89, DOI 10.1111/mcn.12020; Hartman E, 2010, J INTELL DISABIL RES, V54, P468, DOI 10.1111/j.1365-2788.2010.01284.x; Jacobusse G, 2006, STAT MED, V25, P2272, DOI 10.1002/sim.2351; Jenni OG, 2013, DEV NEUROPSYCHOL, V38, P98, DOI 10.1080/87565641.2012.733785; Lagae L, 2008, PEDIATR CLIN N AM, V55, P1259, DOI 10.1016/j.pcl.2008.08.001; Laurent de Angulo MS, 2005, ONTWIKKELINGSONDERZO; Macy M, 2012, INFANT YOUNG CHILD, V25, P19, DOI 10.1097/IYC.0b013e31823d37dd; Marks K, 2008, PEDIATRICS, V122, P866, DOI 10.1542/peds.2007-3142; Mathews KD, 2010, J CHILD NEUROL, V25, P1098, DOI 10.1177/0883073810371001; McGee S, 2002, J GEN INTERN MED, V17, P646; Murray GK, 2006, J CHILD PSYCHOL PSYC, V47, P25, DOI 10.1111/j.1469-7610.2005.01450.x; Murray GK, 2007, ANN NEUROL, V62, P128, DOI 10.1002/ana.21120; NCJ, 2015, BAS JGZ; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Odd DE, 2008, ARCH DIS CHILD-FETAL, V93, pF115, DOI 10.1136/adc.2007.123745; OUDEN LD, 1991, J PEDIATR-US, V118, P399, DOI 10.1016/S0022-3476(05)82154-7; Poranen-Clark T, 2015, AGE, V37, DOI 10.1007/s11357-015-9785-x; Roberts C, 2006, J CLIN CHILD ADOLESC, V35, P180, DOI 10.1207/s15374424jccp3502_2; Roze E, 2010, PEDIATRICS, V126, pE1134, DOI 10.1542/peds.2010-0698; Sandler AD, 2001, PEDIATRICS, V107; Schalock R., 2021, INTELLECTUAL DISABIL; Shevell M, 2003, NEUROLOGY, V60, P367, DOI 10.1212/01.WNL.0000031431.81555.16; Sices L, 2003, J DEV BEHAV PEDIATR, V24, P409, DOI 10.1097/00004703-200312000-00002; SIMEL DL, 1991, J CLIN EPIDEMIOL, V44, P763, DOI 10.1016/0895-4356(91)90128-V; Snijders J.T., 1976, SNIJDERS OOMEN NONVE; Statistics Netherlands, 2008, STAT YB NETH; Taanila A, 2005, DEV MED CHILD NEUROL, V47, P581, DOI 10.1017/S0012162205001155; Verkerk PH, 1993, TIJDSCHRIFT JEUGDGEZ, V25, P71; Visser GHA, 2009, EARLY HUM DEV, V85, P737, DOI 10.1016/j.earlhumdev.2009.09.008; Vuijk PJ, 2010, J INTELL DISABIL RES, V54, P955, DOI 10.1111/j.1365-2788.2010.01318.x; Wechsler D, 1974, WECHSLER INTELLIGENC; Wechsler D., 2014, WECHSLER PRESCHOOL P; Weikart DP, 1998, PREV MED, V27, P233, DOI 10.1006/pmed.1998.0280; Williams Jane, 2004, J Child Health Care, V8, P34, DOI 10.1177/1367493504041852	52	4	4	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214475	10.1371/journal.pone.0214475	http://dx.doi.org/10.1371/journal.pone.0214475			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HQ7IR	30921424	Green Published, gold, Green Submitted			2022-12-26	WOS:000462594000076
J	Yang, Y; Zhou, HQ; Shu, H; Zhong, DM; Zhang, MQ; Xia, JH				Yang, Yang; Zhou, Huiqiang; Shu, Hu; Zhong, Dongming; Zhang, Mingqing; Xia, Jun Hong			Effect of fasting and subsequent refeeding on the transcriptional profiles of brain in juvenile Spinibarbus hollandi	PLOS ONE			English	Article							COMPENSATORY GROWTH; PROTEIN; METABOLISM; IDENTIFICATION; DEPRIVATION; DEPOSITION; EXPRESSION; PERIODS; MUSCLE; GENES	Starvation is a common stress in fish. The underlying molecular mechanisms associated with growth depression caused by feeding restriction and compensatory growth are not well understood. We investigated the effect of fasting and refeeding on the transcriptome profiles of brain in juvenile S. hollandi using RNA-seq. A total of 4.73 x 10(8) raw reads were obtained from nine brain samples. De novo transcriptome assembly identified 387,085 unigenes with 2.1 x 10(9) nucleotides. A total of 936 annotated unigenes showed significantly differential expression among the control, fasting, and fasting-refeeding groups. The down-regulated differentially expressed genes (DEGs) during fasting were mainly associated with cell cycle, DNA replication, and mitosis. The up-regulated DEGs were mainly related to glucose and lipid metabolism, material transportation, and transcription factors. Most decreased DEGs during fasting were restored to normal levels after refeeding. Comparing with the control group, genes associated with protein synthesis, stimulus response, and carbohydrate metabolism were significantly over-expressed and pro-opio melanocortin (POMC) was down-regulated during the refeeding period. In conclusion, fish mobilized stored energetic materials and reduced energy consumption to prolong survival during fasting. After refeeding, the down-regulation of DEGs, e.g., POMC may be associated with compensatory growth. Up-regulation of DEGs related to ribosomal protein, stimulus response, and carbohydrate metabolism may contribute to eliminate negative effect of starvation on brain. This study provided the first transcriptome data related with impact of short-time starvation and refeeding in S. hollandi brains.	[Yang, Yang; Zhou, Huiqiang; Shu, Hu; Zhong, Dongming; Zhang, Mingqing] Guangzhou Univ, Sch Life Sci, Guangzhou, Guangdong, Peoples R China; [Yang, Yang; Xia, Jun Hong] Sun Yat Sen Univ, State Key Lab Biocontrol, Inst Aquat Econ Anim, Coll Life Sci, Guangzhou, Guangdong, Peoples R China; [Yang, Yang; Xia, Jun Hong] Sun Yat Sen Univ, Guangdong Prov Key Lab Aquat Econ Anim, Coll Life Sci, Guangzhou, Guangdong, Peoples R China	Guangzhou University; Sun Yat Sen University; Sun Yat Sen University	Shu, H (corresponding author), Guangzhou Univ, Sch Life Sci, Guangzhou, Guangdong, Peoples R China.; Xia, JH (corresponding author), Sun Yat Sen Univ, State Key Lab Biocontrol, Inst Aquat Econ Anim, Coll Life Sci, Guangzhou, Guangdong, Peoples R China.; Xia, JH (corresponding author), Sun Yat Sen Univ, Guangdong Prov Key Lab Aquat Econ Anim, Coll Life Sci, Guangzhou, Guangdong, Peoples R China.	shuhu001@126.com; xiajunh3@mail.sysu.edu.cn	yang, yang/GVT-5210-2022; Lang, Ming/HIK-0758-2022; yang, yang/HGT-7999-2022		National Public Industry Major Projects of China [201303048]; Guangdong Provincial Science and Technology Program [2014A020208145]	National Public Industry Major Projects of China; Guangdong Provincial Science and Technology Program	This work is supported by the National Public Industry Major Projects of China (No. 201303048; received by HS) and the Guangdong Provincial Science and Technology Program (Nos. 2014A020208145; received by HS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bjursell M, 2007, DIABETES, V56, P583, DOI 10.2337/db06-1432; Chakraborty AK, 1996, BBA-MOL CELL RES, V1313, P130, DOI 10.1016/0167-4889(96)00063-8; Chakrama FZ, 2010, AUTOPHAGY, V6, P495, DOI 10.4161/auto.6.4.11819; Cleveland BM, 2010, COMP BIOCHEM PHYS B, V157, P248, DOI 10.1016/j.cbpb.2010.06.010; Cromphout K, 2006, MOL CELL BIOL, V26, P5621, DOI 10.1128/MCB.02357-05; Dai XX, 2014, MOL CELLS, V37, P126, DOI 10.14348/molcells.2014.2259; Faherty SL, 2018, MOL ECOL, V27, P709, DOI 10.1111/mec.14483; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hasselbalch SG, 1996, AM J PHYSIOL-ENDOC M, V270, pE746, DOI 10.1152/ajpendo.1996.270.5.E746; He LB, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1427-2; Johansen KA, 2006, COMP BIOCHEM PHYS B, V144, P119, DOI 10.1016/j.cbpb.2006.02.001; Johansen SJS, 2001, AQUAC RES, V32, P963, DOI 10.1046/j.1365-2109.2001.00632.x; Keogh K, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2578-5; Lee H, 2018, PSYCHIAT RES, V259, P197, DOI 10.1016/j.psychres.2017.10.018; Leone G, 1998, GENE DEV, V12, P2120, DOI 10.1101/gad.12.14.2120; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Liu LS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074581; Lu D, 2014, J CELL BIOL, V207, P23, DOI 10.1083/jcb.201402041; Mendez KN, 2018, AQUACULTURE, V490, P270, DOI 10.1016/j.aquaculture.2018.02.048; NIGG EA, 1995, BIOESSAYS, V17, P471, DOI 10.1002/bies.950170603; Oehlmann M, 2004, J CELL BIOL, V165, P181, DOI 10.1083/jcb.200311044; Patwari P, 2011, CELL METAB, V14, P671, DOI 10.1016/j.cmet.2011.08.011; Prabhu AV, 2014, BBA-MOL CELL BIOL L, V1841, P1431, DOI 10.1016/j.bbalip.2014.07.006; QIAN B, 2016, PLOS ONE, V11; Qian X, 2014, OMICS, V18, P98, DOI 10.1089/omi.2013.0110; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Reigh RC, 2006, AQUACULTURE, V254, P506, DOI 10.1016/j.aquaculture.2005.10.043; Rescan PY, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3837-9; Rescan PY, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-438; RUSSELL NR, 1992, ENVIRON BIOL FISH, V34, P277, DOI 10.1007/BF00004774; Sancho A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034034; Schmiesing JA, 1998, P NATL ACAD SCI USA, V95, P12906, DOI 10.1073/pnas.95.22.12906; Schmiesing JA, 2000, MOL CELL BIOL, V20, P6996, DOI 10.1128/MCB.20.18.6996-7006.2000; Seda O, 2017, PHYSIOL RES, V66, pS357, DOI 10.33549/physiolres.933730; Sun YB, 2017, ZOOL RES, V38, P110, DOI 10.24272/j.issn.2095-8137.2017.017; Takahashi LS, 2011, J ANIM PHYSIOL AN N, V95, P259, DOI 10.1111/j.1439-0396.2010.01050.x; Tian XL, 2010, AQUACULTURE, V310, P122, DOI 10.1016/j.aquaculture.2010.10.021; Tian XL, 2003, AQUACULTURE, V224, P169, DOI 10.1016/S0044-8486(03)00224-2; Varela L, 2012, EMBO REP, V13, P1079, DOI 10.1038/embor.2012.174; WEINSTEIN J, 1994, MOL CELL BIOL, V14, P3350, DOI 10.1128/MCB.14.5.3350; Won ET, 2013, FRONTIERS ENDOCRINOL, V4; Wu C, 1995, ANNU REV CELL DEV BI, V11, P441, DOI 10.1146/annurev.cellbio.11.1.441; Xie S, 2001, J FISH BIOL, V58, P999, DOI 10.1111/j.1095-8649.2001.tb00550.x; Yang XL, 2018, MAR BIOTECHNOL, V20, P20, DOI 10.1007/s10126-017-9784-2; Yang Y, 2017, FISHERIES SCI, V83, P967, DOI 10.1007/s12562-017-1125-x; Ye H, 2018, MAR BIOTECHNOL, V20, P246, DOI 10.1007/s10126-018-9801-0; Yu LY, 2018, MAR BIOTECHNOL, V20, P467, DOI 10.1007/s10126-018-9809-5; Yue CY, 2018, MAR BIOTECHNOL, V20, P206, DOI 10.1007/s10126-018-9798-4; Zou H, 1999, SCIENCE, V285, P418, DOI 10.1126/science.285.5426.418	50	5	5	4	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214589	10.1371/journal.pone.0214589	http://dx.doi.org/10.1371/journal.pone.0214589			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921420	Green Published, Green Submitted, gold			2022-12-26	WOS:000462594000091
J	Bowles, KR; Julia, TCW; Qian, L; Jadow, BM; Goate, AM				Bowles, Kathryn R.; Julia, T. C. W.; Qian, Lu; Jadow, Benjamin M.; Goate, Alison M.			Reduced variability of neural progenitor cells and improved purity of neuronal cultures using magnetic activated cell sorting	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; DIFFERENTIATION; INDUCTION; LINEAGE; DIVERSE; DISEASE; MARKER; CREST; CD271	Genetic and epigenetic variability between iPSC-derived neural progenitor cells (NPCs) combined with differences in investigator technique and selection protocols contributes to variability between NPC lines, which subsequently impacts the quality of differentiated neuronal cultures. We therefore sought to develop an efficient method to reduce this variability in order to improve the purity of NPC and neuronal cultures. Here, we describe a magnetic activated cell sorting (MACS) method for enriching NPC cultures for CD271-/CD133+ cells at both early (< 2-3) and late (> 10) passage. MACS results in a similar sorting efficiency to fluorescence activated cell sorting (FACS), while achieving an increased yield of live cells and reduced cellular stress. Furthermore, neurons derived from MACS NPCs showed greater homogeneity between cell lines compared to those derived from unsorted NPCs. We conclude that MACS is a cheap technique for incorporation into standard NPC differentiation and maintenance protocols in order to improve culture homogeneity and consistency.	[Bowles, Kathryn R.; Julia, T. C. W.; Qian, Lu; Jadow, Benjamin M.; Goate, Alison M.] Icahn Sch Med Mt Sinai, Dept Neurosci, New York, NY 10029 USA; [Bowles, Kathryn R.; Julia, T. C. W.; Qian, Lu; Jadow, Benjamin M.; Goate, Alison M.] Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA; [Bowles, Kathryn R.; Julia, T. C. W.; Qian, Lu; Jadow, Benjamin M.; Goate, Alison M.] Icahn Sch Med Mt Sinai, Ronald M Loeb Ctr Alzheimers Dis, New York, NY 10029 USA; [Goate, Alison M.] Icahn Sch Med Mt Sinai, Icahn Inst Genom & Multiscale Biol, Dept Genet & Genom Sci, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Goate, AM (corresponding author), Icahn Sch Med Mt Sinai, Dept Neurosci, New York, NY 10029 USA.; Goate, AM (corresponding author), Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA.; Goate, AM (corresponding author), Icahn Sch Med Mt Sinai, Ronald M Loeb Ctr Alzheimers Dis, New York, NY 10029 USA.; Goate, AM (corresponding author), Icahn Sch Med Mt Sinai, Icahn Inst Genom & Multiscale Biol, Dept Genet & Genom Sci, New York, NY 10029 USA.	alison.goate@mssm.edu		Goate, Alison/0000-0002-0576-2472	New York Stem Cell Foundation; BrightFocus [A2017144F]; CurePSP [648-2017-04]; Association for Frontotemporal Degeneration; JPB Foundation; Rainwater Charitable Foundation; Flow Cytometry Core at the Icahn School of Medicine at Mount Sinai; NATIONAL INSTITUTE ON AGING [K01AG062683] Funding Source: NIH RePORTER	New York Stem Cell Foundation; BrightFocus(BrightFocus Foundation); CurePSP; Association for Frontotemporal Degeneration; JPB Foundation; Rainwater Charitable Foundation; Flow Cytometry Core at the Icahn School of Medicine at Mount Sinai; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by the New York Stem Cell Foundation (https://nyscf.org) (J.TCW.), BrightFocus #A2017144F (www.brightfocus.org)(K.R.B), CurePSP #648-2017-04 (www.psp.org)(K.R.B), Association for Frontotemporal Degeneration (www.theaftd.org)(K.R.B), the JPB Foundation (www.jpbfoundation.org) (A.M.G.), and the Rainwater Charitable Foundation (https://rainwatercharitablefoundation.org) (A.M.G.).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The iPSC lines were generated by the Pluripotent Stem Cell Core at Icahn School of Medicine at Mount Sinai (http://labs.icahn.mssm.edu/dsouza-lab/about-us/), New York Stem Cell Foundation (https://nyscf.org/) and the Genome Engineering and iPSC Center at Washington University (http://geic.wustl.edu/services/ipsc-core-facility/). We thank Dr. Celeste Karch for providing lines generated by the Washington University facility. We are grateful for the continuous support of the Flow Cytometry Core at the Icahn School of Medicine at Mount Sinai (http://icahn.mssm.edu/research/portal/resources/deans-cores/flow-cytometry).	Alvarez R, 2015, INT J ORAL SCI, V7, P205, DOI 10.1038/ijos.2015.29; Alvarez-Viejo M, 2015, WORLD J STEM CELLS, V7, P470, DOI 10.4252/wjsc.v7.i2.470; Bardy C, 2015, P NATL ACAD SCI USA, V112, pE3312, DOI 10.1073/pnas.1509741112; Barraud P, 2007, J NEUROSCI RES, V85, P250, DOI 10.1002/jnr.21116; Brennand KJ, 2011, NATURE, V473, P221, DOI 10.1038/nature09915; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Cheng Chialin, 2017, Curr Protoc Hum Genet, V92, DOI 10.1002/cphg.33; Doi D, 2014, STEM CELL REP, V2, P337, DOI 10.1016/j.stemcr.2014.01.013; Ghaffari LT, 2018, FRONT NEUROSCI, V12, P1, DOI [10.3389/fnins.2018.00001, DOI 10.3389/FNINS.2018.00001]; Haggarty SJ, 2016, MOL CELL NEUROSCI, V73, P104, DOI 10.1016/j.mcn.2016.01.011; Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107; Huang X, 2004, DEV BIOL, V275, P1, DOI 10.1016/j.ydbio.2004.07.033; Julia TCW, 2017, STEM CELL REP, V9, P600, DOI 10.1016/j.stemcr.2017.06.018; Li HW, 2009, BMC NEUROSCI, V10, DOI [10.1186/1471-2202-10-122, 10.1186/1471-2105-10-418]; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; Mattis VB, 2017, BRAIN RES, V1656, P76, DOI 10.1016/j.brainres.2015.10.001; McKinney CE, 2017, NEURAL REGEN RES, V12, P1062, DOI 10.4103/1673-5374.211180; Muratore CR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105807; Murray JI, 2004, MOL BIOL CELL, V15, P2361, DOI 10.1091/mbc.E03-11-0799; Paavilainen T, 2018, STEM CELL RES, V27, P151, DOI 10.1016/j.scr.2018.01.018; Pasca AM, 2015, NAT METHODS, V12, P671, DOI [10.1038/nmeth.3415, 10.1038/NMETH.3415]; Schwartz PH, 2008, METHODS, V45, P142, DOI 10.1016/j.ymeth.2008.03.007; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Topol A, 2015, JOVE-J VIS EXP, DOI 10.3791/52495; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Wilson PG, 2006, STEM CELL REV, V2, P67, DOI 10.1385/SCR:2:1:67; Woodhoo A, 2008, GLIA, V56, P1481, DOI 10.1002/glia.20723; Xie YY, 2018, STEM CELL RES, V26, P84, DOI 10.1016/j.scr.2017.12.003; Yuan SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017540; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012	31	18	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2019	14	3							e0213374	10.1371/journal.pone.0213374	http://dx.doi.org/10.1371/journal.pone.0213374			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ5PT	30917153	gold, Green Submitted, Green Published			2022-12-26	WOS:000462465800029
J	Blevins, TP; Yu, YY; Belshe, RB; Bellamy, AR; Morrison, LA				Blevins, Tamara P.; Yu, Yinyi; Belshe, Robert B.; Bellamy, Abbie R.; Morrison, Lynda A.			Correlation between herpes simplex virus neutralizing antibody titers determined by ELVIS cell and traditional plaque reduction assays	PLOS ONE			English	Article							GLYCOPROTEIN-D; FUSION; ENTRY; DOMAIN; HSV-1	Preventive viral vaccine efficacy trials require large-scale sample analysis to quantitate immune responses and their correlation with infection outcomes. Traditional plaque reduction assays measure a functionally important form of humoral immunity, neutralizing antibody titer. These assays, however, are time-consuming and laborious. We previously developed a higher throughput assay of neutralizing antibody to herpes simplex viruses 1 and 2 (Blevins et al., PLOS ONE, 10(12), e0144738) using the enzyme-linked virus inducible system (ELVIS) cell line; this cell line produces beta-galactosidase in response to HSV infection. Here, serum samples from recipients of an investigational vaccine in the Herpevac Trial for Women were used to compare the ELVIS cell assay with the lower throughput, traditional plaque reduction assay. We demonstrate that neutralizing antibody titers to HSV-1 or HSV-2 determined using ELVIS cells positively correlate with neutralizing antibody titers determined by traditional plaque reduction assay, thus validating a higher throughput alternative for large-scale sample analysis.	[Blevins, Tamara P.; Yu, Yinyi; Belshe, Robert B.; Bellamy, Abbie R.; Morrison, Lynda A.] St Louis Univ, Sch Med, Dept Med, Div Infect Dis, St Louis, MO 63104 USA; [Bellamy, Abbie R.] Emmes Corp, Rockville, MD USA; [Morrison, Lynda A.] St Louis Univ, Sch Med, Dept Mol Microbiol & Immunol, St Louis, MO 63104 USA	Saint Louis University; Emmes Corporation; Saint Louis University	Morrison, LA (corresponding author), St Louis Univ, Sch Med, Dept Med, Div Infect Dis, St Louis, MO 63104 USA.; Morrison, LA (corresponding author), St Louis Univ, Sch Med, Dept Mol Microbiol & Immunol, St Louis, MO 63104 USA.	lynda.morrison@health.slu.edu		Blevins, Tamara/0000-0003-1955-2641	Division of Microbiology and Infectious Diseases, National Institutes of Health [HHSN27220130021I, HHSN272201500002C]	Division of Microbiology and Infectious Diseases, National Institutes of Health	This work was performed under contracts #HHSN27220130021I (to RBB and LAM, Saint Louis University) and #HHSN272201500002C (Emmes) from the Division of Microbiology and Infectious Diseases, National Institutes of Health, https://www.niaid.nih.gov/about/dmid.	Ashley RL, 1997, VIRAL IMMUNOL, V10, P213, DOI 10.1089/vim.1997.10.213; Awasthi S, 2014, J INFECT DIS, V210, P571, DOI 10.1093/infdis/jiu177; Baccari A, 2016, VACCINE, V34, P3901, DOI 10.1016/j.vaccine.2016.05.033; Belshe RB, 2014, J INFECT DIS, V209, P828, DOI 10.1093/infdis/jit651; Belshe RB, 2012, NEW ENGL J MED, V366, P34, DOI 10.1056/NEJMoa1103151; Blevins TP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144738; Carfi A, 2001, MOL CELL, V8, P169, DOI 10.1016/S1097-2765(01)00298-2; Cocchi F, 2004, P NATL ACAD SCI USA, V101, P7445, DOI 10.1073/pnas.0401883101; Cooper D, 2004, VACCINE, V23, P236, DOI 10.1016/j.vaccine.2004.05.011; Di Giovine P, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002277; Eisenberg RJ, 2012, VIRUSES-BASEL, V4, P800, DOI 10.3390/v4050800; Fan Q, 2014, J VIROL, V88, P6470, DOI 10.1128/JVI.00465-14; Heldwein EE, 2008, CELL MOL LIFE SCI, V65, P1653, DOI 10.1007/s00018-008-7570-z; Lazear E, 2008, J VIROL, V82, P700, DOI 10.1128/JVI.02192-07; Peng T, 1998, J VIROL, V72, P65, DOI 10.1128/JVI.72.1.65-72.1998; Sathiyamoorthy K, 2017, CURR OPIN VIROL, V24, P97, DOI 10.1016/j.coviro.2017.04.006; STABELL EC, 1992, J VIROL METHODS, V38, P195, DOI 10.1016/0166-0934(92)90110-Y; Whitbeck JC, 2014, J VIROL, V88, P7786, DOI 10.1128/JVI.00544-14	18	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0214467	10.1371/journal.pone.0214467	http://dx.doi.org/10.1371/journal.pone.0214467			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR7EH	30946751	Green Submitted, gold, Green Published			2022-12-26	WOS:000463314500033
J	Henrard, S; Corbiere, V; Schandene, L; Ducarme, M; Van Praet, A; Petit, E; Singh, M; Locht, C; Dirix, V; Mascart, F				Henrard, Sophie; Corbiere, Veronique; Schandene, Liliane; Ducarme, Martine; Van Praet, Anne; Petit, Emmanuelle; Singh, Mahavir; Locht, Camille; Dirix, Violette; Mascart, Francoise			Proportions of interferon-gamma-producing ascites lymphocytes in response to mycobacterial antigens: A help for early diagnosis of peritoneal tuberculosis in a low TB incidence country	PLOS ONE			English	Article							HEPARIN-BINDING; RELEASE ASSAY; ADENOSINE-DEAMINASE; CELL; INFECTION	Background Peritoneal tuberculosis (TB) remains difficult to diagnose because of its non-specific clinical features and the lack of efficient microbiological tests. As delayed diagnosis is associated with high mortality rates, new diagnostic tools are needed. Methods and findings We investigated for 24 patients prospectively enrolled with a possible diagnosis of peritoneal TB, the diagnostic value of the analysis of IFN-gamma production by peritoneal fluid lymphocytes in response to a short in vitro stimulation with mycobacterial antigens. The patients were classified in two groups: non-TB and confirmed or highly probable TB. Diagnosis of TB was based on microbiological and histopathological criteria and/or a favorable response to anti-TB treatment. The IFN-gamma production by peritoneal CD4(+) T lymphocytes was analyzed by flow cytometry after an overnight in vitro stimulation with three different mycobacterial antigens, purified protein derivative (PPD), heparin-binding haemagglutinin (HBHA) or earlysecreted-antigen-target-6 (ESAT-6). The percentages of PPD-, HBHA- or ESAT-6-induced IFN-gamma-producing peritoneal fluid CD4(+) T lymphocytes were higher in the TB group than in the non-TB group (p = 0.0007, p = 0.0004, and p = 0.0002 respectively). Based on cut-off values determined by ROC curve analysis of the results from TB and highly probable TB compared to those of non-TB patients, the sensitivity of these three tests was 100% with a specificity of 92%. Conclusions The analysis of mycobacterial-induced IFN-gamma production by peritoneal lymphocytes is a promising tool to reliably and rapidly diagnose peritoneal TB. Further studies should be performed on larger cohorts of patients in high-TB-incidence countries to confirm the clinical value of this new diagnostic approach for peritoneal TB.	[Henrard, Sophie] Univ Libre Bruxelles, Hop Erasme, Immunodeficiencies Treatment Unit, Brussels, Belgium; [Corbiere, Veronique; Van Praet, Anne; Dirix, Violette; Mascart, Francoise] Univ Libre Bruxelles, Lab Vaccinol & Mucosal Immun, Brussels, Belgium; [Schandene, Liliane; Ducarme, Martine; Mascart, Francoise] Univ Libre Bruxelles, Hop Erasme, Immunobiol Clin, Brussels, Belgium; [Petit, Emmanuelle; Locht, Camille] INSERM, U1019, Lille, France; [Petit, Emmanuelle; Locht, Camille] CNRS, UMR8204, Lille, France; [Petit, Emmanuelle; Locht, Camille] Univ Lille, Lille, France; [Petit, Emmanuelle; Locht, Camille] Inst Pasteur, Ctr Infect & Immunite Lille, Lille, France; [Singh, Mahavir] Lionex Diagnost & Therapeut, Braunschweig, Germany	Universite Libre de Bruxelles; Universite Libre de Bruxelles; Universite Libre de Bruxelles; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Lionex Diagnostics & Therapeutics GmbH	Mascart, F (corresponding author), Univ Libre Bruxelles, Lab Vaccinol & Mucosal Immun, Brussels, Belgium.; Mascart, F (corresponding author), Univ Libre Bruxelles, Hop Erasme, Immunobiol Clin, Brussels, Belgium.	fmascart@ulb.ac.be		Mascart, Francoise/0000-0001-7635-7944	Fonds National de la Recherche Scientifique (FNRS) [PDR T.0147.13]; European Community [643381]; "Region de Bruxelles-Capitale - Innoviris"	Fonds National de la Recherche Scientifique (FNRS)(Fonds de la Recherche Scientifique - FNRS); European Community(European Commission); "Region de Bruxelles-Capitale - Innoviris"(Innoviris)	This work was supported by: F.M., Fonds National de la Recherche Scientifique (FNRS) - PDR T.0147.13; F.M., the European Community within the Horizon2020 program TBVAC2020-grant agreement 643381; and F.M., the "Region de Bruxelles-Capitale - Innoviris". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alshahrani AS, 2016, J GASTRIC CANCER, V16, P111, DOI 10.5230/jgc.2016.16.2.111; ANDERSEN P, 1995, J IMMUNOL, V154, P3359; Bourgain G, 2016, CLIN RES HEPATOL GAS, V40, pE44, DOI 10.1016/j.clinre.2015.11.006; Chow KM, 2002, CLIN INFECT DIS, V35, P409, DOI 10.1086/341898; Guirat A, 2011, CLIN RES HEPATOL GAS, V35, P60, DOI 10.1016/j.gcb.2010.07.023; Horne DJ, 2018, INT J TUBERC LUNG D, V22, P617, DOI 10.5588/ijtld.17.0721; Jafari C, 2009, AM J RESP CRIT CARE, V180, P666, DOI 10.1164/rccm.200904-0557OC; Lataifeh I, 2014, J OBSTET GYNAECOL, V34, P268, DOI 10.3109/01443615.2013.870140; Lee JY, 2015, J INFECTION, V70, P356, DOI 10.1016/j.jinf.2014.09.012; Lorenz R, 2010, INFECTION, V38, P69, DOI 10.1007/s15010-009-9469-5; Losi M, 2007, EUR RESPIR J, V30, P1173, DOI 10.1183/09031936.00067307; Masungi C, 2002, J INFECT DIS, V185, P513, DOI 10.1086/338833; Menozzi FD, 1996, J EXP MED, V184, P993, DOI 10.1084/jem.184.3.993; Metcalfe JZ, 2011, J INFECT DIS, V204, pS1120, DOI 10.1093/infdis/jir410; Muller C, 2012, SCAND J UROL NEPHROL, V46, P314, DOI 10.3109/00365599.2012.659206; Naval-Macabuhay I, 2016, J LEUKOCYTE BIOL, V99, P349, DOI 10.1189/jlb.3A1214-580RR; Place S, 2010, AM J RESP CRIT CARE, V182, P848, DOI 10.1164/rccm.201001-0083OC; Sanai FM, 2005, ALIMENT PHARM THER, V22, P685, DOI 10.1111/j.1365-2036.2005.02645.x; Tao L, 2014, DIAGN MICR INFEC DIS, V79, P102, DOI 10.1016/j.diagmicrobio.2013.12.010; Thomas MM, 2008, INT J TUBERC LUNG D, V12, P651; Vaid U, 2017, MICROBIOL SPECTR, V5, DOI 10.1128/microbiolspec.TNMI7-0006-2016; Vaz AM, 2017, BMJ CASE REP, V2017; Weledji EP, 2017, WORLD J GASTRO SURG, V9, P174, DOI 10.4240/wjgs.v9.i8.174; Wyndham-Thomas C, 2014, CLIN VACCINE IMMUNOL, V21, P321, DOI 10.1128/CVI.00651-13	24	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0214333	10.1371/journal.pone.0214333	http://dx.doi.org/10.1371/journal.pone.0214333			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR7EH	30946755	Green Submitted, Green Published, gold			2022-12-26	WOS:000463314500027
J	Dong, G; Liang, FY; Sun, B; Wang, CC; Liu, YY; Guan, XP; Yang, B; Xiu, CH; Yang, N; Liu, FY; Lu, TY; Han, W				Dong, Guo; Liang, Fengying; Sun, Bo; Wang, Chengcheng; Liu, Yangyang; Guan, Xiangpeng; Yang, Bo; Xiu, Chunhong; Yang, Ning; Liu, Fengyu; Lu, Tianyi; Han, Wei			Presence and function of stress granules in atrial fibrillation	PLOS ONE			English	Article							OXIDATIVE STRESS; PHOSPHORYLATION; TACHYCARDIA; APOPTOSIS; DAMAGE	Aims Stress granules (SGs) are transient cytoplasmic mRNA and protein complexes that form in eukaryotic cells under stress. SGs are related to multiple diseases, but there are no reports of the existence of SGs in atrial fibrillation (AF). Methods and results Cell models of AF were established by field stimulation at 600 times per minute. HL-1 cells, cardiomyocytes and cardiac fibroblasts were transfected with G3BP1-cDNA plasmid by Lipofectamine 2000. The presence of SGs was detected by immunofluorescence analysis against GTPase-activating protein SH3 domain binding protein 1 (G3BP1) and poly(A)-binding protein 1 (PABP-1) and electron microscopy. Stable HL-1 cell lines transfected with lenti-virus overexpressing G3BP1 were constructed to further induce the formation of SGs in AF. Reactive oxygen species (ROS) and calcium overload in tachypaced HL-1 cells were studied by flow cytometry. The effects of G3BP1 overexpression on cardiac fibroblast proliferation and the protein expression level of collagen I/III and fibronectin-1 were also studied. Additionally, we detected protein synthesis in general and in single cells by puromycin incorporation in paced HL-1 cells. Here, we first showed that SGs are present in both tachypaced mouse cardiomyocytes and HL-1 atrial cells, although the presence is partial and at a low level. G3BP1 overexpression promoted SG formation, inhibited the rapid pacing-induced increase in ROS level, and attenuated calcium overload in HL-1 cells (all P<0.05). Furthermore, G3BP1 overexpression inhibited cardiac fibroblast proliferation (P<0.05) and decreased the protein expression level of collagen I and fibronectin-1 in cardiac fibroblasts stimulated by angiotensin II (all P<0.05). The bulk puromycin incorporation analyzed by Western blot did not show a global reduction in protein synthesis. However, puromycin incorporation in single cells detected by immunofluorescence analysis showed that protein synthesis in SG-containing cells significantly reduced (P<0.01). Conclusions SGs are rapidly induced and present parially in AF, and G3BP1 overexpression promotes SG formation and confers cytoprotection against oxidative stress, calcium overload and atrial fibrosis in AF.	[Dong, Guo; Wang, Chengcheng; Liu, Yangyang; Guan, Xiangpeng; Yang, Bo; Xiu, Chunhong; Yang, Ning; Liu, Fengyu; Lu, Tianyi; Han, Wei] Harbin Med Univ, Affiliated Hosp 1, Dept Cardiol, Harbin, Heilongjiang, Peoples R China; [Liang, Fengying] Guangzhou Med Univ, Affiliated Hosp 3, Dept Cardiol, Guangzhou, Guangdong, Peoples R China; [Sun, Bo] Harbin Med Univ, Affiliated Hosp 1, Dept Cardiovasc Surg, Harbin, Heilongjiang, Peoples R China	Harbin Medical University; Guangzhou Medical University; Harbin Medical University	Han, W (corresponding author), Harbin Med Univ, Affiliated Hosp 1, Dept Cardiol, Harbin, Heilongjiang, Peoples R China.	dr.hanwei@foxmail.com			National Natural Science Foundation of China [81470461, 81270251]; Scientific fund for Outstanding People of Heilongjiang Province [JC2016018]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific fund for Outstanding People of Heilongjiang Province	This work was supported primarily by the National Natural Science Foundation of China (81470461 and 81270251 to Dr Han) and the Scientific fund for Outstanding People of Heilongjiang Province (JC2016018 to Dr Han). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera-Aguirre L, 2017, AM J PHYSIOL-LUNG C, V313, pL1058, DOI 10.1152/ajplung.00141.2017; Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Anderson P, 2015, BBA-GENE REGUL MECH, V1849, P861, DOI 10.1016/j.bbagrm.2014.11.009; Arimoto-Matsuzaki K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10252; Aulas A, 2015, J CELL BIOL, V209, P73, DOI 10.1083/jcb.201408092; Buchan JR, 2014, RNA BIOL, V11, P1019, DOI 10.4161/15476286.2014.972208; Carnes CA, 2001, CIRC RES, V89, pE32, DOI 10.1161/hh1801.097644; Chen LH, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/1809592; DeSantiago J, 2018, HEART RHYTHM, V15, P1233, DOI 10.1016/j.hrthm.2018.03.041; Dong ZX, 2017, SCI REP-UK, V7, DOI 10.1038/srep46307; Emara MM, 2012, BIOCHEM BIOPH RES CO, V423, P763, DOI 10.1016/j.bbrc.2012.06.033; Hu YF, 2015, NAT REV CARDIOL, V12, P230, DOI 10.1038/nrcardio.2015.2; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; Kwok HH, 2017, CELL MOL LIFE SCI, V74, P3613, DOI 10.1007/s00018-017-2540-y; Levy S, 1998, EUR HEART J, V19, P1294, DOI 10.1053/euhj.1998.1050; Markmiller S, 2018, CELL, V172, P590, DOI 10.1016/j.cell.2017.12.032; Mihm MJ, 2001, CIRCULATION, V104, P174, DOI 10.1161/01.CIR.104.2.174; Ohashi N, 2004, J CARDIOVASC PHARM, V44, P386, DOI 10.1097/01.fjc.0000138163.11612.7b; Purohit A, 2013, CIRCULATION, V128, P1748, DOI 10.1161/CIRCULATIONAHA.113.003313; Shite J, 2001, J AM COLL CARDIOL, V38, P1734, DOI 10.1016/S0735-1097(01)01596-0; Solomon S, 2007, MOL CELL BIOL, V27, P2324, DOI 10.1128/MCB.02300-06; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Takahashi M, 2013, BLOOD, V122, P715, DOI 10.1182/blood-2013-03-493718; Takahashi M, 2013, MOL CELL BIOL, V33, P815, DOI 10.1128/MCB.00763-12; Thannickal VJ, 2000, AM J PHYSIOL-LUNG C, V279, pL1005; Tourriere H, 2003, J CELL BIOL, V160, P823, DOI 10.1083/jcb.200212128; Wolkowicz PE, 2007, EUR J PHARMACOL, V576, P122, DOI 10.1016/j.ejphar.2007.08.004; Yang XX, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004763; Youn JY, 2013, J MOL CELL CARDIOL, V62, P72, DOI 10.1016/j.yjmcc.2013.04.019	29	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0213769	10.1371/journal.pone.0213769	http://dx.doi.org/10.1371/journal.pone.0213769			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR5NS	30943206	Green Published, Green Submitted, gold			2022-12-26	WOS:000463194300018
J	Zhabokritsky, A; Nelson, LE; Tharao, W; Husbands, W; Sa, T; Zhang, NH; Thomas-Pavanel, J; Baidoobonso, S; Kaul, R				Zhabokritsky, Alice; Nelson, LaRon E.; Tharao, Wangari; Husbands, Winston; Sa, Ting; Zhang, Nanhua; Thomas-Pavanel, Jamie; Baidoobonso, Shamara; Kaul, Rupert			Barriers to HIV pre-exposure prophylaxis among African, Caribbean and Black men in Toronto, Canada	PLOS ONE			English	Article							TRANSGENDER WOMEN; SEX; AWARENESS; PREP; RISK; PREVENTION; WILLINGNESS; INFECTION	Introduction Single-tablet combination emtricitabine/tenofovir is highly effective as HIV pre-exposure prophylaxis (PrEP). Scale-up efforts have targeted men who have sex with men (MSM), but patterns of racial disparities in PrEP use have begun to emerge. African, Caribbean and Black (ACB) communities in Canada and USA are also disproportionately affected by HIV, and there is lack of guidance regarding PrEP implementation in this priority population. Methods ACB men from Toronto, Canada were recruited in community settings by peers. Participants completed a detailed socio-behavioural questionnaire. Biological samples were collected and tested for sexually transmitted infections. Willingness to accept PrEP was assessed in relation to actual and self-perceived risk of acquiring HIV, as well as demographic and behavioural variables. Results 424 ACB men were included in the analysis. ACB MSM were more likely to accept PrEP than ACB men only reporting sex with women (MSW; 50.0% vs. 23.6%). The most common reasons for PrEP non-acceptance were concerns regarding side-effects and low self-perceived risk. PrEP acceptance was lowest among younger men (12.5%) and those born in Canada (15.2%). Men with a high self-perceived HIV risk were more likely to accept PrEP (41.3% vs. 22.7% of men with a low self-perceived risk), but only 25.4% of men who were defined as being at high-risk, self-identified themselves as such. Conclusions Most ACB MSW were unlikely to accept PrEP, largely due to low self-perceived HIV risk, but PrEP acceptance among ACB MSM was similar to other contemporaneous Toronto MSM communities. PrEP acceptance was particularly low among younger ACB men and those born in Canada. Tailored strategies will be needed to effectively implement PrEP in Toronto ACB communities.	[Zhabokritsky, Alice] Univ Toronto, Dept Med, Toronto, ON, Canada; [Nelson, LaRon E.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Ctr Urban Hlth Solut, Toronto, ON, Canada; [Nelson, LaRon E.] Univ Rochester, Sch Nursing, Rochester, NY USA; [Tharao, Wangari] Womens Hlth Womens Hands, Toronto, ON, Canada; [Husbands, Winston] Ontario HIV Treatment Network, Toronto, ON, Canada; [Sa, Ting; Zhang, Nanhua] Cincinnati Childrens Hosp Med Ctr, Dept Biostat & Epidemiol, Cincinnati, OH 45229 USA; [Thomas-Pavanel, Jamie] Womens Coll Hosp, Womens Coll Res Inst, Toronto, ON, Canada; [Baidoobonso, Shamara] Chief Publ Hlth Off, Charlottetown, PE, Canada; [Kaul, Rupert] Univ Toronto, Dept Med, Toronto, ON, Canada; [Kaul, Rupert] Univ Toronto, Dept Immunol, Toronto, ON, Canada	University of Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Rochester; Cincinnati Children's Hospital Medical Center; University of Toronto; University Toronto Affiliates; Womens College Hospital; University of Toronto; University of Toronto	Zhabokritsky, A (corresponding author), Univ Toronto, Dept Med, Toronto, ON, Canada.	azhabokritsky@qmed.ca		Husbands, Winston/0000-0003-4742-5105; Kaul, Rupert/0000-0002-1586-4093; Zhang, Nanhua/0000-0001-5796-3404; Nelson, LaRon/0000-0002-2630-602X	Canadian Institutes of Health Research (CIHR) [HET-85518, TMI-138656]; Ontario HIV Treatment Network (OHTN) Knowledge, Translation and Exchange grant; University of Toronto - OHTN Endowed Chair in HIV Research	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Ontario HIV Treatment Network (OHTN) Knowledge, Translation and Exchange grant; University of Toronto - OHTN Endowed Chair in HIV Research	This research was supported by grants from the Canadian Institutes of Health Research (CIHR; #HET-85518, #TMI-138656) and an Ontario HIV Treatment Network (OHTN) Knowledge, Translation and Exchange grant. RK is supported by a University of Toronto - OHTN Endowed Chair in HIV Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, STIGM DISCR IND 1 AC; [Anonymous], 2006, CAN WE MEAS HIV AIDS; Bourgeois A C, 2017, Can Commun Dis Rep, V43, P248, DOI 10.14745/ccdr.v43i12a01; Calabrese SK, 2015, AM J PUBLIC HEALTH, V105, P1960, DOI 10.2105/AJPH.2015.302816; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Eaton LA, 2017, PREV SCI, V18, P505, DOI 10.1007/s11121-017-0756-6; Eaton LA, 2015, AIDS PATIENT CARE ST, V29, P423, DOI 10.1089/apc.2014.0303; Golub SA, 2013, AIDS PATIENT CARE ST, V27, P248, DOI 10.1089/apc.2012.0419; Grace D, 2018, AIDS PATIENT CARE ST, V32, P24, DOI 10.1089/apc.2017.0153; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Kesler MA, 2016, AIDS CARE, V28, P1378, DOI 10.1080/09540121.2016.1178703; Kesler MA, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2859-6; Khanna AS, 2016, JAMA INTERN MED, V176, P136, DOI 10.1001/jamainternmed.2015.6536; Krakower DS, 2016, CURR OPIN HIV AIDS, V11, P41, DOI 10.1097/COH.0000000000000206; Leonardi M, 2011, INT J STD AIDS, V22, P738, DOI 10.1258/ijsa.2011.011057; Liu J, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1439-5; MacFadden DR, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20791; McCormack S, 2016, LANCET, V387, P53, DOI 10.1016/S0140-6736(15)00056-2; Molina JM, 2015, NEW ENGL J MED, V373, P2237, DOI 10.1056/NEJMoa1506273; Nachega JB, 2014, CLIN INFECT DIS, V58, P1297, DOI 10.1093/cid/ciu046; Nelson LE, BMC INFECT DIS; Rodger AJ, 2016, JAMA-J AM MED ASSOC, V316, P171, DOI 10.1001/jama.2016.5148; Smith DK, 2012, JAIDS-J ACQ IMM DEF, V60, P421, DOI 10.1097/QAI.0b013e318256b2f6; Tan DHS, 2017, CAN MED ASSOC J, V189, pE1448, DOI 10.1503/cmaj.170494; UNAIDS, 2017, LAT STAT STAT AIDS E; Wilton J, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20777; Yi S, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.1.21580	27	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2019	14	3							e0213740	10.1371/journal.pone.0213740	http://dx.doi.org/10.1371/journal.pone.0213740			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HQ9FO	30925582	Green Published, gold, Green Submitted			2022-12-26	WOS:000462732300005
J	Kumar, S; Phogat, BS; Vikas, VK; Sharma, AK; Saharan, MS; Singh, AK; Kumari, J; Singh, R; Jacob, SR; Singh, GP; Sivasamy, M; Jayaprakash, P; Meeta, M; Jaiswal, JP; Shikha, D; Honrao, BK; Kalappanavar, IK; Mishra, PC; Singh, SP; Vaish, SS; Solanki, VA				Kumar, Sundeep; Phogat, B. S.; Vikas, V. K.; Sharma, A. K.; Saharan, M. S.; Singh, Amit Kumar; Kumari, Jyoti; Singh, Rakesh; Jacob, Sherry Rachel; Singh, G. P.; Sivasamy, M.; Jayaprakash, P.; Meeta, M.; Jaiswal, J. P.; Shikha, Deep; Honrao, B. K.; Kalappanavar, I. K.; Mishra, P. C.; Singh, S. P.; Vaish, S. S.; Solanki, V. A.			Mining of Indian wheat germplasm collection for adult plant resistance to leaf rust	PLOS ONE			English	Article							STRIPE RUST; DURABLE RESISTANCE; POWDERY MILDEW; GENE; LR34; ASSOCIATION; IMPROVEMENT; PATHOGENS; FUTURE; LR46	Leaf rust (Puccinia triticina Eriks.) is a fungal disease of wheat (Triticum spp.), which causes considerable yield loss. Adult plant resistance (APR) is one of the most sustainable approaches to control leaf rust. In this study, field-testing was carried out across ten different locations, followed by molecular screening, to detect the presence of APR genes, Lr34+, Lr46+, Lr67+ and Lr68 in Indian wheat germplasm. In field screening, 190 wheat accessions were selected from 6,319 accessions based on leaf tip necrosis (LTN), disease severity and the average coefficient of infection. Molecular screening revealed that 73% of the accessions possessed known APR genes either as single or as a combination of two or three genes. The occurrence of increased LTN intensity, decreased leaf rust severity and greater expression of APR genes were more in relatively cooler locations. In 52 lines, although the presence of the APR genes was not detected, it still displayed high levels of resistance. Furthermore, 49 accessions possessing either two or three APR genes were evaluated for stability across locations for grain yield. It emerged that eight accessions had wider adaptability. Resistance based on APR genes, in the background of high yielding cultivars, is expected to provide a high level of race non-specific resistance, which is durable.	[Kumar, Sundeep; Phogat, B. S.; Singh, Amit Kumar; Kumari, Jyoti; Singh, Rakesh; Jacob, Sherry Rachel] ICAR Natl Bur Plant Genet Resources, Pusa Campus, New Delhi, India; [Vikas, V. K.; Sivasamy, M.; Jayaprakash, P.] ICAR Indian Agr Res Inst, Reg Stn, Wellington, Tamil Nadu, India; [Sharma, A. K.; Saharan, M. S.; Singh, G. P.] ICAR Indian Inst Wheat & Barley Res, Karnal, Haryana, India; [Meeta, M.] Punjab Agr Univ, Ludhiana, Punjab, India; [Jaiswal, J. P.; Shikha, Deep] Govind Ballabh Pant Univ Agr & Technol, Pantnagar, Uttarakhand, India; [Honrao, B. K.] Agharkar Res Inst, Pune, Maharashtra, India; [Kalappanavar, I. K.] Univ Agr Sci, Dharwad, Karnataka, India; [Mishra, P. C.] Zonal Agr Res Stn JNKVV, Powarkheda, Madhya Pradesh, India; [Singh, S. P.] Narendra Deva Univ Agr & Technol, Faizabad, Uttar Pradesh, India; [Vaish, S. S.] Banaras Hindu Univ, Varanasi, Uttar Pradesh, India; [Solanki, V. A.] Sardarkrushinagar Dantiwada Agr Univ, Vijapur, Gujarat, India	Indian Council of Agricultural Research (ICAR); ICAR - National Bureau of Plant Genetics Resources; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - Indian Institute of Wheat & Barley Research; Punjab Agricultural University; Govind Ballabh Pant University of Agriculture Technology; Department of Science & Technology (India); Agharkar Research Institute (ARI); Banaras Hindu University (BHU)	Kumar, S (corresponding author), ICAR Natl Bur Plant Genet Resources, Pusa Campus, New Delhi, India.	Sundeep.Kumar@icar.gov.in	Kumar, Saran/GWQ-9968-2022; Singh, Rakesh/AAI-6165-2020; kumari, Jyoti/GSE-6263-2022; KUMAR, SANDEEP/GZA-7182-2022; Jayaprakash*, P/ABC-7625-2020; Saharan, Mahender/AAI-9831-2020	Singh, Rakesh/0000-0001-7269-6420; Vaish, Shyam Saran/0000-0003-0283-1783; Kumar, Sundeep/0000-0002-0015-8559	CABin project, ICAR, New Delhi [16103]; Indian Council of Agricultural Research, Government of India under ICAR-NBPGR-Multi-location Evaluation Programme	CABin project, ICAR, New Delhi; Indian Council of Agricultural Research, Government of India under ICAR-NBPGR-Multi-location Evaluation Programme	The work was funded by a sponsored research component of CABin project (Scheme Code: 16103), ICAR, New Delhi.; The authors are grateful to Indian Council of Agricultural Research, Government of India for supporting this research under ICAR-NBPGR-Multi-location Evaluation Programme. The authors are thankful to Director, ICAR-NBPGR New Delhi and Director, IIWBR, Karnal for providing the facilities and guidance in germplasm evaluation. The authors are also thankful to Dr. S. C. Bhardwaj, Head, IIWBR RS, Flowerdale, Shimla for providing inoculum during the course of investigation.	Bansal UK, 2008, THEOR APPL GENET, V117, P307, DOI 10.1007/s00122-008-0775-6; Chen WQ, 2013, EUPHYTICA, V192, P339, DOI 10.1007/s10681-012-0854-2; Dakouri A, 2014, MOL BREEDING, V33, P639, DOI 10.1007/s11032-013-9981-2; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; DYCK PL, 1991, CROP SCI, V31, P309, DOI 10.2135/cropsci1991.0011183X003100020016x; DYCK PL, 1979, CAN J PLANT SCI, V59, P329, DOI 10.4141/cjps79-053; Ellis JG, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00641; Forrest K, 2014, MOL BREEDING, V34, P2109, DOI 10.1007/s11032-014-0166-4; Ganal Martin W., 2007, P1, DOI 10.1007/978-1-4020-6297-1_1; Gauch HG, 2013, CROP SCI, V53, P1860, DOI 10.2135/cropsci2013.04.0241; Gauch HG, 2011, CROP SCI, V51, P96, DOI 10.2135/cropsci2010.04.0206; Herrera-Foessel SA, 2014, THEOR APPL GENET, V127, P781, DOI 10.1007/s00122-013-2256-9; Herrera-Foessel SA, 2012, THEOR APPL GENET, V124, P1475, DOI 10.1007/s00122-012-1802-1; Hiebert CW, 2010, THEOR APPL GENET, V121, P1083, DOI 10.1007/s00122-010-1373-y; Hulbert SH, 2007, PHYTOPATHOLOGY, V97, P1083, DOI 10.1094/PHYTO-97-9-1083; Johnson R., 1988, BREEDING STRATEGIES; Joshi AK, 2007, EUPHYTICA, V157, P431, DOI 10.1007/s10681-007-9385-7; Juliana P, 2015, PLANT GENOME-US, V8, DOI 10.3835/plantgenome2015.01.0002; Krattinger SG, 2009, SCIENCE, V323, P1360, DOI 10.1126/science.1166453; Lagudah ES, 2006, THEOR APPL GENET, V114, P21, DOI 10.1007/s00122-006-0406-z; Lagudah ES, 2011, EUPHYTICA, V179, P81, DOI 10.1007/s10681-010-0336-3; Li ZF, 2014, CROP SCI, V54, P1907, DOI 10.2135/cropsci2014.02.0162; Loegering W. Q., 1959, METHODS RECORDING CE; Ma H, 1996, PLANT DIS, V80, P66, DOI 10.1094/PD-80-0066; McIntosh R., 1995, WHEAT RUSTS ATLAS RU, DOI [10.1071/9780643101463, DOI 10.1071/9780643101463]; McIntosh RA, 1998, EUPHYTICA, V100, P19, DOI 10.1023/A:1018387402918; McIntosh RA, 2011, CATALOGUE GENE SYM S; Messmer MM, 2000, THEOR APPL GENET, V100, P419, DOI 10.1007/s001220050055; Moore JW, 2015, NAT GENET, V47, P1494, DOI 10.1038/ng.3439; Nagarajan S, 2005, CURR SCI INDIA, V89, P1467; Pasquini M, 2003, J GENET BREED, V57, P191; Pathan AK, 2006, EUPHYTICA, V149, P327, DOI 10.1007/s10681-005-9081-4; PETERSON RF, 1948, CAN J RES C, V26, P496, DOI 10.1139/cjr48c-033; Risk JM, 2012, PLANT BIOTECHNOL J, V10, P477, DOI 10.1111/j.1467-7652.2012.00683.x; Rosewarne GM, 2006, THEOR APPL GENET, V112, P500, DOI 10.1007/s00122-005-0153-6; RUBIALES D, 1995, PLANT DIS, V79, P1208, DOI 10.1094/PD-79-1208; Singh RP, 2011, EUPHYTICA, V179, P175, DOI 10.1007/s10681-010-0322-9; SINGH RP, 1992, PHYTOPATHOLOGY, V82, P835, DOI 10.1094/Phyto-82-835; SINGH RP, 1992, GENOME, V35, P24, DOI 10.1139/g92-004; Singh RP, 1998, PHYTOPATHOLOGY, V88, P890, DOI 10.1094/PHYTO.1998.88.9.890; Somers DJ, 2004, THEOR APPL GENET, V109, P1105, DOI 10.1007/s00122-004-1740-7; United Nations, 2015, ESAPWP241 UN; William M, 2003, PHYTOPATHOLOGY, V93, P153, DOI 10.1094/PHYTO.2003.93.2.153; ZADOKS JC, 1974, WEED RES, V14, P415, DOI 10.1111/j.1365-3180.1974.tb01084.x; ZOBEL RW, 1988, AGRON J, V80, P388, DOI 10.2134/agronj1988.00021962008000030002x	45	11	13	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0213468	10.1371/journal.pone.0213468	http://dx.doi.org/10.1371/journal.pone.0213468			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921352	Green Published, gold, Green Submitted			2022-12-26	WOS:000462594000017
J	Martinez-Conde, S; McCamy, MB; Troncoso, XG; Otero-Millan, J; Macknik, SL				Martinez-Conde, Susana; McCamy, Michael B.; Troncoso, Xoana G.; Otero-Millan, Jorge; Macknik, Stephen L.			Area V1 responses to illusory corner-folds in Vasarely's nested squares and the Alternating Brightness Star illusions	PLOS ONE			English	Article							RETINAL GANGLION-CELLS; CONTRAST-SENSITIVITY; SALIENCE VARIES; STRIATE CORTEX; MICROSACCADES; NEURONS; DYNAMICS; MONKEY; ANGLE; SHAPE	Vasarely's nested squares illusion shows that the corners of concentric squares, arranged in a gradient of increasing or decreasing luminance, generate illusory "corner-folds," which appear more salient (either brighter or darker) than the adjacent flat (non- corner) regions of each individual square. The Alternating Brightness Star (ABS) illusion, based on Vasarely's classic nested squares, further shows that the strength of these corner-folds depends on corner angle. Previous psychophysical studies showed the relationship between corner angle and perceived contrast in the ABS illusion to be linear, with sharp angles looking higher in contrast, and shallow angles lower in contrast. Center-surround difference-of-Gaussians (DOG) modeling did not replicate this linear relationship, however, suggesting that a full neural explanation of the nested squares and ABS illusions might be found in the visual cortex, rather than at subcortical stages. Here we recorded the responses from single area V1 neurons in the awake primate, during the presentation of visual stimuli containing illusory corner-folds of various angles. Our results showed stronger neural responses for illusory corner-folds made from sharper than from shallower corners, consistent with predictions from the previous psychophysical work. The relationship between corner angle and strength of the neuronal responses, albeit parametric, was apparently non-linear. This finding was in line with the previous DOG data, but not with the psychophysical data. Our combined results suggest that, whereas corner-fold illusions likely originate from center surround retinogeniculate processes, their complete neural explanation may be found in extrastriate visual cortical areas.	[Martinez-Conde, Susana; McCamy, Michael B.; Troncoso, Xoana G.; Otero-Millan, Jorge; Macknik, Stephen L.] Barrow Neurol Inst, Phoenix, AZ 85013 USA; [Martinez-Conde, Susana; Macknik, Stephen L.] Suny Downstate Med Ctr, Brooklyn, NY 11203 USA; [Troncoso, Xoana G.] CNRS, UNIC, Gif Sur Yvette, France; [Otero-Millan, Jorge] Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21218 USA	Barrow Neurological Institute; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Johns Hopkins University	Martinez-Conde, S (corresponding author), Barrow Neurol Inst, Phoenix, AZ 85013 USA.; Martinez-Conde, S (corresponding author), Suny Downstate Med Ctr, Brooklyn, NY 11203 USA.	smart@neuralcorrelate.com	Martinez-Conde, Susana/AAK-6725-2021	Martinez-Conde, Susana/0000-0003-4600-9767; Troncoso, Xoana/0000-0001-7343-1272; Otero-Millan, Jorge/0000-0002-9789-8392	Research to Prevent Blindness Inc.; Empire Innovation Program; Barrow Neurological Foundation; National Eye Institute; National Science Foundation [0643306, 0852636, 113786, 0726113, 1523614]	Research to Prevent Blindness Inc.(Research to Prevent Blindness (RPB)); Empire Innovation Program; Barrow Neurological Foundation; National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Science Foundation(National Science Foundation (NSF))	This study was supported by a challenge grant from Research to Prevent Blindness Inc. to the Department of Ophthalmology at SUNY Downstate, the Empire Innovation Program (Awards to S.L.M. and S.M.-C.), the Barrow Neurological Foundation (Awards to S.L.M. and S.M.-C.), the National Eye Institute (Award to David H. Hubel) and the National Science Foundation (Awards 0643306, 0852636 and 113786 to S.M.C. and Awards 0726113 and 1523614 to S.L.M.). X.G.T. and J.O.-M. were Fellows of the Barrie Foundation (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBRECHT DG, 1982, J NEUROPHYSIOL, V48, P217, DOI 10.1152/jn.1982.48.1.217; Albrecht DG, 2002, J NEUROPHYSIOL, V88, P888, DOI 10.1152/jn.2002.88.2.888; [Anonymous], 1984, J PHYSL, DOI [10.1113/jphysiol.1984.sp015498, DOI 10.1113/JPHYSIOL.1984.SP015498]; ATTNEAVE F, 1954, PSYCHOL REV, V61, P183, DOI 10.1037/h0054663; Barlow H, 1961, POSSIBLE PRINCIPLES; Barlow HB, 1989, NEURAL COMPUT, V1, P295, DOI 10.1162/neco.1989.1.3.295; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chen MG, 2014, NEURON, V82, P682, DOI 10.1016/j.neuron.2014.03.023; Costela FM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110889; Dayan P, 2001, COMPUTATIONAL NEUROS; Engbert R, 2003, VISION RES, V43, P1035, DOI 10.1016/S0042-6989(03)00084-1; Engbert R, 2006, P NATL ACAD SCI USA, V103, P7192, DOI 10.1073/pnas.0509557103; Engbert R, 2006, PROG BRAIN RES, V154, P177, DOI 10.1016/S0079-6123(06)54009-9; ENROTHCUGELL C, 1966, J PHYSIOL-LONDON, V187, P517, DOI 10.1113/jphysiol.1966.sp008107; HUBEL DH, 1965, J NEUROPHYSIOL, V28, P229, DOI 10.1152/jn.1965.28.2.229; Hurvich LM., 1981, COLOR VISION; IRVIN GE, 1993, VISUAL NEUROSCI, V10, P363, DOI 10.1017/S0952523800003758; Laubrock J, 2005, VISION RES, V45, P721, DOI 10.1016/j.visres.2004.09.029; Levitt JB, 2001, J NEUROPHYSIOL, V85, P2111, DOI 10.1152/jn.2001.85.5.2111; Macknik SL, 2000, P NATL ACAD SCI USA, V97, P7556, DOI 10.1073/pnas.110142097; Martinez-Conde S, 2002, P NATL ACAD SCI USA, V99, P13920, DOI 10.1073/pnas.212500599; Martinez-Conde S, 2000, NAT NEUROSCI, V3, P251, DOI 10.1038/72961; Martinez-Conde S, 2001, SOC NEUR 31 ANN M SO; Moller F, 2002, GRAEF ARCH CLIN EXP, V240, P765, DOI 10.1007/s00417-002-0519-2; Myronenko A, 2010, IEEE T PATTERN ANAL, V32, P2262, DOI 10.1109/TPAMI.2010.46; Pasupathy A, 1999, J NEUROPHYSIOL, V82, P2490, DOI 10.1152/jn.1999.82.5.2490; Pasupathy A, 2001, J NEUROPHYSIOL, V86, P2505, DOI 10.1152/jn.2001.86.5.2505; Pasupathy A, 2002, NAT NEUROSCI, V5, P1332, DOI 10.1038/nn972; PELI E, 1990, J OPT SOC AM A, V7, P2032, DOI 10.1364/JOSAA.7.002032; REMMEL RS, 1984, IEEE T BIO-MED ENG, V31, P388, DOI 10.1109/TBME.1984.325352; ROBSON JG, 1966, J OPT SOC AM, V56, P1141, DOI 10.1364/JOSA.56.001141; RODIECK R. W., 1965, VISION RES, V5, P583, DOI 10.1016/0042-6989(65)90033-7; Tadmor Y, 2000, VISION RES, V40, P3145, DOI 10.1016/S0042-6989(00)00166-8; Troncoso XG, 2005, PERCEPTION, V34, P409, DOI 10.1068/p5383; Troncoso XG, 2007, PERCEPTION, V36, P808, DOI 10.1068/p5610; Troncoso XG, 2009, SPATIAL VISION, V22, P211, DOI 10.1163/156856809788313129; van Kerkoerle T, 2014, P NATL ACAD SCI USA, V111, P14332, DOI 10.1073/pnas.1402773111; Vasarely V, 1970, VASARELY 2	38	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0210941	10.1371/journal.pone.0210941	http://dx.doi.org/10.1371/journal.pone.0210941			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HQ7IR	30921330	Green Published, gold, Green Submitted			2022-12-26	WOS:000462594000007
J	Poteet, E; Liu, DL; Liang, ZD; Van Buren, G; Chen, CY; Yao, QZ				Poteet, Ethan; Liu, Dongliang; Liang, Zhengdong; Van Buren, George; Chen, Changyi; Yao, Qizhi			Mesothelin and TGF-alpha predict pancreatic cancer cell sensitivity to EGFR inhibitors and effective combination treatment with trametinib	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; FACTOR RECEPTOR INHIBITORS; MESENCHYMAL TRANSITION; PHASE-III; ANTITUMOR-ACTIVITY; GEFITINIB ZD1839; LUNG; GEMCITABINE; IRESSA; ERLOTINIB	Clinical trials of EGFR inhibitors in combination with gemcitabine for the treatment of pancreatic ductal adenocarcinoma (PDAC) have generated mixed results partially due to the poorly defined effectiveness of EGFR inhibitors in PDAC. Here, we studied a panel of PDAC cell lines to compare the IC50s of the EGFR inhibitors gefitinib and cetuximab. We found that gefitinib induced biphasic inhibition in over 50% of PDAC cells, with the initial growth inhibition occurring at nanomolar concentrations and a second growth inhibition occurring outside the clinical range. In contrast to gefitinib, cetuximab produced a single phase growth inhibition in a subset of PDAC cells. Using this sensitivity data, we screened for correlations between cell morphology proteins and EGFR ligands to EGFR inhibitor sensitivity, and found that mesothelin and the EGFR ligand TGF-alpha have a strong correlation to gefitinib and cetuximab sensitivity. Analysis of downstream signaling pathways indicated that plc-gamma 1 and c-myc were consistently inhibited by EGFR inhibitor treatment in sensitive cell lines. While an inconsistent additive effect was observed with either cetuximab or gefitinib in combination with gemcitabine, the cell pathway data indicated consistent ERK activation, leading us to pursue EGFR inhibitors in combination with trametinib, a MEK1/2 inhibitor. Both cetuximab and gefitinib in combination with trametinib produced an additive effect in all EGFR sensitive cell lines. Our results indicate that mesothelin and TGF-alpha can predict PDAC sensitivity to EGFR inhibitors and a combination of EGFR inhibitors with trametinib could be a novel effective treatment for PDAC.	[Poteet, Ethan; Liu, Dongliang; Liang, Zhengdong; Van Buren, George; Chen, Changyi; Yao, Qizhi] Baylor Coll Med, Michael E DeBakey Dept Surg, Div Surg Res, Houston, TX 77030 USA; [Yao, Qizhi] Michael E DeBakey VA Med Ctr, Ctr Translat Res Inflammatory Dis, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Yao, QZ (corresponding author), Baylor Coll Med, Michael E DeBakey Dept Surg, Div Surg Res, Houston, TX 77030 USA.; Yao, QZ (corresponding author), Michael E DeBakey VA Med Ctr, Ctr Translat Res Inflammatory Dis, Houston, TX 77030 USA.	qizhiyao@bcm.edu	Liu, Dongliang/AAP-6335-2021; Liu, Dongliang/AAM-9595-2021	Liu, Dongliang/0000-0001-5843-5451; Liu, Dongliang/0000-0001-5843-5451; Yao, Cathy/0000-0002-2267-0588	Michael E. DeBakey Department of Surgery Faculty Research Seed Grant from BCM; Dan Duncan Cancer Center Seed Fund from BCM; NIH [P30 AI036211, P30 CA125123, S10 RR024574, R01 CA183984]; Cytometry and Cell Sorting Core at Baylor College of Medicine; NATIONAL CANCER INSTITUTE [R01CA183984, P30CA125123] Funding Source: NIH RePORTER	Michael E. DeBakey Department of Surgery Faculty Research Seed Grant from BCM; Dan Duncan Cancer Center Seed Fund from BCM; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cytometry and Cell Sorting Core at Baylor College of Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was partially supported by Michael E. DeBakey Department of Surgery Faculty Research Seed Grant from BCM (PI: Poteet), Dan Duncan Cancer Center Seed Fund from BCM and NIH R01 CA183984 (PI: Yao). We gratefully acknowledge support from the Cytometry and Cell Sorting Core at Baylor College of Medicine with funding from the NIH (P30 AI036211, P30 CA125123, and S10 RR024574). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2005, MOL CANCER THER, V4, P1943, DOI 10.1158/1535-7163.MCT-05-0065; Argani P, 2001, CLIN CANCER RES, V7, P3862; Arumugam T, 2009, CANCER RES, V69, P5820, DOI 10.1158/0008-5472.CAN-08-2819; Bharadwaj U, 2016, ONCOTARGET, V7, P26307, DOI 10.18632/oncotarget.8368; Biankin AV, 2012, NATURE, V491, P399, DOI 10.1038/nature11547; Bill HM, 2004, MOL CELL BIOL, V24, P8586, DOI 10.1128/MCB.24.19.8586-8599.2004; Buck E, 2007, MOL CANCER THER, V6, P532, DOI 10.1158/1535-7163.MCT-06-0462; Buck E, 2006, MOL CANCER THER, V5, P2676, DOI 10.1158/1535-7163.MCT-06-0166; Chang AY, 2013, ANTI-CANCER DRUG, V24, P251, DOI 10.1097/CAD.0b013e32835ba289; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Ciardiello F, 2000, CLIN CANCER RES, V6, P2053; Cohen MH, 2004, CLIN CANCER RES, V10, P1212, DOI 10.1158/1078-0432.CCR-03-0564; Conradt L, 2011, NEOPLASIA, V13, P1026, DOI 10.1593/neo.111016; De Cesare M, 2014, CLIN CANCER RES, V20, P995, DOI 10.1158/1078-0432.CCR-13-1684; Deer EL, 2010, PANCREAS, V39, P425, DOI 10.1097/MPA.0b013e3181c15963; Diep CH, 2011, CLIN CANCER RES, V17, P2744, DOI 10.1158/1078-0432.CCR-10-2214; Doody JF, 2007, MOL CANCER THER, V6, P2642, DOI 10.1158/1535-7163.MCT-06-0506; Frederick BA, 2007, MOL CANCER THER, V6, P1683, DOI 10.1158/1535-7163.MCT-07-0138; Hayes TK, 2016, CANCER CELL, V29, P75, DOI 10.1016/j.ccell.2015.11.011; Helfrich BA, 2006, CLIN CANCER RES, V12, P7117, DOI 10.1158/1078-0432.CCR-06-0760; Hotz B, 2012, GASTRIC CANCER, V15, P252, DOI 10.1007/s10120-011-0102-9; Kaneko O, 2009, J BIOL CHEM, V284, P3739, DOI 10.1074/jbc.M806776200; Ko AH, 2016, CLIN CANCER RES, V22, P61, DOI 10.1158/1078-0432.CCR-15-0979; Li M, 2008, MOL CANCER THER, V7, P286, DOI 10.1158/1535-7163.MCT-07-0483; Liston DR, 2017, CLIN CANCER RES, V23, P3489, DOI 10.1158/1078-0432.CCR-16-3083; Lo HW, 2006, BREAST CANCER RES TR, V95, P211, DOI 10.1007/s10549-005-9011-0; Miyabayashi K, 2013, CANCER RES, V73, P2221, DOI 10.1158/0008-5472.CAN-12-1453; Moore MJ, 2007, J CLIN ONCOL, V25, P1960, DOI 10.1200/JCO.2006.07.9525; Morgan MA, 2008, CLIN CANCER RES, V14, P5142, DOI 10.1158/1078-0432.CCR-07-4072; Mukohara T, 2005, JNCI-J NATL CANCER I, V97, P1185, DOI 10.1093/jnci/dji238; Navas C, 2012, CANCER CELL, V22, P318, DOI 10.1016/j.ccr.2012.08.001; Oda K, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100014; Ono M, 2004, MOL CANCER THER, V3, P465; Pao W, 2005, PLOS MED, V2, P57, DOI 10.1371/journal.pmed.0020017; Philip PA, 2010, J CLIN ONCOL, V28, P3605, DOI 10.1200/JCO.2009.25.7550; Pino MS, 2006, CANCER RES, V66, P3802, DOI 10.1158/0008-5472.CAN-05-3753; PLUNKETT W, 1995, SEMIN ONCOL, V22, P3; RAN W, 1986, P NATL ACAD SCI USA, V83, P8216, DOI 10.1073/pnas.83.21.8216; Rao TD, 2017, ACS CHEM BIOL, V12, P2085, DOI 10.1021/acschembio.7b00305; Seshacharyulu P, 2012, EXPERT OPIN THER TAR, V16, P15, DOI 10.1517/14728222.2011.648617; Sinn M, 2017, J CLIN ONCOL, V35, P3330, DOI 10.1200/JCO.2017.72.6463; Todorova MG, 2009, CELL SIGNAL, V21, P523, DOI 10.1016/j.cellsig.2008.12.005; Wakeling AE, 2002, CANCER RES, V62, P5749; Witta SE, 2006, CANCER RES, V66, P944, DOI 10.1158/0008-5472.CAN-05-1988; Zhang S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068303	45	5	5	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0213294	10.1371/journal.pone.0213294	http://dx.doi.org/10.1371/journal.pone.0213294			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921351	Green Published, gold, Green Submitted			2022-12-26	WOS:000462594000015
J	Veronese, N; Stubbs, B; Koyanagi, A; Vaona, A; Demurtas, J; Schofield, P; Maggi, S				Veronese, Nicola; Stubbs, Brendon; Koyanagi, Ai; Vaona, Alberto; Demurtas, Jacopo; Schofield, Patricia; Maggi, Stefania			Mitochondrial genetic haplogroups and cardiovascular diseases: Data from the Osteoarthritis Initiative	PLOS ONE			English	Article							MTDNA VARIATION; DNA; SUSCEPTIBILITY; LONGEVITY	Background Some case-control studies reported that mitochondrial haplogroups could be associated with the onset of cardiovascular diseases (CVD), but the literature regarding this topic is limited. We aimed to investigate whether any mitochondrial haplogroup carried a higher or lower risk of CVD in a large cohort of North American people affected by knee osteoarthritis or at high risk for this condition. Materials and methods A longitudinal cohort study including individuals from the Osteoarthritis Initiative was done. Haplogroups were assigned through a combination of sequencing and PCR-RFLP techniques. All the mitochondrial haplogroups have been named following this nomenclature: HV, JT, UK, IWX, and superHV/others. The strength of the association between mitochondrial haplogroups and incident CVD was evaluated through a Cox's regression analysis, adjusted for potential confounders, and reported as hazard ratios (HRs) with their 95% confidence intervals (CIs). Results Overall, 3,288 Caucasian participants (56.8% women) with a mean age of 61.3 +/- 9.2 years without CVD at baseline were included. During a median follow-up of 8 years, 322 individuals (= 9.8% of baseline population) developed a CVD. After adjusting for 11 potential confounders at baseline and taking those with the HV haplotype as reference (the most frequent), those with JT carried a significant lower risk of CVD (HR = 0.75; 95%CI: 0.54-0.96; p = 0.03). Participants with the J haplogroup had the lowest risk of CVD (HR = 0.71; 95%CI: 0.46-0.95; p = 0.02). Conclusions The presence of JT haplogroups (particularly J) may be associated with a reduced risk of CVD. However, this result was not based on a high level of statistical significance. Thus, future research with larger sample size is needed to assess whether our results can be corroborated.	[Veronese, Nicola; Maggi, Stefania] CNR, Neurosci Inst, Aging Branch, Padua, Italy; [Veronese, Nicola; Maggi, Stefania] S De Bellis Res Hosp, Natl Inst Gastroenterol, Castellana Grotte, Ba, Italy; [Stubbs, Brendon] South London & Maudsley NHS Fdn Trust, Denmark Hill, London, England; [Koyanagi, Ai] Fundacio St Joan de Deu, Res & Dev Unit, Parc Sanitari St Joan de Deu, CIBERSAM, Barcelona, Spain; [Vaona, Alberto] Azienda ULSS20 Verona, Primary Care Dept, Verona, Italy; [Demurtas, Jacopo] Azienda USL Toscana Sud Est, Primary Care Dept, Grosseto, Italy; [Schofield, Patricia] Anglia Ruskin Univ, Fac Hlth Social Care & Educ, Chelmsford, England	Consiglio Nazionale delle Ricerche (CNR); CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Anglia Ruskin University	Veronese, N (corresponding author), CNR, Neurosci Inst, Aging Branch, Padua, Italy.; Veronese, N (corresponding author), S De Bellis Res Hosp, Natl Inst Gastroenterol, Castellana Grotte, Ba, Italy.	ilmannato@gmail.com	Stubbs, Brendon/X-1904-2018; Koyanagi, Ai/D-3833-2018; Schofield, Patricia/U-8534-2019; Veronese, Nicola/K-4343-2018; Demurtas, Jacopo/AAA-8814-2019	Stubbs, Brendon/0000-0001-7387-3791; Koyanagi, Ai/0000-0002-9565-5004; Veronese, Nicola/0000-0002-9328-289X; Demurtas, Jacopo/0000-0003-3001-8546	Miguel Servet contract [CP13/00150, PI15/00862]; ISCIII - General Branch Evaluation and Promotion of Health Research; European Regional Development Fund (ERDF-FEDER); National Institutes of Health, a branch of the Department of Health and Human Services [N01-AR-2-2258, N01-AR-2-2259, N01-AR-2-2260, N01-AR-2-2261, N01-AR-2-2262]; Merck Research Laboratories; Novartis Pharmaceuticals Corporation; GlaxoSmithKline; Pfizer, Inc.	Miguel Servet contract; ISCIII - General Branch Evaluation and Promotion of Health Research; European Regional Development Fund (ERDF-FEDER); National Institutes of Health, a branch of the Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Merck Research Laboratories(Merck & Company); Novartis Pharmaceuticals Corporation(Novartis); GlaxoSmithKline(GlaxoSmithKline); Pfizer, Inc.(Pfizer)	Ai Koyanagi's work was supported by the Miguel Servet contract financed by the CP13/00150 and PI15/00862 projects, integrated into the National R + D + I and funded by the ISCIII -General Branch Evaluation and Promotion of Health Research - and the European Regional Development Fund (ERDF-FEDER). The OAI is a public-private partnership comprised of five contracts (N01-AR-2-2258; N01-AR-2-2259; N01-AR-2-2260; N01-AR-2-2261; N01-AR-2-2262) funded by the National Institutes of Health, a branch of the Department of Health and Human Services, and conducted by the OAI Study Investigators. Private funding partners include Merck Research Laboratories; Novartis Pharmaceuticals Corporation, GlaxoSmithKline; and Pfizer, Inc. Private sector funding for the OAI is managed by the Foundation for the National Institutes of Health. This manuscript was prepared using an OAI public use data set and does not necessarily reflect the opinions or views of the OAI investigators, the NIH, or the private funding partners. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], J AFR; Benn M, 2008, CIRCULATION, V117, P2492, DOI 10.1161/CIRCULATIONAHA.107.756809; Cai XY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006423; Chinnery PF, 2010, LANCET NEUROL, V9, P498, DOI 10.1016/S1474-4422(10)70083-1; Copeland WC, 2014, DNA REPAIR, V19, P190, DOI 10.1016/j.dnarep.2014.03.010; Fernandez-Caggiano M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044128; Fernandez-Moreno M, 2016, ANN RHEUMATIC DIS; Fetterman JL, 2013, BIOCHEM J, V455, P157, DOI 10.1042/BJ20130029; Gallardo ME, 2012, EUR HEART J, V33, P346, DOI 10.1093/eurheartj/ehr280; Golubenko MV, 2015, MOL BIOL+, V49, P867, DOI 10.1134/S0026893315050088; Hagen CM, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0071904, 10.1371/currents.hd.d8917b4862929772c5a2f2a34ef1c201]; JOHNS DR, 1995, NEW ENGL J MED, V333, P638, DOI 10.1056/NEJM199509073331007; Kofler B, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-35; Krzywanski DM, 2011, LAB INVEST, V91, P1122, DOI 10.1038/labinvest.2011.95; Latorre-Pellicer A, 2016, NATURE, V535, P561, DOI 10.1038/nature18618; Lemieux H, 2009, J BIOENERG BIOMEMBR, V41, P99, DOI 10.1007/s10863-009-9211-0; Luchini C, 2016, GENE CHROMOSOME CANC, V55, P741, DOI 10.1002/gcc.22381; Mafficini A, 2016, ONCOTARGET, V7, P1076, DOI 10.18632/oncotarget.6834; Martinez-Redondo D, 2010, MITOCHONDRION, V10, P102, DOI 10.1016/j.mito.2009.11.005; Meschia JF, 2010, LANCET NEUROL, V9, P453, DOI 10.1016/S1474-4422(10)70092-2; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; MITOMAP, 2017, MITOMAP HUM MIT GEN; Niemi AK, 2003, HUM GENET, V112, P29, DOI 10.1007/s00439-002-0843-y; Pant S, 2014, J CARDIOVASC PHARM T, V19, P170, DOI 10.1177/1074248413504994; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Picard M, 2016, MITOCHONDRION, V30, P105, DOI 10.1016/j.mito.2016.07.003; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rego-Perez I, 2008, ARTHRITIS RHEUM-US, V58, P2387, DOI 10.1002/art.23659; Samuels DC, 2006, AM J HUM GENET, V78, P713, DOI 10.1086/502682; Torroni A, 1996, GENETICS, V144, P1835; Tranah GJ, 2011, MITOCHONDRION, V11, P855, DOI 10.1016/j.mito.2011.04.005; Venter M, 2017, J GENET GENOMICS, V44, P139, DOI 10.1016/j.jgg.2016.12.003; Veronese N, 2018, J NUTR HEALTH AGING, V22, P371, DOI 10.1007/s12603-017-0941-0; Veronese N, 2018, REJUV RES, V21, P15, DOI 10.1089/rej.2017.1917; Veronese N, 2017, J AFFECT DISORDERS, V217, P55, DOI 10.1016/j.jad.2017.03.069; Wallace DC, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a021220; Wang YW, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00232; Washburn RA, 1999, J CLIN EPIDEMIOL, V52, P643, DOI 10.1016/S0895-4356(99)00049-9	38	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0213656	10.1371/journal.pone.0213656	http://dx.doi.org/10.1371/journal.pone.0213656			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921349	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000462594000021
J	Zito, P; Labbozzetta, M; Notarbartolo, M; Sajeva, M; Poma, P				Zito, Pietro; Labbozzetta, Manuela; Notarbartolo, Monica; Sajeva, Maurizio; Poma, Paola			Essential oil of Cyphostemma juttae (Vitaceae): Chemical composition and antitumor mechanism in triple negative breast cancer cells	PLOS ONE			English	Article							DRUG EFFLUX TRANSPORTERS; CASSETTE ABC FAMILY; MULTIDRUG-RESISTANCE; MEDICINAL-PLANTS; CURCUMIN	The genus Cyphostemma (Planch.) Alston (Vitaceae) includes about 150 species distributed in eastern and southern Africa and Madagascar. Some species are used in traditional medicine and their biological activities, including antiproliferative effects against cancer cell lines, have been demonstrated. To date no investigations on Cyphostemma essential oils have been carried out. Essential oils, which play important roles in plant defenses have been demonstrated to be active in the treatment of several human diseases and to enhance bioavability of other drugs. The aim of this paper was to identify the chemical composition of the essential oil of the leaves of Cyphostemma juttae (Dinter & Gilg) Desc. and to verify some biological activities on two triple negative breast cancer cell lines (MDA-MB-231, SUM 149), characterized by the over-expression of the transcription factor NF-kappa B. In the essential oil, obtained by hydrodistillation and analysed by gas chromatography-mass spectrometry, 39 compounds were detected and with phytol (30%) dominating the chemical composition. C. juttae essential oil reduced cell growth and showed a pro-oxidant activity in both cell lines. Moreover, C. juttae essential oil caused a substantial decrease of NF-kappa B activation and consequently a significant reduction of some NF-kappa B target genes. The present study shows for the first time the cytotoxic properties of C. juttae essential oil and highlight its availability to interfere with NF-kappa B pathway, suggesting a potential therapeutic use in triple negative breast cancers (TNBCs) of this essential oil.	[Zito, Pietro; Labbozzetta, Manuela; Notarbartolo, Monica; Sajeva, Maurizio; Poma, Paola] Univ Palermo, Dept Biol Chem & Pharmaceut Sci & Technol STEBICE, Palermo, Italy	University of Palermo	Notarbartolo, M; Sajeva, M (corresponding author), Univ Palermo, Dept Biol Chem & Pharmaceut Sci & Technol STEBICE, Palermo, Italy.	monica.notarbartolo@unipa.it; maurizio.sajeva@unipa.it	Poma, Paola/AAE-5325-2022; Notarbartolo di Villarosa, Monica/AAE-5324-2022; Labbozzetta, Manuela/AAE-5418-2022; Sajeva, Maurizio/N-7544-2014; Zito, Pietro/N-7527-2014	Sajeva, Maurizio/0000-0003-4731-7112; Zito, Pietro/0000-0002-6188-5434	University of Palermo	University of Palermo	The research was done with the basic funds of University of Palermo (funders) devoted to independent and free research. The authors are employees of the University and their salaries are paid only by the University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams R.P, 2017, IDENTIFICATION ESSEN, V5th; BLOIS MS, 1958, NATURE, V181, P1199, DOI 10.1038/1811199a0; Boichuk S, 2017, ONCOL LETT, V14, P5039, DOI 10.3892/ol.2017.6795; BRAND-WILLIAMS W, 1995, FOOD SCI TECHNOL-LEB, V28, P25; Cao SG, 2011, CHEM BIODIVERS, V8, P643, DOI 10.1002/cbdv.201000061; Chen ZL, 2016, CANCER LETT, V370, P153, DOI 10.1016/j.canlet.2015.10.010; Craven P, 2004, IUCN RED LIST THREAT, DOI DOI 10.2305/IUCN.UK.2004.RLTS.T46838A11084910.EN; Edris AE, 2007, PHYTOTHER RES, V21, P308, DOI 10.1002/ptr.2072; El-Sayed A. M, PHEROBASE DATABASE I; Gershenzon J, 2007, NAT CHEM BIOL, V3, P408, DOI 10.1038/nchembio.2007.5; Islam MT, 2018, FOOD CHEM TOXICOL, V121, P82, DOI 10.1016/j.fct.2018.08.032; Krishna R, 2000, EUR J PHARM SCI, V11, P265, DOI 10.1016/S0928-0987(00)00114-7; Labbozzetta M, 2009, ANN NY ACAD SCI, V1155, P278, DOI 10.1111/j.1749-6632.2009.03699.x; LANGENHEIM JH, 1994, J CHEM ECOL, V20, P1223, DOI 10.1007/BF02059809; Natarajan K, 2012, BIOCHEM PHARMACOL, V83, P1084, DOI 10.1016/j.bcp.2012.01.002; Notarbartolo M, 2005, CANCER LETT, V224, P53, DOI 10.1016/j.canlet.2004.10.051; Ochwang'i DO, 2014, J ETHNOPHARMACOL, V151, P1040, DOI 10.1016/j.jep.2013.11.051; Opoku AR, 2000, PHYTOTHER RES, V14, P534, DOI 10.1002/1099-1573(200011)14:7&lt;534::AID-PTR661&gt;3.0.CO;2-A; Poma P, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196947; Poma P, 2017, OMICS, V21, P225, DOI 10.1089/omi.2017.0020; Sajeva M, 2000, SUCCULENTS; Schinkel AH, 2003, ADV DRUG DELIVER REV, V55, P3, DOI 10.1016/S0169-409X(02)00169-2; Song Y., 2015, BIOCH ANAL BIOCH, V4, P211; Teklehaymanot T, 2007, J ETHNOBIOL ETHNOMED, V3, DOI 10.1186/1746-4269-3-12; Tholl D, 2015, ADV BIOCH ENG BIOTEC, V148; Udegbunam R. I., 2013, African Journal of Biotechnology, V12, P2288; Xie YQ, 2010, MOL PHARMACOL, V78, P310, DOI 10.1124/mol.109.061713	27	8	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214594	10.1371/journal.pone.0214594	http://dx.doi.org/10.1371/journal.pone.0214594			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921428	Green Published, gold, Green Submitted			2022-12-26	WOS:000462594000093
J	Cheng, L; Zhu, M				Cheng, Lu; Zhu, Mu			Compositional epistasis detection using a few prototype disease models	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; MULTIFACTOR-DIMENSIONALITY REDUCTION; BIPOLAR DISORDER; MISSING HERITABILITY; GENE INTERACTIONS; SCHIZOPHRENIA; CLASSIFICATION; METAANALYSIS; STRATEGIES; MECHANISM	We study computational approaches for detecting SNP-SNP interactions that are characterized by a set of "two-locus, two-allele, two-phenotype and complete-penetrance" disease models. We argue that existing methods, which use data to determine a best-fitting disease model for each pair of SNPs prior to screening, may be too greedy. We present a less greedy strategy which, for each given pair of SNPs, limits the number of candidate disease models to a set of prototypes determined a priori.	[Cheng, Lu; Zhu, Mu] Univ Waterloo, Dept Stat & Actuarial Sci, Waterloo, ON, Canada	University of Waterloo	Zhu, M (corresponding author), Univ Waterloo, Dept Stat & Actuarial Sci, Waterloo, ON, Canada.	mu.zhu@uwaterloo.ca			Natural Sciences and Engineering Research Council (NSERC) of Canada [RGPIN-2016-03876]; Wellcome Trust [076113, 085475, 090355]	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was funded by the Natural Sciences and Engineering Research Council (NSERC) of Canada (http://www.nserc-crsng.gc.ca/), grant no. RGPIN-2016-03876. Funding for the project was also provided by the Wellcome Trust under award 076113, 085475 and 090355. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study makes use of data generated by the Wellcome Trust Case-Control Consortium. A full list of the investigators who contributed to the generation of the data is available fromwww.wtccc.org.uk. Funding for the project was provided by the Wellcome Trust under award 076113, 085475 and 090355.	Aken BL, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw093; Baranzini SE, 2010, BRAIN, V133, P2603, DOI 10.1093/brain/awq192; Bateson W, 1909, MOL GEN GENET MGG, V2, P17, DOI DOI 10.1007/BF01975751; Berk M, 2011, NEUROSCI BIOBEHAV R, V35, P804, DOI 10.1016/j.neubiorev.2010.10.001; Blake JA, 2015, NUCLEIC ACIDS RES, V43, pD1049, DOI 10.1093/nar/gku1179; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cerami EG, 2011, NUCLEIC ACIDS RES, V39, pD685, DOI 10.1093/nar/gkq1039; Craddock N, 2013, LANCET, V381, P1654, DOI 10.1016/S0140-6736(13)60855-7; Curtis D, 2011, PSYCHIAT GENET, V21, P1, DOI 10.1097/YPG.0b013e3283413382; Dong CZ, 2008, EUR J HUM GENET, V16, P229, DOI 10.1038/sj.ejhg.5201921; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Emily M, 2012, STAT MED, V31, P2359, DOI 10.1002/sim.5364; Ferreira MAR, 2008, NAT GENET, V40, P1056, DOI 10.1038/ng.209; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; Gao H, 2010, GENETICS, V184, P827, DOI 10.1534/genetics.109.111120; Hallgrimsdottir IB, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-17; He Y, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.76; Hu LW, 2011, PROG NEURO-PSYCHOPH, V35, P11, DOI 10.1016/j.pnpbp.2010.08.031; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; Kathiresan S, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S17; Lee SH, 2011, AM J HUM GENET, V88, P294, DOI 10.1016/j.ajhg.2011.02.002; Lettre G, 2007, GENET EPIDEMIOL, V31, P358, DOI 10.1002/gepi.20217; Lewis Cathryn M, 2002, Brief Bioinform, V3, P146, DOI 10.1093/bib/3.2.146; Li P, 2015, BRIEF FUNCT GENOMICS, V14, P143, DOI 10.1093/bfgp/elu036; Li WT, 2000, HUM HERED, V50, P334, DOI 10.1159/000022939; Likas A, 2003, PATTERN RECOGN, V36, P451, DOI 10.1016/S0031-3203(02)00060-2; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marchini J, 2005, NAT GENET, V37, P413, DOI 10.1038/ng1537; Mei H, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-S1-S145; Minelli C, 2005, INT J EPIDEMIOL, V34, P1319, DOI 10.1093/ije/dyi169; O'Dushlaine C, 2011, MOL PSYCHIATR, V16, P286, DOI 10.1038/mp.2010.7; Oki Noffisat O., 2011, Frontiers in Genetics, V2, P80, DOI 10.3389/fgene.2011.00080; Park MY, 2008, BIOSTATISTICS, V9, P30, DOI 10.1093/biostatistics/kxm010; Perlis RH, 2010, AM J PSYCHIAT, V167, P1499, DOI 10.1176/appi.ajp.2010.10040541; Phillips PC, 2008, NAT REV GENET, V9, P855, DOI 10.1038/nrg2452; Phillips PC, 1998, GENETICS, V149, P1167; Popescu BFG, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-40; RASMUSSEN DD, 1983, J CLIN ENDOCR METAB, V57, P760, DOI 10.1210/jcem-57-4-760; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; Ritchie MD, 2003, GENET EPIDEMIOL, V24, P150, DOI 10.1002/gepi.10218; Roy K, 2007, P NATL ACAD SCI USA, V104, P8131, DOI 10.1073/pnas.0702157104; Sherva R, 2014, ALZHEIMERS DEMENT, V10, P45, DOI 10.1016/j.jalz.2013.01.008; Sklar P, 2008, MOL PSYCHIATR, V13, P558, DOI 10.1038/sj.mp.4002151; Smith EN, 2009, MOL PSYCHIATR, V14, P755, DOI 10.1038/mp.2009.43; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suzuki E, 2015, METHODS MOL BIOL, V1253, P197, DOI 10.1007/978-1-4939-2155-3_11; Tenesa A, 2013, NAT REV GENET, V14, P139, DOI 10.1038/nrg3377; Ullah AZD, 2012, NUCLEIC ACIDS RES, V40, pW65, DOI 10.1093/nar/gks364; Urbanowicz RJ, 2014, BIODATA MIN, V7, DOI 10.1186/1756-0381-7-8; Wan X, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-7; Wan XA, 2010, AM J HUM GENET, V87, P325, DOI 10.1016/j.ajhg.2010.07.021; Wang B, 2012, ADV NUTR, V3, p465S, DOI 10.3945/an.112.001875; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Wang KS, 2010, SCHIZOPHR RES, V124, P192, DOI 10.1016/j.schres.2010.09.002; Willour VL, 2012, MOL PSYCHIATR, V17, P433, DOI 10.1038/mp.2011.4; Xu W, 2014, BMC MED GENET, V15, DOI 10.1186/1471-2350-15-2; Yosifova A, 2011, GENES BRAIN BEHAV, V10, P789, DOI 10.1111/j.1601-183X.2011.00721.x; Yule GU, 1912, J R STAT SOC, V75, P579, DOI 10.2307/2340126; Zhang Y, 2007, NAT GENET, V39, P1167, DOI 10.1038/ng2110; Zhao Z, 2015, MOL PSYCHIATR, V20, P563, DOI 10.1038/mp.2014.82	61	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2019	14	3							e0213236	10.1371/journal.pone.0213236	http://dx.doi.org/10.1371/journal.pone.0213236			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ5PT	30917131	Green Submitted, Green Published, gold			2022-12-26	WOS:000462465800023
J	del Cerro, P; Megias, M; Lopez-Baena, FJ; Gil-Serrano, A; Perez-Montano, F; Ollero, FJ				del Cerro, Pablo; Megias, Manuel; Javier Lopez-Baena, Francisco; Gil-Serrano, Antonio; Perez-Montano, Francisco; Javier Ollero, Francisco			Osmotic stress activates nif and fix genes and induces the Rhizobium tropici CIAT 899 Nod factor production via NodD2 by up-regulation of the nodA2 operon and the nodA3 gene	PLOS ONE			English	Article							NODULATION FACTORS; READ ALIGNMENT; PHASEOLUS; SYMBIOSIS; INDUCTION; TREHALOSE; DISCOVERY; EFFICIENT; PROTEINS; BACTERIA	The symbiosis between rhizobia and legumes is characterized by a complex molecular dialogue in which the bacterial NodD protein plays a major role due to its capacity to activate the expression of the nodulation genes in the presence of appropiate flavonoids. These genes are involved in the synthesis of molecules, the nodulation factors (NF), responsible for launching the nodulation process. Rhizobium tropici CIAT 899, a rhizobial strain that nodulates Phaseolus vulgaris, is characterized by its tolerance to multiple environmental stresses such as high temperatures, acidity or elevated osmolarity. This strain produces nodulation factors under saline stress and the same set of CIAT 899 nodulation genes activated by inducing flavonoids are also up-regulated in a process controlled by the NodD2 protein. In this paper, we have studied the effect of osmotic stress (high mannitol concentrations) on the R. tropici CIAT 899 transcriptomic response. In the same manner as with saline stress, the osmotic stress mediated NF production and export was controlled directly by NodD2. In contrast to previous reports, the nodA2FE operon and the nodA3 and nodD1 genes were up-regulated with mannitol, which correlated with an increase in the production of biologically active NF. Interestingly, in these conditions, this regulatory protein controlled not only the expression of nodulation genes but also the expression of other genes involved in protein folding and synthesis, motility, synthesis of polysaccharides and, surprinsingly, nitrogen fixation. Moreover, the non-metabolizable sugar dulcitol was also able to induce the NF production and the activation of nod genes in CIAT 899.	[del Cerro, Pablo; Megias, Manuel; Javier Lopez-Baena, Francisco; Perez-Montano, Francisco; Javier Ollero, Francisco] Univ Seville, Fac Biol, Dept Microbiol, Seville, Spain; [Gil-Serrano, Antonio] Univ Seville, Fac Quim, Dept Quim Organ, Seville, Spain	University of Sevilla; University of Sevilla	Ollero, FJ (corresponding author), Univ Seville, Fac Biol, Dept Microbiol, Seville, Spain.	fjom@us.es	Pérez-Montaño, Francisco/K-8971-2014; del Cerro Sánhez, Pablo PdC/H-7198-2016; del Cerro Sánchez, Pablo/ABG-1194-2020; Lopez Baena, Francisco Javier/L-4670-2014; Ollero Marquez, Francisco Javier/G-3271-2015	Pérez-Montaño, Francisco/0000-0002-6272-2063; del Cerro Sánhez, Pablo PdC/0000-0002-8030-7226; del Cerro Sánchez, Pablo/0000-0002-8030-7226; Lopez Baena, Francisco Javier/0000-0001-7799-0338; Ollero Marquez, Francisco Javier/0000-0002-3641-7946	Ministerio de Economia y Competitividad [AGL2016-77163-R]; Ministerio de Educacion, Cultura y Deporte [FPU14-00160]; Spanish Ministerio de Economia y Competitividad (MINECO) [AGL2016-77163-R]; FPU fellowship of the Ministerio de Economia y Competitividad (MINECO) [FPU14/00160]	Ministerio de Economia y Competitividad(Spanish Government); Ministerio de Educacion, Cultura y Deporte(Spanish Government); Spanish Ministerio de Economia y Competitividad (MINECO)(Spanish Government); FPU fellowship of the Ministerio de Economia y Competitividad (MINECO)	PdC, MM, AMGS, FJO were supported by Ministerio de Economia y Competitividad, grant reference: AGL2016-77163-R. http://www.ciencia.gob.es/portal/site/MICINN/. PdC was supported by Ministerio de Educacion, Cultura y Deporte, grant reference: FPU14-00160. https://www.mecd.gob.es/portada-mecd/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded with project AGL2016-77163-R from the Spanish Ministerio de Economia y Competitividad (MINECO). Mr. Del Cerro is recipient of an FPU fellowship (FPU14/00160) of the Ministerio de Economia y Competitividad (MINECO). We would like to thank the Servicio de Espectrometria de Masas, Servicio de Resonancia Magnetica Nuclear and Servicio de Biologia of the Centro de Investigacion Tecnologia e Innovaccion (CITIUS) of the University of Seville for technical support.	Alexandre A, 2014, DNA RES, V21, P195, DOI 10.1093/dnares/dst050; Alexandre A, 2011, FEMS MICROBIOL ECOL, V75, P28, DOI 10.1111/j.1574-6941.2010.00993.x; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; BALDANI VLD, 1980, SOIL BIOL BIOCHEM, V12, P433, DOI 10.1016/0038-0717(80)90021-8; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BERINGER JE, 1974, J GEN MICROBIOL, V84, P188; Boboye B, 2004, J APPL MICROBIOL, V97, P256, DOI 10.1111/j.1365-2672.2004.02194.x; BREEDVELD MW, 1991, ARCH MICROBIOL, V156, P501, DOI 10.1007/BF00245399; BUENDIACLAVERIA AM, 1986, J APPL BACTERIOL, V61, P1, DOI 10.1111/j.1365-2672.1986.tb03752.x; Burg MB, 2008, J BIOL CHEM, V283, P7309, DOI 10.1074/jbc.R700042200; CSONKA LN, 1989, MICROBIOL REV, V53, P121, DOI 10.1128/MMBR.53.1.121-147.1989; del Cerro P, 2017, SCI REP-UK, V7, DOI 10.1038/srep46712; del Cerro P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154029; del Cerro P, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2033-z; del Cerro P, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1458-8; DEMAAGD RA, 1988, J BACTERIOL, V170, P4424, DOI 10.1128/jb.170.9.4424-4427.1988; Denarie J, 1996, ANNU REV BIOCHEM, V65, P503, DOI 10.1146/annurev.bi.65.070196.002443; Estevez J, 2009, FEMS MICROBIOL LETT, V293, P220, DOI 10.1111/j.1574-6968.2009.01540.x; Fernandez-Aunion C, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-192; Guasch-Vidal B, 2013, MOL PLANT MICROBE IN, V26, P451, DOI 10.1094/MPMI-09-12-0213-R; Hungria M, 2000, SOIL BIOL BIOCHEM, V32, P1515, DOI 10.1016/S0038-0717(00)00063-8; Hungria M, 2010, PLANT SOIL, V331, P413, DOI 10.1007/s11104-009-0262-0; Jimenez-Guerrero I, 2018, GENES-BASEL, V9, DOI 10.3390/genes9010001; Kelly S, 2018, ENVIRON MICROBIOL, V20, P97, DOI 10.1111/1462-2920.14006; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lamrabet Y, 1999, MOL PLANT MICROBE IN, V12, P207, DOI 10.1094/MPMI.1999.12.3.207; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; LopezLara IM, 1995, PLANT MOL BIOL, V29, P465, DOI 10.1007/BF00020978; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; MARTINEZROMERO E, 1991, INT J SYST BACTERIOL, V41, P417, DOI 10.1099/00207713-41-3-417; Moron B, 2005, CHEM BIOL, V12, P1029, DOI 10.1016/j.chembiol.2005.06.014; Nogales J, 2002, MOL PLANT MICROBE IN, V15, P225, DOI 10.1094/MPMI.2002.15.3.225; Ormeno-Orrillo E, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-735; Perez-Montano F, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2543-3; Picard F, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-588; POUPOT R, 1993, BIOCHEMISTRY-US, V32, P10430, DOI 10.1021/bi00090a019; Ramachandran VK, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r106; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SPAINK HP, 1992, MOL PLANT MICROBE IN, V5, P72, DOI 10.1094/MPMI-5-072; SPAINK HP, 1992, PLANT MOL BIOL, V20, P977, DOI 10.1007/BF00027167; TRUCHET G, 1989, PROTOPLASMA, V149, P82, DOI 10.1007/BF01322980; Vincent JM, 1970, MANUAL PRACTICAL STU, P144; Yeh KC, 2002, J BACTERIOL, V184, P525, DOI 10.1128/JB.184.2.525-530.2002; ZAAT SAJ, 1987, J BACTERIOL, V169, P198, DOI 10.1128/jb.169.1.198-204.1987; Zahran H.H., 1999, REV MICROBIOLOGY MOL, V63, P968; Zipfel C, 2017, NATURE, V543, P328, DOI 10.1038/nature22009	48	13	13	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2019	14	3							e0213298	10.1371/journal.pone.0213298	http://dx.doi.org/10.1371/journal.pone.0213298			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ5PT	30917160	Green Published, Green Submitted, gold			2022-12-26	WOS:000462465800025
J	Jankovic, J; Davidovic, M; Bjegovic-Mikanovic, V; Jankovic, S				Jankovic, Janko; Davidovic, Masa; Bjegovic-Mikanovic, Vesna; Jankovic, Slavenka			Status of cardiovascular health in the Republic of Serbia: Results from the National Health Survey	PLOS ONE			English	Article							COASTAL ECUADOR; DISEASE; PREVALENCE; METRICS; METAANALYSIS; ASSOCIATION; RISK; MEN	Background Cardiovascular diseases (CVD) remain the most significant cause of death in low-and middle- income countries where the burden of CVD continues to rise due to the increasing incidence of CVD. The aim of this study was to assess the prevalence of ideal cardiovascular health (CVH) across sex and age groups and to analyze associations between demographic and socio-economic variables and ideal CVH metrics in the adult population of the Republic of Serbia. Methods Information on demographic (age, sex, marital status, and type of settlement) and socioeconomic characteristics (education, and wealth index), and the 7 ideal CVH metrics (smoking, physical activity, healthy diet, BMI, blood pressure, cholesterol, and glucose) was obtained for 13100 respondents aged 20 years and above, from the 2013 National Health Survey in the Republic of Serbia. According to the American Heart Association, the ideal CVH was defined as the simultaneous presence of 7 ideal CVH metrics. Results Out of all ideal CVH metrics, the most prevalent components were ideal glucose (92.2%), ideal cholesterol (86.4%) and ideal smoking (63%), while the least prevalent ideal CVH component was ideal healthy diet (2.4%). Only 0.1% had all 7 CVH components at the ideal level. According to the multivariable logistic regression analysis the higher number of ideal CVH metrics was observed in women (OR = 4.46), younger people (OR = 7.12), people living without partner (OR = 1.70), more educated (OR = 2.51 for middle educated and OR = 3.57 for high educated), as well as among the rich (OR = 1.43). Conclusion Our findings of existing age-specific, sex and socio-economic differences in the prevalence and number of ideal CVH metrics should serve for the development of appropriate CVD prevention policies tailored to fit specific needs of both sexes, all age groups and people with different socioeconomic status.	[Jankovic, Janko; Davidovic, Masa; Bjegovic-Mikanovic, Vesna] Univ Belgrade, Fac Med, Inst Social Med, Belgrade, Serbia; [Jankovic, Janko; Davidovic, Masa; Bjegovic-Mikanovic, Vesna] Univ Belgrade, Fac Med, Ctr Sch Publ Hlth & Management, Belgrade, Serbia; [Jankovic, Slavenka] Univ Belgrade, Inst Epidemiol, Fac Med, Belgrade, Serbia	University of Belgrade; University of Belgrade; University of Belgrade	Jankovic, J (corresponding author), Univ Belgrade, Fac Med, Inst Social Med, Belgrade, Serbia.; Jankovic, J (corresponding author), Univ Belgrade, Fac Med, Ctr Sch Publ Hlth & Management, Belgrade, Serbia.	drjankojankovic@yahoo.com	Bjegovic-Mikanovic, Vesna/AAD-9847-2019	Bjegovic-Mikanovic, Vesna/0000-0002-8299-6555; Jankovic, Janko/0000-0002-2387-6596; Jankovic, Slavenka/0000-0001-6791-3056	Ministry of Health of the Republic of Serbia; Institute of Public Health of Serbia; Ministry of Education, Science and Technological Development of the Republic of Serbia [175025]	Ministry of Health of the Republic of Serbia; Institute of Public Health of Serbia; Ministry of Education, Science and Technological Development of the Republic of Serbia(Ministry of Education, Science & Technological Development, Serbia)	The 2013 National Health Survey (without data on Kosovo and Metohia) was supported by the Ministry of Health of the Republic of Serbia and the Institute of Public Health of Serbia "Dr. Milan Jovanovic Batut." Funding for this work was obtained by the Ministry of Education, Science and Technological Development of the Republic of Serbia (project No 175025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aneni EC, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.006904; Bambs C, 2011, CIRCULATION, V123, P850, DOI 10.1161/CIRCULATIONAHA.110.980151; Bi YF, 2015, J AM COLL CARDIOL, V65, P1013, DOI 10.1016/j.jacc.2014.12.044; Chang Y, 2016, HEART LUNG CIRC, V25, P982, DOI 10.1016/j.hlc.2016.02.007; Clark H, 2013, LANCET, V381, P510, DOI 10.1016/S0140-6736(13)60058-6; Crichton GE, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-253; Del Brutto OH, 2013, ENVIRON HEALTH PREV, V18, P422, DOI 10.1007/s12199-013-0344-8; Del Brutto OH, 2013, J COMMUN HEALTH, V38, P634, DOI 10.1007/s10900-013-9658-0; European Commission Eurostat, 2013, EUR HLTH INT SURV EH; Fang J, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.005371; Fang N, 2016, INT J CARDIOL, V214, P280, DOI 10.1016/j.ijcard.2016.03.210; Folsom AR, 2011, J AM COLL CARDIOL, V57, P1690, DOI 10.1016/j.jacc.2010.11.041; Graciani A, 2013, CIRC-CARDIOVASC QUAL, V6, P90, DOI 10.1161/CIRCOUTCOMES.112.967893; Guo LL, 2017, CLIN CARDIOL, V40, P1339, DOI 10.1002/clc.22836; Gupta B, 2017, GLOB HEART, V12, P219, DOI 10.1016/j.gheart.2014.09.004; Huffman MD, 2014, CURR PROB CARDIOLOGY, V39, P399, DOI 10.1016/j.cpcardiol.2014.05.005; Huxley RR, 2011, LANCET, V378, P1297, DOI 10.1016/S0140-6736(11)60781-2; Institute of Medicine, 2010, PROMOTING CARDIOVASC; Jankovic J, 2010, EUR J PUBLIC HEALTH, V20, P389, DOI 10.1093/eurpub/ckp189; Jankovic S, 2014, INT J PUBLIC HEALTH, V59, P769, DOI 10.1007/s00038-014-0579-1; Johansson J, 1999, AM J PREV MED, V16, P322, DOI 10.1016/S0749-3797(99)00019-7; Kim Ji Young, 2013, J Prev Med Public Health, V46, P319, DOI 10.3961/jpmph.2013.46.6.319; Lee HJ, 2013, KOREAN J FAM MED, V34, P403, DOI 10.4082/kjfm.2013.34.6.403; Lloyd-Jones DM, 2010, CIRCULATION, V121, P586, DOI 10.1161/CIRCULATIONAHA.109.192703; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/eht151, 10.1093/eurheartj/ehm236]; Moghaddam MM, 2014, ANN SAUDI MED, V34, P134, DOI 10.5144/0256-4947.2014.134; Nichols M, 2013, EUR HEART J, V34, P3028, DOI 10.1093/eurheartj/eht356; Ren J, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3632-6; Rutstein S.O., 2004, DHS COMP REPORTS; Shay CM, 2012, CIRCULATION, V125, P45, DOI 10.1161/CIRCULATIONAHA.111.035733; The Indonesian National Health Research Council, 2013, IND BAS HLTH SURV 20; Townsend N, 2015, EUR HEART J, V36, P2696, DOI 10.1093/eurheartj/ehv428; Velasquez-Melendez Gustavo, 2015, Rev. bras. epidemiol., V18, P97, DOI 10.1590/1980-5497201500060009; WHO, 2014, SERB NONC DIS NCD CO; World Health Organization, 2000, WHO TECHN REP SER, V894, DOI DOI 10.1007/978-0-387-71799-9_454; World Health Organization, 2017, CARDIOVASCULAR DIS; Wu HY, 2013, INT J CARDIOL, V168, P760, DOI 10.1016/j.ijcard.2012.09.235; Younus A, 2016, MAYO CLIN PROC, V91, P649, DOI 10.1016/j.mayocp.2016.01.019; Zeng Q, 2013, INT J CARDIOL, V167, P2311, DOI 10.1016/j.ijcard.2012.06.022	39	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2019	14	3							e0214505	10.1371/journal.pone.0214505	http://dx.doi.org/10.1371/journal.pone.0214505			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ5PT	30917180	Green Published, Green Submitted, gold			2022-12-26	WOS:000462465800069
J	Stoffel, ST; Yang, JH; Vlaev, I; von Wagner, C				Stoffel, Sandro Tiziano; Yang, Jiahong; Vlaev, Ivo; von Wagner, Christian			Testing the decoy effect to increase interest in colorectal cancer screening	PLOS ONE			English	Article							ATTRACTION; ALTERNATIVES; ROBUSTNESS; OPTIONS	Literature on consumer choice has demonstrated that the inclusion of an inferior alternative choice (decoy) can increase interest in a target product or action. In two online studies, we tested the impact of decoys on the probability of previous non-intenders to have a screening test which could significantly lower their chances of dying of colorectal cancer. We find that the presence of a decoy increased the probability to choose screening at the target hospital (over no screening) from 39% to 54% and 37% to 59% depending on how many hospital attributes were communicated and how strongly the decoy was dominated by the target. We also show that the presence of the decoy was associated with lower levels of reported decisional complexity while not undermining information seeking and knowledge acquisition. These findings offer a 'proof of principle' that decoys have the potential to increase screening uptake without negatively influencing informed choice.	[Stoffel, Sandro Tiziano; Yang, Jiahong; von Wagner, Christian] UCL, Res Dept Behav Sci & Hlth, London, England; [Vlaev, Ivo] Univ Warwick, Warwick Business Sch, Coventry, W Midlands, England	University of London; University College London; University of Warwick	von Wagner, C (corresponding author), UCL, Res Dept Behav Sci & Hlth, London, England.	c.wagner@ucl.ac.uk		Stoffel, Sandro Tiziano/0000-0002-0124-0941	Cancer Research UK [C1418/A14134]	Cancer Research UK(Cancer Research UK)	Financial support for this study was provided entirely by a Cancer Research UK (https://www.cancerresearchuk.org, C1418/A14134). The funding agreement ensured the authors' independence in designing the study, interpreting the data, writing, and publishing the report.	Cohen J.E., 1988, STAT POWER ANAL BEHA; Coller M., 1999, Experimental Economics, V2, P107, DOI 10.1007/BF01673482; Doyle JR, 1999, PSYCHOL MARKET, V16, P225, DOI 10.1002/(SICI)1520-6793(199905)16:3<225::AID-MAR3>3.0.CO;2-X; Dumenci L, 2014, J HEALTH COMMUN, V19, P205, DOI 10.1080/10810730.2014.943377; Elkin EB, 2010, MED CARE, V48, P349, DOI 10.1097/MLR.0b013e3181ca3ecb; Frew E, 1999, J MED SCREEN, V6, P119, DOI 10.1136/jms.6.3.119; George AT, 2018, LANCET, V392, P277, DOI 10.1016/S0140-6736(18)31208-X; Hall N, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012304; Harrison GW, 2002, AM ECON REV, V92, P1606, DOI 10.1257/000282802762024674; Heath TB, 1995, J CONSUM RES, V22, P268, DOI 10.1086/209449; Herne K., 1997, EUROPEAN J POLITICAL, V13, P575, DOI [10.1016/S0176-2680(97)00020-7, DOI 10.1016/S0176-2680(97)00020-7]; Herne K., 1999, EXP ECON, V2, P31, DOI [10.1023/A:1009925731240, DOI 10.1023/A:1009925731240]; Highhouse S, 1996, ORGAN BEHAV HUM DEC, V65, P68, DOI 10.1006/obhd.1996.0006; Hofmann B, 2018, PATIENT EDUC COUNS, V101, P1561, DOI 10.1016/j.pec.2018.03.021; HUBER J, 1982, J CONSUM RES, V9, P90, DOI 10.1086/208899; Huber J, 2014, J MARKETING RES, V51, P520, DOI 10.1509/jmr.14.0208; Kaptein MC, 2016, PALGR COMMUN, V2, DOI 10.1057/palcomms.2016.82; Krell M, 2017, COGENT EDUC, V4, DOI 10.1080/2331186X.2017.1280256; Leonard TC, 2008, CONST POLITICAL ECON, V19, P356, DOI 10.1007/s10602-008-9056-2; Li M, 2019, PSYCHOL SCI, V30, P139, DOI 10.1177/0956797618761374; Lipkus IM, 2001, MED DECIS MAKING, V21, P37, DOI 10.1177/0272989X0102100105; McGregor LM, 2016, J MED SCREEN, V23, P77, DOI 10.1177/0969141315604659; Michie S, 2004, PSYCHOL HEALTH, V19, P29, DOI 10.1080/0887044031000141199; Milberg SJ, 2014, EUR J MARKETING, V48, P1413, DOI 10.1108/EJM-07-2012-0391; Ploug T, 2012, J EPIDEMIOL COMMUN H, V66, P1193, DOI 10.1136/jech-2012-201194; PURNELL JQ, 2015, PREV CHRONIC DIS, V12, P90600, DOI DOI 10.5888/PCD12.140346; Rubaltelli E, 2008, XENOTRANSPLANTATION, V15, P159, DOI 10.1111/j.1399-3089.2008.00474.x; Sarma EA, 2015, HEALTH PSYCHOL REV, V9, P42, DOI 10.1080/17437199.2013.766831; Scheibehenne B, 2010, J CONSUM RES, V37, P409, DOI 10.1086/651235; Schwartz JA, 1999, MED DECIS MAKING, V19, P315, DOI 10.1177/0272989X9901900310; Sellers-Rubio R, 2015, INT J RETAIL DISTRIB, V43, P113, DOI 10.1108/IJRDM-07-2013-0144; Sheeran P., 2002, EUR REV SOC PSYCHOL, V12, P1, DOI [10.1080/14792772143000003, DOI 10.1080/14792772143000003]; Sheeran P, 2017, ANNU REV PSYCHOL, V68, P573, DOI 10.1146/annurev-psych-010416-044007; SIMONSON I, 1989, J CONSUM RES, V16, P158, DOI 10.1086/209205; Stoffel ST, 2019, J MED SCREEN, V26, P98, DOI 10.1177/0969141318806322; Sue OCurry Y. P., J CONSUM PSYCHOL, V4, P85, DOI DOI 10.1207/S15327663JCP0401_; Sugden, 2017, INT REV EC, V64, P113, DOI [DOI 10.1007/S12232-016-0264-1, 10.1007/s12232-016-0264-1]; TVERSKY A, 1988, PSYCHOL REV, V95, P371, DOI 10.1037/0033-295X.95.3.371; WEDELL DH, 1991, J EXP PSYCHOL LEARN, V17, P767, DOI 10.1037/0278-7393.17.4.767; Yang S, 2014, J MARKETING RES, V51, P508, DOI 10.1509/jmr.14.0020; Young RF, 2011, J CANCER EDUC, V26, P262, DOI 10.1007/s13187-010-0184-9; Zenko Z, 2016, SPORT EXERC PERFORM, V5, P337, DOI 10.1037/spy0000069	42	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2019	14	3							e0213668	10.1371/journal.pone.0213668	http://dx.doi.org/10.1371/journal.pone.0213668			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HQ3IW	30913209	Green Published, gold, Green Submitted			2022-12-26	WOS:000462305600016
J	Buzgova, R; Kozakova, R; Jurickova, L				Buzgova, Radka; Kozakova, Radka; Jurickova, Lubica			The unmet needs of family members of patients with progressive neurological disease in the Czech Republic	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; PALLIATIVE CARE NEEDS; MULTIPLE-SCLEROSIS; PARKINSONS-DISEASE; CAREGIVER BURDEN; OF-LIFE; PEOPLE; QUALITY; EXPERIENCES; DEPRESSION	Background Caring for patients with a progressive neurological disease (PND) causes stress that may impact on the state of health as well as the quality of life of the caring family. Objective The aim of the study was to explore the unmet needs of the family members of patients with PND in advanced stages. Methods Grounded theory (constructivist approach) was used to conceptualize the patterns of unmet care needs. Data collection methodology involved focus groups (n = 4) and interviews, in which a total of 52 people participated (patients, family members, and professionals). Results Based on the data analysis, three domains (family situation, role of the caregiver, and professional help) were identified, which illustrate the unmet needs. In particular, lack of information about the disease and available support available resulted in a deterioration mutual understanding between the patient, family, and the medical staff; also increased stress for the caregiver, and lowered quality of life for the caring family. Conclusion Family members expect health workers to provide them with support, which includes informing them about the possible help available from the health and social welfare systems.	[Buzgova, Radka; Kozakova, Radka; Jurickova, Lubica] Univ Ostrava, Fac Med, Dept Nursing & Midwifery, Ostrava, Czech Republic	University of Ostrava	Buzgova, R (corresponding author), Univ Ostrava, Fac Med, Dept Nursing & Midwifery, Ostrava, Czech Republic.	radka.buzgova@osu.cz	Kozáková, Radka/D-8597-2014	Kozakova, Radka/0000-0002-6627-187X	Ministry of Health, Czech republic [17-29447A, AZV MZ CR]	Ministry of Health, Czech republic(Ministry of Health, Czech RepublicCzech Republic Government)	The study was funded by the Ministry of Health, Czech republic (no. AZV MZ CR no. 17-29447A) named "A neuropalliative rehabilitation approach to preserve the quality of life in patients with an advanced stage of selected neurological diseases". Specific grant numbers - 17-29447A (Ministry of health, Czech republic) to RB, RK, LJ. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarsland D, 1999, INT J GERIATR PSYCH, V14, P866, DOI 10.1002/(SICI)1099-1166(199910)14:10<866::AID-GPS38>3.3.CO;2-Q; Abendroth M, 2012, INT J NURS STUD, V49, P445, DOI 10.1016/j.ijnurstu.2011.10.003; Aoun S, 2010, J PALLIAT MED, V13, P653, DOI 10.1089/jpm.2009.0318; Aoun SM, 2013, PALLIATIVE MED, V27, P437, DOI 10.1177/0269216312455729; Belanger E, 2014, BMC PALLIAT CARE, V13, DOI 10.1186/1472-684X-13-63; Boersma I, 2016, NEUROL-CLIN PRACT, V6, P209, DOI 10.1212/CPJ.0000000000000233; Borreani C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109679; Bowen C, 2011, PSYCHOL HEALTH, V26, P113, DOI 10.1080/08870440903287934; Burt RS, 2005, BROKERAGE CLOSURE IN; Chahine LM, 2008, EUR J NEUROL, V15, P1265, DOI 10.1111/j.1468-1331.2008.02319.x; Charmaz K., 2000, HDB QUALITATIVE RES, V2nd, P509, DOI DOI 10.1177/0891241609342193; Chaudhuri KR, 2016, PARKINSONISM RELAT D, V33, pS2, DOI 10.1016/j.parkreldis.2016.11.018; Cipolletta S, 2015, INT J PSYCHOL, V50, P288, DOI 10.1002/ijop.12085; Creutzfeldt C, 2015, NEUROL, V82; Deibel F, 2013, EUR J PERSON CTR HEA, V1, P457, DOI DOI 10.5750/EJPCH.V1I2.687; Department of Health, 2009, LIVING WELL DEMENTIA; Edmonds P, 2007, PALLIATIVE MED, V21, P101, DOI 10.1177/0269216307076333; Edmonds P, 2010, MULT SCLER J, V16, P627, DOI 10.1177/1352458510364632; Galushko M, 2014, J PALLIAT MED, V17, P274, DOI 10.1089/jpm.2013.0497; Galvin M, 2016, BMC PALLIAT CARE, V15, DOI 10.1186/s12904-016-0153-0; Gelfman LP, 2008, J PAIN SYMPTOM MANAG, V36, P22, DOI 10.1016/j.jpainsymman.2007.09.008; Giordano A, 2016, J NEUROL SCI, V366, P139, DOI 10.1016/j.jns.2016.05.016; Githaiga JN, 2017, BMC PALLIAT CARE, V16, DOI 10.1186/s12904-017-0222-z; Golla H, 2015, PALLIAT SUPPORT CARE, V13, P1685, DOI 10.1017/S1478951515000607; Golla H, 2014, BMC PALLIAT CARE, V13, DOI 10.1186/1472-684X-13-11; Golla H, 2012, PALLIATIVE MED, V26, P139, DOI 10.1177/0269216311401465; Greenwell K, 2015, PARKINSONISM RELAT D, V21, P1, DOI 10.1016/j.parkreldis.2014.10.013; Hasson F, 2010, PALLIATIVE MED, V24, P731, DOI 10.1177/0269216310371414; Higginson IJ, 2007, J PAIN SYMPTOM MANAG, V33, P500, DOI 10.1016/j.jpainsymman.2007.02.007; Higginson IJ, 2011, POSTGRAD MED J, V87, P769, DOI 10.1136/postgradmedj-2011-130290; Kristjanson LJ, 2006, INT J PALLIAT NURS, V12, P368, DOI 10.12968/ijpn.2006.12.8.368; Kurucova R., 2016, ZATEZ PECOVATELE POS; Lim T, 2007, J PALLIAT MED, V20, P857; Lindop F, 2014, INT J THER REHABIL, V21, P176, DOI 10.12968/ijtr.2014.21.4.176; Martinez-Martin P, 2008, MOVEMENT DISORD, V23, P1673, DOI 10.1002/mds.22106; Martinez-Martin P, 2007, MOVEMENT DISORD, V22, P924, DOI 10.1002/mds.21355; McCabe MP, 2015, J PSYCHOSOM RES, V78, P82, DOI 10.1016/j.jpsychores.2014.05.010; McLaughlin D, 2011, PALLIATIVE MED, V25, P177, DOI 10.1177/0269216310385604; Melo CG, 2011, J PALLIAT CARE, V27, P287, DOI 10.1177/082585971102700405; Mills J., 2006, INT J QUAL METHODS, V5, P25, DOI [DOI 10.1177/160940690600500103, 10.1177/160940690600500103]; Miyasaki JM, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0542-4; Miyashita M, 2009, J NEUROL SCI, V276, P148, DOI 10.1016/j.jns.2008.09.022; National Council for Palliative Care, 2007, FOC NEUR ADDR PALL C; O'Connor EJ, 2011, QUAL LIFE RES, V20, P703, DOI 10.1007/s11136-010-9804-4; Oliver DJ, 2016, EUR J NEUROL, V23, P30, DOI 10.1111/ene.12889; Razali R, 2011, CLIN NEUROL NEUROSUR, V113, P639, DOI 10.1016/j.clineuro.2011.05.008; Salvatore R, 2015, J FAM MED, V2, P1; Strand JJ, 2013, MAYO CLIN PROC, V88, P859, DOI 10.1016/j.mayocp.2013.05.020; Strauss A., 1990, BASICS QUALITATIVE R; Strupp J, 2015, PALLIAT SUPPORT CARE, V13, P733, DOI 10.1017/S1478951514000510; Sutton L., 2008, BRIT J NEUROSCI NURS, V4, P235, DOI 10.12968/bjnn.2008.4.5.29323; The Irish Palliative Care in Parkinson's Disease Group, 2016, PALL CAR PEOPL PARK; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Trail M, 2003, J NEUROL SCI, V209, P79, DOI 10.1016/S0022-510X(03)00003-0; Van der Meer L, 2006, PATIENT EDUC COUNS, V63, P246, DOI 10.1016/j.pec.2005.11.019	55	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2019	14	3							e0214395	10.1371/journal.pone.0214395	http://dx.doi.org/10.1371/journal.pone.0214395			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HQ1KV	30908542	Green Published, Green Submitted, gold			2022-12-26	WOS:000462157600061
J	Das, S; Bansal, M				Das, Sanjukta; Bansal, Manju			Variation of gene expression in plants is influenced by gene architecture and structural properties of promoters	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; DUPLICATED GENES; TRANSCRIPTION INITIATION; SACCHAROMYCES-CEREVISIAE; CURVED DNA; GC CONTENT; TATA BOX; EVOLUTION; ARABIDOPSIS; DIVERGENCE	In higher eukaryotes, gene architecture and structural properties of promoters have emerged as significant factors influencing variation in number of transcripts (expression level) and specificity of gene expression in a tissue (expression breadth), which eventually shape the phenotype. In this study, transcriptome data of different tissue types at various developmental stages of A. thaliana, O. sativa, S. bicolor and Z. mays have been used to understand the relationship between properties of gene components and its expression. Our findings indicate that in plants, among all gene architecture and structural properties of promoters, compactness of genes in terms of intron content is significantly linked to gene expression level and breadth, whereas in human an exactly opposite scenario is seen. In plants, for the first time we have carried out a quantitative estimation of effect of a particular trait on expression level and breadth, by using multiple regression analysis and it confirms that intron content of primary transcript (as %) is a powerful determinant of expression breadth. Similarly, further regression analysis revealed that among structural properties of the promoters, stability is negatively linked to expression breadth, while DNase1 sensitivity strongly governs gene expression breadth in monocots and gene expression level in dicots. In addition, promoter regions of tissue specific genes are found to be enriched with TATA box and Y-patch motifs. Finally, multi copy orthologous genes in plants are found to be longer, highly regulated and tissue specific.	[Das, Sanjukta; Bansal, Manju] Indian Inst Sci, Mol Biophys Unit, Bangalore, Karnataka, India; [Das, Sanjukta] Harvard Med Sch, Dana Farber Canc Inst, Boston, MA 02115 USA	Indian Institute of Science (IISC) - Bangalore; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Bansal, M (corresponding author), Indian Inst Sci, Mol Biophys Unit, Bangalore, Karnataka, India.	mb@iisc.ac.in						Abeel T, 2008, GENOME RES, V18, P310, DOI 10.1101/gr.6991408; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Assis R, 2014, FLY, V8, P91, DOI 10.4161/fly.29131; Atambayeva SA, 2008, MOL BIOL+, V42, P312, DOI 10.1134/S0026893308020180; Bae SH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120848; Bai L, 2011, MOL CELL, V42, P465, DOI 10.1016/j.molcel.2011.03.028; Bai L, 2010, DEV CELL, V18, P544, DOI 10.1016/j.devcel.2010.02.007; Bai YS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r11; BANSAL M, 1995, COMPUT APPL BIOSCI, V11, P281; Bansal M, 2014, CURR OPIN STRUC BIOL, V25, P77, DOI 10.1016/j.sbi.2014.01.007; Barahimipour R, 2015, PLANT J, V84, P704, DOI 10.1111/tpj.13033; Basehoar AD, 2004, CELL, V116, P699, DOI 10.1016/S0092-8674(04)00205-3; Belsley D.A., 2005, REGRESSION DIAGNOSTI; Bernard V, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-166; BHATTACHARYA D, 1988, J BIOMOL STRUCT DYN, V6, P93, DOI 10.1080/07391102.1988.10506484; BLAKE MC, 1990, MOL CELL BIOL, V10, P6632, DOI 10.1128/MCB.10.12.6632; Blanc G, 2004, PLANT CELL, V16, P1679, DOI 10.1105/tpc.021410; BOLSHOY A, 1991, P NATL ACAD SCI USA, V88, P2312, DOI 10.1073/pnas.88.6.2312; Bowers JE, 2003, NATURE, V422, P433, DOI 10.1038/nature01521; BRUKNER I, 1995, EMBO J, V14, P1812, DOI 10.1002/j.1460-2075.1995.tb07169.x; Camiolo S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006356; Carmel L, 2007, GENOME RES, V17, P1045, DOI 10.1101/gr.5978207; Carmel L, 2009, GENOME BIOL EVOL, V1, P382, DOI 10.1093/gbe/evp038; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Castillo-Davis CI, 2002, NAT GENET, V31, P415, DOI 10.1038/ng940; Cenik C, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r29; Choi JK, 2009, NAT GENET, V41, P498, DOI 10.1038/ng.319; Chorev Michal, 2012, Frontiers in Genetics, V3, P55, DOI 10.3389/fgene.2012.00055; Chung BYW, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-120; Civan P, 2009, GENOME, V52, P294, DOI 10.1139/G09-001; Coenders G, 2000, NEW APPROACH APPL ST, V16, P79; Comeron JM, 2004, GENETICS, V167, P1293, DOI 10.1534/genetics.104.026351; De La Torre AR, 2015, GENOME BIOL EVOL, V7, P1002, DOI 10.1093/gbe/evv044; Dolfini D, 2009, CELL CYCLE, V8, P4127, DOI 10.4161/cc.8.24.10240; Dvir S, 2013, P NATL ACAD SCI USA, V110, pE2792, DOI 10.1073/pnas.1222534110; Flagel LE, 2009, NEW PHYTOL, V183, P557, DOI 10.1111/j.1469-8137.2009.02923.x; Friendly M, 2009, AM STAT, V63, P56, DOI 10.1198/tast.2009.0012; Fullerton SM, 2001, MOL BIOL EVOL, V18, P1139, DOI 10.1093/oxfordjournals.molbev.a003886; Ganko EW, 2007, MOL BIOL EVOL, V24, P2298, DOI 10.1093/molbev/msm158; Garcia-Hernandez Margarita, 2002, Funct Integr Genomics, V2, P239, DOI 10.1007/s10142-002-0077-z; Govind CK, 2005, MOL CELL BIOL, V25, P5626, DOI 10.1128/MCB.25.13.5626-5638.2005; Grishkevich V, 2014, GENOME RES, V24, P1497, DOI 10.1101/gr.169722.113; Guo YL, 2013, PLANT J, V73, P941, DOI 10.1111/tpj.12089; Hansen L, 2010, NUCLEIC ACIDS RES, V38, P1772, DOI 10.1093/nar/gkp1195; Hernandez-Garcia CM, 2014, PLANT SCI, V217, P109, DOI 10.1016/j.plantsci.2013.12.007; HOLM S, 1979, SCAND J STAT, V6, P65; Huebert DJ, 2012, MOL CELL BIOL, V32, P1645, DOI 10.1128/MCB.06170-11; Kaessmann H, 2010, GENOME RES, V20, P1313, DOI 10.1101/gr.101386.109; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanhere A, 2005, NUCLEIC ACIDS RES, V33, P3165, DOI 10.1093/nar/gki627; Keren H, 2010, NAT REV GENET, V11, P345, DOI 10.1038/nrg2776; Khaitovich P, 2005, SCIENCE, V309, P1850, DOI 10.1126/science.1108296; Kim Y, 2014, NUCLEIC ACIDS RES, V42, P485, DOI 10.1093/nar/gkt864; Kudla G, 2006, PLOS BIOL, V4, P933, DOI 10.1371/journal.pbio.0040180; Kumar A, 2017, DNA RES, V24, P25, DOI 10.1093/dnares/dsw045; Laloum T, 2013, TRENDS PLANT SCI, V18, P157, DOI 10.1016/j.tplants.2012.07.004; Lercher MJ, 2002, NAT GENET, V31, P180, DOI 10.1038/ng887; Li G, 2014, PLANT J, V78, P706, DOI 10.1111/tpj.12499; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Li Z, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S6-S8; Lianoglou S, 2013, GENE DEV, V27, P2380, DOI 10.1101/gad.229328.113; Liao XP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102868; Lin HN, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r41; Lin ZG, 2012, MOL BIOL EVOL, V29, P81, DOI 10.1093/molbev/msr143; Liu MJ, 2015, GENOME RES, V25, P1182, DOI 10.1101/gr.188680.114; Magadum S, 2013, J GENET, V92, P155, DOI 10.1007/s12041-013-0212-8; Mattenberger F, 2017, G3-GENES GENOM GENET, V7, P63, DOI 10.1534/g3.116.035329; Mejia-Guerra MK, 2015, PLANT CELL, V27, P3309, DOI 10.1105/tpc.15.00630; Molina C, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-25; Montoya-Burgos JI, 2003, TRENDS GENET, V19, P128, DOI 10.1016/S0168-9525(03)00021-0; Morey C, 2011, PLANT PHYSIOL, V156, P1300, DOI 10.1104/pp.110.167809; Nott A, 2003, RNA, V9, P607, DOI 10.1261/rna.5250403; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; Panchy N, 2016, PLANT PHYSIOL, V171, P2294, DOI 10.1104/pp.16.00523; Park J, 2012, HUM MOL GENET, V21, P46, DOI 10.1093/hmg/ddr436; Paterson AH, 2004, P NATL ACAD SCI USA, V101, P9903, DOI 10.1073/pnas.0307901101; Proost S, 2015, NUCLEIC ACIDS RES, V43, pD974, DOI 10.1093/nar/gku986; Quigley F, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2001-3-1-research0001; Rao YS, 2013, GENET SEL EVOL, V45, DOI 10.1186/1297-9686-45-9; Ren XY, 2006, TRENDS GENET, V22, P528, DOI 10.1016/j.tig.2006.08.008; Rosa BA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002678; SantaLucia J, 1998, P NATL ACAD SCI USA, V95, P1460, DOI 10.1073/pnas.95.4.1460; SATCHWELL SC, 1986, J MOL BIOL, V191, P659, DOI 10.1016/0022-2836(86)90452-3; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Schug J, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r33; Schwartz S, 2009, NAT STRUCT MOL BIOL, V16, P990, DOI 10.1038/nsmb.1659; Sekhon RS, 2011, PLANT J, V66, P553, DOI 10.1111/j.1365-313X.2011.04527.x; Seoighe C, 2005, PLOS GENET, V1, P154, DOI 10.1371/journal.pgen.0010013; Shabalina SA, 2010, GENOME BIOL EVOL, V2, P791, DOI 10.1093/gbe/evq058; Shakoor N, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-35; Shi W, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S4-S2; Singh M, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-014-0404-2; Soltani S, 2014, MOL BIOSYST, V10, P273, DOI 10.1039/c3mb70311h; Struhl K, 2013, NAT STRUCT MOL BIOL, V20, P267, DOI 10.1038/nsmb.2506; Taher L, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r117; Tang HB, 2010, P NATL ACAD SCI USA, V107, P472, DOI 10.1073/pnas.0908007107; Tatarinova TV, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-308; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Tirosh Itay, 2009, J Biol, V8, P95, DOI 10.1186/jbiol204; Usadel B, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-535; Vera DL, 2014, PLANT CELL, V26, P3883, DOI 10.1105/tpc.114.130609; Vinayachandran V, 2009, EPIGENET CHROMATIN, V2, DOI 10.1186/1756-8935-2-4; Wang L, 2010, PLANT J, V61, P752, DOI 10.1111/j.1365-313X.2009.04100.x; Wang YP, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-652; Wang YP, 2012, ANN NY ACAD SCI, V1256, P1, DOI 10.1111/j.1749-6632.2011.06384.x; Wang YP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028150; Webster MT, 2006, MOL BIOL EVOL, V23, P1203, DOI 10.1093/molbev/msk008; Wegmann D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003587; WOLFE KH, 1989, P NATL ACAD SCI USA, V86, P6201, DOI 10.1073/pnas.86.16.6201; Woody JL, 2011, GENOME, V54, P10, DOI 10.1139/G10-090; Xu GX, 2012, P NATL ACAD SCI USA, V109, P1187, DOI 10.1073/pnas.1109047109; Yamamoto YY, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-67; Yamamoto YY, 2007, NUCLEIC ACIDS RES, V35, P6219, DOI 10.1093/nar/gkm685; Yang HX, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-45; Yella VR, 2013, J BIOINF COMPUT BIOL, V11, DOI 10.1142/S0219720013430014; Yoo W, 2014, STUDY EFFECTS MULTIC, V4, P9	117	16	16	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2019	14	3							e0212678	10.1371/journal.pone.0212678	http://dx.doi.org/10.1371/journal.pone.0212678			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ1KV	30908494	Green Published, Green Accepted, gold			2022-12-26	WOS:000462157600009
J	De Palma, RM; Parnham, SR; Lo, YT; Oaks, JJ; Peterson, YK; Szulc, ZM; Roth, BM; Xing, YN; Ogretmen, B				De Palma, Ryan M.; Parnham, Stuart R.; Lo, Yitong; Oaks, Joshua J.; Peterson, Yuri K.; Szulc, Zdzislaw M.; Roth, Braden M.; Xing, Yongna; Ogretmen, Besim			The NMR-based characterization of the FTY720-SET complex reveals an alternative mechanism for the attenuation of the inhibitory SET-PP2A interaction	FASEB JOURNAL			English	Article						ceramide; sphingolipid; fingolimod; lipid-protein binding	PROTEIN PHOSPHATASE 2A; TRANSFER DIFFERENCE NMR; TUMOR-SUPPRESSOR PP2A; ACTIVATING FACTOR-I; COUPLING-CONSTANTS; STRUCTURAL BASIS; SKELETAL-MUSCLE; OKADAIC ACID; CELL-GROWTH; SET	The su(var)3-9, enhancer of zeste, trithorax (SET)/inhibitor 2 of protein phosphatase 2A (PP2A) oncoprotein binds and inhibits PP2A, composed of various isoforms of scaffolding, regulatory, and catalytic subunits. Targeting SET with a sphingolipid analog drug fingolimod (FTY720) or ceramide leads to the reactivation of tumor suppressor PP2A. However, molecular details of the SET-FTY720 or SET-ceramide, and mechanism of FTY720-dependent PP2A activation, remain unknown. Here, we report the first in solution examination of the SET-FTY720 or SET-ceramide complexes by NMR spectroscopy. FTY720-ceramide binding resulted in chemical shifts of residues residing at the N terminus of SET, preventing its dimerization or oligomerization. This then released SET from PP2AC alpha, resulting in PP2A activation, while monomeric SET remained associated with the B56 gamma. Our data also suggest that the PP2A holoenzyme, composed of PP2A-A beta, PP2A-B56 gamma, and PP2AC alpha subunits, is selectively activated in response to the formation of the SET-FTY720 complex in A549 cells. Various PP2A-associated downstream effector proteins in the presence or absence of FTY720 were then identified by stable isotope labeling with amino cells in cell culture, including tumor suppressor nonmuscle myosin IIA. Attenuation of FTY720-SET association by point mutations of residues that are involved in FTY720 binding or dephosphorylation of SET at Serine 171, enhanced SET oligomerization and the formation of the SET-PP2A inhibitory complex, leading to resistance to FTY720-dependent PP2A activation.-De Palma, R. M., Parnham, S. R., Li, Y., Oaks, J. J., Peterson, Y. K., Szulc, Z. M., Roth, B. M., Xing, Y., Ogretmen, B. The NMR-based characterization of the FTY720-SET complex reveals an alternative mechanism for the attenuation of the inhibitory SET-PP2A interaction.	[De Palma, Ryan M.; Szulc, Zdzislaw M.; Roth, Braden M.; Ogretmen, Besim] Med Univ South Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [De Palma, Ryan M.; Szulc, Zdzislaw M.; Roth, Braden M.; Ogretmen, Besim] Med Univ South Carolina, Hollings Canc Ctr, 86 Jonathan Lucas St, Charleston, SC 29425 USA; [Peterson, Yuri K.] Med Univ South Carolina, Dept Drug Discovery & Biomed Sci, Charleston, SC 29425 USA; [Parnham, Stuart R.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27515 USA; [Lo, Yitong; Xing, Yongna] Univ Wisconsin, McArdle Lab Canc Res, 1400 Univ Ave, Madison, WI 53706 USA; [Oaks, Joshua J.] Phanes Therapeut, San Diego, CA USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; University of North Carolina; University of North Carolina Chapel Hill; University of Wisconsin System; University of Wisconsin Madison	Ogretmen, B (corresponding author), Med Univ South Carolina, Hollings Canc Ctr, 86 Jonathan Lucas St, Charleston, SC 29425 USA.	ogretmen@musc.edu	Li, Yitong/V-9378-2018; Roth, Braden/L-9386-2015	Li, Yitong/0000-0002-7866-8460; De Palma, Ryan/0000-0001-7460-5676; Roth, Braden/0000-0001-7559-7671	U.S. National Institutes of Health (NIH) National Cancer Institute [CA088932, CA173687, CA214461, P01 CA203628]; NIH National Institute of Dental and Craniofacial Research [DE016572]; NIH National Center for Research Resources [C06 RR015455]; Hollings Cancer Center Support Grant [P30 CA138313]; Center of Biomedical Research Excellence (CoBRE) in Lipidomics and Pathobiology [P30 GM103339]; NATIONAL CANCER INSTITUTE [P30CA138313, R01CA214461, P01CA203628, R01CA173687, R01CA088932] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103339] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIH National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Hollings Cancer Center Support Grant; Center of Biomedical Research Excellence (CoBRE) in Lipidomics and Pathobiology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Dr. Aiping Bai and Mr. Jason Pierce for help in ceramide measurements at the Lipidomics Shared Resource facility, Department of Biochemistry and Molecular Biology, Medical University of South Carolina. The authors also thank Mr. Brett Bechtol (Hollings Cancer Center, Medical University of South Carolina) for editorial review and assistance. The authors thank the members of the B.O. laboratory for technical support and helpful discussions. The authors also thank Dr. Do-Sung Kim (Department of Biochemistry and Molecular Biology, Hollings Cancer Center, Medical University of South Carolina) for help and assistance in our experimental procedures. This work is supported by research funding from the U.S. National Institutes of Health (NIH) National Cancer Institute (CA088932, CA173687, CA214461, and P01 CA203628, to B.O.), and the NIH National Institute of Dental and Craniofacial Research (DE016572, to B.O.). The core facilities utilized were constructed using support from NIH National Center for Research Resources (C06 RR015455), Hollings Cancer Center Support Grant (P30 CA138313), or Center of Biomedical Research Excellence (CoBRE) in Lipidomics and Pathobiology (P30 GM103339). B.O. is the founder and Chief Scientific Officer of LipoImmuno Tech, LLC., and Z.M.S. is the director of synthetic chemistry of the Lipo-Immuno Tech. The authors declare no conflicts of interest.	Adams JM, 2004, DIABETES, V53, P25, DOI 10.2337/diabetes.53.1.25; Agarwal A, 2014, CLIN CANCER RES, V20, P2092, DOI 10.1158/1078-0432.CCR-13-2575; Amati F, 2011, DIABETES, V60, P2588, DOI 10.2337/db10-1221; Anazawa Y, 2005, CANCER RES, V65, P4578, DOI 10.1158/0008-5472.CAN-04-4564; Bharath LP, 2015, DIABETES, V64, P3914, DOI 10.2337/db15-0244; BIALOJAN C, 1988, BIOCHEM J, V256, P283, DOI 10.1042/bj2560283; Boyer RD, 2003, J MAGN RESON, V165, P253, DOI 10.1016/j.jmr.2003.08.009; BRAUTIGAN DL, 1995, SEMIN CANCER BIOL, V6, P211, DOI 10.1006/scbi.1995.0028; Brinkmann V, 2010, NAT REV DRUG DISCOV, V9, P883, DOI 10.1038/nrd3248; Carlson SG, 1998, J AM SOC NEPHROL, V9, P1873; Chalfant CE, 2004, J LIPID RES, V45, P496, DOI 10.1194/jlr.M300347-JLR200; Chavez JA, 2003, J BIOL CHEM, V278, P10297, DOI 10.1074/jbc.M212307200; Chen LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103033; Chen W, 2004, CANCER CELL, V5, P127, DOI 10.1016/S1535-6108(04)00026-1; Chen WB, 2013, GASTROENT RES PRACT, V2013, DOI 10.1155/2013/675429; Christensen DJ, 2011, BLOOD, V118, P4150, DOI 10.1182/blood-2011-04-351072; Cicero DO, 2001, J MAGN RESON, V148, P209, DOI 10.1006/jmre.2000.2234; Deichmann M, 2001, MELANOMA RES, V11, P577, DOI 10.1097/00008390-200112000-00004; DOBROWSKY RT, 1993, J BIOL CHEM, V268, P15523; Favier A, 2011, J BIOMOL NMR, V49, P9, DOI 10.1007/s10858-010-9461-5; FAVRE B, 1994, J BIOL CHEM, V269, P16311; Furuya H, 2011, CANCER METAST REV, V30, P567, DOI 10.1007/s10555-011-9304-1; GRIESINGER C, 1987, J MAGN RESON, V75, P474, DOI 10.1016/0022-2364(87)90102-8; GUO H, 1993, J BIOL CHEM, V268, P11193; Herzog F, 2012, SCIENCE, V337, P1348, DOI 10.1126/science.1221483; Irie A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051242; Janghorban M, 2014, P NATL ACAD SCI USA, V111, P9157, DOI 10.1073/pnas.1317630111; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Janssens V, 2008, TRENDS BIOCHEM SCI, V33, P113, DOI 10.1016/j.tibs.2007.12.004; Johnson CS, 1999, PROG NUCL MAG RES SP, V34, P203, DOI 10.1016/S0079-6565(99)00003-5; Karetsou Z, 2009, BMC BIOCHEM, V10, DOI 10.1186/1471-2091-10-10; Koyrakh L, 2005, AM J TRANSPLANT, V5, P529, DOI 10.1111/j.1600-6143.2005.00754.x; Kudo N, 2008, P NATL ACAD SCI USA, V105, P488, DOI 10.1073/pnas.0709191105; Lescop E, 2007, J MAGN RESON, V187, P163, DOI 10.1016/j.jmr.2007.04.002; Mayer M, 1999, ANGEW CHEM INT EDIT, V38, P1784, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.0.CO;2-Q; Mayer M, 2001, J AM CHEM SOC, V123, P6108, DOI 10.1021/ja0100120; Miyaji-Yamaguchi M, 1999, J MOL BIOL, V290, P547, DOI 10.1006/jmbi.1999.2898; Mukhopadhyay A, 2013, CANCER BIOL THER, V14, P962, DOI 10.4161/cbt.25943; Mukhopadhyay A, 2009, FASEB J, V23, P751, DOI 10.1096/fj.08-120550; Muto S, 2007, P NATL ACAD SCI USA, V104, P4285, DOI 10.1073/pnas.0603762104; Nagahara Y, 2001, JPN J CANCER RES, V92, P680, DOI 10.1111/j.1349-7006.2001.tb01148.x; NAGATA K, 1995, P NATL ACAD SCI USA, V92, P4279, DOI 10.1073/pnas.92.10.4279; Neviani P, 2005, CANCER CELL, V8, P355, DOI 10.1016/j.ccr.2005.10.015; Neviani P, 2014, CLIN CANCER RES, V20, P2026, DOI 10.1158/1078-0432.CCR-14-0166; Nilsson M, 2009, J MAGN RESON, V200, P296, DOI 10.1016/j.jmr.2009.07.022; Nobumori Y, 2013, MOL CANCER RES, V11, P995, DOI 10.1158/1541-7786.MCR-12-0633; Oaks JJ, 2013, BLOOD, V122, P1923, DOI 10.1182/blood-2013-03-492181; Ouellet V, 2006, INT J CANCER, V119, P2119, DOI 10.1002/ijc.22054; Rai V, 2011, EUKARYOT CELL, V10, P604, DOI 10.1128/EC.00296-10; Roberts KG, 2010, CANCER RES, V70, P5438, DOI 10.1158/0008-5472.CAN-09-2544; Sablina AA, 2007, CELL, V129, P969, DOI 10.1016/j.cell.2007.03.047; Saddoughi SA, 2013, EMBO MOL MED, V5, P105, DOI 10.1002/emmm.201201283; Saito S, 1999, BIOCHEM BIOPH RES CO, V259, P471, DOI 10.1006/bbrc.1999.0790; Saito S, 2004, INT J CANCER, V111, P501, DOI 10.1002/ijc.20296; Saydam G, 2003, LEUKEMIA RES, V27, P709, DOI 10.1016/S0145-2126(02)00347-8; Schramek D, 2014, SCIENCE, V343, P309, DOI 10.1126/science.1248627; Schulte-Herbruggen T, 2000, J MAGN RESON, V144, P123, DOI 10.1006/jmre.2000.2020; Seo SB, 2001, CELL, V104, P119, DOI 10.1016/S0092-8674(01)00196-9; Shouse GP, 2010, ONCOGENE, V29, P3933, DOI 10.1038/onc.2010.161; Stanevich V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086955; Stanevich V, 2011, MOL CELL, V41, P331, DOI 10.1016/j.molcel.2010.12.030; STEJSKAL EO, 1965, J CHEM PHYS, V42, P288, DOI 10.1063/1.1695690; SUGANUMA M, 1988, P NATL ACAD SCI USA, V85, P1768, DOI 10.1073/pnas.85.6.1768; Tamaki M, 2004, ONCOL REP, V11, P655; Vasudevan NT, 2011, MOL CELL, V41, P636, DOI 10.1016/j.molcel.2011.02.025; Virshup DM, 2000, CURR OPIN CELL BIOL, V12, P180, DOI 10.1016/S0955-0674(99)00074-5; VONLINDERN M, 1992, MOL CELL BIOL, V12, P3346, DOI 10.1128/MCB.12.8.3346; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wagner R, 1996, J MAGN RESON SER A, V123, P119, DOI 10.1006/jmra.1996.0222; Williamson MP, 2013, PROG NUCL MAG RES SP, V73, P1, DOI 10.1016/j.pnmrs.2013.02.001; WU DH, 1995, J MAGN RESON SER A, V115, P260, DOI 10.1006/jmra.1995.1176; Wuthrich K, 1976, NMR BIOL RES PEPTIDE; Xing Y, 2006, CELL, V127, P341, DOI 10.1016/j.cell.2006.09.025; Xu YH, 2006, CELL, V127, P1239, DOI 10.1016/j.cell.2006.11.033; Xu Z, 2010, ACTA CRYSTALLOGR F, V66, P926, DOI 10.1107/S1744309110021779; Yu G, 2013, NEUROBIOL AGING, V34, P1748, DOI 10.1016/j.neurobiolaging.2012.12.025; Zhou J, 2003, BIOCHEM J, V369, P387, DOI 10.1042/BJ20021244	77	22	22	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					7647	7666		10.1096/fj.201802264R	http://dx.doi.org/10.1096/fj.201802264R			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30917007	Green Published, Bronze			2022-12-26	WOS:000476114200079
J	Farah, E; Li, CH; Cheng, LJ; Kong, YF; Lanman, NA; Pascuzzi, P; Lorenz, GR; Zhang, YQ; Ahmad, N; Li, L; Ratliff, T; Liu, XQ				Farah, Elia; Li, Chaohao; Cheng, Lijun; Kong, Yifan; Lanman, Nadia A.; Pascuzzi, Pete; Lorenz, Gabrielle Renee; Zhang, Yanquan; Ahmad, Nihal; Li, Lang; Ratliff, Tim; Liu, Xiaoqi			NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						drug resistance; prostate cancer; Notch pathway; androgen receptor; anticancer drug; ADAM; androgen receptor; enzalutamide; Notch1; PF-03084014	STEM-LIKE CELLS; CASTRATION-RESISTANT; PATHWAY; INHIBITION; EXPRESSION; DOCETAXEL; DOMAIN	Prostate cancer is the second leading cause of cancer death among men in the United States. The androgen receptor (AR) antagonist enzalutamide is a Food and Drug Administration-approved drug for treatment of patients with late-stage prostate cancer and is currently under clinical study for early-stage prostate cancer treatment. After a short positive response period, tumors will develop drug resistance. In this study using RNA-Seq and bioinformatics analyses, we observed that NOTCH signaling is a deregulated pathway in enzalutamide-resistant cells. NOTCH2 and c-MYC gene expression positively correlated with AR expression in samples from patient with hormone refractory disease in which AR expression levels correspond to those typically observed in enzalutamide resistance. Cleaved NOTCH1, HES1 (Hes family BHLH transcription factor 1), and c-MYC protein expression levels are elevated in two enzalutamide-resistant cell lines, MR49F and C4-2R, indicating NOTCH signaling activation. Moreover, inhibition of the overexpressed ADAM metallopeptidase domain 10 (ADAM10) in the resistant cells induces an exclusive reduction in cleaved NOTCH1 expression. Furthermore, exposure of enzalutamide-resistant cells to both PF-03084014 and enzalutamide increased cell death, decreased colony formation ability, and resensitized cells to enzalutamide. Knockdown of NOTCH1 in C4-2R increased enzalutamide sensitivity by decreasing cell proliferation and increasing cleaved PARP expression. In a 22RV1 xenograft model, PF-03084014 and enzalutamide decreased tumor growth through reducing cell proliferation and increasing apoptosis. These results indicate that NOTCH1 signaling may contribute to enzalutamide resistance in prostate cancer, and inhibition of NOTCH signaling can resensitize resistant cells to enzalutamide.	[Farah, Elia; Lorenz, Gabrielle Renee; Zhang, Yanquan; Liu, Xiaoqi] Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA; [Li, Chaohao; Kong, Yifan] Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA; [Lanman, Nadia A.; Ratliff, Tim; Liu, Xiaoqi] Purdue Univ, Dept Comparat Pathobiol, W Lafayette, IN 47907 USA; [Lanman, Nadia A.; Ratliff, Tim] Purdue Univ, Ctr Canc Res, W Lafayette, IN 47907 USA; [Pascuzzi, Pete] Purdue Univ, Purdue Univ Lib, W Lafayette, IN 47907 USA; [Cheng, Lijun; Li, Lang] Ohio State Univ, Dept Biomed Informat, Columbus, OH 43210 USA; [Ahmad, Nihal] Univ Wisconsin, Dept Dermatol, Madison, WI 53715 USA; [Liu, Xiaoqi] Univ Kentucky, Dept Toxicol & Canc Biol, Lexington, KY 40536 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University System of Ohio; Ohio State University; University of Wisconsin System; University of Wisconsin Madison; University of Kentucky	Liu, XQ (corresponding author), Univ Kentucky, Dept Toxicol & Canc Biol, Lexington, KY 40536 USA.	Xiaoqi.Liu@uky.edu	Ahmad, Nihal/AAR-4249-2021; Zhang, Yanquan/D-5615-2017	Ahmad, Nihal/0000-0002-4239-9887; Zhang, Yanquan/0000-0003-3527-9972; Pascuzzi, Pete/0000-0002-9316-4404; Atallah, Nadia/0000-0002-1819-7070	National Institutes of Health [R01 CA157429, R01 CA192894, R01 CA196835, R01 CA196634]; Purdue University Center for Cancer Research Grant [P30 CA023168]; NATIONAL CANCER INSTITUTE [R01CA192894, R01CA196835, R01CA157429, R01CA196634, P30CA023168] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Purdue University Center for Cancer Research Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grants R01 CA157429, R01 CA192894, R01 CA196835, and R01 CA196634 (to X. L.). The work was also supported by Purdue University Center for Cancer Research Grant P30 CA023168. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alumkal JJ, 2017, CLIN GENITOURIN CANC, V15, P610, DOI 10.1016/j.clgc.2017.02.007; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Atapattu L, 2016, J EXP MED, V213, P1741, DOI 10.1084/jem.20151095; Bahl A, 2014, CANCER TREAT REV, V40, P170, DOI 10.1016/j.ctrv.2013.06.008; Bianchini D, 2014, EUR J CANCER, V50, P78, DOI 10.1016/j.ejca.2013.08.020; Cordle J, 2008, NAT STRUCT MOL BIOL, V15, P849, DOI 10.1038/nsmb.1457; Cui J, 2018, INT J CANCER, V143, P645, DOI 10.1002/ijc.31346; D'Souza B, 2010, CURR TOP DEV BIOL, V92, P73, DOI 10.1016/S0070-2153(10)92003-6; Deng G, 2016, J CANCER RES CLIN, V142, P531, DOI 10.1007/s00432-015-1946-x; Domingo-Domenech J, 2012, CANCER CELL, V22, P373, DOI 10.1016/j.ccr.2012.07.016; Gao LN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063563; Guo HJ, 2014, THORAC CANCER, V5, P473, DOI 10.1111/1759-7714.12143; Habets RAJ, 2015, J BIOL CHEM, V290, P14705, DOI 10.1074/jbc.M115.643676; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kita Y, 2018, CANCERS, V10, DOI 10.3390/cancers10100345; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kuruma H, 2013, MOL CANCER THER, V12, P567, DOI 10.1158/1535-7163.MCT-12-0798; Li DD, 2018, CELL PROLIFERAT, V51, DOI 10.1111/cpr.12480; Liu CF, 2014, CLIN CANCER RES, V20, P3198, DOI 10.1158/1078-0432.CCR-13-3296; LOVE MI, 2014, GENOME BIOL, V15, DOI DOI 10.1186/S13059-014-0550-8; Lubman OY, 2004, MOL CELL, V13, P619, DOI 10.1016/S1097-2765(04)00120-0; Miller MA, 2017, CLIN CANCER RES, V23, P623, DOI 10.1158/1078-0432.CCR-16-0869; Mohamed AA, 2017, MOL CANCER RES, V15, P1308, DOI 10.1158/1541-7786.MCR-17-0058; Ojo D, 2015, CANCERS, V7, P2290, DOI 10.3390/cancers7040890; Prabakaran DS, 2019, INT J BIOL MACROMOL, V126, P1318, DOI 10.1016/j.ijbiomac.2018.09.114; Roberts A, 2011, BIOINFORMATICS, V27, P2325, DOI 10.1093/bioinformatics/btr355; Roberts A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r22; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Sprinzak D, 2010, NATURE, V465, P86, DOI 10.1038/nature08959; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tveriakhina L, 2018, ELIFE, V7, DOI 10.7554/eLife.40045; Venkatesh Vandana, 2018, Stem Cell Investig, V5, P5, DOI 10.21037/sci.2018.02.02; Wolfe MS, 2004, SCIENCE, V305, P1119, DOI 10.1126/science.1096187; Zhang ZZ, 2018, CANCER RES, V78, P3147, DOI 10.1158/0008-5472.CAN-17-3006; Zhou W, 2018, ONCOL LETT, V16, P2805, DOI 10.3892/ol.2018.9039	36	32	34	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2019	294	21					8543	8554		10.1074/jbc.RA118.006983	http://dx.doi.org/10.1074/jbc.RA118.006983			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC6UQ	30940724	hybrid, Green Published			2022-12-26	WOS:000471108200022
J	Hsu, MH; Johnson, EF				Hsu, Mei-Hui; Johnson, Eric F.			Active-site differences between substrate-free and ritonavir-bound cytochrome P450 (CYP) 3A5 reveal plasticity differences between CYP3A5 and CYP3A4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytochrome P450; drug metabolism; protein structure; crystal structure; protein conformation; CYP3A4; CYP3A5; protein plasticity	HUMAN-LIVER; IN-VITRO; STRUCTURAL BASIS; METABOLISM; INHIBITION; EXPRESSION; MICROSOMES; DIVERSITY; MECHANISM; OXIDATION	Cytochrome P450 (CYP) 3A4 is a major contributor to hepatic drug and xenobiotic metabolism in human adults. The related enzyme CYP3A5 is also expressed in adult liver and has broader age and tissue distributions. However, CYP3A5 expression is low in most Caucasians because of the prevalence of an allele that leads to an incorrectly spliced mRNA and premature termination of translation. When expressed, CYP3A5 expands metabolic capabilities and can augment CYP3A4-mediated drug metabolism, thereby reducing drug efficacy and potentially requiring dose adjustments. The extensive role of CYP3A4 in drug metabolism reflects in part the plasticity of the substrate-free enzyme to enlarge its active site and accommodate very large substrates. We have previously shown that the structure of the CYP3A5-ritonavir complex differs substantially from that of the CYP3A4-ritonavir complex. To better understand whether these differences are conserved in other CYP3A5 structures and how they relate to differential plasticity, we determined the X-ray crystallographic structure of the CYP3A5 substrate-free complex to 2.20 resolution. We observed that this structure exhibits a much larger active site than substrate-free CYP3A4 and displays an open substrate access channel. This reflected in part a lower trajectory of the helix F-F connector in CYP3A4 and more extensive -CH interactions between phenylalanine residues forming the roof of the active-site cavity than in CYP3A5. Comparison with the CYP3A5-ritonavir complex confirmed conserved CYP3A5 structural features and indicated differences in plasticity between CYP3A4 and CYP3A5 that favor alternative ritonavir conformations.	[Hsu, Mei-Hui; Johnson, Eric F.] Scripps Res, Dept Mol Med, 10550 North Torrey Pines Dr, La Jolla, CA 92037 USA	Scripps Research Institute	Johnson, EF (corresponding author), Scripps Res, Dept Mol Med, 10550 North Torrey Pines Dr, La Jolla, CA 92037 USA.	johnson@scripps.edu			National Institutes of Health [R01-GM031001]; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; DOE Office of Biological and Environmental Research; National Institutes of Health, National Institute of General Medical Sciences [P41GM103393]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031001, P41GM103393] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01-GM031001 (to E. F. J.). The use of the Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, is supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract DE-AC02-76SF00515. The Stanford Synchrotron Radiation Lightsource Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research and by the National Institutes of Health, National Institute of General Medical Sciences (including Grant P41GM103393). The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of NIGMS or National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; AOYAMA T, 1989, J BIOL CHEM, V264, P10388; Branden G, 2014, DRUG DISCOV TODAY, V19, P905, DOI 10.1016/j.drudis.2014.03.012; Dai Y, 2004, BIOCHEM PHARMACOL, V68, P1889, DOI 10.1016/j.bcp.2004.07.012; DeLano WL, 2005, DRUG DISCOV TODAY, V10, P213, DOI 10.1016/S1359-6446(04)03363-X; Denisov IG, 2007, J BIOL CHEM, V282, P7066, DOI 10.1074/jbc.M609589200; Ekroos M, 2006, P NATL ACAD SCI USA, V103, P13682, DOI 10.1073/pnas.0603236103; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Hsu MH, 2018, MOL PHARMACOL, V93, P14, DOI 10.1124/mol.117.109744; Ince I, 2013, CLIN PHARMACOKINET, V52, P333, DOI 10.1007/s40262-013-0041-1; Johnson EF, 2013, J BIOL CHEM, V288, P17082, DOI 10.1074/jbc.R113.452805; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; Koudriakova T, 1998, DRUG METAB DISPOS, V26, P552; Kuehl P, 2001, NAT GENET, V27, P383, DOI 10.1038/86882; Li XH, 2014, DRUG METAB DISPOS, V42, P334, DOI 10.1124/dmd.113.054726; Lu YH, 2012, DRUG METAB DISPOS, V40, P2221, DOI 10.1124/dmd.112.048298; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Niwa T, 2008, CURR DRUG METAB, V9, P20; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; OMURA T, 1964, J BIOL CHEM, V239, P2379; Rendic S, 2015, CHEM RES TOXICOL, V28, P38, DOI 10.1021/tx500444e; Sevrioukova IF, 2017, P NATL ACAD SCI USA, V114, P486, DOI 10.1073/pnas.1616198114; Sevrioukova IF, 2010, P NATL ACAD SCI USA, V107, P18422, DOI 10.1073/pnas.1010693107; Stevens JC, 2006, DRUG DISCOV TODAY, V11, P440, DOI 10.1016/j.drudis.2006.03.002; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Tseng E, 2014, DRUG METAB DISPOS, V42, P1163, DOI 10.1124/dmd.114.057000; Wang HF, 1998, BIOCHEMISTRY-US, V37, P12536, DOI 10.1021/bi980895g; Williams JA, 2002, DRUG METAB DISPOS, V30, P883, DOI 10.1124/dmd.30.8.883; Williams PA, 2004, SCIENCE, V305, P683, DOI 10.1126/science.1099736; Wu JJ, 2017, J MED CHEM, V60, P3804, DOI 10.1021/acs.jmedchem.7b00001; Yamazaki H, 2010, BRIT J CLIN PHARMACO, V69, P593, DOI 10.1111/j.1365-2125.2010.03656.x; Yano JK, 2004, J BIOL CHEM, V279, P38091, DOI 10.1074/jbc.C400293200; Yuki H, 2007, J COMPUT CHEM, V28, P1091, DOI 10.1002/jcc.20557; Zanger UM, 2008, ANAL BIOANAL CHEM, V392, P1093, DOI 10.1007/s00216-008-2291-6	36	18	18	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2019	294	20					8015	8022		10.1074/jbc.RA119.007928	http://dx.doi.org/10.1074/jbc.RA119.007928			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC0NH	30926609	Green Published, hybrid			2022-12-26	WOS:000470656500005
J	Sieng, M; Hayes, MP; O'Brien, JB; Fowler, CA; Houtman, JC; Roman, DL; Lyon, AM				Sieng, Monita; Hayes, Michael P.; O'Brien, Joseph B.; Fowler, C. Andrew; Houtman, Jon C.; Roman, David L.; Lyon, Angeline M.			High-resolution structure of RGS17 suggests a role for Ca2+ in promoting the GTPase-activating protein activity by RZ subfamily members	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium; regulator of G protein signaling (RGS); crystal structure; heterotrimeric G protein; nuclear magnetic resonance (NMR); isothermal titration calorimetry (ITC); cell signaling; GTPase activating protein (GAP); protein crystallization; G protein-coupled receptor (GPCR); RZ subfamily; RGS17	HIGH-THROUGHPUT SCREEN; SIGNALING RGS; PROSTATE-CANCER; REGULATOR; DOMAIN; GAIP; LUNG; DETERMINANTS; CALORIMETRY; RGS17/RGSZ2	Regulator of G protein signaling (RGS) proteins are negative regulators of G protein-coupled receptor (GPCR) signaling through their ability to act as GTPase-activating proteins (GAPs) for activated G subunits. Members of the RZ subfamily of RGS proteins bind to activated G(o), G(z), and G(i1-3) proteins in the nervous system and thereby inhibit downstream pathways, including those involved in Ca2+-dependent signaling. In contrast to other RGS proteins, little is known about RZ subfamily structure and regulation. Herein, we present the 1.5-angstrom crystal structure of RGS17, the most complete and highest-resolution structure of an RZ subfamily member to date. RGS17 cocrystallized with Ca2+ bound to conserved positions on the predicted G-binding surface of the protein. Using NMR chemical shift perturbations, we confirmed that Ca2+ binds in solution to the same site. Furthermore, RGS17 had greater than 55-fold higher affinity for Ca2+ than for Mg2+. Finally, we found that Ca2+ promotes interactions between RGS17 and activated G and decreases the K-m for GTP hydrolysis, potentially by altering the binding mechanism between these proteins. Taken together, these findings suggest that Ca2+ positively regulates RGS17, which may represent a general mechanism by which increased Ca2+ concentration promotes the GAP activity of the RZ subfamily, leading to RZ-mediated inhibition of Ca2+ signaling.	[Sieng, Monita; Lyon, Angeline M.] Purdue Univ, Dept Chem, 560 Oval Dr, W Lafayette, IN 47907 USA; [Lyon, Angeline M.] Purdue Univ, Dept Biol Sci, 560 Oval Dr, W Lafayette, IN 47907 USA; [Hayes, Michael P.; O'Brien, Joseph B.; Roman, David L.] Univ Iowa, Coll Pharm, Dept Pharmaceut Sci & Expt Therapeut, Iowa City, IA 52242 USA; [Fowler, C. Andrew] Univ Iowa, NMR Facil, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Houtman, Jon C.] Univ Iowa, Dept Microbiol & Immunol, Iowa City, IA 52242 USA; [Fowler, C. Andrew] Bruker BioSpin, 15 Fortune Dr, Billerica, MA 01821 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Iowa; University of Iowa; University of Iowa; Bruker Corporation; Bruker BioSpin GmbH	Lyon, AM (corresponding author), Purdue Univ, Dept Chem, 560 Oval Dr, W Lafayette, IN 47907 USA.; Lyon, AM (corresponding author), Purdue Univ, Dept Biol Sci, 560 Oval Dr, W Lafayette, IN 47907 USA.	lyonam@purdue.edu	; Roman, David/G-2637-2010	Hayes, Michael/0000-0003-2033-6778; Houtman, Jon/0000-0002-5307-9854; Roman, David/0000-0002-8250-0337; O'Brien, Joseph/0000-0003-1113-1279; Lyon, Angeline/0000-0001-7501-0148	United States DOE [DE-AC02-06CH11357]; NATIONAL CANCER INSTITUTE [P30CA086862] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL141076] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008365] Funding Source: NIH RePORTER	United States DOE(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Use of the Advanced Photon Source, an Office of Science User Facility operated for the United States Department of Energy (DOE) Office of Science by Argonne National Laboratory, was supported by the United States DOE under Contract DE-AC02-06CH11357. We thank the Life Sciences Collaborative Access Team (LS-CAT) staff members for help with data collection.	Berman DM, 1996, CELL, V86, P445, DOI 10.1016/S0092-8674(00)80117-8; Bodle CR, 2017, J NAT PROD, V80, P1992, DOI 10.1021/acs.jnatprod.7b00112; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; De Vries L, 2000, ANNU REV PHARMACOL, V40, P235, DOI 10.1146/annurev.pharmtox.40.1.235; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeVries L, 1996, P NATL ACAD SCI USA, V93, P15203, DOI 10.1073/pnas.93.26.15203; DOHLMAN HG, 1995, MOL CELL BIOL, V15, P3635; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Faurobert E, 1997, P NATL ACAD SCI USA, V94, P2945, DOI 10.1073/pnas.94.7.2945; Hayes MP, 2016, AAPS J, V18, P550, DOI 10.1208/s12248-016-9894-1; Ishii M, 2005, BIOCHEM J, V385, P65, DOI 10.1042/BJ20040404; Ishii M, 2004, METHOD ENZYMOL, V389, P105; James MA, 2009, CANCER RES, V69, P2108, DOI 10.1158/0008-5472.CAN-08-3495; Kimple AJ, 2009, J BIOL CHEM, V284, P19402, DOI 10.1074/jbc.M109.024711; Koelle MR, 1996, CELL, V84, P115, DOI 10.1016/S0092-8674(00)80998-8; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Ladbury JE, 2010, BIOCHEM SOC T, V38, P888, DOI 10.1042/BST0380888; Larminie C, 2004, MOL BRAIN RES, V122, P24, DOI 10.1016/j.molbrainres.2003.11.014; Li YH, 2015, J CANCER, V6, P767, DOI 10.7150/jca.11833; Mackie DI, 2011, J BIOMOL SCREEN, V16, P869, DOI 10.1177/1087057111410427; Mao H, 2004, J BIOL CHEM, V279, P26314, DOI 10.1074/jbc.M401800200; Mezzasalma TM, 2007, J BIOMOL SCREEN, V12, P418, DOI 10.1177/1087057106297984; Mondal S, 2015, ASSAY DRUG DEV TECHN, V13, P444, DOI 10.1089/adt.2015.643; Monroy CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062247; Moy FJ, 2000, BIOCHEMISTRY-US, V39, P7063, DOI 10.1021/bi992760w; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nance MR, 2013, STRUCTURE, V21, P438, DOI 10.1016/j.str.2012.12.016; Natochin M, 1998, J BIOL CHEM, V273, P6731, DOI 10.1074/jbc.273.12.6731; Nunn C, 2006, SEMIN CELL DEV BIOL, V17, P390, DOI 10.1016/j.semcdb.2006.04.001; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Popov S, 1997, P NATL ACAD SCI USA, V94, P7216, DOI 10.1073/pnas.94.14.7216; Popov SG, 2000, J BIOL CHEM, V275, P18962, DOI 10.1074/jbc.M001128200; Posner BA, 1999, BIOCHEMISTRY-US, V38, P7773, DOI 10.1021/bi9906367; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Slep KC, 2001, NATURE, V409, P1071, DOI 10.1038/35059138; Sokolov E, 2011, CELL SIGNAL, V23, P1603, DOI 10.1016/j.cellsig.2011.05.012; Soundararajan M, 2008, P NATL ACAD SCI USA, V105, P6457, DOI 10.1073/pnas.0801508105; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Taylor VG, 2016, J BIOL CHEM, V291, P5138, DOI 10.1074/jbc.M115.712075; Tesmer JJG, 1997, CELL, V89, P251, DOI 10.1016/S0092-8674(00)80204-4; Tesmer JJG, 2009, PROG MOL BIOL TRANSL, V86, P75, DOI 10.1016/S1877-1173(09)86004-3; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wang J, 1998, J BIOL CHEM, V273, P26014, DOI 10.1074/jbc.273.40.26014; Ward WHJ, 2001, PROGR MED CHEM, V38, P309, DOI 10.1016/S0079-6468(08)70097-3; You M, 2009, CLIN CANCER RES, V15, P2666, DOI 10.1158/1078-0432.CCR-08-2335; Zielinski T, 2009, J BIOMOL SCREEN, V14, P1195, DOI 10.1177/1087057109347473	46	2	2	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2019	294	20					8148	8160		10.1074/jbc.RA118.006059	http://dx.doi.org/10.1074/jbc.RA118.006059			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC0NH	30940727	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000470656500014
J	Abebaw, Y; Berhe, S; Abebe, SM; Adefris, M; Gebeyehu, A; Gure, T; Asmare, B; Dagnu, M; Alebachew, W; Admasu, S; Abdisa, S; G Egziabher, MA				Abebaw, Yeshiwas; Berhe, Solomon; Abebe, Solomon Mekonnen; Adefris, Mulat; Gebeyehu, Abebaw; Gure, Tadesse; Asmare, Birtukan; Dagnu, Masresha; Alebachew, Wubetu; Admasu, Shumye; Abdisa, Solomon; G Egziabher, Melkamu Axumawit			Providers' knowledge on postpartum intrauterine contraceptive device (PPIUCD) service provision in Amhara region public health facility, Ethiopia	PLOS ONE			English	Article							EXPERIENCES	Introduction Postpartum intrauterine contraceptive devices (PP-IUCD) are one type of post-partum family planning method, which can be provided to a post-partum woman starting from the placental delivery time (within 10 minutes), or within the first 48 hours of postpartum period. In most developing countries, delivery time is the primary opportunity for women to access post-partum family planning methods, especially for those living in remote areas. Hence, this study assesses providers' knowledge on postpartum intrauterine contraceptive device service provision. Methods A facility-based cross-sectional study was conducted in Amhara region health center and hospitals. Health providers surveyed included obstetricians, gynecologists, general practitioners, emergency surgical officers, health officers, midwives and nurses from September 18, 2015 to December18, 2016. Simple random sampling was used to select 864 subjects. Data were collected by using a structured self-administered questionnaire and observing the facility. Multilevel analysis was done to see factors associated with outcome. Results A total of 197 health facilities and 864 providers are included in the final analysis. Of the total providers 524 (60.6%) were from a health center. The mean age (+/- SD) of participants was 27.8 years (+/- 5.4). The number of providers with good knowledge accounted for 253 of those surveyed (29.3%). The proportion of good knowledge among trained PP-IUCD providers was 35.7% (those who scored above average), and 27.9% was untrained about PP-IUCD. A considerable heterogeneity was observed between health facilities for each indicator of provider's knowledge. Gender differences were observed as the mean knowledge score deference on PP-IUCD by 0.4 points (beta= -0.41; -0.72, -0.10) when the participant was female. Having experience of regular counseling of pregnant women increases PP-IUCD knowledge score by 0.97. (beta= 0.97; 95% CI: 0.48, 1.47). Where the health facility requested clients to purchase the IUCD themselves, the mean knowledge score decreased by 0.47 points compared with free of charge at the facility level (beta = -0.47; 95%CI: -0.87, -0.07). Conclusion Our findings showed that providers' knowledge about postpartum IUCD was low in the Amhara region public health facility. The lowest knowledge score was noted among nurses, health Officers, midwives, and general practice professionals. Factors associated with providers' knowledge on PP-IUCD are the status of health facility, female sex, training on PP-IUCD, regular counseling of pregnant women, and unavailability of IUCD service.	[Abebaw, Yeshiwas; Berhe, Solomon; Adefris, Mulat; Gure, Tadesse; Asmare, Birtukan; Dagnu, Masresha; Alebachew, Wubetu; Abdisa, Solomon; G Egziabher, Melkamu Axumawit] Univ Gondar, Coll Med & Hlth Sci, Dept Obstet & Gynecol, Gondar, Ethiopia; [Abebe, Solomon Mekonnen] Univ Gondar, Coll Med & Hlth Sci, Inst Publ Hlth, Dept Human Nutr, Gondar, Ethiopia; [Gebeyehu, Abebaw] Amhara Reg Hlth Biuro, Bahir Dar, Ethiopia; [Admasu, Shumye] Debretabor Univ, Coll Med & Hlth Sci, Dept Obstet & Gynecologyn, Debretabor, Ethiopia	University of Gondar; University of Gondar	Abebe, SM (corresponding author), Univ Gondar, Coll Med & Hlth Sci, Inst Publ Hlth, Dept Human Nutr, Gondar, Ethiopia.	solomekonnen@yahoo.com		Worku, Abebaw Gebeyehu/0000-0002-1146-3399; GURE, TADESSE/0000-0003-1213-1385	Center for International Reproductive Health Training	Center for International Reproductive Health Training	This research was funded by Center for International Reproductive Health Training (CIRHT). Web site: http://cirht.med.umich.edu/.The funder had no role in study design, data collection and analysis, decision to publish, preparation of the manuscript.	Agha S., 2012, CLIN TRAINING ALONE; [Anonymous], 2013, TANZANIA EXPERIENCE; [Anonymous], 2015, INT J GYNECOLOGY OBS, V130, pS54; [Anonymous], 2002, FUT PUBL HLTH 21 CEN; Aruna D. V., 2015, IOSR J DENT MED SCI, V14, P56; Ayiasi RM, 2015, PAN AFR MED J, V21, DOI 10.11604/pamj.2015.21.138.7026; Canning D, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1160-0; Chakraborty NM, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0701-y; Cleland J, 2015, STUD FAMILY PLANN, V46, P423, DOI 10.1111/j.1728-4465.2015.00041.x; Espey D., 2003, IUD RELATED KNOWLEDG, P35; ETHIOPIAN Emergency Obstetric and Newborn Care (EmONC), 2017, EHIOPIAN EM OBST NEW; Ethiopian Public Health Institute Addis Ababa E Federal Ministry of Health Addis Ababa Ethiopia ICF International Rockville Maryland USA, 2014, ETH SERV PROV ASS PL; Idowu A, 2015, Afr J Med Med Sci, V44, P43; Lisanework M. S., POSTPARTUM INTRAUTE; Marlow HM, 2014, HEALTH CARE WOMEN IN, V35, P175, DOI 10.1080/07399332.2013.815753; Mulat A, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/256534; Navodani KT, 2017, CEYLON MED J, V62, P87, DOI 10.4038/cmj.v62i2.8472; NUSEIR K, 2016, PAIN RES MANAG, DOI DOI 10.1155/2016/8432973; Pasha O, 2015, REPROD HEALTH, V12, DOI 10.1186/1742-4755-12-S2-S11; Pfitzer A, 2015, INT J GYNECOL OBSTET, V130, pS54, DOI 10.1016/j.ijgo.2015.03.008; Pleah T, 2016, GLOB HEALTH-SCI PRAC, V4, pS140, DOI 10.9745/GHSP-D-16-00039; Program Learning for Postpartum Intrauterine Contraceptive Device (PPIUCD) Integration with Maternal Health Services, 2010, PROGR EXP MULT COUNT; Rupley DM, 2015, INT J GYNECOL OBSTET, V128, P137, DOI 10.1016/j.ijgo.2014.09.010; SAYEGH J, 1976, JOHNS HOPKINS MED J, V139, P31; Sujnanendra M, 2014, J OBSTET GYN INDIA, V64, P337, DOI 10.1007/s13224-014-0550-3; Zerden ML, 2013, CONTRACEPTION, V88, P624, DOI 10.1016/j.contraception.2013.05.008	26	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0214334	10.1371/journal.pone.0214334	http://dx.doi.org/10.1371/journal.pone.0214334			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR7EH	30946759	Green Published, gold, Green Submitted			2022-12-26	WOS:000463314500028
J	Alexopoulos, AS; Jackson, GL; Edelman, D; Smith, VA; Berkowitz, TSZ; Woolson, SL; Bosworth, HB; Crowley, MJ				Alexopoulos, Anastasia-Stefania; Jackson, George L.; Edelman, David; Smith, Valerie A.; Berkowitz, Theodore S. Z.; Woolson, Sandra L.; Bosworth, Hayden B.; Crowley, Matthew J.			Clinical factors associated with persistently poor diabetes control in the Veterans Health Administration: A nationwide cohort study	PLOS ONE			English	Article							GLYCEMIC CONTROL; GLUCOSE CONTROL; CARE COSTS; TYPE-2; ADULTS; PREDICTORS; COMPLICATIONS; DEPRESSION; MANAGEMENT; ADHERENCE	Objective Patients with persistent poorly-controlled diabetes mellitus (PPDM) despite engagement in clinic-based care are at particularly high risk for diabetes complications and costs. Understanding this population's demographics, comorbidities and care utilization could guide strategies to address PPDM. We characterized factors associated with PPDM in a large sample of Veterans with type 2 diabetes. Methods We identified a cohort of Veterans with medically treated type 2 diabetes, who received Veterans Health Administration primary care during fiscal years 2012 and 2013. PPDM was defined by hemoglobin A1c levels uniformly >8.5% during fiscal year (FY) 2012, despite engagement with care during this period. We used FY 2012 demographic, comorbidity and medication data to describe PPDM in relation to better-controlled diabetes patients and created multivariable models to examine associations between clinical factors and PPDM. We also constructed multivariable models to explore the association between PPDM and FY 2013 care utilization. Results In our cohort of diabetes patients (n = 435,820), 12% met criteria for PPDM. Patients with PPDM were younger than better-controlled patients, less often married, and more often Black/African-American and Hispanic or Latino/Latina. Of included comorbidities, only retinopathy (OR 1.68, 95% confidence interval (CI): 1.63,1.73) and nephropathy (OR 1.26, 95% CI: 1.19,1.34) demonstrated clinically significant associations with PPDM. Complex insulin regimens such as premixed (OR 10.80, 95% CI: 10.11,11.54) and prandial-containing regimens (OR 18.74, 95% CI: 17.73,19.81) were strongly associated with PPDM. Patients with PPDM had higher care utilization, particularly endocrinology care (RR 3.56, 95% CI: 3.47,3.66); although only 26.4% of patients saw endocrinology overall. Conclusion PPDM is strongly associated with complex diabetes regimens, although heterogeneity in care utilization exists. While there is evidence of underutilization, inadequacy of available care may also contribute to PPDM. Our findings should inform tailored approaches to meet the needs of PPDM, who are among the highest-risk, highest-cost patients with diabetes.	[Alexopoulos, Anastasia-Stefania; Jackson, George L.; Edelman, David; Smith, Valerie A.; Berkowitz, Theodore S. Z.; Woolson, Sandra L.; Bosworth, Hayden B.; Crowley, Matthew J.] Durham Vet Affairs Hlth Care Syst, Ctr Innovat Accelerate Discovery & Practice Trans, Durham, NC 27705 USA; [Alexopoulos, Anastasia-Stefania; Crowley, Matthew J.] Duke Univ, Div Endocrinol, Durham, NC 27708 USA; [Jackson, George L.; Smith, Valerie A.; Bosworth, Hayden B.] Duke Univ, Dept Populat Hlth Sci, Durham, NC USA; [Jackson, George L.; Edelman, David; Smith, Valerie A.; Bosworth, Hayden B.] Duke Univ, Div Gen Internal Med, Durham, NC USA; [Bosworth, Hayden B.] Duke Univ, Dept Psychiat & Behav Sci, Durham, NC USA	Duke University; Duke University; Duke University; Duke University	Crowley, MJ (corresponding author), Durham Vet Affairs Hlth Care Syst, Ctr Innovat Accelerate Discovery & Practice Trans, Durham, NC 27705 USA.; Crowley, MJ (corresponding author), Duke Univ, Div Endocrinol, Durham, NC 27708 USA.	matthew.crowley@duke.edu		Smith, Valerie/0000-0001-5170-9819; Edelman, David/0000-0001-7112-6151	Veterans Health Administration (VHA) Health Services Research Development [IIR-13-063]; Durham Veterans Affairs Center of Innovation to Accelerate Discovery and Practice Transformation [CIN 13-410]; National Institutes of Health [T32DK007012]; Health Services Research & Development Senior Career Scientist Award [RCS 08-027]; Career Development Award from VHA Health Services Research Development [CDA 13-261]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007012] Funding Source: NIH RePORTER	Veterans Health Administration (VHA) Health Services Research Development; Durham Veterans Affairs Center of Innovation to Accelerate Discovery and Practice Transformation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Health Services Research & Development Senior Career Scientist Award; Career Development Award from VHA Health Services Research Development; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a grant from Veterans Health Administration (VHA) Health Services Research & Development (IIR-13-063), URL: https://www.hsrd.research.va.gov/funding/iir.cfm, and by the Durham Veterans Affairs Center of Innovation to Accelerate Discovery and Practice Transformation (CIN 13-410), URL: https://www.durham.hsrd.research.va.gov/).Research reported in this publication was also supported by the National Institutes of Health under Award Number T32DK007012 (ASA), URL: https://researchtraining.nih.gov/programs/training-grants/t32.HBB is supported by a Health Services Research & Development Senior Career Scientist Award (RCS 08-027) URL: https://www.hsrd.research.va.gov/cdp/res_career_scientist.cfm.MJC is supported by a Career Development Award from VHA Health Services Research & Development (CDA 13-261), URL: https://www.hsrd.research.va.gov/cdp/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2018, DIABETES CARE, V41, pS55, DOI 10.2337/dc18-S006; Bailey CJ, 2011, INT J CLIN PRACT, V65, P314, DOI 10.1111/j.1742-1241.2010.02544.x; Baxter M, 2016, DIABETIC MED, V33, P1575, DOI 10.1111/dme.13062; Benoit SR, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-36; Centers for Disease Control and Prevention USD of H and HS, 2017, NAT DIAB STAT REP; Control CfD, 2018, PREV DEPR AD AG 20 U; Crowley MJ, 2016, TELEMED E-HEALTH, V22, P376, DOI 10.1089/tmj.2015.0145; Crowley MJ, 2014, CHRONIC ILLN, V10, P291, DOI 10.1177/1742395314523653; Department of Veterans Affairs, 2017, VA DOD CLIN PRACT GU; Dirmaier J, 2010, PSYCHOTHER PSYCHOSOM, V79, P172, DOI 10.1159/000296135; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Egede LE, 2011, DIABETES CARE, V34, P938, DOI 10.2337/dc10-1504; Egede LE, 2011, ANN PHARMACOTHER, V45, P169, DOI 10.1345/aph.1P442; Egede LE, 2010, MED CARE, V48, P527, DOI 10.1097/MLR.0b013e3181d558dc; El-Kebbi IM, 2003, ARCH INTERN MED, V163, P69, DOI 10.1001/archinte.163.1.69; Everett CM, 2018, BMC FAM PRACT, V19, DOI 10.1186/s12875-018-0823-5; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Gilmer TP, 2005, DIABETES CARE, V28, P59, DOI 10.2337/diacare.28.1.59; Herman WH, 2007, DIABETES CARE, V30, P2453, DOI 10.2337/dc06-2003; Hertz RP, 2005, CLIN THER, V27, P1064, DOI 10.1016/j.clinthera.2005.07.009; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Jackson GL, 2018, ANN INTERN MED, V169, P825, DOI 10.7326/M17-1987; Kim S, 2007, DIABETES CARE, V30, P1281, DOI 10.2337/dc06-2070; Kim Y, 2019, J TELEMED TELECARE, V25, P587, DOI 10.1177/1357633X18782599; Kirk JK, 2006, DIABETES CARE, V29, P2130, DOI 10.2337/dc05-1973; Lynch CP, 2015, J GEN INTERN MED, V30, P25, DOI 10.1007/s11606-014-2990-y; McBrien KA, 2013, DIABETES CARE, V36, P1172, DOI 10.2337/dc12-0862; McMahon GT, 2012, DIABETES TECHNOL THE, V14, P1060, DOI 10.1089/dia.2012.0137; Miller DR, 2004, DIABETES CARE, V27, pB10, DOI 10.2337/diacare.27.suppl_2.B10; Morgan P, 2017, INQUIRY-J HEALTH CAR, V54, DOI 10.1177/0046958017712762; Nanayakkara N, 2018, DIABETIC MED, V35, P1087, DOI 10.1111/dme.13660; Nichols GA, 2000, DIABETES CARE, V23, P273, DOI 10.2337/diacare.23.3.273; Preisser JS, 2016, STAT MED, V35, P1722, DOI 10.1002/sim.6804; Reid MW, 2018, DIABETES TECHNOL THE, V20, P370, DOI 10.1089/dia.2017.0450; Richardson LK, 2008, GEN HOSP PSYCHIAT, V30, P509, DOI 10.1016/j.genhosppsych.2008.07.001; Stokes A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170219; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; WEATHERSPOON LJ, 1994, DIABETES CARE, V17, P1148, DOI 10.2337/diacare.17.10.1148; Yang WY, 2018, DIABETES CARE, V41, P917, DOI 10.2337/dci18-0007; Ziemer DC, 2010, ANN INTERN MED, V152, P770, DOI 10.7326/0003-4819-152-12-201006150-00004; Zuur Alain F., 2009, P1	42	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2019	14	3							e0214679	10.1371/journal.pone.0214679	http://dx.doi.org/10.1371/journal.pone.0214679			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HQ9FO	30925177	Green Submitted, Green Published, gold			2022-12-26	WOS:000462732300027
J	Rancourt, A; Sato, S; Satoh, MS				Rancourt, Ann; Sato, Sachiko; Satoh, Masahiko S.			Dose-dependent spatiotemporal responses of mammalian cells to an alkylating agent	PLOS ONE			English	Article							MISMATCH-REPAIR; DNA-REPAIR; HELA-CELLS; STEM-CELLS; MUTS-ALPHA; POLY(ADP-RIBOSE); O-6-METHYLGUANINE; MECHANISMS; DAMAGE; CYCLE	Cultured cell populations are composed of heterogeneous cells, and previous single-cell lineage tracking analysis of individual HeLa cells provided empirical evidence for significant heterogeneity of the rate of cell proliferation and induction of cell death. Nevertheless, such cell lines have been used for investigations of cellular responses to various substances, resulting in incomplete characterizations. This problem caused by heterogeneity within cell lines could be overcome by investigating the spatiotemporal responses of individual cells to a substance. However, no approach to investigate the responses by analyzing spatiotemporal data is currently available. Thus, this study aimed to analyze the spatiotemporal responses of individual HeLa cells to cytotoxic, sub-cytotoxic, and non-cytotoxic doses of the well-characterized carcinogen, N-methyl-N'-nitro-N-nitrosoguanidine (MNNG). Although cytotoxic doses of MNNG are known to induce cell death, the single-cell tracking approach revealed that cell death occurred following at least four different cellular events, suggesting that cell death is induced via multiple processes. We also found that HeLa cells exposed to a sub-cytotoxic dose of MNNG were in a state of equilibrium between cell proliferation and cell death, with cell death again induced through different processes. However, exposure of cells to a non-cytotoxic dose of MNNG promoted growth by reducing the cell doubling time, thus promoting the growth of a sub-population of cells. A single-cell lineage tracking approach could dissect processes leading to cell death in a spatiotemporal manner and the results suggest that spatiotemporal data obtained by tracking individual cells can be used as a new type of bioinformatics data resource that enables the examination of cellular responses to various external substances.	[Rancourt, Ann; Sato, Sachiko] Laval Univ, Fac Med, Lab Glycobiol & Bioimaging, Res Ctr Infect Dis,CHUQ, Quebec City, PQ, Canada; [Rancourt, Ann; Satoh, Masahiko S.] Laval Univ, Lab DNA Damage Responses & Bioimaging, CHUQ, Fac Med, Quebec City, PQ, Canada	Laval University; Laval University	Satoh, MS (corresponding author), Laval Univ, Lab DNA Damage Responses & Bioimaging, CHUQ, Fac Med, Quebec City, PQ, Canada.	masahiko.sato@crchudequebec.ulaval.ca			Canadian Foundation for Innovation [MSS 20155, SS 20155]	Canadian Foundation for Innovation(Canada Foundation for Innovation)	Funded by MSS 20155 Canadian Foundation for Innovation https://www.innovation.ca.SS 20155 Canadian Foundation for Innovation https://www.innovation.ca.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burkle A, 2001, BIOESSAYS, V23, P795, DOI 10.1002/bies.1115; Chaudhuri AR, 2017, NAT REV MOL CELL BIO, V18, P610, DOI 10.1038/nrm.2017.53; CHOPRA DP, 1976, J NATL CANCER I, V56, P583, DOI 10.1093/jnci/56.3.583; CHOPRA DP, 1977, J NATL CANCER I, V58, P923, DOI 10.1093/jnci/58.4.923; Drablos F, 2004, DNA REPAIR, V3, P1389, DOI 10.1016/j.dnarep.2004.05.004; Duckett DR, 1996, P NATL ACAD SCI USA, V93, P6443, DOI 10.1073/pnas.93.13.6443; Duckett DR, 1999, P NATL ACAD SCI USA, V96, P12384, DOI 10.1073/pnas.96.22.12384; EADIE JS, 1984, NATURE, V308, P201, DOI 10.1038/308201a0; Friedman HS, 2000, CLIN CANCER RES, V6, P2585; Galluzzi L, 2018, CELL DEATH DIFFER, V25, P486, DOI 10.1038/s41418-017-0012-4; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Guo SQ, 2014, CELL, V156, P649, DOI 10.1016/j.cell.2014.01.020; HAWN MT, 1995, CANCER RES, V55, P3721; Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794; Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907; Kubota Y, 1996, EMBO J, V15, P6662, DOI 10.1002/j.1460-2075.1996.tb01056.x; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; LINDAHL T, 1995, TRENDS BIOCHEM SCI, V20, P405, DOI 10.1016/S0968-0004(00)89089-1; Luo X, 2012, GENE DEV, V26, P417, DOI 10.1101/gad.183509.111; Mojas N, 2007, GENE DEV, V21, P3342, DOI 10.1101/gad.455407; MYRNES B, 1982, J CELL BIOCHEM, V20, P381, DOI 10.1002/jcb.240200408; Rancourt A, BIORXIV, DOI [10.1101/319525, DOI 10.1101/319525]; ROBERTS DC, 1970, INT J CANCER, V5, P238, DOI 10.1002/ijc.2910050211; Sato S, 2016, SCI REP-UK, V6, DOI 10.1038/srep23328; SATOH MS, 1992, NATURE, V356, P356, DOI 10.1038/356356a0; Schroering AG, 2007, EXP CELL RES, V313, P292, DOI 10.1016/j.yexcr.2006.10.018; Schroering AG, 2009, CANCER RES, V69, P6307, DOI 10.1158/0008-5472.CAN-09-0899; Sedgwick B, 2007, DNA REPAIR, V6, P429, DOI 10.1016/j.dnarep.2006.10.005; Shi QH, 2005, NATURE, V437, P1038, DOI 10.1038/nature03958; SINGER B, 1968, SCIENCE, V160, P1235, DOI 10.1126/science.160.3833.1235; SMITH GJ, 1983, MUTAT RES, V111, P405, DOI 10.1016/0027-5107(83)90036-2; Stojic L, 2004, GENE DEV, V18, P1331, DOI 10.1101/gad.294404; Strauss B, 1975, Basic Life Sci, V5A, P13; Tominaga Y, 1997, CARCINOGENESIS, V18, P889, DOI 10.1093/carcin/18.5.889; Wang Y, 2003, P NATL ACAD SCI USA, V100, P15387, DOI 10.1073/pnas.2536810100; Yang GZ, 2004, CANCER CELL, V6, P139, DOI 10.1016/j.ccr.2004.06.024; York SJ, 2006, J BIOL CHEM, V281, P22674, DOI 10.1074/jbc.M603667200; Yoshioka K, 2006, MOL CELL, V22, P501, DOI 10.1016/j.molcel.2006.04.023; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; ZHUKOVSKAYA N, 1994, CARCINOGENESIS, V15, P2189, DOI 10.1093/carcin/15.10.2189; [No title captured]	41	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2019	14	3							e0214512	10.1371/journal.pone.0214512	http://dx.doi.org/10.1371/journal.pone.0214512			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ9FO	30925183	Green Submitted, Green Published, gold			2022-12-26	WOS:000462732300016
J	Rhee, SG				Rhee, Sue Goo			A catalytic career: Studies spanning glutamine synthetase, phospholipase C, peroxiredoxin, and the intracellular messenger role of hydrogen peroxide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Biographical-Item						glutamine synthase; phospholipase C; peroxiredoxin; peroxidase; hydrogen peroxide; receptor signaling	CYSTEINE-SULFINIC ACID; PROTEIN-TYROSINE PHOSPHATASES; THIOL-SPECIFIC ANTIOXIDANT; REVERSIBLE OXIDATION; CRYSTAL-STRUCTURE; INACTIVATION; ENZYME; CLONING; SEQUENCE; H2O2	I learned biochemistry from P. Boon Chock and Earl Stadtman while working on the regulation of Escherichia coli glutamine synthetase as a postdoctoral fellow at the National Institutes of Health. After becoming a tenured scientist at the same institute, my group discovered, purified, and cloned the first three prototypical members of the phospholipase C family and uncovered the mechanisms by which various cell-surface receptors activate these enzymes to generate diacylglycerol and inositol 1,4,5-trisphosphate. We also discovered the family of peroxiredoxin (Prx) enzymes that catalyze the reduction of H2O2, and we established that mammalian cells express six Prx isoforms that not only protect against oxidative damage but also mediate cell signaling by modulating intracellular H2O2 levels. To validate the signaling role of H2O2, we showed that epidermal growth factor induces a transient increase in intracellular H2O2 levels, and the essential cysteine residue of protein-tyrosine phosphatases is a target for specific and reversible oxidation by the H2O2 produced in such cells. These observations led to a new paradigm in receptor signaling, in which protein tyrosine phosphorylation is achieved not via activation of receptor tyrosine kinases alone but also through concurrent inhibition of protein-tyrosine phosphatases by H2O2. Our studies revealed that Prx isozymes are extensively regulated via phosphorylation as well as by hyperoxidation of the active-site cysteine to cysteine sulfinic acid, with the reverse reaction being catalyzed by sulfiredoxin. This reversible hyperoxidation of Prx was further shown to constitute a universal marker for circadian rhythms in all domains of life.	[Rhee, Sue Goo] Yonsei Univ, Coll Med, Yonsei Biomed Res Inst, Seoul 120752, South Korea; [Rhee, Sue Goo] NHLBI, Biochem & Biophys Ctr, NIH, Bethesda, MD 20892 USA	Yonsei University; Yonsei University Health System; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Rhee, SG (corresponding author), Yonsei Univ, Coll Med, Yonsei Biomed Res Inst, Seoul 120752, South Korea.; Rhee, SG (corresponding author), NHLBI, Biochem & Biophys Ctr, NIH, Bethesda, MD 20892 USA.				Korean Science and Engineering Foundation	Korean Science and Engineering Foundation(Korea Science and Engineering Foundation)	I am grateful to the postdoctoral fellows and visiting scientists who graced my laboratory while I was at the NHLBI, National Institutes of Health, and to technicians, graduate students, and postdoctoral fellows who made invaluable contributions to my research programs at Ewha Womans University and Yonsei University School of Medicine in Korea. My research program in Korea had been supported by grants from the Korean Science and Engineering Foundation (National Honor Scientist Program Grant and BioR&D Program Grant). I especially thank the Journal of Biological Chemistry, a journal in which over 80 publications of my work have been published and in which one of our early works on peroxiredoxin (20) was featured as a JBC Classic, for inviting me to write this Reflections.	Bae YS, 1997, J BIOL CHEM, V272, P217, DOI 10.1074/jbc.272.1.217; BENNETT CF, 1988, NATURE, V334, P268, DOI 10.1038/334268a0; BERRIDGE MJ, 1984, NATURE, V312, P315, DOI 10.1038/312315a0; Biteau B, 2003, NATURE, V425, P980, DOI 10.1038/nature02075; BROWN MS, 1971, P NATL ACAD SCI USA, V68, P2949, DOI 10.1073/pnas.68.12.2949; CHAE HZ, 1993, J BIOL CHEM, V268, P16815; CHAE HZ, 1994, P NATL ACAD SCI USA, V91, P7017, DOI 10.1073/pnas.91.15.7017; CHAE HZ, 1994, J BIOL CHEM, V269, P27670; Chang TS, 2002, J BIOL CHEM, V277, P25370, DOI 10.1074/jbc.M110432200; Cho CS, 2014, P NATL ACAD SCI USA, V111, P12043, DOI 10.1073/pnas.1401100111; Choi HJ, 1998, NAT STRUCT BIOL, V5, P400, DOI 10.1038/nsb0598-400; FISCHER EH, 1991, SCIENCE, V253, P401, DOI 10.1126/science.1650499; GARCIA E, 1983, J BIOL CHEM, V258, P2246; GILMAN AG, 1984, CELL, V36, P577, DOI 10.1016/0092-8674(84)90336-2; GRIENDLING KK, 1994, CIRC RES, V74, P1141, DOI 10.1161/01.RES.74.6.1141; Hirotsu S, 1999, P NATL ACAD SCI USA, V96, P12333, DOI 10.1073/pnas.96.22.12333; Jang HH, 2004, CELL, V117, P625, DOI 10.1016/j.cell.2004.05.002; Jarvis RM, 2012, FREE RADICAL BIO MED, V53, P1522, DOI 10.1016/j.freeradbiomed.2012.08.001; Kang SW, 1998, J BIOL CHEM, V273, P6297, DOI 10.1074/jbc.273.11.6297; Karplus PA, 2015, FREE RADICAL BIO MED, V80, P183, DOI 10.1016/j.freeradbiomed.2014.10.009; Kil IS, 2015, MOL CELL, V59, P651, DOI 10.1016/j.molcel.2015.06.031; KIM HK, 1991, CELL, V65, P435, DOI 10.1016/0092-8674(91)90461-7; KIM KW, 1988, J BIOL CHEM, V263, P4704; KINGDON HS, 1967, P NATL ACAD SCI USA, V58, P1703, DOI 10.1073/pnas.58.4.1703; Kwon J, 2004, P NATL ACAD SCI USA, V101, P16419, DOI 10.1073/pnas.0407396101; Lee SR, 1998, J BIOL CHEM, V273, P15366, DOI 10.1074/jbc.273.25.15366; LEVINE RL, 1981, P NATL ACAD SCI-BIOL, V78, P2120, DOI 10.1073/pnas.78.4.2120; Lim JM, 2015, J CELL BIOL, V210, P23, DOI 10.1083/jcb.201412068; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; Miseta A, 2000, MOL BIOL EVOL, V17, P1232, DOI 10.1093/oxfordjournals.molbev.a026406; NISHIZUKA Y, 1984, NATURE, V308, P693, DOI 10.1038/308693a0; O'Neill JS, 2011, NATURE, V469, P498, DOI 10.1038/nature09702; O'Neill JS, 2011, NATURE, V469, P554, DOI 10.1038/nature09654; Poole LB, 2015, FREE RADICAL BIO MED, V80, P148, DOI 10.1016/j.freeradbiomed.2014.11.013; Rhee S G, 2000, Sci STKE, V2000, ppe1; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; RHEE SG, 1978, P NATL ACAD SCI USA, V75, P3138, DOI 10.1073/pnas.75.7.3138; Rhee SG, 2018, ANTIOXID REDOX SIGN, V28, P537, DOI 10.1089/ars.2017.7167; Rhee SG, 2017, ANNU REV BIOCHEM, V86, P749, DOI 10.1146/annurev-biochem-060815-014431; Rhee SG, 2011, ANTIOXID REDOX SIGN, V15, P781, DOI 10.1089/ars.2010.3393; RYU SH, 1987, P NATL ACAD SCI USA, V84, P6649, DOI 10.1073/pnas.84.19.6649; SHAPIRO BM, 1967, P NATL ACAD SCI USA, V58, P642, DOI 10.1073/pnas.58.2.642; Sobotta MC, 2015, NAT CHEM BIOL, V11, P64, DOI 10.1038/nchembio.1695; Stadtman ER, 2001, J BIOL CHEM, V276, P44357, DOI 10.1074/jbc.R100055200; SUH PG, 1988, CELL, V54, P161, DOI 10.1016/0092-8674(88)90548-X; SUH PG, 1988, P NATL ACAD SCI USA, V85, P5419, DOI 10.1073/pnas.85.15.5419; Suh YA, 1999, NATURE, V401, P79, DOI 10.1038/43459; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; TAYLOR GD, 1992, BIOCHEM BIOPH RES CO, V188, P1176, DOI 10.1016/0006-291X(92)91355-T; Woo HA, 2005, J BIOL CHEM, V280, P3125, DOI 10.1074/jbc.C400496200; Woo HA, 2003, SCIENCE, V300, P653, DOI 10.1126/science.1080273; Woo HA, 2010, CELL, V140, P517, DOI 10.1016/j.cell.2010.01.009; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405; Yang KS, 2002, J BIOL CHEM, V277, P38029, DOI 10.1074/jbc.M206626200	54	2	2	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2019	294	13					5169	5180		10.1074/jbc.X119.007975	http://dx.doi.org/10.1074/jbc.X119.007975			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HS6MI	30926755	Green Published, hybrid			2022-12-26	WOS:000463985600037
J	Chen, L; Zhao, X				Chen, Long; Zhao, Xia			Characterization of air flow and lung function in the pulmonary acinus by fluid-structure interaction in idiopathic interstitial pneumonias	PLOS ONE			English	Article							FUNCTION TESTS; CLASSIFICATION; FIBROSIS; MOTION; DIAGNOSIS; DISEASE; UPDATE; MODELS	Background and objective The idiopathic interstitial pneumonias (IIPs) are diffuse parenchymal lung disorders that are associated with substantial morbidity and mortality. Early diagnosis and disease stratification of IIP patients are important because these are related with the treatment and prognosis. Idiopathic pulmonary fibrosis (IPF) and nonspecific interstitial pneumonia (NSIP) are two major distinctive pathologic patterns of pulmonary fibrosis. We researched the application of the fluid-structure interaction (FSI) to the respiratory system and compared the pulmonary acinus mechanics and functions in healthy and IIP models. Methods The human pulmonary alveolus is idealized by a three-dimensional honeycomb-like geometry, and a fluid-structure interaction analysis is performed to study the normal and diseased breathing mechanics. The computational domain consists of two generations of alveolar ducts within the pulmonary acinus, with alveolar geometries approximated as closely packed 14-sided polygons. Findings In a normal breathing cycle, the flow rate of the healthy model is significantly larger than that of the NSIP and IPF models. Similar trends are observed for the volume change and the maximum pressure drop. The flow rate and the volume change of the NSIP are almost the same as those of IPF. The maximum pressure drop of NSIP is 5.5% larger than that of IPF. There is a 47% decrease in the pulmonary acinus compliance for the NSIP and IPF compared with that of the healthy model. The acinus resistances of NSIP and IPF are higher than those of the healthy lung by 6.4 similar to 11.2%. In particular, the pulmonary acinus resistance of the NSIP lung is higher than that of the IPF lung by 4.5%. Conclusions Our study demonstrates the differences of air flow and lung function in the pulmonary acinus between the healthy and the IIP models. These changes in the lung are important considerations for early diagnosis and disease stratification in patients. Patient-based geometry can to be included in the computational models in future studies.	[Chen, Long] Nanjing Univ Aeronaut & Astronaut, Coll Aerosp Engn, Nanjing, Jiangsu, Peoples R China; [Zhao, Xia] Nanjing Univ Chinese Med, Dept Rheumatol, Affiliated Hosp, Nanjing, Jiangsu, Peoples R China	Nanjing University of Aeronautics & Astronautics; Nanjing University of Chinese Medicine	Zhao, X (corresponding author), Nanjing Univ Chinese Med, Dept Rheumatol, Affiliated Hosp, Nanjing, Jiangsu, Peoples R China.	zhaoxia31600906@sina.com			Cultivation Project of Jiangsu Province Hospital of Traditional Chinese Medicine [Y17006]	Cultivation Project of Jiangsu Province Hospital of Traditional Chinese Medicine	This work was supported by the Cultivation Project of Jiangsu Province Hospital of Traditional Chinese Medicine (Grant No. Y17006).	Aghasafari P, 2019, J GERONTOL A-BIOL, V74, P139, DOI 10.1093/gerona/gly097; Bavo AM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154517; Benito S, 1991, PULMONARY COMPLIANCE, V13, P86; Brusasco V, 1986, CLIN TESTS RESP FUNC; Bungartz H.-J., 2006, LECT NOTES COMPUTATI, V53; CHERNIACK RM, 1995, AM J RESP CRIT CARE, V151, P1180; Cottin V, 2017, AM J RESP CRIT CARE, V196, P1162, DOI 10.1164/rccm.201612-2492OC; Dailey HL, 2007, J AEROSOL SCI, V38, P269, DOI 10.1016/j.jaerosci.2007.01.001; Dempsey TM, 2018, MAYO CLIN PROC, V93, P763, DOI 10.1016/j.mayocp.2018.04.009; Denny E, 1997, J BIOMECH ENG-T ASME, V119, P289, DOI 10.1115/1.2796093; Domino S, 2015, SANDIA NATL LAB SAND; Dutta A, 2018, J BIOMECH ENG-T ASME, V140, DOI 10.1115/1.4039680; Edwards HC, 2010, SANDIA NATL LAB SAND; Fernandez E, 1985, Adv Psychosom Med, V14, P149; FUNG YC, 1988, J APPL PHYSIOL, V64, P2132, DOI 10.1152/jappl.1988.64.5.2132; HAEFELIBLEUER B, 1988, ANAT RECORD, V220, P401, DOI 10.1002/ar.1092200410; Harris R Scott, 2005, Respir Care, V50, P78; HEISTRACHER T, 1995, J AEROSOL SCI, V26, P497, DOI 10.1016/0021-8502(94)00113-D; Heroux M, 2003, SANDIA NATL LAB SAND; Hofemeier P, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4027328; Hutchinson JP, 2016, EUR RESPIR J, V48, P1453, DOI 10.1183/13993003.00378-2016; Katzenstein ALA, 2000, AM J SURG PATHOL, V24, P1, DOI 10.1097/00000478-200001000-00001; Kim JongWon, 2017, Med Sci (Basel), V5, DOI 10.3390/medsci5040021; Kim J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183654; King TE, 2014, NEW ENGL J MED, V370, P2083, DOI 10.1056/NEJMoa1402582; Kolanjiyil AV, 2017, J AEROSOL SCI, V114, P301, DOI 10.1016/j.jaerosci.2017.10.001; Koshiyama K, 2019, CLIN BIOMECH, V66, P32, DOI 10.1016/j.clinbiomech.2018.01.001; Lai-Fook SJ, 2000, J APPL PHYSIOL, V89, P163, DOI 10.1152/jappl.2000.89.1.163; Li XYS, 2003, ACM T MATH SOFTWARE, V29, P110, DOI 10.1145/779359.779361; Montaudon M, 2007, J ANAT, V211, P579, DOI 10.1111/j.1469-7580.2007.00811.x; Neder JA, 1999, BRAZ J MED BIOL RES, V32, P703, DOI 10.1590/S0100-879X1999000600006; Oakes JM, 2016, J BIOMECH, V49, P2213, DOI 10.1016/j.jbiomech.2015.11.026; Oakes JM, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4000870; Ostrovski Y, 2016, INT J NANOMED, V11, P3385, DOI 10.2147/IJN.S102138; Politi AZ, 2010, J THEOR BIOL, V266, P614, DOI 10.1016/j.jtbi.2010.07.032; Raghu G, 2012, NEW ENGL J MED, V366, P1968, DOI 10.1056/NEJMoa1113354; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Rendall TCS, 2009, J COMPUT PHYS, V228, P6231, DOI 10.1016/j.jcp.2009.05.013; Richeldi L, 2014, NEW ENGL J MED, V370, P2071, DOI 10.1056/NEJMoa1402584; Saad SMI, 2010, COLLOID SURFACE A, V354, P34, DOI 10.1016/j.colsurfa.2009.07.046; Salvatore M, 2018, CLIN IMAG, V51, P332, DOI 10.1016/j.clinimag.2018.06.013; Smith ML, 2016, ARCH PATHOL LAB MED, V140, P221, DOI 10.5858/arpa.2015-0288-SA; Sud A, 2001, CLIN RHEUMATOL, V20, P177, DOI 10.1007/s100670170060; Sverzellati N, 2015, RADIOGRAPHICS, V35, P1849, DOI 10.1148/rg.2015140334; Sznitman J, 2007, J BIOMECH ENG-T ASME, V129, P658, DOI 10.1115/1.2768109; Tehrani JN, 2015, PHYS MED BIOL, V60, P8833, DOI 10.1088/0031-9155/60/22/8833; Travis WD, 2000, AM J SURG PATHOL, V24, P19, DOI 10.1097/00000478-200001000-00003; Travis WD, 2013, AM J RESP CRIT CARE, V188, P733, DOI 10.1164/rccm.201308-1483ST; West J.B., 2012, RESP PHYSL ESSENTIAL; Xia GH, 2010, ANN BIOMED ENG, V38, P1836, DOI 10.1007/s10439-010-9956-y; YEH HC, 1980, B MATH BIOL, V42, P461, DOI 10.1007/BF02460796; Zienkiewicz OC, 2005, FINITE ELEMENT METHOD FOR FLUID DYNAMICS, 6TH EDITION, P1	52	5	5	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214441	10.1371/journal.pone.0214441	http://dx.doi.org/10.1371/journal.pone.0214441			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921412	Green Submitted, Green Published, gold			2022-12-26	WOS:000462594000069
J	Derbyshire, MC; Denton-Giles, M; Hane, JK; Chang, S; Mousavi-Derazmahalleh, M; Raffaele, S; Buchwaldt, L; Kamphuis, LG				Derbyshire, Mark Charles; Denton-Giles, Matthew; Hane, James K.; Chang, Steven; Mousavi-Derazmahalleh, Mahsa; Raffaele, Sylvain; Buchwaldt, Lone; Kamphuis, Lars G.			A whole genome scan of SNP data suggests a lack of abundant hard selective sweeps in the genome of the broad host range plant pathogenic fungus Sclerotinia sclerotiorum	PLOS ONE			English	Article							RECENT POSITIVE SELECTION; FUNGICIDE RESISTANCE; POPULATIONS; EVOLUTION; SEQUENCE; RECOMBINATION; ADAPTATION; ALIGNMENT; PROGRAM; GENE	The pathogenic fungus Sclerotinia sclerotiorum infects over 600 species of plant. It is present in numerous environments throughout the world and causes significant damage to many agricultural crops. Fragmentation and lack of gene flow between populations may lead to population sub-structure. Within discrete recombining populations, positive selection may lead to a 'selective sweep'. This is characterised by an increase in frequency of a favourable allele leading to reduction in genotypic diversity in a localised genomic region due to the phenomenon of genetic hitchhiking. We aimed to assess whether isolates of S. sclerotiorum from around the world formed genotypic clusters associated with geographical origin and to determine whether signatures of population-specific positive selection could be detected. To do this, we sequenced the genomes of 25 isolates of S. sclerotiorum collected from four different continents-Australia, Africa (north and south), Europe and North America (Canada and the northen United States) and conducted SNP based analyses of population structure and selective sweeps. Among the 25 isolates, there was evidence for two major population clusters. One of these consisted of 11 isolates from Canada, the USA and France (population 1), and the other consisted of nine isolates from Australia and one from Morocco (population 2). The rest of the isolates were genotypic outliers. We found that there was evidence of outcrossing in these two populations based on linkage disequilibrium decay. However, only a single candidate selective sweep was observed, and it was present in population 2. This sweep was close to a Major Facilitator Superfamily transporter gene, and we speculate that this gene may have a role in nutrient uptake from the host. The low abundance of selective sweeps in the S. sclerotiorum genome contrasts the numerous examples in the genomes of other fungal pathogens. This may be a result of its slow rate of evolution and low effective recombination rate due to self-fertilisation and vegetative reproduction.	[Derbyshire, Mark Charles; Denton-Giles, Matthew; Hane, James K.; Chang, Steven; Mousavi-Derazmahalleh, Mahsa; Kamphuis, Lars G.] Curtin Univ, Ctr Crop & Dis Management, Perth, WA, Australia; [Mousavi-Derazmahalleh, Mahsa] Univ Western Australia, UWA Sch Agr & Environm, Perth, WA, Australia; [Raffaele, Sylvain] Univ Toulouse, Lab Interact Plantes Microorganismes LIPM, Toulouse, France; [Buchwaldt, Lone] Saskatoon Res & Dev Ctr, Agr & Agri Food Canada, Saskatoon, SK, Canada	Curtin University; University of Western Australia; Universite de Toulouse; Agriculture & Agri Food Canada	Derbyshire, MC (corresponding author), Curtin Univ, Ctr Crop & Dis Management, Perth, WA, Australia.	mark.derbyshire@curtin.edu.au	Kamphuis, Lars/GVU-9293-2022; Mousavi-Derazmahalleh, Mahsa/AAH-3001-2020; Kamphuis, Lars G/B-5360-2011; Kamphuis, Lars/X-3458-2019; Hane, James/A-7062-2011; Raffaele, Sylvain/K-6673-2019	Kamphuis, Lars G/0000-0002-9042-0513; Kamphuis, Lars/0000-0002-9042-0513; Hane, James/0000-0002-7651-0977; Raffaele, Sylvain/0000-0002-2442-9632; Denton-Giles, Matthew/0000-0001-8953-871X; Mousavi-Derazmahalleh, Mahsa/0000-0002-2299-2050; Derbyshire, Mark/0000-0001-5302-9868	Grains Research and Development Corporation of (GRDC) Australia [CUR00023]; Centre for Crop and Disease Management in Curtin University [CUR00023]; GRDC; European Research Council [ERC StG 336808]; French Laboratory of Excellence project TULIP [ANR 10 LABX 41, ANR 11 IDEX 0002 02]; Curtin University	Grains Research and Development Corporation of (GRDC) Australia(Grains R&D Corp); Centre for Crop and Disease Management in Curtin University; GRDC; European Research Council(European Research Council (ERC)European Commission); French Laboratory of Excellence project TULIP; Curtin University	MCD, MD-G and LGK are funded through a bilateral agreement between the Grains Research and Development Corporation of (GRDC) Australia and the Centre for Crop and Disease Management in Curtin University on grant number CUR00023. Steven Chang and James K Hane are also funded by the GRDC through a bilateral agreement with the Curtin University. The GRDC had no role in developing this study. SR is supported by a starting grant of the European Research Council (ERC StG 336808) and the French Laboratory of Excellence project TULIP (ANR 10 LABX 41; ANR 11 IDEX 0002 02). Neither of these funding bodies had any role in developing this study.	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Andrew M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029943; Attanayake RN, 2014, HEREDITY, V113, P353, DOI 10.1038/hdy.2014.37; Auton A, 2007, GENOME RES, V17, P1219, DOI 10.1101/gr.6386707; Badet T, 2017, ELIFE, V6, DOI 10.7554/eLife.22472; Badouin H, 2017, MOL ECOL, V26, P2041, DOI 10.1111/mec.13976; Bandyopadhyay B, 1999, ANN NY ACAD SCI, V894, P28, DOI 10.1111/j.1749-6632.1999.tb08040.x; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Burdon JJ, 2016, PHYTOPATHOLOGY, V106, P1117, DOI 10.1094/PHYTO-01-16-0036-FI; Carbone I, 2001, MOL ECOL, V10, P2409, DOI 10.1046/j.0962-1083.2001.01380.x; Carbone I, 2001, MOL ECOL, V10, P947, DOI 10.1046/j.1365-294X.2001.01244.x; Carpenter MA, 1999, NEW ZEAL J CROP HORT, V27, P13, DOI 10.1080/01140671.1999.9514075; Chen WJ, 2007, APPL ENVIRON MICROB, V73, P5162, DOI 10.1128/AEM.00507-07; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Clarkson JP, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00490; Coil D, 2015, BIOINFORMATICS, V31, P587, DOI 10.1093/bioinformatics/btu661; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Delmas CEL, 2017, MOL ECOL, V26, P1936, DOI 10.1111/mec.14006; Derbyshire MC, 2016, PLANT PATHOL, V65, P859, DOI 10.1111/ppa.12517; Derbyshire M, 2017, GENOME BIOL EVOL, V9, P593, DOI 10.1093/gbe/evx030; dos Santos SC, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00180; Ewing G, 2010, BIOINFORMATICS, V26, P2064, DOI 10.1093/bioinformatics/btq322; Fabre F, 2015, EVOL APPL, V8, P919, DOI 10.1111/eva.12304; Grimmer MK, 2015, PEST MANAG SCI, V71, P207, DOI 10.1002/ps.3781; Guindon S, 2009, METHODS MOL BIOL, V537, P113, DOI 10.1007/978-1-59745-251-9_6; Gutenkunst RN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000695; Haasl RJ, 2016, MOL ECOL, V25, P5, DOI 10.1111/mec.13339; Hartmann FE, 2018, MOL ECOL, V27, P2725, DOI 10.1111/mec.14711; Haubold B, 2015, BIOINFORMATICS, V31, P1169, DOI 10.1093/bioinformatics/btu815; Hayes LE, 2016, PLANT DIS, V100, P483, DOI 10.1094/PDIS-02-15-0214-RE; Heick TM, 2017, EUR J PLANT PATHOL, V149, P669, DOI 10.1007/s10658-017-1216-7; Hermisson J, 2005, GENETICS, V169, P2335, DOI 10.1534/genetics.104.036947; Huson DH, 1998, BIOINFORMATICS, V14, P68, DOI 10.1093/bioinformatics/14.1.68; Kamvar ZN, 2017, PEERJ, V5, DOI 10.7717/peerj.4152; Keane TM, 2013, BIOINFORMATICS, V29, P389, DOI 10.1093/bioinformatics/bts697; Kottek M, 2006, METEOROL Z, V15, P259, DOI 10.1127/0941-2948/2006/0130; Leggett Richard M., 2013, Frontiers in Genetics, V4, P288, DOI 10.3389/fgene.2013.00288; Lehner MS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173915; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Long HG, 2016, GENOME BIOL EVOL, V8, P3815, DOI 10.1093/gbe/evw286; Lunter G, 2011, GENOME RES, V21, P936, DOI 10.1101/gr.111120.110; Malvarez G, 2007, PHYTOPATHOLOGY, V97, P470, DOI 10.1094/PHYTO-97-4-0470; Maude RB, 1997, PLANT PATHOGENS WORL, V34, P109; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Messer PW, 2013, TRENDS ECOL EVOL, V28, P659, DOI 10.1016/j.tree.2013.08.003; Mohd-Assaad N, 2018, GENOME BIOL EVOL, V10, P1315, DOI 10.1093/gbe/evy087; Nielsen R, 2005, GENOME RES, V15, P1566, DOI 10.1101/gr.4252305; Ondov BD, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0997-x; Paul S, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00143; Pavlidis P, 2017, J BIOL RES-THESSALON, V24, DOI 10.1186/s40709-017-0064-0; Pavlidis P, 2013, MOL BIOL EVOL, V30, P2224, DOI 10.1093/molbev/mst112; Pereira MF, 2013, J MICROBIOL, V51, P70, DOI 10.1007/s12275-013-2393-5; Pickrell JK, 2009, GENOME RES, V19, P826, DOI 10.1101/gr.087577.108; Pool JE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003080; Porebski S, 1997, PLANT MOL BIOL REP, V15, P8, DOI 10.1007/BF02772108; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rollins JA, 2003, MOL PLANT MICROBE IN, V16, P785, DOI 10.1094/MPMI.2003.16.9.785; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Sun JM, 2005, J INTEGR PLANT BIOL, V47, P385, DOI 10.1111/j.1744-7909.2005.00077.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Williamson SH, 2007, PLOS GENET, V3, P901, DOI 10.1371/journal.pgen.0030090	67	14	14	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214201	10.1371/journal.pone.0214201	http://dx.doi.org/10.1371/journal.pone.0214201			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921376	gold, Green Published, Green Submitted			2022-12-26	WOS:000462594000040
J	Sidhu, JS; Ramakrishnan, SM; Ali, S; Bernardo, A; Bai, GH; Abdullah, S; Ayana, G; Sehgal, SK				Sidhu, Jagdeep Singh; Ramakrishnan, Sai Mukund; Ali, Shaukat; Bernardo, Amy; Bai, Guihua; Abdullah, Sidrat; Ayana, Girma; Sehgal, Sunish K.			Assessing the genetic diversity and characterizing genomic regions conferring Tan Spot resistance in cultivated rye	PLOS ONE			English	Article							SECALE-CEREALE L.; WIDE ASSOCIATION; PHYLOGENETIC-RELATIONSHIPS; CORE COLLECTION; WHEAT; TRAITS; MARKER; ESTABLISHMENT; INFORMATION; COMPONENTS	Rye (Secale cereale L.) is known for its wide adaptation due to its ability to tolerate harsh environments in semiarid areas. To assess the diversity in rye we genotyped a panel of 178 geographically diverse accessions of four Secale sp. from U.S. National Small Grains Collection using 4,037 high-quality SNPs (single nucleotide polymorphisms) developed by genotyping-by-sequencing (GBS). PCA and STRUCTURE analysis revealed three major clusters that separate S. cereale L. from S. strictum and S. sylvestre, however, genetic clusters did not correlate with geographic origins and growth habit (spring/winter). The panel was evaluated for response to Pyrenophora tritici-repentis race 5 (PTR race 5) and nearly 59% accessions showed resistance or moderate resistance. Genome-wide association study (GWAS) was performed on S. cereale subsp. cereale using the 4,037 high-quality SNPs. Two QTLs (QTs.sdsu-5R and QTs.sdsu-2R) on chromosomes 5R and 2R were identified conferring resistance to PTR race 5 (p < 0.001) that explained 13.1% and 11.6% of the phenotypic variation, respectively. Comparative analysis showed a high degree of synteny between rye and wheat with known rearrangements as expected. QTs.sdsu-2R was mapped in the genomic region corresponding to wheat chromosome group 2 and QTs. sdsu-5R was mapped to a small terminal region on chromosome 4BL. Based on the genetic diversity, a set of 32 accessions was identified to represents more than 99% of the allelic diversity with polymorphic information content (PIC) of 0.25. This set can be utilized for genetic characterization of useful traits and genetic improvement of rye, triticale, and wheat.	[Sidhu, Jagdeep Singh; Ramakrishnan, Sai Mukund; Ali, Shaukat; Abdullah, Sidrat; Ayana, Girma; Sehgal, Sunish K.] South Dakota State Univ, Dept Agron Hort & Plant Sci, Brookings, SD 57007 USA; [Bernardo, Amy] Kansas State Univ, Dept Plant Pathol, Throckmorton Hall, Manhattan, KS 66506 USA; [Bai, Guihua] USDA ARS, Hard Winter Wheat Genet Res Unit, Manhattan, KS USA	South Dakota State University; Kansas State University; United States Department of Agriculture (USDA)	Sehgal, SK (corresponding author), South Dakota State Univ, Dept Agron Hort & Plant Sci, Brookings, SD 57007 USA.	sunish.sehgal@sdstate.edu		SEHGAL, SUNISH/0000-0001-5644-7547	USDA hatch project [SD00H538-15]; USDA-CAP [2016-68004-24768]; South Dakota Wheat Commission [3X7262, 3X8258]	USDA hatch project; USDA-CAP; South Dakota Wheat Commission	This project was collectively funded by the USDA hatch project SD00H538-15, USDA-CAP 2016-68004-24768 and South Dakota Wheat Commission 3X7262 and 3X8258. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah S, 2017, PLANT PATHOLOGY J, V33, P229, DOI 10.5423/PPJ.OA.12.2016.0265; Ahmad I., 2017, WHEAT IMPROVEMENT MA, P39, DOI [10.5772/67242, DOI 10.5772/67242]; Ain QU, 2015, FRONT PLANT SCI, V6, DOI [10.3389/fpls.7015.00743, 10.3389/fpls.2015.00743]; Alheit KV, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-235; Alipour H, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01293; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ammar K., 2004, TRITICALE IMPROVEMEN, P1; Andersson R, 2009, J AGR FOOD CHEM, V57, P2004, DOI 10.1021/jf801280f; Appels R, 2018, SCIENCE, V361, P661, DOI 10.1126/science.aar7191; Arruda MP, 2016, PLANT GENOME-US, V9, DOI 10.3835/plantgenome2015.04.0028; Ayana GT, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00926; Bartos J, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-95; Bauer E, 2017, PLANT J, V89, P853, DOI 10.1111/tpj.13436; Bellucci A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173313; Belo A, 2008, MOL GENET GENOMICS, V279, P1, DOI 10.1007/s00438-007-0289-y; Bolibok H, 2005, EUPHYTICA, V146, P109, DOI 10.1007/s10681-005-0548-0; Bolibok-Bragoszewska H, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-184; Bolibok-Bragoszewska H, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-578; Borner A, 2000, EUPHYTICA, V116, P203, DOI 10.1023/A:1004052505692; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Burger JC, 2006, MOL ECOL, V15, P2527, DOI 10.1111/j.1365-294X.2006.02938.x; Bushuk W, 2001, CEREAL FOOD WORLD, V46, P70; CARVER BF, 1994, CROP SCI, V34, P1505, DOI 10.2135/cropsci1994.0011183X003400060017x; Chao SM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-727; Chen J, 2016, G3-GENES GENOM GENET, V6, P3803, DOI 10.1534/g3.116.034561; Chikmawati T, 2005, GENOME, V48, P792, DOI 10.1139/g05-043; Crespo-Herrera LA, 2017, HEREDITAS, V154, P1, DOI 10.1186/s41065-017-0033-5; Cruz VMV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064062; De Bustos A, 2002, PLANT SYST EVOL, V235, P147, DOI 10.1007/s00606-002-0215-z; Dinglasan E, 2016, EUPHYTICA, V209, P693, DOI 10.1007/s10681-016-1660-z; Dong Y.C., 2003, J PLANT GENET RESOUR, V4, P1, DOI DOI 10.13430/J.CNKI.JPGR.2003.01.001; Doyle J. J., 1987, PHYTOCHEM B, P11; Edae EA, 2014, THEOR APPL GENET, V127, P791, DOI 10.1007/s00122-013-2257-8; El Khoury D, 2011, J NUTR METAB, V2012; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Famoso AN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002221; Fan Y, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00946; Farfan IDB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117737; Faris JD, 2013, THEOR APPL GENET, V126, P2197, DOI 10.1007/s00122-013-2157-y; FLAVELL RB, 1974, BIOCHEM GENET, V12, P257, DOI 10.1007/BF00485947; FRIEBE B, 1990, THEOR APPL GENET, V79, P385, DOI 10.1007/BF01186083; Friebe B, 1996, EUPHYTICA, V91, P59, DOI 10.1007/BF00035277; Friesen TL, 2004, THEOR APPL GENET, V109, P464, DOI 10.1007/s00122-004-1678-9; Fu SL, 2010, J GENET, V89, P489, DOI 10.1007/s12041-010-0070-6; Gawenda I, 2015, PLANT BREEDING, V134, P28, DOI 10.1111/pbr.12237; Guo Y, 2014, CROP J, V2, P38, DOI 10.1016/j.cj.2013.11.001; Gurung S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108179; Hagenblad J, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0710-y; Hao CY, 2008, CHINESE SCI BULL, V53, P1518, DOI 10.1007/s11434-008-0212-x; helmholtz Zentrum Munchen, PGSB PLANT GEN SYST; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Isik Z, 2007, GENOME, V50, P724, DOI 10.1139/G07-052; Jannink Jean-Luc, 2002, P59, DOI 10.1079/9780851996011.0059; Juliana P, 2018, THEOR APPL GENET, V131, P1405, DOI 10.1007/s00122-018-3086-6; Khush GS, 1961, AM J BOT JSTOR, P723; Kidane YG, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01586; Kim W, 2004, CROP SCI, V44, P1254, DOI 10.2135/cropsci2004.1254; Kohavi R., 1995, IJCAI-95. Proceedings of the Fourteenth International Joint Conference on Artificial Intelligence, P1137; Korzun V, 1998, THEOR APPL GENET, V96, P203, DOI 10.1007/s001220050728; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; LAMARI L, 1989, CAN J PLANT PATHOL, V11, P49, DOI 10.1080/07060668909501146; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; Li Y, 2004, GENET RESOUR CROP EV, V51, P845, DOI 10.1007/s10722-005-8313-8; Lipka AE, 2012, BIOINFORMATICS, V28, P2397, DOI 10.1093/bioinformatics/bts444; Liu HJ, 2017, MOL PLANT, V10, P414, DOI 10.1016/j.molp.2016.06.016; Liu JD, 2017, BMC PLANT BIOL, V17, DOI 10.1186/s12870-017-1167-3; Lozada DN, 2017, EUPHYTICA, V213, DOI 10.1007/s10681-017-2005-2; Ma R, 2004, HEREDITAS, V140, P210, DOI 10.1111/j.1601-5223.2004.01844.x; Ma XF, 2001, THEOR APPL GENET, V102, P517, DOI 10.1007/s001220051676; Mago R, 2002, THEOR APPL GENET, V104, P1317, DOI 10.1007/s00122-002-0879-3; Martis MM, 2013, PLANT CELL, V25, P3685, DOI 10.1105/tpc.113.114553; Mascher M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076925; Matos M, 2001, HEREDITAS, V134, P229, DOI 10.1111/j.1601-5223.2001.00229.x; McCouch SR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10532; McKendry AL, 1996, CROP SCI, V36, P844, DOI 10.2135/cropsci1996.0011183X003600040003x; Milczarski P, 2016, J APPL GENET, V57, P439, DOI 10.1007/s13353-016-0347-4; Milczarski P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028495; Milczarski Paweland Masojc P, 2017, PLOONE PUBLIC LIB, V12, DOI [10.1371/journal.pone.0189912, DOI 10.1371/JOURNAL.PONE.0189912]; Mohler V, 2001, PLANT BREEDING, V120, P448, DOI 10.1046/j.1439-0523.2001.00622.x; Mullner D, 2013, J STAT SOFTW, V53, P1; Mwadzingeni L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171692; Niedziela A, 2016, GENETIC DIVERSITY TR, V5, P355, DOI [10.1186/s40064-016-1997-8, DOI 10.1186/S40064-016-1997-8]; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pasam RK, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-16; Poland JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032253; Pritchard JK, 2000, GENETICS, V155, P945; Raboin LM, 2016, RICE, V9, DOI 10.1186/s12284-016-0131-4; RCore Team, 2020, R LANG ENV STAT COMP; Reinert S, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01061; Roy JK, 2010, MOL BREEDING, V26, P243, DOI 10.1007/s11032-010-9402-8; Saulescu NN, 2011, CZECH J GENET PLANT, V47, pS56, DOI 10.17221/3255-CJGPB; SENCER HA, 1980, BIOL J LINN SOC, V13, P299, DOI 10.1111/j.1095-8312.1980.tb00089.x; Shang HY, 2006, GENET MOL BIOL, V29, P685, DOI 10.1590/S1415-47572006000400018; Sherwin WB, 2006, MOL ECOL, V15, P2857, DOI 10.1111/j.1365-294X.2006.02992.x; Shi W, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01035; Swiecka S, 2014, J APPL GENET, V55, P469, DOI 10.1007/s13353-014-0223-z; Tadesse W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141339; Targonska M, 2016, PLANT MOL BIOL REP, V34, P37, DOI 10.1007/s11105-015-0896-4; Upadhyaya HD, 2001, THEOR APPL GENET, V102, P1292, DOI 10.1007/s00122-001-0556-y; VanRaden PM, 2011, J DAIRY SCI, V94, P5673, DOI 10.3168/jds.2011-4500; Varshney RK, 2007, THEOR APPL GENET, V114, P1105, DOI 10.1007/s00122-007-0504-6; Virdi SK, 2016, G3-GENES GENOM GENET, V6, P4139, DOI 10.1534/g3.116.036525; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Wang HW, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0919-9; Wojcik-Jaga M, 2018, THEOR APPL GENET, V131, P167, DOI 10.1007/s00122-017-2994-1; Xiao YJ, 2017, MOL PLANT, V10, P359, DOI 10.1016/j.molp.2016.12.008; Yao QiLun, 2008, Agricultural Sciences in China, V7, P1423, DOI 10.1016/S1671-2927(08)60398-3; Zanke CD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113287; Zhang HL, 2011, THEOR APPL GENET, V122, P49, DOI 10.1007/s00122-010-1421-7; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546; Zhao KY, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030004; Zhao K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1467; Zohary D., 1971, ORGIN S W ASIATIC CE, P235	114	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214519	10.1371/journal.pone.0214519	http://dx.doi.org/10.1371/journal.pone.0214519			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921415	Green Published, Green Submitted, gold			2022-12-26	WOS:000462594000081
J	Somann, JP; Wasilczuk, KM; Neihouser, KV; Sturgis, J; Albors, GO; Robinson, JP; Powley, TL; Irazoqui, PP				Somann, Jesse P.; Wasilczuk, Kelsey M.; Neihouser, Kaitlyn V.; Sturgis, Jennifer; Albors, Gabriel O.; Robinson, J. Paul; Powley, Terry L.; Irazoqui, Pedro P.			Characterization of plasma cytokine response to intraperitoneally administered LPS & subdiaphragmatic branch vagus nerve stimulation in rat model	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; CHOLINERGIC ANTIINFLAMMATORY PATHWAY; VAGAL INNERVATION; TNF-ALPHA; ENDOTOXIN; CORTICOSTERONE; INTERLEUKIN-6; LETHALITY; RECEPTOR; RELEASE	Vagus nerve stimulation (VNS) has been on the forefront of inflammatory disorder research and has yielded many promising results. Questions remain, however, about the biological mechanisms of such treatments and the inconsistencies in the methods used in research efforts. Here, we aimed to clarify the inflammatory response to intraperitoneal (IP) injections of lipopolysaccharide (LPS) in rats, while analyzing corresponding effects of electrical stimulation to subdiaphragmatic branches (anterior gastric, accessory celiac, and hepatic) of the left vagus nerve. We accomplished an in-depth characterization of the time-varying cytokine cascade response in the serum of 58 rats to an acute IP LPS challenge over a 330-minute period by utilizing curve-fitting and starting point-alignment methods. We then explored the post-LPS neuromodulation effects of electrically stimulating individually cuffed subdiaphragmatic branches. Through our analysis, we found there to be a consistent order of IP LPS cytokine response (IL-10, TNF-alpha, GM-CSF, IL-17F, IL-6, IL-22, INF-gamma). Apart from IL-10, the IP cytokine cascade was more variable in starting time and occurred later than in previously recorded intravenous (IV) challenges. We also found distinct regulatory effects on multiple cytokine levels by each of the three subdiaphragmatic stimulation subsets. While the time variability of IP LPS use in rats complicates its utility, we have shown it to be a practical, arguably more physiologically relevant method than IV in rats when our methods are used. More importantly, we have shown that selective subdiaphragmatic neurostimulation can be utilized to selectively induce specific effects on inflammation in the body.	[Somann, Jesse P.; Irazoqui, Pedro P.] Purdue Univ, Dept Elect & Comp Engn, W Lafayette, IN 47907 USA; [Somann, Jesse P.; Wasilczuk, Kelsey M.; Neihouser, Kaitlyn V.; Albors, Gabriel O.; Irazoqui, Pedro P.] Purdue Univ, CID, W Lafayette, IN 47907 USA; [Wasilczuk, Kelsey M.; Neihouser, Kaitlyn V.; Albors, Gabriel O.; Robinson, J. Paul; Irazoqui, Pedro P.] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA; [Sturgis, Jennifer; Robinson, J. Paul] Purdue Univ, Purdue Cytometry Labs, W Lafayette, IN 47907 USA; [Powley, Terry L.] Purdue Univ, Dept Psychol Sci, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Somann, JP (corresponding author), Purdue Univ, Dept Elect & Comp Engn, W Lafayette, IN 47907 USA.; Somann, JP (corresponding author), Purdue Univ, CID, W Lafayette, IN 47907 USA.	jsomann@purdue.edu	Robinson, Joseph/AAA-1001-2020	Robinson, Joseph/0000-0001-8383-3240; Somann, Jesse/0000-0001-9022-6051	Defense Advanced Research Projects Agency (DARPA) ElectRx program [N66001-15-2-4056]	Defense Advanced Research Projects Agency (DARPA) ElectRx program	Research by all authors is supported by the Defense Advanced Research Projects Agency (DARPA) ElectRx program under the auspices of Dr. Douglas Weber, Grant No. N66001-15-2-4056. Any opinion, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of DARPA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mousawi AM, 2010, SHOCK, V34, P261, DOI 10.1097/SHK.0b013e3181d8e2a6; [Anonymous], 2007, SURG PROC FEM CANN R; Asari Y, 1996, SHOCK, V5, P208, DOI 10.1097/00024382-199603000-00007; BELLINGER DL, 1993, BRAIN BEHAV IMMUN, V7, P191, DOI 10.1006/brbi.1993.1021; Berthoud HR, 1996, MICROSC RES TECHNIQ, V35, P80, DOI 10.1002/(SICI)1097-0029(19960901)35:1<80::AID-JEMT7>3.0.CO;2-W; BERTHOUD HR, 1993, J AUTONOM NERV SYST, V42, P153, DOI 10.1016/0165-1838(93)90046-W; BERTHOUD HR, 1991, AM J PHYSIOL, V260, pR200, DOI 10.1152/ajpregu.1991.260.1.R200; Berthoud HR, 2000, AUTON NEUROSCI-BASIC, V85, P1, DOI 10.1016/S1566-0702(00)00215-0; Bonaz B, 2016, NEUROGASTROENT MOTIL, V28, P948, DOI 10.1111/nmo.12792; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Bratton BO, 2012, EXP PHYSIOL, V97, P1180, DOI 10.1113/expphysiol.2011.061531; Chapleau MW, 2016, AM J PHYSIOL-HEART C, V311, pH276, DOI 10.1152/ajpheart.00043.2016; DOHERTY GM, 1992, J IMMUNOL, V149, P1666; Fleshner M, 1998, J NEUROIMMUNOL, V86, P134, DOI 10.1016/S0165-5728(98)00026-5; GIVALOIS L, 1994, AM J PHYSIOL, V267, pR164, DOI 10.1152/ajpregu.1994.267.1.R164; Gogos CA, 2000, J INFECT DIS, V181, P176, DOI 10.1086/315214; Grimonprez A, 2015, NEUROSCI BIOBEHAV R, V56, P26, DOI 10.1016/j.neubiorev.2015.06.019; Groves DA, 2005, NEUROSCI BIOBEHAV R, V29, P493, DOI 10.1016/j.neubiorev.2005.01.004; Huston JM, 2008, J IMMUNOL, V181, P3535, DOI 10.4049/jimmunol.181.5.3535; Huston JM, 2006, J EXP MED, V203, P1623, DOI 10.1084/jem.20052362; Jarry KV, 2017, THESIS; Kakizaki Y, 1999, ENDOCR J, V46, P487, DOI 10.1507/endocrj.46.487; Komegae EN, 2018, BRAIN BEHAV IMMUNITY; Koopman FA, 2016, P NATL ACAD SCI USA, V113, P8284, DOI 10.1073/pnas.1605635113; Kraaij MD, 2014, CYTOKINE, V67, P7, DOI 10.1016/j.cyto.2014.02.001; Laemle Lois B., 2012, NOBACKS HUMAN NERVOU; Lenczowski MJP, 1997, AM J PHYSIOL-REG I, V273, pR1870, DOI 10.1152/ajpregu.1997.273.6.R1870; Lenczowski MJP, 1998, ANN NY ACAD SCI, V856, P139, DOI 10.1111/j.1749-6632.1998.tb08322.x; Martelli D, 2014, AUTON NEUROSCI-BASIC, V182, P65, DOI 10.1016/j.autneu.2013.12.007; Matteoli G, 2013, GUT; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Meregnani J, 2011, AUTON NEUROSCI-BASIC, V160, P82, DOI 10.1016/j.autneu.2010.10.007; NORGREN R, 1988, J COMP NEUROL, V273, P207, DOI 10.1002/cne.902730206; Panescu D, 2005, IEEE ENG MED BIOL, V24, P68, DOI 10.1109/MEMB.2005.1549737; Patel YA, 2017, SCI REP-UK, V7, DOI 10.1038/srep39810; Peters S, 2000, CURR SEPARATIONS, V18, P140; PRECHTL JC, 1990, ANAT EMBRYOL, V181, P101; REDL H, 1991, J INFECT DIS, V164, P383, DOI 10.1093/infdis/164.2.383; Rosas-Ballina M, 2011, SCIENCE, V334, P98, DOI 10.1126/science.1209985; Somann JP, 2017, J NEURAL ENG; Stakenborg N, 2017, NEUROGASTROENT MOTIL, V29, DOI 10.1111/nmo.13075; Steven S, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18102176; STREETER AM, 1974, AM J SURG, V128, P340, DOI 10.1016/0002-9610(74)90169-X; SUFFREDINI AF, 1995, J IMMUNOL, V155, P5038; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; VANDERPOLL T, 1994, J EXP MED, V180, P1985, DOI 10.1084/jem.180.5.1985; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Wasilczuk KM, 2019, ULTRASOUND MED BIOL, V45, P481, DOI 10.1016/j.ultrasmedbio.2018.09.005	48	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214317	10.1371/journal.pone.0214317	http://dx.doi.org/10.1371/journal.pone.0214317			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921373	Green Published, gold, Green Submitted			2022-12-26	WOS:000462594000054
J	Strobl, V; Straub, L; Bruckner, S; Albrecht, M; Maitip, J; Kolari, E; Chantawannakul, P; Williams, GR; Neumann, P				Strobl, Verena; Straub, Lars; Bruckner, Selina; Albrecht, Matthias; Maitip, Jakkrawut; Kolari, Eleonora; Chantawannakul, Panuwan; Williams, Geoffrey R.; Neumann, Peter			Not every sperm counts: Male fertility in solitary bees, Osmia cornuta	PLOS ONE			English	Article							RED MASON BEE; BODY-SIZE; HONEY-BEE; REPRODUCTIVE-BEHAVIOR; LIGNARIA HYMENOPTERA; COMPETITION SUCCESS; EXTREME POLYANDRY; MATING SYSTEMS; R-SELECTION; FEMALES	Reproductive strategies can act as strong selective forces on reproductive traits of male insects, resulting in species-specific variation in sperm quantity and viability. For solitary bees, basic measures of sperm quantity and viability are scarce. Here we evaluated for the first time quantity and viability of sperm in male Osmia cornuta solitary bees at different times after emergence, and how they were affected by male body mass and environmental condition (laboratory or semi-field arena). Sperm viability immediately after adult emergence showed no significant difference compared to four day old individuals, suggesting that O. cornuta males are capable of mating immediately post emergence. However, sperm counts were significantly higher in four day old individuals from the semi-field arena when compared to newly emerged males. This might reflect a final phase of sperm maturation. Regardless of individual male age and body mass differences, O. cornuta males produced on average similar to 175'000 spermatozoa that were similar to 65% viable, which are both significantly lower compared to eusocial honeybees and bumblebees. Moreover, sperm quantity, but not viability, was positively correlated with male body mass four days after emergence, while no such relationship was detected immediately after emergence. Even though individuals maintained in semi-field conditions exhibited a significantly greater loss of body mass, experimental arena had no significant effect on male survival, sperm quality or total living sperm produced. This suggests that the proposed laboratory design provides a cost-efficient and simple experimental approach to assess sperm traits in solitary bees. In conclusion, our data suggest a reduced investment in both sperm quantity and quality by male O. cornuta, which appears to be adaptive in light of the life history of this solitary bee.	[Strobl, Verena; Straub, Lars; Bruckner, Selina; Kolari, Eleonora; Williams, Geoffrey R.; Neumann, Peter] Univ Bern, Inst Bee Hlth, Vetsuisse Fac, Bern, Switzerland; [Strobl, Verena; Straub, Lars; Kolari, Eleonora; Williams, Geoffrey R.; Neumann, Peter] Agroscope, Swiss Bee Res Ctr, Bern, Switzerland; [Bruckner, Selina; Williams, Geoffrey R.] Auburn Univ, Dept Entomol & Plant Pathol, Auburn, AL 36849 USA; [Albrecht, Matthias] Agroscope, Agroecol & Environm, Zurich, Switzerland; [Maitip, Jakkrawut] King Mongkuts Univ Technol, Fac Sci Energy & Environm, Rayong Campus, Bankhai, Rayong, Thailand; [Maitip, Jakkrawut; Chantawannakul, Panuwan] Chiang Mai Univ, Dept Biol, Bee Protect Ctr, Fac Sci, Chiang Mai, Thailand; [Chantawannakul, Panuwan] Chiang Mai Univ, Environm Sci Res Ctr, Fac Sci, Chiang Mai, Thailand	University of Bern; Swiss Federal Research Station Agroscope; Auburn University System; Auburn University; Swiss Federal Research Station Agroscope; Chiang Mai University; Chiang Mai University	Strobl, V; Straub, L (corresponding author), Univ Bern, Inst Bee Hlth, Vetsuisse Fac, Bern, Switzerland.; Strobl, V; Straub, L (corresponding author), Agroscope, Swiss Bee Res Ctr, Bern, Switzerland.	verena.strobl@vetsuisse.unibe.ch; lars.straub@vetsuisse.unibe.ch	Neumann, Peter/C-9964-2015; Maitip, Jakkrawut/AAF-7539-2019; Maitip, Jakkrawut/GRO-5473-2022; Maitip, Jakkrawut/AAE-5317-2020; Straub, Lars/AAP-2820-2020; Williams, Geoffrey/C-9637-2015	Neumann, Peter/0000-0001-5163-5215; Maitip, Jakkrawut/0000-0001-6265-1421; Straub, Lars/0000-0002-2091-1499; Williams, Geoffrey/0000-0002-0093-1126	Okotoxzentrum (EAWAG); Bundesamt fur Umwelt (BAFU); Agroscope; Vinetum Foundation; Swiss National Science Foundation (SNSF) [31003A_169751]; Foundation for Food and Agriculture Research Pollinator Health Fund [549003]; Chiang Mai University Fund; ASEM-DUO Fellowship Program	Okotoxzentrum (EAWAG); Bundesamt fur Umwelt (BAFU); Agroscope; Vinetum Foundation; Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); Foundation for Food and Agriculture Research Pollinator Health Fund; Chiang Mai University Fund; ASEM-DUO Fellowship Program	Financial support was provided by the Okotoxzentrum (EAWAG) to V.S. and P.N., by the Bundesamt fur Umwelt (BAFU) to L.S., G.R.W. and P.N., Agroscope to V.S., the Vinetum Foundation to P.N., the Swiss National Science Foundation (SNSF) project 31003A_169751 to G.R.W., the Foundation for Food and Agriculture Research Pollinator Health Fund grant 549003 to G.R.W., the Chiang Mai University Fund to P.N., as well as the ASEM-DUO Fellowship Program to L.S. and J.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALCOCK J, 1980, AM SCI, V68, P146; ALCOCK J, 1994, ANNU REV ENTOMOL, V39, P1, DOI 10.1146/annurev.en.39.010194.000245; ALCOCK J, 1977, BEHAV ECOL SOCIOBIOL, V2, P385, DOI 10.1007/BF00299507; [Anonymous], 1953, PCHELOVODSTVO; [Anonymous], 1984, SPERM COMPETITION EV; Armbruster L, 1913, ARCH ZELLFORSCH, V11, P243; Arnqvist G, 2000, ANIM BEHAV, V60, P145, DOI 10.1006/anbe.2000.1446; Ball MA, 1998, J THEOR BIOL, V194, P251, DOI 10.1006/jtbi.1998.0756; BATEMAN AJ, 1948, HEREDITY, V2, P349, DOI 10.1038/hdy.1948.21; BATRA SWT, 1984, SCI AM, V250, P120, DOI 10.1038/scientificamerican0284-120; Berg S, 1997, APIDOLOGIE, V28, P449, DOI 10.1051/apido:19970611; BIRKHEAD TR, 1990, TRENDS ECOL EVOL, V5, P48, DOI 10.1016/0169-5347(90)90047-H; Bosch J, 2005, BEHAV ECOL SOCIOBIOL, V59, P124, DOI 10.1007/s00265-005-0017-8; Bosch J, 2002, ECOL ENTOMOL, V27, P129, DOI 10.1046/j.1365-2311.2002.00406.x; Bosch J, 2000, ENVIRON ENTOMOL, V29, P8, DOI 10.1603/0046-225X-29.1.8; BOSCH J, 1994, APIDOLOGIE, V25, P265, DOI 10.1051/apido:19940301; Bosch J, 2003, ENVIRON ENTOMOL, V32, P711, DOI 10.1603/0046-225X-32.4.711; BOSCH J, 1994, APIDOLOGIE, V25, P84, DOI 10.1051/apido:19940109; Bosch J, 2002, B ENTOMOL RES, V92, P3, DOI 10.1079/BER2001139; Bosch J, 2008, ANIM BEHAV, V75, P809, DOI 10.1016/j.anbehav.2007.06.018; Bresslau E., 1905, Zoologischer Anzeiger, Vxxix, P299; Brown MJF, 2003, EVOLUTION, V57, P2067, DOI 10.1111/j.0014-3820.2003.tb00386.x; Cane JH, 2016, J INSECT PHYSIOL, V95, P105, DOI 10.1016/j.jinsphys.2016.09.011; Collins AM, 1999, THERIOGENOLOGY, V51, P1513, DOI 10.1016/S0093-691X(99)00094-1; Conrad T, 2010, J EXP BIOL, V213, P4065, DOI 10.1242/jeb.038174; CURRIE RW, 1987, BEE WORLD, V68, P129, DOI 10.1080/0005772X.1987.11098922; Czekonska K, 2015, APIDOLOGIE, V46, P1, DOI 10.1007/s13592-014-0296-z; DANFORTH BN, 1992, ANN ENTOMOL SOC AM, V85, P616, DOI 10.1093/aesa/85.5.616; Danielsson I, 1998, ANN ZOOL FENN, V35, P241; DUCHATEAU MJ, 1995, INSECT SOC, V42, P255, DOI 10.1007/BF01240420; EASAC, 2015, EASAC POLICY REP, V26, P1; ELLIS L, 1988, PERS INDIV DIFFER, V9, P697, DOI 10.1016/0191-8869(88)90059-1; Fliszkiewicz M., 2009, Annals of Warsaw University of Life Sciences - SGGW, Animal Science, P51; Fliszkiewicz M, 2013, J APIC SCI, V57, P73, DOI 10.2478/JAS-2013-0018; GAGE MJG, 1994, P ROY SOC B-BIOL SCI, V258, P247, DOI 10.1098/rspb.1994.0169; Garcia-Gonzalez F, 2005, CURR BIOL, V15, P271, DOI 10.1016/j.cub.2005.01.032; GERBER HS, 1970, SCIENCE, V167, P82, DOI 10.1126/science.167.3914.82; GOMENDIO M, 1991, P ROY SOC B-BIOL SCI, V243, P181, DOI 10.1098/rspb.1991.0029; Greeff M, 2008, EUR J ENTOMOL, V105, P849, DOI 10.14411/eje.2008.112; Greene W.H., 2012, ECONOMETRIC ANAL; Hunter FM, 2002, CURR BIOL, V12, P121, DOI 10.1016/S0960-9822(01)00647-9; Koeniger N, 2005, APIDOLOGIE, V36, P211, DOI 10.1051/apido:2005011; Kraus FB, 2004, BEHAV ECOL SOCIOBIOL, V55, P494, DOI 10.1007/s00265-003-0706-0; Kvarnemo C, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0042; Leckie G., 2010, CTR MULTILEVEL MODEL; MAC ARTHUR ROBERT H., 1967; Madras-Majewska B., 2011, Annals of Warsaw University of Life Sciences - SGGW, Animal Science, P115; Maeta Y., 1978, B TOHOKU NATL AGR EX, V57, P1; Maeta Y., 1974, MANAGE MAMEKO BEE OS; Michener C.D., 2000, BEES WORLD, V1st, DOI DOI 10.7171/JBT.12-2303-004; Mitchell M.N., 2012, INTERPRETING VISUALI; Newson R, 2002, STATA J, V2, P45, DOI 10.1177/1536867X0200200103; Page RE, 2001, EXP GERONTOL, V36, P695, DOI 10.1016/S0531-5565(00)00236-9; PARRY GD, 1981, OECOLOGIA, V48, P260, DOI 10.1007/BF00347974; Paxton RJ, 1999, NATURWISSENSCHAFTEN, V86, P143, DOI 10.1007/s001140050588; Paxton RJ, 2003, BEHAV ECOL SOCIOBIOL, V53, P174, DOI 10.1007/s00265-002-0561-4; Paxton RJ, 2005, APIDOLOGIE, V36, P145, DOI 10.1051/apido:2005007; Pech-May FG, 2012, INSECT SOC, V59, P417, DOI 10.1007/s00040-012-0236-8; PHILLIPS J K, 1978, Journal of the Kansas Entomological Society, V51, P91; PIANKA ER, 1970, AM NAT, V104, P592, DOI 10.1086/282697; PITNICK S, 1995, P NATL ACAD SCI USA, V92, P10614, DOI 10.1073/pnas.92.23.10614; Polaczek B, 2000, APIDOLOGIE, V31, P525, DOI 10.1051/apido:2000143; Ponlawat A, 2007, J MED ENTOMOL, V44, P422, DOI 10.1603/0022-2585(2007)44[422:AABSIM]2.0.CO;2; Radwan J, 1996, P ROY SOC B-BIOL SCI, V263, P855, DOI 10.1098/rspb.1996.0126; RAW A, 1979, BEHAVIOUR, V70, P168, DOI 10.1163/156853979X00043; RAW A, 1972, T ROY ENT SOC LONDON, V124, P213; Retschnig G, 2015, ENVIRON MICROBIOL, V17, P4322, DOI 10.1111/1462-2920.12825; Retschnig G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085261; Rhodes JW, 2011, APIDOLOGIE, V42, P29, DOI 10.1051/apido/2010026; Roman A, 2010, J APIC SCI, V54, P25; Rosenheim JA, 1996, AM NAT, V148, P501, DOI 10.1086/285937; Schiestl FP, 2000, BEHAV ECOL SOCIOBIOL, V48, P303, DOI 10.1007/s002650000241; Schluns H, 2005, ANIM BEHAV, V70, P125, DOI 10.1016/j.anbehav.2004.11.005; Schluns H, 2003, APIDOLOGIE, V34, P577, DOI 10.1051/apido:2003051; Sedivy C, 2011, FUNCT ECOL, V25, P718, DOI 10.1111/j.1365-2435.2010.01828.x; Seidelmann K, 2014, BEHAVIOUR, V151, P1687, DOI 10.1163/1568539X-00003213; Seidelmann K, 2006, BEHAV ECOL, V17, P839, DOI 10.1093/beheco/arl017; Seidelmann K, 2015, BIOL J LINN SOC, V115, P28, DOI 10.1111/bij.12472; Seidemann K, 1999, J INSECT BEHAV, V12, P13, DOI 10.1023/A:1020920929613; SELANDER ROBERT K., 1965, AMER NATUR, V99, P129, DOI 10.1086/282360; SEVERINGHAUS LL, 1981, BEHAV ECOL SOCIOBIOL, V9, P51, DOI 10.1007/BF00299853; Simmons L. W., 2001, MG BEH ECOL; SIMMONS LW, 1992, EVOLUTION, V46, P366, DOI 10.2307/2409857; Snook RR, 2005, TRENDS ECOL EVOL, V20, P46, DOI 10.1016/j.tree.2004.10.011; StataCorp, 2017, STATA STAT SOFTWARE; Strassmann J, 2001, INSECT SOC, V48, P1, DOI 10.1007/PL00001737; Straub L, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0506; Sturup M, 2013, BEHAV ECOL, V24, P1192, DOI 10.1093/beheco/art049; Taniguchi S, 1956, SCI REP HYOGO U AGR, V2, P37, DOI [10.24546/81005994, DOI 10.24546/81005994]; Tasei JN, 1998, J APICULT RES, V37, P107; Thalmann U., 1991, THESIS; Thornhill R., 1983, pi; TORCHIO PF, 1989, ANN ENTOMOL SOC AM, V82, P599, DOI 10.1093/aesa/82.5.599; TORCHIO PF, 1987, ENVIRON ENTOMOL, V16, P664, DOI 10.1093/ee/16.3.664; Uekoetter Laura, 2014, Entomologie Heute, V26, P111; Vance JT, 2009, J EXP BIOL, V212, P2604, DOI 10.1242/jeb.028100; Wedell N, 2002, BEHAV ECOL, V13, P450, DOI 10.1093/beheco/13.4.450; Wedell N, 2002, TRENDS ECOL EVOL, V17, P313, DOI 10.1016/S0169-5347(02)02533-8; Wegener J, 2012, CRYOBIOLOGY, V65, P126, DOI 10.1016/j.cryobiol.2012.04.010; Wiklund C, 2001, P ROY SOC B-BIOL SCI, V268, P1661, DOI 10.1098/rspb.2001.1719; Wilkaniec Zdzislaw, 2004, Journal of Apicultural Science, V48, P47; Williams GR, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.1.04; Winston M.L., 1991, BIOL HONEY BEE; WOYKE J., 1958, BEE WORLD, V39, P3; Zeh JA, 2003, ETHOLOGY, V109, P929, DOI 10.1046/j.1439-0310.2003.00945.x	105	8	8	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214597	10.1371/journal.pone.0214597	http://dx.doi.org/10.1371/journal.pone.0214597			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921425	Green Submitted, Green Published, gold			2022-12-26	WOS:000462594000094
J	Borrell, S; Trauner, A; Brites, D; Rigouts, L; Loiseau, C; Coscolla, M; Niemann, S; De Jong, B; Yeboah-Manu, D; Kato-Maeda, M; Feldmann, J; Reinhard, M; Beisel, C; Gagneux, S				Borrell, Sonia; Trauner, Andrej; Brites, Daniela; Rigouts, Leen; Loiseau, Chloe; Coscolla, Mireia; Niemann, Stefan; De Jong, Bouke; Yeboah-Manu, Dorothy; Kato-Maeda, Midori; Feldmann, Julia; Reinhard, Miriam; Beisel, Christian; Gagneux, Sebastien			Reference set of Mycobacterium tuberculosis clinical strains: A tool for research and product development	PLOS ONE			English	Article							RESISTANCE; MUTATION; LINEAGE; PHYLOGEOGRAPHY; COEXPANSION; EVOLUTION; DISCOVERY; FRAMEWORK; CLASSIFY; COMPLEX	The Mycobacterium tuberculosis complex (MTBC) causes tuberculosis (TB) in humans and various other mammals. The human-adapted members of the MTBC comprise seven phylogenetic lineages that differ in their geographical distribution. There is growing evidence that this phylogeographic diversity modulates the outcome of TB infection and disease. For decades, TB research and development has focused on the two canonical MTBC laboratory strains H37Rv and Erdman, both of which belong to Lineage 4. Relying on only a few laboratory-adapted strains can be misleading as study results might not be directly transferrable to clinical settings where patients are infected with a diverse array of strains, including drug-resistant variants. Here, we argue for the need to expand TB research and development by incorporating the phylogenetic diversity of the MTBC. To facilitate such work, we have assembled a group of 20 genetically well-characterized clinical strains representing the seven known human-adapted MTBC lineages. With the "MTBC clinical strains reference set" we aim to provide a standardized resource for the TB community. We hope it will enable more direct comparisons between studies that explore the physiology of MTBC beyond the laboratory strains used thus far. We anticipate that detailed phenotypic analyses of this reference strain set will increase our understanding of TB biology and assist in the development of new control tools that are broadly effective.	[Borrell, Sonia; Trauner, Andrej; Brites, Daniela; Loiseau, Chloe; Coscolla, Mireia; Feldmann, Julia; Reinhard, Miriam; Gagneux, Sebastien] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Borrell, Sonia; Trauner, Andrej; Brites, Daniela; Loiseau, Chloe; Coscolla, Mireia; Feldmann, Julia; Reinhard, Miriam; Gagneux, Sebastien] Univ Basel, Basel, Switzerland; [Rigouts, Leen; De Jong, Bouke] Inst Trop Med, Dept Biomed Sci, Mycobacteriol Unit, Antwerp, Belgium; [Rigouts, Leen] Inst Trop Med, Collect Mycobacterial Cultures BCCM ITM, Antwerp, Belgium; [Niemann, Stefan] Res Ctr Borstel, Div Mol & Expt Mycobacteriol Grp, Borstel, Germany; [Yeboah-Manu, Dorothy] Univ Ghana, Noguchi Mem Inst Med Res, Accra, Ghana; [Kato-Maeda, Midori] Univ Calif San Francisco, Sch Med, San Francisco, CA USA; [Beisel, Christian] Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, Genom Facil, Basel, Switzerland	University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Institute of Tropical Medicine (ITM); Institute of Tropical Medicine (ITM); Forschungszentrum Borstel; University of Ghana; University of California System; University of California San Francisco; Swiss Federal Institutes of Technology Domain; ETH Zurich	Borrell, S (corresponding author), Swiss Trop & Publ Hlth Inst, Basel, Switzerland.; Borrell, S (corresponding author), Univ Basel, Basel, Switzerland.	sonia.borrell@swisstph.com	Niemann, Stefan/C-9327-2011; Coscolla, Mireia/ABD-7942-2021; Brites, Daniela/AGL-8378-2022; Gagneux, Sebastien/ABE-7909-2020	Brites, Daniela/0000-0002-8090-2287; Loiseau, Chloe/0000-0003-4889-2784; Beisel, Christian/0000-0001-5360-2193; Gagneux, Sebastien/0000-0001-7783-9048	Swiss National Science Foundation [310030_166687, IZRJZ3_164171, IZLSZ3_170834, CRSII5_177163]; European Research Council [309540-EVODRTB]; SystemsX.ch	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Research Council(European Research Council (ERC)European Commission); SystemsX.ch	This work was supported by the Swiss National Science Foundation (grants 310030_166687, IZRJZ3_164171, IZLSZ3_170834 and CRSII5_177163), and by the European Research Council (309540-EVODRTB), and SystemsX.ch.	Achtman M, 2008, ANNU REV MICROBIOL, V62, P53, DOI 10.1146/annurev.micro.62.081307.162832; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brites D, 2017, ADV EXP MED BIOL, V1019, P1, DOI 10.1007/978-3-319-64371-7_1; Colangeli R, 2018, NEW ENGL J MED, V379, P823, DOI 10.1056/NEJMoa1715849; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Coll F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5812; Comas I, 2013, NAT GENET, V45, P1176, DOI 10.1038/ng.2744; Comas I, 2010, NAT GENET, V42, P498, DOI 10.1038/ng.590; Constant P, 2002, J BIOL CHEM, V277, P38148, DOI 10.1074/jbc.M206538200; Coscolla M, 2017, ADV EXP MED BIOL, V1019, P95, DOI 10.1007/978-3-319-64371-7_5; de Jong BC, 2007, INT J TUBERC LUNG D, V11, P450; Domenech P, 2014, INFECT IMMUN, V82, P2902, DOI 10.1128/IAI.01791-14; Flores L, 2007, J CLIN MICROBIOL, V45, P3393, DOI 10.1128/JCM.00828-07; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; Gagneux S, 2006, SCIENCE, V312, P1944, DOI 10.1126/science.1124410; Gagneux S, 2018, NAT REV MICROBIOL, V16, P202, DOI 10.1038/nrmicro.2018.8; Homolka S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000988; Ioerger TR, 2010, J BACTERIOL, V192, P3645, DOI 10.1128/JB.00166-10; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Krishnan N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023870; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Luo T, 2015, P NATL ACAD SCI USA, V112, P8136, DOI 10.1073/pnas.1424063112; Manca C, 1999, J IMMUNOL, V162, P6740; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mokrousov I, 2012, INFECT GENET EVOL, V12, P619, DOI 10.1016/j.meegid.2011.09.026; Parish T, 1998, METHOD MOL BIOL, P31; Portevin D, 2014, MICROBIOLOGYOPEN, V3, P823, DOI 10.1002/mbo3.193; Portevin D, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001307; Rose G, 2013, GENOME BIOL EVOL, V5, P1849, DOI 10.1093/gbe/evt138; ROUSE DA, 1995, INFECT IMMUN, V63, P1427, DOI 10.1128/IAI.63.4.1427-1433.1995; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stavrum R, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-309; Steiner A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-881; Stucki D, 2016, NAT GENET, V48, P1535, DOI 10.1038/ng.3704; Tsolaki AG, 2005, J CLIN MICROBIOL, V43, P3185, DOI 10.1128/JCM.43.7.3185-3191.2005; Walker TM, 2015, LANCET INFECT DIS, V15, P1193, DOI 10.1016/S1473-3099(15)00062-6; Weiner B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0026038; World Health Organization, 2017, GLOB TUB CONTR SURV; Zhu LX, 2016, NUCLEIC ACIDS RES, V44, P730, DOI 10.1093/nar/gkv1498	41	28	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2019	14	3							e0214088	10.1371/journal.pone.0214088	http://dx.doi.org/10.1371/journal.pone.0214088			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ1KV	30908506	Green Submitted, Green Accepted, Green Published, gold			2022-12-26	WOS:000462157600032
J	Chen, B; Xia, XO; Wang, XB				Chen, Bang; Xia, Xiao'ou; Wang, Xiaobo			Synchronization and vibratory synchronization transmission of a weakly damped far-resonance vibrating system	PLOS ONE			English	Article							NONIDENTICAL COUPLED EXCITERS	The self-synchronization of rotors mounted on different vibrating bodies can be easily controlled by adjusting the coupling parameters. To reveal the synchronization characteristics of a weakly damped system with two rotors mounted on different vibrating bodies, we propose a simplified physical model. The topics described in this paper are related to coupling dynamic problems between two vibrating systems. Both synchronization and vibratory synchronization transmission of the system are studied. The coupling mechanism between the two rotors is analyzed to derive the synchronization condition and the stability criterion of the system. The vibration of the system is described by an averaging method that can separate fast motion (high frequency) from slow motion (low frequency). Theoretical research shows that vibration torque is the key factor in balancing the energy distribution between the rotors. Taking the maximum vibration torque (MVT) as a critical parameter, we investigate the synchronization characteristics of the vibrating system in different cases. The curve of the maximum vibration torque (MVT) versus coupling frequency is divided into several parts by the coupling characteristic frequency and the input torque difference between the rotors. Simulations of the system with coupling frequencies from different parts are carried out. For the system with rotational frequencies larger than the natural frequencies, the coupling characteristic frequency or characteristic frequency curve should be considered. When the coupling frequency is close to the characteristic frequency or the vibration state is close to the characteristic frequency curve, self-synchronization of the two rotors can be obtained easily. Under certain conditions when the coupling effect between the rotors is strong enough, the rotors can maintain synchronous rotation even when one of the two motors is shut off after synchronization is achieved, which is called vibratory synchronization transmission. Vibratory synchronization transmission of the system occurs in a new synchronous condition, and the phase difference between the rotors takes on a new value, that is, the system approaches a new synchronization state.	[Chen, Bang; Xia, Xiao'ou] Univ Sci & Technol Beijing, Sch Mech Engn, Beijing, Peoples R China; [Xia, Xiao'ou; Wang, Xiaobo] BGRIMM Technol Grp, Beijing, Peoples R China	University of Science & Technology Beijing	Chen, B (corresponding author), Univ Sci & Technol Beijing, Sch Mech Engn, Beijing, Peoples R China.	cbbgrimm@163.com			International Science and Technology Cooperation Program of China [2015DFR70660]; BGRIMM Technology Group	International Science and Technology Cooperation Program of China; BGRIMM Technology Group	The study is supported by International Science and Technology Cooperation Program of China (Grant no. 2015DFR70660), received by FM Liu. http://www.istcp.org.cn/.Xiao'ou Xia and Xiaobo Wang are employed by BGRIMM Technology Group. BGRIMM Technology Group provided support in the form of salaries for authors XX and XW, but did not have any additional role in the study design, data collection and analysis,	Akhlaq M, 2013, IEEE T INSTRUM MEAS, V62, P578, DOI 10.1109/TIM.2012.2232472; Blekhman II, 2002, MATH COMPUT SIMULAT, V58, P367, DOI 10.1016/S0378-4754(01)00378-0; Blekhman II, 2002, SELECTED TOPICS VIBR; Blekhman II, 2000, VIBRATIONAL MECH; Blekhman II, 1988, SYNCHRONIZATION SCI; Czolczynski K, 2009, PHYSICA A, V388, P5013, DOI 10.1016/j.physa.2009.08.033; Czolczynski K, 2012, COMMUN NONLINEAR SCI, V17, P3658, DOI 10.1016/j.cnsns.2012.01.014; Czolczynski K, 2011, CHAOS, V21, DOI 10.1063/1.3602225; Czolczynski K, 2009, PROG THEOR PHYS, V122, P1027, DOI 10.1143/PTP.122.1027; Dilao R, 2009, CHAOS, V19, DOI 10.1063/1.3139117; Dudkowski D, 2016, SCI REP-UK, V6, DOI 10.1038/srep29833; Fang P, 2018, SHOCK VIB, V2018, DOI 10.1155/2018/9824631; Fang P, 2018, P I MECH ENG C-J MEC, V232, P1802, DOI 10.1177/0954406217711468; Fang P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126069; Jaros P, 2015, EUR PHYS J-SPEC TOP, V224, P1605, DOI 10.1140/epjst/e2015-02483-x; Jovanovic V, 2012, J SOUND VIB, V331, P2887, DOI 10.1016/j.jsv.2012.01.035; Koluda P, 2014, EUR PHYS J-SPEC TOP, V223, P613, DOI 10.1140/epjst/e2014-02129-7; Koluda P, 2014, COMMUN NONLINEAR SCI, V19, P977, DOI 10.1016/j.cnsns.2013.08.008; Ramirez JP, 2014, J SOUND VIB, V333, P7248, DOI 10.1016/j.jsv.2014.08.030; Strzalko J, 2012, CHAOS, V22, P123, DOI [10.1063/1, DOI 10.1063/1]; Wen BC, 2010, THEORY TECHNIQUES VI, P908, DOI [10.1016/j.jsv.2014.01.022, DOI 10.1016/J.JSV.2014.01.022]; Wen BC., 2009, VIBRATORY SYNCHRONIZ; Xu X, 2007, NONLINEAR DYNAM, V47, P311, DOI 10.1007/s11071-006-9074-4; Zanasi R, 2010, P 19 INT C EL MACH I; Zhang LP, 2010, NONLINEAR DYNAM, V59, P529, DOI 10.1007/s11071-009-9559-z; Zhang XL, 2014, J SOUND VIB, V333, P2898, DOI 10.1016/j.jsv.2014.01.022; Zhang XL, 2013, J SOUND VIB, V332, P2300, DOI 10.1016/j.jsv.2012.12.003; Zhao CY, 2010, ACTA MECH SINICA-PRC, V26, P477, DOI 10.1007/s10409-009-0311-1; Zhao CY, 2010, SCI CHINA TECHNOL SC, V53, P405, DOI 10.1007/s11431-009-0376-x	29	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2019	14	3							e0209703	10.1371/journal.pone.0209703	http://dx.doi.org/10.1371/journal.pone.0209703			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ1KV	30908493	Green Published, Green Submitted, gold			2022-12-26	WOS:000462157600003
J	de Oliveira, EA; Bertollo, LAC; Rab, P; Ezaz, T; Yano, CF; Hatanaka, T; Jegede, OI; Tanomtong, A; Liehr, T; Sember, A; Maruyama, SR; Feldberg, E; Viana, PF; Cioffiid, MD				de Oliveira, Ezequiel Aguiar; Carlos Bertollo, Luiz Antonio; Rab, Petr; Ezaz, Tariq; Yano, Cassia Fernanda; Hatanaka, Terumi; Jegede, Oladele Ilesanmi; Tanomtong, Alongklod; Liehr, Thomas; Sember, Alexandr; Maruyama, Sandra Regina; Feldberg, Eliana; Viana, Patrik Ferreira; Cioffiid, Marcelo de Bello			Cytogenetics, genomics and biodiversity of the South American and African Arapaimidae fish family (Teleostei, Osteoglossiformes)	PLOS ONE			English	Article							KARYOTYPE EVOLUTION; HETEROTIS-NILOTICUS; BUTTE FORMATION; NORTH-DAKOTA; GIGAS SCHINZ; R-PACKAGE; CHROMOSOMES; DNA; CHARACIFORMES; ORIGIN	Osteoglossiformes represents one of the most ancestral teleost lineages, currently wide-spread over almost all continents, except for Antarctica. However, data involving advanced molecular cytogenetics or comparative genomics are yet largely limited for this fish group. Therefore, the present investigations focus on the osteoglossiform family Arapaimidae, studying a unique fish model group with advanced molecular cytogenetic genomic tools. The aim is to better explore and clarify certain events and factors that had impact on evolutionary history of this fish group. For that, both South American and African representatives of Arapaimidae, namely Arapaima gigas and Heterotis niloticus, were examined. Both species differed markedly by diploid chromosome numbers, with 2n = 56 found in A. gigas and 2n = 40 exhibited by H. niloticus. Conventional cytogenetics along with fluorescence in situ hybridization revealed some general trends shared by most osteoglossiform species analyzed thus far, such as the presence of only one chromosome pair bearing 18S and 5S rDNA sites and karyotypes dominated by acrocentric chromosomes, resembling thus the patterns of hypothetical ancestral teleost karyotype. Furthermore, the genomes of A. gigas and H. niloticus display remarkable divergence in terms of repetitive DNA content and distribution, as revealed by comparative genomic hybridization (CGH). On the other hand, genomic diversity of single copy sequences studied through principal component analyses (PCA) based on SNP alleles genotyped by the DArT seq procedure demonstrated a very low genetic distance between the South American and African Arapaimidae species; this pattern contrasts sharply with the scenario found in other osteoglossiform species. Underlying evolutionary mechanisms potentially explaining the obtained data have been suggested and discussed.	[de Oliveira, Ezequiel Aguiar; Carlos Bertollo, Luiz Antonio; Yano, Cassia Fernanda; Hatanaka, Terumi; Maruyama, Sandra Regina; Cioffiid, Marcelo de Bello] Univ Fed Sao Carlos, Dept Genet & Evolucao, Rodovia Washington Luiz, Sao Carlos, SP, Brazil; [de Oliveira, Ezequiel Aguiar] Secretaria Estado Educ Mato Grosso SEDUC MT, Cuiaba, MT, Brazil; [Rab, Petr; Sember, Alexandr] Czech Acad Sci, Inst Anim Physiol & Genet, Lab Fish Genet, Prague, Czech Republic; [Ezaz, Tariq] Univ Canberra, Inst Appl Ecol, Canberra, ACT, Australia; [Jegede, Oladele Ilesanmi] Adamawa State Univ, Dept Fisheries & Aquaculture, Mubi, Adamawa State, Nigeria; [Tanomtong, Alongklod] KhonKaen Univ, Tox Subst Livestock & Aquat Anim Res Grp, Muang, Khonkaen, Thailand; [Liehr, Thomas] Univ Hosp Jena, Inst Human Genet, Jena, Germany; [Feldberg, Eliana; Viana, Patrik Ferreira] Inst Nacl de Pesquisas da Amazonia, Coordenacao Biodiversidade, Lab Genet Anim, Manaus, Amazonas, Brazil	Universidade Federal de Sao Carlos; Czech Academy of Sciences; Institute of Animal Physiology & Genetics of the Czech Academy of Sciences; University of Canberra; Khon Kaen University; Friedrich Schiller University of Jena; Institute Nacional de Pesquisas da Amazonia	Cioffiid, MD (corresponding author), Univ Fed Sao Carlos, Dept Genet & Evolucao, Rodovia Washington Luiz, Sao Carlos, SP, Brazil.	mbcioffi@ufscar.br	de Oliveira, Ezequiel Aguiar/D-4925-2018; Maruyama, Sandra R/G-1171-2012; Tanomtong, Alongklod/ABA-4321-2020; Viana, Patrik/Y-8038-2018; Liehr, Thomas/H-2852-2019; Jegede, Oladele Ilesanmi/AHA-1851-2022; Sember, Alexandr/W-4446-2017	de Oliveira, Ezequiel Aguiar/0000-0002-8264-8884; Viana, Patrik/0000-0002-8172-0725; Liehr, Thomas/0000-0003-1672-3054; Jegede, Oladele Ilesanmi/0000-0001-6664-7710; Sember, Alexandr/0000-0003-4441-9615; Cioffi, Marcelo/0000-0003-4340-1464	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [401962/2016-4, 302449/2018-3]; CNPQ; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2017/16328-6, 2016/22196-2]; FAPESP; CAPES/Alexander von Humboldt [88881.136128/2017-01]; CAPES; AVH; project EXCELLENCE [CZ.02.1.01/0.0/0.0/15_003/0000460 OP RDE, RVO: 67985904]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPQ(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES/Alexander von Humboldt; CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); AVH(Alexander von Humboldt Foundation); project EXCELLENCE	MBC was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (Proc. nos 401962/2016-4 and 302449/2018-3), CNPQ: www.cnpq.br, Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) (Proc. No 2016/22196-2), FAPESP: www.fapesp.br, and CAPES/Alexander von Humboldt (Proc. No. 88881.136128/2017-01), CAPES: www.capes.gov.br, AVH: https://www.humboldt-foundation.de/web/home.html. PR was supported by the project EXCELLENCE CZ.02.1.01/0.0/0.0/15_003/0000460 OP RDE and with the institutional support RVO: 67985904 (PR). SRM was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) (2017/16328-6). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adite A, 2005, ENVIRON BIOL FISH, V73, P367, DOI 10.1007/s10641-004-5563-9; Altmanova M, 2016, BIOL J LINN SOC, V118, P618, DOI 10.1111/bij.12751; [Anonymous], EVOLUTIONARY TRENDS; Araripe J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054470; Axelsson E, 2005, GENOME RES, V15, P120, DOI 10.1101/gr.3021305; Bailey JA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-r23; Banarescu P., 1995, ZOOGEOGRAPHY FRESH W, V3; Monteiro Leonardo Bruno Barbosa, 2010, Acta Amaz., V40, P435, DOI 10.1590/S0044-59672010000300004; Barby FF, 2018, GENES-BASEL, V9, DOI 10.3390/genes9060306; BERTOLLO LAC, 1986, J FISH BIOL, V28, P153, DOI 10.1111/j.1095-8649.1986.tb05153.x; Bertollo LAC, 2015, FISH CYTOGENETIC TEC, P21, DOI DOI 10.1201/B18534-4; Betancur-R R, 2017, BMC EVOL BIOL, V17, DOI 10.1186/s12862-017-0958-3; Bian C, 2016, SCI REP-UK, V6, DOI 10.1038/srep24501; Bird CE, 2012, EVOL BIOL, V39, P158, DOI 10.1007/s11692-012-9183-6; Biscotti MA, 2015, CHROMOSOME RES, V23, P415, DOI 10.1007/s10577-015-9499-z; Carvalho PC, 2017, FRONT GENET, V8, DOI 10.3389/fgene.2017.00203; Castello L, 2008, J FISH BIOL, V72, P1520, DOI 10.1111/j.1095-8649.2007.01778.x; Cavalli G, 2013, NAT STRUCT MOL BIOL, V20, P290, DOI 10.1038/nsmb.2474; Cavallini MM, 1988, S CIT EV APL PEIX NE; Chester M, 2010, GENES-BASEL, V1, P166, DOI 10.3390/genes1020166; Cioffi MB, 2012, GENOME DYNAM, V7, P197, DOI 10.1159/000337950; Cioffi MB, 2009, CYTOGENET GENOME RES, V125, P132, DOI 10.1159/000227838; da Rosa Renata, 2009, Open Biology Journal, V2, P91; de Freitas NL, 2018, CURR GENOMICS, V19, P216, DOI 10.2174/1389202918666170711160528; de Oliveira EA, 2018, CHROMOSOMA, V127, P115, DOI 10.1007/s00412-017-0648-3; de Oliveira EA, 2015, MOL CYTOGENET, V8, DOI 10.1186/s13039-015-0161-4; Delprat A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007883; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Feldberg E, 2003, FISH ADAPTATIONS, P285; Fraser J, 2015, MICROBIOL MOL BIOL R, V79, P347, DOI 10.1128/MMBR.00006-15; Gayet M., 1998, PHYLOGENY CLASSIFICA, P85; Gornung E, 2013, CYTOGENET GENOME RES, V141, P90, DOI 10.1159/000354832; Gunther A. XV, 1867, ANN MAG NAT HIST, V20, P110; Gurdak DJ, 2019, AQUAT CONSERV, P1; Hatanaka T, 2018, BIOL J LINN SOC, V125, P83, DOI 10.1093/biolinnean/bly098; HILLIS DM, 1991, Q REV BIOL, V66, P411, DOI 10.1086/417338; Hilton EJ, 2003, ZOOL J LINN SOC-LOND, V137, P1, DOI 10.1046/j.1096-3642.2003.00032.x; Hilton EJ, 2018, NEOTROP ICHTHYOL, V16, DOI 10.1590/1982-0224-20180031; Hirata J, 2000, SCI REP RES I EVOL B, V9, P83; HOWELL WM, 1980, EXPERIENTIA, V36, P1014, DOI 10.1007/BF01953855; Hrbek T, 2005, ANIM CONSERV, V8, P297, DOI 10.1017/S1367943005002210; Hurtado LA, 2013, J FISH BIOL, V83, P682, DOI 10.1111/jfb.12198; KALLIONIEMI A, 1992, SCIENCE, V258, P818, DOI 10.1126/science.1359641; Kato A, 2005, CURR OPIN PLANT BIOL, V8, P148, DOI 10.1016/j.pbi.2005.01.014; Kilian Andrzej, 2012, Methods Mol Biol, V888, P67, DOI 10.1007/978-1-61779-870-2_5; Koubova M, 2014, CHROMOSOME RES, V22, P441, DOI 10.1007/s10577-014-9430-z; Kumazawa Y, 2000, MOL BIOL EVOL, V17, P1869, DOI 10.1093/oxfordjournals.molbev.a026288; Lambert MR, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3209-x; Lavoue S, 2016, MOL PHYLOGENET EVOL, V99, P34, DOI 10.1016/j.ympev.2016.03.008; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Levan A, 1964, HEREDITAS, P52; Li G-Q, 1996, PHYLOGENY OSTEOGLOSS, P163; Li GQ, 1997, J PALEONTOL, V71, P1109; Lim KY, 2007, NEW PHYTOL, V175, P756, DOI 10.1111/j.1469-8137.2007.02121.x; LUNDBERG JG, 1993, BIOLOGICAL RELATIONSHIPS BETWEEN AFRICA AND SOUTH AMERICA, P156; LUNDBERG JG, 1992, BIOTROPICA, V24, P2, DOI 10.2307/2388468; Mahelka V, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-127; Majtanova Z, 2017, J EXP ZOOL PART B, V328, P620, DOI 10.1002/jez.b.22720; Mirande JM, 2017, CLADISTICS, V33, P333, DOI 10.1111/cla.12171; Marques DK, 2006, NEOTROP ICHTHYOL, V4, P215, DOI 10.1590/S1679-62252006000200007; Martins C, 2006, GENETICA, V127, P133, DOI 10.1007/s10709-005-2674-y; McConnell R, 1987, ECOLOGICAL STUDIES T; Milhomem SSR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055608; Mustapha M.K., 2010, Asian Journal of Experimental Biological Sciences, V1, P1; Nelson J.S., 2016, FISHES WORLD, DOI 10.1002/9781119174844; Newbrey MG, 2000, J VERTEBR PALEONTOL, V20, P12, DOI 10.1671/0272-4634(2000)020[0012:ANSOJT]2.0.CO;2; Newbrey MG, 2003, J VERTEBR PALEONTOL, V23, P494, DOI 10.1671/1774; OLIVEIRA C, 1988, CARYOLOGIA, V41, P227, DOI 10.1080/00087114.1988.10797863; Ortiz-Barrientos D, 2016, TRENDS ECOL EVOL, V31, P226, DOI 10.1016/j.tree.2015.12.016; Ozouf-Costaz C, 2015, CYBIUM, V39, P227; Pellestor F, 2011, HUM REPROD UPDATE, V17, P476, DOI 10.1093/humupd/dmr010; PINDELL JL, 1988, TECTONOPHYSICS, V155, P121, DOI 10.1016/0040-1951(88)90262-4; PINKEL D, 1986, P NATL ACAD SCI USA, V83, P2934, DOI 10.1073/pnas.83.9.2934; Poletto AB, 2010, BMC GENET, V11, DOI [10.1186/1471-2156-11-1, 10.1186/1471-2156-11-50]; Queiroz H.L., 2000, THESIS; Rab P, 2016, CYTOGENET GENOME RES, V149, P312, DOI 10.1159/000450534; RABINOWITZ PD, 1979, J GEOPHYS RES, V84, P5973, DOI 10.1029/JB084iB11p05973; Razin SV, 2016, TRANSCR-AUSTIN, V7, P84, DOI 10.1080/21541264.2016.1181489; Reis RE, 2016, J FISH BIOL, V89, P12, DOI 10.1111/jfb.13016; de Moraes RLR, 2017, ZEBRAFISH, V14, P536, DOI 10.1089/zeb.2017.1465; Sambrook J., 2001, MOL CLONING LAB MANU; SCHMID M, 1980, CHROMOSOMA, V77, P83, DOI 10.1007/BF00292043; Schueler MG, 2001, SCIENCE, V294, P109, DOI 10.1126/science.1065042; Sember A, 2018, FRONT GENET, V9, P1, DOI [10.3389/fgene.2018.00001, DOI 10.3389/FGENE.2018.00001]; Sember A, 2018, PLOS ONE, V13, DOI [10.1371/Journal.pone.0195054, 10.1371/journal.pone.0195054]; Silva Santos R., 1985, COLETANEA TRAB PALEO, V27, P161; Smadja CM, 2011, MOL ECOL, V20, P5123, DOI 10.1111/j.1365-294X.2011.05350.x; Stewart DJ, 2013, COPEIA, P38, DOI 10.1643/CI-12-013; Stewart DJ, 2013, COPEIA, P470, DOI 10.1643/CI-12-017; SUMNER AT, 1972, EXP CELL RES, V75, P304, DOI 10.1016/0014-4827(72)90558-7; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Symonova R., 2015, FISH CYTOGENETIC TEC, P118; Symonova R, 2018, GENES-BASEL, V9, DOI 10.3390/genes9030150; Symonova R, 2017, J EXP ZOOL PART B, V328, P607, DOI 10.1002/jez.b.22719; TAVERNE L, 1998, MISCELLANEA, V7, P67; Traut W, 2001, CHROMOSOME RES, V9, P659, DOI 10.1023/A:1012956324417; Trifonov Vladimir A., 2009, P99, DOI 10.1007/978-3-540-70581-9_9; Urushido T., 1975, Chromosome Information Service, V18, P20; Valente GT, 2009, CHROMOSOME RES, V17, P791, DOI 10.1007/s10577-009-9067-5; Vialle RA, 2018, GENOME BIOL EVOL, V10, P2366, DOI 10.1093/gbe/evy130; Webber C, 2005, GENOME RES, V15, P1787, DOI 10.1101/gr.3896805; Wilson MVH, 2008, GEOL SOC SPEC PUBL, V295, P185, DOI 10.1144/SP295.12; Yano CF, 2017, HEREDITY, V118, P276, DOI 10.1038/hdy.2016.83; Zwick MS, 1997, GENOME, V40, P138, DOI 10.1139/g97-020	104	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2019	14	3							e0214225	10.1371/journal.pone.0214225	http://dx.doi.org/10.1371/journal.pone.0214225			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ1KV	30908514	Green Published, Green Submitted, gold			2022-12-26	WOS:000462157600044
J	Esan, EO; Abbey, L; Yurgel, S				Esan, Ebenezer Oluwaseun; Abbey, Lord; Yurgel, Svetlana			Exploring the long-term effect of plastic on compost microbiome	PLOS ONE			English	Article							FUNGAL COMMUNITIES; ENVIRONMENT; SUCCESSION	Little is known about the ecology of microbial plastic degradation. In this study, we employed next generation amplicon sequencing to assess the effect of low-density polyethylene (LDPE) films on the structure of bacterial and fungal communities in four mature compost piles with age ranging between 2 and 10 years. While, bacterial Proteobacteria, Bacteroi-detes, Actinobacteria and fungi Ascomycota were most abundant across all facilities, our data indicated significant differences in compost microbiomes between compost facilities, which might be related to compost chemical parameters, age of piles and characteristics of the feedstock. In addition, a substantial shift in the interaction pattern within microbial communities from bulk and plastic-associated (PA) compost was detected. For example, cooperation between Firmicutes Bacillaceae and Thermoactinomycetaceae was detected only in PA compost. However, based on the analysis of the diversity indices and the relative abundances of microbial taxa we can conclude that the presence of plastics in compost had no significant effect on the structure of microbial community.	[Esan, Ebenezer Oluwaseun; Abbey, Lord; Yurgel, Svetlana] Dalhousie Univ, Dept Plant Food & Environm Sci, Truro, NS, Canada	Dalhousie University	Yurgel, S (corresponding author), Dalhousie Univ, Dept Plant Food & Environm Sci, Truro, NS, Canada.	syurgel@dal.ca		Esan, Ebenezer/0000-0001-7600-4460; Yurgel, Svetlana/0000-0002-6979-1619	Natural Sciences and Engineering Research Council of Canada [RGPIN-2017-04545]; Divert Scotia [SR-R3-16-01]; Compost Council of Canada; Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Divert Scotia; Compost Council of Canada; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	SY received a Discovery Grant from Natural Sciences and Engineering Research Council of Canada, RGPIN-2017-04545. LA received a Student Research Grant (#SR-R3-16-01) from Divert Scotia. We are thankful to the Compost Council of Canada for its support to LA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Discovery Grant from Natural Sciences and Engineering Research Council of Canada to SY. We are thankful to the Compost Council of Canada for its support to LA.	Adamcova D, 2015, POL J ENVIRON STUD, V24, P1497; Andrady AL, 2011, MAR POLLUT BULL, V62, P1596, DOI 10.1016/j.marpolbul.2011.05.030; Blasing M, 2018, SCI TOTAL ENVIRON, V612, P422, DOI 10.1016/j.scitotenv.2017.08.086; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Bushnell B., 2014, BBMAP FAST ACCURATE; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Comeau AM, 2017, MSYSTEMS, V2, DOI 10.1128/mSystems.00127-16; Comeau AM, 2016, SCI REP-UK, V6, DOI 10.1038/srep30120; De Gannes V, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00164; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Fauziah S.H., 2009, MALAYS J SCI, V28, P135, DOI DOI 10.22452/mjs.vol28no2.3; Franke-Whittle IH, 2014, WASTE MANAGE, V34, P632, DOI 10.1016/j.wasman.2013.12.009; Gajst T, ANAL PLASTIC RESIDUE; GOLDIN A, 1987, COMMUN SOIL SCI PLAN, V18, P1111, DOI 10.1080/00103628709367886; Gordon A, 2010, FASTX TOOLKIT FASTQA; Hakkarainen M, 2004, ADV POLYM SCI, V169, P177, DOI 10.1007/b13523; Hauser R, 2005, OCCUP ENVIRON MED, V62, DOI 10.1136/oem.2004.017590; Huhe,, 2017, MICROBIOLOGYOPEN, V6, DOI 10.1002/mbo3.518; Kolodziejek J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13101-z; Kopylova E, 2012, BIOINFORMATICS, V28, P3211, DOI 10.1093/bioinformatics/bts611; Ma AZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066146; Manika S, 2015, CIBTECH J MICROBIOLO, V4, P85; MEHLICH A, 1984, COMMUN SOIL SCI PLAN, V15, P1409, DOI 10.1080/00103628409367568; Mercier C, 2013, SUMATRA SUMACLUSTFAS; Neher DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079512; Parks DH, 2014, BIOINFORMATICS, V30, P3123, DOI 10.1093/bioinformatics/btu494; Partanen P, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-94; Raziyafathima M., 2016, J PHARM CHEM BIOL SC, V4, P231, DOI DOI 10.18231/2348-0335.2017.0009; Sangale M. K., 2012, Journal of Bioremediation and Biodegradation, V3, P1000164; Schlatter DC, 2018, MICROB ECOL, V76, P240, DOI 10.1007/s00248-017-1113-9; Schwager E., DETECTING STAT SIGNI; Sen SK, 2015, J ENVIRON CHEM ENG, V3, P462, DOI 10.1016/j.jece.2015.01.003; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sharma M., 2015, CIBTECH J MICROBIOL, V4, P85; Tarlera S, 2008, FEMS MICROBIOL ECOL, V64, P129, DOI 10.1111/j.1574-6941.2008.00444.x; Teuten EL, 2009, PHILOS T R SOC B, V364, P2027, DOI 10.1098/rstb.2008.0284; Viaene J, 2016, WASTE MANAGE, V48, P181, DOI 10.1016/j.wasman.2015.09.021; Weglarz TC, 2018, J APPL MICROBIOL, V125, P1066, DOI 10.1111/jam.13945; Wei HW, 2018, BIORESOURCE TECHNOL, V256, P333, DOI 10.1016/j.biortech.2018.02.050; Worm B, 2017, ANNU REV ENV RESOUR, V42, P1, DOI 10.1146/annurev-environ-102016-060700; Yuan J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14425-6; Yurgel SN, 2017, PHYTOBIOMES J, V1, P102, DOI 10.1094/PBIOMES-03-17-0012-R; Yurgel SN, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01187; Zafar U, 2013, APPL ENVIRON MICROB, V79, P7313, DOI 10.1128/AEM.02536-13; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593; Zhang LL, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01131; Zhang N, 2006, MYCOLOGIA, V98, P1076, DOI 10.3852/mycologia.98.6.1076	47	18	18	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2019	14	3							e0214376	10.1371/journal.pone.0214376	http://dx.doi.org/10.1371/journal.pone.0214376			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ1KV	30908552	Green Submitted, Green Published, gold			2022-12-26	WOS:000462157600059
J	Vazquez-Mateo, C; Collins, J; Goldberg, SJ; Lawson, M; Hernandez-Escalante, J; Dooms, H				Vazquez-Mateo, Cristina; Collins, Justin; Goldberg, Sarah J.; Lawson, Maxx; Hernandez-Escalante, Jaileene; Dooms, Hans			Combining anti-IL-7Ra antibodies with autoantigen-specific immunotherapy enhances non-specific cytokine production but fails to prevent Type 1 Diabetes	PLOS ONE			English	Article							T-CELLS; NOD MOUSE; B-CELLS; ONSET; PHENOTYPE; CHILDREN; THERAPY; IL-7; RESPONSES; VACCINE	Autoantigen-specific methods to prevent and treat Type 1 Diabetes (T1D) carry high hopes to permanently cure this disease, but have largely failed in clinical trials. One suggested approach to increase the efficacy of islet antigen-specific vaccination is to combine it with a modulator of the T cell response, with the goal of reducing effector differentiation and promoting regulatory T cells (Tregs). Here we asked if addition of antibodies that block the IL-7/IL-7R alpha pathway altered the T cell response to islet antigen vaccination and prevented T1D in non-obese diabetic (NOD) mice. Anti-IL-7R alpha monoclonal antibodies (mAbs) reduced the numbers of islet antigen-specific T cells generated after vaccination with islet peptides and alum. However, addition of anti-IL-7R alpha antibodies to peptide/alum vaccination unexpectedly increased non-specific IFN-gamma, IL-2 and IL-10 cytokine production and did not result in improved prevention of T1D onset. In a second approach, we used a conjugate vaccine to deliver islet autoantigens, using Keyhole Limpet Hemocyanin (KLH) as a carrier. Islet anti-gen-KLH vaccination led to a significant expansion of antigen-specific Tregs and delayed diabetes onset in NOD mice. These outcomes were not further improved by addition of anti-IL-7R alpha antibodies. To the contrary, blocking IL-7R alpha during vaccination led to non-specific cytokine production and reduced the efficacy of a KLH-conjugated vaccine to prevent T1D. Our study thus revealed that adding anti-IL-7R alpha antibodies during autoantigen immunization did not improve the efficacy of such vaccinations to prevent T1D, despite altering some aspects of the T cell response in a potentially advantageous way. Further refinement of this approach will be required to separate the beneficial from the adverse effects of anti-IL-7R alpha antibodies to treat autoimmune disease.	[Vazquez-Mateo, Cristina; Collins, Justin; Goldberg, Sarah J.; Lawson, Maxx; Hernandez-Escalante, Jaileene; Dooms, Hans] Boston Univ, Sch Med, Dept Med, Arthrit Ctr,Rheumatol Sect, Boston, MA 02118 USA; [Hernandez-Escalante, Jaileene; Dooms, Hans] Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02118 USA	Boston University; Boston University	Dooms, H (corresponding author), Boston Univ, Sch Med, Dept Med, Arthrit Ctr,Rheumatol Sect, Boston, MA 02118 USA.; Dooms, H (corresponding author), Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02118 USA.	hdooms@bu.edu		Dooms, Hans/0000-0001-7964-0876	American Diabetes Association [1-13-BS-038]; JDRF [2-SRA-2015-77-QR]; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [1R01 DK-102911]; National Institute of Allergy and Infectious Diseases (NIAID) [T32-AI-007309]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007309] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK102911] Funding Source: NIH RePORTER	American Diabetes Association(American Diabetes Association); JDRF(Juvenile Diabetes Research Foundation); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by American Diabetes Association (www.diabetes.org) Basic Science grant #1-13-BS-038 (HD), JDRF (www.jdrf.org) Strategic Research Agreement 2-SRA-2015-77-QR (HD), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK, www.niddk.nih.gov) 1R01 DK-102911 (HD), and National Institute of Allergy and Infectious Diseases (NIAID, www.niaid.nih.gov) Research Training in Immunology grant T32-AI-007309 (JHE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MS, 2005, ANNU REV IMMUNOL, V23, P447, DOI 10.1146/annurev.immunol.23.021704.115643; Axelsson S, 2012, DIABETIC MED, V29, P1272, DOI 10.1111/j.1464-5491.2012.03710.x; Axelsson S, 2010, DIABETES-METAB RES, V26, P559, DOI 10.1002/dmrr.1126; Bassi R, 2011, CURR DIABETES REP, V11, P355, DOI 10.1007/s11892-011-0211-1; Ben Nasr M, 2015, ACTA DIABETOL, V52, P917, DOI 10.1007/s00592-015-0735-y; Ben Nasr M, 2015, PHARMACOL RES, V98, P31, DOI 10.1016/j.phrs.2014.07.004; Bluestone JA, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad4134; Boettler T, 2013, J AUTOIMMUN, V44, P40, DOI 10.1016/j.jaut.2013.05.002; Cerosaletti K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083811; Coppieters KT, 2013, CLIN IMMUNOL, V149, P345, DOI 10.1016/j.clim.2013.02.002; Dooms H, 2007, J EXP MED, V204, P547, DOI 10.1084/jem.20062381; Dooms H, 2013, J AUTOIMMUN, V45, P40, DOI 10.1016/j.jaut.2013.06.007; Fiorina P, 2008, DIABETES, V57, P3013, DOI 10.2337/db08-0420; Fiorina P, 2007, DIABETES, V56, P912, DOI 10.2337/db06-1445; Frumento D, 2017, J ENDOCRINOL INVEST, V40, P803, DOI 10.1007/s40618-017-0641-y; Goudy KS, 2011, EUR J IMMUNOL, V41, P1480, DOI 10.1002/eji.201040890; Gratz IK, 2013, J IMMUNOL, V190, P4483, DOI 10.4049/jimmunol.1300212; Harrison LC, 2013, CURR DIABETES REP, V13, P616, DOI 10.1007/s11892-013-0415-7; Herold KC, 2013, DIABETES, V62, P3766, DOI 10.2337/db13-0345; Hjorth M, 2011, CLIN IMMUNOL, V138, P117, DOI 10.1016/j.clim.2010.10.004; Hotta-Iwamura C, 2018, J AUTOIMMUN, V90, P39, DOI 10.1016/j.jaut.2018.01.005; Kleffel S, 2015, DIABETES, V64, P158, DOI 10.2337/db13-1639; Lee LF, 2012, P NATL ACAD SCI USA, V109, P12674, DOI 10.1073/pnas.1203795109; Li CR, 2011, J AUTOIMMUN, V37, P217, DOI 10.1016/j.jaut.2011.06.002; Lin MS, 2011, IMMUNOL RES, V50, P213, DOI 10.1007/s12026-011-8215-0; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Long SA, 2012, DIABETES; Ludvigsson J, 2012, NEW ENGL J MED, V366, P433, DOI 10.1056/NEJMoa1107096; Matthews JB, 2010, CLIN EXP IMMUNOL, V160, P176, DOI 10.1111/j.1365-2249.2010.04153.x; Moon JJ, 2009, NAT PROTOC, V4, P565, DOI 10.1038/nprot.2009.9; O'Gorman WE, 2009, J IMMUNOL, V183, P332, DOI 10.4049/jimmunol.0900691; Penaranda C, 2012, P NATL ACAD SCI USA, V109, P12668, DOI 10.1073/pnas.1203692109; Pescovitz MD, 2009, NEW ENGL J MED, V361, P2143, DOI 10.1056/NEJMoa0904452; Pihl M, 2013, CLIN EXP IMMUNOL, V172, P394, DOI 10.1111/cei.12078; Pihl M, 2017, CLIN IMMUNOL, V176, P114, DOI 10.1016/j.clim.2017.01.010; Rigby MR, 2015, J CLIN INVEST, V125, P3285, DOI 10.1172/JCI81722; Shoda LKM, 2005, IMMUNITY, V23, P115, DOI 10.1016/j.immuni.2005.08.002; Stadinski BD, 2010, NAT IMMUNOL, V11, P225, DOI 10.1038/ni.1844; Tang Q, 2008, IMMUNITY, V28, P687, DOI 10.1016/j.immuni.2008.03.016; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Tritt M, 2008, DIABETES, V57, P113, DOI 10.2337/db06-1700; Vazquez-Mateo C, 2017, BMC IMMUNOL, V18, DOI 10.1186/s12865-017-0201-4; von Herrath M, 2013, CLIN EXP IMMUNOL, V172, P186, DOI 10.1111/cei.12085; Wherrett DK, 2011, LANCET, V378, P319, DOI 10.1016/S0140-6736(11)60895-7; Yang JHM, 2015, DIABETES, V64, P3891, DOI 10.2337/db15-0516	45	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2019	14	3							e0214379	10.1371/journal.pone.0214379	http://dx.doi.org/10.1371/journal.pone.0214379			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ1KV	30908554	gold, Green Published, Green Submitted			2022-12-26	WOS:000462157600060
J	Lu, JW; Wang, WS; Zhou, Q; Gan, XW; Myatt, L; Sun, K				Lu, Jiang-Wen; Wang, Wang-Sheng; Zhou, Qiong; Gan, Xiao-Wen; Myatt, Leslie; Sun, Kang			Activation of prostaglandin EP4 receptor attenuates the induction of cyclooxygenase-2 expression by EP2 receptor activation in human amnion fibroblasts: implications for parturition	FASEB JOURNAL			English	Article						COX-2; PI3K; fetal membranes; preterm birth	DEHYDROGENASE TYPE-1 EXPRESSION; H SYNTHASE TYPE-2; PROSTANOID RECEPTORS; GLUCOCORTICOIDS STIMULATE; FETAL MEMBRANES; BINDING PROTEIN; HUMAN PLACENTA; PRETERM BIRTH; IN-VITRO; E-2	Human amnion fibroblasts produce abundant prostaglandin E2 (PGE2), which plays a crucial role in parturition by stimulating not only myometrial contraction and cervical ripening but also the expression of the rate-limiting enzyme in PGE2 synthesis-namely, cyclooxygenase-2 (COX-2). This feed-forward induction of COX-2 expression by PGE2 is mediated via its receptors coupled with the cAMP and PKA pathway and subsequent phosphorylation of the transcription factors cAMP-response element binding protein (CREB) and signal transducer and activator of transcription 3 (STAT3). Although prostaglandin E receptor (EP)-2 and EP4 for PGE2 are coupled with activation of the cAMP and PKA pathway, the exact roles of these 2 receptors in the regulation of COX-2 expression in amnion fibroblasts remain to be determined. Here, we clarify this issue by employing human amnion tissue and fibroblasts with the long-term objective of specific targeting of prostaglandin synthesis in prevention of preterm birth. We find that an EP2 agonist caused long-lasting increases in CREB phosphorylation and COX-2 expression, whereas an EP4 agonist induced only transient increases in CREB phosphorylation and COX-2 expression in amnion fibroblasts. Moreover, only EP2 stimulation increased STAT3 phosphorylation, whereas only EP4 stimulation increased PI3K activity. EP4 antagonist or inhibition of PI3K enhanced the induction of CREB and STAT3 phosphorylation and COX-2 expression by PGE2 or EP2 stimulation, which was attenuated by EP4 overexpression. Of interest, PGE2 and cortisol, both well-demonstrated stimulants of COX-2 expression in amnion fibroblasts, increased EP2 but decreased EP4 receptor expression. Furthermore, increased EP2 but decreased EP4 abundance were observed in amnion tissue at parturition. We conclude that EP2 and EP4 receptors play different roles in the regulation of COX-2 expression in human amnion fibroblasts. EP2 is the dominant PGE2 receptor mediating the induction of COX-2 at parturition, which can be attenuated by simultaneous activation of PI3K coupled to the EP4 receptor.-Lu, J.-W., Wang, W.-S., Zhou, Q., Gan, X.-W., Myatt, L., Sun, K. Activation of prostaglandin EP4 receptor attenuates the induction of cyclooxygenase-2 expression by EP2 receptor activation in human amnion fibroblasts: implications for parturition.	[Lu, Jiang-Wen; Wang, Wang-Sheng; Gan, Xiao-Wen; Sun, Kang] Shanghai Jiao Tong Univ, Ren Ji Hosp, Sch Med, Ctr Reprod Med, 845 Lingshan Rd, Shanghai 200135, Peoples R China; [Zhou, Qiong] Shanghai Jiao Tong Univ, Ren Ji Hosp, Sch Med, Dept Obstet & Gynecol, Shanghai, Peoples R China; [Lu, Jiang-Wen; Wang, Wang-Sheng; Gan, Xiao-Wen; Sun, Kang] Shanghai Key Lab Assisted Reprod & Reprod Genet, Shanghai, Peoples R China; [Myatt, Leslie] Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Portland, OR 97201 USA	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Oregon Health & Science University	Sun, K (corresponding author), Shanghai Jiao Tong Univ, Ren Ji Hosp, Sch Med, Ctr Reprod Med, 845 Lingshan Rd, Shanghai 200135, Peoples R China.	sungangrenji@hotmail.com	Wang, Wang-sheng/E-9811-2017	Wang, Wang-sheng/0000-0003-1429-9237; Sun, Kang/0000-0003-2727-141X	National Natural Science Foundation of China [81830042, 81330018]; National Key Technologies Research and Development Program of China [2017YFC1001403]; Doctorial Innovation Fund of Shanghai Jiao Tong University School of Medicine [BXJ201825]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technologies Research and Development Program of China(National Key Technology R&D Program); Doctorial Innovation Fund of Shanghai Jiao Tong University School of Medicine	This work was supported by The National Natural Science Foundation of China (Grants 81830042 and 81330018), the National Key Technologies Research and Development Program of China (2017YFC1001403), and the Doctorial Innovation Fund of Shanghai Jiao Tong University School of Medicine (BXJ201825). The authors declare no conflicts of interest.	Abramovitz M, 2000, BBA-MOL CELL BIOL L, V1483, P285, DOI 10.1016/S1388-1981(99)00164-X; af Forselles KJ, 2011, BRIT J PHARMACOL, V164, P1847, DOI 10.1111/j.1476-5381.2011.01495.x; Ansari KM, 2007, CARCINOGENESIS, V28, P2063, DOI 10.1093/carcin/bgm011; BERNAL AL, 1982, J ENDOCRINOL, V93, P141, DOI 10.1677/joe.0.0930141; Billot X, 2003, BIOORG MED CHEM LETT, V13, P1129, DOI 10.1016/S0960-894X(03)00042-8; Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; CASEY ML, 1985, J CLIN INVEST, V75, P1852, DOI 10.1172/JCI111899; Challis JRG, 1997, ANN NY ACAD SCI, V828, P254, DOI 10.1111/j.1749-6632.1997.tb48546.x; Claria J, 2003, CURR PHARM DESIGN, V9, P2177, DOI 10.2174/1381612033454054; Desai S, 2000, MOL PHARMACOL, V58, P1279, DOI 10.1124/mol.58.6.1279; DRAY F, 1976, AM J OBSTET GYNECOL, V126, P13, DOI 10.1016/0002-9378(76)90457-9; DUCHESNE MJ, 1978, PROSTAG OTH LIPID M, V15, P19, DOI 10.1016/S0090-6980(78)80003-3; Economopoulos P, 1996, MOL CELL ENDOCRINOL, V117, P141, DOI 10.1016/0303-7207(95)03739-X; Fujino H, 2005, MOL PHARMACOL, V68, P251, DOI 10.1124/mol.105.011833; Fujino H, 2002, J BIOL CHEM, V277, P2614, DOI 10.1074/jbc.M109440200; Fujino H, 2003, J BIOL CHEM, V278, P12151, DOI 10.1074/jbc.M212665200; Grigsby PL, 2006, AM J OBSTET GYNECOL, V195, P260, DOI 10.1016/j.ajog.2006.01.082; Hata AN, 2004, PHARMACOL THERAPEUT, V103, P147, DOI 10.1016/j.pharmthera.2004.06.003; Jo SH, 2002, CIRC RES, V91, P46, DOI 10.1161/01.RES.0000024115.67561.54; Kabashima K, 2002, J CLIN INVEST, V109, P883, DOI 10.1172/JCI14459; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; KREDENTSER JV, 1995, AM J OBSTET GYNECOL, V173, P199, DOI 10.1016/0002-9378(95)90190-6; Legler DF, 2010, INT J BIOCHEM CELL B, V42, P198, DOI 10.1016/j.biocel.2009.09.015; Li JN, 2011, J CLIN ENDOCR METAB, V96, pE899, DOI 10.1210/jc.2010-2852; Li XQ, 2014, PLACENTA, V35, P291, DOI 10.1016/j.placenta.2014.03.005; Liu C, 2016, MOL CELL ENDOCRINOL, V424, P118, DOI 10.1016/j.mce.2016.01.022; Lu JW, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aac6160; Majumder M, 2016, STEM CELLS, V34, P2290, DOI 10.1002/stem.2426; Menon R, 2016, HUM REPROD UPDATE, V22, P535, DOI 10.1093/humupd/dmw022; Myatt L, 2010, INT J DEV BIOL, V54, P545, DOI 10.1387/ijdb.082771lm; Nishigaki N, 1996, MOL PHARMACOL, V50, P1031; Olson DM, 2003, BEST PRACT RES CL OB, V17, P717, DOI 10.1016/S1521-6934(03)00069-5; PHILLIPS CA, 1981, BRIT J PHARMACOL, V73, P75, DOI 10.1111/j.1476-5381.1981.tb16773.x; Pino MS, 2005, CANCER BIOL THER, V4, P1263, DOI 10.4161/cbt.4.11.2138; POYSER NL, 1981, PROSTAGLANDINS REPRO; REGAN JW, 1994, MOL PHARMACOL, V46, P213; REHNSTROM J, 1983, PROSTAGLANDINS, V26, P973, DOI 10.1016/0090-6980(83)90158-2; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Romero R, 2014, SCIENCE, V345, P760, DOI 10.1126/science.1251816; Rundhaug JE, 2011, CANCER METAST REV, V30, P465, DOI 10.1007/s10555-011-9317-9; Saigal S, 2008, LANCET, V371, P261, DOI 10.1016/S0140-6736(08)60136-1; SENIOR J, 1993, BRIT J PHARMACOL, V108, P501, DOI 10.1111/j.1476-5381.1993.tb12832.x; Sugimoto Y, 2007, J BIOL CHEM, V282, P11613, DOI 10.1074/jbc.R600038200; Sun K, 2003, ENDOCRINOLOGY, V144, P5568, DOI 10.1210/en.2003-0780; Sun K, 2003, J CLIN ENDOCR METAB, V88, P5564, DOI 10.1210/jc.2003-030875; Tamiji J, 2010, BIOCHEM BIOPH RES CO, V399, P565, DOI 10.1016/j.bbrc.2010.07.112; Vo BT, 2013, ENDOCRINOLOGY, V154, P1768, DOI 10.1210/en.2012-2074; Wang WS, 2018, ENDOCR REV, V39, P241, DOI 10.1210/er.2017-00188; Wang WS, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aac6151; WIKLAND M, 1982, ACTA OBSTET GYN SCAN, V61, P467, DOI 10.3109/00016348209156592; Winkler M, 1997, OBSTET GYNECOL, V89, P398, DOI 10.1016/S0029-7844(96)00500-5; Yang Z, 2007, J ENDOCRINOL, V195, P241, DOI 10.1677/JOE-07-0303; ZAKAR T, 1995, ENDOCRINOLOGY, V136, P1610, DOI 10.1210/en.136.4.1610; Zhu XO, 2009, MOL ENDOCRINOL, V23, P1839, DOI 10.1210/me.2009-0201	54	15	15	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2019	33	7					8148	8160		10.1096/fj.201802642R	http://dx.doi.org/10.1096/fj.201802642R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ9SM	30917001				2022-12-26	WOS:000476234700028
J	Waldrop, SG; Sriranganathan, N				Waldrop, Steven Grant; Sriranganathan, Nammalwar			Intracellular invasion and survival of Brucella neotomae, another possible zoonotic Brucella species	PLOS ONE			English	Article							MACROPHAGES; INFECTION; VACCINE	In 1967, Brucella neotomae was first isolated from Neotoma lepida, the dessert wood rat, in Utah. With little infection data since its discovery, the zoonotic potential of this Brucella species is largely unknown. Recent reports of isolation from human cerebrospinal fluid, along with current literature suggest that B. neotomae has the ability to infect various hosts and cell types. In this report we extend the knowledge of B. neotomae ATCC 23459's intracellular invasion and survival abilities to a variety of cell lines through gentamicin protection assays. Some of the phagocytic and epithelial cell lines from various mammalian species represent characteristics of some cell types that could be encountered by Brucella in potential hosts. It was found that B. neotomae ATCC 23459 exhibits generally lower intracellular bacterial CFUs compared to the mouse-passaged strain of B. neotomae ATCC 23459, B. suis 1330, and B. abortus 2308. Ultimately, these observations provide a small piece of the puzzle in the investigation of the breadth of B. neotomae's pathogenic potential.	[Waldrop, Steven Grant; Sriranganathan, Nammalwar] Virginia Tech, Dept Biomed Sci & Pathobiol, Virginia Maryland Coll Vet Med, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University	Sriranganathan, N (corresponding author), Virginia Tech, Dept Biomed Sci & Pathobiol, Virginia Maryland Coll Vet Med, Blacksburg, VA 24061 USA.	nathans@vt.edu			Virginia-Maryland College of Veterinary Medicine's Research and Graduate Studies department; USDA; Smithfield; Smithfield Foods Murphy Brown, LLC. (Virginia Tech Foundation, Inc.) [444115]; Virginia APHIS-USDA [422319]; Virginia Tech's Open Access Subvention Fund	Virginia-Maryland College of Veterinary Medicine's Research and Graduate Studies department; USDA(United States Department of Agriculture (USDA)); Smithfield; Smithfield Foods Murphy Brown, LLC. (Virginia Tech Foundation, Inc.); Virginia APHIS-USDA; Virginia Tech's Open Access Subvention Fund	The authors are supported by the Virginia-Maryland College of Veterinary Medicine's Research and Graduate Studies department. Support for this work was provided by the USDA and Smithfield. We thank Smithfield Foods Murphy Brown, LLC. (Virginia Tech Foundation, Inc. Fund #444115) and Virginia APHIS-USDA (Fund #422319) for their support. Additionally, the Virginia Tech's Open Access Subvention Fund covered the article processing charge. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida RA, 1996, J DAIRY SCI, V79, P1021, DOI 10.3168/jds.S0022-0302(96)76454-8; Barquero-Calvo E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000631; BEAL GA, 1959, AM J VET RES, V20, P872; Bohlin J, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-249; Cameron HS, METABOLIC STUDIES BR; Castaneda-Roldan EI, 2004, CELL MICROBIOL, V6, P435, DOI 10.1111/j.1462-5822.2004.00372.x; CDC, 2009, MORBIDITY MORTALITY; Covert J, 2009, EXP BIOL MED, V234, P1450, DOI 10.3181/0904-RM-124; Czibener C, 2016, VACCINE, V34, P1524, DOI 10.1016/j.vaccine.2016.02.025; Dabral N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107180; Dee TA., 1990, THESIS; Ducrotoy MJ, 2015, INFECT DIS POVERTY, V4, DOI 10.1186/s40249-015-0086-5; GIBBY IW, 1965, J BACTERIOL, V89, P9, DOI 10.1128/JB.89.1.9-16.1965; Kang YS, 2019, INFECT IMMUN, V87, DOI 10.1128/IAI.00255-18; Kang YS, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00991-16; Kaur Gurvinder, 2012, Spermatogenesis, V2, P1; Kim S, 2015, INTERACTION BRUCELLA, DOI [10.5772/61463, DOI 10.5772/61463]; Larsen AK, 2015, BIOMED CENTRAL, V58, P9, DOI [10.1186/s13028-016-0188-5, DOI 10.1186/S13028-016-0188-5]; Larsen AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084861; Lindsay DS, 2016, BOVINE MACROPHAGE BM; Lopez-Goni I, 2008, J CLIN MICROBIOL, V46, P3484, DOI 10.1128/JCM.00837-08; LSU, 2009, BRUC SPEC PRES TEST, P1; Macedo AA, 2013, VET IMMUNOL IMMUNOP, V151, P294, DOI 10.1016/j.vetimm.2012.12.001; Martin-Martin AI, 2010, MICROBES INFECT, V12, P246, DOI 10.1016/j.micinf.2009.12.008; MichauxCharachon S, 1997, J BACTERIOL, V179, P3244, DOI 10.1128/jb.179.10.3244-3249.1997; Moustafa D, 2011, VACCINE, V29, P784, DOI 10.1016/j.vaccine.2010.11.018; Moustafa DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014112; Murphy E, 2002, FEMS IMMUNOL MED MIC, V33, P191, DOI 10.1111/j.1574-695X.2002.tb00590.x; Nielsen K, 1990, ANIMAL BRUCELLOSIS; Pan L, 2017, MOL CELLS, V40, P109, DOI 10.14348/molcells.2017.2207; Pappas G, 2006, LANCET INFECT DIS, V6, P91, DOI 10.1016/S1473-3099(06)70382-6; Seleem MN, 2010, VET MICROBIOL, V140, P392, DOI 10.1016/j.vetmic.2009.06.021; Soler-Llorens PF, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00116; STOENNER HG, 1963, AM J VET RES, V24, P376; STOENNER HG, 1957, AM J VET RES, V18, P947; Suarez-Esquivel M, 2017, EMERG INFECT DIS, V23, P997, DOI 10.3201/eid2306.162018; Swearengen JR, 2012, BIODEFENSE RESEARCH METHODOLOGY AND ANIMAL MODELS, 2ND EDITION, P27; Turner K.E., 1990, THESIS TEXAS A M, P62; Verdiguel-Fernandez L, 2017, ARCH MICROBIOL, V199, P971, DOI 10.1007/s00203-017-1360-7; Villalobos-Vindas Juan M, 2017, J Med Case Rep, V11, P352, DOI 10.1186/s13256-017-1496-8; von Bargen K, 2012, FEMS MICROBIOL REV, V36, P533, DOI 10.1111/j.1574-6976.2012.00334.x; Whatmore AM, 2008, EMERG INFECT DIS, V14, P517, DOI 10.3201/eid1403.070829; ZAVIZION B, 1995, J DAIRY SCI, V78, P515, DOI 10.3168/jds.S0022-0302(95)76662-0	43	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0213601	10.1371/journal.pone.0213601	http://dx.doi.org/10.1371/journal.pone.0213601			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR5NS	30943213	Green Published, Green Submitted, gold			2022-12-26	WOS:000463194300016
J	Chen, XL; Xie, YF; Li, JX; Wu, W; Li, GN; Hu, HJ; Wang, XY; Meng, ZJ; Wen, YF; Huang, WH				Chen, Xiao-Long; Xie, Ya-Fen; Li, Jian-Xin; Wu, Wu; Li, Guan-Nan; Hu, Hui-Jing; Wang, Xiao-Yun; Meng, Zhao-Jian; Wen, Yue-Feng; Huang, Wen-Hua			Design and basic research on accuracy of a novel individualized three-dimensional printed navigation template in atlantoaxial pedicle screw placement	PLOS ONE			English	Article							EFFICACY; INJURY	Objective To design and evaluate the accuracy of a novel navigation template suitable for posterior cervical screw placement surgery by using 3D printing technology to improve the existing guiding template design. Methods The researchers (including spine surgeons and technicians) used CT to perform thin-slice scanning on 12 cases of normal upper cervical vertebral specimens and defined the screw channels that were completely located in the pedicle without penetrating the cortex as ideal screw channels, then designed the ideal channel of the upper cervical vertebral (atlantoaxial) pedicle screw by computer software which was regarded as the preset values, and recorded the screw entrance point, transverse angle and sagittal angle of the ideal channel. Then, researchers designed the novel navigation templates for placement pedicle screw according to the ideal screw channel preset values and manufactured them with one for every single vertebra by 3D printer. A senior spine surgeon performed the posterior surgery to implant pedicle screw on the specimens by the novel navigation templates, then performed CT thin-slice scanning on the specimens again after removing the screws, and reconstructed the actual screws channel by computer software, recorded the screw entrance point, transverse angle and sagittal angle of the actual channels which were defined as the actual values and evaluated them according to Kawaguchi's pedicle screw evaluation standard finally. The differences between the preoperative preset values of ideal screw channel and the postoperative actual values of actual screw channel were compared by a nonparametric paired rank test. Results 48 screws were placed on 12 cases of upper cervical vertebral specimens in total. It showed that the grade 0, I, II, III channels in this study were 47, 1, 0, 0, respectively. The grade 0 channels accounted for 97.92% of the total number of channels. There was no significant difference with regard to the screw entrance point, the transverse angle, and the sagittal angle between the preoperative preset values of ideal screw channels and the postoperative actual values of actual screw channels. Conclusion To implant pedicle screw assisted with the novel individually navigation template designed by 3D printed in the posterior cervical surgery can improve accuracy of pedicle screw placement and safety of the surgery.	[Chen, Xiao-Long; Xie, Ya-Fen; Li, Jian-Xin] Guangdong Prov Work Injury Rehabil Hosp, Dept Spine Surg, Guangzhou, Guangdong, Peoples R China; [Wu, Wu; Li, Guan-Nan] Guangdong Prov Work Injury Rehabil Hosp, Dept Joint Surg, Guangzhou, Guangdong, Peoples R China; [Hu, Hui-Jing; Wang, Xiao-Yun; Meng, Zhao-Jian] Guangdong Prov Work Injury Rehabil Hosp, Inst Rehabil Med, Guangzhou, Peoples R China; [Wen, Yue-Feng] Guangzhou Med Univ, Affiliated Canc Hosp & Inst, Dept Radiotherapy, Guangzhou, Guangdong, Peoples R China; [Huang, Wen-Hua] Southern Med Univ, Sch Basic Med Sci, Natl Key Discipline Human Anat, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University; Southern Medical University - China	Chen, XL (corresponding author), Guangdong Prov Work Injury Rehabil Hosp, Dept Spine Surg, Guangzhou, Guangdong, Peoples R China.; Huang, WH (corresponding author), Southern Med Univ, Sch Basic Med Sci, Natl Key Discipline Human Anat, Guangzhou, Guangdong, Peoples R China.	chenxiaolong_1980@126.com; 1073851445@qq.com	li, jian/GSE-0245-2022; Li, Jing/GYU-5036-2022; Li, Jin/GYQ-5363-2022; LI, JIAN/GRY-2197-2022		National Key R&D Program of China [2017YFC1103403]; Science and Technology Project of Guangdong Province [2017B090912006]	National Key R&D Program of China; Science and Technology Project of Guangdong Province	This study was supported by grants from the National Key R&D Program of China (NO. 2017YFC1103403), the Science and Technology Project of Guangdong Province (NO. 2017B090912006).	Hojo Y, 2014, EUR SPINE J, V23, P2166, DOI 10.1007/s00586-014-3470-0; Hu Y, 2014, ORTHOPEDICS, V37, pE420, DOI 10.3928/01477447-20140430-51; Jiang LH, 2016, ARCH ORTHOP TRAUM SU, V136, P1483, DOI 10.1007/s00402-016-2530-9; Kaneyama S, 2015, SPINE, V40, pE341, DOI 10.1097/BRS.0000000000000772; Kaneyama S, 2014, J NEUROSURG-SPINE, V21, P231, DOI 10.3171/2014.3.SPINE13730; Kawaguchi Y, 2012, SPINE, V37, P1983, DOI 10.1097/BRS.0b013e31825ab547; Li XC, 2015, CLIN TRANSPLANT, V29, P786, DOI 10.1111/ctr.12580; Lu S, 2011, COMPUT AIDED SURG, V16, P240, DOI 10.3109/10929088.2011.605173; Lu S, 2009, SPINE, V34, pE959, DOI 10.1097/BRS.0b013e3181c09985; Mueller CA, 2010, EUR SPINE J, V19, P809, DOI 10.1007/s00586-010-1291-3; Neo M, 2005, SPINE, V30, P2800, DOI 10.1097/01.brs.0000192297.07709.5d; Pu XW, 2018, WORLD NEUROSURG, V114, pE1, DOI 10.1016/j.wneu.2017.11.042; Ryken T, 2009, J NEUROSURG-SPINE, V10, P21, DOI 10.3171/2008.9.SPI08229; Vukicevic M, 2017, ANN BIOMED ENG, V45, P508, DOI 10.1007/s10439-016-1676-5	14	6	8	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2019	14	4							e0214460	10.1371/journal.pone.0214460	http://dx.doi.org/10.1371/journal.pone.0214460			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR2UW	30939170	Green Submitted, Green Published, gold			2022-12-26	WOS:000462993900023
J	Aghapour, M; Bockstahler, B; Kneissl, S; Tichy, A; Vidoni, B				Aghapour, Masoud; Bockstahler, Barbara; Kneissl, Sibylle; Tichy, Alexander; Vidoni, Britta			Femoral and tibial alignments in chihuahuas with patellar luxation by radiograph: Angular values and intra- and inter-observer agreement of measurements	PLOS ONE			English	Article							SURGICAL-CORRECTION; ANGLE MEASUREMENTS; PELVIC LIMB; DOGS; INCLINATION; VARUS; NECK; DEFORMITIES; ANTEVERSION; FREQUENCY	Measurement of fore and pelvic limb alignment in veterinary orthopedics is significant, as it is in human medicine. The establishment of reference ranges for alignments and comparing measured ranges in diseased animals to these reference values would allow veterinarians to specify the quantitative degree of an angular deformity, plan suitable treatments and evaluate treatment outcomes. Patellar luxation is a common orthopedic disease in small animal clinics. Severe grades of MPL may present with bone deformities or abnormal alignments; therefore, evaluation of the measurement methods of femoral and tibial alignment in dogs with different grades of patellar luxation to assess the accuracy and reliability of the measurements could be useful. In this retrospective study radiographs of 21 client-owned Chihuahuas that had been presented to the Small Animal Surgery of Vetmeduni Vienna from 2012-2016 with a diagnose of patellar luxation were selected. The measurements were performed on frontal, lateral and axial view radiographs to determine the femoral and tibial angles and to evaluate the intra- and inter-observer variabilities of the protocol. Radiographs of each dog were investigated by three observers. Intra-observer variability was based on measurements by each observer who repeated the protocol two times to evaluate repeatability. Inter-observer variability was based on the measurements between the three observers to evaluate the reproducibility of the protocol. The results of the study showed that 92.85% of inter-observer ICC (intra-class correlation coefficient) had high correlation, and the remaining 7.15% had good correlation. Intra-observer ICCs for measurements of the first observer were 28.57% high correlation and 50% good correlation. For the second observer, 100% high correlation was recorded, and for the third observer 71.42% high correlation and 14.28% good correlation was recorded. These results show that the selected methods have high correlation and could be used as a reliable method in veterinary orthopedics.	[Aghapour, Masoud; Vidoni, Britta] Univ Vet Med, Dept Compan Anim & Horses, Univ Clin Small Anim, Small Anim Surg, Vienna, Austria; [Bockstahler, Barbara] Univ Vet Med, Dept Compan Anim & Horses, Univ Clin Small Anim, Sect Phys Therapy,Small Anim Surg, Vienna, Austria; [Kneissl, Sibylle] Univ Vet Med, Dept Compan Anim & Horses, Univ Clin Small Anim, Diagnost Imaging, Vienna, Austria; [Tichy, Alexander] Univ Vet Med, Dept Biomed Sci Platform Bioinformat & Biostat, Vienna, Austria	University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna	Aghapour, M (corresponding author), Univ Vet Med, Dept Compan Anim & Horses, Univ Clin Small Anim, Small Anim Surg, Vienna, Austria.	masoud.aghapour@vetmeduni.ac.at	Kneissl, Sibylle Maria/ABD-8091-2021; Bockstahler, Barbara/P-3152-2019; Vidoni, Britta/AAD-4498-2021; Aghapour, Masoud/AGK-4911-2022	Kneissl, Sibylle Maria/0000-0001-9588-4715; Bockstahler, Barbara/0000-0002-1499-5753; Aghapour, Masoud/0000-0002-9654-1666				Alam MR, 2007, VET COMP ORTHOPAED, V20, P59; Arthurs GI, 2006, VET SURG, V35, P559, DOI 10.1111/j.1532-950X.2006.00189.x; BARDET JF, 1983, VET SURG, V12, P1, DOI 10.1111/j.1532-950X.1983.tb00693.x; Barnes DM, 2015, VET SURG, V44, P85, DOI 10.1111/j.1532-950X.2014.12265.x; Cicchetti D.V., 1994, PSYCHOL ASSESS, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; Dismukes DI, 2008, VET SURG, V37, P674, DOI 10.1111/j.1532-950X.2008.00434.x; Dismukes DI, 2008, VET SURG, V37, P300, DOI 10.1111/j.1532-950X.2008.00381.x; Dismukes DI, 2007, VET SURG, V36, P699, DOI 10.1111/j.1532-950X.2007.00323.x; Dudley RM, 2006, VET RADIOL ULTRASOUN, V47, P546, DOI 10.1111/j.1740-8261.2006.00184.x; Fossum, 2002, SMALL ANIMAL SURG, P1143; Franklin SP, 2012, VET SURG, V41, P86, DOI 10.1111/j.1532-950X.2011.00923.x; Fuller MC, 2014, CAN VET J, V55, P757; Gibbons SE, 2006, J SMALL ANIM PRACT, V47, P3, DOI 10.1111/j.1748-5827.2006.00067.x; Glassman M, 2011, VET SURG, V40, P830, DOI 10.1111/j.1532-950X.2011.00857.x; HAUPTMAN J, 1983, VET SURG, V12, P189, DOI 10.1111/j.1532-950X.1983.tb00740.x; Hauptman J., 1979, VET SURG, V8, P74, DOI [10.1111/j.1532-950X.1979.tb00612.x, DOI 10.1111/J.1532-950X.1979.TB00612.X]; HAYES AG, 1994, J AM VET MED ASSOC, V205, P716; HULSE DA, 1981, VET MED SM ANIM CLIN, V76, P43; Hulse DA., 1993, DIS MECH SMALL ANIMA, P808; Jackson GM, 2012, VET SURG, V41, P994, DOI 10.1111/j.1532-950X.2012.01059.x; Lambert RJ, 2010, VET SURG, V39, P181, DOI 10.1111/j.1532-950X.2009.00625.x; Macias C, 2002, J SMALL ANIM PRACT, V43, P433, DOI 10.1111/j.1748-5827.2002.tb00009.x; Miles JE, 2015, VET COMP ORTHOPAED, V28, P193, DOI 10.3415/VCOT-14-08-0127; MONTAVON PM, 1985, VET SURG, V14, P277, DOI 10.1111/j.1532-950X.1985.tb00883.x; Mortari AC, 2009, CAN VET J, V50, P1064; NUNAMAKER DM, 1973, J AM VET RADIOL SOC, V14, P45; Olimpo M, 2016, VET ITAL, P1; Osmond CS, 2006, VET RADIOL ULTRASOUN, V47, P136, DOI 10.1111/j.1740-8261.2006.00119.x; Paley D, 2002, PRINCIPLES DEFORMITY, DOI [10.1007/978-3-642-59373-4, DOI 10.1007/978-3-642-59373-4_6]; Phetkaew T, 2018, VET COMP ORTHOPAED, V31, P114, DOI [10.3415/VCOT-17-05-0067, 10.1055/s-0038-1667359]; Piermattei DL., 2006, HDB SMALL ANIMAL ORT, P562; RUMPH PF, 1990, VET SURG, V19, P328, DOI 10.1111/j.1532-950X.1990.tb01200.x; Sarierler M, 2004, ACTA VET HUNG, V52, P245, DOI 10.1556/AVet.52.2004.2.13; Schawalder P, 1981, CENTRUM COLLUM DIAPH; SINGLETO.WB, 1969, J SMALL ANIM PRACT, V10, P59, DOI 10.1111/j.1748-5827.1969.tb04021.x; Soparat C, 2012, VET COMP ORTHOPAED, V25, P197, DOI 10.3415/VCOT-11-04-0057; Swiderski JK, 2008, VET SURG, V37, P43, DOI 10.1111/j.1532-950X.2007.00347.x; Tomlinson J, 2007, VET SURG, V36, P593, DOI 10.1111/j.1532-950X.2007.00309.x; Vasseur P. B., 2003, TXB SMALL ANIMAL SUR, V3rd, P2090; Vedrine B, 2013, VET COMP ORTHOPAED, V26, P266, DOI 10.3415/VCOT-12-02-0018; WILLAUER CC, 1987, VET SURG, V16, P31, DOI 10.1111/j.1532-950X.1987.tb00910.x; Witte PG, 2015, VET COMP ORTHOPAED, V28, P331, DOI 10.3415/VCOT-14-12-0186; Yasukawa S, 2016, VET COMP ORTHOPAED, V29, P29, DOI 10.3415/VCOT-15-05-0089; Zilincik M, 2018, VET COMP ORTHOPAED, V31, P17, DOI 10.3415/VCOT-17-01-0018	44	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214579	10.1371/journal.pone.0214579	http://dx.doi.org/10.1371/journal.pone.0214579			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921407	Green Submitted, gold, Green Published			2022-12-26	WOS:000462594000090
J	Decourt, C; Robert, V; Lomet, D; Anger, K; Georgelin, M; Poissenot, K; Pellicer-Rubio, MT; Aucagne, V; Beltramo, M				Decourt, Caroline; Robert, Vincent; Lomet, Didier; Anger, Karine; Georgelin, Marion; Poissenot, Kevin; Pellicer-Rubio, Maria-Teresa; Aucagne, Vincent; Beltramo, Massimiliano			The kisspeptin analog C6 is a possible alternative to PMSG (pregnant mare serum gonadotropin) for triggering synchronized and fertile ovulations in the Alpine goat	PLOS ONE			English	Article							LUTEINIZING-HORMONE SECRETION; INVESTIGATIONAL METASTIN/KISSPEPTIN ANALOG; ARTIFICIAL-INSEMINATION; PROGESTERONE; ESTRUS; LH; REPRODUCTION; PLASMA; EWES; ESTRADIOL	In temperate regions goat's reproduction is seasonal. To obtain year-round breeding, hormonal treatments are currently applied. These treatments usually combine a progesterone analog with the pregnant mare serum gonadotropin (PMSG). However, their use has significant ethical and environmental drawbacks. Therefore, alternative methods to manage reproduction are needed. The discovery that in mammals the neuropeptide kisspeptin is a major positive regulator of hypothalamo-pituitary gonadal axis offered an attractive alternative strategy to control reproduction. We have previously designed a kisspeptin analog, called C6, which offers pharmacological advantages over endogenous kisspeptin. These include a longer lasting effect and enhanced activity following intramuscular injection. In the present work, we evaluated C6 effect on LH and FSH plasma concentrations in the Alpine goat breed and tested whether C6 could replace PMSG to trigger ovulation. An intramuscular injection of C6 (15 nmol/doe) given 24 hours after the end of progestogen treatment induced a surge-like peak of both LH and FSH. This was followed by an increase of progesterone, a hallmark of ovulation induction and corpus luteus formation. These results were obtained at three different time of the year: during the breeding season, the non-breeding season and at the onset of the breeding season. Furthermore, we compared the efficacy of C6 and PMSG to induce fertile ovulations when these treatments are given at the onset of the breeding season and are followed by artificial insemination. The results of this first attempt were extremely promising with gestation rates of 45% and 64% for C6 and PMSG respectively. Pending optimization of the treatment procedure in order to improve efficacy, kisspeptin analogs could be the long sought-after alternative to PMSG.	[Decourt, Caroline; Robert, Vincent; Lomet, Didier; Anger, Karine; Georgelin, Marion; Poissenot, Kevin; Pellicer-Rubio, Maria-Teresa; Beltramo, Massimiliano] Univ Tours, UMR Physiol Reprod & Comportements INRA, CNRS, UMR85,UMR7247,IFCE, Nouzilly, France; [Aucagne, Vincent] CNRS, UPR 4301, Ctr Biophys Mol, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; Universite de Tours; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC)	Beltramo, M (corresponding author), Univ Tours, UMR Physiol Reprod & Comportements INRA, CNRS, UMR85,UMR7247,IFCE, Nouzilly, France.	Massimiliano.Beltramo@inra.fr	Aucagne, Vincent/AAB-1856-2019; POISSENOT, Kévin/GMW-7942-2022; decourt, caroline/AAF-9534-2019	POISSENOT, Kevin/0000-0003-4236-1421; Ferreira, Agustin Francisco/0000-0003-0286-7524; Beltramo, Massimiliano/0000-0003-3472-2477; Aucagne, Vincent/0000-0002-2647-0188	French National Research Agency (ANR, Kiss project) [ANR-15-CE20-0015-01]; Region Centre Val de Loire (Capriss project)	French National Research Agency (ANR, Kiss project); Region Centre Val de Loire (Capriss project)	CD, VR, DL, KA, MG, KP, M-TP-R, VA and MB were supported by the French National Research Agency (ANR, Kiss project, ANR-15-CE20-0015-01) http://www.agence-nationale-recherche.fr/and Region Centre Val de Loire (Capriss project) http://www.regioncentre-valdeloire.fr/accueil.html.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arjmand Mohammad, 2014, Vet Res Forum, V5, P247; Asami T, 2013, J MED CHEM, V56, P8298, DOI 10.1021/jm401056w; Beltramo M, 2015, J MED CHEM, V58, P3459, DOI 10.1021/jm5019675; Caillat H, 2011, RENC RECH RUMIN, V18, P418; Caraty A, 2007, ENDOCRINOLOGY, V148, P5258, DOI 10.1210/en.2007-0554; CHEMINEAU P, 1982, THERIOGENOLOGY, V17, P313, DOI 10.1016/0093-691X(82)90091-7; Chemineau P., 1994, Productions Animales (Paris), V7, P315; Dardente H, 2016, THERIOGENOLOGY, V86, P324, DOI 10.1016/j.theriogenology.2016.04.045; de Roux N, 2003, P NATL ACAD SCI USA, V100, P10972, DOI 10.1073/pnas.1834399100; Decourt C, 2016, SCI REP-UK, V6, DOI 10.1038/srep26908; Endo N, 2015, ANIM REPROD SCI, DOI [10.1016/j.anireprosci, DOI 10.1016/J.ANIREPROSCI.]; Endo N, 2015, ANIM REPROD SCI, V159, P87, DOI 10.1016/j.anireprosci.2015.05.016; Fatet A, 2011, ANIM REPROD SCI, V124, P211, DOI 10.1016/j.anireprosci.2010.08.029; Goto Y, 2014, REPROD DOMEST ANIM, V49, P338, DOI 10.1111/rda.12283; Hashizume T, 2010, ANIM REPROD SCI, V118, P37, DOI 10.1016/j.anireprosci.2009.05.017; Knights M, 2016, ANIM SCI J, V87, P1084, DOI 10.1111/asj.12627; Leboeuf B, 2008, REPROD DOMEST ANIM, V43, P379, DOI 10.1111/j.1439-0531.2008.01188.x; Lopez-Sebastian A, 2007, THERIOGENOLOGY, V68, P1081, DOI 10.1016/j.theriogenology.2007.08.003; MONTGOMERY GW, 1985, J REPROD FERTIL, V73, P173, DOI 10.1530/jrf.0.0730173; MORI Y, 1984, J REPROD FERTIL, V72, P223, DOI 10.1530/jrf.0.0720223; Motlomelo KC, 2002, SMALL RUMINANT RES, V45, P45, DOI 10.1016/S0921-4488(02)00113-X; PANT HC, 1977, J ENDOCRINOL, V73, P247, DOI 10.1677/joe.0.0730247; PELLETIER J, 1968, CR ACAD SCI D NAT, V266, P2352; Pinilla L, 2012, PHYSIOL REV, V92, P1235, DOI 10.1152/physrev.00037.2010; Romano JE, 2004, SMALL RUMINANT RES, V55, P15, DOI 10.1016/j.smallrumres.2003.10.015; Roy F, 1999, BIOL REPROD, V60, P805, DOI 10.1095/biolreprod60.4.805; Sebert ME, 2010, DOMEST ANIM ENDOCRIN, V38, P289, DOI 10.1016/j.domaniend.2010.01.001; Seminara SB, 2003, NEW ENGL J MED, V349, P1614, DOI 10.1056/NEJMoa035322; Vilarino M, 2011, THERIOGENOLOGY, V75, P1195, DOI 10.1016/j.theriogenology.2010.11.030; WHEATLEY IS, 1969, J REPROD FERTIL, V19, P211, DOI 10.1530/jrf.0.0190211; Yotov S. A., 2016, Asian Pacific Journal of Reproduction, V5, P144	31	15	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214424	10.1371/journal.pone.0214424	http://dx.doi.org/10.1371/journal.pone.0214424			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921391	Green Published, Green Submitted, gold			2022-12-26	WOS:000462594000068
J	Kanda, E; Kato, A; Masakane, I; Kanno, Y				Kanda, Eiichiro; Kato, Akihiko; Masakane, Ikuto; Kanno, Yoshihiko			A new nutritional risk index for predicting mortality in hemodialysis patients: Nationwide cohort study	PLOS ONE			English	Article							BODY-MASS INDEX; DIALYSIS PATIENTS; SERUM-ALBUMIN; DIAGNOSTIC-CRITERIA; FAT MASS; PROTEIN; MALNUTRITION; INFLAMMATION; ASSOCIATION; MUSCLE	Background Protein energy wasting (PEW) is a risk factor for death. However, the cutoff vales for PEW are not optimized for early identification of hemodialysis patients with malnutrition. We evaluated the prognosis of Japanese maintenance hemodialysis patients using nutritional indices optimized for them. Materials and methods We analyzed data from a nation-wide prospective cohort study of the Japanese Society for Dialysis Therapy Renal Data Registry to develop and validate a nutritional risk index (n = 48349, 48349, respectively). The association of nutritional factors with one-year death was tested using Cox proportional hazards models. Their cutoff levels were determined from the hazard ratios or receiver operating characteristic curves. Then, risk index was developed using scoring models. Results Male was 61.4%; average age, 65.7 +/- 12.2 years; and diabetes mellitus, 32.8%. Four clinical factors were retained in the final model: low BMI (<20kg/m(2)), yes = 3, no = 0; low serum albumin level (young <3.7g/dL; old <3.5g/dL), yes = 4, no = 0; abnormal serum total cholesterol level, low (<130mg/dL) = 1, high (220 >= mg/dL) = 2, no = 0; low serum creatinine level (young female, <9.7mg/dL; old female, <8.0mg/dL; young male, <11.6mg/dL; old male, <9.7mg/dL), yes = 4, no = 0. In the validation dataset, medium- and high-risk groups (total score 8 to 10; 11 or more) showed a higher risk of all-cause death than the low-risk group (0 to 7): medium-risk group (10.5%), hazard ratio adjusted for baseline characteristics 1.96 (95% confidence interval 1.77, 2.16); high-risk group (8.2%), 3.91 (3.57, 4.29). The medium-and high-risk groups also showed a higher risk of cardiovascular disease- and infection-caused deaths than the low-risk group. Conclusion We developed a new nutritional risk index for hemodialysis patients, which may detect patients with malnutrition with a high-risk of death.	[Kanda, Eiichiro] Kawasaki Med Sch, Med Sci, Kurashiki, Okayama, Japan; [Kato, Akihiko] Hamamatsu Univ Hosp, Blood Purificat Unit, Hamamatsu, Shizuoka, Japan; [Masakane, Ikuto] Honcho Yabuki Clin, Dept Nephrol, Yamagata, Yamagata, Japan; [Kanno, Yoshihiko] Tokyo Med Univ, Dept Nephrol, Shinjuku Ku, Tokyo, Japan	Kawasaki Medical School; Hamamatsu University School of Medicine; Tokyo Medical University	Kanda, E (corresponding author), Kawasaki Med Sch, Med Sci, Kurashiki, Okayama, Japan.	kms.cds.kanda@gmail.com		Kanda, Eiichiro/0000-0003-0676-096X				[Anonymous], 2000, AM J KIDNEY DIS, V35, pS1, DOI DOI 10.1053/AJKD.2000.V35.AAJKD03517; Celik G, 2011, INT J MED SCI, V8, P628, DOI 10.7150/ijms.8.628; de Mutsert R, 2009, J RENAL NUTR, V19, P127, DOI 10.1053/j.jrn.2008.08.003; Eriguchi R, 2017, CLIN J AM SOC NEPHRO, V12, P1109, DOI 10.2215/CJN.13141216; Fouque D, 2008, KIDNEY INT, V73, P391, DOI 10.1038/sj.ki.5002585; Friedman AN, 2010, J AM SOC NEPHROL, V21, P223, DOI 10.1681/ASN.2009020213; Hoogeveen EK, 2012, CLIN J AM SOC NEPHRO, V7, P280, DOI 10.2215/CJN.05700611; Ikizler TA, 2013, KIDNEY INT, V84, P1096, DOI 10.1038/ki.2013.147; Iseki K, 2002, KIDNEY INT, V61, P1887, DOI 10.1046/j.1523-1755.2002.00324.x; Kalantar-Zadeh K, 2003, AM J KIDNEY DIS, V42, P864, DOI 10.1016/j.ajkd.2003.07.016; Kalantar-Zadeh K, 2003, J RENAL NUTR, V13, P15, DOI 10.1053/jren.2003.50005; Kalantar-Zadeh K, 2003, KIDNEY INT, V63, P793, DOI 10.1046/j.1523-1755.2003.00803.x; Kanda E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128652; Kobayashi I, 2010, NEPHROL DIAL TRANSPL, V25, P3361, DOI 10.1093/ndt/gfq211; Kopple JD, 1997, AM J CLIN NUTR, V65, P1544, DOI 10.1093/ajcn/65.5.1544; Kyle UG, 2001, J AM GERIATR SOC, V49, P1633, DOI 10.1111/j.1532-5415.2001.49272.x; Leavey SF, 2001, NEPHROL DIAL TRANSPL, V16, P2386, DOI 10.1093/ndt/16.12.2386; Masakane I, 2017, REN REPLACE THER, V3, P1; Mehrotra R, 2001, ANNU REV NUTR, V21, P343, DOI 10.1146/annurev.nutr.21.1.343; Ohkawa S, 2005, NEPHROL DIAL TRANSPL, V20, P945, DOI 10.1093/ndt/gfh643; Qureshi AR, 1998, KIDNEY INT, V53, P773, DOI 10.1046/j.1523-1755.1998.00812.x; Takahashi R, 2012, AM J NEPHROL, V36, P136, DOI 10.1159/000339940; Yasui S, 2016, ASIA PAC J CLIN NUTR, V25, P292, DOI 10.6133/apjcn.2016.25.2.10	23	31	32	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214524	10.1371/journal.pone.0214524	http://dx.doi.org/10.1371/journal.pone.0214524			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921398	Green Published, gold, Green Submitted			2022-12-26	WOS:000462594000082
J	Khatri, B; Kang, S; Shouse, S; Anthony, N; Kuenzel, W; Kong, BC				Khatri, Bhuwan; Kang, Seong; Shouse, Stephanie; Anthony, Nicholas; Kuenzel, Wayne; Kong, Byungwhi C.			Copy number variation study in Japanese quail associated with stress related traits using whole genome re-sequencing data	PLOS ONE			English	Article							STRUCTURAL VARIATION; GENE; DUPLICATION; SELECTION; ALIGNMENT; DISEASE; LINES	Copy number variation (CNV) is a major driving factor for genetic variation and phenotypic diversity in animals. To detect CNVs and understand genetic components underlying stress related traits, we performed whole genome re-sequencing of pooled DNA samples of 20 birds each from High Stress (HS) and Low Stress (LS) Japanese quail lines using Illumina HiSeq 2x150 bp paired end method. Sequencing data were aligned to the quail genome and CNVnator was used to detect CNVs in the aligned data sets. The depth of coverage for the data reached to 41.4x and 42.6x for HS and LS birds, respectively. We identified 262 and 168 CNV regions affecting 1.6 and 1.9% of the reference genome that completely overlapped 454 and 493 unique genes in HS and LS birds, respectively. Ingenuity pathway analysis showed that the CNV genes were significantly enriched to phospholipase C signaling, neuregulin signaling, reelin signaling in neurons, endocrine and nervous development, humoral immune response, and carbohydrate and amino acid metabolisms in HS birds, whereas CNV genes in LS birds were enriched in cell-mediated immune response, and protein and lipid metabolisms. These findings suggest CNV genes identified in HS and LS birds could be candidate markers responsible for stress responses in birds.	[Khatri, Bhuwan; Kang, Seong; Shouse, Stephanie; Anthony, Nicholas; Kuenzel, Wayne; Kong, Byungwhi C.] Univ Arkansas, Dept Poultry Sci, Ctr Excellence Poultry Sci, Fayetteville, AR 72701 USA	University of Arkansas System; University of Arkansas Fayetteville	Kong, BC (corresponding author), Univ Arkansas, Dept Poultry Sci, Ctr Excellence Poultry Sci, Fayetteville, AR 72701 USA.	bkong@uark.edu		Khatri, Bhuwan/0000-0001-5456-2963	USDA multistate project, NC1170, Advanced Technologies for the Genetic Improvement of Poultry; Arkansas Agricultural Experimental Station	USDA multistate project, NC1170, Advanced Technologies for the Genetic Improvement of Poultry; Arkansas Agricultural Experimental Station	This work was supported by USDA multistate project, NC1170, Advanced Technologies for the Genetic Improvement of Poultry and Arkansas Agricultural Experimental Station.	Abyzov A, 2011, GENOME RES, V21, P974, DOI 10.1101/gr.114876.110; Berglund J, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-8-r73; Bickhart DM, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00037; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Buchanan JA, 2008, GENET MED, V10, P639, DOI [10.1097/GIM.0b013e318183f848, 10.1097GIM.0b013e318183f848]; Carnero A, 2012, ATLAS GENETICS CYTOG, DOI [10.4267/2042/46943, DOI 10.4267/2042/46943]; Castrillo A, 2001, J EXP MED, V194, P1231, DOI 10.1084/jem.194.9.1231; Cloonan N, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-r127; Crooijmans RPMA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-398; Delany ME, 2009, J HERED, V100, P507, DOI 10.1093/jhered/esp044; Diskin SJ, 2009, NATURE, V459, P987, DOI 10.1038/nature08035; Duan JB, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059128, 10.1371/journal.pone.0062087]; Elferink MG, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-391; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Flisikowski K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015116; Fontanesi L, 2009, CYTOGENET GENOME RES, V126, P333, DOI 10.1159/000268089; Fortna RR, 2004, J BIOL CHEM, V279, P3685, DOI 10.1074/jbc.M310505200; Gill JL, 2011, NEUROBIOL DIS, V43, P184, DOI 10.1016/j.nbd.2011.03.010; Girirajan S, 2011, ANNU REV GENET, V45, P203, DOI 10.1146/annurev-genet-102209-163544; Giuffra E, 2002, MAMM GENOME, V13, P569, DOI 10.1007/s00335-002-2184-5; Goldstein O, 2010, MOL VIS, V16, P1549; Harr B, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.75; Hastings PJ, 2009, NAT REV GENET, V10, P551, DOI 10.1038/nrg2593; Henrichsen CN, 2009, HUM MOL GENET, V18, pR1, DOI 10.1093/hmg/ddp011; Hillbertz NHCS, 2007, NAT GENET, V39, P1318, DOI 10.1038/ng.2007.4; Huff GR, 2013, POULTRY SCI, V92, P603, DOI 10.3382/ps.2012-02518; Hull RM, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2001333; Jia X, 2013, ANIM GENET, V44, P276, DOI 10.1111/age.12009; Jiang L, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-131; Katju Vaishali, 2013, Frontiers in Genetics, V4, P273, DOI 10.3389/fgene.2013.00273; Kowanetz M, 2010, P NATL ACAD SCI USA, V107, P21248, DOI 10.1073/pnas.1015855107; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu GE, 2011, MAMM GENOME, V22, P111, DOI 10.1007/s00335-010-9308-0; Locke MEO, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1713-z; Luo J, 2013, G3-GENES GENOM GENET, V3, P217, DOI 10.1534/g3.112.005132; Medvedev P, 2009, NAT METHODS, V6, pS13, DOI [10.1038/NMETH.1374, 10.1038/nmeth.1374]; Meyers SN, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-337; Neph S, 2012, BIOINFORMATICS, V28, P1919, DOI 10.1093/bioinformatics/bts277; Pezer Z, 2015, GENOME RES, V25, P1114, DOI 10.1101/gr.187187.114; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Satterlee DG, 2002, POULTRY SCI, V81, P1071, DOI 10.1093/ps/81.7.1071; Satterlee DG, 2000, POULTRY SCI, V79, P1710, DOI 10.1093/ps/79.12.1710; SATTERLEE DG, 1988, POULTRY SCI, V67, P25, DOI 10.3382/ps.0670025; Schrider DR, 2010, P ROY SOC B-BIOL SCI, V277, P3213, DOI 10.1098/rspb.2010.1180; Shaikh TH, 2009, GENOME RES, V19, P1682, DOI 10.1101/gr.083501.108; Shinomiya A, 2012, GENETICS, V190, P627, DOI 10.1534/genetics.111.136705; Stankiewicz P, 2010, ANNU REV MED, V61, P437, DOI 10.1146/annurev-med-100708-204735; Stingele S, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.40; Suhr CL, 2010, POULTRY SCI, V89, P633, DOI 10.3382/ps.2009-00288; Tsui J, 2005, J BIOL CHEM, V280, P9210, DOI 10.1074/jbc.M407653200; Veitia RA, 2004, GENETICS, V168, P569, DOI 10.1534/genetics.104.029785; Wang JY, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-273; Wright D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000512; Zarrei M, 2015, NAT REV GENET, V16, P172, DOI 10.1038/nrg3871; Zhang F, 2009, ANNU REV GENOM HUM G, V10, P451, DOI 10.1146/annurev.genom.9.081307.164217; Zhao M, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S11-S1; Zhou W, 2014, GENETICA, V142, P441, DOI 10.1007/s10709-014-9788-z	58	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214543	10.1371/journal.pone.0214543	http://dx.doi.org/10.1371/journal.pone.0214543			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921419	gold, Green Published, Green Submitted			2022-12-26	WOS:000462594000084
J	Miftahussurur, M; Cruz, M; Doohan, D; Subsomwong, P; Abreu, JAJ; Hosking, C; Waskito, LA; Yamaoka, Y				Miftahussurur, Muhammad; Cruz, Modesto; Doohan, Dalla; Subsomwong, Phawinee; Abreu, Jose A. Jimenez; Hosking, Celso; Waskito, Langgeng Agung; Yamaoka, Yoshio			Five alternative Helicobacter pylori antibiotics to counter high levofloxacin and metronidazole resistance in the Dominican Republic	PLOS ONE			English	Article							RIFAXIMIN-BASED REGIMENS; TRIPLE THERAPY; RPOB MUTATIONS; CROSS-RESISTANCE; RESCUE THERAPY; RIFABUTIN; SITAFLOXACIN; ERADICATION; AMOXICILLIN; RIFAMPICIN	The prevalence of Helicobacter pylori resistance to levofloxacin and metronidazole was high in the Dominican Republic. We used two-fold agar dilution method to determine the minimum inhibitory concentration of five alternative antibiotics in 63 Dominican strains. We also assessed the genetic mutations associated with the antibiotic resistance using next-generation sequencing. We revealed that all 63 strains were sensitive towards sitafloxacin, furazolidone, and rifabutin. In contrast, the prevalence of rifaximin and garenoxacin resistance were high (82.5% and 34.9%, respectively). Patients more than or equal to 60 years old had the highest risk of double-antibiotic resistance (7/9, 77.8%, OR = 31.5, P = 0.009) and garenoxacin resistances (8/9, 88.9%, OR = 45.33, P = 0.002) with an increasing risk simultaneously by age (P = 0.004, r = 0.357). Almost all rifaximin resistant strains possessed multiple mutations with more than three mutations within rpoB including the most frequent novel mutations of S352L, I2726L, and V2465A. There was a significant association between vacA genotype and rifaximin resistance (P = 0.042). Among 23 levofloxacin-resistant strains, 82.6% (19/23, P < 0.001) were also resistant to garenoxacin, and 39.1% (9/23) had a high minimal inhibitory concentration. 8 mu g/mL with positive trend correlation (P = < 0.001, r = 0.84). Among 19 garenoxacin resistant strains, 16 (84.2%) contained mutations at D91 and N87 of gyrA. In conclusion, sitafloxacin, rifabutin, and furazolidone might be considered as alternative antibiotics to be included in H. pylori eradication regimen in regions with high prevalence of levofloxacin and metronidazole resistance, such as the Dominican Republic.	[Miftahussurur, Muhammad] Univ Airlangga, Fac Med, Gastroenterohepatol Div, Dept Internal Med,Inst Tropical Dis, Surabaya, Indonesia; [Miftahussurur, Muhammad; Doohan, Dalla; Waskito, Langgeng Agung] Univ Airlangga, Inst Trop Dis, Surabaya, Indonesia; [Cruz, Modesto] Autonomous Univ Santo Domingo, Inst Microbiol & Parasitol, Fac Sci, Santo Domingo, Dominican Rep; [Cruz, Modesto; Hosking, Celso] Natl Inst Med & Diagnost Imaging, Dept Biomed Res, Santo Domingo, Dominican Rep; [Doohan, Dalla; Subsomwong, Phawinee; Waskito, Langgeng Agung; Yamaoka, Yoshio] Oita Univ, Dept Environm & Prevent Med, Fac Med, Yufu, Japan; [Abreu, Jose A. Jimenez] Dr Luis E Aybar Hlth & Hyg City, Dominican Japanese Digest Dis Ctr, Santo Domingo, Dominican Rep; [Yamaoka, Yoshio] Baylor Coll Med, Dept Med, Gastroenterol & Hepatol Sect, Houston, TX 77030 USA; [Yamaoka, Yoshio] Univ Airlangga, Fac Med, Surabaya, Indonesia	Airlangga University; Airlangga University; Universidad Autonoma de Santo Domingo; Oita University; Baylor College of Medicine; Airlangga University	Yamaoka, Y (corresponding author), Oita Univ, Dept Environm & Prevent Med, Fac Med, Yufu, Japan.; Yamaoka, Y (corresponding author), Baylor Coll Med, Dept Med, Gastroenterol & Hepatol Sect, Houston, TX 77030 USA.; Yamaoka, Y (corresponding author), Univ Airlangga, Fac Med, Surabaya, Indonesia.	yyamaoka@oita-u.ac.jp	Miftahussurur, Muhammad/AAB-6151-2021; Cruz, Modesto/AGM-1113-2022	Yamaoka, Yoshio/0000-0002-1222-5819; Cruz, Modesto/0000-0003-0917-5555; Miftahussurur, Muhammad/0000-0003-1415-6033; Doohan, Dalla/0000-0003-3076-571X	National Institutes of Health [DK62813]; Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan [26640114, 221S0002, 16H06279, 15H02657, 16H05191]; Japan Society for the Promotion of Science Institutional Program for Young Researcher Overseas Visits; Strategic Funds for the Promotion of Science and Technology Agency (JST); Ministry of Research [123.4/D2.3/KP/2018]; Ministry of Technology [123.4/D2.3/KP/2018]; Ministry of Higher Education of Indonesia for World Class Professor Program [123.4/D2.3/KP/2018]; Japanese Government (MEXT); National Fund for Innovation and Development of Science and Technology (FONDOCYT) from the Ministry of Higher Education Science and Technology (MESCyT) of the Dominican Republic [2012-2013-2A1-65, 2015-3A1-182]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science Institutional Program for Young Researcher Overseas Visits(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Strategic Funds for the Promotion of Science and Technology Agency (JST); Ministry of Research(Ministry of Research and Technology of the Republic of Indonesia (RISTEK)); Ministry of Technology; Ministry of Higher Education of Indonesia for World Class Professor Program; Japanese Government (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Fund for Innovation and Development of Science and Technology (FONDOCYT) from the Ministry of Higher Education Science and Technology (MESCyT) of the Dominican Republic	This report is based on work supported in part by grants from the National Institutes of Health (DK62813) (YY), and Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan (26640114, 221S0002, 16H06279, 15H02657 and 16H05191) (YY). This work was also supported by the Japan Society for the Promotion of Science Institutional Program for Young Researcher Overseas Visits and the Strategic Funds for the Promotion of Science and Technology Agency (JST) for YY and The Ministries of Research, Technology and Higher Education of Indonesia for World Class Professor Program (no. 123.4/D2.3/KP/2018) to MIL and MM. LAW and DD are PhD students supported by the Japanese Government (MEXT) scholarship program for 2015, 2016, and 2017, respectively. In addition, it was supported in part by a grant from The National Fund for Innovation and Development of Science and Technology (FONDOCYT) from the Ministry of Higher Education Science and Technology (MESCyT) of the Dominican Republic (2012-2013-2A1-65 and 2015-3A1-182) (MC).	Adachi JA, 2006, CLIN INFECT DIS, V42, P541, DOI 10.1086/499950; Borody TJ, 2006, ALIMENT PHARM THER, V23, P481, DOI 10.1111/j.1365-2036.2006.02793.x; Buowari Y.D, 2017, J AGING RES HEALTHC, V1, P1, DOI [10.14302/issn.2474-7785.jarh-16-1396, DOI 10.14302/ISSN.2474-7785.JARH-16-1396]; Camargo MC, 2014, AM J GASTROENTEROL, V109, P485, DOI 10.1038/ajg.2014.24; Cheng H, 2009, WORLD J GASTROENTERO, V15, P860, DOI 10.3748/wjg.15.860; Coelho LGV, 2000, AM J GASTROENTEROL, V95, P2688, DOI 10.1111/j.1572-0241.2000.03174.x; Corral JE, 2017, WORLD J GASTRO ONCOL, V9, P184, DOI 10.4251/wjgo.v9.i4.184; De Giorgio R, 1997, Eur Rev Med Pharmacol Sci, V1, P105; ElMaraachli W, 2015, INT J TUBERC LUNG D, V19, P1222, DOI 10.5588/ijtld.14.0936; Furuta T, 2014, J GASTROEN HEPATOL, V29, P487, DOI 10.1111/jgh.12442; Gasbarrini A, 2006, DIGESTION, V73, P129, DOI 10.1159/000089788; Gasbarrini A, 2006, DIGEST DIS, V24, P195, DOI 10.1159/000090330; Gisbert JP, 2012, ALIMENT PHARM THER, V35, P209, DOI 10.1111/j.1365-2036.2011.04937.x; Glocker E, 2007, J ANTIMICROB CHEMOTH, V59, P874, DOI 10.1093/jac/dkm039; Graham D.Y., 2016, HELICOBACTER PYLORI, P417; Hays C, 2018, HELICOBACTER, V23, DOI 10.1111/hel.12451; Heep M, 1999, ANTIMICROB AGENTS CH, V43, P1497, DOI 10.1128/AAC.43.6.1497; Heep M, 2000, ANTIMICROB AGENTS CH, V44, P1075, DOI 10.1128/AAC.44.4.1075-1077.2000; Hirata Y, 2012, INT J ANTIMICROB AG, V39, P352, DOI 10.1016/j.ijantimicag.2011.12.002; Hooi JKY, 2017, GASTROENTEROLOGY, V153, P420, DOI 10.1053/j.gastro.2017.04.022; Hunt RH, 2011, J GASTROINTEST LIVER, V20, P299, DOI 10.1097/MCG.0b013e31820fb8f6; JABES D, 1994, ANTIMICROB AGENTS CH, V38, P2346, DOI 10.1128/AAC.38.10.2346; Kothary V, 2013, ANTIMICROB AGENTS CH, V57, P811, DOI 10.1128/AAC.02163-12; Kunin CM, 1996, CLIN INFECT DIS, V22, pS3, DOI 10.1093/clinids/22.Supplement_1.S3; Lim HC, 2014, HELICOBACTER, V19, P455, DOI 10.1111/hel.12147; Malfertheiner P, 2017, GUT, V66, P6, DOI 10.1136/gutjnl-2016-312288; Miftahussurur M, 2017, AM J TROP MED HYG, V96, P1050, DOI 10.4269/ajtmh.16-0729; Mori H, 2016, UNITED EUR GASTROENT, V4, P380, DOI 10.1177/2050640615618043; Murakami K, 2009, ANTIMICROB AGENTS CH, V53, P3097, DOI 10.1128/AAC.01552-08; Nishizawa T, 2011, ANTIMICROB AGENTS CH, V55, P5374, DOI 10.1128/AAC.05437-11; Nizhevich A A, 2011, Eksp Klin Gastroenterol, P85; Nizhevich A A, 2009, Eksp Klin Gastroenterol, P98; O'Connor JR, 2008, ANTIMICROB AGENTS CH, V52, P2813, DOI 10.1128/AAC.00342-08; Ogata SK, 2014, BRAZ J MICROBIOL, V45, P1439, DOI 10.1590/S1517-83822014000400039; Segura AM, 1997, ALIMENT PHARM THERAP, V11, P529, DOI 10.1046/j.1365-2036.1997.00172.x; Shiota S, 2014, J MED MICROBIOL, V63, P1189, DOI 10.1099/jmm.0.075275-0; Sousa M, 2008, J ANTIMICROB CHEMOTH, V62, P872, DOI 10.1093/jac/dkn330; Sugimoto M, 2015, ALIMENT PHARM THER, V42, P477, DOI 10.1111/apt.13280; Suzuki H, 2009, ANTIMICROB AGENTS CH, V53, P1720, DOI 10.1128/AAC.00049-09; Wichelhaus TA, 1999, ANTIMICROB AGENTS CH, V43, P2813, DOI 10.1128/AAC.43.11.2813; Williams DL, 1998, ANTIMICROB AGENTS CH, V42, P1853, DOI 10.1128/AAC.42.7.1853; Yang B, 1998, J ANTIMICROB CHEMOTH, V42, P621, DOI 10.1093/jac/42.5.621	42	6	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2019	14	3							e0213868	10.1371/journal.pone.0213868	http://dx.doi.org/10.1371/journal.pone.0213868			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ5PT	30917150	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000462465800043
J	Wood, NE; Doncic, A				Wood, N. Ezgi; Doncic, Andreas			A fully-automated, robust, and versatile algorithm for long-term budding yeast segmentation and tracking	PLOS ONE			English	Article							MICROSCOPY; DYNAMICS; TOOLS; SOFTWARE; NUCLEI; CELLS	Live cell time-lapse microscopy, a widely-used technique to study gene expression and protein dynamics in single cells, relies on segmentation and tracking of individual cells for data generation. The potential of the data that can be extracted from this technique is limited by the inability to accurately segment a large number of cells from such microscopy images and track them over long periods of time. Existing segmentation and tracking algorithms either require additional dyes or markers specific to segmentation or they are highly specific to one imaging condition and cell morphology and/or necessitate manual correction. Here we introduce a fully automated, fast and robust segmentation and tracking algorithm for budding yeast that overcomes these limitations. Full automatization is achieved through a novel automated seeding method, which first generates coarse seeds, then automatically finetunes cell boundaries using these seeds and automatically corrects segmentation mistakes. Our algorithm can accurately segment and track individual yeast cells without any specific dye or biomarker. Moreover, we show how existing channels devoted to a biological process of interest can be used to improve the segmentation. The algorithm is versatile in that it accurately segments not only cycling cells with smooth elliptical shapes, but also cells with arbitrary morphologies (e.g. sporulating and pheromone treated cells). In addition, the algorithm is independent of the specific imaging method (bright-field/phase) and objective used (40X/63X/100X). We validate our algorithm's performance on 9 cases each entailing a different imaging condition, objective magnification and/or cell morphology. Taken together, our algorithm presents a powerful segmentation and tracking tool that can be adapted to numerous budding yeast single-cell studies.	[Wood, N. Ezgi; Doncic, Andreas] UT Southwestern Med Ctr, Dept Cell Biol, Dallas, TX 75390 USA; [Doncic, Andreas] UT Southwestern Med Ctr, Green Ctr Syst Biol, Dallas, TX USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Wood, NE (corresponding author), UT Southwestern Med Ctr, Dept Cell Biol, Dallas, TX 75390 USA.	Nihal.Temamogullari@utsouthwestern.edu		Wood, Nihal Ezgi/0000-0002-1874-9226	Cancer Prevention and Research Institute of Texas [RR150058]; Welch Foundation [I-1919-20170325]	Cancer Prevention and Research Institute of Texas; Welch Foundation(The Welch Foundation)	This work was supported by grants from Cancer Prevention and Research Institute of Texas (RR150058) (AD) (http://www.cprit.state.tx.us) and The Welch Foundation (I-1919-20170325) (AD) (http://www.welch1.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Arguello-Miranda O, 2018, MOL CELL; Bakker E, 2017, BIORXIV; Bardwell L, 2005, PEPTIDES, V26, P337, DOI 10.1016/j.peptides.2004.10.001; Botstein D, 2011, GENETICS, V189, P695, DOI 10.1534/genetics.111.130765; CHEN SH, 2006, COMPUTATIONAL INTELL; Chen XW, 2006, IEEE T BIO-MED ENG, V53, P762, DOI 10.1109/TBME.2006.870201; Cooper S, 2017, TRENDS BIOTECHNOL, V35, P422, DOI 10.1016/j.tibtech.2017.01.002; Costanzo M, 2004, CELL, V117, P899, DOI 10.1016/j.cell.2004.05.024; Coutu DL, 2013, J CELL SCI, V126, P3805, DOI 10.1242/jcs.118349; De Solorzano CO, 2001, J MICROSC-OXFORD, V201, P404, DOI 10.1046/j.1365-2818.2001.00854.x; Delgado-Gonzalo R, 2015, IEEE SIGNAL PROC MAG, V32, P41, DOI 10.1109/MSP.2014.2344552; Di Talia S, 2007, NATURE, V448, P947, DOI 10.1038/nature06072; Doncic A, 2013, MOL CELL, V50, P856, DOI 10.1016/j.molcel.2013.04.014; Doncic A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057970; EAGER DL, 1989, IEEE T COMPUT, V38, P408, DOI 10.1109/12.21127; Eastwood MD, 2012, DEV CELL, V23, P35, DOI 10.1016/j.devcel.2012.05.005; Frigault MM, 2009, J CELL SCI, V122, P753, DOI 10.1242/jcs.033837; Gonzalez R.C., 2017, DIGITAL IMAGE PROCES, V4th ed.; Hansen AS, 2015, NAT PROTOC, V10, P1181, DOI 10.1038/nprot.2015.079; Hilsenbeck O, 2016, NAT BIOTECHNOL, V34, P703, DOI 10.1038/nbt.3626; Huang K, 2004, J BIOMED OPT, V9, P893, DOI 10.1117/1.1779233; Huang K, 2004, BIOM IM NAN 2004 IEE; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Jacquier N, 2011, J CELL SCI; Jones TR, 2005, LECT NOTES COMPUT SC, V3765, P535; Kasprowicz R, 2017, INT J BIOCHEM CELL B, V84, P89, DOI 10.1016/j.biocel.2017.01.004; Kristan K, 2012, J STEROID BIOCHEM, V129, P79, DOI 10.1016/j.jsbmb.2011.08.012; Locke JCW, 2009, NAT REV MICROBIOL, V7, P383, DOI 10.1038/nrmicro2056; Longo D, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100110; Mager WH, 2005, TRENDS PHARMACOL SCI, V26, P265, DOI 10.1016/j.tips.2005.03.004; Murphy D. B., 2012, FUNDAMENTALS LIGHT M, DOI [10.1002/9781118382905.ch1, DOI 10.1002/9781118382905.CH1, 10.1002/9781118382905]; Neiman AM, 2011, GENETICS, V189, P737, DOI 10.1534/genetics.111.127126; Nketia TA, 2017, METHODS, V115, P65, DOI 10.1016/j.ymeth.2017.02.007; Piccirillo S, 2010, GENETICS, V184, P707, DOI 10.1534/genetics.109.113480; Purvis JE, 2013, CELL, V152, P945, DOI 10.1016/j.cell.2013.02.005; Rajaram S, 2012, NAT METHODS, V9, P635, DOI 10.1038/nmeth.2097; Shariff A, 2010, J BIOMOL SCREEN, V15, P726, DOI 10.1177/1087057110370894; Shav-Tal Y, 2004, NAT REV MOL CELL BIO, V5, P855, DOI 10.1038/nrm1494; Smith ZD, 2010, NAT BIOTECHNOL, V28, P521, DOI 10.1038/nbt.1632; Sung MH, 2011, WIRES SYST BIOL MED, V3, P167, DOI 10.1002/wsbm.108; Thorn K, 2017, MOL BIOL CELL, V28, P848, DOI 10.1091/mbc.E16-07-0504; Tscherepanow M, 2008, INT C MASS DAT AN IM; Tsygankov D, 2014, METHOD CELL BIOL, V123, P409, DOI 10.1016/B978-0-12-420138-5.00022-7; Versari C, 2017, J R SOC INTERFACE, V14, DOI 10.1098/rsif.2016.0705; Wang YX, 2008, ANNU REV BIOMED ENG, V10, P1, DOI 10.1146/annurev.bioeng.010308.161731	45	14	15	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2019	14	3							e0206395	10.1371/journal.pone.0206395	http://dx.doi.org/10.1371/journal.pone.0206395			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ5PT	30917124	Green Submitted, gold, Green Published			2022-12-26	WOS:000462465800003
J	Charrow, A; Xia, FD; Lu, J; Waul, M; Joyce, C; Mostaghimi, A				Charrow, Alexandra; Xia, Fan Di; Lu, Jessica; Waul, Michael; Joyce, Cara; Mostaghimi, Arash			Differences in isotretinoin start, interruption, and early termination across race and sex in the iPLEDGE era	PLOS ONE			English	Article							MANAGEMENT	Background iPLEDGE is the mandatory regulatory program for isotretinoin in the United States, aimed to prevent isotretinoin-related teratogenicity. However, little is known about potential unintended impact of the program, including delay in isotretinoin initiation, course interruption, and premature termination, which may vary across sex and racial domains. Objective To determine whether differences in isotretinoin start, interruption, and completion exist across sex and racial domains and whether iPLEDGE regulations contribute to such differences. Methods Retrospective review of isotretinoin courses of patients prescribed isotretinoin for acne at the Brigham & Women's Hospital and Massachusetts General Hospital from 2008-2016. Results 418 patients were included in analysis after being tightly matched across age and gender. 43.5% of non-white patients ended their course early compared to 30.1% of white patients (p = 0.010). iPLEDGE -related barriers were the most commonly specified reasons for delayed starting and interruption. Conclusion iPLEDGE may disproportionately contribute to access barriers for non-white patients. Continued evaluation of iPLEDGE is needed to minimize unintended barriers to access.	[Charrow, Alexandra] Harvard Med Sch, Brigham & Womens Hosp, Harvard Combined Dermatol Residency Training Prog, Boston, MA 02115 USA; [Xia, Fan Di; Waul, Michael] Harvard Med Sch, Boston, MA 02115 USA; [Lu, Jessica] McGill Med Sch, Montreal, PQ, Canada; [Joyce, Cara] Loyola Univ, Dept Publ Hlth Sci, Chicago, IL 60611 USA; [Mostaghimi, Arash] Harvard Med Sch, Brigham & Womens Hosp, Dept Dermatol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; McGill University; Loyola University Chicago; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Mostaghimi, A (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Dept Dermatol, Boston, MA 02115 USA.	amostaghimi@bwh.harvard.edu		Mostaghimi, Arash/0000-0002-6084-5617				Doshi AE, 2006, SETON HALL L REV, V37, P625; Fleischer AB, 2003, J AM ACAD DERMATOL, V49, P662, DOI 10.1067/S0190-9622(03)01584-6; Gonzales A, 2016, INFORM COMMUN SOC, V19, P234, DOI 10.1080/1369118X.2015.1050438; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; James WD, 2005, NEW ENGL J MED, V352, P1463, DOI 10.1056/NEJMcp033487; Katz KA, 2016, JAMA DERMATOL, V152, P513, DOI 10.1001/jamadermatol.2015.5547; Melnik M, DEMOGRAPHIC SOCIOECO; Moodie P, 2011, NZ MED J, V124; Osborn CY, 2013, J MED INTERNET RES, V15, P204, DOI 10.2196/jmir.2589; Shin J, 2011, J AM ACAD DERMATOL, V65, P1117, DOI 10.1016/j.jaad.2010.09.017; Sladden MJ, 2007, ARCH DERMATOL, V143, P1187, DOI 10.1001/archderm.143.9.1187; Smith SG, 2015, J AM MED INFORM ASSN, V22, P888, DOI 10.1093/jamia/ocv025; Zaenglein AL, 2016, J AM ACAD DERMATOL, V74, P945, DOI 10.1016/j.jaad.2015.12.037	13	16	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2019	14	3							e0210445	10.1371/journal.pone.0210445	http://dx.doi.org/10.1371/journal.pone.0210445			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ3IW	30913210	Green Published, gold, Green Submitted			2022-12-26	WOS:000462305600004
J	Dakin, SG; Colas, RA; Newton, J; Gwilym, S; Jones, N; Reid, HAB; Wood, S; Appleton, L; Wheway, K; Watkins, B; Dalli, J; Carr, AJ				Dakin, Stephanie G.; Colas, Romain A.; Newton, Julia; Gwilym, Stephen; Jones, Natasha; Reid, Hamish A. B.; Wood, Simon; Appleton, Louise; Wheway, Kim; Watkins, Bridget; Dalli, Jesmond; Carr, Andrew J.			15-Epi-LXA(4) and MaR1 counter inflammation in stromal cells from patients with Achilles tendinopathy and rupture	FASEB JOURNAL			English	Article						resolution; tendon; 15-epi-LipoxinA(4); maresin-1	RESOLVIN D3; LYN KINASE; TENDON; IDENTIFICATION	Resolution of inflammation is poorly understood in Achilles tendon disorders. Herein, we investigated the bioactive lipid mediator profiles of tendon-derived stromal cells isolated from patients with Achilles tendinopathy (AT) or Achilles rupture (AR) under baseline and IL-1 beta-stimulated conditions. We also determined whether incubating these cells with 2 of the mediators produced by tendon-derived stromal cells, 15-epi-Lipoxin A(4) (15-epi-LXA(4)) or maresin (MaR)-1, moderated their proinflammatory phenotype. Under baseline conditions, AT cells showed concurrent increased levels of proinflammatory eicosanoids and proresolving mediators compared with AR cells. IL-1 beta treatment induced profound prostaglandin E-2 release in AR compared with AT cells. Incubation of IL-1 beta treated AT and AR tendon-derived stromal cells in 15-epi-LXA(4) or MaR1 reduced proinflammatory eicosanoids and potentiated the release of proresolving mediators. These mediators also induced specialized proresolving mediator (SPM) biosynthetic enzymes arachidonate lipoxygenase (ALOX) 12 and ALOX15 and up-regulated the proresolving receptor ALX compared with vehicle-treated cells. Incubation in 15-epi-LXA(4) or MaR1 also moderated the proinflammatory phenotype of AT and AR cells, regulating podoplanin, CD90, signal transducer and activator of transcription (STAT)-1, IL-6, IFN regulatory factor (IRF) 5, and TLR4 and suppressed c-Jun N-terminal kinase 1/2/3, Lyn, STAT-3, and STAT-6 phosphokinase signaling. In summary, we identify proresolving mediators that are active in AT and AR and propose SPMs, including 15-epi-LXA(4) or MaR1, as a potential strategy to counterregulate inflammatory processes in these cells.-Dakin, S. G., Colas, R. A., Newton, J., Gwilym, S., Jones, N., Reid, H. A. B., Wood, S., Appleton, L., Wheway, K., Watkins, B., Dalli, J., Carr, A. J. 15-Epi-LXA(4) and MaR1 counter inflammation in stromal cells from patients with Achilles tendinopathy and rupture.	[Dakin, Stephanie G.; Newton, Julia; Gwilym, Stephen; Jones, Natasha; Reid, Hamish A. B.; Wood, Simon; Appleton, Louise; Wheway, Kim; Watkins, Bridget; Carr, Andrew J.] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Botnar Res Ctr, Nuffield Orthopaed Ctr, Oxford, England; [Colas, Romain A.; Dalli, Jesmond] Queen Mary Univ London, Lipid Mediator Unit, William Harvey Res Inst, Barts & London Sch Med & Dent, London, England; [Dalli, Jesmond] Queen Mary Univ London, Ctr Inflammat & Therapeut Innovat, London, England	Nuffield Orthopaedic Centre; University of Oxford; University of London; Queen Mary University London; University of London; Queen Mary University London	Dakin, SG (corresponding author), Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Nuffield Orthopaed Ctr, Oxford OX3 7LD, England.	stephanie.dakin@ndorms.ox.ac.uk		Reid, Hamish/0000-0003-2094-5506; Dakin, Stephanie Georgina/0000-0003-2470-1031; Dalli, Jesmond/0000-0001-6328-3640	Oxford-Union Chimique Belge (UCB) Prize Fellowship in Biomedical Research; European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program [677542]; Barts Charity [MGU0343]; Sir Henry Dale Fellowship - Wellcome Trust; Sir Henry Dale Fellowship - Royal Society [107613/Z/15/Z]; National Institute for Health Research (NIHR) Oxford Musculoskeletal Biomedical Research Centre (BRC); MRC [MR/J006815/1] Funding Source: UKRI	Oxford-Union Chimique Belge (UCB) Prize Fellowship in Biomedical Research; European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program(European Research Council (ERC)); Barts Charity; Sir Henry Dale Fellowship - Wellcome Trust; Sir Henry Dale Fellowship - Royal Society; National Institute for Health Research (NIHR) Oxford Musculoskeletal Biomedical Research Centre (BRC)(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank the clinical and nursing teams at the Nuffield Orthopaedic Centre and the John Radcliffe Trauma Unit for facilitating the collection of tendinopathic and ruptured Achilles tendon tissue samples used for this study. S.G.D. is a recipient of an Oxford-Union Chimique Belge (UCB) Prize Fellowship in Biomedical Research. J.D. received funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program (Grant 677542) and the Barts Charity (Grant MGU0343). J.D. is also supported by a Sir Henry Dale Fellowship jointly funded by the Wellcome Trust and the Royal Society (Grant 107613/Z/15/Z). Research at Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences (NDORMS), University of Oxford, is supported through the National Institute for Health Research (NIHR) Oxford Musculoskeletal Biomedical Research Centre (BRC). The views expressed are those of the authors and not necessarily those of the National Health Service (NHS), the NIHR, or the Department of Health. The authors declare no conflicts of interest.	Abate M, 2019, PHYSICIAN SPORTSMED, V47, P232, DOI 10.1080/00913847.2018.1548886; Alfredson H, 2000, SPORTS MED, V29, P135, DOI 10.2165/00007256-200029020-00005; Almekinders LC, 1998, MED SCI SPORT EXER, V30, P1183, DOI 10.1097/00005768-199808000-00001; Arnardottir HH, 2016, J IMMUNOL, V197, P2362, DOI 10.4049/jimmunol.1502268; Ban T, 2016, IMMUNITY, V45, P319, DOI 10.1016/j.immuni.2016.07.015; Bussin ER, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-015126; Challoumas D, 2019, BRIT J SPORT MED, V53, P251, DOI 10.1136/bjsports-2018-099552; Colas RA, 2016, J IMMUNOL, V197, P4444, DOI 10.4049/jimmunol.1600837; Colas RA, 2014, AM J PHYSIOL-CELL PH, V307, pC39, DOI 10.1152/ajpcell.00024.2014; Collins M, 2009, MED SPORT SCI, V54, P136, DOI 10.1159/000235701; Dakin SG, 2018, NAT REV RHEUMATOL, V14, P714, DOI 10.1038/s41584-018-0112-7; Dakin SG, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11188-y; Dakin SG, 2017, ARTHRITIS RES THER, V19, DOI 10.1186/s13075-016-1218-4; Dakin SG, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac4269; Dakin SG, 2018, BRIT J SPORT MED, V52, P359, DOI 10.1136/bjsports-2017-098161; Dalli J, 2018, METHODS MOL BIOL, V1730, P59, DOI 10.1007/978-1-4939-7592-1_4; Dalli J, 2013, CHEM BIOL, V20, P188, DOI 10.1016/j.chembiol.2012.11.010; de Vos RJ, 2010, JAMA-J AM MED ASSOC, V303, P144, DOI 10.1001/jama.2009.1986; Dudhia J, 2007, AGING CELL, V6, P547, DOI 10.1111/j.1474-9726.2007.00307.x; Gilroy DW, 2004, NAT REV DRUG DISCOV, V3, P401, DOI 10.1038/nrd1383; Gilroy DW, 1999, NAT MED, V5, P698, DOI 10.1038/9550; Habets B, 2015, SCAND J MED SCI SPOR, V25, P3, DOI 10.1111/sms.12208; Hsiao HM, 2015, AM J PATHOL, V185, P3189, DOI 10.1016/j.ajpath.2015.08.008; Jarvinen Tero A H, 2005, Foot Ankle Clin, V10, P255, DOI 10.1016/j.fcl.2005.01.013; KANNUS P, 1991, J BONE JOINT SURG AM, V73A, P1507, DOI 10.2106/00004623-199173100-00009; Kragsnaes MS, 2014, AM J SPORT MED, V42, P2435, DOI 10.1177/0363546514542329; Kujala UM, 2005, CLIN J SPORT MED, V15, P133, DOI 10.1097/01.jsm.0000165347.55638.23; Lenskjold A, 2015, SCAND J MED SCI SPOR, V25, P25, DOI 10.1111/sms.12143; Maffulli N, 2013, PHYS THER SPORT, V14, P163, DOI 10.1016/j.ptsp.2012.07.002; Meulenkamp B, 2018, SYST REV-LONDON, V7, DOI 10.1186/s13643-018-0912-5; Morita W, 2017, BONE JOINT RES, V6, P656, DOI 10.1302/2046-3758.612.BJR-2017-0112.R1; Norling LV, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.85922; Ochen Y, 2019, BMJ-BRIT MED J, V364, DOI 10.1136/bmj.k5120; Paavola M, 2002, BRIT J SPORT MED, V36, P178, DOI 10.1136/bjsm.36.3.178; Robinson JM, 2001, BRIT J SPORT MED, V35, P335, DOI 10.1136/bjsm.35.5.335; Romano M, 2007, THESCIENTIFICWORLDJO, V7, P1393, DOI 10.1100/tsw.2007.186; Scapini P, 2009, IMMUNOL REV, V228, P23, DOI 10.1111/j.1600-065X.2008.00758.x; Tallon C, 2001, MED SCI SPORT EXER, V33, P1983, DOI 10.1097/00005768-200112000-00002; Xu YK, 2005, IMMUNITY, V22, P9, DOI 10.1016/j.immuni.2004.12.004	39	12	12	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2019	33	7					8043	8054		10.1096/fj.201900196R	http://dx.doi.org/10.1096/fj.201900196R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ9SM	30916999	hybrid, Green Published			2022-12-26	WOS:000476234700020
J	Murugan, AK; Liu, RY; Xing, MZ				Murugan, Avaniyapuram Kannan; Liu, Rengyun; Xing, Mingzhao			Identification and characterization of two novel oncogenic mTOR mutations	ONCOGENE			English	Article							SOMATIC MUTATIONS; MAMMALIAN TARGET; GENETIC ALTERATIONS; POINT MUTATIONS; THYROID-CANCER; PATHWAY; ACTIVATION; KINASE; RAPAMYCIN; CONFER	Mammalian target of rapamycin (mTOR) signaling is often aberrantly activated, particularly when genetically altered, in human cancers. mTOR inhibitors targeting the activated mTOR signaling are highly promising anti-cancer drugs. Knowing the activating genetic change in mTOR can help guide the use of mTOR inhibitors for cancer treatment. This study was conducted to identify and characterize novel oncogenic mTOR mutations that can potentially be therapeutic targets in human cancer. We sequenced 30 exons of the mTOR gene in 12 thyroid cancer cell lines, 3 melanoma cell lines, 20 anaplastic thyroid cancer (ATC) tumors, and 23 melanoma tumors and functionally characterized the identified novel mTOR mutations in vitro and in vivo. We identified a novel point mutation A1256G in ATC cell line and G7076A in melanoma tumor in exon 9 and exon 51 of the mTOR gene, respectively. Over-expression of the corresponding mTOR mutants H419R and G2359E created through induced mutagenesis showed markedly elevated protein kinase activities associated with the activation of mTOR/p70S6K signaling in HEK293T cells. Stable expression of the two mTOR mutants in NIH3T3 cells strongly activated the mTOR/p70S6K signaling pathway and induced morphologic transformation, cell focus formation, anchorage-independent cell growth, and invasion. Inoculation of these mutant-expressing cells in athymic nude mice induced rapid tumor development, showing their driving oncogenicity. We also demonstrated that transfection with the novel mutants conferred cells high sensitivities to the mTOR inhibitor temsirolimus. We speculate that human cancers harboring these mTOR mutations, such as ATC and melanoma, may be effectively treated with inhibitors targeting mTOR.	[Murugan, Avaniyapuram Kannan; Liu, Rengyun; Xing, Mingzhao] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Lab Cellular & Mol Thyroid Res, Sch Med,Dept Med,Div Endocrinol Diabet & Metab, Baltimore, MD 21287 USA	Johns Hopkins University; Johns Hopkins Medicine	Xing, MZ (corresponding author), Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Lab Cellular & Mol Thyroid Res, Sch Med,Dept Med,Div Endocrinol Diabet & Metab, Baltimore, MD 21287 USA.	mxing1@jhmi.edu	Liu, Rengyun/O-4039-2018; Murugan, Avaniyapuram Kannan/AAI-8222-2020	Liu, Rengyun/0000-0002-1408-2372; Murugan, Avaniyapuram Kannan/0000-0002-3096-6100	U.S.A. National Institutes of Health (NIH) [R01CA215142, R01CA189224]; NATIONAL CANCER INSTITUTE [R01CA215142, R01CA189224] Funding Source: NIH RePORTER	U.S.A. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by U.S.A. National Institutes of Health (NIH) grants R01CA215142 and R01CA189224 to M. Xing.	Agrawal N, 2014, CELL, V159, P676, DOI 10.1016/j.cell.2014.09.050; Berven LA, 2000, IMMUNOL CELL BIOL, V78, P447, DOI 10.1046/j.1440-1711.2000.00928.x; Davies H, 2005, CANCER RES, V65, P7591, DOI 10.1158/0008-5472.CAN-05-1855; Edinger AL, 2004, ONCOGENE, V23, P5654, DOI 10.1038/sj.onc.1207738; Fukui Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014180; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Ghosh AP, 2015, ONCOTARGET, V6, P17895, DOI 10.18632/oncotarget.4963; Grabiner BC, 2014, CANCER DISCOV, V4, P554, DOI 10.1158/2159-8290.CD-13-0929; Hardt M, 2011, GENES CELLS, V16, P141, DOI 10.1111/j.1365-2443.2010.01482.x; Janku F, 2018, NAT REV CLIN ONCOL, V15, P273, DOI 10.1038/nrclinonc.2018.28; Jiao QL, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0801-5; Kang SY, 2005, P NATL ACAD SCI USA, V102, P802, DOI 10.1073/pnas.0408864102; Karbowniczek M, 2008, J INVEST DERMATOL, V128, P980, DOI 10.1038/sj.jid.5701074; Kong Y, 2016, CLIN CANCER RES, V22, P1018, DOI 10.1158/1078-0432.CCR-15-1110; Kunstman JW, 2015, HUM MOL GENET, V24, P2318, DOI 10.1093/hmg/ddu749; Lancia I, 2016, J CLIN INVEST, V126, P1052, DOI 10.1172/JCI85271; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Li YY, 2015, CLIN CANCER RES, V21, P1447, DOI 10.1158/1078-0432.CCR-14-1773; de Souza ECL, 2011, EXPERT OPIN THER TAR, V15, P1099, DOI 10.1517/14728222.2011.594044; Liu DX, 2009, CANCER RES, V69, P7311, DOI 10.1158/0008-5472.CAN-09-1077; Liu J, 2010, ANN CLIN LAB SCI, V40, P211; Liu Z, 2008, J CLIN ENDOCR METAB, V93, P3106, DOI 10.1210/jc.2008-0273; Lochhead PA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.254pe4; Murugan AK, 2015, META GENE, V6, P69, DOI 10.1016/j.mgene.2015.08.005; Murugan AK, 2013, J BIOL CHEM, V288, P6511, DOI 10.1074/jbc.M112.399485; Murugan AK, 2011, CANCER RES, V71, P4403, DOI 10.1158/0008-5472.CAN-10-4041; Murugan AK, 2009, CELL CYCLE, V8, P2122, DOI 10.4161/cc.8.13.8710; Neff RL, 2008, ENDOCRIN METAB CLIN, V37, P525, DOI 10.1016/j.ecl.2008.02.003; Ohne Y, 2008, J BIOL CHEM, V283, P31861, DOI 10.1074/jbc.M801546200; Paquette M, 2018, CANCERS, V10, DOI 10.3390/cancers10010018; Prete A, 2018, CLIN CANCER RES, V24, P6078, DOI 10.1158/1078-0432.CCR-18-0693; Sadow PM, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju182; Saji M, 2010, MOL CELL ENDOCRINOL, V321, P20, DOI 10.1016/j.mce.2009.10.016; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sato T, 2010, ONCOGENE, V29, P2746, DOI 10.1038/onc.2010.28; Schweppe RE, 2008, J CLIN ENDOCR METAB, V93, P4331, DOI 10.1210/jc.2008-1102; Sekulic A, 2000, CANCER RES, V60, P3504; Sturgill TW, 2009, ACS CHEM BIOL, V4, P999, DOI 10.1021/cb900193e; Urano J, 2007, P NATL ACAD SCI USA, V104, P3514, DOI 10.1073/pnas.0608510104; Volkers M, 2013, P NATL ACAD SCI USA, V110, P12661, DOI 10.1073/pnas.1301455110; Wagle N, 2014, NEW ENGL J MED, V371, P1426, DOI 10.1056/NEJMoa1403352; Xing MZ, 2010, THYROID, V20, P697, DOI 10.1089/thy.2010.1646; Xu JN, 2016, J CLIN INVEST, V126, P3526, DOI 10.1172/JCI86120; Yamaguchi H, 2015, CANCER SCI, V106, P1687, DOI 10.1111/cas.12828	45	16	17	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 27	2019	38	26					5211	5226		10.1038/s41388-019-0787-5	http://dx.doi.org/10.1038/s41388-019-0787-5			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	IF4AX	30918329	Green Accepted			2022-12-26	WOS:000473025300007
J	Garcia, MG; Pusti, D; Wahl, S; Ohlendorf, A				Garcia, Miguel Garcia; Pusti, Dibyendu; Wahl, Siegfried; Ohlendorf, Arne			A global approach to describe retinal defocus patterns	PLOS ONE			English	Article							PERIPHERAL REFRACTION; GANGLION-CELL; MYOPIA; PROGRESSION; UNDERCORRECTION; MECHANISMS; VISION; TRENDS	The popularity of myopia treatments based on the peripheral defocus theory has risen. So far, little evidence has emerged around the questions which of these treatments are effective and why. In order to establish a framework that enables clinicians and researchers to acknowledge the possible interactions of different defocus patterns across the retina, different peripheral refractive errors (PRX) of subjects and different designs of optical treatments were evaluated. Dioptric defocus patterns on the retinal level have been obtained by merging the matrices of dioptric defocus maps of the visual field of different scenarios with individual peripheral refractive errors and different optical designs of multifocal contact lenses. The newly obtained matrices were statistically compared using a non-parametric test with familywise error algorithms and multi-comparison tests. Results show that asymmetric peripheral refractive error profiles (temporal or nasal positively skewed) appear to be less prone to be changed by the defocus imposition of multifocal contact lenses than those presenting symmetric patterns (relative peripheral myopia or hyperopia).	[Garcia, Miguel Garcia; Wahl, Siegfried; Ohlendorf, Arne] Eberhard Karls Univ Tuebingen, Inst Ophthalm Res, Tubingen, Baden Wuerttemb, Germany; [Garcia, Miguel Garcia; Wahl, Siegfried; Ohlendorf, Arne] Carl Zeiss Vis Int GmbH, Aalen, Baden Wuerttemb, Germany; [Pusti, Dibyendu] Univ Murcia, Lab Opt, Murcia, Spain	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Murcia	Garcia, MG (corresponding author), Eberhard Karls Univ Tuebingen, Inst Ophthalm Res, Tubingen, Baden Wuerttemb, Germany.; Garcia, MG (corresponding author), Carl Zeiss Vis Int GmbH, Aalen, Baden Wuerttemb, Germany.	miguel.garcia-garcia@student.uni-tuebingen.de	Pusti, Dibyendu/AAA-1483-2021; García, Miguel García/V-9225-2019; Ohlendorf, Arne/ABA-6968-2020	Pusti, Dibyendu/0000-0003-3839-7587; García, Miguel García/0000-0001-7379-0080; 	European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant [675137]; Deutsche Forschungsgemeinschaft; Open Access Publishing Fund of the University of Tubingen	European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publishing Fund of the University of Tubingen	MYFUN receives funding from the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No 675137. Carl Zeiss Vision International GmbH provides support in the form of salaries for authors MGG, AO & SW. The University of Murcia provides support in the form of salary for the author DP. The authors acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of the University of Tubingen. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler D, 2006, CLIN EXP OPTOM, V89, P315, DOI 10.1111/j.1444-0938.2006.00055.x; Atchison DA, 2006, VISION RES, V46, P1450, DOI 10.1016/j.visres.2005.10.023; Baden T, 2017, CURR BIOL, V27, pR139, DOI 10.1016/j.cub.2016.12.022; Chakraborty R, 2015, PROG MOL BIOL TRANSL, V134, P249, DOI 10.1016/bs.pmbts.2015.06.013; Charman WN, 2010, OPHTHAL PHYSL OPT, V30, P321, DOI 10.1111/j.1475-1313.2010.00746.x; Chung K, 2002, VISION RES, V42, P2555, DOI 10.1016/S0042-6989(02)00258-4; Conrad F, 2018, OPHTHAL PHYSL OPT, P215, DOI [10.1111/opo.12459, DOI 10.1111/OPO.12459]; Fernandez EJ, 2002, J REFRACT SURG, V18, pS634; Garcia MG, 2018, BIOMED OPT EXPRESS, V9, P347, DOI 10.1364/BOE.9.000347; Holden BA, 2016, OPHTHALMOLOGY, V123, P1036, DOI 10.1016/j.ophtha.2016.01.006; Huang JH, 2016, OPHTHALMOLOGY, V123, P697, DOI 10.1016/j.ophtha.2015.11.010; Jaeken B, 2012, INVEST OPHTH VIS SCI, V53, P3405, DOI 10.1167/iovs.11-8993; Jaeken B, 2011, OPT EXPRESS, V19, P7903, DOI 10.1364/OE.19.007903; KOTULAK JC, 1986, PERCEPTION, V15, P7, DOI 10.1068/p150007; Logan N, 2018, OPHTHAL PHYSL OPT, V38, P207, DOI 10.1111/opo.12461; Lundstrom L, 2017, HDB VISUAL OPTICS; Lundstrom L, 2007, OPT EXPRESS, V15, P12654, DOI 10.1364/OE.15.012654; Maiello G, 2018, BLUR PERCEPTION VISU, V17, P1, DOI [10.1167/17.5.3, DOI 10.1167/17.5.3]; Mani A, 2017, CURR BIOL, V27, P471, DOI 10.1016/j.cub.2016.12.033; Medina A, 2016, GRAEF ARCH CLIN EXP, V254, P409, DOI 10.1007/s00417-015-3111-2; REMPT F, 1971, OPHTHALMOLOGICA, V162, P1, DOI 10.1159/000306229; Rosen R, 2012, OPHTHAL PHYSL OPT, V32, P527, DOI 10.1111/j.1475-1313.2012.00937.x; Ruiz-Alcocer Javier, 2017, J Optom, V10, P266, DOI 10.1016/j.optom.2016.08.003; Sankaridurg P, 2010, OPTOMETRY VISION SCI, V87, P631, DOI 10.1097/OPX.0b013e3181ea19c7; Schaeffel F, 2013, OPHTHAL PHYSL OPT, V33, P362, DOI 10.1111/opo.12058; Schaeffel F, 2015, CLIN EXP OPTOM, V98, P507, DOI 10.1111/cxo.12312; Smith EL, 2013, OPTOMETRY VISION SCI, V90, P1176, DOI 10.1097/OPX.0000000000000038; Sun Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124535; Sun YY, 2017, GRAEF ARCH CLIN EXP, V255, P189, DOI 10.1007/s00417-016-3529-1; Tarutta E. P., 2015, ROS PEDIAT OPHTALMOL, V10, P33; The European Parliament and the Council of the European Union, 2016, OFF J EUR UNION, V59; Wagner S, 2015, CONTACT LENS ANTERIO, V38, P2, DOI 10.1016/j.clae.2014.07.008; Wallman J, 2004, NEURON, V43, P447, DOI 10.1016/j.neuron.2004.08.008; WALLMAN J, 1994, NATURE, V371, P201, DOI 10.1038/371201a0; Wolffsohn JS, 2016, CONTACT LENS ANTERIO, V39, P106, DOI 10.1016/j.clae.2016.02.005	35	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2019	14	4							e0213574	10.1371/journal.pone.0213574	http://dx.doi.org/10.1371/journal.pone.0213574			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR2UW	30939130	Green Published, gold, Green Submitted			2022-12-26	WOS:000462993900006
J	Okawa, Y; Maruko, I; Kawai, M; Hasegawa, T; Arakawa, H; Iida, T				Okawa, Yuka; Maruko, Ichiro; Kawai, Moeko; Hasegawa, Taiji; Arakawa, Hisaya; Iida, Tomohiro			Foveal structure and vasculature in eyes with idiopathic epiretinal membrane	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; LAYER THICKNESS	Purpose To examine the foveal structure and vasculature in eyes with an idiopathic epiretinal membrane (ERM). Methods Forty-nine eyes of 48 patients with an idiopathic ERM were studied. The superficial foveal avascular zone (FAZ) was measured by optical coherence tomography angiography (OCTA; RTVue XR Avanti, Optovue Inc., Fremont, CA), and the central foveal thickness (CFT) was measured by swept source OCT (DRI-OCT, Topcon, Japan). Twenty eyes underwent vitrectomy with internal limiting membrane (ILM) peeling, and the FAZ and CFT were evaluated pre- and postoperatively. Forty-nine eyes of 49 age-matched healthy subjects were also examined as control. Results The FAZ in eyes with an ERM was significantly smaller than that of the control eyes (0.188 +/- 0.16 mm(2) vs 0.328 +/- 0.14 mm(2), P<0.01). The CFT in eyes with an ERM was significantly thicker than that of control eyes (315 +/- 0.14 mu m vs 193 +/- 0.14 mu m, P<0.01). The size of the FAZ was strongly correlated with the CFT (ERM, R = -0.753; control, R = -0.61, both P<0.01). The postoperative size of the FAZ was not significantly different from the preoperative size (0.115 mm(2) vs 0.128 mm(2), P = 0.17) but the CFT was significantly thinner (370 mu m vs 288 mu m, P<0.01) after the vitrectomy with ILM peeling in 20 eyes. Conclusions The results indicate that an ERM might affect the morphology and vasculature of not only the inner but also the outer retina before and after vitrectomy with ILM peeling. The FAZ area might have been affected by the ILM peeling.	[Okawa, Yuka; Maruko, Ichiro; Kawai, Moeko; Hasegawa, Taiji; Arakawa, Hisaya; Iida, Tomohiro] Tokyo Womens Med Univ, Dept Ophthalmol, Shinjuku Ku, Tokyo, Japan	Tokyo Women's Medical University	Maruko, I (corresponding author), Tokyo Womens Med Univ, Dept Ophthalmol, Shinjuku Ku, Tokyo, Japan.	imaruko@twmu.ac.jp	Maruko, Ichiro/AFP-1311-2022; Hasegawa, Taiji/ABG-8260-2021	Maruko, Ichiro/0000-0001-5647-6372; 	JSPS KAKENHI [JP16K11274]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Dr. Okawa has nothing to disclose. Dr. Maruko reports grants from JSPS KAKENHI (Grant Number JP16K11274), grants and personal fees from Novartis Pharma K.K., personal fees from Bayer Yakuhin, Ltd., personal fees from Santen Pharmaceutical Inc., personal fees from Alcon Japan, Ltd., personal fees from Topcon Co., Ltd., personal fees from Senju Pharmaceutical Co., Ltd., personal fees from NIDEK Co., Ltd., outside the submitted work. Dr. Kawai has nothing to disclose. Dr. Hasegawa has nothing to disclose. Dr. Arakawa has nothing to disclose. Dr. Iida reports grants and personal fees from Novartis Pharma K. K. (Japan), personal fees from Bayer Yakuhin, Ltd. (Japan), grants and personal fees from Santen Pharmaceutical Co., Ltd. (Japan), grants from Nidek, research support from Chuosangyo (Japan), outside the submitted work. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bottoni F, 2011, INVEST OPHTH VIS SCI, V52, P4439, DOI 10.1167/iovs.10-6732; Chen H, 2019, EYE, V33, P619, DOI 10.1038/s41433-018-0272-3; Inoue M, 2010, AM J OPHTHALMOL, V150, P834, DOI 10.1016/j.ajo.2010.06.006; Joe SG, 2013, ACTA OPHTHALMOL, V91, pE242, DOI 10.1111/aos.12017; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kim YJ, 2018, BRIT J OPHTHALMOL, V102, P1086, DOI 10.1136/bjophthalmol-2017-311188; Kitagawa Y, 2019, RETINA-J RET VIT DIS, V39, P339, DOI 10.1097/IAE.0000000000001972; Koo HC, 2012, GRAEF ARCH CLIN EXP, V250, P491, DOI 10.1007/s00417-011-1848-9; Kumagai K, 2018, RETINA-J RET VIT DIS, V38, P1786, DOI 10.1097/IAE.0000000000001778; Lee JW, 2010, JPN J OPHTHALMOL, V54, P129, DOI 10.1007/s10384-009-0778-0; Michalewski J, 2007, GRAEF ARCH CLIN EXP, V245, P1623, DOI 10.1007/s00417-007-0579-4; Nelis P, 2017, GRAEF ARCH CLIN EXP, V255, P1319, DOI 10.1007/s00417-017-3640-y; Okamoto F, 2015, RETINA-J RET VIT DIS, V35, P2107, DOI 10.1097/IAE.0000000000000602; Ooto S, 2011, OPHTHALMOLOGY, V118, P873, DOI 10.1016/j.ophtha.2010.08.032; Samara WA, 2015, RETINA-J RET VIT DIS, V35, P2188, DOI 10.1097/IAE.0000000000000847; Spaide RF, 2017, JAMA OPHTHALMOL, V135, P259, DOI 10.1001/jamaophthalmol.2016.5327; Watanabe A, 2009, OPHTHALMOLOGY, V116, P1788, DOI 10.1016/j.ophtha.2009.04.046; Zur D, 2018, AM J OPHTHALMOL, V196, P129, DOI 10.1016/j.ajo.2018.08.037	18	19	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2019	14	4							e0214881	10.1371/journal.pone.0214881	http://dx.doi.org/10.1371/journal.pone.0214881			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR2UW	30939161	gold, Green Submitted, Green Published			2022-12-26	WOS:000462993900045
J	Shawki, HH; Ishikawa-Yamauchi, Y; Kawashima, A; Katoh, Y; Matsuda, M; Al-Soudy, A; Minisy, FM; Kuno, A; Gulibaikelamu, X; Hirokawa, T; Takahashi, S; Oishi, H				Shawki, Hossam H.; Ishikawa-Yamauchi, Yu; Kawashima, Akihiro; Katoh, Yuki; Matsuda, Manabu; Al-Soudy, Al-Sayed; Minisy, Fatma M.; Kuno, Akihiro; Gulibaikelamu, Xiafukaiti; Hirokawa, Takatsugu; Takahashi, Satoru; Oishi, Hisashi			EFCAB2 is a novel calcium-binding protein in mouse testis and sperm	PLOS ONE			English	Article							SIGNALING PATHWAYS; CALMODULIN; MOTILITY; INVOLVEMENT; CABS1	Calcium-binding proteins regulate ion metabolism and the necessary signaling pathways for the maturational events of sperm. Our aim is to identify the novel calcium-binding proteins in testis. The gene EFCAB2 (GenBank NM_026626.3, NP_080902.1) was not previously examined, and its properties and exact mechanisms of action are unknown. In this study, we performed phylogenetic and structure prediction analyses of EFCAB2, which displays definitive structural features. Additionally, the distribution, localization, and calcium binding ability of mouse EFCAB2 were investigated. Results revealed extensive conservation of EFCAB2 among different eukaryotic orthologs. The constructed 3D model predicted that mouse EFCAB2 contains seven a-helices and two EF-hand motifs. The first EF-hand motif is located in N-terminal, while the second is located in C-terminal. By aligning the 3D structure of Ca2+-binding loops from EFCAB2 with calmodulin, we predicted six residues that might be involved in Ca2+ binding. The distribution of the Efcab2 mRNA, as determined by northern blotting, was detected only in the testis among mouse tissues. Native and recombinant EFCAB2 protein were detected by western blotting as one band at 20 kDa. In situ hybridization and immunohistochemical analyses showed its localization specifically in spermatogenic cells from primary spermatocytes to elongate spermatids within the seminiferous epithelium, but neither spermatogonia nor somatic cells were expressed. Moreover, EFCAB2 was specifically localized to the principal piece of cauda epididymal sperm flagellum. Furthermore, the analyses of purified recombinant EFCAB2 by Stains-all, ruthenium red staining, and by applying in vitro autoradiography assay showed that the physiological function of this protein is Ca2+ binding. These results suggested that EFCAB2 might be involved in the control of sperm flagellar movement. Altogether, here we describe about EFCAB2 as a novel calcium-binding protein in mouse testis and sperm.	[Shawki, Hossam H.; Kawashima, Akihiro; Al-Soudy, Al-Sayed; Kuno, Akihiro; Gulibaikelamu, Xiafukaiti; Takahashi, Satoru] Univ Tsukuba, Dept Anat & Embryol, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki, Japan; [Shawki, Hossam H.; Al-Soudy, Al-Sayed] Natl Gene Bank, Dept Anim Genet Resources, Giza, Egypt; [Shawki, Hossam H.; Kawashima, Akihiro; Minisy, Fatma M.; Oishi, Hisashi] Nagoya City Univ, Grad Sch Med Sci, Dept Comparat & Expt Med, Nagoya, Aichi, Japan; [Ishikawa-Yamauchi, Yu] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Katoh, Yuki] Keio Univ, Sch Med, Inst Adv Med Res, Shinjuku Ku, Tokyo, Japan; [Matsuda, Manabu] Kindai Univ, Fac Med, Dept Arts & Sci, Osaka, Japan; [Minisy, Fatma M.] Natl Res Ctr, Pathol Dept, Med Res Div, Giza, Egypt; [Hirokawa, Takatsugu] Natl Inst Adv Ind Sci & Technol, Mol Profiling Res Ctr Drug Discovery, Koutou Ku, Tokyo, Japan	University of Tsukuba; Nagoya City University; University of Tsukuba; Keio University; Kindai University (Kinki University); Egyptian Knowledge Bank (EKB); National Research Centre (NRC); National Institute of Advanced Industrial Science & Technology (AIST)	Shawki, HH; Kawashima, A (corresponding author), Univ Tsukuba, Dept Anat & Embryol, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki, Japan.; Shawki, HH (corresponding author), Natl Gene Bank, Dept Anim Genet Resources, Giza, Egypt.; Shawki, HH; Kawashima, A (corresponding author), Nagoya City Univ, Grad Sch Med Sci, Dept Comparat & Expt Med, Nagoya, Aichi, Japan.	shawkihh@med.nagoya-cu.ac.jp; tsukutsukukawashi@hotmail.com		Kuno, Akihiro/0000-0002-4674-6882; Minisy, Fatma/0000-0001-5089-2199; Al-Soudy, Al-Sayed/0000-0002-7830-9660	Nagoya City University, Japan [201805]	Nagoya City University, Japan	We would like to declare that our work was funded for PI: Dr. Hossam H. Shawki by Nagoya City University, Japan (Grant 201805), and the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMAD K, 1995, ARCH ANDROLOGY, V35, P187, DOI 10.3109/01485019508987871; Al-Soudy AS, 2016, GENESIS, V54, P389, DOI 10.1002/dvg.22944; Bhattacharya S, 2004, BBA-MOL CELL RES, V1742, P69, DOI 10.1016/j.bbamcr.2004.09.002; Brown T, 2001, Curr Protoc Immunol, VChapter 10, DOI 10.1002/0471142735.im1012s07; CADAY CG, 1986, BIOPOLYMERS, V25, P1579, DOI 10.1002/bip.360250814; CADAY CG, 1985, J BIOL CHEM, V260, P5985; CAMPBELL KP, 1983, J BIOL CHEM, V258, P1267; Chazin WJ, 2011, ACCOUNTS CHEM RES, V44, P171, DOI 10.1021/ar100110d; Darszon A, 2011, PHYSIOL REV, V91, P1305, DOI 10.1152/physrev.00028.2010; Denessiouk K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109287; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; Halling DB, 2016, P NATL ACAD SCI USA, V113, pE1216, DOI 10.1073/pnas.1600385113; Ikura M, 2006, P NATL ACAD SCI USA, V103, P1159, DOI 10.1073/pnas.0508640103; Jha KN, 2003, CELL MOL BIOL, V49, P329; KAWASAKI H, 1995, PROTEIN PROFILE, V2, P305; Kawashima A, 2016, MOL REPROD DEV, V83, P912, DOI 10.1002/mrd.22639; Kawashima A, 2009, BIOL REPROD, V80, P1293, DOI 10.1095/biolreprod.108.073866; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Kozlowski LP, 2016, BIOL DIRECT, V11, DOI 10.1186/s13062-016-0159-9; KRETSINGER RH, 1973, J BIOL CHEM, V248, P3313; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lewit-Bentley A, 2000, CURR OPIN STRUC BIOL, V10, P637, DOI 10.1016/S0959-440X(00)00142-1; Li YF, 2007, J BIOL CHEM, V282, P34104, DOI 10.1074/jbc.M702238200; Marin-Briggiler CI, 2005, J CELL SCI, V118, P2013, DOI 10.1242/jcs.02326; MARUYAMA K, 1984, J BIOCHEM-TOKYO, V95, P511, DOI 10.1093/oxfordjournals.jbchem.a134633; Mizuno K, 2012, P NATL ACAD SCI USA, V109, P20497, DOI 10.1073/pnas.1217018109; Nelson MR, 1998, PROTEIN SCI, V7, P270; Nelson MR, 2002, PROTEIN SCI, V11, P198, DOI 10.1110/ps.33302; Phillips BT, 2010, PHILOS T R SOC B, V365, P1663, DOI 10.1098/rstb.2010.0026; Rahman MS, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/841615; Schlingmann K, 2007, J ANDROL, V28, P706, DOI 10.2164/jandrol.106.001669; Shawki HH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190800; Shawki HH, 2016, EXP ANIM TOKYO, V65, P253, DOI 10.1538/expanim.15-0104; Si YM, 2000, BIOL REPROD, V62, P1231, DOI 10.1095/biolreprod62.5.1231; Visconti PE, 2002, J REPROD IMMUNOL, V53, P133, DOI 10.1016/S0165-0378(01)00103-6; Wei Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5060; Will T, 2007, P NATL ACAD SCI USA, V104, P10536, DOI 10.1073/pnas.0703535104; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Yanez M, 2012, ADV EXP MED BIOL, V740, P461, DOI 10.1007/978-94-007-2888-2_19; Yates B, 2017, NUCLEIC ACIDS RES, V45, pD619, DOI 10.1093/nar/gkw1033	42	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2019	14	4							e0214687	10.1371/journal.pone.0214687	http://dx.doi.org/10.1371/journal.pone.0214687			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR1CY	30933994	gold, Green Published, Green Submitted			2022-12-26	WOS:000462867000037
J	Ackermann, D; Groessl, M; Pruijm, M; Ponte, B; Escher, G; d'Uscio, CH; Guessous, I; Ehret, G; Pechere-Bertschi, A; Martin, PY; Burnier, M; Dick, B; Vogt, B; Bochud, M; Rousson, V; Dhayat, NA				Ackermann, Daniel; Groessl, Michael; Pruijm, Menno; Ponte, Belen; Escher, Genevieve; d'Uscio, Claudia H.; Guessous, Idris; Ehret, Georg; Pechere-Bertschi, Antoinette; Martin, Pierre-Yves; Burnier, Michel; Dick, Bernhard; Vogt, Bruno; Bochud, Murielle; Rousson, Valentin; Dhayat, Nasser A.			Reference intervals for the urinary steroid metabolome: The impact of sex, age, day and night time on human adult steroidogenesis	PLOS ONE			English	Article							CHROMATOGRAPHY-MASS-SPECTROMETRY; CIRCADIAN-RHYTHM; CORTISOL; POPULATION; EXCRETION; HORMONES; EXPRESSION; GC/MS; FATE; TOOL	Objective Urinary steroid metabolomics by GC-MS is an established method in both clinical and research settings to describe steroidogenic disorders. However, population-based reference intervals for adults do not exist. Methods We measured daytime and night time urinary excretion of 40 steroid metabolites by GC-MS in 1128 adult participants of European ancestry, aged 18 to 90 years, within a large population-based, multicentric, cross-sectional study. Age and sex-related patterns in adjacent daytime and night time urine collections over 24 hours were modelled for each steroid metabolite by multivariable linear mixed regression. We compared our results with those obtained through a systematic literature review on reference intervals of urinary steroid excretion. Results Flexible models were created for all urinary steroid metabolites thereby estimating sex-and age-related changes of the urinary steroid metabolome. Most urinary steroid metabolites showed an age-dependence with the exception of 6 beta-OH-cortisol, 18-OH-cortisol, and beta-cortol. Reference intervals for all metabolites excreted during 24 hours were derived from the 2.5th and 97.5th percentile of modelled reference curves. The excretion rate per period of metabolites predominantly derived from the adrenals was mainly higher during the day than at night and the correlation between day and night time metabolite excretion was highly positive for most androgens and moderately positive for glucocorticoids. Conclusions This study gives unprecedented new insights into sex-and age-specificity of the human adult steroid metabolome and provides further information on the day/night variation of urinary steroid hormone excretion. The population-based reference ranges for 40 GC-MS-measured metabolites will facilitate the interpretation of steroid profiles in clinical practice.	[Ackermann, Daniel; Groessl, Michael; Escher, Genevieve; d'Uscio, Claudia H.; Dick, Bernhard; Vogt, Bruno; Dhayat, Nasser A.] Univ Bern, Bern Univ Hosp, Inselspital, Dept Hypertens & Nephrol, Bern, Switzerland; [Ackermann, Daniel; Groessl, Michael; Escher, Genevieve; d'Uscio, Claudia H.; Dick, Bernhard; Vogt, Bruno; Dhayat, Nasser A.] Univ Bern, Bern Univ Hosp, Inselspital, Dept Clin Res, Bern, Switzerland; [Pruijm, Menno; Burnier, Michel] Univ Hosp Lausanne, Serv Nephrol, Lausanne, Switzerland; [Ponte, Belen; Martin, Pierre-Yves] Univ Hosp Geneva, Dept Specialties Internal Med, Serv Nephrol, Geneva, Switzerland; [Guessous, Idris] Univ Hosp Geneva, Dept Community Med Primary Care & Emergency Med, Geneva, Switzerland; [Ehret, Georg] Univ Hosp Geneva, Dept Specialties Internal Med, Serv Cardiol, Geneva, Switzerland; [Pechere-Bertschi, Antoinette] Univ Hosp Geneva, Dept Internal Med Specialties, Serv Endocrinol, Geneva, Switzerland; [Bochud, Murielle; Rousson, Valentin] Univ Hosp Lausanne, Inst Social & Prevent Med, Lausanne, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Geneva; University of Geneva; University of Geneva; University of Geneva; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Dhayat, NA (corresponding author), Univ Bern, Bern Univ Hosp, Inselspital, Dept Hypertens & Nephrol, Bern, Switzerland.; Dhayat, NA (corresponding author), Univ Bern, Bern Univ Hosp, Inselspital, Dept Clin Res, Bern, Switzerland.	nasser.dhayat@insel.ch	Pruijm, Menno/AAA-4281-2020; EHRET, Georg B/A-9532-2009; Vogt, Bruno/AAS-2876-2020; Dhayat, Nasser A/J-1350-2016	Pruijm, Menno/0000-0003-1027-1851; EHRET, Georg B/0000-0002-5730-0675; Vogt, Bruno/0000-0002-1548-6387; Dhayat, Nasser A/0000-0001-8310-5921; Rousson, Valentin/0000-0001-8092-4446; Escher, Genevieve/0000-0002-5125-2262	Swiss National Science Foundation [33CM30-124087]; CTU Scientific Grant of the Directorate for Education and Research, Inselspital, Bern University Hospital, University of Bern, Switzerland [84801054]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); CTU Scientific Grant of the Directorate for Education and Research, Inselspital, Bern University Hospital, University of Bern, Switzerland	This work was supported by the Swiss National Science Foundation (grant number 33CM30-124087 to MB, http://p3.snf.ch/Project-124087) and by the CTU Scientific Grant of the Directorate for Education and Research, Inselspital, Bern University Hospital, University of Bern, Switzerland (grant number 84801054 to NAD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann D, 2016, AM J HYPERTENS, V29, P484, DOI 10.1093/ajh/hpv138; Alvarez JD, 2003, BIOL REPROD, V69, P81, DOI 10.1095/biolreprod.102.011833; Arlt W, 2011, J CLIN ENDOCR METAB, V96, P3775, DOI 10.1210/jc.2011-1565; AXELSON M, 1977, J STEROID BIOCHEM, V8, P683, DOI 10.1016/0022-4731(77)90297-7; BEVAN BR, 1986, J CLIN PATHOL, V39, P627, DOI 10.1136/jcp.39.6.627; Bileck A, 2018, J STEROID BIOCH MOL; Bileck A, 2018, ANALYST, V143, P4484, DOI 10.1039/c7an01990d; Bochud M, 2019, J CLIN ENDOCR METAB, V104, P2195, DOI 10.1210/jc.2018-01942; Chan AOK, 2008, STEROIDS, V73, P828, DOI 10.1016/j.steroids.2008.03.004; Chung S, 2011, BBA-MOL BASIS DIS, V1812, P581, DOI 10.1016/j.bbadis.2011.02.003; CZEKALA NM, 1994, AM J PRIMATOL, V34, P29, DOI 10.1002/ajp.1350340107; de Jong WHA, 2018, CLIN CHEM LAB MED, V56, P103, DOI 10.1515/cclm-2016-1072; Dhayat NA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203903; Dhayat NA, 2015, J STEROID BIOCHEM, V154, P226, DOI 10.1016/j.jsbmb.2015.07.024; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; FALES HM, 1965, ANAL CHEM, V37, P955, DOI 10.1021/ac60226a052; Fang K, 2010, CHINESE J ANAL CHEM, V38, P743, DOI 10.3724/SP.J.1096.2010.00743; Farland LV, 2017, CANCER CAUSE CONTROL, V28, P1441, DOI 10.1007/s10552-017-0971-2; Finken MJJ, 1999, J CLIN ENDOCR METAB, V84, P3316, DOI 10.1210/jc.84.9.3316; Firmann M, 2008, BMC CARDIOVASC DISOR, V8, DOI 10.1186/1471-2261-8-6; Foster RG, 1998, NEURON, V20, P829, DOI 10.1016/S0896-6273(00)80464-X; Guessous I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039877; HELLMAN L, 1956, J CLIN INVEST, V35, P1033, DOI 10.1172/JCI103349; Jerjes WK, 2006, ANN CLIN BIOCHEM, V43, P287, DOI 10.1258/000456306777695564; Krone N, 2010, J STEROID BIOCHEM, V121, P496, DOI 10.1016/j.jsbmb.2010.04.010; Kudielka BM, 2003, PSYCHONEUROENDOCRINO, V28, P35, DOI 10.1016/S0306-4530(02)00008-2; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Liang X, 2013, J BIOL RHYTHM, V28, P208, DOI 10.1177/0748730413486873; Miller WL, 2011, ENDOCR REV, V32, P81, DOI 10.1210/er.2010-0013; Morse D, 2003, MOL ENDOCRINOL, V17, P141, DOI 10.1210/me.2002-0184; Ogna VF, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0275-x; Parikh TP, 2018, ENDOCR CONNECT, V7, P1354, DOI 10.1530/EC-18-0417; Petrovic D, 2016, PSYCHONEUROENDOCRINO, V67, P76, DOI 10.1016/j.psyneuen.2016.02.003; R Development Core Team, 2017, R LANG ENV STAT COMP; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Rousson V, 2008, J APPL STAT, V35, P659, DOI 10.1080/02664760801920960; Sellix MT, 2015, J BIOL RHYTHM, V30, P7, DOI 10.1177/0748730414554222; Shackleton C., 2008, LAB GUIDE METHODS BI, P549, DOI 10.1007/978-3-540-76698-8_26.; Shackleton C, 2018, J ENDOCR SOC, V2, P974, DOI 10.1210/js.2018-00135; Shackleton C, 2010, J STEROID BIOCHEM, V121, P481, DOI 10.1016/j.jsbmb.2010.02.017; Shackleton CHL, 2008, STEROIDS, V73, P652, DOI 10.1016/j.steroids.2008.02.001; Shackleton CHJM, ENCY MASS SPECTROMET, P82006; SHACKLETON CHL, 1986, J CHROMATOGR, V379, P91, DOI 10.1016/S0378-4347(00)80683-0; SHACKLETON CHL, 1993, J STEROID BIOCHEM, V45, P127, DOI 10.1016/0960-0760(93)90132-G; Shamim W, 2000, ANN CLIN BIOCHEM, V37, P770, DOI 10.1258/0004563001900084; Siest G, 2013, CLIN CHEM LAB MED, V51, P47, DOI 10.1515/cclm-2012-0682; SLAUNWHITE WR, 1958, J CLIN ENDOCR METAB, V18, P1056, DOI 10.1210/jcem-18-10-1056; Son GH, 2008, P NATL ACAD SCI USA, V105, P20970, DOI 10.1073/pnas.0806962106; Taylor NF, 2013, METHODS MOL BIOL, V1065, P259, DOI 10.1007/978-1-62703-616-0_17; Van Renterghem P, 2010, STEROIDS, V75, P154, DOI 10.1016/j.steroids.2009.11.008; VANCAUTER E, 1990, HORM RES, V34, P45, DOI 10.1159/000181794; VESTERGAARD P, 1980, LIPIDS, V15, P710, DOI 10.1007/BF02534025; WEYKAMP CW, 1989, CLIN CHEM, V35, P2281; Xu X, 1999, J CLIN ENDOCR METAB, V84, P3914, DOI 10.1210/jc.84.11.3914; Zaidi SK, 2012, OPEN LONGEVITY SCI, V6, P1, DOI [10.2174/1876326X01206010001, DOI 10.2174/1876326X01206010001]	55	20	20	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2019	14	3							e0214549	10.1371/journal.pone.0214549	http://dx.doi.org/10.1371/journal.pone.0214549			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ9FO	30925175	Green Published, gold, Green Submitted			2022-12-26	WOS:000462732300019
J	Bishop, SC; Winefield, R; Anbanandam, A; Lampe, JN				Bishop, Stephanie C.; Winefield, Robert; Anbanandam, Asokan; Lampe, Jed N.			Aqueous synthesis of a small-molecule lanthanide chelator amenable to copper-free click chemistry	PLOS ONE			English	Article							BINUCLEAR TERBIUM(III) COMPLEX; BINDING; PROTEIN; ACID; SPECTROSCOPY; EMISSION; PROBE; TAGS	The lanthanides (Ln(3+)), or rare earth elements, have proven to be useful tools for biomolecular NMR, X-ray crystallographic, and fluorescence analyses due to their unique 4f orbitals. However, their utility in biological applications has been limited because site-specific incorporation of a chelating element is required to ensure efficient binding of the free Ln(3+) ion. Additionally, current Ln(3+) chelator syntheses complicate efforts to directly incorporate Ln(3+) chelators into proteins as the multi-step processes and a reliance on organic solvents promote protein denaturation and aggregation which are generally incompatible with direct incorporation into the protein of interest. To overcome these limitations, herein we describe a two-step aqueous synthesis of a small molecule lanthanide chelating agent amenable to site-specific incorporation into a protein using copper-free click chemistry with unnatural amino acids. The bioconjugate combines a diethylenetriaminepentaacetic acid (DTPA) chelating moiety with a clickable dibenzylcyclooctyne-amine (DBCO-amine) to facilitate the reaction with an azide containing unnatural amino acid. Incorporating the DBCO-amine avoids the use of the cytotoxic Cu2+ ion as a catalyst. The clickable lanthanide chelator (CLC) reagent reacted readily with p-azidophenylalanine (paF) without the need of a copper catalyst, thereby demonstrating proof-of-concept. Implementation of the orthogonal click chemistry reaction has the added advantage that the chelator can be used directly in a protein labeling reaction, without the need of extensive purification. Given the inherent advantages of Cu2+-free click chemistry, aqueous synthesis, and facile labeling, we believe that the CLC will find abundant use in both structural and biophysical studies of proteins and their complexes.	[Bishop, Stephanie C.; Winefield, Robert; Lampe, Jed N.] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66103 USA; [Anbanandam, Asokan] Univ S Florida, Ctr Drug Discovery & Innovat, High Field NMR Core Facil, Tampa, FL USA	University of Kansas; University of Kansas Medical Center; State University System of Florida; University of South Florida	Lampe, JN (corresponding author), Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66103 USA.	jiampe@kumc.edu	Lampe, Jed N./J-8930-2019; Winefield, Robert/AAH-9707-2019; Bishop, Stephanie/AAU-7712-2021	Lampe, Jed N./0000-0003-0794-2263; 	National Institute of General Medical Sciences of the National Institutes of Health [R01GM128508, P20GM103549, P30GM118247, R01GM099959]; National Institute of Environmental Health and Sciences Toxicology Training Grant [T32-ES007079]; Kansas IDeA Network of Biomedical Research Excellence Grant [QH846868-K-INBRE]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM118247, R01GM099959, R01GM128508] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Environmental Health and Sciences Toxicology Training Grant; Kansas IDeA Network of Biomedical Research Excellence Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The research reported in this publication was supported by the National Institute of General Medical Sciences of the National Institutes of Health Award Number R01GM128508 (JNL), P20GM103549, P30GM118247 (JNL subaward), R01GM099959 (JNL subaward), National Institute of Environmental Health and Sciences Toxicology Training Grant T32-ES007079 (SCB), and Kansas IDeA Network of Biomedical Research Excellence Grant QH846868-K-INBRE. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelkader EH, 2015, CHEM COMMUN, V51, P15898, DOI 10.1039/c5cc07121f; Agard NJ, 2006, ACS CHEM BIOL, V1, P644, DOI 10.1021/cb6003228; Akiba H, 2015, ANAL CHEM, V87, P3834, DOI 10.1021/ac5045466; Akiba H, 2010, CHEM-EUR J, V16, P5018, DOI 10.1002/chem.200903379; Allen KN, 2010, CURR OPIN CHEM BIOL, V14, P247, DOI 10.1016/j.cbpa.2010.01.004; Almeida RM, 2011, INORG CHEM, V50, P10600, DOI 10.1021/ic200858c; Anderson CJ, 2008, Q J NUCL MED MOL IM, V52, P185; Bandura DR, 2009, ANAL CHEM, V81, P6813, DOI 10.1021/ac901049w; Baskin JM, 2007, P NATL ACAD SCI USA, V104, P16793, DOI 10.1073/pnas.0707090104; Borkow G, 2005, CURR MED CHEM, V12, P2163, DOI 10.2174/0929867054637617; BRITTAIN HG, 1976, J AM CHEM SOC, V98, P8255, DOI 10.1021/ja00441a060; BRITTAIN HG, 1976, BIOCHEM BIOPH RES CO, V68, P1013, DOI 10.1016/0006-291X(76)91247-X; CACHERIS WP, 1987, INORG CHEM, V26, P958, DOI 10.1021/ic00253a038; Chin JW, 2002, J AM CHEM SOC, V124, P9026, DOI 10.1021/ja027007w; Clore GM, 2009, CHEM REV, V109, P4108, DOI 10.1021/cr900033p; Codelli JA, 2008, J AM CHEM SOC, V130, P11486, DOI 10.1021/ja803086r; Gordon CG, 2012, J AM CHEM SOC, V134, P9199, DOI 10.1021/ja3000936; Hagan AK, 2011, ANAL BIOANAL CHEM, V400, P2847, DOI 10.1007/s00216-011-5047-7; Haussinger D, 2009, J AM CHEM SOC, V131, P14761, DOI 10.1021/ja903233w; He Y, 2015, TALANTA, V134, P468, DOI 10.1016/j.talanta.2014.11.049; Hemmila I, 2005, J FLUORESC, V15, P529, DOI 10.1007/s10895-005-2826-6; Hiruma Y, 2013, J MOL BIOL, V425, P4353, DOI 10.1016/j.jmb.2013.07.006; HORROCKS WDW, 1993, METHOD ENZYMOL, V226, P495, DOI 10.1016/0076-6879(93)26023-3; Iwahara J, 2006, NATURE, V440, P1227, DOI 10.1038/nature04673; Jewett JC, 2010, CHEM SOC REV, V39, P1272, DOI 10.1039/b901970g; Knor S, 2007, CHEM-EUR J, V13, P6082, DOI 10.1002/chem.200700231; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Lea WA, 2011, EXPERT OPIN DRUG DIS, V6, P17, DOI 10.1517/17460441.2011.537322; Lebedev AY, 2010, CHEM COMMUN, V46, P1706, DOI 10.1039/b924784j; Liang Y, 2014, ANAL CHEM, V86, P3688, DOI 10.1021/ac500123z; Loh CT, 2013, BIOCONJUGATE CHEM, V24, P260, DOI 10.1021/bc300631z; Madl T, 2009, ANGEW CHEM INT EDIT, V48, P8259, DOI 10.1002/anie.200902561; Mallagaray A, 2016, CHEM COMMUN, V52, P601, DOI 10.1039/c5cc05827a; Martin ME, 2010, BIOORG MED CHEM LETT, V20, P4805, DOI 10.1016/j.bmcl.2010.06.111; Nitz M, 2004, ANGEW CHEM INT EDIT, V43, P3682, DOI 10.1002/anie.200460028; O'Malley WI, 2016, MOLECULES, V21, DOI 10.3390/molecules21020194; O'Malley WI, 2016, INORG CHEM, V55, P1674, DOI 10.1021/acs.inorgchem.5b02605; Otting G, 2008, J BIOMOL NMR, V42, P1, DOI 10.1007/s10858-008-9256-0; Pandya S, 2006, DALTON T, P2757, DOI 10.1039/b514637b; Purdy MD, 2002, ACTA CRYSTALLOGR D, V58, P1111, DOI 10.1107/S0907444902006509; Sandtner W, 2007, BIOPHYS J, V93, pL45, DOI 10.1529/biophysj.107.119073; Spitzer MH, 2016, CELL, V165, P780, DOI 10.1016/j.cell.2016.04.019; Su XC, 2008, J AM CHEM SOC, V130, P10486, DOI 10.1021/ja803741f; Su XC, 2006, CHEMBIOCHEM, V7, P1599, DOI 10.1002/cbic.200600142; Zhang WJ, 2012, AMINO ACIDS, V43, P983, DOI 10.1007/s00726-011-1164-z	45	2	2	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2019	14	3							e0209726	10.1371/journal.pone.0209726	http://dx.doi.org/10.1371/journal.pone.0209726			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ5PT	30917122	Green Submitted, Green Published, gold			2022-12-26	WOS:000462465800005
J	Cransac, A; Aho, S; Chretien, ML; Giroud, M; Caillot, D; Boulin, M				Cransac, Amelie; Aho, Serge; Chretien, Marie-Lorraine; Giroud, Maurice; Caillot, Denis; Boulin, Mathieu			Adherence to immunomodulatory drugs in patients with multiple myeloma	PLOS ONE			English	Article							MEDICATION ADHERENCE; VALIDITY; SAFETY; COST; TOOL	Background Immunomodulatory drugs (thalidomide, lenalidomide and pomalidomide; IMID) are widely used in the treatment of multiple myeloma patients. To date, few data are available on IMID adherence in multiple myeloma patients. The aim of our study was to evaluate IMID adherence and to compare two indirect methods to measure IMID adherence in multiple myeloma patients: a specific questionnaire and the medication possession ratio (MPR). Another aim was to explore this specific questionnaire for the assessment of IMID adherence in multiple myeloma patients. Methods All consecutive multiple myeloma patients, with at least two consecutive dispensations of thalidomide, lenalidomide or pomalidomide in our hospital were included in this prospective study. IMID adherence was measured using a specific questionnaire and the medication possession ratio. Relationship between the questionnaire scores and variables of interest was evaluated by multiple linear regression with a robust variance estimator. Findings Sixty-three patients were included in our study. The mean questionnaire score was 8.2 +/- 1.2 and the mean medication possession ratio value was 0.97 +/- 0.06. A total of 76% of patients were considered adherent according to the questionnaire (i.e. score >= 8), 94% according to the medication possession ratio (i.e. MPR >= 0.90), and 70% according to the questionnaire and the medication possession ratio. No statistically significant linear association was observed between the questionnaire score and any variables of interest including medication possession ratio. All Cronbach's alpha were relatively low (range 0.0342-0.2443), showing a low correlation of the different questions with the questionnaire score. Conclusions Our study is the first prospective study evaluating IMID adherence in multiple myeloma patients in real life. The high adherence to IMIDs reported here, regardless of the drug, is encouraging considering the efficacy, toxicity and elevated cost of IMIDs. The specific questionnaire should be used with caution to evaluate IMID adherence.	[Cransac, Amelie; Boulin, Mathieu] Univ Burgundy & Franche Comte, Dijon Univ Hosp, Dept Pharm, Dijon, France; [Cransac, Amelie; Giroud, Maurice] Univ Burgundy & Franche Comte, LNC, UMR1231, Dijon, France; [Aho, Serge] Univ Hosp, Hosp Epidemiol, Dijon, France; [Aho, Serge] Univ Hosp, Infect Control Dept, Dijon, France; [Chretien, Marie-Lorraine] Univ Burgundy Franche Comte, Univ Hosp, Dept Clin Hematol, Dijon, France; [Chretien, Marie-Lorraine] Univ Burgundy Franche Comte, SAPHIIR, UMR 1231, Dijon, France; [Giroud, Maurice] Univ Burgundy Franche Comte, Dijon Univ Hosp, Dept Neurol, Dijon, France; [Caillot, Denis] Univ Hosp, Dept Clin Hematol, Dijon, France; [Boulin, Mathieu] Univ Burgundy Franche Comte, EPICAD, LNC, UMR1231, Dijon, France	CHU Dijon Bourgogne; Institut Agro; AgroSup Dijon; Universite de Bourgogne; CHU Dijon Bourgogne; CHU Dijon Bourgogne; CHU Dijon Bourgogne; Institut Agro; AgroSup Dijon; Universite de Bourgogne; CHU Dijon Bourgogne; CHU Dijon Bourgogne; Institut Agro; AgroSup Dijon; Universite de Bourgogne	Cransac, A (corresponding author), Univ Burgundy & Franche Comte, Dijon Univ Hosp, Dept Pharm, Dijon, France.; Cransac, A (corresponding author), Univ Burgundy & Franche Comte, LNC, UMR1231, Dijon, France.	amelie.cransac@chu-dijon.fr	AHO, ludwig/AAR-5753-2021; CRANSAC, Amélie/AAH-5651-2020; Serge, Aho Glele Ludwig/AAP-8863-2021	CRANSAC, Amélie/0000-0003-1836-2619; Serge, Aho Glele Ludwig/0000-0001-7590-8644				Allenet B., 2013, ANNALES PHARMACEUTIQUES FRANCAISES, V71, P135, DOI 10.1016/j.pharma.2012.10.001; Arber A, 2017, EUR J CANCER CARE, V26, DOI 10.1111/ecc.12413; Bassan F, 2014, EUR J CANCER CARE, V23, P22, DOI 10.1111/ecc.12124; Daouphars M, 2013, PHARMACOTHERAPY, V33, P152, DOI 10.1002/phar.1174; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Girerd X, 2001, ARCH MAL COEUR VAISS, V94, P839; Greipp PR, 2005, J CLIN ONCOL, V23, P3412, DOI 10.1200/JCO.2005.04.242; Gueneau P, 2018, EUR J HAEMATOL, V100, P518, DOI 10.1111/ejh.13039; Huang WC, 2016, EXPERT REV ANTICANC, V16, P423, DOI 10.1586/14737140.2016.1159515; Huntington SF, 2015, LANCET HAEMATOL, V2, pE408, DOI 10.1016/S2352-3026(15)00151-9; Lee C, 2016, J MED ECON, V19, P397, DOI 10.3111/13696998.2015.1130710; Mateos MV, 2015, BLOOD REV, V29, P387, DOI 10.1016/j.blre.2015.06.001; Moreau P, 2017, ANN ONCOL, V28, P52, DOI 10.1093/annonc/mdx096; MORISKY DE, 1986, MED CARE, V24, P67, DOI 10.1097/00005650-198601000-00007; Muszbek N, 2008, INT J CLIN PRACT, V62, P338, DOI 10.1111/j.1742-1241.2007.01683.x; Partridge AH, 2002, JNCI-J NATL CANCER I, V94, P652; Raab MS, 2016, BRIT J HAEMATOL, V175, P66, DOI 10.1111/bjh.14193; Ribed A, 2016, INT J CLIN PHARM-NET, V38, P280, DOI 10.1007/s11096-015-0235-8; Miguel JS, 2013, LANCET ONCOL, V14, P1055, DOI 10.1016/S1470-2045(13)70380-2; Sokol MC, 2005, MED CARE, V43, P521, DOI 10.1097/01.mlr.0000163641.86870.af; Sperber CM, 2017, PATIENT PREFER ADHER, V11, P1469, DOI 10.2147/PPA.S136890; Thompson K, 2000, SCHIZOPHR RES, V42, P241, DOI 10.1016/S0920-9964(99)00130-9; World Health Organization, 2003, ADHERENCE LONG TERM, P199	23	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2019	14	3							e0214446	10.1371/journal.pone.0214446	http://dx.doi.org/10.1371/journal.pone.0214446			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ5PT	30917164	Green Published, gold, Green Submitted			2022-12-26	WOS:000462465800065
J	Velasquez-Tibata, J; Olaya-Rodriguez, MH; Lopez-Lozano, D; Gutierrez, C; Gonzalez, I; Londono-Murcia, MC				Velasquez-Tibata, Jorge; Olaya-Rodriguez, Maria H.; Lopez-Lozano, Daniel; Gutierrez, Cesar; Gonzalez, Ivan; Londono-Murcia, Maria C.			BioModelos: A collaborative online system to map species distributions	PLOS ONE			English	Article							SELECTING THRESHOLDS; DISTRIBUTION MODELS; OCCURRENCE RECORDS; CLIMATE-CHANGE; COMPLEXITY; PREDICTION; PRIORITIES; ABSENCES; RISK	Information on species distribution is recognized as a crucial input for biodiversity conservation and management. To that end, considerable resources have been dedicated towards increasing the quantity and availability of species occurrence data, boosting their use in species distribution modeling and online platforms for their dissemination. Currently, those platforms face the challenge of bringing biology into modeling by making informed decisions that result in meaningful models, based on limited occurrence and ecological data. Here we describe BioModelos, a modeling approach supported by an online system and a core team of modelers, whereby a network of experts contributes to the development of species distribution models by assessing the quality of occurrence data, identifying potentially limiting environmental variables, establishing species' accessible areas and validating modeling predictions qualitatively. Models developed through BioModelos become freely and publicly available once validated by experts, furthering their use in conservation applications. Our approach has been implemented in Colombia since 2013 and it currently consist of a network of nearly 500 experts that collaboratively contribute to enhance the knowledge on the distribution of a growing number of species and it has aided the development of several decision support products such as national risk assessments and biodiversity compensation manuals. BioModelos is an example of operationalization of an essential biodiversity variable at a national level through the implementation of a research infrastructure that enhances the value of open access species data.	[Velasquez-Tibata, Jorge; Olaya-Rodriguez, Maria H.; Lopez-Lozano, Daniel; Gutierrez, Cesar; Gonzalez, Ivan; Londono-Murcia, Maria C.] Alexander von Humboldt Inst Res Biol Resources, Lab Appl Biogeog, Bogota, Colombia; [Velasquez-Tibata, Jorge] NASCA Conservat Program, Nat Conservancy, Bogota, Colombia		Velasquez-Tibata, J; Londono-Murcia, MC (corresponding author), Alexander von Humboldt Inst Res Biol Resources, Lab Appl Biogeog, Bogota, Colombia.; Velasquez-Tibata, J (corresponding author), NASCA Conservat Program, Nat Conservancy, Bogota, Colombia.	jorge.velasquez@tnc.org; mlondono@humboldt.org.co	Londono Murcia, Maria Cecilia/J-1327-2017	Londono Murcia, Maria Cecilia/0000-0002-2317-5503; Lopez-Lozano, Daniel/0000-0002-8347-0782; Velasquez-Tibata, Jorge/0000-0002-7773-7348; Gutierrez Montoya, Cesar/0000-0002-0801-4904	Colombian Ministry of Environment	Colombian Ministry of Environment	The authors received no specific funding for this work, though they were all employed by Humboldt Institute, an environmental organization partly funded by the Colombian Ministry of Environment. Neither Humboldt Institute nor the Ministry of Environment had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello-Lammens ME, 2015, ECOGRAPHY, V38, P541, DOI 10.1111/ecog.01132; Anderson R.P., 2016, FINAL REPORT TASK GR; Anderson RP, 2012, ANN NY ACAD SCI, V1260, P66, DOI 10.1111/j.1749-6632.2011.06440.x; Anderson RP, 2010, J BIOGEOGR, V37, P1378, DOI 10.1111/j.1365-2699.2010.02290.x; [Anonymous], 2011, ECOLOGICAL NICHES GE; [Anonymous], 2010, MAPPING SPECIES DIST; Araujo MB, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aat4858; Araujo MB, 2011, ECOL LETT, V14, P484, DOI 10.1111/j.1461-0248.2011.01610.x; Barbet-Massin M, 2012, METHODS ECOL EVOL, V3, P327, DOI 10.1111/j.2041-210X.2011.00172.x; Barve N, 2011, ECOL MODEL, V222, P1810, DOI 10.1016/j.ecolmodel.2011.02.011; Beck J, 2013, DIVERS DISTRIB, V19, P1043, DOI 10.1111/ddi.12083; Belbin L, 2013, ZOOKEYS, P67, DOI 10.3897/zookeys.305.5438; Bird JP, 2012, DIVERS DISTRIB, V18, P273, DOI 10.1111/j.1472-4642.2011.00843.x; Bogota D. C., 2016, LIBRO ROJO AVES COLO; Breiner FT, 2015, METHODS ECOL EVOL, V6, P1210, DOI 10.1111/2041-210X.12403; Broennimann O, 2007, ECOL LETT, V10, P701, DOI 10.1111/j.1461-0248.2007.01060.x; BUCKLIN DN, 2015, DIVERS DISTRIB, V21, P23, DOI DOI 10.1111/ddi.12247; Geijzendorffer IR, 2016, J APPL ECOL, V53, P1341, DOI 10.1111/1365-2664.12417; Giannini TC, 2012, ECOL MODEL, V244, P127, DOI 10.1016/j.ecolmodel.2012.06.035; Guevara L, 2018, GLOBAL CHANGE BIOL, V24, P1511, DOI 10.1111/gcb.13992; Guillera-Arroita G, 2015, GLOBAL ECOL BIOGEOGR, V24, P276, DOI 10.1111/geb.12268; Guisan A., 2017, APPL R; Hurlbert AH, 2007, P NATL ACAD SCI USA, V104, P13384, DOI 10.1073/pnas.0704469104; Kass JM, 2018, METHODS ECOL EVOL, V9, P1151, DOI 10.1111/2041-210X.12945; Kissling WD, 2018, BIOL REV, V93, P600, DOI 10.1111/brv.12359; Kremen C, 2008, SCIENCE, V320, P222, DOI 10.1126/science.1155193; Liu C, 2018, ECOGRAPHY; Liu CR, 2013, J BIOGEOGR, V40, P778, DOI 10.1111/jbi.12058; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Lobo JM, 2010, ECOGRAPHY, V33, P103, DOI 10.1111/j.1600-0587.2009.06039.x; Lomolino MV, FRONTIERS BIOGEOGRAP; Lopez-Gallego C, 2019, ATLAS BIODIVERSIDAD; Merow C, 2017, GLOBAL ECOL BIOGEOGR, V26, P243, DOI 10.1111/geb.12539; Meyer C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9221; Muscarella R, 2014, METHODS ECOL EVOL, V5, P1198, DOI 10.1111/2041-210X.12261; Navarro LM, 2017, CURR OPIN ENV SUST, V29, P158, DOI 10.1016/j.cosust.2018.02.005; Ocampo-Penuela N, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1601367; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Pereira HM, 2013, SCIENCE, V339, P277, DOI 10.1126/science.1229931; Peterson AT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000261; Peterson AT, 2006, AM J TROP MED HYG, V75, P9, DOI 10.4269/ajtmh.2006.75.1.0750009; Peterson AT, 2018, BIODIVERS CONSERV, V27, P1277, DOI 10.1007/s10531-017-1479-5; Peterson AT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002441; Peterson AT, 2005, INTERPRETATION; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Qiao HJ, 2015, METHODS ECOL EVOL, V6, P1126, DOI 10.1111/2041-210X.12397; Radosavljevic A, 2014, J BIOGEOGR, V41, P629, DOI 10.1111/jbi.12227; Renjifo LM, 2014, LIBRO ROJO AVES COLO, VI; Renjifo LM, 2016, LIBRO ROJO AVES COLO, VII, P564; Schmeller DS, 2018, BIOL REV, V93, P55, DOI 10.1111/brv.12332; Serra-Diaz JM, 2018, FOR ECOSYST, V4, DOI 10.1186/s40663-017-0120-0; Sousa-Baena MS, 2014, DIVERS DISTRIB, V20, P369, DOI 10.1111/ddi.12136; Syfert MM, 2014, BIOL CONSERV, V177, P174, DOI 10.1016/j.biocon.2014.06.012; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121	55	10	10	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2019	14	3							e0214522	10.1371/journal.pone.0214522	http://dx.doi.org/10.1371/journal.pone.0214522			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ5PT	30917178	gold, Green Published, Green Submitted			2022-12-26	WOS:000462465800070
J	Gorrie, F; Goodall, K; Rush, R; Ravenscroft, J				Gorrie, Fiona; Goodall, Karen; Rush, Robert; Ravenscroft, John			Towards population screening for Cerebral Visual Impairment: Validity of the Five Questions and the CVI Questionnaire	PLOS ONE			English	Article							MAGNOCELLULAR-DEFICIT THEORY; PERCEPTUAL IMPAIRMENT; DEVELOPMENTAL DELAY; CHILDHOOD BLINDNESS; SPECTRUM DISORDER; SEARCH BEHAVIOR; SELF-EFFICACY; CHILDREN; AUTISM; DYSLEXIA	Introduction Cerebral Visual Impairment (CVI) is the most common cause of visual impairment in children in the developed world and appears to be more prevalent in children with additional support needs (ASN). There is an urgent need for routine screening for CVI, particularly in children with ASN, however, current screening questionnaires for CVI have limited validation. The aim of this study was to evaluate two screening tools: the Five Questions and the CVI Questionnaire. Additionally, the distribution of CVI across neurodevelopmental disorders is unknown. This too was investigated. Methods An online survey was completed by 535 parents. The survey was advertised via social media, CVI websites and parent email systems of four schools. The survey comprised of the Five Questions, the CVI Questionnaire and additional questions regarding the child's diagnoses. Whether or not a child had a diagnosis of CVI and/or additional neurodevelopmental disorders was based on parental report. Results Based on parent reports, both the screening tools accurately screened for CVI diagnoses in children. The Five Questions and the CVI Questionnaire have construct validity (as determined through factor analysis), high internal consistency (as determined by Cronbach's alpha) and convergent validity (as determined by correlation analysis of the raw scores of each questionnaire). This study also highlights that among children with neurodevelopmental disorders, a large proportion have parent-reported CVI (23%-39%) and potential CVI (6.59-22.53%; as identified by the questionnaires). Conclusion The current study demonstrates that the Five Questions and CVI Questionnaire have good convergent validity, internal consistency and a reliable factor structure and may therefore be suitable as screening tools. The study also highlights that reported or potential CVI is evident in a large proportion of children with neurodevelopmental disorders.	[Gorrie, Fiona; Goodall, Karen] Univ Edinburgh, Sch Hlth Social Sci, Dept Clin Psychol, Edinburgh, Midlothian, Scotland; [Rush, Robert] Queen Margaret Univ, Sch Hlth Sci, Div Dietet Nutr & Biol Sci Physiotherapy Podiatry, Edinburgh, Midlothian, Scotland; [Ravenscroft, John] Univ Edinburgh, Scottish Sensory Ctr, Edinburgh, Midlothian, Scotland	University of Edinburgh; Queen Margaret University; University of Edinburgh	Gorrie, F (corresponding author), Univ Edinburgh, Sch Hlth Social Sci, Dept Clin Psychol, Edinburgh, Midlothian, Scotland.	f.gorrie@dundee.ac.uk	Goodall, Karen/S-1469-2019	Gorrie, Fiona/0000-0001-5819-3931				Alimovic S, 2014, J MATERN-FETAL NEO M, V27, P1491, DOI 10.3109/14767058.2013.863863; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU; Andersson S, 2006, DEV MED CHILD NEUROL, V48, P836, DOI 10.1017/S0012162206001794; [Anonymous], 2018, SPSS MANUAL EXPLORAT; Barnett WS, 1990, EC COSTS BENEFITS EA; Bates T., 2018, MSC MULTIVARIATE STA; Berument SK, 1999, BRIT J PSYCHIAT, V175, P444, DOI 10.1192/bjp.175.5.444; BIGELOW AE, 1992, INFANT BEHAV DEV, V15, P179, DOI 10.1016/0163-6383(92)80022-M; Bigelow AE, 2003, DEV PSYCHOPATHOL, V15, P259, DOI 10.1017/S0954579403000142; BIGELOW AE, 1983, DEV PSYCHOL, V19, P317, DOI 10.1037/0012-1649.19.3.317; Bland JM, 1997, BRIT MED J, V314, P572, DOI 10.1136/bmj.314.7080.572; Blythe HI, 2018, BRAIN SCI, V8, DOI 10.3390/brainsci8060100; Bowman Richard, 2016, Community Eye Health, V29, P12; Brambring M, 2010, J AUTISM DEV DISORD, V40, P1471, DOI 10.1007/s10803-010-1002-2; Buchholz J, 2004, DYSLEXIA, V10, P24, DOI 10.1002/dys.263; Cavezian C, 2010, RES DEV DISABIL, V31, P1102, DOI 10.1016/j.ridd.2010.03.006; Chadha RK, 2011, BRIT J OPHTHALMOL, V95, P642, DOI 10.1136/bjo.2010.182386; Chevallier C, 2012, TRENDS COGN SCI, V16, P231, DOI 10.1016/j.tics.2012.02.007; Chokron S, 2014, INFORM PSYCHIAT, V90, P819, DOI DOI 10.1684/IPE.2014.1275; Chokron S, 2017, REV NEUROPSYCHOL, V9, P35, DOI DOI 10.3917/RNE.091.0035; Chokron S, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01471; Colenbrander A, 2010, J VISUAL IMPAIR BLIN, V104, P583, DOI 10.1177/0145482X1010401002; Conti-Ramsden G, 2001, J VISUAL IMPAIRMENT, V95; Costello AB, 2005, PRACTICAL ASSESSMENT, V10, P1, DOI [DOI 10.7275/JYJ1-4868, DOI 10.1316/S0782-051X03024046-9]; CRONBACH LJ, 1955, PSYCHOL BULL, V52, P281, DOI 10.1037/h0040957; Dale N, 2015, RUTTERS CHILD ADOLES, P612; Dawson G, 2005, DEV NEUROPSYCHOL, V27, P403, DOI 10.1207/s15326942dn2703_6; de Vet HCW, 2005, QUAL LIFE RES, V14, P1203, DOI 10.1007/s11136-004-5742-3; Denver BD, 2016, DEV MED CHILD NEUROL, V58, P1016, DOI 10.1111/dmcn.13139; Drummond SR, J AM; Dutton G., 2018, CVI INFORM DAY; Dutton GN, 2010, STRUCTURED CLIN HIST, P117; Ego A, 2015, DEV MED CHILD NEUROL, V57, P46, DOI 10.1111/dmcn.12687; Engelbrecht P., 2003, INT J DISABIL DEV ED, V50, P293, DOI [10.1080/1034912032000120462, DOI 10.1080/1034912032000120462]; Fazzi E, 2015, IMPAIRMENT VISION DI; Fazzi E, 2009, DEV MED CHILD NEUROL, V51, P974, DOI 10.1111/j.1469-8749.2009.03272.x; FIELD A., 2009, DESCOBRINDO ESTATIST, V2; Floyd FJ, 1995, PSYCHOL ASSESSMENT, V7, P286, DOI 10.1037/1040-3590.7.3.286; FOWLER AE, 1991, PHONOLOGICAL PROCESSES IN LITERACY, P97; Freeman R.D., 2010, VISUAL IMPAIRMENT DU, V186, P174; Glascoe FP, 2005, MENT RETARD DEV D R, V11, P173, DOI 10.1002/mrdd.20068; GOOD WV, 1994, SURV OPHTHALMOL, V38, P351, DOI 10.1016/0039-6257(94)90073-6; Good WV, 2001, DEV MED CHILD NEUROL, V43, P56, DOI 10.1017/S0012162201000093; Greer F., 2016, PRINCIPLES METHODS T, V3; Houliston MJ, 1999, DEV MED CHILD NEUROL, V41, P298, DOI 10.1017/S0012162299000675; Hyvarinen L., 2005, P SUMM CER CORT VIS, V2006, P35; James TW, 2003, BRAIN, V126, P2463, DOI 10.1093/brain/awg248; KAISER HF, 1974, PSYCHOMETRIKA, V39, P31, DOI 10.1007/BF02291575; Kekelis LS, 1996, J VISUAL IMPAIR BLIN, V90, P423; Kevan A, 2008, NEUROREPORT, V19, P467, DOI 10.1097/WNR.0b013e3282f5f7ad; Koldewyn K, 2010, BRAIN, V133, P599, DOI 10.1093/brain/awp272; Kong LK, 2012, J AAPOS, V16, P501, DOI 10.1016/j.jaapos.2012.09.004; Lalkhen AG, 2008, BJA EDUC, V8, P221, DOI 10.1093/bjaceaccp/mkn041; Little S., 2017, VIS DEV REHABIL, V3, P10; Long J. S., ADV QUANTITATIVE TEC, V7; Macintyre-Beon C, 2012, EYE, V26, P1393, DOI 10.1038/eye.2012.154; Macintyre-Beon C, 2015, THESIS; Maitreya A, 2018, INDIAN J OPHTHALMOL, V66, P279, DOI 10.4103/ijo.IJO_425_17; Martin MBC, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01958; Milne E, 2006, J AUTISM DEV DISORD, V36, P225, DOI 10.1007/s10803-005-0052-3; Neumann G, 2016, NEUROREHAB NEURAL RE, V30, P187, DOI 10.1177/1545968315585355; Newcomb S., THESIS; Norris M, 2010, AUTISM, V14, P263, DOI 10.1177/1362361309348071; Ortibus E, 2011, NEUROPEDIATRICS, V42, P138, DOI 10.1055/s-0031-1285908; Pammer K, 2001, VISION RES, V41, P2139, DOI 10.1016/S0042-6989(01)00092-X; Pawletko T., 2014, IMPAIRMENT VISION DU; Pehere N, 2018, INDIAN J OPHTHALMOL, V66, P812, DOI 10.4103/ijo.IJO_1274_17; Pellicano E, 2005, NEUROPSYCHOLOGIA, V43, P1044, DOI 10.1016/j.neuropsychologia.2004.10.003; Pellicano E, 2008, NEUROPSYCHOLOGIA, V46, P2593, DOI 10.1016/j.neuropsychologia.2008.04.008; Philip SS, 2016, J CLIN DIAGN RES, V10, pNC1, DOI 10.7860/JCDR/2016/22222.8943; Philip SS, 2014, CLIN EXP OPTOM, V97, P196, DOI 10.1111/cxo.12155; Putnam SP, 2006, J PERS ASSESS, V87, P102, DOI 10.1207/s15327752jpa8701_09; Rahi JS, 2007, EYE, V21, P1249, DOI 10.1038/sj.eye.6702837; Rahi JS, 2003, LANCET, V362, P1359, DOI 10.1016/S0140-6736(03)14631-4; Re AM, 2015, J LEARN DISABIL-US, V48, P73, DOI 10.1177/0022219413491287; Ridder WH, 2001, OPTOMETRY VISION SCI, V78, P510, DOI 10.1097/00006324-200107000-00014; Robertson CE, 2014, BRAIN, V137, P2588, DOI 10.1093/brain/awu189; Roman C, 2010, J VISUAL IMPAIR BLIN, V104, P69, DOI 10.1177/0145482X1010400202; Roman-Lantzy C., 2018, CVI SYNOPSYM WE ARE; Saidkasimova S, 2007, J AAPOS, V11, P426, DOI 10.1016/j.jaapos.2007.04.015; Sakki HE, 2017, BRIT J OPHTHALMOLOGY; Salavati M, 2017, CHILD CARE HLTH DEV, V43, P37, DOI 10.1111/cch.12377; Nielsen LS, 2007, ACTA OPHTHALMOL SCAN, V85, P149, DOI 10.1111/j.1600-0420.2006.00867.x; SHARE DL, 1995, COGNITION, V55, P151, DOI 10.1016/0010-0277(94)00645-2; Skottun BC, 2000, TRENDS COGN SCI, V4, P211, DOI 10.1016/S1364-6613(00)01485-6; Skottun BC, 2000, VISION RES, V40, P111, DOI 10.1016/S0042-6989(99)00170-4; Slidsborg C, 2012, ARCH OPHTHALMOL-CHIC, V130, P1410, DOI 10.1001/archophthalmol.2012.1393; Sonksen PM, 2002, DEV MED CHILD NEUROL, V44, P782; Spencer J, 2000, NEUROREPORT, V11, P2765, DOI 10.1097/00001756-200008210-00031; Stein J, 2000, TRENDS COGN SCI, V4, P209, DOI 10.1016/S1364-6613(00)01484-4; Stein J, 1997, TRENDS NEUROSCI, V20, P147, DOI 10.1016/S0166-2236(96)01005-3; Stein J, 2018, BRAIN SCI, V8, DOI 10.3390/brainsci8020026; Stevens J.P., 2009, APPL MULTIVARIATE ST, V5th ed.; Stiers P, 2002, DEV MED CHILD NEUROL, V44, P370; Szumilas M, 2010, J CAN ACAD CHILD ADO, V19, P227; Terwee CB, 2012, QUAL LIFE RES, V21, P651, DOI 10.1007/s11136-011-9960-1; van Genderen M, 2012, STRABISMUS, V20, P78, DOI 10.3109/09273972.2012.680232; Vidyasagar TR, 1999, NEUROREPORT, V10, P1283, DOI 10.1097/00001756-199904260-00024; Welinder LG, 2012, ACTA OPHTHALMOL, V90, P721, DOI 10.1111/j.1755-3768.2011.02239.x; WHITING S, 1985, DEV MED CHILD NEUROL, V27, P730; Williams C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014772; WOODRUFF ME, 1977, CAN J PUBLIC HEALTH, V68, P225; Zihl J, CEREBRAL VISUAL IMPA, P123; Zihl J, CEREBRAL VISUAL IMPA, P237; Zimmerman B, 2007, Z PSYCHOL, V215, P157, DOI 10.1027/0044-3409.215.3.157; Zimmerman BJ, 2005, CONTEMP EDUC PSYCHOL, V30, P397, DOI 10.1016/j.cedpsych.2005.05.003	106	22	23	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2019	14	3							e0214290	10.1371/journal.pone.0214290	http://dx.doi.org/10.1371/journal.pone.0214290			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HQ3IW	30913240	Green Submitted, gold, Green Published			2022-12-26	WOS:000462305600039
J	Spinar, J; Spinarova, L; Malek, F; Ludka, O; Krejci, J; Ostadal, P; Vondrakova, D; Labr, K; Spinarova, M; Goldbergova, MP; Benesova, K; Jarkovsky, J; Parenica, J				Spinar, Jindrich; Spinarova, Lenka; Malek, Filip; Ludka, Ondrej; Krejci, Jan; Ostadal, Petr; Vondrakova, Dagmar; Labr, Karel; Spinarova, Monika; Goldbergova, Monika Pavkova; Benesova, Klara; Jarkovsky, Jiri; Parenica, Jiri			Prognostic value of NT-proBNP added to clinical parameters to predict two-year prognosis of chronic heart failure patients with mid-range and reduced ejection fraction - A report from FAR NHL prospective registry	PLOS ONE			English	Article							NATRIURETIC PEPTIDE; MORTALITY; HOSPITALIZATION; CLASSIFICATION; DECOMPENSATION; BIOMARKERS; SURVIVAL; THERAPY; STROKE	Background According to guidelines, the prognosis of patients with chronic heart failure can be predicted by determining the levels of natriuretic peptides, the NYHA classification and comorbidities. The aim our work was to develop a prognostic score in chronic heart failure patients that would take account of patients' comorbidities, NYHA and NT-proBNP levels. Methods and results A total of 1,088 patients with chronic heart failure with reduced ejection fraction (HFrEF) (LVEF<40%) and mid-range EF (HFmrEF) (LVEF 40-49%) were enrolled consecutively. Two-year all-cause mortality, heart transplantation and/or LVAD implantation were defined as the primary endpoint (EP). The occurrence of EP was 14.9% and grew with higher NYHA, namely 4.9% (NYHA I), 11.4% (NYHA II) and 27.8% (NYHA III-IV) (p<0.001). The occurrence of EP was 3%, 10% and 15-37% in patients with NT-proBNP levels <= 125 ng/L, 126-1000 ng/L and >1000 ng/L respectively. Discrimination abilities of NYHA and NT-proBNP were AUC 0.670 (p<0.001) and AUC 0.722 (p<0.001) respectively. The predictive value of the developed clinical model, which took account of older age, advanced heart failure (NYHA III+IV), anaemia, hyponatraemia, hyperuricaemia and being on a higher dose of furosemide (>40 mg daily) (AUC 0.773; p<0.001) was increased by adding the NT-proBNP level (AUC 0.790). Conclusion The use of prediction models in patients with chronic heart failure, namely those taking account of natriuretic peptides, should become a standard in routine clinical practice. It might contribute to a better identification of a high-risk group of patients in which more intense treatment needs to be considered, such as heart transplantation or LVAD implantation.	[Spinar, Jindrich; Ludka, Ondrej; Parenica, Jiri] Univ Hosp Brno, Dept Cardiol, Brno, Czech Republic; [Spinar, Jindrich; Spinarova, Lenka; Ludka, Ondrej; Krejci, Jan; Labr, Karel; Spinarova, Monika; Parenica, Jiri] Masaryk Univ, Fac Med, Brno, Czech Republic; [Spinarova, Lenka; Krejci, Jan; Labr, Karel; Spinarova, Monika] St Annes Univ Hosp Brno, Dept Internal Med Cardiol & Angiol 1, Brno, Czech Republic; [Malek, Filip; Ostadal, Petr; Vondrakova, Dagmar] Hosp Na Homolce, Dept Cardiol, Prague, Czech Republic; [Goldbergova, Monika Pavkova] Masaryk Univ, Inst Pathol Physiol, Fac Med, Brno, Czech Republic; [Benesova, Klara; Jarkovsky, Jiri] Masaryk Univ, Inst Biostat & Anal, Fac Med, Brno, Czech Republic	University Hospital Brno; Masaryk University Brno; St Anne's University Hospital Brno (FNUSA-ICRC); Na Homolce Hospital; Masaryk University Brno; Institute of Biostatistics & Analyses; Masaryk University Brno	Jarkovsky, J (corresponding author), Masaryk Univ, Inst Biostat & Anal, Fac Med, Brno, Czech Republic.	jarkovsky@iba.muni.cz	Goldbergova, Monika Pavkova/G-3512-2013; Málek, Filip/ABI-1453-2020	Goldbergova, Monika Pavkova/0000-0002-3471-8702; Spinarova, Monika/0000-0003-3291-5160; Labr, Karel/0000-0002-4738-8044	Ministry of Health of the Czech Republic as part of the project Conceptual Development of Research Organisation (University Hospital Brno) [65269705]; Masaryk University, Brno, Czech Republic [MUNI/A/1250/2017]	Ministry of Health of the Czech Republic as part of the project Conceptual Development of Research Organisation (University Hospital Brno); Masaryk University, Brno, Czech Republic(Czech Republic Government)	This work was supported by the Ministry of Health of the Czech Republic as part of the project Conceptual Development of Research Organisation (University Hospital Brno, project 65269705) and a project of the Masaryk University, Brno, Czech Republic (project MUNI/A/1250/2017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Jiri Parenica is currently receiving the above-mentioned grants.	Alhusseiny AH, 2013, EUR J GEN MED, V10, P26, DOI 10.29333/ejgm/82363; Anker SD, 2003, CIRCULATION, V107, P1991, DOI 10.1161/01.CIR.0000065637.10517.A0; [Anonymous], 2017, Circulation, V136, pe196, DOI 10.1161/CIR.0000000000000530; Dunlap ME, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.005261; Felker GM, 2017, JAMA-J AM MED ASSOC, V318, P713, DOI 10.1001/jama.2017.10565; Fox KAA, 2006, BMJ-BRIT MED J, V333, P1091, DOI 10.1136/bmj.38985.646481.55; Frohlich H, 2015, CIRC-HEART FAIL, V8, P887, DOI 10.1161/CIRCHEARTFAILURE.114.001701; HARVEY RM, 1982, CIRCULATION, V66, P249, DOI 10.1161/01.CIR.66.1.249; Hlatky Mark A, 2009, Circulation, V119, P2408, DOI 10.1161/CIRCULATIONAHA.109.192278; Jankowska EA, 2016, EUR J HEART FAIL, V18, P786, DOI 10.1002/ejhf.473; Khanam SS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206380; Konstam MA, 2007, JAMA-J AM MED ASSOC, V297, P1319, DOI 10.1001/jama.297.12.1319; Levy WC, 2006, CIRCULATION, V113, P1424, DOI 10.1161/CIRCULATIONAHA.105.584102; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Lupon J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085466; Malek F, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2012.03.011; McMurray JJV, 2014, NEW ENGL J MED, V371, P993, DOI 10.1056/NEJMoa1409077; Morbach C, 2017, EUR J HEART FAIL, V19, P1166, DOI 10.1002/ejhf.859; Mosterd A, 2007, HEART, V93, P1137, DOI 10.1136/hrt.2003.025270; Mueller C, 2017, EUR J HEART FAIL, V19, P1176, DOI 10.1002/ejhf.893; Pavlusova M, 2018, COR VASA, V60, pE215, DOI 10.1016/j.crvasa.2017.09.007; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; Senni M, 2013, INT J CARDIOL, V163, P206, DOI 10.1016/j.ijcard.2011.10.071; Spinar J, 2016, INT J CARDIOL, V202, P21, DOI 10.1016/j.ijcard.2015.08.187; Swedberg K, 2013, NEW ENGL J MED, V368, P1210, DOI 10.1056/NEJMoa1214865; Troughton RW, 2014, EUR HEART J, V35, P1559, DOI 10.1093/eurheartj/ehu090; Velazquez EJ, 2011, NEW ENGL J MED, V364, P1607, DOI 10.1056/NEJMoa1100356; Wang TJ, 2011, CIRCULATION, V123, P551, DOI 10.1161/CIRCULATIONAHA.109.912568	28	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2019	14	3							e0214363	10.1371/journal.pone.0214363	http://dx.doi.org/10.1371/journal.pone.0214363			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ3IW	30913251	Green Submitted, gold, Green Published			2022-12-26	WOS:000462305600050
J	Beinse, G; Just, PA; Rance, B; Izac, B; Letourneur, F; Saidu, NEB; Chouzenoux, S; Nicco, C; Goldwasser, F; Pasmant, E; Batteux, F; Borghese, B; Alexandre, J; Leroy, K				Beinse, Guillaume; Just, Pierre-Alexandre; Rance, Bastien; Izac, Brigitte; Letourneur, Franck; Saidu, Nathaniel Edward Bennett; Chouzenoux, Sandrine; Nicco, Carole; Goldwasser, Francois; Pasmant, Eric; Batteux, Frederic; Borghese, Bruno; Alexandre, Jerome; Leroy, Karen			The NRF2 transcriptional target NQO1 has low mRNA levels in TP53-mutated endometrial carcinomas	PLOS ONE			English	Article							KEAP1-NRF2 SYSTEM; CANCER; MUTATIONS; PROMOTES; GENES; IMMUNOHISTOCHEMISTRY; CHEMORESISTANCE; IDENTIFICATION; EXPRESSION; SURVIVAL	Background NRF2 is a major transcription factor regulating the expression of antioxidative/detoxifying enzymes, involved in oncogenic processes and drug resistance. We aimed to identify molecular alterations associated with NRF2 activation in endometrial carcinoma (EC). Methods Ninety patients treated (2012-2017) for localized/locally advanced EC were included in this study. Formalin-fixed paraffin-embedded tissue samples were processed for immunohistochemical (NRF2 and Mismatch Repair proteins) analyses. Next generation sequencing (NGS) of a panel of genes including POLE, TP53, NFE2L2, KEAP1 and CUL3 was performed using Ampliseq panels on Ion Torrent PGM (ThermoFisher). NRF2 activity was assessed by NQO1, GCLC, and AKR1C3 mRNA expressions, using TaqMan assays and quantitative RT-PCR. Results Tumors were classified as POLE exonuclease domain mutated (N = 3, 3%), MMR-deficient (MSI-like) (N = 28, 31%), TP53 mutated (Copy-number high-like) (N = 22, 24%), and other tumors (Copy-number low-like) (N = 32, 36%). NRF2 nuclear immunostaining did not correlate with NRF2 target genes expression. The 3 tumors with highest NRF2 target genes expression harbored oncogenic KEAP1 or NFE2L2 mutations. Low NQO1 mRNA and protein levels were observed in the TP53 mutated subgroup compared to others tumors (p < .05) and in silico analyses of The Cancer Genome Atlas data further indicated that NQO1 mRNA levels were lower in serous compared to endometrioid copy-number high EC. Conclusion In contrast with previous reports based on immunohistochemistry, our study indicates that NRF2 activation is a rare event in EC, associated with NFE2L2 or KEAP1 mutations. The subset of aggressive EC with low NQO1 mRNA level might represent a specific subgroup, which could be sensitive to combination therapies targeting oxidative stress.	[Beinse, Guillaume; Just, Pierre-Alexandre; Izac, Brigitte; Letourneur, Franck; Saidu, Nathaniel Edward Bennett; Chouzenoux, Sandrine; Nicco, Carole; Pasmant, Eric; Batteux, Frederic; Alexandre, Jerome; Leroy, Karen] Cochin Inst, CARPEM, INSERM, U1016, Paris, France; [Just, Pierre-Alexandre; Rance, Bastien; Saidu, Nathaniel Edward Bennett; Nicco, Carole; Goldwasser, Francois; Pasmant, Eric; Batteux, Frederic; Borghese, Bruno; Alexandre, Jerome; Leroy, Karen] Paris Descartes Univ, Sorbonne Paris Cite, Paris, France; [Just, Pierre-Alexandre] Cochin Hosp, Assistance Publ Hop Paris, Dept Pathol, Paris, France; [Rance, Bastien] HEGP, Assistance Publ Hop Paris, Dept Med Informat, Paris, France; [Izac, Brigitte; Letourneur, Franck] Cochin Inst, INSERM, U1016, GENOMIC Platform, Paris, France; [Goldwasser, Francois; Alexandre, Jerome] Cochin Hosp, Assistance Publ Hop Paris, Dept Med Oncol, Paris, France; [Pasmant, Eric; Leroy, Karen] Cochin Hosp, Assistance Publ Hop Paris, Dept Genet & Mol Biol, Paris, France; [Batteux, Frederic] Cochin Hosp, Assistance Publ Hop Paris, Dept Immunol, Paris, France; [Borghese, Bruno] Cochin Hosp, Assistance Publ Hop Paris, Dept Gynecol Surg, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite	Leroy, K (corresponding author), Cochin Inst, CARPEM, INSERM, U1016, Paris, France.; Leroy, K (corresponding author), Paris Descartes Univ, Sorbonne Paris Cite, Paris, France.; Leroy, K (corresponding author), Cochin Hosp, Assistance Publ Hop Paris, Dept Genet & Mol Biol, Paris, France.	karen.leroy@aphp.fr	Saidu, Nathaniel/AAK-5626-2020; Nicco, Carole/X-6726-2019; Pasmant, Eric/O-7249-2017; Nicco, Carole/O-8169-2017; Montenarh, Mathias/AAB-6689-2020; Saidu, Nathaniel E B/O-7005-2018; ALEXANDRE, JEROME/O-8350-2017	Saidu, Nathaniel/0000-0001-6427-6813; Nicco, Carole/0000-0001-8211-2556; Pasmant, Eric/0000-0002-1881-8762; Nicco, Carole/0000-0001-8211-2556; Saidu, Nathaniel E B/0000-0001-6427-6813; Rance, Bastien/0000-0003-4417-1197; Borghese, Bruno/0000-0002-6385-5829	Ligue Contre le Cancer, comite de Paris; Cancer Research and Personalized Medicine (CARPEM) program; Association pour la Recherche contre le Cancer (ARC); CARPEM program	Ligue Contre le Cancer, comite de Paris(Ligue nationale contre le cancer); Cancer Research and Personalized Medicine (CARPEM) program; Association pour la Recherche contre le Cancer (ARC)(Fondation ARC pour la Recherche sur le CancerFrench National Research Agency (ANR)); CARPEM program	This study was funded by the "Ligue Contre le Cancer, comite de Paris" and the Cancer Research and Personalized Medicine (CARPEM) program. Guillaume Beinse and Nathaniel EB Saidu received a grant to perform this work from the Association pour la Recherche contre le Cancer (ARC) and the CARPEM program, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chakravarty D, 2017, JCO PRECIS ONCOL, V2017; Chorley BN, 2012, NUCLEIC ACIDS RES, V40, P7416, DOI 10.1093/nar/gks409; de la Vega MR, 2018, CANCER CELL, V34, P21, DOI 10.1016/j.ccell.2018.03.022; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Gorrini C, 2013, NAT REV DRUG DISCOV, V12, P931, DOI 10.1038/nrd4002; Hall G, 2010, PATHOLOGY, V42, P409, DOI 10.3109/00313025.2010.493871; Hast BE, 2014, CANCER RES, V74, P808, DOI 10.1158/0008-5472.CAN-13-1655; Hayes JD, 2009, TRENDS BIOCHEM SCI, V34, P176, DOI 10.1016/j.tibs.2008.12.008; Jiang T, 2010, CANCER RES, V70, P5486, DOI 10.1158/0008-5472.CAN-10-0713; Jung KA, 2013, TOXICOL LETT, V218, P39, DOI 10.1016/j.toxlet.2012.12.026; Kalo E, 2012, J CELL SCI, V125, P5578, DOI 10.1242/jcs.106815; Kemmerer ZA, 2015, TOXICOL LETT, V238, P83, DOI 10.1016/j.toxlet.2015.07.004; Kobel M, 2016, J PATHOL CLIN RES, V2, P247, DOI 10.1002/cjp2.53; Kommoss S, 2018, ANN ONCOL, V29, P1180, DOI 10.1093/annonc/mdy058; Kuosmanen SM, 2016, NUCLEIC ACIDS RES, V44, P1760, DOI 10.1093/nar/gkw052; Li KN, 2014, J MOL HISTOL, V45, P161, DOI 10.1007/s10735-013-9538-z; Liu DS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14844; Malhotra D, 2010, NUCLEIC ACIDS RES, V38, P5718, DOI 10.1093/nar/gkq212; Morice P, 2016, LANCET, V387, P1094, DOI 10.1016/S0140-6736(15)00130-0; Ohta T, 2008, CANCER RES, V68, P1303, DOI 10.1158/0008-5472.CAN-07-5003; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rojo AI, 2014, ANTIOXID REDOX SIGN, V21, P2498, DOI 10.1089/ars.2014.5843; Schemper M, 1996, CONTROL CLIN TRIALS, V17, P343, DOI 10.1016/0197-2456(96)00075-X; Shibata T, 2008, P NATL ACAD SCI USA, V105, P13568, DOI 10.1073/pnas.0806268105; Taguchi K, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00085; Talhouk A, 2017, CANCER-AM CANCER SOC, V123, P802, DOI 10.1002/cncr.30496; Tamborero D, 2018, GENOME MED, V10, DOI 10.1186/s13073-018-0531-8; Tao S, 2014, CANCER RES, V74, P7430, DOI 10.1158/0008-5472.CAN-14-1439; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Turei D, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/737591; Vandenput I, 2009, BRIT J CANCER, V101, P244, DOI 10.1038/sj.bjc.6605157; Walerych D, 2016, NAT CELL BIOL, V18, P897, DOI 10.1038/ncb3380; Wardyn JD, 2015, BIOCHEM SOC T, V43, P621, DOI 10.1042/BST20150014; Yamamoto M, 2018, PHYSIOL REV, V98, P1169, DOI 10.1152/physrev.00023.2017	37	5	5	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2019	14	3							e0214416	10.1371/journal.pone.0214416	http://dx.doi.org/10.1371/journal.pone.0214416			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ1KV	30908539	gold, Green Published, Green Submitted			2022-12-26	WOS:000462157600065
J	Lasa, AV; Masinova, T; Baldrian, P; Fernandez-Lopez, M				Lasa, Ana V.; Masinova, Tereza; Baldrian, Petr; Fernandez-Lopez, Manuel			Bacteria from the endosphere and rhizosphere of Quercus spp. use mainly cell wall-associated enzymes to decompose organic matter	PLOS ONE			English	Article							FUNGAL COMMUNITIES; BETA-GLUCOSIDASE; GLYCOSYL HYDROLASE; FOREST; SOIL; DIVERSITY; CELLULOSE; IDENTIFICATION; PURIFICATION; CELLULASES	Due to the ability of soil bacteria to solubilize minerals, fix N-2 and mobilize nutrients entrapped in the organic matter, their role in nutrient turnover and plant fitness is of high relevance in forest ecosystems. Although several authors have already studied the organic matter decomposing enzymes produced by soil and plant root-interacting bacteria, most of the works did not account for the activity of cell wall-attached enzymes. Therefore, the enzyme deployment strategy of three bacterial collections (genera Luteibacter, Pseudomonas and Arthrobacter) associated with Quercus spp. roots was investigated by exploring both cell-bound and freely-released hydrolytic enzymes. We also studied the potential of these bacterial collections to produce enzymes involved in the transformation of plant and fungal biomass. Remarkably, the cell-associated enzymes accounted for the vast majority of the total activity detected among Luteibacter strains, suggesting that they could have developed a strategy to maintain the decomposition products in their vicinity, and therefore to reduce the diffusional losses of the products. The spectrum of the enzymes synthesized and the titres of activity were diverse among the three bacterial genera. While cellulolytic and hemicellulolytic enzymes were rather common among Luteibacter and Pseudomonas strains and less detected in Arthrobacter collection, the activity of lipase was widespread among all the tested strains. Our results indicate that a large fraction of the extracellular enzymatic activity is due to cell wall-attached enzymes for some bacteria, and that Quercus spp. root bacteria could contribute at different levels to carbon (C), phosphorus (P) and nitrogen (N) cycles.	[Lasa, Ana V.; Fernandez-Lopez, Manuel] CSIC, Dept Soil Microbiol & Symbiot Syst, Estn Expt Zaidin, Granada, Spain; [Masinova, Tereza; Baldrian, Petr] CAS, Inst Microbiol, Lab Environm Microbiol, Prague, Czech Republic	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental del Zaidin (EEZ); Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences	Lasa, AV; Fernandez-Lopez, M (corresponding author), CSIC, Dept Soil Microbiol & Symbiot Syst, Estn Expt Zaidin, Granada, Spain.	ana.vicente@eez.csic.es; manuel.fernandez@eez.csic	Fernández-López, Manuel/K-5800-2014; Baldrian, Petr/A-9170-2009	Fernández-López, Manuel/0000-0003-2366-6908; Baldrian, Petr/0000-0002-8983-2721; Lasa, Ana V/0000-0003-3783-7157; Masinova, Tereza/0000-0001-7448-4368	Spanish Ministry of Economy and Competitiveness [20134R069-RECUPERA 2020]; Spanish Ministry of Education, Culture and Sports [FPU 14/03420, EST16/00202]	Spanish Ministry of Economy and Competitiveness(Spanish Government); Spanish Ministry of Education, Culture and Sports(Spanish Government)	This study was funded by the Spanish Ministry of Economy and Competitiveness 20134R069-RECUPERA 2020. AVL is recipient of a grant of the Spanish Ministry of Education, Culture and Sports (FPU 14/03420) and the stay in Prague was also supported by the same ministry (EST16/00202). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison SD, 2005, ECOL LETT, V8, P626, DOI 10.1111/j.1461-0248.2005.00756.x; Anderson I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039331; [Anonymous], 2017, R LANG ENV STAT COMP, V55, P275; Baldrian P, 2009, PLANT SOIL ENVIRON, V55, P370, DOI 10.17221/134/2009-PSE; Baldrian P, 2017, FEMS MICROBIOL REV, V41, P109, DOI 10.1093/femsre/fuw040; Baldrian P, 2011, PLANT SOIL, V338, P111, DOI 10.1007/s11104-010-0324-3; BARTNICK.S, 1968, ANNU REV MICROBIOL, V22, P87, DOI 10.1146/annurev.mi.22.100168.000511; Bergkemper F, 2016, J MICROBIOL METH, V125, P91, DOI 10.1016/j.mimet.2016.04.011; Berlemont R, 2013, APPL ENVIRON MICROB, V79, P1545, DOI 10.1128/AEM.03305-12; Brabcova V, 2018, SOIL BIOL BIOCHEM, V118, P187, DOI 10.1016/j.soilbio.2017.12.012; Brabcova V, 2016, NEW PHYTOL, V210, P1369, DOI 10.1111/nph.13849; BURNS RG, 1982, SOIL BIOL BIOCHEM, V14, P423, DOI 10.1016/0038-0717(82)90099-2; Burns RG, 2013, SOIL BIOL BIOCHEM, V58, P216, DOI 10.1016/j.soilbio.2012.11.009; Burns RG, 2010, MOLECULAR ENVIRONMENTAL SOIL SCIENCE AT THE INTERFACES IN THE EARTH'S CRITICAL ZONE, P294, DOI 10.1007/978-3-642-05297-2_85; Castro RA, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-382; Cobo-Diaz JF, 2017, FORESTS, V8, DOI 10.3390/f8100390; Cobo-Diaz JF, 2015, MICROB ECOL, V69, P895, DOI 10.1007/s00248-015-0586-7; Crowther TW, 2015, NATURE, V525, P201, DOI 10.1038/nature14967; de Boer W, 2005, FEMS MICROBIOL REV, V29, P795, DOI 10.1016/j.femsre.2004.11.005; Eberspaeaher J, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 5, THIRD EDITION, P250, DOI 10.1007/0-387-30745-1_13; Eichlerova I, 2015, FUNGAL ECOL, V13, P10, DOI 10.1016/j.funeco.2014.08.002; Eichorst SA, 2012, APPL ENVIRON MICROB, V78, P2316, DOI 10.1128/AEM.07313-11; Enkhbaatar B, 2012, APPL ENVIRON MICROB, V78, P607, DOI 10.1128/AEM.06482-11; Evans DE, 2014, J AM SOC BREW CHEM, V72, P192, DOI 10.1094/ASBCJ-2014-0630-01; Fan HX, 2011, ENZYME MICROB TECH, V49, P94, DOI 10.1016/j.enzmictec.2011.03.001; Fernandez-Gonzalez AJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06112-3; Houfani AA, 2017, WORLD J MICROB BIOT, V33, DOI 10.1007/s11274-016-2198-x; Huang Z, 2015, INT J SYST EVOL MICR, V65, P365, DOI 10.1099/ijs.0.069492-0; Carrim AJI, 2006, BRAZ ARCH BIOL TECHN, V49, P353, DOI 10.1590/S1516-89132006000400001; Janssens IA, 2003, SCIENCE, V300, P1538, DOI 10.1126/science.1083592; Jha Sneha, 2016, Cogent Food & Agriculture, V2, DOI 10.1080/23311932.2016.1198225; Jolles P., 1999, CHITIN CHITINASES; Kawase T, 2004, APPL ENVIRON MICROB, V70, P1135, DOI 10.1128/AEM.70.2.1135-1144.2004; Keith SC, 2001, AQUAT MICROB ECOL, V24, P243, DOI 10.3354/ame024243; Lasa AV, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-38123-z; Llado S, 2017, MICROBIOL MOL BIOL R, V81, DOI 10.1128/MMBR.00063-16; Llado S, 2016, BIOL FERT SOILS, V52, P251, DOI 10.1007/s00374-015-1072-6; Lopez-Mondejar R, 2018, ISME J, V12, P1768, DOI 10.1038/s41396-018-0084-2; Lopez-Mondejar R, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0518-x; Lopez-Mondejar R, 2016, SCI REP-UK, V6, DOI 10.1038/srep25279; Masinova T, 2018, FUNGAL ECOL, V34, P10, DOI 10.1016/j.funeco.2018.03.005; Muhling M, 2008, ISME J, V2, P379, DOI 10.1038/ismej.2007.97; Mulet M, 2010, ENVIRON MICROBIOL, V12, P1513, DOI 10.1111/j.1462-2920.2010.02181.x; Nakano H, 1998, J FERMENT BIOENG, V85, P162, DOI 10.1016/S0922-338X(97)86761-X; Naveed M, 2014, BIOL FERT SOILS, V50, P249, DOI 10.1007/s00374-013-0854-y; PAIK J, 1991, Journal of the American Society of Brewing Chemists, V49, P8; QuadtHallmann A, 1997, CAN J MICROBIOL, V43, P577, DOI 10.1139/m97-081; Reilly TJ, 2009, APPL ENVIRON MICROB, V75, P3745, DOI 10.1128/AEM.01599-08; Reintjes G, 2017, ISME J, V11, P1640, DOI 10.1038/ismej.2017.26; Rivas R, 2007, LETT APPL MICROBIOL, V44, P181, DOI 10.1111/j.1472-765X.2006.02050.x; Robledo M, 2008, P NATL ACAD SCI USA, V105, P7064, DOI 10.1073/pnas.0802547105; Shu ZY, 2016, BMC BIOTECHNOL, V16, DOI 10.1186/s12896-016-0269-6; Sigurbjornsdottir MA, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiw090; Song JM, 2010, BIOMASS BIOENERG, V34, P1930, DOI 10.1016/j.biombioe.2010.08.010; Sterkenburg E, 2015, NEW PHYTOL, V207, P1145, DOI 10.1111/nph.13426; Stursova M, 2012, FEMS MICROBIOL ECOL, V80, P735, DOI 10.1111/j.1574-6941.2012.01343.x; Suen G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018814; Traving SJ, 2015, APPL ENVIRON MICROB, V81, P7385, DOI 10.1128/AEM.02070-15; Ulrich A, 2008, MICROB ECOL, V55, P512, DOI 10.1007/s00248-007-9296-0; Valagkova V, 2006, RES MICROBIOL, V157, P119, DOI 10.1016/j.resmic.2005.06.004; van den Brink J, 2011, APPL MICROBIOL BIOT, V91, P1477, DOI 10.1007/s00253-011-3473-2; van der Wal A, 2013, FEMS MICROBIOL REV, V37, P477, DOI 10.1111/1574-6976.12001; Vetrovsky T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089108; Vodovnik M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065333; Voriskova J, 2014, NEW PHYTOL, V201, P269, DOI 10.1111/nph.12481; VRBA J, 1992, ARCH HYDROBIOL, V126, P193; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Yin LJ, 2010, J AGR FOOD CHEM, V58, P9833, DOI 10.1021/jf1019104; Zhang F, 2012, PROCESS BIOCHEM, V47, P225, DOI 10.1016/j.procbio.2011.10.032	70	16	17	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2019	14	3							e0214422	10.1371/journal.pone.0214422	http://dx.doi.org/10.1371/journal.pone.0214422			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ1KV	30908541	Green Published, Green Submitted, gold			2022-12-26	WOS:000462157600066
J	Cui, YM; Wu, XQ; Lin, CY; Zhang, X; Ye, LP; Ren, LL; Chen, M; Yang, MSZ; Li, Y; Li, MF; Li, J; Guan, J; Song, LB				Cui, Yanmei; Wu, Xianqiu; Lin, Chuyong; Zhang, Xin; Ye, Liping; Ren, Liangliang; Chen, Min; Yang, Meisongzhu; Li, Yue; Li, Mengfeng; Li, Jun; Guan, Jian; Song, Libing			AKIP1 promotes early recurrence of hepatocellular carcinoma through activating the Wnt/beta-catenin/CBP signaling pathway	ONCOGENE			English	Article							APC TUMOR-SUPPRESSOR; PROTEIN-KINASE-A; BETA-CATENIN; CELL-LINE; CANCER; PHOSPHORYLATION; MUTATIONS; ASSOCIATION; CLONES; GENES	The early recurrence of hepatocellular carcinoma (HCC) is the main obstacle for long-term survival of patients. Wnt/beta-catenin signaling has been involved in the development and progression of HCC. However, the molecular changes that link Wnt/beta-catenin activation and HCC early recurrence remain poorly understood. Here we identified AKIP1 as a binding partner of beta-catenin. AKIP1 interacted with and sustained beta-catenin in the nuclear by blocking its interaction with adenomatous polyposis coli protein (APC). Moreover, AKIP1 enhanced the protein kinase A catalytic subunit (PKAc)-mediated phosphorylation of beta-catenin, leading to recruitment of cyclic AMP response element-binding protein (CBP) and activation of beta-catenin downstream transcription. Increased AKIP1 expression was observed in HCC clinical samples and correlated with early recurrence and poor prognosis of HCC. AKIP1 promoted invasion and colony outgrowth in vitro and increased intrahepatic and lung metastasis in vivo. Treatment with a CBP inhibitor ICG-001 effectively inhibited the metastatic progression of HCC tumors that had elevated AKIP1 in both cell line and patient-derived xenograft mouse models. Our findings not only establish AKIP1 as a novel regulator of Wnt/beta-catenin signaling as well as HCC early recurrence but also highlight targeting the AKIP1/beta-catenin/CBP axis as attractive therapies for combating HCC metastatic relapse.	[Cui, Yanmei; Wu, Xianqiu; Lin, Chuyong; Zhang, Xin; Ye, Liping; Ren, Liangliang; Li, Yue; Song, Libing] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, Dept Expt Res, State Key Lab Oncol Southern China,Canc Ctr, Guangzhou 510060, Guangdong, Peoples R China; [Cui, Yanmei] Sun Yat Sen Univ, Affiliated Hosp 6, Guangdong Inst Gastroenterol, Guangdong Prov Key Lab Colorectal & Pelv Floor Di, Guangzhou 510655, Guangdong, Peoples R China; [Chen, Min; Guan, Jian] Sourthern Med Univ, Nanfang Hosp, Dept Radiat Oncol, Guangzhou 510515, Guangdong, Peoples R China; [Yang, Meisongzhu; Li, Jun] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Biochem, Guangzhou 510080, Guangdong, Peoples R China; [Li, Mengfeng] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Microbiol, Guangzhou 510080, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University; Southern Medical University - China; Sun Yat Sen University; Sun Yat Sen University	Song, LB (corresponding author), Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, Dept Expt Res, State Key Lab Oncol Southern China,Canc Ctr, Guangzhou 510060, Guangdong, Peoples R China.; Guan, J (corresponding author), Sourthern Med Univ, Nanfang Hosp, Dept Radiat Oncol, Guangzhou 510515, Guangdong, Peoples R China.; Li, J (corresponding author), Sun Yat Sen Univ, Zhongshan Sch Med, Dept Biochem, Guangzhou 510080, Guangdong, Peoples R China.	lijun37@mail.sysu.edu.cn; guanjian5461@163.com; songlb@sysucc.org.cn	Ren, Liangliang/AAR-6436-2020; Zhang, Xin/C-2464-2017; Song, LB/AAL-1968-2020; Lin, Chuyong/AAA-9931-2020	Zhang, Xin/0000-0001-6036-2685; Lin, Chuyong/0000-0003-4887-5386	Natural Science Foundation of China [81572688, 81872386, 81530082, 81773106, 91740118, 81830082, 91740119, 91529301, 81621004, 81472546]; Natural Science Foundation of Guangdong Province [2016A030308002, 2018B030311060, 2018B030311009]; Science and Technology Program of Guangzhou [201504010015]; Guangzhou Science and Technology Plan Projects [201803010098]; Fundamental Research Funds for the Central Universities [17ykjc02]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Science and Technology Program of Guangzhou; Guangzhou Science and Technology Plan Projects; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by The Natural Science Foundation of China (Nos. 81572688, 81872386, 81530082, 81773106, 91740118, 81830082, 91740119, 91529301, 81621004, 81472546); The Natural Science Foundation of Guangdong Province (Nos. 2016A030308002, 2018B030311060, 2018B030311009); The Science and Technology Program of Guangzhou (201504010015); Guangzhou Science and Technology Plan Projects (201803010098); and The Fundamental Research Funds for the Central Universities [No. 17ykjc02].	Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Anson M, 2012, J CLIN INVEST, V122, P586, DOI 10.1172/JCI43937; Arce L, 2006, ONCOGENE, V25, P7492, DOI 10.1038/sj.onc.1210056; Chen JX, 2016, GUT, V65, P1522, DOI 10.1136/gutjnl-2015-310625; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cui YM, 2015, ONCOGENE, V34, P4379, DOI 10.1038/onc.2014.368; Dema A, 2016, J BIOL CHEM, V291, P19618, DOI 10.1074/jbc.M116.738047; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Emami KH, 2004, P NATL ACAD SCI USA, V101, P12682, DOI 10.1073/pnas.0404875101; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Gang EJ, 2014, ONCOGENE, V33, P2169, DOI 10.1038/onc.2013.169; Gao N, 2008, J BIOL CHEM, V283, P7834, DOI 10.1074/jbc.M710285200; Guichard C, 2012, NAT GENET, V44, P694, DOI 10.1038/ng.2256; Hecht A, 2000, EMBO J, V19, P1839, DOI 10.1093/emboj/19.8.1839; Henderson BR, 2000, NAT CELL BIOL, V2, P653, DOI 10.1038/35023605; Hoshida Y, 2009, CANCER RES, V69, P7385, DOI 10.1158/0008-5472.CAN-09-1089; Huang H, 1999, AM J PATHOL, V155, P1795, DOI 10.1016/S0002-9440(10)65496-X; Imamura H, 2003, J HEPATOL, V38, P200, DOI 10.1016/S0168-8278(02)00360-4; Kitching R, 2003, BBA-GENE STRUCT EXPR, V1625, P116, DOI 10.1016/S0167-4781(02)00562-6; Laurent-Puig P, 2001, GASTROENTEROLOGY, V120, P1763, DOI 10.1053/gast.2001.24798; Li CC, 2016, P NATL ACAD SCI USA, V113, P5946, DOI 10.1073/pnas.1601918113; Li Y, 2001, WORLD J GASTROENTERO, V7, P630; Lin C, 2015, ONCOGENE, V34, P332, DOI 10.1038/onc.2013.559; Ma D, 2018, EXP CELL RES, V362, P142, DOI 10.1016/j.yexcr.2017.11.011; Marquardt JU, 2014, CANCER CELL, V25, P550, DOI 10.1016/j.ccr.2014.04.002; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Nagaraj AB, 2015, ONCOTARGET, V6, P23720, DOI 10.18632/oncotarget.4690; Nguyen DX, 2009, CELL, V138, P51, DOI 10.1016/j.cell.2009.04.030; Pez F, 2013, J HEPATOL, V59, P1107, DOI 10.1016/j.jhep.2013.07.001; Rosin-Arbesfeld R, 2000, NATURE, V406, P1009, DOI 10.1038/35023016; Sasaki Y, 2006, ANN SURG, V244, P771, DOI 10.1097/01.sla.0000225126.56483.b3; Sastri M, 2005, P NATL ACAD SCI USA, V102, P349, DOI 10.1073/pnas.0408608102; SU LK, 1993, SCIENCE, V262, P1734, DOI 10.1126/science.8259519; Takemaru KI, 2000, J CELL BIOL, V149, P249, DOI 10.1083/jcb.149.2.249; Taurin S, 2006, J BIOL CHEM, V281, P9971, DOI 10.1074/jbc.M508778200; Tian J, 1999, BRIT J CANCER, V81, P814, DOI 10.1038/sj.bjc.6690769; Valenta T, 2012, EMBO J, V31, P2714, DOI 10.1038/emboj.2012.150; Wang WH, 2016, NEOPLASIA, V18, P711, DOI 10.1016/j.neo.2016.10.004; Wend P, 2013, EMBO J, V32, P1977, DOI 10.1038/emboj.2013.127; Xing Y, 2004, MOL CELL, V15, P523, DOI 10.1016/j.molcel.2004.08.001	42	31	33	3	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 4	2019	38	27					5516	5529		10.1038/s41388-019-0807-5	http://dx.doi.org/10.1038/s41388-019-0807-5			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	IG5KR	30936461				2022-12-26	WOS:000473842500013
J	Yang, JH; Li, Y; Yan, W; Li, WM; Qiu, Q; Ye, HY; Chen, LJ				Yang, Jianhong; Li, Yong; Yan, Wei; Li, Weimin; Qiu, Qiang; Ye, Haoyu; Chen, Lijuan			Covalent modification of Cys-239 in -tubulin by small molecules as a strategy to promote tubulin heterodimer degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						tubulin; microtubule; anticancer drug; cytoskeleton; small molecule; covalent modification; protein degradation; T0070907; tubulin degradation; tubulin inhibitor	BETA-TUBULIN; CANCER-CELLS; GROWTH ARREST; BINDING; AGENT; ALPHA; ISOTHIOCYANATES; POLYMERIZATION; MICROTUBULES; INHIBITORS	Clinical microtubule-targeting drugs are functionally divided into microtubule-destabilizing and microtubule-stabilizing agents. Drugs from both classes achieve microtubule inhibition by binding different sites on tubulin and inhibiting or promoting polymerization with no concomitant effects on the protein levels of tubulin heterodimers. Here, we have identified a series of small molecules with diverse structures potentially representing a third class of novel tubulin inhibitors that promote degradation by covalent binding to Cys-239 of -tubulin. The small molecules highlighted in this study include T0070907 (a peroxisome proliferator-activated receptor inhibitor), T007-1 (a T0070907 derivative), T138067, N,N-ethylene-bis(iodoacetamide) (EBI), and allyl isothiocyanate (AITC). Label-free quantitative proteomic analysis revealed that T007-1 promotes tubulin degradation with high selectivity. Mass spectrometry findings showed covalent binding of both T0070907 and T007-01 to Cys-239 of -tubulin. Furthermore, T007-1 exerted a degradative effect on tubulin isoforms possessing Cys-239 (2, 4, and 5()) but not those containing Ser-239 (3, 6) or mutant -tubulin with a C239S substitution. Three small molecules (T138067, EBI, and AITC) also reported to bind covalently to Cys-239 of -tubulin similarly induced tubulin degradation. Our results strongly suggest that covalent modification of Cys-239 of -tubulin by small molecules could serve as a novel strategy to promote tubulin heterodimer degradation. We propose that these small molecules represent a third novel class of tubulin inhibitor agents that exert their effects through degradation activity.	[Yang, Jianhong; Li, Yong; Yan, Wei; Qiu, Qiang; Ye, Haoyu; Chen, Lijuan] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu 610041, Peoples R China; [Yang, Jianhong; Li, Yong; Yan, Wei; Qiu, Qiang; Ye, Haoyu; Chen, Lijuan] Sichuan Univ, West China Hosp, Ctr Canc, Chengdu 610041, Peoples R China; [Li, Weimin] Sichuan Univ, West China Hosp, Dept Resp Med, Chengdu 610041, Peoples R China	Sichuan University; Sichuan University; Sichuan University	Ye, HY; Chen, LJ (corresponding author), Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu 610041, Peoples R China.; Ye, HY; Chen, LJ (corresponding author), Sichuan Univ, West China Hosp, Ctr Canc, Chengdu 610041, Peoples R China.	yhy1984_hb@163.com; chenlijuan125@163.com			National Natural Science Foundation of China [81803021, 81872900, 81874297]; drug Innovation Major Project [2018ZX09721002-001-004]; 1.3.5 project for disciplines of excellence, the West China Hospital, Sichuan University; Post-doctoral Research Project, West China Hospital, Sichuan University [2018HXBH027]; Sichuan Science and Technology Program [2019YJ0088]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); drug Innovation Major Project; 1.3.5 project for disciplines of excellence, the West China Hospital, Sichuan University; Post-doctoral Research Project, West China Hospital, Sichuan University; Sichuan Science and Technology Program	This work was supported by National Natural Science Foundation of China Grants 81803021, 81872900, and 81874297, the drug Innovation Major Project (2018ZX09721002-001-004), the 1.3.5 project for disciplines of excellence, the West China Hospital, Sichuan University, Post-doctoral Research Project, West China Hospital, Sichuan University Grant 2018HXBH027, and Sichuan Science and Technology Program Grant 2019YJ0088. The authors declare that they have no conflicts of interest with the contents of this article.	Alhosin M, 2012, INVEST NEW DRUG, V30, P1813, DOI 10.1007/s10637-011-9734-1; Antony ML, 2014, J BIOL CHEM, V289, P1852, DOI 10.1074/jbc.M113.496844; Bargagna-Mohan P, 2007, CHEM BIOL, V14, P623, DOI 10.1016/j.chembiol.2007.04.010; Bhalla KN, 2003, ONCOGENE, V22, P9075, DOI 10.1038/sj.onc.1207233; Bruce F., 2008, MED SCI SPORTS EXERC, V30, P100; Clegg A, 2002, THORAX, V57, P20, DOI 10.1136/thorax.57.1.20; Cortes J, 2011, LANCET, V377, P914, DOI 10.1016/S0140-6736(11)60070-6; Doodhi H, 2016, CURR BIOL, V26, P1713, DOI 10.1016/j.cub.2016.04.053; Dumontet C, 2010, NAT REV DRUG DISCOV, V9, P790, DOI 10.1038/nrd3253; Ernest H., 2008, ROLE MICROTUBULES CE; Fortin S, 2011, J PHARMACOL EXP THER, V336, P460, DOI 10.1124/jpet.110.171082; Geng F, 2011, J BIOL CHEM, V286, P32259, DOI 10.1074/jbc.M111.278127; Gil G, 2017, ACS CHEM BIOL, V12, P389, DOI 10.1021/acschembio.6b01018; Harris G, 2009, BIOCHEM BIOPH RES CO, V388, P345, DOI 10.1016/j.bbrc.2009.08.009; Hayashi Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122217; Kaur R, 2014, EUR J MED CHEM, V87, P89, DOI 10.1016/j.ejmech.2014.09.051; Kavallaris M, 2010, NAT REV CANCER, V10, P194, DOI 10.1038/nrc2803; Lallemand-Breitenbach V, 2001, J EXP MED, V193, P1361, DOI 10.1084/jem.193.12.1361; Lee G, 2002, J BIOL CHEM, V277, P19649, DOI 10.1074/jbc.M200743200; Marinelli P, 2018, REDOX BIOL, V14, P566, DOI 10.1016/j.redox.2017.10.022; Mi LX, 2008, J BIOL CHEM, V283, P22136, DOI 10.1074/jbc.M802330200; Mi LX, 2009, J BIOL CHEM, V284, P17039, DOI 10.1074/jbc.M901789200; Michaud LB, 2009, ANN PHARMACOTHER, V43, P1294, DOI 10.1345/aph.1M005; Mollinedo F, 2003, APOPTOSIS, V8, P413, DOI 10.1023/A:1025513106330; NOGALES E, 1995, NATURE, V375, P424, DOI 10.1038/375424a0; Prota AE, 2014, ANGEW CHEM INT EDIT, V53, P1621, DOI 10.1002/anie.201307749; Schaefer KL, 2007, INT J CANCER, V120, P702, DOI 10.1002/ijc.22361; Seve P, 2008, LANCET ONCOL, V9, P168, DOI 10.1016/S1470-2045(08)70029-9; Shan B, 1999, P NATL ACAD SCI USA, V96, P5686, DOI 10.1073/pnas.96.10.5686; Stanton RA, 2011, MED RES REV, V31, P443, DOI 10.1002/med.20242; Wieczorek M, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aag1093; Wu YL, 2005, MOL CELL, V18, P413, DOI 10.1016/j.molcel.2005.04.014; Yang JH, 2018, J BIOL CHEM, V293, P9461, DOI 10.1074/jbc.RA117.001658; Yang JH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12103; Zhu J, 1999, P NATL ACAD SCI USA, V96, P14807, DOI 10.1073/pnas.96.26.14807	35	18	18	5	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2019	294	20					8161	8170		10.1074/jbc.RA118.006325	http://dx.doi.org/10.1074/jbc.RA118.006325			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC0NH	30940730	Green Published, hybrid			2022-12-26	WOS:000470656500015
J	Kristiawan, M; El Hassan, M; El Faye, A; Sobolik, V				Kristiawan, Magdalena; El Hassan, Mouhammad; El Faye, Alioune; Sobolik, Vaclav			Experimental investigation of Taylor-Couette-Poiseuille flow at low Taylor and Reynolds numbers	PLOS ONE			English	Article							ROTATING CYLINDERS; VELOCITY-FIELD; MASS-TRANSFER; AXIAL-FLOW; STABILITY; INSTABILITIES; PARAMETERS; REGIMES; SYSTEM	Flow patterns of a Taylor-Couette-Poiseuille flow were studied at low axial Reynolds and rotational Taylor numbers (Re <= 10.5, Ta <= 319). The radius ratio of the inner and outer cylinders was 0.804 and the ratio of the length of the annulus to the gap width was 44.5. Complete map of the studied flow regimes was elaborated. The axial and azimuthal components of the wall shear rate y were measured at the outer fixed cylinder using a three-segment electrodiffusion probe. The components of the wall shear rate of helices have never been measured in previous investigations. Spatio-temporal description of multiple flow patterns was obtained using flow visualizations and simultaneous measurements of wall shear rate components. The flow structures include Taylor vortices, helices winding in the same direction as the base flow or in the opposite direction, helices that were stagnant or moving in the axial direction, smooth or with superposed azimuthal waves, among others. The influence of different flow structures on the wall shear stress components is discussed with and without axial base flow. It was found that the wall shear stress is a function of Ta but no significant dependence on Re was observed for the studied flow regimes and that the mean wall shear stress increases with the number of azimuthal waves. It was also noted that the ED probes provide a more detailed information about flow patterns than torque measurements and visualizations described in the literature.	[Kristiawan, Magdalena] INRA, UR 1268 BIA, BP 71627, Nantes, France; [El Hassan, Mouhammad] Prince Mohammad Bin Fahd Univ, Fac Engn, Al Khobar, Saudi Arabia; [El Faye, Alioune; Sobolik, Vaclav] Univ La Rochelle, UMR 7356, LaSIE, La Rochelle, France	INRAE; Prince Mohammad Bin Fahd University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); La Rochelle Universite	El Hassan, M (corresponding author), Prince Mohammad Bin Fahd Univ, Fac Engn, Al Khobar, Saudi Arabia.	melhassan@pmu.edu.sa						Abcha N, 2013, EUR PHYS J E, V36, DOI 10.1140/epje/i2013-13020-5; Akonur A, 2003, PHYS FLUIDS, V15, P947, DOI 10.1063/1.1556615; AL-Mahasneh MA, 2017, INT J OIL GAS COAL E, V5, P19, DOI DOI 10.11648/J.0GCE.20170502.12; Altmeyer S, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.046308; Altmeyer S, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.066313; ANDERECK CD, 1986, J FLUID MECH, V164, P155, DOI 10.1017/S0022112086002513; Bouabdallah A., 1981, Symmetries and Broken Symmetries in Condensed Matter Physics. Proceedings of the Colloque Pierre Curie, P407; BUHLER K, 1984, Z ANGEW MATH MECH, V64, pT180; CHANDRASEKHAR S, 1960, P NATL ACAD SCI USA, V46, P141, DOI 10.1073/pnas.46.1.141; CHUNG KC, 1977, J FLUID MECH, V81, P641, DOI 10.1017/S0022112077002274; COGNET G, 1984, J MEC THEOR APPL, P7; Curran SJ, 2004, CHEM ENG SCI, V59, P5859, DOI 10.1016/j.ces.2004.07.044; Deguchi K, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.043017; DIPRIMA RC, 1960, J FLUID MECH, V9, P621, DOI 10.1017/S0022112060001365; DONNELLY RJ, 1960, J FLUID MECH, V7, P401, DOI 10.1017/S0022112060000177; Esser A, 1996, PHYS FLUIDS, V8, P1814, DOI 10.1063/1.868963; Fenot M, 2011, INT J THERM SCI, V50, P1138, DOI 10.1016/j.ijthermalsci.2011.02.013; GU ZH, 1986, CAN J CHEM ENG, V64, P185, DOI 10.1002/cjce.5450640203; Hanratty TJ, 1983, FLUID MECH MEASUREME, P519; Heise M, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.045301; Hwang JY, 2004, COMPUT FLUIDS, V33, P97, DOI 10.1016/S0045-7930(03)00033-1; KATAOKA K, 1977, INT J HEAT MASS TRAN, V20, P57, DOI 10.1016/0017-9310(77)90084-9; Leveque M. A., 1928, ANN MINES, V13, P201; LUEPTOW RM, 1992, PHYS FLUIDS A-FLUID, V4, P2446, DOI 10.1063/1.858485; Martinand D, 2017, J FLUID MECH, V824, P438, DOI 10.1017/jfm.2017.351; Martinand D, 2009, PHYS FLUIDS, V21, DOI 10.1063/1.3243976; Meseguer A, 2002, J FLUID MECH, V455, P129, DOI 10.1017/S0022112001007315; Pinter A, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026318; Pinter A, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.044506; Poncet S, 2011, INT J HEAT FLUID FL, V32, P128, DOI 10.1016/j.ijheatfluidflow.2010.08.003; Raguin LG, 2004, J FLUID MECH, V516, P125, DOI 10.1017/S002211200400059X; RECKTENWALD A, 1993, PHYS REV E, V48, P4444, DOI 10.1103/PhysRevE.48.4444; Resende MM, 2004, BRAZ J CHEM ENG, V21, P175, DOI 10.1590/S0104-66322004000200006; SNYDER HA, 1962, PROC R SOC LON SER-A, V265, P198, DOI 10.1098/rspa.1962.0004; Sobolik V, 2011, J APPL FLUID MECH, V4, P25; TAKEUCHI DI, 1981, J FLUID MECH, V102, P101, DOI 10.1017/S0022112081002565; TSAMERET A, 1994, PHYS REV E, V49, P1291, DOI 10.1103/PhysRevE.49.1291; Vedantam S, 2006, CHEM ENG RES DES, V84, P522, DOI 10.1205/cherd.05219; WEIN O, 1987, COLLECT CZECH CHEM C, V52, P2169, DOI 10.1135/cccc19872169; Wereley ST, 1999, PHYS FLUIDS, V11, P3637, DOI 10.1063/1.870228	40	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0212728	10.1371/journal.pone.0212728	http://dx.doi.org/10.1371/journal.pone.0212728			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR5NS	30943190	Green Published, gold, Green Submitted			2022-12-26	WOS:000463194300007
J	Moncel, MH; Fernandes, P; Willmes, M; James, H; Grun, R				Moncel, Marie-Helene; Fernandes, Paul; Willmes, Malte; James, Hannah; Grun, Rainer			Rocks, teeth, and tools: New insights into early Neanderthal mobility strategies in South-Eastern France from lithic reconstructions and strontium isotope analysis	PLOS ONE			English	Article							MIDDLE PALEOLITHIC SITE; QUARTZITE ARTIFACTS; PECHEURS ARDECHE; FLINT ARTIFACTS; CENTRAL-EUROPE; PAYRE ARDECHE; RATIOS; PATTERNS; SR; TERRITORIES	Neanderthals had complex land use patterns, adapting to diversified landscapes and climates. Over the past decade, considerable progress has been made in reconstructing the chronology, land use and subsistence patterns, and occupation types of sites in the Rhone Valley, southeast France. In this study, Neanderthal mobility at the site of Payre is investigated by combining information from lithic procurement analysis ("chaine evolutive" and "chaine operatoire" concepts) and strontium isotope analysis of teeth (childhood foraging area), from two units (F and G). Both units date to the transition from Marine Isotope Stage (MIS) 8 to MIS 7, and show similar environmental conditions, but represent contrasting occupation durations. Level Gb (unit G) represents a long-term year-round use, in contrast to short-term seasonal use of the cave in level Fb (unit F). For both levels, lithic material and food were generally collected from a local to semi-local region. However, in level Gb, lithic materials were mainly collected from colluviums and food collected in the valley, whereas in level Fb, lithic procurement focused primarily on alluvial deposits and food was collected from higher elevation plateaus. These procurement or exchange patterns might be related to flint availability, knapping advantages of alluvial flint or occupation duration. The site of Payre is located in a flint rich circulation corridor and the movement of groups or exchanges between groups were organized along a north-south axis on the plateaus or towards the east following the river. The ridges were widely used as they are rich in flint, whereas the Rhone Valley is not an important source of lithic raw materials. Compared to other western European Middle Palaeolithic sites, these results indicate that procurement strategies have a moderate link with occupation types and duration, and with lithic technology. The Sr isotope ratios broadly match the proposed foraging areas, with the Rhone Valley being predominantly used in unit G and the ridges and limestone plateaus in unit F. While lithic reconstructions and childhood foraging are not directly related this suggests that the three analysed Neanderthals spend their childhood in the same general area and supports the idea of mobile Neanderthals in the Rhone Valley and neighbouring higher elevation plateaus. The combination of reconstructing lithic raw material sources, provisioning strategies, and strontium isotope analyses provides new details on how Neanderthals at Payre practised land use and mobility in the Early Middle Palaeolithic.	[Moncel, Marie-Helene] Natl Museum Nat Hist, UMR 7194, CNRS, Inst Paleontol Humaine, 1 Rue Rene Panhard, Paris, France; [Fernandes, Paul] SARL Paleotime, Villard De Lans, France; [Fernandes, Paul] Univ Bordeaux, UMR PACEA, CNRS, CS, Pessac, France; [Fernandes, Paul] Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, Leipzig, Germany; [Willmes, Malte] Univ Calif Davis, Dept Wildlife Fish & Conservat Biol, Davis, CA 95616 USA; [James, Hannah] Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT, Australia; [Grun, Rainer] Griffith Univ, Res Ctr Human Evolut, Nathan, Qld, Australia	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Max Planck Society; University of California System; University of California Davis; Australian National University; Griffith University	Moncel, MH (corresponding author), Natl Museum Nat Hist, UMR 7194, CNRS, Inst Paleontol Humaine, 1 Rue Rene Panhard, Paris, France.	marie-helene.moncel@mnhn.fr	Fernandes, Paul/H-2972-2013; Willmes, Malte/J-3710-2015	Fernandes, Paul/0000-0003-4135-115X; Willmes, Malte/0000-0001-8734-5324; James, Hannah F/0000-0001-7953-5240; Moncel, Marie-helene/0000-0002-0398-2316	Ministry of Culture; Service regional de l'Archeologie Auvergne Rhone-Alpes; Center for the Study of Law and Culture, Columbia University (US); Ministry of Culture, Service regional de l'Archeologie Auvergne Rhone-Alpes; Research Centre for Human Evolution, Environmental Futures Research Institute, Griffith University, Gold Coast, Queensland, Australia; Project Origins Region Aquitaine	Ministry of Culture; Service regional de l'Archeologie Auvergne Rhone-Alpes; Center for the Study of Law and Culture, Columbia University (US); Ministry of Culture, Service regional de l'Archeologie Auvergne Rhone-Alpes; Research Centre for Human Evolution, Environmental Futures Research Institute, Griffith University, Gold Coast, Queensland, Australia; Project Origins Region Aquitaine	Funded by MHM: Ministry of Culture. Service regional de l'Archeologie Auvergne Rhone-Alpes (Fieldworks) (Permit 1990-2002); Center for the Study of Law and Culture, Columbia University (US) (Permit 2009-2016). MHM, PF: Ministry of Culture, Service regional de l'Archeologie Auvergne Rhone-Alpes (Collective projects on Neanderthal and flint origins) (Permit 2005-2018) MW, HJ, RG: Research Centre for Human Evolution, Environmental Futures Research Institute, Griffith University, Gold Coast, Queensland 4222, Australia (strontium isotopes) PF: Project Origins Region Aquitaine (Permit 2000-2005) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, THESIS; AUBRY MP, 1975, CR ACAD SCI D NAT, V280, P1509; Baena J, 2017, QUATERN INT, V436, P212, DOI 10.1016/j.quaint.2014.08.031; Baena J, 2012, QUATERN INT, V247, P199, DOI 10.1016/j.quaint.2011.07.031; Beard BL, 2000, J FORENSIC SCI, V45, P1049; Bentley RA, 2006, J ARCHAEOL METHOD TH, V13, P135, DOI 10.1007/s10816-006-9009-x; Bernard-Guell S., 2014, TRANSITION RUPTURES, V2, P229; Bernard-Guelle S, 2005, ANTHROPOLOGIE, V109, P799, DOI 10.1016/j.anthro.2005.10.008; Bernard-Guelle S, 2006, BULL SOC PREHIST FR, V103, P9, DOI 10.3406/bspf.2006.13392; Bernard-Guelle S, 2011, BULL SOC PREHIST FR, V108, P671, DOI 10.3406/bspf.2011.14066; Besancon J., 1982, CMO, V12, P21; Binford L.R., 1982, J ANTHROPOL ARCHAEOL, V1, P5, DOI DOI 10.1016/0278-4165(82)90006-X; BINFORD LR, 1980, AM ANTIQUITY, V45, P4, DOI 10.2307/279653; Binford LR, 1983, PURSUIT; Binford LR., 1984, FAUNAL REMAINS KLASI; Bocherens H, 2016, QUATERNARY SCI REV, V154, P226, DOI 10.1016/j.quascirev.2016.11.004; Boeda E., 1993, BULL SOC PREHIST FR, V90, P392, DOI [10.3406/bspf.1993.9669, DOI 10.3406/BSPF.1993.9669]; Boeda E., 1990, PAL O, V2, P43, DOI DOI 10.3406/PAL.1990.988; Boeda E, 1994, MONOGRAPHIES DU CRA, V9; Bordes F, 1972, A TALE OF 2 CAVES; Bordes F, 1972, QUATERNARIA, V16, P15; Brenet M, 2017, QUATERN INT, V428, P151, DOI 10.1016/j.quaint.2015.12.052; Britton K, 2011, J HUM EVOL, V61, P176, DOI 10.1016/j.jhevol.2011.03.004; Burke A, 2006, J ANTHROPOL ARCHAEOL, V25, P510, DOI 10.1016/j.jaa.2006.03.003; Burke A, 2012, QUATERN INT, V247, P230, DOI 10.1016/j.quaint.2010.10.029; Burroni D, 2002, J ARCHAEOL SCI, V29, P1277, DOI 10.1006/jasc.2001.0771; Bustos-Perez G, 2017, J ARCHAEOL SCI-REP, V12, P658, DOI 10.1016/j.jasrep.2017.02.021; Callow P., 1986, COTTE ST BRELADE 196; Capo RC, 1998, GEODERMA, V82, P197, DOI 10.1016/S0016-7061(97)00102-X; Carmignani L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178550; Combier J., 1967, MEMOIRE, V4; Conard MJ, 2000, INT J OSTEOARCHAEOL, V10, P286, DOI 10.1002/1099-1212(200009/10)10:5<286::AID-OA557>3.0.CO;2-8; Conard NJ, 2012, QUATERN INT, V247, P236, DOI 10.1016/j.quaint.2011.05.043; Conard NJ, 2001, SETTLEMENT DYNAMICS, P7; Costamagno S, 2006, J ANTHROPOL ARCHAEOL, V25, P466, DOI 10.1016/j.jaa.2006.03.008; Cregut-Bonnoure E., 2002, OVIBOVINI CAPRINI MA; Daujeard C., 2011, HALTES CHASSE PREHIS, P77; Daujeard C, 2016, QUATERN INT, V411, P179, DOI 10.1016/j.quaint.2016.02.009; Daujeard C, 2012, QUATERN INT, V252, P32, DOI 10.1016/j.quaint.2011.01.047; Daujeard C, 2010, J ANTHROPOL ARCHAEOL, V29, P368, DOI 10.1016/j.jaa.2010.05.002; Defleur A, 2015, ANTHROPOLOGIE, V119, P170, DOI 10.1016/j.anthro.2015.04.002; Delagnes A., 2010, SYSTEME TECHNIQUES S; Delagnes A, 2011, J ARCHAEOL SCI, V38, P1771, DOI 10.1016/j.jas.2011.04.007; Deschamps M, 2017, QUATERN INT, V433, P33, DOI 10.1016/j.quaint.2016.01.043; Di Modica K, 2016, QUATERN INT, V411, P77, DOI 10.1016/j.quaint.2015.12.072; Di Modica K., 2010, CONTRAINTES NATURELL, P307; Garralda MD, 2014, J HUM EVOL, V75, P1, DOI 10.1016/j.jhevol.2014.02.019; Domingo R, 2017, QUATERN INT, V435, P129, DOI 10.1016/j.quaint.2015.09.088; Doronichev V, 2016, QUATERN INT, V409, P222, DOI 10.1016/j.quaint.2015.05.063; Ecker M, 2013, J HUM EVOL, V65, P363, DOI 10.1016/j.jhevol.2013.06.013; Embry A.F., 1971, B CAN PETROL GEOL, V19, P730, DOI DOI 10.35767/GSCPGBULL.19.4.730; Evans JA, 2010, J GEOL SOC LONDON, V167, P1, DOI 10.1144/0016-76492009-090; Faure G., 2005, ISOTOPES PRINCIPLES, VThird; FEBLOTAUGUSTINS J, 1993, J ANTHROPOL ARCHAEOL, V12, P211, DOI 10.1006/jaar.1993.1007; Fernandes P., 2010, RIV SCI PREISTORICHE, VLVII, P31; Fernandes P, 2012, THESIS; Fernandes P., 2006, MEMOIRE DIPLOME EHES; Fernandes P, 2008, J ARCHAEOL SCI, V35, P2357, DOI 10.1016/j.jas.2008.02.012; Fernandes P, 2007, CR PALEVOL, V6, P557, DOI 10.1016/j.crpv.2007.09.015; Fernandes P, 2006, CR PALEVOL, V5, P981, DOI 10.1016/j.crpv.2006.09.009; Fernandes P, 2006, CR PALEVOL, V5, P829, DOI 10.1016/j.crpv.2006.04.002; Frei R, 2013, APPL GEOCHEM, V38, P147, DOI 10.1016/j.apgeochem.2013.09.007; Gamble C, 1998, WORLD ARCHAEOL, V29, P426, DOI 10.1080/00438243.1998.9980389; Gaudzinski S, 2000, J HUM EVOL, V38, P497, DOI 10.1006/jhev.1999.0359; Geneste J.-M., 1999, BISON GIBIER MOYEN S, P185; Geneste J.-M., 1988, ETUDES RECHERCHES AR, V35, P61; Geneste J-M., 1997, PALEO REV ARCHEOL PR, V9, P101; Goyal E., 2012, PEUPLEMENTS NEANDERT; Graetsch HA, 2012, ARCHAEOMETRY, V54, P18, DOI 10.1111/j.1475-4754.2011.00610.x; Grayson DK, 2002, J ARCHAEOL SCI, V29, P1439, DOI 10.1006/jasc.2002.0806; Grove M, 2009, J ANTHROPOL ARCHAEOL, V28, P222, DOI 10.1016/j.jaa.2009.01.003; Hans U, 2013, EARTH PLANET SC LETT, V374, P204, DOI 10.1016/j.epsl.2013.05.029; Hardaker T, 2012, P GEOLOGIST ASSOC, V123, P692, DOI 10.1016/j.pgeola.2012.05.009; Hardy BL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023768; Khun S., 1995, MOUSTERIAN LITHIC TE; Koehler H, 2016, BULL SOC PREHIST FR, V113, P429; Kowalewski SA, 2008, J ARCHAEOL RES, V16, P225, DOI 10.1007/s10814-008-9020-8; Kozlowski JK, 2014, QUATERN INT, V326, P344, DOI 10.1016/j.quaint.2013.08.020; KUHN SL, 1992, J ANTHROPOL RES, V48, P185, DOI 10.1086/jar.48.3.3630634; Lavin L., 1992, N AM ARCHAEOL, V13, P97, DOI DOI 10.2190/WFXT-26NX-XBP6-X09D; Le Ribault L., 1975, EXOSCOPIE METHODE AP; Lugli F, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09007-5; Machado J, 2013, J ARCHAEOL SCI, V40, P2254, DOI 10.1016/j.jas.2013.01.002; Lopez-Garcia JM, 2012, QUATERNARY SCI REV, V43, P33, DOI 10.1016/j.quascirev.2012.04.008; Masaoudi H., 1994, QUATERNAIRE, V5, P79; Masson A., 1981, THESIS, P1035; Maurer AF, 2012, SCI TOTAL ENVIRON, V433, P216, DOI 10.1016/j.scitotenv.2012.06.046; MCARTHUR JM, 1994, TERRA NOVA, V6, P331, DOI 10.1111/j.1365-3121.1994.tb00507.x; Moncel M.-H., 2007, ANTHROPOLOGIE BRNO, VXLV, P7; Moncel M -H, 2002, TABLE RONDE INT MATI, P227; Moncel M -H, 2003, BAR IS, V1184; Moncel M-H, 1997, BSPF, V94, P68; Moncel MH, 2008, CR PALEVOL, V7, P441, DOI 10.1016/j.crpv.2008.07.004; Moncel MH, 2008, J ANTHROPOL ARCHAEOL, V27, P382, DOI 10.1016/j.jaa.2008.03.005; Moncel MH, 2007, ANTHROPOLOGIE, V111, P211, DOI 10.1016/j.anthro.2007.05.001; Moncel MH, 2015, QUATERN INT, V378, P22, DOI 10.1016/j.quaint.2013.12.009; Moncel MH, 2014, QUATERN INT, V350, P180, DOI 10.1016/j.quaint.2014.05.013; Moncel MH, 2011, J ANTHROPOL RES, V67, P47, DOI 10.3998/jar.0521004.0067.104; Moncel MH, 2011, VERTEBR PALEOBIOL PA, P261, DOI 10.1007/978-94-007-0415-2_22; Moncel MH, 2012, QUATERN INT, V247, P103, DOI 10.1016/j.quaint.2010.10.030; Moncel MH, 2009, J ARCHAEOL SCI, V36, P1892, DOI 10.1016/j.jas.2009.04.018; Moncel MH, 1996, CR ACAD SCI II A, V322, P251; Moncel MH, 2014, TRANSITIONS RUPTURES, V2, P43; Moncel MH, 2002, B SOC PREHISTORIQUE, V99, P249, DOI DOI 10.3406/bspf.2002.12656; Moncel MH, 2008, MEMOIRE SOC PREHISTO, V46; Montgomery J, 2007, APPL GEOCHEM, V22, P1502, DOI 10.1016/j.apgeochem.2007.02.009; MOORE LJ, 1982, J RES NAT BUR STAND, V87, P1, DOI 10.6028/jres.087.001; Neruda P, 2017, QUATERN INT, V435, P58, DOI 10.1016/j.quaint.2015.10.028; Niven L, 2012, J HUM EVOL, V63, P624, DOI 10.1016/j.jhevol.2012.07.002; Nowell GM, 2009, J ARCHAEOL SCI, V36, P1334, DOI 10.1016/j.jas.2009.01.019; Pedergnana A, 2018, ARCHAEOL ANTHROP SCI, V10, P369, DOI 10.1007/s12520-016-0368-2; Peresani M, 2012, QUATERN INT, V247, P125, DOI 10.1016/j.quaint.2011.02.006; Picin A, 2016, CR PALEVOL, V15, P581, DOI 10.1016/j.crpv.2015.09.012; Price TD, 2002, ARCHAEOMETRY, V44, P117, DOI 10.1111/1475-4754.00047; Purdy B.A., 1987, ADV ARCHAEOLOGICAL M, V11, P211; Raynal J. -P., 2012, BAR INT SERIES, V2400, P53; Raynal J -P, 2008, BAR IINT SERIES S, V1725, P141; Raynal Jean-Paul, 2013, Quartaer, V60, P29; Richards M, 2008, J ARCHAEOL SCI, V35, P1251, DOI 10.1016/j.jas.2007.08.018; Richards M, 2009, J ARCHAEOL SCI, V36, P1657, DOI 10.1016/j.jas.2009.03.009; Richter Juergen, 2006, P51; Rios-Garaizar J, 2015, CR PALEVOL, V14, P233, DOI 10.1016/j.crpv.2014.11.006; Rivals F, 2009, J ARCHAEOL SCI, V36, P1070, DOI 10.1016/j.jas.2008.12.009; Roebroeks W., 1999, MIDDLE PALAEOLITHIC, P121; Roebroeks W., 1988, ANALECTA PRAEHISTORI, V21; Rolland N., 2001, SETTLEMENT DYNAMICS, P545; Rosell J, 2010, QUATERNAIRE, V21, P139; Rufa A, 2016, QUATERN INT, V421, P46, DOI 10.1016/j.quaint.2015.05.016; Sanchez-Hernandez C, 2014, J ARCHAEOL SCI, V49, P317, DOI 10.1016/j.jas.2014.06.002; Seronie-Vivien M, 1987, B SOC LINNEENNE BORD, V15; Shea J., 1997, CURR ANTHROPOL, V39, P45; Slovak NM, 2012, HDB ENV ISOTOPE GEOC; Smith TM, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aau9483; Texier P, 1998, EC PREHISTORIQUE COM, P325; Texier P.-J., 2005, TERRITOIRES DEPLACEM, V16, P115; Thiebaut C, 2009, BULL SOC PREHIST FR, V106, P239, DOI 10.3406/bspf.2009.13847; Thiebaut C, 2012, QUATERN INT, V247, P182, DOI 10.1016/j.quaint.2011.05.028; THIRLWALL MF, 1991, CHEM GEOL, V94, P85, DOI 10.1016/0168-9622(91)90002-E; Thiry M, 2014, EARTH-SCI REV, V136, P141, DOI 10.1016/j.earscirev.2014.05.008; Turq A., 1990, CHASSEURS AUROCHS BO, P69, DOI [10.4000/books.editionsmsh.36013, DOI 10.4000/BOOKS.EDITIONSMSH.36013]; Turq A, 2017, QUATERN INT, V433, P88, DOI 10.1016/j.quaint.2016.02.062; Valladas H, 2008, QUAT GEOCHRONOL, V3, P377, DOI 10.1016/j.quageo.2008.01.001; Vaquero M, 2018, J ARCHAEOL METHOD TH, V25, P334, DOI 10.1007/s10816-017-9339-x; Vaquero M, 2012, QUATERN INT, V247, P162, DOI 10.1016/j.quaint.2010.12.015; Willmes M, 2016, J ARCHAEOL SCI, V70, P102, DOI 10.1016/j.jas.2016.04.017; Willmes M, 2014, EARTH SYST SCI DATA, V6, P117, DOI 10.5194/essd-6-117-2014; Willmes M, 2018, APPL GEOCHEM, V90, P75, DOI 10.1016/j.apgeochem.2017.12.025; Wilson L, 2014, J HUM EVOL, V75, P28, DOI 10.1016/j.jhevol.2013.12.018	148	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0214925	10.1371/journal.pone.0214925	http://dx.doi.org/10.1371/journal.pone.0214925			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HR5NS	30943255	gold, Green Published, Green Submitted			2022-12-26	WOS:000463194300071
J	Pau, MC; Pantaleo, A; Tsamesidis, I; Hoang, H; Tran, AT; Nguyen, TLH; Phan, THG; Nu, PAT; Ngo, TMC; Marchetti, G; Schwarzer, E; Fiori, PL; Low, PS; Huynh, CD; Turrini, FM				Pau, Maria Carmina; Pantaleo, Antonella; Tsamesidis, Ioannis; Ha Hoang; Anh Tuan Tran; Thi Lien Hanh Nguyen; Thi Hang Giang Phan; Phuong Anh Ton Nu; Thi Minh Chau Ngo; Marchetti, Giuseppe; Schwarzer, Evelin; Fiori, Pier Luigi; Low, Philip S.; Chien Dinh Huynh; Turrini, Francesco Michelangelo			Clinical impact of the two ART resistance markers, K13 gene mutations and DPC3 in Vietnam	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; EMERGING ARTEMISININ RESISTANCE; DIHYDROARTEMISININ-PIPERAQUINE; PARASITE CLEARANCE; MULTIDRUG-RESISTANCE; WESTERN CAMBODIA; MYANMAR BORDER; SPREAD; PROPELLER; PROVINCE	Background In Vietnam, a rapid decline of P. falciparum malaria cases has been documented in the past years, the number of Plasmodium falciparum malaria cases has rapidly decreased passing from 19.638 in 2012 to 4.073 cases in 2016. Concomitantly, the spread of artemisinin resistance markers is raising concern on the future efficacy of the ACTs. An evaluation of the clinical impact of the artemisinin resistance markers is therefore of interest. Methods The clinical effectiveness of dihydroartemisinin-piperaquine therapy (DHA-PPQ) has been evaluated in three districts characterized by different rates of ART resistance markers: K13 (C580Y) mutation and delayed parasite clearance on day 3 (DPC3). Patients were stratified in 3 groups a) no markers, b) one marker (suspected resistance), c) co-presence of both markers (confirmed resistance). In the studied areas, the clinical effectiveness of DHA-PPQ has been estimated as malaria recrudescence within 60 days. Results The rate of K13(C580Y) ranged from 75.8% in Krong Pa to 1.2% in Huong Hoa district. DPC3 prevalence was higher in Krong Pa than in Huong Hoa (86.2% vs 39.3%). In the two districts, the prevalence of confirmed resistance was found in 69.0% and 1.2% of patients, respectively. In Thuan Bac district, we found intermediate prevalence of confirmed resistance. Treatment failure was not evidenced in any district. PPQ resistance was not evidenced. Confirmed resistance was associated to the persistence of parasites on day 28 and to 3.4-fold higher parasite density at diagnosis. The effectiveness of malaria control strategies was very high in the studied districts. Conclusion No treatment failure has been observed in presence of high prevalence of ART resistance and in absence of PPQ resistance. K13(C580Y) was strongly associated to higher parasitemia at admission, on days 3 and 28. Slower parasite clearance was also observed in younger patients.	[Pau, Maria Carmina; Pantaleo, Antonella; Tsamesidis, Ioannis; Marchetti, Giuseppe; Fiori, Pier Luigi] Univ Sassari, Dept Biomed Sci, Sassari, Italy; [Ha Hoang] Duy Tan Univ, Danang, Vietnam; [Anh Tuan Tran] Huong Hoa Dist Hlth Ctr, Quang Tri, Vietnam; [Thi Lien Hanh Nguyen] Quy Nhon Inst Malaria Parasitol & Entomol, Quy Nhon, Vietnam; [Thi Hang Giang Phan] Hue Univ, Dept Immunol & Pathophysiol, Hue City, Vietnam; [Phuong Anh Ton Nu; Thi Minh Chau Ngo] Hue Univ, Dept Parasitol, Hue City, Vietnam; [Schwarzer, Evelin; Turrini, Francesco Michelangelo] Univ Turin, Dept Oncol, Turin, Italy; [Low, Philip S.] Purdue Univ, Purdue Ctr Drug Discovery, W Lafayette, IN 47907 USA; [Low, Philip S.] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA; [Chien Dinh Huynh] VINMEC Heath Care Syst, Hanoi, Vietnam	University of Sassari; Duy Tan University; Hue University; Hue University; University of Turin; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Pantaleo, A (corresponding author), Univ Sassari, Dept Biomed Sci, Sassari, Italy.	apantaleo@uniss.it	Pantaleo, Antonella/ABA-5190-2020; Tran, Anh Tuan/GZB-0391-2022; TSAMESIDIS, IOANNIS/AAL-7655-2021; Fiori, Pier Luigi/GVU-9300-2022	Fiori, Pier Luigi/0000-0001-6190-612X; Tsamesidis, Ioannis/0000-0002-1439-3920; Phan, Thi Hang Giang/0000-0002-2247-8043; Ngo, Thi Minh Chau/0000-0001-9016-4436	Legge Regionale 7 Agosto 2007, N 7: "Promozione della ricerca scientifica ed innovazione tecnologica in Sardegna"; Hulow Company (USA)	Legge Regionale 7 Agosto 2007, N 7: "Promozione della ricerca scientifica ed innovazione tecnologica in Sardegna"; Hulow Company (USA)	This study was supported by grants from Legge Regionale 7 Agosto 2007, N 7: "Promozione della ricerca scientifica ed innovazione tecnologica in Sardegna" and (in part) by research funding by a grant from Hulow Company (USA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaratunga C, 2016, LANCET INFECT DIS, V16, P357, DOI 10.1016/S1473-3099(15)00487-9; Amaratunga C, 2012, LANCET INFECT DIS, V12, P851, DOI 10.1016/S1473-3099(12)70181-0; Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876; Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981; Ataide R, 2017, P NATL ACAD SCI USA, V114, P3515, DOI 10.1073/pnas.1615875114; Blasco B, 2017, NAT MED, V23, P917, DOI 10.1038/nm.4381; Phuc BQ, 2017, EMERG INFECT DIS, V23, P715, DOI 10.3201/eid2304.161872; Chookajorn T, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006923; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Duru V, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0539-5; Hanboonkunupakarn B, 2016, TRAVEL MED INFECT DI, V14, P548, DOI 10.1016/j.tmaid.2016.11.016; Hastings IM, 2015, ANTIMICROB AGENTS CH, V59, P6428, DOI 10.1128/AAC.00481-15; Huang F, 2015, J INFECT DIS, V212, P1629, DOI 10.1093/infdis/jiv249; Imwong M, 2017, LANCET INFECT DIS, V17, P1022, DOI 10.1016/S1473-3099(17)30524-8; Imwong M, 2017, LANCET INFECT DIS, V17, P491, DOI [10.1016/S1473-3099(17)30048-8, 10.1016/s1473-3099(17)30048-8]; Kamau E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071539; Kyaw MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057689; Lamikanra AA, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-201; Leang R, 2015, ANTIMICROB AGENTS CH, V59, P4719, DOI 10.1128/AAC.00835-15; Matsuoka H, 2007, ACTA MED OKAYAMA, V61, P213; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Ministry of Health Portal VietNam, 2009, GUID MAL DIAGN TREAT; Mintel Mintel's Traditional Toys and Games US, 2016, REP; Miotto O, 2013, NAT GENET, V45, P648, DOI 10.1038/ng.2624; Myint MK, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1775-2; Na-Bangchang K, 2013, EXPERT REV CLIN PHAR, V6, P307, DOI [10.1586/ecp.13.17, 10.1586/ECP.13.17]; Thanh NV, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1680-8; Nguyen TH, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-152; Nguyen TN, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/aac.01578-16, 10.1128/AAC.01578-16]; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; Nyunt MH, 2015, CLIN INFECT DIS, V60, P1208, DOI 10.1093/cid/ciu1160; Pantaleo A, 2015, J INFECT DEV COUNTR, V9, P597, DOI 10.3855/jidc.7015; Phyo AP, 2016, CLIN INFECT DIS, V63, P784, DOI 10.1093/cid/ciw388; Scott N, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2418-y; Spring MD, 2015, LANCET INFECT DIS, V15, P683, DOI 10.1016/S1473-3099(15)70049-6; Thriemer K, 2014, ANTIMICROB AGENTS CH, V58, P7049, DOI 10.1128/AAC.02746-14; Hien TT, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-355; Tun KM, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1240-7; Wang ZL, 2015, ANTIMICROB AGENTS CH, V59, P6952, DOI 10.1128/AAC.01255-15; WHO, 2018, ART RES ART BAS COMB; WHO, 2015, STAT REP ART ACI RES; Witkowski B, 2017, LANCET INFECT DIS, V17, P174, DOI [10.1016/s1473-3099(16)30415-7, 10.1016/S1473-3099(16)30415-7]; World Health Organization, 2009, METH SURV ANT DRUG E; World Health Organization, 2012, UPD ART RES APR; World Health Organization, 2017, STAT REP ART ACT RES; World Health Organization, 2014, STAT REP ART RES SEP; World Health Organization, 2011, UPD ART RES SEPT; World Health Organization, 2018, STAT REP ART RES ACT; World Health Organization, 2014, STAT REP ART RES JAN	49	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2019	14	4							e0214667	10.1371/journal.pone.0214667	http://dx.doi.org/10.1371/journal.pone.0214667			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR2UW	30939179	Green Published, gold, Green Submitted			2022-12-26	WOS:000462993900034
J	Tillmann, FP; Quack, I; Woznowski, M; Rump, LC				Tillmann, Frank-Peter; Quack, Ivo; Woznowski, Magdalena; Rump, Lars Christian			Effect of recipient-donor sex and weight mismatch on graft survival after deceased donor renal transplantation	PLOS ONE			English	Article							KIDNEY-TRANSPLANTATION; H-Y; GLOMERULAR NUMBER; RISK-FACTORS; SIZE; IMPACT; OUTCOMES; BIRTH	This study evaluated the combined effect of recipient-to-donor weight and sex mismatch after deceased-donor renal transplantation in a German transplant cohort and the evolution of recipient-to-donor weight difference over a 13-year observation period. The association of absolute weight and sex difference with graft failure was explored in an outpatient cohort of deceased-donor transplant recipients who underwent kidney transplantation between 2000 and 2012. Graft failure was defined as repeated need for dialysis or death with a functioning graft. Recipient and donor sex pairings were classified as sex concordant (MDMR/FDFR) or discordant (MDFR/FDMR). These classes were further stratified into four groups according to recipient-to-donor weight mismatch >= 10 kg (recipient > donor) or <10 kg (recipient <donor). Multivariable Cox proportional hazards models were applied to evaluate the time to graft loss adjusting for donor, immunologic, surgical, organizational, and recipient predictors. Sex-concordant transplant pairings <10 kg weight difference served as the reference group. Among 826 transplant recipients, 154 developed graft failure (18.6%). Median graft survival time was 3.9 years; first quartile (0.2-1.2), second quartile (1.2-2.9), third quartile (2.9-5.8), and fourth quartile (5.8-12.4). After multivariable adjustment, the highest relative hazard for graft failure was observed for sex-discordant transplant pairings with a. 10 kg weight difference between recipient and donor (compared to the reference group MDMR/FDFR with weight difference <10 kg, MDMR/FDFR with weight difference. 10 kg, hazard ratio 1.86, 95% confidence interval 1.07-3.32-p = 0.029; MDFR/FDMR with weight difference <10 kg, hazard ratio 1.14, 95% confidence interval 0.78-1.68-p = 0.507, and MDFR/FDMR with weight difference >= 10 kg, hazard ratio 2.00, 95% confidence interval 1.15-3.48-p = 0.014). A recipient-to-donor weight mismatch of >= 10 kg was associated with an increased risk of graft loss or recipient death with a functioning graft. Concurrent sex discordance seemed to enhance this effect as indicated by an increase in the hazard ratio. We detected no significant tendency for increasing recipient-to-donor weight differences from 2000 to 2012.	[Tillmann, Frank-Peter; Quack, Ivo; Woznowski, Magdalena; Rump, Lars Christian] Heinrich Heine Univ Dusseldorf, Klin Nephrol, Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Tillmann, FP (corresponding author), Heinrich Heine Univ Dusseldorf, Klin Nephrol, Dusseldorf, Germany.	frank.tillmann@uni-duesseldorf.de	Tillmann, Frank Peter/AAE-1686-2021	Tillmann, Frank Peter/0000-0002-4610-4361				Baldelomar EJ, 2016, KIDNEY INT, V89, P498, DOI 10.1038/ki.2015.316; Bassi R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169077; Beeman SC, 2014, AM J PHYSIOL-RENAL, V306, pF1381, DOI 10.1152/ajprenal.00092.2014; Bertoni E, 2001, TRANSPLANT P, V33, P3363, DOI 10.1016/S0041-1345(01)02448-4; BRENNER BM, 1993, AM J KIDNEY DIS, V21, P66, DOI 10.1016/0272-6386(93)70097-I; Chisholm-Burns MA, 2016, PATIENT PREFER ADHER, V10, P703, DOI 10.2147/PPA.S104646; D'Addio F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053797; Denhaerynck K, 2007, AM J TRANSPLANT, V7, P108, DOI 10.1111/j.1600-6143.2006.01611.x; Denic A, 2017, J AM SOC NEPHROL, V28, P313, DOI 10.1681/ASN.2016020154; Feldman HI, 1996, J AM SOC NEPHROL, V7, P151; Finger JD, 2016, DTSCH ARZTEBL INT, V113, P712, DOI 10.3238/arztebl.2016.0712; Gaston RS, 1996, TRANSPLANTATION, V61, P383, DOI 10.1097/00007890-199602150-00010; Ghafari A, 2008, TRANSPL P, V40, P135, DOI 10.1016/j.transproceed.2007.11.029; Giral M, 2010, J AM SOC NEPHROL, V21, P1022, DOI 10.1681/ASN.2009121296; Goldberg RJ, 2010, TRANSPLANTATION, V90, P867, DOI 10.1097/TP.0b013e3181f24e75; Gratwohl A, 2008, LANCET, V372, P49, DOI 10.1016/S0140-6736(08)60992-7; Heaphy ELG, 2013, AM J TRANSPLANT, V13, P1001, DOI 10.1111/ajt.12154; Hernandez-Fuentes MP, 2018, AM J TRANSPLANT, V18, P1370, DOI 10.1111/ajt.14594; Hughson M, 2003, KIDNEY INT, V63, P2113, DOI 10.1046/j.1523-1755.2003.00018.x; Jindal RM, 2005, AM J NEPHROL, V25, P474, DOI 10.1159/000087920; Kasiske BL, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000024564.22119.3D; Kim SJ, 2009, J AM SOC NEPHROL, V20, P2025, DOI 10.1681/ASN.2008101110; Kolonko A, 2013, TRANSPL P, V45, P1639, DOI 10.1016/j.transproceed.2012.12.019; Manalich R, 2000, KIDNEY INT, V58, P770, DOI 10.1046/j.1523-1755.2000.00225.x; McGee J, 2010, J AM COLL SURGEONS, V210, P718, DOI 10.1016/j.jamcollsurg.2009.12.032; Merion RM, 2005, JAMA-J AM MED ASSOC, V294, P2726, DOI 10.1001/jama.294.21.2726; Miller AJ, 2017, CLIN J AM SOC NEPHRO, V12, P669, DOI 10.2215/CJN.07660716; Narasimhamurthy M, 2017, CLIN KIDNEY J, V10, P116, DOI 10.1093/ckj/sfw097; NYENGAARD JR, 1992, ANAT REC, V232, P194, DOI 10.1002/ar.1092320205; Opelz G, 2013, TRANSPLANT REV-ORLAN, V27, P43, DOI 10.1016/j.trre.2013.01.004; Popli R, 2014, IMMUNOL RES, V58, P249, DOI 10.1007/s12026-014-8514-3; Spivey CA, 2014, CLIN TRANSPLANT, V28, P96, DOI 10.1111/ctr.12283; Tan JC, 2012, GENDER MED, V9, P335, DOI 10.1016/j.genm.2012.07.004	33	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2019	14	3							e0214048	10.1371/journal.pone.0214048	http://dx.doi.org/10.1371/journal.pone.0214048			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ9FO	30925158	Green Published, gold, Green Submitted			2022-12-26	WOS:000462732300009
J	Farrant, BM; White, SW; Shepherd, CCJ				Farrant, Brad M.; White, Scott W.; Shepherd, Carrington C. J.			Trends and predictors of extreme preterm birth: Western Australian population-based cohort study	PLOS ONE			English	Article							RISK-FACTORS; EPIDEMIOLOGY; PREGNANCY; LINKAGE; WOMEN; AGE	Background The preterm birth rate is rising in high-income countries and is associated with increased mortality and morbidity. Although the risks increase with greater prematurity and risk factors have been found to vary with gestational age and labour onset, few studies have focused on the myriad pathways to extreme preterm birth (20-27 weeks' gestation). The current study investigated trends in extreme preterm birth by labour onset type and examined the antecedent risks to further our understanding around the identification of high-risk pregnancies. Methods Retrospective cohort study including all singleton extreme preterm births in Western Australia between 1986 and 2010. De-identified data from six core population health datasets were linked and used to ascertain extreme preterm births (excluding medical terminations and birth defects) after spontaneous onset of labour, preterm pre-labour rupture of membranes, and medically indicated labour onset. Trends over time in extreme preterm birth were analysed using linear regression. Multivariable regression techniques were used to assess the relative risks associated with each salient, independent risk factor and to calculate Population Attributable Risks (PARs). Results The extreme preterm birth rate including medical terminations and birth defects significantly increased over time whereas the extreme preterm birth rate excluding medical terminations and birth defects did not change. After medical terminations and birth defects were excluded, the rate of medically indicated extreme preterm births significantly increased over time whereas the rate of preterm pre-labour rupture of membranes extreme preterm births significantly reduced, and the rate of spontaneous extreme preterm births did not significantly change. In the multivariate analyses, factors associated with placental dysfunction accounted for >10% of the population attributable risk within each labour onset type. Conclusions First study to show that the increase in extreme preterm birth in high-income jurisdiction is no longer evident after medical terminations and birth defects are excluded. Interventions that identify and target women at risk of placental dysfunction presents the greatest opportunity to reduce extreme preterm births.	[Farrant, Brad M.; Shepherd, Carrington C. J.] Univ Western Australia, Telethon Kids Inst, Perth, WA, Australia; [White, Scott W.] Univ Western Australia, Div Obstet & Gynaecol M550, Crawley, WA, Australia; [White, Scott W.] King Edward Mem Hosp, Dept Maternal Fetal Med, Subiaco, WA, Australia	Telethon Kids Institute; University of Western Australia; University of Western Australia; King Edward Memorial Hospital; University of Western Australia	Farrant, BM (corresponding author), Univ Western Australia, Telethon Kids Inst, Perth, WA, Australia.	brad.farrant@telethonkids.org.au	Farrant, Brad M/E-9447-2012	Farrant, Brad M/0000-0002-3903-0990; Shepherd, Carrington C.J./0000-0003-0043-7053; White, Scott/0000-0002-7235-6407	National Health and Medical Research Council (NHMRC) [1127265]; NHMRC [1098844, 1074146]; Zac Pearson Legacy	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Zac Pearson Legacy	The study was supported by funding from the National Health and Medical Research Council (NHMRC; Project Grant 1127265). BMF is funded by the NHMRC (Project Grant 1098844) and Zac Pearson Legacy. CCJS is funded by the NHMRC (Early Career Fellowship 1074146). https://www.nhmrc.gov.au/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audette MC, 2018, SEMIN FETAL NEONAT M, V23, P119, DOI 10.1016/j.siny.2017.11.004; Australian Bureau of Statistics (ABS), 2004, CENS POP HOUS SOC IN; Bourke J, 2005, PAEDIATR PERINAT EP, V19, P284, DOI 10.1111/j.1365-3016.2005.00666.x; Bower C, 2001, TERATOLOGY, V63, P23, DOI 10.1002/1096-9926(200101)63:1<23::AID-TERA1004>3.0.CO;2-S; Dekker GA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039154; Di Renzo GC, 2018, BEST PRACT RES CL OB, V52, P13, DOI 10.1016/j.bpobgyn.2018.01.022; Dickinson JE, 2004, AUST NZ J OBSTET GYN, V44, P337, DOI 10.1111/j.1479-828X.2004.00252.x; Dobbins TA, 2012, MED J AUSTRALIA, V197, P291, DOI 10.5694/mja11.11331; DoHWA, 2014, GUID COMPL NOT CAS A; Downey F., 2007, STAT SERIES, V78; Farrant BM, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0904-1; Gee V., 1994, 59 HLTH DEP W AUSTR; Gimenez LG, 2016, J MATERN-FETAL NEO M, V29, P3153, DOI 10.3109/14767058.2015.1118035; Hammond G, 2013, BJOG-INT J OBSTET GY, V120, P1051, DOI 10.1111/1471-0528.12188; Henderson JJ, 2012, J MATERN-FETAL NEO M, V25, P642, DOI 10.3109/14767058.2011.597899; Hildebrandt Mandy, 2006, BMC Med Res Methodol, V6, P32, DOI 10.1186/1471-2288-6-32; Holman CDJ, 2008, AUST HEALTH REV, V32, P766, DOI 10.1071/AH080766; Holman CDJ, 1999, AUST NZ J PUBL HEAL, V23, P453, DOI 10.1111/j.1467-842X.1999.tb01297.x; Hutchinson M, 2013, INDUCED ABORTIONS W; Jelliffe-Pawlowski LL, 2015, BJOG-INT J OBSTET GY, V122, P1484, DOI 10.1111/1471-0528.13495; Kelman CW, 2002, AUST NZ J PUBL HEAL, V26, P251, DOI 10.1111/j.1467-842X.2002.tb00682.x; Khashan AS, 2009, HUM REPROD, V24, P429, DOI 10.1093/humrep/den418; Langhoff-Roos J, 2006, BMJ-BRIT MED J, V332, P937, DOI 10.1136/bmj.38751.524132.2F; Lawn JE, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-S1-S1; Lumley J, 2003, BJOG-INT J OBSTET GY, V110, P3, DOI 10.1016/S1470-0328(03)00011-9; Lykke JA, 2009, OBSTET GYNECOL, V113, P1217, DOI 10.1097/AOG.0b013e3181a66f2d; Martin Joyce A, 2006, Natl Vital Stat Rep, V55, P1; Norman JE, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000153; Salihu H, 2010, J MATERN-FETAL NEO M, V23, P1444, DOI 10.3109/14767051003678044; Steer P, 2005, BJOG-INT J OBSTET GY, V112, P1, DOI 10.1111/j.1471-0528.2005.00575.x; Tracy SK, 2007, BJOG-INT J OBSTET GY, V114, P731, DOI 10.1111/j.1471-0528.2007.01323.x; Usynina AA, 2016, PAEDIATR PERINAT EP, V30, P462, DOI 10.1111/ppe.12304; Wikstrom AK, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.05.009; Yeoh PL, 2018, INT J QUAL HEALTH C, V30, P466, DOI 10.1093/intqhc/mzy041; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	35	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2019	14	3							e0214445	10.1371/journal.pone.0214445	http://dx.doi.org/10.1371/journal.pone.0214445			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HQ3IW	30913277	gold, Green Submitted, Green Published			2022-12-26	WOS:000462305600062
J	Jenkins, PC; Painter, S; Bell, TM; Kline, JA; Zarzaur, B				Jenkins, Peter C.; Painter, Scott; Bell, Teresa M.; Kline, Jeffrey A.; Zarzaur, Ben L.			The conference effect: National surgery meetings are associated with increased mortality at trauma centers without American College of Surgeons verification	PLOS ONE			English	Article							OUTCOMES; PATIENT; WEEKEND; PERFORMANCE; DEATH; NIGHT; CARE	Background Thousands of physicians attend scientific conferences each year. While recent data indicate that variation in staffing during such meetings impacts survival of non-surgical patients, the association between treatment during conferences and outcomes of a surgical population remain unknown. The purpose of this study was to examine mortality resulting from traumatic injuries and the influence of hospital admission during national surgery meetings. Study design Retrospective analysis of in-hospital mortality using data from the Trauma Quality Improvement Program (2010-2011). Identified patients admitted during four annual meetings and compared their mortality with that of patients admitted during non-conference periods. Analysis included 155 hospitals with 12,256 patients admitted on 42 conference days and 82,399 patients admitted on 270 non-conference days. Multivariate analysis performed separately for hospitals with different levels of trauma center verification by state and American College of Surgeons (ACS) criteria. Results Patient characteristics were similar between meeting and non-meeting dates. At ACS level I and level II trauma centers during conference versus non-conference dates, adjusted mortality was not significantly different. However, adjusted mortality increased significantly for patients admitted to trauma centers that lacked ACS trauma verification during conferences versus non-conference days (OR 1.2, p = 0.008), particularly for patients with penetrating injuries, whose mortality rose from 11.6% to 15.9% (p = 0.006).	[Jenkins, Peter C.; Bell, Teresa M.; Zarzaur, Ben L.] Indiana Univ Sch Med, Dept Surg, Indianapolis, IN 46202 USA; [Painter, Scott] Univ Illinois, Coll Med Peoria, Dept Surg, Peoria, IL USA; [Kline, Jeffrey A.] Indiana Univ Sch Med, Dept Emergency Med, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; University of Illinois System; University of Illinois Peoria; Indiana University System; Indiana University Bloomington	Jenkins, PC (corresponding author), Indiana Univ Sch Med, Dept Surg, Indianapolis, IN 46202 USA.	pjenkins1@iuhealth.org	Bell, Teresa Maria/Q-9271-2019; Zarzaur, Ben/S-6572-2019	Bell, Teresa/0000-0002-6519-4358; Zarzaur, Ben/0000-0001-9988-9572	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002529, TL1TR001107, KL2TR002530] Funding Source: NIH RePORTER; NCATS NIH HHS [KL2 TR002530, UL1 TR002529, TL1 TR001107] Funding Source: Medline	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		American College of Surgeons TQIP, 2012, ACS TQIP BENCHM REP; [Anonymous], 1979, Bull Am Coll Surg, V64, P43; [Anonymous], 2014, RESOURCES OPTIMAL CA; Arbabi S, 2005, J TRAUMA, V59, P815, DOI 10.1097/01.ta.0000188390.80199.37; Calland JF, 2012, J TRAUMA ACUTE CARE, V73, P1086, DOI 10.1097/TA.0b013e31826fc7a0; Carmody IC, 2002, AM SURGEON, V68, P1048; Carr BG, 2011, ARCH SURG-CHICAGO, V146, P810, DOI 10.1001/archsurg.2011.60; Carr BG, 2010, J TRAUMA, V69, P1042, DOI 10.1097/TA.0b013e3181f6f958; Carson JL, 2013, JAMA-J AM MED ASSOC, V309, P83, DOI 10.1001/jama.2012.50429; Claridge JA, 2001, SURGERY, V130, P346, DOI 10.1067/msy.2001.116670; DiRusso S, 2001, J TRAUMA, V51, P294, DOI 10.1097/00005373-200108000-00011; Glance LG, 2016, MED CARE, V54, P608, DOI 10.1097/MLR.0000000000000532; Inaba K, 2010, J TRAUMA, V68, P19, DOI 10.1097/TA.0b013e3181b88dfe; Ioannidis JPA, 2013, JAMA-J AM MED ASSOC, V309, P1410, DOI 10.1001/jama.2013.3150; Jena AB, 2015, JAMA INTERN MED, V175, P237, DOI 10.1001/jamainternmed.2014.6781; Jena AB, 2013, J GEN INTERN MED, V28, P223, DOI 10.1007/s11606-012-2211-5; Joynt KE, 2012, JAMA-J AM MED ASSOC, V308, P1460, DOI 10.1001/jama.2012.12922; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; Maggio PM, 2009, J TRAUMA, V67, P190, DOI 10.1097/TA.0b013e3181a51b2f; Metcalfe D, 2016, EMERG MED J, V33, P836, DOI 10.1136/emermed-2016-206049; Newgard CD, 2013, J AM COLL SURGEONS, V216, P147, DOI 10.1016/j.jamcollsurg.2012.08.017; Prasad V, 2013, JAMA-J AM MED ASSOC, V309, P241, DOI 10.1001/jama.2012.96867; Shah AA, 2016, JAMA SURG, V151, P217, DOI 10.1001/jamasurg.2015.3940; Zhou YF, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.003102	24	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2019	14	3							e0214020	10.1371/journal.pone.0214020	http://dx.doi.org/10.1371/journal.pone.0214020			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ3IW	30913224	Green Published, gold, Green Submitted			2022-12-26	WOS:000462305600022
J	Matha, L; Shim, H; Steer, CA; Yin, YH; Martinez-Gonzalez, I; Takei, F				Matha, Laura; Shim, Hanjoo; Steer, Catherine A.; Yin, Yi Han; Martinez-Gonzalez, Itziar; Takei, Fumio			Female and male mouse lung group 2 innate lymphoid cells differ in gene expression profiles and cytokine production	PLOS ONE			English	Article							REGULATORY T-CELLS; AIRWAY INFLAMMATION; GENDER-DIFFERENCE; TYPE-2 IMMUNITY; SEX-DIFFERENCES; ACTIVATION; ASTHMA; PREVALENCE	Epidemiological studies have shown sex differences in prevalence of non-allergic asthma. Recent reports demonstrated negative effects of androgen signaling on group 2 innate lymphoid cells (ILC2s), explaining a potential mechanism behind sex bias in asthma prevalence. To further understand sex-related differences in ILC2 functions and ILC2 intrinsic or lung environmental mechanisms behind it, we have investigated the effects of sex and age on lung ILC2 function, the amounts of ILC2-activating cytokines in the lung and gene expression profiles of male and female ILC2s. Flow cytometric analyses of naive male and female mouse lung ILC2s showed no difference in their numbers. However, upon three daily intranasal IL-33 injections, lung ILC2s in postpubertal female mice expanded to a greater degree than male counterpart. In line with in vivo results, purified female mouse lung ILC2s produced more cytokines than male ILC2s upon in vitro stimulation. Gene expression profiles of purified naive male and female ILC2s differed in 4% of the genes, and gene set enrichment analysis showed that female ILC2s are enriched for gene signatures of memory T cells. We did not observe similar degree of differences between female and male ILC2s after IL-33 stimulation. ILC2-activating cytokines including IL-33, IL-7 and TSLP were more highly expressed in whole lung homogenate samples prepared from naive post pubertal female mouse lung than male mouse lung. Moreover, the differences in responsiveness of male and female ILC2s to IL-33 were not affected in IL-33-deficient mice. These results suggest that female ILC2s are more readily activated than male ILC2s due to their gene expression at the naive state, which is potentially influenced by the lung environment.	[Matha, Laura; Shim, Hanjoo; Steer, Catherine A.; Yin, Yi Han; Martinez-Gonzalez, Itziar; Takei, Fumio] British Columbia Canc, Terry Fox Lab, Vancouver, BC, Canada; [Matha, Laura; Steer, Catherine A.] Univ British Columbia, Interdisciplinary Oncol Program, Fac Med, Vancouver, BC, Canada; [Martinez-Gonzalez, Itziar; Takei, Fumio] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC, Canada	University of British Columbia; University of British Columbia	Takei, F (corresponding author), British Columbia Canc, Terry Fox Lab, Vancouver, BC, Canada.; Takei, F (corresponding author), Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC, Canada.	ftakei@bccrc.ca		Shim, Hanjoo/0000-0003-2866-8099; Martinez Gonzalez, Itziar/0000-0002-1695-5691; Matha, Laura/0000-0002-4399-6851; Takei, Fumio/0000-0002-3620-5046	University of British Columbia Four Year Fellowship; Vanier Canada Graduate Scholarship; Canadian Institute of Health Research studentship; Canadian Institute of Health Research fellowship; Michael Smith Foundation for Health Research fellowship; Canadian Institute of Health Research [PJT-153304, MOP-126194, SVB-145583]; UBC Four Year Fellowship; CIHR; MSFHR	University of British Columbia Four Year Fellowship; Vanier Canada Graduate Scholarship; Canadian Institute of Health Research studentship(Canadian Institutes of Health Research (CIHR)); Canadian Institute of Health Research fellowship(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research fellowship(Michael Smith Foundation for Health Research); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); UBC Four Year Fellowship; CIHR(Canadian Institutes of Health Research (CIHR)); MSFHR(Michael Smith Foundation for Health Research)	L.M. is a recipient of a University of British Columbia Four Year Fellowship and a Vanier Canada Graduate Scholarship. C.A.S. is a recipient of a University of British Columbia Four Year Fellowship and a Canadian Institute of Health Research studentship. I. M-G. is a recipient of Canadian Institute of Health Research and Michael Smith Foundation for Health Research fellowships. This work was supported by grants from the Canadian Institute of Health Research (http://www.cihr-irsc.gc.ca/e/193.html) (PJT-153304, MOP-126194, SVB-145583) to FT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; L.M. is a recipient of a UBC Four Year Fellowship and a Vanier Canada Graduate Scholarship. C.A.S. is a recipient of a UBC Four Year Fellowship and a CIHR studentship. I.M-G. is a recipient of CIHR and MSFHR fellowships. This work was supported by grants from the Canadian Institute of Health Research (PJT-153304, MOP-126194, SVB-145583).	Afshan G, 2012, CLIN LAB, V58, P567; Ahnstedt H, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00659; Allakhverdi Z, 2009, J ALLERGY CLIN IMMUN, V123, P472, DOI 10.1016/j.jaci.2008.10.022; Bartemes K, 2018, J IMMUNOL, V200, P229, DOI 10.4049/jimmunol.1602085; Bartemes KR, 2014, J ALLERGY CLIN IMMUN, V134, P671, DOI 10.1016/j.jaci.2014.06.024; Bartemes KR, 2012, J IMMUNOL, V188, P1503, DOI 10.4049/jimmunol.1102832; Blacquiere MJ, 2010, INT ARCH ALLERGY IMM, V153, P173, DOI 10.1159/000312635; Cephus JY, 2017, CELL REP, V21, P2487, DOI 10.1016/j.celrep.2017.10.110; Christianson CA, 2015, J ALLERGY CLIN IMMUN, V136, P59, DOI 10.1016/j.jaci.2014.11.037; Cohn L, 2006, J CLIN INVEST, V116, P306, DOI 10.1172/JCI27690; Halim Timotheus Y F, 2014, Curr Protoc Immunol, V106, DOI 10.1002/0471142735.im0325s106; Halim TYF, 2012, IMMUNITY, V36, P451, DOI 10.1016/j.immuni.2011.12.020; Hamelmann E, 2001, IMMUNOL REV, V179, P182, DOI 10.1034/j.1600-065X.2001.790118.x; Kadel Sapana, 2018, Immunohorizons, V2, P74, DOI 10.4049/immunohorizons.1800008; Laffont S, 2017, J EXP MED, V214, P1581, DOI 10.1084/jem.20161807; Leynaert B, 2012, THORAX, V67, P625, DOI 10.1136/thoraxjnl-2011-201249; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Martinez-Gonzalez I, 2015, TRENDS IMMUNOL, V36, P189, DOI 10.1016/j.it.2015.01.005; Melgert BN, 2005, CLIN EXP ALLERGY, V35, P1496, DOI 10.1111/j.1365-2222.2005.02362.x; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Molofsky AB, 2015, IMMUNITY, V43, P161, DOI 10.1016/j.immuni.2015.05.019; Rigas D, 2017, J ALLERGY CLIN IMMUN, V139, P1468, DOI 10.1016/j.jaci.2016.08.034; Steer CA, 2017, J ALLERGY CLIN IMMUN, V140, P593, DOI 10.1016/j.jaci.2016.12.984; Takeda M, 2013, RESPIROLOGY, V18, P797, DOI 10.1111/resp.12078; Warren KJ, 2017, ANN ALLERG ASTHMA IM, V118, P233, DOI 10.1016/j.anai.2016.11.011	25	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2019	14	3							e0214286	10.1371/journal.pone.0214286	http://dx.doi.org/10.1371/journal.pone.0214286			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ3IW	30913260	Green Published, gold, Green Submitted			2022-12-26	WOS:000462305600038
J	Thomas, BJ; Wight, IE; Chou, WYY; Moreno, M; Dawson, Z; Homayouni, A; Huang, HY; Kim, H; Jia, HN; Buland, JR; Wambach, JA; Cole, FS; Pak, SC; Silverman, GA; Luke, CJ				Thomas, Brian J.; Wight, Ira E.; Chou, Wendy Y. Y.; Moreno, Marco; Dawson, Zachary; Homayouni, Arielle; Huang, Huiyan; Kim, Hyori; Jia, Hanna; Buland, Justin R.; Wambach, Jennifer A.; Cole, F. Sessions; Pak, Stephen C.; Silverman, Gary A.; Luke, Cliff J.			CemOrange2 fusions facilitate multifluorophore subcellular imaging in C-elegans	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; CAENORHABDITIS-ELEGANS; ALPHA-1-ANTITRYPSIN DEFICIENCY; CELLULAR-RESPONSE; AUTOPHAGY GENES; EXPRESSION; MODEL; RED; DISEASES; MUTANTS	Due to its ease of genetic manipulation and transparency, Caenorhabditis elegans (C. elegans) has become a preferred model system to study gene function by microscopy. The use of Aequorea victoria green fluorescent protein (GFP) fused to proteins or targeting sequences of interest, further expanded upon the utility of C. elegans by labeling subcellular structures, which enables following their disposition during development or in the presence of genetic mutations. Fluorescent proteins with excitation and emission spectra different from that of GFP accelerated the use of multifluorophore imaging in real time. We have expanded the repertoire of fluorescent proteins for use in C. elegans by developing a codonoptimized version of Orange2 (CemOrange2). Proteins or targeting motifs fused to CemOrange2 were distinguishable from the more common fluorophores used in the nematode; such as GFP, YFP, and mKate2. We generated a panel of CemOrange2 fusion constructs, and confirmed they were targeted to their correct subcellular addresses by colocalization with independent markers. To demonstrate the potential usefulness of this new panel of fluorescent protein markers, we showed that CemOrange2 fusion proteins could be used to: 1) monitor biological pathways, 2) multiplex with other fluorescent proteins to determine colocalization and 3) gain phenotypic knowledge of a human ABCA3 orthologue, ABT-4, trafficking variant in the C. elegans model organism.	[Thomas, Brian J.; Wight, Ira E.; Chou, Wendy Y. Y.; Moreno, Marco; Dawson, Zachary; Huang, Huiyan; Kim, Hyori; Jia, Hanna; Buland, Justin R.; Wambach, Jennifer A.; Cole, F. Sessions; Pak, Stephen C.; Silverman, Gary A.; Luke, Cliff J.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Thomas, Brian J.; Wight, Ira E.; Chou, Wendy Y. Y.; Moreno, Marco; Dawson, Zachary; Huang, Huiyan; Kim, Hyori; Jia, Hanna; Buland, Justin R.; Wambach, Jennifer A.; Cole, F. Sessions; Pak, Stephen C.; Silverman, Gary A.; Luke, Cliff J.] St Louis Childrens Hosp, St Louis, MO 63178 USA; [Homayouni, Arielle] Washington Univ, Div Biol & Biomed Sci, St Louis, MO USA; [Cole, F. Sessions; Silverman, Gary A.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Silverman, Gary A.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA	Washington University (WUSTL); St. Louis Children's Hospital; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Silverman, GA; Luke, CJ (corresponding author), Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA.; Silverman, GA; Luke, CJ (corresponding author), St Louis Childrens Hosp, St Louis, MO 63178 USA.; Silverman, GA (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA.; Silverman, GA (corresponding author), Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA.	gsilverman@wustl.edu; cjluke@wustl.edu	Silverman, Gary/AAJ-1269-2020	Pak, Stephen/0000-0002-8089-3237; Thomas, Brian/0000-0002-0090-905X; Homayouni, Arielle/0000-0002-3934-7242; Dawson, Zachary/0000-0002-3804-1241	National Institute of Health [R01DK104946, R01DK114047, UDN U01HG010215]; Children's Discovery Institute of St. Louis Children's Hospital Foundation; NIH Office of Research Infrastructure Programs [P40 OD010440]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG010215] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK104946, R01DK114047] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Discovery Institute of St. Louis Children's Hospital Foundation; NIH Office of Research Infrastructure Programs; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institute of Health grants R01DK104946 (https://www.niddk.nih.gov/, GAS), R01DK114047 (https://www.niddk.nih.gov/, CJL, GAS), UDN U01HG010215 (https://www.genome.gov/, FSC, JAW), the Children's Discovery Institute of St. Louis Children's Hospital Foundation (http://www.childrensdiscovery.org, CJL, SCP). Some strains were provided by the CGC, which is funded by NIH Office of Research Infrastructure Programs (https://orip.nih.gov/, P40 OD010440). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by National Institute of Health grants R01DK104946 (https://www.niddk.nih.gov/, GAS), R01DK114047 (https://www.niddk.nih.gov/, CJL, GAS), UDN U01HG010215 (https://www.genome.gov/, FSC, JAW), the Children's Discovery Institute of St. Louis Children's Hospital Foundation (http://www.childrensdiscovery.org, CJL, SCP). Some strains were provided by the CGC, which is funded by NIH Office of Research Infrastructure Programs (https://orip.nih.gov/, P40 OD010440). The plasmid constructs described in this manuscript (including CemOrange2, CemCardinal2 and CemNeptune2) were deposited with Addgene (https://www.addgene.org/). C.elegans strains with subcellular structures labeled by CemOrange2 fusion proteins were deposited in the Caenorhabditis Genetics Center (https://cgc.umn.edu/).	Aits S, 2015, AUTOPHAGY, V11, P1408, DOI 10.1080/15548627.2015.1063871; Artal-Sanz M, 2006, J CELL BIOL, V173, P231, DOI 10.1083/jcb.200511103; Blommaart EFC, 1997, EUR J BIOCHEM, V243, P240, DOI 10.1111/j.1432-1033.1997.0240a.x; Bryksin AV, 2010, BIOTECHNIQUES, V48, P463, DOI 10.2144/000113418; Campbell EM, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-40; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Chen BH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001235; Cheong N, 2006, J BIOL CHEM, V281, P9791, DOI 10.1074/jbc.M507515200; Chu J, 2014, NAT METHODS, V11, P572, DOI [10.1038/NMETH.2888, 10.1038/nmeth.2888]; Coburn C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001613; Cummings EE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141542; Day RN, 2009, CHEM SOC REV, V38, P2887, DOI 10.1039/b901966a; Ettinger A, 2014, METHOD CELL BIOL, V123, P77, DOI 10.1016/B978-0-12-420138-5.00005-7; Godley BF, 2005, J BIOL CHEM, V280, P21061, DOI 10.1074/jbc.M502194200; Gosai SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015460; Green RA, 2008, METHOD CELL BIOL, V85, P179, DOI 10.1016/S0091-679X(08)85009-1; Guo B, GENOME WIDE SCREEN I; Guo B, 2014, AUTOPHAGY, V10, P1738, DOI 10.4161/auto.29638; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Heppert JK, 2016, MOL BIOL CELL, V27, P3385, DOI 10.1091/mbc.E16-01-0063; Hermann GJ, 2005, MOL BIOL CELL, V16, P3273, DOI 10.1091/mbc.E05-01-0060; Hermann GJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043043; Huang CG, 2007, AM J PHYSIOL-CELL PH, V292, pC1867, DOI 10.1152/ajpcell.00514.2006; Hutter H, 2012, METHOD CELL BIOL, V107, P67, DOI 10.1016/B978-0-12-394620-1.00003-5; Joo HJ, 2009, BIOCHEM J, V422, P61, DOI 10.1042/BJ20090513; Kostich M, 2000, J CELL SCI, V113, P2595; Labrousse AM, 1999, MOL CELL, V4, P815, DOI 10.1016/S1097-2765(00)80391-3; Lee S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067902; Liu J, 2000, MOL BIOL CELL, V11, P3937, DOI 10.1091/mbc.11.11.3937; Long OS, 2014, HUM MOL GENET, V23, P5109, DOI 10.1093/hmg/ddu235; Luke CJ, 2007, CELL, V130, P1108, DOI 10.1016/j.cell.2007.07.013; Lyssenko NN, 2007, BIOTECHNIQUES, V43, P596, DOI 10.2144/000112615; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Matsumura Y, 2006, J BIOL CHEM, V281, P34503, DOI 10.1074/jbc.M600071200; Melendez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782; Miller DM, 1999, BIOTECHNIQUES, V26, P914, DOI 10.2144/99265rr01; Motley AM, 2000, EMBO REP, V1, P40, DOI 10.1093/embo-reports/kvd010; Nehrke K, 2003, J BIOL CHEM, V278, P44657, DOI 10.1074/jbc.M307351200; O'Kane CJ, 2003, SEMIN CELL DEV BIOL, V14, P3, DOI 10.1016/S1084-9521(02)00162-3; O'Reilly LP, 2014, HUM MOL GENET, V23, P5123, DOI 10.1093/hmg/ddu236; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Paschinger K, 2006, J BIOL CHEM, V281, P28265, DOI 10.1074/jbc.M602878200; Patterson GH, 1997, BIOPHYS J, V73, P2782, DOI 10.1016/S0006-3495(97)78307-3; Perlmutter DH, 2006, AUTOPHAGY, V2, P258, DOI 10.4161/auto.2882; Perlmutter DH, 2002, J CLIN INVEST, V110, P1219, DOI 10.1172/JCI200216780; Pincus Z, 2016, AGING-US, V8, P889, DOI 10.18632/aging.100936; Ranka JK, 2000, OPT LETT, V25, P25, DOI 10.1364/OL.25.000025; Redemann S, 2011, NAT METHODS, V8, P250, DOI [10.1038/nmeth.1565, 10.1038/NMETH.1565]; Rolls MM, 2002, MOL BIOL CELL, V13, P1778, DOI 10.1091/mbc.01-10-0514; Ross CA, 2005, NAT REV MOL CELL BIO, V6, P891, DOI 10.1038/nrm1742; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Sato M, 2014, DEVELOPMENT, V141, P1324, DOI 10.1242/dev.103044; Schroeder LK, 2007, MOL BIOL CELL, V18, P995, DOI 10.1091/mbc.E06-08-0685; Shaner NC, 2008, NAT METHODS, V5, P545, DOI 10.1038/nmeth.1209; Shcherbo D, 2009, BIOCHEM J, V418, P567, DOI 10.1042/BJ20081949; Shulenin S, 2004, NEW ENGL J MED, V350, P1296, DOI 10.1056/NEJMoa032178; Silverman GA, 2009, PEDIATR RES, V65, P10, DOI 10.1203/PDR.0b013e31819009b0; Splinter K, 2018, NEW ENGL J MED, V379, P2131, DOI 10.1056/NEJMoa1714458; Tian Y, 2010, CELL, V141, P1042, DOI 10.1016/j.cell.2010.04.034; Tillement JP, 2010, PHARMACOLOGY, V85, P1, DOI 10.1159/000259044; Treusch S, 2004, P NATL ACAD SCI USA, V101, P4483, DOI 10.1073/pnas.0400709101; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Wambach JA, 2016, AM J RESP CELL MOL, V55, P716, DOI 10.1165/rcmb.2016-0008OC; Wang J, 2017, AM J HUM GENET, V100, P843, DOI 10.1016/j.ajhg.2017.04.010; Weaver DJ, 1998, BIOL CELL, V90, P169, DOI 10.1016/S0248-4900(98)80338-9; Weichert N, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-4; Zhang SBO, 2010, P NATL ACAD SCI USA, V107, P4640, DOI 10.1073/pnas.0912308107	67	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2019	14	3							e0214257	10.1371/journal.pone.0214257	http://dx.doi.org/10.1371/journal.pone.0214257			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ3IW	30913273	Green Published, Green Submitted, gold			2022-12-26	WOS:000462305600035
J	Czubaszek, M; Andraszek, K; Banaszewska, D; Walczak-Jedrzejowska, R				Czubaszek, Magdalena; Andraszek, Katarzyna; Banaszewska, Dorota; Walczak-Jedrzejowska, Renata			The effect of the staining technique on morphological and morphometric parameters of boar sperm	PLOS ONE			English	Article							NUCLEOLAR ORGANIZER REGIONS; STRICT CRITERIA; SUS-SCROFA; SEMEN; SPERMATOZOA; QUALITY; DIMENSIONS; SHAPE; FERTILIZATION; AGE	Sperm morphology and morphometry are important parameters in predicting fertility. Sperm are considered to be normal if the shape and size of the head, midpiece and tail fall within the classification for a given species. It is important to select the appropriate technique for staining the semen of a given species, because, as many authors have pointed out, some methods work well for one species but are not suitable for analysing another. The aim of the study was to assess the morphometric parameters of boar sperm following the use of different staining techniques and to verify the hypothesis that the staining technique affects the morphometric parameters of sperm. The staining method was found to significantly affect the dimensions of the boar sperm head. The semen stained by the SpermBlue technique had the closest morphometric sperm head parameters to those of the unstained sperm, so this technique, rather than the routinely used eosin and gentian complex, should be the leading technique in the evaluation of boar sperm morphometry. Silver nitrate staining reveals the structure of the sperm in the most detail; this method can be considered universal, and can be used independently or to supplement routine diagnostics. As the staining technique should interfere as little as possible with the structure of the sperm, while revealing its morphology in as much detail as possible, it is crucial to establish the natural dimensions of the unstained sperm head before determining the optimal technique and its reference values. The recommended or most commonly-used techniques are not always the best options for the staining and analysis of sperm of a given species.	[Czubaszek, Magdalena; Andraszek, Katarzyna] Siedlce Univ Nat Sci & Humanities, Dept Anim Genet & Horse Breeding, Siedlce, Poland; [Banaszewska, Dorota] Siedlce Univ Nat Sci & Humanities, Dept Breeding Methods & Poultry Breeding, Siedlce, Poland; [Walczak-Jedrzejowska, Renata] Med Univ Lodz, Dept Androl & Repoduct Endocrinol, Lodz, Poland	Medical University Lodz	Andraszek, K (corresponding author), Siedlce Univ Nat Sci & Humanities, Dept Anim Genet & Horse Breeding, Siedlce, Poland.	katarzyna.andraszek@uph.edu.pl	Banaszewska, Dorota/AAE-9859-2019; Andraszek, Katarzyna/V-4928-2017	Banaszewska, Dorota/0000-0002-9894-8590; Andraszek, Katarzyna/0000-0001-5920-4102; Walczak-Jedrzejowska, Renata/0000-0002-4267-5714				Aksoy E, 2012, INT J MORPHOL, V30, P1544, DOI 10.4067/S0717-95022012000400045; Andraszek K, 2018, POULTRY SCI, V97, P2575, DOI 10.3382/ps/pey056; Andraszek K., 2016, Folia Pomeranae Universitatis Technologiae Stetinensis, Agricultura, Alimentaria, Piscaria et Zootechnica, V326, P5; Andraszek K, 2007, ARCH GEFLUGELKD, V71, P237; Andraszek K, 2016, CAN J ANIM SCI, V96, P215, DOI 10.1139/cjas-2015-0076; Andraszek K, 2014, FOLIA BIOL-KRAKOW, V62, P293, DOI 10.3409/fb62_4.293; Andraszek K, 2014, B VET I PULAWY, V58, P487, DOI 10.2478/bvip-2014-0074; Andraszek K, 2014, ARCH TIERZUCHT, V57, DOI 10.7482/0003-9438-57-013; Andraszek K, 2011, CAN J ANIM SCI, V91, P239, DOI [10.4141/CJAS10052, 10.4141/cjas10052]; Andraszek K, 2009, ARCH TIERZUCHT, V52, P177, DOI 10.5194/aab-52-177-2009; Auger J, 2010, ASIAN J ANDROL, V12, P36, DOI 10.1038/aja.2009.8; Banaszewska D, 2015, EUR POULTRY SCI, V79, DOI 10.1399/eps.2015.101; Banaszewska D, 2015, MED WETER, V71, P563; Banaszewska D, 2015, ANIM REPROD SCI, V159, P17, DOI 10.1016/j.anireprosci.2015.06.019; Banaszewska D, 2015, B VET I PULAWY, V59, P271, DOI 10.1515/bvip-2015-0040; Banaszewska D, 2015, B VET I PULAWY, V59, P263, DOI 10.1515/bvip-2015-0039; Banaszewska D, 2015, LIVEST SCI, V175, P128, DOI 10.1016/j.livsci.2015.02.017; Banaszewska D, 2011, ARCH TIERZUCHT, V54, P504, DOI 10.5194/aab-54-504-2011; BLOM E, 1973, NORD VET MED, V25, P383; Blom E., 1981, Medycyna Weterynaryjna, V37, P239; Brito LFC, 2011, THERIOGENOLOGY, V76, P745, DOI 10.1016/j.theriogenology.2011.04.007; Card C, 2005, THERIOGENOLOGY, V64, P558, DOI 10.1016/j.theriogenology.2005.05.014; Casey PJ, 1997, THERIOGENOLOGY, V47, P575, DOI 10.1016/S0093-691X(97)00015-0; Chelmonska B, 1993, HODOWLA UZYTKOWANIE, P40; Chenoweth P, 1992, NEW B BREEDING SOUND, P63; DADOUNE JP, 1988, ANDROLOGIA, V20, P211; Dvorakova K, 2005, REPRODUCTION, V130, P61, DOI 10.1530/rep.1.00549; Esteso MC, 2006, J ANDROL, V27, P662, DOI 10.2164/jandrol.106.000489; Franken DR, 2000, HUM REPROD, V15, P667, DOI 10.1093/humrep/15.3.667; Freneau GE, 2010, ANIM REPROD SCI, V118, P176, DOI 10.1016/j.anireprosci.2009.08.015; Gage MJG, 1998, P ROY SOC B-BIOL SCI, V265, P97, DOI 10.1098/rspb.1998.0269; Gago C, 1998, INT J ANDROL, V21, P169; Gandini L, 2000, HUM REPROD, V15, P830, DOI 10.1093/humrep/15.4.830; Gontarz A, 2016, TURK J VET ANIM SCI, V40, P598, DOI 10.3906/vet-1511-6; GOODPASTURE C, 1975, CHROMOSOMA, V53, P37, DOI 10.1007/BF00329389; Gosz E, 2010, J APPL ICHTHYOL, V26, P784, DOI 10.1111/j.1439-0426.2010.01547.x; HAIDL G, 1993, ARCH ANDROLOGY, V31, P153, DOI 10.3109/01485019308988394; Henkel R, 2008, FERTIL STERIL, V89, P449, DOI 10.1016/j.fertnstert.2007.03.027; Hidalgo M, 2008, ANIM REPROD SCI, V103, P374, DOI 10.1016/j.anireprosci.2007.06.001; Hidalgo M, 2006, THERIOGENOLOGY, V66, P996, DOI 10.1016/j.theriogenology.2006.02.039; Hirai M, 2001, J ANDROL, V22, P104; Hirano Y, 2001, J ASSIST REPROD GEN, V18, P213; HOWELL WM, 1980, EXPERIENTIA, V36, P1014, DOI 10.1007/BF01953855; Iguer-Ouada M, 2001, THERIOGENOLOGY, V55, P1143, DOI 10.1016/S0093-691X(01)00473-3; JEYENDRAN RS, 1984, J REPROD FERTIL, V70, P219; KATZ DF, 1986, J ANDROL, V7, P203; Kazerooni T, 2009, J ASSIST REPROD GEN, V26, P591, DOI 10.1007/s10815-009-9361-3; Keel BA, 2002, FERTIL STERIL, V78, P603, DOI 10.1016/S0015-0282(02)03296-X; Kenney R, 1983, SOC THERIGENOLOGY MA; KING GJ, 1973, J ANIM SCI, V36, P563; Kondracki S, 2005, CELL MOL BIOL LETT, V10, P3; Kondracki S, 2012, FOLIA BIOL-KRAKOW, V60, P85, DOI 10.3409/fb60_1-2.85-91; Kondracki Stanislaw, 2006, Reprod Biol, V6 Suppl 2, P99; Kruger T.F., 2004, ATLAS HUMAN SPERM MO, P13; KRUGER TF, 1986, FERTIL STERIL, V46, P1118; KRUGER TF, 1987, ARCH ANDROLOGY, V18, P275, DOI 10.3109/01485018708988493; Lacka K, 2016, J VET RES, V60, P99, DOI 10.1515/jvetres-2016-0014; Lasiene K, 2013, POL J VET SCI, V16, P773, DOI 10.2478/pjvs-2013-0112; Lukaszewicz E, 2008, RES VET SCI, V85, P583, DOI 10.1016/j.rvsc.2008.03.010; LUKASZEWICZ E., 1988, ZESZ NAUK AR WROC ZO, V68, P43; Maree L, 2010, HUM REPROD, V25, P1369, DOI 10.1093/humrep/deq075; McAlister DA, 2010, THESIS; Menkveld R, 1996, FERTIL STERIL, V65, P637, DOI 10.1016/S0015-0282(16)58167-9; Menkveld R, 2007, MALE INFERTILITY DIA, P141; Menkveld R, 2011, ASIAN J ANDROL, V13, P59, DOI 10.1038/aja.2010.67; MORALES P, 1988, J REPROD FERTIL, V83, P119; Nikolettos N, 1999, HUM REPROD, V14, P47, DOI 10.1093/humrep/14.suppl_1.47; Nunez-Martinez I, 2007, INT J ANDROL, V30, P182, DOI 10.1111/j.1365-2605.2007.00743.x; Oral E, 2002, ARCH ANDROLOGY, V48, P307, DOI 10.1080/01485010290031628; Ostermeier GC, 2001, J ANDROL, V22, P584; Ostermeier GC, 2001, J ANDROL, V22, P595; Partyka A, 2012, CURRENT FRONTIERS IN CRYOBIOLOGY, P547; Partyka A, 2010, THERIOGENOLOGY, V74, P1019, DOI 10.1016/j.theriogenology.2010.04.032; Pena FJ, 2005, J ANDROL, V26, P716, DOI 10.2164/jandrol.05030; Phetudomsinsuk K, 2008, ACTA VET SCAND, V50, DOI 10.1186/1751-0147-50-41; Prisant N, 2007, HUM REPROD, V22, P1052, DOI 10.1093/humrep/del481; Rijsselaere T, 2007, REPROD DOMEST ANIM, V42, P143, DOI 10.1111/j.1439-0531.2006.00743.x; Rijsselaere T, 2004, THERIOGENOLOGY, V62, P1292, DOI 10.1016/j.theriogenology.2004.01.005; Rodriguez I, 2001, 1 JORN INV CORD SPAI, P317; Roslanowski K, 1987, STUDY ASSESSMENT BUL, P9; Sancho M, 1998, THERIOGENOLOGY, V50, P27, DOI 10.1016/S0093-691X(98)00110-1; Saravia F, 2007, THERIOGENOLOGY, V68, P196, DOI 10.1016/j.theriogenology.2007.04.052; Singh S, 2011, AM J CLIN PATHOL, V136, P247, DOI 10.1309/AJCPCLCSPP24QPHR; Sprecher DJ, 1996, THERIOGENOLOGY, V45, P757, DOI 10.1016/0093-691X(96)00005-2; Tasdemir I, 1997, HUM REPROD, V12, P1214, DOI 10.1093/humrep/12.6.1214; Thurston LM, 2001, J ANDROL, V22, P382; van der Horst G, 2009, BIOTECH HISTOCHEM, V84, P299, DOI 10.3109/10520290902984274; Verstegen J, 2002, THERIOGENOLOGY, V57, P149, DOI 10.1016/S0093-691X(01)00664-1; Walczak-Jedrzejowska R, 2013, ASIAN J ANDROL, V15, P616, DOI 10.1038/aja.2013.48; World Health Organization (WHO), 2021, WHO LAB MAN EX PROC, V6th, DOI DOI 10.HTTP://WHQLIBD0C.WH0.INT/PUBLICATI0NS/2010/9789241547789_; Zambelli D, 2006, THERIOGENOLOGY, V66, P159, DOI 10.1016/j.theriogenology.2006.01.054	91	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2019	14	3							e0214243	10.1371/journal.pone.0214243	http://dx.doi.org/10.1371/journal.pone.0214243			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ1KV	30908553	Green Submitted, gold, Green Published			2022-12-26	WOS:000462157600046
J	Konstari, S; Sares-Jaske, L; Heliovaara, M; Rissanen, H; Knekt, P; Arokoski, J; Sundvall, J; Karppinen, J				Konstari, Sanna; Sares-Jaske, Laura; Heliovaara, Markku; Rissanen, Harri; Knekt, Paul; Arokoski, Jari; Sundvall, Jouko; Karppinen, Jaro			Dietary magnesium intake, serum high sensitivity C-reactive protein and the risk of incident knee osteoarthritis leading to hospitalization-A cohort study of 4,953 Finns	PLOS ONE			English	Article							FOOD FREQUENCY QUESTIONNAIRE; HIP OSTEOARTHRITIS; 25-HYDROXYVITAMIN D; ENERGY-INTAKE; FOLLOW-UP; OBESITY; PREVALENCE; DEFICIENCY; REPRODUCIBILITY; ASSOCIATION	Objectives To study whether low dietary magnesium (Mg) intake and serum high sensitivity C-reactive protein (hs-CRP) predict the development of clinical knee osteoarthritis (OA). Methods The cohort consisted of 4,953 participants of a national health examination survey who were free of knee and hip OA at baseline. Information on the incidence of knee OA leading to hospitalization was drawn from the National Care Register for Health Care. During the follow-up of 10 years, 123 participants developed incident knee OA. Dietary magnesium intake was assessed on the basis of a food frequency questionnaire from the preceding year. We used Cox's proportional hazards model to estimate the strength of the association between the tertiles of dietary Mg intake and incident knee OA, adjusted for baseline age, gender, energy intake, BMI, history of physical workload, leisure time physical activity, injuries, knee complaints, the use of Mg supplements, and serum hs-CRP levels. Results At baseline, dietary Mg intake was inversely associated with serum hs-CRP even after adjustment for all the potential confounding factors. During the follow-up, the adjusted hazard ratios (with their 95% confidence intervals) for incident knee OA in dietary Mg intake tertiles were 1.00, 1.28 (0.78-2.10), and 1.38 (0.73-2.62); the p value for trend was 0.31. Serum hs-CRP level at baseline did not predict incident knee OA. Conclusions The results do not support the hypothesis that low dietary Mg intake contributes to the development of clinical knee OA, although Mg intake is inversely associated with serum hs-CRP level.	[Konstari, Sanna; Karppinen, Jaro] Oulu Univ Hosp, Dept Phys & Rehabil Med, Med Res Ctr Oulu, Oulu, Finland; [Konstari, Sanna; Karppinen, Jaro] Univ Oulu, Oulu, Finland; [Sares-Jaske, Laura; Heliovaara, Markku; Rissanen, Harri; Knekt, Paul; Sundvall, Jouko] Natl Inst Hlth & Welf, Dept Publ Hlth Solut, Helsinki, Finland; [Arokoski, Jari] Helsinki Univ Hosp, Dept Phys & Rehabil Med, Helsinki, Finland; [Arokoski, Jari] Univ Helsinki, Helsinki, Finland; [Karppinen, Jaro] Finnish Inst Occupat Hlth, Oulu, Finland	University of Oulu; University of Oulu; Finland National Institute for Health & Welfare; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Finnish Institute of Occupational Health	Konstari, S (corresponding author), Oulu Univ Hosp, Dept Phys & Rehabil Med, Med Res Ctr Oulu, Oulu, Finland.; Konstari, S (corresponding author), Univ Oulu, Oulu, Finland.	sanna.konstari@student.oulu.fi		Konstari, Sanna/0000-0002-1331-6501				ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; Arokoski JPA, 2018, CURRENT CARE GUIDELI; Blagojevic M, 2010, OSTEOARTHR CARTILAGE, V18, P24, DOI 10.1016/j.joca.2009.08.010; Block G, 1990, Epidemiology, V1, P58, DOI 10.1097/00001648-199001000-00013; Bonnet CS, 2005, RHEUMATOLOGY, V44, P7, DOI 10.1093/rheumatology/keh344; Braam LAJLM, 1998, AM J EPIDEMIOL, V147, P1081, DOI 10.1093/oxfordjournals.aje.a009402; Choi J, 2013, OBES REV, V14, P232, DOI 10.1111/obr.12003; Dibaba DT, 2014, EUR J CLIN NUTR, V68, P510, DOI 10.1038/ejcn.2014.7; Ezzat AM, 2014, PHYSIOTHER CAN, V66, P91, DOI 10.3138/ptc.2012-45BC; Felson DT, 2000, ANN INTERN MED, V133, P635, DOI 10.7326/0003-4819-133-8-200010170-00016; Goff DC, 2014, CIRCULATION, V129, pS49, DOI 10.1161/01.cir.0000437741.48606.98; Heistaro S, 2008, METHODOLOGY REPORT H, V26; Heliovaara M, 1993, MUSCULOSKELETAL DIS, P35; Hirvonen T, 1997, EUR J CLIN NUTR, V51, P297, DOI 10.1038/sj.ejcn.1600397; Hosnijeh FS, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-0976-3; Hosnijeh FS, 2015, MATURITAS, V82, P36, DOI 10.1016/j.maturitas.2015.04.004; Kaila-Kangas L, 2007, MUSCULOSKELETAL DISO, V25; Kaila-Kangas L, 2011, OCCUP ENVIRON MED, V68, P734, DOI 10.1136/oem.2010.061390; Kerkhof HJM, 2010, ANN RHEUM DIS, V69, P1976, DOI 10.1136/ard.2009.125260; King DE, 2005, J AM COLL NUTR, V24, P166, DOI 10.1080/07315724.2005.10719461; Konstari S, 2012, SCAND J RHEUMATOL, V41, P124, DOI 10.3109/03009742.2011.617314; Konstari S, 2014, RHEUMATOLOGY, V53, P1778, DOI 10.1093/rheumatology/keu178; Kretsch MJ, 1999, J AM DIET ASSOC, V99, P300, DOI 10.1016/S0002-8223(99)00078-4; LEE J, 1981, J CHRON DIS, V34, P415, DOI 10.1016/0021-9681(81)90040-0; Li HZ, 2016, MATH PROBL ENG, V2016, DOI 10.1155/2016/9842607; Luhrmann PM, 2001, NUTRITION, V17, P912, DOI 10.1016/S0899-9007(01)00664-5; Lutomski JE, 2011, PUBLIC HEALTH NUTR, V14, P532, DOI 10.1017/S1368980010001801; Mak IT, 1997, MOL CELL BIOCHEM, V176, P35, DOI 10.1023/A:1006814609769; Malpuech-Brugere C, 2000, BBA-MOL BASIS DIS, V1501, P91, DOI 10.1016/S0925-4439(00)00018-1; Mannisto S, 1996, J CLIN EPIDEMIOL, V49, P401, DOI 10.1016/0895-4356(95)00551-X; Mazzuca SA, 2002, ARTHRITIS RHEUM-US, V46, P109, DOI 10.1002/1529-0131(200201)46:1<109::AID-ART10040>3.0.CO;2-O; McWilliams DF, 2011, OSTEOARTHR CARTILAGE, V19, P829, DOI 10.1016/j.joca.2011.02.016; Montonen J, 2008, SOCIODEMOGRAPHIC DIF, VB38; Olza J, 2017, NUTRIENTS, V9, DOI 10.3390/nu9020168; Paalanen L, 2006, J CLIN EPIDEMIOL, V59, P994, DOI 10.1016/j.jclinepi.2006.01.002; Pelletier JP, 2010, ANN RHEUM DIS, V69, P2095, DOI 10.1136/ard.2009.122002; Qin B, 2012, ARTHRIT CARE RES, V64, P1306, DOI 10.1002/acr.21708; Reinivuo H, 2010, PUBLIC HEALTH NUTR, V13, P915, DOI 10.1017/S1368980010001096; Richmond SA, 2013, J ORTHOP SPORT PHYS, V43, P515, DOI 10.2519/jospt.2013.4796; Sharif M, 2000, ANN RHEUM DIS, V59, P71, DOI 10.1136/ard.59.1.71; Smith JW, 2012, THER ADV MUSCULOSKEL, V4, P315, DOI 10.1177/1759720X12455959; Song YQ, 2005, DIABETES CARE, V28, P1438, DOI 10.2337/diacare.28.6.1438; Tam M, 2003, EUR J CLIN NUTR, V57, P1193, DOI 10.1038/sj.ejcn.1601689; Toivanen AT, 2007, SCAND J RHEUMATOL, V36, P58, DOI 10.1080/03009740600759886; Toivanen AT, 2010, RHEUMATOLOGY, V49, P308, DOI 10.1093/rheumatology/kep388; Weglicki W. B., 1996, Magnesium Research, V9, P3; WEGLICKI WB, 1992, AM J PHYSIOL, V263, pR734; Zeng C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127666; Zhang YF, 2016, ANN JOINT, V1, DOI 10.21037/aoj.2016.11.04; Zheng HQ, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007568	50	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2019	14	3							e0214064	10.1371/journal.pone.0214064	http://dx.doi.org/10.1371/journal.pone.0214064			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ1KV	30908508	Green Published, Green Submitted, gold			2022-12-26	WOS:000462157600030
J	Lohr, D; Terekhov, M; Weng, AM; Schroeder, A; Walles, H; Schreiber, LM				Lohr, David; Terekhov, Maxim; Weng, Andreas Max; Schroeder, Anja; Walles, Heike; Schreiber, Laura Maria			Spin echo based cardiac diffusion imaging at 7T: An ex vivo study of the porcine heart at 7T and 3T	PLOS ONE			English	Article							TO-NOISE RATIO; CARDIOVASCULAR MAGNETIC-RESONANCE; IN-VIVO; TENSOR MRI; FIBER-ORIENTATION; LEFT-VENTRICLE; MICROSTRUCTURE; ARCHITECTURE; BRAIN; QUANTIFICATION	Purpose of this work was to assess feasibility of cardiac diffusion tensor imaging (cDTI) at 7 T in a set of healthy, unfixed, porcine hearts using various parallel imaging acceleration factors and to compare SNR and derived cDTI metrics to a reference measured at 3 T. Magnetic resonance imaging was performed on 7T and 3T whole body systems using a spin echo diffusion encoding sequence with echo planar imaging readout. Five reference (b = 0 s/mm(2)) images and 30 diffusion directions (b = 700 s/mm(2)) were acquired at both 7 T and 3 T using a GRAPPA acceleration factor R = 1. Scans at 7 T were repeated using R = 2, R = 3, and R = 4. SNR evaluation was based on 30 reference (b = 0 s/mm 2) images of 30 slices of the left ventricle and cardiac DTI metrics were compared within AHA segmentation. The number of hearts scanned at 7 T and 3 T was n = 11. No statistically significant differences were found for evaluated helix angle, secondary eigenvector angle, fractional anisotropy and apparent diffusion coefficient at the different field strengths, given sufficiently high SNR and geometrically undistorted images. R >= 3 was needed to reduce susceptibility induced geometric distortions to an acceptable amount. On average SNR in myocardium of the left ventricle was increased from 29 +/- 3 to 44 +/- 6 in the reference image (b = 0 s/mm(2)) when switching from 3 T to 7 T. Our study demonstrates that high resolution, ex vivo cDTI is feasible at 7 T using commercial hardware.	[Lohr, David; Terekhov, Maxim; Schreiber, Laura Maria] Univ Hosp Wuerzburg, CHFC, Chair Cellular & Mol Imaging, Wurzburg, Germany; [Weng, Andreas Max] Univ Wurzburg, Dept Diagnost & Intervent Radiol, Wurzburg, Germany; [Schroeder, Anja] Univ Hosp Wuerzburg, Chair Tissue Engn & Regenerat Med TERM, Wurzburg, Germany; [Walles, Heike] Fraunhofer Inst Silicate Res ISC, Translat Ctr Regenerat Therapies TLC RT, Wurzburg, Germany	University of Wurzburg; University of Wurzburg; University of Wurzburg; Fraunhofer Gesellschaft	Lohr, D (corresponding author), Univ Hosp Wuerzburg, CHFC, Chair Cellular & Mol Imaging, Wurzburg, Germany.	e_lohr_d@ukw.de	Weng, Andreas Max/H-5564-2019; Schreiber, Laura M./E-1902-2011	Schreiber, Laura M./0000-0002-8827-1838; Lohr, David/0000-0002-6509-3776; Weng, Andreas Max/0000-0001-8943-3539	German Ministry of Education and Research [01EO1004, 01EO1504]; German Research Foundation (DFG); University of Wuerzburg	German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wuerzburg	This work was supported by the German Ministry of Education and Research (grant numbers 01EO1004, 01EO1504). This publication was funded by the German Research Foundation (DFG) and the University of Wuerzburg in the funding programme Open Access Publishing.	Bastin ME, 1998, MAGN RESON IMAGING, V16, P773, DOI 10.1016/S0730-725X(98)00098-8; Breuer FA, 2009, MAGN RESON MED, V62, P739, DOI 10.1002/mrm.22066; Cerqueira MD, 2002, CIRCULATION, V105, P539, DOI 10.1161/hc0402.102975; Chang EY, 2014, J MAGN RESON IMAGING, V40, P496, DOI 10.1002/jmri.24360; Choi S, 2011, MAGN RESON IMAGING, V29, P739, DOI 10.1016/j.mri.2011.02.009; Deoni SCL, 2003, MAGNET RESON MED, V49, P515, DOI 10.1002/mrm.10407; Dibb R, 2017, MAGN RESON MED, V77, P2331, DOI 10.1002/mrm.26321; Dou JG, 2002, MAGNET RESON MED, V48, P105, DOI 10.1002/mrm.10188; Ennis DB, 2005, MAGNET RESON MED, V53, P169, DOI 10.1002/mrm.20318; Ferreira PF, 2014, J CARDIOVASC MAGN R, V16, DOI 10.1186/s12968-014-0087-8; Gahm JK, 2014, MED IMAGE ANAL, V18, P197, DOI 10.1016/j.media.2013.10.009; Gamper U, 2007, MAGN RESON MED, V57, P331, DOI 10.1002/mrm.21127; GREENBAUM RA, 1981, BRIT HEART J, V45, P248; Hales PW, 2011, NMR BIOMED, V24, P836, DOI 10.1002/nbm.1629; Helm P, 2005, ANN NY ACAD SCI, V1047, P296, DOI 10.1196/annals.1341.026; Helm PA, 2005, MAGN RESON MED, V54, P850, DOI 10.1002/mrm.20622; Hsu EW, 1998, AM J PHYSIOL-HEART C, V274, pH1627, DOI 10.1152/ajpheart.1998.274.5.H1627; Jiang HY, 2006, COMPUT METH PROG BIO, V81, P106, DOI 10.1016/j.cmpb.2005.08.004; Juchem C, 2015, NEUROIMAGE, V105, P462, DOI 10.1016/j.neuroimage.2014.11.011; KANAI A, 1995, CIRC RES, V77, P784, DOI 10.1161/01.RES.77.4.784; Kohler S, 2003, MAGN RESON MED, V50, P1144, DOI 10.1002/mrm.10636; Kohler S, 2003, J MAGN RESON, V161, P252, DOI 10.1016/S1090-7807(03)00013-2; Kohler S, 2003, MAGNET RESON MED, V49, P371, DOI 10.1002/mrm.10346; Kung GL, 2011, J MAGN RESON IMAGING, V34, P1080, DOI 10.1002/jmri.22725; Landman BA, 2008, MAGN RESON IMAGING, V26, P790, DOI 10.1016/j.mri.2008.01.034; LeGrice IJ, 1995, AM J PHYSL, V269; Lelovas PP, 2014, J AM ASSOC LAB ANIM, V53, P432; Lohr D, 2017, P 25 ANN M ISMRM HON, P1841; Manjon JV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073021; Mazumder R, 2016, J MED IMAGING RADIAT, V47, P74, DOI 10.1016/j.jmir.2015.10.007; McClymont D, 2017, J CARDIOVASC MAGN R, V19, DOI 10.1186/s12968-017-0395-x; McGill LA, 2012, J CARDIOVASCULAR MAG, V14; Mekkaoui C, 2017, RADIOLOGY, V282, P850, DOI 10.1148/radiol.2016152613; Nielles-Vallespin S, 2017, J AM COLL CARDIOL, V69, P661, DOI 10.1016/j.jacc.2016.11.051; Nielles-Vallespin S, 2013, MAGN RESON MED, V70, P454, DOI 10.1002/mrm.24488; Ohliger MA, 2003, MAGNET RESON MED, V50, P1018, DOI 10.1002/mrm.10597; Pashakhanloo F, 2017, J CARDIOVASC MAGN R, V19, DOI 10.1186/s12968-016-0317-3; Reeder SB, 2005, MAGNET RESON MED, V54, P748, DOI 10.1002/mrm.20636; Robson PM, 2008, MAGN RESON MED, V60, P895, DOI 10.1002/mrm.21728; Schmid P, 2005, EUR J CARDIO-THORAC, V27, P468, DOI 10.1016/j.ejcts.2004.11.036; Schuppert M, 2015, P 23 ANN M ISMRM TOR, P1779; Scollan DF, 1998, AM J PHYSIOL-HEART C, V275, pH2308, DOI 10.1152/ajpheart.1998.275.6.H2308; Scott AD, 2016, NMR BIOMED, V29, P588, DOI 10.1002/nbm.3500; Scott AD, 2015, MAGN RESON MED, V74, P420, DOI 10.1002/mrm.25418; Skare S, 2000, J MAGN RESON, V147, P340, DOI 10.1006/jmre.2000.2209; STREETER DD, 1969, CIRC RES, V24, P339, DOI 10.1161/01.RES.24.3.339; Terekhov M, 2017, P 25 ANN M ISMRM HON, P1841; Tseng WI, 1999, MAGNET RESON MED, V42, P393, DOI 10.1002/(SICI)1522-2594(199908)42:2<393::AID-MRM22>3.0.CO;2-F; Tseng WYI, 2003, J MAGN RESON IMAGING, V17, P31, DOI 10.1002/jmri.10223; von Deuster C, 2016, MAGN RESON MED, V76, P862, DOI 10.1002/mrm.25998; Vu AT, 2015, NEUROIMAGE, V122, P318, DOI 10.1016/j.neuroimage.2015.08.004; WALDMAN LK, 1988, CIRC RES, V63, P550, DOI 10.1161/01.RES.63.3.550; Watson B., 2012, P 20 ANN M ISMRM MEL, V8, P1114; Wu EX, 2007, MAGN RESON MED, V58, P687, DOI 10.1002/mrm.21350; Yeh FC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080713	55	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2019	14	3							e0213994	10.1371/journal.pone.0213994	http://dx.doi.org/10.1371/journal.pone.0213994			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ1KV	30908510	Green Published, gold, Green Submitted			2022-12-26	WOS:000462157600028
J	Scantlebery, AML; Uil, M; Butter, LM; Poelman, R; Claessen, N; Girardin, SE; Florquin, S; Roelofs, JJTH; Leemans, JC				Scantlebery, Angelique M. L.; Uil, Melissa; Butter, Loes M.; Poelman, Renee; Claessen, Nike; Girardin, Stephen E.; Florquin, Sandrine; Roelofs, Joris J. T. H.; Leemans, Jaklien C.			NLRX1 does not play a role in diabetes nor the development of diabetic nephropathy induced by multiple low doses of streptozotocin	PLOS ONE			English	Article							NF-KAPPA-B; OXIDATIVE STRESS; TNF-ALPHA; TYPE-1; PATHOGENESIS; INFLAMMATION; PROGRESSION; RECEPTORS; TARGETS; MICE	Diabetic nephropathy (DN) is a microvascular complication of diabetes mellitus that results in both tubular and glomerular injury. Low-grade inflammation and oxidative stress are two mechanisms known to drive the progression of DN. Nucleotide-binding leucine-rich repeat containing family member X1 (NLRX1) is an innate immune receptor, uniquely located in mitochondria, that has been found to regulate inflammatory responses and to dampen renal oxidative stress by regulating oxidative phosphorylation. For this reason, we investigated the role of NLRX1 in the development of DN in a Type 1 Diabetes mouse model. We analyzed the effect of NLRX1 deficiency on diabetes development and the accompanied renal damage, inflammation, and fibrosis. We found that multiple low doses of streptozotocin induced body weight loss, polydipsia, hyperglycemia, glycosuria, and a mild DN phenotype in wildtype and NLRX1-deficient mice, without significant differences between these mouse strains. Despite increased NLRX1 expression in diabetic wildtype mice, NLRX1 deficiency did not affect the diabetic phenotype induced by streptozotocin treatment, as reflected by similar levels of polyuria, microalbuminuria, and increased renal markers of oxidative stress and inflammation in wildtype and NLRX1-deficient mice. The present findings show that NLRX1 does not mediate the development of streptozotocin-induced diabetes and diabetic-induced nephropathy in mice after multiple low doses of streptozotocin. This data implies that, while NLRX1 can be triggered by cellular stress, its regulatory and functional effects may be dependent on the specific physiological conditions. In the case of DN, NLRX1 may be neither helpful nor harmful, but rather a marker of metabolic stress.	[Scantlebery, Angelique M. L.; Uil, Melissa; Butter, Loes M.; Poelman, Renee; Claessen, Nike; Florquin, Sandrine; Roelofs, Joris J. T. H.; Leemans, Jaklien C.] Univ Amsterdam, Acad Med Ctr, Dept Pathol, Amsterdam, Netherlands; [Girardin, Stephen E.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada	University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Toronto	Scantlebery, AML (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Pathol, Amsterdam, Netherlands.	a.m.scantlebery@amc.uva.nl	Leemans, Jaklien/AAM-4958-2020	Scantlebery, Angelique/0000-0001-9303-6042; Roelofs, Joris/0000-0001-9595-6571; Florquin, Sandrine/0000-0002-9676-1722	ZonMW MKMD [40-42600-98-219]; Netherlands Organization for Scientific Research [91712386]; Netherlands Organisation for Health Research and Development (Clinical Fellowship) [40-00703-97-12480]; Dutch Kidney Foundation [KJP10.017]	ZonMW MKMD; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Netherlands Organisation for Health Research and Development (Clinical Fellowship); Dutch Kidney Foundation	Angelique Scantlebery was supported by ZonMW MKMD grant#40-42600-98-219 (https://www.zonmw.nl/en/), and JCL was supported by The Netherlands Organization for Scientific Research (Vidi grant# 91712386; https://www.nwo.nl/en). This work was also supported by The Netherlands Organisation for Health Research and Development (Clinical Fellowship grant #40-00703-97-12480, awarded to J.J.T.H. Roelofs), and by the Dutch Kidney Foundation (grant #KJP10.017, awarded to J.J.T.H. Roelofs; https://www.nierstichting.nl/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnoult D, 2009, J CELL SCI, V122, P3161, DOI 10.1242/jcs.051193; Arora MK, 2014, CURR DRUG TARGETS, V15, P531, DOI 10.2174/1389450115666140321120635; Brosius FC, 2009, J AM SOC NEPHROL, V20, P2503, DOI 10.1681/ASN.2009070721; Chatzantoni K, 2006, CURR TOP MED CHEM, V6, P1707, DOI 10.2174/156802606778194217; Costford SR, 2018, J ENDOCR SOC, V2, P336, DOI 10.1210/js.2017-00360; Ha H, 1999, DIABETES RES CLIN PR, V45, P147, DOI 10.1016/S0168-8227(99)00044-3; Kashihara N, 2010, CURR MED CHEM, V17, P4256, DOI 10.2174/092986710793348581; Kelly KJ, 2010, AM J NEPHROL, V32, P469, DOI 10.1159/000320749; Kors L, 2018, BBA-MOL BASIS DIS, V1864, P1883, DOI 10.1016/j.bbadis.2018.03.003; Lee LF, 2005, P NATL ACAD SCI USA, V102, P15995, DOI 10.1073/pnas.0508122102; Leemans JC, 2014, NAT REV NEPHROL, V10, P398, DOI 10.1038/nrneph.2014.91; Lin M, 2012, J AM SOC NEPHROL, V23, P86, DOI 10.1681/ASN.2010111210; Maharjan AS, 2010, FIBROGENESIS TISSUE, V3, DOI 10.1186/1755-1536-3-23; Mezzano S, 2004, NEPHROL DIAL TRANSPL, V19, P2505, DOI 10.1093/ndt/gfh207; Mills EL, 2016, EUR J IMMUNOL, V46, P13, DOI 10.1002/eji.201445427; Moore CB, 2008, NATURE, V451, P573, DOI 10.1038/nature06501; Mudaliar H, 2014, CLIN SCI, V126, P685, DOI 10.1042/CS20130267; Najafian B, 2009, DIABETES RES CLIN PR, V83, P1, DOI 10.1016/j.diabres.2008.08.024; O'Neill LAJ, 2016, CELL REP, V17, P625, DOI 10.1016/j.celrep.2016.09.085; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Rich P, 2003, MOL MACHINERY KEILIN; Ruggenenti P, 2000, NEPHROL DIAL TRANSPL, V15, P1900, DOI 10.1093/ndt/15.12.1900; Saraheimo M, 2003, DIABETOLOGIA, V46, P1402, DOI 10.1007/s00125-003-1194-5; Shen Garry X., 2012, Cardiovascular & Hematological Disorders - Drug Targets, V12, P106; Singh B, 2010, WORLD J DIABETES, V1, P36, DOI 10.4239/wjd.v1.i2.36; Soares F, 2013, INNATE IMMUN-LONDON, V19, P438, DOI 10.1177/1753425912467383; Stokman G, 2017, J EXP MED, V214, P2405, DOI 10.1084/jem.20161031; Tattoli I, 2008, EMBO REP, V9, P293, DOI 10.1038/sj.embor.7401161; Toyama T, 2014, CLIN EXP NEPHROL, V18, P201, DOI 10.1007/s10157-013-0898-1; Uil M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23839-9; Yamahara K, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/193757; YANG XD, 1994, J EXP MED, V180, P995, DOI 10.1084/jem.180.3.995	32	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2019	14	3							e0214437	10.1371/journal.pone.0214437	http://dx.doi.org/10.1371/journal.pone.0214437			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ1KV	30908533	gold, Green Published, Green Submitted			2022-12-26	WOS:000462157600068
J	Johnson, T; Payne, S; Grove, R; McCarthy, S; Oeltjen, E; Mach, C; Adamec, J; Wilson, MA; Van Cott, K; Blum, P				Johnson, Tyler; Payne, Sophie; Grove, Ryan; McCarthy, Samuel; Oeltjen, Erin; Mach, Collin; Adamec, Jiri; Wilson, Mark A.; Van Cott, Kevin; Blum, Paul			Methylation deficiency of chromatin proteins is a non-mutational and epigenetic-like trait in evolved lines of the archaeon Sulfolobus solfataricus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						archaea; epigenetics; chromatin modification; protein methylation; evolution; mass spectrometry (MS)	DNA-BINDING PROTEIN; LYSINE METHYLATION; SSO7D; ACETYLATION; SAC7D; CREN7; IDENTIFICATION; FLEXIBILITY; STABILITY; MECHANISM	Archaea are a distinct and deeply rooted lineage that harbor eukaryotic-like mechanisms, including several that manage chromosome function. In previous work, the thermoacidophilic crenarchaeon, Sulfolobus solfataricus, was subjected to adaptive laboratory evolution to produce three strains, called SARC, with a new heritable trait of super acid resistance. These strains acquired heritable conserved transcriptomes, yet one strain contained no mutations. Homologous recombination without allele replacement at SARC acid resistance genes caused changes in both phenotype and expression of the targeted gene. As recombination displaces chromatin proteins, their involvement was predicted in the SARC trait. Native chromatin proteins are basic and highly abundant and undergo post-translational modification through lysine monomethylation. In this work, their modification states were investigated. In all SARC lines, two chromatin proteins, Cren7 and Sso7d, were consistently undermethylated, whereas other chromatin proteins were unaltered. This pattern was heritable in the absence of selection and independent of transient exposure to acid stress. The bulk of Sso7d was undermethylated at three contiguous N-terminal lysine residues but not at central or C-terminal regions. The N-terminal region formed a solvent-exposed patch located on the opposite side of the binding domain associated with the DNA minor groove. By analogy to eukaryotic histones, this patch could interact with other chromosomal proteins and be modulated by differential post-translational modification. Previous work established an epigenetic-like mechanism of adaptation and inheritance in S. solfataricus. The identification of heritable epigenetic marks in this work further supports the occurrence of an epigenetic process in archaea.	[Johnson, Tyler; Payne, Sophie; McCarthy, Samuel; Oeltjen, Erin; Mach, Collin; Blum, Paul] Univ Nebraska, Sch Biol Sci, Beadle Ctr Genet, Lincoln, NE 68588 USA; [Grove, Ryan; Adamec, Jiri; Wilson, Mark A.] Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA; [Grove, Ryan; Adamec, Jiri; Wilson, Mark A.] Univ Nebraska, Redox Biol Ctr, Lincoln, NE 68588 USA; [Van Cott, Kevin] Univ Nebraska, Dept Chem & Biomol Engn, Lincoln, NE 68588 USA; [Blum, Paul] Univ Calif Santa Cruz, Dept Microbiol & Toxicol, Santa Cruz, CA 95064 USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; University of California System; University of California Santa Cruz	Blum, P (corresponding author), Univ Nebraska, Sch Biol Sci, Beadle Ctr Genet E234, 1901 Vine St, Lincoln, NE 68588 USA.	pblum1@unl.edu			National Science Foundation [MCB-1517408]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grant MCB-1517408 (to P. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Agresti A, 2003, CURR OPIN GENET DEV, V13, P170, DOI 10.1016/S0959-437X(03)00023-6; Ball LJ, 1997, EMBO J, V16, P2473, DOI 10.1093/emboj/16.9.2473; BAUMANN H, 1994, NAT STRUCT BIOL, V1, P808, DOI 10.1038/nsb1194-808; Bell SD, 2002, SCIENCE, V296, P148, DOI 10.1126/science.1070506; Bewley CA, 1998, ANNU REV BIOPH BIOM, V27, P105, DOI 10.1146/annurev.biophys.27.1.105; Bianchi ME, 2005, CURR OPIN GENET DEV, V15, P496, DOI 10.1016/j.gde.2005.08.007; Biyani K, 2005, BIOCHEMISTRY-US, V44, P14217, DOI 10.1021/bi051266r; Cheung WL, 2000, CURR OPIN CELL BIOL, V12, P326, DOI 10.1016/S0955-0674(00)00096-X; CHOLI T, 1988, BIOCHIM BIOPHYS ACTA, V950, P193, DOI 10.1016/0167-4781(88)90011-5; Chu YD, 2012, J BACTERIOL, V194, P6917, DOI 10.1128/JB.01535-12; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; Cleynen I, 2008, INT J ONCOL, V32, P289; Couturier M, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00137; Cubonova L, 2005, J BACTERIOL, V187, P5482, DOI 10.1128/JB.187.15.5482-5485.2005; Dijk J., 1986, BACTERIAL CHROMATIN, P184; EDMONDSON SP, 1995, BIOCHEMISTRY-US, V34, P13289, DOI 10.1021/bi00041a004; Edmondson SP, 2001, METHOD ENZYMOL, V334, P129; Feng YG, 2010, PROTEIN SCI, V19, P1253, DOI 10.1002/pro.385; Forbes AJ, 2004, P NATL ACAD SCI USA, V101, P2678, DOI 10.1073/pnas.0306575101; Frasca F, 2006, CANCER RES, V66, P2980, DOI 10.1158/0008-5472.CAN-05-2637; Guagliardi A, 2000, J BIOL CHEM, V275, P31813, DOI 10.1074/jbc.M002122200; Guo L, 2008, NUCLEIC ACIDS RES, V36, P1129, DOI 10.1093/nar/gkm1128; Hamamoto R, 2015, NAT REV CANCER, V15, P110, DOI 10.1038/nrc3884; Hyun K, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2017.11; Jelinska C, 2005, STRUCTURE, V13, P963, DOI 10.1016/j.str.2005.04.016; Kahsai MA, 2005, BIOCHEMISTRY-US, V44, P2822, DOI 10.1021/bi047669t; KUBINYI H, 1991, ANAL CHIM ACTA, V247, P107, DOI 10.1016/S0003-2670(00)83059-7; Lee J, 2008, NAT STRUCT MOL BIOL, V15, P109, DOI 10.1038/nsmb1326; Lundback T, 1998, J MOL BIOL, V276, P775, DOI 10.1006/jmbi.1997.1558; Marino-Ramirez L, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar048; McCarthy S, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.00549-15; McCarthy S, 2016, APPL ENVIRON MICROB, V82, P857, DOI 10.1128/AEM.03225-15; Munshi N, 2001, SCIENCE, V293, P1133, DOI 10.1126/science.293.5532.1133; Najima Y, 2005, J BIOL CHEM, V280, P27523, DOI 10.1074/jbc.M414549200; Napoli A, 2002, NUCLEIC ACIDS RES, V30, P2656, DOI 10.1093/nar/gkf377; Payne S, 2018, P NATL ACAD SCI USA, V115, P12271, DOI 10.1073/pnas.1808221115; Robinson H, 1998, NATURE, V392, P202, DOI 10.1038/32455; ROLFSMEIER M, 1995, J BACTERIOL, V177, P482, DOI 10.1128/jb.177.2.482-485.1995; Sandman K, 2005, CURR OPIN MICROBIOL, V8, P656, DOI 10.1016/j.mib.2005.10.007; Sandman K, 2006, CURR OPIN MICROBIOL, V9, P520, DOI 10.1016/j.mib.2006.08.003; Schelert J, 2004, J BACTERIOL, V186, P427, DOI 10.1128/JB.186.2.427-437.2004; STERNER R, 1979, J BIOL CHEM, V254, P1577; Sun F, 2013, NUCLEIC ACIDS RES, V41, P8182, DOI 10.1093/nar/gkt588; Talbert PB, 2010, NAT REV MOL CELL BIO, V11, P264, DOI 10.1038/nrm2861; Teale MJ, 2003, ACTA CRYSTALLOGR D, V59, P1320, DOI 10.1107/S090744490301062X; Thomas JO, 2001, TRENDS BIOCHEM SCI, V26, P167, DOI 10.1016/S0968-0004(01)01801-1; TJIAN R, 1994, CELL, V77, P5, DOI 10.1016/0092-8674(94)90227-5; Wardleworth BN, 2002, EMBO J, V21, P4654, DOI 10.1093/emboj/cdf465; White MF, 2002, TRENDS GENET, V18, P621, DOI 10.1016/S0168-9525(02)02808-1; Xu D, 1997, PROTEIN ENG, V10, P999, DOI 10.1093/protein/10.9.999; Zhang JY, 2009, NUCLEIC ACIDS RES, V37, P1107, DOI 10.1093/nar/gkn1011; Zhang K, 2013, J PROTEOME RES, V12, P844, DOI 10.1021/pr300912q; Zhang QC, 2010, BBA-GENE REGUL MECH, V1799, P28, DOI 10.1016/j.bbagrm.2009.11.009; Zhang X, 2012, ACTA BIOCH BIOPH SIN, V44, P14, DOI 10.1093/abbs/gmr100; Zhang ZF, 2010, MOL MICROBIOL, V76, P749, DOI 10.1111/j.1365-2958.2010.07136.x; ZINDER SH, 1978, NATURE, V273, P226, DOI 10.1038/273226a0	56	7	7	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2019	294	19					7821	7832		10.1074/jbc.RA118.006469	http://dx.doi.org/10.1074/jbc.RA118.006469			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IB3FL	30918025	Green Published, hybrid			2022-12-26	WOS:000470153300024
J	Segawa, K; Tamura, N; Mima, J				Segawa, Kazuya; Tamura, Naoki; Mima, Joji			Homotypic and heterotypic trans-assembly of human Rab-family small GTPases in reconstituted membrane tethering	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						membrane reconstitution; membrane trafficking; Rab; small GTPase; liposome; endomembrane system; membrane tethering; RAB member RAS oncogene family; Ras superfamily; transport vesicle	FUSION; SPECIFICITY; PROTEINS; DOCKING; SNARES; ARF	Membrane tethering is a highly regulated event occurring during the initial physical contact between membrane-bounded transport carriers and their target subcellular membrane compartments, thereby ensuring the spatiotemporal specificity of intracellular membrane trafficking. Although Rab-family small GTPases and specific Rab-interacting effectors, such as coiled-coil tethering proteins and multisubunit tethering complexes, are known to be involved in membrane tethering, how these protein components directly act upon the tethering event remains enigmatic. Here, using a chemically defined reconstitution system, we investigated the molecular basis of membrane tethering by comprehensively and quantitatively evaluating the intrinsic capacities of 10 representative human Rab-family proteins (Rab1a, -3a, -4a, -5a, -6a, -7a, -9a, -11a, -27a, and -33b) to physically tether two distinct membranes via homotypic and heterotypic Rab-Rab assembly. All of the Rabs tested, except Rab27a, specifically caused homotypic membrane tethering at physiologically relevant Rab densities on membrane surfaces (e.g. Rab/lipid molar ratios of 1:100-1:3,000). Notably, endosomal Rab5a retained its intrinsic potency to drive efficient homotypic tethering even at concentrations below the Rab/lipid ratio of 1:3,000. Comprehensive reconstitution experiments further uncovered that heterotypic combinations of human Rab-family isoforms, including Rab1a/6a, Rab1a/9a, and Rab1a/33b, can directly and selectively mediate membrane tethering. Rab1a and Rab9a in particular synergistically triggered very rapid and efficient membrane tethering reactions through their heterotypic trans-assembly on two opposing membranes. In conclusion, our findings establish that, in the physiological context, homotypic and heterotypic trans-assemblies of Rab-family small GTPases can provide the essential molecular machinery necessary to drive membrane tethering in eukaryotic endomembrane systems.	[Segawa, Kazuya; Tamura, Naoki; Mima, Joji] Osaka Univ, Inst Prot Res, 3-2 Yamadaoka, Suita, Osaka 5650871, Japan	Osaka University	Mima, J (corresponding author), Osaka Univ, Inst Prot Res, 3-2 Yamadaoka, Suita, Osaka 5650871, Japan.	joji.mima@protein.osaka-u.ac.jp		Mima, Joji/0000-0002-0454-8669	Program to Disseminate Tenure Tracking System from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (MEXT); MEXT	Program to Disseminate Tenure Tracking System from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (MEXT); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by the Program to Disseminate Tenure Tracking System from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (MEXT) and Grants-in-Aid for Scientific Research from MEXT (to J. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Baker RW, 2016, NAT REV MOL CELL BIO, V17, P465, DOI 10.1038/nrm.2016.65; Bateman A, 2017, NUCLEIC ACIDS RES, V45, pD158, DOI 10.1093/nar/gkw1099; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Brunet S, 2014, TRAFFIC, V15, P1282, DOI 10.1111/tra.12200; Chia Pei Zhi Cheryl, 2014, F1000Prime Rep, V6, P74, DOI 10.12703/P6-74; Dennison SM, 2006, BIOPHYS J, V90, P1661, DOI 10.1529/biophysj.105.069617; Donaldson JG, 2011, NAT REV MOL CELL BIO, V12, P362, DOI 10.1038/nrm3117; Drin G, 2008, SCIENCE, V320, P670, DOI 10.1126/science.1155821; Erickson HP, 2009, BIOL PROCED ONLINE, V11, P32, DOI 10.1007/s12575-009-9008-x; Furukawa N, 2014, SCI REP-UK, V4, DOI 10.1038/srep04277; Grosshans BL, 2006, P NATL ACAD SCI USA, V103, P11821, DOI 10.1073/pnas.0601617103; Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105; Hernandez JM, 2014, P NATL ACAD SCI USA, V111, P12037, DOI 10.1073/pnas.1407435111; Hickey CM, 2010, MOL BIOL CELL, V21, P2297, DOI 10.1091/mbc.E10-01-0044; Ho RY, 2016, TRAFFIC, V17, P1078, DOI 10.1111/tra.12421; Ho RY, 2015, MOL BIOL CELL, V26, P2655, DOI 10.1091/mbc.E14-04-0922; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Inoshita M, 2017, J BIOL CHEM, V292, P18500, DOI 10.1074/jbc.M117.811356; Izawa R, 2012, J BIOL CHEM, V287, P3445, DOI 10.1074/jbc.M111.307439; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Ji H, 2010, BIOPHYS J, V99, P553, DOI 10.1016/j.bpj.2010.04.060; Khan AR, 2013, STRUCTURE, V21, P1284, DOI 10.1016/j.str.2013.06.016; Kuhlee A, 2015, FEBS LETT, V589, P2487, DOI 10.1016/j.febslet.2015.06.001; Lo SY, 2012, NAT STRUCT MOL BIOL, V19, P40, DOI 10.1038/nsmb.2162; Rojas AM, 2012, J CELL BIOL, V196, P189, DOI 10.1083/jcb.201103008; Mayer A, 1997, J CELL BIOL, V136, P307, DOI 10.1083/jcb.136.2.307; McNew JA, 2000, NATURE, V407, P153, DOI 10.1038/35025000; Mima Joji, 2018, Biophys Rev, V10, P543, DOI 10.1007/s12551-017-0358-3; MOORE I, 1995, TRENDS BIOCHEM SCI, V20, P10, DOI 10.1016/S0968-0004(00)88939-2; Murray DH, 2016, NATURE, V537, P107, DOI 10.1038/nature19326; Nagle JF, 2000, BBA-REV BIOMEMBRANES, V1469, P159, DOI 10.1016/S0304-4157(00)00016-2; Parlati F, 2002, P NATL ACAD SCI USA, V99, P5424, DOI 10.1073/pnas.082100899; Pereira-Leal JB, 2000, J MOL BIOL, V301, P1077, DOI 10.1006/jmbi.2000.4010; Pfeffer SR, 1999, NAT CELL BIOL, V1, pE17, DOI 10.1038/8967; Pylypenko Olena, 2018, Small GTPases, V9, P22, DOI 10.1080/21541248.2017.1336191; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Tamura N, 2014, BIOL OPEN, V3, P1108, DOI 10.1242/bio.20149340; Ungermann C, 1998, NATURE, V396, P543, DOI 10.1038/25069; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Waters MG, 2000, TRAFFIC, V1, P588, DOI 10.1034/j.1600-0854.2000.010802.x; Waters MG, 1999, CURR OPIN CELL BIOL, V11, P453, DOI 10.1016/S0955-0674(99)80065-9; Yu IM, 2010, ANNU REV CELL DEV BI, V26, P137, DOI 10.1146/annurev.cellbio.042308.113327; Zick M, 2014, ELIFE, V3, DOI 10.7554/eLife.01879	44	7	7	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2019	294	19					7722	7739		10.1074/jbc.RA119.007947	http://dx.doi.org/10.1074/jbc.RA119.007947			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IB3FL	30910814	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000470153300017
J	Nomoto, S; Kinno, R; Ochiai, H; Kubota, S; Mori, Y; Futamura, A; Sugimoto, A; Kuroda, T; Yano, S; Murakami, H; Shirasawa, T; Yoshimoto, T; Minoura, A; Kokaze, A; Ono, K				Nomoto, Shohei; Kinno, Ryuta; Ochiai, Hirotaka; Kubota, Satomi; Mori, Yukiko; Futamura, Akinori; Sugimoto, Azusa; Kuroda, Takeshi; Yano, Satoshi; Murakami, Hidetomo; Shirasawa, Takako; Yoshimoto, Takahiko; Minoura, Akira; Kokaze, Akatsuki; Ono, Kenjiro			The relationship between thyroid function and cerebral blood flow in mild cognitive impairment and Alzheimer's disease	PLOS ONE			English	Article							STIMULATING HORMONE; ASSOCIATION WORKGROUPS; DIAGNOSTIC GUIDELINES; NATIONAL INSTITUTE; DEMENTIA; RISK; SPECT; RECOMMENDATIONS; HYPOTHYROIDISM; QUANTIFICATION	The thyroid hormones have been reported to be associated with cognitive decline and Alzheimer's disease. The relationship between thyroid function within the normal range and cerebral blood flow in Alzheimer's disease patients has been shown in a recent study. Mild cognitive impairment is often the first stage of Alzheimer's disease; thus, early diagnosis is important. The present study investigated the relationship between thyroid function and regional cerebral blood flow in patients with mild cognitive impairment and Alzheimer's disease. A total of 122 memory clinic outpatients who underwent thyroid function testing and single photon emission computed tomography were divided into mild cognitive impairment, Alzheimer's disease, and Normal groups. Regional cerebral blood flow was calculated using a three-dimensional stereotactic region of interest template in an automated cerebral perfusion single photon emission computed tomography analysis system. Multiple regression analysis adjusted for age and sex was conducted to examine the relationships between thyroid hormones and regional cerebral blood flow. Thyroid stimulating hormone was significantly associated with regional cerebral blood flow in the bilateral temporal, bilateral pericallosal, and bilateral hippocampal regions in the mild cognitive impairment group. In the Alzheimer's disease group, free triiodothyronine was significantly associated with regional cerebral blood flow in the bilateral parietal, right temporal, and bilateral pericallosal regions. The present study showed the association of thyroid stimulating hormone with regional cerebral blood flow in the mild cognitive impairment group and the association of free triiodothyronine with regional cerebral blood flow in the Alzheimer's disease group. These study findings could contribute to the early diagnosis of mild cognitive impairment at general memory clinics and the prevention of subsequent progression to Alzheimer's disease.	[Nomoto, Shohei; Kinno, Ryuta; Kubota, Satomi; Mori, Yukiko; Futamura, Akinori; Sugimoto, Azusa; Kuroda, Takeshi; Yano, Satoshi; Murakami, Hidetomo; Ono, Kenjiro] Showa Univ, Sch Med, Dept Med, Div Neurol, Tokyo, Japan; [Nomoto, Shohei; Ochiai, Hirotaka; Shirasawa, Takako; Yoshimoto, Takahiko; Minoura, Akira; Kokaze, Akatsuki] Showa Univ, Sch Med, Dept Hyg Publ Hlth & Prevent Med, Tokyo, Japan	Showa University; Showa University	Ono, K (corresponding author), Showa Univ, Sch Med, Dept Med, Div Neurol, Tokyo, Japan.	onoken@med.showa-u.ac.jp	Minoura, Akira/AAM-4103-2021	Minoura, Akira/0000-0002-9805-508X				Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Annerbo Sylvia, 2006, Am J Alzheimers Dis Other Demen, V21, P182, DOI 10.1177/1533317506289282; Chiaravalloti A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06138-7; Davis Jennifer Duncan, 2008, Curr Aging Sci, V1, P175; de Jong FJ, 2009, NEUROBIOL AGING, V30, P600, DOI 10.1016/j.neurobiolaging.2007.07.019; Devanand DP, 2010, AM J GERIAT PSYCHIAT, V18, P959, DOI 10.1097/JGP.0b013e3181ec8696; Edman A, 2011, DEMENT GER COGN D EX, V1, P228, DOI 10.1159/000329447; Etgen T, 2011, DTSCH ARZTEBL INT, V108, P743, DOI 10.3238/arztebl.2011.0743; Forti P, 2012, GERONTOLOGY, V58, P41, DOI 10.1159/000324522; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; Gan EH, 2012, J CLIN ENDOCR METAB, V97, P3438, DOI 10.1210/jc.2012-2284; Haji M, 2015, DEMENT GERIATR COGN, V39, P360, DOI 10.1159/000375298; Ito K, 2014, INT J GERIATR PSYCH, V29, P1079, DOI 10.1002/gps.4102; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Kimura N, 2011, ALZ DIS ASSOC DIS, V25, P138, DOI 10.1097/WAD.0b013e3181f9aff2; Kobayashi S, 2008, J NEUROL SCI, V264, P27, DOI 10.1016/j.jns.2007.07.015; Li YH, 2013, J INVEST MED, V61, P578, DOI [10.231/JIM.0b013e318280aafb, 10.2310/JIM.0b013e318280aafb]; Luo LG, 2002, J ALZHEIMERS DIS, V4, P97, DOI 10.3233/JAD-2002-4204; Marangell LB, 1997, AM J PSYCHIAT, V154, P224; MATSUDA H, 1995, EUR J NUCL MED, V22, P633, DOI 10.1007/BF01254564; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Mitchell AJ, 2009, ACTA PSYCHIAT SCAND, V119, P252, DOI 10.1111/j.1600-0447.2008.01326.x; Nitrini R, 2000, ACTA NEUROL SCAND, V101, P172, DOI 10.1034/j.1600-0404.2000.101003172.x; Ojala AK, 2016, AGE AGEING, V45, P155, DOI 10.1093/ageing/afv160; Parsaik AK, 2014, JAMA NEUROL, V71, P201, DOI 10.1001/jamaneurol.2013.5402; Pasqualetti G, 2015, J CLIN ENDOCR METAB, V100, P4240, DOI 10.1210/jc.2015-2046; Prinz PN, 1999, J GERONTOL A-BIOL, V54, pM111, DOI 10.1093/gerona/54.3.M111; SCHEINBERG P, 1950, J CLIN INVEST, V29, P1139, DOI 10.1172/JCI102351; SENSENBACH W, 1954, J CLIN INVEST, V33, P1434, DOI 10.1172/JCI103021; Takeuchi R, 2003, NEUROL MED-CHIR, V43, P153, DOI 10.2176/nmc.43.153; Takeuchi Ryo, 2003, Nihon Hoshasen Gijutsu Gakkai Zasshi, V59, P1462; THOMAS DR, 1987, ACTA PSYCHIAT SCAND, V76, P158, DOI 10.1111/j.1600-0447.1987.tb02879.x; van Osch LADM, 2004, NEUROLOGY, V62, P1967, DOI 10.1212/01.WNL.0000128134.84230.9F; Winkler A, 2016, J ALZHEIMERS DIS, V49, P797, DOI 10.3233/JAD-150561	34	18	18	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0214676	10.1371/journal.pone.0214676	http://dx.doi.org/10.1371/journal.pone.0214676			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR5NS	30943231	gold, Green Published, Green Submitted			2022-12-26	WOS:000463194300051
J	Platt, EL; Romero, DM				Platt, Edward L.; Romero, Daniel M.			Towards attack tolerant networks: Concurrent multipath routing and the butterfly network	PLOS ONE			English	Article							CENSORSHIP; SECURITY	It is crucial for large-scale communication networks such as the internet to be resilient against attacks such as censorship and surveillance, which pose a threat to free expression and free association. Self-organized networks such as the internet's router network typically have heavy-tailed degree distributions, making them highly vulnerable to targeted attacks against central nodes. While cryptographic solutions exist, they fail to address the underlying topological problem, and remain vulnerable to man-in-the-middle attacks and coercion. Coercion-resistant, topological approaches to attack tolerance are needed to address the current vulnerability of communications infrastructure to censorship and surveillance. We present a novel concurrent multipath routing (CMR) algorithm for the wraparound butterfly network topology, as well as a highly attack-tolerant Structured Multipath Fault Tolerance (SMFT) architecture which incorporates the butterfly CMR algorithm. We also identify a previously unexplored relationship between network topology, trust transitivity, and attack-tolerance, and provide a framework for further exploration of this relationship. Our work is the first theoretical demonstration of a point-to-point communication network architecture that can resist coercion and other non-technical attacks, without requiring infinitely transitive trust. To address cases where the network structure cannot be fully controlled, we demonstrate how a snapshot of the internet's router network can be partially rewired for greater attack-tolerance. More broadly, we hope that this work will serve as a starting point for the evelopment of additional topology-based attack-tolerant communication architectures to guard against the dangers of censorship and surveillance.	[Platt, Edward L.; Romero, Daniel M.] Univ Michigan, Sch Informat, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Platt, EL (corresponding author), Univ Michigan, Sch Informat, Ann Arbor, MI 48109 USA.	elplatt@umich.edu		Platt, Edward/0000-0003-2148-3841	NSF [IIS-1617820]	NSF(National Science Foundation (NSF))	This work was supported by the NSF under Grant No. IIS-1617820 to DMR. There was no additional external funding received for this study.	Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Alrajeh NA, 2013, INT J DISTRIB SENS N, V2013; Avizienis A, 2004, IEEE T DEPEND SECURE, V1, P11, DOI 10.1109/TDSC.2004.2; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barabasi AL, 2009, SCIENCE, V325, P412, DOI 10.1126/science.1173299; Baran P, 1964, RAND CORPORATION RES, VI-XI, P637; Blakley G. R., 1979, P AFIPS 1979 NAT COM, P313, DOI [DOI 10.1109/MARK.1979.8817296, 10.1109/MARK.1979.8817296]; Castro M, 1999, USENIX ASSOCIATION PROCEEDINGS OF THE THIRD SYMPOSIUM ON OPERATING SYSTEMS DESIGN AND IMPLEMENTATION (OSDI '99), P173, DOI 10.1145/571637.571640; Christianson B., 1997, Security Protocols. International Workshop Proceedings, P171; Clarke I, 2001, LECT NOTES COMPUTER, P46, DOI [DOI 10.1007/3-540-44702-4_4, DOI 10.1007/3-540-44702-4]; Dainotti A., 2011, P 2011 ACM SIGCOMM C, P1, DOI DOI 10.1145/2068816.2068818; Dingledine R., 2004, DTIC DOCUMENT; Dwork C., 1993, Advances in Cryptology - CRYPTO '92. 12th Annual International Cryptology Conference Proceedings, P139; Ellison C., 2000, Computer Security Journal, V16, P1; Elmer-Dewitt P., 1993, TIME, V142, P62; Fiat A, 2002, SIAM PROC S, P94; Grewal GS, 2013, P IEEE S SECUR PRIV, P367, DOI 10.1109/SP.2013.32; Hunter P, 2008, COMPUT FRAUD SECUR, P10, DOI 10.1016/S1361-3723(08)70065-4; Khalil I, 2010, AD HOC NETW, V8, P148, DOI 10.1016/j.adhoc.2009.06.002; Khiani SR, 2013, IJACR, V3, P374; Kleinberg J., 2000, Proceedings of the Thirty Second Annual ACM Symposium on Theory of Computing, P163, DOI 10.1145/335305.335325; Kohno E, 2012, J COMPUT SYST SCI, V78, P1703, DOI 10.1016/j.jcss.2011.10.018; Korzun D, 2013, STRUCTURED PEER TO P; Kshemkalyani A.D., 2011, DISTRIB COMPUT, DOI DOI 10.1017/CBO9780511805318; LAMPORT L, 1982, ACM T PROGR LANG SYS, V4, P382, DOI 10.1145/357172.357176; Leskovec J., 2005, P 11 ACM SIGKDD INT, P177, DOI 10.1145/1081870.1081893; Levien R, 2009, HUM-COMPUT INT-SPRIN, P121, DOI 10.1007/978-1-84800-356-9_5; Liu AF, 2012, IEEE T VEH TECHNOL, V61, P3255, DOI 10.1109/TVT.2012.2205284; Lou W, 2006, IEEE T VEH TECHNOL, V55, P1320, DOI 10.1109/TVT.2006.877707; Lua EK, 2005, IEEE COMMUN SURV TUT, V7, P72, DOI 10.1109/COMST.2005.1610546; Mohr LB, 1982, EXPLAINING ORG BEHAV; Nakamoto S., 2008, CONSULTED, V1, P28; Nayak GN, 2010, INT CONF COMP SCI, P491, DOI 10.1109/ICCSIT.2010.5563900; Nickerson JV, 2010, COGSCI, V36; Poulsen K, 2013, WIRED; Qadir J, 2015, IEEE COMMUN SURV TUT, V17, P2176, DOI 10.1109/COMST.2015.2453941; Reiter MK, 1998, IEEE T COMPUT, V47, P1351, DOI 10.1109/12.737682; Richters O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018384; SHAMIR A, 1979, COMMUN ACM, V22, P612, DOI 10.1145/359168.359176; Stellar D., 2015, CONSENSUS PROTOCOL F; Sterbenz JPG, 2010, COMPUT NETW, V54, P1245, DOI 10.1016/j.comnet.2010.03.005; Von Neumann J., 1956, AUTOM STUD, V34, P43, DOI DOI 10.1515/9781400882618-003; Walker DC, 2012, MASS NOTIFICATION AND CRISIS COMMUNICATIONS: PLANNING, PREPAREDNESS, AND SYSTEMS, P1; Xu XY, 2011, LECT NOTES COMPUT SC, V6579, P133, DOI 10.1007/978-3-642-19260-9_14; Zhang H, 2002, IEEE INFOCOM SER, P1228, DOI 10.1109/INFCOM.2002.1019373; Zimmermann P.R., 1995, OFFICIAL PGP USERS G; Zin SM, 2015, J NETW COMPUT APPL, V55, P123, DOI 10.1016/j.jnca.2015.04.018	47	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0214292	10.1371/journal.pone.0214292	http://dx.doi.org/10.1371/journal.pone.0214292			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR5NS	30943216	Green Published, gold, Green Submitted			2022-12-26	WOS:000463194300033
J	Scott, EM; Arnold, C; Dowell, S; Suchodolski, JS				Scott, Erin M.; Arnold, Carolyn; Dowell, Samantha; Suchodolski, Jan S.			Evaluation of the bacterial ocular surface microbiome in clinically normal horses before and after treatment with topical neomycin-polymyxin-bacitracin	PLOS ONE			English	Article							GREENGENES; FLORA	Next generation sequencing (NGS) studies have demonstrated a rich and diverse ocular surface-associated microbiota in people that was previously undetected by traditional culture-based methods. The ocular surface microbiome of horses has yet to be investigated using NGS techniques. This study aimed to determine the bacterial composition of the ocular surface microbiome in healthy horses, and to identify whether there are microbial community changes over time and following topical antibiotic use. One eye of 12 horses was treated 3 times daily for 1 week with neomycin-polymyxin-bacitracin ophthalmic ointment. Contralateral eyes served as untreated controls. The inferior conjunctival fornix of both eyes was sampled at baseline prior to initiating treatment (day 0), after 1 week of treatment (day 7), and 4 weeks after concluding treatment (day 35). Genomic DNA was extracted from ocular surface swabs and sequenced using primers that target the V4 region of bacterial 16S rRNA. At baseline, the most abundant phyla identified were Proteobacteria (46.1%), Firmi-cutes (24.6%), Actinobacteria (12.6%), and Bacteroidetes (11.2%). The most abundant families included Pasteurellaceae (13.7%), Sphingomonadaceae (7.9%), an unclassified Order of Cardiobacteriales (7.7%), and Moraxellaceae (4.8%). Alpha and beta diversity measurements were unchanged in both treatment and control eyes over time. Overall, the major bacterial taxa on the equine ocular surface remained stable over time and following topical antibiotic therapy.	[Scott, Erin M.; Dowell, Samantha; Suchodolski, Jan S.] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Small Anim Clin Sci, College Stn, TX 77843 USA; [Arnold, Carolyn] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Large Anim Clin Sci, College Stn, TX USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Scott, EM (corresponding author), Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Small Anim Clin Sci, College Stn, TX 77843 USA.	escott@cvm.tamu.edu		Dowell, Samantha/0000-0002-9808-5115; Scott, Erin/0000-0002-9702-7298				Andrew SE, 2003, VET OPHTHALMOL, V6, P45, DOI 10.1046/j.1463-5224.2003.00265.x; [Anonymous], 2018, PEER J PREPRINTS; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Doan T, 2016, INVEST OPHTH VIS SCI, V57, P5116, DOI 10.1167/iovs.16-19803; Dong QF, 2011, INVEST OPHTH VIS SCI, V52, P5408, DOI 10.1167/iovs.10-6939; Gemensky-Metzler AJ, 2005, AM J VET RES, V66, P800, DOI 10.2460/ajvr.2005.66.800; Hampson ECGM, 2018, VET OPHTHALMOL; Huang Y, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2016.04.008; Johns IC, 2011, VET OPHTHALMOL, V14, P195, DOI 10.1111/j.1463-5224.2010.00867.x; Karacal Humeyra, 2007, International Ophthalmology, V27, P251, DOI 10.1007/s10792-007-9068-3; Kugadas Abirami, 2016, Ocul Surf, V14, P342, DOI 10.1016/j.jtos.2016.04.004; Langdon A, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0294-z; Leis ML, 2019, VET OPHTHALMOL, V22, P337, DOI 10.1111/vop.12599; Lu Louise J., 2016, Yale Journal of Biology and Medicine, V89, P325; McDermott AM, 2013, EXP EYE RES, V117, P53, DOI 10.1016/j.exer.2013.07.014; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; MOORE CP, 1983, J AM VET MED ASSOC, V182, P600; MOORE CP, 1995, J AM VET MED ASSOC, V207, P928; MOORE CP, 1988, AM J VET RES, V49, P773; Ozkan J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10494-9; Sandmeyer LS, 2017, AM J VET RES, V78, P207, DOI 10.2460/ajvr.78.2.207; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Tyler AD, 2014, AM J GASTROENTEROL, V109, P983, DOI 10.1038/ajg.2014.73; Weese SJ, 2015, VET RES, V46, DOI 10.1186/s13567-014-0140-5; Whitley R. D., 1983, Equine Veterinary Journal, P138; WHITLEY RD, 1984, VET CLIN N AM-LARGE, V6, P451; Willcox MDP, 2013, EXP EYE RES, V117, P99, DOI 10.1016/j.exer.2013.06.003; Zakrzewski M, 2017, BIOINFORMATICS, V33, P782, DOI 10.1093/bioinformatics/btw725; Zegans ME, 2014, AM J OPHTHALMOL, V158, P420, DOI 10.1016/j.ajo.2014.06.014	31	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0214877	10.1371/journal.pone.0214877	http://dx.doi.org/10.1371/journal.pone.0214877			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR5NS	30943258	Green Published, gold, Green Submitted			2022-12-26	WOS:000463194300066
J	Hogestol, EA; Nygaard, GO; Alnaes, D; Beyer, MK; Westlye, LT; Harbo, HF				Hogestol, Einar August; Nygaard, Gro Owren; Alnaes, Dag; Beyer, Mona K.; Westlye, Lars T.; Harbo, Hanne Flinstad			Symptoms of fatigue and depression is reflected in altered default mode network connectivity in multiple sclerosis	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY; COGNITIVE IMPAIRMENT; DYSFUNCTION; ROBUST; SCALE; LINK; SEGMENTATION; DAMAGE	Background Fatigue and depression are frequent and often co-occurring symptoms in multiple sclerosis (MS). Resting-state functional magnetic resonance imaging (rs-fMRI) represents a promising tool for disentangling differential associations between depression and fatigue and brain network function and connectivity. In this study we tested for associations between symptoms of fatigue and depression and DMN connectivity in patients with MS. Materials and methods Seventy-four MS patients were included on average 14 months after diagnosis. They underwent MRI scanning of the brain including rs-fMRI, and symptoms of fatigue and depression were assessed with Fatigue Severity Scale (FSS) and Beck Depression Inventory II (BDI). A principal component analysis (PCA) on FSS and BDI scores was performed, and the component scores were analysed using linear regression models to test for associations with default mode network (DMN) connectivity. Results We observed higher DMN connectivity with higher scores on the primary principal component reflecting common symptom burden for fatigue and depression (Cohen's f(2) = 0.075, t = 2.17, p = 0.03). The secondary principal component reflecting a pattern of low fatigue scores with high scores of depression was associated with lower DMN connectivity (Cohen's f(2) = 0.067, t = -2.1, p = 0.04). Using continuous mean scores of FSS we also observed higher DMN connectivity with higher symptom burden (t = 3.1, p = 0.003), but no significant associations between continuous sum scores of BDI and DMN connectivity (t = 0.8, p = 0.4). Conclusion Multivariate decomposition of FSS and BDI data supported both overlapping and unique manifestation of fatigue and depression in MS patients. Rs-fMRI analyses showed that symptoms of fatigue and depression were reflected in altered DMN connectivity, and that higher DMN activity was seen in MS patients with fatigue even with low depression scores.	[Hogestol, Einar August; Harbo, Hanne Flinstad] Univ Oslo, Inst Clin Med, Dept Neurol, Oslo, Norway; [Nygaard, Gro Owren; Harbo, Hanne Flinstad] Oslo Univ Hosp, Dept Neurol, Oslo, Norway; [Alnaes, Dag; Westlye, Lars T.] Univ Oslo, NORMENT, Div Mental Hlth & Addict, Oslo Univ Hosp, Oslo, Norway; [Alnaes, Dag; Westlye, Lars T.] Univ Oslo, Inst Clin Med, Oslo, Norway; [Beyer, Mona K.] Oslo Univ Hosp, Dept Radiol & Nucl Med, Oslo, Norway; [Westlye, Lars T.] Univ Oslo, Dept Psychol, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo	Hogestol, EA (corresponding author), Univ Oslo, Inst Clin Med, Dept Neurol, Oslo, Norway.	einar.august@gmail.com		Westlye, Lars T./0000-0001-8644-956X; Hogestol, Einar August/0000-0001-8446-2111	Research Council of Norway [240102]; South-Eastern Regional Health Authorities of Norway [2011059/ES563338/Biotek 2021]	Research Council of Norway(Research Council of Norway); South-Eastern Regional Health Authorities of Norway	The project was supported by grants (Principal Investigator for both grants: HFH) from The Research Council of Norway (https://www.forskningsradet.no/en/Home_page/1177315753906) (grant number 240102) and the South-Eastern Regional Health Authorities of Norway (https://www.helse-sorost.no/south-eastern-norway-regional-health-authority) (grant number 2011059/ES563338/Biotek 2021) (Principal Investigator for both grants: HFH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Arnett P, 2005, MULT SCLER J, V11, P328, DOI 10.1191/1352458505ms1162oa; Basile B, 2014, MULT SCLER J, V20, P1050, DOI 10.1177/1352458513515082; Beck A.T., 1996, PSYCHOL ASSESS, V10, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Bisecco A, 2018, MULT SCLER J, V24, P1696, DOI 10.1177/1352458517730932; Bisecco A, 2016, MULT SCLER J, V22, P1676, DOI 10.1177/1352458516628331; Bonavita S, 2017, EUR J NEUROL, V24, P27, DOI 10.1111/ene.13112; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Gomez AJC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077914; Cruz-Gomez AJ, 2014, MULT SCLER J, V20, P338, DOI 10.1177/1352458513495584; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Damangir S, 2012, J NEUROL SCI, V322, P211, DOI 10.1016/j.jns.2012.07.064; Damoiseaux JS, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.06.024; de la Cruz MH, 2018, MULT SCLER J, V24, P1183, DOI 10.1177/1352458517717807; Feinstein A, 2014, NAT REV NEUROL, V10, P507, DOI 10.1038/nrneurol.2014.139; Filippi M, 2019, NEUROIMAGE, V190, P32, DOI 10.1016/j.neuroimage.2017.09.021; Finke C, 2015, MULT SCLER J, V21, P925, DOI 10.1177/1352458514555784; Gobbi C, 2014, MULT SCLER J, V20, P1633, DOI 10.1177/1352458514530022; Goodin DS, 2014, HAND CLINIC, V122, P231, DOI 10.1016/B978-0-444-52001-2.00010-8; Griffanti L, 2014, NEUROIMAGE, V95, P232, DOI 10.1016/j.neuroimage.2014.03.034; Hampson JP, 2015, NEUROIMAGE-CLIN, V8, P305, DOI 10.1016/j.nicl.2015.04.022; Hanken K, 2016, MULT SCLER RELAT DIS, V6, P81, DOI 10.1016/j.msard.2016.02.005; Janardhan V, 2002, J NEUROL SCI, V205, P51, DOI 10.1016/S0022-510X(02)00312-X; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Kaiser RH, 2015, JAMA PSYCHIAT, V72, P603, DOI 10.1001/jamapsychiatry.2015.0071; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Lerdal A, 2007, EUR J NEUROL, V14, P1338, DOI 10.1111/j.1468-1331.2007.01974.x; Nickerson LD, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00115; Nygaard GO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135974; Nygaard GO, 2015, MULT SCLER J, V21, P402, DOI 10.1177/1352458514543811; Penner IK, 2017, NAT REV NEUROL, DOI [10.1038/nrneurol.2017.117, DOI 10.1038/NRNEUROL.2017.117]; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Pruim RHR, 2015, NEUROIMAGE, V112, P267, DOI 10.1016/j.neuroimage.2015.02.064; Reuter M, 2012, NEUROIMAGE, V61, P1402, DOI 10.1016/j.neuroimage.2012.02.084; Rocca MA, 2010, NEUROLOGY, V74, P1252, DOI 10.1212/WNL.0b013e3181d9ed91; Rocca MA, 2014, RADIOLOGY, V273, P511, DOI 10.1148/radiol.14140417; Rocca MA, 2012, NEUROLOGY, V79, P1449, DOI 10.1212/WNL.0b013e31826d5f10; Sbardella E, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/212693; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 1997, INT J COMPUT VISION, V23, P45, DOI 10.1023/A:1007963824710; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Sundgren M, 2013, ARCH CLIN NEUROPSYCH, V28, P144, DOI 10.1093/arclin/acs113	44	12	14	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2019	14	4							e0210375	10.1371/journal.pone.0210375	http://dx.doi.org/10.1371/journal.pone.0210375			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR1CY	30933977	gold, Green Published, Green Submitted			2022-12-26	WOS:000462867000003
J	Cullen, M; Jacob, ME; Cornish, V; VanderSchel, IQ; Cotter, HV; Cubeta, MA; Carbone, I; Gilger, BC				Cullen, Megan; Jacob, Megan E.; Cornish, Vicki; VanderSchel, Ian Q.; Cotter, Henry Van T.; Cubeta, Marc A.; Carbone, Ignazio; Gilger, Brian C.			Multi-locus DNA sequence analysis, antifungal agent susceptibility, and fungal keratitis outcome in horses from Southeastern United States	PLOS ONE			English	Article							EQUINE ULCERATIVE KERATOMYCOSIS; IN-VITRO SUSCEPTIBILITY; ASPERGILLUS-FLAVUS; FUSARIUM KERATITIS; PHYLOGENETIC DIVERSITY; SOUTH-INDIA; BACTERIAL; SNAP; IDENTIFICATION; INFECTIONS	Morphological characterization and multi-locus DNA sequence analysis of fungal isolates obtained from 32 clinical cases of equine fungal keratitis (FK) was performed to identify species and determine associations with antifungal susceptibility, response to therapy and clinical outcome. Two species of Aspergillus (A. flavus and A. fumigatus) and three species of Fusarium (F. falciforme, F. keratoplasticum, and F. proliferatum) were the most common fungi isolated and identified from FK horses. Most (91%) equine FK Fusarium nested within the Fusarium so/anispecies complex (FSSC) with nine genetically diverse strains/lineages, while 83% of equine FK Aspergillus nested within the A. flavus Glade with three genetically diverse lineages. Fungal species and evolutionary lineage were not associated with clinical outcome. However, species of equine FK Fusarium were more likely (p = 0.045) to be associated with stromal keratitis. Species of Aspergillus were more susceptible to voriconazole and terbinafine than species of Fusarium, while species of Fusarium were more susceptible to thiabendazole than species of Aspergillus. At the species level, A. fumigatus and A. flavus were more susceptible to voriconazole and terbinafine than F. falciforme. Natamycin susceptibility was higher for F. falciforme and A. fumigatus compared to A. flavus. Furthermore, F. falciforme was more susceptible to thiabendazole than A. flavus and A. fumigatus. These observed associations of antifungal sensitivity to natamycin, terbinafine, and thiabendazole demonstrate the importance of fungal identification to the species rather than genus level. The results of this study suggest that treatment of equine FK with antifungal agents requires accurate fungal species identification.	[Cullen, Megan; Gilger, Brian C.] NC State Univ, Dept Clin Sci, Raleigh, NC 27695 USA; [Jacob, Megan E.] NC State Univ, Dept Populat Hlth & Pathobiol, Raleigh, NC USA; [Cornish, Vicki; VanderSchel, Ian Q.; Cotter, Henry Van T.; Cubeta, Marc A.; Carbone, Ignazio] NC State Univ, Coll Agr & Life Sci, Ctr Integrated Fungal Res, Raleigh, NC USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Gilger, BC (corresponding author), NC State Univ, Dept Clin Sci, Raleigh, NC 27695 USA.	bgilger@ncsu.edu	Cornish, Vicki/AAW-9370-2020; Gilger, Brian/D-8776-2014	Cornish, Vicki/0000-0001-6253-7266; Gilger, Brian/0000-0002-7771-9166; Cullen, Megan/0000-0003-2651-3798	NC State University College of Agricultural and Life Sciences; NC State University College of Veterinary Medicine; Agriculture and Food Research Initiative Competitive Grants Program from the USDA National Institute of Food and Agriculture (NIFA) [2013-68004-20359]; National Science Foundation (NSF) Genealogy of Life (GoLife) program [DEB-1541418]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI052080] Funding Source: NIH RePORTER	NC State University College of Agricultural and Life Sciences; NC State University College of Veterinary Medicine; Agriculture and Food Research Initiative Competitive Grants Program from the USDA National Institute of Food and Agriculture (NIFA); National Science Foundation (NSF) Genealogy of Life (GoLife) program(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	NC State University College of Agricultural and Life Sciences and the College of Veterinary Medicine provided seed funding. This work was partially supported by the Agriculture and Food Research Initiative Competitive Grants Program grant no. 2013-68004-20359 from the USDA National Institute of Food and Agriculture (NIFA) to IC. The development of T-BAS is supported by the National Science Foundation (NSF) Genealogy of Life (GoLife) program to IC (DEB-1541418). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew SE, 1998, EQUINE VET J, V30, P109, DOI 10.1111/j.2042-3306.1998.tb04469.x; Andrew SE, 2003, VET OPHTHALMOL, V6, P45, DOI 10.1046/j.1463-5224.2003.00265.x; Ashu EE, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00019-17; Aylor DL, 2006, BIOINFORMATICS, V22, P1399, DOI 10.1093/bioinformatics/btl136; Betbeze CM, 2006, AM J VET RES, V67, P1788, DOI 10.2460/ajvr.67.10.1788; Carbone I, 2017, BIOINFORMATICS, V33, P1160, DOI 10.1093/bioinformatics/btw808; Denis HM, 2004, VET CLIN N AM-EQUINE, V20, P361, DOI 10.1016/j.cveq.2004.04.012; Gajjar DU, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/605308; Geiser DM, 2000, FUNGAL GENET BIOL, V31, P169, DOI 10.1006/fgbi.2000.1215; Gower EW, 2010, OPHTHALMOLOGY, V117, P2263, DOI 10.1016/j.ophtha.2010.03.048; He D, 2011, INVEST OPHTH VIS SCI, V52, P2804, DOI 10.1167/iovs.10-5977; Homa M, 2013, MYCOSES, V56, P501, DOI 10.1111/myc.12062; Hua X, 2010, INVEST OPHTH VIS SCI, V51, P1517, DOI 10.1167/iovs.09-4348; James TY, 2006, NATURE, V443, P818, DOI 10.1038/nature05110; Katoh K, 2010, BIOINFORMATICS, V26, P1899, DOI 10.1093/bioinformatics/btq224; Koljalg U, 2013, MOL ECOL, V22, P5271, DOI 10.1111/mec.12481; Kredics L, 2015, MYCOSES, V58, P243, DOI 10.1111/myc.12306; KURTZMAN CP, 1986, MYCOLOGIA, V78, P955, DOI 10.2307/3807436; Lalitha P, 2012, CORNEA, V31, P662, DOI 10.1097/ICO.0b013e31823f8ae0; Ledbetter EC, 2017, VET CLIN N AM-EQUINE, V33, P583, DOI 10.1016/j.cveq.2017.08.001; Manikandan P, 2013, MYCOSES, V56, P26, DOI 10.1111/j.1439-0507.2012.02194.x; Mascarenhas J, 2014, AM J OPHTHALMOL, V157, P56, DOI 10.1016/j.ajo.2013.08.032; Mayer FL, 2013, VIRULENCE, V4, P119, DOI 10.4161/viru.22913; Miller MA, 2015, EVOL BIOINFORM, V11, P43, DOI 10.4137/EBO.S21501; Monacell JT, 2014, BIOINFORMATICS, V30, P1488, DOI 10.1093/bioinformatics/btu055; Moore GG, 2017, ECOL EVOL, V7, P9179, DOI 10.1002/ece3.3464; O'Donnell K, 2008, J CLIN MICROBIOL, V46, P2477, DOI 10.1128/JCM.02371-07; O'Donnell K, 2007, J CLIN MICROBIOL, V45, P2235, DOI 10.1128/JCM.00533-07; O'Donnell K, 2016, J CLIN MICROBIOL, V54, P2813, DOI 10.1128/JCM.01607-16; Oechsler RA, 2013, CORNEA, V32, P667, DOI 10.1097/ICO.0b013e318277ac74; Olarte RA, 2012, MOL ECOL, V21, P1453, DOI 10.1111/j.1365-294X.2011.05398.x; Paoletti M, 2005, CURR BIOL, V15, P1242, DOI 10.1016/j.cub.2005.05.045; Pearce JW, 2009, VET OPHTHALMOL, V12, P318, DOI 10.1111/j.1463-5224.2009.00721.x; Perez-Nadales E, 2014, FUNGAL GENET BIOL, V70, P42, DOI 10.1016/j.fgb.2014.06.011; Price EW, 2005, BIOINFORMATICS, V21, P402, DOI 10.1093/bioinformatics/bti003; Ramirez-Prado JH, 2008, FUNGAL GENET BIOL, V45, P1292, DOI 10.1016/j.fgb.2008.06.007; Reed Z, 2013, EQUINE VET J, V45, P361, DOI 10.1111/j.2042-3306.2012.00623.x; Rex JH, 2008, M38A2 CLSI, V28, pM38; Roy P, 2017, CLIN EPIDEMIOL GLOB, V5, P40, DOI 10.1016/j.cegh.2016.02.001; Sherman AB, 2017, VET OPHTHALMOL, V20, P140, DOI 10.1111/vop.12381; Sousa ES, 2017, PLANT DIS, V101, P1954, DOI 10.1094/PDIS-05-17-0657-PDN; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Tupaki-Sreepurna A, 2017, MYCOSES, V60, P230, DOI 10.1111/myc.12578; Utter ME, 2009, EQUINE VET EDUC, V21, P321, DOI 10.2746/095777309X400270; VILGALYS R, 1990, CURR GENET, V18, P277, DOI 10.1007/BF00318394; Voelter-Ratson K, 2013, EQUINE VET J, V45, P608, DOI 10.1111/evj.12042; Wada S, 2013, VET OPHTHALMOL, V16, P1, DOI 10.1111/j.1463-5224.2012.01004.x; Walther G, 2017, J CLIN MICROBIOL, V55, P2983, DOI 10.1128/JCM.00649-17; Wicklow Donald T., 2002, Mycoscience, V43, P289, DOI 10.1007/s102670200043; Zeiss C, 2013, VET OPHTHALMOL, V16, P341, DOI 10.1111/vop.12004; Zhang N, 2006, J CLIN MICROBIOL, V44, P2186, DOI 10.1128/JCM.00120-06	51	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214214	10.1371/journal.pone.0214214	http://dx.doi.org/10.1371/journal.pone.0214214			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921394	gold, Green Submitted, Green Published			2022-12-26	WOS:000462594000042
J	Canbay, A; Kalsch, J; Neumann, U; Rau, M; Hohenester, S; Baba, HA; Rust, C; Geier, A; Heider, D; Sowa, JP				Canbay, Ali; Kaelsch, Julia; Neumann, Ursula; Rau, Monika; Hohenester, Simon; Baba, Hideo A.; Rust, Christian; Geier, Andreas; Heider, Dominik; Sowa, Jan-Peter			Non-invasive assessment of NAFLD as systemic disease-A machine learning perspective	PLOS ONE			English	Article							FATTY LIVER-DISEASE; CLINICAL SCORING SYSTEM; NONALCOHOLIC STEATOHEPATITIS; HEPATOCELLULAR-CARCINOMA; FIBROSIS; DIAGNOSIS; BIOPSY; PROGRESSION; ADIPONECTIN; VALIDATION	Background & aims Current non-invasive scores for the assessment of severity of non-alcoholic fatty liver disease (NAFLD) and identification of patients with non-alcoholic steatohepatitis (NASH) have insufficient performance to be included in clinical routine. In the current study, we developed a novel machine learning approach to overcome the caveats of existing approaches. Methods Non-invasive parameters were selected by an ensemble feature selection (EFS) from a retrospectively collected training cohort of 164 obese individuals (age: 43.5 +/- 10.3y; BMI: 54.1 +/- 10.1kg/m(2)) to develop a model able to predict the histological assessed NAFLD activity score (NAS). The model was evaluated in an independent validation cohort (122 patients, age: 45.2 +/- 11.75y, BMI: 50.8 +/- 8.61kg/m(2)). Results EFS identified age, yGT, HbA1c, adiponectin, and M30 as being highly associated with NAFLD. The model reached a Spearman correlation coefficient with the NAS of 0.46 in the training cohort and was able to differentiate between NAFL (NAS <= 4) and NASH (NAS>4) with an AUC of 0.73. In the independent validation cohort, an AUC of 0.7 was achieved for this separation. We further analyzed the potential of the new model for disease monitoring in an obese cohort of 38 patients under lifestyle intervention for one year. While all patients lost weight under intervention, increasing scores were observed in 15 patients. Increasing scores were associated with significantly lower absolute weight loss, lower reduction of waist circumference and basal metabolic rate. Conclusions A newly developed model (http://CHek.heiderlab.de) can predict presence or absence of NASH with reasonable performance. The new score could be used to detect NASH and monitor disease progression or therapy response to weight loss interventions.	[Canbay, Ali; Sowa, Jan-Peter] Otto von Guericke Univ, Dept Gastroenterol Hepatol & Infect Dis, Magdeburg, Germany; [Kaelsch, Julia; Sowa, Jan-Peter] Univ Duisburg Essen, Univ Hosp, Dept Gastroenterol & Hepatol, Essen, Germany; [Kaelsch, Julia; Baba, Hideo A.] Univ Duisburg Essen, Univ Hosp, Inst Pathol, Essen, Germany; [Neumann, Ursula; Heider, Dominik] Univ Marburg, Dept Math & Comp Sci, Marburg, Germany; [Rau, Monika; Geier, Andreas] Univ Hosp Wurzburg, Dept Internal Med 2, Div Hepatol, Wurzburg, Germany; [Hohenester, Simon] Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Med 2, Munich, Germany; [Rust, Christian] Hosp Barmherzige Bruder, Dept Med 1, Ctr Nutr Med & Prevent, Munich, Germany	Otto von Guericke University; University of Duisburg Essen; University of Duisburg Essen; Philipps University Marburg; University of Wurzburg; University of Munich	Canbay, A (corresponding author), Otto von Guericke Univ, Dept Gastroenterol Hepatol & Infect Dis, Magdeburg, Germany.	al.canbay@med.ovgu.de	Sowa, Jan-Peter/AAQ-6318-2020; Canbay, Ali/AAL-9620-2020; Heider, Dominik/F-8545-2010	Heider, Dominik/0000-0002-3108-8311	University of Duisburg-Essen (IFORES); Deutsche Forschungsgemeinschaft [RU 742/6-1]; Faculty of Medicine of the University of Munich, LMU (FoFoLe) [905]	University of Duisburg-Essen (IFORES); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Faculty of Medicine of the University of Munich, LMU (FoFoLe)	This work was supported by intramural research funds of the Medical Faculty of the University of Duisburg-Essen (IFORES) to JK, by the Deutsche Forschungsgemeinschaft (RU 742/6-1 to CR) and the Faculty of Medicine of the University of Munich, LMU (FoFoLe #905 to SH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhouri N, 2016, METABOLISM, V65, P1087, DOI 10.1016/j.metabol.2016.01.013; Angulo P, 2007, HEPATOLOGY, V45, P846, DOI 10.1002/hep.21496; Angulo P, 2015, GASTROENTEROLOGY, V149, P389, DOI 10.1053/j.gastro.2015.04.043; Anstee QM, 2013, NAT REV GASTRO HEPAT, V10, P330, DOI 10.1038/nrgastro.2013.41; Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; AWMF, DETAIL; Bedossa P, 2012, HEPATOLOGY, V56, P1751, DOI 10.1002/hep.25889; Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992; Bissonnette J, 2017, HEPATOLOGY, V66, P555, DOI 10.1002/hep.29080; Byrne CD, 2015, J HEPATOL, V62, pS47, DOI 10.1016/j.jhep.2014.12.012; de Abreu VG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180947; Dechene A, 2014, GASTROINTEST ENDOSC, V80, P626, DOI 10.1016/j.gie.2014.02.1028; Gholam PM, 2007, AM J GASTROENTEROL, V102, P399, DOI 10.1111/j.1572-0241.2006.01041.x; Grassmann S, 2017, OBESITY, V25, P1776, DOI 10.1002/oby.21945; Guha IN, 2008, HEPATOLOGY, V47, P455, DOI 10.1002/hep.21984; Harrison SA, 2008, GUT, V57, P1441, DOI 10.1136/gut.2007.146019; Hohenester S, 2018, AM J PHYSIOL-GASTR L, V315, pG329, DOI 10.1152/ajpgi.00044.2018; Joka D, 2012, HEPATOLOGY, V55, P455, DOI 10.1002/hep.24734; Kalsch J, 2016, Z GASTROENTEROL, V54, P1312, DOI 10.1055/s-0042-121899; Kalsch J, 2011, J NUTR METAB, V2011, DOI 10.1155/2011/369168; Karlas T, 2017, GASTROENTEROLOGY, V152, P479, DOI 10.1053/j.gastro.2016.12.013; Kalsch J, 2015, SCI REP-UK, V5, DOI 10.1038/srep13058; Kim CH, 2008, CLEV CLIN J MED, V75, P721, DOI 10.3949/ccjm.75.10.721; Kleiner DE, 2016, CLIN LIVER DIS, V20, P293, DOI 10.1016/j.cld.2015.10.011; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Machado MV, 2013, J HEPATOL, V58, P1007, DOI 10.1016/j.jhep.2012.11.021; Marengo A, 2016, CLIN LIVER DIS, V20, P313, DOI 10.1016/j.cld.2015.10.010; Neumann U, 2017, BIODATA MIN, V10, DOI 10.1186/s13040-017-0142-8; Neumann U, 2016, BIODATA MIN, V9, DOI 10.1186/s13040-016-0114-4; Owei I, 2017, BMJ OPEN DIAB RES CA, V5, DOI 10.1136/bmjdrc-2017-000415; Palekar NA, 2006, LIVER INT, V26, P151, DOI 10.1111/j.1478-3231.2005.01209.x; Poynard T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030325; Ratziu V, 2005, GASTROENTEROLOGY, V128, P1898, DOI 10.1053/j.gastro.2005.03.084; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Rockey DC, 2009, HEPATOLOGY, V49, P1017, DOI 10.1002/hep.22742; Saadeh S, 2002, GASTROENTEROLOGY, V123, P745, DOI 10.1053/gast.2002.35354; Shah AG, 2009, CLIN GASTROENTEROL H, V7, P1104, DOI 10.1016/j.cgh.2009.05.033; Siddiqui MS, 2013, GASTROENTEROLOGY, V145, P1271, DOI 10.1053/j.gastro.2013.08.036; Silva TE, 2014, DIABETES METAB, V40, P95, DOI 10.1016/j.diabet.2013.11.004; Starley BQ, 2010, HEPATOLOGY, V51, P1820, DOI 10.1002/hep.23594; Sumida Y, 2011, J GASTROENTEROL, V46, P257, DOI 10.1007/s00535-010-0305-6; Tapper EB, 2017, NEW ENGL J MED, V377, P756, DOI 10.1056/NEJMra1610570; Tapper EB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147237; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; Wree A, 2014, METABOLISM, V63, P1542, DOI 10.1016/j.metabol.2014.09.001; Younossi ZM, 2017, HEPATOLOGY, V66, p9A; Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431; Younossi ZM, 2011, OBES SURG, V21, P431, DOI 10.1007/s11695-010-0204-1	48	34	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2019	14	3							e0214436	10.1371/journal.pone.0214436	http://dx.doi.org/10.1371/journal.pone.0214436			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ3IW	30913263	Green Published, gold, Green Submitted			2022-12-26	WOS:000462305600060
J	Ghosh, S; Spielman, K; Kershaw, M; Ayele, K; Kidane, Y; Zillmer, K; Wentworth, L; Pokharel, A; Griffiths, JK; Belachew, T; Kennedy, E				Ghosh, Shibani; Spielman, Kathryn; Kershaw, Meghan; Ayele, Kidane; Kidane, Yitbarek; Zillmer, Krista; Wentworth, Leslie; Pokharel, Ashish; Griffiths, Jeffrey K.; Belachew, Tefera; Kennedy, Eileen			Nutrition-specific and nutrition-sensitive factors associated with mid-upper arm circumference as a measure of nutritional status in pregnant Ethiopian women: Implications for programming in the first 1000 days	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; DIETARY DIVERSITY; INTERVENTIONS; DETERMINANTS	Poor nutritional status in pregnancy expressed as low mid-upper arm circumference (MUAC) is associated with low birth weight. The study aims were to assess the nutritional status of pregnant Ethiopian women using MUAC and examine association with nutrition-specific and nutrition-sensitive factors, using baseline data of a prospective longitudinal observational birth cohort study conducted in three rural districts in the Oromia region of Ethiopia. Recruitment into the cohort was rolling over a period of nine months, and the data used for this analysis were collected while the women were between 12-32 weeks of gestation. Detailed household socio-demographics, agricultural production, women's health, morbidity and diets, with weights, heights and MUAC, and anemia prevalence (HemoCue) were collected. The prevalence of low MUAC (< 23 cm) was 41%. Controlling for location and clustering, wealth quintile (OR = 0.88, CI = 0.82 to 0.96, p<0.01) was associated with decreased risk of low MUAC, while trimester (OR = 1.31, CI =1.16 to 1.48, p<0.001) was associated with increased risk of low MUAC. The only significant factor amenable to nutrition-specific interventions was altitude-adjusted anemia, which was associated with increased risk of low MUAC (OR = 1.28, CI = 1.09 to 1.49, p<0.01). Significant factors amenable to nutrition-sensitive factors and associated with higher odds of low MUAC were household food insecurity (OR = 1.04, CI = 1.02 to 1.06, p<0.001), distance to the clinic in minutes (OR = 1.01, CI = 1.0 to 1.01, p<0.0001) and season of recruitment (lean versus non lean) (OR = 1.30, CI = 1.10 to 1.54, p<0.01). Literacy (OR = 0.85, CI = 0.74 to 0.98, p<0.05) and numeracy (OR = 0.75, CI = 0.62 to 0.91, p<0.01) were also significantly associated with lower odds of low MUAC. Poor nutritional status in pregnancy expressed as percent with low MUAC was high in Ethiopian women. It was associated with several nutrition-specific and -sensitive factors indicating the importance of multisectoral actions in improving outcomes within the first 1000 days.	[Ghosh, Shibani; Spielman, Kathryn; Kershaw, Meghan; Ayele, Kidane; Kidane, Yitbarek; Zillmer, Krista; Wentworth, Leslie; Pokharel, Ashish; Griffiths, Jeffrey K.; Kennedy, Eileen] Tufts Univ, Friedman Sch Nutr Sci & Policy, Boston, MA 02111 USA; [Ghosh, Shibani] Nevin Scrimshaw Int Nutr Fdn, Boston, MA 02111 USA; [Griffiths, Jeffrey K.] Tufts Univ, Sch Med, Boston, MA 02111 USA; [Belachew, Tefera] Jimma Univ, Jimma, Ethiopia; [Pokharel, Ashish] Helen Keller Int, Kathmandu, Nepal	Tufts University; Tufts University; Jimma University	Ghosh, S (corresponding author), Tufts Univ, Friedman Sch Nutr Sci & Policy, Boston, MA 02111 USA.; Ghosh, S (corresponding author), Nevin Scrimshaw Int Nutr Fdn, Boston, MA 02111 USA.	Shibani.Ghosh@tufts.edu	Belachew, Tefera/AAO-5877-2020	Ghosh, Shibani/0000-0001-5893-6774	American people through the United States Agency for International Development (USAID) [AID-663-A-11-00017]; USAID Feed the Future Innovation Lab for Nutrition [AID-OAA-L-1-00006]	American people through the United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); USAID Feed the Future Innovation Lab for Nutrition(United States Agency for International Development (USAID))	This research is made possible by the support of the American people through the United States Agency for International Development (USAID) under Agreement No. AID-663-A-11-00017 and the USAID Feed the Future Innovation Lab for Nutrition under Agreement No. AID-OAA-L-1-00006). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abdiwahab Hashi, 2016, Open Journal of Preventive Medicine, V6, P233; Adebowale Ayo Stephen, 2015, BMC Res Notes, V8, P34, DOI 10.1186/s13104-015-1001-7; Alene KA, 2014, ANEMIA, V2014, DOI 10.1155/2014/561567; Assefa N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039957; Benova L, 2014, TROP MED INT HEALTH, V19, P368, DOI 10.1111/tmi.12275; Bhutta ZA, 2013, LANCET, V382, P452, DOI 10.1016/S0140-6736(13)60996-4; Bilinsky P., 2010, MONTHS ADEQUATE HOUS; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Busse H, 2017, AFRICAN J FOOD AGR N, V17, P12227; Coates J., 2007, FOOD NUTR TECHNICAL, DOI 10.1007/s13398-014-0173-7.2; Cohen J H, 1999, Rev Panam Salud Publica, V6, P392; CSA E International I., 2016, ETH DEM HLTH SURV 20; CSA E International I., 2012, ETH DEM HLTH SURV 20; Deribew A, 2016, POPUL HEALTH METR, V14, DOI 10.1186/s12963-016-0112-2; Dillon A, 2015, J DEV STUD, V51, P976, DOI 10.1080/00220388.2015.1018902; Ethiopia Go, 2013, NAT NUTR PROGR; FHI 360/LINKAGES, 2016, MINIMUM DIETARY DIVE; Freisling H, 2006, J HUM NUTR DIET, V19, P437, DOI 10.1111/j.1365-277X.2006.00723.x; Ghosh S, 2014, FACTORS ASS STUNTING; Hirvonen K, 2017, WORLD DEV, V95, P303, DOI 10.1016/j.worlddev.2017.02.031; Hodinott J., 2011, 2020 C LEV AGR IMPR, P4; Katz J, 2010, MATERN CHILD NUTR, V6, P287, DOI 10.1111/j.1740-8709.2009.00211.x; Kiboi W., 2017, BMC NUTR, V3, P12, DOI DOI 10.1186/S40795-017-0126-6; KRAMER MS, 1987, B WORLD HEALTH ORGAN, V65, P663; Krasovec K, 1991, MATERNAL NUTR PREGNA; Moss William, 2002, J Perinatol, V22, P484; Neufeld LM, 2006, PAEDIATR PERINAT EP, V20, P290, DOI 10.1111/j.1365-3016.2006.00741.x; Ogbonna C, 2007, ACTA OBSTET GYN SCAN, V86, P26, DOI 10.1080/00016340600935664; Ojha N, 2007, JNMA J Nepal Med Assoc, V46, P52; Okwaraji YB, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1161-0; Roba KT, 2015, NUTRITION, V31, P1213, DOI 10.1016/j.nut.2015.03.007; Ruel MT, 2013, LANCET, V382, P536, DOI 10.1016/S0140-6736(13)60843-0; Rutstein S. O., 2004, DHS WEALTH INDEX; Saha KK, 2009, PUBLIC HEALTH NUTR, V12, P1556, DOI 10.1017/S1368980009004765; Savy M, 2006, J NUTR, V136, P2625, DOI 10.1093/jn/136.10.2625; Sebayang SK, 2012, TROP MED INT HEALTH, V17, P938, DOI 10.1111/j.1365-3156.2012.03039.x; Sen J, 2010, J TROP PEDIATRICS, V56, P254, DOI 10.1093/tropej/fmp102; Shaffner J., 2005, MEASURING LITERACYIN; Sibhatu KT, 2015, P NATL ACAD SCI USA, V112, P10657, DOI 10.1073/pnas.1510982112; Su Nutrition, 2016, ANN PROGR REP; Tang AM., 2016, DETERMINING GLOBAL M; Tarekegn SM, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-161; USAID, 2014, MULT NUTR STRAT 2014; Ververs MT, 2013, PLOS CURR, DOI [10.1371/currents.dis.54a8b618c1bc031ea140e3f2934599c8, DOI 10.1371/CURRENTS.DIS.54A8B618C1BC031EA140E3F2934599C8]; World Health Organization, 2016, GEN ASS PROCL DEC AC; World Health Organization, 2006, REP WHO TECHN CONS B; Young SL, 2014, MATERN CHILD HLTH J, V18, P2044, DOI 10.1007/s10995-014-1450-y; Zhang Q, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172406; Zillmer Krista, 2017, BMC Nutr, V3, P65, DOI 10.1186/s40795-017-0166-y	49	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2019	14	3							e0214358	10.1371/journal.pone.0214358	http://dx.doi.org/10.1371/journal.pone.0214358			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ3IW	30913234	Green Published, gold, Green Submitted			2022-12-26	WOS:000462305600048
J	Kim, H; Williams, D; Qiu, YN; Song, ZF; Yang, Z; Kimler, V; Goldberg, A; Zhang, R; Yang, ZQ; Chen, XQ; Wang, L; Fang, DY; Lin, JD; Zhang, KZ				Kim, Hyunbae; Williams, Dreana; Qiu, Yining; Song, Zhenfeng; Yang, Zhao; Kimler, Victoria; Goldberg, Andrew; Zhang, Ren; Yang, Zengquan; Chen, Xuequn; Wang, Li; Fang, Deyu; Lin, Jiandie D.; Zhang, Kezhong			Regulation of hepatic autophagy by stress-sensing transcription factor CREBH	FASEB JOURNAL			English	Article						stress response; transcriptional regulation; hepatic lipid homeostasis	ELEMENT-BINDING PROTEIN; ACTIVATED RECEPTOR-ALPHA; LIPID-METABOLISM; BIOGENESIS; EXPRESSION; CAMP; FAMILY	Autophagy, a lysosomal degradative pathway in response to nutrient limitation, plays an important regulatory role in lipid homeostasis upon energy demands. Here, we demonstrated that the endoplasmic reticulum-tethered, stress-sensing transcription factor cAMP-responsive element-binding protein, hepatic-specific (CREBH) functions as a major transcriptional regulator of hepatic autophagy and lysosomal biogenesis in response to nutritional or circadian signals. CREBH deficiency led to decreased hepatic autophagic activities and increased hepatic lipid accumulation upon starvation. Under unfed or during energy-demanding phases of the circadian cycle, CREBH is activated to drive expression of the genes encoding the key enzymes or regulators in autophagosome formation or autophagic process, including microtubule-associated protein 1B-light chain 3, autophagy-related protein (ATG)7, ATG2b, and autophagosome formation Unc-51 like kinase 1, and the genes encoding functions in lysosomal biogenesis and homeostasis. Upon nutrient starvation, CREBH regulates and interacts with peroxisome proliferator-activated receptor alpha (PPAR alpha) and PPAR gamma coactivator 1 alpha to synergistically drive expression of the key autophagy genes and transcription factor EB, a master regulator of lysosomal biogenesis. Furthermore, CREBH regulates rhythmic expression of the key autophagy genes in the liver in a circadian-dependent manner. In summary, we identified CREBH as a key transcriptional regulator of hepatic autophagy and lysosomal biogenesis for the purpose of maintaining hepatic lipid homeostasis under nutritional stress or circadian oscillation.-Kim, H., Williams, D., Qiu, Y., Song, Z., Yang, Z., Kimler, V., Goldberg, A., Zhang, R., Yang, Z., Chen, X., Wang, L., Fang, D., Lin, J. D., Zhang, K. Regulation of hepatic autophagy by stress-sensing transcription factor CREBH.	[Kim, Hyunbae; Williams, Dreana; Song, Zhenfeng; Yang, Zhao; Zhang, Ren; Zhang, Kezhong] Wayne State Univ, Sch Med, Ctr Mol Med & Genet, 3202 Scott Hall,540 E Canfield Ave, Detroit, MI 48201 USA; [Chen, Xuequn] Wayne State Univ, Sch Med, Dept Physiol, Detroit, MI 48201 USA; [Zhang, Kezhong] Wayne State Univ, Sch Med, Dept Biochem Microbiol & Immunol, Detroit, MI 48201 USA; [Yang, Zengquan; Zhang, Kezhong] Wayne State Univ, Karmanos Canc Inst, Detroit, MI 48201 USA; [Qiu, Yining] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Pediat, Wuhan, Hubei, Peoples R China; [Kimler, Victoria; Goldberg, Andrew] Oakland Univ, Eye Res Inst, Rochester, MI USA; [Wang, Li] Univ Connecticut, Dept Physiol & Neurobiol, Inst Syst Genom, Storrs, CT 06269 USA; [Wang, Li] Vet Affairs Connecticut Healthcare Syst, West Haven, CT USA; [Wang, Li] Yale Univ, Liver Ctr, Dept Internal Med, New Haven, CT USA; [Fang, Deyu] Northwestern Univ, Dept Pathol, Feinberg Sch Med, Chicago, IL 60611 USA; [Lin, Jiandie D.] Univ Michigan, Med Sch, Life Sci Inst, Ann Arbor, MI USA	Wayne State University; Wayne State University; Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne State University; Huazhong University of Science & Technology; Oakland University; University of Connecticut; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Yale University; Northwestern University; Feinberg School of Medicine; University of Michigan System; University of Michigan	Zhang, KZ (corresponding author), Wayne State Univ, Sch Med, Ctr Mol Med & Genet, 3202 Scott Hall,540 E Canfield Ave, Detroit, MI 48201 USA.	kzhang@med.wayne.edu		Zhang, Kezhong/0000-0002-6062-235X; Yang, Zhao/0000-0002-4133-3130	U.S. National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases [DK090313, DK110314, DK102456]; NIH National Institute of Environmental Health Sciences [ES017829]; NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases [AR066634]; NIH National Eye Institute [EY025291]; American Heart Association [0635423Z, 09GRNT2280479]; NATIONAL EYE INSTITUTE [R01EY025291] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR066634] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK102456, P30DK020572, R01DK110314, R01DK090313] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); American Heart Association(American Heart Association); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Portions of this work were supported by U.S. National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases Grants DK090313 (to K.Z), DK110314 (to X.C.), and DK102456 (to J.D.L.); NIH National Institute of Environmental Health Sciences Grant ES017829 (to K.Z.); NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases Grant AR066634 (to D.F. and K.Z.); NIH National Eye Institute Grant EY025291 (to A.G.); and American Heart Association Grants 0635423Z and 09GRNT2280479 (to K.Z.). The authors declare no conflicts of interest.	Avila DV, 2016, J PATHOL, V240, P96, DOI 10.1002/path.4760; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Cefalu AB, 2015, ARTERIOSCL THROM VAS, V35, P2694, DOI 10.1161/ATVBAHA.115.306170; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Fullgrabe J, 2014, NAT REV MOL CELL BIO, V15, P65, DOI 10.1038/nrm3716; Ghosh A, 2015, J BIOL CHEM, V290, P10309, DOI 10.1074/jbc.M114.610659; Hailey DW, 2010, CELL, V141, P656, DOI 10.1016/j.cell.2010.04.009; Haspel J, 2011, AUTOPHAGY, V7, P629, DOI 10.4161/auto.7.6.15100; Holen I, 1996, EUR J BIOCHEM, V236, P163, DOI 10.1111/j.1432-1033.1996.00163.x; Johansen CT, 2012, CIRC-CARDIOVASC GENE, V5, P66, DOI 10.1161/CIRCGENETICS.111.960864; Kim H, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00048-17; Kim H, 2015, MOL CELL BIOL, V35, P4121, DOI 10.1128/MCB.00665-15; Kim H, 2014, ENDOCRINOLOGY, V155, P769, DOI 10.1210/en.2013-1490; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Lamb CA, 2013, NAT REV MOL CELL BIO, V14, P759, DOI 10.1038/nrm3696; Lee JM, 2014, NATURE, V516, P112, DOI 10.1038/nature13961; Lee JH, 2011, NAT MED, V17, P812, DOI 10.1038/nm.2347; Lee MW, 2010, CELL METAB, V11, P331, DOI 10.1016/j.cmet.2010.02.016; Li WW, 2012, CELL MOL LIFE SCI, V69, P1125, DOI 10.1007/s00018-011-0865-5; Liu K, 2013, CELL DEATH DIFFER, V20, P3, DOI 10.1038/cdd.2012.63; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Luebke-Wheeler J, 2008, HEPATOLOGY, V48, P1242, DOI 10.1002/hep.22439; Ma D, 2011, EMBO J, V30, P4642, DOI 10.1038/emboj.2011.322; Omori Y, 2001, NUCLEIC ACIDS RES, V29, P2154, DOI 10.1093/nar/29.10.2154; Pietrocola F, 2013, SEMIN CANCER BIOL, V23, P310, DOI 10.1016/j.semcancer.2013.05.008; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Seok S, 2014, NATURE, V516, P108, DOI 10.1038/nature13949; Settembre C, 2013, NAT CELL BIOL, V15, P647, DOI 10.1038/ncb2718; Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Sinha RA, 2014, HEPATOLOGY, V59, P1366, DOI 10.1002/hep.26667; Tanida Isei, 2008, V445, P77, DOI 10.1007/978-1-59745-157-4_4; Yamamoto S, 2018, CELL REP, V23, P3286, DOI 10.1016/j.celrep.2018.05.032; Yang L, 2010, CELL METAB, V11, P467, DOI 10.1016/j.cmet.2010.04.005; Yla-Anttila P, 2009, AUTOPHAGY, V5, P1180; Zhang CB, 2012, HEPATOLOGY, V55, P1070, DOI 10.1002/hep.24783; Zhang KZ, 2006, CELL, V124, P587, DOI 10.1016/j.cell.2005.11.040; Zheng Z, 2016, DIABETES, V65, P3369, DOI 10.2337/db16-0298	38	15	15	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2019	33	7					7896	7914		10.1096/fj.201802528R	http://dx.doi.org/10.1096/fj.201802528R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ9SM	30912978	Green Published, Green Submitted, Bronze			2022-12-26	WOS:000476234700009
J	Li, ZX; Shi, XJ; Liu, JB; Shao, F; Huang, G; Zhou, ZG; Zheng, PL				Li, Zhixia; Shi, Xiajie; Liu, Junbin; Shao, Feng; Huang, Gan; Zhou, Zhiguang; Zheng, Peilin			Artesunate prevents type 1 diabetes in NOD mice mainly by inducing protective IL-4-producing T cells and regulatory T cells	FASEB JOURNAL			English	Article						Chinese traditional medicine; autoimmunity; beta cells	ANTIMALARIAL-DRUG; QINGHAOSU ARTEMISININ; EXPRESSION; ONSET; MAINTENANCE; ISLETS; CANCER; MODEL; VITRO	Type 1 diabetes (T1D) is an autoimmune disease characterized by the immune-mediated destruction of insulin-producing beta cells. Recent studies showed that in addition to malaria, artemisinin and its derivative, artesunate (AS), could alleviate several autoimmune diseases. However, whether AS has a role in the prevention or treatment of T1D is still unknown. Therefore, in this study we administrated AS or DMSO in the drinking water of nonobese diabetic (NOD) mice, a mouse model of T1D. We found that AS administration significantly prevented the incidence of T1D. The frequency of IL-4-producing CD4(+) single-positive T cells and CD8(+) T cells was significantly elevated, and IFN-gamma-producing T cells were reduced in the spleen and pancreatic lymph nodes. In the pancreas, the skewing to IL-4-producing T cells was also observed. In addition, more regulatory T cells were found in the pancreas. mRNA levels of proinflammatory cytokines, including TNF-alpha and IL-6, were decreased. In addition, AS administration promoted the functional maturity of beta cells in vitro. Our findings demonstrate that AS administration can prevent T1D in NOD mice mainly by reducing autoimmune T cells and increasing protective T cells. Our data constitute the first functional study of AS in T1D, which may provide a new rationale for future translational studies.-Li, Z., Shi, X., Liu, J., Shao, F., Huang, G., Zhou, Z., Zheng, P. Artesunate prevents type 1 diabetes in NOD mice mainly by inducing protective IL-4-producing T cells and regulatory T cells.	[Li, Zhixia; Shi, Xiajie; Liu, Junbin; Shao, Feng; Huang, Gan; Zhou, Zhiguang; Zheng, Peilin] Second Xiangya Hosp, Dept Metab & Endocrinol, Changsha, Hunan, Peoples R China; [Li, Zhixia; Shi, Xiajie; Liu, Junbin; Shao, Feng; Huang, Gan; Zhou, Zhiguang; Zheng, Peilin] Cent S Univ, Natl Clin Res Ctr Metab Dis, Key Lab Diabet Immunol, Minist Educ, Changsha, Hunan, Peoples R China; [Zheng, Peilin] Jinan Univ, Dept Endocrinol, Shenzhen Peoples Hosp, Affiliated Hosp 1,Southern Univ Sci & Technol,Cli, Shenzhen, Peoples R China	Central South University; Jinan University; Southern University of Science & Technology	Zhou, ZG; Zheng, PL (corresponding author), Cent S Univ, Dept Metab & Endocrinol, Xiangya Hosp 2, 139 Rennin Middle Rd, Changsha 410011, Hunan, Peoples R China.	zhouzhiguang@csu.edu.cn; peilinz@csu.edu.cn	Zheng, Peilin/B-4360-2015	Zheng, Peilin/0000-0002-4712-4903	National Natural Science Foundation of China [81670716, 81500600]; Hunan Science Fund for Excellent Young Scholars [2019JJ30036]; Graduate Innovation Project of Central South University [502211703, 2018zzts921]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hunan Science Fund for Excellent Young Scholars; Graduate Innovation Project of Central South University	The authors thank Stephan Kissler (Joslin Diabetes Center, Harvard Medical School) for helpful discussion and editing the manuscript. This work is supported by the National Natural Science Foundation of China (Grants 81670716, 81500600), Hunan Science Fund for Excellent Young Scholars (Grant 2019JJ30036), and the Graduate Innovation Project of Central South University (Grants 502211703, 2018zzts921). The authors declare no conflicts of interest.	Ackermann AM, 2018, CELL METAB, V28, P787, DOI 10.1016/j.cmet.2018.07.002; Blum B, 2012, NAT BIOTECHNOL, V30, P261, DOI 10.1038/nbt.2141; CAMPBELL IL, 1991, J CLIN INVEST, V87, P739, DOI 10.1172/JCI115055; Cheng C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020932; Cui C, 2015, INT IMMUNOPHARMACOL, V27, P110, DOI 10.1016/j.intimp.2015.05.004; Da Rosa LC, 2018, DIABETOLOGIA, V61, P1397, DOI 10.1007/s00125-018-4597-z; De Vas MG, 2015, DEVELOPMENT, V142, P871, DOI 10.1242/dev.110759; DEBRAYSACHS M, 1991, J AUTOIMMUN, V4, P237, DOI 10.1016/0896-8411(91)90021-4; Gao T, 2014, CELL METAB, V19, P259, DOI 10.1016/j.cmet.2013.12.002; Green EA, 2003, P NATL ACAD SCI USA, V100, P10878, DOI 10.1073/pnas.1834400100; Gu CY, 2010, CELL METAB, V11, P298, DOI 10.1016/j.cmet.2010.03.006; He XY, 2018, DIABETOLOGIA, V61, P881, DOI 10.1007/s00125-017-4523-9; Ho WE, 2012, FREE RADICAL BIO MED, V53, P498, DOI 10.1016/j.freeradbiomed.2012.05.021; Hou LF, 2011, ARTHRITIS RHEUM-US, V63, P2445, DOI 10.1002/art.30392; Hou LF, 2009, INT IMMUNOPHARMACOL, V9, P1509, DOI 10.1016/j.intimp.2009.09.003; Hou LF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104762; Jin OY, 2009, CELL MOL IMMUNOL, V6, P461, DOI 10.1038/cmi.2009.58; Joseph J, 2012, J IMMUNOL, V188, P216, DOI 10.4049/jimmunol.1101215; KATZ JD, 1995, SCIENCE, V268, P1185, DOI 10.1126/science.7761837; KLAYMAN DL, 1985, SCIENCE, V228, P1049, DOI 10.1126/science.3887571; Li J, 2017, CELL, V168, P86, DOI 10.1016/j.cell.2016.11.010; Li X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074108; Li Y, 2003, CURR MED CHEM, V10, P2197, DOI 10.2174/0929867033456710; Marwaha AK, 2010, J IMMUNOL, V185, P3814, DOI 10.4049/jimmunol.1001860; Mueller R, 1996, J EXP MED, V184, P1093, DOI 10.1084/jem.184.3.1093; Nishimura W, 2015, DIABETOLOGIA, V58, P566, DOI 10.1007/s00125-014-3464-9; Ogura H, 2018, J IMMUNOL, V201, P1662, DOI 10.4049/jimmunol.1800267; RABINOVITCH A, 1994, DIABETES, V43, P613, DOI 10.2337/diabetes.43.5.613; RAPOPORT MJ, 1993, J EXP MED, V178, P87, DOI 10.1084/jem.178.1.87; SARVETNICK N, 1988, CELL, V52, P773, DOI 10.1016/0092-8674(88)90414-X; Seymour PA, 2007, P NATL ACAD SCI USA, V104, P1865, DOI 10.1073/pnas.0609217104; Szot Gregory L, 2007, J Vis Exp, P255, DOI 10.3791/255; Tai NW, 2016, J EXP MED, V213, P2129, DOI 10.1084/jem.20160526; Tang QZ, 2004, J EXP MED, V199, P1455, DOI 10.1084/jem.20040139; Thome R, 2016, CNS NEUROSCI THER, V22, P707, DOI 10.1111/cns.12561; Tu YY, 2011, NAT MED, V17, P1217, DOI 10.1038/nm.2471; van der Meulen T, 2018, CELL METAB, V27, P218, DOI 10.1016/j.cmet.2017.10.002; Verdaguer J, 1997, J EXP MED, V186, P1663, DOI 10.1084/jem.186.10.1663; Walker LSK, 2016, CLIN EXP IMMUNOL, V183, P16, DOI 10.1111/cei.12672; Wang JX, 2008, BRIT J PHARMACOL, V153, P1303, DOI 10.1038/bjp.2008.11; Wong FS, 1996, J EXP MED, V183, P67, DOI 10.1084/jem.183.1.67; Yang Z, 2012, CURR MED CHEM, V19, P4541, DOI 10.2174/092986712803251575; Zhang LX, 2014, CELL BIOL INT, V38, P639, DOI 10.1002/cbin.10244; Zhang XN, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0035700, 10.1371/journal.pone.0035991]; Zheng PL, 2018, DIABETES-METAB RES, V34, DOI 10.1002/dmrr.3043; Zheng PL, 2013, DIABETES, V62, P896, DOI 10.2337/db12-0929	46	19	23	2	22	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2019	33	7					8241	8248		10.1096/fj.201900146R	http://dx.doi.org/10.1096/fj.201900146R			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ9SM	30916998				2022-12-26	WOS:000476234700036
J	Zhang, Y; Unnithan, RVM; Hamidi, A; Caja, L; Saupe, F; Moustakas, A; Cedervall, J; Olsson, AK				Zhang, Yanyu; Unnithan, Ragaseema Valsala Madhavan; Hamidi, Anahita; Caja, Laia; Saupe, Falk; Moustakas, Aristidis; Cedervall, Jessica; Olsson, Anna-Karin			TANK-binding kinase 1 is a mediator of platelet-induced EMT in mammary carcinoma cells	FASEB JOURNAL			English	Article						platelets; cancer; TBK1; NF-kappa B; metastasis	EPITHELIAL-MESENCHYMAL TRANSITION; KAPPA-B ACTIVATION; CANCER-CELLS; THERAPEUTIC TARGET; TBK1; METASTASIS; INHIBITION; TRANSCRIPTION; EXPRESSION; MECHANISM	Platelets can promote several stages of the metastatic process and thus contribute to malignant progression. As an example, platelets promote invasive properties of tumor cells by induction of epithelial to mesenchymal transition (EMT). In this study, we show that tumor necrosis factor receptor-associated factor (TRAF) family member-associated NF-kappa B activator (TANK)-binding kinase 1 (TBK1) is a previously unknown mediator of platelet-induced EMT in mammary carcinoma cells. Coculture of 2 mammary carcinoma cell lines, Ep5 from mice and MCF10A(MII) from humans, with isolated platelets induced morphologic as well as molecular changes characteristic of EMT, which was paralleled with activation of TBK1. TBK1 depletion using small interfering RNA impaired platelet-induced EMT in both Ep5 and MCF10A(MII) cells. Furthermore, platelet-induced activation of the NF-kappa B subunit p65 was suppressed after TBK1 knockdown, demonstrating that TBK1 mediates platelet-induced NF-kappa B signaling and EMT. Using an in vivo metastasis assay, we found that depletion of TBK1 from mammary carcinoma cells during in vitro preconditioning with platelets subsequently suppressed the formation of lung metastases in mice. Altogether, these results suggest that TBK1 contributes to tumor invasiveness and may be a driver of metastatic spread in breast cancer.-Zhang, Y., Unnithan, R. V. M., Hamidi, A., Caja, L., Saupe, F., Moustakas, A., Cedervall, J., Olsson, A.-K. TANK-binding kinase 1 is a mediator of platelet-induced EMT in mammary carcinoma cells.	[Zhang, Yanyu; Unnithan, Ragaseema Valsala Madhavan; Hamidi, Anahita; Caja, Laia; Saupe, Falk; Moustakas, Aristidis; Cedervall, Jessica; Olsson, Anna-Karin] Uppsala Univ, Dept Med Biochem & Microbiol, Sci Life Lab, Uppsala, Sweden; [Unnithan, Ragaseema Valsala Madhavan] Govt Arts Coll, Thiruvananthapuram, Kerala, India	Uppsala University	Cedervall, J (corresponding author), Uppsala Univ, Biomed Ctr, Dept Med Biochem & Microbiol, Sci Life Lab, Box 582, SE-75123 Uppsala, Sweden.	jessica.cedervall@imbim.uu.se	Caja, Laia/J-4618-2019	Caja, Laia/0000-0002-8786-8763; Hamidi, Anahita/0000-0002-5445-2446; Zhang, Yanyu/0000-0001-9939-1838	Swedish Research Council [2016-03036]; Swedish Cancer Society [CAN 2017/522]; Swedish Society of Medicine [SLS-683851]; China Scholarship Council [2011687010]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Swedish Society of Medicine; China Scholarship Council(China Scholarship Council)	This work was supported by grants from the Swedish Research Council (2016-03036), the Swedish Cancer Society (CAN 2017/522 to A.-K.O.), and from the Swedish Society of Medicine to (SLS-683851 to J.C.), and from the China Scholarship Council (2011687010 to Y.Z.). The authors declare no conflicts of interest.	Allen DL, 2010, AM J PHYSIOL-REG I, V298, pR198, DOI 10.1152/ajpregu.00325.2009; Nieto MA, 2016, CELL, V166, P21, DOI 10.1016/j.cell.2016.06.028; Anitua E, 2004, THROMB HAEMOSTASIS, V91, P4, DOI 10.1160/TH03-07-0440; Bambace NM, 2011, J THROMB HAEMOST, V9, P237, DOI 10.1111/j.1538-7836.2010.04131.x; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Cedervall J., 2012, TUMOR ANGIOGENESIS, V17, P115, DOI DOI 10.5772/29318; Cedervall J, 2013, ANGIOGENESIS, V16, P889, DOI 10.1007/s10456-013-9363-8; Chien YC, 2006, CELL, V127, P157, DOI 10.1016/j.cell.2006.08.034; Cooper JM, 2017, CANCER RES, V77, P5077, DOI 10.1158/0008-5472.CAN-17-0829; Cruz VH, 2018, J CELL COMMUN SIGNAL, V12, P83, DOI 10.1007/s12079-017-0438-y; Czabanka M, 2008, FRONT BIOSCI, V13, P7243, DOI 10.2741/3225; Delhase M, 2012, P NATL ACAD SCI USA, V109, pE177, DOI 10.1073/pnas.1119296109; Deng T, 2014, CANCER RES, V74, P2119, DOI 10.1158/0008-5472.CAN-13-2138; Dovizio M, 2013, MOL PHARMACOL, V84, P25, DOI 10.1124/mol.113.084988; Elgueta R, 2009, IMMUNOL REV, V229, P152, DOI 10.1111/j.1600-065X.2009.00782.x; Eskiocak B, 2017, CANCER DISCOV, V7, P832, DOI 10.1158/2159-8290.CD-16-0955; Gay LJ, 2011, NAT REV CANCER, V11, P123, DOI 10.1038/nrc3004; Guillem-Llobat P, 2016, ONCOTARGET, V7, P32462, DOI 10.18632/oncotarget.8655; Hamidi A, 2012, J BIOL CHEM, V287, P123, DOI 10.1074/jbc.M111.285122; Korherr C, 2006, P NATL ACAD SCI USA, V103, P4240, DOI 10.1073/pnas.0511319103; Labelle M, 2012, CANCER DISCOV, V2, P1091, DOI 10.1158/2159-8290.CD-12-0329; Labelle M, 2011, CANCER CELL, V20, P576, DOI 10.1016/j.ccr.2011.09.009; Lee SE, 2017, ONCOTARGET, V8, P16233, DOI 10.18632/oncotarget.9069; LIBERMANN TA, 1990, MOL CELL BIOL, V10, P2327, DOI 10.1128/MCB.10.5.2327; Lin J, 2013, J CELL BIOCHEM, V114, P606, DOI 10.1002/jcb.24398; Lip GYH, 2002, LANCET ONCOL, V3, P27, DOI 10.1016/S1470-2045(01)00619-2; Liu W, 2014, LAB INVEST, V94, P362, DOI 10.1038/labinvest.2013.153; MAKINO H, 1987, INT ARCH ALLER A IMM, V82, P66, DOI 10.1159/000234292; Miyashita T, 2015, J SURG RES, V193, P289, DOI 10.1016/j.jss.2014.07.037; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Olsson AK, 2018, PLATELETS, V29, P569, DOI 10.1080/09537104.2018.1453059; Ou YH, 2011, MOL CELL, V41, P458, DOI 10.1016/j.molcel.2011.01.019; Pillai S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10072; Pomerantz JL, 1999, EMBO J, V18, P6694, DOI 10.1093/emboj/18.23.6694; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; Tang ML, 2017, ONCOTARGET, V8, P97464, DOI 10.18632/oncotarget.22136; Tojima Y, 2000, NATURE, V404, P778, DOI 10.1038/35008109; Vu HL, 2014, MOL CANCER RES, V12, P1509, DOI 10.1158/1541-7786.MCR-14-0204; Xiao YC, 2017, J EXP MED, V214, P1493, DOI 10.1084/jem.20161524; Yang KM, 2013, CANCER RES, V73, P6679, DOI 10.1158/0008-5472.CAN-13-0891; Yun SH, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/9060143; 1988, LAB ANIM, V22, P195	42	12	13	3	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2019	33	7					7822	7832		10.1096/fj.201801936RRR	http://dx.doi.org/10.1096/fj.201801936RRR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ9SM	30912981	Bronze			2022-12-26	WOS:000476234700004
J	Zong, L; Hattori, N; Yasukawa, Y; Kimura, K; Mori, A; Seto, Y; Ushijima, T				Zong, Liang; Hattori, Naoko; Yasukawa, Yoshimi; Kimura, Kana; Mori, Akiko; Seto, Yasuyuki; Ushijima, Toshikazu			LINC00162 confers sensitivity to 5-Aza-2 '-deoxycytidine via modulation of an RNA splicing protein, HNRNPH1	ONCOGENE			English	Article							RISK MYELODYSPLASTIC SYNDROMES; HELICOBACTER-PYLORI INFECTION; ACUTE MYELOID-LEUKEMIA; DNA METHYLATION; HYPOMETHYLATING AGENT; DEMETHYLATING AGENTS; TUMOR-SUPPRESSOR; PHASE-II; CANCER; AZACITIDINE	DNA demethylation therapy is now expanding from hematological tumors to solid tumors. To exploit its maximum efficacy, long-term treatment is needed, and stratification of sensitive patients is critically important. Here, we identified a long non-coding RNA, LINC00162, as highly and frequently expressed in gastric cancer cell lines sensitive to 5-aza-2'-deoxycytidine (5-aza-dC). Knockdown of LINC00162 decreased the sensitivity while its overexpression increased the sensitivity. In vivo experiments also showed that LINC00162 overexpression increased the sensitivity. LINC00162 enhanced cell cycle arrest and apoptosis induced by 5-aza-dC, but did not affect its DNA demethylation effect. Mechanistically, LINC00162 interacted with an RNA splicing protein, HNRNPH1, and decreased splicing of an anti-apoptotic splicing variant, BCL-XL. LINC00162 may have translational value to predict patients who will respond to 5-aza-dC.	[Zong, Liang; Hattori, Naoko; Yasukawa, Yoshimi; Kimura, Kana; Mori, Akiko; Ushijima, Toshikazu] Natl Canc Ctr, Res Inst, Div Epigen, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan; [Zong, Liang; Yasukawa, Yoshimi; Seto, Yasuyuki] Univ Tokyo, Grad Sch Med, Dept Gastrointestinal Surg, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan	National Cancer Center - Japan; University of Tokyo	Ushijima, T (corresponding author), Natl Canc Ctr, Res Inst, Div Epigen, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	tushijim@ncc.go.jp	Ushijima, Toshikazu/AAP-5742-2021	Ushijima, Toshikazu/0000-0003-3405-7817; Hattori, Naoko/0000-0002-0901-4869	AMED [JP18ck0106421]; JSPS KAKENHI [JP18H02704]	AMED(Japan Agency for Medical Research and Development (AMED)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by AMED under Grant Number JP18ck0106421 to Toshikazu Ushijima and JSPS KAKENHI under Grant Number JP18H02704 to Toshikazu Ushijima.	Ajani JA, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.36; Asada K, 2013, ONCOGENE, V32, P2140, DOI 10.1038/onc.2012.228; Belinsky SA, 2003, CANCER RES, V63, P7089; Cascinu S, 1997, J CLIN ONCOL, V15, P3313, DOI 10.1200/JCO.1997.15.11.3313; Chandler DS, 2006, CANCER RES, V66, P9502, DOI 10.1158/0008-5472.CAN-05-4271; Christman JK, 2002, ONCOGENE, V21, P5483, DOI 10.1038/sj.onc.1205699; Chuang JC, 2010, MOL CANCER THER, V9, P1443, DOI 10.1158/1535-7163.MCT-09-1048; Cowan LA, 2010, EPIGENOMICS-UK, V2, P71, DOI 10.2217/EPI.09.44; Cui Y, 2014, CANCER RES, V74, P3834, DOI 10.1158/0008-5472.CAN-13-2287; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Fang F, 2014, CLIN CANCER RES, V20, P6504, DOI 10.1158/1078-0432.CCR-14-1553; Fenaux P, 2009, LANCET ONCOL, V10, P223, DOI 10.1016/S1470-2045(09)70003-8; Gao XD, 2014, ACTA BIOCH BIOPH SIN, V46, P72, DOI 10.1093/abbs/gmt118; Garneau D, 2005, J BIOL CHEM, V280, P22641, DOI 10.1074/jbc.M501070200; Gore SD, 2006, CANCER RES, V66, P6361, DOI 10.1158/0008-5472.CAN-06-0080; Greenberg PL, 2011, J NATL COMPR CANC NE, V9, P30, DOI 10.6004/jnccn.2011.0005; He DX, 2014, MOL PHARMACOL, V86, P536, DOI 10.1124/mol.114.092759; Hironaka S, 2016, LANCET ONCOL, V17, P99, DOI 10.1016/S1470-2045(15)00410-6; Issa JPJ, 2004, BLOOD, V103, P1635, DOI 10.1182/blood-2003-03-0687; JONES PA, 1980, CELL, V20, P85, DOI 10.1016/0092-8674(80)90237-8; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Juergens RA, 2011, CANCER DISCOV, V1, P598, DOI 10.1158/2159-8290.CD-11-0214; JUTTERMANN R, 1994, P NATL ACAD SCI USA, V91, P11797, DOI 10.1073/pnas.91.25.11797; Kantarjian H, 2006, CANCER-AM CANCER SOC, V106, P1794, DOI 10.1002/cncr.21792; Kantarjian H, 2007, BLOOD, V109, P52, DOI 10.1182/blood-2006-05-021162; Katsushima K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13616; Kim JG, 2013, CANCER LETT, V330, P33, DOI 10.1016/j.canlet.2012.11.022; Liu BD, 2015, CANCER CELL, V27, P370, DOI 10.1016/j.ccell.2015.02.004; Lu MR, 2015, SCI REP-UK, V5, DOI 10.1038/srep08735; Lue M, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.267; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Magklara A, 2001, CLIN CANCER RES, V7, P806; Man CH, 2014, BLOOD, V123, P2530, DOI 10.1182/blood-2013-07-512194; Mills JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078480; Navada SC, 2014, J CLIN INVEST, V124, P40, DOI 10.1172/JCI69739; Niwa T, 2013, CANCER PREV RES, V6, P263, DOI 10.1158/1940-6207.CAPR-12-0369; Niwa T, 2010, CANCER RES, V70, P1430, DOI 10.1158/0008-5472.CAN-09-2755; Okochi-Takada E, 2014, ONCOGENE, V33, P2273, DOI 10.1038/onc.2013.174; Piipponen M, 2016, J INVEST DERMATOL, V136, P1701, DOI 10.1016/j.jid.2016.03.028; Schmitt AM, 2016, CANCER CELL, V29, P452, DOI 10.1016/j.ccell.2016.03.010; Schneider BJ, 2017, CLIN CANCER RES, V23, P2673, DOI 10.1158/1078-0432.CCR-16-1896; Sekeres MA, 2017, J CLIN ONCOL, V35, P2745, DOI 10.1200/JCO.2015.66.2510; SORM F, 1968, NEOPLASMA, V15, P339; Stewart ML, 2015, CANCER RES, V75, P2897, DOI 10.1158/0008-5472.CAN-14-2860; Tsai HC, 2012, CANCER CELL, V21, P430, DOI 10.1016/j.ccr.2011.12.029; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Ushijima T, 2005, NAT REV CANCER, V5, P223, DOI 10.1038/nrc1571; Welch JS, 2016, NEW ENGL J MED, V375, P2023, DOI 10.1056/NEJMoa1605949; Wijermans P, 2000, J CLIN ONCOL, V18, P956, DOI 10.1200/JCO.2000.18.5.956; Yun S, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0233-2; Zong L, 2016, GASTRIC CANCER, V19, P361, DOI 10.1007/s10120-015-0475-2; Zouridis H, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004504	52	12	13	1	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 27	2019	38	26					5281	5293		10.1038/s41388-019-0792-8	http://dx.doi.org/10.1038/s41388-019-0792-8			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	IF4AX	30914798				2022-12-26	WOS:000473025300012
J	Garg, RR; Jackson, CB; Rahman, MM; Khan, AR; Lewin, AS; McFadden, G				Garg, Rekha R.; Jackson, Cody B.; Rahman, Masmudur M.; Khan, Amir R.; Lewin, Alfred S.; McFadden, Grant			Myxoma virus M013 protein antagonizes NF-B and inflammasome pathways via distinct structural motifs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						poxvirus; inflammasome; innate immunity; NF-kappa B (NF-KB); host-pathogen interaction; ASC-1; immune evasion; myxoma virus; PYRIN domain	KAPPA-B; PYRIN DOMAIN; HOMEOSTASIS	Among the repertoire of immunoregulatory proteins encoded by myxoma virus, M013 is a viral homologue of the viral pyrin domain-only protein (vPOP) family. In myeloid cells, M013 protein has been shown to inhibit both the inflammasome and NF-B signaling pathways by direct binding to ASC1 and NF-B1, respectively. In this study, a three-dimensional homology model of the M013 pyrin domain (PYD) was built based on similarities to known PYD structures. A distinctive feature of the deduced surface electrostatic map of the M013 PYD is the presence of a negatively region consisting of numerous aspartate and glutamate residues in close proximity. Single-site mutations of aspartate and glutamate residues reveal their role in interactions with ASC-1. The biological significance of charge complementarity in the M013-ASC-1 interaction was further confirmed by functional assays of caspase-1 activation and subsequent secretion of cytokines. M013 also has a unique 33-residue C-terminal tail that follows the N-terminal PYD, and it is enriched in positively charged residues. Deletion of the tail of M013 significantly inhibited the interactions between M013 and NF-B1, thus compromising the ability of the viral protein to suppress the secretion of pro-inflammatory cytokines. These results demonstrate that vPOP M013 exploits distinct structural motifs to regulate both the inflammasome and NF-B pathways.	[Garg, Rekha R.; Jackson, Cody B.; Rahman, Masmudur M.; Lewin, Alfred S.; McFadden, Grant] Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL 32611 USA; [Rahman, Masmudur M.; McFadden, Grant] Arizona State Univ, Ctr Immunotherapy Vaccines & Virotherapy, Biodesign Inst, Tempe, AZ 85281 USA; [Khan, Amir R.] Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Dublin 2, Ireland	State University System of Florida; University of Florida; Arizona State University; Arizona State University-Tempe; Trinity College Dublin	Lewin, AS; McFadden, G (corresponding author), Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL 32611 USA.; McFadden, G (corresponding author), Arizona State Univ, Ctr Immunotherapy Vaccines & Virotherapy, Biodesign Inst, Tempe, AZ 85281 USA.; Khan, AR (corresponding author), Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Dublin 2, Ireland.	Amir.Khan@tcd.ie; lewin@ufl.edu; grantmcf@asu.edu		Jackson, Cody/0000-0002-0686-9423; Lewin, Alfred/0000-0002-4192-9727; Khan, Amir/0000-0003-1176-6952; McFadden, Grant/0000-0002-2556-3526	Science Foundation Ireland [SFI-12/IA/1239]; National Institutes of Health [R01 AI100987]; Arizona State University; Shaler Richardson Professorship Endowment; NATIONAL EYE INSTITUTE [R01EY026268] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI100987] Funding Source: NIH RePORTER	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arizona State University; Shaler Richardson Professorship Endowment; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Science Foundation Ireland Grant SFI-12/IA/1239 (to A. R. K.), National Institutes of Health Grant R01 AI100987 (to G. M. and M. M. R.), start-up funding from Arizona State University (to G. M.), and the Shaler Richardson Professorship Endowment (to A. S. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alcami A, 2003, NAT REV IMMUNOL, V3, P36, DOI 10.1038/nri980; Awad F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175336; Bedoya F, 2007, J IMMUNOL, V178, P3837, DOI 10.4049/jimmunol.178.6.3837; Beinke S, 2004, BIOCHEM J, V382, P393, DOI 10.1042/BJ20040544; Cameron C, 1999, VIROLOGY, V264, P298, DOI 10.1006/viro.1999.0001; Chemical Computing Group, 2018, MOL OP ENV; CORDLE SR, 1993, J BIOL CHEM, V268, P11803; Dorfleutner A, 2007, VIRUS GENES, V35, P685, DOI 10.1007/s11262-007-0141-9; Ferrao R, 2012, CURR OPIN STRUC BIOL, V22, P241, DOI 10.1016/j.sbi.2012.02.006; Franchi L, 2012, NAT IMMUNOL, V13, P325, DOI 10.1038/ni.2231; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Ildefonso CJ, 2015, HUM GENE THER, V26, P59, DOI 10.1089/hum.2014.089; Indramohan M, 2018, J MOL BIOL, V430, P153, DOI 10.1016/j.jmb.2017.10.004; Johnston JB, 2005, IMMUNITY, V23, P587, DOI 10.1016/j.immuni.2005.10.003; Johnston JB, 2003, J VIROL, V77, P5877, DOI 10.1128/JVI.77.10.5877-5888.2003; Kerr PJ, 2015, VIRUSES-BASEL, V7, P1020, DOI 10.3390/v7031020; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Lamkanfi M, 2012, ANNU REV CELL DEV BI, V28, P137, DOI 10.1146/annurev-cellbio-101011-155745; Liepinsh E, 2003, J MOL BIOL, V332, P1155, DOI 10.1016/j.jmb.2003.07.007; Mariathasan S, 2007, NAT REV IMMUNOL, V7, P31, DOI 10.1038/nri1997; Moriya M, 2005, BIOCHEMISTRY-US, V44, P575, DOI 10.1021/bi048374i; Park HH, 2007, ANNU REV IMMUNOL, V25, P561, DOI 10.1146/annurev.immunol.25.022106.141656; Pasparakis M, 2009, NAT REV IMMUNOL, V9, P778, DOI 10.1038/nri2655; Rahman MM, 2011, J VIROL, V85, P12505, DOI 10.1128/JVI.00410-11; Rahman MM, 2011, NAT REV MICROBIOL, V9, P291, DOI 10.1038/nrmicro2539; Rahman MM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000635; Rathinam VAK, 2012, NAT IMMUNOL, V13, P333, DOI 10.1038/ni.2237; ROSS J, 1977, J HYG-CAMBRIDGE, V79, P411, DOI 10.1017/S0022172400053262; Seet BT, 2003, ANNU REV IMMUNOL, V21, P377, DOI 10.1146/annurev.immunol.21.120601.141049; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Smith GL, 2013, J GEN VIROL, V94, P2367, DOI 10.1099/vir.0.055921-0; Stehlik C, 2003, BIOCHEM J, V373, P101, DOI 10.1042/BJ20030304; TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208; Wullaert A, 2011, CELL RES, V21, P146, DOI 10.1038/cr.2010.175	34	5	6	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2019	294	21					8480	8489		10.1074/jbc.RA118.006040	http://dx.doi.org/10.1074/jbc.RA118.006040			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC6UQ	30940649	hybrid, Green Published			2022-12-26	WOS:000471108200017
J	Ortega, JT; Parmar, T; Jastrzebska, B				Ortega, Joseph T.; Parmar, Tanu; Jastrzebska, Beata			Flavonoids enhance rod opsin stability, folding, and self-association by directly binding to ligand-free opsin and modulating its conformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G protein-coupled receptor (GPCR); flavonoid; regeneration; receptor; oligomerization; eye disease; opsin; photoreception; rhodopsin; stability	PH-DEPENDENT INTERACTION; TRANSDUCIN ACTIVATION; BIOLOGICAL EVALUATION; VISUAL CYCLE; IN-VIVO; RHODOPSIN; PHYTOCHEMICALS; DERIVATIVES; DYNAMICS; DISEASE	Rhodopsin (Rho) is a visual G protein-coupled receptor expressed in the rod photoreceptors of the eye, where it mediates transmission of a light signal into a cell and converts this signal into a nerve impulse. More than 100 mutations in Rho are linked to various ocular impairments, including retinitis pigmentosa (RP). Accordingly, much effort has been directed toward developing ligands that target Rho and improve its folding and stability. Natural compounds may provide another viable approach to such drug discovery efforts. The dietary polyphenol compounds, ubiquitously present in fruits and vegetables, have beneficial effects in several eye diseases. However, the underlying mechanism of their activity is not fully understood. In this study, we used a combination of computational methods, biochemical and biophysical approaches, including bioluminescence resonance energy transfer, and mammalian cell expression systems to clarify the effects of four common bioactive flavonoids (quercetin, myricetin, and their mono-glycosylated forms quercetin-3-rhamnoside and myricetrin) on rod opsin stability, function, and membrane organization. We observed that by directly interacting with ligand-free opsin, flavonoids modulate its conformation, thereby causing faster entry of the retinal chromophore into its binding pocket. Moreover, flavonoids significantly increased opsin stability, most likely by introducing structural rigidity and promoting receptor self-association within the biological membranes. Of note, the binding of flavonoids to an RP-linked P23H opsin variant partially restored its normal cellular trafficking. Together, our results suggest that flavonoids could be utilized as lead compounds in the development of effective nonretinoid therapeutics for managing RP-related retinopathies.	[Ortega, Joseph T.; Parmar, Tanu; Jastrzebska, Beata] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland Ctr Membrane & Struct Biol, Cleveland, OH 44106 USA	Case Western Reserve University	Jastrzebska, B (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol, 10900 Euclid Ave, Cleveland, OH 44106 USA.	bxj27@case.edu	Ortega, Joseph/AFN-8883-2022	Jastrzebska, Beata/0000-0001-5209-8685	National Institutes of Health [P30EY11373, P30CA043703]; NATIONAL CANCER INSTITUTE [P30CA043703] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY011373, R01EY025214] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank Drs. Ronald E. Stenkamp and Marcin Golczak for helpful comments on this manuscript. We thank Dr. Yinghua Chen for the assistance with Tecan microplate reader measurement from PEPCMBC at the department of Physiology and Biophysics, Case Western Reserve University. The NEI Visual Sciences Research Center (VSRC) CORE Grant P30EY11373 (Case Western Reserve University) was supported by the National Institutes of Health, and the Small Molecule Drug Development Shared Resource (Case Western Reserve University) was supported by Grant P30CA043703 from the National Institutes of Health.	Anand David Alexander Victor, 2016, Pharmacogn Rev, V10, P84, DOI 10.4103/0973-7847.194044; Athanasiou D, 2018, PROG RETIN EYE RES, V62, P1, DOI 10.1016/j.preteyeres.2017.10.002; Behnen P, 2018, ISCIENCE, V4, P1, DOI 10.1016/j.isci.2018.05.001; Belaunzaran-Zamudio Pablo F, 2017, Pathog Immun, V2, P151, DOI 10.20411/pai.v2i2.181; Bergler-Czop B, 2016, ACTA PHARMACEUT, V66, P471, DOI 10.1515/acph-2016-0039; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Chen YY, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04261-1; Chen Yuanyuan, 2015, Methods Mol Biol, V1271, P369, DOI 10.1007/978-1-4939-2330-4_24; Christopoulos A, 2014, MOL PHARMACOL, V86, P463, DOI 10.1124/mol.114.094342; Comar WD, 2014, J AM CHEM SOC, V136, P8342, DOI 10.1021/ja501948w; Erlandson SC, 2018, ANNU REV BIOPHYS, V47, P1, DOI 10.1146/annurev-biophys-070317-032931; FAHMY K, 1993, BIOCHEMISTRY-US, V32, P7229, DOI 10.1021/bi00079a020; Fan J, 2005, J PHYSIOL-LONDON, V568, P83, DOI 10.1113/jphysiol.2005.091942; FARRENS DL, 1995, J BIOL CHEM, V270, P5073, DOI 10.1074/jbc.270.10.5073; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; Fotiadis D, 2006, CURR OPIN STRUC BIOL, V16, P252, DOI 10.1016/j.sbi.2006.03.013; Fotiadis D, 2003, NATURE, V421, P127, DOI 10.1038/421127a; Gao SQ, 2018, MOL PHARMACOL, V94, P1132, DOI 10.1124/mol.118.112581; Gao SQ, 2018, MOL PHARMACOL, V93, P438, DOI 10.1124/mol.117.111294; GENTRY AH, 1984, J ETHNOPHARMACOL, V11, P337, DOI 10.1016/0378-8741(84)90079-5; Goc A, 2008, BIOCHEMISTRY-US, V47, P12409, DOI 10.1021/bi8015444; Gragg M, 2018, BBA-MOL BASIS DIS, V1864, P2938, DOI 10.1016/j.bbadis.2018.06.004; Herrera-Hernandez MG, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11391-x; Hashemzadeh M, 2015, REV CARDIOVASC MED, V16, P68, DOI 10.3909/ricm0754; Hassan NM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15571-7; Heck M, 2001, J BIOL CHEM, V276, P10000, DOI 10.1074/jbc.M009475200; Hilger D, 2018, NAT STRUCT MOL BIOL, V25, P4, DOI 10.1038/s41594-017-0011-7; Hofmann L, 2016, ANAL BIOCHEM, V499, P63, DOI 10.1016/j.ab.2016.01.016; Hussain RM, 2018, EXPERT OPIN PHARMACO, V19, P471, DOI 10.1080/14656566.2018.1448060; Huvaere K, 2015, J SCI FOOD AGR, V95, P20, DOI 10.1002/jsfa.6796; Jastrzebska B, 2004, J BIOL CHEM, V279, P54663, DOI 10.1074/jbc.M408691200; Jastrzebska B, 2006, J BIOL CHEM, V281, P11917, DOI 10.1074/jbc.M600422200; Jastrzebska B, 2015, J BIOL CHEM, V290, P25728, DOI 10.1074/jbc.M115.662684; Jastrzebska Beata, 2015, Methods Mol Biol, V1271, P221, DOI 10.1007/978-1-4939-2330-4_15; Jastrzebska B, 2013, AMINO ACIDS, V45, P1303, DOI 10.1007/s00726-013-1593-y; Jastrzebska B, 2009, BIOCHEMISTRY-US, V48, P5159, DOI 10.1021/bi900284x; Jeong S, 2016, DRUG DES DEV THER, V10, P2211, DOI 10.2147/DDDT.S103370; Krebs MP, 2010, J MOL BIOL, V395, P1063, DOI 10.1016/j.jmb.2009.11.015; Li Y, 2017, FASEB J, V31, P2603, DOI 10.1096/fj.201601339R; Pinheiro GKLD, 2018, ARQ BRAS OFTALMOL, V81, P443, DOI 10.5935/0004-2749.20180086; Majumdar S, 2010, J PHARM PHARMACOL, V62, P951, DOI 10.1211/jpp.62.08.0001; Mallory DP, 2018, BIOCHEMISTRY-US, V57, P5188, DOI 10.1021/acs.biochem.8b00403; Matsumoto H, 2003, J AGR FOOD CHEM, V51, P3560, DOI 10.1021/jf034132y; Milea D, 2015, GRAEF ARCH CLIN EXP, V253, P1839, DOI 10.1007/s00417-015-3167-z; Miyake S, 2012, LAB INVEST, V92, P102, DOI 10.1038/labinvest.2011.132; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mozaffarieh M, 2007, EXPERT OPIN EMERG DR, V12, P195, DOI 10.1517/14728214.12.2.195; Noorwez SM, 2003, J BIOL CHEM, V278, P14442, DOI 10.1074/jbc.M300087200; Noorwez SM, 2008, INVEST OPHTH VIS SCI, V49, P3224, DOI 10.1167/iovs.07-1539; Ohgane K, 2010, BIOORGAN MED CHEM, V18, P7022, DOI 10.1016/j.bmc.2010.08.014; Palczewski K, 2006, VISION RES, V46, P4425, DOI 10.1016/j.visres.2006.10.009; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; PAPERMASTER DS, 1982, METHOD ENZYMOL, V81, P48; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Parveen A, 2018, MOLECULES, V23, DOI 10.3390/molecules23071519; Parveen A, 2018, PHYTOMEDICINE, V39, P146, DOI 10.1016/j.phymed.2017.12.018; Pedretti A, 2004, J COMPUT AID MOL DES, V18, P167, DOI 10.1023/B:JCAM.0000035186.90683.f2; Perusek L, 2013, NUTRIENTS, V5, P2646, DOI 10.3390/nu5072646; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rakoczy EP, 2011, J MOL BIOL, V405, P584, DOI 10.1016/j.jmb.2010.11.003; Rask-Andersen M, 2011, NAT REV DRUG DISCOV, V10, P579, DOI 10.1038/nrd3478; Rhone M, 2008, NUTR REV, V66, P465, DOI 10.1111/j.1753-4887.2008.00078.x; Salom D, 2006, J STRUCT BIOL, V156, P497, DOI 10.1016/j.jsb.2006.05.003; Sassano MF, 2013, J MED CHEM, V56, P2406, DOI 10.1021/jm301749y; Semwal DK, 2016, NUTRIENTS, V8, DOI 10.3390/nu8020090; SURYA A, 1995, J BIOL CHEM, V270, P5024, DOI 10.1074/jbc.270.10.5024; Tian W, 2018, NUCLEIC ACIDS RES, V46, pW363, DOI 10.1093/nar/gky473; Tirupula KC, 2009, PHOTOCHEM PHOTOBIOL, V85, P463, DOI 10.1111/j.1751-1097.2008.00533.x; Travis GH, 2007, ANNU REV PHARMACOL, V47, P469, DOI 10.1146/annurev.pharmtox.47.120505.105225; Tzekov R, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a007492; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; WALD G, 1953, J GEN PHYSIOL, V37, P189, DOI 10.1085/jgp.37.2.189; Wen G, 2017, CHEM BIOL DRUG DES, V90, P580, DOI 10.1111/cbdd.12981; Woodruff ML, 2003, NAT GENET, V35, P158, DOI 10.1038/ng1246; Xin J, 2018, J ENZYM INHIB MED CH, V33, P1545, DOI 10.1080/14756366.2018.1509212; Yanamala N, 2009, PHOTOCHEM PHOTOBIOL, V85, P454, DOI 10.1111/j.1751-1097.2008.00517.x	76	18	18	3	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2019	294	20					8101	8122		10.1074/jbc.RA119.007808	http://dx.doi.org/10.1074/jbc.RA119.007808			22	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC0NH	30944172	Green Published, hybrid			2022-12-26	WOS:000470656500011
J	Lekamge, S; Miranda, AF; Ball, AS; Shukla, R; Nugegoda, D				Lekamge, Sam; Miranda, Ana F.; Ball, Andrew S.; Shukla, Ravi; Nugegoda, Dayanthi			The toxicity of coated silver nanoparticles to Daphnia carinata and trophic transfer from alga Raphidocelis subcapitata	PLOS ONE			English	Article							METAL-OXIDE NANOPARTICLES; ZINC-OXIDE; GOLD NANOPARTICLES; PSEUDOKIRCHNERIELLA-SUBCAPITATA; CHLAMYDOMONAS-REINHARDTII; ENGINEERED NANOPARTICLES; AGGREGATION KINETICS; OXIDATIVE STRESS; SURFACE-CHARGE; FOOD-CHAIN	Nanoparticles (NPs) are causing threats to the environment. Silver NPs (AgNPs) are increasingly used in commercial products and may end up in freshwater ecosystems. The freshwater organisms are vulnerable due to water-borne and dietary exposure to AgNPs. Surface properties play an important role in the fate and behavior of AgNPs in the aquatic environment and their effects on organisms. However, effects of surface properties of AgNPs on organisms are poorly understood. In this study, we explored the effects of AgNPs coated with three different ligands; Tyrosine (T-AgNP), Epigallocatechin gallate (E-AgNP) and Curcumin (C-AgNP) in relation to the toxicity to a key aquatic organism; Daphnia carinata. The study focused on how coatings determine fate of NPs in the medium, mortality, feeding behaviour, bioaccumulation and trophic transfer from the freshwater alga, Raphidocelis subcapitata to daphnids. NP stability tests indicated that T-AgNPs were least stable in the ASTM daphnia medium while C-AgNPs were most stable. 48 h EC50 values of AgNPs to D. carinata were in the order of E-AgNP (19.37 mu g L-1) > C-AgNP (21.37 mu g L-1) > T-AgNP (49.74 g L-1) while the 48 h EC50 value of Ag+ ions was 1.21 mu g L-1. AgNP contaminated algae significantly decreased the feeding rates of daphnids. However, no significant differences were observed in feeding rates between algae contaminated with differently coated AgNPs. Trophic transfer studies showed that AgNPs were transferred from algae to daphnids. The bioacumulation of AgNPs in algae and the diet-borne bioaccumulation of AgNPs in daphnids varied for differently coated AgNPs. Bioaccumulation of C-AgNPs in algae was 1.5 time higher than T-AgNPs. However, the accumulation of T-AgNPs in daphnids via trophic transfer was 2.6 times higher than T-AgNPs. The knowledge generated from this study enhances the understanding of surface property dependent toxicity, bioaccumulation and trophic transfer of AgNPs in aquatic environments.	[Lekamge, Sam; Miranda, Ana F.; Nugegoda, Dayanthi] RMIT Univ, Sch Sci, Ecotoxicol Res Grp, Bundoora, Vic, Australia; [Lekamge, Sam; Ball, Andrew S.; Nugegoda, Dayanthi] RMIT Univ, Sch Sci, Ctr Environm Sustainabil & Remediat, Bundoora, Vic, Australia; [Shukla, Ravi] RMIT Univ, Sch Sci, Nanobiotechnol Res Lab NBRL, Melbourne, Vic, Australia	Royal Melbourne Institute of Technology (RMIT); Royal Melbourne Institute of Technology (RMIT); Royal Melbourne Institute of Technology (RMIT)	Lekamge, S (corresponding author), RMIT Univ, Sch Sci, Ecotoxicol Res Grp, Bundoora, Vic, Australia.	samlekamge@gmail.com	Miranda, Ana F/AAI-6109-2020; Lekamge, Sam/S-6055-2019	Miranda, Ana F/0000-0003-3941-975X; Lekamge, Sam/0000-0001-5546-3668; Ball, Andrew/0000-0003-2387-968X; Nugegoda, Dayanthi/0000-0002-6327-4581; Shukla, Ravi/0000-0002-1537-9637				Abramenko NB, 2018, J HAZARD MATER, V347, P89, DOI 10.1016/j.jhazmat.2017.12.060; Ahmad N, 2010, COLLOID SURFACE B, V81, P81, DOI 10.1016/j.colsurfb.2010.06.029; Allen HJ, 2010, ENVIRON TOXICOL CHEM, V29, P2742, DOI 10.1002/etc.329; ALLEN Y, 1995, ENVIRON TOXICOL CHEM, V14, P1625, DOI 10.1002/etc.5620140923; Artells E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071260; Asghari S, 2012, J NANOBIOTECHNOL, V10, DOI 10.1186/1477-3155-10-14; Asharani PV, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/25/255102; Barry MJ, 2000, CHEMOSPHERE, V41, P1669, DOI 10.1016/S0045-6535(00)00091-6; Baumann J, 2014, SCI TOTAL ENVIRON, V484, P176, DOI 10.1016/j.scitotenv.2014.03.023; Becaro AA., 2015, ENV NANOTECHNOL MONI, V3, P22, DOI DOI 10.1016/J.ENMM.2014.11.002; Beer C, 2012, TOXICOL LETT, V208, P286, DOI 10.1016/j.toxlet.2011.11.002; Behra R, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0396; Bhuvaneshwari M, 2018, ENVIRON RES, V164, P395, DOI 10.1016/j.envres.2018.03.015; Bhuvaneshwari M, 2017, AQUAT TOXICOL, V183, P63, DOI 10.1016/j.aquatox.2016.12.013; Bianchini A, 2003, ENVIRON TOXICOL CHEM, V22, P1361, DOI [10.1002/etc.5620220624, 10.1897/1551-5028(2003)022&lt;1361:MOASTI&gt;2.0.CO;2]; Blinova I, 2013, ENVIRON SCI POLLUT R, V20, P3456, DOI 10.1007/s11356-012-1290-5; Bolch CJS, 1996, J APPL PHYCOL, V8, P5, DOI 10.1007/BF02186215; Bouldin JL, 2008, ENVIRON TOXICOL CHEM, V27, P1958, DOI 10.1897/07-637.1; Brant J, 2005, J NANOPART RES, V7, P545, DOI 10.1007/s11051-005-4884-8; Bundschuh M, 2016, FRESHWATER BIOL; Cecchin I, 2017, INT BIODETER BIODEGR, V119, P419, DOI 10.1016/j.ibiod.2016.09.027; Chae Y, 2016, AQUAT TOXICOL, V173, P94, DOI 10.1016/j.aquatox.2016.01.011; Choi O, 2008, ENVIRON SCI TECHNOL, V42, P4583, DOI 10.1021/es703238h; Cruz D, 2010, COLLOID SURFACE B, V81, P67, DOI 10.1016/j.colsurfb.2010.06.025; Dabrunz A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020112; Daima HK, 2014, NANOSCALE, V6, P758, DOI 10.1039/c3nr03806h; Djurisic AB, 2015, SMALL, V11, P26, DOI 10.1002/smll.201303947; Dominguez GA, 2015, AQUAT TOXICOL, V162, P1, DOI 10.1016/j.aquatox.2015.02.015; Dubey K, 2015, AMINO ACIDS, V47, P2551, DOI 10.1007/s00726-015-2046-6; El Badawy AM, 2011, ENVIRON SCI TECHNOL, V45, P283, DOI 10.1021/es1034188; El Badawy AM, 2010, ENVIRON SCI TECHNOL, V44, P1260, DOI 10.1021/es902240k; El Khoury E, 2015, COLLOID SURFACE B, V127, P274, DOI 10.1016/j.colsurfb.2015.01.050; Elimelech M., 1995, PARTICLE DEPOSITION, DOI [10.1016/B978-0-7506-7024-1.X5000-6, DOI 10.1016/B978-0-7506-7024-1.X5000-6]; Erbis S, 2016, REV RES TRENDS METHO; Freitas EC, 2011, ARCH ENVIRON CON TOX, V60, P241, DOI 10.1007/s00244-010-9541-2; Gardea-Torresdey JL, 2014, ENVIRON SCI TECHNOL, V48, P2526, DOI 10.1021/es4050665; Gillis PL, 2005, AQUAT TOXICOL, V71, P143, DOI 10.1016/j.aquatox.2004.10.016; Grintzalis K, 2017, ECOTOX ENVIRON SAFE, V139, P352, DOI 10.1016/j.ecoenv.2017.02.002; Hamers RJ, 2017, ACCOUNTS CHEM RES, V50, P633, DOI 10.1021/acs.accounts.6b00634; Hanazato T, 2001, ENVIRON POLLUT, V112, P1, DOI 10.1016/S0269-7491(00)00110-X; Hoheisel SM, 2012, ENVIRON TOXICOL CHEM, V31, P2557, DOI 10.1002/etc.1978; Hunter R. J., 1981, ZETA POTENTIAL COLLO, DOI 10.1016/B978-0-12-361961-7.50006-7; Huynh KA, 2011, ENVIRON SCI TECHNOL, V45, P5564, DOI 10.1021/es200157h; Jak RG, 1996, WATER RES, V30, P1215, DOI 10.1016/0043-1354(95)00272-3; Ji J, 2011, CHEM ENG J, V170, P525, DOI 10.1016/j.cej.2010.11.026; Jiang JK, 2009, J NANOPART RES, V11, P77, DOI 10.1007/s11051-008-9446-4; JONES M, 1991, FRESHWATER BIOL, V26, P35, DOI 10.1111/j.1365-2427.1991.tb00506.x; Kalman J, 2015, ENVIRON CHEM, V12, P662, DOI 10.1071/EN15035; Karimi M, 2018, TRENDS FOOD SCI TECH; Keller AA, 2013, J NANOPART RES, V15, DOI 10.1007/s11051-013-1692-4; Keller AA, 2010, ENVIRON SCI TECHNOL, V44, P1962, DOI 10.1021/es902987d; KIERDASZUK B, 1995, PHOTOCHEM PHOTOBIOL, V61, P319, DOI 10.1111/j.1751-1097.1995.tb08615.x; Kittler S, 2010, CHEM MATER, V22, P4548, DOI 10.1021/cm100023p; Klaine SJ, 2012, ENVIRON TOXICOL CHEM, V31, P3, DOI 10.1002/etc.733; Koser J, 2017, ENVIRON SCI-NANO, V4, P1470, DOI [10.1039/c7en00026j, 10.1039/C7EN00026J]; Larguinho M, 2014, J NANOPART RES, V16, DOI 10.1007/s11051-014-2549-1; Lee WM, 2015, ENVIRON POLLUT, V201, P10, DOI 10.1016/j.envpol.2015.02.021; Levard C, 2013, ENVIRON SCI TECHNOL, V47, P5738, DOI 10.1021/es400396f; Li LZ, 2015, ECOTOX ENVIRON SAFE, V119, P66, DOI 10.1016/j.ecoenv.2015.05.005; Li Y, 2017, ARCH TOXICOL, V91, P509, DOI 10.1007/s00204-016-1730-y; Liu JY, 2010, ACS NANO, V4, P6903, DOI 10.1021/nn102272n; Liu JY, 2010, ENVIRON SCI TECHNOL, V44, P2169, DOI 10.1021/es9035557; Lopes S, 2014, ENVIRON TOXICOL CHEM, V33, P190, DOI 10.1002/etc.2413; Lovern SB, 2007, ENVIRON SCI TECHNOL, V41, P4465, DOI 10.1021/es062146p; Lowry GV, 2012, ENVIRON SCI TECHNOL, V46, P6893, DOI 10.1021/es300839e; Lu GH, 2017, WATER AIR SOIL POLL, V228, DOI 10.1007/s11270-016-3206-3; Maurer-Jones MA, 2013, ANAL CHEM, V85, P3036, DOI 10.1021/ac303636s; McTeer J, 2014, NANOTOXICOLOGY, V8, P305, DOI 10.3109/17435390.2013.778346; Mendonca E, 2011, J HAZARD MATER, V186, P265, DOI 10.1016/j.jhazmat.2010.10.115; Miao AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015196; Miao AJ, 2010, ENVIRON TOXICOL CHEM, V29, P2814, DOI 10.1002/etc.340; MOORE M, 1993, TRENDS ECOL EVOL, V8, P178, DOI 10.1016/0169-5347(93)90144-E; Newton KM, 2013, ENVIRON TOXICOL CHEM, V32, P2356, DOI 10.1002/etc.2300; Nowack B, 2011, ENVIRON SCI TECHNOL, V45, P1177, DOI 10.1021/es103316q; OECD, 2011, TEST 201 FRESHW ALG, DOI [10.1787/9789264069923-en., DOI 10.1787/9789264069923-EN.]; OECD, 2004, OECD GUIDELINES TEST, DOI [10.1787/9789264069947-en, DOI 10.1787/9789264069947-EN]; Petersen EJ, 2009, ENVIRON SCI TECHNOL, V43, P2969, DOI 10.1021/es8029363; Piccapietra F, 2012, ENVIRON SCI TECHNOL, V46, P7390, DOI 10.1021/es300734m; Prabhu S, 2012, INT NANO LETT, V2, DOI 10.1186/2228-5326-2-32; Tran QH, 2013, ADV NAT SCI-NANOSCI, V4, DOI 10.1088/2043-6262/4/3/033001; Rai MK, 2012, J APPL MICROBIOL, V112, P841, DOI 10.1111/j.1365-2672.2012.05253.x; Ribeiro F, 2017, SCI TOTAL ENVIRON, V574, P1633, DOI 10.1016/j.scitotenv.2016.08.204; Ribeiro F, 2014, SCI TOTAL ENVIRON, V466, P232, DOI 10.1016/j.scitotenv.2013.06.101; Rodrigues M.A., 2012, AM J CHEM, V2, P157, DOI DOI 10.5923/j.chemistry.20120203.10; Rodriguez-Leon E, 2013, NANOSCALE RES LETT, V8, DOI 10.1186/1556-276X-8-318; Romer I, 2011, J CHROMATOGR A, V1218, P4226, DOI 10.1016/j.chroma.2011.03.034; Sager TM, 2007, NANOTOXICOLOGY, V1, P118, DOI 10.1080/17435390701381596; Sakamoto M, 2015, ARCH ENVIRON CON TOX, V68, P500, DOI 10.1007/s00244-014-0091-x; Schluesener JK, 2013, ARCH TOXICOL, V87, P569, DOI 10.1007/s00204-012-1007-z; Seitz F, 2015, ECOTOX ENVIRON SAFE, V111, P263, DOI 10.1016/j.ecoenv.2014.09.031; Selvakannan PR, 2004, LANGMUIR, V20, P7825, DOI 10.1021/la049258j; Seo J, 2014, B ENVIRON CONTAM TOX, V93, P257, DOI 10.1007/s00128-014-1337-z; Shen MH, 2015, SCI REP-UK, V5, DOI 10.1038/srep09674; Shukla R, 2012, P NATL ACAD SCI USA, V109, P12426, DOI 10.1073/pnas.1121174109; Silva LP, 2017, NANO STR MED, P577, DOI 10.1016/B978-0-323-46152-8.00026-3; Silva T, 2014, SCI TOTAL ENVIRON, V468, P968, DOI 10.1016/j.scitotenv.2013.09.006; Skjolding LM, 2014, AQUAT TOXICOL, V157, P101, DOI 10.1016/j.aquatox.2014.10.005; Snitsarev V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079834; Stebounova LV, 2011, J NANOPART RES, V13, P233, DOI 10.1007/s11051-010-0022-3; Taylor G, 1998, ENVIRON TOXICOL CHEM, V17, P412, DOI 10.1002/etc.5620170310; Tejamaya M, 2012, ENVIRON SCI TECHNOL, V46, P7011, DOI 10.1021/es2038596; Van Hoecke K, 2008, ENVIRON TOXICOL CHEM, V27, P1948, DOI 10.1897/07-634.1; Vance ME, 2015, BEILSTEIN J NANOTECH, V6, P1769, DOI 10.3762/bjnano.6.181; Varaprasad K, 2011, J APPL POLYM SCI, V121, P784, DOI 10.1002/app.33508; Wong SWY, 2010, ANAL BIOANAL CHEM, V396, P609, DOI 10.1007/s00216-009-3249-z; Wu F, 2017, AQUAT TOXICOL, V190, P78, DOI 10.1016/j.aquatox.2017.06.021; Xia T, 2008, ACS NANO, V2, P2121, DOI 10.1021/nn800511k; Yeo MK, 2013, ENVIRON POLLUT, V178, P166, DOI 10.1016/j.envpol.2013.03.040; Zhang W, 2011, ENVIRON SCI TECHNOL, V45, P4422, DOI 10.1021/es104205a; Zhao CM, 2012, ENVIRON SCI TECHNOL, V46, P11345, DOI 10.1021/es3014375; Zhao CM, 2012, NANOTOXICOLOGY, V6, P361, DOI 10.3109/17435390.2011.579632; Zhao CM, 2011, ENVIRON TOXICOL CHEM, V30, P885, DOI 10.1002/etc.451; Zhao CM, 2010, ENVIRON SCI TECHNOL, V44, P7699, DOI 10.1021/es101484s; Zhou DX, 2010, WATER RES, V44, P2948, DOI 10.1016/j.watres.2010.02.025; Zhu XS, 2010, CHEMOSPHERE, V79, P928, DOI 10.1016/j.chemosphere.2010.03.022; Zhu XS, 2010, CHEMOSPHERE, V78, P209, DOI 10.1016/j.chemosphere.2009.11.013	116	19	19	18	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0214398	10.1371/journal.pone.0214398	http://dx.doi.org/10.1371/journal.pone.0214398			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR5NS	30943225	Green Published, Green Submitted, gold			2022-12-26	WOS:000463194300035
J	Raghavan, R; Aaron, GJ; Nahar, B; Knowles, J; Neufeld, LM; Rahman, S; Mondal, P; Ahmed, T				Raghavan, Ramkripa; Aaron, Grant J.; Nahar, Baitun; Knowles, Jacky; Neufeld, Lynnette M.; Rahman, Sabuktagin; Mondal, Prasenjit; Ahmed, Tahmeed			Household coverage of vitamin A fortification of edible oil in Bangladesh	PLOS ONE			English	Article							EXPENDITURES SURVEYS HCES; SCALE FOOD FORTIFICATION; FORTIFIED VEGETABLE-OIL; WHEAT-FLOUR; YOUNG-CHILDREN; RETINYL PALMITATE; MAIZE FLOUR; DEFICIENCY; CONSUMPTION; PROGRAMS	Mandatory fortification of edible oil (soybean and palm) with vitamin A was decreed in Bangladesh in 2013. Yet, there is a dearth of data on the availability and consumption of vitamin A fortifiable oil at household level across population sub-groups. To fill this gap, our study used a nationally representative survey in Bangladesh to assess the purchase of fortifiable edible oil among households and project potential vitamin A intake across population subgroups. Data is presented by strata, age range and poverty-the factors that potentially influence oil coverage. Across 1,512 households, purchase of commercially produced fortifiable edible oil was high (87.5%). Urban households were more likely to purchase fortifiable oil (94.0%) than households in rural low performing (79.7%) and rural other strata (88.1%) (p value: 0.01). Households in poverty were less likely to purchase fortifiable oil (82.1%) than households not in poverty (91.4%) (p <0.001). Projected estimates suggested that vitamin A fortified edible oil would at least partially meet daily vitamin A estimated average requirement (EAR) for the majority of the population. However, certain population sub-groups may still have vitamin A intake below the EAR and alternative strategies may be applied to address the vitamin A needs of these vulnerable sub-groups. This study concludes that a high percentage of Bangladeshi population across different sub-groups have access to fortifiable edible oil and further provides evidence to support mandatory edible oil fortification with vitamin A in Bangladesh.	[Raghavan, Ramkripa; Aaron, Grant J.; Knowles, Jacky; Neufeld, Lynnette M.; Rahman, Sabuktagin] GAIN, Geneva, Switzerland; [Raghavan, Ramkripa] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Ctr Early Life Origins Dis, Baltimore, MD USA; [Nahar, Baitun; Mondal, Prasenjit; Ahmed, Tahmeed] Int Ctr Diarrhoeal Dis Res Icddr B, Dhaka, Bangladesh; [Ahmed, Tahmeed] BRAC Univ, James P Grant Sch Publ Hlth, Dhaka, Bangladesh	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; International Centre for Diarrhoeal Disease Research (ICDDR); Bangladesh Rural Advancement Committee BRAC; BRAC University	Raghavan, R (corresponding author), GAIN, Geneva, Switzerland.; Raghavan, R (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Ctr Early Life Origins Dis, Baltimore, MD USA.	ramkripa@gmail.com			Bill & Melinda Gates Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	Funding for this research was provided by the Bill & Melinda Gates Foundation (http://www.gatesfoundation.org) to GAIN. The funding covered the costs of implementing the research only. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron GJ, 2017, J NUTR, V147, p984S, DOI 10.3945/jn.116.245753; Aaron GJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163176; Aaron GJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162462; Akhtar S, 2013, J HEALTH POPUL NUTR, V31, P413; Alkire S., 2014, MULTIDIMENSIONAL POV; Alkire S, 2014, WORLD DEV, V59, P251, DOI 10.1016/j.worlddev.2014.01.026; [Anonymous], 2011, BANGL MULT IND CLUST; Arsenault JE, 2013, J NUTR, V143, P197, DOI 10.3945/jn.112.169524; Bermudez OI, 2012, FOOD NUTR BULL, V33, pS208, DOI 10.1177/15648265120333S209; Choudhury R, 2012, INT J SUP CHAIN MGT, V1; Dary O, 2002, J NUTR, V132, p2927S, DOI 10.1093/jn/132.9.2927S; Dary O, 2012, FOOD NUTR BULL, V33, pS190, DOI 10.1177/15648265120333S207; Das JK, 2013, SYST REV-LONDON, V2, DOI 10.1186/2046-4053-2-67; Fiedler JL, 2015, PUBLIC HEALTH NUTR, V18, P414, DOI 10.1017/S1368980014000640; Gain, 2016, FORT ED OILS BANGL; Hammond EG, 2005, SOYBEAN OIL; Hemery YM, 2015, FOOD CHEM, V184, P90, DOI 10.1016/j.foodchem.2015.03.096; Hotz C, 2015, MATERN CHILD NUTR, V11, P39, DOI 10.1111/mcn.12245; Imhoff-Kunsch B, 2007, J NUTR, V137, P1017, DOI 10.1093/jn/137.4.1017; Institute of Medicine, 2000, DRI DIET REF INT APP; Knowles JM, 2017, J NUTR, V147, p1004S, DOI 10.3945/jn.116.242586; Kraemer K, 2008, NUTR REV, V66, P517, DOI 10.1111/j.1753-4887.2008.00084.x; Laillou A, 2013, FOOD NUTR BULL, V34, pS72, DOI 10.1177/15648265130342S109; Leyvraz M, 2015, NUTRIENTS, V7, P9960, DOI [10.3390/nu7125511, 10.3390/nu8090541]; Luthringer CL, 2015, GLOB HEALTH-SCI PRAC, V3, P446, DOI 10.9745/GHSP-D-15-00171; Mekuria Getnet, 2017, BMC Nutr, V3, P28, DOI 10.1186/s40795-017-0148-0; Nahar B., 2015, NATL SALT IODIZATION; Pan SuWen, 2008, Journal of Agricultural and Applied Economics, V40, P821; Parisi P, 2012, MED HYPOTHESES, V79, P246, DOI 10.1016/j.mehy.2012.04.049; Pena-Rosas JP, 2008, NUTR REV, V66, P148, DOI 10.1111/j.1753-4887.2008.00019.x; Pignitter M, 2014, J AGR FOOD CHEM, V62, P7559, DOI 10.1021/jf502109j; Popkin BM, 2001, J NUTR, V131, p871S, DOI 10.1093/jn/131.3.871S; Rahman S, 2017, PUBLIC HEALTH NUTR, V20, P1114, DOI [10.1017/S1368980016003049, 10.1017/s1368980016003049]; Rohner F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158552; Rowe JP, 2009, J FOOD COMPOS ANAL, V22, P33, DOI 10.1016/j.jfca.2008.09.004; Simler K, URBANIZATION RURAL U; Souganidis E, 2013, NUTRIENTS, V5, P3257, DOI 10.3390/nu5083257; Spohrer R, 2013, FOOD NUTR BULL, V34, pS50, DOI 10.1177/15648265130342S107; Tazhibayev S, 2008, FOOD NUTR BULL, V29, P255, DOI 10.1177/156482650802900402; UNICEF, 2014, FACTSH VIT A SUPPL P; van den Wijngaart A, 2013, FOOD NUTR BULL, V34, pS102, DOI 10.1177/15648265130342S112; Watson R, 2010, NUTR DIETARY SUPPLEM; Weisell R, 2012, FOOD NUTR BULL, V33, pS157, DOI 10.1177/15648265120333S203; Zamora G, 2014, ANN NY ACAD SCI, V1312, P40, DOI 10.1111/nyas.12306	44	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0212257	10.1371/journal.pone.0212257	http://dx.doi.org/10.1371/journal.pone.0212257			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR5NS	30943194	Green Submitted, Green Published, gold			2022-12-26	WOS:000463194300005
J	Salcedo-Porras, N; Guarneri, A; Oliveira, PL; Lowenberger, C				Salcedo-Porras, Nicolas; Guarneri, Alessandra; Oliveira, Pedro L.; Lowenberger, Carl			Rhodnius prolixus: Identification of missing components of the IMD immune signaling pathway and functional characterization of its role in eliminating bacteria	PLOS ONE			English	Article							TRYPANOSOMA-CRUZI; GENE-EXPRESSION; VECTOR; TOLL; EVOLUTION; GENOMES; TRIATOMINES; REDUCTION; RESPONSES; RESOURCE	The innate immune system in insects is regulated by specific signalling pathways. Most immune related pathways were identified and characterized in holometabolous insects such as Drosophila melanogaster, and it was assumed they would be highly conserved in all insects. The hemimetabolous insect, Rhodnius prolixus, has served as a model to study basic insect physiology, but also is a major vector of the human parasite, Trypanosome cruzi, that causes 10,000 deaths annually. The publication of the R. prolixus genome revealed that one of the main immune pathways, the Immune-deficiency pathway (IMD), was incomplete and probably non-functional, an observation shared with other hemimetabolous insects including the pea aphid (Acyrthosiphon pisum) and the bedbug (Cimex lectularius). It was proposed that the IMD pathway is inactive in R. prolixus as an adaptation to prevent eliminating beneficial symbiont gut bacteria. We used bioinformatic analyses based on reciprocal BLAST and HMM-profile searches to find orthologs for most of the "missing" elements of the IMD pathway and provide data that these are regulated in response to infection with Gram-negative bacteria. We used RNAi strategies to demonstrate the role of the IMD pathway in regulating the expression of specific antimicrobial peptides (AMPs) in the fat body of R. prolixus. The data indicate that the IMD pathway is present and active in R. prolixus, which opens up new avenues of research on R. prolixus-T. cruzi interactions.	[Salcedo-Porras, Nicolas; Lowenberger, Carl] Simon Fraser Univ, Dept Biol Sci, Ctr Cell Biol Dev & Dis, Burnaby, BC, Canada; [Guarneri, Alessandra] Inst Rene Rachou, Ave Augusto de Lima, Belo Horizonte, MG, Brazil; [Oliveira, Pedro L.] Univ Fed Rio de Janeiro, Inst Bioquim Med, CCS, Rio De Janeiro, RJ, Brazil	Simon Fraser University; Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro	Salcedo-Porras, N (corresponding author), Simon Fraser Univ, Dept Biol Sci, Ctr Cell Biol Dev & Dis, Burnaby, BC, Canada.	nicolas_salcedo@sfu.ca	guarneri, Alessandra A/I-4124-2012; L. Oliveira, Pedro/A-9438-2010	Guarneri, Alessandra Aparecida/0000-0002-9162-2731; L. Oliveira, Pedro/0000-0003-0307-354X; Salcedo-Porras, Nicolas/0000-0002-8291-5233	NSERC Discovery grant [RGPIN261940]; MITACS Globalink Research Award [IT08650]	NSERC Discovery grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); MITACS Globalink Research Award	This work was supported by NSERC Discovery grant to CL (RGPIN261940), www.nserc-crsng.gc.ca; MITACS Globalink Research Award to NSP (IT08650), https://www.mitacs.ca/en/programs/globalink/globalink-research-award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Zumaya-Estrada FA, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-017-2561-2; Alves CL, 2011, J MED ENTOMOL, V48, P372, DOI 10.1603/ME10151; [Anonymous], 2015, Wkly Epidemiol Rec, V90, P33; Anselme C, 2006, APPL ENVIRON MICROB, V72, P6766, DOI 10.1128/AEM.00942-06; Armisen D, 2018, BIORXIV, DOI [10.1101/242230, DOI 10.1101/242230]; Armitage SAO, 2015, DEV COMP IMMUNOL, V48, P315, DOI 10.1016/j.dci.2014.03.004; Arp AP, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00570; Azambuja P, 2004, EXP PARASITOL, V107, P89, DOI 10.1016/j.exppara.2004.04.007; Bao YY, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-160; Begun DJ, 2000, GENETICS, V154, P1231; Behrman EL, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2017.2599; Benoit JB, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10165; Bottino-Rojas V, 2018, J BIOL CHEM, V293, P9053, DOI 10.1074/jbc.RA117.001589; Brucker RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045125; Bulmer MS, 2006, MOL BIOL EVOL, V23, P317, DOI 10.1093/molbev/msj037; Campbell Michael S, 2014, Curr Protoc Bioinformatics, V48, DOI 10.1002/0471250953.bi0411s48; Castro DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036591; Chagas C., 1909, Memorias do Instituto Oswaldo Cruz, V1; Chavez ASO, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00223; Dias FD, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004186; Diaz-Albiter HM, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1401-0; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elsik CG, 2016, NUCLEIC ACIDS RES, V44, pD793, DOI 10.1093/nar/gkv1208; Elsik CG, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-106; Ferreira RC, 2016, PARASITOLOGY, V143, P434, DOI 10.1017/S0031182015001857; Flores-Villegas AL, 2015, B ENTOMOL RES, V105, P523, DOI 10.1017/S0007485315000504; Ganesan S, 2011, CURR TOP MICROBIOL, V349, P25, DOI 10.1007/82_2010_107; Garcia ES, 2010, TRENDS PARASITOL, V26, P499, DOI 10.1016/j.pt.2010.07.003; Gerardo NM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r21; Giraldo-Calderon GI, 2015, NUCLEIC ACIDS RES, V43, pD707, DOI 10.1093/nar/gku1117; Gordon ERL, 2016, APPL ENVIRON MICROB, V82, P7123, DOI 10.1128/AEM.02114-16; Gramates LS, 2017, NUCLEIC ACIDS RES, V45, pD663, DOI 10.1093/nar/gkw1016; Guarneri AA, 2017, J INSECT PHYSIOL, V97, P66, DOI 10.1016/j.jinsphys.2016.07.005; Han M, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-245; Ioannidis P, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-738; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kersey PJ, 2018, NUCLEIC ACIDS RES, V46, pD802, DOI 10.1093/nar/gkx1011; Kim JH, 2011, INSECT BIOCHEM MOLEC, V41, P332, DOI 10.1016/j.ibmb.2011.01.011; Kirkness EF, 2010, P NATL ACAD SCI USA, V107, P12168, DOI 10.1073/pnas.1003379107; Kleino A, 2014, DEV COMP IMMUNOL, V42, P25, DOI 10.1016/j.dci.2013.05.014; Kuechler SM, 2011, APPL ENVIRON MICROB, V77, P2869, DOI 10.1128/AEM.02983-10; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lai AG, 2016, BIORXIV, DOI [10.1101/091835, DOI 10.1101/091835]; Lai AG, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3769-4; Latorre-Estivalis JM, 2017, SCI REP-UK, V7, DOI 10.1038/srep40049; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Lindsay SA, 2014, DEV COMP IMMUNOL, V42, P16, DOI 10.1016/j.dci.2013.04.011; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez L, 2003, INSECT BIOCHEM MOLEC, V33, P439, DOI 10.1016/S0965-1748(03)00008-0; McTaggart SJ, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-63; MELLO CB, 1995, J INVERTEBR PATHOL, V65, P261, DOI 10.1006/jipa.1995.1040; Mesquita RD, 2015, P NATL ACAD SCI USA, V112, P14936, DOI 10.1073/pnas.1506226112; Morin-Poulard Ismael, 2013, JAKSTAT, V2, pe25700, DOI 10.4161/jkst.25700; Myllymaki H, 2014, J IMMUNOL, V192, P3455, DOI 10.4049/jimmunol.1303309; Nishide Y, 2019, P ROY SOC B-BIOL SCI, V286, DOI 10.1098/rspb.2018.2207; Noireau F, 2009, VET RES, V40, DOI 10.1051/vetres/2009009; Obbard DJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000698; Palmer WJ, 2015, MOL BIOL EVOL, V32, P2111, DOI 10.1093/molbev/msv093; Panfilio KA, 2017, BIORXIV, DOI [10. 1101/201731, DOI 10.1101/201731]; Poelchau M, 2015, NUCLEIC ACIDS RES, V43, pD714, DOI 10.1093/nar/gku983; Rao Q, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1379-6; Ribeiro JMC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002594; Sackton TB, 2007, NAT GENET, V39, P1461, DOI 10.1038/ng.2007.60; Saha S, 2017, DATABASE-OXFORD, DOI 10.1093/database/bax032; Savioli L, WHO DEP CONTROL NEGL; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shaw DK, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14401; Sloan DB, 2014, MOL BIOL EVOL, V31, P857, DOI 10.1093/molbev/msu004; Snodgrass RE, 1939, SCIENCE, V90, P159, DOI [10.1126/science.90.2329.159-a, DOI 10.1126/SCIENCE.90.2329.159-A]; Song N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048778; Stanke M, 2005, NUCLEIC ACIDS RES, V33, pW465, DOI 10.1093/nar/gki458; Tanji T, 2007, MOL CELL BIOL, V27, P4578, DOI 10.1128/MCB.01814-06; Tanji T, 2010, P NATL ACAD SCI USA, V107, P14715, DOI 10.1073/pnas.1009473107; TEJERA G. E, 1919, B SOC PATHOL EXOT, V12, P509; Toenshoff ER, 2012, ENVIRON MICROBIOL, V14, P1284, DOI 10.1111/j.1462-2920.2012.02712.x; Toubiana M, 2014, DEV COMP IMMUNOL, V45, P300, DOI 10.1016/j.dci.2014.03.021; Ursic-Bedoya R, 2011, INSECT MOL BIOL, V20, P775, DOI 10.1111/j.1365-2583.2011.01107.x; Ursic-Bedoya RJ, 2008, J INSECT PHYSIOL, V54, P593, DOI 10.1016/j.jinsphys.2007.12.009; Ursic-Bedoya RJ, 2007, DEV COMP IMMUNOL, V31, P109, DOI 10.1016/j.dci.2006.05.008; Valanne S, 2011, J IMMUNOL, V186, P649, DOI 10.4049/jimmunol.1002302; Vieira CS, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1398-4; Vieira CS, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0736-2; Vieira CS, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-232; Wang JW, 2009, P NATL ACAD SCI USA, V106, P12133, DOI 10.1073/pnas.0901226106; Whitten MMA, 2001, EXP PARASITOL, V98, P44, DOI 10.1006/expr.2001.4615; Yin CL, 2016, NUCLEIC ACIDS RES, V44, pD801, DOI 10.1093/nar/gkv1204; Zhang RD, 2017, FRONT CELL INFECT MI, V7, DOI [10.3382/fcimb.2017.00022, 10.3389/fcimb.2017.00022]; Zhong X, 2016, SCI REP-UK, V6, DOI 10.1038/srep20654	90	24	25	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0214794	10.1371/journal.pone.0214794	http://dx.doi.org/10.1371/journal.pone.0214794			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR5NS	30943246	Green Submitted, Green Published, gold			2022-12-26	WOS:000463194300062
J	Serrano, RL; Yu, WF; Graham, RM; Liu-Bryan, R; Terkeltaub, R				Serrano, Ramon L.; Yu, Weifang; Graham, Robert M.; Liu-Bryan, Ru; Terkeltaub, Robert			A vascular smooth muscle cell X-box binding protein 1 and transglutaminase 2 regulatory circuit limits neointimal hyperplasia	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; INTIMAL HYPERPLASIA; TISSUE TRANSGLUTAMINASE; OXIDATIVE STRESS; APOPTOSIS; DIFFERENTIATION; SUMOYLATION; ACTIVATION	Neointimal hyperplasia, stimulated by injury and certain vascular diseases, promotes artery obstruction and tissue ischemia. In vascular smooth muscle cell (VSMCs), multiple modulators of protein handling machinery regulate intimal hyperplasia. These include elements of the VSMC unfolded protein response to endoplasmic reticulum stress (UPRER), and trans-glutaminase 2 (TG2), which catalyzes post-translational protein modification. Previous results for deficiency of UPRER -specific mediator XBP1, and of TG2, have been significant, but in multiple instances contradictory, for effects on cultured VSMC function, and, using multiple models, for neointimal hyperplasia in vivo. Here, we engineered VSMC-specific deficiency of XBP1, and studied cultured VSMCs, and neointimal hyperplasia in response to carotid artery ligation in vivo. Intimal area almost doubled in Xbp1(fl/fl) SM22 alpha-CRE+ mice 21 days post-ligation. Cultured murine Xbp1 deficient VSMCs migrated more in response to platelet derived growth factor (PDGF) than control VSMCs, and had an increased level of inositol-requiring enzyme 1 alpha (Ire1 alpha), a PDGF receptor-binding UPRER transmembrane endonuclease whose substrates include XBP1. Cultured XBP1-deficient VSMCs demonstrated decreased levels of TG2 protein, in association with increased TG2 polyubiquitination, but with increased TG transamidation catalytic activity. Moreover, IRE1 alpha, and TG2-specific transamidation cross-links were increased in carotid artery neointima in Xbp1(fl/fl) SM22 alpha-CRE+ mice. Cultured TG2-deficient VSMCs had decreased XBP1 associated with increased IRE1 alpha, and increased migration in response to PDGF. Neointimal hyperplasia also was significantly increased in Tgm2(fl/fl) SM22 alpha-CRE+ mice at 21 days after carotid ligation. In conclusion, a VSMC regulatory circuit between XBP1 and TG2 limits neointimal hyperplasia in response to carotid ligation.	[Serrano, Ramon L.; Yu, Weifang; Liu-Bryan, Ru; Terkeltaub, Robert] Univ Calif San Diego, Dept Med, Vet Affairs Healthcare Syst, La Jolla, CA 92093 USA; [Graham, Robert M.] Victor Chang Cardiac Res Inst, Darlinghurst, NSW, Australia; [Yu, Weifang] Univ Southern Calif, Dept Cardiovasc Res, Los Angeles, CA USA	University of California System; University of California San Diego; Victor Chang Cardiac Research Institute; University of Southern California	Terkeltaub, R (corresponding author), Univ Calif San Diego, Dept Med, Vet Affairs Healthcare Syst, La Jolla, CA 92093 USA.	rterkeltaub@ucsd.edu			Department of Veterans Affairs Merit Review [I01BX002234, I01BX001660]; NIH [P50 AR060772-6]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR060772] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001660] Funding Source: NIH RePORTER	Department of Veterans Affairs Merit Review(US Department of Veterans Affairs); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Veterans Affairs(US Department of Veterans Affairs)	The study was supported by Department of Veterans Affairs Merit Review grants I01BX002234 (RLB) and I01BX001660 (RT), and NIH grant P50 AR060772-6 Project 1 (RT).	Abdullah A, 2018, EUR J CELL BIOL, V97, P359, DOI 10.1016/j.ejcb.2018.05.002; Agnihotri N, 2017, AMINO ACIDS, V49, P425, DOI 10.1007/s00726-016-2320-2; Almanza A, 2019, FEBS J, V286, P241, DOI 10.1111/febs.14608; Boucher P, 2003, SCIENCE, V300, P329, DOI 10.1126/science.1082095; Covino R, 2018, MOL CELL, V71, P458, DOI 10.1016/j.molcel.2018.07.019; Dammanahalli KJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039106; de Jong RCM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185820; Gao JH, 2011, CIRCULATION, V124, P830, DOI 10.1161/CIRCULATIONAHA.110.014050; Grice GL, 2016, CELL MOL LIFE SCI, V73, P3497, DOI 10.1007/s00018-016-2255-5; Guo FJ, 2014, CELL SIGNAL, V26, P1998, DOI 10.1016/j.cellsig.2014.05.008; Hetz C, 2008, P NATL ACAD SCI USA, V105, P757, DOI 10.1073/pnas.0711094105; Hetz C, 2011, PHYSIOL REV, V91, P1219, DOI 10.1152/physrev.00001.2011; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Hui DY, 2008, CURR DRUG TARGETS, V9, P251, DOI 10.2174/138945008783755601; Ishimura S, 2014, SCI REP-UK, V4, DOI 10.1038/srep06943; Johnson KA, 2008, CIRC RES, V102, P529, DOI 10.1161/CIRCRESAHA.107.154260; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Lee CS, 2017, APOPTOSIS, V22, P1057, DOI 10.1007/s10495-017-1396-9; Liu Y, 2009, CELL DEATH DIFFER, V16, P847, DOI 10.1038/cdd.2009.14; Luciani A, 2009, J IMMUNOL, V183, P2775, DOI 10.4049/jimmunol.0900993; Martinon F, 2010, NAT IMMUNOL, V11, P411, DOI 10.1038/ni.1857; Mendler L, 2016, CIRC RES, V118, P132, DOI 10.1161/CIRCRESAHA.115.307730; Min SK, 2014, J KOREAN MED SCI, V29, P363, DOI 10.3346/jkms.2014.29.3.363; Nanda N, 2001, J BIOL CHEM, V276, P20673, DOI 10.1074/jbc.M010846200; Nurminskaya M, 2014, J VASC RES, V51, P418, DOI 10.1159/000369461; Scott RA, 2014, BIOMACROMOLECULES, V15, P2825, DOI 10.1021/bm5007757; Shin S, 2013, J VASC SURG, V57, P1362, DOI 10.1016/j.jvs.2012.09.062; SLAUGHTER TF, 1992, ANAL BIOCHEM, V205, P166, DOI 10.1016/0003-2697(92)90594-W; Song M, 2018, NATURE, V562, P423, DOI 10.1038/s41586-018-0597-x; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Tatham MH, 2009, NAT PROTOC, V4, P1363, DOI 10.1038/nprot.2009.128; Thorp E, 2009, CELL METAB, V9, P474, DOI 10.1016/j.cmet.2009.03.003; Todd DJ, 2009, J EXP MED, V206, P2151, DOI 10.1084/jem.20090738; van den Akker J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023067; Wu J, 2016, CELL PHYSIOL BIOCHEM, V38, P847, DOI 10.1159/000443039; Yang Xiang-Jiao, 2013, F1000Prime Rep, V5, P45, DOI 10.12703/P5-45; Yu WF, 2012, ATHEROSCLEROSIS, V222, P417, DOI 10.1016/j.atherosclerosis.2012.04.001; Zeng LF, 2015, ARTERIOSCL THROM VAS, V35, P2134, DOI 10.1161/ATVBAHA.115.305420; Zhang JW, 1998, J BIOL CHEM, V273, P2288, DOI 10.1074/jbc.273.4.2288; Zhang W, 2006, CELL METAB, V4, P491, DOI 10.1016/j.cmet.2006.11.002; Zhao Q, 2017, FASEB J, V31, P5321, DOI 10.1096/fj.201700327R	41	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0212235	10.1371/journal.pone.0212235	http://dx.doi.org/10.1371/journal.pone.0212235			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR5NS	30943188	gold, Green Submitted, Green Published			2022-12-26	WOS:000463194300004
J	Zhelezova, A; Chernov, T; Tkhakakhova, A; Xenofontova, N; Semenov, M; Kutovaya, O				Zhelezova, Alena; Chernov, Timofey; Tkhakakhova, Azida; Xenofontova, Natalya; Semenov, Mikhail; Kutovaya, Olga			Prokaryotic community shifts during soil formation on sands in the tundra zone	PLOS ONE			English	Article							BACTERIAL COMMUNITY; DENITRIFYING BACTERIA; MICROBIAL DIVERSITY; FUNGAL COMMUNITIES; EARLIEST STAGES; SUCCESSION; RESPONSES; MOUNTAIN; GENES; LAND	A chronosequence approach, i.e., a comparison of spatially distinct plots with different stages of succession, is commonly used for studying microbial community dynamics during paedogenesis. The successional traits of prokaryotic communities following sand fixation processes have previously been characterized for arid and semi-arid regions, but they have not been considered for the tundra zone, where the environmental conditions are unfavourable for the establishment of complicated biocoenoses. In this research, we characterized the prokaryotic diversity and abundance of microbial genes found in a typical tundra and wooded tundra along a gradient of increasing vegetation-unfixed aeolian sand, semi-fixed surfaces with mosses and lichens, and mature soil under fully developed plant cover. Microbial communities from typical tundra and wooded tundra plots at three stages of sand fixation were compared using quantitative polymerase chain reaction (qPCR) and high-throughput sequencing of 16S rRNA gene libraries. The abundances of ribosomal genes increased gradually in both chronosequences, and a similar trend was observed for the functional genes related to the nitrogen cycle (nifH, bacterial amoA, nirK and nirS). The relative abundance of Planctomycetes increased, while those of Thaumarchaeota, Cyanobacteria and Chloroflexi decreased from unfixed sands to mature soils. According to beta-diversity analysis, prokaryotic communities of unfixed sands were more heterogeneous compared to those of mature soils. Despite the differences in the plant cover of the two mature soils, the structural compositions of the prokaryotic communities were shaped in the same way. Thus, sand fixation in the tundra zone increases archaeal, bacterial and fungal abundances, shifts and unifies prokaryotic communities structure.	[Zhelezova, Alena; Chernov, Timofey; Tkhakakhova, Azida; Xenofontova, Natalya; Semenov, Mikhail; Kutovaya, Olga] VV Dokuchaev Soil Sci Inst, Dept Soil Biol & Biochem, Moscow, Russia; [Xenofontova, Natalya] Lomonosov Moscow State Univ, Dept Soil Sci, Moscow, Russia	Dokuchaev Soil Science Institute; Lomonosov Moscow State University	Zhelezova, A (corresponding author), VV Dokuchaev Soil Sci Inst, Dept Soil Biol & Biochem, Moscow, Russia.	zhelezova.ad@gmail.com	Chernov, Timofey/B-8985-2018; Zhelezova, Alena/GWZ-2540-2022; Semenov, Mikhail V./N-1754-2018; Tkhakakhova, Azida/U-9651-2019; Zhelezova, Alena/X-1944-2019	Semenov, Mikhail V./0000-0001-6811-5793; Zhelezova, Alena/0000-0002-2086-299X	Russian Science Foundation [17-16-01057]; RSF	Russian Science Foundation(Russian Science Foundation (RSF)); RSF(Russian Science Foundation (RSF))	This research was primarily supported by the Russian Science Foundation (project number 17-16-01057). All authors (Alena Zhelezova, Timofey Chernov, Azida Tkhakakhova, Natalya Xenofontova, Mikhail Semenov, Olga Kutovaya) received the financial support from RSF. RSF-http://www.rscf.ru/en/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates ST, 2011, ISME J, V5, P908, DOI 10.1038/ismej.2010.171; Bellezza S, 2003, J APPL PHYCOL, V15, P193, DOI 10.1023/A:1023811311686; Blaud A, 2015, RES MICROBIOL, V166, P796, DOI 10.1016/j.resmic.2015.07.013; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Braker G, 1998, APPL ENVIRON MICROB, V64, P3769; Brankatschk R, 2011, ISME J, V5, P1025, DOI 10.1038/ismej.2010.184; Brown SP, 2014, MOL ECOL, V23, P481, DOI 10.1111/mec.12487; Buckeridge KM, 2013, SOIL BIOL BIOCHEM, V65, P338, DOI 10.1016/j.soilbio.2013.06.012; Cao CY, 2017, APPL MICROBIOL BIOT, V101, P6217, DOI 10.1007/s00253-017-8336-z; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Castle SC, 2017, OECOLOGIA, V185, P513, DOI 10.1007/s00442-017-3965-6; CHAO A, 1984, SCAND J STAT, V11, P265; Chapin F.S, 2012, PRINCIPLES TERRESTRI; Chrismas NAM, 2018, FEMS MICROBIOL ECOL, V94, DOI 10.1093/femsec/fiy032; Ciccazzo S, 2016, ANN MICROBIOL, V66, P43, DOI 10.1007/s13213-015-1130-1; COLWELL RK, 1994, PHILOS T R SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; Esposito A, 2013, CURR MICROBIOL, V67, P472, DOI 10.1007/s00284-013-0391-9; Fierer N, 2005, APPL ENVIRON MICROB, V71, P4117, DOI 10.1128/AEM.71.7.4117-4120.2005; Glanville HC, 2012, FUNCT ECOL, V26, P1366, DOI 10.1111/j.1365-2435.2012.02056.x; Hallin S, 2009, ISME J, V3, P597, DOI 10.1038/ismej.2008.128; Henry S, 2004, J MICROBIOL METH, V59, P327, DOI 10.1016/j.mimet.2004.07.002; ISSS, 2014, WORLD REF BAS SOIL R; Jangid K, 2013, MOL ECOL, V22, P3415, DOI 10.1111/mec.12325; Jones CM, 2010, ISME J, V4, P633, DOI 10.1038/ismej.2009.152; Kelly LC, 2014, MICROB ECOL, V68, P504, DOI 10.1007/s00248-014-0432-3; Kuzyakov Y, 2015, SOIL BIOL BIOCHEM, V83, P184, DOI 10.1016/j.soilbio.2015.01.025; Levy-Booth DJ, 2014, SOIL BIOL BIOCHEM, V75, P11, DOI 10.1016/j.soilbio.2014.03.021; Li J, 2016, J ENVIRON SCI-CHINA, V39, P155, DOI 10.1016/j.jes.2015.10.009; Liu LC, 2017, SOIL BIOL BIOCHEM, V107, P125, DOI 10.1016/j.soilbio.2016.12.030; Liu XY, 2018, P NATL ACAD SCI USA, V115, P3398, DOI 10.1073/pnas.1715382115; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; Ma WB, 2016, SOIL BIOL BIOCHEM, V101, P195, DOI 10.1016/j.soilbio.2016.07.023; Madsen EL, 2011, CURR OPIN BIOTECH, V22, P456, DOI 10.1016/j.copbio.2011.01.008; Makhalanyane TP, 2016, CURR OPIN BIOTECH, V38, P159, DOI 10.1016/j.copbio.2016.01.011; Michotey V, 2000, APPL ENVIRON MICROB, V66, P1564, DOI 10.1128/AEM.66.4.1564-1571.2000; Navarrete AA, 2015, MOL ECOL, V24, P2433, DOI 10.1111/mec.13172; Nemergut DR, 2007, MICROB ECOL, V53, P110, DOI 10.1007/s00248-006-9144-7; Poly F, 2001, APPL ENVIRON MICROB, V67, P2255, DOI 10.1128/AEM.67.5.2255-2262.2001; Prosser JI, 2012, TRENDS MICROBIOL, V20, P523, DOI 10.1016/j.tim.2012.08.001; Regan K, 2017, SOIL BIOL BIOCHEM, V109, P214, DOI 10.1016/j.soilbio.2016.11.011; Ren JS, 2018, SCI TOTAL ENVIRON, V625, P782, DOI 10.1016/j.scitotenv.2017.12.309; Rognes T, 2016, PEERJ, V4, DOI 10.7717/peerj.2584; Rughoft S, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01638; Schaub I, 2019, MICROB ECOL, V77, P217, DOI 10.1007/s00248-018-1220-2; Schmidt SK, 2008, P ROY SOC B-BIOL SCI, V275, P2793, DOI 10.1098/rspb.2008.0808; Schmidt SK, 2014, MOL ECOL, V23, P254, DOI 10.1111/mec.12589; Semenov MV, 2018, APPL SOIL ECOL, V127, P8, DOI 10.1016/j.apsoil.2018.03.002; Sengupta A, 2017, APPL SOIL ECOL, V119, P35, DOI 10.1016/j.apsoil.2017.05.031; Sengupta A, 2015, MICROB ECOL, V70, P853, DOI 10.1007/s00248-015-0609-4; Sigler WV, 2002, MICROB ECOL, V43, P397, DOI 10.1007/s00248-001-0045-5; Sun HY, 2016, J MT SCI-ENGL, V13, P1621, DOI 10.1007/s11629-015-3570-2; Tas N, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03089-z; Throback IN, 2004, FEMS MICROBIOL ECOL, V49, P401, DOI 10.1016/j.femsec.2004.04.011; Turner BL, 2015, ECOSYSTEMS, V18, P287, DOI 10.1007/s10021-014-9830-0; Walker LR, 2010, J ECOL, V98, P725, DOI 10.1111/j.1365-2745.2010.01664.x; Wang SK, 2018, ECOL EVOL, V8, P1693, DOI 10.1002/ece3.3746; Wu XK, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/1/014038; Yabe S, 2017, INT J SYST EVOL MICR, V67, P2615, DOI 10.1099/ijsem.0.001985; Yang YD, 2017, EUR J SOIL BIOL, V82, P1, DOI 10.1016/j.ejsobi.2017.05.006; Yarwood SA, 2017, SOIL BIOL BIOCHEM, V114, P160, DOI 10.1016/j.soilbio.2017.07.017; Yu J, 2016, APPL SOIL ECOL, V101, P124, DOI 10.1016/j.apsoil.2016.01.022; Yu Y, 2005, WATER SCI TECHNOL, V52, P85, DOI 10.2166/wst.2005.0502; Zhan J, 2012, MICROBIOL RES, V167, P157, DOI 10.1016/j.micres.2011.05.006	63	11	14	4	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2019	14	4							e0206777	10.1371/journal.pone.0206777	http://dx.doi.org/10.1371/journal.pone.0206777			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR2UW	30939175	Green Submitted, Green Published, gold			2022-12-26	WOS:000462993900002
J	Vu, HTK; Benjakul, S; Vongkamjan, K				Hue Thi Kim Vu; Benjakul, Soottawat; Vongkamjan, Kitiya			Characterization of Listeria prophages in lysogenic isolates from foods and food processing environments	PLOS ONE			English	Article							GENOME SEQUENCE; SP NOV.; MONOCYTOGENES; BACTERIOPHAGE; DIVERSITY; PHAGES; STRAINS; EVOLUTION; SPP.	Prophages are commonly found in Listeria genomes, potentially enhancing survival or fitness of Listeria spp. Currently, there is still limited information on the distribution of prophages among Listeria isolates of different allelic types and from various sources. In this study, by using mitomycin C induction, prophages were found in 23/144 isolates (16.0%), including 13 L. monocytogenes and 10 Listeria spp. isolates, resulting in 28 and 11 induced phages, respectively. These prophage-carrying isolates (lysogens) were obtained from foods and food-related environments presenting 3 common allelic types (ATs) of L. monocytogenes (lineage I, II and IV), 4 ATs of L. innocua and 1 AT of L. welshimeri. The likelihood of prophage-carrying isolates of L. monocytogenes was 14.4 (95% CI: 4.9-35.4), and 18.5 (95% CI: 4.8-50.2) for Listeria spp. The 39 induced phages were classified into 3 lysis groups by the host range test against 9 major serotypes of L. monocytogenes and 5 species of Listeria. Most phages were host-specific with higher ability to lyse L. monocytogenes serotype 4 than other serotypes. The genome size of phages ranged from 35 +/- 2 kb to 50 +/- 2 kb and belonged to two common phage families, Myoviridae and Siphoviridae. Restriction analysis classified 19 selected phages into 16 restriction profiles, suggesting highly diverse prophages with at least 16 types. This may contribute to the variation in the genomes of Listeria. Information obtained here provides basic knowledge for further study to understand the overall role of prophages in Listeria, including roles in survival or fitness in foods and food processing environments.	[Hue Thi Kim Vu; Benjakul, Soottawat; Vongkamjan, Kitiya] Prince Songkla Univ, Dept Food Technol, Hat Yai, Songkla, Thailand; [Hue Thi Kim Vu] NIVR, Dept Vet Hyg & Food Safety, Hanoi, Vietnam	Prince of Songkla University	Vongkamjan, K (corresponding author), Prince Songkla Univ, Dept Food Technol, Hat Yai, Songkla, Thailand.	kitiya.v@psu.ac.th	Benjakul, Soottawat/C-8927-2009	Benjakul, Soottawat/0000-0001-9433-3671	Higher Education Research Promotion; Thailand's Education Hub for Southern Region of ASEAN Countries Project Office of the Higher Education Commission; Prince of Songkla University [AGR600584S]; TRF Distinguished Research Professor Grant	Higher Education Research Promotion; Thailand's Education Hub for Southern Region of ASEAN Countries Project Office of the Higher Education Commission; Prince of Songkla University; TRF Distinguished Research Professor Grant	This project is financially supported by the Higher Education Research Promotion and the Thailand's Education Hub for Southern Region of ASEAN Countries Project Office of the Higher Education Commission (to HTKV). Funding from Prince of Songkla University (AGR600584S; to KV) and the TRF Distinguished Research Professor Grant (to SB) is also acknowledged.	Bertsch D, 2013, INT J SYST EVOL MICR, V63, P526, DOI 10.1099/ijs.0.036947-0; Bondy-Denomy J, 2016, ISME J, V10, P2854, DOI 10.1038/ismej.2016.79; Burgess CM, 2016, INT J FOOD MICROBIOL, V221, P37, DOI 10.1016/j.ijfoodmicro.2015.12.014; Casjens S, 2003, MOL MICROBIOL, V49, P277, DOI 10.1046/j.1365-2958.2003.03580.x; den Bakker HC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067511; Denes T, 2014, APPL ENVIRON MICROB, V80, P4616, DOI 10.1128/AEM.00720-14; Desiere F, 2002, ANTON LEEUW INT J G, V82, P73, DOI 10.1023/A:1020676825358; Domelier AS, 2009, J BACTERIOL, V191, P4776, DOI 10.1128/JB.00426-09; Dorscht J, 2009, J BACTERIOL, V191, P7206, DOI 10.1128/JB.01041-09; Doumith M, 2004, J CLIN MICROBIOL, V42, P3819, DOI 10.1128/JCM.42.8.3819-3822.2004; Eugster MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021500; Ferreira V, 2011, APPL ENVIRON MICROB, V77, P2701, DOI 10.1128/AEM.02553-10; Fortier LC, 2007, APPL ENVIRON MICROB, V73, P7358, DOI 10.1128/AEM.00582-07; Fortier LC, 2013, VIRULENCE, V4, P354, DOI 10.4161/viru.24498; Goerke C, 2009, J BACTERIOL, V191, P3462, DOI 10.1128/JB.01804-08; Goh S, 2007, MICROBIOL-SGM, V153, P676, DOI 10.1099/mic.0.2006/002436-0; Graves LM, 2010, INT J SYST EVOL MICR, V60, P1280, DOI 10.1099/ijs.0.014118-0; Guttman B, 2005, BACTERIOPHAGE: BIOLOGY AND APPLICATIONS, P29; Hain T, 2006, J BACTERIOL, V188, P7405, DOI 10.1128/JB.00758-06; Halter EL, 2013, INT J SYST EVOL MICR, V63, P641, DOI 10.1099/ijs.0.036830-0; Jiang SC, 1996, MAR ECOL PROG SER, V142, P27, DOI 10.3354/meps142027; Kim JW, 2008, APPL ENVIRON MICROB, V74, P6623, DOI 10.1128/AEM.01282-08; Klumpp Jochen, 2013, Bacteriophage, V3, pe26861; Kuenne C, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-47; Kutter E., 2005, BACTERIOPHAGES BIOL; Lemaitre JP, 1997, LETT APPL MICROBIOL, V24, P51, DOI 10.1046/j.1472-765X.1997.00346.x; Liao JQ, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.00306-17; LOESSNER MJ, 1990, APPL ENVIRON MICROB, V56, P1912, DOI 10.1128/AEM.56.6.1912-1918.1990; Loessner MJ, 2000, MOL MICROBIOL, V35, P324, DOI 10.1046/j.1365-2958.2000.01720.x; LOESSNER MJ, 1991, LETT APPL MICROBIOL, V12, P196, DOI 10.1111/j.1472-765X.1991.tb00538.x; Lopez E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094358; Mammina C, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-152; Marini E, 2016, EUROSURVEILLANCE, V21, P8, DOI 10.2807/1560-7917.ES.2016.21.17.30217; Nale JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037263; Nelson KE, 2004, NUCLEIC ACIDS RES, V32, P2386, DOI 10.1093/nar/gkh562; Nightingale KK, 2005, J BACTERIOL, V187, P5537, DOI 10.1128/JB.187.16.5537-5551.2005; Orsi RH, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-539; PALUMBO S A, 1991, Food Microbiology (London), V8, P63, DOI 10.1016/0740-0020(91)90017-V; Poblet-Icart M, 1998, CURR MICROBIOL, V36, P365, DOI 10.1007/s002849900324; Rabinovich L, 2012, CELL, V150, P792, DOI 10.1016/j.cell.2012.06.036; Rychli K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176857; Swaminathan B, 2007, MICROBES INFECT, V9, P1236, DOI 10.1016/j.micinf.2007.05.011; Switt AIM, 2013, FOOD MICROBIOL, V36, P275, DOI 10.1016/j.fm.2013.06.014; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tolvanen R, 2008, J FOOD PROTECT, V71, P1550, DOI 10.4315/0362-028X-71.8.1550; Verghese B, 2011, APPL ENVIRON MICROB, V77, P3279, DOI 10.1128/AEM.00546-11; Vongkamjan K, 2017, FOOD MICROBIOL, V66, P11, DOI 10.1016/j.fm.2017.03.014; Vongkamjan K, 2016, J FOOD PROTECT, V79, P239, DOI 10.4315/0362-028X.JFP-15-361; Vongkamjan K, 2015, FOOD CONTROL, V50, P265, DOI 10.1016/j.foodcont.2014.09.001; Vongkamjan K, 2012, APPL ENVIRON MICROB, V78, P8666, DOI 10.1128/AEM.01859-12; Wendlinger G, 1996, MICROBIOL-UK, V142, P985, DOI 10.1099/00221287-142-4-985; Wright EE, 2013, J APPL MICROBIOL, V114, P1616, DOI 10.1111/jam.12192; Zimmer M, 2003, MOL MICROBIOL, V50, P303, DOI 10.1046/j.1365-2958.2003.03684.x	53	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2019	14	4							e0214641	10.1371/journal.pone.0214641	http://dx.doi.org/10.1371/journal.pone.0214641			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR1CY	30934000	Green Submitted, gold, Green Published			2022-12-26	WOS:000462867000029
J	Mastromoro, G; Calcagni, G; Versacci, P; Putotto, C; Chinali, M; Lambiase, C; Unolt, M; Pelliccione, E; Anaclerio, S; Caprio, C; Cioffi, S; Bilio, M; Baban, A; Drago, F; Digilio, MC; Marino, B; Baldini, A				Mastromoro, Gioia; Calcagni, Giulio; Versacci, Paolo; Putotto, Carolina; Chinali, Marcello; Lambiase, Caterina; Unolt, Marta; Pelliccione, Elena; Anaclerio, Silvia; Caprio, Cinzia; Cioffi, Sara; Bilio, Marchesa; Baban, Anwar; Drago, Fabrizio; Digilio, Maria Cristina; Marino, Bruno; Baldini, Antonio			Left pulmonary artery in 22q11.2 deletion syndrome. Echocardiographic evaluation in patients without cardiac defects and role of Tbx1 in mice	PLOS ONE			English	Article							AORTIC-ARCH; CHROMOSOME 22Q11; CARDIOVASCULAR DEFECTS; ANOMALOUS ORIGIN; ASCENDING AORTA; TETRALOGY; HEART; ARTERIOSUS; ATRESIA; FALLOT	Introduction and hypothesis Patients with 22q11 deletion syndrome (22q11.2DS) present, in about 75% of cases, typical patterns of cardiac defects, with a particular involvement on the ventricular outflow tract and great arteries. However, in this genetic condition the dimensions of the pulmonary arteries (PAs) never were specifically evaluated. We measured both PAs diameter in patients with 22q11.2DS without cardiac defects, comparing these data to a normal control group. Moreover, we measured the PAs diameter in Tbx1 mutant mice. Finally, a cell fate mapping in Tbx1 mutants was used to study the expression of this gene in the morphogenesis of PAs. Methods We evaluated 58 patients with 22q11.2DS without cardiac defects. The control group consisted of 54 healthy subjects, matched for age and sex. All cases underwent a complete transthoracic echocardiography. Moreover, we crossed Tbx1(+/-) mice and harvested fetuses. We examined the cardiovascular phenotype of 8 wild type (WT), 37 heterozygous (Tbx1(+/-)) and 6 null fetuses (Tbx1(-/-)). Finally, we crossed Tbx1(Cre/+) mice with R26R(mT-mG) Cre reporter mice to study Tbx1 expression in the pulmonary arteries. Results The echocardiographic study showed that the mean of the LPA/RPA ratio in 22q11.2DS was smaller (0.80 +/- 0.12) than in controls (0.97 +/- 0.08; p < 0.0001). Mouse studies resulted in similar data as the size of LPA and RPA was not significantly different in WT embryos, but in Tbx1(+/-) and Tbx1(-/-) embryos the LPA was significantly smaller than the RPA in both mutants (P = 0.0016 and 0.0043, respectively). We found that Tbx1 is expressed near the origin of the PAs and in their adventitia. Conclusions Children with 22q11.2DS without cardiac defects show smaller LPA compared with healthy subjects. Mouse studies suggest that this anomaly is due to haploinsufficiency of Tbx1. These data may be useful in the clinical management of children with 22q11.2DS and should guide further experimental studies as to the mechanisms underlying PAs development.	[Mastromoro, Gioia; Versacci, Paolo; Putotto, Carolina; Lambiase, Caterina; Unolt, Marta; Anaclerio, Silvia; Marino, Bruno] Sapienza Univ Rome, Dept Pediat, Rome, Italy; [Calcagni, Giulio; Chinali, Marcello; Pelliccione, Elena; Baban, Anwar; Drago, Fabrizio; Digilio, Maria Cristina] Bambino Gesu Pediat Hosp & Res Inst, Dept Pediat Cardiol & Cardiac Surg, Rome, Italy; [Caprio, Cinzia; Cioffi, Sara; Bilio, Marchesa; Baldini, Antonio] CNR, Inst Genet & Biophys Adriano Buzzati Traverso, Naples, Italy; [Baldini, Antonio] Univ Naples Federico II, Dept Mol Med & Med Biotechnol, Naples, Italy	Sapienza University Rome; IRCCS Bambino Gesu; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); University of Naples Federico II	Marino, B (corresponding author), Sapienza Univ Rome, Dept Pediat, Rome, Italy.; Baldini, A (corresponding author), CNR, Inst Genet & Biophys Adriano Buzzati Traverso, Naples, Italy.; Baldini, A (corresponding author), Univ Naples Federico II, Dept Mol Med & Med Biotechnol, Naples, Italy.	bruno.marino@uniroma1.it; antonio.baldini@unina.it	Drago, Fabrizio/AAA-6071-2020; Unolt, Marta/AAB-5685-2020; Digilio, Maria Cristina/AAI-2434-2019; Calcagni, Giulio/AAH-9179-2019; CIOFFI, Sara/GWZ-9079-2022; Baldini, Antonio/M-2355-2015	Drago, Fabrizio/0000-0003-1888-373X; Unolt, Marta/0000-0002-4133-714X; CIOFFI, Sara/0000-0003-3197-6578; Mastromoro, Gioia/0000-0003-0788-1683; calcagni, giulio/0000-0003-3187-0829; Baldini, Antonio/0000-0002-5330-0256; VERSACCI, PAOLO/0000-0002-4484-4729; Caprio, Cinzia/0000-0002-3476-5162; Putotto, Carolina/0000-0003-3778-3769; Chinali, Marcello/0000-0002-5813-9465; Baban, Anwar/0000-0002-9428-4934	Fondation Leducq [TNE 15CVD01]; Telethon Foundation [GGP14211]	Fondation Leducq(Leducq Foundation); Telethon Foundation(Fondazione Telethon)	This work was supported by the Baldini: Fondation Leducq (TNE 15CVD01) (https://www.fondationleducq.org/), and by the Baldini: Telethon Foundation (GGP14211) (www.telethon.it).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal V., 2017, CARDIOL YOUNG, V13, P1, DOI [10.1017/S104795111700227X, DOI 10.1017/S104795111700227X]; Babaoglu K, 2013, PEDIATR CARDIOL, V34, P1785, DOI 10.1007/s00246-013-0714-4; DODO H, 1995, AM J CARDIOL, V75, P1294, DOI 10.1016/S0002-9149(99)80788-7; Edelmann L, 1999, AM J HUM GENET, V64, P1076, DOI 10.1086/302343; ELZENGA NJ, 1990, J THORAC CARDIOV SUR, V100, P416; ELZENGA NJ, 1986, INT J CARDIOL, V11, P195, DOI 10.1016/0167-5273(86)90179-8; Goldmuntz E, 1998, J AM COLL CARDIOL, V32, P492, DOI 10.1016/S0735-1097(98)00259-9; Hiruma T, 2002, J ANAT, V201, P15, DOI 10.1046/j.1469-7580.2002.00071.x; Huynh T, 2007, GENESIS, V45, P470, DOI 10.1002/dvg.20317; Jerome LA, 2001, NAT GENET, V27, P286, DOI 10.1038/85845; Kelly RG, 2007, DEV DYNAM, V236, P821, DOI 10.1002/dvdy.21063; KUTSCHE LM, 1988, AM J CARDIOL, V61, P850, DOI 10.1016/0002-9149(88)91078-8; Lewin MB, 1997, AM J CARDIOL, V80, P493, DOI 10.1016/S0002-9149(97)00401-3; Lindsay EA, 2001, NATURE, V410, P97, DOI 10.1038/35065105; Lindsay EA, 1999, NATURE, V401, P379, DOI 10.1038/43900; Maldjian P, 2018, J CLIN IMAG SCI, V8, DOI 10.4103/jcis.JCIS_66_17; Marino B, 1999, GENET COUNSEL, V10, P25; Marino B, 1996, AM J CARDIOL, V77, P505, DOI 10.1016/S0002-9149(97)89345-9; Marino B, 1999, AM J CARDIOL, V84, P360, DOI 10.1016/S0002-9149(99)00297-0; Marino B., 2002, PROG PEDIATR CARDIOL, V15, P9; McElhinney DB, 2001, J AM COLL CARDIOL, V37, P2114, DOI 10.1016/S0735-1097(01)01286-4; Merscher S, 2001, CELL, V104, P619, DOI 10.1016/S0092-8674(01)00247-1; Momma K, 1996, AM J CARDIOL, V78, P591, DOI 10.1016/S0002-9149(96)00374-8; Momma K, 1997, J AM COLL CARDIOL, V30, P1067, DOI 10.1016/S0735-1097(97)00240-4; Momma K, 1996, J AM COLL CARDIOL, V27, P198, DOI 10.1016/0735-1097(95)00415-7; MOMMA K, 1995, AM J CARDIOL, V76, P618, DOI 10.1016/S0002-9149(99)80170-2; MOMMA K, 1986, BRIT HEART J, V55, P39; Momma K, 1999, PEDIATR CARDIOL, V20, P97, DOI 10.1007/s002469900414; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Pettersen MD, 2008, J AM SOC ECHOCARDIOG, V21, P922, DOI 10.1016/j.echo.2008.02.006; PRESBITERO P, 1984, BRIT HEART J, V52, P178; Rana MS, 2014, CIRC RES, V115, P790, DOI 10.1161/CIRCRESAHA.115.305020; Rana MS, 2014, AM J MED GENET A, V164, P1372, DOI 10.1002/ajmg.a.35881; Romano R, 2016, J INVEST ALLERG CLIN, V26, P390, DOI 10.18176/jiaci.0107; Sett SS, 2001, CARDIOL YOUNG, V11, P676, DOI 10.1017/S104795110100110X; Toscano A, 2002, EUR J PEDIATR, V161, P116, DOI 10.1007/s00431-001-0877-5; Vitelli F, 2002, HUM MOL GENET, V11, P915, DOI 10.1093/hmg/11.8.915; Xu HS, 2004, DEVELOPMENT, V131, P3217, DOI 10.1242/dev.01174; Yagi H, 2003, LANCET, V362, P1366, DOI 10.1016/S0140-6736(03)14632-6; Zhang Z, 2005, DEVELOPMENT, V132, P5307, DOI 10.1242/dev.02086	40	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2019	14	4							e0211170	10.1371/journal.pone.0211170	http://dx.doi.org/10.1371/journal.pone.0211170			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR1CY	30933971	gold, Green Published, Green Submitted			2022-12-26	WOS:000462867000004
J	Pietrangelo, A; Ridgway, ND				Pietrangelo, Antonietta; Ridgway, Neale D.			Phosphorylation of a serine/proline-rich motif in oxysterol binding protein-related protein 4L (ORP4L) regulates cholesterol and vimentin binding	PLOS ONE			English	Article							PLASMA-MEMBRANE	The family of oxysterol binding protein (OSBP) and OSBP-related proteins (ORPs) mediate sterol and phospholipid transfer and signaling at membrane contact sites (MCS). The activity of OSBP at MCS is regulated by phosphorylation, but whether this applies to ORPs is unknown. Here we report the functional characterization of a unique proline/serine-rich phosphorylation motif (S762SPSSPSS769) in the lipid binding OSBP-related domain of full-length ORP4L and a truncated variant ORP4S. Phosphorylation was confirmed by mass spectrometry and [P-32]PO4 incorporation, and in silico and in vitro assays using purified ORP4L identified putative proline-directed kinases that phosphorylate the site. The functional significance of the phospho-site was assessed by mutating serine 762, S763, S766 and S768 to aspartate or alanine to produce phosphomimetic (S4D) and phosphorylation-deficient (S4A) mutants, respectively. Solution binding of 25-hydroxycholesterol and cholesterol by recombinant ORP4L-S4D and -S4A was similar to wild-type but ORP4L-S4D more effectively extracted cholesterol from liposomes. ORP4L homo-dimerization was unaffected by phosphorylation but gel filtration of ORP4L-S4D indicated that the native conformation was affected. Confocal microscopy revealed that ORP4L-S4D also strongly associated with bundled vimentin filaments, a feature shared with ORP4S which lacks the PH and dimerization domains. We conclude that phosphorylation of a unique serine/proline motif in the ORD induces a conformation change in ORP4L that enhances interaction with vimentin and cholesterol extraction from membranes.	[Pietrangelo, Antonietta; Ridgway, Neale D.] Dalhousie Univ, Dept Biochem & Mol Biol, Atlantic Res Ctr, Halifax, NS, Canada; [Ridgway, Neale D.] Dalhousie Univ, Dept Pediat, Atlantic Res Ctr, Halifax, NS, Canada; [Pietrangelo, Antonietta] Univ Ottawa, Inst Heart, Ottawa, ON, Canada	Dalhousie University; Dalhousie University; University of Ottawa; University of Ottawa Heart Institute	Ridgway, ND (corresponding author), Dalhousie Univ, Dept Biochem & Mol Biol, Atlantic Res Ctr, Halifax, NS, Canada.; Ridgway, ND (corresponding author), Dalhousie Univ, Dept Pediat, Atlantic Res Ctr, Halifax, NS, Canada.	nridgway@dal.ca		Ridgway, Neale/0000-0002-0441-6228	Canadian Institutes of Health Research; Institute of Nutrition, Metabolism and Diabetes [MOP-15284]; Winnifred Lockwood Endowment for Research, IWK Hospital, Halifax, Nova Scotia, Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Institute of Nutrition, Metabolism and Diabetes; Winnifred Lockwood Endowment for Research, IWK Hospital, Halifax, Nova Scotia, Canada	NDR received funding for this research from the Canadian Institutes of Health Research, Institute of Nutrition, Metabolism and Diabetes (Grant #MOP-15284), http://www.cihr-irsc.gc.ca/e/193.html.NDR also received funding from the Winnifred Lockwood Endowment for Research, IWK Hospital, Halifax, Nova Scotia, Canada. This is an internal award and there is no grant number or web site. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beurel E, 2015, PHARMACOL THERAPEUT, V148, P114, DOI 10.1016/j.pharmthera.2014.11.016; Burgett AWG, 2011, NAT CHEM BIOL, V7, P639, DOI 10.1038/nchembio.625; Charman M, 2014, J BIOL CHEM, V289, P15705, DOI 10.1074/jbc.M114.571216; Chung J, 2015, SCIENCE, V349, P428, DOI 10.1126/science.aab1370; Dong JQ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08791-0; Fournier MV, 1999, CANCER RES, V59, P3748; Ghai R, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00861-5; Goto A, 2012, MOL BIOL CELL, V23, P3624, DOI 10.1091/mbc.E12-04-0283; Heringa J, 1999, COMPUT CHEM, V23, P341, DOI 10.1016/S0097-8485(99)00012-1; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Im YJ, 2005, NATURE, V437, P154, DOI 10.1038/nature03923; Li JW, 2016, ONCOTARGET, V7, P65849, DOI 10.18632/oncotarget.11671; Mesmin B, 2013, CELL, V155, P830, DOI 10.1016/j.cell.2013.09.056; Moreira EF, 2001, J BIOL CHEM, V276, P18570, DOI 10.1074/jbc.M011259200; Nhek S, 2010, MOL BIOL CELL, V21, P2327, DOI 10.1091/mbc.E10-02-0090; Pietrangelo A, 2018, J CELL SCI, V131, DOI 10.1242/jcs.215335; Pietrangelo A, 2018, CELL MOL LIFE SCI, V75, P3079, DOI 10.1007/s00018-018-2795-y; Prashek J, 2017, J BIOL CHEM, V292, P14217, DOI 10.1074/jbc.M117.780007; Schittek B, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-231; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Vazquez-Novelle MD, 2014, CURR BIOL, V24, P638, DOI 10.1016/j.cub.2014.01.034; Wang C, 2002, BIOCHEM J, V361, P461, DOI 10.1042/0264-6021:3610461; Wang H, 2019, MOL CELL, V73, P458, DOI 10.1016/j.molcel.2018.11.014; Wisniewski JR, 2010, J PROTEOME RES, V9, P3280, DOI 10.1021/pr1002214; Wong LH, 2017, TRENDS BIOCHEM SCI, V42, P516, DOI 10.1016/j.tibs.2017.05.001; Zhao KX, 2017, CELL REP, V19, P1807, DOI 10.1016/j.celrep.2017.05.028; Zhong WB, 2019, CELL REP, V26, P2166, DOI 10.1016/j.celrep.2019.01.082; Zhong WB, 2016, CIRC RES, V119, P1296, DOI 10.1161/CIRCRESAHA.116.309603; Zhong WB, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12702; Zhou HJ, 2013, J PROTEOME RES, V12, P260, DOI 10.1021/pr300630k	31	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2019	14	3							e0214768	10.1371/journal.pone.0214768	http://dx.doi.org/10.1371/journal.pone.0214768			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ9FO	30925160	Green Published, gold, Green Submitted			2022-12-26	WOS:000462732300030
J	Sugimori, F; Hirakawa, H; Tsutsui, A; Yamaji, H; Komaru, S; Takasaki, M; Iwamatsu, T; Uemura, T; Uemura, Y; Morita, K; Tsumura, T				Sugimori, Fumiaki; Hirakawa, Hiroyuki; Tsutsui, Ai; Yamaji, Hiroyuki; Komaru, Shohei; Takasaki, Mai; Iwamatsu, Tadashi; Uemura, Toshimasa; Uemura, Yo; Morita, Kenichi; Tsumura, Takashi			A novel electron emission-based cell culture device promotes cell proliferation and differentiation of pre-osteoblastic MC3T3-E1 cells	PLOS ONE			English	Article							TRABECULAR BONE MASS; MESSENGER-RNA; STIMULATION; CBFA1; OSTEOPONTIN; OSTEOCLASTS; EXPRESSION; PLASMA; MUSCLE; GENE	In this report we demonstrate the effect of a novel electron emission-based cell culture device on the proliferation and differentiation of pre-osteoblastic MC3T3-E1 cells. Our device has an electron emission element that allows, for the first time, stable emission of electrons into an atmosphere. Atmospheric electrons react with gas molecules to generate radicals and negative ions, which induce a variety of biochemical reactions in the attached cell culture system. In this study, we demonstrated the effect of this new electron emission-based cell culture device on cell proliferation and differentiation using pre-osteoblastic MC3T3-E1 cells. Electron emission stimulation (EES) was applied directly to culture medium containing plated cells, after which the number of living cells, the mRNA levels of osteogenesis-related genes, and the alkaline phosphatase (ALP) activity were evaluated. The growth rate of EES-exposed cells increased by approximately 20% in comparison with unexposed control cells. We also found the mRNA levels of osteogenic specific genes such as collagen type I alpha-1, core-binding factor alpha-1, and osteocalcin to be up-regulated following EES. ALP activity, a marker for osteogenic activity, was significantly enhanced in EES-treated cells. Furthermore, reactive oxygen species generated by EES were measured to determine their effect on MC3T3-E1 cells. These results suggest that our new electron emission-based cell culture device, while providing a relatively weak stimulus in comparison with atmospheric plasma systems, promotes cell proliferation and differentiation. This system is expected to find application in regenerative medicine, specifically in relation to bone regeneration.	[Sugimori, Fumiaki; Hirakawa, Hiroyuki; Tsutsui, Ai; Yamaji, Hiroyuki; Komaru, Shohei; Takasaki, Mai; Iwamatsu, Tadashi] Sharp Co Ltd, Business Solut Business Unit, Adv Technol Dev Unit, Yamato Koriyama, Nara, Japan; [Uemura, Toshimasa; Uemura, Yo; Morita, Kenichi; Tsumura, Takashi] JTEC COOPERAT, Cell Culture Mkt & Res Ctr, Osaka, Ibaraki, Japan; [Uemura, Toshimasa] Osaka Univ, Grad Sch Engn, Suita, Osaka, Japan	Hisense; Sharp Corporation; Osaka University	Sugimori, F (corresponding author), Sharp Co Ltd, Business Solut Business Unit, Adv Technol Dev Unit, Yamato Koriyama, Nara, Japan.	sugimori.fumiaki@sharp.co.jp	Iwamatsu, Tadashi/U-7826-2018	Iwamatsu, Tadashi/0000-0001-7670-1426; Sugimori, Fumiaki/0000-0002-0588-6117				Bique AM, 2016, ELECTROMAGN BIOL MED, V35, P353, DOI 10.3109/15368378.2016.1138124; Dauben TJ, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/5178640; Diaz-Vegas A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129882; Doucet Barbara M., 2012, Yale Journal of Biology and Medicine, V85, P201; Han I, 2017, ONCOTARGET, V8, P36399, DOI 10.18632/oncotarget.16821; Iwamatsu T., 2017, J IMAG SOC JPN, V56, P16; Iwamatsu T, 2019, APPL PHYS LETT, V114, DOI 10.1063/1.5077062; Jervey C, 1990, Contemp Orthop, V20, P61; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kumar A, 2016, J BIOMATER APPL, V31, P594, DOI 10.1177/0885328216658376; Kumar A, 2016, BIOMATER SCI-UK, V4, P136, DOI 10.1039/c5bm00350d; Lau YC, 2015, OSTEOPOROSIS INT, V26, P481, DOI 10.1007/s00198-014-2866-3; Lau YC, 2014, SPINE J, V14, P2472, DOI 10.1016/j.spinee.2014.04.001; Lee KS, 2000, MOL CELL BIOL, V20, P8783, DOI 10.1128/MCB.20.23.8783-8792.2000; MERRY K, 1993, J CELL SCI, V104, P1013; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Ohta T, 2005, J VAC SCI TECHNOL B, V23, P2336, DOI 10.1116/1.2102928; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; REINHOLT FP, 1990, P NATL ACAD SCI USA, V87, P4473, DOI 10.1073/pnas.87.12.4473; Sasaki S, 2016, SCI REP-UK, V6, DOI 10.1038/srep25728; Schellnack K, 1979, Beitr Orthop Traumatol, V26, P473; Tamaki H, 2015, J MUSCULOSKEL NEURON, V15, P270; Tominami K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180507; Wang YP, 2016, PLOS GENET, V12, DOI [10.1371/journal.pgen.1005803, 10.1371/journal.pgen.1006390]; YOKOO K, 1994, J VAC SCI TECHNOL B, V12, P801, DOI 10.1116/1.587350; Zhang JY, 2016, ACTA BIOMATER, V32, P46, DOI 10.1016/j.actbio.2015.12.024; Zhuang HM, 1997, BIOCHEM BIOPH RES CO, V237, P225, DOI 10.1006/bbrc.1997.7118	27	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0213579	10.1371/journal.pone.0213579	http://dx.doi.org/10.1371/journal.pone.0213579			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921357	Green Submitted, Green Published, gold			2022-12-26	WOS:000462594000019
J	Chakravarty, S; Mandal, RK; Duff, ML; Schmidt, NW				Chakravarty, Shubham; Mandal, Rabindra K.; Duff, Morgan L.; Schmidt, Nathan W.			Intestinal short-chain fatty acid composition does not explain gut microbiota-mediated effects on malaria severity	PLOS ONE			English	Article							INFLAMMATION; METABOLITES; PROPIONATE; BUTYRATE; IMMUNITY; GPR109A	Malaria is a devastating disease resulting in significant morbidity and mortality, especially in the developing world. Previously, we showed that the gut microbiome modulates severity of malaria in mice, though the exact mechanism was unknown. One well-studied mechanism by which the intestinal microbiota exerts an effect on host health is by synthesis of short-chain fatty acids (SCFAs). SCFAs have pleiotropic effects on the host, including modulating the immune system and altering susceptibility to pathogens. The objective of the current work was to explore if gut microbiota-mediated resistance and susceptibility to malaria in mice is through differential production of SCFAs. Of the eight detected SCFAs, only propionic acid (C3) was different between two groups of resistant and two groups of susceptible mice, with higher levels in feces of susceptible mice compared to resistant mice. Nevertheless, subsequent analysis revealed no robust correlation between malaria severity and levels of fecal propionic acid. In spite of the broad effect of SCFAs on host physiology, including host immunity, this study shows that gut microbiota-mediated modulation of malaria severity in mice is independent of fecal SCFA levels. Additionally, our data indicates that intestinal SCFAs do not function as biomarkers for prediction of malaria disease	[Chakravarty, Shubham; Mandal, Rabindra K.; Duff, Morgan L.; Schmidt, Nathan W.] Univ Louisville, Dept Microbiol & Immunol, Louisville, KY 40292 USA	University of Louisville	Schmidt, NW (corresponding author), Univ Louisville, Dept Microbiol & Immunol, Louisville, KY 40292 USA.	nathan.schmidt@louisville.edu		Chakravarty, Shubham/0000-0002-8123-1761	National Institutes of Health [1R01AI123486, 1P20GM113226-01, 1P50AA024337-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI123486] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM113226] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P50AA024337] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by the National Institutes of Health, grant number 1R01AI123486 to NWS and the University of Louisville CREAM Center is partially supported by grants 1P20GM113226-01 and 1P50AA024337-01 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Autino B, 2012, MEDITERR J HEMATOL I, V4, DOI 10.4084/MJHID.2012.061; Azcarate IG, 2013, BRIT J PHARMACOL, V169, P645, DOI 10.1111/bph.12156; Belkaid Y, 2017, IMMUNITY, V46, P562, DOI 10.1016/j.immuni.2017.04.008; Ciarlo E, 2016, SCI REP-UK, V6, DOI 10.1038/srep37944; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; He LQ, 2018, J CHROMATOGR B, V1092, P359, DOI 10.1016/j.jchromb.2018.06.028; Jacobson A, 2018, CELL HOST MICROBE, V24, P296, DOI 10.1016/j.chom.2018.07.002; Kelly CJ, 2015, CELL HOST MICROBE, V17, P662, DOI 10.1016/j.chom.2015.03.005; Kim CH, 2016, MICROB CELL, V3, P398, DOI 10.15698/mic2016.10.536; Kim M, 2017, GUT MICROBES, V8, P392, DOI 10.1080/19490976.2017.1299311; Kim M, 2016, CELL HOST MICROBE, V20, P202, DOI 10.1016/j.chom.2016.07.001; Li M, 2018, EUR J PHARMACOL, V831, P52, DOI 10.1016/j.ejphar.2018.05.003; Macia L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7734; Rodrigues HG, 2016, EUR J PHARMACOL, V785, P50, DOI 10.1016/j.ejphar.2015.03.098; Rooks MG, 2016, NAT REV IMMUNOL, V16, P341, DOI 10.1038/nri.2016.42; Singh N, 2014, IMMUNITY, V40, P128, DOI 10.1016/j.immuni.2013.12.007; Tedelind S, 2007, WORLD J GASTROENTERO, V13, P2826, DOI 10.3748/wjg.v13.i20.2826; Trompette A, 2018, IMMUNITY, V48, P992, DOI 10.1016/j.immuni.2018.04.022; Trompette A, 2014, NAT MED, V20, P159, DOI 10.1038/nm.3444; Villarino N, 2015, ANTIMICROB AGENTS CH, V59, P3672, DOI 10.1128/AAC.02858-14; Villarino NF, 2016, P NATL ACAD SCI USA, V113, P2235, DOI 10.1073/pnas.1504887113; Vinolo MAR, 2011, NUTRIENTS, V3, P858, DOI 10.3390/nu3100858	22	6	7	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2019	14	3							e0214449	10.1371/journal.pone.0214449	http://dx.doi.org/10.1371/journal.pone.0214449			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ5PT	30917184	gold, Green Submitted, Green Published			2022-12-26	WOS:000462465800066
J	Voulgarelis, D; Velayudhan, A; Smith, F				Voulgarelis, Dimitrios; Velayudhan, Ajoy; Smith, Frank			Stability of two competing populations in chemostat where one of the population changes its average mass of division in response to changes of its population	PLOS ONE			English	Article							COEXISTENCE; GROWTH; MODEL	This paper considers a novel dynamical behaviour of two microbial populations, competing in a chemostat over a single substrate, that is only possible through the use of population balance equations (PBEs). PBEs are partial integrodifferential equations that represent a distribution of cells according to some internal state, mass in our case. Using these equations, realistic parameter values and the assumption that one population can deploy an emergency mechanism, where it can change the mean mass of division and hence divide faster, we arrive at two different steady states, one oscillatory and one non-oscillatory both of which seem to be stable. A steady state of either form is normally either unstable or only attainable through external control (cycling the dilution rate). In our case no external control is used. Finally, in the oscillatory case we attempt to explain how oscillations appear in the biomass without any explicit dependence on the division rate (the function that oscillates) through the approximation of fractional moments as a combination of integer moments. That allows an implicit dependence of the biomass on the number of cells which in turn is directly dependent on the division rate function.	[Voulgarelis, Dimitrios] UCL, Ctr Math Phys & Engn Life Sci & Expt Biol, Phys Bldg,Gower Pl, London WC1E 6BN, England; [Velayudhan, Ajoy] UCL, Dept Biochem Engn, Bernard Katz Bldg,Gordon St, London WC1H 0AH, England; [Voulgarelis, Dimitrios; Smith, Frank] UCL, Dept Math, London WC1E 6BT, England	University of London; University College London; University of London; University College London; University of London; University College London	Voulgarelis, D (corresponding author), UCL, Ctr Math Phys & Engn Life Sci & Expt Biol, Phys Bldg,Gower Pl, London WC1E 6BN, England.; Voulgarelis, D (corresponding author), UCL, Dept Math, London WC1E 6BT, England.	dimitrios.voulgarelis.14@ucl.ac.uk			EPSRC DTC [EP/F500351/1]	EPSRC DTC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Dimitrios Voulgarelis was supported by EPSRC DTC (EP/F500351/1) (https://epsrc.ukri.org/).	Alexiadis A, 2004, J COLLOID INTERF SCI, V276, P106, DOI 10.1016/j.jcis.2004.03.052; ARIS R, 1977, BIOTECHNOL BIOENG, V19, P1375, DOI 10.1002/bit.260190910; Eakman J, 1966, STAT DYNAMICS MICROB; FREEDMAN HI, 1989, SIAM J APPL MATH, V49, P859, DOI 10.1137/0149050; Fritsch C, 2017, THEOR POPUL BIOL, V115, P89, DOI 10.1016/j.tpb.2017.05.001; HSU SB, 1978, SIAM J APPL MATH, V34, P760, DOI 10.1137/0134064; Justice SS, 2008, NAT REV MICROBIOL, V6, P162, DOI 10.1038/nrmicro1820; NOVICK A, 1950, SCIENCE, V112, P715, DOI 10.1126/science.112.2920.715; PAVLOU S, 1990, BIOTECHNOL BIOENG, V35, P224, DOI 10.1002/bit.260350303; PINE L, 1967, J BACTERIOL, V94, P875, DOI 10.1128/JB.94.4.875-883.1967; Pisu M, 2004, CHEM ENG SCI, V59, P5035, DOI 10.1016/j.ces.2004.07.101; Pisu M, 2007, J BIOTECHNOL, V130, P171, DOI 10.1016/j.jbiotec.2007.02.028; STEPHANOPOULOS G, 1979, MATH BIOSCI, V45, P99, DOI 10.1016/0025-5564(79)90098-1; Swift S, 2001, QUORUM SENSING POPUL; Violle C, 2009, FUNCT ECOL, V23, P612, DOI 10.1111/j.1365-2435.2009.01539.x; Young KD, 2006, MICROBIOL MOL BIOL R, V70, P660, DOI 10.1128/MMBR.00001-06	16	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2019	14	3							e0213518	10.1371/journal.pone.0213518	http://dx.doi.org/10.1371/journal.pone.0213518			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ5PT	30917145	Green Published, Green Submitted, gold			2022-12-26	WOS:000462465800035
J	Fernandez-Soto, P; Gandasegui, J; Rodriguez, CC; Perez-Arellano, JL; Crego-Vicente, B; Diego, JGB; Lopez-Aban, J; Vicente, B; Muro, A				Fernandez-Soto, Pedro; Gandasegui, Javier; Carranza Rodriguez, Cristina; Luis Perez-Arellano, Jose; Crego-Vicente, Beatriz; Garcia-Bernalt Diego, Juan; Lopez-Aban, Julio; Vicente, Belen; Muro, Antonio			Detection of Schistosoma mansoni-derived DNA in human urine samples by loop-mediated isothermal amplification (LAMP)	PLOS ONE			English	Article							FILTERED URINE; DIAGNOSIS; INFECTION; POINT	Background Schistosoma mansoni is the main species causing hepatic and intestinal schistosomiasis in Sub-Saharan Africa, and it is the only species in South America. Adult stages of the parasite reside in the mesenteric venous plexus of infected hosts, and eggs are shed in feces. Collecting patient stool samples for S. mansoni diagnostic purposes is difficult in large-scale field trials. Urine samples would be an alternative approach for molecular S. mansoni detection since they have several advantages over stool samples, including better handling, management and storage. Additionally, loop-mediated isothermal amplification (LAMP) technology is a powerful molecular diagnostic tool for infectious diseases, particularly under field conditions in developing countries. The present study aimed to assess the effectiveness of our previously developed LAMP assay (SmMIT-LAMP) for S. mansoni-specific detection in clinical urine samples. Methodology/Principal findings The sensitivity of SmMIT-LAMP in urine was established in simulated fresh human urine samples artificially spiked with genomic DNA from S. mansoni. LAMP for 120 min instead of 60 min improved the sensitivity, reaching values of 0.01 fg/mu L. A set of well-defined frozen stored human urine samples collected from Sub-Saharan immigrant patients was selected from a biobank to evaluate the diagnostic validity of SmMIT-LAMP. The set included urine samples from patients with microscopy-confirmed infections with S. mansoni, S. haematobium and other nonschistosome parasites, as well as urine samples from patients with microscopy-negative eosinophilia without a confirmed diagnosis. The SmMIT-LAMP was incubated for 60 and 120 min. A longer incubation time was shown to increase the LAMP-positive results in patient urine samples. We also tested urine samples from mice experimentally infected with S. mansoni, and LAMP-positive results were obtained from the third week after infection. A real-time LAMP assay was also performed with three individual urine samples. Conclusions/Significance The SmMIT-LAMP could effectively detect S. mansoni DNA in mouse urine samples and produced promising results for human clinical samples. The detection of S. mansoni DNA in mouse urine samples from the third week after infection indicates that early diagnosis of active S. mansoni infection is possible using urine as a source of DNA. Further studies are still needed, but our method could be used as a promising molecular tool applicable to urine samples to diagnose human intestinal schistosomiasis caused by S. mansoni.	[Fernandez-Soto, Pedro; Gandasegui, Javier; Crego-Vicente, Beatriz; Garcia-Bernalt Diego, Juan; Lopez-Aban, Julio; Vicente, Belen; Muro, Antonio] Univ Salamanca, Infect & Trop Dis Res Grp E INTRO, Fac Pharm,Univ Salamanca IBSAL CIETUS, Biomed Res Inst,Salamanca Res Ctr Trop Dis, Salamanca, Spain; [Carranza Rodriguez, Cristina; Luis Perez-Arellano, Jose] Univ Las Palmas Gran Canaria, Dept Med & Surg Sci, Las Palmas Gran Canaria, Spain; [Carranza Rodriguez, Cristina; Luis Perez-Arellano, Jose] Maternal & Child Insular Univ Hosp Complex, Infect Dis Unit, Las Palmas Gran Canaria, Spain	University of Salamanca; Universidad de Las Palmas de Gran Canaria	Fernandez-Soto, P; Muro, A (corresponding author), Univ Salamanca, Infect & Trop Dis Res Grp E INTRO, Fac Pharm,Univ Salamanca IBSAL CIETUS, Biomed Res Inst,Salamanca Res Ctr Trop Dis, Salamanca, Spain.	pfsoto@usal.es; ama@usal.es	López-Abán, Julio/B-3557-2015; Gandasegui, Javier/D-7895-2019; García-Bernalt Diego, Juan/D-7919-2019	López-Abán, Julio/0000-0001-8509-0727; Gandasegui, Javier/0000-0001-5519-738X; García-Bernalt Diego, Juan/0000-0001-6947-6806; Crego Vicente, Beatriz/0000-0002-9560-0492	Institute of Health Carlos III, ISCIII, Spain [RICET RD16/0027/0018, DTS16/00207, PI16/01784]; European Union - FEDER (Fondo Europeo de Desarrollo Regional) 'Una manera de hacer Europa'	Institute of Health Carlos III, ISCIII, Spain; European Union - FEDER (Fondo Europeo de Desarrollo Regional) 'Una manera de hacer Europa'	This study was supported by the Institute of Health Carlos III, ISCIII, Spain (www.isciii.es), grants: RICET RD16/0027/0018 (AM), DTS16/00207 (AM), PI16/01784 (PFS), European Union cofinancing by FEDER (Fondo Europeo de Desarrollo Regional) 'Una manera de hacer Europa'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Hafeez Ekhlas Hamed, 2015, Trop Med Health, V43, P205, DOI 10.2149/tmh.2015-22; Abruzzi A, 2011, ADV PARASIT, V77, P1, DOI 10.1016/B978-0-12-391429-3.00005-8; Ahmad F, 2013, ANAL CHIM ACTA, V760, P100, DOI 10.1016/j.aca.2012.11.040; Asiello PJ, 2011, LAB CHIP, V11, P1420, DOI 10.1039/c0lc00666a; Belhassen-Garcia M, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000043; Berhe N, 2004, ACTA TROP, V92, P205, DOI 10.1016/j.actatropica.2004.06.011; Botezatu I, 2000, CLIN CHEM, V46, P1078; Cevallos W, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005672; Chitsulo L, 2004, NAT REV MICROBIOL, V2, P12, DOI 10.1038/nrmicro801; Colley DG, 2014, LANCET, V383, P2253, DOI 10.1016/S0140-6736(13)61949-2; Dawson-Hahn EE, 2010, J PEDIATR-US, V156, P1016, DOI 10.1016/j.jpeds.2010.02.043; Disch J, 1997, T ROY SOC TROP MED H, V91, P222, DOI 10.1016/S0035-9203(97)90233-9; Doenhoff MJ, 2004, TRENDS PARASITOL, V20, P35, DOI 10.1016/j.pt.2003.10.019; Enk Martin J, 2010, BMC Res Notes, V3, P115, DOI 10.1186/1756-0500-3-115; Enk MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038947; Fernandez-Soto P, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003126; Fernandez-Soto P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061703; Francois P, 2011, FEMS IMMUNOL MED MIC, V62, P41, DOI 10.1111/j.1574-695X.2011.00785.x; Freedman DO, 2006, NEW ENGL J MED, V354, P119, DOI 10.1056/NEJMoa051331; Gandasegui J, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003963; Geojith G, 2011, J MICROBIOL METH, V84, P71, DOI 10.1016/j.mimet.2010.10.015; Grobusch MP, 2003, J TRAVEL MED, V10, P164, DOI 10.2310/7060.2003.35759; Ibironke O, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001464; Ibironke OA, 2011, AM J TROP MED HYG, V84, P998, DOI 10.4269/ajtmh.2011.10-0691; Jelinek, 1996, J Travel Med, V3, P160, DOI 10.1111/j.1708-8305.1996.tb00731.x; Kaneko H, 2007, J BIOCHEM BIOPH METH, V70, P499, DOI 10.1016/j.jbbm.2006.08.008; King CH, 2010, ACTA TROP, V113, P95, DOI 10.1016/j.actatropica.2009.11.012; Lecky DM, 2014, BRIT J GEN PRACT, V64, pE684, DOI 10.3399/bjgp14X682261; Lichtenstein AV, 2001, ANN NY ACAD SCI, V945, P239; Lodh N, 2017, ACTA TROP, V173, P125, DOI 10.1016/j.actatropica.2017.06.015; Lodh N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091144; Lodh N, 2013, AM J TROP MED HYG, V89, P46, DOI 10.4269/ajtmh.13-0104; Mauk M, 2017, LAB CHIP, V17, P382, DOI 10.1039/c6lc01239f; Meurs L, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003959; Mori Y, 2013, J INFECT CHEMOTHER, V19, P404, DOI 10.1007/s10156-013-0590-0; Njiru ZK, 2010, PLOS NEGLECT TROP D, V6, pe1572; Notomi T, 2015, J MICROBIOL, V53, P1, DOI 10.1007/s12275-015-4656-9; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Sandoval N, 2006, PARASITOLOGY, V133, P581, DOI 10.1017/S0031182006000898; Schrader C, 2012, J APPL MICROBIOL, V113, P1014, DOI 10.1111/j.1365-2672.2012.05384.x; SMITHERS SR, 1965, PARASITOLOGY, V55, P695, DOI 10.1017/S0031182000086248; Su YH, 2004, J MOL DIAGN, V6, P101, DOI 10.1016/S1525-1578(10)60497-7; Utzinger J, 2009, PARASITOLOGY, V136, P1859, DOI 10.1017/S0031182009991600; Weerakoon KG, 2017, J INFECT DIS, V216, P1611, DOI 10.1093/infdis/jix521; Zanoli LM, 2013, BIOSENSORS-BASEL, V3, P18, DOI 10.3390/bios3010018	45	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2019	14	3							e0214125	10.1371/journal.pone.0214125	http://dx.doi.org/10.1371/journal.pone.0214125			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ3IW	30913249	Green Published, Green Submitted, gold			2022-12-26	WOS:000462305600027
J	Vounba, P; Arsenault, J; Bada-Alambedji, R; Fairbrother, JM				Vounba, Passoret; Arsenault, Julie; Bada-Alambedji, Rianatou; Fairbrother, John M.			Prevalence of antimicrobial resistance and potential pathogenicity, and possible spread of third generation cephalosporin resistance, in Escherichia coli isolated from healthy chicken farms in the region of Dakar, Senegal	PLOS ONE			English	Article							SPECTRUM BETA-LACTAMASE; FIELD GEL-ELECTROPHORESIS; ANTIBIOTIC-RESISTANCE; RISK-FACTORS; CTX-M; FLUOROQUINOLONE RESISTANCE; MOLECULAR CHARACTERIZATION; BROILER-CHICKENS; SALMONELLA; STRAINS	Escherichia coli is a normal inhabitant of the intestinal microbiota of chickens, a small proportion of which may be avian pathogenic E. coli (APEC) or potential extraintestinal pathogenic E. coli (ExPEC), capable of causing disease in humans. These E. coli may also be resistant to antimicrobials of critical importance in human or veterinary health. This study aims to 1) determine the prevalence of antimicrobial resistance (AMR) and resistance genes, multidrug resistance (MDR), chromosomal mechanisms of quinolone-resistance and virulence profiles of E. coli isolated from healthy chicken farms in the region of Dakar, Senegal, 2) investigate the spread of third-generation cephalosporins (3GC) resistance in E. coli isolated from healthy chicken farms with respect to virulence and resistance genes, serogroups, Pulsed-Field Gel Electrophoresis (PFGE), phylogenetic groups, plasmid types and transferability and 3) determine whether nonsusceptibility against 3GC on farms could be linked to risk factors. More than 68% of isolates from environmental faecal and drinking water samples, carcasses and carcass washes collected on 32 healthy chicken farms were multidrug resistant (MDR), resistance to antimicrobials critical in human health (3GC or ciprofloxacin) being found in all types of samples. Ciprofloxacin resistance was due to mutations in the gyrA and parC genes, 95% of tested farms harboring isolates carrying three mutations, in gyrA (Ser83Ile and Asp87Asn) and parC (Ser80Ile). Nine of the 32 farms (28.1%) demonstrated the presence of one or more 3GC-nonsusceptible indicator isolates but none of the potential risk factors were significantly associated with this presence on farms. Following ceftriaxone enrichment, presumptive extended-spectrum beta-lactamase/ AmpC-beta-lactamase (ESBUAmpC)-producer isolates were found in 17 of the 32 farms. 3GC resistance was mediated by bla(CMY-2 )or bla(CTX-M) genes, bla(CTX-M) being of genotypes bla(CTX-M-1),bla(CTX-M-8) and for the first time in chickens in Senegal, the genotype bla(CTX-M-15). Clonally related ESBL/AmpC-producer isolates were found on different farms. In addition, bla(CTX-M) genes were identified on replicon plasmids I1 and K/B and bla(CTX-M )on K/B, I1 and B/O. These plasmids were found in isolates of different clusters. In addition, 18 isolates, some of which were ESBL/AmpC-producers, were defined as potential human ExPEC. In conclusion, E. coli isolates potentially pathogenic for humans and demonstrating MDR, with resistance expressed against antimicrobials of critical importance in human health were found in healthy chickens in Senegal. Our results suggest that both clonal spreading and horizontal gene transfer play a role in the spread of 3GC-resistance and that chickens in Senegal could be a reservoir for AMR and ExPEC for humans. These results highlight the importance of raising awareness about compliance with biosecurity measures and prudent use of antimicrobials.	[Vounba, Passoret; Arsenault, Julie; Fairbrother, John M.] Univ Montreal, Fac Vet Med, Dept Pathol & Microbiol, Swine & Poultry Infect Dis Res Ctr CRIPA, St Hyacinthe, PQ, Canada; [Vounba, Passoret; Arsenault, Julie; Fairbrother, John M.] Res Grp Zoonoses & Publ Hlth GREZOSP, St Hyacinthe, PQ, Canada; [Bada-Alambedji, Rianatou] EISMV, Dept Publ Hlth & Environm, Dakar, Senegal	Universite de Montreal	Fairbrother, JM (corresponding author), Univ Montreal, Fac Vet Med, Dept Pathol & Microbiol, Swine & Poultry Infect Dis Res Ctr CRIPA, St Hyacinthe, PQ, Canada.; Fairbrother, JM (corresponding author), Res Grp Zoonoses & Publ Hlth GREZOSP, St Hyacinthe, PQ, Canada.	john.morris.fairbrother@umontreal.ca	Arsenault, Julie/D-5077-2015; Vounba, Passoret/ABD-6507-2021	Arsenault, Julie/0000-0001-8382-7326; Passoret, Vounba/0000-0001-9684-5777	Agence Universitaire de la Francophonie (AUF) [6319PS003]; Fonds de Recherche du Quebec - Nature et Technologies [111946CRIP]; GREZOSP; CRIPA	Agence Universitaire de la Francophonie (AUF); Fonds de Recherche du Quebec - Nature et Technologies; GREZOSP; CRIPA	This work was supported by: JMF: Grant No 6319PS003 from the Agence Universitaire de la Francophonie (AUF) and Grant No 111946CRIP from Fonds de Recherche du Quebec - Nature et Technologies which financially supports the Centre de recherche en infectiologie porcine et aviaire (CRIPA) of the Universitede Montreal; PV: GREZOSP (Research Group on Epidemiology of Zoonoses and Public Health) and CRIPA (Swine and poultry infectious diseases research center) Scholarship Programs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder provided support in the form of salary for JMF, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Agerso Y, 2014, FOODBORNE PATHOG DIS, V11, P740, DOI 10.1089/fpd.2014.1742; Agerso Y, 2012, J ANTIMICROB CHEMOTH, V67, P582, DOI 10.1093/jac/dkr507; Alves TD, 2018, SCI TOTAL ENVIRON, V633, P1345, DOI 10.1016/j.scitotenv.2018.03.304; Bada-Alambedji R, 2006, BRAZ J MICROBIOL, V37, P510, DOI 10.1590/S1517-83822006000400020; Bevan ER, 2017, J ANTIMICROB CHEMOTH, V72, P2145, DOI 10.1093/jac/dkx146; Bortolaia V, 2011, APPL ENVIRON MICROB, V77, P5830, DOI 10.1128/AEM.02890-10; Brower CH, 2017, ENVIRON HEALTH PERSP, V125, DOI [10.1289/EHP292, 10.1289/ehp292]; Caffrey N, 2017, PREV VET MED, V148, P115, DOI 10.1016/j.prevetmed.2017.11.001; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; Carattoli A, 2009, ANTIMICROB AGENTS CH, V53, P2227, DOI 10.1128/AAC.01707-08; Cardinale E, 2005, J APPL MICROBIOL, V99, P968, DOI 10.1111/j.1365-2672.2005.02618.x; Castellanos LR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170777; Chakraborty A, 2015, ANN MED HEALTH SCI R, V5, P241, DOI 10.4103/2141-9248.160192; Chishimba K, 2016, Int J Microbiol, V2016, P5275724, DOI 10.1155/2016/5275724; Clermont O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000; Clermont O, 2008, J ANTIMICROB CHEMOTH, V61, P1024, DOI 10.1093/jac/dkn084; Clermont O, 2013, ENV MICROBIOL REP, V5, P58, DOI 10.1111/1758-2229.12019; CLSI, 2016, M100 PERF STAND ANT, V26; CLSI, 2021, PERFORMANCE STANDARD, V5th; Denisuik AJ, 2013, J ANTIMICROB CHEMOTH, V68, pi57, DOI 10.1093/jac/dkt027; Dho-Moulin M, 1999, VET RES, V30, P299; Dutil L, 2010, EMERG INFECT DIS, V16, P48, DOI 10.3201/eid1601.090729; Erb A, 2007, EUR J CLIN MICROBIOL, V26, P83, DOI 10.1007/s10096-006-0248-2; European Food Safety Authority, 2017, EFSA J, V15, pe04694, DOI 10.2903/j.efsa.2017.4694; Everett MJ, 1996, ANTIMICROB AGENTS CH, V40, P2380, DOI 10.1128/AAC.40.10.2380; Fu YM, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-8; Fuzi M, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02261; Garcia-Fernandez A, 2009, J ANTIMICROB CHEMOTH, V63, P274, DOI 10.1093/jac/dkn470; Gay N, 2018, VET SCI, V5, DOI 10.3390/vetsci5010022; Hasan B, 2012, EMERG INFECT DIS, V18, P2055, DOI 10.3201/eid1812.120513; Johnson JR, 2003, J INFECT DIS, V188, P759, DOI 10.1086/377455; Johnson JR, 2001, J INFECT DIS, V183, P78, DOI 10.1086/317656; Johnson TJ, 2008, APPL ENVIRON MICROB, V74, P7043, DOI 10.1128/AEM.01395-08; Laube H, 2013, APPL ENVIRON MICROB, V79, P4815, DOI 10.1128/AEM.00856-13; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Maluta RP, 2014, VET MICROBIOL, V169, P89, DOI 10.1016/j.vetmic.2013.12.013; McDonald LC, 2001, ANTIMICROB AGENTS CH, V45, P3084, DOI 10.1128/AAC.45.11.3084-3091.2001; Mellata M, 2013, FOODBORNE PATHOG DIS, V10, P916, DOI 10.1089/fpd.2013.1533; Minarini LAR, 2012, BRAZ J MICROBIOL, V43, P1309, DOI 10.1590/S1517-838220120004000010; Mnif B, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-147; Mo SS, 2016, PREV VET MED, V130, P112, DOI 10.1016/j.prevetmed.2016.06.011; Mora Azucena, 2013, Vet Microbiol, V167, P506, DOI 10.1016/j.vetmic.2013.08.007; Moulin-Schouleur M, 2007, J CLIN MICROBIOL, V45, P3366, DOI 10.1128/JCM.00037-07; Trung NV, 2015, J ANTIMICROB CHEMOTH, V70, P2144, DOI 10.1093/jac/dkv053; Nilsson O, 2014, J ANTIMICROB CHEMOTH, V69, P1497, DOI 10.1093/jac/dku030; Niyibizi B., 2012, THESIS; ORSKOV I, 1977, BACTERIOL REV, V41, P667, DOI 10.1128/MMBR.41.3.667-710.1977; Oulon E., 2010, THESIS; Paul MCB, 2005, THESIS; Pitout JDD, 2005, ANTIMICROB AGENTS CH, V49, P4667, DOI 10.1128/AAC.49.11.4667-4670.2005; Projahn M, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.02364-16; Randall LP, 2011, J ANTIMICROB CHEMOTH, V66, P86, DOI 10.1093/jac/dkq396; Ribot EM, 2006, FOODBORNE PATHOG DIS, V3, P59, DOI 10.1089/fpd.2006.3.59; Ruppe E, 2009, ANTIMICROB AGENTS CH, V53, P3135, DOI 10.1128/AAC.00139-09; Saliu EM, 2017, ANIM HEALTH RES REV, V18, P46, DOI 10.1017/S1466252317000020; Stacy AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086565; Stromberg ZR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180599; Vandekerchove D, 2004, AVIAN PATHOL, V33, P337, DOI 10.1080/0307945042000220679; Vanni M, 2014, POULTRY SCI, V93, P856, DOI 10.3382/ps.2013-03627; Vincent C, 2010, EMERG INFECT DIS, V16, P88, DOI 10.3201/eid1601.091118; Vounba P, 2018, FOODBORNE PATHOG DIS, V15, P517, DOI 10.1089/fpd.2017.2394; Webber MA, 2015, J ANTIMICROB CHEMOTH, V70, P2241, DOI 10.1093/jac/dkv109; Woodford N, 2004, J ANTIMICROB CHEMOTH, V54, P735, DOI 10.1093/jac/dkh424; World Health Organization, ANT RES GLOB REP SUR	64	15	15	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2019	14	3							e0214304	10.1371/journal.pone.0214304	http://dx.doi.org/10.1371/journal.pone.0214304			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ3IW	30913237	Green Submitted, Green Published, gold			2022-12-26	WOS:000462305600043
J	Mourtada, R; Bottomley, C; Houben, F; Bashour, H; Campbell, OMR				Mourtada, Rima; Bottomley, Christian; Houben, Fiona; Bashour, Hyam; Campbell, Oona M. R.			A mixed methods analysis of factors affecting antenatal care content: A Syrian case study	PLOS ONE			English	Article							HEALTH-CARE; INCOME; ACCESS; PERCEPTIONS; QUALITY; LESSONS	Background Maternity care services provide critical interventions aimed at improving maternal and newborn health. In this study, we examined determinants of antenatal care (ANC) content in Syria, together with changes over time. Methods We analysed two national surveys conducted by the Central Bureau of Statistics in Damascus (PAPFAM 2001 and MICS 2006). Findings of this initial analysis led to a qualitative study on adequacy of antenatal care content in two Syrian governorates, Aleppo and Latakia in 2010, which in turn informed further quantitative analysis. The perspectives and practices of doctors, women, midwives and health officials were explored using in-depth interviews. A framework approach was used to analyse the data. Results The quantitative analysis demonstrated that women's education level, the type of health facility they attended and whether they had experienced health complications were important determinants of adequacy of ANC content received. The qualitative study revealed that additional factors related to supply side and demand side factors (e.g. organization of health services, doctors' selective prescription of ANC tests and women's selective uptake of those tests), influenced the quality of ANC and explained some regional differences between Aleppo and Latakia. Conclusions The percentage of women who received adequate ANC content was probably higher in Latakia than in Aleppo because women in Latakia were more educated, and because services were more available, accessible, and acceptable to them. Conclusions The percentage of women who received adequate ANC content was probably higher in Latakia than in Aleppo because women in Latakia were more educated, and because services were more available, accessible, and acceptable to them.	[Mourtada, Rima] Amer Univ Beirut, Dept Epidemiol & Populat Hlth, Fac Hlth Sci, Beirut, Lebanon; [Mourtada, Rima; Bottomley, Christian; Campbell, Oona M. R.] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London, England; [Houben, Fiona] Canterbury Christ Church Univ, Fac Hlth & Wellbeing, Canterbury, Kent, England; [Bashour, Hyam] Univ Damascus, Damascus, Syria	American University of Beirut; University of London; London School of Hygiene & Tropical Medicine; Canterbury Christ Church University	Mourtada, R (corresponding author), Amer Univ Beirut, Dept Epidemiol & Populat Hlth, Fac Hlth Sci, Beirut, Lebanon.; Mourtada, R (corresponding author), London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London, England.	rima.mourtada@yahoo.co.uk		Houben, Fiona/0000-0002-5630-3516; Mourtada, Rima/0000-0002-4009-3411; Bottomley, Christian/0000-0002-5241-8412	Wellcome Trust [074986/Z/04/Z]; MRC [MR/R010161/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was made possible by funding from the Wellcome Trust (grant number 074986/Z/04/Z) (https://wellcome.ac.uk/home). The funder played no role in the collection, analysis or publication of data.	Akhan Suleyman Engin, 2003, Archives of Gynecology and Obstetrics, V268, P9; Al-Qutob R, 2008, HEALTH CARE WOMEN IN, V29, P539, DOI 10.1080/07399330801949657; [Anonymous], 2015, BBC; Balabanova D, 2006, ACCESS HLTH CARE TAK; Balabanova D, 2013, LANCET, V381, P2118, DOI 10.1016/S0140-6736(12)62000-5; Bashour H., 2008, Eastern Mediterranean Health Journal, V14, P595; Bashour H, 2005, REPROD HEALTH MATTER, V13, P147, DOI 10.1016/S0968-8080(05)25164-9; Benova L, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2018-000779; Bhutta ZA, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-S1-S7; Carroli G, 2001, PAEDIATR PERINAT EP, V15, P1; DeJong J, 2017, BMJ GLOB HLTH, V2, P3, DOI [10.1136/bmjgh-2017-000302, DOI 10.1136/BMJGH-2017-000302]; DESAI S, 1994, POPUL DEV REV, V20, P115, DOI 10.2307/2137632; Finlayson K, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001373; Fisher I., 1997, PURCHASING POWER MON; Gabrysch S, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-34; Ghebreyesus TA, 2017, LANCET GLOB HEALTH, V5, pE839, DOI 10.1016/S2214-109X(17)30295-4; Good CM., 1987, ETHNOMEDICAL SYSTEMS; Graham WJ, 1996, HEALTH POLICY PLANN, V11, P16, DOI 10.1093/heapol/11.1.16; Greene J.C., 1989, EDUC EVAL POLICY AN, V11, P255, DOI [10.3102/01623737011003255, DOI 10.3102/01623737011003255]; Jacobs B, 2012, HEALTH POLICY PLANN, V27, P288, DOI 10.1093/heapol/czr038; Kherallah Mazen, 2012, Avicenna J Med, V2, P51; KROEGER A, 1983, SOC SCI MED, V17, P147, DOI 10.1016/0277-9536(83)90248-4; McIntyre D, 2009, HEALTH ECON POLICY L, V4, P179, DOI 10.1017/S1744133109004836; Montenegro H, 2011, J INTEGR CARE, V19, P5, DOI 10.1108/14769011111176707; Mounier-Jack S, 2017, HEALTH POLICY PLANN, V32, P6, DOI 10.1093/heapol/czx039; Nwaeze I L, 2013, Ann Ib Postgrad Med, V11, P22; Parrott FR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027917; Peters DH, 2008, ANN NY ACAD SCI, V1136, P161, DOI 10.1196/annals.1425.011; Powell-Jackson T, 2015, TROP MED INT HEALTH, V20, P230, DOI 10.1111/tmi.12414; Ritchie JSL., 1994, QUALITATIVE DATA ANA, DOI DOI 10.4324/9780203413081_CHAPTER_9; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Sachs JD, 2012, LANCET, V379, P2206, DOI 10.1016/S0140-6736(12)60685-0; Syrian Central Bureau of Statistics (SCBS), 2011, FAM HLTH SURV SYR AR; Syrian Central Bureau of Statistics (SCBS), 2011, STAT COLL SYR YEAR 2; Syrian Central Bureau of Statistics (SCBS), 1995, PAN AR PROJ CHILD HL; Teddlie C., 2006, RES SCH, V13, P12, DOI DOI 10.1177/2345678906293042; Turan JM, 2006, STUD FAMILY PLANN, V37, P49, DOI 10.1111/j.1728-4465.2006.00083.x; UN, 2022, WORLD POP PROSP; Villar J, 2004, SEMIN NEPHROL, V24, P607, DOI 10.1016/S0270-9295(04)00132-9; Villar J, 1997, ACTA OBSTET GYN SCAN, V76, P1, DOI 10.3109/00016349709047778; WHO, 2022, WHO RECOMMENDATIONS; World Health Organization, 2006, HLTH SYST PROF; World Health Organization (WHO), 2012, TRENDS MAT MORT 1990	43	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2019	14	3							e0214375	10.1371/journal.pone.0214375	http://dx.doi.org/10.1371/journal.pone.0214375			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HQ1KV	30908532	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000462157600058
J	Du, W; Wang, N; Li, F; Jia, KQ; An, JH; Liu, YP; Wang, YX; Zhu, L; Zhao, S; Hao, J				Du, Wei; Wang, Na; Li, Fan; Jia, Keqi; An, Jiahui; Liu, Yaping; Wang, Yuxue; Zhu, Lin; Zhao, Song; Hao, Jun			STAT3 phosphorylation mediates high glucose-impaired cell autophagy in an HDAC1-dependent and -independent manner in Schwann cells of diabetic peripheral neuropathy	FASEB JOURNAL			English	Article						histone deacetylase 1; JAK-STAT3 signaling; Atg3; P62; LC3	INHIBITION; JAK/STAT; PATHWAY; HDAC1; BIOENERGETICS; PATHOGENESIS; MECHANISMS	Schwann cells are the main supportive cells of the peripheral nerves. Schwann cells suffer inhibition of autophagy under hyperglycemia treatment in diabetic peripheral neuropathy (DPN). However, the exact mechanism is still not fully elucidated. We first observed the decrease of autophagy markers (LC3-II/LC3-I, P62) in the sciatic nerves of diabetic mice vs. normal mice, accompanied with the loss of myelinated nerve fibers and abnormal myelin sheath. In line with this, LC3-II/LC3-I and P62 were also significantly reduced in high glucose-treated rat Schwann cell 96 (RSC96) cells compared with normal glucose-treated cells. Furthermore, we found that trichostatin A [an inhibitor of histone deacetylase (HDAC)] evidently improved LC3-II/LC3-I in high glucose-treated RSC96 cells, without an effect on P62 expression. Again, HDAC1 and HDAC5 were revealed to be increased in RSC96 cells stimulated with high glucose. Inhibition of HDAC1 but not HDAC5 by small hairpin RNA vector enhanced LC3-II/LC3-I in high glucose-cultured RSC96 cells. In addition, LC3-II conversion regulators [autophagy-related protein (Atg)3, Atg5, and Atg7] were detected in high glucose-treated and HDAC1-knockdown RSC96 cells, and Atg3 was proven to be the key target of HDAC1. The presuppression of Atg3 offset the improvement of LC3-II/LC3-I resulting from HDAC1 inhibition in high glucose-treated RSC96 cells. The Janus kinase (JAK)-signal transducer and activator of transcription (STAT) signaling pathway was activated in RSC96 cells treated with high glucose, which was indicated by increased STAT3 phosphorylation. Blocking STAT3 phosphorylation by chemical inhibitor AG490 induced HDAC1 down-regulation followed by increases in Atg3 and LC3-II/LC3-I. Interestingly, we also found that AG490 treatment enhanced P62 expression in high glucose-stimulated RSC96 cells. Taken together, our findings demonstrate that hyperglycemia inhibits LC3-II/LC3-I in an HDAC1-Atg3-dependent manner and decreases P62 expression in an HDAC-independent manner via the JAK-STAT3 signaling pathway in the Schwann cells of DPN.-Du, W., Wang, N., Li, F. Jia, K., An, J., Liu, Y., Wang, Y., Zhu, L., Zhao, S. Hao, J. STAT3 phosphorylation mediates high glucose-impaired cell autophagy in an HDAC1-dependent and -independent manner in Schwann cells of diabetic peripheral neuropathy.	[Du, Wei; Li, Fan; Jia, Keqi; An, Jiahui; Liu, Yaping; Wang, Yuxue; Zhao, Song; Hao, Jun] Hebei Med Univ, Dept Pathol, Zhongshan East Rd 361, Shijiazhuang 050017, Hebei, Peoples R China; [Wang, Na] Hebei Med Univ, Hosp 2, Dept Pediat, Shijiazhuang, Hebei, Peoples R China; [Zhu, Lin] Hebei Med Univ, Hosp 3, Dept Electromyogram, Shijiazhuang, Hebei, Peoples R China	Hebei Medical University; Hebei Medical University; Hebei Medical University	Zhao, S; Hao, J (corresponding author), Hebei Med Univ, Dept Pathol, Zhongshan East Rd 361, Shijiazhuang 050017, Hebei, Peoples R China.	xljer606@163.com; haojun2004@hotmail.com			National Natural Science Foundation of China [81700715]; Foundation of Hebei Province Education Department [ZD2018251]; Natural Science Foundation of Hebei Province [H2018206096]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of Hebei Province Education Department; Natural Science Foundation of Hebei Province(Natural Science Foundation of Hebei Province)	This research was supported by grants from the National Natural Science Foundation of China (81700715), the Foundation of Hebei Province Education Department (ZD2018251), and the Natural Science Foundation of Hebei Province (H2018206096). The authors declare no conflicts of interest.	Al-Rasheed NM, 2016, DRUG DES DEV THER, V10, P2095, DOI 10.2147/DDDT.S109287; Arrowsmith CH, 2012, NAT REV DRUG DISCOV, V11, P384, DOI 10.1038/nrd3674; Bai Y, 2018, FASEB J, V32, P4573, DOI 10.1096/fj.201701411R; Candeias E, 2018, MOL NEUROBIOL, V55, P4030, DOI 10.1007/s12035-017-0622-3; Cao DJ, 2011, P NATL ACAD SCI USA, V108, P4123, DOI 10.1073/pnas.1015081108; Cheng MJ, 2018, NEUROCHEM RES, V43, P2141, DOI 10.1007/s11064-018-2637-1; Chowdhury SR, 2014, CELL MOL NEUROBIOL, V34, P643, DOI 10.1007/s10571-014-0054-9; Chung YC, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1192-7; Dehdashtian E, 2018, LIFE SCI, V193, P20, DOI 10.1016/j.lfs.2017.12.001; Dodington DW, 2018, TRENDS ENDOCRIN MET, V29, P55, DOI 10.1016/j.tem.2017.11.001; Feldman EL, 2017, NEURON, V93, P1296, DOI 10.1016/j.neuron.2017.02.005; Gilardini Montani MS, 2017, CELL ONCOL, V40, P167, DOI 10.1007/s13402-017-0314-z; Gumy LF, 2008, MOL CELL NEUROSCI, V37, P298, DOI 10.1016/j.mcn.2007.10.004; Hao J, 2009, HISTOCHEM CELL BIOL, V131, P327, DOI 10.1007/s00418-008-0528-2; He XL, 2018, NAT MED, V24, P338, DOI 10.1038/nm.4483; Hur J, 2016, DIABETOLOGIA, V59, P1297, DOI 10.1007/s00125-016-3913-8; Jia LF, 2018, FASEB J, V32, P6911, DOI 10.1096/fj.201800597R; Jo YK, 2018, ANTICANCER RES, V38, P271, DOI 10.21873/anticanres.12218; Khangura RK, 2017, EUR J PHARMACOL, V795, P36, DOI 10.1016/j.ejphar.2016.12.001; Kim M, 2019, J MOL HISTOL, V50, P167, DOI 10.1007/s10735-019-09815-1; Koeneke E, 2015, CELLS-BASEL, V4, P135, DOI 10.3390/cells4020135; Kou ZZ, 2013, PAIN PHYSICIAN, V16, pE71; Kume S, 2014, SEMIN NEPHROL, V34, P9, DOI 10.1016/j.semnephrol.2013.11.003; Liu J, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0374-7; Mrakovcic M, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18091883; Oh M, 2008, BIOCHEM BIOPH RES CO, V369, P1179, DOI 10.1016/j.bbrc.2008.03.019; Ortiz-Munoz G, 2010, J AM SOC NEPHROL, V21, P763, DOI 10.1681/ASN.2009060625; Qu L, 2014, NEURAL REGEN RES, V9, P1195, DOI 10.4103/1673-5374.135328; Reumann S, 2016, J CELL BIOCHEM, V117, P751, DOI 10.1002/jcb.25360; Rikiishi H, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/830260; Tang DF, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22257-1; Villarino AV, 2017, NAT IMMUNOL, V18, P374, DOI 10.1038/ni.3691; Wang FL, 2017, CAN J CARDIOL, V33, P850, DOI 10.1016/j.cjca.2017.01.002; Wang SY, 2018, J MOL CELL CARDIOL, V119, P40, DOI 10.1016/j.yjmcc.2018.04.009; Wang WJ, 2017, AUTOPHAGY, V13, P941, DOI 10.1080/15548627.2017.1293768; Wu S, 2013, J BIOL CHEM, V288, P35500, DOI 10.1074/jbc.M113.479865; Yang XJ, 2007, ONCOGENE, V26, P5310, DOI 10.1038/sj.onc.1210599; Yerra VG, 2016, MED HYPOTHESES, V86, P120, DOI 10.1016/j.mehy.2015.11.004; Zhu L, 2019, J CELL BIOCHEM, V120, P5777, DOI 10.1002/jcb.27864; Zhu L, 2018, EXP CELL RES, V367, P186, DOI 10.1016/j.yexcr.2018.03.034; Zhu L, 2016, J CELL BIOCHEM, V117, P1187, DOI 10.1002/jcb.25402; Zimberlin CD, 2015, FASEB J, V29, P2070, DOI 10.1096/fj.14-257931	42	34	40	1	22	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2019	33	7					8008	8021		10.1096/fj.201900127R	http://dx.doi.org/10.1096/fj.201900127R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ9SM	30913399	Bronze			2022-12-26	WOS:000476234700017
J	Li, Y; Sun, Q; Jiang, MC; Li, S; Zhang, JY; Xu, ZQ; Guo, DY; Gu, TN; Wang, BY; Xiao, L; Zhou, TH; Zhuo, W				Li, Yang; Sun, Qiang; Jiang, Mingchun; Li, Shuang; Zhang, Jiayu; Xu, Zhangqi; Guo, Dongyang; Gu, Tianning; Wang, Boya; Xiao, Lei; Zhou, Tianhua; Zhuo, Wei			KLF9 suppresses gastric cancer cell invasion and metastasis through transcriptional inhibition of MMP28	FASEB JOURNAL			English	Article						GSEA; transwell assay; MTT assay; stomach; pulmonary metastasis	KRUPPEL-LIKE FACTORS; MATRIX METALLOPROTEINASES; MESENCHYMAL TRANSITION; MICE LACKING; GROWTH; GENE; CARCINOMA; MMP-28; PROLIFERATION; ACTIVATION	Gastric cancer (GC) is among the most lethal human malignancies, and the leading cause of GC mortality is metastasis. However, the precise mechanism of GC metastasis remains unclear. To screen key transcriptional factors (TFs) involved in GC metastasis, we performed bioinformatics analysis of The Cancer Genome Atlas database and found that Kruppel-like factor 9 (KLF9) is a GC metastasis-associated TF. KLF9 is significantly decreased in patients with GC with distant metastasis compared with those patients without distant metastasis. Ectopic expression of KLF9 evidently inhibited the migration and invasion capabilities of GC cells. Conversely, knockdown of KLF9 endowed GC cells with stronger invasive capacity. Moreover, tail intravenous injection confirmed that KLF9 strongly inhibits the lung metastasis process of GC in vivo. Mechanistically, chromatin immunoprecipitation coupled with high-throughput sequencing data from Encyclopedia of DNA Elements revealed that KLF9 specifically binds to the promoter region of matrix metalloproteinase (MMP)28. Further quantitative real-time PCR and dual-luciferase assay indicated that KLF9 directly inhibited MMP28 transcription. Importantly, decreased invasion and metastasis capability of GC cells caused by ectopic KLF9 expression could be rescued via reinforcing MMP28 expression in vivo. Collectively, our study indicates that KLF9 significantly suppresses GC cell invasion and metastasis through inhibiting MMP28 transcription.-Li, Y., Sun, Q., Jiang, M., Li, S., Zhang, J., Xu, Z., Guo, D., Gu, T., Wang, B., Xiao, L., Zhou, T., Zhuo, W. KLF9 suppresses gastric cancer cell invasion and metastasis through transcriptional inhibition of MMP28.	[Li, Yang; Xiao, Lei] Zhejiang Univ, Coll Anim Sci, Hangzhou, Zhejiang, Peoples R China; [Zhou, Tianhua; Zhuo, Wei] Zhejiang Univ, Inst Gastroenterol, Hangzhou, Zhejiang, Peoples R China; [Li, Yang; Sun, Qiang; Jiang, Mingchun; Li, Shuang; Zhang, Jiayu; Xu, Zhangqi; Guo, Dongyang; Gu, Tianning; Xiao, Lei; Zhou, Tianhua; Zhuo, Wei] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Cell Biol, Hangzhou, Zhejiang, Peoples R China; [Li, Yang; Sun, Qiang; Jiang, Mingchun; Li, Shuang; Zhang, Jiayu; Xu, Zhangqi; Guo, Dongyang; Gu, Tianning; Xiao, Lei; Zhou, Tianhua; Zhuo, Wei] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Canc Inst, Hangzhou, Zhejiang, Peoples R China; [Wang, Boya] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Pharm, Hangzhou, Zhejiang, Peoples R China; [Zhou, Tianhua] Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases	Zhou, TH; Zhuo, W (corresponding author), Zhejiang Univ, Sch Med, Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China.	tzhou@zju.edu.cn; 0012049@zju.edu.cn	sun, qiang/GQQ-9847-2022; Sun, Qiang/AAL-4865-2020; zhou, tianhua/K-4908-2013	sun, qiang/0000-0002-6621-7064; Sun, Qiang/0000-0002-6621-7064; zhou, tianhua/0000-0002-1791-2124; Zhuo, Wei/0000-0002-8251-4210; Gu, Tianning/0000-0003-1550-1011	National Natural Science Foundation of China [31771540, 91740205, 31620103911, 31571446, 31301149]; Natural Scientific Foundation of Zhejiang Province [LYY19H310011, LQ13H160013]; Fundamental Research Funds for the Central Universities [2017QNA7005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Scientific Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The authors thank Zhaocai Zhou (Shanghai Institute of Biochemistry and Cell Biology, Shanghai, China) for providing the BGC-823 cells and Youyong Lu (Beijing Cancer Hospital, Beijing, China) for providing the SGC-7901 GC cell lines. The authors are grateful to Lydia Zhong (Princeton University, Princeton, NJ, USA) for help with editing the language of our manuscript. This work was supported by the National Natural Science Foundation of China (31771540, 91740205, 31620103911, 31571446, and 31301149), the Natural Scientific Foundation of Zhejiang Province (LYY19H310011, LQ13H160013), and Fundamental Research Funds for the Central Universities (2017QNA7005). The authors declare no conflicts of interest.	Bagamasbad P, 2012, ENDOCRINOLOGY, V153, P5334, DOI 10.1210/en.2012-1303; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Bernards N, 2013, ANN ONCOL, V24, P3056, DOI 10.1093/annonc/mdt401; Bornschein J, 2015, DIAGN PATHOL, V10, DOI 10.1186/s13000-015-0449-z; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Cho JY, 2011, CLIN CANCER RES, V17, P1850, DOI 10.1158/1078-0432.CCR-10-2180; D'Errico M, 2009, EUR J CANCER, V45, P461, DOI 10.1016/j.ejca.2008.10.032; Ding L, 2010, CELL RES, V20, P784, DOI 10.1038/cr.2010.79; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Hanzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Illman SA, 2006, J CELL SCI, V119, P3856, DOI 10.1242/jcs.03157; IMATAKA H, 1992, EMBO J, V11, P3663, DOI 10.1002/j.1460-2075.1992.tb05451.x; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jiao S, 2014, CANCER CELL, V25, P166, DOI 10.1016/j.ccr.2014.01.010; Kang L, 2008, PATHOL INT, V58, P334, DOI 10.1111/j.1440-1827.2008.02233.x; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kubben FJGM, 2006, BRIT J CANCER, V94, P1035, DOI 10.1038/sj.bjc.6603041; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee TI, 2013, CELL, V152, P1237, DOI 10.1016/j.cell.2013.02.014; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Limame R, 2013, ONCOSCIENCE, V1, P69, DOI DOI 10.18632/oncoscience.10; Lizio M, 2017, NUCLEIC ACIDS RES, V45, pD737, DOI 10.1093/nar/gkw995; Lizio M, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-014-0560-6; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Manicone AM, 2009, J IMMUNOL, V182, P3866, DOI 10.4049/jimmunol.0713949; Marchenko GN, 2001, GENE, V265, P87, DOI 10.1016/S0378-1119(01)00360-2; McConnell BB, 2010, PHYSIOL REV, V90, P1337, DOI 10.1152/physrev.00058.2009; Parks WC, 2004, NAT REV IMMUNOL, V4, P617, DOI 10.1038/nri1418; Qiao F, 2016, MOL CARCINOGEN, V55, P280, DOI 10.1002/mc.22277; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Shan YQ, 2015, CANCER GENE THER, V22, P101, DOI 10.1038/cgt.2014.61; Shen MH, 2013, CELL RES, V23, P1284, DOI 10.1038/cr.2013.127; Shen PL, 2014, PROSTATE, V74, P946, DOI 10.1002/pros.22812; Simmen FA, 2007, AM J PHYSIOL-GASTR L, V292, pG1757, DOI 10.1152/ajpgi.00013.2007; Simmen RCM, 2004, J BIOL CHEM, V279, P29286, DOI 10.1074/jbc.M403139200; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun JB, 2014, CANCER LETT, V355, P25, DOI 10.1016/j.canlet.2014.09.022; Tetreault MP, 2013, NAT REV CANCER, V13, P701, DOI 10.1038/nrc3582; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Wang GS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063826; Wang Q, 2012, MED ONCOL, V29, P77, DOI 10.1007/s12032-010-9766-y; WU CW, 1989, CANCER, V64, P2552, DOI 10.1002/1097-0142(19891215)64:12&lt;2552::AID-CNCR2820641224&gt;3.0.CO;2-Y; Xing R, 2012, GUT, V61, P43, DOI 10.1136/gut.2010.230623; Yu GC, 2015, BIOINFORMATICS, V31, P2382, DOI 10.1093/bioinformatics/btv145; Zhang QH, 2015, ARCH GYNECOL OBSTET, V291, P377, DOI 10.1007/s00404-014-3405-3; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zheng HC, 2006, ANTICANCER RES, V26, P3579	51	32	33	5	27	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2019	33	7					7915	7928		10.1096/fj.201802531R	http://dx.doi.org/10.1096/fj.201802531R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ9SM	30913394	Bronze			2022-12-26	WOS:000476234700010
J	Kuan, II; Lee, CC; Chen, CH; Lu, J; Kuo, YS; Wu, HC				Kuan, I-I; Lee, Chi-Chiu; Chen, Chien-Hsu; Lu, Jean; Kuo, Yuan-Sung; Wu, Han-Chung			The extracellular domain of epithelial cell adhesion molecule (EpCAM) enhances multipotency of mesenchymal stem cells through EGFR-LIN28-LET7 signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mesenchymal stem cells (MSCs); epithelial cell adhesion molecule (EpCAM); epidermal growth factor receptor (EGFR); pluripotency; proliferation; HMGA2; Lin28; multipotency	DNA ARCHITECTURAL FACTOR; GROUP PROTEIN HMGA2; TRANSCRIPTION FACTOR; EXPRESSION PATTERNS; SELF-RENEWAL; BONE; OCT4; DIFFERENTIATION; SOX2; PLURIPOTENCY	Mesenchymal stem cells (MSCs) are widely considered to be an attractive cell source for regenerative therapies, but maintaining multipotency and self-renewal in cultured MSCs is especially challenging. Hence, the development and mechanistic description of strategies that help promote multipotency in MSCs will be vital to future clinical use. Here, using an array of techniques and approaches, including cell biology, RT-quantitative PCR, immunoblotting, immunofluorescence, flow cytometry, and ChIP assays, we show that the extracellular domain of epithelial cell adhesion molecule (EpCAM) (EpEX) significantly increases the levels of pluripotency factors through a signaling cascade that includes epidermal growth factor receptor (EGFR), signal transducer and activator of transcription 3 (STAT3), and Lin-28 homolog A (LIN28) and enhances the proliferation of human bone marrow MSCs. Moreover, we found that EpEX-induced LIN28 expression reduces the expression of the microRNA LET7 and up-regulates that of the transcription factor high-mobility group AT-hook 2 (HMGA2), which activates the transcription of pluripotency factors. Surprisingly, we found that EpEX treatment also enhances osteogenesis of MSCs under differentiation conditions, as evidenced by increases in osteogenic markers, including Runt-related transcription factor 2 (RUNX2). Taken together, our results indicate that EpEX stimulates EGFR signaling and thereby context-dependently controls MSC states and activities, promoting cell proliferation and multipotency under maintenance conditions and osteogenesis under differentiation conditions.	[Kuan, I-I; Lee, Chi-Chiu; Chen, Chien-Hsu; Wu, Han-Chung] Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan; [Lu, Jean; Wu, Han-Chung] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Kuo, Yuan-Sung] Natl Taiwan Univ, Dept Surg, Coll Med, Taipei 100, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Taiwan University	Wu, HC (corresponding author), Acad Sinica, Inst Cellular & Organism Biol, 128 Acad Rd,Sect 2, Taipei 11529, Taiwan.	hcw0928@gate.sinica.edu.tw	Wu, Han-Chung/B-1209-2011	Wu, Han-Chung/0000-0002-5185-1169	Ministry of Science and Technology [106-0210-01-15-02, 107-0210-01-19-01]; Academia Sinica	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Academia Sinica(Academia Sinica - Taiwan)	This work was supported by Academia Sinica and Ministry of Science and Technology Grants 106-0210-01-15-02 and 107-0210-01-19-01. The authors declare that they have no conflicts of interest with the contents of this article.	Beltrami AR, 2007, BLOOD, V110, P3438, DOI 10.1182/blood-2006-11-055566; Bittle GJ, 2018, CIRC RES, V123, P288, DOI 10.1161/CIRCRESAHA.117.311206; Boiani M, 2005, NAT REV MOL CELL BIO, V6, P872, DOI 10.1038/nrm1744; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brighton CT, 1997, J ORTHOP TRAUMA, V11, P244, DOI 10.1097/00005131-199705000-00002; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Chambers I, 2009, DEVELOPMENT, V136, P2311, DOI 10.1242/dev.024398; Chaves-Perez A, 2013, ONCOGENE, V32, P641, DOI 10.1038/onc.2012.75; Cheng L, 2007, J PATHOL, V211, P1, DOI 10.1002/path.2105; Chien CS, 2015, CANCER RES, V75, P2553, DOI 10.1158/0008-5472.CAN-14-2215; Cimadamore F, 2013, P NATL ACAD SCI USA, V110, pE3017, DOI 10.1073/pnas.1220176110; Cleynen I, 2008, INT J ONCOL, V32, P289; Dezawa M, 2005, SCIENCE, V309, P314, DOI 10.1126/science.1110364; Duque G, 2008, CURR OPIN RHEUMATOL, V20, P429, DOI 10.1097/BOR.0b013e3283025e9c; Fang XF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-11; Fusco A, 2007, NAT REV CANCER, V7, P899, DOI 10.1038/nrc2271; Ge W, 2009, AM J TRANSPLANT, V9, P1760, DOI 10.1111/j.1600-6143.2009.02721.x; Girouard SD, 2012, LAB INVEST, V92, P362, DOI 10.1038/labinvest.2011.188; Greber B, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-46; Greco SJ, 2007, STEM CELLS, V25, P3143, DOI 10.1634/stemcells.2007-0351; Guo L, 2013, ONCOGENE, V32, P5272, DOI 10.1038/onc.2012.573; Guo YQ, 2006, GENE, V384, P51, DOI 10.1016/j.gene.2006.07.011; Huang HP, 2011, J BIOL CHEM, V286, P33520, DOI 10.1074/jbc.M111.256164; Kerkis I, 2006, CELLS TISSUES ORGANS, V184, P105, DOI 10.1159/000099617; Kim JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007166; Krampera M, 2005, BLOOD, V106, P59, DOI 10.1182/blood-2004-09-3645; Kuan II, 2017, SCI REP-UK, V7, DOI 10.1038/srep41852; Le Blanc K, 2018, CYTOTHERAPY, V20, P273, DOI 10.1016/j.jcyt.2018.01.009; Lee H, 2016, PROTEIN CELL, V7, P100, DOI 10.1007/s13238-015-0212-y; Lengler J, 2005, OPHTHALMIC RES, V37, P301, DOI 10.1159/000087774; Lengner CJ, 2008, CELL CYCLE, V7, P725, DOI 10.4161/cc.7.6.5573; Li O, 2007, FEBS LETT, V581, P3533, DOI 10.1016/j.febslet.2007.06.072; Li O, 2006, GENESIS, V44, P523, DOI 10.1002/dvg.20242; Li ZZ, 2012, DEV CELL, V23, P1176, DOI 10.1016/j.devcel.2012.10.019; Liang KH, 2018, CANCER LETT, V433, P165, DOI 10.1016/j.canlet.2018.06.040; Liao TT, 2016, CELL REP, V14, P520, DOI 10.1016/j.celrep.2015.12.064; Lin CW, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.386235; Lin G, 2008, STEM CELLS DEV, V17, P1053, DOI 10.1089/scd.2008.0117; LITVINOV SV, 1994, J CELL BIOL, V125, P437, DOI 10.1083/jcb.125.2.437; Liu KC, 2013, CELL SIGNAL, V25, P1264, DOI 10.1016/j.cellsig.2013.02.013; Liu LF, 2010, J CELL PHYSIOL, V225, P837, DOI 10.1002/jcp.22291; Liu YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083083; Looijenga LHJ, 2003, CANCER RES, V63, P2244; Lu TY, 2010, J BIOL CHEM, V285, P8719, DOI 10.1074/jbc.M109.077081; Maetzel D, 2009, NAT CELL BIOL, V11, P162, DOI 10.1038/ncb1824; Mahajan A, 2010, MODERN PATHOL, V23, P673, DOI 10.1038/modpathol.2010.49; Markovic A, 2012, EXPERT REV ANTICANC, V12, P1149, DOI [10.1586/ERA.12.91, 10.1586/era.12.91]; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Matic Igor, 2016, Open Access Maced J Med Sci, V4, P9, DOI 10.3889/oamjms.2016.008; Monk M, 2001, ONCOGENE, V20, P8085, DOI 10.1038/sj.onc.1205088; Monzen K, 2008, NAT CELL BIOL, V10, P567, DOI 10.1038/ncb1719; Munz M, 2004, ONCOGENE, V23, P5748, DOI 10.1038/sj.onc.1207610; Nishino J, 2008, CELL, V135, P227, DOI 10.1016/j.cell.2008.09.017; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Oryan A, 2017, CELLS TISSUES ORGANS, V204, P59, DOI 10.1159/000469704; Oshima K, 2005, BIOCHEM BIOPH RES CO, V331, P520, DOI 10.1016/j.bbrc.2005.03.210; PALMIERI SL, 1994, DEV BIOL, V166, P259, DOI 10.1006/dbio.1994.1312; Pan GJ, 2007, CELL RES, V17, P42, DOI 10.1038/sj.cr.7310125; Pan M, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2006624; Peng Guang-Hua, 2013, Methods Mol Biol, V935, P311, DOI 10.1007/978-1-62703-080-9_22; Pesce M, 2001, STEM CELLS, V19, P271, DOI 10.1634/stemcells.19-4-271; Pfannkuche K, 2009, STEM CELL REV REP, V5, P224, DOI 10.1007/s12015-009-9078-9; Pierantozzi E, 2011, STEM CELLS DEV, V20, P915, DOI 10.1089/scd.2010.0353; Piskounova E, 2011, CELL, V147, P1066, DOI 10.1016/j.cell.2011.10.039; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Platt MO, 2009, J CELL PHYSIOL, V221, P306, DOI 10.1002/jcp.21854; Rawlinson NJ, 2008, CANCER GENET CYTOGEN, V181, P119, DOI 10.1016/j.cancergencyto.2007.11.008; Raz R, 1999, P NATL ACAD SCI USA, V96, P2846, DOI 10.1073/pnas.96.6.2846; Reim G, 2002, DEVELOPMENT, V129, P917; Shell S, 2007, P NATL ACAD SCI USA, V104, P11400, DOI 10.1073/pnas.0704372104; Sperger JM, 2003, P NATL ACAD SCI USA, V100, P13350, DOI 10.1073/pnas.2235735100; Stefani G, 2015, RNA, V21, P985, DOI 10.1261/rna.045542.114; Stenderup K, 2003, BONE, V33, P919, DOI 10.1016/j.bone.2003.07.005; Stolzing A, 2008, MECH AGEING DEV, V129, P163, DOI 10.1016/j.mad.2007.12.002; Tai MH, 2005, CARCINOGENESIS, V26, P495, DOI 10.1093/carcin/bgh321; Takahashi K, 2003, NATURE, V423, P541, DOI 10.1038/nature01646; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Taniguchi N, 2011, J BIOL CHEM, V286, P41489, DOI 10.1074/jbc.M111.236984; Thornton JE, 2012, TRENDS CELL BIOL, V22, P474, DOI 10.1016/j.tcb.2012.06.001; Triboulet R, 2015, CELL REP, V13, P260, DOI 10.1016/j.celrep.2015.08.086; Valero MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029760; Wang TZ, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0402-5; Wei JJ, 2010, AM J SURG PATHOL, V34, P18, DOI 10.1097/PAS.0b013e3181be5d72; Xu RH, 2008, CELL STEM CELL, V3, P196, DOI 10.1016/j.stem.2008.07.001; Yeom SY, 2014, MOL CANCER THER, V13, P3049, DOI 10.1158/1535-7163.MCT-14-0244; Yu KR, 2012, STEM CELLS, V30, P876, DOI 10.1002/stem.1052; Zhou S, 2008, AGING CELL, V7, P335, DOI 10.1111/j.1474-9726.2008.00377.x	87	9	10	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2019	294	19					7769	7786		10.1074/jbc.RA119.007386	http://dx.doi.org/10.1074/jbc.RA119.007386			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IB3FL	30926604	Green Published, hybrid			2022-12-26	WOS:000470153300020
J	Chavez-Zarate, A; Maguina, JL; Quichiz-Lara, AD; Zapata-Fajardo, PE; Mayta-Tristan, P				Chavez-Zarate, Airin; Maguina, Jorge L.; Danciana Quichiz-Lara, Antoinette; Edith Zapata-Fajardo, Patricia; Mayta-Tristan, Percy			Relationship between stunting in children 6 to 36 months of age and maternal employment status in Peru: A sub-analysis of the Peruvian Demographic and Health Survey	PLOS ONE			English	Article							YOUNG-CHILDREN; PRESCHOOL-CHILDREN; PRECONCEPTION CARE; DETERMINANTS; PREVALENCE; OVERWEIGHT; MALNUTRITION	Objectives This study aimed to determine the relationship between stunting in children 6 to 36 months old and maternal employment status in Peru. Methods A secondary data analysis was conducted using information from the Demographic and Health Survey (DHS) in Peru. We used a representative sample of 4637 mother-child binomials to determine the association between stunting in children 6 to 36 months of age and the employment status of their mothers. Results The prevalence of stunting among children was 15.9% (95% CI: 13.9-16.7). The prevalence of working mothers was 63.7%. No association was found between maternal employment status and the presence of stunting in children [prevalence ratio (PR) = 1.04; 95% confidence interval (95% CI): 0.9 to 1.2; p = 0.627). However, on multivariate analysis we found that the prevalence of stunting was significantly higher among children of mothers performing unpaid work (12.4%) (PR = 1.38; 95% CI: 1.2-1.6; p < 0.001) compared with those of paid working mothers. Conclusion No significant association was found between maternal employment status and the presence of stunting in children 6 to 36 months of age. However, children of mothers doing unpaid work are at higher risk of stunting. These findings support the implementation of educational programs and labour policies to reduce the prevalence of stunting among children.	[Chavez-Zarate, Airin; Danciana Quichiz-Lara, Antoinette; Edith Zapata-Fajardo, Patricia] Univ Peruana Ciencias Aplicadas, Escuela Nutr & Dietet, Lima, Peru; [Maguina, Jorge L.; Mayta-Tristan, Percy] Univ Peruana Ciencias Aplicadas, Escuela Med, Lima, Peru; [Maguina, Jorge L.] Univ Cient Sur, Fac Ciencias Salud, Lima, Peru; [Mayta-Tristan, Percy] Univ Cient Sur, Direcc Gen Invest Desarrollo & Innovac, Lima, Peru	Universidad Peruana de Ciencias Aplicadas (UPC); Universidad Peruana de Ciencias Aplicadas (UPC); Universidad Cientifica del Sur (CIENTIFICA); Universidad Cientifica del Sur (CIENTIFICA)	Chavez-Zarate, A (corresponding author), Univ Peruana Ciencias Aplicadas, Escuela Nutr & Dietet, Lima, Peru.; Mayta-Tristan, P (corresponding author), Univ Peruana Ciencias Aplicadas, Escuela Med, Lima, Peru.; Mayta-Tristan, P (corresponding author), Univ Cient Sur, Direcc Gen Invest Desarrollo & Innovac, Lima, Peru.	airinchz1@hotmail.com; p.mayta@cientifica.edu.pe	Maguiña, Jorge L./AGQ-6299-2022; Mayta-Tristan, Percy/D-8587-2011	Maguiña, Jorge L./0000-0002-4136-7795; Mayta-Tristan, Percy/0000-0002-0861-6606; Chavez-Zarate, Airin/0000-0001-8094-8819				Arocena Canazas VM, 2009, FACTORES ASOCIADOS D, P7; Ayazi P, 2010, IRAN J PEDIAT SOC, V2, P37; Beltran A, 2009, CTR INVESTIG U PA S3, V1, P1; Chowdhury R, 2013, INDAN J COMMUNITY HE, V25, P251; Cordova-Villalobos JA, 2008, SALUD PUBLICA MEXICO, V50, P419, DOI 10.1590/s0036-36342008000500015; Delgado Sanchez HD, 2015, THESIS; Deshmukh Pradeep R, 2013, Med J Armed Forces India, V69, P213, DOI 10.1016/j.mjafi.2012.10.004; Diaz A, 2015, REV PANAM SALUD PUBL, V38, P49; Duran Rojas BF, 2009, THESIS; Fernald LC, 2007, EUR J CLIN NUTR, V61, P623, DOI 10.1038/sj.ejcn.1602558; Forero-Ramirez N, 2014, REV PANAM SALUD PUBL, V35, P163; Gamboa-Delgado Edna M., 2007, Rev. salud pública, V9, P129, DOI 10.1590/S0124-00642007000100013; Grjibovski AM, 2004, CROAT MED J, V45, P757; Grover N, 2015, INDIAN J BASIC AP S1, V5, P657; Institut Nacional de Estadistica e Investigacion, 2012, MAN ANT; Instituto Nacional de Estadistica e Informatica, 2015, PER ENC DEM SAL FAM; Jesmin A, 2011, J HEALTH POPUL NUTR, V29, P494; Joshi N, 2012, MATERN CHILD NUTR, V8, P45, DOI 10.1111/j.1740-8709.2011.00384.x; Keino S, 2014, FOOD NUTR BULL, V35, P167, DOI 10.1177/156482651403500203; Mamabolo RL, 2005, PUBLIC HEALTH NUTR, V8, P501, DOI 10.1079/PHN2005786; Nakahara S, 2006, AM J HUM BIOL, V18, P169, DOI 10.1002/ajhb.20481; Oficina Tecnica de Difusion del I NEI, 2014, NOT PRENS; Organizacion Panamericana de la Salud Organizacion Mundial de la Salud, 2007, NUEV PATR CREC OMS, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CBO9781107415324.004]; POWELL CA, 1985, AM J CLIN NUTR, V41, P1322, DOI 10.1093/ajcn/41.6.1322; Ramos CV, 2015, J PEDIAT-BRAZIL, V91, P175, DOI 10.1016/j.jped.2014.07.005; Said-Mohamed R, 2009, ANN HUM BIOL, V36, P146, DOI 10.1080/03014460802660526; Sameena Sultan, 2014, Indian Journal of Basic and Applied Medical Research, V3, P51; Sánchez-Abanto José, 2012, Rev. perú. med. exp. salud publica, V29, P402, DOI 10.1590/s1726-46342012000300018; Seedhom AE., 2014, IPHF, V1, P6; Sivakami M., 1997, HLTH TRANSITION REV, V7, P21, DOI DOI 10.2307/40652231; Sobrino M, 2014, REV PANAM SALUD PUBL, V35, P104; Suarez-Lopez MG, 2013, THESIS; United Nations Children's Fund. Improving child nutrition, 2013, IMPR CHILD NUTR ACH; van der Zee B, 2011, J PUBLIC HEALTH POL, V32, P367, DOI 10.1057/jphp.2011.13; Vieira Viviane Laudelino, 2010, Rev. Bras. Saude Mater. Infant., V10, P199, DOI 10.1590/S1519-38292010000200007; Wildschut H I J, 2006, Ned Tijdschr Geneeskd, V150, P1326; Williams L, 2012, MATERN CHILD HLTH J, V16, P1854, DOI 10.1007/s10995-011-0932-4; Woldemariam G, 2002, DETERMINANTS NUTR ST, P1; World Bank, 2016, TAS POBL ACT MUJ POB; World Health Organization, 2015, ENF TRANSM; World Health Organization, 2008, IND EV PRACT AL LACT; World Health Organization, 2013, PROT LACT MAT PER; Zottarelli L. K., 2007, Eastern Mediterranean Health Journal, V13, P1330	43	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0212164	10.1371/journal.pone.0212164	http://dx.doi.org/10.1371/journal.pone.0212164			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HR5NS	30943197	gold, Green Published, Green Submitted			2022-12-26	WOS:000463194300003
J	Corcos, D; Cerretti, P; Caruso, V; Mei, M; Falco, M; Marini, L				Corcos, Daria; Cerretti, Pierfilippo; Caruso, Valerio; Mei, Maurizio; Falco, Matteo; Marini, Lorenzo			Impact of urbanization on predator and parasitoid insects at multiple spatial scales	PLOS ONE			English	Article							WASPS HYMENOPTERA ACULEATA; LANDSCAPE CONTEXT; HABITAT FRAGMENTATION; BEE ASSEMBLAGES; URBAN; RESPONSES; EVENNESS; ECOLOGY; PARKS	Landscapes are becoming increasingly urbanized, causing loss and fragmentation of natural habitats, with potentially negative effects on biodiversity. Insects are among the organisms with the largest diversity in urbanized environments. Here, we sampled predator (Ampulicidae, Sphecidae and Crabronidae) and parasitoid (Tachinidae) flower-visiting insects in 36 sites in the city of Rome (Italy). Although the diversity of herbivorous insects in urban areas mostly depends on the availability of flowering plants and nesting sites, predators and parasitoids generally require a larger number of resources during their life cycle, and are expected to be particularly influenced by urbanization. As flower-visitors can easily move between habitat patches, the effect of urbanization was tested at multiple spatial scales (local, landscape and sub-regional). We found that urbanization influenced predator and parasitoid flower-visitors at all three spatial scales. At the local scale, streets and buildings negatively influenced evenness of predators and species richness and abundance of parasitoids probably acting as dispersal barrier. At the landscape scale, higher percentage of urban decreased predator abundance, while increasing their evenness, suggesting an increase in generalist and highly mobile species. Area and compactness (i.e. Contiguity index) of urban green interactively influenced predator communities, whereas evenness of parasitoids increased with increasing Contiguity index. At the sub-regional scale, species richness and abundance of predators increased with increasing distance from the city center. Compared to previous studies testing the effect of urbanization, we found little variation in species richness, abundance and evenness along our urbanization gradient. The current insect fauna has been probably selected for its tolerance to habitat loss and fragmentation, being the result of the intensive anthropogenic alteration occurred in the area in the last centuries. Conservation strategies aimed at predator and parasitoid flying insects have to take in account variables at multiple spatial-scales, as well as the complementarity of resources across the landscape.	[Corcos, Daria; Cerretti, Pierfilippo; Caruso, Valerio; Mei, Maurizio; Falco, Matteo] Sapienza Univ Rome, Dept Biol & Biotechnol Charles Darwin, Rome, Italy; [Corcos, Daria; Marini, Lorenzo] Univ Padua, Dept Agron Food Nat Resources Anim & Environm DAF, Padua, Italy	Sapienza University Rome; University of Padua	Corcos, D (corresponding author), Sapienza Univ Rome, Dept Biol & Biotechnol Charles Darwin, Rome, Italy.; Corcos, D (corresponding author), Univ Padua, Dept Agron Food Nat Resources Anim & Environm DAF, Padua, Italy.	daria.corcos@uniroma1.it	Cerretti, Pierfilippo/L-6504-2016; Marini, Lorenzo/B-1119-2009	Cerretti, Pierfilippo/0000-0002-9204-3352; Marini, Lorenzo/0000-0001-7429-7685; Falco, Matteo/0000-0002-2386-873X				Ahrne K, 2008, CURRENT SCI, V4, pe5574, DOI [10.1371/journal.pone.0005574, DOI 10.1371/JOURNAL.PONE.0005574]; [Anonymous], 2016, WORLD POPULATION REV; Baldock KCR, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2849; Bates AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023459; Beninde J, 2015, ECOL LETT, V18, P581, DOI 10.1111/ele.12427; Bennett AB, 2014, INSECT CONSERV DIVER, V7, P405, DOI 10.1111/icad.12062; Buczkowski G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041729; Burkman CE, 2014, BIOL CONTROL, V75, P58, DOI 10.1016/j.biocontrol.2014.02.015; Cerretti P., 2010, TACHINIDI FAUNA ITAL, P912; Cerretti Pierfilippo, 2001, Bollettino dell'Associazione Romana di Entomologia, V56, P63; Cherrill A, 2015, LANDSCAPE RES, V40, P476, DOI 10.1080/01426397.2014.902922; Christie F, 2009, J INSECT CONSERV, V13, P213, DOI 10.1007/s10841-008-9146-5; Clergeau P, 2006, TRENDS ECOL EVOL, V21, P660, DOI 10.1016/j.tree.2006.09.006; Corcos D, 2017, INSECT CONSERV DIVER, V10, P462, DOI 10.1111/icad.12249; Deguines N., 2012, SCIENCE, V7, P1, DOI DOI 10.1371/J0URNAL.P0NE.0045822; Fattorini S, 2014, J INSECT CONSERV, V18, P729, DOI 10.1007/s10841-014-9681-1; Fattorini S, 2011, INSECT CONSERV DIVER, V4, P307, DOI 10.1111/j.1752-4598.2010.00129.x; Geographic Information System (GIS), 2020, GEOGR INF MAN SYST G; Geslin B, 2016, ECOL EVOL, V6, P6599, DOI 10.1002/ece3.2374; Geslin B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063421; Heneberg P, 2017, BIODIVERS CONSERV, V26, P843, DOI 10.1007/s10531-016-1275-7; Heneberg P, 2016, ECOL ENG, V93, P187, DOI 10.1016/j.ecoleng.2016.05.026; Inclan DJ, 2014, LANDSCAPE ECOL, V29, P879, DOI 10.1007/s10980-014-0024-0; KAREIVA P, 1987, NATURE, V326, P388, DOI 10.1038/326388a0; Kindt R., 2005, WORLD; Kleijn D, 2006, BASIC APPL ECOL, V7, P201, DOI 10.1016/j.baae.2005.07.011; Koh LP, 2004, ECOL APPL, V14, P1695, DOI 10.1890/03-5269; LAGRO J, 1991, PHOTOGRAMM ENG REM S, V57, P285; Lowry H, 2013, BIOL REV, V88, P537, DOI 10.1111/brv.12012; Marini L, 2014, ECOGRAPHY, V37, P544, DOI 10.1111/j.1600-0587.2013.00369.x; Martin EA, 2016, ECOL APPL, V26, P448, DOI 10.1890/15-0856; McFrederick QS, 2006, BIOL CONSERV, V129, P372, DOI 10.1016/j.biocon.2005.11.004; McGarigal K., 2012, TECH REP; Mei Maurizio, 2012, Ampulex, V5, P37; Niinemets U, 2008, TRENDS PLANT SCI, V13, P60, DOI 10.1016/j.tplants.2007.11.009; PAGLIANO G., 2005, HYMENOPTERA SPHECIDA, V40; Pape T, 2015, BIODIVERS DATA J, V3, DOI 10.3897/BDJ.3.e4187; R Development Core Team R Foundation for Statistical Computing, 2015, R FDN STAT COMP R LA; Ramalho CE, 2012, TRENDS ECOL EVOL, V27, P179, DOI 10.1016/j.tree.2011.10.008; Sattler T, 2010, LANDSCAPE ECOL, V25, P941, DOI 10.1007/s10980-010-9473-2; Fenoglio MS, 2013, BIOL CONSERV, V164, P82, DOI 10.1016/j.biocon.2013.05.002; Smith B, 1996, OIKOS, V76, P70, DOI 10.2307/3545749; Srba M, 2012, J INSECT CONSERV, V16, P557, DOI 10.1007/s10841-011-9441-4; Steffan-Dewenter I, 2002, ECOLOGY, V83, P1421, DOI 10.1890/0012-9658(2002)083[1421:SDEOLC]2.0.CO;2; Stireman JO, 2006, ANNU REV ENTOMOL, V51, P525, DOI 10.1146/annurev.ento.51.110104.151133; Stireman JO, 2016, CURR OPIN INSECT SCI, V14, P87, DOI 10.1016/j.cois.2016.02.002; Su ZM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119276; Tscharntke T, 2002, ECOL RES, V17, P229, DOI 10.1046/j.1440-1703.2002.00482.x; Tscharntke T, 2002, ECOLOGICAL APPL, V21, P2781; Turrini T, 2015, GLOBAL CHANGE BIOL, V21, P1652, DOI 10.1111/gcb.12825; Verboven HAF, 2014, LANDSCAPE URBAN PLAN, V126, P31, DOI 10.1016/j.landurbplan.2014.02.017; Vergnes A, 2014, BIODIVERS CONSERV, V23, P1859, DOI 10.1007/s10531-014-0689-3; Wang XL, 2014, METHODS ECOL EVOL, V5, P634, DOI 10.1111/2041-210X.12198; Westrich P., 1996, The conservation of bees., P1; Zanette LRS, 2005, LANDSCAPE URBAN PLAN, V71, P105, DOI 10.1016/j.landurbplan.2004.02.003; Zapparoli M, 1997, LANDSCAPE URBAN PLAN, V38, P77, DOI 10.1016/S0169-2046(97)00020-0; Zapparoli M., GLI INSETTI DI ROMA	57	26	29	3	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0214068	10.1371/journal.pone.0214068	http://dx.doi.org/10.1371/journal.pone.0214068			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HR5NS	30943220	Green Submitted, gold, Green Published			2022-12-26	WOS:000463194300030
J	Mao, CT; Chen, TH; Tseng, CN; Chen, SW; Hsieh, IC; Hung, MJ; Chu, PH; Wang, CH; Wen, MS; Cherng, WJ; Chen, DY				Mao, Chun-Tai; Chen, Tien-Hsing; Tseng, Chi-Nan; Chen, Shao-Wei; Hsieh, I-Chang; Hung, Ming-Jui; Chu, Pao-Hsien; Wang, Chao-Hung; Wen, Ming-Shien; Cherng, Wen-Jin; Chen, Dong-Yi			Clinical outcomes of second-generation limus-eluting stents compared to paclitaxel-eluting stents for acute myocardial infarction with cardiogenic shock	PLOS ONE			English	Article							BARE-METAL STENTS; INSURANCE RESEARCH DATABASE; XIENCE V STENTS; RESOLUTE STENTS; ISCHEMIC-STROKE; RISK; EFFICACY; REVASCULARIZATION; ASSOCIATION; VALIDATION	Objective Whether the cardiovascular (CV) outcomes of second-generation limus-eluting stents (LESs) differ from those of paclitaxel-eluting stents (PESs) in patients with acute myocardial infarction (AMI) complicated by cardiogenic shock (CS) is still unclear. Methods We used the Taiwan National Health Insurance Research Database to analyse data of 516 patients with AMI and CS diagnosed from January 2007 to December 2011. We used propensity score matching to adjust for the imbalance in covariate baseline values between these two groups. We evaluated clinical outcomes by comparing 197 subjects who used second-generation LESs to 319 matched subjects who used PESs. Results The risk of the primary composite outcomes (i.e., myocardial infarction, coronary revascularisation or CV death) was significantly lower in the second-generation LES group than in the PES group [37.3% vs. 51.8%; hazard ratio (HR), 0.73; 95% CI: 0.56-0.95] at the 12-month follow-up. The patients who received second-generation LESs had a lower risk of coronary revascularisation (HR 0.62; 95% CI: 0.41-0.93) than those who used PESs. However, the risks of myocardial infarction (HR 0.56; 95% CI: 0.26-1.24), ischemic stroke (HR 0.73; 95% CI: 0.23-2.35), or CV death (HR 0.90; 95% CI: 0.63-1.28) were not significantly different between the two groups. Conclusions Among patients with CS-complicating AMI, second-generation LES implantation significantly reduced the risk of coronary revascularisation and composite CV events compared to PES implantation at the 12-month follow-up.	[Mao, Chun-Tai; Chen, Tien-Hsing; Hung, Ming-Jui; Wang, Chao-Hung] Chang Gung Mem Hosp, Div Cardiol, Dept Internal Med, Keelung, Taiwan; [Tseng, Chi-Nan; Chen, Shao-Wei] Chang Gung Mem Hosp Linkou, Dept Thorac & Cardiovasc Surg, Taoyuan, Taiwan; [Hsieh, I-Chang; Chu, Pao-Hsien; Wen, Ming-Shien; Cherng, Wen-Jin; Chen, Dong-Yi] Chang Gung Mem Hosp Linkou, Dept Internal Med, Div Cardiol, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Chen, DY (corresponding author), Chang Gung Mem Hosp Linkou, Dept Internal Med, Div Cardiol, Taoyuan, Taiwan.	dycstudy@gmail.com	Chu, Pao-Hsien/P-5249-2019; Wang, Chao/GXF-8353-2022	Chu, Pao-Hsien/0000-0003-0361-6348; 	Chang Gung Memorial Hospital, Taiwan [CGRPG2F0011, CLRPG2G0081]	Chang Gung Memorial Hospital, Taiwan(Chang Gung Memorial Hospital)	This work was supported by grants from the Chang Gung Memorial Hospital, Taiwan (CGRPG2F0011 and CLRPG2G0081). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Champion S, 2016, INT J CARDIOL, V223, P10, DOI 10.1016/j.ijcard.2016.08.059; Chang KH, 2016, ENVIRON INT, V94, P495, DOI 10.1016/j.envint.2016.06.008; Chen DY, 2016, INT J CARDIOL, V215, P98, DOI 10.1016/j.ijcard.2016.04.014; Chen DY, 2016, CIRC J, V80, P363, DOI 10.1253/circj.CJ-15-0778; Cheng CL, 2014, J EPIDEMIOL, V24, P500, DOI 10.2188/jea.JE20140076; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Chuang YC, 2008, SOC SCI MED, V67, P1321, DOI 10.1016/j.socscimed.2008.06.033; Dangas GD, 2013, JACC-CARDIOVASC INTE, V6, P914, DOI 10.1016/j.jcin.2013.05.005; Hernandez JMD, 2014, REV ESP CARDIOL, V67, P999, DOI 10.1016/j.rec.2014.01.019; Harjola VP, 2015, EUR J HEART FAIL, V17, P501, DOI 10.1002/ejhf.260; Hicks KA, 2010, STANDARDIZED DATA CO; Hochman JS, 1999, NEW ENGL J MED, V341, P625, DOI 10.1056/NEJM199908263410901; Hsieh CY, 2015, J FORMOS MED ASSOC, V114, P254, DOI 10.1016/j.jfma.2013.09.009; Jaguszewski M, 2015, J CARDIOVASC MED, V16, P220, DOI 10.2459/JCM.0000000000000106; Kereiakes DJ, 2010, JACC-CARDIOVASC INTE, V3, P1229, DOI 10.1016/j.jcin.2010.09.014; Lee JM, 2014, AM J CARDIOL, V114, P1329, DOI 10.1016/j.amjcard.2014.07.065; LEOR J, 1993, AM J MED, V94, P265, DOI 10.1016/0002-9343(93)90058-W; Lin CC, 2005, J FORMOS MED ASSOC, V104, P157; Liu YQ, 2015, INT J CARDIOL, V184, P680, DOI 10.1016/j.ijcard.2015.02.002; Mao CT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160070; Mauri L, 2008, NEW ENGL J MED, V359, P1330, DOI 10.1056/NEJMoa0801485; Park DW, 2010, J AM COLL CARDIOL, V56, P1187, DOI 10.1016/j.jacc.2010.03.086; Park KW, 2014, JACC-CARDIOVASC INTE, V7, P471, DOI 10.1016/j.jcin.2013.12.201; Patel BD, 2006, THORAX, V61, P568, DOI 10.1136/thx.2005.053827; Peberdy MA, 2010, CIRCULATION, V122, pS768, DOI 10.1161/CIRCULATIONAHA.110.971002; Roffi M, 2016, EUR HEART J, V37, P267, DOI 10.1093/eurheartj/ehv320; Serruys PW, 2010, NEW ENGL J MED, V363, P136, DOI 10.1056/NEJMoa1004130; Simsek C, 2013, INT J CARDIOL, V170, P36, DOI 10.1016/j.ijcard.2013.10.006; Sleeper LA, 2010, AM HEART J, V160, P443, DOI 10.1016/j.ahj.2010.06.024; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; Thiele H, 2012, NEW ENGL J MED, V367, P1287, DOI 10.1056/NEJMoa1208410; Valgimigli M, 2014, JACC-CARDIOVASC INTE, V7, P20, DOI 10.1016/j.jcin.2013.09.008; van Diepen S, 2017, CIRCULATION, V136, pE232, DOI 10.1161/CIR.0000000000000525; von Birgelen C, 2012, J AM COLL CARDIOL, V59, P1350, DOI 10.1016/j.jacc.2012.01.008; Wu CY, 2012, JAMA-J AM MED ASSOC, V308, P1906, DOI 10.1001/2012.jama.11975	35	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0214417	10.1371/journal.pone.0214417	http://dx.doi.org/10.1371/journal.pone.0214417			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR5NS	30943217	Green Published, Green Submitted, gold			2022-12-26	WOS:000463194300036
J	Deckx, S; Johnson, DM; Rienks, M; Carai, P; Van Deel, E; Van der Velden, J; Sipido, KR; Heymans, S; Papageorgiou, AP				Deckx, Sophie; Johnson, Daniel M.; Rienks, Marieke; Carai, Paolo; Van Deel, Elza; Van der Velden, Jolanda; Sipido, Karin R.; Heymans, Stephane; Papageorgiou, Anna-Pia			Extracellular SPARC increases cardiomyocyte contraction during health and disease	PLOS ONE			English	Article							VIRAL MYOCARDITIS; OSTEOGLYCIN PREVENTS; CARDIAC DILATATION; DYSFUNCTION; COLLAGEN; EXPRESSION; AKT; ACTIVATION; INFARCTION; APOPTOSIS	Secreted protein acidic and rich in cysteine (SPARC) is a non-structural extracellular matrix protein that regulates interactions between the matrix and neighboring cells. In the cardiovascular system, it is expressed by cardiac fibroblasts, endothelial cells, and at lower levels by ventricular cardiomyocytes. SPARC expression levels are increased upon myocardial injury and also during hypertrophy and fibrosis. We have previously shown that SPARC improves cardiac function after myocardial infarction by regulating post-synthetic procollagen processing, however whether SPARC directly affects cardiomyocyte contraction is still unknown. In this study we demonstrate a novel inotropic function for extracellular SPARC in the healthy heart as well as in the diseased state after myocarditis-induced cardiac dysfunction. We demonstrate SPARC presence on the cardiomyocyte membrane where it is co-localized with the integrin-beta1 and the integrin-linked kinase. Moreover, extracellular SPARC directly increases cardiomyocyte cell shortening ex vivo and cardiac function in vivo, both in healthy myocardium and during coxsackie virus-induced cardiac dysfunction. In conclusion, we demonstrate a novel inotropic function for SPARC in the heart, with a potential therapeutic application when myocyte contractile function is diminished such as that caused by a myocarditis-related cardiac injury.	[Deckx, Sophie; Rienks, Marieke; Carai, Paolo; Heymans, Stephane; Papageorgiou, Anna-Pia] Maastricht Univ, Dept Cardiol, Maastricht, Netherlands; [Deckx, Sophie; Johnson, Daniel M.; Carai, Paolo; Sipido, Karin R.; Heymans, Stephane; Papageorgiou, Anna-Pia] Katholieke Univ Leuven, Dept Cardiovasc Sci, Leuven, Belgium; [Johnson, Daniel M.] Univ Birmingham, Inst Cardiovasc Sci, Birmingham, W Midlands, England; [Rienks, Marieke] Kings Coll London, Kings British Heart Fdn Ctr, London, England; [Van Deel, Elza; Van der Velden, Jolanda] Vrije Univ Amsterdam, Amsterdam UMC, Dept Physiol, Amsterdam Cardiovasc Sci, Amsterdam, Netherlands	Maastricht University; KU Leuven; University of Birmingham; University of London; King's College London; University of Amsterdam; Vrije Universiteit Amsterdam	Papageorgiou, AP (corresponding author), Maastricht Univ, Dept Cardiol, Maastricht, Netherlands.; Papageorgiou, AP (corresponding author), Katholieke Univ Leuven, Dept Cardiovasc Sci, Leuven, Belgium.	anna.papageorgiou@maastrichtuniversity.nl	Johnson, Daniel M/A-4654-2010	Johnson, Daniel M/0000-0002-7376-7101; Heymans, Stephane/0000-0001-9477-7803; Carai, Paolo/0000-0003-0718-4773; van der Velden, Jolanda/0000-0001-5224-5788	CARIM; European Commission grant FIBROTARGETS [602904]; European Commission grant MEDIA [261409]; European Commission grant ARENA [CVON2011]; FWO	CARIM; European Commission grant FIBROTARGETS; European Commission grant MEDIA; European Commission grant ARENA [CVON2011]; FWO(FWO)	This work was supported by a CARIM-funded PhD grant, and by the European Commission's grants FIBROTARGETS [602904], MEDIA [261409], and ARENA [CVON2011]. DMJ was funded by a postdoctoral fellowship from the FWO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker TH, 2005, J BIOL CHEM, V280, P36483, DOI 10.1074/jbc.M504663200; Bradshaw AD, 2001, J CLIN INVEST, V107, P1049, DOI 10.1172/JCI12939; Chaanine AH, 2011, EUR J HEART FAIL, V13, P825, DOI 10.1093/eurjhf/hfr080; Chen H, 2004, PHYSIOL GENOMICS, V18, P273, DOI 10.1152/physiolgenomics.00104.2004; Cittadini A, 2006, GENE THER, V13, P8, DOI 10.1038/sj.gt.3302589; Corsten MF, 2012, TRENDS MOL MED, V18, P426, DOI 10.1016/j.molmed.2012.05.005; Deckx S, 2018, MATRIX BIOL, V66, P110, DOI 10.1016/j.matbio.2017.09.002; Harris BS, 2011, AM J PHYSIOL-HEART C, V301, pH841, DOI 10.1152/ajpheart.01247.2010; Hazebroek Mark, 2012, Antiviral Chemistry & Chemotherapy, V22, P249, DOI 10.3851/IMP2047; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Heymans S, 1999, NAT MED, V5, P1135, DOI 10.1038/13459; Heymans S, 2013, CIRCULATION, V128, P1420, DOI 10.1161/CIRCULATIONAHA.112.001357; JUNQUEIRA LCU, 1979, HISTOCHEM J, V11, P447, DOI 10.1007/BF01002772; Kaese S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180029; Kaestner Lars, 2009, J Vis Exp, DOI 10.3791/1433; Lutgens E, 1999, CARDIOVASC RES, V41, P586, DOI 10.1016/S0008-6363(98)00216-8; Mason JW, 2003, CARDIOVASC RES, V60, P5, DOI 10.1016/S0008-6363(03)00437-1; Mooney A, 1999, AM J PATHOL, V155, P599, DOI 10.1016/S0002-9440(10)65155-3; Murphy-Ullrich JE, 2014, MATRIX BIOL, V37, P1, DOI 10.1016/j.matbio.2014.07.005; Papageorgiou AP, 2012, CARDIOVASC RES, V94, P115, DOI 10.1093/cvr/cvs077; Pollack A, 2015, NAT REV CARDIOL, V12, P670, DOI 10.1038/nrcardio.2015.108; Rienks M, 2018, MATRIX BIOL, V74, P21, DOI 10.1016/j.matbio.2018.04.015; Schellings MWM, 2009, J EXP MED, V206, P113, DOI 10.1084/jem.20081244; Sheikh F, 2014, TRENDS CARDIOVAS MED, V24, P133, DOI 10.1016/j.tcm.2013.07.004; Steinke K, 2013, FASEB J, V27, P4108, DOI 10.1096/fj.13-230193; Swinnen M, 2009, CIRCULATION, V120, P1585, DOI 10.1161/CIRCULATIONAHA.109.863266; Terada Y, 2001, KIDNEY INT, V60, P553, DOI 10.1046/j.1523-1755.2001.060002553.x; Van Aelst LNL, 2015, CIRC RES, V116, P425, DOI 10.1161/CIRCRESAHA.116.304599; Vanhoutte D, 2007, CIRCULATION, V115, P475, DOI 10.1161/CIRCULATIONAHA.106.644609; Weaver MS, 2008, J BIOL CHEM, V283, P22826, DOI 10.1074/jbc.M706563200; Wessely R, 1998, J CLIN INVEST, V102, P1444, DOI 10.1172/JCI1972	31	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2019	14	4							e0209534	10.1371/journal.pone.0209534	http://dx.doi.org/10.1371/journal.pone.0209534			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR1CY	30933983	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000462867000001
J	Hussein, H; Fris, ME; Salem, AH; Wiemels, RE; Bastock, RA; Righetti, F; Burke, CA; Narberhaus, F; Carroll, RK; Hassan, NS; Mohamed, SA; Fahmy, AS; Murphy, ER				Hussein, Hebaallaha; Fris, Megan E.; Salem, Ahmed H.; Wiemels, Richard E.; Bastock, Raeven A.; Righetti, Francesco; Burke, Caleb A.; Narberhaus, Franz; Carroll, Ronan K.; Hassan, Nahla S.; Mohamed, Saleh A.; Fahmy, Afaf S.; Murphy, Erin R.			An unconventional RNA-based thermosensor within the 5 ' UTR of Staphylococcus aureus cidA	PLOS ONE			English	Article							METHICILLIN-RESISTANT; VIRULENCE FACTORS; IMMUNE EVASION; MESSENGER-RNA; THERMOMETER; EXPRESSION; TRANSLATION; BACTERIA; FOURU; GENE	Staphylococcus aureus is a Gram-positive bacterial pathogen of global concern and a leading cause of bacterial infections worldwide. Asymptomatic carriage of S. aureus on the skin and in the anterior nares is common and recognized as a predisposing factor to invasive infection. Transition of S. aureus from the carriage state to that of invasive infection is often accompanied by a temperature upshift from approximately 33 degrees C to 37 degrees C. Such a temperature shift is known in other pathogens to influence gene expression, often resulting in increased production of factors that promote survival or virulence within the host. One mechanism by which bacteria modulate gene expression in response to temperature is by the regulatory activity of RNA-based thermosensors, cis-acting riboregulators that control translation efficiency. This study was designed to identify and characterize RNA-based thermosensors in S. aureus. Initially predicted by in silico analyses of the S. aureus USA300 genome, reporter-based gene expression analyses and site-specific mutagenesis were performed to demonstrate the presence of a functional thermosensor within the 5' UTR of cidA, a gene implicated in biofilm formation and survival of the pathogen. The nucleic sequence composing the identified thermosensor are sufficient to confer temperature-dependent post-transcriptional regulation, and activity is predictably altered by the introduction of site-specific mutations designed to stabilize or destabilize the structure within the identified thermosensor. The identified regulator is functional in both the native bacterial host S. aureus and in the distally related species Escherichia coli, suggesting that its regulatory activity is independent of host-specific factors. Interestingly, unlike the majority of bacterial RNA-based thermosensors characterized to date, the cidA thermosensor facilitates increased target gene expression at lower temperatures. In addition to the characterization of the first RNA-based thermosensor in the significant pathogen S. aureus, it highlights the diversity of function within this important class of ribo-regulators.	[Hussein, Hebaallaha; Mohamed, Saleh A.; Fahmy, Afaf S.] Natl Res Ctr, Cairo, Egypt; [Fris, Megan E.; Wiemels, Richard E.; Burke, Caleb A.; Carroll, Ronan K.] Ohio Univ, Dept Biol Sci, Athens, OH 45701 USA; [Fris, Megan E.; Bastock, Raeven A.; Carroll, Ronan K.; Murphy, Erin R.] Ohio Univ, Infect & Top Dis Inst, Athens, OH 45701 USA; [Salem, Ahmed H.; Hassan, Nahla S.] Ain Shams Univ, Cairo, Egypt; [Bastock, Raeven A.; Carroll, Ronan K.; Murphy, Erin R.] Ohio Univ, Mol & Cellular Biol Program, Athens, OH 45701 USA; [Righetti, Francesco; Narberhaus, Franz] Ruhr Univ Bochum, Bochum, Germany; [Murphy, Erin R.] Ohio Univ, Heritage Coll Osteopath Med, Dept Biomed Sci, Athens, OH 45701 USA	Egyptian Knowledge Bank (EKB); National Research Centre (NRC); University System of Ohio; Ohio University; University System of Ohio; Ohio University; Egyptian Knowledge Bank (EKB); Ain Shams University; University System of Ohio; Ohio University; Ruhr University Bochum; University System of Ohio; Ohio University	Murphy, ER (corresponding author), Ohio Univ, Infect & Top Dis Inst, Athens, OH 45701 USA.; Murphy, ER (corresponding author), Ohio Univ, Mol & Cellular Biol Program, Athens, OH 45701 USA.; Murphy, ER (corresponding author), Ohio Univ, Heritage Coll Osteopath Med, Dept Biomed Sci, Athens, OH 45701 USA.	murphye@ohio.edu	fahmy, afaf/ABC-9033-2020	fahmy, afaf/0000-0002-0196-961X; Hussein, Hebaallaha/0000-0001-6821-2198; Hassan, Nahla/0000-0002-9530-0828; Narberhaus, Franz/0000-0002-8552-5310; Righetti, Francesco/0000-0003-4903-2321; Murphy, Erin/0000-0002-5716-4829	National Institutes of Health [1R03AI135788-01A1]; Ohio University Heritage College of Osteopathic Medicine; Embassy of the Arab Republic of Egypt; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI135788] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ohio University Heritage College of Osteopathic Medicine; Embassy of the Arab Republic of Egypt; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Financial support for this work came from National Institutes of Health award 1R03AI135788-01A1, www.nih.gov (ERM and RKC); Ohio University Heritage College of Osteopathic Medicine, www.ohio.edu/medicine (ERM); Embassy of the Arab Republic of Egypt (HH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTUVIA S, 1989, J MOL BIOL, V210, P265, DOI 10.1016/0022-2836(89)90329-X; Barnwal RP, 2016, NUCLEIC ACIDS RES, V44, P9426, DOI 10.1093/nar/gkw584; Boucher H, 2010, CLIN INFECT DIS, V51, pS183, DOI 10.1086/653519; Carroll RK, 2016, MBIO, V7, DOI 10.1128/mBio.01990-15; Carroll RK, 2014, MICROBIOL-SGM, V160, P1737, DOI 10.1099/mic.0.079798-0; Chaudhari SS, 2016, MOL MICROBIOL, V101, P942, DOI 10.1111/mmi.13433; Chen J, 2014, PLASMID, V76, P1, DOI 10.1016/j.plasmid.2014.08.001; Cirz RT, 2007, J BACTERIOL, V189, P531, DOI 10.1128/JB.01464-06; Ellington JK, 2006, J ORTHOP RES, V24, P87, DOI 10.1002/jor.20003; Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289; Garzoni C, 2009, AM J TRANSPLANT, V9, pS41, DOI 10.1111/j.1600-6143.2009.02892.x; Giuliodori AM, 2010, MOL CELL, V37, P21, DOI 10.1016/j.molcel.2009.11.033; Highlander SK, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-99; Johansson J, 2002, CELL, V110, P551, DOI 10.1016/S0092-8674(02)00905-4; Konkel ME, 2000, MICROBES INFECT, V2, P157, DOI 10.1016/S1286-4579(00)00272-0; Kortmann J, 2012, NAT REV MICROBIOL, V10, P255, DOI 10.1038/nrmicro2730; Kouse AB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063781; Krajewski SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065168; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; Lam O, 2014, VIRULENCE, V5, P852, DOI 10.4161/21505594.2014.970949; Loh E, 2018, MICROBIOL SPECTR, V6, DOI 10.1128/microbiolspec.RWR-0012-2017; Lorenz WA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016178; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Moormeier DE, 2014, MBIO, V5, DOI 10.1128/mBio.01341-14; Rice KC, 2003, J BACTERIOL, V185, P2635, DOI 10.1128/JB.185.8.2635-2643.2003; Righetti F, 2016, P NATL ACAD SCI USA, V113, P7237, DOI 10.1073/pnas.1523004113; Rinnenthal J, 2010, NUCLEIC ACIDS RES, V38, P3834, DOI 10.1093/nar/gkq124; Rooijakkers SHM, 2005, TRENDS MICROBIOL, V13, P596, DOI 10.1016/j.tim.2005.10.002; Storz G, 1999, GENE DEV, V13, P633, DOI 10.1101/gad.13.6.633; Urban JH, 2007, NUCLEIC ACIDS RES, V35, P1018, DOI 10.1093/nar/gkl1040; Grosso-Becerraa MV, 2014, P NATL ACAD SCI USA, V111, P15562, DOI 10.1073/pnas.1402536111; von Eiff C, 2001, NEW ENGL J MED, V344, P11, DOI 10.1056/NEJM200101043440102; Waldminghaus T, 2007, MOL MICROBIOL, V65, P413, DOI 10.1111/j.1365-2958.2007.05794.x; Weber GG, 2014, P NATL ACAD SCI USA, V111, P14241, DOI 10.1073/pnas.1411570111; Wei Y, 2016, TEMPERATURE DEPENDEN; Wei YH, 2017, MICROBIOLOGYOPEN, V6, DOI 10.1002/mbo3.442; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	37	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2019	14	4							e0214521	10.1371/journal.pone.0214521	http://dx.doi.org/10.1371/journal.pone.0214521			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR1CY	30933991	Green Submitted, gold, Green Published			2022-12-26	WOS:000462867000019
J	Loi, F; Berchialla, P; Masu, G; Masala, G; Scaramozzino, P; Carvelli, A; Caligiuri, V; Santi, A; Bona, MC; Maresca, C; Zanoni, MG; Capelli, G; Iannetti, S; Coccollone, A; Cappai, S; Rolesu, S; Piseddu, T				Loi, Federica; Berchialla, Paola; Masu, Gabriella; Masala, Giovanna; Scaramozzino, Paola; Carvelli, Andrea; Caligiuri, Vincenzo; Santi, Annalisa; Bona, Maria Cristina; Maresca, Carmen; Zanoni, Maria Grazia; Capelli, Gioia; Iannetti, Simona; Coccollone, Annamaria; Cappai, Stefano; Rolesu, Sandro; Piseddu, Toni			Prevalence estimation of Italian ovine cystic echinococcosis in slaughterhouses: A retrospective Bayesian data analysis, 2010-2015	PLOS ONE			English	Article							ALVEOLAR ECHINOCOCCOSIS; PARATUBERCULOSIS	Cystic echinococcosis (CE) is a complex zoonosis with domestic and sylvatic life-cycles, involving different intermediate and definitive host species. Many previous studies have highlighted the lack of a surveillance system for CE, its persistence in Italy, and endemicity in several Italian regions. Because of the absence of a uniform surveillance program for both humans and animals, disease occurrence is widely underestimated. This study aimed to estimate the prevalence of ovine CE in Italy. Survey data on the prevalence of Echinococcus granulosus complex infections in Italian sheep farms from 2010 to 2015 were obtained in collaboration with Regional Veterinary Epidemiology Observatories (OEVRs). Bayesian analysis was performed to estimate the true CE farm prevalence. The prior true CE prevalence was estimated using data from Sardinia. Second, Bayesian modelling of the observed prevalence in different regions and the true prevalence estimation from the first step were used to ultimately estimate the prevalence of ovine CE in Italy. We obtained survey data from 10 OEVRs, covering 14 Italian regions. We observed that the risk of CE infection decreased over the years, and it was strictly correlated with the density of susceptible species. Using Sardinia as prior distribution, where the disease farm prevalence was approximately 19% (95% CI, 18.82-20.02), we estimated that the highest endemic CE farm prevalence was in Basilicata with a value of 12% (95% BCI: 7.49-18.9%) and in Piemonte 7.64%(95% BCI: 4.12-13.04%). Our results provide spatially relevant data crucial for guiding CE control in Italy. Precise information on disease occurrence location would aid in the identification of priority areas for disease control implementation by the authorities. The current underestimation of CE occurrence should urge the Italian and European governments to become aware of the public health importance of CE and implement targeted interventions for high-risk areas.	[Loi, Federica; Coccollone, Annamaria; Cappai, Stefano; Rolesu, Sandro] Osservatorio Epidemiol Vet Reg, Cagliari, Italy; [Berchialla, Paola] Univ Torino, Dipartimento Sci Clin & Biol, Turin, Italy; [Masu, Gabriella; Masala, Giovanna; Piseddu, Toni] Ist Zooprofilatt Sperimentale Sardegna G Pegreffi, Sassari, Italy; [Scaramozzino, Paola; Carvelli, Andrea] Ist Zooprofilatt Sperimentale Lazio & Toscana, Rome, Italy; [Caligiuri, Vincenzo] Ist Zooprofilatt Sperimentale Mezzogiorno, Portici, Italy; [Santi, Annalisa; Zanoni, Maria Grazia] Ist Zooprofilatt Sperimentale Lombardia Emilia Ro, Brescia, Italy; [Bona, Maria Cristina] Ist Zooprofilatt Sperimentale Piemonte Liguria &, Turin, Italy; [Maresca, Carmen] Ist Zooprofilatt Sperimentale Umbria & Marche, Perugia, Italy; [Capelli, Gioia] Ist Zooprofilatt Sperimentale Venezie, Legnaro, Italy; [Iannetti, Simona] Ist Zooprofilatt Sperimentale Abruzzo & Molise G, Teramo, Italy	University of Turin; IZS Della Sardegna; IZS Lazio e Toscana; IZS del Mezzogiorno; IZS Lombardia e Emilia; IZS Piemonte Liguria e Valle D'aosta; IZS Umbria e Marche; IZS delle Venezie; IZS Dell'abruzzo E Del Molise Giuseppe Caporale	Loi, F (corresponding author), Osservatorio Epidemiol Vet Reg, Cagliari, Italy.	federica.loi@izs-sardegna.it	Iannetti, Simona/AAM-6684-2020; LOI, FEDERICA/AAG-2563-2020; Scaramozzino, Paola/AAS-8717-2020; santi, annalisa/AAX-6603-2021; carvelli, andrea/P-2246-2019; Berchialla, Paola/A-3208-2009	Iannetti, Simona/0000-0001-6380-0898; LOI, FEDERICA/0000-0003-3045-3150; Scaramozzino, Paola/0000-0002-7871-8915; santi, annalisa/0000-0002-7846-8856; carvelli, andrea/0000-0003-1320-9682; Maresca, Carmen/0000-0002-0778-8190; Piseddu, Toni/0000-0002-1024-5250; , Giovanna Masala/0000-0001-5301-2580; Berchialla, Paola/0000-0001-5835-5638	Italian Ministry of Health for the Current Research [IZS SA 05/16 RC]	Italian Ministry of Health for the Current Research	The authors for this work received specific funding from the Italian Ministry of Health for the Current Research IZS SA 05/16 RC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez Rojas CA, 2014, INT J PARASITOL, V44, P9, DOI 10.1016/j.ijpara.2013.08.008; [Anonymous], EUR UN SUMM REP TREN; [Anonymous], 2009, EFSA J; Barbieri MM, 2004, ANN STAT, V32, P870, DOI 10.1214/009053604000000238; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bayarri MJ, 2012, ANN STAT, V40, P1550, DOI 10.1214/12-AOS1013; Boelaert F, 2000, VET MICROBIOL, V77, P269, DOI 10.1016/S0378-1135(00)00312-6; Branscum AJ, 2004, PREV VET MED, V66, P101, DOI 10.1016/j.prevetmed.2004.09.009; Brundu D, 2014, ACTA TROP, V140, P91, DOI 10.1016/j.actatropica.2014.08.011; Brunetti E, 2010, ACTA TROP, V114, P1, DOI 10.1016/j.actatropica.2009.11.001; Budke CM, 2006, EMERG INFECT DIS, V12, P296; CAMERON AC, 1990, J ECONOMETRICS, V46, P347, DOI 10.1016/0304-4076(90)90014-K; Conraths FJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005801; Craig P, 2015, VET PARASITOL, V213, P132, DOI 10.1016/j.vetpar.2015.07.028; CRAIG PS, 1992, LANCET, V340, P826, DOI 10.1016/0140-6736(92)92693-A; Deplazes P, 2017, ADV PARASIT, V95, P315, DOI 10.1016/bs.apar.2016.11.001; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Eckert J, 2001, WHO/OIE MANUAL ON ECHINOCOCCOSIS IN HUMANS AND ANIMALS: A PUBLIC HEALTH PROBLEM OF GLOBAL CONCERN, P238; Eckert J, 2011, OXFORD TXB ZOONOSES; Garcia-Donato G, 2018, BAYESIAN TESTING VAR, V10, P20; Gardner IA, 2002, AUST VET J, V80, P758, DOI 10.1111/j.1751-0813.2002.tb11347.x; Garippa G., 2006, Parassitologia (Rome), V48, P57; Garippa G, 2009, VET RES COMMUN, V33, pS35, DOI 10.1007/s11259-009-9245-0; Gemmell MA, 2001, WHO OIE MANUAL ONECH; Greiner M, 2000, PREV VET MED, V45, P3, DOI 10.1016/S0167-5877(00)00114-8; Heath DD, 1973, RECENT ADV HYDATID D, P7; Hilbe JM, 2011, CAMB CORE; ICD-ICD-9-CM-International Classification of Diseases, ICD 9 CM INT CLASS D; IZS-Sardegna, 1990, SOC IT PAR 16 C ATT; Liu F. J., 1993, Compendium on cystic echinococcosis: with special reference to the Xinjiang Uygur Autonomous Region, The People's Republic of China., P177; McManus DP, 2003, LANCET, V362, P1295, DOI 10.1016/S0140-6736(03)14573-4; Messam Locksley L. McV., 2008, Animal Health Research Reviews, V9, P1, DOI 10.1017/S1466252307001314; Otero-Abad B, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002249; Piseddu T, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005771; Possenti A, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005114; Schantz PM, 1995, ECHINOCOCCUS HYDATID; Siles-Lucas M, 2017, ADV PARASIT, V96, P159, DOI 10.1016/bs.apar.2016.09.003; Tavornpanich S, 2004, AM J VET RES, V65, P1061, DOI 10.2460/ajvr.2004.65.1061; The Community Summary Report on Trends and Sources of Zoonoses, 2006, EFSA J, V130, P207; Thomas A., 2006, R NEWS, V6, P12, DOI DOI 10.1159/000323281; Thompson R. C. A., 1995, P1; Torgerson PR, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000722; Qian W, 2006, AM J TROP MED HYG, V74, P856, DOI 10.4269/ajtmh.2006.74.856; WHO, 2001, NEGL ZOON DIS MAN EC	44	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2019	14	4							e0214224	10.1371/journal.pone.0214224	http://dx.doi.org/10.1371/journal.pone.0214224			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR1CY	30934010	Green Published, Green Submitted, gold			2022-12-26	WOS:000462867000012
J	Mlynarova, J; Trentin-Sonoda, M; da Silva, FG; Major, JL; Salih, M; Carneiro-Ramos, MS; Tuana, BS				Mlynarova, Jana; Trentin-Sonoda, Mayra; da Silva, Fernanda Gaisler; Major, Jennifer L.; Salih, Maysoon; Carneiro-Ramos, Marcela S.; Tuana, Balwant S.			SLMAP3 isoform modulates cardiac gene expression and function	PLOS ONE			English	Article							MEMBRANE-ASSOCIATED PROTEIN; GENOME-WIDE ASSOCIATION; SARCOLEMMAL-ASSOCIATED PROTEINS; VENTRICULAR-TACHYCARDIA; COMMON VARIANTS; PR INTERVAL; HEART-RATE; CHANNELOPATHIES; BRUGADA; ROLES	The sarcolemmal membrane associated proteins (SLMAPs) belong to the super family of tail anchored membrane proteins which serve diverse roles in biology including cell growth, protein trafficking and ion channel regulation. Mutations in human SLMAP have been linked to Brugada syndrome with putative deficits in trafficking of the sodium channel (Na(v)1.5) to the cell membrane resulting in aberrant electrical activity and heart function. Three main SLMAP isoforms (SLMAP1 (35 kDa), SLMAP2 (45 kDa), and SLMAP3 (91 kDa)) are expressed in myocardium but their precise role remains to be defined. Here we generated transgenic (Tg) mice with cardiac-specific expression of the SLMAP3 isoform during postnatal development which present with a significant decrease (20%) in fractional shortening and (11%) in cardiac output at 5 weeks of age. There was a lack of any notable cardiac remodeling (hypertrophy, fibrosis or fetal gene activation) in Tg hearts but the electrocardiogram indicated a significant increase (14%) in the PR interval and a decrease (43%) in the R amplitude. Western blot analysis indicated a selective and significant decrease (55%) in protein levels of Na(v)1.5 while 45% drop in its transcript levels were detectable by qRT-PCR. Significant decreases in the protein and transcript levels of the calcium transport system of the sarcoplasmic reticulum (SERCA2a/PLN) were also evident in Tg hearts. These data reveal a novel role for SLMAP3 in the selective regulation of important ion transport proteins at the level of gene expression and suggest that it may be a unique target in cardiovascular function and disease.	[Mlynarova, Jana; Trentin-Sonoda, Mayra; da Silva, Fernanda Gaisler; Major, Jennifer L.; Salih, Maysoon; Tuana, Balwant S.] Univ Ottawa, Fac Med, Dept Cellular & Mol Med, Ottawa, ON, Canada; [Carneiro-Ramos, Marcela S.] Univ Fed ABC, Ctr Ciencias Nat & Humanas, Santo Andre, SP, Brazil	University of Ottawa; Universidade Federal do ABC (UFABC)	Tuana, BS (corresponding author), Univ Ottawa, Fac Med, Dept Cellular & Mol Med, Ottawa, ON, Canada.	btuana@uottawa.ca	Sonoda, Mayra Trentin/R-9943-2019; Carneiro-Ramos, Marcela/AAP-6258-2021; Carneiro-Ramos, Marcela Sorelli/I-6191-2017	Sonoda, Mayra Trentin/0000-0003-2446-7783; Carneiro-Ramos, Marcela Sorelli/0000-0003-2666-1280	Canadian Institute of Health Research Project Grant	Canadian Institute of Health Research Project Grant(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institute of Health Research Project Grant.	Abriel H, 2015, CIRC RES, V116, P1971, DOI 10.1161/CIRCRESAHA.116.305017; Abriel H, 2013, GENE, V517, P1, DOI 10.1016/j.gene.2012.12.061; Abriel H, 2010, J MOL CELL CARDIOL, V48, P2, DOI 10.1016/j.yjmcc.2009.08.025; Adsit GS, 2013, J MOL CELL CARDIOL, V61, P34, DOI 10.1016/j.yjmcc.2013.03.017; Amin AS, 2010, PFLUG ARCH EUR J PHY, V460, P223, DOI 10.1007/s00424-009-0761-0; Bae SJ, 2017, ELIFE, V6, DOI [10.7554/eLife.30278.001, 10.7554/eLife.30278]; Behere SP, 2015, ANN PEDIAT CARDIOL, V8, P210, DOI 10.4103/0974-2069.164695; Belevych AE, 2013, CARDIOVASC RES, V98, P240, DOI 10.1093/cvr/cvt024; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bers DM, 2014, ANNU REV PHYSIOL, V76, P107, DOI 10.1146/annurev-physiol-020911-153308; Bidstrup Signe, 2013, J Atr Fibrillation, V6, P956, DOI 10.4022/jafib.956; Borgese N, 2003, J CELL BIOL, V161, P1013, DOI 10.1083/jcb.200303069; Butler AM, 2012, CIRC-CARDIOVASC GENE, V5, P639, DOI 10.1161/CIRCGENETICS.112.963991; Byers JT, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-48; Chambers JC, 2010, NAT GENET, V42, P149, DOI 10.1038/ng.516; Chen XL, 2011, EXP DIABETES RES, DOI 10.1155/2011/421982; Couzens AL, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004712; Dewan A, 2015, CIRC RES, V117; Ding H, 2005, AM J PHYSIOL-HEART C, V289, pH206, DOI 10.1152/ajpheart.00037.2005; Durocher D, 2002, FEBS LETT, V513, P58, DOI 10.1016/S0014-5793(01)03294-X; Freyermuth F, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11067; Fu V, 2017, CURR OPIN CELL BIOL, V49, P99, DOI 10.1016/j.ceb.2017.12.012; Gao Shumin, 2011, Curr Protoc Mouse Biol, V1, P71; Goll DE, 1974, SEPARATION SUBCELLUL, P250; Goonasekera SA, 2012, J CLIN INVEST, V122, P280, DOI 10.1172/JCI58227; Graham John M, 2002, ScientificWorldJournal, V2, P1638; Grandi E, 2013, CARDIAC ELECTROPHYSI, P319; Guzzo RM, 2005, AM J PHYSIOL-HEART C, V288, pH1810, DOI 10.1152/ajpheart.01015.2004; Guzzo RM, 2004, BIOCHEM J, V381, P599, DOI 10.1042/BJ20031723; Guzzo RM, 2004, J CELL SCI, V117, P2271, DOI 10.1242/jcs.01079; Gwathmey JK, 2011, J MOL CELL CARDIOL, V50, P803, DOI 10.1016/j.yjmcc.2010.11.011; HOFMANN K, 1995, TRENDS BIOCHEM SCI, V20, P347, DOI 10.1016/S0968-0004(00)89072-6; Holm H, 2010, NAT GENET, V42, P117, DOI 10.1038/ng.511; Ishikawa T, 2012, CIRC-ARRHYTHMIA ELEC, V5, P1098, DOI 10.1161/CIRCEP.111.969972; Kyle John W, 2014, Card Electrophysiol Clin, V6, P797; Lazzerini PE, 2017, NAT REV CARDIOL, V14, P521, DOI 10.1038/nrcardio.2017.61; MEISSNER G, 1975, BIOCHIM BIOPHYS ACTA, V389, P51, DOI 10.1016/0005-2736(75)90385-5; Mitchell GF, 1998, AM J PHYSIOL-HEART C, V274, pH747, DOI 10.1152/ajpheart.1998.274.3.H747; Nader M, 2012, AM J PHYSIOL-HEART C, V302, pH1138, DOI 10.1152/ajpheart.00872.2011; Napolitano C, 2012, CIRCULATION, V125, P2027, DOI 10.1161/CIRCULATIONAHA.111.055947; Nerbonne JM, 2005, PHYSIOL REV, V85, P1205, DOI 10.1152/physrev.00002.2005; Papadatos GA, 2002, P NATL ACAD SCI USA, V99, P6210, DOI 10.1073/pnas.082121299; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pfeufer A, 2010, NAT GENET, V42, P153, DOI 10.1038/ng.517; Remme CA, 2010, CARDIOVASC THER, V28, P287, DOI 10.1111/j.1755-5922.2010.00210.x; SAITO A, 1984, J CELL BIOL, V99, P875, DOI 10.1083/jcb.99.3.875; Salaun C, 2004, BBA-MOL CELL RES, V1693, P81, DOI 10.1016/j.bbamcr.2004.05.008; Sarquella-Brugada G, 2016, GENET MED, V18, P3, DOI 10.1038/gim.2015.35; Schmitt N, 2014, PHYSIOL REV, V94, P609, DOI 10.1152/physrev.00022.2013; Smith JG, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001304; Smith JG, 2009, HEART RHYTHM, V6, P634, DOI 10.1016/j.hrthm.2009.02.022; Sotoodehnia N, 2010, NAT GENET, V42, P1068, DOI 10.1038/ng.716; Sun XR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071876; Teng FYH, 2001, GENOME BIOL, V2; Veerman CC, 2015, GENE, V573, P177, DOI 10.1016/j.gene.2015.08.062; Wattenberg B, 2001, TRAFFIC, V2, P66, DOI 10.1034/j.1600-0854.2001.20108.x; Wehrens XHT, 2005, ANNU REV PHYSIOL, V67, P69, DOI 10.1146/annurev.physiol.67.040403.114521; Wielowieyski PA, 2000, J BIOL CHEM, V275, P38474, DOI 10.1074/jbc.M007682200; Wigle JT, 1997, J BIOL CHEM, V272, P32384, DOI 10.1074/jbc.272.51.32384; Zheng YG, 2017, CELL REP, V21, P3612, DOI 10.1016/j.celrep.2017.11.076	60	4	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2019	14	4							e0214669	10.1371/journal.pone.0214669	http://dx.doi.org/10.1371/journal.pone.0214669			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR1CY	30934005	gold, Green Submitted, Green Published			2022-12-26	WOS:000462867000033
J	Al-Ghafli, H; Varghese, B; Enani, M; Alrajhi, A; Al Johani, S; Albarrak, A; Althawadi, S; Elkizzi, N; Al Hajoj, S				Al-Ghafli, Hawra; Varghese, Bright; Enani, Mushira; Alrajhi, Abdulrahman; Al Johani, Sameera; Albarrak, Ali; Althawadi, Sahar; Elkizzi, Noura; Al Hajoj, Saha			Demographic risk factors for extra-pulmonary tuberculosis among adolescents and adults in Saudi Arabia	PLOS ONE			English	Article							EXTRAPULMONARY TUBERCULOSIS; GENITAL TUBERCULOSIS; CHILDREN	Despite low infectious potential of extrapulmonary tuberculosis (EPTB), it poses significant clinical challenges in terms of diagnosis and treatment monitoring. Understanding the main demographical risk factors for disease characteristics of EPTB plays a crucial role in speeding up diagnosis process and improving overall clinical experience. The aim of this study was to investigate the main demographical and clinical risk factors for EPTB among adults and adolescents for the first time in Saudi Arabia. A cross-sectional multicenter study was carried out on a collection of 902 extrapulmonary Mycobacterium tuberculosis complex (MTBC) isolates with demographical and clinical data. All isolates were subjected to spoligotyping and 24-loci based MIRU-VNTR typing. The association between two potential variables was assessed using odd ratios (OR) calculations. Independent risk factors for EPTB and diseases characteristics of EPTB were identified using multivariate regression model analyses. Gender was found to be significantly associated with lymph node, gastrointestinal, central nervous system and urogenital TB. Lymph node TB showed statistical association to age group below 25 years, non-Saudis and South East Asian ethnicity. While gastrointestinal TB demonstrated an association with patients above 60 years old, and Saudis. Multivariate analysis showed that gender is an independent risk factor to urogenital TB (p 0.03) and lymph node TB (p 0.005). On the other hands, South Asian (p 0.01) and South East Asian (p 0.03) ethnicities were both identified as independent risk factors significantly associated with EPTB. MTBC lineages, site of infections, gender, HIV and smear positivity showed no significant association. Nationwide qualitative-studies are highly warranted in the future to further understand the main demographic risk factors for disease characteristics of EPTB.	[Al-Ghafli, Hawra; Varghese, Bright; Al Hajoj, Saha] King Faisal Specialist Hosp & Res Ctr, Dept Infect & Immun, Riyadh, Saudi Arabia; [Enani, Mushira] King Fahad Med City, Med Specialties Dept, Riyadh, Saudi Arabia; [Alrajhi, Abdulrahman] King Faisal Specialist Hosp & Res Ctr, Dept Med, Riyadh, Saudi Arabia; [Al Johani, Sameera] King Abdul Aziz Med City, Dept Microbiol, Riyadh, Saudi Arabia; [Albarrak, Ali] Prince Sultan Mil Med City, Dept Med, Riyadh, Saudi Arabia; [Althawadi, Sahar] King Faisal Specialist Hosp & Res Ctr, Dept Pathol & Lab Med, Riyadh, Saudi Arabia; [Elkizzi, Noura] Prince Sultan Mil Med City, Dept Microbiol, Riyadh, Saudi Arabia; [Al Hajoj, Saha] Alfaisal Univ, Coll Med, Riyadh, Saudi Arabia	King Faisal Specialist Hospital & Research Center; King Fahad Medical City; King Faisal Specialist Hospital & Research Center; King Abdulaziz Medical City; King Saud Bin Abdulaziz University for Health Sciences; King Abdulaziz Medical City - Riyadh; Prince Sultan Military Medical City; King Faisal Specialist Hospital & Research Center; Prince Sultan Military Medical City; Alfaisal University	Al Hajoj, S (corresponding author), King Faisal Specialist Hosp & Res Ctr, Dept Infect & Immun, Riyadh, Saudi Arabia.; Al Hajoj, S (corresponding author), Alfaisal Univ, Coll Med, Riyadh, Saudi Arabia.	hajoj@kfshrc.edu.sa	Alrajhi, Abdulrahman A/Q-4359-2019	Al-Ghafli, Hawra/0000-0003-0791-8896; Alrajhi, Abdulrahman/0000-0003-0780-6093	King AbdulAziz City for science and technology [AT-34-103]	King AbdulAziz City for science and technology	This work was supported by King AbdulAziz City for science and technology: Grant code AT-34-103. The funders had no rule in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aktogu S, 1996, EUR RESPIR J, V9, P2031, DOI 10.1183/09031936.96.09102031; Al-Eisa ES, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/642187; Al-Hajoj S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0101667; Al-Hajoj S, 2013, INFECT GENET EVOL, V16, P362, DOI 10.1016/j.meegid.2013.03.019; Alshaikh MK, 2016, J ENVIRON PUBLIC HEA, V2016, DOI 10.1155/2016/7479357; Arora V. K., 2006, Indian Journal of Tuberculosis, V53, P77; Biadglegne F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137865; Byng-Maddick R, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1451-0; Caws M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000034; Centre for Diswease Control, 2016, REP TUB US 2015; Chen ST, 2015, SCI REP-UK, V5, DOI 10.1038/srep11084; CHRISTENSEN WI, 1974, MEDICINE, V53, P377, DOI 10.1097/00005792-197409000-00004; Coussens AK, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003468; El Mouzan MI, 2008, ANN SAUDI MED, V28, P169, DOI 10.5144/0256-4947.2008.169; el-Hazmi M A, 2000, East Mediterr Health J, V6, P276; Erie H, 2017, IRAN J MICROBIOL, V9, P312; Eum SY, 2008, RESPIRATION, V76, P331, DOI 10.1159/000113932; Forssbohm M, 2008, EUR RESPIR J, V31, P99, DOI 10.1183/09031936.00020607; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Grace GA, 2017, INDIAN J MED RES, V145, P425, DOI 10.4103/ijmr.IJMR_1550_15; Jahromi BN, 2001, INT J GYNECOL OBSTET, V75, P269, DOI 10.1016/S0020-7292(01)00494-5; Khandkar C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132400; Kruijshaar ME, 2009, THORAX, V64, P1090, DOI 10.1136/thx.2009.118133; Lin CY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063936; Lin JN, 2009, INT J TUBERC LUNG D, V13, P620; Long NH, 2002, J CLIN EPIDEMIOL, V55, P115, DOI 10.1016/S0895-4356(01)00455-3; Lotfian F, 2017, ARCH PEDIATR INFECT, V5, DOI 10.5812/pedinfect.57253; Memish ZA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095654; Mert A, 2002, ACTA CHIR BELG, V102, P118; Ministry of Health Saudi Arabia, 2017, STAT YB, V1437; Montecino-Rodriguez E, 2013, J CLIN INVEST, V123, P958, DOI 10.1172/JCI64096; Nahid P, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195392; Neyrolles O, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000199; Ong A, 2004, CLIN INFECT DIS, V38, P25, DOI 10.1086/380448; Pareek M, 2013, THORAX, V68, P221, DOI 10.1136/thoraxjnl-2012-201824; Peto HM, 2009, CLIN INFECT DIS, V49, P1350, DOI 10.1086/605559; Phongsamart W, 2009, PEDIATR INFECT DIS J, V28, P416, DOI 10.1097/INF.0b013e3181920d4d; Piergallini TJ, 2018, EXP GERONTOL, V105, P32, DOI 10.1016/j.exger.2017.12.021; Sandgren A, 2013, EUR SURVEILL, V18; Sharma JB, 2015, J OBSTET GYN INDIA, V65, P362, DOI 10.1007/s13224-015-0780-z; Sreeramareddy CT, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-8; Temple SEL, 2008, CELL IMMUNOL, V251, P69, DOI 10.1016/j.cellimm.2008.04.013; Varghese B, 2018, RESP RES, V19, DOI 10.1186/s12931-018-0966-x; Varghese B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077635; Varghese B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055598; WHO, 2017, GLOB TUB REP 2017; Wiens KE, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1180-x; Winston CA, 2012, PEDIATRICS, V130, pE1425, DOI 10.1542/peds.2012-1057; Yang Dong, 2015, Front Biol (Beijing), V10, P252	49	9	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2019	14	3							e0213846	10.1371/journal.pone.0213846	http://dx.doi.org/10.1371/journal.pone.0213846			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ5PT	30917151	gold, Green Published, Green Submitted			2022-12-26	WOS:000462465800042
J	Holmes, ND; Spatz, DR; Oppel, S; Tershy, B; Croll, DA; Keitt, B; Genovesi, P; Burfield, IJ; Will, DJ; Bond, AL; Wegmann, A; Aguirre-Munoz, A; Raine, AF; Knapp, CR; Hung, CH; Wingate, D; Hagen, E; Mendez-Sanchez, F; Rocamora, G; Yuan, HW; Fric, J; Millett, J; Russell, J; Liske-Clark, J; Vidal, E; Jourdan, H; Campbell, K; Springer, K; Swinnerton, K; Gibbons-Decherong, L; Langrand, O; Brooke, MD; McMinn, M; Bunbury, N; Oliveira, N; Sposimo, P; Geraldes, P; McClelland, P; Hodum, P; Ryan, PG; Borroto-Paez, R; Pierce, R; Griffiths, R; Fisher, RN; Wanless, R; Pasachnik, SA; Cranwell, S; Micol, T; Butchart, SHM				Holmes, Nick D.; Spatz, Dena R.; Oppel, Steffen; Tershy, Bernie; Croll, Donald A.; Keitt, Brad; Genovesi, Piero; Burfield, Ian J.; Will, David J.; Bond, Alexander L.; Wegmann, Alex; Aguirre-Munoz, Alfonso; Raine, Andre F.; Knapp, Charles R.; Hung, Chung-Hang; Wingate, David; Hagen, Erin; Mendez-Sanchez, Federico; Rocamora, Gerard; Yuan, Hsiao-Wei; Fric, Jakob; Millett, James; Russell, James; Liske-Clark, Jill; Vidal, Eric; Jourdan, Herve; Campbell, Karl; Springer, Keith; Swinnerton, Kirsty; Gibbons-Decherong, Lolita; Langrand, Olivier; Brooke, M. de L.; McMinn, Miguel; Bunbury, Nancy; Oliveira, Nuno; Sposimo, Paolo; Geraldes, Pedro; McClelland, Pete; Hodum, Peter; Ryan, Peter G.; Borroto-Paez, Rafael; Pierce, Ray; Griffiths, Richard; Fisher, Robert N.; Wanless, Ross; Pasachnik, Stesha A.; Cranwell, Steve; Micol, Thierry; Butchart, Stuart H. M.			Globally important islands where eradicating invasive mammals will benefit highly threatened vertebrates	PLOS ONE			English	Article							CLIMATE-CHANGE; BIODIVERSITY; CONSERVATION; RESTORATION; RATS	Invasive alien species are a major threat to native insular species. Eradicating invasive mammals from islands is a feasible and proven approach to prevent biodiversity loss. We developed a conceptual framework to identify globally important islands for invasive mammal eradications to prevent imminent extinctions of highly threatened species using biogeographic and technical factors, plus a novel approach to consider socio-political feasibility. We applied this framework using a comprehensive dataset describing the distribution of 1,184 highly threatened native vertebrate species (i. e. those listed as Critically Endangered or Endangered on the IUCN Red List) and 184 non-native mammals on 1,279 islands worldwide. Based on extinction risk, irreplaceability, severity of impact from invasive species, and technical feasibility of eradication, we identified and ranked 292 of the most important islands where eradicating invasive mammals would benefit highly threatened vertebrates. When socio-political feasibility was considered, we identified 169 of these islands where eradication planning or operation could be initiated by 2020 or 2030 and would improve the survival prospects of 9.4% of the Earth's most highly threatened terrestrial insular vertebrates (111 of 1,184 species). Of these, 107 islands were in 34 countries and territories and could have eradication projects initiated by 2020. Concentrating efforts to eradicate invasive mammals on these 107 islands would benefit 151 populations of 80 highly threatened vertebrates and make a major contribution towards achieving global conservation targets adopted by the world's nations.	[Holmes, Nick D.; Spatz, Dena R.; Keitt, Brad; Will, David J.; Wegmann, Alex; Hagen, Erin; Campbell, Karl; Griffiths, Richard] Isl Conservat, Delaware Ave, Santa Cruz, CA 95060 USA; [Spatz, Dena R.; Tershy, Bernie; Croll, Donald A.] Univ Calif Santa Cruz, Ecol & Evolutionary Biol Dept, Santa Cruz, CA 95064 USA; [Oppel, Steffen; Bond, Alexander L.] Royal Soc Protect Birds, Sandy, Beds, England; [Keitt, Brad] Amer Bird Conservancy, The Plains, VA USA; [Genovesi, Piero] Inst Environm Protect & Res ISPRA, Via V Brancati, Rome, Italy; [Genovesi, Piero] Chair IUCN Invas Species Specialist Grp, Via V Brancati, Rome, Italy; [Burfield, Ian J.; Butchart, Stuart H. M.] BirdLife Int, Cambridge, England; [Bond, Alexander L.] Nat Hist Museum, Dept Life Sci, Bird Grp, Tring, Herts, England; [Wegmann, Alex] Nature Conservancy, Nuuanu Ave, Honolulu, HI USA; [Aguirre-Munoz, Alfonso; Mendez-Sanchez, Federico] Grp Ecol & Conservac Islas, AC Av Moctezuma, Ensenada, BC, Mexico; [Raine, Andre F.] Kauai Endangered Seabird Recovery Project, Kauai, HI USA; [Knapp, Charles R.] IUCN Iguana Specialist Grp, John G Shedd Aquarium, S Lake Shore Dr, Chicago, IL USA; [Hung, Chung-Hang; Yuan, Hsiao-Wei] Natl Taiwan Univ, Sch Forestry & Resource Conservat, Taipei, Taiwan; [Wingate, David] Bermuda Zool Soc, Hamilton, Bermuda; [Rocamora, Gerard] Univ Seychelles, Isl Biodivers & Conservat Ctr, Anse Royale, Mahe, Seychelles; [Fric, Jakob] Nat Conservat Consultants Ltd, Gytheiou Chalandri, Greece; [Russell, James] Univ Auckland, Sch Biol Sci, Auckland, New Zealand; [Liske-Clark, Jill] Div Fish & Wildlife, Lower Base, CM USA; [Vidal, Eric; Jourdan, Herve] Avignon Univ, Aix Marseille Univ, Inst Mediterraneen Biodivers & Ecol Marine & Cont, CNRS,IRD,Ctr IRD Noumea, Noumea, New Caledonia; [Springer, Keith] Rinaldi Ave, The Pines Beach, North Canterbur, New Zealand; [Swinnerton, Kirsty] Isl Endem Fdn, Boqueron, PR USA; [Gibbons-Decherong, Lolita] Palau Conservat Soc, Bai Ra Maibrel, Koror, Palau; [Langrand, Olivier] Crit Ecosyst Partnership Fund, Crystal Dr, Arlington, VA USA; [Brooke, M. de L.; Butchart, Stuart H. M.] Univ Cambridge, Dept Zool, Cambridge, England; [McMinn, Miguel] Univ Balearic Isl, BIOGEOMED Grp, Cra, Valdemossa Bale, Spain; [Bunbury, Nancy] Seychelles Isl Fdn, La Ciotat Bldg, Victoria, Mahe, Seychelles; [Bunbury, Nancy] Univ Exeter, Ctr Ecol & Conservat, Cornwall Campus, Penryn, England; [Oliveira, Nuno; Geraldes, Pedro] Soc Portuguesa Estudo Ayes, Ave Columbano Bordalo Pinheiro, Lisbon, Portugal; [Sposimo, Paolo] NEMO Srl, Piazza DAzeglio, Florence, Italy; [McClelland, Pete] Kennington Roslyn Bush Rd, Invercargill, New Zealand; [Hodum, Peter] Oikonos Ecosyst Knowledge, Kailua, HI USA; [Ryan, Peter G.; Wanless, Ross] Univ Cape Town, FitzPatrick Inst African Ornithol, Rondebosch, South Africa; [Borroto-Paez, Rafael] Soc Cubana Zool, Havana, Cuba; [Pierce, Ray] Stoney Creek Rd, Speewah, Qld, Australia; [Fisher, Robert N.] US Geol Survey, Western Ecol Res Ctr, San Diego, CA USA; [Wanless, Ross] Parklands, BirdLife South Africa, Johannesburg, South Africa; [Pasachnik, Stesha A.] IUCN Iguana Specialist Grp, Ft Worth Zoo, Ft Worth, TX USA; [Cranwell, Steve] BirdLife Pacific, MacGregor Rd, Suva, Fiji; [Micol, Thierry] Fonderies Royales, Ligue Protect Oiseaux, 8 Rue Docteur Pujos, Rochefort, France; [Micol, Thierry] Terres Austr & Antarct Francaises, Rue Gabriel Dejean, St Pierre De La Reun, France	University of California System; University of California Santa Cruz; Royal Society for Protection of Birds; Italian Institute for Environmental Protection & Research (ISPRA); BirdLife International; Natural History Museum London; Nature Conservancy; National Taiwan University; University of Auckland; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; University of Cambridge; Universitat de les Illes Balears; University of Exeter; University of Cape Town; United States Department of the Interior; United States Geological Survey	Holmes, ND (corresponding author), Isl Conservat, Delaware Ave, Santa Cruz, CA 95060 USA.	nick.holmes@islandconservation.org	Jourdan, Herve/D-1452-2011; Genovesi, Piero/Z-1571-2019; Fisher, Robert/AAA-7301-2022; Oppel, Steffen/H-2771-2019; Rocamora, Gerard/AAG-6166-2019; Butchart, Stuart/AAJ-1852-2021; Griffiths, Richard/ABF-9372-2020	Jourdan, Herve/0000-0002-3756-4008; Fisher, Robert/0000-0002-2956-3240; Oppel, Steffen/0000-0002-8220-3789; Butchart, Stuart/0000-0002-1140-4049; 	David and Lucile Packard Foundation; National Fish and Wildlife Foundation; European Commission; Island Conservation; Nature Conservation Consultants Ltd.; NEMO Srl	David and Lucile Packard Foundation(The David & Lucile Packard Foundation); National Fish and Wildlife Foundation; European Commission(European CommissionEuropean Commission Joint Research Centre); Island Conservation; Nature Conservation Consultants Ltd.; NEMO Srl	The underlying data from the Threatened Island Biodiversity database used in the manuscript was collected through research funded by the David and Lucile Packard Foundation (https://www.packard.org); National Fish and Wildlife Foundation (http://www.nfwf.org/); and, Island Conservation (https://www.islandconservation.org/). Nick Holmes and Dena Spatz received salaries from these same sources. These funding sources financially supported the data collection and writing of this report but did not have any other involvement in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Nature Conservation Consultants Ltd. provided support in the form of salaries for author Jakob Fric, and contributed data collected through past and ongoing European Union's LIFENature projects, co-funded by the European Commission, but did not have any additional role in the study design, analysis, decision to publish, or preparation of the manuscript. NEMO Srl provided support in the form of salaries for authors Paolo Sposimo but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. All other authors received support from their affiliated organizations. The specific roles of these authors are articulated in the 'author contributions' section.	Aguirre-Munoz A., 2011, ISLAND INVASIVES ERA, P386; Angel A, 2009, BIOL INVASIONS, V11, P1743, DOI 10.1007/s10530-008-9401-4; [Anonymous], 2004, HOTSPOTS REVISITED E; [Anonymous], 2017, WHAT AR INV AL SPEC; Aslan C, 2015, CONSERV BIOL, V29, P133, DOI 10.1111/cobi.12354; Bellard C, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2015.0623; BirdLife International, 2018, IUCN RED LIST BIRDS; Bonnaud E, 2011, ANIM CONSERV, V14, P468, DOI 10.1111/j.1469-1795.2011.00496.x; Brooke MD, 2007, ANIM CONSERV, V10, P380, DOI 10.1111/j.1469-1795.2007.00123.x; Brooke MD, 2018, ANIM CONSERV, V21, P3, DOI 10.1111/acv.12344; Butchart SHM, 2004, PLOS BIOL, V2, P2294, DOI 10.1371/journal.pbio.0020383; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Campbell KJ, 2015, BIOL CONSERV, V185, P47, DOI 10.1016/j.biocon.2014.10.016; CONAMA, 2003, NAT BIOD STRAT REP C; Conservation Island, 2013, FLOR ISL EC REST ROD; Courchamp F, 2014, TRENDS ECOL EVOL, V29, P127, DOI 10.1016/j.tree.2014.01.001; Crowley SL, 2016, J APPL ECOL, V54, P251; Dawson J, 2015, CONSERV BIOL, V29, P143, DOI 10.1111/cobi.12347; de Wit LA, 2017, AM J TROP MED HYG, V96, P749, DOI 10.4269/ajtmh.16-0573; DIISE, 2018, DAT ISL INV SPEC ER; Doherty TS, 2016, P NATL ACAD SCI USA, V113, P11261, DOI 10.1073/pnas.1602480113; Donlan CJ, 2007, ANIM CONSERV, V10, P154, DOI 10.1111/j.1469-1795.2007.00101.x; Donlan CJ, 2015, CONSERV LETT, V8, P171, DOI 10.1111/conl.12126; Glen AS, 2013, BIOL INVASIONS, V15, P2589, DOI 10.1007/s10530-013-0495-y; Global Environment Facility, 2014, GEF 6 BIOD STRAT; Global Environment Facility, 2017, PROJ SUMM SAF BIOD G; GoS, 2014, SEYCH BIODIVERSITY S; Graham NAJ, 2018, NATURE, V559, P250, DOI 10.1038/s41586-018-0202-3; Heller NE, 2009, BIOL CONSERV, V142, P14, DOI 10.1016/j.biocon.2008.10.006; Helmstedt KJ, 2016, J APPL ECOL, V53, P733, DOI 10.1111/1365-2664.12599; Howald G, 2010, ORYX, V44, P30, DOI 10.1017/S003060530999024X; Jones HP, 2016, P NATL ACAD SCI USA, V113, P4033, DOI 10.1073/pnas.1521179113; Joseph LN, 2009, CONSERV BIOL, V23, P328, DOI 10.1111/j.1523-1739.2008.01124.x; Kappes PJ, 2014, BIODIVERS CONSERV, V23, P503, DOI 10.1007/s10531-013-0608-z; Kier G, 2009, P NATL ACAD SCI USA, V106, P9322, DOI 10.1073/pnas.0810306106; Latofski-Robles M., 2014, Monographs of the Western North American Naturalist, V7, P435, DOI 10.3398/042.007.0133; Luna-Mendoza L, 2017, OPERATIONAL PLAN ERA; Mazza G, 2014, ETHOL ECOL EVOL, V26, P112, DOI 10.1080/03949370.2013.863225; Medina FM, 2011, GLOBAL CHANGE BIOL, V17, P3503, DOI 10.1111/j.1365-2486.2011.02464.x; Ministerio de Medio Ambiente y Recursos Naturales, 2011, ESTR NAC CONS US SOS; Morrison S.A., 2011, Occasional Papers of the IUCN Species Survival Commission, V42, P461; Mwebaze P, 2010, ECOL ECON, V69, P2614, DOI 10.1016/j.ecolecon.2010.08.006; Naidoo R, 2006, TRENDS ECOL EVOL, V21, P681, DOI 10.1016/j.tree.2006.10.003; Oppel S, 2011, CONSERV BIOL, V25, P232, DOI 10.1111/j.1523-1739.2010.01601.x; Parkes J., 2008, 34 RSPB; Peh K., 2014, BIOL INVASIONS, P1; Pierce R, 2016, SPECIES ACTION PLAN; Reynolds MH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136773; Rocamora G., 2015, INVASIVE ALIEN SPECI; Russell JC, 2008, 286 DEP CONS; Russell JC, 2017, ENVIRON CONSERV, P1; Spatz DR, 2017, CONSERV LETT, V10, P736, DOI 10.1111/conl.12373; Spatz DR, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1603080; Tershy BR, 2015, BIOSCIENCE, V65, P592, DOI 10.1093/biosci/biv031; Threatened Island Biodiversity Partners, 2014, THREAT ISL BIOD DAT; Towns DR, 2006, BIOL INVASIONS, V8, P863, DOI 10.1007/s10530-005-0421-z; UNEP-WCMC, 2015, GLOB ISL DAT VERS 2; Veitch CR, 2011, P INT C ISL INV; Wilson KA, 2010, PRIORITIZING TRADE O, P15; Young LC, 2013, BIOL INVASIONS, V15, P2627, DOI 10.1007/s10530-013-0479-y; Zavaleta ES, 2001, TRENDS ECOL EVOL, V16, P454, DOI 10.1016/S0169-5347(01)02194-2	61	71	72	5	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2019	14	3							e0212128	10.1371/journal.pone.0212128	http://dx.doi.org/10.1371/journal.pone.0212128			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ5PT	30917126	Green Published, gold, Green Submitted			2022-12-26	WOS:000462465800010
J	Rentoft, M; Svensson, D; Sjodin, A; Olason, PI; Sjostrom, O; Nylander, C; Osterman, P; Sjogren, R; Netotea, S; Wibom, C; Cederquist, K; Chabes, A; Trygg, J; Melin, BS; Johansson, E				Rentoft, Matilda; Svensson, Daniel; Sjodin, Andreas; Olason, Pall I.; Sjostrom, Olle; Nylander, Carin; Osterman, Pia; Sjogren, Rickard; Netotea, Sergiu; Wibom, Carl; Cederquist, Kristina; Chabes, Andrei; Trygg, Johan; Melin, Beatrice S.; Johansson, Erik			A geographically matched control population efficiently limits the number of candidate disease-causing variants in an unbiased whole-genome analysis	PLOS ONE			English	Article							COLORECTAL-CANCER; HEREDITARY; DISCOVERY; FRAMEWORK; RISK; LOCI	Whole-genome sequencing is a promising approach for human autosomal dominant disease studies. However, the vast number of genetic variants observed by this method constitutes a challenge when trying to identify the causal variants. This is often handled by restricting disease studies to the most damaging variants, e. g. those found in coding regions, and overlooking the remaining genetic variation. Such a biased approach explains in part why the genetic causes of many families with dominantly inherited diseases, in spite of being included in whole-genome sequencing studies, are left unsolved today. Here we explore the use of a geographically matched control population to minimize the number of candidate disease-causing variants without excluding variants based on assumptions on genomic position or functional predictions. To exemplify the benefit of the geographically matched control population we apply a typical disease variant filtering strategy in a family with an autosomal dominant form of colorectal cancer. With the use of the geographically matched control population we end up with 26 candidate variants genome wide. This is in contrast to the tens of thousands of candidates left when only making use of available public variant datasets. The effect of the local control population is dual, it (1) reduces the total number of candidate variants shared between affected individuals, and more importantly (2) increases the rate by which the number of candidate variants are reduced as additional affected family members are included in the filtering strategy. We demonstrate that the application of a geographically matched control population effectively limits the number of candidate disease-causing variants and may provide the means by which variants suitable for functional studies are identified genome wide.	[Rentoft, Matilda; Osterman, Pia; Chabes, Andrei; Johansson, Erik] Umea Univ, Dept Med Biochem & Biophys, Umea, Sweden; [Rentoft, Matilda; Svensson, Daniel; Sjodin, Andreas; Sjogren, Rickard; Netotea, Sergiu; Trygg, Johan] Umea Univ, Dept Chem, Computat Life Sci Cluster, Umea, Sweden; [Sjodin, Andreas] FOI Swedish Def Res Agcy, Div CBRN Secur & Def, Umea, Sweden; [Olason, Pall I.] Uppsala Univ, Dept Cell & Mol Biol, Sci Life Lab, Uppsala, Sweden; [Sjostrom, Olle; Nylander, Carin; Wibom, Carl; Melin, Beatrice S.] Umea Univ, Dept Radiat Sci, Oncol, Umea, Sweden; [Sjostrom, Olle] Unit Res Educ & Dev, Ostersund, Region Jamtland, Sweden; [Netotea, Sergiu] Chalmers Univ Technol, Dept Biol & Biol Engn, Sci Life Lab, Gothenburg, Sweden; [Cederquist, Kristina] Umea Univ, Dept Med Biosci Med & Clin Genet, Umea, Sweden	Umea University; Umea University; FOI - Swedish Defence Research Agency; Uppsala University; Umea University; Chalmers University of Technology; Umea University	Johansson, E (corresponding author), Umea Univ, Dept Med Biochem & Biophys, Umea, Sweden.	erik.tm.johansson@umu.se	Rentoft, Matilda/AAL-2449-2021; Sjödin, Andreas/A-7245-2008	Sjödin, Andreas/0000-0001-5350-4219; Chabes, Andrei/0000-0003-1708-8259; Johansson, Erik/0000-0002-8526-6224; Svensson, Daniel/0000-0002-4476-9255; Osterman, Pia/0000-0001-9360-0782	Knut and Alice Wallenberg Foundation [2011.0042]; Knut and Alice Wallenberg Foundation	Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	This work was funded by a project grant (2011.0042) from the Knut and Alice Wallenberg Foundation (E.J., B.S.M, J.T., A.C.). http://kaw.wallenberg.org/.; We are grateful to all of the patients and individuals for their participation, and we would also like to thank the clinicians and other hospital staff members, cancer registries, the participants of the VIP cohort of the Northern Sweden Health and Disease Study (NSHDS), the staff at the Department of Biobank Research, Umea University, and the study staff members who contributed to the blood sample and data collection. Illumina sequencing was performed by the National Genomics Infrastructure (NGI), which is hosted by SciLifeLab in Stockholm and Uppsala. The computations were performed using resources provided by the Swedish National Infrastructure for Computing (SNIC) through the Uppsala Multidisciplinary Center for Advanced Computational Science (UPPMAX). We acknowledge the support of the National Bioinformatics Infrastructure Sweden (NBIS) and the SciLifeLab Data Centre with help in hosting and sharing the ACpop allele frequency dataset. P. I.O. was supported by a grant from the Knut and Alice Wallenberg Foundation to the Wallenberg Advanced Bioinformatics Infrastructure.	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Boomsma DI, 2014, EUR J HUM GENET, V22, P221, DOI 10.1038/ejhg.2013.118; Chubb D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11883; Dashti MJS, 2017, BIOTECHNIQUES, V62, P18, DOI 10.2144/000114492; Delaneau O, 2013, NAT METHODS, V10, P5, DOI 10.1038/nmeth.2307; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dopazo J, 2016, MOL BIOL EVOL, V33, P1205, DOI 10.1093/molbev/msw005; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fernandez-Rozadilla C, 2013, CARCINOGENESIS, V34, P314, DOI 10.1093/carcin/bgs357; Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690; Gudbjartsson DF, 2015, NAT GENET, V47, P435, DOI 10.1038/ng.3247; Houlston RS, 2008, NAT GENET, V40, P1426, DOI 10.1038/ng.262; Imperiale TF, 2002, NEW ENGL J MED, V346, P1781, DOI 10.1056/NEJM200206063462304; Jarvinen HJ, 2000, GASTROENTEROLOGY, V118, P829, DOI 10.1016/S0016-5085(00)70168-5; Jia WH, 2013, NAT GENET, V45, P191, DOI 10.1038/ng.2505; Keinan A, 2012, SCIENCE, V336, P740, DOI 10.1126/science.1217283; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mahmood K, 2017, HUM GENOMICS, V11, DOI 10.1186/s40246-017-0104-8; Manichaikul A, 2010, BIOINFORMATICS, V26, P2867, DOI 10.1093/bioinformatics/btq559; Mather CA, 2016, GENET MED, V18, P1269, DOI 10.1038/gim.2016.44; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; Norberg M, 2012, GLOBAL HEALTH ACTION, V5, P1, DOI 10.3402/gha.v5i0.19166; Norberg M, 2010, GLOBAL HEALTH ACTION, V3, DOI 10.3402/gha.v3i0.4643; Okonechnikov K, 2016, BIOINFORMATICS, V32, P292, DOI 10.1093/bioinformatics/btv566; Paila U, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003153; Rands CM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004525; Sjostrom O, 2016, FAM CANCER, V15, P543, DOI 10.1007/s10689-016-9867-7; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Tan A, 2015, BIOINFORMATICS, V31, P2202, DOI 10.1093/bioinformatics/btv112; Taylor JC, 2015, NAT GENET, V47, P717, DOI 10.1038/ng.3304; Vasen HFA, 2015, NAT REV GASTRO HEPAT, V12, P88, DOI 10.1038/nrgastro.2014.229; Wang HS, 2013, HUM MOL GENET, V22, P5048, DOI 10.1093/hmg/ddt337	35	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2019	14	3							e0213350	10.1371/journal.pone.0213350	http://dx.doi.org/10.1371/journal.pone.0213350			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ5PT	30917156	Green Published, gold, Green Submitted			2022-12-26	WOS:000462465800028
J	Van den Berghe, F; Paris, MCJ; Sarnyai, Z; Vlamings, B; Millar, RP; Ganswindt, A; Cozzi, A; Pageat, P; Paris, DBBP				Van den Berghe, Femke; Paris, Monique C. J.; Sarnyai, Zoltan; Vlamings, Bart; Millar, Robert P.; Ganswindt, Andre; Cozzi, Alessandro; Pageat, Patrick; Paris, Damien B. B. P.			Dog appeasing pheromone prevents the androgen surge and may reduce contact dominance and active submission after stressful interventions in African wild dogs (Lycaon pictus)	PLOS ONE			English	Article							EFFICACY; REPRODUCTION; BEHAVIORS; FEAR; PATTERNS; ANXIETY; PUPPIES; CANINE; SIGNS; DAP	The endangered African wild dog (AWD; Lycaon pictus) is a highly social canid living in packs with a separate male and female hierarchy. Immobilisation, handling and translocations are acute stressors for AWDs, however such interventions are often needed for species management. In addition, new pack formation or temporary pack separation can lead to an increase in intra-pack aggression. The goal of this double-blinded placebo-controlled study conducted in captive zoo populations was to evaluate whether dog appeasing pheromone (DAP) reduces behavioural stress and faecal glucocorticoid metabolite levels (fGCM) normally associated with pack separation, immobilisation and reintroduction (SIR), and to assess whether this reduces aggressive behaviours and faecal androgen metabolite levels (fAM). Four packs (n = 11 males) were treated with DAP and 4 packs (n = 12 males) were treated with a placebo solution, applied at the end of anaesthesia. Behavioural interactions as well as fGCM and fAM were determined from 3 days before until 4-6 days after SIR. No effect of DAP on fGCM was observed, however, fAM increased after SIR in placebo but not DAP treated animals. Moreover, on the day of reintroduction, DAP treated packs tended to have lower rates of contact-dominance and active-submission behaviour, but higher rates of non-contact dominance behaviour. As these effects could decrease the risk of agonistic interactions, DAP may be a useful tool to help manage new pack formations and temporary pack separation.	[Van den Berghe, Femke; Paris, Damien B. B. P.] James Cook Univ, Gamete & Embryol GAME Lab, Coll Publ Hlth Med & Vet Sci, Townsville, Qld, Australia; [Van den Berghe, Femke; Paris, Monique C. J.; Vlamings, Bart; Millar, Robert P.; Ganswindt, Andre; Paris, Damien B. B. P.] IBREAM, Edinburgh, Midlothian, Scotland; [Paris, Monique C. J.] Wageningen Livestock Res, Wageningen, Netherlands; [Sarnyai, Zoltan] James Cook Univ, Lab Psychiat Neurosci, AITHM, Townsville, Qld, Australia; [Sarnyai, Zoltan] James Cook Univ, Coll Publ Hlth Med & Vet Sci, Townsville, Qld, Australia; [Millar, Robert P.] Univ Pretoria, Dept Immunol, Ctr Neuroendocrinol, Fac Hlth Sci, Pretoria, South Africa; [Ganswindt, Andre] Univ Pretoria, Mammal Res Inst, Fac Nat & Agr Sci, Pretoria, South Africa; [Ganswindt, Andre] Univ Pretoria, Endocrine Res Lab, Fac Vet Sci, Onderstepoort, South Africa; [Cozzi, Alessandro; Pageat, Patrick] Inst Rech Serniochim & Ethol Appl, Apt, France; [Paris, Damien B. B. P.] James Cook Univ, Ctr Trop Environm & Sustainabil Sci, Townsville, Qld, Australia	James Cook University; Wageningen University & Research; James Cook University; James Cook University; University of Pretoria; University of Pretoria; University of Pretoria; James Cook University	Paris, DBBP (corresponding author), James Cook Univ, Gamete & Embryol GAME Lab, Coll Publ Hlth Med & Vet Sci, Townsville, Qld, Australia.; Paris, DBBP (corresponding author), IBREAM, Edinburgh, Midlothian, Scotland.; Paris, DBBP (corresponding author), James Cook Univ, Ctr Trop Environm & Sustainabil Sci, Townsville, Qld, Australia.	damien.paris@jcu.edu.au	Ganswindt, Andre/G-9856-2014; Sarnyai, Zoltan/A-3283-2009	Ganswindt, Andre/0000-0002-1474-7602; Sarnyai, Zoltan/0000-0002-2380-7902; COZZI, Alessandro/0000-0002-4590-2310	Morris Animal Foundation [D15ZO-053]; Roger William Park Zoo; Fresno Chaffee Zoo; James Cook University; IBREAM	Morris Animal Foundation; Roger William Park Zoo; Fresno Chaffee Zoo; James Cook University; IBREAM	This work was financially supported by the Morris Animal Foundation [grant number D15ZO-053], Roger William Park Zoo and Fresno Chaffee Zoo. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Additional funding was also provided by James Cook University and IBREAM, as institutions of several of the authors.	Beerda B, 1999, PHYSIOL BEHAV, V66, P233, DOI 10.1016/S0031-9384(98)00289-3; Comizzoli P, 2009, REPROD DOMEST ANIM, V44, P47, DOI 10.1111/j.1439-0531.2009.01373.x; Creel S, 1997, BEHAV ECOL, V8, P298, DOI 10.1093/beheco/8.3.298; Creel S, 1997, CONSERV BIOL, V11, P544, DOI 10.1046/j.1523-1739.1997.95476.x; Creel S., 2002, AFRICAN WILD DOG BEH; Davies-Mostert HT, 2009, REINTRODUCTION TOP O; delBarco-Trillo J, 2016, HORM BEHAV, V78, P95, DOI 10.1016/j.yhbeh.2015.11.001; Denenberg S, 2008, JAVMA-J AM VET MED A, V233, P1874, DOI 10.2460/javma.233.12.1874; DEVILLIERS MS, 1995, P ROY SOC B-BIOL SCI, V262, P215, DOI 10.1098/rspb.1995.0198; deVilliers MS, 1997, HORM BEHAV, V31, P3, DOI 10.1006/hbeh.1997.1314; Dreher JC, 2016, P NATL ACAD SCI USA, V113, P11633, DOI 10.1073/pnas.1608085113; Foster B., 2014, AFR PAINT DOG C APR, P27; Estelles MG, 2006, VET REC, V159, P143, DOI 10.1136/vr.159.5.143; Ganswindt A, 2002, ZOO BIOL, V21, P27, DOI 10.1002/zoo.10034; Gaultier E, 2008, VET REC, V163, P73, DOI 10.1136/vr.163.3.73; Gaultier E, 2005, VET REC, V156, P533, DOI 10.1136/vr.156.17.533; Gaultier E, 2009, VET REC, V164, P708, DOI 10.1136/vr.164.23.708; Gaultier E, 2005, INTRO FEMALE TIGER P, P1; Gill-Sharma MK, 2009, INT J ENDOCRINOL, V2009, P13; Inoue Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05603-7; Johnston SD, 2007, ANIM REPROD SCI, V100, P338, DOI 10.1016/j.anireprosci.2006.08.017; Kim YM, 2010, CAN VET J, V51, P380; Landsberg GM, 2015, VET REC, V177, DOI 10.1136/vr.103172; Levine ED, 2007, APPL ANIM BEHAV SCI, V105, P311, DOI 10.1016/j.applanim.2006.11.006; LINCOLN GA, 1978, J ENDOCRINOL, V77, P347, DOI 10.1677/joe.0.0770347; Maarschalkerweerd RJ, 1997, VET REC, V140, P617, DOI 10.1136/vr.140.24.617; Mehta PH, 2010, J COGNITIVE NEUROSCI, V22, P2357, DOI 10.1162/jocn.2009.21389; Mengoli M, 2014, BEHAV PROCESS, V106, P141, DOI 10.1016/j.beproc.2014.05.004; Mills DS, 2006, APPL ANIM BEHAV SCI, V98, P114, DOI 10.1016/j.applanim.2005.08.012; Monfort SL, 1997, ZOO BIOL, V16, P533, DOI 10.1002/(SICI)1098-2361(1997)16:6<533::AID-ZOO6>3.0.CO;2-B; Odendaal JSJ, 2003, VET J, V165, P296, DOI 10.1016/S1090-0233(02)00237-X; Pageat P, 2003, VET CLIN N AM-SMALL, V33, P187, DOI 10.1016/S0195-5616(02)00128-6; PALME R, 1994, ADVANCES IN STEROID ANALYSIS '93, P111; Palme R, 1997, Z SAUGETIERKD, V62, P192; Pereira JS, 2016, J FELINE MED SURG, V18, P959, DOI 10.1177/1098612X15599420; Quick M., 2014, AFR PAINT DOG C APR, P21; Rosado B, 2010, APPL ANIM BEHAV SCI, V123, P124, DOI 10.1016/j.applanim.2010.01.009; Scheepers JL, 1995, S AFR J WILDL RES, V25, P138; Sheppard G, 2003, VET REC, V152, P432, DOI 10.1136/vr.152.14.432; Siracusa C, 2010, JAVMA-J AM VET MED A, V237, P673, DOI 10.2460/javma.237.6.673; Taylor K, 2007, APPL ANIM BEHAV SCI, V105, P358, DOI 10.1016/j.applanim.2006.11.003; Tod E, 2005, APPL ANIM BEHAV SCI, V93, P295, DOI 10.1016/j.applanim.2005.01.007; Van den Berghe F, 2012, ANIM REPROD SCI, V133, P1, DOI 10.1016/j.anireprosci.2012.06.003; Van den Berghe F, 2019, REPROD FERT DEVELOP, V31, P875, DOI 10.1071/RD18205; Van den Berghe F, 2018, CRYOBIOLOGY, V80, P18, DOI 10.1016/j.cryobiol.2017.12.095; van der Goot AC, 2015, ANIM REPROD SCI, V161, P89, DOI 10.1016/j.anireprosci.2015.08.009; van der Weyde LK, 2015, ANIM REPROD SCI, V156, P75, DOI 10.1016/j.anireprosci.2015.03.003; Vlamings BHAC, 2011, DOG APPEASING PHEROM; Wacker DW, 2016, J NEUROENDOCRINOL, V28, DOI 10.1111/jne.12443; Woodroffe R, 1999, ORYX, V33, P143, DOI 10.1046/j.1365-3008.1999.00053.x; Yonezawa T, 2009, ZOOL SCI, V26, P739, DOI 10.2108/zsj.26.739; Zilioli S, 2017, FRONT NEUROENDOCRIN, V47, P1, DOI 10.1016/j.yfrne.2017.06.002	52	5	5	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2019	14	3							e0212551	10.1371/journal.pone.0212551	http://dx.doi.org/10.1371/journal.pone.0212551			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ5PT	30917139	Green Published, Green Accepted, gold			2022-12-26	WOS:000462465800013
J	Yee, SH; Kyle, V; Blouet, C; Jones, S; Colledge, WH				Yee, Shel-Hwa; Kyle, Victoria; Blouet, Clemence; Jones, Susan; Colledge, William Henry			Mapping neuronal inputs to Kiss1 neurons in the arcuate nucleus of the mouse	PLOS ONE			English	Article							THYROTROPIN-RELEASING-HORMONE; STRESS-INDUCED SUPPRESSION; PARAVENTRICULAR NUCLEUS; KISSPEPTIN NEURONS; SUBFORNICAL ORGAN; SUBSTANCE-P; MEDIAL AMYGDALA; MESSENGER-RNA; RAT; HYPOTHALAMUS	The normal function of the mammalian reproductive axis is strongly influenced by physiological, metabolic and environmental factors. Kisspeptin neuropeptides, encoded by the Kiss1 gene, are potent regulators of the mammalian reproductive axis by stimulating gonadodropin releasing hormone secretion from the hypothalamus. To understand how the reproductive axis is modulated by higher order neuronal inputs we have mapped the afferent circuits into arcuate (ARC) Kiss1 neurons. We used a transgenic mouse that expresses the CRE recombinase in Kiss1 neurons for conditional viral tracing with genetically modified viruses. CRE-mediated activation of these viruses in Kiss1 neurons allows the virus to move transynaptically to label neurons with primary or secondary afferent inputs into the Kiss1 neurons. Several regions of the brain showed synaptic connectivity to arcuate Kiss1 neurons including proopiomelanocortin neurons in the ARC itself, kisspeptin neurons in the anteroventral periventricular nucleus, vasopressin neurons in the supraoptic and suprachiasmatic nuclei, thyrotropin releasing neurons in the paraventricular nucleus and unidentified neurons in other regions including the subfornical organ, amygdala, interpeduncular nucleus, ventral premammilary nucleus, basal nucleus of stria terminalis and the visual, somatosensory and piriform regions of the cortex. These data provide an insight into how the activity of Kiss1 neurons may be regulated by metabolic signals and provide a detailed neuroanatomical map for future functional studies.	[Yee, Shel-Hwa; Kyle, Victoria; Jones, Susan; Colledge, William Henry] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England; [Blouet, Clemence] Univ Cambridge, Metab Res Labs, WT MRC Inst Metab Sci, MRC Metab Dis Unit, Cambridge, England; [Yee, Shel-Hwa] Univ Otago, Dept Physiol, Ctr Neuroendocrinol, Dunedin, New Zealand	University of Cambridge; University of Cambridge; University of Otago	Colledge, WH (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England.	whc23@cam.ac.uk	Colledge, William/X-4976-2019; Core, Vector/CAF-4832-2022	Colledge, William/0000-0002-9603-4429; Blouet, Clemence/0000-0002-1752-1270	BBSRC [BB/K003178/1]; Ford Physiology Fund; Newton Foundation; British Society for Neuroendocrinology [P40 OD010996]; NIH Virus Center [P40 OD010996]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010996] Funding Source: NIH RePORTER	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Ford Physiology Fund; Newton Foundation; British Society for Neuroendocrinology; NIH Virus Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the BBSRC (BB/K003178/1) https://bbsrc.ukri.org/, the Ford Physiology Fund https://www.admin.cam.ac.uk/univ/so/2017/chapter12-section2.html#heading2-184 (WHC, S-H. Y), the Newton Foundation (S-H. Y), and a fellowship from the British Society for Neuroendocrinology, https://www.neuroendo.org.uk/(S-H.Y).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are indebted to Professor Friedman and Dr Ekstrand (Rockefeller University, USA) for the PRV INTRO vector and Prof Enquist (Princeton University, USA) for supplying us with the PRV Ba2001 (NIH Virus Center Grant No: P40 OD010996).	Adachi S, 2007, J REPROD DEVELOP, V53, P367, DOI 10.1262/jrd.18146; Adekunbi DA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183596; Ahmed AF, 2014, AM J PHYSIOL-REG I, V306, pR363, DOI 10.1152/ajpregu.00462.2013; Armstrong WE, 1995, PROG NEUROBIOL, V47, P291, DOI 10.1016/0301-0082(95)00025-9; Bilkei-Gorzo A, 2002, J NEUROSCI, V22, P10046; Card JP, 1999, J COMP NEUROL, V407, P438, DOI 10.1002/(SICI)1096-9861(19990510)407:3<438::AID-CNE11>3.0.CO;2-2; Castellano JM, 2005, ENDOCRINOLOGY, V146, P3917, DOI 10.1210/en.2005-0337; Cates PS, 1999, J NEUROENDOCRINOL, V11, P677; Cates PS, 2004, STRESS, V7, P113, DOI 10.1080/1025389042000218988; Chachlaki K, 2017, J COMP NEUROL, V525, P3177, DOI 10.1002/cne.24257; Challis C, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00043; Clarkson J, 2009, J NEUROENDOCRINOL, V21, P673, DOI 10.1111/j.1365-2826.2009.01892.x; Clarkson J, 2008, J NEUROSCI, V28, P8691, DOI 10.1523/JNEUROSCI.1775-08.2008; Clarkson J, 2017, P NATL ACAD SCI USA, V114, pE10216, DOI 10.1073/pnas.1713897114; Comninos AN, 2016, BRAIN STRUCT FUNCT, V221, P2035, DOI 10.1007/s00429-015-1024-9; Coomans CP, 2015, FRONT NEUROENDOCRIN, V37, P29, DOI 10.1016/j.yfrne.2014.11.002; Cournil I, 2000, BRAIN RES, V877, P412, DOI 10.1016/S0006-8993(00)02748-7; d'Anglemont de Tassigny X, 2007, P NATL ACAD SCI USA, V104, P10714, DOI 10.1073/pnas.0704114104; de Roux N, 2003, P NATL ACAD SCI USA, V100, P10972, DOI 10.1073/pnas.1834399100; Donato J, 2011, J CLIN INVEST, V121, P355, DOI 10.1172/JCI45106; Driessen TM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083098; Ducret E, 2010, ENDOCRINOLOGY, V151, P2223, DOI 10.1210/en.2009-1480; Ferguson AV, 1997, CLIN EXP PHARMACOL P, V24, P96, DOI 10.1111/j.1440-1681.1997.tb01790.x; Ghamari-Langroudi M, 2010, MOL ENDOCRINOL, V24, P2366, DOI 10.1210/me.2010-0203; Gottsch ML, 2011, ENDOCRINOLOGY, V152, P4298, DOI 10.1210/en.2011-1521; Gottsch ML, 2004, ENDOCRINOLOGY, V145, P4073, DOI 10.1210/en.2004-0431; Gresham R, 2016, NEUROSCI LETT, V627, P13, DOI 10.1016/j.neulet.2016.05.042; GRUBER K, 1987, NEUROSCI LETT, V75, P1, DOI 10.1016/0304-3940(87)90065-6; Hall JE, 2005, J CLIN ENDOCR METAB, V90, P2050, DOI 10.1210/jc.2004-2033; HAMILL GS, 1984, J COMP NEUROL, V226, P580, DOI 10.1002/cne.902260410; Hrabovszky E, 2005, ENDOCRINOLOGY, V146, P341, DOI 10.1210/en.2004-0856; Kirilov M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3492; Korner J, 2001, J NEUROENDOCRINOL, V13, P959, DOI 10.1046/j.1365-2826.2001.00716.x; Leak RK, 2001, J COMP NEUROL, V433, P312, DOI 10.1002/cne.1142; Lee SK, 2013, NEUROSCI LETT, V556, P160, DOI 10.1016/j.neulet.2013.09.070; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Maejima Y, 2014, FEBS LETT, V588, P4404, DOI 10.1016/j.febslet.2014.10.010; Manfredi-Lozano M, 2016, MOL METAB, V5, P844, DOI 10.1016/j.molmet.2016.08.003; McCarthy EA, 2017, EUR J NEUROSCI, V46, P2035, DOI 10.1111/ejn.13636; McKinley MJ, 1998, CLIN EXP PHARMACOL P, V25, pS61, DOI 10.1111/j.1440-1681.1998.tb02303.x; Mimee A, 2013, PHYSIOL BEHAV, V121, P96, DOI 10.1016/j.physbeh.2013.02.012; Nestor CC, 2016, MOL ENDOCRINOL, V30, P630, DOI 10.1210/me.2016-1026; NI L, 1988, J COMP NEUROL, V275, P493, DOI 10.1002/cne.902750403; Padilla SL, 2017, P NATL ACAD SCI USA, V114, P2413, DOI 10.1073/pnas.1621065114; Pineda R, 2016, J NEUROENDOCRINOL, V28, DOI 10.1111/jne.12342; Pineda R, 2017, NEUROENDOCRINOLOGY, V104, P223, DOI 10.1159/000445895; PLANT TM, 1989, P NATL ACAD SCI USA, V86, P2506, DOI 10.1073/pnas.86.7.2506; Pomeranz LE, 2017, J NEUROSCI, V37, P4128, DOI 10.1523/JNEUROSCI.3193-16.2017; Ratra DV, 2014, J CHEM NEUROANAT, V61-62, P233, DOI 10.1016/j.jchemneu.2014.05.005; Robertson JL, 2009, ENDOCRINOLOGY, V150, P3664, DOI 10.1210/en.2009-0247; Ross RA, 2018, ELIFE, V7, DOI 10.7554/eLife.35960; SAPHIER D, 1987, EXP BRAIN RES, V69, P60; Schafer D, 2018, J NEUROENDOCRINOL, V30, DOI 10.1111/jne.12660; Seminara SB, 2003, NEW ENGL J MED, V349, P1614, DOI 10.1056/NEJMoa035322; SILVERMAN AJ, 1981, BRAIN RES BULL, V6, P47, DOI 10.1016/S0361-9230(81)80068-8; Simavli S, 2015, ENDOCRINOLOGY, V156, P2313, DOI 10.1210/en.2014-2012; TRIBOLLET E, 1981, NEUROSCIENCE, V6, P1315, DOI 10.1016/0306-4522(81)90190-1; Ugolini G, 2010, J NEUROSCI METH, V194, P2, DOI 10.1016/j.jneumeth.2009.12.001; Umehara H, 2012, NEUROCHEM INT, V61, P942, DOI 10.1016/j.neuint.2012.05.022; Vida B, 2010, J NEUROENDOCRINOL, V22, P1032, DOI 10.1111/j.1365-2826.2010.02045.x; Wall NR, 2010, P NATL ACAD SCI USA, V107, P21848, DOI 10.1073/pnas.1011756107; Yeo SH, 2016, J NEUROENDOCRINOL, V28, P1, DOI 10.1111/jne.12435; Yeo SH, 2011, ENDOCRINOLOGY, V152, P2387, DOI 10.1210/en.2011-0164; Yip SH, 2015, ENDOCRINOLOGY, V156, P2582, DOI 10.1210/en.2015-1131; Yoon HY, 2005, CELL, V123, P669, DOI 10.1016/j.cell.2005.08.039; Zhang JC, 2012, AM J PHYSIOL-REG I, V302, pR264, DOI 10.1152/ajpregu.00114.2011	66	24	25	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2019	14	3							e0213927	10.1371/journal.pone.0213927	http://dx.doi.org/10.1371/journal.pone.0213927			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ5PT	30917148	Green Published, Green Submitted, gold			2022-12-26	WOS:000462465800044
J	Reindl, W; Baldo, B; Schulz, J; Janack, I; Lindner, I; Kleinschmidt, M; Sedaghat, Y; Thiede, C; Tillack, K; Schmidt, C; Cardaun, I; Schwagarus, T; Herrmann, F; Hotze, M; Osborne, GF; Herrmann, S; Weiss, A; Zerbinatti, C; Bates, GP; Bard, J; Munoz-Sanjuan, I; Macdonald, D				Reindl, Wolfgang; Baldo, Barbara; Schulz, Jana; Janack, Isabell; Lindner, Ilka; Kleinschmidt, Markus; Sedaghat, Yalda; Thiede, Christina; Tillack, Karsten; Schmidt, Christina; Cardaun, Isabell; Schwagarus, Tom; Herrmann, Frank; Hotze, Madlen; Osborne, Georgina F.; Herrmann, Simone; Weiss, Andreas; Zerbinatti, Celina; Bates, Gillian P.; Bard, Jonathan; Munoz-Sanjuan, Ignacio; Macdonald, Douglas			Meso scale discovery-based assays for the detection of aggregated huntingtin	PLOS ONE			English	Article							MUTANT HUNTINGTIN; MOUSE MODEL; DISEASE; PROTEIN; NUCLEAR; EXON-1; R6/2; REVERSAL; REVEALS; NEURONS	Huntington's disease (HD) is a monogenic neurodegenerative disorder caused by an expansion of the CAG trinucleotide repeat domain in the huntingtin (HTT) gene, leading to an expanded poly-glutamine (polyQ) stretch in the HTT protein. This mutant HTT (mHTT) protein is highly prone to intracellular aggregation, causing significant damage and cellular loss in the striatal, cortical, and other regions of the brain. Therefore, modulation of mHTT levels in these brain regions in order to reduce intracellular mHTT and aggregate levels represents a direct approach in the development of HD therapeutics. To this end, assays that can be used to detect changes in HTT levels in biological samples are invaluable tools to assess target engagement and guide dose selection in clinical trials. The Meso Scale Discovery (MSD) ELISA-based assay platform is a robust and sensitive method previously employed for the quantification of HTT. However, the currently available MSD assays for HTT are primarily detecting the monomeric soluble form of the protein, but not aggregated species. In this study, we describe the development of novel MSD assays preferentially detecting mHTT in an aggregated form. Recombinant monomeric HTT(1-97)-Q46, which forms aggregates in a time-dependent manner, was used to characterize the ability of each established assay to distinguish between HTT monomers and HTT in a higher assembly state. Further validation of these assays was performed using brain lysates from R6/2, zQ175 knock-in, and BACHD mouse models, to replicate a previously well-characterized age-dependent increase in brain aggregate signals, as well as a significant reduction of aggregate levels in the striatum following mHTT knockdown with a CAG-directed allele-specific zinc-finger repressor protein (ZFP). Lastly, size exclusion chromatography was used to separate and characterize HTT species from brain tissue lysates to demonstrate specificity of the assays for the fractions containing aggregated HTT. In summary, we demonstrate that the newly developed assays preferentially detect aggregated HTT with improved performance in comparison to previous assay technologies. These assays complement the existing MSD platform assays specific for soluble HTT monomers, allowing for a more comprehensive analysis of disease-relevant HTT species in preclinical models of HD.	[Reindl, Wolfgang; Baldo, Barbara; Schulz, Jana; Janack, Isabell; Lindner, Ilka; Kleinschmidt, Markus; Sedaghat, Yalda; Thiede, Christina; Tillack, Karsten; Schmidt, Christina; Cardaun, Isabell; Schwagarus, Tom; Herrmann, Frank; Hotze, Madlen; Herrmann, Simone; Weiss, Andreas; Zerbinatti, Celina] Evotec AG, Hamburg, Germany; [Osborne, Georgina F.; Bates, Gillian P.] UCL, Huntingtons Dis Ctr, Dept Neurodegenerat Dis, London, England; [Osborne, Georgina F.; Bates, Gillian P.] UCL, Dementia Res Inst, Inst Neurol, London, England; [Bard, Jonathan; Munoz-Sanjuan, Ignacio; Macdonald, Douglas] CHDI Fdn, CHDI Management, Los Angeles, CA 90045 USA	Evotec; University of London; University College London; University of London; University College London	Macdonald, D (corresponding author), CHDI Fdn, CHDI Management, Los Angeles, CA 90045 USA.	Douglas.Macdonald@chdifoundation.org	; Bates, Gillian/E-1146-2012	Osborne, Georgina/0000-0001-8308-3179; Bates, Gillian/0000-0002-4041-6305	CHDI Foundation; MRC [UKDRI-1008/1] Funding Source: UKRI	CHDI Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	CHDI Foundation is a privately-funded not-for-profit biomedical research organization exclusively dedicated to discovering and developing therapeutics that slow the progression of Huntington's Disease. CHDI Foundation conducts research in a number of different ways; for the purposes of this manuscript, research was conducted at the contract research organization Evotec AG under fee-for-service agreements. The listed authors all contributed to the conception, planning, and direction of the research, including generation, analysis, and interpretation of the data.	Baldo B, 2012, CHEM BIOL, V19, P264, DOI 10.1016/j.chembiol.2011.12.020; Carty N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123527; Cong SY, 2005, HYBRIDOMA, V24, P231, DOI 10.1089/hyb.2005.24.231; Garriga-Canut M, 2012, P NATL ACAD SCI USA, V109, pE3136, DOI 10.1073/pnas.1206506109; Gong B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041450; Gray M, 2008, J NEUROSCI, V28, P6182, DOI 10.1523/JNEUROSCI.0857-08.2008; Gutekunst CA, 1999, J NEUROSCI, V19, P2522; Hackam AS, 1998, J CELL BIOL, V141, P1097, DOI 10.1083/jcb.141.5.1097; Huang BY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134715; Jansen AHP, 2017, GLIA, V65, P50, DOI 10.1002/glia.23050; Jayaraman M, 2012, J MOL BIOL, V415, P881, DOI 10.1016/j.jmb.2011.12.010; Ko J, 2001, BRAIN RES BULL, V56, P319, DOI 10.1016/S0361-9230(01)00599-8; Kordasiewicz HB, 2012, NEURON, V74, P1031, DOI 10.1016/j.neuron.2012.05.009; Landles C, 2010, J BIOL CHEM, V285, P8808, DOI 10.1074/jbc.M109.075028; Lane A, 2003, CLIN CHEM, V49, P1774, DOI 10.1373/49.10.1774; Li H, 2001, J NEUROSCI, V21, P8473, DOI 10.1523/JNEUROSCI.21-21-08473.2001; Li SH, 1998, HUM MOL GENET, V7, P777, DOI 10.1093/hmg/7.5.777; Macdonald D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096854; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Massai L, 2013, BMC BIOCHEM, V14, DOI 10.1186/1471-2091-14-34; Matos CA, 2019, J NEUROCHEM, V148, P8, DOI 10.1111/jnc.14541; Menalled LB, 2003, J COMP NEUROL, V465, P11, DOI 10.1002/cne.10776; Menalled L, 2009, NEUROBIOL DIS, V35, P319, DOI 10.1016/j.nbd.2009.05.007; Menalled LB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049838; Murphy MP, 2010, J ALZHEIMERS DIS, V19, P311, DOI [10.3233/JAD-2009-1221, 10.3233/JAD-2010-1221]; Nagai Y, 2000, J BIOL CHEM, V275, P10437, DOI 10.1074/jbc.275.14.10437; Neueder A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01510-z; Popiel H. A., 2011, J AMINO ACIDS, V2011, DOI DOI 10.4061/2011/265084; REINER A, 1988, P NATL ACAD SCI USA, V85, P5733, DOI 10.1073/pnas.85.15.5733; Sathasivam K, 2001, HUM MOL GENET, V10, P2425, DOI 10.1093/hmg/10.21.2425; Sathasivam K, 2013, P NATL ACAD SCI USA, V110, P2366, DOI 10.1073/pnas.1221891110; Sathasivam K, 2010, HUM MOL GENET, V19, P65, DOI 10.1093/hmg/ddp467; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Stanek LM, 2014, HUM GENE THER, V25, P461, DOI 10.1089/hum.2013.200; Vonsattel JPG, 1998, J NEUROPATH EXP NEUR, V57, P369; Walker FO, 2007, LANCET, V369, P218, DOI 10.1016/S0140-6736(07)60111-1; Weiss A, 2008, J NEUROCHEM, V104, P846, DOI 10.1111/j.1471-4159.2007.05032.x; Weiss A, 2011, ANAL BIOCHEM, V410, P304, DOI 10.1016/j.ab.2010.11.044; Weiss A, 2009, ANAL BIOCHEM, V395, P8, DOI 10.1016/j.ab.2009.08.001; Wild EJ, 2015, J CLIN INVEST, V125, P1979, DOI 10.1172/JCI80743; Wilson SM, 2013, Patent US, Patent No. [8,383,617, 8383617]; Yamamoto A, 2000, CELL, V101, P57, DOI 10.1016/S0092-8674(00)80623-6; Yu DB, 2012, CELL, V150, P895, DOI 10.1016/j.cell.2012.08.002; Zeitler BJ, 2019, NAT MED; Zuccato C, 2010, PHYSIOL REV, V90, P905, DOI 10.1152/physrev.00041.2009	46	27	27	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2019	14	3							e0213521	10.1371/journal.pone.0213521	http://dx.doi.org/10.1371/journal.pone.0213521			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ3IW	30913220	Green Published, gold, Green Submitted			2022-12-26	WOS:000462305600015
J	Luhr, M; Torgersen, ML; Szalai, P; Hashim, A; Brech, A; Staerk, J; Engedal, N				Luhr, Morten; Torgersen, Maria Lyngaas; Szalai, Paula; Hashim, Adnan; Brech, Andreas; Staerk, Judith; Engedal, Nikolai			The kinase PERK and the transcription factor ATF4 play distinct and essential roles in autophagy resulting from tunicamycin-induced ER stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						autophagy; endoplasmic reticulum stress (ER stress); unfolded protein response (UPR); protein degradation; signal transduction; activating transcription factor 4 (ATF4); autophagic sequestration; GABA type A receptor-associated protein (GABARAP); microtubule-associated protein 1 light chain 3 (LC3); pancreatic EIF2-kinase (PERK); tunicamycin (TM); inositol-requiring enzyme 1 (IRE1); autophagic degradation	ENDOPLASMIC-RETICULUM TURNOVER; UNFOLDED PROTEIN RESPONSE; INDUCED GENE-EXPRESSION; AMINO-ACID DEPRIVATION; ACTIVATES AUTOPHAGY; PROSTATE-CANCER; CELL-DEATH; NONSELECTIVE AUTOPHAGY; MONITORING AUTOPHAGY; DEGRADATION	Endoplasmic reticulum (ER) stress is thought to activate autophagy via unfolded protein response (UPR)-mediated transcriptional up-regulation of autophagy machinery components and modulation of microtubule-associated protein 1 light chain 3 (LC3). The upstream UPR constituents pancreatic EIF2- kinase (PERK) and inositol-requiring enzyme 1 (IRE1) have been reported to mediate these effects, suggesting that UPR may stimulate autophagy via PERK and IRE1. However, how the UPR and its components affect autophagic activity has not been thoroughly examined. By analyzing the flux of LC3 through the autophagic pathway, as well as the sequestration and degradation of autophagic cargo, we here conclusively show that the classical ER stressor tunicamycin (TM) enhances autophagic activity in mammalian cells. PERK and its downstream factor, activating transcription factor 4 (ATF4), were crucial for this induction, but surprisingly, IRE1 constitutively suppressed autophagic activity. TM-induced autophagy required autophagy-related 13 (ATG13), Unc-51-like autophagy-activating kinases 1/2 (ULK1/ULK2), and GABA type A receptor-associated proteins (GABARAPs), but interestingly, LC3 proteins appeared to be redundant. Strikingly, ATF4 was activated independently of PERK in both LNCaP and HeLa cells, and our further examination revealed that ATF4 and PERK regulated autophagy through separate mechanisms. Specifically, whereas ATF4 controlled transcription and was essential for autophagosome formation, PERK acted in a transcription-independent manner and was required at a post-sequestration step in the autophagic pathway. In conclusion, our results indicate that TM-induced UPR activates functional autophagy, and whereas IRE1 is a negative regulator, PERK and ATF4 are required at distinct steps in the autophagic pathway.	[Luhr, Morten; Szalai, Paula; Hashim, Adnan; Staerk, Judith; Engedal, Nikolai] Univ Oslo, Ctr Mol Med Norway NCMM, Nord EMBL Partnership Mol Med, POB 1137 Blindern, N-0318 Oslo, Norway; [Torgersen, Maria Lyngaas; Brech, Andreas] Oslo Univ Hosp, Inst Canc Res, Dept Mol Cell Biol, N-0379 Oslo, Norway; [Brech, Andreas] Univ Oslo, CanCell, N-0310 Oslo, Norway; [Brech, Andreas] Univ Oslo, Dept Biosci, N-0310 Oslo, Norway; [Engedal, Nikolai] Oslo Univ Hosp, Dept Haematol, N-0372 Oslo, Norway; [Engedal, Nikolai] Oslo Univ Hosp, Norwegian Ctr Stem Cell Res, Dept Immunol, N-0372 Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo	Engedal, N (corresponding author), Univ Oslo, Ctr Mol Med Norway NCMM, Nord EMBL Partnership Mol Med, POB 1137 Blindern, N-0318 Oslo, Norway.	nikolai.engedal@ncmm.uio.no	Torgersen, Maria Lyngaas L/F-3492-2017; Engedal, Nikolai/AAJ-8951-2020; Hashim, Adnan/Y-8924-2019; Lindner, Paula/S-6929-2019	Torgersen, Maria Lyngaas L/0000-0003-2616-7194; Engedal, Nikolai/0000-0003-3718-3464; Lindner, Paula/0000-0003-0734-6429; Staerk, Judith/0000-0001-8698-6998; Brech, Andreas/0000-0002-9803-1774	Research Council of Norway [230686]; University of Oslo; Nansen Foundation; Anders Jahre Foundation; Legacy in memory of Henrik Homan	Research Council of Norway(Research Council of Norway); University of Oslo; Nansen Foundation; Anders Jahre Foundation; Legacy in memory of Henrik Homan	This work was supported by grants from the Research Council of Norway (Project 230686) and the University of Oslo, the Nansen Foundation, the Anders Jahre Foundation, and the Legacy in memory of Henrik Homan (to N. E.). The authors declare that they have no conflicts of interest with the contents of this article.	An H, 2018, NAT CELL BIOL, V20, P135, DOI 10.1038/s41556-017-0007-x; Armstrong JL, 2010, J BIOL CHEM, V285, P6091, DOI 10.1074/jbc.M109.014092; Axten JM, 2017, EXPERT OPIN THER PAT, V27, P37, DOI 10.1080/13543776.2017.1238072; B'chir W, 2013, NUCLEIC ACIDS RES, V41, P7683, DOI 10.1093/nar/gkt563; Bauvy C, 2009, METHOD ENZYMOL, V452, P47, DOI 10.1016/S0076-6879(08)03604-5; Bento CF, 2016, ANNU REV BIOCHEM, V85, P685, DOI 10.1146/annurev-biochem-060815-014556; Bernales S, 2006, PLOS BIOL, V4, P2311, DOI 10.1371/journal.pbio.0040423; Bestebroer J, 2013, TRAFFIC, V14, P1029, DOI 10.1111/tra.12091; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; Cadwell K, 2018, J CELL BIOL, V217, P813, DOI 10.1083/jcb.201706157; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Carson JP, 1999, CANCER RES, V59, P1449; Castillo K, 2011, EMBO J, V30, P4465, DOI 10.1038/emboj.2011.318; Chen SL, 2018, P NATL ACAD SCI USA, V115, pE6237, DOI 10.1073/pnas.1805032115; DATEMA R, 1978, EUR J BIOCHEM, V90, P505, DOI 10.1111/j.1432-1033.1978.tb12630.x; Donoso G, 2005, BIOCHEM J, V387, P897, DOI 10.1042/BJ20041312; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; ELBEIN AD, 1990, J BIOL CHEM, V265, P15599; Engedal N, 2016, AUTOPHAGY, V12, P439, DOI 10.1080/15548627.2015.1076606; Engedal N, 2013, AUTOPHAGY, V9, P1475, DOI 10.4161/auto.25900; Moruno-Manchon JF, 2013, BIOCHEM J, V449, P497, DOI 10.1042/BJ20121122; Fiebiger E, 2004, MOL BIOL CELL, V15, P1635, DOI 10.1091/mbc.E03-07-0506; Fuertes G, 2003, BIOCHEM J, V375, P75, DOI 10.1042/BJ20030282; Fumagalli F, 2016, NAT CELL BIOL, V18, P1173, DOI 10.1038/ncb3423; Fusakio ME, 2016, MOL BIOL CELL, V27, P1536, DOI 10.1091/mbc.E16-01-0039; Garcia-Navas R, 2012, AUTOPHAGY, V8, P1557, DOI 10.4161/auto.21315; Grumati P, 2017, ELIFE, V6, DOI 10.7554/eLife.25555; Hanson HH, 2010, J BIOL CHEM, V285, P20982, DOI 10.1074/jbc.M109.092031; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hart LS, 2012, J CLIN INVEST, V122, P4621, DOI 10.1172/JCI62973; HEIFETZ A, 1979, BIOCHEMISTRY-US, V18, P2186, DOI 10.1021/bi00578a008; Hetz C, 2018, MOL CELL, V69, P169, DOI 10.1016/j.molcel.2017.06.017; Hetz C, 2009, GENE DEV, V23, P2294, DOI 10.1101/gad.1830709; Itkonen HM, 2015, ONCOGENE, V34, P3744, DOI 10.1038/onc.2014.307; Itoh T, 2011, J CELL BIOL, V192, P839, DOI 10.1083/jcb.201008107; Jin HO, 2009, FREE RADICAL BIO MED, V46, P1158, DOI 10.1016/j.freeradbiomed.2009.01.015; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kaufman DR, 2017, MOL BIOL CELL, V28, P1636, DOI 10.1091/mbc.E16-12-0828; Khaminets A, 2015, NATURE, V522, P354, DOI 10.1038/nature14498; Kim KW, 2010, ONCOGENE, V29, P3241, DOI 10.1038/onc.2010.74; Kjos I, 2017, EMBO REP, V18, P1727, DOI 10.15252/embr.201744069; Klionsky DJ, 2007, AUTOPHAGY, V3, P181, DOI 10.4161/auto.3678; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; KOPITZ J, 1990, J CELL BIOL, V111, P941, DOI 10.1083/jcb.111.3.941; Kouroku Y, 2007, CELL DEATH DIFFER, V14, P230, DOI 10.1038/sj.cdd.4401984; Kurtoglu M, 2007, MOL CANCER THER, V6, P3049, DOI 10.1158/1535-7163.MCT-07-0310; Lee H, 2012, HUM MOL GENET, V21, P101, DOI 10.1093/hmg/ddr445; Li WM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01609-x; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lipatova Z, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005390; Lipatova Z, 2013, MOL BIOL CELL, V24, P3133, DOI 10.1091/mbc.E13-05-0269; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luhr M, 2017, METHOD ENZYMOL, V587, P351, DOI 10.1016/bs.mie.2016.09.064; Luhr M, 2018, BIO-PROTOCOL, V8, DOI 10.21769/BioProtoc.2836; Luhr M, 2018, JOVE-J VIS EXP, DOI 10.3791/57971; Mancini R, 2003, J BIOL CHEM, V278, P46895, DOI 10.1074/jbc.M302979200; Margariti A, 2013, J BIOL CHEM, V288, P859, DOI 10.1074/jbc.M112.412783; Mauthe M, 2018, AUTOPHAGY, V14, P1435, DOI 10.1080/15548627.2018.1474314; Mochida K, 2015, NATURE, V522, P359, DOI 10.1038/nature14506; Moretti J, 2017, CELL, V171, P809, DOI 10.1016/j.cell.2017.09.034; Doan NTQ, 2015, STEROIDS, V97, P2, DOI 10.1016/j.steroids.2014.07.009; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Munoz JP, 2013, EMBO J, V32, P2348, DOI 10.1038/emboj.2013.168; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pankiv S, 2010, J CELL BIOL, V188, P253, DOI 10.1083/jcb.200907015; Pattingre S, 2004, METHOD ENZYMOL, V390, P17; Pattingre S, 2009, J BIOL CHEM, V284, P2719, DOI 10.1074/jbc.M805920200; PFEIFER U, 1978, J CELL BIOL, V78, P152, DOI 10.1083/jcb.78.1.152; Pike LRG, 2013, BIOCHEM J, V449, P389, DOI 10.1042/BJ20120972; PLOMP PJAM, 1987, EUR J BIOCHEM, V164, P197, DOI 10.1111/j.1432-1033.1987.tb11011.x; Qin L, 2010, AUTOPHAGY, V6, P239, DOI 10.4161/auto.6.2.11062; Qiu W, 2011, HEPATOLOGY, V53, P1515, DOI 10.1002/hep.24269; Ramkumar A, 2017, AUTOPHAGY, V13, P1331, DOI 10.1080/15548627.2017.1327509; Rogov V, 2014, MOL CELL, V53, P167, DOI 10.1016/j.molcel.2013.12.014; Rouschop KMA, 2010, J CLIN INVEST, V120, P127, DOI 10.1172/JCI40027; Rzymski T, 2010, ONCOGENE, V29, P4424, DOI 10.1038/onc.2010.191; Saetre F, 2015, FEBS J, V282, P2202, DOI 10.1111/febs.13268; Sakaki K, 2008, J BIOL CHEM, V283, P15370, DOI 10.1074/jbc.M710209200; Schuck S, 2014, J CELL SCI, V127, P4078, DOI 10.1242/jcs.154716; SCHWORER CM, 1981, J BIOL CHEM, V256, P7652; Seglen PO, 2015, METHODS, V75, P25, DOI 10.1016/j.ymeth.2014.12.021; Sehgal P, 2017, J BIOL CHEM, V292, P19656, DOI 10.1074/jbc.M117.796920; Sharma M, 2017, J GEN VIROL, V98, P1027, DOI 10.1099/jgv.0.000792; Shenkman M, 2007, CELL STRESS CHAPERON, V12, P373, DOI 10.1379/CSC-281.1; Shimodaira Y, 2014, BIOCHEM BIOPH RES CO, V445, P524, DOI 10.1016/j.bbrc.2014.02.054; Smith MD, 2018, DEV CELL, V44, P217, DOI 10.1016/j.devcel.2017.11.024; Subramani S, 2013, EMBO REP, V14, P143, DOI 10.1038/embor.2012.220; Suzuki J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5153; Szalai P, 2018, BIO-PROTOCOL, V8, DOI 10.21769/BioProtoc.2835; Szalai P, 2015, EXP CELL RES, V333, P21, DOI 10.1016/j.yexcr.2015.02.003; Nguyen TN, 2016, J CELL BIOL, V215, P857, DOI 10.1083/jcb.201607039; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Tsubuki S, 1996, J BIOCHEM-TOKYO, V119, P572, DOI 10.1093/oxfordjournals.jbchem.a021280; Vaites LP, 2018, MOL CELL BIOL, V38, DOI 10.1128/MCB.00392-17; van Vliet AR, 2017, MOL CELL, V65, P885, DOI 10.1016/j.molcel.2017.01.020; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Verfaillie T, 2012, CELL DEATH DIFFER, V19, P1880, DOI 10.1038/cdd.2012.74; Vlietstra RJ, 1998, CANCER RES, V58, P2720; Wang J, 2014, AUTOPHAGY, V10, P766, DOI 10.4161/auto.27954; Weidberg H, 2010, EMBO J, V29, P1792, DOI 10.1038/emboj.2010.74; Xi HB, 2014, IUBMB LIFE, V66, P110, DOI 10.1002/iub.1251; Xi HB, 2011, CANCER CHEMOTH PHARM, V67, P899, DOI 10.1007/s00280-010-1391-0; Yorimitsu T, 2006, J BIOL CHEM, V281, P30299, DOI 10.1074/jbc.M607007200; Zhou CH, 2012, AUTOPHAGY, V8, P1215, DOI 10.4161/auto.20284	106	69	71	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2019	294	20					8197	8217		10.1074/jbc.RA118.002829	http://dx.doi.org/10.1074/jbc.RA118.002829			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC0NH	30926605	Green Published, hybrid			2022-12-26	WOS:000470656500018
J	Vydyam, P; Dutta, D; Sutram, N; Bhattacharyya, S; Bhattacharyya, MK				Vydyam, Pratap; Dutta, Dibyendu; Sutram, Niranjan; Bhattacharyya, Sunanda; Bhattacharyya, Mrinal Kanti			A small-molecule inhibitor of the DNA recombinase Rad51 from Plasmodium falciparum synergizes with the antimalarial drugs artemisinin and chloroquine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						plasmodium; DNA repair; homologous recombination; drug screening; malaria; artemisinin; B02; comet assay; PfRad51; small-molecule inhibitor	DISRUPTS HOMOLOGOUS RECOMBINATION; ATP HYDROLYSIS; CRYSTAL-STRUCTURE; MAMMALIAN RAD51; PROTEIN; IDENTIFICATION; DAMAGE; REPLICATION; MECHANISM; ACCURACY	Malaria parasites repair DNA double-strand breaks (DSBs) primarily through homologous recombination (HR). Here, because the unrepaired DSBs lead to the death of the unicellular parasite Plasmodium falciparum, we investigated its recombinase, PfRad51, as a potential drug target. Undertaking an in silico screening approach, we identified a compound, B02, that docks to the predicted tertiary structure of PfRad51 with high affinity. B02 inhibited a drug-sensitive P. falciparum strain (3D7) and multidrug-resistant parasite (Dd2) in culture, with IC50 values of 8 and 3 m, respectively. We found that B02 is more potent against these P. falciparum strains than against mammalian cell lines. Our findings also revealed that the antimalarial activity of B02 synergizes with those of two first-line malaria drugs, artemisinin (ART) and chloroquine (CQ), lowering the IC50 values of ART and CQ by 15- and 8-fold, respectively. Our results also provide mechanistic insights into the anti-parasitic activity of B02, indicating that it blocks the ATPase and strand-exchange activities of PfRad51 and abrogates the formation of PfRad51 foci on damaged DNA at chromosomal sites, probably by blocking homomeric interactions of PfRad51 proteins. The B02-mediated PfRad51 disruption led to the accumulation of unrepaired parasitic DNA and rendered parasites more sensitive to DNA-damaging agents, including ART. Our findings provide a rationale for targeting the Plasmodium DSB repair pathway in combination with ART. We propose that identification of a specific inhibitor of HR in Plasmodium may enable investigations of HR's role in Plasmodium biology, including generation of antigenic diversity.	[Vydyam, Pratap; Dutta, Dibyendu; Sutram, Niranjan; Bhattacharyya, Mrinal Kanti] Univ Hyderabad, Dept Biochem, Sch Life Sci, Hyderabad 500046, TS, India; [Bhattacharyya, Sunanda] Univ Hyderabad, Dept Biotechnol & Bioinformat, Sch Life Sci, Hyderabad 500046, TS, India	University of Hyderabad; University of Hyderabad	Bhattacharyya, MK (corresponding author), Univ Hyderabad, Dept Biochem, Sch Life Sci, Hyderabad 500046, TS, India.	mkbsl@uohyd.ernet.in	Dutta, Dibyendu/O-6016-2019	Dutta, Dibyendu/0000-0003-1715-173X; Vydyam, Pratap/0000-0003-4944-6006	Department of Science and Technology-FIST; University Grant Commission-SAP	Department of Science and Technology-FIST(Department of Science & Technology (India)); University Grant Commission-SAP	Support from Department of Science and Technology-FIST and University Grant Commission-SAP to the Department of Biochemistry is acknowledged. Computational work incorporated in the paper was carried out at the Department of Biotechnology and funded the Bioinformatics Infrastructure Facility, University of Hyderabad. We thank Mrinnanda Bhattacharya for line editing of the manuscript.	Achanta SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041925; Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876; Badugu SB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125358; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bhattacharyya MK, 2005, MOL BIOCHEM PARASIT, V139, P33, DOI 10.1016/j.molbiopara.2004.09.007; Bhattacharyya MK, 2003, INT J PARASITOL, V33, P1385, DOI 10.1016/S0020-7519(03)00212-1; Bhattacharyya MK, 2004, INFECT GENET EVOL, V4, P91, DOI 10.1016/j.meegid.2004.01.008; Breitinger H-G., 2012, DRUG SYNERGY MECH ME, DOI [10.5772/30922, DOI 10.5772/30922]; Budke B, 2013, J MED CHEM, V56, P254, DOI 10.1021/jm301565b; Budke B, 2012, NUCLEIC ACIDS RES, V40, P7347, DOI 10.1093/nar/gks353; Chalapareddy S, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00025-15; Chalapareddy S, 2014, ANTIMICROB AGENTS CH, V58, P4341, DOI 10.1128/AAC.02519-13; Chang YW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004890; Chen J, 2010, NUCLEIC ACIDS RES, V38, P4889, DOI 10.1093/nar/gkq209; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chi P, 2006, DNA REPAIR, V5, P381, DOI 10.1016/j.dnarep.2005.11.005; Conway AB, 2004, NAT STRUCT MOL BIOL, V11, P791, DOI 10.1038/nsmb795; Fivelman QL, 2004, ANTIMICROB AGENTS CH, V48, P4097, DOI 10.1128/AAC.48.11.4097-4102.2004; FRANKENBERGSCHWAGER M, 1990, INT J RADIAT BIOL, V58, P569, DOI 10.1080/09553009014551931; Gopalakrishnan AM, 2015, ANTIMICROB AGENTS CH, V59, P317, DOI 10.1128/AAC.03663-14; Gopalakrishnan AM, 2013, MBIO, V4, DOI 10.1128/mBio.00252-13; Graves AP, 2008, J MOL BIOL, V377, P914, DOI 10.1016/j.jmb.2008.01.049; Gupta DK, 2016, SCI REP-UK, V6, DOI 10.1038/srep23603; HAAF T, 1995, P NATL ACAD SCI USA, V92, P2298, DOI 10.1073/pnas.92.6.2298; Huang F, 2011, ACS CHEM BIOL, V6, P628, DOI 10.1021/cb100428c; Irwin JJ, 2012, J CHEM INF MODEL, V52, P1757, DOI 10.1021/ci3001277; Klonis N, 2013, CURR OPIN MICROBIOL, V16, P722, DOI 10.1016/j.mib.2013.07.005; Kokabu Y, 2013, BIOPHYS J, V104, P1556, DOI 10.1016/j.bpj.2013.02.014; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; Lang PT, 2009, RNA, V15, P1219, DOI 10.1261/rna.1563609; Miotto O, 2015, NAT GENET, V47, P226, DOI 10.1038/ng.3189; Mitra P, 2015, BIOCHEM J, V470, P115, DOI 10.1042/BJ20150452; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Normand A, 2014, BIOCHEM PHARMACOL, V91, P293, DOI 10.1016/j.bcp.2014.07.033; Roy N, 2014, MOL MICROBIOL, V94, P353, DOI 10.1111/mmi.12762; Schrodinger L.L.C.,, 2015, PYMOL MOL GRAPHICS S; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Shin DS, 2003, EMBO J, V22, P4566, DOI 10.1093/emboj/cdg429; Stark JM, 2002, J BIOL CHEM, V277, P20185, DOI 10.1074/jbc.M112132200; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; Tallarida RJ, 2006, J PHARMACOL EXP THER, V319, P1, DOI 10.1124/jpet.106.104117; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Webb B., 2014, CURR PROTOC BIOINFOR, V5.6, P32, DOI [10.1002/0471250953.bi0506s47, DOI 10.1002/0471250953.BI0506S47]; WHO, 2015, WORLD MAL REP 2015; Wu Y, 2005, J BIOL CHEM, V280, P722, DOI 10.1074/jbc.M411093200; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213	47	14	14	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2019	294	20					8171	8183		10.1074/jbc.RA118.005009	http://dx.doi.org/10.1074/jbc.RA118.005009			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC0NH	30936202	Green Published, hybrid			2022-12-26	WOS:000470656500016
J	Huang, X; Swanson, R; Kroh, HK; Bock, PE				Huang, Xin; Swanson, Richard; Kroh, Heather K.; Bock, Paul E.			Protein Z-dependent protease inhibitor (ZPI) is a physiologically significant inhibitor of prothrombinase function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						coagulation factor; serpin; prothrombin; protease inhibitor; protease; factor Va; factor Xa; protein Z; protein Z-dependent protease inhibitor; prothrombinase	FACTOR PATHWAY INHIBITOR; C-MEDIATED CLEAVAGES; FACTOR-XA; FACTOR-V; KINETIC CHARACTERIZATION; EXTRINSIC PATHWAY; ACTIVE-SITE; BLOOD; ANTITHROMBIN; ACTIVATION	Current thought holds that factor Xa (FXa) bound in the prothrombinase complex is resistant to regulation by protein protease inhibitors during prothrombin activation. Here we provide evidence that, contrary to this view, the FXa-specific serpin inhibitor, protein Z-dependent protease inhibitor (ZPI), complexed with its cofactor, protein Z (PZ), functions as a physiologically significant inhibitor of prothrombinase-bound FXa during prothrombin activation. Kinetics studies showed that the rapid rate of inhibition of FXa by the ZPI-PZ complex on procoagulant membrane vesicles (k(a(app)) approximate to 10(7) m(-1) s(-1)) was decreased approximate to 10-fold when FXa was bound to FVa in prothrombinase and a further approximate to 3-4-fold when plasma levels of S195A prothrombin were present (k(a(app)) 2 x 10(5) m(-1) s(-1)). Nevertheless, the ZPI-PZ complex produced a major inhibition of thrombin generation during prothrombinase-catalyzed activation of prothrombin under physiologically relevant conditions. The importance of ZPI-PZ complex anticoagulant regulation of FXa both before and after incorporation into prothrombinase was supported by thrombin generation assays in plasma. These showed enhanced thrombin generation when the inhibitor was neutralized with a PZ-specific antibody and decreased thrombin generation when exogenous ZPI-PZ complex was added whether prothrombin was activated directly by FXa or through extrinsic or intrinsic pathway activators. Moreover, the PZ antibody enhanced thrombin generation both in the absence and presence of activated protein C (APC) anticoagulant activity. Taken together, these results suggest an important anticoagulant role for the ZPI-PZ complex in regulating both free FXa generated in the initiation phase of coagulation as well as prothrombinase-bound FXa in the propagation phase that complement prothrombinase regulation by APC.	[Huang, Xin; Swanson, Richard] Univ Illinois, Dept Periodont, Chicago, IL 60612 USA; [Kroh, Heather K.; Bock, Paul E.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Vanderbilt University	Huang, X (corresponding author), 801 S Paulina St, Chicago, IL 60612 USA.	xinhuang@uic.edu		Huang, Xin/0000-0002-4730-9318	American Heart Association Scientist Development [SDG 48880022]; National Institutes of Health [R37 HL39888, R01 HL38779]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL039888] Funding Source: NIH RePORTER	American Heart Association Scientist Development(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by American Heart Association Scientist Development Grant SDG 48880022 (to X. H.) and National Institutes of Health Grants R37 HL39888 (to Drs. Steven Olson and X. H.) and R01 HL38779 (to P. E. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anderson PJ, 2000, J BIOL CHEM, V275, P16435, DOI 10.1074/jbc.M001255200; Bafunno V, 2011, THROMB RES, V128, P508, DOI 10.1016/j.thromres.2011.08.007; Bolkun L, 2013, THROMB RES, V131, pE110, DOI 10.1016/j.thromres.2012.11.031; BROZE GJ, 1984, J CLIN INVEST, V73, P933, DOI 10.1172/JCI111317; Brufatto N, 2001, J BIOL CHEM, V276, P17663, DOI 10.1074/jbc.M011586200; Clark SR, 2013, P NATL ACAD SCI USA, V110, P5875, DOI 10.1073/pnas.1222419110; CONARD J, 1983, HAEMOSTASIS, V13, P363; Cui JS, 2000, BLOOD, V96, P4222, DOI 10.1182/blood.V96.13.4222.h8004222_4222_4226; Dentali F, 2008, BRIT J HAEMATOL, V143, P284, DOI 10.1111/j.1365-2141.2008.07331.x; Escriba PV, 2008, J CELL MOL MED, V12, P829, DOI 10.1111/j.1582-4934.2008.00281.x; Girard TJ, 2019, J THROMB HAEMOST, V17, P149, DOI 10.1111/jth.14337; GRUBER A, 1992, BLOOD, V79, P2340; Han X, 1999, BIOCHEMISTRY-US, V38, P11073, DOI 10.1021/bi990641a; Han X, 2000, BLOOD, V96, P3049; Han X, 1998, P NATL ACAD SCI USA, V95, P9250, DOI 10.1073/pnas.95.16.9250; Hille ETM, 1997, BLOOD, V89, P1963, DOI 10.1182/blood.V89.6.1963; Hockin MF, 2002, J BIOL CHEM, V277, P18322, DOI 10.1074/jbc.M201173200; Huang X, 2008, J BIOL CHEM, V283, P29770, DOI 10.1074/jbc.M805214200; Huang X, 2017, J BIOL CHEM, V292, P14625, DOI 10.1074/jbc.M117.793901; Huang X, 2015, J BIOL CHEM, V290, P9906, DOI 10.1074/jbc.M114.633479; Huang X, 2010, J BIOL CHEM, V285, P20399, DOI 10.1074/jbc.M110.112748; Johnson DJD, 2006, EMBO J, V25, P2029, DOI 10.1038/sj.emboj.7601089; Kemkes-Matthes B, 2002, THROMB RES, V106, P183, DOI 10.1016/S0049-3848(02)00181-0; Krishnaswamy S, 1997, BIOCHEMISTRY-US, V36, P12080, DOI 10.1021/bi970979+; KRISHNASWAMY S, 1988, J BIOL CHEM, V263, P3823; KRISHNASWAMY S, 1987, J BIOL CHEM, V262, P3291; Kroh HK, 2011, J BIOL CHEM, V286, P23345, DOI 10.1074/jbc.M111.230292; LAWSON JH, 1991, J BIOL CHEM, V266, P11317; Lechtenberg BC, 2013, BLOOD, V122, P2777, DOI 10.1182/blood-2013-06-511733; LINDHOUT T, 1986, BIOCHEMISTRY-US, V25, P5962, DOI 10.1021/bi00368a019; Lu G, 2004, J BIOL CHEM, V279, P17241, DOI 10.1074/jbc.M312827200; MANN KG, 1992, SEMIN HEMATOL, V29, P213; MARCUM JA, 1986, J BIOL CHEM, V261, P7507; Mast AE, 1996, BLOOD, V87, P1845; MILETICH JP, 1987, BLOOD, V69, P1580; Newell-Caito JL, 2011, J BIOL CHEM, V286, P38286, DOI 10.1074/jbc.M111.247122; Norstrom EA, 2006, J BIOL CHEM, V281, P31486, DOI 10.1074/jbc.M606441200; OLSON ST, 1993, METHOD ENZYMOL, V222, P525; Rand MD, 1996, BLOOD, V88, P3432, DOI 10.1182/blood.V88.9.3432.bloodjournal8893432; Rezaie AR, 2005, J BIOL CHEM, V280, P32722, DOI 10.1074/jbc.M505517200; ROSING J, 1995, J BIOL CHEM, V270, P27852, DOI 10.1074/jbc.270.46.27852; Sengupta T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161896; SILVERBERG SA, 1977, J BIOL CHEM, V252, P8481; Smirnov MD, 1999, BLOOD, V94, P3839, DOI 10.1182/blood.V94.11.3839.423k07_3839_3846; Tabatabai A, 2001, THROMB HAEMOSTASIS, V85, P655, DOI 10.1055/s-0037-1615649; Tran S, 2008, J BIOL CHEM, V283, P6648, DOI 10.1074/jbc.M708036200; VANDIEIJEN G, 1981, J BIOL CHEM, V256, P3433; Yin ZF, 2000, P NATL ACAD SCI USA, V97, P6734, DOI 10.1073/pnas.120081897; Zhang J, 2008, BLOOD, V111, P4973, DOI 10.1182/blood-2007-12-126391	49	10	10	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2019	294	19					7644	7657		10.1074/jbc.RA118.006787	http://dx.doi.org/10.1074/jbc.RA118.006787			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IB3FL	30918026	Green Published, hybrid			2022-12-26	WOS:000470153300011
J	Maenetje, P; Lindan, C; Makkan, H; Chetty-Makkan, CM; Latka, MH; Charalambous, S; Mlotshwa, M; Malefo, M; Brumskine, W; Hills, NK; Price, MA; Edward, V				Maenetje, Pholo; Lindan, Christina; Makkan, Heeran; Chetty-Makkan, Candice M.; Latka, Mary H.; Charalambous, Salome; Mlotshwa, Mandla; Malefo, Matshidiso; Brumskine, William; Hills, Nancy K.; Price, Matthew A.; Edward, Vinodh			HIV incidence and predictors of inconsistent condom use among adult men enrolled into an HIV vaccine preparedness study, Rustenburg, South Africa	PLOS ONE			English	Article							SEXUAL-BEHAVIOR; RISK; ADOLESCENTS; POPULATION; PREVALENCE; INFECTION; COMMUNITY; COHORT	Introduction Understanding HIV incidence and risk behaviour among populations being considered for HIV vaccine studies is necessary for the appropriate design of trials. Methods Between May 2012 and June 2015, we recruited men aged 18-49 years from urban and peri-urban areas of Rustenburg, a mining town in the North West Province, South Africa. Men who reported HIV-risk behaviour were followed for nine to 12 months to determine HIV incidence and factors associated with condom use. Results A total of 400 HIV uninfected men were enrolled; 366 (91.5%) had at least one follow-up visit and were included in the analysis; 47.6% were under 25 years of age. HIV incidence was 1.9 per 100 person-years (95% CI: 0.79-4.56). Among heterosexual men (N = 339), 80.8% reported having vaginal intercourse with multiple partners in the past three months, among whom 74.1% reported inconsistent condom use. Sixty-eight percent reported vaginal intercourse with new female partners, of whom 40.6% reported inconsistent condom use. Over half (55.6%) of men who had sex with men (N = 27) reported anal intercourse with multiple male partners in the past three months, of whom 68.2% reported using condoms inconsistently. Men who had more than two female partners in the last three months (n = 121) were more likely to use condoms inconsistently (aOR 4.31, 95% CI: 1.34-13.8); in contrast, those with more than one new female sex partner (aOR 0.13, 94% CI 0.04-0.44), and whose sexual debut was after 19 years of age (aOR 0.39, 95% CI: 0.15-1.01) were less likely to use condoms inconsistently. Conclusion HIV incidence was low and similar to other studies of heterosexual men in South Africa. To identify men at high risk for HIV for enrolment in prevention trials, future researchers may need to focus on those who report early sexual debut and who report having multiple sexual partners. Men in newer relationships appear to use condoms more frequently.	[Maenetje, Pholo; Makkan, Heeran; Chetty-Makkan, Candice M.; Latka, Mary H.; Charalambous, Salome; Mlotshwa, Mandla; Malefo, Matshidiso; Brumskine, William; Edward, Vinodh] Aurum Inst, Johannesburg, South Africa; [Maenetje, Pholo; Charalambous, Salome; Mlotshwa, Mandla; Edward, Vinodh] South African Med Res Council, Collaborating Ctr, Adv Care & Treatment TB HIV, Johannesburg, South Africa; [Maenetje, Pholo; Mlotshwa, Mandla; Edward, Vinodh] Univ Witwatersrand, Sch Pathol, Fac Hlth Sci, Johannesburg, South Africa; [Lindan, Christina; Hills, Nancy K.; Price, Matthew A.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Charalambous, Salome] Univ Witwatersrand, Sch Publ Hlth, Fac Hlth Sci, Johannesburg, South Africa; [Price, Matthew A.] Int AIDS Vaccine Initiat, New York, NY USA	South African Medical Research Council; University of Witwatersrand; University of California System; University of California San Francisco; University of Witwatersrand; International AIDS Vaccine Initiative	Maenetje, P (corresponding author), Aurum Inst, Johannesburg, South Africa.; Maenetje, P (corresponding author), South African Med Res Council, Collaborating Ctr, Adv Care & Treatment TB HIV, Johannesburg, South Africa.; Maenetje, P (corresponding author), Univ Witwatersrand, Sch Pathol, Fac Hlth Sci, Johannesburg, South Africa.	pmaenetje@auruminstitute.org	Price, Matt/AAK-6881-2021; Makkan, Heeran/GXI-0465-2022	Price, Matt/0000-0002-2918-1373; Charalambous, Salome/0000-0001-7143-1009; Maenetje, Pholo/0000-0001-6063-4353; Brumskine, William/0000-0002-1092-9919; Makkan, Heeran/0000-0002-4737-7804	US Agency for International Development (USAID) [GPO-A-00-05-00022-00]; Contraceptive and Reproductive Health Technologies Research and Utilisation (CRTU) Program; University of California; San Francisco's International Traineeships in AIDS Prevention Studies (ITAPS); U.S. NIMH [R25MH064712]; International AIDS Vaccine Initiative; NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH064712] Funding Source: NIH RePORTER	US Agency for International Development (USAID)(United States Agency for International Development (USAID)); Contraceptive and Reproductive Health Technologies Research and Utilisation (CRTU) Program; University of California(University of California System); San Francisco's International Traineeships in AIDS Prevention Studies (ITAPS); U.S. NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); International AIDS Vaccine Initiative; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was funded by the US Agency for International Development (USAID) under Cooperative Agreement No. GPO-A-00-05-00022-00 and the Contraceptive and Reproductive Health Technologies Research and Utilisation (CRTU) Program. The funders were involved in the study design of the protocols that were implemented at the site. The Aurum Institute conceptualized the idea for the manuscript and the funders provided technical guidance. We wish to acknowledge the support from the University of California, San Francisco's International Traineeships in AIDS Prevention Studies (ITAPS), U.S. NIMH, R25MH064712 and the International AIDS Vaccine Initiative.	Abaasa A, 2016, VACCINE, V34, P1778, DOI 10.1016/j.vaccine.2016.02.048; Baldwin Patrick, 2013, ISRN AIDS, V2013, P976035, DOI 10.1155/2013/976035; Barnighausen T, 2008, AIDS, V22, P139, DOI 10.1097/QAD.0b013e3282f2ef43; Bojanala Platinum District Municipality, 2017, FIN INT DEV PLAN 201; Cauchois, 2014, CONTRACEPTIVES PREDI, P157; Chamratrithirong A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042009; Fearon E, 2017, J INT AIDS SOC, V20, DOI 10.1002/jia2.25029; Feldblum PJ, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000626; Hargreaves JR, 2007, AIDS, V21, pS39, DOI 10.1097/01.aids.0000300534.97601.d6; Justman J, 2017, LANCET HIV, V4, pE83, DOI 10.1016/S2352-3018(16)30190-4; Kamali A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116100; KARIM QA, 1992, AIDS, V6, P1535, DOI 10.1097/00002030-199212000-00018; Karim QA, 2012, AIDS BEHAV, V16, P1870, DOI 10.1007/s10461-012-0209-y; KU L, 1994, FAM PLANN PERSPECT, V26, P246, DOI 10.2307/2135889; Lane T, 2016, JAIDS-J ACQ IMM DEF, V73, P609, DOI 10.1097/QAI.0000000000001162; McDougal JS, 2005, AIDS, V19, pS25, DOI 10.1097/01.aids.0000172874.90133.7a; Metch B, 2013, AIDS BEHAV, V17, P760, DOI 10.1007/s10461-012-0351-6; Metsch LR, 2013, JAMA-J AM MED ASSOC, V310, P1701, DOI 10.1001/jama.2013.280034; Morris L, 2014, AIDS CARE, V26, P1440, DOI 10.1080/09540121.2014.920948; Muchiri E, 2017, SOUTH AFR J INFECT D, V32, P105, DOI 10.1080/23120053.2017.1332800; National Department of health Republic of South Africa,, 2013, 2013 NAT ANT SENT HI; Ramjee G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153969; Ramjee G, 2012, AIDS BEHAV, V16, P2062, DOI 10.1007/s10461-011-0043-7; Ruzagira E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020684; Shai NJ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-462; Sherr L, 2007, AIDS, V21, P851, DOI 10.1097/QAD.0b013e32805e8711; Shisana O, 2014, S AFRICAN NATL HIV P; UNAIDS, 2017, DATA BOOK; UNAIDS, PREV GAP REP 2016; WHO, GUID START ANT THER	30	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0214786	10.1371/journal.pone.0214786	http://dx.doi.org/10.1371/journal.pone.0214786			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR5NS	30943254	Green Published, gold			2022-12-26	WOS:000463194300061
J	Amin, S; Rattner, J; Keramati, MR; Farshidfar, F; McNamara, MG; Knox, JJ; Kopciuk, K; Vogel, HJ; Bathe, OF				Amin, Shahil; Rattner, Jodi; Keramati, Mohammad Reza; Farshidfar, Farshad; McNamara, Mairead G.; Knox, Jennifer J.; Kopciuk, Karen; Vogel, Hans J.; Bathe, Oliver F.			A strategy for early detection of response to chemotherapy drugs based on treatment-related changes in the metabolome	PLOS ONE			English	Article							BEVACIZUMAB; THERAPY; RECIST	We describe a biomarker-based approach to delivering chemotherapy that entails monitoring treatment changes in the circulating metabolome that reflect efficacy. In-vitro, multiple tumor cell lines were exposed to numerous chemotherapeutics. Supernatants were collected at baseline and 72 hours post treatment. MTT assays were used to quantify growth inhibition. Clinical samples were derived from a phase II clinical trial of second-line axitinib in patients with advanced hepatocellular carcinoma. Sera were collected at baseline and 2-4 weeks after treatment initiation. Response to therapy was estimated by CT scan at 8 weeks. Samples were analyzed by gas chromatography-mass spectrometry to identify metabolomic changes associated with response. In vitro, we found drug-specific and generalizable patterns of change in the extracellular metabolome accompany growth inhibition. A cell death signature was also identified. This approach was also applied to clinical samples. While the in vitro signatures were detectable in vivo, a more robust signal was identified clinically that appeared within 4 weeks of administering drug that distinguished individuals with a treatment response. These changes were extinguished as tumor growth resumed. Serial monitoring of the metabolome during chemotherapy is a means to follow treatment efficacy and emergence of resistance, informing the oncologist whether to modify treatment.	[Amin, Shahil; Rattner, Jodi; Keramati, Mohammad Reza; Farshidfar, Farshad; Bathe, Oliver F.] Univ Calgary, Arnie Charbonneau Canc Inst, Calgary, AB, Canada; [Keramati, Mohammad Reza] Univ Tehran Med Sci, Dept Surg, Tehran, Iran; [McNamara, Mairead G.] Christie NHS Fdn Trust, Dept Med Oncol, Manchester, Lancs, England; [McNamara, Mairead G.] Univ Manchester, Div Canc Sci, Manchester, Lancs, England; [Knox, Jennifer J.] Princess Margaret Canc Ctr, Dept Oncol, Toronto, ON, Canada; [Knox, Jennifer J.] Univ Toronto, Toronto, ON, Canada; [Kopciuk, Karen] Univ Calgary, Dept Math & Biostat, Calgary, AB, Canada; [Vogel, Hans J.] Univ Calgary, Dept Biol Sci, Calgary, AB, Canada; [Bathe, Oliver F.] Univ Calgary, Dept Surg, Calgary, AB, Canada; [Bathe, Oliver F.] Univ Calgary, Dept Oncol, Calgary, AB, Canada	University of Calgary; Tehran University of Medical Sciences; Christie NHS Foundation Trust; University of Manchester; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University of Calgary; University of Calgary; University of Calgary; University of Calgary	Bathe, OF (corresponding author), Univ Calgary, Arnie Charbonneau Canc Inst, Calgary, AB, Canada.; Bathe, OF (corresponding author), Univ Calgary, Dept Surg, Calgary, AB, Canada.; Bathe, OF (corresponding author), Univ Calgary, Dept Oncol, Calgary, AB, Canada.	bathe@ucalgary.ca	Keramati, Mohammad Reza/B-4144-2013; Mcnamara, Mairead/J-1621-2015; Farshidfar, Farshad/B-7317-2008	Keramati, Mohammad Reza/0000-0003-0099-7114; Mcnamara, Mairead/0000-0002-2272-3678; Farshidfar, Farshad/0000-0003-3674-7336	Breast Cancer Society of Canada; Cancer Strategic Clinical Network (Alberta Health Services); Alberta Cancer Foundation	Breast Cancer Society of Canada; Cancer Strategic Clinical Network (Alberta Health Services); Alberta Cancer Foundation	OFB received funding for the study from the Breast Cancer Society of Canada (https://bcsc.ca/) and from the Cancer Strategic Clinical Network (Alberta Health Services). HJV was supported by the Alberta Cancer Foundation (https://www.albertacancer.ca/) and holds the Lance Armstrong Chair in Molecular Epidemiology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No grant numbers have been provided by the granting agencies.	Alonezi S, 2017, METABOLITES, V7, DOI 10.3390/metabo7020014; [Anonymous], NON TRADITIONAL REF, DOI [10.1186/1471-2407-12-39, DOI 10.1186/1471-2407-12-39]; Borgan E, 2013, MOL ONCOL, V7, P130, DOI 10.1016/j.molonc.2012.10.005; Cao MD, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-39; Choi H, 2007, J CLIN ONCOL, V25, P1753, DOI 10.1200/JCO.2006.07.3049; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Euceda LR, 2017, J PROTEOME RES, V16, P1868, DOI 10.1021/acs.jproteome.6b00918; Farshidfar F, 2012, GENOME MED, V4, DOI 10.1186/gm341; Huang G, 2014, EUR J PHARMACOL, V729, P132, DOI 10.1016/j.ejphar.2014.01.048; Jobard E, 2015, BRIT J CANCER, V113, P1148, DOI 10.1038/bjc.2015.322; Lastoria S, 2013, J NUCL MED, V54, P2062, DOI 10.2967/jnumed.113.119909; McNamara MG, 2015, CANCER-AM CANCER SOC, V121, P1620, DOI 10.1002/cncr.29227; McNamara MG, 2014, ANN M AM SOC CLIN ON, P39, DOI [10.1186/1471-2407-12-39, DOI 10.1186/1471-2407-12-39]; Morvan D, 2007, CANCER RES, V67, P2150, DOI 10.1158/0008-5472.CAN-06-2346; Pan D, 2016, INT J MOL SCI, P17; Tiziani S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1562; Weaver Z, 2012, CANCER RES, V72, P5921, DOI 10.1158/0008-5472.CAN-12-0736	17	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2019	14	4							e0213942	10.1371/journal.pone.0213942	http://dx.doi.org/10.1371/journal.pone.0213942			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR2UW	30939138	Green Published, Green Submitted, gold			2022-12-26	WOS:000462993900011
J	Jurga-Karwacka, A; Karwacki, GM; Schoetzau, A; Zech, CJ; Heinzelmann-Schwarz, V; Schwab, FD				Jurga-Karwacka, Agnieszka; Karwacki, Grzegorz M.; Schoetzau, Andreas; Zech, Christoph J.; Heinzelmann-Schwarz, Viola; Schwab, Fabienne D.			A forgotten disease: Pelvic congestion syndrome as a cause of chronic lower abdominal pain	PLOS ONE			English	Article							DIAGNOSIS; REFLUX; WOMEN; VEIN	Objectives Pelvic congestion syndrome is defined as chronic pelvic pain due to incompetent (dilated and refluxing) pelvic veins. The aim of this study was to investigate the prevalence of this condition by examining the prevalence of dilated ovarian and para-uterine veins in pre- and postmenopausal female patients, irrespective of their symptoms. We subsequently investigated how many women with dilated veins suffered from chronic pelvic pain. Additionally, we attempted to define diagnostic criteria that may allow for early identification of affected patients. Methods We reassessed 2384 abdomino-pelvic computed tomography scans performed on women at our institution. The maximal diameters of the ovarian and para-uterine veins were measured. Patients with a pathological process in the abdomen or pelvis affecting the veins were excluded. We considered ovarian vein dilation to be 6 mm or more in the axial plane. For patients that met these criteria, we performed a retrospective chart review to evaluate the clinical presentation and/or symptoms of these patients. Results Dilated pelvic veins were present in 293/2384 (12%) patients, 118/559 premenopausal (21%) and 175/1825 postmenopausal (10%). Chronic pelvic pain of unclear etiology had been documented prior to the CT in 54/293 (18%) women with dilated veins-2% of the whole study collective (54/2384); 8% of all premenopausal (44/559) and 0.5% of all postmenopausal (10/1825). It was often accompanied by urological symptoms such as hematuria, dysuria, and urinary frequency, in the absence of infection (p<0.05). We identified a strong correlation between the presence of dilated ovarian veins and chronic pelvic pain in premenopausal parous patients with hematuria. Conclusions Pelvic congestion syndrome appears to be an underdiagnosed and undertreated disease. In our study, 3% of all premenopausal women had documented chronic pelvic pain of unclear etiology and dilated ovarian and pelvic veins on cross-sectional imaging studies. The features we identified in this study as most relevant should enable a faster identification of patients who could benefit from a specific treatment regimen for this condition.	[Jurga-Karwacka, Agnieszka; Heinzelmann-Schwarz, Viola; Schwab, Fabienne D.] Univ Basel, Dept Gynecol & Gynecol Oncol, Univ Womens Hosp Basel, Basel, Switzerland; [Karwacki, Grzegorz M.; Zech, Christoph J.] Univ Basel, Clin Radiol & Nucl Med, Univ Basel Hosp, Basel, Switzerland; [Schoetzau, Andreas; Heinzelmann-Schwarz, Viola] Univ Basel, Dept Biomed, Ovarian Canc Res, Basel, Switzerland	University of Basel; University of Basel; University of Basel	Schwab, FD (corresponding author), Univ Basel, Dept Gynecol & Gynecol Oncol, Univ Womens Hosp Basel, Basel, Switzerland.	fabienne.schwab@usb.ch		Heinzelmann-Schwarz, Viola/0000-0002-4056-3225				Asciutto G, 2008, EUR J VASC ENDOVASC, V36, P491, DOI 10.1016/j.ejvs.2008.06.024; BEARD RW, 1988, BRIT J OBSTET GYNAEC, V95, P153, DOI 10.1111/j.1471-0528.1988.tb06845.x; BEARD RW, 1984, LANCET, V2, P946; BEINART C, 1982, RADIOLOGY, V145, P647, DOI 10.1148/radiology.145.3.7146391; Belenky A, 2002, AM J ROENTGENOL, V179, DOI 10.2214/ajr.179.3.1790625; Burak F, 2009, PHLEBOLYMPHOLOGY, V16, P290; Champaneria R, 2016, HEALTH TECHNOL ASSES, V20, P1, DOI 10.3310/hta20050; Ganeshan A, 2007, CARDIOVASC INTER RAD, V30, P1105, DOI 10.1007/s00270-007-9160-0; Gold EB, 2011, OBSTET GYN CLIN N AM, V38, P425, DOI 10.1016/j.ogc.2011.05.002; Hiromura T, 2004, AM J ROENTGENOL, V183, P1411, DOI 10.2214/ajr.183.5.1831411; HOBBS JT, 1990, BRIT J HOSP MED, V43, P200; Hothorn T, 2006, J COMPUT GRAPH STAT, V15, P651, DOI 10.1198/106186006X133933; Howard FM, 2003, OBSTET GYNECOL, V101, P594, DOI 10.1016/S0029-7844(02)02723-0; Ignacio Elizabeth A, 2008, Semin Intervent Radiol, V25, P361, DOI 10.1055/s-0028-1102998; Jaskolka JD, 2010, CAN ASSOC RADIOL J, V61, P223, DOI 10.1016/j.carj.2009.11.006; KAUFMAN JA, 1995, CARDIOVASC INTER RAD, V18, P153; Kies DD, 2012, PHLEBOLOGY, V27, P52, DOI [10.1258/phleb.2012.012S27, 10.1258/phleb.2012.012s27]; Koc Z, 2007, EUR RADIOL, V17, P1267, DOI 10.1007/s00330-006-0440-x; Labropoulos N, 1997, J VASC SURG, V26, P736, DOI 10.1016/S0741-5214(97)70084-3; Malgor RD, 2014, J VASC SURG-VENOUS L, V2, P34, DOI 10.1016/j.jvsv.2013.06.004; Motta-Ramirez Gaspar Alberto, 2013, Ginecol Obstet Mex, V81, P389; Nasser F, 2014, INT J GYNECOL OBSTET, V125, P65, DOI 10.1016/j.ijgo.2013.10.008; Nicholson T, 2006, TECH VASC INTERV RAD, V9, P19, DOI 10.1053/j.tvir.2006.08.005; Park SJ, 2004, AM J ROENTGENOL, V182, P683, DOI 10.2214/ajr.182.3.1820683; Rozenblit AM, 2001, AM J ROENTGENOL, V176, P119, DOI 10.2214/ajr.176.1.1760119; Sharma D, 2011, ARCH GYNECOL OBSTET, V283, P295, DOI 10.1007/s00404-010-1354-z; Soysal ME, 2001, HUM REPROD, V16, P931, DOI 10.1093/humrep/16.5.931; Stones RW, 2003, CLIN OBSTET GYNECOL, V46, P831, DOI 10.1097/00003081-200312000-00013; TAYLOR HC, 1959, J OBSTET GYNAECOL, V66, P781; TAYLOR HC, 1949, RES PUBL ASSOC RES N, V29, P1051; Yang DM, 2012, BRIT J RADIOL, V85, pE117, DOI 10.1259/bjr/79155839	31	16	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2019	14	4							e0213834	10.1371/journal.pone.0213834	http://dx.doi.org/10.1371/journal.pone.0213834			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR2UW	30939134	Green Published, gold, Green Submitted			2022-12-26	WOS:000462993900009
J	Otoyama, I; Hamada, H; Kimura, T; Namba, H; Sekikawa, K; Kamikawa, N; Kajiwara, T; Aizawa, F; Sato, YM				Otoyama, Ippo; Hamada, Hironobu; Kimura, Tatsushi; Namba, Haruchi; Sekikawa, Kiyokazu; Kamikawa, Norimichi; Kajiwara, Teruki; Aizawa, Fumiya; Sato, Yoshinobu M.			L-cysteine improves blood fluidity impaired by acetaldehyde: In vitro evaluation	PLOS ONE			English	Article							MICROCHANNELS; FLOW	Blood fluidity is reportedly influenced by the volume and function of blood cells and plasma and is a predictor of primary cardiovascular events in patients with traditional cardiovascular risk factors. Heavy alcohol consumption was shown to be associated with a higher risk for cardiovascular diseases. Acetaldehyde (ACD), an oxidizing substance formed from ethanol, reportedly stimulates monocyte adhesion, causes abnormalities in the red blood cell (RBC) membrane, and decreases RBC deformability. In addition, it was reported that blood ACD levels are reduced in mice pretreated with L-cysteine. However, there are no studies on the effect of ACD and/or L-cysteine on blood fluidity. In the present study, we evaluated whether ACD impairs blood fluidity. In addition, the effect of L-cysteine on blood fluidity impaired by ACD was examined. Blood samples were obtained from 10 healthy, non-smoking, male volunteers (age: 23.4 +/- 1.2 years, body mass index: 21.8 +/- 2.6 kg/m(2)). ACD or ACD and L-cysteine were added to the blood samples before each experiment. We measured the passage time of 100 mu L blood and RBC suspension using Kikuchi's microchannel method. Percentage of microchannel obstruction and the number of adherent white blood cells (WBCs) on microchannel terrace were counted. The blood passage time, percentage of microchannel obstruction, and numbers of adherent WBCs on the microchannel terrace increased after adding ACD in a concentration-dependent manner, whereas they decreased after adding ACD and L-cysteine in a L-cysteine concentration-dependent manner. No significant effects were observed in passage time for 100 mu L RBC suspension after adding ACD and L-cysteine. This study suggested that blood fluidity impaired by ACD might improve after adding L-cysteine.	[Otoyama, Ippo; Hamada, Hironobu; Namba, Haruchi; Sekikawa, Kiyokazu; Kamikawa, Norimichi; Kajiwara, Teruki; Aizawa, Fumiya; Sato, Yoshinobu M.] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Phys Anal & Therapeut Sci, Hiroshima, Japan; [Kimura, Tatsushi] Ohkagakuen Univ, Fac Early Childhood Educ & Care, Toyoake, Aichi, Japan	Hiroshima University	Hamada, H (corresponding author), Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Phys Anal & Therapeut Sci, Hiroshima, Japan.	hirohamada@hiroshima-u.ac.jp	Hamada, Hironobu/A-6489-2018; kiyokazu, sekikawa/AAC-1498-2020	Hamada, Hironobu/0000-0002-7979-0708; Aizawa, Fumiya/0000-0003-2239-5771	Fundamental Budget for Education and Research	Fundamental Budget for Education and Research	This work was supported by Fundamental Budget for Education and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	DEBEY HJ, 1958, J NUTR, V66, P607, DOI 10.1093/jn/66.4.607; Eileen M., 2009, ATHEROSCLEROSIS, V204, P372, DOI DOI 10.1016/J.ATHEROSCLEROSIS.2008.10.008; Fedosov DA, 2014, BIOMECH MODEL MECHAN, V13, P239, DOI 10.1007/s10237-013-0497-9; GAINES KC, 1977, FEBS LETT, V75, P115, DOI 10.1016/0014-5793(77)80065-3; Gompper G, 2016, WIRES SYST BIOL MED, V8, P157, DOI 10.1002/wsbm.1326; Hitsumoto T, 2018, CARDIOL RES, V9, P231, DOI 10.14740/cr763w; Ishida K, 2001, MED B FUKUOKA U, V28, P203; Kensey KR, 2003, CLIN APPL THROMB-HEM, V9, P93, DOI 10.1177/107602960300900201; KIKUCHI Y, 1994, MICROVASC RES, V47, P222, DOI 10.1006/mvre.1994.1017; KIKUCHI Y, 1994, MICROVASC RES, V47, P126, DOI 10.1006/mvre.1994.1008; KIKUCHI Y, 1995, MICROVASC RES, V50, P288, DOI 10.1006/mvre.1995.1059; Kim CJ, 2009, BBA-GEN SUBJECTS, V1790, P1161, DOI 10.1016/j.bbagen.2009.05.018; Kimura T, 2016, CLIN HEMORHEOL MICRO, V61, P559, DOI 10.3233/CH-141893; Maxwell PS, 1937, J BIOL CHEM, V121, P539; Mukamal KJ, 2005, ANN INTERN MED, V142, P11, DOI 10.7326/0003-4819-142-1-200501040-00007; Mukamal KJ, 2001, CIRCULATION, V104, P1367, DOI 10.1161/hc3701.096067; Rehm J, 2017, TRENDS CARDIOVAS MED, V27, P534, DOI 10.1016/j.tcm.2017.06.002; Shiraishi Koichi, 2015, Nihon Arukoru Yakubutsu Igakkai Zasshi, V50, P13; Tsukamoto S, 1990, Arukoru Kenkyuto Yakubutsu Ison, V25, P429	19	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2019	14	3							e0214585	10.1371/journal.pone.0214585	http://dx.doi.org/10.1371/journal.pone.0214585			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ9FO	30925182	gold, Green Published, Green Submitted			2022-12-26	WOS:000462732300021
J	Costa, NA; Pansani, AP; de Castro, CH; Colugnati, DB; Xaxier, CH; Guimaraes, KC; Rabelo, LA; Nunes-Souza, V; Caixeta, LFS; Ferreira, RN				Costa, Natalia Alves; Pansani, Aline Priscila; de Castro, Carlos Henrique; Colugnati, Diego Basile; Xaxier, Carlos Henrique; Guimaraes, Katia Cylene; Rabelo, Luiza Antas; Nunes-Souza, Valeria; Souza Caixeta, Luis Fernando; Ferreira, Reginaldo Nassar			Milk restriction or oligosaccharide supplementation in calves improves compensatory gain and digestive tract development without changing hormone levels	PLOS ONE			English	Article							MANNAN OLIGOSACCHARIDE; RUMEN DEVELOPMENT; SMALL-INTESTINE; PLASMA GHRELIN; BEEF-CATTLE; FEED-INTAKE; GROWTH; HEALTH; CONSEQUENCES; ANTIBIOTICS	We estimated the effect of oligosaccharide supplementation and feed restriction on calves. The study was divided into two experimental periods of 28 days each with 20 crossbred calves that had initial body weight of 37 Kg and housed in individual pens. The animals were split in four experimental groups: animals fed 6 L milk/day (CON) in the two periods, animals fed milk restricted (3 L milk/day) in the first period and followed by CON feeding in the second period (RES), animals receiving supplementation of 5 g/day of mannanoligosaccharide (MOS) and animals receiving supplementation of 5 g/day mannan and frutoligosaccharide (MFOS). At the end of the study, all the animals were slaughtered. The average weight gain was lower in the restricted group when compared with CON and MFOS groups in the first period (P < 0.05) and there were no difference among the groups in the second period. Animals supplemented with MOS showed a significant increases in jejunal villus height and rumen papillae, which were not observed for MFOS group (P < 0.05) compared with RES and CON groups. There were no difference in ghrelin and leptin levels among treatments during periods 1 and 2 (P > 0.05). Also, the expression of ghrelin receptors in the paraventricular region of the hypothalamus did not differ among groups. We conclude that milk restriction during the first weeks of life in calves resulted in compensatory gain and did not modify the hormonal profile and expression of the ghrelin receptor in the hypothalamus. Moreover, a prebiotic supplementation changed the development of intestinal and ruminal epithelium.	[Costa, Natalia Alves; Pansani, Aline Priscila; de Castro, Carlos Henrique; Colugnati, Diego Basile; Xaxier, Carlos Henrique; Souza Caixeta, Luis Fernando; Ferreira, Reginaldo Nassar] Univ Fed Goias, Dept Physiol Sci, Inst Biol Sci, Goiania, Go, Brazil; [Guimaraes, Katia Cylene] Goiano Inst Fed, Dept Anim Sci, Anim Nutr Lab, Rio Verde, Go, Brazil; [Rabelo, Luiza Antas] Univ Fed Alagoas, Dept Physiol Sci, Inst Biol Sci, Maceio, Alagoas, Brazil; [Nunes-Souza, Valeria] Univ Fed Pernambuco, Inst Biol Sci, Dept Physiol & Pharmacol Sci, Recife, PE, Brazil	Universidade Federal de Goias; Universidade Federal de Alagoas; Universidade Federal de Pernambuco	Ferreira, RN (corresponding author), Univ Fed Goias, Dept Physiol Sci, Inst Biol Sci, Goiania, Go, Brazil.	reginaldonassar@gmail.com	Colugnati, Diego/AAD-2977-2019; da Saúde, Programa Ciências/ABF-1705-2020; Pansani, Aline Priscila/AAC-8501-2019; Xavier, Carlos H/C-8561-2013; Guimarães, Kátia C/D-3796-2014; Xavier, Carlos Henrique/AAE-8390-2022	Colugnati, Diego/0000-0002-6565-0042; Pansani, Aline Priscila/0000-0001-6898-5940; Xavier, Carlos H/0000-0003-4006-8213; Xavier, Carlos Henrique/0000-0003-4006-8213; Ferreira, Reginaldo/0000-0002-0545-1439	YES Company	YES Company	This work was supported by the YES Company (http://www.yes.ind.br). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Hafeez HM, 2017, ASIAN AUSTRAL J ANIM, V30, P672, DOI 10.5713/ajas.16.0535; Afsharmanesh M, 2016, ANIM NUTR, V2, P168, DOI 10.1016/j.aninu.2016.04.002; Akbarian-Tefaghi M, 2018, J ANIM PHYSIOL AN N, V102, P630, DOI 10.1111/jpn.12842; BAILE CA, 1987, J ANIM SCI, V64, P915, DOI 10.2527/jas1987.643915x; BAILE CA, 1981, J DAIRY SCI, V64, P1140, DOI 10.3168/jds.S0022-0302(81)82693-8; Baldwin R L, 2004, J DAIRY SCI, V87, pE55, DOI [10.3168/jds.2012-5970, DOI 10.3168/JDS.S0022-0302(04)70061-2]; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cani PD, 2009, AM J CLIN NUTR, V90, P1236, DOI 10.3945/ajcn.2009.28095; Chen LL, 2007, COMP BIOCHEM PHYS A, V147, P893, DOI 10.1016/j.cbpa.2007.02.017; Choi YJ, 1997, J DAIRY SCI, V80, P519, DOI 10.3168/jds.S0022-0302(97)75965-4; Cox K.L., 2004, ASSAY GUIDANCE MANUA; Curtis G, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191687; Donovan DC, 2002, J DAIRY SCI, V85, P947, DOI 10.3168/jds.S0022-0302(02)74153-2; Fagliari JJ, 1998, ARQ BRAS MED VET ZOO, V50, P253; Franklin ST, 2005, J DAIRY SCI, V88, P766, DOI 10.3168/jds.S0022-0302(05)72740-5; Ghosh S, 2012, TROP ANIM HEALTH PRO, V44, P617, DOI 10.1007/s11250-011-9944-8; Gorka P, 2011, J DAIRY SCI, V94, P3002, DOI 10.3168/jds.2010-3499; Gorka P, 2008, J PHYSL PHARM S3, V59, P22; Guilloteau P, 2009, J PHYSIOL PHARMACOL, V60, P37; Hammon HM, 2002, J ANIM SCI, V80, P337; Heinrichs AJ, 2009, LIVEST SCI, V125, P149, DOI 10.1016/j.livsci.2009.04.003; Heinrichs AJ, 2003, J DAIRY SCI, V86, P4064, DOI 10.3168/jds.S0022-0302(03)74018-1; Istasse L., 2000, Domestic Animal Endocrinology, V19, P121, DOI 10.1016/S0739-7240(00)00072-2; Jasper J, 2002, J DAIRY SCI, V85, P3054, DOI 10.3168/jds.S0022-0302(02)74391-9; Ji SQ, 1998, ANIM BIOTECHNOL, V9, P1, DOI 10.1080/10495399809525887; Kaufhold J, 2000, J VET MED A, V47, P17, DOI 10.1046/j.1439-0442.2000.00257.x; Keogh K, 2015, J ANIM SCI, V93, P3578, DOI 10.2527/jas.2014-8470; Keogh K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194445; Khan MA, 2011, J DAIRY SCI, V94, P1071, DOI 10.3168/jds.2010-3733; Kim MS, 2003, NEUROREPORT, V14, P1317, DOI [10.1097/01.wnr.0000078703.79393.d2, 10.1097/00001756-200307180-00006]; Kleessen B, 2001, BRIT J NUTR, V86, P291, DOI 10.1079/BJN2001403; Knowles TG, 2000, VET REC, V147, P593, DOI 10.1136/vr.147.21.593; Kuenzel WJ, 1999, J EXP ZOOL, V283, P348, DOI 10.1002/(SICI)1097-010X(19990301/01)283:4/5&lt;348::AID-JEZ5&gt;3.0.CO;2-5; Lalles JP, 2007, P NUTR SOC, V66, P260, DOI 10.1017/S0029665107005484; Lesmeister KE, 2004, J DAIRY SCI, V87, P1832, DOI 10.3168/jds.S0022-0302(04)73340-8; Lesmeister KE, 2004, J DAIRY SCI, V87, P1336, DOI 10.3168/jds.S0022-0302(04)73283-X; Lesson S, 1999, POULTRY SCI, V76, P992; Miura H, 2004, J ANIM SCI, V82, P1329; Montanholi Y, 2013, ACTA VET SCAND, V55, DOI 10.1186/1751-0147-55-9; Morrison SJ, 2010, LIVEST SCI, V131, P292, DOI 10.1016/j.livsci.2010.04.002; Parnell JA, 2012, BRIT J NUTR, V107, P601, DOI 10.1017/S0007114511003163; Samanta A.K., 2012, INDIAN VET J, V89, P41; Steele MA, 2016, J DAIRY SCI, V99, P4955, DOI 10.3168/jds.2015-10351; Sugino T, 2002, BIOCHEM BIOPH RES CO, V298, P785, DOI 10.1016/S0006-291X(02)02572-X; Sweeney BC, 2010, J DAIRY SCI, V93, P148, DOI 10.3168/jds.2009-2427; Wang X, 2012, WORLD J GASTROENTERO, V18, P5719, DOI 10.3748/wjg.v18.i40.5719; Wertz-Lutz AE, 2010, J ANIM SCI, V88, P2289, DOI 10.2527/jas.2009-2447; WILSON PN, 1960, BIOL REV, V35, P324, DOI 10.1111/j.1469-185X.1960.tb01327.x; WINCHESTER CF, 1957, J ANIM SCI, V16, P426, DOI 10.2527/jas1957.162426x; Xu ZR, 2000, ASIAN AUSTRAL J ANIM, V15, P1784	50	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214626	10.1371/journal.pone.0214626	http://dx.doi.org/10.1371/journal.pone.0214626			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921423	Green Published, Green Submitted, gold			2022-12-26	WOS:000462594000100
J	Paska, C; Barta, I; Drozdovszky, O; Antus, B				Paska, Csilla; Barta, Imre; Drozdovszky, Orsolya; Antus, Balazs			Elimination of bacterial DNA during RNA isolation from sputum: Bashing bead vortexing is preferable over prolonged DNase treatment	PLOS ONE			English	Article							REAL-TIME PCR; GENE-EXPRESSION; LOAD	Sputum often contains large amounts of contaminating bacterial DNA that, if not eliminated during RNA isolation, may interfere with gene expression studies. During RNA isolation only repeated DNase treatment can effectively remove contaminating bacterial DNA from samples, but this compromises RNA quality. In this study we tested alternative methods to facilitate the removal of DNA and improve the quality of RNA obtained. Sputum samples obtained from patients with chronic obstructive pulmonary disease were processed with dithiothreitol and subjected to various RNA isolation methods, yet with modified protocols. Modifications included prolonged DNase treatment or vortexing of sputum cells in the presence of beads prior to RNA isolation. Bacterial DNA contamination was tested by PCR using universal bacterial primers, while RNA quality was assessed by real-time PCR using GAPDH primers for amplicons of different length. We found that the RNeasy Plus Mini kit equipped with the gDNA eliminator spin column was able to completely eliminate bacterial DNA, if sputum cells were lysed in the presence of bashing beads. Notably, compared with the standard protocol, the modified procedure yielded better quality RNA as well, as indicated by improved threshold profiles of qPCR. Bead vortexing of cells was less effective when combined with other RNA isolation methods, and the repeated DNase treatment needed to completely remove contaminating DNA from the samples reduced the quality of RNA markedly. Bead vortexing in combination with certain RNA extraction methods greatly facilitates the isolation of sputum RNA that is free of contaminating bacterial DNA, and is suitable for downstream applications.	[Paska, Csilla; Barta, Imre; Drozdovszky, Orsolya; Antus, Balazs] Natl Koranyi Inst Pulmonol, Dept Pathophysiol, Budapest, Hungary; [Antus, Balazs] Natl Koranyi Inst Pulmonol, Dept Pulmonol, Budapest, Hungary		Antus, B (corresponding author), Natl Koranyi Inst Pulmonol, Dept Pathophysiol, Budapest, Hungary.; Antus, B (corresponding author), Natl Koranyi Inst Pulmonol, Dept Pulmonol, Budapest, Hungary.	antusb@hotmail.com	Drozdovszky, Orsolya/AFU-5494-2022		National Research, Development and Innovation Office [K124343]	National Research, Development and Innovation Office(National Research, Development & Innovation Office (NRDIO) - Hungary)	The study was supported by the National Research, Development and Innovation Office, Grant No: K124343 (https://nkfih.gov.hu/) to BA. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaro A, 2008, LETT APPL MICROBIOL, V47, P8, DOI 10.1111/j.1472-765X.2008.02372.x; Antus B, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/2930434; Antus B, 2012, INFLAMM RES, V61, P1141, DOI 10.1007/s00011-012-0508-9; Baines KJ, 2011, J ALLERGY CLIN IMMUN, V127, P153, DOI 10.1016/j.jaci.2010.10.024; Brightling CE, 2006, CHEST, V129, P1344, DOI 10.1378/chest.129.5.1344; de Boer R, 2010, J MICROBIOL METH, V80, P209, DOI 10.1016/j.mimet.2009.11.009; Dragonieri S, 2009, Monaldi Arch Chest Dis, V71, P119; Drozdovszky O, 2014, RESPIRATION, V87, P408, DOI 10.1159/000358099; Fleige Simone, 2006, Molecular Aspects of Medicine, V27, P126, DOI 10.1016/j.mam.2005.12.003; He H, 2017, SCI REP-UK, V7, DOI 10.1038/srep45199; Horz HP, 2005, J CLIN MICROBIOL, V43, P5332, DOI 10.1128/JCM.43.10.5332-5337.2005; Jahn CE, 2008, J MICROBIOL METH, V75, P318, DOI 10.1016/j.mimet.2008.07.004; Kaser M, 2009, APPL ENVIRON MICROB, V75, P414, DOI 10.1128/AEM.01358-08; Korfhage C, EFFECTIVE GENOMIC DN; Louis R, 2012, Monaldi Arch Chest Dis, V77, P5; MEIER A, 1993, J CLIN MICROBIOL, V31, P646, DOI 10.1128/JCM.31.3.646-652.1993; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; Paska C, 2004, DIAGN MOL PATHOL, V13, P234, DOI 10.1097/01.pdm.0000134778.37729.9f; Paska C, 2017, AM J RESP CELL MOL, V57, P626, DOI 10.1165/rcmb.2017-0198LE; Phongsisay V, 2007, J MICROBIOL METH, V68, P427, DOI 10.1016/j.mimet.2006.09.002; RAND KH, 1990, MOL CELL PROBE, V4, P445, DOI 10.1016/0890-8508(90)90003-I; Razzak R, 2016, CURR ONCOL, V23, pE86, DOI 10.3747/co.23.2830; Singh D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107381; Wagener Ariane H, 2013, Ann Am Thorac Soc, V10 Suppl, pS197, DOI 10.1513/AnnalsATS.201302-035AW	24	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214609	10.1371/journal.pone.0214609	http://dx.doi.org/10.1371/journal.pone.0214609			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921416	Green Published, gold, Green Submitted			2022-12-26	WOS:000462594000097
J	Tegegn, HG; Erku, DA; Sebsibe, G; Gizaw, B; Seifu, D; Tigabe, M; Belachew, SA; Ayele, AA				Tegegn, Henok Getachew; Erku, Daniel Asfaw; Sebsibe, Girum; Gizaw, Biruktawit; Seifu, Dawit; Tigabe, Masho; Belachew, Sewunet Admasu; Ayele, Asnakew Achaw			Medication-related quality of life among Ethiopian elderly patients with polypharmacy: A cross-sectional study in an Ethiopia university hospital	PLOS ONE			English	Article							CONTROLLED-TRIAL; OLDER-PEOPLE; HEALTH; CARE; OUTPATIENTS; MANAGEMENT; ADHERENCE	Polypharmacy among older patients has been associated with a decline in their quality of life. We aimed to assess the medication-related quality of life (MRQOL) among older patients with polypharmacy at Gondar University Hospital, Gondar, Ethiopia. A prospective cross-sectional study was carried out among 150 elder patients who had visited the internal medicine ward and ambulatory ward of Gondar referral hospital from March 25 to May 15, 2017, using a validated scale, Medication-Related Quality of Life Scale version 1.0 (MRQoLS-v1.0). A total of 150 older patients with polypharmacy participated in the study with a mean age of 70.06 +/- 5.12, andtwo-thirds of the participants (67.3%) were female. The overall prevalence of poor quality of life due to polypharmacy in the current study was found to be three fourth (75.3%) of the participants. Regarding the severity of impairment in MRQoL, Univariate analysis revealed that frequency of hospital visits (COR = 1.34, 95% CI, 1.02-1.77) and medication number (COR = 1.94, 95% CI, 1.33, 2.8) had a statistically significant positive association with the likelihood of having a severe impairment.The multivariate analysis also showed that one unit increase in the number of hospital visits (AOR = 1.45, 95% CI, 1.040-2.024) and medications greater than 5 (AOR = 1.91, 95% CI, 1.29, 2.84) increases 1.45 and 1.91 times the likely hood of posing severe impairment of MRQoL, respectively. As far as poor MRQoL quality of life is concerned, multivariate analysis did not show any significant association between the poor MRQoL;and Sociodemographic and clinical data of patients. The poor QoL associated with medication was very high in this study. Deprescribing should be sought by the health care providers to optimize drug therapy and minimize the polypharmacy related poor quality of life.	[Tegegn, Henok Getachew; Erku, Daniel Asfaw; Sebsibe, Girum; Gizaw, Biruktawit; Seifu, Dawit; Tigabe, Masho; Belachew, Sewunet Admasu; Ayele, Asnakew Achaw] Univ Gondar, Dept Clin Pharm, Gondar, Amhara, Ethiopia	University of Gondar	Tegegn, HG (corresponding author), Univ Gondar, Dept Clin Pharm, Gondar, Amhara, Ethiopia.	heniget@gmail.com	Tegegn, Henok Getachew/C-2469-2016; Erku, Daniel/AAC-1508-2020	Tegegn, Henok Getachew/0000-0003-0644-0958; Erku, Daniel/0000-0002-8878-0317; Admasu Belachew, Sewunet/0000-0002-1050-8188; Ayele, Asnakew/0000-0001-7837-7228				Azpiazu Garrido M, 2003, ATEN PRIM, V31, P285; Bushardt RL, 2008, CLIN INTERV AGING, V3, P383, DOI 10.2147/CIA.S2468; Casado J, 2001, Aten Primaria, V28, P167; Chang YC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128356; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; Chew BH, 2015, QUAL LIFE RES, V24, P2723, DOI 10.1007/s11136-015-1006-7; Chumney Elinor C., 2006, Pharmacy Pract (Granada), V4, P103, DOI 10.4321/s1885-642x2006000300001; de Rivas B, 2008, QUAL LIFE RES, V17, P1229, DOI 10.1007/s11136-008-9397-3; Ferrer A, 2010, MED CLIN-BARCELONA, V134, P303, DOI 10.1016/j.medcli.2009.06.070; Hajjar Emily R, 2007, Am J Geriatr Pharmacother, V5, P345, DOI 10.1016/j.amjopharm.2007.12.002; Hanlon JT, 1996, AM J MED, V100, P428, DOI 10.1016/S0002-9343(97)89519-8; Henderson JA, 2006, J APPL GERONTOL, V25, p89S, DOI 10.1177/0733464805283035; HERRMAN H, 1993, QUAL LIFE RES, V2, P153; Holt EW, 2010, AGE AGEING, V39, P481, DOI 10.1093/ageing/afq040; Zamora-Sanchez JJ, 2012, ENFERM CLIN, V22, P239, DOI 10.1016/j.enfcli.2012.04.009; Jyrkka J, 2011, PHARMACOEPIDEM DR S, V20, P514, DOI 10.1002/pds.2116; Krska J, 2001, AGE AGEING, V30, P205, DOI 10.1093/ageing/30.3.205; Lalic S, 2016, EUR J CLIN PHARMACOL, V72, P1117, DOI 10.1007/s00228-016-2075-4; Machon M, 2017, BMC GERIATR, V17, DOI 10.1186/s12877-016-0410-3; Makai P, 2014, SOC SCI MED, V102, P83, DOI 10.1016/j.socscimed.2013.11.050; Moen J, 2009, ANN PHARMACOTHER, V43, P1978, DOI 10.1345/aph.1M354; Montiel-Luque A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171320; National Institute of Mental Health, 2018, DEPRESSION; Ong GJ, 2017, PHARMACOL RES PERSPE, V5, DOI 10.1002/prp2.321; Page AT, 2016, RES SOC ADMIN PHARM, V12, P438, DOI 10.1016/j.sapharm.2015.08.011; Page AT, 2016, MATURITAS, V91, P115, DOI 10.1016/j.maturitas.2016.06.006; Parekh N, 2017, THER ADV DRUG SAF, V8, P117, DOI 10.1177/2042098616682721; Patterson SM, 2014, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008165.pub3, 10.1002/14651858.CD008165.pub4]; Reeve E, 2014, BRIT J CLIN PHARMACO, V78, P738, DOI 10.1111/bcp.12386; Riker Gretchen I, 2012, Home Healthc Nurse, V30, P474, DOI 10.1097/NHH.0b013e31826502dd; Rosso AL, 2013, J AM GERIATR SOC, V61, P371, DOI 10.1111/jgs.12147; Saleh F, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-431; Shafie Asrul Akmal, 2013, Value Health Reg Issues, V2, P107, DOI 10.1016/j.vhri.2013.02.005; Shumaker S, 1995, INT ASSESSMENT HLTH; Taylor CT, 2003, AM J HEALTH-SYST PH, V60, P1123, DOI 10.1093/ajhp/60.11.1123; Tegegn HG, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-020590; Tseng HM, 2016, QUAL LIFE RES, V25, P1295, DOI 10.1007/s11136-015-1177-2; Van der Weele GM, 2009, INT J GERIATR PSYCH, V24, P595, DOI 10.1002/gps.2162; Ware JE, 1998, J CLIN EPIDEMIOL, V51, P903, DOI 10.1016/S0895-4356(98)00081-X; Wiebe S, 2003, J CLIN EPIDEMIOL, V56, P52, DOI 10.1016/S0895-4356(02)00537-1	40	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214191	10.1371/journal.pone.0214191	http://dx.doi.org/10.1371/journal.pone.0214191			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HQ7IR	30921379	Green Published, gold, Green Submitted			2022-12-26	WOS:000462594000037
J	Leblanc, CA; Horri, K; Skulason, S; Benhaim, D				Leblanc, C. A.; Horri, K.; Skulason, S.; Benhaim, D.			Subtle temperature increase can interact with individual size and social context in shaping phenotypic traits of a coldwater fish	PLOS ONE			English	Article							CHARR SALVELINUS-ALPINUS; ARCTIC CHARR; EGG SIZE; ATLANTIC SALMON; METABOLIC-RATE; BODY-SIZE; RESOURCE POLYMORPHISMS; SYMPATRIC MORPHS; GROWTH; BEHAVIOR	Temperature and individual egg size have been long studied in the development of fishes because of their direct effects on individual fitness. Here we studied the combined effects of three important factors for fish development, i.e. egg size, social environment and water temperature. Arctic charr (Salvelinus alpinus), a coldwater fish known to be phenotypically plastic, was used to investigate how these factors may affect growth and foraging behaviour of juvenile fish in a benign environment. We accounted for the social environment during early development by comparing fish raised in groups and in isolation. We examined the effect of egg size and a 2 degrees C difference on foraging behaviour, activity and growth a few weeks after first feeding. Growth trajectories of fish originating from large and small eggs were similar within each temperature: larger fish coming large eggs were at all time larger than smaller fish. There was no indication that small fish raised at a higher temperature grew faster than larger fish raised at a lower temperature. A 2 degrees C difference in temperature affected the behaviour of fish differently according to body size and/or social context. The foraging probability difference between fish raised in groups and fish briefly isolated was higher at 4.5 degrees C than at 6.5 degrees C for both size fish. Finally, there was no repeatability in foraging behaviour and mobility for isolated individuals. These results highlight the importance of small changes in temperature when evaluating growth and behaviour of fishes, and reveal the importance of considering the interaction of temperature with other factors, e.g. individual size and social environment, especially at early stages of development in fishes. We discuss these findings in the context of rapid changes in temperature and how temperature and its interaction with other factors may affect the phenotypes, ecology and evolution of coldwater fishes.	[Leblanc, C. A.; Skulason, S.; Benhaim, D.] Holar Univ Coll, Dept Aquaculture & Fish Biol, Saudarkrokur, Iceland; [Horri, K.] Ctr Manche Mer Nord, Lab Ressources Halieut, Ifremer, Boulogne Sur Mer, France; [Horri, K.] Univ Le Havre Normandie, Unite Stress Environm & BlOsurveillance Milieux A, FR CNRS Scale 3730, UMR I 02,SEBIO,INERIS,URCA,ULH, Le Havre, France	Ifremer; Institut National de l'Environnement Industriel et des Risques (INERIS); Universite de Reims Champagne-Ardenne	Leblanc, CA (corresponding author), Holar Univ Coll, Dept Aquaculture & Fish Biol, Saudarkrokur, Iceland.	camille@holar.is	Benhaim, David/A-9991-2019	Horri, Khaled/0000-0002-8408-7531; Leblanc, Camille/0000-0003-4861-9948	Icelandic Center for Research (RANNIS Innovation fund-2007); ERASMUS mobility program; HUC	Icelandic Center for Research (RANNIS Innovation fund-2007); ERASMUS mobility program; HUC	\ Financial support from the Icelandic Center for Research (RANNIS Innovation fund-2007; https://en.rannis.is/), and ERASMUS mobility program was granted to CAL. Support was also provided by HUC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbink W, 2012, AQUACULTURE, V330, P130, DOI 10.1016/j.aquaculture.2011.11.043; Balon E.K., 1980, CHARRS SALMONID FISH; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Batty RS, 1992, J EXP BIOL; BEACHAM TD, 1985, CAN J ZOOL, V63, P847, DOI 10.1139/z85-125; Bellgraph BJ, 2010, J THERM BIOL, V35, P6, DOI 10.1016/j.jtherbio.2009.10.001; Benhaim D, 2003, J FISH BIOL, V62, P1326, DOI 10.1046/j.1095-8649.2003.00114.x; Biro PA, 2007, P NATL ACAD SCI USA, V104, P9715, DOI 10.1073/pnas.0701638104; Biro PA, 2010, P ROY SOC B-BIOL SCI, V277, P71, DOI 10.1098/rspb.2009.1346; Bjorklund M, 2003, J EVOLUTION BIOL, V16, P543, DOI 10.1046/j.1420-9101.2003.00566.x; BUCKEL JA, 1995, J FISH BIOL, V47, P696, DOI 10.1006/jfbi.1995.0172; Cameron AC., 2013, REGRESSION ANAL COUN, V2nd ed, DOI 10.1017/CBO9781139013567; Chambers RC, 1996, AM ZOOL, V36, P180; Cogliati KM, 2018, ECOL EVOL, V8, P778, DOI 10.1002/ece3.3670; Donelson JM, 2009, BIOL LETTERS, V5, P262, DOI 10.1098/rsbl.2008.0642; Einum S, 2000, EVOLUTION, V54, P628, DOI 10.1111/j.0014-3820.2000.tb00064.x; Einum S, 2011, MATERNAL EFFECTS EGG, V266, P2095; ELDRIDGE MB, 1982, FISH B-NOAA, V80, P461; Ferreira CEL, 1998, J FISH BIOL, V53, P222, DOI 10.1006/jfbi.1998.0824; Floeter SR, 2005, MAR BIOL, V147, P1435, DOI 10.1007/s00227-005-0027-0; Fox J., 2014, R COMPANION APPL REG; Glazier DS, 2010, BIOL REV, V85, P111, DOI 10.1111/j.1469-185X.2009.00095.x; Gomez-Laplaza LM, 2003, LAB ANIM-UK, V37, P108, DOI 10.1258/00236770360563741; Heath DD, 1999, EVOLUTION, V53, P1605, DOI 10.1111/j.1558-5646.1999.tb05424.x; Heath DD, 1998, MATERNAL EFFECTS AS ADAPTATIONS, P178; Jackman S, 2017, J STAT SOFTWARE; Jonsson B, 2000, BIOL J LINN SOC, V69, P55, DOI 10.1111/j.1095-8312.2000.tb01669.x; JONSSON B, 1991, CAN J FISH AQUAT SCI, V48, P1838, DOI 10.1139/f91-217; Kamler E., 1992, EARLY LIFE HIST FISH; Kamler E, 2005, REV FISH BIOL FISHER, V15, P399, DOI 10.1007/s11160-006-0002-y; Kaplan RH, 1997, HERPETOLOGICA, V53, P149; Karjalainen J, 2015, ENVIRON BIOL FISH, V98, P979, DOI 10.1007/s10641-014-0331-y; Killen SS, 2010, ECOL LETT, V13, P184, DOI 10.1111/j.1461-0248.2009.01415.x; Klemetsen A, 2003, ECOL FRESHW FISH, V12, P1, DOI 10.1034/j.1600-0633.2003.00010.x; Leblanc CAL, 2011, ETHOLOGY, V117, P664, DOI 10.1111/j.1439-0310.2011.01920.x; Leblanc CAL, 2016, AQUAC RES, V47, P1100, DOI 10.1111/are.12566; Lindholm AK, 2006, BIOL LETTERS, V2, P586, DOI 10.1098/rsbl.2006.0546; MALMQUIST HJ, 1992, J ANIM ECOL, V61, P21, DOI 10.2307/5505; Mauritsen T, 2017, NAT CLIM CHANGE, V7, P652, DOI [10.1038/NCLIMATE3357, 10.1038/nclimate3357]; McKenzie D.J., 2010, P296, DOI 10.1201/b10190-11; McLaughlin RL, 1999, BEHAV ECOL SOCIOBIOL, V45, P386, DOI 10.1007/s002650050575; Metcalfe NB, 2016, J FISH BIOL, V88, P298, DOI 10.1111/jfb.12699; METCALFE NB, 1992, J FISH BIOL, V41, P93, DOI 10.1111/j.1095-8649.1992.tb03871.x; METCALFE NB, 1990, CAN J ZOOL, V68, P2630, DOI 10.1139/z90-367; Monaghan P, 2008, PHILOS T R SOC B, V363, P1635, DOI 10.1098/rstb.2007.0011; Murray R.W., 1971, P121; Nowicki JP, 2012, J EXP MAR BIOL ECOL, V412, P46, DOI 10.1016/j.jembe.2011.10.020; Ohlberger J, 2012, OIKOS, V121, P245, DOI 10.1111/j.1600-0706.2011.19882.x; Pakkasmaa S, 2006, J COMP PHYSIOL B, V176, P387, DOI 10.1007/s00360-005-0057-4; Pang X, 2011, COMP BIOCHEM PHYS A, V159, P253, DOI 10.1016/j.cbpa.2011.03.013; Penghan LY, 2014, AQUAT BIOL, V21, P57, DOI 10.3354/ab00571; Penney HD, 2018, PHENOTYPIC PLASTICIT, P171; Pinheiro J, 2000, MIXED EFFECTS MODELS; POLUNIN NVC, 1989, J EXP MAR BIOL ECOL, V126, P1, DOI 10.1016/0022-0981(89)90121-4; Post JR, 2007, ENERGY ALLOCATION ST, V82, P1040; Quinn Thomas P., 2005, P1; R Core Team, 2021, R LANGUAGE ENV STAT; Regnier T, 2013, ECOL FRESHW FISH, V22, P169, DOI 10.1111/eff.12018; REZNICK DN, 1991, UNITY OF EVOLUTIONARY BIOLOGY, VOLS 1 AND 2, P780; Robertsen G, 2014, J ANIM ECOL, V83, P791, DOI 10.1111/1365-2656.12182; Roff Derek A., 1992; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Segers FHID, 2012, P ROY SOC B-BIOL SCI, V279, P592, DOI 10.1098/rspb.2011.1104; SKULASON S, 1995, TRENDS ECOL EVOL, V10, P366, DOI 10.1016/S0169-5347(00)89135-1; SKULASON S, 1993, ANIM BEHAV, V45, P1179, DOI 10.1006/anbe.1993.1140; SKULASON S, 1989, BIOL J LINN SOC, V38, P281, DOI 10.1111/j.1095-8312.1989.tb01579.x; Smith TB, 2008, CORAL REEFS, V27, P397, DOI 10.1007/s00338-007-0343-6; Smith TB, 1996, ANNU REV ECOL SYST, V27, P111, DOI 10.1146/annurev.ecolsys.27.1.111; Sparks MM, 2017, GLOBAL CHANGE BIOL, V23, P5203, DOI 10.1111/gcb.13782; Stearns SC, 2004, EVOLUTION ILLUMINATE; Theodorou P, 2012, J EXP MAR BIOL ECOL, V413, P192, DOI 10.1016/j.jembe.2011.12.009; Thorn MW, 2018, EVOL APPL, V11, P205, DOI 10.1111/eva.12531; THORPE JE, 1984, AQUACULTURE, V43, P289, DOI 10.1016/0044-8486(84)90030-9; Valdimarsson SK, 2002, ENVIRON BIOL FISH, V65, P463, DOI 10.1023/A:1021107712866; Vonlanthen P, 2012, NATURE, V482, P357, DOI 10.1038/nature10824; WALLACE JC, 1984, AQUACULTURE, V38, P19, DOI 10.1016/0044-8486(84)90134-0; Weetman D, 1999, ANIM BEHAV, V58, P735, DOI 10.1006/anbe.1999.1191; Weetman D, 1998, ANIM BEHAV, V55, P1361, DOI 10.1006/anbe.1997.0666; West MJ, 2003, ANIM BEHAV, V66, P617, DOI 10.1006/anbe.2003.2221; White CR, 2006, BIOL LETTERS, V2, P125, DOI 10.1098/rsbl.2005.0378; Whitney CK, 2014, T AM FISH SOC, V143, P1316, DOI 10.1080/00028487.2014.935481; Wuenschel MJ, 2004, J FISH BIOL, V64, P1088, DOI 10.1111/j.1095-8649.2004.00374.x; Zeileis A, 2008, J STAT SOFTW, V27, P1, DOI 10.18637/jss.v027.i08; Zuur Alain F., 2009, P1	84	2	2	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2019	14	3							e0213061	10.1371/journal.pone.0213061	http://dx.doi.org/10.1371/journal.pone.0213061			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ5PT	30917136	Green Published, Green Submitted, gold			2022-12-26	WOS:000462465800018
J	Rodriguez-Garcia, CM; Ruiz-Ruiz, JC; Peraza-Echeverria, L; Peraza-Sanchez, SR; Torres-Tapia, LW; Perez-Brito, D; Tapia-Tussell, R; Herrera-Chale, FG; Segura-Campos, MR; Quijano-Ramayo, A; Ramon-Sierras, JM; Ortiz-Vazquez, E				Monica Rodriguez-Garcia, Cecilia; Carlos Ruiz-Ruiz, Jorge; Peraza-Echeverria, Leticia; Ruben Peraza-Sanchez, Sergio; Wiliunfo Torres-Tapia, Luis; Perez-Brito, Daisy; Tapia-Tussell, Raul; Gilberto Herrera-Chale, Francisco; Rubi Segura-Campos, Maira; Quijano-Ramayo, Andres; Manuel Ramon-Sierras, Jesus; Ortiz-Vazquez, Elizabeth			Antioxidant, antihypertensive, anti-hyperglycemic, and antimicrobial activity of aqueous extracts from twelve native plants of the Yucatan coast	PLOS ONE			English	Article							IN-VITRO; ANTIFUNGAL ACTIVITY; ALPHA-GLUCOSIDASE; MANILKARA-ZAPOTA; ANTIBACTERIAL; FLAVONOIDS; RESISTANCE; CHEMISTRY; AMYLASE	Looking for a biotechnical potential, aqueous extracts of leaves of 12 native species used in the Mayan traditional medicine of the coastal dune and mangrove of Yucatan (Mexico) were selected to evaluate their biological activities. Rhizophora mangle and Manilkara zapota showed the highest free radical scavenging activity (3.94 +/- 0.19 and 6.42 +/- 0.32 mu g/mL, respectively), and the highest antihypertensive activity was obtained from Solanum donianum (0.38 mu g/mL). The anti-hyperglycemic activity of these species was also tested; the highest activities were registered with R. mangle. The antimicrobial activity of Malvaviscus arboreus, S. donianum, M. zapota, and R. mangle at 10% (w/v) was positive against six human pathogenic bacteria and Bonellia macrocarpa against one pathogenic fungus. Solanum donianum, M. zapota, B. macrocarpa, and R. mangle were positive against two pathogenic plant fungi. These results show that the aqueous extracts of five native plants of the Yucatan coast have potential as antioxidants, ACE inhibitors, alpha-amylase and alpha-glucosidase inhibitors, and as antimicrobials, which make their exploration for utilization in the agricultural and pharmaceutical industries a possibility.	[Monica Rodriguez-Garcia, Cecilia; Peraza-Echeverria, Leticia; Ruben Peraza-Sanchez, Sergio; Wiliunfo Torres-Tapia, Luis; Gilberto Herrera-Chale, Francisco] Ctr Invest Cient Yucatan AC, Unidad Biotecnol, Merida, Yucatan, Mexico; [Carlos Ruiz-Ruiz, Jorge] Inst Tecnol Merida, Dept Ingn Quim Bioquim, Merida, Yucatan, Mexico; [Perez-Brito, Daisy; Tapia-Tussell, Raul; Quijano-Ramayo, Andres] Ctr Invest Cient Yucatan AC, GEMBIO, Merida, Yucatan, Mexico; [Rubi Segura-Campos, Maira] Univ Autonoma Yucatan, Fac Ingn Quim, Merida, Yucatan, Mexico; [Manuel Ramon-Sierras, Jesus; Ortiz-Vazquez, Elizabeth] Inst Tecnol Merida, Div Estudios Postgrad & Invest, Merida, Yucatan, Mexico; [Carlos Ruiz-Ruiz, Jorge] Univ Anahuac Mayab, Div Ciencias Salud, Escuela Nutr, Merida, Yucatan, Mexico; [Tapia-Tussell, Raul] Ctr Invest Cient Yucatan AC, Unidad Energia Renovable, Merida, Yucatan, Mexico; [Gilberto Herrera-Chale, Francisco] Inst Tecnol Super Progreso, Yucatan, Mexico	Centro de Investigacion Cientifica de Yucatan; Centro de Investigacion Cientifica de Yucatan; Universidad Autonoma de Yucatan; Centro de Investigacion Cientifica de Yucatan	Rodriguez-Garcia, CM (corresponding author), Ctr Invest Cient Yucatan AC, Unidad Biotecnol, Merida, Yucatan, Mexico.	koyi@cicy..mx	Ortiz-Vázquez, Elizabeth/GPJ-9528-2022; Segura-Campos, Maira Rubi/AAS-4880-2020; Perez-Brito, Daisy/F-7358-2019	Ortiz-Vázquez, Elizabeth/0000-0002-2881-2110; Perez-Brito, Daisy/0000-0003-2116-0065; Segura Campos, Maira Rubi/0000-0002-7664-6647; Ramon Sierra, Jesus Manuel/0000-0001-7773-190X; Rodriguez-Garcia, Cecilia Monica/0000-0002-4568-5125	National Council of Science and Technology of Mexico (Conacyt) [164458, 22650]	National Council of Science and Technology of Mexico (Conacyt)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	The research was supported by the National Council of Science and Technology of Mexico (Conacyt, grant #164458) and a postdoctoral fellowship for Francisco G. Herrera (#22650).	Abu Osman M, 2011, INT J DRUG DEV RES, V3, P185; Ajith P. S., 2012, The Journal of Plant Protection Sciences, V4, P13; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andrade-Cetto A., 2015, PHARMACOLOGYONLINE, V1, P67; Bari MA, 2010, INT J AGRIC BIOL, V12, P386; Bautista F, 2015, ECOSIS RECUR AGROPEC, V2, P303; Castillo S, 1998, ACTA BOT MEX, V45, P55, DOI DOI 10.21829/ABM45.1998.812; Chanda SV, 2010, NAT SCI, V8, P260; CONAGUA, 2014, COORD GEN SERV MET N; Croft KD, 1998, ANN NY ACAD SCI, V854, P435, DOI 10.1111/j.1749-6632.1998.tb09922.x; Cruz S.M., 2015, INT J PHYTOCOSMET NA, V2, P12, DOI [10.15171/ijpni.2015.12, DOI 10.15171/IJPNI.2015.12]; Dewanto V, 2002, J AGR FOOD CHEM, V50, P3010, DOI 10.1021/jf0115589; DINESHKUMAR B., 2010, INT J ADV PHARM SCI, V1, P75, DOI DOI 10.1021/jf060617l; Duran-Garcia R, 2014, COSTA ESTADO YUCATAN, V2, P95; Espejel I., 1984, BIOTICA, V9, P183; Ferry DR, 1996, CLIN CANCER RES, V2, P659; Garcia-Sosa K, 2011, NAT PROD RES, V25, P1185, DOI 10.1080/14786419.2010.511215; George S, 2005, J AGR FOOD CHEM, V53, P1370, DOI 10.1021/jf048396b; HAYAKARI M, 1978, ANAL BIOCHEM, V84, P361, DOI 10.1016/0003-2697(78)90053-2; Indhumathi T., 2014, International Journal of Current Microbiology and Applied Sciences, V3, P939; Kaneria Mital, 2012, Asian Pacific Journal of Tropical Biomedicine, V2, pS1526; Kannan M., 2012, Journal of Pharmacy Research, V5, P2418; Kathiresan K, 2001, ADV MAR BIOL, V40, P81, DOI 10.1016/S0065-2881(01)40003-4; Kazeem MI, 2013, TROP J PHARM RES, V12, P719, DOI 10.4314/tjpr.v12i5.9; Kwon EK, 2010, J AGR FOOD CHEM, V58, P882, DOI 10.1021/jf903515f; Mahadev R, 2014, DON INT J PHARM SCI, V4, P507; Martin GJ, 1995, ETHNOBOTANY PEOPLE P, P96; Martinez JL, 2008, SCIENCE, V321, P365, DOI 10.1126/science.1159483; Meda A, 2005, FOOD CHEM, V91, P571, DOI 10.1016/j.foodchem.2004.10.006; Medina-Medrano JR, 2016, J CHEM BIOL PHYS SCI, V4, P1135; Mendez-Gonzalez M, 2012, FLORA MED MAYAS PENI; Monk BC, 2008, SCIENCE, V321, P367, DOI 10.1126/science.1159746; Montes de Oca N., 2001, Revista de Salud Animal, V23, P1; Nair R, 2008, INDIAN J PHARM SCI, V70, P390, DOI 10.4103/0250-474X.43012; Nair S.S., 2013, EUR J EXP BIOL, V3, P128; Pan YM, 2004, FOOD CHEM, V88, P347, DOI 10.1016/j.foodchem.2004.02.002; PARISH RC, 1992, DRUG SAFETY, V7, P14, DOI 10.2165/00002018-199207010-00004; Peraza-Echeverria L, 2008, AUSTRALAS PLANT PATH, V37, P460, DOI 10.1071/AP08042; Pérez Bueno Tania, 2011, Rev Cubana Plant Med, V16, P94; Rajeev Kumar, 2010, Der Pharmacia Lettre, V2, P273; Romero Gonzalez R. R, 2011, THESIS; Ruiz-Ruiz J. C., 2016, Journal of Plant Pathology and Microbiology, V7, P332; Russell PE, 2006, PLANT PATHOL, V55, P585, DOI 10.1111/j.1365-3059.2006.01440.x; Russell PE, 2005, J AGR SCI-CAMBRIDGE, V143, P11, DOI 10.1017/S0021859605004971; Sarker S.D., 2006, METHODS BIOTECHNOLOG, V20, P1; Sharififar F, 2009, FOOD CHEM, V112, P885, DOI 10.1016/j.foodchem.2008.06.064; Siddesha JM, 2011, NAT PROD RES, V25, P1931, DOI 10.1080/14786419.2010.497962; Stevenson DE, 2007, CELL MOL LIFE SCI, V64, P2900, DOI 10.1007/s00018-007-7237-1; Tapia-Tussell R, 2006, MOL BIOTECHNOL, V33, P67; Torres W, 2010, B SOC BOT MEX, V86, P37; Tsao R, 2010, NUTRIENTS, V2, P1231, DOI 10.3390/nu2121231; Vera-Ku M, 2015, INT J INDIGENOUS MED, V48, P1793; Yasunaka K, 2005, J ETHNOPHARMACOL, V97, P293, DOI 10.1016/j.jep.2004.11.014	54	18	18	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2019	14	3							e0213493	10.1371/journal.pone.0213493	http://dx.doi.org/10.1371/journal.pone.0213493			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ5PT	30917135	Green Published, Green Submitted, gold			2022-12-26	WOS:000462465800033
J	Scherz, MD; Hutter, CR; Rakotoarison, A; Riemann, JC; Roder, MO; Ndriantsoa, SH; Gloss, J; Roberts, SH; Crottini, A; Vences, M; Glaw, F				Scherz, Mark D.; Hutter, Carl R.; Rakotoarison, Andolalao; Riemann, Jana C.; Roeder, Mark-Oliver; Ndriantsoa, Serge H.; Gloss, Julian; Roberts, Sam Hyde; Crottini, Angelica; Vences, Miguel; Glaw, Frank			Morphological and ecological convergence at the lower size limit for vertebrates highlighted by five new miniaturised microhylid frog species from three different Madagascan genera	PLOS ONE			English	Article							ANURA MICROHYLIDAE; GENUS STUMPFFIA; BODY-SIZE; MOLECULAR PHYLOGENY; COPHYLINE FROGS; LIFE-HISTORY; AMPHIBIA; RHOMBOPHRYNE; DIVERSITY; EVOLUTION	Miniaturised frogs form a fascinating but poorly understood amphibian ecomorph and have been exceptionally prone to taxonomic underestimation. The subfamily Cophylinae (family Microhylidae), endemic to Madagascar, has a particularly large diversity of miniaturised species which have historically been attributed to the single genus Stumpffia largely based on their small size. Recent phylogenetic work has revealed that several independent lineages of cophyline microhylids evolved towards highly miniaturised body sizes, achieving adult snout- vent lengths under 16 mm. Here, we describe five new species belonging to three clades that independently miniaturised and that are all genetically highly divergent from their relatives: (i) a new genus (Mini gen.nov.) with three new species from southern Madagascar, (ii) one species of Rhombophryne, and (iii) one species of Anodonthyla. Mini mum sp. nov. from Manombo in eastern Madagascar is one of the smallest frogs in the world, reaching an adult body size of 9.7 mm in males and 11.3 mm in females. Mini scule sp.nov. from Sainte Luce in southeastern Madagascar is slightly larger and has maxillary teeth. Mini ature sp.nov. from Andohahela in southeast Madagascar is larger than its congeners but is similar in build. Rhombophryne proportionalis sp.nov. from Tsaratanana in northern Madagascar is unique among Madagascar's miniaturised frogs in being a proportional dwarf, exhibiting far less advanced signs of paedomorphism than other species of similar size. Anodonthyla eximia sp.nov. from Ranomafana in eastern Madagascar is distinctly smaller than any of its congeners and is secondarily terrestrial, providing evidence that miniaturisation and terrestriality may be evolutionarily linked. The evolution of body size in Madagascar's microhylids has been more dynamic than previously understood, and future studies will hopefully shed light on the interplay between ecology and evolution of these remarkably diverse frogs.	[Scherz, Mark D.; Glaw, Frank] ZSM, SNSB, Sekt Herpetol, Munich, Germany; [Scherz, Mark D.; Rakotoarison, Andolalao; Vences, Miguel] Tech Univ Carolo Wilhelmina Braunschweig, Zool Inst, Div Evolutionary Biol, Braunschweig, Germany; [Scherz, Mark D.] Ludwig Maximilians Univ Munchen, Dept Biol 2, Biozentrum, Systemat Zool, Planegg Martinsried, Germany; [Hutter, Carl R.] Univ Kansas, Biodivers Inst, Lawrence, KS 66045 USA; [Hutter, Carl R.] Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA; [Rakotoarison, Andolalao; Ndriantsoa, Serge H.] Univ Antananarivo, Ment Zool & Biodiversite Anim, Antananarivo, Madagascar; [Riemann, Jana C.; Gloss, Julian] Univ Hamburg, Inst Zool, Hamburg, Germany; [Roeder, Mark-Oliver] Leibniz Inst Evolut & Biodivers Sci, Museum Nat Kunde, Berlin, Germany; [Roberts, Sam Hyde] SEED Madagascar, London, England; [Roberts, Sam Hyde] Oxford Brookes Univ, Oxford, England; [Crottini, Angelica] Univ Porto, InBIO, Res Ctr Biodivers & Genet Resources, CIBIO, Campus Agr Vairao, Vairao, Portugal	Braunschweig University of Technology; University of Munich; University of Kansas; University of Kansas; University Antananarivo; University of Hamburg; Leibniz Institut fur Evolutions und Biodiversitatsforschung; Oxford Brookes University; Universidade do Porto	Scherz, MD (corresponding author), ZSM, SNSB, Sekt Herpetol, Munich, Germany.; Scherz, MD (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Zool Inst, Div Evolutionary Biol, Braunschweig, Germany.; Scherz, MD (corresponding author), Ludwig Maximilians Univ Munchen, Dept Biol 2, Biozentrum, Systemat Zool, Planegg Martinsried, Germany.	mark.scherz@gmail.com	Scherz, Mark D./C-9870-2019; Hutter, Carl R/A-7380-2015; Crottini, Angelica/I-7680-2013	Scherz, Mark D./0000-0002-4613-7761; Hutter, Carl/0000-0001-6381-6339; Rakotoarison, Andolalao/0000-0003-2620-440X; Vences, Miguel/0000-0003-0747-0817; Crottini, Angelica/0000-0002-8505-3050; Riemann, Jana Carina/0000-0002-5303-3354	Investigador FCT grant from the Portuguese National Funds through FCT (Foundation for Science and Technology) [IF/00209/2014]; Deutsche Forschungsgemeinschaft [GL 665/1-1, RO 3064/2-1, VE 247/13-1]; Volkswagen foundation	Investigador FCT grant from the Portuguese National Funds through FCT (Foundation for Science and Technology); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Volkswagen foundation(Volkswagen)	AC is supported by an Investigador FCT grant from the Portuguese National Funds through FCT (Foundation for Science and Technology) grant IF/00209/2014. JCR, JG, M-OR and SHN were supported by the Deutsche Forschungsgemeinschaft (grant GL 665/1-1 and RO 3064/2-1). Fieldwork of FG and MV was supported by the Volkswagen foundation. MDS and MV were supported by the Deutsche Forschungsgemeinschaft (grant VE 247/13-1). No funders played any role in study design, data collection, analysis, or decision to publish.	ALBERCH P, 1983, J EMBRYOL EXP MORPH, V76, P177; ALBERCH P, 1979, PALEOBIOLOGY, V5, P296, DOI 10.1017/S0094837300006588; ALBERCH P, 1985, EVOLUTION, V39, P8, DOI 10.1111/j.1558-5646.1985.tb04076.x; Andreone F, 2005, MOL PHYLOGENET EVOL, V34, P315, DOI 10.1016/j.ympev.2004.10.013; [Anonymous], 2012, IUCN RED LIST CAT CR, V2nd, P32; Blackburn David C., 2009, Breviora, V517, P1; Blackburn DC, 2008, MOL PHYLOGENET EVOL, V49, P806, DOI 10.1016/j.ympev.2008.08.015; Blommers-Schlosser R.M.A., 1991, Faune de Madagascar, V75, P1; Clarke BT, 1996, SYM ZOOL S, P201; Clemente-Carvalho RBG, 2011, MOL PHYLOGENET EVOL, V61, P79, DOI 10.1016/j.ympev.2011.05.017; Das I, 2010, ZOOTAXA, P37; Monteiro JPDC, 2018, ZOOTAXA, V4407, P483, DOI 10.11646/zootaxa.4407.4.2; de Sa RO, 2019, MOL PHYLOGENET EVOL, V130, P198, DOI 10.1016/j.ympev.2018.10.021; de Sa RO, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-241; Du Preez LH, 2017, COMPLETE GUIDE FROGS; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; EMERSON SB, 1979, BIOL J LINN SOC, V11, P153, DOI 10.1111/j.1095-8312.1979.tb00032.x; Fabrezi M, 1996, HERPETOLOGICA, V52, P188; Feng YJ, 2017, P NATL ACAD SCI USA, V114, pE5864, DOI 10.1073/pnas.1704632114; Garg S, 2017, PEERJ, V5, DOI 10.7717/peerj.3007; Glaw F, 2007, FIELD GUIDE AMPHIBIA; GLAW F, 1994, FIELDGUIDE AMPHIBIAN; Glaw Frank, 2010, Zoosystematics and Evolution, V86, P235, DOI 10.1002/zoos.201000006; Gould S. J., 1977, ONTOGENY PHYLOGENY; Gunther R, 2017, ZOOSYST EVOL, V93, P265, DOI 10.3897/zse.93.11576; Guibe J., 1978, BONN ZOOL MONOGR, V11, P1; HANKEN J, 1993, ANNU REV ECOL SYST, V24, P501, DOI 10.1146/annurev.es.24.110193.002441; HANKEN J, 1985, SCIENCE, V229, P871, DOI 10.1126/science.4023715; Heideman NJL, 2011, MOL PHYLOGENET EVOL, V61, P823, DOI 10.1016/j.ympev.2011.08.021; IUCN SSC Amphibian Specialist Group, 2016, IUCN RED LIST THREAT, V2016, DOI 10.2305/IUCN.UK.2016-1.RLTS.T88219153A88312479; Klages J, 2013, ZOOTAXA, V3717, P280; Klingenberg CP, 1998, BIOL REV, V73, P79, DOI 10.1017/S000632319800512X; Kohler F, 2008, MOL PHYLOGENET EVOL, V47, P353, DOI 10.1016/j.ympev.2007.11.032; Kohler J, 2017, ZOOTAXA, V4251, P1, DOI 10.11646/zootaxa.4251.1.1; Kraus F, 2011, ZOOKEYS, P71, DOI 10.3897/zookeys.154.1963; Kraus F, 2010, ZOOKEYS, P39, DOI 10.3897/zookeys.48.446; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lehr E, 2008, HERPETOLOGICA, V64, P354, DOI 10.1655/07-089.1; *LEW ENV CONS, 1992, ENV IMP ASS STUD 1; Lourenco-de-Moraes R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201781; Marquez R., 2006, CALLS FROGS MADAGASC; Matsui Masafumi, 2011, Zootaxa, V2814, P33; Mott T, 2009, MOL PHYLOGENET EVOL, V51, P190, DOI 10.1016/j.ympev.2009.01.014; Oliver PM, 2017, PEERJ, V5, DOI 10.7717/peerj.3077; Padial JM, 2014, ZOOTAXA, V3825, P1, DOI 10.11646/zootaxa.3825.1.1; Parker HW, 1934, MONOGRAPH FROGS FAMI; Peloso PLV, 2017, MOL PHYLOGENET EVOL, V111, P56, DOI 10.1016/j.ympev.2017.03.016; Peloso PLV, 2016, CLADISTICS, V32, P113, DOI 10.1111/cla.12118; PELOSO PL, 2014, B AM MUS NAT HIST, V386, P1, DOI DOI 10.1206/834.1; Perl RGB, 2014, AMPHIBIA-REPTILIA, V35, P197, DOI 10.1163/15685381-00002942; Poyarkov NA, 2018, ZOOL RES, V39, P130, DOI 10.24272/j.issn.2095-8137.2018.019; Rakotoarison A, 2017, VERTEBR ZOOL, V67, P271; Ramanamanjato J-B, 2011, TSITONGAMBARIKA FORE, P34; Ramanamanjato Jean-Baptiste, 2007, P167; Ribeiro LF, 2015, PEERJ, V3, DOI 10.7717/peerj.1011; Rieppel O, 1996, SYM ZOOL S, P47; Rittmeyer EN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029797; Rodriguez A, 2015, EVOL ECOL, V29, P765, DOI 10.1007/s10682-015-9774-7; Rodriguez A, 2013, MOL PHYLOGENET EVOL, V68, P541, DOI 10.1016/j.ympev.2013.04.031; Rosa GM, 2014, SALAMANDRA, V50, P201; Scherz MD, 2017, SALAMANDRA, V53, P479; Scherz MD, 2017, ZOOTAXA, V4273, P301, DOI 10.11646/zootaxa.4273.3.1; Scherz MD, 2016, SALAMANDRA, V52, P91; Scherz MD, 2016, MOL PHYLOGENET EVOL, V100, P372, DOI 10.1016/j.ympev.2016.04.019; Scherz MD, 2015, ZOOSYST EVOL, V91, P105, DOI 10.3897/zse.91.4979; Scherz MD, 2015, HERPETOLOGICA, V71, P310, DOI 10.1655/HERPETOLOGICA-D-14-00048; Tracy CR, 2010, ECOLOGY, V91, P1477, DOI 10.1890/09-0839.1; Trueb L., 1973, P65; Trueb L., 1985, FUNCTIONAL MORPHOLOG, P113; Trueb L, 1968, CRANIAL OSTEOLOGY HY, V18, P11; Trueb Linda, 1993, P255; Tu N, 2018, MOL PHYLOGENET EVOL, V126, P85, DOI 10.1016/j.ympev.2018.03.036; Vallan D, 2000, REV SUISSE ZOOL, V107, P835, DOI 10.5962/bhl.part.80150; van der Meijden A, 2007, MOL PHYLOGENET EVOL, V44, P1017, DOI 10.1016/j.ympev.2007.02.008; Vences M., 1991, Acta Biologica Benrodis, V3, P203; Vences M, 2013, ZOOTAXA, V3636, P201, DOI 10.11646/zootaxa.3636.2.1; Vences M, 2010, CONTRIB ZOOL, V79, P1; Vieites DR, 2009, P NATL ACAD SCI USA, V106, P8267, DOI 10.1073/pnas.0810821106; Wollenberg KC, 2008, EVOLUTION, V62, P1890, DOI 10.1111/j.1558-5646.2008.00420.x; Yeh J, 2002, EVOLUTION, V56, P628; Zimkus BM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035118	81	23	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2019	14	3							e0213314	10.1371/journal.pone.0213314	http://dx.doi.org/10.1371/journal.pone.0213314			45	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ5PT	30917162	Green Published, gold			2022-12-26	WOS:000462465800026
J	Stepien, CA; Snyder, MR; Elz, AE				Stepien, Carol A.; Snyder, Matthew R.; Elz, Anna E.			Invasion genetics of the silver carp Hypophthalmichthys molitrix across North America: Differentiation of fronts, introgression, and eDNA metabarcode detection	PLOS ONE			English	Article							LAURENTIAN GREAT-LAKES; EURASIAN ROUND GOBY; GRASS CARP; ASIAN CARP; POPULATION-GENETICS; RANGE EXPANSION; BIGHEAD CARP; ARISTICHTHYS-NOBILIS; DREISSENID MUSSEL; ILLINOIS RIVER	In the 1970s, the introduced silver carp Hypophthalmichthys molitrix (which is indigenous to eastern Asia) escaped from southern U. S. aquaculture to spread throughout the Mississippi River basin, and since has steadily moved northward. This large, prolific filter-feeder reduces food availability for other fishes. It now has reached the threshold of the Laurentian Great Lakes, where it likely will significantly impact food chains and fisheries. Our study evaluates population genetic variability and differentiation of the silver carp using 10 nuclear DNA microsatellite loci, and sequences of two mitochondrial genes-cytochrome b and cytochrome c oxidase subunit 1, along with the nuclear ribosomal protein S7 gene intron 1. We analyze population samples from: two primary Great Lakes' invasion fronts (at the Illinois River outside of Chicago, IL in Lake Michigan and in the Wabash River, which leads into the Maumee River and western Lake Erie), the original establishment "core" in the Lower Mississippi River, and expansion areas in the Upper Mississippi and Missouri rivers. We analyze and compare our results with bighead and other invasive carps, and cyprinid relatives. Results reveal that the silver carp invasion possesses moderate levels of genetic diversity, with more mtDNA haplotypes and unique microsatellite alleles in the "core" Lower Mississippi River population, which also diverges the most. The two invasion fronts also significantly genetically differ. About 3% of individuals (including all populations except the Illinois River) contain a unique and very divergent mtDNA haplotype, which likely stems from historic introgression in Asia with female largescale silver carp H. harmandi. The nuclear microsatellites and S7 sequences of the introgressed individuals do not differ from silver carp and are very distant from bighead carp. These sequence variation data are employed to design and evaluate a targeted high-throughput metabarcoding sequence assay that identifies and distinguishes among species of invasive carps (i. e., silver, bighead, grass, black, and common carps, along with goldfish), as well as native cyprinids, using cytochrome b. Our assay further differentiates among selected silver carp haplotypes (including between H. molitrix and H. harmandi), for use in population genetics and future analyses of spread pathways. We test and evaluate this assay on environmental (e) DNA water samples from 48 bait shops in the Great Lakes' region (along the Lake Erie, Lake St. Clair, and Wabash River watersheds), using positive and negative controls and custom bioinformatic processing. Test results discern silver carp eDNA in four of the shops-three in Lake Erie and one in the Wabash River watershed-and bighead carp from one of the same Lake Erie venues, suggesting that retailers (who often source from established southerly populations) comprise another introduction vector. Our overall findings thus provide key population genetic and phylogenetic data for understanding and tracing introductions, vectors, and spread pathways for silver carp, their variants, and their relatives.	[Stepien, Carol A.; Snyder, Matthew R.; Elz, Anna E.] NOAA, Pacific Marine Environm Lab, Genet & Genom Grp G3, 7600 Sand Point Way Ne, Seattle, WA 98115 USA	National Oceanic Atmospheric Admin (NOAA) - USA	Stepien, CA (corresponding author), NOAA, Pacific Marine Environm Lab, Genet & Genom Grp G3, 7600 Sand Point Way Ne, Seattle, WA 98115 USA.	Carol.Stepien@noaa.gov	A.Stepien, Carol/AAW-5270-2020; Stepien, Carol A./A-7898-2011; Stepien, Carol Ann/GWU-8631-2022	Stepien, Carol A./0000-0002-5544-4333; 	CAS-USEPA GLRI [GL-00E01898]; USEPA Great Lakes Restoration Initiative (GLRI) [GL-00E01898]	CAS-USEPA GLRI; USEPA Great Lakes Restoration Initiative (GLRI)	This work was supported by CAS-USEPA GLRI #GL-00E01898. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by a grant award to CAS from the USEPA Great Lakes Restoration Initiative (GLRI) #GL-00E01898. Specimens either were collected by us and other members of CAS' Genetics and Genomics Group laboratory or were provided by various colleagues, including: M. Bartron, D. Chapman, A. Coulter, J. Lamer, R. Lance, and M. Pyron. Our laboratory relocated during this project from the University of Toledo to NOAA PMEL in October 2016. We thank T. Ackerman, K. Andrews, F. Averick, N. Bond, D. Butterfield, F. Calzonetti, D. Funches, J. Guyton, E. Kramer, S. McBride, N. Marshall, C. Prichard, and C. Sabine for various logistical help. This is NOAA Pacific Marine Environmental Laboratory (PMEL) contribution #4825.	Akihito, 2000, GENE, V259, P5, DOI 10.1016/S0378-1119(00)00488-1; Allendorf FW, 2013, CONSERV GENET, P421; Antao T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-323; Bai WN, 2015, J SYST EVOL, V53, P163, DOI 10.1111/jse.12128; Baker H. G., 1965, The genetics of colonizing species., P147; Barbiero RP, 2004, CAN J FISH AQUAT SCI, V61, P2111, DOI 10.1139/f04-149; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; Belkhir K, 1996, GENETIX 4 05 LOGICIE; Benzecri JP, 1978, CAH ANAL DONNEES, V3, P131; Betancur-R R, 2011, J BIOGEOGR, V38, P1281, DOI 10.1111/j.1365-2699.2011.02496.x; Bock DG, 2015, MOL ECOL, V24, P2277, DOI 10.1111/mec.13032; Bonferroni CE, 1936, SUPERIORE SCI EC COM, V8, P3; Brown JE, 2008, MOL ECOL, V17, P2598, DOI 10.1111/j.1365-294X.2008.03777.x; Brown JE, 2010, BIOL INVASIONS, V12, P3687, DOI 10.1007/s10530-010-9763-2; Brown JE, 2009, MOL ECOL, V18, P64, DOI 10.1111/j.1365-294X.2008.04014.x; Bubac CM, 2016, AUK, V133, P213, DOI 10.1642/AUK-15-124.1; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; CASSANI JR, 1985, AQUACULTURE, V46, P37, DOI 10.1016/0044-8486(85)90173-5; CASSANI JR, 1986, AQUACULTURE, V55, P43, DOI 10.1016/0044-8486(86)90054-2; Chen Q, 2012, GENETICA, V140, P115, DOI 10.1007/s10709-012-9663-8; Cheng L, 2008, MOL ECOL RESOUR, V8, P656, DOI 10.1111/j.1471-8286.2007.02037.x; Chow S, 1998, MOL ECOL, V7, P1255; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; COCKERHAM CC, 1993, EVOLUTION, V47, P855, DOI 10.1111/j.1558-5646.1993.tb01239.x; Colautti RI, 2015, MOL ECOL, V24, P1999, DOI 10.1111/mec.13162; Cooke SL, 2010, FRESHWATER BIOL, V55, P2138, DOI 10.1111/j.1365-2427.2010.02474.x; Coulter AA, 2016, BIOL INVASIONS, V18, P471, DOI 10.1007/s10530-015-1020-2; Coulter AA, 2013, FRESHWATER BIOL, V58, P1029, DOI 10.1111/fwb.12106; COURTENAY W R JR, 1990, Journal of the World Aquaculture Society, V21, P145, DOI 10.1111/j.1749-7345.1990.tb01017.x; Courtenay W.R. Jr, 1984, P41; Cristescu MEA, 2004, HEREDITY, V92, P197, DOI 10.1038/sj.hdy.6800395; Cristescu ME, 2018, ANNU REV ECOL EVOL S, V49, P209, DOI 10.1146/annurev-ecolsys-110617-062306; Cuddington K, 2014, BIOL INVASIONS, V16, P903, DOI 10.1007/s10530-013-0547-3; Cudmore B, 2011, AM FISH S S, V74, P15; DeBoer JA, 2018, FRESHWATER BIOL, V63, P597, DOI 10.1111/fwb.13097; DeVanna KM, 2011, J GREAT LAKES RES, V37, P632, DOI 10.1016/j.jglr.2011.07.005; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Elvira B, 2001, J FISH BIOL, V59, P323, DOI 10.1006/jfbi.2001.1753; Embke HS, 2016, J GREAT LAKES RES, V42, P899, DOI 10.1016/j.jglr.2016.05.002; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Farrington HL, 2017, BIOL INVASIONS, V19, P2789, DOI 10.1007/s10530-017-1484-3; Ficetola GF, 2015, MOL ECOL RESOUR, V15, P543, DOI 10.1111/1755-0998.12338; Forsman A, 2014, P NATL ACAD SCI USA, V111, P302, DOI 10.1073/pnas.1317745111; Freeze M., 1982, North American Journal of Fisheries Management, V2, P197, DOI 10.1577/1548-8659(1982)2<197:DASOTB>2.0.CO;2; Glaubitz JC, 2004, MOL ECOL NOTES, V4, P309, DOI 10.1111/j.1471-8286.2004.00597.x; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Grabowska J, 2010, FOLIA ZOOL, V59, P73; Great Lakes Fishery Commission (GLFC), 2018, AS CARP; Guo WJ, 2013, AQUACULTURE, V412, P97, DOI 10.1016/j.aquaculture.2013.06.027; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Hubbs CL, 2007, FISHES GREAT LAKES R; Huey RB, 2005, SPECIES INVASIONS: INSIGHTS INTO ECOLOGY, EVOLUTION, AND BIOGEORGRAPHY, P139; Indiana Department of Natural Resources (IDNR), 2015, EAGL MARSH BERM BLOC; Irons KS, 2007, J FISH BIOL, V71, P258, DOI 10.1111/j.1095-8649.2007.01670.x; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Jerde CL, 2013, CAN J FISH AQUAT SCI, V70, P522, DOI 10.1139/cjfas-2012-0478; Jones OR, 2010, MOL ECOL RESOUR, V10, P551, DOI 10.1111/j.1755-0998.2009.02787.x; JUDE DJ, 1992, CAN J FISH AQUAT SCI, V49, P416, DOI 10.1139/f92-047; Karatayev AY, 2011, HYDROBIOLOGIA, V668, P183, DOI 10.1007/s10750-010-0533-z; Khodakov D, 2016, ADV DRUG DELIVER REV, V105, P3, DOI 10.1016/j.addr.2016.04.005; King TL, 2011, CONSERV GENET RESOUR, V3, P397, DOI 10.1007/s12686-010-9285-3; Kinziger AP, 2014, CONSERV GENET, V15, P1, DOI 10.1007/s10592-013-0516-5; Klymus KE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177643; Kocovsky PM, 2011, BIOL INVASIONS, V13, P2775, DOI 10.1007/s10530-011-9962-5; Koel T. M., 2000, ASIAN CARP INVASION; Kolar C.S., 2007, AM FISHERIES SOC SPE; Kornis MS, 2012, J FISH BIOL, V80, P235, DOI 10.1111/j.1095-8649.2011.03157.x; Lamer JT, 2015, MOL ECOL, V24, P3931, DOI 10.1111/mec.13285; Lamer JT, 2010, N AM J FISH MANAGE, V30, P1452, DOI 10.1577/M10-053.1; Li SF, 2011, ENVIRON BIOL FISH, V92, P503, DOI 10.1007/s10641-011-9870-7; Liu J., FRESHWATER FISHES GU, P106, DOI [10.1016/j.aquaculture.2013.06.027, DOI 10.1016/J.AQUACULTURE.2013.06.027]; Lockwood JL, 2013, INVASION ECOLOGY, P277; Lockwood JL, 2013, INVASION ECOLOGY, P75; MacConaill LE, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-017-4428-5; Mahon AR, 2014, CONSERV GENET RESOUR, V6, P563, DOI 10.1007/s12686-014-0213-9; Marshall NT, 2019, ECOL EVOL, V9, P3515, DOI 10.1002/ece3.4985; MAY B, 1992, CAN J FISH AQUAT SCI, V49, P1501, DOI 10.1139/f92-166; Meirmans PG, 2011, MOL ECOL RESOUR, V11, P5, DOI 10.1111/j.1755-0998.2010.02927.x; Mia MY, 2005, AQUACULTURE, V247, P267, DOI 10.1016/j.aquaculture.2005.02.018; MILLS EL, 1994, BIOSCIENCE, V44, P666, DOI 10.2307/1312510; Mooney HA, 2001, P NATL ACAD SCI USA, V98, P5446, DOI 10.1073/pnas.091093398; Nalepa TF, 2010, J GREAT LAKES RES, V36, P5, DOI 10.1016/j.jglr.2010.03.013; Nalepa TF, 2009, FRESHWATER BIOL, V54, P466, DOI 10.1111/j.1365-2427.2008.02123.x; National Oceanic and Atmospheric Administration, 2018, GREAT LAK ENV RES LA; NEI M, 1975, EVOLUTION, V29, P1, DOI 10.2307/2407137; Nico L.G., 2005, SPECIAL PUBLICATION, V32; Ochocki BM, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14315; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; Parker AD, 2015, J GREAT LAKES RES, V41, P396, DOI 10.1016/j.jglr.2015.03.004; Perkins TA, 2013, ECOL LETT, V16, P1079, DOI 10.1111/ele.12136; Piaggio AJ, 2017, ECOL EVOL, V7, P5343, DOI 10.1002/ece3.3087; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Pritchard JK, 2000, GENETICS, V155, P945; Quinn A, 2014, AQUAT CONSERV, V24, P324, DOI 10.1002/aqc.2414; R Development Core Team, 2015, R LANG STAT COMP VER; Raymond M, 1995, EVOLUTION, V49, P1280, DOI 10.1111/j.1558-5646.1995.tb04456.x; Ricciardi A, 2001, CAN J FISH AQUAT SCI, V58, P2513, DOI 10.1139/cjfas-58-12-2513; Ricciardi A, 2006, DIVERS DISTRIB, V12, P425, DOI 10.1111/j.1366-9516.2006.00262.x; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rius M, 2015, BIOL INVASIONS, V17, P869, DOI 10.1007/s10530-014-0792-0; Robison H. W, 1988, FISHES ARKANSAS; Roman J, 2007, TRENDS ECOL EVOL, V22, P454, DOI 10.1016/j.tree.2007.07.002; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Sampson SJ, 2009, BIOL INVASIONS, V11, P483, DOI 10.1007/s10530-008-9265-7; Sass GG, 2014, J GREAT LAKES RES, V40, P911, DOI 10.1016/j.jglr.2014.08.010; Schofield P.J., 2005, 20055041 US GEOL SUR, P103, DOI DOI 10.3996/112012-JFWM-101/SUPPL_FILE/10.3996_112012-JFWM-101.S1.PDF; Sepulveda-Villet OJ, 2012, MOL ECOL, V21, P5795, DOI 10.1111/mec.12044; Shine R, 2011, P NATL ACAD SCI USA, V108, P5708, DOI 10.1073/pnas.1018989108; Simberloff D, 2006, ECOL LETT, V9, P912, DOI 10.1111/j.1461-0248.2006.00939.x; Simberloff D, 2009, ANNU REV ECOL EVOL S, V40, P81, DOI 10.1146/annurev.ecolsys.110308.120304; Slatkin M, 2012, GENETICS, V191, P171, DOI 10.1534/genetics.112.139022; SMITH BR, 1980, CAN J FISH AQUAT SCI, V37, P1780, DOI 10.1139/f80-222; Snyder MR, 2017, MOL ECOL, V26, P1075, DOI 10.1111/mec.13997; Song CB, 1998, MOL PHYLOGENET EVOL, V10, P343, DOI 10.1006/mpev.1998.0542; Stepien C, 2013, QUAGGA ZEBRA MUSSELS, P403, DOI DOI 10.1201/B15437-33; Stepien CA, 2006, BIOL INVASIONS, V8, P61, DOI 10.1007/s10530-005-0237-x; Stepien CA, 2005, RISK ANAL, V25, P1043, DOI 10.1111/j.1539-6924.2005.00655.x; Stepien CA, 2018, AQUAT INVASIONS, V13, P537, DOI 10.3391/ai.2018.13.4.11; Stepien Carol A., 1997, P1, DOI 10.1016/B978-012417540-2/50002-6; Stern CV, 2014, 75700 C RES SERV; Szpiech ZA, 2008, BIOINFORMATICS, V24, P2498, DOI 10.1093/bioinformatics/btn478; Tepolt CK, 2015, MOL ECOL, V24, P4145, DOI 10.1111/mec.13294; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Voisin M, 2005, P NATL ACAD SCI USA, V102, P5432, DOI 10.1073/pnas.0501754102; Waples RS, 1998, J HERED, V89, P438, DOI 10.1093/jhered/89.5.438; Wares JP, 2005, SPECIES INVASIONS: INSIGHTS INTO ECOLOGY, EVOLUTION, AND BIOGEORGRAPHY, P229; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; White TA, 2013, MOL ECOL, V22, P2971, DOI 10.1111/mec.12343; Williamson M, 1999, ECOGRAPHY, V22, P5, DOI 10.1111/j.1600-0587.1999.tb00449.x; Wilson KA, 2004, CAN J FISH AQUAT SCI, V61, P2255, DOI [10.1139/f04-170, 10.1139/F04-170]; Yeh YC, 2018, MSYSTEMS, V3, DOI 10.1128/mSystems.00023-18	133	19	21	7	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2019	14	3							e0203012	10.1371/journal.pone.0203012	http://dx.doi.org/10.1371/journal.pone.0203012			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ5PT	30917127	Green Submitted, Green Published, gold			2022-12-26	WOS:000462465800002
J	Prabhakar, A; Vujovic, D; Cui, L; Olson, W; Luo, WQ				Prabhakar, Arthi; Vujovic, Dragan; Cui, Lian; Olson, William; Luo, Wenqin			Leaky expression of channelrhodopsin-2 (ChR2) in Ai32 mouse lines	PLOS ONE			English	Article								Optogenetics enables the selective activation of genetically-targeted neuronal populations using light-sensitive ion channels. Genetic strategies using Cre-dependent mouse strains, especially the Ai32 line expressing Channelrhodopsin (ChR2)-EYFP fusion protein, have been a popular means to drive opsin expression in a cell-type specific manner. Here we report a low level of leaky 'off-target' (Cre-independent) ChR2-EYFP expression in Ai32/Ai32 homozygous mice throughout the nervous system. This leaky off-target expression was characterized in multiple prevalent nervous system regions using anti-EYFP immunostaining. Expression of full-length ChR2-EYFP protein was confirmed using immunoprecipitation followed by Western blotting. Notably, light stimulation of these ChR2-EYFP expressing neurons in the spinal cord dorsal horn did not induce detectable photocurrents in juvenile 4-week old mice. Given the wide use of the Ai32 line by many labs, our results suggest researchers should be vigilant of possible off-target ChR2-EYFP expression in their region of interest, especially when generating Ai32/Ai32 homozygotes to drive high levels of ChR2-EYFP expression in adult mice.	[Prabhakar, Arthi] Univ Texas Dallas, Dallas, TX USA; [Vujovic, Dragan] Williams Coll, Williamstown, MA 01267 USA; [Cui, Lian; Olson, William; Luo, Wenqin] Univ Penn, Dept Neurosci, Philadelphia, PA 19104 USA; [Olson, William] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	University of Texas System; University of Texas Dallas; Williams College; University of Pennsylvania; Johns Hopkins University	Olson, W; Luo, WQ (corresponding author), Univ Penn, Dept Neurosci, Philadelphia, PA 19104 USA.; Olson, W (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA.	wolson6@jhmi.edu; luow@pennmedicine.upenn.edu	Luo, Wen/GRO-5989-2022	Luo, Wenqin/0000-0002-2486-807X	National Institutes of Health (NIH) [NS083702, NS094224, NS092297]; Klingenstein-Simons Fellowship Award in the Neurosciences; NIH [NS083702, NS094224, NS092297]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS094224, F31NS092297, R01NS083702] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Klingenstein-Simons Fellowship Award in the Neurosciences; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health (NIH,www.nih.gov) (NS083702 and NS094224 to W.L and NS092297 to W.O.) and the Klingenstein-Simons Fellowship Award in the Neurosciences (http://www.klingfund.org) to W.L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Peter Dong and Andrew Moberly for providing mouse tissue for these studies, as well as Dr. Alice Chen-Plotkin for the use of the ChemiDoc Western Blot imaging system. This work was supported by NIH grants to W.L (NS083702 and NS094224) and W.O. (NS092297).	Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Cui L, 2016, NEURON, V91, P1413, DOI 10.1016/j.neuron.2016.09.010; Fleming MS, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-52; Heinke B, 2004, J PHYSIOL-LONDON, V560, P249, DOI 10.1113/jphysiol.2004.070540; Kuhlman SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002005; Madisen L, 2012, NAT NEUROSCI, V15, P793, DOI 10.1038/nn.3078; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Niu JW, 2013, J NEUROSCI, V33, P17691, DOI 10.1523/JNEUROSCI.3429-13.2013; Scanziani M, 2009, NATURE, V461, P930, DOI 10.1038/nature08540; Seidler B, 2008, P NATL ACAD SCI USA, V105, P10137, DOI 10.1073/pnas.0800487105; Ting JT, 2014, METHODS MOL BIOL, V1183, P221, DOI 10.1007/978-1-4939-1096-0_14	11	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2019	14	3							e0213326	10.1371/journal.pone.0213326	http://dx.doi.org/10.1371/journal.pone.0213326			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ3IW	30913225	gold, Green Submitted, Green Published			2022-12-26	WOS:000462305600013
J	Giantin, M; Kublbeck, J; Zancanella, V; Prantner, V; Sansonetti, F; Schoeniger, A; Tolosi, R; Guerra, G; Da Ros, S; Dacasto, M; Honkakoski, P				Giantin, Mery; Kublbeck, Jenni; Zancanella, Vanessa; Prantner, Viktoria; Sansonetti, Fabiana; Schoeniger, Axel; Tolosi, Roberta; Guerra, Giorgia; Da Ros, Silvia; Dacasto, Mauro; Honkakoski, Paavo			DNA elements for constitutive androstane receptor- and pregnane X receptor-mediated regulation of bovine CYP3A28 gene	PLOS ONE			English	Article							TRANSCRIPTION FACTOR-BINDING; MESSENGER-RNA ABUNDANCE; NUCLEAR RECEPTOR; CYTOCHROMES P450; TARGET GENES; EXPRESSION; CATTLE; LIVER; CAR; METABOLISM	The regulation of cytochrome P450 3A (CYP3A) enzymes is established in humans, but molecular mechanisms of its basal and xenobiotic-mediated regulation in cattle are still unknown. Here, similar to 10 kbp of the bovine CYP3A28 gene promoter were cloned and sequenced, and putative transcription factor binding sites were predicted. The CYP3A28 proximal promoter (PP; -284/+71 bp) contained DNA elements conserved among species. Co-transfection of bovine nuclear receptors (NRs) pregnane X and constitutive androstane receptor (bPXR and bCAR) with various CYP3A28 promoter constructs into hepatoma cell lines identified two main regions, the PP and the distal fragment F3 (-6899/-4937 bp), that were responsive to bPXR (both) and bCAR (F3 fragment only). Site-directed mutagenesis and deletion of NR motif ER6, hepatocyte nuclear factor 1 (HNF-1) and HNF-4 binding sites in the PP suggested either the involvement of ER6 element in bPXR-mediated activation or the cooperation between bPXR and liver-enriched transcription factors (LETFs) in PP trans-activation. A putative DR5 element within the F3 fragment was involved in bCAR-mediated PP+F3 transactivation. Although DNA enrichment by anti-human NR antibodies was quite low, ChIP investigations in control and RU486-treated BFH12 cells, suggested that retinoid X receptor alpha (RXR alpha) bound to ER6 and DR5 motifs and its recruitment was enhanced by RU486 treatment. The DR5 element seemed to be recognized mainly by bCAR, while no clear-cut results were obtained for bPXR. Present results point to species-differences in CYP3A regulation and the complexity of bovine CYP3A28 regulatory elements, but further confirmatory studies are needed.	[Giantin, Mery; Zancanella, Vanessa; Sansonetti, Fabiana; Tolosi, Roberta; Guerra, Giorgia; Da Ros, Silvia; Dacasto, Mauro] Univ Padua, Dept Comparat Biomed & Food Sci, Padua, Italy; [Kublbeck, Jenni; Prantner, Viktoria; Honkakoski, Paavo] Univ Eastern Finland, Sch Pharm, Fac Hlth Sci, Kuopio, Finland; [Schoeniger, Axel] Univ Leipzig, Inst Biochem, Leipzig, Germany	University of Padua; University of Eastern Finland; Leipzig University	Giantin, M (corresponding author), Univ Padua, Dept Comparat Biomed & Food Sci, Padua, Italy.	mery.giantin@unipd.it	Giantin, Mery/AAX-3235-2020; Honkakoski, Paavo/AAJ-1278-2020; Küblbeck, Jenni/ABE-3846-2021	Honkakoski, Paavo/0000-0002-4332-3577; Küblbeck, Jenni/0000-0002-6439-4403; GIANTIN, Mery/0000-0003-0015-3800	University of Padua [CPDA109434, DOR1673992, DOR1732295, 60A08-4783/14]; Academy of Finland; European Union ERASMUS+ program; University of Eastern Finland Doctoral Program in Drug Research	University of Padua; Academy of Finland(Academy of Finland); European Union ERASMUS+ program(European Commission); University of Eastern Finland Doctoral Program in Drug Research	This research was supported by the University of Padua [Grants CPDA109434, DOR1673992, DOR1732295 to MG and 60A08-4783/14 to MD] and by Academy of Finland to JK and PH, European Union ERASMUS+ program to PH and the University of Eastern Finland Doctoral Program in Drug Research to VP.	Ali HO, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152114; Ashwell MS, 2011, RES VET SCI, V90, P235, DOI 10.1016/j.rvsc.2010.05.029; Barwick JL, 1996, MOL PHARMACOL, V50, P10; Bertilsson G, 1998, P NATL ACAD SCI USA, V95, P12208, DOI 10.1073/pnas.95.21.12208; Bian YC, 2015, DRUG METAB DISPOS, V43, P1336, DOI 10.1124/dmd.115.064717; Biggs JS, 2007, MOL PHARMACOL, V72, P514, DOI 10.1124/mol.106.033795; Blumberg B, 1998, GENE DEV, V12, P3195, DOI 10.1101/gad.12.20.3195; Cantiello M, 2009, BIOCHEM PHARMACOL, V77, P451, DOI 10.1016/j.bcp.2008.10.025; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Dacasto M, 2005, VET RES, V36, P179, DOI 10.1051/vetres:2004066; di Masi A, 2009, MOL ASPECTS MED, V30, P297, DOI 10.1016/j.mam.2009.04.002; Dong LF, 2015, DRUG METAB DISPOS, V43, P1458, DOI 10.1124/dmd.115.065565; Dupuy J, 2001, VET RES COMMUN, V25, P345, DOI 10.1023/A:1010686508307; Erster O, 2010, METHODS MOL BIOL, V634, P157, DOI 10.1007/978-1-60761-652-8_12; Frank C, 2004, J BIOL CHEM, V279, P33558, DOI 10.1074/jbc.M403946200; Frank C, 2003, J BIOL CHEM, V278, P43299, DOI 10.1074/jbc.M305186200; Gamou T, 2015, DRUG METAB PHARMACOK, V30, P188, DOI 10.1016/j.dmpk.2014.12.008; Giantin M, 2008, DRUG METAB DISPOS, V36, P885, DOI 10.1124/dmd.107.019042; Gleich A, 2016, IN VITRO CELL DEV-AN, V52, P662, DOI 10.1007/s11626-016-0018-0; Goodwin B, 2002, MOL PHARMACOL, V62, P359, DOI 10.1124/mol.62.2.359; Goodwin B, 1999, MOL PHARMACOL, V56, P1329, DOI 10.1124/mol.56.6.1329; Gray MA, 2009, XENOBIOTICA, V39, P915, DOI 10.3109/00498250903330348; Gray MA, 2010, EXP BIOL MED, V235, P718, DOI 10.1258/ebm.2010.009339; Greger DL, 2007, J ANIM PHYSIOL AN N, V91, P62, DOI 10.1111/j.1439-0396.2006.00642.x; Greger DL, 2006, DOMEST ANIM ENDOCRIN, V31, P76, DOI 10.1016/j.domaniend.2005.09.007; GREGORI C, 1994, NUCLEIC ACIDS RES, V22, P1242, DOI 10.1093/nar/22.7.1242; Haque ME, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197126; He YC, 2018, COMP BIOCHEM PHYS C, V214, P9, DOI 10.1016/j.cbpc.2018.08.006; Honkakoski P, 2001, PHARMACEUT RES, V18, P146, DOI 10.1023/A:1011068015301; Kaestner KH, 2000, TRENDS ENDOCRIN MET, V11, P281, DOI 10.1016/S1043-2760(00)00271-X; Klein Kathrin, 2013, Frontiers in Genetics, V4, P12, DOI 10.3389/fgene.2013.00012; Kublbeck J, 2016, XENOBIOTICA, V46, P200, DOI 10.3109/00498254.2015.1060374; Kublbeck J, 2011, MOL PHARMACEUT, V8, P2424, DOI 10.1021/mp2003658; Kublbeck J, 2011, BIOCHEM PHARMACOL, V82, P1994, DOI 10.1016/j.bcp.2011.08.027; Kublbeck J, 2010, EUR J PHARM SCI, V40, P263, DOI 10.1016/j.ejps.2010.03.022; Kuilman MEM, 2000, TOXICOL IN VITRO, V14, P321, DOI 10.1016/S0887-2333(00)00025-4; Lamba JK, 2002, ADV DRUG DELIVER REV, V54, P1271, DOI 10.1016/S0169-409X(02)00066-2; Mate ML, 2015, XENOBIOTICA, V45, P563, DOI 10.3109/00498254.2014.1002122; Lehmann JM, 1998, J CLIN INVEST, V102, P1016, DOI 10.1172/JCI3703; Li XW, 2015, XENOBIOTICA, V45, P373, DOI 10.3109/00498254.2014.985761; Li XW, 2014, BIOCHEM BIOPH RES CO, V445, P469, DOI 10.1016/j.bbrc.2014.02.011; Liu FJ, 2008, BIOCHEM J, V409, P243, DOI 10.1042/BJ20070613; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lolodi O, 2017, CURR DRUG METAB, V18, P1095, DOI 10.2174/1389200218666170531112038; Makinen JM, 2002, MOL PHARMACOL, V62, P366, DOI 10.1124/mol.62.2.366; Matsumura K, 2004, MOL PHARMACOL, V65, P326, DOI 10.1124/mol.65.2.326; Molnar Ferdinand, 2013, Drug Metabolism and Drug Interactions, V28, P79, DOI 10.1515/dmdi-2013-0009; Moubarak AS, 2000, BIOCHEM BIOPH RES CO, V274, P746, DOI 10.1006/bbrc.2000.3210; Nagalingam K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194420; Nebbia C, 2001, J VET PHARMACOL THER, V24, P399, DOI 10.1046/j.1365-2885.2001.00362.x; Nem D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030895; Podvinec M, 2002, MOL ENDOCRINOL, V16, P1269, DOI 10.1210/me.16.6.1269; Puccinelli E, 2011, CURR DRUG METAB, V12, P507; Qiu H, 2010, PHARMACOGENET GENOM, V20, P167, DOI 10.1097/FPC.0b013e328336bbeb; ROUET P, 1995, NUCLEIC ACIDS RES, V23, P395, DOI 10.1093/nar/23.3.395; Sandelin A, 2005, MOL ENDOCRINOL, V19, P595, DOI 10.1210/me.2004-0101; Smith CL, 1997, J BIOL CHEM, V272, P27493, DOI 10.1074/jbc.272.44.27493; Stanley LA, 2006, DRUG METAB REV, V38, P515, DOI 10.1080/03602530600786232; Sueyoshi T, 1999, J BIOL CHEM, V274, P6043, DOI 10.1074/jbc.274.10.6043; Urdinguio RG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003669; Zancanella V, 2014, VET J, V202, P106, DOI 10.1016/j.tvjl.2014.07.028; Zancanella V, 2010, J VET PHARMACOL THER, V33, P528, DOI 10.1111/j.1365-2885.2010.01173.x; Zancanella V, 2012, XENOBIOTICA, V42, P1096, DOI 10.3109/00498254.2012.694493; Zanger UM, 2013, PHARMACOL THERAPEUT, V138, P103, DOI 10.1016/j.pharmthera.2012.12.007; Zweers-Zeilmaker WM, 1999, RES VET SCI, V66, P51, DOI 10.1053/rvsc.1998.0239	65	4	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2019	14	3							e0214338	10.1371/journal.pone.0214338	http://dx.doi.org/10.1371/journal.pone.0214338			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ1KV	30908543	Green Published, Green Submitted, gold			2022-12-26	WOS:000462157600056
J	Liu, Y; Feng, ZH; Qin, ST; Yang, JJ; Han, C; Wang, XY				Liu, Yi; Feng, Zonghao; Qin, Shengtang; Yang, Jiejin; Han, Chao; Wang, Xiaoying			Structured reports of pelvic magnetic resonance imaging in primary endometrial cancer: Potential benefits for clinical decision-making	PLOS ONE			English	Article							RADIOLOGY; PREFERENCES; CARCINOMA; TEMPLATE; QUALITY; FORMAT; STYLE	Background Although evidence is increasing that the implementation of structured reports (SRs) may increase the standardization of reports and improve communication between radiologists and end-users, it is unclear whether these alternative formats of Chinese radiological narratives are appealing or even acceptable to radiologists and clinicians. Objective To compare the effect of SRs and non-structured reports (NSRs) of pelvic magnetic resonance imaging (MRI) in patients with primary endometrial cancer on referring gynecologists' satisfaction, further decision-making and efficiency. Methods Forty-one patients with histologically proven endometrial cancer were included in this study. SRs and NSRs for local MRI staging of endometrial cancer were generated for all subjects. NSRs were generated during clinical routine practice. The same 41 uterine studies were reviewed by the same radiologist using structured reporting system after a period of time. Two radiologists compared SRs on the number of key features related to cancer staging and writing efficiency with NSRs together. Five gynecologists filled in questionnaires regarding satisfaction with content, clinical usefulness, report' quality and time consumption. Statistical analysis included Kendall'sWtest, paired-sample t test and Wilcoxon signed rank test. Results There was no significant difference in the number of key features in NSRs comparison to SRs (p = 0.055). A statistically significant difference was observed in the satisfaction with linguistic quality for NSRs versus SRs by three gynaecologists (reader 1: 4.02 vs. 4.63, p = 0.002; reader 3: 3.86 vs. 4.02, p = 0.035; reader 4: 4.05 vs. 4.27, p = 0.024). The radiologist spent less time finishing SRs compared with NSRs (727.22 +/- 38.42 sec vs. 616.44 +/- 60.00 sec, p = 0.037). Conclusions The application of SRs significantly increased the value of female pelvic MRI reports by increasing radiologists' work efficiency and gynaecologists' satisfaction.	[Liu, Yi; Yang, Jiejin; Han, Chao; Wang, Xiaoying] Peking Univ, Dept Radiol, Hosp 1, Beijing, Peoples R China; [Feng, Zonghao; Qin, Shengtang] Peking Univ, Dept Obstet & Gynecol, Hosp 1, Beijing, Peoples R China	Peking University; Peking University	Wang, XY (corresponding author), Peking Univ, Dept Radiol, Hosp 1, Beijing, Peoples R China.	cjr.wangxiaoying@vip.163.com		Wang, Xiaoying/0000-0001-6406-0895				Amant F, 2005, LANCET, V366, P491, DOI 10.1016/S0140-6736(05)67063-8; Brook OR, 2015, RADIOLOGY, V274, P464, DOI 10.1148/radiol.14140206; Colombo N, 2013, ANN ONCOL, V24, P33, DOI 10.1093/annonc/mdt353; Creasman W, 2009, INT J GYNECOL OBSTET, V105, P109, DOI 10.1016/j.ijgo.2009.02.010; Dickerson E, 2017, J AM COLL RADIOL, V14, P371, DOI 10.1016/j.jacr.2016.09.037; Hawkins CM, 2014, J DIGIT IMAGING, V27, P581, DOI 10.1007/s10278-014-9699-7; Johnson AJ, 2002, ACAD RADIOL, V9, P1056, DOI 10.1016/S1076-6332(03)80483-X; Johnson AJ, 2009, RADIOLOGY, V253, P74, DOI 10.1148/radiol.2531090138; Krupinski EA, 2012, J DIGIT IMAGING, V25, P63, DOI 10.1007/s10278-011-9424-8; Lei JB, 2014, J AM MED INFORM ASSN, V21, P808, DOI 10.1136/amiajnl-2013-002381; Levin DC, 2012, J AM COLL RADIOL, V9, P388, DOI 10.1016/j.jacr.2011.12.022; Lin E, 2014, J DIGIT IMAGING, V27, P588, DOI 10.1007/s10278-014-9703-2; Naik SS, 2001, AM J ROENTGENOL, V176, P591, DOI 10.2214/ajr.176.3.1760591; Pecorelli S, 2009, INT J GYNECOL OBSTET, V105, P103, DOI 10.1016/j.ijgo.2009.02.012; Plumb AAO, 2009, CLIN RADIOL, V64, P386, DOI 10.1016/j.crad.2008.11.009; Powell DK, 2015, ACAD RADIOL, V22, P226, DOI 10.1016/j.acra.2014.08.014; Sala E, 2008, RADIOLOGIA-MADRID, V50, P449, DOI 10.1016/S0033-8338(08)76332-X; Sistrom CL, 2005, AM J ROENTGENOL, V185, P804, DOI 10.2214/ajr.185.3.01850804; Suri V, 2015, REV RECENT CLIN TRIA, V10, P309, DOI 10.2174/1574887110666150923115228; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Travis AR, 2014, ACAD RADIOL, V21, P785, DOI 10.1016/j.acra.2014.02.008	21	6	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2019	14	3							e0213928	10.1371/journal.pone.0213928	http://dx.doi.org/10.1371/journal.pone.0213928			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ1KV	30908525	Green Published, Green Submitted, gold			2022-12-26	WOS:000462157600026
J	Srinivasan, P				Srinivasan, Prasanna			Detecting In-Situ oligomerization of engineered STIM1 proteins by diffraction-limited optical imaging	PLOS ONE			English	Article							STROMAL INTERACTION MOLECULE-1; GREEN FLUORESCENT PROTEIN; MECHANISTIC INSIGHTS; STORE; ORAI1; ACTIVATION; STOICHIOMETRY; REGULATOR; REPORTER	Several signaling proteins require self-association of individual monomer units to be activated for triggering downstream signaling cascades in cells. Methods that allow visualizing their underlying molecular mechanisms will immensely benefit cell biology. Using enhanced Green Fluorescent Protein (eGFP) complementation, here I present a functional imaging approach for visualizing the protein-protein interaction in cells. Activation mechanism of an ER (endoplasmic reticulum) resident Ca2+ sensor, STIM1 (Stromal Interaction Molecule 1) that regulates store-operated Ca2+ entry in cells is considered as a model system. Co-expression of engineered full-length human STIM1 (ehSTIM1) with N-terminal complementary split eGFP pairs in mammalian cells fluoresces to form 'puncta' upon a drop in ER lumen Ca2+ concentration. Quantization of discrete fluorescent intensities of ehSTIM1 molecules at a diffraction-limited resolution revealed a diverse set of intensity levels not exceeding six-fold. Detailed screening of the ehSTIM1 molecular entities characterized by one to six fluorescent emitters across various in-plane sections shows a greater probability of occurrence for entities with six emitters in the vicinity of the plasma membrane (PM) than at the interior sections. However, the number density of entities with six emitters was lesser than that of others localized close to the PM. This finding led to hypothesize that activated ehSTIM1 dimers perhaps oligomerize in bundles ranging from 1-6 with an increased propensity for the occurrence of hexamers of ehSTIM1 dimer units close to PM even when its partner protein, ORAI1 (PM resident Ca2+ channel) is not sufficiently over-expressed in cells. The experimental data presented here provide direct evidence for luminal domain association of ehSTIM1 monomer units to trigger activation and allow enumerating various oligomers of ehSTIM1 in cells.	[Srinivasan, Prasanna] La Jolla Inst Allergy & Immunol, La Jolla, CA 92037 USA; [Srinivasan, Prasanna] Univ Calif Santa Barbara, Ctr Bioengn, Santa Barbara, CA 93106 USA	La Jolla Institute for Immunology; University of California System; University of California Santa Barbara	Srinivasan, P (corresponding author), La Jolla Inst Allergy & Immunol, La Jolla, CA 92037 USA.; Srinivasan, P (corresponding author), Univ Calif Santa Barbara, Ctr Bioengn, Santa Barbara, CA 93106 USA.	prasri@ucsb.edu			International Human Frontier Science Program [LT-000055/2011-C]	International Human Frontier Science Program(Human Frontier Science Program)	PS was funded by International Human Frontier Science Program (www.hfsp.org) cross-disciplinary fellowship (LT-000055/2011-C) between 2011-2014 during which this work was conducted. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbe E, 1874, PROC BRISTOL NAT SOC, VI, P200; Arpino JAJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047132; Backer AS, 2014, J PHYS CHEM B, V118, P8313, DOI 10.1021/jp501778z; Cabantous S, 2013, SCI REP-UK, V3, DOI 10.1038/srep02854; Cai XY, 2016, J BIOL CHEM, V291, P25764, DOI 10.1074/jbc.M116.758813; Covington ED, 2010, MOL BIOL CELL, V21, P1897, DOI 10.1091/mbc.E10-02-0145; Ghosh I, 2000, J AM CHEM SOC, V122, P5658, DOI 10.1021/ja994421w; Gudlur A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06816-8; Henke N, 2012, J BIOL CHEM, V287, P42042, DOI 10.1074/jbc.M112.417212; Hirve N, 2018, CELL REP, V22, P72, DOI 10.1016/j.celrep.2017.12.030; Hoover PJ, 2011, P NATL ACAD SCI USA, V108, P13299, DOI 10.1073/pnas.1101664108; Iino R, 2001, BIOPHYS J, V80, P2667, DOI 10.1016/S0006-3495(01)76236-4; Ji W, 2008, P NATL ACAD SCI USA, V105, P13668, DOI 10.1073/pnas.0806499105; Jiang WX, 2016, SCI REP-UK, V6, DOI 10.1038/srep20568; Jing J, 2015, NAT CELL BIOL, V17, P1339, DOI 10.1038/ncb3234; Kastrup L, 2004, ANGEW CHEM INT EDIT, V43, P2; Li ZZ, 2011, CELL RES, V21, P305, DOI 10.1038/cr.2010.131; Liou J, 2007, P NATL ACAD SCI USA, V104, P9301, DOI 10.1073/pnas.0702866104; Luik RM, 2008, NATURE, V454, P538, DOI 10.1038/nature07065; Ma GL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8826; Magliery TJ, 2005, J AM CHEM SOC, V127, P146, DOI 10.1021/ja046699g; Miller KE, 2015, J MOL BIOL, V427, P2039, DOI 10.1016/j.jmb.2015.03.005; Moerner WE, 2007, P NATL ACAD SCI USA, V104, P12596, DOI 10.1073/pnas.0610081104; Nguyen HB, 2013, ACTA CRYSTALLOGR D, V69, P2513, DOI 10.1107/S0907444913024608; Ozawa T, 2006, ANAL CHIM ACTA, V556, P58, DOI 10.1016/j.aca.2005.06.026; Park K, 2007, PROTEIN J, V26, P107, DOI 10.1007/s10930-006-9051-2; Perni S, 2015, P NATL ACAD SCI USA, V112, pE5533, DOI 10.1073/pnas.1515606112; Srinivasan P, 2017, CHEMISTRYSELECT, V2, P9563, DOI 10.1002/slct.201701904; Stathopulos PB, 2008, CELL, V135, P110, DOI 10.1016/j.cell.2008.08.006; Stathopulos PB, 2009, J BIOL CHEM, V284, P728, DOI 10.1074/jbc.C800178200; Thompson JL, 2013, SCI REP-UK, V3, DOI 10.1038/srep01961; Tian CS, 2016, FUTURE MED CHEM, V8, P817, DOI 10.4155/fmc-2016-0024; Vukojevic V, 2008, P NATL ACAD SCI USA, V105, P18176, DOI 10.1073/pnas.0809250105; Wilson T, 2011, J MICROSC-OXFORD, V244, P113, DOI 10.1111/j.1365-2818.2011.03549.x; Xia T, 2013, ANNU REV PHYS CHEM, V64, P459, DOI 10.1146/annurev-physchem-040412-110127; Xu PY, 2006, BIOCHEM BIOPH RES CO, V350, P969, DOI 10.1016/j.bbrc.2006.09.134; Yang X, 2012, P NATL ACAD SCI USA, V109, P5657, DOI 10.1073/pnas.1118947109; Yen M, 2018, J GEN PHYSIOL, V150, P1373, DOI 10.1085/jgp.201711985; Yen M, 2016, BIOPHYS J, V111, P1897, DOI 10.1016/j.bpj.2016.09.020; Zal T, 2004, BIOPHYS J, V86, P3923, DOI 10.1529/biophysj.103.022087; Zhao GL, 2015, P NATL ACAD SCI USA, V112, pE4792, DOI 10.1073/pnas.1423295112; Zhou YD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9395; Zhou YB, 2013, NAT STRUCT MOL BIOL, V20, P973, DOI 10.1038/nsmb.2625; Zhou YB, 2010, NAT STRUCT MOL BIOL, V17, P112, DOI 10.1038/nsmb.1724	44	0	0	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2019	14	3							e0213655	10.1371/journal.pone.0213655	http://dx.doi.org/10.1371/journal.pone.0213655			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ1KV	30908505	Green Submitted, Green Published, gold			2022-12-26	WOS:000462157600014
J	Arenas, J; Pupo, E; de Jonge, E; Perez-Ortega, J; Schaarschmidt, J; van der Ley, P; Tommassen, J				Arenas, Jesus; Pupo, Elder; de Jonge, Eline; Perez-Ortega, Jesus; Schaarschmidt, Joerg; van der Ley, Peter; Tommassen, Jan			Substrate specificity of the pyrophosphohydrolase LpxH determines the asymmetry of Bordetella pertussis lipid A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bordetella pertussis; lipopolysaccharide (LPS); endotoxin; lipid A; Toll-like receptor 4 (TLR4); innate immunity; acyl chain length; LpxA; LpxH; Neisseria meningitidis	STRUCTURAL-CHARACTERIZATION; EXPRESSION; EPIDEMIOLOGY	Lipopolysaccharides are anchored to the outer membrane of Gram-negative bacteria by a hydrophobic moiety known as lipid A, which potently activates the host innate immune response. Lipid A of Bordetella pertussis, the causative agent of whooping cough, displays unusual structural asymmetry with respect to the length of the acyl chains at the 3 and 3 positions, which are 3OH-C10 and 3OH-C14 chains, respectively. Both chains are attached by the acyltransferase LpxA, the first enzyme in the lipid A biosynthesis pathway, which, in B. pertussis, has limited chain length specificity. However, this only partially explains the strict asymmetry of lipid A. In attempts to modulate the endotoxicity of B. pertussis lipid A, here we expressed the gene encoding LpxA from Neisseria meningitidis, which specifically attaches 3OH-C12 chains, in B. pertussis. This expression was lethal, suggesting that one of the downstream enzymes in the lipid A biosynthesis pathway in B. pertussis cannot handle precursors with a 3OH-C12 chain. We considered that the UDP-diacylglucosamine pyrophosphohydrolase LpxH could be responsible for this defect as well as for the asymmetry of B. pertussis lipid A. Expression of meningococcal LpxH in B. pertussis indeed resulted in new symmetric lipid A species with 3OH-C10 or 3OH-C14 chains at both the 3 and 3 positions, as revealed by MS analysis. Furthermore, co-expression of meningococcal lpxH and lpxA resulted in viable cells that incorporated 3OH-C12 chains in B. pertussis lipid A. We conclude that the asymmetry of B. pertussis lipid A is determined by the acyl chain length specificity of LpxH.	[Arenas, Jesus; de Jonge, Eline; Perez-Ortega, Jesus; Tommassen, Jan] Univ Utrecht, Dept Mol Microbiol, Padualaan 8, NL-3584 CH Utrecht, Netherlands; [Arenas, Jesus; de Jonge, Eline; Perez-Ortega, Jesus; Tommassen, Jan] Univ Utrecht, Inst Biomembranes, Padualaan 8, NL-3584 CH Utrecht, Netherlands; [Pupo, Elder; van der Ley, Peter] Inst Translat Vaccinol Intravacc, Antonie van Leeuwenhoeklaan 9, NL-3721 MA Bilthoven, Netherlands; [Schaarschmidt, Joerg] Univ Utrecht, Computat Struct Biol Grp, Bijvoet Ctr Biomol Res, Padualaan 8, NL-3584 CH Utrecht, Netherlands	Utrecht University; Utrecht University; Utrecht University	Arenas, J (corresponding author), Univ Utrecht, Dept Mol Microbiol, Padualaan 8, NL-3584 CH Utrecht, Netherlands.; Arenas, J (corresponding author), Univ Utrecht, Inst Biomembranes, Padualaan 8, NL-3584 CH Utrecht, Netherlands.; Arenas, J (corresponding author), Univ Zaragoza, Unit Microbiol & Immunol, Ave Miguel Servet 177, E-50013 Zaragoza, Spain.	jaarenas@unizar.es	Arenas, Jesús/A-5420-2017	Arenas, Jesús/0000-0002-8134-0693; Perez-Ortega, Jesus/0000-0002-8022-499X; de Jonge, Eline/0000-0003-3089-5899	IntraVacc	IntraVacc	This work was partially funded by IntraVacc. Part of this work is included in a European Patent Application with reference number 17160604.9.	Arenas J, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00162; Arenas J, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0493-6; Brummelman J, 2015, INFECT IMMUN, V83, P227, DOI 10.1128/IAI.02197-14; CAROFF M, 1994, J BACTERIOL, V176, P5156, DOI 10.1128/jb.176.16.5156-5159.1994; Caroff M, 2000, FEBS LETT, V477, P8, DOI 10.1016/S0014-5793(00)01720-8; Cho J, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.154, 10.1038/nmicrobiol.2016.154]; Clark TA, 2014, J INFECT DIS, V209, P978, DOI 10.1093/infdis/jiu001; Geurtsen J, 2006, INFECT IMMUN, V74, P5574, DOI 10.1128/IAI.00834-06; Kondakov A, 2005, EUR J MASS SPECTROM, V11, P535, DOI 10.1255/ejms.721; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Li SC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-25; Li YY, 2012, P NATL ACAD SCI USA, V109, P8716, DOI 10.1073/pnas.1202908109; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Needham BD, 2013, NAT REV MICROBIOL, V11, P467, DOI 10.1038/nrmicro3047; Okada C, 2016, SCI REP-UK, V6, DOI 10.1038/srep32822; Piet JR, 2011, J BACTERIOL, V193, P2371, DOI 10.1128/JB.01331-10; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Richie DL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160918; Sealey KL, 2016, INFECT GENET EVOL, V40, P136, DOI 10.1016/j.meegid.2016.02.032; Shah NR, 2014, ANTIMICROB AGENTS CH, V58, P4931, DOI 10.1128/AAC.02590-14; Shah NR, 2013, J BIOL CHEM, V288, P11751, DOI 10.1074/jbc.M112.434365; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Smith EW, 2015, BIOCHEMISTRY-US, V54, P5937, DOI 10.1021/acs.biochem.5b00720; Song YF, 2013, STRUCTURE, V21, P1735, DOI 10.1016/j.str.2013.08.005; Steeghs L, 2002, CELL MICROBIOL, V4, P599, DOI 10.1046/j.1462-5822.2002.00214.x; Stover AG, 2004, J BIOL CHEM, V279, P4440, DOI 10.1074/jbc.M310760200; Sweet CR, 2002, J BIOL CHEM, V277, P18281, DOI 10.1074/jbc.M201057200; Vadovic P, 2007, ACTA VIROL, V51, P249; van Zundert GCP, 2016, J MOL BIOL, V428, P720, DOI 10.1016/j.jmb.2015.09.014; VERWEY WF, 1949, J BACTERIOL, V58, P127, DOI 10.1128/JB.58.2.127-134.1949; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Westphal O., 1965, METHODS CARBOHYDRATE, V5, P83, DOI DOI 10.1016/J.WATRES.2010.04.030; Wyckoff TJO, 1998, J BIOL CHEM, V273, P32369, DOI 10.1074/jbc.273.49.32369	34	4	4	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2019	294	20					7982	7989		10.1074/jbc.RA118.004680	http://dx.doi.org/10.1074/jbc.RA118.004680			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC0NH	30926608	Green Published, hybrid			2022-12-26	WOS:000470656500002
J	Tejero, J; Hunt, AP; Santolini, J; Lehnert, N; Stuehr, DJ				Tejero, Jesus; Hunt, Andrew P.; Santolini, Jerome; Lehnert, Nicolai; Stuehr, Dennis J.			Mechanism and regulation of ferrous heme-nitric oxide (NO) oxidation in NO synthases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						nitric oxide; nitric-oxide synthase; heme; enzyme mechanism; computational biology; thermodynamics; enzyme kinetics; dioxygenation; heme protein; heme-thiolate; reaction mechanism; redox reaction	LIGAND-PROTEIN INTERACTIONS; GAUSSIAN-BASIS SETS; SUBUNIT DIMERIZATION; KINETIC-PARAMETERS; ELECTRON-TRANSFER; OXYGENASE DOMAIN; L-ARGININE; ATOMS LI; TETRAHYDROBIOPTERIN; CATALYSIS	Nitric oxide (NO) synthases (NOSs) catalyze the formation of NO from l-arginine. We have shown previously that the NOS enzyme catalytic cycle involves a large number of reactions but can be characterized by a global model with three main rate-limiting steps. These are the rate of heme reduction by the flavin domain (k(r)), of dissociation of NO from the ferric heme-NO complex (k(d)), and of oxidation of the ferrous heme-NO complex (k(ox)). The reaction of oxygen with the ferrous heme-NO species is part of a futile cycle that does not directly contribute to NO synthesis but allows a population of inactive enzyme molecules to return to the catalytic cycle, and thus, enables a steady-state NO synthesis rate. Previously, we have reported that this reaction does involve the reaction of oxygen with the NO-bound ferrous heme complex, but the mechanistic details of the reaction, that could proceed via either an inner-sphere or an outer-sphere mechanism, remained unclear. Here, we present additional experiments with neuronal NOS (nNOS) and inducible NOS (iNOS) variants (nNOS W409F and iNOS K82A and V346I) and computational methods to study how changes in heme access and electronics affect the reaction. Our results support an inner-sphere mechanism and indicate that the particular heme-thiolate environment of the NOS enzymes can stabilize an N-bound Fe-III-N(O)OO- intermediate species and thereby catalyze this reaction, which otherwise is not observed or favorable in proteins like globins that contain a histidine-coordinated heme.	[Tejero, Jesus; Santolini, Jerome; Stuehr, Dennis J.] Cleveland Clin Fdn, Lerner Res Inst, Dept Pathobiol, 9500 Euclid Ave, Cleveland, OH 44195 USA; [Hunt, Andrew P.; Lehnert, Nicolai] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; [Hunt, Andrew P.; Lehnert, Nicolai] Univ Michigan, Dept Biophys, Ann Arbor, MI 48109 USA; [Tejero, Jesus] Univ Pittsburgh, Pittsburgh Heart Lung Blood & Vasc Med Inst, Pittsburgh, PA 15213 USA; [Santolini, Jerome] Univ Paris Saclay, Univ Paris Sud, CNRS, CEA,I2BC,UMR 9891, F-91191 Gif Sur Yvette, France	Cleveland Clinic Foundation; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Stuehr, DJ (corresponding author), Cleveland Clin Fdn, Dept Pathobiol, NC 22,9500 Euclid Ave, Cleveland, OH 44195 USA.	stuehrd@ccf.org	Tejero, Jesus/G-3953-2017	Tejero, Jesus/0000-0003-3245-9978; Hunt, Andrew/0000-0003-0565-9050; Santolini, Jerome/0000-0001-8919-112X	National Institutes of Health [GM51491]; National Science Foundation [CHE-1464696]; American Heart Association [0625632B]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051491] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM51491 (to D. J. S.) and by National Science Foundation Grant CHE-1464696 (to N. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by American Heart Association Postdoctoral Fellowship 0625632B. Present address: Pittsburgh Heart, Lung, Blood, and Vascular Medicine Institute, University of Pittsburgh, Pittsburgh, PA 15213.	AbuSoud HM, 1997, J BIOL CHEM, V272, P17349, DOI 10.1074/jbc.272.28.17349; Adak S, 1999, J BIOL CHEM, V274, P26907, DOI 10.1074/jbc.274.38.26907; Adak S, 2000, J BIOL CHEM, V275, P17434, DOI 10.1074/jbc.M000846200; Adak S, 2001, J INORG BIOCHEM, V83, P301, DOI 10.1016/S0162-0134(00)00176-8; Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Andersen JF, 2000, BIOCHEMISTRY-US, V39, P10118, DOI 10.1021/bi000766b; Arnold EV, 1996, METHOD ENZYMOL, V269, P41; BAEK KJ, 1993, J BIOL CHEM, V268, P21120; Bec N, 1998, J BIOL CHEM, V273, P13502, DOI 10.1074/jbc.273.22.13502; BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; Blomberg LM, 2004, J BIOL INORG CHEM, V9, P923, DOI 10.1007/s00775-004-0585-5; Brunel A, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.195446; Carabet LA, 2017, J PHYS CHEM B, V121, P8706, DOI 10.1021/acs.jpcb.7b06494; CHEUNG E, 1995, CAN J CHEM, V73, P1181, DOI 10.1139/v95-145; Copeland DM, 2003, PROTEINS, V53, P182, DOI 10.1002/prot.10495; Couture M, 2001, J BIOL CHEM, V276, P38280; Crane BR, 1997, SCIENCE, V278, P425, DOI 10.1126/science.278.5337.425; Crane BR, 1998, SCIENCE, V279, P2121, DOI 10.1126/science.279.5359.2121; Crane BR, 2008, BIOCHEM SOC T, V36, P1149, DOI 10.1042/BST0361149; Fernandez ML, 2005, J BIOL INORG CHEM, V10, P595, DOI 10.1007/s00775-005-0004-6; Frisch G. W., 2013, GAUSSIAN 09; Gao YT, 2004, J BIOL CHEM, V279, P18759, DOI 10.1074/jbc.M308936200; Ghosh DK, 1999, EMBO J, V18, P6260, DOI 10.1093/emboj/18.22.6260; Ghosh DK, 1997, BIOCHEMISTRY-US, V36, P10609, DOI 10.1021/bi9702290; Gorren ACF, 2007, BBA-GEN SUBJECTS, V1770, P432, DOI 10.1016/j.bbagen.2006.08.019; Hannibal L, 2011, J BIOL CHEM, V286, P39224, DOI 10.1074/jbc.M111.286351; Haque MM, 2013, FEBS J, V280, P4439, DOI 10.1111/febs.12404; Herold S, 2005, BIOCHEMISTRY-US, V44, P6223, DOI 10.1021/bi0475929; Herold S, 1999, ARCH BIOCHEM BIOPHYS, V372, P393, DOI 10.1006/abbi.1999.1534; Ilagan RP, 2008, J BIOL CHEM, V283, P19603, DOI 10.1074/jbc.M802914200; KLATT P, 1995, EMBO J, V14, P3687, DOI 10.1002/j.1460-2075.1995.tb00038.x; Konas DW, 2006, BIOCHEMISTRY-US, V45, P12596, DOI 10.1021/bi061011t; Lang J, 2011, BIOCHEMISTRY-US, V50, P10069, DOI 10.1021/bi200965e; Lang J, 2009, J INORG BIOCHEM, V103, P1102, DOI 10.1016/j.jinorgbio.2009.05.011; Li D, 2004, J BIOL CHEM, V279, P26489, DOI 10.1074/jbc.M400968200; Li HY, 2006, J BIOL INORG CHEM, V11, P753, DOI 10.1007/s00775-006-0123-8; LIND J, 1989, J AM CHEM SOC, V111, P7654, DOI 10.1021/ja00201a078; Marchal S, 2004, J BIOL CHEM, V279, P19824, DOI 10.1074/jbc.M313587200; MARCUS RA, 1985, BIOCHIM BIOPHYS ACTA, V811, P265, DOI 10.1016/0304-4173(85)90014-X; Moller JKS, 2004, CHEM-EUR J, V10, P2291, DOI 10.1002/chem.200305368; Ost TWB, 2005, J BIOL CHEM, V280, P965, DOI 10.1074/jbc.M411191200; Pant K, 2006, BIOCHEMISTRY-US, V45, P2537, DOI 10.1021/bi0518848; Pant K, 2005, J MOL BIOL, V352, P932, DOI 10.1016/j.jmb.2005.07.070; PERDEW JP, 1986, PHYS REV B, V33, P8822, DOI 10.1103/PhysRevB.33.8822; Presta A, 1998, J AM CHEM SOC, V120, P9460, DOI 10.1021/ja9740374; Presta A, 1998, BIOCHEMISTRY-US, V37, P298, DOI 10.1021/bi971944c; PRYOR WA, 1995, AM J PHYSIOL-LUNG C, V268, pL699, DOI 10.1152/ajplung.1995.268.5.L699; Rousseau DL, 2005, J INORG BIOCHEM, V99, P306, DOI 10.1016/j.jinorgbio.2004.11.007; Salerno JC, 2009, FEBS J, V276, P6677, DOI 10.1111/j.1742-4658.2009.07382.x; Santolini J, 2001, J BIOL CHEM, V276, P48887, DOI 10.1074/jbc.M108666200; Santolini J, 2001, J BIOL CHEM, V276, P1233, DOI 10.1074/jbc.M006858200; Santolini J, 2019, FRONT BIOSCI-LANDMRK, V24, P133, DOI 10.2741/4711; SCHAFER A, 1994, J CHEM PHYS, V100, P5829, DOI 10.1063/1.467146; SCHAFER A, 1992, J CHEM PHYS, V97, P2571, DOI 10.1063/1.463096; Simonneaux G, 2005, CHEM REV, V105, P2627, DOI 10.1021/cr030731s; Stuehr DJ, 1999, BBA-BIOENERGETICS, V1411, P217, DOI 10.1016/S0005-2728(99)00016-X; Stuehr DJ, 2004, J BIOL CHEM, V279, P36167, DOI 10.1074/jbc.R400017200; STUEHR DJ, 1992, J BIOL CHEM, V267, P20547; Tejero JS, 2008, J BIOL CHEM, V283, P33498, DOI 10.1074/jbc.M806122200; Tejero J, 2009, FEBS J, V276, P4505, DOI 10.1111/j.1742-4658.2009.07157.x; TSAI JHM, 1994, J AM CHEM SOC, V116, P4115, DOI 10.1021/ja00088a072; Wang ZQ, 2004, J BIOL CHEM, V279, P19018, DOI 10.1074/jbc.M311663200; Whited CA, 2012, J AM CHEM SOC, V134, P27, DOI 10.1021/ja2069533	63	12	12	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2019	294	19					7904	7916		10.1074/jbc.RA119.007810	http://dx.doi.org/10.1074/jbc.RA119.007810			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IB3FL	30926606	Green Published, hybrid			2022-12-26	WOS:000470153300030
J	Ordonez-Gomez, JD; Santillan-Doherty, AM; Hammerschmidt, K				Ordonez-Gomez, Jose D.; Santillan-Doherty, Ana M.; Hammerschmidt, Kurt			Acoustic variation of spider monkey (Ateles geoffroyi) contact calls is related to caller isolation and affects listeners' responses	PLOS ONE			English	Article							COMMUNICATION; SOUND	Group living animals produce vocalizations denominated "contact calls" to maintain contact with out-of-sight group members. These calls have been shown to vary with caller identity and distance to potential listeners. However, it is not clear whether the acoustic variation of contact calls is related to caller social isolation (e.g., inside or outside a subgroup) and listeners' responses that can be helpful to maintain contact. Here, we addressed these questions in spider monkeys (Ateles geoffroyi), a Neotropical primate that exchanges contact calls denominated "whinnies", which show graded variation related to caller immediate behavior and distance between callers. Using 566 whinnies produced by 35 free-ranging adult spider monkeys recorded at <= 20 m from microphones, we first analyzed whether the acoustic variation of spontaneous whinnies (i.e., whinnies that are not responses to previous whinnies) is related to caller social isolation or whether acoustic variation is related to the likelihood of eliciting a response whinny from another individual. Secondly, we assessed whether listeners' responses (i.e., time to respond vocally, acoustic characteristics of response whinnies, orienting behaviors) were related to the acoustic variation of previous whinnies. Our study revealed that callers that were outside a subgroup produced whinnies with a lower fundamental frequency (F0), which travels longer distances, and increases the likelihood of producing a response whinny. Moreover, listeners (i.e., responders) responded faster to lower F0 whinnies. However, the acoustic variation (i.e., F0 variation) in response whinnies was better explained by the separation distance between callers, than by the acoustic variation of the previous whinny. Overall, our results suggest that whinny variation facilitates vocal contact to callers that are outside a subgroup, and that context and whinny variation affect listeners' responses.	[Ordonez-Gomez, Jose D.; Hammerschmidt, Kurt] German Primate Ctr, Cognit Ethol Lab, Gottingen, Germany; [Santillan-Doherty, Ana M.] Inst Nacl Psiquiatria Ramon de la Fuente Muniz, Neurociencias, Mexico City, DF, Mexico	Deutsches Primatenzentrum (DPZ); Instituto Nacional de Psiquiatria Ramon de la Fuente Muniz	Ordonez-Gomez, JD (corresponding author), German Primate Ctr, Cognit Ethol Lab, Gottingen, Germany.	josed_ordonez@hotmail.com		Ordonez Gomez, Jose Domingo/0000-0002-6929-1470	Consejo Nacional de Ciencia y Tecnologia [215506]; program of Estancias Posdoctorales en el Extranjero Vinculadas a la Consolidacion de Grupos de Investigacion y Fortalecimiento del Posgrado Nacional of the Consejo Nacional de Ciencia y Tecnologia (CONACyT)	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); program of Estancias Posdoctorales en el Extranjero Vinculadas a la Consolidacion de Grupos de Investigacion y Fortalecimiento del Posgrado Nacional of the Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	JDOG received financial support by the Consejo Nacional de Ciencia y Tecnologia (https://www.conacyt.gob.mx/), under Grant No. 215506. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Financial support was provided by the program of Estancias Posdoctorales en el Extranjero Vinculadas a la Consolidacion de Grupos de Investigacion y Fortalecimiento del Posgrado Nacional of the Consejo Nacional de Ciencia y Tecnologia (CONACyT). We thank B. Hernandez for his invaluable field assistance and the people of the ejido Reforma Agraria for allowing us to conduct this study in their natural reserve. Sofi Blue greatly helped with getting the manuscript in shape, and Julia Fischer provided valuable feed-back. Finally, we thank Jon T. Sakata and two anonymous reviewers for their very helpful suggestions and comments.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Berry DA, 1996, J VOICE, V10, P129, DOI 10.1016/S0892-1997(96)80039-7; Bouchet H, 2017, ANIM BEHAV, V129, P81, DOI 10.1016/j.anbehav.2017.05.012; Briefer EF, 2012, J ZOOL, V288, P1, DOI 10.1111/j.1469-7998.2012.00920.x; CHAPMAN CA, 1990, AM J PRIMATOL, V22, P279, DOI 10.1002/ajp.1350220407; Chatterjee S., 2012, REGRESSION ANAL EXAM; Cheney DL, 1996, ANIM BEHAV, V52, P507, DOI 10.1006/anbe.1996.0193; Dittus W., 1988, P31; Fischer J, 2017, NEUROSCI BIOBEHAV R, V82, P22, DOI 10.1016/j.neubiorev.2016.10.014; Fitch WT, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600723; Fox J., 2019, R COMPANION APPL REG, V.; Gomez JD, 2018, AM J PRIMATOL, V80, P1; Liao DNA, 2018, P NATL ACAD SCI USA, V115, P3978, DOI 10.1073/pnas.1722426115; McComb K, 2003, ANIM BEHAV, V65, P317, DOI 10.1006/anbe.2003.2047; Oda R, 1996, INT J PRIMATOL, V17, P191, DOI 10.1007/BF02735447; Ordonez-Gomez JD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149671; Ordonez-Gomez JD, 2015, INT J PRIMATOL, V36, P429, DOI 10.1007/s10764-015-9833-5; Owren MJ, 2001, EVOL ANTHROPOL, V10, P58, DOI 10.1002/evan.1014; Padgham M, 2004, J ACOUST SOC AM, V115, P402, DOI 10.1121/1.1629304; Price T, 2015, SCI REP-UK, V5, DOI 10.1038/srep13220; Ramos-Fernandez G, 2005, INT J PRIMATOL, V26, P1077, DOI 10.1007/s10764-005-6459-z; Ramos-Fernandez G, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.0532; Ramos-Fernandez G, 2008, CAM S BIO EVOL ANTHR, V55, P220; Rendall D, 2009, ANIM BEHAV, V78, P233, DOI 10.1016/j.anbehav.2009.06.007; Rivera-Caceres KD, 2018, ROY SOC OPEN SCI, V5, DOI 10.1098/rsos.171791; Santorelli CJ, 2013, INT J PRIMATOL, V34, P1172, DOI 10.1007/s10764-013-9736-2; Schamberg I, 2018, BIOL REV, V93, P2071, DOI 10.1111/brv.12437; SEYFARTH RM, 1980, ANIM BEHAV, V28, P1070, DOI 10.1016/S0003-3472(80)80097-2; Seyfarth RM, 2010, ANIM BEHAV, V80, P3, DOI 10.1016/j.anbehav.2010.04.012; Slabbekoorn H, 2002, CONDOR, V104, P564, DOI 10.1650/0010-5422(2002)104[0564:BASTTB]2.0.CO;2; Slocombe KE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011473; Sugiura H, 2007, AM J PRIMATOL, V69, P1412, DOI 10.1002/ajp.20447; Takahashi DY, 2013, CURR BIOL, V23, P2162, DOI 10.1016/j.cub.2013.09.005; Teixidor P, 1999, BEHAVIOUR, V136, P279, DOI 10.1163/156853999501333; WASER PM, 1986, AM J PRIMATOL, V10, P135, DOI 10.1002/ajp.1350100205; Watts DP, 2001, BEHAVIOUR, V138, P299, DOI 10.1163/15685390152032488; Wheeler BC, 2012, EVOL ANTHROPOL, V21, P195, DOI 10.1002/evan.21319; Wilden I., 1998, Bioacoustics, V9, P171	38	4	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0213914	10.1371/journal.pone.0213914	http://dx.doi.org/10.1371/journal.pone.0213914			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR5NS	30943237	Green Submitted, gold, Green Published			2022-12-26	WOS:000463194300021
J	Chen, YT; Hsu, HJ; Hsu, CK; Lee, CC; Hsu, KH; Sun, CY; Chen, CY; Chen, YC; Yu, YC; Wu, IW				Chen, Yih-Ting; Hsu, Heng-Jung; Hsu, Cheng-Kai; Lee, Chin-Chan; Hsu, Kuang-Hung; Sun, Chiao-Yin; Chen, Chun-Yu; Chen, Yung-Chang; Yu, Yi-Ching; Wu, I-Wen			Correlation between spot and 24h proteinuria: Derivation and validation of equation to estimate daily proteinuria	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; URINARY PROTEIN/CREATININE RATIO; TO-CREATININE RATIO; EXCRETION RATE; SAMPLES	Daily urine protein (UP) loss is a cumbersome but important measurement to guide diagnosis and treatment of renal disease. Spot urine protein-creatinine ratio (UPCR) can been applied to estimate daily proteinuria. However, the correlations between spot and 24h proteinuria remain controversial. In this cross-sectional study, simultaneous collection of 24h and spot urines were performed from 1,039 (derivation cohort) and 204 CKD patients (validation cohort) of Chang Gung Memorial Hospital, from 2007 to 2017. The correlations between spot UPCR and 24h proteinuria were compared. The mean age of patients of derivation and validation cohort was 63 and 55 years and the mean estimated glomerular filtration rate was 62 +/- 35 and 59 +/- 36 mL/min/m(2), respectively. The correlation coefficient was 0.819 between UPCR and 24hUP. Prediction equation was derived as: Log(10)24hUP (g) = 0.814 x Log(10)UPCR (mg/mg) + 0.110 x Gender-0.004 x Age + 0.004 x Body weight (kg) + 0.002 x CKD stage coefficient-0.018, where CKD stage coefficient: CKD stage G1 = 1, G2 = 2, G3a = 3.1, G3b = 3.2, G4 = 4, G5 = 5. Correlation coefficient between measured and predicted 24hUP among derivation group and validation group is 0.866 and 0.915, respectively. However, the agreement of spot and daily estimates was less pronounced with proteinuria > 3g than lower values in Bland-Altman analysis. Spot UPCR can accurately predict 24hUP in patients with daily proteinuria below 3g. The development of this equation may facilitate estimation of 24hUP in the clinical practice.	[Chen, Yih-Ting; Hsu, Heng-Jung; Hsu, Cheng-Kai; Lee, Chin-Chan; Sun, Chiao-Yin; Chen, Chun-Yu; Chen, Yung-Chang; Wu, I-Wen] Chang Gung Mem Hosp, Dept Nephrol, Keelung, Taiwan; [Hsu, Heng-Jung; Wu, I-Wen] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Hsu, Kuang-Hung] Chang Gung Univ, Dept Hlth Care Management, Lab Epidemiol, Hlth Aging Res Ctr, Taoyuan, Taiwan; [Yu, Yi-Ching] Chang Gung Mem Hosp, Dept Neurol, Keelung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital	Wu, IW (corresponding author), Chang Gung Mem Hosp, Dept Nephrol, Keelung, Taiwan.; Wu, IW (corresponding author), Chang Gung Univ, Coll Med, Taoyuan, Taiwan.	fliawu@yahoo.com		Hsu, Cheng-Kai/0000-0002-6812-526X; WU, I-WEN/0000-0001-8535-3582	Chang Gung Memorial Hospital [CMRPG260323, CMRPG2C0342, CMRPG2F0072, CIRPG2E0013]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	I.W.W. received grants sponsored by Chang Gung Memorial Hospital (CMRPG260323, CMRPG2C0342, CMRPG2F0072, CIRPG2E0013).	Bhide A, 2015, ACTA OBSTET GYN SCAN, V94, P542, DOI 10.1111/aogs.12624; Chen CF, 2015, AM J MED SCI, V349, P477, DOI 10.1097/MAJ.0000000000000488; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Fotheringham J, 2014, AM J KIDNEY DIS, V63, P405, DOI 10.1053/j.ajkd.2013.08.009; Fox CS, 2004, JAMA-J AM MED ASSOC, V291, P844, DOI 10.1001/jama.291.7.844; Gansevoort RT, 2013, LANCET, V382, P339, DOI 10.1016/S0140-6736(13)60595-4; Gaspari F, 2006, AM J KIDNEY DIS, V47, P1, DOI 10.1053/j.ajkd.2005.10.014; GINSBERG JM, 1983, NEW ENGL J MED, V309, P1543, DOI 10.1056/NEJM198312223092503; Hogan MC, 2016, KIDNEY INT, V90, P1080, DOI 10.1016/j.kint.2016.06.020; KOOPMAN MG, 1989, NEPHROL DIAL TRANSPL, V4, P9; Levey AS, 2011, KIDNEY INT, V80, P17, DOI 10.1038/ki.2010.483; Medina-Rosas J, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0808-x; Methven S, 2010, NEPHROL DIAL TRANSPL, V25, P2991, DOI 10.1093/ndt/gfq140; Morales JV, 2004, J NEPHROL, V17, P666; Naresh CN, 2013, AM J KIDNEY DIS, V62, P1095, DOI 10.1053/j.ajkd.2013.06.016; Nayak R, 2013, Indian J Nephrol, V23, P428, DOI 10.4103/0971-4065.120340; Price CP, 2005, CLIN CHEM, V51, P1577, DOI 10.1373/clinchem.2005.049742; Rodby RA, 1995, AM J KIDNEY DIS, V26, P904, DOI 10.1016/0272-6386(95)90054-3; Roderick PJ, 2009, AM J KIDNEY DIS, V53, P950, DOI 10.1053/j.ajkd.2008.12.036; Ruggenenti P, 1998, BRIT MED J, V316, P504, DOI 10.1136/bmj.316.7130.504; Rush EC, 2009, BRIT J NUTR, V102, P632, DOI 10.1017/S0007114508207221; Stevens PE, 2013, ANN INTERN MED, V158, P825, DOI 10.7326/0003-4819-158-11-201306040-00007; Talreja H, 2014, AM J KIDNEY DIS, V64, P962, DOI 10.1053/j.ajkd.2014.07.027; Teo BW, 2015, INT J NEPHROL, V2015, DOI 10.1155/2015/156484; Ubukata M, 2016, CLIN EXP NEPHROL, V20, P456, DOI 10.1007/s10157-015-1178-z; Wahbeh AM, 2009, SAUDI J KIDNEY DIS T, V20, P443; Wuerzner G, 2014, NEPHROL DIAL TRANSPL, V29, P1475, DOI 10.1093/ndt/gft525; Yang EM, 2017, PEDIATR NEPHROL, V32, P1045, DOI 10.1007/s00467-017-3587-6	28	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2019	14	4							e0214614	10.1371/journal.pone.0214614	http://dx.doi.org/10.1371/journal.pone.0214614			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR2UW	30939176	gold, Green Published, Green Submitted			2022-12-26	WOS:000462993900033
J	Ocimati, W; Bouwmeester, H; Groot, JCJ; Tittonell, P; Brown, D; Blomme, G				Ocimati, Walter; Bouwmeester, Hein; Groot, Jeroen C. J.; Tittonell, Pablo; Brown, David; Blomme, Guy			The risk posed by Xanthomonas wilt disease of banana: Mapping of disease hotspots, fronts and vulnerable landscapes	PLOS ONE			English	Article							CAMPESTRIS-PV.-MUSACEARUM; BACTERIAL WILT; EAST; INFECTION; SPREAD; SPACE; TIME	Banana production landscapes in the African Great Lakes Region (AGLR) have been under immense pressure from Xanthomonas wilt (XW) disease over the past two decades. XW, first reported on banana in central Uganda and eastern DR Congo in 2001, has since spread to the entire AGLR. XW is currently spreading westwards from hot spots in eastern DR Congo highlands, putting the plantain (Musa AAB genome) belt of central and west Africa at risk. In-depth understanding of the key variables responsible for disease spread, current hotspots, and vulnerable landscapes is crucial for disease early warning and management. We mapped aggregated disease distribution and hotspots in the AGLR and identified vulnerable landscapes across African banana production zones. Available data on disease prevalence collected over 11 years was regressed against environmental and expert developed covariates to develop the AGLR XW hotspots map. For the Africa-wide risk map, precipitation, distance to hotspots, degree of trade in fresh banana products, production zone interconnectedness and banana genotype composition were used as covariates. In the AGLR, XW was mainly correlated to precipitation and disease/banana management. Altitude and temperature had unexpectedly low effects, possibly due to an overriding impact of tool-mediated spread which is part of the management covariate. In the AGLR, the eastern part of DR Congo was a large hotspot with highest vulnerability. Apart from endemic zones in the AGLR and Ethiopia, northern Mozambique was perceived as a moderate risk zone mainly due to the predominance of ' Bluggoe' (Musa ABB type) which is highly susceptible to insect-vectored transmission. Presence of XW hotspots (e.g. eastern DR Congo) and vulnerable areas with low (e.g. north-western Tanzania) or no disease (e.g. Congo basin, western DR Congo and northern Mozambique) pressure suggest key areas where proactive measures e.g. quarantines and information sharing on XW diagnosis, epidemiology, and control could be beneficial.	[Ocimati, Walter] Biovers Int, Kampala, Uganda; [Ocimati, Walter; Groot, Jeroen C. J.] Wageningen Univ & Res, Farming Syst Ecol, Wageningen, Netherlands; [Bouwmeester, Hein] GeoSpace, Ede, Netherlands; [Tittonell, Pablo] INTA CONICET, Agroecol Environm & Syst Grp, Inst Invest Forestales & Agr Bariloche IFAB, San Carlos De Bariloche, Rio Negro, Argentina; [Tittonell, Pablo] Univ Groningen, Groningen Inst Evolutionary Life Sci, Groningen, Netherlands; [Brown, David] Biovers Int, Turrialba, Cartago, Costa Rica; [Blomme, Guy] Biovers Int, Addis Ababa, Ethiopia	Alliance; Bioversity International; Wageningen University & Research; Instituto Nacional de Tecnologia Agropecuaria (INTA); University of Groningen; Alliance; Bioversity International; Alliance; Bioversity International	Ocimati, W (corresponding author), Biovers Int, Kampala, Uganda.; Ocimati, W (corresponding author), Wageningen Univ & Res, Farming Syst Ecol, Wageningen, Netherlands.	w.ocimati@cgiar.org	Brown, David/AAV-1842-2021	Brown, David/0000-0003-2859-1618; Tittonell, Pablo/0000-0002-0284-2514; Ocimati, Walter/0000-0001-6177-7073	RTB Program Management Unit	RTB Program Management Unit	The fieldwork of this study was conducted within the framework of the CGIAR Research Program on Roots, Tubers and Bananas (RTB) and was led by Bioversity International. This study was supported by the CGIAR Fund Donors (https://www.cgiar.org/funders/) with support through the RTB Program Management Unit (https://www.cgiar.org/research/program-platform/roots-tubers-and-bananas/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abele S, 2007, J CROP IMPROV, V19, P173, DOI 10.1300/J411v19n01_09; Abele S., 2007, FOOD SECURITY E AFRI, P110; Agrios G., 2005, PLANT PATHOL, DOI [10.1016/C2009-0-02037-6, DOI 10.1016/C2009-0-02037-6]; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; [Anonymous], 1966, TROPICAL AGR SERIES; Aung K, 2018, PLANT J, V93, P771, DOI 10.1111/tpj.13795; Bioversity International, 2017, XANTH WILT BAN S KIV, P103; Biruma M, 2007, AFR J BIOTECHNOL, V6, P953; Blomme G, 2013, ANN APPL BIOL, V162, P4, DOI 10.1111/aab.12002; Blomme G., 2005, P AFR CROP SCI C, V7, P317; Blomme G, 2017, EUR J PLANT PATHOL, V149, P385, DOI 10.1007/s10658-017-1189-6; Blomme G, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01290; Blomme G, 2014, EUR J PLANT PATHOL, V139, P265, DOI 10.1007/s10658-014-0402-0; Bouwmeester H, 2016, EUR J AGRON, V74, P173, DOI 10.1016/j.eja.2015.12.013; Carter BA, 2010, PLANT PATHOL, V59, P403, DOI 10.1111/j.1365-3059.2009.02124.x; Desktop ESRI ArcGIS, 2014, REL 10 2 2 REDL; Eden-Green S., 2004, Infomusa, V13, P38; Edmeades S, 2007, IFPRI RES REPORT, V155, P49; Goovaerts P., 1997, GEOSTATISTICS NATURA, P483; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hijmans RJ., 2017, GEOGRAPHIC DATA ANAL, V2, P15; Hirano SS, 2000, MICROBIOL MOL BIOL R, V64, P624, DOI 10.1128/MMBR.64.3.624-653.2000; Hosmer D. W., 2000, APPL LOGISTIC REGRES, DOI [10.1002/0471722146, DOI 10.1002/0471722146]; Jarvis A, 2008, HOLE FILLED SEAMLESS; Kalyebara M. R., 2006, African Crop Science Journal, V14, P93; Kang WS, 2010, PLANT PATHOLOGY J, V26, P17, DOI 10.5423/PPJ.2010.26.1.017; Kubiriba J., 2012, Journal of Development and Agricultural Economics, V4, P125; Markham R., 2008, DIAGNOSTIC MANAGEMEN; Meki Shehabu, 2010, Tree and Forestry Science and Biotechnology, V4, P63; Mina U., 2008, ENV NEWS, V14, P6; Nakato G. V., 2013, J CROP PROT, V2, P151; Nakato GV, 2015, CAN J PLANT PATHOL, V36, P418; Ndungo V, 2006, PLANT PATHOL, V55, P294, DOI 10.1111/j.1365-3059.2005.01258.x; Ndungo V., 2008, Journal of Applied Biosciences, V1, P1; Nkuba J., 2015, African Journal of Plant Science, V9, P279; Ochola D, 2015, PLANT PATHOL, V64, P552, DOI 10.1111/ppa.12281; Ochola D., 2014, African Journal of Agricultural Research, V9, P2727; Ocimati W, 2015, PLANT PATHOL, V64, P81, DOI 10.1111/ppa.12233; Ocimati W, 2013, ACTA HORTIC, V986, P103; Ocimati W, 2013, PLANT PATHOL, V62, P777, DOI 10.1111/j.1365-3059.2012.02697.x; Ocimati W, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01471; Okech SHO, 2004, UGANDA J AGR SCI, V9, P437; Pebesma EJ, 2004, COMPUT GEOSCI-UK, V30, P683, DOI 10.1016/j.cageo.2004.03.012; Reeder RH, 2007, PLANT PATHOL, V56, P1038, DOI 10.1111/j.1365-3059.2007.01640.x; Rutikanga A., 2015, Proceedings of the 7th Congress on Plant Protection "Integrated Plant Protection - a Knowledge-Based Step Towards Sustainable Agriculture, Forestry and Landscape Architecture". November 24-28, 2014, Zlatibor, Serbia, P139; Rutikanga A, 2016, J PHYTOPATHOL, V164, P659, DOI 10.1111/jph.12489; SADDLER GS, 2005, BERGEYS MANUAL SYSTE, V2, P63, DOI DOI 10.1007/0-387-28022-7_3; Shimelash D., 2008, African Crop Science Journal, V16, P75; Shimwela MM, 2017, PLANT PATHOL, V66, P1003, DOI 10.1111/ppa.12637; Simmonds NW., 1995, BOT J LINN SOC, V55, P302, DOI [10.1111/j.1095-8339.1955.tb00015.x, DOI 10.1111/J.1095-8339.1955.TB00015.X]; Ssekiwoko F, 2006, AFR CROP SCI J, V14; Taketani RG, 2017, MICROB ECOL, V73, P153, DOI 10.1007/s00248-016-0835-4; Tinzaara W., 2006, African Crop Science Journal, V14, P105; Tinzaara W., 2013, Acta Horticulturae, P157; Tripathi L, 2009, PLANT DIS, V93, P440, DOI 10.1094/PDIS-93-5-0440; Tushemereirwe W, 2004, PLANT PATHOL, V53, P802, DOI 10.1111/j.1365-3059.2004.01090.x; Tushemereiwe W. K., 2006, African Crop Science Journal, V14, P73; Wang CC, 2005, PLANTA, V222, P947, DOI 10.1007/s00425-005-0036-8; Webster R., 2007, STAT PRACTICE; Xin XF, 2016, NATURE, V539, P524, DOI 10.1038/nature20166; Yirgou D., 1974, East African Agricultural and Forestry Journal, V40, P111; You L., 2017, SPATIAL PRODUCTION A	62	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2019	14	4							e0213691	10.1371/journal.pone.0213691	http://dx.doi.org/10.1371/journal.pone.0213691			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR2UW	30939129	Green Submitted, Green Published, gold			2022-12-26	WOS:000462993900007
J	Kumpeangkeaw, A; Tan, DG; Fu, LL; Han, BY; Sun, XP; Hu, XW; Ding, ZH; Zhang, JM				Kumpeangkeaw, Anuwat; Tan, Deguan; Fu, Lili; Han, Bingying; Sun, Xuepiao; Hu, Xiaowen; Ding, Zehong; Zhang, Jiaming			Asymmetric birth and death of type I and type II MADS-box gene subfamilies in the rubber tree facilitating laticifer development	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; HOMEOTIC GENE; TRANSCRIPTION FACTOR; ALTERNATIVE SOURCES; FLOWER DEVELOPMENT; EARLY EVOLUTION; ARABIDOPSIS; FAMILY; EXPRESSION; ORIGIN	The rubber tree (Hevea brasiliensis Muell. Arg.) is a rubber producing crop and contains specialized laticifers. MADS-box genes are a family of transcription factor genes that regulate plant development, especially floral organ and gametophyte development. 97 MADS-box genes were identified in the rubber tree through transcriptomes and genome mining. 93.8% of the genes were mapped onto the genome scaffolds in correspondence to the coverage (93.8%) of current version of sequenced genome. Phylogenetic analysis indicates that type II MADS-box genes have been more actively duplicated than their orthologous genes in Arabidopsis and rice, so that most (70, 72.2%) of the MADS-box genes in the rubber tree belong to type II subfamily. This is a high percentage compared to those in Arabidopsis (43.7%) and rice (56.8%). Moreover, 69 out of 70 type II genes in the rubber tree are transcribed, and they are mostly predominantly expressed in flowers, but some genes are predominantly expressed in laticifers, suggesting their roles in both flower and laticifer development. The number of type I genes in the rubber tree is only 27 (27.8%), a much smaller number compared to their orthologous genes in Arabidopsis (56.3%) and rice (43.2%). At the same time, most of the type I genes (55.6%, 15) in the rubber tree are silent and are probably pseudogenes. The high birth rate and low death rate of type II genes and low birth rate and high death rate of type I genes may corresponds to special developmental requirements in the rubber tree, e.g. the development of laticifer system for biosynthesis of cis-poly-isoprene, the rubber. Moreover, atypical MIKC* factors (e.g. HbMADS1 in S-clade, and HbMADS20 in P-clade) are identified. These genes are diverged to typical MIKC* genes in sequences and facilitate functions required in laticifer development and rubber biosynthesis, which is not necessary in Arabidopsis and rice.	[Kumpeangkeaw, Anuwat] Huazhong Agr Univ, Int Coll, Wuhan, Hubei, Peoples R China; [Kumpeangkeaw, Anuwat; Tan, Deguan; Fu, Lili; Han, Bingying; Sun, Xuepiao; Ding, Zehong; Zhang, Jiaming] CATAS, Hainan Bioenergy Ctr, MOA Key Lab Trop Crops Biol & Genet Resources, Inst Trop Biosci & Biotechnol, Haikou, Hainan, Peoples R China; [Kumpeangkeaw, Anuwat] Minist Agr & Cooperat, Dept Agr, Song Khla Rubber Res Ctr, Hat Yai, Song Khla, Thailand; [Hu, Xiaowen] CATAS, Zhanjiang Expt Stn, Zhanjiang, Guangdong, Peoples R China	Huazhong Agricultural University; Chinese Academy of Tropical Agricultural Sciences; Chinese Academy of Tropical Agricultural Sciences	Zhang, JM (corresponding author), CATAS, Hainan Bioenergy Ctr, MOA Key Lab Trop Crops Biol & Genet Resources, Inst Trop Biosci & Biotechnol, Haikou, Hainan, Peoples R China.	zhangjiaming@itbb.org.cn			Natural Science Foundation of China [31471561]; National Key R&D Program of China [2018YFD1000500]; Natural Science Foundation of Hainan Province [318MS091]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key R&D Program of China; Natural Science Foundation of Hainan Province	This study was funded by the Natural Science Foundation of China (31471561), National Key R&D Program of China (2018YFD1000500), and the Natural Science Foundation of Hainan Province (318MS091).	Alvarez-Buylla ER, 2000, PLANT J, V24, P457, DOI 10.1046/j.1365-313x.2000.00891.x; Arora R, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-242; Bailey TL, 2015, NUCLEIC ACIDS RES, V43, pW39, DOI 10.1093/nar/gkv416; Becker A, 2003, MOL PHYLOGENET EVOL, V29, P464, DOI 10.1016/S1055-7903(03)00207-0; Bennici A, 2007, RIV BIOL-BIOL FORUM, V100, P55; Bennici Andrea, 2008, Commun Integr Biol, V1, P212; BOWMAN JL, 1989, PLANT CELL, V1, P37, DOI 10.1105/tpc.1.1.37; COEN ES, 1991, NATURE, V353, P31, DOI 10.1038/353031a0; De Bodt S, 2003, J MOL EVOL, V56, P573, DOI 10.1007/s00239-002-2426-x; Duan WK, 2015, MOL GENET GENOMICS, V290, P239, DOI 10.1007/s00438-014-0912-7; Friedman WE, 2000, PHILOS T R SOC B, V355, P857, DOI 10.1098/rstb.2000.0620; Fu LL, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030283; Garcia-Cruz KV, 2016, ANN BOT-LONDON, V118, P787, DOI 10.1093/aob/mcw126; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gramzow L, 2015, J EXP ZOOL PART B, V324, P353, DOI 10.1002/jez.b.22598; Gramzow L, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00214; Gramzow L, 2010, TRENDS GENET, V26, P149, DOI 10.1016/j.tig.2010.01.004; Gu Q, 1998, DEVELOPMENT, V125, P1509; Guo XH, 2016, MOL BREEDING, V36, DOI 10.1007/s11032-016-0544-1; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Henschel K, 2002, MOL BIOL EVOL, V19, P801, DOI 10.1093/oxfordjournals.molbev.a004137; Honys D, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r85; Hu B, 2015, BIOINFORMATICS, V31, P1296, DOI 10.1093/bioinformatics/btu817; Hu LF, 2012, GENOME, V55, P245, DOI [10.1139/G2012-009, 10.1139/g2012-009]; JACK T, 1994, CELL, V76, P703, DOI 10.1016/0092-8674(94)90509-6; Jiang SC, 2014, J INTEGR AGR, V13, P1239, DOI 10.1016/S2095-3119(13)60520-1; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kofuji R, 2003, MOL BIOL EVOL, V20, P1963, DOI 10.1093/molbev/msg216; Kozlowski LP, 2016, BIOL DIRECT, V11, DOI 10.1186/s13062-016-0159-9; Kumar G, 2016, SCI REP-UK, V6, DOI 10.1038/srep20695; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Kwantes M, 2012, MOL BIOL EVOL, V29, P293, DOI 10.1093/molbev/msr200; Li C, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fols.2016.01390; Li HP, 2011, PLANT SCI, V181, P132, DOI 10.1016/j.plantsci.2011.04.014; Li HL, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01709; Li HL, 2011, MOL BIOL REP, V38, P4045, DOI 10.1007/s11033-010-0523-2; Li QX, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0832-2; Lin CS, 2016, PLANT BIOTECHNOL J, V14, P284, DOI 10.1111/pbi.12383; Liu JY, 2018, HORTIC RES-ENGLAND, V5, DOI 10.1038/s41438-018-0031-4; Liu Y, 2013, PLANT CELL, V25, P1288, DOI 10.1105/tpc.113.110049; Ma J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181443; Marchler-Bauer A, 2017, NUCLEIC ACIDS RES, V45, pD200, DOI 10.1093/nar/gkw1129; Messenguy F, 2003, GENE, V316, P1, DOI 10.1016/S0378-1119(03)00747-9; Mooibroek H, 2000, APPL MICROBIOL BIOT, V53, P355, DOI 10.1007/s002530051627; Nam J, 2004, P NATL ACAD SCI USA, V101, P1910, DOI 10.1073/pnas.0308430100; NORMAN C, 1988, CELL, V55, P989, DOI 10.1016/0092-8674(88)90244-9; Parenicova L, 2003, PLANT CELL, V15, P1538, DOI 10.1105/tpc.011544; PASSMORE S, 1988, J MOL BIOL, V204, P593, DOI 10.1016/0022-2836(88)90358-0; Pootakham W, 2017, SCI REP-UK, V7, DOI 10.1038/srep41457; Ruelens P, 2017, PLANT CELL, V29, P229, DOI 10.1105/tpc.16.00366; Saha G, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1349-z; Sakdapipanich JT, 2007, J BIOSCI BIOENG, V103, P287, DOI 10.1263/jbb.103.287; SCHWARZSOMMER Z, 1992, EMBO J, V11, P251, DOI 10.1002/j.1460-2075.1992.tb05048.x; SOMMER H, 1990, EMBO J, V9, P605, DOI 10.1002/j.1460-2075.1990.tb08152.x; Tan DG, 2019, TREES-STRUCT FUNCT, V33, P193, DOI 10.1007/s00468-018-1768-y; Tan DG, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03083-3; Tang CR, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.73, 10.1038/nplants.2016.73]; Tapia-Lopez R, 2008, PLANT PHYSIOL, V146, P1182, DOI 10.1104/pp.107.108647; Thangavel G, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00510; Theissen G, 2000, PLANT MOL BIOL, V42, P115, DOI 10.1023/A:1006332105728; Theissen G, 1996, J MOL EVOL, V43, P484, DOI 10.1007/PL00006110; Theissen G, 2001, NATURE, V409, P469, DOI 10.1038/35054172; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TROBNER W, 1992, EMBO J, V11, P4693, DOI 10.1002/j.1460-2075.1992.tb05574.x; van Beilen JB, 2007, CRIT REV BIOTECHNOL, V27, P217, DOI 10.1080/07388550701775927; Verelst W, 2007, PLANT PHYSIOL, V143, P447, DOI 10.1104/pp.106.089805; Verelst W, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r249; Wang YQ, 2010, PLANT J, V64, P177, DOI 10.1111/j.1365-313X.2010.04325.x; Winter KU, 2002, PLANT J, V31, P457, DOI 10.1046/j.1365-313X.2002.01375.x; Yang XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051435; YANOFSKY MF, 1990, NATURE, V346, P35, DOI 10.1038/346035a0; Zhang LM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01159-8; Zobell O, 2010, MOL BIOL EVOL, V27, P1201, DOI 10.1093/molbev/msq005	73	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2019	14	4							e0214335	10.1371/journal.pone.0214335	http://dx.doi.org/10.1371/journal.pone.0214335			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR1CY	30934009	Green Published, gold, Green Submitted			2022-12-26	WOS:000462867000014
J	Liu, TW; Ng, SSM				Liu, Tai-Wa; Ng, Shamay S. M.			The reliability and validity of the Survey of Activities and Fear of Falling in the Elderly for assessing fear and activity avoidance among stroke survivors	PLOS ONE			English	Article							BALANCE CONFIDENCE; SENIORS	Introduction Activity restriction due to fear of falling is a common problem after a stroke. It can lead to deteriorated physical condition, restricted social participation and deprived quality of life. The Survey of Activities and Fear of Falling in the Elderly (SAFE) was developed to assess these difficulties, and its utility has been demonstrated among the older adults and older people with Parkinson's disease. This study aimed to expand those demonstrations to community-dwelling chronic stroke survivors using a Chinese translation of the instrument. Methods One hundred and eight elderly individuals with a history of stroke completed the Chinese version of the SAFE (SAFE-C). The internal consistency of their responses was assessed using Cronbach's alpha. Twenty of the same subjects were reassessed after a 1-week interval to assess the instrument's test-retest reliability. Structure validity was examined by exploratory factor analysis. Pearson correlation was used to establish the instrument's convergent validity with respect to the results from the Chinese version of the Activities-specific Balance Confidence Scale (ABC-C) and the Chinese version of the Lawton Instrumental Activities of Daily Living scale (IADL-C). Results The items of the SAFE-C demonstrated excellent internal consistency with a Cronbach's alphas of 0.90. The SAFE-C also had excellent test-retest reliability with an overall intra-class correlaton coefficient of 0.91. A 1-factor structure termed "fear avoidance circumstances" was identified and it was shown to be consistent with the original measure developed among community-living older people. The correlations between the SAFE-C and the ABC-C (r = -0.68) and the IADL-C (r = -0.57) confirmed the convergent validity. Conclusions Fear avoidance behavior is a homogeneous construct applicable to people with stroke-specific impairments alike. The SAFE-C is a reliable and valid instrument for measuring the level of fear avoidance behavior among community-dwelling stroke survivors. Stroke survivors with good functional mobility revealed a low level of fear and avoidance as measured by the SAFE-C.	[Liu, Tai-Wa; Ng, Shamay S. M.] Hong Kong Polytech Univ, Dept Rehabil Sci, Hung Hom, Hong Kong, Peoples R China; [Liu, Tai-Wa] Open Univ Hong Kong, Sch Nursing & Hlth Studies, Ho Man Tin, Hong Kong, Peoples R China	Hong Kong Polytechnic University; Hong Kong Metropolitan University	Ng, SSM (corresponding author), Hong Kong Polytech Univ, Dept Rehabil Sci, Hung Hom, Hong Kong, Peoples R China.	Shamay.Ng@polyu.edu.hk	NG, Sheung Mei Shamay/E-2731-2016	NG, Sheung Mei Shamay/0000-0003-1660-0548	General Research Fund [15101217]; Research Grants Council, Hong Kong	General Research Fund; Research Grants Council, Hong Kong(Hong Kong Research Grants Council)	This study was supported by the General Research Fund (reference number 15101217) from the Research Grants Council, Hong Kong to Dr. Shamay S. M. Ng and her team. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brouwer B, 2004, GERONTOLOGY, V50, P135, DOI 10.1159/000076771; Chou KL, 2005, AGING MENT HEALTH, V9, P255, DOI 10.1080/13607860500114035; Chu L. W., 1995, Hong Kong Medical Journal, V1, P207; Field A., 2009, DISCOVERING STAT USI, V3, DOI DOI 10.1080/1057610X.2016.1157408; Fletcher PC, 2004, AGE AGEING, V33, P273, DOI 10.1093/ageing/afh077; Howland J, 1998, GERONTOLOGIST, V38, P549, DOI 10.1093/geront/38.5.549; KAISER HF, 1974, PSYCHOMETRIKA, V39, P31, DOI 10.1007/BF02291575; Kempen GIJM, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-170; Kline P., 2000, HDB PSYCHOL TESTING; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Lachman ME, 1998, J GERONTOL B-PSYCHOL, V53, pP43, DOI 10.1093/geronb/53B.1.P43; Li FZ, 2003, J GERONTOL B-PSYCHOL, V58, pP283, DOI 10.1093/geronb/58.5.P283; Liu TW, 2015, ARCH PHYS MED REHAB, V96, P1684, DOI 10.1016/j.apmr.2015.05.005; Mak MK, 2007, ARCH PHYS MED REHAB, V88, P496, DOI 10.1016/j.apmr.2007.01.018; Masoumeh Z, 2016, MIDDLE E J REHABIL H, V3; Myers AM, 1998, J GERONTOL A-BIOL, V53, pM287, DOI 10.1093/gerona/53A.4.M287; Ng SSM, 2011, DISABIL REHABIL, V33, P2291, DOI 10.3109/09638288.2011.568667; Nunnally JC, 1994, PSYCHOMETRIC THEORY, V3rd, DOI DOI 10.1037/018882; Tong AY, OTJR OCCUPATION PART; Ware J.E., 2000, SF 36 HLTH SURVEY MA; Wilson MMG, 2005, J GERONTOL A-BIOL, V60, P355, DOI 10.1093/gerona/60.3.355; Zijlstra GAR, 2009, J AM GERIATR SOC, V57, P2020, DOI 10.1111/j.1532-5415.2009.02489.x	22	3	3	5	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2019	14	4							e0214796	10.1371/journal.pone.0214796	http://dx.doi.org/10.1371/journal.pone.0214796			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HR1CY	30934022	Green Published, gold			2022-12-26	WOS:000462867000042
J	Sekhar, KR; Wang, J; Freeman, ML; Kirschner, AN				Sekhar, Konjeti R.; Wang, Jian; Freeman, Michael L.; Kirschner, Austin N.			Radiosensitization by enzalutamide for human prostate cancer is mediated through the DNA damage repair pathway	PLOS ONE			English	Article							ANDROGEN RECEPTOR; CELLS; ATM	Radiation therapy is often combined with androgen deprivation therapy in the treatment of aggressive localized prostate cancer. However, castration-resistant disease may not respond to testosterone deprivation approaches. Enzalutamide is a second-generation antiandrogen with high affinity and activity that is used for the treatment of metastatic disease. Although radiosensitization mechanisms are known to be mediated through androgen receptor activity, this project aims to uncover the detailed DNA damage repair factors influenced by enzalutamide using multiple models of androgen-sensitive (LNCaP) and castration-resistant human prostate cancer (22Rv1 and DU145). Enzalutamide is able to radiosensitize both androgen-dependent and androgen-independent human prostate cancer models in cell culture and xenografts in mice, as well as a treatment-resistant patient-derived xenograft. The enzalutamide-mediated mechanism of radiosensitization includes delay of DNA repair through temporal prolongation of the repair factor complexes and halting the cell cycle, which results in decreased colony survival. Altogether, these findings support the use of enzalutamide concurrently with radiotherapy to enhance the treatment efficacy for prostate cancer.	[Sekhar, Konjeti R.; Wang, Jian; Freeman, Michael L.; Kirschner, Austin N.] Vanderbilt Univ, Med Ctr, Dept Radiat Oncol, 221 Kirkland Hall, Nashville, TN 37235 USA	Vanderbilt University	Kirschner, AN (corresponding author), Vanderbilt Univ, Med Ctr, Dept Radiat Oncol, 221 Kirkland Hall, Nashville, TN 37235 USA.	austin.kirschner@vumg.org	Kirschner, Austin/AAI-8383-2020	Kirschner, Austin/0000-0003-3807-6900; Konjeti, Sekhar/0000-0003-2930-0739	Astellas Pharma Global Development, Inc. [ENZA-15C03]; K12 award from the Vanderbilt Clinical Oncology Research Career Development Program [5K12CA090625-18]; NCI/NIH Cancer Center Support Grant [5P30 CA68485-19]; Vanderbilt Mouse Metabolic Phenotyping Center Grant [5U24DK059637-13]; Vanderbilt Ingram Cancer Center [P30 CA68485]; Vanderbilt Digestive Disease Research Center [DK058404]; NATIONAL CANCER INSTITUTE [P30CA068485, K12CA090625] Funding Source: NIH RePORTER	Astellas Pharma Global Development, Inc.; K12 award from the Vanderbilt Clinical Oncology Research Career Development Program; NCI/NIH Cancer Center Support Grant; Vanderbilt Mouse Metabolic Phenotyping Center Grant; Vanderbilt Ingram Cancer Center; Vanderbilt Digestive Disease Research Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Astellas Pharma Global Development, Inc. provided enzalutamide and funding for this project (ENZA-15C03 to ANK). ANK is also supported by a K12 award from the Vanderbilt Clinical Oncology Research Career Development Program (5K12CA090625-18). We appreciate the skilled services and assistance from the VUMC Digital Histology Shared Resource, VUMC Flow Cytometry Shared Resource, and the VUMC Translational Pathology Shared Resource supported by NCI/NIH Cancer Center Support Grant 5P30 CA68485-19 and the Vanderbilt Mouse Metabolic Phenotyping Center Grant 5U24DK059637-13. Whole slide imaging and quantification of immunostaining were performed in the Digital Histology Shared Resource at VUMC (www.mc.vanderbilt.edu/dhsr).The VUMC Flow Cytometry Shared Resource is supported by the Vanderbilt Ingram Cancer Center (P30 CA68485) and the Vanderbilt Digestive Disease Research Center (DK058404). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal P, 2016, BIOCHEM CELL BIOL, V94, P381, DOI 10.1139/bcb-2016-0017; Alimirah F, 2006, FEBS LETT, V580, P2294, DOI 10.1016/j.febslet.2006.03.041; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Barrado M, 2018, RADIOPOTENTIATION EN, DOI 10.1101/324889; EUHUS DM, 1986, J SURG ONCOL, V31, P229, DOI 10.1002/jso.2930310402; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Ghashghaei M, 2018, PROSTATE, V78, P64, DOI 10.1002/pros.23445; Goodwin JF, 2013, CANCER DISCOV, V3, P1254, DOI 10.1158/2159-8290.CD-13-0108; Guerrero J, 2013, PROSTATE, V73, P1291, DOI 10.1002/pros.22674; Hoefer J, 2016, ONCOTARGET, V7, P59781, DOI 10.18632/oncotarget.10926; Hussain M, 2018, NEW ENGL J MED, V378, P2465, DOI 10.1056/NEJMoa1800536; Kirschner AN, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/dju407; Martinez HD, 2008, J BIOL CHEM, V283, P29938, DOI 10.1074/jbc.M800534200; Mohiuddin JJ, 2015, NAT REV UROL, V12, P145, DOI 10.1038/nrurol.2015.25; Ning YMM, 2013, CLIN CANCER RES, V19, P6067, DOI 10.1158/1078-0432.CCR-13-1763; Palacios DA, 2013, BMC UROL, V13, DOI 10.1186/1471-2490-13-4; Polkinghorn WR, 2013, CANCER DISCOV, V3, P1245, DOI 10.1158/2159-8290.CD-13-0172; Reddy V, 2015, J BIOL CHEM, V290, P25522, DOI 10.1074/jbc.M115.671404; Rodriguez-Berriguete G, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1839-z; Rothkamm K, 2003, P NATL ACAD SCI USA, V100, P5057, DOI 10.1073/pnas.0830918100; Siegel RL, 2018, CA-CANCER J CLIN, V68, P7, DOI 10.3322/caac.21442; Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Tran C, 2009, SCIENCE, V324, P787, DOI 10.1126/science.1168175; Ullman-Cullere MH, 1999, LAB ANIM SCI, V49, P319; van Bokhoven A, 2003, PROSTATE, V57, P205, DOI 10.1002/pros.10290; Yan Y, 2008, CANCER RES, V68, P5113, DOI 10.1158/0008-5472.CAN-07-5818	27	19	19	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2019	14	4							e0214670	10.1371/journal.pone.0214670	http://dx.doi.org/10.1371/journal.pone.0214670			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR1CY	30933998	gold, Green Submitted, Green Published			2022-12-26	WOS:000462867000034
J	Alsous, M; Jalil, MA; Odeh, M; Al Kurdi, R; Alnan, M				Alsous, Mervat; Jalil, Mariam Abdel; Odeh, Mohanad; Al Kurdi, Rasha; Alnan, Murhaf			Public knowledge, attitudes and practices toward diabetes mellitus: A cross-sectional study from Jordan	PLOS ONE			English	Article							RISK; ASSOCIATION; PREVALENCE; MANAGEMENT; STATEMENT; AWARENESS	Aims To assess the knowledge and practices toward diabetes in the Jordanian community. Methods This study was conducted as a public based cross-sectional study in different cities in Jordan. A previously published validated questionnaire about knowledge, attitudes, and practices (KAP) toward diabetes mellitus (DM) was translated from the Arabic version and used in this study with very minor modification to be suitable for this study of the Jordanian population. Results A total of 1,702 participants were recruited in the present study. About half of the participants (53.3%) had good knowledge scores. The respondents' knowledge scores were significantly correlated with attitudes (p < 0.001). The education level (university or higher) and education related to a field were predictors for good knowledge and positive attitudes. About 46.3% of participants had positive attitudes toward the disease. As for practices, 37.7% of participants did not engage in regular exercise while more than half of the study subjects had never checked their blood glucose level on an annual basis. The factors influencing the practice of checking blood glucose level have been investigated. Conclusion This study has highlighted the need for more educational interventions to address negative attitudes and promote healthy lifestyle practices and regular health checks especially in certain subgroups of patients, such as those not having a degree related to the medical field and not having a first-degree relative with DM.	[Alsous, Mervat] Yarmouk Univ, Dept Pharm Practice, Fac Pharm, Irbid, Jordan; [Jalil, Mariam Abdel; Odeh, Mohanad] Univ Jordan, Dept Biopharmaceut & Clin Pharm, Fac Pharm, Amman, Jordan; [Odeh, Mohanad] Hashemite Univ, Dept Clin Pharm & Pharm Practice, Fac Pharmaceut Sci, Zarqa, Jordan; [Al Kurdi, Rasha; Alnan, Murhaf] Appl Sci Private Univ, Dept Clin Pharm & Therapeut, Fac Pharm, Amman, Jordan	Yarmouk University; University of Jordan; Hashemite University	Alsous, M (corresponding author), Yarmouk Univ, Dept Pharm Practice, Fac Pharm, Irbid, Jordan.	mervat_alsous@yahoo.com	Hamoury, Mariam/Q-8423-2019; Alsous, Mervat/AAF-2470-2019	Hamoury, Mariam/0000-0002-3976-5444; Odeh, Mohanad/0000-0002-6060-8283; Alsous, Mervat/0000-0002-6678-670X				Ajlouni K, 2008, J DIABETES COMPLICAT, V22, P317, DOI 10.1016/j.jdiacomp.2007.01.004; Al-Maskari F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052857; Al-Saeedi M, 2003, East Mediterr Health J, V9, P99; Al-Tamimi S, 1998, INT DENT J, V48, P180, DOI 10.1111/j.1875-595X.1998.tb00475.x; Chen L, 2010, MED J AUSTRALIA, V192, P197, DOI 10.5694/j.1326-5377.2010.tb03478.x; Dajani R, 2012, J DIABETES COMPLICAT, V26, P175, DOI 10.1016/j.jdiacomp.2012.03.009; Deepa M, 2014, Indian J Endocrinol Metab, V18, P379, DOI 10.4103/2230-8210.131191; Demaio AR, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-236; du Monde M, 2011, KNOWLEDGE ATTITUDES; Herath HMM, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4459-5; Islam FMA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110368; Kamel N M, 1999, East Mediterr Health J, V5, P967; Khalaf AJ, 2010, BMC COMPLEM ALTERN M, V10, DOI 10.1186/1472-6882-10-35; Mohan Deepa, 2005, J Assoc Physicians India, V53, P283; Nathan DM, 2009, DIABETES CARE, V32, P193, DOI 10.2337/dc08-9025; Nazer LH, 2017, CAN J HOSP PHARM, V70, P150; Niroomand M, 2016, DIABETES METAB SYND, V10, pS114, DOI 10.1016/j.dsx.2015.10.006; Powers MA, 2017, DIABETES EDUCATOR, V43, P40, DOI 10.1177/0145721716689694; Rani PK, 2008, RURAL REMOTE HEALTH, V8; Saleh F, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1112; Salpeter S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002967.pub2; Shah VN, 2009, INT J DIABETES DEV C, V29, P118, DOI 10.4103/0973-3930.54288; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Shrivastava SR, 2013, J DIABETES METAB DIS, V12, DOI 10.1186/2251-6581-12-14; Walter FM, 2004, ANN FAM MED, V2, P583, DOI 10.1370/afm.242; Wee H. L., 2002, SMJ Singapore Medical Journal, V43, P128; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1	27	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2019	14	3							e0214479	10.1371/journal.pone.0214479	http://dx.doi.org/10.1371/journal.pone.0214479			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ9FO	30925187	gold, Green Submitted, Green Published			2022-12-26	WOS:000462732300015
J	Schindler, C; Collinson, A; Matthews, C; Pointon, A; Jenkinson, L; Minter, RR; Vaughan, TJ; Tigue, NJ				Schindler, Christina; Collinson, Andie; Matthews, Carl; Pointon, Amy; Jenkinson, Lesley; Minter, Ralph R.; Vaughan, Tristan J.; Tigue, Natalie J.			Exosomal delivery of doxorubicin enables rapid cell entry and enhanced in vitro potency	PLOS ONE			English	Article							THERAPEUTIC INDEX; DRUG-DELIVERY; EXTRACELLULAR VESICLES; LIPOSOMAL FORMULATION; BREAST; DNA; BIODISTRIBUTION; CARDIOTOXICITY; MECHANISMS; TOXICITY	Doxorubicin is a chemotherapeutic agent that is commonly used to treat a broad range of cancers. However, significant cardiotoxicity, associated with prolonged exposure to doxorubicin, limits its continued therapeutic use. One strategy to prevent the uptake of doxorubicin into cardiac cells is the encapsulation of the drug to prevent non-specific uptake and also to improve the drugs' pharmacokinetic properties. Although encapsulated forms of doxorubicin limit the cardiotoxicity observed, they are not without their own liabilities as an increased amount of drug is deposited in the skin where liposomal doxorubicin can cause palmar-plantar erythrodysesthesia. Exosomes are small endogenous extracellular vesicles, that transfer bioactive material from one cell to another, and are considered attractive drug delivery vehicles due to their natural origin. In this study, we generated doxorubicin-loaded exosomes and demonstrate their rapid cellular uptake and re-distribution of doxorubicin from endosomes to the cytoplasm and nucleus resulting in enhanced potency in a number of cultured and primary cell lines when compared to free doxorubicin and liposomal formulations of doxorubicin. In contrast to other delivery methods for doxorubicin, exosomes do not accumulate in the heart, thereby providing potential for limiting the cardiac side effects and improved therapeutic index.	[Schindler, Christina; Collinson, Andie; Matthews, Carl; Jenkinson, Lesley; Minter, Ralph R.; Vaughan, Tristan J.; Tigue, Natalie J.] MedImmune Ltd, Dept Antibody Discovery & Prot Engn, Cambridge, England; [Pointon, Amy] AstraZeneca, IMED Biotech Unit, Mech Safety & ADME Sci, Drug Safety & Metab, Cambridge, England	AstraZeneca; Medimmune; AstraZeneca	Tigue, NJ (corresponding author), MedImmune Ltd, Dept Antibody Discovery & Prot Engn, Cambridge, England.	tiguen@medimmune.com		Tigue, Natalie/0000-0001-9916-0255	MedImmune Ltd, a subsidiary of AstraZeneca PLC; AstraZeneca PLC	MedImmune Ltd, a subsidiary of AstraZeneca PLC; AstraZeneca PLC(AstraZeneca)	This study was funded solely by MedImmune Ltd which is a subsidiary of AstraZeneca PLC and AstraZeneca PLC. Support was provided in the form of salaries to all authors (CS, AC, CM, AP, LJ, RRM, TJV, NJT) and procurement of materials but funders did not have any additional role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham SA, 2005, METHOD ENZYMOL, V391, P71, DOI 10.1016/S0076-6879(05)91004-5; Alvarez-Erviti L, 2011, NAT BIOTECHNOL, V29, P341, DOI 10.1038/nbt.1807; Ashley N, 2009, BIOCHEM BIOPH RES CO, V378, P450, DOI 10.1016/j.bbrc.2008.11.059; BALLY MB, 1988, CHEM PHYS LIPIDS, V47, P97, DOI 10.1016/0009-3084(88)90078-3; Box VGS, 2007, J MOL GRAPH MODEL, V26, P14, DOI 10.1016/j.jmgm.2006.09.005; Carvalho FS, 2014, MED RES REV, V34, P106, DOI 10.1002/med.21280; Cen H, 2008, FASEB J, V22, P2243, DOI 10.1096/fj.07-099234; Charrois GJR, 2004, BBA-BIOMEMBRANES, V1663, P167, DOI 10.1016/j.bbamem.2004.03.006; Chavez K. J., 2011, BREAST DIS, V32, P35; Chen L, 2016, FEBS LETT, V590, P4263, DOI 10.1002/1873-3468.12448; Clark Amy S, 2004, Support Cancer Ther, V1, P213, DOI 10.3816/SCT.2004.n.013; Escrevente C, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-108; Fitzner D, 2011, J CELL SCI, V124, P447, DOI 10.1242/jcs.074088; Furedia A, 2017, J CONTROL RELEASE, V261, P287, DOI 10.1016/j.jconrel.2017.07.010; Gorini Stefania, 2018, Oxid Med Cell Longev, V2018, P7582730, DOI 10.1155/2018/7582730; Gyorgy B, 2015, ANNU REV PHARMACOL, V55, P439, DOI 10.1146/annurev-pharmtox-010814-124630; Hadla M, 2016, NANOMEDICINE-UK, V11, P2431, DOI 10.2217/nnm-2016-0154; Kim MS, 2016, NANOMED-NANOTECHNOL, V12, P655, DOI 10.1016/j.nano.2015.10.012; Kooijmans SAA, 2016, PHARMACOL RES, V111, P487, DOI 10.1016/j.phrs.2016.07.006; Kooijmans SAA, 2016, J EXTRACELL VESICLES, V5, DOI 10.3402/jev.v5.31053; Longatti A, 2018, NANOSCALE, V10, P14230, DOI 10.1039/c8nr03970d; Lorusso D, 2007, ANN ONCOL, V18, P1159, DOI 10.1093/annonc/mdl477; Lotvall J, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.26913; Maeda H, 2009, EUR J PHARM BIOPHARM, V71, P409, DOI 10.1016/j.ejpb.2008.11.010; Montaigne D, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/951539; Mulcahy LA, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.24641; Muller PY, 2012, NAT REV DRUG DISCOV, V11, P751, DOI 10.1038/nrd3801; Ohno S-i, 2012, MOL THERAPY, DOI [10.10238/MT.2012.180, DOI 10.10238/MT.2012.180]; Reynolds JG, 2012, TOXICOL APPL PHARM, V262, P1, DOI 10.1016/j.taap.2012.04.008; Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496; SEIFERT CF, 1994, ANN PHARMACOTHER, V28, P1063, DOI 10.1177/106002809402800912; Shi JJ, 2010, NANO LETT, V10, P3223, DOI 10.1021/nl102184c; Smith LA, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-337; Smyth T, 2014, BIOCONJUGATE CHEM, V25, P1777, DOI 10.1021/bc500291r; Soininen SK, 2016, MOL PHARMACEUT, V13, P1358, DOI 10.1021/acs.molpharmaceut.6b00008; Speelmans G, 1996, BBA-BIOMEMBRANES, V1284, P240, DOI 10.1016/S0005-2736(96)00137-X; Swain SM, 2003, CANCER, V97, P2869, DOI 10.1002/cncr.11407; Tacar O, 2013, J PHARM PHARMACOL, V65, P157, DOI 10.1111/j.2042-7158.2012.01567.x; Tahover E, 2015, ANTI-CANCER DRUG, V26, P241, DOI 10.1097/CAD.0000000000000182; Takemura G, 2007, PROG CARDIOVASC DIS, V49, P330, DOI 10.1016/j.pcad.2006.10.002; TEWEY KM, 1984, SCIENCE, V226, P466, DOI 10.1126/science.6093249; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Tian T, 2014, J BIOL CHEM, V289, P22258, DOI 10.1074/jbc.M114.588046; Tian T, 2013, J CELL PHYSIOL, V228, P1487, DOI 10.1002/jcp.24304; Tian YH, 2014, BIOMATERIALS, V35, P2383, DOI 10.1016/j.biomaterials.2013.11.083; Toffoli G, 2015, NANOMEDICINE-UK, V10, P2963, DOI 10.2217/nnm.15.118; Webber J, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.19861; WEISS RB, 1992, SEMIN ONCOL, V19, P670; Wiklander OPB, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.26316; Yang ZG, 2016, J CONTROL RELEASE, V243, P160, DOI 10.1016/j.jconrel.2016.10.008; Zhao LQ, 2017, PSYCHOGERIATRICS, V17, P3, DOI 10.1111/psyg.12180; Zhuang XY, 2011, MOL THER, V19, P1769, DOI 10.1038/mt.2011.164	52	73	75	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2019	14	3							e0214545	10.1371/journal.pone.0214545	http://dx.doi.org/10.1371/journal.pone.0214545			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ9FO	30925190	Green Published, Green Submitted, gold			2022-12-26	WOS:000462732300018
J	Cohen, R; Babushkin, F; Geller, K; Finn, T				Cohen, Regev; Babushkin, Frida; Geller, Keren; Finn, Talya			Characteristics of hospitalized adult patients with laboratory documented Influenza A, B and Respiratory Syncytial Virus - A single center retrospective observational study	PLOS ONE			English	Article							INFECTION; EPIDEMIOLOGY; POPULATION; MORBIDITY; MORTALITY; CHILDREN; SUBTYPE; DISEASE; ILLNESS	Introduction The epidemiology, clinical features and outcomes of hospitalized adult patients with Influenza A (FluA), Influenza B (FluB) and Respiratory Syncytial Virus (RSV) have not been thoroughly compared. The aim of this study was to describe the differences between these viruses during 3 winter seasons. Methods A retrospective observational study was conducted consisting of all the polymerase chain reaction (PCR)-based diagnoses of FluA, FluB and RSV among adults during 2015-2018, in one regional hospital. Epidemiology, clinical symptoms and outcome-related data were comparatively analyzed. Results Between November 2015 and April 2018, 759 patients were diagnosed with FluA, FluB or RSV. Study cohort included 539 adult patients (306 FluA, 148 FluB and 85 RSV). FluB was predominant during the winter of 2017-18. RSV caused 15.7% of hospitalizations with diagnosed viral infection and in comparison to influenza, had distinct epidemiological, clinical features and outcomes, including older age (74.2 vs 66.2, p = 0.001) and higher rates of comorbidities; complications including bacterial pneumonia (31 vs 18%, p = 0.02), mechanical ventilation (20 vs 7%, p = 0.001), and viral-related death (13 vs 6.6%, p = 0.04). FluA and FluB had similar epidemiology, clinical symptoms and outcomes, but vaccinated patients were less prone to be hospitalized with FluB as compared with FluA (3 vs 14%, p = 0.001). Paroxysmal atrial fibrillation and falls were common (8.7 and 8.5% respectively). Conclusions FluA and FluB had similar epidemiological, clinical features and contributed equally to hospitalization burden and complications. RSV had a major impact on hospitalizations, occurring among the more elderly and sick populations and causing significantly worse outcomes, when compared to influenza patients. Vaccination appeared as a protective factor against hospitalizations with FluB as compared with FluA.	[Cohen, Regev; Babushkin, Frida; Geller, Keren; Finn, Talya] Laniado Hosp, Sanz Med Ctr, Infect Dis Unit, Neytanya, Israel; [Cohen, Regev; Finn, Talya] Technion, Ruth & Bruce Rappaport Fac Med, Haifa, Israel	Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Cohen, R (corresponding author), Laniado Hosp, Sanz Med Ctr, Infect Dis Unit, Neytanya, Israel.; Cohen, R (corresponding author), Technion, Ruth & Bruce Rappaport Fac Med, Haifa, Israel.	regevco@gmail.com		Cohen, Regev/0000-0001-7773-350X				Adlhoch C, 2018, EUROSURVEILLANCE, V23, P7, DOI 10.2807/1560-7917.ES.2018.23.13.18-00146; Anderson NW, 2016, DIAGN MICR INFEC DIS, V85, P367, DOI 10.1016/j.diagmicrobio.2016.02.025; [Anonymous], 2018, CONTROL ECFDPA INFLU; [Anonymous], 2018, CONTROL ICFD; Babcock HM, 2006, INFECT CONT HOSP EP, V27, P266, DOI 10.1086/501539; Beaute J, 2015, EPIDEMIOL INFECT, V143, P2950, DOI 10.1017/S0950268814003422; Belongia EA, 2016, LANCET INFECT DIS, V16, P942, DOI 10.1016/S1473-3099(16)00129-8; Bennett JE, 2015, MANDELL DOUGLAS BENN, Veighth, DOI DOI 10.1016/B978-1-4557-4801-3.00034-5; Branche AR, 2015, DRUG AGING, V32, P261, DOI 10.1007/s40266-015-0258-9; Caini S, 2018, INFLUENZA OTHER RESP, V12, P780, DOI 10.1111/irv.12575; Caram LB, 2009, J AM GERIATR SOC, V57, P482, DOI 10.1111/j.1532-5415.2008.02153.x; Chagvardieff A, 2018, MED MALADIES INFECT, V48, P180, DOI 10.1016/j.medmal.2017.11.007; Chang TY, 2016, HEART RHYTHM, V13, P1189, DOI 10.1016/j.hrthm.2016.01.026; Cohen JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139431; Dowell SF, 1996, J INFECT DIS, V174, P456, DOI 10.1093/infdis/174.3.456; Falsey AR, 2005, DRUG AGING, V22, P577, DOI 10.2165/00002512-200522070-00004; Falsey AR, 2005, NEW ENGL J MED, V352, P1749, DOI 10.1056/NEJMoa043951; Flannery B, 2019, CLIN INFECT DIS, V68, P1798, DOI 10.1093/cid/ciy775; Glezen WP, 2013, AM J PUBLIC HEALTH, V103, pE43, DOI 10.2105/AJPH.2012.301137; Hall CB, 2001, CLIN INFECT DIS, V33, P792, DOI 10.1086/322657; Hong KW, 2015, JPN J INFECT DIS, V68, P20, DOI 10.7883/yoken.JJID.2013.466; Irving SA, 2012, INFLUENZA OTHER RESP, V6, P37, DOI 10.1111/j.1750-2659.2011.00263.x; Ivey KS, 2018, J AM COLL CARDIOL, V71, P1574, DOI 10.1016/j.jacc.2018.02.013; Jennings L, 2018, INFLUENZA OTHER RESP, V12, P383, DOI 10.1111/irv.12522; Kestler M, 2018, J HOSP INFECT, V100, P463, DOI 10.1016/j.jhin.2018.03.034; Kwong JC, 2018, NEW ENGL J MED, V378, P345, DOI 10.1056/NEJMoa1702090; Lee N, 2013, CLIN INFECT DIS, V57, P1069, DOI 10.1093/cid/cit471; Malosh RE, 2017, J CLIN VIROL, V96, P37, DOI 10.1016/j.jcv.2017.09.001; Moa AM, 2017, INFLUENZA OTHER RESP, V11, P102, DOI 10.1111/irv.12432; Mosnier A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136186; Pretorius MA, 2016, J CLIN VIROL, V75, P21, DOI 10.1016/j.jcv.2015.12.004; Puig-Barbera J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100497; Sharabi Sivan, 2018, Oncotarget, V9, P6623, DOI 10.18632/oncotarget.23601; Sharabi S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161195; Su S, 2014, CLIN INFECT DIS, V59, P252, DOI 10.1093/cid/ciu269; van de Sandt CE, 2015, FUTURE MICROBIOL, V10, P1447, DOI 10.2217/fmb.15.65; Volling C, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0665-2; Wang D, 2016, J MED VIROL, V88, P1334, DOI 10.1002/jmv.24480; Wie SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062685	39	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214517	10.1371/journal.pone.0214517	http://dx.doi.org/10.1371/journal.pone.0214517			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HQ7IR	30921408	Green Published, Green Submitted, gold			2022-12-26	WOS:000462594000080
J	Montel, L; Sotiropoulos, A; Henon, S				Montel, Lorraine; Sotiropoulos, Athanassia; Henon, Sylvie			The nature and intensity of mechanical stimulation drive different dynamics of MRTF-A nuclear redistribution after actin remodeling in myoblasts	PLOS ONE			English	Article							SERUM RESPONSE FACTOR; TRANSCRIPTIONAL COACTIVATOR; RPEL MOTIFS; FACTOR SRF; MYOCARDIN; ACTIVATION; CELLS; REORGANIZATION; NETWORK; LIFEACT	Serum response factor and its cofactor myocardin-related transcription factor (MRTF) are key elements of muscle-mass adaptation to workload. The transcription of target genes is activated when MRTF is present in the nucleus. The localization of MRTF is controlled by its binding to G-actin. Thus, the pathway can be mechanically activated through the mechano-sensitivity of the actin cytoskeleton. The pathway has been widely investigated from a biochemical point of view, but its mechanical activation and the timescales involved are poorly understood. Here, we applied local and global mechanical cues to myoblasts through two custom-built set-ups, magnetic tweezers and stretchable substrates. Both induced nuclear accumulation of MRTF-A. However, the dynamics of the response varied with the nature and level of mechanical stimulation and correlated with the polymerization of different actin sub-structures. Local repeated force induced local actin polymerization and nuclear accumulation of MRTF-A by 30 minutes, whereas a global static strain induced both rapid (minutes) transient nuclear accumulation, associated with the polymerization of an actin cap above the nucleus, and long-term accumulation, with a global increase in polymerized actin. Conversely, high strain induced actin depolymerization at intermediate times, associated with cytoplasmic MRTF accumulation.	[Montel, Lorraine; Henon, Sylvie] Univ Paris Diderot, Sorbonne Paris Cite, CNRS, UMR 7057,Matiere & Syst Complexes, Paris, France; [Sotiropoulos, Athanassia] Univ Paris 05, Sorbonne Paris Cite, CNRS, UMR 8104,Inst Cochin,INSERM,U1016, Paris, France; [Montel, Lorraine] PSL Univ, Sorbonne Univ, CNRS, Inst Pierre Gilles Gennes Microfluid, Paris, France; [Montel, Lorraine] PSL Univ, Sorbonne Univ, CNRS, PASTEUR,Dept Chim,Ecole Normale Super, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Sorbonne Universite	Henon, S (corresponding author), Univ Paris Diderot, Sorbonne Paris Cite, CNRS, UMR 7057,Matiere & Syst Complexes, Paris, France.	sylvie.henon@univ-paris-diderot.fr		HENON, SYLVIE/0000-0002-4633-3957; Sotiropoulos, Athanassia/0000-0002-7265-1473	Agence Nationale de la Recherche [ANR-13-BSV1-0005]; Universite Sorbonne Paris Cite (Appel a projets de recherche USPC); Labex WhoAmI? transition post-doc program	Agence Nationale de la Recherche(French National Research Agency (ANR)); Universite Sorbonne Paris Cite (Appel a projets de recherche USPC); Labex WhoAmI? transition post-doc program	This research was funded by Agence Nationale de la Recherche (ANR-13-BSV1-0005 to AS and SH), Universite Sorbonne Paris Cite (Appel a projets de recherche USPC 2012 to AS and SH), and Labex WhoAmI? transition post-doc program, LM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed WW, 2010, BIOMATERIALS, V31, P250, DOI 10.1016/j.biomaterials.2009.09.047; Albinsson S, 2004, J BIOL CHEM, V279, P34849, DOI 10.1074/jbc.M403370200; Baarlink C, 2013, SCIENCE, V340, P864, DOI 10.1126/science.1235038; Ben-Ari Y, 2010, J CELL SCI, V123, P1761, DOI 10.1242/jcs.062638; Blanchoin L, 2014, PHYSIOL REV, V94, P235, DOI 10.1152/physrev.00018.2013; Cen B, 2003, MOL CELL BIOL, V23, P6597, DOI 10.1128/MCB.23.18.6597-6608.2003; Chambliss AB, 2013, SCI REP-UK, V3, DOI 10.1038/srep01087; Chan MWC, 2010, J BIOL CHEM, V285, P9273, DOI 10.1074/jbc.M109.075218; Charrier EE, 2018, BIOL CELL, V110, P77, DOI 10.1111/boc.201700040; Collard L, 2014, J CELL SCI, V127, P5157, DOI 10.1242/jcs.155911; Connelly JT, 2010, NAT CELL BIOL, V12, P711, DOI 10.1038/ncb2074; Courtemanche N, 2016, NAT CELL BIOL, V18, P676, DOI 10.1038/ncb3351; Cramer LP, 2002, CELL MOTIL CYTOSKEL, V51, P27, DOI 10.1002/cm.10013; Elosegui-Artola A, 2017, CELL, V171, P1397, DOI 10.1016/j.cell.2017.10.008; Esnault C, 2014, GENE DEV, V28, P943, DOI 10.1101/gad.239327.114; Gerber A, 2013, CELL, V152, P492, DOI 10.1016/j.cell.2012.12.027; Gomez EW, 2010, J CELLULAR BIOCH; Guerci A, 2012, CELL METAB, V15, P25, DOI 10.1016/j.cmet.2011.12.001; Guettler S, 2008, MOL CELL BIOL, V28, P732, DOI 10.1128/MCB.01623-07; Hirano H, 2011, BIOCHEM BIOPH RES CO, V414, P373, DOI 10.1016/j.bbrc.2011.09.079; Huang XW, 2012, AM J RESP CELL MOL, V47, P340, DOI 10.1165/rcmb.2012-0050OC; IBA T, 1991, MICROVASC RES, V42, P245, DOI 10.1016/0026-2862(91)90059-K; Icard-Arcizet D, 2008, BIOPHYS J, V94, P2906, DOI 10.1529/biophysj.107.118265; Iyer KV, 2012, BIOPHYS J, V103, P1416, DOI 10.1016/j.bpj.2012.08.041; Janmey PA, 2013, DIFFERENTIATION, V86, P112, DOI 10.1016/j.diff.2013.07.004; Janostiak R, 2014, EUR J CELL BIOL, V93, P445, DOI 10.1016/j.ejcb.2014.07.002; Kalita K, 2006, J NEUROSCI, V26, P10020, DOI 10.1523/JNEUROSCI.2644-06.2006; Kalita K, 2012, INT J BIOCHEM CELL B, V44, P1444, DOI 10.1016/j.biocel.2012.05.008; Khatau SB, 2009, P NATL ACAD SCI USA, V106, P19017, DOI 10.1073/pnas.0908686106; Kuwahara K, 2010, MOL CELL BIOL, V30, P4134, DOI 10.1128/MCB.00154-10; Li SJ, 2005, P NATL ACAD SCI USA, V102, P1082, DOI 10.1073/pnas.0409103102; Lukinavicius G, 2014, NAT METHODS, V11, P731, DOI [10.1038/NMETH.2972, 10.1038/nmeth.2972]; Lundquist MR, 2014, CELL, V156, P563, DOI 10.1016/j.cell.2013.12.035; Mendez MG, 2012, INT J BIOCHEM CELL B, V44, P728, DOI 10.1016/j.biocel.2012.02.003; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Morita T, 2007, EXP CELL RES, V313, P3432, DOI 10.1016/j.yexcr.2007.07.008; Mouilleron S, 2008, EMBO J, V27, P3198, DOI 10.1038/emboj.2008.235; Pawlowski R, 2010, EMBO J, V29, P3448, DOI 10.1038/emboj.2010.216; Randrianarison-Huetz V, 2018, J CELL BIOL, V217, P685, DOI 10.1083/jcb.201705130; Scharenberg MA, 2014, J CELL SCI, V127, P1079, DOI 10.1242/jcs.142075; Selvaraj A, 2003, J BIOL CHEM, V278, P41977, DOI 10.1074/jbc.M305679200; Sotiropoulos A, 1999, CELL, V98, P159, DOI 10.1016/S0092-8674(00)81011-9; Staus DP, 2007, ARTERIOSCL THROM VAS, V27, P478, DOI 10.1161/01.ATV.0000255559.77687.c1; Strale PO, 2015, J CELL BIOL, V210, P333, DOI 10.1083/jcb.201410111; van der Honing HS, 2011, CYTOSKELETON, V68, P578, DOI 10.1002/cm.20534; Vartiainen MK, 2007, SCIENCE, V316, P1749, DOI 10.1126/science.1141084; Wang DZ, 2002, P NATL ACAD SCI USA, V99, P14855, DOI 10.1073/pnas.222561499; Zhao XH, 2007, J CELL SCI, V120, P1801, DOI 10.1242/jcs.001586	48	9	9	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214385	10.1371/journal.pone.0214385	http://dx.doi.org/10.1371/journal.pone.0214385			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921405	Green Published, gold, Green Submitted			2022-12-26	WOS:000462594000063
J	Pons, BJ; Bezine, E; Hanique, M; Guillet, V; Mourey, L; Chicher, J; Frisan, T; Vignard, J; Mirey, G				Pons, Benoit J.; Bezine, Elisabeth; Hanique, Melissa; Guillet, Valerie; Mourey, Lionel; Chicher, Johana; Frisan, Teresa; Vignard, Julien; Mirey, Gladys			Cell transfection of purified cytolethal distending toxin B subunits allows comparing their nuclease activity while plasmid degradation assay does not	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; ESCHERICHIA-COLI; DNA-DAMAGE; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; BACTERIAL GENOTOXIN; HELICOBACTER-HEPATICUS; DEOXYRIBONUCLEASE I; CYCLE PROGRESSION; APOPTOTIC DEATH; G(2) ARREST	The Cytolethal Distending Toxin (CDT) is produced by many pathogenic bacteria. CDT is known to induce genomic DNA damage to host eukaryotic cells through its catalytic subunit, CdtB. CdtB is structurally homologous to DNase I and has a nuclease activity, dependent on several key residues. Yet some differences between various CdtB subunit activities, and discrepancies between biochemical and cellular data, have been observed. To better characterise the role of CdtB in the induction of DNA damage, we affinity-purified wild-type and mutants of CdtB, issued from E. coli and H. ducreyi, under native and denaturing conditions. We then compared their nuclease activity by a classic in vitro assay using plasmid DNA, and two different eukaryotic assays-the first assay where host cells were transfected with a plasmid encoding CdtB, the second assay where host cells were directly transfected with purified CdtB. We show here that in vitro nuclease activities are difficult to quantify, whereas CdtB activities in host cells can be easily interpreted and confirmed the loss of function of the catalytic mutant. Our results highlight the importance of performing multiple assays while studying the effects of bacterial genotoxins, and indicate that the classic in vitro assay should be complemented with cellular assays.	[Pons, Benoit J.; Bezine, Elisabeth; Hanique, Melissa; Vignard, Julien; Mirey, Gladys] INRA, Toxalim, Res Ctr Food Toxicol, UMR1331, Toulouse, France; [Pons, Benoit J.; Guillet, Valerie; Mourey, Lionel; Mirey, Gladys] Univ Toulouse III Paul Sabatier UPS, Toulouse, France; [Bezine, Elisabeth] Inst Natl Polytech Toulouse, Toulouse, France; [Guillet, Valerie; Mourey, Lionel] CNRS, IPBS, Toulouse, France; [Chicher, Johana] IBMC, Plateforme Prote Strasbourg Esplande, FRC1589, Strasbourg, France; [Frisan, Teresa] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden	INRAE; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite de Toulouse; Institut National Polytechnique de Toulouse; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Karolinska Institutet	Vignard, J; Mirey, G (corresponding author), INRA, Toxalim, Res Ctr Food Toxicol, UMR1331, Toulouse, France.; Mirey, G (corresponding author), Univ Toulouse III Paul Sabatier UPS, Toulouse, France.	julien.vignard@toulouse.inra.fr; gladys.mirey@toulouse.inra.fr	Mirey, Gladys/H-5676-2019; Frisan, Teresa/H-8444-2019; PONS, Benoît/AAA-6340-2020	Mirey, Gladys/0000-0002-0095-1864; Frisan, Teresa/0000-0002-1209-0942; PONS, Benoît/0000-0002-9137-1047; Mourey, Lionel/0000-0002-8259-1259; Chicher, Johana/0000-0002-4403-7484	ANR [ANR-10-CESA-011]; Institut National de la Recherche Agronomique (INRA); Toxalim internal program; French Ministry of Research; COLiveTox IDEXToulouse University fellowship	ANR(French National Research Agency (ANR)); Institut National de la Recherche Agronomique (INRA); Toxalim internal program; French Ministry of Research(Ministry of Research, FranceEuropean Commission); COLiveTox IDEXToulouse University fellowship	This work was supported by the ANR Grant No ANR-10-CESA-011 to GM, the Institut National de la Recherche Agronomique (INRA) and the Toxalim internal program to JV. E. Bezine was supported by a Ph.D. fellowship of the French Ministry of Research, B, Pons by the COLiveTox IDEXToulouse University fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avenaud P, 2004, BIOCHEM BIOPH RES CO, V318, P739, DOI 10.1016/j.bbrc.2004.04.089; Baranovskii AG, 2004, BIOCHEMISTRY-MOSCOW+, V69, P587, DOI 10.1023/B:BIRY.0000033731.50496.01; Bezine E, 2016, SCI REP-UK, V6, DOI 10.1038/srep36022; Bielaszewska M, 2005, INFECT IMMUN, V73, P552, DOI 10.1128/IAI.73.1.552-562.2005; Blazkova H, 2010, J CELL MOL MED, V14, P357, DOI 10.1111/j.1582-4934.2009.00862.x; Cope LD, 1997, P NATL ACAD SCI USA, V94, P4056, DOI 10.1073/pnas.94.8.4056; Dassanayake RP, 2005, FEMS MICROBIOL LETT, V251, P219, DOI 10.1016/j.femsle.2005.08.005; DiRienzo JM, 2014, TOXINS, V6, P3098, DOI 10.3390/toxins6113098; DiRienzo JM, 2009, FEMS MICROBIOL LETT, V291, P222, DOI 10.1111/j.1574-6968.2008.01457.x; Dlakic M, 2000, TRENDS BIOCHEM SCI, V25, P272, DOI 10.1016/S0968-0004(00)01582-6; Elwell C, 2001, INFECT IMMUN, V69, P3418, DOI 10.1128/IAI.69.5.3418-3422.2001; Elwell CA, 2000, MOL MICROBIOL, V37, P952, DOI 10.1046/j.1365-2958.2000.02070.x; Fahrer J, 2014, DNA REPAIR, V18, P31, DOI 10.1016/j.dnarep.2014.03.002; Fedor Y, 2013, CELL MICROBIOL, V15, P1, DOI 10.1111/cmi.12028; Frisan T, 2003, CELL MICROBIOL, V5, P695, DOI 10.1046/j.1462-5822.2003.00311.x; Gelfanova V, 1999, INFECT IMMUN, V67, P6394; Graillot V, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00034; Grasso F, 2015, BIOMOLECULES, V5, P1762, DOI 10.3390/biom5031762; Hadi MZ, 2000, NUCLEIC ACIDS RES, V28, P3871, DOI 10.1093/nar/28.20.3871; Hassane DC, 2003, INFECT IMMUN, V71, P541, DOI 10.1128/IAI.71.1.541-545.2003; He Z, 2019, GUT, V68, P289, DOI 10.1136/gutjnl-2018-317200; Hu X, 2005, BIOORGAN MED CHEM, V13, P1101, DOI 10.1016/j.bmc.2004.11.026; Hu X, 2006, PROTEINS, V65, P843, DOI 10.1002/prot.21167; Jinadasa RN, 2011, MICROBIOL-SGM, V157, P1851, DOI 10.1099/mic.0.049536-0; JOHNSON WM, 1988, MICROB PATHOGENESIS, V4, P115, DOI 10.1016/0882-4010(88)90053-8; JOHNSON WM, 1987, FEMS MICROBIOL LETT, V43, P19, DOI 10.1111/j.1574-6968.1987.tb02091.x; Kanno F, 2005, J PERIODONTOL, V76, P1189, DOI 10.1902/jop.2005.76.7.1189; Kim HS, 2017, J BIOL CHEM, V292, P2795, DOI 10.1074/jbc.M116.758235; Lara-Tejero M, 2000, SCIENCE, V290, P354, DOI 10.1126/science.290.5490.354; Ledesma FC, 2009, NATURE, V461, P674, DOI 10.1038/nature08444; Li LQ, 2002, CELL MICROBIOL, V4, P87, DOI 10.1046/j.1462-5822.2002.00174.x; Liyanage NPM, 2013, HELICOBACTER, V18, P433, DOI 10.1111/hel.12084; Mao XQ, 2002, CELL MICROBIOL, V4, P245, DOI 10.1046/j.1462-5822.2002.00186.x; Nalbant A, 2003, ORAL MICROBIOL IMMUN, V18, P339, DOI 10.1046/j.0902-0055.2003.00082.x; Nesic D, 2004, NATURE, V429, P429, DOI 10.1038/nature02532; Nishikubo S, 2003, J BIOL CHEM, V278, P50671, DOI 10.1074/jbc.M305062200; Obradovic D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159231; Pan CQ, 1997, BIOCHEMISTRY-US, V36, P6624, DOI 10.1021/bi962960x; Pan CQ, 1998, PROTEIN SCI, V7, P628, DOI 10.1002/pro.5560070312; PICKETT CL, 1994, INFECT IMMUN, V62, P1046, DOI 10.1128/IAI.62.3.1046-1051.1994; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; SCOTT DA, 1994, INFECT IMMUN, V62, P244, DOI 10.1128/IAI.62.1.244-251.1994; SEKI S, 1991, BIOCHIM BIOPHYS ACTA, V1079, P57, DOI 10.1016/0167-4838(91)90024-T; Shenker BJ, 2001, J IMMUNOL, V167, P435, DOI 10.4049/jimmunol.167.1.435; Shenker BJ, 2007, J IMMUNOL, V178, P5099, DOI 10.4049/jimmunol.178.8.5099; Shenker BJ, 2016, CELL MICROBIOL, V18, P223, DOI 10.1111/cmi.12497; Solier S, 2014, CELL MOL LIFE SCI, V71, P2289, DOI 10.1007/s00018-013-1555-2; Song JM, 2013, NATURE, V499, P350, DOI 10.1038/nature12377; Sugai M, 1998, INFECT IMMUN, V66, P5008, DOI 10.1128/IAI.66.10.5008-5019.1998; Taieb F, 2006, CELL MICROBIOL, V8, P1910, DOI 10.1111/j.1462-5822.2006.00757.x; Yamamoto K, 2004, EUR J ORAL SCI, V112, P445, DOI 10.1111/j.1600-0722.2004.00157.x; Yang SW, 1996, P NATL ACAD SCI USA, V93, P11534, DOI 10.1073/pnas.93.21.11534	52	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214313	10.1371/journal.pone.0214313	http://dx.doi.org/10.1371/journal.pone.0214313			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921382	Green Published, gold, Green Submitted			2022-12-26	WOS:000462594000053
J	He, YY; Wu, P; Xiao, W; Li, GY; Yi, JC; He, YF; Chen, CM; Ding, P; Duan, YY				He, Yayuan; Wu, Pian; Xiao, Wen; Li, Guiyin; Yi, Jiecan; He, Yafei; Chen, Cuimei; Ding, Ping; Duan, Yanying			Efficient removal of Pb( II) from aqueous solution by a novel ion imprinted magnetic biosorbent: Adsorption kinetics and mechanisms	PLOS ONE			English	Article							HEAVY-METAL IONS; SERRATIA-MARCESCENS; SELECTIVE REMOVAL; GRAPHENE OXIDE; MASS-TRANSFER; SOLID-PHASE; LEAD; POLYMER; BIOSORPTION; CADMIUM	It is vital to understand the adsorption mechanisms and identify the adsorption kinetics when applying an adsorbent to remove heavy metals from aqueous solution. A Pb(II) imprinted magnetic biosorbent (Pb(II)-IMB) was developed for the removal of Pb2+ via lead ion imprinting technology and crosslinking reactions among chitosan (CTS), Serratia marcescens and Fe3O4. The effect of different parameters such as solution pH, adsorbent dosage, selectivity sorption and desorption were investigated on the absorption of lead ion by Pb(II)-IMB. The adsorbent was characterized by a Brunauer-Emmett Teller (BET) analysis, X-ray diffraction (XRD), vibrating sample magnetometry (VSM), scanning electron microscopy (SEM) and energy dispersive spectrometry (EDS). The adsorption kinetics, equilibrium and thermodynamics of Pb(II)-IMB for Pb(II) were studied. The results of the abovementioned analyses showed that the adsorption kinetic process fit well with the second-order equation. The adsorption isotherm process of Pb(II) on the Pb(II)-IMB was closely related to the Langmuir model. Thermodynamic studies suggested the spontaneous and endothermic nature of adsorption of Pb(II) by Pb(II)-IMB. The adsorption mechanism of Pb(II)-IMB was studied by Fourier transform infrared spectroscopy (FTIR) and X-ray photoelectron spectroscopy (XPS). The results indicated that the nitrogen in the amino group and the oxygen in the hydroxyl group of Pb(II)-IMB were coordination atoms.	[He, Yayuan; Wu, Pian; Yi, Jiecan; He, Yafei; Ding, Ping; Duan, Yanying] Cent S Univ, Xiang Ya Sch Publ Hlth, Changsha, Hunan, Peoples R China; [Xiao, Wen] Hunan Inst Food Qual Supervis Inspect & Res, Changsha, Hunan, Peoples R China; [Li, Guiyin] Guilin Univ Elect Technol, Sch Life & Environm Sci, Guilin, Guangxi, Peoples R China; [Chen, Cuimei] Xiangnan Univ, Chenzhou, Hunan, Peoples R China	Central South University; Guilin University of Electronic Technology; Xiangnan University	Ding, P; Duan, YY (corresponding author), Cent S Univ, Xiang Ya Sch Publ Hlth, Changsha, Hunan, Peoples R China.	pingshui@csu.edu.cn; duany@csu.edu.cn		Ding, Ping/0000-0003-4476-8700; Wu, Pian/0000-0002-8194-231X	National Natural Science Foundation of China [21676305]; Fundamental Research Funds for the Central Universities of Central South University [2018zzts847, 2018zzts855]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities of Central South University	This work was supported by research grants from the National Natural Science Foundation of China (grant number 21676305) and the Fundamental Research Funds for the Central Universities of Central South University (grant number 2018zzts847 and number 2018zzts855).	Ajitha P, 2017, INT J BIOL MACROMOL, V104, P1469, DOI 10.1016/j.ijbiomac.2017.05.111; Bae JY, 2016, J HAZARD MATER, V320, P133, DOI 10.1016/j.jhazmat.2016.07.067; Chen FY, 2015, SEP PURIF TECHNOL, V151, P225, DOI 10.1016/j.seppur.2015.07.024; Chen LX, 2016, CHEM SOC REV, V45, P2137, DOI 10.1039/c6cs00061d; Cristani M, 2012, ENVIRON SCI POLLUT R, V19, P161, DOI 10.1007/s11356-011-0539-8; Dahaghin Z, 2017, FOOD CHEM, V237, P275, DOI 10.1016/j.foodchem.2017.05.118; Daley JC, 2013, LEAD REMOVAL ION EXC, DOI [10.1002/9781118788073.ch59, DOI 10.1002/9781118788073.CH59]; Fulazzaky MA, 2017, PROCESS SAF ENVIRON, V107, P259, DOI 10.1016/j.psep.2017.02.016; Fulazzaky MA, 2015, RSC ADV, V5, P104666, DOI 10.1039/c5ra20794k; Gao BJ, 2007, POLYMER, V48, P2288, DOI 10.1016/j.polymer.2006.12.041; Ge F, 2012, J HAZARD MATER, V211, P366, DOI 10.1016/j.jhazmat.2011.12.013; Giraldo JD, 2017, J APPL POLYM SCI, V134, DOI 10.1002/app.45511; Gomez-Pastora J, 2014, CHEM ENG J, V256, P187, DOI 10.1016/j.cej.2014.06.119; Gumpu MB, 2015, SENSOR ACTUAT B-CHEM, V213, P515, DOI 10.1016/j.snb.2015.02.122; Hafshejani LD, 2015, J MOL LIQ, V211, P448, DOI 10.1016/j.molliq.2015.07.044; Hajdu I, 2012, J MEMBRANE SCI, V409, P44, DOI 10.1016/j.memsci.2012.03.011; Hasany SF, 2012, AIP CONF PROC, V1502, P298, DOI 10.1063/1.4769153; He YY, 2019, ENVIRON TECHNOL, V40, P499, DOI 10.1080/09593330.2017.1397762; Huang JC, 1982, P IND WASTE C US, V1, P36; Huang MR, 2010, J PHYS CHEM B, V114, P3534, DOI 10.1021/jp910697s; Javanbakht V, 2014, WATER SCI TECHNOL, V69, P1775, DOI 10.2166/wst.2013.718; Kavak D, 2013, DESALIN WATER TREAT, V51, P1720, DOI 10.1080/19443994.2012.714652; Krishna D, 2014, J NUCL SCI TECHNOL, V41, P235, DOI [10.1080/s11356-011-0539-8, DOI 10.1080/S11356-011-0539-8]; Kumar R, 2011, J MICROBIOL, V49, P568, DOI 10.1007/s12275-011-0366-0; Lalchhingpuii, 2017, CHEM ENG J, V328, P434, DOI 10.1016/j.cej.2017.07.053; Li J, 2009, ANAL CHIM ACTA, V649, P196, DOI 10.1016/j.aca.2009.07.030; Li M, 2015, APPL SURF SCI, V332, P463, DOI 10.1016/j.apsusc.2015.01.201; Li RJ, 2013, CHEM ENG J, V229, P460, DOI 10.1016/j.cej.2013.05.089; Li XH, 2017, J ELECTROCHEM SOC, V164, pE71, DOI 10.1149/2.1211704jes; Lin S, 2012, CHEM ENG J, V211, P46, DOI 10.1016/j.cej.2012.09.018; Liu YW, 2005, ANAL CHIM ACTA, V538, P85, DOI 10.1016/j.aca.2005.02.017; Low KS, 2000, PROCESS BIOCHEM, V36, P59, DOI 10.1016/S0032-9592(00)00177-1; Luo XB, 2017, RSC ADV, V7, P25811, DOI 10.1039/c7ra03536e; Lv L, 2017, RSC ADV, V7, P27992, DOI 10.1039/c7ra02810e; Mahmoud ME, 2012, SCI WORLD J, DOI 10.1100/2012/604198; Needleman H, 2004, ANNU REV MED, V55, P209, DOI 10.1146/annurev.med.55.091902.103653; NISHIDE H, 1976, CHEM LETT, P169, DOI 10.1246/cl.1976.169; Pal P, 2017, INT J BIOL MACROMOL, V104, P1548, DOI 10.1016/j.ijbiomac.2017.02.042; Rao TP, 2006, ANAL CHIM ACTA, V578, P105, DOI 10.1016/j.aca.2006.06.065; Rashed M. N., 2001, Environmentalist, V21, P187, DOI 10.1023/A:1017931404249; Shahat A, 2015, CHEM ENG J, V273, P286, DOI 10.1016/j.cej.2015.03.073; Tawinteung N, 2005, J ENVIRON SCI HEAL A, V40, P385, DOI 10.1081/ESE-200045631; Thornton GJP, 2001, SCI TOTAL ENVIRON, V278, P45, DOI 10.1016/S0048-9697(00)00887-1; Venkateswarlu S, 2015, ACS APPL MATER INTER, V7, P25362, DOI 10.1021/acsami.5b07723; Verma R, 2015, FOOD CHEM, V166, P568, DOI 10.1016/j.foodchem.2014.06.045; Wang X, 2016, IND ENG CHEM RES, V55, P4911, DOI 10.1021/acs.iecr.5b04630; Wang XS, 2011, J CHEM ENG DATA, V56, P444, DOI 10.1021/je101079w; Xiang GQ, 2009, MICROCHIM ACTA, V165, P237, DOI 10.1007/s00604-008-0126-y; Yang HF, 2014, INT J MIN MET MATER, V21, P210, DOI 10.1007/s12613-014-0887-8; Yao J, 2016, RSC ADV, V6, P101353, DOI 10.1039/c6ra16246k; Zhou K, 2016, J TAIWAN INST CHEM E, V63, P453, DOI 10.1016/j.jtice.2016.02.031; Zhou K, 2015, J ENVIRON CHEM ENG, V3, P2219, DOI 10.1016/j.jece.2015.08.002; Zhou ZY, 2018, J HAZARD MATER, V341, P355, DOI 10.1016/j.jhazmat.2017.06.010	53	38	40	6	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2019	14	3							e0213377	10.1371/journal.pone.0213377	http://dx.doi.org/10.1371/journal.pone.0213377			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ5PT	30917141	Green Published, Green Submitted, gold			2022-12-26	WOS:000462465800030
J	Sun, R; Vuillier, L; Hui, BPH; Kogan, A				Sun, Rui; Vuillier, Laura; Hui, Bryant P. H.; Kogan, Aleksandr			Caring helps: Trait empathy is related to better coping strategies and differs in the poor versus the rich	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; EMOTIONAL EMPATHY; POLYMORPHISM OXTR; COGNITIVE EMPATHY; SOCIAL SUPPORT; LIFE STRESS; OXYTOCIN; HEALTH; ASSOCIATION; PERSONALITY	Coping has been extensively studied in health psychology; however, factors influencing the usage of different coping strategies have received limited attention. In five studies (N = 3702), we explored the relationship between trait empathy and coping strategies, and how subjective socioeconomic status (SES) moderates this relationship. In Studies 1-4, we found that people with higher level of empathic concern use more adaptive coping strategies, seek more social support, and use fewer maladaptive coping strategies. Moreover, higher trait empathy related to more adaptive coping strategies among the poor, and fewer maladaptive coping strategies among the rich. In Study 5, we tested the potential biological basis of the relationship between trait empathy and coping by examining the effect of the oxytocin receptor gene (OXTR) rs53576 polymorphism on coping. We found that individuals with the GG phenotype-who in previous research have been found to be more empathic-were more likely to seek social support than AG or AA individuals. Furthermore, in line with findings in Studies 1-4, amongst people with low SES, individuals with GG genotype used more adaptive coping strategies than AG or AA individuals. Our results highlight the selective role trait empathy plays in influencing coping strategy deployment, depending on the SES of individuals.	[Sun, Rui] Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands; [Vuillier, Laura] Bournemouth Univ, Dept Psychol, Poole, Dorset, England; [Hui, Bryant P. H.] Univ Hong Kong, Dept Sociol, Hong Kong, Peoples R China; [Kogan, Aleksandr] Univ Cambridge, Dept Psychol, Cambridge, England	University of Amsterdam; Bournemouth University; University of Hong Kong; University of Cambridge	Sun, R (corresponding author), Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands.	r.sun@uva.nl	hui, Bryant/ABF-9656-2021; Hui, Bryant Pui Hung/P-8673-2018	Hui, Bryant Pui Hung/0000-0003-3063-9297; Vuillier, Laura/0000-0002-1596-9303	Economic and Social Research Council (UK) [ES/K008331/1]	Economic and Social Research Council (UK)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This research is funded by Economic and Social Research Council (UK) to AK with the grant reference ES/K008331/1. URLs:http://www.researchcatalogue.esrc.ac.uk/grants/ES.K008331.1/read.	Adler NE, 2000, HEALTH PSYCHOL, V19, P586, DOI 10.1037/0278-6133.19.6.586; ADLER NE, 1994, AM PSYCHOL, V49, P15, DOI 10.1037/0003-066X.49.1.15; Baker JP, 2007, COGNITION EMOTION, V21, P95, DOI 10.1080/02699930600562276; Bakermans-Kranenburg MJ, 2014, PSYCHIAT GENET, V24, P45, DOI 10.1097/YPG.0b013e3283643684; Barrett JE, 1979, STRESS MENTAL DISORD, P37; Bartz JA, 2010, PSYCHOL SCI, V21, P1426, DOI 10.1177/0956797610383439; BATSON CD, 1983, J PERS SOC PSYCHOL, V45, P706, DOI 10.1037//0022-3514.45.3.706; Baum A, 1999, ANN NY ACAD SCI, V896, P131, DOI 10.1111/j.1749-6632.1999.tb08111.x; Berinsky AJ, 2012, POLIT ANAL, V20, P351, DOI 10.1093/pan/mpr057; Billings A G, 1981, J Behav Med, V4, P139, DOI 10.1007/BF00844267; BILLINGS AG, 1982, J OCCUP BEHAV, V3, P215, DOI 10.1002/job.4030030303; Cantril H, 1943, J ABNORM SOC PSYCH, V38, P74, DOI 10.1037/h0054069; Carver CS, 1997, INT J BEHAV MED, V4, P92, DOI 10.1207/s15327558ijbm0401_6; CARVER CS, 1989, J PERS SOC PSYCHOL, V56, P267, DOI 10.1037/0022-3514.56.2.267; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Chandler J, 2014, BEHAV RES METHODS, V46, P112, DOI 10.3758/s13428-013-0365-7; Cote S, 2011, J PERS SOC PSYCHOL, V101, P217, DOI 10.1037/a0023171; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; Decety J, 2006, CURR DIR PSYCHOL SCI, V15, P54, DOI 10.1111/j.0963-7214.2006.00406.x; Decety Jean, 2004, Behav Cogn Neurosci Rev, V3, P71, DOI 10.1177/1534582304267187; Decety J, 2011, ANN NY ACAD SCI, V1231, P35, DOI 10.1111/j.1749-6632.2011.06027.x; DeLongis A, 2005, J PERS, V73, P1633, DOI 10.1111/j.1467-6494.2005.00361.x; Di Giunta L, 2010, EUR J PSYCHOL ASSESS, V26, P77, DOI 10.1027/1015-5759/a000012; Dohrenwend B. S., 1981, AM J COMMUN PSYCHOL, V9, P123, DOI [10.1007/BF00896364, DOI 10.1007/BF00896364]; DOMHOFF GW, 1998, WHO RULES AM POWER P; Duan CM, 2000, MOTIV EMOTION, V24, P29, DOI 10.1023/A:1005587525609; EISENBERG N, 1987, PSYCHOL BULL, V101, P91, DOI 10.1037/0033-2909.101.1.91; Eisenberg N, 1990, EMPATHY ITS DEV, V11; ENDLER NS, 1990, J PERS SOC PSYCHOL, V58, P844, DOI 10.1037/0022-3514.58.5.844; Fischer C. S., 1982, DWELL FRIENDS PERSON; FISKE ST, 1993, AM PSYCHOL, V48, P621, DOI 10.1037/0003-066X.48.6.621; Fiske ST., 1996, EUR REV SOC PSYCHOL, V7, P31, DOI DOI 10.1080/14792779443000094; FOLKMAN S, 1985, J PERS SOC PSYCHOL, V48, P150, DOI 10.1037/0022-3514.48.1.150; Folkman S, 2004, ANNU REV PSYCHOL, V55, P745, DOI 10.1146/annurev.psych.55.090902.141456; FOLKMAN S, 1986, J PERS SOC PSYCHOL, V50, P992, DOI 10.1037/0022-3514.50.5.992; FOLKMAN S, 1980, J HEALTH SOC BEHAV, V21, P219, DOI 10.2307/2136617; Folkman S, 1988, MANUAL WAYS COPING Q; Gilbert P., 2022, COMPASSION FOCUSED T; Gilbert P., 2017, COMPASSION CONCEPTS, P31, DOI DOI 10.4324/9781315564296; Gilbert P., 2009, ADV PSYCHIAT TREATME, V15, P199, DOI [DOI 10.1192/APT.BP.107.005264, 10.1192/apt.bp.107.005264]; Gong PY, 2017, PSYCHONEUROENDOCRINO, V80, P131, DOI 10.1016/j.psyneuen.2017.03.005; Goodman JK, 2013, J BEHAV DECIS MAKING, V26, P213, DOI 10.1002/bdm.1753; Gyurak A, 2013, EMOTION, V13, P25, DOI 10.1037/a0029616; Haan N, 1977, COPING AND DEFENDING; Halbwachs M., 1959, PSYCHOL SOCIAL CLASS; HARVEY RJ, 1985, J APPL PSYCHOL, V70, P461, DOI 10.1037/0021-9010.70.3.461; Huetter FK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160059; Hurlemann R, 2010, J NEUROSCI, V30, P4999, DOI 10.1523/JNEUROSCI.5538-09.2010; Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749; Jacobson JM, 2006, J WORKPLACE BEHAV HE, V21, P133, DOI 10.1300/J490v21n03_08; Jansen DEMC, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-440; Keltner D, 2003, PSYCHOL REV, V110, P265, DOI 10.1037/0033-295X.110.2.265; KENDLER KS, 1991, PSYCHOL MED, V21, P337, DOI 10.1017/S0033291700020444; Kim HS, 2011, SOC PSYCHOL PERS SCI, V2, P665, DOI 10.1177/1948550611405854; Kim HS, 2010, P NATL ACAD SCI USA, V107, P15717, DOI 10.1073/pnas.1010830107; KOBASA SC, 1982, J PERS SOC PSYCHOL, V42, P168, DOI 10.1037/0022-3514.42.1.168; Koenig JI, 2011, STRESS, V14, P475, DOI 10.3109/10253890.2011.604879; Kogan A, 2011, P NATL ACAD SCI USA, V108, P19189, DOI 10.1073/pnas.1112658108; Kosfeld M, 2005, NATURE, V435, P673, DOI 10.1038/nature03701; Krageloh CU, 2011, RELIGIONS, V2, P216, DOI 10.3390/rel2030216; KRAMER BJ, 1993, FAM RELAT, V42, P383, DOI 10.2307/585338; Kraus MW, 2010, PSYCHOL SCI, V21, P1716, DOI 10.1177/0956797610387613; Kumsta R, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00083; Lazarus R, STRESS COPING APPRAI; Lemstra M, 2008, CAN J PUBLIC HEALTH, V99, P125, DOI 10.1007/BF03405459; MacDonald K, 2010, HARVARD REV PSYCHIAT, V18, P1, DOI 10.3109/10673220903523615; MCCRAE RR, 1984, J PERS SOC PSYCHOL, V46, P919, DOI 10.1037/0022-3514.46.4.919; Moons WG, 2014, EMOTION, V14, P562, DOI 10.1037/a0035503; Moos R.H., 1993, COPING RESPONSES INV; Ng SKS, 2006, COMMUNITY DENT ORAL, V34, P252, DOI 10.1111/j.1600-0528.2006.00282.x; Norman GJ, 2012, HORM BEHAV, V61, P134, DOI 10.1016/j.yhbeh.2011.11.006; NORMAN RMG, 1993, BRIT J PSYCHIAT, V162, P161, DOI 10.1192/bjp.162.2.161; O'Brien TB, 2009, EUR PSYCHOL, V14, P18, DOI 10.1027/1016-9040.14.1.18; OBrien TB, 1996, J PERS, V64, P775, DOI 10.1111/j.1467-6494.1996.tb00944.x; Pagliaccio D, 2014, NEUROPSYCHOPHARMACOL, V39, P1245, DOI 10.1038/npp.2013.327; PARKER JDA, 1992, EUR J PERSONALITY, V6, P321, DOI 10.1002/per.2410060502; PEARLIN LI, 1978, J HEALTH SOC BEHAV, V19, P2, DOI 10.2307/2136319; Penley JA, 2002, J BEHAV MED, V25, P551, DOI 10.1023/A:1020641400589; Piff PK, 2010, J PERS SOC PSYCHOL, V99, P771, DOI 10.1037/a0020092; Poulin MJ, 2012, PSYCHOL SCI, V23, P446, DOI 10.1177/0956797611428471; Prag P, 2016, SOC SCI MED, V149, P84, DOI 10.1016/j.socscimed.2015.11.044; Radat F, 2009, CEPHALALGIA, V29, P338, DOI 10.1111/j.1468-2982.2008.01718.x; Ritter K, 2011, PSYCHIAT RES, V187, P241, DOI 10.1016/j.psychres.2010.09.013; Rodrigues SM, 2009, P NATL ACAD SCI USA, V106, P21437, DOI 10.1073/pnas.0909579106; Schottenbauer MA, 2006, MENT HEALTH RELIG CU, V9, P448, DOI 10.1080/13694670500440684; Shamay-Tsoory SG, 2009, BRAIN, V132, P617, DOI 10.1093/brain/awn279; Skinner EA, 2003, PSYCHOL BULL, V129, P216, DOI 10.1037/0033-2909.129.2.216; Skuse DH, 2011, PEDIATR RES, V69, p85R, DOI 10.1203/PDR.0b013e318212f562; Smith A, 2006, PSYCHOL REC, V56, P3, DOI 10.1007/BF03395534; Stellar JE, 2012, EMOTION, V12, P449, DOI 10.1037/a0026508; Stevens J., 1992, APPL MULTIVARIATE ST; Stroebe M., 2001, HDB BEREAVEMENT RES, P375; Taylor SE, 2000, PSYCHOL REV, V107, P411, DOI 10.1037/0033-295X.107.3.411; THOITS PA, 1986, J CONSULT CLIN PSYCH, V54, P416, DOI 10.1037/0022-006X.54.4.416; TOBIN DL, 1989, COGNITIVE THER RES, V13, P343, DOI 10.1007/BF01173478; Tollenaar MS, 2017, EUR ARCH PSY CLIN N, V267, P517, DOI 10.1007/s00406-017-0784-z; TOOTHMAKER LE, 1994, J OPER RES SOC, V45, P119; Vandenberg RJ, 2006, ORGAN RES METHODS, V9, P194, DOI 10.1177/1094428105285506; Varnum M.E.W., 2015, CULTURE BRAIN, V3, P122, DOI DOI 10.1007/S40167-015-0031-2; Worthington RL, 2006, COUNS PSYCHOL, V34, P806, DOI 10.1177/0011000006288127; Wu N, 2012, J AFFECT DISORDERS, V138, P468, DOI 10.1016/j.jad.2012.01.009; Zelikovsky N, 2007, J CLIN PSYCHOL MED S, V14, P320, DOI 10.1007/s10880-007-9084-5	103	12	12	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2019	14	3							e0213142	10.1371/journal.pone.0213142	http://dx.doi.org/10.1371/journal.pone.0213142			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HQ5PT	30917144	Green Submitted, gold, Green Published			2022-12-26	WOS:000462465800021
J	Valerio, L; Peters, RJ; Zwinderman, AH; Pinto-Sietsma, SJ				Valerio, Luca; Peters, Ron J.; Zwinderman, Aeilko H.; Pinto-Sietsma, Sara-Joan			Sublingual endothelial glycocalyx and atherosclerosis. A cross-sectional study	PLOS ONE			English	Article							SELF-REPORTS; DYSFUNCTION; PREVALENCE; COINCIDES; DISEASE	Background Damage to endothelial glycocalyx is thought to be an early marker of atherosclerosis and measuring reduced glycocalyx size clinically via the Perfused Boundary Region (PBR) may allow early detection of cardiovascular disease. However, the true value of the glycocalyx in estimating cardiovascular risk or detecting cardiovascular disease is uncertain. We therefore investigated whether small glycocalyx size is associated with cardiovascular risk or disease in a large multi-ethnic cohort. Methods In a multi-ethnic community-based sample (N = 6169, 42.4% male, mean age 43.6 +/- 13) we applied multiple imputation for missing data and used logistic regression and odds ratios to cross-sectionally investigate the relationship of small glycocalyx size as estimated by highest quartile of PBR with, on the one hand, classical risk factors for atherosclerosis including age, sex, diastolic and systolic blood pressure, LDL, HDL, triglycerides, BMI, diabetes, smoking status, and antihypertensive and lipid-lowering medication; on the other hand, prevalent cardiovascular disease. Analyses were additionally adjusted for ethnicity. Results With PBR divided in quartiles, the highest PBR quartile (smallest glycocalyx size) as dependent variable was independently associated with female sex (OR for male versus female: 0.61, 95% CI: 0.53, 0.70) and diabetes (OR: 1.28, 95% CI: 1.03-1.59) in a model adjusted for all classical risk factors of atherosclerosis and for ethnicity. With regard to cardiovascular disease, no association was found between the smallest glycocalyx size as independent variable and overall cardiovascular disease, coronary heart disease and revascularization procedures, or stroke. Conclusions Small glycocalyx size as estimated by highest PBR is associated with female sex and diabetes, which do not completely reflect a high cardiovascular risk profile. At the same time, glycocalyx size is not associated with prevalent cardiovascular disease.	[Valerio, Luca] Univ Amsterdam, Amsterdam UMC, Dept Publ Hlth, Amsterdam, Netherlands; [Valerio, Luca; Peters, Ron J.] Univ Amsterdam, Amsterdam UMC, Dept Cardiol, Amsterdam, Netherlands; [Zwinderman, Aeilko H.; Pinto-Sietsma, Sara-Joan] Univ Amsterdam, Amsterdam UMC, Dept Clin Epidemiol & Biostat, Amsterdam, Netherlands; [Pinto-Sietsma, Sara-Joan] Univ Amsterdam, Amsterdam UMC, Dept Vasc Med, Amsterdam, Netherlands; [Valerio, Luca] Johannes Gutenberg Univ Mainz, Ctr Thrombosis & Hemostasis, Mainz, Germany	University of Amsterdam; University of Amsterdam; University of Amsterdam; University of Amsterdam; Johannes Gutenberg University of Mainz	Valerio, L (corresponding author), Univ Amsterdam, Amsterdam UMC, Dept Publ Hlth, Amsterdam, Netherlands.; Valerio, L (corresponding author), Univ Amsterdam, Amsterdam UMC, Dept Cardiol, Amsterdam, Netherlands.; Pinto-Sietsma, SJ (corresponding author), Univ Amsterdam, Amsterdam UMC, Dept Clin Epidemiol & Biostat, Amsterdam, Netherlands.; Pinto-Sietsma, SJ (corresponding author), Univ Amsterdam, Amsterdam UMC, Dept Vasc Med, Amsterdam, Netherlands.; Valerio, L (corresponding author), Johannes Gutenberg Univ Mainz, Ctr Thrombosis & Hemostasis, Mainz, Germany.	l.valerio@amc.uva.nl; s.j.pinto@amc.uva.nl	Valerio, Luca/AGX-7211-2022; SJ, Pinto-Sietsma/AAI-3207-2021	Valerio, Luca/0000-0003-4466-0724; 	CTMM, the Center for Translational Molecular Medicine, project PREDICCt [01C-104]; Dutch Heart Foundation; Dutch Diabetes Research Foundation; Dutch Kidney Foundation; Netherlands Organization for Health Research and Development (ZonMw); European Union (FP-7); European Fund for the Integration of non-EU immigrants (EIF)	CTMM, the Center for Translational Molecular Medicine, project PREDICCt; Dutch Heart Foundation(Netherlands Heart Foundation); Dutch Diabetes Research Foundation; Dutch Kidney Foundation; Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); European Union (FP-7); European Fund for the Integration of non-EU immigrants (EIF)	This research was performed within the framework of CTMM, the Center for Translational Molecular Medicine (www.ctmm.nl), project PREDICCt (grant 01C-104 awarded to Sara-Joan Pinto-Sietsma [SJ-PS]), and supported by the Dutch Heart Foundation, Dutch Diabetes Research Foundation and Dutch Kidney Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The HELIUS study is also funded by the Dutch Heart Foundation, the Netherlands Organization for Health Research and Development (ZonMw), the European Union (FP-7), and the European Fund for the Integration of non-EU immigrants (EIF).	Amraoui F, 2014, MICROCIRCULATION, V21, P499, DOI 10.1111/micc.12125; Benedict KF, 2011, MICROCIRCULATION, V18, P63, DOI 10.1111/j.1549-8719.2010.00069.x; Broekhuizen LN, 2010, DIABETOLOGIA, V53, P2646, DOI 10.1007/s00125-010-1910-x; Broekhuizen LN, 2009, CURR OPIN LIPIDOL, V20, P57, DOI 10.1097/MOL.0b013e328321b587; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; CASTELLI WP, 1986, AM J MED, V80, P23, DOI 10.1016/0002-9343(86)90157-9; Dane MJC, 2014, CLIN J AM SOC NEPHRO, V9, P698, DOI 10.2215/CJN.08160813; Deanfield JE, 2007, CIRCULATION, V115, P1285, DOI 10.1161/CIRCULATIONAHA.106.652859; Donati A, 2013, CRIT CARE RES PRACT, V2013, DOI DOI 10.HTTPS://D0I.0RG/10.1155/2013/; Galenkamp H, 2014, J CLIN EPIDEMIOL, V67, P773, DOI 10.1016/j.jclinepi.2014.02.002; Gorshkov AY, 2018, MICROCIRCULATION, V25, DOI 10.1111/micc.12454; Groen BBL, 2014, J APPL PHYSIOL, V116, P998, DOI 10.1152/japplphysiol.00919.2013; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Gu YM, 2015, HYPERTENSION, V65, P993, DOI 10.1161/HYPERTENSIONAHA.114.05119; Ikonomidis I, 2018, J CLIN HYPERTENS, V20, P672, DOI 10.1111/jch.13236; Janssen KJM, 2010, J CLIN EPIDEMIOL, V63, P721, DOI 10.1016/j.jclinepi.2009.12.008; Lee DH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096477; Mancia G, 2013, J HYPERTENS, V31, P1281, DOI 10.1097/01.hjh.0000431740.32696.cc; Mannan H, 2010, HEART INT, V5, P49, DOI 10.4081/hi.2010.e11; Martens RJH, 2013, CEREBROVASC DIS, V35, P451, DOI 10.1159/000348854; Meuwese MC, 2009, J LIPID RES, V50, P148, DOI 10.1194/jlr.P800025-JLR200; Mulders TA, 2013, INT J CARDIOL, V168, P5026, DOI 10.1016/j.ijcard.2013.07.166; Nieuwdorp M, 2007, DIABETOLOGIA, V50, P1288, DOI 10.1007/s00125-007-0666-4; Nieuwdorp M, 2006, DIABETES, V55, P1127, DOI 10.2337/diabetes.55.04.06.db05-1619; Nieuwdorp M, 2006, DIABETES, V55, P480, DOI 10.2337/diabetes.55.02.06.db05-1103; Nieuwdorp M, 2005, CURR OPIN LIPIDOL, V16, P507, DOI 10.1097/01.mol.0000181325.08926.9c; Snijder MB, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017873; Stronks K, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-402; Stronks K, 2009, ETHNIC HEALTH, V14, P255, DOI 10.1080/13557850802509206; Valerio L, 2019, REPROD SUBLINGUAL MI; van den Akker M, 2015, EUR J GEN PRACT, V21, P45, DOI 10.3109/13814788.2014.907266	31	14	14	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2019	14	3							e0213097	10.1371/journal.pone.0213097	http://dx.doi.org/10.1371/journal.pone.0213097			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ5PT	30917159	Green Submitted, gold, Green Published			2022-12-26	WOS:000462465800020
J	Bickmeyer, U; Thorns, S; Koch, F; Mukagatare, LP; Silalahi, R; Sartoris, FJ				Bickmeyer, Ulf; Thorns, Silke; Koch, Florian; Mukagatare, Liliane Petety; Silalahi, Romaston; Sartoris, Franz Josef			Enhancement of photosynthesis in Synechococcus bacillaris by sponge-derived Ageladine A	PLOS ONE			English	Article							MARINE SPONGES; QUANTUM YIELD; FLUORESCENCE; LIGHT; ELECTRON; CYANOBACTERIA; INHIBITOR; GROWTH; ALGA; FLUX	This study is a proof of concept that the sponge derived pyrrole-imidazole alkaloid Ageladine A acts as an additional light harvesting molecule for photosynthesis of symbionts of marine sponges. The absorbance of Ageladine A is in the UV range and fluoresces blue, matching the blue absorbance of chlorophyll a. A joint modeling and experimental approach demonstrates that Ageladine A increases photosynthetic O-2 production of Synechococcus bacillaris WH5701 (CCMP1333), when the cells are exposed to UV light, which is marginally used for photosynthesis. Due to the presence of Ageladine A, production of O-2 increased 2.54 and 3.1-fold, in the experiments and the model, respectively.	[Bickmeyer, Ulf; Thorns, Silke; Koch, Florian; Mukagatare, Liliane Petety; Silalahi, Romaston; Sartoris, Franz Josef] Alfred Wegener Inst, Helmholtz Ctr Polar & Marine Res, Dept Biosci, Bremerhaven, Germany	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Bickmeyer, U (corresponding author), Alfred Wegener Inst, Helmholtz Ctr Polar & Marine Res, Dept Biosci, Bremerhaven, Germany.	UIf.Bickmeyer@awi.de		Koch, Florian/0000-0001-7107-4160; Bickmeyer, Ulf/0000-0002-5351-2902	 [PACES II T2W3]		We would like to thank the Helmholtz Research Program PACES II T2W3 for funding.	Ando N, 2009, BIOORG MED CHEM LETT, V19, P5461, DOI 10.1016/j.bmcl.2009.07.099; Bandaranayake WM, 1998, NAT PROD REP, V15, P159; Bickmeyer U, 2008, BIOCHEM BIOPH RES CO, V373, P419, DOI 10.1016/j.bbrc.2008.06.056; Bickmeyer U, 2010, BIOCHEM BIOPH RES CO, V402, P489, DOI 10.1016/j.bbrc.2010.10.055; BIDIGARE RR, 1990, P SOC PHOTO-OPT INS, V1302, P290, DOI 10.1117/12.21451; Brinkmann CM, 2017, DIVERSITY-BASEL, V9, DOI 10.3390/d9040040; Brouwer AM, 2011, PURE APPL CHEM, V83, P2213, DOI 10.1351/PAC-REP-10-09-31; Chanas B, 1997, J EXP MAR BIOL ECOL, V208, P185, DOI 10.1016/S0022-0981(96)02653-6; Collier JL, 2012, J PHYCOL, V48, P106, DOI 10.1111/j.1529-8817.2011.01100.x; Croce R, 2014, NAT CHEM BIOL, V10, P492, DOI [10.1038/NCHEMBIO.1555, 10.1038/nchembio.1555]; Erwin PM, 2008, MAR ECOL PROG SER, V362, P139, DOI 10.3354/meps07464; FALKNER G, 1976, PLANT PHYSIOL, V58, P717, DOI 10.1104/pp.58.6.717; Faulkner D. John, 2000, P107, DOI 10.1159/000062486; Fujita M, 2003, J AM CHEM SOC, V125, P15700, DOI 10.1021/ja038025w; Gao ZM, 2014, MBIO, V5, DOI 10.1128/mBio.00079-14; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; Guillard R.R.L., 1975, CULTURE MARINE INVER, P29, DOI [10.1007/978-1-4615-8714-9_3, DOI 10.1007/978-1-4615-8714-9_3]; Harke MJ, 2011, HARMFUL ALGAE, V10, P503, DOI 10.1016/j.hal.2011.03.005; Hentschel U, 2012, NAT REV MICROBIOL, V10, P641, DOI 10.1038/nrmicro2839; Huot Y., 2010, CHLOROPHYLL FLUORESC; Kalinin VI, 2012, MAR DRUGS, V10, P1671, DOI 10.3390/md10081671; Kolber ZS, 1998, BBA-BIOENERGETICS, V1367, P88, DOI 10.1016/S0005-2728(98)00135-2; Kroon BMA, 2006, J PHYCOL, V42, P593, DOI 10.1111/j.1529-8817.2006.00221.x; Kulchin Yu. N., 2009, V47, P315, DOI 10.1007/978-3-540-88552-8_14; Kupper H, 2007, ANAL CHEM, V79, P7611, DOI 10.1021/ac070236m; Lichtenthaler H.K., 2001, CURR PROTOC FOOD ANA, V1, pF4.3.1, DOI [10.1002/0471142913.faf0403s01, DOI 10.1002/0471142913.FAF0403S01]; Mehbub MF, 2014, MAR DRUGS, V12, P4539, DOI 10.3390/md12084539; Meketa ML, 2006, ORG LETT, V8, P1443, DOI 10.1021/ol0602304; Mordhorst T, 2015, TETRAHEDRON LETT, V56, P4363, DOI 10.1016/j.tetlet.2015.05.081; Oxborough K, 2012, LIMNOL OCEANOGR-METH, V10, P142, DOI 10.4319/lom.2012.10.142; Radecker N, 2015, TRENDS MICROBIOL, V23, P490, DOI 10.1016/j.tim.2015.03.008; Ralph PJ, 2005, AQUAT BOT, V82, P222, DOI 10.1016/j.aquabot.2005.02.006; READ KRH, 1968, COMP BIOCHEM PHYSIOL, V25, P873, DOI 10.1016/0010-406X(68)90575-6; Shengule SR, 2006, ORG LETT, V8, P4083, DOI 10.1021/ol061584y; Silalahi R., 2013, THESIS; Staehelin LA, 1996, OXYGENIC PHOTOSYNTHE, P11; Suggett DJ, 2009, MAR ECOL PROG SER, V376, P1, DOI 10.3354/meps07830; Sundar VC, 2003, NATURE, V424, P899, DOI 10.1038/424899a; Trimborn S, 2017, PHYSIOL PLANTARUM, V160, P155, DOI 10.1111/ppl.12539; UNSON MD, 1994, MAR BIOL, V119, P1, DOI 10.1007/BF00350100; VAARA T, 1979, APPL ENVIRON MICROB, V38, P1011, DOI 10.1128/AEM.38.5.1011-1014.1979; Vermaas WFJ, 2008, P NATL ACAD SCI USA, V105, P4050, DOI 10.1073/pnas.0708090105; Webster NS, 2012, ENVIRON MICROBIOL, V14, P335, DOI 10.1111/j.1462-2920.2011.02460.x; Zea S., 2014, SPONGE GUIDE PICTURE, V3rd	44	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2019	14	3							e0213771	10.1371/journal.pone.0213771	http://dx.doi.org/10.1371/journal.pone.0213771			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ3IW	30913222	Green Published, gold			2022-12-26	WOS:000462305600020
J	da Silva, RH; Ferreira, WS; de Medeiros, PM; Albuquerque, UP				da Silva, Risoneide Henriques; Ferreira Junior, Washington Soares; de Medeiros, Patricia Muniz; Albuquerque, Ulysses Paulino			Adaptive memory and evolution of the human naturalistic mind: Insights from the use of medicinal plants	PLOS ONE			English	Article							CONFORMIST TRANSMISSION; MNEMONIC VALUE; RISK; PERCEPTIONS; ANIMALS	Throughout evolutionary history, humans have been exposed to a wide variety of diseases, some of which have serious and even lethal consequences. Memorizing medicinal plants for the treatment of serious diseases likely maximized the chances of survival and reproduction and was instrumental in the evolutionary success of our species. In the present study, we used the idea of adaptive memory to understand whether human memory evolved to recall information about medicinal plants for the treatment of serious diseases. We considered plant-disease pairs of words as units of information available in a medical system based on the use of medicinal plants. The pairs included in the categories of chronic infectious diseases and transmissible infectious diseases were considered to be of higher adaptive value, whereas those included in the category of common conditions were considered to be of lower adaptive value. Pairs grouped into the category of emerging and reemerging diseases were employed to investigate conformity bias; pairs belonging to the category esthetic uses were considered to be of little adaptive relevance and utilized as an experimental control. Our results revealed that plant-disease pairs associated with the category of common conditions, considered by us to be of lower severity and less adaptive relevance for humans, were better remembered and retained in the participants' memory. We believe that prior experience with common conditions and the frequency of these conditions in the population may have intensified the ability to remember the plant-disease pairs associated with this group of diseases.	[da Silva, Risoneide Henriques] Univ Fed Rural Pernambuco, Programa Posgrad Bot, Recife, PE, Brazil; [da Silva, Risoneide Henriques; Albuquerque, Ulysses Paulino] Univ Fed Pernambuco, Dept Bot, Ctr Biociencias, Lab Ecol & Evolucao Sistemas Socioecol LEA, Recife, PE, Brazil; [Ferreira Junior, Washington Soares] Univ Pernambuco, Petrolina, PE, Brazil; [de Medeiros, Patricia Muniz] Univ Fed Alagoas, Ctr Ciencias Agr, Grp Etnobiol & Ecol Humana, Rio Largo, Alagoas, Brazil	Universidade Federal Rural de Pernambuco (UFRPE); Universidade Federal de Pernambuco; Universidade de Pernambuco (UPE); Universidade Federal de Alagoas	Albuquerque, UP (corresponding author), Univ Fed Pernambuco, Dept Bot, Ctr Biociencias, Lab Ecol & Evolucao Sistemas Socioecol LEA, Recife, PE, Brazil.	upa677@hotmail.com	Júnior, Washington Soares Ferreira/F-8600-2018; Albuquerque, Ulysses P/I-5037-2012	Júnior, Washington Soares Ferreira/0000-0002-3128-0514; Albuquerque, Ulysses P/0000-0002-8131-8429; Henriques da Silva, Risoneide/0000-0002-7405-8884	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) [001]; FACEPE (Foundation for Support to Science and Technology of the State of Pernambuco -Grant) [APQ-0562-2.01/17]; Postgraduate Program in Botany of the Federal Rural University of Pernambuco; CNPq	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FACEPE (Foundation for Support to Science and Technology of the State of Pernambuco -Grant); Postgraduate Program in Botany of the Federal Rural University of Pernambuco; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was financed in part by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) - Finance Code 001 to RS. Contribution of the INCT Ethnobiology, Bioprospecting and Nature Conservation, certified by CNPq, with financial support from FACEPE (Foundation for Support to Science and Technology of the State of Pernambuco -Grant number: APQ-0562-2.01/17 to UPA). This study was also supported by the Postgraduate Program in Botany of the Federal Rural University of Pernambuco through the award of the Academic Master's Degree and by CNPq through the research productivity grant awarded to UPA and PMM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque UP, 2017, EVOL BIOL, V44, P206, DOI 10.1007/s11692-016-9398-z; Alqahtani AS, 2017, TRAVEL MED INFECT DI, V15, P81, DOI 10.1016/j.tmaid.2016.11.002; [Anonymous], [No title captured]; Aslan A, 2012, PSYCHOL AGING, V27, P1027, DOI 10.1037/a0028379; Barrett HC, 2016, CHILD DEV, V87, P770, DOI 10.1111/cdev.12495; Barrett HC, 2012, EVOL HUM BEHAV, V33, P499, DOI 10.1016/j.evolhumbehav.2012.01.003; Bonin P, 2019, EVOL PSYCHOL SCI, V5, P300, DOI [10.1007/s40806-019-00188-y, 10.1007/s40806-019-00220-1]; Bonin P, 2014, MEM COGNITION, V42, P370, DOI 10.3758/s13421-013-0368-8; Bonita R, 2009, EPIDEMIOLOGIA BASICA, V31; Brasil. Ministerio da Sau de, 2015, SAUD BRAS 2013 AN SI; Broesch J, 2014, HUM NATURE-INT BIOS, V25, P181, DOI 10.1007/s12110-014-9196-1; Chaves LD, 2019, ACTA BOT BRAS, V33, P360, DOI 10.1590/0102-33062018abb0330; de Medeiros PM, 2013, J ETHNOPHARMACOL, V150, P729, DOI 10.1016/j.jep.2013.09.026; Fabrega H., 1997, EVOLUTION OF SICKNES; Fernandes NL, 2017, EVOL HUM BEHAV, V38, P451, DOI 10.1016/j.evolhumbehav.2017.04.003; Gibbons A, 2016, J HEALTH PSYCHOL, V21, P2052, DOI 10.1177/1359105315570984; Hart BL, 2005, ANIM BEHAV, V70, P975, DOI 10.1016/j.anbehav.2005.03.005; Henrich J, 1998, EVOL HUM BEHAV, V19, P215, DOI 10.1016/S1090-5138(98)00018-X; Jain S, 2005, STUD TRIBES TRIBALS, V3, P15, DOI DOI 10.1080/; KLEINMAN A, 1978, SOC SCI MED-MED ANTH, V12, P85, DOI 10.1016/0160-7987(78)90014-5; Miceli R, 2008, J ENVIRON PSYCHOL, V28, P164, DOI 10.1016/j.jenvp.2007.10.006; Moura JMB, 2018, ETHNOBIOLOGY CONSERV, V9, P1, DOI [10.3389/fpsyg.2018.00001, DOI 10.15451/EC2017076.916]; Moura JMB, 2018, FRONT PSYCHOL, V9, P1, DOI [10.3389/fpsyg.2018.00001, DOI 10.3389/FPSYG.2018.00001]; Nairne JS, 2008, J MEM LANG, V59, P377, DOI 10.1016/j.jml.2008.06.001; Nairne JS, 2008, CURR DIR PSYCHOL SCI, V17, P239, DOI 10.1111/j.1467-8721.2008.00582.x; Nairne JS, 2008, PSYCHOL SCI, V19, P176, DOI 10.1111/j.1467-9280.2008.02064.x; Nairne JS, 2007, J EXP PSYCHOL LEARN, V33, P263, DOI 10.1037/0278-7393.33.2.263; Nairne JS, 2016, PERSPECT PSYCHOL SCI, V11, P496, DOI 10.1177/1745691616635613; Nairne JS, 2013, PSYCHOL SCI, V24, P2099, DOI 10.1177/0956797613480803; Nairne JS, 2012, J EXP PSYCHOL LEARN, V38, P495, DOI 10.1037/a0025728; Nairne JS, 2010, AM J PSYCHOL, V123, P381, DOI 10.5406/amerjpsyc.123.4.0381; Nakahashi W, 2007, THEOR POPUL BIOL, V72, P52, DOI 10.1016/j.tpb.2007.03.003; Nouchi R, 2012, JPN PSYCHOL RES, V54, P210, DOI 10.1111/j.1468-5884.2011.00483.x; Otgaar H, 2010, MEM COGNITION, V38, P23, DOI 10.3758/MC.38.1.23; Pandeirada JNS, 2017, EVOL PSYCHOL-US, V15, DOI 10.1177/1474704917742807; Polyn SM, 2009, NEUROPSYCHOLOGIA, V47, P2158, DOI 10.1016/j.neuropsychologia.2009.02.013; Prokop P, 2014, J BIOL EDUC, V48, P127, DOI 10.1080/00219266.2013.837407; R Core Team, 2018, R LANG ENV STAT COMP; Ruin I., 2007, ENVIRON HAZARDS-UK, V7, P235, DOI [10.1016/j.envhaz.2007.07.005, DOI 10.1016/J.ENVHAZ.2007.07.005]; Sachs ML, 2017, PHARM MED, V31, P245, DOI 10.1007/s40290-017-0200-z; Sandry J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060868; Scheideler JK, 2017, J BEHAV MED, V40, P839, DOI 10.1007/s10865-017-9860-0; Sutrop Urmas, 2001, FIELD METHOD, V13, P263; VanArsdall JE, 2013, EXP PSYCHOL, V60, P172, DOI 10.1027/1618-3169/a000186; Yang LX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095792	45	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2019	14	3							e0214300	10.1371/journal.pone.0214300	http://dx.doi.org/10.1371/journal.pone.0214300			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HQ3IW	30913230	gold, Green Submitted, Green Published			2022-12-26	WOS:000462305600042
J	Chen, LH; Wu, M; Zhang, SN; Tan, WJ; Guan, M; Feng, LQ; Chen, C; Tao, J; Chen, L; Qu, LB				Chen, Longhui; Wu, Min; Zhang, Shengnan; Tan, Wenjuan; Guan, Min; Feng, Liqiang; Chen, Chen; Tao, Jun; Chen, Ling; Qu, Linbing			Estrogen-related receptor gamma regulates hepatic triglyceride metabolism through phospholipase A2 G12B	FASEB JOURNAL			English	Article						hypertriglyceridemia; VLDL secretion; ERR gamma; PLA2G12B	ERR-GAMMA; ORPHAN; EXPRESSION; VLDL; A(2); OVERPRODUCTION; SECRETION; HYPERTRIGLYCERIDEMIA; PGC-1-ALPHA; INHIBITION	Hypersecretion of hepatic very LDL (VLDL)-associated triglyceride (TG) is the hallmark of hypertriglyceridemia. The estrogen-related receptor gamma (ERR gamma), an orphan nuclear receptor, plays crucial roles in the regulation of metabolic homeostasis, including TG formation in the liver. It remains unclear whether ERR gamma regulates hepatic VLDL-TG secretion. We demonstrated that knockdown of ERR gamma impairs hepatic VLDL-TG secretion in mice, whereas overexpression of ERR gamma favors the secretion, indicating a novel role of ERR gamma in hepatic TG metabolism. We found that ERR gamma transcriptionally regulates the expression of PLA2G12B by binding to the promoter region of the Pla2g12b gene. In Pla2g12b-null mice, ERR gamma fails to regulate hepatic VLDL-TG secretion. There is an apparent accumulation of large lipid droplets in the liver of Pla2g12b-null mice. These data suggest that ERR gamma is a novel regulator of hepatic VLDL-TG secretion, which is mediated through the action on PLA2G12B.-Chen, L., Wu, M., Zhang, S., Tan, W., Guan, M., Feng, L., Chen, C., Tao, J., Chen, L., Qu, L. Estrogen-related receptor gamma regulates hepatic triglyceride metabolism through phospholipase A2 G12B.	[Chen, Longhui; Wu, Min; Zhang, Shengnan; Feng, Liqiang; Chen, Ling; Qu, Linbing] Chinese Acad Sci, Guangdong Lab Computat Biomed, Guangzhou Inst Biomed & Hlth, Guangzhou, Guangdong, Peoples R China; [Feng, Liqiang; Chen, Ling] Chinese Acad Sci, Ghuangzhou Inst Biomed & Hlth, State Key Labs Resp Dis, Guangzhou, Guangdong, Peoples R China; [Zhang, Shengnan; Chen, Ling] Univ Sci & Technol China, Sch Life Sci, Hefei, Anhui, Peoples R China; [Tan, Wenjuan] Chinese Univ Hong Kong, Fac Sci, Sch Life Sci, Hong Kong, Peoples R China; [Guan, Min] Chinese Acad Sci, Ctr Human Tissues & Organs Degenerat, Shenzhen Inst Adv Technol, Shenzhen, Peoples R China; [Chen, Chen] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia; [Tao, Jun] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Hypertens & Vasc Dis, Guangzhou, Guangdong, Peoples R China	Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese University of Hong Kong; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; University of Queensland; Sun Yat Sen University	Chen, L; Qu, LB (corresponding author), Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, 190 Kaiyuan Ave, Guangzhou 510530, Guangdong, Peoples R China.	chen_ling@gibh.ac.cn; qu_linbing@gibh.ac.cn	chen, chen/GRY-7085-2022; Chen, Chen/B-4284-2010; CHEN, CHEN/HDM-6657-2022	Chen, Chen/0000-0003-2104-534X; Guan, Min/0000-0003-3851-8553	National Natural Science Foundation of China [81470570]; Department of Science and Technology of Guangdong Province [2015A030312017]; Guangzhou Health Care and Cooperative Innovation Major Project [201704020212]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Department of Science and Technology of Guangdong Province; Guangzhou Health Care and Cooperative Innovation Major Project	The authors thank Qingqing Wang and Xuehua Zheng (Guangzhou Institutes of Biomedicine and Health) for technical assistance in lentivirus and adenovirus vector preparation. The authors also thank Zheyu Cai and Erjun Zhang (Laboratory Animal Center, Beijing, China) for assistance in animal experiments. This work was supported by the National Natural Science Foundation of China (81470570), a grant from the Department of Science and Technology of Guangdong Province (2015A030312017), and by the Guangzhou Health Care and Cooperative Innovation Major Project (201704020212). The authors declare no conflicts of interest.	Adiels M, 2005, ARTERIOSCL THROM VAS, V25, P1697, DOI 10.1161/01.ATV.0000172689.53992.25; Adiels M, 2008, ARTERIOSCL THROM VAS, V28, P1225, DOI 10.1161/ATVBAHA.107.160192; Alaynick WA, 2007, CELL METAB, V6, P13, DOI 10.1016/j.cmet.2007.06.007; Alaynick WA, 2010, MOL ENDOCRINOL, V24, P299, DOI 10.1210/me.2009-0114; Bookout AL, 2006, CELL, V126, P789, DOI 10.1016/j.cell.2006.06.049; Bryant KJ, 2011, J BIOL CHEM, V286, P2492, DOI 10.1074/jbc.M110.123927; Eudy JD, 1998, GENOMICS, V50, P382, DOI 10.1006/geno.1998.5345; Granata F, 2005, J IMMUNOL, V174, P464, DOI 10.4049/jimmunol.174.1.464; Guan M, 2011, HEPATOLOGY, V53, P458, DOI 10.1002/hep.24066; Hassing HC, 2012, BBA-MOL CELL BIOL L, V1821, P826, DOI 10.1016/j.bbalip.2011.11.010; Hodges BDM, 2010, J LIPID RES, V51, P262, DOI 10.1194/jlr.R003582; Huss JM, 2002, J BIOL CHEM, V277, P40265, DOI 10.1074/jbc.M206324200; Hussain MM, 2003, J LIPID RES, V44, P22, DOI 10.1194/jlr.R200014-JLR200; Kim DK, 2014, DIABETOLOGIA, V57, P2576, DOI 10.1007/s00125-014-3366-x; Kim DK, 2013, DIABETES, V62, P3093, DOI 10.2337/db12-0946; Kim DK, 2013, GUT, V62, P1044, DOI 10.1136/gutjnl-2012-303347; Kim DK, 2012, J BIOL CHEM, V287, P21628, DOI 10.1074/jbc.M111.315168; Kim DK, 2011, J BIOL CHEM, V286, P38035, DOI 10.1074/jbc.M111.250613; Kutner RH, 2009, NAT PROTOC, V4, P495, DOI 10.1038/nprot.2009.22; Li XH, 1996, J LIPID RES, V37, P210; Li XL, 2014, J VIROL, V88, P612, DOI 10.1128/JVI.02068-13; Misra J, 2017, TRENDS ENDOCRIN MET, V28, P261, DOI 10.1016/j.tem.2016.12.005; Misra J, 2016, DIABETES, V65, P2835, DOI 10.2337/db15-1523; Murakami M, 2011, PROG LIPID RES, V50, P152, DOI 10.1016/j.plipres.2010.12.001; Olofsson SO, 2009, BBA-MOL CELL BIOL L, V1791, P448, DOI 10.1016/j.bbalip.2008.08.001; Park DW, 2003, J IMMUNOL, V170, P2093, DOI 10.4049/jimmunol.170.4.2093; Pedersen SB, 2016, JAMA INTERN MED, V176, P1834, DOI 10.1001/jamainternmed.2016.6875; Razzaque MA, 2004, GENE, V340, P275, DOI 10.1016/j.gene.2004.07.010; Ren Y, 2011, HUM MOL GENET, V20, P1074, DOI 10.1093/hmg/ddq550; Rouault M, 2003, BIOCHEMISTRY-US, V42, P11494, DOI 10.1021/bi0349930; Rygiel K, 2018, CURR CARDIOL REV, V14, P67, DOI 10.2174/1573403X14666180123165542; Silliman CC, 2002, AM J PHYSIOL-CELL PH, V283, pC1102, DOI 10.1152/ajpcell.00608.2001; Sorensen LP, 2011, DIABETES, V60, P2257, DOI 10.2337/db11-0040; Sparks JD, 2012, ARTERIOSCL THROM VAS, V32, P2104, DOI 10.1161/ATVBAHA.111.241463; SPARKS JD, 1990, J BIOL CHEM, V265, P8854; von Allmen CE, 2009, P NATL ACAD SCI USA, V106, P11673, DOI 10.1073/pnas.0812569106; Walther TC, 2017, ANNU REV CELL DEV BI, V33, P491, DOI 10.1146/annurev-cellbio-100616-060608; Wang JJ, 2009, FEBS LETT, V583, P643, DOI 10.1016/j.febslet.2009.01.030; Wende AR, 2005, MOL CELL BIOL, V25, P10684, DOI 10.1128/MCB.25.24.10684-10694.2005; Xiao CT, 2011, AM J PHYSIOL-ENDOC M, V301, pE429, DOI 10.1152/ajpendo.00178.2011; Ye J, 2009, CELL METAB, V9, P177, DOI 10.1016/j.cmet.2008.12.013; Yoshihara E, 2016, CELL METAB, V23, P622, DOI 10.1016/j.cmet.2016.03.005; Zhang YC, 2015, BIOCHEM J, V470, P181, DOI 10.1042/BJ20141494; Zhang Y, 2006, J BIOL CHEM, V281, P39897, DOI 10.1074/jbc.M608657200	44	4	4	1	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2019	33	7					7942	7952		10.1096/fj.201802704R	http://dx.doi.org/10.1096/fj.201802704R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ9SM	30922124	Bronze			2022-12-26	WOS:000476234700012
J	Mansueto, MS; Reens, A; Rakhilina, L; Chi, A; Pan, BS; Miller, JR				Mansueto, My S.; Reens, Abigail; Rakhilina, Larissa; Chi, An; Pan, Bo-Sheng; Miller, J. Richard			A reevaluation of the spleen tyrosine kinase (SYK) activation mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						spleen tyrosine kinase (SYK); enzyme kinetics; autophosphorylation; phosphorylation; non-receptor tyrosine kinase (nRTK); cell signaling; conformational change; enzyme activation; immunity; ITAM (immune-receptor tyrosine activation motif); tonic signalling	MOLECULAR-MECHANISM; ANTIGEN-RECEPTOR; STRUCTURAL BASIS; LOOP TYROSINES; IN-VIVO; PHOSPHORYLATION; SITES	Spleen tyrosine kinase (SYK) is a signaling node in many immune pathways and comprises two tandem Src homology (SH) 2 domains, an SH2-kinase linker, and a C-terminal tyrosine kinase domain. Two prevalent models of SYK activation exist. The OR-gate model contends that SYK can be fully activated by phosphorylation or binding of its SH2 domains to a dual-phosphorylated immune-receptor tyrosine-based activation motif (ppITAM). An alternative model proposes that SYK activation requires ppITAM binding and phosphorylation of the SH2-kinase linker by a SRC family kinase such as LYN proto-oncogene, SRC family tyrosine kinase (LYN). To evaluate these two models, we generated directly comparable unphosphorylated (upSYK) and phosphorylated (pSYK) proteins with or without an N-terminal glutathione S-transferase (GST) tag, resulting in monomeric or obligatory dimeric SYK, respectively. We assessed the ability of a ppITAM peptide and LYN to activate these SYK proteins. The ppITAM peptide strongly activated GST-SYK but was less effective in activating upSYK untagged with GST. LYN alone activated untagged upSYK to a greater extent than did ppITAM, and inclusion of both proteins rapidly and fully activated upSYK. Using immunoblot and phosphoproteomic approaches, we correlated the kinetics and order of site-specific SYK phosphorylation. Our results are consistent with the alternative model, indicating that ppITAM binding primes SYK for rapid LYN-mediated phosphorylation of Tyr-352 and then Tyr-348 of the SH2-kinase linker, which facilitates activation loop phosphorylation and full SYK activation. This gradual activation mechanism may also explain how SYK maintains ligand-independent tonic signaling, important for B-cell development and survival.	[Mansueto, My S.; Reens, Abigail; Rakhilina, Larissa; Pan, Bo-Sheng; Miller, J. Richard] Merck & Co Inc, Dept Pharmacol, Boston, MA 02115 USA; [Chi, An] Merck & Co Inc, Dept Chem Biol, Boston, MA 02115 USA; [Reens, Abigail] Univ Colorado, Boulder, CO 80309 USA	Merck & Company; Merck & Company; University of Colorado System; University of Colorado Boulder	Miller, JR (corresponding author), 33 Ave Louis Pasteur, Boston, MA 02115 USA.	james.miller2@merck.com						Antenucci L, 2018, J BIOL CHEM, V293, P4591, DOI 10.1074/jbc.RA117.000660; Arias-Palomo E, 2009, BBA-PROTEINS PROTEOM, V1794, P1211, DOI 10.1016/j.bbapap.2009.04.010; Bohnenberger H, 2011, EUR J IMMUNOL, V41, P1550, DOI 10.1002/eji.201041326; Bond PJ, 2011, J BIOL CHEM, V286, P25872, DOI 10.1074/jbc.M111.223321; Cha HS, 2006, J PHARMACOL EXP THER, V317, P571, DOI 10.1124/jpet.105.097436; Chrestensen CA, 2004, J BIOL CHEM, V279, P10176, DOI 10.1074/jbc.M310486200; Couture C, 1997, EUR J BIOCHEM, V246, P447, DOI 10.1111/j.1432-1033.1997.00447.x; Dueber JE, 2003, SCIENCE, V301, P1904, DOI 10.1126/science.1085945; Furlong MT, 1997, BBA-MOL CELL RES, V1355, P177, DOI 10.1016/S0167-4889(96)00131-0; Futterer K, 1998, J MOL BIOL, V281, P523, DOI 10.1006/jmbi.1998.1964; Geahlen RL, 2014, TRENDS PHARMACOL SCI, V35, P414, DOI 10.1016/j.tips.2014.05.007; Geahlen RL, 2009, BBA-MOL CELL RES, V1793, P1115, DOI 10.1016/j.bbamcr.2009.03.004; Gradler U, 2013, J MOL BIOL, V425, P309, DOI 10.1016/j.jmb.2012.11.007; Keshvara LM, 1998, J IMMUNOL, V161, P5276; Kulathu Y, 2009, IMMUNOL REV, V232, P286, DOI 10.1111/j.1600-065X.2009.00837.x; Lowell CA, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a002352; Meng FY, 2007, J AM SOC MASS SPECTR, V18, P226, DOI 10.1016/j.jasms.2006.09.014; Mocsai A, 2010, NAT REV IMMUNOL, V10, P387, DOI 10.1038/nri2765; Monroe JG, 2006, NAT REV IMMUNOL, V6, P283, DOI 10.1038/nri1808; NARULA SS, 1995, STRUCTURE, V3, P1061, DOI 10.1016/S0969-2126(01)00242-8; Norman P, 2014, EXPERT OPIN THER PAT, V24, P573, DOI 10.1517/13543776.2014.890184; Papp E, 2007, BIOCHEMISTRY-US, V46, P15103, DOI 10.1021/bi701596u; PARKER MW, 1990, J MOL BIOL, V213, P221, DOI 10.1016/S0022-2836(05)80183-4; Sanderson MP, 2010, MOL IMMUNOL, V48, P171, DOI 10.1016/j.molimm.2010.08.012; Shults MD, 2005, NAT METHODS, V2, P277, DOI 10.1038/NMETH747; Tsang E, 2008, J BIOL CHEM, V283, P32650, DOI 10.1074/jbc.M806340200; Xu YK, 2005, IMMUNITY, V22, P9, DOI 10.1016/j.immuni.2004.12.004; Yan QR, 2013, MOL CELL BIOL, V33, P2188, DOI 10.1128/MCB.01637-12; Yates JR, 1998, ANAL CHEM, V70, P3557, DOI 10.1021/ac980122y; Zhang J, 2000, J BIOL CHEM, V275, P35442, DOI 10.1074/jbc.M004549200; Zhang J, 1998, J IMMUNOL, V161, P4366; Zhang YJ, 2008, P NATL ACAD SCI USA, V105, P11760, DOI 10.1073/pnas.0708583105	32	12	12	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2019	294	19					7658	7668		10.1074/jbc.RA119.008045	http://dx.doi.org/10.1074/jbc.RA119.008045			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IB3FL	30923129	Green Published, hybrid			2022-12-26	WOS:000470153300012
J	Akole, A; Warner, JM				Akole, Ajit; Warner, Jason M.			Model of influenza virus acidification	PLOS ONE			English	Article							KINETICS; FUSION; PROTON; PH	Internal acidification of the influenza virus, mediated by the M2 proton channel, is a key step in its life cycle. The interior M1 protein shell dissolves at pH similar to 5.5 to 6.0, allowing the release of vRNA to the cytoplasm upon fusion of the viral envelope with the endosomal membrane. Previous models have described the mechanisms and rate constants of M2-mediated transport but did not describe the kinetics of pH changes inside the virus or consider exterior pH changes due to endosome maturation. Therefore, we developed a mathematical model of M2-mediated virion acidification. We find that similar to 32,000 protons are required to acidify a typically-sized virion. Predicted acidification kinetics were consistent with published in vitro experiments following internal acidification. Finally, we applied the model to the in vivo situation. For all rates of endosomal maturation considered, internal acidification lagged similar to 1 min behind endosomal acidification to pH 6. For slow endosomal maturation requiring several minutes or more, internal and endosomal pH decay together in pseudo-equilibrium to the late endosomal pH similar to 5.0. For fast endosomal maturation (less than or similar to 2 min), a lag of tens of seconds continued toward the late endosomal pH. Recent experiments suggest in vivo maturation is in this "fast" regime where lag is considerable. We predict that internal pH reaches the threshold for M1 shell solvation just before the external pH triggers membrane fusion mediated by the influenza protein hemagglutinin, critical because outward proton diffusion through a single small fusion pore is faster than the collective M2-mediated transport inward.	[Akole, Ajit; Warner, Jason M.] St Lukes Sch, New Canaan, CT 06840 USA		Warner, JM (corresponding author), St Lukes Sch, New Canaan, CT 06840 USA.	warnerj@stlukesct.org		Warner, Jason/0000-0003-4675-3385	St. Luke's School	St. Luke's School	St. Luke's School funded this work. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batishchev OV, 2016, J VIROL, V90, P575, DOI 10.1128/JVI.01539-15; Bouvier NM, 2008, VACCINE, V26, pD49, DOI 10.1016/j.vaccine.2008.07.039; Dadonaite B, 2016, J GEN VIROL, V97, P1755, DOI 10.1099/jgv.0.000535; Floyd DL, 2008, P NATL ACAD SCI USA, V105, P15382, DOI 10.1073/pnas.0807771105; HALL JE, 1975, J GEN PHYSIOL, V66, P531, DOI 10.1085/jgp.66.4.531; HELENIUS A, 1992, CELL, V69, P577, DOI 10.1016/0092-8674(92)90219-3; HILLE B, 1968, J GEN PHYSIOL, V51, P199, DOI 10.1085/jgp.51.2.199; Huotari J, 2011, EMBO J, V30, P3481, DOI 10.1038/emboj.2011.286; Ivanovic T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031566; Lagachelt T, 2017, FRONT PHYS, V5, DOI 10.3389/fphy2017DOC25; Lakadamyali M, 2003, P NATL ACAD SCI USA, V100, P9280, DOI 10.1073/pnas.0832269100; Lee KK, 2010, EMBO J, V29, P1299, DOI 10.1038/emboj.2010.13; Lee SH, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3632990; Leiding T, 2010, P NATL ACAD SCI USA, V107, P15409, DOI 10.1073/pnas.1009997107; Li S, 2014, BIOPHYS J, V106, P1447, DOI 10.1016/j.bpj.2014.02.018; MELIKYAN GB, 1993, J GEN PHYSIOL, V102, P1151, DOI 10.1085/jgp.102.6.1151; MELIKYAN GB, 1995, J GEN PHYSIOL, V106, P783, DOI 10.1085/jgp.106.5.783; NCBI, 1998, P NATL ACAD SCI USA, V105, P15382; Pielak RM, 2010, J AM CHEM SOC, V132, P17695, DOI 10.1021/ja108458u; Rossman JS, 2011, VIROLOGY, V411, P229, DOI 10.1016/j.virol.2010.12.003; Ruigrok RWH, 2000, VIROLOGY, V267, P289, DOI 10.1006/viro.1999.0134; Schmitt AP, 2005, ADV VIRUS RES, V64, P383, DOI 10.1016/S0065-3527(05)64012-2; Sehgal AA, 2014, CHEM-EUR J, V20, P6332, DOI 10.1002/chem.201304992; Shtykova EV, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16986-y; Shtykova EV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082431; Sundberg R.J., 2007, ADV ORGANIC CHEM A; Zaraket H, 2013, J VIROL, V87, P4826, DOI 10.1128/JVI.03110-12	27	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0214448	10.1371/journal.pone.0214448	http://dx.doi.org/10.1371/journal.pone.0214448			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR7EH	30946753	Green Published, gold, Green Submitted			2022-12-26	WOS:000463314500032
J	Ahsan, A; Khan, AZ; Javed, H; Mirza, S; Chaudhary, SU; Shahzad-ul-Hussan, S				Ahsan, Asma; Khan, Adnan Zafar; Javed, Hasnain; Mirza, Shaper; Chaudhary, Safee Ullah; Shahzad-ul-Hussan, Syed			Estimation of hepatitis C prevalence in the Punjab province of Pakistan: A retrospective study on general population	PLOS ONE			English	Article							VIRUS-INFECTION; SPONTANEOUS CLEARANCE; VIRAL-HEPATITIS; DRUG-USERS; EPIDEMIOLOGY; POLICY; INDIA; HIV; HCV	Background Hepatitis C virus (HCV) infections are amongst the leading public health concerns in Pakistan with a high disease burden. Despite the availability of effective antiviral treatments in the country the disease burden in general population has not lowered. This could be attributed to the asymptomatic nature of this infection that results in lack of diagnosis until the late symptomatic stage. To better estimate and map HCV infections in the country a population based analysis is necessary for an effective control of the infection. Methods Serologic samples of similar to 66,000 participants from all major cities of the Punjab province were tested for anti-HCV antibodies. The antibody-based seroprevalence was associated with socio-demographic variables including geographical region, age, gender and sex, and occupation. Results Overall serological response to HCV surface antigens was observed in over 17% of the population. Two of the districts were identified with significantly high prevalence in general population. Analysis by occupation showed significantly high prevalence in farmers (over 40%) followed by jobless and retired individuals, laborers and transporters. A significant difference in seroprevalence was observed in different age groups amongst sex and genders (male, female and transgender) with highest response in individuals of over 40 years of age. Moreover, most of the tested IDUs showed positive response for anti-HCV antibody. Conclusion This study represents a retrospective analysis of HCV infections in general population of the most populated province of Pakistan to identify socio-demographic groups at higher risk. Two geographical regions, Faisalabad and Okara districts, and an occupational group, farmers, were identified with significantly high HCV seroprevalence. These socio-demo- graphic groups are the potential focused groups for follow-up studies on factors contributing to the high HCV prevalence in these groups towards orchestrating effective prevention, control-and treatment.	[Ahsan, Asma; Mirza, Shaper; Chaudhary, Safee Ullah; Shahzad-ul-Hussan, Syed] Lahore Univ Management Sci, Syed Babar Ali Sch Sci & Engn, Dept Biol, Lahore, Pakistan; [Khan, Adnan Zafar; Javed, Hasnain] Govt Punjab, Punjab AIDS Control Program, Lahore, Pakistan	Lahore University of Management Sciences	Shahzad-ul-Hussan, S (corresponding author), Lahore Univ Management Sci, Syed Babar Ali Sch Sci & Engn, Dept Biol, Lahore, Pakistan.	shahazad.hussan@lums.edu.pk	Chaudhary, Safee Ullah/AAY-5013-2020	Chaudhary, Safee Ullah/0000-0002-3758-6581; Javed, Dr. Hasnain/0000-0001-6877-6807; Shahzad-ul-Hussan, Syed/0000-0001-7736-1072				Abdullah MA, 2012, BMC INT HEALTH HUM R, V12, DOI 10.1186/1472-698X-12-32; Aisyah DN, 2018, J VIRAL HEPAT, DOI 10.1002/jmv.20103; Ali SA, 2009, INT J INFECT DIS, V13, P9, DOI 10.1016/j.ijid.2008.06.019; Ashraf Sadia, 2015, Asian Pacific Journal of Tropical Biomedicine, V5, P190, DOI 10.1016/S2221-1691(15)30004-6; Aslam Zeeshan, 2015, INT J VIROLOGY MOL B, V4, P19; But DYK, 2008, WORLD J GASTROENTERO, V14, P1652, DOI 10.3748/wjg.14.1652; Butt T., 2008, Eastern Mediterranean Health Journal, V14, P791; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Hamid S., 2004, JPMA Journal of the Pakistan Medical Association, V54, P146; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Hoofnagle JH, 2002, HEPATOLOGY, V36, pS21, DOI 10.1053/jhep.2002.36227; Hutin Y, 2004, J CLIN PHARMACOL, V44, P20, DOI 10.1177/0091270003258669; Idrees M, 2008, J DIGEST DIS, V9, P95, DOI 10.1111/j.1751-2980.2008.00329.x; Iqbal Mazhar, 2013, VIROLOGY, V10; Janjua NZ, 2006, PUBLIC HEALTH, V120, P824, DOI 10.1016/j.puhe.2006.05.004; Kandeel A, 2017, LIVER INT, V37, P45, DOI 10.1111/liv.13186; Lavanchy D, 2011, CLIN MICROBIOL INFEC, V17, P107, DOI 10.1111/j.1469-0691.2010.03432.x; Lehmann M, 2004, J MED VIROL, V73, P387, DOI 10.1002/jmv.20103; Lim AG, 2018, INT J EPIDEMIOL, V47, P550, DOI 10.1093/ije/dyx270; Ming LC, 2016, LANCET, V388, P2601, DOI 10.1016/S0140-6736(16)32222-X; Mirza IA, 2007, JCPSP-J COLL PHYSICI, V17, P114; Panda S, 2014, INT J STD AIDS, V25, P596, DOI 10.1177/0956462413515659; Platt L, 2009, SEX TRANSM INFECT, V85, P17, DOI 10.1136/sti.2008.034090; Raja NS, 2008, J MICROBIOL IMMUNOL, V41, P4; Rehman LU, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-327; Sibley A, 2015, J VIRAL HEPATITIS, V22, P21, DOI 10.1111/jvh.12476; Singh S, 2014, INT J DRUG POLICY, V25, P26, DOI 10.1016/j.drugpo.2013.05.011; Tamhane AR, 2016, STAT MED, V35, P5730, DOI 10.1002/sim.7059; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Thrift AP, 2017, NAT REV GASTRO HEPAT, V14, P122, DOI 10.1038/nrgastro.2016.176; Umer M, 2016, WORLD J GASTROENTERO, V22, P1684, DOI 10.3748/wjg.v22.i4.1684; Waqar M, 2014, EUR J GASTROEN HEPAT, V26, P59, DOI 10.1097/MEG.0b013e328362dc3f; WHO, 2017, NEW HEP DAT HIGHL NE; WHO, PAK TACKL HIGH RAT H; World Health Organization, 2018, HEP C KEY FACTS REP	35	13	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0214435	10.1371/journal.pone.0214435	http://dx.doi.org/10.1371/journal.pone.0214435			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR5NS	30943224	Green Submitted, gold, Green Published			2022-12-26	WOS:000463194300037
J	Li, ZW; Guan, YA; Yuan, X; Zheng, P; Zhu, H				Li, Zhongwei; Guan, Yanan; Yuan, Xiang; Zheng, Pan; Zhu, Hu			Prediction of Sphingosine protein-coding regions with a self adaptive spectral rotation method	PLOS ONE			English	Article							HIDDEN MARKOV-MODELS; NEURAL P SYSTEMS; TRIPLET PERIODICITY; GENE IDENTIFICATION; DNA-SEQUENCES; CLASSIFICATION; WELAN	Identifying protein coding regions in DNA sequences by computational methods is an active research topic. Welan gum produced by Sphingomonas sp. WG has great application potential in oil recovery and concrete construction industry. Predicting the coding regions in the Sphingomonas sp. WG genome and addressing the mechanism underlying the explanation for the synthesis of Welan gum metabolism is an important issue at present. In this study, we apply a self adaptive spectral rotation (SASR, for short) method, which is based on the investigation of the Triplet Periodicity property, to predict the coding regions of the whole-genome data of Sphingomonas sp. WG without any previous training process, and 1115 suspected gene fragments are obtained. Suspected gene fragments are subjected to a similarity search against the non-redundant protein sequences (nr) database of NCBI with blastx, and 762 suspected gene fragments have been labeled as genes in the nr database.	[Li, Zhongwei; Guan, Yanan; Yuan, Xiang] China Univ Petr, Coll Comp & Commun Engn, Qingdao, Shandong, Peoples R China; [Zheng, Pan] Univ Canterbury, Dept Accounting & Informat Syst, Christchurch, New Zealand; [Zhu, Hu] Fujian Normal Univ, Coll Chem & Mat, Fuzhou, Fujian, Peoples R China	China University of Petroleum; University of Canterbury; Fujian Normal University	Guan, YA (corresponding author), China Univ Petr, Coll Comp & Commun Engn, Qingdao, Shandong, Peoples R China.	guanyanan_gyn@sina.com	Zheng, Pan/A-5435-2009; zhu, hu/GQQ-8365-2022	Zheng, Pan/0000-0002-6067-626X; 	National Natural Science Foundation of China [61873280, 61672033, 61672248]; PetroChina Innovation Foundation [2016D-5007-0305]; Key Research and Development Program of Shandong Province [2017GGX10147]; Natural Science Foundation of Shandong Province [ZR2017MF004]; Fundamental Research Funds for the Central Universities [18CX02152A]; Talent introduction project of China University of Petroleum [2017010054]; AEI/FEDER, Spain-EU [TIN2016-81079-R]; Talento-Comunidad de Madrid [2016-T2/TIC-2024]; MINECO AEI/FEDER, Spain-EU [TIN2016-81079-R]; InGEMICS-CM Project (FSE/FEDER, Comunidad de Madrid-EU) [B2017/BMD-3691]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); PetroChina Innovation Foundation; Key Research and Development Program of Shandong Province; Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Talent introduction project of China University of Petroleum; AEI/FEDER, Spain-EU(Spanish Government); Talento-Comunidad de Madrid; MINECO AEI/FEDER, Spain-EU; InGEMICS-CM Project (FSE/FEDER, Comunidad de Madrid-EU)	This work was supported by the National Natural Science Foundation of China (Grant Nos. 61873280, 61672033, and 61672248), PetroChina Innovation Foundation (2016D-5007-0305), Key Research and Development Program of Shandong Province (No. 2017GGX10147), Natural Science Foundation of Shandong Province (No. ZR2017MF004), Fundamental Research Funds for the Central Universities (No. 18CX02152A), Talent introduction project of China University of Petroleum (No. 2017010054), Research Project TIN2016-81079-R (AEI/FEDER, Spain-EU) and Grant 2016-T2/TIC-2024 from Talento-Comunidad de Madrid, Project TIN2016-81079-R (MINECO AEI/FEDER, Spain-EU), and the InGEMICS-CM Project (B2017/BMD-3691, FSE/FEDER, Comunidad de Madrid-EU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal G, 2002, J BIOSCIENCES, V27, P7, DOI 10.1007/BF02703679; Akhtar M, 2007, IEEE INT WORK GENOM, P54; Anastassiou D, 2000, BIOINFORMATICS, V16, P1073, DOI 10.1093/bioinformatics/16.12.1073; Azad RK, 2004, BRIEF BIOINFORM, V5, P118, DOI 10.1093/bib/5.2.118; Birney E, 2001, IBM J RES DEV, V45, P449, DOI 10.1147/rd.453.0449; Borodovsky Mark, 2011, Curr Protoc Bioinformatics, VChapter 4, DOI [10.1002/0471250953.bi0406s35, 10.1002/0471250953.bi0405s35]; Cao Yinhe, 2005, Journal of Bioinformatics and Computational Biology, V3, P677, DOI 10.1142/S0219720005001235; Chen B, 2012, J THEOR BIOL, V296, P95, DOI 10.1016/j.jtbi.2011.12.002; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Do JH, 2006, J MICROBIOL, V44, P137; Durbin  Richard, 1998, BIOL SEQUENCE ANAL P, P549; Farsani Mahsa Saffari, 2016, J Med Signals Sens, V6, P130; FICKETT JW, 1982, NUCLEIC ACIDS RES, V10, P5303, DOI 10.1093/nar/10.17.5303; Frenkel FE, 2008, GENE, V421, P52, DOI 10.1016/j.gene.2008.06.012; Frenkel FE, 2008, MOL BIOL+, V42, P629, DOI 10.1134/S0026893308040201; Frenkel FE, 2009, DNA RES, V16, P105, DOI 10.1093/dnares/dsp002; Gao C., 2016, INT J OIL GAS COAL E, V4, P16, DOI [10.11648/j.ogce.20160402.12, DOI 10.11648/J.OGCE.20160402.12]; Gao CH, 2015, J PET EXPLOR PROD TE, V5, P109, DOI 10.1007/s13202-014-0114-1; Guda C, 2014, CURRENT LAB METHODS; Henderson J, 1997, J COMPUT BIOL, V4, P127, DOI 10.1089/cmb.1997.4.127; Issac B, 2002, BIOINFORMATICS, V18, P196, DOI 10.1093/bioinformatics/18.1.196; Korotkov EV, 2010, J INTEGR BIOINFORMAT, V7, DOI 10.2390/biecoll-jib-2010-131; Kotlar D, 2003, GENOME RES, V13, P1930, DOI 10.1101/gr.1261703; KROGH A, 1994, NUCLEIC ACIDS RES, V22, P4768, DOI 10.1093/nar/22.22.4768; Kulp D, 1996, INT C INT SYST MOL B, V4, P353; Li H, 2011, BIOPROC BIOSYST ENG, V34, P95, DOI 10.1007/s00449-010-0450-6; Liu G, 2019, GENOMICS, V111, P1167, DOI 10.1016/j.ygeno.2018.07.013; Lukashin AV, 1998, NUCLEIC ACIDS RES, V26, P1107, DOI 10.1093/nar/26.4.1107; Manavalan B, 2018, ONCOTARGET, V9, P1944, DOI 10.18632/oncotarget.23099; Marhon SA, 2015, NETW MODEL ANAL HLTH, V4, DOI 10.1007/s13721-015-0103-4; Morange M, 2009, RESONANCE, V14, P236, DOI 10.1007/s12045-009-0024-6; Mork S, 2012, BIOINFORMATICS, V28, P636, DOI 10.1093/bioinformatics/btr698; ONEILL MA, 1986, CARBOHYD RES, V147, P295, DOI 10.1016/S0008-6215(00)90638-4; Pang SC, 2018, IEEE ACCESS, V6, P65548, DOI 10.1109/ACCESS.2018.2876364; Putluri S R, 2018, IDENTIFICATION PROTE; Reese MG, 2000, GENOME RES, V10, P529, DOI 10.1101/gr.10.4.529; Roy S S, 2015, COMPUTATIONAL ADVANC; Salzberg SL, 1998, NUCLEIC ACIDS RES, V26, P544, DOI 10.1093/nar/26.2.544; SANGILL R, 1994, J MAGN RESON SER A, V107, P67, DOI 10.1006/jmra.1994.1048; Sedaaghi MH, 2013, INT J COMPUTER APPL, V67, P25; Sharma S, 2017, INT C COMP IEEE; SNYDER EE, 1993, NUCLEIC ACIDS RES, V21, P607, DOI 10.1093/nar/21.3.607; Song T, 2019, IEEE T NANOBIOSCI, V18, P176, DOI 10.1109/TNB.2019.2896981; Song T, 2018, IEEE T NANOBIOSCI, V17, P474, DOI 10.1109/TNB.2018.2873221; Song T, 2018, IEEE T COGN DEV SYST, V10, P1106, DOI 10.1109/TCDS.2017.2785332; Song T, 2016, IEEE T NANOBIOSCI, V15, P666, DOI 10.1109/TNB.2016.2598879; Song T, 2016, INFORM SCIENCES, V372, P380, DOI 10.1016/j.ins.2016.08.055; Song T, 2016, NEUROCOMPUTING, V193, P193, DOI 10.1016/j.neucom.2016.02.023; Song T, 2014, NEURAL COMPUT APPL, V24, P1833, DOI 10.1007/s00521-013-1397-8; Stanke M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-62; Stanke M, 2004, NUCLEIC ACIDS RES, V32, pW309, DOI 10.1093/nar/gkh379; STANKOWSKI JD, 1992, CARBOHYD RES, V224, P337, DOI 10.1016/0008-6215(92)84122-9; Suvorova YM, 2012, GENE, V491, P58, DOI 10.1016/j.gene.2011.08.032; THOMAS A, 1994, IMA J MATH APPL MED, V11, P149; Ureta-Vidal A, 2003, NAT REV GENET, V4, P251, DOI 10.1038/nrg1043; Verma S, 2015, PROPAGATION CHARACTE; Wang LY, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-550; Wang M, 2003, COLD SPRING HARB SYM, V68, P125, DOI 10.1101/sqb.2003.68.125; Wei LY, 2018, MOL THER-NUCL ACIDS, V12, P635, DOI 10.1016/j.omtn.2018.07.004; Yang H, 2018, J COMPUT BIOL, V25, P1266, DOI 10.1089/cmb.2018.0004; Yin CC, 2007, J THEOR BIOL, V247, P687, DOI 10.1016/j.jtbi.2007.03.038; Yoon BJ, 2009, CURR GENOMICS, V10, P402, DOI 10.2174/138920209789177575	63	2	2	1	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0214442	10.1371/journal.pone.0214442	http://dx.doi.org/10.1371/journal.pone.0214442			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR5NS	30943219	Green Published, gold, Green Submitted			2022-12-26	WOS:000463194300039
J	O'Reilly, AO; Hofmann, G; Mettke-Hofmann, C				O'Reilly, Andrias O.; Hofmann, Gerhard; Mettke-Hofmann, Claudia			Gouldian finches are followers with black-headed females taking the lead	PLOS ONE			English	Article							PERSONALITY-TRAITS; COLOR POLYMORPHISM; REPRODUCTIVE SUCCESS; LEADERSHIP; DOMINANCE; BEHAVIOR; MORPHS; NEST; ELEPHANTS; HABITAT	Colour polymorphism is a widespread phenomenon and often encompasses different behavioural traits and strategies. More recently, it has been shown that morphs can also signal consistent individual differences (personality). An example are Gouldian finches that show discrete head colour morphs in the same population with red-headed birds being more aggressive but less risk-taking and explorative than black-headed birds in the lab. The current study aimed to investigate the link between head colour and behavioural traits in a naturally risky situation in the wild by recording the order of descent at waterholes in relation to hypotheses considering conspicuousness, dominance relationships and experience. Other bird species at the waterholes were also included in the study. Adult Gouldian finches generally preceded juveniles and among the adults the least conspicuous black-headed females descended first to the waterhole. Overall, females descended before the males though this pattern disappeared later in the season likely due to family groups breaking up and releasing males from attending to the juveniles. Finally, Gouldian finches almost always followed other species, particularly Long-tailed finches, to the ground rather than taking the lead. A two-level process of decision-making seems to explain the responses best: on the first level, experience separates adults from juveniles with adults preceding juveniles and on the second level, conspicuousness acts as a factor among the adults with the least conspicuous category taking the lead. Future studies should directly test the link between head colour and personality in the wild, look more into seasonal effects and investigate whether Gouldian finches use Long-tailed finches as an indicator of safety.	[O'Reilly, Andrias O.; Mettke-Hofmann, Claudia] Liverpool John Moores Univ, Sch Nat Sci & Psychol, James Parsons Bldg, Liverpool, Merseyside, England	Liverpool John Moores University	Mettke-Hofmann, C (corresponding author), Liverpool John Moores Univ, Sch Nat Sci & Psychol, James Parsons Bldg, Liverpool, Merseyside, England.	C.C.Mettke-Hofmann@ljmu.ac.uk	O'Reilly, Andrias/AAC-7628-2022	O'Reilly, Andrias/0000-0003-3449-2368; Mettke-Hofmann, Claudia/0000-0003-3874-5035	German Ornithologists' Society; Society for Tropical Ornithology (GTO); Society of Species Conservation and Aviculture	German Ornithologists' Society; Society for Tropical Ornithology (GTO); Society of Species Conservation and Aviculture	The study was supported by grants from the German Ornithologists' Society, the Society for Tropical Ornithology (GTO) and the Society of Species Conservation and Aviculture (AZ) to CMH. German Ornithologists' Society: http://www.do-g.de/news/?L=1 Society for Tropical Ornithology: https://www.tropenornithologie.de/; Society of Species Conservation and Aviculture: https://www.azvogelzucht.de/content/index.php?sess_az_hp=c9157b82f35d2aeb6783d04ddfc277a6. None of the sponsors played any role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Amaral PP, 2008, BRAZ J BIOL, V68, P511, DOI 10.1590/S1519-69842008000300007; Aplin LM, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1016; BirdLife International, 2016, IUCN RED LIST THREAT, V2016, DOI [10.2305/IUCN.UK.2016-3.RLTS.T22719744A94642482.en, DOI 10.2305/IUCN.UK.2016-3.RLTS.T22719744A94642482]; Brazill-Boast J, 2013, EVOL ECOL, V27, P1189, DOI 10.1007/s10682-013-9651-1; Brazill-Boast J, 2013, AUSTRAL ECOL, V38, P405, DOI 10.1111/j.1442-9993.2012.02424.x; Brazill-Boast J, 2011, EMU, V111, P304, DOI 10.1071/MU10064; Brazill-Boast J, 2011, J ANIM ECOL, V80, P39, DOI 10.1111/j.1365-2656.2010.01756.x; Brazill-Boast J, 2010, EMU, V110, P170, DOI 10.1071/MU09045; BRUSH AH, 1968, AUK, V85, P416, DOI 10.2307/4083290; Da Silva A, 2013, BEHAV ECOL SOCIOBIOL, V67, P1041, DOI 10.1007/s00265-013-1529-2; Davis JF, 2009, NEUROSCIENCE, V162, P23, DOI 10.1016/j.neuroscience.2009.04.039; Dingemanse NJ, 2004, P ROY SOC B-BIOL SCI, V271, P847, DOI 10.1098/rspb.2004.2680; Ducrest AL, 2008, TRENDS ECOL EVOL, V23, P502, DOI 10.1016/j.tree.2008.06.001; EPBC, 2018, SPEC PROF THREATS DA; EVANS SM, 1985, IBIS, V127, P348, DOI 10.1111/j.1474-919X.1985.tb05076.x; Fischhoff IR, 2007, ANIM BEHAV, V73, P825, DOI 10.1016/j.anbehav.2006.10.012; Franklin Donald C., 1999, Australian Zoologist, V31, P92; Galeotti P, 2003, J EVOLUTION BIOL, V16, P635, DOI 10.1046/j.1420-9101.2003.00569.x; Ioannou CC, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602682; KATZIR G, 1982, BEHAVIOUR, V81, P231, DOI 10.1163/156853982X00157; King AJ, 2015, ANIM BEHAV, V99, P25, DOI 10.1016/j.anbehav.2014.10.016; King AJ, 2008, CURR BIOL, V18, P1833, DOI 10.1016/j.cub.2008.10.048; Kupper C, 2016, NAT GENET, V48, P79, DOI 10.1038/ng.3443; Langham GM, 2006, BEHAV ECOL, V17, P285, DOI 10.1093/beheco/arj027; Lee PC, 2012, J COMP PSYCHOL, V126, P224, DOI 10.1037/a0026566; Mafli A, 2011, ANIM BEHAV, V81, P859, DOI 10.1016/j.anbehav.2011.01.025; McComb K, 2011, P ROY SOC B-BIOL SCI, V278, P3270, DOI 10.1098/rspb.2011.0168; Mettke-Hofmann C., 2000, International Zoo Yearbook, V37, P244, DOI 10.1111/j.1748-1090.2000.tb00730.x; Mettke-Hofmann C, 2012, ETHOLOGY, V118, P906, DOI 10.1111/j.1439-0310.2012.02079.x; Muniz L, 2010, AM J PRIMATOL, V72, P1118, DOI 10.1002/ajp.20876; Nicolai J., 2001, PRACHTFINKEN AUSTR O; O'Malley C., 2006, NATL RECOVERY PLAN G; Pruitt JN, 2011, P ROY SOC B-BIOL SCI, V278, P1209, DOI 10.1098/rspb.2010.1700; Pryke SR, 2007, BIOLOGY LETT, V3, P494, DOI 10.1098/rsbl.2007.0213; Pryke SR, 2007, BEHAV ECOL, V18, P621, DOI 10.1093/beheco/arm020; Pryke SR, 2009, AM NAT, V174, P455, DOI 10.1086/605376; Pryke SR, 2006, P ROY SOC B-BIOL SCI, V273, P949, DOI 10.1098/rspb.2005.3362; Roulin A, 2004, BIOL REV, V79, P815, DOI 10.1017/S1464793104006487; Roulin A, 2011, EUR J PHARMACOL, V660, P226, DOI 10.1016/j.ejphar.2011.01.036; Stamps JA, 2007, ECOL LETT, V10, P355, DOI 10.1111/j.1461-0248.2007.01034.x; TIDEMANN SC, 1992, J TROP ECOL, V8, P373, DOI 10.1017/S0266467400006702; Toth Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026605; Williams LJ, 2012, ANIM BEHAV, V84, P159, DOI 10.1016/j.anbehav.2012.04.025; Wolf M, 2008, P NATL ACAD SCI USA, V105, P15825, DOI 10.1073/pnas.0805473105; Wright CM, 2015, ANIM BEHAV, V105, P47, DOI 10.1016/j.anbehav.2015.04.001; ZANETTE L, 1994, ANIM BEHAV, V48, P119, DOI 10.1006/anbe.1994.1218	46	5	5	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0214531	10.1371/journal.pone.0214531	http://dx.doi.org/10.1371/journal.pone.0214531			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR5NS	30943239	gold, Green Submitted, Green Published, Green Accepted			2022-12-26	WOS:000463194300045
J	Freeman-Hildreth, Y; Aron, D; Cola, PA; Wang, YM				Freeman-Hildreth, Yolonda; Aron, David; Cola, Philip A.; Wang, Yunmei			Coping with diabetes: Provider attributes that influence type 2 diabetes adherence	PLOS ONE			English	Article							HEALTH-CARE; COMPASSIONATE CARE; SELF-CARE; MEDICATION; COMMUNICATION; BEHAVIOR; OPTIMISM; HOPE; LIFE; ASSOCIATIONS	Diabetes, a chronic disease affecting over 29 million people in the United States, requires the integration of complex medical tasks into a person's daily life. Patient-centered care and compassion are recognized as essential dimensions of the quality care experience. This research examined provider attributes that influence adherence to type 2 diabetes mellitus (T2DM) regimens and sought to understand the phenomena of provider attributes, treatment adherence, and their relationship to coping ability and treatment outcomes. This quantitative study sampled 474 people with T2DM using a 62-item online survey administered to three different groups. The sample population included people over age 18 diagnosed with T2DM. The first group included 91 persons with T2DM identified through a Facebook group and personal social media connections, the second group included 120 Amazon Mechanical Turk participants with T2DM, and the third group included 263 respondents from a Qualtrics panel who had T2DM. Results indicated that perceived provider compassion (beta = .41, p < .001) and optimism (beta = .48, p < .001) positively affected coping ability. Additionally, full mediation effects for self-management were revealed, with coping ability positively mediating the effect of compassion on self-management and the effects of optimism on self-management. Furthermore, full mediation effects were found for treatment satisfaction, with coping ability positively mediating the effect of compassion on treatment satisfaction and the effects of optimism on treatment satisfaction. This research has implications for patients, healthcare professionals, and leaders suggesting that providers who communicate with optimism and compassion positively affect coping ability. As a result, healthcare providers and professionals have an opportunity to enhance self-management adherence by helping their patients cope with the burdens of diabetes. In addition, this study has implications for developing provider communication tools aimed at assessing patients' coping capacity and increasing compassionate communication.	[Freeman-Hildreth, Yolonda] Univ Detroit Mercy, Coll Hlth Profess, Detroit, MI 48221 USA; [Aron, David] Case Western Reserve Univ, Dept Med, Louis Stokes VA Med Ctr, Cleveland, OH 44106 USA; [Cola, Philip A.] Case Western Reserve Univ, Weatherhead Sch Management, Dept Design & Innovat, Cleveland, OH 44106 USA; [Wang, Yunmei] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA	University of Detroit Mercy; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Case Western Reserve University; Case Western Reserve University	Freeman-Hildreth, Y (corresponding author), Univ Detroit Mercy, Coll Hlth Profess, Detroit, MI 48221 USA.	freemayf@udmercy.edu		Cola, Philip/0000-0003-4131-4180; Freeman-Hildreth, Yolonda/0000-0003-0440-8647				Aikens JE, 2005, DIABETES EDUCATOR, V31, P681, DOI 10.1177/0145721705280829; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; American Diabetes Association, 2018, Clin Diabetes, V36, P14, DOI 10.2337/cd17-0119; American Diabetes Association, 2014, DIABETES CARE, V37, P887, DOI [10.2337/dc14-er03, DOI 10.2337/DC14-ER03]; Bagozzi RP, 2012, J ACAD MARKET SCI, V40, P8, DOI 10.1007/s11747-011-0278-x; Bandura A, 2001, ANNU REV PSYCHOL, V52, P1, DOI 10.1146/annurev.psych.52.1.1; Barrett P, 2007, PERS INDIV DIFFER, V42, P815, DOI 10.1016/j.paid.2006.09.018; Blanchard J, 2013, ANN EMERG MED, V62, P475, DOI 10.1016/j.annemergmed.2013.04.013; BRADLEY C, 1990, DIABETIC MED, V7, P445, DOI 10.1111/j.1464-5491.1990.tb01421.x; Bradley C, 2002, DIABETES-METAB RES, V18, pS64, DOI 10.1002/dmrr.279; BURGELMAN RA, 1983, MANAGE SCI, V29, P1349, DOI 10.1287/mnsc.29.12.1349; Bussell Jennifer K, 2017, Clin Diabetes, V35, P171, DOI 10.2337/cd016-0029; Capehorn M, 2017, DIABETIC MED, V34, P1100, DOI 10.1111/dme.13357; Cardenas-Valladolid J, 2010, DRUG AGING, V27, P641, DOI 10.2165/11537320-000000000-00000; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; Chakravarthy B.S., 1982, ACAD MANAGE REV, V7, P35, DOI DOI 10.5465/AMR.1982.4285438; Claxton AJ, 2001, CLIN THER, V23, P1296, DOI 10.1016/S0149-2918(01)80109-0; Cramer JA, 2004, DIABETES CARE, V27, P1218, DOI 10.2337/diacare.27.5.1218; de Zulueta PC, 2016, J HEALTHC LEADERSH, V8, P1, DOI 10.2147/JHL.S93724; Edelman SV, 2017, DIABETES CARE, V40, P1425, DOI 10.2337/dc16-1974; EMANUEL EJ, 1992, JAMA-J AM MED ASSOC, V267, P2221, DOI 10.1001/jama.267.16.2221; Feldman DB, 2005, J SOC CLIN PSYCHOL, V24, P401, DOI 10.1521/jscp.24.3.401.65616; Fishbein M., 1979, NEBRASKA S MOTIVATIO, V27; Frankl VE., 1962, MANS SEARCH ULTIMATE; Franklin M, 2017, CHRONIC ILLN; Freeman-Hildreth Y., 2017, MOTIVATING AFR UNPUB; Gabay G, 2015, PATIENT EDUC COUNS, V98, P1550, DOI 10.1016/j.pec.2015.06.019; Gaskin J., 2016, ESTIMAND GASKINATION; Ghasemi A, 2012, INT J ENDOCRINOL MET, V10, P486, DOI 10.5812/ijem.3505; Gray SL, 2001, ANN PHARMACOTHER, V35, P539, DOI 10.1345/aph.10295; Guastello S, 2014, J COMPASSIONATE HLTH, V1, P2; Hair J., 2010, MULTIVARIATE DATA AN, V7; Hayes AF., 2017, MEDIATION MODERATION, V2nd edn; Hester PT, 2014, TOP SAF RISK RELIAB, V26, P1, DOI 10.1007/978-3-319-07629-4; Hooper D., 2008, EJBRM, V6, P53, DOI [DOI 10.1037/1082[HYPHEN]989X.12.1.58, 10.21427/D79B73]; House RJ, 1996, LEADERSHIP QUART, V7, P323, DOI 10.1016/S1048-9843(96)90024-7; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Jortberg BT, 2012, CURR DIABETES REP, V12, P721, DOI 10.1007/s11892-012-0316-1; Krass I, 2015, DIABETIC MED, V32, P725, DOI 10.1111/dme.12651; Lorig KR, 2003, ANN BEHAV MED, V26, P1, DOI 10.1207/S15324796ABM2601_01; Lown BA, 2015, PATIENT EDUC COUNS, V98, P1005, DOI 10.1016/j.pec.2015.03.019; Lown BA, 2011, HEALTH AFFAIR, V30, P1772, DOI 10.1377/hlthaff.2011.0539; Manteuffel M, 2014, J WOMENS HEALTH, V23, P112, DOI 10.1089/jwh.2012.3972; Matsunaga M, 2010, INT J PSYCHOL RES, V3, P97, DOI 10.21500/20112084.854; Matthews SM, 2009, PATIENT EDUC COUNS, V76, P31, DOI 10.1016/j.pec.2008.11.022; McClintock HFDV, 2016, BEHAV MED, V42, P63, DOI 10.1080/08964289.2014.904767; MILLER WR, 1975, J ABNORM PSYCHOL, V84, P228, DOI 10.1037/h0076720; Nigg CR, 2002, HEALTH EDUC RES, V17, P670, DOI 10.1093/her/17.5.670; Packer TL, 2018, PATIENT EDUC COUNS, V101, P579, DOI 10.1016/j.pec.2017.10.014; Paolacci G, 2010, JUDGM DECIS MAK, V5, P411; Park C.L., 1997, REV GEN PSYCHOL, V1, P115, DOI [10.1037/1089-2680.1.2.115, DOI 10.1037/1089-2680.1.2.115, 10.1037//1089-2680.1.2.115, DOI 10.1037//1089-2680.1.2.115]; Podsakoff PM, 2012, ANNU REV PSYCHOL, V63, P539, DOI 10.1146/annurev-psych-120710-100452; POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754; Pope JP, 2018, HEALTH COMMUN, V33, P1068, DOI 10.1080/10410236.2017.1331305; Prochaska JO, 1997, AM J HEALTH PROMOT, V12, P38, DOI 10.4278/0890-1171-12.1.38; Rasmussen HN, 2009, ANN BEHAV MED, V37, P239, DOI 10.1007/s12160-009-9111-x; Rosenbloom AL, 1999, DIABETES CARE, V22, P345, DOI 10.2337/diacare.22.2.345; Rowley W., 2017, POPUL HLTH MANAG, V20, P6; Moral RR, 2015, PATIENT EDUC COUNS, V98, P977, DOI 10.1016/j.pec.2015.03.008; SCHEIER MF, 1985, HEALTH PSYCHOL, V4, P219, DOI 10.1037/0278-6133.4.3.219; SCHEIER MF, 1994, J PERS SOC PSYCHOL, V67, P1063, DOI 10.1037/0022-3514.67.6.1063; Schmitt A, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-138; Schwartz David D, 2017, Clin Diabetes, V35, P35, DOI 10.2337/cd16-0007; Scioli A, 1997, PSYCHOL REP, V81, P723, DOI 10.2466/pr0.1997.81.3.723; Sclar DL, 1999, DIABETES EDUCATOR, V25, P531, DOI 10.1177/014572179902500406; Seppala E.M., 2014, J COMPASSIONATE HLTH, V1, P1, DOI [https://doi.org/10.1186/s40639-014-0005-9, DOI 10.1186/S40639-014-0005-9, 10.1186/s40639-014-0005-9]; Shrivastava SR, 2013, J DIABETES METAB DIS, V12, DOI 10.1186/2251-6581-12-14; Sinclair S, 2016, J PAIN SYMPTOM MANAG, V51, P193, DOI 10.1016/j.jpainsymman.2015.10.009; Snoek FJ, 2006, MEDICINE, V34, P61, DOI DOI 10.1383/medc.2006.34.2.61; Snyder CR, 2002, PSYCHOL INQ, V13, P249, DOI 10.1207/S15327965PLI1304_01; SPOSITO VA, 1983, COMMUN STAT-SIMUL C, V12, P265, DOI 10.1080/03610918308812318; Strauss C, 2016, CLIN PSYCHOL REV, V47, P15, DOI 10.1016/j.cpr.2016.05.004; Strecher VJ., 1997, CAMB HDB PSYCHOL HLT, P113; Thomas DM, 2002, COMMUN ASS INF SYST, V8, P9; Thoolen BJ, 2009, PSYCHOL HEALTH, V24, P237, DOI 10.1080/08870440701864504; Tielemans NS, 2014, ARCH PHYS MED REHAB, V95, P670, DOI 10.1016/j.apmr.2013.11.010; Tierney Stephanie., 2017, J COMPASSIONATE HLTH, V4, P1, DOI [10. 1186/s40639-016-0030-y, DOI 10.1186/S40639-016-0030-Y, 10.1186/s40639-016-0030-y]; Trejo BC, 2015, MIL PSYCHOL, V27, P276, DOI 10.1037/mil0000081; Vriticka P., 2017, COMPASSION CONCEPTS, P135, DOI DOI 10.4324/9781315564296-8; Williams JS, 2016, DIABETES TECHNOL THE, V18, P644, DOI 10.1089/dia.2016.0079; Yu YS, 2015, J BEHAV MED, V38, P565, DOI 10.1007/s10865-015-9636-3	81	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2019	14	4							e0214713	10.1371/journal.pone.0214713	http://dx.doi.org/10.1371/journal.pone.0214713			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HR2UW	30939144	Green Published, Green Submitted, gold			2022-12-26	WOS:000462993900038
J	Kabir, AH; Rahman, MM; Das, U; Sarkar, U; Roy, NC; Abu Reza, M; Talukder, MR; Uddin, MA				Kabir, Ahmad Humayan; Rahman, Md Mosiur; Das, Urmi; Sarkar, Urmi; Roy, Nepal Chandra; Abu Reza, Md; Talukder, Mamunur Rashid; Uddin, Md Alfaz			Reduction of cadmium toxicity in wheat through plasma technology	PLOS ONE			English	Article							SEED-GERMINATION; PLANT-GROWTH; STRESS; COLD; RHIZOSPHERE; TOLERANCE; SEEDLINGS; DROUGHT; LEAVES; YIELD	Cadmium (Cd) contamination in plant-derived food is a big concern. This study examines whether and how Ar/O-2 and Ar/Air plasma techniques lead to Cd detoxification in wheat. Treatment with Ar/O-2 and Ar/Air changed the seed surface and decreased the pH of seeds as well as the cultivation media. Generally, plants subjected to Cd treatment from seeds treated with Ar/O-2 and Ar/Air plasma showed considerable progress in morphology and total chlorophyll synthesis compared to Cd-treated wheat, suggesting that plasma technology is effective for Cd detoxification. Furthermore, Ar/O-2 and Ar/Air plasma treated plants showed a significant decrease in root and shoot Cd concentration, which is consistent with the reduced expression of Cd transporters in the root (TaLCT1 and TaHMA2) compared with the plants not treated with plasma in response to Cd stress. This Cd inhibition is possibly accomplished by the decrease of pH reducing the bioavailability of Cd in the rhizosphere. These observations are in line with maintenance of total soluble protein along with reduced electrolyte leakage and cell death (%) in root and shoot due to Ar/O-2 and Ar/Air treatments. Further, Cd-induced elevated H2O2 or oxidative damage in tissues was mainly diminished through the upregulation of antioxidant enzymes (SOD and CAT) and their corresponding genes (TaSOD and TaCAT) induced by Ar/O-2 and Ar/Air plasma. Grafting results suggest that root originating nitric oxide signal possibly drives the mechanisms of Cd detoxification due to plasma treatment in wheat. These findings provide a novel and eco-friendly use of plasma technology for the mitigation of Cd toxicity in wheat plants.	[Kabir, Ahmad Humayan; Rahman, Md Mosiur; Das, Urmi; Sarkar, Urmi] Univ Rajshahi, Dept Bot, Mol Plant Physiol Lab, Rajshahi, Bangladesh; [Roy, Nepal Chandra; Talukder, Mamunur Rashid] Univ Rajshahi, Dept Appl Phys & Elect Engn, Plasma Sci & Technol Lab, Rajshahi, Bangladesh; [Abu Reza, Md] Univ Rajshahi, Dept Genet Engn & Biotechnol, Mol Biol & Prot Sci Lab, Rajshahi, Bangladesh; [Uddin, Md Alfaz] Univ Rajshahi, Dept Phys, Rajshahi, Bangladesh	University of Rajshahi; University of Rajshahi; University of Rajshahi; University of Rajshahi	Kabir, AH (corresponding author), Univ Rajshahi, Dept Bot, Mol Plant Physiol Lab, Rajshahi, Bangladesh.	ahmad.kabir@ru.ac.bd	Kabir, Ahmad H/B-2738-2017; Talukder, M R/AAX-2018-2020; Abu Reza/ABE-6824-2020; Das, Urmi/AGU-1735-2022	Kabir, Ahmad H/0000-0001-6893-9418; Talukder, M R/0000-0003-2639-2148; Das, Urmi/0000-0002-6350-3049				Alexieva V, 2001, PLANT CELL ENVIRON, V24, P1337, DOI 10.1046/j.1365-3040.2001.00778.x; Bari MA, 2019, PLANT PHYSIOL BIOCH, V136, P22, DOI 10.1016/j.plaphy.2019.01.007; Bethke PC, 2001, PLANT J, V25, P19, DOI 10.1046/j.1365-313x.2001.00930.x; Burzynski M, 2007, PHOTOSYNTHETICA, V45, P239, DOI 10.1007/s11099-007-0038-9; Calba H, 2004, PLANT SOIL, V260, P33, DOI 10.1023/B:PLSO.0000030169.75523.52; Dong J, 2007, PLANT SOIL ENVIRON, V53, P193, DOI 10.17221/2205-PSE; Ferrell J. R., 2013, J BIOTECHNOL BIOMATE, V3, P155, DOI [10.4172/2155-952X.1000155, DOI 10.4172/2155-952X.1000155]; Goud PB, 2012, PLANT SIGNAL BEHAV, V7, P1258, DOI 10.4161/psb.21584; Greger M, 2016, ENVIRON POLLUT, V211, P90, DOI 10.1016/j.envpol.2015.12.027; GUY C, 1992, PLANTA, V188, P265, DOI 10.1007/BF00216823; HATCH DJ, 1988, PLANT SOIL, V105, P121, DOI 10.1007/BF02371149; Hinsinger P, 2006, J GEOCHEM EXPLOR, V88, P210, DOI 10.1016/j.gexplo.2005.08.041; Hoagland DR, 1950, CALI AGR EXP STAT, V347; Kabir AH, 2016, FRONT PLANT SCI, V7, DOI [10.3389/fpls.2016.01117, 10.3389/fpls.2010.01117]; Lichtenthaler H.K., 1985, BIOL SOC T, V11, P591, DOI DOI 10.1042/BST0110591; Lutts S, 1996, ANN BOT-LONDON, V78, P389, DOI 10.1006/anbo.1996.0134; McDonald MB, 1999, SEED SCI TECHNOL, V27, P177; Ortiz R, 2008, AGR ECOSYST ENVIRON, V126, P46, DOI 10.1016/j.agee.2008.01.019; Park DP, 2013, CURR APPL PHYS, V13, pS19, DOI 10.1016/j.cap.2012.12.019; Prasad MNV, 2013, HEAVY METAL STRESS P; Rahman M, 2016, ECOTOX ENVIRON SAFE, V135, P165; Rahman MM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28960-3; Rascio N, 2008, ENVIRON EXP BOT, V62, P267, DOI 10.1016/j.envexpbot.2007.09.002; REDDY CN, 1977, J ENVIRON QUAL, V6, P259, DOI 10.2134/jeq1977.00472425000600030005x; Roy NC, 2018, PLASMA CHEM PLASMA P, V38, P13, DOI 10.1007/s11090-017-9855-1; Sera B, 2008, PLASMA SCI TECHNOL, V10, P506, DOI 10.1088/1009-0630/10/4/22; Sera B, 2013, PLASMA SCI TECHNOL, V15, DOI 10.1088/1009-0630/15/9/19; Sivachandiran L, 2017, RSC ADV, V7, P1822, DOI 10.1039/c6ra24762h; Sreethawong T, 2007, INT J HYDROGEN ENERG, V32, P1067, DOI 10.1016/j.ijhydene.2006.07.013; SUN M, 1978, ANAL BIOCHEM, V90, P81, DOI 10.1016/0003-2697(78)90010-6; Volin JC, 2000, CROP SCI, V40, P1706, DOI 10.2135/cropsci2000.4061706x; Wang YW, 2014, BIOMETALS, V27, P389, DOI 10.1007/s10534-014-9720-0; Wojtyla L, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00066; Yu L, 2010, J PHYS CHEM A, V114, P360, DOI 10.1021/jp905082s; Zhao C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13530; Zhao J, 2005, BIOTECHNOL BIOENG, V90, P621, DOI 10.1002/bit.20465; Zhou ZhuWen, 2011, Agricultural Sciences, V2, P23, DOI 10.4236/as.2011.21004	37	24	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2019	14	4							e0214509	10.1371/journal.pone.0214509	http://dx.doi.org/10.1371/journal.pone.0214509			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR1CY	30933989	Green Published, gold, Green Submitted			2022-12-26	WOS:000462867000018
J	Kahn-Kirby, AH; Amagata, A; Maeder, CI; Mei, JJ; Sideris, S; Kosaka, Y; Hinman, A; Malone, SA; Bruegger, JJ; Wang, L; Kim, V; Shrader, WD; Hoff, KG; Latham, JC; Ashley, EA; Wheeler, MT; Bertini, E; Carrozzo, R; Martinelli, D; Dionisi-Vici, C; Chapman, KA; Enns, GM; Gahl, W; Wolfe, L; Saneto, RP; Johnson, SC; Trimmer, JK; Klein, MB; Holst, CR				Kahn-Kirby, Amanda H.; Amagata, Akiko; Maeder, Celine I.; Mei, Janet J.; Sideris, Steve; Kosaka, Yuko; Hinman, Andrew; Malone, Stephanie A.; Bruegger, Joel J.; Wang, Leslie; Kim, Virna; Shrader, William D.; Hoff, Kevin G.; Latham, Joey C.; Ashley, Euan A.; Wheeler, Matthew T.; Bertini, Enrico; Carrozzo, Rosalba; Martinelli, Diego; Dionisi-Vici, Carlo; Chapman, Kimberly A.; Enns, Gregory M.; Gahl, William; Wolfe, Lynne; Saneto, Russell P.; Johnson, Simon C.; Trimmer, Jeffrey K.; Klein, Matthew B.; Holst, Charles R.			Targeting ferroptosis: A novel therapeutic strategy for the treatment of mitochondrial disease-related epilepsy	PLOS ONE			English	Article							HYPOPLASIA TYPE 6; PONTOCEREBELLAR HYPOPLASIA; CELL-DEATH; UNDIAGNOSED DISEASES; LIPID-PEROXIDATION; OXIDATIVE STRESS; SPONDYLOMETAPHYSEAL DYSPLASIA; SELENOPROTEIN BIOSYNTHESIS; CEREBELLAR HYPOPLASIA; RARS2 MUTATIONS	Background Mitochondrial disease is a family of genetic disorders characterized by defects in the generation and regulation of energy. Epilepsy is a common symptom of mitochondrial disease, and in the vast majority of cases, refractory to commonly used antiepileptic drugs. Ferroptosis is a recently-described form of iron- and lipid-dependent regulated cell death associated with glutathione depletion and production of lipid peroxides by lipoxygenase enzymes. Activation of the ferroptosis pathway has been implicated in a growing number of disorders, including epilepsy. Given that ferroptosis is regulated by balancing the activities of glutathione peroxidase-4 (GPX4) and 15-lipoxygenase (15-LO), targeting these enzymes may provide a rational therapeutic strategy to modulate seizure. The clinical-stage therapeutic vatiquinone (EPI-743, a-tocotrienol quinone) was reported to reduce seizure frequency and associated morbidity in children with the mitochondrial disorder pontocerebellar hypoplasia type 6. We sought to elucidate the molecular mechanism of EPI-743 and explore the potential of targeting 15-LO to treat additional mitochondrial disease-associated epilepsies. Methods Primary fibroblasts and B-lymphocytes derived from patients with mitochondrial disease-associated epilepsy were cultured under standardized conditions. Ferroptosis was induced by treatment with the irreversible GPX4 inhibitor RSL3 or a combination of pharmacological glutathione depletion and excess iron. EPI-743 was co-administered and endpoints, including cell viability and 15-LO-dependent lipid oxidation, were measured. Results EPI-743 potently prevented ferroptosis in patient cells representing five distinct pediatric disease syndromes with associated epilepsy. Cytoprotection was preceded by a dose-dependent decrease in general lipid oxidation and the specific 15-LO product 15-hydroxyeicosatetraenoic acid (15-HETE). Conclusions These findings support the continued clinical evaluation of EPI-743 as a therapeutic agent for PCH6 and other mitochondrial diseases with associated epilepsy.	[Kahn-Kirby, Amanda H.; Amagata, Akiko; Maeder, Celine I.; Mei, Janet J.; Sideris, Steve; Kosaka, Yuko; Hinman, Andrew; Malone, Stephanie A.; Bruegger, Joel J.; Wang, Leslie; Kim, Virna; Shrader, William D.; Hoff, Kevin G.; Latham, Joey C.; Trimmer, Jeffrey K.; Klein, Matthew B.; Holst, Charles R.] BioElectron Technol Corp, Mountain View, CA 94043 USA; [Ashley, Euan A.; Wheeler, Matthew T.] Stanford Univ, Sch Med, Stanford Ctr Undiagnosed Dis, Stanford, CA 94305 USA; [Bertini, Enrico; Carrozzo, Rosalba; Martinelli, Diego] Bambino Gesu Childrens Res Hosp, Unit Neuromuscular & Neurodegenerat Disorders, Rome, Italy; [Dionisi-Vici, Carlo] Bambino Gesu Pediat Hosp, Clin Div, Rome, Italy; [Dionisi-Vici, Carlo] Bambino Gesu Pediat Hosp, Res Unit Metab Dis, Rome, Italy; [Chapman, Kimberly A.] Childrens Natl Rare Dis Inst, Childrens Natl Hlth Syst, Washington, DC USA; [Enns, Gregory M.] Stanford Univ, Dept Pediat, Div Med Genet, Sch Med, Stanford, CA 94305 USA; [Gahl, William; Wolfe, Lynne] NHGRI, NIH, Undiagnosed Dis Program, Bethesda, MD 20892 USA; [Saneto, Russell P.] Seattle Childrens Hosp, Neurosci Inst, Div Pediat Neurol, Dept Neurol, Seattle, WA USA; [Johnson, Simon C.] Seattle Childrens Res Inst, Ctr Integrat Brain Res, Seattle, WA USA; [Johnson, Simon C.] Univ Washington, Dept Neurol, Seattle, WA 98195 USA	Stanford University; IRCCS Bambino Gesu; IRCCS Bambino Gesu; IRCCS Bambino Gesu; Children's National Health System; Stanford University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Seattle Children's Hospital; Seattle Children's Hospital; University of Washington; University of Washington Seattle	Kahn-Kirby, AH (corresponding author), BioElectron Technol Corp, Mountain View, CA 94043 USA.	AKahn-Kirby@BioElectron.com	Bertini, Enrico/ABG-1278-2020; Carrozzo, Rosalba/A-2808-2014; Bertini, Enrico/A-2284-2014; Dionisi-Vici, Carlo/K-2045-2018	Johnson, Simon/0000-0002-1942-3674; Holst, Charles/0000-0001-8010-1677; Carrozzo, Rosalba/0000-0002-3327-4054; Bertini, Enrico/0000-0001-9276-4590; Dionisi-Vici, Carlo/0000-0002-0007-3379; Wheeler, Matthew/0000-0001-8721-3022	BioElectron Technology Corporation, Inc.; National Institutes of Health (NIH) award [1K99GM126147-01]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000215] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K99GM126147] Funding Source: NIH RePORTER	BioElectron Technology Corporation, Inc.; National Institutes of Health (NIH) award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by BioElectron Technology Corporation, Inc. The funder provided support in the form of salaries for authors AA, JJB, AH, KGH, CRH, AHKK, VK, MBK, YK, JCL, CIM, SAM, JJM, WDS, SS, JKT, LWang. In addition, the funding entity had a direct role in study design, data collection and analysis, decision to publish, and preparation of the manuscript. SCJ is supported by National Institutes of Health (NIH) award 1K99GM126147-01.	Abeti R, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.111; Agamy O, 2010, AM J HUM GENET, V87, P538, DOI 10.1016/j.ajhg.2010.09.007; Amagata T, 2003, J NAT PROD, V66, P230, DOI 10.1021/np020462l; Anttonen AK, 2015, NEUROLOGY, V85, P306, DOI 10.1212/WNL.0000000000001787; Aygun C, 2012, AM J MED GENET A, V158A, P1400, DOI 10.1002/ajmg.a.35306; Cassandrini D, 2013, J INHERIT METAB DIS, V36, P43, DOI 10.1007/s10545-012-9487-9; Conrad M, 2018, GENE DEV, V32, P602, DOI 10.1101/gad.314674.118; Cotticelli MG, 2019, J PHARMACOL EXP THER; Cserep C, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0390-17.2018; Debray FG, 2007, PEDIATRICS, V119, P722, DOI 10.1542/peds.2006-1866; Diodato Daria, 2014, Int J Cell Biol, V2014, P787956, DOI 10.1155/2014/787956; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Doll S, 2017, NAT CHEM BIOL, V13, P91, DOI [10.1038/NCHEMBIO.2239, 10.1038/nchembio.2239]; Edvardson S, 2007, AM J HUM GENET, V81, P857, DOI 10.1086/521227; English SJ, 2006, AM J MED GENET A, V140A, P1854, DOI 10.1002/ajmg.a.31376; Enns GM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100001; Enns GM, 2012, MOL GENET METAB, V105, P91, DOI 10.1016/j.ymgme.2011.10.009; Finsterer J, 2017, EPILEPSY RES, V136, P5, DOI 10.1016/j.eplepsyres.2017.07.003; Fradejas-Villar N, 2018, FREE RADICAL BIO MED, V127, P206, DOI 10.1016/j.freeradbiomed.2018.04.572; Friedmann Angeli JP, 2014, NAT CELL BIOL, V3, P1; Gahl WA, 2016, MOL GENET METAB, V117, P393, DOI 10.1016/j.ymgme.2016.01.007; Gahl WA, 2012, GENET MED, V14, P51, DOI 10.1038/gim.0b013e318232a005; Gahl WA, 2011, JAMA-J AM MED ASSOC, V305, P1904, DOI 10.1001/jama.2011.613; Glamuzina E, 2012, J INHERIT METAB DIS, V35, P459, DOI 10.1007/s10545-011-9413-6; Gulyas AI, 2006, EUR J NEUROSCI, V23, P2581, DOI 10.1111/j.1460-9568.2006.04814.x; Hayhurst H, 2019, BRAIN PATHOL, V29, P97, DOI 10.1111/bpa.12640; Hinman A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201369; Ingold I, 2017, CELL, P1, DOI [10.1016/j.cell.2013.12.010, DOI 10.1016/J.CELL.2013.12.010]; Jaeger B, 2017, JIMD REP; Joseph JT, 2014, J NEUROPATH EXP NEUR, V73, P1009, DOI 10.1097/NEN.0000000000000123; Kagan VE, 2017, NAT CHEM BIOL, V13, P81, DOI [10.1038/nchembio.2238, 10.1038/NCHEMBIO.2238]; Kann O, 2014, J CEREBR BLOOD F MET, V34, P1270, DOI 10.1038/jcbfm.2014.104; Khanna S, 2003, J BIOL CHEM, V278, P43508, DOI 10.1074/jbc.M307075200; Khurana DS, 2008, NEUROPEDIATRICS, V39, P8, DOI 10.1055/s-2008-1076737; Kovac S, 2018, MOL NEUROBIOL, P1; Lax NZ, 2015, J NEUROPATH EXP NEUR, V74, P688, DOI 10.1097/NEN.0000000000000209; Lewerenz J, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00214; Li ZJ, 2015, J HUM GENET, V60, P363, DOI 10.1038/jhg.2015.31; Lin CM, 2007, METAB BRAIN DIS, V22, P105, DOI 10.1007/s11011-006-9039-9; Lord LD, 2013, J CEREBR BLOOD F MET, V33, P1347, DOI 10.1038/jcbfm.2013.94; Luhl S, 2016, ORPHANET J RARE DIS, V11, DOI 10.1186/s13023-016-0525-9; Martinc B, 2014, CURR NEUROPHARMACOL, V12, P527, DOI 10.2174/1570159X12666140923205715; Martinelli D., 2013, J INHERIT METAB DIS, V36, pS110; Masaldan S, 2018, REDOX BIOL, V14, P100, DOI 10.1016/j.redox.2017.08.015; Menon B, 2012, SEIZURE-EUR J EPILEP, V21, P780, DOI 10.1016/j.seizure.2012.09.003; Namavar Y, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-50; Namavar Y, 2011, BRAIN, V134, P143, DOI 10.1093/brain/awq287; Ngoh A, 2016, EPILEPSIA, V57, pE97, DOI 10.1111/epi.13358; Nishri D, 2016, EUR J PAEDIATR NEURO, V20, P412, DOI 10.1016/j.ejpn.2016.02.012; Pitts MW, 2014, BIOL TRACE ELEM RES, V161, P231, DOI 10.1007/s12011-014-0060-2; Rahman S, 2012, DEV MED CHILD NEUROL, V54, P397, DOI 10.1111/j.1469-8749.2011.04214.x; Ramoni RB, 2017, AM J HUM GENET, V100, P185, DOI 10.1016/j.ajhg.2017.01.006; Rankin J, 2010, AM J MED GENET A, V152A, P2079, DOI 10.1002/ajmg.a.33531; Roels F, 2018, ORPHANET J RARE DIS, V13, P1, DOI [10.1186/s13023-017-0741-y, DOI 10.1186/S13023-017-0741-Y]; Sanders LH, 2013, FREE RADICAL BIO MED, V62, P111, DOI 10.1016/j.freeradbiomed.2013.01.003; Saneto RP, 2017, J INBORN ERRORS META, V5, DOI [10.1177/2326409817697399, DOI 10.1177/2326409817697399]; Seiler A, 2008, CELL METAB, V8, P237, DOI 10.1016/j.cmet.2008.07.005; Shah R, 2018, ACS CENTRAL SCI, V4, P387, DOI 10.1021/acscentsci.7b00589; Smith AC, 2014, J MED GENET, V51, P470, DOI 10.1136/jmedgenet-2013-102218; Stockwell BR, 2017, CELL, V171, P273, DOI 10.1016/j.cell.2017.09.021; Tan Shirlee, 2001, Current Topics in Medicinal Chemistry, V1, P497, DOI 10.2174/1568026013394741; Turkdogan D, 2002, J CHILD NEUROL, V17, P673, DOI 10.1177/088307380201700904; WASLIDGE NB, 1995, ANAL BIOCHEM, V231, P354, DOI 10.1006/abio.1995.0063; WEBER GF, 1991, LANCET, V337, P1443, DOI 10.1016/0140-6736(91)93130-2; Wenzel SE, 2017, CELL, V171, P628, DOI 10.1016/j.cell.2017.09.044; Wirth EK, 2014, BIOL TRACE ELEM RES, V158, P203, DOI 10.1007/s12011-014-9920-z; Wirth EK, 2010, FASEB J, V24, P844, DOI 10.1096/fj.09-143974; Yang WS, 2008, CHEM BIOL, V15, P234, DOI 10.1016/j.chembiol.2008.02.010; Yang WS, 2014, CELL, V156, P317, DOI 10.1016/j.cell.2013.12.010; Zsurka G, 2015, LANCET NEUROL, V14, P956, DOI 10.1016/S1474-4422(15)00148-9	70	30	30	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214250	10.1371/journal.pone.0214250	http://dx.doi.org/10.1371/journal.pone.0214250			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921410	gold, Green Published, Green Submitted			2022-12-26	WOS:000462594000047
J	Bagchi, S; Lingaiah, R; Mani, K; Barwad, A; Singh, G; Balooni, V; Bhowmik, D; Agarwal, SK				Bagchi, Soumita; Lingaiah, Raghavendra; Mani, Kalaivani; Barwad, Adarsh; Singh, Geetika; Balooni, Veena; Bhowmik, Dipankar; Agarwal, Sanjay Kumar			Significance of serum galactose deficient IgA1 as a potential biomarker for IgA nephropathy: A case control study	PLOS ONE			English	Article							GLYCOSYLATION; INDIA	Background IgA nephropathy(IgAN) is a common glomerular disease with a higher risk of progression to end stage renal disease (ESRD) in certain ethnic populations. Since galactose deficient IgA1(Gd-IgA1) is a critical molecule in its pathogenesis, it has generated interest as a biomarker for this disease. Methods We measured serum Gd-IgA1 levels using a non-lectin based enzyme linked immunoassay (ELISA) in 136 immunosuppression naive patients with primary IgAN and 110 controls(60non IgA glomerular diseases, 50-healthy volunteers). Results Median serum Gd-IgA1 levels were significantly higher in IgAN patients [13135.6(2723.3, 59603.8) ng/ml] compared to those with non IgA glomerular disease [4954.8(892.9,18256.2) ng/ml] and healthy controls [6299.5(1993.2,19256) ng/ml] and this was observed even after log transformation and adjustment for age and gender(p<0.0001). Considering a cut-off value of serum Gd-IGA1 >= 7982.1ng/ml, the sensitivity for diagnosing IgAN compared to healthy controls was 74.3% and specificity was 72.0% with a positive predictive value of 87.8% and negative predictive value of 50.7%. The serum Gd-IgA1 level did not co-relate with baseline estimated glomerular filtration rate, urine protein creatinine ratio and the M, E, S, T and C scores on renal biopsy. The renal survival (absence of >30% decrease in eGFR, ESRD or death) was lower in patients with higher serum Gd-IgA1 levels(>= 7982ng/ml) than those who had lower levels but it was not statistically significant(p = 0.486). Conclusion Serum Gd-IgA1 level is higher in IgAN patients compared to non-IgA glomerular diseases and healthy controls and has a good positive predictive value for diagnosis. However, it does not correlate with clinical and histological characteristics of disease severity and does not predict disease progression.	[Bagchi, Soumita; Bhowmik, Dipankar; Agarwal, Sanjay Kumar] All India Inst Med Sci, Dept Nephrol, New Delhi, India; [Lingaiah, Raghavendra; Balooni, Veena] All India Inst Med Sci, Dept Lab Med, New Delhi, India; [Mani, Kalaivani] All India Inst Med Sci, Dept Biostat, New Delhi, India; [Barwad, Adarsh; Singh, Geetika] All India Inst Med Sci, Dept Pathol, New Delhi, India; [Lingaiah, Raghavendra] Sanjay Gandhi Post Grad Inst Med Sci, Dept Pathol, Lucknow, Uttar Pradesh, India	All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi; Sanjay Gandhi Postgraduate Institute of Medical Sciences	Bagchi, S (corresponding author), All India Inst Med Sci, Dept Nephrol, New Delhi, India.	soumita_bagchi@yahoo.co.in		Agarwal, Sanjay Kumar/0000-0002-5200-7605	All India Institute of Medical Sciences, New Delhi, India [A-538]	All India Institute of Medical Sciences, New Delhi, India	SB received an intramural grant (Code No A-538) from All India Institute of Medical Sciences, New Delhi, India, for this study. The funding authority did not play any role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	ALLEN AC, 1995, CLIN EXP IMMUNOL, V100, P470; Amore A, 2001, J AM SOC NEPHROL, V12, P1862, DOI 10.1681/ASN.V1291862; Bagchi S, 2016, RENAL FAILURE, V38, P431, DOI 10.3109/0886022X.2016.1138817; Berthoux F, 2012, J AM SOC NEPHROL, V23, P1579, DOI 10.1681/ASN.2012010053; Cattran DC, 2009, KIDNEY INT, V76, P534, DOI 10.1038/ki.2009.243; Chacko B, 2005, NEPHROLOGY, V10, P496, DOI 10.1111/j.1440-1797.2005.00445.x; Chandrika BK, 2009, INDIAN J PATHOL MICR, V52, P14, DOI 10.4103/0377-4929.44954; Coppo R, 2004, KIDNEY INT, V65, P1544, DOI 10.1111/j.1523-1755.2004.05407.x; D'Amico G, 2004, SEMIN NEPHROL, V24, P179, DOI 10.1016/j.semnephrol.2004.01.001; Hastings MC, 2010, CLIN J AM SOC NEPHRO, V5, P2069, DOI 10.2215/CJN.03270410; Kim MB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148466; Lin XJ, 2009, NEPHROL DIAL TRANSPL, V24, P3372, DOI 10.1093/ndt/gfp294; Mittal N, 2012, POSTGRAD MED J, V88, P15, DOI 10.1136/postgradmedj-2011-130077; Moldoveanu Z, 2007, KIDNEY INT, V71, P1148, DOI 10.1038/sj.ki.5002185; Nguyen C, 2019, CLIN KIDNEY J, V12, P232, DOI 10.1093/ckj/sfy068; Placzek WJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190967; Sanders JT, 2017, INT J NEPHROL, V2017, DOI 10.1155/2017/8210641; Shimozato S, 2008, NEPHROL DIAL TRANSPL, V23, P1931, DOI 10.1093/ndt/gfm913; Sun Q, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166700; Suzuki H, 2018, KIDNEY INT, V93, P700, DOI 10.1016/j.kint.2017.10.019; Suzuki H, 2011, J AM SOC NEPHROL, V22, P1795, DOI 10.1681/ASN.2011050464; Tomana M, 1999, J CLIN INVEST, V104, P73, DOI 10.1172/JCI5535; Wyatt RJ, 2013, NEW ENGL J MED, V368, P2402, DOI 10.1056/NEJMra1206793; Xu LX, 2005, KIDNEY INT, V68, P167, DOI 10.1111/j.1523-1755.2005.00390.x; Yasutake J, 2015, NEPHROL DIAL TRANSPL, V30, P1315, DOI 10.1093/ndt/gfv221; Zhao N, 2012, KIDNEY INT, V82, P790, DOI 10.1038/ki.2012.197	26	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2019	14	3							e0214256	10.1371/journal.pone.0214256	http://dx.doi.org/10.1371/journal.pone.0214256			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ5PT	30917188	gold, Green Submitted, Green Published			2022-12-26	WOS:000462465800058
J	Liu, J; Hu, TT; Feng, PY; Wang, L; Yang, SH				Liu, Jie; Hu, Tiantian; Feng, Puyu; Wang, Li; Yang, Shuohuan			Tomato yield and water use efficiency change with various soil moisture and potassium levels during different growth stages	PLOS ONE			English	Article							LYCOPERSICON-ESCULENTUM MILL.; BLOSSOM-END ROT; FRUIT-QUALITY; PROCESSING TOMATO; DEFICIT IRRIGATION; DRIP-IRRIGATION; CALCIUM; STRESS; PLANTS; NUTRITION	Faced with the scarcity of water resource and irrational fertilizer use, it is highly important to supply plants with water and fertilizer at desiderated stages to improve yield with high water use efficiency (WUE). A pot experiment was conducted to investigate the effects of growth stage-specific water deficiency and potassium (K) fertilization on tomato yield and WUE. The entire growing season of tomato was divided into 5 stages: vegetative growth stage (VG), flowering and fruit setting stage (FS), early fruit growth stage (FG), fruit development stage (FD) and fruit maturity stage (FM). Three soil moisture (W) and three K fertilization levels were set up. W levels included W1, W2 and W3, indicating that soil water was maintained at 60-70% field capacity, 70-80% field capacity, and 80-90% field capacity, respectively. K levels included K1, K2 and K3, indicating that 0 g K2O per kg soil, 0.46 g K2O per kg soil and 0.92 g K2O per kg soil was applied. All combinations of the three W and three K levels were solely imposed at each of the five growth stages, for other four stages, plants were watered to 80-90% field capacity without K fertilizer (W3K1). The permanent W3K1 over the entire growth stage was taken as control (CK). The results showed that W deficiency imposed at all stages significantly affected tomato yield (P<0.01), except for VG stage in which W deficiency did not cause yield loss. K fertilization level during FS or FM stage had a significant effect on yield (P<0.01). A significant interaction effect of W and K on yield was only observed during FM stage. For WUE, significant effect of W deficiency at FS, FD and FM stages were observed, and a significant effect of K levels at FS, FD and FM stages was observed. Specifically, K fertilization was necessary during specific growth stage of tomato (i.e. FS and FM). During FS stage, even if a sufficient water supply seems necessary, a deficit irrigation with K fertilization could be applied as K fertilization could alleviate the negative effect of soil water deficit, however, excess of K fertilization during FM stage should be avoided to maintain tomato yield and WUE.	[Liu, Jie; Hu, Tiantian; Feng, Puyu; Wang, Li; Yang, Shuohuan] Northwest A&F Univ, Coll Water Resources & Architectural Engn, Yangling, Shaanxi, Peoples R China; [Liu, Jie; Hu, Tiantian; Feng, Puyu; Wang, Li; Yang, Shuohuan] Northwest A&F Univ, Minist Educ, Key Lab Agr Soil & Water Engn Arid & Semiarid Are, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; Northwest A&F University - China	Hu, TT (corresponding author), Northwest A&F Univ, Coll Water Resources & Architectural Engn, Yangling, Shaanxi, Peoples R China.; Hu, TT (corresponding author), Northwest A&F Univ, Minist Educ, Key Lab Agr Soil & Water Engn Arid & Semiarid Are, Yangling, Shaanxi, Peoples R China.	hutiant@nwsuaf.edu.cn			National Natural Science Foundation of China [51279169]; National High Technology Research and Development Program of China [2011AA100504]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This work was supported by the National Natural Science Foundation of China (51279169), http://www.nsfc.gov.cn/, the National High Technology Research and Development Program of China (2011AA100504).	Abd El-Mageed TA, 2017, ARCH AGRON SOIL SCI, V63, P827, DOI 10.1080/03650340.2016.1240363; Adams SR, 2001, ANN BOT-LONDON, V88, P869, DOI 10.1006/anbo.2001.1524; Akhtar ME, 2010, PAK J BOT, V42, P1695; Amjad M, 2016, J PLANT NUTR, V39, P1926, DOI 10.1080/01904167.2016.1201107; Amjad M, 2014, TURK J BIOL, V38, P208, DOI 10.3906/biy-1305-54; Amtmann A, 2006, ADV BOT RES, V43, P209, DOI 10.1016/S0065-2296(05)43005-0; Bar-Tal A, 1996, J AM SOC HORTIC SCI, V121, P649, DOI 10.21273/JASHS.121.4.649; Birhanu K., 2010, African Journal of Food, Agriculture, Nutrition and Development, V10, P2139; Cahn MD, 2001, ACTA HORTIC, P111, DOI 10.17660/ActaHortic.2001.542.13; Chen JL, 2013, AGR WATER MANAGE, V129, P152, DOI 10.1016/j.agwat.2013.07.011; Chen S, 2015, ACTA AGR SCAND B-S P, V65, P460, DOI 10.1080/09064710.2015.1024279; Colpan E, 2013, HORTIC ENVIRON BIOTE, V54, P20, DOI 10.1007/s13580-013-0080-4; DENMEAD OT, 1962, AGRON J, V54, P385, DOI 10.2134/agronj1962.00021962005400050005x; Doorenbos J., 1979, UN FAO PUBLICATION, V33; [杜太生 Du Taisheng], 2011, [水利学报, Journal of Hydraulic Engineering], V42, P245; Gregory PJ, 2000, AGRON J, V92, P814, DOI 10.2134/agronj2000.925814x; Grzebisz W, 2013, J PLANT NUTR SOIL SC, V176, P355, DOI 10.1002/jpln.201200287; Gunter C C, 2005, HORTSCIENCE, V216, P1073; Han QH, 2012, ACTA HORTIC, V944, P45; Harmanto, 2005, AGR WATER MANAGE, V71, P225, DOI 10.1016/j.agwat.2004.09.003; Hartz TK, 2005, HORTSCIENCE, V40, P1862, DOI 10.21273/HORTSCI.40.6.1862; Hartz TK, 1999, J AM SOC HORTIC SCI, V124, P199, DOI 10.21273/JASHS.124.2.199; Hu Y, 2010, J PLANT NUTR SOIL SC, V168, P541; Huang JS, 2009, COMMUN SOIL SCI PLAN, V40, P1937, DOI 10.1080/00103620902896811; HUBER SC, 1984, PLANT PHYSIOL, V76, P424, DOI 10.1104/pp.76.2.424; Ju XT, 2007, ENVIRON POLLUT, V145, P497, DOI 10.1016/j.envpol.2006.04.017; Kanai S, 2007, J EXP BOT, V58, P2917, DOI 10.1093/jxb/erm149; Kanai S, 2011, PLANT SCI, V180, P368, DOI 10.1016/j.plantsci.2010.10.011; Kang SZ, 2002, AGR WATER MANAGE, V55, P203, DOI 10.1016/S0378-3774(01)00180-9; Kuscu H, 2014, AGR WATER MANAGE, V133, P92, DOI 10.1016/j.agwat.2013.11.008; Li B.Y., 2007, THESIS; Li J M, 2000, ACTA AGR BOREALI OCC, V4, P71; Liu K, 2011, AGRON J, V103, P1339, DOI 10.2134/agronj2011.0111; Lopez MV, 1996, PLANT SCI, V114, P19, DOI 10.1016/0168-9452(95)04300-4; Marouelli WA, 2007, IRRIGATION SCI, V25, P411, DOI 10.1007/s00271-006-0056-6; Nangare DD, 2016, AGR WATER MANAGE, V171, P73, DOI 10.1016/j.agwat.2016.03.016; Nuruddin MM, 2003, HORTSCIENCE, V38, P1389, DOI 10.21273/HORTSCI.38.7.1389; Padilla FM, 2018, SCI TOTAL ENVIRON, V643, P400, DOI 10.1016/j.scitotenv.2018.06.215; Patane C, 2010, AGR WATER MANAGE, V97, P131, DOI 10.1016/j.agwat.2009.08.021; Patane C, 2011, SCI HORTIC-AMSTERDAM, V129, P590, DOI 10.1016/j.scienta.2011.04.030; Peiter E, 2011, CELL CALCIUM, V50, P120, DOI 10.1016/j.ceca.2011.02.002; Pujos A, 1997, PLANT SOIL, V189, P189, DOI 10.1023/A:1004263304657; Rahmati M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120246; Romheld V, 2007, P 616 INT FERT SOC Y; San-Martin-Hernandez C, 2016, INTERCIENCIA, V41, P60; Sato S, 2010, PLANT CELL ENVIRON, V23, P719; Saure MC, 2001, SCI HORTIC-AMSTERDAM, V90, P193, DOI 10.1016/S0304-4238(01)00227-8; Schilling G, 2016, J PLANT NUTR SOIL SC, V179, P234, DOI 10.1002/jpln.201500407; Serio F, 2007, J HORTIC SCI BIOTECH, V82, P941, DOI 10.1080/14620316.2007.11512330; Stanhill G., 1973, EVAPORATION TRANSPIR; Tuna AL, 2010, J PLANT NUTR, V33, P1276, DOI 10.1080/01904167.2010.484089; Turhan A, 2016, ACTA HORTIC, V1145, P85, DOI 10.17660/ActaHortic.2016.1145.13; Wang F, 2011, AGR WATER MANAGE, V98, P1228, DOI 10.1016/j.agwat.2011.03.004; Wei ZH, 2018, AGR WATER MANAGE, V202, P174, DOI 10.1016/j.agwat.2018.02.027; White PJ, 2013, J PLANT NUTR SOIL SC, V176, P305, DOI 10.1002/jpln.201200121; White PJ, 2010, PLANT CELL MONOGR, V17, P199, DOI 10.1007/978-3-642-10613-2_9; Yang H, 2016, AGR WATER MANAGE, DOI [10.1016/j.agwat.2016.05.010, DOI 10.1016/J.AGWAT.2016.05.010]; Zahoor R, 2017, ENVIRON EXP BOT, V137, P73, DOI 10.1016/j.envexpbot.2017.02.002; Zhang TQ, 2011, SOIL SCI SOC AM J, V75, P738, DOI 10.2136/sssaj2009.0365; Zheng JH, 2013, AGR WATER MANAGE, V129, P181, DOI 10.1016/j.agwat.2013.08.001; Zorb C, 2014, J PLANT PHYSIOL, V171, P656, DOI 10.1016/j.jplph.2013.08.008	61	20	21	4	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2019	14	3							e0213643	10.1371/journal.pone.0213643	http://dx.doi.org/10.1371/journal.pone.0213643			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ5PT	30917147	Green Published, gold, Green Submitted			2022-12-26	WOS:000462465800038
J	Rashid, TA; Abbas, DK; Turel, YK				Rashid, Tarik A.; Abbas, Dosti K.; Turel, Yalin K.			A multi hidden recurrent neural network with a modified grey wolf optimizer	PLOS ONE			English	Article								Identifying university students' weaknesses results in better learning and can function as an early warning system to enable students to improve. However, the satisfaction level of existing systems is not promising. New and dynamic hybrid systems are needed to imitate this mechanism. A hybrid system (a modified Recurrent Neural Network with an adapted Grey Wolf Optimizer) is used to forecast students' outcomes. This proposed system would improve instruction by the faculty and enhance the students' learning experiences. The results show that a modified recurrent neural network with an adapted Grey Wolf Optimizer has the best accuracy when compared with other models.	[Rashid, Tarik A.] Univ Kurdistan Hewler, Comp Sci & Engn Dept, Kurdistan, Iraq; [Rashid, Tarik A.] Salahaddin Univ Erbil, Software & Informat Engn, Kurdistan, Iraq; [Abbas, Dosti K.] Soran Univ, Fac Engn, Kurdistan, Iraq; [Turel, Yalin K.] Firat Univ, Dept Comp Educ & Instruct Technol, Elazig, Turkey	Salahaddin University; Soran University; Firat University	Rashid, TA (corresponding author), Univ Kurdistan Hewler, Comp Sci & Engn Dept, Kurdistan, Iraq.; Rashid, TA (corresponding author), Salahaddin Univ Erbil, Software & Informat Engn, Kurdistan, Iraq.	tarik.ahmed@ukh.edu.krd	Rashid, Tarik A./P-3473-2019; Turel, Yalin K/W-4703-2018	Rashid, Tarik A./0000-0002-8661-258X; Turel, Yalin K/0000-0002-0021-0484; Abbas, dosti/0000-0002-8541-4071	University of Kurdistan Hewler (UKH)	University of Kurdistan Hewler (UKH)	The research and publication fees are part of the funding granted by the University of Kurdistan Hewler (UKH) to TR.	Ahmad H., 2016, J COMPUT SCI-NETH, V12, P255, DOI [10.3844/jcssp.2016.255.264, DOI 10.3844/JCSSP.2016.255.264]; Al-Radaideh Q. A., 2006, INT AR C INF TECHN A; Baradwaj B. K., 2012, ARXIV12013417; Bebis G., 1994, IEEE Potentials, V13, P27, DOI 10.1109/45.329294; Dorffner G., 1996, NEURAL NETWORKS TIME; Dorigo M., 2011, ENCY MACHINE LEARNIN, P36, DOI DOI 10.1002/9780470400531.EORMS0030; ELMAN JL, 1990, COGNITIVE SCI, V14, P179, DOI 10.1207/s15516709cog1402_1; Emary E, 2015, PROCEDIA COMPUT SCI, V65, P623, DOI 10.1016/j.procs.2015.09.006; Guo B, 2015, 2015 INTERNATIONAL SYMPOSIUM ON EDUCATIONAL TECHNOLOGY (ISET 2015), P125, DOI 10.1109/ISET.2015.33; Hagan MT., 1997, NEURAL NETWORK DESIG; Han J, 2012, MOR KAUF D, P1; Iasemidis LD, 2009, INT J NEURAL SYSTEMS, V19; Kennedy J., ENCY MACHINE LEARNIN, P760; Khandelwal A, 2018, ARAB J SCI ENG, V43, P2899, DOI 10.1007/s13369-017-2967-3; Kohonen T, 1998, NEUROCOMPUTING, V21, P1, DOI 10.1016/S0925-2312(98)00030-7; Kovacic Z., EARLY PREDICTION STU; Madhiarasan M., 2016, CIRCUITS SYST, V7, P2975; McCulloch Warren S., 1943, BULL MATH BIOPHYS, V5, P115, DOI 10.1007/BF02478259; Mirjalili S, 2014, ADV ENG SOFTW, V69, P46, DOI 10.1016/j.advengsoft.2013.12.007; Mosavi MR, 2016, NEURAL NETW WORLD, V26, P393, DOI 10.14311/NNW.2016.26.023; PARK J, 1993, NEURAL COMPUT, V5, P305, DOI 10.1162/neco.1993.5.2.305; Pham D. T., 2006, IPROMS, P454, DOI DOI 10.1016/B978-008045157-2/50081-X; Rashid T. A., 2016, ZANCO J PURE APPL SC, V28; Rashid T, 2009, INT J COMPUT SCI NET, V9, P335; Rashid TA, 2016, COMPUT APPL ENG EDUC, V24, P629, DOI 10.1002/cae.21737; Romero C, 2010, IEEE T SYST MAN CY C, V40, P601, DOI 10.1109/TSMCC.2010.2053532; Sikder MF, 2016, 2016 5TH INTERNATIONAL CONFERENCE ON INFORMATICS, ELECTRONICS AND VISION (ICIEV), P524, DOI 10.1109/ICIEV.2016.7760058; Sweidan AH, 2015, INT CONF SOFT COMPUT, P1, DOI 10.1109/SOCPAR.2015.7492777; Tape T.G, 2018, INTERPRETING DIAGNOS; Umamaheswari K, 2013, INT J ADV RES COMPUT, V3, P117; Vosooghifard M, 2015, 2015 5TH INTERNATIONAL CONFERENCE ON COMPUTER AND KNOWLEDGE ENGINEERING (ICCKE), P147, DOI 10.1109/ICCKE.2015.7365818; WIGTON RS, 1986, ARCH INTERN MED, V146, P81, DOI 10.1001/archinte.146.1.81; Yacef K, 2009, J ED DATA MINING, V1, P3; Yukselturk E, 2014, EUROPEAN J OPEN DIST, P17	34	23	27	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2019	14	3							e0213237	10.1371/journal.pone.0213237	http://dx.doi.org/10.1371/journal.pone.0213237			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ5PT	30917155	Green Published, Green Submitted, gold			2022-12-26	WOS:000462465800024
J	Cluxton, CD; Spillane, C; O'Toole, SA; Sheils, O; Gardiner, CM; O'Leary, JJ				Cluxton, Christopher D.; Spillane, Cathy; O'Toole, Sharon A.; Sheils, Orla; Gardiner, Clair M.; O'Leary, John J.			Suppression of Natural Killer cell NKG2D and CD226 anti-tumour cascades by platelet cloaked cancer cells: Implications for the metastatic cascade	PLOS ONE			English	Article							RECEPTOR; CARCINOMA; SERUM; CD96; MICA	Tumour cell immune evasion is a principal hallmark of successful metastasis. Tumour cells in the vasculature adopt a platelet cloak that efficiently suppresses the innate immune system by directly inhibiting Natural Killer (NK) cells, which normally function to neutralise spreading cancers. Here we describe two novel mechanisms of tumour cell evasion of NK cell anti-tumour functions. The first, an 'immune decoy' mechanism in which platelets induce the release of soluble NKG2D ligands from the tumour cell to mask detection and actively suppress NK cell degranulation and inflammatory cytokine (IFN gamma) production, concomitantly. This represents a double-hit to immune clearance of malignant cells during metastasis. The second mechanism, a platelet-derived TGF beta-mediated suppression of the CD226/CD96-CD112/CD155 axis, is a novel pathway with poorly understood anti-cancer functions. We have demonstrated that platelets robustly suppress surface expression of CD226 and CD96 on the NK cell surface and their associated ligands on the tumour cell to further enhance NK cell suppression. These highly evolved mechanisms promote successful tumour immune evasion during metastasis and provide a unique opportunity for studying the complexity of cellular interactions in the metastatic cascade and thus novel targets for cancer immunotherapy.	[Cluxton, Christopher D.; Spillane, Cathy; O'Toole, Sharon A.; Sheils, Orla; O'Leary, John J.] Trinity Coll Dublin, Dept Histopathol, Dublin, Ireland; [Cluxton, Christopher D.; Spillane, Cathy; O'Leary, John J.] Coombe Women & Infants Univ Hosp, Emer Casey Res Lab, Dublin, Ireland; [Cluxton, Christopher D.; Gardiner, Clair M.] Trinity Coll Dublin, Trinity Biomed Sci Inst, Dublin, Ireland; [Spillane, Cathy; O'Toole, Sharon A.; Sheils, Orla; O'Leary, John J.] Trinity Coll Dublin, Trinity Translat Med Inst, Dublin, Ireland; [O'Toole, Sharon A.] Trinity Coll Dublin, Dept Obstet & Gynaecol, Dublin, Ireland	Trinity College Dublin; Trinity College Dublin; Trinity College Dublin; Trinity College Dublin; Trinity College Dublin	Cluxton, CD (corresponding author), Trinity Coll Dublin, Dept Histopathol, Dublin, Ireland.; Cluxton, CD (corresponding author), Coombe Women & Infants Univ Hosp, Emer Casey Res Lab, Dublin, Ireland.; Cluxton, CD (corresponding author), Trinity Coll Dublin, Trinity Biomed Sci Inst, Dublin, Ireland.	cluxtoc@tcd.ie	; Sheils, Orla/B-8461-2015	Gardiner, Clair/0000-0001-5643-9432; Sheils, Orla/0000-0002-4493-9496; O'Leary, John/0000-0001-7311-9326; o toole, sharon/0000-0002-9260-3225	SFI (SFI CSET) [10/CE/B1821]; Friends of the Coombe (Friends of the Coombe grant); Emer Casey Foundation (Emer Casey Foundation)	SFI (SFI CSET); Friends of the Coombe (Friends of the Coombe grant); Emer Casey Foundation (Emer Casey Foundation)	This work was funded by SFI (SFI CSET [10/CE/B1821]; JOL received this award; www.sfi.ie), Friends of the Coombe (Friends of the Coombe grant - no grant number; JOL; http://www.friendsofthecoombe.ie) and the Emer Casey Foundation (Emer Casey Foundation grand - no grant number; JOL; http://www.emercaseyfoundation.com). No commercial companies were involved in the project. Authors did not receive a salary. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aceto N, 2014, CELL, V158, P1110, DOI 10.1016/j.cell.2014.07.013; Amo L, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00245; Ascierto ML, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-145; Carlsten M, 2007, CANCER RES, V67, P1317, DOI 10.1158/0008-5472.CAN-06-2264; Chan CJ, 2014, NAT IMMUNOL, V15, P431, DOI 10.1038/ni.2850; Chen J, 2016, THER CLIN RISK MANAG, V12, P11, DOI 10.2147/TCRM.S96869; Egan K, 2014, CLIN EXP METASTAS, V31, P697, DOI 10.1007/s10585-014-9660-7; Egan K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026125; Fraietta JA, 2016, BLOOD, V127, P1117, DOI 10.1182/blood-2015-11-679134; Fuchs A, 2004, J IMMUNOL, V172, P3994, DOI 10.4049/jimmunol.172.7.3994; Gasser S, 2006, IMMUNOL REV, V214, P130, DOI 10.1111/j.1600-065X.2006.00460.x; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Kopp HG, 2009, CANCER RES, V69, P7775, DOI 10.1158/0008-5472.CAN-09-2123; Leblanc R, 2016, BLOOD, V128, P24, DOI 10.1182/blood-2016-01-636399; Li JJ, 2013, CHIN J CANCER, V32, P141, DOI 10.5732/cjc.012.10025; Li TJ, 2012, CANCER LETT, V318, P154, DOI 10.1016/j.canlet.2011.12.020; Maurer S, 2018, ONCOIMMUNOLOGY, V7, DOI 10.1080/2162402X.2017.1364827; Navarro AG, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00202; Pauken KE, 2014, CANCER CELL, V26, P785, DOI 10.1016/j.ccell.2014.11.016; Pende D, 2005, MOL IMMUNOL, V42, P463, DOI 10.1016/j.molimm.2004.07.028; Peng YP, 2016, ONCOTARGET, V7, P66586, DOI 10.18632/oncotarget.11953; Placke T, 2012, CANCER RES, V72, P440, DOI 10.1158/0008-5472.CAN-11-1872; Smyth T, 2014, MOL CANCER THER, V13, P2793, DOI 10.1158/1535-7163.MCT-14-0452; Tamaki S, 2010, ANTICANCER RES, V30, P4097; Vahlne G, 2008, SCAND J IMMUNOL, V67, P1, DOI 10.1111/j.1365-3083.2007.02026.x; Vivier E, 2012, NAT REV IMMUNOL, V12, P239, DOI 10.1038/nri3174; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687; Waldhauer I, 2008, CANCER RES, V68, P6368, DOI 10.1158/0008-5472.CAN-07-6768; Yu M, 2013, SCIENCE, V339, P580, DOI 10.1126/science.1228522	29	32	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2019	14	3							e0211538	10.1371/journal.pone.0211538	http://dx.doi.org/10.1371/journal.pone.0211538			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ1KV	30908480	Green Published, Green Submitted, gold			2022-12-26	WOS:000462157600006
J	Sanchez, SS; Tachachartvanich, P; Stanczyk, FZ; Gomez, SL; John, EM; Smith, MT; Fejerman, L				Sanchez, Sylvia S.; Tachachartvanich, Phum; Stanczyk, Frank Z.; Gomez, Scarlett L.; John, Esther M.; Smith, Martyn T.; Fejerman, Laura			Estrogenic activity, race/ethnicity, and Indigenous American ancestry among San Francisco Bay Area women	PLOS ONE			English	Article							BREAST-CANCER RISK; ENDOGENOUS SEX-HORMONES; POSTMENOPAUSAL WOMEN; DEMOGRAPHIC-FACTORS; METABOLISM; XENOESTROGENS; ASSOCIATION; HISTORY; DIETARY	Estrogens play a significant role in breast cancer development and are not only produced endogenously, but are also mimicked by estrogen-like compounds from environmental exposures. We evaluated associations between estrogenic (E) activity, demographic factors and breast cancer risk factors in Non-Latina Black (NLB), Non-Latina White (NLW), and Latina women. We examined the association between E activity and Indigenous American (IA) ancestry in Latina women. Total E activity was measured with a bioassay in plasma samples of 503 women who served as controls in the San Francisco Bay Area Breast Cancer Study. In the univariate model that included all women with race/ethnicity as the independent predictor, Latinas had 13% lower E activity (p = 0.239) and NLBs had 35% higher activity (p = 0.04) compared to NLWs. In the multivariable model that adjusted for demographic factors, Latinas continued to show lower E activity levels (26%, p = 0.026), but the difference between NLBs and NLWs was no longer statistically significant (p = 0.431). An inverse association was observed between E activity and IA ancestry among Latina women (50% lower in 0% vs. 100% European ancestry, p = 0.027) consistent with our previously reported association between IA ancestry and breast cancer risk. These findings suggest that endogenous estrogens and exogenous estrogen-like compounds that act on the estrogen receptor and modulate E activity may partially explain racial/ethnic differences in breast cancer risk.	[Sanchez, Sylvia S.; Tachachartvanich, Phum; Smith, Martyn T.] Univ Calif Berkeley, Sch Publ Hlth, Div Environm Hlth Sci, Berkeley, CA 94720 USA; [Stanczyk, Frank Z.] Univ Southern Calif, Keck Sch Med, Dept Obstet & Gynecol, Los Angeles, CA USA; [Gomez, Scarlett L.; John, Esther M.] Stanford Sch Med, Dept Med, Div Oncol, Stanford, CA 94305 USA; [Gomez, Scarlett L.; John, Esther M.] Stanford Sch Med, Stanford Canc Inst, Stanford, CA 94305 USA; [Gomez, Scarlett L.] Univ Calif San Francisco, Dept Epidemiol & Biostat, Helen Diller Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Fejerman, Laura] Univ Calif San Francisco, Div Gen Internal Med, Inst Human Genet, Helen Diller Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Fejerman, Laura] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	University of California System; University of California Berkeley; University of Southern California; Stanford University; Stanford Cancer Institute; Stanford University; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco	Fejerman, L (corresponding author), Univ Calif San Francisco, Div Gen Internal Med, Inst Human Genet, Helen Diller Comprehens Canc Ctr, San Francisco, CA 94143 USA.; Fejerman, L (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	Laura.Fejerman@ucsf.edu		Fejerman, Laura/0000-0003-3179-1151; Tachachartvanich, Phum/0000-0002-9783-6482; Stanczyk, Frank/0000-0002-3607-121X	R21 grant [R21CA210023]; California Breast Cancer Research Program [7PB-0068, 19IB-0147]; Royal Thai Government scholarship; National Cancer Institute [R01CA63446, R01CA77305]; U.S. Department of Defense Breast Cancer Research Program [DAMD17-96-1-6071]; Plumpjack Fund; NATIONAL CANCER INSTITUTE [R21CA210023] Funding Source: NIH RePORTER	R21 grant; California Breast Cancer Research Program; Royal Thai Government scholarship; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); U.S. Department of Defense Breast Cancer Research Program(United States Department of Defense); Plumpjack Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the R21 grant (grant number: R21CA210023 to L.F.); California Breast Cancer Research Program (Award 19IB-0147 to L.F.), and a Royal Thai Government scholarship for doctoral study (to P.T.). The San Francisco Bay Area Breast Cancer Study was supported by the National Cancer Institute (R01CA63446 and R01CA77305 to E.M.J.), the U.S. Department of Defense Breast Cancer Research Program (DAMD17-96-1-6071 to E.M.J.), and the California Breast Cancer Research Program (7PB-0068 to E.M.J.). Some of the hormone analyses were funded by a grant from the Plumpjack Fund (to E.M.J.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belanger C, 2002, HORM METAB RES, V34, P737, DOI 10.1055/s-2002-38265; Brinton LA, 2016, CANCER EPIDEM BIOMAR, V25, P1081, DOI 10.1158/1055-9965.EPI-16-0225; Brown SB, 2015, STEROIDS, V99, P8, DOI 10.1016/j.steroids.2014.12.013; Chavez-Suarez KM, 2017, NUTRIENTS, V9, DOI 10.3390/nu9101078; Darbre PD, 2010, ANTICANCER RES, V30, P815; Dey S, 2009, MED HYPOTHESES, V72, P652, DOI 10.1016/j.mehy.2008.10.025; Dorgan JF, 2002, JNCI-J NATL CANCER I, V94, P606; Fejerman L, 2016, CARCINOGENESIS, V37, P904, DOI 10.1093/carcin/bgw074; Fernandez SV, 2010, TOXICOL PATHOL, V38, P110, DOI 10.1177/0192623309354108; Frydenberg H, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0620-1; HANKINSON SE, 1995, J NATL CANCER I, V87, P1297, DOI 10.1093/jnci/87.17.1297; HANKINSON SE, 1995, CANCER EPIDEM BIOMAR, V4, P649; John EM, 2005, CANCER EPIDEM BIOMAR, V14, P2905, DOI 10.1158/1055-9965.EPI-05-0483; Keegan THM, 2010, CANCER EPIDEM BIOMAR, V19, P1208, DOI 10.1158/1055-9965.EPI-10-0021; Key TJ, 2011, STEROIDS, V76, P812, DOI 10.1016/j.steroids.2011.02.029; Lim VW, 2014, LUNG CANCER, V85, P293, DOI 10.1016/j.lungcan.2014.05.019; Lorand T, 2010, CURR MED CHEM, V17, P3542, DOI 10.2174/092986710792927813; McTiernan A, 2008, BREAST CANCER RES TR, V108, P217, DOI 10.1007/s10549-007-9588-6; McTiernan A, 2006, OBESITY, V14, P1662, DOI 10.1038/oby.2006.191; Meseguer A, 2002, HORM METAB RES, V34, P731, DOI 10.1055/s-2002-38249; Moore SC, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djw103; Roddam AW, 2008, J NATL CANCER I, V100, P170, DOI 10.1093/jnci/djm323; Samavat H, 2015, CANCER LETT, V356, P231, DOI 10.1016/j.canlet.2014.04.018; Sampson JN, 2017, CANCER RES, V77, P918, DOI 10.1158/0008-5472.CAN-16-1717; Schairer C, 2016, CANCER EPIDEM BIOMAR, V25, P105, DOI 10.1158/1055-9965.EPI-15-0687; Setiawan VW, 2006, CANCER EPIDEM BIOMAR, V15, P1849, DOI 10.1158/1055-9965.EPI-06-0307; StataCorp, 2013, STAT STAT SOFTW REL; Tchernof A, 2002, CIRCULATION, V105, P564, DOI 10.1161/hc0502.103331; Touillaud MS, 2007, JNCI-J NATL CANCER I, V99, P475, DOI 10.1093/jnci/djk096; Wacker M, 2009, J WOMENS HEALTH, V18, P487, DOI 10.1089/jwh.2008.0835; Williams GP, 2010, EUR J CANCER PREV, V19, P256, DOI 10.1097/CEJ.0b013e328338f7d2; Wilson VS, 2004, TOXICOL SCI, V81, P69, DOI 10.1093/toxsci/kfh180; Ziegler RG, 2015, STEROIDS, V99, P67, DOI 10.1016/j.steroids.2015.02.015	33	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2019	14	3							e0213809	10.1371/journal.pone.0213809	http://dx.doi.org/10.1371/journal.pone.0213809			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ1KV	30908519	Green Published, gold, Green Submitted			2022-12-26	WOS:000462157600021
J	Colige, A; Monseur, C; Crawley, JTB; Santamaria, S; de Groot, R				Colige, Alain; Monseur, Christine; Crawley, James T. B.; Santamaria, Salvatore; de Groot, Rens			Proteomic discovery of substrates of the cardiovascular protease ADAMTS7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ADAMTS; substrate specificity; proteolysis; tissue inhibitor of metalloproteinase (TIMP); proteolytic enzyme; ADAMTS7; autolysis; cleavage sites; LTBP4; TIMP-4	MUSCLE-CELL MIGRATION; TISSUE INHIBITORS; SPACER DOMAIN; LONG FORM; BINDING; CLEAVAGE; GENE; DISEASE; TIMP4; AGGRECANASE-1	The protease ADAMTS7 functions in the extracellular matrix (ECM) of the cardiovascular system. However, its physiological substrate specificity and mechanism of regulation remain to be explored. To address this, we conducted an unbiased substrate analysis using terminal amine isotopic labeling of substrates (TAILS). The analysis identified candidate substrates of ADAMTS7 in the human fibroblast secretome, including proteins with a wide range of functions, such as collagenous and noncollagenous extracellular matrix proteins, growth factors, proteases, and cell-surface receptors. It also suggested that autolysis occurs at Glu-729-Val-730 and Glu-732-Ala-733 in the ADAMTS7 Spacer domain, which was corroborated by N-terminal sequencing and Western blotting. Importantly, TAILS also identified proteolysis of the latent TGF--binding proteins 3 and 4 (LTBP3/4) at a Glu-Val and Glu-Ala site, respectively. Using purified enzyme and substrate, we confirmed ADAMTS7-catalyzed proteolysis of recombinant LTBP4. Moreover, we identified multiple additional scissile bonds in an N-terminal linker region of LTBP4 that connects fibulin-5/tropoelastin and fibrillin-1-binding regions, which have an important role in elastogenesis. ADAMTS7-mediated cleavage of LTBP4 was efficiently inhibited by the metalloprotease inhibitor TIMP-4, but not by TIMP-1 and less efficiently by TIMP-2 and TIMP-3. As TIMP-4 expression is prevalent in cardiovascular tissues, we propose that TIMP-4 represents the primary endogenous ADAMTS7 inhibitor. In summary, our findings reveal LTBP4 as an ADAMTS7 substrate, whose cleavage may potentially impact elastogenesis in the cardiovascular system. We also identify TIMP-4 as a likely physiological ADAMTS7 inhibitor.	[Colige, Alain; Monseur, Christine] Univ Liege, GIGA, Lab Connect Tissue Biol, B-4000 Liege, Belgium; [Crawley, James T. B.; Santamaria, Salvatore; de Groot, Rens] Imperial Coll London, Ctr Haematol, London W12 0NN, England	University of Liege; Imperial College London	de Groot, R (corresponding author), 5th Fl,Commonwealth Bldg,Hammersmith Hosp Campus, London W12 0NN, England.	R.deGroot@imperial.ac.uk	Crawley, James TB/A-9290-2008	Crawley, James TB/0000-0002-6723-7841; Santamaria, Salvatore/0000-0001-8670-7776; de Groot, Rens/0000-0002-1044-9499	British Heart Foundation [PG/18/19/33584]; Imperial College London; Fonds De La Recherche Scientifique-FNRS Grant [7.6536.18]; Fonds Leon Fredericq; ULiege	British Heart Foundation(British Heart Foundation); Imperial College London(General Electric); Fonds De La Recherche Scientifique-FNRS Grant(Fonds de la Recherche Scientifique - FNRS); Fonds Leon Fredericq; ULiege	This work was supported by British Heart Foundation Grant PG/18/19/33584 (to R. d. G. and J. T. B. C.), Imperial College London (to S. S. and R. d. G.), Fonds De La Recherche Scientifique-FNRS Grant 7.6536.18 (to A. C. and C. M.), Fonds Leon Fredericq and ULiege (to A. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Akiyama M, 2009, P NATL ACAD SCI USA, V106, P19274, DOI 10.1073/pnas.0909755106; Arroyo AG, 2015, CIRCULATION, V131, P1156, DOI 10.1161/CIRCULATIONAHA.115.015711; Bauer RC, 2015, CIRCULATION, V131, P1202, DOI 10.1161/CIRCULATIONAHA.114.012669; Bekhouche M, 2016, FASEB J, V30, P1741, DOI 10.1096/fj.15-279869; Bengtsson E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03573-4; Brew K, 2010, BBA-MOL CELL RES, V1803, P55, DOI 10.1016/j.bbamcr.2010.01.003; Cain SA, 2016, SCI REP-UK, V6, DOI 10.1038/srep35956; de Groot R., 2019, METHODS MOL BIOL; de Groot R, 2015, BLOOD, V125, P1968, DOI 10.1182/blood-2014-08-594556; de Groot R, 2009, BLOOD, V113, P5609, DOI 10.1182/blood-2008-11-187914; Desiere F, 2006, NUCLEIC ACIDS RES, V34, pD655, DOI [10.1093/nar/gkj040, 10.1007/978-1-60761-444-9_19]; Doll S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01747-2; Fabre B, 2014, J MED CHEM, V57, P10205, DOI 10.1021/jm500505f; Flannery CR, 2002, J BIOL CHEM, V277, P42775, DOI 10.1074/jbc.M205309200; Gendron C, 2007, J BIOL CHEM, V282, P18294, DOI 10.1074/jbc.M701523200; Georgiadis K., 2002, T ORTHOP RES SOC, V48, P167; Guo CQ, 2016, BIOMED REP, V4, P73, DOI 10.3892/br.2015.535; Guo DC, 2018, AM J HUM GENET, V102, P706, DOI 10.1016/j.ajhg.2018.03.002; Hashimoto G, 2001, FEBS LETT, V494, P192, DOI 10.1016/S0014-5793(01)02323-7; Hubmacher D, 2017, SCI REP-UK, V7, DOI 10.1038/srep41871; Hubmacher D, 2015, MATRIX BIOL, V47, P34, DOI 10.1016/j.matbio.2015.05.004; Huckert M, 2015, HUM MOL GENET, V24, P3038, DOI 10.1093/hmg/ddv053; Jin SY, 2010, BLOOD, V115, P2300, DOI 10.1182/blood-2009-07-235101; Kashiwagi M, 2001, J BIOL CHEM, V276, P12501, DOI 10.1074/jbc.C000848200; Kessler T, 2015, CIRCULATION, V131, P1191, DOI 10.1161/CIRCULATIONAHA.114.014072; Kleifeld O, 2010, NAT BIOTECHNOL, V28, P281, DOI 10.1038/nbt.1611; KNIGHT CG, 1995, METHOD ENZYMOL, V248, P85; Koski C, 1999, J BIOL CHEM, V274, P32619, DOI 10.1074/jbc.274.46.32619; Koskivirta I, 2006, HISTOCHEM CELL BIOL, V126, P335, DOI 10.1007/s00418-006-0163-8; Koskivirta I, 2010, J BIOL CHEM, V285, P24487, DOI 10.1074/jbc.M110.136820; Liu CJ, 2006, FASEB J, V20, P988, DOI 10.1096/fj.05-3877fje; Longpre JM, 2009, INT J BIOCHEM CELL B, V41, P1116, DOI 10.1016/j.biocel.2008.10.008; Mead TJ, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.92941; Muller M, 2016, BIOCHEM BIOPH RES CO, V471, P380, DOI 10.1016/j.bbrc.2016.02.025; Mularczyk EJ, 2018, HUM MOL GENET, V27, P3675, DOI 10.1093/hmg/ddy276; Nicholson AC, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-11; Noda K, 2013, P NATL ACAD SCI USA, V110, P2852, DOI 10.1073/pnas.1215779110; Pos W, 2010, BLOOD, V115, P1640, DOI 10.1182/blood-2009-06-229203; Pu XY, 2013, AM J HUM GENET, V92, P366, DOI 10.1016/j.ajhg.2013.01.012; Rahkonen OP, 2002, BBA-GENE STRUCT EXPR, V1577, P45, DOI 10.1016/S0167-4781(02)00404-9; Reilly MP, 2011, LANCET, V377, P383, DOI 10.1016/S0140-6736(10)61996-4; Rifkin DB, 2018, MATRIX BIOL, V71-72, P90, DOI 10.1016/j.matbio.2017.11.014; Robertson IB, 2015, MATRIX BIOL, V47, P44, DOI 10.1016/j.matbio.2015.05.005; Rodriguez-Manzaneque JC, 2002, BIOCHEM BIOPH RES CO, V293, P501; Santamaria S, 2017, INT J EXP PATHOL, V98, pA3; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Somerville RPT, 2004, J BIOL CHEM, V279, P35159, DOI 10.1074/jbc.M402380200; Sterner-Kock A, 2002, GENE DEV, V16, P2264, DOI 10.1101/gad.229102; Todorovic V, 2007, DEVELOPMENT, V134, P3723, DOI 10.1242/dev.008599; Todorovic V, 2011, DEV DYNAM, V240, P176, DOI 10.1002/dvdy.22521; Wang LW, 2019, MATRIX BIOL, V77, P117, DOI 10.1016/j.matbio.2018.09.004; Wang L, 2009, CIRC RES, V104, P688, DOI 10.1161/CIRCRESAHA.108.188425; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Gomis-Ruth FX, 2009, J BIOL CHEM, V284, P15353, DOI 10.1074/jbc.R800069200; Zimmermann L, 2018, J MOL BIOL, V430, P2237, DOI 10.1016/j.jmb.2017.12.007	55	23	25	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2019	294	20					8037	8045		10.1074/jbc.RA119.007492	http://dx.doi.org/10.1074/jbc.RA119.007492			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC0NH	30926607	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000470656500007
J	Yu, A; Fox, SG; Cavallini, A; Kerridge, C; O'Neill, MJ; Wolak, J; Bose, S; Morimoto, RI				Yu, Anan; Fox, Susan G.; Cavallini, Annalisa; Kerridge, Caroline; O'Neill, Michael J.; Wolak, Joanna; Bose, Suchira; Morimoto, Richard I.			Tau protein aggregates inhibit the protein-folding and vesicular trafficking arms of the cellular proteostasis network	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Tau protein (Tau); chaperone; heat-shock protein (HSP); protein aggregation; heat-shock protein 90 (Hsp90); chaperone competition; Clathrin-mediated endocytosis; HSC70; HSP27; HSP70	CLATHRIN-MEDIATED ENDOCYTOSIS; UBIQUITIN-PROTEASOME SYSTEM; AMPA RECEPTOR ENDOCYTOSIS; PAIRED HELICAL FILAMENTS; ALZHEIMERS-DISEASE; ABNORMAL PHOSPHORYLATION; NEUROFIBRILLARY TANGLES; PATHOLOGY; PROPAGATION; CHAPERONES	Tauopathies are a diverse class of neurodegenerative diseases characterized by the formation of insoluble tau aggregates and the loss of cellular function and neuronal death. Tau inclusions have been shown to contain a number of proteins, including molecular chaperones, but the consequences of these entrapments are not well established. Here, using a human cell system for seeding-dependent tau aggregation, we demonstrate that the molecular chaperones heat-shock cognate 71-kDa protein (HSC70)/heat-shock protein 70 (HSP70), HSP90, and J-domain co-chaperones are sequestered by tau aggregates. By employing single-cell analysis of protein-folding and clathrin-mediated endocytosis, we show that both chaperone-dependent cellular activities are significantly impaired by tau aggregation and can be reversed by treatment with small-molecule regulators of heat-shock transcription factor 1 (HSF1) proteostasis that induce the expression of cytosolic chaperones. These results reveal that the sequestration of cytoplasmic molecular chaperones by tau aggregates interferes with two arms of the proteostasis network, likely having profound negative consequences for cellular function.	[Yu, Anan; Fox, Susan G.; Morimoto, Richard I.] Northwestern Univ, Rice Inst Biomed Res, Dept Mol Biosci, 2205 Tech Dr,Hogan 2-100, Evanston, IL 60208 USA; [Cavallini, Annalisa; Kerridge, Caroline; O'Neill, Michael J.; Wolak, Joanna; Bose, Suchira] Eli Lilly & Co Ltd, Lilly Res Ctr, Sunninghill Rd, Windlesham GU20 6PH, Surrey, England	Northwestern University; Eli Lilly	Morimoto, RI (corresponding author), Northwestern Univ, Rice Inst Biomed Res, Dept Mol Biosci, 2205 Tech Dr,Hogan 2-100, Evanston, IL 60208 USA.	r-morimoto@northwestern.edu		Morimoto, Richard/0000-0002-3431-445X; Wolak, Joanna/0000-0003-1068-1770	National Institutes of Health from NIA [R37-AG026647, P01-AG054409]; Daniel F. and Ada L. Rice Foundation; Eli Lilly & Co. Ltd., Lilly Research Centre; NATIONAL INSTITUTE ON AGING [RF1AG054409, R37AG026647, P01AG054407] Funding Source: NIH RePORTER	National Institutes of Health from NIA; Daniel F. and Ada L. Rice Foundation; Eli Lilly & Co. Ltd., Lilly Research Centre; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grants R37-AG026647 and P01-AG054409 from NIA, the Daniel F. and Ada L. Rice Foundation (to R. I. M.), and a research grant from Eli Lilly & Co. Ltd., Lilly Research Centre. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abisambra JF, 2010, J NEUROSCI, V30, P15374, DOI 10.1523/JNEUROSCI.3155-10.2010; Ahmadian G, 2004, EMBO J, V23, P1040, DOI 10.1038/sj.emboj.7600126; Ahmed Z, 2014, ACTA NEUROPATHOL, V127, P667, DOI 10.1007/s00401-014-1254-6; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Barghorn S, 2000, BIOCHEMISTRY-US, V39, P11714, DOI 10.1021/bi000850r; Baughman HER, 2018, J BIOL CHEM, V293, P2687, DOI 10.1074/jbc.M117.803411; Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bennett EJ, 2005, MOL CELL, V17, P351, DOI 10.1016/j.molcel.2004.12.021; BRORSON JR, 1995, J NEUROSCI, V15, P4515; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Calamini B, 2012, NAT CHEM BIOL, V8, P185, DOI 10.1038/nchembio.763; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Chai YH, 2002, P NATL ACAD SCI USA, V99, P9310, DOI 10.1073/pnas.152101299; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Ciryam P, 2015, TRENDS PHARMACOL SCI, V36, P72, DOI 10.1016/j.tips.2014.12.004; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; Cosker KE, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a020669; de Calignon A, 2012, NEURON, V73, P685, DOI 10.1016/j.neuron.2011.11.033; DeVos SL, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00267; Dickey CA, 2007, J CLIN INVEST, V117, P648, DOI 10.1172/JCI29715; Donaldson KM, 2003, P NATL ACAD SCI USA, V100, P8892, DOI 10.1073/pnas.1530212100; Dou F, 2003, P NATL ACAD SCI USA, V100, P721, DOI 10.1073/pnas.242720499; Eroglu B, 2010, MOL CELL BIOL, V30, P4626, DOI 10.1128/MCB.01493-09; Escusa-Toret S, 2013, NAT CELL BIOL, V15, P1231, DOI 10.1038/ncb2838; Falcon B, 2015, J BIOL CHEM, V290, P1049, DOI 10.1074/jbc.M114.589309; FREEMAN BC, 1995, EMBO J, V14, P2281, DOI 10.1002/j.1460-2075.1995.tb07222.x; Freeman BC, 1996, EMBO J, V15, P2969, DOI 10.1002/j.1460-2075.1996.tb00660.x; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; FRYDMAN J, 1994, NATURE, V370, P111, DOI 10.1038/370111a0; Gidalevitz T, 2006, SCIENCE, V311, P1471, DOI 10.1126/science.1124514; Gidalevitz T, 2010, CURR OPIN STRUC BIOL, V20, P23, DOI 10.1016/j.sbi.2009.11.001; Granseth B, 2006, NEURON, V51, P773, DOI 10.1016/j.neuron.2006.08.029; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Guo JL, 2011, J BIOL CHEM, V286, P15317, DOI 10.1074/jbc.M110.209296; Gupta R, 2011, NAT METHODS, V8, P879, DOI [10.1038/NMETH.1697, 10.1038/nmeth.1697]; Hageman J, 2009, CELL STRESS CHAPERON, V14, P1, DOI 10.1007/s12192-008-0060-2; Holmberg CI, 2004, EMBO J, V23, P4307, DOI 10.1038/sj.emboj.7600426; Hong M, 1998, SCIENCE, V282, P1914, DOI 10.1126/science.282.5395.1914; Iba M, 2015, ACTA NEUROPATHOL, V130, P349, DOI 10.1007/s00401-015-1458-4; Jackson SJ, 2016, J NEUROSCI, V36, P762, DOI 10.1523/JNEUROSCI.3542-15.2016; Jicha GA, 1999, J NEUROSCI, V19, P7486, DOI 10.1523/JNEUROSCI.19-17-07486.1999; Jicha GA, 1997, J NEUROSCI RES, V48, P128, DOI 10.1002/(SICI)1097-4547(19970415)48:2<128::AID-JNR5>3.0.CO;2-E; Jinwal UK, 2010, J BIOL CHEM, V285, P16798, DOI 10.1074/jbc.M110.113753; Jinwal UK, 2010, J NEUROSCI, V30, P591, DOI 10.1523/JNEUROSCI.4815-09.2010; Karagoz GE, 2014, CELL, V156, P963, DOI 10.1016/j.cell.2014.01.037; Kaufman SK, 2016, NEURON, V92, P796, DOI 10.1016/j.neuron.2016.09.055; Klaips CL, 2018, J CELL BIOL, V217, P51, DOI 10.1083/jcb.201709072; Knowles TPJ, 2014, NAT REV MOL CELL BIO, V15, P384, DOI 10.1038/nrm3810; KOPKE E, 1993, J BIOL CHEM, V268, P24374; Kundra R, 2017, P NATL ACAD SCI USA, V114, pE5703, DOI 10.1073/pnas.1618417114; Labbadia J, 2015, MOL CELL, V59, P639, DOI 10.1016/j.molcel.2015.06.027; Labbadia J, 2015, ANNU REV BIOCHEM, V84, P435, DOI 10.1146/annurev-biochem-060614-033955; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; McDonald JW, 1998, NAT MED, V4, P291, DOI 10.1038/nm0398-291; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Mead E, 2016, J ALZHEIMERS DIS, V54, P1521, DOI 10.3233/JAD-150960; Minjarez B, 2013, J ALZHEIMERS DIS, V34, P239, DOI 10.3233/JAD-121480; Mok SA, 2018, NAT STRUCT MOL BIOL, V25, P384, DOI 10.1038/s41594-018-0057-1; Nacharaju P, 1999, FEBS LETT, V447, P195, DOI 10.1016/S0014-5793(99)00294-X; Olzscha H, 2011, CELL, V144, P67, DOI 10.1016/j.cell.2010.11.050; Park SH, 2013, CELL, V154, P134, DOI 10.1016/j.cell.2013.06.003; PARSELL DA, 1994, NATURE, V372, P475, DOI 10.1038/372475a0; Petrucelli L, 2004, HUM MOL GENET, V13, P703, DOI 10.1093/hmg/ddh083; Saheki Y, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005645; Sanders DW, 2014, NEURON, V82, P1271, DOI 10.1016/j.neuron.2014.04.047; Satyal SH, 2000, P NATL ACAD SCI USA, V97, P5750, DOI 10.1073/pnas.100107297; Schmidt T, 2002, ANN NEUROL, V51, P302, DOI 10.1002/ana.10101; SCHWEERS O, 1994, J BIOL CHEM, V269, P24290; Soto C, 2003, NAT REV NEUROSCI, V4, P49, DOI 10.1038/nrn1007; Spillantini MG, 2013, LANCET NEUROL, V12, P609, DOI 10.1016/S1474-4422(13)70090-5; Spires-Jones TL, 2009, TRENDS NEUROSCI, V32, P150, DOI 10.1016/j.tins.2008.11.007; Stenoien DL, 1999, HUM MOL GENET, V8, P731, DOI 10.1093/hmg/8.5.731; Takei K, 1996, J CELL BIOL, V133, P1237, DOI 10.1083/jcb.133.6.1237; Vingtdeux V, 2011, ACTA NEUROPATHOL, V121, P337, DOI 10.1007/s00401-010-0759-x; Vitale F, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0585-2; Voss K, 2012, BIOCHEMISTRY-US, V51, P888, DOI 10.1021/bi2018078; Wang Q, 2005, FASEB J, V19, P869, DOI 10.1096/fj.04-3210fje; Wang YP, 2016, NAT REV NEUROSCI, V17, P5, DOI 10.1038/nrn.2015.1; Watanabe S, 2014, NATURE, V515, P228, DOI 10.1038/nature13846; Weaver CL, 2000, NEUROBIOL AGING, V21, P719, DOI 10.1016/S0197-4580(00)00157-3; WITMAN GB, 1976, P NATL ACAD SCI USA, V73, P4070, DOI 10.1073/pnas.73.11.4070; Woerner AC, 2016, SCIENCE, V351, P173, DOI 10.1126/science.aad2033; Wolff S, 2014, CELL, V157, P52, DOI 10.1016/j.cell.2014.03.007; WOLOZIN BL, 1986, SCIENCE, V232, P648, DOI 10.1126/science.3083509; Wu JW, 2016, NAT NEUROSCI, V19, P1085, DOI 10.1038/nn.4328; Yu A, 2014, P NATL ACAD SCI USA, V111, pE1481, DOI 10.1073/pnas.1321811111; ZHANG JZ, 1994, CELL, V78, P751, DOI 10.1016/S0092-8674(94)90442-1	89	28	28	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2019	294	19					7917	7930		10.1074/jbc.RA119.007527	http://dx.doi.org/10.1074/jbc.RA119.007527			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IB3FL	30936201	hybrid, Green Published			2022-12-26	WOS:000470153300031
J	Harada, H; Hosoda, K; Moriya, H; Mieno, H; Ema, A; Ushiku, H; Washio, M; Nishizawa, N; Ishii, S; Yokota, K; Tanaka, Y; Kaida, T; Soeno, T; Kosaka, Y; Watanabe, M; Yamashita, K				Harada, Hiroki; Hosoda, Kei; Moriya, Hiromitsu; Mieno, Hiroaki; Ema, Akira; Ushiku, Hideki; Washio, Marie; Nishizawa, Nobuyuki; Ishii, Satoru; Yokota, Kazuko; Tanaka, Yoko; Kaida, Takeshi; Soeno, Takafumi; Kosaka, Yoshimasa; Watanabe, Masahiko; Yamashita, Keishi			Cancer-specific promoter DNA methylation of Cysteine dioxygenase type 1 (CDO1) gene as an important prognostic biomarker of gastric cancer	PLOS ONE			English	Article							TUMOR-SUPPRESSIVE ACTIVITY; ADJUVANT CHEMOTHERAPY; SURVIVAL; EXPRESSION; IMPACT; S-1; RECEPTOR; MARKERS; CELLS; TRIAL	Background There have been few available prognostic biomarkers in gastric cancer. We rigorously assessed the clinical relevance of promoter DNA methylation of Cysteine dioxygenase type 1 (CDO1) gene, a cancer-specific aberration, in human gastric cancer. Methods Quantitative CDO1 methylation value (TaqMeth V) was initially calculated in 138 gastric cancer patients operated in 2005, and its clinical significance was elucidated. As a subsequent expanded set, 154 gastric cancer patients with pathological stage (pStage) II/III with no postoperative therapy were validated between 2000 and 2010. Results (1) Median TaqMeth V of CDO1 gene methylation of gastric cancer was 25.6, ranging from 0 to 120.9. As pStage progressed, CDO1 TaqMeth V became higher (p < 0.0001). (2) The optimal cut-off value was determined to be 32.6; gastric cancer patients with high CDO1 gene methylation showed a significantly worse prognosis than those with low CDO1 gene methylation (p < 0.0001). (3) A multivariate cox proportional hazards model identified high CDO1 gene methylation (p = 0.033) as an independent prognostic factor. (4) The results were recapitulated in the expanded set in pStage III, where high CDO1 gene methylation group had a significantly worse prognosis than low CDO1 gene methylation group (p = 0.0065). Hematogenous metastasis was unique in pStage III with high CDO1 gene methylation (p = 0.0075). (5) Anchorage independent growth was reduced in several gastric cancer cell lines due to forced expression of the CDO1 gene, suggesting that abnormal CDO1 gene expression may represent distant metastatic ability. Conclusions Promoter DNA hypermethylation of CDO1 gene was rigorously validated as an important prognostic biomarker in primary gastric cancer with specific stage.	[Harada, Hiroki; Hosoda, Kei; Moriya, Hiromitsu; Mieno, Hiroaki; Ema, Akira; Ushiku, Hideki; Washio, Marie; Nishizawa, Nobuyuki; Ishii, Satoru; Yokota, Kazuko; Kaida, Takeshi; Soeno, Takafumi; Watanabe, Masahiko; Yamashita, Keishi] Kitasato Univ, Sch Med, Dept Surg, Minami Ku, Sagamihara, Kanagawa, Japan; [Tanaka, Yoko; Kosaka, Yoshimasa] Kitasato Univ, Sch Med, Dept Breast & Endocrine Surg, Minami Ku, Sagamihara, Kanagawa, Japan; [Yamashita, Keishi] Kitasato Univ, Sch Med, Div Adv Surg Oncol, Dept Res & Dev,Ctr New Med Frontiers,Minami Ku, Sagamihara, Kanagawa, Japan	Kitasato University; Kitasato University; Kitasato University	Yamashita, K (corresponding author), Kitasato Univ, Sch Med, Dept Surg, Minami Ku, Sagamihara, Kanagawa, Japan.; Yamashita, K (corresponding author), Kitasato Univ, Sch Med, Div Adv Surg Oncol, Dept Res & Dev,Ctr New Med Frontiers,Minami Ku, Sagamihara, Kanagawa, Japan.	keishi23@med.kitasato-u.ac.jp	Hosoda, Kei/W-8009-2019	Hosoda, Kei/0000-0002-9787-2889; Harada, Hiroki/0000-0002-1983-4692				Brait M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044951; Cheong JH, 2018, LANCET ONCOL, V19, P629, DOI 10.1016/S1470-2045(18)30108-6; Deckers IAG, 2015, CLIN CANCER RES, V21, P3492, DOI 10.1158/1078-0432.CCR-14-2049; Feber A, 2015, CLIN CANCER RES, V21, P1196, DOI 10.1158/1078-0432.CCR-14-1656; Ichikawa W, 2017, GASTRIC CANCER, V20, P263, DOI 10.1007/s10120-016-0600-x; Igarashi K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188178; Ishimoto T, 2011, CANCER CELL, V19, P387, DOI 10.1016/j.ccr.2011.01.038; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Jeschke J, 2013, CLIN CANCER RES, V19, P3201, DOI 10.1158/1078-0432.CCR-12-3751; Kalmar A, 2015, PATHOL ONCOL RES, V21, P1149, DOI 10.1007/s12253-015-9945-4; Katoh H, 2012, NEOPLASIA, V14, P559, DOI 10.1593/neo.12330; Kim MS, 2008, ONCOGENE, V27, P3624, DOI 10.1038/sj.onc.1211021; Kim MS, 2006, CANCER RES, V66, P3409, DOI 10.1158/0008-5472.CAN-05-1608; Kojima K, 2017, DIS ESOPHAGUS, V30, DOI 10.1093/dote/dow001; Kojima K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194785; Meller S, 2016, EPIGENETICS-US, V11, P871, DOI 10.1080/15592294.2016.1241931; Minatani N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0144862; Noh SH, 2014, LANCET ONCOL, V15, P1389, DOI 10.1016/S1470-2045(14)70473-5; Ooki A, 2010, ONCOGENE, V29, P3263, DOI 10.1038/onc.2010.76; Ooki A, 2017, CLIN CANCER RES, V23, P7141, DOI 10.1158/1078-0432.CCR-17-1222; Ooki A, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-122; Prabhu A, 2014, CANCER RES, V74, P787, DOI 10.1158/0008-5472.CAN-13-1423; Rohrmann S, 2015, INT J CANCER, V136, pE423, DOI 10.1002/ijc.29236; Sakuramoto S, 2007, NEW ENGL J MED, V357, P1810, DOI 10.1056/NEJMoa072252; Sasako M, 2015, GASTRIC CANCER, V18, P538, DOI 10.1007/s10120-014-0413-8; Sasako M, 2011, J CLIN ONCOL, V29, P4387, DOI 10.1200/JCO.2011.36.5908; Terashima M, 2012, CLIN CANCER RES, V18, P5992, DOI 10.1158/1078-0432.CCR-12-1318; Ushiku H, 2017, GASTRIC CANCER, V20, P784, DOI 10.1007/s10120-017-0697-6; Ushiku Hideki, 2017, Dis Esophagus, V30, P1, DOI 10.1111/dote.12496; Vedeld HM, 2015, INT J CANCER, V136, P844, DOI 10.1002/ijc.29039; von Ahlfen S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001261; Yamashita K, 2006, CANCER RES, V66, P3921, DOI 10.1158/0008-5472.CAN-05-1511; Yamashita K, 2002, CANCER CELL, V2, P485, DOI 10.1016/S1535-6108(02)00215-5; Yamashita K, 2018, CANCER SCI, V109, P3695, DOI 10.1111/cas.13812; Yamashita K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113546	35	13	13	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2019	14	4							e0214872	10.1371/journal.pone.0214872	http://dx.doi.org/10.1371/journal.pone.0214872			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR1CY	30934021	Green Published, Green Submitted, gold			2022-12-26	WOS:000462867000043
J	Bierings, RAJM; Gordijn, MCM; Jansonius, NM				Bierings, Ronald A. J. M.; Gordijn, Marijke C. M.; Jansonius, Nomdo M.			Chronotyping glaucoma patients with the Munich Chrono Type Questionnaire: A case-control study	PLOS ONE			English	Article							RETINAL GANGLION-CELLS; QUALITY-OF-LIFE; PUPILLARY LIGHT REFLEX; HUMAN CIRCADIAN SYSTEM; VISUAL-FIELD LOSS; MORNINGNESS-EVENINGNESS; SLEEP; MELATONIN; RHYTHMS; PERIOD	Purpose The circadian clock is entrained to light by the intrinsically photosensitive retinal ganglion cells. Loss of these cells in glaucoma, an eye disease with loss of retinal ganglion cells as its key feature, might thus result in a change in chronotype. We aimed to compare the chrono-type between glaucoma patients and healthy subjects. Methods We sent the Munich Chrono Type Questionnaire to 221 glaucoma patients (response rate 81%); controls (primary control group) were primarily their spouses. After exclusion of shift workers and participants who woke-up due to an alarm clock on days off, 159 glaucoma patients (88 early, 21 moderate, 23 severe) and 163 controls remained. We calculated chronotype as the mid-sleep on days off, corrected for workweek accumulated sleep debt (MSFsc). We compared means and variances between groups using Welch's tests and F-tests, respectively. A secondary control group was recruited from participants in a citizen-science project (n = 17073) who completed an online questionnaire. A resampling method was applied to enable an age- and gender- matched comparison with the glaucoma patients. Results Compared to the primary control group, glaucoma did not affect the mean MSFsc (controls 3:47; early, moderate, and severe glaucoma 3:40, 3:45, and 3:33, respectively [P = 0.62]). Chrono type variability seemed to increase with increasing disease severity (severe glaucoma versus controls: P = 0.023). The mean MSFsc of the secondary control group was 3:50 (95% confidence interval 3:48 to 3:52); significantly later than that of the glaucoma patients (3:40; P = 0.024). Mean MSFsc did not differ significantly between the control groups (P = 0.42). Conclusions No clear changes were found in the chronotype as determined by sleep phase in patients with glaucoma, especially not in early and moderate glaucoma. In severe glaucoma, chrono-type variability seems to increase, possibly alongside a small advancement.	[Bierings, Ronald A. J. M.; Jansonius, Nomdo M.] Univ Groningen, Univ Med Ctr Groningen, Dept Ophthalmol, Groningen, Netherlands; [Gordijn, Marijke C. M.] Univ Groningen, Groningen Inst Evolutionary Life Sci, Chronobiol Unit, Groningen, Netherlands; [Gordijn, Marijke C. M.] Chrono Work BV, Groningen, Netherlands	University of Groningen; University of Groningen	Jansonius, NM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Ophthalmol, Groningen, Netherlands.	n.m.jansonius@umcg.nl	Gordijn, Marijke CM/I-5132-2013	Jansonius, Nomdo/0000-0002-6495-6568; Gordijn, Marijke/0000-0001-9521-8085	Stichting Nederlands Oogheelkundig Onderzoek, Nijmegen, the Netherlands	Stichting Nederlands Oogheelkundig Onderzoek, Nijmegen, the Netherlands(Netherlands Government)	This study was supported by Stichting Nederlands Oogheelkundig Onderzoek, Nijmegen, the Netherlands. This funder provided support in the form of part of the salary for author RB. MG is founder/owner of Chrono@WorkBV.MG receives financial support in the form of salary from Chrono@WorkBV.The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Agorastos A, 2013, J NEUROPSYCH CLIN N, V25, P205, DOI 10.1176/appi.neuropsych.12020030; Altimus CM, 2008, P NATL ACAD SCI USA, V105, P19998, DOI 10.1073/pnas.0808312105; ASCHOFF J, 1965, SCIENCE, V148, P1427, DOI 10.1126/science.148.3676.1427; Ayaki M, 2016, SCI REP-UK, V6, DOI 10.1038/srep25699; Berson DM, 2003, TRENDS NEUROSCI, V26, P314, DOI 10.1016/S0166-2236(03)00130-9; Bierings RAJM, 2018, ACTA OPHTHALMOL, V96, P288, DOI 10.1111/aos.13695; CAMPBELL SS, 1993, SLEEP, V16, P638; Chen SK, 2011, NATURE, V476, P92, DOI 10.1038/nature10206; CHIQUET C, 2004, INVEST OPHTH VIS S2, V45, P3164; Cooper HM, 2008, ARVO ANN M; Czeisler CA, 1999, SCIENCE, V284, P2177, DOI 10.1126/science.284.5423.2177; Dacey DM, 2005, NATURE, V433, P749, DOI 10.1038/nature03387; de Zavalia N, 2011, J NEUROCHEM, V117, P904, DOI 10.1111/j.1471-4159.2011.07260.x; Drouyer E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003931; Duffy JF, 2005, J BIOL RHYTHM, V20, P326, DOI 10.1177/0748730405277983; Duffy JF, 2001, BEHAV NEUROSCI, V115, P895, DOI 10.1037//0735-7044.115.4.895; Emens JS, 2009, CHRONOBIOL INT, V26, P474, DOI 10.1080/07420520902821077; Feigl B, 2011, INVEST OPHTH VIS SCI, V52, P4362, DOI 10.1167/iovs.10-7069; Lanzani MF, 2012, CHRONOBIOL INT, V29, P911, DOI 10.3109/07420528.2012.691146; Freeman EE, 2008, OPHTHALMOLOGY, V115, P233, DOI 10.1016/j.ophtha.2007.04.050; Gamlin PDR, 2007, VISION RES, V47, P946, DOI 10.1016/j.visres.2006.12.015; Gimenez Marina, 2016, Biology-Basel, V5, DOI 10.3390/biology5010012; Gimenez MC, 2014, CHRONOBIOL INT, V31, P690, DOI 10.3109/07420528.2014.893242; Gracitelli CPB, 2015, OPHTHALMOLOGY, V122, P1139, DOI 10.1016/j.ophtha.2015.02.030; Gracitelli CPB, 2014, INVEST OPHTH VIS SCI, V55, P7997, DOI 10.1167/iovs.14-15146; Guler AD, 2008, NATURE, V453, P102, DOI 10.1038/nature06829; Gutierrez P, 1997, ARCH OPHTHALMOL-CHIC, V115, P777, DOI 10.1001/archopht.1997.01100150779014; Hatori M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002451; Heeg GP, 2005, ACTA OPHTHALMOL SCAN, V83, P46, DOI 10.1111/j.1600-0420.2005.00423.x; Hiddinga AE, 1997, J SLEEP RES, V6, P156, DOI 10.1046/j.1365-2869.1997.00047.x; Hur YM, 1998, PERS INDIV DIFFER, V25, P917, DOI 10.1016/S0191-8869(98)00089-0; Hut RA, 2008, J BIOL RHYTHM, V23, P37, DOI 10.1177/0748730407311851; Jakobs TC, 2005, J CELL BIOL, V171, P313, DOI 10.1083/jcb.200506099; Jean-Louis Girardin, 2008, J Circadian Rhythms, V6, P1, DOI 10.1186/1740-3391-6-1; Kankipati L, 2011, INVEST OPHTH VIS SCI, V52, P2287, DOI 10.1167/iovs.10-6023; Kantermann T, 2015, J BIOL RHYTHM, V30, P449, DOI 10.1177/0748730415597520; KATZ J, 1991, ARCH OPHTHALMOL-CHIC, V109, P1684, DOI 10.1001/archopht.1991.01080120068028; Kawasaki A, 2007, J NEURO-OPHTHALMOL, V27, P195, DOI 10.1097/WNO.0b013e31814b1df9; Kulkarni KM, 2012, AM J OPHTHALMOL, V154, P445, DOI 10.1016/j.ajo.2012.03.030; Lazar AS, 2013, J SLEEP RES, V22, P155, DOI 10.1111/jsr.12001; Lee JA, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005704; LeGates TA, 2014, NAT REV NEUROSCI, V15, P443, DOI 10.1038/nrn3743; Li RS, 2006, INVEST OPHTH VIS SCI, V47, P2951, DOI 10.1167/iovs.05-1295; Lucas RJ, 2003, SCIENCE, V299, P245, DOI 10.1126/science.1077293; Middleton B, 1996, J SLEEP RES, V5, P69, DOI 10.1046/j.1365-2869.1996.d01-67.x; Mills RP, 2001, J GLAUCOMA, V10, P192, DOI 10.1097/00061198-200106000-00008; Mongrain V, 2004, J BIOL RHYTHM, V19, P248, DOI 10.1177/0748730404264365; Montolio FGJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151006; Najjar RP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085837; Obara EA, 2016, INVEST OPHTH VIS SCI, V57, P4661, DOI 10.1167/iovs.16-19997; Perez-Rico C, 2010, EXP EYE RES, V91, P578, DOI 10.1016/j.exer.2010.07.012; Peters D, 2015, ACTA OPHTHALMOL, V93, P745, DOI 10.1111/aos.12839; Randler C, 2011, INT J PSYCHOL, V46, P91, DOI 10.1080/00207594.2010.518237; Roenneberg T, 2004, CURR BIOL, V14, pR1038, DOI 10.1016/j.cub.2004.11.039; Roenneberg T, 2003, J BIOL RHYTHM, V18, P80, DOI 10.1177/0748730402239679; van Gestel A, 2010, EYE, V24, P1759, DOI 10.1038/eye.2010.133; Wang HZ, 2008, CHINESE MED J-PEKING, V121, P1015, DOI 10.1097/00029330-200806010-00010; Wang HZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062841; Wee R, 2004, OPHTHALMOLOGY, V111, P297, DOI 10.1016/j.ophtha.2003.05.014; Woelders T, 2017, J BIOL RHYTHM, V32, P274, DOI 10.1177/0748730417696787; Wolfs RCW, 2000, INVEST OPHTH VIS SCI, V41, P3309; Zaidi FH, 2007, CURR BIOL, V17, P2122, DOI 10.1016/j.cub.2007.11.034; Zavada A, 2005, CHRONOBIOL INT, V22, P267, DOI 10.1081/CBI-200053536; Zele AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017860	64	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214046	10.1371/journal.pone.0214046	http://dx.doi.org/10.1371/journal.pone.0214046			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921336	gold, Green Submitted, Green Published			2022-12-26	WOS:000462594000032
J	Kim, CR; Jeon, YJ; Jeong, T				Kim, Chung Reen; Jeon, Young-Jee; Jeong, Taeheum			Risk factors associated with low handgrip strength in the older Korean population	PLOS ONE			English	Article							GRIP STRENGTH; SKELETAL-MUSCLE; ALCOHOL-CONSUMPTION; ELDERLY SUBJECTS; SARCOPENIA; EXERCISE; HEALTH; WOMEN; MASS; MEN	Hand grip strength (HGS) is a means to assess health status and physical abilities indirectly. Various factors are known to be related to HGS, but data on the factors influencing HGS in the Korean population are lacking. Recently, the Korea National Health and Nutrition Examination Survey (KNHANES) conducted by the Korea Centers for Disease Control and Prevention surveyed social status, nutrition, physical status, and other medical history including HGS. This study aimed to investigate the social, physical, and individual health behavior factors associated with low HGS in the elderly Korean population. This population-based cross-sectional study was based on the 2014-2016 KNHANES. Community-dwelling Korean elderly (aged >= 65 years) were included in this survey. The relationship between HGS and socioeconomic status, nutrition, exercise, and other clinical characteristics were analyzed using multivariate logistic regression. The sample size was 3,634 (weighted: 6,006,406). Elderly men and women with low HGS showed lower body mass index, reduced physical activity and lower education level. Among elderly men, excessive carbohydrate and inadequate protein intake were observed in the low HGS group. Meanwhile, older women who did not drink alcohol and had diabetes were at higher risk of low HGS. In conclusion, various physical, nutritional, socioeconomic and comorbidity statuses were seemed to be the factors associated with HGS in Korean elderly. However, further cohort or case-control study will be necessary to determine the causal relationship of those factors and HGS.	[Kim, Chung Reen] Univ Ulsan, Coll Med, Dept Phys Med & Rehabil, Ulsan Univ Hosp, Ulsan, South Korea; [Jeon, Young-Jee; Jeong, Taeheum] Univ Ulsan, Coll Med, Dept Family Med, Ulsan Univ Hosp, Ulsan, South Korea	University of Ulsan; Ulsan University Hospital; University of Ulsan; Ulsan University Hospital	Jeon, YJ (corresponding author), Univ Ulsan, Coll Med, Dept Family Med, Ulsan Univ Hosp, Ulsan, South Korea.	yjjeon@uuh.ulsan.kr		Jeong, Tae Heum/0000-0001-7994-6242; Jeon, Young-Jee/0000-0002-8070-2453				Al-Obaidi S, 2014, J PHYS ACT HEALTH, V11, P1025, DOI 10.1123/jpah.2011-0357; Artaza-Artabe I, 2016, MATURITAS, V93, P89, DOI 10.1016/j.maturitas.2016.04.009; Baek Y, 2015, PUBLIC HLTH WKLY REP, V8, P75; Bohannon Richard W, 2008, J Geriatr Phys Ther, V31, P3; Braveman P, 2011, ANNU REV PUBL HEALTH, V32, P381, DOI 10.1146/annurev-publhealth-031210-101218; Cesari M, 2009, J GERONTOL A-BIOL, V64, P377, DOI 10.1093/gerona/gln031; Cetinus E, 2005, DIABETES RES CLIN PR, V70, P278, DOI 10.1016/j.diabres.2005.03.028; Chang SS, 2000, KOREAN J SOCIOLOGY, V34, P671; Chen LK, 2016, J AM MED DIR ASSOC, V17, DOI 10.1016/j.jamda.2016.05.016; Chen LK, 2014, J AM MED DIR ASSOC, V15, P95, DOI 10.1016/j.jamda.2013.11.025; Choi E., 2017, HLTH WELFARE POLICY, V246, P22; Cooper R, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4467; Coups EJ, 2005, PREV MED, V40, P702, DOI 10.1016/j.ypmed.2004.09.011; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; de Lima TR, 2017, J BODYW MOV THER, V21, P401, DOI 10.1016/j.jbmt.2016.08.017; Denison HJ, 2015, CLIN INTERV AGING, V10, P859, DOI 10.2147/CIA.S55842; Giglio Bruna M, 2018, Clin Nutr Res, V7, P112, DOI 10.7762/cnr.2018.7.2.112; Hairi FM, 2010, J EPIDEMIOL COMMUN H, V64, P829, DOI 10.1136/jech.2009.088476; Hutton Brian, 2002, J Can Dent Assoc, V68, P182; Janssen I, 2004, AM J EPIDEMIOL, V159, P413, DOI 10.1093/aje/kwh058; Kawamoto R, 2018, INT J GERONTOL, V12, P294, DOI 10.1016/j.ijge.2018.03.005; Kerstetter JE, 2003, J NUTR, V133, p855S, DOI 10.1093/jn/133.3.855S; Kim CR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195485; Kim HK, 2012, J AM GERIATR SOC, V60, P16, DOI 10.1111/j.1532-5415.2011.03776.x; Kuh D, 2005, J GERONTOL A-BIOL, V60, P224, DOI 10.1093/gerona/60.2.224; Kwon YJ, 2017, MENOPAUSE, V24, P1022, DOI 10.1097/GME.0000000000000879; Lee MJ, 1998, KOREAN J SOCIOLOGY, V32, P63; Lee Sun Jae, 2014, INT J SOCIAL SCI HUM, V4, P242; Lenardt MH, 2014, REV ESC ENFERM USP, V48, P1004, DOI 10.1590/S0080-623420140000700007; Lenardt MH, 2016, ESCOLA A NERY, V20; Leong DP, 2015, LANCET, V386, P266, DOI 10.1016/S0140-6736(14)62000-6; Ministry of Health and Welfare (KR), 2016, KOR NUTR SOC DIET RE; Ministry of Health and Welfare of Korea Korea Centers for Disease Control and Prevention., 2019, 2017 KOR HLTH STAT; Miyazaki Ryo, 2016, J Clin Med Res, V8, P848; Murakami M, 2015, GERIATR GERONTOL INT, V15, P1007, DOI 10.1111/ggi.12399; Nofuji Y, 2016, J AM MED DIR ASSOC, V17, DOI 10.1016/j.jamda.2015.11.003; Quan S, 2013, EPIDEMIOL HEALTH, V35, DOI 10.4178/epih/e2013001; Robert S, 1996, J AGING HEALTH, V8, P359, DOI 10.1177/089826439600800304; Roberts HC, 2011, AGE AGEING, V40, P423, DOI 10.1093/ageing/afr051; Rural Development Administration National Academy of Agricultural Science, 2011, FOOD COMP TABL; Lino VTS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166373; Sayer AA, 2006, AM J EPIDEMIOL, V164, P665, DOI 10.1093/aje/kwj255; Shafiee G, 2017, J DIABETES METAB DIS, V16, DOI 10.1186/s40200-017-0302-x; Solerte SB, 2008, AM J CARDIOL, V101, p69E, DOI 10.1016/j.amjcard.2008.03.004; Stenholm S, 2012, J AM GERIATR SOC, V60, P77, DOI 10.1111/j.1532-5415.2011.03779.x; Takahashi M, 2018, GERIATR GERONTOL INT, V18, P915, DOI 10.1111/ggi.13279; Tanimoto Y, 2012, ARCH GERONTOL GERIAT, V55, pE9, DOI 10.1016/j.archger.2012.06.015; Verreijen AM, 2015, AM J CLIN NUTR, V101, P279, DOI 10.3945/ajcn.114.090290; Yamada M, 2015, J AM MED DIR ASSOC, V16, P654, DOI 10.1016/j.jamda.2015.02.017	49	26	27	5	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214612	10.1371/journal.pone.0214612	http://dx.doi.org/10.1371/journal.pone.0214612			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HQ7IR	30921399	gold, Green Submitted, Green Published			2022-12-26	WOS:000462594000098
J	Pichitpunpong, C; Thongkorn, S; Kanlayaprasit, S; Yuwattana, W; Plaingam, W; Sangsuthum, S; Aizat, WM; Baharum, SN; Tencomnao, T; Hu, VW; Sarachana, T				Pichitpunpong, Chatravee; Thongkorn, Surangrat; Kanlayaprasit, Songphon; Yuwattana, Wasana; Plaingam, Waluga; Sangsuthum, Siriporn; Aizat, Wan Mohd; Baharum, Syarul Nataqain; Tencomnao, Tewin; Hu, Valerie Wailin; Sarachana, Tewarit			Phenotypic subgrouping and multi-omics analyses reveal reduced diazepam-binding inhibitor (DBI) protein levels in autism spectrum disorder with severe language impairment	PLOS ONE			English	Article							GENE-EXPRESSION; PERSONALIZED TREATMENT; PROTEOMIC ANALYSIS; OXIDATIVE STRESS; FETUIN-A; CHILDREN; BRAIN; IDENTIFICATION; DYSFUNCTION; BIOMARKERS	Background The mechanisms underlying autism spectrum disorder (ASD) remain unclear, and clinical biomarkers are not yet available for ASD. Differences in dysregulated proteins in ASD have shown little reproducibility, which is partly due to ASD heterogeneity. Recent studies have demonstrated that subgrouping ASD cases based on clinical phenotypes is useful for identifying candidate genes that are dysregulated in ASD subgroups. However, this strategy has not been employed in proteome profiling analyses to identify ASD biomarker proteins for specific subgroups. Methods We therefore conducted a cluster analysis of the Autism Diagnostic Interview-Revised (ADI-R) scores from 85 individuals with ASD to predict subgroups and subsequently identified dysregulated genes by reanalyzing the transcriptome profiles of individuals with ASD and unaffected individuals. Proteome profiling of lymphoblastoid cell lines from these individuals was performed via 2D-gel electrophoresis, and then mass spectrometry. Disrupted proteins were identified and compared to the dysregulated transcripts and reported dysregulated proteins from previous proteome studies. Biological functions were predicted using the 16 Ingenuity Pathway Analysis (IPA) program. Selected proteins were also analyzed by Western blotting. Results The cluster analysis of ADI-R data revealed four ASD subgroups, including ASD with severe language impairment, and transcriptome profiling identified dysregulated genes in each subgroup. Screening via proteome analysis revealed 82 altered proteins in the ASD subgroup with severe language impairment. Eighteen of these proteins were further identified by nano-LC-MS/MS. Among these proteins, fourteen were predicted by IPA to be associated with neurological functions and inflammation. Among these proteins, diazepam-binding inhibitor (DBI) protein was confirmed by Western blot analysis to be expressed at significantly decreased levels in the ASD subgroup with severe language impairment, and the DBI expression levels were correlated with the scores of several ADI-R items. Conclusions By subgrouping individuals with ASD based on clinical phenotypes, and then performing an integrated transcriptome-proteome analysis, we identified DBI as a novel candidate protein for ASD with severe language impairment. The mechanisms of this protein and its potential use as an ASD biomarker warrant further study.	[Pichitpunpong, Chatravee] Chulalongkorn Univ, Fac Allied Hlth Sci, Dept Clin Chem, MSc Program Clin Biochem & Mol Med, Bangkok, Thailand; [Thongkorn, Surangrat; Kanlayaprasit, Songphon] Chulalongkorn Univ, Fac Allied Hlth Sci, Dept Clin Chem, PhD Program Clin Biochem & Mol Med, Bangkok, Thailand; [Yuwattana, Wasana] Chulalongkorn Univ, Fac Allied Hlth Sci, BSc Program Med Technol, Bangkok, Thailand; [Plaingam, Waluga] Rangsit Univ, Coll Oriental Med, Pathum Thani, Thailand; [Sangsuthum, Siriporn] Chulalongkorn Univ, Fac Allied Hlth Sci, Dept Clin Chem, Bangkok, Thailand; [Aizat, Wan Mohd; Baharum, Syarul Nataqain] Univ Kebangsaan Malaysia, Inst Syst Biol INBIOSIS, Bangi, Selangor, Malaysia; [Tencomnao, Tewin; Sarachana, Tewarit] Chulalongkorn Univ, Fac Allied Hlth Sci, Dept Clin Chem, Age Related Inflammat & Degenerat Res Unit, Bangkok, Thailand; [Hu, Valerie Wailin] George Washington Univ, Sch Med & Hlth Sci, Dept Biochem & Mol Med, Washington, DC USA	Chulalongkorn University; Chulalongkorn University; Chulalongkorn University; Rangsit University; Chulalongkorn University; Universiti Kebangsaan Malaysia; Chulalongkorn University; George Washington University	Sarachana, T (corresponding author), Chulalongkorn Univ, Fac Allied Hlth Sci, Dept Clin Chem, Age Related Inflammat & Degenerat Res Unit, Bangkok, Thailand.	tewarit.sa@chula.ac.th	Baharum, Syarul Nataqain/H-1022-2016; Aizat, Wan Mohd/P-5204-2016	Baharum, Syarul Nataqain/0000-0001-8376-1224; Aizat, Wan Mohd/0000-0001-8115-9774; Tencomnao, Tewin/0000-0003-4177-2165	Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University [CU59-004-HR]; 90th Anniversary Chulalongkorn University Fund (Ratchadaphiseksomphot Endowment Fund) [GCUGR1125601057M 533, GCUGR1125601056M 53-2]; Graduate School, Chulalongkorn University; Faculty of Allied Health Sciences, Chulalongkorn University; Thailand Research Fund [PHD/0029/2561]; 100th Anniversary Chulalongkorn University Fund; NIEHS [R21 ES023061, R21 ES028124]; National Institute of Mental Health [1U24 MH081810]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES028124] Funding Source: NIH RePORTER	Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University(Chulalongkorn University); 90th Anniversary Chulalongkorn University Fund (Ratchadaphiseksomphot Endowment Fund); Graduate School, Chulalongkorn University(Chulalongkorn University); Faculty of Allied Health Sciences, Chulalongkorn University(Chulalongkorn University); Thailand Research Fund(Thailand Research Fund (TRF)); 100th Anniversary Chulalongkorn University Fund; NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by the Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University (CU59-004-HR) granted to TS. CP, ST, and SK are graduate students in the M.Sc. and Ph.D. Programs in Clinical Biochemistry and Molecular Medicine, Department of Clinical Chemistry, Faculty of Allied Health Sciences, Chulalongkorn University. CP and ST were financially supported by the 90th Anniversary Chulalongkorn University Fund (Ratchadaphiseksomphot Endowment Fund: CP GCUGR1125601057M 53-3; ST GCUGR1125601056M 53-2) and received additional financial support from a "Scholarship from the Graduate School Chulalongkorn University to commemorate the 72nd anniversary of His Majesty King Bhumibala Aduladeja". CP was also financially supported by the Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University (CU59-004-HR) as a research assistant. ST received "The Overseas Research Experience Scholarship for Graduate Students" from the Graduate School and Faculty of Allied Health Sciences, Chulalongkorn University, and also received the Royal Golden Jubilee Ph.D. Programme Scholarship (Grant No. PHD/0029/2561) by Thailand Research Fund. SK was supported by The 100th Anniversary Chulalongkorn University Fund for Doctoral Scholarship. VWH is supported by NIEHS grants R21 ES023061 and R21 ES028124.; We thank Ms. Kanlayaphat Hussem, Mr. Phanuwat Chanasikunphithaya, Ms. Sineemas Naokeaw, Ms. Thanida Tohthong, and Mr. Tiradej Asavachamnan for their help regarding LCL culture. We also thank Ms. Chayanin Tangsuwannasri and Mr. Thanit Saeliw for their help with image analysis. This research was supported by the Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University (CU59-004-HR) granted to TS. CP, ST, and SK are graduate students in the M.Sc. and Ph.D. Programs in Clinical Biochemistry and Molecular Medicine, Department of Clinical Chemistry, Faculty of Allied Health Sciences, Chulalongkorn University. CP and ST were financially supported by the 90th Anniversary Chulalongkorn University Fund (Ratchadaphiseksomphot Endowment Fund: CP GCUGR1125601057M 533; ST GCUGR1125601056M 53-2) and received additional financial support from a "Scholarship from the Graduate School Chulalongkorn University to commemorate the 72nd anniversary of His Majesty King Bhumibala Aduladeja". CP was also financially supported by the Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University (CU59-004-HR) as a research assistant. ST received "The Overseas Research Experience Scholarship for Graduate Students" from the Graduate School and Faculty of Allied Health Sciences, Chulalongkorn University, and also received the Royal Golden Jubilee Ph.D. Programme Scholarship (Grant No. PHD/0029/2561) by the Thailand Research Fund. SK was supported by the 100th Anniversary Chulalongkorn University Fund for Doctoral Scholarship. VWH is supported by NIEHS grants R21 ES023061 and R21 ES028124. We also gratefully acknowledge the resources provided by the Autism Genetic Resource Exchange (AGRE) Consortium. and the participating AGRE families. The Autism Genetic Resource Exchange is a program of Autism Speaks and is supported in part by grant 1U24 MH081810 from the National Institute of Mental Health to ClaraMLajonchere (PI). *The AGRE Consortium: Dan Geschwind, MD, PhD, UCLA, Los Angeles, CA; Maja Bucan, PhD, University of Pennsylvania, Philadelphia, PA; W Ted Brown, MD, PhD, FACMG, NYS Institute for Basic Research in Developmental Disabilities, Long Island, NY; RitaMCantor, PhD, UCLA School of Medicine, Los Angeles, CA; John N Constantino, MD, Washington University School of Medicine, St Louis, MO; T Conrad Gilliam, PhD, University of Chicago, Chicago, IL; Martha Herbert, MD, PhD, Harvard Medical School, Boston, MA; Clara Lajonchere, PhD, Cure Autism Now, Los Angeles, CA; David H Ledbetter, PhD, Emory University, Atlanta, GA; Christa Lese-Martin, PhD, Emory University, Atlanta, GA; Janet Miller, JD, PhD, Cure Autism Now, Los Angeles, CA; Stanley F Nelson, MD, UCLA School of Medicine, Los Angeles, CA; Gerard D Schellenberg, PhD, University of Washington, Seattle, WA; Carol A Samango-Sprouse, EdD, George Washington University, Washington, DC; Sarah Spence, MD, PhD, UCLA, Los Angeles, CA; Matthew State, MD, PhD, Yale University, New Haven, CT; and Rudolph E Tanzi, PhD, Massachusetts General Hospital, Boston, MA.	Abu-Elneel K, 2008, NEUROGENETICS, V9, P153, DOI 10.1007/s10048-008-0133-5; Akbay EA, 2014, GENE DEV, V28, P479, DOI 10.1101/gad.231233.113; ALHO H, 1988, P NATL ACAD SCI USA, V85, P7018, DOI 10.1073/pnas.85.18.7018; Allen-Brady K, 2009, MOL PSYCHIATR, V14, P590, DOI 10.1038/mp.2008.14; Alter MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016715; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU; Baio J, 2018, MMWR SURVEILL SUMM, V67, P1, DOI 10.15585/mmwr.ss6706a1; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Bolte S, 2018, CELLULAR MOL LIFE SC, P1; Brambilla P, 2003, BRAIN RES BULL, V61, P557, DOI 10.1016/j.brainresbull.2003.06.001; Breuss M, 2012, CELL REP, V2, P1554, DOI 10.1016/j.celrep.2012.11.017; Broek JAC, 2014, MOL AUTISM, V5, DOI 10.1186/2040-2392-5-41; Castagnola M, 2008, J PROTEOME RES, V7, P5327, DOI 10.1021/pr8004088; Chen R, 2011, PEDIATR RES, V69, p63R, DOI 10.1203/PDR.0b013e318212c2b3; Corbett BA, 2007, MOL PSYCHIATR, V12, P292, DOI 10.1038/sj.mp.4001943; Cortelazzo A, 2016, PROTEOM CLIN APPL, V10, P1103, DOI 10.1002/prca.201500076; DiCicco-Bloom E, 2006, J NEUROSCI, V26, P6897, DOI 10.1523/JNEUROSCI.1712-06.2006; Elsas J, 2013, DEV NEUROBIOL, V73, P354, DOI 10.1002/dneu.22064; Feng CY, 2017, CLIN PROTEOM, V14, DOI 10.1186/s12014-017-9138-0; Geschwind DH, 2001, AM J HUM GENET, V69, P463, DOI 10.1086/321292; Gregg JP, 2008, GENOMICS, V91, P22, DOI 10.1016/j.ygeno.2007.09.003; GUIDOTTI A, 1983, P NATL ACAD SCI-BIOL, V80, P3531, DOI 10.1073/pnas.80.11.3531; Hollis F, 2017, CURR OPIN NEUROBIOL, V45, P178, DOI 10.1016/j.conb.2017.05.018; Hu V. W., 2013, N AM J MED SCI BOSTO, V6; Hu VW, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-118; Hu VW, 2015, MOL AUTISM, V6, DOI 10.1186/2040-2392-6-7; Hu VW, 2013, FUTUR NEUROL, V8, P29, DOI 10.2217/FNL.12.83; Hu VW, 2012, DIS MARKERS, V33, P277, DOI [10.1155/2012/835728, 10.3233/DMA-2012-0916]; Hu VW, 2011, PHARMACOGENOMICS, V12, P1235, DOI [10.2217/pgs.11.94, 10.2217/PGS.11.94]; Hu VW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019067; Hu VW, 2009, AUTISM RES, V2, P78, DOI 10.1002/aur.73; Hu VW, 2009, AUTISM RES, V2, P67, DOI 10.1002/aur.72; Hu VW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005775; Kong SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049475; Krakowiak P, 2015, BIOL PSYCHIAT; Li QR, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00120; Manzi B, 2008, J CHILD NEUROL, V23, P307, DOI 10.1177/0883073807308698; Moosa A, 2018, HORM BEHAV, V101, P13, DOI 10.1016/j.yhbeh.2017.10.003; Mori K, 2011, RECENT PATENTS ENDOC, V5, P124, DOI 10.2174/187221411799015372; Nguyen A, 2010, FASEB J, V24, P3036, DOI 10.1096/fj.10-154484; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Plaingam Waluga, 2017, J Tradit Complement Med, V7, P538, DOI 10.1016/j.jtcme.2017.01.002; Pramparo T, 2015, JAMA PSYCHIAT, V72, P386, DOI 10.1001/jamapsychiatry.2014.3008; Ramsey JM, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-27; Rebhan M, 1997, TRENDS GENET, V13, P163, DOI 10.1016/S0168-9525(97)01103-7; Rossignol DA, 2012, MOL PSYCHIATR, V17, P290, DOI 10.1038/mp.2010.136; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saeliw T, 2018, MOL AUTISM, V9, DOI 10.1186/s13229-018-0213-9; Sarachana T, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-39; Sarachana T, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-14; Sarachana T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017116; Sarachana T, 2010, GENOME MED, V2, DOI 10.1186/gm144; Shen C, 2011, J MOL NEUROSCI, V43, P443, DOI 10.1007/s12031-010-9463-5; Shen L, 2017, PROTEOMICS CLIN APPL; Stanfield AC, 2008, EUR PSYCHIAT, V23, P289, DOI 10.1016/j.eurpsy.2007.05.006; Szoko N, 2017, AUTISM RES, V10, P1460, DOI 10.1002/aur.1803; Talebizadeh Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067569; Talebizadeh Z, 2008, AUTISM RES, V1, P240, DOI 10.1002/aur.33; Tangsuwansri C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201071; Thongkorn S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39386-w; Ujjainwala AL, 2017, GENES BRAIN BEHAV; van Tilborg E, 2018, GLIA, V66, P78, DOI 10.1002/glia.23216; Vorstman JAS, 2017, NAT REV GENET, V18, DOI 10.1038/nrg.2017.4; Wetie AGN, 2015, J CELL MOL MED, V19, P2664, DOI 10.1111/jcmm.12658; Wetie AGN, 2015, AUTISM RES, V8, P338, DOI 10.1002/aur.1450; Wetie AGN, 2014, ELECTROPHORESIS, V35, P2046, DOI 10.1002/elps.201300370; Xu LM, 2012, NUCLEIC ACIDS RES, V40, pD1016, DOI 10.1093/nar/gkr1145; Yang L., 2016, J PROTEOM BIOINFORM, VS14, P004, DOI [10.4172/jpb.S14-004, DOI 10.4172/JPB.S14-004]; Zerbo O, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-113; Zoroglu SS, 2004, EUR ARCH PSY CLIN N, V254, P143, DOI 10.1007/s00406-004-0456-7	70	14	14	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214198	10.1371/journal.pone.0214198	http://dx.doi.org/10.1371/journal.pone.0214198			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HQ7IR	30921354	Green Submitted, Green Published, gold			2022-12-26	WOS:000462594000039
J	Sun, JC; Cheng, S; Ma, J; Xiong, KW; Su, M; Hu, WD				Sun, Jicheng; Cheng, Shan; Ma, Jin; Xiong, Kaiwen; Su, Miao; Hu, Wendong			Assessment of the static upright balance index and brain blood oxygen levels as parameters to evaluate pilot workload	PLOS ONE			English	Article							FATIGUE ASSESSMENT; POSTURAL CONTROL; PERFORMANCE; ACTIVATION	Objective To investigate the potential for static upright balance function and brain-blood oxygen parameters to evaluate pilot workload. Methods Phase 1: The NASA Task Load Index (NASA-TLX) was used to compare the workloads of real flights with flight simulator simulated flight tasks in 15 pilots (Cohort 1). Phase 2: To determine the effects of workload, 50 cadets were divided equally into simulated flight task load (experimental) and control groups (Cohort 2). The experimental group underwent 2 h of simulated flight tasks, while the control group rested for 2 h. Their static upright balance function was evaluated using balance index-1 (BI-1), before and after the tasks, with balance system posturography equipment and cerebral blood oxygen parameters monitored with near infrared spectroscopy (NIRS) in real time. Sternberg dual-task and reaction time tests were performed in the experimental and control groups before and after the simulated flight tasks. Results (Phase1) There was a significant correlation between the workload caused by real flight and simulated flight tasks (P<0.01), indicating that NASA-TLX scales were also a tool for measuring workloads of the stimulated flight tasks. (Phase 2) For the simulated flight task experiments, the NASA-TLX total scores were significantly different between the two groups (P<0.001) and (pre-to-post) changes of the BI-1 index were greater in the experimental group than in controls (P<0.001). The cerebral blood oxygen saturation levels (rsO(2)) (P<0.01) and Delta Hb reductions (P<0.05) were significantly higher in the experimental, compared to the control group, during the simulated flight task. In contrast to the control group the error rates (P = 0.002) and accuracy (P<0.001) changed significantly in the experimental group after the simulated flight tasks. Conclusions The simulated flight task model could simulate the real flight task load and static balance and NIRS were useful for evaluating pilots' workload/fatigue.	[Sun, Jicheng; Cheng, Shan; Ma, Jin; Xiong, Kaiwen; Su, Miao; Hu, Wendong] Fourth Mil Med Univ, Deparment Aerosp Med, Xian, Shaanxi, Peoples R China	Air Force Military Medical University	Ma, J; Hu, WD (corresponding author), Fourth Mil Med Univ, Deparment Aerosp Med, Xian, Shaanxi, Peoples R China.	doatea@fmmu.com; huwend@fmmu.edu.cn			National Natural Science Foundation of China [U1733101]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was supported by the National Natural Science Foundation of China (Grant No. U1733101 to JM). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong WJ, 2004, MED SCI SPORTS EX S1, V35; Bennett SA, 2012, AVIAT FOCUS J AERONA, V3; Borghini G, 2014, NEUROSCI BIOBEHAV R, V44, P58, DOI 10.1016/j.neubiorev.2012.10.003; CAANL, 2008, CIV AV AUTH TRANSP W; Caldwell JA, 2009, AVIAT SPACE ENVIR MD, V80, P29, DOI 10.3357/ASEM.2435.2009; Caron RR, 2013, J BIOMECH, V46, P70, DOI 10.1016/j.jbiomech.2012.10.004; Chen S, 2015, PROG MOD BIOMED, V15, P1735; Chen S, 2018, GAIT POSTURE, V63, P97, DOI 10.1016/j.gaitpost.2018.04.037; Cheng S, 2014, PROG MOD BIOMED, V52, P1110; Cheng S, 2018, AEROSP MED HUM PERF, V89, P961, DOI 10.3357/AMHP.5128.2018; Dey A, 2010, ERGONOMICS, V53, P848, DOI 10.1080/00140139.2010.489960; Eoh HJ, 2005, INT J IND ERGONOM, V35, P307, DOI 10.1016/j.ergon.2004.09.006; Estevan I, 2018, MOTOR CONTROL, V22, P425, DOI 10.1123/mc.2017-0063; Fallgatter AJ, 1998, EUR ARCH PSY CLIN N, V248, P245, DOI 10.1007/s004060050045; Gateau T, 2018, FRONT HUM NEUROSCI, V12, DOI 10.3389/fnhum.2018.00187; Gergelyfi M, 2015, FRONT BEHAV NEUROSCI, V9, DOI [10.3389/fnbeh.2015,00176, 10.3389/fnbeh.2015.00176]; HAGBERG M, 1981, J APPL PHYSIOL, V51, P1; Han J, 2014, CHIN J BIOMED ENG; Han QY, 2014, MED PHYS, V41, DOI 10.1118/1.4896113; Hart S.G., 2006, P HUM FACT ERG SOC A, DOI [10.1177/154193120605000909, DOI 10.1177/154193120605000909]; Herath P, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00483; Huang X, 2013, CHIN NURS RES, V15, P2749; Hursh SR, 2004, AVIAT SPACE ENVIR MD, V75, pA44; Jagannath M, 2014, APPL ERGON, V45, P1140, DOI 10.1016/j.apergo.2014.02.001; Jung CM, 2011, J SLEEP RES, V20, P348, DOI 10.1111/j.1365-2869.2010.00877.x; Katerndahl D A, 1993, Fam Pract Res J, V13, P81; Keeley DW, 2014, J SPORT MED PHYS FIT, V54, P118; Keramidas ME, 2018, EUR J APPL PHYSIOL, V118, P1373, DOI 10.1007/s00421-018-3869-0; Li ZY, 2009, EUR J APPL PHYSIOL, V107, P281, DOI 10.1007/s00421-009-1122-6; LIGHT A I, 1989, Current Surgery, V46, P29; Longo A, 2018, EXP BRAIN RES, V236, P1611, DOI 10.1007/s00221-018-5241-3; Ma J, 2009, J INT MED RES, V37, P1311, DOI 10.1177/147323000903700506; Marcora SM, 2009, J APPL PHYSIOL, V106, P857, DOI 10.1152/japplphysiol.91324.2008; Meeusen R, 2006, SPORTS MED, V36, P881, DOI 10.2165/00007256-200636100-00006; Michielsen HJ, 2003, J PSYCHOSOM RES, V54, P345, DOI 10.1016/S0022-3999(02)00392-6; Monjo F, 2017, HUM MOVEMENT SCI, V54, P1, DOI 10.1016/j.humov.2017.03.001; Morad Y, 2007, AVIAT SPACE ENVIR MD, V78, P859; Ochi G, 2018, NEUROIMAGE, V171, P75, DOI 10.1016/j.neuroimage.2017.12.091; Reid G.B., 1988, ADV PSYCHOL, V52, p185?218, DOI DOI 10.1016/S0166-4115(08)62387-0; Song G, 2015, CHIN J REHABIL THEOR; Takagi S, 2013, ADV EXP MED BIOL, V789, P157, DOI 10.1007/978-1-4614-7411-1_22; Tan W, 2014, 2014 2 INT C SYST IN; Vanicek N, 2013, JOVE-J VIS EXP, DOI 10.3791/51077; VILLRINGER A, 1993, NEUROSCI LETT, V154, P101, DOI 10.1016/0304-3940(93)90181-J; Wang B, 2012, SPACE MED MED ENG, V25; Watson DW, 2001, 2001 PEOPL CONTR 2 I; Williamson A, 2011, ACCIDENT ANAL PREV, V43, P498, DOI 10.1016/j.aap.2009.11.011; Xie X, 2010, SHANDONG MED J, V50, P97	48	1	2	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214277	10.1371/journal.pone.0214277	http://dx.doi.org/10.1371/journal.pone.0214277			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HQ7IR	30921375	gold, Green Published, Green Submitted			2022-12-26	WOS:000462594000048
J	Kaundal, A; Sandhu, D; Duenas, M; Ferreira, JFS				Kaundal, Amita; Sandhu, Devinder; Duenas, Marco; Ferreira, Jorge F. S.			Expression of the high-affinity K+ transporter 1 (PpHKT1) gene from almond rootstock 'Nemaguard' improved salt tolerance of transgenic Arabidopsis	PLOS ONE			English	Article							SALINITY TOLERANCE; HKT TRANSPORTERS; PLASMA-MEMBRANE; NA+ EXCLUSION; STRESS; SODIUM; POTASSIUM; PLANTS	Soil salinity affects plant growth and development, which directly impact yield. Plants deploy many mechanisms to cope with, or mitigate, salt stress. One of such mechanism is to control movement of ions from root to shoot by regulating the loading of Na+ in the transpiration stream. The high-affinity K+ transporter 1 (HKT1) is known to play a role in the removal of Na+ from the xylem and bring it back to the root. As almond is a salt-sensitive crop, the rootstock plays an important role in successful almond cultivation in salt-affected regions. We currently lack knowledge on the molecular mechanisms involved in salt tolerance of almond rootstocks. In this study, we complemented the Arabidopsis athktl knockout mutant with HKT1 ortholog (PpHKT1) from the almond rootstock 'Nemaguard'. Arabidopsis transgenic lines that were generated in athktl background with the constitutive promoter (PpHKT1OE2.2) and the native promoter (PpHKT1NP6) were subjected to different salt treatments. Both transgenic lines survived salt concentrations up to 120 mM NaCl, however, the mutant athktl died after 18 days under 120 mM NaCl. At 90 mM NaCl, the dry weight of athktl decreased significantly compared to the transgenic lines. Both transgenic lines showed significantly longer lateral roots compared to the athktl mutant at 80 mM NaCl treatment. The transgenic lines, PpHKT1OE2.2 and PpHKTNP6 had lower electrolyte leakage and higher relative water content compared to athktl, suggesting that transgenic plants coped well with increased salt concentration by maintaining the integrity of the membranes. The expression analyses showed that PpHKT1 was induced in PpHKT1OE2.2 and PpHKTNP6 lines under salt treatment, which confirmed that both over-expression and native expression of PpHKT1 in the Arabidopsis mutant can complement salt tolerance function.	[Kaundal, Amita; Sandhu, Devinder; Duenas, Marco; Ferreira, Jorge F. S.] USDA ARS, US Salin Lab, 4500 Glenwood Dr, Riverside, CA 92501 USA; [Kaundal, Amita] Utah State Univ, Coll Agr & Appl Sci, Logan, UT 84322 USA; [Duenas, Marco] Univ Calif Riverside, Coll Nat & Agr Sci, Riverside, CA 92521 USA	United States Department of Agriculture (USDA); Utah System of Higher Education; Utah State University; University of California System; University of California Riverside	Sandhu, D (corresponding author), USDA ARS, US Salin Lab, 4500 Glenwood Dr, Riverside, CA 92501 USA.	devinder.sandhu@ars.usda.gov	Kaundal, Amita/AAG-3326-2021; Ferreira, Jorge/AAJ-7178-2020	Kaundal, Amita/0000-0002-9154-1173; Sandhu, Devinder/0000-0003-4193-3408	Almond Board of California [18.Hort26.Sandhu-COC]	Almond Board of California	This study was supported by a grant funded to Devinder Sandhu by Almond Board of California (18.Hort26.Sandhu-COC) (https://www.almonds.com/). The funder did not play any role in design, data collection and analysis, decision to publish or preparation of the manuscript. There was no additional funding received for this study.	Almeida P, 2013, INT J MOL SCI, V14, P20359, DOI 10.3390/ijms141020359; Berthomieu Pierre, 2003, EMBO (European Molecular Biology Organization) Journal, V22, P2004, DOI 10.1093/emboj/cdg207; BLUM A, 1981, CROP SCI, V21, P43, DOI 10.2135/cropsci1981.0011183X002100010013x; Butcher K, 2016, AGRON J, V108, P2189, DOI 10.2134/agronj2016.06.0368; Byrt CS, 2007, PLANT PHYSIOL, V143, P1918, DOI 10.1104/pp.106.093476; (CDFA) California Department of Food and Agriculture, 2017, CAL AGR STAT REV 201; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Corrales A.R., 2014, BIOPROTOC, V4, pe1216, DOI 10.21769/BioProtoc.1216; Cotsaftis O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039865; Dexter ST, 1932, PLANT PHYSIOL, V7, P63, DOI 10.1104/pp.7.1.63; Duan LN, 2013, PLANT CELL, V25, P324, DOI 10.1105/tpc.112.107227; Fulton J, 2019, ECOL INDIC, V96, P711, DOI 10.1016/j.ecolind.2017.12.063; Gupta B, 2014, INT J GENOMICS, V2014, DOI 10.1155/2014/701596; He F, 2018, PLANT PHYSIOL, V177, P775, DOI 10.1104/pp.17.01559; Horie T, 2007, EMBO J, V26, P3003, DOI 10.1038/sj.emboj.7601732; Houimli S. Ibn Maaouia, 2008, Advances in Horticultural Science, V22, P205; Huang SB, 2006, PLANT PHYSIOL, V142, P1718, DOI 10.1104/pp.106.088864; Jha D, 2010, PLANT CELL ENVIRON, V33, P793, DOI 10.1111/j.1365-3040.2009.02105.x; Julkowska MM, 2017, PLANT CELL, V29, P3198, DOI 10.1105/tpc.16.00680; Khan M. M., 2013, International Proceedings of Chemical, Biological and Environmental Engineering (IPCBEE), V55, P28; Kotagiri D., 2017, BIOMED PHARMACOL J, V10, P1639, DOI DOI 10.13005/bpj/1275; LEOPOLD AC, 1981, PLANT PHYSIOL, V68, P1222, DOI 10.1104/pp.68.6.1222; Liang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083056; Maathuis FJM, 2014, J EXP BOT, V65, P849, DOI 10.1093/jxb/ert326; Marin E, 2010, PLANT CELL, V22, P1104, DOI 10.1105/tpc.109.072553; Mass E.V., 1977, ASCE J IRRIGATION DR, V103, P115; Moller IS, 2009, PLANT CELL, V21, P2163, DOI 10.1105/tpc.108.064568; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; NASSERY H, 1979, NEW PHYTOL, V83, P23, DOI 10.1111/j.1469-8137.1979.tb00722.x; PALTA JP, 1977, PLANT PHYSIOL, V60, P393, DOI 10.1104/pp.60.3.393; Platten JD, 2006, TRENDS PLANT SCI, V11, P372, DOI 10.1016/j.tplants.2006.06.001; Plett D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012571; Qiu QS, 2003, PLANT PHYSIOL, V132, P1041, DOI 10.1104/pp.102.010421; Ren ZH, 2005, NAT GENET, V37, P1141, DOI 10.1038/ng1643; Saeed R., 2014, FUUAST J BIOL, V4, P221; Sahito ZA, 2017, BMC PLANT BIOL, V17, DOI 10.1186/s12870-017-1161-9; Sandhu D, 2017, SCI REP-UK, V7, DOI 10.1038/srep42958; Shi HZ, 2003, NAT BIOTECHNOL, V21, P81, DOI 10.1038/nbt766; Tester M, 2003, ANN BOT-LONDON, V91, P503, DOI 10.1093/aob/mcg058; Wang M, 2013, INT J MOL SCI, V14, P7370, DOI 10.3390/ijms14047370; Wang R, 2015, PLANT PHYSIOL, V168, P1076, DOI 10.1104/pp.15.00298; Welle PD, 2017, ENVIRON RES LETT, V12, DOI 10.1088/1748-9326/aa848e; Yeo A, 1998, J EXP BOT, V49, P915, DOI 10.1093/jexbot/49.323.915; Yoon EK, 2010, NUCLEIC ACIDS RES, V38, P1382, DOI 10.1093/nar/gkp1128; Zhang XX, 2019, ENVIRON EXP BOT, V157, P79, DOI 10.1016/j.envexpbot.2018.09.022; Zhao YK, 2011, NEW PHYTOL, V189, P1122, DOI 10.1111/j.1469-8137.2010.03545.x; Zhu JK, 2001, TRENDS PLANT SCI, V6, P66, DOI 10.1016/S1360-1385(00)01838-0; Zrig A, 2016, S AFR J BOT, V102, P50, DOI 10.1016/j.sajb.2015.09.001	48	8	8	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2019	14	3							e0214473	10.1371/journal.pone.0214473	http://dx.doi.org/10.1371/journal.pone.0214473			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ3IW	30913281	Green Published, gold			2022-12-26	WOS:000462305600066
J	Kumar, L; Brice, J; Toberer, L; Klein-Seetharaman, J; Knauss, D; Sarkar, SK				Kumar, Lokender; Brice, John; Toberer, Linda; Klein-Seetharaman, Judith; Knauss, Daniel; Sarkar, Susanta K.			Antimicrobial biopolymer formation from sodium alginate and algae extract using aminoglycosides	PLOS ONE			English	Article							CELL-CULTURE; HYDROGELS; POLYMERS; MATRIX; NANOPARTICLES; ANTIBIOTICS; INFECTIONS; CHITOSAN; FILMS	Antimicrobial biopolymers provide a biodegradable, sustainable, safe, and cheap approach to drug delivery and wound dressing to control bacterial infection and improve wound healing respectively. Here, we report a one-step method of making antimicrobial alginate polymer from sodium alginate and aqueous extract of Wakame using antibiotic aminoglycosides. Thin layer chromatography of commercially available sodium alginate and Wakame extract showed similar oligosaccharide profiles. Screening of six aminoglycosides showed that kanamycin disulfate and neomycin sulfate produces the highest amount of biopolymer; however, kanamycin disulfate produces the most malleable and form fitting biopolymer. Image texture analysis of biopolymers showed similar quantification parameters for all the six aminoglycosides. Weight of alginate polymer as a function of aminoglycoside concentration follows a growth model of prion protein, consistent with the aggregating nature of both processes. Slow release of antibiotics and the resulting zone of inhibition against E. coli DH5 alpha were observed by agar well diffusion assay. Inexpensive method of production and slow release of antibiotics will enable diverse applications of antimicrobial alginate biopolymer reported in this paper.	[Kumar, Lokender; Brice, John; Toberer, Linda; Sarkar, Susanta K.] Colorado Sch Mines, Dept Phys, Golden, CO 80401 USA; [Klein-Seetharaman, Judith; Knauss, Daniel] Colorado Sch Mines, Dept Chem, Golden, CO 80401 USA	Colorado School of Mines; Colorado School of Mines	Sarkar, SK (corresponding author), Colorado Sch Mines, Dept Phys, Golden, CO 80401 USA.	ssarkar@mines.edu	Kumar, Lokender/AAY-6862-2020	Kumar, Lokender/0000-0002-0692-0137	Colorado School of Mines Foundation [494001]; Slater Fund from the Colorado School of Mines Foundation	Colorado School of Mines Foundation; Slater Fund from the Colorado School of Mines Foundation	This work was supported by Grant# 494001, Colorado School of Mines Foundation, www.mines.edu, to SKS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge Slater Fund from the Colorado School of Mines Foundation for the research.	Akagi T, 2005, J CONTROL RELEASE, V108, P226, DOI 10.1016/j.jconrel.2005.08.003; Andersen Therese, 2015, Microarrays (Basel), V4, P133, DOI 10.3390/microarrays4020133; Arzate-Vazquez I, 2012, CARBOHYD POLYM, V87, P289, DOI 10.1016/j.carbpol.2011.07.044; Bielecka ZF, 2017, BIOL REV, V92, P1505, DOI 10.1111/brv.12293; Boateng JS, 2008, J PHARM SCI-US, V97, P2892, DOI 10.1002/jps.21210; Bodenberger N, 2018, BIOMACROMOLECULES, V19, P2472, DOI 10.1021/acs.biomac.8b00089; Bonev B, 2008, J ANTIMICROB CHEMOTH, V61, P1295, DOI 10.1093/jac/dkn090; Boontheekul T, 2005, BIOMATERIALS, V26, P2455, DOI 10.1016/j.biomaterials.2004.06.044; Cabrera J, 2005, TEXTURE ANAL; Calo E, 2015, EUR POLYM J, V65, P252, DOI 10.1016/j.eurpolymj.2014.11.024; Carmona-Ribeiro AM, 2014, INT J MOL SCI, V15, P18040, DOI 10.3390/ijms151018040; Carmona-Ribeiro AM, 2013, INT J MOL SCI, V14, P9906, DOI 10.3390/ijms14059906; Cha DS, 2004, CRIT REV FOOD SCI, V44, P223, DOI 10.1080/10408690490464276; Chen WS, 2003, OPT ENG, V42, P2452, DOI 10.1117/1.1585061; Choi JS, 2016, DRUG DELIV, V23, P2806, DOI 10.3109/10717544.2015.1089958; Cibor U, 2017, PHARM RES-DORDR, V34, P2075, DOI 10.1007/s11095-017-2212-5; Craig WA, 2011, CRIT CARE CLIN, V27, P107, DOI 10.1016/j.ccc.2010.11.006; Deacon J, 2015, J CONTROL RELEASE, V198, P55, DOI 10.1016/j.jconrel.2014.11.022; Gombotz WR, 1998, ADV DRUG DELIVER REV, V31, P267, DOI 10.1016/S0169-409X(97)00124-5; Gross RA, 2002, SCIENCE, V297, P803, DOI 10.1126/science.297.5582.803; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Hermann T, 2007, CELL MOL LIFE SCI, V64, P1841, DOI 10.1007/s00018-007-7034-x; Hernandez-Montelongo J, 2016, CARBOHYD POLYM, V136, P1, DOI 10.1016/j.carbpol.2015.08.076; Hill R. G., 2005, BIOMATERIALS ARTIFIC, P97, DOI DOI 10.1533/9781845690861.2.97; Hinderer S, 2016, ADV DRUG DELIVER REV, V97, P260, DOI 10.1016/j.addr.2015.11.019; Jose D, 2009, P NATL ACAD SCI; Karampatakis T, 2018, EUR J CLIN MICROBIOL, V37, P1211, DOI 10.1007/s10096-018-3244-4; Karperien A, 1999, FRACLAC; Kashuba ADM, 1999, ANTIMICROB AGENTS CH, V43, P623, DOI 10.1128/AAC.43.3.623; Kenawy ER, 2007, BIOMACROMOLECULES, V8, P1359, DOI 10.1021/bm061150q; KLOTZ IM, 1971, BIOCHEMISTRY-US, V10, P3065, DOI 10.1021/bi00792a013; Kondaveeti S, 2018, CARBOHYD POLYM, V186, P159, DOI 10.1016/j.carbpol.2018.01.044; Kondaveeti S, 2017, CARBOHYD POLYM, V165, P285, DOI 10.1016/j.carbpol.2017.02.066; Kulengowski B, 2019, CLIN MICROBIOL INFEC, V25, P92, DOI 10.1016/j.cmi.2018.04.008; LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529; Larobina D, 2013, SOFT MATTER, V9, P10005, DOI 10.1039/c3sm52006d; Lee KY, 2012, PROG POLYM SCI, V37, P106, DOI 10.1016/j.progpolymsci.2011.06.003; Lee YR, 2018, EUR J CLIN MICROBIOL, V37, P1411, DOI 10.1007/s10096-018-3260-4; Liu Y, 2017, INT J BIOL MACROMOL, V98, P550, DOI 10.1016/j.ijbiomac.2017.01.121; Maamar E, 2018, INT J ANTIMICROB AG, V52, P910, DOI 10.1016/j.ijantimicag.2018.04.008; Myers JA, 2013, BMC BIOPHYS, V6, DOI 10.1186/2046-1682-6-4; Nicodemus GD, 2008, TISSUE ENG PT B-REV, V14, P149, DOI 10.1089/ten.teb.2007.0332; Nischal PM, 2014, NATL MED J INDIA, V27, P241; Obradovic B, 2012, J MATER SCI-MATER M, V23, P99, DOI 10.1007/s10856-011-4522-1; Poschel T, 2003, BIOPHYS J, V85, P3460, DOI 10.1016/S0006-3495(03)74767-5; Prayle A, 2010, THORAX, V65, P654, DOI 10.1136/thx.2009.131532; Qiao SP, 2016, ACTA BIOMATER, V37, P83, DOI 10.1016/j.actbio.2016.04.032; Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0; Ruedinger F, 2015, APPL MICROBIOL BIOT, V99, P623, DOI 10.1007/s00253-014-6253-y; Sankar MU, 2013, P NATL ACAD SCI USA, V110, P8459, DOI 10.1073/pnas.1220222110; Santos MRE, 2016, MATERIALS, V9, DOI 10.3390/ma9070599; Shahid-ul-Islam, 2013, IND ENG CHEM RES, V52, P5245, DOI 10.1021/ie303627x; Shapiro L, 1997, BIOMATERIALS, V18, P583, DOI 10.1016/S0142-9612(96)00181-0; Tibbitt MW, 2009, BIOTECHNOL BIOENG, V103, P655, DOI 10.1002/bit.22361; Veiga AS, 2013, BIOPOLYMERS, V100, P637, DOI 10.1002/bip.22412; Voisin M, 2005, P NATL ACAD SCI USA, V102, P5432, DOI 10.1073/pnas.0501754102; Walker RF, 1995, DICTA 95 3 C DIG IM; Wang MP, 2016, MICROBIOLOGYOPEN, V5, P1038, DOI 10.1002/mbo3.387; Weiswald LB, 2015, NEOPLASIA, V17, P1, DOI 10.1016/j.neo.2014.12.004; Wu HG, 2018, EUR REV MED PHARMACO, V22, P1782, DOI 10.26355/eurrev_201803_14597; Yadav P, 2015, J CLIN DIAGN RES, V9, pZE21, DOI 10.7860/JCDR/2015/13907.6565; Yang XM, 2013, TISSUE ENG PT A, V19, P669, DOI [10.1089/ten.TEA.2012.0333, 10.1089/ten.tea.2012.0333]	62	15	15	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2019	14	3							e0214411	10.1371/journal.pone.0214411	http://dx.doi.org/10.1371/journal.pone.0214411			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ3IW	30913239	Green Published, Green Submitted, gold			2022-12-26	WOS:000462305600056
J	Leitholf, AM; Fretz, CE; Mahanke, R; Santangelo, Z; Senko, JM				Leitholf, Andrew M.; Fretz, Chrystal E.; Mahanke, Raymond; Santangelo, Zachary; Senko, John M.			An integrated microbiological and electrochemical approach to determine distributions of Fe metabolism in acid mine drainage-induced "iron mound" sediments	PLOS ONE			English	Article							SP-NOV.; ELECTRON-TRANSFER; MICROBIAL COMMUNITIES; OXIDIZING BACTERIA; GEN. NOV.; REDOX; WATER; PH; FE(III); DIVERSITY	Fe(III)-rich deposits referred to as "iron mounds" develop when Fe(II)-rich acid mine drainage (AMD) emerges at the terrestrial surface, and aeration of the fluids induces oxidation of Fe(II), with subsequent precipitation of Fe(III) phases. As Fe(III) phases accumulate in these systems, O-2 gradients may develop in the sediments and influence the distributions and extents of aerobic and anaerobic microbiological Fe metabolism, and in turn the solubility of Fe. To determine how intrusion of O-2 into iron mound sediments influences microbial community composition and Fe metabolism, we incubated samples of these sediments in a column format. O-2 was only supplied through the top of the columns, and microbiological, geochemical, and electrochemical changes at discrete depths were determined with time. Despite the development of dramatic gradients in dissolved Fe(II) concentrations, indicating Fe(II) oxidation in shallower portions and Fe(III) reduction in the deeper portions, microbial communities varied little with depth, suggesting the metabolic versatility of organisms in the sediments with respect to Fe metabolism. Additionally, the availability of O-2 in shallow portions of the sediments influenced Fe metabolism in deeper, O-2-free sediments. Total potential (E-H + self-potential) measurements at discrete depths in the columns indicated that Fe transformations and electron transfer processes were occurring through the sediments and could explain the impact of O-2 on Fe metabolism past where it penetrates into the sediments. This work shows that O-2 availability (or lack of it) minimally influences microbial communities, but influences microbial activities beyond its penetration depth in AMD-derived Fe (III) rich sediments. Our results indicate that O-2 can modulate Fe redox state and solubility in larger volumes of iron mound sediments than only those directly exposed to O-2.	[Leitholf, Andrew M.; Fretz, Chrystal E.; Santangelo, Zachary; Senko, John M.] Univ Akron, Dept Geosci, Akron, OH 44325 USA; [Mahanke, Raymond; Senko, John M.] Univ Akron, Dept Biol, Akron, OH 44325 USA; [Senko, John M.] Univ Akron, Integrated Biosci Program, Akron, OH 44325 USA	University System of Ohio; University of Akron; University System of Ohio; University of Akron; University System of Ohio; University of Akron	Senko, JM (corresponding author), Univ Akron, Dept Geosci, Akron, OH 44325 USA.; Senko, JM (corresponding author), Univ Akron, Dept Biol, Akron, OH 44325 USA.; Senko, JM (corresponding author), Univ Akron, Integrated Biosci Program, Akron, OH 44325 USA.	senko@uakron.edu		Senko, John/0000-0001-5854-0497	National Science Foundation EAR Geobiology and Low Temperature Geochemistry Program [0851847]	National Science Foundation EAR Geobiology and Low Temperature Geochemistry Program	This work was supported by National Science Foundation EAR Geobiology and Low Temperature Geochemistry Program award number 0851847. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by National Science Foundation EAR Geobiology and Low Temperature Geochemistry Program award number 0851847. We thank John Burwick for assistance with DO and pH profiling, Hae Nim Cho for assistance with column sampling and analyses, and Kimberly Landreth and Nicholas Wander for assistance with DNA extraction from sediments. We thank John Wilson and Northeast Oklahoma A & M College for granting us access to the Mushroom Farm for sediment collection. We thank the anonymous reviewers of this manuscript for their constructive comments on the manuscript. RM performed this work while a student at the Akron Public Schools' National Inventors Hall of Fame High School.	Akob DM, 2014, APPL ENVIRON MICROB, V80, P5086, DOI 10.1128/AEM.01296-14; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amaral-Zettler LA, 2011, ISME J, V5, P42, DOI 10.1038/ismej.2010.101; Bowman KS, 2010, INT J SYST EVOL MICR, V60, P358, DOI 10.1099/ijs.0.013169-0; Brantner JS, 2014, ENVIRON SCI TECHNOL, V48, P8556, DOI 10.1021/es502261u; Brantner JS, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00215; Breuker A, 2009, ADV MAT RES, V71-73, P47, DOI 10.4028/www.scientific.net/AMR.71-73.47; Brito EMS, 2014, EXTREMOPHILES, V18, P385, DOI 10.1007/s00792-013-0624-7; Brown JF, 2011, APPL ENVIRON MICROB, V77, P545, DOI 10.1128/AEM.01550-10; Burwick JE, 2017, CHEM GEOL, V457, P107, DOI 10.1016/j.chemgeo.2017.03.023; Byrne JM, 2015, SCIENCE, V347, P1473, DOI 10.1126/science.aaa4834; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Cavaletti L, 2006, APPL ENVIRON MICROB, V72, P4360, DOI 10.1128/AEM.00132-06; Chen Q, 2015, BIORESOURCE TECHNOL, V183, P25, DOI 10.1016/j.biortech.2015.02.022; Cutright TJ, 2012, SOIL SEDIMENT CONTAM, V21, P970, DOI 10.1080/15320383.2012.712070; Diaby N, 2007, ENVIRON MICROBIOL, V9, P298, DOI 10.1111/j.1462-2920.2006.01138.x; Druschel GK, 2008, GEOCHIM COSMOCHIM AC, V72, P3358, DOI 10.1016/j.gca.2008.04.035; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Emerson D, 2010, ANNU REV MICROBIOL, V64, P561, DOI 10.1146/annurev.micro.112408.134208; Fabisch M, 2016, GEOBIOLOGY, V14, P68, DOI 10.1111/gbi.12162; Falteisek L, 2016, MICROB ECOL, V72, P163, DOI 10.1007/s00248-016-0760-6; Falteisek L, 2012, EXTREMOPHILES, V16, P911, DOI 10.1007/s00792-012-0488-2; Garcia-Moyano A, 2012, FEMS MICROBIOL ECOL, V81, P303, DOI 10.1111/j.1574-6941.2012.01346.x; Giam X, 2018, NAT SUSTAIN, V1, P176, DOI 10.1038/s41893-018-0048-6; Gorski CA, 2012, ENVIRON SCI TECHNOL, V46, P12399, DOI 10.1021/es204649a; Gouin M, 2013, GEM INT J GEOMATHEMA, V4, P27, DOI 10.1007/s13137-012-0044-3; Grettenberger CL, 2017, APPL ENVIRON MICROB, V83, DOI [10.1128/AEM.00015-17, 10.1128/aem.00015-17]; Guo X, 2013, APPL ENVIRON MICROB, V79, P2019, DOI 10.1128/AEM.03400-12; Hamilton SM, 2004, GEOCHEM-EXPLOR ENV A, V4, P33, DOI 10.1144/1467-7873/03-020; Hamilton SM, 2004, GEOCHEM-EXPLOR ENV A, V4, P5; Hansel CM, 2015, ISME J, V9, P2400, DOI 10.1038/ismej.2015.50; Hedrich S, 2011, MICROBIOL-SGM, V157, P1551, DOI 10.1099/mic.0.045344-0; Itoh T, 2011, INT J SYST EVOL MICR, V61, P1281, DOI 10.1099/ijs.0.023044-0; Menes RJ, 2016, EXTREMOPHILES, V20, P19, DOI 10.1007/s00792-015-0793-7; Jiang SH, 2013, ENVIRON SCI TECHNOL, V47, P10078, DOI 10.1021/es402412c; Johnson DB, 2009, ADV MICROB PHYSIOL, V54, P201, DOI 10.1016/S0065-2911(08)00003-9; JOHNSON DB, 1991, APPL ENVIRON MICROB, V57, P207, DOI 10.1128/AEM.57.1.207-211.1991; Johnson DB, 2005, SCI TOTAL ENVIRON, V338, P3, DOI 10.1016/j.scitotenv.2004.09.002; JOHNSON DB, 1995, J MICROBIOL METH, V23, P205, DOI 10.1016/0167-7012(95)00015-D; Kato S, 2013, MICROBES ENVIRON, V28, P141, DOI 10.1264/jsme2.ME12161; Kato S, 2012, P NATL ACAD SCI USA, V109, P10042, DOI 10.1073/pnas.1117592109; Kato S, 2010, ENVIRON MICROBIOL, V12, P3114, DOI 10.1111/j.1462-2920.2010.02284.x; Kay CM, 2014, RES MICROBIOL, V165, P705, DOI 10.1016/j.resmic.2014.07.007; King CE, 2014, INT J SYST EVOL MICR, V64, P1244, DOI 10.1099/ijs.0.059675-0; Kusel K, 1999, APPL ENVIRON MICROB, V65, P3633; Kusel K, 2002, ENVIRON MICROBIOL, V4, P414, DOI 10.1046/j.1462-2920.2002.00314.x; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; Lu SP, 2013, APPL ENVIRON MICROB, V79, P4272, DOI 10.1128/AEM.00467-13; Lu SP, 2010, APPL ENVIRON MICROB, V76, P8174, DOI 10.1128/AEM.01931-10; Mendez MO, 2008, APPL ENVIRON MICROB, V74, P3899, DOI 10.1128/AEM.02883-07; Mills JV, 2016, EARTH PLANET SC LETT, V453, P23, DOI 10.1016/j.epsl.2016.08.001; Mori JF, 2016, MICROBIOL-SGM, V162, P62, DOI 10.1099/mic.0.000205; Naudet V, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022735; Naudet V, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018096; Neumann A, 2013, ENVIRON SCI TECHNOL, V47, P6969, DOI 10.1021/es304744v; Nicomrat D, 2006, MICROB ECOL, V51, P83, DOI 10.1007/s00248-005-0267-z; Ntarlagiannis D, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030426; Okamura K, 2011, FEMS MICROBIOL LETT, V317, P138, DOI 10.1111/j.1574-6968.2011.02224.x; Palacios C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003853; Parkhurst D.L., 2013, US GEOLOGICAL SURVEY, V6, P497; PRONK JT, 1992, APPL ENVIRON MICROB, V58, P2227, DOI 10.1128/AEM.58.7.2227-2230.1992; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Regberg A, 2011, WATER RESOUR RES, V47, DOI 10.1029/2010WR009551; Revil A, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2009JG001065; Rosso KM, 2010, ENVIRON SCI TECHNOL, V44, P61, DOI 10.1021/es901882a; Saini-Eidukat B, 1999, COMPUT GEOSCI, V25, P347, DOI 10.1016/S0098-3004(98)00138-1; Santofimia E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066746; Sato M., 1960, GEOPHYSICS, V25, P226, DOI [10.1190/1.1438689, DOI 10.1190/1.1438689]; Schorr MS, 2006, J FRESHWATER ECOL, V21, P17, DOI 10.1080/02705060.2006.9664091; Senko JM, 2008, ISME J, V2, P1134, DOI 10.1038/ismej.2008.60; Senko JM, 2011, MINE WATER ENVIRON, V30, P38, DOI 10.1007/s10230-010-0123-3; Sheng YZ, 2017, RSC ADV, V7, P35962, DOI 10.1039/c7ra03717a; Shi L, 2016, NAT REV MICROBIOL, V14, P651, DOI 10.1038/nrmicro.2016.93; SHORT TM, 1990, ARCH ENVIRON CON TOX, V19, P241, DOI 10.1007/BF01056093; Silvester E, 2005, GEOCHIM COSMOCHIM AC, V69, P4801, DOI 10.1016/j.gca.2005.06.013; Sizova MV, 2012, APPL ENVIRON MICROB, V78, P194, DOI 10.1128/AEM.06813-11; Smucker NJ, 2011, J N AM BENTHOL SOC, V30, P728, DOI 10.1899/10-139.1; Sokolova TG, 2004, INT J SYST EVOL MICR, V54, P2353, DOI 10.1099/ijs.0.63186-0; Sorokin DY, 2006, MICROBIOL-SGM, V152, P3013, DOI 10.1099/mic.0.29106-0; STOOKEY LL, 1970, ANAL CHEM, V42, P779, DOI 10.1021/ac60289a016; Timm F, 2001, J GEOCHEM EXPLOR, V72, P115, DOI 10.1016/S0375-6742(01)00157-1; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Werner JJ, 2012, ISME J, V6, P94, DOI 10.1038/ismej.2011.82; Williams KH, 2007, J GEOPHYS RES-BIOGEO, V112, DOI 10.1029/2007JG000440; Wu XF, 2013, FEMS MICROBIOL ECOL, V84, P555, DOI 10.1111/1574-6941.12084; Wu XC, 2011, INT J SYST EVOL MICR, V61, P1133, DOI 10.1099/ijs.0.024109-0; Yanina SV, 2008, SCIENCE, V320, P218, DOI 10.1126/science.1154833; Yuan X, 2014, INT J SYST EVOL MICR, V64, P3994, DOI 10.1099/ijs.0.067769-0; Zavarzina DG, 2002, INT J SYST EVOL MICR, V52, P1737, DOI [10.1099/ijs.0.02214-0, 10.1099/00207713-52-5-1737]; Ziegler S, 2013, INT J SYST EVOL MICR, V63, P1499, DOI 10.1099/ijs.0.042986-0	92	6	6	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2019	14	3							e0213807	10.1371/journal.pone.0213807	http://dx.doi.org/10.1371/journal.pone.0213807			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ3IW	30913215	Green Published, gold			2022-12-26	WOS:000462305600021
J	Studivan, MS; Milstein, G; Voss, JD				Studivan, Michael S.; Milstein, Gillian; Voss, Joshua D.			Montastraea cavernosa corallite structure demonstrates distinct morphotypes across shallow and mesophotic depth zones in the Gulf of Mexico	PLOS ONE			English	Article							REEF CORALS; ANNULARIS ELLIS; MORPHOLOGICAL PLASTICITY; PHENOTYPIC PLASTICITY; POPULATION-STRUCTURE; GENETIC-STRUCTURE; LIGHT-ABSORPTION; ALGAL SYMBIONTS; CONNECTIVITY; SOLANDER	This study assessed morphological variation of the depth-generalist coral Montastraea cavernosa across shallow and mesophotic coral ecosystems in the Gulf of Mexico (GOM) using thirteen corallite metrics. While corallite structure differed significantly across sites, we observed that mean corallite diameters were smaller and spacing was greater in mesophotic corals as compared to shallow corals. Additional corallite variation, including greater mean corallite height of mesophotic samples, are hypothesized to be photoadaptive responses to low light environments. Multivariate analyses also revealed two distinct morphotypes identified by significant variation in corallite spacing with >90% accuracy. A 'shallow' morphotype was characterized by larger, more closely-spaced corallites, while a 'depth-generalist' type exhibited smaller, further-spaced corallites. Variable presence of morphotypes within some sites suggests genotypic influence on corallite morphology as there was a slight, but significant, impact of morphotype on genetic structure within shallow zones in the Flower Garden Banks. Patterns of increased algal symbiont (Symbiodiniaceae) density and chlorophyll concentration were retained in the depth-generalist morphotype even in shallow zones, identifying multiple photoadaptive strategies between morphotypes. The results of this study suggest that morphological variation among M. cavernosa represents a combination of genotypic variation and phenotypic plasticity rather than responses to environmental stimuli alone.	[Studivan, Michael S.; Voss, Joshua D.] Florida Atlantic Univ, Harbor Branch, Dept Biol Sci, Oceanog Inst, Ft Pierce, FL 34946 USA; [Milstein, Gillian] Maine Maritime Acad, Corning Sch Ocean Studies, Castine, ME USA; [Milstein, Gillian] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	Harbor Branch Oceanographic Institute Foundation; State University System of Florida; Florida Atlantic University; University of Washington; University of Washington Seattle	Studivan, MS (corresponding author), Florida Atlantic Univ, Harbor Branch, Dept Biol Sci, Oceanog Inst, Ft Pierce, FL 34946 USA.	studivanms@gmail.com		Voss, Joshua/0000-0002-0653-2767; Studivan, Michael/0000-0002-3771-0415	NOAA Office of Ocean Exploration and Research [NA09OAR4320073, NA14OAR4320260]; NOAA National Centers for Coastal Ocean Science [NA11NOS4780045]; Banbury Foundation through the Robertson Coral Reef Research and Conservation Program; Florida Atlantic University	NOAA Office of Ocean Exploration and Research; NOAA National Centers for Coastal Ocean Science; Banbury Foundation through the Robertson Coral Reef Research and Conservation Program; Florida Atlantic University	This research was funded to JDV by the NOAA Office of Ocean Exploration and Research (http://explore.noaa.gov) under awards NA09OAR4320073 and NA14OAR4320260 to the Cooperative Institute for Ocean Exploration, Research and Technology (CIOERT) at Florida Atlantic University's (FAU) Harbor Branch Oceanographic Institute (HBOI) and to JDV by the NOAA National Centers for Coastal Ocean Science (https://coastalscience.noaa.gov) under award NA11NOS4780045 to the Cooperative Institute for Marine and Atmospheric Studies (CIMAS) at the University of Miami. Additional funding was provided to JDV by the Banbury Foundation through the Robertson Coral Reef Research and Conservation Program (http://www.fau.edu/hboi/meh/crrobertson.php) at HBOI, and to MSS by graduate student fellowships/grants from Florida Atlantic University (http://www.fau.edu/graduate/current-students/fellowships-and-awards.php). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; AMARAL FD, 1994, CORAL REEFS, V13, P113, DOI 10.1007/BF00300771; Anderson MJ, 2013, ECOL MONOGR, V83, P557, DOI 10.1890/12-2010.1; Ayre DJ, 2000, EVOLUTION, V54, P1590; Barshis DJ, 2010, MOL ECOL, V19, P1705, DOI 10.1111/j.1365-294X.2010.04574.x; BELTRANTORRES AU, 1993, REV BIOL TROP, V41, P559; Benzie JAH, 1999, AM ZOOL, V39, P131; Bongaerts P, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602373; Brazeau DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065845; Bruno JF, 1997, ECOLOGY, V78, P2177, DOI 10.2307/2265954; Budd AF, 2012, ZOOL J LINN SOC-LOND, V166, P465, DOI 10.1111/j.1096-3642.2012.00855.x; Budd AF, 2012, EVOL ECOL, V26, P265, DOI 10.1007/s10682-010-9460-8; Clarke K.R., 2014, CHANGE MARINE COMMUN, V3; Clarke K.R., 2016, PRIMER V7 USER MANUA; Cunning R, 2013, NAT CLIM CHANGE, V3, P259, DOI [10.1038/NCLIMATE1711, 10.1038/nclimate1711]; DUSTAN P, 1979, B MAR SCI, V29, P79; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Enriquez S, 2005, LIMNOL OCEANOGR, V50, P1025, DOI 10.4319/lo.2005.50.4.1025; Enriquez S, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2016.1667; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; FOSTER AB, 1979, J EXP MAR BIOL ECOL, V39, P25, DOI 10.1016/0022-0981(79)90003-0; FOSTER AB, 1985, J PALEONTOL, V59, P1359; Gillespie J., 2010, BIOMETRICS, DOI DOI 10.2307/2533705; Goodbody-Gringley G, 2018, ECOLOGY, V99, P1688, DOI 10.1002/ecy.2232; Goodbody-Gringley G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142427; Goodbody-Gringley G, 2012, MAR ECOL-EVOL PERSP, V33, P32, DOI 10.1111/j.1439-0485.2011.00452.x; Kahng SE, 2014, CURR OPIN ENV SUST, V7, P72, DOI 10.1016/j.cosust.2013.11.019; Kahng SE, 2010, CORAL REEFS, V29, P255, DOI 10.1007/s00338-010-0593-6; Kahng SE, 2012, MAR ECOL PROG SER, V455, P65, DOI 10.3354/meps09657; KAISER P, 1993, MAR BIOL, V117, P45, DOI 10.1007/BF00346424; Kassambara A., 2017, GGPUBR GGPLOT2 BASED; Klaus JS, 2007, B MAR SCI, V80, P233; LASKER HR, 1980, J EXP MAR BIOL ECOL, V47, P77, DOI 10.1016/0022-0981(80)90139-2; LASKER HR, 1981, BIOL BULL, V160, P292, DOI 10.2307/1540889; LASKER HR, 1979, BIOL BULL, V156, P196, DOI 10.2307/1541043; LASKER HR, 1976, COELENTERATE ECOLOGY, P101; Lesser MP, 2010, ECOLOGY, V91, P990, DOI 10.1890/09-0313.1; Lesser MP, 2009, J EXP MAR BIOL ECOL, V375, P1, DOI 10.1016/j.jembe.2009.05.009; Lesser MP, 2000, LIMNOL OCEANOGR, V45, P76, DOI 10.4319/lo.2000.45.1.0076; Marcelino LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061492; Menezes Natalia, 2014, Pap. Avulsos Zool. (São Paulo), V54, P199, DOI 10.1590/0031-1049.2014.54.16; Muir P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117933; Nunes F, 2009, MOL ECOL, V18, P4283, DOI 10.1111/j.1365-294X.2009.04347.x; Ogle D, 2017, FSA FISHERIES STOCK; Pandolfi JM, 2008, MAR ECOL PROG SER, V369, P89, DOI 10.3354/meps07570; Paz-Garcia DA, 2015, AM NAT, V186, P434, DOI 10.1086/682363; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Polinski JM, 2018, CORAL REEFS, V37, P779, DOI 10.1007/s00338-018-1701-2; Polinski JM, 2016, THESIS; Pritchard JK, 2000, GENETICS, V155, P945; Puglise KA, 2009, MESOPHOTIC CORAL ECO; Reed JK, 2017, CHARACTERIZATION MES; Reid NM, 2016, SCIENCE, V354, P1305, DOI 10.1126/science.aah4993; Rocha RJM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105863; Ruiz Torres H., 2004, THESIS; Scheufen T, 2017, FRONT MAR SCI, V4, DOI 10.3389/fmars.2017.00309; Schmahl George R., 2008, V1, P221, DOI 10.1007/978-1-4020-6847-8_6; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SEBENS KP, 1997, P 8 INT COR REEF S, P1053; Serrano X, 2014, MOL ECOL, V23, P4226, DOI 10.1111/mec.12861; Slattery M, 2018, CORAL REEFS, V37, P391, DOI 10.1007/s00338-018-1664-3; Smith EG, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.0320; Soto D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202586; Studivan MS, 2018, CORAL REEFS, V37, P1183, DOI 10.1007/s00338-018-1733-7; Todd PA, 2004, MAR ECOL PROG SER, V271, P167, DOI 10.3354/meps271167; Todd PA, 2008, BIOL REV, V83, P315, DOI 10.1111/j.1469-185X.2008.00045.x; VIA S, 1985, EVOLUTION, V39, P505, DOI [10.2307/2408649, 10.1111/j.1558-5646.1985.tb00391.x]; WEIL E, 1994, B MAR SCI, V55, P151; WEST JM, 1993, MAR ECOL PROG SER, V94, P61, DOI 10.3354/meps094061; Willis BL, 1985, OECOLOGIA, V65, P516, DOI 10.1007/BF00379666; Wirshing HH, 2014, MOL PHYLOGENET EVOL, V77, P281, DOI 10.1016/j.ympev.2014.04.015; Ziegler M, 2015, FRONT MAR SCI, V2, DOI 10.3389/fmars.2015.00004	73	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2019	14	3							e0203732	10.1371/journal.pone.0203732	http://dx.doi.org/10.1371/journal.pone.0203732			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ3IW	30913227	Green Submitted, Green Published, gold			2022-12-26	WOS:000462305600001
J	Clark, JE; Ng, WF; Rushton, S; Watson, S; Newton, JL				Clark, James E.; Ng, Wan-Fai; Rushton, Stephen; Watson, Stuart; Newton, Julia L.			Network structure underpinning (dys) homeostasis in chronic fatigue syndrome; Preliminary findings	PLOS ONE			English	Article							BLOOD-PRESSURE VARIABILITY; AUTONOMIC NERVOUS-SYSTEM; AXIS HYPOFUNCTION; MODEL; INFLAMMATION; CYTOSCAPE; REFLEX	Introduction A large body of evidence has established a pattern of altered functioning in the immune system, autonomic nervous system and hypothalamic pituitary adrenal axis in chronic fatigue syndrome. However, the relationship between components within and between these systems is unclear. In this paper we investigated the underlying network structure of the autonomic system in patients and controls, and a larger network comprising all three systems in patients alone. Methods In a sample of patients and controls we took several measures of autonomic nervous system output during 10 minutes of supine rest covering tests of blood pressure variability, heart rate variability and cardiac output. Awakening salivary cortisol was measured on each of two days with participants receiving 0.5mg dexamethasone during the afternoon of the first day. Basal plasma cytokine levels and the in vitro cytokine response to dexamethasone were also measured. Symptom outcome measures used were the fatigue impact scale and cognitive failures questionnaire. Mutual information criteria were used to construct networks describing the dependency amongst variables. Data from 42 patients and 9 controls were used in constructing autonomic networks, and 15 patients in constructing the combined network. Results The autonomic network in patients showed a more uneven distribution of information, with two distinct modules emerging dominated by systolic blood pressure during active stand and end diastolic volume and stroke volume respectively. The combined network revealed strong links between elements of each of the three regulatory systems, characterised by three higher modules the centres of which were systolic blood pressure during active stand, stroke volume and ejection fraction respectively. Conclusions CFS is a complex condition affecting physiological systems. It is important that novel analytical techniques are used to understand the abnormalities that lead to CFS. The underlying network structure of the autonomic system is significantly different to that of controls, with a small number of individual nodes being highly influential. The combined network suggests links across regulatory systems which shows how alterations in single nodes might spread throughout the network to produce alterations in other, even distant, nodes. Replication in a larger cohort is warranted.	[Clark, James E.; Watson, Stuart] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne, Tyne & Wear, England; [Ng, Wan-Fai; Newton, Julia L.] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England; [Rushton, Stephen] Newcastle Univ, BCES Modelling, Newcastle Upon Tyne, Tyne & Wear, England; [Newton, Julia L.] Newcastle Tyne Hosp NHS Fdn Trust, Newcastle Upon Tyne, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust	Newton, JL (corresponding author), Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England.; Newton, JL (corresponding author), Newcastle Tyne Hosp NHS Fdn Trust, Newcastle Upon Tyne, Tyne & Wear, England.	Julia.newton@ncl.ac.uk	; Ng, Wan-Fai/R-8083-2016; watson, stuart/B-8728-2009	Newton, Julia/0000-0002-1249-5253; Ng, Wan-Fai/0000-0002-5539-388X; watson, stuart/0000-0002-2558-3367	UK Medical Research Council	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The funders of the study were the UK Medical Research Council, who the authors can confirm had no role in the delivery of the study or the interpretation of the results. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Assenov Y, 2008, BIOINFORMATICS, V24, P282, DOI 10.1093/bioinformatics/btm554; Barnden LR, 2016, NEUROIMAGE-CLIN, V11, P530, DOI 10.1016/j.nicl.2016.03.017; Bellinger DL, 2014, AUTON NEUROSCI-BASIC, V182, P15, DOI 10.1016/j.autneu.2014.01.006; Boissoneault J, 2016, MAGN RESON IMAGING, V34, P603, DOI 10.1016/j.mri.2015.12.008; BROADBENT DE, 1982, BRIT J CLIN PSYCHOL, V21, P1, DOI 10.1111/j.2044-8260.1982.tb01421.x; Broderick G, 2010, BRAIN BEHAV IMMUN, V24, P1209, DOI 10.1016/j.bbi.2010.04.012; Camm AJ, 1996, EUR HEART J, V17, P354; Clark JE, 2016, BRIT MED BULL, V117, P139, DOI 10.1093/bmb/ldv057; Edwards J. C. W, 2016, BIOL CHALLENGE MYALG; FISK JD, 1994, CLIN INFECT DIS, V18, pS79, DOI 10.1093/clinids/18.Supplement_1.S79; Fletcher MA, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-96; Fluge O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129898; Frith J, 2012, QJM-INT J MED, V105, P831, DOI 10.1093/qjmed/hcs085; Fuite J, 2008, GENOMICS, V92, P393, DOI 10.1016/j.ygeno.2008.08.008; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; Gottesman RF, 2009, BEHAV NEUROL, V22, P63, DOI 10.3233/BEN-2009-0261; Grubb B, 2008, CLIN MED CARDIOL, V2, P289; Hammer PE, 2005, AM J PHYSIOL-REG I, V288, pR1637, DOI 10.1152/ajpregu.00050.2004; Hanna P, 2017, AUTON NEUROSCI-BASIC; Hiner BC, 2005, CLIN MED RES, V3, P55, DOI 10.3121/cmr.3.2.55; Hoad A, 2008, QJM-INT J MED, V101, P961, DOI 10.1093/qjmed/hcn123; Hollingsworth KG, 2010, EUR J CLIN INVEST, V40, P608, DOI 10.1111/j.1365-2362.2010.02310.x; Hornig M, 2016, MOL PSYCHIATR, V21, P261, DOI 10.1038/mp.2015.29; Janig W, 2014, AUTON NEUROSCI-BASIC, V182, P4, DOI 10.1016/j.autneu.2014.01.004; Jones DEJ, 2010, J INTERN MED, V267, P394, DOI 10.1111/j.1365-2796.2009.02160.x; Kovacs IA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012528; Liang FY, 2006, J PHYSIOL SCI, V56, P45, DOI 10.2170/physiolsci.RP001305; Lorton D, 2015, INT J MOL SCI, V16, P5635, DOI 10.3390/ijms16035635; Maes M, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-35; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Margolin AA, 2006, NAT PROTOC, V1, P663, DOI 10.1038/nprot.2006.106; Martelli D, 2014, J PHYSIOL-LONDON, V592, P1677, DOI 10.1113/jphysiol.2013.268573; Morris G, 2013, METAB BRAIN DIS, V28, P523, DOI 10.1007/s11011-012-9324-8; Nacul LC, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-91; Newton JL, 2007, QJM-INT J MED, V100, P519, DOI 10.1093/qjmed/hcm057; Newton JL, 2016, OPEN HEART, V3, DOI 10.1136/openhrt-2015-000381; Nijs J, 2012, EUR J CLIN INVEST, V42, P203, DOI 10.1111/j.1365-2362.2011.02575.x; Papadopoulos A, 2009, J AFFECT DISORDERS, V112, P289, DOI 10.1016/j.jad.2008.05.001; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shi Z, 2011, ACTA PHYSIOL, V203, P289, DOI 10.1111/j.1748-1716.2011.02313.x; Stevanovic P, 2008, SIGNA VITAE, V3, P22, DOI 10.22514/SV31.022008.5; Szalay-Beko M, 2012, BIOINFORMATICS, V28, P2202, DOI 10.1093/bioinformatics/bts352; Team RC, 2014, R LANG ENV STAT COMP; Tomas Cara, 2013, ISRN Neurosci, V2013, P784520, DOI 10.1155/2013/784520; Van Cauwenbergh D, 2014, EUR J CLIN INVEST, V44, P516, DOI 10.1111/eci.12256; Van Houdenhove B, 2009, MED HYPOTHESES, V72, P701, DOI 10.1016/j.mehy.2008.11.044; Vangeel E, 2015, PSYCHOSOM MED, V77, P853, DOI 10.1097/PSY.0000000000000224; Wallace JC, 2002, J GEN PSYCHOL, V129, P238, DOI 10.1080/00221300209602098; Wyller VB, 2007, ACTA NEUROL SCAND, V115, P7, DOI 10.1111/j.1600-0404.2007.00840.x; Wyller VB, 2011, EUR J APPL PHYSIOL, V111, P497, DOI 10.1007/s00421-010-1670-9	50	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2019	14	3							e0213724	10.1371/journal.pone.0213724	http://dx.doi.org/10.1371/journal.pone.0213724			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HQ1KV	30908516	Green Published, Green Submitted, gold			2022-12-26	WOS:000462157600016
J	Kim, EJ; Woo, HS; Cho, JH; Sym, SJ; Baek, JH; Lee, WS; Kwon, KA; Kim, KO; Chung, JW; Park, DK; Kim, YJ				Kim, Eui Joo; Woo, Hyun Sun; Cho, Jae Hee; Sym, Sun Jin; Baek, Jeong-Heum; Lee, Won-Suk; Kwon, Kwang An; Kim, Kyoung Oh; Chung, Jun-Won; Park, Dong Kyun; Kim, Yoon Jae			Early experience with Watson for oncology in Korean patients with colorectal cancer	PLOS ONE			English	Article							SURGICAL ADJUVANT BREAST; COLON-CANCER; 1ST-LINE THERAPY; FLUOROURACIL; CHEMOTHERAPY; BEVACIZUMAB; LEUCOVORIN; EFFICACY; OXALIPLATIN; TRIAL	Background Watson for oncology (WFO) is a cognitive computing system providing decision support. We evaluated the concordance rates between the treatment options determined by WFO and those determined by a multidisciplinary team (MDT). Methods We reviewed the medical charts of patients diagnosed with colorectal cancer who visited the MDT at a single tertiary medical center from November 2016 to April 2017. WFO classified the treatment options for specific patients into three categories: 'Recommended', 'For consideration', and 'Not recommended'. Concordance rates between the WFO- and MDT-determined chemotherapy options, and the factors that potentially influence the concordance rate, were analyzed. Results Sixty-nine patients with colorectal cancer met with the MDT from Nov. 2016 to Feb. 2017. The mean age of the patients was 62 years (range: 34-86 years), and more patients were male (47/69) than female. Of the 69 patients, 51 (73.9%) were diagnosed with colon cancer, of whom 46.4% received the same regimen recommendation from WFO ('Recommended') as they did from the MDT. After inclusion of the 'For consideration' category from WFO, the concordance rate increased to 87.0%. The concordance rate between MDT and NCCN guidelines was 97.1%, and that between the WFO and NCCN guidelines was 88.4%. The concordance rates between WFO and MDT were significantly lower in patients with stage II, IIIC, or IV disease (P<0.001), and the colorectal cancer stage was the only statistically significant factor discriminating between WFO and MDT. Conclusions The concordance rate between chemotherapy regimens for colorectal cancer determined by MDT versus WFO recommendations was 46.4%. After including the 'For consideration' category from WFO, the concordance rate increased to 88.4%. Further modification and improvement of the WFO prioritizing algorithm used to recommend treatment may increase the usefulness of WFO in the clinic.	[Kim, Eui Joo; Woo, Hyun Sun; Cho, Jae Hee; Kwon, Kwang An; Kim, Kyoung Oh; Chung, Jun-Won; Park, Dong Kyun; Kim, Yoon Jae] Gachon Univ, Coll Med, Gil Med Ctr, Div Gastroenterol,Dept Internal Med, Incheon, South Korea; [Sym, Sun Jin] Gachon Univ, Coll Med, Gil Med Ctr, Div Oncol,Dept Internal Med, Incheon, South Korea; [Baek, Jeong-Heum; Lee, Won-Suk] Gachon Univ, Coll Med, Gil Med Ctr, Dept Surg, Incheon, South Korea	Gachon University; Gachon University; Gachon University	Kim, YJ (corresponding author), Gachon Univ, Coll Med, Gil Med Ctr, Div Gastroenterol,Dept Internal Med, Incheon, South Korea.	yoonmed@gilhospital.com	Kim, Eui Joo/P-8348-2019; Cho, Jae Hee/AAL-8192-2020	Kim, Eui Joo/0000-0001-5573-7083; Cho, Jae Hee/0000-0003-4174-0091; Kwon, Kwang An/0000-0002-2947-2111; Woo, Hyun Sun/0000-0003-2388-9896				[Anonymous], 2017, P WORKSH IN BRIEF NA; Benson AB, 2004, J CLIN ONCOL, V22, P3408, DOI 10.1200/JCO.2004.05.063; Cassidy J, 2011, BRIT J CANCER, V105, P58, DOI 10.1038/bjc.2011.201; Colucci G, 2005, J CLIN ONCOL, V23, P4866, DOI 10.1200/JCO.2005.07.113; Dotan E, 2012, J NATL COMPR CANC NE, V10, P25; Dotan E, 2012, J NATL COMPR CANC NE, V10, P213, DOI 10.6004/jnccn.2012.0020; Gorunescu F, 2016, J BIOMED INFORM, V63, P74, DOI 10.1016/j.jbi.2016.08.004; Gray R, 2007, LANCET, V370, P2020, DOI 10.1016/s0140-6736(07)61866-2; Grothey A, 2013, LANCET, V381, P303, DOI 10.1016/S0140-6736(12)61900-X; Hochster HS, 2008, J CLIN ONCOL, V26, P3523, DOI 10.1200/JCO.2007.15.4138; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; LABIANCA R, 1995, LANCET, V345, P939; Martinelli E, 2016, ESMO OPEN, V1, DOI 10.1136/esmoopen-2016-000086; Meropol NJ, 2011, J CLIN ONCOL, V29, P3346, DOI 10.1200/JCO.2011.35.4571; Musib M, 2017, SCIENCE, V357, P28, DOI 10.1126/science.357.6346.28; National Comprehensive Cancer Network, 2017, NCCN CLIN PRACT GUID; O'Connor ES, 2011, J CLIN ONCOL, V29, P3381, DOI 10.1200/JCO.2010.34.3426; Ribic CM, 2003, NEW ENGL J MED, V349, P247, DOI 10.1056/NEJMoa022289; Saltz LB, 2008, J CLIN ONCOL, V26, P2013, DOI 10.1200/JCO.2007.14.9930; Sargent DJ, 2010, J CLIN ONCOL, V28, P3219, DOI 10.1200/JCO.2009.27.1825; Sobrero A, 2009, ONCOLOGY-BASEL, V77, P113, DOI 10.1159/000229787; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; WOLMARK N, 1993, J CLIN ONCOL, V11, P1879, DOI 10.1200/JCO.1993.11.10.1879; Wolmark N, 1999, J CLIN ONCOL, V17, P3553, DOI 10.1200/JCO.1999.17.11.3553; Yang YF, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000006335; Yothers G, 2011, J CLIN ONCOL, V29, P3768, DOI 10.1200/JCO.2011.36.4539	26	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2019	14	3							e0213640	10.1371/journal.pone.0213640	http://dx.doi.org/10.1371/journal.pone.0213640			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ1KV	30908530	Green Published, Green Submitted, gold			2022-12-26	WOS:000462157600012
J	Adetunji, AE; Adeniran, KA; Olomu, SC; Odike, AI; Ewah-Odiase, RO; Omoike, IU; Akpede, GO				Adetunji, Adewale Elijah; Adeniran, Kayode Adesoye; Olomu, Sylvia Chinwendu; Odike, Angela Ifeoma; Ewah-Odiase, Rosemary Omonigho; Omoike, Irekpono Ukhueleigbe; Akpede, George Obozokhale			Socio-demographic factors associated with overweight and obesity among primary school children in semi-urban areas of mid-western Nigeria	PLOS ONE			English	Article							BODY-MASS INDEX; CHILDHOOD OBESITY; SOCIOECONOMIC-STATUS; NUTRITIONAL-STATUS; BLOOD-PRESSURE; PREVALENCE; ADOLESCENTS; CIRCUMFERENCE; EPIDEMIOLOGY; HYPERTENSION	Background Many developing countries are in a state of nutritional transition from prevalent under-nutrition to the emergent problem of over-nutrition (overweight and obesity), which is associated with increased morbidity and mortality, and whose complications can persist into adulthood with long-term consequences. However, data are limited on the risk factors for overweight and obesity (O&O) among primary school children, particularly those in rural and semiurban areas in these countries. Aim and objectives To determine the socio-demographic factors associated with overweight and obesity among primary school children in semi-urban areas. Subjects and methods 1187 school pupils aged 6-11 years recruited from semi-urban areas using multistage sampling were interviewed for risk factors of overweight and obesity using a structured questionnaire. Nutritional status was assessed using body mass index and this was classified using a standard method. The proportions were compared using Pearson's chi-squared. Multivariate logistic regression analysis was also carried out with overweight and obesity as the dependent variable and socio demographic factors as independent variables. The level of statistical significance was set at p <0.05 in all the statistical analyses. Results Fifty-eight pupils (4.9%) had overweight and obesity while 1129 (95.1%) were either of normal nutritional status (1088, 91.6%) or were thin/severely thin (41, 3.5%). Among those with overweight and obesity, 41 (3.5%) were overweight and 17 (1.4%) obese. A higher prevalence of overweight and obesity was significantly associated (in unadjusted analysis) with female gender [unadjusted Odds Ratio, OR (95% CI) = 2.42 (1.37, 4.28)], attendance at private schools [OR (95% CI) = 3.34 (1.86, 6.00)], higher socio-economic status families [OR (95% CI) = 2.32 (1.65, 5.80)] and presence of a television in the pupil's bedrooms [OR (95% CI) = 2.22 (1.02, 4.82)] on bivariate analyses. However, only gender, school type and family socioeconomic status were independently associated with overweight and obesity on multivariate logistic regression analysis. Conclusion We conclude that overweight and obesity among primary school pupils in semi-urban areas is associated with female gender, attendance at private schools and higher socioeconomic status families. Preventive programmes should accordingly be more directed at children from affluent families; particularly those who are females and those attending private schools.	[Adetunji, Adewale Elijah; Olomu, Sylvia Chinwendu; Odike, Angela Ifeoma; Ewah-Odiase, Rosemary Omonigho; Omoike, Irekpono Ukhueleigbe; Akpede, George Obozokhale] Irrua Specialist Teaching Hosp, Dept Paediat, Irrua, Edo State, Nigeria; [Adeniran, Kayode Adesoye] Fed Med Ctr, Dept Paediat, Asaba, Delta State, Nigeria; [Olomu, Sylvia Chinwendu; Odike, Angela Ifeoma; Ewah-Odiase, Rosemary Omonigho; Akpede, George Obozokhale] Ambrose Alli Univ, Coll Med, Fac Clin Sci, Dept Paediat, Ekpoma, Edo Sate, Nigeria		Adetunji, AE (corresponding author), Irrua Specialist Teaching Hosp, Dept Paediat, Irrua, Edo State, Nigeria.	tunjiwale2007@yahoo.com						Abah S. O., 2012, Journal of Biology, Agriculture and Healthcare, V2, P51; Adebayo A M, 2011, Ann Ib Postgrad Med, V9, P14; Adegoke S A, 2009, West Afr J Med, V28, P216; Adegoke SA, 2009, NIGERIAN ENDOCRINE P, V2, P35; Alhaji, 2015, SAUDI J OBESITY, V3, P59, DOI DOI 10.4103/2347-2618.171959; Ansa V O, 2010, West Afr J Med, V29, P146; Aounallah-Skhiri H, 2008, PUBLIC HEALTH NUTR, V11, P1306, DOI 10.1017/S1368980008002693; Armstrong MEG, 2011, EUR J CLIN NUTR, V65, P835, DOI 10.1038/ejcn.2011.46; Ayoola O, 2009, ANN HUM BIOL, V36, P388, DOI 10.1080/03014460902835606; Ben-Bassey UP, 2007, OBES REV, V8, P475, DOI 10.1111/j.1467-789X.2007.00408.x; Chen JL, 2011, J IMMIGR MINOR HEALT, V13, P268, DOI 10.1007/s10903-009-9288-x; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Crispim P. A. A, RISK FACTORS ASS HIG, DOI [10.5935/abc.20130227, DOI 10.5935/ABC.20130227]; Das JC, 2015, MED CLIN REV, V1, P1, DOI [10.21767/2471-299X.1000001, DOI 10.21767/2471-299X.1000001]; Dehghan M, 2005, NUTR J, V4, DOI 10.1186/1475-2891-4-24; Ebenizer O O, 2011, J PUBLIC HLTH AFRICA, V2, P45; Ejike CE, HYPERBOLIC RELATIONS; Fetuga M B, 2011, West Afr J Med, V30, P331; Gahagan S., 2011, OVERWEIGHT OBESITY N, P179; GEORGE AB, 2004, J CLIN ENDOCR METAB, V89, P2583, DOI DOI 10.1210/JC.2004-0535; Goran MI, 2001, AM J CLIN NUTR, V73, P158; Han TS, 2006, BMJ-BRIT MED J, V333, P695, DOI 10.1136/bmj.333.7570.695; Hassink S. G, 2009, AM ACAD PEDIAT TXB P; Intiful F. D., 2013, Journal of Biology, Agriculture and Healthcare, V3, P156; Jafar TH, 2008, ARCH DIS CHILD, V93, P373, DOI 10.1136/adc.2007.125641; Janjua NZ, 2012, J OBES, V2012, DOI 10.1155/2012/457173; Kapoor SK, 2002, J EPIDEMIOL COMMUN H, V56, P804, DOI 10.1136/jech.56.11.804; Landry GL, 2007, NELSON TXB PAEDIAT, P18; Longo-Mbenza B, 2007, INT J CARDIOL, V121, P171, DOI 10.1016/j.ijcard.2006.11.004; Lopes HS, 2011, THESIS; Mohammed H, 2012, Ghana Med J, V46, P124; Moselakgomo Violet Kankane, 2012, Rev. paul. pediatr., V30, P562; Musa DI, 2012, TROP MED INT HEALTH, V17, P1369, DOI 10.1111/j.1365-3156.2012.03083.x; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Olamoyegun MA, 2016, CARDIOVASC J AFR, V27, P356, DOI 10.5830/CVJA-2016-037; Onokerhoraye AG, 1986, URBAN SYSTEMS PLANNI, P2; Owa JA, 1997, J TROP PEDIATRICS, V43, P13, DOI 10.1093/tropej/43.1.13; OYEDEJI G A, 1985, Nigerian Journal of Paediatrics, V12, P111; Rao G, 2008, AM FAM PHYSICIAN, V78, P56; Robinson TN, 2001, PEDIATR CLIN N AM, V48, P1017, DOI 10.1016/S0031-3955(05)70354-0; Senbanjo IO, 2010, WORLD J PEDIATR, V6, P217, DOI 10.1007/s12519-010-0209-9; Senbanjo IO, 2009, ANN NUTR METAB, V54, P145, DOI 10.1159/000214833; Sidik Sherina Mohd, 2004, Malays J Nutr, V10, P13; SOBAL J, 1989, PSYCHOL BULL, V105, P260, DOI 10.1037/0033-2909.105.2.260; Sobal J, 2001, INT J EPIDEMIOL, V30, P1136, DOI 10.1093/ije/30.5.1136; Sorof JM, 2004, PEDIATRICS, V113, P475, DOI 10.1542/peds.113.3.475; Strasburger V. C, 2009, AM ACAD PEDIAT TXB P; Strauss RS, 2001, JAMA-J AM MED ASSOC, V286, P2845, DOI 10.1001/jama.286.22.2845; Sweeting HN, 2008, NUTR J, V7, DOI 10.1186/1475-2891-7-1; Wamba PCF, 2013, J OBES, V2013, DOI 10.1155/2013/737592; Wang YF, 2001, INT J EPIDEMIOL, V30, P1129, DOI 10.1093/ije/30.5.1129; Wang Z.G., 2004, THESIS NE FORESTRY U	52	5	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0214570	10.1371/journal.pone.0214570	http://dx.doi.org/10.1371/journal.pone.0214570			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR5NS	30943233	Green Published, gold, Green Submitted			2022-12-26	WOS:000463194300047
J	Francis, D; Chanana, B; Fernandez, B; Gordon, B; Mak, T; Palacios, IM				Francis, Deepthy; Chanana, Bhavna; Fernandez, Beatriz; Gordon, Benjamin; Mak, Tiffany; Palacios, Isabel M.			YAP/Yorkie in the germline modulates the age-related decline of germline stem cells and niche cells	PLOS ONE			English	Article							SELF-RENEWAL; DROSOPHILA TESTIS; TUMOR-SUPPRESSOR; HIPPO PATHWAY; PROLIFERATION; TRANSCRIPTION; DOWNSTREAM; CONTRIBUTE; DIVISION; SALVADOR	The properties and behaviour of stem cells rely heavily on signaling from the local microenvironment. At the apical end of Drosophila testis, self-renewal and differentiation of germline stem cells (GSCs) are tightly controlled by distinct somatic cells that comprise a specialised stem cell niche known as the hub. The hub maintains GSC homeostasis through adhesion and cell signaling. The Salvador/Warts/Hippo (SWH) pathway, which suppresses the transcriptional co-activator YAP/Yki via a kinase cascade, is a known regulator of stem cell proliferation and differentiation. Here, we show that increasing YAP/Yki expression in the germline, as well as reducing Warts levels, blocks the decrease of GSC numbers observed in aging flies, with only a small increase on their proliferation. An increased expression of YAP/Yki in the germline or a reduction in Warts levels also stymies an age-related reduction in hub cell number, suggesting a bilateral relationship between GSCs and the hub. Conversely, RNAi-based knockdown of YAP/Yki in the germline leads to a significant drop in hub cell number, further suggesting the existence of such a SC-to-niche relationship. All together, our data implicate the SWH pathway in Drosophila GSC maintenance and raise questions about its role in stem cell homeostasis in aging organisms.	[Francis, Deepthy; Chanana, Bhavna; Gordon, Benjamin; Mak, Tiffany; Palacios, Isabel M.] Univ Cambridge, Cambridge, England; [Fernandez, Beatriz; Palacios, Isabel M.] Queen Mary Univ London, Sch Biol & Chem Sci, Mile End Rd, London, England; [Francis, Deepthy] Cambridge Univ Hosp, IBD BioResource, Cambridge, England; [Chanana, Bhavna] ClearView Healthcare Partners, New York, NY USA; [Gordon, Benjamin] Univ Illinois, Med Scientist Training Program, Chicago, IL USA; [Mak, Tiffany] Francis Crick Inst, London, England	University of Cambridge; University of London; Queen Mary University London; University of Cambridge; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Francis Crick Institute	Palacios, IM (corresponding author), Univ Cambridge, Cambridge, England.; Palacios, IM (corresponding author), Queen Mary Univ London, Sch Biol & Chem Sci, Mile End Rd, London, England.	i.palacios@qmul.ac.uk	Palacios, Isabel/X-4807-2019	Fernandez, Beatriz F/0000-0002-8612-0251; Palacios, Isabel M/0000-0002-3450-7884; Gordon, Benjamin/0000-0002-3856-0500; Mak, Tiffany/0000-0001-6134-4999	Wellcome Trust [087899]; Biotechnology and Biological Sciences Research Council [BB/L001748/1]; EMBO; Isaac Newton Trust [11.35(af)]; School of Biological and Chemical Sciences (Queen Mary University of London); Meinig Family Cornell National Scholarship; Department of Zoology; University of Cambridge; BBSRC [BB/L001748/1] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EMBO(European Molecular Biology Organization (EMBO)); Isaac Newton Trust; School of Biological and Chemical Sciences (Queen Mary University of London)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Meinig Family Cornell National Scholarship; Department of Zoology; University of Cambridge(University of Cambridge); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. DF and IMP was supported by the Wellcome Trust (087899), and Biotechnology and Biological Sciences Research Council (BB/L001748/1); BC by EMBO, The Isaac Newton Trust (11.35(af)) (Trinity College, University of Cambridge) and the Wellcome Trust (087899); BF by the School of Biological and Chemical Sciences (Queen Mary University of London); BG by the Meinig Family Cornell National Scholarship; IMP by the School of Biological and Chemical Sciences (Queen Mary University of London), Biotechnology and Biological Sciences Research Council (BB/L001748/1), and the Department of Zoology and University of Cambridge.	Amoyel M, 2014, EMBO J, V33, P2295, DOI 10.15252/embj.201387500; Amoyel M, 2013, DEVELOPMENT, V140, P56, DOI 10.1242/dev.086413; Arama E, 2003, DEV CELL, V4, P687, DOI 10.1016/S1534-5807(03)00120-5; Bonfini A, 2015, BMC DEV BIOL, V15, DOI 10.1186/s12861-015-0059-8; Boyle M, 2007, CELL STEM CELL, V1, P470, DOI 10.1016/j.stem.2007.08.002; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Cheng J, 2008, NATURE, V456, P599, DOI 10.1038/nature07386; Ding R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10510; Gonczy P, 1996, DEVELOPMENT, V122, P2437; Greenspan LJ, 2015, ANNU REV CELL DEV BI, V31, P291, DOI 10.1146/annurev-cellbio-100913-013344; Herrera SC, 2018, ELIFE, V7, DOI 10.7554/eLife.36095; Karpowicz P, 2010, DEVELOPMENT, V137, P4135, DOI 10.1242/dev.060483; Kawase E, 2004, DEVELOPMENT, V131, P1365, DOI 10.1242/dev.01025; Kiger AA, 2001, SCIENCE, V294, P2542, DOI 10.1126/science.1066707; Leatherman JL, 2008, CELL STEM CELL, V3, P44, DOI 10.1016/j.stem.2008.05.001; Lee JY, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006043; Leung CY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3251; Lian I, 2010, GENE DEV, V24, P1106, DOI 10.1101/gad.1903310; Meignin C, 2007, CURR BIOL, V17, P1871, DOI 10.1016/j.cub.2007.09.062; Michel M, 2012, DEVELOPMENT, V139, P2663, DOI 10.1242/dev.075242; Nishioka N, 2009, DEV CELL, V16, P398, DOI 10.1016/j.devcel.2009.02.003; Pan L, 2007, CELL STEM CELL, V1, P458, DOI 10.1016/j.stem.2007.09.010; Ren FF, 2010, P NATL ACAD SCI USA, V107, P21064, DOI 10.1073/pnas.1012759107; Resende LPF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068026; Ryu BY, 2006, STEM CELLS, V24, P1505, DOI 10.1634/stemcells.2005-0580; Sano H, 2002, MECH DEVELOP, V112, P129, DOI 10.1016/S0925-4773(01)00654-2; Sarikaya DP, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004962; Schlegelmilch K, 2011, CELL, V144, P782, DOI 10.1016/j.cell.2011.02.031; Shaw RL, 2010, DEVELOPMENT, V137, P4147, DOI 10.1242/dev.052506; Sun SG, 2008, DEV DYNAM, V237, P270, DOI 10.1002/dvdy.21411; Tulina N, 2001, SCIENCE, V294, P2546, DOI 10.1126/science.1066700; Voog J, 2008, NATURE, V454, P1132, DOI 10.1038/nature07173; Wallenfang MR, 2006, AGING CELL, V5, P297, DOI 10.1111/j.1474-9726.2006.00221.x; Ward EJ, 2006, CURR BIOL, V16, P2352, DOI 10.1016/j.cub.2006.10.022; White-Cooper Helen, 2012, Spermatogenesis, V2, P11; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; XU TA, 1995, DEVELOPMENT, V121, P1053; Yamashita YM, 2003, SCIENCE, V301, P1547, DOI 10.1126/science.1087795; Zhang JM, 2009, NAT CELL BIOL, V11, P1444, DOI 10.1038/ncb1993; Zhang XF, 2006, BIOL REPROD, V74, P119, DOI 10.1095/biolreprod.105.045591; Zhao SW, 2013, DEV BIOL, V376, P163, DOI 10.1016/j.ydbio.2013.01.023	41	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0213327	10.1371/journal.pone.0213327	http://dx.doi.org/10.1371/journal.pone.0213327			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR5NS	30943201	gold, Green Submitted, Green Published			2022-12-26	WOS:000463194300012
J	Vupputuri, S; Rubenstein, KB; Derus, AJ; Loftus, BC; Horberg, MA				Vupputuri, Suma; Rubenstein, Kevin B.; Derus, Alphonse J.; Loftus, Bernadette C.; Horberg, Michael A.			Factors contributing to racial disparities in influenza vaccinations	PLOS ONE			English	Article							ETHNIC DISPARITIES; SEASONAL INFLUENZA; UNITED-STATES; POPULATIONS; VACCINES; COVERAGE	Background Racial/ethnic disparities in rates of influenza vaccinations in the US remain an issue even among those with access, no out-of-pocket costs, and after adjusting for confounders. We used an approach called the Oaxaca-Blinder (OB) decomposition method to ascertain the contribution of covariates individually and in aggregate to the racial disparity in influenza vaccination. Methods We included members > = 18 years of age as of 05/01/2014 with continuous enrollment through 04/30/2015. Influenza vaccination was defined by diagnosis, procedure, or medication codes, or documentation in the immunization table. Characteristics were reported by race. Logistic regression models estimated the odds of vaccination associated with: (1) race; and (2) covariates stratified by race. The Oaxaca-Blinder (OB) method calculated the contribution of covariates to the difference or disparity in vaccination between Blacks and Whites. Results We found that among adults, 44% were vaccinated; 55% were Black; and 45% were White. Black members have 42% lower odds of vaccination than White members. The contribution of the differences in the average value of the study covariates between Black and White members (the OB covariate effect) accounted for 29% of the racial disparity. The contributions to the total White-Black disparity in vaccination included: age (16%), neighborhood median income (11%), and registration on the online patient portal (13%). The contribution of the differences in how the covariates impact vaccination (OB coefficient effect) accounted for 71% of the disparity in vaccination between Blacks and Whites. Conclusion In conclusion, equalizing average covariate values in Blacks and Whites could reduce the racial disparity in influenza vaccination by 29%. For health system vaccine campaigns, improving registration on the patient portal may be a target component of an effective system-level strategy to reduce racial disparities in vaccination. Additional information on patient-centered factors could further improve the value of the OB approach.	[Vupputuri, Suma; Rubenstein, Kevin B.; Derus, Alphonse J.; Horberg, Michael A.] Kaiser Permanente Midatlantic States, Midatlantic Permanente Med Grp, Midatlantic Permanente Res Inst, Rockville, MD 20852 USA; [Loftus, Bernadette C.] Kaiser Permanente Midatlantic States, Midatlantic Permanente Med Grp, Rockville, MD USA	Kaiser Permanente; Permanente Medical Groups; Kaiser Permanente; Permanente Medical Groups	Vupputuri, S (corresponding author), Kaiser Permanente Midatlantic States, Midatlantic Permanente Med Grp, Midatlantic Permanente Res Inst, Rockville, MD 20852 USA.	suma.vupputuri@kp.org		Rubenstein, Kevin/0000-0003-3516-5932; Vupputuri, Suma/0000-0001-6848-2649				BLINDER AS, 1973, J HUM RESOUR, V8, P436, DOI 10.2307/144855; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; CHERNOFF H, 1954, ANN MATH STAT, V25, P579, DOI 10.1214/aoms/1177728726; Cullen KA, 2016, MMWR SURVEILL SUMM, V65, P1, DOI 10.15585/mmwr.ss6502a1; Derrick B, 2016, QUANT METH PSYCHOL, V12, P30, DOI 10.20982/tqmp.12.1.p030; Dushoff J, 2006, AM J EPIDEMIOL, V163, P181, DOI 10.1093/aje/kwj024; Fiscella K, 2005, HEALTH SERV RES, V40, P539, DOI 10.1111/j.1475-6773.2005.0w372.x; Gasparini R, 2016, J Prev Med Hyg, V57, pE1; Jann B, 2008, STATA J, V8, P453, DOI 10.1177/1536867X0800800401; Link MW, 2006, AM J EPIDEMIOL, V163, P571, DOI 10.1093/aje/kwj086; Lu PJ, 2015, VACCINE, V33, pD83, DOI 10.1016/j.vaccine.2015.09.031; Marin MG, 2002, PREV MED, V34, P235, DOI 10.1006/pmed.2001.0983; Oaxaca R., 1973, INT ECON REV, V14, P693, DOI DOI 10.2307/2525981; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Ruxton GD, 2006, BEHAV ECOL, V17, P688, DOI 10.1093/beheco/ark016; Santibanez T. A. e. a., 2015, FLU VACCINATION COVE; Thompson WW, 2006, J INFECT DIS, V194, pS82, DOI 10.1086/507558; Wang JL, 2014, RES SOC ADMIN PHARM, V10, P126, DOI 10.1016/j.sapharm.2013.04.011; WELCH BL, 1947, BIOMETRIKA, V34, P28, DOI 10.2307/2332510; Yoo BK, 2015, VACCINE, V33, P2997, DOI 10.1016/j.vaccine.2015.03.054; Yun MS, 2004, ECON LETT, V82, P275, DOI 10.1016/j.econlet.2003.09.008	22	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0213972	10.1371/journal.pone.0213972	http://dx.doi.org/10.1371/journal.pone.0213972			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HR5NS	30943242	Green Submitted, gold, Green Published			2022-12-26	WOS:000463194300025
J	Klopfstein, S; Spasojevic, T				Klopfstein, Seraina; Spasojevic, Tamara			Illustrating phylogenetic placement of fossils using RoguePlots: An example from ichneumonid parasitoid wasps (Hymenoptera, Ichneumonidae) and an extensive morphological matrix	PLOS ONE			English	Article							LIKELIHOOD-ESTIMATION; EVOLUTIONARY TREES; DNA-SEQUENCES; CHARACTER; EOCENE; RADIATION; INFERENCE; CLOCKS; ORIGIN; IMPACT	The fossil record constitutes the primary source of information about the evolutionary history of extant and extinct groups, and many analyses of macroevolution rely on fossils that are accurately placed within phylogenies. To avoid misinterpretation of the fossil record, especially by non-palaeontologists, the proper assessment and communication of uncertainty in fossil placement is crucial. We here use Bayesian morphological phylogenetics to evaluate the classifications of fossil parasitoid wasps (Hymenoptera, lchneumonidae) and introduce `RoguePlots' to illustrate placement uncertainty on the phylogeny of extant taxa. Based on an extensive, newly constructed morphological matrix of 222 characters in 24 fossil and 103 extant taxa, we test three different aspects of models of morphological evolution. We find that a model that includes ordered characters, among-character rate variation, and a state space restricted to observed states achieves the highest marginal likelihoods. The individual RoguePlots reveal large differences in confidence in the placement of the different fossils and allow some refinements to their classification: Polyhelictes bipolarus and Ichninsum appendicrassum are moved from an uncertain subfamily placement to Pimplinae, Plectiscidea lanhami is transferred to Allomacrus in Cylloceriinae (Allomacrus lanhami, comb. nov.), Lithotorus cressoni is moved from Diplazontinae to Orthocentrinae, and we note uncertainty in the generic placements of Rhyssella? vera and Xanthopimpla? messelensis. We discuss potential artefacts that might result in biased posterior probabilities in Bayesian morphological phylogenetic analyses, pertaining to character and taxon sampling, fossilization biases, and model misspecification. Finally, we suggest future directions both in ichneumonid palaeontology and in the way RoguePlots can improve both assessment and representation of placement uncertainty, both in fossils and other rogue taxa.	[Klopfstein, Seraina] Nat Hist Museum Basel, Biowissensch, Basel, Switzerland; [Klopfstein, Seraina; Spasojevic, Tamara] Univ Bern, Inst Ecol & Evolut, Bern, Switzerland; [Klopfstein, Seraina; Spasojevic, Tamara] Nat Hist Museum Basel, Dept Invertebrates, Bern, Switzerland	University of Bern	Klopfstein, S (corresponding author), Nat Hist Museum Basel, Biowissensch, Basel, Switzerland.; Klopfstein, S (corresponding author), Univ Bern, Inst Ecol & Evolut, Bern, Switzerland.; Klopfstein, S (corresponding author), Nat Hist Museum Basel, Dept Invertebrates, Bern, Switzerland.	seraina.klopfstein@bs.ch		Klopfstein, Seraina/0000-0002-4025-975X; Spasojevic, Tamara/0000-0001-5301-5722	Swiss National Science Foundation [PZ00P3_154791]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was funded by the Swiss National Science Foundation (grant PZ00P3_154791 to SK) (www.snf.ch).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberer AJ, 2013, SYST BIOL, V62, P162, DOI 10.1093/sysbio/sys078; Alekseyenko AV, 2008, SYST BIOL, V57, P772, DOI 10.1080/10635150802434394; Antropov AV, 2014, EARTH ENV SCI T R SO, V104, P335, DOI 10.1017/S1755691014000103; Bapst DW, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2016.0237; Beck RMD, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1278; Bennett A.M.R., 2015, MEMOIRS AM ENTOMOLOG, V86, P1; Brues Charles T., 1910, Bulletin of the Museum of Comparative Zoology at Harvard College, V54; Clarke JA, 2008, SYST BIOL, V57, P185, DOI 10.1080/10635150802022231; Close RA, 2015, CURR BIOL, V25, P2137, DOI 10.1016/j.cub.2015.06.047; Cockerell T. D. A., 1921, Proceedings of the United States National Museum, V59, P29; Cockerell T. D. A., 1920, Proceedings of the United States National Museum, V57; Cockerell TDA, 1941, AM J SCI, V239, P354, DOI 10.2475/ajs.239.5.354; Cockerell TDA, 1919, AM J SCI, V47, P376; Cockerell TDA, 1931, AM NAT, V65, P351, DOI 10.1086/280378; Donoghue PCJ, 2007, TRENDS ECOL EVOL, V22, P424, DOI 10.1016/j.tree.2007.05.005; Estes JA, 2005, PALEOBIOLOGY, V31, P591, DOI 10.1666/04059.1; FELSENSTEIN J, 1973, AM J HUM GENET, V25, P471; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Gauld ID, 2002, ZOOL J LINN SOC-LOND, V136, P421, DOI 10.1046/j.1096-3642.2002.00031.x; GAULD ID, 1982, SYST ENTOMOL, V7, P73, DOI 10.1111/j.1365-3113.1982.tb00127.x; Goloboff PA, 2018, PALAEONTOLOGY, V61, P625, DOI 10.1111/pala.12353; Gorscak E, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2015.1047; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Kay RF, 2015, MOL PHYLOGENET EVOL, V82, P358, DOI 10.1016/j.ympev.2013.12.002; Khalaim Andrey I., 2008, Alavesia, V2, P101; Klopfstein S, 2018, SYSTEMATIC ENTOMOLOG; Klopfstein S, 2015, SYST BIOL, V64, P1089, DOI 10.1093/sysbio/syv052; Kopylov DS, 2018, ZOOTAXA, V4442, P319, DOI 10.11646/zootaxa.4442.2.8; Kopylov DS, 2012, PALEONTOL J+, V46, P383, DOI 10.1134/S0031030112040041; Kopylov DS, 2012, PALEONTOL J+, V46, P66, DOI 10.1134/S0031030112010078; Kopylov D.S., 2010, Paleontologicheskii Zhurnal, V4, P59; Kopylov D.S., 2009, Paleontologicheskii Zhurnal, V1, P76; Kopylov DS, 2010, AFR INVERTEBR, V51, P423, DOI 10.5733/afin.051.0211; Labandeira CC, 2013, ANNU REV EARTH PL SC, V41, P287, DOI 10.1146/annurev-earth-050212-124139; Lee MSY, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2016.0033; Lee MSY, 2015, CURR BIOL, V25, pR922, DOI 10.1016/j.cub.2015.07.009; Lee MSY, 2014, SYST BIOL, V63, P442, DOI 10.1093/sysbio/syt110; Lewis PO, 2001, SYST BIOL, V50, P913, DOI 10.1080/106351501753462876; Littlewood D. Timothy J., 2003, Geology Today, V19, P136, DOI 10.1046/j.1365-2451.2003.00406.x; Martinez-Delclos X, 2004, PALAEOGEOGR PALAEOCL, V203, P19, DOI 10.1016/S0031-0182(03)00643-6; MATTHEWS S C, 1973, Palaeontology (Oxford), V16, P713; Mitchell A.A, 2013, EDNA FOSSIL INSECT D; O'Reilly JE, 2018, PALAEONTOLOGY, V61, P631, DOI 10.1111/pala.12361; O'Reilly JE, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2016.0081; Parham JF, 2012, SYST BIOL, V61, P346, DOI 10.1093/sysbio/syr107; Pham Nhi Thi, 2011, Zootaxa, V3056, P1; Pyron RA, 2011, SYST BIOL, V60, P466, DOI 10.1093/sysbio/syr047; Ronquist F, 2012, SYST BIOL, V61, P973, DOI 10.1093/sysbio/sys058; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Rust Jes, 1998, Palaeontologische Zeitschrift, V72, P41; Sansom RS, 2013, SCI REP-UK, V3, DOI 10.1038/srep02545; Santos BF, 2017, SYST ENTOMOL, V42, P650, DOI 10.1111/syen.12238; Scudder S.H., 1890, REPORT US GEOLOGICAL, V13, P1, DOI [10.5962/bhl.title.44698, DOI 10.5962/BHL.TITLE.44698, 10.5962/bhl.title.2507]; Slater GJ, 2012, EVOLUTION, V66, P3931, DOI 10.1111/j.1558-5646.2012.01723.x; SLOWINSKI JB, 1993, SYST BIOL, V42, P155, DOI 10.2307/2992538; Spasojevic T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197477; Spasojevic T, 2018, PALZ, V92, P35, DOI 10.1007/s12542-017-0365-5; THIELE K, 1993, CLADISTICS, V9, P275, DOI 10.1111/j.1096-0031.1993.tb00226.x; Townes H., 1969, Memoirs of the American Entomological Institute, V11, P1; TOWNES H, 1966, P ENTOMOL SOC WASH, V68, P132; Wagner PJ, 1998, PALEOBIOLOGY, V24, P430, DOI 10.1017/S0094837300020091; Wiens JJ, 2004, SYST BIOL, V53, P653, DOI 10.1080/10635150490472959; Wilkinson M, 1996, MOL BIOL EVOL, V13, P437, DOI 10.1093/oxfordjournals.molbev.a025604; Wills MA, 2001, GEOL J, V36, P187, DOI 10.1002/gj.882; Wortley AH, 2006, SYST BIOL, V55, P677, DOI 10.1080/10635150600899798; Wright AM, 2016, SYST BIOL, V65, P602, DOI 10.1093/sysbio/syv122; Wright DF, 2017, J PALEONTOL, V91, P799, DOI 10.1017/jpa.2016.141; Xie WG, 2011, SYST BIOL, V60, P150, DOI 10.1093/sysbio/syq085; Xu X, 2011, NATURE, V475, P465, DOI 10.1038/nature10288; Yang ZH, 1996, TRENDS ECOL EVOL, V11, P367, DOI 10.1016/0169-5347(96)10041-0; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154; Yu D.S.K., 2016, DATABASE FLASH DRIVE	72	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2019	14	4							e0212942	10.1371/journal.pone.0212942	http://dx.doi.org/10.1371/journal.pone.0212942			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR2UW	30939174	gold, Green Published, Green Submitted			2022-12-26	WOS:000462993900004
J	Lee, YC; Hu, TH; Hung, CH; Lu, SN; Chen, CH; Wang, JH				Lee, Yu-Chi; Hu, Tsung-Hui; Hung, Chao-Hung; Lu, Sheng-Nan; Chen, Chien-Hung; Wang, Jing-Houng			The change in liver stiffness, controlled attenuation parameter and fibrosis-4 index for chronic hepatitis C patients with direct-acting antivirals	PLOS ONE			English	Article							TRANSIENT ELASTOGRAPHY; VIRUS-INFECTION; THERAPY; STEATOSIS	Background and aim Transient elastography and fibrosis-4 index (FIB-4) have been proposed to access hepatic fibrosis and steatosis for patients with chronic liver disease. This study was to determine the changes of liver stiffness (LS), controlled attenuation parameter (CAP) value and FIB-4 and their associated factors for chronic hepatitis C (CHC) patients who underwent direct-acting antivirals (DAAs). Patients and methods Consecutive patients with CHC in advanced fibrosis or compensated cirrhosis undergoing paritaprevir/ritonavir/ombitasvir plus dasabuvir therapy and with LS and CAP before and 12 weeks after treatment were enrolled. The demographics, clinical characteristics and treatment outcomes were reviewed. The changes of LS, FIB-4, CAP and their associated factors were analyzed. Results A total of 213 patients (mean age: 63.7 years) with complete recommended treatment were enrolled. All patients achieved sustained virological response at 12 weeks (SVR12) of follow-up. The mean values of LS, CAP and FIB-4 index before treatment were 18.5kPa, 283dB/m and 5.05 respectively. While there was no significant change in CAP, LS and FIB-4 decreased significantly at the time of SVR12 (p<0.001). Compared with follow-up period, LS and FIB-4 decreased rapidly during DDAs. Multivariate analysis showed that higher baseline LS and FIB-4 were associated with greater reductions at the time of SVR12. Conclusion For CHC patients in advanced fibrosis or compensated cirrhosis, DAAs improved LS and FIB-4 index at SVR12. Higher baseline LS and FIB-4 contributed to greater reductions. However, there was no significant change in CAP value.	[Lee, Yu-Chi; Hu, Tsung-Hui; Hung, Chao-Hung; Lu, Sheng-Nan; Chen, Chien-Hung; Wang, Jing-Houng] Kaohsiung Chang Gung Mem Hosp, Div Hepatogastroenterol, Dept Med Kaohsiung, Kaohsiung, Taiwan; [Lee, Yu-Chi; Hu, Tsung-Hui; Hung, Chao-Hung; Lu, Sheng-Nan; Chen, Chien-Hung; Wang, Jing-Houng] Chang Gung Univ, Kaohsiung, Taiwan; [Hung, Chao-Hung; Lu, Sheng-Nan] Chia Yi Chang Gung Mem Hosp, Div Hepatogastroenterol, Dept Med, Chiayi, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital	Wang, JH (corresponding author), Kaohsiung Chang Gung Mem Hosp, Div Hepatogastroenterol, Dept Med Kaohsiung, Kaohsiung, Taiwan.; Wang, JH (corresponding author), Chang Gung Univ, Kaohsiung, Taiwan.	wajing@cgmh.org.tw						[Anonymous], 2015, J HEPATOL, V63, P237, DOI 10.1016/j.jhep.2015.04.006; Arena U, 2008, HEPATOLOGY, V47, P380, DOI 10.1002/hep.22007; Axley P, 2018, J CLIN TRANSL HEPATO, V6, P79, DOI 10.14218/JCTH.2017.00067; Bachofner JA, 2017, LIVER INT, V37, P369, DOI 10.1111/liv.13256; Blach S, 2017, LANCET GASTROENTEROL, V2, P161, DOI 10.1016/S2468-1253(16)30181-9; Chekuri S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159413; Coco B, 2007, J VIRAL HEPATITIS, V14, P360, DOI 10.1111/j.1365-2893.2006.00811.x; Elsharkawy A, 2017, J GASTROEN HEPATOL, V32, P1624, DOI 10.1111/jgh.13758; European Ass Study Liver, 2017, J HEPATOL, V66, P153, DOI 10.1016/j.jhep.2016.09.001; Ferraioli G, 2018, ULTRASOUND MED BIOL, V44, P2419, DOI 10.1016/j.ultrasmedbio.2018.07.008; Friedrich-Rust M, 2008, GASTROENTEROLOGY, V134, P960, DOI 10.1053/j.gastro.2008.01.034; George SL, 2009, HEPATOLOGY, V49, P729, DOI 10.1002/hep.22694; Hezode C, 2018, LIVER INT, V38, P21, DOI 10.1111/liv.13638; Karlas T, 2017, J HEPATOL, V66, P1022, DOI 10.1016/j.jhep.2016.12.022; Kobayashi N, 2018, EUR J GASTROEN HEPAT, V30, P546, DOI [10.1097/MEG.0000000000001106, 10.1097/meg.0000000000001106]; Ogasawara N, 2018, J MED VIROL, V90, P313, DOI 10.1002/jmv.24950; Rubbia-Brandt L, 2001, HISTOPATHOLOGY, V39, P119, DOI 10.1046/j.1365-2559.2001.01208.x; Sasso M, 2010, ULTRASOUND MED BIOL, V36, P1825, DOI 10.1016/j.ultrasmedbio.2010.07.005; Singh S, 2018, CLIN GASTROENTEROL H, V16, P27, DOI 10.1016/j.cgh.2017.04.038; Tada T, 2018, ALIMENT PHARM THER, V47, P1012, DOI 10.1111/apt.14554; Turner BJ, 2017, EUR J GASTROEN HEPAT, V29, P192, DOI 10.1097/MEG.0000000000000766	21	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2019	14	4							e0214323	10.1371/journal.pone.0214323	http://dx.doi.org/10.1371/journal.pone.0214323			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR2UW	30939158	Green Submitted, Green Published, gold			2022-12-26	WOS:000462993900017
J	Lin, CK; Liu, ST; Chang, CC; Huang, SM				Lin, Chi-Kang; Liu, Shu-Ting; Chang, Cheng-Chang; Huang, Shih-Ming			Regulatory mechanisms of fluvastatin and lovastatin for the p21 induction in human cervical cancer HeLa cells	PLOS ONE			English	Article							TRANSCRIPTIONAL ACTIVATION; P21(WAF1/CIP1) GENE; CARDIAC-GLYCOSIDES; P53; CARCINOMA; UBIQUITINATION; DEGRADATION; INHIBITION; EXPRESSION; REDUCTASE	p21, an inhibitor of cyclin-dependent kinase, functions as an oncogene or tumor suppressor depending on the context of a variety of extracellular and intracellular signals. The expression of p21 could be regulated at the transcriptional and/or post-translational levels. The p21 gene is well-known to be regulated in both p53-dependent and -independent manners. However, the detailed regulatory mechanisms of p21 messenger RNA and protein expression via statins remain unknown, and the possible application of statins as anticancer reagents remains to be controversial. Our data showed that the statins-fluvastatin and lovastatin-induced p21 expression as general histone deacetylase inhibitors in a p53-independent manner, which is mediated through various pathways, such as apoptosis, autophagy, cell cycle progression, and DNA damage, to be involved in the function of p21 in HeLa cells. The curative effect repositioning of digoxin, a cardiovascular medication, was combined with fluvastatin and lovastatin, and the results further implied that p21 induction is involved in a p53-dependent and p53-independent manner. Digoxin modified the effects of statins on ATF3, p21, p53, and cyclin D1 expression, while fluvastatin boosted its DNA damage effect and lovastatin impeded its DNA damage effect. Fluvastatin and lovastatin combined with digoxin further support the localization specificity of their interactivity with our subcellular localization data. This study will not only clarify the regulatory mechanisms of p21 induction by statins but will also shed light on the repurposing of widely cardiovascular medications for the treatment of cervical cancer.	[Lin, Chi-Kang; Chang, Cheng-Chang] Natl Def Med Ctr, Triserv Gen Hosp, Dept Obstet & Gynecol, Taipei, Taiwan; [Liu, Shu-Ting; Huang, Shih-Ming] Natl Def Med Ctr, Dept Biochem, Taipei, Taiwan	National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center	Chang, CC (corresponding author), Natl Def Med Ctr, Triserv Gen Hosp, Dept Obstet & Gynecol, Taipei, Taiwan.; Huang, SM (corresponding author), Natl Def Med Ctr, Dept Biochem, Taipei, Taiwan.	obsgynchang@gmail.com; shihming@ndmctsgh.edu.tw		Lin, Chi-Kang/0000-0001-8608-1320; Chang, Cheng-Chang/0000-0002-7356-446X; Huang, Shih-Ming/0000-0001-9305-921X	Ministry of Science and Technology [MOST 106-2314-B-016-042, 107-2314-B-016-036]; Tri-Service General Hospital [TSGH-C107-083]; Ministry of National Defense-Medical Affairs Bureau, Taiwan, ROC [MAB-107-010]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Tri-Service General Hospital; Ministry of National Defense-Medical Affairs Bureau, Taiwan, ROC	This work was supported by grants from the Ministry of Science and Technology [MOST 106-2314-B-016-042 and 107-2314-B-016-036 to C-C Chang], the Tri-Service General Hospital [TSGH-C107-083 to C-C Chang], and the Ministry of National Defense-Medical Affairs Bureau [MAB-107-010 to S-M HUANG], Taiwan, ROC". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Bagrov AY, 2009, PHARMACOL REV, V61, P9, DOI 10.1124/pr.108.000711; Biggs JR, 1996, J BIOL CHEM, V271, P901, DOI 10.1074/jbc.271.2.901; Brooks CL, 2004, CELL CYCLE, V3, P895; Chang YH, 2011, ACCIDENT ANAL PREV, V43, P1049, DOI 10.1016/j.aap.2010.12.009; Chang YL, 2017, INT J BIOCHEM CELL B, V92, P155, DOI 10.1016/j.biocel.2017.10.003; Chen JB, 2013, J MED CHEM, V56, P3645, DOI 10.1021/jm400179b; Chen YC, 2013, CELL DEATH DIFFER, V20, P732, DOI 10.1038/cdd.2013.1; Elbaz HA, 2012, EXP HEMATOL ONCOL, V1, DOI 10.1186/2162-3619-1-4; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Haines BE, 2013, ACCOUNTS CHEM RES, V46, P2416, DOI 10.1021/ar3003267; Hao ZF, 2015, TUMOR BIOL, V36, P1471, DOI 10.1007/s13277-014-2618-1; Istvan ES, 2000, EMBO J, V19, P819, DOI 10.1093/emboj/19.5.819; Istvan ES, 2001, SCIENCE, V292, P1160, DOI 10.1126/science.1059344; Knox JJ, 2005, EUR J CANCER, V41, P523, DOI 10.1016/j.ejca.2004.12.013; Kulikov A, 2007, BBA-BIOMEMBRANES, V1768, P1691, DOI 10.1016/j.bbamem.2007.04.012; Lin YC, 2009, ENERG ENVIRON SCI, V2, P68, DOI 10.1039/b814955k; Liu M, 1996, GENE DEV, V10, P142, DOI 10.1101/gad.10.2.142; Liu M, 1996, J BIOL CHEM, V271, P31723, DOI 10.1074/jbc.271.49.31723; Liu PY, 2008, MOL CANCER RES, V6, P1204, DOI 10.1158/1541-7786.MCR-08-0123; Liu PY, 2011, EXP CELL RES, V317, P2925, DOI 10.1016/j.yexcr.2011.09.018; Lu GY, 2014, BIOCHIMIE, V106, P131, DOI 10.1016/j.biochi.2014.08.013; Menger L, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003807; Mo PL, 2010, J BIOL CHEM, V285, P26908, DOI 10.1074/jbc.M110.132597; Nickless A, 2014, NAT MED, V20, P961, DOI 10.1038/nm.3620; Ocker M, 2007, INT J BIOCHEM CELL B, V39, P1367, DOI 10.1016/j.biocel.2007.03.001; Perne A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008292; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; Schoner W, 2007, AM J CARDIOVASC DRUG, V7, P173, DOI 10.2165/00129784-200707030-00004; SCHWARZ E, 1985, NATURE, V314, P111, DOI 10.1038/314111a0; Vaklavas C, 2011, PHARMACOL THERAPEUT, V130, P177, DOI 10.1016/j.pharmthera.2011.01.009; Wang HB, 2010, J BIOL CHEM, V285, P13201, DOI 10.1074/jbc.M109.058669; Wang Z, 2009, CANCER RES, V69, P6556, DOI 10.1158/0008-5472.CAN-09-0891; Warfel NA, 2013, CURR OPIN ONCOL, V25, P52, DOI 10.1097/CCO.0b013e32835b639e	34	6	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2019	14	4							e0214408	10.1371/journal.pone.0214408	http://dx.doi.org/10.1371/journal.pone.0214408			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR2UW	30939155	Green Published, Green Submitted, gold			2022-12-26	WOS:000462993900021
J	Alem, KD; Arega, DD; Weldegiorgis, ST; Agaje, BG; Tigneh, EG				Alem, Kindie Desta; Arega, Demoze Delelegn; Weldegiorgis, Samson Tesfaye; Agaje, Bekalu Getahun; Tigneh, Emebet Girma			Profile of ocular trauma in patients presenting to the department of ophthalmology at Hawassa University: Retrospective study	PLOS ONE			English	Article							PATTERN	Purpose To assess the pattern, presentation and risk factors of ocular trauma among patients treated at Hawassa University, Referral Hospital, Ophthalmology Department, South Ethiopia, 2014. Methods The medical records of all patients treated for ocular trauma at Hawassa University, Referral Hospital, Ophthalmology Department, during the period January 01, 2012 to July 31, 2014, were retrospectively reviewed. Trained optometrists, ophthalmic nurses and ophthalmic officer collected the data using a pretested data abstraction form. The descriptive and analytic statistics was carried out. Results A total of 773 patients (549 males and 224 females) were included in the study. Closed globe injury was more common in males (P = 0.019) and open globe injury was significantly common in children (P < 0.001). Corneal tear was the most frequently observed finding (39.33%). Surgery, secondary to trauma, was common in open globe injury (P < 0.001). About 98% of the patients presented after 6 hours post trauma. Among 84.61% patients whose visual acuity (VA) was recorded at presentation, 12.23% had VA of 6/6 and 65.90% had VA of <3/60. Conclusion Ocular trauma was more common in males and children. Majority of patients (98%) presented after 6 hours post trauma. Cornea was the most commonly affected ocular structure by trauma.	[Alem, Kindie Desta; Arega, Demoze Delelegn; Agaje, Bekalu Getahun; Tigneh, Emebet Girma] Hawassa Univ, Coll Med & Hlth Sci, Dept Ophthalmol & Optometry, Hawassa, Ethiopia; [Weldegiorgis, Samson Tesfaye] Orbis Int Ethiopia, Addis Ababa, Ethiopia	Hawassa University	Alem, KD (corresponding author), Hawassa Univ, Coll Med & Hlth Sci, Dept Ophthalmol & Optometry, Hawassa, Ethiopia.	kindudiaopt@gmail.com	Desta, Kindie/R-4616-2019	Desta, Kindie/0000-0002-3772-1712	Orbis International-Ethiopia	Orbis International-Ethiopia	The research was financially supported by Orbis International-Ethiopia to KDA. Except the one who coauthored here, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addisu Z, 2011, ETHIOP J HEALTH DEV, V25, P150; Alemayehu W, 2015, JOECSA, V18; Babar TF, 2007, JCPSP-J COLL PHYSICI, V17, P148; Dhasmana R, 2012, INDAN J COMMUNITY HE, V24, P297; Ferenc K, 2002, ZDR VESTN, V71, P17; Jahangir T, 2011, PAK J OPHTHALMOL, V27, P96; Khan S, 2012, SAUDI J OPHTHALMOL, V26, P327, DOI 10.1016/j.sjopt.2012.04.004; Khurana A., 2007, COMPREHENSIVE OPHTHA; Kinderan YV, 2012, NEPAL J OPHTHALMOL, V4, P5, DOI 10.3126/nepjoph.v4i1.5843; Lee Ching-Hsing, 2008, Chang Gung Med J, V31, P59; Lewallen S, 2001, BRIT J OPHTHALMOL, V85, P897, DOI 10.1136/bjo.85.8.897; MacEwen CJ, 1999, J ROY COLL SURG EDIN, V44, P317; Omolase Charles Oluwole, 2011, J Ophthalmic Vis Res, V6, P114; Soliman MM, 2008, GRAEF ARCH CLIN EXP, V246, P205, DOI 10.1007/s00417-007-0720-4; Sthapit P R, 2011, Kathmandu Univ Med J (KUMJ), V9, P54; Tejas D, 2013, NHL J MED SCI, V2, P37; Tesfaye A, 2008, East Afr Med J, V85, P593; Titiyal GS, 2013, J INDIAN ACAD FORENS, V35, P116	18	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0213893	10.1371/journal.pone.0213893	http://dx.doi.org/10.1371/journal.pone.0213893			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921358	Green Published, Green Submitted, gold			2022-12-26	WOS:000462594000027
J	Gunn, KM; Holly, MA; Veith, TL; Buda, AR; Prasad, R; Rotz, CA; Soder, KJ; Stoner, AMK				Gunn, Kpoti M.; Holly, Michael A.; Veith, Tamie L.; Buda, Anthony R.; Prasad, Rishi; Rotz, C. Alan; Soder, Kathy J.; Stoner, Anne M. K.			Projected heat stress challenges and abatement opportunities for US milk production	PLOS ONE			English	Article							CALF BIRTH-WEIGHT; DAIRY-COWS; CLIMATE-CHANGE; LATE-GESTATION; HOLSTEIN COWS; DRY COWS; TEMPERATURE; YIELD; PERFORMANCE; HUMIDITY	Cost-effective heat mitigation strategies are imperative for maintaining milk production and dairy farm profitability in the U.S. with projected climate change. This study investigated the cost-effectiveness of four heat abatement strategies, including Minimal (open barn or shading), Moderate (forced ventilation), High (fans and misting), and Intense (air conditioning). Heat stress and subsequent impacts on milk production per cow were predicted across nine climatic regions in the U.S. for early (2015 to 2034), mid (2045 to 2064) and late (2081 to 2100) 21st century, using downscaled climate projections. Heat abatements were used to adjust predicted milk production losses and illustrate the potential to reduce milk production losses due to heat stress. Economic analysis included a cost-benefit ratio calculation associated with the implementation of each heat abatement. Results showed that milk production losses were expected to accelerate across the U.S. at a mean rate of 174 +/- 7 kg/cow/decade, with the fastest rate in the Southeast region. Relative to Minimal heat abatement, Moderate, High, and Intense heat abatements increased annual milk production per cow by 3%, 4%, and 6% during early-21st century, 3%, 6%, and 11% during mid-21st century, and 3%, 8%, and 21% during late-21st century, respectively. The cost effectiveness of different heat abatement strategies generally increased with subsequently stronger heat abatements. In mid- and late-21st century, mean annual net values of High and Intense heat stress abatement implementation approached -$30 to $190 /cow and -$20 to $590 /cow, respectively, with the largest net annual benefit in late-21st century under Intense abatement. Findings from the study demonstrate the value of using downscaled climate projections to shed light on local and regional strategies to abate heat stress on cattle and mitigate potential milk production losses due to climate change.	[Gunn, Kpoti M.; Holly, Michael A.; Veith, Tamie L.; Buda, Anthony R.; Rotz, C. Alan; Soder, Kathy J.] USDA ARS, Pasture Syst & Watershed Management Res Unit, University Pk, PA 16802 USA; [Prasad, Rishi] Auburn Univ, Crop Soil & Environm Sci, Auburn, AL 36849 USA; [Stoner, Anne M. K.] Texas Tech Univ, Climate Sci Ctr, Lubbock, TX 79409 USA	United States Department of Agriculture (USDA); Auburn University System; Auburn University; Texas Tech University System; Texas Tech University	Gunn, KM (corresponding author), USDA ARS, Pasture Syst & Watershed Management Res Unit, University Pk, PA 16802 USA.	Stephankpoti.Gunn@ars.usda.gov	Buda, Anthony/ABA-3525-2021	, Stephan Kpoti/0000-0002-8181-7447; Rumery, Holly/0000-0002-9970-1098				Aguilar I, 2010, J DAIRY SCI, V93, P1754, DOI 10.3168/jds.2009-2756; Bennett J, 2010, DEPRECIATION CLASS L; BERMAN A, 1985, J DAIRY SCI, V68, P1488, DOI 10.3168/jds.S0022-0302(85)80987-5; Bohmanova J, 2007, J DAIRY SCI, V90, P1947, DOI 10.3168/jds.2006-513; Bucklin RA, 2009, APPL ENG AGRIC, V25, P727; Carabano MJ, 2016, J DAIRY SCI, V99, P3798, DOI 10.3168/jds.2015-10212; Coffel ED, 2018, ENVIRON RES LETT, V13, DOI 10.1088/1748-9326/aaa00e; COLLIER RJ, 1982, J ANIM SCI, V54, P309, DOI 10.2527/jas1982.542309x; Collier RJ, 2006, J DAIRY SCI, V89, P1244, DOI 10.3168/jds.S0022-0302(06)72193-2; COLLIER RJ, 1981, J DAIRY SCI, V64, P844, DOI 10.3168/jds.S0022-0302(81)82656-2; Dahl GE, 2016, J DAIRY SCI, V99, P3193, DOI 10.3168/jds.2015-9990; Das R, 2016, VET WORLD, V9, P260, DOI 10.14202/vetworld.2016.260-268; de Mendiburu F, 2016, AGRICOLAE STAT PROCE; De Rensis F, 2015, THERIOGENOLOGY, V84, P659, DOI 10.1016/j.theriogenology.2015.04.021; Dunn RJH, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/6/064006; Federal Reserve, 2018, DISC RAT DAT; Ferrazza RD, 2017, J THERM BIOL, V66, P68, DOI 10.1016/j.jtherbio.2017.03.014; Ferreira FC, 2016, J DAIRY SCI, V99, P9931, DOI 10.3168/jds.2016-11566; FINCH VA, 1984, J AGR SCI-CAMBRIDGE, V102, P141, DOI 10.1017/S0021859600041575; Fournel S, 2017, ANIMALS-BASEL, V7, DOI 10.3390/ani7050037; Gauly M, 2013, ANIMAL, V7, P843, DOI 10.1017/S1751731112002352; Gooch CA, 2000, ASAE ANN INT; Gooch CA, 2003, 5 INT DAIR HOUS C P, P227; Gould B, 2017, UNDERSTANDING DAIRY; Hahn L, 1970, T ASAE, V12, P448; Harner JP, 1999, SPRINKLER SYSTEMS CO; Hatfield JL, 2011, AGRON J, V103, P351, DOI 10.2134/agronj2010.0303; HER E, 1988, J DAIRY SCI, V71, P1085, DOI 10.3168/jds.S0022-0302(88)79656-3; Hill DL, 2015, ANIMAL, V9, P138, DOI 10.1017/S1751731114002456; Holly MA, 2018, J DAIRY SCI, V101, P6632, DOI 10.3168/jds.2017-13819; Hristov AN, 2018, CLIMATIC CHANGE, V146, P33, DOI 10.1007/s10584-017-2023-z; IGONO MO, 1992, INT J BIOMETEOROL, V36, P77, DOI 10.1007/BF01208917; IGONO MO, 1987, J DAIRY SCI, V70, P1069, DOI 10.3168/jds.S0022-0302(87)80113-3; Johnson H D, 1962, RES B MISSOURI AGR E, V79; Jones G.A., 2017, LARGE DAIRY HERD MAN, V3rd, P71; Kadzere CT, 2002, LIVEST PROD SCI, V77, P59, DOI 10.1016/S0301-6226(01)00330-X; Kammel DW, 2015, BUILDING COSTS ESTIM; Karl T.R., 1984, HIST CLIMATOLOGY SER, V4-3; Key N, 2014, AM J AGR ECON, V96, P1136, DOI 10.1093/ajae/aau002; Khongdee S, 2006, INT J BIOMETEOROL, V50, P253, DOI 10.1007/s00484-006-0030-2; Laporta J, 2017, J DAIRY SCI, V100, P2976, DOI 10.3168/jds.2016-11993; Lawrence MG, 2005, B AM METEOROL SOC, V86, P225, DOI 10.1175/BAMS-86-2-225; Manning MR, 2010, NAT GEOSCI, V3, P376, DOI 10.1038/ngeo880; Mauger G, 2015, PROF GEOGR, V67, P121, DOI 10.1080/00330124.2014.921017; Monteiro APA, 2016, J DAIRY SCI, V99, P8443, DOI 10.3168/jds.2016-11072; Moriasi DN, 2007, T ASABE, V50, P885, DOI 10.13031/2013.23153; Nidumolu U, 2014, INT J BIOMETEOROL, V58, P1095, DOI 10.1007/s00484-013-0703-6; OECD (Organisation for Economic Co-operation and Development), 2014, EC OUTL 95 LONG TERM; Ravagnolo O, 2000, J DAIRY SCI, V83, P2120, DOI 10.3168/jds.S0022-0302(00)75094-6; RCore Team, 2020, R LANG ENV STAT COMP; Romero-Lankao P, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT B: REGIONAL ASPECTS, P1439; Russo S, 2014, J GEOPHYS RES-ATMOS, V119, P12500, DOI 10.1002/2014JD022098; RYAN DP, 1992, J DAIRY SCI, V75, P1052, DOI 10.3168/jds.S0022-0302(92)77849-7; Schonhart M., 2015, ADV ANIM BIOSCI, V6, P17, DOI DOI 10.1017/S2040470014000430; Segnalini M, 2013, INT J BIOMETEOROL, V57, P451, DOI 10.1007/s00484-012-0571-5; Smith J. R., 2012, Environmental physiology of livestock, P267; Smith TR, 2006, J DAIRY SCI, V89, P3915, DOI 10.3168/jds.S0022-0302(06)72434-1; St-Pierre NR, 2003, J DAIRY SCI, V86, pE52, DOI 10.3168/jds.S0022-0302(03)74040-5; Stoner AMK, 2013, INT J CLIMATOL, V33, P2473, DOI 10.1002/joc.3603; Stowell RR, 2001, LIVESTOCK ENV, P29; Tao S, 2013, J DAIRY SCI, V96, P4079, DOI 10.3168/jds.2012-6278; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; Tucker CB, 2007, APPL ANIM BEHAV SCI, V105, P1, DOI [10.1016/j.applanim.2006.06.009, 10.1016/j.applanim.2007.03.015]; Turner L. W., 1992, Applied Engineering in Agriculture, V8, P251; USDA-NASS, 2014, 2012 CENS AGR COUNT; USEIA, EL DAT; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P95, DOI [10.1007/s10584-011-0152-3, 10.1007/s10584-011-0157-y]; West JW, 2003, J DAIRY SCI, V86, P2131, DOI 10.3168/jds.S0022-0302(03)73803-X; West JW, 2003, J DAIRY SCI, V86, P232, DOI 10.3168/jds.S0022-0302(03)73602-9; Wolfe DW, 2008, MITIG ADAPT STRAT GL, V13, P555, DOI 10.1007/s11027-007-9125-2; WOLFENSON D, 1988, J DAIRY SCI, V71, P809, DOI 10.3168/jds.S0022-0302(88)79621-6; Yousef MK, 1985, STRESS PHYSL LIVESTO	72	22	23	5	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214665	10.1371/journal.pone.0214665	http://dx.doi.org/10.1371/journal.pone.0214665			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921450	gold, Green Submitted, Green Published			2022-12-26	WOS:000462594000106
J	Hall, ME; O'Bryon, I; Wilcox, WF; Osier, MV; Cadle-Davidson, L				Hall, Megan E.; O'Bryon, Isabelle; Wilcox, Wayne F.; Osier, Michael V.; Cadle-Davidson, Lance			The epiphytic microbiota of sour rot-affected grapes differs minimally from that of healthy grapes, indicating causal organisms are already present on healthy berries	PLOS ONE			English	Article								Sour rot is a disease complex produced by an interaction between grape berries and various species of yeast and acetic acid bacteria in the presence of Drosophila fruit flies. While yeast and bacteria are consistently found on healthy grape berries worldwide, we explored whether the composition of these epiphytic communities differed depending on the presence or absence of sour rot symptoms. Using high-throughput sequencing, we characterized the microbiome of sour rot-affected grapes from two geographical areas across two years. In 2015 and 2016, both healthy and sour rot-affected berries were collected from commercial and research vineyards in Geneva, NY and commercial vineyards in Tasmania, AUS. In this experiment, all associated organisms grouped together primarily by location, and not by presence/absence of symptoms or cultivar. The predominant difference between asymptomatic and symptomatic samples, regardless of location, was the abundance of Acetobacter species, which were significantly more plentiful in the symptomatic samples. Yeast genera such as Candida, Hanseniaspora, Pichia and Saccharomyces were abundant in both sets of samples, but varied by region. The consistent presence of yeast species and the increased abundance of acetic acid-generating bacteria is consistent with our understanding of their etiological role in sour rot development. In 2016, diseased grapes also were collected from vineyards in Fredonia, NY, and Modesto, CA. Consistent with our comparison study, all associated organisms again grouped together primarily by location. Yeast genera such as Candida, Hanseniaspora, Pichia and Saccharomyces were abundant in both sets of samples, but varied by region. The consistent presence of yeast species and the abundance of acetic acid-generating bacteria in both experiments is consistent with our understanding of their etiological role in sour rot development.	[Hall, Megan E.; Wilcox, Wayne F.; Cadle-Davidson, Lance] Cornell Univ, Sch Integrat Plant Sci, Sect Plant Pathol & Plant Microbe Biol, NYS Agr Expt Stn, Geneva, NY 14456 USA; [O'Bryon, Isabelle; Osier, Michael V.] Rochester Inst Technol, Thomas H Gosnell Sch Life Sci, Rochester, NY 14623 USA; [Cadle-Davidson, Lance] USDA ARS, Grape Genet Res Unit, Geneva, NY USA	Cornell University; Rochester Institute of Technology; United States Department of Agriculture (USDA)	Hall, ME (corresponding author), Cornell Univ, Sch Integrat Plant Sci, Sect Plant Pathol & Plant Microbe Biol, NYS Agr Expt Stn, Geneva, NY 14456 USA.	hallmegan@missauri.edu		Hall, Megan/0000-0001-8301-6128	NY State Dept. of Agriculture and Markets; NY Wine and Grape Foundation; Specialty Crops Research Initiative; Dyson Fund	NY State Dept. of Agriculture and Markets; NY Wine and Grape Foundation; Specialty Crops Research Initiative; Dyson Fund	This work was supported the NY State Dept. of Agriculture and Markets (WF), NY Wine and Grape Foundation (WF), Specialty Crops Research Initiative (WF) and the Dyson Fund (WF). Mention of trade names or commercial products is solely for the purpose of providing specific information and does not imply recommendation or endorsement by the U.S. Department of Agriculture (USDA). USDA is an equal opportunity provider and employer.; The authors thank Katherine Evans and Fiona Kerslake at the University of Tasmania of identifying sampling sites, Peter Cousins of E&J Gallo for sample collection in Modesto and Rick Dunst of Double A Vineyard for sample collection in Fredonia. This work was supported the NY State Dept. of Agriculture and Markets, NY Wine and Grape Foundation, Specialty Crops Research Initiative and the Dyson Fund.	Bokulich NA, 2016, MBIO, V7, DOI 10.1128/mBio.00631-16; Bokulich NA, 2014, P NATL ACAD SCI USA, V111, pE139, DOI 10.1073/pnas.1317377110; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Hall ME, 2018, PHYTOPATHOLOGY, V108, P1429, DOI 10.1094/PHYTO-03-18-0098-R; Kolde R., 2013, PHEATMAP PRETTY HEAT; Mezzasalma V, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184615; Pinto C, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00905; R Core Team, 2021, R LANGUAGE ENV STAT; Setati ME, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01358; Yang SS, 2016, HORTIC RES-ENGLAND, V3, DOI 10.1038/hortres.2016.2; Zarraonaindia I, 2015, MBIO, V6, DOI 10.1128/mBio.02527-14	14	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2019	14	3							e0211378	10.1371/journal.pone.0211378	http://dx.doi.org/10.1371/journal.pone.0211378			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ5PT	30917111	Green Submitted, Green Published, gold			2022-12-26	WOS:000462465800008
J	Cai, HM; Deng, JB; Li, JQ; Ma, MP; Huang, CY; Zhao, PJ; Ming, FP; Liang, QY; Jia, JH; Zhang, SX; Zeng, M; Zhang, LH				Cai, Haiming; Deng, Jinbo; Li, Jiaoqing; Ma, Miaopeng; Huang, Chaoyuan; Zhao, Peijing; Ming, Feiping; Liang, Qianyi; Jia, Junhao; Zhang, Shuxia; Zeng, Min; Zhang, Linghua			Modulating the 3 ' end-DNA and the fermentation process for enhanced production and biological activity of porcine interferon-gamma	PLOS ONE			English	Article							PICHIA-PASTORIS; PROTEIN EXPRESSION; MX PROTEINS; ALPHA; OPTIMIZATION; GTPASES	Porcine gamma interferon is a cytokine produced by activated T cells and NK cells with broad-spectrum antiviral activity and immunomodulatory function. However, pIFN-gamma is a secretory protein that has a short half-life in organisms and is easily inactivated, making it difficult to apply widely in clinics. Therefore, we tried to optimize the expression of pIFN-gamma in Pichia pastoris to obtain a large amount of highly active, easily purified pIFN-gamma protein in vitro. Through C-terminal sequence analysis, we found a signal sequence (EKREAEAE) that was easily enzymolysed by a signal peptide enzyme, resulting in degradation and inactivation of the pIFN-gamma protein. In this study, we optimized the pIFN-gamma gene recombination sequence and mutated the 3' end of the pIFN-gamma gene, resulting in a higher expression level and stronger biological activity, as well as a significant upregulation in the expression of the interferon-stimulated genes Mx/ and OAS1 in IPEC-J2 jejunal epithelial cells. Our data also showed that the fermentation process could significantly improve productivity. A recombinant Pichia pastoris strain with the optimized pIFN-gamma gene could obtain a high yield of pIFN-gamma protein, up to 9536 mg/L, after staged incubation for 0-24 h at 28 degrees C, pH 6.0, and 50% dissolved oxygen (DO), followed by incubation for 24-72 h at 25 degrees C, pH 6.0 and 30% DO. These data demonstrated, for the first time, that the expression level of pIFN-gamma in Pichia pastoris was improved significantly by gene optimization with 3' end mutation and a fermentation process that maintained good biological activity, which is beneficial to the application of pIFN-gamma in animal husbandry.	[Cai, Haiming; Deng, Jinbo; Li, Jiaoqing; Ma, Miaopeng; Huang, Chaoyuan; Zhao, Peijing; Ming, Feiping; Liang, Qianyi; Jia, Junhao; Zhang, Shuxia; Zeng, Min; Zhang, Linghua] South China Agr Univ, Coll Life Sci, Guangdong Prov Key Lab Prot Funct & Regulat Agr O, Guangzhou, Guangdong, Peoples R China	South China Agricultural University	Zhang, LH (corresponding author), South China Agr Univ, Coll Life Sci, Guangdong Prov Key Lab Prot Funct & Regulat Agr O, Guangzhou, Guangdong, Peoples R China.	lhzhang@scau.edu.cn			Natural Science Foundation of Guangdong Province [2015A030312005, 2018A030313625]; Guangzhou science and technology project [201803020001]	Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Guangzhou science and technology project	The study is supported by the grant from Natural Science Foundation of Guangdong Province (2015A030312005, 2018A030313625) and Guangzhou science and technology project (201803020001).	Cao R, 2003, J NANJING AGR U, P71; Celik E, 2012, BIOTECHNOL ADV, V30, P1108, DOI 10.1016/j.biotechadv.2011.09.011; Cereghino JL, 2000, FEMS MICROBIOL REV, V24, P45, DOI 10.1111/j.1574-6976.2000.tb00532.x; Chen Xuemei, 2009, Sheng Wu Gong Cheng Xue Bao, V25, P806; Chesler DA, 2002, CYTOKINE GROWTH F R, V13, P441, DOI 10.1016/S1359-6101(02)00044-8; Dale C, 1999, BIOPHARM-APPL T BIO, V12, P36; Degelmann A, 2002, FEMS YEAST RES, V2, P349, DOI 10.1016/S1567-1356(02)00096-X; Donnelly N, 2013, CELL MOL LIFE SCI, V70, P3493, DOI 10.1007/s00018-012-1252-6; Dragosits M, 2009, J PROTEOME RES, V8, P1380, DOI 10.1021/pr8007623; Files D, 2001, ENZYME MICROB TECH, V29, P335, DOI 10.1016/S0141-0229(01)00395-7; Haller O, 2002, TRAFFIC, V3, P710, DOI 10.1034/j.1600-0854.2002.31003.x; Hu SY, 2006, PROTEIN EXPRES PURIF, V47, P249, DOI 10.1016/j.pep.2005.11.014; Huang Zhi-Qing, 2005, Sheng Wu Gong Cheng Xue Bao, V21, P731; Kashyap DR, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004280; Li WD, 2005, SCIENCE, V310, P676, DOI 10.1126/science.1118391; Li ZX, 2008, J BIOTECHNOL, V138, P1, DOI 10.1016/j.jbiotec.2008.07.1989; Lin-Cereghino GP, 2013, GENE, V519, P311, DOI 10.1016/j.gene.2013.01.062; Liu XW, 2014, J THEOR BIOL, V344, P19, DOI 10.1016/j.jtbi.2013.11.022; Micheelsen PO, 2008, J BIOTECHNOL, V133, P424, DOI 10.1016/j.jbiotec.2007.11.012; Rogez C, 2003, J VIROL, V77, P12914, DOI 10.1128/JVI.77.23.12914-12920.2003; Shen Q, 2012, APPL MICROBIOL BIOT, V96, P763, DOI 10.1007/s00253-012-4337-0; Shi Qi-Qi, 2006, Sheng Wu Gong Cheng Xue Bao, V22, P311; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; SOH J, 1994, CELL, V76, P793, DOI 10.1016/0092-8674(94)90354-9; Spadiut O, 2014, BIOENGINEERED, V5, P401, DOI 10.4161/bioe.36152; Sreekrishna K, 1998, EXPRESSION HUMAN SER, P1346; Staeheli Peter, 1993, Trends in Cell Biology, V3, P268, DOI 10.1016/0962-8924(93)90055-6; Tian Yuan, 2010, Chinese Journal of Biologicals, V23, P416; Underberg WJM, 2000, J CHROMATOGR B, V742, P401, DOI 10.1016/S0378-4347(00)00198-5; Wang L, 2007, CHINA MED ENG, P628; Wang YanBin, 2011, Scientia Agricultura Sinica, V44, P1931; Xu YL, 2009, WORLD J MICROB BIOT, V25, P1453, DOI 10.1007/s11274-009-0035-1; Zhang Dingyong, 2010, Sheng Wu Gong Cheng Xue Bao, V26, P1652; Zhuo X, 2015, SWINE IND, V32, P104	34	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2019	14	3							e0214319	10.1371/journal.pone.0214319	http://dx.doi.org/10.1371/journal.pone.0214319			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ3IW	30913245	gold, Green Published, Green Submitted			2022-12-26	WOS:000462305600045
J	Fievez, AMD; Silva-Freitas, ML; Sousa, AD; Santos-Oliveira, JR; Da-Cruz, AM				da Cunha Fievez, Aline Mireille; Silva-Freitas, Maria Luciana; Sousa, Anastacio de Queiroz; Santos-Oliveira, Joanna R.; Da-Cruz, Alda M.			Lower levels of leptin are associated with severity parameters in visceral leishmaniasis patients	PLOS ONE			English	Article							IMMUNITY	Visceral leishmaniasis (VL) is the most severe clinical form of leishmaniasis, and if untreated may be fatal. It affects important organs of the immune system and is characterized by a specific immunosuppression, along with intense cellular activation and cytokine storm. Moreover, VL is now recognized as a systemic inflammatory response syndrome (SIRS), in which multiple cytokines and other pro-inflammatory molecules are released. The action of these inflammatory mediators may be considered risk factors for poor prognosis and death. Leptin, a hormone derived from adipose tissue, has been described with several immuno-regulatory functions in vitro and in vivo Leishmania infection models, particularly for enhancing the macrophage microbicidal mechanisms. Considering that evaluation of immunologic parameters that may be associated with this clinical scenario may help to decrease VL lethality, we evaluated whether leptin is associated with VL pathogenesis. Thirty-one patients were recruited in the active phase of VL, of which 22 were followed up until one month after therapy (1 mpt). Except for creatinine levels, all clinical parameters were altered in active VL patients, especially leucocyte counts and albumin and hemoglobin levels. Also, elevated levels of lipopolysaccharide (LPS), immunoglobulins (Ig)G1 and G3 anti-Leishmania and interleukins (IL)-6 and -10 were higher than in healthy individuals. In contrast, active VL patients presented diminished serum leptin levels and positive correlation with leukocytes counts and hemoglobin and albumin levels. After 1 mpt, VL patients showed a significant increase in leptin levels, reaching values similar to healthy volunteers. As expected, only LPS levels remained elevated after 1 mpt. These findings suggest that leptin levels are affected in Leishmania infection and the correlation with important parameters associated with the prognosis of VL points to the involvement of this molecule in VL immunopathogenesis. Additional studies are needed to evaluate the possibility of leptin as a prognostic marker of VL.	[da Cunha Fievez, Aline Mireille; Sousa, Anastacio de Queiroz] Univ Fed Ceara, Hosp Sao Jose Doencas Infecciosas, Fortaleza, Ceara, Brazil; [da Cunha Fievez, Aline Mireille; Silva-Freitas, Maria Luciana; Santos-Oliveira, Joanna R.; Da-Cruz, Alda M.] Fiocruz MS, Inst Oswaldo Cruz, Lab Interdisciplinar Pesquisas Med, Rio De Janeiro, Brazil; [Santos-Oliveira, Joanna R.] Inst Fed Educ Ciencia & Tecnol IFRJ, Nucleo Ciencias Biomed Aplicadas, Rio De Janeiro, Brazil; [Santos-Oliveira, Joanna R.; Da-Cruz, Alda M.] Natl Inst Sci & Technol Neuroimmunomodulat INCT N, Rio De Janeiro, Brazil	Universidade Federal do Ceara; Fundacao Oswaldo Cruz; Instituto Federal do Rio de Janeiro (IFRJ)	Santos-Oliveira, JR; Da-Cruz, AM (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Interdisciplinar Pesquisas Med, Rio De Janeiro, Brazil.; Santos-Oliveira, JR (corresponding author), Inst Fed Educ Ciencia & Tecnol IFRJ, Nucleo Ciencias Biomed Aplicadas, Rio De Janeiro, Brazil.; Santos-Oliveira, JR; Da-Cruz, AM (corresponding author), Natl Inst Sci & Technol Neuroimmunomodulat INCT N, Rio De Janeiro, Brazil.	jaannaoliveira@fl.edutr; alda@ioc.facruz.br	Patologia, Programa/AAI-4877-2021; Da-Cruz, Alda Maria/J-2152-2012		Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq; Instituto Federal de Educacao, Ciencia e Tecnologia (Prociencia)	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Federal de Educacao, Ciencia e Tecnologia (Prociencia)	This research was funded by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Fellowship to AMDC), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Fellowship to MLSF), and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico -CNPq (Fellowship to AMdCF), and Instituto Federal de Educacao, Ciencia e Tecnologia (Prociencia, intern funds to JRSO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade BB, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-13; Araujo-Santos T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04595-8; Bhattacharyya T, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003273; Bozza FA, 2007, CRIT CARE, V11, DOI 10.1186/cc5783; Brazil Ministry of Health, 2011, VISC LEISHM CLIN REC, V1, P78; Brazil Ministry of Health-SVS, 2018, VISC LEISHM EP SIT D; Caldas A, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-113; Costa DL, 2013, PATHOG GLOB HEALTH, V107, P78, DOI 10.1179/2047773213Y.0000000078; Dayakar A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15288-7; Dayakar A, 2016, EXP PARASITOL, V160, P54, DOI 10.1016/j.exppara.2015.12.002; dos Santos PL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004375; Fagundes-Silva GA, 2012, PARASITE IMMUNOL, V34, P486, DOI 10.1111/j.1365-3024.2012.01379.x; Gomes IT, 2010, J IMMUNOL METHODS, V360, P76, DOI 10.1016/j.jim.2010.06.011; Goto H, 2009, REV I MED TROP, V51, P241, DOI 10.1590/S0036-46652009000500002; Jacobsson S, 2017, J INFLAMM-LOND, V14, DOI 10.1186/s12950-017-0167-2; Kip AE, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00181; Liu Q, 2016, CELL MOL IMMUNOL, V13, P3, DOI 10.1038/cmi.2015.74; Silva RLL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005486; Luz KG, 2010, REV SOC BRAS MED TRO, V43, P393, DOI 10.1590/S0037-86822010000400011; Mancuso P, 2010, J APPL PHYSIOL, V108, P722, DOI 10.1152/japplphysiol.00781.2009; de Araujo VEM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001511; MUIGAI R, 1983, LANCET, V2, P476; Naylor C, 2016, TRENDS MOL MED, V22, P88, DOI 10.1016/j.molmed.2015.12.001; Costa CHN, 2010, REV SOC BRAS MED TRO, V43, P386, DOI 10.1590/S0037-86822010000400010; Nylen S, 2007, TRENDS IMMUNOL, V28, P378, DOI 10.1016/j.it.2007.07.004; Peruhype-Magalhaes V, 2006, CLIN EXP IMMUNOL, V146, P124, DOI 10.1111/j.1365-2249.2006.03171.x; Rodrigues V, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1412-x; Santos-Oliveira JR, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001198; Shivahare R, 2015, ACTA TROP, V150, P35, DOI 10.1016/j.actatropica.2015.06.024; Srikiatkhachorn A, 2017, SEMIN IMMUNOPATHOL, V39, P563, DOI 10.1007/s00281-017-0625-1; Tanaka T, 2016, ADV EXP MED BIOL, V941, P79, DOI 10.1007/978-94-024-0921-5_4; Younan P, 2017, MBIO, V8, DOI [10.1128/mBio.00845-17, 10.1128/mbio.00845-17]	32	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2019	14	3							e0214413	10.1371/journal.pone.0214413	http://dx.doi.org/10.1371/journal.pone.0214413			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ3IW	30913261	gold, Green Published, Green Submitted			2022-12-26	WOS:000462305600057
J	Hulsenboom, ADJ; Verdurmen, KMJ; Vullings, R; van der Hout-van der Jagt, MB; Kwee, A; van Laar, JOEH; Oei, SG				Hulsenboom, Alexandra D. J.; Verdurmen, Kim M. J.; Vullings, Rik; van der Hout-van der Jagt, M. Beatrijs; Kwee, Anneke; van Laar, Judith O. E. H.; Oei, S. Guid			Relative versus absolute rises in T/QRS ratio by ST analysis of fetal electrocardiograms in labour: A case-control pilot study	PLOS ONE			English	Article							WAVE-FORM ANALYSIS; LAMB ELECTROCARDIOGRAM; RANDOMIZED-TRIAL; HEART-RATE; CARDIOTOCOGRAPHY; ECG; GROWTH	Introduction The additional value of ST analysis during labour is uncertain. In ST analysis, a T/QRS baseline value is calculated from the fetal electrocardiogram and successive T/QRS ratios are compared to this baseline. However, variation in the orientation of the electrical heart axis between fetuses may yield different T/QRS baseline values. In case of a higher T/QRS baseline value more ST events are encountered, although not always related to perinatal outcome. We hypothesised that we can partly correct for this effect by analysing T/QRS rises as a percentage from baseline (relative ST analysis). This study aimed to explore whether relative ST analysis has better diagnostic value for cord acidaemia compared to conventional ST analysis, where predefined fixed T/QRS ratios are used. Methods and materials A case-control study was performed in 20 term human fetuses during labour; 10 cases (umbilical cord artery pH <7.05 at birth, defining acidaemia) and 10 controls (pH >7.20) were included. The fetal electrocardiogram was recorded using a STAN monitor. We electronically extracted all T/QRS values, baseline and episodic ST events from the STAN monitor and calculated the relative T/QRS changes. The cut-off for relative ST events was determined in a receiver operator characteristic (ROC) curve at optimal specificity for cord acidaemia. Parameters of interest were area under the curve (AUC) of the ROC curve for relative ST events and test performance of both conventional and relative ST analysis. Results Relative ST analysis showed an AUC of 0.99. The optimal cut-off value for relative T/QRS rise was determined at 0.70. Relative vs conventional (absolute) ST analysis showed a specificity of 100% vs 40% (p = 0.031); sensitivity 90% vs 90%; positive likelihood ratio infinity vs 1.5; negative likelihood ratio 0.10 vs 0.25, respectively. Conclusion Relative ST analysis seems to be a promising method to detect impending fetal acidaemia during labour. Further studies are required to determine the diagnostic accuracy.	[Hulsenboom, Alexandra D. J.; Verdurmen, Kim M. J.; van Laar, Judith O. E. H.; Oei, S. Guid] Maxima Med Ctr, Dept Obstet & Gynaecol, Veldhoven, Netherlands; [Vullings, Rik; van der Hout-van der Jagt, M. Beatrijs; Oei, S. Guid] Eindhoven Univ Technol, Dept Elect Engn, Eindhoven, Netherlands; [Kwee, Anneke] Univ Med Ctr Utrecht, Dept Obstet & Gynaecol, Utrecht, Netherlands	Maxima Medical Center; Eindhoven University of Technology; Utrecht University; Utrecht University Medical Center	Hulsenboom, ADJ (corresponding author), Maxima Med Ctr, Dept Obstet & Gynaecol, Veldhoven, Netherlands.	o.hulsenboom@gmail.com	Vullings, Rik/GQP-6225-2022	Vullings, Rik/0000-0002-2392-6098; Hulsenboom, Alexandra/0000-0001-8186-5484; van der Hout-van der Jagt, M. Beatrijs/0000-0002-5805-5333	Dutch Technology Foundation STW	Dutch Technology Foundation STW(Technologiestichting STW)	This research was financially supported by Dutch Technology Foundation STW. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funding was received by RV.	Alfirevic Z, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006066.pub2; Amer-Wahlin I, 2007, BJOG-INT J OBSTET GY, V114, P1191, DOI 10.1111/j.1471-0528.2007.01479.x; Amer-Wahlin I, 2001, LANCET, V358, P534, DOI 10.1016/S0140-6736(01)05703-8; Amer-Wahlin I, 2016, BEST PRACT RES CL OB, V30, P48, DOI 10.1016/j.bpobgyn.2015.05.007; Ayres-De-Campos D, 1999, BRIT J OBSTET GYNAEC, V106, P1307, DOI 10.1111/j.1471-0528.1999.tb08187.x; Baltabaeva A, 2008, EUR J ECHOCARDIOGR, V9, P501, DOI 10.1016/j.euje.2007.08.004; Becker JH, 2015, ACTA OBSTET GYN SCAN, V94, P175, DOI 10.1111/aogs.12548; Becker JH, 2012, ACTA OBSTET GYN SCAN, V91, P189, DOI 10.1111/j.1600-0412.2011.01320.x; Belfort MA, 2015, NEW ENGL J MED, V373, P632, DOI 10.1056/NEJMoa1500600; Blix E, 2016, ACTA OBSTET GYN SCAN, V95, P16, DOI 10.1111/aogs.12828; GREENE KR, 1982, AM J OBSTET GYNECOL, V144, P950, DOI 10.1016/0002-9378(82)90190-9; Anneke K, 2007, EUR J OBSTET GYN R B, V135, P28, DOI 10.1016/j.ejogrb.2006.10.022; LEE KH, 1974, J OBSTET GYN BR COMM, V81, P61; Ojala K, 2006, BJOG-INT J OBSTET GY, V113, P419, DOI 10.1111/j.1471-0528.2006.00886.x; ROSEN KG, 1984, AM J OBSTET GYNECOL, V149, P190, DOI 10.1016/0002-9378(84)90197-2; ROSEN KG, 1976, BIOL NEONATE, V30, P17; Saccone G, 2016, OBSTET GYNECOL, V127, P127, DOI 10.1097/AOG.0000000000001198; Schuit E, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2013.01.028; Sehgal A, 2017, J PEDIATR-US, V188, P128, DOI 10.1016/j.jpeds.2017.05.076; Sundstrom A, 2006, TECH REP; van Laar JOEH, 2010, BJOG-INT J OBSTET GY, V117, P429, DOI 10.1111/j.1471-0528.2009.02456.x; Vayssiere C, 2016, ACTA OBSTET GYN SCAN, V95, P1190, DOI 10.1111/aogs.12923; Vayssiere C, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.07.007; Verburg BO, 2008, CIRCULATION, V117, P649, DOI 10.1161/CIRCULATIONAHA.107.709717; Verdurmen KMJ, 2016, EUR J OBSTET GYN R B, V207, P243, DOI 10.1016/j.ejogrb.2016.10.030; Visser GH, 2015, INT J GYNECOL OBSTET, V131, P25, DOI 10.1016/j.ijgo.2015.06.021; Vullings R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175823; Westerhuis MEMH, 2011, OBSTET GYNECOL, V117, P406, DOI 10.1097/AOG.0b013e3182083dcd; WESTGATE J, 1993, AM J OBSTET GYNECOL, V169, P1151, DOI 10.1016/0002-9378(93)90273-L; Yli BM, 2008, J MATERN-FETAL NEO M, V21, P231, DOI 10.1080/14767050801924431	30	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2019	14	3							e0214357	10.1371/journal.pone.0214357	http://dx.doi.org/10.1371/journal.pone.0214357			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ3IW	30913253	Green Published, Green Submitted, gold			2022-12-26	WOS:000462305600047
J	Majidian, S; Kahaei, MH				Majidian, Sina; Kahaei, Mohammad Hossein			NGS based haplotype assembly using matrix completion	PLOS ONE			English	Article							ALGORITHMS	We apply matrix completion methods for haplotype assembly from NGS reads to develop the new HapSVT, HapNuc, and HapOPT algorithms. This is performed by applying a mathematical model to convert the reads to an incomplete matrix and estimating unknown components. This process is followed by quantizing and decoding the completed matrix in order to estimate haplotypes. These algorithms are compared to the state-of-the-art algorithms using simulated data as well as the real fosmid data. It is shown that the SNP missing rate and the haplotype block length of the proposed HapOPT are better than those of HapCUT2 with comparable accuracy in terms of reconstruction rate and switch error rate. A program implementing the proposed algorithms in MATLAB is freely available at https://github.com/smajidian/HapMC.	[Majidian, Sina; Kahaei, Mohammad Hossein] Iran Univ Sci & Technol, Sch Elect Engn, Tehran 1684613114, Iran	Iran University Science & Technology	Kahaei, MH (corresponding author), Iran Univ Sci & Technol, Sch Elect Engn, Tehran 1684613114, Iran.	kahaei@iust.ac.ir	Majidian, Sina/AAF-2257-2019; Kahaei, Mohammad Hossein/T-3022-2018	Majidian, Sina/0000-0001-5345-6982; 				Berger E, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003502; Cai CX, 2016, IEEE J-STSP, V10, P647, DOI 10.1109/JSTSP.2016.2547860; Cai JF, 2010, SIAM J OPTIMIZ, V20, P1956, DOI 10.1137/080738970; Candes EJ, 2010, IEEE T INFORM THEORY, V56, P2053, DOI 10.1109/TIT.2010.2044061; Candes EJ, 2009, FOUND COMPUT MATH, V9, P717, DOI 10.1007/s10208-009-9045-5; Chen ZZ, 2013, BIOINFORMATICS, V29, P1938, DOI 10.1093/bioinformatics/btt349; Das S, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1408-5; Davenport MA, 2016, IEEE J-STSP, V10, P608, DOI 10.1109/JSTSP.2016.2539100; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Deng F, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S2-S2; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Duitama J, 2012, NUCLEIC ACIDS RES, V40, P2041, DOI 10.1093/nar/gkr1042; Edge P, 2017, GENOME RES, V27, P801, DOI 10.1101/gr.213462.116; Geraci F, 2010, BIOINFORMATICS, V26, P2217, DOI 10.1093/bioinformatics/btq411; Grant M, 2013, BOYD S CVX MATLAB SO; Hashemi A, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4551-y; Keshavan RH, 2010, IEEE T INFORM THEORY, V56, P2980, DOI 10.1109/TIT.2010.2046205; Kuleshov V, 2014, BIOINFORMATICS, V30, pI379, DOI 10.1093/bioinformatics/btu484; Motazedi E, 2018, BRIEF BIOINFORM, V19, P387, DOI 10.1093/bib/bbw126; Mousavi SR, 2014, J THEOR BIOL, V350, P49, DOI 10.1016/j.jtbi.2014.01.036; O'Connell J, 2016, NAT GENET, V48, P817, DOI 10.1038/ng.3583; Recht B, 2010, SIAM REV, V52, P471, DOI 10.1137/070697835; Snyder MW, 2015, NAT REV GENET, V16, P344, DOI 10.1038/nrg3903; Wang LS, 2003, BIOINFORMATICS, V19, P1773, DOI 10.1093/bioinformatics/btg239; Xie MZ, 2016, BIOINFORMATICS, V32, P3735, DOI 10.1093/bioinformatics/btw537; Xie MZ, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-S2-S8	26	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2019	14	3							e0214455	10.1371/journal.pone.0214455	http://dx.doi.org/10.1371/journal.pone.0214455			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ3IW	30913270	gold, Green Submitted, Green Published			2022-12-26	WOS:000462305600064
J	Suh, JW; Park, SY; Lee, CY; Song, SH; Kim, DJ; Paik, HC; Chung, KY; Hong, MH; Kim, HR; Cho, BC; Lee, JG				Suh, Jee Won; Park, Seong Yong; Lee, Chang Young; Song, Seung Hwan; Kim, Dae Joon; Paik, Hyo Chae; Chung, Kyoung Young; Hong, Min Hee; Kim, Hye Ryun; Cho, Byoung Chul; Lee, Jin Gu			Neoadjuvant therapy for thymic neoplasms reduces tumor volume per 3D-reconstructed images but does not improve the complete resection rate	PLOS ONE			English	Article							INDUCTION THERAPY; MULTIMODALITY TREATMENT; SURGICAL RESECTION; STAGE-III; THYMOMAS	Objectives Complete resection of thymic neoplasms is important for achieving a favorable prognosis; however, the efficacy of neoadjuvant therapy remains controversial. We investigated the effect of induction therapy on complete resection and survival using 3-dimensionally reconstructed images to measure tumor volume. Methods Eighty-nine patients who underwent surgical resection for Masaoka-Koga stage III-IV thymic neoplasms between January 2000 and December 2013 were enrolled, including 71 and 18 in the primary surgery and neoadjuvant therapy groups, respectively. Baseline characteristics, postoperative outcomes, and survival rates were analyzed. Moreover, baseline and post-neoadjuvant therapy tumor volumes were compared among patients in the neoadjuvant group. Results Adjacent mediastinal structure invasion was significantly rarer in the primary surgery group than in the neoadjuvant group (1.27 +/- 1.09 vs. 2.61 +/- 1.42, p<0.001). On subgroup analysis of patients who underwent neoadjuvant therapy, tumor volumes decreased significantly from 206.08 +/- 132.32 cm(3) to 81.25 +/- 71.24 cm(3) post-therapy (p = 0.001). Interestingly, only the pre-neoadjuvant tumor volume was significantly associated with complete resection, while the post-neoadjuvant volume was not (p = 0.012 and p = 0.458, respectively). Moreover, despite significantly reduced tumor volumes, patients in the neoadjuvant therapy group did not exhibit significantly different R0 resection rates (odds ratio 1.490, p = 0.581) or overall survival (p = 0.285) compared to those in the primary surgery group. Conclusions Neoadjuvant therapy does not significantly influence the R0 resection rate or overall survival relative to primary surgery. Nevertheless, it may by useful for patients planning surgical resection because it significantly reduces the presurgical tumor volume and extent of invasion.	[Suh, Jee Won; Park, Seong Yong; Lee, Chang Young; Song, Seung Hwan; Kim, Dae Joon; Paik, Hyo Chae; Chung, Kyoung Young; Lee, Jin Gu] Yonsei Univ, Severance Hosp, Dept Thorac & Cardiovasc Surg, Coll Med, Seoul, South Korea; [Hong, Min Hee; Kim, Hye Ryun; Cho, Byoung Chul] Yonsei Univ, Div Med Oncol, Dept Internal Med, Yonsei Canc Ctr,Coll Med, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Lee, JG (corresponding author), Yonsei Univ, Severance Hosp, Dept Thorac & Cardiovasc Surg, Coll Med, Seoul, South Korea.	csjglee@yuhs.ac		Hong, Min Hee/0000-0003-3490-2195; Song, Seung Hwan/0000-0002-3910-5585; Kim, Hye Ryun/0000-0002-1842-9070; Park, Seong Yong/0000-0002-5180-3853; Song, Seung Hwan/0000-0003-3247-3817; Suh, Jee Won/0000-0003-0287-0651; Paik, Hyo Chae/0000-0001-9309-8235; Cho, Byoung Chul/0000-0002-5562-270X				Ahmad U, 2016, THORAC SURG CLIN, V26, P325, DOI 10.1016/j.thorsurg.2016.04.011; Hamaji M, 2015, ANN THORAC SURG, V99, P1848, DOI 10.1016/j.athoracsur.2014.12.048; Huang J, 2014, J THORAC ONCOL, V9, P1573, DOI 10.1097/JTO.0000000000000269; Johnson GB, 2017, J THORAC ONCOL, V12, P354, DOI 10.1016/j.jtho.2016.09.118; Kim ES, 2004, LUNG CANCER, V44, P369, DOI 10.1016/j.lungcan.2003.12.010; Leuzzi G, 2017, THORAC CARDIOV SURG, V65, P234, DOI 10.1055/s-0035-1564890; Lucchi M, 2005, ANN THORAC SURG, V79, P1840, DOI 10.1016/j.athoracsur.2004.12.047; Shintani Y, 2015, GEN THORAC CARDIOVAS, V63, P159, DOI 10.1007/s11748-014-0486-7; Venuta F, 2003, ANN THORAC SURG, V76, P1866, DOI 10.1016/S0003-4975(03)01020-8; Wright CD, 2008, ANN THORAC SURG, V85, P385, DOI 10.1016/j.athoracsur.2007.08.051	10	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2019	14	3							e0214291	10.1371/journal.pone.0214291	http://dx.doi.org/10.1371/journal.pone.0214291			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ3IW	30913241	Green Submitted, Green Published, gold			2022-12-26	WOS:000462305600040
J	Bae, GH; Bae, SH; Choi, DG				Bae, Gi Hyun; Bae, Seok Hyun; Choi, Dong Gyu			Surgical outcomes of intermittent exotropia according to exotropia type based on distance/near differences	PLOS ONE			English	Article							SURGERY; CLASSIFICATION; MANAGEMENT	We compare the surgical outcomes of intermittent exotropia of the basic, pseudo-divergence excess (pseudo-DE) and true divergence excess (true DE) types. A study was performed with 342 patients who had undergone surgery for intermittent exotropia of the basic, pseudo-DE or true DE type with a postoperative follow-up period of 6 months or more. The main outcome measures were postoperative angles of deviation at distance and near, and surgical success rates. Surgical success was defined as alignment between exodeviation of 10 PD and esodeviation of 5 PD at distance and near. Additionally, survival curves of recurrence were analyzed by the Kaplan-Meier method. The postoperative angles of deviation at both distance and near in pseudo-DE type were significantly smaller than those in basic type at the final examination (p = 0.003, <0.001). The final surgical success rate in pseudo-DE (70.2%) was better than in basic (46.3%) or true DE (28.6%) (p = 0.003, 0.01). Reoperation for recurrent exotropia was performed in 27% of the basic, 17% of the pseudo-DE, and 35.7% of the true DE cases. According to a survival analysis for recurrence, patients with pseudo-DE showed lower incidence of recurrence than did patients with basic and true DE (p = 0.003, 0.02). In conclusion, the patients with intermittent exotropia of the pseudo-DE type showed better surgical outcomes than those with the basic or true DE type. Pseudo-DE also showed a lower recurrence rate than did the other 2 groups.	[Bae, Gi Hyun] Sahmyook Med Ctr, Dept Ophthalmol, Seoul, South Korea; [Bae, Seok Hyun; Choi, Dong Gyu] Hallym Univ, Coll Med, Kangnam Sacred Heart Hosp, Dept Ophthalmol, Seoul, South Korea	Hallym University	Choi, DG (corresponding author), Hallym Univ, Coll Med, Kangnam Sacred Heart Hosp, Dept Ophthalmol, Seoul, South Korea.	eyechoi602@naver.com						Burian H M, 1971, Trans Am Ophthalmol Soc, V69, P188; BURIAN HM, 1966, AM J OPHTHALMOL, V62, P1161, DOI 10.1016/0002-9394(66)92570-0; BURIAN HM, 1965, AM J OPHTHALMOL, V59, P603, DOI 10.1016/0002-9394(65)93991-7; BURIAN HM, 1971, AM J OPHTHALMOL, V71, P34, DOI 10.1016/0002-9394(71)91091-9; COOPER J, 1982, BRIT J OPHTHALMOL, V66, P398, DOI 10.1136/bjo.66.6.398; DYER JA, 1960, AM J OPHTHALMOL, V50, P297, DOI 10.1016/0002-9394(60)90011-8; Ekdawi NS, 2009, J AAPOS, V13, P4, DOI 10.1016/j.jaapos.2008.06.001; HARDESTY HH, 1978, ARCH OPHTHALMOL-CHIC, V96, P268; Jampolsky A, 1970, Trans Am Ophthalmol Soc, V68, P730; KEENAN JM, 1994, EYE, V8, P632, DOI 10.1038/eye.1994.158; Kim HJ, 2016, ACTA OPHTHALMOL, V94, pE85, DOI 10.1111/aos.12849; Kushner BJ, 1998, ARCH OPHTHALMOL-CHIC, V116, P189; Kushner BJ, 1998, ARCH OPHTHALMOL-CHIC, V116, P478, DOI 10.1001/archopht.116.4.478; Kushner BJ, 1998, ARCH OPHTHALMOL-CHIC, V116, P324, DOI 10.1001/archopht.116.3.324; Mitchell P, 2000, CONCOMITANT EXODEVIA; Nusz KJ, 2006, OPHTHALMOLOGY, V113, P1154, DOI 10.1016/j.ophtha.2006.01.033; Oh JY, 2006, EYE, V20, P1268, DOI 10.1038/sj.eye.6702091; Pineles SL, 2010, J AAPOS, V14, P298, DOI 10.1016/j.jaapos.2010.06.007; Scobee RG, 1952, OCULOROTARY MUSCLES	19	3	3	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2019	14	3							e0214478	10.1371/journal.pone.0214478	http://dx.doi.org/10.1371/journal.pone.0214478			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ1KV	30908548	Green Published, Green Submitted, gold			2022-12-26	WOS:000462157600069
J	D'Errico, G; Alonso-Nocelo, M; Vallespinos, M; Hermann, PC; Alcala, S; Garcia, CP; Martin-Hijano, L; Valle, S; Earl, J; Cassiano, C; Lombardia, L; Feliu, J; Monti, MC; Seufferlein, T; Garcia-Bermejo, L; Martinelli, P; Carrato, A; Sainz, B				D'Errico, Gabriele; Alonso-Nocelo, Marta; Vallespinos, Mireia; Hermann, Patrick C.; Alcala, Sonia; Pedrero Garcia, Coral; Martin-Hijano, Laura; Valle, Sandra; Earl, Julie; Cassiano, Chiara; Lombardia, Luis; Feliu, Jaime; Monti, Maria Chiara; Seufferlein, Thomas; Garcia-Bermejo, Laura; Martinelli, Paola; Carrato, Alfredo; Sainz, Bruno, Jr.			Tumor-associated macrophage-secreted 14-3-3 zeta signals via AXL to promote pancreatic cancer chemoresistance	ONCOGENE			English	Article							DUCTAL ADENOCARCINOMA; CELL-DEATH; GROWTH; CHEMOTHERAPY; METASTASIS; INHIBITION; LIVER; IDENTIFICATION; INFLAMMATION; EXPRESSION	Pancreatic ductal adenocarcinoma (PDAC) is an inherently chemoresistant tumor. Chemotherapy leads to apoptosis of cancer cells, and in previous studies we have shown that tumor-associated macrophage (TAM) infiltration increases following chemotherapy in PDAC. Since one of the main functions of macrophages is to eliminate apoptotic cells, we hypothesized that TAMs phagocytose chemotherapy-induced apoptotic cells and secrete factors, which favor PDAC chemoresistance. To test this hypothesis, primary human PDAC cultures were treated with conditioned media (CM) from monocyte-derived macrophage cultures incubated with apoptotic PDAC cells (Mempty set(Apop)CM). Mempty set(Apop)CM pretreatment rendered naive PDAC cells resistant to Gemcitabine- or Abraxane-induced apoptosis. Proteomic analysis of Mempty set(Apop)CM identified YWHAZ/14-3-3 protein zeta/delta (14-3-3 zeta), a major regulator of apoptotic cellular pathways, as a potential mediator of chemoresistance, which was subsequently validated in patient transcriptional datasets, serum samples from PDAC patients and using recombinant 14-3-3 zeta and inhibitors thereof Moreover, in mice bearing orthotopic PDAC tumors, the antitumor potential of Gemcitabine was significantly enhanced by elimination of TAMs using clodronate liposomes or by pharmacological inhibition of the Axl receptor tyrosine kinase, a 14-3-3 zeta interacting partner. These data highlight a unique regulatory mechanism by which chemotherapy-induced apoptosis acts as a switch to initiate a protumor/antiapoptotic mechanism in PDAC via 14-3-3 zeta/Axl signaling, leading to phosphorylation of Akt and activation of cellular prosurvival mechanisms The data presented therefore challenge the idea that apoptosis of tumor cells is therapeutically beneficial, at least when immune sensor cells, such as macrophages, are present.	[D'Errico, Gabriele; Alonso-Nocelo, Marta; Vallespinos, Mireia; Alcala, Sonia; Pedrero Garcia, Coral; Martin-Hijano, Laura; Valle, Sandra; Sainz, Bruno, Jr.] UAM, Dept Biochem, Madrid, Spain; [D'Errico, Gabriele; Feliu, Jaime] La Paz Univ Hosp, Dept Med Oncol, Madrid, Spain; [Alonso-Nocelo, Marta; Vallespinos, Mireia; Alcala, Sonia; Pedrero Garcia, Coral; Martin-Hijano, Laura; Valle, Sandra; Sainz, Bruno, Jr.] CSIC UAM, Inst Invest Biomed Alberto Sols IIBM, Dept Canc Biol, Madrid, Spain; [Alonso-Nocelo, Marta; Vallespinos, Mireia; Alcala, Sonia; Pedrero Garcia, Coral; Martin-Hijano, Laura; Valle, Sandra; Earl, Julie; Carrato, Alfredo; Sainz, Bruno, Jr.] IRYCIS, Chron Dis & Canc Area 3, Madrid, Spain; [Hermann, Patrick C.; Seufferlein, Thomas] Ulm Univ, Dept Internal Med 1, Ulm, Germany; [Earl, Julie; Feliu, Jaime; Carrato, Alfredo] Biomed Res Network Canc CIBERONC, CB16 12 00446, Madrid, Spain; [Earl, Julie; Feliu, Jaime; Carrato, Alfredo] Biomed Res Network Canc CIBERONC, CB16 12 00398, Madrid, Spain; [Earl, Julie; Carrato, Alfredo] Alcala Univ, Ramon y Cajal Univ Hosp, Med Oncol Dept, Madrid, Spain; [Cassiano, Chiara; Monti, Maria Chiara] Univ Salerno, Dept Pharm, Salerno, Italy; [Lombardia, Luis] Spanish Natl Canc Res Ctr CNIO, Mol Diagnost Unit, Clin Res Programme, Madrid, Spain; [Garcia-Bermejo, Laura] Biomarkers & Therapeut Targets Grp IRYCIS, Madrid, Spain; [Martinelli, Paola] Med Univ Wien, Inst Canc Res, Comprehens Canc Ctr, Vienna, Austria	Autonomous University of Madrid; Hospital Universitario La Paz; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Ulm University; Hospital Universitario Ramon y Cajal; Universidad de Alcala; University of Salerno; Centro Nacional de Investigaciones Oncologicas (CNIO); Medical University of Vienna	Sainz, B (corresponding author), UAM, Dept Biochem, Madrid, Spain.; Sainz, B (corresponding author), CSIC UAM, Inst Invest Biomed Alberto Sols IIBM, Dept Canc Biol, Madrid, Spain.; Sainz, B (corresponding author), IRYCIS, Chron Dis & Canc Area 3, Madrid, Spain.	bruno.sainz@uam.es	Hermann, Patrick/Y-6254-2019; Seufferlein, Thomas TW/P-7147-2018; Anding, Bruno Sainz/ABH-5365-2020; Vallespinós, Mireia/AAL-1708-2021; Vallespinós, Mireia/AAC-9628-2022	Hermann, Patrick/0000-0003-0418-0478; Anding, Bruno Sainz/0000-0003-4829-7651; Alcala, Sonia/0000-0002-7644-4973; CARRATO, ALFREDO/0000-0001-7749-8140; Earl, Julie/0000-0001-9360-4716; Alonso-Nocelo, Marta/0000-0001-8838-363X	Ministerio de Economia y Competitividad, Spain [RYC-2012-12104]; Clinic and Laboratory Integration Program (CLIP) grant from the Cancer Research Institute (CRI), NY; Fundacion Asociacion Espanola Contra el Cancer (AECC) [GC16173694BARB]; Fondo de Investigaciones Sanitarias (FIS) from the Instituto de Salud Carlos III (ISCIII), Spain [PI15/01507, PI15/01715, PI15/02101]; Fondo Europeo de Desarrollo Regional (FEDER); Biomedical Research Network in Cancer [CIBER-ONC:CB16/12/00446]; Austrian Science Fund [FWF-B27361]; Ingrid Shaker-Nessmann Foundation; Max Eder Fellowship of the German Cancer Aid [111746]; German Research Foundation (DFG) [CRC 1279]	Ministerio de Economia y Competitividad, Spain; Clinic and Laboratory Integration Program (CLIP) grant from the Cancer Research Institute (CRI), NY; Fundacion Asociacion Espanola Contra el Cancer (AECC); Fondo de Investigaciones Sanitarias (FIS) from the Instituto de Salud Carlos III (ISCIII), Spain; Fondo Europeo de Desarrollo Regional (FEDER)(European Commission); Biomedical Research Network in Cancer; Austrian Science Fund(Austrian Science Fund (FWF)); Ingrid Shaker-Nessmann Foundation; Max Eder Fellowship of the German Cancer Aid; German Research Foundation (DFG)(German Research Foundation (DFG))	We are indebted to Jose German Casas for CD14-enriched monocyte preparations, Carmen Sanchez Palomo and Esperanza Macarena Rodriguez Serrano for IHC and histological assistance, and Maria Gonzalez Dionis for in vitro technical assistance. The research was supported by a Ramon y Cajal Merit Award (RYC-2012-12104) from the Ministerio de Economia y Competitividad, Spain (BS, Jr.), a Clinic and Laboratory Integration Program (CLIP) grant from the Cancer Research Institute (CRI), NY (BS, Jr.), a Coordinated grant (GC16173694BARB) from the Fundacion Asociacion Espanola Contra el Cancer (AECC) (AC and BS, Jr.), Fondo de Investigaciones Sanitarias (FIS) grants PI15/01507 (BS, Jr.), PI15/01715 (LGB) and PI15/02101 (AC) (co-financed through Fondo Europeo de Desarrollo Regional (FEDER) "Una manera de hacer Europa") from the Instituto de Salud Carlos III (ISCIII), Spain, funding from the Biomedical Research Network in Cancer (CIBER-ONC:CB16/12/00446) for clinical sample and data collection (AC), funding from the Austrian Science Fund (FWF-B27361) and Ingrid Shaker-Nessmann Foundation for Cancer Research (PM), a Max Eder Fellowship of the German Cancer Aid (111746) (PCH), and by the German Research Foundation (DFG, CRC 1279 "Exploiting the human peptidome for Novel Antimicrobial and Anticancer Agents") (PCH).	Bailey P, 2016, NATURE, V531, P47, DOI 10.1038/nature16965; Byers LA, 2013, CLIN CANCER RES, V19, P279, DOI 10.1158/1078-0432.CCR-12-1558; D'Costa Z, 2017, CANCER RES, V77, P5952, DOI 10.1158/0008-5472.CAN-16-2833; Dengler M, 2017, ONCOTARGET, V8, P46234, DOI 10.18632/oncotarget.17598; DUVALL E, 1985, IMMUNOLOGY, V56, P351; Eng EW, 2007, MOL BIOL CELL, V18, P2389, DOI 10.1091/mbc.e06-12-1128; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Gjerdrum C, 2010, P NATL ACAD SCI USA, V107, P1124, DOI 10.1073/pnas.0909333107; Hidalgo M, 2015, PANCREATOLOGY, V15, P8, DOI 10.1016/j.pan.2014.10.001; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Hu H, 2016, TUMOR BIOL, V37, P8657, DOI 10.1007/s13277-015-4741-z; Ireland L, 2016, CANCER RES, V76, P6851, DOI 10.1158/0008-5472.CAN-16-1201; Jandaghi P, 2016, GASTROENTEROLOGY, V151, P1218, DOI 10.1053/j.gastro.2016.08.040; Janky R, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2540-6; Kariolis MS, 2017, J CLIN INVEST, V127, P183, DOI 10.1172/JCI85610; Khorrami A, 2017, HORM MOL BIOL CLIN I, V32, DOI 10.1515/hmbci-2017-0032; Kirane A, 2015, CANCER RES, V75, P3699, DOI 10.1158/0008-5472.CAN-14-2887-T; Kitamura T, 2015, NAT REV IMMUNOL, V15, P73, DOI 10.1038/nri3789; Klemm C, 2014, PATHOL RES PRACT, V210, P335, DOI 10.1016/j.prp.2014.01.001; Ko AH, 2015, J CLIN ONCOL, V33, P1779, DOI 10.1200/JCO.2014.59.7625; Kobayashi R, 2009, CANCER IMMUNOL IMMUN, V58, P247, DOI 10.1007/s00262-008-0549-7; Korshunov VA, 2012, CLIN SCI, V122, P361, DOI 10.1042/CS20110411; Ludwig KF, 2018, CANCER RES, V78, P246, DOI 10.1158/0008-5472.CAN-17-1973; Martinelli P, 2017, GUT, V66, P1665, DOI 10.1136/gutjnl-2015-311256; Masters SC, 2001, J BIOL CHEM, V276, P45193, DOI 10.1074/jbc.M105971200; Matta A, 2016, PROTEOMICS, V16, P1079, DOI 10.1002/pmic.201500489; Matta A, 2012, EXPERT OPIN THER TAR, V16, P515, DOI 10.1517/14728222.2012.668185; Mueller MT, 2009, GASTROENTEROLOGY, V137, P1102, DOI 10.1053/j.gastro.2009.05.053; Nielsen SR, 2016, NAT CELL BIOL, V18, P549, DOI 10.1038/ncb3340; Nywening TM, 2016, LANCET ONCOL, V17, P651, DOI 10.1016/S1470-2045(16)00078-4; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Olson OC, 2017, CELL REP, V19, P101, DOI 10.1016/j.celrep.2017.03.038; Powell DW, 2002, J BIOL CHEM, V277, P21639, DOI 10.1074/jbc.M203167200; Rahib L, 2014, CANCER RES, V74, P2913, DOI 10.1158/0008-5472.CAN-14-0155; Reichl P, 2015, HEPATOLOGY, V61, P930, DOI 10.1002/hep.27492; Sainz B, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/9012369; Sainz B, 2015, GUT, V64, P1921, DOI 10.1136/gutjnl-2014-308935; Sainz B, 2014, CANCER RES, V74, P7309, DOI 10.1158/0008-5472.CAN-14-1354; Seifert L, 2016, GASTROENTEROLOGY, V150, P1659, DOI 10.1053/j.gastro.2016.02.070; Sica A, 2008, CANCER LETT, V267, P204, DOI 10.1016/j.canlet.2008.03.028; Vakkila J, 2004, NAT REV IMMUNOL, V4, P641, DOI 10.1038/nri1415; Wang WQ, 2016, BRIT J SURG, V103, P1189, DOI 10.1002/bjs.10187; Wang XC, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0180-7; Weizman N, 2014, ONCOGENE, V33, P3812, DOI 10.1038/onc.2013.357; Werba G, 2016, CELL CYCLE, V15, P2095, DOI 10.1080/15384101.2016.1191251; Wu GL, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.113; Zhang X, 2016, CANCER LETT, V381, P305, DOI 10.1016/j.canlet.2016.08.004; Zhou N, 2015, INT J MOL SCI, V16, P11966, DOI 10.3390/ijms160611966	48	35	35	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 4	2019	38	27					5469	5485		10.1038/s41388-019-0803-9	http://dx.doi.org/10.1038/s41388-019-0803-9			17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	IG5KR	30936462				2022-12-26	WOS:000473842500010
J	Haney, SL; Varney, ML; Chhonker, YS; Shin, S; Mehla, K; Crawford, AJ; Smith, HJ; Smith, LM; Murry, DJ; Hollingsworth, MA; Holstein, SA				Haney, Staci L.; Varney, Michelle L.; Chhonker, Yashpal S.; Shin, Simon; Mehla, Kamiya; Crawford, Ayrianne J.; Smith, Heather Jensen; Smith, Lynette M.; Murry, Daryl J.; Hollingsworth, Michael A.; Holstein, Sarah A.			Inhibition of geranylgeranyl diphosphate synthase is a novel therapeutic strategy for pancreatic ductal adenocarcinoma	ONCOGENE			English	Article							CANCER; MUC1; MUCINS; TRAFFICKING; BORTEZOMIB; ANTIBODY; CELLS	Rab proteins play an essential role in regulating intracellular membrane trafficking processes. Rab activity is dependent upon geranylgeranylation, a post-translational modification that involves the addition of 20-carbon isoprenoid chains via the enzyme geranylgeranyl transferase (GGTase) II. We have focused on the development of inhibitors against geranylgeranyl diphosphate synthase (GGDPS), which generates the isoprenoid donor (GGPP), as anti-Rab agents. Pancreatic ductal adenocarcinoma (PDAC) is characterized by abnormal mucin production and these mucins play important roles in tumor development, metastasis and chemo-resistance. We hypothesized that GGDPS inhibitor (GGDPSi) treatment would induce PDAC cell death by disrupting mucin trafficking, thereby inducing the unfolded protein response pathway (UPR) and apoptosis. To this end, we evaluated the effects of RAM2061, a potent GGDPSi, against PDAC. Our studies revealed that GGDPSi treatment activates the UPR and triggers apoptosis in a variety of human and mouse PDAC cell lines. Furthermore, GGDPSi treatment was found to disrupt the intracellular trafficking of key mucins such as MUC1. These effects could be recapitulated by incubation with a specific GGTase II inhibitor, but not a GGTase I inhibitor, consistent with the effect being dependent on disruption of Rab-mediated activities. In addition, siRNA-mediated knockdown of GGDPS induces upregulation of UPR markers and disrupts MUC1 trafficking in PDAC cells. Experiments in two mouse models of PDAC demonstrated that GGDPSi treatment significantly slows tumor growth. Collectively, these data support further development of GGDPSi therapy as a novel strategy for the treatment of PDAC.	[Haney, Staci L.; Varney, Michelle L.; Holstein, Sarah A.] Univ Nebraska Med Ctr, Dept Internal Med, Omaha, NE 68198 USA; [Haney, Staci L.; Varney, Michelle L.; Shin, Simon; Mehla, Kamiya; Crawford, Ayrianne J.; Smith, Heather Jensen; Murry, Daryl J.; Hollingsworth, Michael A.; Holstein, Sarah A.] Univ Nebraska Med Ctr, Fred & Pamela Buffett Canc Ctr, Omaha, NE 68198 USA; [Chhonker, Yashpal S.; Murry, Daryl J.] Univ Nebraska Med Ctr, Dept Pharm Practice, Omaha, NE USA; [Shin, Simon; Mehla, Kamiya; Crawford, Ayrianne J.; Smith, Heather Jensen; Hollingsworth, Michael A.] Univ Nebraska Med Ctr, Eppley Inst Res Canc, Omaha, NE USA; [Smith, Lynette M.] Univ Nebraska Med Ctr, Coll Publ Hlth, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Holstein, SA (corresponding author), Univ Nebraska Med Ctr, Dept Internal Med, Omaha, NE 68198 USA.; Holstein, SA (corresponding author), Univ Nebraska Med Ctr, Fred & Pamela Buffett Canc Ctr, Omaha, NE 68198 USA.	sarah.holstein@unmc.edu		Varney, Michelle/0000-0001-5339-2077	Fred & Pamela Buffett Cancer Center Support Grant from the National Cancer Institute [P30 CA036727]; National Institutes of Health [P50CA127297]; Fred & Pamela Buffett Cancer Center Advanced Microscopy Core Facility; Flow Cytometry Research Facility; National Cancer Institute [P30 CA036727]; NATIONAL CANCER INSTITUTE [P30CA036727, P50CA127297] Funding Source: NIH RePORTER	Fred & Pamela Buffett Cancer Center Support Grant from the National Cancer Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fred & Pamela Buffett Cancer Center Advanced Microscopy Core Facility; Flow Cytometry Research Facility; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Fred & Pamela Buffett Cancer Center Support Grant from the National Cancer Institute under award P30 CA036727 and the National Institutes of Health P50CA127297. The authors wish to acknowledge the support of the Fred & Pamela Buffett Cancer Center Advanced Microscopy Core Facility and the Flow Cytometry Research Facility, supported by the National Cancer Institute under award P30 CA036727. We thank Janice A. Taylor and James R. Talaska of the Advanced Microscopy Core Facility for providing assistance with confocal microscopy.	Besmer DM, 2011, CANCER RES, V71, P4432, DOI 10.1158/0008-5472.CAN-10-4439; Born EJ, 2013, BLOOD CANCER J, V3, DOI 10.1038/bcj.2013.64; Chhonker YS, 2018, MOLECULES, V23, DOI 10.3390/molecules23123275; Coxon FP, 2014, EUR J MED CHEM, V84, P77, DOI 10.1016/j.ejmech.2014.06.062; Deer EL, 2010, PANCREAS, V39, P425, DOI 10.1097/MPA.0b013e3181c15963; Haney SL, 2018, INVEST NEW DRUG, V36, P810, DOI 10.1007/s10637-018-0571-3; Haney SL, 2017, MOLECULES, V22, DOI 10.3390/molecules22060886; Hanson RL, 2016, BIOMOLECULES, V6, DOI 10.3390/biom6030034; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Holstein SA, 2001, LEUKEMIA RES, V25, P651, DOI 10.1016/S0145-2126(00)00162-4; Holstein SA, 2011, LEUKEMIA RES, V35, P551, DOI 10.1016/j.leukres.2010.08.008; Igarashi T, 2017, ONCOTARGET, V8, P12290, DOI 10.18632/oncotarget.14703; IWAMURA T, 1992, J GASTROEN HEPATOL, V7, P512, DOI 10.1111/j.1440-1746.1992.tb01030.x; Jin CN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039432; Jonckheere N, 2014, BBA-REV CANCER, V1846, P142, DOI 10.1016/j.bbcan.2014.04.008; Kaur S, 2013, NAT REV GASTRO HEPAT, V10, P607, DOI 10.1038/nrgastro.2013.120; Kinlough CL, 2006, J BIOL CHEM, V281, P12112, DOI 10.1074/jbc.M512996200; Liu XL, 2008, BIOCHEM BIOPH RES CO, V376, P688, DOI 10.1016/j.bbrc.2008.09.065; Luberice K, 2017, AM J SURG, V214, P341, DOI 10.1016/j.amjsurg.2017.05.007; Marten A, 2008, MOL CANCER THER, V7, P3624, DOI 10.1158/1535-7163.MCT-08-0393; Matthiesen RA, 2018, BIOORGAN MED CHEM, V26, P376, DOI 10.1016/j.bmc.2017.10.023; MISUMI Y, 1986, J BIOL CHEM, V261, P1398; Nath S, 2014, TRENDS MOL MED, V20, P332, DOI 10.1016/j.molmed.2014.02.007; Qi WM, 2001, HYBRIDOMA HYBRIDOM, V20, P313, DOI 10.1089/15368590152740716; Sorensen AL, 2006, GLYCOBIOLOGY, V16, P96, DOI 10.1093/glycob/cwj044; Suh H, 2017, AM J CANCER RES, V7, P1372; Taylor-Papadimitriou J, 2018, BIOCHEM SOC T, V46, P659, DOI 10.1042/BST20170400; TAYLORPAPADIMITRIOU J, 1981, INT J CANCER, V28, P17, DOI 10.1002/ijc.2910280104; Wang HB, 2012, ANTICANCER RES, V32, P1027; Wills VS, 2015, ACS MED CHEM LETT, V6, P1195, DOI 10.1021/acsmedchemlett.5b00334; Wssniowski TT, 2012, INT J ONCOL, V40, P1581, DOI 10.3892/ijo.2012.1337; Yan Y, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-445; Yu DC, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-248	34	12	12	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 27	2019	38	26					5308	5320		10.1038/s41388-019-0794-6	http://dx.doi.org/10.1038/s41388-019-0794-6			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	IF4AX	30918331	Green Accepted			2022-12-26	WOS:000473025300014
J	Vogel, D; Rosenthal, M; Gogrefe, N; Reindl, S; Gunther, S				Vogel, Dominik; Rosenthal, Maria; Gogrefe, Nadja; Reindl, Sophia; Guenther, Stephan			Biochemical characterization of the Lassa virus L protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						viral polymerase; recombinant protein expression; viral replication; RNA polymerase; viral transcription; arenavirus; genome replication initiation; hemorrhagic fever; LASV; prime-and-realign mechanism	DE-NOVO INITIATION; DEPENDENT RNA-POLYMERASE; CRYSTAL-STRUCTURE; IN-VITRO; 5 ENDS; REPLICATION; TRANSCRIPTION; BUNYAVIRIDAE; SYSTEM; MECHANISM	The L protein of arena- and bunyaviruses is structurally and functionally related to the orthomyxovirus polymerase complex. It plays a central role in the viral life cycle, as it replicates the virus genome and generates viral mRNA via a cap-snatching mechanism. Here, we aimed to biochemically characterize the L protein of Lassa virus, a human-pathogenic arenavirus endemic in West Africa. Full-length 250-kDa L protein was expressed using a baculovirus expression system. A low-resolution structure calculated from small-angle X-ray scattering data revealed a conformation similar to that in the crystal structure of the orthomyxovirus polymerase complex. Although the L protein did not exhibit cap-snatching endonuclease activity, it synthesized RNA in vitro. RNA polymerization required manganese rather than magnesium ions, was independent of nucleotide primers, and was inhibited by viral Z protein. Maximum activity was mediated by double-stranded promoter sequences with a minimum length of 17 nucleotides, containing a nontemplated 5-G overhang, as in the natural genome context, as well as the naturally occurring base mismatches between the complementary promoter strands. Experiments with various short primers revealed the presence of two replication initiation sites at the template strand and evidence for primer translocation as proposed by the prime-and-realign hypothesis. Overall, our findings provide the foundation for a detailed understanding of the mechanistic differences and communalities in the polymerase proteins of segmented negative-strand RNA viruses and for the search for antiviral compounds targeting the RNA polymerase of Lassa virus.	[Vogel, Dominik; Rosenthal, Maria; Gogrefe, Nadja; Reindl, Sophia; Guenther, Stephan] Bernhard Nocht Inst Trop Med, Dept Virol, Bernhard Nocht Str 74, D-20359 Hamburg, Germany; [Guenther, Stephan] German Ctr Infect Res DZIF, Partner Site Hamburg Lubeck Borstel Riems, D-20359 Hamburg, Germany	Bernhard Nocht Institut fur Tropenmedizin; German Center for Infection Research	Reindl, S; Gunther, S (corresponding author), Bernhard Nocht Inst Trop Med, Dept Virol, Bernhard Nocht Str 74, D-20359 Hamburg, Germany.; Gunther, S (corresponding author), German Ctr Infect Res DZIF, Partner Site Hamburg Lubeck Borstel Riems, D-20359 Hamburg, Germany.	reindl@bnitm.de; guenther@bni.uni-hamburg.de	Rosenthal, Maria/M-1857-2019	Rosenthal, Maria/0000-0003-2986-936X; Gunther, Stephan/0000-0002-6562-0230; Vogel, Dominik/0000-0001-6797-9696	German Research Foundation (Deutsche Forschungsgemeinschaft) [GU 883/4-1]; Dr. Ing. Wilhelm und Maria Kirmser-Stiftung	German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); Dr. Ing. Wilhelm und Maria Kirmser-Stiftung	This work was supported by the German Research Foundation (Deutsche Forschungsgemeinschaft) Grant GU 883/4-1 (to S. G.) and the Dr. Ing. Wilhelm und Maria Kirmser-Stiftung. The authors declare that they have no conflicts of interest with the contents of this article.	Amroun A, 2017, CRIT REV MICROBIOL, V43, P753, DOI [10.1080/1040841X.2017.1307805, 10.1080/1040841x.2017.1307805]; Arnold JJ, 2004, BIOCHEMISTRY-US, V43, P5138, DOI 10.1021/bi035213q; AUPERIN DD, 1984, J VIROL, V52, P897, DOI 10.1128/JVI.52.3.897-904.1984; AUPERIN DD, 1986, VIROLOGY, V154, P155, DOI 10.1016/0042-6822(86)90438-1; Berrow NS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm047; Bieniossek C, 2012, TRENDS BIOCHEM SCI, V37, P49, DOI 10.1016/j.tibs.2011.10.005; Blanchet CE, 2015, J APPL CRYSTALLOGR, V48, P431, DOI 10.1107/S160057671500254X; Brunotte L, 2011, J VIROL, V85, P324, DOI 10.1128/JVI.00721-10; Cornu TI, 2001, J VIROL, V75, P9415, DOI 10.1128/JVI.75.19.9415-9426.2001; Deng T, 2006, J VIROL, V80, P2337, DOI 10.1128/JVI.80.5.2337-2348.2006; Dias A, 2009, NATURE, V458, P914, DOI 10.1038/nature07745; Dulin D, 2015, CELL REP, V10, P983, DOI 10.1016/j.celrep.2015.01.031; Loureiro ME, 2011, J VIROL, V85, P12304, DOI 10.1128/JVI.05691-11; Fernandez-Garcia Y, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005635; Ferron F, 2017, VIRUS RES, V234, P118, DOI 10.1016/j.virusres.2017.01.018; Fitzgerald DJ, 2006, NAT METHODS, V3, P1021, DOI 10.1038/nmeth983; Franke D, 2017, J APPL CRYSTALLOGR, V50, P1212, DOI 10.1107/S1600576717007786; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; GARCIN D, 1995, J VIROL, V69, P5754, DOI 10.1128/JVI.69.9.5754-5762.1995; GARCIN D, 1992, J VIROL, V66, P1370, DOI 10.1128/JVI.66.3.1370-1376.1992; Gerlach P, 2015, CELL, V161, P1267, DOI 10.1016/j.cell.2015.05.006; Hass M, 2004, J VIROL, V78, P13793, DOI 10.1128/JVI.78.24.13793-13803.2004; Hass M, 2008, J VIROL, V82, P10207, DOI 10.1128/JVI.00220-08; Hass M, 2006, J VIROL, V80, P12414, DOI 10.1128/JVI.01374-06; Hastie KM, 2016, J VIROL, V90, P4556, DOI 10.1128/JVI.02896-15; Hays H, 2002, BIOCHEMISTRY-US, V41, P4771, DOI 10.1021/bi0120648; Hengrung N, 2015, NATURE, V527, P114, DOI 10.1038/nature15525; Jacamo R, 2003, J VIROL, V77, P10383, DOI 10.1128/JVI.77.19.10383-10393.2003; JIN H, 1993, J GEN VIROL, V74, P2293, DOI 10.1099/0022-1317-74-10-2293; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Kranzusch PJ, 2011, P NATL ACAD SCI USA, V108, P19743, DOI 10.1073/pnas.1112742108; Kranzusch PJ, 2010, P NATL ACAD SCI USA, V107, P20069, DOI 10.1073/pnas.1007152107; Lehmann M, 2014, J VIROL, V88, P8713, DOI 10.1128/JVI.00652-14; Lelke M, 2010, J VIROL, V84, P1934, DOI 10.1128/JVI.01657-09; Liu XJ, 2018, J VIROL, V92, DOI [10.1128/JVI.01414-17, 10.1128/jvi.01414-17]; Marq JB, 2010, J BIOL CHEM, V285, P18208, DOI 10.1074/jbc.M109.089425; Morin B, 2013, CURR OPIN VIROL, V3, P103, DOI 10.1016/j.coviro.2013.03.008; Morin B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001038; Ortin J, 2015, VIROLOGY, V479, P532, DOI 10.1016/j.virol.2015.03.018; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pflug A, 2014, NATURE, V516, P355, DOI 10.1038/nature14008; POLYAK SJ, 1995, J VIROL, V69, P3211, DOI 10.1128/JVI.69.5.3211-3215.1995; RAJU R, 1990, VIROLOGY, V174, P53, DOI 10.1016/0042-6822(90)90053-T; Ranjith-Kumar CT, 2002, J VIROL, V76, P12513, DOI 10.1128/JVI.76.24.12513-12525.2002; Ranjith-Kumar CT, 2001, J VIROL, V75, P8615, DOI 10.1128/JVI.75.18.8615-8623.2001; Reguera J, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005636; Reguera J, 2016, CURR OPIN STRUC BIOL, V36, P75, DOI 10.1016/j.sbi.2016.01.002; Reich S, 2017, NUCLEIC ACIDS RES, V45, P3353, DOI 10.1093/nar/gkx043; Reich S, 2014, NATURE, V516, P361, DOI 10.1038/nature14009; Rosenthal M, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006400; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tambo E, 2018, INFECT DIS POVERTY, V7, DOI 10.1186/s40249-018-0421-8; te Velthuis AJW, 2018, J VIROL, V92, DOI 10.1128/JVI.01775-17; Thierry E, 2016, MOL CELL, V61, P125, DOI 10.1016/j.molcel.2015.11.016; Vieth S, 2004, VIROLOGY, V318, P153, DOI 10.1016/j.virol.2003.09.009; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wallat GD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087577; Zhong WD, 2000, J VIROL, V74, P2017, DOI 10.1128/JVI.74.4.2017-2022.2000	61	16	16	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2019	294	20					8088	8100		10.1074/jbc.RA118.006973	http://dx.doi.org/10.1074/jbc.RA118.006973			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC0NH	30926610	hybrid, Green Published			2022-12-26	WOS:000470656500010
J	Broekhuis, F; Madsen, EK; Keiwua, K; Macdonald, DW				Broekhuis, Femke; Madsen, Emily K.; Keiwua, Kosiom; Macdonald, David W.			Using GPS collars to investigate the frequency and behavioural outcomes of intraspecific interactions among carnivores: A case study of male cheetahs in the Maasai Mara, Kenya	PLOS ONE			English	Article							POPULATION; ECOLOGY; ORGANIZATION; EVOLUTION; HABITAT; SOCIETY	Intraspecific interactions between individuals or groups of individuals of the same species are an important component of population dynamics. Interactions can be static, such as spatial overlap, or dynamic based on the interactions of movements, and can be mediated through communication, such as the deployment of scent marks. Interactions and their behavioural outcomes can be difficult to determine, especially for species that live at low densities. With the use of GPS collars we quantify both static and dynamic interactions between male cheetahs (Acinonyx jubatus) and the behavioural outcomes. The 99% homeranges of males overlapped significantly while there was little overlap of the 50% homeranges. Despite this overlap, male cheetahs rarely came into close proximity of one another, possibly because presence was communicated through frequent visits to marking posts. The minimum distance between individuals in a dyad ranged from 89m to 196m but the average proximity between individuals ranged from 17,145 +/- 6,865m to 26,367 +/- 11,288m. Possible interactions took place more frequently at night than by day and occurred mostly in the 50% home-range of one individual of a dyad or where cores of both individuals overlapped. After a possible encounter male cheetahs stayed in close proximity to each other for up to 6 hours, which could be the result of a territory defence strategy or the presence of a receptive female. We believe that one of the encounters between a singleton and a 5-male coalition resulted in the death of the singleton. Our results give new insights into cheetah interactions, which could help our understanding of ecological processes such as disease transmission.	[Broekhuis, Femke; Keiwua, Kosiom] Kenya Wildlife Trust, Nairobi, Kenya; [Broekhuis, Femke; Macdonald, David W.] Univ Oxford, Recanati Kaplan Ctr, Wildlife Conservat Res Unit, Dept Zool, Tubney, England; [Madsen, Emily K.] UCL, Ctr Biodivers & Environm Res, London, England	University of Oxford; University of London; University College London	Broekhuis, F (corresponding author), Kenya Wildlife Trust, Nairobi, Kenya.; Broekhuis, F (corresponding author), Univ Oxford, Recanati Kaplan Ctr, Wildlife Conservat Res Unit, Dept Zool, Tubney, England.	femke.broekhuis@gmail.com		Broekhuis, Femke/0000-0002-4216-8819; Madsen, Emily/0000-0003-4108-6608	Banovich Wildscapes Foundation; African Wildlife Foundation; Vidda Foundation; BAND Foundation	Banovich Wildscapes Foundation; African Wildlife Foundation; Vidda Foundation; BAND Foundation	Funding was provided by the Banovich Wildscapes Foundation (www.wildscapesfoundation.org), the African Wildlife Foundation (www.awf.org), Vidda Foundation (www.vidda.org), BAND Foundation (www.bandfdn.org) and donations made through the Kenya Wildlife Trust (www.kenyawildlifetrust.org).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen ML, 2016, SCI REP-UK, V6, DOI 10.1038/srep27257; Andreassen HP, 2006, ECOLOGY, V87, P88, DOI 10.1890/04-1574; Arnold J, 2011, CAN J ZOOL, V89, P808, DOI 10.1139/Z11-069; Bohm M, 2008, J ANIM ECOL, V77, P735, DOI 10.1111/j.1365-2656.2008.01377.x; Bracis Chloe, 2018, ECOGRAPHY; Broekhuis F, 2018, J ZOOL, V304, P65, DOI 10.1111/jzo.12499; Broekhuis F, 2016, MARA CHEETAH PROJECT; Broekhuis F, 2018, BIODIVER WORL CONS, P447, DOI 10.1016/B978-0-12-804088-1.00032-0; Broekhuis F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153875; Brown J.L., 1970, ANNU REV ECOL SYST, V1, P239; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Cant MA, 2002, ETHOLOGY, V108, P541, DOI 10.1046/j.1439-0310.2002.00795.x; Carazo P, 2008, ANIM BEHAV, V76, P1953, DOI 10.1016/j.anbehav.2008.08.018; Caro T.M., 1989, Special Publication of the British Ecological Society, P41; Caro T. M., 1994, CHEETAHS SERENGETI G; CARO TM, 1987, ETHOLOGY, V74, P52; CARO TM, 1989, ANIM BEHAV, V38, P309, DOI 10.1016/S0003-3472(89)80092-2; CARO TM, 1987, J ZOOL, V211, P89, DOI 10.1111/j.1469-7998.1987.tb07455.x; Chaber AL, 2017, J WILDLIFE DIS, V53, P170, DOI 10.7589/2015-11-302; Christensen C., 2016, BEHAV ECOLOGY; Cozzi G, 2012, ECOLOGY, V93, P2590, DOI 10.1890/12-0017.1; Crofoot MC, 2013, AM J PHYS ANTHROPOL, V152, P79, DOI 10.1002/ajpa.22330; Cross PC, 2012, BEHAV ECOL SOCIOBIOL, V66, P1437, DOI 10.1007/s00265-012-1376-6; Devenish-Nelson ES, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0524; Duquette JF, 2017, CAN J ZOOL, V95, P203, DOI 10.1139/cjz-2016-0031; Durant SM, 2007, CONSERV BIOL, V21, P602, DOI 10.1111/j.1523-1739.2007.00702.x; Eaton R.L., 1970, Z TIERPSYCHOL, V27, P481, DOI DOI 10.1111/J.1439-0310.1970.TB01882.X; Elbroch LM, 2017, CURR ZOOL, V63, P357, DOI 10.1093/cz/zow080; ENQUIST M, 1990, ANIM BEHAV, V39, P1, DOI 10.1016/S0003-3472(05)80721-3; Gakuya F, 2012, PARASITOLOGY, V139, P1587, DOI 10.1017/S0031182012000935; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; Gottelli D, 2007, P ROY SOC B-BIOL SCI, V274, P1993, DOI 10.1098/rspb.2007.0502; Grunewalder S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049120; Hunter L. T. B., 2003, Transactions of the Royal Society of South Africa, V58, P79; Jordan NR, 2017, BEHAV ECOL SOCIOBIOL, V71, DOI 10.1007/s00265-017-2338-9; Kelly MJ, 1998, J ZOOL, V244, P473, DOI 10.1017/S0952836998004014; Kusler A, 2019, AFR J ECOL, V57, P419, DOI 10.1111/aje.12602; LONG J. A., 2014, WILDLIFEDI CALCULATE; Lopez-Bao JV, 2008, MAMM BIOL, V73, P404, DOI 10.1016/j.mambio.2007.10.012; Loveridge AJ, 2001, J ZOOL, V253, P101, DOI 10.1017/S0952836901000097; Lukas D, 2014, SCIENCE, V346, P841, DOI 10.1126/science.1257226; Macdonald DW, 2015, J ZOOL, V295, P75, DOI 10.1111/jzo.12202; Macdonald David W., 2010, P125; MACDONALD DW, 1983, NATURE, V301, P379, DOI 10.1038/301379a0; MacDonald DW., 1980, HDB BIOTELEMETRY RAD, P143; Marker LL, 2008, J ZOOL, V274, P226, DOI 10.1111/j.1469-7998.2007.00375.x; Marnewick KA, 2006, S AFR J WILDL RES, V36, P139; Mattisson J, 2013, MAMM BIOL, V78, P304, DOI 10.1016/j.mambio.2012.11.006; Meltzer D., 2006, CHEM PHYS RESTRAINT; Melzheimer J, 2018, ECOSPHERE, V9, DOI 10.1002/ecs2.2308; Mills G., 2017, KALAHARI CHEETAHS AD; Munson L, 2004, J WILDLIFE DIS, V40, P23, DOI 10.7589/0090-3558-40.1.23; Ogutu JO, 2008, J ANIM ECOL, V77, P814, DOI 10.1111/j.1365-2656.2008.01392.x; Oindo BO, 2003, INT J REMOTE SENS, V24, P1053, DOI 10.1080/01431160210144552; Packer C, 1984, INFANTICIDE CARNIVOR; Papastamatiou YP, 2018, OIKOS, V127, P767, DOI 10.1111/oik.04289; R Development Core Team, 2016, R LANG ENV STAT COMP; Rankin DJ, 2007, OIKOS, V116, P335, DOI [10.1111/j.2006.0030-1299.15451.x, 10.1111/j.0030-1299.2007.15451.x]; Robert K, 2012, J WILDLIFE MANAGE, V76, P1670, DOI 10.1002/jwmg.435; Schwalb-Willmann J., 2019, moveVis: Movement Data Visualization; VANWINKLE W, 1975, J WILDLIFE MANAGE, V39, P118; White LA, 2018, P NATL ACAD SCI USA, V115, P7374, DOI 10.1073/pnas.1801383115; Whitehead H, 2009, BEHAV ECOL SOCIOBIOL, V63, P765, DOI 10.1007/s00265-008-0697-y; Wielgus RB, 2000, BIOL CONSERV, V93, P145, DOI 10.1016/S0006-3207(99)00152-4; Wiley R. H., 1979, SOCIAL BEHAV COMMUNI, P159	65	16	16	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0213910	10.1371/journal.pone.0213910	http://dx.doi.org/10.1371/journal.pone.0213910			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR5NS	30943236	Green Published, Green Submitted, gold			2022-12-26	WOS:000463194300020
J	Borpatragohain, P; Rose, TJ; Liu, L; Raymond, CA; Barkla, BJ; King, GJ				Borpatragohain, Priyakshee; Rose, Terry J.; Liu, Lei; Raymond, Carolyn A.; Barkla, Bronwyn J.; King, Graham J.			Seed glucosinolate yield is maximized by higher rates of sulfur nutrition than required for seed yield in condiment mustard (Brassica juncea L.)	PLOS ONE			English	Article							GENETIC-ANALYSIS; RAPESEED; QUALITY; METABOLISM; PROTEINS; PATHWAY; LINE	Brassica crops require high amounts of inorganic sulfur (S) for optimum yield, and are characterized by the synthesis of S-rich glucosinolates (GSL). Although it is well established that seed and GSL yield can be increased by S fertilizer, the detailed relationship between S supply as primary source and the harvestable sinks of seed GSL and storage proteins is poorly understood. We tested the hypothesis that Brassica juncea mustard seed acts as a secondary S sink, and so require a higher rate of S to achieve maximum seed GSL compared to rates required to attain maximum seed biomass. Our experimental strategy involved comparing responses to available S for seed biomass, GSL, and protein. This was carried out in a protected environment using sand culture for a high-GSL condiment-type homozygous B. juncea genotype. A low-GSL canola-type was used as a control, in order to establish a base-line of response. Significantly more S was required to achieve maximum seed GSL than was required to achieve maximum seed mass. Total seed protein content was not significantly affected by increased S. The high-GSL line appeared to have an efficient mechanism of S supply to the secondary S sink, given the observed increase in seed S with increased S availability. From a practical point of view, increases in seed GSL with S availability suggests that S fertilizer rates should be optimized for maximum seed GSL yield, rather that optimizing for seed yield, as occurs for most other crops.	[Borpatragohain, Priyakshee; Rose, Terry J.; Liu, Lei; Raymond, Carolyn A.; Barkla, Bronwyn J.; King, Graham J.] Southern Cross Univ, Southern Cross Plant Sci, Lismore, NSW, Australia	Southern Cross University	King, GJ (corresponding author), Southern Cross Univ, Southern Cross Plant Sci, Lismore, NSW, Australia.	graham.king@scu.edu.au	Liu, Lei/AAM-2739-2021; Barkla, Bronwyn J/O-6301-2017; BORPATRAGOHAIN, PRIYAKSHEE/AAM-2080-2020; King, Graham J/AAW-3368-2020; Raymond, Carolyn A/P-4764-2017	Liu, Lei/0000-0002-3710-7042; Barkla, Bronwyn J/0000-0002-4691-8023; BORPATRAGOHAIN, PRIYAKSHEE/0000-0002-9598-5986; King, Graham J/0000-0002-5975-6051; Raymond, Carolyn A/0000-0003-2887-9267; Rose, Terry/0000-0001-5386-6818	Australian Mustard Oil Pty. Ltd, Australia; Department of Biotechnology Center of Assam Agricultural University, India; Southern Cross Plant Science Centre, Southern Cross University, Australia	Australian Mustard Oil Pty. Ltd, Australia; Department of Biotechnology Center of Assam Agricultural University, India; Southern Cross Plant Science Centre, Southern Cross University, Australia	PB received scholarship funding from Australian Mustard Oil Pty. Ltd, Australia, Department of Biotechnology Center of Assam Agricultural University, India and Southern Cross Plant Science Centre, Southern Cross University, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen TG, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/psb.27740; Anjum NA, 2012, SCI WORLD J, DOI 10.1100/2012/657808; BARROW NJ, 1990, FERT RES, V22, P181, DOI 10.1007/BF01120393; Bednarek P, 2009, SCIENCE, V323, P101, DOI 10.1126/science.1163732; Bellostas N, 2007, GCIRC B; Bones AM, 1996, PHYSIOL PLANTARUM, V97, P194, DOI [10.1034/j.1399-3054.1996.970128.x, 10.1111/j.1399-3054.1996.tb00497.x]; Borpatragohain P, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01735; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cheng BF, 2001, GENOME, V44, P738, DOI 10.1139/gen-44-4-738; Crocoll Christoph, 2016, Curr Protoc Plant Biol, V1, P385, DOI 10.1002/cppb.20027; CROUCH ML, 1981, PLANTA, V153, P64, DOI 10.1007/BF00385319; Dimov Z, 2012, PLANT BREEDING, V131, P361, DOI 10.1111/j.1439-0523.2012.01951.x; Fahey JW, 2001, PHYTOCHEMISTRY, V56, P5, DOI 10.1016/S0031-9422(00)00316-2; Falk KL, 2007, PLANT BIOLOGY, V9, P573, DOI 10.1055/s-2007-965431; Griffiths DW, 1998, J HORTIC SCI BIOTECH, V73, P1; Haskins B, 2009, JUNCEA CANOLA LOW RA; Hassan F, 2007, INT J AGR BIOL PAKIS; Ishida M, 2014, BREEDING SCI, V64, P48, DOI 10.1270/jsbbs.64.48; Jankowski K, 2008, J ELEM, V13, P521; Koprivova A, 2016, J GENET GENOMICS; LAKKINENI KC, 1992, PHYTON-ANN REI BOT A, V32, P75; Li GY, 2002, GENETICS, V162, P1937; Liu Z, 2011, MOL BREEDING, V27, P467, DOI 10.1007/s11032-010-9444-y; LOVE HK, 1990, CAN J PLANT SCI, V70, P419, DOI 10.4141/cjps90-049; Malhi SS, 2007, AGRON J, V99, P570, DOI 10.2134/agronj2006.0269; MONSALVE R, 2001, INT S FOOD ALL; Mugford SG, 2011, PLANT J, V65, P96, DOI 10.1111/j.1365-313X.2010.04410.x; Nesi N, 2008, CR BIOL, V331, P763, DOI 10.1016/j.crvi.2008.07.018; Nishinari K, 2014, FOOD HYDROCOLLOID, V39, P301, DOI 10.1016/j.foodhyd.2014.01.013; Nour-Eldin HH, 2017, NATURE BIOTECHNOLOGY; OHLSON R, 1979, J AM OIL CHEM SOC, V56, P431, DOI 10.1007/BF02671531; Othmane M., 2015, J CHEM, V2015, P6, DOI [10.1155/2015/606142, DOI 10.1155/2015/606142]; Rhee MS, 2003, APPL ENVIRON MICROB, V69, P2959, DOI 10.1128/AEM.69.5.2959-2963.2003; Schatzki J, 2014, THEOR APPL GENET, V127, P1213, DOI 10.1007/s00122-014-2292-0; Sodhi YS, 2002, PLANT BREEDING, V121, P508, DOI 10.1046/j.1439-0523.2002.00747.x; SOSULSKI F, 1979, J AM OIL CHEM SOC, V56, P711, DOI 10.1007/BF02663047; Tian QG, 2005, ANAL BIOCHEM, V343, P93, DOI 10.1016/j.ab.2005.04.045; Wittstock U, 2010, GLUC BREAKD AR MECH; Zhao FJ, 1997, SOIL SCI PLANT NUTR, V43, P1137	39	4	4	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2019	14	4							e0213429	10.1371/journal.pone.0213429	http://dx.doi.org/10.1371/journal.pone.0213429			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR2UW	30939141	gold, Green Published			2022-12-26	WOS:000462993900005
J	Dahood, A; Watters, GM; de Mutsert, K				Dahood, Adrian; Watters, George M.; de Mutsert, Kim			Using sea-ice to calibrate a dynamic trophic model for the Western Antarctic Peninsula	PLOS ONE			English	Article							SOUTH SHETLAND ISLANDS; KRILL EUPHAUSIA-SUPERBA; CHINSTRAP PENGUINS; CLIMATE-CHANGE; POPULATION-CHANGES; MARINE ECOSYSTEM; ELEPHANT ISLAND; SCOTIA SEA; FOOD-WEB; BIOMASS	The pelagic ecosystems of the Western Antarctic Peninsula are dynamic and changing rapidly in the face of sustained warming. There is already evidence that warming may be impacting the food web. Antarctic krill, Euphausia superba, is an ice-associated species that is both an important prey item and the target of the only commercial fishery operating in the region. The goal of this study is to develop a dynamic trophic model for the region that includes the impact of the sea-ice regime on krill and krill predators. Such a model may be helpful to fisheries managers as they develop new management strategies in the face of continued sea-ice loss. A mass balanced food-web model (Ecopath) and time dynamic simulations (Ecosim) were created. The Ecopath model includes eight currently monitored species as single species to facilitate its future development into a model that could be used for marine protected area planning in the region. The Ecosim model is calibrated for the years 1996-2012. The successful calibration represents an improvement over existing Ecopath models for the region. Simulations indicate that the role of sea ice is both central and complex. The simulations are only able to recreate observed biomass trends for the monitored species when metrics describing the sea-ice regime are used to force key predator-prey interactions, and to drive the biomasses of Antarctic krill and the fish species Gobionotothen gibberifrons. This model is ready to be used for exploring results from sea-ice scenarios or to be developed into a spatial model that informs discussions regarding the design of marine protected areas in the region.	[Dahood, Adrian; de Mutsert, Kim] George Mason Univ, Dept Environm Sci & Policy, Fairfax, VA 22030 USA; [Dahood, Adrian; Watters, George M.] NOAA, Antarctic Ecosyst Res Div, Southwest Fisheries Sci Ctr, Natl Marine Fisheries Serv, La Jolla, CA 92037 USA; [Dahood, Adrian] Univ Calif Santa Cruz, Inst Marine Sci, Santa Cruz, CA 95064 USA	George Mason University; National Oceanic Atmospheric Admin (NOAA) - USA; University of California System; University of California Santa Cruz	Dahood, A (corresponding author), George Mason Univ, Dept Environm Sci & Policy, Fairfax, VA 22030 USA.; Dahood, A (corresponding author), NOAA, Antarctic Ecosyst Res Div, Southwest Fisheries Sci Ctr, Natl Marine Fisheries Serv, La Jolla, CA 92037 USA.; Dahood, A (corresponding author), Univ Calif Santa Cruz, Inst Marine Sci, Santa Cruz, CA 95064 USA.	adahood@gmail.com	de Mutsert, Kim/AAV-1035-2020	de Mutsert, Kim/0000-0002-7902-3787; Dahood, Adrian/0000-0001-5346-8537	Pew Charitable Trusts [31815]; Environmental Science and Policy Department at George Mason University	Pew Charitable Trusts; Environmental Science and Policy Department at George Mason University	This work was supported by funding from the Pew Charitable Trusts, contract ID#31815. A.D. was a graduate student during model development and benefitted from funding from the Environmental Science and Policy Department at George Mason University. The funders had no role in study design, data collection and analysis, or preparation of the manuscript. The Pew Charitable Trusts required publication in a peer reviewed journal, but did not influence the decision on where to submit.	Acker J.G., 2007, EOS T AM GEOPHYS UN, V88, P14, DOI [DOI 10.1029/2007EO020003, 10.1029/2007EO020003]; Agnew DJ, 1997, ANTARCT SCI, V9, P235, DOI 10.1017/S095410209700031X; Atkinson A, 2004, NATURE, V432, P100, DOI 10.1038/nature02996; Ballerini T, 2014, PROG OCEANOGR, V122, P10, DOI 10.1016/j.pocean.2013.11.007; BANSE K, 1980, ECOL MONOGR, V50, P355, DOI 10.2307/2937256; Barrera-Oro ER, 2000, CCAMLR SCI, V7, P43; Branch T. A., 2011, Journal of Cetacean Research and Management, P53; Candy SG, 2006, MAR ECOL PROG SER, V306, P17, DOI 10.3354/meps306017; Casaux R, 2009, POLAR BIOL, V32, P833, DOI 10.1007/s00300-009-0583-8; Casaux R, 2009, POLAR BIOL, V32, P307, DOI 10.1007/s00300-008-0567-0; CCAMLR, 2011, COBS MEAS 91 04 GEN; CCAMLR, 2017, 36 M COMM HOB TASM; CCAMLR, 2011, WORKSH MAR PROT AR A; CCAMLR (Commission for the Conservation of Antarctic Marine Living Resources), 2018, CCAMLR STAT B, V30; Christensen V, 2004, ECOL MODEL, V172, P109, DOI 10.1016/j.ecolmodel.2003.09.003; Christensen V, 2014, ECOSYSTEMS, V17, P1397, DOI 10.1007/s10021-014-9803-3; Constable AJ, 2002, CCAMLR SCI, V9, P233; Constable AJ, 2000, ICES J MAR SCI, V57, P778, DOI 10.1006/jmsc.2000.0725; Constable AJ, 2011, FISH FISH, V12, P138, DOI 10.1111/j.1467-2979.2011.00410.x; Cooper APR, 2013, SCAR ANTARCTIC DIGIT; Cornejo-Donoso J, 2008, ECOL MODEL, V218, P1, DOI 10.1016/j.ecolmodel.2008.06.011; Daly KL, 2004, DEEP-SEA RES PT II, V51, P2139, DOI 10.1016/j.dsr2.2004.07.010; Ducklow HW, 2008, DEEP-SEA RES PT II, V55, P2118, DOI 10.1016/j.dsr2.2008.04.028; Ducklow HW, 2007, PHILOS T R SOC B, V362, P67, DOI 10.1098/rstb.2006.1955; Ducklow HW, 2013, OCEANOGRAPHY, V26, P190, DOI 10.5670/oceanog.2013.62; Erfran, 2005, FISHERIES CTR RES RE, V13, P5; Everson I, 2000, KRILL BIOL ECOLOGY F; Field C.B., 2014, SPEC REP GLOB WARM 1, DOI 10.1017/cbo9780511976988.002; Flores H, 2004, POLAR BIOL, V27, P119, DOI 10.1007/s00300-003-0570-4; Forcada J, 2006, GLOBAL CHANGE BIOL, V12, P411, DOI 10.1111/j.1365-2486.2006.01108.x; Forcada J, 2009, GLOBAL CHANGE BIOL, V15, P1618, DOI 10.1111/j.1365-2486.2009.01909.x; Fraser WR, 2003, MAR ECOL PROG SER, V265, P1, DOI 10.3354/meps265001; Goebel M.E., 2014, WGEMM1439; Hewitt RP, 2004, DEEP-SEA RES PT II, V51, P1215, DOI 10.1016/j.dsr2.2004.06.011; Heymans JJ, 2016, ECOL MODEL, V331, P173, DOI 10.1016/j.ecolmodel.2015.12.007; Hill SL, 2007, CCAMLR SCI, V14, P1; Hill SL, 2012, DEEP-SEA RES PT II, V59, P237, DOI 10.1016/j.dsr2.2011.09.001; Hinke JT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170132; Hinke JT, 2014, POLAR BIOL, V37, P1797, DOI 10.1007/s00300-014-1562-2; Hinke JT, 2007, OECOLOGIA, V153, P845, DOI 10.1007/s00442-007-0781-4; Hoover C., 2012, FROM TROPICS POLES E, P108; Hucke-Gaete R, 2004, POLAR BIOL, V27, P304, DOI 10.1007/s00300-003-0587-8; [Information Manager PAL Palmer Station Antarctica LTER], 2018, BAS W ANT PEN SURV G, DOI [10.6073/pasta/fc528df1b8b8971a4fd28754101f5d6b, DOI 10.6073/PASTA/FC528DF1B8B8971A4FD28754101F5D6B]; Iverson I, 1998, CCAMLR SCI, V5, P245; Kinzey D, 2013, CCAMLR SCI, V20, P81; Klein ES, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191011; Kock KH, 2005, REV FISH SCI, V13, P75, DOI 10.1080/10641260590953900; Kock KH, 2012, 2012WGFSA120 CCAMLR; Loeb VJ, 2012, PROG OCEANOGR, V96, P93, DOI 10.1016/j.pocean.2011.11.001; Lynch HJ, 2012, ECOLOGY, V93, P1367; Lynnes AS, 2004, POLAR BIOL, V27, P544, DOI 10.1007/s00300-004-0617-1; Meredith MP, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024042; Miller AK, 2010, CONDOR, V112, P683, DOI 10.1525/cond.2010.090221; Miller DGM, 2002, CCAMLR SCI, V9, P175; Mori M, 2006, CCAMLR SCI, V13, P217; Murphy EJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07205-9; Nicol S, 2006, BIOSCIENCE, V56, P111, DOI 10.1641/0006-3568(2006)056[0111:KCASIE]2.0.CO;2; Nicol S, 2012, FISH FISH, V13, P30, DOI 10.1111/j.1467-2979.2011.00406.x; Pakhomov EA, 2004, DEEP-SEA RES PT II, V51, P2645, DOI 10.1016/j.dsr2.2001.03.001; Pastene LA, 2016, WGEMM1626; Pauly D, 2000, ICES J MAR SCI, V57, P697, DOI 10.1006/jmsc.2000.0726; Ramm DC, 2015, CCAMLR STAT AR BOUND; Reiss CS, 2008, ICES J MAR SCI, V65, P497, DOI 10.1093/icesjms/fsn033; Reiss CS, 2017, MAR ECOL PROG SER, V568, P1, DOI 10.3354/meps12099; Reiss CS, 2016, ADV POL ECO, P101, DOI 10.1007/978-3-319-29279-3_3; Ribic CA, 2011, DEEP-SEA RES PT II, V58, P1695, DOI 10.1016/j.dsr2.2009.09.017; ROSENBERG AA, 1986, NATURE, V324, P152, DOI 10.1038/324152a0; Santora JA, 2013, MAR BIOL, V160, P1383, DOI 10.1007/s00227-013-2190-z; Santora JA, 2009, FISH OCEANOGR, V18, P20, DOI 10.1111/j.1365-2419.2008.00490.x; Schofield O., 2020, ENV DATA INITIATIVE, Vv7, DOI [10.6073/pasta/1201-43cf21718c300db9777f89e09f8, DOI 10.6073/PASTA/1201-43CF21718C300DB9777F89E09F8]; SIEGEL V, 1995, MAR ECOL PROG SER, V123, P45, DOI 10.3354/meps123045; Stammerjohn S.E., 2013, AVERAGE MONTHLY SEA; Stammerjohn S, 2011, DEEP-SEA RES PT II, V58, P999, DOI 10.1016/j.dsr2.2010.10.026; Steele JH, 2011, J MARINE SYST, V87, P227, DOI 10.1016/j.jmarsys.2011.04.005; Steig EJ, 2009, NATURE, V457, P459, DOI 10.1038/nature07669; Stroeve J., 2018, Sea Ice Trends and Climatologies From SMMR and SSM/ISSMIS, Version 3.1, DOI 10.5067/IJ0T7HFHB9Y6; Suprenand PM, 2017, MAR ECOL PROG SER, V569, P37, DOI 10.3354/meps12100; Taki K, 2006, FISHERIES SCI, V72, P221, DOI 10.1111/j.1444-2906.2006.01142.x; Townsend C. R., 2003, ESSENTIALS ECOLOGY; Trathan PN, 2016, ADV POL ECO, P321, DOI 10.1007/978-3-319-29279-3_9; Trivelpiece WZ, 2011, P NATL ACAD SCI USA, V108, P7625, DOI 10.1073/pnas.1016560108; TRIVELPIECE WZ, 1987, ECOLOGY, V68, P351, DOI 10.2307/1939266; Vaughan DG, 2003, CLIMATIC CHANGE, V60, P243, DOI 10.1023/A:1026021217991; VEIT RR, 1993, J ANIM ECOL, V62, P551, DOI 10.2307/5204; Zeng C, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16122075	85	16	17	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2019	14	4							e0214814	10.1371/journal.pone.0214814	http://dx.doi.org/10.1371/journal.pone.0214814			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR2UW	30939156	Green Submitted, Green Published, gold			2022-12-26	WOS:000462993900041
J	Chang, TC; Goud, S; Torcivia-Rodriguez, J; Hu, Y; Pan, Q; Kahsay, R; Blomberg, J; Mazumder, R				Chang, Ting-Chia; Goud, Santosh; Torcivia-Rodriguez, John; Hu, Yu; Pan, Qing; Kahsay, Robel; Blomberg, Jonas; Mazumder, Raja			Investigation of somatic single nucleotide variations in human endogenous retrovirus elements and their potential association with cancer	PLOS ONE			English	Article							TRANSFER-RNA GENES; NONCODING RNA; EVOLUTIONARY DYNAMICS; REPBASE UPDATE; DATABASE; MUTATIONS; TRANSCRIPTION; EXPRESSION; IDENTIFICATION; ACTIVATION	Human endogenous retroviruses (HERVs) have been investigated for potential links with human cancer. However, the distribution of somatic nucleotide variations in HERV elements has not been explored in detail. This study aims to identify HERV elements with an over-representation of somatic mutations (hot spots) in cancer patients. Four HERV elements with mutation hotspots were identified that overlap with exons of four human protein coding genes. These hotspots were identified based on the significant over-representation (p<8.62e-4) of non-synonymous single-nucleotide variations (nsSNVs). These genes are TNN (HERV-9/LTR12), OR4K15 (HERV-IP10F/LTR10F), ZNF99 (HERV-W/HERV17/LTR17), and KIR2DL1 (MST/MaLR). In an effort to identify mutations that effect survival, all nsSNVs were further evaluated and it was found that kidney cancer patients with mutation C2270G in ZNF99 have a significantly lower survival rate (hazard ratio = 2.6) compared to those without it. Among HERV elements in the human non-protein coding regions, we found 788 HERVs with significantly elevated numbers of somatic single-nucleotide variations (SNVs) (p<1.60e-5). From this category the top three HERV elements with significantly over-represented SNVs are HERV-H/LTR7, HERV-9/LTR12 and HERV-L/MLT2. Majority of the SNVs in these 788 HERV elements are located in three DNA functional groups: long non-coding RNAs (lncRNAs) (60%), introns (22.2%) and transcriptional factor binding sites (TFBS) (14.8%). This study provides a list of mutational hotspots in HERVs, which could potentially be used as biomarkers and therapeutic targets.	[Chang, Ting-Chia; Torcivia-Rodriguez, John; Hu, Yu; Kahsay, Robel; Mazumder, Raja] George Washington Univ, Med Ctr, Dept Biochem & Mol Med, Washington, DC 20037 USA; [Goud, Santosh] George Mason Univ, Sch Syst Biol, Manassas, VA USA; [Pan, Qing] George Washington Univ, Dept Stat, Washington, DC 20052 USA; [Blomberg, Jonas] Uppsala Univ Hosp, Dept Med Sci, Uppsala, Sweden; [Mazumder, Raja] George Washington Univ, McCormick Genom & Prote Ctr, Washington, DC 20037 USA	George Washington University; George Mason University; George Washington University; Uppsala University; Uppsala University Hospital; George Washington University	Mazumder, R (corresponding author), George Washington Univ, Med Ctr, Dept Biochem & Mol Med, Washington, DC 20037 USA.; Mazumder, R (corresponding author), George Washington Univ, McCormick Genom & Prote Ctr, Washington, DC 20037 USA.	mazumder@gwu.edu	Torcivia, John Paul/AAZ-8456-2020; Hu, Yu/AAI-1837-2020	Torcivia, John Paul/0000-0002-9307-5778; Mazumder, Raja/0000-0001-8823-9945; Hu, Yu/0000-0003-3178-0874	McCormick Genomic and Proteomic Center at George Washington University	McCormick Genomic and Proteomic Center at George Washington University	This work was supported by McCormick Genomic and Proteomic Center at George Washington University. There was no additional external funding received for this study.	Alioto TS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10001; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Andersson ML, 1999, J GEN VIROL, V80, P255, DOI 10.1099/0022-1317-80-1-255; Armbruester V, 2004, J VIROL, V78, P10310, DOI 10.1128/JVI.78.19.10310-10319.2004; Balestrieri E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048831; Bannert N, 2006, ANNU REV GENOM HUM G, V7, P149, DOI 10.1146/annurev.genom.7.080505.115700; Benachenhou F, 2009, GENE, V448, P134, DOI 10.1016/j.gene.2009.07.002; Blomberg J, 2009, GENE, V448, P115, DOI 10.1016/j.gene.2009.06.007; Boutet E, 2016, METHODS MOL BIOL, V1374, P23, DOI 10.1007/978-1-4939-3167-5_2; Calin GA, 2007, CANCER CELL, V12, P215, DOI 10.1016/j.ccr.2007.07.027; Chan PP, 2009, NUCLEIC ACIDS RES, V37, pD93, DOI 10.1093/nar/gkn787; Chiovaro F, 2015, INT J CANCER, V137, P1842, DOI 10.1002/ijc.29565; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Contreras-Galindo R, 2008, J VIROL, V82, P9329, DOI 10.1128/JVI.00646-08; de Parseval N, 2003, J VIROL, V77, P10414, DOI 10.1128/JVI.77.19.10414-10422.2003; Denne M, 2007, J VIROL, V81, P5607, DOI 10.1128/JVI.02771-06; Diederichs S, 2016, EMBO MOL MED, V8, P442, DOI 10.15252/emmm.201506055; Dingerdissen HM, 2018, NUCLEIC ACIDS RES, V46, pD1128, DOI 10.1093/nar/gkx907; Dutta A, 2014, IMMUNOGENETICS, V66, P439, DOI 10.1007/s00251-014-0778-1; EDDY SR, 1994, NUCLEIC ACIDS RES, V22, P2079, DOI 10.1093/nar/22.11.2079; Elfaitouri A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024602; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Galli UM, 2005, ONCOGENE, V24, P3223, DOI 10.1038/sj.onc.1208543; George B, 2014, J NUCL CARDIOL, V21, P686, DOI 10.1007/s12350-014-9908-2; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Gibb EA, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0142-6; Gifford RJ, 2018, RETROVIROLOGY, V15, DOI 10.1186/s12977-018-0442-1; Gilroy KL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154070; Glinsky GV, 2016, CANCER LETT, V381, P176, DOI 10.1016/j.canlet.2016.08.001; Goff SP, 2007, NAT REV MICROBIOL, V5, P253, DOI 10.1038/nrmicro1541; Gonzalez-Perez A, 2013, NAT METHODS, V10, P1081, DOI [10.1038/NMETH.2642, 10.1038/nmeth.2642]; Griffith OL, 2008, NUCLEIC ACIDS RES, V36, pD107, DOI 10.1093/nar/gkm967; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Grow EJ, 2015, NATURE, V522, P221, DOI 10.1038/nature14308; Gustedt J., 2008, J DISCRETE ALGORITHM, V6; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Jern P, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-50; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Jurka J, 2000, TRENDS GENET, V16, P418, DOI 10.1016/S0168-9525(00)02093-X; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Karagiannis Konstantinos, 2013, Genomics Proteomics & Bioinformatics, V11, P122, DOI 10.1016/j.gpb.2012.10.003; Katzourakis A, 2005, TRENDS MICROBIOL, V13, P463, DOI 10.1016/j.tim.2005.08.004; Kuntzer J, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq015; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113; Latos PA, 2012, SCIENCE, V338, P1469, DOI 10.1126/science.1228110; Lehrach Hans, 2013, F1000Prime Rep, V5, P34, DOI 10.12703/P5-34; Lestrade L, 2006, NUCLEIC ACIDS RES, V34, pD158, DOI 10.1093/nar/gkj002; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liang QY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029950; Ling H, 2013, GENOME RES, V23, P1446, DOI 10.1101/gr.152942.112; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; McElroy K, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-501; Mi HY, 2009, METHODS MOL BIOL, V563, P123, DOI 10.1007/978-1-60761-175-2_7; Miller ML, 2015, CELL SYST, V1, P197, DOI 10.1016/j.cels.2015.08.014; Montgomery SB, 2006, BIOINFORMATICS, V22, P637, DOI 10.1093/bioinformatics/btk027; Onishi A, 2013, ARTHRITIS RHEUM-US, V65, P1913, DOI 10.1002/art.37969; Pan Y, 2014, NUCLEIC ACIDS RES, V42, P11570, DOI 10.1093/nar/gku772; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Perron H, 2005, J NEUROVIROL, V11, P23, DOI 10.1080/13550280590901741; Piriyapongsa J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-291; Reimand J, 2013, SCI REP-UK, V3, DOI 10.1038/srep02651; Romanish MT, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030010; Sasani F, 2013, VET PATHOL, V50, P543, DOI 10.1177/0300985812469632; Saunders CT, 2012, BIOINFORMATICS, V28, P1811, DOI 10.1093/bioinformatics/bts271; Schmitt AM, 2016, CANCER CELL, V29, P452, DOI 10.1016/j.ccell.2016.03.010; Schmitt K, 2013, J VIROL, V87, P13837, DOI 10.1128/JVI.02388-13; Sin HS, 2006, ARCH VIROL, V151, P1985, DOI 10.1007/s00705-006-0764-5; Sperber GO, 2007, NUCLEIC ACIDS RES, V35, P4964, DOI 10.1093/nar/gkm515; Stauffer Yves, 2004, Cancer Immun, V4, P2; Stoye JP, 2012, NAT REV MICROBIOL, V10, P395, DOI 10.1038/nrmicro2783; Strick R, 2007, J MOL MED, V85, P23, DOI 10.1007/s00109-006-0104-y; Treangen TJ, 2012, NAT REV GENET, V13, P36, DOI 10.1038/nrg3117; Tristem M, 2000, J VIROL, V74, P3715, DOI 10.1128/JVI.74.8.3715-3730.2000; Vargiu L, 2016, RETROVIROLOGY, V13, DOI 10.1186/s12977-015-0232-y; Volders PJ, 2015, NUCLEIC ACIDS RES, V43, pD174, DOI 10.1093/nar/gku1060; Wan Q, 2015, DATABASE-OXFORD, DOI 10.1093/database/bav019; Wang J, 2013, NUCLEIC ACIDS RES, V41, pD171, DOI 10.1093/nar/gks1221; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Wilkinson DA MD, 1994, ENDOGENOUS HUMAN RET; Wu TJ, 2015, DATABASE-OXFORD, DOI 10.1093/database/bav032; Wu TJ, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau022; Xiang JF, 2014, CELL RES, V24, P513, DOI 10.1038/cr.2014.35; Yu H, 2014, ONCOGENE, V33, P3947, DOI 10.1038/onc.2013.366; Zhang ZL, 2003, GENOME RES, V13, P2541, DOI 10.1101/gr.1429003; Zheng DY, 2005, J MOL BIOL, V349, P27, DOI 10.1016/j.jmb.2005.02.072	88	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2019	14	4							e0213770	10.1371/journal.pone.0213770	http://dx.doi.org/10.1371/journal.pone.0213770			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR1CY	30934003	gold, Green Published, Green Submitted			2022-12-26	WOS:000462867000006
J	Silva, FBD; Miguel, DC; Machado, VE; Oliveira, WHC; Goulart, TM; Tosta, CD; Pinheiro, HP; Pinto, MC				da Rocha Silva, Flavia Benini; Miguel, Danilo Ciccone; Machado, Vicente Estevam; Cruz Oliveira, Wanderson Henrique; Goulart, Thais Marchi; Tosta, Christiann Davis; Pinheiro, Hildete Prisco; Pinto, Mara Cristina			Influence of Leishmania (Viannia) braziliensis infection on the attractiveness of BALB/c mice to Nyssomyia neivai (Diptera: Psychodidae)	PLOS ONE			English	Article							PHLEBOTOMINE SAND FLIES; TRIATOMA-INFESTANS; CARBON-DIOXIDE; HUMAN ODOR; IDENTIFICATION; ATTRACTANT; VECTORS; TRANSMISSION; MANIPULATION; BIOMARKERS	Background Phlebotomine sand flies are vectors for several pathogens, with Leishmania being the most important. In Brazil, the main aetiological agent of American cutaneous leishmaniasis (ACL) is Leishmania (Viannia) braziliensis, and Nyssomyia neivai is one of its main vectors in Sao Paulo state and other areas of South America. Similar to other haematophagous insects, sand flies use volatile compounds called kairomones to locate their hosts for blood meals. A possible increase in the attractiveness of hosts infected with Leishmania infantum to their vectors has been demonstrated. In the present study, we aimed to investigate whether L. braziliensis-infected hosts present higher attractiveness to Ny. neivai and to identify differences in the volatile compounds released by infected and uninfected mice. Results Behavioural experiments in which sand fly females directly fed on infected or uninfected mice showed no significant differences in the attractiveness of the mice or the blood volume ingested. Y-tube olfactometer bioassays also revealed no significant differences in the attractiveness of these hosts to Ny. neivai. No differences were observed in the profiles of the volatile compounds released by the two groups of mice. However, PCA and cluster analysis were able to classify the 31 identified compounds into three clusters according to their abundances. This classification showed a possible role for individual variation in the absence of differences in volatile profiles and attractiveness between infected and uninfected mice. Conclusion In this first cross-sectional study with an aetiological agent of ACL, there were no statistically significant differences in the attractiveness of infected hosts to their vector.	[da Rocha Silva, Flavia Benini; Machado, Vicente Estevam; Cruz Oliveira, Wanderson Henrique; Pinto, Mara Cristina] Univ Estadual Paulista UNESP, Fac Ciencias Farmaceut, Dept Ciencias Biol, Campus Araraquara, Araraquara, SP, Brazil; [Miguel, Danilo Ciccone; Goulart, Thais Marchi] Univ Estadual Campinas UNICAMP, Dept Biol Anim, Campinas, SP, Brazil; [Tosta, Christiann Davis] Inst Fed Educ Ciencia & Tecnol Sao Paulo IFSP, Campus Matao, Matao, SP, Brazil; [Pinheiro, Hildete Prisco] Univ Estadual Campinas UNICAMP, Dept Estat, Campinas, SP, Brazil	Universidade Estadual Paulista; Universidade Estadual de Campinas; Instituto Federal de Sao Paulo (IFSP); Universidade Estadual de Campinas	Pinto, MC (corresponding author), Univ Estadual Paulista UNESP, Fac Ciencias Farmaceut, Dept Ciencias Biol, Campus Araraquara, Araraquara, SP, Brazil.	marap@fcfar.unesp.br	Pinto, Mara C/H-9111-2012; da Rocha Silva, Flávia Benini/AGU-8137-2022; Miguel, Danilo Ciccone/C-1484-2012	Pinto, Mara C/0000-0003-3941-9792; da Rocha Silva, Flávia Benini/0000-0002-3361-0687; Miguel, Danilo Ciccone/0000-0003-0522-6562	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2012/23832-9, 2015/21100-9]; FAPESP Young Investigator Grant from (FAPESP) [2014/21129-4]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP Young Investigator Grant from (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP - TMG Grant: 2012/23832-9 and FBRS Grant: 2015/21100-9). DCM is supported by a FAPESP Young Investigator Grant from (FAPESP Grant number 2014/21129-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdeladhim M, 2014, INFECT GENET EVOL, V28, P691, DOI 10.1016/j.meegid.2014.07.028; Agresti A, 2002, CATEGORICAL DATA ANA, P710, DOI [10.1002/0471249688, DOI 10.1002/0471249688]; Andrade AJ, 2008, MEM I OSWALDO CRUZ, V103, P337, DOI 10.1590/S0074-02762008000400004; Andrade MS, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004137; [Anonymous], 2017, LEISHMANIASIS; [Anonymous], [No title captured]; ARTHUR CL, 1990, ANAL CHEM, V62, P2145, DOI 10.1021/ac00218a019; Batista EPA, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-251; Beavers GM, 2004, J AM MOSQUITO CONTR, V20, P130; Bernier UR, 2000, ANAL CHEM, V72, P747, DOI 10.1021/ac990963k; Brazil R.P., 2015, ENTOMOLOGY ORNITHOLO, V04, P4, DOI [10.4172/2161, DOI 10.1089/VBZ.2007.0180.V, DOI 10.4172/2161-0983.1000144]; BRIEGEL H, 1979, J MED ENTOMOL, V15, P235, DOI 10.1093/jmedent/15.3.235; Busula AO, 2017, TRENDS PARASITOL, V33, P961, DOI 10.1016/j.pt.2017.08.010; Carregaro V, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-102; Cornet S, 2013, ECOL LETT, V16, P323, DOI 10.1111/ele.12041; de Boer JG, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08978-9; De Moraes CM, 2018, P NATL ACAD SCI USA, V115, P5780, DOI 10.1073/pnas.1801512115; De Moraes CM, 2014, P NATL ACAD SCI USA, V111, P11079, DOI 10.1073/pnas.1405617111; de Oliveira CI, 2004, MICROBES INFECT, V6, P977, DOI 10.1016/j.micinf.2004.05.009; Diniz MMCDL, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-139; Dormont L, 2013, J EXP BIOL, V216, P2783, DOI 10.1242/jeb.085936; Dormont L, 2013, J CHEM ECOL, V39, P569, DOI 10.1007/s10886-013-0286-z; Emami SN, 2017, SCIENCE, V355, P1076, DOI 10.1126/science.aah4563; ERHARDT W, 1984, RES EXP MED, V184, P159, DOI 10.1007/BF01852390; Fleiss JL, 2004, STAT METHODS RATES P, P598, DOI DOI 10.1002/0471445428.CH18; Fontan A, 2002, J MED ENTOMOL, V39, P191, DOI 10.1603/0022-2585-39.1.191; Goulart TM, 2017, ACTA TROP, V174, P102, DOI 10.1016/j.actatropica.2017.07.010; Goulart TM, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1035-7; Guerenstein PG, 2001, J EXP BIOL, V204, P585; Hurd H, 2003, ANNU REV ENTOMOL, V48, P141, DOI 10.1146/annurev.ento.48.091801.112722; Innocent E, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.5701; Kelly M, 2015, MBIO, V6, DOI 10.1128/mBio.00235-15; Lacroix R, 2005, PLOS BIOL, V3, P1590, DOI 10.1371/journal.pbio.0030298; Leal WS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003045; Logan JG, 2008, J CHEM ECOL, V34, P308, DOI 10.1007/s10886-008-9436-0; Logan JG, 2007, PEST MANAG SCI, V63, P647, DOI 10.1002/ps.1408; Logan JG, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-239; Machado VE, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0748-y; Maciel C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110551; Magalhaes JT, 2014, ANAL BIOANAL CHEM, V406, P6691, DOI 10.1007/s00216-014-8103-2; Magalhaes JT, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-60; Mweresa CK, 2016, J CHEM ECOL, V42, P508, DOI 10.1007/s10886-016-0711-1; Nevatte TM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06313-w; O'Shea B, 2002, T ROY SOC TROP MED H, V96, P117, DOI 10.1016/S0035-9203(02)90273-7; Omolo MO, 2004, PHYTOCHEMISTRY, V65, P2797, DOI 10.1016/j.phytochem.2004.08.035; Osada K, 2003, P ROY SOC B-BIOL SCI, V270, P929, DOI 10.1098/rspb.2002.2308; Perez-Gonzalez A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187919; Pinto MC, 2011, J MED ENTOMOL, V48, P39, DOI 10.1603/ME10081; Pinto MC, 2001, MED VET ENTOMOL, V15, P132, DOI 10.1046/j.1365-2915.2001.00294.x; Quinnell RJ, 2009, PARASITOLOGY, V136, P1915, DOI 10.1017/S0031182009991156; Ready PD, 2013, ANNU REV ENTOMOL, V58, P227, DOI 10.1146/annurev-ento-120811-153557; Robinson A, 2018, P NATL ACAD SCI USA, V115, pE4209, DOI 10.1073/pnas.1721610115; Rock F, 2006, J CHEM ECOL, V32, P1333, DOI 10.1007/s10886-006-9091-2; Rogers ME, 2007, PLOS PATHOG, V3, P818, DOI 10.1371/journal.ppat.0030091; Rogers ME, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00223; Roque Andre Luiz R., 2014, International Journal for Parasitology Parasites and Wildlife, V3, P251, DOI 10.1016/j.ijppaw.2014.08.004; Sacks D, 2001, ANNU REV MICROBIOL, V55, P453, DOI 10.1146/annurev.micro.55.1.453; Schaber CL, 2018, J INFECT DIS, V217, P1553, DOI 10.1093/infdis/jiy072; de Freitas TPT, 2012, VECTOR-BORNE ZOONOT, V12, P81, DOI 10.1089/vbz.2010.0268; Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338; Zauli RC, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-11; Zhang ZM, 2010, MICROCHEM J, V95, P127, DOI 10.1016/j.microc.2009.12.017	62	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2019	14	4							e0214574	10.1371/journal.pone.0214574	http://dx.doi.org/10.1371/journal.pone.0214574			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR1CY	30934013	gold, Green Submitted, Green Published			2022-12-26	WOS:000462867000022
J	Franck, JA; Smeets, RJEM; Seelen, HAM				Franck, Johan Anton; Smeets, Rob Johannes Elise Marie; Seelen, Henk Alexander Maria			Changes in actual arm-hand use in stroke patients during and after clinical rehabilitation involving a well-defined arm-hand rehabilitation program: A prospective cohort study	PLOS ONE			English	Article							UPPER-LIMB ACTIVITY; UPPER EXTREMITY IMPAIRMENT; QUALITY-OF-LIFE; SUBACUTE STROKE; PHYSICAL-ACTIVITY; MOTOR RECOVERY; ACCELEROMETRY; MOVEMENT; PARTICIPATION; ASSOCIATION	Introduction Improvement of arm-hand function and arm-hand skill performance in stroke patients is reported by many authors. However, therapy content often is poorly described, data on actual arm-hand use are scarce, and, as follow-up time often is very short, little information on patients' mid-and long-term progression is available. Also, outcome data mainly stem from either a general patient group, unstratified for the severity of arm-hand impairment, or a very specific patient group. Objectives To investigate to what extent the rate of improvement or deterioration of actual arm-hand use differs between stroke patients with either a severely, moderately or mildly affected arm-hand, during and after rehabilitation involving a well-defined rehabilitation program. Methods Design: single-armed prospective cohort study. Outcome measure: affected arm-hand use during daily tasks (accelerometry), expressed as 'Intensity-of arm-hand-use' and 'Duration-of-arm-hand-use' during waking hours. Measurement dates: at admission, clinical discharge and 3, 6, 9, and 12 months post-discharge. Statistics: Two-way repeated measures ANOVAs. Results Seventy-six patients (63 males); mean age: 57.6 years (sd: 10.6); post-stroke time: 29.8 days (sd: 20.1) participated. Between baseline and 1-year follow-up, Intensity-of-arm-hand-use on the affected side increased by 51%, 114% and 14% (p < .000) in the mildly, moderately and severely affected patients, respectively. Similarly, Duration-of-arm-hand-use increased by 26%, 220% and 161% (p < .000). Regarding bimanual arm-hand use: Intensity-of-arm-hand-use increased by 44%, 74% and 30% (p <.000), whereas Duration-of-arm-hand-use increased by 10%, 22% and 16% (p < .000). Conclusion Stroke survivors with a severely, moderately or mildly affected arm-hand showed different, though (clinically) important, improvements in actual arm-hand use during the rehabilitation phase. Intensity-of-arm-hand-use and Duration-of-arm-hand-use significantly improved in both unimanual and bimanual tasks/skills. These improvements were maintained until at least 1 year post-discharge.	[Franck, Johan Anton] Adelante Rehabil Ctr, Dept Brain Injury Rehabil, Hoensbroek, Netherlands; [Franck, Johan Anton; Seelen, Henk Alexander Maria] Adelante Ctr Expertise Rehabil & Audiol, Hoensbroek, Netherlands; [Smeets, Rob Johannes Elise Marie; Seelen, Henk Alexander Maria] Maastricht Univ, Res Sch CAPHRI, Dept Rehabil Med, Maastricht, Netherlands	Maastricht University	Franck, JA (corresponding author), Adelante Rehabil Ctr, Dept Brain Injury Rehabil, Hoensbroek, Netherlands.; Franck, JA (corresponding author), Adelante Ctr Expertise Rehabil & Audiol, Hoensbroek, Netherlands.	h.franck@adelante-zorggroep.nl	Smeets, Rob JEM/D-1522-2011	Smeets, Rob JEM/0000-0002-9503-366X				[Anonymous], 2003, APPL LONGITUDINAL AN; Bailey RR, 2015, NEUROREHAB NEURAL RE, V29, P969, DOI 10.1177/1545968315583720; Barker RN, 2005, DISABIL REHABIL, V27, P1213, DOI 10.1080/09638280500075717; Block VAJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154335; Boomkamp-Koppen HGM, 2005, CLIN REHABIL, V19, P552, DOI 10.1191/0269215505cr846oa; Buma F, 2013, RESTOR NEUROL NEUROS, V31, P707, DOI 10.3233/RNN-130332; Cambridge_ Neurology_ ltd, 2008, ACT GUID GETT START; Canning CG, 2004, CLIN REHABIL, V18, P300, DOI 10.1191/0269215504cr715oa; Chen KY, 2005, MED SCI SPORT EXER, V37, pS490, DOI 10.1249/01.mss.0000185571.49104.82; Connell L, 2014, ARCH PHYS MED REHABI, V95; de Niet M, 2007, ARCH PHYS MED REHAB, V88, P1121, DOI 10.1016/j.apmr.2007.06.005; Doman CA, 2016, AM J OCCUP THER, V70, DOI 10.5014/ajot.2016.020891; Franceschini M, 2010, EUR J PHYS REHAB MED, V46, P389; Franck J.A., 2015, OPEN J OCCUP THER, V3, P10, DOI [10.15453/2168-6408.1164, DOI 10.15453/2168-6408.1164]; Frank J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175211; Gebruers N, 2008, CEREBROVASC DIS, V26, P533, DOI 10.1159/000160210; Gebruers N, 2010, ARCH PHYS MED REHAB, V91, P288, DOI 10.1016/j.apmr.2009.10.025; Guidetti S, 2014, J REHABIL MED, V46, P963, DOI 10.2340/16501977-1865; Hardwick DD, 2011, J NEUROL PHYS THER, V35, P18, DOI 10.1097/NPT.0b013e318208efa1; Hayward KS, 2016, BRAIN IMPAIR, P1; Jung SH, 2005, ARCH PHYS MED REHAB, V86, P1706, DOI 10.1016/j.apmr.2004.11.043; Kilbreath SL, 2005, AUSTR J PHYSIOTHERAP, V51; Kwakkel G, 2006, STROKE, V37, P2348, DOI 10.1161/01.STR.0000238594.91938.1e; Lang Catherine E, 2007, J Neurol Phys Ther, V31, P56; Lang Catherine E, 2007, J Neurol Phys Ther, V31, P3; Lang CE, 2013, J HAND THER, V26, P104, DOI 10.1016/j.jht.2012.06.005; Lee JY, 2018, PLOS ONE, V13; Lemmens RJM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118642; Lemmens RJM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096414; Lemmens RJM, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-21; Liao WW, 2012, CLIN REHABIL, V26, P111, DOI 10.1177/0269215511416383; Mallinson T, 2010, ARCH PHYS MED REHAB, V91, pS29, DOI 10.1016/j.apmr.2010.04.027; Mayo NE, 2002, ARCH PHYS MED REHAB, V83, P1035, DOI 10.1053/apmr.2002.33984; Michielsen ME, 2012, ARCH PHYS MED REHAB, V93, P1975, DOI 10.1016/j.apmr.2012.03.016; Mullick AA, 2015, RESTOR NEUROL NEUROS, V33, P389, DOI 10.3233/RNN-150510; Narai E, 2016, J GERIATR PHYS THER, V39, P171, DOI 10.1519/JPT.0000000000000067; Nichols-Larsen DS, 2005, STROKE, V36, P1480, DOI 10.1161/01.STR.0000170706.13595.4f; Noorkoiv M, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-144; Pollock A, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010820.pub2; Prabhakaran S, 2008, NEUROREHAB NEURAL RE, V22, P64, DOI 10.1177/1545968307305302; Rand D, 2015, J STROKE CEREBROVASC, V24, P274, DOI 10.1016/j.jstrokecerebrovasdis.2014.07.039; Rand D, 2012, NEUROREHAB NEURAL RE, V26, P76, DOI 10.1177/1545968311408918; Rand D, 2010, AM J OCCUP THER, V64, P877, DOI 10.5014/ajot.2010.09043; Rauch A, 2008, EUR J PHYS REHAB MED, V44, P329; Reenen ETKV, 2009, DISABIL REHABIL, V31, P1338, DOI 10.1080/09638280902846855; Santello M., 2014, HUMAN HAND INSPIRATI, V1; Schaefer SY, 2013, NEUROREHAB NEURAL RE, V27, P602, DOI 10.1177/1545968313481279; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Sveen U, 1999, DISABIL REHABIL, V21, P372, DOI 10.1080/096382899297477; Taub E, 2006, Eura Medicophys, V42, P241; Taub E., 2013, NEUROL REHABIL, V19, P161; Thrane G, 2011, J REHABIL MED, V43, P299, DOI 10.2340/16501977-0676; Timmermans AA, 2014, J NEUROENG REHABIL, V31, P11; Tornbom K, 2017, J STROKE CEREBROVASC, V26, P57, DOI 10.1016/j.jstrokecerebrovasdis.2016.08.029; Urbin MA, 2015, ARCH PHYS MED REHAB, V96, P854, DOI 10.1016/j.apmr.2014.11.018; Uswatte G, 2005, ARCH PHYS MED REHAB, V86, P1498, DOI 10.1016/j.apmr.2005.01.010; Uswatte G, 2005, STROKE, V36, P2493, DOI 10.1161/01.STR.0000185928.90848.2e; Uswatte G, 2006, ARCH PHYS MED REHAB, V87, P1340, DOI 10.1016/j.apmr.2006.06.006; Uswatte G, 2006, NEUROREHABILITATION, V21, P147; van der Pas SC, 2011, ARCH PHYS MED REHAB, V92, P1437, DOI 10.1016/j.apmr.2011.02.021; Vanroy C, PLOS ONE, V9, P1; Veerbeek JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087987; Vega-Gonzalez A, 2005, ARCH PHYS MED REHAB, V86, P541, DOI 10.1016/j.apmr.2004.04.049; Waddell KJ, 2017, NEUROREHAB NEURAL RE, V31, P290, DOI 10.1177/1545968316680493; White MJ, 2018, PUBLIC HEALTH NUTR, V21, P2866, DOI 10.1017/S1368980018001751; WHO, 2001, WHO INT CLASS FUNCT; Winters C, 2015, NEUROREHAB NEURAL RE, V29, P614, DOI 10.1177/1545968314562115; Wolf T, 2013, DISABIL REHABIL, V35, P1143, DOI 10.3109/09638288.2012.720635; Wolfe CDA, 2000, BRIT MED BULL, V56, P275, DOI 10.1258/0007142001903120; Wyller TB, 1997, CLIN REHABIL, V11, P139, DOI 10.1177/026921559701100207	70	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2019	14	4							e0214651	10.1371/journal.pone.0214651	http://dx.doi.org/10.1371/journal.pone.0214651			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HR1CY	30934015	Green Published, gold, Green Submitted			2022-12-26	WOS:000462867000031
J	Kassem, E; Na'amnih, W; Bdair-Amsha, A; Zahalkah, H; Muhsen, K				Kassem, Eias; Na'amnih, Wasef; Bdair-Amsha, Amna; Zahalkah, Hazar; Muhsen, Khitam			Comparisons between ethnic groups in hospitalizations for respiratory syncytial virus bronchiolitis in Israel	PLOS ONE			English	Article							RISK-FACTORS; PALIVIZUMAB PROPHYLAXIS; YOUNG-CHILDREN; INFANTS; RSV; INFECTION; DISPARITIES; ILLNESS; BURDEN; IMPACT	Background Ethnic disparities have been shown in respiratory syncytial virus (RSV) bronchiolitis. However, it is unclear whether such differences are related to access to care. We compared demographic and clinical characteristics of Arab and Jewish children hospitalized for RSV bronchiolitis in Israel, a country with universal health insurance. Methods We reviewed the medical records of all children (n = 309) aged less than 24 months who were hospitalized with RSV between 2008 and 2011 in one medical center in Israel. Demographic, clinical, laboratory and radiological data were collected. The RSV antigen was identified using immunochromatography. Results The annual incidence of RSV hospitalization was 5.4/1000 and 6.8/1000 among Arab and Jewish children, respectively. Arab patients were significantly younger and had significantly younger parents; most lived in low socioeconomic status towns (93.7% vs. 13.3%; p<0.001) and had more siblings (median 2 vs. 1; p = 0.01) compared to Jewish patients. Disease severity did not differ between the two ethnic groups (p = 0.3). The main predictors of severe illness were having pneumonia (adjusted odds ratio [OR] 3.86; 95% confidence intervals [CI] 1.87-7.97) and history of respiratory diseases (adjusted OR 3.89; 95% CI 1.22-12.38). Conclusions The incidence of hospitalizations for RSV bronchiolitis tended to be higher among Jewish than Arab children, possibly due to differences in health care utilization patterns. Differences between the Jewish and Arab patients in demographic factors likely mirror differences between the groups in the general population. Pneumonia, and not ethnicity, affected the severity of RSV bronchiolitis.	[Kassem, Eias; Zahalkah, Hazar] Hillel Yaffe Med Ctr, Dept Pediat, Hadera, Israel; [Na'amnih, Wasef; Bdair-Amsha, Amna; Muhsen, Khitam] Tel Aviv Univ, Sackler Fac Med, Sch Publ Hlth, Dept Epidemiol & Prevent Med, Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine	Muhsen, K (corresponding author), Tel Aviv Univ, Sackler Fac Med, Sch Publ Hlth, Dept Epidemiol & Prevent Med, Tel Aviv, Israel.	kmuhsen@post.tau.ac.il		Na'amnih, Wasef/0000-0003-4457-5669				Aberle JH, 2005, PEDIATR INFECT DIS J, V24, P605, DOI 10.1097/01.inf.0000168741.59747.2d; [Anonymous], 2014, HLTH STAT NUTR INF B; [Anonymous], 2013, CHARACTERIZATION CLA, V1530; Ben Natan M, 2016, MIDWIFERY, V34, P173, DOI 10.1016/j.midw.2015.11.013; Brady MT, 2014, PEDIATRICS, V134, pE620, DOI [10.1542/peds.2014-1665, 10.1542/peds.2014-1666]; Bulkow LR, 2002, PEDIATRICS, V109, P210, DOI 10.1542/peds.109.2.210; DAGAN R, 1993, PEDIATR INFECT DIS J, V12, P381, DOI 10.1097/00006454-199305000-00006; Eidelman AI, 2009, ISR MED ASSOC J, V11, P533; Englund J A, 1999, J Pediatr, V135, P38; Feltes TF, 2003, J PEDIATR-US, V143, P532, DOI 10.1067/S0022-3476(03)00454-2; Fitzgerald DA, 2009, PAEDIATR RESPIR REV, V10, P143, DOI 10.1016/j.prrv.2009.06.002; Geskey JM, 2007, BIOL-TARGETS THER, V1, P33; Gilca R, 2006, J INFECT DIS, V193, P54, DOI 10.1086/498526; Goddard NL, 2007, EPIDEMIOL INFECT, V135, P159, DOI 10.1017/S0950268806006601; Grimwood K, 2008, EPIDEMIOL INFECT, V136, P1333, DOI 10.1017/S0950268807000180; Gross I, 2017, NEONATOLOGY, V111, P240, DOI 10.1159/000452196; Halasa N, 2015, VACCINE, V33, P6479, DOI 10.1016/j.vaccine.2015.08.048; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; Higgins D, 2016, VACCINE, V34, P2870, DOI 10.1016/j.vaccine.2016.03.109; Holman RC, 2004, PEDIATRICS, V114, pE437, DOI 10.1542/peds.2004-0049; Homaira N, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011398; Israel Central Bureau of Statistics, 2012, STAT ABSTRACTS ISR; Iwane MK, 2013, AM J EPIDEMIOL, V177, P656, DOI 10.1093/aje/kws299; Jansson L, 2002, ACTA PAEDIATR, V91, P335, DOI 10.1080/08035250252834021; Jennings LC, 2004, PEDIATR INFECT DIS J, V23, P1003, DOI 10.1097/01.inf.0000143648.04673.6c; Kaaijk P, 2013, HUM VACC IMMUNOTHER, V9, P1263, DOI 10.4161/hv.24096; Law B, 1998, Paediatr Child Health, V3, P402; Leader S, 2003, J PEDIATR-US, V143, pS127, DOI 10.1067/S0022-3476(03)00510-9; Levy A, 1998, EUR J EPIDEMIOL, V14, P179, DOI 10.1023/A:1007439908351; Lieberthal AS, 2006, PEDIATRICS, V118, P1774, DOI 10.1542/peds.2006-2223; Modjarrad K, 2016, VACCINE, V34, P190, DOI 10.1016/j.vaccine.2015.05.093; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Ohm-Smith MJ, 2004, J CLIN MICROBIOL, V42, P2996, DOI 10.1128/JCM.42.7.2996-2999.2004; Papadopoulos NG, 2004, RESP MED, V98, P879, DOI 10.1016/j.rmed.2004.01.009; Papoff P, 2011, ACTA PAEDIATR, V100, pe17, DOI 10.1111/j.1651-2227.2011.02181.x; Reeve CA, 2006, J PAEDIATR CHILD H, V42, P248, DOI 10.1111/j.1440-1754.2006.00849.x; Sangare L, 2006, J PEDIATR-US, V149, P373, DOI 10.1016/j.jpeds.2006.04.063; Selvarangan R, 2008, DIAGN MICR INFEC DIS, V62, P157, DOI 10.1016/j.diagmicrobio.2008.05.005; Simoes EAF, 2003, J PEDIATR-US, V143, pS118, DOI 10.1067/S0022-3476(03)00511-0; Valet RS, 2013, J PEDIATR-US, V163, P1186, DOI 10.1016/j.jpeds.2013.04.029	40	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2019	14	4							e0214197	10.1371/journal.pone.0214197	http://dx.doi.org/10.1371/journal.pone.0214197			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR1CY	30933992	Green Submitted, Green Published, gold			2022-12-26	WOS:000462867000011
J	Ding, SB; Yuan, CY; Si, BJ; Wang, MR; Da, SY; Bai, LX; Wu, WD				Ding, Shibin; Yuan, Chunyan; Si, Bingjie; Wang, Mengruo; Da, Shuyan; Bai, Lanxin; Wu, Weidong			Combined effects of ambient particulate matter exposure and a high-fat diet on oxidative stress and steatohepatitis in mice	PLOS ONE			English	Article							LIVER-DISEASE; NONALCOHOLIC STEATOHEPATITIS; METABOLIC SYNDROME; HEPATIC STEATOSIS; INFLAMMATION; RESPONSES; NAFLD; ATHEROSCLEROSIS; CHOLESTEROL; PROGRESSION	Background Chronic exposure to ambient particulate matter with aerodynamic diameters < 2.5 (PM2.5) induces oxidative injury and liver pathogenesis. The present study assessed the effect and mechanism of long-term, real-world airborne particulate matter (PM) exposure on oxidative stress and hepatic steatosis in the context of a standard chow diet (STD) and a high-fat diet (HFD); the study further explored whether a combination of PM exposure and HFD treatment exacerbates the adverse effects in mice. Methods C57BL/6J mice fed with STD or HFD (41.26% kcal fat) were exposed to PM or filtered air (FA) for 5 months. Lipid metabolism, oxidative stress and liver pathogenesis were evaluated. Real-time PCR and western blotting were performed to determine gene expression and molecular signal transduction in liver. Results Chronic airborne PM exposure impaired oxidative homeostasis, caused inflammation and induced hepatic steatosis in mice. Further investigation found that exposure to real-world PM increased the expression of hepatic Nrf2 and Nrf2-regulated antioxidant enzyme gene. The increased protein expression of the sterol regulatory element binding protein-1c (SREBP-1c) and fatty acid synthase (FAS) in the liver were also observed in PM-exposed groups. Furthermore, the combination of PM exposure and HFD treatment caused a synergistic effect on the changes of lipid accumulation oxidative stress, inflammation in the mouse liver. Conclusions Through in vivo study, we reveal that the combination of real-world ambient PM exposure and HFD treatment aggravates hepatic lipid metabolism disorders, inflammation and oxidative stress. PM exposure may accelerate the progression to non-alcoholic steatohepatitis by regulating SREBP-1c/FAS regulatory axis.	[Ding, Shibin; Yuan, Chunyan; Si, Bingjie; Wang, Mengruo; Da, Shuyan; Bai, Lanxin; Wu, Weidong] Xinxiang Med Univ, Sch Publ Hlth, Dept Nutr & Food Hyg, Xinxiang, Henan, Peoples R China; [Ding, Shibin] Xinxiang Med Univ, Henan Collaborat Innovat Ctr Mol Diag & Lab Med, Xinxiang, Henan, Peoples R China	Xinxiang Medical University; Xinxiang Medical University	Ding, SB (corresponding author), Xinxiang Med Univ, Sch Publ Hlth, Dept Nutr & Food Hyg, Xinxiang, Henan, Peoples R China.; Ding, SB (corresponding author), Xinxiang Med Univ, Henan Collaborat Innovat Ctr Mol Diag & Lab Med, Xinxiang, Henan, Peoples R China.	dingshibin@163.com			Peak Subject Project of Public Health in Xinxiang Medical University	Peak Subject Project of Public Health in Xinxiang Medical University	This work was supported by Peak Subject Project of Public Health in Xinxiang Medical University.	Araujo JA, 2008, CIRC RES, V102, P589, DOI 10.1161/CIRCRESAHA.107.164970; Bagul PK, 2012, PHARMACOL RES, V66, P260, DOI 10.1016/j.phrs.2012.05.003; Bian ZL, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00248; Catta-Preta M, 2011, VIRCHOWS ARCH, V459, P477, DOI 10.1007/s00428-011-1147-1; Chen T, 2013, TOXICOL LETT, V223, P146, DOI 10.1016/j.toxlet.2013.09.004; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; Ding SB, 2018, CHEMOSPHERE, V199, P538, DOI 10.1016/j.chemosphere.2018.02.082; Ding SB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183541; Du YX, 2016, J THORAC DIS, V8, pE8, DOI 10.3978/j.issn.2072-1439.2015.11.37; Duvnjak M, 2007, WORLD J GASTROENTERO, V13, P4539, DOI 10.3748/wjg.v13.i34.4539; Foulds C, 2017, NAT REV ENDOCRINOL, V13, P445, DOI 10.1038/nrendo.2017.42; Ge CX, 2017, BIOCHEM BIOPH RES CO, V493, P1402, DOI 10.1016/j.bbrc.2017.09.152; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Kawano Y, 2013, J GASTROENTEROL, V48, P434, DOI 10.1007/s00535-013-0758-5; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Laing S, 2010, AM J PHYSIOL-CELL PH, V299, pC736, DOI 10.1152/ajpcell.00529.2009; Lawal AO, 2016, TOXICOL IN VITRO, V32, P92, DOI 10.1016/j.tiv.2015.12.015; Lee MS, 2014, INT J CARDIOL, V176, P166, DOI 10.1016/j.ijcard.2014.07.012; Li JH, 2016, MOL NUTR FOOD RES, V60, P858, DOI 10.1002/mnfr.201500814; Loison C, 2002, BRIT J NUTR, V87, P199, DOI [10.1079/BJNBJN2002521, 10.1079/BJN2002521]; McPherson S, 2015, J HEPATOL, V62, P1148, DOI 10.1016/j.jhep.2014.11.034; Moller P, 2014, MUTAT RES-REV MUTAT, V762, P133, DOI 10.1016/j.mrrev.2014.09.001; Nguyen T, 2003, ANNU REV PHARMACOL, V43, P233, DOI 10.1146/annurev.pharmtox.43.100901.140229; Qiu H, 2018, ENVIRON INT, V113, P350, DOI 10.1016/j.envint.2018.01.008; Qiu YN, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16490-3; Romero-Gomez M, 2017, J HEPATOL, V67, P829, DOI 10.1016/j.jhep.2017.05.016; Sayiner M, 2016, CLIN LIVER DIS, V20, P205, DOI 10.1016/j.cld.2015.10.001; Shimomura I, 1999, J BIOL CHEM, V274, P30028, DOI 10.1074/jbc.274.42.30028; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Sookoian S, 2017, CLIN MOL HEPATOL, V23, P1, DOI 10.3350/cmh.2016.0109; Sun Q, 2018, TOXICOL SCI, V164, P240, DOI 10.1093/toxsci/kfy079; Tan HH, 2009, J IMMUNOTOXICOL, V6, P266, DOI [10.3109/15476910903241704, 10.1080/15476910903241704]; Tarantino G, 2015, FUTURE MICROBIOL, V10, P889, DOI [10.2217/FMB.15.13, 10.2217/fmb.15.13]; Tarantino G, 2013, WORLD J GASTROENTERO, V19, P3951, DOI 10.3748/wjg.v19.i25.3951; Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001; Videla LA, 2009, WORLD J HEPATOL, V1, P72, DOI 10.4254/wjh.v1.i1.72; Wallwork RS, 2017, AM J EPIDEMIOL, V185, P30, DOI 10.1093/aje/kww157; Win S, 2018, HEPATOLOGY, V67, P2013, DOI 10.1002/hep.29689; Xia SF, 2018, FOOD FUNCT, V9, P906, DOI 10.1039/c7fo01051f; Xu JX, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14070787; Xu JQ, 2017, NUTRIENTS, V9, DOI 10.3390/nu9030271; Yang BY, 2018, ENVIRON RES, V164, P204, DOI 10.1016/j.envres.2018.02.029; Yang J, 2008, P NATL ACAD SCI USA, V105, P10750, DOI 10.1073/pnas.0805353105; Zhang HQ, 2012, FREE RADICAL BIO MED, V52, P2038, DOI 10.1016/j.freeradbiomed.2012.02.042; Zheng Z, 2015, J HEPATOL, V63, P1397, DOI 10.1016/j.jhep.2015.07.020; Zheng Z, 2013, J HEPATOL, V58, P148, DOI 10.1016/j.jhep.2012.08.009	48	19	20	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214680	10.1371/journal.pone.0214680	http://dx.doi.org/10.1371/journal.pone.0214680			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921449	Green Published, Green Submitted, gold			2022-12-26	WOS:000462594000108
J	Kruk, J; Dziurka, M; Plytycz, B				Kruk, Jerzy; Dziurka, Michal; Plytycz, Barbara			Identification of new fluorophores in coelomic fluid of Eisenia andrei earthworms	PLOS ONE			English	Article							RIBOFLAVIN STORAGE; FLUORESCENCE; AUTOFLUORESCENCE; CELOMOCYTES; ELEOCYTES; FOETIDA	Coelomic fluid of Eisenia andrei contains a number of UV-fluorescent compounds. In the present study we have found that four of these compounds showed identical fluorescence excitation and emission maxima at 310 nm and 364 nm, respectively, suggesting they share the same chromophore. NMR and HR-MS spectroscopy of the most abundant fluorophore reavealed that its molecule is composed of two quinazoline-2,4-dione rings connected by spermine linker. This compound was earlier indentified in Eisenia andrei as SP-8203. Moreover, we have identified the structure of the two other fluorophores, one differing from SP-8203 by the absence of N-acetyl group, the compound not reported in any other organisms before, and the other already found in E. fetida and regarded as species specific. However, our results indicate that this metabolite is also present in E. andrei in significant amounts. The possible origin and function of these new metabolites is discussed.	[Kruk, Jerzy] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Plant Physiol & Biochem, Krakow, Poland; [Dziurka, Michal] Polish Acad Sci, Inst Plant Physiol, Krakow, Poland; [Plytycz, Barbara] Jagiellonian Univ, Fac Biol, Inst Zool & Biochem Res, Dept Evolutionary Immunol, Krakow, Poland	Jagiellonian University; Polish Academy of Sciences; Franciszek Gorski Institute of Plant Physiology Polish Academy of Sciences; Jagiellonian University	Kruk, J (corresponding author), Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Plant Physiol & Biochem, Krakow, Poland.	jerzy.kruk@uj.edu.pl	Dziurka, Michal/H-1228-2016	Dziurka, Michal/0000-0002-8265-6243	Jagiellonian University [K/ZDS/005405]; National Centre of Science [2016/23/B/NZ8/00748]	Jagiellonian University; National Centre of Science	This research was financially supported by the Jagiellonian University (K/ZDS/005405) and the National Centre of Science (2016/23/B/NZ8/00748). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albani JR, 2003, PHOTOCHEM PHOTOBIOL, V78, P599, DOI 10.1562/0031-8655(2003)078<0599:FFOEFA>2.0.CO;2; Bundy JG, 2002, FEBS LETT, V521, P115, DOI 10.1016/S0014-5793(02)02854-5; Choi YH, 2009, CHROMATOGRAPHIA, V70, P1435, DOI 10.1365/s10337-009-1327-1; Cholewa J, 2006, FOLIA HISTOCHEM CYTO, V44, P65; D'yakonov A. L., 1997, Chemistry of Natural Compounds, V33, P221, DOI 10.1007/BF02234869; Davidson SK, 2013, MOL PHYLOGENET EVOL, V67, P188, DOI 10.1016/j.ympev.2012.12.005; Fior S, 2009, PLANT SCI, V176, P130, DOI 10.1016/j.plantsci.2008.10.001; Griffith CM, 2017, J PROTEOME RES, V16, P3407, DOI 10.1021/acs.jproteome.7b00439; Hadjmohamadi MR, 2008, SPECTROCHIM ACTA A, V70, P358, DOI 10.1016/j.saa.2007.10.029; Kavitha K., 2018, WORLD J PHARM PHARM, V7, P628; Koziol B, 2006, PHOTOCHEM PHOTOBIOL, V82, P570, DOI 10.1562/2005-11-23-RA-738; Lund MB, 2010, ENVIRON MICROBIOL, V12, P2142, DOI 10.1111/j.1462-2920.2009.02084.x; Martinsson S, 2018, EUR J SOIL BIOL, V88, P41, DOI 10.1016/j.ejsobi.2018.06.003; Mazur AI, 2011, PEDOBIOLOGIA, V54, pS37, DOI 10.1016/j.pedobi.2011.09.008; Mazur-Bialy AI, 2015, J PHYSIOL PHARMACOL, V66, P793; Michael JP, 2008, NAT PROD REP, V25, P166, DOI 10.1039/b612168n; MICHMAN M, 1978, ORG PREP PROCED INT, V10, P13, DOI 10.1080/00304947809354998; Noh SJ, 2011, PHARMACOL BIOCHEM BE, V100, P73, DOI 10.1016/j.pbb.2011.07.018; Noh SJ, 2011, PHARMACOL BIOCHEM BE, V98, P150, DOI 10.1016/j.pbb.2010.12.014; Plytycz B, 2016, ISJ-INVERT SURVIV J, V13, P315; Plytycz B, 2011, ISJ-INVERT SURVIV J, V8, P199; Plytycz B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204469; Plytycz B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191711; Plytycz B, 2009, ENVIRON POLLUT, V157, P3042, DOI 10.1016/j.envpol.2009.05.046; Rochfort S, 2017, EUR J SOIL BIOL, V78, P17, DOI 10.1016/j.ejsobi.2016.11.008; Rorat A, 2014, J EXP ZOOL PART A, V321, P28, DOI 10.1002/jez.1834; Santocki M, 2016, FOLIA BIOL-KRAKOW, V64, P121, DOI 10.3409/fb64_2.121; Santocki M, 2016, APPL SOIL ECOL, V104, P163, DOI 10.1016/j.apsoil.2015.08.022	28	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214757	10.1371/journal.pone.0214757	http://dx.doi.org/10.1371/journal.pone.0214757			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921437	Green Published, gold, Green Submitted			2022-12-26	WOS:000462594000110
J	Amulen, DR; D'Haese, M; D'Haene, E; Acai, JO; Agea, JG; Smagghe, G; Cross, P				Amulen, Deborah Ruth; D'Haese, Marijke; D'Haene, Eline; Acai, James Okwee; Agea, Jacob Godfrey; Smagghe, Guy; Cross, Paul			Estimating the potential of beekeeping to alleviate household poverty in rural Uganda	PLOS ONE			English	Article							ADOPTION; TECHNOLOGY; BEHAVIOR	Robust evidence underpinning the role of beekeeping in poverty alleviation is currently lacking. This study estimated the production potential for beekeepers in Northern Uganda by quantifying current production assets (equipment and knowledge) and impact on rural income streams range of proposed interventions. Intervention scenarios evaluated the economic benefits to be derived from different hive types combined with year-round provision of a nectar source (Calliandra calothyrsus) planted at varying density. Findings show that the type and number of beehive combinations used influenced the amount of revenue streams generated by the beekeepers. Addition of 20 log hives increased incomes 10 times, 20 KTBs increased revenues 16 times and Langstroth 18 times. Adding Calliandra trees as a forage source to the baseline scenario yielded revenues up to 17.6 times higher than the baseline. Implying that good management plus the introduction of a reliable nectar source, to off-set dry season challenges (absconding), could improve beekeeping productivity in Northern Uganda. Further research is required to validate in situ the impact of modelled scenarios on both honey yield and other ecosystem service benefits.	[Amulen, Deborah Ruth; Acai, James Okwee] Makerere Univ, Dept Livestock Ind Resources, Kampala, Uganda; [Amulen, Deborah Ruth; Smagghe, Guy] Univ Ghent, Dept Plants & Crops, Ghent, Belgium; [D'Haese, Marijke; D'Haene, Eline] Univ Ghent, Dept Agr Econ, Ghent, Belgium; [Agea, Jacob Godfrey] Makerere Univ, Dept Extens & Innovat Studies, Kampala, Uganda; [Cross, Paul] Bangor Univ, Sch Environm Nat Resources & Geog, Bangor, Gwynedd, Wales	Makerere University; Ghent University; Ghent University; Makerere University; Bangor University	Amulen, DR (corresponding author), Makerere Univ, Dept Livestock Ind Resources, Kampala, Uganda.; Amulen, DR (corresponding author), Univ Ghent, Dept Plants & Crops, Ghent, Belgium.	amulendeborah@gmail.com	Smagghe, Guy/AAE-8914-2019	Smagghe, Guy/0000-0001-8334-3313; D'Haene, Eline/0000-0002-6261-4353; D'Haese, Marijke/0000-0002-0544-3420	Erasmus Mundus Action 2-CARIBU grant	Erasmus Mundus Action 2-CARIBU grant	The study was part of a PhD exchange scholarship to Deborah Ruth Amulen covered under Erasmus Mundus Action 2-CARIBU grant (http://www.caribu.be/). The funders had no role study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adgaba N, 2014, J ANIM PLANT SCI, V24, P1876; Aemera J., 2014, MONEY IS HONEY, V18; Al-Ghamdi A, 2016, SAUDI J BIOL SCI, V23, P92, DOI 10.1016/j.sjbs.2014.09.020; Amulen DR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172820; Arslan A, 2014, AGR ECOSYST ENVIRON, V187, P72, DOI 10.1016/j.agee.2013.08.017; Awotide B. A, 2014, J DEV AGR EC; Bees for Development, 2006, EN SMALL COMM PROD D; Boland DJ, 1996, FOR FARM COMM TREE R, P49; Bradbear N., 2009, NONWOOD FOREST PRODU; Breed MD, 2004, ANNU REV ENTOMOL, V49, P271, DOI 10.1146/annurev.ento.49.061802.123155; Buyinza Mukadazi, 2007, UGANDA J APPL SCI, V2, P1087; Carroll T, 2013, DEV PRACT, V23, P332, DOI 10.1080/09614524.2013.781123; Centenary Bank, 2014, CENT BANK ANN REP, V8; Chamberlain J.R, 2001, CALLIANDRA CALOTHYRS; Chamberlain JR, 1996, FOR FARM COMM TREE R, P34; Chemurot M., 2013, Bee World, V90, P33; Dafni A, 2005, PRACT POLLINAT BIOL, P274; David S, 2003, AGR ECOSYST ENVIRON, V95, P359, DOI 10.1016/S0167-8809(02)00046-4; Diederen P., 2003, Cahiers d'Economie et Sociologie Rurales, P29; Dubale Bekele Tesfaye, 2015, BEEKEEPING PRACTICES; FEDER G, 1993, TECHNOL FORECAST SOC, V43, P215, DOI 10.1016/0040-1625(93)90053-A; Ghadim AKA, 1999, AGR ECON-BLACKWELL, V21, P145, DOI 10.1016/S0169-5150(99)00023-7; Government of Kenya, 2009, NAT BEEK POL; Gupta RC, 2014, BIOMARKERS IN TOXICOLOGY, P3, DOI 10.1016/B978-0-12-404630-6.00001-4; Hacura A, 2001, EUR PHYS J B, V20, P551, DOI 10.1007/s100510170238; Hernandez-Conrique D, 2007, BIOTROPICA, V39, P459, DOI 10.1111/j.1744-7429.2007.00277.x; Hilmi M, 2011, BEEKEEPING SUSTAINAB, P1; Hope Aldo, 2011, USING MULTIPLE PARTN; Kalanzi F, 2015, INT J RES LAND USE S, V2, P81, DOI DOI 10.13140/RG.2.1.2647.4329; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Kumar Mishra P, 2014, INDIA SOURCE MT RES, P27; LAWAL B, 2003, CATEGORICAL DATA ANA; Macqueen D. J., 1992, Commonwealth Forestry Review, V71, P20; Majaliwa JGM, 2010, 2 REFORUM BIENN M 20; Malede Birhan, 2015, ACAD J ENTOMOL, V8, P127; Mwakalalukwa E. E., 2016, APIEXPO AFRICA 2016; Okwee-Acai James, 2010, LIVEST RES RURAL DEV, V22; Platon V, 2014, PROC ECON FINANC, V15, P393, DOI 10.1016/S2212-5671(14)00463-8; Poedianto M., 1980, CALLIANDRA PLANTATIO; Robert Kajobe, 2009, NATL BEEKEEPING CALE; Rodriguez M, 2015, AGR SYST, V135, P122; Saturni FT, 2016, AGR ECOSYST ENVIRON, V235, P1, DOI 10.1016/j.agee.2016.10.008; Simtowe F., 2011, Quarterly Journal of International Agriculture, V50, P325; Simtowe F, 2013, DIFFUSION ADOPTION G, V13, P2; Torne-Noguera A, 2016, BASIC APPL ECOL, V17, P199, DOI 10.1016/j.baae.2015.11.004; TUNADO, 2012, NAT AP MULT PLATF WO; UBOS MAAIF, 2009, NAT LIV CENS REP; Wagner K., 2019, J RURAL STUD; Yildirim I, 2008, ASIAN J ANIM VET ADV, V3, P314, DOI 10.3923/ajava.2008.314.320; Yirga G, 2010, NO ETHIOPIA AGR J, V5, P201; Yirga G, 2010, MOMONA ETHIOP J SCI, V2, P76, DOI 10.4314/mejs.v2i1.49654	51	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2019	14	3							e0214113	10.1371/journal.pone.0214113	http://dx.doi.org/10.1371/journal.pone.0214113			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ5PT	30917187	Green Published, gold			2022-12-26	WOS:000462465800052
J	Cavedon, V; Sandri, M; Pirlo, M; Petrone, N; Zancanaro, C; Milanese, C				Cavedon, Valentina; Sandri, Marco; Pirlo, Mariola; Petrone, Nicola; Zancanaro, Carlo; Milanese, Chiara			Anthropometry-driven block setting improves starting block performance in sprinters	PLOS ONE			English	Article							FORCE APPLICATION; KINEMATICS; VELOCITY; PHASE; ELITE; POWER; MOVEMENT	This study tested the effect of two block setting conditions i.e., the usual block setting [US] and an anthropometry-driven block setting [AS] on the kinematic and kinetic parameters of the sprint start. Furthermore, we verified whether this effect is influenced by the relative lengths of the sprinter's trunk and lower limbs i.e., the Cormic Index by subdividing sprinters into brachycormic, metricormic and macrocormic groups. Forty-two sprinters performed 6 maximal-effort 10 m sprints using the US and AS conditions. Dynamometric starting blocks measured forces generated by the sprinters. The times at 5 m and 10 m in the sprint trials were measured with photocells. Results showed that the anteroposterior block distances were significantly different between the two conditions (P< 0.001). Across the sample, the horizontal block velocity, the rear peak force, the rear force impulse, the total force impulse, the horizontal block power, the ratio of horizontal to resultant impulse in the rear block, the first and second step lengths and the times at 5m and 10 mimproved in AS vs. US (P values from 0.05 to 0.001). Considering the interaction between the block setting condition and the Cormic Index, the rear peak force and the rear force impulse were significantly increased in the metricormic and brachycormic groups (P <= 0.001) and the metricormic group (P< 0.001), respectively. Kinetic variables in the rear block and the difference (Delta) in the front block/starting line distance between US and AS were related with each other (Adjusted R-2 values from 0.07 to 0.36). In conclusion, AS was associated with improvement in the kinematic and kinetic parameters of the sprint start performance vs. US; however, AS is apparently best suited for metricormic sprinters. Further work is needed to verify how the sprint start kinetic and kinematic parameters are related to the front block/starting line distance and whether a block setting driven by the sprinter's Cormic Index is able to improve sprint start performance.	[Cavedon, Valentina; Sandri, Marco; Zancanaro, Carlo; Milanese, Chiara] Univ Verona, Dept Neurosci Biomed & Movement Sci, Verona, Italy; [Pirlo, Mariola] OMR Automot, Brescia, Italy; [Petrone, Nicola] Univ Padua, Dept Ind Engn, Padua, Italy	University of Verona; University of Padua	Milanese, C (corresponding author), Univ Verona, Dept Neurosci Biomed & Movement Sci, Verona, Italy.	chiara.milanese@univr.it	Sandri, Marco/L-2875-2013; Cavedon, Valentina/AAL-3002-2020	Sandri, Marco/0000-0002-1422-5695; Milanese, Chiara/0000-0002-8011-4379; Cavedon, Valentina/0000-0002-2464-1019; PETRONE, NICOLA/0000-0002-6638-484X	University of Verona	University of Verona	This work was supported in part by Departmental intramural funds (Joint Projects 2009) to CM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study. The funding organization (OMR Automotive) did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder provided support in the form of salaries for an author [PM], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.; The authors thank all the participants for kind cooperation. This study was supported by a grant from the University of Verona (Joint Projects 2009) to CM.	Bartlett RM, 2007, INTRO SPORTS BIOMECH, P126; Bezodis NE, 2018, J SPORTS SCI, V11, P1; Bezodis NE, 2010, SPORT BIOMECH, V9, P258, DOI 10.1080/14763141.2010.538713; Bezodis NE, 2015, EUR J SPORT SCI, V15, P118, DOI 10.1080/17461391.2014.928915; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Bradshaw EJ, 2007, SPORT BIOMECH, V6, P246, DOI 10.1080/14763140701489660; Brazil A, 2018, J SPORT SCI, V36, P1656, DOI 10.1080/02640414.2017.1409608; Brazil A, 2017, J SPORT SCI, V35, P1629, DOI 10.1080/02640414.2016.1227465; Cagnazzo F, 2009, VALUTAZIONE ANTROPOM, P65; Chamari K, 2008, J STRENGTH COND RES, V22, P944, DOI 10.1519/JSC.0b013e31816a57c6; Ciacci S, 2017, J SPORT SCI, V35, P1270, DOI 10.1080/02640414.2016.1221519; Coh M, 2017, J HUM KINET, V56, P29, DOI 10.1515/hukin-2017-0020; Cohen J.E., 1988, STAT POWER ANAL BEHA; Debaere S, 2013, J SPORT SCI, V31, P137, DOI 10.1080/02640414.2012.722225; Dickinson AD, 1934, RES QUART, V5, P12; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Fleisig Glenn, 2003, Sports Biomech, V2, P51, DOI 10.1080/14763140308522807; Fortier S, 2005, J SPORT SCI MED, V4, P134; Frossard L, 2005, INT COUNCIL SPORT SC; GUISSARD N, 1992, MED SCI SPORT EXER, V24, P1257; Harland MJ, 1997, SPORTS MED, V23, P11, DOI 10.2165/00007256-199723010-00002; Henry FM, 1952, RES QUART, V23, P301, DOI 10.1080/10671188.1952.10624871; Kraan GA, 2001, J BIOMECH, V34, P211, DOI 10.1016/S0021-9290(00)00178-0; LEMAIRE ED, 1990, CAN J SPORT SCI, V15, P149; Lohman T. G., 1992, MANUALE RIFERIMENTO; Massidda M, 2013, COLL ANTROPOL; Mero A, 2006, J SPORT SCI, V24, P165, DOI 10.1080/02640410500131753; MERO A, 1988, RES Q EXERCISE SPORT, V59, P94, DOI 10.1080/02701367.1988.10605484; Mero A., 1983, SCANDINAVIAN J SPORT, V5, P20; Milanese C, 2014, BIOL SPORT, V31, P209, DOI 10.5604/20831862.1111848; Milanese C, 2014, 19 ANN C EUR COLL SP, P283; Morin JB, 2011, MED SCI SPORT EXER, V43, P1680, DOI 10.1249/MSS.0b013e318216ea37; oh M., 1998, GYMNICA, V28, P33; oh M., 2006, NEW STUDIES ATHLETIC, V21, P23; Otsuka M, 2014, J APPL BIOMECH, V30, P390, DOI 10.1123/jab.2013-0017; Payne AH, 1971, BIOMECHANICS 2, VII, P225; Reinschmidt C, 1997, J BIOMECH, V30, P729, DOI 10.1016/S0021-9290(97)00001-8; SCHOT PK, 1992, RES Q EXERCISE SPORT, V63, P137, DOI 10.1080/02701367.1992.10607573; Schrodter E, 2017, INT J SPORT PHYSIOL, V12, P448, DOI 10.1123/ijspp.2015-0512; SIGERSETH PO, 1962, RES QUART, V33, P599, DOI 10.1080/10671188.1962.10762113; Slawinski J, 2012, INT J SPORTS MED, V33, P555, DOI 10.1055/s-0032-1304587; Slawinski J, 2013, J SPORT SCI, V31, P256, DOI 10.1080/02640414.2012.729076; Slawinski J, 2010, J STRENGTH COND RES, V24, P896, DOI 10.1519/JSC.0b013e3181ad3448; STOCK M, 1962, RES QUART, V33, P607, DOI 10.1080/10671188.1962.10762114; Ukwuma M., 2009, INTERNET J BIOL ANTH, V4, P1, DOI [10.5580/2971, DOI 10.5580/2971]; van Coppenolle H., 1989, ATHL COACH, V23, P82; Vucetic V, 2008, COLLEGIUM ANTROPOL, V32, P863; Willwacher S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166219; Willwacher S, 2013, PROCEDIA ENGINEER, V60, P124, DOI 10.1016/j.proeng.2013.07.073	49	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2019	14	3							e0213979	10.1371/journal.pone.0213979	http://dx.doi.org/10.1371/journal.pone.0213979			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ5PT	30917173	Green Published, Green Submitted, gold			2022-12-26	WOS:000462465800045
J	Mutua, MM; Achia, TNO; Manderson, L; Musenge, E				Mutua, Michael M.; Achia, Thomas N. O.; Manderson, Lenore; Musenge, Eustasius			Spatial and socio-economic correlates of effective contraception among women seeking post-abortion care in healthcare facilities in Kenya	PLOS ONE			English	Article							FAMILY-PLANNING-SERVICES; ABORTION SERVICES; PREGNANCY; ATTITUDES	Introduction Information, counseling, availability of contraceptives, and their adoption by post-abortion care (PAC) patients are central to the quality of PAC in healthcare facilities. Effective contraceptive adoption by these patients reduces the risks of unintended pregnancy and repeat abortion. Methods This study uses data from the Incidence and Magnitude of Unsafe Abortion Study of 2012 to assess the level and determinants of highly effective contraception among patients treated with complications from an unsafe abortion in healthcare facilities in Kenya. Highly effective contraception was defined as any method adopted by a PAC patient that reduces pregnancy rate by over 99%. Results Generally, contraceptive counseling was high among all PAC patients (90%). However, only 54% of them received a modern family planning method-45% a short-acting method and 9% a long-acting and permanent method. Adoption of highly effective contraception was determined by patient's previous exposure to unintended pregnancies, induced abortion and modern family planning (FP). Facility level factors associated with the uptake of highly effective contraceptives included: facility ownership, availability of evacuation procedure room, whether the facility had a specialized obstetric-gynecologist, a facility that also had maternity services and the number of FP methods available for PAC patients. Discussion and conclusion For better adoption of highly effective FP, counseling of PAC patients requires an understanding of the patient's past experience with contraception and their future fertility intentions and desires in order to meet their reproductive needs more specifically. Family planning integration with PAC can increase contraceptive uptake and improve the reproductive health of post-abortion care patients.	[Mutua, Michael M.] APHRC, Nairobi, Kenya; [Mutua, Michael M.; Achia, Thomas N. O.; Manderson, Lenore; Musenge, Eustasius] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa; [Achia, Thomas N. O.] Ctr Dis Control & Prevent, Nairobi, Kenya; [Manderson, Lenore] Brown Univ, IBES, Providence, RI 02912 USA	African Population & Health Research Centre; University of Witwatersrand; Brown University	Mutua, MM (corresponding author), APHRC, Nairobi, Kenya.; Mutua, MM (corresponding author), Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa.	mmutua@aphrc.org	Achia, Thomas N. O./I-3674-2013	Achia, Thomas N. O./0000-0002-0700-9468	Consortium for Advanced Research Training in Africa (CARTA); Consortium for Research on Unsafe Abortion in Africa; Wellcome Trust (UK) [087547/Z/08/Z]; Department for International Development (DfID) under the Development Partnerships in Higher Education (DelPHE); Carnegie Corporation of New York [B 8606]; Ford Foundation [1100-0399]; Google. Org [191994]; Sida [54100029]; John D. and Catherine T. MacArthur Foundation [10-95915-000-INP]	Consortium for Advanced Research Training in Africa (CARTA); Consortium for Research on Unsafe Abortion in Africa; Wellcome Trust (UK)(Wellcome Trust); Department for International Development (DfID) under the Development Partnerships in Higher Education (DelPHE); Carnegie Corporation of New York; Ford Foundation; Google. Org; Sida; John D. and Catherine T. MacArthur Foundation	Consortium for Advanced Research Training in Africa (CARTA) The study on which we draw is based on research funded by the Consortium for Research on Unsafe Abortion in Africa and its principal donors, the UK Department for International Development, and the Government of the Netherlands. MM's analysis and writing time was supported through funding from the Consortium for Advanced Research Training in Africa (CARTA), a jointly led consortium by the African Population and Health Research Center and the University of the Witwatersrand and is funded by the Wellcome Trust (UK) [Grant no. 087547/Z/08/Z], the Department for International Development (DfID) under the Development Partnerships in Higher Education (DelPHE), the Carnegie Corporation of New York [Grant no. B 8606], the Ford Foundation [Grant no. 1100-0399], Google. Org [Grant no. 191994], Sida [grant number 54100029] and John D. and Catherine T. MacArthur Foundation [Grant no. 10-95915-000-INP].	[Anonymous], 2013, BAYESIAN DIS MAPPING; [Anonymous], 2011, FAMILY PLANNING GLOB; Bakibinga P, 2016, J RELIG HEALTH, V55, P192, DOI 10.1007/s10943-015-0030-9; Banerjee S, 2004, BIOMETRICS, V60, P268, DOI 10.1111/j.0006-341X.2004.00032.x; Banerjee S., 2014, HIERARCHICAL MODELIN; Banerjee SK, 2015, STUD FAMILY PLANN, V46, P387, DOI 10.1111/j.1728-4465.2015.00039.x; Basu S., 2016, INT STAT REV, V84, P159; Belitz C., 2015, SOFTWARE BAYESIAN IN; Benson J, 2018, GLOB PUBLIC HEALTH, V13, P35, DOI 10.1080/17441692.2016.1174280; BESAG J, 1991, ANN I STAT MATH, V43, P1, DOI 10.1007/BF00116466; Biney Adriana A E, 2011, Afr J Reprod Health, V15, P37; Boes S, 2006, ALLGEMEINES STAT ARC, P167, DOI [DOI 10.1007/S10182-006-0228-Y, 10.1007/s10182-006-0228-y]; Borges ALV, 2016, POSTABORTION CONTRAC, P32; Bradley EH, 2002, HEALTH SERV RES, V37, P1221, DOI 10.1111/1475-6773.01053; Center for Reproductive Rights, 2010, HARMS WAY IMP KEN RE; Curtis C, 2010, INT PERSPECT SEX R H, V36, P44, DOI 10.1363/ipsrh.36.044.10; Earnest A, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-54; Gemzell-Danielsson K, 2015, WOMENS HEALTH, V11, P779, DOI 10.2217/whe.15.72; HATCHER RA, 2007, CONTRACEPTIVE TECHNO; Juma PA, 2015, AFR HEALTH SCI, V15, P161, DOI 10.4314/ahs.v15i1.22; Keene M, 2015, CONTRACEPTION, V91, P398, DOI 10.1016/j.contraception.2014.10.011; Kenya National Bureau of Statistics (KNBS) and ICF Macro, 2014, KEN DEM HLTH SURV; Langer A, 1997, REPROD HEALTH MATTER, V5, P20; Lawson AB, 1977, STAT METHODS SPAT EP, P363; Madden T, 2013, CONTRACEPTION, V88, P243, DOI 10.1016/j.contraception.2012.07.015; Marston C, 2003, INT FAM PLAN PERSPEC, V29, P6, DOI 10.2307/3180995; Mutombo N, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004643; Mutua MM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204240; Naanyu Violet, 2013, Afr J Reprod Health, V17, P44; National Coordinating Agency for Population and Development (NCAPD) [Kenya] Ministry of Medical Services (MOMS) [Kenya] Ministry of Public Health and Sanitation (MOPHS) [Kenya] Kenya National Bureau of Statistics (KNBS) [Kenya] ICF Macro, 2011, KEN SERV PROV ASS SU; Nguyen MH, 2007, REPROD HEALTH MATTER, V15, P172, DOI 10.1016/S0968-8080(07)29283-3; Nobili MP, 2007, PATIENT ED COUNS; Ohannessian A, 2016, J GYNECOL OBST BIO R, V45, P1568, DOI 10.1016/j.jgyn.2016.09.017; Olenick I, 2000, INT FAM PLAN PERSPEC, V26, P48, DOI 10.2307/2648294; Opollo VSA, 2017, IMP HIV AIDS SCAL UP; Osur J, 2013, GLOBAL HEALTH ACTION, V6, P1, DOI 10.3402/gha.v6i0.19649; Patel R, 2014, AIDS PATIENT CARE ST, V28, P418, DOI 10.1089/apc.2014.0046; Prata N, 2013, AFR J REPROD HLTH, V17; Roberts H, 2010, CONTRACEPTION, V82, P260, DOI 10.1016/j.contraception.2010.03.003; Schreiber CA, 2011, CONTRACEPTION, V84, P230, DOI 10.1016/j.contraception.2011.01.013; Schunmann C, 2006, HUM REPROD, V21, P2296, DOI 10.1093/humrep/del168; Secura GM, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.04.017; Sedgh G, 2016, LANCET, V388, P258, DOI 10.1016/S0140-6736(16)30380-4; Senlet P, 2001, INT FAM PLAN PERSPEC, V27, P90, DOI 10.2307/2673821; Solo J, 1999, STUD FAMILY PLANN, V30, P17, DOI 10.1111/j.1728-4465.1999.00017.x; Thompson KMJ, 2011, CONTRACEPTION, V83, P41, DOI 10.1016/j.contraception.2010.06.008; World Health Organization, 2013, UNS AB GLOB REG EST; World Health Organization, 2005, REP WHO TECHN CONS B; Zhu JL, 2009, EUR J CONTRACEP REPR, V14, P46, DOI 10.1080/13625180802512994	49	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2019	14	3							e0214049	10.1371/journal.pone.0214049	http://dx.doi.org/10.1371/journal.pone.0214049			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HQ5PT	30917161	Green Submitted, Green Published, gold			2022-12-26	WOS:000462465800048
J	Serrano, N; Colenso-Semple, LM; Lazauskus, KK; Siu, JW; Bagley, JR; Lockie, RG; Costal, PB; Galpin, AJ				Serrano, Nathan; Colenso-Semple, Lauren M.; Lazauskus, Kara K.; Siu, Jeremy W.; Bagley, James R.; Lockie, Robert G.; Costal, Pablo B.; Galpin, Andrew J.			Extraordinary fast-twitch fiber abundance in elite weightlifters	PLOS ONE			English	Article							HEAVY-CHAIN COMPOSITION; M-VASTUS-LATERALIS; SKELETAL-MUSCLE; SINGLE FIBERS; MYOSIN; POWER; STRENGTH; ISOFORMS; EXPRESSION; HYPERTROPHY	Human skeletal muscle fibers exist across a continuum of slow! fast-twitch. The amount of each fiber type (FT) influences muscle performance but remains largely unexplored in elite athletes, particularly from strength/power sports. To address this nescience, vastus lateralis (VL) biopsies were performed on World/Olympic (female, n = 6, "WCF") and National-caliber (female, n = 9, "NCF"; and male, n = 6, "NCM") American weightlifters. Participant accolades included 3 Olympic Games, 19 World Championships, 25 National records, and >170 National/International medals. Samples were analyzed for myosin heavy chain (MHC) content via SDS-PAGE using two distinct techniques: single fiber (SF) distribution (%) and homogenate (HG) composition. The main finding was that these athletes displayed the highest pure MHC IIa concentrations ever reported in healthy VL (23 +/- 9% I, 5 +/- 3% I/IIa,67 +/- 13% IIa, and 6 +/- 10% IIa/IIx), with WCF expressing a notable 71 +/- 17% (NCF=67 +/- 8%, NCM=63 +/- 16%). No pure MHC IIx were found with SF. Secondary analysis revealed the heavyweights accounted for 91% of the MHC IIa/IIx fibers, which caused a correlation between this FT and body mass. Additionally, when compared to SF, HG overestimated MHC I (23 +/- 9 vs. 31 +/- 9%) and IIx (0 +/- 0 vs. 3 +/- 6%) by misclassifying I/IIa fibers as I and IIa/IIx fibers as IIx, highlighting the limitation of HG as a measure of isoform distribution. These results collectively suggest that athlete caliber (World vs. National) and/or years competing in the sport determine FT% more than sex, particularly for MHC IIa. The extreme fast-twitch myofiber abundance likely explains how elite weightlifters generate high forces in rapid timeframes.	[Serrano, Nathan; Colenso-Semple, Lauren M.; Lazauskus, Kara K.; Siu, Jeremy W.; Lockie, Robert G.; Costal, Pablo B.; Galpin, Andrew J.] Calif State Univ Fullerton, Ctr Sport Performance, Biochem & Mol Exercise Physiol Lab, Fullerton, CA 92634 USA; [Bagley, James R.] San Francisco State Univ, Muscle Physiol Lab, San Francisco, CA 94132 USA	California State University System; California State University Fullerton; California State University System; San Francisco State University	Galpin, AJ (corresponding author), Calif State Univ Fullerton, Ctr Sport Performance, Biochem & Mol Exercise Physiol Lab, Fullerton, CA 92634 USA.	agalpin@fullerton.edu	Bagley, James R./H-9982-2019	Bagley, James R./0000-0002-2709-548X; Siu, Jeremy/0000-0001-8474-862X	Renaissance Periodization	Renaissance Periodization	Funding for this project was provided by Renaissance Periodization. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard P, 2007, MED SCI SPORT EXER, V39, P1989, DOI 10.1249/mss.0b013e31814fb402; ADAMS GR, 1993, J APPL PHYSIOL, V74, P911, DOI 10.1152/jappl.1993.74.2.911; ANDERSEN JL, 1994, ACTA PHYSIOL SCAND, V150, P21, DOI 10.1111/j.1748-1716.1994.tb09655.x; ANDERSEN JL, 1994, ACTA PHYSIOL SCAND, V151, P135, DOI 10.1111/j.1748-1716.1994.tb09730.x; Arevalo JA, 2018, MED SCI SPORT EXER, V50, P1054, DOI 10.1249/MSS.0000000000001533; Bagley J., 2012, BIOLOGY-BASEL, V26, P34; Bagley JR, 2017, J STRENGTH COND RES, V31, P602, DOI 10.1519/JSC.0000000000001759; Bagley JR, 2015, BIOCHEM MOL BIOL EDU, V43, P403, DOI 10.1002/bmb.20891; Bagley JR, 2014, J PHYSIOL-LONDON, V592, P5147, DOI 10.1113/jphysiol.2014.282574; Bathgate KE, 2018, EUR J APPL PHYSIOL, V118, P2097, DOI 10.1007/s00421-018-3943-7; Bergstrom J, 1962, SCANDINAVIAN J C S68, P14; Borina E, 2010, SCAND J MED SCI SPOR, V20, P65, DOI 10.1111/j.1600-0838.2009.01029.x; Bottinelli R, 1999, J ELECTROMYOGR KINES, V9, P87, DOI 10.1016/S1050-6411(98)00040-6; COSTILL DL, 1976, J APPL PHYSIOL, V40, P149, DOI 10.1152/jappl.1976.40.2.149; Fry AC, 2003, J STRENGTH COND RES, V17, P746; Fry AC, 2003, J STRENGTH COND RES, V17, P402; FRY AC, 1994, EUR J APPL PHYSIOL O, V68, P246, DOI 10.1007/BF00376773; Galpin AJ, 2012, ANAL BIOCHEM, V425, P175, DOI 10.1016/j.ab.2012.03.018; Galpin AJ, 2012, APPL PHYSIOL NUTR ME, V37, P80, DOI [10.1139/h11-131, 10.1139/H11-131]; GOLLNICK PD, 1972, J APPL PHYSIOL, V33, P312, DOI 10.1152/jappl.1972.33.3.312; Grgic J, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00402; Haizlip KM, 2015, PHYSIOLOGY, V30, P30, DOI 10.1152/physiol.00024.2014; Jones N, 2016, BIOL SPORT, V33, P117, DOI 10.5604/20831862.1198210; Kesidis N, 2008, EUR J APPL PHYSIOL, V103, P579, DOI 10.1007/s00421-008-0751-5; KLITGAARD H, 1990, ACTA PHYSIOL SCAND, V140, P55, DOI 10.1111/j.1748-1716.1990.tb08975.x; KLITGAARD H, 1990, ACTA PHYSIOL SCAND, V140, P175, DOI 10.1111/j.1748-1716.1990.tb08989.x; Kryger AI, 2007, SCAND J MED SCI SPOR, V17, P422, DOI 10.1111/j.1600-0838.2006.00575.x; LEXELL J, 1983, ACTA PHYSIOL SCAND, V117, P115, DOI 10.1111/j.1748-1716.1983.tb07185.x; Liu Y, 2003, J APPL PHYSIOL, V94, P2282, DOI 10.1152/japplphysiol.00830.2002; Malisoux L, 2007, J APPL PHYSIOL, V102, P340, DOI 10.1152/japplphysiol.00609.2006; Malisoux L, 2006, MED SCI SPORT EXER, V38, P1901, DOI 10.1249/01.mss.0000232022.21361.47; Methenitis S, 2016, MED SCI SPORT EXER, V48, P1761, DOI 10.1249/MSS.0000000000000954; Miller MS, 2017, J APPL PHYSIOL, V122, P775, DOI 10.1152/japplphysiol.00830.2016; Murach KA, 2016, J MUSCLE RES CELL M, V37, P1, DOI 10.1007/s10974-016-9441-9; Norman B, 2009, J APPL PHYSIOL, V106, P959, DOI 10.1152/japplphysiol.91435.2008; Pandorf CE, 2010, J APPL PHYSIOL, V108, P222, DOI 10.1152/japplphysiol.01233.2009; Parcell AC, 2005, MED SCI SPORT EXER, V37, P1133, DOI 10.1249/01.mss.0000170123.27209.e1; Parcell AC, 2003, MED SCI SPORT EXER, V35, P434, DOI 10.1249/01.MSS.0000053735.99344.C0; Pette D, 2000, MICROSC RES TECHNIQ, V50, P500, DOI 10.1002/1097-0029(20000915)50:6<500::AID-JEMT7>3.0.CO;2-7; Pette D, 2002, CAN J APPL PHYSIOL, V27, P423, DOI 10.1139/h02-023; Pette D, 1997, Int Rev Cytol, V170, P143, DOI 10.1016/S0074-7696(08)61622-8; PRINCE FP, 1977, PFLUG ARCH EUR J PHY, V371, P161, DOI 10.1007/BF00580785; PRINCE FP, 1976, PFLUG ARCH EUR J PHY, V363, P19, DOI 10.1007/BF00587397; Purves-Smith FM, 2014, EXERC SPORT SCI REV, V42, P45, DOI 10.1249/JES.0000000000000012; Raue U, 2005, INT J SPORTS MED, V26, P339, DOI 10.1055/s-2004-821041; SIMONEAU JA, 1989, AM J PHYSIOL, V257, pE567, DOI 10.1152/ajpendo.1989.257.4.E567; Staron RS, 2000, J HISTOCHEM CYTOCHEM, V48, P623, DOI 10.1177/002215540004800506; STARON RS, 1991, HISTOCHEMISTRY, V96, P21, DOI 10.1007/BF00266756; Terzis G, 2010, J SPORT SCI MED, V9, P104; TESCH PA, 1982, EUR J APPL PHYSIOL O, V49, P301, DOI 10.1007/BF00441291; TESCH PA, 1985, J APPL PHYSIOL, V59, P1716, DOI 10.1152/jappl.1985.59.6.1716; TESCH PA, 1984, J APPL PHYSIOL, V56, P35, DOI 10.1152/jappl.1984.56.1.35; Tobias IS, 2018, J APPL PHYSIOL, V124, P840, DOI 10.1152/japplphysiol.00894.2017; Trappe S, 2006, J APPL PHYSIOL, V101, P721, DOI 10.1152/japplphysiol.01595.2005; Trappe S, 2015, J APPL PHYSIOL, V118, P1460, DOI 10.1152/japplphysiol.00037.2015; Welle S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001385; Williamson DL, 2001, J APPL PHYSIOL, V91, P1955, DOI 10.1152/jappl.2001.91.5.1955	57	21	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2019	14	3							e0207975	10.1371/journal.pone.0207975	http://dx.doi.org/10.1371/journal.pone.0207975			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ5PT	30917128	Green Published, gold, Green Submitted			2022-12-26	WOS:000462465800004
J	Dolfing, AG; Leuven, JRFW; Dermody, BJ				Dolfing, Alexander G.; Leuven, Jasper R. F. W.; Dermody, Brian J.			The effects of network topology, climate variability and shocks on the evolution and resilience of a food trade network	PLOS ONE			English	Article							EL-NINO; OSCILLATION; SECURITY	Future climate change will impose increased variability on food production and food trading networks. However, the effect of climate variability and sudden shocks on resource availability through trade and its subsequent effect on population growth is largely unknown. Here we study the effect of resource variability and network topology on access to resources and population growth, using a model of population growth limited by resource availability in a trading network. Resources are redistributed in the network based on supply and the distance between nodes (i.e. cities or countries). Resources at nodes vary over time with wave parameters that mimic changes in biomass production arising from known climate variability. Random perturbations to resources are applied to study resilience of individual nodes and the system as a whole. The model demonstrates that redistribution of resources increases the maximum population that can be supported (carrying capacity) by the network. Fluctuations in carrying capacity depend on the amplitude and frequency of resource variability: fluctuations become larger for increasing amplitude and decreasing frequency. Our study shows that topology is the key factor determining the carrying capacity of a node. In larger networks the carrying capacity increases and the distribution of resources in the network becomes more equal. The most central nodes achieve a higher carrying capacity than nodes with a lower centrality. Moreover, central nodes are less susceptible to long-term resource variability and shocks. These insights can be used to understand how worldwide equitable access to resources can be maintained under increasing climate variability.	[Dolfing, Alexander G.; Dermody, Brian J.] Univ Utrecht, Fac Geosci, Copernicus Inst Sustainable Dev, Utrecht, Netherlands; [Dolfing, Alexander G.] Natuur & Milieu, Org Protect Nat & Environm, Utrecht, Netherlands; [Leuven, Jasper R. F. W.] Univ Utrecht, Fac Geosci, Dept Phys Geog, Utrecht, Netherlands	Utrecht University; Utrecht University	Dolfing, AG (corresponding author), Univ Utrecht, Fac Geosci, Copernicus Inst Sustainable Dev, Utrecht, Netherlands.; Dolfing, AG (corresponding author), Natuur & Milieu, Org Protect Nat & Environm, Utrecht, Netherlands.	lexdolfing@gmail.com						Anderson W, 2018, AGR FOREST METEOROL, V262, P298, DOI 10.1016/j.agrformet.2018.07.023; d'Amour CB, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/3/035007; Dermody BJ, 2014, HYDROL EARTH SYST SC, V18, P5025, DOI 10.5194/hess-18-5025-2014; Dermody BJ, 2018, EARTH SYST DYNAM, V9, P103, DOI 10.5194/esd-9-103-2018; Distefano T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200639; Ethier WJ, 1991, TRADE POLICY INT ADJ, P3; Fair KR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07202-y; Food and Agriculture Organaisation-FAO, 2010, EC SOC PERSP POL BRI; FRUCHTERMAN TMJ, 1991, SOFTWARE PRACT EXPER, V21, P1129, DOI 10.1002/spe.4380211102; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Gregory PJ, 2005, PHILOS T R SOC B, V360, P2139, DOI 10.1098/rstb.2005.1745; Handmer J.W., 1999, MITIG ADAPT STRATEG, V4, P267, DOI [10.1023/A:1009611621048, DOI 10.1023/A:1009611621048]; Lee R, 2011, SCIENCE, V333, P569, DOI 10.1126/science.1208859; LIN N, 1972, Q REV BIOL, V47, P131, DOI 10.1086/407216; Marchand P, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/9/095009; MENGE BA, 1987, AM NAT, V130, P730, DOI 10.1086/284741; Nelson Gerald C, 2014, Proc Natl Acad Sci U S A, V111, P3274, DOI 10.1073/pnas.1222465110; Okamoto K, 2008, LECT NOTES COMPUT SC, V5059, P186; Pandey DN, 2003, CURR SCI INDIA, V85, P46; Parry ML, 2004, GLOBAL ENVIRON CHANG, V14, P53, DOI 10.1016/j.gloenvcha.2003.10.008; Puma MJ, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/2/024007; Ray DK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066428; SCHLESINGER ME, 1994, NATURE, V367, P723, DOI 10.1038/367723a0; Schmidhuber J, 2007, P NATL ACAD SCI USA, V104, P19703, DOI 10.1073/pnas.0701976104; Schott PK, 2004, Q J ECON, V119, P647, DOI 10.1162/0033553041382201; Steingress W., 2015, SPECIALIZATION PATTE; Stenseth NC, 2003, P ROY SOC B-BIOL SCI, V270, P2087, DOI 10.1098/rspb.2003.2415; Suweis S, 2015, P NATL ACAD SCI USA, V112, P6902, DOI 10.1073/pnas.1507366112; Tamea S, 2016, SCI REP-UK, V6, DOI 10.1038/srep18803; Tinbergen J., 1962, ECON J, V76, P92; Tudhope AW, 2001, SCIENCE, V291, P1511, DOI 10.1126/science.1057969; United Nations Department of Economic and Social Affairs, ESAPWP241 UN; Verhulst P. F., 1838, CORRES MATH PHYS, V10, P113, DOI DOI 10.1007/BF02309004; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wheeler T, 2013, SCIENCE, V341, P508, DOI 10.1126/science.1239402; Wilhite A., 2001, Computational Economics, V18, P49, DOI 10.1023/A:1013814511151; World Bank, 2016, POP GROWTH ANN PERC; ZEBIAK SE, 1987, MON WEATHER REV, V115, P2262, DOI 10.1175/1520-0493(1987)115<2262:AMENO>2.0.CO;2; Zhang DD, 2007, P NATL ACAD SCI USA, V104, P19214, DOI 10.1073/pnas.0703073104	39	11	11	4	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2019	14	3							e0213378	10.1371/journal.pone.0213378	http://dx.doi.org/10.1371/journal.pone.0213378			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ3IW	30913228	Green Submitted, gold, Green Published			2022-12-26	WOS:000462305600014
J	Anand, S; Ganaie, AA; Sharma, C				Anand, Shashi; Ganaie, Arsheed Ahmad; Sharma, Charu			Differential thermal stability, conformational stability and unfolding behavior of Eis proteins from Mycobacterium smegmatis and Mycobacterium tuberculosis	PLOS ONE			English	Article							SODIUM DODECYL-SULFATE; GLOBULE-LIKE STATE; AMINOGLYCOSIDE ACETYLTRANSFERASE EIS; INTRACELLULAR SURVIVAL PROTEIN; MOLTEN GLOBULE; SUBSTRATE-SPECIFICITY; STRUCTURAL-ANALYSIS; CIRCULAR-DICHROISM; SELF-ASSOCIATION; RESISTANCE	Eis (Enhanced Intracellular Survival) is an important aminoglycoside N-acetyltransferase enzyme contributing to kanamycin resistance in Mtb clinical isolates. Eis proteins from M. tuberculosis (RvEis) and M. smegmatis (MsEis) have 58% identical and 69% similar amino acid sequences and acetylate aminoglycosides at multiple amines. Both the Eis proteins are hexameric and composed of two symmetric trimers. RvEis has remarkable structural stability and heat-stable aminoglycoside acetyltransferase activity. Although the structure and biochemical properties of MsEis have been studied earlier, the detailed characterization of its acetyltransferase activity and structural stability is lacking. In this study, we have performed comparative analysis of structural stability and aminoglycoside acetyltransferase activity of RvEis and MsEis proteins. Unlike RvEis, MsEis undergoes a three-state unfolding induced by heat or chemical denaturants and involves self-association of partially unfolded oligomers to form high molecular weight soluble aggregates. MsEis is highly susceptible to chemical denaturants and unfolds completely at lower concentrations of GdmCl and urea when compared to RvEis. In contrast to RvEis, the oligomeric forms of MsEis are SDS sensitive. However, SDS treatment resulted in increased helix formation in MsEis than RvEis. MsEis shows lesser thermostable activity with a decreased efficiency of kanamycin acetylation in comparison to RvEis. Furthermore, overexpression of MsEis does not provide thermal resistance to M. smegmatis unlike RvEis. Collectively, this study reveals that homologous proteins from pathogenic and nonpathogenic mycobacteria follow different modes of unfolding and demonstrate differential structural stability and activity despite highly similar sequences and oligomeric organization.	[Anand, Shashi; Ganaie, Arsheed Ahmad; Sharma, Charu] CSIR Inst Microbial Technol, Chandigarh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Sharma, C (corresponding author), CSIR Inst Microbial Technol, Chandigarh, India.	charu@imtech.res.in	Ganaie, Arsheed/Y-1556-2019; Anand, Shashi/AAA-7413-2022	Ganaie, Arsheed/0000-0003-3460-1755; Anand, Shashi/0000-0002-9615-3452	Council of Scientific and Industrial Research (CSIR) [OLP0109, BSC0104]; CSIR, New Delhi	Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); CSIR, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by funding from Council of Scientific and Industrial Research (CSIR) (Grant numbers OLP0109 and BSC0104) to CS. SA and AAG received their Senior Research Fellowship (SRF) from CSIR, New Delhi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand S, 2018, INT J BIOL MACROMOL, V109, P124, DOI 10.1016/j.ijbiomac.2017.12.058; Asghari SM, 2004, ENZYME MICROB TECH, V35, P51, DOI 10.1016/j.enzmictec.2004.03.006; Chen WJ, 2012, BIOCHEMISTRY-US, V51, P4959, DOI 10.1021/bi3004473; Chen WJ, 2011, P NATL ACAD SCI USA, V108, P9804, DOI 10.1073/pnas.1105379108; CHEN YH, 1972, BIOCHEMISTRY-US, V11, P4120, DOI 10.1021/bi00772a015; CHRISTENSEN H, 1991, EUR BIOPHYS J, V19, P221, DOI 10.1007/BF00183530; Daigle DM, 1999, CHEM BIOL, V6, P99, DOI 10.1016/S1074-5521(99)80006-4; Dar MA, 2016, INT J BIOL MACROMOL, V89, P605, DOI 10.1016/j.ijbiomac.2016.05.036; Duy C, 2006, BIOPHYS J, V90, P3704, DOI 10.1529/biophysj.105.078980; Ganaie AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027590; Goyal M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115877; Green KD, 2015, BIOCHEMISTRY-US, V54, P3197, DOI 10.1021/acs.biochem.5b00244; Green KD, 2011, ANTIMICROB AGENTS CH, V55, P3207, DOI 10.1128/AAC.00312-11; Gupta P, 2003, INT J BIOL MACROMOL, V33, P167, DOI 10.1016/j.ijbiomac.2003.08.001; Hamano Y, 2004, J BIOCHEM, V136, P517, DOI 10.1093/jb/mvh146; Jennings BC, 2013, BIOCHEMISTRY-US, V52, P5125, DOI 10.1021/bi4002985; Kim C, 2007, BIOCHEMISTRY-US, V46, P5270, DOI 10.1021/bi700111z; Kim C, 2006, BIOCHEMISTRY-US, V45, P8368, DOI 10.1021/bi060723g; Kim KH, 2012, P NATL ACAD SCI USA, V109, P7729, DOI 10.1073/pnas.1120251109; Kuznetsova IM, 1999, BIOPHYS J, V77, P2788, DOI 10.1016/S0006-3495(99)77111-0; Lella RK, 2007, J BIOL CHEM, V282, P18671, DOI 10.1074/jbc.C600280200; Maheshwari A, 2010, BIOCHIMIE, V92, P491, DOI 10.1016/j.biochi.2010.01.009; Manning M, 2004, BIOCHEMISTRY-US, V43, P11248, DOI 10.1021/bi0491898; Micsonai A, 2015, P NATL ACAD SCI USA, V112, pE3095, DOI 10.1073/pnas.1500851112; Parkinson EJ, 2000, BIOCHEMISTRY-US, V39, P12345, DOI 10.1021/bi0005658; Pricer RE, 2012, MOL BIOSYST, V8, P3305, DOI 10.1039/c2mb25341k; Ptitsyn OB, 1995, ADV PROTEIN CHEM, V47, P83, DOI 10.1016/S0065-3233(08)60546-X; Qadeer A, 2014, BIOCHEMISTRY-MOSCOW+, V79, P785, DOI 10.1134/S0006297914080069; Ramirez MS, 2010, DRUG RESIST UPDATE, V13, P151, DOI 10.1016/j.drup.2010.08.003; Reddy GB, 1999, J BIOL CHEM, V274, P4500, DOI 10.1074/jbc.274.8.4500; SANCHEZRUIZ JM, 1988, BIOCHEMISTRY-US, V27, P1648, DOI 10.1021/bi00405a039; SURESHCHANDRA BR, 1987, J AGR FOOD CHEM, V35, P244, DOI 10.1021/jf00074a019; UVERSKY VN, 1993, BIOCHEMISTRY-US, V32, P13288, DOI 10.1021/bi00211a042; Weichel M, 2008, BIOPROCESS INT, P48; Zaidi N, 2014, J PHYS CHEM B, V118, P13025, DOI 10.1021/jp501515g; Zaunbrecher MA, 2009, P NATL ACAD SCI USA, V106, P20004, DOI 10.1073/pnas.0907925106	36	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2019	14	3							e0213933	10.1371/journal.pone.0213933	http://dx.doi.org/10.1371/journal.pone.0213933			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ1KV	30908529	Green Published, gold, Green Submitted			2022-12-26	WOS:000462157600027
J	Medrano, G; Cailleux, F; Guan, PH; Kuruvilla, K; Barlow-Anacker, AJ; Gosain, A				Medrano, Giuliana; Cailleux, Frederic; Guan, Peihong; Kuruvilla, Korah; Barlow-Anacker, Amanda J.; Gosain, Ankush			B-lymphocyte-intrinsic and -extrinsic defects in secretory immunoglobulin A production in the neural crest-conditional deletion of endothelin receptor B model of Hirschsprung-associated enterocolitis	FASEB JOURNAL			English	Article						IgA; polymeric Ig receptor; aganglionosis; megacolon; mucosal immunity	CROHNS-DISEASE; BASIC SCIENCE; MURINE MODEL; IGA; ANTAGONIST; BOSENTAN	Hirschsprung disease (HSCR) is a common cause of intestinal obstruction in the newborn. Hirschsprung-associated enterocolitis (HAEC) is a significant and life-threatening complication of HSCR, affecting up to 60% of patients. Animal models of endothelin receptor B (EdnrB) mutation reliably model human HSCR and HAEC. We previously demonstrated intestinal dysbiosis and a gut-specific deficiency of B-lymphocyte-produced secretory IgA (sIgA), the primary effector molecule of mucosal immunity, in mice with homozygous neural crest cell-conditional deletion of EdnrB (EdnrB(NCC-/-)). To determine mechanisms for sIgA deficiency, we examined intrinsic and extrinsic aspects of B-lymphocyte development and function. Expression of the endothelin axis components [endothelin-1 (ET-1), endothelin-3 (ET-3), endothelin receptor A (EdnrA), EdnrB] were determined over a developmental time course. B-lymphocyte survival and Ig production were assayed in vitro. Polymeric Ig receptor (pIgR)-mediated IgA transport into the intestinal lumen was interrogated. We found endothelin axis component (EdnrA, EdnrB, ET-1, ET-3) expression in developing extramedullary hematopoietic organs and that some splenic B lymphocytes express EdnrB. Splenic B lymphocytes from EdnrB(NCC-/-) mice showed no intrinsic defect in survival vs. wild-type (WT) B lymphocytes. In vitro stimulation of splenic B lymphocytes demonstrated decreased IgA, IgG, and IgM production in EdnrB(NCC-/-) vs. WT mice. Additionally, small intestinal pIgR was decreased similar to 50% in EdnrB(NCC-/-) mice. These results suggest an intrinsic B-lymphocyte defect in antibody production as well as an extrinsic defect in IgA transport in the EdnrB(NCC-/-) model of HAEC. Our results are consistent with human HAEC observations of decreased luminal sIgA and mouse models of other inflammatory bowel diseases, in which decreased pIgR is seen in concert with a dysregulated microbiota. Finally, our results suggest targeting the dysbiotic microbiome and pIgR-mediated sIgA transport as potential therapeutic approaches in prevention and treatment of HAEC.-Medrano, G., Cailleux, F., Guan, P., Kuruvilla, K., Barlow-Anacker, A. J., Gosain, A. B-lymphocyte-intrinsic and -extrinsic defects in secretory immunoglobulinA production in the neural crest-conditional deletion of endothelin receptor B model of Hirschsprung-associated enterocolitis.	[Medrano, Giuliana; Cailleux, Frederic; Guan, Peihong; Kuruvilla, Korah; Gosain, Ankush] Univ Tennessee, Hlth Sci Ctr, Dept Surg, Div Pediat Surg, Memphis, TN USA; [Barlow-Anacker, Amanda J.] Univ Wisconsin, Dept Surg, Sch Med & Publ Hlth, Madison, WI USA; [Gosain, Ankush] Le Bonheur Childrens Hosp, Childrens Fdn Res Inst, 50 N Dunlap St,Room 320, Memphis, TN 38105 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Wisconsin System; University of Wisconsin Madison	Gosain, A (corresponding author), Le Bonheur Childrens Hosp, Childrens Fdn Res Inst, 50 N Dunlap St,Room 320, Memphis, TN 38105 USA.	agosain@uthsc.edu	Pushpamangalam Kuruvilla, Korah/AFS-1915-2022	Pushpamangalam Kuruvilla, Korah/0000-0001-5722-7562; Gosain, Ankush/0000-0002-0428-1503	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases [DK098271, DK114543]; American College of Surgeons (George H. A. Clowes Career Development Award); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK098271, R03DK114543] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American College of Surgeons (George H. A. Clowes Career Development Award); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Kara Matteson, M.S. (Department of Clinical Laboratory Services, University of Tennessee Health Science Center), for technical assistance and Joseph Pierre, Ph.D. (Department of Pediatrics, University of Tennessee Health Science Center), for assistance in interpreting results. This work was supported by grants from the U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (DK098271, DK114543) and the American College of Surgeons (George H. A. Clowes Career Development Award to A.G.). The authors declare no conflicts of interest.	Abreu MT, 2004, J PEDIATR-US, V144, P421, DOI 10.1016/j.jpeds.2004.01.057; Agace WW, 2017, IMMUNITY, V46, P532, DOI 10.1016/j.immuni.2017.04.004; Aghamohammadi A, 2009, J CLIN IMMUNOL, V29, P130, DOI 10.1007/s10875-008-9229-9; Anthoni C, 2006, INT J COLORECTAL DIS, V21, P409, DOI 10.1007/s00384-005-0015-3; Arsenescu R, 2008, MUCOSAL IMMUNOL, V1, P399, DOI 10.1038/mi.2008.32; Barlow-Anacker AJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep45645; Brandtzaeg P, 2008, MUCOSAL IMMUNOL, V1, P31, DOI 10.1038/mi.2007.9; Bruno MEC, 2011, MUCOSAL IMMUNOL, V4, P468, DOI 10.1038/mi.2011.8; Cheng Z, 2011, PEDIATR SURG INT, V27, P145, DOI 10.1007/s00383-010-2787-y; Druckenbrod NR, 2008, GENESIS, V46, P396, DOI 10.1002/dvg.20415; Elisa T, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/147616; Frantz AL, 2012, MUCOSAL IMMUNOL, V5, P501, DOI 10.1038/mi.2012.23; Gosain A, 2017, PEDIATR SURG INT, V33, P517, DOI 10.1007/s00383-017-4065-8; Gosain A, 2016, PEDIATR SURG INT, V32, P313, DOI 10.1007/s00383-016-3862-9; Gosain A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128822; Guruli G, 2004, BLOOD, V104, P2107, DOI 10.1182/blood-2003-10-3559; Hermsen JL, 2009, LANGENBECK ARCH SURG, V394, P17, DOI 10.1007/s00423-008-0339-x; Heuckeroth RO, 2018, NAT REV GASTRO HEPAT, V15, P152, DOI 10.1038/nrgastro.2017.149; Hogaboam CM, 1996, EUR J PHARMACOL, V309, P261, DOI 10.1016/0014-2999(96)00276-2; IMAMURA A, 1992, GUT, V33, P801, DOI 10.1136/gut.33.6.801; Kaetzel CS, 2014, IMMUNOL LETT, V162, P10, DOI 10.1016/j.imlet.2014.05.008; Kandalaft LE, 2009, CLIN CANCER RES, V15, P4521, DOI 10.1158/1078-0432.CCR-08-0543; Khimji AK, 2010, CELL SIGNAL, V22, P1615, DOI 10.1016/j.cellsig.2010.05.002; Kowalczyk A, 2015, ARCH IMMUNOL THER EX, V63, P41, DOI 10.1007/s00005-014-0310-1; Lee HO, 2003, DEV BIOL, V259, P162, DOI 10.1016/S0012-1606(03)00160-X; MacLean GA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26123-y; Malendowicz LK, 1998, LIFE SCI, V62, P1959, DOI 10.1016/S0024-3205(98)00165-9; Medrano G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181881; MURCH SH, 1992, LANCET, V339, P381, DOI 10.1016/0140-6736(92)90077-G; Parker KD, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01598; Pierre JF, 2014, J PEDIATR SURG, V49, P1242, DOI 10.1016/j.jpedsurg.2014.01.060; Reikvam DH, 2012, EUR J IMMUNOL, V42, P2959, DOI 10.1002/eji.201242543; Rolig AS, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2000689; Sampaio ALF, 2000, J LEUKOCYTE BIOL, V67, P189, DOI 10.1002/jlb.67.2.189; Sano Y, 2009, AM J SURG, V198, P105, DOI 10.1016/j.amjsurg.2008.08.018; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Suzuki K, 2004, P NATL ACAD SCI USA, V101, P1981, DOI 10.1073/pnas.0307317101; TEITELBAUM DH, 1989, J PEDIATR SURG, V24, P1271, DOI 10.1016/S0022-3468(89)80566-4; Turula H, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10050237; Wang N, 2012, CURR OPIN ALLERGY CL, V12, P602, DOI 10.1097/ACI.0b013e3283594219; Ward NL, 2012, NEUROGASTROENT MOTIL, V24, P874, DOI 10.1111/j.1365-2982.2012.01937.x; Wijburg OLC, 2006, J EXP MED, V203, P21, DOI 10.1084/jem.20052093; Yamaguchi E, 2007, J GASTROEN HEPATOL, V22, P1134, DOI 10.1111/j.1440-1746.2006.04822.x	43	5	6	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					7615	7624		10.1096/fj.201801913R	http://dx.doi.org/10.1096/fj.201801913R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30908942	Green Published, Bronze			2022-12-26	WOS:000476114200076
J	De Pauw, K; Cherelle, P; Tassignon, B; Van Cutsem, J; Roelands, B; Marulanda, FG; Lefeber, D; Vanderborght, B; Meeusen, R				De Pauw, Kevin; Cherelle, Pierre; Tassignon, Bruno; Van Cutsem, Jeroen; Roelands, Bart; Marulanda, Felipe Gomez; Lefeber, Dirk; Vanderborght, Bram; Meeusen, Romain			Cognitive performance and brain dynamics during walking with a novel bionic foot: A pilot study	PLOS ONE			English	Article							GAIT INITIATION; MOVEMENT; ATTENTION; CORTEX; NETWORK; POSTURE; SINGLE; SPEED; TASK	Objectives The objectives are to determine neural dynamics during gait using electro-encephalography and source localization, and to investigate the attentional demand during walking in able-bodied individuals, and individuals with an amputation. Materials & methods Six able-bodied individuals conducted one experimental trial, and 6 unilateral transtibial and 6 unilateral transfemoral amputees performed 2 experimental trials; the first with the prosthesis currently used by the subjects and the second with a novel powered transtibial prosthesis, i.e. the Ankle Mimicking Prosthetic foot 4.0. Each experimental trial comprised 2 walking tasks; 6 and 2 minutes treadmill walking at normal speed interspersed by 5 minutes of rest. During 6 minutes walking the Sustained Attention to Response (go-no go) Task, which measures reaction time and accuracy, was performed. Electro-encephalographic data were gathered when subjects walked 2 minutes. Motor-related cortical potentials and brain source activity during gait were examined. Normality and (non-) parametric tests were conducted (p<0.05). Results and discussion In contrast to transtibial amputees, transfemoral amputees required more attentional demands during walking with Ankle Mimicking Prosthetic foot 4.0 compared to the current passive prosthetic device and able-bodied individuals (reaction time and accuracy: p <= 0.028). Since risk of falling is associated with altered attentional demands, propulsive forces of the novel device need to be better controlled for transfemoral amputees. No motor-related cortical potentials at Cz were observed in transfemoral amputees walking with the novel prosthesis, whereas motor-related cortical potentials between transtibial amputees and able-bodied individuals during walking at normal speed did not differ. The first positive electro-physiological peak deflection appeared during toe-off phase and showed higher activity within the underlying brain sources in transtibial amputees walking with Ankle Mimicking Prosthetic foot 4.0 compared to able-bodied individuals. The required higher neural input to accomplish the same physical activity compared to able-bodied individuals is possibly due to the limited acclimation period to the novel device and consequently increased afferent sensory feedback for postural control.	[De Pauw, Kevin; Tassignon, Bruno; Van Cutsem, Jeroen; Roelands, Bart; Meeusen, Romain] Vrije Univ Brussel, Res Grp Human Physiol, Fac Phys Educ & Phys Therapy, Brussels, Belgium; [De Pauw, Kevin; Lefeber, Dirk; Vanderborght, Bram; Meeusen, Romain] Vrije Univ Brussel, Strateg Res Program Exercise & Brain Hlth & Dis A, Brussels, Belgium; [Cherelle, Pierre; Lefeber, Dirk; Vanderborght, Bram] Vrije Univ Brussel, Fac Sci Appl, Dept Mech Engn, Brussels, Belgium; [Cherelle, Pierre; Lefeber, Dirk; Vanderborght, Bram] Flanders Make, Brussels, Belgium; [Marulanda, Felipe Gomez] Vrije Univ Brussel, Fac Sci & Bioengn Sci, Artificial Intelligence Lab, Brussels, Belgium	Vrije Universiteit Brussel; Vrije Universiteit Brussel; Vrije Universiteit Brussel; Vrije Universiteit Brussel	Meeusen, R (corresponding author), Vrije Univ Brussel, Res Grp Human Physiol, Fac Phys Educ & Phys Therapy, Brussels, Belgium.; Meeusen, R (corresponding author), Vrije Univ Brussel, Strateg Res Program Exercise & Brain Hlth & Dis A, Brussels, Belgium.	romain.meeusen@vub.be	Roelands, Bart/E-2337-2011; Tassignon, Bruno/M-8793-2017; Van Cutsem, Jeroen/AAZ-6281-2021; De Pauw, Kevin/E-8937-2018; Vanderborght, Bram/A-1599-2008; Van Cutsem, Jeroen/AAZ-7325-2021	Roelands, Bart/0000-0002-2808-044X; Tassignon, Bruno/0000-0003-3216-4045; Vanderborght, Bram/0000-0003-4881-9341; De Pauw, Kevin/0000-0002-6901-7199; Van Cutsem, Jeroen/0000-0001-6122-7629; Lefeber, Dirk/0000-0003-4442-4473				Brunner R, 2013, J CHILD ORTHOP, V7, P367, DOI 10.1007/s11832-013-0508-5; Bulea TC, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00247; Castermans T, 2014, BRAIN SCI, V4, P1, DOI 10.3390/brainsci4010001; Castermans T, 2014, NEUROSCI LETT, V561, P166, DOI 10.1016/j.neulet.2013.12.059; Cherelle P, 2014, ADV MECH ENG, V14, P1; Cherelle P, 2016, BIOMED ENG ONLINE, V15, DOI 10.1186/s12938-016-0285-8; Cherelle P, 2014, IEEE T NEUR SYS REH, V22, P138, DOI 10.1109/TNSRE.2013.2282416; Christoff K, 2009, P NATL ACAD SCI USA, V106, P8719, DOI 10.1073/pnas.0900234106; De Pauw K, 2018, PROSTHET ORTHOT INT, V42, P504, DOI 10.1177/0309364618767141; DEECKE L, 1982, EXP BRAIN RES, V48, P144; Deecke L, 1996, COGNITIVE BRAIN RES, V3, P59, DOI 10.1016/0926-6410(95)00046-1; DEECKE L, 1976, BIOL CYBERN, V23, P99, DOI 10.1007/BF00336013; do Nascimento OF, 2005, BEHAV BRAIN RES, V161, P141, DOI 10.1016/j.bbr.2005.02.031; ELBERT T, 1994, NEUROREPORT, V5, P2593, DOI 10.1097/00001756-199412000-00047; Forner-Cordero A, 2006, J BIOMECH, V39, P948, DOI 10.1016/j.jbiomech.2005.01.019; Gramann K, 2014, INT J PSYCHOPHYSIOL, V91, P22, DOI 10.1016/j.ijpsycho.2013.09.003; Gwin JT, 2011, NEUROIMAGE, V54, P1289, DOI 10.1016/j.neuroimage.2010.08.066; Gwin JT, 2010, J NEUROPHYSIOL, V103, P3526, DOI 10.1152/jn.00105.2010; Hargrove L, 2009, P EMBC 2009 ANN INT; Jahanshahi M., 2012, BEREITSCHAFTSPOTENTI; JASPER HH, 1958, ELECTROENCEPHALOGRAP, V10, P370, DOI DOI 10.1016/0013-4694(58)90053-1; Jiang N, 2015, CLIN NEUROPHYSIOL, V126, P154, DOI 10.1016/j.clinph.2014.05.003; Karimi F, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00356; Kline JE, 2015, J NEURAL ENG, V12, DOI 10.1088/1741-2560/12/4/046022; Knaepen K, 2015, NEUROSCI LETT, V599, P75, DOI 10.1016/j.neulet.2015.05.036; Koeneke S, 2009, J MOTOR BEHAV, V41, P347, DOI 10.3200/JMBR.41.4.347-356; MASSION J, 1992, PROG NEUROBIOL, V38, P35, DOI 10.1016/0301-0082(92)90034-C; Menant JC, 2014, AGEING RES REV, V16, P83, DOI 10.1016/j.arr.2014.06.001; Morgan SJ, 2016, PROSTHET ORTHOT INT, V40, P490, DOI 10.1177/0309364615596066; O'Connell RG, 2009, J COGNITIVE NEUROSCI, V21, P93, DOI 10.1162/jocn.2009.21008; Penfield W, 1950, CEREBRAL CORTEX MAN; Petersen TH, 2012, J PHYSIOL-LONDON, V590, P2443, DOI 10.1113/jphysiol.2012.227397; Robertson CV, 2016, J APPL PHYSIOL, V120, P464, DOI 10.1152/japplphysiol.00363.2015; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Sadeghi H, 2000, GAIT POSTURE, V12, P257, DOI 10.1016/S0966-6362(00)00085-0; Snyder KL, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00639; Luu TP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188500; Wagner J, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00093; Wieser M, 2010, EXP BRAIN RES, V203, P181, DOI 10.1007/s00221-010-2223-5; Woollacott M, 2002, GAIT POSTURE, V16, P1, DOI 10.1016/S0966-6362(01)00156-4; Wright DJ, 2011, J MOTOR BEHAV, V43, P193, DOI 10.1080/00222895.2011.557751; Yogev-Seligmann G, 2008, MOVEMENT DISORD, V23, P329, DOI 10.1002/mds.21720	42	3	3	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0214711	10.1371/journal.pone.0214711	http://dx.doi.org/10.1371/journal.pone.0214711			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HR5NS	30943265	Green Published, Green Submitted, gold			2022-12-26	WOS:000463194300052
J	Li, T; Zhou, WJ; Li, YM; Gan, YQ; Peng, YL; Xiao, Q; Ouyang, CL; Wu, AQ; Zhang, S; Liu, JQ; Fan, LL; Han, D; Wei, Y; Shu, G; Yin, G				Li, Tong; Zhou, Wenjuan; Li, Yimin; Gan, Yaqi; Peng, Yulong; Xiao, Qing; Ouyang, Chunli; Wu, Anqi; Zhang, Sai; Liu, Jiaqi; Fan, Lili; Han, Duo; Wei, Yu; Shu, Guang; Yin, Gang			MiR-4524b-5p/WTX/beta-catenin axis functions as a regulator of metastasis in cervical cancer	PLOS ONE			English	Article							WTX; EXPRESSION; MICRORNAS; PROLIFERATION; PROGRESSION; SUPPRESSES; INVASION; PATHWAY; TARGETS; GENE	Cervical cancer is the second most deadly gynecological tumor worldwide. MicroRNAs (miRNAs) play very important roles in tumor oncogenesis and progression. The mechanism of post-transcription regulation of WTX gene is still unknown. A series of differential miRNAs were discovered by microarray analysis comparing three pairs of primary cervical cancer specimens and their relapsed tumors from three patients. Quantitative reverse transcriptase PCR (qRT-PCR), Western Blot (WB) and lmmunohistochemistry (IHC) was used to detect the expression of miR-4524b-5p and WTX in cervical cell lines and tissues. The biological function of miR-4524b-5p and WTX was investigated through knockdown and overexpression with inhibitor/siRNA and mimic/plasmid in vitro and in vivo. In this study, we found that miR-4524b-5p is highly expressed in relapsed cervical cancer specimens. Combined in vitro and in vivo experiments, showed that miR-4524b-5p could regulate the migration and invasion ability of cervical cancer. Furthermore, we also found that miR-4524b-5p could regulate the migration and invasion of cervical cancer by targeting WTX and that WTX could regulate the expression of beta-catenin. Taken together, our data identified a miR-4524b-5p/WTX/beta-catenin regulatory axis for cervical cancer, and miR-4524b-5p may be a potential target for cervical cancer therapy.	[Li, Tong; Li, Yimin; Gan, Yaqi; Peng, Yulong; Xiao, Qing; Ouyang, Chunli; Wu, Anqi; Zhang, Sai; Liu, Jiaqi; Fan, Lili; Shu, Guang; Yin, Gang] Cent S Univ, Sch Basic Med Sci, Xiangya Hosp, Dept Pathol, Changsha, Hunan, Peoples R China; [Zhou, Wenjuan] Cent S Univ, Xiangya Sch Nursing, Changsha, Hunan, Peoples R China; [Han, Duo] Cent S Univ, Dept Gen Surg, Xiangya Hosp 3, Changsha, Hunan, Peoples R China; [Wei, Yu] Inner Mongolia Univ, Sch Life Sci, Hohhot, Inner Mongolia, Peoples R China	Central South University; Central South University; Central South University; Inner Mongolia University	Yin, G (corresponding author), Cent S Univ, Sch Basic Med Sci, Xiangya Hosp, Dept Pathol, Changsha, Hunan, Peoples R China.	gangyin@csu.edu.cn		Gan, Yaqi/0000-0001-8097-4603	National Natural Science Foundation of China [81572900]; National Key R&D Program of China, Stem Cell and Translation Research [2016YFA0102000]; Key Project of Hunan Province 2016 [2016JC2036]; Fundamental Research Funds for the Central Universities of Central South University [1053320171187]; Hunan Provincial Natural Science Foundation of China [2017JJ3513]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key R&D Program of China, Stem Cell and Translation Research; Key Project of Hunan Province 2016; Fundamental Research Funds for the Central Universities of Central South University; Hunan Provincial Natural Science Foundation of China(Natural Science Foundation of Hunan Province)	This study was supported by grants from the National Natural Science Foundation of China (no. 81572900), the National Key R&D Program of China, Stem Cell and Translation Research (no. 2016YFA0102000), the Key Project of Hunan Province 2016 (no. 2016JC2036), the Fundamental Research Funds for the Central Universities of Central South University (no. 1053320171187), and the Hunan Provincial Natural Science Foundation of China (no. 2017JJ3513).	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Chandeying N, 2017, J OBSTET GYNAECOL, V37, P347, DOI 10.1080/01443615.2016.1245279; Choong ES, 2016, BRACHYTHERAPY, V15, P40, DOI 10.1016/j.brachy.2015.09.002; Du K, 2014, ASIAN PAC J CANCER P, V15, P8793, DOI 10.7314/APJCP.2014.15.20.8793; Gao JK, 2019, MOL THER-ONCOLYTICS, V12, P214, DOI 10.1016/j.omto.2019.01.006; Golubovic M, 2017, VOJNOSANIT PREGL, V74, P24, DOI 10.2298/VSP150205143G; Grohmann A, 2007, J CELL SCI, V120, P3738, DOI 10.1242/jcs.011320; Hayes J, 2014, TRENDS MOL MED, V20, P460, DOI 10.1016/j.molmed.2014.06.005; Hou T, 2014, BRIT J CANCER, V110, P1260, DOI 10.1038/bjc.2013.829; Jenkins ZA, 2009, NAT GENET, V41, P95, DOI 10.1038/ng.270; Kefas B, 2008, CANCER RES, V68, P3566, DOI 10.1158/0008-5472.CAN-07-6639; Kilic S, 2015, ANN TRANSL MED, V3, DOI 10.3978/j.issn.2305-5839.2015.10.18; Li G, 2019, J CELL BIOCHEM, V120, P10587, DOI 10.1002/jcb.28345; Li N, 2019, ONCOL LETT, V17, P2631, DOI 10.3892/ol.2019.9923; Li X, 2016, WORLD J GASTROENTERO, V22, P5317, DOI 10.3748/wjg.v22.i23.5317; Li Y, 2011, J PATHOL, V224, P484, DOI 10.1002/path.2873; Liu Xia, 2013, Nan Fang Yi Ke Da Xue Xue Bao, V33, P318; Luo ST, 2017, EXP THER MED, V14, P1227, DOI 10.3892/etm.2017.4586; Major MB, 2007, SCIENCE, V316, P1043, DOI 10.1126/science/1141515; Razumilava N, 2012, HEPATOLOGY, V55, P465, DOI 10.1002/hep.24698; Rennie D, 2015, AUST FAM PHYSICIAN, V44, P515; Rivera MN, 2007, SCIENCE, V315, P642, DOI 10.1126/science.1137509; Rivera MN, 2009, P NATL ACAD SCI USA, V106, P8338, DOI 10.1073/pnas.0811349106; Rothschild SI, 2012, ONCOGENE, V31, P4221, DOI 10.1038/onc.2011.578; Seppa K, 2016, BJOG-INT J OBSTET GY, V123, P772, DOI 10.1111/1471-0528.13754; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Wang W, 2018, ONCOL LETT, V15, P6131, DOI 10.3892/ol.2018.8110; Yao GD, 2018, ONCOL LETT, V15, P991, DOI 10.3892/ol.2017.7381; Yeung CLA, 2011, ONCOGENE, V30, P2401, DOI 10.1038/onc.2010.613; Yin MZ, 2012, J SURG ONCOL, V105, P206, DOI 10.1002/jso.22052; Zhang YY, 2017, PATHOL ONCOL RES, V23, P439, DOI 10.1007/s12253-016-0168-0; Zuo XL, 2018, AM J CANCER RES, V8, P662	33	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2019	14	4							e0214822	10.1371/journal.pone.0214822	http://dx.doi.org/10.1371/journal.pone.0214822			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR2UW	30939162	Green Submitted, Green Published, gold			2022-12-26	WOS:000462993900044
J	Zitouni, S; Laurent, C; Dyke, G; Jalil, NE				Zitouni, Slimane; Laurent, Christian; Dyke, Gareth; Jalil, Nour-Eddine			An abelisaurid (Dinosauria: Theropoda) ilium from the Upper Cretaceous (Cenomanian) of the Kem Kem beds, Morocco	PLOS ONE			English	Article							EVOLUTION	Abelisaurid theropods first appear in the fossil record in the early Jurassic and survived at least until the end of the Mesozoic. They were known to have dominated South America, India and Madagascar but were not so abundant in North America or Asia. Much less is known about their presence in Africa, although there has been several recent discoveries of abelisaurid material in Morocco. Here we add a partially preserved ilium to a growing body of evidence that suggests abelisaurs might also have dominated Africa.	[Zitouni, Slimane; Jalil, Nour-Eddine] Univ Cadi Ayyad, Dept Geol, Marrakech, Morocco; [Zitouni, Slimane] MHNM, Marrakech, Morocco; [Laurent, Christian] Natl Oceanog Ctr, Ocean & Earth Sci, Southampton, Hants, England; [Laurent, Christian; Dyke, Gareth] Babes Bolyai Univ, Dept Geol, Cluj Napoca, Romania; [Dyke, Gareth] Univ Debrecen, Dept Evolutionary Zool, Debrecen, Hungary; [Jalil, Nour-Eddine] Sorbonne Univ, Museum Natl Hist Nat, Paris, France	Cadi Ayyad University of Marrakech; NERC National Oceanography Centre; Babes Bolyai University from Cluj; University of Debrecen; Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite	Laurent, C (corresponding author), Natl Oceanog Ctr, Ocean & Earth Sci, Southampton, Hants, England.; Laurent, C (corresponding author), Babes Bolyai Univ, Dept Geol, Cluj Napoca, Romania.	christian_laurent@live.com		JALIL, Nour-Eddine/0000-0002-7617-7625; Laurent, Christian/0000-0002-2946-9705	UK Natural Environmental Research Council (NERC) [NE/L002531/1]; UK Engineering and Physical Sciences Research Council (EPSRC) [EP/M5081471/1]; Executive Agency for Higher Education, Research, Development and Innovation Funding (UEFISCDI) Romania [PN-III-P4-ID-PCE-2016-0572]; Enterprise Ireland; University College Dublin	UK Natural Environmental Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); UK Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Executive Agency for Higher Education, Research, Development and Innovation Funding (UEFISCDI) Romania(Consiliul National al Cercetarii Stiintifice (CNCS)Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii (UEFISCDI)); Enterprise Ireland; University College Dublin	CL was supported by the UK Natural Environmental Research Council (NERC) [grant number NE/L002531/1], https://nerc.ukri.org/and the UK Engineering and Physical Sciences Research Council (EPSRC) [grant number EP/M5081471/1], https://epsrc.ukri.org.CL and GD were supported by the Executive Agency for Higher Education, Research, Development and Innovation Funding (UEFISCDI) Romania [grant number PN-III-P4-ID-PCE-2016-0572], https://www.uefiscdi.ro/.Fieldwork in Morocco in 2007 was supported by Enterprise Ireland and University College Dublin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allain R, 2007, J VERTEBR PALEONTOL, V27, P610, DOI 10.1671/0272-4634(2007)27[610:AADTFT]2.0.CO;2; Allain R, 2012, NATURWISSENSCHAFTEN, V99, P369, DOI 10.1007/s00114-012-0911-7; Arden TMS, 2019, CRETACEOUS RES, V93, P275, DOI 10.1016/j.cretres.2018.06.013; Bakker R. T., 1986, DINOSAUR HERESIES NE, P481; Belvedere M, 2013, PALAEOGEOGR PALAEOCL, V383, P52, DOI 10.1016/j.palaeo.2013.04.026; Buffetaut E, 2005, NATURWISSENSCHAFTEN, V92, P477, DOI 10.1007/s00114-005-0022-9; Canale J, 2009, NATURWISSENSCHAFTEN, V96, P409, DOI 10.1007/s00114-008-0487-4; Carrano MT, 2008, J SYST PALAEONTOL, V6, P183, DOI 10.1017/S1477201907002246; Chiarenza AA, 2016, PEERJ, V4, DOI 10.7717/peerj.1754; Choubert G., 1948, Vol Jubilaire Soc Sci nat Maroc, P307; Dubar G., 1949, NOTES MEMOIRES SERVI, P60; Dutheil Didier B., 1999, P553; Ettachfini EM, 2004, CRETACEOUS RES, V25, P277, DOI 10.1016/j.cretres.2004.01.001; Gauthier J., 1986, Memoirs of the California Academy of Sciences, P1; Hendrickx C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0144695; Ibrahim N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090751; Joly F., 1961, INF GEOGR PERSEE POR, V25, P225, DOI [10.1007/s00114-012-0911-7, DOI 10.1007/S00114-012-0911-7]; Kilian C., 1931, COMPTES RENDUS SOMMA, V9, P109; Longrich NR, 2017, CRETACEOUS RES, V76, P40, DOI 10.1016/j.cretres.2017.03.021; Maganuco S, 2018, PEERJ, V6, DOI 10.7717/peerj.4785; Mahler L, 2005, J VERTEBR PALEONTOL, V25, P236, DOI 10.1671/0272-4634(2005)025[0236:ROADTF]2.0.CO;2; McGowan AJ, 2009, GEOLOGY, V37, P843, DOI 10.1130/G30188A.1; Novas Fernando E., 1993, Journal of Vertebrate Paleontology, V13, P400; Richter U, 2013, PALAEONTOL Z, V87, P291, DOI 10.1007/s12542-012-0153-1; Russell Dale A., 1996, Bulletin du Museum National d'Histoire Naturelle Section C Sciences de la Terre Paleontologie Geologie Mineralogie, V18, P349; Sasso CD, 2005, J VERTEBR PALEONTOL, DOI [10.1671/0272-4634(2005)025[0888:NIOTSO]2.0.CO;2, DOI 10.1671/0272-4634(2005)025[0888:NIOTSO]2.0.CO;2]; Sereno PC, 2008, ACTA PALAEONTOL POL, V53, P15, DOI 10.4202/app.2008.0102; Sereno PC, 2004, P ROY SOC B-BIOL SCI, V271, P1325, DOI 10.1098/rspb.2004.2692; SERENO PC, 1993, NATURE, V361, P64, DOI 10.1038/361064a0; Sereno PC, 1996, SCIENCE, V272, P986, DOI 10.1126/science.272.5264.986; Smith JB, 2006, NATURWISSENSCHAFTEN, V93, P242, DOI 10.1007/s00114-006-0092-3; Tortosa T, 2014, ANN PALEONTOL, V100, P63, DOI 10.1016/j.annpal.2013.10.003; Tykoski RS, 2004, DINOSAURIA, 2ND EDITION, P47; Wellnhofer Peter, 1999, Palaeontologische Zeitschrift, V73, P133; Wenz S., 1981, Annales de Paleontologie Vertebres, V67, P1; Xu X, 2009, NATURE, V459, P940, DOI 10.1038/nature08124	36	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2019	14	4							e0214055	10.1371/journal.pone.0214055	http://dx.doi.org/10.1371/journal.pone.0214055			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR2UW	30939139	Green Accepted, Green Published, gold			2022-12-26	WOS:000462993900012
J	Kaihan, AB; Yasuda, Y; Imaizumi, T; Inagaki, K; Ozeki, T; Hishida, M; Katsuno, T; Tsuboi, N; Maruyama, S				Kaihan, Ahmad Baseer; Yasuda, Yoshinari; Imaizumi, Takahiro; Inagaki, Koji; Ozeki, Takaya; Hishida, Manabu; Katsuno, Takayuki; Tsuboi, Naotake; Maruyama, Shoichi			Clinical impact of endocapillary proliferation with modified cutoff points in IgA nephropathy patients	PLOS ONE			English	Article							OXFORD CLASSIFICATION; HISTOLOGIC CLASSIFICATION; VALIDATION; PROGNOSIS	Predictive values of mesangial proliferation (M), endocapillary proliferation (E), segmental glomerulosclerosis (S), and crescents (C) among 19 validation studies of the Oxford Classification of IgA nephropathy (IgAN) were discrepant, especially in Asian patients. These validation studies indicate that cutoffs of MESC score in the Oxford Classification may not be generalizable. Thus, we aimed to improve the clinical value of MESC scores by modifying the cutoff points. A total of 104 patients with IgAN were diagnosed from 2001 to 2012 vai renal biopsy and retrospectively evaluated at Nagoya University Hospital. The cutoff point for modified (M'E'S'C') was determined using the receiver operating characteristic curve in association with renal outcome in the training cohort. Clinical values of the Oxford MESTC vs M'E'S'C' cutoff points were analyzed using Kaplan-Meier and Cox regression in association with poor renal outcome in the validation and the entire cohort. Of 104 patients, 12.5% reached poor renal outcome over a median of 6.25 [4.16-9.61] years of follow-up. The modified cutoffs were defined as >= 40%, >= 10%, >= 20%, and >= 5% in the glomeruli for M'E'S', and C' respectively. In univariate analysis, E', S', and T were significantly associated with poor renal outcome, whereas Oxford MESC, M', and C' in the training and validation cohort were not associated with poor renal outcome. Using multivariate analysis in the presence of estimated glomerular filtration rate (eGFR), only E' was a significant predictive factor for poor renal outcome. The E' with modified cutoff point of 10% significantly improved predictive value for poor renal outcome in IgAN. Therefore, the clinical value of modified cutoff points for M'E'S'C' scores should be validated with various cohort studies in different regions.	[Kaihan, Ahmad Baseer; Yasuda, Yoshinari; Imaizumi, Takahiro; Inagaki, Koji; Ozeki, Takaya; Hishida, Manabu; Katsuno, Takayuki; Tsuboi, Naotake; Maruyama, Shoichi] Nagoya Univ, Grad Sch Med, Dept Nephrol, Nagoya, Aichi, Japan; [Yasuda, Yoshinari] Nagoya Univ, Grad Sch Med, Dept Nephrol, CKD Initiat, Nagoya, Aichi, Japan	Nagoya University; Nagoya University	Yasuda, Y (corresponding author), Nagoya Univ, Grad Sch Med, Dept Nephrol, Nagoya, Aichi, Japan.; Yasuda, Y (corresponding author), Nagoya Univ, Grad Sch Med, Dept Nephrol, CKD Initiat, Nagoya, Aichi, Japan.	yyasuda@med.nagoya-u.ac.jp	Tsuboi, Naotake/L-5960-2019	Tsuboi, Naotake/0000-0003-0760-845X	JSPS KAKENHI [15H05291]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The current study was supported by JSPS KAKENHI Grant (15H05291 to SM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALAMARTINE E, 1990, CLIN NEPHROL, V34, P45; Alamartine E, 2011, CLIN J AM SOC NEPHRO, V6, P2384, DOI 10.2215/CJN.01170211; [Anonymous], 1999, J AM SOC NEPHROL, V10, P1772; Ballardie FW, 2002, J AM SOC NEPHROL, V13, P142, DOI 10.1681/ASN.V131142; Bartosik LP, 2001, AM J KIDNEY DIS, V38, P728, DOI 10.1053/ajkd.2001.27689; Cattran DC, 2009, KIDNEY INT, V76, P534, DOI 10.1038/ki.2009.243; Donadio JV, 2002, NEW ENGL J MED, V347, P738, DOI 10.1056/NEJMra020109; Kaihan AB, 2017, CLIN EXP NEPHROL, V21, P986, DOI 10.1007/s10157-017-1393-x; Kang SH, 2012, NEPHROL DIAL TRANSPL, V27, P252, DOI 10.1093/ndt/gfr295; Katafuchi R, 2011, CLIN J AM SOC NEPHRO, V6, P2806, DOI 10.2215/CJN.02890311; Kawamura T, 2013, J NEPHROL, V26, P350, DOI 10.5301/jn.5000151; Kfoury H, 2014, HK NEPHROPATHOL, V16, P29, DOI DOI 10.1016/J.HKJN.2014.04.001; Le WB, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-158; Lee H, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-94; LEE HS, 1987, CLIN NEPHROL, V27, P131; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Nasri Hamid, 2012, J Nephropathol, V1, P31, DOI 10.5812/jnp.7; Park KS, 2014, HUM PATHOL, V45, P236, DOI 10.1016/j.humpath.2013.08.019; Peters HPE, IMMUNOSUPPRESSIVE TH, P284; Pozzi C, 1999, LANCET, V353, P883, DOI 10.1016/S0140-6736(98)03563-6; Roberts ISD, 2009, KIDNEY INT, V76, P546, DOI 10.1038/ki.2009.168; Shi SF, 2011, CLIN J AM SOC NEPHRO, V6, P2175, DOI 10.2215/CJN.11521210; Shima Y, 2012, PEDIATR NEPHROL, V27, P783, DOI 10.1007/s00467-011-2061-0; Stefan G, 2016, PATHOL INT, V66, P453, DOI 10.1111/pin.12442; Stefan M, 2011, P ROMANIAN ACAD A, V12, P269; Tatematsu M, 2012, CLIN EXP NEPHROL, V16, P883, DOI 10.1007/s10157-012-0644-0; Trimarchi H, 2017, KIDNEY INT, V91, P1014, DOI 10.1016/j.kint.2017.02.003; Walsh M, 2010, CLIN J AM SOC NEPHRO, V5, P425, DOI 10.2215/CJN.06530909	28	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2019	14	3							e0214414	10.1371/journal.pone.0214414	http://dx.doi.org/10.1371/journal.pone.0214414			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ9FO	30925188	Green Published, Green Submitted, gold			2022-12-26	WOS:000462732300014
J	Kim, YG; Shim, J; Boo, KY; Kim, DY; Oh, SK; Lee, KN; Choi, JI; Kim, YH				Kim, Yun Gi; Shim, Jaemin; Boo, Ki Yung; Kim, Do Young; Oh, Suk-Kyu; Lee, Kwang-No; Choi, Jong-Il; Kim, Young-Hoon			Different influence of cardiac hemodynamics on thromboembolic events in patients with paroxysmal and non-paroxysmal atrial fibrillation	PLOS ONE			English	Article							SPONTANEOUS ECHO CONTRAST; RISK; STROKE; FIBROSIS; PATHOPHYSIOLOGY; ABLATION	Blood stasis in left atrium (LA) or LA appendage (LAA) is thought to be the main cause of thrombus formation and systemic embolism in atrial fibrillation (AF) patients. Paroxysmal and non-paroxysmal AF differ significantly in various aspects. Impact of cardiac hemodynamics on systemic embolism might also differ between the 2 distinct AF entities. This study was performed to evaluate the influence of cardiac hemodynamics on systemic embolism in both paroxysmal and non-paroxysmal AF. Consecutive AF patients undergoing radiofrequency catheter ablation (RFCA) in Korea University Medical Center Anam Hospital between June 1998 and February 2018 were analyzed. Among 2,801 patients who underwent first-time RFCA, a total of 231 patients had either previous ischemic stroke, transient ischemic attack, or arterial embolism. In paroxysmal AF, LA diameter, LA volume (measured with magnetic resonance imaging), left ventricular (LV) ejection fraction, E/e', LAA flow velocity, and prevalence of spontaneous echocontrast (SEC) and dense SEC were significantly different between patients with and without thromboembolic events. However, only E/e' was different between patients with and without thromboembolic events in non-paroxysmal AF. The influence of LA diameter, LA volume, LV EF, LAA flow velocity, and dense SEC on thromboembolic events was significantly moderated by the type of AF. In conclusion, paroxysmal and non-paroxysmal AF might have a different mechanism responsible for thrombus formation and consequent embolic events. Relative contribution of hemodynamic parameters and other factors such as atrial myopathy to thromboembolic events in paroxysmal versus non-paroxysmal AF needs further evaluation.	[Kim, Yun Gi; Shim, Jaemin; Boo, Ki Yung; Kim, Do Young; Oh, Suk-Kyu; Lee, Kwang-No; Choi, Jong-Il; Kim, Young-Hoon] Korea Univ, Med Ctr, Anam Hosp, Arrhythmia Ctr, Seoul, South Korea	Korea University; Korea University Medicine (KU Medicine)	Shim, J; Kim, YH (corresponding author), Korea Univ, Med Ctr, Anam Hosp, Arrhythmia Ctr, Seoul, South Korea.	jaemins@korea.ac.kr; yhkmd@korea.ac.kr	Kim, Young-Hoon/AAO-5792-2021	Choi, Jong-Il/0000-0001-6617-508X; Kim, Young-Hoon/0000-0002-4254-647X				Andrade J, 2014, CIRC RES, V114, P1453, DOI 10.1161/CIRCRESAHA.114.303211; BLACK IW, 1993, J AM COLL CARDIOL, V21, P451, DOI 10.1016/0735-1097(93)90688-W; Black IW, 2000, ECHOCARDIOGR-J CARD, V17, P373, DOI 10.1111/j.1540-8175.2000.tb01153.x; Boldt A, 2004, HEART, V90, P400, DOI 10.1136/hrt.2003.015347; Calenda BW, 2016, NAT REV CARDIOL, V13, P549, DOI 10.1038/nrcardio.2016.106; Conway DSG, 2004, J AM COLL CARDIOL, V43, P2075, DOI 10.1016/j.jacc.2003.11.062; Daccarett M, 2011, J AM COLL CARDIOL, V57, P831, DOI 10.1016/j.jacc.2010.09.049; Fiala M, 2010, PACE, V33, P541, DOI 10.1111/j.1540-8159.2009.02646.x; Friberg L, 2016, EUR HEART J, V37, P2478, DOI 10.1093/eurheartj/ehw087; Gaita F, 2011, NAT REV CARDIOL, V8, P307, DOI 10.1038/nrcardio.2011.63; Glotzer TV, 2009, CIRC-ARRHYTHMIA ELEC, V2, P474, DOI 10.1161/CIRCEP.109.849638; Hatzinikolaou-Kotsakou E, 2003, J THROMB THROMBOLYS, V16, P155, DOI 10.1023/B:THRO.0000024053.45693.fc; Healey JS, 2012, NEW ENGL J MED, V366, P120, DOI 10.1056/NEJMoa1105575; Karasoy D, 2015, EUR HEART J, V36, P307, DOI 10.1093/eurheartj/ehu421; Khan AA, 2019, CARDIOVASC RES, V115, P31, DOI 10.1093/cvr/cvy272; Kim YG, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26212-y; Kostin S, 2002, CARDIOVASC RES, V54, P361, DOI 10.1016/S0008-6363(02)00273-0; Kottkamp H, 2013, EUR HEART J, V34, P2731, DOI 10.1093/eurheartj/eht194; Kottkamp H, 2012, J CARDIOVASC ELECTR, V23, P797, DOI 10.1111/j.1540-8167.2012.02341.x; Lau DH, 2017, HEART LUNG CIRC, V26, P887, DOI 10.1016/j.hlc.2017.05.119; Lau DH, 2016, EUR HEART J, V37, P1573, DOI 10.1093/eurheartj/ehv375; Lip GYH, 2012, LANCET, V379, P648, DOI 10.1016/S0140-6736(11)61514-6; PETERSEN P, 1990, STROKE, V21, P4, DOI 10.1161/01.STR.21.1.4; Vazquez-Garza E, 2017, J THROMB THROMBOLYS, V44, P377, DOI 10.1007/s11239-017-1528-7; Zabalgoitia M, 1998, J AM COLL CARDIOL, V31, P1622, DOI 10.1016/S0735-1097(98)00146-6	25	4	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2019	14	3							e0214743	10.1371/journal.pone.0214743	http://dx.doi.org/10.1371/journal.pone.0214743			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ9FO	30925176	Green Published, gold, Green Submitted			2022-12-26	WOS:000462732300029
J	Seal, S; Polley, S; Sau, S				Seal, Soham; Polley, Soumitra; Sau, Subrata			A staphylococcal cyclophilin carries a single domain and unfolds via the formation of an intermediate that preserves cyclosporin A binding activity	PLOS ONE			English	Article							X-RAY; LIGAND-BINDING; DENATURATION; STABILITY; PROTEINS; COMPLEX; STABILIZATION; ISOMERASES; AUREUS; MODEL	Cyclophilin (Cyp), a peptidyl-prolyl cis-trans isomerase (PPIase), acts as a virulence factor in many bacteria including Staphylococcus aureus. The enzymatic activity of Cyp is inhibited by cyclosporin A (CsA), an immunosuppressive drug. To precisely determine the unfolding mechanism and the domain structure of Cyp, we have investigated a chimeric S. aureus Cyp (rCyp) using various probes. Our limited proteolysis and the consequent analysis of the proteolytic fragments indicate that rCyp is composed of one domain with a short flexible tail at the C-terminal end. We also show that the urea-induced unfolding of both rCyp and rCyp-CsA is completely reversible and proceeds via the synthesis of at least one stable intermediate. Both the secondary structure and the tertiary structure of each intermediate appears very similar to those of the corresponding native protein. Conversely, the hydrophobic surface areas of the intermediates are comparatively less. Further analyses reveal no loss of CsA binding activity in rCyp intermediate. The thermodynamic stability of rCyp was also significantly increased in the presence of CsA, recommending that this protein could be employed to screen new CsA derivatives in the future.	[Seal, Soham; Polley, Soumitra; Sau, Subrata] Bose Inst, Dept Biochem, Kolkata, W Bengal, India	Department of Science & Technology (India); Bose Institute	Sau, S (corresponding author), Bose Inst, Dept Biochem, Kolkata, W Bengal, India.	subratasau@gmail.com		Polley, Soumitra/0000-0002-6337-7935				Akhtar MS, 2002, BIOCHEMISTRY-US, V41, P3819, DOI 10.1021/bi0116700; Anderson KL, 2006, J BACTERIOL, V188, P6739, DOI 10.1128/JB.00609-06; Assis LM, 2017, DRUG RESIST UPDATE, V31, P1, DOI 10.1016/j.drup.2017.03.001; Aucamp JP, 2008, BIOTECHNOL BIOENG, V99, P1303, DOI 10.1002/bit.21705; Aucamp JP, 2005, BIOTECHNOL BIOENG, V89, P599, DOI 10.1002/bit.20397; AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; Barik S, 2018, COMPUT STRUCT BIOTEC, V16, P231, DOI 10.1016/j.csbj.2018.07.001; Bychkova VE, 2018, BIOCHEMISTRY-MOSCOW+, V83, pS33, DOI 10.1134/S0006297918140043; Cimmperman P, 2008, BIOPHYS J, V95, P3222, DOI 10.1529/biophysj.108.134973; CONNELLY PR, 1992, P NATL ACAD SCI USA, V89, P4781, DOI 10.1073/pnas.89.11.4781; Davis TL, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000439; Dawar FU, 2017, J LEUKOCYTE BIOL, V102, P989, DOI 10.1189/jlb.3RU0317-090RR; de Wilde AH, 2018, VIROLOGY, V517, P148, DOI 10.1016/j.virol.2017.11.022; Dimou M, 2017, WORLD J MICROB BIOT, V33, DOI 10.1007/s11274-017-2330-6; Dunyak BM, 2016, J MED CHEM, V59, P9622, DOI 10.1021/acs.jmedchem.6b00411; Fontana A, 2004, ACTA BIOCHIM POL, V51, P299; Foster TJ, 2017, FEMS MICROBIOL REV, V41, P430, DOI 10.1093/femsre/fux007; Gaudet M, 2010, PROTEIN SCI, V19, P1544, DOI 10.1002/pro.433; GOLDENBERG DP, 1984, ANAL BIOCHEM, V138, P1, DOI 10.1016/0003-2697(84)90761-9; Gothel SF, 1999, CELL MOL LIFE SCI, V55, P423, DOI 10.1007/s000180050299; Harikishore A, 2016, CURR MOL PHARMACOL, V9, P37, DOI 10.2174/1874467208666150519113427; Hiramatsu K, 2014, J INFECT CHEMOTHER, V20, P593, DOI 10.1016/j.jiac.2014.08.001; Hopkins S, 2015, BBA-GEN SUBJECTS, V1850, P2103, DOI 10.1016/j.bbagen.2014.11.011; Jaenicke R, 2000, J BIOTECHNOL, V79, P193, DOI 10.1016/S0168-1656(00)00236-4; Jana B, 2012, BIOCHEMISTRY-US, V51, P1223, DOI 10.1021/bi2015037; Jha SK, 2009, P NATL ACAD SCI USA, V106, P12289, DOI 10.1073/pnas.0905744106; Kahlert V, 2018, ORG BIOMOL CHEM, V16, P4338, DOI 10.1039/c8ob00980e; KALLEN J, 1991, NATURE, V353, P276, DOI 10.1038/353276a0; KE HM, 1993, P NATL ACAD SCI USA, V90, P11850, DOI 10.1073/pnas.90.24.11850; Keogh RA, 2018, INFECT IMMUN, V86, DOI 10.1128/IAI.00379-18; Kuznetsova IM, 2004, J PROTEOME RES, V3, P485, DOI 10.1021/pr034094y; Lavin PTM, 2016, CURR MOL PHARMACOL, V9, P148, DOI 10.2174/1874467208666150519115443; Liu CP, 2005, BIOCHIMIE, V87, P1023, DOI 10.1016/j.biochi.2005.03.017; Mahapa A, 2018, PROTEIN J, V37, P103, DOI 10.1007/s10930-018-9762-1; Mahapa A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122168; Mahendrarajah K, 2011, ANAL BIOCHEM, V411, P155, DOI 10.1016/j.ab.2010.12.001; Main ERG, 1998, BIOCHEMISTRY-US, V37, P6145, DOI 10.1021/bi973111s; Mandal S, 2018, INT J BIOL MACROMOL, V113, P1221, DOI 10.1016/j.ijbiomac.2018.03.045; Matsuda S, 2000, IMMUNOPHARMACOLOGY, V47, P119, DOI 10.1016/S0162-3109(00)00192-2; MCCAFFREY PG, 1993, SCIENCE, V262, P750, DOI 10.1126/science.8235597; MIKOL V, 1994, P NATL ACAD SCI USA, V91, P5183, DOI 10.1073/pnas.91.11.5183; Mishra P, 2017, J PHYS CHEM B, V121, P9336, DOI 10.1021/acs.jpcb.7b07032; Mitra D, 2006, FEBS LETT, V580, P6846, DOI 10.1016/j.febslet.2006.11.042; Naesens M, 2009, CLIN J AM SOC NEPHRO, V4, P481, DOI 10.2215/CJN.04800908; Naoumov NV, 2014, J HEPATOL, V61, P1166, DOI 10.1016/j.jhep.2014.07.008; Nigro P, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.410; Pace CN, 2000, PROTEINS, P1; Pace CN, 1996, FASEB J, V10, P75, DOI 10.1096/fasebj.10.1.8566551; Pal A, 2008, J BIOMOL STRUCT DYN, V26, P339, DOI 10.1080/07391102.2008.10507249; Peterson MR, 2000, J MOL BIOL, V298, P123, DOI 10.1006/jmbi.2000.3633; Polley S, 2017, BIOINFORMATION, V13, P78, DOI 10.6026/97320630013078; Polley Soumitra, 2015, Biochim Open, V1, P28, DOI 10.1016/j.biopen.2015.07.001; Polley S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102891; Quarato G, 2012, HEPATOLOGY, V55, P1333, DOI 10.1002/hep.25514; Rashid F, 2005, PROTEIN J, V24, P283, DOI 10.1007/s10930-005-6749-5; Roy S, 2014, INT J BIOL MACROMOL, V69, P353, DOI 10.1016/j.ijbiomac.2014.05.063; Sambrook J., 2001, MOL CLONING LAB MANU; Sancho J, 2013, ARCH BIOCHEM BIOPHYS, V531, P4, DOI 10.1016/j.abb.2012.10.014; Schiene-Fischer C, 2015, ELS CITABLE REV LIFE; Schon A, 2013, ANAL BIOCHEM, V443, P52, DOI 10.1016/j.ab.2013.08.015; Senisterra G, 2012, ASSAY DRUG DEV TECHN, V10, P128, DOI 10.1089/adt.2011.0390; Shukla VK, 2017, BIOPHYS J, V112, P605, DOI 10.1016/j.bpj.2016.12.020; Singh AR, 2010, EUR BIOPHYS J BIOPHY, V39, P289, DOI 10.1007/s00249-009-0539-5; Sinha D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195416; SPITZFADEN C, 1992, FEBS LETT, V300, P291, DOI 10.1016/0014-5793(92)80866-F; Unal CM, 2014, MICROBIOL MOL BIOL R, V78, P544, DOI 10.1128/MMBR.00015-14; Venugopal V, 2009, ACTA CRYSTALLOGR D, V65, P1187, DOI 10.1107/S0907444909034234; Waldron TT, 2003, BIOCHEMISTRY-US, V42, P5058, DOI 10.1021/bi034212v; Wang P, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-7-226; Wiemels RE, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00453-16; Zhang R, 2009, NUCLEIC ACIDS RES, V37, pD455, DOI 10.1093/nar/gkn858; Zhao XM, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00126	72	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2019	14	3							e0210771	10.1371/journal.pone.0210771	http://dx.doi.org/10.1371/journal.pone.0210771			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ9FO	30925148	Green Submitted, Green Published, gold			2022-12-26	WOS:000462732300001
J	Carstensen-Kirberg, M; Rohrig, K; Niersmann, C; Ouwens, M; Belgardt, BF; Roden, M; Herder, C				Carstensen-Kirberg, Maren; Roehrig, Karin; Niersmann, Corinna; Ouwens, Margriet; Belgardt, Bengt F.; Roden, Michael; Herder, Christian			Sfrp5 increases glucose-stimulated insulin secretion in the rat pancreatic beta cell line INS-1E	PLOS ONE			English	Article							INHIBITION; PROLIFERATION; RESISTANCE	Previous studies reported that secreted frizzled-related protein-5 (Sfrp5) decreases beta cell proliferation and increases fasting insulin levels, but studies on direct effects of Sfrp5 on insulin secretion and its underlying mechanisms are missing. This study examined effects of Sfrp5 on (i) beta cell viability and proliferation, (ii) basal and glucose-stimulated insulin secretion and (iii) canonical and non-canonical Wnt signalling pathways. We incubated rat INS-1E cells with 0.1, 1 or 5 mu g/ml recombinant Sfrp5 for 24h. We measured basal and glucose-stimulated insulin secretion at glucose concentrations of 2.5 and 20 mmol/l. Phosphorylated and total protein content as well as mRNA levels of markers of cell proliferation, canonical and non-canonical Wnt signalling pathways were examined using Western blotting and real-time PCR. Differences between treatments were analysed by repeated measurement one-way ANOVA or Friedman's test followed by correction for multiple testing using the Benjamini-Hochberg procedure. At 5 mu g/ml, Sfrp5 reduced mRNA levels of cyclin -B1 by 25% (p<0.05). At 1 and 5 mu g/ml, Sfrp5 increased glucose-stimulated insulin secretion by 24% and by 34% (both p<0.05), respectively, but had no impact on basal insulin secretion. Sfrp5 reduced the phosphorylation of the splicing forms p46 and p54 of JNK by 39% (p<0.01) and 49% (p<0.05), respectively. In conclusion, Sfrp5 reduced markers of cell proliferation, but increased in parallel dose-dependently glucose-stimulated insulin secretion in INS-1E cells. This effect is likely mediated by reduced JNK activity, an important component of the non-canonical Wnt signalling pathway.	[Carstensen-Kirberg, Maren; Roehrig, Karin; Niersmann, Corinna; Roden, Michael; Herder, Christian] Heinrich Heine Univ Dusseldorf, Leibniz Ctr Diabet Res, Inst Clin Diabetol, German Diabet Ctr, Dusseldorf, Germany; [Carstensen-Kirberg, Maren; Roehrig, Karin; Niersmann, Corinna; Ouwens, Margriet; Belgardt, Bengt F.; Roden, Michael; Herder, Christian] German Ctr Diabet Res DZD, Partner Dusseldorf, Dusseldorf, Germany; [Ouwens, Margriet] Heinrich Heine Univ Dusseldorf, Inst Clin Biochem & Pathobiochem, German Diabet Ctr, Leibniz Ctr Diabet Res, Dusseldorf, Germany; [Ouwens, Margriet] Ghent Univ Hosp, Dept Endocrinol, Ghent, Belgium; [Belgardt, Bengt F.] Heinrich Heine Univ Dusseldorf, Inst Beta Cell Biol, German Diabet Ctr, Leibniz Ctr Diabet Res, Dusseldorf, Germany; [Roden, Michael] Heinrich Heine Univ, Fac Med, Div Endocrinol & Diabetol, Dusseldorf, Germany; [Herder, Christian] Heinrich Heine Univ, Fac Med, Dusseldorf, Germany	Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; Ghent University; Ghent University Hospital; Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf	Carstensen-Kirberg, M (corresponding author), Heinrich Heine Univ Dusseldorf, Leibniz Ctr Diabet Res, Inst Clin Diabetol, German Diabet Ctr, Dusseldorf, Germany.; Carstensen-Kirberg, M (corresponding author), German Ctr Diabet Res DZD, Partner Dusseldorf, Dusseldorf, Germany.	maren.carstensen@ddz.de	Roden, Michael/AAD-3843-2019; Ouwens, Margriet/H-2442-2013	Ouwens, Margriet/0000-0001-6709-2702; Belgardt, Bengt-Frederik/0000-0003-4537-9002	German Diabetes Association (Deutsche Diabetes-Gesellschaft, DDG); Ministry of Culture and Science of the State of North Rhine-Westphalia; German Federal Ministry of Health (BMG); German Federal Ministry of Education and Research (BMBF)	German Diabetes Association (Deutsche Diabetes-Gesellschaft, DDG); Ministry of Culture and Science of the State of North Rhine-Westphalia; German Federal Ministry of Health (BMG); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This study was supported by research grants from the German Diabetes Association (Deutsche Diabetes-Gesellschaft, DDG) to MCK. This work was also supported by the Ministry of Culture and Science of the State of North Rhine-Westphalia and the German Federal Ministry of Health (BMG). This study was supported in part by a grant from the German Federal Ministry of Education and Research (BMBF) to the German Center for Diabetes Research (DZD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beekman C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195850; Bovolenta P, 2008, J CELL SCI, V121, P737, DOI 10.1242/jcs.026096; Canivell S, 2015, DIABETES-METAB RES, V31, P212, DOI 10.1002/dmrr.2599; Carstensen M, 2013, EUR J CLIN INVEST, V43, P350, DOI 10.1111/eci.12052; Catalan V, 2014, J CLIN ENDOCR METAB, V99, pE1407, DOI 10.1210/jc.2014-1191; Cerf Marlon E, 2013, Front Endocrinol (Lausanne), V4, P37, DOI 10.3389/fendo.2013.00037; Corlateanu Alexandru, 2017, COPD RES PRACTICE, V3, DOI [DOI 10.1186/S12933-017-0591-X, 10.1186/s40749-017-0025-x, DOI 10.1186/S40749-017-0025-X]; Guan BB, 2016, J ENDOCRINOL, V229, P73, DOI 10.1530/JOE-15-0535; Kim HE, 2008, J ENDOCRINOL, V198, P549, DOI 10.1677/JOE-08-0131; Li Y, 2008, GENE DEV, V22, P3050, DOI 10.1101/gad.1687308; Nakamura K, 2016, J BIOL CHEM, V291, P2566, DOI 10.1074/jbc.M115.693937; Nowotny B, 2013, DIABETES, V62, P2240, DOI 10.2337/db12-1179; Ouchi N, 2010, SCIENCE, V329, P454, DOI 10.1126/science.1188280; Ploton M, 2018, J HEPATOL, V69, P1099, DOI 10.1016/j.jhep.2018.06.022; Rebuffat SA, 2013, DIABETOLOGIA, V56, P2446, DOI 10.1007/s00125-013-3030-x; Rulifson IC, 2014, AM J PHYSIOL-ENDOC M, V307, pE1144, DOI 10.1152/ajpendo.00283.2014; Schulte DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032437; Waasdorp M, 2019, J CELL MOL MED, V23, P1268, DOI 10.1111/jcmm.14028; Yamanaka H, 2002, EMBO REP, V3, P69, DOI 10.1093/embo-reports/kvf008	19	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0213650	10.1371/journal.pone.0213650	http://dx.doi.org/10.1371/journal.pone.0213650			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921355	Green Published, Green Submitted, gold			2022-12-26	WOS:000462594000020
J	Valente, D; Palama, A; Malsert, J; Bolens, G; Gentaz, E				Valente, Dannyelle; Palama, Amaya; Malsert, Jennifer; Bolens, Guillemette; Gentaz, Edouard			Adults' visual recognition of actions simulations by finger gestures (ASFGs) produced by sighted and blind individuals	PLOS ONE			English	Article							PICTURE; CHILDREN	The present study examines the visual recognition of action simulations by finger gestures (ASFGs) produced by sighted and blind individuals. In ASFGs, fingers simulate legs to represent actions such as jumping, spinning, climbing, etc. The question is to determine whether the common motor experience of one's own body is sufficient to produce adequate ASFGs or whether the possibility to see gestures from others are also necessary to do it. Three experiments were carried out to address this question. Experiment 1 examined in 74 sighted adults the recognition of 18 types of ASFGs produced by 20 blindfolded sighted adults. Results showed that rates of correct recognition were globally very high, but varied with the type of ASFG. Experiment 2 studied in 91 other sighted adults the recognition of ASFGs produced by 10 early blind and 7 late blind adults. Results also showed a high level of recognition with a similar order of recognizability by type of ASFG. However, ASFGs produced by early blind individuals were more poorly recognized than those produced by late blind individuals. In order to match data of recognition obtained with the form that gestures are produced by individuals, two independant judges evaluated prototypical and atypical attributes of ASFG produced by blindfolded sighted, early blind and late blind individuals in Experiment 3. Results revealed the occurrence of more atypical attributes in ASFG produced by blind individuals: their ASFGs transpose more body movements from a characterviewpoint in less agreement with visual rules. The practical interest of the study relates to the relevance of including ASFGs as a new exploratory procedure in tactile devices which are more apt to convey action concepts to blind users/readers.	[Valente, Dannyelle; Palama, Amaya; Malsert, Jennifer; Gentaz, Edouard] Univ Geneva, Fac Psychol & Educ Sci, Geneva, Switzerland; [Valente, Dannyelle] Univ Lumiere Lyon, Dept Dev Psychol, Bron, France; [Bolens, Guillemette] Univ Geneva, Fac Humanities, Geneva, Switzerland	University of Geneva; Universite Lyon 2; University of Geneva	Valente, D (corresponding author), Univ Geneva, Fac Psychol & Educ Sci, Geneva, Switzerland.; Valente, D (corresponding author), Univ Lumiere Lyon, Dept Dev Psychol, Bron, France.	dannyelle.valente@univ-lyon2.fr		Palama, Amaya/0000-0002-9251-0520; Gentaz, Edouard/0000-0003-0574-5557; Valente, Dannyelle/0000-0003-2686-4379	Swiss National Science Foundation - SNF [100019_162688]	Swiss National Science Foundation - SNF(Swiss National Science Foundation (SNSF))	This study was supported by Swiss National Science Foundation - SNF (CH), http://www.snf.ch, research grant 100019_162688, awarded by Pr. Edouard Gentaz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bara F, J VISUAL IMPAIRMENT; Barsalou LW, 2008, ANNU REV PSYCHOL, V59, P617, DOI 10.1146/annurev.psych.59.103006.093639; Barsalou LW, 2010, TOP COGN SCI, V2, P716, DOI 10.1111/j.1756-8765.2010.01115.x; BLASS T, 1974, PERCEPT MOTOR SKILL, V39, P279, DOI 10.2466/pms.1974.39.1.279; Bolens G., 2012, STYLE GESTURES EMBOD; Cuxac, 2000, LANGUE SIGNES FRANCA; Frame MJ, 2000, J VISUAL IMPAIR BLIN, V94, P155, DOI 10.1177/0145482X0009400304; Hainselin M., 2013, REV NEUROPSYCHOL, V5, P129, DOI DOI 10.3917/RNE.052.0129; HELLER MA, 1989, PERCEPTION, V18, P379, DOI 10.1068/p180379; Heller MA, 2014, PSYCHOL TOUCH BLINDN; Hostetter AB, 2008, PSYCHON B REV, V15, P495, DOI 10.3758/PBR.15.3.495; Howell D.C., 2010, STAT METHODS PSYCHOL, V7; Iverson JM, 1997, DEV PSYCHOL, V33, P453, DOI 10.1037/0012-1649.33.3.453; Iverson JM, 2001, DEVELOPMENTAL SCI, V4, P416, DOI 10.1111/1467-7687.00183; Iverson JM, 2000, J NONVERBAL BEHAV, V24, P105, DOI 10.1023/A:1006605912965; Kendon A., 2004, GESTURE VISIBLE ACTI, DOI DOI 10.1017/CBO9780511807572; KLATZKY RL, 1993, PERCEPT PSYCHOPHYS, V54, P170, DOI 10.3758/BF03211752; LEDERMAN SJ, 1990, PERCEPT PSYCHOPHYS, V47, P54, DOI 10.3758/BF03208164; Madan CR, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00507; McNeill D, 2016, WHY WE GESTURE: THE SURPRISING ROLE OF HAND MOVEMENTS IN COMMUNICATION, P1, DOI 10.1017/CBO9781316480526; McNeill D, 1992, MIND WHAT GESTURES R; ROSCH E, 1975, COGNITIVE PSYCHOL, V7, P573, DOI 10.1016/0010-0285(75)90024-9; Sharkey WF, 2000, J VISUAL IMPAIR BLIN, V94, P549, DOI 10.1177/0145482X0009400902; Theurel A, 2013, J EXP PSYCHOL-APPL, V19, P233, DOI 10.1037/a0034255; Theurel A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040251; Thompson LJ, 2006, EUR PSYCHOL, V11, P110, DOI 10.1027/1016-9040.11.2.110; Valente D, J EXPT PSYCHOL UNPUB; Valente D, RECONNAISSANCE ILLUS; Wilson M, 2002, PSYCHON B REV, V9, P625, DOI 10.3758/BF03196322	29	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214371	10.1371/journal.pone.0214371	http://dx.doi.org/10.1371/journal.pone.0214371			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HQ7IR	30921397	gold, Green Published, Green Submitted			2022-12-26	WOS:000462594000061
J	Mouhid, L; de Cedron, MG; Garcia-Carrascosa, E; Reglero, G; Fornari, T; de Molina, AR				Mouhid, Lamia; Gomez de Cedron, Marta; Garcia-Carrascosa, Elena; Reglero, Guillermo; Fornari, Tiziana; Ramirez de Molina, Ana			Yarrow supercritical extract exerts antitumoral properties by targeting lipid metabolism in pancreatic cancer	PLOS ONE			English	Article							FATTY-ACID SYNTHASE; ELEMENT-BINDING PROTEIN-1; ENDOMETRIAL TUMOR-GROWTH; GENE-EXPRESSION; POOR-PROGNOSIS; CELL-PROLIFERATION; SUPPRESSOR CDC73; NATURAL-PRODUCTS; HLA-G; TRANSCRIPTION	Metabolic reprogramming is considered a hallmark of cancer. Currently, the altered lipid metabolism in cancer is a topic of interest due to the prominent role of lipids regulating the progression of various types of tumors. Lipids and lipid-derived molecules have been shown to activate growth regulatory pathways and to promote malignancy in pancreatic cancer. In a previous work, we have described the antitumoral properties of Yarrow (Achillea Millefolium) CO2 supercritical extract (Yarrow SFE) in pancreatic cancer. Herein, we aim to investigate the underlaying molecular mechanisms by which Yarrow SFE induces cytotoxicity in pancreatic cancer cells. Yarrow SFE downregulates SREBF1 and downstream molecular targets of this transcription factor, such as fatty acid synthase (FASN) and stearoyl-CoA desaturase (SCD). Importantly, we demonstrate the in vivo effect of Yarrow SFE diminishing the tumor growth in a xenograft mouse model of pancreatic cancer. Our data suggest that Yarrow SFE can be proposed as a complementary adjuvant or nutritional supplement in pancreatic cancer therapy.	[Mouhid, Lamia; Gomez de Cedron, Marta; Garcia-Carrascosa, Elena; Reglero, Guillermo; Ramirez de Molina, Ana] CEI UAM CSIC, IMDEA Food Inst, Mol Oncol & Nutr Genom Canc, Madrid, Spain; [Reglero, Guillermo; Fornari, Tiziana] CEI UAM CSIC, Inst Food Sci Res CIAL, Prod & Characterizat Novel Foods Dept, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UAM - Instituto de Investigacion en Ciencias de la Alimentacion (CIAL)	de Cedron, MG; de Molina, AR (corresponding author), CEI UAM CSIC, IMDEA Food Inst, Mol Oncol & Nutr Genom Canc, Madrid, Spain.	marta.gomezdecedro@imdea.org; ana.ramirez@imdea.org	de Cedrón, Marta Gómez/M-7764-2014; de Molina, Ana Ramirez/AAA-3848-2019; Reglero, Guillermo/K-6658-2014	de Cedrón, Marta Gómez/0000-0002-0894-970X; Reglero, Guillermo/0000-0002-7730-3486	Ministerio de Economia y Competitividad del Gobierno de Espana (MINECO, Plan Nacional I+D+i ) [AGL2013-48943-C2, AGL2016-76736-C3]; Gobierno regional de la Comunidad de Madrid (ALIBIRD-CM) [P2013/ABI-2728]; EU Structural Funds	Ministerio de Economia y Competitividad del Gobierno de Espana (MINECO, Plan Nacional I+D+i ); Gobierno regional de la Comunidad de Madrid (ALIBIRD-CM); EU Structural Funds	This work was supported by Ministerio de Economia y Competitividad del Gobierno de Espana (MINECO, Plan Nacional I+D+i AGL2013-48943-C2 and AGL2016-76736-C3), Gobierno regional de la Comunidad de Madrid (P2013/ABI-2728, ALIBIRD-CM) and EU Structural Funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre-Ghiso JA, 2007, NAT REV CANCER, V7, P834, DOI 10.1038/nrc2256; Albrecht I, 2013, ANGIOGENESIS, V16, P795, DOI 10.1007/s10456-013-9356-7; Asanuma K, 2000, JPN J CANCER RES, V91, P1204, DOI 10.1111/j.1349-7006.2000.tb00906.x; Bagchi A, 2007, CELL, V128, P459, DOI 10.1016/j.cell.2006.11.052; Beloribi-Djefaflia S, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2015.49; Blum R, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.38; Bowles TL, 2008, INT J CANCER, V123, P1950, DOI 10.1002/ijc.23723; Cao M, 2011, TISSUE ANTIGENS, V78, P120, DOI 10.1111/j.1399-0039.2011.01716.x; Choi KY, 2015, BIOCHEM BIOPH RES CO, V463, P673, DOI 10.1016/j.bbrc.2015.05.123; Choi WI, 2008, J BIOL CHEM, V283, P29341, DOI 10.1074/jbc.M802477200; Cragg GM, 2005, J ETHNOPHARMACOL, V100, P72, DOI 10.1016/j.jep.2005.05.011; Cruz PMR, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00119; Currie E, 2013, CELL METAB, V18, P153, DOI 10.1016/j.cmet.2013.05.017; Dang CV, 2010, CANCER RES, V70, P859, DOI 10.1158/0008-5472.CAN-09-3556; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Deisenroth C, 2011, J BIOL CHEM, V286, P28343, DOI 10.1074/jbc.M111.254227; Demoulin JB, 2004, J BIOL CHEM, V279, P35392, DOI 10.1074/jbc.M405924200; Dimberg J, 2011, ONCOL LETT, V2, P413, DOI 10.3892/ol.2011.280; Djidja MC, 2009, J PROTEOME RES, V8, P4876, DOI 10.1021/pr900522m; Doyon Y, 2006, MOL CELL, V21, P51, DOI 10.1016/j.molcel.2005.12.007; Eberhard Y, 2011, ONCOTARGET, V2, P186; Eberle D, 2004, BIOCHIMIE, V86, P839, DOI 10.1016/j.biochi.2004.09.018; Falasca M, 2016, BBA-REV CANCER, V1865, P123, DOI 10.1016/j.bbcan.2016.01.001; Fan TWM, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-41; Fleischmann M, 2000, BIOCHEM J, V349, P13, DOI 10.1042/bj3490013; Garcia-Risco MR, 2017, PLANT FOOD HUM NUTR, V72, P96, DOI 10.1007/s11130-016-0596-8; Gonzalez-Vallinas M, 2013, NUTR REV, V71, P585, DOI 10.1111/nure.12051; Gordon-Dseagu VL, 2017, EPIDEMIOL END RESULT; Griffiths B, 2013, CANCER METAB, V1, DOI 10.1186/2049-3002-1-3; Gunduz M, 2008, CANCER SCI, V99, P531, DOI 10.1111/j.1349-7006.2007.00708.x; Guo DL, 2014, CURR PHARM DESIGN, V20, P2619, DOI 10.2174/13816128113199990486; Hall WA, 2014, ONCOGENE, V33, P5450, DOI 10.1038/onc.2013.488; Hamada S, 2014, CELL SIGNAL, V26, P179, DOI 10.1016/j.cellsig.2013.11.003; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hansel Donna E, 2005, Int J Gastrointest Cancer, V35, P15, DOI 10.1385/IJGC:35:1:015; Harada T, 2008, ONCOGENE, V27, P1951, DOI 10.1038/sj.onc.1210832; Hensley CT, 2013, J CLIN INVEST, V123, P3678, DOI 10.1172/JCI69600; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Huang WC, 2012, MOL CANCER RES, V10, P133, DOI 10.1158/1541-7786.MCR-11-0206; Igal RA, 2010, CARCINOGENESIS, V31, P1509, DOI 10.1093/carcin/bgq131; Kammerer S, 2004, CANCER RES, V64, P8906, DOI 10.1158/0008-5472.CAN-04-1788; Kashimoto K, 2012, CANCER SCI, V103, P2021, DOI 10.1111/j.1349-7006.2012.02407.x; Kim RH, 2009, CANCER RES, V69, P700, DOI 10.1158/0008-5472.CAN-08-3157; Kirschner RD, 2010, CELL CYCLE, V9, P2177, DOI 10.4161/cc.9.11.11844; Kloth JN, 2008, J PATHOL, V215, P222, DOI 10.1002/path.2347; Kolla V, 2014, CANCER RES, V74, P652, DOI 10.1158/0008-5472.CAN-13-3056; Kotecha R, 2016, ONCOTARGET, V7, P52517, DOI 10.18632/oncotarget.9593; Kridel SJ, 2007, EXPERT OPIN INV DRUG, V16, P1817, DOI 10.1517/13543784.16.11.1817; Kuranami S, 2015, ANTICANCER RES, V35, P2410; Lee AS, 2007, CANCER RES, V67, P3496, DOI 10.1158/0008-5472.CAN-07-0325; Li C, 2014, INT J MOL SCI, V15, P7124, DOI 10.3390/ijms15057124; Li J, 2016, ONCOGENE; Li JN, 2001, CANCER RES, V61, P1493; Li WH, 2012, CELL CYCLE, V11, P2348, DOI 10.4161/cc.20811; Lin L, 2014, ONCOL REP, V32, P2831, DOI 10.3892/or.2014.3521; Liu P, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-18; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long XH, 2013, EXP THER MED, V5, P1048, DOI 10.3892/etm.2013.959; Lopez-Mateo I, 2012, CELL CYCLE, V11, P3887, DOI 10.4161/cc.22133; Ma LN, 2014, CANCER RES, V74, P1452, DOI 10.1158/0008-5472.CAN-13-2171; Macasek J, 2012, NUTR CANCER, V64, P946, DOI 10.1080/01635581.2012.716138; Maruya SI, 2005, ORAL ONCOL, V41, P580, DOI 10.1016/j.oraloncology.2005.01.002; MEDES G, 1953, CANCER RES, V13, P27; Michaud DS, 2017, EPIDEMIOLOGY PANCREA, P471; Mouhid L, 2017, J ONCOL, V2017, DOI [10.1016/J.CELL.2011.02.013, DOI 10.1016/J.CELL.2011.02.013]; Mouhid L, 2018, BMC COMPLEM ALTERN M, V18, DOI 10.1186/s12906-018-2322-6; Nazemalhosseini-Mojarad Ehsan, 2014, Gastroenterol Hepatol Bed Bench, V7, P79; Nie LY, 2013, ONCOL REP, V30, P1346, DOI 10.3892/or.2013.2575; Niu Zhe-Yu, 2015, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V37, P259, DOI 10.3881/j.issn.1000-503X.2015.03.002; Oh SY, 2003, J BIOL CHEM, V278, P28410, DOI 10.1074/jbc.M300553200; Ong CAJ, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju050; Ouyang L, 2014, CELL PROLIFERAT, V47, P506, DOI 10.1111/cpr.12143; Peck B, 2016, FEBS J, V283, P2767, DOI 10.1111/febs.13681; Phillips MM, 2013, CANCER RES TREAT, V45, P251, DOI 10.4143/crt.2013.45.4.251; Qiu FM, 2015, CANCER LETT, V364, P1, DOI 10.1016/j.canlet.2015.04.020; Rather MI, 2013, J BIOL CHEM, V288, P608, DOI 10.1074/jbc.M112.425736; Rozenblatt-Rosen O, 2009, P NATL ACAD SCI USA, V106, P755, DOI 10.1073/pnas.0812023106; Siqingaowa, 2017, BIOCHEM BIOPH RES CO, V488, P136, DOI 10.1016/j.bbrc.2017.05.023; Song L, 2016, TUMOR BIOL, V37, P2891, DOI 10.1007/s13277-015-4038-2; Subramani D, 2010, MOL CANCER, V9, P1, DOI [10.1186/1476-4598-9-1, DOI 10.1186/1476-4598-9-1]; Sullivan LB, 2016, NAT REV CANCER, V16, P680, DOI 10.1038/nrc.2016.85; Sun Y., 2015, INT J DISTRIB SENS N, V2015, P1; Surh YJ, 2003, NAT REV CANCER, V3, P768, DOI 10.1038/nrc1189; Swierczynski J, 2014, WORLD J GASTROENTERO, V20, P2279, DOI 10.3748/wjg.v20.i9.2279; Tanaka M, 2016, CANCER RES, V76, P358, DOI 10.1158/0008-5472.CAN-15-1879; Turk CM, 2012, CANCER CELL INT, V12, DOI 10.1186/1475-2867-12-17; Uckun FM, 2011, BRIT J HAEMATOL, V153, P741, DOI 10.1111/j.1365-2141.2011.08671.x; Vargas T, 2015, ONCOTARGET, V6, P7348, DOI 10.18632/oncotarget.3130; Vazquez-Martin A, 2007, ONCOL REP, V18, P973; Walter K, 2009, CANCER EPIDEM BIOMAR, V18, P2380, DOI 10.1158/1055-9965.EPI-09-0144; Wise DR, 2010, TRENDS BIOCHEM SCI, V35, P427, DOI 10.1016/j.tibs.2010.05.003; Wu Xi, 2014, Advances in Biological Regulation, V54, P214, DOI 10.1016/j.jbior.2013.09.004; Xing Y, 2016, ONCOTARGET, V7, P30479, DOI 10.18632/oncotarget.8586; Xu YF, 2015, CURR MOL MED, V15, P360, DOI 10.2174/1566524015666150401102218; Yabushita S, 2013, PANCREAS, V42, P1034, DOI 10.1097/MPA.0b013e3182883624; Yan Wei-Hua, 2011, Endocrine Metabolic & Immune Disorders-Drug Targets, V11, P76; Yang Youyun, 2011, Int J Biochem Mol Biol, V2, P89; Yang ZG, 2015, INT J MED SCI, V12, P256, DOI 10.7150/ijms.10735; Yin T, 2011, INT J MOL SCI, V12, P1595, DOI 10.3390/ijms12031595; Yuan XP, 2015, MOL CELL BIOCHEM, V398, P55, DOI 10.1007/s11010-014-2204-2; Zecchin KG, 2011, LAB INVEST, V91, P232, DOI 10.1038/labinvest.2010.157; Zhang AH, 2013, EUR J MED CHEM, V63, P570, DOI 10.1016/j.ejmech.2012.12.062; Zhang ML, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-150; Zhang R, 2015, BMC VET RES, V11, P1, DOI [10.1186/S12917-014-0312-6, DOI 10.1186/S12917-014-0312-6]; Zhang YJ, 2015, MOLECULES, V20, P21138, DOI 10.3390/molecules201219753; Zhao R, 2012, LUNG CANCER, V76, P324, DOI 10.1016/j.lungcan.2011.11.019	108	9	9	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2019	14	3							e0214294	10.1371/journal.pone.0214294	http://dx.doi.org/10.1371/journal.pone.0214294			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ3IW	30913248	Green Published, Green Submitted, gold			2022-12-26	WOS:000462305600041
J	Mcgill, JL; Guerra-Maupome, M; Schneider, S				Mcgill, Jodi L.; Guerra-Maupome, Mariana; Schneider, Sarah			Prophylactic digoxin treatment reduces IL-17 production in vivo in the neonatal calf and moderates RSV-associated disease	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; GENE-EXPRESSION; INFLAMMATORY RESPONSES; IMMUNE-RESPONSE; VIRAL-INFECTION; ANIMAL-MODELS; URSOLIC ACID; PHARMACOKINETICS; DIFFERENTIATION; INDUCTION	Respiratory syncytial virus (RSV) is a leading cause of morbidity and mortality in human infants. Bovine RSV infection of neonatal calves is pathologically and immunologically similar to RSV infection in infants, and is therefore a useful preclinical model for testing novel therapeutics. Treatment of severe RSV bronchiolitis relies on supportive care and may include use of bronchodilators and inhaled or systemic corticosteroids. Interleukin-17A (IL-17) is an inflammatory cytokine that plays an important role in neutrophil recruitment and activation. IL-17 is increased in children and rodents with severe RSV infection; and in calves with severe BRSV infection. It is currently unclear if IL-17 and Th17 immunity is beneficial or detrimental to the host during RSV infection. Digoxin was recently identified to selectively inhibit IL-17 production by antagonizing its transcription factor, retinoid-related orphan receptor gamma t (ROR gamma t). Digoxin inhibits ROR gamma t binding to IL-17 and Th17 associated genes, and suppresses IL-17 production in vitro in human and murine leukocytes and in vivo in rodent models of autoimmune disease. We demonstrate here that in vitro and in vivo digoxin treatment also inhibits IL-17 production by bovine leukocytes. To determine the role of IL-17 in primary RSV infection, calves were treated prophylactically with digoxin and infected with BRSV. Digoxin treated calves demonstrated reduced signs of clinical illness after BRSV infection, and reduced lung pathology compared to untreated control calves. Digoxin treatment did not adversely affect virus shedding or lung viral burden, but had a significant impact on pulmonary inflammatory cytokine expression on day 10 post infection. Together, our results suggest that exacerbated expression of IL-17 has a negative impact on RSV disease, and that development of specific therapies targeting Th17 immunity may be a promising strategy to improve disease outcome during severe RSV infection.	[Mcgill, Jodi L.; Guerra-Maupome, Mariana] Iowa State Univ, Dept Vet Microbiol & Preventat Med, Ames, IA 50011 USA; [Schneider, Sarah] Kansas State Univ, Dept Diagnost Med & Pathobiol, Manhattan, KS 66506 USA	Iowa State University; Kansas State University	Mcgill, JL (corresponding author), Iowa State Univ, Dept Vet Microbiol & Preventat Med, Ames, IA 50011 USA.	jlmcgill@iastate.edu		McGill, Jodi/0000-0001-7637-1455; Schneider, Sarah/0000-0001-9063-8574	NIH [R21 AI127895, P20 GM103638]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI127895] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103638] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by NIH grant R21 AI127895 and P20 GM103638 to JLM. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bem RA, 2011, AM J PHYSIOL-LUNG C, V301, pL148, DOI 10.1152/ajplung.00065.2011; Brodersen BW, 2010, VET CLIN N AM-FOOD A, V26, P323, DOI 10.1016/j.cvfa.2010.04.010; Bystrom J, 2013, VIRUSES-BASEL, V5, P777, DOI 10.3390/v5030777; Carraro S, 2013, EARLY HUM DEV, V89, pS3, DOI 10.1016/j.earlhumdev.2013.07.015; Cascao R, 2012, AUTOIMMUN REV, V11, P856, DOI 10.1016/j.autrev.2012.02.022; Christiaansen AF, 2016, PEDIATR RES, V80, P702, DOI 10.1038/pr.2016.130; Collins PL, 2011, VIRUS RES, V162, P80, DOI 10.1016/j.virusres.2011.09.020; DIX LP, 1985, AM J VET RES, V46, P470; ESPOSITO AL, 1989, AM REV RESPIR DIS, V140, P1590, DOI 10.1164/ajrccm/140.6.1590; ESPOSITO AL, 1985, J INFECT DIS, V152, P14, DOI 10.1093/infdis/152.1.14; EVERARD ML, 1994, ARCH DIS CHILD, V71, P428, DOI 10.1136/adc.71.5.428; Faber TE, 2012, J MED VIROL, V84, P1084, DOI 10.1002/jmv.23291; Furst R, 2017, PLANTA MED, V83, P977, DOI 10.1055/s-0043-105390; Guillot A, 2014, HEPATOLOGY, V59, P296, DOI 10.1002/hep.26598; Hall CB, 2001, NEW ENGL J MED, V344, P1917, DOI 10.1056/NEJM200106213442507; Hall SL, 2017, J ALLERGY CLIN IMMUN, V139, P462, DOI 10.1016/j.jaci.2016.04.037; Hashimoto K, 2005, J ALLERGY CLIN IMMUN, V116, P550, DOI 10.1016/j.jaci.2005.03.051; Henrickson KJ, 2004, PEDIATR INFECT DIS J, V23, pS11, DOI 10.1097/01.inf.0000108188.37237.48; Hinshaw SJH, 2016, INVEST OPHTH VIS SCI, V57, P1441, DOI 10.1167/iovs.15-19040; Huang HQ, 2015, IMMUNOL CELL BIOL, V93, P126, DOI 10.1038/icb.2014.79; Huh JR, 2011, NATURE, V472, P486, DOI 10.1038/nature09978; Ihenetu K, 2008, INFLAMM RES, V57, P519, DOI 10.1007/s00011-008-7249-9; Jee J, 2015, MUCOSAL IMMUNOL, V8, P735, DOI 10.1038/mi.2014.105; Johnson JE, 2007, MODERN PATHOL, V20, P108, DOI 10.1038/modpathol.3800725; Kallal LE, 2010, J IMMUNOL, V185, P4137, DOI 10.4049/jimmunol.1000677; Kim SH, 2013, EUR J PHARMACOL, V701, P131, DOI 10.1016/j.ejphar.2012.11.033; KIMMAN TG, 1987, J CLIN MICROBIOL, V25, P1097, DOI 10.1128/JCM.25.6.1097-1106.1987; Kinyanjui MW, 2013, J IMMUNOL, V190, P3859, DOI 10.4049/jimmunol.1200506; KORITZ GD, 1983, J VET PHARMACOL THER, V6, P141, DOI 10.1111/j.1365-2885.1983.tb00391.x; Larranaga CL, 2009, PEDIATR INFECT DIS J, V28, P867, DOI 10.1097/INF.0b013e3181a3ea71; Lee J, 2015, INT IMMUNOPHARMACOL, V26, P103, DOI 10.1016/j.intimp.2015.03.017; Leliefeld PHC, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00471; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lukens MV, 2010, J VIROL, V84, P2374, DOI 10.1128/JVI.01807-09; Manni ML, 2014, EXPERT REV RESP MED, V8, P25, DOI 10.1586/17476348.2014.854167; Martin B, 2009, IMMUNITY, V31, P321, DOI 10.1016/j.immuni.2009.06.020; McGill JL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21292-2; McGill JL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151083; McGill JL, 2013, IMMUNOLOGY, V139, P227, DOI 10.1111/imm.12075; Meyer G, 2008, COMP IMMUNOL MICROB, V31, P191, DOI 10.1016/j.cimid.2007.07.008; Mukherjee S, 2011, AM J PATHOL, V179, P248, DOI 10.1016/j.ajpath.2011.03.003; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Newcomb DC, 2013, THORAX, V68, P717, DOI 10.1136/thoraxjnl-2012-202404; Openshaw PJM, 2017, ANNU REV IMMUNOL, V35, P501, DOI 10.1146/annurev-immunol-051116-052206; Sacco RE, 2014, VET PATHOL, V51, P427, DOI 10.1177/0300985813501341; Sacco RE, 2015, CURR OPIN VIROL, V13, P117, DOI 10.1016/j.coviro.2015.06.003; Sacco RE, 2012, VIRUSES-BASEL, V4, P3731, DOI 10.3390/v4123731; Sacco RE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033074; Shi HR, 2016, BRIT J PHARMACOL, V173, P1517, DOI 10.1111/bph.13453; Skepner J, 2015, IMMUNOLOGY, V145, P347, DOI 10.1111/imm.12444; Skepner J, 2014, J IMMUNOL, V192, P2564, DOI 10.4049/jimmunol.1302190; Smith PK, 2001, J PAEDIATR CHILD H, V37, P146, DOI 10.1046/j.1440-1754.2001.00618.x; Stokes KL, 2013, J VIROL, V87, P10070, DOI 10.1128/JVI.01347-13; Stoppelenburg AJ, 2014, AM J PATHOL, V184, P1274, DOI 10.1016/j.ajpath.2014.01.033; Stoppelenburg AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078461; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Viuff B, 2002, AM J PATHOL, V161, P2195, DOI 10.1016/S0002-9440(10)64496-3; Wei ZJ, 2014, ARTERIOSCL THROM VAS, V34, P2429, DOI 10.1161/ATVBAHA.114.304435; Welliver RC, 2010, CURR MED RES OPIN, V26, P2175, DOI 10.1185/03007995.2010.505126; Wu J, 2013, TRANSPLANTATION, V95, P434, DOI 10.1097/TP.0b013e31827a48f5; Xiao S, 2014, IMMUNITY, V40, P477, DOI 10.1016/j.immuni.2014.04.004; Xu T, 2011, J BIOL CHEM, V286, P22707, DOI 10.1074/jbc.C111.250407; Zhang LQ, 2002, J VIROL, V76, P5654, DOI 10.1128/JVI.76.11.5654-5666.2002; Zhang QB, 1999, CLIN SCI, V96, P409, DOI 10.1042/CS19980401	65	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2019	14	3							e0214407	10.1371/journal.pone.0214407	http://dx.doi.org/10.1371/journal.pone.0214407			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ1KV	30908540	gold, Green Published, Green Submitted			2022-12-26	WOS:000462157600063
J	Kim, SH; Das, A; Choi, HI; Kim, KH; Chai, JC; Choi, MR; Binas, B; Park, KS; Lee, YS; Jung, KH; Chai, YG				Kim, Sun Hwa; Das, Amitabh; Choi, Hae In; Kim, Ki Hoon; Chai, Jin Choul; Choi, Mi Ran; Binas, Bert; Park, Kyoung Sun; Lee, Young Seek; Jung, Kyoung Hwa; Chai, Young Gyu			Forkhead box O1 (FOXO1) controls the migratory response of Toll-like receptor (TLR3)-stimulated human mesenchymal stromal cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mesenchymal stem cells (MSCs); Toll-like receptor (TLR); gene expression; cell migration; transcriptomics; forkhead box protein O; polyinosinic:polycytidylic acid; RNA-sequencing	STEM-CELLS; BONE-MARROW; TRANSCRIPTION FACTOR; TNF-ALPHA; IMMUNOSUPPRESSIVE PROPERTIES; THERAPEUTIC-EFFICACY; INDUCED COLITIS; LINKING INNATE; IMMUNOMODULATION; ACTIVATION	Mesenchymal stromal cells (MSCs) can potently regulate the functions of immune cells and are being investigated for the management of inflammatory diseases. Toll-like receptor 3 (TLR3)-stimulated human MSCs (hMSCs) exhibit increased migration and chemotaxis within and toward damaged tissues. However, the regulatory mechanisms underlying these migratory activities are unclear. Therefore, we analyzed the migration capability and gene expression profiles of TLR3-stimulated hMSCs using RNA-Seq, wound healing, and transwell cell migration assay. Along with increased cell migration, the TLR3 stimulation also increased the expression of cytokines, chemokines, and cell migration-related genes. The promoter regions of the latter showed an enrichment of putative motifs for binding the transcription factors forkhead box O1 (FOXO1), FOXO3, NF-B (NF-B1), and RELA proto-oncogene and NF-B subunit. Of note, FOXO1 inhibition by the FOXO1-selective inhibitor AS1842856 significantly reduced both migration and the expression of migration-related genes. In summary, our results indicate that TLR3 stimulation induces hMSC migration through the expression of FOXO1-activated genes.	[Kim, Sun Hwa; Kim, Ki Hoon; Chai, Jin Choul; Binas, Bert; Lee, Young Seek; Chai, Young Gyu] Hanyang Univ, Dept Mol & Life Sci, Ansan 15588, South Korea; [Das, Amitabh; Choi, Mi Ran; Park, Kyoung Sun; Jung, Kyoung Hwa] Hanyang Univ, Inst Nat Sci & Technol, Ansan 15588, South Korea; [Choi, Hae In; Chai, Young Gyu] Hanyang Univ, Dept Bionanotechnol, Seoul 04673, South Korea; [Das, Amitabh] Univ Maryland, Sch Dent, Div Periodontol, Baltimore, MD 21201 USA; [Chai, Jin Choul] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10461 USA; [Choi, Mi Ran] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Psychiat, Seoul, South Korea; [Park, Kyoung Sun] Seoul Natl Univ, Coll Med, Wide River Inst Immunol, Hongcheon 25159, South Korea	Hanyang University; Hanyang University; Hanyang University; University System of Maryland; University of Maryland Baltimore; Yeshiva University; Albert Einstein College of Medicine; Catholic University of Korea; Seoul St. Mary's Hospital; Seoul National University (SNU)	Chai, YG (corresponding author), Hanyang Univ, Dept Mol & Life Sci, Ansan 15588, South Korea.; Jung, KH (corresponding author), Korea Polytech II, Convergence Technol Campus, Incheon 21417, South Korea.	khjung@kopo.ac.kr; ygchai@hanyang.ac.kr	Kim, Sun/GSN-4867-2022		National Research Foundation of Korea (NRF) from the Korean government [2017M3A9G7073033, 2017R1A2B4012905, 2011-0030049, 2016R1D1A1B04934970]	National Research Foundation of Korea (NRF) from the Korean government	This work was supported by National Research Foundation of Korea (NRF) Grants 2017M3A9G7073033, 2017R1A2B4012905, and 2011-0030049 (to Y. G. C.) and 2016R1D1A1B04934970 (to K. H. J.) from the Korean government. The authors declare that they have no conflicts of interest with the contents of this article.	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Almalki SG, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0393-1; Beyth S, 2005, BLOOD, V105, P2214, DOI 10.1182/blood-2004-07-2921; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bunnell BA, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt34; Carrero R, 2012, STEM CELL REV REP, V8, P905, DOI 10.1007/s12015-012-9364-9; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Chen X, 2014, DEV GROWTH DIFFER, V56, P233, DOI 10.1111/dgd.12124; Cho HH, 2006, STEM CELLS, V24, P2744, DOI 10.1634/stemcells.2006-0189; Chung S, 2016, ONCOTARGET, V7, P17532, DOI 10.18632/oncotarget.8162; Das A, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1728-5; De Miguel MP, 2012, CURR MOL MED, V12, P574; DelaRosa O, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00182; DelaRosa O, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/865601; Djouad F, 2003, BLOOD, V102, P3837, DOI 10.1182/blood-2003-04-1193; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; English K, 2013, IMMUNOL CELL BIOL, V91, P19, DOI 10.1038/icb.2012.56; Fuenzalida P, 2016, CYTOTHERAPY, V18, P630, DOI 10.1016/j.jcyt.2016.02.002; Glenn Justin D, 2014, World J Stem Cells, V6, P526, DOI 10.4252/wjsc.v6.i5.526; Hameedaldeen A, 2014, INT J MOL SCI, V15, P16257, DOI 10.3390/ijms150916257; Hinden L, 2015, STEM CELLS, V33, P2256, DOI 10.1002/stem.2026; Ho IAW, 2009, STEM CELLS, V27, P1366, DOI 10.1002/stem.50; Hu CJ, 2013, J SURG RES, V183, P427, DOI 10.1016/j.jss.2013.01.019; Hu Y, 2008, J LEUKOCYTE BIOL, V84, P1353, DOI 10.1189/jlb.0107040; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jung KH, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0260-5; Kaplan JM, 2011, CURR STEM CELL RES T, V6, P297; Karp JM, 2009, CELL STEM CELL, V4, P206, DOI 10.1016/j.stem.2009.02.001; Kasashima H, 2016, AM J PATHOL, V186, P3028, DOI 10.1016/j.ajpath.2016.07.024; Katanov C, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0080-7; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Keating A, 2012, CELL STEM CELL, V10, P709, DOI 10.1016/j.stem.2012.05.015; Kim DS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083363; Kim SH, 2016, SCI REP-UK, V6, DOI 10.1038/srep30311; Kode JA, 2009, CYTOTHERAPY, V11, P377, DOI 10.1080/14653240903080367; Krampera Mauro, 2007, Blood Transfus, V5, P120, DOI 10.2450/2007.0029-07; LAZARUS HM, 1995, BONE MARROW TRANSPL, V16, P557; Lee MW, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0178-y; Lee MW, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/154919; Lin Q, 2012, J INVEST DERMATOL, V132, P2085, DOI 10.1038/jid.2012.120; Liu HB, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034608, 10.1371/journal.pone.0050785]; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Maijenburg MW, 2012, STEM CELLS DEV, V21, P19, DOI 10.1089/scd.2011.0270; Mastri M, 2012, AM J PHYSIOL-CELL PH, V303, pC1021, DOI 10.1152/ajpcell.00191.2012; Mathelier A, 2016, NUCLEIC ACIDS RES, V44, pD110, DOI 10.1093/nar/gkv1176; Monsel A, 2014, ANESTHESIOLOGY, V121, P1099, DOI 10.1097/ALN.0000000000000446; Murray IR, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0212-7; Nagashima T, 2010, MOL PHARMACOL, V78, P961, DOI 10.1124/mol.110.065714; Opitz CA, 2009, STEM CELLS, V27, P909, DOI 10.1002/stem.7; Pasare C, 2004, MICROBES INFECT, V6, P1382, DOI 10.1016/j.micinf.2004.08.018; Patel SA, 2008, ARCH IMMUNOL THER EX, V56, P1, DOI 10.1007/s00005-008-0001-x; Pevsner-Fischer M, 2007, BLOOD, V109, P1422, DOI 10.1182/blood-2006-06-028704; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prockop DJ, 2012, MOL THER, V20, P14, DOI 10.1038/mt.2011.211; Pu YF, 2017, J CELL MOL MED, V21, P1411, DOI 10.1111/jcmm.13070; Qiu Y, 2017, MUCOSAL IMMUNOL, V10, P727, DOI 10.1038/mi.2016.78; Ramirez SH, 2010, AM J PATHOL, V176, P881, DOI 10.2353/ajpath.2010.090671; Rastegar Farbod, 2010, World J Stem Cells, V2, P67, DOI 10.4252/wjsc.v2.i4.67; Ren GW, 2011, CELL ADHES MIGR, V5, P20, DOI 10.4161/cam.5.1.13491; Savai R, 2014, NAT MED, V20, P1289, DOI 10.1038/nm.3695; Schnare M, 2001, NAT IMMUNOL, V2, P947, DOI 10.1038/ni712; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shi YF, 2010, CELL RES, V20, P510, DOI 10.1038/cr.2010.44; Son BR, 2006, STEM CELLS, V24, P1254, DOI 10.1634/stemcells.2005-0271; Stagg J, 2007, TISSUE ANTIGENS, V69, P1, DOI 10.1111/j.1399-0039.2006.00739.x; Suzuki K, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/3296498; Tomchuck SL, 2008, STEM CELLS, V26, P99, DOI 10.1634/stemcells.2007-0563; Wang Y, 2014, NAT IMMUNOL, V15, P1009, DOI 10.1038/ni.3002; Waterman RS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010088; West AP, 2006, ANNU REV CELL DEV BI, V22, P409, DOI 10.1146/annurev.cellbio.21.122303.115827; Xiao Q, 2012, CELL BIOCHEM BIOPHYS, V62, P409, DOI 10.1007/s12013-011-9317-y; Xu F, 2010, ONCOL REP, V23, P1561, DOI 10.3892/or_00000796; Yan CH, 2016, TUMOR BIOL, V37, P8425, DOI 10.1007/s13277-015-4746-7; Yu Y, 2017, CELL PROLIFERAT, V50, DOI 10.1111/cpr.12309; Zambelli F, 2009, NUCLEIC ACIDS RES, V37, pW247, DOI 10.1093/nar/gkp464; Zhang CY, 2015, J CELL BIOL, V209, P289, DOI 10.1083/jcb.201409032; Zhao XY, 2014, STEM CELLS, V32, P521, DOI 10.1002/stem.1543	78	3	4	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2019	294	21					8424	8437		10.1074/jbc.RA119.008673	http://dx.doi.org/10.1074/jbc.RA119.008673			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC6UQ	30944148	Green Published, hybrid			2022-12-26	WOS:000471108200013
J	Chua, NK; Hart-Smith, G; Brown, AJ				Chua, Ngee Kiat; Hart-Smith, Gene; Brown, Andrew J.			Non-canonical ubiquitination of the cholesterol-regulated degron of squalene monooxygenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cholesterol; cholesterol regulation; ubiquitin; protein degradation; endoplasmic-reticulum-associated protein degradation (ERAD); degron; lipid homeostasis; membrane-associated ring-CH-type finger 6 (MARCH6); SQLE; squalene monooxygenase	COENZYME-A REDUCTASE; HMG-COA REDUCTASE; CONJUGATING ENZYMES; SACCHAROMYCES-CEREVISIAE; FEEDBACK-REGULATION; DISORDERED REGION; E2 ENZYMES; WEB SERVER; PROTEIN; DEGRADATION	Squalene monooxygenase (SM) is a rate-limiting enzyme in cholesterol synthesis. The region comprising the first 100 amino acids, termed SM N100, represents the shortest cholesterol-responsive degron and enables SM to sense excess cholesterol in the endoplasmic reticulum (ER) membrane. Cholesterol accelerates the ubiquitination of SM by membrane-associated ring-CH type finger 6 (MARCH6), a key E3 ubiquitin ligase involved in ER-associated degradation. However, the ubiquitination site required for cholesterol regulation of SM N100 is unknown. Here, we used SM N100 fused to GFP as a model degron to recapitulate cholesterol-mediated SM degradation and show that neither SM lysine residues nor the N terminus impart instability. Instead, we discovered four serines (Ser-59, Ser-61, Ser-83, and Ser-87) that are critical for cholesterol-accelerated degradation, with MS analysis confirming Ser-83 as a ubiquitination site. Notably, these two clusters of closely spaced serine residues are located in disordered domains flanking a 12-amino acid-long amphipathic helix (residues Gln-62-Leu-73) that together confer cholesterol responsiveness. In summary, our findings reveal the degron architecture of SM N100, introducing the role of non-canonical ubiquitination sites and deepening our molecular understanding of how SM is degraded in response to cholesterol.	[Chua, Ngee Kiat; Hart-Smith, Gene; Brown, Andrew J.] UNSW Sydney, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia	University of New South Wales Sydney	Brown, AJ (corresponding author), UNSW Sydney, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia.	aj.brown@unsw.edu.au	Chua, Ngee Kiat/AAG-6793-2021	Chua, Ngee Kiat/0000-0003-2785-2767; Hart-Smith, Gene/0000-0003-3907-0367	National Health and Medical Research Council [1060515]; Australian Research Council [DP170101178]; Gold Star award from University of New South Wales Sydney	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Gold Star award from University of New South Wales Sydney	This work was supported by National Health and Medical Research Council Grant 1060515, Australian Research Council Grant DP170101178, and a Gold Star award from University of New South Wales Sydney (to A. J. B). The authors declare that they have no conflicts of interest with the contents of this article.	Akimov V, 2018, NAT STRUCT MOL BIOL, V25, P631, DOI 10.1038/s41594-018-0084-y; Aufderheide A, 2015, FEBS LETT, V589, P2552, DOI 10.1016/j.febslet.2015.07.034; Belter A, 2011, BIOL CHEM, V392, P1053, DOI [10.1515/BC-2011-195, 10.1515/BC.2011.195]; Boban M, 2015, J BIOL CHEM, V290, P2489, DOI 10.1074/jbc.M114.600593; Boeing S, 2016, CELL REP, V15, P1597, DOI 10.1016/j.celrep.2016.04.047; Brown AJ, 2002, MOL CELL, V10, P237, DOI 10.1016/S1097-2765(02)00591-9; BROWN MS, 1980, J LIPID RES, V21, P505; Brown NG, 2016, CELL, V165, P1440, DOI 10.1016/j.cell.2016.05.037; Buchovecky CM, 2013, NAT GENET, V45, P1013, DOI 10.1038/ng.2714; CHEN P, 1993, CELL, V74, P357, DOI 10.1016/0092-8674(93)90426-Q; Christianson JC, 2012, NAT CELL BIOL, V14, P93, DOI 10.1038/ncb2383; Chua NK, 2017, J BIOL CHEM, V292, P19959, DOI 10.1074/jbc.M117.794230; Chugh A, 2003, PROG LIPID RES, V42, P37, DOI 10.1016/S0163-7827(02)00029-2; Ciechanover A, 2004, TRENDS CELL BIOL, V14, P103, DOI 10.1016/j.tcb.2004.01.004; Cirmena G, 2018, CANCER LETT, V425, P13, DOI 10.1016/j.canlet.2018.03.034; CLARKE PR, 1990, EMBO J, V9, P2439, DOI 10.1002/j.1460-2075.1990.tb07420.x; Dai ZB, 2013, METAB ENG, V20, P146, DOI 10.1016/j.ymben.2013.10.004; DeBose-Boyd RA, 2008, CELL RES, V18, P609, DOI 10.1038/cr.2008.61; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; ENDO A, 1976, FEBS LETT, V72, P323, DOI 10.1016/0014-5793(76)80996-9; Fischer ES, 2011, CELL, V147, P1024, DOI 10.1016/j.cell.2011.10.035; Fishbain S, 2015, NAT STRUCT MOL BIOL, V22, P214, DOI 10.1038/nsmb.2958; Foresti O, 2013, ELIFE, V2, DOI 10.7554/eLife.00953; Gallop JL, 2006, EMBO J, V25, P2898, DOI 10.1038/sj.emboj.7601174; Garaiova M, 2014, FEMS YEAST RES, V14, P310, DOI 10.1111/1567-1364.12107; Garcia-Bermudez J, 2019, NATURE, V567, P118, DOI 10.1038/s41586-019-0945-5; Garner, 1999, Genome Inform Ser Workshop Genome Inform, V10, P41; Gautier R, 2008, BIOINFORMATICS, V24, P2101, DOI 10.1093/bioinformatics/btn392; Gill S, 2011, CELL METAB, V13, P260, DOI 10.1016/j.cmet.2011.01.015; Gimenez-Andres M, 2018, BIOMOLECULES, V8, DOI 10.3390/biom8030045; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Guharoy M, 2016, J BIOL CHEM, V291, P6723, DOI 10.1074/jbc.R115.692665; Hart-Smith G, 2014, J PROTEOME RES, V13, P1744, DOI 10.1021/pr401251k; Hart-Smith G, 2012, J AM SOC MASS SPECTR, V23, P124, DOI 10.1007/s13361-011-0273-y; Hassink G, 2005, BIOCHEM J, V388, P647, DOI 10.1042/BJ20041241; HIDAKA Y, 1991, J BIOL CHEM, V266, P13171; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Howe V, 2015, J BIOL CHEM, V290, P27533, DOI 10.1074/jbc.M115.675181; Hulce JJ, 2013, NAT METHODS, V10, P259, DOI [10.1038/NMETH.2368, 10.1038/nmeth.2368]; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Ishida T, 2007, NUCLEIC ACIDS RES, V35, pW460, DOI 10.1093/nar/gkm363; Ishikura S, 2010, J BIOL CHEM, V285, P23916, DOI 10.1074/jbc.M110.127936; Jones DT, 2015, BIOINFORMATICS, V31, P857, DOI 10.1093/bioinformatics/btu744; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kostova Z, 2007, SEMIN CELL DEV BIOL, V18, P770, DOI 10.1016/j.semcdb.2007.09.002; Kreft SG, 2006, J BIOL CHEM, V281, P4646, DOI 10.1074/jbc.M512215200; Kristiana I, 2012, J BIOL CHEM, V287, P33897, DOI 10.1074/jbc.M112.360537; Kuzu OF, 2016, CANCER RES, V76, P2063, DOI 10.1158/0008-5472.CAN-15-2613; Lam SY, 2014, BIOCHEM BIOPH RES CO, V451, P361, DOI 10.1016/j.bbrc.2014.07.099; Lenk U, 2002, J CELL SCI, V115, P3007; Li, 1999, Genome Inform Ser Workshop Genome Inform, V10, P30; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Liu DB, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aap9840; Liu YF, 2014, ELIFE, V3, DOI 10.7554/eLife.01369; Lumpkin RJ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01271-3; Luu W, 2014, J LIPID RES, V55, P410, DOI 10.1194/jlr.M043257; Mahoney CE, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-07959-4; Mattiroli F, 2014, NAT STRUCT MOL BIOL, V21, P308, DOI 10.1038/nsmb.2792; McDowell GS, 2013, INT J BIOCHEM CELL B, V45, P1833, DOI 10.1016/j.biocel.2013.05.026; Melo SP, 2011, J BIOL CHEM, V286, P36559, DOI 10.1074/jbc.M111.274258; Mertins P, 2013, NAT METHODS, V10, P634, DOI 10.1038/nmeth.2518; Mullen PJ, 2016, NAT REV CANCER, V16, P718, DOI 10.1038/nrc.2016.76; Nielsen ML, 2008, NAT METHODS, V5, P459, DOI 10.1038/nmeth0608-459; Okumoto K, 2011, TRAFFIC, V12, P1067, DOI 10.1111/j.1600-0854.2011.01217.x; Pao KC, 2018, NATURE, V556, P381, DOI 10.1038/s41586-018-0026-1; Peng Kang, 2005, Journal of Bioinformatics and Computational Biology, V3, P35, DOI 10.1142/S0219720005000886; Porter FD, 2011, J LIPID RES, V52, P6, DOI 10.1194/jlr.R009548; Prabhu AV, 2017, J STEROID BIOCHEM, V165, P363, DOI 10.1016/j.jsbmb.2016.08.003; Prabhu AV, 2014, BBA-MOL CELL BIOL L, V1841, P1431, DOI 10.1016/j.bbalip.2014.07.006; Prinz WA, 2017, J BIOL CHEM, V292, P19974, DOI 10.1074/jbc.H117.794230; Ravid T, 2008, NAT REV MOL CELL BIO, V9, P679, DOI 10.1038/nrm2468; Romero, 1997, Genome Inform Ser Workshop Genome Inform, V8, P110; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shimizu Y, 2010, MOL CELL, V40, P917, DOI 10.1016/j.molcel.2010.11.033; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Smith DL, 2018, ANAL CHEM, V90, P9101, DOI 10.1021/acs.analchem.8b01525; Stefanovic-Barrett S, 2018, EMBO REP, V19, DOI 10.15252/embr.201745603; Stewart MD, 2016, CELL RES, V26, P423, DOI 10.1038/cr.2016.35; Stopsack KH, 2016, CANCER RES, V76, P4785, DOI 10.1158/0008-5472.CAN-16-0903; Swaney DL, 2013, NAT METHODS, V10, P676, DOI [10.1038/NMETH.2519, 10.1038/nmeth.2519]; Swanson R, 2001, GENE DEV, V15, P2660, DOI 10.1101/gad.933301; Tan JME, 2019, ATHEROSCLEROSIS, V281, P137, DOI 10.1016/j.atherosclerosis.2018.12.008; Udeshi ND, 2013, NAT PROTOC, V8, P1950, DOI 10.1038/nprot.2013.120; Valenza M, 2005, J NEUROSCI, V25, P9932, DOI 10.1523/JNEUROSCI.3355-05.2005; Wang XL, 2007, J CELL BIOL, V177, P613, DOI 10.1083/jcb.200611063; Wang XL, 2009, J CELL BIOL, V187, P655, DOI 10.1083/jcb.200908036; Wang YJ, 2017, NAT CELL BIOL, V19, P808, DOI 10.1038/ncb3551; Weber A, 2016, MOL CELL, V63, P827, DOI 10.1016/j.molcel.2016.07.020; Wood WG, 2014, J NEUROCHEM, V129, P559, DOI 10.1111/jnc.12637; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Wu Q, 2015, SCI REP-UK, V5, DOI 10.1038/srep09520; Xiao X, 2017, MOL CELL, V66, P154, DOI 10.1016/j.molcel.2017.02.015; Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780; Yu H, 1997, J BIOL CHEM, V272, P20800, DOI 10.1074/jbc.272.33.20800; Zelcer N, 2014, MOL CELL BIOL, V34, P1262, DOI 10.1128/MCB.01140-13	97	23	23	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2019	294	20					8134	8147		10.1074/jbc.RA119.007798	http://dx.doi.org/10.1074/jbc.RA119.007798			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC0NH	30940729	Green Published, hybrid			2022-12-26	WOS:000470656500013
J	Budkaew, J; Chumworathayi, B; Pientong, C; Ekalaksananan, T				Budkaew, Jiratha; Chumworathayi, Bandit; Pientong, Chamsai; Ekalaksananan, Tipaya			Prevalence and factors associated with gonorrhea infection with respect to anatomic distributions among men who have sex with men	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; ACID AMPLIFICATION TESTS; NEISSERIA-GONORRHOEAE; CHLAMYDIA-TRACHOMATIS; RISK-FACTORS; PHARYNGEAL; TRANSMISSION; POPULATION; CHALLENGES; SPECIMENS	Introduction Gonorrhea (GC) infection caused by Neisseria gonorrhoeae has been steadily increasing in Thailand over the last decade. Men who have sex with men (MSM) are at high risk for gonorrhea infection. Materials and methods In this study, we determined the prevalence of and risk factors associated with gonococcal infections by three anatomical sites among MSM. We have conducted a cross-sectional analysis of a sexually transmitted disease (STD), gonorrhea among MSM attending two STD clinics in Khon Kaen, Thailand. We included 358 MSM over 18 years of age. Data were collected using self-administered questionnaire. In each participant, an oropharyngeal, anorectal, and endourethral swab were tested with culture and nucleic acid amplification test (NAAT). However, 267 urine samples were tested by both methods. Factors associated with gonorrhea infections were assessed using univariate and multivariate logistic regression. Results One hundred and ninety-five out of 358 (54.47%) MSM tested were found to be positive for gonorrhea using a porA gene targeted NAAT by Real-time PCR with TaqMan probes, but there was no positive result by culture. The gonorrheal prevalence for male genital site, anal, and oropharyngeal, were 34.73% (95% CI 33.07, 45.08), 29.01% (95% CI 24.61, 34.33), and 27.93% (95% CI 23.35, 32.89), respectively, while 5.9% (21/355) were positive for gonococcal infection in all anatomic sites (oropharynx + anus + urethra) of one participant. Previous history of diagnosed STDs was a significant factor associated urethral gonorrhea (odds ratio = 3.52, 95%CI 1.87-6.66, P Value< 0.001). In addition, having more than one partner was increased urethral gonorrhea (adjusted odds ratio = 2.26, 95%CI 1.10-4.68, P Value = 0.026). 100% of condom use was found decreasing urethral infection (adjusted odds ratio = 0.39, 95%CI 0.15-0.99, P Value = 0.046). Conclusions The most common anatomic site of gonorrhea infection was male genital site, and the independent risk factors were having history of diagnosed STDs and having more than one partner in the past 3 months, but 100% condom use was a protective factor of this infection.	[Budkaew, Jiratha] Khon Kaen Ctr Hosp, Dept Social Med, Khon Kaen, Khon Kaen Provi, Thailand; [Chumworathayi, Bandit] Khon Kaen Univ, Dept Obstet & Gynecol, Fac Med, Srinagarind Hosp, Khon Kaen, Thailand; [Pientong, Chamsai] Khon Kaen Univ, Srinagarind Hosp, Dept Microbiol, Fac Med, Khon Kaen, Thailand; [Ekalaksananan, Tipaya] Khon Kaen Univ, Srinagarind Hosp, Dept Microbiol, Fac Med, Khon Kaen, Thailand	Khon Kaen University; Khon Kaen University; Khon Kaen University	Chumworathayi, B (corresponding author), Khon Kaen Univ, Dept Obstet & Gynecol, Fac Med, Srinagarind Hosp, Khon Kaen, Thailand.	bchumworathayi@gmail.com	Chumworathayi, Bandit/J-9927-2019	Chumworathayi, Bandit/0000-0003-1214-1962	Royal Golden Jubilee Ph. D Program (RGJPHD) from Thai Government	Royal Golden Jubilee Ph. D Program (RGJPHD) from Thai Government	The authors received fund from The Royal Golden Jubilee Ph. D Program (RGJPHD) to JB from Thai Government.	Alexander S, 2009, SEX TRANSM INFECT, V85, P159, DOI 10.1136/sti.2008.035469; [Anonymous], 2013, ANN REP CLIN CONS HL; Barbee LA, 2013, CLIN INFECT DIS, V56, P1539, DOI 10.1093/cid/cit084; Bergey DH., 1994, BERGEYS MANUAL DETER, pp. 395; Bolan GA, 2012, NEW ENGL J MED, V366, P485, DOI 10.1056/NEJMp1112456; Budkaew Jiratha, 2018, Journal of the Medical Association of Thailand, V101, P323; Budkaew J, 2017, PRAGMAT OBS RES, V8, P167, DOI 10.2147/POR.S137377; Carpenter RJ, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002775; Centers for Disease Control and Prevention (CDC), 2014, GON CDC FACT SHEET; Centers for Disease Control and Prevention (CDC), MMWR, V55, P1; Charlotte KK, 2005, CLIN INFECT DIS, V41, P67, DOI DOI 10.1086/430704; Chonwattana W, 2013, 7 IAS C HIV PATH TRE; Crotchfelt KA, 1997, J CLIN MICROBIOL, V35, P1536, DOI 10.1128/JCM.35.6.1536-1540.1997; Dallabetta G, 2008, SEXUALLY TRANSMITTED; Detels R, 2011, SEX TRANSM DIS, V38, P503, DOI 10.1097/OLQ.0b013e318206c288; Dosekun O, 2010, CURR OPIN HIV AIDS, V5, P291, DOI 10.1097/COH.0b013e32833a88a3; Dutt K, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1971-3; Erbelding EJ, 2003, JAIDS-J ACQ IMM DEF, V33, P247, DOI 10.1097/00126334-200306010-00021; Fenton KA, 2005, J INFECT DIS, V191, pS127, DOI 10.1086/425286; Geral M., 1999, MECH MICROBIAL DIS; Global Forum on MSM and HIV, 2010, OUR OWN WORDS PREF V; Gurung A, 2010, INT AIDS C JUL 18 23; Handsfield HH., 2008, SEXUALLY TRANSMITTED, V16, P627; Hazel A, 2014, EPIDEMIOL INFECT, V142, P2422, DOI 10.1017/S0950268813003488; Hjelmevoll SO, 2006, J MOL DIAGN, V8, P574, DOI 10.2353/jmoldx.2006.060024; Justin LH., 1980, PHARYNGEAL GONOCOCCA, V31, P255; Kohli Ruchika, 2013, BMC Res Notes, V6, P44, DOI 10.1186/1756-0500-6-44; Komisaruk B. R, 2009, ORGASM ANSWER GUIDE, P108; LeFevre ML, 2014, ANN INTERN MED, V161, P894, DOI 10.7326/M14-1965; Martin DH, 2000, J CLIN MICROBIOL, V38, P3544, DOI 10.1128/JCM.38.10.3544-3549.2000; Masek BJ, 2009, J CLIN MICROBIOL, V47, P1663, DOI 10.1128/JCM.02387-08; Michael EW, 1972, J INFECT DIS, V126, P601; Mimiaga MJ, 2009, SEX TRANSM DIS, V36, P507, DOI 10.1097/OLQ.0b013e3181a2ad98; Morris SR, 2006, CLIN INFECT DIS, V43, P1284, DOI 10.1086/508460; Newman L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143304; Ng Lai-King, 2005, Can J Infect Dis Med Microbiol, V16, P15; Ojanen TT, 2009, SEX RES SOC POLICY, V6, P4, DOI 10.1525/srsp.2009.6.2.4; Ota KV, 2009, SEX TRANSM INFECT, V85, P182, DOI 10.1136/sti.2008.034140; Podgore JK, 1986, J INFECT DIS, V154; POTTERAT JJ, 1987, SEX TRANSM DIS, V14, P107, DOI 10.1097/00007435-198704000-00010; Rebe K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138315; Rieg G, 2008, AIDS PATIENT CARE ST, V22, P947, DOI 10.1089/apc.2007.0240; Sanders EJ, 2010, SEX TRANSM INFECT, V86, P440, DOI 10.1136/sti.2010.043224; Savage E J, 2012, Euro Surveill, V17; Shafer MA, 2002, MIL MED, V167, P496, DOI 10.1093/milmed/167.6.496; Staras SAS, 2009, SEX TRANSM DIS, V36, P232, DOI 10.1097/OLQ.0b013e3181901e32; Stolte IG, 2006, SEX TRANSM DIS, V33, P201, DOI 10.1097/01.olq.0000194596.78637.8e; Stoner BP, 2003, SEX TRANSM INFECT, V79, P197, DOI 10.1136/sti.79.3.197; Templeton DJ, 2008, SEX TRANSM INFECT, V84, P361, DOI 10.1136/sti.2008.032037; Todar K., 2009, TXB MICROBIOLOGY; U.S. Center for Disease Control and Prevention, 2007, THAIL STDS AR SPREAD; US Department of Health and Human Services Centers for Disease Control and Prevention., 2013, ANT RES THREATS US; Ward H, 2010, CURR OPIN HIV AIDS, V5, P305, DOI 10.1097/COH.0b013e32833a8844; Warner L, 2004, AM J EPIDEMIOL, V159, P242, DOI 10.1093/aje/kwh044; Watcharapol S., 2012, WEEKLY EPIDEMIOLO S1, V43, pS47; Workowski KA, 2015, MMWR RECOMM REP, V64, P1, DOI 10.15585/mmwr.rr7004a1; World Health Organization, 2007, MOD 2 INTR STI S TI, V2nd; Yin YP, 2008, INT J STD AIDS, V19, P381, DOI 10.1258/ijsa.2007.007273; Young H, 2003, SEX TRANSM INFECT, V79, P484, DOI 10.1136/sti.79.6.484	59	6	6	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0211682	10.1371/journal.pone.0211682	http://dx.doi.org/10.1371/journal.pone.0211682			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR5NS	30943191	Green Published, gold, Green Submitted			2022-12-26	WOS:000463194300002
J	Tejera, B; Lopez, RE; Hidalgo, P; Cardenas, R; Ballesteros, G; Rivillas, L; French, L; Amero, C; Pastor, N; Santiago, A; Groitl, P; Dobner, T; Gonzalez, RA				Tejera, Berto; Lopez, Raul E.; Hidalgo, Paloma; Cardenas, Reinier; Ballesteros, Grisel; Rivillas, Lina; French, Leidys; Amero, Carlos; Pastor, Nina; Santiago, Angel; Groitl, Peter; Dobner, Thomas; Gonzalez, Ramon A.			The human adenovirus type 5 E1B 55kDa protein interacts with RNA promoting timely DNA replication and viral late mRNA metabolism	PLOS ONE			English	Article							55-KILODALTON PROTEIN; NUCLEAR EXPORT; TRANSCRIPTIONAL REPRESSION; TRIPARTITE LEADER; BINDING ACTIVITY; E1B-55K PROTEIN; GENE-EXPRESSION; P53; DEGRADATION; LIGASE	The E1B 55kDa produced by human adenovirus type 5 is a multifunctional protein that participates in the regulation of several steps during the viral replication cycle. Previous studies suggest this protein plays an important role in postranscriptional regulation of viral and cellular gene expression, as it is required for the selective accumulation of maximal levels of viral late mRNA in the cytoplasm of the infected cell; however the molecular mechanisms that are altered or regulated by this protein have not been elucidated. A ribonucleoprotein motif that could implicate the direct interaction of the protein with RNA was initially predicted and tested in vitro, but the interaction with RNA could not be detected in infected cells, suggesting the interaction may be weak or transient. Here it was determined that the E1B 55kDa interacts with RNA in the context of the viral infection in non-transformed human cells, and its contribution to the adenovirus replication cycle was evaluated. Using recombinant adeno-viruses with amino acid substitutions or a deletion in the ribonucleoprotein motif the interaction of E1B 55kDa with RNA was found to correlate with timely and efficient viral DNA replication and viral late mRNA accumulation and splicing.	[Tejera, Berto; Lopez, Raul E.; Hidalgo, Paloma; Cardenas, Reinier; Ballesteros, Grisel; Rivillas, Lina; French, Leidys; Pastor, Nina; Santiago, Angel; Gonzalez, Ramon A.] Univ Autonoma Estado Morelos, Inst Invest Ciencias Basicas & Aplicadas, Ctr Invest Dinam Celular, Cuernavaca, Morelos, Mexico; [Lopez, Raul E.] Univ Nacl Autonoma Mexico, Inst Biotecnol, Cuernavaca, Morelos, Mexico; [Cardenas, Reinier; French, Leidys; Amero, Carlos] Univ Autonoma Estado Morelos, Inst Invest Ciencias Basicas & Aplicadas, Ctr Invest Quim, Lab Bioquim & Resonancia Magnet Nucl, Cuernavaca, Morelos, Mexico; [Groitl, Peter] Tech Univ Munich, Helmholtz Zentrum Munchen, Inst Virol, Munich, Germany; [Dobner, Thomas] Leibniz Inst Expt Virol, Heinrich Pette Inst, Hamburg, Germany	Universidad Autonoma del Estado de Morelos; Universidad Nacional Autonoma de Mexico; Universidad Autonoma del Estado de Morelos; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Heinrich Pette Institute	Gonzalez, RA (corresponding author), Univ Autonoma Estado Morelos, Inst Invest Ciencias Basicas & Aplicadas, Ctr Invest Dinam Celular, Cuernavaca, Morelos, Mexico.	rgonzalez@uaem.mx	Amero, Carlos/C-6952-2011; Pastor, Nina/W-4452-2019; Amero, Carlos/AAE-7733-2020; Pacheco, Leidys French/AAE-4987-2020	Amero, Carlos/0000-0001-6300-0241; Pastor, Nina/0000-0001-7755-2936; Tejera-Hernandez, Berto/0000-0002-5418-4955; Cardenas, Reinier Felipe/0000-0001-7213-4081; French-Pacheco, Leidys/0000-0002-4053-5013; Hidalgo, Paloma/0000-0001-5867-0128; Gonzalez, Ramon A./0000-0001-9689-8529; Santiago, Angel/0000-0002-3957-0970	Consejo Nacional de Ciencia y Tecnologia (CONACyT) Scholarship, Mexico [447442, 266820]; CONACyT [CB-2011-01-168497]; Programa para el Desarrollo Profesional Docente-Secretaria de Educacion Publica (PRODEP-SEP); Freie und Hansestadt Hamburg; Bundesministerium fur Gesundheit (BMG); Research Group Linkage Program of the Alexander von Humboldt Foundation	Consejo Nacional de Ciencia y Tecnologia (CONACyT) Scholarship, Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Programa para el Desarrollo Profesional Docente-Secretaria de Educacion Publica (PRODEP-SEP); Freie und Hansestadt Hamburg; Bundesministerium fur Gesundheit (BMG); Research Group Linkage Program of the Alexander von Humboldt Foundation	BT received support from Consejo Nacional de Ciencia y Tecnologia (CONACyT) Scholarship 266820, Mexico. https://www.conacyt.gob.mx; PH received support from Consejo Nacional de Ciencia y Tecnologia (CONACyT) Scholarship 447442, Mexico. https://www.conacyt.gob.mx; RAG was supported by grants from CONACyT CB-2011-01-168497 and Programa para el Desarrollo Profesional Docente-Secretaria de Educacion Publica (PRODEP-SEP). http://www.dgesu.ses.sep.gob.mx/prodep.htm; TD and the Heinrich Pette Institute is supported by the Freie und Hansestadt Hamburg and the Bundesministerium fur Gesundheit (BMG). https://www.bundesgesundheitsministerium.de/; R.A.G. and T. D. received support from the Research Group Linkage Program of the Alexander von Humboldt Foundation. https://www.humboldt.foundation.de/web/home.html; NO - The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahi YS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07997-w; Bachi A, 2000, RNA, V6, P136, DOI 10.1017/S1355838200991994; Baker A, 2007, J VIROL, V81, P7034, DOI 10.1128/JVI.00029-07; BELTZ GA, 1979, J MOL BIOL, V131, P353, DOI 10.1016/0022-2836(79)90081-0; BERGET SM, 1977, P NATL ACAD SCI USA, V74, P3171, DOI 10.1073/pnas.74.8.3171; Berk AJ, 2005, ONCOGENE, V24, P7673, DOI 10.1038/sj.onc.1209040; BERKNER KL, 1985, NUCLEIC ACIDS RES, V13, P841, DOI 10.1093/nar/13.3.841; Berscheminski J, 2014, J VIROL, V88, P6076, DOI 10.1128/JVI.00469-14; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Bischoff JR, 1996, SCIENCE, V274, P373, DOI 10.1126/science.274.5286.373; Brautigam CA, 2015, METHOD ENZYMOL, V562, P109, DOI 10.1016/bs.mie.2015.05.001; Burck C, 2016, J VIROL, V90, P930, DOI 10.1128/JVI.01836-15; Carson CT, 2003, EMBO J, V22, P6610, DOI 10.1093/emboj/cdg630; Chahal JS, 2013, J VIROL, V87, P4432, DOI 10.1128/JVI.03387-12; Chahal JS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002853; Condezo GN, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006320; Dallaire F, 2009, J VIROL, V83, P5329, DOI 10.1128/JVI.00089-09; Dobbelstein M, 1997, EMBO J, V16, P4276, DOI 10.1093/emboj/16.14.4276; Dobner T, 2001, CURR TOP MICROBIOL, V259, P25; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Endter C, 2001, P NATL ACAD SCI USA, V98, P11312, DOI 10.1073/pnas.191361798; Flint SJ, 2003, CURR TOP MICROBIOL, V272, P287; Gabler S, 1998, J VIROL, V72, P7960, DOI 10.1128/JVI.72.10.7960-7971.1998; Gonzalez R, 2006, J VIROL, V80, P964, DOI 10.1128/JVI.80.2.964-974.2006; Gonzalez RA, 2002, J VIROL, V76, P4507, DOI 10.1128/JVI.76.9.4507-4519.2002; Groitl Peter, 2007, Methods Mol Med, V130, P29; Gupta A, 2013, ONCOGENE, V32, P5017, DOI 10.1038/onc.2012.534; Hagkarim NC, 2018, J VIROL, V92, DOI 10.1128/JVI.02034-17; Harada JN, 2002, J VIROL, V76, P9194, DOI 10.1128/JVI.76.18.9194-9206.2002; Harada JN, 1999, J VIROL, V73, P5333, DOI 10.1128/JVI.73.7.5333-5344.1999; Hidalgo P, 2016, J VIROL, V90, P3411, DOI 10.1128/JVI.00033-16; Horridge JJ, 1998, J VIROL, V72, P9374, DOI 10.1128/JVI.72.11.9374-9379.1998; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hung G, 2017, VIROLOGY, V504, P12, DOI 10.1016/j.virol.2017.01.013; Jurrus E, 2018, PROTEIN SCI, V27, P112, DOI 10.1002/pro.3280; Kallay C, 2011, DALTON T, V40, P9711, DOI 10.1039/c1dt10835b; Kato SEM, 2011, VIROLOGY, V417, P9, DOI 10.1016/j.virol.2011.04.014; Keller S, 2012, ANAL CHEM, V84, P5066, DOI 10.1021/ac3007522; Kindsmuller K, 2007, P NATL ACAD SCI USA, V104, P6684, DOI 10.1073/pnas.0702158104; Komatsu T, 2018, J VIROL, V92, DOI 10.1128/JVI.00795-18; Kratzer F, 2000, ONCOGENE, V19, P850, DOI 10.1038/sj.onc.1203395; LEPPARD KN, 1989, EMBO J, V8, P2329, DOI 10.1002/j.1460-2075.1989.tb08360.x; LOGAN J, 1984, P NATL ACAD SCI-BIOL, V81, P3655, DOI 10.1073/pnas.81.12.3655; Lu W, 2004, WORLD J GASTROENTERO, V10, P3634, DOI 10.3748/wjg.v10.i24.3634; Martin MED, 1998, J VIROL, V72, P3146, DOI 10.1128/JVI.72.4.3146-3154.1998; Menendez-Conejero R, 2017, STRUCTURE, V25, P1562, DOI 10.1016/j.str.2017.08.007; Miller DL, 2009, J VIROL, V83, P3591, DOI 10.1128/JVI.02269-08; O'Shea CC, 2004, CANCER CELL, V6, P611, DOI 10.1016/j.ccr.2004.11.012; Orazio NI, 2011, J VIROL, V85, P1887, DOI 10.1128/JVI.02134-10; ORNELLES DA, 1991, J VIROL, V65, P424, DOI 10.1128/JVI.65.1.424-429.1991; Pennella MA, 2010, J VIROL, V84, P12210, DOI 10.1128/JVI.01442-10; Querido E, 2001, GENE DEV, V15, P3104, DOI 10.1101/gad.926401; REICH NC, 1983, VIROLOGY, V128, P480, DOI 10.1016/0042-6822(83)90274-X; Rothmann T, 1998, J VIROL, V72, P9470, DOI 10.1128/JVI.72.12.9470-9478.1998; SARNOW P, 1984, J VIROL, V49, P692, DOI 10.1128/JVI.49.3.692-700.1984; Schmid M, 2014, J VIROL, V88, P1404, DOI 10.1128/JVI.02046-13; Schmid M, 2011, J VIROL, V85, P7081, DOI 10.1128/JVI.02368-10; Schreiner S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003775; Schreiner S, 2013, NUCLEIC ACIDS RES, V41, P3532, DOI 10.1093/nar/gkt064; Schreiner S, 2010, J VIROL, V84, P7029, DOI 10.1128/JVI.00074-10; Schwartz RA, 2008, J VIROL, V82, P9043, DOI 10.1128/JVI.00925-08; Sieber T, 2011, VIROLOGY, V418, P133, DOI 10.1016/j.virol.2011.07.012; SIGEL H, 1982, CHEM REV, V82, P385, DOI 10.1021/cr00050a003; Stracker TH, 2002, NATURE, V418, P348, DOI 10.1038/nature00863; Teodoro JG, 1997, J VIROL, V71, P3620, DOI 10.1128/JVI.71.5.3620-3627.1997; TEODORO JG, 1994, J VIROL, V68, P776, DOI 10.1128/JVI.68.2.776-786.1994; Turnell AS, 1999, J VIROL, V73, P2074, DOI 10.1128/JVI.73.3.2074-2083.1999; WILLIAMS JF, 1973, NATURE, V243, P162, DOI 10.1038/243162a0; Wimmer P, 2013, ONCOGENE, V32, P1626, DOI 10.1038/onc.2012.187; Yan YM, 2017, NUCLEIC ACIDS RES, V45, pW365, DOI 10.1093/nar/gkx407; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Yatherajam G, 2011, J VIROL, V85, P1429, DOI 10.1128/JVI.02108-10; YEW PR, 1994, GENE DEV, V8, P190, DOI 10.1101/gad.8.2.190; Yu W, 2007, CURR CANCER DRUG TAR, V7, P141, DOI 10.2174/156800907780058817; Zhao HY, 2015, METHODS, V76, P137, DOI 10.1016/j.ymeth.2014.11.012	75	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0214882	10.1371/journal.pone.0214882	http://dx.doi.org/10.1371/journal.pone.0214882			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR5NS	30943256	gold, Green Published, Green Submitted			2022-12-26	WOS:000463194300069
J	van Wijngaarden, E; Alma, M; The, AM				van Wijngaarden, Els; Alma, Manna; The, Anne-Mei			'The eyes of others' are what really matters: The experience of living with dementia from an insider perspective	PLOS ONE			English	Article							EARLY-STAGE DEMENTIA; ILLNESS REPRESENTATIONS; PHENOMENOLOGY; EMBODIMENT; CRITIQUE; PEOPLE; HEALTH; DIPEX; SELF; CARE	Introduction This Dutch study is a qualitative interview study. It aims to contribute to our understanding of the day-to-day experiences by providing an idiographic description of what it means existentially to be in the world as a person affected by a form of dementia, taking into account the contextual nature of these embodied experiences. Methods We used a combination of narrative accounts of people from dementia. We first collected 322 recorded messages of 16 diarists who joined the Dutch Dementia Diaries project. This data was supplemented with 37 interview accounts. Our data analysis was inspired by Van Manen's existential phenomenological approach. Results The findings show that living with dementia-from a first-person perspective-can be understood as a severely unsettling experience: the people concerned enter a very uncertain, unpredictable and ambiguous period of life. They have to face all kinds of losses that considerably change and disrupt their relationships with 1) their own body, 2) with others and 3) with the surrounding world. This experience is explicated in the following themes: la) scrutinizing your disrupted body; 1b) trying to control your bodily loss-of-control; 2a) feeling scrutinized by the suspicious gaze of others; 2b) drifting away from significant others; 2c) having difficulties sharing the struggle; 2d) longing to be taken seriously; 2e) engaging in a world of peers; and 3a) sensing disorientation in an alien place; 3b) feeling closed in within a shrinking space; 3c) trying to control a dreaded future; 3d) trying to control a dreaded future by means of euthanasia. Discussion Our study demonstrates how the people with dementia are affected by 'the eyes of others'. They longed for a safe and accepting environment, but quite often felt scrutinized by inquisitive and disapproving looks. The outcomes also reveal a connection between dominant social imaginaries and people's self-understanding of dementia. Much of the suffering stems from living under the shadow of negative imaginaries. Furthermore, our study supports the demand for a socio-relational approach by demonstrating that-from a first-person perspective-dementia can be seen a disorder that is related in particular to questions about self-hood, social relations and social roles. For the people involved, instead of what dementia is, the focus is on what Alzheimer's disease means and does and how it affects daily life.	[van Wijngaarden, Els] Univ Humanist Studies, Res Grp Care Eth, Utrecht, Netherlands; [van Wijngaarden, Els] Res Org Tao Care, Amsterdam, Netherlands; [Alma, Manna] Univ Groningen, Univ Med Ctr Groningen, Appl Hlth Res, Dept Hlth Sci, Groningen, Netherlands; [The, Anne-Mei] Univ Amsterdam, Fac Social & Behav Sci, Amsterdam, Netherlands	University of Groningen; University of Amsterdam	van Wijngaarden, E (corresponding author), Univ Humanist Studies, Res Grp Care Eth, Utrecht, Netherlands.; van Wijngaarden, E (corresponding author), Res Org Tao Care, Amsterdam, Netherlands.	e.vanwijngaarden@uvh.nl	van Wijngaarden, Els/AAH-3414-2021; Alma, Manna/G-7987-2011; The, Anne-Mei/AAE-3468-2020	van Wijngaarden, Els/0000-0002-2940-9163; Alma, Manna/0000-0002-8203-2713	Netherlands Organization for Health Research and Development (ZonMw), research program "National Care for the Elderly" [314010301]	Netherlands Organization for Health Research and Development (ZonMw), research program "National Care for the Elderly"	The first and third author received no specific funding for this work. The second author works for the project PratenOverGezondheid. This PratenOverGezondheid study was supported by a grant (314010301) from the Netherlands Organization for Health Research and Development (ZonMw), research program "National Care for the Elderly", appointed by the Ministry of Health (VWS) and the Netherlands Organization for Scientific Research (NWO).	[Anonymous], 2017, THEOLOGICAL ETHICS M; Ashworth A., 2003, J PHENOMENOLOGICAL P, V34, P179, DOI DOI 10.1163/156916203322847137; Carel H, 2012, J MED PHILOS, V37, P96, DOI 10.1093/jmp/jhs008; Cassell EricJ., 1998, LOSS GRIEF CARE, V8, P129, DOI [DOI 10.1300/J132V08N01_18, 10.1300/J132v08n01_18]; Castoriadis C., 1997, IMAGINARY I SOC; Cheston R, 2015, SCI PROGRESS-UK, V98, P416, DOI 10.3184/003685015X14467423210693; Clare L, 2003, SOC SCI MED, V57, P1017, DOI 10.1016/S0277-9536(02)00476-8; Clare L, 2006, INT J GERIATR PSYCH, V21, P761, DOI 10.1002/gps.1558; Clare L, 2008, GERONTOLOGIST, V48, P711, DOI 10.1093/geront/48.6.711; Coyne IT, 1997, J ADV NURS, V26, P623, DOI 10.1046/j.1365-2648.1997.t01-25-00999.x; Dahlberg K., 2008, REFLECTIVE LIFEWORLD, V2nd ed.; Dahlberg K., 2006, INDO-PAC J PHENOMEN, DOI [DOI 10.1080/20797222.2006.11433932, 10.1080/20797222.2006.11433932]; Davis DHJ, 2004, SOC SCI MED, V58, P369, DOI 10.1016/S0277-9536(03)00202-8; de Boer ME, 2007, INT PSYCHOGERIATR, V19, P1021, DOI 10.1017/S1041610207005765; Downs M, 2000, AGEING SOC, V20, P369, DOI 10.1017/S0144686X99007758; Droes RM, 2010, NON PHARM THER DEMEN, V1, P139; Droes RM, 2011, EXPERT REV NEUROTHER, V11, P1769, DOI [10.1586/ern.11.167, 10.1586/ERN.11.167]; Finlay L, 2011, PHENOMENOLOGY FOR THERAPISTS: RESEARCHING THE LIVED WORLD, P1, DOI 10.1002/9781119975144; Giddens A., 1991, MODERNITY SELF IDENT; Gilleard, 2015, RETHINKING OLD AGE T; Gilleard C, 2013, J AGING STUD, V27, P368, DOI 10.1016/j.jaging.2013.08.004; Gilleard C, 2011, J AGING STUD, V25, P135, DOI 10.1016/j.jaging.2010.08.018; Gouras GK, 2014, DEMENTIA REFERENCE M, DOI 10.1016/B978-0-12-801238-3.00159-8; Harman G, 2006, QUAL HEALTH RES, V16, P484, DOI 10.1177/1049732306286851; Hayne Y, 2002, WRITING DARK PHENOME, P179; Herxheimer A, 2000, LANCET, V355, P1540, DOI 10.1016/S0140-6736(00)02174-7; Herxheimer A, 2004, NARRATIVE RES HLTH I, P115; Johnston B, 2016, BMC GERIATR, V16, DOI 10.1186/s12877-016-0250-1; Leventhal H, 2001, HANDBOOK OF HEALTH PSYCHOLOGY, P19; Leventhal H., ILLNESS REPRESENTATI; LYMAN KA, 1989, GERONTOLOGIST, V29, P597, DOI 10.1093/geront/29.5.597; Macquarrie CR, 2005, AGING MENT HEALTH, V9, P430, DOI 10.1080/13607860500142853; Martinsen EH, 2011, HEALTH CARE ANAL, V19, P15, DOI 10.1007/s10728-010-0161-9; Matchwick C, 2014, GERONTOLOGIST, V54, P268, DOI 10.1093/geront/gnt014; Onwuteaka-Philipsen B., 2017, 3 EVALUATIE WET TOET; Patton M. Q., 2002, QUALITATIVE RES EVAL, V3rd; Post S.G., 2000, CONCEPTS ALZHEIMERS, P245; Prince M., 2016, WORLD ALZHEIMER REPO; Riessman C.K., 2008, NARRATIVE METHODS HU, P21; Sabat, 2006, DEMENTIA MIND MEANIN; Seaman Aaron, 2016, FIGURING FAMILIES CA; Slatman J, 2014, MED HEALTH CARE PHIL, V17, P549, DOI 10.1007/s11019-014-9544-2; Steeman E, 2006, J ADV NURS, V54, P722, DOI 10.1111/j.1365-2648.2006.03874.x; Svenaeus F, 2015, CONT PHILOS REV, V48, P107, DOI 10.1007/s11007-015-9325-5; Svenaeus F, 2009, HUM STUD, V32, P53, DOI 10.1007/s10746-009-9109-1; Taylor Charles, 2004, MODERN SOCIAL IMAGER; Taylor Charles, 1989, SOURCES SELF MAKING; Taylor Janelle S, 2011, ANTHR NOW, V3, P62; The AM, 2017, DAG LEV MET DEM BLIK; Todres, 2013, CARING WELL BEING LI; Todres L, 2007, EMBODIED ENQUIRY: PHENOMENOLOGICAL TOUCHSTONES FOR RESEARCH, PSYCHOTHERAPY AND SPIRITUALITY, P1, DOI 10.1057/9780230598850; Todres Les, 2007, Med Health Care Philos, V10, P53, DOI 10.1007/s11019-006-9012-8; Todres L, 2014, INT J QUAL STUD HEAL, V9, DOI 10.3402/qhw.v9.21421; van Manen M., 1990, RES LIVED EXPERIENCE; Van Manen M., 1984, PHENOMENOLOGY PEDAGO, V2, P36, DOI DOI 10.29173/pandp14931; Van Manen Max., 2014, PHENOMENOLOGY PRACTI, V13; Van Wijngaarden E, 2018, PLOS ONE, V13, P1; van Wijngaarden EJ, BRIDGE GAP AVAILABLE; van Wijngaarden Els, 2017, Tijdschr Gerontol Geriatr, V48, P169, DOI 10.1007/s12439-017-0222-8; van Wijngaarden E, 2017, QUAL HEALTH RES, V27, P1738, DOI 10.1177/1049732317711133; van Wijngaarden E, 2016, MED HEALTH CARE PHIL, V19, P265, DOI 10.1007/s11019-016-9687-4; Ziebland S, 2006, MED EDUC, V40, P405, DOI 10.1111/j.1365-2929.2006.02467.x	62	15	15	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0214724	10.1371/journal.pone.0214724	http://dx.doi.org/10.1371/journal.pone.0214724			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HR5NS	30943277	Green Published, gold, Green Submitted			2022-12-26	WOS:000463194300055
J	Aikins, AD; Dodoo, F; Awuah, RB; Owusu-Dabo, E; Addo, J; Nicolaou, M; Beune, E; Mockenhaupt, FP; Danquah, I; Bahendeka, S; Meeks, K; Klipstein-Grobusch, K; Afrifa-Anane, E; Smeeth, L; Stronks, K; Agyemang, C				Aikins, Ama de-Graft; Dodoo, Francis; Awuah, Raphael Baffour; Owusu-Dabo, Ellis; Addo, Juliet; Nicolaou, Mary; Beune, Erik; Mockenhaupt, Frank P.; Danquah, Ina; Bahendeka, Silver; Meeks, Karlijn; Klipstein-Grobusch, Kirstin; Afrifa-Anane, Ernest; Smeeth, Liam; Stronks, Karien; Agyemang, Charles			Knowledge and perceptions of type 2 diabetes among Ghanaian migrants in three European countries and Ghanaians in rural and urban Ghana: The RODAM qualitative study	PLOS ONE			English	Article							SOCIAL REPRESENTATIONS; AFRICAN-SURINAMESE; EXPLANATORY MODELS; HEALTH; HYPERTENSION; BELIEFS; ILLNESS	African migrants in Europe and continental Africans are disproportionately affected by type 2 diabetes (T2D). Both groups develop T2D at a younger age, and have higher morbidity and mortality from T2D and complications, compared to European populations. To reduce risk, and avoidable disability and premature deaths, culturally congruent and context specific interventions are required. This study aimed to: (a) assess perceptions and knowledge of T2D among Ghanaian migrants in Europe and their compatriots in Ghana and (b) identify specific perceptions and knowledge gaps that might predispose migrants to higher risk of diabetes. Data was gathered through 26 focus groups with 180 individuals, aged 21 to 70, from Amsterdam, Berlin and London and rural and urban Ashanti Region, Ghana. Thematic analysis of the data was informed by Social Representations Theory, which focuses on the sources, content and functions of social knowledge. Three key insights emerged from analysis. First, there was general awareness, across migrant and non-migrant groups, of T2D as a serious chronic condition with life threatening complications, and some knowledge of biomedical strategies to prevent diabetes (e.g healthy eating) and diabetes complications (e.g medication adherence). However, knowledge of T2D prevention and reduction of diabetes complications was not comprehensive. Secondly, knowledge of biomedical diabetes theories and interventions co-existed with theories about psychosocial and supernatural causes of diabetes and the efficacy of herbal and faith-based treatment of diabetes. Finally, migrants' knowledge was informed by both Ghanaian and European systems of T2D knowledge suggesting enculturation dynamics. We discuss the development of culturally congruent and context-specific T2D interventions for the research communities.	[Aikins, Ama de-Graft; Dodoo, Francis; Awuah, Raphael Baffour; Afrifa-Anane, Ernest] Univ Ghana, Reg Inst Populat Studies, Legon, Ghana; [Owusu-Dabo, Ellis] Kwame Nkrumah Univ Sci & Technol, Kumasi Ctr Collaborat Res, Kumasi, Ghana; [Addo, Juliet; Smeeth, Liam] London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, London, England; [Nicolaou, Mary; Beune, Erik; Meeks, Karlijn; Stronks, Karien; Agyemang, Charles] Univ Amsterdam, Acad Med Ctr, Dept Publ Hlth, Amsterdam, Netherlands; [Mockenhaupt, Frank P.] Charite Univ Med Berlin, Inst Trop Med & Int Hlth, Berlin, Germany; [Danquah, Ina] German Inst Human Nutr, Dept Mol Epidemiol, Potsdam, Nuthetal, Germany; [Bahendeka, Silver] Uganda Matyrs Univ, MKPGMS, Kampala, Uganda; [Klipstein-Grobusch, Kirstin] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Julius Global Hlth, Utrecht, Netherlands	University of Ghana; Kumasi Center for Collaborative Research; Kwame Nkrumah University Science & Technology; University of London; London School of Hygiene & Tropical Medicine; University of Amsterdam; Academic Medical Center Amsterdam; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Utrecht University; Utrecht University Medical Center	Aikins, AD (corresponding author), Univ Ghana, Reg Inst Populat Studies, Legon, Ghana.	adaikins@ug.edu.gh	Mockenhaupt, Frank P/U-9824-2017; Klipstein-Grobusch, Kerstin/F-5555-2016; Smeeth, Liam/X-5862-2018	Mockenhaupt, Frank P/0000-0002-8117-5421; Klipstein-Grobusch, Kerstin/0000-0002-5462-9889; Danquah, Ina/0000-0003-3222-3498; Meeks, Karlijn/0000-0003-3032-405X; Smeeth, Liam/0000-0002-9168-6022; Stronks, Karien/0000-0002-0921-2232	European Commission [278901]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the European Commission under the Framework Programme: Grant Number 278901.	Agyemang C, 2017, ANN NY ACAD SCI, V1391, P54, DOI 10.1111/nyas.13204; Agyemang C, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-004877; Agyemang C, 2013, EUR J PREV CARDIOL, V20, P938, DOI 10.1177/2047487312451540; Agyemang C, 2009, GLOBALIZATION HEALTH, V5, DOI 10.1186/1744-8603-5-7; Aikins AD, 2005, BMJ-BRIT MED J, V331, P737, DOI 10.1136/bmj.331.7519.737; Aikins ADG, 2004, J HEALTH PSYCHOL, V9, P295, DOI 10.1177/1359105304040895; Aikins AD, 2012, GLOBALIZATION HEALTH, V8, DOI 10.1186/1744-8603-8-29; [Anonymous], 2002, FORUM QUAL SOC RES, V30, P3; Attride-Stirling J, 2001, QUAL RES, V1, P385, DOI DOI 10.1177/146879410100100307; Awah PK, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-43; Awah PK, 2008, AFRICA, V78, P475, DOI 10.3366/E0001972008000405; Beune EJAJ, 2006, J HUM HYPERTENS, V20, P946, DOI 10.1038/sj.jhh.1002094; Beune EJAJ, 2008, J HYPERTENS, V26, P648, DOI 10.1097/HJH.0b013e3282f4d20b; Cole D. C., 2008, HLTH CITY HARVESTS G; Cooper M, 2012, ETHNIC HEALTH, V17, P597, DOI 10.1080/13557858.2012.740003; de Graft Aikins A, 2012, Ghana Med J, V46, P59; de-Graft Aikins A, 2014, ETHN HLTH, V20, P391, DOI [DOI 10.1080/13557858.2014.921896, 10.1080/13557858.2014.921896]; Duveen G, 1998, CULT PSYCHOL, V4, P455, DOI 10.1177/1354067X9800400402; Garro L C, 1995, Soc Sci Med, V40, P37, DOI 10.1016/0277-9536(94)00125-D; Greenhalgh T, 1998, BRIT MED J, V316, P978, DOI 10.1136/bmj.316.7136.978; Hjelm K, 2008, INT NURS REV, V55, P434, DOI 10.1111/j.1466-7657.2008.00665.x; Hjelm K, 2010, BMC INT HEALTH HUM R, V10, DOI 10.1186/1472-698X-10-7; Joffe H, 2002, SOC SCI INFORM, V41, P559, DOI 10.1177/0539018402041004004; Joychelovitch S., 2002, PSYCHOL SOC, V5, P121; Kiawi E, 2006, ETHNIC DIS, V16, P503; Kolling M, 2010, GLOBALIZATION HEALTH, V6, DOI 10.1186/1744-8603-6-8; Krause K, 2008, J ETHN MIGR STUD, V34, P235, DOI 10.1080/13691830701823863; MOSCOVICI S, 1988, EUR J SOC PSYCHOL, V18, P211, DOI 10.1002/ejsp.2420180303; nternational Diabetes Federation, 2015, DIABETES ATLAS; Parish Jane, 2011, Anthropol Med, V18, P303, DOI 10.1080/13648470.2011.615910; Sabone MB, 2008, J FAM NURS, V14, P363, DOI 10.1177/1074840708323047; Schwartz SJ, 2010, AM PSYCHOL, V65, P237, DOI 10.1037/a0019330; Simao TP, 2016, RELIGIONS, V7, DOI 10.3390/rel7010011; Taylor KD, 2012, ETHNIC HEALTH, V17, P615, DOI 10.1080/13557858.2013.771151; Vickers T., 2012, RES BLACK MINORITY E; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; Yates-Doerr E, 2016, MED ANTHROPOL, V35, P305, DOI 10.1080/01459740.2015.1030402	37	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2019	14	4							e0214501	10.1371/journal.pone.0214501	http://dx.doi.org/10.1371/journal.pone.0214501			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HR2UW	30939148	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000462993900027
J	Tayler, NM; Boya, CA; Herrera, L; Moy, J; Ng, M; Pineda, L; Almanza, A; Rosero, S; Coronado, LM; Correa, R; Santamaria, R; Caballero, Z; Durant-Archibold, AA; Currency, KJT; Balunas, MJ; Gerwick, WH; Spadafora, A; Gutierrez, M; SpadaforaID, C				Tayler, Nicole M.; Boya, Cristopher A.; Herrera, Liuris; Moy, Jamie; Ng, Michelle; Pineda, Laura; Almanza, Alejandro; Rosero, Sara; Coronado, Lorena M.; Correa, Ricardo; Santamaria, Ricardo; Caballero, Zuleima; Durant-Archibold, Armando A.; Currency, Kevin J. Tidgewell; Balunas, Marcy J.; Gerwick, William H.; Spadafora, Alida; Gutierrez, Marcelino; SpadaforaID, Carmenza			Analysis of the antiparasitic and anticancer activity of the coconut palm (Cocos nucifera L. ARECACEAE) from the natural reserve of Punta Patino, Darien	PLOS ONE			English	Article							IN-VITRO; DRUG; PARASITES	Cocos nucifera (C. nucifera) (the coconut palm tree) has been traditionally used to fight a number of human diseases, but only a few studies have tested its components against parasites such as those that cause malaria. In this study, C. nucifera samples were collected from a private natural reserve in Punta Patino, Darien, Panama. The husk, leaves, pulp, and milk of C. nucifera were extracted and evaluated against the parasites that cause Chagas' disease or American trypanosomiasis (Trypanosoma cruzi), leishmaniasis (Leishmania donovani) and malaria (Plasmodium falciparum), as well as against a line of breast cancer cells. While there was no activity in the rest of the tests, five and fifteen-minute aqueous decoctions of leaves showed antiplasmodial activity at 10% v/v concentration. Removal of some HPLC fractions resulted in loss of activity, pointing to the presence of synergy between the components of the decoction. Chemical molecules were separated and identified using an ultra-performance liquid chromatography (UPLC) approach coupled to tandem mass spectrometry (LC-MS/MS) using atmospheric pressure chemical ionization quadrupole-time of flight mass spectrometry (APCI-Q-TOF-MS) and molecular networking analysis, revealing the presence of compounds including polyphenol, flavone, sterol, fatty acid and chlorophyll families, among others.	[Tayler, Nicole M.; Herrera, Liuris; Ng, Michelle; Pineda, Laura; Almanza, Alejandro; Rosero, Sara; Coronado, Lorena M.; Correa, Ricardo; Caballero, Zuleima; SpadaforaID, Carmenza] Inst Invest Cienti & Serv Alta Tecnol INDICASAT A, Ctr Biol Celular & Mol Enfermedades, Panama City, Panama; [Tayler, Nicole M.; Boya, Cristopher A.; Coronado, Lorena M.; Correa, Ricardo; Gutierrez, Marcelino] Acharya Nagarjuna Univ, Dept Biotechnol, Guntur, AP, India; [Boya, Cristopher A.; Santamaria, Ricardo; Durant-Archibold, Armando A.] INDICASAT AIP, Ctr Biodiversidad & Descubrimiento Drogas, Panama City, Panama; [Herrera, Liuris; Moy, Jamie; Ng, Michelle; Pineda, Laura; Almanza, Alejandro; Currency, Kevin J. Tidgewell] Smithsonian Trop Res Inst, Panama City, Panama; [Balunas, Marcy J.] Univ Connecticut, Div Med Chem, Dept Pharmaceut Sci, Storrs, CT USA; [Gerwick, William H.] Univ Calif San Diego, Scripps Inst Oceanog, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Gerwick, William H.] Univ Calif San Diego, Scripps Inst Oceanog, Ctr Marine Biotechnol & Biomed, La Jolla, CA 92093 USA; [Spadafora, Alida] Asociac Nacl Conservac Nat ANCON, Panama City, Panama	Acharya Nagarjuna University; Instituto de Investigacion Cientificas y Servicios de Alta Tecnologia (INDICASAT-AIP); Smithsonian Institution; Smithsonian Tropical Research Institute; University of Connecticut; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of California System; University of California San Diego; Scripps Institution of Oceanography	SpadaforaID, C (corresponding author), Inst Invest Cienti & Serv Alta Tecnol INDICASAT A, Ctr Biol Celular & Mol Enfermedades, Panama City, Panama.	cspadafora@indicasat.org.pa	Spadafora, Carmenza/ABE-8973-2020; Gutiérrez, Marcelino/V-8134-2019	Spadafora, Carmenza/0000-0002-3002-9467; Gutiérrez, Marcelino/0000-0003-1423-3772; Correa, Ricardo/0000-0001-5475-5407; Boya P., Cristopher A./0000-0002-8093-596X; DURANT ARCHIBOLD, ARMANDO/0000-0002-6516-9427; Coronado, Lorena/0000-0001-6755-3118; Tidgewell, Kevin/0000-0002-0501-2604; Tayler, Nicole/0000-0003-4431-6464; Balunas, Marcy/0000-0003-2374-4048	SENACYT, Panama [CCP10-PP013]; NIH (The International Fogarty Center), USA [ICBG TW006634]; FIC International Research Scientist Development Award (IRSDA) [K01 TW008002]; UCSC NIH MHIRT Research Training Grant [5T37MD001480-22]; Panama National System of Investigation (SNI) [SNI 120-2018, SNI 33-2015, SNI 170-2016, SNI 214-2017, SNI 162-2018]; Instituto para la Formacion y Aprovechamiento de los Recursos Humanos-Panama; National Institute on Minority Health and Health Disparities [T37MD001480] Funding Source: NIH RePORTER	SENACYT, Panama; NIH (The International Fogarty Center), USA; FIC International Research Scientist Development Award (IRSDA); UCSC NIH MHIRT Research Training Grant; Panama National System of Investigation (SNI); Instituto para la Formacion y Aprovechamiento de los Recursos Humanos-Panama; National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This project was supported by the following research grants: SENACYT, Panama (CCP10-PP013) to A.S. and C.S.; NIH (The International Fogarty Center), USA (ICBG TW006634) to W.H.G.; FIC International Research Scientist Development Award (IRSDA) (K01 TW008002) to M.J.B.; and UCSC NIH MHIRT Research Training Grant 5T37MD001480-22 supporting J.M., C.S. and M.G. The Panama National System of Investigation (SNI) supported in part the following persons: C.S. (SNI 120-2018), A.A.D.(SNI 33-2015), R.C. (SNI 170-2016), Z.C. (SNI 214-2017) and L.M.C. (SNI 162-2018). SENACYT together with the Instituto para la Formacion y Aprovechamiento de los Recursos Humanos-Panama supported N.T., L.M.C. and R.C. with doctoral scholarships.	Achan J, 2018, EXPERT REV CLIN PHAR, V11, P61, DOI 10.1080/17512433.2018.1387773; Adebayo JO, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/742476; Almanza A., 2011, Current Trends in Biotechnology and Pharmacy, V5, P1130; Bianchi S, 2015, PHYTOCHEMISTRY, V120, P53, DOI 10.1016/j.phytochem.2015.10.006; Buckner FS, 1996, ANTIMICROB AGENTS CH, V40, P2592, DOI 10.1128/AAC.40.11.2592; Calderon AI, 2006, PHARM BIOL, V44, P487, DOI 10.1080/13880200600878361; Chandrashekaran IR, 2011, ARCH BIOCHEM BIOPHYS, V513, P153, DOI 10.1016/j.abb.2011.07.008; Chang CL, 2011, FOOD CHEM, V126, P710, DOI 10.1016/j.foodchem.2010.11.034; Chithambo B, 2017, J ETHNOPHARMACOL, V199, P91, DOI 10.1016/j.jep.2017.01.051; Corbett Y, 2004, AM J TROP MED HYG, V70, P119, DOI 10.4269/ajtmh.2004.70.119; Fund CEP, MESOAMERICA; Jansen O, 2017, J ETHNOPHARMACOL, V203, P20, DOI 10.1016/j.jep.2017.03.021; Lehane Adele M, 2008, BMC Res Notes, V1, P26, DOI 10.1186/1756-0500-1-26; Manalo RV, 2017, BIOMEDICINES, V5, DOI 10.3390/biomedicines5020017; Mendonca RR, 2004, RES MICROBIOL, V155, P136, DOI 10.1016/j.resmic.2003.12.001; MONKS A, 1991, J NATL CANCER I, V83, P757, DOI 10.1093/jnci/83.11.757; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Romanha AJ, 2010, MEM I OSWALDO CRUZ, V105, P233, DOI 10.1590/S0074-02762010000200022; Roopan SM, 2016, APPL BIOCHEM BIOTECH, V179, P1309, DOI 10.1007/s12010-016-2067-y; Ross IA, 1993, CHEM CONSTITUENTS TR; Schoenen F.J., 2010, PROBE REPORTS NIH MO; Seto R, 1997, BIOSCI BIOTECH BIOCH, V61, P1434, DOI 10.1271/bbb.61.1434; Spadafora C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000968; Thomas R, 2008, CURR PHARM BIOTECHNO, V9, P315, DOI 10.2174/138920108785161505; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Wang MX, 2016, NAT BIOTECHNOL, V34, P828, DOI 10.1038/nbt.3597; WHO, 2016, WHAT IS CHAG DIS; World Health Organization, 2017, FACT SHEET WORLD MAL	28	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2019	14	4							e0214193	10.1371/journal.pone.0214193	http://dx.doi.org/10.1371/journal.pone.0214193			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR2UW	30939131	gold, Green Published, Green Submitted			2022-12-26	WOS:000462993900015
J	Han, S; Jeong, HS; Kim, H; Suh, HS				Han, Sola; Jeong, Hwa Seop; Kim, Hyungtae; Suh, Hae Sun			The treatment pattern and adherence to direct oral anticoagulants in patients with atrial fibrillation aged over 65	PLOS ONE			English	Article							WARFARIN; STROKE; PERSISTENCE; DABIGATRAN	Objective In this study, we aimed to assess the utilization pattern (potentially inappropriate dosing and concomitant use of contraindicated drugs) and adherence to direct oral anticoagulants (DOACs), including apixaban, dabigatran, and rivaroxaban, in patients with atrial fibrillation (AF) unsuitable for warfarin. Methods We used nationally representative data, namely Health Insurance Review and Assessment Service-Aged Patient Sample 2014, that included medical and pharmacy claims of approximately 1 million patients aged 65 or older. We included patients who had at least one diagnosis of AF and at least one prescription of DOAC between January 1 and December 31, 2014. In 2014, DOACs were reimbursed only to patients with AF unsuitable for warfarin. Appropriate dosing and contraindicated drugs were determined according to the Summary of Product Characteristics for each DOAC. Multivariate logistic regression was performed to examine the factors contributing to the concomitant use of contraindicated drugs. To assess adherence, we calculated the medication possession ratio (MPR). Results The percentage of inappropriate dosing was 11.8% among 1,234 patients with AF; it was the highest in rivaroxaban users (16.8%). Contraindicated drugs were prescribed to 236 patients (19.1%). Clinics, smaller healthcare institutions, and outpatient visits were significantly related to contraindicated drug use. The mean MPRs were 0.95, 0.93, and 0.91 for apixaban, dabigatran, and rivaroxaban, respectively (P = 0.075). Conclusions Careful monitoring is warranted in patients with AF aged over 65 who were unsuitable for warfarin to reduce the incidence of inappropriate dosing and concomitant use of contraindicated drugs.	[Han, Sola; Jeong, Hwa Seop; Kim, Hyungtae; Suh, Hae Sun] Pusan Natl Univ, Coll Pharm, Busan, South Korea	Pusan National University	Suh, HS (corresponding author), Pusan Natl Univ, Coll Pharm, Busan, South Korea.	haesun.suh@pusan.ac.kr	Han, Sola/ABE-5476-2021	Han, Sola/0000-0002-6269-172X	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [NRF-2016R1C1B1009198]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (NRF-2016R1C1B1009198).	Barra ME, 2016, AM J MED, V129, P1198, DOI 10.1016/j.amjmed.2016.05.041; Beyer-Westendorf J, 2016, EUROPACE, V18, P1150, DOI 10.1093/europace/euv421; Carter Aleesa A, 2015, Can J Hosp Pharm, V68, P369; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Harper P, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-020212; Howard M, 2017, J THROMB THROMBOLYS, V43, P149, DOI 10.1007/s11239-016-1435-3; Jung BC, 2015, KOREAN CIRC J, V45, P9, DOI 10.4070/kcj.2015.45.1.9; Kim L, 2014, EPIDEMIOL HEALTH, V36, DOI 10.4178/epih/e2014008; Ko YJ, 2018, J KOREAN MED SCI, V33, DOI 10.3346/jkms.2018.33.e163; Nishimura RA, 2014, J THORAC CARDIOV SUR, V148, pE1, DOI 10.1016/j.jtcvs.2014.05.014; Olesen JB, 2015, EUROPACE, V17, P187, DOI 10.1093/europace/euu225; Patel MR, 2010, NEW ENGL J MED, V362, P886, DOI 10.1056/NEJMoa0907272; Peterson AM, 2007, VALUE HEALTH, V10, P3, DOI 10.1111/j.1524-4733.2006.00139.x; Reilly PA, 2014, J AM COLL CARDIOL, V63, P321, DOI 10.1016/j.jacc.2013.07.104; Sinnaeve PR, 2012, J INTERN MED, V271, P15, DOI 10.1111/j.1365-2796.2011.02464.x; Vrijens B, 2012, BRIT J CLIN PHARMACO, V73, P691, DOI 10.1111/j.1365-2125.2012.04167.x; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; Zhou M, 2015, J MANAG CARE SPEC PH, V21, P1054, DOI 10.18553/jmcp.2015.21.11.1054; 고점석, 2011, [The Korean Journal of Medicine, 대한내과학회지], V81, P434	21	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2019	14	4							e0214666	10.1371/journal.pone.0214666	http://dx.doi.org/10.1371/journal.pone.0214666			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR1CY	30934004	Green Published, gold, Green Submitted			2022-12-26	WOS:000462867000032
J	Iyer, RG; Rogers, DV; Levine, M; Winchell, CJ; Weisblat, DA				Iyer, Roshni G.; Rogers, D. Valle; Levine, Michelle; Winchell, Christopher J.; Weisblat, David A.			Reproductive differences among species, and between individuals and cohorts, in the leech genus Helobdella (Lophotrochozoa; Annelida; Clitellata; Hirudinida; Glossiphoniidae), with implications for reproductive resource allocation in hermaphrodites	PLOS ONE			English	Article							LIFE-HISTORY; ZEYLANICOBDELLA-ARUGAMENSIS; MARINE LEECH; TRISERIALIS; PHYLOGENY; MORPHOLOGY; SEQUENCE; ACCURACY; BEHAVIOR; ECOLOGY	Leeches and oligochaetes comprise a monophyletic group of annelids, the Clitellata, whose reproduction is characterized by simultaneous hermaphroditism. While most clitellate species reproduce by cross-fertilization, self-fertilization has been described within the speciose genus Helobdella. Here we document the reproductive life histories and reproductive capacities for three other Helobdella species. Under laboratory conditions, both H. robusta and H. octatestisaca exhibit uniparental reproduction, apparently reflecting self-fertility, and suggesting that this trait is ancestral for the genus. However, the third species, H. austinensis, seems incapable of reproduction by self-fertilization, so we inferred its reproductive life history by analyzing reproduction in breeding cohorts. Comparing the reproductive parameters for H. robusta reproducing in isolation and in cohorts revealed that reproduction in cohorts is dramatically delayed with respect to that of isolated individuals, and that cohorts of leeches coordinate their cocoon deposition in a manner that is not predicted from the reproductive parameters of individuals reproducing in isolation. Finally, our comparisons of reproductive capacity for individuals versus cohorts for H. robusta, and between different sizes of cohorts for H. austinensis, reveal differences in resource allocation between male and female reproductive roles that are consistent with evolutionary theory.	[Iyer, Roshni G.] Univ Calif Berkeley, Dept Elect Engn & Comp Sci, Berkeley, CA 94720 USA; [Rogers, D. Valle; Levine, Michelle; Winchell, Christopher J.; Weisblat, David A.] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Levine, Michelle] Rocky Vista Univ, Coll Osteopath Med, Parker, CO USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Weisblat, DA (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	weisblat@berkeley.edu		Weisblat, David/0000-0002-9617-4130; Rogers, Dylan/0000-0001-7674-2199				Anisimova M, 2011, SYST BIOL, V60, P685, DOI 10.1093/sysbio/syr041; Apakupakul K, 1999, MOL PHYLOGENET EVOL, V12, P350, DOI 10.1006/mpev.1999.0639; ASTROW SH, 1989, DEV BIOL, V135, P306, DOI 10.1016/0012-1606(89)90181-4; Bely AE, 2006, EVOL DEV, V8, P491, DOI 10.1111/j.1525-142X.2006.00122.x; Beresic-Perrins RK, 2017, ZOOKEYS, P137, DOI 10.3897/zookeys.661.9728; BLINN DW, 1989, OECOLOGIA, V79, P6, DOI 10.1007/BF00378232; Boore JL, 2000, MOL BIOL EVOL, V17, P87, DOI 10.1093/oxfordjournals.molbev.a026241; Cannarsa E, 2017, CURR ZOOL, V63, P151, DOI 10.1093/cz/zow030; Cho SJ, 2014, MOL BIOL EVOL, V31, P341, DOI 10.1093/molbev/mst201; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; DAVIES R W, 1982, Freshwater Invertebrate Biology, V1, P40, DOI 10.2307/1467140; DAVIES RW, 1989, OECOLOGIA, V81, P329, DOI 10.1007/BF00377079; Davies RW, 1996, FRESHWATER BIOL, V36, P563, DOI 10.1046/j.1365-2427.1996.00121.x; Deiner K, 2013, MOL ECOL RESOUR, V13, P820, DOI 10.1111/1755-0998.12130; ELSHIMY NA, 1991, HYDROBIOLOGIA, V222, P173, DOI 10.1007/BF00016156; Fischer A, 1999, HYDROBIOLOGIA, V402, P1, DOI 10.1023/A:1003719906378; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Kua BC, 2010, AQUACULTURE, V302, P153, DOI 10.1016/j.aquaculture.2010.02.029; Kuo DH, 2017, DEV BIOL, V427, P230, DOI 10.1016/j.ydbio.2017.01.016; Kutschera U, 2013, ZOOSYST EVOL, V89, P239, DOI 10.1002/zoos.201300010; Lai YT, 2009, ZOOTAXA, P27, DOI 10.11646/zootaxa.2068.1.2; LEARNER MA, 1974, J ANIM ECOL, V43, P199, DOI 10.2307/3167; Lively CM, 2014, J EVOLUTION BIOL, V27, P1292, DOI 10.1111/jeb.12354; MULLER KJ, 1981, NEUROBIOLOGY LEECH; MURPHY PM, 1982, FRESHWATER BIOL, V12, P321, DOI 10.1111/j.1365-2427.1982.tb00626.x; Oceguera-Figueroa A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155441; Oceguera-Figueroa A, 2012, MOL PHYLOGENET EVOL, V62, P508, DOI 10.1016/j.ympev.2011.10.020; Oceguera-Figueroa A, 2010, MITOCHONDR DNA, V21, P24, DOI 10.3109/19401736.2010.527965; OOSTHUIZEN JH, 1985, S AFR J WILDL RES, V15, P98; Pamungkas J, 2015, ZOOKEYS, P1, DOI 10.3897/zookeys.520.9581; Pfeiffer I, 2004, MOL PHYLOGENET EVOL, V33, P214, DOI 10.1016/j.ympev.2004.04.010; Ravi R, 2017, ASIAN PAC J TROP BIO, V7, P473, DOI 10.1016/j.apjtb.2017.01.018; Reyes-Prieto M, 2014, MITOCHONDR DNA, V25, P387, DOI 10.3109/19401736.2013.809426; Romdhane Y, 2017, INVERTEBR REPROD DEV, V61, P253, DOI 10.1080/07924259.2017.1340354; Saglam N, 2018, ZOOTAXA, V4403, P61, DOI 10.11646/zootaxa.4403.1.3; Salas-Montiel R, 2014, ZOOTAXA, V3900, P77, DOI 10.11646/zootaxa.3900.1.4; SAWYER R.T., 1986, LEECH BIOL BEHAV, VII; Scharer L, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0052; Scharer L, 2009, EVOLUTION, V63, P1377, DOI 10.1111/j.1558-5646.2009.00669.x; SHANKLAND M, 1992, CAN J ZOOL, V70, P1258, DOI 10.1139/z92-174; Siddall ME, 2005, CONSERV GENET, V6, P467, DOI 10.1007/s10592-005-4986-y; Siddall ME, 2005, INVERTEBR SYST, V19, P105, DOI 10.1071/IS04034; Siddall ME, 2003, ZOOL SCR, V32, P23, DOI 10.1046/j.1463-6409.2003.00098.x; Siddall ME, 1998, MOL PHYLOGENET EVOL, V9, P156, DOI 10.1006/mpev.1997.0455; Siddall ME, 2001, AM MUS NAT HIST NOVI, P3341; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Simakov O, 2013, NATURE, V493, P526, DOI 10.1038/nature11696; Struck TH, 2011, NATURE, V471, P95, DOI 10.1038/nature09864; Tan GN, 2004, J EVOLUTION BIOL, V17, P574, DOI 10.1111/j.1420-9101.2004.00692.x; Tessler M, 2018, MOL PHYLOGENET EVOL, V127, P129, DOI 10.1016/j.ympev.2018.05.001; VANDERLANDE VM, 1976, J ZOOL, V180, P537, DOI 10.1111/j.1469-7998.1976.tb04703.x; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wedeen C.J., 1990, P145; Weigert A, 2014, MOL BIOL EVOL, V31, P1391, DOI 10.1093/molbev/msu080; WEISBLAT DA, 2009, EMERGING MODEL ORGAN, V1, P245; Weisblat DA, 2014, INT J DEV BIOL, V58, P429, DOI 10.1387/ijdb.140132dw; Whitman C. O., 1878, Q J MICROSC SCI, V18, P215; WILKIALIS J, 1980, J ZOOL, V192, P421; Zattara EE, 2013, J EXP ZOOL PART B, V320, P471, DOI 10.1002/jez.b.22523; Zattara EE, 2011, EVOL DEV, V13, P80, DOI 10.1111/j.1525-142X.2010.00458.x; Zrzavy J, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-189	62	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2019	14	4							e0214581	10.1371/journal.pone.0214581	http://dx.doi.org/10.1371/journal.pone.0214581			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR1CY	30934006	Green Submitted, gold, Green Published			2022-12-26	WOS:000462867000023
J	Saeterbakken, AH; Olsen, A; Behm, DG; Bardstu, HB; Andersen, V				Saeterbakken, Atle Hole; Olsen, Alexander; Behm, David George; Bardstu, Hilde Bremseth; Andersen, Vidar			The short- and long-term effects of resistance training with different stability requirements	PLOS ONE			English	Article							ELECTROMYOGRAPHIC ACTIVITY; MUSCLE-ACTIVITY; FORCE OUTPUT; UNSTABLE SURFACES; INSTABILITY; STRENGTH; BALANCE; PERFORMANCE; ACTIVATION; EXERCISES	The aim of this study was to assess the short- and long-term effects of resistance training (RT) with different stability requirements. Fifty-nine men underwent a 3-week familiarization period followed by a 7-week training period. During familiarization, all participants trained four sessions of squats with a Smith machine, free weights and free weights standing on a wobble board. After week-3, participants were randomized into a low (Smith machine), medium (Free-weight) or high (Wobble board) stability RT program, and Control group. All participants were tested pre-, after week-3 and post-intervention. Ten repetition maximum (10RM), rate of force development (RFD), electromyography (EMG) and maximum voluntary isometric contraction (MVIC) were tested in all three squat conditions in addition to countermovement jump (CMJ) on stable and unstable surfaces, and muscle thickness. After familiarization, greater 10RM loads (21.8-27.3%), MVIC (7.4-13.5%), RFD (29.7-43.8%) and CMJ (4.9-8.5%) were observed in all conditions. Between week 3 and 10, the Free-weight and Wobble board groups similarly improved 10RM in all conditions. Smith machine group demonstrated greater improvement in the trained exercise than the medium and high stability exercises. All training groups showed similar improvement in muscle thickness, RFD and MVIC. There was no CMJ improvement on the stable surface, but the Wobble board group demonstrated significantly greater improvement on the unstable surface. In conclusion, low, medium or high stability RT resulted in similar improvements in trained and non-trained testing conditions except for greater CMJ on the unstable surface in the Wobble group. Greater 10RM strength in trained than non-trained exercise was only observed in low stability group. Familiarization was associated with substantial improvements in 10RM and CMJ, with greater improvement associated with higher stability requirements. These findings suggest that high stability can increase strength, muscle thickness and explosive measurements similar to training with lower stability.	[Saeterbakken, Atle Hole; Olsen, Alexander; Bardstu, Hilde Bremseth; Andersen, Vidar] Western Norway Univ, Fac Educ Arts & Sports, Dept Sport Food & Nat Sciens, Sogndal, Sogn Og Fjordan, Norway; [Behm, David George] Mem Univ Newfoundland, Sch Human Kinet & Recreat, St John, NF, Canada	Memorial University Newfoundland	Saeterbakken, AH (corresponding author), Western Norway Univ, Fac Educ Arts & Sports, Dept Sport Food & Nat Sciens, Sogndal, Sogn Og Fjordan, Norway.	atle.saeterbakken@hvl.no	Behm, David George/I-6509-2019	Behm, David George/0000-0002-9406-6056				Andersen V, 2018, J STRENGTH COND RES, V32, P587, DOI 10.1519/JSC.0000000000001826; Andersen V, 2015, J STRENGTH COND RES, V29, P2932, DOI 10.1519/JSC.0000000000000950; Anderson K, 2005, CAN J APPL PHYSIOL, V30, P33, DOI 10.1139/h05-103; Anderson K, 2005, SPORTS MED, V35, P43, DOI 10.2165/00007256-200535010-00004; Anderson KG, 2004, J STRENGTH COND RES, V18, P637; Augustsson J, 1998, J ORTHOP SPORT PHYS, V27, P3, DOI 10.2519/jospt.1998.27.1.3; Behm D, 2012, INT J SPORTS PHYS TH, V7, P226; Behm DG, 2006, J STRENGTH COND RES, V20, P716; Behm DG, 2015, SPORTS MED, V45, P1645, DOI 10.1007/s40279-015-0384-x; BEHM DG, 1993, SPORTS MED, V15, P374, DOI 10.2165/00007256-199315060-00003; Behm DG, 2005, J STRENGTH COND RES, V19, P193; Behm DG, 2002, J STRENGTH COND RES, V16, P416; Bloomquist K, 2013, EUR J APPL PHYSIOL, V113, P2133, DOI 10.1007/s00421-013-2642-7; Burden A, 2010, J ELECTROMYOGR KINES, V20, P1023, DOI 10.1016/j.jelekin.2010.07.004; Campos GER, 2002, EUR J APPL PHYSIOL, V88, P50, DOI 10.1007/s00421-002-0681-6; Chulvi-Medrano I, 2012, INT J SPORTS PHYS TH, V7, P586; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; Cowley PM, 2007, INT J SPORTS MED, V28, P829, DOI 10.1055/s-2007-964893; Cressey EM, 2007, J STRENGTH COND RES, V21, P561, DOI 10.1519/R-19845.1; Drinkwater EJ, 2007, INT J SPORT PHYSIOL, V2, P400, DOI 10.1123/ijspp.2.4.400; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; Kean CO, 2006, J SPORT SCI MED, V5, P138; Kibele A, 2014, BMC SPORTS SCI MED R, V6, DOI 10.1186/2052-1847-6-30; Kibele A, 2009, J STRENGTH COND RES, V23, P2443, DOI 10.1519/JSC.0b013e3181bf0489; Marshall PWM, 2011, EUR J APPL PHYSIOL, V111, P3007, DOI 10.1007/s00421-011-1944-x; Mate-Munoz JL, 2014, J SPORT SCI MED, V13, P460; McBride JM, 2006, J STRENGTH COND RES, V20, P915; McBride JM, 2010, INT J SPORT PHYSIOL, V5, P177, DOI 10.1123/ijspp.5.2.177; Norwood JT, 2007, J STRENGTH COND RES, V21, P343, DOI 10.1519/R-17435.1; Prieske O, 2013, EUR J APPL PHYSIOL, V113, P2943, DOI 10.1007/s00421-013-2724-6; Rutherford OM, 1986, J SPORT SCI, V4, P101, DOI 10.1080/02640418608732105; RUTHERFORD OM, 1986, EUR J APPL PHYSIOL O, V55, P100, DOI 10.1007/BF00422902; Saeterbakken AH, 2013, J STRENGTH COND RES, V27, P1101, DOI 10.1519/JSC.0b013e3182606d3d; Saeterbakken AH, 2013, J STRENGTH COND RES, V27, P130, DOI 10.1519/JSC.0b013e3182541d43; Saeterbakken AH, 2011, J SPORT SCI, V29, P533, DOI 10.1080/02640414.2010.543916; Saeterbakken AH, 2016, EUR J APPL PHYSIOL, V116, P2247, DOI 10.1007/s00421-016-3470-3; SALE D, 1981, Canadian Journal of Applied Sport Sciences, V6, P87; Sparkes R, 2010, J STRENGTH COND RES, V24, P1931, DOI 10.1519/JSC.0b013e3181df7fe4; THORSTENSSON A, 1976, ACTA PHYSIOL SCAND, V96, P392, DOI 10.1111/j.1748-1716.1976.tb10207.x; Wahl MJ, 2008, J STRENGTH COND RES, V22, P1360, DOI 10.1519/JSC.0b013e318175ca3c	40	10	10	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2019	14	4							e0214302	10.1371/journal.pone.0214302	http://dx.doi.org/10.1371/journal.pone.0214302			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR1CY	30934001	Green Submitted, Green Published, gold			2022-12-26	WOS:000462867000013
J	Ahrens, A; Lund, KD; Marschall, M; Dau, T				Ahrens, Axel; Lund, Kasper Duemose; Marschall, Marton; Dau, Torsten			Sound source localization with varying amount of visual information in virtual reality	PLOS ONE			English	Article							DIFFERENCE THRESHOLDS; SPECTRAL CUES; VISION	To achieve accurate spatial auditory perception, subjects typically require personal head-related transfer functions (HRTFs) and the freedom for head movements. Loudspeaker-based virtual sound environments allow for realism without individualized measurements. To study audio-visual perception in realistic environments, the combination of spatially tracked head mounted displays (HMDs), also known as virtual reality glasses, and virtual sound environments may be valuable. However, HMDs were recently shown to affect the subjects' HRTFs and thus might influence sound localization performance. Furthermore, due to limitations of the reproduction of visual information on the HMD, audio-visual perception might be influenced. Here, a sound localization experiment was conducted both with and without an HMD and with a varying amount of visual information provided to the subjects. Furthermore, interaural time and level difference errors (ITDs and ILDs) as well as spectral perturbations induced by the HMD were analyzed and compared to the perceptual localization data. The results showed a reduction of the localization accuracy when the subjects were wearing an HMD and when they were blindfolded. The HMD-induced error in azimuth localization was found to be larger in the left than in the right hemisphere. When visual information of the limited set of source locations was provided, the localization error induced by the HMD was found to be negligible. Presenting visual information of hand-location and room dimensions showed better sound localization performance compared to the condition with no visual information. The addition of possible source locations further improved the localization accuracy. Also adding pointing feedback in form of a virtual laser pointer improved the accuracy of elevation perception but not of azimuth perception.	[Ahrens, Axel; Lund, Kasper Duemose; Marschall, Marton; Dau, Torsten] Tech Univ Denmark, Hearing Syst Sect, Dept Hlth Technol, Lyngby, Denmark	Technical University of Denmark	Ahrens, A (corresponding author), Tech Univ Denmark, Hearing Syst Sect, Dept Hlth Technol, Lyngby, Denmark.	aahr@dtu.dk	Ahrens, Axel/ABB-3395-2020; Dau, Torsten/AAJ-3709-2020	Ahrens, Axel/0000-0001-8800-2497; Dau, Torsten/0000-0001-8110-4343	Oticon Centre of Excellence for Hearing and Speech Sciences - Centre for Applied Hearing Research	Oticon Centre of Excellence for Hearing and Speech Sciences - Centre for Applied Hearing Research	The authors AA and KDL were funded by the Oticon Centre of Excellence for Hearing and Speech Sciences. MM was funded by the Centre for Applied Hearing Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumgartner R, 2014, J ACOUST SOC AM, V136, P791, DOI 10.1121/1.4887447; Blauert J., 1997, SPATIAL HEARING PSYC; Borrego A, 2018, GAMES HEALTH J, V7, P151, DOI 10.1089/g4h.2017.0114; Carlile S, 1997, HEARING RES, V114, P179, DOI 10.1016/S0378-5955(97)00161-5; Dobreva MS, 2011, J NEUROPHYSIOL, V105, P2471, DOI 10.1152/jn.00951.2010; Dufour A, 2002, VIS COGN, V9, P741, DOI 10.1080/13506280042000250; Ege R, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34512-6; Genovese A, 2018, AES INT C AUD VIRT A; GLASBERG BR, 1990, HEARING RES, V47, P103, DOI 10.1016/0378-5955(90)90170-T; Gupta R., 2018, AES INT C AUD VIRT A, pP8; HAFTER ER, 1975, J ACOUST SOC AM, V57, P181, DOI 10.1121/1.380412; HAFTER ER, 1977, J ACOUST SOC AM, V61, P829, DOI 10.1121/1.381372; HEBRANK J, 1974, J ACOUST SOC AM, V56, P1829, DOI 10.1121/1.1903520; Hofman PM, 1998, NAT NEUROSCI, V1, P417, DOI 10.1038/1633; Howard I. P., 1966, HUMAN SPATIAL ORIENT; Kuznetsova A, 2015, FOOD QUAL PREFER, V40, P31, DOI 10.1016/j.foodqual.2014.08.004; Lenth RV, 2016, J STAT SOFTW, V69, P1, DOI 10.18637/jss.v069.i01; Macpherson EA, 2013, HEARING RES, V306, P76, DOI 10.1016/j.heares.2013.09.007; Maddox RK, 2014, CURR BIOL, V24, P748, DOI 10.1016/j.cub.2014.02.021; Majdak P, 2010, ATTEN PERCEPT PSYCHO, V72, P454, DOI 10.3758/APP.72.2.454; MAKOUS JC, 1990, J ACOUST SOC AM, V87, P2188, DOI 10.1121/1.399186; Middlebrooks JC, 1999, J ACOUST SOC AM, V106, P1493, DOI 10.1121/1.427147; MILLS AW, 1960, J ACOUST SOC AM, V32, P132, DOI 10.1121/1.1907864; Muller S, 2001, J AUDIO ENG SOC, V49, P443; MUSICANT AD, 1984, J ACOUST SOC AM, V75, P1195, DOI 10.1121/1.390770; Nam J, 2008, AUDIO ENG SOC CONV, V125; Niehorster DC, 2017, I-PERCEPTION, V8, DOI 10.1177/2041669517708205; OLDFIELD SR, 1984, PERCEPTION, V13, P581, DOI 10.1068/p130581; Perrett S, 1997, J ACOUST SOC AM, V102, P2325, DOI 10.1121/1.419642; Recanzone GH, 2009, HEARING RES, V258, P89, DOI 10.1016/j.heares.2009.04.009; SHELTON BR, 1980, PERCEPT PSYCHOPHYS, V28, P589, DOI 10.3758/BF03198830; Shinn-Cunningham BG, 1998, J ACOUST SOC AM, V103, P3667, DOI 10.1121/1.423107; Shinn-Cunningham BG, 1998, J ACOUST SOC AM, V103, P3656, DOI 10.1121/1.423088; Sondergaard P., 2013, TECHNOLOGY BINAURAL, P33, DOI 10.1007/978-3-642-37762-4_2; Strutt J., 1907, PHILOS MAG, V13, P214, DOI [DOI 10.1080/14786440709463595, 10.1080/14786440709463595]; Tabry V, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00932; van Beers RJ, 1999, EXP BRAIN RES, V125, P43, DOI 10.1007/s002210050656; Van Opstal AJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174185	38	25	26	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2019	14	3							e0214603	10.1371/journal.pone.0214603	http://dx.doi.org/10.1371/journal.pone.0214603			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ9FO	30925174	gold, Green Published, Green Submitted			2022-12-26	WOS:000462732300024
J	Bowie, AG				Bowie, Andrew G.			Harnessing poxviral know-how for anti-cytokine therapies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material								Poxviruses have evolved efficient proteins that bind mammalian cytokines and chemokines to suppress host immunity. Here Pontejo et al. examine in detail how one such poxviral protein, CrmD, that has activity against both mammalian tumor necrosis factor and chemokines, interacts with its host targets. They apply their findings to refine a human anti-cytokine therapeutic and increase its specificity, providing an elegant example of the benefits of mining viral proteins for therapeutically useful information.	[Bowie, Andrew G.] Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Dublin 2, Ireland	Trinity College Dublin	Bowie, AG (corresponding author), Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Dublin 2, Ireland.	agbowie@tcd.ie		Bowie, Andrew/0000-0001-5316-4373	Science Foundation Ireland [16/IA/4376]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This work was supported by Science Foundation Ireland Grant 16/IA/4376. The author declares that he has no conflicts of interest with the contents of this article.	Alcami A, 2003, NAT REV IMMUNOL, V3, P36, DOI 10.1038/nri980; Lysakova-Devine T, 2010, J IMMUNOL, V185, P4261, DOI 10.4049/jimmunol.1002013; Murray KM, 1997, ANN PHARMACOTHER, V31, P1335, DOI 10.1177/106002809703101111; Pontejo SM, 2019, J BIOL CHEM, V294, P5214, DOI 10.1074/jbc.RA118.005828; Pontejo SM, 2015, J BIOL CHEM, V290, P15973, DOI 10.1074/jbc.M115.650119; Roach DR, 2001, J EXP MED, V193, P239, DOI 10.1084/jem.193.2.239; Zhang GY, 2004, CURR OPIN STRUC BIOL, V14, P154, DOI 10.1016/j.sbi.2004.03.003	7	0	0	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2019	294	13					5228	5229		10.1074/jbc.H119.008151	http://dx.doi.org/10.1074/jbc.H119.008151			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HS6MI	30926761	Green Published, hybrid			2022-12-26	WOS:000463985600046
J	Jiang, Y; Chen, L; Zhang, H; Xiao, X				Jiang, Yun; Chen, Li; Zhang, Hai; Xiao, Xiao			Breast cancer histopathological image classification using convolutional neural networks with small SE-ResNet module	PLOS ONE			English	Article								Although successful detection of malignant tumors from histopathological images largely depends on the long-term experience of radiologists, experts sometimes disagree with their decisions. Computer-aided diagnosis provides a second option for image diagnosis, which can improve the reliability of experts' decision-making. Automatic and precision classification for breast cancer histopathological image is of great importance in clinical application for identifying malignant tumors from histopathological images. Advanced convolution neural network technology has achieved great success in natural image classification, and it has been used widely in biomedical image processing. In this paper, we design a novel convolutional neural network, which includes a convolutional layer, small SE-ResNet module, and fully connected layer. We propose a small SE-ResNet module which is an improvement on the combination of residual module and Squeeze-and-Excitation block, and achieves the similar performance with fewer parameters. In addition, we propose a new learning rate scheduler which can get excellent performance without complicatedly fine-tuning the learning rate. We use our model for the automatic classification of breast cancer histology images (BreakHis dataset) into benign and malignant and eight subtypes. The results show that our model achieves the accuracy between 98.87% and 99.34% for the binary classification and achieve the accuracy between 90.66% and 93.81% for the multi-class classification.	[Jiang, Yun; Chen, Li; Zhang, Hai; Xiao, Xiao] Northwest Normal Univ, Coll Comp Sci & Engn, Lanzhou 730070, Gansu, Peoples R China	Northwest Normal University - China	Chen, L (corresponding author), Northwest Normal Univ, Coll Comp Sci & Engn, Lanzhou 730070, Gansu, Peoples R China.	fightinggirllichen@163.com			National Natural Science Foundation of China [61163036]; 2016 Gansu Provincial Science and Technology Plan Funded Natural Science Fund Project [1606RJZA047]; 2012 Gansu Provincial University Basic Research Business Expenses Special Fund Project; Gansu Provincial University Graduate Tutor Project [1201-16]; Northwest Normal University knowledge and innovation engineering research backbone project [nwnu-kjcxgc-03-67]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 2016 Gansu Provincial Science and Technology Plan Funded Natural Science Fund Project; 2012 Gansu Provincial University Basic Research Business Expenses Special Fund Project; Gansu Provincial University Graduate Tutor Project; Northwest Normal University knowledge and innovation engineering research backbone project	This work was supported by National Natural Science Foundation of China (61163036), 2016 Gansu Provincial Science and Technology Plan Funded Natural Science Fund Project (1606RJZA047), 2012 Gansu Provincial University Basic Research Business Expenses Special Fund Project, Gansu Provincial University Graduate Tutor Project (1201-16), The third phase of the Northwest Normal University knowledge and innovation engineering research backbone project (nwnu-kjcxgc-03-67). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbar S, 2018, COMPUTER METHODBIO, P1; AlRahhal MM., 2018, BREAST CANC, V9; Araujo T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177544; Bardou D, IEEE ACCESS, P1; Chan A, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160558; Chang SH, 2011, IEEE T COMMUN, V59, P2939, DOI 10.1109/TCOMM.2011.072011.100049; Chollet F., 2015, KERAS; Das K, 2018, I S BIOMED IMAGING, P578; Devries T., 2017, IMPROVED REGULARIZAT; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Guo Y., 2018, INT C IM AN REC, P827, DOI [DOI 10.1007/978-3-319-93000-8_94, 10.1007/978-3-319-93000-8_94]; Han ZY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04075-z; He KM, 2016, LECT NOTES COMPUT SC, V9908, P630, DOI 10.1007/978-3-319-46493-0_38; He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90; He KM, 2015, IEEE I CONF COMP VIS, P1026, DOI 10.1109/ICCV.2015.123; Horvat JV, 2019, RADIOGRAPHICS; Hu J., 2017, ARXIV170901507; Huang YL, 2019, ARXIV190109407; Hutter F ., 2016, ARXIV160803983; Ioffe S., 2015, INT C ONMACHINE LEAR, V37, P448, DOI DOI 10.1007/S13398-014-0173-7.2; Jurman G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041882; Kahya MA., 2017, J APPL MATH BIOINFOR, V7, P49; Karthiga R, 2018, 2018 2 INT C EL COMM, P274, DOI DOI 10.1109/ICECA.2018.8474739; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Krizhevsky A, 2009, THESIS U TORONTO TOR; Krizhevsky A., 2012, ADV NEURAL INF PROCE; Kumar K., 2018, 2018 4 INT C RECENT, P1; Lim CN, 2019, RECENT ADV BREAST CA; Nahid AA, 2018, INFORMATION, V9, DOI 10.3390/info9010019; Nair V., 2010, P 27 INT C INT C MAC, P807; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Pratiher S, 2018, ARXIV180606876; Ruder S., 2016, ARXIV; Rusk N, 2016, NAT METHODS, V13, P35, DOI 10.1038/nmeth.3707; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Spanhol FA, 2017, IEEE SYS MAN CYBERN, P1868; Spanhol FA, 2016, IEEE T BIO-MED ENG, V63, P1455, DOI 10.1109/TBME.2015.2496264; Wang J, 2018, ENVIRON TECHNOL, V39, P3055, DOI 10.1080/09593330.2017.1371797; Wang Zheng-peng, 2012, Computer Engineering, V38, P38, DOI 10.3969/j.issn.1000-3428.2012.10.010; Wei BZ, 2017, 2017 2ND IEEE INTERNATIONAL CONFERENCE ON CLOUD COMPUTING AND BIG DATA ANALYSIS (ICCCBDA 2017), P348, DOI 10.1109/ICCCBDA.2017.7951937; Zagoruyko S., 2016, WIDE RESIDUAL NETWOR, DOI DOI 10.5244/C.30.87	41	90	92	8	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2019	14	3							e0214587	10.1371/journal.pone.0214587	http://dx.doi.org/10.1371/journal.pone.0214587			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ9FO	30925170	Green Published, gold, Green Submitted			2022-12-26	WOS:000462732300022
J	Belikov, S; Belkova, N; Butina, T; Chernogor, L; Martynova-Van Kley, A; Nalian, A; Rorex, C; Khanaev, I; Maikova, O; Feranchuk, S				Belikov, Sergei; Belkova, Natalia; Butina, Tatiana; Chernogor, Lubov; Martynova-Van Kley, Alexandra; Nalian, Armen; Rorex, Colin; Khanaev, Igor; Maikova, Olga; Feranchuk, Sergey			Diversity and shifts of the bacterial community associated with Baikal sponge mass mortalities	PLOS ONE			English	Article							FRESH-WATER SPONGE; MICROBIAL DIVERSITY; MARINE SPONGES; LAKE BAIKAL; DISEASE; SYMBIONTS; EPHYDATIA; ABUNDANCE; MICROORGANISMS; IDENTIFICATION	The disease of freshwater sponges was first discovered in 2011, when pink samples were found in the Central Basin of Lake Baikal. Subsequently, the visible signs of the disease have changed, and now sponges appear with various symptoms of damage to the body, such as discoloration, tissue necrosis, the formation of brown patches and dirty-purple bio-films on some branches. These signs of the disease are accompanied by the mass death of sponges. We identified differences in microbiomes by sequencing 16S rRNA genes and found changes in the consortium of microorganisms of freshwater Baikal sponges. We found that the observed imbalance in the studied microbial communities of diseased sponges is caused by several different conditionally pathogenic microorganisms that increase their negative effect by acting together and in concert, which leads to the death of photosynthetic microalgae and sponges. Sponges are an important component of coastal communities, and the massive loss of sponges can obviously affect the structure of benthic communities and the purity of water.	[Belikov, Sergei; Belkova, Natalia; Butina, Tatiana; Chernogor, Lubov; Khanaev, Igor; Maikova, Olga; Feranchuk, Sergey] Russian Acad Sci, Siberian Branch, Limnol Inst, Lab Analyt Bioorgan Chem, Irkutsk, Russia; [Martynova-Van Kley, Alexandra; Nalian, Armen; Rorex, Colin] Stephen F Austin State Univ, Dept Biol, Nacogdoches, TX 75962 USA; [Feranchuk, Sergey] Natl Res Tech Univ, Dept Informat, Irkutsk, Russia	Irkutsk Science Centre of the Russian Academy of Sciences; Russian Academy of Sciences; Limnological Institute SB RAS; Irkutsk National Research Technical University (INRTU)	Belikov, S (corresponding author), Russian Acad Sci, Siberian Branch, Limnol Inst, Lab Analyt Bioorgan Chem, Irkutsk, Russia.	sergeibelikov47@gmail.com	Belkova, Natalia/N-6987-2014; Maikova, Olga/AAA-4422-2021; Belikov, Sergei/L-3373-2013	Belkova, Natalia/0000-0001-9720-068X; Maikova, Olga/0000-0001-7263-5767; Khanaev, Igor/0000-0001-6431-2765; Butina, Tatyana/0000-0002-2147-6695; Belikov, Sergei/0000-0001-7206-8299	Federal Agency of Scientific Organizations [0345-2016-0002]; Russian Foundation for Basic Research [16-04-00065, 18-04-00224, 16-54-150007]	Federal Agency of Scientific Organizations; Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	This research was supported by Funding by budget project of Federal Agency of Scientific Organizations (no 0345-2016-0002 to SB); Russian Foundation for Basic Research (grants no 16-54-150007 to SB); Russian Foundation for Basic Research (grants no 18-04-00224 to SB); and Russian Foundation for Basic Research (grants no 16-04-00065 to LC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alex A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127455; Alex A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051834; Angermeier H, 2012, DIS AQUAT ORGAN, V99, P95, DOI 10.3354/dao02460; Angermeier H, 2011, FEMS MICROBIOL ECOL, V75, P218, DOI 10.1111/j.1574-6941.2010.01001.x; [Anonymous], 1941, ECOLOGY, V22, P415, DOI 10.2307/1930719; BAILEY RC, 1995, J GREAT LAKES RES, V21, P42, DOI 10.1016/S0380-1330(95)71019-X; Baldani J.I., 2014, PROKARYOTES, P533, DOI [DOI 10.1007/978-3-642-30197-1_300, 10.1007/978-3-642-30197-1_300]; Barb JJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148047; Bell JJ, 2015, CONSERV BIOL, V29, P42, DOI 10.1111/cobi.12447; Belykh O. I., 2011, International Journal on Algae, V13, P149; Blanquer A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00752; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bormotov AE., 2012, SCI 1 HAND, V32, P20; Bourne DG, 2016, ANNU REV MICROBIOL, V70, P317, DOI 10.1146/annurev-micro-102215-095440; Butina T V, 2015, Genetika, V51, P384; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carballo JL, 2013, ECOL EVOL, V3, P872, DOI 10.1002/ece3.452; Cardenas CA, 2014, FEMS MICROBIOL ECOL, V88, P516, DOI 10.1111/1574-6941.12317; Cebrian E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020211; Certner RH, 2018, ENVIRON MICROBIOL, V20, P645, DOI 10.1111/1462-2920.13991; Cervino JM, 2006, MAR ECOL PROG SER, V324, P139, DOI 10.3354/meps324139; Chernogor L, 2013, EUR J PHYCOL, V48, P497, DOI 10.1080/09670262.2013.862306; Choudhury JD, 2015, MAR BIOTECHNOL, V17, P463, DOI 10.1007/s10126-015-9627-y; Correa AMS, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00127; Costa R, 2013, MICROB ECOL, V65, P232, DOI 10.1007/s00248-012-0102-2; Cuvelier ML, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00581; DAYTON PK, 1974, ECOL MONOGR, V44, P105, DOI 10.2307/1942321; Deignan LK, 2018, MICROB ECOL, V76, P459, DOI 10.1007/s00248-017-1135-3; Della Sala G, 2013, ENV MICROBIOL REP, V5, P809, DOI 10.1111/1758-2229.12081; Denikina NN, 2016, BIOL BULL+, V43, P263, DOI 10.1134/S106235901603002X; Di Camillo CG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126689; Dupont S, 2013, FEMS MICROBIOL ECOL, V86, P520, DOI 10.1111/1574-6941.12178; Efremova S.M., 2004, P1261; Fan Lu, 2012, Proc Natl Acad Sci U S A, V109, pE1878, DOI 10.1073/pnas.1203287109; Feranchuk S, 2018, RES MICROBIOL, V169, P254, DOI 10.1016/j.resmic.2018.03.004; GAINO E, 1992, B ZOOL, V59, P79, DOI 10.1080/11250009209386652; Gao ZM, 2015, PEERJ, V3, DOI 10.7717/peerj.890; Garrabou J, 2009, GLOBAL CHANGE BIOL, V15, P1090, DOI 10.1111/j.1365-2486.2008.01823.x; Gernert C, 2005, MICROB ECOL, V50, P206, DOI 10.1007/s00248-004-0172-x; Gignoux-Wolfsohn SA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134416; Gladkikh A S, 2014, Mikrobiologiia, V83, P682; He Y, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0081-x; Hentschel U, 2006, FEMS MICROBIOL ECOL, V55, P167, DOI 10.1111/j.1574-6941.2005.00046.x; Hentschel U, 2003, MAR MOL BIOTECHNOL, P59; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; Hugerth LW, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0834-7; Itskovich V, 2017, INLAND WATERS, V7, P259, DOI 10.1080/20442041.2017.1320507; Jezberova J, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.01530-17; Kelly TL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007038; Khanaev IV, 2018, J GREAT LAKES RES, V44, P77, DOI 10.1016/j.jglr.2017.10.004; Kopylova E, 2016, MSYSTEMS, V1, DOI 10.1128/mSystems.00003-15; KOZHOV M. M, 1972, ESSAYS BAIKAL STUDIE; Kravtsova LS, 2014, J GREAT LAKES RES, V40, P441, DOI 10.1016/j.jglr.2014.02.019; Kulakova NV, 2018, MICROB ECOL, V75, P1024, DOI 10.1007/s00248-017-1097-5; Lebret K, 2016, MAR GENOM, V29, P39, DOI 10.1016/j.margen.2016.09.001; Lejeusne C, 2010, TRENDS ECOL EVOL, V25, P250, DOI 10.1016/j.tree.2009.10.009; Luter HM, 2017, FEMS MICROBIOL ECOL, V93, DOI 10.1093/femsec/fix074; Luter HM, 2010, APPL ENVIRON MICROB, V76, P5736, DOI 10.1128/AEM.00653-10; Luter HM, 2017, CLIMATE CHANGE OCEAN, P411, DOI [10.1007/978-3-319-59008-0_9, DOI 10.1007/978-3-319-59008-0_9]; Maldonado M, 2010, MAR BIOL, V157, P1577, DOI 10.1007/s00227-010-1431-7; Manconi R, 2008, HYDROBIOLOGIA, V595, P27, DOI 10.1007/s10750-007-9000-x; Manconi R, 2002, SYSTEMA PORIFERA GUI, P921; Masuda Yoshiki, 2009, V47, P81, DOI 10.1007/978-3-540-88552-8_4; Mats V. D., 2011, GEOSCI FRONT, V2, P349, DOI [10.1016/j.gsf.2011.06.002, DOI 10.1016/J.GSF.2011.06.002]; Mukherjee A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01126-3; Mukherjee J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007177; NEALSON KH, 1970, J BACTERIOL, V104, P313, DOI 10.1128/JB.104.1.313-322.1970; Olson JB, 2006, DIS AQUAT ORGAN, V71, P163, DOI 10.3354/dao071163; Parada AE, 2016, ENVIRON MICROBIOL, V18, P1403, DOI 10.1111/1462-2920.13023; Perez T, 2014, Mediterranean Sea: Its History and Present Challenges, P577, DOI 10.1007/978-94-007-6704-1_35; Petit C, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2006GC001265; Pile AJ, 1997, LIMNOL OCEANOGR, V42, P178, DOI 10.4319/lo.1997.42.1.0178; Pisera A, 2016, PALAEONTOL Z, V90, P673, DOI 10.1007/s12542-016-0328-2; Pita L, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02102; PROKSCH P, 1994, TOXICON, V32, P639, DOI 10.1016/0041-0101(94)90334-4; Pulkkinen K, 2010, P ROY SOC B-BIOL SCI, V277, P593, DOI 10.1098/rspb.2009.1659; Raharinirina NA, 2017, FRONT ECOL EVOL, V5, DOI 10.3389/fevo.2017.00031; Richardson C, 2012, FEMS MICROBIOL ECOL, V81, P407, DOI 10.1111/j.1574-6941.2012.01365.x; RUTZLER K, 1988, DIS AQUAT ORGAN, V5, P143, DOI 10.3354/dao005143; SANDJENSEN K, 1994, LIMNOL OCEANOGR, V39, P551, DOI 10.4319/lo.1994.39.3.0551; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Semiturkina N.A., 2009, P891; Seo EY, 2016, ANN LIMNOL-INT J LIM, V52, P27, DOI 10.1051/limn/2015035; Stabili L, 2012, MICROB ECOL, V64, P802, DOI 10.1007/s00248-012-0068-0; Steinert G, 2016, PEERJ, V4, DOI 10.7717/peerj.1936; Sweet M, 2015, CORAL REEFS, V34, P871, DOI 10.1007/s00338-015-1284-0; Sweet M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062580; Tan CH, 2014, ISME J, V8, P1186, DOI 10.1038/ismej.2013.240; Taylor MW, 2007, MICROBIOL MOL BIOL R, V71, P295, DOI 10.1128/MMBR.00040-06; Timoshkin OA, 2016, J GREAT LAKES RES, V42, P487, DOI 10.1016/j.jglr.2016.02.011; VACELET J, 1978, J INVERTEBR PATHOL, V31, P246, DOI 10.1016/0022-2011(78)90014-9; Van Soest RWM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035105; Vargas S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039345; Webster NS, 2008, ENVIRON MICROBIOL, V10, P3366, DOI 10.1111/j.1462-2920.2008.01734.x; Webster NS, 2007, ENVIRON MICROBIOL, V9, P1363, DOI 10.1111/j.1462-2920.2007.01303.x; Webster NS, 2016, MBIO, V7, DOI 10.1128/mBio.00135-16; Webster NS, 2002, MAR ECOL PROG SER, V232, P305, DOI 10.3354/meps232305; Weigel BL, 2016, APPL ENVIRON MICROB, V82, P650, DOI 10.1128/AEM.02980-15; Weisz JB, 2008, OECOLOGIA, V155, P367, DOI 10.1007/s00442-007-0910-0; Whitehead NA, 2001, FEMS MICROBIOL REV, V25, P365, DOI 10.1111/j.1574-6976.2001.tb00583.x; WILKINSON CR, 1980, HYDROBIOLOGIA, V75, P241, DOI 10.1007/BF00006488; WILKINSON CR, 1987, CORAL REEFS, V5, P183, DOI 10.1007/BF00300961; Wulff JL, 2006, BIOL CONSERV, V127, P167, DOI 10.1016/j.biocon.2005.08.007; Ziegler M, 2017, J BIOGEOGR, V44, P674, DOI 10.1111/jbi.12913	104	19	19	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0213926	10.1371/journal.pone.0213926	http://dx.doi.org/10.1371/journal.pone.0213926			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921366	gold, Green Published			2022-12-26	WOS:000462594000029
J	Bluhm, SL; Eitzinger, B; Ferlian, O; Bluhm, C; Schroter, K; Pena, R; Maraun, M; Scheu, S				Bluhm, Sarah L.; Eitzinger, Bernhard; Ferlian, Olga; Bluhm, Christian; Schroeter, Kristina; Pena, Rodica; Maraun, Mark; Scheu, Stefan			Deprivation of root-derived resources affects microbial biomass but not community structure in litter and soil	PLOS ONE			English	Article							CARBON STOCKS; TEMPERATE FORESTS; FAGUS-SYLVATICA; MINERAL SOIL; DOUGLAS-FIR; FATTY-ACIDS; FOOD-WEB; NITROGEN; PLANT; INPUT	The input of plant leaf litter has been assumed to be the most important resource for soil organisms of forest ecosystems, but there is increasing evidence that root-derived resources may be more important. By trenching roots of trees in deciduous and coniferous forests, we cut-off the input of root-derived resources and investigated the response of microorganisms using substrate-induced respiration and phospholipid fatty acid (PLFA) analysis. After one and three years, root trenching strongly decreased microbial biomass and concentrations of PLFAs by about 20%, but the microbial community structure was little affected and the effects were similar in deciduous and coniferous forests. However, the reduction in microbial biomass varied between regions and was more pronounced in forests on limestone soils (Hainich) than in those on sandy soils (Schorfheide). Trenching also reduced microbial biomass in the litter layer but only in the Hainich after one year, whereas fungal and bacterial marker PLFAs as well as the fungal-to-plant marker ratio in litter were reduced in the Schorfheide both after one and three years. The pronounced differences between forests of the two regions suggest that root-derived resources are more important in fueling soil microorganisms of base-rich forests characterized by mull humus than in forests poor in base cations characterized by moder soils. The reduction in microbial biomass and changes in microbial community characteristics in the litter layer suggests that litter microorganisms do not exclusively rely on resources from decomposing litter but also from roots, i.e. from resources based on labile recently fixed carbon. Our results suggest that both bacteria and fungi heavily depend on root-derived resources with both suffering to a similar extent to deprivation of these resources. Further, the results indicate that the community structure of microorganisms is remarkably resistant to changes in resource supply and adapts quickly to new conditions irrespective of tree species composition and forest management.	[Bluhm, Sarah L.; Eitzinger, Bernhard; Ferlian, Olga; Bluhm, Christian; Maraun, Mark; Scheu, Stefan] Univ Gottingen, JF Blumenbach Inst Zool & Anthropol, Anim Ecol, Untere Karspule 2, Gottingen, Germany; [Schroeter, Kristina; Pena, Rodica] Univ Gottingen, Busgen Inst, Forest Bot & Tree Physiol, Busgenweg 2, Gottingen, Germany; [Scheu, Stefan] Univ Gottingen, Ctr Biodivers & Sustainable Land Use, Gottingen, Germany; [Eitzinger, Bernhard] Univ Freiburg, Chair Nat Conservat & Landscape Ecol, Freiburg, Germany; [Eitzinger, Bernhard] Philipps Univ Marburg, Conservat Ecol, Karl von Frisch Str 8, Marburg, Germany; [Ferlian, Olga] German Ctr Integrat Biodivers Res iDiv, Deutsch Pl 5e, Leipzig, Germany; [Ferlian, Olga] Univ Leipzig, Inst Biol, Deutsch Pl 5e, Leipzig, Germany	University of Gottingen; University of Gottingen; University of Gottingen; University of Freiburg; Philipps University Marburg; Leipzig University	Bluhm, SL (corresponding author), Univ Gottingen, JF Blumenbach Inst Zool & Anthropol, Anim Ecol, Untere Karspule 2, Gottingen, Germany.	szieger@gwdg.de	Eitzinger, Bernhard/M-5104-2015	Eitzinger, Bernhard/0000-0001-5903-4887; Bluhm, Sarah L./0000-0001-7314-7415	German Research Foundation (DFG) [SCHE 376/22-3]	German Research Foundation (DFG)(German Research Foundation (DFG))	This project was funded by the German Research Foundation (DFG; SCHE 376/22-3 to S. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON JPE, 1978, SOIL BIOL BIOCHEM, V10, P215, DOI 10.1016/0038-0717(78)90099-8; Averill C, 2016, ECOL LETT, V19, P937, DOI 10.1111/ele.12631; Bais HP, 2006, ANNU REV PLANT BIOL, V57, P233, DOI 10.1146/annurev.arplant.57.032905.105159; Bakker MR, 2008, J FOREST RES-JPN, V13, P176, DOI 10.1007/s10310-008-0068-6; Beck T, 1997, SOIL BIOL BIOCHEM, V29, P1023, DOI 10.1016/S0038-0717(97)00030-8; Brant JB, 2006, OECOLOGIA, V148, P650, DOI 10.1007/s00442-006-0402-7; Claus A, 2005, CAN J FOREST RES, V35, P1617, DOI 10.1139/x05-079; Clemmensen KE, 2013, SCIENCE, V339, P1615, DOI 10.1126/science.1231923; Cremer M, 2016, FOREST ECOL MANAG, V367, P30, DOI 10.1016/j.foreco.2016.02.020; Dai AG, 2013, NAT CLIM CHANGE, V3, P52, DOI [10.1038/nclimate1633, 10.1038/NCLIMATE1633]; De Vos B, 2015, GEODERMA, V251, P33, DOI 10.1016/j.geoderma.2015.03.008; de Vries FT, 2016, SOIL BIOL BIOCHEM, V102, P4, DOI 10.1016/j.soilbio.2016.06.023; Diaz-Pines E, 2010, EUR J FOREST RES, V129, P101, DOI 10.1007/s10342-008-0250-6; DIXON RK, 1994, SCIENCE, V263, P185, DOI 10.1126/science.263.5144.185; Eisenhauer N, 2017, SCI REP-UK, V7, DOI 10.1038/srep44641; Felsmann K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122539; Finer L, 2007, PLANT BIOSYST, V141, P394, DOI 10.1080/11263500701625897; Fischer M, 2010, BASIC APPL ECOL, V11, P473, DOI 10.1016/j.baae.2010.07.009; Frostegard A, 1996, BIOL FERT SOILS, V22, P59, DOI 10.1007/BF00384433; FROSTEGARD A, 1991, J MICROBIOL METH, V14, P151, DOI 10.1016/0167-7012(91)90018-L; Goldmann K, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01300; Griffiths BS, 1999, SOIL BIOL BIOCHEM, V31, P145, DOI 10.1016/S0038-0717(98)00117-5; GUCKERT JB, 1986, APPL ENVIRON MICROB, V52, P794, DOI 10.1128/AEM.52.4.794-801.1986; Hart SC, 1998, CAN J FOREST RES, V28, P1261, DOI 10.1139/cjfr-28-8-1261; Hogberg P, 2006, TRENDS ECOL EVOL, V21, P548, DOI 10.1016/j.tree.2006.06.004; HUNT HW, 1987, BIOL FERT SOILS, V3, P57, DOI 10.1007/BF00260580; Jagodzinski AM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148668; Jandl R, 2007, GEODERMA, V137, P253, DOI 10.1016/j.geoderma.2006.09.003; Janssens IA, 2003, SCIENCE, V300, P1538, DOI 10.1126/science.1083592; Joergensen RG, 1999, PEDOBIOLOGIA, V43, P134; Jones DL, 2009, PLANT SOIL, V321, P5, DOI 10.1007/s11104-009-9925-0; Jones DL, 2004, NEW PHYTOL, V163, P459, DOI 10.1111/j.1469-8137.2004.01130.x; Kaiser C, 2010, SOIL BIOL BIOCHEM, V42, P1650, DOI 10.1016/j.soilbio.2010.05.019; Kaiser K, 2016, SCI REP-UK, V6, DOI 10.1038/srep33696; Klarner B, 2014, OIKOS, V123, P1173, DOI 10.1111/j.1600-0706.2013.00939.x; Kuzyakov Y, 2002, J PLANT NUTR SOIL SC, V165, P382, DOI 10.1002/1522-2624(200208)165:4<382::AID-JPLN382>3.0.CO;2-#; Kuzyakov Y, 2000, J PLANT NUTR SOIL SC, V163, P421, DOI 10.1002/1522-2624(200008)163:4<421::AID-JPLN421>3.0.CO;2-R; Kuzyakov Y, 2015, SOIL BIOL BIOCHEM, V83, P184, DOI 10.1016/j.soilbio.2015.01.025; Lal R, 2005, FOREST ECOL MANAG, V220, P242, DOI 10.1016/j.foreco.2005.08.015; Lang C, 2011, MYCORRHIZA, V21, P297, DOI 10.1007/s00572-010-0338-y; Lemanski K, 2014, SOIL BIOL BIOCHEM, V69, P38, DOI 10.1016/j.soilbio.2013.10.034; Litton CM, 2007, GLOBAL CHANGE BIOL, V13, P2089, DOI 10.1111/j.1365-2486.2007.01420.x; Meinen C, 2009, OECOLOGIA, V161, P99, DOI 10.1007/s00442-009-1352-7; MIKOLA PEITSA, 1966, ANN BOT FENN, V3, P406; MOORE JC, 1988, NATURE, V333, P261, DOI 10.1038/333261a0; Moore-Kucera J, 2008, MICROB ECOL, V55, P500, DOI 10.1007/s00248-007-9295-1; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Orwin KH, 2018, SOIL BIOL BIOCHEM, V117, P27, DOI 10.1016/j.soilbio.2017.10.036; Paterson E, 2007, NEW PHYTOL, V173, P600, DOI 10.1111/j.1469-8137.2006.01931.x; Pausch J, 2018, GLOBAL CHANGE BIOL, V24, P1, DOI 10.1111/gcb.13850; Pollierer MM, 2007, ECOL LETT, V10, P729, DOI 10.1111/j.1461-0248.2007.01064.x; Pollierer MM, 2015, SOIL BIOL BIOCHEM, V91, P248, DOI 10.1016/j.soilbio.2015.08.035; Preece C, 2018, TREE PHYSIOL, V38, P690, DOI 10.1093/treephys/tpx163; Preece C, 2016, PLANT SOIL, V409, P1, DOI 10.1007/s11104-016-3090-z; Pregitzer KS, 2004, GLOBAL CHANGE BIOL, V10, P2052, DOI 10.1111/j.1365-2486.2004.00866.x; Pregitzer KS, 2008, GLOBAL CHANGE BIOL, V14, P142, DOI 10.1111/j.1365-2486.2007.01465.x; Raats M. M., 1991, Food Quality and Preference, V3, P89, DOI 10.1016/0950-3293(91)90028-D; Rosling A, 2003, NEW PHYTOL, V159, P775, DOI 10.1046/j.1469-8137.2003.00829.x; Rousk J, 2015, FUNCT ECOL, V29, P285, DOI 10.1111/1365-2435.12377; Ruess L, 2010, SOIL BIOL BIOCHEM, V42, P1898, DOI 10.1016/j.soilbio.2010.07.020; Samaniego L, 2018, NAT CLIM CHANGE, V8, P421, DOI 10.1038/s41558-018-0138-5; SCHEU S, 1992, SOIL BIOL BIOCHEM, V24, P1113, DOI 10.1016/0038-0717(92)90061-2; Scheunemann N, 2015, OECOLOGIA, V179, P1135, DOI 10.1007/s00442-015-3415-2; Schulp CJE, 2008, FOREST ECOL MANAG, V256, P482, DOI 10.1016/j.foreco.2008.05.007; Siira-Pietikainen A, 2003, BIOL FERT SOILS, V37, P163, DOI 10.1007/s00374-002-0571-4; Sokol NW, 2019, NAT GEOSCI, V12, P46, DOI 10.1038/s41561-018-0258-6; Solly E, 2013, BIOGEOSCIENCES, V10, P4833, DOI 10.5194/bg-10-4833-2013; Vesterdal L, 2008, FOREST ECOL MANAG, V255, P35, DOI 10.1016/j.foreco.2007.08.015; Vesterdal L, 2013, FOREST ECOL MANAG, V309, P4, DOI 10.1016/j.foreco.2013.01.017; Zieger SL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189502	70	5	7	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214233	10.1371/journal.pone.0214233	http://dx.doi.org/10.1371/journal.pone.0214233			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921392	gold, Green Published			2022-12-26	WOS:000462594000044
J	Ciejka, J; Botwina, P; Nowakowska, M; Szczubialka, K; Pyrc, K				Ciejka, Justyna; Botwina, Pawel; Nowakowska, Maria; Szczubialka, Krzysztof; Pyrc, Krzysztof			Synthetic sulfonated derivatives of poly (allylamine hydrochloride) as inhibitors of human metapneumovirus	PLOS ONE			English	Article							ANTIVIRAL ACTIVITY; INFECTION; CARRAGEENAN; CHILDREN; REPLICATION; BINDING; 1-YEAR	Human metapneumovirus (hMPV) is a widely distributed pathogen responsible for acute upper and lower respiratory infections of varying severity. Previously, we reported that Nsulfonated derivatives of poly(allylamine hydrochloride) (NSPAHs) efficiently inhibit replication of the influenza virus in vitro and ex vivo. Here, we show a dose dependent inhibition of hMPV infection by NSPAHs in LLC-MK2 cells. The results showed strong antiviral properties of NSPAHs. While the activity of NSPAHs is comparable to those of carrageenans, they show better physicochemical properties and may be delivered at high concentrations. The functional assays showed that tested polymers block hMPV release from infected cells and, consequently, constrain virus spread. Moreover, further studies on viruses utilizing different egress mechanisms suggest that observed antiviral effect depend on selective inhibition of viruses budding from the cell surface.	[Ciejka, Justyna; Botwina, Pawel; Pyrc, Krzysztof] Jagiellonian Univ, Malopolska Ctr Biotechnol, Virogenet Lab Virol, Krakow, Poland; [Ciejka, Justyna; Nowakowska, Maria; Szczubialka, Krzysztof] Jagiellonian Univ, Fac Chem, Krakow, Poland; [Botwina, Pawel] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Microbiol, Krakow, Poland	Jagiellonian University; Jagiellonian University; Jagiellonian University	Pyrc, K (corresponding author), Jagiellonian Univ, Malopolska Ctr Biotechnol, Virogenet Lab Virol, Krakow, Poland.; Szczubialka, K (corresponding author), Jagiellonian Univ, Fac Chem, Krakow, Poland.	szczubia@chemia.uj.edu.pl; k.a.pyrc@uj.edu.pl	Botwina, Paweł/ABC-9799-2020; Botwina, Paweł/ABI-7838-2020; Szczubiałka, Krzysztof/D-4728-2016; Ciejka, Justyna/AAL-4155-2020	Szczubiałka, Krzysztof/0000-0001-6612-1102; Ciejka, Justyna/0000-0003-2532-3386; Pyrc, Krzysztof/0000-0002-3867-7688	National Science Center [UMO-2012/07/E/NZ6/01712, UMO-2016/21/D/ST5/01661]; National Centre for Research and Development [Lider/27/55/L-2/10/2011]; Foundation for Polish Science - EU European Regional Development Fund [VENTURES/2013-11/1]; COST Action [CM1407]; European Union [POIG.02.01.00-12-064/08]; Ministry of Science and Higher Education of the Republic of Poland	National Science Center(National Science Centre, Poland); National Centre for Research and Development(National Centre for Research & Development, Poland); Foundation for Polish Science - EU European Regional Development Fund; COST Action(European Cooperation in Science and Technology (COST)); European Union(European Commission); Ministry of Science and Higher Education of the Republic of Poland(Ministry of Science and Higher Education, Poland)	This work was supported by grants from the National Science Center (UMO-2012/07/E/NZ6/01712 and UMO-2016/21/D/ST5/01661) (KP and JC, respectively), grant Lider/27/55/L-2/10/2011 (to KP) from the National Centre for Research and Development, Foundation for Polish Science provided funding to JC under grant number VENTURES/2013-11/1 cofinanced by the EU European Regional Development Fund. KP would like to acknowledge networking contribution by the COST Action CM1407 "Challenging organic syntheses inspired by nature - from natural products chemistry to drug discovery" from European Cooperation in Science and Technology. The Faculty of Biochemistry, Biophysics and Biotechnology of the Jagiellonian University is a beneficiary of the structural funds from the European Union (grant No: POIG.02.01.00-12-064/08 - "Molecular biotechnology for health"). Faculty of Biochemistry, Biophysics and Biotechnology of the Jagiellonian University is a partner of the Leading National Research Center supported by the Ministry of Science and Higher Education of the Republic of Poland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boivin G, 2003, EMERG INFECT DIS, V9, P634; Buck CB, 2006, PLOS PATHOG, V2, P671, DOI 10.1371/journal.ppat.0020069; Camps M, 2008, J MED VIROL, V80, P1452, DOI 10.1002/jmv.21209; Carlucci MJ, 2004, ANTIVIR RES, V64, P137, DOI 10.1016/j.antiviral.2004.07.001; Chang A, 2012, J VIROL, V86, P3230, DOI 10.1128/JVI.06706-11; Ciejka J, 2016, ANTIMICROB AGENTS CH, V60, P1955, DOI 10.1128/AAC.02183-15; Diogo JV, 2015, RES VET SCI, V98, P142, DOI 10.1016/j.rvsc.2014.11.010; Ebihara T, 2003, J MED VIROL, V70, P281, DOI 10.1002/jmv.10391; Eccles R, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0281-8; Edwards KM, 2013, NEW ENGL J MED, V368, P633, DOI 10.1056/NEJMoa1204630; Esper F, 2004, J INFECT DIS, V189, P1388, DOI 10.1086/382482; Esper F, 2003, PEDIATRICS, V111, P1407, DOI 10.1542/peds.111.6.1407; Fazekas T, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-147; GIROND S, 1991, RES VIROLOGY, V142, P261, DOI 10.1016/0923-2516(91)90011-Q; Grassauer A, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-107; Harden EA, 2009, ANTIVIR RES, V83, P282, DOI 10.1016/j.antiviral.2009.06.007; Hopkins P, 2008, AM J RESP CRIT CARE, V178, P876, DOI 10.1164/rccm.200711-1657OC; Klimyte EM, 2016, J VIROL, V90, P9237, DOI 10.1128/JVI.01362-16; Leibbrandt A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014320; Luo ZC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140586; LYNCH G, 1994, J LEUKOCYTE BIOL, V56, P266, DOI 10.1002/jlb.56.3.266; Mendes GS, 2014, CARBOHYD POLYM, V101, P313, DOI 10.1016/j.carbpol.2013.09.026; Milewska A, 2018, J VIROL, V92, DOI 10.1128/JVI.01933-17; Milewska A, 2014, J VIROL, V88, P13221, DOI 10.1128/JVI.02078-14; Milewska A, 2013, ANTIVIR RES, V97, P112, DOI 10.1016/j.antiviral.2012.11.006; Necas J, 2013, VET MED-CZECH, V58, P187, DOI 10.17221/6758-VETMED; Oliveira DBL, 2009, J MED VIROL, V81, P915, DOI 10.1002/jmv.21436; Orenstein Jan M, 2008, Open Infect Dis J, V2, P52; Pyrc K, 2011, J GEN VIROL, V92, P2324, DOI 10.1099/vir.0.032094-0; REED L. J., 1938, AMER JOUR HYG, V27, P493; Talarico LB, 2011, J GEN VIROL, V92, P1332, DOI 10.1099/vir.0.028522-0; van den Hoogen BG, 2001, NAT MED, V7, P719, DOI 10.1038/89098; Williams JV, 2006, J INFECT DIS, V193, P387, DOI 10.1086/499274	33	12	13	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214646	10.1371/journal.pone.0214646	http://dx.doi.org/10.1371/journal.pone.0214646			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921418	Green Published, gold, Green Submitted			2022-12-26	WOS:000462594000102
J	Koester, KA; Johnson, MO; Wood, T; Fredericksen, R; Neilands, TB; Sauceda, J; Crane, HM; Mugavero, MJ; Christopoulos, KA				Koester, Kimberly A.; Johnson, Mallory O.; Wood, Troy; Fredericksen, Rob; Neilands, Torsten B.; Sauceda, John; Crane, Heidi M.; Mugavero, Michael J.; Christopoulos, Katerina A.			The influence of the 'good' patient ideal on engagement in HIV care	PLOS ONE			English	Article							HEALTH OUTCOMES; RETENTION; ACTIVATION; ADHERENCE; LINKAGE; PHYSICIANS; CONTINUUM; TRUST	Research on patient engagement in health care shows that better health outcomes and lower healthcare costs are observed among highly engaged patients. Similar to other illnesses, high levels of patient engagement in HIV care are considered essential to maintaining optimal health, and patients who are on treatment and retained in HIV care are known to have better health outcomes. In this article, we draw on focus group discussion data with patients living with HIV in order to explain tacit expectations associated with engagement in care. The main objective of our research was to elicit an explanatory model of engagement in HIV care from the patients' perspective. We conducted focus group discussions with a sample of two distinct types of patients: those who regularly attended medical appointments and those who did not. In total, we conducted six focus group discussions (n = 43) across in three cities in the US; these included two focus group discussions with a well-engaged and less-well-engaged group in each location. Both types of patients assigned a moral dimension to engagement in care, in that well-engaged patients were considered to be 'good' patients. Aspiring to become a 'good' patient provided a meaningful goal for some and deepened vulnerabilities among patients that struggled to achieve this status. More vulnerable patients may feel less secure in health care interactions and these feelings may be amplified if patients have an unreasonable impression of what constitutes a 'good' patient; thereby leading to disengagement in care. Our findings can inform the development of patient-centered, tailored messages to better serve patients struggling to stay engaged in HIV care.	[Koester, Kimberly A.; Johnson, Mallory O.; Wood, Troy; Neilands, Torsten B.; Sauceda, John; Christopoulos, Katerina A.] Univ Calif San Francisco, Dept Med, Ctr AIDS Prevent Studies, San Francisco, CA 94143 USA; [Fredericksen, Rob; Crane, Heidi M.] Univ Washington, Dept Med, Seattle, WA USA; [Mugavero, Michael J.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA	University of California System; University of California San Francisco; University of Washington; University of Washington Seattle; University of Alabama System; University of Alabama Birmingham	Koester, KA (corresponding author), Univ Calif San Francisco, Dept Med, Ctr AIDS Prevent Studies, San Francisco, CA 94143 USA.	Kimberly.koester@ucsf.edu			National Institutes of Health (NIH) [R01MH102198]; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062246, R01MH102198] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The investigators (MOJ & KAC) have received grant funding (R01MH102198) from the National Institutes of Health (NIH) to conduct this study (Development and Validation of a Multidimensional Index of Engagement in HIV Care). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, DED V7 0 23; Ayres L, 2003, QUAL HEALTH RES, V13, P871, DOI 10.1177/1049732303013006008; Barello S, J PARTICIP MED, V6, pe9; Barello S, 2012, NURS RES PRACT, V2012, DOI 10.1155/2012/905934; Beach MC, 2006, J GEN INTERN MED, V21, P661, DOI 10.1111/j.1525-1497.2006.00399.x; Campbell C, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1139-x; Carman KL, 2013, HEALTH AFFAIR, V32, P223, DOI 10.1377/hlthaff.2012.1133; Castel AD, 2015, JAIDS-J ACQ IMM DEF, V69, pS44, DOI 10.1097/QAI.0000000000000575; Christopoulos KA, 2013, AIDS PATIENT CARE ST, V27, P223, DOI 10.1089/apc.2012.0418; Colasanti J, 2016, CLIN INFECT DIS, V62, P648, DOI 10.1093/cid/civ941; Creswell John W., 1994, RES DESIGN QUALITATI; Dawson-Rose C, 2016, J ASSOC NURSE AIDS C, V27, P574, DOI 10.1016/j.jana.2016.03.001; Dentzer S, 2013, HEALTH AFFAIR, V32, P202, DOI 10.1377/hlthaff.2013.0037; Entwistle V A, 1998, J Health Serv Res Policy, V3, P100; Flickinger TE, 2016, PATIENT EDUC COUNS, V99, P250, DOI 10.1016/j.pec.2015.08.020; Flickinger TE, 2013, JAIDS-J ACQ IMM DEF, V63, P362, DOI 10.1097/QAI.0b013e318295b86a; Flores D, 2016, INT J NURS STUD, V62, P126, DOI 10.1016/j.ijnurstu.2016.07.016; Forbat L, 2009, PATIENT EDUC COUNS, V74, P84, DOI 10.1016/j.pec.2008.07.055; Fredericksen RJ, 2015, AIDS CARE, V27, P1255, DOI 10.1080/09540121.2015.1050983; Frosch DL, 2012, HEALTH AFFAIR, V31, P1030, DOI 10.1377/hlthaff.2011.0576; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Graham JL, 2015, AIDS PATIENT CARE ST, V29, P661, DOI 10.1089/apc.2015.0156; Greene J, 2015, HEALTH AFFAIR, V34, P431, DOI 10.1377/hlthaff.2014.0452; Greene J, 2012, J GEN INTERN MED, V27, P520, DOI 10.1007/s11606-011-1931-2; Higgins T, 2017, PATIENT EDUC COUNS, V100, P30, DOI 10.1016/j.pec.2016.09.002; Ibe C, 2017, PATIENT EDUC COUNS, V100, P1258, DOI 10.1016/j.pec.2016.12.016; Johnson MO, 2017, JMIR RES PROTOC, V6, DOI 10.2196/resprot.8520; Johnson MO, 2006, AIDS PATIENT CARE ST, V20, P258, DOI 10.1089/apc.2006.20.258; Kay ES, 2016, AIDS RES THER, V13, DOI 10.1186/s12981-016-0120-0; Lindlof T., 2011, QUALITATIVE COMMUNIC; Marshall R, 2013, J GEN INTERN MED, V28, P668, DOI 10.1007/s11606-012-2307-y; Mayer KH, 2011, CLIN INFECT DIS, V52, pS205, DOI 10.1093/cid/ciq043; McCreaddie M, 2009, INT J NURS STUD, V46, P1079, DOI 10.1016/j.ijnurstu.2009.01.008; Mohta NS, 2016, PATIENT ENGAGEMENT S; Mugavero MJ, 2009, CLIN INFECT DIS, V48, P248, DOI 10.1086/595705; Nakagawa F, 2012, AIDS, V26, P335, DOI 10.1097/QAD.0b013e32834dcec9; Ondenge K, 2017, SEX TRANSM INFECT, V93, DOI 10.1136/sextrans-2016-052973; Ritchie J, 2003, QUALITATIVE RES PRAC, P219, DOI DOI 10.1186/1471-2288-13-117; Simon Wand GHJ, 1986, SEXUAL SCRIPTS PERMA, V15; Ulett KB, 2009, AIDS PATIENT CARE ST, V23, P41, DOI 10.1089/apc.2008.0132	40	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214636	10.1371/journal.pone.0214636	http://dx.doi.org/10.1371/journal.pone.0214636			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HQ7IR	30921440	Green Published, Green Submitted, gold			2022-12-26	WOS:000462594000101
J	Maezawa, Y; Nakaminami, H; Takadama, S; Hayashi, M; Wajima, T; Nakase, K; Yamada, T; Ikoshi, H; Noguchi, N				Maezawa, Yuka; Nakaminami, Hidemasa; Takadama, Shunsuke; Hayashi, Minami; Wajima, Takeaki; Nakase, Keisuke; Yamada, Tetsuya; Ikoshi, Hideaki; Noguchi, Norihisa			Tokiinshi, a traditional Japanese medicine (Kampo), suppresses Panton-Valentine leukocidin production in the methicillin-resistant Staphylococcus aureus USA300 clone	PLOS ONE			English	Article							GENE; ANTIBIOTICS; EPIDERMIDIS; MICROBIOTA; PNEUMONIA; STRAIN; HOST	It is necessary to develop agents other than antimicrobials for the treatment of Staphylococcus aureus infections to prevent the emergence of antimicrobial-resistant strains. Particularly, anti-virulence agents against the Panton-Valentine leukocidin (PVL)-positive methicillin-resistant S. aureus (MRSA), USA300 clone, is desired due to its high pathogenicity. Here, we investigated the potential anti-virulence effect of Tokiinshi, which is a traditional Japanese medicine (Kampo) used for skin diseases, against the USA300 clone. A growth inhibition assay showed that a conventional dose (20 mg/ml) of Tokiinshi has bactericidal effects against the clinical USA300 clones. Notably, the growth inhibition effects of Tokiinshi against S. epidermidis strains, which are the major constituents of the skin microbiome, was a bacteriostatic effect. The data suggested that Tokiinshi is unlikely to affect skin flora of S. epidermidis. Furthermore, PVL production and the expression of its gene were significantly suppressed in the USA300 clone by a lower concentration (5 mg/ml) of Tokiinshi. This did not affect the number of viable bacteria. Moreover, Tokiinshi significantly suppressed the expression of the agrA gene, which regulates PVL gene expression. For the first time, our findings strongly suggest that Tokiinshi has the potential to attenuate the virulence of the USA300 clone by suppressing PVL production via agrA gene suppression.	[Maezawa, Yuka; Nakaminami, Hidemasa; Takadama, Shunsuke; Hayashi, Minami; Wajima, Takeaki; Nakase, Keisuke; Noguchi, Norihisa] Tokyo Univ Pharm & Life Sci, Sch Pharm, Dept Microbiol, Hachioji, Tokyo, Japan; [Yamada, Tetsuya; Ikoshi, Hideaki] Tokyo Univ Pharm & Life Sci, Sch Pharm, Dept Tradit Chinese Med, Hachioji, Tokyo, Japan	Tokyo University of Pharmacy & Life Sciences; Tokyo University of Pharmacy & Life Sciences	Nakaminami, H (corresponding author), Tokyo Univ Pharm & Life Sci, Sch Pharm, Dept Microbiol, Hachioji, Tokyo, Japan.	nakami@toyaku.ac.jp	Nakase, Keisuke/AEP-0804-2022; Nakase, Keisuke/AAQ-2777-2020; Wajma, Takeaki/AAF-4743-2020	Wajma, Takeaki/0000-0001-9506-707X; Nakase, Keisuke/0000-0002-9205-3008; Nakaminami, Hidemasa/0000-0003-2889-8257	Japan Society for the Promotion of Science KAKENHI [JP18H00370]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science KAKENHI Grant Number JP18H00370 (N.N). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Christensen GJM, 2014, BENEF MICROBES, V5, P201, DOI 10.3920/BM2012.0062; Dumitrescu O, 2008, CLIN MICROBIOL INFEC, V14, P384, DOI 10.1111/j.1469-0691.2007.01947.x; Genestier AL, 2005, J CLIN INVEST, V115, P3117, DOI 10.1172/JCI22684; Gillet Y, 2002, LANCET, V359, P753, DOI 10.1016/S0140-6736(02)07877-7; Guidos RJ, 2011, CLIN INFECT DIS, V52, pS397, DOI 10.1093/cid/cir153; Kaito C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001267; Kaneko J, 2004, BIOSCI BIOTECH BIOCH, V68, P981, DOI 10.1271/bbb.68.981; Khodaverdian V, 2013, ANTIMICROB AGENTS CH, V57, P3645, DOI 10.1128/AAC.00269-13; Kong C, 2016, TOXINS, V8, DOI 10.3390/toxins8030072; Laborel-Preneron E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141067; Lai YP, 2010, J INVEST DERMATOL, V130, P2211, DOI 10.1038/jid.2010.123; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Miller LG, 2005, NEW ENGL J MED, V352, P1445, DOI 10.1056/NEJMoa042683; Morgun A, 2015, GUT, V64, P1732, DOI 10.1136/gutjnl-2014-308820; Nakaminami H, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00358-17; Nimmo GR, 2012, CLIN MICROBIOL INFEC, V18, P725, DOI 10.1111/j.1469-0691.2012.03822.x; Nose M, 1999, BIOL PHARM BULL, V22, P48, DOI 10.1248/bpb.22.48; Planet PJ, 2015, J INFECT DIS, V212, P1874, DOI 10.1093/infdis/jiv320; Sanford JA, 2013, SEMIN IMMUNOL, V25, P370, DOI 10.1016/j.smim.2013.09.005; Takadama S, 2018, Clin Microbiol Infect, V24, DOI 10.1016/j.cmi.2018.02.012; Takadama S, 2017, J INFECT CHEMOTHER, V23, P800, DOI 10.1016/j.jiac.2017.04.016; Tenover FC, 2009, J ANTIMICROB CHEMOTH, V64, P441, DOI 10.1093/jac/dkp241; Villaruz AE, 2009, J INFECT DIS, V200, P724, DOI 10.1086/604728; Wajima T, 2019, PHARMACOLOGY, V103, P221, DOI 10.1159/000496830; Wajima T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167335; Wang LQ, 2015, ACTA PHARM SIN B, V5, P310, DOI [10.1016/j.apsb.2015.05.005, 10.1016//j.apsb.2015.05.005]; Wang YH, 2014, APPL MICROBIOL BIOT, V98, P411, DOI 10.1007/s00253-013-5394-8; Yamada T, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1431-3; Yamamoto T, 2010, J INFECT CHEMOTHER, V16, P225, DOI 10.1007/s10156-010-0045-9	29	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214470	10.1371/journal.pone.0214470	http://dx.doi.org/10.1371/journal.pone.0214470			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921402	Green Published, Green Submitted, gold			2022-12-26	WOS:000462594000075
J	Otsuka, M; Isaka, T				Otsuka, Mitsuo; Isaka, Tadao			Intra-athlete and inter-group comparisons: Running pace and step characteristics of elite athletes in the 400-m hurdles	PLOS ONE			English	Article							BLOOD LACTATE; SPRINT; 100-M; VELOCITY; LENGTH; 200-M	The aim of this study was to investigate the running pace and step characteristics among various competitive-level 400-m hurdlers through inter-group and intra-athlete comparisons. We analysed spatiotemporal data involving the split time, mean step length (SL) and mean step frequency (SF) for 13 male world-class and 14 male national-level 400-m hurdlers. We analysed 16.5 +/- 3.9 races for each world-class hurdler and 19.8 +/- 6.0 races for each national-level hurdler (the total number of analysed runs was 491) using publicly available television and internet broadcasts. Inter-group comparisons showed that both first- and latter-halves split times of the world-class hurdlers were significantly shorter than those of the national-level hurdlers. In the latter-half phase, no significant differences of SL and SF were observed between the world-class and national level hurdlers. Intra-athlete comparisons showed that no athletes favoured only first-half phase in terms of running speed in short finish times. In contrast, finish times of all hurdlers were sensitive to running speed in the latter half phase. In the latter half of the race, 18 of the 27 hurdlers were identified as being SF reliant during speed enhancements; running speed of the other 9 hurdlers were also sensitive to high SF. In conclusions, important findings regarding high performance in inter-group comparisons do not always corresponded with those in intra-athlete comparisons. All athletes and coaches should first prioritize maintaining high running speeds in the latter half of 400-m hurdles rather than in the first half of the race.	[Otsuka, Mitsuo; Isaka, Tadao] Ritsumeikan Univ, Fac Sport & Hlth Sci, Kusatsu, Shiga, Japan	Ritsumeikan University	Otsuka, M (corresponding author), Ritsumeikan Univ, Fac Sport & Hlth Sci, Kusatsu, Shiga, Japan.	otsuka-a@st.ritsumei.ac.jp	Otsuka, Mitsuo/AAB-4120-2019	Otsuka, Mitsuo/0000-0003-1391-4939	Yamaha Motor Foundation	Yamaha Motor Foundation	This work was supported by Yamaha Motor Foundation (http://www.ymfs.jp/project/assist/challenger/otsukam/) to M.O. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEAULIEU P, 1995, BRIT J SPORT MED, V29, P80, DOI 10.1136/bjsm.29.2.80; Breizer V, 1990, NEW STUD ATHL, V4, P21; Chow JW, 2011, SPORT BIOMECH, V10, P219, DOI 10.1080/14763141.2011.592212; Ditroilo M, 2001, NEW STUDIES ATHLETIC, V16, P15; Donati A, 1995, NEW STUDIES ATHLETIC, V10, P51; Furusawa K, 1927, P R SOC LOND B-CONTA, V102, P43, DOI 10.1098/rspb.1927.0036; Girard O, 2016, J BIOMECH, V49, P1490, DOI 10.1016/j.jbiomech.2016.03.020; Hanon C, 2011, J SPORT SCI, V29, P905, DOI 10.1080/02640414.2011.562232; Hanon C, 2009, J STRENGTH COND RES, V23, P524, DOI 10.1519/JSC.0b013e318194e071; HIRVONEN J, 1992, CAN J SPORT SCI, V17, P141; Hobara H, 2016, INT J SPORTS MED, V37, P165, DOI 10.1055/s-0035-1564171; Hobara H, 2015, INT J SPORTS MED, V36, P494, DOI 10.1055/s-0034-1387794; Hobara H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163712; Hunter JP, 2004, MED SCI SPORT EXER, V36, P261, DOI 10.1249/01.MSS.0000113664.15777.53; Ito A, 2006, NEW STUD ATHLET, V21, P35; McDonald C, 2004, HURDLES CONT THEORY, P12; Mero A, 1985, INT J SPORT BIOMECH, V1, P240, DOI [https://doi.org/10.1123/ijsb.1.3.240, DOI 10.1123/IJSB.1.3.240]; Nummela A, 1992, J SPORT SCI, V10, P217, DOI 10.1080/02640419208729920; Otsuka M., 2010, INT J SPORT HLTH SCI, V8, P35, DOI DOI 10.5432/IJSHS.20090027; Otsuka M, 2016, J STRENGTH COND RES, V30, P635, DOI 10.1519/JSC.0000000000001162; Paradisis GP, 2001, J SPORT SCI, V19, P149, DOI 10.1080/026404101300036370; Przednowek K, 2017, J HUM KINET, V60, P175, DOI 10.1515/hukin-2017-0101; Quinn MD, 2010, J APPL BIOMECH, V26, P171, DOI 10.1123/jab.26.2.171; Salo AIT, 2006, SPORT BIOMECH, V5, P155, DOI 10.1080/14763140608522871; Salo AIT, 2011, MED SCI SPORT EXER, V43, P1055, DOI 10.1249/MSS.0b013e318201f6f8; Saraslanidis PJ, 2011, EUR J APPL PHYSIOL, V111, P1579, DOI 10.1007/s00421-010-1772-4; Theodorou AS, 2017, J SPORT SCI, V35, P346, DOI 10.1080/02640414.2016.1164884; Weyand PG, 2000, J APPL PHYSIOL, V89, P1991, DOI 10.1152/jappl.2000.89.5.1991; Yasui T, 1996, P 14 INT S BIOM SPOR, P77; Zouhal H, 2010, J STRENGTH COND RES, V24, P2309, DOI 10.1519/JSC.0b013e3181e31287	30	5	5	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0204185	10.1371/journal.pone.0204185	http://dx.doi.org/10.1371/journal.pone.0204185			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921329	Green Submitted, Green Published, gold			2022-12-26	WOS:000462594000001
J	Yuan, CL; Sun, QX; Kong, YZ				Yuan, Cuiling; Sun, Quanxi; Kong, Yingzhen			Genome-wide mining seed-specific candidate genes from peanut for promoter cloning	PLOS ONE			English	Article							STORAGE-PROTEIN PROMOTER; ARACHIS-HYPOGAEA L.; BRASSICA-NAPUS; EXPRESSION; ENDOSPERM; RICE; IDENTIFICATION; ELEMENTS; TRANSCRIPTION; BIOSYNTHESIS	Peanut seeds are ideal bioreactors for the production of foreign recombinant proteins and/or nutrient metabolites. Seed-Specific Promoters (SSPs) are important molecular tools for bioreactor research. However, few SSPs have been characterized in peanut seeds. The mining of Seed-Specific Candidate Genes (SSCGs) is a prerequisite for promoter cloning. Here, we described an approach for the genome-wide mining of SSCGs via comparative gene expression between seed and nonseed tissues. Three hundred thirty-seven SSCGs were ultimately identified, and the top 108 SSCGs were characterized. Gene Ontology (GO) analysis revealed that some SSCGs were involved in seed development, allergens, seed storage and fatty acid metabolism. RY REPEAT and GCN4 motifs, which are commonly found in SSPs, were dispersed throughout most of the promoters of SSCGs. Expression pattern analysis revealed that all 108 SSCGs were expressed specifically or preferentially in the seed. These results indicated that the promoters of the 108 SSCGs may perform functions in a seed-specific and/or seed-preferential manner. Moreover, a novel SSP was cloned and characterized from a paralogous gene of SSCG29 from cultivated peanut. Together with the previously characterized SSP of the SSCG5 paralogous gene in cultivated peanut, these results implied that the method for SSCG identification in this study was feasible and accurate. The SSCGs identified in this work could be widely applied to SSP cloning by other researchers. Additionally, this study identified a low-cost, high-throughput approach for exploring tissue-specific genes in other crop species.	[Yuan, Cuiling; Kong, Yingzhen] Chinese Acad Agr Sci, Tobacco Res Inst, Key Lab Tobacco Gene Resources, Qingdao, Shandong, Peoples R China; [Yuan, Cuiling; Sun, Quanxi] Shandong Peanut Res Inst, Qingdao, Shandong, Peoples R China; [Yuan, Cuiling] Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Tobacco Research Institute, CAAS; Chinese Academy of Agricultural Sciences; Biotechnology Research Institute, CAAS	Kong, YZ (corresponding author), Chinese Acad Agr Sci, Tobacco Res Inst, Key Lab Tobacco Gene Resources, Qingdao, Shandong, Peoples R China.; Sun, QX (corresponding author), Shandong Peanut Res Inst, Qingdao, Shandong, Peoples R China.	squanxi@163.com; kongyingzhen@caas.cn	kong, yingzhen/AAB-1623-2022		National Natural Science Foundation of China [31601336, 31670302]; National Key Technology RD Program [2015BAD15B03-05]; Elite Youth Program of CAAS	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology RD Program(National Key Technology R&D Program); Elite Youth Program of CAAS	This work was supported by National Natural Science Foundation of China (31601336 and 31670302), the National Key Technology R&D Program (2015BAD15B03-05), the Elite Youth Program of CAAS (to YK).	Abbadi A, 2004, PLANT CELL, V16, P2734, DOI 10.1105/tpc.104.026070; Abid G, 2012, PLANT MOL BIOL REP, V30, P719, DOI 10.1007/s11105-011-0381-7; Aluru M, 2008, J EXP BOT, V59, P3551, DOI 10.1093/jxb/ern212; Bertioli DJ, 2016, NAT GENET, V48, P438, DOI 10.1038/ng.3517; Buchanan-Wollaston V, 2005, PLANT J, V42, P567, DOI 10.1111/j.1365-313X.2005.02399.x; Chang YJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142952; Chi XY, 2012, MOL GENET GENOMICS, V287, P167, DOI 10.1007/s00438-011-0665-5; Chi XY, 2011, PLANT CELL REP, V30, P1393, DOI 10.1007/s00299-011-1048-4; Clevenger J, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01446; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; De Wilde C, 2000, PLANT MOL BIOL, V43, P347, DOI 10.1023/A:1006464304199; Deng WK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111988; Ezcurra I, 1999, PLANT MOL BIOL, V40, P699, DOI 10.1023/A:1006206124512; Ezura K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180003; Fu GH, 2010, PLANTA, V231, P1049, DOI 10.1007/s00425-010-1111-3; Geng LL, 2014, PLANT CELL PHYSIOL, V55, P1793, DOI 10.1093/pcp/pcu111; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Hood EE, 2003, PLANT BIOTECHNOL J, V1, P129, DOI 10.1046/j.1467-7652.2003.00014.x; Hsieh TH, 2002, PLANT PHYSIOL, V130, P618, DOI 10.1104/pp.006783; JEFFERSON RA, 1987, EMBO J, V6, P3901; Jiang SJ, 2011, PLANT CELL REP, V30, P1135, DOI 10.1007/s00299-011-1022-1; Kang IH, 2007, PLANT PHYSIOL, V144, P836, DOI 10.1104/pp.107.096933; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Knoll JE, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-81; Li MY, 2014, HORTIC RES-ENGLAND, V1, DOI 10.1038/hortres.2014.10; Li N, 2017, SCI REP-UK, V7, DOI 10.1038/srep42059; Liu XQ, 2018, PLANT BIOTECHNOL J, V16, P1107, DOI 10.1111/pbi.12883; Liu XQ, 2014, PLANT BIOTECHNOL J, V12, P1286, DOI 10.1111/pbi.12227; Napier JA, 2019, PLANT BIOTECHNOL J, V17, P703, DOI 10.1111/pbi.13045; Naqvi S, 2010, TRENDS PLANT SCI, V15, P48, DOI 10.1016/j.tplants.2009.09.010; Nie DM, 2013, GENE, V530, P236, DOI 10.1016/j.gene.2013.07.088; Onodera Y, 2001, J BIOL CHEM, V276, P14139, DOI 10.1074/jbc.M007405200; Paine JA, 2005, NAT BIOTECHNOL, V23, P482, DOI 10.1038/nbt1082; Park JS, 2006, J PLANT BIOL, V49, P133, DOI 10.1007/BF03031009; Pessina S, 2016, PLANT BIOTECHNOL J, V14, P2033, DOI 10.1111/pbi.12562; Stalberg K, 1996, PLANTA, V199, P515, DOI 10.1007/BF00195181; STALBERG K, 1993, PLANT MOL BIOL, V23, P671, DOI 10.1007/BF00021523; Sunkara S, 2014, APPL BIOCHEM BIOTECH, V172, P325, DOI 10.1007/s12010-013-0482-x; Tang GY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139213; Washida H, 1999, PLANT MOL BIOL, V40, P1, DOI 10.1023/A:1026459229671; Wei ZY, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17050624; Xu N, 2016, PLANT CELL, V28, P485, DOI 10.1105/tpc.15.00567; Yang P, 2015, PLANT BIOLOGY, V17, P522, DOI 10.1111/plb.12268; Zhang YX, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155780; Zhao XB, 2018, MOL BIOL REP, V45, P119, DOI 10.1007/s11033-018-4145-4; Zhong RQ, 2006, PLANT CELL, V18, P3158, DOI 10.1105/tpc.106.047399; Zhu QL, 2017, MOL PLANT, V10, P918, DOI 10.1016/j.molp.2017.05.008; ZIMMERMANN CR, 1980, CELL, V21, P709, DOI 10.1016/0092-8674(80)90434-1	48	6	7	9	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214025	10.1371/journal.pone.0214025	http://dx.doi.org/10.1371/journal.pone.0214025			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921362	Green Published, gold, Green Submitted			2022-12-26	WOS:000462594000030
J	Zhang, LY; Hemminki, O; Chen, TH; Yu, HY; Zheng, GQ; Chattopadhyay, S; Forsti, A; Sundquist, K; Sundquist, J; Hemminki, K				Zhang, Luyao; Hemminki, Otto; Chen, Tianhui; Yu, Hongyao; Zheng, Guoqiao; Chattopadhyay, Subhayan; Foersti, Asta; Sundquist, Kristina; Sundquist, Jan; Hemminki, Kari			Second cancers and causes of death in patients with testicular cancer in Sweden	PLOS ONE			English	Article							GERM-CELL CANCER; CHILDHOOD-CANCER; ADULT SURVIVORS; SOLID TUMORS; RISK; CHEMOTHERAPY; DIAGNOSIS; LEUKEMIA; LYMPHOMA; REGISTRY	While treatment for testicular cancer (TC) has become standardized after the 1980s with an associated significant improvement in patient survival, this has been accompanied by an increased risk of second primary cancers (SPCs). Patients were identified from the Swedish Cancer Registry spanning the years from 1980 to 2015, including 8788 individuals with primary TC and their SPCs. Relative risks (RRs) for SPC were calculated using the generalized Poisson regression model. SPCs were diagnosed in 9.4% of patients with TC and half of them were late onset cancers not common in the population in their 40s. Overall RR of SPCs (excluding second TC) was 1.30 (95%CI: 1.20-1.40), including high risks for seven solid cancers, non-Hodgkin lymphoma and leukemia. Second TC was the most common SPC and the RR of 17.19 (95%CI: 14.89-19.85) was the highest recorded. Cancers known to be fatal as first primary cancers were also fatal as SPC in TC patients. Survival at 30 years of follow-up was approximately 80% for TC patients without SPC but it decreased to 40% for patients with SPC. The unexpected finding that half of the identified SPCs were typical late onset cancers in the middle-aged population raises concerns that therapy may facilitate premature aging. The risks of SPC are clinically important for the long-term management of TC patients and the high-mortality calls for a future management strategy.	[Zhang, Luyao; Yu, Hongyao; Zheng, Guoqiao; Chattopadhyay, Subhayan; Foersti, Asta; Hemminki, Kari] German Canc Res Ctr, Div Mol Genet Epidemiol, Heidelberg, Germany; [Zhang, Luyao; Yu, Hongyao; Zheng, Guoqiao; Chattopadhyay, Subhayan] Heidelberg Univ, Fac Med, Heidelberg, Germany; [Hemminki, Otto] Helsinki Univ Hosp, Dept Urol, Helsinki, Finland; [Hemminki, Otto] Univ Helsinki, Canc Gene Therapy Grp, Fac Med, Helsinki, Finland; [Chen, Tianhui; Hemminki, Kari] Zhejiang Acad Med Sci ZJAMS, Grp Mol Epidemiol & Canc Precis Prevent, Hangzhou, Zhejiang, Peoples R China; [Foersti, Asta; Sundquist, Kristina; Sundquist, Jan] Lund Univ, Ctr Primary Hlth Care Res, Malmo, Sweden; [Sundquist, Kristina; Sundquist, Jan] Icahn Sch Med Mt Sinai, Dept Populat Hlth Sci & Policy, Dept Family Med & Community Hlth, New York, NY 10029 USA; [Sundquist, Kristina; Sundquist, Jan] Shimane Univ, Sch Med, Dept Funct Pathol, Ctr Community Based Healthcare Res & Educ CoHRE, Matsue, Shimane, Japan	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Lund University; Icahn School of Medicine at Mount Sinai; Shimane University	Zhang, LY (corresponding author), German Canc Res Ctr, Div Mol Genet Epidemiol, Heidelberg, Germany.; Zhang, LY (corresponding author), Heidelberg Univ, Fac Med, Heidelberg, Germany.	luyao.zhang@dkfz-heidelberg.de	Chen, Tianhui/Y-3500-2018	Chen, Tianhui/0000-0003-4677-0361; Chattopadhyay, Subhayan/0000-0002-8599-2971	Deutsche Krebshilfe; Swedish Research Council [2014-2517, 2014-10134, 2016-01176]; ALF from Region Skane	Deutsche Krebshilfe(Deutsche Krebshilfe); Swedish Research Council(Swedish Research CouncilEuropean Commission); ALF from Region Skane	This work was supported by Deutsche Krebshilfe, the Swedish Research Council (2014-2517, 2014-10134 and 2016-01176) and ALF funding from Region Skane. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariffin H, 2017, CANCER-AM CANCER SOC, V123, P4207, DOI 10.1002/cncr.30857; Bray F, 2006, INT J CANCER, V118, P3099, DOI 10.1002/ijc.21747; CenterforEpidemiology, 2010, CANC INC SWED 2009; Chovanec M, 2017, ANN ONCOL, V28, P2670, DOI 10.1093/annonc/mdx360; Eble J, 2003, TUMORS URINARY SYSTE; Frodin JE, 1997, ACTA ONCOL, V36, P465; Fung C, 2018, ADV UROL, V2018, DOI 10.1155/2018/8671832; Fung C, 2013, J CLIN ONCOL, V31, P3807, DOI 10.1200/JCO.2013.50.3409; Groot HJ, 2018, J CLIN ONCOL, V36, P2504, DOI 10.1200/JCO.2017.77.4174; Hanna N, 2014, J CLIN ONCOL, V32, P3085, DOI 10.1200/JCO.2014.56.0896; Hemminki K, 2010, ANN ONCOL, V21, P1546, DOI 10.1093/annonc/mdp562; Hemminki K, 2008, J CLIN ONCOL, V26, P1850, DOI 10.1200/JCO.2007.14.6068; Hemminki K, 2010, INT J CANCER, V126, P2259, DOI 10.1002/ijc.24795; Honecker F, 2018, ANN ONCOL, V29, P1658, DOI 10.1093/annonc/mdy217; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2012, REV HUMAN CARCINOGEN, V100, P1; International Agency for Research on Cancer (IARC), 2007, CANC INCIDENCE 5 CON, V9; Ji JG, 2012, INT J CANCER, V131, P2085, DOI 10.1002/ijc.27462; Kier MG, 2016, JAMA ONCOL, V2, P1624, DOI 10.1001/jamaoncol.2016.3651; Kvammen O, 2016, CANCER EPIDEM BIOMAR, V25, P773, DOI 10.1158/1055-9965.EPI-15-1153; Le Cornet C, 2014, EUR J CANCER, V50, P831, DOI 10.1016/j.ejca.2013.11.035; Ness KK, 2015, CANCER-AM CANCER SOC, V121, P1540, DOI 10.1002/cncr.29211; Ness KK, 2013, J CLIN ONCOL, V31, P4496, DOI 10.1200/JCO.2013.52.2268; Prener A, 1996, EPIDEMIOLOGY, V7, P14, DOI 10.1097/00001648-199601000-00004; Pukkala E, 2018, ACTA ONCOL, V57, P440, DOI 10.1080/0284186X.2017.1407039; Pyle LC, 2016, SEMIN ONCOL, V43, P575, DOI 10.1053/j.seminoncol.2016.08.004; Rajpert-De Meyts E, 2016, LANCET, V387, P1762, DOI 10.1016/S0140-6736(15)00991-5; Riihimaki M, 2016, SCI REP-UK, V6, DOI 10.1038/srep29765; Skakkebaek NE, 2016, HORM RES PAEDIAT, V86, P240, DOI 10.1159/000443400; Sud A, 2017, J CLIN ONCOL, V35, P1584, DOI 10.1200/JCO.2016.70.9709; Trabert B, 2013, INT J CANCER, V133, P1900, DOI 10.1002/ijc.28207; Travis LB, 2005, JNCI-J NATL CANCER I, V97, P1354, DOI 10.1093/jnci/dji278; van den Belt-Dusebout AW, 2007, J CLIN ONCOL, V25, P4370, DOI 10.1200/JCO.2006.10.5296; Verhoeven RHA, 2013, ANN ONCOL, V24, P508, DOI 10.1093/annonc/mds460; Wierecky J, 2005, J CANCER RES CLIN, V131, P255, DOI 10.1007/s00432-004-0628-x; Zequi SD, 2012, BJU INT, V110, P1102, DOI 10.1111/j.1464-410X.2012.11056.x	35	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214410	10.1371/journal.pone.0214410	http://dx.doi.org/10.1371/journal.pone.0214410			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921367	gold, Green Submitted, Green Published			2022-12-26	WOS:000462594000066
J	Lima, NGS; Oliveira, U; Souza, RCC; Eterovick, PC				Lima, Nathalia G. S.; Oliveira, Ubirajara; Souza, Rafael C. C.; Eterovick, Paula C.			Dynamic and diverse amphibian assemblages: Can we differentiate natural processes from human induced changes?	PLOS ONE			English	Article							ESTIMATING SITE OCCUPANCY; DETECTION PROBABILITY PARAMETERS; POPULATION DECLINES; HABITAT; FOREST; FROG; CONSERVATION; COMMUNITIES; DISTURBANCE; EXTINCTION	Amphibians are sensitive to anthropogenic habitat alterations but also respond to natural drivers of assemblage composition at many levels. Additionally, they are usually hard to detect in field inventories. We used a multiscale approach, from microhabitat to the landscape levels, to try to understand the effects of natural changes, and try to distinguish them from the effects of landscape level anthropogenic changes, on dynamic and diverse anuran assemblages, taking imperfect detection into account. We conducted thorough field inventories in 16 streams at Serra do Cipo, in the southern portion of Espinhaco Mountain Range, southeastern Brazil, during two time periods separated by 16 years. We compared species richness and diversity between periods, sampling both tadpoles and adult frogs. We quantified tadpole microhabitat availability, alterations in immediate riparian vegetation, and changes in classes of land cover within buffers around streams (adult habitats) to test for their effects on species composition. We also tested for effects of human occupancy around streams on nestedness and turnover components of species diversity. Microhabitats and riparian vegetation explained some of the changes in species composition (or detection) between time periods. Nestedness seemed to be influenced by the stability of the landscape. Detectabilities were too low to support robust occupancy estimates for most species. Natural changes in local habitats occupied by anurans in montane meadows are likely to influence species distribution. Some species with robust estimates experienced change in their occupancy over the studied 16-year interval, although no anthropogenic causes could be directly associated with such changes. The low detectability of most species, even with thorough sampling effort, makes it very hard to detect amphibian declines and possibly tell them apart from natural population fluctuations. New techniques are needed that improve species detectability in such diverse tropical habitats.	[Lima, Nathalia G. S.] Univ Fed Minas Gerais, Inst Ciencias Biol, Programa Posgrad Ecol, Belo Horizonte, MG, Brazil; [Oliveira, Ubirajara] Univ Fed Minas Gerais, Inst Geociencias, Ctr Sensoriamento Remoto, Belo Horizonte, MG, Brazil; [Souza, Rafael C. C.; Eterovick, Paula C.] Pontificia Univ Catolica Minas Gerais, Programa Posgrad Biol Vertebrados, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Pontificia Universidade Catolica de Minas Gerais	Eterovick, PC (corresponding author), Pontificia Univ Catolica Minas Gerais, Programa Posgrad Biol Vertebrados, Belo Horizonte, MG, Brazil.	pceterovick@gmail.com	Eterovick, Paula Cabral/AGC-1678-2022	Eterovick, Paula Cabral/0000-0002-1316-1255	Fundo de Incentivo a Pesquisa - PUC Minas [2016/10292-S1]; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) [APQ 01959-15]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [CNPq - 426368/2016-9, 310162/2017-3]; CNPq	Fundo de Incentivo a Pesquisa - PUC Minas; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was funded by Fundo de Incentivo a Pesquisa - PUC Minas (2016/10292-S1), the Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG, APQ 01959-15) and the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq - 426368/2016-9 and 310162/2017-3) all grants awarded in name of Paula C. Eterovick. Nathalia G. S. Lima received a scholarship from CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, ESRI ARCGIS DESKTOP; Bailey LL, 2004, ECOL APPL, V14, P692, DOI 10.1890/03-5012; Barrett K, 2008, BIOL CONSERV, V141, P2290, DOI 10.1016/j.biocon.2008.06.019; Barrett K, 2010, BIOL CONSERV, V143, P1998, DOI 10.1016/j.biocon.2010.05.001; Baselga A, 2012, METHODS ECOL EVOL, V3, P808, DOI 10.1111/j.2041-210X.2012.00224.x; Baselga A, 2010, GLOBAL ECOL BIOGEOGR, V19, P134, DOI 10.1111/j.1466-8238.2009.00490.x; Becker CG, 2007, SCIENCE, V318, P1775, DOI 10.1126/science.1149374; Beebee TJC, 2005, BIOL CONSERV, V125, P271, DOI 10.1016/j.biocon.2005.04.009; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; BLAUSTEIN AR, 1994, CONSERV BIOL, V8, P60, DOI 10.1046/j.1523-1739.1994.08010060.x; Calegario Natalino, 2005, Rev. Árvore, V29, P251, DOI 10.1590/S0100-67622005000200008; Canessa S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070262; Chelgren ND, 2011, ECOLOGY, V92, P408, DOI 10.1890/10-0322.1; Cole EM, 2014, GLOB ECOL CONSERV, V1, P60, DOI 10.1016/j.gecco.2014.06.002; Colwell RK, 2009, ESTIMATES STAT ESTIM; Costa CMR, 1998, BIODIVERSIDADE MINAS; D'Amen M, 2017, BIOL REV, V92, P169, DOI 10.1111/brv.12222; Davidson C, 2001, ECOL APPL, V11, P464, DOI 10.1890/1051-0761(2001)011[0464:DOTCRL]2.0.CO;2; Diniz JAF, 2003, GLOBAL ECOL BIOGEOGR, V12, P53, DOI 10.1046/j.1466-822X.2003.00322.x; Entsminger G.L., 2001, ECOSIM NULL MODELS S; Ernst R, 2006, BIOL CONSERV, V133, P143, DOI 10.1016/j.biocon.2006.05.028; Eterovick P.C., 2020, ANFIBIOS ANUROS SERR; Eterovick PC, 2016, BIOL CONSERV, V195, P52, DOI 10.1016/j.biocon.2015.12.036; Eterovick Paula C., 2009, South American Journal of Herpetology, V4, P235, DOI 10.2994/057.004.0306; Eterovick PC, 2005, BIOTROPICA, V37, P166, DOI 10.1111/j.1744-7429.2005.00024.x; Eterovick PC, 2003, J TROP ECOL, V19, P439, DOI 10.1017/S026646740300347X; Eterovick PC, 2003, J TROP ECOL, V19, P219, DOI 10.1017/S0266467403003250; Ficetola GF, 2011, ECOL APPL, V21, P1272, DOI 10.1890/10-0431.1; Funk WC, 2005, BIOL LETT-UK, V1, P13, DOI 10.1098/rsbl.2004.0270; Gillespie GR, 2015, BIOL CONSERV, V192, P161, DOI 10.1016/j.biocon.2015.08.034; Guadagnin DL, 2005, WATERBIRDS, V28, P261, DOI 10.1675/1524-4695(2005)028[0261:SATPOW]2.0.CO;2; Guimaraes M, 2014, S AM J HERPETOL, V9, P1, DOI 10.2994/SAJH-D-13-00020.1; Houlahan JE, 2000, NATURE, V404, P752, DOI 10.1038/35008052; IUCN, 2017, VERS 2017 3; Kamino L. H. Y., 2008, MEGADIVERSIDADE, V4, P39; Kloh JS, 2019, HYDROBIOLOGIA, V828, P271, DOI 10.1007/s10750-018-3818-2; Kopp K, 2006, CAN J ZOOL, V84, P136, DOI 10.1139/Z05-186; Kupferberg SJ, 1997, AM ZOOL, V37, P146; Legendre P, 2014, GLOBAL ECOL BIOGEOGR, V23, P1324, DOI 10.1111/geb.12207; Leite F.S.F., 2008, MEGADIVERSIDADE, V4, P158; MacKenzie DI, 2003, ECOLOGY, V84, P2200, DOI 10.1890/02-3090; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Marsh DM, 2001, CONSERV BIOL, V15, P40, DOI 10.1046/j.1523-1739.2001.00129.x; Martinez-Blancas A, 2018, J APPL ECOL, V55, P1860, DOI 10.1111/1365-2664.13151; Mascarenhas L, 2015, J NAT HIST, V50, P1; Mazerolle MJ, 2007, J HERPETOL, V41, P672, DOI 10.1670/07-061.1; McCarthy MA, 2013, OIKOS, V122, P717, DOI 10.1111/j.1600-0706.2012.20781.x; Mendes R.S., 2003, THESIS; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; Munoz A, 2016, PEERJ, V4, DOI 10.7717/peerj.2405; O'Connell AF, 2006, J WILDLIFE MANAGE, V70, P1625, DOI 10.2193/0022-541X(2006)70[1625:ESOADP]2.0.CO;2; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Perroca Márcia Galan, 2003, Rev. esc. enferm. USP, V37, P72; Pezzuti TL, 2011, THESIS; Pollock KH, 2002, ENVIRONMETRICS, V13, P105, DOI 10.1002/env.514; Prevedello JA, 2010, BIODIVERS CONSERV, V19, P1205, DOI 10.1007/s10531-009-9750-z; R Core Team, 2013, R LANG ENV STAT COMP; Rangel TF, 2010, ECOGRAPHY, V33, P46, DOI 10.1111/j.1600-0587.2009.06299.x; Rapini A., 2008, MEGADIVERSIDADE, V4, P15, DOI DOI 10.1590/S0100-84042011000200012; Riley SPD, 2005, CONSERV BIOL, V19, P1894, DOI 10.1111/j.1523-1739.2005.00295.x; Rothermel BB, 2002, CONSERV BIOL, V16, P1324, DOI 10.1046/j.1523-1739.2002.01085.x; Rothermel BB, 2004, ECOL APPL, V14, P1535, DOI 10.1890/03-5206; Ryan MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098351; Semlitsch RD, 2003, CONSERV BIOL, V17, P1219, DOI 10.1046/j.1523-1739.2003.02177.x; Sewell D, 2010, BIOL CONSERV, V143, P2102, DOI 10.1016/j.biocon.2010.05.019; Si XF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127692; Silveira FAO, 2016, PLANT SOIL, V403, P129, DOI 10.1007/s11104-015-2637-8; Soares C, 2007, BIODIVERS CONSERV, V16, P1087, DOI 10.1007/s10531-006-9070-5; STEINWASCHER K, 1983, COPEIA, P238; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Tanadini LG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028244; Venables WN., 2002, MODERN APPL STAT S, V4, DOI 10.1007/978-0-387-21706-2; Wake DB, 2008, P NATL ACAD SCI USA, V105, P11466, DOI 10.1073/pnas.0801921105; Westgate MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140973; Williams B. K., 2002, ANAL MANAGEMENT ANIM; Young BE, 2001, CONSERV BIOL, V15, P1213, DOI 10.1046/j.1523-1739.2001.00218.x	76	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2019	14	3							e0214316	10.1371/journal.pone.0214316	http://dx.doi.org/10.1371/journal.pone.0214316			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ3IW	30913242	gold, Green Published, Green Submitted			2022-12-26	WOS:000462305600044
J	Liu, JQ; Curtin, J; You, D; Hillerman, S; Li-Wang, B; Eraslan, R; Xie, J; Swanson, J; Ho, CP; Oppenheimer, S; Warrack, BM; McNaney, CA; Nelson, DM; Blum, J; Kim, T; Fereshteh, M; Reily, M; Shipkova, P; Murtaza, A; Sanjuan, M; Hunt, JT; Salter-Cid, L				Liu, Jinqi; Curtin, Joshua; You, Dan; Hillerman, Stephen; Li-Wang, Bifang; Eraslan, Rukiye; Xie, Jenny; Swanson, Jesse; Ho, Ching-Ping; Oppenheimer, Simone; Warrack, Bethanne M.; McNaney, Colleen A.; Nelson, David M.; Blum, Jordan; Kim, Taeg; Fereshteh, Mark; Reily, Michael; Shipkova, Petia; Murtaza, Anwar; Sanjuan, Miguel; Hunt, John T.; Salter-Cid, Luisa			Critical role of kinase activity of hematopoietic progenitor kinase 1 in anti-tumor immune surveillance	PLOS ONE			English	Article							T-CELLS; FOXP3 EXPRESSION; GENE-EXPRESSION; DOWN-REGULATION; CANCER; PROSTAGLANDIN; HPK1; MEMORY; RESISTANCE; GROWTH	Immunotherapy has fundamentally changed the landscape of cancer treatment. Despite the encouraging results with the checkpoint modulators, response rates vary widely across tumor types, with a majority of patients exhibiting either primary resistance without a significant initial response to treatment or acquired resistance with subsequent disease progression. Hematopoietic progenitor kinase 1 (HPK1) is predominantly expressed in hematopoietic cell linages and serves as a negative regulator in T cells and dendritic cells (DC). While HPK1 gene knockout (KO) studies suggest its role in anti-tumor immune responses, the involvement of kinase activity and thereof its therapeutic potential remain unknown. To investigate the potential of pharmacological intervention using inhibitors of HPK1, we generated HPK1 kinase dead (KD) mice which carry a single loss-of-function point mutation in the kinase domain and interrogated the role of kinase activity in immune cells in the context of suppressive factors or the tumor microenvironment (TME). Our data provide novel findings that HKP1 kinase activity is critical in conferring suppressive functions of HPK1 in a wide range of immune cells including CD4+, CD8+, DC, NK to Tregs, and inactivation of kinase domain was sufficient to elicit robust anti-tumor immune responses. These data support the concept that an HPK1 small molecule kinase inhibitor could serve as a novel agent to provide additional benefit in combination with existing immunotherapies, particularly to overcome resistance to current treatment regimens.	[Liu, Jinqi; Curtin, Joshua; You, Dan; Hillerman, Stephen; Li-Wang, Bifang; Eraslan, Rukiye; Xie, Jenny; Swanson, Jesse; Ho, Ching-Ping; Oppenheimer, Simone; Warrack, Bethanne M.; McNaney, Colleen A.; Nelson, David M.; Blum, Jordan; Kim, Taeg; Fereshteh, Mark; Reily, Michael; Shipkova, Petia; Murtaza, Anwar; Sanjuan, Miguel; Hunt, John T.; Salter-Cid, Luisa] Bristol Myers Squibb, Immunooncol Discovery, Princeton, NJ 08540 USA; [Curtin, Joshua] Johnson & Johnson Pharmaceut, Spring House, PA USA	Bristol-Myers Squibb; Johnson & Johnson; Johnson & Johnson USA	Liu, JQ (corresponding author), Bristol Myers Squibb, Immunooncol Discovery, Princeton, NJ 08540 USA.	jinqi.liu@bms.com						Alzabin S, 2010, CANCER IMMUNOL IMMUN, V59, P419, DOI 10.1007/s00262-009-0761-0; Alzabin S, 2009, J IMMUNOL, V182, P6187, DOI 10.4049/jimmunol.0802631; Baratelli F, 2005, J IMMUNOL, V175, P1483, DOI 10.4049/jimmunol.175.3.1483; Brose SA, 2013, LIPIDS, V48, P411, DOI 10.1007/s11745-013-3767-5; Chen DS, 2013, IMMUNITY, V39, P1, DOI 10.1016/j.immuni.2013.07.012; Colombo MP, 2007, NAT REV CANCER, V7, P880, DOI 10.1038/nrc2250; DIGHE AS, 1994, IMMUNITY, V1, P447, DOI 10.1016/1074-7613(94)90087-6; Dubinett Steven M., 2003, VVolume 37, P138; Dumont N, 2002, DIFFERENTIATION, V70, P574, DOI 10.1046/j.1432-0436.2002.700910.x; Fantini MC, 2004, J IMMUNOL, V172, P5149, DOI 10.4049/jimmunol.172.9.5149; Fletcher JM, 2009, J IMMUNOL, V183, P7602, DOI 10.4049/jimmunol.0901881; GOODWIN JS, 1977, J EXP MED, V146, P1719, DOI 10.1084/jem.146.6.1719; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hernandez S, 2018, CELL REP, V25, P80, DOI 10.1016/j.celrep.2018.09.012; Hnatyshyn S, 2013, BIOANALYSIS, V5, P1195, DOI [10.4155/BIO.13.86, 10.4155/bio.13.86]; Hu MCT, 1996, GENE DEV, V10, P2251, DOI 10.1101/gad.10.18.2251; Huang M, 1998, CANCER RES, V58, P1208; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; Janssen EM, 2005, NATURE, V434, P88, DOI 10.1038/nature03337; Krysan K, 2003, FASEB J; Ling P, 2001, J BIOL CHEM, V276, P18908, DOI 10.1074/jbc.M101485200; Liou J, 2000, IMMUNITY, V12, P399, DOI 10.1016/S1074-7613(00)80192-2; Liu SK, 2000, J IMMUNOL, V165, P1417, DOI 10.4049/jimmunol.165.3.1417; Liu VC, 2007, J IMMUNOL, V178, P2883, DOI 10.4049/jimmunol.178.5.2883; Lu L, 2010, EUR J IMMUNOL, V40, P142, DOI 10.1002/eji.200939618; Maj T, 2017, NAT IMMUNOL, V18, P1332, DOI 10.1038/ni.3868; Mandapathil M, 2010, J BIOL CHEM, V285, P7176, DOI 10.1074/jbc.M109.047423; Masopust D, 2004, CURR OPIN IMMUNOL, V16, P217, DOI 10.1016/j.coi.2004.02.005; Navas VH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170396; Ohta A, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00109; Pyzik M, 2007, J LEUKOCYTE BIOL, V82, P335, DOI 10.1189/jlb.1006644; RAPPAPORT RS, 1982, J EXP MED, V155, P943, DOI 10.1084/jem.155.3.943; Sauer K, 2001, J BIOL CHEM, V276, P45207, DOI 10.1074/jbc.M106811200; Sawasdikosol S, 2003, BLOOD, V101, P3687, DOI 10.1182/blood-2002-07-2316; Sawasdikosol S, 2007, J BIOL CHEM, V282, P34693, DOI 10.1074/jbc.M707425200; Sawasdikosol S, 2012, IMMUNOL RES, V54, P262, DOI 10.1007/s12026-012-8319-1; Sawasdikosol S, 2012, J IMMUNOL, V188; SCALES WE, 1989, J LEUKOCYTE BIOL, V45, P416, DOI 10.1002/jlb.45.5.416; Selby MJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161779; Sharma P, 2017, CELL, V168, P707, DOI 10.1016/j.cell.2017.01.017; Sharma S, 2005, CANCER RES, V65, P5211, DOI 10.1158/0008-5472.CAN-05-0141; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Shen H, DRUG METAB DISPOS; Shui JW, 2007, NAT IMMUNOL, V8, P84, DOI 10.1038/ni1416; Su YY, 2008, CANCER IMMUNOL IMMUN, V57, P1611, DOI 10.1007/s00262-008-0494-5; Sun JC, 2003, SCIENCE, V300, P339, DOI 10.1126/science.1083317; Tsujii M, 1998, CELL, V93, P705, DOI 10.1016/S0092-8674(00)81433-6; Zelenay S, 2015, CELL, V162, P1257, DOI 10.1016/j.cell.2015.08.015; Zhang Q, 2011, J AUTOIMMUN, V37, P180, DOI 10.1016/j.jaut.2011.09.006; Zhou GS, 1999, J BIOL CHEM, V274, P13133, DOI 10.1074/jbc.274.19.13133	50	19	19	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2019	14	3							e0212670	10.1371/journal.pone.0212670	http://dx.doi.org/10.1371/journal.pone.0212670			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ3IW	30913212	Green Submitted, Green Published, gold			2022-12-26	WOS:000462305600007
J	Comrie, ML; Monteith, G; Linden, AZ; Oblak, M; Phillips, J; James, FMK				Comrie, Michaela L.; Monteith, Gabrielle; Linden, Alex Zur; Oblak, Michelle; Phillips, John; James, Fiona M. K.		Ontario Vet College Rapid	The accuracy of computed tomography scans for rapid prototyping of canine skulls	PLOS ONE			English	Article							MODELS	This study's objective was to determine the accuracy of using current computed tomography (CT) scan and software techniques for rapid prototyping by quantifying the margin of error between CT models and laser scans of canine skull specimens. Twenty canine skulls of varying morphology were selected from an anatomy collection at a veterinary school. CT scans (bone and standard algorithms) were performed for each skull, and data segmented (testing two lower threshold settings of 226HU and -650HU) into 3-D CT models. Laser scans were then performed on each skull. The CT models were compared to the corresponding laser scan to determine the error generated from the different types of CT model parameters. This error was then compared between the different types of CT models to determine the most accurate parameters. The mean errors for the 226HU CT models, both bone and standard algorithms, were not significant from zero error (p = 0.1076 and p = 0.0580, respectively). The mean errors for both -650HU CT models were significant from zero error (p < 0.001). Significant differences were detected between CT models for 3 CT model comparisons: Bone (p < 0.0001); Standard (p < 0.0001); and -650HU (p < 0.0001). For 226HU CT models, a significant difference was not detected between CT models (p = 0.2268). Independent of the parameters tested, the 3-D models derived from CT imaging accurately represent the real skull dimensions, with CT models differing less than 0.42 mm from the real skull dimensions. The 226HU threshold was more accurate than the -650HU threshold. For the 226HU CT models, accuracy was not dependent on the CT algorithm. For the -650 CT models, bone was more accurate than standard algorithms. Knowing the inherent error of this procedure is important for use in 3-D printing for surgical planning and medical education.	[Comrie, Michaela L.] Univ Guelph, Dept Human Hlth & Nutr Sci, Coll Biol Sci, Guelph, ON, Canada; [Comrie, Michaela L.] Univ Guelph, Dept Biomed Sci, Ontario Vet Coll, Guelph, ON, Canada; [Monteith, Gabrielle; Linden, Alex Zur; Oblak, Michelle; James, Fiona M. K.] Univ Guelph, Dept Clin Studies, Ontario Vet Coll, Guelph, ON, Canada; [Phillips, John] Sheridan Coll, Ctr Adv Mfg & Design Technol, Brampton, ON, Canada	University of Guelph; University of Guelph; University of Guelph	James, FMK (corresponding author), Univ Guelph, Dept Clin Studies, Ontario Vet Coll, Guelph, ON, Canada.	jamesf@uoguelph.ca	Oblak, Michelle L/F-4982-2015	Oblak, Michelle L/0000-0001-8489-4643; James, Fiona/0000-0003-4331-4993; zur Linden, Alex/0000-0002-5663-0197	Ontario Veterinary College Pet Trust Fund [053521]	Ontario Veterinary College Pet Trust Fund	Funding was provided by the Ontario Veterinary College Pet Trust Fund (grant number: 053521) to FMKJ (https://ovc.uoguelph.ca/pettrust/investing-discoveries).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlAli Ahmad B, 2015, Eplasty, V15, pe37; Arzi B, 2015, FRONT VET SCI, V2, DOI 10.3389/fvets.2015.00004; Bagaria V, 2017, INJURY, V48, P2501, DOI 10.1016/j.injury.2017.08.058; Carrel JP, 2016, CLIN IMPLANT DENT R, V18, P1183, DOI 10.1111/cid.12394; Castilho M, 2017, J MECH BEHAV BIOMED, V65, P344, DOI 10.1016/j.jmbbm.2016.08.036; Castilho M, 2013, BIOFABRICATION, V5, DOI 10.1088/1758-5082/5/3/035012; Costelloe CM, 2013, J CANCER, V4, P524, DOI 10.7150/jca.6259; Dorbandt DM, 2017, VET OPHTHALMOL, V20, P58, DOI 10.1111/vop.12352; Hoang D, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.12.18; Kang SH, 2014, J CRANIO MAXILL SURG, V42, P1530, DOI 10.1016/j.jcms.2014.04.025; Kim MS, 2008, CIRCULATION, V117, P2388, DOI 10.1161/CIRCULATIONAHA.107.740977; Leng Shuai, 2017, 3D Print Med, V3, P6, DOI 10.1186/s41205-017-0014-3; Li XJ, 2014, EUR J CARDIO-THORAC, V46, pE67, DOI 10.1093/ejcts/ezu296; Luangphakdy V, 2013, TISSUE ENG PT A, V19, P634, DOI [10.1089/ten.tea.2012.0289, 10.1089/ten.TEA.2012.0289]; Martelli N, 2016, SURGERY, V159, P1485, DOI 10.1016/j.surg.2015.12.017; Naftulin JS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136198; Pucci JU, 2017, BIOTECHNOL ADV, V35, P521, DOI 10.1016/j.biotechadv.2017.05.007; Silva DN, 2008, J CRANIO MAXILL SURG, V36, P443, DOI 10.1016/j.jcms.2008.04.003; Tack P, 2016, BIOMED ENG ONLINE, V15, DOI 10.1186/s12938-016-0236-4; Taft RM, 2011, J PROSTHET DENT, V106, P399, DOI 10.1016/S0022-3913(11)60154-6; Webb PA, 2000, J MED ENG TECHNOL, V24, P149, DOI 10.1080/03091900050163427	21	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2019	14	3							e0214123	10.1371/journal.pone.0214123	http://dx.doi.org/10.1371/journal.pone.0214123			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ1KV	30908536	gold, Green Submitted, Green Published			2022-12-26	WOS:000462157600037
J	Hu, JW; Mirshahidi, S; Simental, A; Lee, SC; Filho, PAD; Peterson, NR; Duerksen-Hughes, P; Yuan, XP				Hu, Jinwei; Mirshahidi, Saied; Simental, Alfred; Lee, Steve C.; Filho, Pedro A. De Andrade; Peterson, Nathaniel R.; Duerksen-Hughes, Penelope; Yuan, Xiangpeng			Cancer stem cell self-renewal as a therapeutic target in human oral cancer	ONCOGENE			English	Article							TUMOR-GROWTH; BMI-1; HEAD; IDENTIFICATION; KINASE; METASTASES; MITOPHAGY; PROMOTES; SURVIVAL; SITES	Tumor recurrence following treatment remains a major clinical challenge in oral cavity cancer. Cancer stem cells (CSCs) have been isolated from human oral cancers and been considered as the driving force of tumor recurrence and metastasis. However, it still remains unclear whether targeting CSCs in oral cancer is a clinically relevant strategy to combat cancer recurrence and metastasis. Here, using clinical cancer specimens and patient-derived xenografts, we show that the self-renewal regulator BMI1 is highly expressed in CSCs of oral cavity squamous cell carcinoma. Inhibition of BMI1 decreases oral CSCs' self-renewal and tumor-initiating potential. Treatment of pre-established human oral cancer xenografts with a BMI1 inhibitor resulted in abrogation of tumor progression and reduced the frequency of CSCs in the xenografts. Remarkably, the BMI1 inhibitor has therapeutic effects in cisplatin-resistant tumors and can reduce metastases initiated by circulating CSCs. Mechanistically, BMI1-inhibition leads to oral CSC necroptotic cell death, which underlies the self-renewal impairment after inhibiting BMIl. Our data provide a pre-clinical proof-of-concept that targeting BMI1-related CSC self-renewal is a clinically relevant anti-cancer therapy in human oral cavity squamous cell carcinoma.	[Hu, Jinwei; Simental, Alfred; Lee, Steve C.; Filho, Pedro A. De Andrade; Peterson, Nathaniel R.; Yuan, Xiangpeng] Loma Linda Univ, Med Ctr, Dept Otolaryngol Head & Neck Surg, Loma Linda, CA 92354 USA; [Mirshahidi, Saied] Loma Linda Univ, Canc Ctr Biospecimen Lab, Med Ctr, Loma Linda, CA 92354 USA; [Mirshahidi, Saied; Duerksen-Hughes, Penelope; Yuan, Xiangpeng] Loma Linda Univ, Sch Med, Dept Basic Sci, Loma Linda, CA 92354 USA; [Hu, Jinwei] Kaiser Permanente, Fontana Med Ctr, Dept Head & Neck Surg, Fontana, CA 92335 USA	Loma Linda University; Loma Linda University; Loma Linda University; Kaiser Permanente	Yuan, XP (corresponding author), Loma Linda Univ, Med Ctr, Dept Otolaryngol Head & Neck Surg, Loma Linda, CA 92354 USA.; Yuan, XP (corresponding author), Loma Linda Univ, Sch Med, Dept Basic Sci, Loma Linda, CA 92354 USA.	xyuan@llu.edu		Lee, Steve/0000-0002-4460-4303; Duerksen-Hughes, Penelope/0000-0002-0998-2157	Department of Otolaryngology-Head & Neck Surgery and Cancer Center at Loma Linda University;  [GCAT 2140225];  [GRASP 2140307];  [GCAT 2150204]	Department of Otolaryngology-Head & Neck Surgery and Cancer Center at Loma Linda University; ; ; 	This work was supported in parts by the Department of Otolaryngology-Head & Neck Surgery and Cancer Center at Loma Linda University, and by institutional grants GCAT 2140225, GCAT 2150204, and GRASP 2140307.	Ablett MP, 2014, ONCOTARGET, V5, P599, DOI 10.18632/oncotarget.1169; Bansal N, 2016, CLIN CANCER RES, V22, P6176, DOI 10.1158/1078-0432.CCR-15-3107; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Brooks MD, 2015, CELL STEM CELL, V17, P260, DOI 10.1016/j.stem.2015.08.014; Bruggeman SWM, 2007, CANCER CELL, V12, P328, DOI 10.1016/j.ccr.2007.08.032; Cai ZY, 2014, NAT CELL BIOL, V16, P55, DOI 10.1038/ncb2883; Chen DM, 2017, CELL STEM CELL, V20, P621, DOI 10.1016/j.stem.2017.02.003; Clay MR, 2010, HEAD NECK-J SCI SPEC, V32, P1195, DOI 10.1002/hed.21315; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Dey A, 2016, AUTOPHAGY, V12, P659, DOI 10.1080/15548627.2016.1147670; Dovey JS, 2008, P NATL ACAD SCI USA, V105, P11857, DOI 10.1073/pnas.0803574105; Du JJ, 2010, MED ONCOL, V27, P1273, DOI 10.1007/s12032-009-9373-y; Ferlito A, 2001, ORL-J OTO-RHIN-LARYN, V63, P202, DOI 10.1159/000055740; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Greene AW, 2012, EMBO REP, V13, P378, DOI 10.1038/embor.2012.14; Hu JW, 2006, CANCER RES, V66, P8887, DOI 10.1158/0008-5472.CAN-05-3448; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Kim JH, 2004, CANCER LETT, V203, P217, DOI 10.1016/j.canlet.2003.07.009; Kreso A, 2014, CELL STEM CELL, V14, P275, DOI 10.1016/j.stem.2014.02.006; Kreso A, 2014, NAT MED, V20, P29, DOI 10.1038/nm.3418; Kreso A, 2013, SCIENCE, V339, P543, DOI 10.1126/science.1227670; Krishnamurthy S, 2010, CANCER RES, V70, P9969, DOI 10.1158/0008-5472.CAN-10-1712; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Leung C, 2004, NATURE, V428, P337, DOI 10.1038/nature02385; Li DW, 2010, J CANCER RES CLIN, V136, P997, DOI 10.1007/s00432-009-0745-7; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Lim YC, 2014, ORAL ONCOL, V50, P633, DOI 10.1016/j.oraloncology.2014.04.004; Lukacs RU, 2010, CELL STEM CELL, V7, P682, DOI 10.1016/j.stem.2010.11.013; Majeti R, 2009, CELL, V138, P286, DOI 10.1016/j.cell.2009.05.045; Mandal P, 2014, MOL CELL, V56, P481, DOI 10.1016/j.molcel.2014.10.021; Mirshahidi S, 2018, EXP CELL RES, V362, P515, DOI 10.1016/j.yexcr.2017.12.017; Mizumura K, 2014, J CLIN INVEST, V124, P3987, DOI 10.1172/JCI74985; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Nor C, 2014, NEOPLASIA, V16, P137, DOI 10.1593/neo.131744; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Pastrana E, 2011, CELL STEM CELL, V8, P486, DOI 10.1016/j.stem.2011.04.007; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Sauvageau M, 2010, CELL STEM CELL, V7, P299, DOI 10.1016/j.stem.2010.08.002; Scott FL, 2005, EMBO J, V24, P645, DOI 10.1038/sj.emboj.7600544; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Song J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011456; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Tehranchi R, 2010, NEW ENGL J MED, V363, P1025, DOI 10.1056/NEJMoa0912228; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; Todaro M, 2007, CELL STEM CELL, V1, P389, DOI 10.1016/j.stem.2007.08.001; Trumpp A, 2008, NAT CLIN PRACT ONCOL, V5, P337, DOI 10.1038/ncponc1110; Wang JCY, 2007, CELL STEM CELL, V1, P497, DOI 10.1016/j.stem.2007.10.005; White RA, 2013, J CLIN INVEST, V123, P4390, DOI 10.1172/JCI65856; Yang MH, 2010, NAT CELL BIOL, V12, P982, DOI 10.1038/ncb2099; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645	52	26	27	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 4	2019	38	27					5440	5456		10.1038/s41388-019-0800-z	http://dx.doi.org/10.1038/s41388-019-0800-z			17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	IG5KR	30936460				2022-12-26	WOS:000473842500008
J	Abulizi, A; Camporez, JP; Jurczak, MJ; Royer, KF; Zhang, DY; Cline, GW; Samuel, VT; Shulman, GI; Vatner, DF				Abulizi, Abudukadier; Camporez, Joao-Paulo; Jurczak, Michael J.; Royer, Kasper F.; Zhang, Dongyan; Cline, Gary W.; Samuel, Varman T.; Shulman, Gerald, I; Vatner, Daniel F.			Adipose glucocorticoid action influences whole-body metabolism via modulation of hepatic insulin action	FASEB JOURNAL			English	Article						white adipose tissue; hepatic steatosis; glycogen synthesis; insulin resistance	HORMONE-SENSITIVE LIPASE; LEPTIN LEVELS; RESISTANCE; TISSUE; RECEPTOR; MECHANISM; OBESITY; DEXAMETHASONE; ACTIVATION; LIPOLYSIS	The connection between adipose glucocorticoid action and whole-body metabolism is incompletely understood. Thus, we generated adipose tissue-specific glucocorticoid receptor-knockout (Ad-GcR(-/-)) mice to explore potential mechanisms. Ad-GcR(-/-) mice had a lower concentration of fasting plasma nonesterified fatty acids and less hepatic steatosis. This was associated with increased protein kinase B phosphorylation and increased hepatic glycogen synthesis after an oral glucose challenge. High-fat diet (HFD)-fed Ad-GcR(-/-) mice were protected against the development of hepatic steatosis and diacylglycerol-PKC epsilon-induced impairments in hepatic insulin signaling. Under hyperinsulinemic-euglycemic conditions, hepatic insulin response was similar to 10-fold higher in HFD-fed Ad-GcR(-/-) mice. Insulin-mediated suppression of adipose lipolysis was improved by 40% in Ad-GcR(-/-) mice. Adipose triglyceride lipase expression was decreased and insulin-mediated perilipin dephosphorylation was increased in Ad-GcR(-/-) mice. In metabolic cages, food intake decreased by 3 kcal/kg per hour in Ad-GcR(-/-) mice. Therefore, physiologic adipose glucocorticoid action appears to drive hepatic lipid accumulation during stressors such as fasting. The resultant hepatic insulin resistance prevents hepatic glycogen synthesis, preserving glucose for glucose-dependent organs. Absence of adipose glucocorticoid action attenuates HFD-induced hepatic insulin resistance; potential explanations for reduction in hepatic steatosis include reductions in adipose lipolysis and food intake.-Abulizi, A., Camporez, J.-P., Jurczak, M. J., HOyer, K. F., Zhang, D., Cline, G. W., Samuel, V. T., Shulman, G. I., Vatner, D. F. Adipose glucocorticoid action influences whole-body metabolism via modulation of hepatic insulin action.	[Abulizi, Abudukadier; Camporez, Joao-Paulo; Jurczak, Michael J.; Royer, Kasper F.; Cline, Gary W.; Samuel, Varman T.; Shulman, Gerald, I; Vatner, Daniel F.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA; [Zhang, Dongyan; Shulman, Gerald, I] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA; [Shulman, Gerald, I] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA; [Royer, Kasper F.] Aarhus Univ, Magnet Resonance Res Ctr, Dept Clin Med, Aarhus, Denmark; [Samuel, Varman T.] Vet Affairs Med Ctr, West Haven, CT USA; [Camporez, Joao-Paulo] Univ Sao Paulo, Sao Paulo, Brazil; [Jurczak, Michael J.] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA	Yale University; Howard Hughes Medical Institute; Yale University; Yale University; Aarhus University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Universidade de Sao Paulo; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Vatner, DF (corresponding author), Yale Univ, Sch Med, Dept Internal Med Endocrinol, POB 208020, New Haven, CT 06520 USA.	daniel.vatner@yale.edu		Camporez, Joao Paulo/0000-0003-3486-4301	U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases [K23 DK10287, K01 DK099402, R01 DK116774, P30 DK045735]; Veterans Health Administration [I01 BX000901]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK045735, R01DK116774] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000901] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Health Administration(US Department of Veterans Affairs); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	The authors thank Mario Kahn, Gina Butrico, Ali Nasiri, Xiaoxian Ma, Irina Smolgovsky, Codruta Todeasa, Maria Batsu (all from the Yale University School of Medicine), and the Yale Diabetes Research Core Facility for excellent technical support. The authors also thank Dr. Jackie Fretz (Yale University School of Medicine) for the use of urine collection cages. This work was supported by grants from the U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (K23 DK10287, K01 DK099402, R01 DK116774, and P30 DK045735) and the Veterans Health Administration (Merit Review Award I01 BX000901). The authors declare no conflicts of interest.	Birkenfeld AL, 2011, CELL METAB, V14, P184, DOI 10.1016/j.cmet.2011.06.009; Bose SK, 2016, ENDOCRINOLOGY, V157, P4943, DOI 10.1210/en.2016-1615; Bruun JM, 2004, AM J PHYSIOL-ENDOC M, V286, pE8, DOI 10.1152/ajpendo.00269.2003; Campbell JE, 2011, AM J PHYSIOL-CELL PH, V300, pC198, DOI 10.1152/ajpcell.00045.2010; Cohen DM, 2017, TRENDS ENDOCRIN MET, V28, P531, DOI 10.1016/j.tem.2017.04.001; Cuthbertson DJ, 2017, INT J OBESITY, V41, P853, DOI 10.1038/ijo.2017.4; DagogoJack S, 1997, J CLIN ENDOCR METAB, V82, P3230, DOI 10.1210/jc.82.10.3230; Desarzens S, 2016, J ENDOCRINOL, V230, P1, DOI 10.1530/JOE-16-0121; Fasshauer M, 2015, TRENDS PHARMACOL SCI, V36, P461, DOI 10.1016/j.tips.2015.04.014; Fried SK, 2000, J NUTR, V130, p3127S, DOI 10.1093/jn/130.12.3127S; Fried SK, 1998, J CLIN ENDOCR METAB, V83, P847, DOI 10.1210/jc.83.3.847; Galon J, 2002, FASEB J, V16, P61, DOI 10.1096/fj.01-0245com; Geer EB, 2014, ENDOCRIN METAB CLIN, V43, P75, DOI 10.1016/j.ecl.2013.10.005; Geisler CE, 2016, NUTR METAB, V13, DOI 10.1186/s12986-016-0122-x; Girousse A, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001485; HAUNER H, 1987, J CLIN ENDOCR METAB, V64, P832, DOI 10.1210/jcem-64-4-832; Jeffery E, 2014, ADIPOCYTE, V3, P206, DOI 10.4161/adip.29674; Johnston JC, 2014, BIOCHEM BIOPH RES CO, V451, P473, DOI 10.1016/j.bbrc.2014.07.063; Jornayvaz FR, 2011, P NATL ACAD SCI USA, V108, P5748, DOI 10.1073/pnas.1103451108; Kershaw EE, 2005, DIABETES, V54, P1023, DOI 10.2337/diabetes.54.4.1023; Kraemer FB, 2002, J LIPID RES, V43, P1585, DOI 10.1194/jlr.R200009-JLR200; Kumashiro N, 2011, P NATL ACAD SCI USA, V108, P16381, DOI 10.1073/pnas.1113359108; Kwon Hyokjoon, 2013, Front Endocrinol (Lausanne), V4, P71, DOI 10.3389/fendo.2013.00071; Licinio J, 1997, NAT MED, V3, P575, DOI 10.1038/nm0597-575; Londos C, 2005, BIOCHIMIE, V87, P45, DOI 10.1016/j.biochi.2004.12.010; Masuzaki H, 2001, SCIENCE, V294, P2166, DOI 10.1126/science.1066285; Mueller KM, 2017, DIABETES, V66, P272, DOI 10.2337/db16-0381; Newton R, 2007, MOL PHARMACOL, V72, P799, DOI 10.1124/mol.107.038794; Patsouris D, 2009, J BIOL CHEM, V284, P31223, DOI 10.1074/jbc.M109.041665; Peckett AJ, 2011, METABOLISM, V60, P1500, DOI 10.1016/j.metabol.2011.06.012; Perry RJ, 2015, CELL, V160, P745, DOI 10.1016/j.cell.2015.01.012; Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314; Petersen MC, 2017, NAT REV ENDOCRINOL, V13, P572, DOI 10.1038/nrendo.2017.80; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Qu X, 1999, J ENDOCRINOL, V162, P207, DOI 10.1677/joe.0.1620207; Rose AJ, 2013, MOL CELL ENDOCRINOL, V380, P65, DOI 10.1016/j.mce.2013.03.007; Samuel VT, 2016, J CLIN INVEST, V126, P12, DOI 10.1172/JCI77812; Samuel VT, 2010, LANCET, V375, P2267, DOI 10.1016/S0140-6736(10)60408-4; Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200; Seckl JR, 2001, ENDOCRINOLOGY, V142, P1371, DOI 10.1210/en.142.4.1371; Shen YC, 2017, MOL METAB, V6, P1150, DOI 10.1016/j.molmet.2017.06.013; SLAVIN BG, 1994, J LIPID RES, V35, P1535; Takahashi N, 2007, KIDNEY INT, V71, P266, DOI 10.1038/sj.ki.5002033; Tataranni PA, 1996, AM J PHYSIOL-ENDOC M, V271, pE317, DOI 10.1152/ajpendo.1996.271.2.E317; Udden J, 2003, J INTERN MED, V253, P225, DOI 10.1046/j.1365-2796.2003.01099.x; Vatner DF, 2015, P NATL ACAD SCI USA, V112, P1143, DOI 10.1073/pnas.1423952112; Villena JA, 2004, J BIOL CHEM, V279, P47066, DOI 10.1074/jbc.M403855200; Wang JC, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-19; Watts LM, 2005, DIABETES, V54, P1846, DOI 10.2337/diabetes.54.6.1846; WURDEMAN R, 1978, J NUTR, V108, P1457, DOI 10.1093/jn/108.9.1457; Xu C, 2009, MOL ENDOCRINOL, V23, P1161, DOI 10.1210/me.2008-0464; Yu CY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015188; Yu CL, 2002, J BIOL CHEM, V277, P50230, DOI 10.1074/jbc.M200958200; Yu J, 2014, POLYMERS, V6, P9, DOI DOI 10.1371/J0UMAL.P0NE.0112628	54	8	8	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2019	33	7					8174	8185		10.1096/fj.201802706R	http://dx.doi.org/10.1096/fj.201802706R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ9SM	30922125	Green Published			2022-12-26	WOS:000476234700030
J	Jiang, X; Zhang, ZT; Cheng, K; Wu, Q; Jiang, L; Pielak, GJ; Liu, ML; Li, CG				Jiang, Xin; Zhang, Zeting; Cheng, Kai; Wu, Qiong; Jiang, Ling; Pielak, Gary J.; Liu, Maili; Li, Conggang			Membrane-mediated disorder-to-order transition of SNAP25 flexible linker facilitates its interaction with syntaxin-1 and SNARE-complex assembly	FASEB JOURNAL			English	Article						prefusion state; protein NMR; intrinsically disordered region; circular dichroism	CYSTEINE-RICH DOMAIN; SNAP-25; SYNAPTOBREVIN; PALMITOYLATION; PHOSPHORYLATION; ASSOCIATION; EXOCYTOSIS; MECHANISM; SUGGESTS	The soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) complex comprises synaptosome-associated protein of 25 kDa (SNAP25), syntaxin-1a (syx-1), and synaptobrevin 2, which is essential for many physiologic processes requiring membrane fusion. Several studies imply that the loop region of SNAP25 plays important roles in SNARE-complex assembly. However, why and how the flexible loop facilitates the complex assembly remains poorly understood because it is purposely deleted in almost all structural studies. By using NMR spectroscopy and circular dichroism spectropolarimetry, we characterized SNAP25 structure and interactions with other SNAREs in aqueous buffer and in the membrane. We found that the N-terminal of the SNAP25 loop region binds with membrane, and this interaction induced a disorder-to-order conformational change of the loop, resulting in enhanced interaction between the C-terminal of the SNAP25 loop and syx-1. We further proved that SNARE-complex assembly efficiency decreased when we disrupted the electrostatic interaction between C-terminal of the SNAP25 loop and syx-1, suggesting that the SNAP25 loop region facilitates SNARE-complex assembly through promoting prefusion SNARE binary complex formation. Our work elucidates the role of the flexible loop and the membrane environment in SNARE-complex assembly at the residue level, which helps to understand membrane fusion, a fundamental transport and communication process in cells.-Jiang, X., Zhang, Z., Cheng, K., Wu, Q., Jiang, L., Pielak, G. J., Liu, M., Li, C. Membrane-mediated disorder-to-order transition of SNAP25 flexible linker facilitates its interaction with syntaxin-1 and SNARE-complex assembly.	[Jiang, Xin; Zhang, Zeting; Cheng, Kai; Wu, Qiong; Jiang, Ling; Liu, Maili; Li, Conggang] Chinese Acad Sci, Natl Ctr Magnet Resonance Wuhan, Wuhan Inst Phys & Math,Wuhan Natl Lab Optoelect, Key Lab Magnet Resonance Biol Syst,State Key Lab, Wuhan 430072, Hubei, Peoples R China; [Jiang, Xin; Jiang, Ling; Liu, Maili; Li, Conggang] Grad Univ Chinese Acad Sci, Beijing, Peoples R China; [Pielak, Gary J.] Univ North Carolina Chapel Hill, Dept Chem, Chapel Hill, NC USA; [Pielak, Gary J.] Univ North Carolina Chapel Hill, Dept Biochem & Biophys, Chapel Hill, NC USA; [Pielak, Gary J.] Univ North Carolina Chapel Hill, Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA; [Pielak, Gary J.] Univ North Carolina Chapel Hill, Integrat Program Biol & Genome Sci, Chapel Hill, NC USA	Chinese Academy of Sciences; Wuhan Institute of Physics & Mathematics, CAS; Huazhong University of Science & Technology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Liu, ML (corresponding author), Chinese Acad Sci, Natl Ctr Magnet Resonance Wuhan, Wuhan Inst Phys & Math,Wuhan Natl Lab Optoelect, Key Lab Magnet Resonance Biol Syst,State Key Lab, Wuhan 430072, Hubei, Peoples R China.; Li, CG (corresponding author), Chinese Acad Sci, West Xiaohongshan 30, Wuhan 430072, Hubei, Peoples R China.	ml.liu@wipm.ac.cn; conggangli@wipm.ac.cn	Liu, Maili/A-8543-2011; Li, Conggang/B-6363-2011	Liu, Maili/0000-0002-9359-915X; Li, Conggang/0000-0002-5798-1722	Ministry of Science and Technology of China [2017YFA0505400]; Innovation Team of Hubei Province [2016CFA002]; National Natural Sciences Foundation of China [21735005, 21575156, 21203243, 21673284]; K. C. Wong Education Foundation; Chinese Academy of Sciences [QYZDJ-SSW-SLH027]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Innovation Team of Hubei Province; National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); K. C. Wong Education Foundation; Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by Ministry of Science and Technology of China Grant 2017YFA0505400; Innovation Team of Hubei Province Grant 2016CFA002; National Natural Sciences Foundation of China Grants 21735005, 21575156, 21203243, and 21673284; the K. C. Wong Education Foundation; and the Chinese Academy of Sciences (QYZDJ-SSW-SLH027). The authors declare no conflicts of interest.	Bazan JF, 1997, NATURE, V385, P640, DOI 10.1038/385640a0; Brewer KD, 2011, P NATL ACAD SCI USA, V108, P12723, DOI 10.1073/pnas.1105128108; Brunger AT, 2005, Q REV BIOPHYS, V38, P1, DOI 10.1017/S0033583505004051; Chamberlain LH, 2013, BIOCHEM SOC T, V41, P62, DOI 10.1042/BST20120243; Chen XC, 2006, BIOPHYS J, V90, P2062, DOI 10.1529/biophysj.105.071415; Chen XC, 2002, NEURON, V33, P397, DOI 10.1016/S0896-6273(02)00583-4; Dawidowski D, 2016, STRUCTURE, V24, P392, DOI 10.1016/j.str.2016.01.005; Domanska MK, 2009, J BIOL CHEM, V284, P32158, DOI 10.1074/jbc.M109.047381; Ellena JF, 2009, P NATL ACAD SCI USA, V106, P20306, DOI 10.1073/pnas.0908317106; Fasshauer D, 2004, J BIOL CHEM, V279, P7613, DOI 10.1074/jbc.M312064200; Foley TD, 2012, CELL MOL NEUROBIOL, V32, P201, DOI 10.1007/s10571-011-9748-4; Galves JM, 2014, ADHD-ATTEND DEFICIT, V6, P19, DOI 10.1007/s12402-013-0123-9; Gao J, 2016, CELL SIGNAL, V28, P425, DOI 10.1016/j.cellsig.2015.12.014; Gerber SH, 2008, SCIENCE, V321, P1507, DOI 10.1126/science.1163174; Gonzalo S, 1998, MOL BIOL CELL, V9, P585, DOI 10.1091/mbc.9.3.585; Greaves J, 2011, J CELL SCI, V124, P1351, DOI 10.1242/jcs.079095; Greaves J, 2009, MOL BIOL CELL, V20, P1845, DOI 10.1091/mbc.E08-09-0944; Hazzard J, 1999, J BIOMOL NMR, V14, P203, DOI 10.1023/A:1008382027065; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Karatekin E, 2010, P NATL ACAD SCI USA, V107, P3517, DOI 10.1073/pnas.0914723107; Karlsen AS, 2013, NEUROCHEM RES, V38, P1219, DOI 10.1007/s11064-012-0918-7; Kiessling V, 2010, BIOPHYS J, V99, P4047, DOI 10.1016/j.bpj.2010.10.022; Kreutzberger AJB, 2016, BIOPHYS J, V110, P2147, DOI 10.1016/j.bpj.2016.04.011; Kunieda K, 2015, ACS CHEM NEUROSCI, V6, P1715, DOI 10.1021/acschemneuro.5b00196; Laidlaw KME, 2017, BIOCHEM SOC T, V45, P1271, DOI 10.1042/BST20170202; Liang BY, 2013, P NATL ACAD SCI USA, V110, P19384, DOI 10.1073/pnas.1314699110; Margittai M, 2003, P NATL ACAD SCI USA, V100, P15516, DOI 10.1073/pnas.2331232100; Nagy G, 2008, MOL BIOL CELL, V19, P3769, DOI 10.1091/mbc.E07-12-1218; Pallavi B, 2003, J BIOL CHEM, V278, P12737, DOI 10.1074/jbc.M208598200; Salaun C, 2005, J BIOL CHEM, V280, P1236, DOI 10.1074/jbc.M410674200; Sudhof T. C., 2011, CSH PERSPECT BIOL, V3, P3, DOI DOI 10.1101/CSHPERSPECT.A005637; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Ungar D, 2003, ANNU REV CELL DEV BI, V19, P493, DOI 10.1146/annurev.cellbio.19.110701.155609; Vogel K, 2000, J BIOL CHEM, V275, P2959, DOI 10.1074/jbc.275.4.2959; Weber P, 2017, ELIFE, V6, DOI [10.7554/elife.19394, 10.7554/eLife.19394]; Weninger K, 2008, STRUCTURE, V16, P308, DOI 10.1016/j.str.2007.12.010; Xu JH, 2013, CELL REP, V3, P1414, DOI 10.1016/j.celrep.2013.03.010; Yu HJ, 2015, J AM CHEM SOC, V137, P12873, DOI 10.1021/jacs.5b08306	38	4	4	1	26	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2019	33	7					7985	7994		10.1096/fj.201802796R	http://dx.doi.org/10.1096/fj.201802796R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ9SM	30916996	Bronze			2022-12-26	WOS:000476234700015
J	Yu, J; Luan, XJ; Yan, YD; Qiao, C; Liu, YY; Zhao, D; Xie, B; Zheng, QW; Wang, M; Chen, WY; Shen, C; He, ZY; Hu, X; Huang, XY; Li, H; Chen, BH; Zheng, B; Chen, X; Fang, J				Yu, Jun; Luan, Xiaojin; Yan, Yidan; Qiao, Chen; Liu, Yuanyuan; Zhao, Dan; Xie, Bing; Zheng, Qianwen; Wang, Min; Chen, Wanyin; Shen, Cong; He, Zeyu; Hu, Xing; Huang, Xiaoyan; Li, Hong; Chen, Binghai; Zheng, Bo; Chen, Xia; Fang, Jie			Small ribonucleoprotein particle protein SmD3 governs the homeostasis of germline stem cells and the crosstalk between the spliceosome and ribosome signals in Drosophila	FASEB JOURNAL			English	Article						SmD3; RpL18; GSCs	SELF-RENEWAL; DIFFERENTIATION; MAINTENANCE; SPERMATOGENESIS; MARBLES; LESSONS; LINEAGE; TESTIS; SNRNP; BAG	The ribonucleoprotein (RNP) spliceosome machinery triggers the precursor RNA splicing process in eukaryotes. Major spliceosome defects are implicated in male infertility; however, the underlying mechanistic links between the spliceosome and the ribosome in Drosophila testes remains largely unresolved. Small ribonucleoprotein particle protein SmD3 (SmD3) is a novel germline stem cell (GSC) regulatory gene identified in our previous screen of Drosophila testes. In the present study, using genetic manipulation in a Drosophila model, we demonstrated that SmD3 is required for the GSC niche and controls the self-renewal and differentiation of GSCs in the testis. Using in vitro assays in Schneider 2 cells, we showed that SmD3 also regulates the homeostasis of proliferation and apoptosis in Drosophila. Furthermore, using liquid chromatography-tandem mass spectrometry methods, SmD3 was identified as binding with ribosomal protein (Rp)L18, which is a key regulator of the large subunit in the ribosome. Moreover, SmD3 was observed to regulate spliceosome and ribosome subunit expression levels and controlled spliceosome and ribosome function via RpL18. Significantly, our findings revealed the genetic causes and molecular mechanisms underlying the stem cell niche and the crosstalk between the spliceosome and the ribosome.-Yu, J., Luan, X., Yan, Y., Qiao, C., Liu, Y., Zhao, D., Xie, B., Zheng, Q., Wang, M., Chen, W., Shen, C., He, Z., Hu, X., Huang, X., Li, H., Chen, B., Zheng, B., Chen, X., Fang, J. Small ribonucleoprotein particle protein SmD3 governs the homeostasis of germline stem cells and the crosstalk between the spliceosome and ribosome signals in Drosophila.	[Yu, Jun; Luan, Xiaojin; Yan, Yidan; Zheng, Qianwen; Wang, Min; Chen, Wanyin; Hu, Xing; Chen, Xia; Fang, Jie] Jiangsu Univ, Dept Gynecol, Affiliated Hosp, 438 Jiefang Rd, Zhenjiang 212001, Jiangsu, Peoples R China; [Qiao, Chen] Jiangsu Univ, Dept Clin Pharm, Affiliated Hosp, Zhenjiang, Jiangsu, Peoples R China; [Chen, Binghai] Jiangsu Univ, Dept Urol, Affiliated Hosp, Zhenjiang, Jiangsu, Peoples R China; [Yu, Jun; Luan, Xiaojin; Yan, Yidan; Zhao, Dan; Zheng, Qianwen; Chen, Xia] Jiangsu Univ, Reprod Sci Inst, Zhenjiang, Jiangsu, Peoples R China; [Liu, Yuanyuan; Shen, Cong; Li, Hong; Zheng, Bo] Nanjing Med Univ, Ctr Reprod & Genet, Suzhou Municipal Hosp, Affiliated Suzhou Hosp, Suzhou, Peoples R China; [Zhao, Dan] Jiangsu Univ, Peoples Hosp Zhenjiang 4, Affiliated Hosp 4, Ctr Reprod, Zhenjiang, Jiangsu, Peoples R China; [Xie, Bing] Jiangsu Univ, Peoples Hosp Zhenjiang 4, Affiliated Hosp 4, Dept Obstet & Gynecol, Zhenjiang, Jiangsu, Peoples R China; [He, Zeyu] China Med Univ, Dept Clin Med, Shenyang, Liaoning, Peoples R China; [Huang, Xiaoyan] Nanjing Med Univ, Dept Histol & Embryol, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China	Jiangsu University; Jiangsu University; Jiangsu University; Jiangsu University; Nanjing Medical University; Jiangsu University; Jiangsu University; China Medical University; Nanjing Medical University	Yu, J; Fang, J (corresponding author), Jiangsu Univ, Dept Gynecol, Affiliated Hosp, 438 Jiefang Rd, Zhenjiang 212001, Jiangsu, Peoples R China.	yujun9117@126.com; fangjie070@163.com	Liu, Yuanyuan/AAO-3761-2021; Zheng, Bo/AAC-6993-2022	Zheng, Bo/0000-0002-1496-0753; liu, Yuanyuan/0000-0003-0127-6060	National Natural Science Foundation of China [31701298, 81803505, 81402100]; Natural Science Foundation of Jiangsu Province [BK20170562, BK20170564]; Key Research Foundation of Zhenjiang Social Development [SH2016028, SH2017013, SH2017020, SH2018065]; Suzhou Key Laboratory of Male Reproduction Research [SZS201718]; Basic Program of Nanjing Medical University [2017NJMU163]; Suzhou Key Medical Center [SZZX201505]; Suzhou Introduced Project of Clinical Medical Expert Team [SZYJTD201708]; Jiangsu Provincial Medical Innovation Team [CXTDB2017013]; Foundation of Health and Family Planning Commission of Jiangsu Province [Q201408]; Foundation for Young Medical Talents of Jiangsu Province [QNRC2016840]; Six Talent Peaks Project in Jiangsu Province [WSW-007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Key Research Foundation of Zhenjiang Social Development; Suzhou Key Laboratory of Male Reproduction Research; Basic Program of Nanjing Medical University; Suzhou Key Medical Center; Suzhou Introduced Project of Clinical Medical Expert Team; Jiangsu Provincial Medical Innovation Team; Foundation of Health and Family Planning Commission of Jiangsu Province; Foundation for Young Medical Talents of Jiangsu Province; Six Talent Peaks Project in Jiangsu Province	The authors thank all study participants, research staff, and students who assisted with this work. The authors also thank Prof. Chao Tong (Zhejiang University, Hangzhou, China) for sharing reagents and stocks. The authors are grateful to the TsingHua Fly Center, the Bloomington Drosophila Stock Center, the Drosophila Genetic Resource Consortium, and the Developmental Studies Hybridoma Bank for providing fly strains and antibodies. This work was supported by the National Natural Science Foundation of China (31701298, 81803505, 81402100), the Natural Science Foundation of Jiangsu Province (BK20170562, BK20170564), the Key Research Foundation of Zhenjiang Social Development (SH2016028, SH2017013, SH2017020, SH2018065), the Suzhou Key Laboratory of Male Reproduction Research (SZS201718), the Basic Program of Nanjing Medical University (2017NJMU163), the Suzhou Key Medical Center (SZZX201505), the Suzhou Introduced Project of Clinical Medical Expert Team (SZYJTD201708), the Jiangsu Provincial Medical Innovation Team (CXTDB2017013), the Foundation of Health and Family Planning Commission of Jiangsu Province (Q201408), the Foundation for Young Medical Talents of Jiangsu Province (QNRC2016840), and the Six Talent Peaks Project in Jiangsu Province (WSW-007). The authors declare no conflicts of interest.	Akpinar M, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006660; Chen D, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004797; Cherry CM, 2010, CELL STEM CELL, V6, P557, DOI 10.1016/j.stem.2010.04.018; Davies EL, 2008, COLD SH Q B, V73, P137, DOI 10.1101/sqb.2008.73.063; de Cuevas M, 2011, DEVELOPMENT, V138, P2861, DOI 10.1242/dev.056242; Eun SH, 2013, DEVELOPMENT, V140, P23, DOI 10.1242/dev.086397; Feng LJ, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006571; Fuller MT, 2007, SCIENCE, V316, P402, DOI 10.1126/science.1140861; Gateff E, 1982, Prog Clin Biol Res, V85 Pt B, P621; Gonsalvez GB, 2008, RNA, V14, P878, DOI 10.1261/rna.940708; Gonsalvez GB, 2006, CURR BIOL, V16, P1077, DOI 10.1016/j.cub.2006.04.037; Hime GR, 2007, INT J ANDROL, V30, P265, DOI 10.1111/j.1365-2605.2007.00767.x; Insco ML, 2012, CELL STEM CELL, V11, P689, DOI 10.1016/j.stem.2012.08.012; Kang Y, 2015, HUM MOL GENET, V24, P7255, DOI 10.1093/hmg/ddv425; Katayama H, 2001, RAPID COMMUN MASS SP, V15, P1416, DOI 10.1002/rcm.379; Kawase E, 2004, DEVELOPMENT, V131, P1365, DOI 10.1242/dev.01025; Kiger AA, 2000, NATURE, V407, P750, DOI 10.1038/35037606; Kiger AA, 2001, SCIENCE, V294, P2542, DOI 10.1126/science.1066707; Kondo Y, 2015, ELIFE, V4, DOI 10.7554/eLife.04986; Matera AG, 2014, NAT REV MOL CELL BIO, V15, P108, DOI 10.1038/nrm3742; MCKEARIN DM, 1990, GENE DEV, V4, P2242, DOI 10.1101/gad.4.12b.2242; Michel M, 2012, DEVELOPMENT, V139, P2663, DOI 10.1242/dev.075242; Pek JW, 2009, DEV CELL, V17, P417, DOI 10.1016/j.devcel.2009.07.017; Pelava A, 2016, BIOCHEM SOC T, V44, P1086, DOI 10.1042/BST20160106; Schulz C, 2002, DEVELOPMENT, V129, P4523; Schwer B, 2015, RNA, V21, P1173, DOI 10.1261/rna.050583.115; Shi YG, 2017, J MOL BIOL, V429, P2640, DOI 10.1016/j.jmb.2017.07.010; Shields AR, 2014, DEVELOPMENT, V141, P73, DOI 10.1242/dev.101931; Singh RK, 2012, TRENDS MOL MED, V18, P472, DOI 10.1016/j.molmed.2012.06.006; Spradling A, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a002642; Tong Chao, 2007, V397, P215; Tran J, 2000, NATURE, V407, P754, DOI 10.1038/35037613; Tulina N, 2001, SCIENCE, V294, P2546, DOI 10.1126/science.1066700; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; White-Cooper H, 2009, MOL CELL ENDOCRINOL, V306, P66, DOI 10.1016/j.mce.2008.11.026; Wu H, 2016, P NATL ACAD SCI USA, V113, P4134, DOI 10.1073/pnas.1513682113; Yan CY, 2017, SCIENCE, V355, P149, DOI 10.1126/science.aak9979; Yu J, 2016, DEVELOPMENT, V143, P2930, DOI 10.1242/dev.134247; Zhan XC, 2018, SCIENCE, V359, P537, DOI 10.1126/science.aar6401; Zhang XF, 2018, CELL RES, V28, P307, DOI 10.1038/cr.2018.14; Zhang XF, 2017, CELL, V169, P918, DOI 10.1016/j.cell.2017.04.033; Zhang Z, 2013, CELL RES, V23, P573, DOI 10.1038/cr.2013.29; Zitzmann Jan, 2018, Biotechnology Reports, V19, pe00272, DOI 10.1016/j.btre.2018.e00272	43	9	9	1	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2019	33	7					8125	8137		10.1096/fj.201802536RR	http://dx.doi.org/10.1096/fj.201802536RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ9SM	30921522	Bronze			2022-12-26	WOS:000476234700026
J	Gyimesi, G; Albano, G; Fuster, DG; Hediger, MA; Pujol-Gimenez, J				Gyimesi, Gergely; Albano, Giuseppe; Fuster, Daniel G.; Hediger, Matthias A.; Pujol-Gimenez, Jonai			Unraveling the structural elements of pH sensitivity and substrate binding in the human zinc transporter SLC39A2 (ZIP2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						zinc; membrane transport; homology modeling; structure-function; site-directed mutagenesis; metal homeostasis; SLC; ZIP	PROSTATE-CANCER; PROTEIN; EXPRESSION; FAMILY; ROLES	The transport and ion-coupling mechanisms of ZIP transporters remain largely uncharacterized. Previous work in our laboratory has revealed that the solute carrier family 39 member A2 (SLC39A2/ZIP2) increases its substrate transport rate in the presence of extracellular H+. Here, we used a combination of in silico and in vitro techniques involving structural modeling, mutagenesis, and functional characterization in HEK293 cells to identify amino acid residues potentially relevant for both the ZIP2-H+ interaction and substrate binding. Our ZIP2 models revealed a cluster of charged residues close to the substrate-translocation pore. Interestingly, the H63A substitution completely abrogated pH sensitivity, and substitutions of Glu-67 and Phe-269 altered the pH and voltage modulation of transport. In contrast, substitution of Glu-106, which might be part of a dimerization interface, altered pH but not voltage modulation. Substitution of Phe-269, located close to the substrate-binding site, also affected substrate selectivity. These findings were supported by an additional model of ZIP2 that was based on the structure of a prokaryotic homolog, Bordetella bronchiseptica ZrT/Irt-like protein (bbZIP), and in silico pK(a) calculations. We also found that residues Glu-179, His-175, His-202, and Glu-276 are directly involved in the coordination of the substrate metal ion. We noted that, unlike bbZIP, human ZIP2 is predicted to harbor a single divalent metal-binding site, with the charged side chain of Lys-203 replacing the second bound ion. Our results provide the first structural evidence for the previously observed pH and voltage modulation of ZIP2-mediated metal transport, identify the substrate-binding site, and suggest a structure-based transport mechanism for the ZIP2 transporter.	[Gyimesi, Gergely; Albano, Giuseppe; Fuster, Daniel G.; Hediger, Matthias A.; Pujol-Gimenez, Jonai] Univ Bern, Inst Biochem & Mol Med, Buhlstr 28, CH-3012 Bern, Switzerland; [Gyimesi, Gergely; Albano, Giuseppe; Fuster, Daniel G.; Hediger, Matthias A.; Pujol-Gimenez, Jonai] NCCR TransCure, Natl Ctr Competence Res, Buhlstr 28, CH-3012 Bern, Switzerland; [Gyimesi, Gergely; Albano, Giuseppe; Fuster, Daniel G.; Hediger, Matthias A.; Pujol-Gimenez, Jonai] Univ Bern, Univ Hosp Bern, Dept Hypertens & Nephrol, Inselspital, Freiburgstr 18, CH-3010 Bern, Switzerland	University of Bern; University of Bern; University Hospital of Bern	Hediger, MA; Pujol-Gimenez, J (corresponding author), Univ Bern, Univ Hosp Bern, Dept Hypertens & Nephrol, Inselspital, Freiburgstr 18, CH-3010 Bern, Switzerland.	matthias.hediger@ibmm.unibe.ch; jonai.pujol@dbmr.unibe.ch	Gyimesi, Gergely/AAL-7340-2021; Fuster, Daniel G/AAA-7079-2021	Gyimesi, Gergely/0000-0002-2054-4633; Fuster, Daniel G/0000-0001-7220-1803; Pujol, Jonai/0000-0002-9951-1390; Hediger, Matthias/0000-0003-1946-027X	Swiss National Centre of Competence in Research (NCCR); Swiss National Science Foundation (SNF) [31003A_156376, 310030_18272]	Swiss National Centre of Competence in Research (NCCR)(Swiss National Science Foundation (SNSF)); Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF))	This work was supported by the Swiss National Centre of Competence in Research (NCCR) and Swiss National Science Foundation (SNF) Grants 31003A_156376 and 310030_18272 (to M. A. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Alford RF, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004398; Antala S, 2015, J BIOL CHEM, V290, P17796, DOI 10.1074/jbc.M114.617613; Bafaro E, 2017, SIGNAL TRANSDUCT TAR, V2, DOI 10.1038/sigtrans.2017.29; Baltaci AK, 2018, NEUROCHEM RES, V43, P517, DOI 10.1007/s11064-017-2454-y; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Cao J, 2001, J LEUKOCYTE BIOL, V70, P559; Cong Q, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-82; Costello LC, 2011, CANCER BIOL THER, V12, P1078, DOI 10.4161/cbt.12.12.18367; Cousins RJ, 2003, P NATL ACAD SCI USA, V100, P6952, DOI 10.1073/pnas.0732111100; Desouki MM, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-37; Tommaso P, 2011, NUCLEIC ACIDS RES, V39, pW13, DOI 10.1093/nar/gkr245; Forrest LR, 2011, BBA-BIOENERGETICS, V1807, P167, DOI 10.1016/j.bbabio.2010.10.014; Franklin RB, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-32; Franz MC, 2013, MOL ASPECTS MED, V34, P735, DOI 10.1016/j.mam.2012.11.007; Franz MC, 2018, BIOCHEMISTRY-US, V57, P3976, DOI 10.1021/acs.biochem.8b00511; Franz MC, 2014, J BIOMOL SCREEN, V19, P909, DOI 10.1177/1087057114526781; Gaither LA, 2000, J BIOL CHEM, V275, P5560, DOI 10.1074/jbc.275.8.5560; Gaither LA, 2001, J BIOL CHEM, V276, P22258, DOI 10.1074/jbc.M101772200; Girijashanker K, 2008, MOL PHARMACOL, V73, P1413, DOI 10.1124/mol.107.043588; Hamon R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110056; Hara T, 2017, J PHYSIOL SCI, V67, P283, DOI 10.1007/s12576-017-0521-4; He L, 2006, MOL PHARMACOL, V70, P171, DOI 10.1124/mol.106.021521; Hopf TA, 2012, CELL, V149, P1607, DOI 10.1016/j.cell.2012.04.012; Inoue Y, 2014, J BIOL CHEM, V289, P21451, DOI 10.1074/jbc.M114.560821; Jenkitkasemwong S, 2012, BIOMETALS, V25, P643, DOI 10.1007/s10534-012-9526-x; Jeong J, 2013, MOL ASPECTS MED, V34, P612, DOI 10.1016/j.mam.2012.05.011; Johnson LA, 2010, METHODS, V52, P316, DOI 10.1016/j.ymeth.2010.08.004; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kambe T, 2015, PHYSIOL REV, V95, P749, DOI 10.1152/physrev.00035.2014; Kemena C, 2009, BIOINFORMATICS, V25, P2455, DOI 10.1093/bioinformatics/btp452; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lin W, 2010, J BIOL CHEM, V285, P39013, DOI 10.1074/jbc.M110.180620; Lomize MA, 2006, BIOINFORMATICS, V22, P623, DOI 10.1093/bioinformatics/btk023; Lu M, 2007, SCIENCE, V317, P1746, DOI 10.1126/science.1143748; Marcoline FV, 2015, STRUCTURE, V23, P1526, DOI 10.1016/j.str.2015.05.014; Nivon LG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059004; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Pujol-Gimenez J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06446-y; Rishi I, 2003, APPL IMMUNOHISTO M M, V11, P253; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sondergaard CR, 2011, J CHEM THEORY COMPUT, V7, P2284, DOI 10.1021/ct200133y; Stamm M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057731; Tao YT, 2013, MOL BIOL REP, V40, P4979, DOI 10.1007/s11033-013-2598-z; Wang CY, 2012, J BIOL CHEM, V287, P34032, DOI 10.1074/jbc.M112.367284; Webb B., 2014, CURR PROTOC BIOINFOR, V5.6, P32, DOI [10.1002/0471250953.bi0506s47, DOI 10.1002/0471250953.BI0506S47]; Zhang T, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700344	47	11	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2019	294	20					8046	8063		10.1074/jbc.RA118.006113	http://dx.doi.org/10.1074/jbc.RA118.006113			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC0NH	30914478	Green Published, hybrid			2022-12-26	WOS:000470656500008
J	Hong, SM; Lee, YK; Park, I; Kwon, SM; Min, S; Yoon, G				Hong, Sun Mi; Lee, Young-Kyoung; Park, Imkyong; Kwon, So Mee; Min, Seongki; Yoon, Gyesoon			Lactic acidosis caused by repressed lactate dehydrogenase subunit B expression down-regulates mitochondrial oxidative phosphorylation via the pyruvate dehydrogenase (PDH)-PDH kinase axis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						hepatocellular carcinoma; lactic acid; mitochondria; pyruvate dehydrogenase complex (PDC); liver cancer; mitochondrial respiratory chain complex	MONOCARBOXYLATE TRANSPORTERS MCTS; CANCER; HYPOXIA; DYSFUNCTION; METABOLISM; TARGET; MYC; PROMOTES; ISOENZYMES; SIGNATURE	Aerobic glycolysis and mitochondrial dysfunction are key metabolic features of cancer cells, but their interplay during cancer development remains unclear. We previously reported that human hepatoma cells with mitochondrial defects exhibit down-regulated lactate dehydrogenase subunit B (LDHB) expression. Here, using several molecular and biochemical assays and informatics analyses, we investigated how LDHB suppression regulates mitochondrial respiratory activity and contributes to liver cancer progression. We found that transcriptional LDHB down-regulation is an upstream event during suppressed oxidative phosphorylation. We also observed that LDHB knockdown increases inhibitory phosphorylation of pyruvate dehydrogenase (PDH) via lactate-mediated PDH kinase (PDK) activation and thereby attenuates oxidative phosphorylation activity. Interestingly, monocarboxylate transporter 1 was the major lactate transporter in hepatoma cells, and its expression was essential for PDH phosphorylation by modulating intracellular lactate levels. Finally, bioinformatics analysis of the hepatocellular carcinoma cohort from The Cancer Genome Atlas revealed that a low LDHB/LDHA ratio is statistically significantly associated with poor prognostic outcomes. A low ratio was also associated with a significant enrichment in glycolysis genes and negatively correlated with PDK1 and 2 expression, supporting a close link between LDHB suppression and the PDK-PDH axis. These results suggest that LDHB suppression is a key mechanism that enhances glycolysis and is critically involved in the maintenance and propagation of mitochondrial dysfunction via lactate release in liver cancer progression.	[Hong, Sun Mi; Lee, Young-Kyoung; Park, Imkyong; Kwon, So Mee; Min, Seongki; Yoon, Gyesoon] Ajou Univ, Sch Med, Dept Biochem, Suwon 16499, South Korea; [Hong, Sun Mi; Park, Imkyong; Min, Seongki; Yoon, Gyesoon] Ajou Univ, Sch Med, Dept Biomed Sci BK21 Plus, Suwon 16499, South Korea	Ajou University; Ajou University	Yoon, G (corresponding author), Ajou Univ, Sch Med, Dept Biochem, Suwon 16499, South Korea.	ypeace@ajou.ac.kr			Basic Science Research Program through the National Research Foundation - Ministry of Science, ICT, and Future Planning of Korea [2012R1A5A2048183, 2015R1A2 A1A10055038, 2016R1A6A3A11932420]	Basic Science Research Program through the National Research Foundation - Ministry of Science, ICT, and Future Planning of Korea	This work was supported by Grants 2012R1A5A2048183, 2015R1A2 A1A10055038, and 2016R1A6A3A11932420 from the Basic Science Research Program through the National Research Foundation funded by the Ministry of Science, ICT, and Future Planning of Korea. The authors declare that they have no conflicts of interest with the contents of this article.	Chang CJ, 2009, CELL MOL LIFE SCI, V66, P1755, DOI 10.1007/s00018-009-8767-5; Chen EI, 2012, J BIOENERG BIOMEMBR, V44, P619, DOI 10.1007/s10863-012-9465-9; Cuezva JM, 2002, CANCER RES, V62, P6674; Cui JJ, 2015, MED ONCOL, V32, DOI 10.1007/s12032-015-0589-8; Dang CV, 2008, NAT REV CANCER, V8, P51, DOI 10.1038/nrc2274; Dang CV, 1999, MOL CELL BIOL, V19, P1; Doherty JR, 2014, CANCER RES, V74, P908, DOI 10.1158/0008-5472.CAN-13-2034; Doherty JR, 2013, J CLIN INVEST, V123, P3685, DOI 10.1172/JCI69741; Drent M, 1996, EUR RESPIR J, V9, P1736, DOI 10.1183/09031936.96.09081736; Enerson BE, 2003, J PHARM SCI-US, V92, P1531, DOI 10.1002/jps.10389; Fan J, 2014, J BIOL CHEM, V289, P26533, DOI 10.1074/jbc.M114.593970; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Guo M, 2006, APOPTOSIS, V11, P67, DOI 10.1007/s10495-005-3085-3; Halestrap AP, 2012, IUBMB LIFE, V64, P109, DOI 10.1002/iub.572; Halestrap AP, 2012, IUBMB LIFE, V64, P1, DOI 10.1002/iub.573; Halestrap AP, 2004, PFLUG ARCH EUR J PHY, V447, P619, DOI 10.1007/s00424-003-1067-2; Harris RA, 2002, ADV ENZYME REGUL, V42, P249, DOI 10.1016/S0065-2571(01)00061-9; Hiromasa Y, 2004, J BIOL CHEM, V279, P6921, DOI 10.1074/jbc.M308172200; Hitosugi T, 2011, MOL CELL, V44, P864, DOI 10.1016/j.molcel.2011.10.015; Hsu CC, 2016, EXP BIOL MED, V241, P1281, DOI 10.1177/1535370216641787; Hung WY, 2012, BBA-GEN SUBJECTS, V1820, P1102, DOI 10.1016/j.bbagen.2012.04.016; Ji YP, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15308; Jin L, 2017, ONCOGENE, V36, P3797, DOI 10.1038/onc.2017.6; Kamp WM, 2016, CURR OPIN GENET DEV, V38, P16, DOI 10.1016/j.gde.2016.02.007; Kato Y, 2018, JPN DENT SCI REV, V54, P8, DOI 10.1016/j.jdsr.2017.08.003; Kim JH, 2011, AUTOPHAGY, V7, P1187, DOI 10.4161/auto.7.10.16643; Kim JH, 2011, EXP CELL RES, V317, P1108, DOI 10.1016/j.yexcr.2011.02.011; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Kolobova E, 2001, BIOCHEM J, V358, P69, DOI 10.1042/0264-6021:3580069; Koukourakis MI, 2003, BRIT J CANCER, V89, P877, DOI 10.1038/sj.bjc.6601205; Koukourakis MI, 2005, CLIN EXP METASTAS, V22, P25, DOI 10.1007/s10585-005-2343-7; Lee DC, 2015, CELL, V161, P595, DOI 10.1016/j.cell.2015.03.011; Lee YK, 2017, J BIOL CHEM, V292, P20208, DOI 10.1074/jbc.M117.809012; Lee YK, 2015, HEPATOLOGY, V62, P1174, DOI 10.1002/hep.27976; Lewis BC, 2000, CANCER RES, V60, P6178; Lutz NW, 2013, CANCER RES, V73, P4616, DOI 10.1158/0008-5472.CAN-13-0767; Ma JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064912; Maekawa M, 2003, CLIN CHEM, V49, P1518, DOI 10.1373/49.9.1518; Miao P, 2013, IUBMB LIFE, V65, P904, DOI 10.1002/iub.1216; Miranda-Goncalves V, 2013, NEURO-ONCOLOGY, V15, P172, DOI 10.1093/neuonc/nos298; Parks SK, 2013, NAT REV CANCER, V13, P611, DOI 10.1038/nrc3579; Perez-Escuredo J, 2016, BBA-MOL CELL RES, V1863, P2481, DOI 10.1016/j.bbamcr.2016.03.013; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Romero-Garcia S, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00052; Ruan GX, 2013, J BIOL CHEM, V288, P21161, DOI 10.1074/jbc.M113.474619; San-Millan I, 2017, CARCINOGENESIS, V38, P119, DOI 10.1093/carcin/bgw127; Saunier E, 2016, INT J CANCER, V138, P809, DOI 10.1002/ijc.29564; Semenza GL, 2013, J CLIN INVEST, V123, P3664, DOI 10.1172/JCI67230; Singh KK, 2004, ANN NY ACAD SCI, V1019, P260, DOI 10.1196/annals.1297.043; Srinivasan S, 2016, MOL CELL ONCOL, V3, DOI 10.1080/23723556.2015.1085120; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thomson JM, 2005, NAT GENET, V37, P630, DOI 10.1038/ng1553; Valvona CJ, 2016, BRAIN PATHOL, V26, P3, DOI 10.1111/bpa.12299; Walenta S, 2004, CURR MED CHEM, V11, P2195, DOI 10.2174/0929867043364711; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309	55	15	16	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2019	294	19					7810	7820		10.1074/jbc.RA118.006095	http://dx.doi.org/10.1074/jbc.RA118.006095			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IB3FL	30923124	Green Published, hybrid			2022-12-26	WOS:000470153300023
J	Bonora, G; Rubbi, L; Morselli, M; Ma, FY; Chronis, C; Plath, K; Pellegrini, M				Bonora, Giancarlo; Rubbi, Liudmilla; Morselli, Marco; Ma, Feiyang; Chronis, Constantinos; Plath, Kathrin; Pellegrini, Matteo			DNA methylation estimation using methylation-sensitive restriction enzyme bisulfite sequencing (MREBS)	PLOS ONE			English	Article							EPIGENETIC MEMORY; DISCOVERY; SITES	Whole-genome bisulfite sequencing (WGBS) and reduced representation bisulfite sequencing (RRBS) are widely used for measuring DNA methylation levels on a genome-wide scale. Both methods have limitations: WGBS is expensive and prohibitive for most large-scale projects; RRBS only interrogates 6-12% of the CpGs in the human genome. Here, we introduce methylation-sensitive restriction enzyme bisulfite sequencing (MREBS) which has the reduced sequencing requirements of RRBS, but significantly expands the coverage of CpG sites in the genome. We built a multiple regression model that combines the two features of MREBS: the bisulfite conversion ratios of single cytosines (as in WGBS and RRBS) as well as the number of reads that cover each locus (as in MRE-seq). This combined approach allowed us to estimate differential methylation across 60% of the genome using read count data alone, and where counts were sufficiently high in both samples (about 1.5% of the genome), our estimates were significantly improved by the single CpG conversion information. We show that differential DNA methylation values based on MREBS data correlate well with those based on WGBS and RRBS. This newly developed technique combines the sequencing cost of RRBS and DNA methylation estimates on a portion of the genome similar to WGBS, making it ideal for large-scale projects of mammalian genomes.	[Bonora, Giancarlo; Rubbi, Liudmilla; Morselli, Marco; Chronis, Constantinos; Plath, Kathrin; Pellegrini, Matteo] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA; [Bonora, Giancarlo; Plath, Kathrin; Pellegrini, Matteo] Univ Calif Los Angeles, Bioinformat Interdept Program, Los Angeles, CA 90024 USA; [Bonora, Giancarlo; Chronis, Constantinos; Plath, Kathrin] Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90024 USA; [Bonora, Giancarlo; Rubbi, Liudmilla; Morselli, Marco; Pellegrini, Matteo] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Bonora, Giancarlo] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Ma, Feiyang; Plath, Kathrin; Pellegrini, Matteo] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA; [Plath, Kathrin; Pellegrini, Matteo] Univ Calif Los Angeles, David Geffen Sch Med, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Washington; University of Washington Seattle; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Plath, K; Pellegrini, M (corresponding author), Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA.; Plath, K; Pellegrini, M (corresponding author), Univ Calif Los Angeles, Bioinformat Interdept Program, Los Angeles, CA 90024 USA.; Plath, K (corresponding author), Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90024 USA.; Pellegrini, M (corresponding author), Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA.; Plath, K; Pellegrini, M (corresponding author), Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA.; Plath, K; Pellegrini, M (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA.	kplath@mednet.ucla.edu; matteop@mcdb.ucla.edu	Ma, Feiyang/GLN-6180-2022; Morselli, Marco/AAF-3182-2019	Morselli, Marco/0000-0003-3351-5791; Plath, Kathrin/0000-0001-7796-3372; chronis, Constantinos/0000-0002-7783-8202; Pellegrini, Matteo/0000-0001-9355-9564	UCLA Philip Whitcome Pre-doctoral Training Fellowship; UCLA Dissertation Year Fellowship; UCLA Quantitative and Computational Biosciences Postdoctoral Fellowship; CIRM Training Grant; Leukemia and Lymphoma Research Visiting Fellowship [10040]; UCLA David Geffen School of Medicine; CIRM; NIH [P01 GM099134]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM099134] Funding Source: NIH RePORTER	UCLA Philip Whitcome Pre-doctoral Training Fellowship; UCLA Dissertation Year Fellowship; UCLA Quantitative and Computational Biosciences Postdoctoral Fellowship; CIRM Training Grant; Leukemia and Lymphoma Research Visiting Fellowship; UCLA David Geffen School of Medicine; CIRM(California Institute for Regenerative Medicine); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	G.B. was supported by a UCLA Philip Whitcome Pre-doctoral Training Fellowship, a UCLA Dissertation Year Fellowship and a UCLA Quantitative and Computational Biosciences Postdoctoral Fellowship; CC by a CIRM Training Grant and a Leukemia and Lymphoma Research Visiting Fellowship (10040); M.M. was supported by a UCLA Philip Whitcome Pre-doctoral Training Fellowship and a UCLA Dissertation Year Fellowship. KP by the UCLA Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, funds from the UCLA David Geffen School of Medicine, CIRM, and NIH P01 GM099134; and MP from NIH P01 GM099134.	Chronis C, 2017, CELL, V168, P442, DOI 10.1016/j.cell.2016.12.016; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Ernst J, 2010, NAT BIOTECHNOL, V28, P817, DOI 10.1038/nbt.1662; Feng SH, 2011, METHODS MOL BIOL, V733, P223, DOI 10.1007/978-1-61779-089-8_16; Feng SH, 2010, P NATL ACAD SCI USA, V107, P8689, DOI 10.1073/pnas.1002720107; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Gu HC, 2011, NAT PROTOC, V6, P468, DOI 10.1038/nprot.2010.190; Guo WL, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-774; Hon GC, 2013, NAT GENET, V45, P1198, DOI 10.1038/ng.2746; Jacinto FV, 2008, BIOTECHNIQUES, V44, P35, DOI 10.2144/000112708; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Laird PW, 2010, NAT REV GENET, V11, P191, DOI 10.1038/nrg2732; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee DS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6619; Lister R, 2009, GENOME RES, V19, P959, DOI 10.1101/gr.083451.108; Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165; Meissner A, 2005, NUCLEIC ACIDS RES, V33, P5868, DOI 10.1093/nar/gki901; Sandoval J, 2011, EPIGENETICS-US, V6, P692, DOI 10.4161/epi.6.6.16196; Shipony Z, 2014, NATURE, V513, P115, DOI 10.1038/nature13458; Smith ZD, 2014, NATURE, V511, P611, DOI 10.1038/nature13581; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Smith ZD, 2009, METHODS, V48, P226, DOI 10.1016/j.ymeth.2009.05.003; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Xie W, 2013, CELL, V153, P1134, DOI 10.1016/j.cell.2013.04.022; Yang Y, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1572-7; Zemach A, 2010, SCIENCE, V328, P916, DOI 10.1126/science.1186366; Ziller MJ, 2013, NATURE, V500, P477, DOI 10.1038/nature12433	28	7	7	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0214368	10.1371/journal.pone.0214368	http://dx.doi.org/10.1371/journal.pone.0214368			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR7EH	30946758	Green Published, Green Submitted, gold			2022-12-26	WOS:000463314500029
J	Andrade, VLC; Flores, BM; Levis, C; Clement, CR; Roberts, P; Schongart, J				Caetano Andrade, Victor L.; Flores, Bernardo M.; Levis, Carolina; Clement, Charles R.; Roberts, Patrick; Schongart, Jochen			Growth rings of Brazil nut trees (Bertholletia excelsa) as a living record of historical human disturbance in Central Amazonia	PLOS ONE			English	Article							SEASONAL TROPICAL FOREST; RAIN-FOREST; DRY FOREST; PATTERNS; DOMESTICATION; DROUGHT; RECRUITMENT; IMPACT; AGE; CONSEQUENCES	The Brazil nut tree (Bertholletia excelsa) is an iconic and economically valuable species that dominates vast swathes of the Amazon Basin. This species seems to have been an important part of human subsistence strategies in the region from at least the Early Holocene, and its current distribution may be a legacy of past human settlement. Because B. excelsa is a long-lived pioneer tree it requires natural or human disturbances to increase light availability in the understory for a successful establishment. However, it remains unclear how the long-term population dynamics of this species have been shaped by pre-colonial and post-colonial human practices. Here, we use tree-ring analyses to look at changes in growing conditions over the past 400 years in a Brazil nut tree population in Central Amazonia. We identify changes in tree recruitment and growth rates associated not only with regional climatic variability, but also major political and socio-economic activities recorded by historical documents in the vicinity of Manaus. We demonstrate that the expansion of a post-colonial political center (Manaus) from the middle of the 18th century onwards coincided with a reduction in recruitment of B. excelsa. We argue that this hiatus suggests the interruption of indigenous management practices, probably due to the collapse of pre-Columbian societies. A second recruitment pulse, and unprecedented cycles of growth release and suppression, aligns with a shift to modern exploitation of the forest into the 20th century. Our findings shed light on how past histories of human-forest interactions can be revealed by the growth rings of trees in Amazonia. Future interdisciplinary analysis of these trees should enable more detailed investigation of how human forest management has changed in this part of the world, through pre-colonial, colonial, and industrial periods of human activity, with potential implications for conservation.	[Caetano Andrade, Victor L.; Levis, Carolina; Clement, Charles R.; Schongart, Jochen] Inst Nacl de Pesquisas da Amazonia, Manaus, AM, Brazil; [Caetano Andrade, Victor L.; Roberts, Patrick] Max Planck Inst Sci Human Hist, Dept Archaeol, Jena, Thuringen, Germany; [Flores, Bernardo M.] Univ Estadual Campinas, Inst Biol, Dept Biol Vegetal, Campinas, SP, Brazil; [Levis, Carolina] Wageningen Univ & Res, Forest Ecol & Forest Management Grp, Wageningen, Netherlands	Institute Nacional de Pesquisas da Amazonia; Universidade de Sao Paulo; Universidade Estadual de Campinas; Wageningen University & Research	Andrade, VLC (corresponding author), Inst Nacl de Pesquisas da Amazonia, Manaus, AM, Brazil.; Andrade, VLC (corresponding author), Max Planck Inst Sci Human Hist, Dept Archaeol, Jena, Thuringen, Germany.	caetano_andrade@shh.mpg.de	Clement, Charles Roland/G-6081-2010	Clement, Charles Roland/0000-0002-8421-1029; Schongart, Jochen/0000-0002-7696-9657; Roberts, Patrick/0000-0002-4403-7548; Caetano Andrade, Victor Lery/0000-0002-1333-569X	Dendroecology Laboratory of the Ecology, Monitoring and Sustainable Use of Wetlands Research Group (MAUA) at the National Institute for Amazonian Research; CAPES (Comissao de Aperfeicoamento de Pessoal do Nivel Superior); Sao Paulo Research Foundation [2016/25086-3]; CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); CNPq; Max Planck Society	Dendroecology Laboratory of the Ecology, Monitoring and Sustainable Use of Wetlands Research Group (MAUA) at the National Institute for Amazonian Research; CAPES (Comissao de Aperfeicoamento de Pessoal do Nivel Superior); Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Max Planck Society(Max Planck SocietyFoundation CELLEX)	Support for this study was provided by the Dendroecology Laboratory of the Ecology, Monitoring and Sustainable Use of Wetlands Research Group (MAUA) at the National Institute for Amazonian Research. Victor L. Caetano Andrade thanks CAPES (Comissao de Aperfeicoamento de Pessoal do Nivel Superior) for a Master's degree scholarship, Bernardo M. Flores is funded by Sao Paulo Research Foundation Grant {2016/25086-3}, Carolina Levis thanks CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) for a doctoral degree scholarship, Charles R. Clement thanks CNPq for a research fellowship, Patrick Roberts and Victor L. Caetano Andrade thank the Max Planck Society for funding and support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; Almeida JJ, 2016, 6 C INT HIST EC 8 EN, P1; Amoroso MR, 2009, HIST INDIOS BRASIL, P297; Antunes AP, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600936; Arroyo-Kalin M., 2010, Diversity, V2, P473; Arroyo-Kalin M, 2012, QUATERN INT, V249, P4, DOI 10.1016/j.quaint.2011.08.004; Baker PJ, 2006, J TROP ECOL, V22, P521, DOI 10.1017/S0266467406003312; Baker PJ, 2005, ECOL MONOGR, V75, P317, DOI 10.1890/04-0488; Baker PJ, 2003, ECOL APPL, V13, P1718, DOI 10.1890/02-5025; Balee W, 2006, ANNU REV ANTHROPOL, V35, P75, DOI 10.1146/annurev.anthro.35.081705.123231; Benchimol S, 1947, GROWTH CITY AMAZON V; Benchimol S, 1977, POUCO ANTES ALEM DEP; Brasil. Projeto Radambrasil, 1973, LEVANTAMENTO RECURSO, P34; Brienen RJW, 2006, J ECOL, V94, P481, DOI 10.1111/j.1365-2745.2005.01080.x; Brienen RJW, 2005, OECOLOGIA, V146, P1, DOI 10.1007/s00442-005-0160-y; Brienen RJW, 2010, GLOBAL CHANGE BIOL, V16, P2001, DOI 10.1111/j.1365-2486.2009.02059.x; Brienen RJW, 2010, OECOLOGIA, V163, P485, DOI 10.1007/s00442-009-1540-5; Burslem DFRP, 2000, J ECOL, V88, P1063, DOI 10.1046/j.1365-2745.2000.00517.x; Caldas YP, 2007, ANAIS DO SETA2007, P1981; Camargo P. B. de, 1994, Scientia Agricola, V51, P389; Cintra BBL, 2013, BIOGEOSCIENCES, V10, P7759, DOI 10.5194/bg-10-7759-2013; CLARK DA, 1992, ECOL MONOGR, V62, P315, DOI 10.2307/2937114; Clement CR, 2015, P ROY SOC B-BIOL SCI, V282, P32, DOI 10.1098/rspb.2015.0813; Clement CR, 1999, ECON BOT, V53, P188, DOI 10.1007/BF02866498; Costa VP, 2013, MURAIDA TRADICAOLITE; CUNHA M. C., POLITICA INDIGENISTA; Dawkins H.C., 1978, LONG TERM SURVEILLAN; DENEVAN WM, 1992, ANN ASSOC AM GEOGR, V82, P369, DOI 10.1111/j.1467-8306.1992.tb01965.x; Fauset S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7857; Forline L, 2008, J ECOL ANTHR, V12, P69; Granato-Souza D, 2019, CLIM DYNAM, V52, P1857, DOI 10.1007/s00382-018-4227-y; Guariguata MR, 2017, BIODIVERS CONSERV, V26, P2007, DOI 10.1007/s10531-017-1355-3; Portes MCGD, 2018, ANTHROPOCENE, V24, P61, DOI 10.1016/j.ancene.2018.11.004; HARTIGAN JA, 1985, ANN STAT, V13, P70, DOI 10.1214/aos/1176346577; Hecht S.B., 2013, SCRAMBLE AMAZON LOST; Heckenberger MJ, 2008, SCIENCE, V321, P1214, DOI 10.1126/science.1159769; Hemming J, 1995, RED GOLD CONQUEST BR; Herraiz AD, 2017, FOREST ECOL MANAG, V406, P46, DOI 10.1016/j.foreco.2017.09.053; Iriarte J, 2007, ENVIRON ARCHAEOL, V12, P115, DOI 10.1179/174963107x226390; Kainer KA, 2006, J TROP ECOL, V22, P147, DOI 10.1017/S0266467405002981; Leite E, 2000, NOTORIOS REBELDES EX, P1; Levis C, 2017, SCIENCE, V355, P925, DOI 10.1126/science.aal0157; Levis C, 2013, ANTES ORELLANA, P305; Levis C, 2018, FRONT ECOL EVOL, V5, DOI 10.3389/fevo.2017.00171; Levis C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048559; Locosselli GM, 2016, TREES-STRUCT FUNCT, V30, P1127, DOI 10.1007/s00468-015-1351-8; Maezumi SY, 2018, NATURE PLANTS, V23; Marengo JA, 2016, INT J CLIMATOL, V36, P1033, DOI 10.1002/joc.4420; McClenachan L, 2015, BIOSCIENCE, V65, P932, DOI 10.1093/biosci/biv100; McMichael CH, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2475; McMichael CNH, 2017, P NATL ACAD SCI USA, V114, P522, DOI 10.1073/pnas.1614577114; Meggers BJ, 1974, ENV CULTURE AMAZONIA, P911; Metcalfe DB, 2010, NEW PHYTOL, V187, P608, DOI 10.1111/j.1469-8137.2010.03319.x; Mori S. A., 1990, Advances in Economic Botany, V8, P130; NELSON BW, 1994, ECOLOGY, V75, P853, DOI 10.2307/1941742; Nepstad DC, 2007, ECOLOGY, V88, P2259, DOI 10.1890/06-1046.1; Neves EG, 2004, AMAZONIAN DARK EARTHS: ORIGIN, PROPERTIES, MANAGEMENT, P29, DOI 10.1007/1-4020-2597-1_3; Neves EG, 2004, AMAZONIAN DARK EARTHS: EXPLORATIONS IN SPACE AND TIME, P125; Nimuendaj? Curt., 1948, HDB S AM INDIANS, V3, P255; Nowacki GJ, 1997, ECOL MONOGR, V67, P225, DOI 10.1890/0012-9615(1997)067[0225:RGACFR]2.0.CO;2; O'Fallon BD, 2011, P NATL ACAD SCI USA, V108, P20444, DOI 10.1073/pnas.1112563108; Paiva PM, 2011, FOREST ECOL MANAG, V261, P508, DOI 10.1016/j.foreco.2010.11.001; Pequeno ED, 2006, REV ESTUDOS PESQUISA, V3, P133; Piperno DR, 2011, CURR ANTHROPOL, V52, pS453, DOI 10.1086/659998; Porcher V, 2018, FOREST ECOL MANAG, V427, P52, DOI 10.1016/j.foreco.2018.05.052; Potts MD, 2003, J ECOL, V91, P467, DOI 10.1046/j.1365-2745.2003.00779.x; R Core Team, 2021, R LANGUAGE ENV STAT; Ribeiro MBN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102187; Roberts P, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2017.93; Roosevelt AC, 1996, SCIENCE, V272, P373, DOI 10.1126/science.272.5260.373; Roosevelt AC, 1996, SCIENCE, V274, P1823; Rozendaal DMA, 2011, TREES-STRUCT FUNCT, V25, P115, DOI 10.1007/s00468-010-0478-x; Schongart J, 2015, BIOTROPICA, V47, P550, DOI 10.1111/btp.12243; Scoles R., 2014, B MUS EM LIO GOELDI, V9, P321; Scoles R, 2011, HUM ECOL, V39, P455, DOI 10.1007/s10745-011-9412-0; Scrucca L, 2016, R J, V8, P289; Shepard GH, 2011, ECON BOT, V65, P44, DOI 10.1007/s12231-011-9151-6; Silva AG, 2008, ALDEIAS INDIGENAS MU; Sombroek W, 2001, AMBIO, V30, P388, DOI 10.1639/0044-7447(2001)030[0388:SATPOA]2.0.CO;2; Souza M, 2009, HIST DA AMAZONIA; Sternberg H.O.R, 1998, AGUA HOMEM VARZEA CA; ter Steege H, 2013, SCIENCE, V342, P325, DOI 10.1126/science.1243092; Thomas E, 2015, J BIOGEOGR, V42, P1367, DOI 10.1111/jbi.12540; Vandermeer J, 2000, SCIENCE, V290, P788, DOI 10.1126/science.290.5492.788; Vieira S, 2005, P NATL ACAD SCI USA, V102, P18502, DOI 10.1073/pnas.0505966102; Vlam M, 2017, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01984; Worbes M, 1999, IAWA J, V20, P255, DOI 10.1163/22941932-90000689; Zuidema PA, 2002, J TROP ECOL, V18, P1, DOI 10.1017/S0266467402002018	88	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0214128	10.1371/journal.pone.0214128	http://dx.doi.org/10.1371/journal.pone.0214128			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR5NS	30943230	gold, Green Submitted, Green Published			2022-12-26	WOS:000463194300032
J	Garcia-Jaramillo, M; Spooner, MH; Lohr, CV; Wong, CP; Zhang, WJ; Jump, DB				Garcia-Jaramillo, Manuel; Spooner, Melinda H.; Lohr, Christiane V.; Wong, Carmen P.; Zhang, Weijian; Jump, Donald B.			Lipidomic and transcriptomic analysis of western diet-induced nonalcoholic steatohepatitis (NASH) in female LdIr(-/-) mice	PLOS ONE			English	Article							FATTY LIVER-DISEASE; MASS-SPECTROMETRIC ANALYSIS; HEPATIC STEATOSIS; DOCOSAHEXAENOIC ACID; METABOLIC SYNDROME; AMERICAN ASSOCIATION; PRACTICE GUIDELINE; ARACHIDONIC-ACID; NATURAL-HISTORY; SEX-DIFFERENCES	Background Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease worldwide, particularly in obese and type 2 diabetic individuals. NAFLD ranges in severity from benign steatosis to nonalcoholic steatohepatitis (NASH); and NASH can progress to cirrhosis, primary hepatocellular carcinoma (HCC) and liver failure. As such, NAFLD has emerged as a major public health concern. Herein, we used a lipidomic and transcriptomic approach to identify lipid markers associated with western diet (WD) induced NASH in female mice. Methods Female mice (low-density lipoprotein receptor null (LdIr(-/-)) were fed a reference or WD diet for 38 and 46 weeks. Transcriptomic and lipidomic approaches, coupled with statistical analyses, were used to identify associations between major NASH markers and transcriptomic & lipidomic markers. Results The WD induced all major hallmarks of NASH in female Ldlr(-/-)r mice, including steatosis (SFA, MUFA, MUFA-containing di- and triacylglycerols), inflammation (TNF alpha), oxidative stress (Ncf2), and fibrosis (Coll A). The WD also increased transcripts associated with membrane remodeling (LpCat), apoptosis & autophagy (Caspl, CtsS), hedgehog (Taz) & notch signaling (Hey1), epithelial-mesenchymal transition (S1004A) and cancer (Gpc3). WD feeding, however, suppressed the expression of the hedgehog inhibitory protein (Hhip), and enzymes involved in triglyceride catabolism (Tgh/Ces3, Ces1 g), as well as the hepatic abundance of C18-22 PUFA-containing phosphoglycerolipids (GpCho, GpEtn, GpSer, Gpins). WD feeding also increased hepatic cyclooxygenase (Cox1 & 2) expression and pro-inflammatory omega 6 PUFA-derived oxylipins (PGE2), as well as lipid markers of oxidative stress 8-iso-PGF2 alpha). The WD suppressed the hepatic abundance of reparative oxylipins (19, 20-DiHDPA) as well as the expression of enzymes involved in fatty epoxide metabolism (Cyp2C, Ephx). Conclusion WD-induced NASH in female LdIr(-/-) mice was characterized by a massive increase in hepatic neutral and membrane lipids containing SFA and MUFA and a loss of C18-22 PUFA-containing membrane lipids. Moreover, the WD increased hepatic pro-inflammatory oxylipins and suppressed the hepatic abundance of reparative oxylipins. Such global changes in the type and abundance of hepatic lipids likely contributes to tissue remodeling and NASH severity.	[Garcia-Jaramillo, Manuel; Spooner, Melinda H.; Wong, Carmen P.; Jump, Donald B.] Oregon State Univ, Sch Biol & Populat Hlth Sci, Nutr Program, Corvallis, OR 97331 USA; [Garcia-Jaramillo, Manuel; Spooner, Melinda H.; Wong, Carmen P.; Zhang, Weijian; Jump, Donald B.] Oregon State Univ, Linus Pauling Inst, Corvallis, OR 97331 USA; [Garcia-Jaramillo, Manuel] Oregon State Univ, Dept Chem, Gilbert Hall 153, Corvallis, OR 97331 USA; [Lohr, Christiane V.] Oregon State Univ, Carlson Coll Vet Med, Anat Pathol, Corvallis, OR 97331 USA	Oregon State University; Oregon State University; Oregon State University; Oregon State University	Jump, DB (corresponding author), Oregon State Univ, Sch Biol & Populat Hlth Sci, Nutr Program, Corvallis, OR 97331 USA.; Jump, DB (corresponding author), Oregon State Univ, Linus Pauling Inst, Corvallis, OR 97331 USA.	Donald.Jump@oregonstate.edu	Löhr, C. V./AAU-4902-2020	Löhr, C. V./0000-0003-3787-5583; Garcia-Jaramillo, Manuel/0000-0003-2987-2913	National Institutes of Health (NIH) [DK094600, DK112360]; Linus Pauling Institute (LPI) at Oregon State University; National Institutes of Health [NIH 1S10RR022589-01, NIH 1S10RR027878-01]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK112360] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Linus Pauling Institute (LPI) at Oregon State University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was funded by grants from the National Institutes of Health (NIH) to DBJ (DK094600 and DK112360). Additionally, WZ was the recipient of discretionary funds from the Linus Pauling Institute (LPI) at Oregon State University. The Oregon State University Mass Spectrometry Center received the following instrumentation grants from the National Institutes of Health for instruments used in this study: NIH 1S10RR022589-01 [Applied Biosystems 4000 Qtrap] and NIH 1S10RR027878-01 [ABSciex TripleToF 5600]. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript. Competing interests: The authors have declared	Adams LA, 2005, GASTROENTEROLOGY, V129, P113, DOI 10.1053/j.gastro.2005.04.014; Adibhatla RM, 2006, FREE RADICAL BIO MED, V40, P376, DOI 10.1016/j.freeradbiomed.2005.08.044; Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Arab JP, 2018, ANNU REV PATHOL-MECH, V13, P321, DOI 10.1146/annurev-pathol-020117-043617; Aukema HM, 2016, LIPIDS, V51, P591, DOI 10.1007/s11745-015-4074-0; Ballestri S, 2017, ADV THER, V34, P1291, DOI 10.1007/s12325-017-0556-1; Barupal DK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15231-w; Bieghs V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030668; Cajka T, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-015-0929-x; Cajka T, 2014, TRAC-TREND ANAL CHEM, V61, P192, DOI 10.1016/j.trac.2014.04.017; Calder PC, 2012, J NUTR, V142, p592S, DOI 10.3945/jn.111.155259; Chalasani N, 2018, HEPATOLOGY, V67, P328, DOI 10.1002/hep.29367; Chalasani N, 2012, AM J GASTROENTEROL, V107, P811, DOI 10.1038/ajg.2012.128; Chalasani N, 2012, GASTROENTEROLOGY, V142, P1592, DOI 10.1053/j.gastro.2012.04.001; Chalasani NP, 2009, CONTEMP CLIN TRIALS, V30, P88, DOI 10.1016/j.cct.2008.09.003; Chang WH, 2018, LIPIDS HEALTH DIS, V17, DOI 10.1186/s12944-018-0845-y; Chen HY, 2013, CANCER LETT, V336, P204, DOI 10.1016/j.canlet.2013.04.031; Choi J, 2015, J LIPID RES, V56, P1182, DOI 10.1194/jlr.M058941; Chong J, 2018, NUCLEIC ACIDS RES, V46, pW486, DOI 10.1093/nar/gky310; Ciccimaro E, 2010, BIOANALYSIS, V2, P311, DOI 10.4155/BIO.09.185; CLARKE SD, 1990, J NUTR, V120, P225, DOI 10.1093/jn/120.2.225; CLARKE SD, 1990, J NUTR, V120, P218, DOI 10.1093/jn/120.2.218; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Cordain L, 2005, AM J CLIN NUTR, V81, P341, DOI 10.1093/ajcn.81.2.341; Deems R, 2007, METHOD ENZYMOL, V432, P59, DOI 10.1016/S0076-6879(07)32003-X; Depner CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083756; Depner CM, 2013, J NUTR, V143, P315, DOI 10.3945/jn.112.171322; Depner CM, 2012, J NUTR, V142, P1495, DOI 10.3945/jn.112.158865; Dumlao DS, 2011, BBA-MOL CELL BIOL L, V1811, P724, DOI 10.1016/j.bbalip.2011.06.005; Ekstedt M, 2006, HEPATOLOGY, V44, P865, DOI 10.1002/hep.21327; Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973; Gabbs M, 2015, ADV NUTR, V6, P513, DOI 10.3945/an.114.007732; Gassaway BM, 2018, P NATL ACAD SCI USA, V115, pE8996, DOI 10.1073/pnas.1804379115; Geisler F, 2015, HEPATOLOGY, V61, P382, DOI 10.1002/hep.27268; Gorden DL, 2015, J LIPID RES, V56, P722, DOI 10.1194/jlr.P056002; Guillou H, 2010, PROG LIPID RES, V49, P186, DOI 10.1016/j.plipres.2009.12.002; Hall LM, 1998, J AM SOC MASS SPECTR, V9, P527, DOI 10.1016/S1044-0305(98)00013-0; Hernandez C, 2018, J CLIN INVEST, V128, P2436, DOI 10.1172/JCI91786; Housley L, 2018, MOL NUTR FOOD RES, V62, DOI 10.1002/mnfr.201700665; Hussain MM, 2003, J LIPID RES, V44, P22, DOI 10.1194/jlr.R200014-JLR200; Ikonen E, 2001, CURR OPIN CELL BIOL, V13, P470, DOI 10.1016/S0955-0674(00)00238-6; Inceoglu B, 2017, PROSTAG OTH LIPID M, V133, P68, DOI 10.1016/j.prostaglandins.2017.08.003; Jump DB, 2002, J BIOL CHEM, V277, P8755, DOI 10.1074/jbc.R100062200; Jump DB, 1999, ANNU REV NUTR, V19, P63, DOI 10.1146/annurev.nutr.19.1.63; Jump DB, 2016, P NUTR SOC, V75, P1, DOI 10.1017/S002966511500244X; Jump DB, 2011, BIOCHEM PHARMACOL, V81, P649, DOI 10.1016/j.bcp.2010.12.014; Kanda T, 2018, WORLD J GASTROENTERO, V24, P2661, DOI 10.3748/wjg.v24.i25.2661; KENNEDY EP, 1957, ANNU REV BIOCHEM, V26, P119, DOI 10.1146/annurev.bi.26.070157.001003; Kim DH, 2016, CELL REP, V17, P1671, DOI 10.1016/j.celrep.2016.10.023; Kirkwood JS, 2012, J BIOL CHEM, V287, P3833, DOI 10.1074/jbc.M111.316018; LANDS WEM, 1958, J BIOL CHEM, V231, P883; Leslie M, 2015, SCIENCE, V347, P1058, DOI 10.1126/science.347.6226.1058; Lian JH, 2012, HEPATOLOGY, V56, P2154, DOI 10.1002/hep.25881; Liang W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115922; Liang XR, 2011, BIOANALYSIS, V3, P1923, DOI [10.4155/BIO.11.181, 10.4155/bio.11.181]; Link JC, 2017, ANNU REV NUTR, V37, P225, DOI 10.1146/annurev-nutr-071816-064827; Loomba R, 2013, NAT REV GASTRO HEPAT, V10, P686, DOI 10.1038/nrgastro.2013.171; Lytle KA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173376; Lytle KA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146942; Lytle KA, 2015, J LIPID RES, V56, P1936, DOI 10.1194/jlr.M061275; Machado MV, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060857; Machado MV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127991; Maciejewska D, 2015, PROSTAG OTH LIPID M, V121, P184, DOI 10.1016/j.prostaglandins.2015.09.003; Mater MK, 1999, J LIPID RES, V40, P1045; McCullough Arthur J, 2004, Clin Liver Dis, V8, P521, DOI 10.1016/j.cld.2004.04.004; McCullough AJ, 2011, J DIGEST DIS, V12, P333, DOI 10.1111/j.1751-2980.2010.00469.x; Moran-Salvador E, 2011, FASEB J, V25, P2538, DOI 10.1096/fj.10-173716; Nettschwander-Tetri BA, 2010, HEPATOLOGY, V52, P913, DOI 10.1002/hep.23784; Norheim F, 2017, J LIPID RES, V58, P178, DOI 10.1194/jlr.M071522; Owada S, 2018, ONCOL REP, V39, P1805, DOI 10.3892/or.2018.6279; Pan JJ, 2014, WORLD J HEPATOL, V6, P274, DOI 10.4254/wjh.v6.i5.274; Panigrahy D, 2013, P NATL ACAD SCI USA, V110, P13528, DOI 10.1073/pnas.1311565110; Park HG, 2016, BBA-MOL CELL BIOL L, V1861, P91, DOI 10.1016/j.bbalip.2015.11.007; Peet DJ, 1998, CELL, V93, P693, DOI 10.1016/S0092-8674(00)81432-4; Peyta L, 2015, BBA-MOL CELL BIOL L, V1851, P1490, DOI 10.1016/j.bbalip.2015.08.008; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Prashanth M, 2009, J Assoc Physicians India, V57, P205; Puri P, 2007, HEPATOLOGY, V46, P1081, DOI 10.1002/hep.21763; Quiroga AD, 2012, HEPATOLOGY, V56, P2188, DOI 10.1002/hep.25961; Reue K, 2017, PHYSIOL BEHAV, V176, P174, DOI 10.1016/j.physbeh.2017.02.040; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Schuck RN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110162; Showalter MR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190632; Gasparin FRS, 2018, BBA-MOL BASIS DIS, V1864, P2495, DOI 10.1016/j.bbadis.2018.04.004; Soderberg C, 2010, HEPATOLOGY, V51, P595, DOI 10.1002/hep.23314; Sparks JD, 2008, J CLIN INVEST, V118, P2012, DOI 10.1172/JCI35693; Strassburg K, 2012, ANAL BIOANAL CHEM, V404, P1413, DOI 10.1007/s00216-012-6226-x; Strazzabosco M, 2012, GASTROENTEROLOGY, V143, P1430, DOI 10.1053/j.gastro.2012.10.025; Sugden MC, 2003, OBES RES, V11, P167, DOI 10.1038/oby.2003.26; Sun CX, 2016, CELL REP, V17, P2015, DOI 10.1016/j.celrep.2016.10.070; Swiderska-Syn M, 2013, HEPATOLOGY, V57, P1814, DOI 10.1002/hep.26230; Tao RY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071997; Tripathy S, 2014, J LIPID RES, V55, P1448, DOI 10.1194/jlr.M050062; Tripathy S, 2010, J LIPID RES, V51, P2642, DOI 10.1194/jlr.M006080; van der Veen JN, 2017, BBA-BIOMEMBRANES, V1859, P1558, DOI 10.1016/j.bbamem.2017.04.006; Vernon G, 2011, ALIMENT PHARM THER, V34, P274, DOI 10.1111/j.1365-2036.2011.04724.x; Wang XB, 2016, CELL METAB, V24, P848, DOI 10.1016/j.cmet.2016.09.016; Wang Y, 2014, J CHROMATOGR A, V1359, P60, DOI 10.1016/j.chroma.2014.07.006; Wang Y, 2006, J LIPID RES, V47, P2028, DOI 10.1194/jlr.M600177-JLR200; Wishart DS, 2007, NUCLEIC ACIDS RES, V35, pD521, DOI 10.1093/nar/gkl923; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; Xu XR, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/623509; Yang YB, 2014, OBESITY, V22, P2147, DOI 10.1002/oby.20811; Younossi ZM, 2012, MEDICINE, V91, P319, DOI 10.1097/MD.0b013e3182779d49; Zavadil J, 2004, EMBO J, V23, P1155, DOI 10.1038/sj.emboj.7600069; Zechner R, 2017, NAT REV MOL CELL BIO, V18, P671, DOI 10.1038/nrm.2017.76; Zhang H, 2013, J LIPID RES, V54, P345, DOI 10.1194/jlr.M028969; Zhang J, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000011130; Zheng X, 2010, MOL MED REP, V3, P965, DOI 10.3892/mmr.2010.375	109	24	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0214387	10.1371/journal.pone.0214387	http://dx.doi.org/10.1371/journal.pone.0214387			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR5NS	30943218	gold, Green Published, Green Submitted			2022-12-26	WOS:000463194300034
J	Guthrie, JL; Marchand-Austin, A; Cronin, K; Lam, K; Pyskir, D; Kong, C; Jorgensen, D; Rodrigues, M; Roth, D; Tang, P; Cook, VJ; Johnston, J; Jamieson, FB; Gardy, JL				Guthrie, Jennifer L.; Marchand-Austin, Alex; Cronin, Kirby; Lam, Karen; Pyskir, Daria; Kong, Clare; Jorgensen, Danielle; Rodrigues, Mabel; Roth, David; Tang, Patrick; Cook, Victoria J.; Johnston, James; Jamieson, Frances B.; Gardy, Jennifer L.			Universal genotyping reveals province-level differences in the molecular epidemiology of tuberculosis	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; BRITISH-COLUMBIA; TRANSMISSION; POPULATION; OUTBREAK; STRAINS; CANADA	Objectives Compare the molecular epidemiology of tuberculosis (TB) between two large Canadian provinces-Ontario and British Columbia (BC)-to identify genotypic clusters within and across both provinces, allowing for an improved understanding of genotype data and providing context to more accurately identify clusters representing local transmission. Design We compared 24-locus Mycobacterial Interspersed Repetitive Units-Variable Number of Tandem Repeats (MIRU-VNTR) genotyping for 3,314 Ontario and 1,602 BC clinical Mycobacterium tuberculosis isolates collected from 2008 through 2014. Laboratory data for each isolate was linked to case-level records to obtain clinical and demographic data. Results The demographic characteristics of persons with TB varied between provinces, most notably in the proportion of persons born outside Canada, which was reflected in the large number of unique genotypes (n = 3,461). The proportion of clustered isolates was significantly higher in BC. Substantial clustering amongst non-Lineage 4 TB strains was observed within and across the provinces. Only two large clusters (>= 10 cases/cluster) representing within province transmission had interprovincial genotype matches. Conclusion We recommend expanding analysis of shared genotypes to include neighbouring jurisdictions, and implementing whole genome sequencing to improve identification of TB transmission, recognize outbreaks, and monitor changing trends in TB epidemiology.	[Guthrie, Jennifer L.; Gardy, Jennifer L.] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada; [Guthrie, Jennifer L.; Marchand-Austin, Alex; Cronin, Kirby; Lam, Karen; Pyskir, Daria; Jamieson, Frances B.] Publ Hlth Ontario, Toronto, ON, Canada; [Cronin, Kirby] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada; [Kong, Clare; Jorgensen, Danielle; Rodrigues, Mabel; Tang, Patrick] British Columbia Ctr Dis Control, Publ Hlth Lab, Vancouver, BC, Canada; [Roth, David; Cook, Victoria J.; Johnston, James; Gardy, Jennifer L.] British Columbia Ctr Dis Control, Vancouver, BC, Canada; [Tang, Patrick] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC, Canada; [Cook, Victoria J.; Johnston, James] Univ British Columbia, Resp Med, Vancouver, BC, Canada; [Jamieson, Frances B.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada	University of British Columbia; Public Health Agency of Canada; University of British Columbia; University of British Columbia; University of Toronto	Guthrie, JL (corresponding author), Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada.; Guthrie, JL (corresponding author), Publ Hlth Ontario, Toronto, ON, Canada.	jennifer.guthrie@alumni.ubc.ca	Guthrie, Jennifer/ABE-2378-2021	Guthrie, Jennifer/0000-0001-8565-203X; Cronin, Kirby/0000-0002-5124-3446	2008-2009 OPS Innovation Fund (Ontario Ministry of Government and Consumer Services) [08507]; British Columbia Centre for Disease Control Foundation for Population and Public Health; British Columbia Lung Association; University of British Columbia; Canadian Institutes of Health Research; Canada Research Chairs Program; Killam Trusts; Michael Smith Foundation	2008-2009 OPS Innovation Fund (Ontario Ministry of Government and Consumer Services); British Columbia Centre for Disease Control Foundation for Population and Public Health; British Columbia Lung Association; University of British Columbia; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs Program(Canada Research Chairs); Killam Trusts; Michael Smith Foundation(Michael Smith Foundation for Health Research)	This work was supported in part by the 2008-2009 OPS Innovation Fund (Ontario Ministry of Government and Consumer Services; https://www.ontario.ca/page/ministry-government-and-consumer-services) grant number 08507, and the British Columbia Centre for Disease Control Foundation for Population and Public Health (http://bccdcfoundation.org/), and the British Columbia Lung Association (https://bc.lung.ca/).Financial support was obtained from the University of British Columbia (https://www.ubc.ca/) 4-year doctoral fellowship to J. L. Guthrie, the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html) doctoral research award to J. L. Guthrie, Killam Trusts (http://www.killamlaureates.ca/) doctoral scholarship to J. L. Guthrie, the Michael Smith Foundation (https://www.msfhr.org/) scholar awards to J. J. and J. L. Gardy, and the Canada Research Chairs Program (http://www.chairs-chaires.gc.ca/) to J. L. Gardy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam HJ, 2010, INT J TUBERC LUNG D, V14, P1350; Allidina A, 2015, LINKING SERVICES OUT; Aze J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130912; Canada Statistics, 2017, ANN DEM EST CAN PROV; Cheng JM, 2015, EPIDEMIOL INFECT, V143, P3220, DOI 10.1017/S0950268815000825; Comas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007815; Eberle MP, 2001, HOMELESSNESS CAUSES, V2; Fiebig L, 2017, EUROSURVEILLANCE, V22, P15, DOI 10.2807/1560-7917.ES.2017.22.2.30439; FitzGerald JM, 2003, INT J TUBERC LUNG D, V7, P132; Francisco AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-87; Gagneux S, 2012, PHILOS T R SOC B, V367, P850, DOI 10.1098/rstb.2011.0316; Gardy JL, 2011, NEW ENGL J MED, V364, P730, DOI 10.1056/NEJMoa1003176; Garzelli C, 2012, INFECT GENET EVOL, V12, P610, DOI 10.1016/j.meegid.2011.10.015; Guthrie JL, 2018, CLIN INFECT DIS, V66, P849, DOI 10.1093/cid/cix906; Guthrie JL, 2017, J AM MED INFORM ASSN, V24, pE136, DOI 10.1093/jamia/ocw130; Hamblion EL, 2016, THORAX, V71, P749, DOI 10.1136/thoraxjnl-2014-206608; Jamieson FB, 2014, J CLIN MICROBIOL, V52, P3795, DOI 10.1128/JCM.01726-14; Jonsson J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095159; Lambregts-van Weezenbeek CSB, 2003, INT J TUBERC LUNG D, V7, pS463; Lathan M, 2002, EMERG INFECT DIS, V8, P1249; Mears J, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1023; Mehaffy C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112928; Menendez MC, 2007, TUBERCULOSIS, V87, P426, DOI 10.1016/j.tube.2007.05.017; Mitruka K, 2014, PUBLIC HEALTH REP, V129, P78, DOI 10.1177/003335491412900112; Montoya Jaime C, 2013, Kekkaku, V88, P543; Murdie RA, 2011, DIVERSITY CONCENTRAT; Palittapongarnpim P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29986-3; Public Health Agency of Canada, 2014, CANADIAN TUBERCULOSI; Shabbeer A, 2012, INFECT GENET EVOL, V12, P789, DOI 10.1016/j.meegid.2012.02.010; Sloot R, 2013, J CLIN MICROBIOL, V51, P2427, DOI 10.1128/JCM.00489-13; SMALL PM, 1994, NEW ENGL J MED, V330, P1703, DOI 10.1056/NEJM199406163302402; Statistic Canada, 2011, IMM ETHN DIV CAN; Stucki D, 2016, J CLIN MICROBIOL, V54, P1862, DOI 10.1128/JCM.00126-16; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Thwaites G, 2008, J CLIN MICROBIOL, V46, P1363, DOI 10.1128/JCM.02180-07; Vachon J, 2018, TUBERCULOSIS CANADA, V44; Wyllie DH, 2018, EBIOMEDICINE, V34, P122, DOI 10.1016/j.ebiom.2018.07.019	37	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2019	14	4							e0214870	10.1371/journal.pone.0214870	http://dx.doi.org/10.1371/journal.pone.0214870			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR5NS	30943250	Green Published, gold, Green Submitted			2022-12-26	WOS:000463194300065
J	Consoli, F; Manganoni, AM; Grisanti, S; Petrelli, F; Venturini, M; Rangoni, G; Guarneri, F; Incardona, P; Vermi, W; Pinton, PGC; Berruti, A				Consoli, Francesca; Manganoni, Ausilia Maria; Grisanti, Salvatore; Petrelli, Fausto; Venturini, Marina; Rangoni, Giovanni; Guarneri, Francesco; Incardona, Paolo; Vermi, William; Pinton, Pier Giacomo Calzavara; Berruti, Alfredo			Panniculitis and vitiligo occurring during BRAF and MEK inhibitors combination in advanced melanoma patients: Potential predictive role of treatment efficacy	PLOS ONE			English	Article							V600-MUTANT METASTATIC MELANOMA; POOLED ANALYSIS; DABRAFENIB; TRAMETINIB; SURVIVAL; VEMURAFENIB; OUTCOMES	Panniculitis and vitiligo-like lesions have been recently identified as rare cutaneous side effects of the combination of BRAF and MEK inhibitors, a standard of care in metastatic and locally advanced BRAF V600 mutated melanoma. An immune-mediated mechanism has been advocated in the pathogenesis of these skin lesions. Herein we retrospectively reviewed our institutional experience with the aim to explore the association between the occurrence of panniculitis and vitiligo-like lesions during combination therapy with dabrafenib (D) and trametinib (T) and outcome of advanced melanoma patients. Among 52 consecutive BRAF V600 mutated melanoma patients submitted to DT in our center, 12 (23%) developed immune related skin lesions (IRSLs): 8 panniculitis and 4 vitiligo. Patients with IRSLs diagnosis obtained a better disease response (83% versus 25%) (p = 0.001) than their counterpart and had a longer progression free survival and overall survival. The association of IRSLs and lower risk of disease progression (HR 0.19; CI 95% 0.04-0.90; p = 0.043) was confirmed after adjusting for major prognostic factors in multivariate analysis. IRSLs might represent an easy predictive surrogate marker for treatment response and favourable outcome in melanoma patients submitted to DT combination therapy.	[Consoli, Francesca; Grisanti, Salvatore; Rangoni, Giovanni; Berruti, Alfredo] Univ Brescia ASST Spedali Civili, Dept Med & Surg Specialties, Radiol Sci & Publ Hlth, Med Oncol, Brescia, Italy; [Manganoni, Ausilia Maria; Venturini, Marina; Pinton, Pier Giacomo Calzavara] Univ Brescia ASST Spedali Civili, Dept Dermatol, Brescia, Italy; [Petrelli, Fausto] ASST Bergamo Ovest, Oncol Unit, Treviglio, Italy; [Guarneri, Francesco] ASST Spedali Civili, Dept Pharm, Brescia, Italy; [Incardona, Paolo] ASST Spedali Civili, Dept Lab Med, Unit Pathol, Brescia, Italy; [Vermi, William] Univ Brescia ASST Spedali Civili, Sch Med, Sect Pathol, Dept Mol & Translat Med, Brescia, Italy	Hospital Spedali Civili Brescia; Hospital Spedali Civili Brescia	Consoli, F (corresponding author), Univ Brescia ASST Spedali Civili, Dept Med & Surg Specialties, Radiol Sci & Publ Hlth, Med Oncol, Brescia, Italy.	francesca.consoli@icloud.com	calzavara-pinton, piergiacomo/AAH-5597-2021; Berruti, Alfredo/AAC-2069-2019					Ascierto PA, 2018, ONCOIMMUNOLOGY, V7, DOI 10.1080/2162402X.2018.1468955; Ben-Betzalel G, 2018, EUR J CANCER, V101, P229, DOI 10.1016/j.ejca.2018.06.030; de Golian E, 2016, CURR TREAT OPTION ON, V17, DOI 10.1007/s11864-016-0434-0; Frederick DT, 2013, CLIN CANCER RES, V19, P1225, DOI 10.1158/1078-0432.CCR-12-1630; Galliker NA, 2015, EUR J DERMATOL, V25, P177, DOI 10.1684/ejd.2014.2512; Hauschild A, 2018, JAMA ONCOL, V4, P1382, DOI 10.1001/jamaoncol.2018.2668; Long GV, 2017, ANN ONCOL, V28, P1631, DOI 10.1093/annonc/mdx176; Long GV, 2018, J CLIN ONCOL, V36, P667, DOI 10.1200/JCO.2017.74.1025; Long GV, 2016, LANCET ONCOL, V17, P1743, DOI 10.1016/S1470-2045(16)30578-2; Long GV, 2016, J CLIN ONCOL, V34, P871, DOI 10.1200/JCO.2015.62.9345; Manganoni AM, 2012, GIORN ITAL DERMAT V, V147, P210; Mossner R, 2015, J EUR ACAD DERMATOL, V29, P1797, DOI 10.1111/jdv.13039; Nasca MR, 2016, J DRUGS DERMATOL, V15, P766; Renner K, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00248; Ruiz-Villaverde R, 2016, BALK MED J, V33, P115, DOI 10.5152/balkanmedj.2015.15157; Schadendorf D, 2017, EUR J CANCER, V82, P45, DOI 10.1016/j.ejca.2017.05.033; Yan Y, 2016, ANN ONCOL, V27, DOI 10.1093/annonc/mdw379.3	17	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2019	14	4							e0214884	10.1371/journal.pone.0214884	http://dx.doi.org/10.1371/journal.pone.0214884			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR2UW	30939167	Green Published, Green Submitted, gold			2022-12-26	WOS:000462993900046
J	Sarin, S; Huddart, S; Raizada, N; Parija, D; Kalra, A; Rao, R; Salhotra, VS; Khaparde, SD; Boehme, C; Denkinger, CM; Sohn, H				Sarin, Sanjay; Huddart, Sophie; Raizada, Neeraj; Parija, Debadutta; Kalra, Aakshi; Rao, Raghuram; Salhotra, Virender Singh; Khaparde, Sunil D.; Boehme, Catharina; Denkinger, Claudia M.; Sohn, Hojoon			Cost and operational impact of promoting upfront GeneXpert MTB/RIF test referrals for presumptive pediatric tuberculosis patients in India	PLOS ONE			English	Article								Background Outreach and promotion programs are essential to ensuring uptake of new public health interventions and guidelines. We assessed the costs and operation dynamics of outreach and promotion efforts for up front Xpert MTB/RIF (Xpert) testing for pediatric presumptive tuberculosis (TB) patients in four major Indian cities. Methods Xpert test costs were assessed as weighted average per-test costs based on the daily workload dynamics matched by test volume specific Xpert unit cost at each study site. Costs of outreach programs to recruit health providers to refer pediatric patients for Xpert testing were assessed as cost per referral for each quarter based on total program costs and referral data. All costs were assessed in the health service provider's perspective and expressed in 2015 USD. Results Weighted average per-test costs ranged from $14.71 to $17.81 at the four laboratories assessed. Differences between laboratories were associated with unused testing capacity and/or frequencies of overtime work to cope with increasing demand and same-day testing requirements. Outreach activities generated between 825 and 2,065 Xpert testing referrals on average each quarter across the four study sites, translating into $0.63 to $2.55 per patient referred. Overall outreach costs per referral decreased with time, stabilizing at an average cost of $1.10, and demonstrated a clear association with increased referrals. Conclusions Xpert test and outreach program costs within and across study sites were mainly driven by the dynamics of Xpert testing demand resulting from the combined outreach activities. However, these increases in demand required considerable overtime work resulting in additional costs and operational challenges at the study laboratories. Therefore, careful laboratory operational adjustment should be evaluated at target areas in parallel to the anticipated demand from the Xpert referral outreach program scale-up in other Indian regions.	[Sarin, Sanjay; Raizada, Neeraj; Parija, Debadutta; Kalra, Aakshi] Fdn Innovat New Diagnost, New Delhi, India; [Huddart, Sophie] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Huddart, Sophie] McGill Int TB Ctr, Montreal, PQ, Canada; [Rao, Raghuram; Salhotra, Virender Singh; Khaparde, Sunil D.] Govt India, Cent TB Div, New Delhi, India; [Boehme, Catharina; Denkinger, Claudia M.] Fdn Innovat New Diagnost, Geneva, Switzerland; [Sohn, Hojoon] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA	Foundation For Innovative New Diagnostics; McGill University; Foundation For Innovative New Diagnostics; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Sohn, H (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA.	hsohn6@jhu.edu	Huddart, Sophie/AAF-8844-2020; Sohn, Hojoon/AAL-2856-2020	Huddart, Sophie/0000-0001-6425-3371; Sohn, Hojoon/0000-0001-5837-3844; Raizada, Neeraj/0000-0003-2116-332X	United States Agency for International Development (USAID) under the Challenge TB project	United States Agency for International Development (USAID) under the Challenge TB project(United States Agency for International Development (USAID))	The FIND/RNTCP pediatric GeneXpert implementation project was funded by United States Agency for International Development (USAID) under the Challenge TB project. FIND was responsible for the implementation, training, coordination, monitoring, data analysis and writing of the report in close coordination with the Central TB Division, Ministry of Health and Family Welfare, Government of India.	[Anonymous], 2009, FINANCIAL MANAGEMENT; Bratt JH, 1999, HEALTH POLICY PLANN, V14, P374, DOI 10.1093/heapol/14.4.374; Central TB Division, 2017, DRAFT NAT STRAT PLAN; Cunnama L, 2016, HEALTH ECON, V25, P53, DOI 10.1002/hec.3295; Edejer T, 2003, MAKING CHOICES HLTH; IPAQT, IN PROM AFF QUAL TB; Kumaranayake L, 2000, HEALTH POLICY PLANN, V15, P230, DOI 10.1093/heapol/15.2.230; Raizada N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193194; Rupert S, 2016, BOTTOM UP TOP DOWN U, V21, P375; Vassall A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001120; WHO, 2017, GLOB TUB REP	11	8	8	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2019	14	4							e0214675	10.1371/journal.pone.0214675	http://dx.doi.org/10.1371/journal.pone.0214675			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HR1CY	30933997	gold, Green Published, Green Submitted			2022-12-26	WOS:000462867000035
J	Gregorio, ER; Medina, JRC; Lomboy, MFTC; Talaga, ADP; Hernandez, PMR; Kodama, M; Kobayashi, J				Gregorio, Ernesto R., Jr.; Medina, John Robert C.; Lomboy, Marian Fe Theresa C.; Talaga, Andre Dominic P.; Hernandez, Paul Michael R.; Kodama, Mitsuya; Kobayashi, Jun			Knowledge, attitudes, and practices of public secondary school teachers on Zika Virus Disease: A basis for the development of evidence-based Zika educational materials for schools in the Philippines	PLOS ONE			English	Article								The Philippines is at risk in developing a Zika Virus (ZIKV) Disease Outbreak. One of the possible interventions is health education because students are potential health advocates and influencers to their communities through the knowledge transfers from their teachers. The competency of Filipino teachers on ZIKV Disease is yet to be described. This study aimed to assess the knowledge, attitudes, and practices of public secondary school teachers on ZIKV Disease. A modified version of the Knowledge, Attitudes, and Practices Survey Tool on Zika Virus Disease from the World Health Organization-Pan American Health Organization (WHO-PAHO) was used to assess the knowledge, attitudes, and practices of teachers of eight public secondary schools in five villages in Quezon City, Philippines. Out of the 609 respondents, 87.3% reported that their main source of information about ZIKV is tri-media, which includes television, print, and radio. Majority of the respondents mentioned that ZIKV is transmitted through a mosquito bite (80.3%). However, only half of the participants identified vector control as a preventive strategy. Moreover, only 54% admitted to have cleaned their water containers or water sources within the last week. Only a few identified mother-to-child (23%) and sexual intercourse (8%) as other means of transmission. Half (49.8%) of the respondents felt that it is possible to acquire ZIKV in their community, while 90% perceived that a private doctor (90%) or a public hospital (88%) can effectively treat the disease. Perceived stigma is high at 50%. This study showed there was good knowledge among teachers on vector transmission of ZIKV but poor knowledge on other aspects of the disease. Also, there was a low level of perceived susceptibility and severity ZIKV which can be explained by the absence of a personal encounter with a Zika patient and the low number of cases in the Philippines. Half of the respondents said that they cleaned the possible mosquito breeding sites within the last week, followed by those who cleaned their water source more than a week ago (19%). None of the socio-demographic characteristics is significantly associated with respondents' knowledge on Zika. Only income and location of residence were found to be significantly associated with attitudes towards Zika. These findings call for a comprehensive training program that includes development of teaching materials for public secondary school teachers on ZIKV Disease based from this study.	[Gregorio, Ernesto R., Jr.; Medina, John Robert C.; Talaga, Andre Dominic P.; Kodama, Mitsuya; Kobayashi, Jun] Univ Philippines Manila, SEAMEO TROPMED Reg Ctr Publ Hlth Hosp Adm & Envir, Coll Publ Hlth, Dept Hlth Promot & Educ, Manila, Philippines; [Lomboy, Marian Fe Theresa C.; Hernandez, Paul Michael R.] Univ Philippines Manila, SEAMEO TROPMED Reg Ctr Publ Hlth Hosp Adm & Envir, Coll Publ Hlth, Dept Environm & Occupat Hlth, Manila, Philippines; [Gregorio, Ernesto R., Jr.; Medina, John Robert C.; Kodama, Mitsuya; Kobayashi, Jun] Univ Ryukyus, Grad Sch Hlth Sci, Dept Global Hlth, Nishihara, Okinawa, Japan; [Kobayashi, Jun] Univ Ryukyus, Japanese Consortium Global Sch Hlth Res, Nishihara, Okinawa, Japan	University of the Philippines System; University of the Philippines Manila; University of the Philippines System; University of the Philippines Manila; University of the Ryukyus; University of the Ryukyus	Gregorio, ER (corresponding author), Univ Philippines Manila, SEAMEO TROPMED Reg Ctr Publ Hlth Hosp Adm & Envir, Coll Publ Hlth, Dept Hlth Promot & Educ, Manila, Philippines.; Gregorio, ER (corresponding author), Univ Ryukyus, Grad Sch Hlth Sci, Dept Global Hlth, Nishihara, Okinawa, Japan.	ergregorio@up.edu.ph	Hernandez, Paul Michael/AAP-9266-2021; Medina, John Robert/AGL-6564-2022	Hernandez, Paul Michael/0000-0003-0528-9766; Medina, John Robert/0000-0001-6647-5453; Gregorio, Ernesto Jr/0000-0003-1931-0458	Okinawa Prefecture of Japan	Okinawa Prefecture of Japan	JK received a funding from the Okinawa Prefecture of Japan. http://www.infection.okinawa/.Okinawa Prefecture had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aidoo-Frimpong G, 2017, ANN GLOB HEALTH, V83, P59; Alvarez LS, 2017, OPEN PUBLIC HLTH J, V10; [Anonymous], 2003, BUILD TEACH QUAL WHA; [Anonymous], 2017, ABS CBN NEWS    0203; Arief M., 2017, J PHARM PRACTICE COM, V3, P81, DOI [10.5530/jppcm.2017.2.20, DOI 10.5530/JPPCM.2017.2.20, DOI 10.5530/jppcm.2017.2.20]; Ayi I, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-98; Bonalos P, 2016, CNN PHILIPPINES 0817; Bulario JS, 2018, KNE SOC SCI, V3, P891; Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI [10.3201/eid2006.140138, 10.3201/eid2011.141380]; Casapulla SL, 2018, AIMS PUBLIC HEALTH, V5, P49, DOI 10.3934/publichealth.2018.1.49; Castro M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081875; Chaw LL, 2018, ASIAN PAC J TROP MED, V11, P638, DOI 10.4103/1995-7645.246340; Cheema S, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2603-6; Department of Health, DIS SURV 2015 DENG M; Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715; Harapan H, 2018, J INFECT PUBLIC HEAL, V11, P99, DOI 10.1016/j.jiph.2017.06.013; Heitzinger Kristen, 2018, Prev Med Rep, V10, P20, DOI 10.1016/j.pmedr.2018.01.002; Huang Y, 2017, JMIR PUBLIC HLTH SUR, V3, DOI DOI 10.1186/S12889-017-4991-3; Jayawardene WP, 2011, J SCHOOL HEALTH, V81, P566, DOI 10.1111/j.1746-1561.2011.00628.x; Katler Quinton, 2017, Infect Dis Obstet Gynecol, V2017, P6350602, DOI 10.1155/2017/6350602; Lohrmann C, 2000, J ADV NURS, V31, P696, DOI 10.1046/j.1365-2648.2000.01326.x; Massad E, 2016, GLOBAL HEALTH ACTION, V9, P1, DOI 10.3402/gha.v9.31669; Moorhead SA, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.1933; Mouchtouri VA, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14040367; Mwamwenda TS, MEDITERRANEAN J SOCI, V5, P500; Painter JE, 2017, VACCINE, V35, P960, DOI 10.1016/j.vaccine.2016.12.050; Philippine Statistics Authority, 2016, 2015 FULL YEAR OFF P; Philippine Statistics Authority (PSA) and ICF, 2018, KEY FIND PHIL NAT DE; Plaster AN, 2018, J COMMUNITY HLTH, P1; Samuel G, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-017-4991-3; Tun MMN, 2018, AM J TROP MED HYG, V98, P868, DOI 10.4269/ajtmh.17-0708; Borges ALV, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190024; Whiteman A, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-6172-4; World Health Organization, 2016, KNOWL ATT PRACT SURV; World Health Organization [ WHO]/ PAHO, 2016, ZIK STRAT RESP PLAN; World Health Organization [ WHO]/ PAHO, 2016, ZIK STRAT RESP PLAN	36	9	9	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214515	10.1371/journal.pone.0214515	http://dx.doi.org/10.1371/journal.pone.0214515			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921441	Green Published, Green Submitted, gold			2022-12-26	WOS:000462594000079
J	Meikle, WG; Corby-Harris, V; Carroll, MJ; Weiss, M; Snyder, LA; Meador, CAD; Beren, E; Brown, N				Meikle, William G.; Corby-Harris, Vanessa; Carroll, Mark J.; Weiss, Milagra; Snyder, Lucy A.; Meador, Charlotte A. D.; Beren, Eli; Brown, Nicholas			Exposure to sublethal concentrations of methoxyfenozide disrupts honey bee colony activity and thermoregulation	PLOS ONE			English	Article							PESTICIDES; INSECTICIDES; TOXICITY	Methoxyfenozide is an insect growth regulator (IGR) commonly used in agriculture to simultaneously control pests and preserve beneficial insect populations; however, its impact on honey bees in not fully understood. We conducted field and laboratory experiments to investigate bee health in response to field-relevant concentrations of this pesticide. Significant effects were observed in honey bee colony flight activity and thermoregulation after being exposed over 9 weeks to supplemental protein patty containing methoxyfenozide. Compared to bee colonies in the control group, colonies fed pollen patty with 200 ppb methoxyfenozide (as measured by residue analysis) had: 1) a significantly reduced rate of weight loss due to forager departure in the morning; and 2) higher temperature variability during the winter. Colonies in the 100 ppb (as measured by residue analysis) treatment group had values between the 200 ppb group and control for both response variables. The dusk break point, which is the time associated with the end of forager return, differed among all treatment groups but may have been confounded with direction the hives were facing. Bee colony metrics of adult bee mass and brood surface area, and measurements of bee head weight, newly-emerged bee weight, and hypopharyngeal gland size were not significantly affected by methoxyfenozide exposure, suggesting that there may be significant effects on honey bee colony behavior and health in the field that are difficult to detect using standard methods for assessing bee colonies and individuals. The second experiment was continued into the following spring, using the same treatment groups as in the fall. Fewer differences were observed among groups in the spring than the fall, possibly because of abundant spring forage and consequent reduced treatment patty consumption. Residue analyses showed that: 1) observed methoxyfenozide concentrations in treatment patty were about 18-60% lower than the calculated concentrations; 2) no residues were observed in wax in any treatment; and 3) methoxyfenozide was detected in bee bread only in the 200 ppb treatment group, at about 1-2.5% of the observed patty concentration.	[Meikle, William G.; Corby-Harris, Vanessa; Carroll, Mark J.; Weiss, Milagra; Snyder, Lucy A.; Meador, Charlotte A. D.; Beren, Eli; Brown, Nicholas] USDA ARS, Carl Hayden Bee Res Ctr, Tucson, AZ 85719 USA	United States Department of Agriculture (USDA)	Meikle, WG (corresponding author), USDA ARS, Carl Hayden Bee Res Ctr, Tucson, AZ 85719 USA.	william.meikle@ars.usda.gov	Meikle, William/AAC-2481-2022	Meikle, William/0000-0002-1759-6950				[Anonymous], 2003, 20033 CAL DEP PEST R; Baker NT, 2017, Estimated annual agricultural pesticide use by crop group for states of the conterminous United States, 1992-2014, DOI [10.5066/F7NP22KM, DOI 10.5066/F7NP22KM]; Corby-Harris V, 2018, JOVE-J VIS EXP, DOI 10.3791/58261; Corby-Harris V, 2016, J INSECT PHYSIOL, V85, P65, DOI 10.1016/j.jinsphys.2015.11.016; Curtis B, 2013, BEST MANAGEMENT PRAC, P1; De Smet L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171529; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Despres L, 2007, TRENDS ECOL EVOL, V22, P298, DOI 10.1016/j.tree.2007.02.010; Dhadialla TS, 1998, ANNU REV ENTOMOL, V43, P545, DOI 10.1146/annurev.ento.43.1.545; du Rand EE, 2015, SCI REP-UK, V5, DOI 10.1038/srep11779; Fisher A, 2018, J ECON ENTOMOL, V111, P510, DOI 10.1093/jee/tox347; Fourrier J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132985; Heylen K, 2011, APIDOLOGIE, V42, P103, DOI 10.1051/apido/2010043; Higbee BS, 2012, J ECON ENTOMOL, V105, P1702, DOI 10.1603/EC11389; Hrassnigg N, 1998, J INSECT PHYSIOL, V44, P393, DOI 10.1016/S0022-1910(98)00022-5; Johnson RM, 2015, ANNU REV ENTOMOL, V60, P415, DOI 10.1146/annurev-ento-011613-162005; Johnson RM, 2010, APIDOLOGIE, V41, P312, DOI 10.1051/apido/2010018; Kliot A, 2012, PEST MANAG SCI, V68, P1431, DOI 10.1002/ps.3395; Mao WF, 2011, P NATL ACAD SCI USA, V108, P12657, DOI 10.1073/pnas.1109535108; Meikle WG, 2016, APIDOLOGIE, V47, P1, DOI 10.1007/s13592-015-0370-1; Meikle WG, 2015, APIDOLOGIE, V46, P10, DOI 10.1007/s13592-014-0298-x; Meikle WG, 2018, APIDOLOGIE, V49, P581, DOI 10.1007/s13592-018-0585-z; Meikle WG, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197589; Meikle WG, 2017, JOVE-J VIS EXP, DOI 10.3791/56355; Meikle WG, 2017, APIDOLOGIE, V48, P666, DOI 10.1007/s13592-017-0512-8; Meikle WG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168603; Meikle WG, 2008, APIDOLOGIE, V39, P694, DOI 10.1051/apido:2008055; Muggeo V.M., 2008, R NEWS, V8, P20; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; Retnakaran A, 2003, ARCH INSECT BIOCHEM, V54, P187, DOI 10.1002/arch.10116; Ricigliano VA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28732-z; Sanchez-Bayo F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094482; Smagghe G, 2012, ADV INSECT PHYSIOL, V43, P163, DOI 10.1016/B978-0-12-391500-9.00002-4; Stabentheiner A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008967; Wood SC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190517; Wood SN, 2001, BIOMETRICS, V57, P240, DOI 10.1111/j.0006-341X.2001.00240.x; Zhu YC, 2015, J ECON ENTOMOL, V108, P2640, DOI 10.1093/jee/tov269	37	17	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0204635	10.1371/journal.pone.0204635	http://dx.doi.org/10.1371/journal.pone.0204635			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921332	Green Published, Green Submitted, gold			2022-12-26	WOS:000462594000003
J	Rataj, F; Planel, S; Denis, J; Roelants, C; Filhol, O; Guyon, L; Feige, JJ; Cherradi, N				Rataj, Felicitas; Planel, Severine; Denis, Josiane; Roelants, Caroline; Filhol, Odile; Guyon, Laurent; Feige, Jean-Jacques; Cherradi, Nadia			Targeting AU-rich element-mediated mRNA decay with a truncated active form of the zinc-finger protein TIS11b/BRF1 impairs major hallmarks of mammary tumorigenesis	ONCOGENE			English	Article							BREAST-CANCER; BINDING PROTEIN; CXCR4/CXCL12 AXIS; TRISTETRAPROLIN; EXPRESSION; TTP; DESTABILIZATION; SEQUENCE; TIMP-1; GROWTH	Altered expression of regulatory RNA-binding proteins (RBPs) in cancer leads to abnormal expression of mRNAs encoding many factors involved in cancer hallmarks. While conventional anticancer therapies usually target one pathway at a time, targeting key RBP would affect multiple genes and thus overcome drug resistance. Among the Tristetraprolin family of RBP, TIS11b/BRF1/ZFP36L1 mediates mRNA decay through binding to Adenylate/Uridylate (AU-rich elements) in mRNA 3'-untranslated region and recruitment of mRNA degradation enzymes. Here, we show that TIS11b is markedly underexpressed in three breast cancer cell lines, as well as in breast tumor samples. We hypothesized that restoring intracellular TIS11b levels could impair cancer cell phenotypic traits. We thus generated a derivative of TIS11b called R9-ZnCS334D, by combining N-terminal domain deletion, serine-to-aspartate substitution at position 334 to enhance the function of the protein and fusion to the cell-penetrating peptide polyarginine R9. R9-ZnCS334D not only blunted secretion of vascular endothelial growth factor (VEGF) but also inhibited proliferation, migration, invasion, and anchorage-independent growth of murine 4T1 or human MDA-MB-231 breast cancer cells. Moreover, R9-ZnCS334D prevented endothelial cell organization into vessel-like structures, suggesting that it could potentially target various cell types within the tumor microenvironment. In vivo, injection of R9-ZnCS334D in 4T1 tumors impaired tumor growth, decreased tumor hypoxia, and expression of the epithelial-to-mesenchymal transition (EMT) markers Snail, Vimentin, and N-cadherin. R9-ZnCS334D also hindered the expression of chemokines and proteins involved in cancer-related inflammation and invasion including Fractalkine (CX3CL1), SDF-1 (CXCL12), MCP-1 (CCL2), NOV (CCN3), and Pentraxin-3 (PTX3). Collectively, our data indicate that R9-ZnCS334D counteracts multiple traits of breast cancer cell aggressiveness and suggest that this novel protein could serve as the basis for innovative multi-target therapies in cancer.	[Rataj, Felicitas; Planel, Severine; Denis, Josiane; Filhol, Odile; Guyon, Laurent; Feige, Jean-Jacques; Cherradi, Nadia] Univ Grenoble Alpes, INSERM, Biosci & Biotechnol Inst Grenoble, CEA,Biol Canc & Infect UMR S 1036, F-38000 Grenoble, France; [Roelants, Caroline] Inovarion, Paris, France	CEA; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm)	Cherradi, N (corresponding author), Univ Grenoble Alpes, INSERM, Biosci & Biotechnol Inst Grenoble, CEA,Biol Canc & Infect UMR S 1036, F-38000 Grenoble, France.	nadia.cherradi@cea.fr	Filhol-Cochet, Odile/I-3962-2016; Cherradi, Nadia/K-9695-2016; Feige, Jean-Jacques/F-5534-2013	Cherradi, Nadia/0000-0002-4292-774X; Guyon, Laurent/0000-0002-7674-2348; Filhol, Odile/0000-0003-1964-7958; Feige, Jean-Jacques/0000-0002-1354-7692	Institut National de la Sante et de la Recherche Medicale [INSERM U1036]; Commissariat a l'Energie Atomique; University Grenoble Alpes (UGA); Labex GRAL [ANR-10-LABX-49-01]; Fondation ARC; Fondation pour la Recherche Medicale	Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Commissariat a l'Energie Atomique(French Atomic Energy Commission); University Grenoble Alpes (UGA); Labex GRAL; Fondation ARC; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This work was supported by the Institut National de la Sante et de la Recherche Medicale (INSERM U1036), the Commissariat a l'Energie Atomique (to FR), The University Grenoble Alpes (UGA), the Labex GRAL (ANR-10-LABX-49-01), the Fondation ARC and the Fondation pour la Recherche Medicale (to SP). We thank Dr. Jean-Luc Coll (Institute for Advanced Biosciences, Grenoble, France) and Dr. Olivier Peyruchaud (INSERM U1033, Faculte de Medecine Laennec, Lyon, France) for providing the 4T1-luc and 4T1 cell lines, respectively. We thank the animal facility staff at Biosciences and Biotechnology Institute of Grenoble (BIG) for animal care.	Al-Souhibani N, 2010, ONCOGENE, V29, P4205, DOI 10.1038/onc.2010.168; Al-Souhibani N, 2014, CARCINOGENESIS, V35, P1983, DOI 10.1093/carcin/bgu080; Baklaushev VP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07851-z; Barcellos-Hoff MH, 2013, NAT REV CANCER, V13, P511, DOI 10.1038/nrc3536; Bell SE, 2006, DEV DYNAM, V235, P3144, DOI 10.1002/dvdy.20949; Benjamin D, 2007, EXPERT OPIN BIOL TH, V7, P1515, DOI 10.1517/14712598.7.10.1515; Bisogno LS, 2018, CURR OPIN GENET DEV, V48, P97, DOI 10.1016/j.gde.2017.11.004; Bleau AM, 2005, FRONT BIOSCI-LANDMRK, V10, P998, DOI 10.2741/1594; Brennan SE, 2009, CANCER RES, V69, P5168, DOI 10.1158/0008-5472.CAN-08-4238; Brooks SA, 2013, BBA-GENE REGUL MECH, V1829, P666, DOI 10.1016/j.bbagrm.2013.02.003; Carrick DM, 2007, ARCH BIOCHEM BIOPHYS, V462, P278, DOI 10.1016/j.abb.2007.04.011; Chamboredon S, 2011, MOL BIOL CELL, V22, P3366, DOI 10.1091/mbc.E10-07-0617; Chen PC, 2014, ONCOTARGET, V5, P1595, DOI 10.18632/oncotarget.1570; Cherradi N, 2006, MOL ENDOCRINOL, V20, P916, DOI 10.1210/me.2005-0121; Choi B, 2014, ONCOTARGET, V5, P481, DOI 10.18632/oncotarget.1664; Ciais D, 2004, ONCOGENE, V23, P8673, DOI 10.1038/sj.onc.1207939; Ciais D, 2013, CELL MOL LIFE SCI, V70, P2031, DOI 10.1007/s00018-012-1150-y; D'Angelo RC, 2014, MOL CANCER RES, V12, P1324, DOI 10.1158/1541-7786.MCR-14-0105; Diamandis EP, 2011, CLIN CANCER RES, V17, P2395, DOI 10.1158/1078-0432.CCR-10-3024; Domanska UM, 2013, EUR J CANCER, V49, P219, DOI 10.1016/j.ejca.2012.05.005; Duan H, 2009, MOL ENDOCRINOL, V23, P497, DOI 10.1210/me.2008-0296; Galloway A, 2016, SCIENCE, V352, P453, DOI 10.1126/science.aad5978; Griseri P, 2011, HUM MOL GENET, V20, P4556, DOI 10.1093/hmg/ddr390; Gruber AR, 2011, NUCLEIC ACIDS RES, V39, pD66, DOI 10.1093/nar/gkq990; Guidotti G, 2017, TRENDS PHARMACOL SCI, V38, P406, DOI 10.1016/j.tips.2017.01.003; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hekmat O, 2013, J PROTEOME RES, V12, P4136, DOI 10.1021/pr400457u; Jamieson-Gladney WL, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3016; Johnson BA, 2002, ONCOGENE, V21, P4237, DOI 10.1038/sj.onc.1205526; Khabar KS, 2017, WILEY INTERDISCIP RE, V8, P1; Kondo S, 2013, BRIT J CANCER, V109, P739, DOI 10.1038/bjc.2013.348; LAI WS, 1990, J BIOL CHEM, V265, P16556; Lee HH, 2014, J MICROBIOL BIOTECHN, V24, P287, DOI 10.4014/jmb.1309.09070; Lee SK, 2005, INT J CANCER, V117, P32, DOI 10.1002/ijc.21133; Liang Z, 2007, BIOCHEM BIOPH RES CO, V359, P716, DOI 10.1016/j.bbrc.2007.05.182; Locatelli M, 2013, J NEUROIMMUNOL, V260, P99, DOI 10.1016/j.jneuroim.2013.04.009; Lykke-Andersen J, 2005, GENE DEV, V19, P351, DOI 10.1101/gad.1282305; Milke L, 2013, CARCINOGENESIS, V34, P850, DOI 10.1093/carcin/bgs387; Nagel S, 2017, LEUKEMIA LYMPHOMA, V58, P2196, DOI 10.1080/10428194.2017.1283029; Ouellet V, 2011, AM J PATHOL, V178, P2377, DOI 10.1016/j.ajpath.2011.01.033; Planel S, 2010, ONCOGENE, V29, P5989, DOI 10.1038/onc.2010.341; Planel S, 2014, MOL MECH ANGIOGENESI, P353, DOI 10.1007/978-2-8178-0466-8; Presta M, 2007, J CELL MOL MED, V11, P723, DOI 10.1111/j.1582-4934.2007.00061.x; Rataj F, 2016, MOL BIOL CELL, V27, P3841, DOI 10.1091/mbc.E16-06-0379; Reed JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045877; Sanduja S, 2012, FRONT BIOSCI-LANDMRK, V17, P174, DOI 10.2741/3920; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; Soria G, 2008, CANCER LETT, V267, P271, DOI 10.1016/j.canlet.2008.03.018; Tao K, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-228; Wurtz SO, 2008, ACTA ONCOL, V47, P580, DOI 10.1080/02841860802022976; Yoshimura T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058791	51	8	8	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 27	2019	38	26					5174	5190		10.1038/s41388-019-0784-8	http://dx.doi.org/10.1038/s41388-019-0784-8			17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	IF4AX	30914800				2022-12-26	WOS:000473025300005
J	Van Krieken, R; Mehta, N; Wang, T; Zheng, MY; Li, RZ; Gao, B; Ayaub, E; Ask, K; Paton, JC; Paton, AW; Austin, RC; Krepinsky, JC				Van Krieken, Richard; Mehta, Neel; Wang, Tony; Zheng, Mengyu; Li, Renzhong; Gao, Bo; Ayaub, Ehab; Ask, Kjetil; Paton, James C.; Paton, Adrienne W.; Austin, Richard C.; Krepinsky, Joan C.			Cell surface expression of 78-kDa glucose-regulated protein (GRP78) mediates diabetic nephropathy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fibrosis; diabetic nephropathy; integrin; extracellular matrix; chaperone; 78-kDa glucose-regulated protein (GRP78); cell stress; kidney disease	ENDOPLASMIC-RETICULUM STRESS; RECEPTOR-RECOGNIZED FORMS; GROWTH-FACTOR RECEPTOR; COOH-TERMINAL DOMAIN; SIGNAL-TRANSDUCTION; ACTIVATION; APOPTOSIS; LIGATION; ANTIBODIES; BINDING	The 78-kDa glucose-regulated protein (GRP78) is a well-established endoplasmic reticulum (ER)-resident chaperone that maintains protein homeostasis and regulates the unfolded protein response. Under conditions of ER stress, GRP78 is also expressed at the cell surface and implicated in tumorigenesis, immunity, and cellular signaling events. The role of cell surface-associated GRP78 (csGRP78) in the pathogenesis of diabetic nephropathy has not yet been defined. Here we explored the role of csGRP78 in regulating high glucose (HG)-induced profibrotic AKT Ser/Thr kinase (AKT) signaling and up-regulation of extracellular matrix proteins. Using primary kidney mesangial cells, we show that HG treatment, but not the osmotic control mannitol, induces csGRP78 expression through an ER stress-dependent mechanism. We found that csGRP78, known to be located on the outer membrane leaflet, interacts with the transmembrane protein integrin 1 and activates focal adhesion kinase and downstream PI3K/AKT signaling. Localization of GRP78 at the cell surface and its interaction with integrin 1 were also required for extracellular matrix protein synthesis in response to HG. Surprisingly, both the N and C termini of csGRP78 were necessary for this profibrotic response. Increased localization of GRP78 at the plasma membrane was also found in the glomerular mesangial area of type 1 diabetic mice in two different models (streptozotocin-induced and Akita). In freshly isolated glomeruli from Akita mice, csGRP78 co-localized with the mesangial cell surface marker 8-integrin. In conclusion, our work reveals a role for csGRP78 in HG-induced profibrotic responses in mesangial cells, informing a potential approach to treating diabetic nephropathy.	[Van Krieken, Richard; Mehta, Neel; Wang, Tony; Zheng, Mengyu; Li, Renzhong; Gao, Bo; Austin, Richard C.; Krepinsky, Joan C.] McMaster Univ, Dept Nephrol, Hamilton, ON L8N 4A6, Canada; [Van Krieken, Richard; Mehta, Neel; Wang, Tony; Zheng, Mengyu; Li, Renzhong; Gao, Bo; Austin, Richard C.; Krepinsky, Joan C.] St Josephs Healthcare, Hamilton, ON L8N 4A6, Canada; [Ayaub, Ehab; Ask, Kjetil] McMaster Univ, Firestone Inst Resp Hlth, Dept Med, Hamilton, ON L8N 4A6, Canada; [Ayaub, Ehab; Ask, Kjetil] St Joes Hosp, Res Inst, Hamilton, ON L8N 4A6, Canada; [Ayaub, Ehab; Ask, Kjetil] McMaster Univ, McMaster Immunol Res Ctr, Dept Pathol & Mol Med, Hamilton, ON L8S 4L8, Canada; [Paton, James C.; Paton, Adrienne W.] Univ Adelaide, Dept Mol & Biomed Sci, Res Ctr Infect Dis, Adelaide, SA 5005, Australia	McMaster University; McMaster University; McMaster University; University of Adelaide	Krepinsky, JC (corresponding author), St Josephs Hosp, 50 Charlton Ave E,Rm T3311, Hamilton, ON L8N 4A6, Canada.	krepinj@mcmaster.ca	Ask, Kjetil/AGE-0063-2022; Ask, Kjetil/B-6833-2015	Mehta, Neel/0000-0001-6143-9840; Ask, Kjetil/0000-0002-0202-735X	Canadian Institutes of Health Research Grant [PJT-148628]; Heart and Stroke Foundation of Canada [G-15-0009389]	Canadian Institutes of Health Research Grant(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada)	This work was supported by Canadian Institutes of Health Research Grant PJT-148628 (to J.C.K.) and Heart and Stroke Foundation of Canada Grant G-15-0009389 (to R.C.A.). The authors declare that they have no conflicts of interest with the contents of this article.	Alpers CE, 2011, CURR OPIN NEPHROL HY, V20, P278, DOI 10.1097/MNH.0b013e3283451901; AYO SH, 1990, AM J PATHOL, V136, P1339; Brosius FC, 2008, REV ENDOCR METAB DIS, V9, P245, DOI 10.1007/s11154-008-9100-6; CHEN HC, 1994, P NATL ACAD SCI USA, V91, P10148, DOI 10.1073/pnas.91.21.10148; Cohen M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080231; Crane ED, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.99363; Fan Y, 2017, CURR DIABETES REP, V17, DOI 10.1007/s11892-017-0842-y; Gonzalez-Gronow M, 2006, CANCER RES, V66, P11424, DOI 10.1158/0008-5472.CAN-06-1721; Gonzalez-Gronow M, 2009, ANTIOXID REDOX SIGN, V11, P2299, DOI [10.1089/ars.2009.2568, 10.1089/ARS.2009.2568]; Gray PC, 2012, FEBS LETT, V586, P1836, DOI 10.1016/j.febslet.2012.01.051; Hartner A, 2008, AM J NEPHROL, V28, P168, DOI 10.1159/000110022; Hartner A, 2010, AM J PHYSIOL-RENAL, V299, pF1151, DOI 10.1152/ajprenal.00058.2010; Hathaway CK, 2015, P NATL ACAD SCI USA, V112, P5815, DOI 10.1073/pnas.1504777112; Holman D, 2007, J NEUROSCI METH, V160, P302, DOI 10.1016/j.jneumeth.2006.09.018; Li JH, 2003, KIDNEY INT, V63, P2010, DOI 10.1046/j.1523-1755.2003.00016.x; Li RZ, 2018, J CELL SCI, V131, DOI 10.1242/jcs.208629; Li ZW, 2013, INT J BIOCHEM CELL B, V45, P987, DOI 10.1016/j.biocel.2013.02.002; Lindenmeyer MT, 2008, J AM SOC NEPHROL, V19, P2225, DOI 10.1681/ASN.2007121313; Liu C, 2003, AM J PATHOL, V163, P1859, DOI 10.1016/S0002-9440(10)63545-6; Liu GG, 2008, BIOCHEM BIOPH RES CO, V370, P651, DOI 10.1016/j.bbrc.2008.04.031; Liu MF, 2010, J CLIN INVEST, V120, P1914, DOI 10.1172/JCI42164; Miller CG, 2014, MOL BIOL CELL, V25, P2342, DOI 10.1091/mbc.E14-03-0800; Mintz PJ, 2003, NAT BIOTECHNOL, V21, P57, DOI 10.1038/nbt774; Misra UK, 2006, J BIOL CHEM, V281, P13694, DOI 10.1074/jbc.M511694200; Misra UK, 2005, J IMMUNOL, V175, P2525, DOI 10.4049/jimmunol.175.4.2525; Misra UK, 2005, J IMMUNOL, V174, P2092, DOI 10.4049/jimmunol.174.4.2092; Misra UK, 2004, CELL SIGNAL, V16, P487, DOI 10.1016/j.cellsig.2003.09.010; Misra UK, 2002, J BIOL CHEM, V277, P42082, DOI 10.1074/jbc.M206174200; Misra UK, 2010, CANCER BIOL THER, V9, P142, DOI 10.4161/cbt.9.2.10422; Misra UK, 2009, MOL CANCER THER, V8, P1350, DOI 10.1158/1535-7163.MCT-08-0990; Nakatsuka A, 2012, DIABETES, V61, P2823, DOI 10.2337/db12-0232; Ni M, 2011, BIOCHEM J, V434, P181, DOI 10.1042/BJ20101569; Peng FF, 2010, CELL SIGNAL, V22, P34, DOI 10.1016/j.cellsig.2009.09.003; Philippova M, 2008, MOL CELL BIOL, V28, P4004, DOI 10.1128/MCB.00157-08; Quinones QJ, 2008, HISTOL HISTOPATHOL, V23, P1409, DOI 10.14670/HH-23.1409; Raiter A, 2016, EXP CLIN ENDOCR DIAB, V124, P239, DOI 10.1055/s-0035-1569356; Raiter A, 2010, J VASC RES, V47, P399, DOI 10.1159/000281580; Ray R, 2012, J BIOL CHEM, V287, P32755, DOI 10.1074/jbc.M112.399808; Rondas Dieter, 2015, Diabetes, V64, P573, DOI 10.2337/db14-0621; Sanchez-Nino MD, 2010, KIDNEY INT, V78, P737, DOI 10.1038/ki.2010.270; Schlondorff D, 2009, J AM SOC NEPHROL, V20, P1179, DOI 10.1681/ASN.2008050549; Shimizu F, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aai9111; Steiner N, 2017, ONCOTARGET, V8, P56243, DOI 10.18632/oncotarget.17353; Tsai YL, 2018, P NATL ACAD SCI USA, V115, pE4245, DOI 10.1073/pnas.1714866115; Tsai YL, 2015, J BIOL CHEM, V290, P8049, DOI 10.1074/jbc.M114.618736; Uttarwar L, 2011, AM J PHYSIOL-RENAL, V300, pF921, DOI 10.1152/ajprenal.00436.2010; Uttarwar L, 2012, AM J PHYSIOL-RENAL, V302, pF329, DOI 10.1152/ajprenal.00136.2011; Van Krieken R, 2018, ENDOCRINOLOGY, V159, P1479, DOI 10.1210/en.2018-00093; Weston BS, 2003, J AM SOC NEPHROL, V14, P601, DOI 10.1097/01.ASN.0000051600.53134.B9; Wu D, 2007, DIABETOLOGIA, V50, P2008, DOI 10.1007/s00125-007-0721-1; Wu DC, 2009, J AM SOC NEPHROL, V20, P554, DOI 10.1681/ASN.2008040445; Xu Z, 2017, ONCOTARGET, V8, P32655, DOI 10.18632/oncotarget.15948; Yao F, 2015, MOL CELL ENDOCRINOL, V411, P232, DOI 10.1016/j.mce.2015.05.003; Zhang Y, 2012, AM J PHYSIOL-RENAL, V302, pF159, DOI 10.1152/ajprenal.00749.2010; Zhang Y, 2010, J BIOL CHEM, V285, P15065, DOI 10.1074/jbc.M109.087445; Zhang Y, 2010, ANTIOXID REDOX SIGN, V13, P959, DOI 10.1089/ars.2009.2908; Zhang Y, 2017, CELL SIGNAL, V31, P31, DOI 10.1016/j.cellsig.2016.12.009; Zhu M, 2014, ENDOCRINE, V47, P129, DOI 10.1007/s12020-013-0132-7	58	20	20	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2019	294	19					7755	7768		10.1074/jbc.RA118.006939	http://dx.doi.org/10.1074/jbc.RA118.006939			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IB3FL	30914477	Green Published, hybrid			2022-12-26	WOS:000470153300019
J	Chevallier, M; Ancel, PY; Torchin, H; Marchand-Martin, L; Lorthe, E; Truffert, P; Jarreau, PH; Roze, JC; Pierrat, V; Marret, S; Baud, O; Benhammou, V; Ego, A; Debillon, T				Chevallier, Marie; Ancel, Pierre-Yves; Torchin, Heloise; Marchand-Martin, Laetitia; Lorthe, Elsa; Truffert, Patrick; Jarreau, Pierre Henri; Roze, Jean Christophe; Pierrat, Veronique; Marret, Stephane; Baud, Olivier; Benhammou, Valerie; Ego, Anne; Debillon, Thierry			Early extubation is not associated with severe intraventricular hemorrhage in preterm infants born before 29 weeks of gestation. Results of an EPIPAGE-2 cohort study	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; NEURODEVELOPMENTAL OUTCOMES; CEREBRAL OXYGENATION; RISK-FACTORS; PREDICTORS; MANAGEMENT; MORBIDITY; SUCCESS; GROWTH	Objective To determine whether there is an association between severe intraventricular hemorrhage and early extubation in preterm infants born before 29 weeks of gestational age and intubated at birth. Methods This study included 1587 preterm infants from a nationwide French population cohort (EPIPAGE-2). Secondary data on intubated preterm infants were analyzed. After gestational age and propensity score matching (1:1) we built two comparable groups: an early extubation group and a delayed extubation group. Each neonate in one group was paired with a neonate in the other group having the same propensity score and gestational age. Early extubation was defined as extubation within 48 hours of life. Severe intraventricular hemorrhages were defined as grade III or IV hemorrhages according to the Papile classification. Results After matching, there were 398 neonates in each group. Using a generalized estimating equation model, we found that intraventricular hemorrhage was not associated with early extubation (adjusted OR 0.9, 95%CI 0.6-1.4). This result was supported by sensitivity analyses. Conclusion The practice of early extubation was not associated with an increased proportion of intraventricular hemorrhages. To complete these results, the long-term neurologic outcomes of these infants need to be assessed.	[Chevallier, Marie; Ego, Anne; Debillon, Thierry] Grenoble Alpes Univ, TIMC IMAG, CNRS, UMR 5525 ThEMAS, Grenoble, France; [Chevallier, Marie; Debillon, Thierry] Grenoble Alpes Univ Hosp, Neonatal Intens Care Unit, Grenoble, France; [Ancel, Pierre-Yves; Torchin, Heloise; Marchand-Martin, Laetitia; Lorthe, Elsa; Pierrat, Veronique; Benhammou, Valerie] Paris Descartes Univ, Sorbonne Paris Cite, Obstet Perinatal & Pediat Epidemiol ResearchTeam, INSERM,UMR 1153,Ctr Epidemiol & Biostat, Paris, France; [Ancel, Pierre-Yves] Cochin Hotel Dieu Hosp, AP HP, Risk Pregnancy DHU, Paris, France; [Lorthe, Elsa] Univ Porto, Inst Publ Hlth, EPIUnit, Porto, Portugal; [Truffert, Patrick; Pierrat, Veronique] CHRU Lille, Jeanne de Flandre Hosp, Neonatal Intens Care Unit, Lille, France; [Jarreau, Pierre Henri] Hop Cochin, AP HP, Neonatal Intens Care Unit Port Royal, Paris, France; [Roze, Jean Christophe] CHU Nantes, Dept Neonatal Med, Nantes, France; [Marret, Stephane] CHU Rouen, Dept Neonatal Med & Intens Care, Rouen, France; [Baud, Olivier] CHU Geneva, Div Neonatol & Pediat Intens Care, Geneva, Switzerland	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Universidade do Porto; Universite de Lille - ISITE; CHU Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Nantes Universite; CHU de Nantes; CHU de Rouen; University of Geneva	Chevallier, M (corresponding author), Grenoble Alpes Univ, TIMC IMAG, CNRS, UMR 5525 ThEMAS, Grenoble, France.; Chevallier, M (corresponding author), Grenoble Alpes Univ Hosp, Neonatal Intens Care Unit, Grenoble, France.	mchevallier3@chu-grenoble.fr	Torchin, Héloise/AAM-5170-2020; Lorthe, Elsa/I-9902-2019; Rozé, Jean-Christophe/AAS-1314-2021; EGO, Anne/G-7071-2011	Torchin, Héloise/0000-0003-4699-5384; Lorthe, Elsa/0000-0002-9654-8104; EGO, Anne/0000-0002-1025-910X; Marret, Stephane/0000-0002-2858-148X; Marchand-Martin, Laetitia/0000-0002-8036-8387	French Institute of Public Health Research/Institute of Public Health; French Health Ministry; National Institute of Health and Medical Research (INSERM); National Institute of Cancer; National Solidarity Fund for Autonomy (CNSA); National Research Agency through the French EQUIPEX program of investments in the future [ANR-11-EQPX-0038]; PREMUP Foundation	French Institute of Public Health Research/Institute of Public Health; French Health Ministry; National Institute of Health and Medical Research (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); National Institute of Cancer; National Solidarity Fund for Autonomy (CNSA); National Research Agency through the French EQUIPEX program of investments in the future; PREMUP Foundation	This project has been funded with support from the following organizations: The French Institute of Public Health Research/Institute of Public Health and its partners: the French Health Ministry, the National Institute of Health and Medical Research (INSERM), the National Institute of Cancer, and the National Solidarity Fund for Autonomy (CNSA); The National Research Agency through the French EQUIPEX program of investments in the future (reference ANR-11-EQPX-0038); the PREMUP Foundation. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Faleh K, 2011, ANN SAUDI MED, V31, P577, DOI 10.4103/0256-4947.87092; Al-Mandari H, 2015, ARCH DIS CHILD-FETAL, V100, pF428, DOI 10.1136/archdischild-2015-308549; Alderliesten T, 2013, J PEDIATR-US, V162, P698, DOI 10.1016/j.jpeds.2012.09.038; Ambalavanan N, 2006, SEMIN PERINATOL, V30, P192, DOI 10.1053/j.semperi.2006.05.006; Ancel PY, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-97; Austeng D, 2010, ACTA PAEDIATR, V99, P978, DOI 10.1111/j.1651-2227.2010.01846.x; Balany J, 2015, FRONT MED, V2, DOI 10.3389/fmed.2015.00090; Bassan H, 2006, PEDIATR NEUROL, V35, P85, DOI 10.1016/j.pediatrneurol.2006.03.005; Berger J, 2014, AM J PERINAT, V31, P1063, DOI 10.1055/s-0034-1371702; Bolisetty S, 2014, PEDIATRICS, V133, P55, DOI 10.1542/peds.2013-0372; Calisici E, 2015, J MATERN-FETAL NEO M, V28, P2115, DOI 10.3109/14767058.2014.979783; Chawla S, 2017, J PEDIATR-US, V189, P113, DOI 10.1016/j.jpeds.2017.04.050; Corp Stata, 2013, STATA STAT SOFTW REL; de Vries L S, 2001, Eur J Paediatr Neurol, V5, P139, DOI 10.1053/ejpn.2001.0494; Durrmeyer X, 2017, ARCH DIS CHILD-FETAL, pF1, DOI [10.1161/STROKEAHA.110.597229, DOI 10.1161/STROKEAHA.110.597229]; Finer NN, 2010, NEW ENGL J MED, V362, P1970, DOI 10.1056/NEJMoa0911783; GARDOSI J, 1992, LANCET, V339, P283, DOI 10.1016/0140-6736(92)91342-6; Garrido MM, 2014, HEALTH SERV RES, V49, P1701, DOI 10.1111/1475-6773.12182; Jensen EA, 2015, JAMA PEDIATR, V169, P1011, DOI 10.1001/jamapediatrics.2015.2401; Laughon MM, 2011, AM J RESP CRIT CARE, V183, P1715, DOI 10.1164/rccm.201101-0055OC; LEVENE MI, 1981, ARCH DIS CHILD, V56, P900, DOI 10.1136/adc.56.12.900; Manley BJ, 2016, J PEDIATR-US, V173, P45, DOI 10.1016/j.jpeds.2016.02.016; Miletin J, 2008, ARCH DIS CHILD-FETAL, V93, pF368, DOI 10.1136/adc.2007.129304; Morley CJ, 2008, NEW ENGL J MED, V358, P700, DOI 10.1056/NEJMoa072788; Noori S, 2015, SEMIN FETAL NEONAT M, V20, P232, DOI 10.1016/j.siny.2015.02.004; Noori S, 2009, CLIN PERINATOL, V36, P723, DOI 10.1016/j.clp.2009.07.015; PAPILE LA, 1978, J PEDIATR-US, V92, P529, DOI 10.1016/S0022-3476(78)80282-0; Shah PS, 2016, J PEDIATR-US, V177, P144, DOI 10.1016/j.jpeds.2016.04.083; Sweet DG, 2010, NEONATOLOGY, V97, P402, DOI 10.1159/000297773; Thome UH, 2009, SEMIN FETAL NEONAT M, V14, P21, DOI 10.1016/j.siny.2008.08.005; Tsai AJ, 2014, J PERINATOL, V34, P399, DOI 10.1038/jp.2014.21; van den Berg E, 2010, ARCH DIS CHILD-FETAL, V95, pF53, DOI 10.1136/adc.2008.156414; VERDER H, 1994, NEW ENGL J MED, V331, P1051, DOI 10.1056/NEJM199410203311603; Verhagen EA, 2010, STROKE, V41, P2901, DOI 10.1161/STROKEAHA.110.597229; Vesoulis ZA, 2017, FRONT PEDIATR, V5, DOI 10.3389/fped.2017.00064; 2004, PEDIATRICS, V114, P1341, DOI DOI 10.1542/PEDS.2004-1697	36	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2019	14	4							e0214232	10.1371/journal.pone.0214232	http://dx.doi.org/10.1371/journal.pone.0214232			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR7EH	30946750	Green Published, gold, Green Submitted			2022-12-26	WOS:000463314500021
J	Visscher, RMS; Feddermann-Demont, N; Romano, F; Straumann, D; Bertolini, G				Visscher, Rosa M. S.; Feddermann-Demont, Nina; Romano, Fausto; Straumann, Dominik; Bertolini, Giovanni			Artificial intelligence for understanding concussion: Retrospective cluster analysis on the balance and vestibular diagnostic data of concussion patients	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; SELF-ORGANIZING MAP; POSTCONCUSSION SYNDROME; CLASSIFICATION	Objectives We propose a bottom-up, machine-learning approach, for the objective vestibular and balance diagnostic data of concussion patients, to provide insight into the differences in patients' phenotypes, independent of existing diagnoses (unsupervised learning). Methods Diagnostic data from a battery of validated balance and vestibular assessments were extracted from the database of the Swiss Concussion Center. The desired number of clusters within the patient database was estimated using Calinski-Harabasz criteria. Complex (self-organizing map, SOM) and standard (k-means) clustering tools were used, and the formed clusters were compared. Results A total of 96 patients (81.3% male, age (median [IQR]): 25.0[10.8]) who were expected to suffer from sports-related concussion or post-concussive syndrome (52[140] days between diagnostic testing and the concussive episode) were included. The cluster evaluation indicated dividing the data into two groups. Only the SOM gave a stable clustering outcome, dividing the patients in group-1 (n = 38) and group-2 (n = 58). A large significant difference was found for the caloric summary score for the maximal speed of the slow phase, where group-1 scored 30.7% lower than group-2 (27.6[18.2] vs. 51.0[31.0]). Group-1 also scored significantly lower on the sensory organisation test composite score (69.0[22.3] vs. 79.0 [10.5]) and higher on the visual acuity (-0.03[0.33] vs. -0.14[0.12]) and dynamic visual acuity (0.38[0.84] vs. 0.20[0.20]) tests. The importance of caloric, SOT and DVA, was supported by the PCA outcomes. Group-1 tended to report headaches, blurred vision and balance problems more frequently than group-2 (>10% difference). Conclusion The SOM divided the data into one group with prominent vestibular disorders and another with no clear vestibular or balance problems, suggesting that artificial intelligence might help improve the diagnostic process.	[Visscher, Rosa M. S.] Swiss Fed Inst Technol, Inst Biomech, Zurich, Switzerland; [Visscher, Rosa M. S.; Feddermann-Demont, Nina; Romano, Fausto; Straumann, Dominik; Bertolini, Giovanni] Univ Zurich, Univ Hosp Zurich, Interdisciplinary Ctr Vertigo & Neurol Visual Dis, Dept Neurol, Zurich, Switzerland; [Feddermann-Demont, Nina; Romano, Fausto; Straumann, Dominik; Bertolini, Giovanni] Schulthess Clin, Swiss Concuss Ctr, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University Zurich Hospital; Schulthess Clinic	Visscher, RMS (corresponding author), Swiss Fed Inst Technol, Inst Biomech, Zurich, Switzerland.; Visscher, RMS (corresponding author), Univ Zurich, Univ Hosp Zurich, Interdisciplinary Ctr Vertigo & Neurol Visual Dis, Dept Neurol, Zurich, Switzerland.	rosa.visscher@hest.ethz.ch	Bertolini, Giovanni/W-4117-2019	Bertolini, Giovanni/0000-0003-2428-9454; Visscher, Rosa Maria Sija/0000-0003-2817-9359; Romano, Fausto/0000-0002-6166-7461				Abdi H, 2010, WIRES COMPUT STAT, V2, P433, DOI 10.1002/wics.101; Al Sayegh A, 2010, J NEUROL NEUROSUR PS, V81, P1128, DOI 10.1136/jnnp.2008.170092; [Anonymous], TKK REPORTS INFORM C; Armstrong RA, 2014, OPHTHAL PHYSL OPT, V34, P502, DOI 10.1111/opo.12131; Arneson D, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06222-0; Arthur D., 2007, P 18 ANN ACMS S, P1027, DOI DOI 10.1145/1283383.1283494; Ben Slama A, 2016, IEEE IND ELEC, P5165, DOI 10.1109/IECON.2016.7793010; Bohmer A, 1995, J Vestib Res, V5, P35; Borah Diganta, 2007, Indian J Physiol Pharmacol, V51, P395; Calinski R.B., 1974, COMMUNICATIONS STAT, V3, P1, DOI [10.1080/03610927408827101, DOI 10.1080/03610927408827101]; Caplain S, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00666; Collins MW, 2016, NEUROSURGERY, V79, P912, DOI 10.1227/NEU.0000000000001447; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Corwin DJ, 2015, J PEDIATR-US, V166, P1221, DOI 10.1016/j.jpeds.2015.01.039; Costello AB., 2005, PRACT ASSESS RES EVA, V10, P7; DAVIES DL, 1979, IEEE T PATTERN ANAL, V1, P224, DOI 10.1109/TPAMI.1979.4766909; Ding C, 2004, SIAM PROC S, P497; Ellis MJ, 2015, BRAIN INJURY, V29, P238, DOI 10.3109/02699052.2014.965207; Feddermann-Demont N, 2017, BRIT J SPORT MED, V51, P903, DOI 10.1136/bjsports-2016-097403; Fritz CO, 2012, J EXP PSYCHOL GEN, V141, P2, DOI 10.1037/a0024338; Fujimoto C, 2018, CLIN NEUROPHYSIOL, V129, P238, DOI 10.1016/j.clinph.2017.11.006; Gottshall K, 2003, LARYNGOSCOPE, V113, P1746, DOI 10.1097/00005537-200310000-00016; Incorporated NM, 2016, NEUROCOM BAL MAN SEN; Juengst SB, 2017, J CLIN EXP NEUROPSYC, V39, P513, DOI 10.1080/13803395.2016.1240758; Kelly KM, 2018, J HEAD TRAUMA REHAB, DOI [10.1097/HTR, DOI 10.1097/HTR]; Kohonen T, 2013, NEURAL NETWORKS, V37, P52, DOI 10.1016/j.neunet.2012.09.018; Kontos AP, 2017, J ATHL TRAINING, V52, P256, DOI 10.4085/1062-6050-51.11.05; Landry AP, 2019, J NEUROSURG, V131, P1235, DOI 10.3171/2018.6.JNS18607; Lin FR, 2005, ANN OTO RHINOL LARYN, V114, P777, DOI 10.1177/000348940511401007; Liu YG, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003117; MacDougall HG, 2009, NEUROLOGY, V73, P1134, DOI 10.1212/WNL.0b013e3181bacf85; Mayer AR, 2017, NEUROLOGY, V89, P623, DOI 10.1212/WNL.0000000000004214; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McInnes L, 2018, 180203426 ARXIV; Minaee Shervin, 2018, Annu Int Conf IEEE Eng Med Biol Soc, V2018, P1267, DOI 10.1109/EMBC.2018.8512556; Nanetti L, 2009, NEUROIMAGE, V47, P1666, DOI 10.1016/j.neuroimage.2009.06.014; Nielson JL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169490; Oh JH, 2016, METHOD INFORM MED, V55, P431, DOI 10.3414/ME16-01-0035; Park K, 2018, J SPORT REHABIL, V27, P485, DOI 10.1123/jsr.2016-0222; Peacock WF, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00641; Pereira F, 2009, NEUROIMAGE, V45, pS199, DOI 10.1016/j.neuroimage.2008.11.007; Peters BT, 2012, J VESTIBUL RES-EQUIL, V22, P145, DOI 10.3233/VES-2012-0440; Polzlbauer G., 2004, WORKSH DAT AN SLIEZS; Randolph C, 2005, CONCUSSION SYMPTOMS; Resch JE., 2016, BMJ OPEN SPORT EXERC, V2, pe000012, DOI [10.1136/BMJSEM-2015-000012, DOI 10.1136/BMJSEM-2015-000012]; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Sakai K, 2019, JPN J RADIOL, V37, P34, DOI 10.1007/s11604-018-0794-4; Schmid-Priscoveanu A, 1999, ACTA OTO-LARYNGOL, V119, P750, DOI 10.1080/00016489950180379; Sharp David J, 2015, Pract Neurol, V15, P172, DOI 10.1136/practneurol-2015-001087; Si B, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00606; Si B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198741; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P313, DOI 10.1097/HTR.0b013e3182915cb5; Sun Y, 2000, NEUROCOMPUTING, V34, P169, DOI 10.1016/S0925-2312(00)00292-7; Tibshirani R, 2001, J ROY STAT SOC B, V63, P411, DOI 10.1111/1467-9868.00293; Vakorin VA, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004914; van de Berg R, 2018, CURR OPIN NEUROL, V31, P111, DOI 10.1097/WCO.0000000000000526; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5; VANEGMOND AAJ, 1954, ACTA OTO-LARYNGOL, V44, P589, DOI 10.3109/00016485409127671; Vesanto J, 2000, IEEE T NEURAL NETWOR, V11, P586, DOI 10.1109/72.846731; Vesanto J., 2000, SOM TOOLBOX MATLAB 5, V57, P60; Voutilainen A, 2018, GERONTOLOGIST, V58, pE138, DOI 10.1093/geront/gnw251; Wallace B, 2016, EYE BRAIN, V8, P153, DOI 10.2147/EB.S82670; WOLD S, 1987, CHEMOMETR INTELL LAB, V2, P37, DOI 10.1016/0169-7439(87)80084-9; Worts PR, 2018, AM J SPORT MED, V46, P2004, DOI 10.1177/0363546518768750; Zhao Xinyu, 2018, Front Appl Math Stat, V4, DOI 10.3389/fams.2018.00025; Zhou GW, 2015, OTOLARYNG HEAD NECK, V152, P1133, DOI 10.1177/0194599815576720	68	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2019	14	4							e0214525	10.1371/journal.pone.0214525	http://dx.doi.org/10.1371/journal.pone.0214525			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HR2UW	30939164	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000462993900031
J	Correa, S; Puertas, S; Gutierrez, L; Asin, L; de la Fuente, JM; Grazu, V; Betancor, L				Correa, Sonali; Puertas, Sara; Gutierrez, Lucia; Asin, Laura; Martinez de la Fuente, Jesus; Grazu, Valeria; Betancor, Lorena			Design of stable magnetic hybrid nanoparticles of Si-entrapped HRP	PLOS ONE			English	Article							HORSERADISH-PEROXIDASE; ENZYME; IMMOBILIZATION; STABILIZATION; ENCAPSULATION; BIOCATALYST; PROTEIN; POLYETHYLENEIMINE	Hybrid and composite nanoparticles represent an attractive material for enzyme integration due to possible synergic advantages of the structural builders in the properties of the nanobiocatalyst. In this study, we report the synthesis of a new stable hybrid nanobiocatalyst formed by biomimetic silica (Si) nanoparticles entrapping both Horseradish Peroxidase (HRP) (EC 1.11.1.7) and magnetic nanoparticles (MNPs). We have demonstrated that tailoring of the synthetic reagents and post immobilization treatments greatly impacted physical and biocatalytic properties such as an unprecedented similar to 280 times increase in the half-life time in thermal stability experiments. The optimized nanohybrid biocatalyst that showed superparamagnetic behaviour, was effective in the batch conversion of indole-3-acetic acid, a prodrug used in Direct Enzyme Prodrug Therapy (DEPT). Our system, that was not cytotoxic per se, showed enhanced cytotoxic activity in the presence of the prodrug towards HCT-116, a colorectal cancer cell line. The strategy developed proved to be effective in obtaining a stabilized nanobiocatalyst combining three different organic/inorganic materials with potential in DEPT and other biotechnological applications.	[Correa, Sonali; Betancor, Lorena] Univ ORT Uruguay, Lab Biotecnol, Montevideo, Uruguay; [Puertas, Sara] Nanoimmunotech SL, Zaragoza, Spain; [Gutierrez, Lucia] Univ Zaragoza, Inst Nanociencia Aragon, Campus Rio Ebro,Edificio I D, Zaragoza, Spain; [Gutierrez, Lucia; Martinez de la Fuente, Jesus; Grazu, Valeria] CSIC, ICMA, Zaragoza, Spain; [Gutierrez, Lucia; Asin, Laura; Martinez de la Fuente, Jesus; Grazu, Valeria] CIBER BBN, Ctr Invest Biomed Red Bioingn Biomat & Nanomed, Madrid, Spain	University ORT Uruguay; University of Zaragoza; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Quimica y Materiales de Aragon (CEQMA); CSIC - Instituto de Ciencia de Materiales de Aragon (ICMA); CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN	Betancor, L (corresponding author), Univ ORT Uruguay, Lab Biotecnol, Montevideo, Uruguay.; Grazu, V (corresponding author), CSIC, ICMA, Zaragoza, Spain.; Grazu, V (corresponding author), CIBER BBN, Ctr Invest Biomed Red Bioingn Biomat & Nanomed, Madrid, Spain.	vgrazu@unizar.es; betancor@ort.edu.uy	de la Fuente, Jesus M/L-8361-2016; Betancor, Lorena/AAO-6710-2021; Gutierrez, Lucia/A-4305-2008; ASIN, LAURA/H-7276-2017	de la Fuente, Jesus M/0000-0003-1081-8482; Betancor, Lorena/0000-0002-0569-0499; Gutierrez, Lucia/0000-0003-2366-3598; ASIN, LAURA/0000-0003-0641-3407	ANII [POS_NAC_2015_1_109910]	ANII	SC is funded by ANII (POS_NAC_2015_1_109910).	BAHULEKAR R, 1991, ENZYME MICROB TECH, V13, P858, DOI 10.1016/0141-0229(91)90101-F; Berne C, 2006, BIOMACROMOLECULES, V7, P2631, DOI 10.1021/bm060166d; Betancor L, 2008, TRENDS BIOTECHNOL, V26, P566, DOI 10.1016/j.tibtech.2008.06.009; Betancor L, 2006, CHEM COMMUN, P3640, DOI 10.1039/b604689d; Betancor L, 2010, BIOTECHNOL GENET ENG, V27, P95, DOI 10.1080/02648725.2010.10648146; Bolivar JM, 2013, GREEN PROCESS SYNTH, V2, P541, DOI 10.1515/gps-2013-0091; Cao SL, 2014, J MATER CHEM B, V2, P5522, DOI 10.1039/c4tb00584h; Cazaban D, 2017, CURR ORG CHEM, V21, P96, DOI 10.2174/1385272821666161108103040; Chiu YR, 2012, J NANOPART RES, V14, DOI 10.1007/s11051-012-0829-1; Consolati T, 2018, ACS APPL MATER INTER, V10, P6858, DOI 10.1021/acsami.7b16639; Cui JD, 2015, APPL BIOCHEM BIOTECH, V176, P999, DOI 10.1007/s12010-015-1624-0; Fejerskov B, 2017, ADV DRUG DELIVER REV, V118, P24, DOI 10.1016/j.addr.2017.04.013; Guisan JM, 2013, METHODS MOL BIOL, V1051, P1, DOI 10.1007/978-1-62703-550-7_1; HENLEY JP, 1985, ENZYME MICROB TECH, V7, P50, DOI 10.1016/0141-0229(85)90013-4; Hyde EDER, 2016, IND ENG CHEM RES, V55, P8891, DOI 10.1021/acs.iecr.6b01839; Jackson E, 2016, PROCESS BIOCHEM, DOI [10.1016/j.procbio.2016.03.002, DOI 10.1016/J.PROCBIO.2016.03.002]; Jackson E, 2015, LANGMUIR, V31, P3687, DOI 10.1021/la504978r; Jiang YJ, 2014, ENZYME MICROB TECH, V55, P1, DOI 10.1016/j.enzmictec.2013.11.005; Johnson GR, 2017, METHODS MOL BIOL, V1504, P61, DOI 10.1007/978-1-4939-6499-4_6; Karthikeyan S, 2016, ENVIRON SCI TECHNOL, V50, P11193, DOI 10.1021/acs.est.6b03044; Krainer FW, 2015, APPL MICROBIOL BIOT, V99, P1611, DOI 10.1007/s00253-014-6346-7; Lechner CC, 2015, MAR DRUGS, V13, P5297, DOI 10.3390/md13085297; Liu J, 2015, CHEM COMMUN, V51, P13731, DOI 10.1039/c5cc04590h; Liu RR, 2016, APPL BIOCHEM BIOTECH, V178, P1612, DOI 10.1007/s12010-015-1971-x; Loncar N, 2015, APPL MICROBIOL BIOT, V99, P3351, DOI 10.1007/s00253-015-6512-6; Lopez-Gallego F, 2007, ENZYME MICROB TECH, V40, P278, DOI 10.1016/j.enzmictec.2006.04.021; Lungu CN, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17040555; Makizumi R, 2008, INT J CLIN EXP MED, V1, P117; Maximov V, 2009, J DRUG DELIV SCI TEC, V19, P311, DOI 10.1016/S1773-2247(09)50066-4; Nanayakkara S, 2014, ACS SUSTAIN CHEM ENG, V2, P1947, DOI 10.1021/sc500392k; Palomo JM, 2013, METHODS MOL BIOL, V1051, P255, DOI 10.1007/978-1-62703-550-7_17; Pavlovic M, 2018, J COLLOID INTERF SCI, V524, P114, DOI 10.1016/j.jcis.2018.04.007; Rakhi RB, 2016, SCI REP, V6, P1, DOI [10.1038/s41598-016-0001-8, DOI 10.1038/S41598-016-0001-8]; Tapias YAR, 2016, FOOD CHEM, V208, P252, DOI 10.1016/j.foodchem.2016.03.086; Ribeiro LMO, 2019, J POROUS MAT, V26, P77, DOI 10.1007/s10934-018-0615-2; Ritter DW, 2013, ENZYME MICROB TECH, V52, P279, DOI 10.1016/j.enzmictec.2013.01.004; Rodriguez F, 2004, BIOMACROMOLECULES, V5, P261, DOI 10.1021/bm034232c; Romero-Fernandez M, 2018, BIORESOURCE TECHNOL, V266, P249, DOI 10.1016/j.biortech.2018.06.070; Sahare P, 2016, NANOSCALE RES LETT, V11, DOI 10.1186/s11671-016-1605-4; Sahare P, 2014, NANOSCALE RES LETT, V9, DOI 10.1186/1556-276X-9-409; Seo JH, 2007, TRANSDUCERS EUROSENS, DOI [10.1109/SENSOR.2007.4300488, DOI 10.1109/SENSOR.2007.4300488]; Sharma SK, 2017, ANAL BIOCHEM, V535, P1, DOI 10.1016/j.ab.2017.07.019; Sipponen MH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04715-6; Temocin Z, 2018, POLYM BULL, V75, P1843, DOI 10.1007/s00289-017-2129-5; Wang M, 2015, ACS NANO, V9, P10931, DOI 10.1021/acsnano.5b04073; Wu CZ, 2015, SOFT MATTER, V11, P972, DOI 10.1039/c4sm01746c; Zakharova GS, 2011, BIOCHEMISTRY-MOSCOW+, V76, P1391, DOI 10.1134/S0006297911130037; Zamora P, 2009, BIOELECTROCHEMISTRY, V76, P100, DOI 10.1016/j.bioelechem.2009.05.006; Zdarta J, 2018, CATALYSTS, V8, DOI 10.3390/catal8020092	49	6	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2019	14	4							e0214004	10.1371/journal.pone.0214004	http://dx.doi.org/10.1371/journal.pone.0214004			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR1CY	30933987	Green Published, gold			2022-12-26	WOS:000462867000009
J	Sanzari, M; Ntouskos, V; Pirri, F				Sanzari, Marta; Ntouskos, Valsamis; Pirri, Fiora			Discovery and recognition of motion primitives in human activities	PLOS ONE			English	Article							AFFINE DIFFERENTIAL GEOMETRY; MOVEMENT PRIMITIVES; REPRESENTATION; MODELS	We present a novel framework for the automatic discovery and recognition of motion primitives in videos of human activities. Given the 3D pose of a human in a video, human motion primitives are discovered by optimizing the 'motion flux', a quantity which captures the motion variation of a group of skeletal joints. A normalization of the primitives is proposed in order to make them invariant with respect to a subject anatomical variations and data sampling rate. The discovered primitives are unknown and unlabeled and are unsupervisedly collected into classes via a hierarchical non-parametric Bayes mixture model. Once classes are determined and labeled they are further analyzed for establishing models for recognizing discovered primitives. Each primitive model is defined by a set of learned parameters. Given new video data and given the estimated pose of the subject appearing on the video, the motion is segmented into primitives, which are recognized with a probability given according to the parameters of the learned models. Using our framework we build a publicly available dataset of human motion primitives, using sequences taken from well-known motion capture datasets. We expect that our framework, by providing an objective way for discovering and categorizing human motion, will be a useful tool in numerous research fields including video analysis, human inspired motion generation, learning by demonstration, intuitive human-robot interaction, and human behavior analysis.	[Sanzari, Marta; Ntouskos, Valsamis; Pirri, Fiora] Univ Rome Sapienza, Alcor LAB, Dipartimento Ingn Informat Automat & Gest, Rome, Italy	Sapienza University Rome	Pirri, F (corresponding author), Univ Rome Sapienza, Alcor LAB, Dipartimento Ingn Informat Automat & Gest, Rome, Italy.	pirri@diag.uniroma1.it		Sanzari, Marta/0000-0002-4640-9122	EU [643950]	EU(European Commission)	This work is supported by the EU H2020 SecondHands project, url: https://secondhands.eu/; research and Innovation programme (call: H2020-ICT-2014-1, RIA) under grant agreement No 643950 (Recipient of funding F.P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abernethy B., 2013, HUMAN KINETICS, DOI [10.1214/aos/1176342360, DOI 10.1214/AOS/1176342360]; Akhter I, 2015, PROC CVPR IEEE, P1446, DOI 10.1109/CVPR.2015.7298751; Alt H, 2000, HANDBOOK OF COMPUTATIONAL GEOMETRY, P121, DOI 10.1016/B978-044482537-7/50004-8; [Anonymous], 2015, REP; ANTONIAK CE, 1974, ANN STAT, V2, P1152, DOI 10.1214/aos/1176342871; Asfour T, 2006, IEEE-RAS INT C HUMAN, P40, DOI 10.1109/ICHR.2006.321361; Azad P, 2007, IEEE INT CONF ROBOT, P2558, DOI 10.1109/ROBOT.2007.363850; Ben Amor H, 2014, IEEE INT CONF ROBOT, P2831, DOI 10.1109/ICRA.2014.6907265; Ben Mabrouk A, 2018, EXPERT SYST APPL, V91, P480, DOI 10.1016/j.eswa.2017.09.029; Nievas EB, 2011, LECT NOTES COMPUT SC, V6855, P332, DOI 10.1007/978-3-642-23678-5_39; Biess A, 2007, J NEUROSCI, V27, P13045, DOI 10.1523/JNEUROSCI.4334-06.2007; Bizzi Emilio, 1995, P495; Bouchard D, 2007, SEMANTIC SEGMENTATIO, P37; Reyes-Guzman ADL, 2014, CLIN BIOMECH, V29, P719, DOI 10.1016/j.clinbiomech.2014.06.013; Del Vecchio D, 2003, AUTOMATICA, V39, P2085, DOI 10.1016/S0005-1098(03)00250-4; Deniz O, 2014, PROCEEDINGS OF THE 2014 9TH INTERNATIONAL CONFERENCE ON COMPUTER VISION, THEORY AND APPLICATIONS (VISAPP 2014), VOL 2, P478; Endres D, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00068; Fanello SRF, 2010, LECT NOTES COMPUT SC, V6454, P616, DOI 10.1007/978-3-642-17274-8_60; FERGUSON TS, 1973, ANN STAT, V1, P209, DOI 10.1214/aos/1176342360; Fisher R, 2010, ANN OF THE BMVA, V4, P4; Flash T, 2005, CURR OPIN NEUROBIOL, V15, P660, DOI 10.1016/j.conb.2005.10.011; Flash T, 2007, BIOL CYBERN, V96, P577, DOI 10.1007/s00422-007-0145-5; Flash T, 2013, ROBOT AUTON SYST, V61, P330, DOI 10.1016/j.robot.2012.09.020; Gams A, 2016, ROBOT AUTON SYST, V75, P340, DOI 10.1016/j.robot.2015.09.011; Gao Y, 2016, IMAGE VISION COMPUT, V48-49, P37, DOI 10.1016/j.imavis.2016.01.006; Gates DH, 2016, AM J OCCUP THER, V70, DOI 10.5014/ajot.2016.015487; Ghanem B., 2017, ARXIV171008011; Gong D, 2014, IEEE T PATTERN ANAL, V36, P1414, DOI 10.1109/TPAMI.2013.244; Hamill J, 2006, BIOMECHANICAL BASIS; Hasan M., 2016, CVPR; Hassner T., 2012, P 2012 IEEE COMPUTER, P1, DOI DOI 10.1109/CVPRW.2012.6239348; Hogan N, 2012, BIOL CYBERN, V106, P727, DOI 10.1007/s00422-012-0527-1; Holte MB, 2010, COMPUT VIS IMAGE UND, V114, P1353, DOI 10.1016/j.cviu.2010.07.012; Ijspeert AJ, 2013, NEURAL COMPUT, V25, P328, DOI 10.1162/NECO_a_00393; Ionescu C, 2014, IEEE T PATTERN ANAL, V36, P1325, DOI 10.1109/TPAMI.2013.248; Jain S, 2004, J COMPUT GRAPH STAT, V13, P158, DOI 10.1198/1061860043001; Kanazawa A, 2018, IEEE C COMP VIS PATT; Kober J., 2009, PROC NEURAL INF PROC, P849; Kooij JFP, 2016, COMPUT VIS IMAGE UND, V144, P106, DOI 10.1016/j.cviu.2015.06.009; LACQUANITI F, 1983, ACTA PSYCHOL, V54, P115, DOI 10.1016/0001-6918(83)90027-6; Li Y, 2010, PROC CVPR IEEE, P2630, DOI 10.1109/CVPR.2010.5539977; Lillo I., 2016, CVPR; Lin HT, 2007, MACH LEARN, V68, P267, DOI 10.1007/s10994-007-5018-6; Loper M, 2015, ACM T GRAPHIC, V34, DOI 10.1145/2816795.2818013; Loper M, 2014, ACM T GRAPHIC, V33, DOI 10.1145/2661229.2661273; Lu C., 2013, ICCV; Lu CW, 2013, IEEE I CONF COMP VIS, P2720, DOI 10.1109/ICCV.2013.338; Lu JS, 2015, PROC CVPR IEEE, P3762, DOI 10.1109/CVPR.2015.7299000; Luo RK, 2015, IEEE INT C INT ROBOT, P2426, DOI 10.1109/IROS.2015.7353706; MAHADEVAN V, 2010, PROC CVPR IEEE, P1975, DOI DOI 10.1109/CVPR.2010.5539872; Mandery C, 2015, PROCEEDINGS OF THE 17TH INTERNATIONAL CONFERENCE ON ADVANCED ROBOTICS (ICAR), P329, DOI 10.1109/ICAR.2015.7251476; Maoz U, 2014, J NEUROPHYSIOL, V111, P336, DOI 10.1152/jn.01071.2012; MARR D, 1982, PROC R SOC SER B-BIO, V214, P501, DOI 10.1098/rspb.1982.0024; Moeslund TB, 2006, COMPUT VIS IMAGE UND, V104, P90, DOI 10.1016/j.cviu.2006.08.002; Mohammadi S, 2016, LECT NOTES COMPUT SC, V9911, P3, DOI 10.1007/978-3-319-46478-7_1; Mohammadi S, 2015, 2015 12TH INTERNATIONAL IRANIAN SOCIETY OF CRYPTOLOGY CONFERENCE ON INFORMATION SECURITY AND CRYPTOLOGY (ISCISC), P6, DOI 10.1109/ISCISC.2015.7387890; Moro Federico L, 2012, Front Neurorobot, V6, P10, DOI 10.3389/fnbot.2012.00010; Mousavi H, 2015, IEEE WINT CONF APPL, P148, DOI 10.1109/WACV.2015.27; Natola F, 2015, THESIS; Natola F, 2015, IEEE I CONF COMP VIS, P4606, DOI 10.1109/ICCV.2015.523; Ntouskos Valsamis, 2013, Proceedings of the 2nd International Conference on Pattern Recognition Applications and Methods. ICPRAM 2013, P87; Ntouskos V, 2015, ADV INTELL SYST, V318, P137, DOI 10.1007/978-3-319-12610-4_9; Park DH, 2008, IEEE-RAS INT C HUMAN, P91, DOI 10.1109/ICHR.2008.4755937; Pastor P., 2009, IEEE INT C ROB AUT, P763, DOI DOI 10.1109/ROBOT.2009.5152385; Pirri F, 2011, KNOWING REASONING AC; Platt JC, 2000, ADV NEUR IN, P61; Polyakov F, 2017, BIOL CYBERN, V111, P5, DOI 10.1007/s00422-016-0705-7; Sanzari M, 2016, LECT NOTES COMPUT SC, V9912, P566, DOI 10.1007/978-3-319-46484-8_34; Scholkopf B., 2001, LEARNING KERNELS; Gracia IS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120448; Soomro K., 2012, UCF101 ACTION RECOGN; Sultani W., 2018, REAL WORLD ANOMALY D; Tekin B, 2016, PROC CVPR IEEE, pCP8, DOI 10.1109/CVPR.2016.113; Ting LH, 2015, NEURON, V86, P38, DOI 10.1016/j.neuron.2015.02.042; Tome Denis, 2017, CVPR 2017 P, P2500; Turaga P, 2008, IEEE T CIRC SYST VID, V18, P1473, DOI 10.1109/TCSVT.2008.2005594; Ureche ALP, 2015, IEEE T ROBOT; Vapnik V., 2013, NATURE STAT LEARNING; Varol Gul, 2017, 2017 IEEE C COMP VIS; VIVIANI P, 1995, J EXP PSYCHOL HUMAN, V21, P32, DOI 10.1037/0096-1523.21.1.32; Viviani P, 1991, J EXPT PSYCHOL HUMAN, V17; Weinland D, 2006, P IEEE C COMP VIS PA, P1639; West M., 1992, 92A03 ISDS DUK U; Xu L, 2014, INT CONF ACOUST SPEE; Yang Y, 2013, IEEE T PATTERN ANAL, V35, P1635, DOI 10.1109/TPAMI.2012.253; Zhou PP, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203668; Zhou X., 2016, CVPR	88	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2019	14	4							e0214499	10.1371/journal.pone.0214499	http://dx.doi.org/10.1371/journal.pone.0214499			39	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR1CY	30933990	Green Submitted, gold, Green Published			2022-12-26	WOS:000462867000017
J	Schmidt, MJ; Knemeyer, C; Heinsen, H				Schmidt, Martin J.; Knemeyer, Carola; Heinsen, Helmut			Neuroanatomy of the equine brain as revealed by high-field (3Tesla) magnetic-resonance-imaging	PLOS ONE			English	Article							CEREBRAL-CORTEX; HYDROCEPHALUS; MAMMALS; FOAL	In this study, the morphology of the horse brain (Equus caballus) is decribed in detail using high field MRI. The study includes sagittal, dorsal, and transverse T2-weighted images at 0.25 mm resolution at 3 Tesla and 3D models of the brain presenting the external morphology of the brain. Representative gallocyanin stained histological slides of the same brain are presented. The images represent a useful tool for MR image interpretation in horses and may serve as a starting point for further research aiming at in vivo analysis in this species.	[Schmidt, Martin J.; Knemeyer, Carola] Justus Liebig Univ, Small Anim Clin Neurosurg Neuroradiol & Clin Neur, Giessen, Germany; [Heinsen, Helmut] Univ Hosp, Mental Hlth Ctr, Dept Psychiat Psychosomat & Psychotherapy, Wurzburg, Germany; [Heinsen, Helmut] Univ Sao Paulo, Dept Pathol, Med Sch, Sao Paulo, Brazil	Justus Liebig University Giessen; University of Wurzburg; Universidade de Sao Paulo	Schmidt, MJ (corresponding author), Justus Liebig Univ, Small Anim Clin Neurosurg Neuroradiol & Clin Neur, Giessen, Germany.	Martin.J.Schmidt@vetmed.uni-giessen.de						Adrian ED, 1943, BRAIN, V66, P89, DOI 10.1093/brain/66.2.89; [Anonymous], 2012, NOM AN VET; Arencibia A, 2001, VET RADIOL ULTRASOUN, V42, P405, DOI 10.1111/j.1740-8261.2001.tb00959.x; Audigie F, 2004, VET RADIOL ULTRASOUN, V45, P210, DOI 10.1111/j.1740-8261.2004.04035.x; Back W., 2013, EQUINE LOCOMOTION, V2nd; Barton RA, 2000, NATURE, V405, P1055, DOI 10.1038/35016580; Becht K., 1987, THESIS; Bolk L, 1906, CEREBELLUM SAUGETIER; Bradley O C, 1899, J Anat Physiol, V33, P587; Brauer K, 1970, KATALOG SAUGETIERGEH, V2; Brettschneider H., 1955, Gegenbaurs Jahrbuch, V96, P265; Cavalleri JMV, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-105; Chaffin MK, 1997, VET RADIOL ULTRASOUN, V38, P102, DOI 10.1111/j.1740-8261.1997.tb00823.x; Chukwuezie CI, 2008, THESIS, P49; Constantinescu M, 1992, ILLUSTRATED VET ANAT; de No RL, 1934, J PSYCHOL NEUROL, V46, P113; De Zani D, 2013, EQUINE VET EDUC, V25, P493, DOI 10.1111/eve.12003; DONE JT, 1968, RES VET SCI, V9, P143; Done JT, 1986, LAB ANIM, V2, P207; Dyson PK, 2007, EQUINE VET EDUC, V19, P173, DOI 10.2746/095777307X190771; Edinger T., EVOLUTION HORSE BRAI; Ellenberger W., 1977, HDB VERGLEICHENDEN A, V18; Felix B, 1999, BRAIN RES BULL, V49, P1, DOI 10.1016/S0361-9230(99)00012-X; Ferrell EA, 2002, VET RADIOL ULTRASOUN, V43, P510, DOI 10.1111/j.1740-8261.2002.tb01041.x; Forel A., 1877, ARCH F R PSYCHIATR N, V7, P393, DOI [10.1007/BF02041873, DOI 10.1007/BF02041873]; Heinsen H, 2000, J CHEM NEUROANAT, V20, P49, DOI 10.1016/S0891-0618(00)00067-3; HOFMAN MA, 1985, BRAIN BEHAV EVOLUT, V27, P28, DOI 10.1159/000118718; Holmes SP, 2014, EQUINE VET EDUC, V26, P605, DOI 10.1111/eve.12039; Hummel G, 1976, Zentralbl Veterinarmed C, V5, P35; Jost K., 1992, THESIS; Kuhlenbeck H., 1927, VORLESUNGEN ZENTRALN; Lassek AM, 1942, J COMP NEUROL, V77, P399, DOI 10.1002/cne.900770205; Manso-Diaz G, 2015, VET RADIOL ULTRASOUN, V56, P176, DOI 10.1111/vru.12210; Maulet BEB, 2008, EQUINE VET EDUC, V20, P74, DOI 10.2746/095777308X273787; McGann JP, 2017, SCIENCE, V356, DOI 10.1126/science.aam7263; Nickel R, 1992, LEHRBUCH ANATOMIE HA, VIV; Nieuwenhuys R., 1998, CENTRAL NERVOUS SYST; Niimi K., 1950, COMP ANATOMICAL STUD; Nitzsche B, 2015, FRONT NEUROANAT, V9, DOI 10.3389/fnana.2015.00069; Oey L, 2011, TIERAERZTL PRAX G N, V39, P41; Pillay P, 2007, EUR J NEUROSCI, V25, P2705, DOI 10.1111/j.1460-9568.2007.05524.x; Pongratz MC, 2010, PFERDEHEILKUNDE, V26, P559, DOI 10.21836/PEM20100410; Porter EG, 2014, VET CLIN N AM-EQUINE, V30, P239, DOI 10.1016/j.cveq.2013.11.001; Russo D, 2008, ACTA HISTOCHEM, V110, P245, DOI 10.1016/j.acthis.2007.10.015; Sakamoto K., 1957, REPORTS 2 SECTION AN; Sanders SG, 2001, VET RADIOL ULTRASOUN, V42, P291, DOI 10.1111/j.1740-8261.2001.tb00942.x; Schellenberg K., 1900, THESIS; Schmidt M., 2006, THESIS; Schmidt MJ, 2009, J MORPHOL, V270, P745, DOI 10.1002/jmor.10717; Schmidt MJ, 2011, VET J; Schober W., 1974, Handbuch der Zoologie, V8, P1; SCHULZ L. -C., 1953, ANAT ANZ, V100, P65; Staudacher A, 2014, BMC VET RES, V10, DOI 10.1186/s12917-014-0216-5; STEPHAN H, 1983, NEUROSCI BIOBEHAV R, V7, P367, DOI 10.1016/0149-7634(83)90041-6; Takeuchi Tamaki, 2001, Acta Anatomica Nipponica, V76, P213; Tucker RL, 2001, VET CLIN N AM-EQUINE, V17, P131, DOI 10.1016/S0749-0739(17)30079-2; VOOGD J, 1998, CENTRAL NERVOUS SYST, P1724; WOOLSEY CN, 1946, SURGERY, V19, P684; Yoshikawa T., 1968, ATLAS BRAIN DOMESTIC	59	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2019	14	4							e0213814	10.1371/journal.pone.0213814	http://dx.doi.org/10.1371/journal.pone.0213814			49	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR1CY	30933986	Green Submitted, Green Published, gold			2022-12-26	WOS:000462867000007
J	Bhandari, R; Pokhrel, KN; Gabrielle, N; Amatya, A				Bhandari, Rajan; Pokhrel, Khem Narayan; Gabrielle, Nguyen; Amatya, Archana			Long acting reversible contraception use and associated factors among married women of reproductive age in Nepal	PLOS ONE			English	Article								Modern contraceptives are highly effective and proven means of preventing unintended pregnancy and reducing maternal mortality. Social and economic characteristics are some of the key determinants of health and utilization family planning. However, studies examining the factors associated with utilization of long acting reversible contraception (LARC) are limited in Nepal. This study assessed the factors associated with utilization of LARC methods among married women of reproductive age in Nepal. Secondary data analysis was conducted using the 2016 Nepal Demographic and Health Survey (NDHS). A logistic regression model examined the association of socioeconomic, demographic, or fertility related characteristics with the use of LARCs among 9875 ever married women of reproductive age. The overall utilization rate of LARC in this study was 4.7%. Women in the age group of <25 years (AOR: 0.65, 95% CI: 0.45-0.92) and 25-35 years (AOR: 0.70, 95% CI: 0.56-0.89), having husbands with primary education (AOR:0.71; 95%CI: 0.64-0.84) and no education (AOR: 0.54; 95%CI: 0.38-0.73), belonging to Janajatis (AOR: 0.55; 95%CI: 0.42-0.71) and Newars (AOR: 0.29; 95%CI: 0.19-42), poor wealth quintile (AOR: 0.60; 95% CI: 0.45-0.86) had negative association with LARC use. On the other hand, women having their husband as a skilled worker (AOR: 1.49; 95%CI: 1.10-2), having two or less than two children (AOR: 1.46; 95% CI: 1.15-1.186), and having desire for children in future (AOR: 3.24; 95% CI: 2.29-4.57) had positive association with the use of LARC. In this study, younger women's age, low or no husband's education, from indigenous community such as Janajati and Newer, being in lowest wealth quintile negatively influenced the use of LARC. Conversely, women having her husband as skilled worker, parity less than two, and desire of having future children, positively influenced the use of LARC. The study highlights the need to reach women who were in the lower socioeconomic background to improve LARC use.	[Bhandari, Rajan] GHAN, Kathmandu, Nepal; [Pokhrel, Khem Narayan] Georgetown Univ, Inst Reprod Hlth, Airport Gate Area, Kathmandu, Nepal; [Gabrielle, Nguyen] Save Children, Washington, DC USA; [Amatya, Archana] Tribhuvan Univ, Dept Community Med & Publ Hlth, Inst Med, Kathmandu, Nepal	Save the Children; Tribhuvan University; Institute of Medicine (IoM) - Nepal	Bhandari, R (corresponding author), GHAN, Kathmandu, Nepal.	rjbhandari11@gmail.com	pokhrel, khem/AAT-6102-2021	pokhrel, khem/0000-0001-6956-1672				Abdisa B, 2017, ANAT PHYSL, V07, P2, DOI [10.4172/2161-0940.1000254, DOI 10.4172/2161-0940.1000254]; ACOG Committee, 2018, OBS GYNECOL, V131, P130; Azmoude E, 2017, WOOMENS HLTH B, V4; Bagade O., 2014, WORLD J PHARM PHARM, V3, P364; Baldwin MK, 2013, J ADOLESCENT HEALTH, V52, pS47, DOI 10.1016/j.jadohealth.2012.10.278; Biza N, 2017, LONG ACTING REVERSIB, V4, P469; Budihastuti UR, 2014, E JAVA APPL SOCIAL C, V1172, P313; Chandra-Mouli V, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-1; Dempsey AR, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2012.02.014; Desta SA., 2017, SCIENCE, V5, P428, DOI [10.11648/j.sjph.20170506.14, DOI 10.11648/J.SJPH.20170506.14]; Dockalova BLK, 2016, SUSTAINABLE DEV GOAL; Earsido A., 2015, J PREG CHILD HLTH, V2, P165; Frost JJ, 2008, PERSPECT SEX REPRO H, V40, P94, DOI 10.1363/4009408; Getinet S., 2014, GREENER J EPIDEMIOL, V2, P23, DOI [10.15580/GJEPH.2014.1.070514294, DOI 10.15580/GJEPH.2014.1.070514294]; Gudaynhe SW, 2014, GLOB J MED RES, V14; Gultie T, 2016, QUAL PRIM CARE, V24, P17; ICF International, 2012, MEASURE DHS, P41; Johnson OE, 2017, AFR J REPROD HEALTH, V21, P89, DOI 10.29063/ajrh2017/v21i3.8; Lotke PS, 2015, OBSTET GYN CLIN N AM, V42, P557, DOI 10.1016/j.ogc.2015.07.008; Manoj PDS, 2015, IEEE T COMPUT, V64, P3022, DOI 10.1109/TC.2015.2389827; Ministry of Health and Population, 2015, NAT FAM PLANN COST I, V39, P90; Ministry of Health and Population (MoHP), 2015, NEP HLTH SECT STRAT, P75; Ministry of Health Nepal; New ERA; and ICF, 2017, NEP DEM HLTH SURV 20; Ministry of Health (Nepal) New Era Macro International, 1996, NEP DEM HLTH SURV; Mishra MK, 2011, ETHNIC DISPARITIES C, V6, P14; Mustafa R, 2008, JCPSP-J COLL PHYSICI, V18, P542, DOI 09.2008/JCPSP.542545; Rose SB, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2011.06.102; Senarath U, 2009, ASIA-PAC J PUBLIC HE, V21, P137, DOI 10.1177/1010539509331590; Sharma SK, 2011, DEMOGR RES, V25, P837, DOI 10.4054/DemRes.2011.25.27; Melka AS, 2015, PAN AFR MED J, V21, DOI 10.11604/pamj.2015.21.246.5835; Tamang L, 2017, CONTRACEP REPROD MED, V2, DOI 10.1186/s40834-017-0040-y; Tekelab T., 2015, FAM MED MED SCI RES, V4, P2, DOI [10.4172/2327-4972.1000158, DOI 10.4172/2327-4972.1000158]; Tibaijuka L, 2017, BMC WOMENS HEALTH, V17, DOI 10.1186/s12905-017-0382-2; Townsend JW, 2007, CONTRACEPTION, V75, pS35, DOI 10.1016/j.contraception.2007.01.023; Wasti S P, 2017, Kathmandu Univ Med J (KUMJ), V15, P222; World Health Organisation, 2007, REP WHO TECHN CONS B, P34; World Health Organization, 2018, INT SOC BEH CHANG CO; Yalew Saleamlak Adbaru, 2015, BMC Res Notes, V8, P29, DOI 10.1186/s13104-015-0974-6	38	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2019	14	3							e0214590	10.1371/journal.pone.0214590	http://dx.doi.org/10.1371/journal.pone.0214590			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ7IR	30921403	gold, Green Published, Green Submitted			2022-12-26	WOS:000462594000092
J	Pirim, D; Radwan, ZH; Wang, XB; Niemsiri, V; Hokanson, JE; Hamman, RF; Feingold, E; Bunker, CH; Demirci, FY; Kamboh, MI				Pirim, Dilek; Radwan, Zaheda H.; Wang, Xingbin; Niemsiri, Vipavee; Hokanson, John E.; Hamman, Richard F.; Feingold, Eleanor; Bunker, Clareann H.; Demirci, F. Yesim; Kamboh, M. Ilyas			Apolipoprotein E-C1-C4-C2 gene cluster region and inter-individual variation in plasma lipoprotein levels: a comprehensive genetic association study in two ethnic groups	PLOS ONE			English	Article							HEPATIC CONTROL REGION; GENOME-WIDE ASSOCIATION; HEART-DISEASE RISK; SAN-LUIS-VALLEY; LIPID-LEVELS; DENSITY LIPOPROTEINS; RARE VARIANTS; I GENE; POLYMORPHISM; POPULATION	The apolipoprotein E-C1-C4-C2 gene cluster at 19q13.32 encodes four amphipathic apolipo proteins. The influence of APOE common polymorphisms on plasma lipid/lipoprotein profile, especially on LDL-related traits, is well recognized; however, little is known about the role of other genes/variants in this gene cluster. In this study, we evaluated the role of common and uncommon/rare genetic variation in this gene region on inter-individual variation in plasma lipoprotein levels in non-Hispanic Whites (NHWs) and African blacks (ABs). In the variant discovery step, the APOE, APOC1, APOC4, APOC2 genes were sequenced along with their flanking and hepatic control regions (HCR1 and HCR2) in 190 subjects with extreme HDL-C/TG levels. The next step involved the genotyping of 623 NHWs and 788 ABs for the identified uncommon/rare variants and common tagSNPs along with additional relevant SNPs selected from public resources, followed by association analyses with lipid traits. A total of 230 sequence variants, including 15 indels were identified, of which 65 were novel. A total of 70 QC-passed variants in NHWs and 108 QC-passed variants in ABs were included in the final association analyses. Single-site association analysis of SNPs with MAF>1% revealed 20 variants in NHWs and 24 variants in ABs showing evidence of association with at least one lipid trait, including several variants exhibiting independent associations from the established APOE polymorphism even after multiple-testing correction. Overall, our study has confirmed known associations and also identified novel associations in this genomic region with various lipid traits. Our data also support the contribution of both common and uncommon/rare variation in this gene region in affecting plasma lipid profile in the general population.	[Pirim, Dilek; Radwan, Zaheda H.; Wang, Xingbin; Niemsiri, Vipavee; Feingold, Eleanor; Demirci, F. Yesim; Kamboh, M. Ilyas] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA; [Pirim, Dilek] Uludag Univ, Fac Arts & Sci, Dept Mol Biol & Genet, Gorukle, Bursa, Turkey; [Hokanson, John E.; Hamman, Richard F.] Univ Colorado Denver, Colorado Sch Publ Hlth, Dept Epidemiol, Aurora, CO USA; [Bunker, Clareann H.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Uludag University; Children's Hospital Colorado; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Demirci, FY; Kamboh, MI (corresponding author), Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA.	fyd1@pitt.edu; kamboh@pitt.edu	PIRIM, DILEK/ABA-4957-2020	PIRIM, DILEK/0000-0002-0522-9432	National Heart, Lung and Blood Institute (NHLBI) [HL084613]	National Heart, Lung and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by the National Heart, Lung and Blood Institute (NHLBI) grant, HL084613.	ALLAN CM, 1995, J BIOL CHEM, V270, P26278, DOI 10.1074/jbc.270.44.26278; Allan CM, 1997, J BIOL CHEM, V272, P29113, DOI 10.1074/jbc.272.46.29113; Allan CM, 1996, J LIPID RES, V37, P1510; Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Beekman M, 2003, EUR J HUM GENET, V11, P845, DOI 10.1038/sj.ejhg.5201053; BUNKER CH, 1995, HYPERTENSION, V26, P616, DOI 10.1161/01.HYP.26.4.616; Bunker CH, 1996, ATHEROSCLEROSIS, V123, P215, DOI 10.1016/0021-9150(96)05810-8; Cai YP, 2009, J EPIDEMIOL, V19, P260, DOI 10.2188/jea.JE20081037; Chasman DI, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000730; Cohen J, 2005, NAT GENET, V37, P328, DOI 10.1038/ng0305-328c; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Coram MA, 2013, AM J HUM GENET, V92, P904, DOI 10.1016/j.ajhg.2013.04.025; DANG Q, 1995, J BIOL CHEM, V270, P22577, DOI 10.1074/jbc.270.38.22577; de Haan W, 2008, BIOCHEM BIOPH RES CO, V377, P1294, DOI 10.1016/j.bbrc.2008.10.147; Gao Li, 2002, BMC Med Genet, V3, P13, DOI 10.1186/1471-2350-3-13; Gautier T, 2000, J BIOL CHEM, V275, P37504, DOI 10.1074/jbc.M007210200; HAMMAN RF, 1989, AM J EPIDEMIOL, V129, P295, DOI 10.1093/oxfordjournals.aje.a115134; Harris MR, 1998, ATHEROSCLEROSIS, V137, P187, DOI 10.1016/S0021-9150(97)00230-X; HAVEL RJ, 1983, J CLIN INVEST, V72, P379, DOI 10.1172/JCI110978; Jeemon P, 2011, WORLD J CARDIOL, V3, P230, DOI 10.4330/wjc.v3.i7.230; Johansen CT, 2012, CURR ATHEROSCLER REP, V14, P227, DOI 10.1007/s11883-012-0243-2; Johansen CT, 2010, NAT GENET, V42, P684, DOI 10.1038/ng.628; Jong MC, 1999, ARTERIOSCL THROM VAS, V19, P472, DOI 10.1161/01.ATV.19.3.472; Kamboh MI, 1997, AM J EPIDEMIOL, V146, P1011, DOI 10.1093/oxfordjournals.aje.a009229; Ken-Dror G, 2010, MOL MED, V16, P389, DOI 10.2119/molmed.2010.00044; Klos K, 2008, HUM MOL GENET, V17, P2039, DOI 10.1093/hmg/ddn101; Klos KLE, 2006, ARTERIOSCL THROM VAS, V26, P1828, DOI 10.1161/01.ATV.0000231523.19199.45; Kones R, 2011, DRUG DES DEV THER, V5, P325, DOI 10.2147/DDDT.S14934; Kotowski IK, 2006, AM J HUM GENET, V78, P410, DOI 10.1086/500615; Kraja AT, 2011, DIABETES, V60, P1329, DOI 10.2337/db10-1011; Lake SL, 2003, HUM HERED, V55, P56, DOI 10.1159/000071811; Lambert JC, 2000, HUM MOL GENET, V9, P57, DOI 10.1093/hmg/9.1.57; LAUER SJ, 1988, J BIOL CHEM, V263, P7277; Lee S, 2012, BIOSTATISTICS, V13, P762, DOI 10.1093/biostatistics/kxs014; Lettre G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001300; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; LI WH, 1988, J LIPID RES, V29, P245; Lusis MJ, 2004, ANNU REV GENOM HUM G, V5, P189, DOI [10.1146/annurev.genom.5.061903.175930, 10.1016/j.tig.2012.03.001]; MIETTINEN TA, 1992, ARTERIOSCLER THROMB, V12, P1044, DOI 10.1161/01.ATV.12.9.1044; Moreno JA, 2003, J LIPID RES, V44, P2059, DOI 10.1194/jlr.M300124-JLR200; Musunuru K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036473; Ozturk Z, 2010, METAB SYNDR RELAT D, V8, P531, DOI 10.1089/met.2010.0034; Pollin TI, 2008, SCIENCE, V322, P1702, DOI 10.1126/science.1161524; Radwan ZH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114618; RALL SC, 1989, J CLIN INVEST, V83, P1095, DOI 10.1172/JCI113988; Retz W, 2001, PSYCHIATR GENET, V11, P115, DOI 10.1097/00041444-200109000-00002; Rewers Marian, 1993, Ethnicity and Disease, V3, P44; Romeo S, 2007, NAT GENET, V39, P513, DOI 10.1038/ng1984; SHACHTER NS, 1993, J LIPID RES, V34, P1699; Shi J, 2004, ACTA NEUROL SCAND, V109, P140, DOI 10.1034/j.1600-0404.2003.00193.x; Silander K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003615; SIMONET WS, 1993, J BIOL CHEM, V268, P8221; Son KY, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0111-5; Surakka I, 2015, NAT GENET, V47, P589, DOI 10.1038/ng.3300; Talmud PJ, 2009, AM J HUM GENET, V85, P628, DOI 10.1016/j.ajhg.2009.10.014; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Waterworth DM, 2010, ARTERIOSCL THROM VAS, V30, P2264, DOI 10.1161/ATVBAHA.109.201020; WEISGRABER KH, 1990, J BIOL CHEM, V265, P22453; Weissglas-Volkov D, 2010, J LIPID RES, V51, P2032, DOI 10.1194/jlr.R004739; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Xu Y, 1999, J LIPID RES, V40, P50	62	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2019	14	3							e0214060	10.1371/journal.pone.0214060	http://dx.doi.org/10.1371/journal.pone.0214060			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ3IW	30913229	Green Submitted, gold, Green Published			2022-12-26	WOS:000462305600025
J	Spaunhorst, DJ; Nie, HZ; Todd, JR; Young, JM; Young, BG; Johnson, WG				Spaunhorst, Douglas J.; Nie, Haozhen; Todd, James R.; Young, Julie M.; Young, Bryan G.; Johnson, William G.			Confirmation of herbicide resistance mutations Trp574Leu, Delta G210, and EPSPS gene amplification and control of multiple herbicide-resistant Palmer amaranth (Amaranthus palmeri) with chlorimuron-ethyl, fomesafen, and glyphosate	PLOS ONE			English	Article							NONTARGET-SITE RESISTANCE; INHIBITING HERBICIDES; WEED-CONTROL; ALS; RUDIS; TUBERCULATUS; RETROFLEXUS; IMAZETHAPYR; POPULATION; MANAGEMENT	Herbicide-resistant weeds, especially Palmer amaranth (Amaranthus palmeri S. Watson), are problematic in row-crop producing areas of the United States. The objectives of this study were to determine if chlorimuron-ethyl, fomesafen, and glyphosate applied separately and in mixtures control A. palmeri and confirm the presence of various genotypes surviving two- and three-way herbicide mixtures. Fifteen percent of A. palmeri treated with the three-way herbicide mixture survived. Mixing fomesafen with chlorimuron-ethyl or fomesafen with glyphosate to create a two-way mixture reduced A. palmerisurvival 22 to 24% and 60 to 62% more than glyphosate and chlorimuron-ethyl alone, respectively. Previously characterized mutations associated with A. palmeri survival to chlorimuron-ethyl, fomesafen, and glyphosate Trp(574)Leu, a missing glycine codon at position 210 of the PPX2L gene (Delta G210), and 5-enolpyruvylshikimate-3-phosphase synthase (EPSPS) gene amplification; respectively, were present in surviving plants. However, 37% of plants treated with chlorimuronethyl did not contain heterozygous or homozygous alleles for the Trp(574)Leu mutation, suggesting alternative genotypes contributed to plant survival. All surviving A. palmeri treated with fomesafen or glyphosate possessed genotypes previously documented to confer resistance. Indiana soybean [Glycine max (L.) Merr] fields infested with A. palmeri possessed diverse genotypes and herbicide surviving plants are likely to produce seed and spread if alternative control measures are not implemented.	[Spaunhorst, Douglas J.; Todd, James R.] ARS, USDA, Sugarcane Res Unit, Houma, LA 70360 USA; [Nie, Haozhen; Young, Julie M.; Young, Bryan G.; Johnson, William G.] Purdue Univ, Dept Bot & Plant Pathol, W Lafayette, IN 47907 USA	United States Department of Agriculture (USDA); Purdue University System; Purdue University; Purdue University West Lafayette Campus	Spaunhorst, DJ (corresponding author), ARS, USDA, Sugarcane Res Unit, Houma, LA 70360 USA.	Douglas.Spaunhorst@usda.gov	Johnson, William G/R-5507-2017	Johnson, William G/0000-0001-9145-1058	United Soybean Board	United Soybean Board	The research was funded by the United Soybean Board. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to recognize the United Soybean Board for funding this research. The authors would also like to thank the Purdue Weed Science graduate students and program technicians: Dustin Johnson, Travis Legleiter, and Joe Ikley for reviewing this manuscript. No conflicts of interest have been declared. Mention of trade names or commercial products does not imply recommendation or endorsement by the U.S. Department of Agriculture. USDA is an equal opportunity provider and employer.	Bagavathiannan MV, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148748; Beckie HJ, 2006, WEED TECHNOL, V20, P793, DOI 10.1614/WT-05-084R1.1; Burgos NR, 2015, WEED SCI, V63, P152, DOI 10.1614/WS-D-14-00019.1; Chahal PS, 2017, WEED TECHNOL, V31, P80, DOI 10.1614/WT-D-16-00109.1; Crespo RJ, 2017, WEED SCI, V65, P743, DOI 10.1017/wsc.2017.39; Culpepper AS, 2006, WEED SCI, V54, P620, DOI 10.1614/WS-06-001R.1; Culpepper AS, 2006, WEED TECHNOL, V20, P277, DOI 10.1614/WT-04-155R.1; Dill GM, 2008, PEST MANAG SCI, V64, P326, DOI 10.1002/ps.1501; Fernandez-Cornejo Jorge, 2014, ADOPTION GENETICALLY; Foes MJ, 1999, WEED SCI, V47, P20, DOI 10.1017/S0043174500090603; FREAR DS, 1983, PESTIC BIOCHEM PHYS, V20, P299, DOI 10.1016/0048-3575(83)90104-9; Gaines TA, 2010, P NATL ACAD SCI USA, V107, P1029, DOI 10.1073/pnas.0906649107; Giacomini D, 2014, WEED SCI, V62, P29, DOI 10.1614/WS-D-13-00066.1; Giacomini DA, 2017, PEST MANAG SCI, V73, P1559, DOI 10.1002/ps.4581; Green JM, 2014, PEST MANAG SCI, V70, P1351, DOI 10.1002/ps.3727; Guo JQ, 2015, WEED SCI, V63, P399, DOI 10.1614/WS-D-14-00139.1; HARRIS JR, 1991, J PROD AGRIC, V4, P407, DOI 10.2134/jpa1991.0407; Heap I., 2017, INT SURVEY HERBICIDE; Huang ZF, 2016, PESTIC BIOCHEM PHYS, V128, P10, DOI 10.1016/j.pestbp.2015.10.011; Jhala AJ, 2014, WEED TECHNOL, V28, P28, DOI 10.1614/WT-D-13-00090.1; Johnson WG, 2009, EUR J AGRON, V31, P162, DOI 10.1016/j.eja.2009.03.008; Kohrt JR, 2017, WEED SCI, V65, P327, DOI 10.1017/wsc.2017.2; LIVAK KJ, 1995, NAT GENET, V9, P341, DOI 10.1038/ng0495-341; McNaughton KE, 2005, WEED SCI, V53, P17, DOI 10.1614/WS-04-109; Meyer CJ, 2015, WEED TECHNOL, V29, P716, DOI 10.1614/WT-D-15-00045.1; Molin WT, 2016, WEED SCI, V64, P240, DOI 10.1614/WS-D-15-00172.1; Nandula VK, 2012, WEED SCI, V60, P179, DOI 10.1614/WS-D-11-00157.1; Pline WA, 2002, WEED TECHNOL, V16, P737, DOI 10.1614/0890-037X(2002)016[0737:PWCISG]2.0.CO;2; Saghai-Maroof MA, 1984, P NATL ACAD SCI USA, V103, P12329; Salas RA, 2016, PEST MANAG SCI, V72, P864, DOI 10.1002/ps.4241; Schultz JL, 2015, WEED SCI, V63, P336, DOI 10.1614/WS-D-14-00102.1; Shaw DR, 2002, WEED TECHNOL, V16, P1, DOI 10.1614/0890-037X(2002)016[0001:WCFHCW]2.0.CO;2; Singh S, 2018, WEED SCI, V66, P293, DOI 10.1017/wsc.2017.83; Spaunhorst DJ, 2016, CROP FORAGE TURFGRAS, V2, P1; Spaunhorst DJ, 2018, WEED SCI, V66, P457, DOI 10.1017/wsc.2018.12; Spaunhorst DJ, 2017, WEED SCI, V65, P787, DOI 10.1017/wsc.2017.50; Spaunhorst DJ, 2014, WEED TECHNOL, V28, P131, DOI 10.1614/WT-D-13-00091.1; Starke RJ, 1998, WEED SCI, V46, P652, DOI 10.1017/S0043174500089670; Tranel P.J., 2018, MUTATIONS HERBICIDE; Tranel PJ, 2017, WEED SCI, V65, P4, DOI 10.1614/WS-D-16-00090.1; Tranel PJ, 2002, WEED SCI, V50, P700, DOI 10.1614/0043-1745(2002)050[0700:RROWTA]2.0.CO;2; Umphres AM, 2018, WEED TECHNOL, V32, P95, DOI 10.1017/wet.2017.78; Varanasi VK, 2018, WEED SCI, V66, P702, DOI 10.1017/wsc.2018.60; Vila-Aiub MM, 2009, NEW PHYTOL, V184, P751, DOI 10.1111/j.1469-8137.2009.03055.x; Webster TM, 2010, WEED SCI, V58, P73, DOI 10.1614/WS-09-058.1; Wuerffel RJ, 2015, WEED SCI, V63, P839, DOI 10.1614/WS-D-15-00037.1	46	5	5	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2019	14	3							e0214458	10.1371/journal.pone.0214458	http://dx.doi.org/10.1371/journal.pone.0214458			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ3IW	30913269	Green Published, Green Submitted, gold			2022-12-26	WOS:000462305600065
